PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Lau, S; Aziz, YFA; Ng, KH				Lau, Susie; Aziz, Yang Faridah Abdul; Ng, Kwan Hoong			Mammographic compression in Asian women	PLOS ONE			English	Article							BREAST COMPRESSION; DIGITAL MAMMOGRAPHY; FILM MAMMOGRAPHY; PAIN; CANCER; STANDARDIZATION; PRESSURE	Objectives To investigate: (1) the variability of mammographic compression parameters amongst Asian women; and (2) the effects of reducing compression force on image quality and mean glandular dose (MGD) in Asian women based on phantom study. Methods We retrospectively collected 15818 raw digital mammograms from 3772 Asian women aged 35-80 years who underwent screening or diagnostic mammography between Jan 2012 and Dec 2014 at our center. The mammograms were processed using a volumetric breast density (VBD) measurement software (Volpara) to assess compression force, compression pressure, compressed breast thickness (CBT), breast volume, VBD and MGD against breast contact area. The effects of reducing compression force on image quality and MGD were also evaluated based on measurement obtained from 105 Asian women, as well as using the RMI156 Mammographic Accreditation Phantom and polymethyl methacrylate (PMMA) slabs. Results Compression force, compression pressure, CBT, breast volume, VBD and MGD correlated significantly with breast contact area (p<0.0001). Compression parameters including compression force, compression pressure, CBT and breast contact area were widely variable between [relative standard deviation (RSD) >= 21.0%] and within (p<0.0001) Asian women. The median compression force should be about 8.1 daN compared to the current 12.0 daN. Decreasing compression force from 12.0 daN to 9.0 daN increased CBT by 3.3 +/- 1.4 mm, MGD by 6.2-11.0%, and caused no significant effects on image quality (p>0.05). Conclusions Force-standardized protocol led to widely variable compression parameters in Asian women. Based on phantom study, it is feasible to reduce compression force up to 32.5% with minimal effects on image quality and MGD.	[Lau, Susie; Aziz, Yang Faridah Abdul; Ng, Kwan Hoong] Univ Malaya, Fac Med, Dept Biomed Imaging, Kuala Lumpur, Malaysia; [Lau, Susie; Aziz, Yang Faridah Abdul; Ng, Kwan Hoong] Univ Malaya, Res Imaging Ctr, Fac Med, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Malaya	Ng, KH (corresponding author), Univ Malaya, Fac Med, Dept Biomed Imaging, Kuala Lumpur, Malaysia.; Ng, KH (corresponding author), Univ Malaya, Res Imaging Ctr, Fac Med, Kuala Lumpur, Malaysia.	ngkh@ummc.edu.my	Ng, Kwan Hoong/D-2231-2009; Aziz, Yang Faridah Abdul/C-7945-2012	Aziz, Yang Faridah Abdul/0000-0002-0869-1972	High Impact Research Grant from the Ministry of Education, Malaysia [UM.C/HIR/MOHE/06]; Postgraduate Research Grant from the University of Malaya, Malaysia [PG035-2013A]	High Impact Research Grant from the Ministry of Education, Malaysia; Postgraduate Research Grant from the University of Malaya, Malaysia	This study was supported by the High Impact Research Grant UM.C/HIR/MOHE/06 from the Ministry of Education, Malaysia (hir.um.edu.my), and the Postgraduate Research Grant PG035-2013A from the University of Malaya, Malaysia (ips.um.edu.my). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by the High Impact Research Grant UM.C/HIR/MOHE/06 from the Ministry of Education, Malaysia, and the Postgraduate Research Grant PG035-2013A from the University of Malaya, Malaysia. The authors would like to thank the radiologists and radiographers at the University of Malaya Medical Centre, Malaysia for their professional support in this study. The authors would also like to thank Dr. Ralph Highnam and Dr. Ariane Chan from Volpara Solutions Limited, New Zealand for their technical support in this study.	American College of Radiology, 2003, BREAST IM REP DAT SY; Andrews F J, 2001, Australas Radiol, V45, P113, DOI 10.1046/j.1440-1673.2001.00889.x; Branderhorst W, 2015, EUR J RADIOL, V84, P596, DOI 10.1016/j.ejrad.2014.12.012; Broeders MJM, 2015, EUR RADIOL, V25, P821, DOI 10.1007/s00330-014-3422-4; Chen BY, 2012, EUR J RADIOL, V81, P868, DOI 10.1016/j.ejrad.2011.02.027; Chida K, 2009, CLIN IMAG, V33, P7, DOI 10.1016/j.clinimag.2008.06.025; de Groot JE, 2014, MED PHYS, V41, DOI 10.1118/1.4862512; de Groot JE, 2013, MED PHYS, V40, DOI 10.1118/1.4812418; de Groot JE, 2015, BMC WOMENS HEALTH, V15, DOI 10.1186/s12905-015-0185-2; de Groot JE, 2015, EUR J RADIOL, V84, P384, DOI 10.1016/j.ejrad.2014.12.005; Dustler M, 2012, ACTA RADIOL, V53, P973, DOI 10.1258/ar.2012.120238; EKLUND GW, 1991, RADIOLOGY, V181, P339, DOI 10.1148/radiology.181.2.1924767; Elwood M, 1998, NEW ZEAL MED J, V111, P180; European Commission, 2006, EUROPEAN GUIDELINES; Hendrick RE, 2010, AM J ROENTGENOL, V194, P362, DOI 10.2214/AJR.08.2114; International Atomic Energy Agency, 2011, QUAL ASS PROGR DIG M; International Atomic Energy Agency, 2009, QUAL ASS PROGR SCR F; Kornguth PJ, 2000, J PAIN, V1, P268, DOI 10.1054/jpai.2000.7884; Mercer CE, 2013, BRIT J RADIOL, V86, DOI 10.1259/bjr.20110596; Mercer CE, 2015, RADIOGRAPHY, V21, P68, DOI 10.1016/j.radi.2014.07.004; Mercer CE, 2013, RADIOGRAPHY, V19, P200, DOI 10.1016/j.radi.2013.06.001; Ng KH, 2015, MED PHYS, V42, P7059, DOI 10.1118/1.4935141; Pisano ED, 2005, NEW ENGL J MED, V353, P1773, DOI 10.1056/NEJMoa052911; Pisano ED, 2008, RADIOLOGY, V246, P376, DOI 10.1148/radiol.2461070200; Poulos A., 2004, RADIOGRAPHY, V10, P131, DOI DOI 10.1016/J.RADI.2004.02.012; Poulos Ann, 2003, Australas Radiol, V47, P121, DOI 10.1046/j.0004-8461.2003.01139.x; Sapir R, 2003, J PAIN SYMPTOM MANAG, V25, P53, DOI 10.1016/S0885-3924(02)00598-5; Saunders RS, 2008, MED PHYS, V35, P4464, DOI 10.1118/1.2977600; SULLIVAN DC, 1991, RADIOLOGY, V181, P355, DOI 10.1148/radiology.181.2.1924771; US Food and Drug Administration, 2013, MAMMOGRAPHY QUALITY; Whelehan P, 2013, BREAST, V22, P389, DOI 10.1016/j.breast.2013.03.003; Yaffe MJ, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2102; YAFFE MJ, 1990, RADIOGRAPHICS, V10, P341, DOI 10.1148/radiographics.10.2.2183301	33	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2017	12	4							e0175781	10.1371/journal.pone.0175781	http://dx.doi.org/10.1371/journal.pone.0175781			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KH	28419125	gold, Green Submitted, Green Published			2022-12-27	WOS:000399875200046
J	Nhavoto, JA; Gronlund, A; Klein, GO				Nhavoto, Jose Antonio; Gronlund, Ake; Klein, Gunnar O.			Mobile health treatment support intervention for HIV and tuberculosis in Mozambique: Perspectives of patients and healthcare workers	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; PROVIDER RELATIONSHIP; ADHERENCE; REMINDERS; PHONES	Background Studies have been conducted in developing countries using SMS to communicate with patients to reduce the number of missed appointments and improve retention in treatment, however; very few have been scaled up. One possible reason for this could be that patients or staff are dissatisfied with the method in some way. This paper reports a study of patients' and healthcare workers' (HCW) views on an mHealth intervention aiming to support retention in antiretroviral therapy (ART) and tuberculosis (TB) treatment in Mozambique. Methods The study was conducted at five healthcare centres in Mozambique. Automated SMS health promotions and reminders were sent to patients in a RCT. A total of 141 patients and 40 HCWs were interviewed. Respondents rated usefulness, perceived benefits, ease of use, satisfaction, and risks of the SMS system using a Likert scale questionnaire. A semi-structured interview guide was followed. Interviews were transcribed and thematic analysis was conducted. Results Both patients and HCW found the SMS system useful and reliable. Most highly rated positive effects were reducing the number of failures to collect medication and avoiding missing appointments. Patients' confidence in the system was high. Most perceived the system to improve communication between health-care provider and patient and assist in education and motivation. The automatic recognition of questions from patients and the provision of appropriate answers (a unique feature of this system) was especially appreciated. A majority would recommend the system to other patients or healthcare centres. Risks also were mentioned, mostly by HCW, of unintentional disclosure of health status in cases where patients use shared phones. Conclusions The results suggest that SMS technology for HIV and TB should be used to transmit reminders for appointments, medications, motivational texts, and health education to increase retention in care. Measures must be taken to reduce risks of privacy intrusion, but these are not a main obstacle for scaling up systems of this kind.	[Nhavoto, Jose Antonio; Gronlund, Ake; Klein, Gunnar O.] Orebro Univ, Sch Business, Informat, Orebro, Sweden; [Nhavoto, Jose Antonio] Eduardo Mondlane Univ, Dept Math & Informat, Informat, Maputo, Mozambique	Orebro University; Eduardo Mondlane University	Nhavoto, JA (corresponding author), Orebro Univ, Sch Business, Informat, Orebro, Sweden.; Nhavoto, JA (corresponding author), Eduardo Mondlane Univ, Dept Math & Informat, Informat, Maputo, Mozambique.	jose.nhavoto@oru.se	alturbag, Majed/I-6243-2017	Nhavoto, Jose Antonio/0000-0001-8933-2906				Anhoj Jacob, 2004, J Med Internet Res, V6, pe42, DOI 10.2196/jmir.6.4.e42; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Brion J, 2014, J ASSOC NURSE AIDS C, V25, P123, DOI 10.1016/j.jana.2013.01.006; Crankshaw T, 2010, AIDS PATIENT CARE ST, V24, P729, DOI 10.1089/apc.2010.0146; Curioso Walter H, 2009, AMIA Annu Symp Proc, V2009, P129; Davey DJ, 2016, JAIDS-J ACQ IMM DEF, V73, pE23, DOI 10.1097/QAI.0000000000001115; DeSilva MB, 2013, AIDS RES TREAT, V2013, DOI 10.1155/2013/957862; Earth Institute, 2010, BARR GAPS AFF MHEALT, P1; Haynes RB, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000011.pub3; Heron KE, 2010, BRIT J HEALTH PSYCH, V15, P1, DOI 10.1348/135910709X466063; Hoffman JA, 2010, AM J PREV MED, V39, P78, DOI 10.1016/j.amepre.2010.02.018; Huang D, 2013, EFFECTS PHONE CALL I, V2013; Instituto Nacional de Saude (INS) Instituto Nacional de Estatistica (INE) e ICF Macro, 2010, NAT SURV PREV BEH RI; Jennings L, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1131; Johnson BT, 2010, AIDS BEHAV, V14, pS204, DOI 10.1007/s10461-010-9803-z; Lester RT, 2006, AIDS, V20, P2242, DOI 10.1097/QAD.0b013e3280108508; Lester RT, 2010, LANCET, V376, P1838, DOI 10.1016/S0140-6736(10)61997-6; Martinez M, 2006, USE CELL PHONE REMIN, V20, P1; Mbuagbaw L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046909; National AIDS Council (CNCS), 2012, GLOB AIDS RESP PROGR; Nhavoto JA, 2015, JMIR MHEALTH UHEALTH, V3, DOI 10.2196/mhealth.3854; Nhavoto JA, 2014, JMIR MHEALTH UHEALTH, V2, DOI 10.2196/mhealth.3216; Nieuwlaat R, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000011.pub4; Pop-Eleches C, 2011, AIDS, V25, P825, DOI 10.1097/QAD.0b013e32834380c1; Puccio JA, 2006, AIDS PATIENT CARE ST, V20, P438, DOI 10.1089/apc.2006.20.438; Rodrigues R, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-007574; Roter DL, 1998, MED CARE, V36, P1138, DOI 10.1097/00005650-199808000-00004; Russell J, 2004, J ASSOC NURSE AIDS C, V15, P40, DOI 10.1177/1055329004269283; Shaw RJ, 2013, JMIR MHEALTH UHEALTH, V1, DOI 10.2196/mhealth.2343; Tucker JA, 2013, AIDS PATIENT CARE ST, V27, P280, DOI 10.1089/apc.2012.0322; Van Der Kop M L, 2013, J MTM, V2; van der Kop ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046033; World Health Organization, 2015, MOZ TUB PROF; World Health Organization, 2016, UN TB HIV COINF	34	36	37	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2017	12	4							e0176051	10.1371/journal.pone.0176051	http://dx.doi.org/10.1371/journal.pone.0176051			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES9KH	28419149	gold, Green Published, Green Submitted			2022-12-27	WOS:000399875200064
J	Zeiger, K; Popp, J; Becker, A; Hankel, J; Visscher, C; Klein, G; Meemken, D				Zeiger, Katrin; Popp, Johanna; Becker, Andre; Hankel, Julia; Visscher, Christian; Klein, Guenter; Meemken, Diana			Lauric acid as feed additive - An approach to reducing Campylobacter spp. in broiler meat	PLOS ONE			English	Article							JEJUNI COLONIZATION; ORGANIC-ACIDS; FATTY-ACIDS; CLOSTRIDIUM-PERFRINGENS; CROSS-CONTAMINATION; DRINKING-WATER; QUALITY; SUSCEPTIBILITY; CHICKENS; SURVIVAL	The increasing prevalence of Campylobacter spp. within broiler populations is a major problem for food safety and consumer protection worldwide. In vitro studies could already demonstrate that Campylobacter spp. are susceptible to lauric acid. The purpose of this study was to examine in vivo the influence of lauric acid as a feed additive on slaughter parameters, muscle fatty acid profile, meat quality traits and the reduction of Campylobacter coli in inoculated meat of Ross 308 (R308) and Hubbard JA 757 (HJA) broilers in three independent trials (n = 3). Although slaughter parameters did not show any significant differences, the fatty acid profile of both breeds revealed significantly higher lauric acid concentrations (P < 0.0001) in the Musculus pectoralis superficialis of treated broilers. Comparing both tested breeds, R308 test broilers had significantly higher lauric acid concentrations than HJA test broilers (P < 0.0001), indicating a higher conversion rate in those animals. The meat quality traits showed no differences in the R308 breed (P > 0.05), but HJA test broilers had higher values for drip loss, electrical conductivity, CIE color values L* and b*, and lower pH values. The inoculation trials of R308 showed that initial bacterial loads of 5.9 log10 cfu/g were reduced during six days of storage (4 degrees C) to approximately 4.3 log10 cfu/g in the control groups compared to 3.5 log10 cfu/g in the treatment groups (P = 0.0295), which could be due to antimicrobial effects of lauric acid within the muscle. This study therefore suggests that lauric acid as a feed additive has the potential to improve food safety by reducing the numbers of Campylobacter coli in broiler meat. However, this effect seems to be dependent on the breed determining the feed intake capacity, the fat deposition and therefore the ability to incorporate lauric acid in the muscle.	[Zeiger, Katrin; Popp, Johanna; Becker, Andre; Klein, Guenter; Meemken, Diana] Univ Vet Med Hannover, Inst Food Qual & Food Safety, Bischofsholer Damm 15, Hannover, Germany; [Hankel, Julia; Visscher, Christian] Univ Vet Med Hannover, Inst Anim Nutr, Bischofsholer Damm 15, Hannover, Germany; [Meemken, Diana] Univ Halle Wittenberg, Inst Agr & Nutrit Sci, Theodor Lieser Str 11, Halle, Germany	University of Veterinary Medicine Hannover, Foundation; University of Veterinary Medicine Hannover, Foundation; Martin Luther University Halle Wittenberg	Popp, J (corresponding author), Univ Vet Med Hannover, Inst Food Qual & Food Safety, Bischofsholer Damm 15, Hannover, Germany.	johanna.popp@tiho-hannover.de		Hankel, Julia/0000-0002-4347-3161				ACAR N, 1991, POULTRY SCI, V70, P2315, DOI 10.3382/ps.0702315; Allen VM, 2007, INT J FOOD MICROBIOL, V113, P54, DOI 10.1016/j.ijfoodmicro.2006.07.011; Byrne CE, 2000, MEAT SCI, V54, P23, DOI 10.1016/S0309-1740(99)00055-8; Chan KF, 2001, APPL ENVIRON MICROB, V67, P4186, DOI 10.1128/AEM.67.9.4186-4191.2001; de los Santos FS, 2008, POULTRY SCI, V87, P800, DOI 10.3382/ps.2007-00280; de los Santos FS, 2009, POULTRY SCI, V88, P61, DOI 10.3382/ps.2008-00228; EFSA, 2015, EUR UN SUMM REP TREN; Ellerbroek LI, 2010, ZOONOSES PUBLIC HLTH, V57, pE81, DOI 10.1111/j.1863-2378.2009.01267.x; England EM, 2013, MEAT SCI, V95, P837, DOI 10.1016/j.meatsci.2013.04.031; Ferguson DM, 2014, ANIM PROD SCI, V54, P464, DOI 10.1071/AN13088; Hermans D, 2012, POULTRY SCI, V91, P1733, DOI 10.3382/ps.2011-02106; Hilmarsson H, 2006, POULTRY SCI, V85, P588, DOI 10.1093/ps/85.4.588; Jansen W, 2014, J APPL MICROBIOL, V116, P1676, DOI 10.1111/jam.12490; Klein G, 2015, BERL MUNCH TIERARZTL, V128, P132, DOI 10.2376/0005-9366-128-132; Lee S, 2000, MEAT SCI, V55, P385, DOI 10.1016/S0309-1740(99)00166-7; Lehner Y, 2014, CURR MICROBIOL, V69, P240, DOI 10.1007/s00284-014-0575-y; LEPAGE G, 1986, J LIPID RES, V27, P114; Lindqvist R, 2008, INT J FOOD MICROBIOL, V121, P41, DOI 10.1016/j.ijfoodmicro.2007.10.008; Marotta F, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/859845; Mehaffey JM, 2006, POULTRY SCI, V85, P902, DOI 10.1093/ps/85.5.902; Molatova Z, 2010, FOLIA MICROBIOL, V55, P215, DOI 10.1007/s12223-010-0031-8; Otto G, 2004, MEAT SCI, V68, P401, DOI 10.1016/j.meatsci.2004.04.007; Oyarzabal OA, 2010, J FOOD PROTECT, V73, P1438, DOI 10.4315/0362-028X-73.8.1438; Pradhan AK, 2012, POULTRY SCI, V91, P1482, DOI 10.3382/ps.2011-01851; Rosenquist H, 2006, INT J FOOD MICROBIOL, V108, P226, DOI 10.1016/j.ijfoodmicro.2005.12.007; ROTH FX, 1993, ARCH GEFLUGELKD, V57, P256; Sanchez MX, 2002, J FOOD PROTECT, V65, P948, DOI 10.4315/0362-028X-65.6.948; Seedat J., 2016, AKTUELLE STAT MELDEP; Skrivanova E, 2006, VET MED-CZECH, V51, P81, DOI 10.17221/5524-VETMED; Skrivanova E, 2005, LETT APPL MICROBIOL, V41, P77, DOI 10.1111/j.1472-765X.2005.01709.x; van der Hoeven-Hangoor E, 2013, POULTRY SCI, V92, P2713, DOI 10.3382/ps.2013-03017; Zeitz JO, 2015, POULTRY SCI, V94, P2404, DOI 10.3382/ps/pev191	32	27	29	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2017	12	4							e0175693	10.1371/journal.pone.0175693	http://dx.doi.org/10.1371/journal.pone.0175693			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KH	28419122	Green Published, gold, Green Submitted			2022-12-27	WOS:000399875200034
J	Arruda, AG; Vilalta, C; Perez, A; Morrison, R				Arruda, Andreia Goncalves; Vilalta, Carles; Perez, Andres; Morrison, Robert			Land altitude, slope, and coverage as risk factors for Porcine Reproductive and Respiratory Syndrome (PRRS) outbreaks in the United States	PLOS ONE			English	Article							SYNDROME VIRUS-INFECTION; DISTANCE AIRBORNE TRANSPORT; MYCOPLASMA-HYOPNEUMONIAE; VEGETATIVE BUFFERS; FOLIAR NITROGEN; POULTRY FARMS; FAN EMISSIONS; DISEASE; AMMONIA; HERDS	Porcine reproductive and respiratory syndrome (PRRS) is, arguably, the most impactful disease on the North American swine industry. The Swine Health Monitoring Project (SHMP) is a national volunteer initiative aimed at monitoring incidence and, ultimately, supporting swine disease control, including PRRS. Data collected through the SHMP currently represents approximately 42% of the sow population of the United States. The objective of the study here was to investigate the association between geographical factors (including land elevation, and land coverage) and PRRS incidence as recorded in the SHMP. Weekly PRRS status data from sites participating in the SHMP from 2009 to 2016 (n = 706) was assessed. Number of PRRS outbreaks, years of participation in the SHMP, and site location were collected from the SHMP database. Environmental features hypothesized to influence PRRS risk included land coverage (cultivated areas, shrubs and trees), land altitude (in meters above sea level) and land slope (in degrees compared to surrounding areas). Other risk factors considered included region, production system to which the site belonged, herd size, and swine density in the area in which the site was located. Land-related variables and pig density were captured in raster format from a number of sources and extracted to points (farm locations). A mixed-effects Poisson regression model was built; and dependence among sites that belonged to a given production system was accounted for using a random effect at the system level. The annual mean and median number of outbreaks per farm was 1.38 (SD: 1.6), and 1 (IQR: 2.0), respectively. The maximum annual number of outbreaks per farm was 9, and approximately 40% of the farms did not report any outbreak. Results from the final multivariable model suggested that increments of swine density and herd size increased the risk for PRRS outbreaks (P < 0.01). Even though altitude (meters above sea level) was not significant in the final model, farms located in terrains with a slope of 9% or higher had lower rates of PRRS outbreaks compared to farms located in terrains with slopes lower than 2% (P < 0.01). Finally, being located in an area of shrubs/herbaceous cover and trees lowered the incidence rate of PRRS outbreaks compared to being located in cultivated/ managed areas (P < 0.05). In conclusion, highly inclined terrains were associated with fewer PRRS outbreaks in US sow farms, as was the presence of shrubs and trees when compared to cultivated/managed areas. Influence of terrain characteristics on spread of airborne diseases, such as PRRS, may help to predicting disease risk, and effective planning of measures intended to mitigate and prevent risk of infection.	[Arruda, Andreia Goncalves; Vilalta, Carles; Perez, Andres; Morrison, Robert] Univ Minnesota, Coll Vet Med, Dept Vet Populat Med, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities	Arruda, AG (corresponding author), Univ Minnesota, Coll Vet Med, Dept Vet Populat Med, St Paul, MN 55108 USA.	arrud002@umn.edu	Perez, Andres/HGD-8377-2022	Vilalta, Carles/0000-0002-9220-8620; Arruda, Andreia/0000-0001-7040-9686	Swine Health Monitoring Project; Swine Health Information Center; National Pork Board; MnDrive program	Swine Health Monitoring Project; Swine Health Information Center; National Pork Board; MnDrive program	Funding for the Swine Health Monitoring Project and this study was provided by the Swine Health Information Center, the National Pork Board, and the MnDrive program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrizal A, 2008, J ENVIRON SCI HEAL B, V43, P96, DOI 10.1080/03601230701735078; Alvarez J, 2016, PORCINE HEALTH MANAG, V2, DOI 10.1186/s40813-016-0019-0; Anderson N, 2003, ENVIRON INT, V29, P277, DOI 10.1016/S0160-4120(02)00186-1; [Anonymous], [No title captured]; Arruda AG, 2016, PREV VET MED, V128, P41, DOI 10.1016/j.prevetmed.2016.03.010; Betlach C, 2016, NATL HOG FARMER; Cutler TD, 2012, VET MICROBIOL, V159, P47, DOI 10.1016/j.vetmic.2012.03.044; Dee SA, 2004, CAN J VET RES, V68, P128; Dee S, 2009, VET RES, V40, DOI 10.1051/vetres/2009022; Dohoo I., 2009, VET EPIDEMIOLOGIC RE; European Commission, 2003, GLOB LAND COV 2000 D; Fernstrom A, 2013, J PATHOG, V2013, DOI [10.1155/013/493960, 10.1155/2013/493960]; Firkins LD, 2004, J SWINE HEALTH PROD, V12, P23; Gloster J, 2007, VET J, V174, P42, DOI 10.1016/j.tvjl.2006.05.020; Gloster J, 2010, VET J, V183, P278, DOI 10.1016/j.tvjl.2008.11.011; Holtkamp DJ, 2013, J SWINE HEALTH PROD, V21, P72; Janhall S, 2015, ATMOS ENVIRON, V105, P130, DOI 10.1016/j.atmosenv.2015.01.052; Lambert ME, 2012, PREV VET MED, V104, P84, DOI 10.1016/j.prevetmed.2011.11.002; Lambin EF, 2010, INT J HEALTH GEOGR, V9, DOI 10.1186/1476-072X-9-54; Otake S, 2010, VET MICROBIOL, V145, P198, DOI 10.1016/j.vetmic.2010.03.028; Patterson PH, 2008, J ENVIRON SCI HEAL B, V43, P199, DOI 10.1080/03601230801890179; Perez AM, 2015, JAVMA-J AM VET MED A, V246, P1304, DOI 10.2460/javma.246.12.1304; Pfeiffer DU, 2008, Spatial Analysis in Epidemiology, P1; Tousignant SJP, 2015, CAN VET J, V56, P1087; Tousignant SJP, 2015, AM J VET RES, V76, P70, DOI 10.2460/ajvr.76.1.70; United States Department of Agriculture, Q HOGS PIGS; USGS, 2002, GTOPO30 GLOB 30 ARC; Vanwambeke SO, 2011, TROP MED INT HEALTH, V16, P174, DOI 10.1111/j.1365-3156.2010.02671.x; Velasova M, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-184; Wills RW, 1997, VET MICROBIOL, V55, P231, DOI 10.1016/S0378-1135(96)01337-5	30	19	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2017	12	4							e0172638	10.1371/journal.pone.0172638	http://dx.doi.org/10.1371/journal.pone.0172638			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KD	28414720	gold, Green Published, Green Submitted			2022-12-27	WOS:000399874800001
J	Jankowiak, K; Rataj, K; Naskrecki, R				Jankowiak, Katarzyna; Rataj, Karolina; Naskrecki, Ryszard			To electrify bilingualism: Electrophysiological insights into bilingual metaphor comprehension	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; TIME-COURSE; WORD RECOGNITION; WORKING-MEMORY; ERP EVIDENCE; LANGUAGE; 2ND-LANGUAGE; FREQUENCY; PROFICIENCY; ACTIVATION	Though metaphoric language comprehension has previously been investigated with event-related potentials, little attention has been devoted to extending this research from the monolingual to the bilingual context. In the current study, late proficient unbalanced Polish (L1)-English (L2) bilinguals performed a semantic decision task to novel metaphoric, conventional metaphoric, literal, and anomalous word pairs presented in L1 and L2. The results showed more pronounced P200 amplitudes to L2 than L1, which can be accounted for by differences in the subjective frequency of the native and non-native lexical items. Within the early N400 time window (300-400 ms), L2 word dyads evoked delayed and attenuated amplitudes relative to L1 word pairs, possibly indicating extended lexical search during foreign language processing, and weaker semantic interconnectivity for L2 compared to L1 words within the memory system. The effect of utterance type was observed within the late N400 time window (400-500 ms), with smallest amplitudes evoked by literal, followed by conventional metaphoric, novel metaphoric, and anomalous word dyads. Such findings are interpreted as reflecting more resource intensive cognitive mechanisms governing novel compared to conventional metaphor comprehension in both the native and non-native language. Within the late positivity time window (500-800 ms), Polish novel metaphors evoked reduced amplitudes relative to literal utterances. In English, on the other hand, this effect was observed for both novel and conventional metaphoric word dyads. This finding might indicate continued effort in information retrieval or access to the non-literal route during novel metaphor comprehension in L1, and during novel and conventional metaphor comprehension in L2. Altogether, the present results point to decreased automaticity of cognitive mechanisms engaged in non-native and non-dominant language processing, and suggest a decreased sensitivity to the levels of conventionality of metaphoric meanings in late proficient unbalanced bilingual speakers.	[Jankowiak, Katarzyna; Rataj, Karolina] Adam Mickiewicz Univ, Fac English, Poznan, Poland; [Naskrecki, Ryszard] Adam Mickiewicz Univ, NanoBioMed Ctr, Poznan, Poland; [Naskrecki, Ryszard] Adam Mickiewicz Univ, Fac Phys, Lab Visi Sci & Optometry, Poznan, Poland	Adam Mickiewicz University; Adam Mickiewicz University; Adam Mickiewicz University	Jankowiak, K (corresponding author), Adam Mickiewicz Univ, Fac English, Poznan, Poland.	kjankowiak@wa.amu.edu.pl	Naskrecki, Ryszard/AAB-1865-2020; Jankowiak, Katarzyna/G-7983-2017; Rataj, Karolina/AAF-6861-2021	Naskrecki, Ryszard/0000-0002-7925-047X; Jankowiak, Katarzyna/0000-0003-1200-9347; Rataj, Karolina/0000-0002-6845-5293				Anderson JR, 1996, COGNITIVE PSYCHOL, V30, P221, DOI 10.1006/cogp.1996.0007; Arzouan Y, 2007, BRAIN RES, V1160, P69, DOI 10.1016/j.brainres.2007.05.034; Assadollahi R, 2001, NEUROREPORT, V12, P207, DOI 10.1097/00001756-200102120-00007; Barber H, 2004, NEUROREPORT, V15, P545, DOI 10.1097/00001756-200403010-00032; BENTIN S, 1985, ELECTROEN CLIN NEURO, V60, P343, DOI 10.1016/0013-4694(85)90008-2; BLASKO DG, 1993, J EXP PSYCHOL LEARN, V19, P295, DOI 10.1037/0278-7393.19.2.295; Bowdle BF, 2005, PSYCHOL REV, V112, P193, DOI 10.1037/0033-295X.112.1.193; Braunstein V, 2012, ACTA NEUROBIOL EXP, V72, P421; Bromberek-Dyzman K., 2016, PSYCHOL LANGUAGE COM, V20, P336, DOI [10.1515/plc-2016-0020, DOI 10.1515/PLC-2016-0020]; Brouwer H, 2012, BRAIN RES, V1446, P127, DOI 10.1016/j.brainres.2012.01.055; Camp E, 2006, PHILOS COMPASS, V1, P154, DOI 10.1111/j.1747-9991.2006.00013.x; Cieslicka A, 2010, COGNITIVE PROCESSING, P149; Coulson S, 2001, NEUROSCI LETT, V316, P71, DOI 10.1016/S0304-3940(01)02387-4; Coulson S, 2002, MEM COGNITION, V30, P958, DOI 10.3758/BF03195780; Coulson S, 2007, BRAIN RES, V1146, P128, DOI 10.1016/j.brainres.2007.03.008; Dambacher M, 2006, BRAIN RES, V1084, P89, DOI 10.1016/j.brainres.2006.02.010; De Grauwe S, 2010, NEUROPSYCHOLOGIA, V48, P1965, DOI 10.1016/j.neuropsychologia.2010.03.017; Dijkstra T, 2002, BILINGUALISM LANGUAG, V5; Federmeier KD, 2005, MEM COGNITION, V33, P871, DOI 10.3758/BF03193082; Federmeier KD, 2002, NEUROPSYCHOLOGIA, V40, P730, DOI 10.1016/S0028-3932(01)00193-2; Freunberger R, 2007, NEUROSCI LETT, V426, P181, DOI 10.1016/j.neulet.2007.08.062; FRIEDERICI AD, 1995, BRAIN LANG, V50, P259, DOI 10.1006/brln.1995.1048; Friedman D, 2000, MICROSC RES TECHNIQ, V51, P6, DOI 10.1002/1097-0029(20001001)51:1<6::AID-JEMT2>3.0.CO;2-R; Gentner D, 2001, ANALOGICAL MIND, P199; Gentner D., 2001, METAPHOR SYMBOL, DOI [DOI 10.1080/10926488.2001.9678896, 10.1080/10926488.2001.9678896]; GERRIG RJ, 1983, J EXP PSYCHOL LEARN, V9, P667, DOI 10.1037/0278-7393.9.4.667; Giora R, 2002, J PRAGMATICS, V34, P487, DOI 10.1016/S0378-2166(01)00045-5; GLUCKSBERG S, 1982, J VERB LEARN VERB BE, V21, P85, DOI 10.1016/S0022-5371(82)90467-4; Glucksberg S, 2003, TRENDS COGN SCI, V7, P92, DOI 10.1016/S1364-6613(02)00040-2; Goldstein A, 2012, BRAIN LANG, V123, P137, DOI 10.1016/j.bandl.2012.09.008; Gunter TC, 2000, J COGNITIVE NEUROSCI, V12, P556, DOI 10.1162/089892900562336; HAGOORT P, 1993, LANG COGNITIVE PROC, V8, P439, DOI 10.1080/01690969308407585; Hauk O, 2004, CLIN NEUROPHYSIOL, V115, P1090, DOI 10.1016/j.clinph.2003.12.020; Heidlmayr K, 2015, FRONT PSYCHOL, V6, P17; Jiang XM, 2009, NEUROPSYCHOLOGIA, V47, P1799, DOI 10.1016/j.neuropsychologia.2009.02.020; KEYSAR B, 1989, J MEM LANG, V28, P375, DOI 10.1016/0749-596X(89)90017-X; Kotz S.A., 2012, HDB NEUROPSYCHOLOGY, P760; Kutas M, 2000, TRENDS COGN SCI, V4, P463, DOI 10.1016/S1364-6613(00)01560-6; KUTAS M, 1980, BIOL PSYCHOL, V11, P99, DOI 10.1016/0301-0511(80)90046-0; Kutas M., 2006, HDB PSYCHOLINGUISTIC, P659, DOI [10.1016/B978-012369374-7/50018-3, DOI 10.1016/B978-012369374-7/50018-3]; Kutas M, 2011, ANNU REV PSYCHOL, V62, P621, DOI 10.1146/annurev.psych.093008.131123; Lai VT, 2013, BRAIN LANG, V127, P484, DOI 10.1016/j.bandl.2013.09.010; Lai VT, 2009, BRAIN RES, V1284, P145, DOI 10.1016/j.brainres.2009.05.088; Littlemore J, 2006, APPL LINGUIST, V27, P268, DOI 10.1093/applin/aml004; LUCK SJ, 1994, PSYCHOPHYSIOLOGY, V31, P291, DOI 10.1111/j.1469-8986.1994.tb02218.x; MATLOCK T., 2002, BILINGUAL SENTENCE P, P251, DOI DOI 10.1016/S0166-4115(02)80014-0; McElree B, 1999, PSYCHON B REV, V6, P486, DOI 10.3758/BF03210839; Midgley KJ, 2009, J NEUROLINGUIST, V22, P281, DOI 10.1016/j.jneuroling.2008.08.001; Moreno EM, 2005, COGNITIVE BRAIN RES, V22, P205, DOI 10.1016/j.cogbrainres.2004.08.010; Moreno EM, 2008, J NEUROLINGUIST, V21, P477, DOI 10.1016/j.jneuroling.2008.01.003; Newman AJ, 2012, J COGNITIVE NEUROSCI, V24, P1205, DOI 10.1162/jocn_a_00143; Oberauer K, 2001, MEM COGNITION, V29, P18, DOI 10.3758/BF03195737; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Osterhout L, 1999, LANG COGNITIVE PROC, V14, P283, DOI 10.1080/016909699386310; Phillips NA, 2004, J NEUROLINGUIST, V17, P237, DOI 10.1016/S0911-6044(03)00055-1; Proverbio AM, 2002, J COGNITIVE NEUROSCI, V14, P994, DOI 10.1162/089892902320474463; Pynte J, 1996, BRAIN LANG, V55, P293, DOI 10.1006/brln.1996.0107; Rataj K, 2014, POZ STUD CONTEMP LIN, V50, P55, DOI 10.1515/psicl-2014-0004; Regel S, 2011, J COGNITIVE NEUROSCI, V23, P277, DOI 10.1162/jocn.2010.21411; RUCHKIN DS, 1988, PSYCHOPHYSIOLOGY, V25, P339, DOI 10.1111/j.1469-8986.1988.tb01253.x; RUGG MD, 1987, MEM COGNITION, V15, P473, DOI 10.3758/BF03198381; Rutter B, 2012, BRAIN COGNITION, V80, P301, DOI 10.1016/j.bandc.2012.08.003; Sereno SC, 1998, NEUROREPORT, V9, P2195, DOI 10.1097/00001756-199807130-00009; Spotorno N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066839; Swaab T. Y., 2012, OXFORD HDB EVENT REL, P397, DOI DOI 10.1093/OXFORDHB/9780195374148.013.0197; Tartter VC, 2002, BRAIN LANG, V80, P488, DOI 10.1006/brln.2001.2610; van Berkum JJA, 1999, J MEM LANG, V41, P147, DOI 10.1006/jmla.1999.2641; van Herten M, 2005, COGNITIVE BRAIN RES, V22, P241, DOI 10.1016/j.cogbrainres.2004.09.002; van Heuven WJB, 2010, BRAIN RES REV, V64, P104, DOI 10.1016/j.brainresrev.2010.03.002; VanRullen R, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00365; WeberFox CM, 1996, J COGNITIVE NEUROSCI, V8, P231, DOI 10.1162/jocn.1996.8.3.231; Wlotko EW, 2007, NEUROPSYCHOLOGIA, V45, P3001, DOI 10.1016/j.neuropsychologia.2007.05.013	72	22	22	4	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2017	12	4							e0175578	10.1371/journal.pone.0175578	http://dx.doi.org/10.1371/journal.pone.0175578			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	ES9KD	28414742	Green Submitted, Green Published, gold			2022-12-27	WOS:000399874800037
J	Fausto, AKS; Silva, TD; Romanel, E; Vaslin, MFS				Silva Fausto, Anna Karoline; Silva, Tatiane da Franca; Romanel, Elisson; Vaslin, Maite F. S.			microRNAs as reference genes for quantitative PCR in cotton	PLOS ONE			English	Article							REAL-TIME PCR; POLYMERASE-CHAIN-REACTION; GOSSYPIUM-HIRSUTUM L.; RELIABLE REFERENCE GENES; SUITABLE REFERENCE GENES; INTERNAL CONTROL GENES; RT-PCR; EXPRESSION ANALYSIS; HOUSEKEEPING GENES; ABIOTIC STRESS	Cotton (Gossypium hirsutum) is the most important non-food plant in the world. Studies concerning the fiber quality and plant fitness of cotton at molecular level depend on high sensitive and reproducible gene-expression assays. However, only a few reports have described genes suitable for normalizing gene expression data. In this study, we report for the first time that microRNAs (miRNAs) are reliable reference genes (RGs) for cotton gene expression normalization in quantitative real-time reverse transcription (RT)-PCR. The stability of cotton miRNAs was assayed in root, stem, leaf and flower samples from three different cultivars [FiberMax (FM966), Delta Opal (DO) and Cedro] and under conditions of biotic stress caused by infection with Cotton leafroll dwarf virus (CLRDV). The stability of mRNAs already described as reference genes in cotton was also assessed. The geNorm, NormFinder, BestKeeper and Delta Ct algorithms were used to select the best reference genes. In 8 of the 12 sets tested, miRNAs (miR172, 168 and 390) were found to be the best RGs. To validate the best selected RGs, miR159, miR164, miR2118, miR2910, miR3476, GhDCL2 and GhDCL4 expression levels were evaluated under biotic stress conditions, and miR164 and a putative myo-inositol oxigenase gene (GhMIOX) were assessed in leaves and flowers. The RGs selected in this work proved to be excellent reference genes in the two cases studied. Our results support the use of miRNAs as reference genes for miRNA and protein-coding genes.	[Silva Fausto, Anna Karoline; Silva, Tatiane da Franca; Romanel, Elisson; Vaslin, Maite F. S.] Univ Fed Rio de Janeiro, IMPPG, Lab Virol Mol Vegetal, Dept Virol, Rio De Janeiro, RJ, Brazil; [Silva, Tatiane da Franca; Romanel, Elisson] Univ Sao Paulo, Escola Engn Lorena, Dept Biotecnol, Lorena, SP, Brazil	Universidade Federal do Rio de Janeiro; Universidade de Sao Paulo	Vaslin, MFS (corresponding author), Univ Fed Rio de Janeiro, IMPPG, Lab Virol Mol Vegetal, Dept Virol, Rio De Janeiro, RJ, Brazil.	maite@micro.ufrj.br	Romanel, Elisson AC/F-1933-2013; Silva, Tatiane Franca/L-6767-2014; Vaslin, Maite F/G-5074-2011; Romanel, Elisson AC/E-5888-2019; Karol, Anna/N-1992-2019	Romanel, Elisson AC/0000-0002-4794-4215; Silva, Tatiane Franca/0000-0002-2829-6099; Vaslin, Maite F/0000-0002-7252-7050; Romanel, Elisson AC/0000-0002-4794-4215; 	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [308797/2013-2]; fora postdoctoral fellowship; Fundagao Carlos Chagas de Amparo a Pesquisa do Estado do Rio de Janeiro [APQ1 E-26/110.348/2012, Sediadas E-26/010.002906/2014]; Coordenagao de Aperfeicoamento de Pessoal de Nivel Superior; CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico) [308797/2013-2]; Universal [484335/2013-8]; FAPERJ (Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro) [APQ1 E-26/110.348/2012, Sediadas E-26/010.002906/2014]; CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); fora postdoctoral fellowship; Fundagao Carlos Chagas de Amparo a Pesquisa do Estado do Rio de Janeiro; Coordenagao de Aperfeicoamento de Pessoal de Nivel Superior; CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Universal; FAPERJ (Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, grants 308797/2013-2 for MFSV, and Universal 484335/2013-8 for research financial support for MFSV and fora postdoctoral fellowship to ER. Fundagao Carlos Chagas de Amparo a Pesquisa do Estado do Rio de Janeiro for reagents financial support to MFSV grants APQ1 E-26/110.348/2012 and Sediadas E-26/010.002906/2014, and Coordenagao de Aperfeicoamento de Pessoal de Nivel Superior for the studentship to AKSF and TS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the Brazilian sponsoring agency CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, for grant 308797/2013-2 and Universal 484335/2013-8 for financial support for MFSV and for a postdoctoral fellowship to ER, FAPERJ (Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro) for financial support to MFSV through APQ1 E-26/110.348/2012 and Sediadas E-26/010.002906/2014, and CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior) for the studentship to AKSF and TS.	Amin I, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-143; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Artico S, 2014, PLANT MOL BIOL REP, V32, P630, DOI 10.1007/s11105-013-0674-0; Artico S, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-49; Balaji B, 2003, PHYTOPATHOLOGY, V93, P1386, DOI 10.1094/PHYTO.2003.93.11.1386; Barsalobres-Cavallari CF, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-1; Bazzini AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028466; Borowski JM, 2014, PLANTA, V239, P1187, DOI 10.1007/s00425-014-2041-2; Brunner Amy M., 2004, BMC Plant Biology, V4, P14, DOI 10.1186/1471-2229-4-14; Bustin SA, 2005, J MOL ENDOCRINOL, V34, P597, DOI 10.1677/jme.1.01755; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen D, 2011, JOURNAL CEL PHYSIOL, V226, P1; Chen XM, 2004, SCIENCE, V303, P2022, DOI 10.1126/science.1088060; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; D'haene Barbara, 2012, Methods Mol Biol, V822, P261, DOI 10.1007/978-1-61779-427-8_18; Davoren PA, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-76; Dheda K, 2004, BIOTECHNIQUES, V37, P112, DOI 10.2144/04371RR03; Die JV, 2010, PLANTA, V232, P145, DOI 10.1007/s00425-010-1158-1; Feng H, 2012, PLANT PHYSIOL BIOCH, V51, P116, DOI 10.1016/j.plaphy.2011.10.010; Ferdous J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118503; Silva GFFE, 2014, PLANT J, V78, P604, DOI 10.1111/tpj.12493; Gachon C, 2004, J EXP BOT, V55, P1445, DOI 10.1093/jxb/erh181; Gao S, 2016, SCI REP-UK, V6, DOI 10.1038/srep19736; Gou JY, 2011, PLANT CELL, V23, P1512, DOI 10.1105/tpc.111.084525; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Hinchliffe DJ, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-445; Hoerndli FJ, 2004, ANAL BIOCHEM, V335, P30, DOI 10.1016/j.ab.2004.08.028; Hruz T, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-156; Hsu SH, 2016, HEPATOLOGY, V64, P599, DOI 10.1002/hep.28573; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Huggett JF, 2013, CLIN CHEM, V59, P892, DOI 10.1373/clinchem.2013.206375; Klie Maik, 2011, BMC Res Notes, V4, P518, DOI 10.1186/1756-0500-4-518; Kos A, 2016, CELL MOL LIFE SCI, V73, P3555, DOI 10.1007/s00018-016-2179-0; Kou SJ, 2012, PLANT CELL REP, V31, P2151, DOI 10.1007/s00299-012-1325-x; Kulcheski FR, 2010, ANAL BIOCHEM, V406, P185, DOI 10.1016/j.ab.2010.07.020; Lao KQ, 2006, BIOCHEM BIOPH RES CO, V343, P85, DOI 10.1016/j.bbrc.2006.02.106; Lauter N, 2005, P NATL ACAD SCI USA, V102, P9412, DOI 10.1073/pnas.0503927102; Li FG, 2015, NAT BIOTECHNOL, V33, P524, DOI 10.1038/nbt.3208; Li FG, 2014, NAT GENET, V46, P567, DOI 10.1038/ng.2987; Li XB, 2005, PLANT CELL, V17, P859, DOI 10.1105/tpc.104.029629; Lin YL, 2013, PLANT PHYSIOL BIOCH, V66, P20, DOI 10.1016/j.plaphy.2013.02.002; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Machado RD, 2015, PLANT CELL REP, V34, P1139, DOI 10.1007/s00299-015-1773-1; Maroniche GA, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-308; Maroufi A, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-15; Moreno I, 2011, J VIROL METHODS, V177, P49, DOI 10.1016/j.jviromet.2011.06.013; Nicot N, 2005, J EXP BOT, V56, P2907, DOI 10.1093/jxb/eri285; Pang MX, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r122; Paolacci AR, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-11; Paterson AH, 2012, NATURE, V492, P423, DOI 10.1038/nature11798; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Remans T, 2008, PLANTA, V227, P1343, DOI 10.1007/s00425-008-0706-4; Romanel E, 2012, PLANT MOL BIOL, V80, P443, DOI 10.1007/s11103-012-9959-1; Schmid H, 2003, KIDNEY INT, V64, P356, DOI 10.1046/j.1523-1755.2003.00074.x; Schmidt GW, 2010, MOL GENET GENOMICS, V283, P233, DOI 10.1007/s00438-010-0511-1; Silva TF, 2011, BMC MOL BIOL, V12, DOI 10.1186/1471-2199-12-40; Silver N, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-33; Sun GL, 2012, PLANT MOL BIOL, V80, P17, DOI 10.1007/s11103-011-9817-6; Sun RR, 2015, BIOTECHNOL LETT, V37, P1483, DOI 10.1007/s10529-015-1810-8; Suzuki T, 2000, BIOTECHNIQUES, V29, P332, DOI 10.2144/00292rv02; Thellin O, 2009, BIOTECHNOL ADV, V27, P323, DOI 10.1016/j.biotechadv.2009.01.010; Thiebaut F, 2012, PLANT CELL ENVIRON, V35, P502, DOI 10.1111/j.1365-3040.2011.02430.x; Tu LL, 2007, CHINESE SCI BULL, V52, P3110, DOI 10.1007/s11434-007-0461-0; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wan HJ, 2011, BIOCHEM BIOPH RES CO, V416, P24, DOI 10.1016/j.bbrc.2011.10.105; Wang M, 2013, GENE, V530, P44, DOI 10.1016/j.gene.2013.07.084; Waxman S, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-243; Yin ZJ, 2012, MOL BIOL REP, V39, P4961, DOI 10.1007/s11033-011-1292-2; Zhang BH, 2007, GENE, V397, P26, DOI 10.1016/j.gene.2007.03.020; Zhang BH, 2009, MOL BIOTECHNOL, V42, P269, DOI 10.1007/s12033-009-9163-y; Zhang YJ, 2015, INT J MOL SCI, V16, P14749, DOI 10.3390/ijms160714749; Zhang ZH, 2010, NUCLEIC ACIDS RES, V38, pD806, DOI 10.1093/nar/gkp818; Zhao S, 2005, J COMPUT BIOL, V12, P1047, DOI 10.1089/cmb.2005.12.1047	73	14	15	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2017	12	4							e0174722	10.1371/journal.pone.0174722	http://dx.doi.org/10.1371/journal.pone.0174722			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KD	28414734	Green Submitted, Green Published, gold			2022-12-27	WOS:000399874800006
J	Williams, M; Bozhilov, K; Ghai, S; Talbot, P				Williams, Monique; Bozhilov, Krassimir; Ghai, Sanjay; Talbot, Prue			Elements including metals in the atomizer and aerosol of disposable electronic cigarettes and electronic hookahs	PLOS ONE			English	Article							TRACE-ELEMENTS; IN-VITRO; MAINSTREAM; TOBACCO; COPPER	Objective Our purpose was to quantify 36 inorganic chemical elements in aerosols from disposable electronic cigarettes (ECs) and electronic hookahs (EHs), examine the effect of puffing topography on elements in aerosols, and identify the source of the elements. Methods Thirty-six inorganic chemical elements and their concentrations in EC/EH aerosols were determined using inductively coupled plasma optical emission spectroscopy, and their source was identified by analyzing disassembled atomizers using scanning electron microscopy and energy dispersive X-ray spectroscopy. Results Of 36 elements screened, 35 were detected in EC/EH aerosols, while only 15 were detected in conventional tobacco smoke. Some elements/metals were present in significantly higher concentrations in EC/EH aerosol than in cigarette smoke. Concentrations of particular elements/metals within EC/EH brands were sometimes variable. Aerosols generated at low and high air-flow rates produced the same pattern of elements, although the total element concentration decreased at the higher air flow rate. The relative amount of elements in the first and last 60 puffs was generally different. Silicon was the dominant element in aerosols from all EC/EH brands and in cigarette smoke. The elements appeared to come from the filament (nickel, chromium), thick wire (copper coated with silver), brass clamp (copper, zinc), solder joints (tin, lead), and wick and sheath (silicon, oxygen, calcium, magnesium, aluminum). Lead was identified in the solder and aerosol of two brands of EHs (up to 0.165 mu g/10 puffs). Conclusion These data show that EC/EH aerosols contain a mixture of elements, including heavy metals, with concentrations often significantly higher than in conventional cigarette smoke. While the health effects of inhaling mixtures of heated metals is currently not known, these data will be valuable in future risk assessments involving EC/EH elements/metals.	[Williams, Monique; Ghai, Sanjay; Talbot, Prue] Univ Calif Riverside, Dept Cell Biol & Neurosci, Riverside, CA 92521 USA; [Bozhilov, Krassimir] Univ Calif Riverside, Cent Facil Adv Microscopy & Microanal, Riverside, CA 92521 USA	University of California System; University of California Riverside; University of California System; University of California Riverside	Talbot, P (corresponding author), Univ Calif Riverside, Dept Cell Biol & Neurosci, Riverside, CA 92521 USA.	talbot@ucr.edu	Talbot, Prue/AAY-3896-2021		Tobacco-Related Disease Research Program of California [22RT-0127]; Graduate Research Mentorship Program Award; Predoctoral Fellowship from the Tobacco-Related Disease Research Program of California [23DT-0101]; NIH [R01 DA036493]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA036493] Funding Source: NIH RePORTER	Tobacco-Related Disease Research Program of California(University of California System); Graduate Research Mentorship Program Award; Predoctoral Fellowship from the Tobacco-Related Disease Research Program of California; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Support was provided by the Tobacco-Related Disease Research Program of California Grant #22RT-0127 (PT) (trdrp.org), a Graduate Research Mentorship Program Award (MW), a Predoctoral Fellowship from the Tobacco-Related Disease Research Program of California #23DT-0101 (MW), and a NIH grant #R01 DA036493 (PT) (NIH.gov). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Administration D., 2012, FED REGISTER, V77, P20034; ASTDR, 2004, TOX PROF COPP, P121; ATSDR Division of Toxicology HHS, 2015, SUMM DAT 2015 PRIOR, P1; ATSDR U., 2007, TOXICOLOGICAL PROFIL, V1, P582; Behar RZ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117222; Bernhard D, 2005, IUBMB LIFE, V57, P805, DOI 10.1080/15216540500459667; Bourgeois MM, 2015, HAMILTON HARDYS IND, P109; Buhler Wayne, 2006, FQPA FOOD QUALITY PR, V1996; Chen Z, 2006, TOXICOL LETT, V163, P109, DOI 10.1016/j.toxlet.2005.10.003; Cheng TR, 2014, TOB CONTROL, V23, P11, DOI 10.1136/tobaccocontrol-2013-051482; CHIBA M, 1992, B WORLD HEALTH ORGAN, V70, P269; Coyle JC., 2015, HAMILTON HARDYS IND, P127; Cross FB, 2001, HUM EXP TOXICOL, V20, P122, DOI 10.1191/096032701678126525; Das S., 2011, INT J PHARM SCI REV, V11, P13; Goniewicz ML, 2014, TOB CONTROL, V23, P133, DOI 10.1136/tobaccocontrol-2012-050859; Harbison Raymond D A, 2015, HAMILTON HARDYS IND, P247; Harper C., 2005, TOXICOLOGICAL PROFIL, P302; Hua My, 2016, Prev Med Rep, V4, P169, DOI 10.1016/j.pmedr.2016.06.002; Hua M, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2324; Hua M, 2013, TOB CONTROL, V22, P103, DOI 10.1136/tobaccocontrol-2011-050226; Jenkins S, 2011, ELECT CIGARETTES MAY; Johnson G., 2015, HAMILTON HARDYS IND, P33; Knoll M, 1998, REPROD TOXICOL, V12, P57, DOI 10.1016/S0890-6238(97)00100-7; KNOLL M, 1995, BIOL REPROD, V53, P29, DOI 10.1095/biolreprod53.1.29; Laugesen M., 2008, SAFETY REPORT RUYAN; Lee N-C, 2009, MAT ADV PACKAGING, P181, DOI DOI 10.1007/978-0-387-78219-5_5; Lerner CA, 2015, ENVIRON POLLUT, V198, P100, DOI 10.1016/j.envpol.2014.12.033; LeTran D., 2017, THE IDEAL GAS LAW; Prueitt R. L., 2015, HAMILTON HARDYS IND, P173, DOI [10.1002/9781118834015.ch25, DOI 10.1002/9781118834015.CH25]; Roney N., 2005, TOXICOLOGICAL PROFIL, P352; Ryan J, 2010, J ANAL CHEM+, V1, P34; Samczytiski Z, 2012, SCI WORLD J, V216380, P1; Smith CJ, 1997, FOOD CHEM TOXICOL, V35, P1107, DOI 10.1016/S0278-6915(97)00063-X; Stephen FD, 2015, HAMILTON HARDYS IND, P131; Steve Morris, 2015, HAMILTON HARDYS IND, P25; Stohs SJ, 1997, INHAL TOXICOL, V9, P867; Talih S, 2015, NICOTINE TOB RES, V17, P150, DOI 10.1093/ntr/ntu174; Trtchounian A, 2010, NICOTINE TOB RES, V12, P905, DOI 10.1093/ntr/ntq114; Truncale T, 2015, HAMILTON HARDYS IND, P289; WHO, 2012, SOP01 WHO TOBLABNET; Williams M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138933; Williams M, 2015, NICOTINE TOB RES, V17, P201, DOI 10.1093/ntr/ntu118; Williams M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057987; Yogesh P., 2015, SPECTROSCOPY-US, V31, P8	44	82	87	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2017	12	4							e0175430	10.1371/journal.pone.0175430	http://dx.doi.org/10.1371/journal.pone.0175430			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KD	28414730	Green Published, gold			2022-12-27	WOS:000399874800025
J	Zhang, CW; Wang, AY; Hei, XJ				Zhang, Chengwei; Wang, Angela Yunxian; Hei, Xiaojun			Relay discovery and selection for large-scale P2P streaming	PLOS ONE			English	Article							OVERLAY; PERFORMANCE; ALLOCATION	In peer-to-peer networks, application relays have been commonly used to provide various networking services. The service performance often improves significantly if a relay is selected appropriately based on its network location. In this paper, we studied the location-aware relay discovery and selection problem for large-scale P2P streaming networks. In these large-scale and dynamic overlays, it incurs significant communication and computation cost to discover a sufficiently large relay candidate set and further to select one relay with good performance. The network location can be measured directly or indirectly with the tradeoffs between timeliness, overhead and accuracy. Based on a measurement study and the associated error analysis, we demonstrate that indirect measurements, such as King and Internet Coordinate Systems (ICS), can only achieve a coarse estimation of peers' network location and those methods based on pure indirect measurements cannot lead to a good relay selection. We also demonstrate that there exists significant error amplification of the commonly used "best-out-of-K" selection methodology using three RTT data sets publicly available. We propose a two-phase approach to achieve efficient relay discovery and accurate relay selection. Indirect measurements are used to narrow down a small number of high-quality relay candidates and the final relay selection is refined based on direct probing. This two-phase approach enjoys an efficient implementation using the Distributed Hash-Table (DHT). When the DHT is constructed, the node keys carry the location information and they are generated scalably using indirect measurements, such as the ICS coordinates. The relay discovery is achieved efficiently utilizing the DHT-based search. We evaluated various aspects of this DHT-based approach, including the DHT indexing procedure, key generation under peer churn and message costs.	[Zhang, Chengwei; Hei, Xiaojun] Huazhong Univ Sci & Technol, Sch Elect Informat & Commun, Wuhan, Hubei, Peoples R China; [Wang, Angela Yunxian] Akamai Technol Inc, Cambridge, MA USA	Huazhong University of Science & Technology	Hei, XJ (corresponding author), Huazhong Univ Sci & Technol, Sch Elect Informat & Commun, Wuhan, Hubei, Peoples R China.	heixj@hust.edu.cn	Hei, Xiaojun/E-7970-2012	Hei, Xiaojun/0000-0002-6766-4923	National Natural Science Foundation of China [61370231]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was partly funded by the National Natural Science Foundation of China (No. 61370231) to Xiaojun Hei. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen D., 2001, Operating Systems Review, V35, P131, DOI 10.1145/502059.502048; Buford J, 2007, GLOB TELECOMM CONF, P242; Cha M, 2006, IEEE INFOCOM SER, P1094; Cheng CM, 2004, GLOB TELECOMM CONF, P1359; Cohen R, 2014, IEEE ACM T NETWORK, V22, P636, DOI 10.1109/TNET.2013.2260867; Dabek F, 2004, ACM SIGCOMM COMP COM, V34, P15, DOI 10.1145/1030194.1015471; Dischinger M, 2007, IMC'07: PROCEEDINGS OF THE 2007 ACM SIGCOMM INTERNET MEASUREMENT CONFERENCE, P43; Donnet B, 2010, IEEE COMMUN SURV TUT, V12, P488, DOI 10.1109/SURV.2010.032810.00007; Du W, 2015, IEEE ACM T NETWORK, V23, P1661, DOI 10.1109/TNET.2014.2337371; Fei T., 2006, P IEEE INFOCOM, P1, DOI [DOI 10.1109/INFOCOM.2006.179, DOI 10.1109/INFOCOM.2006.48]; Ford B., 2005, P ANN C USENIX ANN T, P13, DOI DOI 10.1177/0165551506078083; GRIFFIN T., 2005, P 5 ACM IMC INT MEAS, P125; Gummadi KP, 2004, USENIX ASSOCIATION PROCEEDINGS OF THE SIXTH SYMPOSIUM ON OPERATING SYSTEMS DESIGN AND IMPLEMENTATION (OSDE '04), P183; Gummadi KP, 2002, IMW 2002: PROCEEDINGS OF THE SECOND INTERNET MEASUREMENT WORKSHOP, P5, DOI 10.1145/637201.637203; Haddow T, 2011, LECT NOTES COMPUT SC, V6579, P81, DOI 10.1007/978-3-642-19260-9_9; Hei XJ, 2006, IEEE ICC, P1065; Huffaker B., 2002, P IEEE INT TEL S ITS, P200; Jiang JC, 2016, PROCEEDINGS OF THE 2016 ACM CONFERENCE ON SPECIAL INTEREST GROUP ON DATA COMMUNICATION (SIGCOMM '16), P286; Karbhari P, 2005, LECT NOTES COMPUT SC, V3462, P943; Ledlie J., 2007, P 4 USENIX C NETW SY, P22; Liang J, 2006, COMPUT NETW, V50, P842, DOI 10.1016/j.comnet.2005.07.014; Liu Y., 2004, PROC EARS RT 04 WORK, P1; Lumezanu C, 2009, LECT NOTES COMPUT SC, V5448, P45, DOI 10.1007/978-3-642-00975-4_5; Maki I, 2005, IEEE ICC, P184; Malboubi M., 2015, P INT C COMP COMM NE, P1; Ng ISE, 2002, IEEE INFOCOM SER, P170, DOI 10.1109/INFCOM.2002.1019258; Nguyen HX, 2008, IEEE INFOCOM SER, P601; Pietzuch P, 2005, LECT NOTES COMPUT SC, V3640, P275, DOI 10.1007/11558989_25; Pucha H, 2005, P ACM SIGCOMM POST P, P1; Ren S, 2006, P 26 IEEE INT C DIST, P70; Roy S, 2009, IEEE ACM T NETWORK, V17, P1298, DOI 10.1109/TNET.2008.2007433; Samimi Farshad A., 2007, IEEE Transactions on Network and Service Management, V4, P84, DOI 10.1109/TNSM.2007.070901; Sanchez MA, 2015, IEEE ACM T NETWORK, V23, P1944, DOI 10.1109/TNET.2014.2354348; Tang L., 2003, P 3 ACM SIGCOMM C IN, P143, DOI DOI 10.1145/948205.948223; Wang B., 2009, BIOINFORMATICS BIOME, V3, P1, DOI DOI 10.1145/1556134.1556142.25; Wang G, 2013, MULTIMED TOOLS APPL, V64, P599, DOI 10.1007/s11042-011-0952-5; Wang GH, 2007, IMC'07: PROCEEDINGS OF THE 2007 ACM SIGCOMM INTERNET MEASUREMENT CONFERENCE, P175; Wong B, 2005, ACM SIGCOMM COMP COM, V35, P85, DOI 10.1145/1090191.1080103; Xu Y, 2014, IEEE ACM T NETWORK, V22, P826, DOI 10.1109/TNET.2013.2260354; Yin Chen, 2008, 2008 28th International Conference on Distributed Computing Systems Workshops (ICDCS Workshops), P465, DOI 10.1109/ICDCS.Workshops.2008.45; Zeitoun A, 2003, PROCEEDINGS OF THE 3RD IEEE WORKSHOP ON IP OPERATIONS & MANAGEMENT (IPOM2003), P127; Zhang CW, 2013, ASIA-PAC CONF COMMUN, P728, DOI 10.1109/APCC.2013.6766045; Zhang CW, 2012, IEEE INT CONF NETWOR, P447, DOI 10.1109/ICON.2012.6506599	43	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2017	12	4							e0175360	10.1371/journal.pone.0175360	http://dx.doi.org/10.1371/journal.pone.0175360			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0MD	28410384	Green Submitted, Green Published, gold			2022-12-27	WOS:000399955600015
J	Huang, X; Liu, Y; Bai, S; Peng, LD; Zhang, BA; Lu, H				Huang, Xin; Liu, Yu; Bai, Shuang; Peng, Lidan; Zhang, Boai; Lu, Hong			Granulocyte colony stimulating factor therapy for stroke: A pairwise meta-analysis of randomized controlled trial	PLOS ONE			English	Article							ACUTE ISCHEMIC-STROKE; MARROW STEM-CELLS; G-CSF; RECOVERY ENHANCEMENT; INHIBITION; SUPPRESSION; EFFICACY	Granulocyte colony-stimulating factor (G-CSF) is atherapeutic candidate for stroke that has demonstrated anti-inflammatory and neuroprotective properties. Data from preclinical and clinical studies have suggested the safety and efficacy of G-CSF in stroke; however, the exact effects and utility of this cytokine in patients remain disputed. We performed a metaanalysis of randomized controlled trials of G-CSF in ischemic and hemorrhagic stroke to assess its clinical safety and efficacy. Electronic databases were searched for relevant publications in English and Chinese. A total of 14 trials met the inclusion criteria. G-CSF (cumulative dose range, 1-135 mu g/kg/day) was tested against placebo in a total of 1037 participants. There was no difference in the rate of mortality between groups (odds ratio, 1.23; 95% confidence interval, 0.76 -1.97, p = 0.40). Moreover, the rate of serious adverse events did not differ between groups and provided evidence for the safety of G-CSF administration in stroke patients (odds ratio, 1.11; 95% confidence interval, 0.77-1.61, p = 0.57). No significant outcome benefits were noted with respect to the National Institutes of Health Stroke Scale (mean difference, -0.16; 95% confidence interval, -1.02-0.70, p = 0.72); however, improvements were noted with respect to the Barthel Index (mean difference, 8.65; 95% confidence interval 0.98-16.32; p = 0.03). In conclusion, it appears to be safe in administration of G-CSF, but it will increase leukocyte count. G-CSF was weakly significant benefit with improving the BI scores, while there was no improvement in the NIHSS scores. Larger and more robustly designed trials of G-CSF in stroke are needed to confirm the results.	[Huang, Xin; Liu, Yu; Bai, Shuang; Peng, Lidan; Zhang, Boai; Lu, Hong] Zhengzhou Univ, Affiliated Hosp 1, Dept Neurol, Zhengzhou, Henan, Peoples R China	Zhengzhou University	Liu, Y (corresponding author), Zhengzhou Univ, Affiliated Hosp 1, Dept Neurol, Zhengzhou, Henan, Peoples R China.	martinsums@sina.com			Creative Talent Project; Henan Province Health Department [20104160]	Creative Talent Project; Henan Province Health Department	This work was supported only by the Creative Talent Project supported by Henan Province Health Department, Grant number: 20104160, URL: http://www.hnwsf.gov.cn, Recipient: YL. And this funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alasheev AM, 2011, TRANSL STROKE RES, V2, P358, DOI 10.1007/s12975-011-0091-3; Bath PMW, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005207.pub4; Boneberg EM, 2000, BLOOD, V95, P270, DOI 10.1182/blood.V95.1.270; DEMETRI GD, 1991, BLOOD, V78, P2791; England TJ, 2012, STROKE, V43, P405, DOI 10.1161/STROKEAHA.111.636449; England TJ, 2009, BRAIN RES REV, V62, P71, DOI 10.1016/j.brainresrev.2009.09.002; Fan ZZ, 2015, J STROKE CEREBROVASC, V24, P1701, DOI 10.1016/j.jstrokecerebrovasdis.2014.11.033; Gorthi S, 2014, NEUROLOGY, V82, P10; Guo-dong X, 2011, CHIN J DIFFIC COMPL, V10, P54; Hamilton JA, 2008, NAT REV IMMUNOL, V8, P533, DOI 10.1038/nri2356; HARTUNG T, 1995, BLOOD, V85, P2482, DOI 10.1182/blood.V85.9.2482.bloodjournal8592482; Higgins JPT., 2008, COCHRANE HDB SYSTEMA, V1 edn; Jing L, 2005, CEREBROVASC DIS FORE, V13, P106; Juttler E, 2014, NEW ENGL J MED, V370, P1091, DOI 10.1056/NEJMoa1311367; Kim SO, 2006, CELL MICROBIOL, V8, P1958, DOI 10.1111/j.1462-5822.2006.00763.x; Lee ST, 2005, BRAIN RES, V1058, P120, DOI 10.1016/j.brainres.2005.07.076; Martins A, 2010, IUBMB LIFE, V62, P611, DOI 10.1002/iub.361; Mehta HM, 2015, J IMMUNOL, V195, P1341, DOI 10.4049/jimmunol.1500861; Mingou H, 2015, CHINESE J PRACTICAL, V18, P126; Minnerup J, 2008, STROKE, V39, P1855, DOI 10.1161/STROKEAHA.107.506816; Mizuma A, 2016, J STROKE CEREBROVASC, V25, P1451, DOI 10.1016/j.jstrokecerebrovasdis.2016.01.022; Nishiki S, 2004, AM J PHYSIOL-CELL PH, V286, pC1302, DOI 10.1152/ajpcell.00387.2003; Prasad K, 2011, STROKE RES TREAT, V2011, DOI 10.4061/2011/283473; Ringelstein EB, 2013, STROKE, V44, P2681, DOI 10.1161/STROKEAHA.113.001531; Schabitz WR, 2010, STROKE, V41, P2545, DOI 10.1161/STROKEAHA.110.579508; Schneider A, 2005, J CLIN INVEST, V115, P2083, DOI 10.1172/JCI23559; Shyu WC, 2006, CAN MED ASSOC J, V174, P927, DOI 10.1503/cmaj.051322; Solaroglu I, 2009, NEUROL RES, V31, P167, DOI 10.1179/174313209X393582; Sprigg N, 2006, STROKE, V37, P2979, DOI 10.1161/01.STR.0000248763.49831.c3; Valente JF, 2002, SHOCK, V17, P23, DOI 10.1097/00024382-200201000-00005; WELTE K, 1985, P NATL ACAD SCI USA, V82, P1526, DOI 10.1073/pnas.82.5.1526; Zhang JJ, 2006, CEREBROVASC DIS, V21, P143; Zhaoli G, 2005, STROKE NERVOTIS DIS, V12, P161; [周育苗 Zhou Yumiao], 2013, [中国全科医学, Chinese General Practice], V16, P4148	34	19	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2017	12	4							e0175774	10.1371/journal.pone.0175774	http://dx.doi.org/10.1371/journal.pone.0175774			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0MB	28406964	Green Published, gold, Green Submitted			2022-12-27	WOS:000399955400098
J	Lou, J; Hu, PP; Qian, HZ; Ruan, YH; Jin, Z; Xing, H; Shao, YM; Vermund, SH				Lou, Jie; Hu, Peipei; Qian, Han-Zhu; Ruan, Yuhua; Jin, Zhen; Xing, Hui; Shao, Yiming; Vermund, Sten H.			Expanded antiretroviral treatment, sexual networks, and condom use: Treatment as prevention unlikely to succeed without partner reduction among men who have sex with men in China	PLOS ONE			English	Article							HIV RISK; TRANSMITTED INFECTIONS; THERAPY; BEHAVIORS; EPIDEMIC; TRANSMISSION; MODELS; IMPLEMENTATION; INTERVENTION; POPULATION	Background To project the impact of partner reduction on preventing new HIV infections among men who have sex with men (MSM) under varying conditions of enhanced HIV testing and treatment (T&T) and condom use in Beijing, China. Methods and findings A complex network model was fitted to predict the number of new HIV infections averted from 2014 to 2023 under four scenarios of sexual behavior risk reduction (S)-(S1) under bar: Male sexual partners decrease (reduced by a random value m from 1-50) while condom use increases (risk constant p is a random value between 0.2 and 1]); (S2) under bar: Both sexual partners and condom use decrease (m 1, 50; p 1, 1.8); (S3) under bar: Sexual partners reduce (m 1, 10) while condom use increases or decreases (p 0.2, 1.8); (S4) under bar: Only MSM with >= 100 male sexual partners reduce their partners (m 1, 50) while condom use increases (p 0.2, 1). HIV prevalence will reach 23.2% by 2023 among Beijing MSM if T&T remains at the 2013 level. The three most influential factors are: T&T coverage; partner reduction (m); and the background risk (p). Under scenarios 1-4 of sexual behavioral changes with enhanced T&T interventions, the cumulative HIV new infections prevented over the 10 years will be 46.8% for (S4) under bar (interquartile range [IQR] 32.4%, 60.1%); 29.7% for (S2) under bar (IQR 18.0%, 41.4%), 23.2% for (S3) under bar (IQR 12.2%, 37.0%) and 11.6% for (S4) under bar (IQR 4.0%, 26.6%), respectively. The reproduction number R-0 could drop below 1 if there were a substantial reduction of male sexual partners and/or expanded condom use. Conclusion Partner reduction is a vital factor within HIV combination interventions to reduce HIV incidence among Beijing MSM, with substantial additional benefits derived from condom use. T&T without substantial partner reduction and increased condom use is less promising unless its implementation were extremely (and improbably) efficicient.	[Lou, Jie; Hu, Peipei] Shanghai Univ, Dept Math, Shanghai, Peoples R China; [Qian, Han-Zhu; Vermund, Sten H.] Vanderbilt Univ, Vanderbilt Inst Global Hlth, 221 Kirkland Hall, Nashville, TN 37235 USA; [Qian, Han-Zhu] Vanderbilt Univ, Sch Med, Div Epidemiol, Dept Med, Nashville, TN 37212 USA; [Ruan, Yuhua; Xing, Hui; Shao, Yiming] Chinese Ctr Dis Control & Prevent, Collaborat Innovat Ctr Diag & Treatment Infect Di, State Key Lab Infect Dis Prevent & Control, Natl Ctr AIDS STD Control & Prevent, Beijing, Peoples R China; [Jin, Zhen] Shanxi Univ, Complex Syst Res Ctr, Taiyuan, Peoples R China; [Vermund, Sten H.] Vanderbilt Univ, Sch Med, Dept Pediat, Nashville, TN 37212 USA	Shanghai University; Vanderbilt University; Vanderbilt University; Chinese Center for Disease Control & Prevention; National Center for AIDS/STD Control & Prevention, Chinese Center for Disease Control & Prevention; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; Shanxi University; Vanderbilt University	Vermund, SH (corresponding author), Vanderbilt Univ, Vanderbilt Inst Global Hlth, 221 Kirkland Hall, Nashville, TN 37235 USA.; Shao, YM (corresponding author), Chinese Ctr Dis Control & Prevent, Collaborat Innovat Ctr Diag & Treatment Infect Di, State Key Lab Infect Dis Prevent & Control, Natl Ctr AIDS STD Control & Prevent, Beijing, Peoples R China.; Vermund, SH (corresponding author), Vanderbilt Univ, Sch Med, Dept Pediat, Nashville, TN 37212 USA.	yshao08@gmail.com; sten.vermund@yale.edu	jin, zhen/B-6563-2015; Vermund, Sten/AAD-3592-2020	jin, zhen/0000-0002-9763-707X; Vermund, Sten/0000-0001-7289-8698	Natural Science Foundation of China [11271246, 11331009]; U. S. National Institute Of Allergy and Infectious Diseases of the National Institutes of Health [R01AI094562]; International Development Research Center of Canada [104519-010]; Chinese State Key Laboratory for Infectious Disease Develop Grant [2012SKLID103]; Ministry of Science and Technology of China [2012ZX10001-002]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI094562] Funding Source: NIH RePORTER	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); U. S. National Institute Of Allergy and Infectious Diseases of the National Institutes of Health; International Development Research Center of Canada; Chinese State Key Laboratory for Infectious Disease Develop Grant; Ministry of Science and Technology of China(Ministry of Science and Technology, China); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was sponsored by grants from the Natural Science Foundation of China (Grant #11271246, PI: Jie Lou; #11331009; PI: Zhen Jin), U. S. National Institute Of Allergy and Infectious Diseases of the National Institutes of Health (R01A1094562, Pls: Sten H. Vermund & Han-Zhu Qian), the International Development Research Center of Canada (#104519-010, PI: Yiming Shao), Chinese State Key Laboratory for Infectious Disease Develop Grant (#2012SKLID103, PI: Yiming Shao), and the Ministry of Science and Technology of China (#2012ZX10001-002, PI: Hui Xing). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was sponsored by grants from the Natural Science Foundation of China (Grant #11271246, PI: Jie Lou; #11331009; PI: Zhen Jin), U. S. National Institute Of Allergy and Infectious Diseases of the National Institutes of Health (R01AI094562, PIs: Sten H. Vermund & Han-Zhu Qian), the International Development Research Center of Canada (# 104519-010, PI: Yiming Shao), Chinese State Key Laboratory for Infectious Disease Develop Grant (# 2012SKLID103, PI: Yiming Shao), and the Ministry of Science and Technology of China (# 2012ZX10001-002, PI: Hui Xing). We thank Dr. Edward C. Mignot at Shandong University for his editorial assistance.	AHLGREN DJ, 1990, J ACQ IMMUN DEF SYND, V3, P631; Allison S, 2012, J ADOLESCENT HEALTH, V51, P207, DOI 10.1016/j.jadohealth.2012.06.012; Beyrer C, 2012, LANCET, V380, P367, DOI 10.1016/S0140-6736(12)60821-6; Blower SM, 2000, SCIENCE, V287, P650, DOI 10.1126/science.287.5453.650; Blower SM, 1996, SCIENCE, V273, P497, DOI 10.1126/science.273.5274.497; Boily MC, 2004, SEX TRANSM DIS, V31, P100, DOI 10.1097/01.OLQ.0000112721.21285.A2; Cai R, 2014, AIDS BEHAV, V18, P1560, DOI 10.1007/s10461-014-0735-x; Chang LW, 2013, LANCET INFECT DIS, V13, P65, DOI 10.1016/S1473-3099(12)70273-6; Chinese Center for Disease Control and Prevention, AN HIV STD EP 2005; Chow EPF, 2013, SEX HEALTH, V10, P533, DOI 10.1071/SH13097; Chow EPF, 2012, AIDS BEHAV, V16, P653, DOI 10.1007/s10461-011-9935-9; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Cori A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084511; DiClemente RJ, 2002, SOUTH MED J, V95, P421, DOI 10.1097/00007611-200204000-00009; Fan S, 2012, AIDS PATIENT CARE ST, V26, P148, DOI 10.1089/apc.2011.0277; Fan WS, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/232451; Finlayson Teresa J., 2011, Morbidity and Mortality Weekly Report, V60, P1; Garnett GP, 1996, J INFECT DIS, V174, pS150, DOI 10.1093/infdis/174.Supplement_2.S150; Ghani AC, 1997, SEX TRANSM DIS, V24, P45, DOI 10.1097/00007435-199701000-00009; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Hufnagel L, 2004, P NATL ACAD SCI USA, V101, P15124, DOI 10.1073/pnas.0308344101; IMAN RL, 1981, J QUAL TECHNOL, V13, P174, DOI 10.1080/00224065.1981.11978748; JACQUEZ JA, 1994, J ACQ IMMUN DEF SYND, V7, P1169; Jia ZW, 2013, LANCET, V382, P1195, DOI 10.1016/S0140-6736(12)61898-4; Johnson LF, 2006, DEMOGR RES, V14, P541, DOI 10.4054/DemRes.2006.14.22; Johnson N. L., 1970, DISTRIBUTIONS STAT C, V2; Koblin BA, 2006, AIDS, V20, P731, DOI 10.1097/01.aids.0000216374.61442.55; Kurth Ann E, 2011, Curr HIV/AIDS Rep, V8, P62, DOI 10.1007/s11904-010-0063-3; Laumann E. O., 1994, SOCIAL ORG SEXUALITY; Law MG, 2001, AIDS, V15, P1287, DOI 10.1097/00002030-200107060-00011; Li HM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023431; Li L, 2007, AIDS CARE, V19, P1288, DOI 10.1080/09540120701402855; Liljeros F, 2003, MICROBES INFECT, V5, P189, DOI 10.1016/S1286-4579(02)00058-8; Liljeros F, 2001, NATURE, V411, P907, DOI 10.1038/35082140; Lima VD, 2008, J INFECT DIS, V198, P59, DOI 10.1086/588673; Liu Y, 2015, AIDS PATIENT CARE ST, V29, P481, DOI 10.1089/apc.2015.0083; Lou J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090985; Lu L, 2008, NATURE, V455, P609, DOI 10.1038/455609a; Luo ST, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126893; May RM, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.066112; Mbuagbaw L, 2015, AIDS PATIENT CARE ST, V29, P248, DOI 10.1089/apc.2014.0308; Mendelsohn JB, 2015, EMERG THEMES EPIDEMI, V12, DOI 10.1186/s12982-015-0033-8; Miranda J, 2013, JMIR RES PROTOC, V2, DOI 10.2196/resprot.2723; Morris M, 1997, AIDS, V11, P641, DOI 10.1097/00002030-199705000-00012; Nelson KM, 2014, AIDS CARE, V26, P931, DOI 10.1080/09540121.2013.871219; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Pastor-Satorras R, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.066117; Phillips AN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055312; Porco TC, 2004, AIDS, V18, P81, DOI 10.1097/00002030-200401020-00010; Qian HZ, 2006, AIDS, V20, P1429, DOI 10.1097/01.aids.0000233577.33973.fa; Raboud JM, 2003, J URBAN HEALTH, V80, P302, DOI 10.1093/jurban/jtg033; Rosenberg ES, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-189; Ruan YH, 2009, AIDS BEHAV, V13, P663, DOI 10.1007/s10461-008-9503-0; Schneeberger A, 2004, SEX TRANSM DIS, V31, P380, DOI 10.1097/00007435-200406000-00012; Shao B, 2013, AIDS RES HUM RETROV, V29, P1260, DOI [10.1089/aid.2013.0135, 10.1089/AID.2013.0135]; Stattner E, 2014, INT J INFORM SYSTEM, V3, P46; Sun XD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150513; Swartzman G. L., 1987, ECOLOGICAL SIMULATIO; Tan WY, 1999, J STAT PLAN INFER, V78, P71, DOI 10.1016/S0378-3758(98)00207-9; van den Driessche P, 2002, MATH BIOSCI, V180, P29, DOI 10.1016/S0025-5564(02)00108-6; van Sighem A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044819; Vardavas R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000152; Velasco-Hernandez JX, 2002, LANCET INFECT DIS, V2, P487, DOI 10.1016/S1473-3099(02)00346-8; Vermund SH, 2014, JAIDS-J ACQ IMM DEF, V66, pS237, DOI 10.1097/QAI.0000000000000244; Vermund SH, 2013, CURR HIV-AIDS REP, V10, P169, DOI 10.1007/s11904-013-0155-y; Wang KW, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1152; Wang SJ, 2015, AIDS EDUC PREV, V27, P126, DOI 10.1521/aeap.2015.27.2.126; WASSERMAN S., 1994, SOCIAL NETWORK ANAL, DOI DOI 10.1017/CBO9780511815478; Wilson DP, 2009, SEX HEALTH, V6, P19, DOI 10.1071/SH08081; Wirtz AL, 2013, INT J STD AIDS, V24, P18, DOI 10.1177/0956462412472291; Wu ZY, 2007, LANCET, V369, P679, DOI 10.1016/S0140-6736(07)60315-8; [许娟 Xu Juan], 2010, [中华预防医学杂志, Chinese Journal of Preventive Medicine], V44, P975; Xu JJ, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0642-9; Ye SD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090788; Ye SD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050873; Yin L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107652; Yin WY, 2010, INT J EPIDEMIOL, V39, pII29, DOI 10.1093/ije/dyq210; Zhang FJ, 2011, LANCET INFECT DIS, V11, P516, DOI 10.1016/S1473-3099(11)70097-4; Zhang H, 2016, DRUG ALCOHOL DEPEN, V160, P42, DOI 10.1016/j.drugalcdep.2015.11.037	79	4	5	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2017	12	4							e0171295	10.1371/journal.pone.0171295	http://dx.doi.org/10.1371/journal.pone.0171295			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET0MB	28406992	Green Published, Green Submitted, gold			2022-12-27	WOS:000399955400003
J	Tan, B; Luo, HQ; Xu, H; Lv, NH; Shi, RH; Luo, HS; Li, JS; Ren, JL; Zou, YY; Li, YQ; Ji, F; Fang, JY; Qian, JM				Tan, Bei; Luo, Han-Qing; Xu, Hong; Lv, Nong-Hua; Shi, Rui-Hua; Luo, He-Sheng; Li, Jian-Sheng; Ren, Jian-Lin; Zou, Yi-You; Li, Yan-Qing; Ji, Feng; Fang, Jing-Yuan; Qian, Jia-Ming			Polaprezinc combined with clarithromycin-based triple therapy for Helicobacter pylori-associated gastritis: A prospective, multicenter, randomized clinical trial	PLOS ONE			English	Article							L-CARNOSINE; ANTIBIOTIC-RESISTANCE; CONSENSUS REPORT; ZINC-CHLORIDE; OPEN-LABEL; BISMUTH; COMPLEX; INFECTION; ERADICATION; AMOXICILLIN	The efficacy and safety of polaprezinc combined with triple therapy was compared with triple therapy alone in the eradication of Helicobacter pylori. A randomized, parallel-group, open-label, controlled, prospective multicenter study was conducted in 11 cities in China. Treatment- naive patients with H. pylori-associated gastritis were randomly assigned to one of three arms for a 14-day treatment: Arm A triple therapy (omeprazole 20 mg, amoxicillin 1 g, and clarithromycin 500 mg, each twice daily) plus polaprezinc 75 mg twice daily; Arm B triple therapy plus polaprezinc 150 mg twice daily, or Arm C triple therapy alone. The rate of H. pylori eradication was the primary endpoint. Secondary endpoints were symptom improvement and lower incidence of adverse events. 303 patients completed the study- 106, 96, and 101 patients in Arms A, B, and C, respectively. Intention-to-treat (ITT) analysis showed that the rate of H. pylori eradication was significantly higher for Arms A (77.0%) and B (75.9%) compared to Arm C (58.6%) (P < 0.01), whereas there was no difference between Arms A and B (P = 0.90). Per-protocol (PP) analysis showed that the rate of H. pylori eradication was significantly higher for Arms A (81.1%) and B (83.3%) compared to Arm C (61.4%) (P < 0.01), whereas there was no significant difference between Arms A and B (P = 0.62). All three groups reported significant symptom improvement at 7, 14, and 28 days after treatment, compared to baseline (P < 0.0001). The adverse event rate for Arm B (5.1%) was higher than for Arms A (2.8%) (P = 0.04) and C (1.9%) (P = 0.02). There were no serious adverse events in any group. It appears that standard dose polaprezinc combined with triple therapy can significantly improve the H. pylori eradication rate, without an increase in toxicity.	[Tan, Bei; Luo, Han-Qing; Qian, Jia-Ming] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Gastroenterol, Beijing, Peoples R China; [Tan, Bei; Luo, Han-Qing; Qian, Jia-Ming] Peking Union Med Coll, Beijing, Peoples R China; [Xu, Hong] Jilin Univ, Bethune Hosp 1, Dept Gastroenterol, Changchun, Jilin, Peoples R China; [Lv, Nong-Hua] Nanchang Univ, Affiliated Hosp 1, Dept Gastroenterol, Nanchang, Jiangxi, Peoples R China; [Shi, Rui-Hua] Nanjing Med Univ, Jiangsu Prov Hosp, Dept Gastroenterol, Nanjing, Jiangsu, Peoples R China; [Shi, Rui-Hua] Nanjing Med Univ, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China; [Luo, He-Sheng] Wuhan Univ, Renmin Hosp, Dept Gastroenterol, Wuhan, Peoples R China; [Luo, He-Sheng] Hubei Gen Hosp, Wuhan, Peoples R China; [Li, Jian-Sheng] Zhengzhou Univ, Affiliated Hosp 1, Dept Gastroenterol, Zhengzhou, Peoples R China; [Ren, Jian-Lin] Xiamen Univ, Zhongshan Hosp, Dept Gastroenterol, Xiamen, Peoples R China; [Zou, Yi-You] Cent S Univ, Xiangya Hosp, Dept Gastroenterol, Changsha, Hunan, Peoples R China; [Li, Yan-Qing] Shandong Univ, Qilu Hosp, Dept Gastroenterol, Jinan, Peoples R China; [Ji, Feng] Zhejiang Univ, Affiliated Hosp 1, Dept Gastroenterol, Hangzhou, Zhejiang, Peoples R China; [Fang, Jing-Yuan] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Gastroenterol, Shanghai, Peoples R China; [Luo, Han-Qing] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Hlth Care, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Jilin University; Nanchang University; Nanjing Medical University; Nanjing Medical University; Wuhan University; Zhengzhou University; Xiamen University; Central South University; Shandong University; Zhejiang University; Shanghai Jiao Tong University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital	Qian, JM (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Gastroenterol, Beijing, Peoples R China.; Qian, JM (corresponding author), Peking Union Med Coll, Beijing, Peoples R China.	qianjiaming1957@126.com			Broadwell Pharmaceutical Co., Ltd.	Broadwell Pharmaceutical Co., Ltd.	This study was sponsored by Broadwell Pharmaceutical Co., Ltd., the manufacturer of polaprezinc. There was no additional external or internal funding received. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin M, 2010, J ENZYM INHIB MED CH, V25, P383, DOI 10.3109/14756360903179518; Dore MP, 2016, GUT, V65, P870, DOI 10.1136/gutjnl-2015-311019; Graham DY, 2016, HELICOBACTER, V21, P85, DOI 10.1111/hel.12287; Ishihara R, 2002, HELICOBACTER, V7, P384, DOI 10.1046/j.1523-5378.2002.00114.x; Kashimura H, 1999, ALIMENT PHARM THERAP, V13, P483; Kuwayama H., 1995, GASTROENTEROLOGY, V108, pA138; Liang J, 2012, HELICOBACTER, V17, P458, DOI 10.1111/j.1523-5378.2012.00971.x; Liu WZ, 2013, J DIGEST DIS, V14, P211, DOI 10.1111/1751-2980.12034; Malfertheiner P., 2017, Gut, V66, P6, DOI [10.1136/gutjnl-2016-312288, DOI 10.1136/GUTJNL-2016-312288]; Matsukura T, 2000, BIOCHEMISTRY-MOSCOW+, V65, P817; Sakae K, 2014, BIOL TRACE ELEM RES, V158, P280, DOI 10.1007/s12011-014-9943-5; Sakae K, 2013, NUTR CLIN PRACT, V28, P609, DOI 10.1177/0884533613493333; Song ZQ, 2014, DIGEST LIVER DIS, V46, P1077, DOI 10.1016/j.dld.2014.08.038; Sugano K, 2015, GUT, V64, P1353, DOI 10.1136/gutjnl-2015-309252; Thung I, 2016, ALIMENT PHARM THER, V43, P514, DOI 10.1111/apt.13497; Watanabe T, 2010, INT J CANCER, V127, P1984, DOI 10.1002/ijc.25200; Watari I, 2013, BMC GASTROENTEROL, V13, DOI 10.1186/1471-230X-13-108; Yakoob J, 2014, BRIT J BIOMED SCI, V71, P43, DOI 10.1080/09674845.2014.11669962; Yakoob J, 2014, MICROB DRUG RESIST, V20, P305, DOI 10.1089/mdr.2013.0086; Zhou LY, 2016, HELICOBACTER, V21, P91, DOI 10.1111/hel.12242; Zhou LY, 2014, AM J GASTROENTEROL, V109, P535, DOI 10.1038/ajg.2014.26	21	16	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2017	12	4							e0175625	10.1371/journal.pone.0175625	http://dx.doi.org/10.1371/journal.pone.0175625			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0MB	28407007	gold, Green Submitted, Green Published			2022-12-27	WOS:000399955400073
J	Tao, ED; Wan, L; Wang, WJ; Luo, YL; Zeng, JF; Wu, X				Tao, Ende; Wan, Li; Wang, WenJun; Luo, YunLong; Zeng, JinFu; Wu, Xia			The prognosis of infective endocarditis treated with biological valves versus mechanical valves: A meta-analysis	PLOS ONE			English	Article							AORTIC ROOT; SURGERY; REPLACEMENT; OUTCOMES; MORTALITY; SOCIETY	Objective Surgery remains the primary form of treatment for infective endocarditis (IE). However, it is not clear what type of prosthetic valve provides a better prognosis. We conducted a metaanalysis to compare the prognosis of infective endocarditis treated with biological valves to cases treated with mechanical valves. Methods Pubmed, Embase and Cochrane databases were searched from January 1960 to November 2016. Randomized controlled trials, retrospective cohorts and prospective studies comparing outcomes between biological valve and mechanical valve management for infective endocarditis were analyzed. The Newcastle-Ottawa Scale(NOS) was used to evaluate the quality of the literature and extracted data, and Stata 12.0 software was used for the metaanalysis. Results A total of 11 publications were included; 10,754 cases were selected, involving 6776 cases of biological valves and 3,978 cases of mechanical valves. The all-cause mortality risk of the biological valve group was higher than that of the mechanical valve group (HR = 1.22, 95% CI 1.03 to 1.44, P = 0.023), as was early mortality (RR = 1.21, 95% CI 1.02 to 1.43, P = 0.033). The recurrence of endocarditis (HR = 1.75, 95% CI 1.26 to 2.42, P = 0.001), as well as the risk of reoperation (HR = 1.79, 95% CI 1.15 to 2.80, P = 0.010) were more likely to occur in the biological valve group. The incidence of postoperative embolism was less in the biological valve group than in the mechanical valve group, but this difference was not statistically significant (RR = 0.90, 95% CI 0.76 to 1.07, P = 0.245). For patients with prosthetic valve endocarditis (PVE), there was no significant difference in survival rates between the biological valve group and the mechanical valve group (HR = 0.91, 95% CI 0.68 to 1.21, P = 0.520). Conclusion The results of our meta-analysis suggest that mechanical valves can provide a significantly better prognosis in patients with infective endocarditis. There were significant differences in the clinical features of patients receiving a biological valve compared to patients receiving a mechanical valve. A large, multicenter retrospective study included in our meta-analysis suggested that any mortality risk of the biological valve group was significant higher than that of the mechanical valve group. However, the risk was no different after risk was adjusted. So, we thought the reason for this result may be related to the characteristics of the patient rather than valve dysfunction. It is still necessary to future randomized studies to verify this conclusion.	[Tao, Ende; Wan, Li; Wang, WenJun; Zeng, JinFu; Wu, Xia] Nanchang Univ, Affiliated Hosp 1, Dept Cardiovasc Surg, Nanchang, Jiangxi, Peoples R China; [Luo, YunLong] Nanchang Univ, Affiliated Hosp 1, Dept Neurosurg, Nanchang, Jiangxi, Peoples R China	Nanchang University; Nanchang University	Wan, L (corresponding author), Nanchang Univ, Affiliated Hosp 1, Dept Cardiovasc Surg, Nanchang, Jiangxi, Peoples R China.	3456191067@qq.com		Wang, wenjun/0000-0001-6359-0034	National Natural Science Foundation of China [81260055]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by National Natural Science Foundation of China (grant number 81260055 to LW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGNIHOTRI AK, 1995, J THORAC CARDIOV SUR, V110, P1708, DOI 10.1016/S0022-5223(95)70035-8; [Anonymous], 2015, Eur Heart J, V36, P3036, DOI 10.1093/eurheartj/ehv488; Byrne JG, 2011, ANN THORAC SURG, V91, P2012, DOI 10.1016/j.athoracsur.2011.01.106; Cahill Thomas J, 2015, F1000Res, V4, DOI 10.12688/f1000research.6949.1; Delahaye F, 2015, INT J CARDIOL, V178, P117, DOI 10.1016/j.ijcard.2014.10.125; Duval X, 2012, J AM COLL CARDIOL, V59, P1968, DOI 10.1016/j.jacc.2012.02.029; Edwards MB, 1998, EUR J CARDIO-THORAC, V14, P156, DOI 10.1016/S1010-7940(98)00148-1; Fedoruk LM, 2009, J THORAC CARDIOV SUR, V137, P326, DOI 10.1016/j.jtcvs.2008.08.024; Greason KL, 2014, J THORAC CARDIOV SUR, V147, P349, DOI 10.1016/j.jtcvs.2012.12.007; Habib G, 2008, PROG CARDIOVASC DIS, V50, P274, DOI 10.1016/j.pcad.2007.10.007; Habib G, 2015, EUR HEART J, V36, P3075, DOI [10.1093/eurheartj/ehv319, 10.5603/KP.2015.0227]; Hammermeister K, 2000, J AM COLL CARDIOL, V36, P1152, DOI 10.1016/S0735-1097(00)00834-2; Harold JG, 2014, J AM COLL CARDIOL, V63, pE57, DOI 10.1016/j.jacc.2014.02.536; Jassar AS, 2012, ANN THORAC SURG, V93, P480, DOI 10.1016/j.athoracsur.2011.09.074; Kim JB, 2016, J THORAC CARDIOV SUR, V151, P1239, DOI 10.1016/j.jtcvs.2015.12.061; Li JS, 2000, CLIN INFECT DIS, V30, P633, DOI 10.1086/313753; Lund O, 2006, J THORAC CARDIOV SUR, V132, P20, DOI 10.1016/j.jtcvs.2006.01.043; Martinez-Selles M, 2008, MAYO CLIN PROC, V83, P1213, DOI 10.4065/83.11.1213; Moon MR, 2001, ANN THORAC SURG, V71, P1164, DOI 10.1016/S0003-4975(00)02665-5; Musci M, 2010, EUR J CARDIO-THORAC, V38, P528, DOI 10.1016/j.ejcts.2010.03.019; Newton S, 2010, INTERACT CARDIOV TH, V11, P784, DOI 10.1510/icvts.2010.234450; Nguyen DT, 2010, EUR J CARDIO-THORAC, V37, P1025, DOI 10.1016/j.ejcts.2009.11.035; Prendergast BD, 2010, CIRCULATION, V121, P1141, DOI 10.1161/CIRCULATIONAHA.108.773598; Que YA, 2011, NAT REV CARDIOL, V8, P322, DOI 10.1038/nrcardio.2011.43; Reul G J, 1989, J Card Surg, V4, P348, DOI 10.1111/j.1540-8191.1989.tb00302.x; Savage EB, 2014, ANN THORAC SURG, V98, P806, DOI 10.1016/j.athoracsur.2014.05.010; Tierney JF, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-16; Wang A, 2007, JAMA-J AM MED ASSOC, V297, P1354, DOI 10.1001/jama.297.12.1354; Wos S, 1996, J Cardiovasc Surg (Torino), V37, P29; Yankah AC, 2005, EUR J CARDIO-THORAC, V28, P69, DOI 10.1016/j.ejcts.2005.03.017	30	16	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2017	12	4							e0174519	10.1371/journal.pone.0174519	http://dx.doi.org/10.1371/journal.pone.0174519			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0MB	28407024	Green Published, gold, Green Submitted			2022-12-27	WOS:000399955400011
J	Bedoya, CA; Dreisigacker, S; Hearne, S; Franco, J; Mir, C; Prasanna, BM; Taba, S; Charcosset, A; Warburton, ML				Bedoya, Claudia A.; Dreisigacker, Susanne; Hearne, Sarah; Franco, Jorge; Mir, Celine; Prasanna, Boddupalli M.; Taba, Suketoshi; Charcosset, Alain; Warburton, Marilyn L.			Genetic diversity and population structure of native maize populations in Latin America and the Caribbean	PLOS ONE			English	Article							MICROSATELLITE MARKERS; LANDRACES; DOMESTICATION; VARIETIES; MEXICAN; EUROPE; RACES; LINES	This study describes the genetic diversity and population structure of 194 native maize populations from 23 countries of Latin America and the Caribbean. The germplasm, representing 131 distinct landraces, was genetically characterized as population bulks using 28 SSR markers. Three main groups of maize germplasm were identified. The first, the Mexico and Southern Andes group, highlights the Pre-Columbian and modern exchange of germplasm between North and South America. The second group, Mesoamerica lowland, supports the hypothesis that two separate human migration events could have contributed to Caribbean maize germplasm. The third, the Andean group, displayed early introduction of maize into the Andes, with little mixing since then, other than a regional interchange zone active in the past. Events and activities in the pre- and post-Columbian Americas including the development and expansion of pre-Columbian cultures and the arrival of Europeans to the Americas are discussed in relation to the history of maize migration from its point of domestication in Mesoamerica to South America and the Caribbean through sea and land routes.	[Bedoya, Claudia A.; Dreisigacker, Susanne; Hearne, Sarah; Prasanna, Boddupalli M.; Taba, Suketoshi] Int Maize & Wheat Improvement Ctr, Appl Biotechnol Ctr, Texcoco, Mexico; [Bedoya, Claudia A.] Univ Illes Balears, Dept Biol, Illes Balears, Spain; [Franco, Jorge] Univ Republ, Fac Agron Estadist & Comp, Paysandu, Uruguay; [Mir, Celine; Charcosset, Alain] Univ Paris Sud, Unite Mixte Rech Genet Vegetale, INRA, AgroParisTech,CNRS, Yvette, France; [Warburton, Marilyn L.] Mississippi State Univ, USDA, Corn Host Plant Res Resistance Unit, Mississippi State, MS 39762 USA	CGIAR; International Maize & Wheat Improvement Center (CIMMYT); Universitat de les Illes Balears; Universidad de la Republica, Uruguay; AgroParisTech; Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Universite Paris Saclay; Mississippi State University; United States Department of Agriculture (USDA)	Warburton, ML (corresponding author), Mississippi State Univ, USDA, Corn Host Plant Res Resistance Unit, Mississippi State, MS 39762 USA.	Marilyn.Warburton@ARS.USDA.GOV	Franco, Jorge/AAF-4161-2020; Warburton, Marilyn/J-2250-2017	Franco, Jorge/0000-0001-8082-4007; Charcosset, Alain/0000-0001-6125-503X; Boddupalli, Prasanna/0000-0002-5761-2273; Hearne, Sarah/0000-0003-2015-2450; Warburton, Marilyn/0000-0002-9542-9912	Generation Challenge Program [3005.14]; CGIAR	Generation Challenge Program; CGIAR(CGIAR)	All work, prior to statistical analysis and publication, was funded by the Generation Challenge Program (grant 3005.14). The GCP has concluded its work and has evolved into the Integrated Breeding Platform (https://www.integratedbreeding.net/). The GCP was funded by the CGIAR (www.cgiar.org).; We thank Dr. D. Costich for her critical review of the manuscript. This work was supported by the Generation Challenge Program (grant 3005.14).	[Anonymous], 1988, ASA MONOGRAPH, DOI DOI 10.2134/AGR0NM0N0GR18.3ED.C2; Barros C., 1997, ARQUEOL MEX, VV, P6; Benz BF, 2000, CURR ANTHROPOL, V41, P459; Benz BF, 1999, ARQUEOL MEX, V5, P16; Blake Michael, 2006, HIST MAIZE MULTIDISC, P55; Brown WL, 1960, PUB NATL ACAD SCI NA, V792; Castillo N., 2009, DIARIO CAMPO INAH, V52, P8; CIMMYT, 2005, LAB PROT CIMMYT APPL; Dubreuil P, 2006, MAYDICA, V51, P281; Franco J, 2005, USERS MANUAL FREQAS; Franco J, 2007, USERS MANUAL FTOL R; Freitas FO, 2003, J ARCHAEOL SCI, V30, P901, DOI 10.1016/S0305-4403(02)00269-8; Gonzales S, 2006, RITUALES MAIZ ARTES, V78, P15; Goodman, 1977, RACES MAIZE BRAZIL A; Grobman A, 2012, P NATL ACAD SCI USA, V109, P1755, DOI 10.1073/pnas.1120270109; Jiang C, 1999, THEOR APPL GENET, V99, P1106, DOI 10.1007/s001220051315; Lia VV, 2009, THEOR APPL GENET, V119, P1053, DOI 10.1007/s00122-009-1108-0; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Mangelsdorf Paul C., 1974, CORN ITS ORIGIN EVOL; Manrique PA, 1997, EL MAIZ EN PERU; Matsuoka Y, 2002, P NATL ACAD SCI USA, V99, P6080, DOI 10.1073/pnas.052125199; McClintock B., 1981, CONSTITUCION CROMOSO; Melgar-Tisoc E, 2000, AMERISTICA, V5, P101; Mir C, 2013, THEOR APPL GENET, V126, P2671, DOI 10.1007/s00122-013-2164-z; Newsom Lee A, 2006, HIST MAIZE MULTIDISC, P325; Oppong A, 2014, MAYDICA, V59, P1; Perrier X., 2006, DARWIN SOFTWARE; Pierno D, 2009, P NATL ACAD SCI USA, V106, P5019; Piperno D.R., 1998, ORIGINS AGR LOWLAND; Pressoir G, 2004, HEREDITY, V92, P88, DOI 10.1038/sj.hdy.6800387; Pritchard JK, 2000, GENETICS, V155, P945; RAMIREZ R, 1961, RAZAS MAIZ BOLIVIA; Ramos-Madrigal J, 2016, CURR BIOL, V26, P3195, DOI 10.1016/j.cub.2016.09.036; Rebourg C, 2003, THEOR APPL GENET, V106, P895, DOI 10.1007/s00122-002-1140-9; Reif J, 2006, THEOR APPL GENET, V113, P177, DOI 10.1007/s00122-006-0283-5; Reyna RM, 2009, DIARIO CAMPO DESGRAN, V52, P28; Roberts LM, 1957, COLABORACION MANGELS; Ron-Parra J., 2006, COLECTAS 2004 SCENTI; Salhuana W, 1999, RACES MAIZE PARAGUAY; Sanchez-Gonzales JJ, 2011, INFORME PREPARADO PR; Santacruz-Varela A, 2004, CROP SCI, V44, P1456, DOI 10.2135/cropsci2004.1456; Semagn K, 2014, MOL BREEDING, V34, P1423, DOI 10.1007/s11032-014-0126-z; Smalley J, 2003, CURR ANTHROPOL, V44, P675, DOI 10.1086/377664; Staller JE, 2002, J ARCHAEOL SCI, V29, P33, DOI 10.1006/jasc.2001.0750; Staller JE, 2010, MAIZE COBS AND CULTURES: HISTORY OF ZEA MAYS L., P149, DOI 10.1007/978-3-642-04506-6_4; Timothy DH, 1961, PUB NAT ACAD SCI NAT, V847; van Heerwaarden J, 2011, P NATL ACAD SCI USA, V108, P1088, DOI 10.1073/pnas.1013011108; Vela E, 2010, ARQUEOL MEX, V38, P10; Vielle-Calzada Jean-Philippe, 2009, P543, DOI 10.1007/978-0-387-79418-1_27; Vigouroux Y, 2008, AM J BOT, V95, P1240, DOI 10.3732/ajb.0800097; Wang S, 2007, PLOS GENET, V3, P2049, DOI 10.1371/journal.pgen.0030185; Warburton ML, 2008, CROP SCI, V48, P617, DOI 10.2135/cropsci2007.02.0103; Warburton ML, 2011, GENET RESOUR CROP EV, V58, P1243, DOI 10.1007/s10722-010-9658-1; Warburton ML, 2002, CROP SCI, V42, P1832, DOI 10.2135/cropsci2002.1832; Wellhausen EJ, 1951, COLABORACION MANGELS	55	31	32	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2017	12	4							e0173488	10.1371/journal.pone.0173488	http://dx.doi.org/10.1371/journal.pone.0173488			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET0LZ	28403177	Green Published, gold			2022-12-27	WOS:000399955200006
J	Thomen, P; Robert, J; Monmeyran, A; Bitbol, AF; Douarche, C; Henry, N				Thomen, Philippe; Robert, Jerome; Monmeyran, Amaury; Bitbol, Anne-Florence; Douarche, Carine; Henry, Nelly			Bacterial biofilm under flow: First a physical struggle to stay, then a matter of breathing	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION ANALYSIS; ESCHERICHIA-COLI; GENE-EXPRESSION; FLUID-SHEAR; MECHANICAL-PROPERTIES; STAPHYLOCOCCUS-EPIDERMIDIS; LIFE-STYLE; IV PILI; ADHESION; STRESS	Bacterial communities attached to surfaces under fluid flow represent a widespread lifestyle of the microbial world. Through shear stress generation and molecular transport regulation, hydrodynamics conveys effects that are very different by nature but strongly coupled. To decipher the influence of these levers on bacterial biofilms immersed in moving fluids, we quantitatively and simultaneously investigated physicochemical and biological properties of the biofilm. We designed a millifluidic setup allowing to control hydrodynamic conditions and to monitor biofilm development in real time using microscope imaging. We also conducted a transcriptomic analysis to detect a potential physiological response to hydrodynamics. We discovered that a threshold value of shear stress determined biofilm settlement, with sub-piconewton forces sufficient to prevent biofilm initiation. As a consequence, distinct hydrodynamic conditions, which set spatial distribution of shear stress, promoted distinct colonization patterns with consequences on the growth mode. However, no direct impact of mechanical forces on biofilm growth rate was observed. Consistently, no mechanosensing gene emerged from our differential transcriptomic analysis comparing distinct hydrodynamic conditions. Instead, we found that hydrodynamic molecular transport crucially impacts biofilm growth by controlling oxygen availability. Our results shed light on biofilm response to hydrodynamics and open new avenues to achieve informed design of fluidic setups for investigating, engineering or fighting adherent communities.	[Thomen, Philippe; Robert, Jerome; Monmeyran, Amaury; Bitbol, Anne-Florence; Henry, Nelly] UPMC Univ Paris 06, Sorbonne Univ, Paris, France; [Thomen, Philippe; Robert, Jerome; Monmeyran, Amaury; Bitbol, Anne-Florence; Henry, Nelly] CNRS, UMR 8237, Lab Jean Perrin, Paris, France; [Douarche, Carine] Univ Paris Sud, Lab Phys Solides, UMR 8502, Orsay, France	UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Universite Paris Saclay	Henry, N (corresponding author), UPMC Univ Paris 06, Sorbonne Univ, Paris, France.; Henry, N (corresponding author), CNRS, UMR 8237, Lab Jean Perrin, Paris, France.	nelly.henry@upmc.fr		Thomen, Philippe/0000-0003-1136-4144; Bitbol, Anne-Florence/0000-0003-1020-494X; Douarche, Carine/0000-0001-5216-8997	Agence Nationale de la Recherche [ANR CE02-0001-01 ACToP]; French Agence Nationale pour la Recherche [ANR-15-CE02-0001-01 ACToP]	Agence Nationale de la Recherche(French National Research Agency (ANR)); French Agence Nationale pour la Recherche(French National Research Agency (ANR))	This work was supported by Agence Nationale de la Recherche - ANR CE02-0001-01 ACToP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The work was supported in part by a grant from the French Agence Nationale pour la Recherche (ANR-15-CE02-0001-01 ACToP).	Aggarwal S, 2012, LANGMUIR, V28, P2812, DOI 10.1021/la204342q; Alpkvist E, 2007, WATER SCI TECHNOL, V55, P265, DOI 10.2166/wst.2007.267; Alsharif G, 2015, P NATL ACAD SCI USA, V112, P5503, DOI 10.1073/pnas.1422986112; Belas R, 2014, TRENDS MICROBIOL, V22, P517, DOI 10.1016/j.tim.2014.05.002; Beloin C, 2005, TRENDS MICROBIOL, V13, P16, DOI 10.1016/j.tim.2004.11.008; Beloin C, 2004, MOL MICROBIOL, V51, P659, DOI 10.1046/j.1365-2958.2003.03865.x; Bershadsky AD, 2003, ANNU REV CELL DEV BI, V19, P677, DOI 10.1146/annurev.cellbio.19.111301.153011; Boks NP, 2008, MICROBIOL-SGM, V154, P3122, DOI 10.1099/mic.0.2008/018622-0; Castro SL, 2011, APPL ENVIRON MICROB, V77, P6368, DOI 10.1128/AEM.00175-11; Cense AW, 2006, J MICROBIOL METH, V67, P463, DOI 10.1016/j.mimet.2006.04.023; Coetser SE, 2005, CRIT REV MICROBIOL, V31, P213, DOI 10.1080/10408410500304074; Cunliffe M, 2009, ISME J, V3, P1001, DOI 10.1038/ismej.2009.69; De la Fuente L, 2007, APPL ENVIRON MICROB, V73, P2690, DOI 10.1128/AEM.02649-06; Domka J, 2007, ENVIRON MICROBIOL, V9, P332, DOI 10.1111/j.1462-2920.2006.01143.x; Douarche C, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.198101; Droppo IG, 2011, WATER RES, V45, P3797, DOI 10.1016/j.watres.2011.04.032; Dufrene YF, 2015, TRENDS MICROBIOL, V23, P376, DOI 10.1016/j.tim.2015.01.011; FRANKE RP, 1984, NATURE, V307, P648, DOI 10.1038/307648a0; Galy O, 2012, BIOPHYS J, V103, P1400, DOI 10.1016/j.bpj.2012.07.001; Geng J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102049; Ghigo JM, 2001, NATURE, V412, P442, DOI 10.1038/35086581; Grant MAA, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0400; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; Ingber D E, 2004, Mech Chem Biosyst, V1, P53; Israelachvili JN, 2011, INTERMOLECULAR AND SURFACE FORCES, 3RD EDITION, P53, DOI 10.1016/B978-0-12-375182-9.10003-X; Kim J, 2013, LAB CHIP, V13, P1846, DOI 10.1039/c3lc40802g; Kim J, 2012, MOLECULES, V17, P9818, DOI 10.3390/molecules17089818; Kim MK, 2016, NAT MICROBIOL, V1, DOI [10.1038/nmicrobiol.2015.5, 10.1038/NMICROBIOL.2015.5]; Kirisits MJ, 2007, J BACTERIOL, V189, P8357, DOI 10.1128/JB.01040-07; Kolter R, 2006, NATURE, V441, P300, DOI 10.1038/441300a; Kung C, 2010, ANNU REV MICROBIOL, V64, P313, DOI 10.1146/annurev.micro.112408.134106; Lecuyer S, 2011, BIOPHYS J, V100, P341, DOI 10.1016/j.bpj.2010.11.078; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Liu Y, 2001, J APPL MICROBIOL, V90, P337, DOI 10.1046/j.1365-2672.2001.01244.x; Marquezin CA, 2016, ANAL CHEM; Mathias JD, 2009, BIOFOULING, V25, P695, DOI 10.1080/08927010903104984; Mbaye S, 2013, BIOMICROFLUIDICS, V7, DOI 10.1063/1.4821244; Mosier AP, 2012, J MICROBIOL METH, V91, P198, DOI 10.1016/j.mimet.2012.07.006; Nickerson CA, 2003, J MICROBIOL METH, V54, P1, DOI 10.1016/S0167-7012(03)00018-6; O'Toole GA, 2016, CURR OPIN MICROBIOL, V30, P139, DOI 10.1016/j.mib.2016.02.004; OBRIEN V, 1975, J FRANKLIN I, V300, P225, DOI 10.1016/0016-0032(75)90106-4; Okegbe C, 2014, CURR OPIN MICROBIOL, V18, P39, DOI 10.1016/j.mib.2014.01.006; Otto M, 2014, FEMS MICROBIOL REV, V38, P1250, DOI 10.1111/1574-6976.12088; Pamp SJ, 2009, CYTOM PART A, V75A, P90, DOI 10.1002/cyto.a.20685; Persat A, 2015, P NATL ACAD SCI USA, V112, P7563, DOI 10.1073/pnas.1502025112; Persat A, 2015, CELL, V161, P988, DOI 10.1016/j.cell.2015.05.005; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rusconi R, 2014, ANNU REV BIOPHYS, V43, P65, DOI 10.1146/annurev-biophys-051013-022916; Schembri MA, 2003, MOL MICROBIOL, V48, P253, DOI 10.1046/j.1365-2958.2003.03432.x; Shen Y, 2012, BIOPHYS J, V103, P146, DOI 10.1016/j.bpj.2012.05.045; Shiku H, 2006, CHEM LETT, V35, P234, DOI 10.1246/cl.2006.234; Siryaporn A, 2014, P NATL ACAD SCI USA, V111, P16860, DOI 10.1073/pnas.1415712111; Song JSL, 2014, BIOTECHNOL BIOENG, V111, P597, DOI 10.1002/bit.25107; Stewart PS, 2008, NAT REV MICROBIOL, V6, P199, DOI 10.1038/nrmicro1838; Stewart PS, 2016, NPJ BIOFILMS MICROBI, V2, DOI 10.1038/npjbiofilms.2016.12; Stoodley P, 1999, BIOTECHNOL BIOENG, V65, P83, DOI 10.1002/(SICI)1097-0290(19991005)65:1<83::AID-BIT10>3.0.CO;2-B; Stoodley P, 2002, ANNU REV MICROBIOL, V56, P187, DOI 10.1146/annurev.micro.56.012302.160705; Stoodley P, 2002, J IND MICROBIOL BIOT, V29, P361, DOI 10.1038/sj.jim.7000282; Sud D, 2006, OPT EXPRESS, V14, P4412, DOI 10.1364/OE.14.004412; Thomas WE, 2002, CELL, V109, P913, DOI 10.1016/S0092-8674(02)00796-1; Trotter EW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025501; Vo GD, 2011, BIOTECHNOL BIOENG, V108, P1893, DOI 10.1002/bit.23139; WANG IW, 1995, J BIOMED MATER RES, V29, P485, DOI 10.1002/jbm.820290408	66	64	65	6	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2017	12	4							e0175197	10.1371/journal.pone.0175197	http://dx.doi.org/10.1371/journal.pone.0175197			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LZ	28403171	Green Published, gold, Green Submitted			2022-12-27	WOS:000399955200042
J	Ullal, P; Vilella-Mitjana, F; Jarmuz, A; Aragon, L				Ullal, Pranav; Vilella-Mitjana, Felipe; Jarmuz, Adam; Aragon, Luis			RETRACTION: Rtt107 Phosphorylation Promotes Localisation to DNA Double-Stranded Breaks (DSBs) and Recombinational Repair between Sister Chromatids (Retraction of Vol 6, art no E20152, 2011)	PLOS ONE			English	Retraction													Vilella, Felipe/C-2970-2018					Ullal P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020152	1	0	0	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2017	12	4							e0176035	10.1371/journal.pone.0176035	http://dx.doi.org/10.1371/journal.pone.0176035			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LZ	28403246	Green Published, gold, Green Submitted			2022-12-27	WOS:000399955200098
J	Wu, JL; Zhou, CX; Wu, PJ; Xu, J; Guo, YQ; Xue, F; Getachew, A; Xu, SF				Wu, Jiang-Li; Zhou, Chun-Xue; Wu, Peng-Jie; Xu, Jin; Guo, Yue-Qin; Xue, Fei; Getachew, Awraris; Xu, Shu-Fa			Brain metabolomic profiling of eastern honey bee (Apis cerana) infested with the mite Varroa destructor	PLOS ONE			English	Article							PARASITIC MITE; BEHAVIOR; RESPONSES; IMMUNITY; SYSTEMS	The mite Varroa destructor is currently the greatest threat to apiculture as it is causing a global decrease in honey bee colonies. However, it rarely causes serious damage to its native hosts, the eastern honey bees Apis cerana. To better understand the mechanism of resistance of A. cerana against the V. destructor mite, we profiled the metabolic changes that occur in the honey bee brain during V. destructor infestation. Brain samples were collected from infested and control honey bees and then measured using an untargeted liquid chromatography-tandem mass spectrometry (LC-MS/MS)-based global metabolomics method, in which 7918 and 7462 ions in ESI+ and ESI-mode, respectively, were successfully identified. Multivariate statistical analyses were applied, and 64 dysregulated metabolites, including fatty acids, amino acids, carboxylic acid, and phospholipids, amongst others, were identified. Pathway analysis further revealed that linoleic acid metabolism; propanoate metabolism; and glycine, serine, and threonine metabolism were acutely perturbed. The data obtained in this study offer insight into the defense mechanisms of A. cerana against V. destructor mites and provide a better method for understanding the synergistic effects of parasitism on honey bee colonies.	[Wu, Jiang-Li; Wu, Peng-Jie; Xu, Jin; Guo, Yue-Qin; Xue, Fei; Getachew, Awraris; Xu, Shu-Fa] Chinese Acad Agr Sci, Inst Apiculture Res, Key Lab Pollinating Insect Biol, Minist Agr, Beijing, Peoples R China; [Zhou, Chun-Xue] Shandong Univ, Dept Parasitol, Sch Basic Med, Jinan, Shandong, Peoples R China; [Zhou, Chun-Xue] China Agr Univ, Natl Anim Protozoa Lab, Beijing, Peoples R China; [Zhou, Chun-Xue] China Agr Univ, Coll Vet Med, Beijing, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Apicultural Research, CAAS; Ministry of Agriculture & Rural Affairs; Shandong University; China Agricultural University; China Agricultural University	Xu, SF (corresponding author), Chinese Acad Agr Sci, Inst Apiculture Res, Key Lab Pollinating Insect Biol, Minist Agr, Beijing, Peoples R China.	xushufa@caas.cn			Modern Agro-industry Technology Research System [CARS-45]; Agricultural Science and Technology Innovation Program [CAAS-ASTIP-2016-IAR]; National Natural Science Foundation of China [31372384]; Fundamental Research Funds of Institute of Apicultural Research, CAAS [16089]	Modern Agro-industry Technology Research System; Agricultural Science and Technology Innovation Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds of Institute of Apicultural Research, CAAS	Project support was provided by the Modern Agro-industry Technology Research System (CARS-45), the Agricultural Science and Technology Innovation Program (CAAS-ASTIP-2016-IAR), the National Natural Science Foundation of China (Grant No. 31372384) and the Fundamental Research Funds of Institute of Apicultural Research, CAAS (Grant No. 16089). We thank BGI-Shenzhen for technical assistance.; Project support was provided by the Modern Agro-industry Technology Research System (CARS-45), the Agricultural Science and Technology Innovation Program (CAAS-ASTIP-2016-IAR), the National Natural Science Foundation of China (Grant No. 31372384) and the Fundamental Research Funds of Institute of Apicultural Research, CAAS (Grant No. 16089).	Almeida RF, 2010, PHARMACOL BIOCHEM BE, V96, P306, DOI 10.1016/j.pbb.2010.05.022; Arechavaleta-Velasco ME, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047269; Aumeier P., 2000, APIDOLOGIE, V31, P633; Bang S, 2011, PAIN, V152, P1156, DOI 10.1016/j.pain.2011.01.044; BEUTLER JA, 1985, BRAIN RES, V330, P135, DOI 10.1016/0006-8993(85)90014-9; Chen YP, 2007, ADV VIRUS RES, V70, P33, DOI 10.1016/S0065-3527(07)70002-7; Di Prisco G, 2016, P NATL ACAD SCI USA, V113, P3203, DOI 10.1073/pnas.1523515113; Dobrosotskaya IY, 2002, SCIENCE, V296, P879, DOI 10.1126/science.1071124; Du JL, 2014, MOL BIOSYST, V10, P2441, DOI 10.1039/c4mb00287c; Fussnecker BL, 2006, J INSECT PHYSIOL, V52, P1083, DOI 10.1016/j.jinsphys.2006.07.008; Genersch E, 2010, APPL MICROBIOL BIOT, V87, P87, DOI 10.1007/s00253-010-2573-8; Halama A, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0576-z; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Kang Y, 2016, MATH BIOSCI, V275, P71, DOI 10.1016/j.mbs.2016.02.012; Lamattina L, 2003, ANNU REV PLANT BIOL, V54, P109, DOI 10.1146/annurev.arplant.54.031902.134752; Lee KR, 2003, PROTEOMICS, V3, P1680, DOI 10.1002/pmic.200300515; Locke B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099998; Marder E, 2001, CURR BIOL, V11, pR986, DOI 10.1016/S0960-9822(01)00581-4; McDonnell CM, 2013, BMC ECOL, V13, DOI 10.1186/1472-6785-13-25; Micheli V, 2011, CURR TOP MED CHEM, V11, P923, DOI 10.2174/156802611795347645; Mondet F, 2015, SCI REP-UK, V5, DOI 10.1038/srep10454; Mustard JA, 2010, J INSECT PHYSIOL, V56, P422, DOI 10.1016/j.jinsphys.2009.11.018; Navajas M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-301; Nicholson JK, 2008, NATURE, V455, P1054, DOI 10.1038/4551054a; Nicholson JK, 1999, XENOBIOTICA, V29, P1181, DOI 10.1080/004982599238047; Ohashi Y, 2008, MOL BIOSYST, V4, P135, DOI 10.1039/b714176a; Olszewski KL, 2009, CELL HOST MICROBE, V5, P191, DOI 10.1016/j.chom.2009.01.004; Parker R, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r81; Rosenkranz P, 2010, J INVERTEBR PATHOL, V103, pS96, DOI 10.1016/j.jip.2009.07.016; Santos JD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160465; Schmidt AP, 2007, PHARMACOL THERAPEUT, V116, P401, DOI 10.1016/j.pharmthera.2007.07.004; Spivak M, 2003, J NEUROBIOL, V55, P341, DOI 10.1002/neu.10219; Umezawa M, 1999, J NUTR, V129, P431, DOI 10.1093/jn/129.2.431; Vance JE, 2013, BBA-MOL CELL BIOL L, V1831, P543, DOI 10.1016/j.bbalip.2012.08.016; vanEngelsdorp D, 2010, J INVERTEBR PATHOL, V103, pS80, DOI 10.1016/j.jip.2009.06.011; Wang C, 2013, SCIENCE, V340, P610, DOI 10.1126/science.1232807; Wishart DS, 2013, NUCLEIC ACIDS RES, V41, pD801, DOI 10.1093/nar/gks1065; Wu H, 2009, ANAL CHIM ACTA, V648, P98, DOI 10.1016/j.aca.2009.06.033; Xia JG, 2015, NUCLEIC ACIDS RES, V43, pW251, DOI 10.1093/nar/gkv380; Zhou CX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139635; Zhukovskaya Marianna, 2013, Insects, V4, P609, DOI 10.3390/insects4040609	41	15	17	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2017	12	4							e0175573	10.1371/journal.pone.0175573	http://dx.doi.org/10.1371/journal.pone.0175573			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LZ	28403242	Green Submitted, Green Published, gold			2022-12-27	WOS:000399955200081
J	Li, P; Tong, ZD; Li, KF; Tang, A; Dai, YX; Yan, JB				Li, Peng; Tong, Zhen-Dong; Li, Ke-Feng; Tang, An; Dai, Ya-Xin; Yan, Jian-Bo			Seroprevalence of severe fever with thrombocytopenia syndrome virus in China: A systematic review and meta-analysis	PLOS ONE			English	Review							SHANDONG PROVINCE; RISK-FACTORS; EPIDEMIOLOGIC FEATURES; SYNDROME BUNYAVIRUS; TICK-BORNE; SFTS VIRUS; INFECTION; ANTIBODIES; TRANSMISSION; ANIMALS	Objective Severe fever with thrombocytopenia syndrome (SFTS) is an emerging infectious disease caused by a novel bunyavirus-SFTSV. The seroprevalence of anti-SFTSV antibodies including immunoglobulin G (IgG) and immunoglobulin M (IgM), specific to SFTSV in the general population has been investigated in various epidemiological studies with inconsistent results. Here, we clarify this discrepancy and reach a more comprehensive result by mean of a meta-analysis. Methods All relevant articles were searched in the electronic databases (PubMed, Web of science, Embase, Chinese National Knowledge Infrastructure database, Chinese Wanfang database) up to November 2016. The pooled seroprevalence and 95% confidence intervals (95% CIs) were calculated by random-or fixed-model on the basis of heterogeneity. Results In total, 21 studies containing 23,848 blood samples from 7 provinces were included in this meta-analysis. The minimum and maximum reported seroprevalences of SFTSV among humans in China were 0.23% and 9.17%, respectively. The overall pooled seroprevalence of SFTSV antibodies was 4.3% (95% CI: 3.2%-5.5%). The pooled prevalence was 5.9% (95% CI: 4.7%-7.0%) in Zhejiang province, 4.9% (95% CI: 4.1-5.8%) in Anhui province, 3.9% (95% CI: 1.3%-6.4%) in Shandong province, and 0.7% (95% CI: 0.2%-1.1%) in Jiangsu province. Stratified by occupation, the pooled prevalence of farmer was 6.1% (95% CI: 3.4%-8.9%) and others (mainly are students) was 3.3% (95% CI: 2.4%-4.2%). Additionally, seroprevalence of SFTSV in people who lived in the same village with the patient were higher than that of people who lived in a different village. Seropositive rates in sampling years after 2012 were higher than that before 2012. The prevalence of SFTSV did not differ by age or gender. Sensitive analysis by omitting one study at a time indicated the results of the pooled seroprevalence were robust. Conclusions Seroprevalence of SFTSV among healthy population in central and eastern China is high. Surveillance efforts on mild or asymptomatic infections among endemic persons are needed.	[Li, Peng; Tong, Zhen-Dong; Li, Ke-Feng; Tang, An; Dai, Ya-Xin; Yan, Jian-Bo] Zhoushan Municipal Ctr Dis Control & Prevent, Zhoushan, Zhejiang, Peoples R China; [Li, Peng; Tong, Zhen-Dong; Li, Ke-Feng; Tang, An; Dai, Ya-Xin; Yan, Jian-Bo] Zhoushan Municipal Ctr Dis Control & Prevent, Zhejiang Prov Key Lab Hlth Risk Factors Seafood, Zhoushan, Zhejiang, Peoples R China		Tong, ZD; Yan, JB (corresponding author), Zhoushan Municipal Ctr Dis Control & Prevent, Zhoushan, Zhejiang, Peoples R China.; Tong, ZD; Yan, JB (corresponding author), Zhoushan Municipal Ctr Dis Control & Prevent, Zhejiang Prov Key Lab Hlth Risk Factors Seafood, Zhoushan, Zhejiang, Peoples R China.	zscdc@hotmail.com; yanjianbo02@163.com		Li, Peng/0000-0002-2533-1864; Tong, Zhen-Dong/0000-0003-3309-0674	science and technology program of Zhoushan City [2014C31075]; medical and health projects of Zhoushan City [2016A12]	science and technology program of Zhoushan City; medical and health projects of Zhoushan City	This work was supported by the science and technology program of Zhoushan City (2014C31075) and the medical and health projects of Zhoushan City (2016A12). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ades AE, 2005, MED DECIS MAKING, V25, P646, DOI 10.1177/0272989X05282643; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Cui F, 2013, AM J TROP MED HYG, V88, P510, DOI 10.4269/ajtmh.11-0760; Diang SJ, 2014, JPN J INFECT DIS, V67, P1, DOI 10.7883/yoken.67.1; Ding F, 2013, CLIN INFECT DIS, V56, P1682, DOI 10.1093/cid/cit100; Gai ZT, 2012, CLIN INFECT DIS, V54, P249, DOI 10.1093/cid/cir776; Hu CY, 2015, AM J TROP MED HYG, V92, P479, DOI 10.4269/ajtmh.14-0447; Huang X, 2016, JPN J INFECT DIS; Jiang XL, 2015, CLIN MICROBIOL INFEC, V21, P274, DOI 10.1016/j.cmi.2014.10.006; Jiao YJ, 2012, J CLIN MICROBIOL, V50, P372, DOI 10.1128/JCM.01319-11; Khan SU, 2015, J INFECT DIS, V212, P562, DOI 10.1093/infdis/jiv109; Li DX, 2015, CLIN MICROBIOL INFEC, V21, P614, DOI 10.1016/j.cmi.2015.03.001; Li YC, 2014, BIOTECHNOL LETT, V36, P2011, DOI 10.1007/s10529-014-1581-7; Li ZF, 2014, J CLIN VIROL, V60, P185, DOI 10.1016/j.jcv.2014.03.020; Liang S, 2011, AM J TROP MED HYG, V90, P256, DOI DOI 10.4269/AJTMH.13-0423; Liu JW, 2014, EMERG INFECT DIS, V20, P2126, DOI 10.3201/eid2012.141013; Liu K, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002820; Liu Q, 2014, LANCET INFECT DIS, V14, P763, DOI 10.1016/S1473-3099(14)70718-2; Liu Y, 2012, VECTOR-BORNE ZOONOT, V12, P156, DOI 10.1089/vbz.2011.0758; Luo LM, 2015, EMERG INFECT DIS, V21, P1770, DOI 10.3201/eid2110.150126; Luo LM, 2016, INVESTIGATION OF RES; Lyu Y, 2016, INFECT DIS-NOR, V48, P544, DOI 10.3109/23744235.2016.1165351; Meng K, 2015, PARASITOL RES, V114, P4703, DOI 10.1007/s00436-015-4718-2; Niu GY, 2016, EPIDEMIOLOGICAL INVE; Nyakarahuka L, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-2045-6; Rostom A, CELIAC DIS; Sun JM, 2015, EPIDEMIOL INFECT, V143, P851, DOI 10.1017/S0950268814001319; Sun JM, 2014, INT J INFECT DIS, V25, P180, DOI 10.1016/j.ijid.2014.02.022; Takahashi T, 2014, J INFECT DIS, V209, P816, DOI 10.1093/infdis/jit603; Tan WenWen, 2015, China Tropical Medicine, V15, P359; Wang D, 2016, EXP APPL ACAROL, V68, P213, DOI 10.1007/s10493-015-9992-2; Wang Jingli, 2016, J CHINESE AGR MECH, V37, P37, DOI DOI 10.3760/CMA.J.ISSN.0254-6450.2016.02.029; WANG L, 2013, MODERN PREVENTIVE ME, V40, P3471; Wang SW, 2015, AM J TROP MED HYG, V92, P684, DOI 10.4269/ajtmh.14-0008; Wei J, 2015, INT J INFECT DIS, V35, P37, DOI 10.1016/j.ijid.2015.02.014; Xing XS, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002533; Xu PengPeng, 2015, Modern Preventive Medicine, V42, P1948; Yang BY, 2015, PEDIATR INFECT DIS J, V34, P1399, DOI 10.1097/INF.0000000000000900; Yu XJ, 2011, NEW ENGL J MED, V364, P1523, DOI 10.1056/NEJMoa1010095; Zhan JB, 2013, CHIN J HLTH LAB TECH, V23, P992; Zhang L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111127; Zhang L, 2014, EMERG INFECT DIS, V20, P1355, DOI 10.3201/eid2008.131796; Zhang WenShuai, 2011, Disease Surveillance, V26, P676; Zhao L, 2012, EMERG INFECT DIS, V18, P963, DOI 10.3201/eid1806.111345; Zhou ShuQin, 2015, Modern Preventive Medicine, V42, P476	45	19	23	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2017	12	4							e0175592	10.1371/journal.pone.0175592	http://dx.doi.org/10.1371/journal.pone.0175592			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0JS	28399161	gold, Green Published, Green Submitted			2022-12-27	WOS:000399949000052
J	Tsai, HJ; Chang, FK				Tsai, Hsin-Jen; Chang, Fu-Kuei			Associations between body mass index, mid-arm circumference, calf circumference, and functional ability over time in an elderly Taiwanese population	PLOS ONE			English	Article							MINI NUTRITIONAL ASSESSMENT; PHYSICAL FUNCTION; ANTHROPOMETRIC MEASUREMENTS; MORTALITY RISK; HEALTH-STATUS; OBESITY; BMI; DISABILITY; DECLINE; FRAILTY	Background Anthropometric measurements such as body mass index (BMI), mid-arm circumference (MAC), and calf-circumference (CC) are assessed with ease during regular health visits, but the associations between these anthropometric parameters and functional ability in elderly population over time has not been studied in detail. This study aimed to examine the associations between functional ability and the anthropometric parameters BMI, MAC, and CC in Taiwanese adults >= 65 years old. Methods Data were obtained from the Taiwan Longitudinal Study of Aging and analyzed retrospectively. Results Functional decline over a 4- and 8-year period was noted in approximately 14% and 21% of study participants, respectively. BMI was negatively associated with participants' current Activities of Daily Living (ADL) scores, and was positively associated with 4-year ADL scores in adults >= 65 years old (beta = -1.19 and 1.14, P = 0.0010 and 0.0420, respectively). MAC and CC were negatively associated with current ADL scores (beta = -1.46, P < 0.0001 and beta = -4.68, P < 0.0001, respectively). The association between CC and current ADL score was stronger than the association between current ADL score and either BMI or MAC. For adults >= 65 years old, a high BMI increased the risk of ADL decline over 4 and 8 years by 4-fold and 3-fold (adjusted odds ratio = 4.23 and 2.64, 95% confidential interval = 1.95-9.19 and 1.22-5.71, P = 0.0003 and 0.0141, respectively). Conclusions BMI is a significant predictor of decline of functional ability in Taiwanese adults >= 65 years old. CC is an important anthropometric indicator of current functional ability among older adults.	[Tsai, Hsin-Jen; Chang, Fu-Kuei] I Shou Univ, Dept Hlth Management, Kaohsiung, Taiwan	I Shou University	Tsai, HJ (corresponding author), I Shou Univ, Dept Hlth Management, Kaohsiung, Taiwan.	hsinjen@gmail.com						Al Snih S, 2007, ARCH INTERN MED, V167, P774, DOI 10.1001/archinte.167.8.774; Aoki Y, 2014, NCHS DATA BRIEF, V140, P1; Asakawa T, 2000, INT J AGING HUM DEV, V50, P319, DOI 10.2190/3TR1-4V6R-MA5M-U1BV; Bahat G, 2012, ARCH GERONTOL GERIAT, V54, P78, DOI 10.1016/j.archger.2011.04.019; Booth HP, 2014, FAM PRACT, V31, P38, DOI 10.1093/fampra/cmt061; Chen CY, 2010, ARCH GERONTOL GERIAT, V50, pS43, DOI 10.1016/S0167-4943(10)70012-1; Corona LP, 2014, PUBLIC HEALTH NUTR, V17, P390, DOI 10.1017/S1368980012005319; Cournot M, 2006, NEUROLOGY, V67, P1208, DOI 10.1212/01.wnl.0000238082.13860.50; Deschamps V, 2002, EUR J CLIN NUTR, V56, P305, DOI 10.1038/sj.ejcn.1601311; Enoki H, 2007, CLIN NUTR, V26, P597, DOI 10.1016/j.clnu.2007.06.008; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Hermalin A. L., 1989, 891 U MICH; Izawa S, 2010, BRIT J NUTR, V103, P289, DOI 10.1017/S0007114509991723; KATZ S, 1963, JAMA-J AM MED ASSOC, V185, P914, DOI 10.1001/jama.1963.03060120024016; Kivipelto M, 2005, ARCH NEUROL-CHICAGO, V62, P1556, DOI 10.1001/archneur.62.10.1556; Landi F, 2014, CLIN NUTR, V33, P539, DOI 10.1016/j.clnu.2013.07.013; Lang IA, 2008, J AM GERIATR SOC, V56, P1474, DOI 10.1111/j.1532-5415.2008.01813.x; Larrieu S, 2004, INT J OBESITY, V28, P1555, DOI 10.1038/sj.ijo.0802755; Lin SJ, 2012, J NURS RES, V20, P110, DOI 10.1097/jnr.0b013e318254eac9; National Development Council, 2018, AN POP PROJ TAIW AR; REUBEN DB, 1992, J GERONTOL, V47, pM106, DOI 10.1093/geronj/47.4.M106; Rolland Y, 2003, J AM GERIATR SOC, V51, P1120, DOI 10.1046/j.1532-5415.2003.51362.x; Scott WK, 1997, J CLIN EPIDEMIOL, V50, P291, DOI 10.1016/S0895-4356(96)00365-4; Tsai AC, 2008, J NUTR HEALTH AGING, V12, P696; Tsai AC, 2011, BRIT J NUTR, V105, P275, DOI 10.1017/S0007114510003429; Tsai ACH, 2007, ASIA PAC J CLIN NUTR, V16, P656; Tsai ACH, 2012, ARCH GERONTOL GERIAT, V54, P443, DOI 10.1016/j.archger.2011.05.015; Tsai ACH, 2011, ARCH GERONTOL GERIAT, V53, P298, DOI 10.1016/j.archger.2010.12.003; Wee CC, 2011, ANN INTERN MED, V154, P645, DOI 10.7326/0003-4819-154-10-201105170-00003; Whitmer RA, 2005, BMJ-BRIT MED J, V330, P1360, DOI 10.1136/bmj.38446.466238.E0; Wikstrom K, 2015, EUR J INTERN MED, V26, P211, DOI 10.1016/j.ejim.2015.02.012; Wong CH, 2010, AGING CLIN EXP RES, V22, P54, DOI [10.1007/BF03324816, 10.3275/6675]; Woo J, 2001, J AM GERIATR SOC, V49, P737, DOI 10.1046/j.1532-5415.2001.49150.x; World Health Organization, 1995, 854 WHO; World Health Organization, 2013, WHAT WHO IS DOING GU; Wu CY, 2013, ARCH GERONTOL GERIAT, V57, P177, DOI 10.1016/j.archger.2013.04.011; Zimmer Z, 1998, DEMOGRAPHY, V35, P361, DOI 10.2307/3004043; Zimmer Z, 2002, POP STUD-J DEMOG, V56, P265, DOI 10.1080/00324720215931	38	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2017	12	4							e0175062	10.1371/journal.pone.0175062	http://dx.doi.org/10.1371/journal.pone.0175062			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET0JS	28399183	gold, Green Published, Green Submitted			2022-12-27	WOS:000399949000017
J	Shalabaeva, V; Lovato, L; La Rocca, R; Messina, GC; Dipalo, M; Miele, E; Perrone, M; Gentile, F; De Angelis, F				Shalabaeva, Victoria; Lovato, Laura; La Rocca, Rosanna; Messina, Gabriele C.; Dipalo, Michele; Miele, Ermanno; Perrone, Michela; Gentile, Francesco; De Angelis, Francesco			Time resolved and label free monitoring of extracellular metabolites by surface enhanced Raman spectroscopy	PLOS ONE			English	Article							3D NANOSTAR DIMERS; GOLD NANOPARTICLES; LIVE CELLS; SERS; SCATTERING; METABOLOMICS; NANOSTRUCTURES; MOLECULE; FABRICATION; PLASMONICS	Metabolomics is an emerging field of cell biology that aims at the comprehensive identification of metabolite levels in biological fluids or cells in a specific functional state. Currently, the major tools for determining metabolite concentrations are mass spectrometry coupled with chromatographic techniques and nuclear magnetic resonance, which are expensive, time consuming and destructive for the samples. Here, we report a time resolved approach to monitor metabolite dynamics in cell cultures, based on Surface Enhanced Raman Scattering (SERS). This method is label-free, easy to use and provides the opportunity to simultaneously study a broad range of molecules, without the need to process the biological samples. As proof of concept, NIH/3T3 cells were cultured in vitro, and the extracellular medium was collected at different time points to be analyzed with our engineered SERS substrates. By identifying individual peaks of the Raman spectra, we showed the simultaneous detection of several components of the conditioned medium, such as L-tyrosine, L-tryptophan, glycine, L-phenylalanine, L-histidine and fetal bovine serum proteins, as well as their intensity changes during time. Furthermore, analyzing the whole Raman data set with the Principal Component Analysis (PCA), we demonstrated that the Raman spectra collected at different days of culture and clustered by similarity, described a well-defined trajectory in the principal component plot. This approach was then utilized to determine indirectly the functional state of the macrophage cell line Raw 264.7, stimulated with the lipopolysaccharide (LPS) for 24 hours. The collected spectra at different time points, clustered by the PCA analysis, followed a well-defined trajectory, corresponding to the functional change of cells toward the activated pro-inflammatory state induced by the LPS. This study suggests that our engineered SERS surfaces can be used as a versatile tool both for the characterization of cell culture conditions and the functional state of cells over time.	[Shalabaeva, Victoria; Lovato, Laura; La Rocca, Rosanna; Messina, Gabriele C.; Dipalo, Michele; Miele, Ermanno; Perrone, Michela; De Angelis, Francesco] Ist Italiano Tecnol, Plasmon Nanotechnol, Genoa, Italy; [Gentile, Francesco] Univ Naples Federico II, Dept Elect Engn & Informat Technol DIETI, Naples, Italy	Istituto Italiano di Tecnologia - IIT; University of Naples Federico II	Lovato, L; De Angelis, F (corresponding author), Ist Italiano Tecnol, Plasmon Nanotechnol, Genoa, Italy.	laura.lovato@iit.it; francesco.deangelis@iit.it	Dipalo, Michele/D-6708-2014; GENTILE, Francesco/K-8565-2016	Dipalo, Michele/0000-0002-1823-8231; GENTILE, Francesco/0000-0002-1724-6301; Lovato, Laura/0000-0003-2067-8858; Shalabaeva, Victoria/0000-0001-6418-0248	European Research Council under the European Union's [616213]; CoG: Neuro-Plasmonics	European Research Council under the European Union's; CoG: Neuro-Plasmonics	FDA: European Research Council under the European Union's Seventh Framework Programme (FP/2007-2013) /ERC Grant Agreement n. [616213], CoG: Neuro-Plasmonics. https://erc.europa.eu/.	Accardo A, 2014, LANGMUIR, V30, P3191, DOI 10.1021/la500145r; Ando J, 2011, NANO LETT, V11, P5344, DOI 10.1021/nl202877r; Bailey MR, 2015, ANAL CHEM, V87, P4347, DOI 10.1021/acs.analchem.5b00075; Berger AG, 2017, ANAL CHIM ACTA, V949, P59, DOI 10.1016/j.aca.2016.10.035; Blanc M, 2013, IMMUNITY, V38, P106, DOI 10.1016/j.immuni.2012.11.004; Bozzetto S., 2016, PHARM RES, V115, P162; Carr EL, 2010, J IMMUNOL, V185, P1037, DOI 10.4049/jimmunol.0903586; Cheng SC, 2014, SCIENCE, V345, P1579, DOI 10.1126/science.1250684; Chirumamilla M, 2014, ADV MATER, V26, P2353, DOI 10.1002/adma.201304553; Chou IH, 2008, NANO LETT, V8, P1729, DOI 10.1021/nl0808132; Coluccio ML, 2014, SENSORS-BASEL, V14, P6056, DOI 10.3390/s140406056; Culha M., 2012, J NANOTECHNOL; Das G, 2011, J MOL STRUCT, V993, P500, DOI 10.1016/j.molstruc.2010.12.044; De Angelis F, 2011, NANOSCALE, V3, P2689, DOI 10.1039/c1nr10124b; De Angelis F, 2013, NANO LETT, V13, P3553, DOI 10.1021/nl401100x; De Gelder J, 2007, J RAMAN SPECTROSC, V38, P1133, DOI 10.1002/jrs.1734; De Luca AC, 2014, ACS NANO, V8, P2575, DOI 10.1021/nn406200y; Dieringer JA, 2009, J AM CHEM SOC, V131, P849, DOI 10.1021/ja8080154; Dipalo M, 2015, NANOSCALE, V7, P3703, DOI 10.1039/c4nr05578k; Elsheikha Hany M, 2014, BMC Res Notes, V7, P406, DOI 10.1186/1756-0500-7-406; Garrett R., 2010, BIOCHEMISTRY; Gopalakrishnan A, 2014, ACS NANO, V8, P7986, DOI 10.1021/nn5020038; Guicheteau J, 2008, APPL SPECTROSC, V62, P267, DOI 10.1366/000370208783759623; Hamon C, 2014, ACS NANO, V8, P10694, DOI 10.1021/nn504407z; HAYASHI S, 1985, SURF SCI, V158, P229, DOI 10.1016/0039-6028(85)90297-3; Hodges MD, 2011, ACS NANO, V5, P9535, DOI 10.1021/nn202652h; Hudson SD, 2009, ANAL BIOANAL CHEM, V394, P679, DOI 10.1007/s00216-009-2756-2; Ichimura T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084478; Kang B, 2014, ACS NANO, V8, P4883, DOI 10.1021/nn500840x; Kang JW, 2015, NANO LETT, V15, P1766, DOI 10.1021/nl504444w; Khlebtsov BN, 2015, ACS APPL MATER INTER, V7, P6518, DOI 10.1021/acsami.5b01652; Kneipp J, 2006, NANO LETT, V6, P2225, DOI 10.1021/nl061517x; Kneipp J, 2014, FRONTIERS OF SURFACE-ENHANCED RAMAN SCATTERING: SINGLE NANOPARTICLES AND SINGLE CELLS, P285; Kneipp J, 2010, NANOMED-NANOTECHNOL, V6, P214, DOI 10.1016/j.nano.2009.07.009; La Rocca R, 2015, SMALL, V11, P4632, DOI 10.1002/smll.201500891; Lu A.Y., 2016, J NEUROSURG, V25, P1; Lyandres O, 2008, BIOMEDICAL VIBRATION, P221; Meng J, 2017, TALANTA, V164, P693, DOI 10.1016/j.talanta.2016.10.101; Metallo CM, 2013, MOL CELL, V49, P388, DOI 10.1016/j.molcel.2013.01.018; Notingher I, 2007, SENSORS-BASEL, V7, P1343, DOI 10.3390/s7081343; Ock K, 2012, ANAL CHEM, V84, P2172, DOI 10.1021/ac2024188; Ozturk SS, 1997, BIOTECHNOL BIOENG, V53, P372, DOI 10.1002/(SICI)1097-0290(19970220)53:4<372::AID-BIT3>3.0.CO;2-K; Palonpon AF, 2013, CURR OPIN CHEM BIOL, V17, P708, DOI 10.1016/j.cbpa.2013.05.021; Palonpon AF, 2013, NAT PROTOC, V8, P677, DOI 10.1038/nprot.2013.030; Patti GJ, 2012, NAT REV MOL CELL BIO, V13, P263, DOI 10.1038/nrm3314; Premasiri WR, 2014, FRONTIERS OF SURFACE-ENHANCED RAMAN SCATTERING: SINGLE NANOPARTICLES AND SINGLE CELLS, P257; Robinette SL, 2012, ACCOUNTS CHEM RES, V45, P288, DOI 10.1021/ar2001606; Rodriguez A, 2014, SCIENCE, V344, P1492, DOI 10.1126/science.1242072; Rusciano G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072127; SIAMWIZA MN, 1975, BIOCHEMISTRY-US, V14, P4870, DOI 10.1021/bi00693a014; Sjoberg B, 2014, SPECTROCHIM ACTA A, V128, P300, DOI 10.1016/j.saa.2014.02.080; Smith E, 2005, MODERN RAMAN SPECTROSCOPY: A PRACTICAL APPROACH, P1; Sreekumar A, 2009, NATURE, V457, P910, DOI 10.1038/nature07762; Sun L, 2009, BIOPHYS J, V96, P4709, DOI 10.1016/j.bpj.2009.03.021; Swain RJ, 2010, BIOPHYS J, V98, P1703, DOI 10.1016/j.bpj.2009.12.4289; Tsimbouri PM, 2012, ACS NANO, V6, P10239, DOI 10.1021/nn304046m; Wishart DS, 2013, NUCLEIC ACIDS RES, V41, pD801, DOI 10.1093/nar/gks1065; Wurtz P, 2016, INT J EPIDEMIOL, V45, P1539, DOI 10.1093/ije/dyw255; Xie YL, 2014, ACS NANO, V8, P12175, DOI 10.1021/nn503826r; Yamazoe S, 2014, ACS NANO, V8, P5622, DOI 10.1021/nn4065692; Yuan M, 2012, NAT PROTOC, V7, P872, DOI 10.1038/nprot.2012.024; Zavaleta CL, 2009, P NATL ACAD SCI USA, V106, P13511, DOI 10.1073/pnas.0813327106; Zhu GY, 2011, SPECTROCHIM ACTA A, V78, P1187, DOI [10.1016/j.saa.2010.12.079, 10.1016/j.saa.2010.12.07]	63	27	27	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2017	12	4							e0175581	10.1371/journal.pone.0175581	http://dx.doi.org/10.1371/journal.pone.0175581			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KH	28419111	Green Published, gold, Green Submitted			2022-12-27	WOS:000399875200028
J	Caletti, E; Marotta, G; Del Vecchio, G; Paoli, RA; Cigliobianco, M; Prunas, C; Zugno, E; Bottinelli, F; Brambilla, P; Altamura, AC				Caletti, Elisabetta; Marotta, Giorgio; Del Vecchio, Giuseppe; Paoli, Riccardo A.; Cigliobianco, Michela; Prunas, Cecilia; Zugno, Elisa; Bottinelli, Francesca; Brambilla, Paolo; Altamura, A. Carlo			The metabolic basis of cognitive insight in psychosis: A positron emission tomography study	PLOS ONE			English	Article							SUPERIOR TEMPORAL GYRUS; MINI-MENTAL-STATE; BIPOLAR DISORDER; ORBITOFRONTAL CORTEX; POOR INSIGHT; SCHIZOPHRENIA EVIDENCE; MATTER ABNORMALITIES; PREFRONTAL CORTEX; NEGATIVE SYMPTOMS; MAJOR DEPRESSION	The purpose of this study was to investigate the relationship between cognitive insight and cerebral metabolism in patients suffering from psychosis. The Beck Cognitive Insight Scale (BCIS) was administered to 63 patients with psychosis undergoing Positron Emission Tomography investigation. The sample was divided into two groups considering the BCIS score. Data were analyzed using Statistical Parametric Mapping. Results: patients with low insight, compared to those with high insight, showed decreased metabolism in the right fusiform gyrus, left precuneus, superior temporal gyrus and insula bilaterally, as well as increased metabolism in the left orbito-frontal gyrus (all p<0.005). Our results suggest that reduced posterior (occipito-temporo-insulo-parietal) and increased anterior (orbitofrontal) cerebral metabolism may sustain low cognitive insight in psychosis.	[Caletti, Elisabetta; Paoli, Riccardo A.; Cigliobianco, Michela; Prunas, Cecilia; Zugno, Elisa; Bottinelli, Francesca; Brambilla, Paolo; Altamura, A. Carlo] Univ Milan, Fdn IRCCS Ca Granda Osped Maggiore Policlin, Dept Psychiat, Milan, Italy; [Marotta, Giorgio] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Nucl Med Sect, Milan, Italy; [Del Vecchio, Giuseppe] IRCCS E Medea, San Vito Al Tagliamento, PN, Italy; [Brambilla, Paolo] Univ Texas Houston, Dept Psychiat & Behav Neurosci, Houston, TX USA	IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico; IRCCS Eugenio Medea; University of Texas System; University of Texas Health Science Center Houston	Paoli, RA; Brambilla, P (corresponding author), Univ Milan, Fdn IRCCS Ca Granda Osped Maggiore Policlin, Dept Psychiat, Milan, Italy.; Brambilla, P (corresponding author), Univ Texas Houston, Dept Psychiat & Behav Neurosci, Houston, TX USA.	riccardo.paoli@guest.unimi.it; paolo.brambilla1@unimi.it	brambilla, paolo/B-4184-2010; prunas, cecilia/AAB-7687-2019; Delvecchio, Giuseppe/J-7721-2016	brambilla, paolo/0000-0002-4021-8456; Delvecchio, Giuseppe/0000-0003-4750-1980; Marotta, Giorgio/0000-0002-5945-8628; Caletti, Elisabetta/0000-0002-2924-7088				Alaimo SM, 2015, PSYCHOLOGY, V6, P1940; Altamura AC, 2013, PSYCHIAT RES-NEUROIM, V214, P410, DOI 10.1016/j.pscychresns.2013.08.011; Amador Xavier F., 1993, Psychiatric Quarterly (New York), V64, P305, DOI 10.1007/BF01064924; Amador XF, 1998, INSIGHT AND PSYCHOSIS, P15; AMADOR XF, 1991, SCHIZOPHRENIA BULL, V17, P113, DOI 10.1093/schbul/17.1.113; AMADOR XF, 1994, ARCH GEN PSYCHIAT, V51, P826; Antonius D, 2011, SCHIZOPHR RES, V128, P76, DOI 10.1016/j.schres.2011.02.020; Baas D, 2008, NEUROIMAGE, V40, P719, DOI 10.1016/j.neuroimage.2007.12.039; Baier M, 2010, CURR PSYCHIAT REP, V12, P356, DOI 10.1007/s11920-010-0125-7; Barr WB, 1998, INSIGHT AND PSYCHOSIS, P107; Bechara A, 2004, BRAIN COGNITION, V55, P30, DOI 10.1016/j.bandc.2003.04.001; Beck A. T., 2004, INSIGHT PSYCHOSIS AW, P79; Beck AT, 2004, SCHIZOPHR RES, V68, P319, DOI 10.1016/s0920-9964(03)00189-0; Bellani M, 2010, EPIDEMIOL PSICHIAT S, V19, P23; Berge D, 2011, ACTA PSYCHIAT SCAND, V123, P431, DOI 10.1111/j.1600-0447.2010.01635.x; Bigler ED, 2007, DEV NEUROPSYCHOL, V31, P217, DOI 10.1080/87565640701190841; Blumberg HP, 1999, AM J PSYCHIAT, V156, P1986; Bora E, 2007, EUR ARCH PSY CLIN N, V257, P104, DOI 10.1007/s00406-006-0681-3; Brambilla P, 2013, PSYCHOL MED, V43, P571, DOI 10.1017/S0033291712001304; Brambilla P, 2011, PROG NEURO-PSYCHOPH, V35, P1093, DOI 10.1016/j.pnpbp.2011.03.007; Brune M, 2011, CURR PSYCHIATRY REV, V7, P239, DOI 10.2174/157340011797183210; Buchy L, 2009, SCHIZOPHR RES, V112, P187, DOI 10.1016/j.schres.2009.03.019; Buchy L, 2014, PSYCHIAT CLIN NEUROS, V68, P683, DOI 10.1111/pcn.12177; Buchy L, 2011, J PSYCHIATR RES, V45, P781, DOI 10.1016/j.jpsychires.2010.10.016; Buchy L, 2010, SCHIZOPHR RES, V117, P224, DOI 10.1016/j.schres.2010.02.323; Cassidy F, 2010, NEUROPSYCH DIS TREAT, V6, P627, DOI 10.2147/NDT.S12663; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Chen X, 2015, SCHIZOPHR RES, V166, P151, DOI 10.1016/j.schres.2015.06.014; CORCORAN R, 1995, SCHIZOPHR RES, V17, P5, DOI 10.1016/0920-9964(95)00024-G; Cotter D, 2005, BIPOLAR DISORD, V7, P358, DOI 10.1111/j.1399-5618.2005.00230.x; Couture SM, 2011, SCHIZOPHR RES, V125, P152, DOI 10.1016/j.schres.2010.09.020; Dam J, 2006, NORD J PSYCHIAT, V60, P114, DOI 10.1080/08039480600600185; DAMASIO AR, 1982, NEUROLOGY, V32, P331, DOI 10.1212/WNL.32.4.331; David A. S, 2004, INSIGHT PSYCHOSIS AW; David AS, 2012, PHILOS T R SOC B, V367, P1379, DOI 10.1098/rstb.2012.0002; Dell'Osso L, 2002, BIPOLAR DISORD, V4, P315, DOI 10.1034/j.1399-5618.2002.01192.x; Dimaggio G., 2010, METACOGNITION SEVERE; Donohoe G, 2009, J INT NEUROPSYCH SOC, V15, P471, DOI 10.1017/S1355617709090559; Dresler M, 2015, SLEEP MED REV, V20, P92, DOI 10.1016/j.smrv.2014.06.004; Faget-Agius C, 2012, J PSYCHIATR NEUROSCI, V37, P297, DOI 10.1503/jpn.110125; First MB, 2002, STRUCTURED CLIN INTE; Flashman LA, 2001, J NEUROPSYCH CLIN N, V13, P255, DOI 10.1176/appi.neuropsych.13.2.255; Fleming SM, 2012, PHILOS T R SOC B, V367, P1338, DOI 10.1098/rstb.2011.0417; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Frangou S, 2002, BIPOLAR DISORD, V4, P378, DOI 10.1034/j.1399-5618.2002.01223.x; Frith CD, 2000, BRAIN RES REV, V31, P357, DOI 10.1016/S0165-0173(99)00052-1; Gallagher HL, 2003, TRENDS COGN SCI, V7, P77, DOI 10.1016/S1364-6613(02)00025-6; Gerretsen P, 2013, HUM BRAIN MAPP, V34, P1035, DOI 10.1002/hbm.21490; Gilleen J, 2011, SCHIZOPHRENIA BULL, V37, P61, DOI 10.1093/schbul/sbq100; Goldberg RW, 2001, J NERV MENT DIS, V189, P137, DOI 10.1097/00005053-200103000-00001; Green MF, 2004, SCHIZOPHR RES, V72, P41, DOI 10.1016/j.schres.2004.09.009; Ha TH, 2004, PSYCHIAT RES-NEUROIM, V132, P251, DOI 10.1016/j.pscychresns.2004.05.001; Heinisch C, 2013, EUR ARCH PSY CLIN N, V263, P655, DOI 10.1007/s00406-013-0400-9; Heinrichs RW, 1998, NEUROPSYCHOLOGY, V12, P426, DOI 10.1037/0894-4105.12.3.426; Jaspers Karl, 1963, GEN PSYCHOPATHOLOGY; Kao YC, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-170; Keshavan MS, 2011, SCHIZOPHR RES, V133, P250, DOI 10.1016/j.schres.2011.09.005; Kringelbach ML, 2004, PROG NEUROBIOL, V72, P341, DOI 10.1016/j.pneurobio.2004.03.006; Lacerda ALT, 2007, PROG NEURO-PSYCHOPH, V31, P510, DOI 10.1016/j.pnpbp.2006.11.022; Langdon R, 2006, BEHAV RES THER, V44, P699, DOI 10.1016/j.brat.2005.03.012; Laroi F, 2000, PSYCHIAT RES-NEUROIM, V100, P49, DOI 10.1016/S0925-4927(00)00063-9; Lee KH, 2006, AM J PSYCHIAT, V163, P1926, DOI 10.1176/appi.ajp.163.11.1926; Lincoln TM, 2007, SCHIZOPHRENIA BULL, V33, P1324, DOI 10.1093/schbul/sbm002; Lopez-Larson MP, 2002, BIOL PSYCHIAT, V52, P93, DOI 10.1016/S0006-3223(02)01350-1; Lysaker PH, 2011, COMPR PSYCHIAT, V52, P253, DOI 10.1016/j.comppsych.2010.07.007; Maggioni E, 2016, EPIDEMIOL PSYCH SCI, V25, P312, DOI 10.1017/S2045796016000275; Markova IS, 2005, AGING MENT HEALTH, V9, P386, DOI 10.1080/13607860500142945; Mathew I, 2014, JAMA PSYCHIAT, V71, P769, DOI 10.1001/jamapsychiatry.2014.453; McClure MM, 2007, SCHIZOPHR RES, V89, P330, DOI 10.1016/j.schres.2006.07.024; MCEVOY JP, 1989, J NERV MENT DIS, V177, P48, DOI 10.1097/00005053-198901000-00008; MEASSO G, 1993, DEV NEUROPSYCHOL, V9, P77, DOI 10.1080/87565649109540545; Mohamed S, 2009, SCHIZOPHRENIA BULL, V35, P336, DOI 10.1093/schbul/sbn067; Moran JM, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00391; Nair A, 2014, SCHIZOPHR RES, V152, P191, DOI 10.1016/j.schres.2013.11.033; Narayanaswamy JC, 2015, J NEUROPSYCH CLIN N, V27, pE128, DOI 10.1176/appi.neuropsych.14030049; Ohi K, 2016, EUR PSYCHIAT, V35, P25, DOI 10.1016/j.eurpsy.2016.02.002; Orfei MD, 2013, SOC COGN AFFECT NEUR, V8, P418, DOI 10.1093/scan/nss016; OVERALL JE, 1962, PSYCHOL REP, V10, P799; Perlini C, 2012, ACTA PSYCHIAT SCAND, V126, P363, DOI 10.1111/j.1600-0447.2012.01864.x; Raffard S, 2014, SCHIZOPHR RES, V159, P471, DOI 10.1016/j.schres.2014.08.023; Riggs SE, 2010, SCHIZOPHRENIA B; Rossell SL, 2003, PSYCHOL MED, V33, P111, DOI 10.1017/S0033291702006803; Sapara A, 2007, SCHIZOPHR RES, V89, P22, DOI 10.1016/j.schres.2006.09.016; Schurz M, 2014, NEUROSCI BIOBEHAV R, V42, P9, DOI 10.1016/j.neubiorev.2014.01.009; Shimamura AP, 2000, CONSCIOUS COGN, V9, P313, DOI 10.1006/ccog.2000.0450; Squarcina L, 2015, PHYS MED BIOL, V60, P1697, DOI 10.1088/0031-9155/60/4/1697; Startup M, 1996, PSYCHOL MED, V26, P1277, DOI 10.1017/S003329170003600X; Tamminga CA, 2014, SCHIZOPHRENIA BULL, V40, pS131, DOI 10.1093/schbul/sbt179; Varga M, 2006, J AFFECT DISORDERS, V91, P1, DOI 10.1016/j.jad.2005.09.002; Vollm BA, 2006, NEUROIMAGE, V29, P90, DOI 10.1016/j.neuroimage.2005.07.022; Volz KG, 2006, J COGNITIVE NEUROSCI, V18, P2077, DOI 10.1162/jocn.2006.18.12.2077; Volz KG, 2009, PROG BRAIN RES, V174, P61, DOI 10.1016/S0079-6123(09)01306-5; Warman DM, 2006, SCHIZOPHR RES, V84, P297, DOI 10.1016/j.schres.2006.02.004; Wobrock T, 2009, WORLD J BIOL PSYCHIA, V10, P442, DOI 10.1080/15622970701849986; Wolthusen RPF, 2015, WORLD J BIOL PSYCHIA, V16, P430, DOI 10.3109/15622975.2015.1062915; Xavier RM, 2016, NURS RES, V65, P224, DOI 10.1097/NNR.0000000000000159; Yen CF, 2007, BIPOLAR DISORD, V9, P238, DOI 10.1111/j.1399-5618.2007.00407.x; Zhang LW, 2015, NEUROIMAGE-CLIN, V8, P202, DOI 10.1016/j.nicl.2015.04.010; Zigmond MJ, 1999, FUNDAMENTAL NEUROSCI	99	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2017	12	4							e0175803	10.1371/journal.pone.0175803	http://dx.doi.org/10.1371/journal.pone.0175803			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES9KD	28414766	Green Published, Green Submitted, gold			2022-12-27	WOS:000399874800058
J	Demakakos, P; Muniz-Terrera, G; Nouwen, A				Demakakos, Panayotes; Muniz-Terrera, Graciela; Nouwen, Arie			Type 2 diabetes, depressive symptoms and trajectories of cognitive decline in a national sample of community-dwellers: A prospective cohort study	PLOS ONE			English	Article							RISK-FACTOR; COMORBID DEPRESSION; DEVELOPING DEMENTIA; GLYCEMIC CONTROL; LIFE-SPAN; METAANALYSIS; MELLITUS; ASSOCIATION; BRAIN; INFLAMMATION	We examined the individual and synergistic effects of type 2 diabetes and elevated depressive symptoms on memory and executive function trajectories over 10 and eight years of follow-up, respectively. Our sample comprised 10,524 community-dwellers aged >= 50 years in 2002-03 from the English Longitudinal Study of Ageing. With respect to memory (word recall), participants with either diabetes or elevated depressive symptoms recalled significantly fewer words compared with those free of these conditions (reference category), but more words compared with those with both conditions. There was a significant acceleration in the rate of memory decline in participants aged 50-64 years with both conditions (-0.27, 95% CI,-0.45 to -0.08, per study wave), which was not observed in those with either condition or aged >= 65 years. With respect to executive function (animal naming), participants aged >= 65 years with diabetes or those with elevated depressive symptoms named significantly fewer animals compared with the reference category, while those with both conditions named fewer animals compared with any other category. The rate of executive function decline was significantly greater in participants with both conditions (-0.54, 95% CI,-0.99 to -0.10; and -0.71, 95% CI,-1.16 to -0.27, per study wave, for those aged 50-64 and >= 65 years, respectively), but not in participants with either condition. Diabetes and elevated depressive symptoms are inversely associated with memory and executive function, but, individually, do not accelerate cognitive decline. The co-occurrence of diabetes and elevated depressive symptoms significantly accelerates cognitive decline over time, especially among those aged 50-64 years.	[Demakakos, Panayotes] UCL, Dept Epidemiol & Publ Hlth, London, England; [Muniz-Terrera, Graciela] Univ Edinburgh, Ctr Dementia Prevent, Edinburgh, Midlothian, Scotland; [Nouwen, Arie] Middlesex Univ, Dept Psychol, London, England	University of London; University College London; University of Edinburgh; Middlesex University	Demakakos, P (corresponding author), UCL, Dept Epidemiol & Publ Hlth, London, England.	p.demakakos@ucl.ac.uk		Demakakos, Panayotes/0000-0002-7663-2122; Muniz Terrera, Graciela/0000-0002-4516-0337	National Institute on Aging [2R01AG7644 and 2R01AG01764401A1]	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors received no specific funding for this work. The English Longitudinal Study of Ageing is supported by the National Institute on Aging (grants 2R01AG7644 and 2R01AG01764401A1) and a consortium of the United Kingdom government departments coordinated by the Office for National Statistics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali S, 2006, DIABETIC MED, V23, P1165, DOI 10.1111/j.1464-5491.2006.01943.x; Byers AL, 2011, NAT REV NEUROL, V7, P323, DOI 10.1038/nrneurol.2011.60; Cheng G, 2012, INTERN MED J, V42, P484, DOI 10.1111/j.1445-5994.2012.02758.x; Chida Y, 2008, DIABETOLOGIA, V51, P2168, DOI 10.1007/s00125-008-1154-1; Chodosh J, 2010, J AM GERIATR SOC, V58, P2350, DOI 10.1111/j.1532-5415.2010.03171.x; da Silva J, 2013, BRIT J PSYCHIAT, V202, P177, DOI 10.1192/bjp.bp.111.101931; Dantzer R, 2008, NAT REV NEUROSCI, V9, P46, DOI 10.1038/nrn2297; Demakakos P, 2014, PSYCHOSOM MED, V76, P555, DOI 10.1097/PSY.0000000000000082; Downer B, 2016, J AM GERIATR SOC, V64, P109, DOI 10.1111/jgs.13883; Gale CR, 2012, PSYCHOL MED, V42, P2057, DOI 10.1017/S0033291712000402; Geijselaers SLC, 2015, LANCET DIABETES ENDO, V3, P75, DOI 10.1016/S2213-8587(14)70148-2; Golden SH, 2008, JAMA-J AM MED ASSOC, V299, P2751, DOI 10.1001/jama.299.23.2751; Jorm AF, 2000, GERONTOLOGY, V46, P219, DOI 10.1159/000022163; Katon W, 2015, JAMA PSYCHIAT, V72, P612, DOI 10.1001/jamapsychiatry.2015.0082; Katon W, 2012, ARCH GEN PSYCHIAT, V69, P410, DOI 10.1001/archgenpsychiatry.2011.154; Katon WJ, 2010, J GEN INTERN MED, V25, P423, DOI 10.1007/s11606-009-1248-6; Koekkoek PS, 2013, PSYCHONEUROENDOCRINO, V38, P376, DOI 10.1016/j.psyneuen.2012.06.014; Langa KM, 2005, NEUROEPIDEMIOLOGY, V25, P181, DOI 10.1159/000087448; Lim A, 2013, MOD TR PHARMACOPSYCH, V28, P175, DOI 10.1159/000346362; Lu FP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004144; Lupien SJ, 2009, NAT REV NEUROSCI, V10, P434, DOI 10.1038/nrn2639; Lustman PJ, 2000, DIABETES CARE, V23, P934, DOI 10.2337/diacare.23.7.934; Marsland AL, 2015, BRAIN BEHAV IMMUN, V48, P195, DOI 10.1016/j.bbi.2015.03.015; McCrimmon RJ, 2012, LANCET, V379, P2291, DOI 10.1016/S0140-6736(12)60360-2; Mezuk B, 2008, DIABETES CARE, V31, P2383, DOI 10.2337/dc08-0985; Moheet A, 2015, ANN NY ACAD SCI, V1353, P60, DOI 10.1111/nyas.12807; Nouwen A, 2010, DIABETOLOGIA, V53, P2480, DOI 10.1007/s00125-010-1874-x; Ownby RL, 2006, ARCH GEN PSYCHIAT, V63, P530, DOI 10.1001/archpsyc.63.5.530; Palta P, 2014, J INT NEUROPSYCH SOC, V20, P278, DOI 10.1017/S1355617713001483; Pan A, 2011, JAMA-J AM MED ASSOC, V306, P1241, DOI 10.1001/jama.2011.1282; Rawlings AM, 2017, EUR J EPIDEMIOL, V32, P55, DOI 10.1007/s10654-016-0197-8; Rotella F, 2013, DIABETES RES CLIN PR, V99, P98, DOI 10.1016/j.diabres.2012.11.022; Rotella F, 2013, J CLIN PSYCHIAT, V74, P32, DOI 10.4088/JCP.12r07922; Sadanand S, 2016, DIABETES-METAB RES, V32, P132, DOI 10.1002/dmrr.2664; Sarwar N, 2010, LANCET, V375, P2215, DOI 10.1016/S0140-6736(10)60484-9; Steffick DE, 2000, DOCUMENTATION AFFECT; Sullivan MD, 2013, JAMA PSYCHIAT, V70, P1041, DOI 10.1001/jamapsychiatry.2013.1965; Tuligenga RH, 2015, ENDOCR CONNECT, V4, pR16, DOI 10.1530/EC-15-0004; Wilson RS, 2014, NEUROLOGY, V83, P702, DOI 10.1212/WNL.0000000000000715	39	24	24	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2017	12	4							e0175827	10.1371/journal.pone.0175827	http://dx.doi.org/10.1371/journal.pone.0175827			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES9KD	28414754	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000399874800061
J	Gomez-Sanchez, L; Garcia-Ortiz, L; Patino-Alonso, MC; Recio-Rodriguez, JI; Feuerbach, N; Marti, R; Agudo-Conde, C; Rodriguez-Sanchez, E; Maderuelo-Fernandez, JA; Ramos, R; Gomez-Marcos, MA				Gomez-Sanchez, Leticia; Garcia-Ortiz, Luis; Patino-Alonso, Maria C.; Recio-Rodriguez, Jose I.; Feuerbach, Natalia; Marti, Ruth; Agudo-Conde, Cristina; Rodriguez-Sanchez, Emiliano; Maderuelo-Fernandez, Jose A.; Ramos, Rafel; Gomez-Marcos, Manuel A.		MARK Grp	Glycemic markers and relation with arterial stiffness in Caucasian subjects of the MARK study	PLOS ONE			English	Article							ANKLE VASCULAR INDEX; PULSE-WAVE VELOCITY; IMPAIRED FASTING GLUCOSE; DIABETES-MELLITUS; BLOOD-PRESSURE; CAROTID ATHEROSCLEROSIS; CARDIOVASCULAR-DISEASE; CLINICAL-SIGNIFICANCE; GLYCATED HEMOGLOBIN; RISK	Background Effect of prediabetes and normal glucose on arterial stiffness remains controversial. The primary aim of this study was to investigate the relationship of fasting plasma glucose (FPG), postprandial glucose (PG) and glycosylated haemoglobin (HbA1c) with brachial-ankle pulse wave velocity (baPWV) and cardio-ankle vascular index (CAVI) in Caucasian adults. The secondary aim was to analyse this relationship by glycaemic status. Methods Cross-sectional study. Setting: Primary care. Participants: 2,233 subjects, 35-74 years. Measures: FPG (mg/dL) and HbA1c (%) of all subjects were measured using standard automated enzymatic methods. PG (mg/dL) was self-measured at home two hours after meals (breakfast, lunch and dinner) for one day using an Accu-chek (R) glucometer. CAVI was measured using a VaSera VS-1500 (R) device (Fukuda Denshi), and baPWV was calculated using a validated equation. Results CAVI and baPWV values were significantly higher in subjects with diabetes mellitus than in glucose normal and prediabetes groups (p<0.001). FPG, PG and HbA1c were positively associated with CAVI and baPWV. The beta regression coefficient for: HbA1c was 0.112 (CI95% 0.068 to 0.155) with CAVI, 0.266 (CI 95% 0.172 to 0.359) with baPWV; for PG was 0.006 (CI 95% 0.004 to 0.009 and for FPG was 0.005 (CI 95% 0.002 to 0.008) with baPWV; and for PG was 0.002 (CI 95% 0.001 to 0.003) and 0.003 (CI 95% 0.002 to 0.004) with CAVI (p<0.01 in all cases). When analysing by hyperglycaemic status, FPG, PG and HbA1c were positively associated with CAVI and baPWV in subjects with type 2 diabetes mellitus. Conclusion FPG, PG and HbA1c show a positive association with CAVI and baPWV, in Caucasian adults with intermediate cardiovascular risk factors. When analysing by hyperglycaemic status, the association is only maintained in subjects with type 2 diabetes mellitus.	[Gomez-Sanchez, Leticia; Garcia-Ortiz, Luis; Patino-Alonso, Maria C.; Recio-Rodriguez, Jose I.; Agudo-Conde, Cristina; Rodriguez-Sanchez, Emiliano; Maderuelo-Fernandez, Jose A.; Gomez-Marcos, Manuel A.] Castilla & Leon Hlth Serv SACyL, Alamedilla Hlth Ctr, Primary Care Res Unit, Salamanca, Spain; [Garcia-Ortiz, Luis; Patino-Alonso, Maria C.; Recio-Rodriguez, Jose I.; Agudo-Conde, Cristina; Rodriguez-Sanchez, Emiliano; Maderuelo-Fernandez, Jose A.; Gomez-Marcos, Manuel A.] Biomed Res Inst Salamanca IBSAL, Salamanca, Spain; [Garcia-Ortiz, Luis] Univ Salamanca, Biomed & Diagnost Sci Dept, Salamanca, Spain; [Patino-Alonso, Maria C.] Univ Salamanca, Stat Dept, Salamanca, Spain; [Recio-Rodriguez, Jose I.] Univ Salamanca, Dept Nursing & Physiotherapy, Salamanca, Spain; [Feuerbach, Natalia] Illes Balears Hlth Serv IBSALUT, San Agustin Hlth Ctr, Palma Of Mallorca, Spain; [Marti, Ruth; Ramos, Rafel] Inst Univ Invest Atencio Primaria Jordi Gol IDIAP, Unitat Suport Recerca Girona, Girona, Spain; [Marti, Ruth; Ramos, Rafel] Inst Invest Biomed Girona Dr Josep Trueta IDBGI, Girona, Spain; [Rodriguez-Sanchez, Emiliano; Gomez-Marcos, Manuel A.] Univ Salamanca, Dept Med, Salamanca, Spain; [Ramos, Rafel] Univ Girona, Fac Med, Dept Ciencies Med, Girona, Spain; [MARK Grp] RedIAPP Res Network Prevent Act & Hlth Promot, MARK Grp, Girona, Spain	University of Salamanca; University of Salamanca; University of Salamanca; Atencio Primaria de Mallorca; University of Salamanca; Universitat de Girona	Gomez-Sanchez, L (corresponding author), Castilla & Leon Hlth Serv SACyL, Alamedilla Hlth Ctr, Primary Care Res Unit, Salamanca, Spain.	leticiagmzsnchz@gmail.com	Gomez-Sanchez, Leticia/AAR-8735-2021; Maderuelo-Fernandez, Jose-Angel/R-8868-2018; Patino-Alonso, Carmen/I-4608-2014; Rodríguez-Sánchez, Emiliano/N-5582-2014; Ramos, Rafel/P-2083-2019; Ramos, Rafel/D-9627-2016; Recio-Rodriguez, Jose I/AAA-8588-2020; Martí, Ruth/H-8198-2014	Gomez-Sanchez, Leticia/0000-0001-8663-9339; Maderuelo-Fernandez, Jose-Angel/0000-0001-7544-8684; Patino-Alonso, Carmen/0000-0001-8232-6685; Rodríguez-Sánchez, Emiliano/0000-0003-3667-7155; Ramos, Rafel/0000-0001-7970-5537; Ramos, Rafel/0000-0001-7970-5537; Martí, Ruth/0000-0002-7320-9521; Recio-Rodriguez, Jose I/0000-0002-3772-8746	Spanish Ministry of Science and Innovation (MICINN); Carlos III Health Institute/European Regional Development Fund (ERDF) (MICINN, ISCIII/FEDER) [Red RedIAPP RD06/0018, RD16/0007/0003, RD16/0007/0004, RD16/0007/0008]; Health Research Fund [PI10/01088, PI10/02077, PI10/02043, PI13/01930]; Regional Health Management of Castile and Leon [GRS 635/A/11, GRS 906/B/14]	Spanish Ministry of Science and Innovation (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Carlos III Health Institute/European Regional Development Fund (ERDF) (MICINN, ISCIII/FEDER)(Instituto de Salud Carlos IIIMinistry of Science and Innovation, Spain (MICINN)Spanish Government); Health Research Fund(Instituto de Salud Carlos III); Regional Health Management of Castile and Leon	This work was supported by grants from the Spanish Ministry of Science and Innovation (MICINN), the Carlos III Health Institute/European Regional Development Fund (ERDF) (MICINN, ISCIII/FEDER) (Red RedIAPP RD06/0018, Research Groups: RD16/0007/0003, RD16/0007/0004, RD16/0007/0008), the Health Research Fund (PI10/01088, PI10/02077, PI10/02043; PI13/01930), and the Regional Health Management of Castile and Leon (GRS 635/A/11; GRS 906/B/14).	Cameron JD, 2003, DIABETES CARE, V26, P2133, DOI 10.2337/diacare.26.7.2133; Cecelja M, 2009, HYPERTENSION, V54, P1328, DOI 10.1161/HYPERTENSIONAHA.109.137653; Chen YH, 2009, ENDOCRINE, V36, P262, DOI 10.1007/s12020-009-9221-z; Chirinos JA, 2013, DIABETES CARE, V36, P2359, DOI 10.2337/dc12-1463; Conroy RM, 2003, EUR HEART J, V24, P987, DOI 10.1016/S0195-668X(03)00114-3; Cruickshank K, 2002, CIRCULATION, V106, P2085, DOI 10.1161/01.CIR.0000033824.02722.F7; Davies MJ, 2000, DIABETIC MED, V17, P433, DOI 10.1046/j.1464-5491.2000.00246.x; Fang FS, 2014, INTERNAL MED, V53, P189, DOI 10.2169/internalmedicine.53.0690; Ferreira MT, 2015, DIABETES CARE, V38, P897, DOI 10.2337/dc14-2791; Gomez-Sanchez L, 2015, J ATHEROSCLER THROMB, V22, P901, DOI 10.5551/jat.28035; Herman WH, 2016, DIABETES CARE, V39, pS3, DOI 10.2337/dc16-S002; Hu HQ, 2013, HYPERTENS RES, V36, P334, DOI 10.1038/hr.2012.192; Kubozono T, 2007, CIRC J, V71, P89, DOI 10.1253/circj.71.89; Lee YH, 2016, ATHEROSCLEROSIS, V247, P1, DOI 10.1016/j.atherosclerosis.2016.01.032; Li CH, 2012, J CLIN ENDOCR METAB, V97, pE658, DOI 10.1210/jc.2011-2595; Liang J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038485; Lukich E, 2010, DIABETES-METAB RES, V26, P365, DOI 10.1002/dmrr.1086; Mancia G, 2013, J HYPERTENS, V31, P1281, DOI 10.1097/01.hjh.0000431740.32696.cc; Marrugat J, 2003, J EPIDEMIOL COMMUN H, V57, P634, DOI 10.1136/jech.57.8.634; Marti R, 2011, BMC CARDIOVASC DISOR, V11, DOI 10.1186/1471-2261-11-61; Mostafa SA, 2010, POSTGRAD MED J, V86, P656, DOI 10.1136/pgmj.2009.091215; O'Brien E, 2005, J HYPERTENS, V23, P697, DOI 10.1097/01.hjh.0000163132.84890.c4; Ohnishi H, 2003, DIABETES CARE, V26, P437, DOI 10.2337/diacare.26.2.437; Prenner SB, 2015, ATHEROSCLEROSIS, V238, P370, DOI 10.1016/j.atherosclerosis.2014.12.023; Rahman S, 2008, DIABETES RES CLIN PR, V80, P253, DOI 10.1016/j.diabres.2007.12.010; Rhee SY, 2007, DIABETES RES CLIN PR, V76, P82, DOI 10.1016/j.diabres.2006.07.029; Rubin J, 2012, ATHEROSCLEROSIS, V225, P246, DOI 10.1016/j.atherosclerosis.2012.09.003; Salas-Salvado J, 2007, MED CLIN-BARCELONA, V128, P184, DOI 10.1016/S0025-7753(07)72531-9; Sarwar N, 2010, LANCET, V375, P2215, DOI 10.1016/S0140-6736(10)60484-9; Satoh N, 2008, HYPERTENS RES, V31, P1921, DOI 10.1291/hypres.31.1921; Schottker B, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0570-1; Schram MT, 2004, HYPERTENSION, V43, P176, DOI 10.1161/01.HYP.0000111829.46090.92; Selvin E, 2004, ANN INTERN MED, V141, P421, DOI 10.7326/0003-4819-141-6-200409210-00007; Shen L, 2013, BIOMED ENVIRON SCI, V26, P717, DOI 10.3967/0895-3988.2013.09.002; Shin JY, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-30; Shirai K, 2006, J ATHEROSCLER THROMB, V13, P101, DOI 10.5551/jat.13.101; Shirai K, 2011, J ATHEROSCLER THROMB, V18, P924; Shirai K, 2011, J ATHEROSCLER THROMB, V18, P49, DOI 10.5551/jat.3582; Singh AS, 2013, ANN INDIAN ACAD NEUR, V16, P185, DOI 10.4103/0972-2327.112462; Sun CK, 2013, INTEGR BLOOD PRESS C, V6, P27, DOI 10.2147/IBPC.S34423; Takaki A, 2008, HYPERTENS RES, V31, P1347, DOI 10.1291/hypres.31.1347; Tsuboi A, 2015, INTERNAL MED, V54, P1961, DOI 10.2169/internalmedicine.54.3596; Wang HY, 2013, J AM SOC HYPERTENS, V7, P426, DOI 10.1016/j.jash.2013.06.003; Wang J, 2014, NEUROL RES, V36, P427, DOI 10.1179/1743132814Y.0000000345; Xu L, 2010, DIABETES-METAB RES, V26, P133, DOI 10.1002/dmrr.1059; Xu L, 2010, METABOLISM, V59, P367, DOI 10.1016/j.metabol.2009.08.004; Yamashina A, 2002, HYPERTENS RES, V25, P359, DOI 10.1291/hypres.25.359; Zieman SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047941	48	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2017	12	4							e0175982	10.1371/journal.pone.0175982	http://dx.doi.org/10.1371/journal.pone.0175982			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KD	28414819	Green Published, Green Submitted, gold			2022-12-27	WOS:000399874800083
J	Kant, R; Palva, A; von Ossowski, I				Kant, Ravi; Palva, Airi; von Ossowski, Ingemar			An in silico pan-genomic probe for the molecular traits behind Lactobacillus ruminis gut autochthony	PLOS ONE			English	Article							GRAM-POSITIVE BACTERIA; LACTIC-ACID BACTERIA; SIGNAL PEPTIDES; ADHESION PROPERTIES; PROTEIN SECRETION; SURFACE DISPLAY; SP-NOV; MICROBIOTA; SEQUENCE; STRAINS	As an ecological niche, the mammalian intestine provides the ideal habitat for a variety of bacterial microorganisms. Purportedly, some commensal genera and species offer a beneficial mix of metabolic, protective, and structural processes that help sustain the natural digestive health of the host. Among these sort of gut inhabitants is the Gram-positive lactic acid bacterium Lactobacillus ruminis, a strict anaerobe with both pili and flagella on its cell surface, but also known for being autochthonous (indigenous) to the intestinal environment. Given that the molecular basis of gut autochthony for this species is largely unexplored and unknown, we undertook a study at the genome level to pinpoint some of the adaptive traits behind its colonization behavior. In our pan-genomic probe of L. ruminis, the genomes of nine different strains isolated from human, bovine, porcine, and equine host guts were compiled and compared for in silico analysis. For this, we conducted a geno-phenotypic assessment of protein-coding genes, with an emphasis on those products involved with cell-surface morphology and anaerobic fermentation and respiration. We also categorized and examined the core and accessory genes that define the L. ruminis species and its strains. Here, we made an attempt to identify those genes having ecologically relevant phenotypes that might support or bring about intestinal indigenousness.	[Kant, Ravi; Palva, Airi; von Ossowski, Ingemar] Univ Helsinki, Fac Vet Med, Dept Vet Biosci, Helsinki, Finland	University of Helsinki	von Ossowski, I (corresponding author), Univ Helsinki, Fac Vet Med, Dept Vet Biosci, Helsinki, Finland.	ingemar.von.ossowski@helsinki.fi	Kant, Ravi/AAF-8495-2021	Kant, Ravi/0000-0003-3878-9775; von Ossowski, Ingemar Eric/0000-0002-9899-671X	Academy of Finland general research grant [277362]	Academy of Finland general research grant	Operational expenditures and salaries for this study were financed through the funding support of an Academy of Finland general research grant (No. 277362) (http://www.aka.fi). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Jassim RAM, 2003, LETT APPL MICROBIOL, V37, P213, DOI 10.1046/j.1472-765X.2003.01380.x; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; [Anonymous], 2012, ADV MICROBIOL-IRVINE, DOI DOI 10.4236/AIM.2012.23051; Arboleya S, 2012, GUT MICROBES, V3, P583, DOI 10.4161/gmic.21942; Arkhipova OV, 2005, MICROBIOLOGY+, V74, P629, DOI 10.1007/s11021-005-0116-6; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Bagos PG, 2008, J PROTEOME RES, V7, P5082, DOI 10.1021/pr800162c; Baker MD, 2006, BIOESSAYS, V28, P9, DOI 10.1002/bies.20343; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bendtsen JD, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-58; Bendtsen JD, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-167; Blom J, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-154; Brooijmans Rob, 2009, F1000 Biol Rep, V1, P34, DOI 10.3410/B1-34; Buist G, 2006, MICROBIOL-SGM, V152, P2867, DOI 10.1099/mic.0.29113-0; Chaban B, 2015, SEMIN CELL DEV BIOL, V46, P91, DOI 10.1016/j.semcdb.2015.10.032; Chesworth JM, 1998, INTRO AGR BIOCH, P395; Dang SY, 2010, NATURE, V467, P734, DOI 10.1038/nature09406; Desvaux M, 2006, FEMS MICROBIOL LETT, V256, P1, DOI 10.1111/j.1574-6968.2006.00122.x; Donnell MMO, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-S1-S12; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Espey MG, 2013, FREE RADICAL BIO MED, V55, P130, DOI 10.1016/j.freeradbiomed.2012.10.554; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Fimereli Danai K., 2012, Artificial Intelligence: Theories and Applications. Proceedings 7th Hellenic Conference on AI, SETN 2012, P285, DOI 10.1007/978-3-642-30448-4_36; Forde BM, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-S1-S13; Gonzalez PJ, 2006, J INORG BIOCHEM, V100, P1015, DOI 10.1016/j.jinorgbio.2005.11.024; Hammes W.P., 2009, BERGEYS MANUAL SYSTE, VVolume 3, P465; Hattori M, 2009, DNA RES, V16, P1, DOI 10.1093/dnares/dsn033; Henderson B, 2011, FEMS MICROBIOL REV, V35, P147, DOI 10.1111/j.1574-6976.2010.00243.x; Hooper LV, 1999, P NATL ACAD SCI USA, V96, P9833, DOI 10.1073/pnas.96.17.9833; Huycke MM, 2001, MOL MICROBIOL, V42, P729, DOI 10.1046/j.1365-2958.2001.02638.x; Hymes JP, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01504; Johansson MEV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041009; Jones Rheinallt M., 2016, Yale Journal of Biology and Medicine, V89, P285; KANDLER O, 1983, A VAN LEEUW J MICROB, V49, P209, DOI 10.1007/BF00399499; Kandler O., 1986, BERGEYS MANUAL SYSTE, P1208; Kankainen M, 2009, P NATL ACAD SCI USA, V106, P17193, DOI 10.1073/pnas.0908876106; Kant R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102762; Kant R, 2011, MICROB BIOTECHNOL, V4, P323, DOI 10.1111/j.1751-7915.2010.00215.x; Karasov WH, 2013, COMPR PHYSIOL, V3, P741, DOI 10.1002/cphy.c110054; Katayama T, 2005, J BIOSCI BIOENG, V99, P457, DOI 10.1263/jbb.99.457; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lee S, 2011, J BACTERIOL, V193, P5034, DOI 10.1128/JB.05601-11; Lerat E, 2003, PLOS BIOL, V1, P101, DOI 10.1371/journal.pbio.0000019; Lerche M, 1961, ZENTRALBL BAKTERIOL, V180, P324; Lundin S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010029; Mani S, 2014, ANNU REV PHARMACOL, V54, P559, DOI 10.1146/annurev-pharmtox-011613-140007; McLeod A, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-145; McNally L, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0298; Mira A, 2010, INT MICROBIOL, V13, P45, DOI 10.2436/20.1501.01.110; Munoz-Provencio D, 2010, J APPL MICROBIOL, V108, P1050, DOI 10.1111/j.1365-2672.2009.04508.x; Nava GM, 2011, GUT MICROBES, V2, P99, DOI 10.4161/gmic.2.2.15416; Navarre WW, 1999, MICROBIOL MOL BIOL R, V63, P174, DOI 10.1128/MMBR.63.1.174-229.1999; Neville BA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040592; Nishiyama K, 2016, MICROORGANISMS, V4, DOI 10.3390/microorganisms4030034; O'Callaghan J, 2013, CURR TOP MICROBIOL, V358, P119, DOI 10.1007/82_2011_187; O'Donnell MM, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0403-y; Payne WJ., 2001, ANAEROBIC RESPIRATIO; Pedersen MB, 2012, ANNU REV FOOD SCI T, V3, P37, DOI 10.1146/annurev-food-022811-101255; Pessione A, 2010, MOL BIOSYST, V6, P1419, DOI 10.1039/c001948h; Pessione E, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00086; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Reuter G, 2001, Curr Issues Intest Microbiol, V2, P43; Ribet D, 2015, MICROBES INFECT, V17, P173, DOI 10.1016/j.micinf.2015.01.004; Rintahaka J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113922; Salvetti E, 2012, PROBIOTICS ANTIMICRO, V4, P217, DOI 10.1007/s12602-012-9117-8; Savage DC, 1977, MICROBIAL ECOLOGY GU, P277; Schneewind O, 2012, PHILOS T R SOC B, V367, P1123, DOI 10.1098/rstb.2011.0210; Segerman B, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00116; SHARPE ME, 1973, J GEN MICROBIOL, V77, P37, DOI 10.1099/00221287-77-1-37; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Tanasupawat S, 2000, INT J SYST EVOL MICR, V50, P1479, DOI 10.1099/00207713-50-4-1479; Tannock GW, 2004, APPL ENVIRON MICROB, V70, P3189, DOI 10.1128/AEM.70.6.3189-3194.2004; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Tettelin H, 2005, P NATL ACAD SCI USA, V102, P13950, DOI 10.1073/pnas.0506758102; Tettelin H, 2008, CURR OPIN MICROBIOL, V11, P472, DOI 10.1016/j.mib.2008.09.006; von Ossowski I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064416; von Ossowski I, 2010, APPL ENVIRON MICROB, V76, P2049, DOI 10.1128/AEM.01958-09; Walter J, 2005, PROBIOTICS AND PREBIOTICS: SCIENTIFIC ASPECTS, P51; Walter J, 2008, APPL ENVIRON MICROB, V74, P4985, DOI 10.1128/AEM.00753-08; Yu X, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145718; Zdobnov EM, 2007, TRENDS GENET, V23, P16, DOI 10.1016/j.tig.2006.10.004	82	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2017	12	4							e0175541	10.1371/journal.pone.0175541	http://dx.doi.org/10.1371/journal.pone.0175541			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KD	28414739	gold, Green Submitted, Green Published			2022-12-27	WOS:000399874800035
J	Ye, J; Wen, B				Ye, Juan; Wen, Bin			Seed germination in relation to the invasiveness in spiny amaranth and edible amaranth in Xishuangbanna, SW China	PLOS ONE			English	Article							ENVIRONMENTAL-FACTORS; WATER POTENTIALS; SPINOSUS L; ALIEN; TEMPERATURE; INVASION; ECOLOGY; TRAITS; GROWTH	Both spiny and edible amaranths (Amaranthus spinosusand A. tricolor) are exotic annuals in China that produce numerous small seeds every year. Spiny amaranth has become a successful invader and a troublesome weed in Xishuangbanna, but edible amaranth has not, although it is widely grown as a vegetable there. As seed germination is one of the most important life-stages contributing to the ability of a plant to become invasive, we conducted experiments to compare the effects of high temperature and water stress on seed germination in two varieties each of spiny amaranth and edible amaranth. Overall, the seeds of both amaranth species exhibited adaptation to high temperature and water stress, including tolerance to ground temperatures of 70 degrees C for air-dried seeds, which is consistent with their behavior in their native ranges in the tropics. As expected, the invasive spiny amaranth seeds exhibited higher tolerance to both continuous and daily periodic high-temperature treatment at 45 degrees C, and to imbibition-desiccation treatment, compared to edible amaranth seeds. Unexpectedly, edible amaranth seeds exhibited higher germination at extreme temperatures (10 degrees C, 15 degrees C, and 40 degrees C), and at lower water potential (below -0.6 MPa). It is likely that cultivation of edible amaranth has selected seed traits that include rapid germination and germination under stressful conditions, either of which, under natural conditions, may result in the death of most germinating edible amaranth seeds and prevent them from becoming invasive weeds in Xishuangbanna. This study suggests that rapid germination and high germination under stress conditions-excellent seed traits for crops and for many invasive species-might be a disadvantage under natural conditions if these traits are asynchronous with natural local conditions that support successful germination.	[Ye, Juan; Wen, Bin] Chinese Acad Sci, Ctr Integrat Conservat, Xishuangbanna Trop Bot Garden, Mengla, Yunnan, Peoples R China; [Ye, Juan] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Xishuangbanna Tropical Botanical Garden, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Wen, B (corresponding author), Chinese Acad Sci, Ctr Integrat Conservat, Xishuangbanna Trop Bot Garden, Mengla, Yunnan, Peoples R China.	wenb@xtbg.org.cn			National Natural Science Foundation of China; [31170626]	National Natural Science Foundation of China;(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China; Award Number 31170626; Recipient: Bin Wen.	Baker H. G., 1975, Annual Review of Ecology and Systematics, V5, P1, DOI 10.1146/annurev.es.05.110174.000245; BALYAN RS, 1986, WEED SCI, V34, P513, DOI 10.1017/S0043174500067333; Baskin CC, 2004, WEED RES, V44, P60, DOI 10.1046/j.1365-3180.2003.00373.x; Beckmann M, 2011, ECOL RES, V26, P763, DOI 10.1007/s11284-011-0834-3; Bochenek A, 2016, ACTA PHYSIOL PLANT, V38, DOI 10.1007/s11738-016-2179-6; Cervera JC, 2009, PLANT ECOL, V205, P285, DOI 10.1007/s11258-009-9617-0; Chauhan BS, 2009, WEED SCI, V57, P379, DOI 10.1614/WS-08-179.1; Cristaudo A, 2007, WEED RES, V47, P327, DOI 10.1111/j.1365-3180.2007.00574.x; David RS, 1991, WEED SCI, V39, P33; DeSousa N, 2003, WEED SCI, V51, P60, DOI 10.1614/0043-1745(2003)051[0060:PSPORP]2.0.CO;2; Donohue K, 2010, ANNU REV ECOL EVOL S, V41, P293, DOI 10.1146/annurev-ecolsys-102209-144715; Erfmeier A, 2005, ECOGRAPHY, V28, P417, DOI 10.1111/j.0906-7590.2005.03967.x; GRICHAR WJ, 1994, WEED TECHNOL, V8, P199, DOI 10.1017/S0890037X00038641; Guan ZB, 2007, TROPICAL AGR SCI TEC, V29, P35; Guo PG, 2003, WEED SCI, V51, P869, DOI 10.1614/P2002-127; LANG ARG, 1967, AUST J CHEM, V20, P2017, DOI 10.1071/CH9672017; Li Z., 2002, INVESTIGATION COMPUT, P1; Mandak B, 2003, FLORA, V198, P45, DOI 10.1078/0367-2530-00075; Meyerson LA, 2007, FRONT ECOL ENVIRON, V5, P199, DOI 10.1890/1540-9295(2007)5[199:IASIAE]2.0.CO;2; MICHEL BE, 1983, PLANT PHYSIOL, V72, P66, DOI 10.1104/pp.72.1.66; Milbau A, 2003, NEW PHYTOL, V159, P657, DOI 10.1046/j.1469-8137.2003.00833.x; Perglova I, 2009, PRESLIA, V81, P357; Pimentel D, 2000, BIOSCIENCE, V50, P53, DOI 10.1641/0006-3568(2000)050[0053:EAECON]2.3.CO;2; Pimentel David, 2009, V5, P1; Pysek Petr, 2007, V193, P97; Qiang, 2011, CHINAS INVASIVE ALIE; Radford IJ, 2000, OECOLOGIA, V125, P531, DOI 10.1007/s004420000474; Rashid I, 2007, ANN APPL BIOL, V150, P361, DOI 10.1111/j.1744-7348.2007.00136.x; Rejmanek M., 2005, Invasive alien species: a new synthesis, P161; Ren MX, 2009, WEED RES, V49, P449, DOI 10.1111/j.1365-3180.2009.00723.x; Sellers BA, 2003, WEED SCI, V51, P329, DOI 10.1614/0043-1745(2003)051[0329:CGOSAS]2.0.CO;2; Shrefler JW, 1996, HORTSCIENCE, V31, P347, DOI 10.21273/HORTSCI.31.3.347; Steckel LE, 2004, WEED SCI, V52, P217, DOI 10.1614/WS-03-012R; Thomas WE, 2006, WEED SCI, V54, P316; Wainwright CE, 2013, BIOL INVASIONS, V15, P2253, DOI 10.1007/s10530-013-0449-4; Wen B, 2015, WEED RES, V55, P155, DOI 10.1111/wre.12134; Bin W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141567	37	8	8	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2017	12	4							e0175948	10.1371/journal.pone.0175948	http://dx.doi.org/10.1371/journal.pone.0175948			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KD	28414779	Green Submitted, Green Published, gold			2022-12-27	WOS:000399874800079
J	Fan, LX; Chen, LQ; Ni, XL; Guo, SC; Zhou, YH; Wang, CJ; Zheng, YB; Shen, FY; Kolluri, VK; Muktiali, M; Zhao, ZH; Wu, JJ; Zhao, DM; He, ZL; Feng, XL; Yuan, ZY; Zhang, J; Jin, L; Wang, JC; Wang, MH				Fan, Lixia; Chen, Linqi; Ni, Xiaoling; Guo, Shicheng; Zhou, Yinghui; Wang, Chenji; Zheng, Yabiao; Shen, Fangyuan; Kolluri, Vijay Kumar; Muktiali, Merlin; Zhao, Zhenhong; Wu, Junjie; Zhao, Dunmei; He, Zhenglei; Feng, Xulong; Yuan, Ziyu; Zhang, Juan; Jin, Li; Wang, Jiucun; Wang, Minghua			Genetic variant of miR-4293 rs12220909 is associated with susceptibility to non-small cell lung cancer in a Chinese Han population	PLOS ONE			English	Article							POLYMORPHISMS; IDENTIFICATION; MICRORNAS; SURVIVAL	Non-small cell lung cancer is one of the most common cancers and the leading cause of cancer death worldwide. Genetic variants in regulatory regions of some miRNAs might be involved in non-small cell lung cancer susceptibility and survival. rs12220909 (G/C) genetic polymorphism in miR-4293 has been shown to be associated with decreased risk of esophageal squamous cell carcinoma. However, the influence of rs12220909 genetic variation on non-small cell lung cancer susceptibility has not been reported. In order to evaluate the potential association between miR-4293 rs12220909 and non-small cell lung cancer risk in a Chinese population, we performed a case-control study among 998 non-small cell lung cancer cases and 1471 controls. The data shows that miR-4293 rs12220909 was significantly associated with decreased susceptibility to non-small cell lung cancer (GC vs. GG: OR = 0.681, 95% CI = 0.555-0.835, P = 2.19E-4; GG vs. GC+CC: OR = 0.687, 95% CI = 0.564-0.837, P = 1.95E-4), which indicates that rs12220909 in miR-4293 may play a significant role in the development of non-small cell lung cancer.	[Fan, Lixia; Zhou, Yinghui; Wang, Chenji; Zheng, Yabiao; Shen, Fangyuan; Kolluri, Vijay Kumar; Muktiali, Merlin; Zhao, Dunmei; He, Zhenglei; Feng, Xulong; Wang, Minghua] Soochow Univ, Med Coll, Dept Biochem & Mol Biol, Suzhou, Peoples R China; [Chen, Linqi; Guo, Shicheng; Zhao, Zhenhong; Wu, Junjie; Jin, Li; Wang, Jiucun] Fudan Univ, MOE Key Lab Contemporary Anthropol, Sch Life Sci, Shanghai, Peoples R China; [Chen, Linqi; Guo, Shicheng; Zhao, Zhenhong; Wu, Junjie; Jin, Li; Wang, Jiucun] Fudan Univ, State Key Lab Genet Engn, Sch Life Sci, Shanghai, Peoples R China; [Ni, Xiaoling] Fudan Univ, Zhongshan Hosp, Dept Gen Surg, Shanghai, Peoples R China; [Wu, Junjie] Changhai Hosp Shanghai, Dept Pneumol, Shanghai, Peoples R China; [Yuan, Ziyu; Zhang, Juan; Jin, Li; Wang, Jiucun] Fudan Taizhou Inst Hlth Sci, Yaocheng Rd, Taizhou, Jiangsu, Peoples R China	Soochow University - China; Fudan University; Fudan University; Fudan University; Naval Medical University	Wang, MH (corresponding author), Soochow Univ, Med Coll, Dept Biochem & Mol Biol, Suzhou, Peoples R China.; Wang, JC (corresponding author), Fudan Univ, MOE Key Lab Contemporary Anthropol, Sch Life Sci, Shanghai, Peoples R China.; Wang, JC (corresponding author), Fudan Univ, State Key Lab Genet Engn, Sch Life Sci, Shanghai, Peoples R China.; Wang, JC (corresponding author), Fudan Taizhou Inst Hlth Sci, Yaocheng Rd, Taizhou, Jiangsu, Peoples R China.	jcwang@fudan.edu.cn; mhwang@suda.edu.cn	Jin, Li/M-5063-2019; Guo, Shicheng/A-1204-2016; Jin, Li/C-1468-2009	Guo, Shicheng/0000-0002-7047-9972; Jin, Li/0000-0002-4546-2415	National Natural Science Foundation of China [81071957]; Key Project in the National Science & Technology Pillar Program [2011BA109B00]; Suzhou City Science and Technology Program [SYS201419]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Project in the National Science & Technology Pillar Program; Suzhou City Science and Technology Program	Support was provided by the National Natural Science Foundation of China (grant number 81071957) (MW received the funding); the Key Project in the National Science & Technology Pillar Program (grant number 2011BA109B00) (LJ received the funding); Suzhou City Science and Technology Program (grant number SYS201419) (MW received the funding).	Ambros V, 2003, CELL, V113, P673, DOI 10.1016/S0092-8674(03)00428-8; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Chen J, 2009, NUCLEIC ACIDS RES, V37, pW305, DOI 10.1093/nar/gkp427; Croce CM, 2005, CELL, V122, P6, DOI 10.1016/j.cell.2005.06.036; Duan RH, 2007, HUM MOL GENET, V16, P1124, DOI 10.1093/hmg/ddm062; Ferreira Carlos Gil, 2013, Am Soc Clin Oncol Educ Book, P327, DOI 10.1200/EdBook_AM.2013.33.327; Gong J, 2012, HUM MUTAT, V33, P254, DOI 10.1002/humu.21641; HARRIS RE, 1989, CANCER-AM CANCER SOC, V64, P1160, DOI 10.1002/1097-0142(19890901)64:5<1160::AID-CNCR2820640533>3.0.CO;2-B; Isla D, 2004, ANN ONCOL, V15, P1194, DOI 10.1093/annonc/mdh319; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lee SY, 2015, ANN ONCOL, V26, P1142, DOI 10.1093/annonc/mdv100; Li BA, 2012, ACTA PHARMACOL SIN, V33, P3, DOI 10.1038/aps.2011.198; Ma Ji-Yong, 2015, Asian Pac J Cancer Prev, V16, P1939; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Ryan BM, 2010, NAT REV CANCER, V10, P389, DOI 10.1038/nrc2867; Tay Y, 2008, NATURE, V455, P1124, DOI 10.1038/nature07299; Voorhoeve PM, 2007, ADV EXP MED BIOL, V604, P17, DOI 10.1007/978-0-387-69116-9_2; Wang Q, 2015, J NANOMATER, V2015, DOI 10.1155/2015/408634; Zhang P, 2015, TUMOR BIOL, V36, P8789, DOI 10.1007/s13277-015-3422-2; Zhao Y, 2014, CANCER EPIDEM BIOMAR, V23, P2503, DOI 10.1158/1055-9965.EPI-14-0389	21	9	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2017	12	4							e0175666	10.1371/journal.pone.0175666	http://dx.doi.org/10.1371/journal.pone.0175666			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0MD	28410417	Green Published, gold, Green Submitted			2022-12-27	WOS:000399955600032
J	Sinanoglou, VJ; Cavouras, D; Boutsikou, T; Briana, DD; Lantzouraki, DZ; Paliatsiou, S; Volaki, P; Bratakos, S; Malamitsi-Puchner, A; Zoumpoulakis, P				Sinanoglou, Vassilia J.; Cavouras, Dionisis; Boutsikou, Theodora; Briana, Despina D.; Lantzouraki, Dimitra Z.; Paliatsiou, Stella; Volaki, Paraskevi; Bratakos, Sotiris; Malamitsi-Puchner, Ariadne; Zoumpoulakis, Panagiotis			Factors affecting human colostrum fatty acid profile: A case study	PLOS ONE			English	Article							BREAST-MILK; MATERNAL OBESITY; LACTATION; PRETERM; ASSOCIATION; QUALITY; WOMEN	The role of maternal colostrum to infant development has been extensively studied and presented. Among the main factors which contribute to breast milk composition are maternal diet, age and body mass index, parity, duration of pregnancy and stage of lactation. This study aims to investigate the potential impact of several factors including demographic (i.e. maternal age and nationality) on the colostrum fatty acid profile. Colostrum was collected the third day postpartum in a Greek maternity hospital. Certain lipid quality indices and fatty acid ratios were estimated and results were statistically processed. The main identified fatty acids were palmitic (C16: 0), oleic (C18: 1 omega-9), and linoleic (C18: 2 omega-6) acids. Among fatty acids, saturated fatty acids predominated (47.61%), followed by monounsaturated fatty acids (39.26%), while polyunsaturated fatty acids had the lowest proportion (13.13%). Values of lipid quality indices were within the reported in the literature ranges. Maternal body mass index, nationality, age, mode of delivery, gender and fetal weight percentile were studied in respect to their potential influence on the fatty acid profile of colostrum fat. Results suggest that colostrum fatty acid profile was mainly dependent on maternal nationality and age rather than mode of delivery and maternal BMI. Regarding the effect of maternal nationality, significant differences were found for saturated and monounsaturated fatty acids. Of the most interesting findings is that colostrum fat from older (>= 35 years) mothers had less saturated fat and more appropriate LQIs values. Finally, a reversed correlation was observed between the customized centile of the infants and the colostrum fat content.	[Sinanoglou, Vassilia J.; Lantzouraki, Dimitra Z.; Bratakos, Sotiris] Technol Educ Inst Athens, Dept Food Technol, Lab Chem Anal & Design Food Proc, Instrumental Food Anal, Athens, Greece; [Cavouras, Dionisis] Technol Educ Inst Athens, Dept Biomed Engn, Med Image & Signal Proc Lab, Athens, Greece; [Boutsikou, Theodora; Briana, Despina D.; Paliatsiou, Stella; Volaki, Paraskevi; Malamitsi-Puchner, Ariadne] Natl & Kapodistrian Univ Athens, Aretaieio Univ Hosp, Med Sch, Dept Neonatol, Athens, Greece; [Lantzouraki, Dimitra Z.; Zoumpoulakis, Panagiotis] Natl Hellen Res Fdn, Inst Biol Med Chem & Biotechnol, Athens, Greece	University of West Attica; University of West Attica; National & Kapodistrian University of Athens; National Hellenic Research Foundation	Sinanoglou, VJ (corresponding author), Technol Educ Inst Athens, Dept Food Technol, Lab Chem Anal & Design Food Proc, Instrumental Food Anal, Athens, Greece.; Zoumpoulakis, P (corresponding author), Natl Hellen Res Fdn, Inst Biol Med Chem & Biotechnol, Athens, Greece.	vsina@teiath.gr; pzoump@eie.gr	Cavouras, Dionisis/U-9454-2019; Zoumpoulakis, Panagiotis/AAR-8625-2021; Sinanoglou, Vassilia/AAR-7532-2021; Lantzouraki, Dimitra Z./J-4818-2019; Zoumpoulakis, Panagiotis/B-2806-2019	Sinanoglou, Vassilia/0000-0001-8109-5563; Lantzouraki, Dimitra Z./0000-0001-5598-1959; Zoumpoulakis, Panagiotis/0000-0001-9348-6078	Internal Programme for Supporting Researchers of TEI Athens [80252]	Internal Programme for Supporting Researchers of TEI Athens	This research was funded from the Internal Programme for Supporting Researchers of TEI Athens (Code 80252, Research Committee TEI A 2015). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was funded from the Internal Programme for Supporting Researchers of TEI Athens (Code 80252, Research Committee TEI A 2015).	Allayee H, 2009, J NUTRIGENET NUTRIGE, V2, P140, DOI 10.1159/000235562; [Anonymous], 2008, MILK LACT WOM INF; Antonakou A, 2013, EUR J NUTR, V52, P963, DOI 10.1007/s00394-012-0403-8; Ballard O, 2013, PEDIATR CLIN N AM, V60, P49, DOI 10.1016/j.pcl.2012.10.002; Batovska DI, 2009, POL J MICROBIOL, V58, P43; BUTTE NF, 1984, AM J CLIN NUTR, V39, P296, DOI 10.1093/ajcn/39.2.296; da Cunha J, 2005, EARLY HUM DEV, V81, P303, DOI 10.1016/j.earlhumdev.2004.08.004; DENKE MA, 1992, AM J CLIN NUTR, V56, P895, DOI 10.1093/ajcn/56.5.895; ERICKSON MC, 1992, J SCI FOOD AGR, V59, P529, DOI 10.1002/jsfa.2740590416; Fares S, 2016, PROSTAG LEUKOTR ESS, V112, P32, DOI 10.1016/j.plefa.2016.08.002; Fidler N, 2000, EUR J NUTR, V39, P31, DOI 10.1007/s003940050073; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fuke G, 2017, CRIT REV FOOD SCI, V57, P1, DOI 10.1080/10408398.2012.716800; Gorski JN, 2006, AM J PHYSIOL-REG I, V291, pR768, DOI 10.1152/ajpregu.00138.2006; HACHEY DL, 1989, PEDIATR RES, V25, P63, DOI 10.1203/00006450-198901000-00015; Haro C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154090; Innis SM, 2007, EARLY HUM DEV, V83, P761, DOI 10.1016/j.earlhumdev.2007.09.004; Jenkins B, 2015, MOLECULES, V20, P2425, DOI 10.3390/molecules20022425; Kim J. H., 2016, SCI TECHNOL NUCL INS, V2016, P7, DOI [DOI 10.1155/2016/8634080, DOI 10.1146/ANNUREV-F00D-041715-033028]; Koba K, 2014, OBES RES CLIN PRACT, V8, pE525, DOI 10.1016/j.orcp.2013.10.001; Koletzko B, 1999, J MAMMARY GLAND BIOL, V4, P269, DOI 10.1023/A:1018749913421; Koletzko B, 2001, EARLY HUM DEV, V65, pS3, DOI 10.1016/S0378-3782(01)00204-3; Kovacs A, 2005, J PEDIATR GASTR NUTR, V41, P454, DOI 10.1097/01.mpg.0000176181.66390.54; Kuipers RS, 2012, PROSTAG LEUKOTR ESS, V86, P201, DOI 10.1016/j.plefa.2012.02.006; Larque E, 2001, EARLY HUM DEV; Levin BE, 2010, BRAIN RES, V1350, P10, DOI 10.1016/j.brainres.2009.12.085; Marin MC, 2005, PROSTAG LEUKOTR ESS, V73, P355, DOI 10.1016/j.plefa.2005.07.005; Markiewicz-Keszycka M, 2014, INT DAIRY J, V38, P31, DOI 10.1016/j.idairyj.2014.04.003; Mohammad MA, 2014, AM J PHYSIOL-ENDOC M, V306, pE838, DOI 10.1152/ajpendo.00605.2013; Mulford C., 1992, J OBSTET GYNECOLOGIC, P351; Nasser R, 2010, INT BREASTFEED J, V5, DOI 10.1186/1746-4358-5-3; Nishimura RY, 2013, J PEDIAT-BRAZIL, V89, P263, DOI 10.1016/j.jped.2012.11.007; Osmari EK, 2011, SMALL RUMINANT RES, V98, P128, DOI 10.1016/j.smallrumres.2011.03.030; Pu S, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01612; Rasmussen KM, 2007, ANNU REV NUTR, V27, P103, DOI 10.1146/annurev.nutr.27.061406.093738; Ruager-Martin R, 2010, EARLY HUM DEV, V86, P715, DOI 10.1016/j.earlhumdev.2010.08.007; Rudolph MC, 2016, INT J OBES NATURE PU; Ruiz-Nunez B, 2016, J NUTR BIOCHEM, V36, P1, DOI 10.1016/j.jnutbio.2015.12.007; Salamon S., 2009, REVIEW, V2, P174; Santos-Silva J, 2002, LIVEST PROD SCI, V77, P187, DOI 10.1016/S0301-6226(02)00059-3; Silva MHL, 2005, FOOD CHEM, V93, P297, DOI 10.1016/j.foodchem.2004.09.026; Sinanoglou V.J., 2013, ISRN CHROMATOGR, V2013, P859024, DOI [10.1155/2013/859024, DOI 10.1155/2013/859024]; Smit EN, 2002, PROSTAG LEUKOTR ESS, V66, P549, DOI 10.1054/plef.2002.0398; Smithers LG, 2010, PROSTAG LEUKOTR ESS, V83, P9, DOI 10.1016/j.plefa.2010.02.034; Storlien L, 2004, P NUTR SOC, V63, P363, DOI 10.1079/PNS2004349; ULBRICHT TLV, 1991, LANCET, V338, P985, DOI 10.1016/0140-6736(91)91846-M	46	28	31	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2017	12	4							e0175817	10.1371/journal.pone.0175817	http://dx.doi.org/10.1371/journal.pone.0175817			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0MD	28410426	Green Published, Green Submitted, gold			2022-12-27	WOS:000399955600045
J	Parvin, R; Saito-Hakoda, A; Shimoda, H; Shimizu, K; Noro, E; Iwasaki, Y; Fujiwara, K; Yokoyama, A; Sugawara, A				Parvin, Rehana; Saito-Hakoda, Akiko; Shimoda, Hiroki; Shimizu, Kyoko; Noro, Erika; Iwasaki, Yasumasa; Fujiwara, Ken; Yokoyama, Atsushi; Sugawara, Akira			Role of NeuroD1 on the negative regulation of Pomc expression by glucocorticoid	PLOS ONE			English	Article							PROOPIOMELANOCORTIN GENE-EXPRESSION; HELIX TRANSCRIPTION FACTORS; BETA-CELL FUNCTION; RETINOIC ACID; RECEPTOR GENE; PITUITARY; HORMONE; PROTEIN; DIFFERENTIATION; CORTICOTROPIN	The mechanism of the negative regulation of proopiomelanocortin gene (Pomc) by glucocorticoids (Gcs) is still unclear in many points. Here, we demonstrated the involvement of neurogenic differentiation factor 1 (NeuroD1) in the Gc-mediated negative regulation of Pomc. Murine pituitary adrenocorticotropic hormone (ACTH) producing corticotroph tumor-derived AtT20 cells were treated with dexamethasone (DEX) (1-100 nM) and cultured for 24 hrs. Thereafter, Pomc mRNA expression was studied by quantitative real-time PCR and rat Pomc promoter (-703/+58) activity was examined by luciferase assay. Both Pomc mRNA expression and Pomc promoter activity were inhibited by DEX in a dose-dependent manner. Deletion and point mutant analyses of Pomc promoter suggested that the DEX-mediated transcriptional repression was mediated via E-box that exists at -376/-371 in the promoter. Since NeuroD1 is known to bind to and activate E-box of the Pomc promoter, we next examined the effect of DEX on NeuroD1 expression. Interestingly, DEX dose-dependently inhibited NeuroD1 mRNA expression, mouse NeuroD1 promoter (-2.2-kb) activity, and NeuroD1 protein expression in AtT20 cells. In addition, we confirmed the inhibitory effect of DEX on the interaction of NeuroD1 and E-box on Pomc promoter by chromatin immunoprecipitation (ChIP) assay. Finally, overexpression of mouse NeuroD1 could rescue the DEX-mediated inhibition of Pomc mRNA expression and Pomc promoter activity. Taken together, it is suggested that the suppression of NeuroD1 expression and the inhibition of NeuroD1/E-box interaction may play an important role in the Gc-mediated negative regulation of Pomc.	[Parvin, Rehana; Saito-Hakoda, Akiko; Shimoda, Hiroki; Shimizu, Kyoko; Noro, Erika; Yokoyama, Atsushi; Sugawara, Akira] Tohoku Univ, Grad Sch Med, Dept Mol Endocrinol, Sendai, Miyagi, Japan; [Iwasaki, Yasumasa] Kochi Univ, Hlth Serv Ctr, Kochi, Kochi, Japan; [Fujiwara, Ken] Jichi Med Univ, Sch Med, Dept Anat, Div Histol & Cell Biol, Jichi, Tochigi, Japan	Tohoku University; Kochi University; Jichi Medical University	Sugawara, A (corresponding author), Tohoku Univ, Grad Sch Med, Dept Mol Endocrinol, Sendai, Miyagi, Japan.	akiras2i@med.tohoku.ac.jp	Yokoyama, Atsushi/W-3519-2019	Yokoyama, Atsushi/0000-0003-2842-4334; Sugawara, Akira/0000-0003-4511-8101	Ministry of Health, Labor and Welfare, Japan,	Ministry of Health, Labor and Welfare, Japan,(Ministry of Health, Labour and Welfare, Japan)	AS is funded by the Grants-in-Aid for Scientific Research (Research on Hypothalamohypophyseal Disorders) from the Ministry of Health, Labor and Welfare, Japan, and the Platform Project for Supporting in Drug Discovery and Life Science Research (Platform for Drug Discovery, Informatics, and Structural Life Science) from Japan Agency for Medical Research and Development (AMED). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson KR, 2009, J BIOL CHEM, V284, P31236, DOI 10.1074/jbc.M109.048694; AXELROD J, 1984, SCIENCE, V224, P452, DOI 10.1126/science.6143403; Batsche E, 2005, J BIOL CHEM, V280, P16088, DOI 10.1074/jbc.M413427200; Bell GI, 2001, NATURE, V414, P788, DOI 10.1038/414788a; BERTAGNA X, 1994, ENDOCRIN METAB CLIN, V23, P467, DOI 10.1016/S0889-8529(18)30079-3; Bilodeau S, 2006, GENE DEV, V20, P2871, DOI 10.1101/gad.1444606; BLOOMQUIST BT, 1991, MOL ENDOCRINOL, V5, P2014, DOI 10.1210/mend-5-12-2014; CADEPOND F, 1991, J BIOL CHEM, V266, P5834; Castro MG, 1997, CRIT REV NEUROBIOL, V11, P35; Cerf ME, 2006, EUR J ENDOCRINOL, V155, P671, DOI 10.1530/eje.1.02277; Dai AY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039950; Dostert A, 2004, CURR PHARM DESIGN, V10, P2807; DROUIN J, 1989, MOL CELL BIOL, V9, P5305, DOI 10.1128/MCB.9.12.5305; DROUIN J, 1993, EMBO J, V12, P145, DOI 10.1002/j.1460-2075.1993.tb05640.x; Drouin J, 2016, J MOL ENDOCRINOL, V56, pT99, DOI 10.1530/JME-15-0289; Dumonteil E, 1998, J BIOL CHEM, V273, P19945, DOI 10.1074/jbc.273.32.19945; EBERWINE JH, 1984, J BIOL CHEM, V259, P2166; GAGNER JP, 1985, MOL CELL ENDOCRINOL, V40, P25, DOI 10.1016/0303-7207(85)90154-6; Huang HP, 2000, MOL CELL BIOL, V20, P3292, DOI 10.1128/MCB.20.9.3292-3307.2000; JEANNOTTE L, 1987, MOL CELL BIOL, V7, P4058, DOI 10.1128/MCB.7.11.4058; Jenks BG, 2009, ANN NY ACAD SCI, V1163, P17, DOI 10.1111/j.1749-6632.2008.03620.x; Karalis KP, 2004, J BIOL CHEM, V279, P10837, DOI 10.1074/jbc.M313063200; Konishi Y, 1999, J NEUROCHEM, V72, P1717, DOI 10.1046/j.1471-4159.1999.721717.x; Kumar R, 2005, J STEROID BIOCHEM, V94, P383, DOI 10.1016/j.jsbmb.2004.12.046; Lamolet B, 2001, CELL, V104, P849, DOI 10.1016/S0092-8674(01)00282-3; Lamolet B, 2004, MOL ENDOCRINOL, V18, P995, DOI 10.1210/me.2003-0127; LEE JE, 1995, SCIENCE, V268, P836, DOI 10.1126/science.7754368; Liu M, 2000, GENE DEV, V14, P2839, DOI 10.1101/gad.840500; Maira M, 1999, MOL CELL BIOL, V19, P7549; Maliza R, 2016, ENDOCR J, V63, P555, DOI 10.1507/endocrj.EJ16-0086; Massari ME, 2000, MOL CELL BIOL, V20, P429, DOI 10.1128/MCB.20.2.429-440.2000; Mercau ME, 2016, ENDOCRINOLOGY, V157, P1135, DOI 10.1210/en.2015-1777; Miyata T, 1999, GENE DEV, V13, P1647, DOI 10.1101/gad.13.13.1647; Moates JM, 2003, DIABETES, V52, P403, DOI 10.2337/diabetes.52.2.403; Murakami I, 2007, J ENDOCRINOL, V193, P279, DOI 10.1677/JOE-06-0143; Mutoh H, 1998, GENE DEV, V12, P820, DOI 10.1101/gad.12.6.820; Pecori Giraldi F, 2011, END SOC 93 ANN M BOS, pP1; Phillips A, 1997, MOL CELL BIOL, V17, P5946, DOI 10.1128/MCB.17.10.5946; PICARD D, 1987, EMBO J, V6, P3333, DOI 10.1002/j.1460-2075.1987.tb02654.x; Poulin G, 1997, MOL CELL BIOL, V17, P6673, DOI 10.1128/MCB.17.11.6673; Poulin G, 2000, MOL CELL BIOL, V20, P4826, DOI 10.1128/MCB.20.13.4826-4837.2000; Pozzoli O, 2001, DEV BIOL, V233, P495, DOI 10.1006/dbio.2001.0230; Saito-Hakoda A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141960; Sharma A, 1999, MOL CELL BIOL, V19, P704; Shinozuka Y, 2001, BIOCHEM BIOPH RES CO, V287, P229, DOI 10.1006/bbrc.2001.5573; SMITH EM, 1981, P NATL ACAD SCI-BIOL, V78, P7530, DOI 10.1073/pnas.78.12.7530; Spyroglou A, 2009, J MOL ENDOCRINOL, V42, P407, DOI 10.1677/JME-08-0167; THERRIEN M, 1991, MOL CELL BIOL, V11, P3492, DOI 10.1128/MCB.11.7.3492; THERRIEN M, 1993, MOL CELL BIOL, V13, P2342, DOI 10.1128/MCB.13.4.2342; Uruno A, 2014, ENDOCR J, V61, P1105, DOI 10.1507/endocrj.EJ14-0115; WALSH D, 1992, CLEV CLIN J MED, V59, P505, DOI 10.3949/ccjm.59.5.505; Wardlaw SL, 1998, NEUROENDOCRINOLOGY, V67, P51, DOI 10.1159/000054298; WILSON TE, 1991, SCIENCE, V252, P1296, DOI 10.1126/science.1925541; Zhang Y, 2007, CHINESE MED J-PEKING, V120, P988, DOI 10.1097/00029330-200706010-00009; ZHOU A, 1993, J BIOL CHEM, V268, P1763	55	14	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2017	12	4							e0175435	10.1371/journal.pone.0175435	http://dx.doi.org/10.1371/journal.pone.0175435			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0MB	28406939	Green Published, gold, Green Submitted			2022-12-27	WOS:000399955400052
J	Young, GC; Dey, S; Rogers, AD; Exton, D				Young, G. C.; Dey, S.; Rogers, A. D.; Exton, D.			Cost and time-effective method for multiscale measures of rugosity, fractal dimension, and vector dispersion from coral reef 3D models	PLOS ONE			English	Article							HABITAT COMPLEXITY; STRUCTURAL COMPLEXITY; ACCURACY ASSESSMENT; FISH ASSEMBLAGES; ARTIFICIAL REEFS; SURFACE; TOPOGRAPHY; RICHNESS; REFUGES; METRICS	We present a method to construct and analyse 3D models of underwater scenes using a single cost-effective camera on a standard laptop with (a) free or low-cost software, (b) no computer programming ability, and (c) minimal man hours for both filming and analysis. This study focuses on four key structural complexity metrics: point-to-point distances, linear rugosity (R), fractal dimension (D), and vector dispersion (1/k). We present the first assessment of accuracy and precision of structure-from-motion (SfM) 3D models from an uncalibrated GoPro (TM) camera at a small scale (4 m(2)) and show that they can provide meaningful, ecologically relevant results. Models had root mean square errors of 1.48 cm in X-Y and 1.35 in Z, and accuracies of 86.8% (R), 99.6% (D at scales 30-60 cm), 93.6% (D at scales 1-5 cm), and 86.9 (1/k). Values of R were compared to in-situ chain-and-tape measurements, while values of D and 1/k were compared with ground truths from 3D printed objects modelled underwater. All metrics varied less than 3% between independently rendered models. We thereby improve and rigorously validate a tool for ecologists to non-invasively quantify coral reef structural complexity with a variety of multi-scale metrics.	[Young, G. C.; Rogers, A. D.] Univ Oxford, Dept Zool, Oxford, England; [Young, G. C.; Exton, D.] Operat Wallacea, Wallace House, Old Bolingbroke, Lincs, England; [Dey, S.] ThinkSee3D Ltd, Eynsham, England	University of Oxford	Young, GC (corresponding author), Univ Oxford, Dept Zool, Oxford, England.; Young, GC (corresponding author), Operat Wallacea, Wallace House, Old Bolingbroke, Lincs, England.	grace@robots.ox.ac.uk	Exton, Dan/L-5695-2019	Exton, Dan/0000-0001-8885-5828				Alvarez-Filip L, 2011, ECOL APPL, V21, P2223, DOI 10.1890/10-1563.1; Alvarez-Filip L, 2009, P ROY SOC B-BIOL SCI, V276, P3019, DOI 10.1098/rspb.2009.0339; Balletti C, 2014, SENSORS-BASEL, V14, P17471, DOI 10.3390/s140917471; BRADBURY RH, 1983, MAR ECOL PROG SER, V10, P169, DOI 10.3354/meps010169; Burns J, 2015, PEER J; Burns JHR, 2016, METHODS IN OCEANOGRA, P1; CARLETON JH, 1987, B MAR SCI, V40, P85; Carr MH, 1997, FISHERIES, V22, P28, DOI 10.1577/1548-8446(1997)022<0028:ARTIOC>2.0.CO;2; Casanova D, 2016, INFORM SCIENCES, V346, P58, DOI 10.1016/j.ins.2016.01.077; Casella E, 2017, CORAL REEFS, V36, P269, DOI 10.1007/s00338-016-1522-0; Dandois JP, 2013, REMOTE SENS ENVIRON, V136, P259, DOI 10.1016/j.rse.2013.04.005; Dustan P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057386; Ferrari R, 2016, REMOTE SENS-BASEL, V8, DOI 10.3390/rs8020113; Figueira W, 2015, REMOTE SENS-BASEL, V7, P16883, DOI 10.3390/rs71215859; Friedlander AM, 1998, J EXP MAR BIOL ECOL, V224, P1, DOI 10.1016/S0022-0981(97)00164-0; Friedman A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050440; Gneiting T, 2012, STAT SCI, V27, P247, DOI 10.1214/11-STS370; GOATLEY C, 2011, PLOS ONE, V6; Graham NAJ, 2013, CORAL REEFS, V32, P315, DOI 10.1007/s00338-012-0984-y; Gratwicke B, 2005, J FISH BIOL, V66, P650, DOI 10.1111/j.0022-1112.2005.00629.x; Guo T, 2016, INT ARCH PHOTOGRAMM, V41, P821, DOI 10.5194/isprsarchives-XLI-B5-821-2016; Gutierrez-Heredia L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149641; Harborne AR, 2012, ENVIRON BIOL FISH, V94, P431, DOI 10.1007/s10641-011-9956-2; Hearn CJ, 2001, CORAL REEFS, V20, P347, DOI 10.1007/s00338-001-0185-6; Helmholz P, 2016, INT ARCH PHOTOGRAMM, V41, P477, DOI 10.5194/isprsarchives-XLI-B5-477-2016; Herzfeld UC, 1999, COMPUT GEOSCI-UK, V25, P979, DOI 10.1016/S0098-3004(99)00062-X; HIATT RW, 1960, ECOL MONOGR, V30, P66; HIXON MA, 1993, ECOL MONOGR, V63, P77, DOI 10.2307/2937124; Hsui CY, 2013, ECOL ENG, V53, P6, DOI 10.1016/j.ecoleng.2013.01.014; Hu H, 2012, INT COR REEF S JUL 9, V12, P9; Javemick L, 2014, GEOMORPHOLOGY, V213, P166, DOI 10.1016/j.geomorph.2014.01.006; Johansen JL, 2008, MAR ECOL PROG SER, V360, P219, DOI 10.3354/meps07482; Kerry JT, 2012, CORAL REEFS, V31, P415, DOI 10.1007/s00338-011-0859-7; KLINKENBERG B, 1992, EARTH SURF PROC LAND, V17, P217, DOI 10.1002/esp.3290170303; Knudby A, 2007, P AM ACAD UNDERWATER, P181; Kostylev VE, 2005, ECOL COMPLEX, V2, P272, DOI 10.1016/j.ecocom.2005.04.002; Lavy A, 2015, METHODS ECOL EVOL, V6, P521, DOI 10.1111/2041-210X.12331; Ledlie MH, 2007, CORAL REEFS, V26, P641, DOI 10.1007/s00338-007-0230-1; Leon JX, 2015, GEOMORPHOLOGY, V242, P21, DOI 10.1016/j.geomorph.2015.01.030; LUCKHURST BE, 1978, MAR BIOL, V49, P317, DOI 10.1007/BF00455026; Mandelbrot B B, 1982, THE FRACTAL GEOMETRY; MARK DM, 1984, MAR ECOL PROG SER, V14, P293, DOI 10.3354/meps014293; Martin-Garin B, 2007, CORAL REEFS, V26, P541, DOI 10.1007/s00338-007-0256-4; MCCORMICK MI, 1994, MAR ECOL PROG SER, V112, P87, DOI 10.3354/meps112087; Merks R, 2003, LECT NOTES COMPUT SC, V2657, P639; Mumby P, 2014, TOWARDS REEF RESILIE; Newman SP, 2015, J ANIM ECOL, V84, P1678, DOI 10.1111/1365-2656.12429; Novianto S, 2003, PATTERN RECOGN LETT, V24, P365, DOI 10.1016/S0167-8655(02)00261-1; Perkol-Finkel S, 2006, MAR ENVIRON RES, V61, P121, DOI 10.1016/j.marenvres.2005.08.001; Pittman SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020583; Risk M.J., 1972, Atoll Res Bull, VNo. 153, P1; Storlazzi CD, 2016, CORAL REEFS, V35, P889, DOI 10.1007/s00338-016-1462-8; Wedding LM, 2008, REMOTE SENS ENVIRON, V112, P4159, DOI 10.1016/j.rse.2008.01.025; Westoby MJ, 2012, GEOMORPHOLOGY, V179, P300, DOI 10.1016/j.geomorph.2012.08.021; Wilson MFJ, 2007, MAR GEOD, V30, P3, DOI 10.1080/01490410701295962; Zawada DG, 2009, J COASTAL RES, V25, P6, DOI [10.2112/SI53-002.1, 10.2112/S153-002.1]; Zhou GY, 2005, COMPUT GEOSCI-UK, V31, P1260, DOI 10.1016/j.cageo.2005.03.016; Zhou HW, 2003, SURF REV LETT, V10, P751, DOI 10.1142/S0218625X03005591	58	63	63	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2017	12	4							e0175341	10.1371/journal.pone.0175341	http://dx.doi.org/10.1371/journal.pone.0175341			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0MB	28406937	gold, Green Published, Green Submitted			2022-12-27	WOS:000399955400042
J	Nguyen, HM; Sy, BT; Trung, NT; Hoan, NX; Wedemeyer, H; Velavan, TP; Bock, CT				Hung Minh Nguyen; Bui Tien Sy; Nguyen Thanh Trung; Nghiem Xuan Hoan; Wedemeyer, Heiner; Velavan, Thirumalaisamy P.; Bock, C-Thomas			Prevalence and genotype distribution of hepatitis delta virus among chronic hepatitis B carriers in Central Vietnam	PLOS ONE			English	Article							AMAZON REGION; ENDEMIC AREA; INFECTION; EPIDEMIOLOGY; DISEASE; LIVER; PATHOGENESIS; COINFECTION; ANTIGEN; UPDATE	Hepatitis D virus (HDV) infection plays an important role in liver diseases. However, the molecular epidemiology and impact of HDV infection in chronic hepatitis B (CHB) remain uncertain in Vietnam. This cross-sectional study aimed to investigate the prevalence and genotype distribution of HDV among HBsAg-positive patients in Central Vietnam. 250 CHB patients were tested for HDV using newly established HDV-specific RT-PCR techniques. HDV genotypes were determined by direct sequencing. Of the 250 patients 25 (10%) had detectable copies of HDV viral RNA. HDV-2 was predominant (20/25; 80%) followed by HDV-1 (5/25; 20%). Proven HDV genotypes share the Asian nomenclature. Chronic hepatitis B patients with concomitant HDV-1 showed higher HBV loads as compared to HDV-2 infected patients [median log10 (HBV-DNA copies/ml): 8.5 vs. 4.4, P = 0.036]. Our findings indicate that HDV infection is highly prevalent and HDV-2 is predominant in Central Vietnam. The data will add new information to the management of HBsAg-positive patients in a highly HBV endemic region to in-or exclude HDV infection in terms of diagnostic and treatment options.	[Hung Minh Nguyen; Nguyen Thanh Trung; Velavan, Thirumalaisamy P.] Duy Tan Univ, Inst Res & Dev, Ctr Mol Biol, Da Nang, Vietnam; [Bui Tien Sy] 108 Mil Cent Hosp, Dept Mol Biol, Hanoi, Vietnam; [Nghiem Xuan Hoan; Velavan, Thirumalaisamy P.] Univ Tubingen, Inst Trop Med, Tubingen, Germany; [Wedemeyer, Heiner] Med Sch Hannover, German Ctr Infect Res, Dept Gastroenterol Hepatol & Endocrinol, Hannover, Germany; [Velavan, Thirumalaisamy P.] Vietnamese German Ctr Med Res, Hanoi, Vietnam; [Bock, C-Thomas] Robert Koch Inst, Dept Infect Dis, Berlin, Germany	Duy Tan University; Eberhard Karls University of Tubingen; German Center for Infection Research; Hannover Medical School; Robert Koch Institute	Nguyen, HM (corresponding author), Duy Tan Univ, Inst Res & Dev, Ctr Mol Biol, Da Nang, Vietnam.; Bock, CT (corresponding author), Robert Koch Inst, Dept Infect Dis, Berlin, Germany.	hungmolbio@gmail.com; bockc@rki.de	Velavan, Thirumalaisamy P/C-1223-2010; Bock, C.-Thomas/A-3518-2012	Velavan, Thirumalaisamy P/0000-0002-9809-9883; Bock, C.-Thomas/0000-0002-2773-486X; Thanh Trung, Nguyen/0000-0002-9554-9092	Vietnam's National Foundation for Science and Technology Development (NAFOSTED) [106-YS.022014.03]; hepatitis international delta network (HDIN)	Vietnam's National Foundation for Science and Technology Development (NAFOSTED)(National Foundation for Science & Technology Development (NAFOSTED)); hepatitis international delta network (HDIN)	This work was sponsored by Vietnam's National Foundation for Science and Technology Development (NAFOSTED) grant no. 106-YS.022014.03 and hepatitis international delta network (HDIN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas Z, 2010, WORLD J GASTROENTERO, V16, P554, DOI 10.3748/wjg.v16.i5.554; Al Baqlani SA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097759; Alvarado-Mora MV, 2013, ANTIVIR THER, V18, P541, DOI 10.3851/IMP2598; Alvarado-Mora MV, 2011, INFECT GENET EVOL, V11, P1462, DOI 10.1016/j.meegid.2011.05.020; Andernach IE, 2014, J CLIN MICROBIOL, V52, P1629, DOI 10.1128/JCM.02297-13; Arakawa Y, 2000, J VIRAL HEPATITIS, V7, P375; Botelho-Souza LF, 2015, INTERVIROLOGY, V58, P166, DOI 10.1159/000431040; Sy BT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078094; Bulut Y, 2014, J INFECT DEV COUNTR, V8, P74, DOI 10.3855/jidc.3910; Butt FA, 2014, EUR J GASTROEN HEPAT, V26, P319, DOI 10.1097/MEG.0000000000000007; Casaca A, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-358; Celik I, 2011, ARCH VIROL, V156, P2215, DOI 10.1007/s00705-011-1120-y; CHANG FL, 1991, P NATL ACAD SCI USA, V88, P8490, DOI 10.1073/pnas.88.19.8490; Chen RX, 2010, VIRUSES-BASEL, V2, P131, DOI 10.3390/v2010131; Cross TJS, 2008, J MED VIROL, V80, P277, DOI 10.1002/jmv.21078; Degertekin H, 2008, LIVER INT, V28, P494, DOI 10.1111/j.1478-3231.2008.01673.x; Villa DD, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0402-5; Fattovich G, 2000, GUT, V46, P420, DOI 10.1136/gut.46.3.420; Gaeta GB, 2000, HEPATOLOGY, V32, P824, DOI 10.1053/jhep.2000.17711; Giersch K, 2014, J HEPATOL, V60, P538, DOI 10.1016/j.jhep.2013.11.010; Gish RG, 2013, J GASTROEN HEPATOL, V28, P1521, DOI 10.1111/jgh.12217; Heidrich B, 2012, LIVER INT, V32, P1415, DOI 10.1111/j.1478-3231.2012.02831.x; Hsu SC, 2002, HEPATOLOGY, V35, P665, DOI 10.1053/jhep.2002.31777; Hughes SA, 2011, LANCET, V378, P73, DOI 10.1016/S0140-6736(10)61931-9; IMAZEKI F, 1990, J VIROL, V64, P5594, DOI 10.1128/JVI.64.11.5594-5599.1990; Ivaniushina V, 2001, J GEN VIROL, V82, P2709, DOI 10.1099/0022-1317-82-11-2709; Kim HS, 2011, J MED VIROL, V83, P1172, DOI 10.1002/jmv.22095; Kumar S., 2016, MOL BIOL EVOLUTION, V33, DOI [DOI 10.1093/M0LBEV/MSW054, https://doi.org/10.1093/molbev/msw054, 10.1093/molbev/msw054]; Le Gal F, 2006, EMERG INFECT DIS, V12, P1447, DOI 10.3201/eid1209.060112; Lin HH, 2015, HEPATOLOGY, V61, P1870, DOI 10.1002/hep.27742; Lu SN, 2003, J MED VIROL, V70, P74, DOI 10.1002/jmv.10361; Mumtaz K, 2005, J GASTROEN HEPATOL, V20, P1503, DOI 10.1111/j.1440-1746.2005.03857.x; Murhekar MV, 2005, T ROY SOC TROP MED H, V99, P483, DOI 10.1016/j.trstmh.2004.10.002; Hoan NX, 2015, EBIOMEDICINE, V2, P2080, DOI 10.1016/j.ebiom.2015.11.020; Nguyen VTT, 2012, ASIA-PAC J PUBLIC HE, V24, P361, DOI 10.1177/1010539510385220; Nguyen VTT, 2007, J GASTROEN HEPATOL, V22, P2093, DOI 10.1111/j.1440-1746.2007.05010.x; Opaleye OO, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0514-6; Pascarella S, 2011, LIVER INT, V31, P7, DOI 10.1111/j.1478-3231.2010.02320.x; Popescu GA, 2013, J MED VIROL, V85, P769, DOI 10.1002/jmv.23524; Radjef N, 2004, J VIROL, V78, P2537, DOI 10.1128/JVI.78.5.2537-2544.2004; RIZZETTO M, 1977, GUT, V18, P997, DOI 10.1136/gut.18.12.997; Schweitzer A, 2015, LANCET, V386, P1546, DOI 10.1016/S0140-6736(15)61412-X; Shirvani-Dastgerdi Elham, 2015, World J Virol, V4, P36, DOI 10.5501/wjv.v4.i2.36; Sureau C, 2016, J HEPATOL, V64, pS102, DOI 10.1016/j.jhep.2016.02.013; Sy BT, 2015, J VIRAL HEPATITIS, V22, P55, DOI 10.1111/jvh.12228; Sy N E, 1990, Southeast Asian J Trop Med Public Health, V21, P69; Tsatsralt-Od B, 2005, J MED VIROL, V77, P491, DOI 10.1002/jmv.20482; Uzunalimoglu O, 2001, DIGEST DIS SCI, V46, P1022, DOI 10.1023/A:1010705910858; Wedemeyer H, 2011, LIVER INT, V31, P140, DOI 10.1111/j.1478-3231.2010.02408.x; Wedemeyer H, 2010, NAT REV GASTRO HEPAT, V7, P31, DOI 10.1038/nrgastro.2009.205; Yurdaydin C, 2010, J VIRAL HEPATITIS, V17, P749, DOI 10.1111/j.1365-2893.2010.01353.x	51	12	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2017	12	4							e0175304	10.1371/journal.pone.0175304	http://dx.doi.org/10.1371/journal.pone.0175304			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LZ	28403190	Green Published, Green Submitted, gold			2022-12-27	WOS:000399955200048
J	Tian, XC; Du, HD; Li, LM; Bennett, D; Gao, RQ; Li, SP; Wang, SJ; Guo, Y; Bian, Z; Yang, L; Chen, YP; Chen, JS; Gao, Y; Weng, M; Pang, ZC; Jiang, BF; Chen, ZM				Tian, Xiaocao; Du, Huaidong; Li, Liming; Bennett, Derrick; Gao, Ruqin; Li, Shanpeng; Wang, Shaojie; Guo, Yu; Bian, Zheng; Yang, Ling; Chen, Yiping; Chen, Junshi; Gao, Yan; Weng, Min; Pang, Zengchang; Jiang, Baofa; Chen, Zhengming		China Kadoorie Biobank Study	Fruit consumption and physical activity in relation to all-cause and cardiovascular mortality among 70,000 Chinese adults with pre-existing vascular disease	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; LOW-INCOME COUNTRIES; MYOCARDIAL-INFARCTION; SECONDARY PREVENTION; MEDITERRANEAN DIET; VEGETABLE CONSUMPTION; REGRESSION DILUTION; LIFE-STYLE; RISK; STROKE	Objectives To assess the associations of fresh fruit consumption and total physical activity with all-cause and cardiovascular mortality among Chinese adults who have been diagnosed with cardiovascular disease (CVD) or hypertension. Methods During 2004-08, the China Kadoorie Biobank study recruited 70,047 adults, aged 30-79 years, with physician-diagnosed stroke or transient ischaemic attack, ischemic heart disease, or hypertension. Information on diet and physical activity was collected using an inter-viewer- administered electronic questionnaire. Cox regression was used to yield hazard ratios (HRs) for the independent and joint associations of fresh fruit consumption and total physical activity with mortality. Results At baseline, 32.9% of participants consumed fresh fruit regularly (i.e. > 3 days/week) and the mean total physical activity were 15.8 (SD = 11.8) MET-hr/day. During similar to 7-years follow-up, 6569 deaths occurred with 3563 from CVD. Compared to participants with < 1 day/week fruit consumption, regular consumers had HR (95% CI) of 0.84 (0.79-0.89) for all-cause mortality and 0.79 (0.73-0.86) for CVD mortality. The HRs for the top vs bottom tertile of physical activity were 0.68 (0.64-0.72) and 0.65 (0.60-0.71), respectively, with no clear evidence of reverse causality. After correcting for regression dilution, each 100 g/day usual consumption of fresh fruit or 10 MET-hr/day usual levels of physical activity was associated with 23-29% lower mortality. The combination of regular fruit consumption with top 3(rd) of physical activity (> 16.53 MET-hr/day) was associated with about 40% lower mortality. Conclusion Among Chinese adults with pre-existing vascular disease, higher physical activity and fruit consumption were both independently and jointly associated with lower mortality.	[Tian, Xiaocao; Jiang, Baofa] Shandong Univ, Sch Publ Hlth, Jinan, Shandong, Peoples R China; [Tian, Xiaocao; Gao, Ruqin; Li, Shanpeng; Wang, Shaojie; Pang, Zengchang] Qingdao Ctr Dis Prevent & Control, Qingdao, Shandong, Peoples R China; [Du, Huaidong; Yang, Ling; Chen, Yiping] Univ Oxford, MRC, Populat Hlth Res Unit, Nuffield Dept Populat Hlth, Oxford, England; [Du, Huaidong; Bennett, Derrick; Yang, Ling; Chen, Yiping; Chen, Zhengming] Univ Oxford, Nuffield Dept Populat Hlth, Clin Trial Serv Unit, Oxford, England; [Du, Huaidong; Bennett, Derrick; Yang, Ling; Chen, Yiping; Chen, Zhengming] Univ Oxford, Nuffield Dept Populat Hlth, Epidemiol Studies Unit CTSU, Oxford, England; [Li, Liming] Peking Univ, Hlth Sci Ctr, Dept Epidemiol, Sch Publ Hlth, Beijing, Peoples R China; [Li, Liming; Guo, Yu; Bian, Zheng] Chinese Acad Med Sci, Beijing, Peoples R China; [Chen, Junshi] China Natl Ctr Food Safety Risk Assessment, Beijing, Peoples R China; [Gao, Yan] Suzhou CDC, Suzhou, Jiangsu, Peoples R China; [Weng, Min] Meilan CDC, Haikou, Hainan, Peoples R China	Shandong University; University of Oxford; University of Oxford; University of Oxford; Peking University; Chinese Academy of Medical Sciences - Peking Union Medical College	Jiang, BF (corresponding author), Shandong Univ, Sch Publ Hlth, Jinan, Shandong, Peoples R China.; Pang, ZC (corresponding author), Qingdao Ctr Dis Prevent & Control, Qingdao, Shandong, Peoples R China.; Du, HD (corresponding author), Univ Oxford, MRC, Populat Hlth Res Unit, Nuffield Dept Populat Hlth, Oxford, England.; Du, HD (corresponding author), Univ Oxford, Nuffield Dept Populat Hlth, Clin Trial Serv Unit, Oxford, England.; Du, HD (corresponding author), Univ Oxford, Nuffield Dept Populat Hlth, Epidemiol Studies Unit CTSU, Oxford, England.	huaidong.du@ctsu.ox.ac.uk; cdcpang@126.com; bjiang@sdu.edu.cn	Bennett, Derrick/AAH-1220-2022; , Bennett/O-7998-2019; Bennett, Derrick/AFL-9254-2022	Bennett, Derrick/0000-0002-9170-8447; Bennett, Derrick/0000-0002-9170-8447; Lv, Jun/0000-0001-7916-3870; Du, Huaidong/0000-0002-9814-0049; Tian, Xiaocao/0000-0002-4275-3719; Kurmi, Om Prakash/0000-0002-9518-4716	Kadoorie Charitable Foundation, Hong Kong; UK Wellcome Trust [088158/Z/09/Z, 104085/Z/14/Z]; Chinese Ministry of Science and Technology [2011BAI09B01]; Chinese National Natural Science Foundation [81390541]; Kadoorie Charitable Foundation in HongKong; British Heart Foundation; UK Medical Research Council; Cancer Research UK; Medical Research Council [MC_UU_12026/2, MC_U137686851] Funding Source: researchfish; MRC [MC_U137686851, MC_UU_12026/2] Funding Source: UKRI	Kadoorie Charitable Foundation, Hong Kong; UK Wellcome Trust(Wellcome Trust); Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Kadoorie Charitable Foundation in HongKong; British Heart Foundation(British Heart Foundation); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported as follows: Baseline survey: Kadoorie Charitable Foundation, Hong Kong. Long-term continuation: UK Wellcome Trust (088158/Z/09/Z, 104085/Z/14/Z), Chinese Ministry of Science and Technology (2011BAI09B01, 2012-14), Chinese National Natural Science Foundation (81390541). The baseline survey and the first re-survey were supported by are search grant from the Kadoorie Charitable Foundation in HongKong. The longterm continuation of the project is supported by program grants from the UK Wellcome Trust (088158/Z/09/Z, 104085/Z/14/Z, http://www.wellcome.ac.uk/); the Chinese Ministry of Science and Technology (2011BAI09B01, 2012-14); and the Chinese National Natural Science Foundation (81390541, http://www.nsfc.gov.cn/). The British Heart Foundation (https://www.bhf.org.uk/); UK Medical Research Council (http://www.mrc.ac.uk/); and Cancer Research UK (http://www.cancerresearchuk.org/) provide core funding to the Oxford CTSU.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong MEG, 2015, CIRCULATION, V131, P721, DOI 10.1161/CIRCULATIONAHA.114.010296; Barzi F, 2003, EUR J CLIN NUTR, V57, P604, DOI 10.1038/sj.ejcn.1601575; Bennett D, 2015, EUR HEART J, V36, P465; Billinger SA, 2014, STROKE, V45, P2532, DOI 10.1161/STR.0000000000000022; Booth JN, 2014, AM J CARDIOL, V113, P1933, DOI 10.1016/j.amjcard.2014.03.033; Chen ZM, 2011, INT J EPIDEMIOL, V40, P1652, DOI 10.1093/ije/dyr120; Clarke R, 1999, AM J EPIDEMIOL, V150, P341; de Lorgeril M, 1999, CIRCULATION, V99, P779, DOI 10.1161/01.CIR.99.6.779; Dehghan M, 2012, CIRCULATION, V126, P2705, DOI 10.1161/CIRCULATIONAHA.112.103234; Du H, 2013, AM J CLIN NUTR, V97, P487, DOI DOI 10.3945/AJCN.112.046854; Du HD, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002279; Du HD, 2016, NEW ENGL J MED, V374, P1332, DOI 10.1056/NEJMoa1501451; Du HD, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-826; Frost C, 2000, J R STAT SOC A STAT, V163, P173, DOI 10.1111/1467-985X.00164; Gersh BJ, 2010, EUR HEART J, V31, P642, DOI 10.1093/eurheartj/ehq030; Greenlund KJ, 2002, STROKE, V33, P565, DOI 10.1161/hs0202.102882; Heran BS, 2011, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001800.pub2, 10.1002/14651858.CD001800.pub3]; Jones K, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6544; Kernan WN, 2014, STROKE, V45, P2160, DOI 10.1161/STR.0000000000000024; Lampe JW, 1999, AM J CLIN NUTR, V70, p475S, DOI 10.1093/ajcn/70.3.475s; Larsson SC, 2013, ATHEROSCLEROSIS, V227, P147, DOI 10.1016/j.atherosclerosis.2012.12.022; Lawrence Maggie, 2011, Nurs Stand, V26, P41; Leenders M, 2013, AM J EPIDEMIOL, V178, P590, DOI 10.1093/aje/kwt006; Li J, 2012, INT J ENV RES PUB HE, V9, P391, DOI 10.3390/ijerph9020391; Li SS, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2659; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; MACMAHON S, 1990, LANCET, V335, P765, DOI 10.1016/0140-6736(90)90878-9; Myers J, 2002, NEW ENGL J MED, V346, P793, DOI 10.1056/NEJMoa011858; Nakamura K, 2008, J NUTR, V138, P1129, DOI 10.1093/jn/138.6.1129; Ning M, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009836; Okura Y, 2004, J CLIN EPIDEMIOL, V57, P1096, DOI 10.1016/j.jclinepi.2004.04.005; Oyebode O, 2014, J EPIDEMIOL COMMUN H, V68, P856, DOI 10.1136/jech-2013-203500; PATE RR, 1995, JAMA-J AM MED ASSOC, V273, P402, DOI 10.1001/jama.273.5.402; Sadarangani KP, 2014, DIABETES CARE, V37, P1016, DOI 10.2337/dc13-1816; Smith SC, 2011, CIRCULATION, V124, P2458, DOI 10.1161/CIR.0b013e318235eb4d; Sofi F, 2008, EUR J CARDIOV PREV R, V15, P247, DOI 10.1097/HJR.0b013e3282f232ac; Teo K, 2013, JAMA-J AM MED ASSOC, V309, P1613, DOI 10.1001/jama.2013.3519; Thompson PD, 2003, CIRCULATION, V107, P3109, DOI 10.1161/01.CIR.0000075572.40158.77; Trichopoulou A, 2007, EUR J EPIDEMIOL, V22, P871, DOI 10.1007/s10654-007-9190-6; Wang X, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4490; Woodcock J, 2011, INT J EPIDEMIOL, V40, P121, DOI 10.1093/ije/dyq104; Yusuf S, 2011, LANCET, V378, P1231, DOI 10.1016/S0140-6736(11)61215-4	42	13	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2017	12	4							e173054	10.1371/journal.pone.0173054	http://dx.doi.org/10.1371/journal.pone.0173054			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LZ	28403155	Green Published, gold, Green Submitted			2022-12-27	WOS:000399955200004
J	He, M; Yang, ZY; Zhang, L; Song, CL; Li, YJ; Zhang, XY				He, Miao; Yang, Zhaoying; Zhang, Le; Song, Changlong; Li, Youjun; Zhang, Xingyi			Additive effects of cherlerythrine chloride combination with erlotinib in human non-small cell lung cancer cells	PLOS ONE			English	Article							CHELERYTHRINE CHLORIDE; KINASE; SURVIVAL; PATHWAY; STAT3; RESISTANCE; INHIBITOR; APOPTOSIS; GROWTH; BAD	Several studies implicate that lung cancer progression is governed by the interaction between epidermal growth factor receptor (EGFR) signaling and protein kinase C (PKC) pathways. Combined the targeting of EGFR and PKC may have an additive or synergistic effects in lung cancer treatment. The aim of this study is to explore the potential utility by inhibiting these two pathways with the combination of erlotinib and chelerythrine chloride in non-small cell lung cancer (NSCLC) cell lines. The erlotinib-less sensitive cell lines SK-MES- 1 and A549 were treated with erlotinib or chelerythrine by themselves or in combination with each other. The cell viability, clonogenic survival, cell migration, invasion, cell apoptosis effects and immunoblotting were accessed in vitro. Tumor growth was evaluated in vivo. There were additive effects of chelerythrine combined with erlotinib treatment in all NSCLC cell lines, resulting in a significant decrease in cell viability, clonogenicity, migratory and invasive capabilities as well as in the induction of apoptosis. Concordantly, the combined treatment caused a significant delay in tumor growth. The treatment effectively blocked EGFR signaling through decreasing phosphorylation of downstream targets such as STAT3, ERK1/2, p38 MAPK and Bad proteins. Our study supports the functional interaction between the EGFR and PKC pathways in lung cancer and provides a clinically exploitable strategy for erlotinib-less sensitive non-small cell lung cancer patients.	[He, Miao] Jilin Univ, Hosp 2, Dept Anesthesia, Changchun, Peoples R China; [Yang, Zhaoying; Zhang, Le; Song, Changlong] Jilin Univ, China Japan Union Hosp, Dept Breast Surg, Changchun, Peoples R China; [Li, Youjun] Jilin Univ, Norman Bethune Hlth Sci Ctr, Dept Anat, Changchun, Peoples R China; [Zhang, Xingyi] Jilin Univ, Hosp 2, Dept Thorax Surg, Changchun, Peoples R China	Jilin University; Jilin University; Jilin University; Jilin University	Li, YJ (corresponding author), Jilin Univ, Norman Bethune Hlth Sci Ctr, Dept Anat, Changchun, Peoples R China.; Zhang, XY (corresponding author), Jilin Univ, Hosp 2, Dept Thorax Surg, Changchun, Peoples R China.	youjun.li@yahoo.com; xyzhangjeu@sina.com		Zhang, Le/0000-0003-4622-5750	National Natural Science Foundation of China [81272472, 81372456]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (No.81272472; No.81372456).	Abera MB, 2015, MOL PHARMACOL, V87, P832, DOI 10.1124/mol.115.097725; Axelrod M, 2013, ONCOTARGET, V4, P622, DOI 10.18632/oncotarget.938; Barre B, 2007, TRENDS MOL MED, V13, P4, DOI 10.1016/j.molmed.2006.11.001; Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; Burke WM, 2001, ONCOGENE, V20, P7925, DOI 10.1038/sj.onc.1204990; Chan SL, 2003, J BIOL CHEM, V278, P20453, DOI 10.1074/jbc.C300138200; Chiu HC, 2011, BIOCHEM PHARMACOL, V81, P1263, DOI 10.1016/j.bcp.2011.03.003; Chmura SJ, 2000, CLIN CANCER RES, V6, P737; Clark AS, 2003, CANCER RES, V63, P780; Coco S, 2015, TARGET ONCOL, V10, P393, DOI 10.1007/s11523-014-0344-7; Datta SR, 2002, DEV CELL, V3, P631, DOI 10.1016/S1534-5807(02)00326-X; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; delPeso L, 1997, SCIENCE, V278, P687; Doornbos RP, 1999, J BIOL CHEM, V274, P8589, DOI 10.1074/jbc.274.13.8589; Fumarola C, 2014, BIOCHEM PHARMACOL, V90, P197, DOI 10.1016/j.bcp.2014.05.011; Gilmore AP, 2002, J BIOL CHEM, V277, P27643, DOI 10.1074/jbc.M108863200; Gridelli C, 2007, ONCOLOGIST, V12, P840, DOI 10.1634/theoncologist.12-7-840; Harada D, 2014, CANCERS, V6, P708, DOI 10.3390/cancers6020708; HERBERT JM, 1990, BIOCHEM BIOPH RES CO, V172, P993, DOI 10.1016/0006-291X(90)91544-3; Herbst RS, 2008, NEW ENGL J MED, V359, P1367, DOI 10.1056/NEJMra0802714; Horiguchi A, 2010, BRIT J CANCER, V102, P1592, DOI 10.1038/sj.bjc.6605691; Iwabu A, 2004, J BIOL CHEM, V279, P14551, DOI 10.1074/jbc.M311981200; Kusne Y, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005196; Li WQ, 1999, ONCOGENE, V18, P6564, DOI 10.1038/sj.onc.1203065; Liu L, 2011, MOL CANCER THER, V10, P518, DOI 10.1158/1535-7163.MCT-10-0698; Liu Y, 2009, LUNG CANCER, V63, P210, DOI 10.1016/j.lungcan.2008.05.010; Medvetz D, 2015, MOL CANCER RES, V13, P50, DOI 10.1158/1541-7786.MCR-14-0440; Morgan S, 2009, EXP CELL RES, V315, P572, DOI 10.1016/j.yexcr.2008.08.009; Poomakkoth N, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-0768-1; Sano S, 2005, CANCER RES, V65, P5720, DOI 10.1158/0008-5472.CAN-04-4359; Shimamura A, 2000, CURR BIOL, V10, P127, DOI 10.1016/S0960-9822(00)00310-9; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Sierra JR, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-75; Wang JH, 2012, ONCOL REP, V27, P1341, DOI 10.3892/or.2012.1677; Wang Yong-chuan, 2012, Cancer Biology Medicine, V9, P128, DOI 10.3969/j.issn.2095-3941.2012.02.009; Wong KK, 2010, CURR OPIN GENET DEV, V20, P87, DOI 10.1016/j.gde.2009.11.002; Yamamoto S, 2001, J MOL CELL CARDIOL, V33, P1829, DOI 10.1006/jmcc.2001.1446; Yang R, 2008, CLIN CANCER RES, V14, P6396, DOI 10.1158/1078-0432.CCR-07-5113; Yang ZY, 2014, INT J CLIN EXP PATHO, V7, P7563; Zhang L, 2016, ONCOTARGET; Zhang ZF, 2011, ARCH PHARM RES, V34, P791, DOI 10.1007/s12272-011-0513-5	41	15	15	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2017	12	4							e0175466	10.1371/journal.pone.0175466	http://dx.doi.org/10.1371/journal.pone.0175466			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0JS	28399187	gold, Green Submitted, Green Published			2022-12-27	WOS:000399949000041
J	Wang, AS; Gopurenko, D; Wu, HW; Lepschi, B				Wang, Aisuo; Gopurenko, David; Wu, Hanwen; Lepschi, Brendan			Evaluation of six candidate DNA barcode loci for identification of five important invasive grasses in eastern Australia	PLOS ONE			English	Article							INTERNAL TRANSCRIBED SPACERS; POA POACEAE; RBCL GENE; CHLOROPLAST; PHYLOGENIES; SEQUENCES; EXAMPLE; REGIONS; PLANTS	Invasive grass weeds reduce farm productivity, threaten biodiversity, and increase weed control costs. Identification of invasive grasses from native grasses has generally relied on the morphological examination of grass floral material. DNA barcoding may provide an alternative means to identify co-occurring native and invasive grasses, particularly during early growth stages when floral characters are unavailable for analysis. However, there are no universal loci available for grass barcoding. We herein evaluated the utility of six candidate loci (atpF intron, matK, ndhK-ndhC, psbE-petL, ETS and ITS) for barcode identification of several economically important invasive grass species frequently found among native grasses in eastern Australia. We evaluated these loci in 66 specimens representing five invasive grass species (Chloris gayana, Eragrostis curvula, Hyparrhenia hirta, Nassella neesiana, Nassella trichotoma) and seven native grass species. Our results indicated that, while no single locus can be universally used as a DNA barcode for distinguishing the grass species examined in this study, two plastid loci (atpF and matK) showed good distinguishing power to separate most of the taxa examined, and could be used as a dual locus to distinguish several of the invasive from the native species. Low PCR success rates were evidenced among two nuclear loci (ETS and ITS), and few species were amplified at these loci, however ETS was able to genetically distinguish the two important invasive Nassella species. Multiple loci analyses also suggested that ETS played a crucial role in allowing identification of the two Nassella species in the multiple loci combinations.	[Wang, Aisuo; Gopurenko, David; Wu, Hanwen] Wagga Wagga Agr Inst, NSW Dept Primary Ind, Wagga Wagga, NSW, Australia; [Wang, Aisuo; Gopurenko, David; Wu, Hanwen] Graham Ctr Agr Innovat, An Alliance NSW Dept Primary Ind & Charles Sturt, Wagga Wagga, NSW, Australia; [Lepschi, Brendan] Ctr Australian Natl Biodivers Res, Australian Natl Herbarium, Canberra, ACT, Australia	NSW Department of Primary Industries; NSW Department of Primary Industries	Wang, AS (corresponding author), Wagga Wagga Agr Inst, NSW Dept Primary Ind, Wagga Wagga, NSW, Australia.; Wang, AS (corresponding author), Graham Ctr Agr Innovat, An Alliance NSW Dept Primary Ind & Charles Sturt, Wagga Wagga, NSW, Australia.	aisuo.wang@dpi.nsw.gov.au	Gopurenko, David/H-3341-2014; Wu, Hanwen/B-7901-2010	Gopurenko, David/0000-0003-2886-1614; Wu, Hanwen/0000-0001-5157-4977	NSW Weeds Action Programs (WAP)	NSW Weeds Action Programs (WAP)	This work was supported by NSW Weeds Action Programs (WAP).; This study was funded by the NSW Weeds Action Program (WAP). Mr Adam Shephard, Mr Peter Deane, Mr Malcolm Ross, Mr Jeremy Crocker and other Council Weeds Officers provided assistances in field sampling. We thank Dr Pina Milne and Mr Wayne Gebert from the National Herbarium of Victoria for providing herbarium samples (MEL 2375629A and MEL 2330503A). Native grasses were provided by Mr Ian Chivers (Native Seeds Nursery in Melbourne) and Dr Peter Orchard (Charles Sturt University).	Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0905845106, 10.1073/pnas.0812297106]; Ayres L, 2006, SERRATED TUSSOCK IDE, P44; Baldwin BG, 1992, MOL PHYLOGENET EVOL, V1, P3, DOI 10.1016/1055-7903(92)90030-K; Birch JL, 2014, BOT J LINN SOC, V175, P523, DOI 10.1111/boj.12185; Campbell M., 2002, GRASSLANDS SOC NEWSL, V17; Chase MW, 2007, TAXON, V56, P295, DOI 10.1002/tax.562004; CRC for Australian Weed Management, 2007, COOL GRASS HYP HIRT; deWaard JR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014280; Diekmann K, 2012, ANN BOT-LONDON, V110, P1327, DOI 10.1093/aob/mcs044; Dong WP, 2015, SCI REPORTS, V5; Ford CS, 2009, BOT J LINN SOC, V159, P1, DOI 10.1111/j.1095-8339.2008.00938.x; Gillespie LJ, 2009, AUST SYST BOT, V22, P413, DOI 10.1071/SB09016; Guindon S, 2009, METHODS MOL BIOL, V537, P113, DOI 10.1007/978-1-59745-251-9_6; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hollingsworth PM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019254; Kass E, 1997, PLANT SYST EVOL, V208, P139, DOI 10.1007/BF00985439; Kress WJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000508; Kress WJ, 2008, P NATL ACAD SCI USA, V105, P2761, DOI 10.1073/pnas.0800476105; Kress WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/pnas.0503123102; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Mahadani P, 2013, DNA BARCODES, P35; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Smith MA, 2006, P NATL ACAD SCI USA, V103, P3657, DOI 10.1073/pnas.0511318103; Starr JR, 2003, INT J PLANT SCI, V164, P213, DOI 10.1086/346168; SUN Y, 1994, THEOR APPL GENET, V89, P26, DOI 10.1007/BF00226978; Syme AE, 2013, DNA BARCODES, V1, P19; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Wang A., 2014, J NANOMATER, V2014, P1, DOI DOI 10.1371/J0URNAL.P0NE.0135538; Weller SL, 2016, SCI REP-UK, V6, DOI 10.1038/srep22345; WOLFE KH, 1987, P NATL ACAD SCI USA, V84, P9054, DOI 10.1073/pnas.84.24.9054; Zhang JQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119921	33	15	15	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2017	12	4							e0175338	10.1371/journal.pone.0175338	http://dx.doi.org/10.1371/journal.pone.0175338			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0JS	28399170	gold, Green Submitted, Green Published			2022-12-27	WOS:000399949000033
J	Han, XM; Han, Y; Zheng, YS; Sung, Q; Ma, T; Zhang, JY; Xu, LJ				Han, Xinming; Han, Yan; Zheng, Yongsheng; Sung, Qiang; Ma, Tao; Zhang, Junyi; Xu, Lianji			Chaetocin induces apoptosis in human melanoma cells through the generation of reactive oxygen species and the intrinsic mitochondrial pathway, and exerts its anti-tumor activity in vivo	PLOS ONE			English	Article							ANTILEUKEMIA ACTIVITY; DEATH; INHIBITION; AGENT; LEADS	Chaetocin is a small-molecule natural product produced by Chaetomium species fungi, and it has a potent anti-proliferative pharmacological activity on various cancer cells. However, the effect of chaetocin on anti-melanoma pharmacological role has not been investigated. Therefore, in this study, we explored the effect of chaetocin on cell proliferation in the human melanoma Sk-Mel-28 and A375 cells and the growth of tumor xenografts in nude mice. The results indicated that chaetocin treatment significantly suppressed cell proliferation and induced apoptosis in the Sk-Mel-28 and A375 cells in a dose-and time-dependent manner. Furthermore, chaetocin treatment resulted in an increased level of cellular reactive oxygen species (ROS), and pre-incubation of cells with N-acetylcysteine (NAC) significantly abrogated chaetocin-induced apoptosis in the melanoma cells. A significant reduction of mitochondrial membrane potential and the release of cytochrome c were observed after chaetocin treatment. Additionally, chaetocin treatment significantly up-regulated the protein levels of Bax, cleaved caspase-9/-3, simultaneously down-regulated the protein levels of Bcl-2, procaspase-9/-3, and activated caspase-9/-3 activity in the melanoma cells. The in vivo data demonstrated that chaetocin treatment significantly inhibited the growth of melanoma tumor xenografts in nude mice, which was closely associated with apoptosis induction, a reduced level of PCNA (proliferating cell nuclear antigen) expression, and activation of capase-9/-3 in tumor xenografts. These are the first data to demonstrate that chaetocin exerts a proapoptotic activity on human melanoma cells through ROS generation and the intrinsic mitochondrial pathway. Therefore, chaetocin might represent an effective candidate for melanoma chemotherapy..	[Han, Xinming; Han, Yan] Chinese Peoples Liberat Army Gen Hosp, Dept Plast & Reconstruct Surg, Beijing, Peoples R China; [Han, Xinming; Zheng, Yongsheng; Sung, Qiang; Ma, Tao; Zhang, Junyi; Xu, Lianji] Capital Med Univ, Beijing Tongren Hosp, Med Cosmet Ctr, Beijing, Peoples R China	Chinese People's Liberation Army General Hospital; Capital Medical University	Han, Y (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Dept Plast & Reconstruct Surg, Beijing, Peoples R China.	han8yan@sina.com	Zhang, Junyi/HDN-7815-2022					Bae JS, 2016, CHEM-BIOL INTERACT, V245, P66, DOI 10.1016/j.cbi.2015.12.021; Chaib H, 2012, LEUKEMIA, V26, P662, DOI 10.1038/leu.2011.271; Chipuk JE, 2010, MOL CELL, V37, P299, DOI 10.1016/j.molcel.2010.01.025; Dixit D, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.179; Dixit D, 2009, FREE RADICAL BIO MED, V47, P364, DOI 10.1016/j.freeradbiomed.2009.04.031; Dong Y, 2014, ONCOL REP, V31, P1788, DOI 10.3892/or.2014.3034; Eggermont AMM, 2014, LANCET, V383, P816, DOI 10.1016/S0140-6736(13)60802-8; Fang J, 2009, ADV DRUG DELIVER REV, V61, P290, DOI 10.1016/j.addr.2009.02.005; Farias CF, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1835-3; Fiandalo M. V., 2012, Experimental Oncology, V34, P165; Freire FDO, 2000, MYCOPATHOLOGIA, V149, P13, DOI 10.1023/A:1007241827937; Fulda S, 2012, NAT REV DRUG DISCOV, V11, P109, DOI 10.1038/nrd3627; HAUSER D, 1970, HELV CHIM ACTA, V53, P1061, DOI 10.1002/hlca.19700530521; Isham CR, 2007, BLOOD, V109, P2579, DOI 10.1182/blood-2006-07-027326; Jeong SY, 2008, BMB REP, V41, P11, DOI 10.1146/annurev-genet-102108-134850; Jung HJ, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.15; Kiraz Y, 2016, TUMOR BIOL, V37, P8471, DOI 10.1007/s13277-016-5035-9; Krammer PH, 2007, NAT REV IMMUNOL, V7, P532, DOI 10.1038/nri2115; Kuo LM, 2014, MOLECULES, V19, P3327, DOI 10.3390/molecules19033327; Kwong LN, 2014, ONCOGENE, V33, P1, DOI 10.1038/onc.2013.34; Lin B, 2014, SCI REP-UK, V4, DOI 10.1038/srep07041; Liu XF, 2015, APOPTOSIS, V20, P1499, DOI 10.1007/s10495-015-1167-4; Martinou JC, 2011, DEV CELL, V21, P92, DOI 10.1016/j.devcel.2011.06.017; McStay Gavin P, 2014, Cold Spring Harb Protoc, V2014, P799, DOI 10.1101/pdb.top070359; Park HH, 2012, INT J MOL SCI, V13, P4807, DOI 10.3390/ijms13044807; Rombo Roman, 2016, Ger Med Sci, V14, pDoc04, DOI 10.3205/000231; SEKITA S, 1981, CAN J MICROBIOL, V27, P766, DOI 10.1139/m81-119; Singh AP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054655; Tibodeau JD, 2009, ANTIOXID REDOX SIGN, V11, P1097, DOI 10.1089/ARS.2008.2318; Truitt L, 2014, ONCOGENESIS, V3, DOI 10.1038/oncsis.2014.37; Tse AKW, 2014, J INVEST DERMATOL, V134, P1397, DOI 10.1038/jid.2013.471; Vaid M, 2016, INT J ONCOL, V48, P624, DOI 10.3892/ijo.2015.3286; Vaid M, 2010, CARCINOGENESIS, V31, P2004, DOI 10.1093/carcin/bgq186; Yamadori T, 2012, ONCOGENE, V31, P4768, DOI 10.1038/onc.2011.628; Yang J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102983; Zeng GF, 2014, ONCOL REP, V31, P2713, DOI 10.3892/or.2014.3160; Zeng GF, 2012, GENE, V492, P229, DOI 10.1016/j.gene.2011.10.024	37	13	14	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2017	12	4							e0175950	10.1371/journal.pone.0175950	http://dx.doi.org/10.1371/journal.pone.0175950			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KH	28419143	Green Published, Green Submitted, gold			2022-12-27	WOS:000399875200055
J	Mmongoyo, JA; Wu, F; Linz, JE; Nair, MG; Mugula, JK; Tempelman, RJ; Strasburg, GM				Mmongoyo, Juma A.; Wu, Felicia; Linz, John E.; Nair, Muraleedharan G.; Mugula, Jovin K.; Tempelman, Robert J.; Strasburg, Gale M.			Aflatoxin levels in sunflower seeds and cakes collected from micro- and small-scale sunflower oil processors in Tanzania	PLOS ONE			English	Article							CLIMATE-CHANGE; CONTAMINATION; MAIZE; MILK; ACCUMULATION; GROWTH; IMPACT; FUNGI	Aflatoxin, a mycotoxin found commonly in maize and peanuts worldwide, is associated with liver cancer, acute toxicosis, and growth impairment in humans and animals. In Tanzania, sunflower seeds are a source of snacks, cooking oil, and animal feed. These seeds are a potential source of aflatoxin contamination. However, reports on aflatoxin contamination in sunflower seeds and cakes are scarce. The objective of the current study was to determine total aflatoxin concentrations in sunflower seeds and cakes from small-scale oil processors across Tanzania. Samples of sunflower seeds (n = 90) and cakes (n = 92) were collected across two years, and analyzed for total aflatoxin concentrations using a direct competitive enzyme-linked immunosorbent assay (ELISA). For seed samples collected June-August 2014, the highest aflatoxin concentrations were from Dodoma (1.7-280.6 ng/g), Singida (1.4-261.8 ng/g), and Babati-Manyara (1.8-162.0 ng/g). The highest concentrations for cakes were from Mbeya (2.8-97.7 ng/g), Dodoma (1.9-88.2 ng/g), and Singida (2.0-34.3 ng/g). For seed samples collected August-October 2015, the highest concentrations were from Morogoro (2.8-662.7 ng/g), Singida (1.6-217.6 ng/g) and Mbeya (1.4-174.2 ng/g). The highest concentrations for cakes were from Morogoro (2.7-536.0 ng/g), Dodoma (1.4-598.4 ng/g) and Singida (3.2-52.8 ng/g). In summary, humans and animals are potentially at high risk of exposure to aflatoxins through sunflower seeds and cakes from micro-scale millers in Tanzania; and location influences risk.	[Mmongoyo, Juma A.; Wu, Felicia; Linz, John E.; Strasburg, Gale M.] Michigan State Univ, Dept Food Sci & Human Nutr, E Lansing, MI 48824 USA; [Mmongoyo, Juma A.; Mugula, Jovin K.] Sokoine Univ Agr, Dept Food Technol Nutr & Consumer Sci, Morogoro, Tanzania; [Nair, Muraleedharan G.] Michigan State Univ, Dept Hort, E Lansing, MI 48824 USA; [Tempelman, Robert J.] Michigan State Univ, Dept Anim Sci, E Lansing, MI 48824 USA	Michigan State University; Sokoine University of Agriculture; Michigan State University; Michigan State University	Strasburg, GM (corresponding author), Michigan State Univ, Dept Food Sci & Human Nutr, E Lansing, MI 48824 USA.	stragale@anr.rnsu.edu	Nair, Muraleedharan G./AAF-9984-2019; Linz, John/AAF-1682-2020; Tempelman, R. J./J-9566-2019	Nair, Muraleedharan G./0000-0001-9604-0055; Mmongoyo, Juma A./0000-0002-3928-4886; Tempelman, Robert/0000-0002-7833-6730; Strasburg, Gale/0000-0002-3897-4340	United States Agency for International Development (USAID) [CA-621-A-00-11-00009-00]	United States Agency for International Development (USAID)(United States Agency for International Development (USAID))	This work was funded by the United States Agency for International Development (USAID)-funded Innovative Agricultural Research Initiative project (iAGRI) (Award No. CA-621-A-00-11-00009-00). The opinions expressed herein are those of the authors and do not necessarily reflect the views of the U.S. Agency for International Development or the United States Government.	AMEMIYA T, 1984, J ECONOMETRICS, V24, P3, DOI 10.1016/0304-4076(84)90074-5; Banu N., 2005, MYCOL PROG, V4, P195, DOI DOI 10.1007/S11557-006-0123-7; Beheshti HR, 2013, FOOD ADDIT CONTAM B, V6, P68, DOI 10.1080/19393210.2012.725227; BHAT RV, 1988, INT J FOOD MICROBIOL, V7, P219, DOI [10.1016/0168-1605(88)90041-4, 10.1016/S0168-1605(00)00157-4]; Cotty PJ, 2007, INT J FOOD MICROBIOL, V119, P109, DOI 10.1016/j.ijfoodmicro.2007.07.060; CULLEN JM, 1987, CANCER RES, V47, P1913; DAWAR S, 1991, PAKISTAN J BOT, V23, P173; DAWAR S, 1991, PAKISTAN J BOT, V23, P123; Donner M, 2009, SOIL BIOL BIOCHEM, V41, P37, DOI 10.1016/j.soilbio.2008.09.013; Elzupir Amin O, 2010, Mycotoxin Res, V26, P69, DOI 10.1007/s12550-010-0041-z; FROBISH RA, 1986, J FOOD PROTECT, V49, P781, DOI 10.4315/0362-028X-49.10.781; HILL RA, 1983, APPL ENVIRON MICROB, V45, P628, DOI 10.1128/AEM.45.2.628-633.1983; Idris YMA, 2010, FOOD CHEM TOXICOL, V48, P2539, DOI 10.1016/j.fct.2010.05.021; INT AGCY RES CANC, 1993, IARC MONOG EVAL CARC, V56, P245; Jiang Y, 2008, CLIN DEV IMMUNOL, DOI 10.1155/2008/790309; JIMENEZ M, 1991, MYCOPATHOLOGIA, V115, P121, DOI 10.1007/BF00436800; Kang'ethe EK, 2009, AFR HEALTH SCI, V9, P218; Khlangwiset P, 2010, FOOD ADDIT CONTAM A, V27, P998, DOI 10.1080/19440041003677475; Khlangwiset P, 2011, CRIT REV TOXICOL, V41, P740, DOI 10.3109/10408444.2011.575766; Kimanya ME, 2008, FOOD ADDIT CONTAM A, V25, P1353, DOI 10.1080/02652030802112601; Lewis L, 2005, ENVIRON HEALTH PERSP, V113, P1763, DOI 10.1289/ehp.7998; Liu Y, 2010, ENVIRON HEALTH PERSP, V118, P818, DOI 10.1289/ehp.0901388; Magan N, 2003, EUR J PLANT PATHOL, V109, P723, DOI 10.1023/A:1026082425177; Magan N, 2011, PLANT PATHOL, V60, P150, DOI 10.1111/j.1365-3059.2010.02412.x; Manjula K, 2009, TOXIN REV, V28, P63, DOI 10.1080/15569540802462214; Mayaya HK, 2015, EHIOPIAN J ENV STUD, P364; Medina A, 2015, CURR OPIN FOOD SCI, V5, P99, DOI 10.1016/j.cofs.2015.11.002; Mohammed S, 2016, FOOD ADDIT CONTAM B, V3210; MUGULA JK, 1992, J FOOD SAFETY, V13, P33, DOI 10.1111/j.1745-4565.1992.tb00092.x; Paavola J, 2008, ENVIRON SCI POLICY, V11, P642, DOI 10.1016/j.envsci.2008.06.002; Paterson RRM, 2010, FOOD RES INT, V43, P1902, DOI 10.1016/j.foodres.2009.07.010; PRICE WD, 1993, J ANIM SCI, V71, P2556, DOI 10.2527/1993.7192556x; Probst C, 2014, INT J FOOD MICROBIOL, V174, P113, DOI 10.1016/j.ijfoodmicro.2013.12.010; Probst C, 2007, APPL ENVIRON MICROB, V73, P2762, DOI 10.1128/AEM.02370-06; RLDC, 2008, SUNFL SECT MARK DEV; Strosnider H, 2006, ENVIRON HEALTH PERSP, V114, P1898, DOI 10.1289/ehp.9302; Urio EM, 2006, MYCOTOXINS AND PHYCOTOXINS, PROCEEDINGS, P203; Whitaker TB, 2006, FOOD ADDIT CONTAM, V23, P50, DOI 10.1080/02652030500241587; WOTTON HR, 1987, APPL ENVIRON MICROB, V53, P270, DOI 10.1128/AEM.53.2.270-273.1987; Wu F, 2011, WORLD MYCOTOXIN J, V4, P79, DOI 10.3920/WMJ2010.1246; ZARBA A, 1992, CARCINOGENESIS, V13, P891, DOI 10.1093/carcin/13.5.891	41	22	24	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2017	12	4							e0175801	10.1371/journal.pone.0175801	http://dx.doi.org/10.1371/journal.pone.0175801			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KH	28419131	Green Submitted, Green Published, gold			2022-12-27	WOS:000399875200047
J	Huang, WJ; Itayama, M; Arai, F; Furukawa, KS; Ushida, T; Kawahara, T				Huang, Wenjing; Itayama, Makoto; Arai, Fumihito; Furukawa, Katsuko S.; Ushida, Takashi; Kawahara, Tomohiro			An angiogenesis platform using a cubic artificial eggshell with patterned blood vessels on chicken chorioallantoic membrane	PLOS ONE			English	Article							IN-VIVO MODEL; ANIMAL EXPERIMENTATION; VASCULAR ENDOTHELIUM; ETHICAL ISSUES; STEM-CELLS; EMBRYO; CAM; MOLECULES; INVASION; BIOLOGY	The chorioallantoic membrane (CAM) containing tiny blood vessels is an alternative to large animals for studies involving angiogenesis and tissue engineering. However, there is no technique to design the direction of growing blood vessels on the CAM at the microscale level for tissue engineering experiments. Here, a methodology is provided to direct blood vessel formation on the surface of a three-dimensional egg yolk using a cubic artificial eggshell with six functionalized membranes. A structure on the lateral side of the eggshell containing a straight channel and an interlinked chamber was designed, and the direction and formation area of blood vessels with blood flow was artfully defined by channels with widths of 70-2000 mu m, without sharply reducing embryo viability. The relationship between the size of interlinked chamber and the induction of blood vessels was investigated to establish a theory of design. Role of negative and positive pressure in the induction of CAM with blood vessels was investigated, and air pressure change in the culture chamber was measured to demonstrate the mechanism for blood vessel induction. Histological evaluation showed that components of CAM including chorionic membrane and blood vessels were induced into the channels. Based on our design theory, blood vessels were induced into arrayed channels, and channel-specific injection and screening were realized, which demonstrated proposed applications. The platform with position-and space-controlled blood vessels is therefore a powerful tool for biomedical research, which may afford exciting applications in studies involved in local stimulation of blood vessel networks and those necessary to establish a living system with blood flow from a beating heart.	[Huang, Wenjing; Itayama, Makoto; Kawahara, Tomohiro] Kyushu Inst Technol, Dept Biol Funct Engn, Wakamatsu Ku, Kitakyushu, Fukuoka, Japan; [Arai, Fumihito] Nagoya Univ, Dept Micronano Syst Engn, Chikusa Ku, Nagoya, Aichi, Japan; [Furukawa, Katsuko S.; Ushida, Takashi] Univ Tokyo, Sch Engn, Dept Bioengn, Bunkyo Ku, Tokyo, Japan; [Ushida, Takashi] Univ Tokyo, Ctr Dis Biol & Integrat Med, Grad Sch Med, Bunkyo Ku, Tokyo, Japan	Kyushu Institute of Technology; Nagoya University; University of Tokyo; University of Tokyo	Kawahara, T (corresponding author), Kyushu Inst Technol, Dept Biol Funct Engn, Wakamatsu Ku, Kitakyushu, Fukuoka, Japan.	kawahara@lsse.kyutech.ac.jp	Huang, Wenjing/AAV-9101-2021	Huang, Wenjing/0000-0003-1406-0031	JSPS KAKENHI [16K14200, 26630100, 23106002]; Kieikai Research Foundation; Program to Disseminate Tenure Track System, MEXT, Japan	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Kieikai Research Foundation(Kieikai Research Foundation); Program to Disseminate Tenure Track System, MEXT, Japan	This work was partially supported by JSPS KAKENHI (16K14200, 26630100, 23106002), Kieikai Research Foundation, and the Program to Disseminate Tenure Track System, MEXT, Japan.; This work was partially supported by JSPS KAKENHI (16K14200, 26630100, 23106002), Kieikai Research Foundation, and the Program to Disseminate Tenure Track System, MEXT, Japan. The authors would like to acknowledge Ms. Kiyoko Iseri and Mr. Shinya Ando at the Kyushu Institute of Technology and Ms. Masayo Yokota at the University of Tokyo for their support in preparing experiments.	[Anonymous], 1987, CAT BIOM EXP BAS INC, P11; AUERBACH R, 1974, DEV BIOL, V41, P391, DOI 10.1016/0012-1606(74)90316-9; AUSPRUNK DH, 1974, DEV BIOL, V38, P237, DOI 10.1016/0012-1606(74)90004-9; Baker M, 2011, NATURE, V471, P661, DOI 10.1038/471661a; Banjo T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2978; Baviskar SN, 2011, AM BIOL TEACH, V73, P554, DOI 10.1525/abt.2011.73.9.9; Borges J, 2003, TISSUE ENG, V9, P441, DOI 10.1089/107632703322066624; Brey EM, 2015, VASCULARIZATION: REGENERATIVE MEDICINE AND TISSUE ENGINEERING, P1; CAPLAN AL, 1983, ANN NY ACAD SCI, V406, P159, DOI 10.1111/j.1749-6632.1983.tb53500.x; CARLSSON B, 1986, ACTA PHYSIOL SCAND, V128, P50; Chrobak KM, 2006, MICROVASC RES, V71, P185, DOI 10.1016/j.mvr.2006.02.005; Deryugina EI, 2008, METHOD ENZYMOL, V444, P21, DOI 10.1016/S0076-6879(08)02802-4; Dohle D. S., 2009, J VISUALIZED EXPT JO; Dunn LK, 2005, ANAT REC PART A, V285A, P771, DOI 10.1002/ar.a.20212; Friend J, 2010, BIOMICROFLUIDICS, V4; Gabrielli MG, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/940741; Gimbrone Jr, 1999, J Vasc Surg, V29, P1104, DOI 10.1016/S0741-5214(99)70252-1; Guo ZY, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt363; Hagen K., 2012, LARGE ANIMALS BIOMED; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Hardt S, 2007, MEMS REF SHELF, P1, DOI 10.1007/978-0-387-68424-6_1; Harland RM, 2011, TRENDS GENET, V27, P507, DOI 10.1016/j.tig.2011.08.003; Hasan A, 2014, BIOMATERIALS, V35, P7308, DOI 10.1016/j.biomaterials.2014.04.091; Heck TAM, 2015, MATH MODEL NAT PHENO, V10, P108, DOI 10.1051/mmnp/201510106; Huang WJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118624; Huang WJ, 2011, CELL MOL BIOENG, V4, P368, DOI 10.1007/s12195-011-0194-7; Jenkins NT, 2013, HYPERTENSION, V61, P615, DOI 10.1161/HYPERTENSIONAHA.111.00561; Jensen EC, 2013, ANAT REC, V296, P378, DOI 10.1002/ar.22641; Kanthou C, 2009, INT J EXP PATHOL, V90, P284, DOI 10.1111/j.1365-2613.2009.00651.x; Korn Matthew J, 2007, J Vis Exp, P306, DOI 10.3791/306; Korostyshevskaya IM, 2009, RUSS J DEV BIOL+, V40, P104, DOI 10.1134/S1062360409020064; Kue CS, 2015, EXP ANIM TOKYO, V64, P129, DOI 10.1538/expanim.14-0059; LEENE W, 1973, Z ZELLFORSCH MIK ANA, V136, P521, DOI 10.1007/BF00307368; Leng T, 2004, RETINA-J RET VIT DIS, V24, P427, DOI 10.1097/00006982-200406000-00014; Lokman NA, 2012, INT J MOL SCI, V13, P9959, DOI 10.3390/ijms13089959; Melkonian G, 2002, J EXP ZOOL, V292, P241, DOI 10.1002/jez.10014; Merkel TC, 2000, J POLYM SCI POL PHYS, V38, P415, DOI 10.1002/(SICI)1099-0488(20000201)38:3<415::AID-POLB8>3.0.CO;2-Z; Morgan JP, 2013, NAT PROTOC, V8, P1820, DOI 10.1038/nprot.2013.110; NGUYEN M, 1994, MICROVASC RES, V47, P31, DOI 10.1006/mvre.1994.1003; Nowak-Sliwinska P, 2014, ANGIOGENESIS, V17, P779, DOI 10.1007/s10456-014-9440-7; Poelma C, 2010, J R SOC INTERFACE, V7, P91, DOI 10.1098/rsif.2009.0063; Ponce M Lourdes, 2003, Curr Protoc Cell Biol, VChapter 19, DOI 10.1002/0471143030.cb1905s18; Qutub AA, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-13; Rema RB, 2012, VASC CELL, V4, DOI 10.1186/2045-824X-4-8; Ribatti D, 2000, INFLAMM RES, V49, P418, DOI 10.1007/s000110050610; RIBATTI D, 1991, ACTA ANAT, V142, P334; Ribatti D, 2001, ANAT RECORD, V264, P317, DOI 10.1002/ar.10021; Ribatti D, 1997, INT J ONCOL, V11, P1191; Ribatti D, 1997, MICROVASC RES, V53, P187, DOI 10.1006/mvre.1996.1993; Ribatti D, 2008, INT REV CEL MOL BIO, V270, P181, DOI 10.1016/S1937-6448(08)01405-6; Ribatti D, 2006, NAT PROTOC, V1, P85, DOI 10.1038/nprot.2006.13; Ribatti D, 2014, EXP CELL RES, V328, P314, DOI 10.1016/j.yexcr.2014.06.010; Romijn C, 1938, J PHYSIOL-LONDON, V94, P365, DOI 10.1113/jphysiol.1938.sp003687; Rudy SF, 2016, J OTOLARYNGOL-HEAD N, V45, DOI 10.1186/s40463-016-0140-8; Schlatter P, 1997, MICROVASC RES, V54, P65, DOI 10.1006/mvre.1997.2022; Schmidt-Nielsen K., 1984, SCALING WHY IS ANIMA; Seabra R, 2010, IN VIVO, V24, P457; Slodownik D, 2009, EXP DERMATOL, V18, P409, DOI 10.1111/j.1600-0625.2008.00803.x; Smith A, 2015, FASEB J, V29; Song JW, 2011, P NATL ACAD SCI USA, V108, P15342, DOI 10.1073/pnas.1105316108; Strassburg S, 2016, J TISSUE ENG REGEN M, V10, P496, DOI 10.1002/term.1769; TALJA M, 1986, EUR UROL, V12, P340; Tufan AC, 2005, CURR CANCER DRUG TAR, V5, P249, DOI 10.2174/1568009054064624; Valdes TI, 2003, J BIOMED MATER RES A, V67A, P215, DOI 10.1002/jbm.a.10055; Wallingford JB, 2010, CURR BIOL, V20, pR263, DOI 10.1016/j.cub.2010.01.012; West DC, 2001, METH MOLEC MED, V46, P107, DOI 10.1385/1-59259-143-4:107; Xiao X., 2015, PLOS ONE, V10; Yalcin H. C., 2010, J VISUALIZED EXPT JO; Yang HB, 2015, DEV BIOL, V404, P49, DOI 10.1016/j.ydbio.2015.05.011; Yeung ES, 2004, ANNU REV PHYS CHEM, V55, P97, DOI 10.1146/annurev.physchem.54.011002.103820; Yuan YJ, 2014, INT J MED SCI, V11, P1275, DOI 10.7150/ijms.10443	71	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2017	12	4							e0175595	10.1371/journal.pone.0175595	http://dx.doi.org/10.1371/journal.pone.0175595			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KD	28414752	Green Published, gold, Green Submitted			2022-12-27	WOS:000399874800040
J	Miki, A; Ikuno, Y; Weinreb, RN; Yokoyama, J; Asai, T; Usui, S; Nishida, K				Miki, Atsuya; Ikuno, Yasushi; Weinreb, Robert N.; Yokoyama, Junko; Asai, Tomoko; Usui, Shinichi; Nishida, Kohji			Measurements of the parapapillary atrophy zones in en face optical coherence tomography images	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; CHORIORETINAL ATROPHY; BEIJING EYE; PERIPAPILLARY ATROPHY; JAPANESE POPULATION; REFRACTIVE ERROR; MYOPIC EYES; GAMMA ZONE; BETA-ZONE; DISC	Objective To measure the parapapillary atrophy (PPA) area in en face images obtained with swept-source optical coherence tomography (SS-OCT), and to evaluate its relationship to glaucoma, myopia, and age in non-highly myopic subjects. Design Retrospective, cross-sectional study. Participants Fifty eyes of 30 subjects with open-angle glaucoma (G group) and forty-three eyes of 26 healthy control subjects (C group). Eyes with high myopia (spherical equivalent refractive error <= -8 diopters or axial length >= 26.5 mm) were excluded. Methods Mean age +/- standard deviation was 59.9 +/- 12.4 years. The beta zone and the gamma zone PPA areas were measured in en face images reconstructed from three-dimensional SS-OCT images. Relationship between the PPA areas and patient characteristics such as glaucoma, axial length, and age was statistically evaluated using multivariate mixed-effects models. Main outcome measures Areas of the beta zone and the gamma zone PPA measured on en face OCT images. Results Average +/- standard deviation area of the beta and the gamma zone was 0.64 +/- 0.79 and 0.16 +/- 0.30 mm(2), respectively. In multivariate models, the gamma zone significantly correlated with axial length (P = 0.001) but not with glaucoma (P = 0.944). In contrast, the beta zone significantly correlated with age (P = 0.0249) and glaucoma (P = 0.014). Conclusions En face images reconstructed from 3D SS-OCT data facilitated measurements of the beta and the gamma PPA zones even in eyes with optic disc distortion. The OCT-defined beta zone is associated with glaucoma and age, whereas the gamma zone correlated with myopia but not with glaucoma. This study confirmed the clinical usefulness of OCT-based classification of the PPA zones in distinguishing glaucomatous damage of the optic nerve from myopic damage in non-highly myopic eyes.	[Miki, Atsuya; Ikuno, Yasushi; Yokoyama, Junko; Asai, Tomoko; Usui, Shinichi; Nishida, Kohji] Osaka Univ, Dept Ophthalmol, Grad Sch Med, Osaka, Japan; [Weinreb, Robert N.] Univ Calif San Diego, Dept Ophthalmol, Hamilton Glaucoma Ctr, La Jolla, CA 92093 USA; [Weinreb, Robert N.] Univ Calif San Diego, Shiley Eye Inst, La Jolla, CA 92093 USA; [Yokoyama, Junko] Osaka Natl Hosp, Natl Hosp Org, Dept Ophthalmol, Osaka, Japan	Osaka University; University of California System; University of California San Diego; University of California System; University of California San Diego; Osaka National Hospital	Miki, A (corresponding author), Osaka Univ, Dept Ophthalmol, Grad Sch Med, Osaka, Japan.	amiki@ophthal.med.osaka-u.ac.jp		Nishida, Kohji/0000-0001-9069-3610				Bruton A, 2000, PHYSIOTHERAPY, V86, P94, DOI [10.1016/S0031-9406(05)61211-4, DOI 10.1016/S0031-9406(05)61211-4, 10.1016/s0031-9406(05)61211-4]; Chang RT, 2013, CURR OPIN OPHTHALMOL, V24, P96, DOI 10.1097/ICU.0b013e32835cef31; Curcio CA, 2000, OPHTHALMOLOGY, V107, P334, DOI 10.1016/S0161-6420(99)00037-8; Dai Y, 2013, INVEST OPHTH VIS SCI, V54, P2013, DOI 10.1167/iovs.12-11255; Dichtl A, 1998, BRIT J OPHTHALMOL, V82, P286, DOI 10.1136/bjo.82.3.286; Gordon MO, 2002, ARCH OPHTHALMOL-CHIC, V120, P714; Holden BA, 2016, OPHTHALMOLOGY, V123, P1036, DOI 10.1016/j.ophtha.2016.01.006; Hwang YH, 2012, J GLAUCOMA, V21, P260, DOI 10.1097/IJG.0b013e31820719e1; JONAS JB, 1989, INVEST OPHTH VIS SCI, V30, P908; JONAS JB, 1989, INVEST OPHTH VIS SCI, V30, P919; Jonas JB, 2005, AM J OPHTHALMOL, V139, P346, DOI 10.1016/j.ajo.2004.07.047; Jonas JB, 1997, GRAEF ARCH CLIN EXP, V235, P627, DOI 10.1007/BF00946938; Jonas JB, 2014, PATHOLOGIC MYOPIA, P133; Jonas Jost B, 2005, Curr Opin Ophthalmol, V16, P84, DOI 10.1097/01.icu.0000156135.20570.30; Jonas JB, 2016, INVEST OPHTH VIS SCI, V57, P396, DOI 10.1167/iovs.15-18263; Kim M, 2013, OPHTHALMOLOGY, V120, P1790, DOI 10.1016/j.ophtha.2013.02.011; Kim NR, 2011, OPHTHALMOLOGY, V118, P1774, DOI 10.1016/j.ophtha.2011.01.058; Kim YW, 2014, OPHTHALMOLOGY, V121, P1341, DOI 10.1016/j.ophtha.2014.01.008; Miki A, 2015, PLOS ONE, V10; Miki A, 2013, CLIN OPHTHALMOL, V7, P1995, DOI 10.2147/OPTH.S50120; Mitchell P, 1999, OPHTHALMOLOGY, V106, P2010, DOI 10.1016/S0161-6420(99)90416-5; Ramrattan RS, 1999, OPHTHALMOLOGY, V106, P1588, DOI 10.1016/S0161-6420(99)90457-8; ROCKWOOD EJ, 1988, GRAEF ARCH CLIN EXP, V226, P510, DOI 10.1007/BF02169197; Sawada A, 2008, OPHTHALMOLOGY, V115, P363, DOI 10.1016/j.ophtha.2007.03.075; Suzuki Y, 2006, OPHTHALMOLOGY, V113, P1613, DOI 10.1016/j.ophtha.2006.03.059; Teng CC, 2010, OPHTHALMOLOGY, V117, P909, DOI 10.1016/j.ophtha.2009.10.016; Uchida H, 1998, OPHTHALMOLOGY, V105, P1541, DOI 10.1016/S0161-6420(98)98044-7; Vianna JR, 2016, INVEST OPHTH VIS SCI, V57, P3103, DOI 10.1167/iovs.16-19646; Vongphanit J, 2002, AM J OPHTHALMOL, V133, P679, DOI 10.1016/S0002-9394(02)01339-9; Wang Y, 2006, BRIT J OPHTHALMOL, V90, P353, DOI 10.1136/bjo.2005.081521; Xu LA, 2007, OPHTHALMOLOGY, V114, P216, DOI 10.1016/j.ophtha.2006.06.050; Yamada H, 2016, OPHTHALMOLOGY, V123, P542, DOI 10.1016/j.ophtha.2015.10.061; Yasuno Y, 2007, OPT EXPRESS, V15, P6121, DOI 10.1364/OE.15.006121	33	14	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2017	12	4							e0175347	10.1371/journal.pone.0175347	http://dx.doi.org/10.1371/journal.pone.0175347			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KD	28414805	Green Submitted, Green Published, gold			2022-12-27	WOS:000399874800022
J	van Manen, L; Stegehuis, PL; Farina-Sarasqueta, A; de Haan, LM; Eggermont, J; Bonsing, BA; Morreau, H; Lelieveldt, BPF; van de Velde, CJH; Vahrmeijer, AL; Dijkstra, J; Mieog, JSD				van Manen, Labrinus; Stegehuis, Paulien L.; Farina-Sarasqueta, Arantza; de Haan, Lorraine M.; Eggermont, Jeroen; Bonsing, Bert A.; Morreau, Hans; Lelieveldt, Boudewijn P. F.; van de Velde, Cornelis J. H.; Vahrmeijer, Alexander L.; Dijkstra, Jouke; Mieog, J. Sven D.			Validation of full-field optical coherence tomography in distinguishing malignant and benign tissue in resected pancreatic cancer specimens	PLOS ONE			English	Article							DUCTAL ADENOCARCINOMA; IN-VIVO; PANCREATICODUODENECTOMY; MARGINS; TUMOR; INVOLVEMENT; MORBIDITY; ORIGIN; OCT	Background Pancreatic cancer is the fourth leading cause of cancer-related mortality in the United States. The minority of patients can undergo curative-intended surgical therapy due to progressive disease stage at time of diagnosis. Nonetheless, tumor involvement of surgical margins is seen in up to 70% of resections, being a strong negative prognostic factor. Real-time intraoperative imaging modalities may aid surgeons to obtain tumor-free resection margins. Full-field optical coherence tomography (FF-OCT) is a promising diagnostic tool using high-resolution white-light interference microscopy without tissue processing. Therefore, we composed an atlas of FF-OCT images of malignant and benign pancreatic tissue, and investigated the accuracy with which the pathologists could distinguish these. Materials and methods One hundred FF-OCT images were collected from specimens of 29 patients who underwent pancreatic resection for various indications between 2014 and 2016. One experienced gastrointestinal pathologist and one pathologist in training scored independently the FF-OCT images as malignant or benign blinded to the final pathology conclusion. Results were compared to those obtained with standard hematoxylin and eosin (H&E) slides. Results Overall, combined test characteristics of both pathologists showed a sensitivity of 72%, specificity of 74%, positive predictive value of 69%, negative predictive value of 79% and an overall accuracy of 73%. In the subset of pancreatic ductal adenocarcinoma patients, 97% of the FF-OCT images (n = 35) were interpreted as tumor by at least one pathologist. Moreover, normal pancreatic tissue was recognised in all cases by at least one pathologist. However, atrophy and fibrosis, serous cystadenoma and neuroendocrine tumors were more often wrongly scored, in 63%, 100% and 25% respectively. Conclusion FF-OCT could distinguish normal pancreatic tissue from pathologic pancreatic tissue in both processed as non-processed specimens using architectural features. The accuracy in pancreatic ductal adenocarcinoma is promising and warrants further evaluation using improved assessment criteria.	[van Manen, Labrinus; Stegehuis, Paulien L.; Bonsing, Bert A.; van de Velde, Cornelis J. H.; Vahrmeijer, Alexander L.; Mieog, J. Sven D.] Leiden Univ, Med Ctr, Dept Surg, Leiden, Netherlands; [Stegehuis, Paulien L.; Eggermont, Jeroen; Lelieveldt, Boudewijn P. F.; Dijkstra, Jouke] Leiden Univ, Med Ctr, Div Image Proc, Dept Radiol, Leiden, Netherlands; [Farina-Sarasqueta, Arantza; de Haan, Lorraine M.; Morreau, Hans] Leiden Univ, Med Ctr, Dept Pathol, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Mieog, JSD (corresponding author), Leiden Univ, Med Ctr, Dept Surg, Leiden, Netherlands.	i.s.d.mieog@lumc.nl	Lelieveldt, Boudewijn/B-6501-2008; Vahrmeijer, Alexander/AAG-3329-2022; Vahrmeijer, Alexander/AFK-4657-2022	Lelieveldt, Boudewijn/0000-0001-8269-7603; Vahrmeijer, Alexander/0000-0001-9370-0011; Vahrmeijer, Alexander/0000-0001-9370-0011; Farina Sarasqueta, Aranzazu/0000-0002-6173-592X; Farina Sarasqueta, Arantza/0000-0002-4307-1568	European Union [FP7-ICT2011-8]; Bas Mulder Award [UL2015-7665]; Alpe d'HuZes foundation/Dutch Cancer Society; CARelOCA project [318729]	European Union(European Commission); Bas Mulder Award; Alpe d'HuZes foundation/Dutch Cancer Society; CARelOCA project	This work was funded by the European Union Seventh Framework Program FP7-ICT2011-8 under grant agreement number 318729 (CARelOCA project) and by the Bas Mulder Award (grant UL2015-7665) from the Alpe d'HuZes foundation/Dutch Cancer Society.	Apelian C, 2016, BIOMED OPT EXPRESS, V7, P1511, DOI 10.1364/BOE.7.001511; Assayag O, 2014, TECHNOL CANCER RES T, V13, P455, DOI [10.7785/tcrt.2013.600254, 10.7785/tcrtexpress.2013.600254]; Binding J, 2011, OPT EXPRESS, V19, P4833, DOI 10.1364/OE.19.004833; Boonstra MC, 2015, INT J CANCER, V137, P1910, DOI 10.1002/ijc.29571; Bredfeldt Jeremy S, 2014, J Pathol Inform, V5, P28, DOI 10.4103/2153-3539.139707; Campbell F, 2009, HISTOPATHOLOGY, V55, P277, DOI 10.1111/j.1365-2559.2009.03376.x; de Geus SW, 2016, MOL IMAGING BIOL; Delpero JR, 2014, HPB, V16, P20, DOI 10.1111/hpb.12061; Drifka CR, 2015, MODERN PATHOL, V28, P1470, DOI 10.1038/modpathol.2015.97; Dubois A, 2004, APPL OPTICS, V43, P2874, DOI 10.1364/AO.43.002874; Dubois A, 2002, APPL OPTICS, V41, P805, DOI 10.1364/AO.41.000805; Dubois A., 2012, SELECTED TOPICS OPTI, P3; Eberlin LS, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002108; Erickson-Bhatt SJ, 2015, CANCER RES, V75, P3706, DOI 10.1158/0008-5472.CAN-15-0464; Erkan M, 2012, NAT REV GASTRO HEPAT, V9, P454, DOI 10.1038/nrgastro.2012.115; Esposito I, 2008, ANN SURG ONCOL, V15, P1651, DOI 10.1245/s10434-008-9839-8; Grieve K, 2005, OPT EXPRESS, V13, P6286, DOI 10.1364/OPEX.13.006286; Grieve K, 2015, GASTROINTEST ENDOSC, V81, P342, DOI 10.1016/j.gie.2014.06.037; Handgraaf HJM, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/890230; Hruban RH, 2007, MODERN PATHOL, V20, pS61, DOI 10.1038/modpathol.3800685; Hu WY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037962; HUANG D, 1991, SCIENCE, V254, P1178, DOI 10.1126/science.1957169; Hutteman M, 2011, EUR SURG RES, V47, P90, DOI 10.1159/000329411; Jamieson NB, 2010, ANN SURG, V251, P1003, DOI 10.1097/SLA.0b013e3181d77369; la Guillaume EBA, 2016, J BIOMED OPT, V21, DOI 10.1117/1.JBO.21.2.026005; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lopater J, 2015, WORLD J UROLOGY; Nelson DW, 2013, AM J SURG, V205, P613, DOI 10.1016/j.amjsurg.2013.01.015; Neoptolemos JP, 2010, JAMA-J AM MED ASSOC, V304, P1073, DOI 10.1001/jama.2010.1275; Neoptolemos JP, 2017, LANCET; Nitschke P, 2016, ANN SURG; Peters IT, 2016, CLIN CANC RES; Reddy S, 2009, ANN SURG, V250, P282, DOI 10.1097/SLA.0b013e3181ae9f93; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Tao YK, 2014, P NATL ACAD SCI USA, V111, P15304, DOI 10.1073/pnas.1416955111; Tran KTC, 2004, ANN SURG, V240, P738, DOI 10.1097/01.sla.0000143248.71964.29; Vakoc BJ, 2012, NAT REV CANCER, V12, P363, DOI 10.1038/nrc3235; van der Vorst JR, 2012, WORLD J GASTRO SURG, V4, P180, DOI 10.4240/wjgs.v4.i7.180; Verbeke CS, 2012, BRIT J SURG, V99, P1036, DOI 10.1002/bjs.8734; Wagner M, 2004, BRIT J SURG, V91, P586, DOI 10.1002/bjs.4484; Yang C, 2016, PROC SPIE, V9689, DOI 10.1117/12.2210955; Yeo CJ, 1999, ANN SURG, V229, P613, DOI 10.1097/00000658-199905000-00003	42	10	10	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2017	12	4							e0175862	10.1371/journal.pone.0175862	http://dx.doi.org/10.1371/journal.pone.0175862			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KD	28414765	Green Published, gold, Green Submitted			2022-12-27	WOS:000399874800069
J	Wankhade, UD; Zhong, Y; Kang, P; Alfaro, M; Chintapalli, SV; Thakali, KM; Shankar, K				Wankhade, Umesh D.; Zhong, Ying; Kang, Ping; Alfaro, Maria; Chintapalli, Sree V.; Thakali, Keshari M.; Shankar, Kartik			Enhanced offspring predisposition to steatohepatitis with maternal high-fat diet is associated with epigenetic and microbiome alterations	PLOS ONE			English	Article							SKELETAL-MUSCLE DEVELOPMENT; CHOLINE-DEFICIENT DIET; LIVER-DISEASE; DNA-DAMAGE; OBESITY; RAT; DYSFUNCTION; PREGNANCY; PROGRAMS; ALTERS	Objective Non-alcoholic fatty liver disease (NAFLD) is an important co-morbidity associated with obesity and a precursor to steatohepatitis. However, the contributions of gestational and early life influences on development of NAFLD and NASH remain poorly appreciated. Methods Two independent studies were performed to examine whether maternal over-nutrition via exposure to high fat diet (HFD) leads to exacerbated hepatic responses to post-natal HFD and methionine choline deficient (MCD) diets in the offspring. Offspring of both control diet- and HFD-fed dams were weaned onto control and HFD, creating four groups. Results When compared to their control diet-fed littermates, offspring of HF-dams weaned onto HFD gained greater body weight; had increased relative liver weight and showed hepatic steatosis and inflammation. Similarly, this group revealed significantly greater immune response and pro-fibrogenic gene expression via RNA-seq. In parallel, 7-8 week old offspring were challenged with either control or MCD diets for 3 weeks. Responses to MCD diets were also exacerbated due to maternal HFD as seen by gene expression of classical pro-fibrogenic genes. Quantitative genome-scale DNA methylation analysis of over 1 million CpGs showed persistent epigenetic changes in key genes in tissue development and metabolism (Fgf21, Ppargc1 beta) with maternal HFD and in cell adhesion and communication (VWF, Ephb2) in the combination of maternal HFD and offspring MCD diets. Maternal HFD also influenced gut microbiome profiles in offspring leading to a decrease in alpha-diversity. Linear regression analysis revealed association between serum ALT levels and Coprococcus, Coriobacteriacae, Helicobacterioceae and Allobaculum. Conclusion Our findings indicate that maternal HFD detrimentally alters epigenetic and gut microbiome pathways to favor development of fatty liver disease and its progressive sequelae.	[Wankhade, Umesh D.; Chintapalli, Sree V.; Thakali, Keshari M.; Shankar, Kartik] Arkansas Childrens Nutr Ctr, Little Rock, AR 72202 USA; [Wankhade, Umesh D.; Zhong, Ying; Kang, Ping; Chintapalli, Sree V.; Thakali, Keshari M.; Shankar, Kartik] Univ Arkansas Med Sci, Dept Pediat, Little Rock, AR 72205 USA; [Alfaro, Maria] Arkansas Childrens Hosp, Mol Genet Pathol Lab, 800 Marshall St, Little Rock, AR 72202 USA	University of Arkansas System; University of Arkansas Medical Sciences; Arkansas Children's Hospital	Shankar, K (corresponding author), Arkansas Childrens Nutr Ctr, Little Rock, AR 72202 USA.; Shankar, K (corresponding author), Univ Arkansas Med Sci, Dept Pediat, Little Rock, AR 72205 USA.	ShankarKartik@uams.edu	Wankhade, Umesh/J-8739-2015	Wankhade, Umesh/0000-0003-4810-221X; Shankar, Kartik/0000-0002-7964-9026	United States Department of Agriculture-Agricultural Research Service [6026-51000-010-05S]; National Institute of Diabetes and Digestive and Kidney Diseases [R01-DK-084225]; NIH-CTSA program [UL1-TR-000039, KL2-TR-000063]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000063, UL1TR000039] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK084225] Funding Source: NIH RePORTER	United States Department of Agriculture-Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH-CTSA program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	These studies were supported in part by the United States Department of Agriculture-Agricultural Research Service Project 6026-51000-010-05S and National Institute of Diabetes and Digestive and Kidney Diseases Grant R01-DK-084225 (to K. Shankar). Support for the sequencing core is provided in part by the UAMS Translational Research Institute funded by the NIH-CTSA program, Grants UL1-TR-000039 and KL2-TR-000063.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; These studies were supported in part by the United States Department of Agriculture-Agricultural Research Service Project 6026-51000-010-05S and National Institute of Diabetes and Digestive and Kidney Diseases Grant R01-DK-084225 (to K. Shankar). The funding agencies had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. We thank Matt Ferguson and other members of the Arkansas Children's Nutrition Center Animal Research Core Facility for assistance with animal studies and Renee Till for assistance with histology. We also thank Dr. Stewart MacLeod at the Winthrop P. Rockefeller Cancer Institute Genomics Core Facility and the UAMS Translational Research Institute for assistance with sequencing. Support for the sequencing core is provided in part by the UAMS Translational Research Institute funded by the NIH-CTSA program, Grants UL1-TR-000039 and KL2-TR-000063.	Ainge H, 2011, INT J OBESITY, V35, P325, DOI 10.1038/ijo.2010.149; Bayol SA, 2005, J PHYSIOL-LONDON, V567, P951, DOI 10.1113/jphysiol.2005.088989; Bohinc BN, 2012, CLIN LIVER DIS, V16, P549, DOI 10.1016/j.cld.2012.05.002; Borengasser SJ, 2014, PHYSIOL GENOMICS, V46, P841, DOI 10.1152/physiolgenomics.00059.2014; Borengasser SJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084209; Borengasser SJ, 2013, ENDOCRINOLOGY, V154, P4113, DOI 10.1210/en.2012-2255; Borengasser SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024068; Bruce KD, 2009, POSTGRAD MED J, V85, P614, DOI 10.1136/pgmj.2008.078014; Bruce KD, 2009, HEPATOLOGY, V50, P1796, DOI 10.1002/hep.23205; Brumbaugh DE, 2014, PEDIATR RES, V75, P140, DOI 10.1038/pr.2013.193; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Compare D, 2012, NUTR METAB CARDIOVAS, V22, P471, DOI 10.1016/j.numecd.2012.02.007; da Costa KA, 2006, AM J CLIN NUTR, V84, P88, DOI 10.1093/ajcn/84.1.88; Delidaki M, 2011, MOL CELL ENDOCRINOL, V332, P213, DOI 10.1016/j.mce.2010.10.013; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Itagaki H, 2013, INT J CLIN EXP PATHO, V6, P2683; Khan I, 2004, CIRCULATION, V110, P1097, DOI 10.1161/01.CIR.0000139843.05436.A0; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Koleva PT, 2015, NUTRIENTS, V7, P2237, DOI 10.3390/nu7042237; Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13; Kulinski A, 2004, J BIOL CHEM, V279, P23916, DOI 10.1074/jbc.M312676200; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Lawlor DA, 2007, AM J EPIDEMIOL, V165, P418, DOI 10.1093/aje/kwk030; Lemas DJ, 2016, AM J CLIN NUTR, V103, P1291, DOI 10.3945/ajcn.115.126375; Levin BE, 1998, AM J PHYSIOL-REG I, V275, pR1374, DOI 10.1152/ajpregu.1998.275.4.R1374; Lisman T, 2006, HEPATOLOGY, V44, P53, DOI 10.1002/hep.21231; Ma J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4889; McCurdy CE, 2009, J CLIN INVEST, V119, P323, DOI 10.1172/JCI32661; Mimche PN, 2015, HEPATOLOGY, V62, P900, DOI 10.1002/hep.27792; Mimche PN, 2016, J IMMUNOLOGY, V194; Mouralidarane A, 2015, INT J OBESITY, V39, P1339, DOI 10.1038/ijo.2015.85; Mouralidarane A, 2013, HEPATOLOGY, V58, P128, DOI 10.1002/hep.26248; Niculescu MD, 2004, J NEUROCHEM, V89, P1252, DOI 10.1111/j.1471-4159.2004.02414.x; Oben JA, 2010, J HEPATOL, V52, P913, DOI 10.1016/j.jhep.2009.12.042; Oz HS, 2008, DIGEST DIS SCI, V53, P767, DOI 10.1007/s10620-007-9900-7; Parks DH, 2014, BIOINFORMATICS, V30, P3123, DOI 10.1093/bioinformatics/btu494; RUSHMORE TH, 1986, CARCINOGENESIS, V7, P1677, DOI 10.1093/carcin/7.10.1677; Samuelsson AM, 2008, HYPERTENSION, V51, P383, DOI 10.1161/HYPERTENSIONAHA.107.101477; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Shankar K, 2008, AM J PHYSIOL-REG I, V294, pR528, DOI 10.1152/ajpregu.00316.2007; Shankar K, 2015, PLACENTA, V36, P1342, DOI 10.1016/j.placenta.2015.10.010; Shankar K, 2012, ENDOCRINOLOGY, V153, P1999, DOI 10.1210/en.2011-1833; Shankar K, 2010, ENDOCRINOLOGY, V151, P2577, DOI 10.1210/en.2010-0017; Wu H, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv715; Yilmaz Y, 2010, EUR J CLIN INVEST, V40, P887, DOI 10.1111/j.1365-2362.2010.02338.x; Zhu LX, 2013, HEPATOLOGY, V57, P601, DOI 10.1002/hep.26093; Zhu MJ, 2008, J PHYSIOL-LONDON, V586, P2651, DOI 10.1113/jphysiol.2007.149633	47	101	106	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2017	12	4							e0175675	10.1371/journal.pone.0175675	http://dx.doi.org/10.1371/journal.pone.0175675			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KD	28414763	Green Published, gold, Green Submitted			2022-12-27	WOS:000399874800046
J	Ceulemans, T; Hulsmans, E; Ende, WV; Honnay, O				Ceulemans, Tobias; Hulsmans, Eva; Ende, Wim Vanden; Honnay, Olivier			Nutrient enrichment is associated with altered nectar and pollen chemical composition in Succisa pratensis Moench and increased larval mortality of its pollinator Bombus terrestris L.	PLOS ONE			English	Article							PLANT-SPECIES LOSS; AMINO-ACID; SUGAR COMPOSITION; FLORAL NECTAR; HONEY-BEES; NITROGEN; DIVERSITY; PREFERENCES; HYMENOPTERA; GRASSLANDS	Pollinators are declining worldwide and possible underlying causes include disease, invasive pest species and large scale land use changes resulting in habitat loss and degradation. One particular cause of habitat degradation is the increased inflow of nutrients due to anthropogenic combustion processes and large scale application of agricultural fertilizers. This nutrient pollution has been shown to affect pollinators through the loss of nectar and pollen-providing plant species. However, it may also affect pollinators through altering the nectar and pollen chemical composition of plant species, hence influencing pollinator food quality. Here, we experimentally investigated the effect of nutrient enrichment on amino acid and sugar composition of nectar and pollen in the grassland plant Sucissa pratensis, and the subsequent colony size and larval mortality of the pollinating bumblebee Bombus terrestris. We found less of the essential amino acids glycine and arginine in the pollen of fertilized plants, and more arginine, ornithine and threonine in the pollen of control plants. Nectar glucose and pollen fructose levels were lower in fertilized plants as compared to control plants. Furthermore, bumblebee colonies visiting fertilized plants showed more dead larvae than colonies visiting control plants. Our results suggest that the fitness of bumblebees can be negatively affected by changes in their food quality following nutrient pollution. If similar patterns hold for other plant and pollinator species, this may have far reaching implications for the maintenance of pollination ecosystem services, as nutrient pollution continues to rise worldwide.	[Ceulemans, Tobias; Hulsmans, Eva; Honnay, Olivier] Univ Leuven, Plant Conservat & Populat Biol, Leuven, Belgium; [Ende, Wim Vanden] Univ Leuven, Mol Physiol Plants & Microorganisms, Leuven, Belgium	KU Leuven; KU Leuven	Ceulemans, T (corresponding author), Univ Leuven, Plant Conservat & Populat Biol, Leuven, Belgium.	tobias.ceulemans@bio.kuleuven.be	Honnay, Olivier/AAH-8625-2019; Van den Ende, Wim/I-6899-2013	Honnay, Olivier/0000-0002-4287-8511; Ceulemans, Tobias/0000-0001-6861-4613; Hulsmans, Eva/0000-0001-6942-7342; Van den Ende, Wim/0000-0003-1137-3614	postdoctoral fellowship of the Research Foundation Flanders (FWO); FWO	postdoctoral fellowship of the Research Foundation Flanders (FWO); FWO(FWO)	Tobias Ceulemans holds a postdoctoral fellowship of the Research Foundation Flanders (FWO). This work was funded by FWO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.; Tobias Ceulemans holds a postdoctoral fellowship of the Research Foundation Flanders (FWO). This work was funded by FWO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study. We thank Timmy Reynders, Gerrit Peeters, Kasper van Acker and Poi Verwilt for their practical and technical assistance. We also thank dr. Maribel Pozo Romero and Alfredo Benavente Martinez for helpful insights in the pollinator Bombus terrestris.	ADAMS AW, 1955, J ECOL, V43, P709, DOI 10.2307/2257031; Adler LS, 2000, OIKOS, V91, P409, DOI 10.1034/j.1600-0706.2000.910301.x; BAKER HG, 1990, ISRAEL J BOT, V39, P157; Baude M, 2016, NATURE, V530, P85, DOI 10.1038/nature16532; Behmer ST, 2003, ADV INSECT PHYSIOL, V31, P1, DOI 10.1016/S0065-2806(03)31001-X; Biesmeijer JC, 2006, SCIENCE, V313, P351, DOI 10.1126/science.1127863; Bobbink R, 2010, ECOL APPL, V20, P30, DOI 10.1890/08-1140.1; Cameron SA, 2011, P NATL ACAD SCI USA, V108, P662, DOI 10.1073/pnas.1014743108; Carvell C, 2007, J APPL ECOL, V44, P29, DOI 10.1111/j.1365-2664.2006.01249.x; Ceulemans T, 2013, GLOBAL ECOL BIOGEOGR, V22, P73, DOI 10.1111/j.1466-8238.2012.00771.x; Ceulemans T, 2011, J APPL ECOL, V48, P1155, DOI 10.1111/j.1365-2664.2011.02023.x; Cook SM, 2003, ECOL ENTOMOL, V28, P622, DOI 10.1046/j.1365-2311.2003.00548.x; Dafni A, 1998, BEE WORLD, V79, P113, DOI 10.1080/0005772X.1998.11099392; Dupont YL, 2004, FUNCT ECOL, V18, P670, DOI 10.1111/j.0269-8463.2004.00891.x; Ellis A, 2013, IFAS EXTENSION ENY, V152, P1; Fujita Y, 2014, NATURE, V505, P82, DOI 10.1038/nature12733; Gallai N, 2009, ECOL ECON, V68, P810, DOI 10.1016/j.ecolecon.2008.06.014; Galloway JN, 2008, SCIENCE, V320, P889, DOI 10.1126/science.1136674; Gardener MC, 2001, OIKOS, V92, P101, DOI 10.1034/j.1600-0706.2001.920112.x; Garibaldi L.A., 2014, SCIENCE, V339, P1608, DOI [10.1126/science.1230200, DOI 10.1126/SCIENCE.1230200]; Gijbels P, 2015, OECOLOGIA, V179, P785, DOI 10.1007/s00442-015-3381-8; Gijbels P, 2014, J ECOL, V102, P136, DOI 10.1111/1365-2745.12183; Goulson D, 2005, BIOL CONSERV, V122, P1, DOI 10.1016/j.biocon.2004.06.017; Goulson D, 2015, SCIENCE, V347, DOI 10.1126/science.1255957; Hanley ME, 2008, FUNCT ECOL, V22, P592, DOI 10.1111/j.1365-2435.2008.01415.x; Herrera CM, 2008, ECOLOGY, V89, P2369, DOI 10.1890/08-0241.1; Hingston AB, 2002, AUSTRAL ECOL, V27, P162, DOI 10.1046/j.1442-9993.2002.01179.x; Holland JG, 2015, FUNCT ECOL, V29, P1209, DOI 10.1111/1365-2435.12480; Hoover SER, 2012, ECOL LETT, V15, P227, DOI 10.1111/j.1461-0248.2011.01729.x; Hopkins I., 1914, HIST INTRO BUMBLE BE; Jongejans E, 2005, J ECOL, V93, P681, DOI 10.1111/j.1365-2745.2005.01003.x; Keller I, 2005, BEE WORLD, V86, P3, DOI 10.1080/0005772X.2005.11099641; Kim YS, 2000, J INSECT PHYSIOL, V46, P793, DOI 10.1016/S0022-1910(99)00168-7; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Kromer T, 2008, PLANT BIOLOGY, V10, P502, DOI 10.1111/j.1438-8677.2008.00058.x; Matsumura Chizuru, 2004, Global Environmental Research, V8, P51; Mattila HR, 2007, SCIENCE, V317, P362, DOI 10.1126/science.1143046; Nicolson SW, 2011, AFR ZOOL, V46, P197, DOI 10.3377/004.046.0201; Oksanen J, 2022, R PACKAGE VERSION; Payne RJ, 2013, P NATL ACAD SCI USA, V110, P984, DOI 10.1073/pnas.1214299109; Penuelas J, 2012, GLOBAL CHANGE BIOL, V18, P3, DOI 10.1111/j.1365-2486.2011.02568.x; Petanidou T, 2005, J CHEM ECOL, V31, P1065, DOI 10.1007/s10886-005-4248-y; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; Ricketts TH, 2008, ECOL LETT, V11, P499, DOI 10.1111/j.1461-0248.2008.01157.x; Rockstrom J, 2009, NATURE, V461, P472, DOI 10.1038/461472a; ROUBIK DW, 1995, APIDOLOGIE, V26, P197, DOI 10.1051/apido:19950303; Roulston TH, 2002, EVOL ECOL, V16, P49, DOI 10.1023/A:1016048526475; Rutrecht ST, 2009, OIKOS, V118, P941, DOI 10.1111/j.1600-0706.2009.17392.x; Scheper J, 2014, MUSEUM SPECIMENS REV, V111, P3; Schmidt JO, 2006, J INSECT BEHAV, V19, P521, DOI 10.1007/s10905-006-9039-y; SHIRAISHI A, 1970, J GEN PHYSIOL, V56, P768, DOI 10.1085/jgp.56.6.768; Stevens CJ, 2010, ENVIRON POLLUT, V158, P2940, DOI 10.1016/j.envpol.2010.06.006; Tilman D, 2001, SCIENCE, V292, P281, DOI 10.1126/science.1057544; van der Meer S, 2014, POPUL ECOL, V56, P151, DOI 10.1007/s10144-013-0400-7; Van der Meijden R., 2000, GORTERIA, V26, P85; Velthuis HHW, 2006, APIDOLOGIE, V37, P421, DOI 10.1051/apido:2006019; Vergeer P, 2003, J ECOL, V91, P18, DOI 10.1046/j.1365-2745.2003.00736.x	57	16	17	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2017	12	4							e0175160	10.1371/journal.pone.0175160	http://dx.doi.org/10.1371/journal.pone.0175160			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0MB	28406910	gold, Green Published, Green Submitted			2022-12-27	WOS:000399955400032
J	Chen, LY; Xu, AL; Yin, NN; Zhao, M; Wang, ZG; Chen, T; Gao, YS; Chen, ZB				Chen, Longyun; Xu, Anli; Yin, Nina; Zhao, Min; Wang, Zhigang; Chen, Tao; Gao, Yisheng; Chen, Zebin			Enhancement of immune cytokines and splenic CD4+T cells by electroacupuncture at ST36 acupoint of SD rats	PLOS ONE			English	Article							IL-2 RECEPTOR EXPRESSION; INTERFERON-GAMMA; ACUPUNCTURE; CALCIUM; STIMULATION; PAIN; CYTOTOXICITY; MECHANISM; TISSUE	Electroacupuncture at the ST36 acupoint can enhance the body's immune function. However, the mechanism for this enhancement has not been fully described. Our study was designed to investigate the effect of electroacupuncture on the immune function of Sprague-Dawley (SD) rats. The rats were randomly divided into three groups: a control group, a non-acupoint group (abdominal muscle acupuntured) and a ST36 acupoint group. Our results showed that successive electroacupuncture at the ST36 acupoint for 3 d significantly enhanced the interferon-gamma (IFN-gamma) level in the serum of SD rats. The results also showed that the serum and extracts from spleen cells of the ST36 acupoint group contained higher levels of interleukin (IL)-2 and IL-17 compared to those of the other two groups. Immunohistochemical analysis showed that electroacupuncture applied to the ST36 acupoint enhanced the expression level of CD4 in spleen cells. Furthermore, it was observed that CD4 co-localized with transient receptor potential vanilloid (TRPV) channels at the membrane of splenic CD4+ T cells and the expression level of CD4 was related to TRPV channels in the electroacupuncture treatment. These observations indicated that electroacupuncture stimulation at the ST36 acupoint enhanced the level of immune cytokines and splenic CD4+ T cells through TRPV channels in this system.	[Chen, Longyun; Xu, Anli; Zhao, Min] Hubei Univ Chinese Med, Dept Biochem, Basic Med Coll, Wuhan, Peoples R China; [Yin, Nina; Chen, Tao; Gao, Yisheng; Chen, Zebin] Hubei Univ Chinese Med, Dept Anat, Basic Med Coll, Wuhan, Peoples R China; [Wang, Zhigang] Hubei Univ Chinese Med, Dept Pathogen Biol, Basic Med Coll, Wuhan, Peoples R China	Hubei University of Chinese Medicine; Hubei University of Chinese Medicine; Hubei University of Chinese Medicine	Chen, ZB (corresponding author), Hubei Univ Chinese Med, Dept Anat, Basic Med Coll, Wuhan, Peoples R China.	chenzebin-hbtcm@outlook.com			Health and Family Planning Commission of Hubei Province [2013Z-Z01]; Hubei Provincial Department of Education [B2016112]	Health and Family Planning Commission of Hubei Province; Hubei Provincial Department of Education	This study was supported by grants from the Health and Family Planning Commission of Hubei Province (no. 2013Z-Z01) and Hubei Provincial Department of Education (no. B2016112). The funders' websites are http://www.hbwsjs.gov.cn/ and http://www.hbe.gov.cn/. Zebin Chen received the funding. He had a role in the study design.	Chen WH, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/636848; Chen WH, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-82; Deknuydt F, 2009, CLIN IMMUNOL, V131, P298, DOI 10.1016/j.clim.2008.12.008; DENG QS, 1995, AM J CHINESE MED, V23, P1, DOI 10.1142/S0192415X9500002X; Feske S, 2007, NAT REV IMMUNOL, V7, P690, DOI 10.1038/nri2152; Han JS, 2003, TRENDS NEUROSCI, V26, P17, DOI 10.1016/S0166-2236(02)00006-1; Komada H, 1996, CELL IMMUNOL, V173, P215, DOI 10.1006/cimm.1996.0270; Langevin HM, 2006, J CELL PHYSIOL, V207, P767, DOI 10.1002/jcp.20623; Langevin HM, 2001, FASEB J, V15, P2275, DOI 10.1096/fj.01-0015hyp; Lin JG, 2002, PAIN, V99, P509, DOI 10.1016/S0304-3959(02)00261-0; Lin JX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0114948; LU GW, 1983, AM J PHYSIOL, V245, pR606, DOI 10.1152/ajpregu.1983.245.4.R606; Luckheeram RV, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/925135; Majhi RK, 2015, FEBS J, V282, P2661, DOI 10.1111/febs.13306; Monchanok C, 2015, SCI REPORTS, P1; Oh-Hora M, 2008, CURR OPIN IMMUNOL, V20, P250, DOI 10.1016/j.coi.2008.04.004; Park JY, 2014, J PAIN, V15, P535, DOI 10.1016/j.jpain.2014.01.498; REICHLIN S, 1993, NEW ENGL J MED, V329, P1246; RICHARDSON PH, 1986, PAIN, V24, P15, DOI 10.1016/0304-3959(86)90023-0; ROBERTSON MJ, 1990, BLOOD, V76, P2421; Rogers P A, 1992, Probl Vet Med, V4, P162; Sato T, 1996, JPN J PHYSIOL, V46, P131, DOI 10.2170/jjphysiol.46.131; SHALABY MR, 1985, J INTERFERON RES, V5, P571, DOI 10.1089/jir.1985.5.571; TRINCHIERI G, 1985, IMMUNOL TODAY, V6, P131, DOI 10.1016/0167-5699(85)90080-5; Vickers AJ, 2012, ARCH INTERN MED, V172, P1444, DOI 10.1001/archinternmed.2012.3654; Vig M, 2009, NAT IMMUNOL, V10, P21, DOI 10.1038/ni.f.220; WATMAN NP, 1988, CELL IMMUNOL, V111, P158, DOI 10.1016/0008-8749(88)90060-3; Wu B, 1996, Zhongguo Zhong Xi Yi Jie He Za Zhi, V16, P139; Wu B, 1994, Zhongguo Zhong Xi Yi Jie He Za Zhi, V14, P537; YE JP, 1995, J LEUKOCYTE BIOL, V58, P225, DOI 10.1002/jlb.58.2.225; Yu Y, 1998, J NEUROIMMUNOL, V90, P176, DOI 10.1016/S0165-5728(98)00143-X; Yu Y, 1997, JPN J PHYSIOL, V47, P173, DOI 10.2170/jjphysiol.47.173	32	16	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2017	12	4							e0175568	10.1371/journal.pone.0175568	http://dx.doi.org/10.1371/journal.pone.0175568			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0MB	28406959	Green Published, gold, Green Submitted			2022-12-27	WOS:000399955400070
J	Gao, YJ; Ou, YS; Deng, QX; He, B; Du, X; Li, JX				Gao, Yongjian; Ou, Yunsheng; Deng, Qianxing; He, Bin; Du, Xing; Li, Jianxiao			Comparison between titanium mesh and autogenous iliac bone graft to restore vertebral height through posterior approach for the treatment of thoracic and lumbar spinal tuberculosis	PLOS ONE			English	Article							SURGICAL-TREATMENT; THORACOLUMBAR TUBERCULOSIS; RADICAL DEBRIDEMENT; JOINT TUBERCULOSIS; INSTRUMENTATION; FUSION; RECONSTRUCTION; SPONDYLITIS; MANAGEMENT; INFECTION	Object To compare the clinical efficacy of titanium mesh cages and autogenous iliac bone graft to restore vertebral height through posterior approach in patients with thoracic and lumbar spinal tuberculosis. Method 59 patients with spinal tuberculosis underwent interbody fusion and internal fixation through posterior approach in our department from January 2011 to December 2013. In group A, 34 patients obtained titanium mesh for the reconstruction of vertebral height, among them 25 patients (group A1) suffered from single-segment spinal tuberculosis, and 9 patients, (group A2) had multi-segment spinal tuberculosis. In group B, 25 patients got autogenous iliac bone graft to restore vertebral height, including 24 patients with single-segment spinal tuberculosis (group B1), and 1 patient with multi-segment spinal tuberculosis (group B2). The clinical efficacy was evaluated based on average operation time, blood loss, hospital stays, hospitalization expenses, visual analog scale (VAS), Oswestry Disability Index (ODI), erythrocyte sedimentation rate (ESR), C-Reactive protein (CRP), neurological function recovery, bony fusion, intervertebral height, Cobb angle and postoperative complications. Results Final follow-up time was an average of 35.5 months ranging from 15 to 56 months. All patients were completely cured and obtained solid bone fusion. The bony fusion time was 9.4 +/- 6.1 months in group A1, 10.2 +/- 2.7 months in group A2 and 8.7 +/- 3.6 months in group B1. There were no significant difference among three groups (P>0.05). The Cobb correction and restoration of intervertebral height significantly improved compared with those in preoperation, but without significant difference among three groups (P>0.05). The loss of angular correction and intervertebral height in group A1 were found to be less than those in group B1 (P<0.05), but with no significant difference between group A1 and group A2, and between group A2 and group B1 (P>0.05). Patients in group B1 got the most loss of angular correction and intervertebral height. In addition, neurological function was revealed to be significantly improved after surgery. There were significant differences of VAS, ODI, ESR and CRP between preoperation and postoperation at the final follow-up time (P<0.05), with no significant difference among three groups (P>0.05). No statistically significant difference was found when analyzing blood loss, hospital stays, hospitalization expenses, and corrective cost among three groups (P>0.05). Complications included cerebrospinal fluid leakage (2 cases in group A1 and group A2), sinus formation (3 cases in group A1, group A2 and group B1), and intervertebral infection (1 case in group B1), but no implant failure or donor site complications was found in any patient. Conclusions Titanium mesh cages could obtain good clinical efficacy comparable to autogenous iliac bone graft when treating single-segment spinal tuberculosis, and may be better than autogenous iliac bone graft for treating multi-segment spinal tuberculosis.	[Gao, Yongjian; Ou, Yunsheng; He, Bin; Du, Xing; Li, Jianxiao] Chongqing Med Univ, Affiliated Hosp 1, Dept Orthoped, Chongqing, Peoples R China; [Deng, Qianxing] Fengdu peoples Hosp Chongqing, Dept Orthoped, Chongqing, Peoples R China	Chongqing Medical University	Ou, YS (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Dept Orthoped, Chongqing, Peoples R China.	ouyunsheng2001@163.com	Du, Xing/AAR-8888-2021	Du, Xing/0000-0001-7959-7847; ou, yunsheng/0000-0001-8578-3523; gao, yongjian/0000-0002-0581-026X				Arrington ED, 1996, CLIN ORTHOP RELAT R, P300, DOI 10.1097/00003086-199608000-00037; Azam MQ, 2015, ASIAN SPINE J, V9, P984, DOI 10.4184/asj.2015.9.6.984; BASS JB, 1994, AM J RESP CRIT CARE, V149, P1359, DOI 10.1164/ajrccm.149.5.8173779; BRIDWELL KH, 1995, SPINE, V20, P1410, DOI 10.1097/00007632-199506000-00014; Chen ST, 2015, SCI REP-UK, V5, DOI 10.1038/srep11084; Christodoulou AG, 2006, CLIN ORTHOP RELAT R, P60, DOI 10.1097/01.blo.0000201175.87635.28; Donald PR, 2011, J INFECTION, V62, P411, DOI 10.1016/j.jinf.2011.04.239; Erturer E, 2010, EUR SPINE J, V19, P2209, DOI 10.1007/s00586-010-1481-z; Gao ZC, 2015, SPINE J, V15, P71, DOI 10.1016/j.spinee.2014.06.025; Garg RK, 2011, J SPINAL CORD MED, V34, P440, DOI 10.1179/2045772311Y.0000000023; Gong K, 2011, ARCH ORTHOP TRAUM SU, V131, P217, DOI 10.1007/s00402-010-1138-8; Korovessis P, 2006, SPINE, V31, P1014, DOI 10.1097/01.brs.0000215049.08622.9d; Mei G, 2016, ORTHOPEDICS, V39, pE19, DOI 10.3928/01477447-20151218-04; OGA M, 1993, SPINE, V18, P1890, DOI 10.1097/00007632-199310000-00028; Ormerod P, 1998, THORAX, V53, P536; Ozdemir HM, 2003, SPINE, V28, P474, DOI 10.1097/00007632-200303010-00012; Panchmatia JR, 2015, J ORTHOP SURG-HONG K, V23, P391, DOI 10.1177/230949901502300328; Pang XY, 2013, ARCH ORTHOP TRAUM SU, V133, P765, DOI 10.1007/s00402-013-1722-9; Qureshi MA, 2013, EUR SPINE J, V22, P618, DOI 10.1007/s00586-012-2459-9; Sahoo MM, 2012, J SPINAL DISORD TECH, V25, pE217, DOI 10.1097/BSD.0b013e31826a088e; Sandher DS, 2007, J BONE JOINT SURG BR, V89B, P1379, DOI 10.1302/0301-620X.89B10.18943; Shen XJ, 2015, INT J CLIN EXP PATHO, V8, P11051; Shi J, 2014, J SPINAL DISORD TECH, V27, pE247, DOI 10.1097/BSD.0000000000000100; Sundararaj GD, 2011, ASIAN SPINE J, V5, P155, DOI 10.4184/asj.2011.5.3.155; TANG S, 2013, CHIN J ANTITUBERC, V35, P488; Tosun B, 2014, EUR SPINE J, V23, P2299, DOI 10.1007/s00586-014-3565-7; van Loenhout-Rooyackers JH, 2002, INT J TUBERC LUNG D, V6, P259; Wang B, 2011, TURK NEUROSURG, V21, P575, DOI [10.5137/1019-5149.JTN .4639-11.1, 10.5137/1019-5149.JTN.4639-11.1]; WHO, 2010, TREATMENT OF TUBERCULOSIS: GUIDELINES, FOURTH EDITION, P1; Yin XH, 2015, EUR SPINE J; Yin XH, 2016, EUR SPINE J, V25, P1047, DOI 10.1007/s00586-015-4283-5; Yin XH, 2016, CHILD NERV SYST, V32, P127, DOI 10.1007/s00381-015-2935-8; Zeng H, 2015, BMC MUSCULOSKEL DIS, V16, DOI 10.1186/s12891-015-0640-0; Zhang H, 2015, J ORTHOP SURG RES, V10; Zhang HQ, 2012, ARCH ORTHOP TRAUM SU, V132, P1717, DOI 10.1007/s00402-012-1618-0; Zhang HQ, 2012, ARCH ORTHOP TRAUM SU, V132, P751, DOI 10.1007/s00402-012-1473-z	36	23	32	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2017	12	4							e0175567	10.1371/journal.pone.0175567	http://dx.doi.org/10.1371/journal.pone.0175567			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0MB	28407019	Green Published, gold, Green Submitted			2022-12-27	WOS:000399955400069
J	Lindkvist, E; Basurto, X; Schluter, M				Lindkvist, Emilie; Basurto, Xavier; Schluter, Maja			Micro-level explanations for emergent patterns of self-governance arrangements in small-scale fisheries-A modeling approach	PLOS ONE			English	Article							BAJA-CALIFORNIA-SUR; SYSTEMS; COMANAGEMENT; FRAMEWORK; MIDDLEMEN	Small-scale fisheries (SSFs) in developing countries are expected to play a significant role in poverty alleviation and enhancing food security in the decades to come. To realize this expectation, a better understanding of their informal self-governance arrangements is critical for developing policies that can improve fishers' livelihoods and lead to sustainable ecosystem stewardship. The goal of this paper is to develop a more nuanced understanding of micro-level factors-such as fishers' characteristics and behavior-to explain observed differences in self-governance arrangements in Northwest Mexico. We focus on two ubiquitous forms of self-governance: hierarchical non-cooperative arrangements between fishers and fishbuyers, such as patron-client relationships (PCs), versus more cooperative arrangements amongst fishers, such as fishing cooperatives (co-ops). We developed an agent-based model of an archetypical SSF that captures key hypotheses from in-depth fieldwork in Northwest Mexico of fishers' day-to-day fishing and trading. Results from our model indicate that high diversity in fishers' reliability, and low initial trust between co-op members, makes co-ops' establishment difficult. PCs cope better with this kind of diversity because, in contrast to co-ops, they have more flexibility in choosing whom to work with. However, once co-ops establish, they cope better with seasonal variability in fish abundance and provide long-term security for the fishers. We argue that existing levels of trust and diversity among fishers matter for different self-governance arrangements to establish and persist, and should therefore be taken into account when developing better, targeted policies for improved SSFs governance.	[Lindkvist, Emilie; Schluter, Maja] Stockholm Univ, Stockholm Resilience Ctr, Stockholm, Sweden; [Basurto, Xavier] Duke Univ, Marine Lab, Nicholas Sch Environm, Beaufort, NC 28516 USA	Stockholm University; Duke University	Lindkvist, E (corresponding author), Stockholm Univ, Stockholm Resilience Ctr, Stockholm, Sweden.	emilie.lindkvist@su.se	Schlüter, Maja/C-2374-2015; Lindkvist, Emilie/ABH-5635-2020	Schlüter, Maja/0000-0002-7780-1039; Lindkvist, Emilie/0000-0003-1546-0934; Basurto, Xavier/0000-0002-5321-3654	Mistra; European Research Council [283950]; Duke University; David and Lucile Packard Foundation [2014-39664]; Walton Family Foundation [2013-1295]; National Science Foundation [1518361, 1632648]	Mistra; European Research Council(European Research Council (ERC)European Commission); Duke University; David and Lucile Packard Foundation(The David & Lucile Packard Foundation); Walton Family Foundation; National Science Foundation(National Science Foundation (NSF))	Financial support was provided by a core grant to the Stockholm Resilience Centre by Mistra http://www.mistra.org/en/ and by the European Research Council https://erc.europa.eu under the European Union's Seventh Framework Program (FP/2007-2013)/ERC grant agreement no. 283950 SES-LINK http://www.seslink.org (EL, MS). Duke University https://www.duke.edu/ (XB), the David and Lucile Packard Foundation https://www.packard.org grant#2014-39664 (XB), Walton Family Foundation http://www.waltonfamilyfoundation.org grant#2013-1295 (XB), and the National Science Foundation https://www.nsf.gov/ grant#1518361 (XB) and grant#1632648 (EL, XB).	Basurto X., 2016, 2873306 SOC SCI RES; Basurto X, 2013, GLOBAL ENVIRON CHANG, V23, P1366, DOI 10.1016/j.gloenvcha.2013.08.001; Basurto X, 2013, ECOL SOC, V18, DOI 10.5751/ES-05673-180438; Bennett A, 2016, LOCAL I RESPONSES GL; Bennett A, 2016, INFLUENCE NEOLIBERAL; Berkes F., 1998, LINKING SOCIAL ECOLO, P1; Bodin O, 2009, GLOBAL ENVIRON CHANG, V19, P366, DOI 10.1016/j.gloenvcha.2009.05.002; Bonabeau E, 2002, P NATL ACAD SCI USA, V99, P7280, DOI 10.1073/pnas.082080899; Bravo G, 2011, RATION SOC, V23, P117, DOI 10.1177/1043463110387268; Cinti A, 2010, MAR POLICY, V34, P328, DOI 10.1016/j.marpol.2009.08.002; Cisneros-Mata M.A., 2010, IMPORTANCE FISHERIES; Clark C.W., 2010, MATH BIOECONOMICS, V3rd; Crona B, 2010, MAR POLICY, V34, P761, DOI 10.1016/j.marpol.2010.01.023; FAO, 2014, STAT WORLD FISH AQ, P3; Ferrol-Schulte D, 2014, OCEAN COAST MANAGE, V100, P63, DOI 10.1016/j.ocecoaman.2014.07.016; Finkbeiner EM, 2015, GLOBAL ENVIRON CHANG, V32, P139, DOI 10.1016/j.gloenvcha.2015.03.009; Finkbeiner EM, 2015, MAR POLICY, V51, P433, DOI 10.1016/j.marpol.2014.10.010; Ghorbani A, 2016, INT J COMMONS, V10, P200, DOI 10.18352/ijc.606; Glaeser EL, 2000, Q J ECON, V115, P811, DOI 10.1162/003355300554926; Grimm V, 2010, ECOL MODEL, V221, P2760, DOI 10.1016/j.ecolmodel.2010.08.019; Gutierrez NL, 2011, NATURE, V470, P386, DOI 10.1038/nature09689; Hedstrom P, 2010, ANNU REV SOCIOL, V36, P49, DOI 10.1146/annurev.soc.012809.102632; Janssen M. A., 2006, INEQUALITY COOPERATI, P60; JENSEN MC, 1976, J FINANC ECON, V3, P305, DOI 10.1016/0304-405X(76)90026-X; JENTOFT S, 1986, REV CAN ETUD DEV, V7, P197, DOI 10.1080/02255189.1986.9670154; Jentoft S, 2015, MARE PUBL SER, V13, P705, DOI 10.1007/978-3-319-17034-3_36; Johnson DS, 2010, FISH FISH, V11, P264, DOI 10.1111/j.1467-2979.2010.00376.x; Kallis G, 2010, ECOL ECON, V69, P690, DOI 10.1016/j.ecolecon.2009.09.017; Ruddle K, 2011, HUM ORGAN, V70, P224, DOI 10.17730/humo.70.3.v4810k37717h9g01; Kobayashi M, 2011, 69544 WORLD BANK, P1; Kurien J, 2011, WORLD SMALL SCALE FI; Leslie HM, 2015, P NATL ACAD SCI USA, V112, P5979, DOI 10.1073/pnas.1414640112; Lindkvist E, 2017, COMSES COMPUT MODEL; Lluch-Cota SE, 2007, PROG OCEANOGR, V73, P1, DOI 10.1016/j.pocean.2007.01.013; Mahon R, 2008, MAR POLICY, V32, P104, DOI 10.1016/j.marpol.2007.04.011; McCay BJ, 2011, WORLD FISH SOC ECOL, V14, P381; McCay BJ, 2014, MAR POLICY, V44, P49, DOI 10.1016/j.marpol.2013.08.001; MCGOODWIN JR, 1980, ANTHROPOL QUART, V53, P39, DOI 10.2307/3317879; Mendez-Medina C, 2015, MARIT STUD, V14, DOI 10.1186/s40152-015-0026-9; MERLIJN AG, 1989, DEV CHANGE, V20, P683, DOI 10.1111/j.1467-7660.1989.tb00362.x; Muller B, 2013, ENVIRON MODELL SOFTW, V48, P37, DOI 10.1016/j.envsoft.2013.06.003; Noailly J, 2007, ENVIRON RESOUR ECON, V36, P113, DOI 10.1007/s10640-006-9046-7; Noailly J, 2009, COMPUT ECON, V33, P155, DOI 10.1007/s10614-008-9154-2; North D. C., 1990, I I CHANGE EC PERFOR; Ostrom, 2015, GOVERNING COMMONS EV, DOI DOI 10.1017/CBO9780511807763; Ostrom E, 2003, RUSSELL SAGE TRUST, V6, P19; Ostrom E, 2007, P NATL ACAD SCI USA, V104, P15181, DOI 10.1073/pnas.0702288104; Ovando DA, 2013, MAR POLICY, V37, P132, DOI 10.1016/j.marpol.2012.03.012; Pachauri R.K., 2014, CONTRIBUTION WORKING, P151, DOI DOI 10.1016/S0022-0248(00)00575-3; Pauly D, 1997, AM FISH S S, V20, P40; Pedroza C, 2013, MAR POLICY, V39, P135, DOI 10.1016/j.marpol.2012.10.011; Pinsky M., 2014, OCEANOGRAPHY, V2014; Poteete AR, 2010, WORKING TOGETHER: COLLECTIVE ACTION, THE COMMONS, AND MULTIPLE METHODS IN PRACTICE, P1; R Core Team, 2021, R LANGUAGE ENV STAT; Salas Silvia, 2011, FAO Fisheries and Aquaculture Technical Paper, V544, P1; Sasaki T, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2498; Schluter M, 2012, NAT RESOUR MODEL, V25, P219, DOI 10.1111/j.1939-7445.2011.00108.x; Schluter M, 2016, P R SOC B, V283, P1; Sethi R, 1996, AM ECON REV, V86, P766; Shapiro SP, 2005, ANNU REV SOCIOL, V31, P263, DOI 10.1146/annurev.soc.31.041304.122159; Sievanen L, 2014, MARIT STUD, V13, DOI 10.1186/s40152-014-0009-2; Soberanes Fernandez JL, 1994, HIST CONT LEGISLACIO, P1; Tavoni A, 2012, J THEOR BIOL, V299, P152, DOI 10.1016/j.jtbi.2011.07.003; Townsend R, 2008, CASE STUDIES FISHERI; Wilensky U., 1999, NETLOGO; Young E, 2001, ANN ASSOC AM GEOGR, V91, P283, DOI 10.1111/0004-5608.00244	66	25	26	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2017	12	4							e0175532	10.1371/journal.pone.0175532	http://dx.doi.org/10.1371/journal.pone.0175532			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET0MB	28406935	Green Published, Green Submitted, gold			2022-12-27	WOS:000399955400066
J	Long, JB; Wang, HB; Zha, DF; Li, P; Xie, HC; Mao, LL				Long, Junbo; Wang, Haibin; Zha, Daifeng; Li, Peng; Xie, Huicheng; Mao, Lili			Applications of fractional lower order S transform time frequency filtering algorithm to machine fault diagnosis	PLOS ONE			English	Article							IDENTIFICATION	Stockwell transform(ST) time-frequency representation(ST-TFR) is a time frequency analysis method which combines short time Fourier transform with wavelet transform, and ST time frequency filtering(ST-TFF) method which takes advantage of time-frequency localized spectra can separate the signals from Gaussian noise. The ST-TFR and ST-TFF methods are used to analyze the fault signals, which is reasonable and effective in general Gaussian noise cases. However, it is proved that the mechanical bearing fault signal belongs to Alpha (alpha) stable distribution process(1 < alpha < 2) in this paper, even the noise also is alpha stable distribution in some special cases. The performance of ST-TFR method will degrade under alpha stable distribution noise environment, following the ST-TFF method fail. Hence, a new fractional lower order ST time frequency representation(FLOST-TFR) method employing fractional lower order moment and ST and inverse FLOST(IFLOST) are proposed in this paper. A new FLOST time frequency filtering(FLOST-TFF) algorithm based on FLOST-TFR method and IFLOST is also proposed, whose simplified method is presented in this paper. The discrete implementation of FLOST-TFF algorithm is deduced, and relevant steps are summarized. Simulation results demonstrate that FLOST-TFR algorithm is obviously better than the existing ST-TFR algorithm under alpha stable distribution noise, which can work better under Gaussian noise environment, and is robust. The FLOST-TFF method can effectively filter out alpha stable distribution noise, and restore the original signal. The performance of FLOST-TFF algorithm is better than the ST-TFF method, employing which mixed MSEs are smaller when alpha and generalized signal noise ratio(GSNR) change. Finally, the FLOST-TFR and FLOST-TFF methods are applied to analyze the outer race fault signal and extract their fault features under a stable distribution noise, where excellent performances can be shown.	[Long, Junbo; Li, Peng; Xie, Huicheng; Mao, Lili] Jiujiang Univ, Coll Elect & Engn, Jiujiang, Peoples R China; [Wang, Haibin] Jiujiang Univ, Coll Informat Sci & Engn Technol, Jiujiang, Peoples R China; [Zha, Daifeng] Jiujiang Univ, Coll Sci, Jiujiang, Peoples R China	Jiujiang University; Jiujiang University; Jiujiang University	Wang, HB (corresponding author), Jiujiang Univ, Coll Informat Sci & Engn Technol, Jiujiang, Peoples R China.	29757916@qq.com			Natural Science Foundation of China [61261046, 61362038]; Natural Science Foundation of Jiangxi Province China [20151BAB207013]; Research Foundation of health department of Jiangxi Province China [20175561]; jiujiang university China [2016KJ001, 2016KJ002, 2016KJ003]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangxi Province China(Natural Science Foundation of Jiangxi Province); Research Foundation of health department of Jiangxi Province China; jiujiang university China	This work is financially supported by Natural Science Foundation of China (61261046, 61362038), the Natural Science Foundation of Jiangxi Province China(20151BAB207013), the Research Foundation of health department of Jiangxi Province China(20175561), science and technology project of jiujiang university China(2016KJ001, 2016KJ002, 2016KJ003).; This work is financially supported by Natural Science Foundation of China (61261046, 61362038), the Natural Science Foundation of Jiangxi Province China(20151BAB207013), the Research Foundation of health department of Jiangxi Province China(20175561), science and technology project of jiujiang university China(2016KJ001, 2016KJ002, 2016KJ003).	Chandra NH, 2016, MECH SYST SIGNAL PR, V72-73, P105, DOI 10.1016/j.ymssp.2015.11.013; Feng ZP, 2013, MECH SYST SIGNAL PR, V38, P165, DOI 10.1016/j.ymssp.2013.01.017; Gao HZ, 2015, CHIN J MECH ENG-EN, V28, P96, DOI 10.3901/CJME.2014.1103.166; Gao Yu-bao, 2012, Computer Engineering, V38, P186, DOI 10.3969/j.issn.1000-3428.2012.04.057; [郭奇 Guo Qi], 2012, [振动与冲击, Journal of Vibration and Shock], V31, P129; Guo Yuan-jing, 2014, Journal of Vibration Engineering, V27, P621; Li C, 2010, 2 INT C COMP MOD SIM, P386; Long JB, 2013, 2013 INT C SENS MEAS; Long JB, 2016, IEEE CAA J AUT SIN D, p[99, 1]; [龙俊波 Long Junbo], 2016, [电子与信息学报, Journal of Electronics & Information Technology], V38, P1710; Long Junbo, 2015, Sheng Wu Yi Xue Gong Cheng Xue Za Zhi, V32, P269; [龙俊波 Long Junbo], 2014, [信号处理, Journal of Signal Processing], V30, P1150; Ma H, 2009, J SOUND VIB, V321, P1109, DOI 10.1016/j.jsv.2008.09.054; Ma XY, 1996, IEEE T SIGNAL PROCES, V44, P2669, DOI 10.1109/78.542175; Ma XY, 1995, IEEE T SIGNAL PROCES, V43, P2884, DOI 10.1109/78.476432; Schimmel M, 2007, IEEE T SIGNAL PROCES, V55, P5120, DOI 10.1109/TSP.2007.896053; Schimmel M, 2005, IEEE T SIGNAL PROCES, V53, P4417, DOI 10.1109/TSP.2005.857065; SHAO M, 1993, P IEEE, V81, P986, DOI 10.1109/5.231338; Stockwell RG, 1996, IEEE T SIGNAL PROCES, V44, P998, DOI 10.1109/78.492555; Wang DW, 2015, 2015 21ST INTERNATIONAL CONFERENCE ON AUTOMATION AND COMPUTING (ICAC), P353; Wang Juan, 2012, Application Research of Computers, V29, P4254, DOI 10.3969/j.issn.1001-3695.2012.11.064; Wang X, 2015, SENSORS-BASEL, V15, P16225, DOI 10.3390/s150716225; Yang XY, 2010, J ZHEJIANG U, V44, P2087; Yu G, 2013, MECH SYST SIGNAL PR, V41, P155, DOI 10.1016/j.ymssp.2013.08.015; Yu X. M., 2012, MEAS CONTROL, V31, P21; Zhang L, 2016, J POWER SOURCES, V314, P28, DOI 10.1016/j.jpowsour.2016.01.066; Zhang L, 2014, ENERGIES, V7, P3204, DOI 10.3390/en7053204; Zhang YH, 2015, J CHEM-NY, V2015, DOI 10.1155/2015/402746; Zhu D, 2014, SIGNAL PROCESS, V96, P80, DOI 10.1016/j.sigpro.2013.04.019	29	9	9	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2017	12	4							e0175202	10.1371/journal.pone.0175202	http://dx.doi.org/10.1371/journal.pone.0175202			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0MB	28406916	Green Published, gold, Green Submitted			2022-12-27	WOS:000399955400034
J	Verheyen, N; Fahrleitner-Pammer, A; Belyavskiy, E; Gruebler, MR; Dimai, HP; Amrein, K; Ablasser, K; Martensen, J; Catena, C; Pieske-Kraigher, E; Colantonio, C; Voelkl, J; Lang, F; Alesutan, L; Meinitzer, A; Marz, W; Brussee, H; Pieske, B; Pilz, S; Tomaschitz, A				Verheyen, Nicolas; Fahrleitner-Pammer, Astrid; Belyavskiy, Evgeny; Gruebler, Martin R.; Dimai, Hans Peter; Amrein, Karin; Ablasser, Klemens; Martensen, Johann; Catena, Cristiana; Pieske-Kraigher, Elisabeth; Colantonio, Caterina; Voelkl, Jakob; Lang, Florian; Alesutan, Loana; Meinitzer, Andreas; Maerz, Winfried; Brussee, Helmut; Pieske, Burkert; Pilz, Stefan; Tomaschitz, Andreas			Relationship between bone turnover and left ventricular function in primary hyperparathyroidism: The EPATH trial	PLOS ONE			English	Article							PARATHYROID-HORMONE LEVELS; CHRONIC HEART-FAILURE; VERTEBRAL FRACTURES; MORTALITY; RISK; MEN; ASSOCIATION; MARKERS; ECHOCARDIOGRAPHY; OSTEOCALCIN	Observational studies suggested a link between bone disease and left ventricular (LV) dysfunction that may be pronounced in hyperparathyroid conditions. We therefore aimed to test the hypothesis that circulating markers of bone turnover correlate with LV function in a cohort of patients with primary hyperparathyroidism (pHPT). Cross-sectional data of 155 subjects with pHPT were analyzed who participated in the "Eplerenone in Primary Hyper-parathyroidism" (EPATH) Trial. Multivariate linear regression analyses with LV ejection fraction (LVEF, systolic function) or peak early transmitral filling velocity (e', diastolic function) as dependent variables and N-terminal propeptide of procollagen type 1 (P1NP), osteocalcin (OC), bone-specific alkaline phosphatase (BALP), or beta-crosslaps (CTX) as the respective independent variable were performed. Analyses were additionally adjusted for plasma parathyroid hormone, plasma calcium, age, sex, HbA1c, body mass index, mean 24-hours systolic blood pressure, smoking status, estimated glomerular filtration rate, antihypertensive treatment, osteoporosis treatment, 25-hydroxy vitamin D and N-terminal probrain B-type natriuretic peptide. Independent relationships were observed between P1NP and LVEF (adjusted beta-coefficient = 0.201, P = 0.035) and e' (beta = 0.188, P = 0.042), respectively. OC (beta = 0.192, P = 0.039) and BALP (beta = 0.198, P = 0.030) were each independently related with e'. CTX showed no correlations with LVEF or e'. In conclusion, high bone formation markers were independently and paradoxically related with better LV diastolic and, partly, better systolic function, in the setting of pHPT. Potentially cardio-protective properties of stimulated bone formation in the context of hyperparathyroidism should be explored in future studies.	[Verheyen, Nicolas; Ablasser, Klemens; Martensen, Johann; Colantonio, Caterina; Brussee, Helmut; Pieske, Burkert; Tomaschitz, Andreas] Med Univ Graz, Dept Cardiol, Graz, Austria; [Fahrleitner-Pammer, Astrid; Gruebler, Martin R.; Amrein, Karin; Pilz, Stefan] Med Univ Graz, Div Endocrinol & Metab, Dept Internal Med, Graz, Austria; [Belyavskiy, Evgeny; Pieske-Kraigher, Elisabeth; Pieske, Burkert] Charite, Campus Virchow Klinikum, Med Klin Schwerpunkt Kardiol, Berlin, Germany; [Gruebler, Martin R.] Bern Univ Hosp, Swiss Cardiovasc Ctr Bern, Dept Cardiol, Bern, Switzerland; [Catena, Cristiana] Univ Udine, Dept Expt & Clin Med Sci, Hypertens Unit, Internal Med, Udine, Italy; [Voelkl, Jakob; Lang, Florian; Alesutan, Loana] Univ Tubingen, Dept Physiol, Tubingen, Germany; [Maerz, Winfried] Med Univ Graz, Clin Inst Med & Chem Lab Diagnost, Graz, Austria; [Maerz, Winfried] Synlab Serv LLC, Synlab Acad, Mannheim, Germany; [Maerz, Winfried; Tomaschitz, Andreas] Ruperto Carola Univ Heidelberg, Med Fac Mannheim, Med Clin Nephrol Hypertensiol Endocrinol 5, Mannheim, Germany; [Pilz, Stefan] Vrije Univ Amsterdam, Dept Hlth Sci, Amsterdam, Netherlands; [Pilz, Stefan] Vrije Univ Amsterdam, EMGO Inst, Amsterdam, Netherlands; [Tomaschitz, Andreas] Specialist Clin Rehabil Bad Gleichenberg, Bad Gleichenberg, Austria	Medical University of Graz; Medical University of Graz; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Bern; University Hospital of Bern; University of Udine; Eberhard Karls University of Tubingen; Medical University of Graz; SYNLAB Group; Ruprecht Karls University Heidelberg; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	Verheyen, N (corresponding author), Med Univ Graz, Dept Cardiol, Graz, Austria.	nicolas.verheyen@medunigraz.at	Verheyen, Nicolas/HHT-0941-2022; Belyavskiy, Evgeny/AAD-1898-2021; Voelkl, Jakob/T-4298-2019; Pieske, Burkert/M-8089-2016	Belyavskiy, Evgeny/0000-0001-9940-0829; Amrein, Karin/0000-0003-0915-085X; Pieske, Burkert/0000-0002-6466-5306; Pilz, Stefan/0000-0002-7959-1311	Laboratory of the Division of Endocrinology and Metabolism; Austrian National Bank [14621]; Austrian Society for Bone and Mineral Research	Laboratory of the Division of Endocrinology and Metabolism; Austrian National Bank; Austrian Society for Bone and Mineral Research	The study was funded by the Austrian National Bank (Jubilaeumsfond: project #14621) and by the Austrian Society for Bone and Mineral Research (Felix-Bronner Grant 2014, Project Prize 2014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the Laboratory of the Division of Endocrinology and Metabolism for its work and support to the present research. Probes used for the present analyses were partly provided by the Biobank Graz. We thank Annemarie Ferstl, Edith Zeltner and Sascha Skralik for their support.	Brunner S, 2007, AM J PHYSIOL-ENDOC M, V293, pE1670, DOI 10.1152/ajpendo.00287.2007; Carbone L, 2010, EUR HEART J, V31, P77, DOI 10.1093/eurheartj/ehp483; Confavreux CB, 2013, J CLIN ENDOCR METAB, V98, P1084, DOI 10.1210/jc.2012-3426; Eastell R, 2014, J CLIN ENDOCR METAB, V99, P3570, DOI 10.1210/jc.2014-1414; Ellegaard M, 2012, SCAND J CLIN LAB INV, V72, P518, DOI 10.3109/00365513.2012.701321; Fraser WD, 2009, LANCET, V374, P145, DOI 10.1016/S0140-6736(09)60507-9; Hagstrom E, 2010, EUR J HEART FAIL, V12, P1186, DOI 10.1093/eurjhf/hfq134; Hansen S, 2012, J BONE MINER RES, V27, P1150, DOI 10.1002/jbmr.1540; Kerschan-Schindl K, 2012, HORM METAB RES, V44, P476, DOI 10.1055/s-0032-1308998; Khosla S, 1999, J BONE MINER RES, V14, P1700, DOI 10.1359/jbmr.1999.14.10.1700; Lang RM, 2015, J AM SOC ECHOCARDIOG, V28, P1, DOI 10.1016/j.echo.2014.10.003; Leistner DM, 2012, CIRC-HEART FAIL, V5, P769, DOI 10.1161/CIRCHEARTFAILURE.111.966093; Lerchbaum E, 2014, OSTEOPOROSIS INT, V25, P455, DOI 10.1007/s00198-013-2411-9; Lerchbaum E, 2013, OSTEOPOROSIS INT, V24, P1321, DOI 10.1007/s00198-012-2076-9; Lin YH, 2006, J HUM HYPERTENS, V20, P964, DOI 10.1038/sj.jhh.1002092; Lowe H, 2007, J CLIN ENDOCR METAB, V92, P3001, DOI 10.1210/jc.2006-2802; Lyons KJ, 2011, CIRC-HEART FAIL, V4, P419, DOI 10.1161/CIRCHEARTFAILURE.111.961185; Magni P, 2016, CLIN CHEM LAB MED; Mazziotti G, 2012, EUR J ENDOCRINOL, V167, P865, DOI 10.1530/EJE-12-0566; Nagueh SF, 2016, J AM SOC ECHOCARDIOG, V29, P277, DOI 10.1016/j.echo.2016.01.011; Ozdemir D, 2014, ENDOCRINE, V47, P609, DOI 10.1007/s12020-014-0245-7; Pfister R, 2014, JACC-HEART FAIL, V2, P380, DOI 10.1016/j.jchf.2014.03.010; Prisby R, 2013, BONE, V54, P68, DOI 10.1016/j.bone.2013.01.028; Prisby R, 2011, J BONE MINER RES, V26, P2583, DOI 10.1002/jbmr.459; Ramasamy SK, 2014, NATURE, V507, P376, DOI 10.1038/nature13146; Sambrook PN, 2006, J BONE MINER RES, V21, P549, DOI 10.1359/JBMR.060104; Schleithoff SS, 2003, J BONE MINER METAB, V21, P247, DOI 10.1007/s00774-003-0417-7; Souberbielle JC, 2001, J CLIN ENDOCR METAB, V86, P3086, DOI 10.1210/jc.86.7.3086; Stein EM, 2013, J BONE MINER RES, V28, P1029, DOI 10.1002/jbmr.1841; Terrovitis J, 2012, EUR J HEART FAIL, V14, P326, DOI 10.1093/eurjhf/hfs002; Tomaschitz A, 2016, J HYPERTENS, V34, P1347, DOI 10.1097/HJH.0000000000000927; Tomaschitz A, 2015, AM J MED SCI, V349, P306, DOI 10.1097/MAJ.0000000000000419; Tomaschitz A, 2012, BMC ENDOCR DISORD, V12, DOI 10.1186/1472-6823-12-19; Walker MD, 2010, J CLIN ENDOCR METAB, V95, P2172, DOI 10.1210/jc.2009-2072; Wannamethee SG, 2014, CIRC-HEART FAIL, V7, P732, DOI 10.1161/CIRCHEARTFAILURE.114.001272; Wu C, 2012, EUR J HEART FAIL, V14, P1356, DOI 10.1093/eurjhf/hfs138; Yoda M, 2015, CALCIFIED TISSUE INT, V97, P32, DOI 10.1007/s00223-015-0007-4; Yu EW, 2014, J BONE MINER RES, V29, P1380, DOI 10.1002/jbmr.2171; Yu N, 2010, CLIN ENDOCRINOL, V73, P30, DOI 10.1111/j.1365-2265.2009.03766.x; Zaruba MM, 2008, CARDIOVASC RES, V77, P722, DOI 10.1093/cvr/cvm080	40	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2017	12	4							e0173799	10.1371/journal.pone.0173799	http://dx.doi.org/10.1371/journal.pone.0173799			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0MB	28406904	Green Published, gold, Green Submitted			2022-12-27	WOS:000399955400004
J	Kurthy, M; Lawford-Smith, H; Sousa, P				Kurthy, Miklos; Lawford-Smith, Holly; Sousa, Paulo			Does ought imply can?	PLOS ONE			English	Article							BLAME	Most philosophers believe that a person can have an obligation only insofar as she is able to fulfil it, a principle generally referred to as "Ought Implies Can". Arguably, this principle reflects something basic about the ordinary concept of obligation. However, in a paper published recently in this journal, Wesley Buckwalter and John Turri presented evidence for the conclusion that ordinary people in fact reject that principle. With a series of studies, they claimed to have demonstrated that, in people's judgements, obligations persist irrespective of whether those who hold them have the ability to fulfil them. We argue in this paper that due to some problems in their design, Buckwalter & Turri's conclusions may not be warranted. We present the results of a series of studies demonstrating the problems with their design and showing that, with an improved design, people judge that obligation depends on ability after all.	[Kurthy, Miklos; Lawford-Smith, Holly] Univ Sheffield, Dept Philosophy, Sheffield, S Yorkshire, England; [Sousa, Paulo] Queens Univ Belfast, Inst Cognit & Culture, Belfast, Antrim, North Ireland	University of Sheffield; Queens University Belfast	Kurthy, M (corresponding author), Univ Sheffield, Dept Philosophy, Sheffield, S Yorkshire, England.	mkurthy1@sheffield.ac.uk			Department of Philosophy, University of Sheffield; School of History, Anthropology, Philosophy and Politics, Queen's University Belfast	Department of Philosophy, University of Sheffield; School of History, Anthropology, Philosophy and Politics, Queen's University Belfast	This research was funded by the Department of Philosophy, University of Sheffield, and by the School of History, Anthropology, Philosophy and Politics, Queen's University Belfast.	Beller S, 2008, P 30 ANN C COGN SCI; Beller S, 2008, THINK REASONING, V14, P305, DOI 10.1080/13546780802222258; Bender A, 2003, P 25 ANN C COGN SCI; Brown D. E., 1991, HUMAN UNIVERSALS; Buckwalter W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136589; Chituc V, 2016, COGNITION, V150, P20, DOI 10.1016/j.cognition.2016.01.013; Griffin J, 1992, GOOD LIFE HUMAN GOOD; Hare RM, 1963, FREEDOM REASON, P53; Hart H. L. A., 1968, PUNISHMENT RESPONSIB; Henne P, 2016, ANALYSIS; Hieronymi P, 2004, NOUS, P115; Jackendoff, 2007, LANGUAGE CONSCIOUSNE; Joerden JC, 2012, LOG UNIVERSALIS, V6, P201, DOI 10.1007/s11787-012-0041-1; Kant I., 1902, CRITIQUE PURE REASON; Kurthy M., 2015, METHODE, V4, P244; Levy Neil., 2005, J ETHICS SOCIAL PHIL, V1, P2; Machery E., 2009, DOING CONCEPTS, DOI DOI 10.1093/ACPROF:OSO/9780195306880.001.0001; Margolis Eric, 1999, CONCEPTS CORE READIN, P3; Mizrahi M., 2015, METHODE ANAL PERSPEC, V4, P232, DOI https://doi.org/10.13135/2281-0498/137; Sapontzis S., 1991, S J PHILOS, V29, P382; SINNOTTARMSTRONG W, 1984, PHILOS REV, V93, P249, DOI 10.2307/2184585; Sousa P, 2009, J COGN CULT, V9, P171, DOI 10.1163/156770909X12489459066183; Stern N., 2004, UTILITAS, V16, P42, DOI [https://doi.org/10.1017/S0953820803001055, DOI 10.1017/S0953820803001055]; Turri J, 2015, PHILOS STUD, V172, P615, DOI 10.1007/s11098-014-0322-z; Vicente A, 2014, BR J PHILOS SCI, V67, P1; Vranas PBM, 2007, PHILOS STUD, V136, P167, DOI 10.1007/s11098-007-9071-6; Zimmerman M., 1996, CONCEPT MORAL OBLIGA	27	15	15	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2017	12	4							e0175206	10.1371/journal.pone.0175206	http://dx.doi.org/10.1371/journal.pone.0175206			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LZ	28403195	Green Published, gold, Green Accepted			2022-12-27	WOS:000399955200044
J	Weichenberger, M; Bauer, M; Kuhler, R; Hensel, J; Forlim, CG; Ihlenfeld, A; Ittermann, B; Gallinat, J; Koch, C; Kuhn, S				Weichenberger, Markus; Bauer, Martin; Kuehler, Robert; Hensel, Johannes; Forlim, Caroline Garcia; Ihlenfeld, Albrecht; Ittermann, Bernd; Gallinat, Juergen; Koch, Christian; Kuehn, Simone			Altered cortical and subcortical connectivity due to infrasound administered near the hearing threshold - Evidence from fMRI	PLOS ONE			English	Article							INDEPENDENT COMPONENT ANALYSIS; LOW-FREQUENCY SOUNDS; FUNCTIONAL CONNECTIVITY; RESTING-STATE; REGIONAL HOMOGENEITY; DEFAULT MODE; AMYGDALA ACTIVATION; PREFRONTAL CORTEX; NEURAL RESPONSES; AUDITORY-CORTEX	In the present study, the brain's response towards near-and supra-threshold infrasound (IS) stimulation (sound frequency < 20 Hz) was investigated under resting-state fMRI conditions. The study involved two consecutive sessions. In the first session, 14 healthy participants underwent a hearing threshold - as well as a categorical loudness scaling measurement in which the individual loudness perception for IS was assessed across different sound pressure levels (SPL). In the second session, these participants underwent three resting-state acquisitions, one without auditory stimulation (no-tone), one with a monaurally presented 12-Hz IS tone (near-threshold) and one with a similar tone above the individual hearing threshold corresponding to a `medium loud' hearing sensation (supra-threshold). Data analysis mainly focused on local connectivity measures by means of regional homogeneity (ReHo), but also involved independent component analysis (ICA) to investigate interregional connectivity. ReHo analysis revealed significantly higher local connectivity in right superior temporal gyrus (STG) adjacent to primary auditory cortex, in anterior cingulate cortex (ACC) and, when allowing smaller cluster sizes, also in the right amygdala (rAmyg) during the near-threshold, compared to both the supra-threshold and the no-tone condition. Additional independent component analysis (ICA) revealed large-scale changes of functional connectivity, reflected in a stronger activation of the right amygdala (rAmyg) in the opposite contrast (no-tone > near-threshold) as well as the right superior frontal gyrus (rSFG) during the near-threshold condition. In summary, this study is the first to demonstrate that infrasound near the hearing threshold may induce changes of neural activity across several brain regions, some of which are known to be involved in auditory processing, while others are regarded as keyplayers in emotional and autonomic control. These findings thus allow us to speculate on how continuous exposure to (sub-)liminalIScouldexert a pathogenic influence on the organism, yet further (especially longitudinal) studies are required in order to substantialize these findings.	[Weichenberger, Markus] Charite, Dept Psychiat & Psychotherapy, Berlin, Germany; [Bauer, Martin; Kuehler, Robert; Hensel, Johannes; Ihlenfeld, Albrecht; Ittermann, Bernd; Koch, Christian] PTB, Braunschweig, Germany; [Bauer, Martin; Kuehler, Robert; Hensel, Johannes; Ihlenfeld, Albrecht; Ittermann, Bernd; Koch, Christian] PTB, Berlin, Germany; [Forlim, Caroline Garcia; Gallinat, Juergen; Kuehn, Simone] Univ Clin Hamburg Eppendorf, Clin & Policlin Psychiat & Psychotherapy, Hamburg, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Physikalisch-Technische Bundesanstalt (PTB); Physikalisch-Technische Bundesanstalt (PTB); University of Hamburg; University Medical Center Hamburg-Eppendorf	Weichenberger, M (corresponding author), Charite, Dept Psychiat & Psychotherapy, Berlin, Germany.	markus.weichenberger@charite.de	Forlim, Caroline G/GLU-9139-2022; Kuehn, Simone/P-6145-2014	Kuhn, Simone/0000-0001-6823-7969; Forlim, Caroline G/0000-0003-4709-7797; Bauer, Martin/0000-0002-3120-7405	EMRP research grant [HLT01]	EMRP research grant	The study was funded by the EMRP research grant HLT01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitkin L.M., 1986, AUDITORY MIDBRAIN ST; [Anonymous], 2003, 2262003 ISO; Auerbach BD, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00206; Berglund B, 1995, COMMUNITY NOISE, V2, P1; Bishop SR, 2004, CLIN PSYCHOL-SCI PR, V11, P230, DOI 10.1093/clipsy/bph077; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Botvinick M, 1999, NATURE, V402, P179, DOI 10.1038/46035; Brand T, 2002, J ACOUST SOC AM, V112, P1597, DOI 10.1121/1.1502902; BROWN MC, 1988, J COMP NEUROL, V278, P581, DOI 10.1002/cne.902780409; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Calhoun VD, 2004, MAGN RESON IMAGING, V22, P1181, DOI 10.1016/j.mri.2004.09.004; CANTRELL RW, 1974, LARYNGOSCOPE, V84, P1; CAVATORTA A, 1987, J HYPERTENS, V5, P463; Cheatham MA, 2001, J ACOUST SOC AM, V110, P2034, DOI 10.1121/1.1397357; Compton RJ, 2003, COGN AFFECT BEHAV NE, V3, P81, DOI 10.3758/CABN.3.2.81; CORSO JF, 1958, AM J PSYCHOL, V71, P367, DOI 10.2307/1420081; Curtis CE, 2003, TRENDS COGN SCI, V7, P415, DOI 10.1016/S1364-6613(03)00197-9; DALLOS P, 1970, J ACOUST SOC AM, V48, P489, DOI 10.1121/1.1912163; Dallos P., 1973, AUDITORY PERIPHERY, P228; DANIELSSON A, 1985, ACTA MED SCAND, V217, P531; Davis M, 2001, MOL PSYCHIATR, V6, P13, DOI 10.1038/sj.mp.4000812; Devlin JT, 2003, J NEUROSCI, V23, P11516; DIXON NF, 1991, J NERV MENT DIS, V179, P243, DOI 10.1097/00005053-199105000-00001; Dommes E, 2009, BRAIN RES, V1304, P129, DOI 10.1016/j.brainres.2009.09.089; Egner T, 2005, NEUROIMAGE, V24, P539, DOI 10.1016/j.neuroimage.2004.09.007; Enbom Hakan, 2013, Lakartidningen, V110, P1388; Etkin A, 2006, NEURON, V50, P127, DOI 10.1016/j.neuron.2006.03.013; Farboud A, 2013, J LARYNGOL OTOL, V127, P222, DOI 10.1017/S0022215112002964; FRANKE R, 1982, ARCH OTO-RHINO-LARYN, V234, P213, DOI 10.1007/BF00453634; Geerligs L, 2015, J NEUROSCI, V35, P13949, DOI 10.1523/JNEUROSCI.1324-15.2015; Glascher J, 2003, J NEUROSCI, V23, P10274; Godfrey DA, 1997, ACOUSTICAL SIGNAL PROCESSING IN THE CENTRAL AUDITORY SYSTEM, P139, DOI 10.1007/978-1-4419-8712-9_13; GRAYBIEL AM, 1972, BRAIN RES, V44, P99, DOI 10.1016/0006-8993(72)90369-1; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Grill-Spector K, 1999, NEURON, V24, P187, DOI 10.1016/S0896-6273(00)80832-6; Grill-Spector K, 2001, ACTA PSYCHOL, V107, P293, DOI 10.1016/S0001-6918(01)00019-1; Gusnard DA, 2001, P NATL ACAD SCI USA, V98, P4259, DOI 10.1073/pnas.071043098; Henckens MJAG, 2012, CEREB CORTEX, V22, P2336, DOI 10.1093/cercor/bhr313; Hensel J, 2007, HEARING RES, V233, P67, DOI 10.1016/j.heares.2007.07.004; Hurlburt RT, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01535; HURLEY KM, 1991, J COMP NEUROL, V308, P249, DOI 10.1002/cne.903080210; International Standards Organization (ISO), 2009, 38992009 ISO; Irwin W, 1996, NEUROREPORT, V7, P1765, DOI 10.1097/00001756-199607290-00014; Jakobsen J, 2005, J LOW FREQ NOISE V A, V24, P145, DOI 10.1260/026309205775374451; Jancke L, 2002, HEARING RES, V170, P166, DOI 10.1016/S0378-5955(02)00488-4; Jung SS, 2008, J KOREAN PHYS SOC, V53, P1897, DOI 10.3938/jkps.53.1897; Kaernbach C, 2001, PERCEPT PSYCHOPHYS, V63, P1377, DOI 10.3758/BF03194549; Karpova N., 1970, NOISE VIBRATION B, V11, P100; Katanoda K, 2002, NEUROIMAGE, V17, P1415, DOI 10.1006/nimg.2002.1209; Kendall M.G., 1990, RANK CORRELATION MET, V5th; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; Khalfa S, 1996, NEUROREPORT, V7, P993, DOI 10.1097/00001756-199604100-00008; Khalfa S, 1998, EUR J NEUROSCI, V10, P2731, DOI 10.1046/j.1460-9568.1998.00286.x; Kuehler R, 2015, J ACOUST SOC AM, V137, pEL347, DOI 10.1121/1.4916795; Kuhn S, 2014, SOC COGN AFFECT NEUR, V9, P1320, DOI 10.1093/scan/nst117; Kuhler R, P EUR 2015 JUN 1 3; Landstrom U., 1988, Journal of Low Frequency Noise & Vibration, V7, P104; Lane RD, 1997, NEUROPSYCHOLOGIA, V35, P1437, DOI 10.1016/S0028-3932(97)00070-5; LeDoux J E, 1992, Curr Opin Neurobiol, V2, P191, DOI 10.1016/0959-4388(92)90011-9; Leventhall G, 2007, PROG BIOPHYS MOL BIO, V93, P130, DOI 10.1016/j.pbiomolbio.2006.07.006; Leventhall H G, 2004, Noise Health, V6, P59; Liu HH, 2006, NEUROREPORT, V17, P19, DOI 10.1097/01.wnr.0000195666.22714.35; Long XY, 2008, J NEUROSCI METH, V171, P349, DOI 10.1016/j.jneumeth.2008.03.021; Marquardt T, 2007, J ACOUST SOC AM, V121, P3628, DOI 10.1121/1.2722506; McKeown MJ, 2003, CURR OPIN NEUROBIOL, V13, P620, DOI 10.1016/j.conb.2003.09.012; Meneguzzo Paolo, 2014, BMC Psychol, V2, P52, DOI 10.1186/s40359-014-0052-1; Mirz F, 2000, NEUROREPORT, V11, P633, DOI 10.1097/00001756-200002280-00039; Moller AR, 2003, OTOLARYNG CLIN N AM, V36, P249, DOI 10.1016/S0030-6665(02)00170-6; Moller AR, 2002, NEUROSCI LETT, V319, P41, DOI 10.1016/S0304-3940(01)02516-2; MOLLER AR, 1992, LARYNGOSCOPE, V102, P1165; Moller H, 2004, Noise Health, V6, P37; Morris JS, 1999, NEUROPSYCHOLOGIA, V37, P1155, DOI 10.1016/S0028-3932(99)00015-9; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Phillips ML, 1998, P ROY SOC B-BIOL SCI, V265, P1809, DOI 10.1098/rspb.1998.0506; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; ROBINSON DW, 1956, BRIT J APPL PHYS, V7, P166, DOI 10.1088/0508-3443/7/5/302; Roy AK, 2009, NEUROIMAGE, V45, P614, DOI 10.1016/j.neuroimage.2008.11.030; Salt AN, 2013, J ACOUST SOC AM, V133, P1561, DOI 10.1121/1.4789005; Salt AN, 2010, HEARING RES, V268, P12, DOI 10.1016/j.heares.2010.06.007; Salt AN, 2011, 4 INT M WIND TURB NO; Salt AN., 2011, B SCI TECHNOL SOC, V31, P296, DOI [10.1177/0270467611412555, DOI 10.1177/0270467611412555]; Sander K, 2001, COGNITIVE BRAIN RES, V12, P181, DOI 10.1016/S0926-6410(01)00045-3; Schonwiesner M, 2007, CEREB CORTEX, V17, P492, DOI 10.1093/cercor/bhj165; Scholz G, 2009, 16 INT C SOUND VIBR; Schust M, 2004, Noise Health, V6, P73; Shepherd D, 2011, NOISE HEALTH, V13, P333, DOI 10.4103/1463-1741.85502; Shore SE, 2005, EUR J NEUROSCI, V21, P3334, DOI 10.1111/j.1460-9568.2005.04142.x; Sugimoto T, 2008, SICE ANN C TOK; Swingle PG, 1991, SUBLIMINAL TREATMENT; Taylor E, 1994, THINKING THINKING; Taylor SF, 1998, NEUROIMAGE, V8, P188, DOI 10.1006/nimg.1998.0356; TERREBERRY RR, 1983, BRAIN RES, V278, P245, DOI 10.1016/0006-8993(83)90246-9; Tononi G, 1998, NEUROIMAGE, V7, P133, DOI 10.1006/nimg.1997.0313; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Ulanovsky N, 2004, J NEUROSCI, V24, P10440, DOI 10.1523/JNEUROSCI.1905-04.2004; van den Berg G. P., 2006, THESIS; Verzini AM, 1999, APPL ACOUST, V57, P69, DOI 10.1016/S0003-682X(98)00025-5; Ward B. D., 2000, SIMULTANEOUS INFEREN, DOI https://afni.nimh.nih.gov/pub/dist/doc/manuals/AlphaSim.pdf; Weichenberger M, 2015, HEARING RES, V328, P87, DOI 10.1016/j.heares.2015.08.001; WELCH BL, 1970, PHYSL EFFECTS NOISE; WHITTLE LS, 1972, J SOUND VIB, V21, P431, DOI 10.1016/0022-460X(72)90828-0; Wu QZ, 2011, HUM BRAIN MAPP, V32, P1290, DOI 10.1002/hbm.21108; Wu T, 2009, HUM BRAIN MAPP, V30, P1502, DOI 10.1002/hbm.20622; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013; YEOWART NS, 1974, J ACOUST SOC AM, V55, P814, DOI 10.1121/1.1914605; Zald DH, 2002, NEUROIMAGE, V16, P746, DOI 10.1006/nimg.2002.1115; Zald DH, 1997, P NATL ACAD SCI USA, V94, P4119, DOI 10.1073/pnas.94.8.4119; Zald DH, 1998, BRAIN, V121, P1143, DOI 10.1093/brain/121.6.1143; Zang YF, 2004, NEUROIMAGE, V22, P394, DOI 10.1016/j.neuroimage.2003.12.030	110	16	16	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2017	12	4							e0174420	10.1371/journal.pone.0174420	http://dx.doi.org/10.1371/journal.pone.0174420			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LZ	28403175	Green Submitted, Green Published, gold			2022-12-27	WOS:000399955200012
J	Yaakov, N; Barak, Y; Pereman, I; Christie, PJ; Elbaum, M				Yaakov, Noga; Barak, Yoav; Pereman, Idan; Christie, Peter J.; Elbaum, Michael			Direct fluorescence detection of VirE2 secretion by Agrobacterium tumefaciens	PLOS ONE			English	Article							SINGLE-STRANDED-DNA; BINDING PROTEIN VIRE2; T-DNA; PLANT TRANSFORMATION; NUCLEAR-LOCALIZATION; DIRECT VISUALIZATION; HOST-CELLS; CROWN-GALL; ARABIDOPSIS; VIRULENCE	VirE2 is a ssDNA binding protein essential for virulence in Agrobacterium tumefaciens. A tetracysteine mutant (VirE2-TC) was prepared for in vitro and in vivo fluorescence imaging based on the ReAsH reagent. VirE2-TC was found to be biochemically active as it binds both ssDNA and the acidic secretion chaperone VirE1. It was also biologically functional in complementing virE2 null strains transforming Arabidopsis thaliana roots and Nicotiana tabacum leaves. In vitro experiments demonstrated a two-color fluorescent complex using VirE2-TC/ReAsH and Alexa Fluor 488 labeled ssDNA. In vivo, fluorescent VirE2-TC/ReAsH was detected in bacteria and in plant cells at time frames relevant to transformation.	[Yaakov, Noga; Elbaum, Michael] Weizmann Inst Sci, Dept Mat & Interfaces, Rehovot, Israel; [Barak, Yoav] Weizmann Inst Sci, Chem Res Support Dept, Rehovot, Israel; [Pereman, Idan] Weizmann Inst Sci, Dept Plant & Environm Sci, Rehovot, Israel; [Christie, Peter J.] UT Houston Med Sch, Dept Microbiol & Mol Genet, Houston, TX USA	Weizmann Institute of Science; Weizmann Institute of Science; Weizmann Institute of Science; University of Texas System; University of Texas Health Science Center Houston	Elbaum, M (corresponding author), Weizmann Inst Sci, Dept Mat & Interfaces, Rehovot, Israel.	michael.elbaum@weizmann.ac.il			European Research Council TRACTAR project; US-Israel Binational Agricultural Research and Development Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM048746] Funding Source: NIH RePORTER	European Research Council TRACTAR project; US-Israel Binational Agricultural Research and Development Fund(US-Israel Binational Science Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by the European Research Council TRACTAR project, and by a grant from the US-Israel Binational Agricultural Research and Development Fund to PC and ME. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Arish A, 2004, J BIOL CHEM, V279, P25359, DOI 10.1074/jbc.M401804200; Adams SR, 2002, J AM CHEM SOC, V124, P6063, DOI 10.1021/ja017687n; Avilov SV, 2012, VACCINE, V30, P7411, DOI 10.1016/j.vaccine.2012.09.077; Babic A, 2008, SCIENCE, V319, P1533, DOI 10.1126/science.1153498; BARKER RF, 1983, PLANT MOL BIOL, V2, P335, DOI 10.1007/BF01578595; BERTANI G, 1951, J BACTERIOL, V62, P293, DOI 10.1128/JB.62.3.293-300.1951; Bharat TAM, 2013, STRUCTURE, V21, P1158, DOI 10.1016/j.str.2013.04.027; Bhattacharjee S, 2008, PLANT CELL, V20, P2661, DOI 10.1105/tpc.108.060467; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Cabantous S, 2005, NAT BIOTECHNOL, V23, P102, DOI 10.1038/nbt1044; CHILTON MD, 1977, CELL, V11, P263, DOI 10.1016/0092-8674(77)90043-5; Citovsky V, 1997, J MOL BIOL, V271, P718, DOI 10.1006/jmbi.1997.1230; CITOVSKY V, 1989, P NATL ACAD SCI USA, V86, P1193, DOI 10.1073/pnas.86.4.1193; CITOVSKY V, 1994, P NATL ACAD SCI USA, V91, P3210, DOI 10.1073/pnas.91.8.3210; CITOVSKY V, 1992, SCIENCE, V256, P1802, DOI 10.1126/science.1615325; Crivat G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022975; DAS A, 1988, P NATL ACAD SCI USA, V85, P2909, DOI 10.1073/pnas.85.9.2909; Deng WY, 1999, MOL MICROBIOL, V31, P1795, DOI 10.1046/j.1365-2958.1999.01316.x; Dym O, 2008, P NATL ACAD SCI USA, V105, P11170, DOI 10.1073/pnas.0801525105; Enninga J, 2005, NAT METHODS, V2, P959, DOI 10.1038/NMETH804; Estevez JM, 2006, BIOTECHNIQUES, V41, P569, DOI 10.2144/000112264; Fernandez D, 1996, J BACTERIOL, V178, P3156, DOI 10.1128/jb.178.11.3156-3167.1996; Frenkiel-Krispin D, 2007, J BIOL CHEM, V282, P3458, DOI 10.1074/jbc.M605270200; Fullner KJ, 1996, J BACTERIOL, V178, P1498, DOI 10.1128/jb.178.6.1498-1504.1996; GARFINKEL DJ, 1981, CELL, V27, P143, DOI 10.1016/0092-8674(81)90368-8; Gelvin SB, 2006, BIOTECHNOL AGRIC FOR, V58, P195; Gelvin SB, 2003, MICROBIOL MOL BIOL R, V67, P16, DOI 10.1128/MMBR.67.1.16-37.2003; GIETL C, 1987, P NATL ACAD SCI USA, V84, P9006, DOI 10.1073/pnas.84.24.9006; Grange W, 2008, PLOS BIOL, V6, P343, DOI 10.1371/journal.pbio.0060044; GREENBERG EP, 1979, ARCH MICROBIOL, V120, P87, DOI 10.1007/BF00409093; Griffin BA, 1998, SCIENCE, V281, P269, DOI 10.1126/science.281.5374.269; Guralnick B, 1996, PLANT CELL, V8, P363, DOI 10.1105/tpc.8.3.363; HOOD EE, 1993, TRANSGENIC RES, V2, P208, DOI 10.1007/BF01977351; Li XY, 2014, PLANT J, V77, P487, DOI 10.1111/tpj.12397; LICHTENSTEIN C, 1985, DNA CLONING, V2, P67; Maes M, 2014, PROTEIN ENG DES SEL, V27, P439, DOI 10.1093/protein/gzu036; Mills E, 2008, CELL HOST MICROBE, V3, P104, DOI 10.1016/j.chom.2007.11.007; Narasimhulu SB, 1996, PLANT CELL, V8, P873, DOI 10.1105/tpc.8.5.873; Nickerson A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100589; OTTEN L, 1984, MOL GEN GENET, V195, P159, DOI 10.1007/BF00332739; Pitzschke A, 2010, EMBO J, V29, P1021, DOI 10.1038/emboj.2010.8; ROSSI L, 1993, MOL GEN GENET, V239, P345, DOI 10.1007/BF00276932; Rossi L, 1996, P NATL ACAD SCI USA, V93, P126, DOI 10.1073/pnas.93.1.126; Sakalis PA, 2014, MICROBIOLOGYOPEN, V3, P104, DOI 10.1002/mbo3.152; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Sheffield P, 1999, PROTEIN EXPRES PURIF, V15, P34, DOI 10.1006/prep.1998.1003; Sundberg C, 1996, J BACTERIOL, V178, P1207, DOI 10.1128/jb.178.4.1207-1212.1996; Tzfira T, 2001, EMBO J, V20, P3596, DOI 10.1093/emboj/20.13.3596; Ward DV, 2001, P NATL ACAD SCI USA, V98, P385, DOI 10.1073/pnas.98.2.385; Yang QH, 2017, P NATL ACAD SCI USA, V114, P2982, DOI 10.1073/pnas.1612098114; Zupan J, 2007, J BACTERIOL, V189, P6551, DOI 10.1128/JB.00480-07; Zupan JR, 1996, P NATL ACAD SCI USA, V93, P2392, DOI 10.1073/pnas.93.6.2392	52	1	1	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2017	12	4							e0175273	10.1371/journal.pone.0175273	http://dx.doi.org/10.1371/journal.pone.0175273			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LZ	28403156	Green Published, gold, Green Submitted			2022-12-27	WOS:000399955200046
J	Liu, Z; Liu, JX; Li, HH; Li, ZZ; Tan, ZR; Liu, RW; Liu, Y				Liu, Zhao; Liu, Jingxian; Li, Huanhuan; Li, Zongzhi; Tan, Zhirong; Liu, Ryan Wen; Liu, Yi			Hierarchical and coupling model of factors influencing vessel traffic flow	PLOS ONE			English	Article							AIS DATA; SIMULATION; MANAGEMENT; SYSTEM	Understanding the characteristics of vessel traffic flow is crucial in maintaining navigation safety, efficiency, and overall waterway transportation management. Factors influencing vessel traffic flow possess diverse features such as hierarchy, uncertainty, nonlinearity, complexity, and interdependency. To reveal the impact mechanism of the factors influencing vessel traffic flow, a hierarchical model and a coupling model are proposed in this study based on the interpretative structural modeling method. The hierarchical model explains the hierarchies and relationships of the factors using a graph. The coupling model provides a quantitative method that explores interaction effects of factors using a coupling coefficient. The coupling coefficient is obtained by determining the quantitative indicators of the factors and their weights. Thereafter, the data obtained from Port of Tianjin is used to verify the proposed coupling model. The results show that the hierarchical model of the factors influencing vessel traffic flow can explain the level, structure, and interaction effect of the factors; the coupling model is efficient in analyzing factors influencing traffic volumes. The proposed method can be used for analyzing increases in vessel traffic flow in waterway transportation system.	[Liu, Zhao; Liu, Jingxian; Li, Huanhuan; Tan, Zhirong; Liu, Ryan Wen; Liu, Yi] Wuhan Univ Technol, Hubei Key Lab Inland Shipping Technol, Sch Nav, Wuhan, Peoples R China; [Liu, Zhao; Liu, Jingxian; Li, Huanhuan; Tan, Zhirong; Liu, Ryan Wen; Liu, Yi] Natl Engn Res Ctr Water Transport Safety, Wuhan, Peoples R China; [Li, Zongzhi] IIT, Dept Civil Architectural & Environm Engn, Chicago, IL 60616 USA	Hubei Key Laboratory of Inland Shipping Technology; Wuhan University of Technology; National Engineering Research Center for Water Transport Safety; Illinois Institute of Technology	Liu, Y (corresponding author), Wuhan Univ Technol, Hubei Key Lab Inland Shipping Technol, Sch Nav, Wuhan, Peoples R China.; Liu, Y (corresponding author), Natl Engn Res Ctr Water Transport Safety, Wuhan, Peoples R China.	liuyi_hy@whut.edu.cn	Li, Huanhuan/R-6207-2018; Liu, Ryan Wen/U-6910-2019; Liu, Wen/H-4047-2014; Liu, Zhao/F-6248-2017; Li, Zongzhi/AAE-9740-2020; Li, Zongzhi/AFL-7886-2022	Li, Huanhuan/0000-0002-4293-4763; Liu, Wen/0000-0002-1591-5583; Liu, Zhao/0000-0002-7339-7403; Li, Zongzhi/0000-0002-6500-7460; 	National Natural Science Foundation of China [51179147, 51479157]; Fundamental Research Funds for the Central Universities program of Wuhan University of Technology [2013-YB-004]; Science and Technology Project for Communication Construction of Ministry of Transport [2015 318 J34 090]; Science and Technology Department of Hubei Province [2015BHE004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities program of Wuhan University of Technology; Science and Technology Project for Communication Construction of Ministry of Transport; Science and Technology Department of Hubei Province	This study was supported by a grant from the National Natural Science Foundation of China (Nos.: 51179147 and 51479157), a grant from the "Fundamental Research Funds for the Central Universities" program of Wuhan University of Technology (No. 2013-YB-004), a grant from the Science and Technology Project for Communication Construction of Ministry of Transport (No.: 2015 318 J34 090), and a grant from the Science and Technology Department of Hubei Province (No.: 2015BHE004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agi MAN, 2017, J ENVIRON MANAGE, V188, P351, DOI 10.1016/j.jenvman.2016.11.081; Aydogdu YV, 2012, J NAVIGATION, V65, P99, DOI 10.1017/S0373463311000555; Feng H, 2013, INT J U AND E SERVIC, V6, P111, DOI DOI 10.14257/IJUNESST.2013.6.6.12; George J.P., 2014, INT J RES ENG TECHNO, V2, P161; Goerlandt F, 2011, RELIAB ENG SYST SAFE, V96, P91, DOI 10.1016/j.ress.2010.09.003; Kose E, 2003, SIMUL MODEL PRACT TH, V11, P597, DOI 10.1016/j.simpat.2003.10.001; Li MW, 2015, NEUROCOMPUTING, V157, P243, DOI 10.1016/j.neucom.2015.01.010; Liu JX, 2016, J NAVIGATION, V69, P481, DOI 10.1017/S0373463315000764; [刘钊 Liu Zhao], 2014, [大连海事大学学报, Journal of Dalian Maritime University], V40, P22; MALONE DW, 1975, P IEEE, V63, P397, DOI 10.1109/PROC.1975.9765; Merrick JRW, 2003, RELIAB ENG SYST SAFE, V81, P119, DOI 10.1016/S0951-8320(03)00054-1; Raj T, 2008, INT J PROD RES, V46, P6883, DOI 10.1080/00207540701429926; Sage A. P., 1977, METHODOLOGY LARGE SC, P91; Sharma V., 2013, RES J MANAGEMENT SCI, V2, P3, DOI DOI 10.1108/01443579410062086; Shen LY, 2016, J CLEAN PROD, V127, P214, DOI 10.1016/j.jclepro.2016.03.151; Silveira PAM, 2013, J NAVIGATION, V66, P879, DOI 10.1017/S0373463313000519; van Dorp JR, 2011, ANN OPER RES, V187, P249, DOI 10.1007/s10479-009-0678-1; Wen YQ, 2015, OCEAN ENG, V104, P500, DOI 10.1016/j.oceaneng.2015.04.051; Xiao FL, 2015, OCEAN ENG, V95, P84, DOI 10.1016/j.oceaneng.2014.11.020; Zheng B, 2008, INTERNATIONAL CONFERENCE ON INTELLIGENT COMPUTATION TECHNOLOGY AND AUTOMATION, VOL 2, PROCEEDINGS, P243, DOI 10.1109/ICICTA.2008.127	20	4	5	3	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2017	12	4							e0175840	10.1371/journal.pone.0175840	http://dx.doi.org/10.1371/journal.pone.0175840			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KD	28414747	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000399874800066
J	Suijker, JJ; MacNeil-Vroomen, JL; van Rijn, M; Buurman, BM; de Rooij, SE; van Charente, EPM; Bosmans, JE				Suijker, Jacqueline J.; MacNeil-Vroomen, Janet L.; van Rijn, Marjon; Buurman, Bianca M.; de Rooij, Sophia E.; van Charente, Eric P. Moll; Bosmans, Judith E.			Cost-effectiveness of nurse-led multifactorial care to prevent or postpone new disabilities in community-living older people: Results of a cluster randomized trial	PLOS ONE			English	Article							COMPREHENSIVE GERIATRIC ASSESSMENT; QUALITY-OF-LIFE; FUNCTIONAL DECLINE; ECONOMIC-EVALUATION; ELDERLY-PEOPLE; HOME VISITS; INTERDISCIPLINARY INTERVENTION; MANAGEMENT INTERVENTION; INTEGRATED CARE; MISSING DATA	Objective To evaluate the cost-effectiveness of nurse-led multifactorial care to prevent or postpone new disabilities in community-living older people in comparison with usual care. Methods We conducted cost-effectiveness and cost-utility analyses alongside a cluster randomized trial with one-year follow-up. Participants were aged >= 70 years and at increased risk of functional decline. Participants in the intervention group (n = 1209) received a comprehensive geriatric assessment and individually tailored multifactorial interventions coordinated by a community-care registered nurse with multiple follow-up visits. The control group (n = 1074) received usual care. Costs were assessed from a healthcare perspective. Outcome measures included disability (modified Katz-Activities of Daily Living (ADL) index score), and quality-adjusted life-years (QALYs). Statistical uncertainty surrounding Incremental Cost-Effectiveness Ratios (ICERs) was estimated using bootstrapped bivariate regression models while adjusting for confounders. Results There were no statistically significant differences in Katz-ADL index score and QALYs between the two groups. Total mean costs were significantly higher in the intervention group (EUR 6518 (SE 472) compared with usual care (EUR 5214 (SE 338); adjusted mean difference (sic) 1457 (95% CI: 572; 2537). Cost-effectiveness acceptability curves showed that the maximum probability of the intervention being cost-effective was 0.14 at a willingness to pay (WTP) of EUR 50,000 per one point improvement on the Katz-ADL index score and 0.04 at a WTP of EUR 50,000 per QALY gained. Conclusion The current intervention was not cost-effective compared to usual care to prevent or postpone new disabilities over a one-year period. Based on these findings, implementation of the evaluated multifactorial nurse-led care model is not to be recommended.	[Suijker, Jacqueline J.; van Charente, Eric P. Moll] Acad Med Ctr, Dept Gen Practice, Amsterdam, Netherlands; [MacNeil-Vroomen, Janet L.; van Rijn, Marjon; Buurman, Bianca M.; de Rooij, Sophia E.] Acad Med Ctr, Dept Internal Med, Geriatr Med Sect, Amsterdam, Netherlands; [de Rooij, Sophia E.] Univ Groningen, Univ Med Ctr Groningen, Univ Ctr Geriatr Med, Groningen, Netherlands; [Bosmans, Judith E.] Vrije Univ Amsterdam, Dept Hlth Sci, Amsterdam, Netherlands; [Bosmans, Judith E.] Vrije Univ Amsterdam, EMGO Inst Hlth & Care Res, Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Groningen; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	Suijker, JJ (corresponding author), Acad Med Ctr, Dept Gen Practice, Amsterdam, Netherlands.	b.m.vanes@amc.uva.nl	Vroomen, Janet MacNeil/M-5358-2017	Vroomen, Janet MacNeil/0000-0001-6400-7189; Bosmans, Judith/0000-0002-1443-1026	ZonMW 'The Netherlands Organization for Health Research and Development' (ZonMw) [313020201]; Dutch National Care for the Elderly Programme	ZonMW 'The Netherlands Organization for Health Research and Development' (ZonMw); Dutch National Care for the Elderly Programme	This work was supported by ZonMW 'The Netherlands Organization for Health Research and Development' (ZonMw no. 313020201) and was part of the Dutch National Care for the Elderly Programme. http://www.zonmw.nl/en/.	Beaton K, 2014, GERIATRICS GERONTOLO; Bernabei R, 1998, BMJ-BRIT MED J, V316, P1348, DOI 10.1136/bmj.316.7141.1348; Beswick AD, 2008, LANCET, V371, P725, DOI 10.1016/S0140-6736(08)60342-6; Blom J, 2016, AGE AGEING, V45, P30, DOI 10.1093/ageing/afv174; Bouman A, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-74; Boumans CAM, 2010, HANDLEIDING KOSTENON; Brooks R, 1996, HEALTH POLICY, V37, P53, DOI 10.1016/0168-8510(96)00822-6; Centraal Bureau voor de Statistiek, 2010, PRIJS; Cesari M, 2014, J GERONTOLOGY A; Counsell SR, 2009, J AM GERIATR SOC, V57, P1420, DOI 10.1111/j.1532-5415.2009.02383.x; Department of Health, 2001, NATIONAL SERVICE FRA; Drubbel I., 2013, FRAILTY SCREENING OL; Dutch College of General Practitioners, 2011, COR VAL GEN PRACT UT; Eekhout I, 2014, J CLIN EPIDEMIOL, V67, P335, DOI 10.1016/j.jclinepi.2013.09.009; Eklund K, 2009, HEALTH SOC CARE COMM, V17, P447, DOI 10.1111/j.1365-2524.2009.00844.x; Elkan R, 2001, BMJ-BRIT MED J, V323, P719, DOI 10.1136/bmj.323.7315.719; Fairhall N, 2015, J AM MED DIR ASSOC, V16, P41, DOI 10.1016/j.jamda.2014.07.006; Fairhall N, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-120; Faria R, 2014, PHARMACOECONOMICS, V32, P1157, DOI 10.1007/s40273-014-0193-3; Fenwick E, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-52; Fried LP, 2004, J GERONTOL A-BIOL, V59, P255; Groessl EJ, 2007, AM J PREV MED, V33, P214, DOI 10.1016/j.amepre.2007.04.031; Hardy SE, 2006, J GERONTOL A-BIOL, V61, P272, DOI 10.1093/gerona/61.3.272; Health Counsil of the Netherlands, 2008, HLTH CAR ELD MULT; Hebert R, 2010, J GERONTOL B-PSYCHOL, V65, P107, DOI 10.1093/geronb/gbp027; Huss A, 2008, J GERONTOL A-BIOL, V63, P298, DOI 10.1093/gerona/63.3.298; Jones R, 2004, FAM PRACT, V21, P597, DOI 10.1093/fampra/cmh603; Kehusmaa S, 2010, J REHABIL MED, V42, P949, DOI 10.2340/16501977-0623; Lamers LM, 2005, NED TIJDSCHR GENEES, V149, P1574; Latour CHM, 2007, J PSYCHOSOM RES, V62, P363, DOI 10.1016/j.jpsychores.2006.10.016; Lin Jennifer S, 2012, J Am Geriatr Soc, V60, P2157, DOI 10.1111/j.1532-5415.2012.04214.x; Looman WM, 2016, FAMILY PRACTICE; Lutomski JE, 2015, J CLIN EPIDEMIOLOGY; Markle-Reid M, 2006, MED CARE RES REV, V63, P531, DOI 10.1177/1077558706290941; Mayo-Wilson E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089257; Melis RJF, 2008, J GERONTOL A-BIOL, V63, P275, DOI 10.1093/gerona/63.3.275; Metzelthin SF, 2015, AGE AGEING, V44, P390, DOI 10.1093/ageing/afu200; Rechel B., 2010, CAN HLTH SYSTEMS RES; Rechel B, 2013, LANCET, V381, P1312, DOI 10.1016/S0140-6736(12)62087-X; RUBIN DB, 1976, BIOMETRIKA, V63, P581, DOI 10.2307/2335739; Stuck AE, 2000, ARCH INTERN MED, V160, P977, DOI 10.1001/archinte.160.7.977; Stuck AE, 2002, JAMA-J AM MED ASSOC, V287, P1022, DOI 10.1001/jama.287.8.1022; Stuck AE, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001889; Suijker JJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158714; Suijker JJ, 2014, J CLIN EPIDEMIOL, V67, P1121, DOI 10.1016/j.jclinepi.2014.05.014; Suijker JJ, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-85; van Dalen MT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093372; van Hout HPJ, 2010, J GERONTOL A-BIOL, V65, P734, DOI 10.1093/gerona/glq037; van Leeuwen KM, 2015, J AM GERIATR SOC, V63, P2494, DOI 10.1111/jgs.13834; van Leeuwen KM, 2015, VALUE HEALTH, V18, P35, DOI 10.1016/j.jval.2014.09.006; van Rijn M, 2016, AGE AGEING, V45, P894, DOI 10.1093/ageing/afw157; WEINBERGER M, 1992, J AM GERIATR SOC, V40, P585, DOI 10.1111/j.1532-5415.1992.tb02107.x; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067; Williamson EJ, 2014, RESPIROLOGY, V19, P303, DOI 10.1111/resp.12238	54	7	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2017	12	4							e0175272	10.1371/journal.pone.0175272	http://dx.doi.org/10.1371/journal.pone.0175272			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES9KD	28414806	Green Submitted, Green Published, gold			2022-12-27	WOS:000399874800019
J	Argy, N; Kendjo, E; Auge-Courtoi, C; Cojean, S; Clain, J; Houze, P; Thellier, M; Hubert, V; Deloron, P; Houze, S				Argy, Nicolas; Kendjo, Eric; Auge-Courtoi, Claire; Cojean, Sandrine; Clain, Jerome; Houze, Pascal; Thellier, Marc; Hubert, Veronique; Deloron, Philippe; Houze, Sandrine		CNRP Study Grp	Influence of host factors and parasite biomass on the severity of imported Plasmodium falciparum malaria	PLOS ONE			English	Article							ENDOTHELIAL ACTIVATION; INTENSIVE-CARE; RISK-FACTORS; ADULTS; MANIFESTATIONS; ADHESION; IMMUNITY; CELLS	Objectives Imported malaria in France is characterized by various clinical manifestations observed in a heterogeneous population of patients such as travelers/expatriates and African migrants. In this population, host factors and parasite biomass associated with severe imported malaria are poorly known. Methods From data collected by the Centre National de Reference du Paludisme, we identified epidemiological, demographic and biological features including parasite biomass and anti-plasmodial antibody levels (negative, positive and strongly positive serology) associated with different disease severity groups (very severe, moderately severe, and uncomplicated malaria) in 3 epidemiological groups (travelers/expatriates, first-and second-generation migrants). Results Age, ethnicity, absence of prior infection with P. falciparum, antibody levels, plasma PfHRP2 levels, total and circulating parasite biomass were related to severe malaria onset. Sequestered parasite biomass tended to be increased in very severe malaria, and was strongly correlated to the antibody level of the host. Conclusions Prior exposure to P. falciparum is associated with high anti-plasmodial antibody levels which influence clinical presentation of imported malaria and its correlated circulating and sequestered parasite burden.	[Argy, Nicolas; Houze, Sandrine] Hop Bichat Claude Bernard, AP HP, Lab Parasitol, Paris, France; [Argy, Nicolas; Kendjo, Eric; Cojean, Sandrine; Clain, Jerome; Hubert, Veronique; Houze, Sandrine] Hop Bichat Claude Bernard, AP HP, Ctr Natl Reference Paludisme, Paris, France; [Argy, Nicolas; Auge-Courtoi, Claire; Clain, Jerome; Houze, Pascal; Deloron, Philippe; Houze, Sandrine] Univ Paris 05, COMUE Sorbonne Paris Cite, Fac Pharm, Paris, France; [Argy, Nicolas; Auge-Courtoi, Claire; Clain, Jerome; Deloron, Philippe; Houze, Sandrine] Inst Rech Dev, UMR MERIT 216, Paris, France; [Houze, Pascal] Hop St Louis, AP HP, Lab Pharmacol, Paris, France; [Thellier, Marc] Hop La Pitie Salpetriere, AP HP, Lab Parasitol, Paris, France; [Thellier, Marc] Univ Paris 06, Fac Med, COMUE Sorbonne Paris Cite, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite	Argy, N (corresponding author), Hop Bichat Claude Bernard, AP HP, Lab Parasitol, Paris, France.; Argy, N (corresponding author), Hop Bichat Claude Bernard, AP HP, Ctr Natl Reference Paludisme, Paris, France.; Argy, N (corresponding author), Univ Paris 05, COMUE Sorbonne Paris Cite, Fac Pharm, Paris, France.; Argy, N (corresponding author), Inst Rech Dev, UMR MERIT 216, Paris, France.	nicolas.argy@gmail.com	Kamaliddin, Claire/ABD-1836-2021; KENDJO, Eric/AAI-7830-2021; Deloron, Philippe/G-6305-2010; Thellier, Marc/AAI-3311-2021; sandrine, houze/M-3260-2017	Kamaliddin, Claire/0000-0001-8198-6235; KENDJO, Eric/0000-0002-2632-0964; Deloron, Philippe/0000-0003-4705-2484; Thellier, Marc/0000-0003-4867-2423; Cojean, Sandrine/0000-0001-6914-7957; sandrine, houze/0000-0001-9016-3847; Clain, Jerome/0000-0002-0232-5058; Argy, Nicolas/0000-0002-0458-2664	Sante Publique France	Sante Publique France	All the funding of support has been provided by Sante Publique France (https://www. santepubliquefrance.fr). This funding aims to support the Centre National de Reference du Paludisme in the exercise of their public health missions as the surveillance of imported malaria in metropolitan France and the malaria expertise diagnosis. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beales PF, 2000, T ROY SOC TROP MED H, V94, pS1; Bouchaud O, 2005, AM J TROP MED HYG, V72, P21, DOI 10.4269/ajtmh.2005.72.21; Bruneel F, 2003, AM J RESP CRIT CARE, V167, P684, DOI 10.1164/rccm.200206-631OC; Bruneel F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013236; Centre National de Reference du Paludisme pour la France metropolitaine, RAPP ANN 2015; Checkley AM, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2116; Cserti-Gazdewich CM, 2011, VOX SANG, V100, P99, DOI 10.1111/j.1423-0410.2010.01429.x; Cunnington AJ, 2013, J INFECTION, V67, P220, DOI 10.1016/j.jinf.2013.04.013; Dondorp AM, 2005, PLOS MED, V2, P788, DOI 10.1371/journal.pmed.0020204; Doolan DL, 2009, CLIN MICROBIOL REV, V22, P13, DOI 10.1128/CMR.00025-08; European Centre for Disease Prevention and Control, 2014, ANN EP REP; Goncalves BP, 2014, NEW ENGL J MED, V370, P1799, DOI [10.1056/NEJMoa1303944, 10.1056/NEJMc1407114]; Gonzalez A, 2009, AM J TROP MED HYG, V81, P595, DOI 10.4269/ajtmh.2009.08-0637; Gupta S, 1999, NAT MED, V5, P340, DOI 10.1038/6560; Hanson J, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0365-9; Haut Conseil de la sante publique, PLAC ART INJ TRAIT P; Hendriksen ICE, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001297; Kurtis JD, 2001, INFECT IMMUN, V69, P123, DOI 10.1128/IAI.69.1.123-128.2001; Lampah DA, 2014, INDONESIA J INFECT D, V211, P623; MACPHERSON GG, 1985, AM J PATHOL, V119, P385; Marchiafava E., 1894, 2 MONOGRAPHS MALAIRA, P1; Marks ME, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-118; Muhlberger N, 2003, CLIN INFECT DIS, V36, P990, DOI 10.1086/374224; Ndungu FM, 2013, EUR J IMMUNOL, V43, P2919, DOI 10.1002/eji.201343630; Phillips A, 2009, CLIN INFECT DIS, V48, P871, DOI 10.1086/597258; Rowe JA, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001082; Rubach MP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035985; Seringe E, 2011, EMERG INFECT DIS, V17, P807, DOI 10.3201/eid1705.101527; Smith JD, 2013, CELL MICROBIOL, V15, P1976, DOI 10.1111/cmi.12183; SNOUNOU G, 1993, MOL BIOCHEM PARASIT, V61, P315, DOI 10.1016/0166-6851(93)90077-B; SNOUNOU G, 1993, MOL BIOCHEM PARASIT, V58, P283, DOI 10.1016/0166-6851(93)90050-8; Societe de Pathologie Infectieuse de Langue Francaise, 2008, Med Mal Infect, V38, P68, DOI 10.1016/j.medmal.2007.11.009; Taylor SM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003327; TURNER GDH, 1994, AM J PATHOL, V145, P1057; World Health Organization, 2015, GUID TREATM MAL, Vthird	35	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2017	12	4							e0175328	10.1371/journal.pone.0175328	http://dx.doi.org/10.1371/journal.pone.0175328			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0MD	28410415	Green Published, gold, Green Submitted			2022-12-27	WOS:000399955600014
J	Moya, P; Molins, A; Martinez-Alberola, F; Muggia, L; Barreno, E				Moya, Patricia; Molins, Arantzazu; Martinez-Alberola, Fernando; Muggia, Lucia; Barreno, Eva			Unexpected associated microalgal diversity in the lichen Ramalina farinacea is uncovered by pyrosequencing analyses	PLOS ONE			English	Article							PHYLOGENETIC ANALYSES; TREBOUXIA MICROALGAE; COMMUNITIES; ALGAL; FUNGI; PARMELIACEAE; SPECIFICITY; COEXISTENCE; SELECTIVITY; SYMBIONT	The current literature reveals that the intrathalline coexistence of multiple microalgal taxa in lichens is more common than previously thought, and additional complexity is supported by the coexistence of bacteria and basidiomycete yeasts in lichen thalli. This replaces the old paradigm that lichen symbiosis occurs between a fungus and a single photobiont. The lichen Ramalina farinacea has proven to be a suitable model to study the multiplicity of microalgae in lichen thalli due to the constant coexistence of Trebouxia sp. TR9 and T. jamesii in long-distance populations. To date, studies involving phycobiont diversity within entire thalli are based on Sanger sequencing, but this method seems to underestimate the diversity. Here, we aim to analyze both the microalgal diversity and its community structure in a single thallus of the lichen R. farinacea by applying a 454 pyrosequencing approach coupled with a careful ad hoc-performed protocol for lichen sample processing prior to DNA extraction. To ascertain the reliability of the pyrosequencing results and the applied bioinformatics pipeline results, the thalli were divided into three sections (apical, middle and basal zones), and a mock community sample was used. The developed methodology allowed 40448 filtered algal reads to be obtained from a single lichen thallus, which encompassed 31 OTUs representative of different microalgae genera. In addition to corroborating the coexistence of the two Trebouxia sp. TR9 and T. jamesii taxa in the same thallus, this study showed a much higher microalgal diversity associated with the lichen. Along the thallus ramifications, we also detected variations in phycobiont distribution that might correlate with different micro environmental conditions. These results highlight R. farinacea as a suitable material for studying microalgal diversity and further strengthen the concept of lichens as multispecies microecosystems. Future analyses will be relevant to ecophysiological and evolutionary studies to understand the roles of the multiple photobionts in lichen symbioses.	[Moya, Patricia; Molins, Arantzazu; Martinez-Alberola, Fernando; Barreno, Eva] Univ Valencia, Fac CC Biol, Inst Cavanilles Biodiversidad & Biol Evolut, Dept Bot, Valencia, Spain; [Muggia, Lucia] Univ Trieste, Dept Life Sci, Trieste, Italy	University of Valencia; University of Trieste	Moya, P (corresponding author), Univ Valencia, Fac CC Biol, Inst Cavanilles Biodiversidad & Biol Evolut, Dept Bot, Valencia, Spain.	patricia.moya@uv.es	Moya, Patricia/AAU-6751-2021; Rodríguez, Eva Barreno/M-2525-2014	Moya, Patricia/0000-0003-0397-863X; Rodríguez, Eva Barreno/0000-0002-2622-4550	Excellence in Research, Generalitat Valenciana, Spain, EB [Prometeoll-2013/021]; Ministerio de Economia y Competitividad, Spain, EB [MINECO CGL2016-79158-P]	Excellence in Research, Generalitat Valenciana, Spain, EB; Ministerio de Economia y Competitividad, Spain, EB	This work was funded by the research projects Prometeoll-2013/021 (Excellence in Research, Generalitat Valenciana, Spain), EB; MINECO CGL2016-79158-P (Ministerio de Economia y Competitividad, Spain), EB. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth TD, 2015, ISME J, V9, P2261, DOI 10.1038/ismej.2015.39; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Alvarez R, 2012, J PLANT PHYSIOL, V169, P1797, DOI 10.1016/j.jplph.2012.07.005; Amend AS, 2010, MOL ECOL, V19, P5555, DOI 10.1111/j.1365-294X.2010.04898.x; Andrews S., 2010, FASTQC QUALITY CONTR; [Anonymous], RECENT ADV LICHENOLO; Aschenbrenner IA, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00180; Barreno E, 2008, GUIA MARCOLIQUENES E; Bates ST, 2012, LICHENOLOGIST, V44, P137, DOI 10.1017/S0024282911000648; Bates ST, 2011, APPL ENVIRON MICROB, V77, P1309, DOI 10.1128/AEM.02257-10; Biosca EG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160328; Casano LM, 2015, PLANT SCI, V236, P195, DOI 10.1016/j.plantsci.2015.04.003; Casano LM, 2011, ENVIRON MICROBIOL, V13, P806, DOI 10.1111/j.1462-2920.2010.02386.x; Catala S, 2016, MOL PHYLOGENET EVOL, V94, P765, DOI 10.1016/j.ympev.2015.10.021; Catala S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119311; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Dal Grande F, 2014, MOL PHYLOGENET EVOL, V72, P54, DOI 10.1016/j.ympev.2013.12.010; Del Campo EM, 2010, BIBL LICHENOL, V105, P247; del Campo EM, 2010, MOL PHYLOGENET EVOL, V54, P437, DOI 10.1016/j.ympev.2009.10.024; del Campo EM, 2013, FEMS MICROBIOL ECOL, V83, P310, DOI 10.1111/j.1574-6941.2012.01474.x; del Hoyo A, 2011, ANN BOT-LONDON, V107, P109, DOI 10.1093/aob/mcq206; Dupont AOC, 2016, ENVIRON MICROBIOL, V18, P2010, DOI 10.1111/1462-2920.13220; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; GarciaBreijo F, 2011, B CIENCIAS NATURALES, V51, P325; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Grube M, 2015, ISME J, V9, P412, DOI 10.1038/ismej.2014.138; Helms G., 2003, THESIS; Herrera-Campos MA, 22 C SLI SOC LICH IT; Hodkinson BP, 2012, ENVIRON MICROBIOL, V14, P147, DOI 10.1111/j.1462-2920.2011.02560.x; Leavitt SD, 2015, MOL ECOL, V24, P3779, DOI 10.1111/mec.13271; Lexerod NL, 2006, FOREST ECOL MANAG, V222, P17, DOI 10.1016/j.foreco.2005.10.046; Margulis L, 2003, BIOSCIENCE, V53, P776, DOI DOI 10.1641/0006-3568(2003)053[0776:LAL]2.0.CO;2; Mark K, 2016, GENOME, V59, P685, DOI 10.1139/gen-2015-0189; Meiser A, 2014, NEW PHYTOL, V201, P623, DOI 10.1111/nph.12532; Molins Arantxa, 2013, Vieraea, V41, P349; Montano Garcia J., 2014, THESIS; Muggia L, 2016, FUNGAL DIVERS, V76, P119, DOI 10.1007/s13225-015-0343-8; Muggia L, 2014, ANN BOT-LONDON, V114, P463, DOI 10.1093/aob/mcu146; Muggia L, 2013, FEMS MICROBIOL ECOL, V85, P313, DOI 10.1111/1574-6941.12120; Muggia L, 2010, SYMBIOSIS, V51, P149, DOI 10.1007/s13199-010-0060-8; Park CH, 2015, J EUKARYOT MICROBIOL, V62, P196, DOI 10.1111/jeu.12159; Pessi IS, 2016, J PHYCOL, V52, P356, DOI 10.1111/jpy.12399; Piercey-Normore MD, 2001, AM J BOT, V88, P1490, DOI 10.2307/3558457; Puillandre N, 2012, MOL ECOL, V21, P1864, DOI 10.1111/j.1365-294X.2011.05239.x; Samo A, 2008, INTRO PRACTICA ECOLO; SANDERS W, 1989, AM J BOT, V76, P666, DOI 10.2307/2444414; Sanders WB, 2015, LICHENOLOGIST, V47, P51, DOI 10.1017/S0024282914000504; Sanders WB, 2012, AM J BOT, V99, P998, DOI 10.3732/ajb.1100287; Shakya M, 2013, ENVIRON MICROBIOL, V15, P1882, DOI 10.1111/1462-2920.12086; Skaloud P, 2015, J PHYCOL, V51, P507, DOI 10.1111/jpy.12295; Skaloud P, 2010, MOL PHYLOGENET EVOL, V54, P36, DOI 10.1016/j.ympev.2009.09.035; Spribille T, 2016, SCIENCE, V353, P488, DOI 10.1126/science.aaf8287; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stewart FJ, 2009, ENVIRON MICROBIOL, V11, P2136, DOI 10.1111/j.1462-2920.2009.01933.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; U'Ren JM, 2014, MOL ECOL RESOUR, V14, P1032, DOI 10.1111/1755-0998.12252; U'Ren JM, 2012, AM J BOT, V99, P898, DOI 10.3732/ajb.1100459; Ushio M, 2014, SOIL BIOL BIOCHEM, V76, P53, DOI 10.1016/j.soilbio.2014.05.010; Voytsekhovich A, 2015, SYMBIOSIS, P1; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Yang RH, 2015, FEMS MICROBIOL LETT, V362, DOI 10.1093/femsle/fnu044; Zhang T, SCI REPORT	62	60	60	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2017	12	4							e0175091	10.1371/journal.pone.0175091	http://dx.doi.org/10.1371/journal.pone.0175091			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0MD	28410402	Green Submitted, gold, Green Published			2022-12-27	WOS:000399955600011
J	Cai, L; Wang, YH; Gao, H; Li, YQ; Luo, XY				Cai, Li; Wang, Yongheng; Gao, Hao; Li, Yiqiang; Luo, Xiaoyu			A mathematical model for active contraction in healthy and failing myocytes and left ventricles	PLOS ONE			English	Article							HEART-FAILURE; ACTION-POTENTIALS; TRANSMURAL HETEROGENEITY; MYOCARDIAL-INFARCTION; CARDIAC MYOCYTES; SIMULATION; THERAPY; STRAIN; REPOLARIZATION; DYSFUNCTION	Cardiovascular disease is one of the leading causes of death worldwide, in particular myocardial dysfunction, which may lead to heart failure eventually. Understanding the electromechanics of the heart will help in developing more effective clinical treatments. In this paper, we present a multi-scale electro-mechanics model of the left ventricle (LV). The Holzapfel-Ogden constitutive law was used to describe the passive myocardial response in tissue level, a modified Grandi-Pasqualini-Bers model was adopted to model calcium dynamics in individual myocytes, and the active tension was described using the Niederer-Hunter-Smith myofilament model. We first studied the electro-mechanics coupling in a single myocyte in the healthy and diseased left ventricle, and then the single cell model was embedded in a dynamic LV model to investigate the compensation mechanism of LV pump function due to myocardial dysfunction caused by abnormality in cellular calcium dynamics. The multi-scale LV model was solved using an in-house developed hybrid immersed boundary method with finite element extension. The predictions of the healthy LV model agreed well with the clinical measurements and other studies, and likewise, the results in the failing states were also consistent with clinical observations. In particular, we found that a low level of intracellular Ca2+ transient in myocytes can result in LV pump function failure even with increased myocardial contractility, decreased systolic blood pressure, and increased diastolic filling pressure, even though they will increase LV stroke volume. Our work suggested that treatments targeted at increased contractility and lowering the systolic blood pressure alone are not sufficient in preventing LV pump dysfunction, restoring a balanced physiological Ca2+ handling mechanism is necessary.	[Cai, Li; Wang, Yongheng; Li, Yiqiang] Northwestern Polytech Univ, NPU UoG Int Cooperat Lab Computat & Applicat Card, Xian, Shanxi Province, Peoples R China; [Gao, Hao; Luo, Xiaoyu] Univ Glasgow, Sch Math & Stat, Glasgow, Lanark, Scotland	Northwestern Polytechnical University; University of Glasgow	Cai, L (corresponding author), Northwestern Polytech Univ, NPU UoG Int Cooperat Lab Computat & Applicat Card, Xian, Shanxi Province, Peoples R China.; Gao, H (corresponding author), Univ Glasgow, Sch Math & Stat, Glasgow, Lanark, Scotland.	caili@nwpu.edu.cn; hao.gao@glasgow.ac.uk	Li, Cai/Y-7599-2018	Gao, Hao/0000-0001-6852-9435	National Natural Science Foundation of China [11471261, 11101333]; NPU Foundation for Fundamental Research; UK EPSRC [EP/N014642/1, EP/ 1029990/1]; British Heart Foundation [PG/ 14/64/31043]; Leverhulme Research Fellowship [RF-2015-510]; British Heart Foundation [PG/14/64/31043, FS/15/54/31639] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/N014642/1] Funding Source: researchfish; EPSRC [EP/N014642/1] Funding Source: UKRI	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NPU Foundation for Fundamental Research; UK EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); British Heart Foundation(British Heart Foundation); Leverhulme Research Fellowship(Leverhulme Trust); British Heart Foundation(British Heart Foundation); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	Cai L and Wang YH are funded by the National Natural Science Foundation of China (11471261, 11101333) and NPU Foundation for Fundamental Research. Gao H and Luo XY are funded by the UK EPSRC (EP/N014642/1 and EP/ 1029990/1) and the British Heart Foundation (PG/ 14/64/31043). In addition, Luo XY is funded by a Leverhulme Research Fellowship (RF-2015-510). The funders had role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Bers DM, 2006, J PHARMACOL SCI, V100, P315, DOI 10.1254/jphs.CPJ06001X; Cai L., 2013, P IET INT RAD C XIAN, P1; Cai L, 2015, SCIENTIA SINICA PHYS, V45; Cardona K, 2011, COMPUT CARDIOL CONF, V38, P461; Clancy CE, 2007, AM J PHYSIOL-HEART C, V292, pH66, DOI 10.1152/ajpheart.00312.2006; Clayton RH, 2008, PROG BIOPHYS MOL BIO, V96, P19, DOI 10.1016/j.pbiomolbio.2007.07.004; de Couto G, 2010, NAT REV CARDIOL, V7, P334, DOI 10.1038/nrcardio.2010.51; Doenst T, 2013, CIRC RES, V113, P709, DOI 10.1161/CIRCRESAHA.113.300376; Drouin E, 1998, J AM COLL CARDIOL, V32, P1063, DOI 10.1016/S0735-1097(98)00330-1; Elshrif MM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084401; Felker GM, 2001, AM HEART J, V142, P393, DOI 10.1067/mhj.2001.117606; Fenton F, 1998, CHAOS, V8, P20, DOI 10.1063/1.166311; Gao H, 2014, IMA J APPL MATH, V79, P978, DOI 10.1093/imamat/hxu029; Gao H, 2014, INT J NUMER METH BIO, V30, P1199, DOI 10.1002/cnm.2652; Genet M, 2014, J APPL PHYSIOL, V117, P142, DOI 10.1152/japplphysiol.00255.2014; GERDES AM, 1995, J MOL CELL CARDIOL, V27, P849, DOI 10.1016/0022-2828(95)90000-4; Gjuvsland AB, 2013, J PHYSIOL-LONDON, V591, P2055, DOI 10.1113/jphysiol.2012.248864; Gomez JF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103273; Grandi E, 2007, BIOPHYS J, V93, P3835, DOI 10.1529/biophysj.107.114868; Grandi E, 2010, J MOL CELL CARDIOL, V48, P112, DOI 10.1016/j.yjmcc.2009.09.019; Griffith BE, 2012, HYBRID FINITE DIFFER; Guo A, 2013, CARDIOVASC RES; Holzapfel GA, 2009, PHILOS T R SOC A, V367, P3445, DOI 10.1098/rsta.2009.0091; Hund TJ, 2004, CIRCULATION, V110, P3168, DOI 10.1161/01.CIR.0000147231.69595.D3; Janse MJ, 2004, CARDIOVASC RES, V61, P208, DOI 10.1016/j.cardiores.2003.11.018; Krishnamurthy A, 2013, J COMPUT PHYS, V244, P4, DOI 10.1016/j.jcp.2012.09.015; Li GR, 1999, AM J PHYSIOL-HEART C, V276, pH98, DOI 10.1152/ajpheart.1999.276.1.H98; Li GR, 2002, AM J PHYSIOL-HEART C, V283, pH1031, DOI 10.1152/ajpheart.00105.2002; Li GR, 1998, AM J PHYSIOL-HEART C, V275, pH369, DOI 10.1152/ajpheart.1998.275.2.H369; LUO CH, 1994, CIRC RES, V74, P1071, DOI 10.1161/01.RES.74.6.1071; Luo M, 2013, CIRC RES, V113, P690, DOI 10.1161/CIRCRESAHA.113.301651; Machackova J, 2006, CAN J CARDIOL, V22, P953, DOI 10.1016/S0828-282X(06)70315-4; Maltsev VA, 2007, EUR J HEART FAIL, V9, P219, DOI 10.1016/j.ejheart.2006.08.007; Mann DL, 2005, CIRCULATION, V111, P2837, DOI 10.1161/CIRCULATIONAHA.104.500546; Mielniczuk Lisa M, 2007, Congest Heart Fail, V13, P209, DOI 10.1111/j.1527-5299.2007.06624.x; Moller JE, 2006, CIRCULATION, V114, P438, DOI 10.1161/CIRCULATIONAHA.105.601005; Nabauer M, 1996, CIRCULATION, V93, P168, DOI 10.1161/01.CIR.93.1.168; Nash MP, 2000, J ELASTICITY, V61, P113, DOI 10.1023/A:1011084330767; Niederer SA, 2006, BIOPHYS J, V90, P1697, DOI 10.1529/biophysj.105.069534; O'Hara T, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002061; Pereon Y, 2000, AM J PHYSIOL-HEART C, V278, pH1908, DOI 10.1152/ajpheart.2000.278.6.H1908; PESKIN CS, 1972, J COMPUT PHYS, V10, P252, DOI 10.1016/0021-9991(72)90065-4; Petersen John W, 2008, Crit Care Med, V36, pS106, DOI 10.1097/01.CCM.0000296273.72952.39; Piacentino V, 2003, CIRC RES, V92, P651, DOI 10.1161/01.RES.0000062469.83985.9B; Piper S, 2014, EUR J HEART FAIL, V16, P827, DOI 10.1002/ejhf.123; Quarteroni A, 2017, COMPUT METHOD APPL M, V314, P345, DOI 10.1016/j.cma.2016.05.031; Smith N, 2011, INTERFACE FOCUS; Sutton MGS, 2000, CIRCULATION, V101, P2981, DOI 10.1161/01.CIR.101.25.2981; Taggart P, 2003, PROG BIOPHYS MOL BIO, V82, P243, DOI 10.1016/S0079-6107(03)00025-7; ten Tusscher KHWJ, 2004, AM J PHYSIOL-HEART C, V286, pH1573, DOI 10.1152/ajpheart.00794.2003; Trenor B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032659; Usyk TP, 2000, J ELASTICITY, V61, P143, DOI 10.1023/A:1010883920374; Wang HM, 2013, INT J NUMER METH BIO, V29, P83, DOI 10.1002/cnm.2497; Zile MR, 2004, NEW ENGL J MED, V350, P1953, DOI 10.1056/NEJMoa032566; Zima A.V., 2013, BIOPHYSICS FAILING H, P5	56	8	8	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2017	12	4							e0174834	10.1371/journal.pone.0174834	http://dx.doi.org/10.1371/journal.pone.0174834			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0MB	28406991	gold, Green Submitted, Green Accepted, Green Published			2022-12-27	WOS:000399955400016
J	Kim, SY; Bang, W; Choi, HG				Kim, So Young; Bang, Woojin; Choi, Hyo Geun			Analysis of the prevalence and associated factors of overactive bladder in adult Korean men	PLOS ONE			English	Article							URINARY-TRACT SYMPTOMS; QUALITY-OF-LIFE; RISK-FACTORS; UNITED-STATES; METABOLIC SYNDROME; PHYSICAL-ACTIVITY; POPULATION; IMPACT; WOMEN; INCONTINENCE	Overactive bladder (OAB) is a prevalent condition characterized by lower urinary tract symptoms (LUTS). Age, education, income, marital status, sleep, and emotional problems have been associated with OAB; however, conflicting results exist. The present study was conducted to estimate the prevalence of OAB and comprehensively analyze its associated factors in a large cross-sectional, population-based study. The data of 94,554 participants aged 19- 107 were analyzed from the Korean Community Health Survey (KCHS) of 2012. Data on marital status, physical activity, education level, occupation, body mass index (BMI), income level, sleep time, and stress level were retrieved for all enrolled participants. The overactive bladder symptom score (OABSS) was used to evaluate the presence and degree of OAB. Simple and multiple logistic regression analyses with complex sampling were used for the associations between various factors and the presence of OAB. Overall, OAB was present in approximately 2.9% of the participants. The prevalence of OAB increased with age and steeply increased after 60 years of age (adjusted odds ratio [AOR] for each 10 years = 1.70, 95% confidence interval [CI] = 1.61-1.80, P<0.001). The prevalence of OAB was lower in married than unmarried subjects (AOR = 0.59, 95% CI = 0.48-0.72, P<0.001). The prevalence of OAB was significantly different according to occupation Compared to manager, expert, specialist, clerk group, the prevalence of OAB was highest in unemployed group (AOR = 1.90, 95% CI = 1.55-2.32, P < 0.001). Being underweight was correlated with OAB (AOR = 1.29, 95% CI = 1.08-1.55, P = 0.018). Inadequate sleep showed a significant association with OAB (AOR = 1.13, 95% CI = 1.02-1.25 for <= 6 hours of sleep time and AOR = 1.53, 95% CI = 1.27-1.86 for >= 9 hours of sleep, P<0.001). Stress level showed a dose-dependent positive association with OAB [AOR (95% CI) = 3.91 (3.13-4.89) > 2.16 (1.88-2.48) > 1.39 (1.23-1.57) for severe stress > moderate stress > some stress, respectively, P<0.001]. A medical history of diabetes mellitus, hyperlipidemia, and/or cerebral stroke was significantly related to OAB. Approximately 2.9% of adult Korean men experienced OAB based on the OABSS. Unmarried status; occupation; being underweight; inadequate sleep; stress; and medical history of diabetes mellitus, hyperlipidemia, or cerebral stroke were significantly correlated with OAB.	[Kim, So Young] CHA Univ, CHA Bundang Med Ctr, Dept Otorhinolaryngol Head & Neck Surg, Seongnam, South Korea; [Bang, Woojin] Hallym Univ, Dept Urol, Sacred Heart Hosp, Anyang, South Korea; [Choi, Hyo Geun] Hallym Univ, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Anyang, South Korea	Pochon Cha University; Hallym University; Hallym University	Choi, HG (corresponding author), Hallym Univ, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Anyang, South Korea.	pupen@naver.com	Choi, Hyo Geun/K-4461-2019	Choi, Hyo Geun/0000-0003-1655-9549	National Research Foundation (NRF) of Korea [NRF-2015-R1D1A1A01060860]; Hallym University Sacred Heart Hospital [HURF-2016-38]	National Research Foundation (NRF) of Korea(National Research Foundation of Korea); Hallym University Sacred Heart Hospital	This work was supported in part by a research grant (NRF-2015-R1D1A1A01060860) from the National Research Foundation (NRF) of Korea and a Research Grant funded by Hallym University Sacred Heart Hospital (HURF-2016-38) to HGC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barozzi L, 2010, RADIOL MED, V115, P272, DOI 10.1007/s11547-010-0509-0; Bei B, 2016, SLEEP; Brubaker L, 2010, BJU INT, V105, P1283, DOI 10.1111/j.1464-410X.2009.09035.x; Bunn F, 2015, INT J CLIN PRACT, V69, P199, DOI 10.1111/ijcp.12518; Camoes J, 2015, UROL INT, V95, P373, DOI 10.1159/000437336; Chang SJ, 2015, NEUROUROL URODYNAM, V34, P123, DOI 10.1002/nau.22532; Cheung WW, 2010, INT J MED SCI, V7, P391; Choo MS, 2008, NEUROUROL URODYNAM, V27, P60, DOI 10.1002/nau.20458; Choo MS, 2007, INT UROGYNECOL J, V18, P1309, DOI 10.1007/s00192-007-0322-z; Chung HY, 2006, ANTIOXID REDOX SIGN, V8, P572, DOI 10.1089/ars.2006.8.572; Coyne KS, 2013, UROLOGY, V82, P799, DOI 10.1016/j.urology.2013.05.035; Coyne KS, 2012, UROLOGY, V80, P97, DOI 10.1016/j.urology.2012.03.039; Coyne KS, 2012, UROLOGY, V79, P95, DOI 10.1016/j.urology.2011.09.010; Dallosso HM, 2003, BJU INT, V92, P69, DOI 10.1046/j.1464-410X.2003.04271.x; de Boer TA, 2011, INT UROGYNECOL J, V22, P569, DOI 10.1007/s00192-010-1323-x; Drossaerts J, 2015, NEUROUROL URODYN; Echeverria-Esnal D, 2016, ENFERM INFEC MICR CL, V34, P213, DOI 10.1016/j.eimc.2015.06.012; Hirayama A, 2012, UROLOGY, V80, P71, DOI 10.1016/j.urology.2012.04.019; Homma Y, 2006, UROLOGY, V68, P318, DOI 10.1016/j.urology.2006.02.042; International Obesity TaskForce, 2000, AS PAC PERSP RED OB; Irwin DE, 2006, BJU INT, V97, P96, DOI 10.1111/j.1464-410X.2005.05889.x; Jo JK, 2012, KOREAN J UROL, V53, P541, DOI 10.4111/kju.2012.53.8.541; Kabra AT, 2015, J PEDIATR UROL, V11, DOI 10.1016/j.jpurol.2014.11.017; Kim JH, 2013, INT J CLIN PRACT, V67, P795, DOI 10.1111/ijcp.12080; Kinsey D, 2016, J HEALTH PSYCHOL, V21, P69, DOI 10.1177/1359105314522084; Kirby MG, 2010, NEUROUROL URODYNAM, V29, P1360, DOI 10.1002/nau.20892; Korea Centers for Disease Control and Prevention, 2013, COMM HLTH SURV; Korneyev IA, 2016, INT J IMPOT RES, V28, P74, DOI 10.1038/ijir.2016.8; Kregel KC, 2007, AM J PHYSIOL-REG I, V292, pR18, DOI 10.1152/ajpregu.00327.2006; Kumar V, 2005, CURR OPIN UROL, V15, P222, DOI 10.1097/01.mou.0000172393.52857.92; Lee KS, 2015, HEALTH QUAL LIFE OUT, V13, DOI 10.1186/s12955-015-0274-9; Lee YS, 2011, WORLD J UROL, V29, P185, DOI 10.1007/s00345-009-0490-1; Madhu C, 2015, UROL INT, V95, P478, DOI 10.1159/000438928; Maserejian NN, 2012, J UROLOGY, V188, P490, DOI 10.1016/j.juro.2012.03.128; McCabe MP, 2016, J SEX MED, V13, P144, DOI 10.1016/j.jsxm.2015.12.034; Migita K, 2016, GASTRIC CANCER, V19, P735, DOI 10.1007/s10120-015-0531-y; Milsom I, 2001, BJU INT, V87, P760, DOI 10.1046/j.1464-410x.2001.02228.x; Milsom I, 2012, UROLOGY, V80, P90, DOI 10.1016/j.urology.2012.04.004; OECD Project on Income Distribution and Poverty, 2009, WHAT AR EQ SCAL; Oh DH, 2013, J KOREAN MED SCI, V28, P128, DOI 10.3346/jkms.2013.28.1.128; Rim H, 2011, J KOREAN MED SCI, V26, P1409, DOI 10.3346/jkms.2011.26.11.1409; Sacco E, 2011, UROLOGIA J, V78, P241, DOI 10.5301/RU.2011.8886; Sakakibara R, 2014, INT J UROL, V21, P33, DOI 10.1111/iju.12288; Sakakibara R, 2013, LUTS, V5, P109, DOI 10.1111/luts.12018; Stewart WF, 2002, WORLD J UROL, V20, P327, DOI 10.1007/s00345-002-0301-4; Tannenbaum C, 2015, CLIN GERIATR MED, V31, P581, DOI 10.1016/j.cger.2015.06.007; Wang Y, 2011, COMPUT GRAPH FORUM, V30, DOI DOI 10.1007/S10096-011-1159-4; Wu EQ, 2005, J OCCUP ENVIRON MED, V47, P439, DOI 10.1097/01.jom.0000161744.21780.c1	48	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2017	12	4							e0175641	10.1371/journal.pone.0175641	http://dx.doi.org/10.1371/journal.pone.0175641			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0MB	28407021	Green Published, gold, Green Submitted			2022-12-27	WOS:000399955400076
J	Spaller, T; Groth, M; Glockner, G; Winckler, T				Spaller, Thomas; Groth, Marco; Gloeckner, Gernot; Winckler, Thomas			TRE5-A retrotransposition profiling reveals putative RNA polymerase III transcription complex binding sites on the Dictyostelium extrachromosomal rDNA element	PLOS ONE			English	Article							GENOME EVOLUTION; DISCOIDEUM GENOME; DNA-REPLICATION; MOBILE ELEMENTS; TARGET SITE; HUMAN-CELLS; INTEGRATION; GENES; SEQUENCE; INITIATION	The amoeba Dictyostelium discoideum has a haploid genome in which two thirds of the DNA encodes proteins. Consequently, the space available for selfish mobile elements to expand without excess damage to the host genome is limited. The non-long terminal repeat retrotran-sposon TRE5-A maintains an active population in the D. discoideum genome and apparently adapted to this gene-dense environment by targeting positions similar to 47 bp upstream of tRNA genes that are devoid of protein-coding regions. Because only similar to 24% of tRNA genes are associated with a TRE5-A element in the reference genome, we evaluated whether TRE5-A retrotransposition is limited to this subset of tRNA genes. We determined that a tagged TRE5-A element (TRE5-A(bsr)) integrated at 384 of 405 tRNA genes, suggesting that expansion of the current natural TRE5-A population is not limited by the availability of targets. We further observed that TRE5-A(bsr) targets the ribosomal 5S gene on the multicopy extrachromosomal DNA element that carries the ribosomal RNA genes, indicating that TRE5-A integration may extend to the entire RNA polymerase III (Pol III) transcriptome. We determined that both natural TRE5-A and cloned TRE5-A(bsr) retrotranspose to locations on the extrachromosomal rDNA element that contain tRNA gene-typical A/B box promoter motifs without displaying any other tRNA gene context. Based on previous data suggesting that TRE5-A targets tRNA genes by locating Pol III transcription complexes, we propose that A/B box loci reflect Pol III transcription complex assembly sites that possess a function in the biology of the extrachromosomal rDNA element.	[Spaller, Thomas; Winckler, Thomas] Univ Jena, Inst Pharm, Pharmaceut Biol, Jena, Germany; [Groth, Marco] Fritz Lipmann Inst, Leibniz Inst Age Res, Core Facil DNA Sequencing, Jena, Germany; [Gloeckner, Gernot] Univ Cologne, Inst Biochem 1, Med Fac, Cologne, Germany	Friedrich Schiller University of Jena; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); University of Cologne	Winckler, T (corresponding author), Univ Jena, Inst Pharm, Pharmaceut Biol, Jena, Germany.	t.winckler@uni-jena.de	Glöckner, Gernot/A-7800-2010; Spaller, Thomas/ABB-9787-2021	Glöckner, Gernot/0000-0002-9061-1061; Groth, Marco/0000-0002-9199-8990	German Research Foundation (Deutsche Forschungsgemeinschaft) [WI 1142/10-1]	German Research Foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG))	This work was supported by grant WI 1142/10-1 from the German Research Foundation (Deutsche Forschungsgemeinschaft; www.dfg.de).	BAKER RE, 1987, P NATL ACAD SCI USA, V84, P8768, DOI 10.1073/pnas.84.24.8768; Beck P, 2002, J MOL BIOL, V318, P273, DOI 10.1016/S0022-2836(02)00097-9; BENARD M, 1995, NUCLEIC ACIDS RES, V23, P1447, DOI 10.1093/nar/23.9.1447; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Boesler C, 2011, J BIOL CHEM, V286, P17693, DOI 10.1074/jbc.M110.208306; CHALKER DL, 1992, GENE DEV, V6, P117, DOI 10.1101/gad.6.1.117; Chisholm RL, 2006, NUCLEIC ACIDS RES, V34, pD423, DOI 10.1093/nar/gkj090; Chung T, 2007, MOL CELL BIOL, V27, P8492, DOI 10.1128/MCB.01173-07; Cordaux R, 2009, NAT REV GENET, V10, P691, DOI 10.1038/nrg2640; Costanzo G, 2001, MOL CELL BIOL, V21, P3166, DOI 10.1128/MCB.21.9.3166-3178.2001; Deininger PL, 2003, CURR OPIN GENET DEV, V13, P651, DOI 10.1016/j.gde.2003.10.013; Deshpande AM, 1996, SCIENCE, V272, P1030, DOI 10.1126/science.272.5264.1030; Devine SE, 1996, GENE DEV, V10, P620, DOI 10.1101/gad.10.5.620; Eichinger L, 2005, NATURE, V435, P43, DOI 10.1038/nature03481; Eickbush T.H., 2002, MOBILE DNA, P813; Eickbush TH, 2007, GENETICS, V175, P477, DOI 10.1534/genetics.107.071399; Feng QH, 1998, P NATL ACAD SCI USA, V95, P2083, DOI 10.1073/pnas.95.5.2083; Geiduschek EP, 2001, J MOL BIOL, V310, P1, DOI 10.1006/jmbi.2001.4732; Gilbert N, 2005, MOL CELL BIOL, V25, P7780, DOI 10.1128/MCB.25.17.7780-7795.2005; Glockner G, 2001, GENOME RES, V11, P585, DOI 10.1101/gr.GR-1622RR; Kazazian HH, 2004, SCIENCE, V303, P1626, DOI 10.1126/science.1089670; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kolosha VO, 2003, J BIOL CHEM, V278, P8112, DOI 10.1074/jbc.M210487200; Levin HL, 2011, NAT REV GENET, V12, P615, DOI 10.1038/nrg3030; LUAN DD, 1993, CELL, V72, P595, DOI 10.1016/0092-8674(93)90078-5; Martin SL, 2008, NUCLEIC ACIDS RES, V36, P5845, DOI 10.1093/nar/gkn554; MCKEOWN M, 1981, CELL, V24, P799, DOI 10.1016/0092-8674(81)90105-7; Mita P, 2016, CURR OPIN GENET DEV, V37, P90, DOI 10.1016/j.gde.2016.01.001; Moqtaderi Z, 2004, MOL CELL BIOL, V24, P4118, DOI 10.1128/MCB.24.10.4118-4127.2004; Moqtaderi Z, 2010, NAT STRUCT MOL BIOL, V17, P635, DOI 10.1038/nsmb.1794; Moran J.V., 2002, MOBILE DNA, P836; MUELLER PR, 1989, SCIENCE, V246, P780, DOI 10.1126/science.2814500; Ning ZM, 2001, GENOME RES, V11, P1725, DOI 10.1101/gr.194201; Noma KI, 2006, CELL, V125, P859, DOI 10.1016/j.cell.2006.04.028; Paruzynski A, 2010, NAT PROTOC, V5, P1379, DOI 10.1038/nprot.2010.87; Qi XJ, 2012, GENOME RES, V22, P681, DOI 10.1101/gr.131219.111; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; SCHUMANN G, 1994, MOL CELL BIOL, V14, P3074, DOI 10.1128/MCB.14.5.3074; Sekedat MD, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.8; SILVER J, 1989, J VIROL, V63, P1924, DOI 10.1128/JVI.63.5.1924-1928.1989; Siol O, 2006, MOL CELL BIOL, V26, P8242, DOI 10.1128/MCB.01348-06; Siol O, 2011, NUCLEIC ACIDS RES, V39, P6608, DOI 10.1093/nar/gkr261; Spaller T, 2016, MOBILE DNA-UK, V7, DOI 10.1186/s13100-016-0073-9; Sucgang R, 2003, NUCLEIC ACIDS RES, V31, P2361, DOI 10.1093/nar/gkg348; Szafranski K, 1999, MOL GEN GENET, V262, P772, DOI 10.1007/s004380051140; WELKER DL, 1985, MOL CELL BIOL, V5, P273, DOI 10.1128/MCB.5.2.273; Winckler T, 2005, CYTOGENET GENOME RES, V110, P288, DOI 10.1159/000084961; XIONG Y, 1990, EMBO J, V9, P3353, DOI 10.1002/j.1460-2075.1990.tb07536.x; Yieh L, 2000, J BIOL CHEM, V275, P29800, DOI 10.1074/jbc.M003149200	49	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2017	12	4							e0175729	10.1371/journal.pone.0175729	http://dx.doi.org/10.1371/journal.pone.0175729			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0MB	28406973	Green Published, gold			2022-12-27	WOS:000399955400088
J	Muschettl, G; Umbers, KDL; Herberstein, ME				Muschettl, Giselle; Umbers, Kate D. L.; Herberstein, Marie E.			Within-season variability of fighting behaviour in an Australian alpine grasshopper	PLOS ONE			English	Article							SEXUAL SELECTION; MATE CHOICE; COPULATION DURATION; SPERM PRECEDENCE; EGG DEVELOPMENT; FIELD CRICKETS; MATING STATUS; SEED BEETLE; BODY-SIZE; LIFE-SPAN	Throughout the breeding season, changing environmental and biological conditions can lead to variation in the reproductive landscape of many species. In alpine environments temperature is a key driver of behaviour for small ectotherms such as insects, but variable biotic factors such as mate quality and availability can also influence behaviour. Kosicuscola tristis is a small semelparous grasshopper of the Australian alpine region. In a rare behaviour among grasshoppers, K. tristis males engage in vigorous fights over access to females, involving mandible displays, kicking, biting and grappling. In this study we describe the variation in fighting behaviour of K. tristis throughout the breeding season and test several hypotheses related to temperature, body size, mating behaviour, and female quality. We show that K. tristis males are more aggressive toward each other at the end of the breeding season than at the beginning. This increased aggression is associated with decreased daily average temperatures (from similar to 20 degrees C to similar to 9 degrees C), decreased mating activity, increased female fecundity, and an unexpected trend toward an increase in female-to-male aggression. These results suggest that K. tristis is likely under increased selective pressure to time key life cycle events with favourable biological and climatic conditions. The stochastic nature of alpine environments combined with a relatively short life span and breeding season, as well as limited mating opportunities toward the end of the season may have contributed to the evolution of this extraordinary mating system.	[Muschettl, Giselle; Herberstein, Marie E.] Macquarie Univ, Dept Biol Sci, N Ryde, NSW, Australia; [Umbers, Kate D. L.] Western Sydney Univ, Sch Sci & Hlth, Richmond, NSW, Australia	Macquarie University; Western Sydney University	Muschettl, G (corresponding author), Macquarie Univ, Dept Biol Sci, N Ryde, NSW, Australia.	giselle.muschett@students.mq.edu.au	Herberstein, Marie/D-2042-2011	Herberstein, Marie/0000-0001-5071-2952	Macquarie University Higher Degree Research Scholarship; Australian Biological Resources Study [RF211-29]; Thredbo Sports	Macquarie University Higher Degree Research Scholarship; Australian Biological Resources Study; Thredbo Sports	GM was supported by the Macquarie University Higher Degree Research Scholarship, http://www.hdr.mq.edu.au; Funding provided by the Australian Biological Resources Study RF211-29, https://www.environment.gov.au/science/abrs/ grants; Partial funding provided by Thredbo Sports, https://www.thredbo.com.au/activities/winter-activities/leisure-centre/timetable/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMO SA, 1995, ANIM BEHAV, V49, P1491, DOI 10.1016/0003-3472(95)90070-5; Akman Olcay, 2008, Journal of Orthoptera Research, V17, P249, DOI 10.1665/1082-6467-17.2.249; ALCOCK J, 1994, ANNU REV ENTOMOL, V39, P1, DOI 10.1146/annurev.en.39.010194.000245; [Anonymous], 1957, GRASSHOPPERS LOCUSTS; Arnott G, 2008, ANIM BEHAV, V76, P529, DOI 10.1016/j.anbehav.2008.04.019; Arnqvist G, 2005, AM NAT, V165, pS26, DOI 10.1086/429350; Bale JS, 1996, EUR J ENTOMOL, V93, P369; Bale JS, 2002, GLOBAL CHANGE BIOL, V8, P1, DOI 10.1046/j.1365-2486.2002.00451.x; Berner D, 2004, ECOGRAPHY, V27, P733, DOI 10.1111/j.0906-7590.2005.04012.x; Bonduriansky R, 2001, BIOL REV, V76, P305, DOI 10.1017/S1464793101005693; Boulton RA, 2015, BIOL REV, V90, P599, DOI 10.1111/brv.12126; Briffa M, 2004, P ROY SOC B-BIOL SCI, V271, P373, DOI 10.1098/rspb.2003.2633; Briffa M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108491; Bryant SR, 1997, ECOL ENTOMOL, V22, P390, DOI 10.1046/j.1365-2311.1997.00082.x; Buckley LB, 2013, PHYSL RESPONSES SIMU, P1; BUTLIN RK, 1987, EVOLUTION, V41, P221, DOI 10.1111/j.1558-5646.1987.tb05785.x; Chapman RF, 2013, J CHEM INF MODEL, V5th; Cisneiros RA, 2012, J INSECT SCI, V12, DOI 10.1673/031.012.7901; CLUTTONBROCK TH, 1984, AM NAT, V123, P212, DOI 10.1086/284198; Cratsley CK, 2005, ETHOLOGY, V111, P89, DOI 10.1111/j.1439-0310.2004.01049.x; DAVEY KG, 1965, J EXP BIOL, V42, P373; DEARN JM, 1977, OECOLOGIA, V28, P67, DOI 10.1007/BF00346837; Del Castillo RC, 1999, EVOLUTION, V53, P209, DOI 10.1111/j.1558-5646.1999.tb05346.x; DENLINGER DL, 1986, ANNU REV ENTOMOL, V31, P239, DOI 10.1146/annurev.en.31.010186.001323; Dushimirimana S, 2012, BIOL OPEN, V1, P232, DOI 10.1242/bio.2012323; Edvardsson M, 2006, BEHAV ECOL, V17, P430, DOI 10.1093/beheco/arj045; Edward DA, 2011, TRENDS ECOL EVOL, V26, P647, DOI 10.1016/j.tree.2011.07.012; EMLEN ST, 1977, SCIENCE, V197, P215, DOI 10.1126/science.327542; ENQUIST M, 1987, J THEOR BIOL, V127, P187, DOI 10.1016/S0022-5193(87)80130-3; Ernsting G, 1997, ECOL ENTOMOL, V22, P32, DOI 10.1046/j.1365-2311.1997.00040.x; Fischer B, 2011, EVOLUTION, V65, P1221, DOI 10.1111/j.1558-5646.2010.01198.x; FOX CW, 1994, FUNCT ECOL, V8, P600, DOI 10.2307/2389921; Fox CW, 2003, FUNCT ECOL, V17, P811, DOI 10.1111/j.1365-2435.2003.00799.x; Garcia-Gonzalez F, 2004, BEHAV ECOL, V15, P23, DOI 10.1093/beheco/arg095; GREEN K, 1981, AUST WILDLIFE RES, V8, P349; GREENFIELD MD, 1993, ETHOLOGY, V95, P309, DOI 10.1111/j.1439-0310.1993.tb00480.x; Greenfield Michael D., 1997, P75, DOI 10.1017/CBO9780511721946.005; Hack MA, 1997, ANIM BEHAV, V53, P733, DOI 10.1006/anbe.1996.0310; HAMILTON LD, 1989, J TROP ECOL, V5, P159, DOI 10.1017/S0266467400003424; Hartmann R, 1999, J COMP PHYSIOL A, V184, P325, DOI 10.1007/s003590050330; Hatle JD, 2006, MECH AGEING DEV, V127, P883, DOI 10.1016/j.mad.2006.09.003; Higgins L, 2000, OECOLOGIA, V122, P51, DOI 10.1007/PL00008835; HIGHNAM KC, 1962, Q J MICROSC SCI, V103, P57; Hinn Jerry C., 2001, Journal of Orthoptera Research, V10, P147, DOI 10.1665/1082-6467(2001)010[0147:SNTILW]2.0.CO;2; Hoefler CD, 2009, ETHOLOGY, V115, P331, DOI 10.1111/j.1439-0310.2009.01627.x; Hofmann HA, 2001, ANIM BEHAV, V62, P337, DOI 10.1006/anbe.2001.1746; Hsu YY, 2006, BIOL REV, V81, P33, DOI 10.1017/S146479310500686X; JAKOBSSON S, 1995, ANIM BEHAV, V49, P235, DOI 10.1016/0003-3472(95)80172-3; Jarosik Vojtech, 2007, P205; Johansson F, 2001, ECOLOGY, V82, P1857, DOI 10.1890/0012-9658(2001)082[1857:LHPIAD]2.0.CO;2; KEY KHL, 1954, AUST J ZOOL, V2, P309, DOI 10.1071/ZO9540309; KLOWDEN MJ, 1991, J INSECT PHYSIOL, V37, P721, DOI 10.1016/0022-1910(91)90105-9; Kokko H, 2013, ENTOMOL EXP APPL, V146, P26, DOI 10.1111/j.1570-7458.2012.01296.x; LANDA K, 1992, EVOLUTION, V46, P121, DOI [10.1111/j.1558-5646.1992.tb01989.x, 10.2307/2409809]; LOPEZLEON MD, 1993, HEREDITY, V71, P539, DOI 10.1038/hdy.1993.173; LORCH PD, 1993, BEHAV ECOL SOCIOBIOL, V32, P303; Mariottini Y, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.9201; Maynard Smith J., 1982, pi; MCLAIN DK, 1987, BEHAV ECOL SOCIOBIOL, V20, P239, DOI 10.1007/BF00292176; Morbey YE, 2001, ECOL LETT, V4, P663, DOI 10.1046/j.1461-0248.2001.00265.x; Morbey YE, 2013, J THEOR BIOL, V339, P93, DOI 10.1016/j.jtbi.2013.05.009; Otte D, 1970, MISC PUB MUSEUM ZOOL, V1, P1; PARKER GA, 1974, J THEOR BIOL, V47, P223, DOI 10.1016/0022-5193(74)90111-8; Payne RJH, 1996, J THEOR BIOL, V183, P185, DOI 10.1006/jtbi.1996.0212; Pitcher TE, 2003, P ROY SOC B-BIOL SCI, V270, P1623, DOI 10.1098/rspb.2002.2280; Quinn GP, 2003, EXPT DESIGN DATA ANA; R Core Team, 2010, R LANG ENV STAT COMP; Regniere J, 2012, J INSECT PHYSIOL, V58, P634, DOI 10.1016/j.jinsphys.2012.01.010; Reinhardt K, 1999, J INSECT BEHAV, V12, P283, DOI 10.1023/A:1020854403805; Reinhardt K, 2000, PHYSIOL ENTOMOL, V25, P324, DOI 10.1046/j.1365-3032.2000.00200.x; Reinhardt K, 1999, P ROY SOC B-BIOL SCI, V266, P2003, DOI 10.1098/rspb.1999.0878; Reinhardt Klaus, 2001, Journal of Orthoptera Research, V10, P263, DOI 10.1665/1082-6467(2001)010[0263:DASMPI]2.0.CO;2; Seidelmann K, 2002, J INSECT PHYSIOL, V48, P991, DOI 10.1016/S0022-1910(02)00178-6; Simmons LW, 2001, MONOGRAPHS BEHAV ECO; Slatyer RA, 2015, ECOGRAPHY, V38, P001; Slatyer RA, 2012, BIOL REV, V87, P1, DOI 10.1111/j.1469-185X.2011.00182.x; SMITH JM, 1974, J THEOR BIOL, V47, P209, DOI 10.1016/0022-5193(74)90110-6; Switzer PV, 2002, J KANSAS ENTOMOL SOC, V75, P145; Tatarnic NJ, 2013, INVERTEBR SYST, V27, P307, DOI 10.1071/IS12072; Taylor PW, 2003, ANIM BEHAV, V65, P1195, DOI 10.1006/anbe.2003.2169; Thomas ML, 2011, BIOL REV, V86, P1, DOI 10.1111/j.1469-185X.2010.00130.x; Thornhill R., 1983, pi; Umbers KDL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121685; Umbers KDL, 2013, BEHAV ECOL SOCIOBIOL, V67, P439, DOI 10.1007/s00265-012-1464-7; Umbers KDL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049600; Umbers KDL, 2010, THESIS; Uvarov B. P., 1977, GRASSHOPPERS LOCUSTS, V2; Uvarov BP., 1966, GRASSHOPPERS LOCUSTS, V1; VANWINGERDEN WKRE, 1991, OECOLOGIA, V87, P417, DOI 10.1007/BF00634600; WANG GY, 1990, BEHAV ECOL SOCIOBIOL, V27, P191, DOI 10.1007/BF00180303; Watts PC, 2012, HEREDITY, V108, P236, DOI 10.1038/hdy.2011.63; Weir LK, 2011, AM NAT, V177, P167, DOI 10.1086/657918; Whitehouse MEA, 1997, BEHAV ECOL, V8, P663; WOLDA H, 1988, ANNU REV ECOL SYST, V19, P1, DOI 10.1146/annurev.es.19.110188.000245; ZUK M, 1987, CAN J ZOOL, V65, P1564, DOI 10.1139/z87-242; Zuk Marlene, 1997, P89, DOI 10.1017/CBO9780511721946.006	96	7	7	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2017	12	4							e0171697	10.1371/journal.pone.0171697	http://dx.doi.org/10.1371/journal.pone.0171697			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LZ	28403243	Green Published, gold			2022-12-27	WOS:000399955200002
J	Perez, P; Rodriguez-Peralvarez, M; Guerrero, L; Gonzalez, V; Sanchez, R; Centeno, M; Poyato, A; Briceno, J; Sanchez-Frias, M; Montero, JL; De la Mata, M				Perez, Pablo; Rodriguez-Peralvarez, Manuel; Guerrero, Lourdes; Gonzalez, Victor; Sanchez, Rafael; Centeno, Macarena; Poyato, Antonio; Briceno, Javier; Sanchez-Frias, Marina; Luis Montero, Jose; De la Mata, Manuel			Incidental hepatocellular carcinoma after liver transplantation: Prevalence, histopathological features and prognostic impact	PLOS ONE			English	Article							TUMOR CHARACTERISTICS; EXPLANTED LIVERS; RECURRENCE RATE; CIRRHOSIS; PRETRANSPLANTATION; EXPOSURE; LESIONS; SCORE	Background Incidental hepatocellular carcinoma (iHCC) is a histological finding after liver transplantation (LT) which relevance has been scarcely studied. Aims to describe the histopathological features of iHCC and to determine its prognostic impact in terms of tumor recurrence and overall survival. Methods Observational study including 451 consecutive adult LT patients (2000 -2013). Patients aged < 18, retransplanted or with early postoperative death were excluded. Median follow-up after LT was 58 months. Multiple Cox's regression was used to assess the prognostic impact of iHCC on tumor recurrence and mortality while controlling for potential confounders. Results 141 patients had known HCC before LT (31.3%). Among the remaining 310 patients, the prevalence of iHCC was 8.7% (n = 27). In the explanted liver, 36.2% of patients with known HCC and 25.9% of patients with iHCC trespassed Milan criteria (p = 0.30). Patients with known and iHCC had similar rates of multinodular disease (50.4% vs 55.6%; p = 0.62), macrovascular invasion (6.5% vs 3.7%; p = 0.58), microvascular invasion (12.9% vs 14.8%; p = 0.76) and moderate-poor tumor differentiation (53.9% vs 70.4%; p = 0.09). In the multivariate analysis, iHCC and known HCC had identical recurrence-free survival after controlling for histological features (RR = 1.06, 95% CI 0.36 - 3.14; p = 0.90). Cumulative 5-yearoverall survival rates were similar between patients with known and iHCC (65% vs 52.8% respectively; log rank p = 0.44), but significantly inferior as compared with patients without HCC (77.8%) (p = 0.002 and p = 0.007 respectively). Indeed, in the overall cohort, iHCC was an independent predictor of mortality (RR = 3.02; 95% CI 1.62 - 5.65; p = 0.001). Conclusion The risk of tumor recurrence after LT is similar in patients with iHCC and known HCC. A close imaging surveillance is strongly recommended for patients awaiting LT in order to detect HCC prior to LT, thus allowing for an adequate selection of candidates, prioritization and indication of bridging therapies.	[Perez, Pablo; Rodriguez-Peralvarez, Manuel; Guerrero, Lourdes; Gonzalez, Victor; Poyato, Antonio; Briceno, Javier; Luis Montero, Jose; De la Mata, Manuel] Reina Sofia Univ Hosp, Dept Hepatol & Liver Transplantat, Cordoba, Spain; [Rodriguez-Peralvarez, Manuel; Poyato, Antonio; Briceno, Javier; Luis Montero, Jose; De la Mata, Manuel] Maimonides Inst Biomed Res Cordoba IMIBIC, Cordoba, Spain; [Rodriguez-Peralvarez, Manuel; Poyato, Antonio; Luis Montero, Jose; De la Mata, Manuel] Inst Salud Carlos III, CIBERehd, Madrid, Spain; [Sanchez, Rafael; Centeno, Macarena; Sanchez-Frias, Marina] Reina Sofia Univ Hosp, Dept Pathol, Cordoba, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Instituto de Salud Carlos III; Hospital Universitario Reina Sofia - Cordoba	Rodriguez-Peralvarez, M (corresponding author), Reina Sofia Univ Hosp, Dept Hepatol & Liver Transplantat, Cordoba, Spain.; Rodriguez-Peralvarez, M (corresponding author), Maimonides Inst Biomed Res Cordoba IMIBIC, Cordoba, Spain.; Rodriguez-Peralvarez, M (corresponding author), Inst Salud Carlos III, CIBERehd, Madrid, Spain.	ropeml@hotmail.com	Rodríguez-Perálvarez, Manuel/AAO-8616-2021; Rodríguez-perálvarez, Manuel/AGR-2409-2022	Rodríguez-perálvarez, Manuel/0000-0002-1795-2919	Institute de Salud Carlos III [FIS PI14/01469]; FEDER; European Association for the Study of the Liver (EASL)	Institute de Salud Carlos III(Instituto de Salud Carlos III); FEDER(European Commission); European Association for the Study of the Liver (EASL)	The present project has been partially supported by the Institute de Salud Carlos III (FIS PI14/01469) and co-funded by FEDER. M. Rodriguez-Peralvarez is a recipient of the EASL physician scientist Fellowship awarded by the European Association for the Study of the Liver (EASL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelfattah MR, 2015, ANN TRANSPL, V20, P366, DOI 10.12659/AOT.893782; Adam R, 2012, J HEPATOL, V57, P675, DOI 10.1016/j.jhep.2012.04.015; Allard MA, 2015, J HEPATOL, V63, P83, DOI 10.1016/j.jhep.2015.01.023; Castillo E, 2009, TRANSPL P, V41, P219, DOI 10.1016/j.transproceed.2008.10.053; Cescon M, 2013, J HEPATOL, V58, P609, DOI 10.1016/j.jhep.2012.09.021; Cho CS, 2001, J GASTROINTEST SURG, V5, P594, DOI 10.1016/S1091-255X(01)80101-3; Chui AKK, 2003, TRANSPLANT P, V35, P350, DOI 10.1016/S0041-1345(02)04010-1; EDMONDSON HA, 1954, CANCER-AM CANCER SOC, V7, P462, DOI 10.1002/1097-0142(195405)7:3<462::AID-CNCR2820070308>3.0.CO;2-E; Geissler EK, 2016, TRANSPLANTATION, V100, P116, DOI 10.1097/TP.0000000000000965; Guerrero-Misas M, 2015, WORLD J HEPATOL, V7, P649, DOI 10.4254/wjh.v7.i4.649; Krinsky GA, 2001, RADIOLOGY, V219, P445, DOI 10.1148/radiology.219.2.r01ma40445; Libbrecht L, 2002, LIVER TRANSPLANT, V8, P749, DOI 10.1053/jlts.2002.34922; Llovet JM, 2012, J HEPATOL, V56, P908, DOI 10.1016/j.jhep.2011.12.001; Madaleno J, 2015, TRANSPL P, V47, P1051, DOI 10.1016/j.transproceed.2015.04.002; Marvin MR, 2015, LIVER TRANSPLANT, V21, P612, DOI 10.1002/lt.24098; Mazzaferro V, 1996, NEW ENGL J MED, V334, P693, DOI 10.1056/NEJM199603143341104; Mazzaferro V, 2009, LANCET ONCOL, V10, P35, DOI 10.1016/S1470-2045(08)70284-5; Mion F, 1996, GASTROENTEROLOGY, V111, P1587, DOI 10.1016/S0016-5085(96)70021-5; Mourad MM, 2015, EXP CLIN TRANSPLANT, V13, P333, DOI 10.6002/ect.2014.0266; Pawlotsky JM, 2015, J HEPATOL, V63, P199, DOI 10.1016/j.jhep.2015.03.025; Pinero F, 2014, ANN HEPATOL, V13, P211, DOI 10.1016/S1665-2681(19)30884-1; Raphe R, 2010, TRANSPL P, V42, P505, DOI 10.1016/j.transproceed.2010.01.034; Rodriguez-Peralvarez M, 2015, TRANSPL IMMUNOL, V33, P146, DOI 10.1016/j.trim.2015.09.002; Rodriguez-Peralvarez M, 2013, J HEPATOL, V59, P1193, DOI 10.1016/j.jhep.2013.07.012; Rodriguez-Peralvarez M, 2013, J HEPATOL, V58, P262, DOI 10.1016/j.jhep.2012.09.019; Rodriguez-Peralvarez M, 2013, ANN SURG ONCOL, V20, P325, DOI 10.1245/s10434-012-2513-1; Senkerikova R, 2014, TRANSPL P, V46, P1426, DOI 10.1016/j.transproceed.2014.03.010; Sotiropoulos GC, 2006, TRANSPLANTATION, V81, P531, DOI 10.1097/01.tp.0000198739.42548.3e; Taniguchi Michiko, 2012, Clin Transpl, P41; Tsochatzis E, 2013, LIVER INT, V33, P944, DOI 10.1111/liv.12144	30	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2017	12	4							e0175010	10.1371/journal.pone.0175010	http://dx.doi.org/10.1371/journal.pone.0175010			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LZ	28403219	gold, Green Submitted, Green Published			2022-12-27	WOS:000399955200029
J	Aass, C; Norheim, I; Eriksen, EF; Bornick, EC; Thorsby, PM; Pepaj, M				Aass, Cecilie; Norheim, Ingrid; Eriksen, Erik Fink; Bornick, Ellen Charlotte; Thorsby, Per Medboe; Pepaj, Milaim			Establishment of a tear protein biomarker panel differentiating between Graves' disease with or without orbitopathy	PLOS ONE			English	Article							HYPERTHYROIDISM; MANAGEMENT; OPHTHALMOPATHY; SEVERITY; FLUID	Background Graves' orbitopathy (GO) is an autoimmune inflammatory ocular complication and one of the most frequent manifestations of Graves' disease (GD). Clinical judgment of GO is subjective sometimes leading to clinical and therapeutic challenges. Better tools to diagnose this severe complication are warranted. Patients and methods The aim of the present study was to evaluate tear levels of LYZ, LACRT and AZGP1 in GD patients with or without GO, as possible biomarkers for GO. Tear samples were collected from GD patients with moderate-to-severe GO (n = 21) and no clinical signs of GO (n = 21). Additionally, 18 GD patients with mild GO and 9 patients without GO were included in a further part of the study. Results Tear levels of LYZ (p < 0.001), LACRT (p = 0.004) and AZGP1 (p = 0.001) were significantly elevated in GD patients with moderate-to-severe GO compared to GD patients without GO. The discriminatory power of the three biomarkers, combined in a panel was confirmed by ROC plot analysis, with an AUC value of 0.93 (sensitivity of 95%; specificity of 80%). Since LYZ showed the best performance in discriminating between GD patients with (moderateto- severe) and without GO (in combination with limited sample volume available), LYZ levels were also measured in tears from GD patients with mild GO and without GO. Significantly higher levels of LYZ were measured in GD patients with mild GO compared to those without GO (p = 0.003). Conclusions We have established a novel three-protein biomarker panel that is able to discriminate between GD patients with and without GO, which might aid in diagnostic evaluation of GO as well as an indicator for disease activity.	[Aass, Cecilie; Thorsby, Per Medboe; Pepaj, Milaim] Oslo Univ Hosp, Dept Med Biochem, Hormone Lab, Oslo, Norway; [Aass, Cecilie; Eriksen, Erik Fink] Univ Oslo, Inst Clin Med, Fac Med, Oslo, Norway; [Norheim, Ingrid; Eriksen, Erik Fink] Oslo Univ Hosp, Dept Endocrinol Morbid Obes & Prevent Med, Oslo, Norway; [Bornick, Ellen Charlotte] Oslo Univ Hosp, Univ Dept Ophthalmol, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; University of Oslo	Aass, C (corresponding author), Oslo Univ Hosp, Dept Med Biochem, Hormone Lab, Oslo, Norway.; Aass, C (corresponding author), Univ Oslo, Inst Clin Med, Fac Med, Oslo, Norway.	cecilaas@medisin.uio.no	Thorsby, Per Medbøe/A-1268-2017; Eriksen, Erik Fink/AAF-5056-2020	Thorsby, Per Medbøe/0000-0002-9615-1035; 	 [Helse SorOst 2013052]		This work was supported by a Grant from Helse SorOst 2013052. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aass C, 2016, CLIN ENDOCRINOL, P1; Abraham-Nordling M, 2008, EUR J ENDOCRINOL, V158, P823, DOI 10.1530/EJE-07-0877; Abraham-Nordling M, 2011, EUR J ENDOCRINOL, V165, P899, DOI 10.1530/EJE-11-0548; Bahn RS, 2010, NEW ENGL J MED, V362, P726, DOI 10.1056/NEJMra0905750; Baker GRC, 2006, ARCH OPHTHALMOL-CHIC, V124, P1451, DOI 10.1001/archopht.124.10.1451; Bartalena L, 2016, EUR THYROID J, V5, P9, DOI 10.1159/000443828; Bartalena L, 2014, J ENDOCRINOL INVEST, V37, P691, DOI 10.1007/s40618-014-0097-2; de Souza GA, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-8-r72; Eckstein AK, 2009, HORM METAB RES, V41, P456, DOI 10.1055/s-0029-1220935; Ginsberg J, 2003, CAN MED ASSOC J, V168, P575; Hassan MI, 2008, MOL CANCER RES, V6, P892, DOI 10.1158/1541-7786.MCR-07-2195; HEUFELDER AE, 1993, THYROID, V3, P297, DOI 10.1089/thy.1993.3.297; KHALIL HA, 1989, DOC OPHTHALMOL, V72, P329, DOI 10.1007/BF00153500; Matheis N, 2012, THYROID, V22, P1039, DOI 10.1089/thy.2012.0119; PERROS P, 1993, CLIN ENDOCRINOL, V38, P367, DOI 10.1111/j.1365-2265.1993.tb00516.x; Pfeilschifter J, 1996, CLIN ENDOCRINOL, V45, P477, DOI 10.1046/j.1365-2265.1996.8220832.x; Tanda ML, 2013, J CLIN ENDOCR METAB, V98, P1443, DOI 10.1210/jc.2012-3873; Tong L, 2015, J PROTEOMICS, V115, P36, DOI 10.1016/j.jprot.2014.12.002; Wiersinga WM, 2007, NAT CLIN PRACT ENDOC, V3, P396, DOI 10.1038/ncpendmet0497; Wiersinga WM, 2002, THYROID, V12, P855, DOI 10.1089/105072502761016476; World Med Assoc, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI 10.1001/jama.2013.281053; Zhou L, 2012, J PROTEOMICS, V75, P3877, DOI 10.1016/j.jprot.2012.04.053; Zhou L, 2009, J PROTEOME RES, V8, P4889, DOI 10.1021/pr900686s	23	10	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2017	12	4							e0175274	10.1371/journal.pone.0175274	http://dx.doi.org/10.1371/journal.pone.0175274			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KH	28419103	Green Published, gold, Green Submitted			2022-12-27	WOS:000399875200014
J	Park, DY; Kim, HC; Chung, JW; Hur, S; Kim, M; Lee, M; Jae, HJ				Park, Dae Yong; Kim, Hyo-Cheol; Chung, Jin Wook; Hur, Saebeom; Kim, Minuk; Lee, Myungsu; Jae, Hwan Jun			Cone-beam computed tomography with automated bone subtraction in preoperative embolization for pelvic bone tumors	PLOS ONE			English	Article							C-ARM CT; SOFT-TISSUE TUMORS; HEPATOCELLULAR-CARCINOMA; CHEMOEMBOLIZATION; EXTREMITIES; METASTASIS; GUIDANCE	Purpose To evaluate the usefulness of cone-beam computed tomography with automated bone subtraction (CBCT-ABS) in the preoperative embolization of hypervascular tumors located in the pelvic bone. Materials and methods This retrospective study included 26 patients with pelvic bone tumors who underwent preoperative embolization between January 2014 and October 2016. A CBCT-ABS scan was taken in a total of 17 patients (CBCT-ABS group), and only a series of digital subtraction angiographies (DSAs) was taken in the remaining 9 patients (DSA group). The percent devascularization, number of angiographic runs, total dose-area product (DAP), fluoroscopy time, interventional procedure time, operative time, and estimated blood loss were compared between the two groups using Mann-Whitney test. Results The percent devascularization, interventional procedure time, fluoroscopy time, operative time, and estimated blood loss were not statistically different between the two groups (p > 0.05). On the other hand, the number of angiographic runs in the CBCT-ABS group was significantly lower than that in the DSA group (p = 0.029). The total DAP of the CBCT-ABS group (mean, 17700.7 mu Gym(2)) was higher than that of the DSA group (mean, 8939.4 mu Gym(2)) (p = 0.002). Conclusions The use of CBCT-ABS during the preoperative embolization of pelvic bone tumors significantly reduces the number of angiographic runs at the cost of an increased radiation dose.	[Park, Dae Yong; Kim, Hyo-Cheol; Chung, Jin Wook; Hur, Saebeom; Kim, Minuk; Lee, Myungsu; Jae, Hwan Jun] Seoul Natl Univ Hosp, Dept Radiol, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital	Kim, HC; Chung, JW (corresponding author), Seoul Natl Univ Hosp, Dept Radiol, Seoul, South Korea.	angiointervention@gmail.com; chungjw@snu.ac.kr		Kim, Min Uk/0000-0003-0564-5724; Kim, Hyo-Cheol/0000-0002-6016-247X	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI15C1532]	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea	This research was supported by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant number: HI15C1532), http://www.khidi.or.kr. JW Chung received this fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barton PP, 1996, J VASC INTERV RADIOL, V7, P81, DOI 10.1016/S1051-0443(96)70738-8; Basile A, 2004, CARDIOVASC INTER RAD, V27, P495, DOI 10.1007/s00270-003-0147-1; Boruban S, 2007, DIAGN INTERV RADIOL, V13, P164; Choi WS, 2014, J VASC INTERV RADIOL, V25, P1380, DOI 10.1016/j.jvir.2014.02.028; Fukutomi M, 2001, EUR J GASTROEN HEPAT, V13, P1083, DOI 10.1097/00042737-200109000-00015; Kickuth R, 2008, AM J ROENTGENOL, V191, pW240, DOI 10.2214/AJR.07.4037; Kim HC, 2015, KOREAN J RADIOL, V16, P114, DOI 10.3348/kjr.2015.16.1.114; Kim W, 2015, ORTHOPEDICS, V38, pE99, DOI 10.3928/01477447-20150204-56; Kobayashi K, 2012, ACTA RADIOL, V53, P935, DOI 10.1258/ar.2012.120314; Kothary N, 2011, J VASC INTERV RADIOL, V22, P1535, DOI 10.1016/j.jvir.2011.07.008; Kwon JH, 2010, ACTA RADIOL, V51, P396, DOI 10.3109/02841851003660081; McKay T, 2016, J VASC INTERV RADIOL, V27, P52, DOI 10.1016/j.jvir.2015.09.016; Miller DL, 2009, RADIOLOGY, V253, P753, DOI 10.1148/radiol.2533090354; Owen Richard J T, 2010, Semin Intervent Radiol, V27, P111, DOI 10.1055/s-0030-1253510; Park SI, 2014, CARDIOVASC INTER RAD, V37, P1469, DOI 10.1007/s00270-013-0820-y; Shimohira M, 2016, ACTA RADIOL, V57, P457, DOI 10.1177/0284185115590435; Wallace MJ, 2009, J VASC INTERV RADIOL, V20, pS523, DOI 10.1016/j.jvir.2009.04.059	17	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2017	12	4							e0175907	10.1371/journal.pone.0175907	http://dx.doi.org/10.1371/journal.pone.0175907			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KH	28419147	Green Published, gold, Green Submitted			2022-12-27	WOS:000399875200052
J	Rodriguez, L; Bustamante, B; Huaroto, L; Agurto, C; Illescas, R; Ramirez, R; Diaz, A; Hidalgo, J				Rodriguez, Lourdes; Bustamante, Beatriz; Huaroto, Luz; Agurto, Cecilia; Illescas, Ricardo; Ramirez, Rafael; Diaz, Alberto; Hidalgo, Jose			A multi-centric Study of Candida bloodstream infection in Lima-Callao, Peru: Species distribution, antifungal resistance and clinical outcomes	PLOS ONE			English	Article							INTERNAL-MEDICINE WARDS; SUSCEPTIBILITY PROFILE; NOSOCOMIAL CANDIDEMIA; ELDERLY-PATIENTS; LATIN-AMERICA; EPIDEMIOLOGY; SURVEILLANCE; SPP.; HOSPITALS; MORTALITY	Background The incidence of candidemia is increasing in developing countries. Very little is known about the epidemiology of candidemia in Peru. The aim of this study is to describe the incidence, microbiology, clinical presentation and outcomes of Candida bloodstream infections in three Lima-Callao hospitals. Methods Candida spp. isolates were identified prospectively at participant hospitals between November 2013 and January 2015. Susceptibility testing for amphotericin B, fluconazole, posaconazole, voriconazole and anidulafungin was performed using broth microdilution method. Clinical information was obtained from medical records and evaluated. Results We collected information on 158 isolates and 157 patients. Median age of patients was 55.0 yrs., and 64.1% were males. Thirty-eight (24.2%) episodes of candidemia occurred in those < 18 yrs. The frequency of non-Candida albicans was 72.1%. The most frequently recovered species were C. albicans (n = 44, 27.8%), C. parapsilosis (n = 40, 25.3%), C. tropicalis (n = 39, 24.7%) and C. glabrata (n = 15, 9.5%). Only four isolates were resistant to fluconazole, 86.7% (n = 137) were susceptible and 17 were susceptible-dose dependent. Decreased susceptibility to posaconazole was also observed in three isolates, and one to voriconazole. All isolates were susceptible to anidulafungin and amphotericin B. The most commonly associated co-morbid conditions were recent surgery (n = 61, 38.9%), mechanical ventilation (n = 60, 38.2%) and total parenteral nutrition (n = 57, 36.3%). The incidence of candidemia by center ranged between 1.01 and 2.63 cases per 1,000 admissions, with a globalincidence of 2.04. Only 28.1% of cases received treatment within 72 hrs. of diagnosis. Overall, the 30-day survival was 60.4% (treated subjects, 67.4%; not-treated patients, 50.9%). Conclusions We found a very high proportion of non-albicans Candida species. Despite this, the decreased susceptibility/resistance to fluconazole was only 13.3% and not seen in the other antifungals. Overall, the incidence of candidemia mortality was high when compared to other international studies. It is possible, that the delay in initiating antifungal treatment contributed to the elevated mortality rate, in spite of low antifungal resistance.	[Rodriguez, Lourdes; Illescas, Ricardo; Ramirez, Rafael; Diaz, Alberto; Hidalgo, Jose] Guillermo Almenara Hosp, Lima, Peru; [Bustamante, Beatriz] Cayetano Heredia Univ, Inst Med Trop Alexander von Humboldt, Lima, Peru; [Huaroto, Luz] Dos de Mayo Hosp, Lima, Peru; [Agurto, Cecilia] Alberto Sabogal Hosp, Callao, Peru; [Rodriguez, Lourdes] Merck Sharp & Dohme Peru, Av Circunvalanc Club Golf Los Incas 134,Torre 2, Lima 33, Peru	Seguro Social de Salud del Peru; Universidad Peruana Cayetano Heredia	Rodriguez, L (corresponding author), Guillermo Almenara Hosp, Lima, Peru.; Rodriguez, L (corresponding author), Merck Sharp & Dohme Peru, Av Circunvalanc Club Golf Los Incas 134,Torre 2, Lima 33, Peru.	lourdesrod@gmail.com		Hidalgo, Jose/0000-0002-5789-3263; Bustamante, Beatriz/0000-0002-6826-5211; Huaroto Valdivia, Luz Maria/0000-0002-1197-7250	Merck Investigator-Initiated Studies Program of Merck Co., Inc. MISP [50384]	Merck Investigator-Initiated Studies Program of Merck Co., Inc. MISP	This study was supported by an independent medical grant from the Merck Investigator-Initiated Studies Program of Merck & Co., Inc. MISP #50384 awarded to Lourdes Rodriguez. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cortes JA, 2014, BRAZ J INFECT DIS, V18, P631, DOI 10.1016/j.bjid.2014.06.009; Barchiesi F, 2016, INFECTION, V44, P205, DOI 10.1007/s15010-015-0845-z; Bassetti M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127534; Bustamante B, 2014, J MED MICROBIOL, V63, P855, DOI 10.1099/jmm.0.071167-0; Cleveland AA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120452; Colombo AL, 2006, J CLIN MICROBIOL, V44, P2816, DOI 10.1128/JCM.00773-06; Colombo AL, 2013, REV IBEROAM MICOL, V30, P150, DOI 10.1016/j.riam.2013.05.008; De Rosa FG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125149; Doi AM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146909; Eliakim-Raz N, 2016, INT J INFECT DIS, V52, P49, DOI 10.1016/j.ijid.2016.09.018; Ghannoum MA, 2012, CLIN LAB STANDARDS; Godoy P, 2003, MEM I OSWALDO CRUZ, V98, P401, DOI 10.1590/S0074-02762003000300020; Guinea J, 2014, CLIN MICROBIOL INFEC, V20, P5, DOI 10.1111/1469-0691.12539; Li Y, 2016, MYCOPATHOLOGIA, V181, P485, DOI 10.1007/s11046-016-9997-3; Luzzati R, 2016, INFECTION, V44, P747, DOI 10.1007/s15010-016-0924-9; Luzzati R, 2015, AGING CLIN EXP RES, V27, P131, DOI 10.1007/s40520-014-0251-x; Meyer E, 2013, EUROSURVEILLANCE EUR, V18; Milazzo L, 2014, MYCOPATHOLOGIA, V178, P227, DOI 10.1007/s11046-014-9786-9; Nucci M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059373; Pappas PG, 2016, CLIN INFECT DIS, V62, pE1, DOI 10.1093/cid/civ933; Pfaller MA, 2012, J CLIN MICROBIOL, V50, P2846, DOI 10.1128/JCM.00937-12; Pfaller MA, 2011, J CLIN MICROBIOL, V49, P630, DOI 10.1128/JCM.02161-10; Pfaller MA, 2014, DIAGN MICR INFEC DIS, V79, P198, DOI 10.1016/j.diagmicrobio.2014.03.004; Pfaller MA, 2011, INT J ANTIMICROB AG, V38, P65, DOI 10.1016/j.ijantimicag.2011.02.016; Puig-Asensio M, 2014, CLIN MICROBIOL INFEC, V20, pO245, DOI 10.1111/1469-0691.12380; Rex JH, 2008, CLIN LAB STANDARDS; Riera F, 2014, Rev Fac Cien Med Univ Nac Cordoba, V71, P89; Rosenthal VD, 2006, ANN INTERN MED, V145, P582, DOI 10.7326/0003-4819-145-8-200610170-00007; Santolaya ME, 2014, PEDIATR INFECT DIS J, V33, pE40, DOI 10.1097/INF.0000000000000039; Santos ER, 2014, REV I MED TROP S PAU, V56; Servicio de Microbiologia Hospital Guillermo Almenara, 2009, REP DAT SUSC ANT; Servicio de Microbiologia Hospital Guillermo Almenara, RES ANT HOSP NAC GUI; Tak Vibhor, 2014, J Lab Physicians, V6, P96, DOI 10.4103/0974-2727.141506; Tan TY, 2016, MED MYCOL; Tang HJ, 2015, GERIATR GERONTOL INT, V15, P688, DOI 10.1111/ggi.12329; Tedeschi S, 2016, EUR J INTERN MED, V34, P39, DOI 10.1016/j.ejim.2016.08.020; Wille MP, 2013, MEM I O CRUZ, V108; Yang ZT, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-241	38	33	41	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2017	12	4							e0175172	10.1371/journal.pone.0175172	http://dx.doi.org/10.1371/journal.pone.0175172			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KH	28419092	Green Submitted, gold, Green Published			2022-12-27	WOS:000399875200012
J	Giofre, D; Cumming, G; Fresc, L; Boedker, I; Tressoldi, P				Giofre, David; Cumming, Geoff; Fresc, Luca; Boedker, Ingrid; Tressoldi, Patrizio			The influence of journal submission guidelines on authors' reporting of statistics and use of open research practices	PLOS ONE			English	Article							QUESTIONABLE RESEARCH PRACTICES; POWER; REPLICABILITY; FIELD	From January 2014, Psychological Science introduced new submission guidelines that encouraged the use of effect sizes, estimation, and meta-analysis (the "new statistics"), required extra detail of methods, and offered badges for use of open science practices. We investigated the use of these practices in empirical articles published by Psychological Science and, for comparison, by the Journal of Experimental Psychology: General, during the period of January 2013 to December 2015. The use of null hypothesis significance testing (NHST) was extremely high at all times and in both journals. In Psychological Science, the use of confidence intervals increased markedly overall, from 28% of articles in 2013 to 70% in 2015, as did the availability of open data (3 to 39%) and open materials (7 to 31%). The other journal showed smaller or much smaller changes. Our findings suggest that journal-specific submission guidelines may encourage desirable changes in authors' practices.	[Giofre, David] Liverpool John Moores Univ, Sch Nat Sci & Psychol, Liverpool, Merseyside, England; [Cumming, Geoff] La Trobe Univ, Sch Psychol & Publ Hlth, Melbourne, Vic, Australia; [Fresc, Luca; Tressoldi, Patrizio] Univ Padua, Dept Gen Psychol, Padua, Italy; [Boedker, Ingrid] Univ Liverpool, Inst Psychol Hlth & Soc, Liverpool, Merseyside, England	Liverpool John Moores University; La Trobe University; University of Padua; University of Liverpool	Giofre, D (corresponding author), Liverpool John Moores Univ, Sch Nat Sci & Psychol, Liverpool, Merseyside, England.	david.giofre@gmail.com	GIOFRE', DAVID/N-8808-2019; Tressoldi, Patrizio E./A-5566-2009	GIOFRE', DAVID/0000-0002-1992-6271; Tressoldi, Patrizio E./0000-0002-6404-0058; Boedker, Ingrid/0000-0003-4053-6486				Aarts AA, 2015, SCIENCE, V349, DOI 10.1126/science.aac4716; Agnoli F, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172792; Aleksic J, 2015, F1000RESEARCH; [Anonymous], 2016, PSYCHONOMIC B REV; APA, 2010, MANUAL OF THE AMERIC; Asendorpf JB, 2013, EUR J PERSONALITY, V27, P108, DOI 10.1002/per.1919; Bakker M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103360; Bakker M, 2014, PSYCHOL METHODS, V19, P409, DOI 10.1037/met0000014; Bakker M, 2011, BEHAV RES METHODS, V43, P666, DOI 10.3758/s13428-011-0089-5; Banks GC, 2016, J BUS PSYCHOL, V31, P323, DOI 10.1007/s10869-016-9456-7; Banks GC, 2016, J MANAGE, V42, P5, DOI 10.1177/0149206315619011; Cumming G, 2014, PSYCHOL SCI, V25, P7, DOI 10.1177/0956797613504966; Eich E, 2014, PSYCHOL SCI, V25, P3, DOI 10.1177/0956797613512465; Ferguson CJ, 2012, PERSPECT PSYCHOL SCI, V7, P555, DOI 10.1177/1745691612459059; Finch S., 2015, BEHAV RES METHODS, V36, P312; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; John LK, 2012, PSYCHOL SCI, V23, P524, DOI 10.1177/0956797611430953; Kidwell MC, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002456; Krawczyk M, 2012, ACCOUNT RES, V19, P175, DOI 10.1080/08989621.2012.678688; Loewenstein G, 2012, EC INFORM CAN, V43, P9; Nosek BA, 2015, SCIENCE, V348, P1422, DOI 10.1126/science.aab2374; Nuijten MB, 2016, BEHAV RES METHODS, V48, P1205, DOI 10.3758/s13428-015-0664-2; Pashler H, 2012, PERSPECT PSYCHOL SCI, V7, P528, DOI 10.1177/1745691612465253; Psychological Science, 2016, ISTRUCTIONS FOR AUTH; Sijtsma K, 2016, PSYCHOMETRIKA, V81, P1, DOI 10.1007/s11336-015-9446-0; Tishkovskaya S, 2012, J STAT EDUC, V20, DOI 10.1080/10691898.2012.11889641; Trafimow D, 2014, BASIC APPL SOC PSYCH, V36, P1, DOI [10.1080/01973533.2014.865505, 10.1080/01973533.2015.1064290]; Tressoldi PE, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00726; van Assen MALM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084896; Vankov I, 2014, Q J EXP PSYCHOL, V67, P1037, DOI 10.1080/17470218.2014.885986; Vanpaemel W., 2015, COLLABRA, V1, DOI [10.1525/COLLABRA.13, DOI 10.1525/COLLABRA.13, 10.1525/collabra.13]; Veldkamp CLS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114876; Wagenmakers EJ, 2011, J PERS SOC PSYCHOL, V100, P426, DOI 10.1037/a0022790; Wicherts JM, 2006, AM PSYCHOL, V61, P726, DOI 10.1037/0003-066X.61.7.726; Wicherts JM, 2012, INTELLIGENCE, V40, P73, DOI 10.1016/j.intell.2012.01.004; Wicherts JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026828; YourMorals collaboration, 2016, UNPUB	37	53	53	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2017	12	4							e0175583	10.1371/journal.pone.0175583	http://dx.doi.org/10.1371/journal.pone.0175583			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES9KD	28414751	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000399874800038
J	He, J; Yi, B; Chen, Y; Huang, Q; Wang, H; Lu, KZ; Fu, WL				He, Jing; Yi, Bin; Chen, Yang; Huang, Qing; Wang, Huan; Lu, Kaizhi; Fu, Weiling			The ET-1-mediated carbonylation and degradation of ANXA1 induce inflammatory phenotype and proliferation of pulmonary artery smooth muscle cells in HPS	PLOS ONE			English	Article							HEPATOPULMONARY SYNDROME; PROTEIN CARBONYLATION; ANNEXIN A1; CARDIOVASCULAR-DISEASE; CATALYZED OXIDATION; NADPH OXIDASE; ETB-RECEPTOR; RAT MODEL; ENDOTHELIN; HYPERTENSION	Hepatopulmonary syndrome (HPS) is a serious complication of advanced liver disease, which markedly increases mortality. Pulmonary vascular remodelling (PVR) induced by circulating mediators plays an important role in the pathogenesis of HPS, while the underlying mechanism remains undefined. In the present study, we reported that endothelin-1 (ET-1) is up-regulated and annexin A1(ANXA1) is down-regulated in HPS rat, and ET-1 decreases the ANXA1 expression in a dose-dependent manner in rat pulmonary arterial smooth muscle cells (PASMCs). Then, we showed that ANXA1 can decrease nuclear p-ERK1/2 accumulation and decrease the cyclin D1 expression, thus resulting in the subsequent inhibition of PASMCs proliferation. As previously reported, we confirmed that ET-1 decreases the ANXA1 protein levels by the carbonylation and degradation of ANXA1. In conclusion, our research links the signaling cascade of ET1-ANXA1-cell proliferation to a potential therapeutic strategy for blocking IPS-associated PVR.	[He, Jing; Yi, Bin; Chen, Yang; Lu, Kaizhi] Third Mil Med Univ, Southwest Hosp, Dept Anesthesia, Chongqing, Peoples R China; [Huang, Qing; Wang, Huan; Fu, Weiling] Third Mil Med Univ, Southwest Hosp, Dept Lab Med, Chongqing, Peoples R China	Army Medical University; Army Medical University	Lu, KZ (corresponding author), Third Mil Med Univ, Southwest Hosp, Dept Anesthesia, Chongqing, Peoples R China.; Fu, WL (corresponding author), Third Mil Med Univ, Southwest Hosp, Dept Lab Med, Chongqing, Peoples R China.	lukaizhi2010@163.com; fwl@tmmu.edu.cn	Huang, Qing/E-1872-2017; yi, bin/ABF-6425-2021; fu, weiling/AAX-3286-2021	Huang, Qing/0000-0002-0140-8978; yi, bin/0000-0001-5840-2086; fu, weiling/0000-0002-5768-6563	National Science Foundation of China (NSFC) [81670552, 81600035]; Science and Technology Foundation of Chongqing [cstc2016jcyjA0120]	National Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Science and Technology Foundation of Chongqing	This work is supported by grant nos. 81670552 (Bin Yi) and 81600035 (Yang Chen) from the National Science Foundation of China (NSFC) and cstc2016jcyjA0120 (Bin Yi) from the Science and Technology Foundation of Chongqing (http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelsaid M, 2014, LIFE SCI, V118, P268, DOI 10.1016/j.lfs.2014.01.008; AMICI A, 1989, J BIOL CHEM, V264, P3341; Anggrahini DW, 2009, CARDIOVASC RES, V82, P143, DOI 10.1093/cvr/cvp026; Aryal B, 2014, P NATL ACAD SCI USA, V111, P2011, DOI 10.1073/pnas.1321783111; Bizzarro V, 2012, J CELL PHYSIOL, V227, P3007, DOI 10.1002/jcp.24032; Bizzarro V, 2010, J CELL PHYSIOL, V224, P757, DOI 10.1002/jcp.22178; Brancaleone V, 2014, J PHARMACOL EXP THER, V351, P96, DOI 10.1124/jpet.114.217034; Chen Y, 2014, MOL BIOSYST, V10, P759, DOI 10.1039/c3mb70391f; Dalle-Donne I, 2006, J CELL MOL MED, V10, P389, DOI 10.1111/j.1582-4934.2006.tb00407.x; Dong F, 2005, BRIT J PHARMACOL, V145, P323, DOI 10.1038/sj.bjp.0706193; Duda M, 2007, J MOL CELL CARDIOL, V42, P400, DOI 10.1016/j.yjmcc.2006.10.014; Fang Y, 2016, MOL MED REP, V13, P3858, DOI 10.3892/mmr.2016.5022; KOMURO I, 1988, FEBS LETT, V238, P249, DOI 10.1016/0014-5793(88)80489-7; Lee H, 2016, PEDIATR RES, V80, P119, DOI 10.1038/pr.2016.38; Luscher TF, 2000, CIRCULATION, V102, P2434, DOI 10.1161/01.CIR.102.19.2434; Mandell M Susan, 2006, Clin Liver Dis, V10, P387, DOI 10.1016/j.cld.2006.05.007; Meliton AY, 2008, J LEUKOCYTE BIOL, V83, P344, DOI 10.1189/jlb.0707495; Morrow D, 2008, CIRC RES, V103, P1370, DOI 10.1161/CIRCRESAHA.108.187534; Park AM, 2010, HYPERTENSION, V56, P1145, DOI 10.1161/HYPERTENSIONAHA.110.160515; Pathak BR, 2016, MOL CELL BIOCHEM, V411, P11, DOI 10.1007/s11010-015-2564-2; Rautureau Y, 2012, CURR OPIN NEPHROL HY, V21, P128, DOI 10.1097/MNH.0b013e32834f0092; Rich S, 2003, CIRCULATION, V108, P2184, DOI 10.1161/01.CIR.0000094397.19932.78; Rodriguez-Roisin R, 2008, NEW ENGL J MED, V358, P2378, DOI 10.1056/NEJMra0707185; Schneider MP, 2007, ANNU REV PHARMACOL, V47, P731, DOI 10.1146/annurev.pharmtox.47.120505.105134; Sedeek MH, 2003, HYPERTENSION, V42, P806, DOI 10.1161/01.HYP.0000084372.91932.BA; Shikata F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094550; Shu MQ, 2008, EXP MOL PATHOL, V84, P206, DOI 10.1016/j.yexmp.2008.03.001; Sindhu S, 2007, INDIAN J PEDIATR, V74, P1127, DOI 10.1007/s12098-007-0213-9; Spagnolo P, 2010, J VIRAL HEPATITIS, V17, P381, DOI 10.1111/j.1365-2893.2010.01307.x; STADTMAN ER, 1990, FREE RADICAL BIO MED, V9, P315, DOI 10.1016/0891-5849(90)90006-5; Tanaki K, 2001, J AM COLL CARDIOL, V37, P676, DOI 10.1016/S0735-1097(00)01123-2; Wong CM, 2008, CIRC RES, V102, P310, DOI 10.1161/CIRCRESAHA.107.159814; Wong CM, 2010, ANTIOXID REDOX SIGN, V12, P393, DOI 10.1089/ars.2009.2805; Wong CM, 2013, ANTIOXID REDOX SIGN, V18, P1789, DOI 10.1089/ars.2012.4568; Wong CM, 2012, FREE RADICAL BIO MED, V53, P1738, DOI 10.1016/j.freeradbiomed.2012.08.576; Yang XR, 2012, AM J PHYSIOL-LUNG C, V302, pL555, DOI 10.1152/ajplung.00005.2011; Yang Y, 2015, LAB ANIM-UK, V49, P71, DOI 10.1177/0023677214558701; Yang YH, 2009, J IMMUNOL, V183, P1435, DOI 10.4049/jimmunol.0804000; Zhang JL, 2009, GASTROENTEROLOGY, V136, P1070, DOI 10.1053/j.gastro.2008.12.001	39	7	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2017	12	4							e0175443	10.1371/journal.pone.0175443	http://dx.doi.org/10.1371/journal.pone.0175443			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KD	28414743	Green Published, Green Submitted, gold			2022-12-27	WOS:000399874800026
J	Kuan, G; Morris, T; Terry, P				Kuan, Garry; Morris, Tony; Terry, Peter			Effects of music on arousal during imagery in elite shooters: A pilot study	PLOS ONE			English	Article							EXERCISE DOMAIN; RELAXATION	Beneficial effects of music on several performance-related aspects of sport have been reported, but the processes involved are not well understood. The purpose of the present study was to investigate effects of relaxing and arousing classical music on physiological indicators and subjective perceptions of arousal during imagery of a sport task. First, appropriate music excerpts were selected. Then, 12 skilled shooters performed shooting imagery while listening to the three preselected music excerpts in randomized order. Participants' galvanic skin response, peripheral temperature, and electromyography were monitored during music played concurrently with imagery. Subjective music ratings and physiological measures showed, as hypothesized, that unfamiliar relaxing music was the most relaxing and unfamiliar arousing music was the most arousing. Researchers should examine the impact of unfamiliar relaxing and arousing music played during imagery on subsequent performance in diverse sports. Practitioners can apply unfamiliar relaxing and arousing music with imagery to manipulate arousal level.	[Kuan, Garry] Univ Sains Malaysia, Sch Hlth Sci, Exercise & Sports Sci, Kubang Kerian, Kelantan, Malaysia; [Kuan, Garry; Morris, Tony] Victoria Univ, Coll Sport & Exercise Sci, Melbourne, Vic, Australia; [Kuan, Garry; Morris, Tony] Victoria Univ, Inst Sport Exercise & Act Living, Melbourne, Vic, Australia; [Terry, Peter] Univ Southern Queensland, Div Res & Innovat, Toowoomba, Qld, Australia	Universiti Sains Malaysia; Victoria University; Victoria University; University of Southern Queensland	Kuan, G (corresponding author), Univ Sains Malaysia, Sch Hlth Sci, Exercise & Sports Sci, Kubang Kerian, Kelantan, Malaysia.	garry@usm.my	Kuan, Garry/H-4450-2016	Kuan, Garry/0000-0003-1103-3871; Terry, Peter/0000-0002-7018-4533	Fundamental Research Grant Scheme, Ministry of Higher Education, Ministry of Education, Malaysia [FRGS/1/2014/SS02/USM/03/1]; Fundamental Research Grant Scheme, Ministry of Higher Education, Malaysia	Fundamental Research Grant Scheme, Ministry of Higher Education, Ministry of Education, Malaysia; Fundamental Research Grant Scheme, Ministry of Higher Education, Malaysia	This present study was support by the Fundamental Research Grant Scheme, Ministry of Higher Education, Ministry of Education, Malaysia (FRGS/1/2014/SS02/USM/03/1).; This present study was supported by the Fundamental Research Grant Scheme, Ministry of Higher Education, Malaysia. The authors wish to thank the study participants for their involvement.	ALLEN K, 1994, JAMA-J AM MED ASSOC, V272, P882, DOI 10.1001/jama.272.11.882; Andreassi J.L., 2010, PSYCHOPHYSIOLOGY HUM, V5, P314, DOI [10.4324/9780203880340, DOI 10.4324/9780203880340]; BARRY RJ, 1993, INT J PSYCHOPHYSIOL, V15, P39, DOI 10.1016/0167-8760(93)90093-5; Burns J, 1999, APPL PSYCHOPHYS BIOF, V24, P197, DOI 10.1023/A:1023488614364; Burns JL, 2002, J MUSIC THER, V39, P101, DOI 10.1093/jmt/39.2.101; Clark IN, 2016, PSYCHOL MUSIC, V44, P249, DOI 10.1177/0305735614565830; Cooley S. J., 2013, J IMAGERY RES SPORT, V8, P1, DOI [10.1515/jirspa-2012-0005, DOI 10.1515/JIRSPA-2012-0005]; Crust L, 2004, PERCEPT MOTOR SKILL, V99, P361, DOI 10.2466/PMS.99.5.361-368; Dorney L., 1992, Journal of Sport Behavior, V15, P21; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Fontani G, 2014, J IMAGERY RES SPORT, V9, P1; GUZZETTA CE, 1989, HEART LUNG, V18, P609; Holmes P, 2008, J MOTOR BEHAV, V40, P433, DOI 10.3200/JMBR.40.5.433-445; Job A, 2004, HEARING RES, V193, P31, DOI 10.1016/j.heares.2004.02.010; Karageorghis CI, 2016, APPLYING MUSIC EXERC; Karageorghis CI, 2012, J DANCE MED SCI, V16, P1; Karageorghis CI, 2012, INT REV SPORT EXER P, V5, P67, DOI 10.1080/1750984X.2011.631027; Landers D.M., 2001, APPL SPORT PSYCHOL P, P206; Landers D.M., 2007, ESSENTIAL READINGS S, P211; Lowis MJ, 1998, MANKIND QUART, V39, P203; Miller B., 1997, GUIDED IMAGERY ACHIE; MilukKolasa B, 1996, J MUSIC THER, V33, P208, DOI 10.1093/jmt/33.3.208; Morales J, 2013, INT J SPORTS MED, V34, P144, DOI 10.1055/s-0032-1323719; Morris T., 2005, IMAGERY SPORT; Nercessian A., 2007, DEFINING MUSIC ETHNO; Nezam S.E., 2014, INT RES J APPL BASIC, V8, P712; Suinn RM, 1976, COUNSELLING METHODS, P360; Terry PC, PSYCHOL REV IN PRESS; Terry PC, 2011, NEW SPORT EXERCISE P, P359; Thompson J., 1995, IMAGERY PEAK PERFORM; Watt AP, 2004, J MENTAL IMAGERY, V28, P112	31	13	15	3	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2017	12	4							e0175022	10.1371/journal.pone.0175022	http://dx.doi.org/10.1371/journal.pone.0175022			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES9KD	28414741	Green Published, Green Accepted, gold			2022-12-27	WOS:000399874800014
J	Yeoh, WK; Lee, JKW; Lim, HY; Gan, CW; Liang, W; Tan, KK				Yeoh, Wui Keat; Lee, Jason Kai Wei; Lim, Hsueh Yee; Gan, Chee Wee; Liang, Wenyu; Tan, Kok Kiong			Re-visiting the tympanic membrane vicinity as core body temperature measurement site	PLOS ONE			English	Article							PULMONARY-ARTERY TEMPERATURES; THERAPEUTIC HYPOTHERMIA; CARDIAC-SURGERY; ESOPHAGEAL; CHILDREN; AGREEMENT; AXILLARY; BLADDER	Core body temperature (CBT) is an important and commonly used indicator of human health and endurance performance. A rise in baseline CBT can be attributed to an onset of flu, infection or even thermoregulatory failure when it becomes excessive. Sites which have been used for measurement of CBT include the pulmonary artery, the esophagus, the rectum and the tympanic membrane. Among them, the tympanic membrane is an attractive measurement site for CBT due to its unobtrusive nature and ease of measurement facilitated, especially when continuous CBT measurements are needed for monitoring such as during military, occupational and sporting settings. However, to-date, there are still polarizing views on the suitability of tympanic membrane as a CBT site. This paper will revisit a number of key unresolved issues in the literature and also presents, for the first time, a benchmark of the middle ear temperature against temperature measurements from other sites. Results from experiments carried out on human and primate subjects will be presented to draw a fresh set of insights against the backdrop of hypotheses and controversies.	[Yeoh, Wui Keat; Liang, Wenyu; Tan, Kok Kiong] Natl Univ Singapore, Dept Elect & Comp Engn, Singapore, Singapore; [Lee, Jason Kai Wei] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Physiol, Singapore, Singapore; [Lee, Jason Kai Wei] DSO Natl Labs, Human Performance Lab, Combat Protect & Performance, Singapore, Singapore; [Lim, Hsueh Yee; Gan, Chee Wee] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Otolaryngol, Singapore, Singapore	National University of Singapore; National University of Singapore; National University of Singapore	Yeoh, WK (corresponding author), Natl Univ Singapore, Dept Elect & Comp Engn, Singapore, Singapore.	yeohwk@u.nus.edu	Yeoh, Wui Keat/AAY-6277-2021; Lee, Jason/R-6208-2019; Lee, Jason Kai Wei/GMX-3030-2022	Lee, Jason Kai Wei/0000-0003-4042-795X; Liang, Wenyu/0000-0003-0278-2723; Yeoh, Wui Keat/0000-0002-9126-6474				Akata Takashi, 2004, J Anesth, V18, P73, DOI 10.1007/s00540-003-0225-1; BENZINGER T. H., 1959, PROC NATL ACAD SCI, V45, P645, DOI 10.1073/pnas.45.4.645; Benzinger T H, 1969, PHYSL REV, V49; BENZINGER TH, 1969, J AMER MED ASSOC, V209, P1200, DOI 10.1001/jama.209.8.1200; BRINNEL H, 1989, J THERM BIOL, V14, P47, DOI 10.1016/0306-4565(89)90029-6; Brodsky L, 1999, LARYNGOSCOPE, V109, P2009, DOI 10.1097/00005537-199912000-00022; CRANSTON WI, 1954, J PHYSIOL-LONDON, V126, P347, DOI 10.1113/jphysiol.1954.sp005214; Eyelade OR, 2011, J PERIANESTH NURS, V26, P151, DOI 10.1016/j.jopan.2011.03.009; Fulbrook P, 1997, Intensive Crit Care Nurs, V13, P266, DOI 10.1016/S0964-3397(97)80425-9; Holtzclaw B J, 1993, AACN Clin Issues Crit Care Nurs, V4, P44, DOI 10.1097/00044067-199302000-00005; Huggins R, 2012, J ATHL TRAINING, V47, P329, DOI 10.4085/1062-6050-47.3.09; Krizanac D, 2013, RESUSCITATION, V84, P805, DOI 10.1016/j.resuscitation.2012.11.022; LATTAVO K, 1995, RES NURS HEALTH, V18, P365, DOI 10.1002/nur.4770180410; Mansour S., 2013, COMPREHENSIVE CLIN A, V1st ed., DOI [10.1007/978-3-642-36967-4, DOI 10.1007/978-3-642-36967-4]; Mansour S, 2013, COMPREHENSIVE CLIN A, P141; Maxton FJC, 2004, J ADV NURS, V45, P214, DOI 10.1046/j.1365-2648.2003.02883.x; MCCAFFREY TV, 1975, J APPL PHYSIOL, V39, P114, DOI 10.1152/jappl.1975.39.1.114; NIELSEN B, 1988, PFLUG ARCH EUR J PHY, V411, P456, DOI 10.1007/BF00587727; Robinson J, 1998, CAN J ANAESTH, V45, P317, DOI 10.1007/BF03012021; Robinson JL, 1998, J PEDIATR-US, V133, P553, DOI 10.1016/S0022-3476(98)70067-8; Roth RN, 1996, ANN EMERG MED, V28, P414, DOI 10.1016/S0196-0644(96)70007-0; Sarkar S, 2013, J PEDIATR-US, V162, P208, DOI 10.1016/j.jpeds.2012.08.039; Sato KT, 1996, J APPL PHYSIOL, V80, P1233, DOI 10.1152/jappl.1996.80.4.1233; Sessler DI, 2008, ANESTHESIOLOGY, V109, P318, DOI 10.1097/ALN.0b013e31817f6d76; Shin J, 2013, RESUSCITATION, V84, P810, DOI 10.1016/j.resuscitation.2012.12.023; Van der Jeught S, 2013, JARO-J ASSOC RES OTO, V14, P483, DOI 10.1007/s10162-013-0394-z	26	28	28	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2017	12	4							e0174120	10.1371/journal.pone.0174120	http://dx.doi.org/10.1371/journal.pone.0174120			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KD	28414722	gold, Green Published, Green Submitted			2022-12-27	WOS:000399874800002
J	Zhang, YB; Wang, HY; Pan, XF; Teng, WP; Shan, ZY				Zhang, Yibing; Wang, Haoyu; Pan, Xifeng; Teng, Weiping; Shan, Zhongyan			Patients with subclinical hypothyroidism before 20 weeks of pregnancy have a higher risk of miscarriage: A systematic review and meta-analysis	PLOS ONE			English	Review							THYROID-DYSFUNCTION; 1ST TRIMESTER; TSH LEVELS; WOMEN; OUTCOMES; AUTOIMMUNITY; POPULATION; MANAGEMENT; DISEASE; COHORT	Objective To evaluate the relationship between subclinical hypothyroidism (SCH) and the risk of miscarriage before 20 weeks of pregnancy. Methods Literature databases were searched, including the PubMed, Web of Science, Embase and Cochrane databases, from January 1, 1980, to December 31, 2015. The following search terms were used: subclinical hypothyroidism, hypothyroidism, thyroid dysfunction, thyroid hypofunction, subclinical thyroid disease, thyroid dysfunction, pregnancy loss, abortion and miscarriage. Studies comparing the prevalence of miscarriage in pregnant women with SCH with those who were euthyroid were selected. From the studies matched, the relative risk (RR) and corresponding 95% confidence interval (95% CI) were calculated to yield outcomes. All the statistical analyses were performed using Review Manager (Revman) Version 5.3 and Stata Version 12.0 software. The publication bias of the studies was assessed by forest plot and Begg's test, while the stability of the results was evaluated by sensitivity analysis. Results Nine articles satisfying the inclusion criteria were analysed. Compared to euthyroid pregnant women, patients with non-treated SCH had a higher prevalence of miscarriage (RR = 1.90, 95% CI1.59-2.27, P<0.01). Additionally, SCH patients in the international diagnostic criteria group were more likely to suffer miscarriages than those in the ATA diagnostic criteria group (chi(2) = 11.493, P<0.01). Moreover, there was no difference between patients with treated SCH and euthyroid women (RR = 1.14, 95% CI0.82-1.58, P = 0.43). Compared to isolated SCH women, the miscarriage risk of SCH patients with thyroid autoimmunity (TAI) was obviously higher (RR = 2.47, 95% CI1.77-3.45, P<0.01), and isolated SCH patients also had a higher prevalence of miscarriages than euthyroid women (RR = 1.45, 95% CI1.07-1.96, P = 0.02). A heterogeneity test, forest plot and Begg's test suggested that there was no significant heterogeneity or publication bias among the included articles, while the result of sensitivity analysis showed that our study exhibited high stability. Conclusion SCH is a risk factor for miscarriage in women before 20 weeks of pregnancy, and early treatments can reduce the miscarriage rate. Regardless of the diagnostic criteria used, the miscarriage rate increased as long as a pregnant woman was confirmed to have SCH. The results show that the omission diagnostic rate may increase when the ATA diagnostic criteria are used. In addition, SCH patients with TAI have a higher prevalence of miscarriage, while isolated SCH patients also have a higher miscarriage rate than euthyroid women. Thus, we recommend early treatments to avoid adverse pregnancy outcomes and complications.	[Shan, Zhongyan] China Med Univ, Hosp 1, Endocrine Inst, Shenyang, Peoples R China; China Med Univ, Hosp 1, Liaoning Prov Key Lab Endocrine Dis, Dept Endocrinol & Metab, Shenyang, Peoples R China	China Medical University; China Medical University	Shan, ZY (corresponding author), China Med Univ, Hosp 1, Endocrine Inst, Shenyang, Peoples R China.	shanzhongyan@medmail.com.cn		shan, zhongyan/0000-0002-2849-2380	National Science and technology support program [2014BAI06B02]; Chinese National Natural Science Foundation [81170730, 81570709]; Research Foundation of Key laboratory of endocrine diseases; Department of education in Liaoning Province China [LZ2014035]; Key plat form foundation of science and technology for the universities in Liaoning Province [16010]	National Science and technology support program; Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Research Foundation of Key laboratory of endocrine diseases; Department of education in Liaoning Province China; Key plat form foundation of science and technology for the universities in Liaoning Province	The study was supported by the National Science and technology support program (2014BAI06B02); Chinese National Natural Science Foundation (81170730, 81570709); Research Foundation of Key laboratory of endocrine diseases, Department of education in Liaoning Province China (LZ2014035); Key plat form foundation of science and technology for the universities in Liaoning Province (16010). The funders had no role in study design, data collection and analysis, decision to publish,or preparation of the manuscript.	Aguayo A, 2013, J TRACE ELEM MED BIO, V27, P302, DOI 10.1016/j.jtemb.2013.07.002; Benhadi N, 2009, EUR J ENDOCRINOL, V160, P985, DOI 10.1530/EJE-08-0953; Bliddal S, 2014, EUR J ENDOCRINOL, V170, P329, DOI 10.1530/EJE-13-0672; Canaris GJ, 2000, ARCH INTERN MED, V160, P526, DOI 10.1001/archinte.160.4.526; Casey BM, 2005, OBSTET GYNECOL, V105, P239, DOI 10.1097/01.AOG.0000152345.99421.22; Cleary-Goldman J, 2008, OBSTET GYNECOL, V112, P85, DOI 10.1097/AOG.0b013e3181788dd7; De Groot L, 2012, J CLIN ENDOCR METAB, V97, P2543, DOI 10.1210/jc.2011-2803; Glinoer D, 2006, J CLIN ENDOCR METAB, V91, P2500, DOI 10.1210/jc.2006-0834; He Yiping, 2014, Zhonghua Fu Chan Ke Za Zhi, V49, P824; Karakosta P, 2012, J CLIN ENDOCR METAB, V97, P4464, DOI 10.1210/jc.2012-2540; Li CY, 2014, J CLIN ENDOCR METAB, V99, P73, DOI 10.1210/jc.2013-1674; Liu HX, 2014, THYROID, V24, P1642, DOI 10.1089/thy.2014.0029; Maraka S, 2016, THYROID, V26, P580, DOI 10.1089/thy.2015.0418; Nangia AS, 2014, J OBSTET GYN INDIA, V64, P105, DOI 10.1007/s13224-013-0487-y; Negro R, 2006, J CLIN ENDOCR METAB, V91, P2587, DOI 10.1210/jc.2005-1603; Negro R, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4929; Negro R, 2010, J CLIN ENDOCR METAB, V95, pE44, DOI 10.1210/jc.2010-0340; Oztas E, 2015, J OBSTET GYNAECOL RE, V41, P1700, DOI 10.1111/jog.12799; Su PY, 2011, J CLIN ENDOCR METAB, V96, P3234, DOI 10.1210/jc.2011-0274; Teng WP, 2013, LANCET DIABETES ENDO, V1, P228, DOI 10.1016/S2213-8587(13)70109-8; van den Boogaard E, 2011, HUM REPROD UPDATE, V17, P605, DOI 10.1093/humupd/dmr024; Wang S, 2012, J ENDOCRINOL INVEST, V35, P322, DOI 10.3275/7772; Wang Shaowei, 2014, Zhonghua Fu Chan Ke Za Zhi, V49, P816; Yang Junjuan, 2015, Zhonghua Fu Chan Ke Za Zhi, V50, P652	24	55	69	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2017	12	4							e0175708	10.1371/journal.pone.0175708	http://dx.doi.org/10.1371/journal.pone.0175708			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KD	28414788	Green Submitted, Green Published, gold			2022-12-27	WOS:000399874800049
J	Farzana, FD; Rahman, AS; Sultana, S; Raihan, MJ; Hague, MA; Waid, JL; Choudhury, N; Ahmed, T				Farzana, Fahmida Dil; Rahman, Ahmed Shafiqur; Sultana, Sabiha; Raihan, Mohammad Jyoti; Hague, Md Ahshanul; Waid, Jillian L.; Choudhury, Nuzhat; Ahmed, Tahmeed			Coping strategies related to food insecurity at the household level in Bangladesh	PLOS ONE			English	Article							NUTRITIONAL-STATUS; SECURITY; DETERMINANTS; COMMUNITY; ETHIOPIA	Introduction In connection to food insecurity, adaptation of new techniques or alteration of regular behavior is executed that translates to coping strategies. This paper has used data from food security and nutrition surveillance project (FSNSP), which collects information from a nationally representative sample in Bangladesh on coping behaviors associated with household food insecurity. To complement the current understanding of different coping strategies implemented by the Bangladeshi households, the objective of this paper has been set to examine the demographic and socio-economic characteristics of the food insecure households which define their propensity towards adaptation of different types of coping strategies. Methodology FSNSP follows a repeated cross-sectional survey design. Information of 23,374 food insecure households available from February 2011 to November 2013 was selected for the analyses. Coping strategies were categorized as financial, food compromised and both. Multinomial logistic regression was employed to draw inference. Results Majority of the households were significantly more inclined to adopt both multiple financial and food compromisation coping strategies. Post-aman season, educational status of the household head and household women, occupation of the household's main earner, household income, food insecurity status, asset, size and possession of agricultural land were found to be independently and significantly associated with adaptation of both financial and food compromisation coping strategies relative to only financial coping strategies. The relative risk ratio of adopting food compromisation coping relative to financial coping strategies when compared to mildly food insecure households, was 4.54 times higher for households with moderate food insecurity but 0.3 times lower when the households were severely food insecure. Whereas, households were 8.04 times and 4.98 times more likely to adopt both food compromisation and financial relative to only financial coping strategies if moderately and severely food insecure respectively when compared to being mildly food insecure. Conclusion Households suffering from moderate and severe food insecurity, are more likely to adopt both financial and food compromisation coping strategies.	[Farzana, Fahmida Dil; Rahman, Ahmed Shafiqur; Raihan, Mohammad Jyoti; Hague, Md Ahshanul; Choudhury, Nuzhat; Ahmed, Tahmeed] Int Ctr Diarrhoeal Dis Res, Nutr & Clin Serv Div, Dhaka, Bangladesh; [Sultana, Sabiha; Ahmed, Tahmeed] BRAC Univ, James P Grant Sch Publ Hlth, Dhaka, Bangladesh; [Waid, Jillian L.] Helen Keller Int, Dhaka, Bangladesh	International Centre for Diarrhoeal Disease Research (ICDDR); Bangladesh Rural Advancement Committee BRAC; BRAC University	Choudhury, N (corresponding author), Int Ctr Diarrhoeal Dis Res, Nutr & Clin Serv Div, Dhaka, Bangladesh.	nuzhat@icddrb.org			European Commission	European Commission(European CommissionEuropean Commission Joint Research Centre)	This study was made possible by the committed contribution and partnership of James P Grant School of Public Health (JPGSPH), BRAC University and icddr,b. This project itself is a joint partnership between JPGSPH, BRAC University, Bangladesh 264 Bureau of Statistics and Helen Keller International (HKI), Bangladesh and funded by European Commission.	Ahamad M, 2010, CLIMATE RISKS SEASON; Ahmed A. U., 2007, RELATIVE EFFICACY FO; Alam GM, 2009, AFR J AGR RES, V4, P1334; [Anonymous], 2009, COMP FOOD CASH TRANS; Arene C.J., 2010, PAKISTAN J SOCIAL SC, V30, P9; Ayieko MA, 2010, J FOOD SCI TECHNOLOG; Babatunde R. O., 2007, Pakistan Journal of Nutrition, V6, P49; Babatunde R.O., 2008, INDIAN J AGR EC, V63, P1; Bickel G., 2000, J COOK GUIDE MEASURI; Bird K, 1998, ANALYSIS, V97; Bushamuka Victor N., 2005, Food and Nutrition Bulletin, V26, P17; Chilowa W, 1991, FOOD INSECURITY COPI; Chinnakali P, 2014, J HEALTH POPUL NUTR, V32, P227; Coates J., 2007, FOOD NUTR TECHNICAL, DOI 10.1007/s13398-014-0173-7.2; DIAZ-BONILLA E., 2001, SHAPING GLOBALIZATIO; Endale Worku, 2014, BMC Res Notes, V7, P130, DOI 10.1186/1756-0500-7-130; Faridi R., 2010, BANGLADESH DEV STUD, P97; Faridi R, 2010, BANGLADESH DEV STUDI, P97; Feleke ST, 2005, AGR ECON-BLACKWELL, V33, P351, DOI 10.1111/j.1574-0864.2005.00074.x; Fintrac Inc, 2014, BANGL USAID BEST AN; Food U, 2008, STATE FOOD INSECURIT, P22; Gardener J, 2009, COUNTRY PROGRAMME BA; Garrett JL, 1999, WORLD DEV, V27, P1955, DOI 10.1016/S0305-750X(99)00091-1; Ghattas H, 2013, J NUTR, V143, P1666, DOI 10.3945/jn.113.176388; Guha-Khasnobis B, 2007, STUD DEV ECON POLICY, P308; Gundersen C, 2014, FUTURE CHILDREN; Gupta P., 2015, J FOOD SECUR, V3, P6, DOI DOI 10.12691/JFS-3-1-2; Helen Keller International (HKI) JPGSoPHJ, 2013, STAT FOOD SEC NUTR B; Hillbruner C, 2008, FOOD NUTR BULL, V29, P221, DOI 10.1177/156482650802900308; Hossain M., 2009, IMPACT SHALLOW TUBEW; Hossain M, 2006, DEV ECON, V44, P149, DOI 10.1111/j.1746-1049.2006.00011.x; James P, 2011, STAT FOOD SEC NUTR B; Kazal MMH, 2010, FOOD SECURITY STRATE; Kyaw D, 2009, RURAL HOUSEHOLDS FOO; Mahabub Hossain, 2005, eJADE - Electronic Journal of Agricultural and Development Economics, V2, P103; Matin I, 2003, WORLD DEV, V31, P647, DOI 10.1016/S0305-750X(02)00223-1; Maxwell D., 2008, COPING STRATEGIES IN; Maxwell DG, 1996, FOOD POLICY, V21, P291, DOI 10.1016/0306-9192(96)00005-X; McDonald CM, 2015, ASIA PAC J CLIN NUTR, V24, P720, DOI 10.6133/apjcn.2015.24.4.14; Mostofa M. G., 2010, Thai Journal of Agricultural Science, V43, P175; Nord M., 2005, HOUSEHOLD FOOD SECUR; Olayemi AO., 2012, ASIAN J AGR RURAL DE, V2, P136; Olumakaiye M. F., 2006, Journal of Human Ecology, V19, P51; Osmani SR., 1983, BANGLADESH DEV STUDI, V11, P135; Quaye W, 2008, FOOD SECURITY SITUAT; Quisumbing A.R., 1995, COMMUNICATION; Rahman S, 2009, FOOD POLICY, V34, P340, DOI 10.1016/j.foodpol.2009.02.004; Rashid DA, 2006, LIVELIHOOD SHOCKS CO, P23; Regassa N, 2011, ETHIOPIAN J ENV STUD, V4; Ruel MT, 2010, J NUTR, V140, p170S, DOI 10.3945/jn.109.110791; Shariff Zalilah Mohd, 2008, Nutr Res Pract, V2, P26, DOI 10.4162/nrp.2008.2.1.26; Slater R., 2003, FOOD SECURITY MILLEN; Tefera T., 2014, J FOOD SECURITY, V2, P92, DOI [10.12691/jfs-2-3-4, DOI 10.12691/JFS-2-3-4]; The World Bank, 2006, 9 WORLD BANK; Thorne-Lyman AL, 2010, J NUTR, V140, p182S, DOI 10.3945/jn.109.110809; Uddin M. E., 2012, The Agriculturists, V10, P98, DOI 10.3329/agric.v10i1.11070; United States Agency for International Development (USAID), 2015, DRAFT COUNTR SPEC IN; Zug S, 2006, J SOCIAL STUDIES, V111, P1	58	34	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2017	12	4							e0171411	10.1371/journal.pone.0171411	http://dx.doi.org/10.1371/journal.pone.0171411			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET0MD	28410375	Green Published, Green Submitted, gold			2022-12-27	WOS:000399955600001
J	Zhang, RL; Wang, QQ; Zhang, JP; Yang, LJ				Zhang, Rui-Li; Wang, Qian-Qiu; Zhang, Jin-Ping; Yang, Li-Jia			Molecular subtyping of Treponema pallidum and associated factors of serofast status in early syphilis patients: Identified novel genotype and cytokine marker	PLOS ONE			English	Article							SEROLOGICAL RESPONSE; REAL-TIME; CHEMERIN; RECEPTOR; INFLAMMATION; PREDICTORS; GUIDELINES; MANAGEMENT; THERAPY; CHEMR23	Serofast, a persistent nontreponemal serological response observed in early syphilis patients after conventional treatment, remains a concern of clinicians and syphilis patients. No consensus has been established, however, that defines an effective treatment strategy and clarifies the pathogenesis. In this study, 517 patients with early syphilis were enrolled and treated. Twelve months after treatment, 79.3% (410/517) of patients achieved serological cure, 20.1% (104/517) were serofast, and 0.6% (3/517) were serological failures. Multivariate analysis demonstrated that older age (>40 years) and lower baseline RPR titer (<= 1: 8) were associated with serofast status. We also identified 21 T. pallidum molecular subtypes among early syphilis patients and detected a new subtype, 14i/a. We found that the proportion of 14i/a type in serofast patients was significantly higher than that in patients with serological cure, predicting an increasing risk of serofast status. Levels of chemerin were higher in the serum of serofast cases than serological cure cases, potentially indicating a novel cytokine marker for serofast in early syphilis patients after therapy. We hope that these results contribute to improve guidelines for the management of syphilis patients who experience serofast.	[Zhang, Rui-Li; Yang, Li-Jia] Nanjing Med Univ, Wuxi Hosp 2, Dept Dermatol, Wuxi, Peoples R China; [Wang, Qian-Qiu; Zhang, Jin-Ping] Chinese Acad Med Sci, China Ctr Dis Control & Prevent, Natl Ctr STD Control & Prevent, Inst Dermatol, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Dermatology - CAMS; Chinese Center for Disease Control & Prevention	Wang, QQ (corresponding author), Chinese Acad Med Sci, China Ctr Dis Control & Prevent, Natl Ctr STD Control & Prevent, Inst Dermatol, Nanjing, Jiangsu, Peoples R China.	doctorwqq@163.com	zhang, jin/GXV-9154-2022	, Rui-Li/0000-0001-7364-4649	Natural Science Foundation of Jiangsu Province of China [BK20150121]; Jiangsu Provincial Special Program of Medical Science [BL2012003]	Natural Science Foundation of Jiangsu Province of China(Natural Science Foundation of Jiangsu Province); Jiangsu Provincial Special Program of Medical Science	Financial support for this research came from Natural Science Foundation of Jiangsu Province of China (BK20150121) and Jiangsu Provincial Special Program of Medical Science (BL2012003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albanesi C, 2009, J EXP MED, V206, P249, DOI 10.1084/jem.20080129; Cash JL, 2008, J EXP MED, V205, P767, DOI 10.1084/jem.20071601; Chemerin P., 2016, THER ADV ENDOCRINOL, V7, P57; Clement ME, 2014, JAMA-J AM MED ASSOC, V312, P1905, DOI 10.1001/jama.2014.13259; Dionne-Odom J, 2013, CLIN INFECT DIS, V56, P1829, DOI 10.1093/cid/cit146; Fatima SS, 2014, PEPTIDES, V62, P15, DOI 10.1016/j.peptides.2014.09.019; Gayet-Ageron A, 2009, SEX TRANSM INFECT, V85, P264, DOI 10.1136/sti.2008.034314; Gayet-Ageron A, 2013, SEX TRANSM INFECT, V89, P251, DOI 10.1136/sextrans-2012-050622; GOEMAN J, 1995, GENITOURIN MED, V71, P275; Gong XiangDong, 2014, Chinese Journal of Dermatology, V47, P310; Gonzalvo-Feo S, 2014, J IMMUNOL, V192, P2366, DOI 10.4049/jimmunol.1302028; Herova M, 2015, J IMMUNOL, V194, P2330, DOI 10.4049/jimmunol.1402166; Holman KM, 2013, EXPERT REV ANTI-INFE, V11, P839, DOI 10.1586/14787210.2013.814865; Kaur J, 2010, BIOCHEM BIOPH RES CO, V391, P1762, DOI 10.1016/j.bbrc.2009.12.150; Kim JH, 2011, CHINESE MED J-PEKING, V124, P2123, DOI 10.3760/cma.j.issn.0366-6999.2011.14.008; Kwak J, 2015, PEDIATR ANN, V44, pE108, DOI 10.3928/00904481-20150512-10; Li J, 2013, SEX TRANSM INFECT, V89, P69, DOI 10.1136/sextrans-2012-050711; Li Jun, 2009, Zhonghua Yi Xue Za Zhi, V89, P813; Liang Z, 2016, INT J ANTIMICROB AG, V47, P6, DOI 10.1016/j.ijantimicag.2015.10.020; Lin LR, 2011, DIAGN MICR INFEC DIS, V71, P201, DOI 10.1016/j.diagmicrobio.2011.07.005; Lin YJ, 2013, CHINESE J HUMAN SEXU, V22, P30; Manavi K, 2007, INT J STD AIDS, V18, P814, DOI 10.1258/095646207782717018; Mariani F, 2015, INFLAMM RES, V64, P85, DOI 10.1007/s00011-014-0792-7; Marra CM, 2010, J INFECT DIS, V202, P1380, DOI 10.1086/656533; Mattei PL, 2012, AM FAM PHYSICIAN, V86, P433; Monnier J, 2012, J IMMUNOL, V189, P956, DOI 10.4049/jimmunol.1102871; MOORE J E, 1946, Bull Colo, V10, P9; Parolini S, 2007, BLOOD, V109, P3625, DOI 10.1182/blood-2006-08-038844; Pillay A, 1998, SEX TRANSM DIS, V25, P408, DOI 10.1097/00007435-199809000-00004; Qin JB, 2015, IRAN J PUBLIC HEALTH, V44, P155; Ren RX, 2016, INT J STD AIDS, V27, P58, DOI 10.1177/0956462415573677; Salazar JC, 2002, MICROBES INFECT, V4, P1133, DOI 10.1016/S1286-4579(02)01638-6; Sena AC, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1209-0; Sena AC, 2013, CLIN INFECT DIS, V56, P420, DOI 10.1093/cid/cis918; Skrzeczynska-Moncznik J, 2009, ACTA BIOCHIM POL, V56, P355; Tiplica GS, 2015, J EUR ACAD DERMATOL, V29, P1251, DOI 10.1111/jdv.13181; Tong ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070102; Tsai JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109813; Workowski KA, 2015, MMWR RECOMM REP, V64, P1, DOI 10.15585/mmwr.rr7004a1; Xie HL, 2013, CHIN J DERM VENEREOL, V27, P485; [杨文林 YANG Wenlin], 2011, [中国现代医学杂志, China Journal of Modern Medicine], V21, P1821; Ying ZL, 2012, J DERMATOLOGY VENERE, V34, P106; Zabel BA, 2014, AM J CLIN EXP IMMUNO, V3, P1; Zhang WJ, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1072-z	44	20	23	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2017	12	4							e0175477	10.1371/journal.pone.0175477	http://dx.doi.org/10.1371/journal.pone.0175477			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0MD	28410389	Green Published, gold, Green Submitted			2022-12-27	WOS:000399955600021
J	Abimanyi-Ochom, J; Mannan, H; Groce, NE; McVeigh, J				Abimanyi-Ochom, Julie; Mannan, Hasheem; Groce, Nora Ellen; McVeigh, Joanne			HIV/AIDS knowledge, attitudes and behaviour of persons with and without disabilities from the Uganda Demographic and Health Survey 2011: Differential access to HIV/AIDS information and services	PLOS ONE			English	Article							SOUTHERN AFRICA; HEARING PEOPLE; HIV; ZAMBIA; RIGHTS; DEAF; INTERRELATIONSHIP; EXPERIENCES; ADOLESCENTS; INCLUSION	Uganda is among the first to use the Washington Group Short Set of Questions on Disability to identify persons with disabilities in its Demographic and Health Survey. In this paper, we review the HIV Knowledge, Attitudes and Behaviour component of the 2011 Ugandan Demographic and Health Survey, analysing a series of questions comparing those with and without disabilities in relation to HIV/AIDS knowledge, attitudes and practices. We found comparable levels of knowledge on HIV/AIDS for those with and those without disabilities in relation to HIV transmission during delivery (93.89%, 93.26%) and through breastfeeding (89.91%, 90.63%), which may reflect increased attention to reaching the community of persons with disabilities. However, several gaps in the knowledge base of persons with disabilities stood out, including misconceptions of risk of HIV infection through mosquito bites and caring for a relative with HIV in own household (34.39%, 29.86%; p<0.001; 91.53%, 89.00%; p = 0.001, respectively). The issue is not just access to appropriate information but also equitable access to HIV/AIDS services and support. Here we found that persons with multiple disabilities were less likely than individuals without disabilities to return to receive results from their most recent HIV test (0.60[0.41-0.87], p<0.05). HIV testing means little if people do not return for follow-up to know their HIV status and, if necessary, to be connected to available services and supports. Additional findings of note were that persons with disabilities reported having a first sexual encounter at a slightly younger age than peers without disabilities; and persons with disabilities also reported having a sexually transmitted disease (STD) within the last 12 months at significantly higher rates than peers without disabilities (1.38[1.18-1.63], p<0.01), despite reporting comparable knowledge of the need for safer sex practices. This analysis is among the first to use HIV/AIDS-related questions from Demographic Health Surveys to provide information about persons with disabilities in Uganda in comparison to those without disabilities. These findings present a more complex and nuanced understanding of persons with disabilities and HIV/AIDS. If persons with disabilities are becoming sexually active earlier, are more likely to have an STD within the preceding 12 month period and are less likely to receive HIV test results, it is important to understand why. Recommendations are also made for the inclusion of disability measures in Uganda's AIDS Indicator Survey to provide cyclical and systematic data on disability and HIV/AIDS, including HIV prevalence amongst persons with disabilities.	[Abimanyi-Ochom, Julie] Deakin Univ, Sch Hlth & Social Dev, Melbourne, Vic, Australia; [Mannan, Hasheem] Univ Coll Dublin, Sch Nursing Midwifery & Hlth Syst, Hlth Sci Ctr, Dublin, Ireland; [Groce, Nora Ellen] UCL, Leonard Cheshire Disabil & Inclus Dev Ctr, Dept Epidemiol & Publ Hlth, London, England; [McVeigh, Joanne] Trinity Coll Dublin, Ctr Global Hlth, Dublin, Ireland; [McVeigh, Joanne] Trinity Coll Dublin, Sch Psychol, Dublin, Ireland	Deakin University; University College Dublin; University of London; University College London; Trinity College Dublin; Trinity College Dublin	Abimanyi-Ochom, J (corresponding author), Deakin Univ, Sch Hlth & Social Dev, Melbourne, Vic, Australia.	j.abimanyiochom@deakin.edu.au	McVeigh, Joanne/C-9363-2016	McVeigh, Joanne/0000-0002-2446-3814; Groce, Nora/0000-0002-7885-7042	Deakin University, Australia	Deakin University, Australia	This work was funded by an Open Access Publication Grant: Deakin University, Australia.	Abimanyi-Ochom J, 2014, AFR J DISABIL, V3, DOI 10.4102/ajod.v3i1.108; Aderemi TJ, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.17331; Amin M, 2011, HEALTH HUM RIGHTS, V13, P82; [Anonymous], 2012, UG DEM HLTH SURV 201; Babu M. Martin, CASE STUDY UGANDA PR; Bat-Chava Y, 2005, AIDS CARE, V17, P623, DOI 10.1080/09540120412331291751; Bisol CA, 2008, AM ANN DEAF, V153, P349; Cameron A. C., 2010, MICROECONOMETRICS US; Centers for Disease Control and Prevention, 2010, RAT SHORT SET; Centers for Disease Control and Prevention, 2010, PROT IMPL TESTS WG S; Chirawu P, 2014, SEX DISABIL, V32, P259, DOI 10.1007/s11195-014-9355-7; De Beaudrap P, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-008934; DHS Program, DEM HLTH SURV DHS PR; Eide AH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125915; Federici S, 2016, DISABIL REHABIL, P1; Gerntholtz L, 2010, DISABILITY RIGHTS HI; Grant K, 2009, DISABILITY NATL STRA; Grant K, 2012, 19 INT AIDS C; Groce N, 2008, GUIDELINES INCLUSION; Groce NE, 2007, DISABIL REHABIL, V29, P367, DOI 10.1080/09638280600834567; Groce N.E., 2004, GLOBAL SURVEY HIV AI; Groce NE, 2003, LANCET, V361, P1401, DOI 10.1016/S0140-6736(03)13146-7; Groce NE, 2014, LEONARD CHESHIRE DIS, V23; Groce Nora Ellen, 2005, Health Hum Rights, V8, P215, DOI 10.2307/4065341; Groce NE, 2013, SOC SCI MED, V77, P31, DOI 10.1016/j.socscimed.2012.10.024; Hanass-Hancock J, 2009, DISABILITY HIV AIDS; Hanass-Hancock J, 2013, CLOS GAP ADDR DIS HI; Hanass-Hancock J, 2012, CLOSING GAP TRAINING; Hanass-Hancock J, 2013, DISABILITY HIV RES C; Hanass-Hancock J, 2009, J INT AIDS SOC, V12, P1; Hanass-Hancock J, 2010, HIV DISABILITY REHAB; Hanass-Hancock J, 2013, AJOD, V2, P1; Hanass-Hancock J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143936; Hanass-Hancock J, 2015, DISABIL REHABIL, V37, P2012, DOI 10.3109/09638288.2014.991455; Hanass-Hancock J, 2014, J ASSOC NURSE AIDS C, V25, P351, DOI 10.1016/j.jana.2013.10.001; Hanass-Hancock J, 2012, DISABIL REHABIL, V34, P2184, DOI 10.3109/09638288.2012.672541; Hanass-Hancock J, 2011, DISABIL REHABIL, V33, P2389, DOI 10.3109/09638288.2011.573055; Hanass-Hancock J, 2009, SEX DISABIL, V27, P35, DOI 10.1007/s11195-008-9105-9; Human Rights Watch, 2014, WE AR ALS DYING AIDS; Keatley R., 2016, THESIS; Krahn GL, 2015, AM J PUBLIC HEALTH, V105, pS198, DOI 10.2105/AJPH.2014.302182; MacLachlan M, 2013, SOC INCL, V1, P139, DOI 10.17645/si.v1i2.110; Madans JH, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S4-S4; Mannan H, 2013, SOC INCL, V1, P37, DOI 10.17645/si.v1i1.108; MEASURE DHS/ICF International, 2013, STAND REC MAN DHS 6; Mitra S, 2013, LANCET GLOB HEALTH, V1, pE178, DOI 10.1016/S2214-109X(13)70016-0; Mulindwa IN., 2003, STUDY REPROD HLTH HI; Murangira A., 2005, DEV OUTREACH, V7, P30; National Union of Disabled Persons of Uganda (NUDIPU), 2013, DIS HIV AIDS; Nixon SA, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18806; Nyirenda M, 2013, GLOBAL HEALTH ACTION, V6, P1, DOI 10.3402/gha.v6i0.19201; OHCHR, STAT RAT INT DASHB; Pappas G, 2005, GLOBAL HLTH, V1, P1; Rohleder P, 2009, J HEALTH PSYCHOL, V14, P4; Rohleder P, 2009, DISABIL REHABIL, V31, P51, DOI 10.1080/09638280802280585; Rutstein S., 2006, GUIDE DHS STAT DEMOG; Shakespeare T, 2012, DISABIL HEALTH J, V5, P129, DOI 10.1016/j.dhjo.2012.04.002; The DHS Program, SURV TYP; The DHS Program, WEALTH IND CONSTR; Touko A, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-5; Tun W, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.5.20829; Uganda AIDS Commission, 2015, HIV AIDS UG COUNTR P; Uganda Ministry of Health, 2010, UG HIV COUNS TEST; Uganda Ministry of Health, 2012, UG AIDS IND SURV AIS; Uganda National Association of the Deaf (UNAD), 2014, CRAN SURV DEAF KAMP; Uganda National Bureau of Statistics (UBOS), 2010, UG NAT HOUS SURV 200; UNAIDS, 2021, YOUNG PEOPL HIV; UNAIDS, 2014, GAP REP 2014 PEOPL D; UNAIDS WHO Working Group on Global HIV/AIDS and STI Surveillance, 2015, MWHO WORK GROUP GLOB; UNICEF Pacific, 2014, CHILDR WOM MEN DIS V; United Nations Convention on the Rights of Persons with Disabilities (UNCRPD), 2006, CONV RIGHTS PERS DIS; United Nations Development Programme (UNDP), 2016, SUSTAINABLE DEV GOAL; United Nations Economic and Social Commission for Asia and the Pacific (ESCAP) Statistics Division, 2010, GUID COGN PIL TEST Q; United Nations Statistics Division, 2016, WASHINGTON GROUP ON; Ustun B., 2010, MEASURING HLTH DISAB; Washington Group on Disability Statistics, 2016, SHORT SET DIS QUEST; WHO, 2011, WORLD REPORT ON DISABILITY, P1; World Bank, 2010, HIV AIDS DIS 3 COUNT; World Health Organization (WHO), 2002, WHO WORLD HLTH SURV; Yoshida K, 2014, DISABIL REHABIL, V36, P2161, DOI 10.3109/09638288.2014.894144; Yousafzai AK, 2005, DISABIL REHABIL, V27, P1357, DOI 10.1080/09638280500164297; Yousafzai AK, 2004, INT J REHABIL RES, V27, P247, DOI 10.1097/00004356-200409000-00012	82	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2017	12	4							e0174877	10.1371/journal.pone.0174877	http://dx.doi.org/10.1371/journal.pone.0174877			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET0MB	28406929	gold, Green Published, Green Submitted			2022-12-27	WOS:000399955400022
J	Galka, P; Jamez, E; Joachim, G; Soumillion, P				Galka, Pierre; Jamez, Elisabeth; Joachim, Gilles; Soumillion, Patrice			QuickLib, a method for building fully synthetic plasmid libraries by seamless cloning of degenerate oligonucleotides	PLOS ONE			English	Article							DNA	Incorporation of synthetic degenerate oligonucleotides into plasmids for building highly diverse genetic libraries requires efficient and quantitative DNA manipulation. We present a fast and seamless method for generating libraries of PCR-synthesized plasmids designed with a degenerate sequence and short overlapping ends. Our method called QuickLib should find many applications in synthetic biology; as an example, we easily prepared genetic libraries of Escherichia coli expressing billions of different backbone cyclic peptides.	[Galka, Pierre; Jamez, Elisabeth; Joachim, Gilles; Soumillion, Patrice] Catholic Univ Louvain, Inst Sci Vie, Louvain La Neuve, Belgium	Universite Catholique Louvain	Soumillion, P (corresponding author), Catholic Univ Louvain, Inst Sci Vie, Louvain La Neuve, Belgium.	patrice.soumillion@uclouvain.be			Belgian "Politique Scientifique Federale" program [IAP P7/44 iPROS]; FRFC program of the Belgian National Fund for Scientific Research F.R.S- FNRS [2.4522.12]; Universite A catholique de Louvain	Belgian "Politique Scientifique Federale" program; FRFC program of the Belgian National Fund for Scientific Research F.R.S- FNRS(Fonds de la Recherche Scientifique - FNRS); Universite A catholique de Louvain	This work was supported by the Belgian "Politique Scientifique Federale" program IAP P7/44 iPROS (https://www.belspo.be/belspo/index_fr. strn), and by the FRFC program of the Belgian National Fund for Scientific Research F.R.S-FNRS (grant 2.4522.12) (vAtml.frs-fnrs.be/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Belgian "Politique Scientifique Federale" program IAP P7/44 iPROS, by the FRFC program of the Belgian National Fund for Scientific Research F.R.S- FNRS (grant 2.4522.12) and the Universite A catholique de Louvain. We thank Julia Wessel and Heykel Trabelsi for interesting suggestions in elaboration of this method.	CLARK JM, 1988, NUCLEIC ACIDS RES, V16, P9677, DOI 10.1093/nar/16.20.9677; Deschuyteneer G, 2010, ACS CHEM BIOL, V5, P691, DOI 10.1021/cb100072u; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; HU GX, 1993, DNA CELL BIOL, V12, P763, DOI 10.1089/dna.1993.12.763; LACKS S, 1975, J BIOL CHEM, V250, P4060; Legendre D, 1999, NAT BIOTECHNOL, V17, P67, DOI 10.1038/5243; Mitchell LA, 2013, ACS SYNTH BIOL, V2, P473, DOI 10.1021/sb300131w; Scott CP, 1999, P NATL ACAD SCI USA, V96, P13638, DOI 10.1073/pnas.96.24.13638; Tavassoli A, 2007, NAT PROTOC, V2, P1126, DOI 10.1038/nprot.2007.152	9	4	20	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2017	12	4							e0175146	10.1371/journal.pone.0175146	http://dx.doi.org/10.1371/journal.pone.0175146			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0MB	28406948	gold, Green Submitted, Green Published			2022-12-27	WOS:000399955400030
J	Johnson, AF; Moreno-Baez, M; Giron-Nava, A; Corominas, J; Erisman, B; Ezcurra, E; Aburto-Oropeza, O				Johnson, Andrew Frederick; Moreno-Baez, Marcia; Giron-Nava, Alfredo; Corominas, Julia; Erisman, Brad; Ezcurra, Exequiel; Aburto-Oropeza, Octavio			A spatial method to calculate small-scale fisheries effort in data poor scenarios	PLOS ONE			English	Article							FISHING EFFORT; MANAGEMENT	To gauge the collateral impacts of fishing we must know where fishing boats operate and how much they fish. Although small-scale fisheries land approximately the same amount of fish for human consumption as industrial fleets globally, methods of estimating their fishing effort are comparatively poor. We present an accessible, spatial method of calculating the effort of small-scale fisheries based on two simple measures that are available, or at least easily estimated, in even the most data-poor fisheries: the number of boats and the local coastal human population. We illustrate the method using a small-scale fisheries case study from the Gulf of California, Mexico, and show that our measure of Predicted Fishing Effort (PFE), measured as the number of boats operating in a given area per day adjusted by the number of people in local coastal populations, can accurately predict fisheries landings in the Gulf. Comparing our values of PFE to commercial fishery landings throughout the Gulf also indicates that the current number of small-scale fishing boats in the Gulf is approximately double what is required to land theoretical maximum fish biomass. Our method is fishery-type independent and can be used to quantitatively evaluate the efficacy of growth in small-scale fisheries. This new method provides an important first step towards estimating the fishing effort of small-scale fleets globally.	[Johnson, Andrew Frederick; Moreno-Baez, Marcia; Giron-Nava, Alfredo; Aburto-Oropeza, Octavio] Scripps Inst Oceanog, Div Marine Biol Res, La Jolla, CA 92037 USA; [Moreno-Baez, Marcia] Ctr Biodiversidad Marina & Conservac, La Paz, Mexico; [Corominas, Julia] Univ Politecn Cataluna, Barcelona, Spain; [Erisman, Brad] Univ Texas Austin, Inst Marine Sci, Austin, TX 78712 USA; [Ezcurra, Exequiel] Univ Calif Riverside, UC MEXUS, Riverside, CA 92521 USA	University of California System; University of California San Diego; Scripps Institution of Oceanography; Universitat Politecnica de Catalunya; University of Texas System; University of Texas Austin; University of California System; University of California Riverside	Johnson, AF (corresponding author), Scripps Inst Oceanog, Div Marine Biol Res, La Jolla, CA 92037 USA.	afjohnson@ucsd.edu	Erisman, Brad/P-1640-2019; Erisman, Brad/R-8827-2019	Erisman, Brad/0000-0002-9336-7957; Erisman, Brad/0000-0002-9336-7957; Aburto-Oropeza, Octavio/0000-0002-8173-1432; Moreno-Baez, Marcia/0000-0002-5976-0229	CONACYT [CVU 579904]; Fulbright Garcia-Robles [20140963]; NSF [DEB-1632648]; Commission for Mexico and the United States (COMEXUS); Helmsley Charitable Trust; International Community Foundation; National Science Foundation [DEB-1632648]; Packard Foundation; Walton Family Foundation; Division Of Environmental Biology [1632648] Funding Source: National Science Foundation	CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Fulbright Garcia-Robles; NSF(National Science Foundation (NSF)); Commission for Mexico and the United States (COMEXUS); Helmsley Charitable Trust; International Community Foundation; National Science Foundation(National Science Foundation (NSF)); Packard Foundation(The David & Lucile Packard Foundation); Walton Family Foundation; Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The authors would like to thank the following funders for financial support: CONACYT the Mexican National Council of Science and Technology (CVU 579904) to AGN; The Fulbright-Garcia Robles Program (LASPAU ID 20140963) doctoral program fellowships to AGN; The Commission for Mexico and the United States (COMEXUS); The Helmsley Charitable Trust (http://helmsleytrust.org/); The International Community Foundation (https://icfdn.org/); The National Science Foundation (https://www.nsf.gov/), grant DEB-1632648 (2016) to AFJ; The Nature Conservancy (http://www.nature.org/); The Packard Foundation (https://www.packard.org/); and The Walton Family Foundation (http://www.waltonfamilyfoundation.org/).; We would like to thank CONAPESCA, WWF and T. Plomozo for access to their databases. This work is part of an ongoing effort by the Gulf of California Marine Program (http://gulfprogram.ucsd.edu) to understand the exploitation of resources from the Sea of Cortez and promote the sustainable management of marine fish stocks in the area. We would also like to thank authors contributing to dataMares (http://datamares.ucsd.edu/eng/) whose articles greatly aid the interpretation and dissemination of these results. AGN was funded by CONACYT (CVU 579904) and Fulbright Garcia-Robles (LASPAU ID 20140963) doctoral program fellowships. AFJ was supported by NSF grant DEB-1632648 (2016). We would also like to thank C Lopez-Sagastegui and CR Taft whose comments greatly strengthened this manuscript.	Aburto-Oropeza O, 2015, ECOL INDIC, V52, P353, DOI 10.1016/j.ecolind.2014.12.006; Anderson SC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024368; [Anonymous], 2014, FAO YB FISHERY AQUAC, V2012, P1; Bastardie F, 2010, FISH RES, V106, P41, DOI 10.1016/j.fishres.2010.06.016; Cisneros-Mata Miguel A., 2010, P119; Corominas J, 2012, SIG COMO HERRRAMIIEN; Cox SP, 2003, N AM J FISH MANAGE, V23, P1294, DOI 10.1577/M01-228AM; Dichmont CM, 2010, P NATL ACAD SCI USA, V107, P16, DOI 10.1073/pnas.0912091107; Erisman BE, 2011, CAN J FISH AQUAT SCI, V68, P1705, DOI 10.1139/F2011-090; Erisman BE, 2011, ICES J MAR SCI, V68, P564, DOI 10.1093/icesjms/fsq179; Guillemot N, 2009, FISH RES, V98, P51, DOI 10.1016/j.fishres.2009.03.013; Hilborn R., 2013, NATURE; Hinz H, 2013, FISH FISH, V14, P110, DOI 10.1111/j.1467-2979.2012.00475.x; INEGI, 2022, CENS POBL VIV; Jacquet J, 2008, CONSERV BIOL, V22, P832, DOI 10.1111/j.1523-1739.2008.00978.x; Lee J, 2010, ICES J MAR SCI, V67, P1260, DOI 10.1093/icesjms/fsq010; Lluch-Cota SE, 2007, PROG OCEANOGR, V73, P1, DOI 10.1016/j.pocean.2007.01.013; Marsden AD, 2005, FISH RES, V73, P259, DOI 10.1016/j.fishres.2004.12.007; McCluskey SM, 2008, FISH FISH, V9, P188, DOI 10.1111/j.1467-2979.2008.00283.x; Moreno-Baez M, 2014, DATAMARES; Moreno-Baez M, 2010, MAPPING HUMAN DIMENS; Piet GJ, 2007, ICES J MARINE SCI; Plomozo Lugo T, 2010, PROPUESTA REGIONALIZ, P1; Ricel JC, 2011, ICES J MAR SCI, V68, P1343, DOI 10.1093/icesjms/fsr041; Rodriguez-Valencia JA, TAMANO DISTRIBUCION, P1; Silverman B. W., 1986, DENSITY ESTIMATION S, P120; Stewart KR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014451; Watson RA, 2013, FISH FISH, V14, P493, DOI 10.1111/j.1467-2979.2012.00483.x; Worm B, 2009, SCIENCE, V325, P578, DOI 10.1126/science.1173146; Ye YM, 2013, FISH FISH, V14, P174, DOI 10.1111/j.1467-2979.2012.00460.x	30	34	34	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2017	12	4							e0174064	10.1371/journal.pone.0174064	http://dx.doi.org/10.1371/journal.pone.0174064			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0MB	28406918	gold, Green Published, Green Submitted			2022-12-27	WOS:000399955400006
J	Requena-Morales, R; Palazon-Bru, A; Rizo-Baeza, MM; Adsuar-Quesada, JM; Gil-Guillen, VF; Cortes-Castell, E				Requena-Morales, Rosa; Palazon-Bru, Antonio; Mercedes Rizo-Baeza, Maria; Manuel Adsuar-Quesada, Jose; Francisco Gil-Guillen, Vicente; Cortes-Castell, Ernesto			Mortality after out-of-hospital cardiac arrest in a Spanish Region	PLOS ONE			English	Article							CARDIOPULMONARY-RESUSCITATION; SURVIVAL; GUIDELINES; AGE	Aims To determine out-of-hospital cardiac arrest mortality in the province of Alicante (Spain) and its associated factors. Methods Cross-sectional observational study of all patients who received cardiopulmonary resuscitation (CPR) by the Emergency Medical Services (EMS) (n = 422) in the province of Alicante in 2013. To determine associated factors, a binary logistic regression model was constructed. Primary outcome: death before arriving at the hospital. Predictive variables: gender, age, artificial respiration, prior functional status, asystole, cardiogenic aetiology, bystander CPR, time from the cardiac arrest to the arrival of the EMS and location of cardiac arrest. Results There were 337 deaths (79.9%; 95% Cl: 76.0-83.7%). Factors independently associated (p<0.05) with death were: male gender (OR = 2.11; 95% Cl: 1.20-3.72; p = 0.010), asystole (OR = 1.99, 95% Cl: 1.17-3.39; p = 0.012), cardiac arrest at home (OR = 2.44; 95% Cl: 1.42-4.18; p = 0.001) and an increased time between arrest and EMS arrival (OR = 1.05, 95% Cl: 1.01-1.09, p = 0.009). Having a worse prior functional status had a tendency towards significance (OR = 0.56, 95% Cl: 0.31-1.02, p = 0.059). Conclusions Mortality was high. The associated factors were: male gender, asystole, worse prior functional status, longer time from the cardiac arrest to the arrival of the EMS and having the cardiac arrest at home. The clearly negative impact of experiencing a cardiac arrest at home necessitates modifying training policies in Spain. These policies should be focused on providing information about CPR in schools in order to decrease the mortality of these events.	[Requena-Morales, Rosa; Mercedes Rizo-Baeza, Maria] Univ Alicante, Dept Nursing, Alicante, Spain; [Requena-Morales, Rosa; Manuel Adsuar-Quesada, Jose] Valencian Reg Minist Hlth, Emergency Med Serv, Alicante, Spain; [Palazon-Bru, Antonio; Francisco Gil-Guillen, Vicente] Miguel Hernandez Univ, Dept Clin Med, Alicante, Spain; [Cortes-Castell, Ernesto] Miguel Hernandez Univ, Dept Pharmacol Pediat & Organ Chem, Alicante, Spain	Universitat d'Alacant; Universidad Miguel Hernandez de Elche; Universidad Miguel Hernandez de Elche	Palazon-Bru, A (corresponding author), Miguel Hernandez Univ, Dept Clin Med, Alicante, Spain.	antonio.pb23@gmail.com	Cortés-Castell, Ernesto/H-8528-2019; Rizo-Baeza, Mercedes/J-3974-2017; Guillén, Vicente Francisco Gil/AAE-8201-2019	Rizo-Baeza, Mercedes/0000-0002-6754-6505; Palazon-Bru, Antonio/0000-0002-5959-9631; Gil-Guillen, Vicente F/0000-0003-3793-9786; CORTES CASTELL, ERNESTO/0000-0002-8079-1695				[Anonymous], 2005, CIRCULATION, V112, pIV1, DOI 10.1161/CIRCULATIONAHA.105.166550; Ballesteros-Pena S, 2013, EMERGENCIAS, V25, P137; Ballesteros-Pena S, 2013, REV ESP CARDIOL, V66, P269, DOI 10.1016/j.rec.2012.09.014; Berdowski J, 2010, RESUSCITATION, V81, P1479, DOI 10.1016/j.resuscitation.2010.08.006; Bottiger BW, 2015, LANCET, V385, P2353, DOI 10.1016/S0140-6736(15)61099-6; Clark Angela P, 2005, Crit Care Nurs Clin North Am, V17, P23, DOI 10.1016/j.ccell.2004.09.004; Curos Abadal A, 2001, Rev Esp Cardiol, V54, P827; Escorial Hernandez V, 2001, Rev Esp Cardiol, V54, P832; Fothergill RT, 2013, RESUSCITATION, V84, P1089, DOI 10.1016/j.resuscitation.2013.03.034; Grasner JT, 2013, BEST PRAC RES-CL ANA, V27, P293, DOI 10.1016/j.bpa.2013.07.008; Handley AJ, 2005, RESUSCITATION, V67, pS7, DOI 10.1016/j.resuscitation.2005.10.007; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Iqbal MB, 2015, AM J CARDIOL, V115, P730, DOI 10.1016/j.amjcard.2014.12.033; JENNETT B, 1975, LANCET, V1, P480; Kwok H, 2013, RESUSCITATION, V84, P1353, DOI 10.1016/j.resuscitation.2013.04.015; Marijon E, 2015, CIRCULATION, V131, P1546, DOI 10.1161/CIRCULATIONAHA.114.010498; Montgomery W H, 1992, Ann Acad Med Singap, V21, P69; Nakanishi N, 2011, PREHOSP EMERG CARE, V15, P271, DOI 10.3109/10903127.2010.545475; Nehme Z, 2015, CIRC-CARDIOVASC QUAL, V8, P56, DOI 10.1161/CIRCOUTCOMES.114.001185; Neumar RW, 2015, CIRCULATION, V132, pS315, DOI 10.1161/CIR.0000000000000252; Ringh M, 2015, NEW ENGL J MED, V372, P2316, DOI 10.1056/NEJMoa1406038; Safdar B, 2014, ACAD EMERG MED, V21, P1503, DOI 10.1111/acem.12540; Sasson C, 2014, ACAD EMERG MED, V21, P1042, DOI 10.1111/acem.12455; Silfvast T, 1996, RESUSCITATION, V31, P101, DOI 10.1016/0300-9572(95)00915-9; Wissenberg M, 2015, CIRCULATION, V131, P1536, DOI 10.1161/CIRCULATIONAHA.114.013122	25	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2017	12	4							e0175818	10.1371/journal.pone.0175818	http://dx.doi.org/10.1371/journal.pone.0175818			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0MB	28407020	gold, Green Published, Green Submitted			2022-12-27	WOS:000399955400101
J	Tsunaka, M; Shinki, H; Koyama, T				Tsunaka, Misae; Shinki, Haruka; Koyama, Takatoshi			Cell-based evaluation of changes in coagulation activity induced by antineoplastic drugs for the treatment of acute myeloid leukemia	PLOS ONE			English	Article							ACUTE PROMYELOCYTIC LEUKEMIA; TISSUE-FACTOR; THROMBOMODULIN; BINDING; CANCER; THROMBOSIS	Idarubicin (IDR), cytarabine (AraC), and tamibarotene (Am80) are effective for treatment of acute myeloid leukemia (AML). In acute leukemia, the incidence of venous thromboembolism or disseminated intravascular coagulation is associated with induction chemotherapy. Procoagulant effects of IDR, AraC, and Am80 were investigated in a vascular endothelial cell line EAhy926 and AML cell lines HL60 (AML M2), NB4 (AML M3, APL), and U937 (AML M5), focusing on tissue factor (TF), phosphatidylserine (PS), and thrombomodulin (TM). IDR induced procoagulant activity on the surface of vascular endothelial and AML cell lines. Expression of TF antigen, TM antigen, and PS were induced by IDR on the surface of each cell line, whereas expression of TF and TM mRNAs were unchanged. Conversely, Am80 decreased TF exposure and procoagulant activity, and increased TM exposure on NB4 cells. In NB4 cells, we observed downregulation of TF mRNA and upregulation of TM mRNA. These data suggest IDR may induce procoagulant activity in vessels by apoptosis through PS exposure and/or TF expression on vascular endothelial and AML cell lines. Am80 may suppress blood coagulation through downregulation of TF expression and induction of TM expression. Our methods could be useful to investigate changes in procoagulant activity induced by antineoplastic drugs.	[Tsunaka, Misae; Shinki, Haruka; Koyama, Takatoshi] Tokyo Med & Dent Univ, Grad Sch Hlth Care Sci, Field Appl Lab Sci, Lab Mol Genet Hematol, Tokyo, Japan	Tokyo Medical & Dental University (TMDU)	Koyama, T (corresponding author), Tokyo Med & Dent Univ, Grad Sch Hlth Care Sci, Field Appl Lab Sci, Lab Mol Genet Hematol, Tokyo, Japan.	koyama.lmg@tmd.ac.jp						ANDREE HAM, 1990, J BIOL CHEM, V265, P4923; Bach RR, 2006, ARTERIOSCL THROM VAS, V26, P456, DOI 10.1161/01.ATV.0000202656.53964.04; Blom JW, 2006, J THROMB HAEMOST, V4, P529, DOI 10.1111/j.1538-7836.2006.01804.x; DALTON WT, 1988, BLOOD, V71, P242; Date K, 2013, THROMB RES, V131, P109, DOI 10.1016/j.thromres.2012.11.013; Falanga A, 2009, J CLIN ONCOL, V27, P4848, DOI 10.1200/JCO.2009.22.8197; Franchini M, 2010, SEMIN THROMB HEMOST, V36, P388, DOI 10.1055/s-0030-1254048; Heit JA, 2000, ARCH INTERN MED, V160, P809, DOI 10.1001/archinte.160.6.809; Hoshi A, 2011, BLOOD COAGUL FIBRIN, V22, P532, DOI 10.1097/MBC.0b013e328348629d; Isozumi Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064369; Khorshid O, 2011, MEDITERR J HEMATOL I, V3, DOI 10.4084/MJHID.2011.060; KIMURA S, 1989, J BIOCHEM-TOKYO, V105, P478, DOI 10.1093/oxfordjournals.jbchem.a122690; KOYAMA T, 1994, BLOOD, V84, P3001; Lee AYY, 2003, CIRCULATION, V107, pI17, DOI 10.1161/01.CIR.0000078466.72504.AC; Manly DA, 2011, ANNU REV PHYSIOL, V73, P515, DOI 10.1146/annurev-physiol-042210-121137; RAI KR, 1981, BLOOD, V58, P1203; Robak T, 2009, CLIN THER, V31, P2349, DOI 10.1016/j.clinthera.2009.11.017; TAIT JF, 1989, J BIOL CHEM, V264, P7944; TAKANO S, 1990, BLOOD, V76, P2024; Takeshita A, 1996, ANN INTERN MED, V124, P893, DOI 10.7326/0003-4819-124-10-199605150-00006; Tobita T, 1997, BLOOD, V90, P967, DOI 10.1182/blood.V90.3.967.967_967_973	21	6	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2017	12	4							e0175765	10.1371/journal.pone.0175765	http://dx.doi.org/10.1371/journal.pone.0175765			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0MB	28406995	Green Published, gold, Green Submitted			2022-12-27	WOS:000399955400094
J	Cherniak, W; Anguyo, G; Meaney, C; Kong, LY; Malhame, I; Pace, R; Sodhi, S; Silverman, M				Cherniak, William; Anguyo, Geoffrey; Meaney, Christopher; Kong, Ling Yuan; Malhame, Isabelle; Pace, Romina; Sodhi, Sumeet; Silverman, Michael			Effectiveness of advertising availability of prenatal ultrasound on uptake of antenatal care in rural Uganda: A cluster randomized trial	PLOS ONE			English	Article							LOW-INCOME COUNTRIES; MATERNITY SERVICES; HEALTH; DELIVERY; IMPACT; WOMEN; PREGNANCY; COMMUNITY; SETTINGS; BENEFITS	In rural Uganda pregnant women often lack access to health services, do not attend antenatal care, and tend to utilize traditional healers/birth attendants. We hypothesized that receiving a message advertising that "you will be able to see your baby by ultrasound" would motivate rural Ugandan women who otherwise might use a traditional birth attendant to attend antenatal care, and that those women would subsequently be more satisfied with care. A cluster randomized trial was conducted across eight rural sub-counties in southwestern Uganda. Sub-counties were randomized to a control arm, with advertisement of antenatal care with no mention of portable obstetric ultrasound (four communities, n = 59), or an intervention arm, with advertisement of portable obstetric ultrasound. Advertisement of portable obstetric ultrasound was further divided into intervention A) word of mouth advertisement of portable obstetric ultrasound and antenatal care (one communitity, n = 16), B) radio advertisement of only antenatal care and word of mouth advertisement of antenatal care and portable obstetric ultrasound (one community, n = 7), or C) word of mouth + radio advertisement of both antenatal care and portable obstetric ultrasound (two communities, n = 75). The primary outcome was attendance to antenatal care. 159 women presented to antenatal care across eight sub-counties. The rate of attendance was 65.1 (per 1000 pregnant women, 95% CI 38.3-110.4) where portable obstetric ultrasound was advertised by radio and word of mouth, as compared to a rate of 11.1 (95% CI 6.1-20.1) in control communities (rate ratio 5.9, 95% CI 2.6-13.0, p<0.0001). Attendance was also improved in women who had previously seen a traditional healer (13.0, 95% CI 5.4-31.2) compared to control (1.5, 95% CI 0.5-5.0, rate ratio 8.7, 95% CI 2.0-38.1, p = 0.004). By advertising antenatal care and portable obstetric ultrasound by radio attendance was significantly improved. This study suggests that women can be motivated to attend antenatal care when offered the concrete incentive of seeing their baby.	[Cherniak, William; Meaney, Christopher; Sodhi, Sumeet] Univ Toronto, Markham Stouffville Hosp, Div Emergency Med, Dept Family & Community Med, Toronto, ON, Canada; [Cherniak, William; Kong, Ling Yuan; Malhame, Isabelle; Pace, Romina; Silverman, Michael] Bridge Hlth Med & Dent, Toronto, ON, Canada; [Anguyo, Geoffrey] Kigezi Healthcare Fdn, Kabale, Uganda; [Anguyo, Geoffrey] Mbarara Univ Sci & Technol, Kabale, Uganda; [Kong, Ling Yuan; Malhame, Isabelle; Pace, Romina] McGill Univ, Dept Internal Med, Montreal, PQ, Canada; [Sodhi, Sumeet] Univ Hlth Network, Toronto Western Hosp, Dept Family & Community Med, Toronto, ON, Canada; [Silverman, Michael] Western Univ, Div Infect Dis, London, ON, Canada	University of Toronto; Mbarara University of Science & Technology; McGill University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Western University (University of Western Ontario)	Cherniak, W (corresponding author), Univ Toronto, Markham Stouffville Hosp, Div Emergency Med, Dept Family & Community Med, Toronto, ON, Canada.; Cherniak, W (corresponding author), Bridge Hlth Med & Dent, Toronto, ON, Canada.	w.cherniak@mail.utoronto.ca	Meaney, Christopher/R-8349-2018; Silverman, Michael/J-3776-2014	Meaney, Christopher/0000-0002-5429-5233; Silverman, Michael/0000-0002-0389-7656; Pace, Romina/0000-0002-3976-2753	Bridge to Health Medical and Dental (BTH); BTH	Bridge to Health Medical and Dental (BTH); BTH	The funding source of this study was provided by Bridge to Health Medical and Dental (BTH), www.bridgetohealth.ca. BTH is primarily funded through unrestricted donations from Canadian corporations (such as Cole Engineering, Lebovic Enterprises and other smaller donors), Canadian Rotary Clubs, and small private donors. None of the donors had any conflicts of interest. None of the Canadian investigators received any personal compensation for their work on this project. The organization has no proprietary holdings on the technology used in this study nor does it, or its investigators, receive any financial compensation for sales of portable ultrasound technology. Some compensation for time spent was provided by BTH to the Ugandan research team.	[Anonymous], 2010, WORLD HLTH STAT 2010; [Anonymous], 2010, REP WHO TECHN CONS T; Carroli G, 2001, PAEDIATR PERINAT EP, V15, P1; Conrad P, 2012, QUAL HEALTH RES, V22, P619, DOI 10.1177/1049732311431897; Dixon J, 2014, TROP MED INT HEALTH, V19, P98, DOI 10.1111/tmi.12223; Ediau M, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-189; El Arifeen S, 2013, LANCET, V382, P2012, DOI 10.1016/S0140-6736(13)62149-2; Firth Emma Rebecca, 2011, Afr J Reprod Health, V15, P91; Glei DA, 2003, SOC SCI MED, V57, P2447, DOI 10.1016/S0277-9536(03)00140-0; Guliani H, 2014, HEALTH POLICY PLANN, V29, P589, DOI 10.1093/heapol/czt045; Guliani H, 2012, SOC SCI MED, V74, P1882, DOI 10.1016/j.socscimed.2012.02.008; Halim N, 2011, HEALTH POLICY PLANN, V26, P242, DOI 10.1093/heapol/czq040; Harris RD, 2009, J ULTRAS MED, V28, P1067, DOI 10.7863/jum.2009.28.8.1067; Houweling TAJ, 2007, B WORLD HEALTH ORGAN, V85, P745, DOI 10.2471/BLT.06.038588; Kakaire O, 2011, REPROD HEALTH, V8, DOI 10.1186/1742-4755-8-12; Kiwuwa MS, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-44; Kyomuhendo GB, 2003, REPROD HEALTH MATTER, V11, P16, DOI 10.1016/S0968-8080(03)02176-1; Lincetto O, 2006, ANTENATAL CARE OPPOR, P55; McClure EM, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-73; Ministry of Health, 2012, HLTH SYST 2020 MAK U; Ndyomugyenyi R, 1998, HEALTH POLICY PLANN, V13, P94, DOI 10.1093/heapol/13.1.94; Ross AB, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/s12884-014-0424-9; Ross AB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078450; Rutanga M, 2011, RELIG POWER GREAT LA; Shah SP, 2009, BMC INT HEALTH HUM R, V9, DOI 10.1186/1472-698X-9-4; Stolz LA, 2015, TROP MED INT HEALTH, V20, P1067, DOI 10.1111/tmi.12511; The Partnership for Maternal, NEWB CHILD HLTH WORL; The Women and Girls Empowerment Project (WOGE), KAB DISTR UG FACT SH; WHO, GLOBAL HEALTH OBSERV; Yaw AW, ULTRASOUND IMAGING D	30	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2017	12	4							e0175440	10.1371/journal.pone.0175440	http://dx.doi.org/10.1371/journal.pone.0175440			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET0LZ	28403187	Green Submitted, Green Published, gold			2022-12-27	WOS:000399955200068
J	Monteiro, BP; Klinck, MP; Moreau, M; Guillot, M; Steagall, PVM; Pelletier, JP; Martel-Pelletier, J; Gauvin, D; del Castillo, JRE; Troncy, E				Monteiro, Beatriz P.; Klinck, Mary P.; Moreau, Maxim; Guillot, Martin; Steagall, Paulo V. M.; Pelletier, Jean-Pierre; Martel-Pelletier, Johanne; Gauvin, Dominique; del Castillo, Jerome R. E.; Troncy, Eric			Analgesic efficacy of tramadol in cats with naturally occurring osteoarthritis	PLOS ONE			English	Article							DEGENERATIVE JOINT DISEASE; FELINE OSTEOARTHRITIS; PAIN; MELOXICAM; MECHANISM; DIAGNOSIS; SAFETY; BRAIN; DRUGS; DOGS	Objectives This study aimed to (1) compare outcome assessments in normal and osteoarthritic cats and (2) evaluate the analgesic efficacy of tramadol in feline osteoarthritis (OA), in a prospective, randomised, blinded, placebo-controlled, crossover design. Methods Twenty cats were included after clinical examination, blood work and full body radiographs were performed. In Phase 1, outcome assessments aimed to differentiate normal (n = 5; i. e. exempt of any radiographic and clinical sign of OA) from OA (n = 15) cats. In Phase 2, OA cats were treated twice daily with a placebo (PG: cornstarch 15 mg) or tramadol (TG: 3 mg/kg) orally for 19 days, with a 3-month washout period between treatments. Evaluations were performed in normal and OA cats at baseline and consisted of: 1) peak vertical force (PVF) after staircase exercise; 2) telemetered night-time motor activity (NMA); and 3) response to mechanical temporal summation (RMTS). After treatment, PVF, NMA and RMTS evaluations were repeated in OA cats. Data were analysed with mixed model methods with an alpha-threshold of 5%. Results Phase 1: 1) PVF (% of body weight; mean +/- SD) was higher in normal (59 +/- 10.5) than in OA cats (50.6 +/- 5.7) (p = 0.005); 2) NMA (no unit) was not different between groups; 3) RMTS (number of stimuli; median (range)) was higher in normal [29.5 (23.5 +/- 30)] than in OA cats [14 (8.5 +/- 28)] (p < 0.0001). Phase 2: PVF, NMA and RMTS presented a treatment effect (p = 0.024, p = 0.008 and p = 0.018, respectively). No clinically important adverse-effects were observed. Conclusion Outcome assessments such as kinetics (PVF) and evaluation of central sensitisation (RMTS) are discriminant of OA status. Mobility measured by NMA was not discriminant of OA status, however it increased in OA cats with tramadol treatment. Nociceptive hypersensitivity quantified by RMTS was evident in OA cats and was responsive to tramadol treatment.	[Monteiro, Beatriz P.; Klinck, Mary P.; Moreau, Maxim; Guillot, Martin; Gauvin, Dominique; del Castillo, Jerome R. E.; Troncy, Eric] Univ Montreal, Fac Med Vet, GREPAQ Anim Pharmacol Res Grp Quebec, St Hyacinthe, PQ, Canada; [Klinck, Mary P.; Moreau, Maxim; Guillot, Martin; Pelletier, Jean-Pierre; Martel-Pelletier, Johanne; Troncy, Eric] Univ Montreal Hosp Ctr, Res Ctr, Osteoarthrit Res Unit, Montreal, PQ, Canada; [Steagall, Paulo V. M.] Univ Montreal, Fac Med Vet, Dept Clin Sci, St Hyacinthe, PQ, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal	Troncy, E (corresponding author), Univ Montreal, Fac Med Vet, GREPAQ Anim Pharmacol Res Grp Quebec, St Hyacinthe, PQ, Canada.; Troncy, E (corresponding author), Univ Montreal Hosp Ctr, Res Ctr, Osteoarthrit Res Unit, Montreal, PQ, Canada.	eric.troncy@umontreal.ca	Steagall, Paulo/W-6043-2019; Martel-Pelletier, Johanne/AAG-2928-2019; Troncy, Eric/J-6650-2013; del Castillo, Jérôme RE/J-6976-2013; del Castillo, Jerome/AAM-9409-2020; Pelletier, Jean-Pierre/AAG-2896-2019; Monteiro, Beatriz/W-7596-2019	Steagall, Paulo/0000-0003-4150-6043; Troncy, Eric/0000-0003-0209-5261; del Castillo, Jérôme RE/0000-0001-5046-7926; del Castillo, Jerome/0000-0001-5046-7926; Monteiro, Beatriz/0000-0002-5722-5687	Morris Animal Foundation Grant [D09FE-803A]; TOP-CAT: Tracking Osteoarthritis Pain in the CAT; Natural Sciences and Engineering Research Council (NSERC) of Canada [RDCPJ 491953-2016, RDCPJ 418399-2011]; New Opportunities Fund grant [9483]; Foundation for Innovation; Elanco Animal Health, a division of Eli Lilly and company; Vanier Canada Graduate Scholarship; Alexander Graham Bell NSERC Canada Graduate Scholarship [D10-901]; Fonds de recherche du Quebec-Sante; Canadian Institutes of Health Research MENTOR Strategic Training Initiative in Health Research Program; Alexander Graham Bell NSERC Canada Graduate Scholarship for Doctorate research;  [441651-2013]	Morris Animal Foundation Grant; TOP-CAT: Tracking Osteoarthritis Pain in the CAT; Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); New Opportunities Fund grant; Foundation for Innovation; Elanco Animal Health, a division of Eli Lilly and company; Vanier Canada Graduate Scholarship; Alexander Graham Bell NSERC Canada Graduate Scholarship; Fonds de recherche du Quebec-Sante(Fonds de la Recherche en Sante du Quebec); Canadian Institutes of Health Research MENTOR Strategic Training Initiative in Health Research Program(Canadian Institutes of Health Research (CIHR)); Alexander Graham Bell NSERC Canada Graduate Scholarship for Doctorate research; 	This study was funded (Pr. Eric Troncy) in part by a Morris Animal Foundation Grant (#D09FE-803A), "TOP-CAT: Tracking Osteoarthritis Pain in the CAT", by a Discovery grant (#441651-2013 supporting salaries) and a Collaborative Research and Development grant (#RDCPJ 418399-2011, #RDCPJ 491953-2016 supporting operations and salaries in partnership with ArthroLab Inc.) from the Natural Sciences and Engineering Research Council (NSERC) of Canada, as well as by an ongoing New Opportunities Fund grant (#9483) and a Leader Opportunity Fund grant (#24601), supporting pain/function equipment, from the Canada Foundation for Innovation. Funding for the clinical trial study was provided by a grant from Elanco Animal Health, a division of Eli Lilly and company. The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript. Dr. Beatriz Monteiro is the recipient of a Vanier Canada Graduate Scholarship. Dr. Mary Klinck was the recipient of an Alexander Graham Bell NSERC Canada Graduate Scholarship for Master's research, of a Zoetis Morris Animal Foundation (#D10-901) Doctoral Fellowship. Dr. Maxim Moreau received a Doctoral Scholarship from the Fonds de recherche du Quebec-Sante, and a Doctoral Scholarship from the Canadian Institutes of Health Research MENTOR Strategic Training Initiative in Health Research Program. Dr. Martin Guillot was the recipient of an Alexander Graham Bell NSERC Canada Graduate Scholarship for Doctorate research, and a Doctoral Scholarship from the Canadian Institutes of Health Research MENTOR Strategic Training Initiative in Health Research Program.	Andriacchi TP, 2004, ANN BIOMED ENG, V32, P447, DOI 10.1023/B:ABME.0000017541.82498.37; Benito J, 2013, J VET INTERN MED, V27, P474, DOI 10.1111/jvim.12077; Bianchi M, 1998, BRAIN RES, V797, P163, DOI 10.1016/S0006-8993(98)00388-6; Clarke SP, 2006, J SMALL ANIM PRACT, V47, P439, DOI 10.1111/j.1748-5827.2006.00143.x; Desmeules JA, 1996, BRIT J CLIN PHARMACO, V41, P7, DOI 10.1111/j.1365-2125.1996.tb00152.x; Farnworth MJ, 2015, VET ANAESTH ANALG, V42, P638, DOI 10.1111/vaa.12245; FOX SM, 2010, MULTIMODAL MANAGEMEN; Frink MC, 1996, ARZNEIMITTEL-FORSCH, V46, P1029; Gowan RA, 2011, J FELINE MED SURG, V13, P752, DOI 10.1016/j.jfms.2011.06.008; Guillot M, 2013, VET J, V196, P360, DOI 10.1016/j.tvjl.2013.01.009; Guillot M, 2015, VET J, V204, P299, DOI 10.1016/j.tvjl.2015.03.023; Guillot M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097347; Guillot M, 2012, VET SURG, V41, P328, DOI 10.1111/j.1532-950X.2012.00976.x; Gunew MN, 2008, J FELINE MED SURG, V10, P235, DOI 10.1016/j.jfms.2007.10.007; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Klinck MP, 2012, CAN VET J, V53, P1181; Klinck MP, 2017, APPL ANIM B IN PRESS; KuKanich B, 2004, J VET PHARMACOL THER, V27, P239, DOI 10.1111/j.1365-2885.2004.00578.x; KuKanich B, 2013, VET CLIN N AM-SMALL, V43, P1109, DOI 10.1016/j.cvsm.2013.04.007; Lascelles BDX, 2010, J VET INTERN MED, V24, P487, DOI 10.1111/j.1939-1676.2010.0495.x; Lascelles BDX, 2007, J VET INTERN MED, V21, P410, DOI 10.1892/0891-6640(2007)21[410:EOCOMA]2.0.CO;2; Minami K, 2015, N-S ARCH PHARMACOL, V388, P999, DOI 10.1007/s00210-015-1167-5; Monteiro BP, 2016, VET ANAESTH ANALG; Moreau M, 2014, CAN VET J, V70, P287; Moreau M, 2013, RES VET SCI, V95, P219, DOI 10.1016/j.rvsc.2013.01.020; Neogi T, 2013, OSTEOARTHR CARTILAGE, V21, P1145, DOI 10.1016/j.joca.2013.03.018; Pypendop BH, 2008, J VET PHARMACOL THER, V31, P52, DOI 10.1111/j.1365-2885.2007.00921.x; Pypendop BH, 2009, AM J VET RES, V70, P1465, DOI 10.2460/ajvr.70.12.1465; RAFFA RB, 1992, J PHARMACOL EXP THER, V260, P275; Schaefert R, 2015, SCHMERZ, V29, P47, DOI 10.1007/s00482-014-1451-1; Schnabl E, 2015, VET J, V206, P83, DOI 10.1016/j.tvjl.2015.05.017; Slingerland LI, 2011, VET J, V187, P304, DOI 10.1016/j.tvjl.2009.12.014; Steagall PVM, 2008, J FELINE MED SURG, V10, P24, DOI 10.1016/j.jfms.2007.06.009; Vranken Jan H., 2012, Central Nervous System Agents in Medicinal Chemistry, V12, P304; Woolf CJ, 2011, PAIN, V152, pS2, DOI 10.1016/j.pain.2010.09.030; ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4	36	26	26	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2017	12	4							e0175565	10.1371/journal.pone.0175565	http://dx.doi.org/10.1371/journal.pone.0175565			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LZ	28403198	gold, Green Published, Green Submitted			2022-12-27	WOS:000399955200080
J	Beall, T; Massiot, E; Arsenault, JE; Smith, MR; Hijmans, RJ				Beall, Ty; Massiot, Eric; Arsenault, Joanne E.; Smith, Matthew R.; Hijmans, Robert J.			Global trends in dietary micronutrient supplies and estimated prevalence of inadequate intakes	PLOS ONE			English	Article							FOOD BALANCE SHEETS; PREDICTED PREVALENCE; VILLAGE POPULATIONS; IRON-ABSORPTION; NUTRITION; BIOAVAILABILITY; CHILDREN; ZINC; BIOFORTIFICATION; AGRICULTURE	Understanding dietary patterns is vital to reducing the number of people experiencing hunger (about 795 million), micronutrient deficiencies (2 billion), and overweight or obesity (2.1 billion). We characterize global trends in dietary quality by estimating micronutrient density of the food supply, prevalence of inadequate intake of 14 micronutrients, and average prevalence of inadequate intake of these micronutrients for all countries between 1961 and 2011. Over this 50-year period, the estimated prevalence of inadequate intakes of micronutrients has declined in all regions due to increased total production of food and/or micronutrient density. This decline has been particularly strong in East and Southeast Asia and weaker in South Asia and sub-Saharan Africa. Sub-Saharan Africa is the only region where dietary micronutrient density has declined over this 50-year period. At the global level, micronutrients with the lowest levels of adequate estimated intake are calcium, iron, vitamin A, and zinc, but there are strong differences between countries and regions. Fortification has reduced the estimated prevalence of inadequate micronutrient intakes in all low-income regions, except South Asia. The food supply in many countries is still far below energy requirements, which suggests a need to increase the availability and accessibility of nutritious foods. Countries where the food energy supply is adequate show a very large variation in dietary quality, and in many of these countries people would benefit from more diverse diets with a greater proportion of micronutrient-dense foods. Dietary quality can be improved through fortification, biofortification, and agricultural diversification, as well as efforts to improve access to and use of micronutrient-dense foods and nutritional knowledge. Reducing poverty and increasing education, especially of women, are integral to sustainably addressing malnutrition.	[Beall, Ty; Massiot, Eric; Hijmans, Robert J.] Univ Calif Davis, Dept Environm Sci & Policy, Davis, CA 95616 USA; [Beall, Ty; Arsenault, Joanne E.; Hijmans, Robert J.] Univ Calif Davis, Program Int & Community Nutr, Davis, CA 95616 USA; [Arsenault, Joanne E.] Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA; [Smith, Matthew R.] Harvard TH Chan Sch Publ Hlth, Dept Environm Hlth, Boston, MA USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; Harvard University; Harvard T.H. Chan School of Public Health	Beall, T (corresponding author), Univ Calif Davis, Dept Environm Sci & Policy, Davis, CA 95616 USA.; Beall, T (corresponding author), Univ Calif Davis, Program Int & Community Nutr, Davis, CA 95616 USA.	tbeal@ucdavis.edu		Smith, Matthew/0000-0001-5207-2370; Beal, Ty/0000-0002-0398-9825	Feed the Future Sustainable Intensification Innovation Lab through the United States Agency for International Development [AID-OOA-L-14-00006]; National Science Foundation Graduate Research Fellowship Program [1650042]	Feed the Future Sustainable Intensification Innovation Lab through the United States Agency for International Development(United States Agency for International Development (USAID)); National Science Foundation Graduate Research Fellowship Program(National Science Foundation (NSF))	Funding for this project was provided by the Feed the Future Sustainable Intensification Innovation Lab through the United States Agency for International Development received by RJH (grant # AID-OOA-L-14-00006) (http://www.k-state.edu/siil/). This work was also supported by the National Science Foundation Graduate Research Fellowship Program received by TB (grant # 1650042) (https://www.nsfgrfp.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen L, 2006, GUIDELINES FOOD FORT; [Anonymous], 2001, STATE FOOD INWORLD; [Anonymous], 1998, DIET REF INT THIAM R; Archer E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076632; Arimond M, 2011, COMBATING MICRONUTRIENT DEFICIENCIES: FOOD-BASED APPROACHES, P41, DOI 10.1079/9781845937140.0041; Arsenault JE, 2015, FOOD SECUR, V7, P693, DOI 10.1007/s12571-015-0452-y; Balder HF, 2006, CANCER EPIDEM BIOMAR, V15, P717, DOI 10.1158/1055-9965.EPI-05-0772; Beaton G.H, 1994, CRITERIA ADEQUATE DI, P1491; Biesalski HK, 2016, WORLD REV NUTR DIET; CALLOWAY DH, 1993, AM J CLIN NUTR, V58, P376, DOI 10.1093/ajcn/58.3.376; Cotruvo J., 2009, CALCIUM MAGNESIUM DR; DeFries R, 2015, SCIENCE, V349, P238, DOI 10.1126/science.aaa5766; Del Gobbo LC, 2015, AM J CLIN NUTR, V101, P1038, DOI 10.3945/ajcn.114.087403; Di Cesare M, 2016, LANCET, V387, P1377, DOI 10.1016/S0140-6736(16)30054-X; FAO, 2001, FOOD BAL SHEETS HDB; Food and Agriculture Organization (FAO), 2011, WORLD LIV 2011 LIV F, DOI DOI 10.1080/; Frison EA, 2011, SUSTAINABILITY-BASEL, V3, P238, DOI 10.3390/su3010238; Ghavami A, 2012, BRIT J NUTR, V107, P1350, DOI 10.1017/S000711451100451X; Gibson RS, 2006, P NUTR SOC, V65, P160, DOI 10.1079/PNS2006489; Haas J, 2014, FASEB J S, V28; Hallberg L, 1997, AM J CLIN NUTR, V66, P347, DOI 10.1093/ajcn/66.2.347; HALLBERG L, 1979, SCAND J GASTROENTERO, V14, P769, DOI 10.3109/00365527909181403; Hotz C, 2012, J NUTR, V142, P1871, DOI 10.3945/jn.111.151829; icddrb  UNICEF  Global Alliance for Improved Nutrition, 2013, NAT MICR STAT SURV 2; Institute of Medicine Panel on Macronutrients Institute of Medicine Standing Committee on the Scientific Evaluation of Dietary Reference Intakes, 2005, DIET REF INT EN CARB; Institute of Medicine Standing Committee on the Scientific Evaluation of Dietary Reference Intakes, 1997, DIET REF INT CALC PH; Institute of Medicine (US), 2001, DIET REF INT VIT C V; Joint FAO/WHO Expert Consultation, 2005, VIT MIN REQ HUM NUTR; Joy EJM, 2014, PHYSIOL PLANTARUM, V151, P208, DOI 10.1111/ppl.12144; Kumssa DB, 2015, CROP PASTURE SCI, V66, P1278, DOI 10.1071/CP15096; Kumssa DB, 2015, SCI REP-UK, V5, DOI 10.1038/srep10974; Lee SK, 2000, POSTHARVEST BIOL TEC, V20, P207, DOI 10.1016/S0925-5214(00)00133-2; Low JW, 2007, J NUTR, V137, P1320; Mark HE, 2016, ASIA PAC J CLIN NUTR, V25, P368, DOI 10.6133/apjcn.2016.25.2.11; Matthews R.H., 1975, FOOD YIELDS SUMMARIZ; Miller LV, 2007, J NUTR, V137, P135, DOI 10.1093/jn/137.1.135; Moshfegh A., 2005, WHAT WE EAT AM NHANE; MURPHY SP, 1992, AM J CLIN NUTR, V56, P565, DOI 10.1093/ajcn/56.3.565; NELSON M, 1989, AM J CLIN NUTR, V50, P155, DOI 10.1093/ajcn/50.1.155; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Olney DK, 2015, J NUTR, V145, P1317, DOI 10.3945/jn.114.203539; Paine JA, 2005, NAT BIOTECHNOL, V23, P482, DOI 10.1038/nbt1082; Pourkhalili A, 2013, SCI WORLD J, DOI 10.1155/2013/374030; Reddy MB, 2000, AM J CLIN NUTR, V71, P937; Ross AC, 2011, DIETARY REFERENCE INTAKES FOR CALCIUM AND VITAMIN D, P35; Sahni S, 2010, J BONE MINER RES, V25, P2494, DOI 10.1002/jbmr.194; Sayre R, 2011, ANNU REV PLANT BIOL, V62, P251, DOI 10.1146/annurev-arplant-042110-103751; Schakel SF, 2001, J FOOD COMPOS ANAL, V14, P315, DOI 10.1006/jfca.2001.0992; Schmid A, 2011, CRIT REV FOOD SCI, V51, P50, DOI 10.1080/10408390903044636; Serra-Majem L, 2003, J EPIDEMIOL COMMUN H, V57, P74, DOI 10.1136/jech.57.1.74; Smith MR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146976; Stadlmayr B., 2012, W AFRICAN FOOD COMPO; Svedberg P, 1999, WORLD DEV, V27, P2081, DOI 10.1016/S0305-750X(99)00102-3; Tilman D, 2014, NATURE, V515, P518, DOI 10.1038/nature13959; United Nations, 2014, ESAPWP235 UN; University of California at Berkeley International Minilist, WORLDFOOD DIET ASS S; US Department of Agriculture Agricultural Research Service, 2019, USDA NATL NUTR DATAB; von Grebmer K, 2015, 2015 GLOBAL HUNGER I; Wessells KR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050565; White PJ, 2009, NEW PHYTOL, V182, P49, DOI 10.1111/j.1469-8137.2008.02738.x; WILLETT WC, 1985, AM J EPIDEMIOL, V122, P51, DOI 10.1093/oxfordjournals.aje.a114086; Zijp IM, 2000, CRIT REV FOOD SCI, V40, P371, DOI 10.1080/10408690091189194	62	147	151	8	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2017	12	4							e0175554	10.1371/journal.pone.0175554	http://dx.doi.org/10.1371/journal.pone.0175554			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0JS	28399168	Green Published, gold, Green Submitted			2022-12-27	WOS:000399949000048
J	Blazquez, E; Rodriguez, C; Rodenas, J; de Rozas, AP; Segales, J; Pujols, J; Polo, J				Blazquez, Elena; Rodriguez, Carmen; Rodenas, Jesus; Perez de Rozas, Ana; Segales, Joaquim; Pujols, Joan; Polo, Javier			Ultraviolet (UV-C) inactivation of Enterococcus faecium, Salmonella choleraesuis and Salmonella typhimurium in porcine plasma	PLOS ONE			English	Article							EPIDEMIC DIARRHEA VIRUS; WEANLING PIGS; LIGHT; MODEL; FOOD; MICROORGANISMS; VALIDATION; RADIATION; EFFICACY; CURVES	The objective of this study was to assess the effectiveness of an ultraviolet (UV-C, 254 nm) irradiation system on reducing the load of Salmonella typhimurium (S. typhimurium), Salmonella choleraesuis (S. choleraesuis) resistant to streptomycin and Enterococcus faecium (E. faecium) inoculated in sterile porcine plasma and then subjected to different UV-C irradiation doses (750, 1500, 3000, 6000 and 9000 J/L) using a pilot plant UV-C device working under turbulent flow. Results indicated that UV-C treatment induced a viability reduction of 0.38, 1.18, 3.59, 4.72 and 5.06 log10 S. typhimurium when irradiated at 750, 1500, 3000, 6000 and 9000 J/L, respectively. The observed log10 reduction of S. choleraesuis was 1.44, 2.68, 5.55, 7.07 and 7.97 at 750, 1500, 3000, 6000 and 9000 J/L, respectively. The best-fit inactivation for S. choleraesuis was the Weibull distribution curve, while the best-fit curve for S. typhimurium was the Weibull plus tail model, indicating that around 10 2 cfu/mL resistant S. typhimurium was detected when the liquid plasma was UV-C irradiated at doses up to 9000 J/L. Viability reduction for E. faecium was 0.44, 1.01, 3.70, 5.61 and 6.22 log10 when irradiated at 750, 1500, 3000, 6000 and 9000 J/L, respectively, with no bacterial resistance observed with UV-C doses of 6000 J/L or higher. The biphasic model was the best fit model for the inactivation curve for E. faecium. For the three microorganisms tested, about a 4 log-unit reduction was achieved when the liquid plasma was irradiated at 3000J/L. Overall results demonstrate the usefulness of the UV-C system to inactivate bacteria in liquid plasma before spray-drying. We conclude that the UV-C system can provide an additional biosafety feature that can be incorporated into the manufacturing process for spray-dried animal plasma.	[Blazquez, Elena; Rodriguez, Carmen; Rodenas, Jesus; Polo, Javier] APC EUROPE SA, Pol Ind Congost, Granollers, Spain; [Blazquez, Elena; Perez de Rozas, Ana; Pujols, Joan] Campus Univ Autanoma Barcelona, IRTA, Ctr Rec Sanitat Anim CReSA IRTA UAB, Barcelona, Spain; [Segales, Joaquim] Univ Autonoma Barcelona, Dept Sanitat & Anat Anim, Barcelona, Spain; [Segales, Joaquim] Univ Autonoma Barcelona, Ctr Rec Sanitat Anim CReSA IRTA UAB, Barcelona, Spain	IRTA; Autonomous University of Barcelona; Autonomous University of Barcelona; IRTA	Polo, J (corresponding author), APC EUROPE SA, Pol Ind Congost, Granollers, Spain.	Javier.polo@apc-europe.com	Pujols, Joan/S-1141-2018; Segalés, Joaquim/A-4933-2011; Segalés, Joaquim/AAB-4815-2020; Pujols, Joan/AAV-6427-2020	Segalés, Joaquim/0000-0002-1539-7261; Segalés, Joaquim/0000-0002-1539-7261; Pujols, Joan/0000-0002-6940-1529; Blazquez Salvador, Elena/0000-0001-8115-3225; Polo, Javier/0000-0003-0990-2230	APC Europe, S.A., Granollers, Spain; de Universitats i Recerca del Departament d'Economia i Coneixement of the Generalitat de Catalunya [2014 DI 066]; CERCA Programme/Generalitat de Catalunya; APC EUROPE	APC Europe, S.A., Granollers, Spain; de Universitats i Recerca del Departament d'Economia i Coneixement of the Generalitat de Catalunya; CERCA Programme/Generalitat de Catalunya; APC EUROPE	Funding for this study was provided in part by APC Europe, S.A., Granollers, Spain. This study was partly supported by Secretaria de Universitats i Recerca del Departament d'Economia i Coneixement of the Generalitat de Catalunya (2014 DI 066) to EB. The funding from CERCA Programme/Generalitat de Catalunya to IRTA is also acknowledged. APC EUROPE provided support in the form of salaries for authors EB, CR, JR and JPolo retrospectively, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Albert I, 2005, INT J FOOD MICROBIOL, V100, P197, DOI 10.1016/j.ijfoodmicro.2004.10.016; Baysal AH, 2013, INT J FOOD MICROBIOL, V166, P494, DOI 10.1016/j.ijfoodmicro.2013.08.015; Bintsis T, 2000, J SCI FOOD AGR, V80, P637, DOI 10.1002/(SICI)1097-0010(20000501)80:6<637::AID-JSFA603>3.0.CO;2-1; Boyen F, 2008, VET MICROBIOL, V130, P1, DOI 10.1016/j.vetmic.2007.12.017; CERF O, 1977, J APPL BACTERIOL, V42, P1, DOI 10.1111/j.1365-2672.1977.tb00665.x; Cerf O, 1977, J APPL MICROBIOL, V42, P92; Dee S, 2011, VET MICROBIOL, V150, P96, DOI 10.1016/j.vetmic.2011.01.014; Donaghy J, 2009, LETT APPL MICROBIOL, V49, P217, DOI 10.1111/j.1472-765X.2009.02644.x; Fredericks IN, 2011, FOOD MICROBIOL, V28, P510, DOI 10.1016/j.fm.2010.10.018; Gebreyes WA, 2004, J FOOD PROTECT, V67, P698, DOI 10.4315/0362-028X-67.4.698; Geeraerd AH, 2000, INT J FOOD MICROBIOL, V59, P185, DOI 10.1016/S0168-1605(00)00362-7; Geeraerd AH, 2005, INT J FOOD MICROBIOL, V102, P95, DOI 10.1016/j.ijfoodmicro.2004.11.038; Gerber PF, 2014, VET MICROBIOL, V174, P86, DOI 10.1016/j.vetmic.2014.09.008; GRAY JT, 1995, VET MICROBIOL, V47, P43, DOI 10.1016/0378-1135(95)00060-N; Groenewald WH, 2013, J NEW GENER SCI, V11, P19; Guerrero-Beltran JA, 2004, FOOD SCI TECHNOL INT, V10, P137, DOI 10.1177/1082013204044359; Hijnen WAM, 2006, WATER RES, V40, P3, DOI 10.1016/j.watres.2005.10.030; Hohmann EL, 2001, CLIN INFECT DIS, V32, P263, DOI 10.1086/318457; Jagger J., 1967, INTRO RES ULTRAVIOLE; Keyser M, 2008, INNOV FOOD SCI EMERG, V9, P348, DOI 10.1016/j.ifset.2007.09.002; Kopit LM, 2014, APPL ENVIRON MICROB, V80, P1899, DOI 10.1128/AEM.03859-13; Lin CH, 2012, J HAZARD MATER, V30, P209; Luksiene Z, 2007, J APPL MICROBIOL, V103, P1545, DOI 10.1111/j.1365-2672.2007.03403.x; Ma L, 2007, J FOOD PROTECT, V70, P952, DOI 10.4315/0362-028X-70.4.952; Mafart P, 2002, INT J FOOD MICROBIOL, V72, P107, DOI 10.1016/S0168-1605(01)00624-9; Matak KE, 2005, J FOOD PROTECT, V68, P2212, DOI 10.4315/0362-028X-68.10.2212; Polo J, 2005, J ANIM SCI, V83, P1933; Polo J, 2002, P 48 INT C MEAT SCI, V1, P194; Polo J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133008; Pujols J, 2008, VET REC, V163, P536, DOI 10.1136/vr.163.18.536; PUJOLS J, 2007, P AM ASS SWIN VET AM, P281; Pujols J, 2011, VET J, V190, P16; Pujols J, 2014, VET MICROBIOL, V174, P427, DOI 10.1016/j.vetmic.2014.10.021; Shama G, 1992, ENCY FOOD MICROBIOLO, V3, P2208; Shen HG, 2011, J ANIM SCI, V89, P1930, DOI 10.2527/jas.2010-3502; Simmons MJH, 2012, INNOV FOOD SCI EMERG, V14, P122, DOI 10.1016/j.ifset.2011.11.006; Torrallardona D, 2010, ASIAN AUSTRAL J ANIM, V23, P131	37	11	11	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2017	12	4							e0175289	10.1371/journal.pone.0175289	http://dx.doi.org/10.1371/journal.pone.0175289			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0JS	28399166	Green Published, gold, Green Submitted			2022-12-27	WOS:000399949000027
J	Hu, C; Kumar, S; Huang, J; Ratnavelu, K				Hu, Chuan; Kumar, Sameer; Huang, Jiao; Ratnavelu, Kurunathan			Disinhibition of negative true self for identity reconstructions in cyberspace: Advancing self-discrepancy theory for virtual setting	PLOS ONE			English	Article							INTERNET; PERSONALITY; SATISFACTION; FACEBOOK; EXPRESSION; MOTIVATION; MOTIVES; RATINGS; ONLINE; OTHERS	In face-to-face communications, to avoid sanctions and disapproval from others, people are more likely to hide negative aspects of their true self (such as socially undesirable personalities, minds, beliefs and consciousness) to avoid conflict with social norms and laws. The anonymity of cyberspace provides people a unique environment to behave more freely and openly with less restraint from the real word. Existing research related to online true self expression has mainly explored true self as an independent aspect of self. Regarding true self as a two-dimensional concept, this study investigates true self from the perspective of individuals' self-guide and identity reconstruction in both online and offline world. Using qualitative research methods, the current study investigates 57 participants through interviews and questionnaires. Content analysis reveals four factors that motivate people to express more true self (especially negative true self) when reconstructing their online identity and involve true self as a part of their self-guide in anonymous environment. By incorporating true self as an important part of individuals' self-guide and identity online, the current study advances self-discrepancy theory, making it more comprehensive for cyberspace. The results are also interpreted based on self-determination theory. The theoretical contributions of this study are discussed and practical implications are also presented.	[Hu, Chuan] Univ Malaya, Inst Grad Studies, Kuala Lumpur, Malaysia; [Kumar, Sameer; Huang, Jiao] Univ Malaya, Asia Europe Inst, Kuala Lumpur, Malaysia; [Ratnavelu, Kurunathan] Univ Malaya, Inst Math Sci, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Malaya; Universiti Malaya	Hu, C (corresponding author), Univ Malaya, Inst Grad Studies, Kuala Lumpur, Malaysia.	hu_chuan@yahoo.com	Ratnavelu, Kurunathan/A-5463-2009; Kumar, Sameer/E-3246-2010	Ratnavelu, Kurunathan/0000-0002-0774-5086; Kumar, Sameer/0000-0002-6425-278X; Hu, Chuan/0000-0003-1449-725X	University of Malaya grant [UM.C/625/1/HIR/MOHE/SC/13/3]	University of Malaya grant	The study is supported by University of Malaya grant UM.C/625/1/HIR/MOHE/SC/13/3 (http://hir.um.edu.my//). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahadzadeh AS, 2017, COMPUT HUM BEHAV, V68, P8, DOI 10.1016/j.chb.2016.11.011; Amichai-Hamburger Y, 2002, CYBERPSYCHOL BEHAV, V5, P125, DOI 10.1089/109493102753770507; ANDERSON NH, 1968, J PERS SOC PSYCHOL, V9, P272, DOI 10.1037/h0025907; Bargh JA, 2004, ANNU REV PSYCHOL, V55, P573, DOI 10.1146/annurev.psych.55.090902.141922; Bargh JA, 2002, J SOC ISSUES, V58, P33, DOI 10.1111/1540-4560.00247; BAUMEISTER RF, 1995, PSYCHOL BULL, V117, P497, DOI 10.1037/0033-2909.117.3.497; Baumeister RF, 1998, HDB SOCIAL PSYCHOL, P680; Bizman A, 2001, PERS SOC PSYCHOL B, V27, P1291, DOI 10.1177/01461672012710005; Bryant JA, 2006, J COMPUT-MEDIAT COMM, V11; Cahyani N.D.W., 2016, AUST J FORENSIC SCI, V49, P1; Cahyani NDW, 2016, P ANN HICSS, P5617, DOI 10.1109/HICSS.2016.695; Casale Silvia, 2015, Addict Behav Rep, V1, P34, DOI 10.1016/j.abrep.2015.03.008; Cavanagh S, 1997, Nurse Res, V4, P5, DOI 10.7748/nr.4.3.5.s2; Chin CPY, 2015, J ORG COMP ELECT COM, V25, P289, DOI 10.1080/10919392.2015.1058118; Chin CP-Y, 2015, AMCIS 2015 PROCEEDIN; Choo K.-K. R., 2014, ICTS MILLENNIUM DEV, P81, DOI DOI 10.1007/978-1-4899-7439-6_6; Choo KKR, 2011, COMPUT SECUR, V30, P719, DOI 10.1016/j.cose.2011.08.004; Christopherson KM, 2007, COMPUT HUM BEHAV, V23, P3038, DOI 10.1016/j.chb.2006.09.001; Deci E. L., 2002, HDB SELF DETERMINATI, P3, DOI DOI 10.1006/CEPS.1999.1020; Deci EL, 2000, PSYCHOL INQ, V11, P227, DOI 10.1207/S15327965PLI1104_01; DECI EL, 1994, J PERS, V62, P119, DOI 10.1111/j.1467-6494.1994.tb00797.x; Deci EL, 1985, INTRINSIC MOTIVATION; Denzin N. K., 1995, CANADIAN J AGING, V14, P796; Elo S, 2008, J ADV NURS, V62, P107, DOI 10.1111/j.1365-2648.2007.04569.x; Evans LM, 2003, PERS SOC PSYCHOL B, V29, P313, DOI 10.1177/0146167202250090; Gee James Paul, 2001, REV RES EDUC, V25, P99, DOI [DOI 10.3102/0091732X025001099, 10.2307/1167322]; GEER JG, 1988, PUBLIC OPIN QUART, V52, P365, DOI 10.1086/269113; Gollwitzer P., 1986, PUBLIC SELF PRIVATE, P143, DOI DOI 10.1007/978-1-4613-9564-5_7; Hacking I, 1983, REPRESENTING AND INT; Hacking Ian, 1986, RECONSTRUCTING INDIV, P222; Hare R.D., 1991, THE HARE PSYCHOPATHY; Higgins E. T., 1989, ADV EXP SOC PSYCHOL, V22, P93, DOI DOI 10.1016/S0065-2601(08)60306-8; HIGGINS ET, 1987, PSYCHOL REV, V94, P319, DOI 10.1037/0033-295X.94.3.319; HIGGINS ET, 1986, HDB MOTIVATION COGNI, P23; Hu C, 2014, PACIS 2014 PROCEEDIN; Hu C, 2015, COMPUT HUM BEHAV, V50, P465, DOI 10.1016/j.chb.2015.04.027; Imgraben J, 2014, BEHAV INFORM TECHNOL, V33, P1347, DOI 10.1080/0144929X.2014.934286; Jaishankar K, 2008, CRIMES INTERNET, P283; Jin SAA, 2012, COMPUT HUM BEHAV, V28, P2160, DOI 10.1016/j.chb.2012.06.022; Jones D, 2014, ECIS 2014 PROCEEDING; Kelley S, 1983, INTERPRETING ELECTIO; Krishen AS, 2016, J BUS RES, V69, P5248, DOI 10.1016/j.jbusres.2016.04.120; LEVENSON MR, 1995, J PERS SOC PSYCHOL, V68, P151, DOI 10.1037/0022-3514.68.1.151; Mancini T, 2017, COMPUT HUM BEHAV, V69, P275, DOI 10.1016/j.chb.2016.12.031; MANNING P, 1993, SOC PSYCHOL QUART, V56, P178, DOI 10.2307/2786777; Marriott TC, 2014, COMPUT HUM BEHAV, V32, P171, DOI 10.1016/j.chb.2013.11.014; Martini B, 2014, ECIS 2014 PROCEEDING; Mason J., 2002, QUALITATIVE RES; Masur PK, 2014, COMPUT HUM BEHAV, V39, P376, DOI 10.1016/j.chb.2014.05.047; McHoskey JW, 1998, J PERS SOC PSYCHOL, V74, P192, DOI 10.1037/0022-3514.74.1.192; McKenna KYA, 1998, J PERS SOC PSYCHOL, V75, P681, DOI 10.1037/0022-3514.75.3.681; McKenna KYA, 2002, J SOC ISSUES, V58, P9, DOI 10.1111/1540-4560.00246; Myers M. D., 2007, Information and Organization, V17, P2, DOI 10.1016/j.infoandorg.2006.11.001; Poerio GL, 2015, CONSCIOUS COGN, V33, P135, DOI 10.1016/j.concog.2014.12.011; REPASS DE, 1971, AM POLIT SCI REV, V65, P389, DOI 10.2307/1954456; ROGERS CR, 1951, CLIENT CENTERED THER; RUBIN Z, 1975, J EXP SOC PSYCHOL, V11, P233, DOI 10.1016/S0022-1031(75)80025-4; Runeson P, 2009, EMPIR SOFTW ENG, V14, P131, DOI 10.1007/s10664-008-9102-8; Ryan RM, 2000, CONTEMP EDUC PSYCHOL, V25, P54, DOI 10.1006/ceps.1999.1020; Ryan RM, 2000, AM PSYCHOL, V55, P68, DOI 10.1037/0003-066X.55.1.68; Seidman G, 2014, COMPUT HUM BEHAV, V31, P367, DOI 10.1016/j.chb.2013.10.052; Snyder C. R., 2002, HDB POSITIVE PSYCHOL, P382, DOI DOI 10.1111/J.1467-8624.1996.TB01738.X; Strauman TJ, 1996, J PERS SOC PSYCHOL, V71, P1142, DOI 10.1037/0022-3514.71.6.1142; Strauss A., 1990, BASICS OF QUALITATIV; Suh A, 2013, COMPUT HUM BEHAV, V29, P246, DOI 10.1016/j.chb.2012.09.001; Suler J, 2004, CYBERPSYCHOL BEHAV, V7, P321, DOI 10.1089/1094931041291295; Tencent, 2016, TENCENT ANNOUNCES 20; Toma CL, 2013, PERS SOC PSYCHOL B, V39, P321, DOI 10.1177/0146167212474694; Tosun LP, 2012, COMPUT HUM BEHAV, V28, P1510, DOI 10.1016/j.chb.2012.03.018; Tosun LP, 2010, COMPUT HUM BEHAV, V26, P162, DOI 10.1016/j.chb.2009.10.010; Tosun LP, 2009, CYBERPSYCHOL BEHAV, V12, P401, DOI 10.1089/cpb.2009.0006; Ventegodt Soren, 2003, ScientificWorldJournal, V3, P1302; Wallenberg M, 1998, THE DECLINE OF AMERI; Wang YC, 2016, 34TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, CHI 2016, P125, DOI 10.1145/2858036.2858502; Weber R. P., 1990, BASIC CONTENT ANALYS; WHITE RW, 1959, PSYCHOL REV, V66, P297, DOI 10.1037/h0040934; Wylie RC., 1979, THE SELF CONCEPT THE; Yurchisin J, 2005, SOC BEHAV PERSONAL, V33, P735, DOI 10.2224/sbp.2005.33.8.735	78	16	16	6	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2017	12	4							e0175623	10.1371/journal.pone.0175623	http://dx.doi.org/10.1371/journal.pone.0175623			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET0JS	28399153	Green Submitted, Green Published, gold			2022-12-27	WOS:000399949000054
J	Li, YJ; Su, J; Li, FF; Chen, X; Zhang, GY				Li, Yongjian; Su, Juan; Li, Fangfang; Chen, Xiang; Zhang, Guiying			MiR-150 regulates human keratinocyte proliferation in hypoxic conditions through targeting HIF-1 alpha and VEGFA: Implications for psoriasis treatment	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; OVER-EXPRESSION; UP-REGULATION; MICRORNAS; ANGIOGENESIS; SKIN; INFLAMMATION; RNAS	Psoriasis is a common and chronic autoimmune skin disease which affects 2 to 3% of the world population. Abnormal proliferation of human keratinocytes is an important feature of psoriasis, along with local hypoxia and vascular abnormal growth. To leverage recent molecular findings into the personalized treatment of psoriasis, we need a strategy that integrates clinical stratification with molecular phenotyping. MicroRNAs (miRNAs) are a large family of small non-coding RNA which regulates diverse biological process, including cell proliferation, by modulating gene expression at the posttranscriptional level. In the present study, we indicated that miR-150 specifically down-regulated expressed in psoriatic skin lesions, and could inhibit HaCaT cells and primary adult human keratinocytes (HKCs)' proliferation in either normal or hypoxia conditions; by direct targeting, miR-150 could also regulate the expression of hypoxia-inducible factor-1 alpha (HIF-1 alpha) and vascular endothelial growth factor A (VEGFA). In addition, we found that HIF-1 alpha and VEGFA were highly expressed in the lesional psoriatic skin compared with the non-lesional psoriatic skin, and negatively correlated with miR-150 expression. Taken together, we indicated miR-150 regulates human keratinocytes' proliferation in hypoxic conditions through targeting HIF-1 alpha and VEGFA in psoriasis for the first time, and provide diagnostic markers and a novel target for psoriasis treatment.	[Li, Yongjian] Nanhua Univ, Affiliated Hosp 2, Dept Dermatol, Hengyang, Hunan, Peoples R China; [Su, Juan; Li, Fangfang] Cent S Univ, XiangYa Hosp, Dept Dermatol, Hunan Key Lab Skin Canc & Psoriasis, Changsha, Hunan, Peoples R China; [Chen, Xiang] Cent S Univ, XiangYa Hosp, Dept Dermatol, Changsha, Hunan, Peoples R China; [Zhang, Guiying] Cent S Univ, Xiangya Hosp 2, Dept Dermatol, Changsha, Hunan, Peoples R China	University of South China; Central South University; Central South University; Central South University	Zhang, GY (corresponding author), Cent S Univ, Xiangya Hosp 2, Dept Dermatol, Changsha, Hunan, Peoples R China.	Zhangguiying67@aliyun.com			Science and Technology Plan Project of Hunan [2013FJ3131]	Science and Technology Plan Project of Hunan	This work was supported by the Science and Technology Plan Project of Hunan (2013FJ3131) to YL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albanesi C, 2007, CLIN DERMATOL, V25, P581, DOI 10.1016/j.clindermatol.2007.08.013; [Anonymous], 2016, T AUTOM SCI ENG, DOI DOI 10.1038/ONCSIS.2016.35; Boehncke WH, 2011, EXP DERMATOL, V20, P303, DOI 10.1111/j.1600-0625.2011.01261.x; Campanati A, 2009, INT J IMMUNOPATH PH, V22, P371, DOI 10.1177/039463200902200214; Esteller M, 2011, NAT REV GENET, V12, P861, DOI 10.1038/nrg3074; Gladman DD, 2005, ANN RHEUM DIS, V64, P14, DOI 10.1136/ard.2004.032482; Gu X, 2010, P63 AND EPITHELIAL H; Hawkes JE, 2016, J INVEST DERMATOL, V136, P365, DOI 10.1038/JID.2015.409; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Jimenez SA, 2013, AUTOIMMUN REV, V12, P1046, DOI 10.1016/j.autrev.2013.04.004; Jinnin Masatoshi, 2011, Nihon Rinsho Meneki Gakkai Kaishi, V34, P439; Bueno MJ, 2008, CELL CYCLE, V7, P3143, DOI 10.4161/cc.7.20.6833; Kim J, 2015, PLOS ONE, V10; Koo J, 1996, DERMATOL CLIN, V14, P485, DOI 10.1016/S0733-8635(05)70376-4; Lambert JLW, 2015, BRIT J DERMATOL, V173, P323, DOI 10.1111/bjd.13837; Lerman G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020916; Li W, 2014, DISCOV MED, V18, P97; Li Y., 2014, J BIOMATER TISS ENG, V4, P1; Liu YC, 2013, PROTEIN CELL, V4, P932, DOI 10.1007/s13238-013-3092-z; Meki ARMA, 2014, J CLIN LAB ANAL, V28, P496, DOI 10.1002/jcla.21717; Mendell JT, 2005, CELL CYCLE, V4, P1179, DOI 10.4161/cc.4.9.2032; Neimann AL, 2006, J AM ACAD DERMATOL, V55, P829, DOI 10.1016/j.jaad.2006.08.040; Rosenberger C, 2007, J INVEST DERMATOL, V127, P2445, DOI 10.1038/sj.jid.5700874; Schon MP, 2005, LANCET, V366, P1333, DOI 10.1016/S0140-6736(05)67542-3; Simonetti O, 2006, INT J IMMUNOPATH PH, V19, P751, DOI 10.1177/039463200601900405; Singh RP, 2013, AUTOIMMUN REV, V12, P1160, DOI 10.1016/j.autrev.2013.07.003; Sun JJ, 2016, MOL MED REP, V13, P4499, DOI 10.3892/mmr.2016.5066; Tao J, 2008, J DERMATOL SCI, V51, P203, DOI 10.1016/j.jdermsci.2008.04.012; Torales-Cardena A, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/607363; Tovar-Castillo LE, 2007, INT J DERMATOL, V46, P239, DOI 10.1111/j.1365-4632.2006.02962.x; Vasilopoulos Y, 2013, CYTOKINE, V62, P38, DOI 10.1016/j.cyto.2013.02.029; Wang M, 2016, ONCOTARGET; Wang R, 2014, FEBS LETT, V588, P4438, DOI 10.1016/j.febslet.2014.09.045; Wu ZH, 2016, ONCOL REP, V35, P1696, DOI 10.3892/or.2015.4529; Yu ZY, 2013, MOL MED REP, V8, P287, DOI 10.3892/mmr.2013.1493	35	28	28	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2017	12	4							e0175459	10.1371/journal.pone.0175459	http://dx.doi.org/10.1371/journal.pone.0175459			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0JS	28399173	Green Published, gold, Green Submitted			2022-12-27	WOS:000399949000039
J	Sartakhti, JS; Manshaei, MH; Basanta, D; Sadeghi, M				Sartakhti, Javad Salimi; Manshaei, Mohammad Hossein; Basanta, David; Sadeghi, Mehdi			Evolutionary emergence of angiogenesis in avascular tumors using a spatial public goods game	PLOS ONE			English	Article							CANCER; COOPERATION; DYNAMICS; NORMALIZATION; HETEROGENEITY; VASCULATURE; COMPETITION; MECHANISMS; RESISTANCE; DIFFUSION	Natural selection in cancer often results in the emergence of increasingly malignant tumor cells that display many if not all of the hallmarks of cancer. One of the most important traits acquired during cancer progression is angiogenesis. Tumor cells capable of secreting pro-angiogenic factors can be seen as cooperators where the improved oxygenation, nutrient delivery and waste disposal resulting from angiogenesis could be seen as a public good. Under this view, the relatively costly secretion of molecular signals required to orchestrate angiogenesis would be undertaken exclusively by cooperating tumor cells but the benefits of angiogenesis would be felt by neighboring tumor cells regardless of their contribution to the process. In this work we detail a mathematical model to better understand how clones capable of secreting pro-angiogenic factors can emerge in a tumor made of non-cooperative tumor cells. Given the importance of the spatial configuration of the tumor in determining the efficacy of the secretion of pro-angiogenic factors as well as the benefits of angiogenesis we have developed a spatial game theoretic approach where interactions and public good diffusion are described by graphs. The results show that structure of the population affects the evolutionary dynamics of the pro-angiogenic clone. Specifically, when the benefit of angiogenesis is represented by sigmoid function with regards to the number of pro-angiogenic clones then the probability of the coexistence of pro-angiogenic and angiogenesis-neutral clones increases. Our results demonstrate that pro-angiogenic clone equilibrates into clusters that appear from surrounding vascular tissues towards the center of tumor. These clusters appear notably less dense after anti-angiogenic therapy.	[Sartakhti, Javad Salimi; Manshaei, Mohammad Hossein] Isfahan Univ Technol, Dept Elect & Comp Engn, Esfahan 8415683111, Iran; [Basanta, David] H Lee Moffitt Canc Ctr & Res Inst, Integrated Math Oncol, Tampa, FL 33612 USA; [Sadeghi, Mehdi] Natl Inst Genet Engn & Biotechnol, Tehran, Iran; [Sadeghi, Mehdi] Inst Res Fundamental Sci, Sch Biol Sci, Tehran, Iran	Isfahan University of Technology; H Lee Moffitt Cancer Center & Research Institute	Manshaei, MH (corresponding author), Isfahan Univ Technol, Dept Elect & Comp Engn, Esfahan 8415683111, Iran.	manshaei@cc.iut.ac.ir		Basanta, David/0000-0002-8527-0776				Ahmad SA, 2002, SEMIN CANCER BIOL, V12, P105, DOI 10.1006/scbi.2001.0418; Anderson ARA, 1998, B MATH BIOL, V60, P857, DOI 10.1006/bulm.1998.0042; Archetti M, 2013, BRIT J CANCER, V109, P1056, DOI 10.1038/bjc.2013.336; Archetti M, 2016, J THEOR BIOL, V396, P191, DOI 10.1016/j.jtbi.2016.02.027; Archetti M, 2015, P NATL ACAD SCI USA, V112, P1833, DOI 10.1073/pnas.1414653112; Archetti M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108526; Archetti M, 2014, J THEOR BIOL, V341, P1, DOI 10.1016/j.jtbi.2013.09.017; Axelrod R, 2006, P NATL ACAD SCI USA, V103, P13474, DOI 10.1073/pnas.0606053103; Azam F, 2010, EUR J CANCER, V46, P1323, DOI 10.1016/j.ejca.2010.02.020; Bach LA, 2001, EUR J CANCER, V37, P2116, DOI 10.1016/S0959-8049(01)00246-5; Bejan A, 2011, J APPL PHYS, V110, DOI 10.1063/1.3606555; Bergers G, 2003, NAT REV CANCER, V3, P401, DOI 10.1038/nrc1093; Bickel ST, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091992; Chen MH, 2016, PHYS LETT A, V380, P40, DOI 10.1016/j.physleta.2015.09.047; Chen MH, 2015, APPL MATH COMPUT, V251, P192, DOI 10.1016/j.amc.2014.11.052; Crowther M, 2001, J LEUKOCYTE BIOL, V70, P478; Csikasz-Nagy A, 2013, SEMIN CANCER BIOL, V23, P293, DOI 10.1016/j.semcancer.2013.05.009; Dobay A, 2014, J EVOLUTION BIOL, V27, P1869, DOI 10.1111/jeb.12437; Eichhorn ME, 2007, LANGENBECK ARCH SURG, V392, P371, DOI 10.1007/s00423-007-0150-0; Fang JS, 2008, SEMIN CANCER BIOL, V18, P330, DOI 10.1016/j.semcancer.2008.03.011; Gibbs MN, 2000, IEEE T NEURAL NETWOR, V11, P1458, DOI 10.1109/72.883477; GIMBRONE MA, 1976, JNCI-J NATL CANCER I, V56, P305, DOI 10.1093/jnci/56.2.305; Goel S, 2011, PHYSIOL REV, V91, P1071, DOI 10.1152/physrev.00038.2010; Goymer P, 2008, NATURE, V454, P1047, DOI 10.1038/4541046a; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hermann PC, 2010, SEMIN CANCER BIOL, V20, P77, DOI 10.1016/j.semcancer.2010.03.004; Hofbauer J, 1998, EVOLUTIONARY GAMES P; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; Jana BK, 2010, IMPACT OF CLIMATE CHANGE ON NATURAL RESOURCE MANAGEMENT, P1, DOI 10.1007/978-90-481-3581-3; JOUANNEAU J, 1994, P NATL ACAD SCI USA, V91, P286, DOI 10.1073/pnas.91.1.286; Julou T, 2013, P NATL ACAD SCI USA, V110, P12577, DOI 10.1073/pnas.1301428110; Krock Bryan L, 2011, Genes Cancer, V2, P1117, DOI 10.1177/1947601911423654; Kunz Manfred, 2003, Mol Cancer, V2, P23, DOI 10.1186/1476-4598-2-23; Loeschcke, 2003, J THEORETICAL MED, P5, DOI [10.1080/10273660310001630443, DOI 10.1080/10273660310001630443]; Merlo LMF, 2006, NAT REV CANCER, V6, P924, DOI 10.1038/nrc2013; Morikawa S, 2002, AM J PATHOL, V160, P985, DOI 10.1016/S0002-9440(10)64920-6; Nadell CD, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000716; Nagy JD, 2004, B MATH BIOL, V66, P663, DOI 10.1016/j.bulm.2003.10.001; Nagy JD, 2012, MATH BIOSCI ENG, V9, P843, DOI 10.3934/mbe.2012.9.843; Neufeld G, 1999, FASEB J, V13, P9, DOI 10.1096/fasebj.13.1.9; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; Sartakhti JS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168856; Shoham Y., 2008, MULTIAGENT SYSTEMS A, DOI DOI 10.1017/CBO9780511811654; Spencer SL, 2006, PLOS COMPUT BIOL, V2, P939, DOI 10.1371/journal.pcbi.0020108; Tarnita CE, 2009, P NATL ACAD SCI USA, V106, P8601, DOI 10.1073/pnas.0903019106; Tomlinson IPM, 1997, BRIT J CANCER, V75, P157, DOI 10.1038/bjc.1997.26; Tonini T, 2003, ONCOGENE, V22, P6549, DOI 10.1038/sj.onc.1206816; Vasudev NS, 2014, ANGIOGENESIS, V17, P471, DOI 10.1007/s10456-014-9420-y; Veikkola T, 1999, SEMIN CANCER BIOL, V9, P211, DOI 10.1006/scbi.1998.0091; Willett CG, 2004, NAT MED, V10, P145, DOI 10.1038/nm988; Ziyad Safiyyah, 2011, Genes Cancer, V2, P1085, DOI 10.1177/1947601911432334; Zong WX, 2006, GENE DEV, V20, P1, DOI 10.1101/gad.1376506	52	4	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2017	12	4							e0175063	10.1371/journal.pone.0175063	http://dx.doi.org/10.1371/journal.pone.0175063			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0JS	28399181	Green Submitted, gold, Green Published			2022-12-27	WOS:000399949000018
J	Kronander, E; Michalski, N; Lebrand, C; Hornung, JP; Schneggenburger, R				Kronander, Elin; Michalski, Nicolas; Lebrand, Cecile; Hornung, Jean-Pierre; Schneggenburger, Ralf			An organotypic slice culture to study the formation of calyx of Held synapses in-vitro	PLOS ONE			English	Article							VENTRAL COCHLEAR NUCLEUS; REGULATES SYNAPTIC GROWTH; SUPERIOR OLIVARY COMPLEX; TRAPEZOID BODY; POSTNATAL-DEVELOPMENT; MEDIAL NUCLEUS; II RECEPTOR; PROJECTIONS; EXPRESSION; RELEASE	The calyx of Held, a large axo-somatic relay synapse containing hundreds of presynaptic active zones, is possibly the largest nerve terminal in the mammalian CNS. Studying its initial growth in-vitro might provide insights into the specification of synaptic connection size in the developing brain. However, attempts to maintain calyces of Held in organotypic cultures have not been fruitful in past studies. Here, we describe an organotypic slice culture method in which calyces of Held form in-vitro. We made coronal brainstem slices with an optimized slice angle using newborn mice in which calyces have not yet formed; the presynaptic bushy cells were genetically labeled using the Math5 promoter. After six to nine days of culturing, we readily observed large Math5-positive nerve terminals in the medial nucleus of the trapezoid body (MNTB), but not in the neighboring lateral superior olive nucleus (LSO). These calyx-like synapses expressed the Ca2+- sensor Synaptotagmin-2 (Syt-2) and the Ca2+ binding protein Parvalbumin (PV), two markers of developing calyces of Held in vivo. Application of the BMP inhibitor LDN-193189 significantly inhibited the growth of calyx synapses, demonstrating the feasibility of long-term pharmacological manipulation using this organotypic culture method. These experiments provide a method for organotypic culturing of calyces of Held, and show that the formation of calyx-like synapses onto MNTB neurons can be preserved in-vitro. Furthermore, our study adds pharmacological evidence for a role of BMP-signaling in the formation of large calyx of Held synapses.	[Kronander, Elin; Michalski, Nicolas; Schneggenburger, Ralf] Brain Mind Inst, Sch Life Sci, EPFL, Lab Synapt Mech, Lausanne, Switzerland; [Lebrand, Cecile; Hornung, Jean-Pierre] Univ Lausanne, Dept Fundamental Neurosci, Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Lausanne	Schneggenburger, R (corresponding author), Brain Mind Inst, Sch Life Sci, EPFL, Lab Synapt Mech, Lausanne, Switzerland.	ralf.schneggenburger@epfl.ch	; Lebrand, Cecile/G-1394-2015	michalski, nicolas/0000-0002-1287-2709; Kronander, Elin/0000-0003-0280-6318; Lebrand, Cecile/0000-0002-2750-3164	Swiss National Science Foundation [CRSII3_154455/1]; Deutsche Forschungsgemeinschaft (DFG) [SCHN 451/5-2]; Marie-Curie program of the European Union [IEF-235223-Calyx-MMFF]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Marie-Curie program of the European Union(European Commission)	This research was supported by grants of the Swiss National Science Foundation (Sinergia program CRSII3_154455/1) http://www.snf.ch/en/Pages/default.aspx, the Deutsche Forschungsgemeinschaft (DFG Priority Program 1608" Ultrafast and temporally precise information processing: Normal and dysfunctional hearing", SCHN 451/5-2) http://www.pp1608.com/ to RS, and by a post-doctoral fellowship to NM (Marie-Curie program of the European Union, IEF-235223-Calyx-MMFF) http://ec.europa.eu/research/mariecurieactions/index_en.htm. The funders had no role instudy design,data collection and analysis,decision to publish,or preparation of the manuscript.	Aberle H, 2002, NEURON, V33, P545, DOI 10.1016/S0896-6273(02)00589-5; Borst JGG, 2012, ANNU REV PHYSIOL, V74, P199, DOI 10.1146/annurev-physiol-020911-153236; Borst JGG, 1995, J PHYSIOL-LONDON, V489, P825, DOI 10.1113/jphysiol.1995.sp021095; Cant NB, 2003, BRAIN RES BULL, V60, P457, DOI 10.1016/S0361-9230(03)00050-9; Cuny GD, 2008, BIOORG MED CHEM LETT, V18, P4388, DOI 10.1016/j.bmcl.2008.06.052; Dimitrov D, 2016, J NEUROSCI, V36, P3600, DOI 10.1523/JNEUROSCI.3869-15.2016; Dudu V, 2006, CURR BIOL, V16, P625, DOI 10.1016/j.cub.2006.02.061; Felmy F, 2004, EUR J NEUROSCI, V20, P1473, DOI 10.1111/j.1460-9568.2004.03604.x; FORSYTHE ID, 1994, J PHYSIOL-LONDON, V479, P381, DOI 10.1113/jphysiol.1994.sp020303; FRIAUF E, 1993, J COMP NEUROL, V334, P59, DOI 10.1002/cne.903340105; FRIAUF E, 1988, EXP BRAIN RES, V73, P263; HARRISON JM, 1966, J COMP NEUROL, V126, P51, DOI 10.1002/cne.901260105; Hoffpauir BK, 2006, J NEUROSCI, V26, P5511, DOI 10.1523/JNEUROSCI.5525-05.2006; Holcomb PS, 2013, J NEUROSCI, V33, P12954, DOI 10.1523/JNEUROSCI.1087-13.2013; Howell DM, 2007, J COMP NEUROL, V504, P533, DOI 10.1002/cne.21443; Hsieh CY, 2006, J COMP NEUROL, V497, P589, DOI 10.1002/cne.21002; KANDLER K, 1993, J COMP NEUROL, V328, P161, DOI 10.1002/cne.903280202; KITZES LM, 1995, J COMP NEUROL, V353, P341, DOI 10.1002/cne.903530303; Kochubey O, 2011, NEURON, V69, P736, DOI 10.1016/j.neuron.2011.01.013; Lauer AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073308; Livet J, 2007, NATURE, V450, P56, DOI 10.1038/nature06293; Lohmann C, 1998, J NEUROBIOL, V34, P97, DOI 10.1002/(SICI)1097-4695(19980205)34:2<97::AID-NEU1>3.0.CO;2-6; Longair MH, 2011, BIOINFORMATICS, V27, P2453, DOI 10.1093/bioinformatics/btr390; Lou XL, 2008, J NEUROSCI, V28, P8257, DOI 10.1523/JNEUROSCI.0550-08.2008; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Marques G, 2002, NEURON, V33, P529, DOI 10.1016/S0896-6273(02)00595-0; McCabe BD, 2003, NEURON, V39, P241, DOI 10.1016/S0896-6273(03)00426-4; Miyazono K, 2010, J BIOCHEM, V147, P35, DOI 10.1093/jb/mvp148; Renier N, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000325; Rodriguez-Contreras A, 2006, J COMP NEUROL, V496, P214, DOI 10.1002/cne.20918; Rodriguez-Contreras A, 2008, P NATL ACAD SCI USA, V105, P5603, DOI 10.1073/pnas.0801395105; Saitoh N, 2001, P NATL ACAD SCI USA, V98, P14017, DOI 10.1073/pnas.241333598; Saul SM, 2008, MOL CELL NEUROSCI, V37, P153, DOI 10.1016/j.mcn.2007.09.006; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schneggenburger R, 2006, CELL TISSUE RES, V326, P311, DOI 10.1007/s00441-006-0272-7; SMITH PH, 1991, J COMP NEUROL, V304, P387, DOI 10.1002/cne.903040305; SPIROU GA, 1990, J NEUROPHYSIOL, V63, P1169, DOI 10.1152/jn.1990.63.5.1169; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Sun J, 2007, NATURE, V450, P676, DOI 10.1038/nature06308; Tong HX, 2010, J PHYSIOL-LONDON, V588, P1451, DOI 10.1113/jphysiol.2009.186676; Toyoshima M, 2009, DEV BIOL, V336, P192, DOI 10.1016/j.ydbio.2009.09.043; WEBSTER DB, 1982, AM J ANAT, V163, P103, DOI 10.1002/aja.1001630202; Xiao L, 2013, NAT NEUROSCI, V16, P856, DOI 10.1038/nn.3414; Xu JH, 2016, J NEUROSCI, V36, P4408, DOI 10.1523/JNEUROSCI.3627-15.2016; Yang ZY, 2003, DEV BIOL, V264, P240, DOI 10.1016/j.ydbio.2003.08.005; Yu WM, 2014, HEARING RES, V311, P3, DOI 10.1016/j.heares.2014.01.007	46	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2017	12	4							e0175964	10.1371/journal.pone.0175964	http://dx.doi.org/10.1371/journal.pone.0175964			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KH	28419135	Green Published, Green Submitted, gold			2022-12-27	WOS:000399875200057
J	Chilimampunga, C; Lijenje, S; Sherman, J; Nindi, K; Mavhu, W				Chilimampunga, Charles; Lijenje, Simeon; Sherman, Judith; Nindi, Kelvin; Mavhu, Webster			Acceptability and feasibility of early infant male circumcision for HIV prevention in Malawi	PLOS ONE			English	Article							RANDOMIZED NONINFERIORITY TRIAL; NEONATAL MALE CIRCUMCISION; ACCUCIRC DEVICE; MOGEN CLAMP; QUALITATIVE FINDINGS; NURSE-MIDWIVES; SCALING-UP; ZIMBABWE; BOTSWANA; LUSAKA	Background Voluntary medical male circumcision (VMMC) has been successfully implemented in 14 countries as an additional HIV prevention intervention. As VMMC programs mature in most countries, the focus is now on how to sustain the HIV prevention gains realised from VMMC. As part of preparations for the sustainability phase, countries are either piloting or preparing to pilot early infant male circumcision (EIMC). This qualitative study explored the acceptability and feasibility of EIMC in Malawi in order to inform pilot implementation. Methods In 2016, 23 focus group discussions were held across Malawi with participants from several ethnicities and religions/faiths. Additionally, 21 key informant interviews were held with traditional and religious leaders, traditional circumcisers (ngalibas), policy-makers, programme managers and health-care workers. Audio recordings were transcribed, translated into English (where necessary), and thematically coded using NVivo 10. Results Discussions highlighted the socio-cultural significance of MC in Malawi. Knowledge or experience of EIMC was poor although acceptability was high among most ethnic/religious groups and key informants. Participants identified EIMC's comparative HIV benefits although a few health-care workers expressed scepticism. All participants said EIMC should be offered within a clinical setting. In addition to fathers, maternal uncles and traditional leaders were deemed key decision-makers. Potential barriers to EIMC included concerns about procedure safety as well as cultural considerations. Key informants felt it was feasible to offer EIMC in Malawi. Participants' recommendations, including phased implementation, engagement of traditional leaders, use of external mobilisers and initially reaching out to influential parents, will be taken into account when designing a pilot EIMC program. Conclusions EIMC is potentially an acceptable and feasible HIV prevention intervention for most ethnic/ religious groups in Malawi if wide-ranging, culturally appropriate demand-creation activities are developed, piloted, evaluated and appropriately implemented.	[Chilimampunga, Charles] Univ Malawi, Chancellor Coll, Zomba, Malawi; [Lijenje, Simeon] Minist Hlth, Lilongwe, Malawi; [Sherman, Judith; Nindi, Kelvin] UNICEF, Lilongwe, Malawi; [Mavhu, Webster] Ctr Sexual Hlth & HIV AIDS Res CeSHHAR, Harare, Zimbabwe; [Mavhu, Webster] Univ Liverpool Liverpool Sch Trop Med, Liverpool, Merseyside, England	University of Malawi; Liverpool School of Tropical Medicine	Mavhu, W (corresponding author), Ctr Sexual Hlth & HIV AIDS Res CeSHHAR, Harare, Zimbabwe.; Mavhu, W (corresponding author), Univ Liverpool Liverpool Sch Trop Med, Liverpool, Merseyside, England.	wmavhu@gmail.com		Mavhu, Webster/0000-0003-1881-4398	UNICEF Malawi	UNICEF Malawi	The study was funded by UNICEF Malawi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amuri M, 2016, GLOB HEALTH-SCI PRAC, V4, pS29, DOI 10.9745/GHSP-D-15-00210; BENGO JM, 2010, SITUATION ANAL MALE; Binagwaho A, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000211; Bowa K, 2013, JAIDS-J ACQ IMM DEF, V62, pE1, DOI 10.1097/QAI.0b013e318275741b; Bowen GA, 2008, QUAL RES, V8, P137, DOI 10.1177/1468794107085301; Davey DLJ, 2016, AIDS, V30, P1847, DOI 10.1097/QAD.0000000000001121; Fitzgerald L, 2016, GLOB HEALTH-SCI PRAC, V4, pS76, DOI 10.9745/GHSP-D-15-00186; Green J, 2009, QUALITATIVE METHODS; Homfray V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130396; Kahn JG, 2006, PLOS MED, V3, P2349, DOI 10.1371/journal.pmed.0030517; Kalichman SC, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000219; Kankaka EN, 2016, BJU INT; Kikaya V, 2016, GLOB HEALTH-SCI PRAC, V4, pS87, DOI 10.9745/GHSP-D-15-00231; Luo CW, 2016, GLOB HEALTH-SCI PRAC, V4, pS1, DOI 10.9745/GHSP-D-16-00106; Mangenah C, 2016, GLOB HEALTH-SCI PRAC, V4, pS68, DOI 10.9745/GHSP-D-15-00201; Mangenah C, 2015, JAIDS-J ACQ IMM DEF, V69, P560, DOI 10.1097/QAI.0000000000000699; Mavhu W, 2014, FEASIBILITY ACCEPTAB; Mavhu W, 2017, BMC INT HEALTH HUM R, V17, DOI 10.1186/s12914-016-0111-1; Mavhu W, 2016, GLOB HEALTH-SCI PRAC, V4, pS42, DOI 10.9745/GHSP-D-15-00199; Mavhu W, 2016, GLOB HEALTH-SCI PRAC, V4, pS55, DOI 10.9745/GHSP-D-15-00200; Mavhu W, 2015, JAIDS-J ACQ IMM DEF, V69, pe156, DOI 10.1097/QAI.0000000000000694; Mavhu W, 2014, AIDS BEHAV, V18, P1776, DOI 10.1007/s10461-014-0835-7; Mavhu W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032475; Mavhu W, 2011, TROP MED INT HEALTH, V16, P589, DOI 10.1111/j.1365-3156.2011.02744.x; Mavundla TR, 2009, J TRANSCULT NURS, V20, P395, DOI 10.1177/1043659609340801; Mutombo N, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2384-z; National Statistical Office (NSO) and ICF Macro, 2011, MAL DEM HLTH SURV 20; Njeuhmeli E, 2016, GLOB HEALTH-SCI PRAC, V4, pS9, DOI 10.9745/GHSP-D-16-00159; Njeuhmeli E, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001132; Parkhurst JO, 2015, SOC SCI MED, V135, P15, DOI 10.1016/j.socscimed.2015.04.020; Plank RM, 2014, JAIDS-J ACQ IMM DEF, V66, P1, DOI 10.1097/QAI.0000000000000136; Plank RM, 2013, JAIDS-J ACQ IMM DEF, V62, pE131, DOI 10.1097/QAI.0b013e318285d449; Plank RM, 2010, AIDS BEHAV, V14, P1198, DOI 10.1007/s10461-009-9632-0; Ritchie J., 2003, GUIDE SOCIAL SCI STU, P77; Sint TT, 2016, GLOB HEALTH-SCI PRAC, V4, pS3, DOI 10.9745/GHSP-D-15-00229; United Nations Children's Fund (UNICEF), 2014, EARL INF MAL CIRC RE; Waters E, 2013, AIDS BEHAV, V17, P2114, DOI 10.1007/s10461-012-0297-8; Weiss HA, 2006, SEX TRANSM INFECT, V82, P101, DOI 10.1136/sti.2005.017442; World Health Organization, 2016, VOL MED MAL CIRC HIV; World Health Organization, 2007, NEW DAT MAL CIRC HIV; Young MR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047395	41	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2017	12	4							e0175873	10.1371/journal.pone.0175873	http://dx.doi.org/10.1371/journal.pone.0175873			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KD	28414783	gold, Green Accepted, Green Published			2022-12-27	WOS:000399874800071
J	Jain, V; Marshall, IJ; Crichton, SL; McKevitt, C; Rudd, AG; Wolfe, CDA				Jain, Vageesh; Marshall, Iain J.; Crichton, Siobhan L.; McKevitt, Christopher; Rudd, Anthony G.; Wolfe, Charles D. A.			Trends in the prevalence and management of pre-stroke atrial fibrillation, the South London Stroke Register, 1995-2014	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; SHARED DECISION-MAKING; RISK STRATIFICATION; ANTITHROMBOTIC TREATMENT; ORAL ANTICOAGULANTS; WARFARIN USE; THROMBOEMBOLISM; METAANALYSIS; POPULATION; PREDICTORS	Background Previous studies have found low use of anticoagulation prior to stroke, in people with atrial fibrillation (AF). This study examined data on patients with AF-related stroke from a population- based stroke register, and sought to examine changes in management of AF prior to stroke, and reasons for suboptimal treatment, in those who were known to be at a high risk of stroke. Methods The South London Stroke Register (SLSR) is an ongoing population-based register recording first-in-a-lifetime stroke. Trends in the prevalence of AF, and antithrombotic medication prescribed before the stroke, were investigated from 1995 to 2014. Multivariable logistic regression analyses were conducted to assess the factors associated with appropriate management. Results Of the 5041 patients on the register, 816 (16.2%) were diagnosed with AF before their stroke. AF related stroke increased substantially among Black Carribean and Black African patients, comprising 5% of the overall cohort in 1995 - 1998, increasing to 25% by 2011 - 2014 (p<0.001). Anticoagulant prescription in AF patients at high-risk of stroke (CHADS2 score [> = 2]) increased from 9% (1995 - 1998) to 30% (2011 - 2014) (p<0.001). Antiplatelet prescription was more commonly prescribed throughout all time periods (43% to 64% of high-risk patients.) Elderly patients (> 65) were significantly less likely to be prescribed an anticoagulant, with ethnicity, gender and deprivation showing no association with anticoagulation. Conclusions Most AF-related strokes occurred in people who could have been predicted to be at high risk before their stroke, yet were not prescribed optimal preventative treatment. The elderly, despite being at highest stroke risk, were rarely prescribed anticoagulants.	[Jain, Vageesh] Kings Coll London, Sch Med, London, England; [Marshall, Iain J.; Crichton, Siobhan L.; McKevitt, Christopher; Rudd, Anthony G.; Wolfe, Charles D. A.] Kings Coll London, Div Hlth & Social Care Res, London, England; [McKevitt, Christopher; Rudd, Anthony G.; Wolfe, Charles D. A.] Guys & St Thomas NHS Fdn Trust, Natl Inst Hlth Res, Comprehens Biomed Res Ctr, London, England; [McKevitt, Christopher; Rudd, Anthony G.; Wolfe, Charles D. A.] Kings Coll London, London, England	University of London; King's College London; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Jain, V (corresponding author), Kings Coll London, Sch Med, London, England.	vageesh.jain@kcl.ac.uk	mckevitt, christopher/AAN-7271-2021	Marshall, Iain/0000-0003-2594-2654; Crichton, Siobhan/0000-0001-9962-083X; MCKEVITT, CHRISTOPHER/0000-0002-5290-4613	National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care South London at King's College Hospital NHS Foundation Trust; NIHR Program Grant for Applied Research funding scheme [RP-PG-0407-10184]; Northern & Yorkshire NHS R&D Program in Cardiovascular Disease and Stroke; Guy's and St Thomas' Hospitals Charitable Foundation; Stanley Thomas Johnson Foundation; Stroke Association; Department of Health Healthcare Quality Improvement Partnership; National Institute for Health Research (NIHR) Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust and King's College London; UK Medical Research Council (MRC), through its Skills Development Fellowship program [MR/N015185/1]; MRC [MR/N015185/1] Funding Source: UKRI; Medical Research Council [MR/N015185/1] Funding Source: researchfish	National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care South London at King's College Hospital NHS Foundation Trust; NIHR Program Grant for Applied Research funding scheme; Northern & Yorkshire NHS R&D Program in Cardiovascular Disease and Stroke; Guy's and St Thomas' Hospitals Charitable Foundation; Stanley Thomas Johnson Foundation; Stroke Association; Department of Health Healthcare Quality Improvement Partnership; National Institute for Health Research (NIHR) Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust and King's College London; UK Medical Research Council (MRC), through its Skills Development Fellowship program; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The research supported by the National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care South London at King's College Hospital NHS Foundation Trust, and the NIHR Program Grant for Applied Research funding scheme (RP-PG-0407-10184). The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health who had no role in study design, data collection/analysis, decision to publish, or preparation of manuscript. The SLSR has also received funding from the Northern & Yorkshire NHS R&D Program in Cardiovascular Disease and Stroke, Guy's and St Thomas' Hospitals Charitable Foundation, the Stanley Thomas Johnson Foundation, the Stroke Association, and Department of Health Healthcare Quality Improvement Partnership.; CW and CM acknowledge support from the National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care South London at King's College Hospital NHS Foundation Trust.; CW and CM acknowledge support from the National Institute for Health Research (NIHR) Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust and King's College London.; IJM acknowledges support from the UK Medical Research Council (MRC), through its Skills Development Fellowship program, grant MR/N015185/1	Ansell J, 2012, CIRCULATION, V125, P165, DOI 10.1161/CIRCULATIONAHA.111.031153; Baczek VL, 2012, BMC FAM PRACT, V13, DOI 10.1186/1471-2296-13-5; Bauer KA, 2013, HEMATOL-AM SOC HEMAT, P464, DOI 10.1182/asheducation-2013.1.464; Chen JY, 2013, J GERIATR CARDIOL, V10, P258, DOI 10.3969/j.issn.1671-5411.2013.03.004; Dentali F, 2012, CIRCULATION, V126, P2381, DOI 10.1161/CIRCULATIONAHA.112.115410; DeWilde S, 2006, HEART, V92, P1064, DOI 10.1136/hrt.2005.069492; Fang MC, 2004, ANN INTERN MED, V141, P745, DOI 10.7326/0003-4819-141-10-200411160-00005; Gage BF, 2004, CIRCULATION, V110, P2287, DOI 10.1161/01.CIR.0000145172.55640.93; Greater London Authority, 2014, 2009 ROUND ETHN GROU; Heuschmann PU, 2008, STROKE, V39, P2204, DOI 10.1161/STROKEAHA.107.507285; Howitt A, 1999, BMJ-BRIT MED J, V318, P1324, DOI 10.1136/bmj.318.7194.1324; Ingelgard A, 2006, J THROMB THROMBOLYS, V21, P257, DOI 10.1007/s11239-006-5633-2; Lin HJ, 1996, STROKE, V27, P1760, DOI 10.1161/01.STR.27.10.1760; Mant J, 2007, LANCET, V370, P493, DOI 10.1016/S0140-6736(07)61233-1; Marshall IJ, 2013, STROKE, V44, P1809, DOI 10.1161/STROKEAHA.111.000655; MATCHAR DB, 1994, ANN INTERN MED, V121, P41, DOI 10.7326/0003-4819-121-1-199407010-00008; National Institute for Health and Care Excellence (Nice), 2014, ATR FIBR MAN ATR FIB; O'Donnell MJ, 2010, LANCET, V376, P112, DOI 10.1016/S0140-6736(10)60834-3; Office for National Statistics, 2012, 2011 CENS ETHN; Ogilvie IM, 2010, AM J MED, V123, P638, DOI 10.1016/j.amjmed.2009.11.025; Olesen JB, 2011, THROMB HAEMOSTASIS, V106, P739, DOI 10.1160/TH11-05-0364; Olesen JB, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d124; Parker CS, 2007, J GEN INTERN MED, V22, P1254, DOI 10.1007/s11606-007-0233-1; Pisters R, 2010, CHEST, V138, P1093, DOI 10.1378/chest.10-0134; ROSMAN KD, 1986, STROKE, V17, P667, DOI 10.1161/01.STR.17.4.667; Ryder KM, 1999, AM J CARDIOL, V84, p131R; Stewart JA, 1999, BRIT MED J, V318, P967, DOI 10.1136/bmj.318.7189.967; Stiggelbout AM, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e256; Thomson RG, 2007, QUAL SAF HEALTH CARE, V16, P216, DOI 10.1136/qshc.2006.018481; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983; Xuereb CB, 2012, PATIENT EDUC COUNS, V88, P330, DOI 10.1016/j.pec.2012.05.011	31	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2017	12	4							e0175980	10.1371/journal.pone.0175980	http://dx.doi.org/10.1371/journal.pone.0175980			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0MD	28410424	Green Published, gold, Green Submitted			2022-12-27	WOS:000399955600054
J	Sullivan, E; Piercy, J; Waller, J; Black, CM; Kachroo, S				Sullivan, Emma; Piercy, James; Waller, John; Black, Christopher M.; Kachroo, Sumesh			Assessing gastroenterologist and patient acceptance of biosimilars in ulcerative colitis and Crohn's disease across Germany	PLOS ONE			English	Article							ANTIBODIES; ONCOLOGY; DMARDS; ACCESS	Objectives This study examined gastroenterologists' motivation for prescribing biosimilars, assessed their treatment preferences in relation to prescribing behaviour, and explored patient attitudes to biosimilars. Methods Data were taken from the Adelphi Real World Biosimilars Programme, a real-world, cross-sectional study undertaken in 2015-2016 with German gastroenterologists and patients with ulcerative colitis or Crohn's disease. Gastroenterologists provided data on their prescribing behaviour and attitudes towards biosimilars, and invited the next eight eligible consecutive consulting patients to complete a detailed questionnaire. For analysis, gastroenterologists were split into 'Investigative', 'Conservative', and 'Other' groups. Results Overall, 25 gastroenterologists and 136 patients participated. Biosimilars accounted for < 15% of all biologic therapies and > 80% of gastroenterologists would prescribe a bio-originator rather than biosimilar as 1 st line therapy if unrestricted. Patients showed some reluctance to accept biosimilars, although of those receiving biosimilars, 79% were satisfied with the current treatment of their condition, and 69% were satisfied with the control of symptoms. Although at least 35% of patients in each analysis group reported no concerns when starting treatment with a bio-originator or biosimilar, 41% of previously biologic-naive patients prescribed a biosimilar indicated potential side effects and potential long-term problems, and 24% not knowing enough about the drug, as concerns. Conclusion Results demonstrate that there is reluctance from patients to accept biosimilars and the need to further educate patients who are unsure to allow them to be involved in decision making, highlighting the importance of patient and physician communication. There remains a need for further research into non-clinical switching and the long term impact of prescribing biosimilars.	[Sullivan, Emma; Piercy, James; Waller, John] Adelphi Real World, Manchester, Lancs, England; [Black, Christopher M.; Kachroo, Sumesh] Merck & Co Inc, Kenilworth, NJ 07033 USA	Adelphi Group Ltd; Merck & Company	Kachroo, S (corresponding author), Merck & Co Inc, Kenilworth, NJ 07033 USA.	sumesh.kachroo@merck.com	; aubertin, rebeckah/O-9624-2015	Sullivan, Emma/0000-0001-7780-1939; aubertin, rebeckah/0000-0002-0558-7571; Black, Christopher/0000-0003-2934-108X	Merck Co.; Merck	Merck Co.(Merck & Company); Merck(Merck & Company)	This study was funded by Merck & Co. Christopher M Black and Sumesh Kachroo are employed by Merck & Co. Merck & Co. provided support in the form of salaries for authors CMB and SK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. Emma Sullivan, James Piercy and John Waller are employed by Adelphi Real World. Adelphi Real World provided support in the form of salaries for authors ES, JP and JW, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; This study was funded by Merck & Co, they did not contribute to the salaries of Adelphi Real World employees John Waller, Emma Sullivan and James Piercy. The database is propriety to Adelphi Real World. Merck employees Sumesh Kachroo and Christopher M Black provided sponsorship and input on all aspects of the study.	Aapro MS, 2012, TARGET ONCOL, V7, pS51, DOI 10.1007/s11523-011-0193-6; Aapro M, 2013, GABI J, V2, P91, DOI 10.5639/gabij.2013.0202.023; Agostoni C, 2015, EFSA J, V13, DOI 10.2903/j.efsa.2015.4102; Anderson P, 2008, CURR MED RES OPIN, V24, P3063, DOI 10.1185/03007990802457040 ; [Anonymous], 2015, PFENEX BIOSIMILARS B; Beck A, 2013, MABS-AUSTIN, V5, P621, DOI 10.4161/mabs.25864; Casey D, 2016, DRUG DISCOV TODAY, V21, P208, DOI 10.1016/j.drudis.2015.09.008; Chao JD, 2015, ADV THER, V32, P270, DOI 10.1007/s12325-015-0193-5; Committee for Medicinal Products for Human Use (CHMP), 2012, GUID SIM BIOL MED PR, P1; Danese S, 2016, J CROHNS COLITIS; Danese S, 2014, J CROHNS COLITIS, V8, P1548, DOI 10.1016/j.crohns.2014.06.007; Dolinar RO, 2014, GABI J, V3, P58, DOI 10.5639/gabij.2014.0302.018; EXPERT COMMITTEE ON BIOLOGICAL STANDARDIZATION, 2009, GANS PROV DEV STRAT, P1; Generics and Biosimilars Initiative, 2014, US BIOS EUR DIFF COU; Generics and Biosimilars Initiative, 2014, BIOS AD; IMS, 2016, DEL POT BIOS MED ROL, P1; Jacobs I, 2016, PATIENT PREFER ADHER, V10, P937, DOI 10.2147/PPA.S104891; Jahnsen J, 2016, THER ADV GASTROENTER, V9, P322, DOI 10.1177/1756283X16636764; McKee S., 2015, HOSPIRA LAUNCHES REM; Moorkens E, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00193; Niederwieser D, 2011, EUR J HAEMATOL, V86, P277, DOI 10.1111/j.1600-0609.2010.01566.x; Nota I, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-333; Peyrin-Biroulet L, 2016, J CROHNS COLITIS; Putrik P, 2016, RHEUMATOLOGY, V55, P1217, DOI 10.1093/rheumatology/kew048; Putrik P, 2014, ANN RHEUM DIS, V73, P2010, DOI 10.1136/annrheumdis-2013-203819; Putrik P, 2014, ANN RHEUM DIS, V73, P198, DOI 10.1136/annrheumdis-2012-202603; Rovira J, 2011, IMPACT BIOSIMILARS E; Tkaczuk KHR, 2014, SEMIN ONCOL, V41, pS3, DOI 10.1053/j.seminoncol.2014.03.008; U. S. Food and Drug Administration, 2012, QUAL CONS DEM BIOS R; Waller J, 2017, PATIENT PREFERENCE A; Weise M, 2014, BLOOD, V124, P3191, DOI 10.1182/blood-2014-06-583617; Zelenetz AD, 2011, J NATL COMPR CANC NE, V9, pS1	32	33	34	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2017	12	4							e0175826	10.1371/journal.pone.0175826	http://dx.doi.org/10.1371/journal.pone.0175826			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0MD	28410403	gold, Green Published, Green Submitted			2022-12-27	WOS:000399955600047
J	Channanath, AM; Elkum, N; Al-Abdulrazzaq, D; Tuomilehto, J; Shaltout, A; Thanaraj, TA				Channanath, Arshad M.; Elkum, Naser; Al-Abdulrazzaq, Dalia; Tuomilehto, Jaakko; Shaltout, Azza; Thanaraj, Thangavel Alphonse			Ethnic differences in association of high body mass index with early onset of Type 1 diabetes - Arab ethnicity as case study	PLOS ONE			English	Article							ACCELERATOR HYPOTHESIS; INCREASING INCIDENCE; AGE; CHILDREN; CHILDHOOD; DIAGNOSIS; WEIGHT; TRENDS; MELLITUS; SUPPORT	Objective The "accelerator hypothesis" predicts early onset of Type 1 diabetes (T1D) in heavier children. Studies testing direction of correlation between body mass index (BMI) and age at onset of T1D in different continental populations have reported differing results-inverse, direct, and neutral. Evaluating the correlation in diverse ethnic populations is required to generalize the accelerator hypothesis. Methods The study cohort comprised 474 Kuwaiti children of Arab ethnicity diagnosed with T1D at age 6 to 18 years during 2011-2013. Age-and sex-adjusted BMI z-scores were calculated by comparing the BMI measured at diagnosis with Kuwaiti pediatric population reference data recorded during comparable time-period. Multiple linear regression and Pearson correlation analyses were performed. Results BMI z-score was seen inversely associated with onset age (r,-0.28; p-value< 0.001). Children with BMI z-score>0 (i.e. BMI > national average) showed a stronger correlation (r,-0.38; p-value< 0.001) than those with BMI z-score<0 (r,-0.19; p-value< 0.001); the former group showed significantly lower mean onset age than the latter group (9.6 +/- 2.4 versus 10.5 +/- 2.7; p-value< 0.001). Observed inverse correlation was consistent with that seen in Anglo-saxon, central european, caucasian, and white children while inconsistent with that seen in Indian, New Zealander, and Australian children. Conclusions The accelerator hypothesis generalizes in Arab pediatric population from Kuwait.	[Channanath, Arshad M.; Elkum, Naser; Tuomilehto, Jaakko; Shaltout, Azza; Thanaraj, Thangavel Alphonse] Dasman Diabet Inst, Dasman, Kuwait; [Al-Abdulrazzaq, Dalia] Kuwait Univ, Fac Med, Dept Pediat, Safat, Kuwait	Kuwait University	Thanaraj, TA (corresponding author), Dasman Diabet Inst, Dasman, Kuwait.	Alphonse.Thangavel@dasmaninstitute.org	Elkum, Naser/AAU-5555-2020	Elkum, Naser/0000-0002-0457-0444	Kuwait Foundation for Advancement of the Sciences	Kuwait Foundation for Advancement of the Sciences	The authors acknowledge the Kuwait Foundation for Advancement of the Sciences for funding this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors wish to thank the members of the Steering Group for Childhood-Onset Diabetes e Registry for data collection and validation. The Ethical Review Committee for Human Subjects Protection, and the International Scientific Advisory Board at Dasman Diabetes Institute are acknowledged for approving the study. The authors acknowledge the Kuwait Foundation for Advancement of the Sciences for funding this study.	Abdul-Ghani MA, 2005, ISR MED ASSOC J, V7, P360; Abduljabbar MA, 2010, SAUDI MED J, V31, P413; ALAWADI SA, 1985, CLIN GENET, V27, P483; Alhyas L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040948; Badran M, 2012, INT J ENDOCRINOL, V2012, DOI 10.1155/2012/902873; Basevi V, 2011, DIABETES CARE, V34, P1887, DOI 10.2337/dc11-s011; Betts P, 2005, DIABETIC MED, V22, P144, DOI 10.1111/j.1464-5491.2004.01368.x; Channanath AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095308; Channanath AM, 2013, DIABETES CARE, V36, pE75, DOI 10.2337/dc12-2451; COLE TJ, 1992, STAT MED, V11, P1305, DOI 10.1002/sim.4780111005; Dabelea D, 2006, DIABETES CARE, V29, P290, DOI 10.2337/diacare.29.02.06.dc05-1339; Dayal D, 2016, CLIN ENDOCRINOL, V84, P338, DOI 10.1111/cen.12941; Derraik JGB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032640; Elkum N, 2015, PEDIAT OBES, V11; Evertsen J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006873; Farran B, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002457; Gabir MM, 2000, DIABETES CARE, V23, P1108, DOI 10.2337/diacare.23.8.1108; Gillespie KM, 2005, DIABETES, V54, P1245, DOI 10.2337/diabetes.54.4.1245; Gimenez M, 2007, DIABETES CARE, V30, P1593, DOI 10.2337/dc06-2578; Hillier TA, 2001, DIABETES CARE, V24, P1522, DOI 10.2337/diacare.24.9.1522; Kibirige M, 2003, DIABETES CARE, V26, P2865, DOI 10.2337/diacare.26.10.2865; Knerr I, 2005, DIABETOLOGIA, V48, P2501, DOI 10.1007/s00125-005-0033-2; Knip M, 2008, PEDIATR DIABETES, V9, P46, DOI 10.1111/j.1399-5448.2007.00344.x; Lauria A, 2015, EUR J ENDOCRINOL, V172, DOI 10.1530/EJE-14-0522; Logue J, 2011, DIABETOLOGIA, V54, P3003, DOI 10.1007/s00125-011-2313-3; Moussa MAA, 2005, MED PRIN PRACT, V14, P87, DOI 10.1159/000083917; Natl High Blood Pressure Educ Prog, 2004, PEDIATRICS, V114, P555; O'Connell MA, 2007, DIABETIC MED, V24, P920, DOI 10.1111/j.1464-5491.2007.02203.x; Porter JR, 2004, DIABETOLOGIA, V47, P352, DOI 10.1007/s00125-003-1291-5; Raab J, 2013, DIABETES-METAB RES, V29, P631, DOI 10.1002/dmrr.2438; Rewers M, 2012, PEDIATR DIABETES, V13, P333, DOI 10.1111/j.1399-5448.2011.00832.x; ROBINSON S, 1992, BAILLIERE CLIN ENDOC, V6, P867, DOI 10.1016/S0950-351X(05)80171-5; SHALTOUT AA, 1995, DIABETES CARE, V18, P923, DOI 10.2337/diacare.18.7.923; Shaltout AA, 2002, DIABETIC MED, V19, P522, DOI 10.1046/j.1464-5491.2002.00703.x; Shaltout AA, 2016, PEDIAT DIABETES; Shaltout AA, 2016, SCI REP-UK, V6, DOI 10.1038/srep27519; TEEBI AS, 1994, J MED GENET, V31, P224, DOI 10.1136/jmg.31.3.224; Tuomilehto J, 2013, CURR DIABETES REP, V13, P795, DOI 10.1007/s11892-013-0433-5; Wilkin TJ, 2012, PEDIATR DIABETES, V13, P327, DOI 10.1111/j.1399-5448.2011.00831.x; Wilkin TJ, 2001, DIABETOLOGIA, V44, P914, DOI 10.1007/s001250100548; Winkler C, 2009, DIABETOLOGIA, V52, P2072, DOI 10.1007/s00125-009-1461-1	41	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2017	12	4							e0175728	10.1371/journal.pone.0175728	http://dx.doi.org/10.1371/journal.pone.0175728			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0MB	28406962	Green Published, Green Submitted, gold			2022-12-27	WOS:000399955400087
J	Irizarry, AR; Yan, GR; Zeng, QQ; Lucchesi, J; Hamang, MJ; Ma, YFL; Rong, JXJ				Irizarry, Armando R.; Yan, Guirui; Zeng, Qingqiang; Lucchesi, Jonathan; Hamang, Matthew J.; Ma, Yanfei L.; Rong, James Xiaojun			Defective enamel and bone development in sodium-dependent citrate transporter (NaCT) Slc13a5 deficient mice	PLOS ONE			English	Article							GENOMIC ORGANIZATION; APATITE NANOCRYSTALS; CITRIC-ACID; EXPRESSION; MINERALIZATION; DICARBOXYLATE; HUMANS; FAMILY	There has been growing recognition of the essential roles of citrate in biomechanical properties of mineralized tissues, including teeth and bone. However, the sources of citrate in these tissues have not been well defined, and the contribution of citrate to the regulation of odontogenesis and osteogenesis has not been examined. Here, tooth and bone phenotypes were examined in sodium-dependent citrate transporter (NaCT) Slc13a5 deficient C57BL/6 mice at 13 and 32 weeks of age. Slc13a5 deficiency led to defective tooth development, characterized by absence of mature enamel, formation of aberrant enamel matrix, and dysplasia and hyperplasia of the enamel organ epithelium that progressed with age. These abnormalities were associated with fragile teeth with a possible predisposition to tooth abscesses. The lack of mature enamel was consistent with amelogenesis imperfecta. Furthermore, Slc13a5 deficiency led to decreased bone mineral density and impaired bone formation in 13-week-old mice but not in older mice. The findings revealed the potentially important role of citrate and Slc13a5 in the development and function of teeth and bone.	[Irizarry, Armando R.] Eli Lilly & Co, Dept Pathol, Lilly Res Labs, Indianapolis, IN 46285 USA; [Yan, Guirui; Rong, James Xiaojun] Eli Lilly & Co, Lilly China R&D Ctr, Bldg 8,338 Zhangjiang Hi Tech Pk, Shanghai, Peoples R China; [Zeng, Qingqiang; Lucchesi, Jonathan; Hamang, Matthew J.; Ma, Yanfei L.] Eli Lilly & Co, Lilly Res Labs, Musculoskeletal Res, Indianapolis, IN 46285 USA	Eli Lilly; Eli Lilly; Eli Lilly	Irizarry, AR (corresponding author), Eli Lilly & Co, Dept Pathol, Lilly Res Labs, Indianapolis, IN 46285 USA.; Rong, JXJ (corresponding author), Eli Lilly & Co, Lilly China R&D Ctr, Bldg 8,338 Zhangjiang Hi Tech Pk, Shanghai, Peoples R China.	irizarryar@lilly.com; rong_xiao_jun_james@lilly.com			Eli Lilly Company	Eli Lilly Company(Eli Lilly)	All authors are employees of Eli Lilly & Company. Eli Lilly & Company provided financial support in the form of salaries for all authors, and research materials, but did not have any additional role in the study design, data collection and analysis, or preparation of the manuscript. Eli Lilly & Company had no role in the decision to publish, which was made by the authors, but Eli Lilly & Company was responsible for approving the authors' request to disclose the reported work to the public domain. The specific roles of all authors are articulated in the 'author contributions' section.	Anselm I, 2016, DIS HETEROGENEITY NA; Antoine D, 2009, J ANAT, V214, P45, DOI 10.1111/j.1469-7580.2008.01010.x; Birkenfeld AL, 2011, CELL METAB, V14, P184, DOI 10.1016/j.cmet.2011.06.009; Boskey AL, 2007, ELEMENTS, V3, P385, DOI 10.2113/GSELEMENTS.3.6.385; Brommage R, 2014, BONE RES, V2, DOI 10.1038/boneres.2014.34; Combes C, 2016, MINERALS-BASEL, V6, DOI 10.3390/min6020034; Costello LC, 2012, OPEN BONE J, V4; Dickens F, 1941, BIOCHEM J, V35, P1011, DOI 10.1042/bj0351011; Franklin Renty B, 2014, Open Bone J, V6, P1; Hale LV, 2000, CALCIFIED TISSUE INT, V67, P80, DOI 10.1007/s00223001101; Hardies K, 2015, BRAIN, V138, DOI 10.1093/brain/awv263; Hartles R., 1963, ADV ORAL BIOL, V1, P225; Hu YY, 2010, P NATL ACAD SCI USA, V107, P22425, DOI 10.1073/pnas.1009219107; Huard K, 2015, SCI REP-UK, V5, DOI 10.1038/srep17391; Inoue K, 2004, BIOCHEM J, V378, P949, DOI 10.1042/BJ20031261; Inoue K, 2002, BIOCHEM BIOPH RES CO, V299, P465, DOI 10.1016/S0006-291X(02)02669-4; Inoue K, 2002, J BIOL CHEM, V277, P39469, DOI 10.1074/jbc.M207072200; Jiang WG, 2009, J PHYS CHEM B, V113, P10838, DOI 10.1021/jp904633f; Kawasaki K, 2009, ANNU REV GENET, V43, P119, DOI 10.1146/annurev-genet-102108-134242; Klotz J, 2016, MOL MED, V22, P310, DOI 10.2119/molmed.2016.00077; Liu C., 2015, AM SOC MECH ENG POWE, V2015, P1, DOI DOI 10.3389/FNCEL.2015.00517; Liu SG, 2009, MOL ENDOCRINOL, V23, P1505, DOI 10.1210/me.2009-0085; Ma YFL, 2011, ENDOCRINOLOGY, V152, P1767, DOI 10.1210/en.2010-1112; Markovich D, 2004, PFLUG ARCH EUR J PHY, V447, P594, DOI 10.1007/s00424-003-1128-6; Pajor AM, 2006, PFLUG ARCH EUR J PHY, V451, P597, DOI 10.1007/s00424-005-1487-2; Pajor AM, 2014, PFLUG ARCH EUR J PHY, V466, P119, DOI 10.1007/s00424-013-1369-y; Pemberton TJ, 2007, DEV DYNAM, V236, P2245, DOI 10.1002/dvdy.21226; Pesta DH, 2015, AGING, V7; Rhee SH, 1999, BIOMATERIALS, V20, P2155, DOI 10.1016/S0142-9612(99)00118-0; Roosa SMM, 2011, J BONE MINER RES, V26, P100, DOI 10.1002/jbmr.193; Schossig A, 2016, J MED GENETICS; St John HC, 2014, MOL ENDOCRINOL, V28, P1150, DOI 10.1210/me.2014-1091; Thevenon J, 2014, AM J HUM GENET, V95, P113, DOI 10.1016/j.ajhg.2014.06.006; Urzua B, 2011, BIOCHEM GENET, V49, P104, DOI 10.1007/s10528-010-9392-6; Willmes DM, 2013, COMPUT STRUCT BIOTEC, V6, DOI 10.5936/csbj.201303020; Xie BQ, 2010, P NATL ACAD SCI USA, V107, P22369, DOI 10.1073/pnas.1017493108	36	22	24	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2017	12	4							e0175465	10.1371/journal.pone.0175465	http://dx.doi.org/10.1371/journal.pone.0175465			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0MB	28406943	gold, Green Submitted, Green Published			2022-12-27	WOS:000399955400058
J	Kramer, J; Tenberge, JG; Kleiter, I; Gaissmaier, W; Ruck, T; Heesen, C; Meuth, SG				Kraemer, Julia; Tenberge, Jan-Gerd; Kleiter, Ingo; Gaissmaier, Wolfgang; Ruck, Tobias; Heesen, Christoph; Meuth, Sven G.			Is the risk of progressive multifocal leukoencephalopathy the real reason for natalizumab discontinuation in patients with multiple sclerosis?	PLOS ONE			English	Article							PML RISK; ANTIBODY-LEVELS; STRATIFICATION; SEROCONVERSION; SELECTION	Background Progressive multifocal leukoencephalopathy (PML) is one of the major risks of natalizumab therapy. Despite introduction of the currently employed PML risk stratification algorithm, the incidence of natalizumab-associated PML cases is not decreasing. Objectives We addressed the following questions: How do natalizumab-treated multiple sclerosis patients and their treating physicians assess and deal with PML risk? Is PML risk the real reason for natalizumab discontinuation? Methods 699 natalizumab-treated multiple sclerosis patients and 99 physicians were included in this prospective observational study. Questionnaires were completed at 5 different time points. Patients were stratified into 5 subgroups according to the presence of PML risk factors (prior immunosuppression, anti-JCV antibody status, treatment duration). Patients with prior immunosuppression (n = 30, treated by n = 7 physicians) were excluded from analyses, because patient numbers were too small. Patients' anti-JCV antibody index was not considered because data recruitment ended in 2014. Using Bayesian network and regression analysis, we examined the relationship between different patient- and physician-related factors and patients' discontinuation of natalizumab. Results Patients of all subgroups and physicians assessed the PML risk as low. Overall patient adherence to natalizumab was high (87%). Only 13% of patients discontinued therapy. Natalizumab treatment cessation was associated with different patient- and physician related factors (physicians' assessment of general PML risk, number of treated patients per year, natalizumab treatment duration, relapses during the course of study) upon which only physicians' judgment on treatment continuation, patients' perception of personal PML risk, and JCV seroconversion showed significant relationships. Conclusion According to the currently employed risk stratification algorithm, the objective PML risk probably doesn't play a dominant role in a patients' decision to continue or stop natalizumab treatment. The decision-making process is rather guided by subjective views and experiences of patients and treating neurologists. Treating physicians should consider this discrepancy in their advice to improve the risk-benefit-ratio for the individual patient.	[Kraemer, Julia; Tenberge, Jan-Gerd; Ruck, Tobias; Meuth, Sven G.] Wesffal Wilhelms Univ, Dept Neurol, Clin Neurol, Munster, Germany; [Kraemer, Julia; Tenberge, Jan-Gerd; Ruck, Tobias; Meuth, Sven G.] Wesffal Wilhelms Univ, Inst Translat Neurol, Munster, Germany; [Kleiter, Ingo] Ruhr Univ Bochum, St Josef Hosp, Dept Neurol, Bochum, Germany; [Gaissmaier, Wolfgang] Univ Konstanz, Dept Psychol, Constance, Germany; [Heesen, Christoph] Univ Med Ctr Hamburg Eppendorf, Inst Neuroimmunol & MS INIMS, Dept Neurol, Hamburg, Germany	Ruhr University Bochum; University of Konstanz; University of Hamburg; University Medical Center Hamburg-Eppendorf	Kramer, J; Meuth, SG (corresponding author), Wesffal Wilhelms Univ, Dept Neurol, Clin Neurol, Munster, Germany.; Kramer, J; Meuth, SG (corresponding author), Wesffal Wilhelms Univ, Inst Translat Neurol, Munster, Germany.	julia.kraemer@ukmuenster.de; sven.meuth@ukmuenster.de	Ruck, Tobias/AAH-4627-2021; Meuth, Sven G/HHM-8941-2022; Ruck, Tobias/AAQ-3703-2020; Kleiter, Ingo/AAD-1132-2020	Meuth, Sven G/0000-0003-2571-3501; Kleiter, Ingo/0000-0002-8249-4408; Gaissmaier, Wolfgang/0000-0001-6273-178X; Tenberge, Jan-Gerd/0000-0002-6300-8013; Ruck, Tobias/0000-0001-6332-8650	PERCEPT; Biogen, Ismaning, Germany	PERCEPT; Biogen, Ismaning, Germany	The study PERCEPT was funded by Biogen, Ismaning, Germany. Biogen determined the study design among others and selected arbitrarily the participating multiple sclerosis treatment centers spread over Germany and collected all data. Biogen had no role in data analysis, decision to publish, or preparation of the manuscript.	Antoniol C, 2015, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00668; Baldwin KJ, 2013, CURR OPIN NEUROL, V26, P318, DOI 10.1097/WCO.0b013e328360279f; Bloomgren G, 2012, NEW ENGL J MED, V366, P1870, DOI 10.1056/NEJMoa1107829; Clifford DB, 2010, LANCET NEUROL, V9, P438, DOI 10.1016/S1474-4422(10)70028-4; Cutter GR, 2014, MULT SCLER J, V20, P1304, DOI 10.1177/1352458514531843; Foley J, 2016, NEUROLOGY S, V86; Foley J, 2014, NEUROLOGY S, V82, P244; Fox RJ, 2015, MULT SCLER RELAT DIS, V4, P241, DOI 10.1016/j.msard.2015.03.003; Gold R, 2014, DIAGNOSE THERAPIE MU; Gorelik L, 2010, ANN NEUROL, V68, P295, DOI 10.1002/ana.22128; Havla J, 2013, THER CLIN RISK MANAG, V9, P361, DOI 10.2147/TCRM.S41552; Heesen C, 2010, MULT SCLER J, V16, P1507, DOI 10.1177/1352458510379819; Koendgen H, 2016, NEW ALGORITHM TO EST; Kornek B, 2015, PATIENT PREFER ADHER, V9, P675, DOI 10.2147/PPA.S20791; Nicholas JA, 2014, THER ADV CHRONIC DIS, V5, P62, DOI 10.1177/2040622313514790; Outteryck O, 2014, MULT SCLER J, V20, P822, DOI 10.1177/1352458513505353; Plavina T, 2014, ANN NEUROL, V76, P802, DOI 10.1002/ana.24286; Polman CH, 2006, NEW ENGL J MED, V354, P899, DOI 10.1056/NEJMoa044397; Rudick RA, 2006, NEW ENGL J MED, V354, P911, DOI 10.1056/NEJMoa044396; Rudick Richard A, 2011, Cleve Clin J Med, V78 Suppl 2, pS18, DOI 10.3949/ccjm.78.s2.05; Schwab N, 2016, NEUROL-NEUROIMMUNOL, V3, DOI 10.1212/NXI.0000000000000195; Schwab N, 2013, NEUROLOGY, V81, P865, DOI 10.1212/WNL.0b013e3182a351fb; Scutari M, 2010, J STAT SOFTW, V35, P1, DOI 10.18637/jss.v035.i03; Serana F, 2014, J NEUROIMMUNOL, V277, P6, DOI 10.1016/j.jneuroim.2014.10.011; Sorensen PS, 2012, MULT SCLER J, V18, P143, DOI 10.1177/1352458511435105; Trampe AK, 2012, NEUROLOGY, V78, P1736, DOI 10.1212/WNL.0b013e3182583022; Tur C, 2013, PLOS ONE, V8; Tur C, 2014, CNS DRUGS, V28, P641, DOI 10.1007/s40263-014-0168-0; Tur C, 2012, MULT SCLER J, V18, P1193, DOI 10.1177/1352458512439238; Villar LM, 2015, ANN NEUROL, V77, P447, DOI 10.1002/ana.24345; Warnke C, 2015, TRENDS PHARMACOL SCI, V36, P799, DOI 10.1016/j.tips.2015.09.006; Warnke C, 2015, MULT SCLER J, V21, P1036, DOI 10.1177/1352458514556296; Warnke C, 2013, J NEUROL NEUROSUR PS, V84, P1199, DOI 10.1136/jnnp-2012-304332; West TW, 2010, ANN NEUROL, V68, P395, DOI 10.1002/ana.22163	34	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2017	12	4							e0174858	10.1371/journal.pone.0174858	http://dx.doi.org/10.1371/journal.pone.0174858			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0MB	28406921	Green Submitted, gold, Green Published			2022-12-27	WOS:000399955400019
J	Hintsa, S; Dube, L; Abay, M; Angesom, T; Workicho, A				Hintsa, Solomon; Dube, Lamessa; Abay, Mebrahtu; Angesom, Teklit; Workicho, Abdulhalik			Determinants of diabetic nephropathy in Ayder Referral Hospital, Northern Ethiopia: A case-control study	PLOS ONE			English	Article							RISK-FACTORS; COMPLICATIONS	Background Diabetic nephropathy is the most serious complication of diabetes which leads to end-stage renal failure and other complication of diabetes mellitus. Determinants of Diabetic nephropathy are not consistent in different studies and associated factors to chronic complications of diabetes are not specific and there are limited studies specific to diabetic nephropathy. Thus, the aim of this study is to identify determinants of diabetic nephropathy in Ayder Referral Hospital, Northern Ethiopia. Methods A case-control study was conducted from February 14 to May 8 2016. Diabetic patients who developed nephropathy in the last two years were the cases and diabetic patients free of nephropathy were controls. Cases and controls were identified detailed review of the chronic care follow up chart. Then simple random sampling was used to select sample of 420 ( with control to case ratio of 4: 1) resulting in 84 cases and 336 controls. Record review and interviewer administered questionnaire were used to collect data. Data was coded and entered in to Epi-Data version 3.1 and then exported to STATA 12 for analysis. Variables with P-values< 0.25 in Bivariate logistic regression were selected for multiple logistic regressions to determine independent determinants of diabetic nephropathy. OR was calculated with 95% CI to show strength of association. Result The mean age (+/- Standard deviation) for the cases and the controls were 52( SD: +/- 1.34) and 42.4( SD: +/- 0.8) respectively. In multiple logistic regressions age of patient ( AOR: 1.037 95% CI: 1.01 - 1.064), duration of diabetes after diagnosis ( AOR for one year increase: 1.09 95% CI: 1.036 - 1.15), not-adhered to blood glucose measurement at home ( AOR: 6.81 95% CI: 1.15 - 40.24), having Systolic Hypertension ( AOR; 2.13 ( 1.002 - 4.51), poor glycemic control (AOR; 2.71 95% CI: ( 1.49 - 4.95), being overweight( AOR; 2.7( 1.47 - 4.96) were the independent predictors of diabetic nephropathy. Conclusion In the light of these findings, targeted interventions should be designed at the follow up clinic to address the risk of developing diabetic nephropathy among the risk groups.	[Hintsa, Solomon; Abay, Mebrahtu; Angesom, Teklit] Aksum Univ Ksum, Coll Hlth Sci, Dept Publ Hlth, Aksum, Ethiopia; [Dube, Lamessa; Workicho, Abdulhalik] Jimma Univ, Coll Hlth Sci, Dept Epidemiol, Jimma, Ethiopia	Jimma University	Hintsa, S (corresponding author), Aksum Univ Ksum, Coll Hlth Sci, Dept Publ Hlth, Aksum, Ethiopia.	solomonhintsa2013@gmail.com		angesom, teklit/0000-0002-7216-8617; Hintsa, Solomon/0000-0003-1270-4817; Workicho, Abdulhalik/0000-0001-8422-1983; Abay, Mebrahtu/0000-0002-3307-0588	Ayder Referral Hospital	Ayder Referral Hospital	We sincerely thank, to Jimma University, for giving us the chance to do this research work and Ayder Referral Hospital for their support in collecting the actual data. We would also like to thank the data collectors and study participants for their participation.	Abejew AA, 2015, DIABETIC COMPLICATIO, V2015; Ahn JH, 2014, DIABETES METAB J, V38, P109, DOI 10.4093/dmj.2014.38.2.109; Amogne W, 2011, ETHIOP J HEALTH DEV, V25, P17; [Anonymous], 2005, DIABETES CARE, V28, P164; [Anonymous], 2015, PUBLIC HEAL ACTION, VI, P74; Care M, 2003, DIABETES CARE, V26, ps33; Chowdhury TA, 1999, CLIN SCI, V96, P221, DOI 10.1042/CS19980331; de Luis DA, 2005, J DIABETES COMPLICAT, V19, P42, DOI 10.1016/j.jdiacomp.2003.12.003; Effective health care program, 2014, EV BAS PRACT CTR SYS, P1; Ferreira SRG, 1997, BRAZ J MED BIOL RES, V30, P735, DOI 10.1590/S0100-879X1997000600006; Fleiss, 1981, STAT METHODS RATES P, P38; George L, 2015, PATIENT INFORM DIABE; Guariguata L, 2014, DIABETES RES CLIN PR, V103, P137, DOI 10.1016/j.diabres.2013.11.002; Heydari I, 2010, INT J DIABET MELLIT, V2, P61; ISAK, 2001, INT STAND ANTHR ASS; LESTER FT, 1984, DIABETES CARE, V7, P6, DOI 10.2337/diacare.7.1.6; Liu ZL, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-62; National Health and Nutrition Examination Survey (NHANES), 2016, ANTHR PROC MAN; Noubiap JJN, 2015, WORLD J DIABETES, V6, P759, DOI 10.4239/wjd.v6.i5.759; Schena FP, 2005, J AM SOC NEPHROL, V16, pS30, DOI 10.1681/ASN.2004110970; Seifu W, 2015, MOJ PUBLIC HEAL, V2; Shera AS, PREVALENCE CHR UNPUB; Tefera G., 2014, ADV DIABETES METAB, V2, P48; Tesfaye S, 2011, AFRICAN J DIABETES M, V19; Viswanathan V, 2012, INDIAN J MED RES, V136, P46; Worku D, 2010, ETHIOP J HEALTH SCI, V20, P33	26	11	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2017	12	4							e0173566	10.1371/journal.pone.0173566	http://dx.doi.org/10.1371/journal.pone.0173566			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LZ	28403160	Green Submitted, Green Published, gold			2022-12-27	WOS:000399955200007
J	Kroon, F; Streten, C; Harries, S				Kroon, Frederieke; Streten, Claire; Harries, Simon			A protocol for identifying suitable biomarkers to assess fish health: A systematic review	PLOS ONE			English	Review							FLOUNDER PLATICHTHYS-FLESUS; BASS DICENTRARCHUS-LABRAX; BARRAMUNDI LATES-CALCARIFER; MUMMICHOGS FUNDULUS-HETEROCLITUS; ENVIRONMENTAL RISK-ASSESSMENT; TISSUE-SPECIFIC ACCUMULATION; OXIDATIVE STRESS BIOMARKERS; TURBOT SCOPHTHALMUS-MAXIMUS; ADVERSE OUTCOME PATHWAYS; SOLE SOLEA-SENEGALENSIS	Background Biomarkers have been used extensively to provide the connection between external levels of contaminant exposure, internal levels of tissue contamination, and early adverse effects in organisms. Objectives To present a three-step protocol for identifying suitable biomarkers to assess fish health in coastal and marine ecosystems, using Gladstone Harbour (Australia) as a case study. Methods Prior to applying our protocol, clear working definitions for biomarkers were developed to ensure consistency with the global literature on fish health assessment. First, contaminants of concern were identified based on the presence of point and diffuse sources of pollution and available monitoring data for the ecosystem of interest. Second, suitable fish species were identified using fisheries dependent and independent data, and prioritised based on potential pathways of exposure to the contaminants of concern. Finally, a systematic and critical literature review was conducted on the use of biomarkers to assess the health of fish exposed to the contaminants of concern. Results/Discussion We present clear working definitions for bioaccumulation markers, biomarkers of exposure, biomarkers of effect and biomarkers of susceptibility. Based on emission and concentration information, seven metals were identified as contaminants of concern for Gladstone Harbour. Twenty out of 232 fish species were abundant enough to be potentially suitable for biomarker studies; five of these were prioritised based on potential pathways of exposure and susceptibility to metals. The literature search on biomarkers yielded 5,035 articles, of which 151met the inclusion criteria. Based on our review, the most suitable biomarkers include bioaccumulation markers, biomarkers of exposure (CYP1A, EROD, SOD, LPOX, HSP, MT, DNA strand breaks, micronuclei, apoptosis), and biomarkers of effect (histopathology, TAG: ST). Conclusion Our protocol outlines a clear pathway to identify suitable biomarkers to assess fish health in coastal and marine ecosystems, which can be applied to biomarker studies in aquatic ecosystems around the world.	[Kroon, Frederieke] Australian Inst Marine Sci, Townsville, Qld, Australia; [Streten, Claire; Harries, Simon] Australian Inst Marine Sci, Arafura Timor Res Facil, Brinkin, NT, Australia	Australian Institute of Marine Science; Australian Institute of Marine Science	Kroon, F (corresponding author), Australian Inst Marine Sci, Townsville, Qld, Australia.	f.kroon@aims.gov.au	Harries, Simon J/F-2543-2017; Kroon, Frederieke J/G-1072-2010	Harries, Simon J/0000-0002-3270-6206; Kroon, Frederieke J/0000-0001-8771-6543	Glad stone Healthy Harbour Partnership	Glad stone Healthy Harbour Partnership	This study was supported by the Glad stone Healthy Harbour Partnership. The funders had no role in study design, data collection and analysis ,decision to publish, or preparation of the manuscript.	Adams SM, 2005, MAR POLLUT BULL, V51, P649, DOI 10.1016/j.marpolbul.2004.11.040; Almroth BC, 2008, MAR ENVIRON RES, V66, P271, DOI 10.1016/j.marenvres.2008.04.002; Anastasi Amie, 2010, Australasian Journal of Ecotoxicology, V16, P119; Andersen L, 2005, METAL BIOACCUMULATIO; Angel BM, 2012, METAL CONCENTRATIONS; Angel BM, 2010, MAR FRESHWATER RES, V61, P170, DOI 10.1071/MF09046; Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34; Annabi A, 2012, AQUAT BIOL, V17, P285, DOI 10.3354/ab00482; [Anonymous], 1987, Environ Health Perspect, V74, P3; [Anonymous], 1993, ECOLOGICAL RISK ASSE; ANZECC/ARMCANZ, 2000, 4 ANZECCARMCANZ; Apte S, 2006, CONTGAMINANT PATHWAY; Apte S, 2005, CONTAMINANTS PORT CU; Arango C, 2013, POSTFLOOD WATER QUAL; Australian Department of the Environment and Energy, 2016, NAT POLL INV; Australian Department of the Environment Water Heritage and the Arts, 2009, WAT HER ARTS NAT ASS; Barbee NC, 2014, AQUAT TOXICOL, V152, P244, DOI 10.1016/j.aquatox.2014.04.012; Beg MU, 2015, MAR POLLUT BULL, V100, P662, DOI 10.1016/j.marpolbul.2015.07.058; Benedetti M, 2012, ENVIRON INT, V38, P17, DOI 10.1016/j.envint.2011.08.003; Benhamed S, 2016, TOXICOL REP, V3, P364, DOI 10.1016/j.toxrep.2016.02.006; Beyer J, 1996, AQUAT TOXICOL, V36, P75, DOI 10.1016/S0166-445X(96)00798-9; Beyer J, 2013, MAR POLLUT BULL, V69, P28, DOI 10.1016/j.marpolbul.2013.01.001; Cao L, 2012, ENVIRON TOXICOL PHAR, V33, P16, DOI 10.1016/j.etap.2011.10.003; Cao L, 2010, COMP BIOCHEM PHYS C, V151, P386, DOI 10.1016/j.cbpc.2010.01.004; Cavanagh JE, 2000, MAR POLLUT BULL, V41, P377, DOI 10.1016/S0025-326X(00)00135-1; Chen MH, 1999, MAR POLLUT BULL, V39, P239, DOI 10.1016/S0025-326X(99)00027-2; Chen MH, 2002, MAR POLLUT BULL, V44, P703, DOI 10.1016/S0025-326X(02)00066-8; Codi S, 2004, ENVIRON TOXICOL CHEM, V23, P2737, DOI 10.1897/03-499; Connolly RM, 2006, INTERTIDAL WETLANDS; Corsi I, 2003, MAR POLLUT BULL, V46, P203, DOI 10.1016/S0025-326X(02)00359-4; Costa PM, 2008, MUTAT RES-GEN TOX EN, V654, P29, DOI 10.1016/j.mrgentox.2008.04.007; Costa PM, 2012, ENVIRON POLLUT, V161, P107, DOI 10.1016/j.envpol.2011.10.010; Costa PM, 2011, ENVIRON RES, V111, P25, DOI 10.1016/j.envres.2010.09.011; Cotou E, 2012, CHEMOSPHERE, V89, P1091, DOI 10.1016/j.chemosphere.2012.05.075; Dang F, 2009, AQUAT TOXICOL, V95, P248, DOI 10.1016/j.aquatox.2009.09.013; De Domenico E, 2013, ECOTOX ENVIRON SAFE, V97, P114, DOI 10.1016/j.ecoenv.2013.07.015; De Domenico E, 2011, AQUAT TOXICOL, V105, P688, DOI 10.1016/j.aquatox.2011.08.026; de Mora S, 2004, MAR POLLUT BULL, V49, P410, DOI 10.1016/j.marpolbul.2004.02.029; Machado AAD, 2013, AQUAT TOXICOL, V138, P60, DOI 10.1016/j.aquatox.2013.04.009; Deng DF, 2008, SCI TOTAL ENVIRON, V407, P197, DOI 10.1016/j.scitotenv.2008.08.028; Dutton J, 2010, AQUAT BIOL, V10, P211, DOI 10.3354/ab00276; Edwards JW, 2001, MAR POLLUT BULL, V42, P389, DOI 10.1016/S0025-326X(00)00168-5; Eyckmans M, 2013, AQUAT TOXICOL, V126, P373, DOI 10.1016/j.aquatox.2012.09.004; Fasulo S, 2010, ECOTOX ENVIRON SAFE, V73, P873, DOI 10.1016/j.ecoenv.2009.12.025; Faucher K, 2008, ENVIRON POLLUT, V151, P148, DOI 10.1016/j.envpol.2007.02.017; Fernandes C, 2007, ECOTOX ENVIRON SAFE, V66, P426, DOI 10.1016/j.ecoenv.2006.02.007; Ferreira M, 2008, SCI TOTAL ENVIRON, V407, P638, DOI 10.1016/j.scitotenv.2008.07.058; Fonseca VF, 2015, ECOL INDIC, V58, P335, DOI 10.1016/j.ecolind.2015.05.064; Fonseca VF, 2014, MAR ENVIRON RES, V96, P45, DOI 10.1016/j.marenvres.2013.10.011; Fonseca VF, 2011, AQUAT TOXICOL, V102, P216, DOI 10.1016/j.aquatox.2011.01.018; GHD Pty Ltd, 2009, GLADST PORT CORP REP; Gladstone Healthy Harbour Partnership, 2015, TECHNICAL REPORT; Gladstone Port Corporation, 2012, CURT COAST COAST MAR; GOKSOYR A, 1992, AQUAT TOXICOL, V22, P287, DOI 10.1016/0166-445X(92)90046-P; Gorbi S, 2005, ARCH ENVIRON CON TOX, V49, P62, DOI 10.1007/s00244-004-0150-9; Granek EF, 2010, CONSERV BIOL, V24, P207, DOI 10.1111/j.1523-1739.2009.01355.x; Gravato C, 2010, ECOTOX ENVIRON SAFE, V73, P524, DOI 10.1016/j.ecoenv.2009.11.009; Great Barrier Reef Marine Park Authority, 2014, GREAT BARR REEF OUTL; Groen S., ENV ECOSYSTEMS CASE; Handy RD, 2003, ECOTOXICOLOGY, V12, P331, DOI 10.1023/A:1022527432252; Hanson N, 2013, BIOMARKERS ENV MONIT; Hariharan G, 2016, ENVIRON TOXICOL, V31, P24, DOI 10.1002/tox.22019; Hartl MGJ, 2007, MAR ENVIRON RES, V64, P191, DOI 10.1016/j.marenvres.2007.01.002; Henry F, 2012, J ENVIRON MONITOR, V14, P3211, DOI 10.1039/c2em30765k; Hook SE, 2017, ENVIRON TOXICOL CHEM, V36, P103, DOI 10.1002/etc.3505; Hook SE, 2014, INTEGR ENVIRON ASSES, V10, P327, DOI [10.1002/ieam.1530, 10]; Humphrey CA, 2007, MAR POLLUT BULL, V54, P1569, DOI 10.1016/j.marpolbul.2007.06.004; Isani G, 2009, ECOTOXICOL ENVIRON S; Isani G, 2011, FISH SHELLFISH IMMUN, V31, P1051, DOI 10.1016/j.fsi.2011.09.005; Jara-Marini ME, 2009, CHEMOSPHERE, V77, P1366, DOI 10.1016/j.chemosphere.2009.09.025; Jeffree RA, 2006, SCI TOTAL ENVIRON, V368, P839, DOI 10.1016/j.scitotenv.2006.03.026; Jezierska B, 2006, NATO SCI S SS IV EAR, V69, P107; Jia R, 2016, COMP BIOCHEM PHYS C, V181, P40, DOI 10.1016/j.cbpc.2016.01.002; Jimenez-Tenorio N, 2007, ENVIRON INT, V33, P474, DOI 10.1016/j.envint.2006.11.009; Jones HJ, 2014, ESTUAR COAST SHELF S, V137, P14, DOI 10.1016/j.ecss.2013.11.024; Jones MA, 2005, MAR POLLUT BULL, V51, P448, DOI 10.1016/j.marpolbul.2004.10.021; Kailola P.J., 1993, FISHERIES RESOURCES; Kalantzi I, 2014, SCI TOTAL ENVIRON, V470, P742, DOI 10.1016/j.scitotenv.2013.10.020; Kelada SN, 2001, AM J EPIDEMIOL, V154, P1, DOI 10.1093/aje/154.1.1; Kerambrun E, 2013, CHEMOSPHERE, V91, P498, DOI 10.1016/j.chemosphere.2012.12.010; Kerambrun E, 2012, ECOTOX ENVIRON SAFE, V80, P45, DOI 10.1016/j.ecoenv.2012.02.010; Kerambrun E, 2012, ECOL INDIC, V19, P161, DOI 10.1016/j.ecolind.2011.06.035; Kerambrun E, 2012, AQUAT TOXICOL, V108, P130, DOI 10.1016/j.aquatox.2011.07.016; Kerambrun E, 2011, COMP BIOCHEM PHYS C, V154, P187, DOI 10.1016/j.cbpc.2011.05.006; Kessabi K, 2012, J ENVIRON MONITOR, V14, P2254, DOI 10.1039/c2em30329a; KIME DE, 1995, REV FISH BIOL FISHER, V5, P52, DOI 10.1007/BF01103366; Kroon F.J., 2015, IDENTIFICATION IMPAC; Kroon FJ, 2015, ENVIRON TOXICOL CHEM, V34, P1881, DOI 10.1002/etc.3011; Kroon FJ, 2015, MAR ENVIRON RES, V104, P51, DOI 10.1016/j.marenvres.2015.01.002; Kroon FJ, 2014, ENVIRON TOXICOL CHEM, V33, P1607, DOI 10.1002/etc.2594; Kroon FJ, 2012, MAR POLLUT BULL, V65, P167, DOI 10.1016/j.marpolbul.2011.10.018; Kuiter R. H., 1993, COASTAL FISHES S E A; Le KT, 2014, AQUACULTURE, V433, P229, DOI 10.1016/j.aquaculture.2014.06.021; Leaver MJ, 2010, AQUAT TOXICOL, V96, P234, DOI 10.1016/j.aquatox.2009.10.025; Lee JW, 2015, J ENVIRON SCI, V35, P115, DOI 10.1016/j.jes.2015.05.002; Liu K, 2015, AQUAT TOXICOL, V165, P120, DOI 10.1016/j.aquatox.2015.05.013; Liu XJ, 2011, ECOTOX ENVIRON SAFE, V74, P1156, DOI 10.1016/j.ecoenv.2011.02.015; LIVINGSTONE DR, 1992, MAR ECOL PROG SER, V91, P97, DOI 10.3354/meps091097; Loro VL, 2014, COMP BIOCHEM PHYS C, V166, P96, DOI 10.1016/j.cbpc.2014.07.004; Maharajan A., 2016, J BASIC APPL ZOOL, V77, P21, DOI DOI 10.1016/J.JOBAZ.2016.02.001; Martinez-Gomez C, 2012, MAR ENVIRON RES, V77, P50, DOI 10.1016/j.marenvres.2012.02.002; McCarty LS, 2002, HUM ECOL RISK ASSESS, V8, P159, DOI 10.1080/20028091056791; Migliarini B, 2005, GEN COMP ENDOCR, V142, P241, DOI 10.1016/j.ygcen.2004.12.012; Minghetti M, 2008, COMP BIOCHEM PHYS C, V147, P450, DOI 10.1016/j.cbpc.2008.01.014; Mohammed A, 2012, MAR POLLUT BULL, V64, P169, DOI 10.1016/j.marpolbul.2011.10.036; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Mortimer M, 2013, POSTFLOOD WATER QUAL; Mzimela HM, 2003, MAR POLLUT BULL, V46, P659, DOI 10.1016/S0025-326X(03)00088-2; Nel L, 2015, MAR POLLUT BULL, V101, P878, DOI 10.1016/j.marpolbul.2015.11.015; Oliva M, 2014, COMP BIOCHEM PHYS C, V166, P134, DOI 10.1016/j.cbpc.2014.07.010; Oliva M, 2012, MAR POLLUT BULL, V64, P2097, DOI 10.1016/j.marpolbul.2012.07.017; Oliva M, 2012, ECOTOX ENVIRON SAFE, V75, P151, DOI 10.1016/j.ecoenv.2011.08.017; Oliveira BL, 2014, NEOTROP ICHTHYOL, V12, P845, DOI 10.1590/1982-0224-20140040; Oliveira M, 2010, MAR ENVIRON RES, V69, P227, DOI 10.1016/j.marenvres.2009.10.012; Olvera-Nestor CG, 2016, B ENVIRON CONTAM TOX, V96, P326, DOI 10.1007/s00128-015-1721-3; Omar WA, 2016, ECOTOXICOLOGY, V25, P253, DOI 10.1007/s10646-015-1584-8; Omar WA, 2012, MUTAT RES-GEN TOX EN, V746, P7, DOI 10.1016/j.mrgentox.2012.01.013; Padmini E, 2009, ECOTOXICOLOGY, V18, P304, DOI 10.1007/s10646-008-0282-1; Padmini E, 2009, SCI TOTAL ENVIRON, V407, P4533, DOI 10.1016/j.scitotenv.2009.04.005; Pamplona JH, 2010, ECOTOX ENVIRON SAFE, V74, P342; Papetti P, 2009, ENVIRON MONIT ASSESS, V159, P589, DOI 10.1007/s10661-008-0725-4; PEAKALL DB, 1994, ECOTOXICOLOGY, V3, P173, DOI 10.1007/BF00117082; PEAKALL DB, 1994, ECOTOXICOLOGY, V3, P157, DOI 10.1007/BF00117080; Pereira P, 2010, ECOTOX ENVIRON SAFE, V73, P805, DOI 10.1016/j.ecoenv.2010.02.020; Pereira P, 2010, MAR ENVIRON RES, V69, P53, DOI 10.1016/j.marenvres.2009.08.003; Peters GM, 1999, MAR ENVIRON RES, V47, P491, DOI 10.1016/S0141-1136(99)00027-6; Piva F, 2011, CHEMOSPHERE, V83, P475, DOI 10.1016/j.chemosphere.2010.12.064; Platten JR, 2004, HIST TRENDS RECREATI; Qian X, 2014, OMICS, V18, P98, DOI 10.1089/omi.2013.0110; Qiu YW, 2015, ESTUAR COAST SHELF S, V163, P7, DOI 10.1016/j.ecss.2015.05.036; Qiu YW, 2011, ECOTOX ENVIRON SAFE, V74, P284, DOI 10.1016/j.ecoenv.2010.10.008; Queensland Department of Agriculture, 2016, QUEENSL FISH QFISH; Queensland Department of Agriculture, 2012, COMM CATCH KEY SPEC; Queensland Department of Agriculture and Fisheries, 2016, SHARK CATCH NUMB; Queensland Department of Environment and Heritage Protection, 2017, SEW TREATM FAC MON P; Queensland Department of Environment and Heritage Protection, 2012, UPD QUAL SED PORT CU; Queensland Department of Environment and Resource Management, 2011, WAT QUAL PORT CURT T; Queensland Department of the Environment and Heritage Protection, 2012, 11 UPD WAT QUAL PORT; Queensland Government, 2016, COMM FISH LOGB MAPS; Rajeshkumar S, 2011, CHEMOSPHERE, V83, P415, DOI 10.1016/j.chemosphere.2010.12.086; Ransberry VE, 2015, AQUAT TOXICOL, V161, P242, DOI 10.1016/j.aquatox.2015.02.013; Ribecco C, 2011, AQUAT TOXICOL, V104, P308, DOI 10.1016/j.aquatox.2011.05.005; Rodrigues RV, 2011, AQUACULTURE, V322, P223, DOI 10.1016/j.aquaculture.2011.09.040; Rose WL, 2006, AQUAT TOXICOL, V80, P298, DOI 10.1016/j.aquatox.2006.09.007; Rowling K, 2010, STATUS FISHERIES RES; Sawynok B, 2014, ASSESSING TRENDS REC; Sawynok B, 2012, ASSESSING TRENDS REC; Sawynok B, 2015, CALLIOPE RIVER FISH; Schaffelke B, 2012, MAR POLLUT BULL, V65, P249, DOI 10.1016/j.marpolbul.2011.10.031; Schipper CA, 2009, ICES J MAR SCI, V66, P2089, DOI 10.1093/icesjms/fsp194; Schlenk D, 1999, MAR POLLUT BULL, V39, P48, DOI 10.1016/S0025-326X(99)00015-6; Schmidt V, 2003, HELGOLAND MAR RES, V57, P262, DOI 10.1007/s10152-003-0159-x; Seafood Standards, 2016, 53002015 AS; Serafim A, 2012, ECOL INDIC, V19, P215, DOI 10.1016/j.ecolind.2011.08.009; Simpson S.L., 2013, CSIRO LAND WATER, P132, DOI DOI 10.4225/08/5894C6184320C; Siscar R, 2013, MAR POLLUT BULL, V77, P90, DOI 10.1016/j.marpolbul.2013.10.026; Smit MGD, 2009, ENVIRON TOXICOL CHEM, V28, P1104, DOI 10.1897/08-464.1; Soto-Jimenez MF, 2008, MAR ENVIRON RES, V66, P451, DOI 10.1016/j.marenvres.2008.07.009; Souza IC, 2013, ENVIRON POLLUT, V180, P136, DOI 10.1016/j.envpol.2013.05.017; Stronkhorst J, 2003, ENVIRON POLLUT, V124, P17, DOI 10.1016/S0269-7491(02)00430-X; Taylor AM, 2010, OCEANOGR OCEAN ENG, P1; Tigano C, 2009, ECOTOX ENVIRON SAFE, V72, P1278, DOI 10.1016/j.ecoenv.2008.09.028; Townsend DM, 2003, ONCOGENE, V22, P7369, DOI 10.1038/sj.onc.1206940; Traven L, 2013, ENVIRON MONIT ASSESS, V185, P9009, DOI 10.1007/s10661-013-3230-3; Tsangaris C, 2011, ARCH ENVIRON CON TOX, V61, P482, DOI 10.1007/s00244-010-9629-8; Tse CY, 2010, FISH PHYSIOL BIOCHEM, V36, P141, DOI 10.1007/s10695-008-9243-0; van Bussel CGJ, 2014, AQUACULT ENG, V61, P35, DOI 10.1016/j.aquaeng.2014.05.003; van der Oost R, 2003, ENVIRON TOXICOL PHAR, V13, P57, DOI 10.1016/S1382-6689(02)00126-6; vanGestel CAM, 1996, ECOTOXICOLOGY, V5, P217, DOI 10.1007/BF00118992; Vethaak AD, 1996, ENVIRON HEALTH PERSP, V104, P1218, DOI 10.2307/3432916; Vicente-Beckett V, 2006, METAL POLYCYCLIC ARO; Vicente-Martorell JJ, 2009, J HAZARD MATER, V162, P823, DOI 10.1016/j.jhazmat.2008.05.106; Vision Environment QLD, 2011, PORT CURT EC HLTH RE; Waltham NJ, 2011, J ENVIRON MONITOR, V13, P3409, DOI 10.1039/c1em10664c; Wang T, 2015, INT J GENOMICS, V2015, DOI 10.1155/2015/783021; Waters D.K., 2014, MODELLING REDUCTIONS; Weis JS, 2003, MAR ENVIRON RES, V55, P27, DOI 10.1016/S0141-1136(02)00204-0; Weis JS, 2001, CAN J FISH AQUAT SCI, V58, P1442, DOI 10.1139/cjfas-58-7-1442; WHO (World Health Organization), 1993, BIOM RISK ASS CONC P; Williams TD, 2014, CHEMOSPHERE, V108, P152, DOI 10.1016/j.chemosphere.2014.01.028; Wilson S, 2012, ARROW LNG PLANT SUPP; Zhang L, 2005, AQUAT TOXICOL, V73, P353, DOI 10.1016/j.aquatox.2005.04.001; Zhang L, 2015, MAR POLLUT BULL, V101, P930, DOI 10.1016/j.marpolbul.2015.10.041; Zhu SQ, 2008, MAR ENVIRON RES, V65, P315, DOI 10.1016/j.marenvres.2007.11.007; Zhu SQ, 2006, MAR ENVIRON RES, V62, pS322, DOI 10.1016/j.marenvres.2006.04.058	185	60	62	3	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2017	12	4							e0174762	10.1371/journal.pone.0174762	http://dx.doi.org/10.1371/journal.pone.0174762			43	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LZ	28403149	Green Published, Green Submitted, gold			2022-12-27	WOS:000399955200020
J	Szoeke, C; Dang, C; Lehert, P; Hickey, M; Morris, ME; Dennerstein, L; Campbell, S				Szoeke, Cassandra; Dang, Christa; Lehert, Philippe; Hickey, Martha; Morris, Meg E.; Dennerstein, Lorraine; Campbell, Stephen			Unhealthy habits persist: The ongoing presence of modifiable risk factors for disease in women	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; CARDIOVASCULAR-DISEASE; LIFE-STYLE; AUSTRALIAN WOMEN; ADULT-POPULATION; FACTOR REDUCTION; FOLLOW-UP; PREVENTION; HEALTH; PREVALENCE	Objectives Vascular disease remains a leading cause of death. There are several vascular risk factors identified that can mitigate development of disease in ageing. We examine reported rates of modifiable risk factors in women responding to an online health questionnaire advertised by popular media. Methods A sample of 26 620 women aged over 18 was examined in 2015 with a cross-sectional health questionnaire. The questionnaire included self-reported health, mood, lifestyle and vascular risk factors. Results There remains high rates of modifiable risk factors present in women. The vast majority of women (80%) reported not eating enough fruit and vegetables. Compared to the guidelines for health, the majority did not perform enough weekly physical activity (70%) and more than half the participants were overweight (54%). Sufficient fruit, vegetables, fish, legumes and physical activity were reported in less than 30% of women! Conclusions Women continue to report low rates of physical activity, fruit and vegetable intake and higher BMI than recommended for good health, despite worldwide health promotion activities aimed at changing these lifestyle factors. Programs to support healthy living need to be reviewed and revised to reduce the burden of vascular disease and dementia in women. Previous guidelines are not having the important impact they should, particularly in women.	[Szoeke, Cassandra; Dang, Christa; Hickey, Martha; Dennerstein, Lorraine] Univ Melbourne, Fac Med Dent & Hlth Sci, Melbourne, Vic, Australia; [Szoeke, Cassandra] Australian Catholic Univ, Inst Hlth & Ageing, Melbourne, Vic, Australia; [Lehert, Philippe] Univ Mons, Dept Math & Stat, Mons, Belgium; [Morris, Meg E.] La Trobe Univ, Sch Allied Hlth, Melbourne, Vic, Australia; [Campbell, Stephen] Melbourne Hlth, Melbourne, Vic, Australia	University of Melbourne; Australian Catholic University; University of Mons; La Trobe University	Szoeke, C (corresponding author), Univ Melbourne, Fac Med Dent & Hlth Sci, Melbourne, Vic, Australia.; Szoeke, C (corresponding author), Australian Catholic Univ, Inst Hlth & Ageing, Melbourne, Vic, Australia.	cszoeke@unimelb.edu.au	Szoeke, Cassandra/AAI-8631-2021; Szoeke, CAssandra/AAE-8715-2019	Szoeke, Cassandra/0000-0002-3698-2590; Dang, Christa/0000-0003-0905-282X; Morris, Meg/0000-0002-0114-4175	National Health and Medical Research Council [547500]; Department of Medicine - Royal Melbourne Hospital, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Department of Medicine - Royal Melbourne Hospital, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne	CS received funding from the National Health and Medical Research Council (grant 547500), https//www.nhmrc.gov.au/. CS received funding from the Department of Medicine - Royal Melbourne Hospital, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, http://www.medrmhwh.unimelb.edu.au/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AA, 2014, ALZH DIS FACTS FIG I; ABS, 2008, CAUS DEATH AUSTR 200; ABS, ABS PUBLIC; AIHW, 2010, WOM HEART DIS CARD P; Anderson R, 2010, MATURITAS, V67, P151, DOI 10.1016/j.maturitas.2010.06.007; Australian Institute of Health and Welfare, 2014, AUSTR HLTH SER, V14; Australian Institute of Health andWelfare (AIHW), 2011, CARD DIS AUSTR FACTS; Barnes DE, 2011, LANCET NEUROL, V10, P819, DOI 10.1016/S1474-4422(11)70072-2; Bogers RP, 2007, ARCH INTERN MED, V167, P1720, DOI 10.1001/archinte.167.16.1720; Booth-Kewley S, 2007, COMPUT HUM BEHAV, V23, P463, DOI 10.1016/j.chb.2004.10.020; Brown WJ, 2000, RES Q EXERCISE SPORT, V71, P206, DOI 10.1080/02701367.2000.10608901; Cameron AJ, 2003, MED J AUSTRALIA, V178, P427, DOI 10.5694/j.1326-5377.2003.tb05283.x; Critchley JA, 2003, J EPIDEMIOL COMMUN H, V57, P243, DOI 10.1136/jech.57.4.243; Dalton M, 2003, J INTERN MED, V254, P555, DOI 10.1111/j.1365-2796.2003.01229.x; Dobson R., 2008, BRIT MED J; DOH, 2008, PUTTING PREVENTION F; DOHA, 2010, NAT WOM HLTH POL, P69; Emberson J, 2004, EUR HEART J, V25, P484, DOI 10.1016/j.ehj.2003.11.012; Ferretti F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141834; Goldman L, 2001, J AM COLL CARDIOL, V38, P1012, DOI 10.1016/S0735-1097(01)01512-1; Graham IM, 2005, CURR OPIN CARDIOL, V20, P430, DOI 10.1097/01.hco.0000176405.56119.54; Hammond Jean, 2007, Aust Crit Care, V20, P53, DOI 10.1016/j.aucc.2007.02.001; HASKELL WL, 1994, CIRCULATION, V89, P975, DOI 10.1161/01.CIR.89.3.975; Hendrie G, 2016, CSIRO HLTH DIET SCOR, V2016; Hung J., 2008, MED J AUSTRALIA, V184, P206; Huxley RR, 2015, CIRC J, V79, P1662, DOI 10.1253/circj.CJ-15-0661; Juster RP, 2010, NEUROSCI BIOBEHAV R, V35, P2, DOI 10.1016/j.neubiorev.2009.10.002; Kopjar B, 2005, PREV CHRONIC DIS, V2, pA18; Kuulasmaa K, 2000, LANCET, V355, P675, DOI 10.1016/S0140-6736(99)11180-2; LAW MR, 1994, BMJ-BRIT MED J, V308, P367, DOI 10.1136/bmj.308.6925.367; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Maas AHEM, 2010, NETH HEART J, V18, P598, DOI 10.1007/s12471-010-0841-y; Magarey A, 2006, AUST NZ J PUBL HEAL, V30, P32, DOI 10.1111/j.1467-842X.2006.tb00083.x; McPherson K, 2002, CORONARY HEART DIS E; Mosca L, 2006, CIRCULATION, V113, P525, DOI 10.1161/CIRCULATIONAHA.105.588103; Mosca L, 2005, CIRCULATION, V111, P499, DOI 10.1161/01.CIR.0000154568.43333.82; Mosca L, 2013, CIRCULATION, V127, P1254, DOI 10.1161/CIR.0b013e318287cf2f; Mosca L, 2011, CIRCULATION, V124, P2145, DOI 10.1161/CIRCULATIONAHA.110.968792; Mosca L, 2010, CIRC-CARDIOVASC QUAL, V3, P120, DOI 10.1161/CIRCOUTCOMES.109.915538; Poortinga W, 2007, PREV MED, V44, P124, DOI 10.1016/j.ypmed.2006.10.006; Reblin M, 2008, CURR OPIN PSYCHIATR, V21, P201, DOI 10.1097/YCO.0b013e3282f3ad89; Rose G., 1992, STRATEGY PREVENTIVE; Schuit AJ, 2002, PREV MED, V35, P219, DOI 10.1006/pmed.2002.1064; Seib C, 2014, WOMEN HEALTH ISS, V24, pE43, DOI 10.1016/j.whi.2013.11.004; Shaw LJ, 2009, J AM COLL CARDIOL, V54, P1561, DOI 10.1016/j.jacc.2009.04.098; Smith-DiJulio K, 2009, HEALTH CARE WOMEN IN, V30, P1111, DOI 10.1080/07399330903104524; Taskforce NPH, 2008, AUSTRALIA HEALTHIEST; van Lennep JER, 2002, CARDIOVASC RES, V53, P538, DOI 10.1016/S0008-6363(01)00388-1; Wenger NK, 2013, ADV CHRONIC KIDNEY D, V20, P419, DOI 10.1053/j.ackd.2013.02.006; Yeats B., 2008, WOMEN CARDIOVASCULAR	50	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2017	12	4							e0173603	10.1371/journal.pone.0173603	http://dx.doi.org/10.1371/journal.pone.0173603			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET0LZ	28403144	Green Published, gold			2022-12-27	WOS:000399955200008
J	Toledo, RD; Martins, FDC; Ferreira, FP; de Almeida, JC; Ogawa, L; dos Santos, HLEPL; dos Santos, MM; Pinheiro, FA; Navarro, IT; Garcia, JL; Freire, RL				Toledo, Roberta dos Santos; Cardoso Martins, Felippe Danyel; Ferreira, Fernanda Pinto; de Almeida, Jonatas Campos; Ogawa, Liza; Peruch Lemos dos Santos, Hannah Lia Ettiene; dos Santos, Maira Moreira; Pinheiro, Filipe Aguera; Navarro, Italmar Teodorico; Garcia, Joao Luis; Freire, Roberta Lemos			Cryptosporidium spp. and Giardia spp. in feces and water and the associated exposure factors on dairy farms	PLOS ONE			English	Article							MOLECULAR CHARACTERIZATION; DUODENALIS GENOTYPES; GENETIC-CHARACTERIZATION; PROTOZOAN PARASITES; SUBTYPE ANALYSES; PARVUM OOCYSTS; SURFACE-WATER; BEEF-CALVES; PREVALENCE; CATTLE	The aims of this study were to verify the prevalence of Cryptosporidium spp. and Giardia spp. in animal feces and drinking water on dairy farms and to identify a possible relation between the exposure factors and the presence of these parasites. Fecal samples from cattle and humans and water samples were collected on dairy farms in Parana A, Brazil. Analysis of (oo) cysts in the feces was performed by the modified Ziehl-Neelsen staining and centrifugal flotation in zinc sulfate. Test-positive samples were subjected to nested PCR amplification of the 18SSU ribosomal RNA gene for identification of Cryptosporidium and Giardia and of the gp60 gene for subtyping of Cryptosporidium. Microbiological analysis of water was carried out by the multiple-tube method and by means of a chromogenic substrate, and parasitological analysis was performed on 31 samples by direct immunofluorescence and nested PCR of the genes mentioned above. Identification of the species of Cryptosporidium was performed by sequencing and PCR with analysis of restriction fragment length polymorphisms. The prevalence of Giardia and Cryptosporidium was higher in calves than in adults. Among the samples of cattle feces, Cryptosporidium parvum was identified in 41 (64%), C. ryanae in eight (12.5%), C. bovis in four (6.3%), C. andersoni in five (7.8%), and a mixed infection in 20 samples (31.3%). These parasites were not identified in the samples of human feces. Thermotolerant coliform bacteria were identified in 25 samples of water (45.5%). Giardia duodenalis and C. parvum were identified in three water samples. The gp60 gene analysis of C. parvum isolates revealed the presence of two strains (IIaA20G1R1 and IIaA17G2R2) in the fecal samples and one (IIaA17G2R1) in the water samples. The presence of coliforms was associated with the water source, structure and degradation of springs, rain, and turbidity. The prevalence of protozoa was higher in calves up to six months of age. C. parvum and G. duodenalis were identified in the water of dairy farms, as were thermotolerant coliforms; these findings point to the need for guidance on handling of animals, preservation of water sources, and water treatment.	[Toledo, Roberta dos Santos; Cardoso Martins, Felippe Danyel; Ferreira, Fernanda Pinto; de Almeida, Jonatas Campos; Peruch Lemos dos Santos, Hannah Lia Ettiene; dos Santos, Maira Moreira; Pinheiro, Filipe Aguera; Navarro, Italmar Teodorico; Garcia, Joao Luis; Freire, Roberta Lemos] Univ Estadual Londrina, DMVP, Londrina, Parana, Brazil; [Ogawa, Liza] UENP, Ctr Ciencias Agr, Bandeirantes, Parana, Brazil	Universidade Estadual de Londrina; Universidade Estadual do Norte do Parana (UENP)	Toledo, RD (corresponding author), Univ Estadual Londrina, DMVP, Londrina, Parana, Brazil.	betatoledo@yahoo.com.br	ALMEIDA, JONATAS/AAB-4140-2020; Garcia, Joao Luis/Y-8864-2019; Martins, Felippe Danyel Cardoso/T-5710-2019; Garcia, João Luis/X-4279-2019; Luis, João/AAE-9252-2019	ALMEIDA, JONATAS/0000-0002-2282-4268; Garcia, Joao Luis/0000-0002-5736-7511; Garcia, João Luis/0000-0003-1826-7582; Moreira Santos, Maira/0000-0002-2483-9009; Ogawa, Liza/0000-0002-2509-386X	Araucaria Foundation [24/2012]; Araucaria Foundation of the Universal Program of Basic and Applied Research [196/2014]	Araucaria Foundation(Fundacao Araucaria de Apoio ao Desenvolvimento Cientifico e Tecnologico do Estado do Parana FA); Araucaria Foundation of the Universal Program of Basic and Applied Research(Fundacao Araucaria de Apoio ao Desenvolvimento Cientifico e Tecnologico do Estado do Parana FA)	This work was funded by the Araucaria Foundation to support the scientific and technological development of Parana, after approval of funding in the call for projects 24/2012 of the Universal Program of Basic and Applied Research. The agreement was established under number 196/2014. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves M, 2003, J CLIN MICROBIOL, V41, P2744, DOI 10.1128/JCM.41.6.2744-2747.2003; American Public Health Association (APHA), 2005, STANDARD METHODS EXA; Andrade J, 2005, ESPACO ENERGIA, V3, P6; Appelbee AJ, 2003, VET PARASITOL, V112, P289, DOI 10.1016/S0304-4017(02)00422-3; Lima RCA, 2013, SEMIN-CIENC AGRAR, V34, P3747, DOI 10.5433/1679-0359.2013v34n6Supl2p3747; Baldursson S, 2011, WATER RES, V45, P6603, DOI 10.1016/j.watres.2011.10.013; Branco N, 2012, VECTOR-BORNE ZOONOT, V12, P410, DOI 10.1089/vbz.2011.0679; Brasil Ministerio da Saude., 2013, MAN PRAT AN AG; Brasil Ministerio do Planejamento Orcamento e Instituto Brasileiro de Geografia e Estatistica -IBGE, 2012, PESQ NAC AM DOM PNAD; Budu-Amoako E, 2012, J VET INTERN MED, V26, P668, DOI 10.1111/j.1939-1676.2012.00930.x; Caccio SM, 2008, MOL BIOCHEM PARASIT, V160, P75, DOI 10.1016/j.molbiopara.2008.04.006; Caccio SM, 2010, EXP PARASITOL, V124, P107, DOI 10.1016/j.exppara.2009.02.007; Cama V, 2006, EMERG INFECT DIS, V12, P1025, DOI 10.3201/eid1206.060015; CANTUSIO NETO R, 2004, HIGIENE ALIMENTAR, V18, P52, DOI DOI 10.1007/S00436-009-1440-Y; Capp N., 2012, Geografia Ensino & Pesquisa, V16, P77; Cardoso Jose Marcio S, 2008, Rev Bras Parasitol Vet, V17 Suppl 1, P239; Chalmers RM, 2011, EPIDEMIOL INFECT, V139, P700, DOI 10.1017/S0950268810001688; Coklin T, 2007, VET PARASITOL, V150, P297, DOI 10.1016/j.vetpar.2007.09.014; Collier Sarah A., 2011, Morbidity and Mortality Weekly Report, V60, P918; Del Coco VF, 2014, RES VET SCI, V96, P311, DOI 10.1016/j.rvsc.2013.12.010; Efstratiou A, 2017, WATER RES, V114, P14, DOI 10.1016/j.watres.2017.01.036; Faust E.C., 1939, Journal of Parasitology Urbana, V25, P241, DOI 10.2307/3272508; Fayer R, 2005, J PARASITOL, V91, P624, DOI 10.1645/GE-3435; Fayer R, 2004, VET PARASITOL, V126, P37, DOI 10.1016/j.vetpar.2004.09.004; Fayer R, 2007, VET PARASITOL, V145, P260, DOI 10.1016/j.vetpar.2006.12.009; Feitosa Francisco Leydson Formiga, 2004, Cienc. Rural, V34, P189, DOI 10.1590/S0103-84782004000100029; Feltus DC, 2006, J CLIN MICROBIOL, V44, P4303, DOI 10.1128/JCM.01067-06; Feng YY, 2007, VET PARASITOL, V144, P1, DOI 10.1016/j.vetpar.2006.10.001; Follet J, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-116; Franco RM., 2007, REV PANAM INFECTOL, V9, P36; Geurden T, 2007, PARASITOLOGY, V134, P1981, DOI 10.1017/S0031182007003460; Geurden T, 2012, VET PARASITOL, V190, P383, DOI 10.1016/j.vetpar.2012.06.039; Geurden T, 2010, EXP PARASITOL, V124, P98, DOI 10.1016/j.exppara.2009.03.001; Heller L., 2004, EPIDEMIOL SERV SAUDE, V13, P79, DOI [10.5123/S1679-49742004000200002, DOI 10.5123/S1679-49742004000200002]; HENRIKSEN SA, 1981, ACTA VET SCAND, V22, P594; Hopkins RM, 1997, J PARASITOL, V83, P44, DOI 10.2307/3284315; Huetink REC, 2001, VET PARASITOL, V102, P53, DOI 10.1016/S0304-4017(01)00514-3; Karanis P, 1998, WATER SCI TECHNOL, V37, P9, DOI 10.1016/S0273-1223(98)00046-8; Karanis P, 1996, ZBL BAKT-INT J MED M, V284, P107; Karanis P, 1998, PARASITOL RES, V84, P442, DOI 10.1007/s004360050427; Karanis P, 1996, ZBL BAKT-INT J MED M, V284, P302; Karanis P, 2007, J WATER HEALTH, V5, P1, DOI 10.2166/wh.2006.002; Kaupke A, 2015, PARASITOL RES, V114, P4709, DOI 10.1007/s00436-015-4719-1; Koehler AV, 2013, ELECTROPHORESIS, V34, P1720, DOI 10.1002/elps.201300100; Lalonde LF, 2009, VET PARASITOL, V160, P185, DOI 10.1016/j.vetpar.2008.11.022; Langoni H., 2004, Brazilian Journal of Veterinary Research and Animal Science, V41, P313, DOI 10.1590/S1413-95962004000500004; Martins-Vieira MBC, 2009, ARQ BRAS MED VET ZOO, V61, P1454, DOI 10.1590/S0102-09352009000600030; McAllister TA, 2005, CAN VET J, V46, P47; Meireles MV, 2011, PARASITOL RES, V109, P949, DOI 10.1007/s00436-011-2336-1; Misic Z, 2007, PARASITOLOGY, V134, P351, DOI 10.1017/S0031182006001508; Neta EDM, 2010, REV BRAS MED VET, V32, P201; Nishi L, 2009, VECTOR-BORNE ZOONOT, V9, P543, DOI 10.1089/vbz.2008.0021; Nolan MJ, 2009, ELECTROPHORESIS, V30, P2640, DOI 10.1002/elps.200900071; O'Handley RM, 2000, VET PARASITOL, V90, P193, DOI 10.1016/S0304-4017(00)00235-1; O'Handley RM, 2003, VET PARASITOL, V113, P89, DOI 10.1016/S0304-4017(03)00059-1; Oliveira JP, 2007, PESQUI VET BRASIL, V27, P419, DOI 10.1590/S0100-736X2007001000006; Ortolani E. L., 2003, Parasitologia Latinoamericana, V58, P122; OUCHENE N, 2014, J PARASITOL VECTOR B, V6, P61; Silva FMPE, 2013, REV BRAS PARASITOL V, V22, P22, DOI 10.1590/S1984-29612013005000010; Paz e Silva FM, 2012, FOLIA PARASIT, V59, P15; Plutzer J, 2010, LETT APPL MICROBIOL, V50, P82, DOI 10.1111/j.1472-765X.2009.02758.x; Plutzer J, 2007, VET PARASITOL, V146, P357, DOI 10.1016/j.vetpar.2007.02.030; Plutzer J, 2016, WATER RES, V101, P318, DOI 10.1016/j.watres.2016.05.085; Plutzer J, 2009, VET PARASITOL, V165, P187, DOI 10.1016/j.vetpar.2009.07.003; Redlinger T, 2002, AM J TROP MED HYG, V66, P794, DOI 10.4269/ajtmh.2002.66.794; Ryan U, 2014, PARASITOLOGY, V141, P1667, DOI 10.1017/S0031182014001085; Ryan U, 2013, INT J PARASITOL, V43, P943, DOI 10.1016/j.ijpara.2013.06.001; Santin M, 2004, VET PARASITOL, V122, P103, DOI 10.1016/j.vetpar.2004.03.020; Santin M, 2008, VET PARASITOL, V155, P15, DOI 10.1016/j.vetpar.2008.04.018; Santin M, 2009, VET PARASITOL, V162, P40, DOI 10.1016/j.vetpar.2009.02.008; Seva AD, 2010, REV BRAS PARASITOL V, V19, P249; Silva CV, 2012, ENG SANIT AMBIENT, V17, P293; Silverlas C, 2013, INT J PARASITOL, V43, P155, DOI 10.1016/j.ijpara.2012.10.009; Smith RP, 2014, VET PARASITOL, V204, P111, DOI 10.1016/j.vetpar.2014.05.022; Swaffer BA, 2014, WATER RES, V67, P310, DOI 10.1016/j.watres.2014.08.055; Taylor R, 2004, FEMS MICROBIOL ECOL, V49, P17, DOI 10.1016/j.femsec.2004.02.018; Thompson RCA, 2008, VET J, V177, P18, DOI 10.1016/j.tvjl.2007.09.022; Thompson RCA, 2004, VET PARASITOL, V126, P15, DOI 10.1016/j.vetpar.2004.09.008; Thompson RCA, 2004, ADV PARASIT, V58, P69, DOI 10.1016/S0065-308X(04)58002-8; Tomazic ML, 2013, VET PARASITOL, V198, P382, DOI 10.1016/j.vetpar.2013.09.022; Trotz-Williams LA, 2006, PARASITOL RES, V99, P346, DOI 10.1007/s00436-006-0157-4; Trout JM, 2007, VET PARASITOL, V147, P205, DOI 10.1016/j.vetpar.2007.05.014; Trout JM, 2006, VET PARASITOL, V140, P217, DOI 10.1016/j.vetpar.2006.03.025; Trout JM, 2004, VET PARASITOL, V124, P179, DOI 10.1016/j.vetpar.2004.07.010; Trout JM, 2005, VET PARASITOL, V130, P177, DOI 10.1016/j.vetpar.2005.03.032; Vargas SF, 2014, PESQUI VET BRASIL, V34, P749, DOI 10.1590/S0100-736X2014000800007; Vaz L, 2012, 21 ENC NAC GEOGR AGR, V21, P1; VESEY G, 1993, J APPL BACTERIOL, V75, P82, DOI 10.1111/j.1365-2672.1993.tb03412.x; Wells B, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0684-x; Wilkes G, 2013, APPL ENVIRON MICROB, V79, P434, DOI 10.1128/AEM.01924-12; World Health Organization, 2009, DIARRH WHY CHILDR AR; Xiao LH, 1999, APPL ENVIRON MICROB, V65, P3386; Xiao LH, 2001, APPL ENVIRON MICROB, V67, P1097, DOI 10.1128/AEM.67.3.1097-1101.2001; Xiao LH, 2004, CLIN MICROBIOL REV, V17, P72, DOI 10.1128/CMR.17.1.72-97.2004; Xiao LH, 2010, EXP PARASITOL, V124, P80, DOI 10.1016/j.exppara.2009.03.018; Zintl A, 2009, EPIDEMIOL INFECT, V137, P270, DOI 10.1017/S0950268808000769	96	26	27	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2017	12	4							e0175311	10.1371/journal.pone.0175311	http://dx.doi.org/10.1371/journal.pone.0175311			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LZ	28403147	Green Published, gold, Green Submitted			2022-12-27	WOS:000399955200050
J	Leon-Ortega, M; Jimenez-Franco, MV; Martinez, JE; Calvo, JF				Leon-Ortega, Mario; Jimenez-Franco, Maria V.; Martinez, Jose E.; Calvo, Jose F.			Factors influencing territorial occupancy and reproductive success in a Eurasian Eagle-owl (Bubo bubo) population	PLOS ONE			English	Article							SPECIES OCCURRENCE DYNAMICS; CALIFORNIA SPOTTED OWL; CLIFF-NESTING RAPTORS; BREEDING PERFORMANCE; HIERAAETUS-PENNATUS; AQUILA-CHRYSAETOS; SPATIAL-PATTERNS; MULTIPLE STATES; SITE FIDELITY; LARGE-SCALE	Modelling territorial occupancy and reproductive success is a key issue for better understanding the population dynamics of territorial species. This study aimed to investigate these ecological processes in a Eurasian Eagle-owl (Bubo bubo) population in south-eastern Spain during a seven-year period. A multi-season, multi-state modelling approach was followed to estimate the probabilities of occupancy and reproductive success in relation to previous state, time and habitat covariates, and accounting for imperfect detection. The best estimated models showed past breeding success in the territories to be the most important factor determining a high probability of reoccupation and reproductive success in the following year. In addition, alternative occupancy models suggested the positive influence of crops on the probability of territory occupation. By contrast, the best reproductive model revealed strong interannual variations in the rates of breeding success, which may be related to changes in the abundance of the European Rabbit, the main prey of the Eurasian Eagle-owl. Our models also estimated the probabilities of detecting the presence of owls in a given territory and the probability of detecting evidence of successful reproduction. Estimated detection probabilities were high throughout the breeding season, decreasing in time for unsuccessful breeders but increasing for successful breeders. The probability of detecting reproductive success increased with time, being close to one in the last survey. These results suggest that reproduction failure in the early stages of the breeding season is a determinant factor in the probability of detecting occupancy and reproductive success.	[Leon-Ortega, Mario; Jimenez-Franco, Maria V.; Martinez, Jose E.; Calvo, Jose F.] Univ Murcia, Fac Biol, Dept Ecol & Hidrol, Murcia, Spain; [Martinez, Jose E.] Bonellis Eagle Study & Conservat Grp, Murcia, Spain; [Jimenez-Franco, Maria V.] Univ Miguel Hernandez Elche, Area Ecol, Elche, Spain	University of Murcia; Universidad Miguel Hernandez de Elche	Calvo, JF (corresponding author), Univ Murcia, Fac Biol, Dept Ecol & Hidrol, Murcia, Spain.	ifcalvo@um.es	Jiménez-Franco, Maria Victoria/M-2041-2014; Calvo, José Francisco/C-7076-2009	Jiménez-Franco, Maria Victoria/0000-0002-7254-0431; Calvo, José Francisco/0000-0002-3813-4333; Martinez, Jose Enrique/0000-0002-1200-5795	FPU grant from the Spanish Ministry of Educationand Science [AP2009-2073]	FPU grant from the Spanish Ministry of Educationand Science(German Research Foundation (DFG))	MVJ-F was partially supported by a FPU grant (reference AP2009-2073) from the Spanish Ministry of Educationand Science (http://www.mecd.gob.es/educacion-mecd/areas-educacion/profesorado/universitarios/becas-ayudas/formacion.html). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold TW, 2010, J WILDLIFE MANAGE, V74, P1175, DOI 10.2193/2009-367; Bionda R, 2012, J ORNITHOL, V153, P167, DOI 10.1007/s10336-011-0721-2; Booms TL, 2010, J RAPTOR RES, V44, P175, DOI 10.3356/JRR-09-70.1; Boughton DA, 2000, AM NAT, V156, P131, DOI 10.1086/303380; Bouvier JC, 2014, ACTA ORNITHOL, V49, P23, DOI 10.3161/000164514X682869; Brambilla M, 2013, ORNIS FENNICA, V90, P50; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Campioni L, 2013, OECOLOGIA, V172, P371, DOI 10.1007/s00442-012-2493-7; Carrete M, 2005, OIKOS, V108, P125, DOI 10.1111/j.0030-1299.2005.12942.x; Casado E, 2008, IBIS, V150, P788, DOI 10.1111/j.1474-919X.2008.00862.x; Delgado MM, 2007, J ZOOL, V271, P3, DOI 10.1111/j.1469-7998.2006.00205.x; Delibes-Mateos M, 2009, MAMMAL REV, V39, P124, DOI 10.1111/j.1365-2907.2009.00140.x; Donazar J.A., 1988, Ardeola, V35, P233; DONAZAR JA, 1990, J ORNITHOL, V131, P439, DOI 10.1007/BF01639820; Espin S, 2014, SCI TOTAL ENVIRON, V470, P1132, DOI 10.1016/j.scitotenv.2013.10.063; Fernandez-de-Simon J, 2014, ACTA OECOL, V60, P1, DOI 10.1016/j.actao.2014.06.006; Fisher JT, 2014, CONSERV BIOL, V28, P1249, DOI 10.1111/cobi.12302; FORSLUND P, 1995, TRENDS ECOL EVOL, V10, P374, DOI 10.1016/S0169-5347(00)89141-7; Gomez-Rodriguez C, 2012, DIVERS DISTRIB, V18, P260, DOI 10.1111/j.1472-4642.2011.00837.x; Grady MJ, 2017, IBIS, V159, P285; Guillod N, 2016, J AVIAN BIOL, V47, P697, DOI 10.1111/jav.00990; Hines JE., 2006, PRESENCESOFTWARE EST; Hoover JP, 2003, ECOLOGY, V84, P416, DOI 10.1890/0012-9658(2003)084[0416:DRFSFI]2.0.CO;2; Jimenez-Franco MV, 2014, J ZOOL, V292, P64, DOI 10.1111/jzo.12085; Jimenez-Franco MV, 2013, J ORNITHOL, V154, P311, DOI 10.1007/s10336-012-0895-2; Jimenez-Franco MV, 2011, OECOLOGIA, V166, P507, DOI 10.1007/s00442-010-1857-0; Kaisanlahti-Jokimaki ML, 2008, ORNIS FENNICA, V85, P2; Karanth KK, 2010, P ROY SOC B-BIOL SCI, V277, P1971, DOI 10.1098/rspb.2010.0171; Kellner KF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111436; Kruger SC, 2015, CONDOR, V117, P94, DOI 10.1650/CONDOR-14-121.1; Kruger O, 2002, ECOGRAPHY, V25, P523, DOI 10.1034/j.1600-0587.2002.250502.x; LANDE R, 1988, OECOLOGIA, V75, P601, DOI 10.1007/BF00776426; Lee DE, 2012, CONDOR, V114, P792, DOI 10.1525/cond.2012.110147; Leon-Ortega M, 2016, EUR J WILDLIFE RES, V62, P643, DOI 10.1007/s10344-016-1036-7; Leon-Ortega M, 2014, ARDEOLA, V61, P45, DOI 10.13157/arla.61.1.2014.45; Linkhart BD, 2007, AUK, V124, P264, DOI 10.1642/0004-8038(2007)124[264:RRFADI]2.0.CO;2; Lohmus A, 2004, J AVIAN BIOL, V35, P455, DOI 10.1111/j.0908-8857.2004.03228.x; Lopez-Lopez P, 2009, BIODIVERS CONSERV, V18, P1389, DOI 10.1007/s10531-008-9469-2; MacKenzie D. I., 2017, OCCUPANCY ESTIMATION; MacKenzie DI, 2011, METHODS ECOL EVOL, V2, P612, DOI 10.1111/j.2041-210X.2011.00110.x; Mackenzie DI, 2009, ECOLOGY, V90, P823, DOI 10.1890/08-0141.1; Marchesi L, 2002, IBIS, V144, pE164, DOI 10.1046/j.1474-919X.2002.t01-2-00094_2.x; Margalida A, 2011, ANIM CONSERV, V14, P167, DOI 10.1111/j.1469-1795.2010.00412.x; Margalida A, 2007, J ORNITHOL, V148, P309, DOI 10.1007/s10336-007-0133-5; Martin J, 2009, BIOL CONSERV, V142, P2726, DOI 10.1016/j.biocon.2009.06.027; MARTIN K, 1995, AM ZOOL, V35, P340; Martinez JA, 2003, ECOGRAPHY, V26, P21, DOI 10.1034/j.1600-0587.2003.03368.x; Martinez Jose Antonio, 2002, Ardeola, V49, P1; Martinez JE, 2008, ORNIS FENNICA, V85, P13; Martinez JE, 2006, IBIS, V148, P807, DOI 10.1111/j.1474-919X.2006.00586.x; Martinez Jose Enrique, 2000, Ardeola, V47, P215; Martinez-Abrain A., 2002, Animal Biodiversity and Conservation, V25, P47; Martinez-Marti C, 2016, SCI REP-UK, V6, DOI 10.1038/srep33838; Mcintyre CL, 2012, IBIS, V154, P124, DOI 10.1111/j.1474-919X.2011.01181.x; Millon A, 2008, J ZOOL, V275, P349, DOI 10.1111/j.1469-7998.2008.00447.x; Neteler M., 2013, OPEN SOURCE GIS GRAS; Newton I., 1998, POPULATION LIMITATIO; Nichols JD, 2007, ECOLOGY, V88, P1395, DOI 10.1890/06-1474; Ortego J, 2004, ARDEOLA, V51, P385; Ortego J, 2007, ORNIS FENNICA, V84, P78; Pagan I, 2009, J ZOOL, V279, P36, DOI 10.1111/j.1469-7998.2009.00587.x; Penteriani V, 2002, J ZOOL, V257, P365, DOI 10.1017/S0952836902000961; Penteriani V, 2001, ARDEA, V89, P331; Penteriani V, 2010, ORNIS FENNICA, V87, P135; Penteriani V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003014; Peterson SL, 2014, CONDOR, V116, P527, DOI 10.1650/CONDOR-14-45.1; Sadoti G, 2014, WILDLIFE BIOL, V20, P97, DOI 10.2981/wlb.13056; Schmidt KA, 2004, ECOL LETT, V7, P176, DOI 10.1111/j.1461-0248.2003.00565.x; Seamans M., 2010, J ORNITHOL, DOI DOI 10.1007/S10336-010-0544-6; Seamans ME, 2007, CONDOR, V109, P566, DOI 10.1650/8352.1; Serrano D, 2001, J ANIM ECOL, V70, P568, DOI 10.1046/j.1365-2656.2001.00512.x; Steenhof Karen, 2007, P181; Strasser EH, 2013, J APPL ECOL, V50, P912, DOI 10.1111/1365-2664.12103; Switzer PV, 1997, BEHAV ECOL SOCIOBIOL, V40, P307, DOI 10.1007/s002650050346; Tempel DJ, 2013, CONSERV BIOL, V27, P1087, DOI 10.1111/cobi.12074; Tingley MW, 2016, METHODS ECOL EVOL, V7, P508, DOI 10.1111/2041-210X.12500; Zabala J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090254	77	16	17	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2017	12	4							e0175597	10.1371/journal.pone.0175597	http://dx.doi.org/10.1371/journal.pone.0175597			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0JS	28399175	Green Submitted, gold, Green Published			2022-12-27	WOS:000399949000053
J	Zgambo, M; Mbakaya, BC; Kalembo, FW				Zgambo, Maggie; Mbakaya, Balwani Chingatichifwe; Kalembo, Fatch Welcome			Prevalence and factors associated with malaria parasitaemia in children under the age of five years in Malawi: A comparison study of the 2012 and 2014 Malaria Indicator Surveys (MISs)	PLOS ONE			English	Article							RISK-FACTORS; TRANSMISSION	Background Malaria is the main cause of morbidity and mortality among children under the age of five years in Malawi. The aim of this study was to compare the prevalence and factors associated with malaria parasitaemia among children under the age of five years in Malawi between the 2014 and 2012 Malaria Indicator Surveys (MISs). Methodology Data on demographic factors, vector control interventions, and blood for malaria test were collected from a representative sample of children under the age of five years in Malawi through multistage cluster sampling method. Data were analysed by chi-square test and logistic regression using complex samples analysis of the Statistical Package for the Social Sciences (SPSS) version 22. Results The prevalence of malaria parasitaemia among children under the age of five years increased from 28% in 2012 to 33% in 2014 (p > 0.05). Likewise, the proportion of children using long-lasting insecticide-treated net (LLIN) increased significantly from 54% in 2012 to 65% in 2014 MIS (p < 0.05). The proportion of households that had used indoor residual spraying (IRS) was 9% for both surveys. In multivariate analysis, use of LLIN significantly predicted for malaria parasitaemia in the 2012 MIS but not in the 2014 MIS. Older children and those coming from the poorest families were significantly associated with having malaria parasites in both surveys. Conclusion The increase in the use of LLIN among children in 2014, did not result in the reduction of malaria parasitaemia in children. The use of LLIN significantly predicted for malaria parasitaemia among children in the 2012 MIS but not in the 2014 MIS. The results of this study underscore the need to increase the coverage of IRS, mosquito repellents and larvicide alongside LLINs in order to reduce the burden of malaria among children in Malawi.	[Zgambo, Maggie; Mbakaya, Balwani Chingatichifwe] St Johns Coll Nursing, Mzuzu, Malawi; [Kalembo, Fatch Welcome] Mzuzu Univ, Private Bag 201,Luwinga Mzuzu 2, Mzuzu, Malawi		Zgambo, M (corresponding author), St Johns Coll Nursing, Mzuzu, Malawi.	zgambo.maggie@yahoo.ca		Mbakaya, Balwani Chingatichifwe/0000-0002-4705-9064; Kalembo, Fatch W./0000-0003-3032-3495; Zgambo, Maggie/0000-0001-8667-795X				Atieli HE, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-113; Byakika-Kibwika P, 2010, HLTH CARE RELATED FA; Chanda E, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0759-3; Deressa W, 2014, INDIVIDUAL HOUSEHOLD; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Government of Malawi, 2010, HLTH MAN INF SYST HM; GWATKIN DR, 2000, SOCIOECONOMIC DIFFER; Jagannathan P, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-435; Kazembe Lawrence N, 2006, Int J Health Geogr, V5, P41, DOI 10.1186/1476-072X-5-41; Kazembe LN, 2007, ACTA TROP, V102, P126, DOI 10.1016/j.actatropica.2007.04.012; Kyu HH, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/604974; Louis VR, 2015, B WORLD HEALTH ORGAN, V93, P750, DOI 10.2471/BLT.14.147702; Malawi National Malaria Control Programme, 2015, 2015 MASS DISTR CAMP; Mathanga DP, 2012, ACTA TROP, V121, P212, DOI 10.1016/j.actatropica.2011.06.017; Ministry of Health Malawi, 2011, MAL STRAT PLAN 2011; Mugisha F, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-40; Mukonka VM, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-153; Mwareya Y, 2016, MISUSE MOSQUITO NETS; Nadimpalli V., 2012, SIMPLIFYING ANAL COM; Ricci F, 2012, MEDITERR J HEMATOL I, V4, DOI 10.4084/MJHID.2012.048; Roberts D, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1290-x; Rowe AK, 2006, INT J EPIDEMIOL, V35, P691, DOI 10.1093/ije/dyl027; Ruyange MM, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1403-6; SAWYER D, 1993, SOC SCI MED, V37, P1131, DOI 10.1016/0277-9536(93)90252-Y; Simon C, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-458; Siri JG, 2014, ECOL SOC, V19, DOI 10.5751/ES-06134-190133; Sonko ST, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-449; Sun GW, 1996, J CLIN EPIDEMIOL, V49, P907, DOI 10.1016/0895-4356(96)00025-X; Teklehaimanot A, 2008, ANN NY ACAD SCI, V1136, P32, DOI 10.1196/annals.1425.037; Tusting LS, 2013, LANCET, V382, P963, DOI 10.1016/S0140-6736(13)60851-X; USAID, 2016, PRES MAL IN MAL MAL; USAID, 2016, EV IMP MAL CONTR INT; Walldorf JA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134061; WHO, 2016, MAL NEON CHILD HLTH; Winskill P, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-98	35	20	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2017	12	4							e0175537	10.1371/journal.pone.0175537	http://dx.doi.org/10.1371/journal.pone.0175537			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0JS	28399179	Green Published, Green Submitted, gold			2022-12-27	WOS:000399949000045
J	Ingargiola, A; Lerner, E; Chung, S; Panzeri, F; Gulinatti, A; Rech, I; Ghioni, M; Weiss, S; Michalet, X				Ingargiola, Antonino; Lerner, Eitan; Chung, SangYoon; Panzeri, Francesco; Gulinatti, Angelo; Rech, Ivan; Ghioni, Massimo; Weiss, Shimon; Michalet, Xavier			Multispot single-molecule FRET: High-throughput analysis of freely diffusing molecules	PLOS ONE			English	Article							ALTERNATING-LASER EXCITATION; RESONANCE ENERGY-TRANSFER; RNA-POLYMERASE; PROMOTER ESCAPE; TRANSCRIPTION; INITIATION; ACCURATE; SPECTROSCOPY; ARRAY; IDENTIFICATION	We describe an 8-spot confocal setup for high-throughput smFRET assays and illustrate its performance with two characteristic experiments. First, measurements on a series of freely diffusing doubly-labeled dsDNA samples allow us to demonstrate that data acquired in multiple spots in parallel can be properly corrected and result in measured sample characteristics consistent with those obtained with a standard single-spot setup. We then take advantage of the higher throughput provided by parallel acquisition to address an outstanding question about the kinetics of the initial steps of bacterial RNA transcription. Our real-time kinetic analysis of promoter escape by bacterial RNA polymerase confirms results obtained by a more indirect route, shedding additional light on the initial steps of transcription. Finally, we discuss the advantages of our multispot setup, while pointing potential limitations of the current single laser excitation design, as well as analysis challenges and their solutions.	[Ingargiola, Antonino; Lerner, Eitan; Chung, SangYoon; Weiss, Shimon; Michalet, Xavier] Univ Calif Los Angeles, Dept Chem & Biochem, 405 Hilgard Ave, Los Angeles, CA 90024 USA; [Panzeri, Francesco; Gulinatti, Angelo; Rech, Ivan; Ghioni, Massimo] Politecn Milan, Dipartimento Elettron Informaz & Bioingn, Milan, Italy	University of California System; University of California Los Angeles; Polytechnic University of Milan	Ingargiola, A; Michalet, X (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, 405 Hilgard Ave, Los Angeles, CA 90024 USA.	tritemio@gmail.com; michalet@chem.ucla.edu	Lerner, Eitan/S-5576-2018; GULINATTI, ANGELO/F-1335-2010; Michalet, Xavier/A-9704-2009; Ghioni, Massimo A/J-4338-2017; weiss, shimon/B-4164-2009	Lerner, Eitan/0000-0002-3791-5277; GULINATTI, ANGELO/0000-0001-6701-9126; Michalet, Xavier/0000-0001-6602-7693; Ghioni, Massimo A/0000-0002-8626-3658; Chung, SangYoon/0000-0002-0592-4099; Ingargiola, Antonino/0000-0002-9348-1397; weiss, shimon/0000-0002-0720-5426; Rech, Ivan/0000-0002-1430-1010	NIH [R01 GM095904, R01 GM069709]; NSF [MCB 1244175]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069709, R01GM095904] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grants R01 GM095904 & R01 GM069709 and NSF grant MCB 1244175. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Maya Lerner for preparation of RNAP and transcription illustrations and Maya Segal for manuscript editing. This work was supported by NIH grants R01 GM095904 & R01 GM069709 and NSF grant MCB 1244175.	Abbondanzieri EA, 2005, BIOPHYS J, V89, pL61, DOI 10.1529/biophysj.105.074195; Abbondanzieri EA, 2005, NATURE, V438, P460, DOI 10.1038/nature04268; Adelman K, 2002, P NATL ACAD SCI USA, V99, P13538, DOI 10.1073/pnas.212358999; Buchholz J, 2012, OPT EXPRESS, V20, P17767, DOI 10.1364/OE.20.017767; Campagne S, 2014, NAT STRUCT MOL BIOL, V21, P269, DOI 10.1038/nsmb.2777; Campbell EA, 2002, MOL CELL, V9, P527, DOI 10.1016/S1097-2765(02)00470-7; Colyer RA, 2011, PROC SPIE, V7905, DOI 10.1117/12.874238; Colyer RA, 2010, BIOMED OPT EXPRESS, V1, P1408, DOI 10.1364/BOE.1.001408; Cuccato A, 2013, P SOC PHOTO-OPT INS, V8773; Dahan M, 1999, CHEM PHYS, V247, P85, DOI 10.1016/S0301-0104(99)00132-9; Deniz AA, 1999, P NATL ACAD SCI USA, V96, P3670, DOI 10.1073/pnas.96.7.3670; Dertinger T, 2007, CHEMPHYSCHEM, V8, P433, DOI 10.1002/cphc.200600638; Eggeling C, 2001, J BIOTECHNOL, V86, P163, DOI 10.1016/S0168-1656(00)00412-0; ELLINGER T, 1994, J MOL BIOL, V239, P455, DOI 10.1006/jmbi.1994.1388; Fries JR, 1998, J PHYS CHEM A, V102, P6601, DOI 10.1021/jp980965t; Ghioni M, 2007, IEEE J SEL TOP QUANT, V13, P852, DOI 10.1109/JSTQE.2007.902088; Gopich IV, 2006, JOURNAL OF CHEMICAL, V124; Gulinatti A, 2013, PROC SPIE, V8631, DOI 10.1117/12.2003984; Gulinatti A, 2011, PROC SPIE, V8033, DOI 10.1117/12.883863; Gulinatti A, 2011, PROC SPIE, V7945, DOI 10.1117/12.874685; Hillesheim LN, 2003, BIOPHYS J, V85, P1948, DOI 10.1016/S0006-3495(03)74622-0; Hsu LM, 2006, BIOCHEMISTRY-US, V45, P8841, DOI 10.1021/bi060247u; Hsu LM, 2008, ECOSAL PLUS, V3, P1, DOI DOI 10.1128/EC0SALPLUS.4.5.2.2; Ingargiola A, 2012, PROC SPIE, V8228, DOI 10.1117/12.909470; Ingargiola A., 2016, PREPRINT; Ingargiola A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160716; Ingargiola A, 2016, BIOPHYS J, V110, P26, DOI 10.1016/j.bpj.2015.11.013; Ingargiola A, 2013, PROC SPIE, V8590, DOI 10.1117/12.2003704; Kapanidis AN, 2005, MOL CELL, V20, P347, DOI 10.1016/j.molcel.2005.10.012; Kapanidis AN, 2004, P NATL ACAD SCI USA, V101, P8936, DOI 10.1073/pnas.0401690101; Kapanidis AN, 2005, ACCOUNTS CHEM RES, V38, P523, DOI 10.1021/ar0401348; Kim JY, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7992; Kim S, 2011, NAT METHODS, V8, P242, DOI 10.1038/NMETH.1569; Kong XX, 2007, J AM CHEM SOC, V129, P4643, DOI 10.1021/ja068002s; Kudryavtsev V, 2012, CHEMPHYSCHEM, V13, P1060, DOI 10.1002/cphc.201100822; Lee NK, 2007, BIOPHYS J, V92, P303, DOI 10.1529/biophysj.106.093211; Lee NK, 2005, BIOPHYS J, V88, P2939, DOI 10.1529/biophysj.104.054114; Lerner E, 2016, P NATL ACAD SCI USA, V113, pE6562, DOI 10.1073/pnas.1605038113; Levene MJ, 2003, SCIENCE, V299, P682, DOI 10.1126/science.1079700; Margeat E, 2006, BIOPHYS J, V90, P1419, DOI 10.1529/biophysj.105.069252; Mekler V, 2002, CELL, V108, P599, DOI 10.1016/S0092-8674(02)00667-0; Michalet X, 2008, PROC SPIE, V6862, DOI 10.1117/12.763449; Michalet X, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0035; Michalet X, 2014, JOURNAL OF SELECTED, V20; Mukhopadhyay J, 2001, CELL, V106, P453, DOI 10.1016/S0092-8674(01)00464-0; Muller BK, 2005, BIOPHYS J, V89, P3508, DOI 10.1529/biophysj.105.064766; Nir E, 2006, J PHYS CHEM B, V110, P22103, DOI 10.1021/jp063483n; Oikawa H, 2013, SCI REP-UK, V3, DOI 10.1038/srep02151; Panzeri F, 2013, P SPIE, V8590; Rech I, 2007, PROC SPIE, V6771, DOI 10.1117/12.749483; Rech I, 2008, OPT EXPRESS, V16, P8381, DOI 10.1364/OE.16.008381; Rech I, 2009, J MOD OPTIC, V56, P326, DOI 10.1080/09500340802318309; Rhoades E, 2003, P NATL ACAD SCI USA, V100, P3197, DOI 10.1073/pnas.2628068100; Rondelez Y, 2005, NAT BIOTECHNOL, V23, P361, DOI 10.1038/nbt1072; Roy R, 2008, NAT METHODS, V5, P507, DOI 10.1038/NMETH.1208; Sisamakis E, 2010, METHOD ENZYMOL, V475, P455, DOI 10.1016/S0076-6879(10)75018-7; Weidemann T, 2002, SINGLE MOL, V3, P49, DOI 10.1002/1438-5171(200204)3:1<49::AID-SIMO49>3.3.CO;2-K; Wunderlich B, 2013, NAT PROTOC, V8, P1459, DOI 10.1038/nprot.2013.082; Zuo YH, 2015, MOL CELL, V58, P534, DOI 10.1016/j.molcel.2015.03.010	59	19	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2017	12	4							e0175766	10.1371/journal.pone.0175766	http://dx.doi.org/10.1371/journal.pone.0175766			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KH	28419142	Green Published, Green Submitted, gold			2022-12-27	WOS:000399875200045
J	Kuczynski, L; Chevalier, M; Laffaille, P; Legrand, M; Grenouillet, G				Kuczynski, Lucie; Chevalier, Mathieu; Laffaille, Pascal; Legrand, Marion; Grenouillet, Gael			Indirect effect of temperature on fish population abundances through phenological changes	PLOS ONE			English	Article							SALMON SALMO-SALAR; CLIMATE-CHANGE; REPRODUCTIVE SUCCESS; BREEDING PHENOLOGY; EVOLUTIONARY; BIODIVERSITY; RESPONSES; MARINE; SHIFTS; RESILIENCE	In response to climate change, earlier phenological events have been reported for a large range of taxa such that phenological shifts are considered as one of the fingerprints of the effect of climate change on organisms. Evidence further suggests that changes in the timing of phenological events might decouple biotic interactions due to differential phenological adjustment among interacting species, ultimately leading to population declines. Nonetheless, few studies have investigated how climate-driven changes in the timing of phenological events influence population abundances. In this study, we investigated how two environmental variables known to influence the migration timing of freshwater fish (i.e. water discharge and temperature) directly or indirectly influenced abundances of 21 fish species using daily time series gathered at four sites located in France over a period spanning from 9 to 21 years. We found no evidence for long-term trends in migration timing or fish abundances over time. Using piecewise structural equation models, we demonstrate that inter-annual variations in abundances were driven by inter-annual variations in temperature through variations in migration timing. Overall, our results suggest that climate change may concomitantly influence different biological aspects (e.g. phenology, abundance) of fish species. We argue that considering different responses to climate change is paramount if we are to improve our understanding of how organisms and populations are influenced by climate change in order to set-up efficient conservation strategies.	[Kuczynski, Lucie; Chevalier, Mathieu; Grenouillet, Gael] Univ Toulouse 3 Paul Sabatier, CNRS, EDB Lab Evolut & Diversite Biol, Toulouse, France; [Laffaille, Pascal; Legrand, Marion] UPS, EcoLab, INP, ENSAT, Castanet Tolosan, France; [Legrand, Marion] Logrami Loire Grands Migrateurs, Orleans, France; [Grenouillet, Gael] Inst Univ France, Paris, France	Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Ecole Nationale Formation Agronomique (ENSFEA); Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National Polytechnique de Toulouse; Institut Universitaire de France	Kuczynski, L (corresponding author), Univ Toulouse 3 Paul Sabatier, CNRS, EDB Lab Evolut & Diversite Biol, Toulouse, France.	lucie.kuczynski@hotmail.com	Chevalier, Mathieu/AAU-6540-2020; Grenouillet, Gael/E-6518-2019	Chevalier, Mathieu/0000-0002-1170-5343				Bertrand R, 2011, NATURE, V479, P517, DOI 10.1038/nature10548; Both C, 2006, NATURE, V441, P81, DOI 10.1038/nature04539; Both C, 2009, J ANIM ECOL, V78, P73, DOI 10.1111/j.1365-2656.2008.01458.x; Boutin S, 2014, EVOL APPL, V7, P29, DOI 10.1111/eva.12121; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Capdevielle-Vargas R, 2015, AGR FOREST METEOROL, V211, P13, DOI 10.1016/j.agrformet.2015.03.019; Charmantier A, 2014, EVOL APPL, V7, P15, DOI 10.1111/eva.12126; Chen IC, 2011, SCIENCE, V333, P1024, DOI 10.1126/science.1206432; Chessel D., 2004, R NEWS, V4, P5; Comte L, 2013, ECOGRAPHY, V36, P1236, DOI 10.1111/j.1600-0587.2013.00282.x; CUSHING DH, 1969, J CONSEIL, V33, P81; Daunt F, 2006, BEHAV ECOL SOCIOBIOL, V59, P381, DOI 10.1007/s00265-005-0061-4; Devictor V, 2007, FRENCH BIRDS LAG CLI, P1; Dufour F, 2010, PROG OCEANOGR, V86, P283, DOI 10.1016/j.pocean.2010.04.007; Durant JM, 2007, CLIM RES, V33, P271, DOI 10.3354/cr033271; Elmqvist T, 2003, FRONT ECOL ENVIRON, V1, P488, DOI 10.2307/3868116; Finstad AG, 2012, GLOBAL CHANGE BIOL, V18, P2487, DOI 10.1111/j.1365-2486.2012.02717.x; Fletcher K, 2013, IBIS, V155, P456, DOI 10.1111/ibi.12055; Folke C, 2004, ANNU REV ECOL EVOL S, V35, P557, DOI 10.1146/annurev.ecolsys.35.021103.105711; Garant D, 2003, EVOLUTION, V57, P1133; Gordo O, 2005, OECOLOGIA, V146, P484, DOI 10.1007/s00442-005-0240-z; Gratani L., 2014, ADV BOT, DOI [10.1155/2014/208747, DOI 10.1155/2014/208747]; Harley CDG, 2006, ECOL LETT, V9, P228, DOI 10.1111/j.1461-0248.2005.00871.x; Harrington R, 1999, TRENDS ECOL EVOL, V14, P146, DOI 10.1016/S0169-5347(99)01604-3; Hjort J., 1914, RAPP P V REUN CONS I, V20, P1; Holmlund CM, 1999, ECOL ECON, V29, P253, DOI 10.1016/S0921-8009(99)00015-4; Hughes L, 2000, TRENDS ECOL EVOL, V15, P56, DOI 10.1016/S0169-5347(99)01764-4; Jonsson B, 2009, J FISH BIOL, V75, P2381, DOI 10.1111/j.1095-8649.2009.02380.x; Lane JE, 2012, NATURE, V489, P554, DOI 10.1038/nature11335; Lefcheck JS, 2015, METHODS ECOL EVOL, P1; Lindstrom A, 2013, ECOGRAPHY, V36, P313, DOI 10.1111/j.1600-0587.2012.07799.x; Mackenzie BR, 2007, GLOBAL CHANGE BIOL, V13, P1348, DOI 10.1111/j.1365-2486.2007.01369.x; Martins EG, 2012, REV FISH BIOL FISHER, V22, P887, DOI 10.1007/s11160-012-9271-9; Mclean N, 2016, ECOL LETT; Ministere de l'Ecologie du Developpement Durable et de l'Energie, BANQ DONN HYDRO; Moller AP, 2008, P NATL ACAD SCI USA, V105, P16195, DOI 10.1073/pnas.0803825105; Oliver TH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10122; Pachauri R.K., 2014, CONTRIBUTION WORKING, P151, DOI DOI 10.1016/S0022-0248(00)00575-3; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 2007, GLOBAL CHANGE BIOL, V13, P1860, DOI 10.1111/j.1365-2486.2007.01404.x; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Perry AL, 2005, SCIENCE, V308, P1912, DOI 10.1126/science.1111322; Pinheiro J, 2020, R PACKAGE VERSION 31; Poff N.L., 2002, AQUATIC ECOSYSTEMS G; Post E, 2008, PHILOS T R SOC B, V363, P2369, DOI 10.1098/rstb.2007.2207; Rahel FJ, 2008, CONSERV BIOL, V22, P551, DOI 10.1111/j.1523-1739.2008.00953.x; Rijnsdorp AD, 2009, ICES J MAR SCI, V66, P1570, DOI 10.1093/icesjms/fsp056; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; Sunday JM, 2012, NAT CLIM CHANGE, V2, P686, DOI 10.1038/NCLIMATE1539; Thackeray SJ, 2010, GLOBAL CHANGE BIOL, V16, P3304, DOI 10.1111/j.1365-2486.2010.02165.x; Urban MC, 2014, EVOL APPL, V7, P88, DOI 10.1111/eva.12114; Vedder O, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001605; Vitasse Y, 2013, OECOLOGIA, V171, P663, DOI 10.1007/s00442-012-2580-9; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Willis CG, 2008, P NATL ACAD SCI USA, P105; Woodward G, 2009, FRESHWATER BIOL, V54, P2171, DOI 10.1111/j.1365-2427.2008.02081.x	56	26	27	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2017	12	4							e0175735	10.1371/journal.pone.0175735	http://dx.doi.org/10.1371/journal.pone.0175735			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KH	28419117	Green Published, gold			2022-12-27	WOS:000399875200042
J	Nawale, L; Dubey, P; Chaudhari, B; Sarkar, D; Prabhune, A				Nawale, Laxman; Dubey, Parul; Chaudhari, Bhushan; Sarkar, Dhiman; Prabhune, Asmita			Anti-proliferative effect of novel primary cetyl alcohol derived sophorolipids against human cervical cancer cells HeLa	PLOS ONE			English	Article							ACTIVATION	Sophorolipids (SLs) are glycolipid biosurfactants that have been shown to display anticancer activity. In the present study, we report anti-proliferative studies on purified forms of novel SLs synthesized using cetyl alcohol as the substrate (referred as SLCA) and their anticancer mechanism in human cervical cancer cells. Antiproliferative effect of column purified SLCA fractions (A, B, C, D, E and F) was examined in panel of human cancer cell lines as well as primary cells. Among these fractions, SLCA B and C significantly inhibited the survival of HeLa and HCT 116 cells without affecting the viability of normal human umbilical vein endothelial cells (HUVEC). The two fractions were identified as cetyl alcohol sophorolipids with non-hydroxylated tail differing in the degree of acetylation on sophorose head group. At an IC50 concentration SLCA B (16.32 mu g ml(-1)) and SLCA C (14.14 mu g ml(-1)) blocked the cell cycle progression of HeLa cells at G1/S phase in time-dependent manner. Moreover, SLCA B and SLCA C induced apoptosis in HeLa cells through an increase in intracellular Ca2+ leading to depolarization of mitochondrial membrane potential and increase in the caspase-3, -8 and -9 activity. All these findings suggest that these SLCAs could be explored for their chemopreventive potential in cervical cancer.	[Nawale, Laxman; Sarkar, Dhiman] Natl Chem Lab, OCD, Combichem Bioresource Ctr, Pune, Maharashtra, India; [Dubey, Parul; Chaudhari, Bhushan; Prabhune, Asmita] Natl Chem Lab, Biochem Sci Div, Pune, Maharashtra, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Chemical Laboratory (NCL); Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Chemical Laboratory (NCL)	Sarkar, D (corresponding author), Natl Chem Lab, OCD, Combichem Bioresource Ctr, Pune, Maharashtra, India.; Prabhune, A (corresponding author), Natl Chem Lab, Biochem Sci Div, Pune, Maharashtra, India.	d.sarkar@ncl.res.in; aa.prabhune@ncl.res.in	Sarkar, Dhiman/AAK-7481-2020	Sarkar, Dhiman/0000-0002-3912-1104; Nawale, Laxman/0000-0002-9538-6561	Council of Scientific and Industrial research	Council of Scientific and Industrial research(Council of Scientific & Industrial Research (CSIR) - India)	PD has received senior research fellowship from Council of Scientific and Industrial research.	Aggarwal S, 2015, TUMOR BIOL; Alenzi FQB, 2004, BRIT J BIOMED SCI, V61, P99, DOI 10.1080/09674845.2004.11732652; ALLEY MC, 1988, CANCER RES, V48, P589; Arvanitis DA, 2008, ONCOL REP, V20, P751, DOI 10.3892/or_00000070; Bruce A., 2002, MOL BIOL CELL, V4th ed.; Cao X, 2010, J Insect Sci, V10, P164, DOI 10.1673/031.010.14124; Chandra D, 2002, J BIOL CHEM, V277, P50842, DOI 10.1074/jbc.M207622200; Chen J, 2006, APPL MICROBIOL BIOT, V72, P52, DOI 10.1007/s00253-005-0243-z; Choudhari AS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070127; Dubey P., 2016, INT J PHARM PHARM SC, V8, P399; Dubey P., 2014, WORLD J PHARM PHARM, V3, P993; Fu SL, 2008, J SURG RES, V148, P77, DOI 10.1016/j.jss.2008.03.005; Jiang CP, 2012, WORLD J GASTROENTERO, V18, P1753, DOI 10.3748/wjg.v18.i15.1753; Jing C, 2006, ENZYME MICROB TECH, V39, P501, DOI 10.1016/j.enzmictec.2005.12.022; Joshi-Navare K, 2011, BIOTECHNOL J, V6, P509, DOI 10.1002/biot.201000345; Li H, 2016, APPL BIOCH BIOTECHNO; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Rashad MM, 2014, GRASAS ACEITES, V65, DOI 10.3989/gya.098413; Rieger AM, 2011, JOVE-J VIS EXP, DOI 10.3791/2597; Roos WP, 2006, TRENDS MOL MED, V12, P440, DOI 10.1016/j.molmed.2006.07.007; Shao Lingjian, 2012, CANC CELLS, V173, P286, DOI [10.1016/j.jss.2010.09.013, DOI 10.1016/J.JSS.2010.09.013]; Singh R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146110; Slee EA, 1999, J CELL BIOL, V144, P281, DOI 10.1083/jcb.144.2.281; Van Bogaert INA, 2007, APPL MICROBIOL BIOT, V76, P23, DOI 10.1007/s00253-007-0988-7	24	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2017	12	4							e0174241	10.1371/journal.pone.0174241	http://dx.doi.org/10.1371/journal.pone.0174241			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KH	28419101	Green Published, gold, Green Submitted			2022-12-27	WOS:000399875200002
J	Ben-Pazi, H; Cohen, A; Kroyzer, N; Lotem-Ophir, R; Shvili, Y; Winter, G; Deutsch, L; Pollak, Y				Ben-Pazi, Hilla; Cohen, Avraham; Kroyzer, Naama; Lotem-Ophir, Renana; Shvili, Yaakov; Winter, Gidon; Deutsch, Lisa; Pollak, Yehuda			Clown-care reduces pain in children with cerebral palsy undergoing recurrent botulinum toxin injections-A quasi-randomized controlled crossover study	PLOS ONE			English	Article							NITROUS-OXIDE; PREOPERATIVE ANXIETY; EMERGENCY-DEPARTMENT; ENTERAL MIDAZOLAM; CONTROLLED-TRIAL; INTERVENTIONS; MANAGEMENT	Objective We investigated the impact of clown-care on pain in 45 children with cerebral palsy who underwent recurrent Botulinum-toxin injections (age 7.04 +/- 4.68 years). Participants were randomized to receive either clown (n = 20) or standard (n = 25) -care. Methods Pain Visual-Analogue-Scale (range 1 - 5) was reported before and after procedures. Pain assessment was lower for children undergoing Botulinum-toxin injections with clown-care (2.89 +/- 1.36) compared to standard-care (3.85 +/- 1.39; p = 0.036) even though pain anticipated prior to procedures was similar (similar to 3). Findings Children who underwent the first procedure with clown-care reported lower pain even after they crossed-over to the following procedure which was standard (p = 0.048). Carryover effect was more prominent in injection-naive children (p = 0.019) and during multiple procedures (p = 0.009). Prior pain experience correlated with pain in subsequent procedures only when first experience was standard-care (p = 0.001). Conclusions Clown-care alleviated pain sensation during Botulinum-toxin injections and initial clown-care experience reduced pain during subsequent injections even though clowns were not present.	[Ben-Pazi, Hilla; Kroyzer, Naama; Winter, Gidon] Shaare Zedek Med Ctr, Neuropediatr Unit, Jerusalem, Israel; [Cohen, Avraham; Lotem-Ophir, Renana; Shvili, Yaakov] Shaare Zedek Med Ctr, Dept Pediat, Jerusalem, Israel; [Deutsch, Lisa] Biostatist Consulting LD, Modien, Israel; [Pollak, Yehuda] Hebrew Univ Jerusalem, Sch Educ, Jerusalem, Israel	Hebrew University of Jerusalem; Shaare Zedek Medical Center; Hebrew University of Jerusalem; Shaare Zedek Medical Center; Hebrew University of Jerusalem	Ben-Pazi, H (corresponding author), Shaare Zedek Med Ctr, Neuropediatr Unit, Jerusalem, Israel.	Benpazi@gmail.com		benpazi, hilla/0000-0002-8039-4761; Pollak, Yehuda/0000-0002-1293-499X	Magi Foundation [HB 19003249]	Magi Foundation	Shaare Zedek Medical Center partially covered study expenses (HB, AC, YS, RLO). The second phase of this study (crossover) was funded by the Magi Foundation (HB 19003249), http://132.74.7.18/showpage_new.asp?ldnn=1489&namef=Magi%20Foundation&otkuda=pass.asp&order=submission_deadline.namef&view=. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Biostatistical Consulting (owned by the author LD) provided support in the form of salary for author LD but did not have any additional role in the study design, data collection, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Bakheit AMO, 2003, EUR J NEUROL, V10, P415, DOI 10.1046/j.1468-1331.2003.00619.x; Brochard S, 2011, EUR J PAEDIATR NEURO, V15, P310, DOI 10.1016/j.ejpn.2010.12.006; Castle K, 2007, DEV MED CHILD NEUROL, V49, P445, DOI 10.1111/j.1469-8749.2007.00445.x; Charles James A, 2005, J Headache Pain, V6, P51, DOI 10.1007/s10194-005-0148-3; Crocker PJ, 2012, AM J EMERG MED, V30, P861, DOI 10.1016/j.ajem.2011.05.030; Dunbar RIM, 2012, P ROY SOC B-BIOL SCI, V279, P1161, DOI 10.1098/rspb.2011.1373; Eccleston C, COCHRANE DATABASE SY, V12; Engel Joyce M, 2005, Phys Occup Ther Pediatr, V25, P73, DOI 10.1300/J006v25n04_06; Felluga M, 2016, EUR J PEDIATR, V175, P645, DOI 10.1007/s00431-015-2688-0; Fernandes SC, 2010, J HEALTH PSYCHOL, V15, P405, DOI 10.1177/1359105309350231; Friedler S, 2011, FERTIL STERIL, V95, P2127, DOI 10.1016/j.fertnstert.2010.12.016; Golan G, 2009, PEDIATR ANESTH, V19, P262, DOI 10.1111/j.1460-9592.2008.02903.x; Gubbay A, 2009, DEV MED CHILD NEUROL, V51, P491, DOI 10.1111/j.1469-8749.2009.03297_1.x; Gulur P, 2009, J PAIN, V10, P173, DOI 10.1016/j.jpain.2008.08.005; Hagberg B, 1996, ACTA PAEDIATR, V85, P954, DOI 10.1111/j.1651-2227.1996.tb14193.x; Hansen Lars Kjaersgaard, 2011, J Pain Res, V4, P297, DOI 10.2147/JPR.S23199; Hanuka P, MEDICAL CLOWNS FACIL; Hicks CL, 2006, J PEDIATR PSYCHOL, V31, P724, DOI 10.1093/jpepsy/jsj065; Knaepen L, 2013, DEV NEUROBIOL, V73, P85, DOI 10.1002/dneu.22047; Kumar R, 2009, DEV MED CHILD NEUROL, V51, P838, DOI 10.1111/j.1469-8749.2009.03355.x; Linge L, 2013, INT J QUAL STUD HEAL, V8, DOI 10.3402/qhw.v8i0.18907; Minute M, 2012, Pediatr Med Chir, V34, P77; Noel M, 2012, PAIN MANAG, V2, P487, DOI [10.2217/pmt.12.41, 10.2217/PMT.12.41]; Novak I, 2013, DEV MED CHILD NEUROL, V55, P885, DOI 10.1111/dmcn.12246; Raphael BS, 2010, CLIN ORTHOP RELAT R, V468, P1845, DOI 10.1007/s11999-009-1167-1; Rothrock JF, 2000, HEADACHE, V40, P17, DOI 10.1046/j.1526-4610.2000.00002.x; Sanger Terence D, 2005, Curr Treat Options Neurol, V7, P427, DOI 10.1007/s11940-005-0043-x; Scheffer ART, 2010, ARCH OTOLARYNGOL, V136, P873, DOI 10.1001/archoto.2010.147; Uman LS, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005179; Uman LS, 2008, J PEDIATR PSYCHOL, V33, P842, DOI 10.1093/jpepsy/jsn031; Vagnoli L, 2010, PEDIATR ANESTH, V20, P937, DOI 10.1111/j.1460-9592.2010.03403.x; Voepel-Lewis T, PAIN MANAGEMENT NURS, V6, P168; Voepel-Lewis Terri, 2005, Pain Manag Nurs, V6, P168, DOI 10.1016/j.pmn.2005.08.004; von Baeyer Carl L, 2006, Pain Res Manag, V11, P157; Weisman SJ, 1998, ARCH PEDIAT ADOL MED, V152, P147; Wolyniez I, 2013, CLIN PEDIATR, V52, P1168, DOI 10.1177/0009922813502257	36	22	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2017	12	4							e0175028	10.1371/journal.pone.0175028	http://dx.doi.org/10.1371/journal.pone.0175028			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KD	28414728	Green Submitted, Green Published, gold			2022-12-27	WOS:000399874800015
J	Lundqvist, M; Augustsson, C; Lilja, M; Lundkvist, K; Dahlback, B; Linse, S; Cedervall, T				Lundqvist, Martin; Augustsson, Cecilia; Lilja, Malin; Lundkvist, Kristoffer; Dahlback, Bjorn; Linse, Sara; Cedervall, Tommy			The nanoparticle protein corona formed in human blood or human blood fractions	PLOS ONE			English	Article							GOLD NANOPARTICLES; DELIVERY; AFFINITY; SIZE	The protein corona formed around nanoparticles in protein-rich fluids plays an important role for nanoparticle biocompatibility, as found in several studies during the last decade. Biological fluids have complex compositions and the molecular components interact and function together in intricate networks. Therefore, the process to isolate blood or the preparation of blood derivatives may lead to differences in the composition of the identified protein corona around nanoparticles. Here, we show distinct differences in the protein corona formed in whole blood, whole blood with EDTA, plasma, or serum. Furthermore, the ratio between particle surface area to protein concentration influences the detected corona. We also show that the nanoparticle size per se influences the formed protein corona due to curvature effects. These results emphasize the need of investigating the formation and biological importance of the protein corona in the same environment as the nanoparticles are intended for or released into.	[Lundqvist, Martin; Linse, Sara; Cedervall, Tommy] Lund Univ, Ctr Mol Prot Sci, Biochem, Lund, Sweden; [Augustsson, Cecilia; Dahlback, Bjorn] Lund Univ, Univ Hosp SUS, Dept Translat Med, Malmo, Sweden; [Lilja, Malin; Lundkvist, Kristoffer] Upper 2nd Sch, Klippan, Sweden; [Cedervall, Tommy] Upper 2nd Sch, NanoLund, Lund, Sweden	Lund University; Lund University	Lundqvist, M (corresponding author), Lund Univ, Ctr Mol Prot Sci, Biochem, Lund, Sweden.	Martin.Lundqvist@biochemistry.lu.se	Lundqvist, Martin/K-3908-2012; Cedervall, Tommy/AAT-9766-2021	Lundqvist, Martin/0000-0003-1175-9103; Cedervall, Tommy/0000-0003-2255-8446; Dahlback, Bjorn/0000-0003-1546-0328	Kemilaktorslank projekt; Marianne and Marcus Wallenbergs Foundation; Magn. Bergwall Foundation; Nanometer Structure Consortium at Lund University (NanoLund); Nanometer Structure Consortium at Lund University (NanoLund)(TC)	Kemilaktorslank projekt; Marianne and Marcus Wallenbergs Foundation; Magn. Bergwall Foundation; Nanometer Structure Consortium at Lund University (NanoLund); Nanometer Structure Consortium at Lund University (NanoLund)(TC)	Klippan municipal is gratefully acknowledged for the support during the Kemilaktorslank projekt (to M. Lu). Marianne and Marcus Wallenbergs Foundation is gratefully acknowledged for the financial support during the Kemilaktorslank projekt (to M. Lu). Magn. Bergwall Foundation is gratefully acknowledged for the financial support (to M. Lu). The Nanometer Structure Consortium at Lund University (NanoLund) is gratefully acknowledged for the support (to TC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r Klippan municipal is gratefully acknowledged for the support during the Kemilaktorslank projekt. Financial supports are gratefully acknowledged from Marianne and Marcus Wallenbergs Foundation, Magn. Bergwall Foundation (ML) and the Nanometer Structure Consortium at Lund University (NanoLund) (TC).	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Ahmadi A, 2014, J DRUG TARGET, V22, P175, DOI 10.3109/1061186X.2013.839684; Ali N, 2016, NANOTOXICOLOGY, V10, P226, DOI 10.3109/17435390.2015.1048324; Berggard T, 2006, J PROTEOME RES, V5, P669, DOI 10.1021/pr050421l; BJORK I, 1982, MOL CELL BIOCHEM, V48, P161, DOI 10.1007/BF00421226; Cedervall T, 2007, ANGEW CHEM INT EDIT, V46, P5754, DOI 10.1002/anie.200700465; Cedervall T, 2007, P NATL ACAD SCI USA, V104, P2050, DOI 10.1073/pnas.0608582104; Cukalevski R, 2011, LANGMUIR, V27, P14360, DOI 10.1021/la203290a; de Morais MG, 2014, J NANOSCI NANOTECHNO, V14, P1007, DOI 10.1166/jnn.2014.8748; Dell'Orco D, 2014, NANOMEDICINE-UK, V9, P851, DOI [10.2217/NNM.14.39, 10.2217/nnm.14.39]; Dell'Orco D, 2012, NANOMED-NANOTECHNOL, V8, P1271, DOI 10.1016/j.nano.2012.02.006; Dell'Orco D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010949; Deng ZJ, 2012, ACS NANO, V6, P8962, DOI 10.1021/nn3029953; Farokhzad OC, 2006, ADV DRUG DELIVER REV, V58, P1456, DOI 10.1016/j.addr.2006.09.011; Fedeli C, 2015, NANOSCALE, V7, P17710, DOI 10.1039/c5nr05290d; Ferreira SA, 2012, BBA-GEN SUBJECTS, V1820, P1043, DOI 10.1016/j.bbagen.2012.04.015; Fischer H, 2004, PROTEIN SCI, V13, P2825, DOI 10.1110/ps.04688204; Foffi G, 2002, PHYS REV E, V65; Forster SP, 2011, INT J NANOTECHNOL, V8, P592, DOI 10.1504/IJNT.2011.040193; Franke ME, 2006, SMALL, V2, P36, DOI 10.1002/smll.200500261; GEKKO K, 1979, J PHYS CHEM-US, V83, P2706, DOI 10.1021/j100484a006; Krisinger MJ, 2009, FEBS J, V276, P6586, DOI 10.1111/j.1742-4658.2009.07371.x; Lagaron JM, 2011, TRENDS FOOD SCI TECH, V22, P611, DOI 10.1016/j.tifs.2011.01.007; Lee J, 2010, ACS NANO, V4, P3580, DOI 10.1021/nn100866w; Lundqvist M, 2008, P NATL ACAD SCI USA, V105, P14265, DOI 10.1073/pnas.0805135105; Lundqvist M, 2011, ACS NANO, V5, P7503, DOI 10.1021/nn202458g; Lynch I, 2007, ADV COLLOID INTERFAC, V134-35, P167, DOI 10.1016/j.cis.2007.04.021; Mahmoudi M, 2014, NANO LETT, V14, P6, DOI 10.1021/nl403419e; Muthusamy B, 2005, PROTEOMICS, V5, P3531, DOI 10.1002/pmic.200401335; Neagu M, 2017, ARCH TOXICOL, V91, P1031, DOI 10.1007/s00204-016-1797-5; Oslakovic C, 2012, NANOMED-NANOTECHNOL, V8, P981, DOI 10.1016/j.nano.2011.12.001; Ranjan S, 2014, J NANOPART RES, V16, DOI 10.1007/s11051-014-2464-5; Ritz S, 2015, BIOMACROMOLECULES, V16, P1311, DOI 10.1021/acs.biomac.5b00108; Sahoo SK, 2003, DRUG DISCOV TODAY, V8, P1112, DOI 10.1016/S1359-6446(03)02903-9; Salvati A, 2013, NAT NANOTECHNOL, V8, P137, DOI [10.1038/nnano.2012.237, 10.1038/NNANO.2012.237]; Sanfins E, 2014, NANO LETT, V14, P4736, DOI 10.1021/nl501863u; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shannahan JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074001; SHARP DG, 1950, J BIOL CHEM, V185, P247; SQUIRE PG, 1979, ARCH BIOCHEM BIOPHYS, V196, P165, DOI 10.1016/0003-9861(79)90563-0; Stephanopoulos G, 2011, CHEM ENG SCI, V66, P4272, DOI 10.1016/j.ces.2011.05.049; Tenzer S, 2013, NAT NANOTECHNOL, V8, P772, DOI 10.1038/nnano.2013.181; Weissig V, 2014, INT J NANOMED, V9, P4357, DOI 10.2147/IJN.S46900; Winzen S, 2015, NANOSCALE, V7, P2992, DOI 10.1039/c4nr05982d	44	126	126	4	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2017	12	4							e0175871	10.1371/journal.pone.0175871	http://dx.doi.org/10.1371/journal.pone.0175871			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KD	28414772	Green Submitted, gold, Green Published			2022-12-27	WOS:000399874800070
J	Moron-Lopez, S; Puertas, MC; Galvez, C; Navarro, J; Carrasco, A; Esteve, M; Manye, J; Crespo, M; Salgadol, M; Martinez-Picado, J				Moron-Lopez, Sara; Puertas, Maria C.; Galvez, Cristina; Navarro, Jordi; Carrasco, Anna; Esteve, Maria; Manye, Josep; Crespo, Manel; Salgadol, Maria; Martinez-Picado, Javier			Sensitive quantification of the HIV-1 reservoir in gut-associated lymphoid tissue	PLOS ONE			English	Article							CD4(+) T-CELLS; ANTIRETROVIRAL THERAPY; POSITIVE PATIENTS; BLOOD; DNA; INFECTION; PCR; LYMPHOCYTES; PERSISTENCE; BURDEN	Background The implementation of successful strategies to achieve an HIV cure has become a priority in HIV research. However, the current location and size of HIV reservoirs is still unknown since there are limited tools to evaluate HIV latency in viral sanctuaries such as gut-associated lymphoid tissue (GALT). As reported in the so called "Boston Patients", despite undetectable levels of proviral HIV-1 DNA in blood and GALT, viral rebound happens in just few months after ART interruption. This fact might imply that current methods are not sensitive enough to detect residual reservoirs. Showing that, it is imperative to improve the detection and quantification of HIV-1 reservoir in tissue samples. Herein, we propose a novel nonenzymatic protocol for purification of Lamina Propria Leukocytes (LPL) from gut biopsies combined to viral HIV DNA (vDNA) quantification by droplet digital PCR (ddPCR) to improve the sensitivity and accuracy of viral reservoir measurements (LPL-vDNA assay). Methods Endoscopic ileum biopsies were sampled from 12 HIV-1-infected cART-suppressed subjects. We performed a DTT/EDTA-based treatment for epithelial layer removal followed by non-enzymatic disruption of the tissue to obtain lamina propria cell suspension (LP). CD45(+) cells were subsequently purified by flow sorting and vDNA was determined by ddPCR. Results vDNA quantification levels were significantly higher in purified LPLs (CD45(+)) than in bulk LPs (p<0.01). The levels of vDNA were higher in ileum samples than in concurrent PBMC from the same individuals (p = 0.002). As a result of the increased sensitivity of this purification method, the Poisson 95% confidence intervals of the vDNA quantification data from LPLs were narrower than that from bulk LPs. Of note, vDNA was unambiguously quantified above the detection limit in 100% of LPL samples, while only in 58% of bulk LPs. Conclusion We propose an innovative combined protocol for a more sensitive detection of the HIV reservoir in gut-associated viral sanctuaries, which might be used to evaluate any proposed eradication strategy.	[Moron-Lopez, Sara; Puertas, Maria C.; Galvez, Cristina; Salgadol, Maria; Martinez-Picado, Javier] Univ Autonoma Barcelona, AIDS Res Inst IrsiCaixa, Inst Invest Ciencias Salut Germans Trias & Pujol, Badalona, Spain; [Navarro, Jordi; Crespo, Manel] Hosp Univ Vall Hebron, Dept Infect Dis, Barcelona, Spain; [Carrasco, Anna; Esteve, Maria] Univ Barcelona, Hosp Univ Mutua Terrassa, Dept Gastroenterol, Res Fdn Mutua Terrassa, Terrassa, Spain; [Carrasco, Anna; Esteve, Maria] Ctr Invest Biomed Red Enfermedades Hepat & Digest, Barcelona, Spain; [Manye, Josep] Germans Trias i Pujol Res Inst, IBD Unit, CIBEREHD Ctr Invest Biomed Red Enfermedades Hepat, Badalona, Spain; [Martinez-Picado, Javier] Univ Cent Catalunya, Univ Vic, Vic, Spain; [Martinez-Picado, Javier] Inst Catalana Recerca & Estudis Avancats, Barcelona, Spain	Autonomous University of Barcelona; Institut de Recerca de la Sida - IrsiCaixa; Hospital Universitari Vall d'Hebron; Hospital Universitario Mutua Terrassa; University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; CIBEREHD; Universitat de Vic - Universitat Central de Catalunya (UVic-UCC); ICREA	Salgadol, M; Martinez-Picado, J (corresponding author), Univ Autonoma Barcelona, AIDS Res Inst IrsiCaixa, Inst Invest Ciencias Salut Germans Trias & Pujol, Badalona, Spain.; Martinez-Picado, J (corresponding author), Univ Cent Catalunya, Univ Vic, Vic, Spain.; Martinez-Picado, J (corresponding author), Inst Catalana Recerca & Estudis Avancats, Barcelona, Spain.	msalgado@irsicaixa.es; jmpicado@irsicaixa.es	Martinez-Picado, Javier/G-5507-2012; Navarro, Jordi/AGO-2330-2022; Salgado, Maria/G-3462-2016; Puertas, Maria/G-3251-2016; Morón-López, Sara/AAA-8246-2020; Navarro, Jordi/N-5499-2015; Celada, Cristina Gálvez/F-3304-2016; Crespo, Manuel/H-8868-2015	Martinez-Picado, Javier/0000-0002-4916-2129; Navarro, Jordi/0000-0002-7187-0367; Salgado, Maria/0000-0003-1551-7216; Puertas, Maria/0000-0002-6750-2318; Morón-López, Sara/0000-0003-0800-9205; Navarro, Jordi/0000-0002-7187-0367; Crespo, Manuel/0000-0001-9016-0515; ESTEVE, MARIA/0000-0002-3178-7008; Carrasco, Anna/0000-0001-8810-1583; Galvez, Cristina/0000-0002-2286-6193; ESTEVE, MARIA/0000-0001-7716-0027	ViiV; American Foundation for AIDS Research (amfAR) (ARCHE); IrsiCaixa; CERCA programme from Generalitat de Catalunya; MS; post-doctoral training scholarship (Juan de la Cierva) of the Spanish Economy and Competitiveness Ministry [FPDI2013-17134]; Agenda de Gestio d'Ajuts Universitaris i de Recerca [2013E1_B 00275]; ICREA Funding Source: Custom	ViiV; American Foundation for AIDS Research (amfAR) (ARCHE); IrsiCaixa; CERCA programme from Generalitat de Catalunya; MS; post-doctoral training scholarship (Juan de la Cierva) of the Spanish Economy and Competitiveness Ministry; Agenda de Gestio d'Ajuts Universitaris i de Recerca; ICREA(ICREA)	This substudy was supported by ViiV and the American Foundation for AIDS Research (amfAR) (ARCHE). IrsiCaixa was supported by the CERCA programme from Generalitat de Catalunya. MS was supported by the post-doctoral training scholarship (Juan de la Cierva) of the Spanish Economy and Competitiveness Ministry (FPDI2013-17134). SM-L received a fellowship from the Agenda de Gestio d'Ajuts Universitaris i de Recerca (2013E1_B 00275). CG was partially supported by the pre-doctoral fellowship of the Spanish Education, Culture and Sport Ministry (FPU15/03698). The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.	Alter Galit, 2016, FULL RECOMMENDATIONS; Ananworanich J, 2016, J VIRUS ERAD, V2, P43; Anton PA, 2003, AIDS, V17, P53, DOI 10.1097/00002030-200301030-00008; Avettand-Fenoel V, 2008, AIDS, V22, P1880, DOI 10.1097/QAD.0b013e32830fbdbc; Barton K, 2016, TRENDS MICROBIOL, V24, P345, DOI 10.1016/j.tim.2016.01.006; Carrasco A, 2013, J IMMUNOL METHODS, V389, P29, DOI 10.1016/j.jim.2012.12.006; Chun TW, 2008, J INFECT DIS, V197, P714, DOI 10.1086/527324; Depince-Berger AE, 2016, RETROVIROLOGY, V13, DOI 10.1186/s12977-016-0278-5; Descours B, 2013, JAIDS-J ACQ IMM DEF, V62, P255, DOI 10.1097/QAI.0b013e318282537f; Duarte RF, 2015, LANCET HIV, V3018, P1; Eriksson S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003174; Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295; GUYGRAND D, 1993, CURR OPIN IMMUNOL, V5, P247, DOI 10.1016/0952-7915(93)90012-H; Henrich TJ, 2014, ANN INTERN MED, V161, P319, DOI 10.7326/M14-1027; Hindson BJ, 2011, ANAL CHEM, V83, P8604, DOI 10.1021/ac202028g; Lee SA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160192; Li QS, 2005, NATURE, V434, P1148, DOI 10.1038/nature03513; Liszewski MK, 2009, METHODS, V47, P254, DOI 10.1016/j.ymeth.2009.01.002; Mahida YR, 1997, CLIN EXP IMMUNOL, V109, P377, DOI 10.1046/j.1365-2249.1997.4481346.x; Malatinkova E, 2015, ELIFE, V4, DOI 10.7554/eLife.09115; Martinez-Bonet M, 2015, CLIN INFECT DIS, V61, P1169, DOI 10.1093/cid/civ456; Mattapallil JJ, 2005, NATURE, V434, P1093, DOI 10.1038/nature03501; Ostrowski M, 2015, OPEN FORUM INFECT DI, V2, DOI 10.1093/ofid/ofv138; Palmer S, 2003, J CLIN MICROBIOL, V41, P4531, DOI 10.1128/JCM.41.10.4531-4536.2003; Poles MA, 2006, JAIDS-J ACQ IMM DEF, V43, P65, DOI 10.1097/01.qai.0000230524.71717.14; Salgado Maria, 2016, C RETR VIR OPP INF C; Shacklett BL, 2003, J IMMUNOL METHODS, V279, P17, DOI 10.1016/S0022-1759(03)00255-2; Strain MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055943; Yukl SA, 2014, AIDS, V28, P439, DOI 10.1097/QAD.0000000000000166; Yukl SA, 2013, J INFECT DIS, V208, P1212, DOI 10.1093/infdis/jit308; Yukl SA, 2010, J INFECT DIS, V202, P1553, DOI 10.1086/656722	31	41	41	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2017	12	4							e0175899	10.1371/journal.pone.0175899	http://dx.doi.org/10.1371/journal.pone.0175899			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KD	28414780	Green Published, gold, Green Submitted			2022-12-27	WOS:000399874800075
J	Navas-Madronal, M; Valero-Mut, A; Martinez-Zapata, MJ; Simon-Talero, MJ; Figueroa, S; Vidal-Fernandez, N; Lopez-Gongora, M; Escartin, A; Querol, L				Navas-Madronal, Miguel; Valero-Mut, Ana; Jose Martinez-Zapata, Maria; Javier Simon-Talero, Manuel; Figueroa, Sebastian; Vidal-Fernandez, Nuria; Lopez-Gongora, Mariana; Escartin, Antonio; Querol, Luis			Absence of antibodies against KIR4.1 in multiple sclerosis: A three-technique approach and systematic review	PLOS ONE			English	Review							POTASSIUM CHANNEL; IMMUNE TARGET; B-CELLS; AUTOANTIBODIES; AUTOANTIGEN	Introduction Antibodies targeting the inward-rectifying potassium channel KIR4.1 have been associated with multiple sclerosis (MS) but studies using diverse techniques have failed to replicate this association. The detection of these antibodies is challenging; KIR4.1 glycosylation patterns and the use of diverse technical approaches may account for the disparity of results. We aimed to replicate the association using three different approaches to overcome the technical limitations of a single technique. We also performed a systematic review to examine the association of anti-KIR4.1 antibodies with MS. Methods Serum samples from patients with MS (n = 108) and controls (n = 77) were tested for the presence of anti-KIR4.1 antibodies using three methods: 1) by ELISA with the low-glycosylated fraction of recombinant KIR4.1 purified from transfected HEK293 cells according to original protocols; 2) by immunocytochemistry using KIR4.1-transfected HEK293 cells; and 3) by immunocytochemistry using the KIR4.1.-transfected MO3.13 oligodendrocyte cell line. We developed a systematic review and meta-analysis of the association of anti-KIR4.1 antibodies with MS according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Results We did not detect anti-KIR4.1 antibodies in the MS patients or in controls using ELISA. Neither did we detect any significant reactivity against the antigen on the cell surface using the KIR4.1-transfected HEK293 cells or the KIR4.1-transfected MO3.13 cells. We included 13 prospective controlled studies in the systematic review. Only three studies showed a positive association between anti-KIR4.1 and MS. Clinical and statistical heterogeneity between studies precluded meta-analysis of their results. Conclusion We found no association between anti-KIR4.1 antibody positivity and MS. Although this lack of replication may be due to technical limitations, evidence from our study and others is mounting against the role of KIR4.1 as a relevant MS autoantigen.	[Navas-Madronal, Miguel; Valero-Mut, Ana; Javier Simon-Talero, Manuel; Figueroa, Sebastian; Vidal-Fernandez, Nuria; Lopez-Gongora, Mariana; Escartin, Antonio; Querol, Luis] Univ Autanoma Barcelona, Hosp Santa Creu Sant Pau, Dept Neurol, Multiple Sclerosis Unit, Barcelona, Spain; [Jose Martinez-Zapata, Maria] Iberoamer Cochrane Ctr, Biomed Res Inst Sant Pau IIB Sant Pau, CIBER Epidemiol & Salud Publ CIBERESP, Barcelona, Spain	Autonomous University of Barcelona; Hospital of Santa Creu i Sant Pau; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP	Querol, L (corresponding author), Univ Autanoma Barcelona, Hosp Santa Creu Sant Pau, Dept Neurol, Multiple Sclerosis Unit, Barcelona, Spain.	lquerol@santpau.cat	Querol, Luis/H-2119-2015	Querol, Luis/0000-0002-4289-8264; Navas Madronal, Miquel/0000-0003-2984-1471; Martinez-Zapata/0000-0002-5836-1138	Novartis Spain; Institute de Salud Carlos III, Ministry of Economy and Innovation, Spain [JR13/00014]	Novartis Spain(Novartis); Institute de Salud Carlos III, Ministry of Economy and Innovation, Spain	The experimental study has been funded with an unrestricted grant from Novartis Spain. LQ is supported by the JR13/00014 of the Institute de Salud Carlos III, Ministry of Economy and Innovation, Spain. The systematic review was performed independently and was not funded by the leading funding source.; We also thank Novartis Spain for providing funds to complete this study.	[Anonymous], [No title captured]; Ayoglu B, 2016, P NATL ACAD SCI USA, V113, P2188, DOI 10.1073/pnas.1518553113; Brickshawana A, 2014, LANCET NEUROL, V13, P795, DOI 10.1016/S1474-4422(14)70141-3; Brill L, 2015, MULT SCLER J, V21, P572, DOI 10.1177/1352458514551779; Buntinx M, 2003, J NEUROCYTOL, V32, P25, DOI 10.1023/A:1027324230923; Chastre A, 2016, NEW ENGL J MED, V374, P1495, DOI 10.1056/NEJMc1513302; Dale RC, 2014, NEUROL-NEUROIMMUNOL, V1, DOI 10.1212/NXI.0000000000000012; Deeks JJ, 2009, COCHRANE HDB SYST RE, V5; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Disanto G, 2012, NEUROLOGY, V78, P823, DOI 10.1212/WNL.0b013e318249f6f0; Fraussen J, 2014, AUTOIMMUN REV, V13, P1126, DOI 10.1016/j.autrev.2014.07.002; Hauser Stephen L, 2008, N Engl J Med, V358, P676, DOI 10.1056/NEJMoa0706383; Higuchi O, 2016, NEUROL-NEUROIMMUNOL, V3, DOI 10.1212/NXI.0000000000000263; Housley WJ, 2015, CLIN IMMUNOL, V161, P51, DOI 10.1016/j.clim.2015.06.015; Kaya D, 2015, EXISTENCE SIGNIFICAN; Kraus V, 2014, NEUROLOGY, V82, P470, DOI 10.1212/WNL.0000000000000097; Krumbholz M, 2012, NAT REV NEUROL, V8, P613, DOI 10.1038/nrneurol.2012.203; Lennon VA, 2004, LANCET, V364, P2106, DOI 10.1016/S0140-6736(04)17551-X; Lily O, 2004, BRAIN, V127, P269, DOI 10.1093/brain/awh031; Malyavantham K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129503; Marignier R, 2014, POTASSIUM CHANNEL KI, P64827; Marnetto F, 2015, ANTIKIR4 1 ANTIBODIE; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Nagelhus EA, 2004, NEUROSCIENCE, V129, P905, DOI 10.1016/j.neuroscience.2004.08.053; Nerrant E, 2014, MULT SCLER J, V20, P1699, DOI 10.1177/1352458514531086; Nylander A, 2012, J CLIN INVEST, V122, P1180, DOI 10.1172/JCI58649; Polman Chris H, 2011, Ann Neurol, V69, P292, DOI 10.1002/ana.22366; Probstel AK, 2016, NEW ENGL J MED, V374, P1496, DOI 10.1056/NEJMc1507131; Querol L, 2013, NEUROLOGY, V81, P956, DOI 10.1212/WNL.0b013e3182a43b48; Racke MK, 2012, NAT REV NEUROL, V8, P595, DOI 10.1038/nrneurol.2012.193; Ransohoff RM, 2015, NAT REV NEUROL, V11, DOI 10.1038/nrneurol.2015.14; Schirmer L, 2014, ANN NEUROL, P1; Srivastava R., 2014, DIFFERENTIAL GLYCOSY, P64326; Srivastava R, 2012, NEW ENGL J MED, V367, P115, DOI 10.1056/NEJMoa1110740; Thomas B H, 2004, Worldviews Evid Based Nurs, V1, P176, DOI 10.1111/j.1524-475X.2004.04006.x; Villar LM, 2005, J CLIN INVEST, V115, P187, DOI 10.1172/JCI200522833; Villar LM, 2014, ANN NEUROL, V76, P231, DOI 10.1002/ana.24190; Watanabe M, 2013, CLIN EXP NEUROIMMUNO, V4, P241, DOI DOI 10.1111/CEN3.12029	38	10	10	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2017	12	4							e0175538	10.1371/journal.pone.0175538	http://dx.doi.org/10.1371/journal.pone.0175538			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KD	28414733	Green Submitted, Green Published, gold			2022-12-27	WOS:000399874800033
J	Peng, X; Yuan, H; Chen, WF; Wang, T; Ding, L				Peng, Xian; Yuan, Han; Chen, Wufan; Wang, Tao; Ding, Lei			New metric for optimizing Continuous Loop Averaging Deconvolution (CLAD) sequences under the 1/f noise model	PLOS ONE			English	Article							MIDDLE-LATENCY RESPONSE; STEADY-STATE RESPONSES; OVERLAPPING EVOKED-POTENTIALS; MAXIMUM LENGTH SEQUENCES; PATTERN ELECTRORETINOGRAMS; TRANSIENT; BRAIN; ANESTHESIA; GENERATION; FREQUENCY	Continuous loop averaging deconvolution (CLAD) is one of the proven methods for recovering transient auditory evoked potentials (AEPs) in rapid stimulation paradigms, which requires an elaborated stimulus sequence design to attenuate impacts from noise in data. The present study aimed to develop a new metric in gauging a CLAD sequence in terms of noise gain factor (NGF), which has been proposed previously but with less effectiveness in the presence of pink (1/f) noise. We derived the new metric by explicitly introducing the 1/f model into the proposed time-continuous sequence. We selected several representative CLAD sequences to test their noise property on typical EEG recordings, as well as on five real CLAD electroencephalogram (EEG) recordings to retrieve the middle latency responses. We also demonstrated the merit of the new metric in generating and quantifying optimized sequences using a classic genetic algorithm. The new metric shows evident improvements in measuring actual noise gains at different frequencies, and better performance than the original NGF in various aspects. The new metric is a generalized NGF measurement that can better quantify the performance of a CLAD sequence, and provide a more efficient mean of generating CLAD sequences via the incorporation with optimization algorithms. The present study can facilitate the specific application of CLAD paradigm with desired sequences in the clinic.	[Peng, Xian; Chen, Wufan; Wang, Tao] Southern Med Univ, Sch Biomed Engn, Guangzhou, Guangdong, Peoples R China; [Yuan, Han; Ding, Lei] Univ Oklahoma, Stephenson Sch Biomed Engn, Norman, OK 73019 USA	Southern Medical University - China; University of Oklahoma System; University of Oklahoma - Norman	Wang, T (corresponding author), Southern Med Univ, Sch Biomed Engn, Guangzhou, Guangdong, Peoples R China.; Ding, L (corresponding author), Univ Oklahoma, Stephenson Sch Biomed Engn, Norman, OK 73019 USA.	taowang@smu.edu.cn; leiding@ou.edu	Yuan, Han/AAH-2894-2019	Yuan, Han/0000-0003-0055-9691; Wang, Tao/0000-0002-9715-9389	National Natural Science Foundation of China [61172033, 61271154]; NSF [ECCS-0955260, 1539068]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NSF(National Science Foundation (NSF))	This work was supported in part by the National Natural Science Foundation of China (61172033 and 61271154), and supported in part by NSF CAREER ECCS-0955260 and NSF RII Track-2 FEC 1539068.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AZZENA GB, 1995, HEARING RES, V83, P1, DOI 10.1016/0378-5955(94)00184-R; Bardy F, 2014, CLIN NEUROPHYSIOL, V125, P727, DOI 10.1016/j.clinph.2013.09.030; Bell SL, 2006, ANESTH ANALG, V102, P495, DOI 10.1213/01.ane.0000189191.71449.48; Bohorquez J, 2008, CLIN NEUROPHYSIOL, V119, P2598, DOI 10.1016/j.clinph.2008.08.002; Cone-Wesson Barbara, 2002, J Am Acad Audiol, V13, P260; Delgado RE, 2004, J ACOUST SOC AM, V115, P1242, DOI 10.1121/1.1639327; EYSHOLDT U, 1982, AUDIOLOGY, V21, P242; GALAMBOS R, 1981, P NATL ACAD SCI-BIOL, V78, P2643, DOI 10.1073/pnas.78.4.2643; Gransier R, 2016, HEARING RES, V335, P149, DOI 10.1016/j.heares.2016.03.006; Jewett DL, 2004, CLIN NEUROPHYSIOL, V115, P2754, DOI 10.1016/j.clinph.2004.06.014; Kaf WA, 2017, EAR HEARING, V38, P244, DOI 10.1097/AUD.0000000000000381; Luck SJ, 2005, INTRO EVENT RELATED, P131; McNeer RR, 2009, ANESTHESIOLOGY, V110, P1026, DOI 10.1097/ALN.0b013e31819dad6f; Ozdamar O, 2008, CLIN NEUROPHYSIOL, V119, P1870, DOI 10.1016/j.clinph.2008.03.023; Ozdamar O, 2014, INVEST OPHTH VIS SCI, V55, P8560, DOI 10.1167/iovs.14-15685; Ozdamar O, 2006, J ACOUST SOC AM, V119, P429, DOI 10.1121/1.2133682; Ozdamar O, 2007, CLIN NEUROPHYSIOL, V118, P1261, DOI 10.1016/j.clinph.2007.02.016; Picton TW., 2001, HUMAN AUDITORY EVOKE, P634; PLOURDE G, 1991, ACTA OTO-LARYNGOL, P153; Presacco A, 2010, CLIN NEUROPHYSIOL, V121, P1540, DOI 10.1016/j.clinph.2010.03.020; PRITCHARD WS, 1992, INT J NEUROSCI, V66, P119, DOI 10.3109/00207459208999796; SCHIMMEL H, 1967, SCIENCE, V157, P92, DOI 10.1126/science.157.3784.92; Talsma D., 2005, EVENT RELATED POTENT; Tan XD, 2016, IEEE T BIO-MED ENG, V63, P1157, DOI 10.1109/TBME.2015.2485273; Toft-Nielsen J, 2014, CLIN NEUROPHYSIOL, V125, P2079, DOI 10.1016/j.clinph.2014.02.002; Valderrama JT, 2014, CLIN NEUROPHYSIOL, V125, P805, DOI 10.1016/j.clinph.2013.06.190; Wang T, 2006, J NEUROSCI METH, V158, P260, DOI 10.1016/j.jneumeth.2006.05.023; Wang T, 2013, BIOMED SIGNAL PROCES, V8, P858, DOI 10.1016/j.bspc.2013.08.004; Wang T, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/2/026023; WHITLEY D, 1994, STAT COMPUT, V4, P65, DOI 10.1007/BF00175354; WOLDORFF MG, 1993, PSYCHOPHYSIOLOGY, V30, P98, DOI 10.1111/j.1469-8986.1993.tb03209.x	31	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2017	12	4							e0175354	10.1371/journal.pone.0175354	http://dx.doi.org/10.1371/journal.pone.0175354			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KD	28414803	Green Published, Green Submitted, gold			2022-12-27	WOS:000399874800023
J	Sarkar, M; Ghost, S; Bhuniya, A; Ghost, T; Guha, I; Barik, S; Biswas, J; Bose, A; Baral, R				Sarkar, Madhurima; Ghost, Sarbari; Bhuniya, Avishek; Ghost, Tithi; Guha, Ipsita; Barik, Subhasis; Biswas, Jaydip; Bose, Anamika; Baral, Rathindranath			Neem leaf glycoprotein prevents post-surgical sarcoma recurrence in Swiss mice by differentially regulating cytotoxic T and myeloid-derived suppressor cells	PLOS ONE			English	Article							IMMUNE EVASION; BREAST-CANCER; TUMOR; FAS; EXPRESSION; SURVIVAL; IMMUNOTHERAPY; ACCUMULATION; COMBINATION; ESCAPE	Post-surgical tumor recurrence is a common problem in cancer treatment. In the present study, the role of neem leaf glycoprotein (NLGP), a novel immunomodulator, in prevention of post-surgical recurrence of solid sarcoma was examined. Data suggest that NLGP prevents tumor recurrence after surgical removal of sarcoma in Swiss mice and increases their tumor-free survival time. In NLGP-treated tumor-free mice, increased cytotoxic CD8(+) T cells and a decreased population of suppressor cells, especially myeloid-derived suppressor cells (MDSCs) was observed. NLGP-treated CD8(+) T cells showed greater cytotoxicity towards tumor-derived MDSCs and supernatants from the same CD8(+) T cell culture caused upregulation of FasR and downregulation of cFLIP in MDSCs. To elucidate the role of CD8(+) T cells, specifically in association with the downregulation in MDSCs, CD8(+) T cells were depleted in vivo before NLGP immunization in surgically tumor removed mice and tumor recurrence was noted. These mice also exhibited increased MDSCs along with decreased levels of Caspase 3, Caspase 8 and increased cFLIP expression. In conclusion, it can be stated that NLGP, by activating CD8(+) T cells, down regulates the proportion of MDSCs. Accordingly, suppressive effects of MDSCs on CD8(+) T cells are minimized and optimum immune surveillance in tumor hosts is maintained to eliminate the residual tumor mass appearing during recurrence.	[Sarkar, Madhurima; Ghost, Sarbari; Bhuniya, Avishek; Ghost, Tithi; Guha, Ipsita; Barik, Subhasis; Bose, Anamika; Baral, Rathindranath] CNCI, Dept Immunoregulat & Immunodiagnost, Kolkata 700026, India; [Biswas, Jaydip] CNCI, Dept Surg Oncol & Med Oncol, Kolkata 700026, India		Baral, R (corresponding author), CNCI, Dept Immunoregulat & Immunodiagnost, Kolkata 700026, India.	baralrathin@hotmail.com		GHOSH HALDER, TITHI/0000-0002-4292-1153; Barik, Subhasis/0000-0002-0488-0434; Bhuniya, Avishek/0000-0001-6253-0400	Indian Council of Medical Research, New Delhi [59/6/2011/BMS/TRM]; Department of Science and Technology, New Delhi [DST/INSPIRE FELLOWSHIP/2011/188, SB/YS/LS-289/2013]; Indian Council of Medical Research [59/6/2011/BMS/TRM]; Department of Science and Technology [DST/INSPIRE FELLOWSHIP/2011/188, SBNS/LS-289/2013]	Indian Council of Medical Research, New Delhi(Indian Council of Medical Research (ICMR)); Department of Science and Technology, New Delhi(Department of Science & Technology (India)); Indian Council of Medical Research(Indian Council of Medical Research (ICMR)); Department of Science and Technology(Department of Science & Technology (India))	The authors acknowledge Director, CNCI, Kolkata, India, for providing necessary facilities. Thanks to Dr. Subrata Laskar, Burdwan University, India, for his help in characterization of NLGP. The work was partially supported by Indian Council of Medical Research, New Delhi (grant no. 59/6/2011/BMS/TRM), Department of Science and Technology, New Delhi (DST/INSPIRE FELLOWSHIP/2011/188 to SG and DST Young Scientist Scheme SB/YS/LS-289/2013 to AB). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Funded by 1. 59/6/2011/BMS/TRM, Indian Council of Medical Research, RB. 2. DST/INSPIRE FELLOWSHIP/2011/188, Department of Science and Technology, SG. 3. SBNS/LS-289/2013, Department of Science and Technology, AB2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angell TE, 2016, THYROID, V26, P381, DOI 10.1089/thy.2015.0289; Banerjee S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110040; Baral R, 2005, INT IMMUNOPHARMACOL, V5, P1343, DOI 10.1016/j.intimp.2005.03.008; Barik S, 2015, TRIALS VACCINOL, pe80; Barik S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066501; Berg KD, 2016, VIRCHOWS ARCH, V468, P345, DOI 10.1007/s00428-015-1880-y; Bhuniya A, 2016, J CARCINOG, V15, pS283; Bose A, 2009, J IMMUNOTHER, V32, P42, DOI 10.1097/CJI.0b013e31818e997d; Caldwell SA, 2003, J IMMUNOL, V171, P2402, DOI 10.4049/jimmunol.171.5.2402; Chakraborty T, 2012, INT IMMUNOPHARMACOL, V12, P326, DOI 10.1016/j.intimp.2011.12.002; Cheng PY, 2008, J EXP MED, V205, P2235, DOI 10.1084/jem.20080132; Condamine T, 2011, TRENDS IMMUNOL, V32, P19, DOI 10.1016/j.it.2010.10.002; Fish FR, 2008, ANESTHESIA ANALGESIA; Gabrilovich DI, 2012, NAT REV IMMUNOL, V12, P253, DOI 10.1038/nri3175; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Ghosh S, 2016, MOL IMMUNOL, V71, P42, DOI 10.1016/j.molimm.2016.01.007; Goswami KK, 2014, MOL IMMUNOL, V59, P119, DOI 10.1016/j.molimm.2014.01.015; Goswami S, 2010, VACCINE, V28, P1241, DOI 10.1016/j.vaccine.2009.11.018; GUNDUZ N, 1979, CANCER RES, V39, P3861; Haque E, 2006, IMMUNOPHARM IMMUNOT, V28, P33, DOI 10.1080/08923970600623632; Harms W, 2015, BREAST CARE, V10, P265, DOI 10.1159/000439151; Igney FH, 2002, J LEUKOCYTE BIOL, V71, P907; Janeway Jr C.A., 2001, IMMUNOBIOLOGY IMMUNE, V5th; Kadota K, 2015, ONCOTARGET, V6, P27505, DOI 10.18632/oncotarget.4752; Kataoka T, 1996, J IMMUNOL, V156, P3678; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Maeda N, 2014, ANN SURG ONCOL, V21, pS546, DOI 10.1245/s10434-014-3564-2; Mahoney KM, 2015, NAT REV DRUG DISCOV, V14, P561, DOI 10.1038/nrd4591; Mallick A, 2014, IMMUNOTHERAPY-UK, V6, P821, DOI [10.2217/imt.14.53, 10.2217/IMT.14.53]; Mallick A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0047434; Mallick A, 2013, INT IMMUNOPHARMACOL, V15, P73, DOI 10.1016/j.intimp.2012.11.006; Marrelli D, 2005, ANN SURG, V241, P247, DOI 10.1097/01.sla.0000152019.14741.97; MCARDLE CS, 1991, BRIT MED J, V302, P1501, DOI 10.1136/bmj.302.6791.1501; Monu NR, 2012, IMMUNOL INVEST, V41, P595, DOI 10.3109/08820139.2012.673191; Nagaraj S, 2008, CANCER RES, V68, P2561, DOI 10.1158/0008-5472.CAN-07-6229; Ouyen TN, 2010, P NATL ACAD SCI USA, V107, P4317; Shinoura N, 2002, J NEURO-ONCOL, V60, P71, DOI 10.1023/A:1020256721761; Sinha P, 2008, J IMMUNOL, V181, P4666, DOI 10.4049/jimmunol.181.7.4666; Sinha P, 2011, BLOOD, V117, P5381, DOI 10.1182/blood-2010-11-321752; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Swain SM, 2015, ADV THER, V32, P1222, DOI 10.1007/s12325-015-0268-3; Tavare AN, 2012, INT J CANCER, V130, P1237, DOI 10.1002/ijc.26448; Wlodkowic D, 2007, LEUKEMIA RES, V31, P1687, DOI 10.1016/j.leukres.2007.03.008; Xia R, NUMBER MYELOID DERIV; Zhang L, 2003, NEW ENGL J MED, V348, P203, DOI 10.1056/NEJMoa020177; Zhang WL, 2013, ASIAN PAC J TROP MED, V6, P995, DOI 10.1016/S1995-7645(13)60179-0; Zhang YL, 2009, J IMMUNOL, V182, P3801, DOI 10.4049/jimmunol.0801548	47	6	6	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2017	12	4							e0175540	10.1371/journal.pone.0175540	http://dx.doi.org/10.1371/journal.pone.0175540			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KD	28414726	gold, Green Published, Green Submitted			2022-12-27	WOS:000399874800034
J	So, WKY; Wong, SWH; Mak, JN; Chan, RHM				So, Winnie K. Y.; Wong, Savio W. H.; Mak, Joseph N.; Chan, Rosa H. M.			An evaluation of mental workload with frontal EEG	PLOS ONE			English	Article							WORKING-MEMORY; THETA-OSCILLATIONS; FREQUENCY; DYNAMICS; ALPHA	Using a wireless single channel EEG device, we investigated the feasibility of using shortterm frontal EEG as a means to evaluate the dynamic changes of mental workload. Frontal EEG signals were recorded from twenty healthy subjects performing four cognitive and motor tasks, including arithmetic operation, finger tapping, mental rotation and lexical decision task. Our findings revealed that theta activity is the common EEG feature that increases with difficulty across four tasks. Meanwhile, with a short-time analysis window, the level of mental workload could be classified from EEG features with 65% - 75% accuracy across subjects using a SVM model. These findings suggest that frontal EEG could be used for evaluating the dynamic changes of mental workload.	[So, Winnie K. Y.; Chan, Rosa H. M.] City Univ Hong Kong, Dept Elect Engn, Hong Kong, Hong Kong, Peoples R China; [Wong, Savio W. H.] Educ Univ Hong Kong, Ctr Brain & Educ, Hong Kong, Hong Kong, Peoples R China; [Wong, Savio W. H.] Educ Univ Hong Kong, Dept Special Educ & Counselling, Hong Kong, Hong Kong, Peoples R China; [Mak, Joseph N.] NeuroSky Hong Kong Res Lab, Hong Kong, Hong Kong, Peoples R China	City University of Hong Kong; Education University of Hong Kong (EdUHK); Education University of Hong Kong (EdUHK)	Chan, RHM (corresponding author), City Univ Hong Kong, Dept Elect Engn, Hong Kong, Hong Kong, Peoples R China.	rosachan@cityu.edu.hk	So, Winnie/AAK-2582-2021	So, Winnie/0000-0003-3013-1135; CHAN, Rosa/0000-0003-4808-2490; Wong, Savio/0000-0003-2854-5830	Research Grants Council of the Hong Kong Special Administrative Region, China [CityU110813, ECS-28403414]; Innovation and Technology Fund [ITS/139/14FX, ITS/141/14FX]; Innovation and Technology Commission; HKSAR; Research Support Scheme of the Department of Special Education and Counselling at the Education University of Hong Kong	Research Grants Council of the Hong Kong Special Administrative Region, China(Hong Kong Research Grants Council); Innovation and Technology Fund; Innovation and Technology Commission; HKSAR; Research Support Scheme of the Department of Special Education and Counselling at the Education University of Hong Kong	The work described in this paper was supported by grants from the Research Grants Council of the Hong Kong Special Administrative Region, China [Project No. CityU110813, ECS-28403414] the Innovation and Technology Fund (ITS/139/14FX, ITS/141/14FX) provided by the Innovation and Technology Commission, HKSAR and Research Support Scheme 2016/2017 of the Department of Special Education and Counselling at the Education University of Hong Kong. Any opinions, findings, conclusions or recommendations expressed in this material/event (or by members of the project team) do not reflect the views of the Government of the Hong Kong Special Administrative Region, the Innovation and Technology Commission or the Panel of Assessors for the Innovation and Technology Support Programme of the Innovation and Technology Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funder provided support in the form of salaries for author JNM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section.	[Anonymous], 2015, CISC VIS NETW IND GL; Ashcraft MH, COGNITION; Baddeley A, 2003, NAT REV NEUROSCI, V4, P829, DOI 10.1038/nrn1201; Berg DH, 2008, J EXP CHILD PSYCHOL, V99, P288, DOI 10.1016/j.jecp.2007.12.002; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Brouwer AM, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/4/045008; Burgess AP, 2002, INT J PSYCHOPHYSIOL, V46, P91, DOI 10.1016/S0167-8760(02)00108-3; Cai D, 2011, VLDB J, V20, P21, DOI 10.1007/s00778-010-0189-3; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Dai ZX, 2015, LECT NOTES COMPUT SC, V9491, P692, DOI 10.1007/978-3-319-26555-1_78; Davies M., 2008, CORPUS CONT AM ENGLI; Doppelmayr M, 1998, BIOL CYBERN, V79, P49, DOI 10.1007/s004220050457; Fredricks JA, 2004, REV EDUC RES, V74, P59, DOI 10.3102/00346543074001059; Friston KJ, 2005, NEUROIMAGE, V25, P661, DOI 10.1016/j.neuroimage.2005.01.013; Grandy TH, 2013, PSYCHOPHYSIOLOGY, V50, P570, DOI 10.1111/psyp.12043; Hirshfield LM, 2009, LECT NOTES ARTIF INT, V5638, P239, DOI 10.1007/978-3-642-02812-0_28; Hogervorst MA, 2015, USING NEUROPHYSIOLOG, P213; Kapoor A, 2007, INT J HUM-COMPUT ST, V65, P724, DOI 10.1016/j.ijhcs.2007.02.003; Keuleers E, 2010, BEHAV RES METHODS, V42, P627, DOI 10.3758/BRM.42.3.627; Klimesch W, 1999, BRAIN RES REV, V29, P169, DOI 10.1016/S0165-0173(98)00056-3; Kumar P.S., 2008, INT J OPEN PROBL COM, V1, P188, DOI [10.1109/JBHI.2021.3131186, DOI 10.1109/JBHI.2021.3131186, DOI 10.1007/S11277-014-1961-2]; Lim CK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039139; Liu M, 2015, IEEE T LEARN TECHNOL, V8, P215, DOI 10.1109/TLT.2014.2378786; Mak JN, 2013, IEEE IND ELEC, P8426, DOI 10.1109/IECON.2013.6700546; Miyake S, 2001, INT J PSYCHOPHYSIOL, V40, P233, DOI 10.1016/S0167-8760(00)00191-4; Muller L, 2015, IEEE T LEARN TECHNOL, V8, P111, DOI 10.1109/TLT.2014.2377732; Mullen TR, 2015, IEEE T BIO-MED ENG, V62, P2553, DOI 10.1109/TBME.2015.2481482; Onton J, 2005, NEUROIMAGE, V27, P341, DOI 10.1016/j.neuroimage.2005.04.014; Paris SG, 2001, EDUC PSYCHOL-US, V36, P89, DOI 10.1207/S15326985EP3602_4; Raghavachari S, 2001, J NEUROSCI, V21, P3175, DOI 10.1523/JNEUROSCI.21-09-03175.2001; Sauro J, 2009, CHI2009: PROCEEDINGS OF THE 27TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, VOLS 1-4, P1599; She Q, 2015, IEEE ENG MED BIO, P2506, DOI 10.1109/EMBC.2015.7318901; So WKY, 2016, IEEE ENG MED BIO, P4531, DOI 10.1109/EMBC.2016.7591735; Spironelli C, 2008, BIOL PSYCHOL, V77, P123, DOI 10.1016/j.biopsycho.2007.09.009; Stopczynski A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086733; Wickens CD, 2008, HUM FACTORS, V50, P397, DOI 10.1518/001872008X288420; Wong SWH, 2014, INT J PSYCHOPHYSIOL, V91, P16, DOI 10.1016/j.ijpsycho.2013.09.004	37	72	75	8	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2017	12	4							e0174949	10.1371/journal.pone.0174949	http://dx.doi.org/10.1371/journal.pone.0174949			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KD	28414729	Green Published, Green Submitted, gold			2022-12-27	WOS:000399874800011
J	Wong, CKH; Cheung, PWH; Samartzis, D; Luk, KDK; Cheung, KMC; Lam, CLK; Cheung, JPY				Wong, Carlos King Ho; Cheung, Prudence Wing Hang; Samartzis, Dino; Luk, Keith Dip-Kei; Cheung, Kenneth M. C.; Lam, Cindy Lo Kuen; Cheung, Jason Pui Yin			Mapping the SRS-22r questionnaire onto the EQ-5D-5L utility score in patients with adolescent idiopathic scoliosis	PLOS ONE			English	Article							QUALITY-OF-LIFE; CHINESE PATIENTS; HEALTH OUTCOMES; SURGERY; BRACE; EUROQOL; VALUES; CURVE	This is a prospective study to establish prediction models that map the refined Scoliosis Research Society 22-item (SRS-22r) onto EuroQoL-5 dimension 5-level (EQ-5D-5L) utility scores in adolescent idiopathic scoliosis (AIS) patients. Comparison of treatment outcomes in AIS can be determined by cost-utility analysis. However, the mainstay spine-specific health-related quality of life outcome measure, the SRS-22r questionnaire does not provide utility assessment. In this study, AIS patients were prospectively recruited to complete both the EQ-5D-5L and SRS-22r questionnaires by trained interviewers. Ordinary least squares regression was undertaken to develop mapping models, which the validity and robustness were assessed by using the 10-fold cross-validation procedure. EQ-5D-5L utility scores were regressed on demographics, Cobb angle, curve types, treatment modalities, and five domains of the SRS-22r questionnaire. Three models were developed using stepwise selection method. EQ-5D-5L scores were regressed on 1) main effects of SRS-22r subscale scores, 2) as per 1 plus squared and interaction terms, and 3) as per 2 plus demographic and clinical characteristics. Model goodness-of-fit was assessed using R-square, adjusted R-square, and information criteria; whereas the predictive performance was evaluated using root mean square error (RMSE), mean absolute error (MAE), and the proportion of absolute error within the threshold of 0.05 and 0.10. A total of 227 AIS patients with mean age of 15.6 years were recruited. The EQ-5D-5L scores were predicted by four domains of SRS-22r (main effects of 'Function', 'Pain', 'Appearance' and 'Mental Health', and squared term of 'Function' and 'Pain'), and Cobb angle in Model 3 with the best goodness-of-fit (R-square/adjusted R-square: 62.1%/60.9%). Three models demonstrated an acceptance predictive performance in error analysis applying 10-fold cross-validation to three models where RMSE and MAE were between 0.063-0.065 and between 0.039-0.044, respectively. Model 3 was therefore recommended out of three mapping models established in this paper. To our knowledge, this is the first study to map a spine-specific health-related quality of life measure onto EQ-5D-5L for AIS patients. With the consideration and incorporation of demographic and clinical characteristics, over 60% variance explained by mapping model 3 enabled the satisfactory prediction of EQ-5D-5L utility scores from existing SRS-22r data for health economic appraisal of different treatment options.	[Wong, Carlos King Ho; Lam, Cindy Lo Kuen] Univ Hong Kong, Dept Family Med & Primary Care, Hong Kong, Hong Kong, Peoples R China; [Cheung, Prudence Wing Hang; Samartzis, Dino; Luk, Keith Dip-Kei; Cheung, Kenneth M. C.; Cheung, Jason Pui Yin] Univ Hong Kong, Dept Orthopaed & Traumatol, Pokfulam, Hong Kong, Peoples R China; [Cheung, Jason Pui Yin] Univ Hong Kong, Dept Orthopaed & Traumatol, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong	Cheung, JPY (corresponding author), Univ Hong Kong, Dept Orthopaed & Traumatol, Pokfulam, Hong Kong, Peoples R China.; Cheung, JPY (corresponding author), Univ Hong Kong, Dept Orthopaed & Traumatol, Hong Kong, Hong Kong, Peoples R China.	cheungjp@hku.hk	Cheung, Jason Pui Yin/J-2214-2012; Cheung, Jason Pui Yin/AAJ-2016-2020	Cheung, Jason Pui Yin/0000-0002-7052-0875; Cheung, Prudence/0000-0002-3213-7373; Cheung, Kenneth/0000-0001-8304-0419; Samartzis, Dino/0000-0002-7473-1311				Asher MA, 2006, SPINE, V31, P593, DOI 10.1097/01.brs.0000201331.50597.ea; Brazier JE, 2010, EUR J HEALTH ECON, V11, P215, DOI 10.1007/s10198-009-0168-z; Brooks R, 1996, HEALTH POLICY, V37, P53, DOI 10.1016/0168-8510(96)00822-6; Cheung KMC, 2007, INT ORTHOP, V31, P507, DOI 10.1007/s00264-006-0209-5; Cheung KMC, 2007, SPINE, V32, P1141, DOI 10.1097/01.brs.0000261562.48888.e3; Cheung PWH, 2016, SCOLIOSIS SPINAL DIS, V11, DOI 10.1186/s13013-016-0083-x; Climent JM, 1999, SPINE, V24, P1903, DOI 10.1097/00007632-199909150-00007; Cobb J., 1948, AM ACADEMY ORTHOPAED, V5, P261; Cutler Holt S, 2015, Spine Deform, V3, P136, DOI 10.1016/j.jspd.2014.08.009; Dakin H, 2013, HEALTH QUAL LIFE OUT, V11, DOI 10.1186/1477-7525-11-151; Earnshaw J, 2008, PHARMACOECONOMICS, V26, P725, DOI 10.2165/00019053-200826090-00002; Ghandehari H, 2015, ARCH BONE JT SURG-AB, V3, P109; Huh Seokwon, 2015, Korean J Pediatr, V58, P218, DOI 10.3345/kjp.2015.58.6.218; Janssen MF, 2013, QUAL LIFE RES, V22, P1717, DOI 10.1007/s11136-012-0322-4; Lai SM, 2006, SPINE, V31, P473, DOI 10.1097/01.brs.0000200049.94329.f4; Lenke LG, 2001, J BONE JOINT SURG AM, V83A, P1169, DOI 10.2106/00004623-200108000-00006; Liu GG, 2014, VALUE HEALTH, V17, P597, DOI 10.1016/j.jval.2014.05.007; Longworth L, 2013, VALUE HEALTH, V16, P202, DOI 10.1016/j.jval.2012.10.010; LONSTEIN JE, 1994, LANCET, V344, P1407; National Institute for Health and Clinical Excellence, 2013, GUID METH TECHN APPR; Noonan KJ, 1997, J PEDIATR ORTHOPED, V17, P712, DOI 10.1097/00004694-199711000-00004; Odermatt D, 2003, J ORTHOP RES, V21, P931, DOI 10.1016/S0736-0266(03)00038-X; Oppe M, 2014, VALUE HEALTH, V17, P445, DOI 10.1016/j.jval.2014.04.002; Pan CW, 2016, MED DECIS MAKING, V36, P234, DOI 10.1177/0272989X15606903; Pan CW, 2015, QUAL LIFE RES, V24, P1767, DOI 10.1007/s11136-014-0902-6; PATRICK DL, 1989, MED CARE, V27, pS217, DOI 10.1097/00005650-198903001-00018; Pehrsson K, 2001, THORAX, V56, P388, DOI 10.1136/thorax.56.5.388; Petrou S, 2015, INT J TECHNOL ASSESS, V31, P230, DOI [10.1017/S0266462315000379, 10.1007/s40273-015-0319-2]; Revicki DA, 1998, CHEST, V114, P998, DOI 10.1378/chest.114.4.998; Richardson G, 2004, HEALTH ECON, V13, P1203, DOI 10.1002/hec.901; RISEBOROUGH EJ, 1973, J BONE JOINT SURG AM, VA 55, P974, DOI 10.2106/00004623-197355050-00006; Telang SS, 2006, J SPINAL DISORD TECH, V19, P534, DOI 10.1097/01.bsd.0000211216.43813.90; Tones M, 2006, SPINE, V31, P3027, DOI 10.1097/01.brs.0000249555.87601.fc; Ugwonali Obinwanne F, 2004, Spine J, V4, P254; van Hout B, 2012, VALUE HEALTH, V15, P708, DOI 10.1016/j.jval.2012.02.008; Vasiliadis E, 2006, STUD HEALTH TECHNOL, V123, P352; WEINSTEIN SL, 1983, J BONE JOINT SURG AM, V65, P447, DOI 10.2106/00004623-198365040-00004; Weinstein SL, 2003, JAMA-J AM MED ASSOC, V289, P559, DOI 10.1001/jama.289.5.559; Weinstein SL, 2013, NEW ENGL J MED, V369, P1512, DOI 10.1056/NEJMoa1307337; Weiss HR, 2008, DISABIL REHABIL, V30, P799, DOI 10.1080/09638280801889717; Whitehead SJ, 2010, BRIT MED BULL, V96, P5, DOI 10.1093/bmb/ldq033; Wong CKH, 2012, VALUE HEALTH, V15, P495, DOI 10.1016/j.jval.2011.12.009; Wu EQ, 2007, VALUE HEALTH, V10, P408, DOI 10.1111/j.1524-4733.2007.00195.x	43	16	16	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2017	12	4							e0175847	10.1371/journal.pone.0175847	http://dx.doi.org/10.1371/journal.pone.0175847			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES9KD	28414745	Green Submitted, Green Published, gold			2022-12-27	WOS:000399874800068
J	Alguero-Muniz, M; Alvarez-Fernandez, S; Thor, P; Bach, LT; Esposito, M; Horn, HG; Ecker, U; Langer, JAF; Taucher, J; Malzahn, AM; Riebesell, U; Boersma, M				Alguero-Muniz, Maria; Alvarez-Fernandez, Santiago; Thor, Peter; Bach, Lennart T.; Esposito, Mario; Horn, Henriette G.; Ecker, Ursula; Langer, Julia A. F.; Taucher, Jan; Malzahn, Arne M.; Riebesell, Ulf; Boersma, Maarten			Ocean acidification effects on mesozooplankton community development: Results from a long-term mesocosm experiment	PLOS ONE			English	Article							CALANUS-FINMARCHICUS GUNNERUS; EUROPEAN ATHECATE HYDROIDS; CLIMATE-CHANGE; CO2 CONCENTRATIONS; MEDUSAE HYDROZOA; ELEVATED CO2; JELLYFISH; COPEPODS; IMPACT; PLANKTON	Ocean acidification may affect zooplankton directly by decreasing in pH, as well as indirectly via trophic pathways, where changes in carbon availability or pH effects on primary producers may cascade up the food web thereby altering ecosystem functioning and community composition. Here, we present results from a mesocosm experiment carried out during 113 days in the Gullmar Fjord, Skagerrak coast of Sweden, studying plankton responses to predicted end-of-century pCO(2) levels. We did not observe any pCO(2) effect on the diversity of the mesozooplankton community, but a positive pCO(2) effect on the total mesozooplankton abundance. Furthermore, we observed species-specific sensitivities to pCO(2) in the two major groups in this experiment, copepods and hydromedusae. Also stage-specific pCO(2) sensitivities were detected in copepods, with copepodites being the most responsive stage. Focusing on the most abundant species, Pseudocalanus acuspes, we observed that copepodites were significantly more abundant in the high-pCO(2) treatment during most of the experiment, probably fuelled by phytoplankton community responses to high-pCO(2) conditions. Physiological and reproductive output was analysed on P. acuspes females through two additional laboratory experiments, showing no pCO(2) effect on females' condition nor on egg hatching. Overall, our results suggest that the Gullmar Fjord mesozooplankton community structure is not expected to change much under realistic end-of-century OA scenarios as used here. However, the positive pCO(2) effect detected on mesozooplankton abundance could potentially affect biomass transfer to higher trophic levels in the future.	[Alguero-Muniz, Maria; Alvarez-Fernandez, Santiago; Horn, Henriette G.; Ecker, Ursula; Langer, Julia A. F.; Boersma, Maarten] Helmholtz Zentrum Polar & Meeresforsch, Alfred Wegener Inst, Biol Anstalt Helgoland, Helgoland, Germany; [Thor, Peter] Norwegian Polar Res Inst, Framctr, Tromso, Norway; [Bach, Lennart T.; Taucher, Jan; Riebesell, Ulf] GEOMAR Helmholtz Ctr Ocean Res Kiel, Kiel, Germany; [Esposito, Mario] Univ Southampton, Natl Oceanog Ctr, Southampton, Hants, England; [Malzahn, Arne M.] Sintef Ocean AS, Marine Resource Technol, Trondheim, Norway; [Boersma, Maarten] Univ Bremen, FB2, Bremen, Germany	Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; Norwegian Polar Institute; Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel; NERC National Oceanography Centre; University of Southampton; SINTEF; University of Bremen	Alguero-Muniz, M (corresponding author), Helmholtz Zentrum Polar & Meeresforsch, Alfred Wegener Inst, Biol Anstalt Helgoland, Helgoland, Germany.	malguero@awi.de	Riebesell, Ulf/AAC-9717-2020; Ecker, Ursula/F-8235-2019; Thor, Peter/A-7522-2009; Malzahn, Arne/C-5851-2013; Thor, Peter/ABF-1114-2021; Malzahn, Arne/AAD-6356-2022; Taucher, Jan/AAA-9195-2019; Algueró-Muñiz, María/AAA-9748-2020; Boersma, Maarten/A-5475-2013; Horn, Henriette G./R-7667-2016	Ecker, Ursula/0000-0001-7177-727X; Thor, Peter/0000-0002-2603-2284; Malzahn, Arne/0000-0002-2027-0804; Thor, Peter/0000-0002-2603-2284; Algueró-Muñiz, María/0000-0001-8064-6212; Boersma, Maarten/0000-0003-1010-026X; Taucher, Jan/0000-0001-9944-0775; Horn, Henriette G./0000-0002-4020-5559; Bach, Lennart/0000-0003-0202-3671	German Ministry of Education and Research through phase II and III of the BIOACID [FKZ 03F0655A, FKZ 03F0728B]; Swedish Academy of Sciences; SINTEF Ocean	German Ministry of Education and Research through phase II and III of the BIOACID; Swedish Academy of Sciences; SINTEF Ocean(SINTEF)	Financial support for this study was provided by the German Ministry of Education and Research through phase II (BMBF, FKZ 03F0655A) and III (BMBF, FKZ 03F0728B) of the BIOACID (Biological Impacts of Ocean ACIDification) project and the Swedish Academy of Sciences. SINTEF Ocean provided support in the form of salaries for author AMM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Alguero-Muniz M, 2016, MAR BIOL, V163, DOI 10.1007/s00227-016-2958-z; Almen AK, 2014, J EXP MAR BIOL ECOL, V460, P120, DOI 10.1016/j.jembe.2014.07.001; Alvarez-Fernandez S, 2015, ICES J MAR SCI; Bach LT, 2016, GLOBAL BIOGEOCHEM CY, V30, P1145, DOI 10.1002/2016GB005372; Bach LT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159068; Boersma M, 2008, INT REV HYDROBIOL, V93, P479, DOI 10.1002/iroh.200811066; Boersma M, 2014, MAR BIOL, V161, P733, DOI 10.1007/s00227-013-2373-7; Bouillon J., 2006, INTRO HYDROZOA; Buttigieg PL, 2014, FEMS MICROBIOL ECOL, V90, P543, DOI 10.1111/1574-6941.12437; Calbet A, 2005, AQUAT MICROB ECOL, V38, P157, DOI 10.3354/ame038157; Caldeira K, 2003, NATURE, V425, P365, DOI 10.1038/425365a; CHECKLEY DM, 1982, MAR ECOL PROG SER, V9, P245, DOI 10.3354/meps009245; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Condon RH, 2012, BIOSCIENCE, V62, P160, DOI 10.1525/bio.2012.62.2.9; Cripps G, 2014, J PLANKTON RES; Cripps G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151739; Cripps G, 2014, GLOBAL CHANGE BIOL, V20, P3377, DOI 10.1111/gcb.12582; Denis J, 2016, J SEA RES, V115, P33, DOI 10.1016/j.seares.2016.07.003; Doney SC, 2009, ANNU REV MAR SCI, V1, P169, DOI 10.1146/annurev.marine.010908.163834; Dorey N, 2013, GLOBAL CHANGE BIOL, V19, P3355, DOI 10.1111/gcb.12276; Dupont S, 2013, MAR BIOL, V160, P1835, DOI 10.1007/s00227-012-1921-x; Dutkiewicz S, 2015, NAT CLIM CHANGE, V5, P1002, DOI [10.1038/NCLIMATE2722, 10.1038/nclimate2722]; Eberlein T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172594; Fabry VJ, 2008, ICES J MAR SCI, V65, P414, DOI 10.1093/icesjms/fsn048; Fitzer SC, 2012, J EXP MAR BIOL ECOL, V418, P30, DOI 10.1016/j.jembe.2012.03.009; Gobler CJ, 2016, BIOL LETTERS, V12, DOI 10.1098/rsbl.2015.0976; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hoegh-Guldberg O, 2010, SCIENCE, V328, P1523, DOI 10.1126/science.1189930; Horn HG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165800; Hufnagl M, 2011, ICES J MAR SCI, V68, P1170, DOI 10.1093/icesjms/fsr078; IPCC (Intergovernmental Panel on Climate Change), 2013, CLIMATE CHANGE 2013; Isari S, 2015, ICES J MAR SCI; Kikkawa Takashi, 2010, Plankton & Benthos Research, V5, P119; KLEPPEL GS, 1993, MAR ECOL PROG SER, V99, P183, DOI 10.3354/meps099183; Kurihara H, 2008, MAR POLLUT BULL, V56, P1086, DOI 10.1016/j.marpolbul.2008.03.023; Landry MR, 2004, ICES J MAR SCI, V61, P501, DOI 10.1016/j.icesjms.2004.03.011; Legendre P, 1999, ECOL MONOGR, V69, P1, DOI 10.1890/0012-9615(1999)069[0001:DBRATM]2.0.CO;2; Lewis CN, 2013, P NATL ACAD SCI USA, V110, pE4960, DOI 10.1073/pnas.1315162110; Lischka S, 2011, BIOGEOSCIENCES, V8, P919, DOI 10.5194/bg-8-919-2011; Lischka S., 2015, BIOGEOSCIENCES DISCU, V12, P20025, DOI [10.5194/bgd-12-20025-2015, DOI 10.5194/BGD-12-20025-2015]; Loder MGJ, 2011, MAR BIOL, V158, P1551, DOI 10.1007/s00227-011-1670-2; Malzahn AM, 2010, OECOLOGIA, V162, P35, DOI 10.1007/s00442-009-1458-y; Mayor DJ, 2007, MAR ECOL PROG SER, V350, P91, DOI 10.3354/meps07142; McConville K, 2013, MAR POLLUT BULL, V73, P428, DOI 10.1016/j.marpolbul.2013.02.010; Meunier CL, 2016, MAR FRESHW RES; Niehoff B, 1999, MAR ECOL PROG SER, V176, P81, DOI 10.3354/meps176081; Niehoff B, 2013, BIOGEOSCIENCES, V10, P1391, DOI 10.5194/bg-10-1391-2013; Niehoff B, 2003, MAR BIOL, V143, P759, DOI 10.1007/s00227-003-1034-7; Oksanen J., 2012, VEGAN COMMUNITY ECOL; Orr JC, 2005, NATURE, V437, P681, DOI 10.1038/nature04095; Pedersen MF, 2003, MAR ECOL PROG SER, V260, P19; Pedersen SA, 2013, BIOGEOSCIENCES, V10, P7481, DOI 10.5194/bg-10-7481-2013; Pedersen SA, 2014, ENVIRON SCI TECHNOL, V48, P12275, DOI 10.1021/es501581j; Pedersen SA, 2014, J TOXICOL ENV HEAL A, V77, P535, DOI 10.1080/15287394.2014.887421; Purcell JE, 2007, MAR ECOL PROG SER, V350, P153, DOI 10.3354/meps07093; Purcell JE, 2012, ANNU REV MAR SCI, V4, P209, DOI 10.1146/annurev-marine-120709-142751; Razouls C., 2020, DIVERSITY GEOGRAPHIC; Richardson AJ, 2008, LIMNOL OCEANOGR, V53, P2040, DOI 10.4319/lo.2008.53.5.2040; Riebesell U, 2000, NATURE, V407, P364, DOI 10.1038/35030078; Riebesell U, 2013, BIOGEOSCIENCES, V10, P1835, DOI 10.5194/bg-10-1835-2013; Rossoll D, 2013, MAR ECOL PROG SER, V486, P37, DOI 10.3354/meps10352; Rossoll D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034737; Sabine CL, 2004, SCIENCE, V305, P367, DOI 10.1126/science.1097403; Sala MM, 2016, ICES J MAR SCI, V73, P670, DOI 10.1093/icesjms/fsv130; Sars GO, 1913, COPEPODA CYCLOPOID 1; Sars GO, 1903, COPEPODA HARPACTIC 1; Sars GO, 1901, AN ACCOUNT OF THE CR; Scheinin M, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0056; Schoo KL, 2013, MAR BIOL, V160, P2145, DOI 10.1007/s00227-012-2121-4; Schuchert P, 2007, REV SUISSE ZOOL, V114, P195, DOI 10.5962/bhl.part.80395; Schuchert P, 2010, REV SUISSE ZOOL, V117, P337; Sswat M, 2013, VIDEO PLANKTON COMMU; Sswat M, HERRING LARVAE UNPUB; Taucher J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169737; Team RC, 2012, R LANG ENV STAT COMP; Thor P, 2002, J PLANKTON RES, V24, P293, DOI 10.1093/plankt/24.4.293; Thor P, 2015, GLOBAL CHANGE BIOL, V21, P2261, DOI 10.1111/gcb.12815; Thor P, 2015, MAR BIOL, V162, P799, DOI 10.1007/s00227-015-2625-9; Turner JT, 2004, ZOOL STUD, V43, P255; Wallace RB, 2014, ESTUAR COAST SHELF S, V148, P1, DOI 10.1016/j.ecss.2014.05.027; Winans AK, 2010, HYDROBIOLOGIA, V645, P39, DOI 10.1007/s10750-010-0224-9; Wolf-Gladrow DA, 1999, TELLUS B, V51, P461, DOI 10.1034/j.1600-0889.1999.00023.x; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Zuur Alain F., 2009, P1	84	16	16	1	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2017	12	4							e0175851	10.1371/journal.pone.0175851	http://dx.doi.org/10.1371/journal.pone.0175851			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0MD	28410436	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000399955600050
J	Kato, T; Honda, Y; Kurita, Y; Iwasaki, A; Sato, T; Kessoku, T; Uchiyama, S; Ogawa, Y; Ohkubo, H; Higurashi, T; Yamanaka, T; Usuda, H; Wada, K; Nakajima, A				Kato, Takayuki; Honda, Yasushi; Kurita, Yusuke; Iwasaki, Akito; Sato, Takamitsu; Kessoku, Takaomi; Uchiyama, Shiori; Ogawa, Yuji; Ohkubo, Hidenori; Higurashi, Takuma; Yamanaka, Takeharu; Usuda, Haruki; Wada, Koichiro; Nakajima, Atsushi			Lubiprostone improves intestinal permeability in humans, a novel therapy for the leaky gut: A prospective randomized pilot study in healthy volunteers	PLOS ONE			English	Article							TIGHT JUNCTION BARRIER; CROHNS-DISEASE; INFLAMMATION; CONSTIPATION; EXPRESSION; ENDOTOXIN; RESTORES; ARTICLE; BLOOD; ASSAY	Background and aims The barrier function of the small intestinal mucosa prevents the introduction of undesired pathogens into the body. Breakdown of this barrier function increases intestinal permeability. This has been proposed to induce not only gastrointestinal diseases, including inflammatory bowel disease and irritable bowel syndrome, but also various other diseases, including allergies, diabetes mellitus, liver diseases, and collagen diseases, which are associated with this so called "leaky gut syndrome As such, a method to prevent leaky gut syndrome would have substantial clinical value. However, no drugs have been demonstrated to improve disturbed intestinal permeability in humans to date. Therefore, we investigated whether a drug used to treat chronic constipation, lubiprostone, was effective for this purpose. Methods Healthy male volunteers were treated with lubiprostone (24 mu g/day) for 28 days. Intestinal permeability was evaluated by measuring the lactulose-mannitol ratio (LMR) after administration of diclofenac and compared with an untreated group. The examination was conducted three times in total, i.e., at baseline before diclofenac administration and after 14 and 28 days of lubiprostone treatment. Blood endotoxin activity was also evaluated at the same time points. Results The final analysis was conducted on 28 subjects (14 in the lubiprostone group and 14 in the untreated group). The LMR after 28 days of treatment was significantly lower in the lubiprostone group than that in the untreated group (0.017 vs. 0.028, respectively; 95% confidence interval, -0.022--0.0001; p = 0.049). Blood endotoxin activity exhibited almost no change over time in the lubiprostone and untreated groups and displayed no significant differences at any time point of examination. Conclusions This study is the first to report an improvement in leaky gut using an available drug in humans. The result suggests that lubiprostone may prevent and ameliorate "leaky gut syndrome". However, a pivotal trial is needed to confirm our finding.	[Kato, Takayuki; Honda, Yasushi; Kurita, Yusuke; Iwasaki, Akito; Sato, Takamitsu; Kessoku, Takaomi; Uchiyama, Shiori; Ogawa, Yuji; Ohkubo, Hidenori; Higurashi, Takuma; Nakajima, Atsushi] Yokohama City Univ, Dept Gastroenterol & Hepatol, Sch Med, Yokohama, Kanagawa, Japan; [Yamanaka, Takeharu] Yokohama City Univ, Dept Biostat, Sch Med, Yokohama, Kanagawa, Japan; [Usuda, Haruki; Wada, Koichiro] Shimane Univ, Dept Pharmacol, Sch Med, Izumo, Shimane, Japan	Yokohama City University; Yokohama City University; Shimane University	Nakajima, A (corresponding author), Yokohama City Univ, Dept Gastroenterol & Hepatol, Sch Med, Yokohama, Kanagawa, Japan.	nakajima-tky@umin.ac.jp	Higurashi, Takuma/AAD-7747-2022; Kurita, Yusuke/GPK-7068-2022	Kato, Takayuki/0000-0001-8839-9594; Usuda, Haruki/0000-0002-3664-5519; Kessoku, Takaomi/0000-0002-5587-1386	Mylan EPD G.K.	Mylan EPD G.K.	This research was funded by a grant from Mylan EPD G.K. (Mylan EPD), which is the distributor of lubiprostone in Japan. There are no grant numbers. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arrieta MC, 2006, GUT, V55, DOI 10.1136/gut.2005.085373; Arseneault-Breard J, 2012, BRIT J NUTR, V107, P1793, DOI 10.1017/S0007114511005137; Bassil AK, 2008, BRIT J PHARMACOL, V154, P126, DOI 10.1038/bjp.2008.84; Berkes J, 2003, GUT, V52, P439, DOI 10.1136/gut.52.3.439; BJARNASON I, 1986, GUT, V27, P1292, DOI 10.1136/gut.27.11.1292; Davies NM, 1998, ALIMENT PHARM THER, V12, P303; Del Piano M, 2014, J CLIN GASTROENTEROL, V48, pS56, DOI 10.1097/MCG.0000000000000254; Eun CS, 2011, APMIS, V119, P49, DOI 10.1111/j.1600-0463.2010.02691.x; Farhadi A, 2003, J GASTROEN HEPATOL, V18, P479, DOI 10.1046/j.1440-1746.2003.03032.x; Fresko I, 2001, ANN RHEUM DIS, V60, P65, DOI 10.1136/ard.60.1.65; Fukudo S, 2011, NEUROGASTROENT MOTIL, V23, P544, DOI 10.1111/j.1365-2982.2011.01668.x; Fukudo S, 2015, CLIN GASTROENTEROL H, V13, P294, DOI 10.1016/j.cgh.2014.08.026; Gnauck A, 2015, INNATE IMMUN-LONDON, V21, P537, DOI 10.1177/1753425914557101; Hayashi S, 2014, J PHARMACOL EXP THER, V349, P470, DOI 10.1124/jpet.114.213991; Ito Y, 2013, J CLIN BIOCHEM NUTR, V53, P55, DOI 10.3164/jcbn.12-116; Johanson JF, 2008, ALIMENT PHARM THER, V27, P685, DOI 10.1111/j.1365-2036.2008.03629.x; Julio-Pieper M, 2014, ALIMENT PHARM THER, V40, P1187, DOI 10.1111/apt.12950; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Kazuaki A, 2007, JAPANESE J INTENSIVE, V31, P407; Lamprecht M, 2015, J INT SOC SPORT NUTR, V12, DOI 10.1186/s12970-015-0101-z; Marshall JC, 2004, J INFECT DIS, V190, P527, DOI 10.1086/422254; Miele L, 2009, HEPATOLOGY, V49, P1877, DOI 10.1002/hep.22848; Nighot PK, 2012, AM J PHYSIOL-CELL PH, V302, pC178, DOI 10.1152/ajpcell.00072.2011; Okano M, 2009, J ALLERGY CLIN IMMUN, V123, P868, DOI 10.1016/j.jaci.2009.01.047; Perrier C, 2011, CLIN EXP ALLERGY, V41, P20, DOI 10.1111/j.1365-2222.2010.03639.x; Romaschin AD, 1998, J IMMUNOL METHODS, V212, P169, DOI 10.1016/S0022-1759(98)00003-9; Romaschin AD, 2012, CRIT CARE, V16, DOI 10.1186/cc11495; Secondulfo M, 2004, DIGEST LIVER DIS, V36, P35, DOI 10.1016/j.dld.2003.09.016; Sequeira IR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099256; Suenaert P, 2002, AM J GASTROENTEROL, V97, P2000; Wild GE, 2003, ALIMENT PHARM THER, V18, P309, DOI 10.1046/j.1365-2036.2003.01611.x	31	27	29	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2017	12	4							e0175626	10.1371/journal.pone.0175626	http://dx.doi.org/10.1371/journal.pone.0175626			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0MD	28410406	Green Published, Green Submitted, gold			2022-12-27	WOS:000399955600029
J	Miranda, EA; Ferreira, KM; Carvalho, AT; Martins, CF; Fernandes, CR; Del Lama, MA				Miranda, Elder Assis; Ferreira, Katie Maria; Carvalho, Airton Torres; Martins, Celso Feitosa; Fernandes, Carlo Rivero; Del Lama, Marco Antonio			Pleistocene climate changes shaped the population structure of Partamona seridoensis (Apidae, Meliponini), an endemic stingless bee from the Neotropical dry forest	PLOS ONE			English	Article							GENETIC-STRUCTURE; HISTORICAL BIOGEOGRAPHY; SEX DETERMINATION; HYMENOPTERA; DIVERSIFICATION; CONSERVATION; EVENTS; PHYLOGEOGRAPHY; POLLINATION; DISPERSAL	Partamona seridoensis is an endemic stingless bee from the Caatinga, a Neotropical dry forest in northeastern Brazil. Like other stingless bees, this species plays an important ecological role as a pollinator. The aim of the present study was to investigate the genetic structure and evolutionary history of P. seridoensis across its current geographic range. Workers from 84 nests from 17 localities were analyzed for COI and Cytb genic regions. The population structure tests (Bayesian phylogenetic inference, AMOVA and haplotype network) consistently characterized two haplogroups (northwestern and eastern), with little gene flow between them, generating a high differentiation between them as well as among the populations within each haplogroup. The Mantel test revealed no isolation by distance. No evidence of a potential geographic barrier in the present that could explain the diversification between the P. seridoensis haplogroups was found. However, Pleistocene climatic changes may explain this differentiation, since the initial time for the P. seridoensis lineages diversification took place during the mid-Pleistocene, specifically the interglacial period, when the biota is presumed to have been more associated with dry conditions and had more restricted, fragmented geographical distribution. This event may have driven diversification by isolating the two haplogroups. Otherwise, the climatic changes in the late Pleistocene must not have drastically affected the population dynamics of P. seridoensis, since the Bayesian Skyline Plot did not reveal any substantial fluctuation in effective population size in either haplogroup. Considering its importance and the fact that it is an endemic bee from a very threatened Neotropical dry forest, the results herein could be useful to the development of conservation strategies for P. seridoensis.	[Miranda, Elder Assis; Ferreira, Katie Maria; Del Lama, Marco Antonio] Univ Fed Sao Carlos, Dept Genet & Evolucao, Lab Genet Evolut Himenopteros, Sao Carlos, SP, Brazil; [Miranda, Elder Assis] Univ Estadual Santa Cruz, Dept Ciencias Biol, Ilheus, BA, Brazil; [Carvalho, Airton Torres] Univ Fed Rural Pernambuco, Unidade Acad Serra Talhada, Serra Talhada, PE, Brazil; [Martins, Celso Feitosa] Univ Fed Paraiba, Dept Sistemat & Ecol, Joao Pessoa, PB, Brazil; [Fernandes, Carlo Rivero] UNESC, Uniao Ensino Super Campina Grande, Campina Grande, PB, Brazil	Universidade Federal de Sao Carlos; Universidade Estadual de Santa Cruz; Universidade Federal Rural de Pernambuco (UFRPE); Universidade Federal da Paraiba	Miranda, EA (corresponding author), Univ Fed Sao Carlos, Dept Genet & Evolucao, Lab Genet Evolut Himenopteros, Sao Carlos, SP, Brazil.; Miranda, EA (corresponding author), Univ Estadual Santa Cruz, Dept Ciencias Biol, Ilheus, BA, Brazil.	elderamiranda@gmail.com	Martins, Celso/H-9339-2012; Carvalho, Airton Torres/I-2540-2013	Martins, Celso/0000-0001-5953-3758; Carvalho, Airton Torres/0000-0003-3395-4444; martins, charles/0000-0002-5282-7961	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP [2012/23342-1, 2011/21501-2]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [475642/2007-4]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP (Project Number: 2012/23342-1), and Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP (Project Number: 2011/21501-2) Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, processes 475642/2007-4).	AbSaber AN, 1977, PALEOCLIMAS, V3, P1; Almeida FC, 2007, MOL PHYLOGENET EVOL, V42, P449, DOI 10.1016/j.ympev.2006.07.005; [Anonymous], 2013, CATALOGUE BEES HYMEN; Auler AS, 2004, J QUATERNARY SCI, V19, P693, DOI 10.1002/jqs.876; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Basu P, 2011, DECLINE POLLINATOR D; Batalha H, 2010, APIDOLOGIE, V41, P534, DOI 10.1051/apido/2010001; BECKENBACH AT, 1993, MOL BIOL EVOL, V10, P619; Beerli P, 2010, GENETICS, V185, P313, DOI 10.1534/genetics.109.112532; Bonatti V, 2014, NATURWISSENSCHAFTEN, V101, P17, DOI 10.1007/s00114-013-1123-5; Brito DV, 2015, INSECT BIOCHEM MOLEC, V66, P24, DOI 10.1016/j.ibmb.2015.09.008; Brown MJF, 2009, APIDOLOGIE, V40, P410, DOI 10.1051/apido/2009019; Camargo João M. F., 2003, Rev. Bras. entomol., V47, P311, DOI 10.1590/S0085-56262003000300001; Cameron EC, 2004, MOL ECOL, V13, P2357, DOI 10.1111/j.1365-294X.2004.02194.x; Carnaval AC, 2008, J BIOGEOGR, V35, P1187, DOI 10.1111/j.1365-2699.2007.01870.x; Carnaval AC, 2007, EVOLUTION, V61, P2942, DOI 10.1111/j.1558-5646.2007.00241.x; Carnaval AC, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1461; COOK JM, 1995, TRENDS ECOL EVOL, V10, P281, DOI 10.1016/0169-5347(95)90011-X; CROZIER RH, 1993, GENETICS, V133, P97; da Rocha LC, 2013, GENETICA, V141, P65, DOI 10.1007/s10709-013-9706-9; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Dellicour S, 2017, J BIOGEOGR, V44, P39, DOI 10.1111/jbi.12748; Dick CW, 2004, MOL ECOL, V13, P3775, DOI 10.1111/j.1365-294X.2004.02374.x; Drummond AJ, 2013, BEAST V1 8 0 2002 20; Engels W, 1990, CONSERV GENET, P166; Esseghir S, 2000, BIOL J LINN SOC, V70, P189, DOI 10.1111/j.1095-8312.2000.tb00207.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Farrell BD, 2001, MOL PHYLOGENET EVOL, V18, P467, DOI 10.1006/mpev.2000.0888; Fernandes CRM, 2017, SOCIOBIOLOG IN PRESS, V64; Franco FF, 2013, J BIOGEOGR, V40, P142, DOI 10.1111/j.1365-2699.2012.02777.x; Frankham R., 2010, INTRO CONSERVATION G, DOI DOI 10.1017/CBO9780511809002; Giannini TC, 2013, AGR ECOSYST ENVIRON, V171, P39, DOI 10.1016/j.agee.2013.03.003; Grant WS, 2015, J HERED, V16, P1; Groom SVC, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3293; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hasselmann M, 2008, NATURE, V454, P519, DOI 10.1038/nature07052; Ho SYW, 2011, MOL ECOL, V20, P3087, DOI 10.1111/j.1365-294X.2011.05178.x; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Klink CA, 2005, CONSERV BIOL, V19, P707, DOI 10.1111/j.1523-1739.2005.00702.x; Kukla G, 2005, QUATERNARY SCI REV, V24, P1573, DOI 10.1016/j.quascirev.2004.08.023; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lopez-Uribe MM, 2014, MOL ECOL, V23, P1874, DOI 10.1111/mec.12689; Machado CA, 2001, P ROY SOC B-BIOL SCI, V268, P685, DOI 10.1098/rspb.2000.1418; Michener C.D., 2007, BEES WORLD, Vsecond; Miranda EA, 2015, INSECT SOC, V62, P255, DOI 10.1007/s00040-015-0400-z; Miranda EA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164441; Fernandes CRM, 2012, BIOCHEM GENET, V50, P325, DOI 10.1007/s10528-011-9465-1; Cerantola NDM, 2011, APIDOLOGIE, V42, P214, DOI 10.1051/apido/2010055; Neves E.L., 2006, CANDOMBA REV VIRTUAL, V2, P1; Nogueira-Neto P., 1954, ARQ MUS NAC, V42, P419; NYLANDER J.A.A., 2004, MRMODELTEST 2 2 PROG; Oliveira TFFN, 2016, SOCIOBIOLOGY; Papadopoulou A, 2010, MOL BIOL EVOL, V27, P1659, DOI 10.1093/molbev/msq051; Pedro SRM, 2014, SOCIOBIOLOGY, V61, P348; Pennington RT, 2000, J BIOGEOGR, V27, P261, DOI 10.1046/j.1365-2699.2000.00397.x; Pons J, 2005, MOL BIOL EVOL, V22, P991, DOI 10.1093/molbev/msi085; Pullin AS, 2009, CONSERV BIOL, V23, P818, DOI 10.1111/j.1523-1739.2009.01283.x; Rambaut A., 2009, TRACER VERSION 1 5; Reid NM, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-196; Resende HC, 2010, BIOL J LINN SOC, V101, P949, DOI 10.1111/j.1095-8312.2010.01534.x; Sanchez-Azofeifa GA, 2005, BIOTROPICA, V37, P477, DOI 10.1111/j.1744-7429.2005.00066.x; Shapiro LH, 2006, MOL PHYLOGENET EVOL, V41, P53, DOI 10.1016/j.ympev.2006.04.006; Sheppard W.S., 1991, P89; Slaa EJ, 2006, APIDOLOGIE, V37, P293, DOI 10.1051/apido:2006022; Smith MR, 2015, LANCET, V386, P1964, DOI 10.1016/S0140-6736(15)61085-6; Tavares MG, 2010, GENET MOL BIOL, V33, P491, DOI 10.1590/S1415-47572010000300019; Werneck FP, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0368-3; Werneck FP, 2011, QUATERNARY SCI REV, V30, P1630, DOI 10.1016/j.quascirev.2011.03.009; Werneck FP, 2011, GLOBAL ECOL BIOGEOGR, V20, P272, DOI 10.1111/j.1466-8238.2010.00596.x; Wille A., 1975, Revista de Biologia Tropical, V22, P253; Wuster W, 2005, MOL ECOL, V14, P1095, DOI 10.1111/j.1365-294X.2005.02471.x; Xu X, 2016, J BIOGEOGR, V43, P1004, DOI 10.1111/jbi.12687; Zanella FCV, 2003, ECOLOGIA CONSERVAC C	75	11	11	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2017	12	4							e0175725	10.1371/journal.pone.0175725	http://dx.doi.org/10.1371/journal.pone.0175725			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0MD	28410408	Green Submitted, gold, Green Published			2022-12-27	WOS:000399955600040
J	Sohnesen, TP; Ambel, AA; Fisker, P; Andrews, C; Khan, Q				Sohnesen, Thomas Pave; Ambel, Alemayehu Azeze; Fisker, Peter; Andrews, Colin; Khan, Qaiser			Small area estimation of child undernutrition in Ethiopian woredas	PLOS ONE			English	Article							MICROLEVEL ESTIMATION; FOOD AID; NUTRITION	Reducing child undernutrition is a key social policy objective of the Ethiopian government. Despite substantial reduction over the last decade and a half, child undernutrition is still high; with 48 percent of children either stunted, underweight or wasted, undernutrition remains an important child health challenge. The existing literature highlights that targeting of efforts to reduce undernutrition in Ethiopia is inefficient, in part due to lack of data and updated information. This paper remedies some of this shortfall by estimating levels of stunting and underweight in each woreda for 2014. The estimates are small area estimations based on the 2014 Demographic and Health Survey and the latest population census. It is shown that small area estimations are powerful predictors of undernutrition, even compared to household characteristics, such as wealth and education, and hence a valuable targeting metric. The results show large variations in share of children undernourished within each region, more than between regions. The results also show that the locations with larger challenges depend on the chosen undernutrition statistic, as the share, number and concentration of undernourished children point to vastly different locations. There is also limited correlation between share of children underweight and stunted across woredas, indicating that different locations face different challenges.	[Ambel, Alemayehu Azeze; Andrews, Colin; Khan, Qaiser] World Bank, 1818 H St NW, Washington, DC 20433 USA; [Fisker, Peter] Univ Copenhagen, Dept Food & Resource Econ, Changing Disasters, Copenhagen, Denmark	The World Bank; University of Copenhagen		tpavesohnesen@worldbank.org	Sohnesen, Thomas/AAI-7255-2020	Sohnesen, Thomas/0000-0003-3942-8568; Ambel, Alemayehu/0000-0002-0990-4466	World Bank Promoting Basic Services Program Phase 3; World Bank	World Bank Promoting Basic Services Program Phase 3; World Bank(The World Bank India)	This work was funded by the World Bank Promoting Basic Services Program Phase 3. Additionally, World Bank provided support in the form of salaries for authors TS, AA, CA, and QK. The funder did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Agency CS, 2014, ETH MIN DEM HLTH SUR; Ainsworth M., 2010, WHAT CAN WE LEARN NU; Ambel AA, 2014, INT J AFRICAN DEV, V1; [Anonymous], 2014, J NUTR FOOD SCI, V4; Asfaw M, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1370-9; Ayele DG, 2016, J APPL STAT, P1, DOI DOI 10.1080/02664763.2016.11447; Ayele DG, 2015, BMC PUBLIC HEALTH, V15, P1; Bantamen G, 2014, J NUTR FOOD SCI; Christiaensen L, 2004, ECON DEV CULT CHANGE, V52, P287, DOI 10.1086/380822; Consensus C, COPENHAGEN CONSENSUS; Development MoAaR, 1998, AGR ZON DEF MAPS; Elbers C, 2003, ECONOMETRICA, V71, P355, DOI 10.1111/1468-0262.00399; Elbers C, 4513 WORLD BANK POL; Ethiopia GotFDRo, 2013, NAT NUTR PROGR JUN 2; Fujii T, 2010, WORLD BANK ECON REV, V24, P520, DOI 10.1093/wber/lhq016; Genebo T., 1999, Ethiopian Journal of Health Development, V13, P55; Gilligan DO, 2003, EVALUATION GEOGRAPHI; Girma W., 2002, DETERMINANTS NUTR ST; Haslett S., 2013, SMALL AREA ESTIMATIO; Haslett S, 2014, SMALL AREA ESTIMATIO; Haslett S, 2006, SMALL AREA ESTIMATIO, V184; Headey D., 2014, ANAL TRENDS DETERMIN; Hoddinott J, 2015, J DEV STUD, V51, P958, DOI 10.1080/00220388.2015.1018903; Kandala NB, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-261; Mekonnen A, 2005, 19 INT STUD CHILD PO; Motbainor A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133542; Negash C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142301; Pratesi M., 2016, ANAL POVERTY DATA SM; Quisumbing AR, 2003, WORLD DEV, V31, P1309, DOI 10.1016/S0305-750X(03)00067-6; Rajkumar A.S., 2011, COMBATING MALNUTRITI; Rao JN, 2015, SMALL AREA ESTIMATIO; Rogers BL, 2007, MAPPING HUNGER REPOR; Simler KR, 2006, IFPRI FOOD CONSUMPTI; Tarozzi A, 2009, REV ECON STAT, V91, P773, DOI 10.1162/rest.91.4.773; van derWeide R, 2014, ESTIMATION NORMAL MI; [WHO M. Growth Reference Study Group], 2006, WHO CHILD GROWTH STA; Yamano T, 2005, AM J AGR ECON, V87, P273, DOI 10.1111/j.1467-8276.2005.00721.x	37	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2017	12	4							e0175445	10.1371/journal.pone.0175445	http://dx.doi.org/10.1371/journal.pone.0175445			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET0MD	28410435	Green Published, gold, Green Submitted			2022-12-27	WOS:000399955600018
J	Boyd, A; Stoodley, P; Richards, D; Hui, R; Harnett, P; Vo, K; Marwick, T; Thomas, L				Boyd, Anita; Stoodley, Paul; Richards, David; Hui, Rina; Harnett, Paul; Vo, Kim; Marwick, Tom; Thomas, Liza			Anthracyclines induce early changes in left ventricular systolic and diastolic function: A single centre study	PLOS ONE			English	Article							GLOBAL LONGITUDINAL STRAIN; BREAST-CANCER; CARDIAC DYSFUNCTION; EUROPEAN ASSOCIATION; DEFORMATION INDEXES; EJECTION FRACTION; AMERICAN SOCIETY; HEART-FAILURE; FOLLOW-UP; CARDIOTOXICITY	Aims 2 dimensional (2D) strain analysis detects subclinical left ventricular (LV) systolic dysfunction. Our aim was to evaluate changes in LV systolic and diastolic function in breast cancer patients early after anthracycline chemotherapy, and to identify predisposing factors. Methods and results 140 patients were assessed by detailed echocardiography before and within seven days post treatment. LV ejection fraction (LVEF), global longitudinal strain (GLS), strain rate and radial and circumferential strain were assessed. Additionally, left atrial volumes and LV diastolic parameters were evaluated. LVEF although reduced after treatment, remained within the normal range (60 +/- 3% vs. 59 +/- 3%, p = 0.04). Triplane GLS was significantly reduced after treatment (-20.0 +/- 1.6% vs. -19.1 +/- 1.8%, p<0.001). Subclinical LV dysfunction (>11% reduction in GLS compared to before therapy) occurred in 22% (29/135). Impaired diastolic function grade significantly increased from 46% to 57% (p<0.001) after treatment. Furthermore, diastolic dysfunction was more common in the subgroup group with reduced systolic GLS compared to those without changes in GLS (30% vs. 11%; p = 0.04). No risk factors or clinical parameters were associated with the development of subclinical LV dysfunction; however the percentage change in early diastolic strain rate and the E velocity were independent predictors of >11% reduction in GLS. Conclusion Twenty two percent of patients had subclinical LV dysfunction by GLS, whilst none had cardiotoxicity defined by LVEF, demonstrating that GLS is more sensitive for detection of subclinical LV systolic dysfunction immediately after anthracycline therapy. Diastolic dysfunction increased, particularly in the group with reduced GLS, demonstrating the close pathophysiological relationship between systolic and diastolic function.	[Boyd, Anita; Stoodley, Paul; Richards, David; Vo, Kim; Thomas, Liza] Westmead Private Cardiol, Westmead, NSW, Australia; [Stoodley, Paul] Western Sydney Univ, Sch Med, Campbelltown, NSW, Australia; [Richards, David; Thomas, Liza] Univ New South Wales, Sydney South West Clin Sch, Sydney, NSW, Australia; [Hui, Rina; Harnett, Paul] Westmead Hosp, Crown Princess Mary Canc Ctr, Westmead, NSW, Australia; [Hui, Rina; Harnett, Paul; Thomas, Liza] Univ Sydney, Westmead Hosp, Sydney, NSW, Australia; [Hui, Rina; Harnett, Paul; Thomas, Liza] Univ Sydney, Westmead Clin Sch, Sydney, NSW, Australia; [Marwick, Tom] Baker IDI, Melbourne, Vic, Australia; [Marwick, Tom] Univ Tasmania, Hobart, Tas, Australia	University of Sydney; Western Sydney University; University of New South Wales Sydney; University of Sydney; University of Sydney; University of Sydney; Baker Heart and Diabetes Institute; University of Tasmania	Thomas, L (corresponding author), Westmead Private Cardiol, Westmead, NSW, Australia.; Thomas, L (corresponding author), Univ New South Wales, Sydney South West Clin Sch, Sydney, NSW, Australia.; Thomas, L (corresponding author), Univ Sydney, Westmead Hosp, Sydney, NSW, Australia.; Thomas, L (corresponding author), Univ Sydney, Westmead Clin Sch, Sydney, NSW, Australia.	l.thomas@unsw.edu.au	Hui, Rina/L-6114-2019; Harnett, Paul R/D-4090-2014; Marwick, Thomas/AAK-3869-2021	Harnett, Paul R/0000-0001-7021-0642; Marwick, Thomas/0000-0001-9065-0899; Stoodley, Paul/0000-0003-4048-5877	NHMRC (National Health and Medical Research Council) Project Grant [APP1048681]	NHMRC (National Health and Medical Research Council) Project Grant	This work was supported by the NHMRC (National Health and Medical Research Council) Project Grant (APP1048681) and was obtained (2013-2015) for research investigating the early detection of chemotherapy related cardioxicity. The funder had no role instudy design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cardinale D, 2015, CIRCULATION, V131, P1981, DOI 10.1161/CIRCULATIONAHA.114.013777; Drafts BC, 2013, JACC-CARDIOVASC IMAG, V6, P877, DOI 10.1016/j.jcmg.2012.11.017; Ewer MS, 2005, J CLIN ONCOL, V23, P2900, DOI 10.1200/JCO.2005.05.827; Farsalinos KE, 2015, J AM SOC ECHOCARDIOG, V28, P1171, DOI 10.1016/j.echo.2015.06.011; Fei HW, 2016, ECHOCARDIOGR-J CARD, V33, P519, DOI 10.1111/echo.13168; Gianni L, 2008, J CLIN ONCOL, V26, P3777, DOI 10.1200/JCO.2007.14.9401; Gianni L, 2009, J CLIN ONCOL, V27, P4798, DOI 10.1200/JCO.2008.21.4791; Gulati G, 2016, EUR HEART J, V37, P1671, DOI 10.1093/eurheartj/ehw022; Ho E, 2010, HEART, V96, P701, DOI 10.1136/hrt.2009.173997; Khasraw M, 2012, BREAST, V21, P142, DOI 10.1016/j.breast.2011.12.012; Khouri MG, 2012, CIRCULATION, V126, P2749, DOI 10.1161/CIRCULATIONAHA.112.100560; Lang RM, 2015, J AM SOC ECHOCARDIOG, V28, P1, DOI 10.1016/j.echo.2014.10.003; LEE BH, 1987, J AM COLL CARDIOL, V9, P184, DOI 10.1016/S0735-1097(87)80099-2; Mele D, 2016, HEART FAIL REV, V21, P621, DOI 10.1007/s10741-016-9564-5; Nagueh SF, 2016, J AM SOC ECHOCARDIOG, V29, P277, DOI 10.1016/j.echo.2016.01.011; Negishi K, 2014, EUR HEART J-CARD IMG, V15, P324, DOI 10.1093/ehjci/jet159; Negishi K, 2013, J AM SOC ECHOCARDIOG, V26, P493, DOI 10.1016/j.echo.2013.02.008; Neilan TG, 2006, EUR HEART J, V27, P1868, DOI 10.1093/eurheartj/ehl013; Plana JC, 2014, J AM SOC ECHOCARDIOG, V27, P911, DOI [10.1016/j.echo.2014.07.012, 10.1093/ehjci/jeu192]; Rhea IB, 2015, J AM SOC ECHOCARDIOG, V28, P667, DOI 10.1016/j.echo.2015.02.006; Sawaya H, 2012, CIRC-CARDIOVASC IMAG, V5, P596, DOI 10.1161/CIRCIMAGING.112.973321; Seicean S, 2013, CIRC-HEART FAIL, V6, P420, DOI 10.1161/CIRCHEARTFAILURE.112.000055; Serrano JM, 2015, ONCOLOGIST, V20, P864, DOI 10.1634/theoncologist.2014-0500; Singal P, 2000, MOL CELL BIOCHEM, V207, P77, DOI 10.1023/A:1007094214460; Singal PK, 1998, NEW ENGL J MED, V339, P900, DOI 10.1056/NEJM199809243391307; STODDARD MF, 1992, J AM COLL CARDIOL, V20, P62, DOI 10.1016/0735-1097(92)90138-D; Stoodley PW, 2013, EUR J CANCER, V49, P3396, DOI 10.1016/j.ejca.2013.06.046; Stoodley PW, 2013, EUR HEART J-CARD IMG, V14, P228, DOI 10.1093/ehjci/jes139; Stoodley PW, 2011, EUR J ECHOCARDIOGR, V12, P945, DOI 10.1093/ejechocard/jer187; Sysa-Shah P, 2016, CARDIOVASC RES, V109, P358, DOI 10.1093/cvr/cvv274; Tan TC, 2015, J AM SOC ECHOCARDIOG, V28, P509, DOI 10.1016/j.echo.2015.02.001; Thavendiranathan P, 2016, J CLIN ONCOL, V34, P2238, DOI 10.1200/JCO.2015.65.1505; Thavendiranathan P, 2014, J AM COLL CARDIOL, V63, P2751, DOI 10.1016/j.jacc.2014.01.073	33	42	46	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2017	12	4							e0175544	10.1371/journal.pone.0175544	http://dx.doi.org/10.1371/journal.pone.0175544			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0MB	28407011	Green Accepted, Green Published, gold			2022-12-27	WOS:000399955400067
J	Guibert, M; Gasser, A; Kempf, H; Bianchi, A				Guibert, Mathilde; Gasser, Adeline; Kempf, Herve; Bianchi, Arnaud			Fibroblast-growth factor 23 promotes terminal differentiation of ATDC5 cells	PLOS ONE			English	Article							SIGNALING PATHWAYS; PROLIFERATION; RECEPTOR; KLOTHO; FGF23	Objectives Fibroblast Growth Factor 23 (FGF23) is well documented as a crucial player in the systemic regulation of phosphate homeostasis. Moreover, loss-of-function experiments have revealed that FGF23 also has a phosphate-independent and local impact on skeletogenesis. Here, we used ATDC5 cell line to investigate the expression of FGF23 and the role it may play locally during the differentiation of these cells. Methods ATDC5 cells were differentiated in the presence of insulin, and treated with recombinant FGF23 (rFGF23), inorganic phosphate (Pi) and/or PD173074, an inhibitor of FGF receptors (FGFRs). The mRNA expressions of FGF23, FGFRs and markers of hypertophy, Col X and MMP13, were determined by qPCR analysis and FGF23 production was assessed by ELISA. FGFR activation was determined by immunoprecipitation and immunoblotting. Results FGF23 mRNA expression and production were increased during ATDC5 differentiation. At D28 in particular, rFGF23 stimulation increased hypertrophic markers expression, as Col X and MMP13, and mineralization. A synergic effect of Pi and rFGF23 stimulation was observed on these markers and on the mineralization process. The use of PD173074, a pan-FGFR inhibitor, decreased terminal differentiation of ATDC5 by preventing rFGF23 pro-hypertrophic effects. Conclusions Altogether, our results provide evidence that FGF23 plays an important role during differentiation of ATDC5 cell line, by promoting both hypertrophy and mineralization.	[Guibert, Mathilde; Gasser, Adeline; Kempf, Herve; Bianchi, Arnaud] Univ Lorraine Ingn Mol & Physiopathol Articulaire, UMR 7365, CNRS, Biopole Univ Lorraine, Campus Biol Sante, Vandoeuvre Les Nancy, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Universite de Lorraine	Guibert, M; Bianchi, A (corresponding author), Univ Lorraine Ingn Mol & Physiopathol Articulaire, UMR 7365, CNRS, Biopole Univ Lorraine, Campus Biol Sante, Vandoeuvre Les Nancy, France.	mathilde.guibert@univ-lorraine.fr; arnaud.bianchi@univ-lorraine.fr	bianchi, arnaud/AAY-7059-2021; Kempf, Herve/F-1171-2011	bianchi, arnaud/0000-0003-4925-5269; Kempf, Herve/0000-0003-1818-2327; Reboul, Pascal/0000-0003-3546-2152; GASSER, Adeline/0000-0003-2678-327X	Bonus "Qualite Recherche, Universite de Lorraine"; Bonus "Region Lorraine"	Bonus "Qualite Recherche, Universite de Lorraine"; Bonus "Region Lorraine"	The research leading to these results was supported by grants from Bonus "Qualite Recherche, Universite de Lorraine" and "Region Lorraine." MG received a price from the "Societe Frangaise de Biologie des Tissus Mineralises" at the annual JFBTM meeting.	ATSUMI T, 1990, CELL DIFFER DEV, V30, P109, DOI 10.1016/0922-3371(90)90079-C; Barnard JC, 2005, ENDOCRINOLOGY, V146, P5568, DOI 10.1210/en.2005-0762; Bianchi A, 2016, OSTEOARTHR CARTIL; Challa TD, 2010, MOL CELL ENDOCRINOL, V323, P282, DOI 10.1016/j.mce.2010.03.025; Fujita T, 2001, JPN J PHARMACOL, V85, P278, DOI 10.1254/jjp.85.278; Goldring MB, 2012, THER ADV MUSCULOSKEL, V4, P269, DOI 10.1177/1759720X12448454; Grabner A, 2015, CELL METAB, V22, P1020, DOI 10.1016/j.cmet.2015.09.002; Kawai M, 2013, J BIOL CHEM, V288, P2414, DOI 10.1074/jbc.M112.410043; Kim HJ, 2010, BONE, V47, P657, DOI 10.1016/j.bone.2010.06.018; Leifheit-Nestler M, 2016, NEPHROL DIAL TRANSPL, V31, P1088, DOI 10.1093/ndt/gfv421; Ornitz DM, 2015, WIRES DEV BIOL, V4, P215, DOI 10.1002/wdev.176; Ornitz DM, 2002, GENE DEV, V16, P1446, DOI 10.1101/gad.990702; Pallu S, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3048; Raimann A, 2013, CONNECT TISSUE RES, V54, P108, DOI 10.3109/03008207.2012.753879; Shimizu A, 2002, BIOCHEM BIOPH RES CO, V290, P113, DOI 10.1006/bbrc.2001.6190; Shimizu A, 2001, J BIOL CHEM, V276, P11031, DOI 10.1074/jbc.M003535200; Singh S., 2016, KIDNEY INT; Sitara D, 2004, MATRIX BIOL, V23, P421, DOI 10.1016/j.matbio.2004.09.007; Sitara D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000154; Urakawa I, 2006, NATURE, V444, P770, DOI 10.1038/nature05315	20	6	7	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2017	12	4							e0174969	10.1371/journal.pone.0174969	http://dx.doi.org/10.1371/journal.pone.0174969			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0MB	28406928	Green Submitted, gold, Green Published			2022-12-27	WOS:000399955400024
J	Hyer, MM; Glasper, ER				Hyer, Molly M.; Glasper, Erica R.			Separation increases passive stress-coping behaviors during forced swim and alters hippocampal dendritic morphology in California mice	PLOS ONE			English	Article							MEDIAL PREFRONTAL CORTEX; DEPRESSION-LIKE BEHAVIOR; CELL-PROLIFERATION; PYRAMIDAL NEURONS; PEROMYSCUS-CALIFORNICUS; PATERNAL BEHAVIOR; POSTPARTUM PERIOD; APICAL DENDRITES; BIPARENTAL CARE; SPINE DENSITY	Individuals within monogamous species form bonds that may buffer against the negative effects of stress on physiology and behavior. In some species, involuntary termination of the mother-offspring bond results in increased symptoms of negative affect in the mother, suggesting that the parent-offspring bond may be equally as important as the pair bond. To our knowledge, the extent to which affect in paternal rodents is altered by involuntary termination of the father-offspring bond is currently unknown. Here, we investigated to what extent separation and paternal experience alters passive stress-coping behaviors and dendritic morphology in hippocampal subfields of California mice (Peromyscus californicus). Irrespective of paternal experience, separated mice displayed shorter latencies to the first bout of immobility, longer durations of immobility, and more bouts of immobility than control (non-separated) mice. This effect of separation was exacerbated by paternal experience in some measures of behavioral despair D separation from offspring further decreased the latency to immobility and increased bouts of immobility. In the dentate gyrus, separation reduced dendritic spine density regardless of paternal experience. Increased spine density was observed on CA1 basal, but not apical, dendrites following paternal experience. Regardless of offspring presence, fatherhood was associated with reduced apical dendritic spine density in area CA3 of the hippocampus. Separation enhanced complexity of both basal and apical dendrites in CA1, while fatherhood reduced dendritic complexity in this region. Our data suggest that forced dissolution of the pair bond induces passive stress-coping behaviors and contributes to region-specific alterations in hippocampal structure in California mouse males.	[Hyer, Molly M.; Glasper, Erica R.] Univ Maryland, Program Neurosci & Cognit Sci, College Pk, MD 20742 USA; [Glasper, Erica R.] Univ Maryland, Dept Psychol, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park	Glasper, ER (corresponding author), Univ Maryland, Program Neurosci & Cognit Sci, College Pk, MD 20742 USA.; Glasper, ER (corresponding author), Univ Maryland, Dept Psychol, College Pk, MD 20742 USA.	eglasper@umd.edu	GLASPER, ERICA/GOK-0082-2022	GLASPER, ERICA/0000-0003-1938-2144; Hyer, Molly/0000-0001-7687-2030	University of Maryland	University of Maryland	This research was supported by the University of Maryland. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahern TH, 2011, DEV PSYCHOBIOL, V53, P118, DOI 10.1002/dev.20498; Bannerman DM, 2003, BEHAV BRAIN RES, V139, P197, DOI 10.1016/S0166-4328(02)00268-1; Benjamin Y, 1995, J R STAT SOC; Bester-Meredith JK, 1999, HORM BEHAV, V36, P25, DOI 10.1006/hbeh.1999.1522; Boccia ML, 2007, PSYCHONEUROENDOCRINO, V32, P65, DOI 10.1016/j.psyneuen.2006.10.004; Bogdanova OV, 2013, PHYSIOL BEHAV, V118, P227, DOI 10.1016/j.physbeh.2013.05.012; Bogels SM, 2008, COGNITION EMOTION, V22, P522, DOI 10.1080/02699930801886706; Bosch OJ, 2009, NEUROPSYCHOPHARMACOL, V34, P1406, DOI 10.1038/npp.2008.154; Bredy TW, 2007, EUR J NEUROSCI, V25, P567, DOI 10.1111/j.1460-9568.2006.05266.x; Can A, 2012, JOVE-J VIS EXP, DOI 10.3791/3638; Castro WLR, 1997, PHYSIOL BEHAV, V61, P477, DOI 10.1016/S0031-9384(96)00456-8; CONNOR JR, 1982, J COMP NEUROL, V210, P99, DOI 10.1002/cne.902100111; de Kloet ER, 2016, HINDAWI PUBLISHING C, V2016, P1, DOI DOI 10.1155/2016/6503162; DeVries AC, 2003, PHYSIOL BEHAV, V79, P399, DOI 10.1016/S0031-9384(03)00152-5; Furuta M, 2009, BRAIN RES BULL, V80, P408, DOI 10.1016/j.brainresbull.2009.08.011; Galea LAM, 1997, NEUROSCIENCE, V81, P689, DOI 10.1016/S0306-4522(97)00233-9; Glasper ER, 2011, BEHAV BRAIN RES; Glasper ER, 2016, BRAIN BEHAV, V6, DOI 10.1002/brb3.416; Glasper ER, 2011, J COMP NEUROL, V519, P2271, DOI 10.1002/cne.22628; GOULD E, 1990, J NEUROSCI, V10, P1286; Grippo AJ, 2007, PSYCHONEUROENDOCRINO, V32, P966, DOI 10.1016/j.psyneuen.2007.07.004; Grippo Angela J, 2008, Depress Anxiety, V25, pE17, DOI 10.1002/da.20375; Groer MW, 2005, BIOL RES NURS, V7, P106, DOI 10.1177/1099800405280936; GUBERNICK DJ, 1987, J COMP PSYCHOL, V101, P169, DOI 10.1037/0735-7036.101.2.169; GUBERNICK DJ, 1989, HORM BEHAV, V23, P203, DOI 10.1016/0018-506X(89)90061-5; GUBERNICK DJ, 1993, ANIM BEHAV, V46, P539, DOI 10.1006/anbe.1993.1221; Hyer MM, 2016, EUR J NEUROSCI, P1; Kheirbek MA, 2013, NEURON, V77, P955, DOI 10.1016/j.neuron.2012.12.038; Kikusui T, 2006, PHILOS T R SOC B, V361, P2215, DOI 10.1098/rstb.2006.1941; Kim P, 2010, BEHAV NEUROSCI, V124, P695, DOI 10.1037/a0020884; Kim Pilyoung, 2014, SOCIAL NEUROSCIENCE, V9, P1; Kjelstrup KG, 2002, P NATL ACAD SCI USA, V99, P10825, DOI 10.1073/pnas.152112399; Leuner B, 2007, HIPPOCAMPUS, V17, P434, DOI 10.1002/hipo.20278; Leuner B, 2010, TRENDS NEUROSCI, V33, P465, DOI 10.1016/j.tins.2010.07.003; Leuner B, 2010, J NEUROSCI, V30, P13499, DOI 10.1523/JNEUROSCI.3388-10.2010; Lieberwirth C, 2016, CURR OPIN NEUROBIOL, V40, P8, DOI 10.1016/j.conb.2016.05.006; Lieberwirth C, 2012, HORM BEHAV, V62, P357, DOI 10.1016/j.yhbeh.2012.03.005; Lim MM, 2006, HORM BEHAV, V50, P506, DOI 10.1016/j.yhbeh.2006.06.028; Lonstein JS, 2005, HORM BEHAV, V47, P241, DOI 10.1016/j.yhbeh.2004.11.001; Macbeth AH, 2008, HORM BEHAV, V54, P7, DOI 10.1016/j.yhbeh.2007.08.011; MAGARINOS AM, 1995, NEUROSCIENCE, V69, P89, DOI 10.1016/0306-4522(95)00259-L; Maniam J, 2010, BEHAV BRAIN RES, V208, P72, DOI 10.1016/j.bbr.2009.11.005; Machado MCM, 2014, REV SAUDE PUBL, V48, P985, DOI [10.1590/S0034-8910.2014048005340, 10.1590/s0034-8910.2014048005340]; McCabe T.T., 1950, 3 SPECIES PEROMYSCUS; McEwen BS, 1997, EUR NEUROPSYCHOPHARM, V7, P323, DOI 10.1016/S0924-977X(97)00064-3; McGraw LA, 2010, TRENDS NEUROSCI, V33, P103, DOI 10.1016/j.tins.2009.11.006; Moller EL, 2016, CLIN PSYCHOL REV, V45, P17, DOI 10.1016/j.cpr.2016.03.002; Moser MB, 1997, J COMP NEUROL, V380, P373, DOI 10.1002/(SICI)1096-9861(19970414)380:3<373::AID-CNE6>3.0.CO;2-#; Murray Lynne, 2014, Community Pract, V87, P34; Norcross JL, 1999, AM J PRIMATOL, V47, P209; Pawluski JL, 2007, NEUROSCIENCE, V149, P53, DOI 10.1016/j.neuroscience.2007.07.031; Pawluski JL, 2006, J NEUROBIOL, V66, P71, DOI 10.1002/neu.20194; Pawuski JL, 2009, BEHAV BRAIN RES, V197, P55, DOI 10.1016/j.bbr.2008.08.001; Petit-Demouliere B, 2005, PSYCHOPHARMACOLOGY, V177, P245, DOI 10.1007/s00213-004-2048-7; PORSOLT RD, 1977, ARCH INT PHARMACOD T, V229, P327; Ramchandani P, 2009, LANCET, V374, P646, DOI 10.1016/S0140-6736(09)60238-5; RIBBLE DO, 1990, BEHAV ECOL SOCIOBIOL, V26, P9; RIBBLE DO, 1991, BEHAV ECOL SOCIOBIOL, V29, P161, DOI 10.1007/BF00166397; Rilling JK, 2014, SCIENCE, V345, P771, DOI 10.1126/science.1252723; Ruscio MG, 2008, BEHAV BRAIN RES, V187, P9, DOI 10.1016/j.bbr.2007.08.028; Ruscio MG, 2015, PHYSIOL BEHAV, V151, P570, DOI 10.1016/j.physbeh.2015.08.039; Silva-Gomez AB, 2003, BRAIN RES, V983, P128, DOI 10.1016/S0006-8993(03)03042-7; Sun P, 2014, BEHAV BRAIN RES; Sung YH, 2010, NEUROSCI LETT, V470, P86, DOI 10.1016/j.neulet.2009.12.063; Swain JE, 2011, PROG NEURO-PSYCHOPH, V35, P1242, DOI 10.1016/j.pnpbp.2010.10.017; Wang YC, 2012, BRAIN STRUCT FUNCT, V217, P337, DOI 10.1007/s00429-011-0355-4; WATANABE Y, 1992, BRAIN RES, V588, P341, DOI 10.1016/0006-8993(92)91597-8; WOOLLEY CS, 1990, BRAIN RES, V531, P225, DOI 10.1016/0006-8993(90)90778-A; Workman JL, 2013, J NEUROENDOCRINOL, V25, P119, DOI 10.1111/j.1365-2826.2012.02380.x	69	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2017	12	4							e0175713	10.1371/journal.pone.0175713	http://dx.doi.org/10.1371/journal.pone.0175713			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0MB	28406977	gold, Green Published, Green Submitted			2022-12-27	WOS:000399955400086
J	Melendez, MJ; Baez, JC; Serna-Quintero, JM; Caminas, JA; Fernandez, ID; Real, R; Macias, D				Jose Melendez, Maria; Carlos Baez, Jose; Miguel Serna-Quintero, Jose; Antonio Caminas, Juan; de Loyola Fernandez, Ignacio; Real, Raimundo; Macias, David			Historical and ecological drivers of the spatial pattern of Chondrichthyes species richness in the Mediterranean Sea	PLOS ONE			English	Article							BIOGEOGRAPHY; DIVERSITY	Chondrichthyes, which include Elasmobranchii (sharks and batoids) and Holocephali (chimaeras), are a relatively small group in the Mediterranean Sea (89 species) playing a key role in the ecosystems where they are found. At present, many species of this group are threatened as a result of anthropogenic effects, including fishing activity. Knowledge of the spatial distribution of these species is of great importance to understand their ecological role and for the efficient management of their populations, particularly if affected by fisheries. This study aims to analyze the spatial patterns of the distribution of Chondrichthyes species richness in the Mediterranean Sea. Information provided by the studied countries was used to model geographical and ecological variables affecting the Chondrichthyes species richness. The species were distributed in 16 Operational Geographical Units (OGUs), derived from the Geographical Sub-Areas (GSA) adopted by the General Fisheries Commission of the Mediterranean Sea (GFCM). Regression analyses with the species richness as a target variable were adjusted with a set of environmental and geographical variables, being the model that links richness of Chondrichthyes species with distance to the Strait of Gibraltar and number of taxonomic families of bony fishes the one that best explains it. This suggests that both historical and ecological factors affect the current distribution of Chondrichthyes within the Mediterranean Sea.	[Jose Melendez, Maria; Miguel Serna-Quintero, Jose; Antonio Caminas, Juan; Macias, David] IEO, Ctr Oceanog Malaga, Fuengirola, Spain; [Jose Melendez, Maria; de Loyola Fernandez, Ignacio; Real, Raimundo] Univ Malaga, Dept Biol Anim, Malaga, Spain; [Carlos Baez, Jose] IEO, Ctr Oceanog Canarias, Santa Cruz De Tenerife, Spain; [Carlos Baez, Jose] Univ Autonoma Chile, Fac Ciencias Salud, Santiago, Chile	Spanish Institute of Oceanography; Universidad de Malaga; Spanish Institute of Oceanography; Universidad Autonoma de Chile	Baez, JC (corresponding author), IEO, Ctr Oceanog Canarias, Santa Cruz De Tenerife, Spain.; Baez, JC (corresponding author), Univ Autonoma Chile, Fac Ciencias Salud, Santiago, Chile.	granbaez_29@hotmail.com	Real, Raimundo/E-6559-2010; Baez, Jose C/I-2644-2013	Real, Raimundo/0000-0002-6642-1284; Baez, Jose C/0000-0003-2049-0409; Macias, David/0000-0003-3054-2858				Battisti C, 2014, J NAT HIST, V48, P2701, DOI 10.1080/00222933.2014.925599; Baum JK, 2003, SCIENCE, V299, P389, DOI 10.1126/science.1079777; Bilecenoglu Murat, 2002, Zootaxa, V113, P1; Bradai M. N., 2012, ELASMOBRANCHS MEDITE; BUSACK SD, 1984, AM NAT, V123, P266, DOI 10.1086/284201; Cavanagh R.D., 2007, OVERVIEW CONSERVATIO; Coll M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011842; CROVELLO TJ, 1981, TAXON, V30, P563, DOI 10.2307/1219938; Dulvy NK, 2014, ELIFE, V3, DOI 10.7554/eLife.00590; Garcia-Castellanos D, 2009, NATURE, V462, P778, DOI 10.1038/nature08555; Gray JS, 2001, SCI MAR, V65, P41, DOI 10.3989/scimar.2001.65s241; Hassan Mohamad, 2013, Marine Biodiversity Records, V6, pe7, DOI 10.1017/S175526721200111X; HSU KJ, 1977, NATURE, V267, P399, DOI 10.1038/267399a0; LEGENDRE P, 1993, ECOLOGY, V74, P1659, DOI 10.2307/1939924; Macias D, 2005, P INT WORKSH MED CAR, P194; Mancini PL, 2015, IUCN RED LIST THREAT, V2015; Nunez NE Garcia, 2008, TIBURONES CONSERVACI; Real R., 1992, Monografias de Herpetologia, V2, P85; Rodriguez J., 1982, OCEANOGRAF MAR MEDIT; Romero D., 2015, ECOGRAPHY, V38, P001; Saad Adib, 2004, Rapport du Congress de la CIESM, V37, P430; Serena F., 2005, FIELD IDENTIFICATION; Shark Species Group Intersessional, 2016, 2016 INT M SHARK SPE; TAYLOR RJ, 1978, AM NAT, V112, P583, DOI 10.1086/283299; Tobuni Ibrahim M., 2016, Marine Biodiversity Records, V9, P94, DOI 10.1186/s41200-016-0089-3; Zar J. H., 1996, BIOSTATISTICAL ANAL	26	8	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2017	12	4							e0175699	10.1371/journal.pone.0175699	http://dx.doi.org/10.1371/journal.pone.0175699			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0MB	28406963	Green Published, gold, Green Submitted			2022-12-27	WOS:000399955400084
J	Song, HB; Jun, HO; Kim, JH; Lee, YH; Choi, MH; Kim, JH				Song, Hyun Beom; Jun, Hyoung-Oh; Kim, Jin Hyoung; Lee, Young-Ha; Choi, Min-Ho; Kim, Jeong Hun			Disruption of outer blood-retinal barrier by Toxoplasma gondii-infected monocytes is mediated by paracrinely activated FAK signaling	PLOS ONE			English	Article							PIGMENT EPITHELIAL-CELLS; EXPERIMENTAL AUTOIMMUNE UVEORETINITIS; TIGHT JUNCTION; OCULAR TOXOPLASMOSIS; GROWTH-FACTOR; TRANSEPITHELIAL MIGRATION; PROTEIN; TACHYZOITES; MECHANISMS; EXPRESSION	Ocular toxoplasmosis is mediated by monocytes infected with Toxoplasma gondii that are disseminated to target organs. Although infected monocytes can easily access to outer blood-retinal barrier due to leaky choroidal vasculatures, not much is known about the effect of T. gondii-infected monocytes on outer blood-retinal barrier. We prepared human monocytes, THP-1, infected with T. gondii and human retinal pigment epithelial cells, ARPE-19, grown on transwells as an in vitro model of outer blood-retinal barrier. Exposure to infected monocytes resulted in disruption of tight junction protein, ZO-1, and decrease in transepithelial electrical resistance of retinal pigment epithelium. Supernatants alone separated from infected monocytes also decreased transepithelial electrical resistance and disrupted tight junction protein. Further investigation revealed that the supernatants could activate focal adhesion kinase (FAK) signaling in retinal pigment epithelium and the disruption was attenuated by FAK inhibitor. The disrupted barrier was partly restored by blocking CXCL8, a FAK activating factor secreted by infected monocytes. In this study, we demonstrated that monocytes infected with T. gondii can disrupt outer blood-retinal barrier, which is mediated by paracrinely activated FAK signaling. FAK signaling can be a target of therapeutic approach to prevent negative influence of infected monocytes on outer blood-retinal barrier.	[Song, Hyun Beom; Jun, Hyoung-Oh; Kim, Jin Hyoung; Kim, Jeong Hun] Seoul Natl Univ Hosp, Biomed Res Inst, Fight Angiogenesis Related Blindness FARB Lab, Seoul, South Korea; [Song, Hyun Beom; Kim, Jeong Hun] Seoul Natl Univ, Dept Biomed Sci, Coll Med, Seoul, South Korea; [Song, Hyun Beom; Choi, Min-Ho] Seoul Natl Univ, Dept Parasitol & Trop Med, Coll Med, Seoul, South Korea; [Song, Hyun Beom; Choi, Min-Ho] Seoul Natl Univ, Inst Endem Dis, Med Res Ctr, Seoul, South Korea; [Lee, Young-Ha] Chungnam Natl Univ, Sch Med, Dept Infect Biol, Daejeon, South Korea; [Kim, Jeong Hun] Seoul Natl Univ, Dept Ophthalmol, Coll Med, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Chungnam National University; Seoul National University (SNU)	Kim, JH (corresponding author), Seoul Natl Univ Hosp, Biomed Res Inst, Fight Angiogenesis Related Blindness FARB Lab, Seoul, South Korea.; Kim, JH (corresponding author), Seoul Natl Univ, Dept Biomed Sci, Coll Med, Seoul, South Korea.; Choi, MH (corresponding author), Seoul Natl Univ, Dept Parasitol & Trop Med, Coll Med, Seoul, South Korea.; Choi, MH (corresponding author), Seoul Natl Univ, Inst Endem Dis, Med Res Ctr, Seoul, South Korea.; Kim, JH (corresponding author), Seoul Natl Univ, Dept Ophthalmol, Coll Med, Seoul, South Korea.	mhchoi@snu.ac.kr; steph25@snu.ac.kr		Kim, Jeong Hun/0000-0003-2957-1766; Song, Hyun Beom/0000-0002-3500-2984	Seoul National University Hospital Research Grant [04-2015-0270]; Pioneer Research Program of the National Research Foundation of Korea/Ministry of Education, Science and Technology [2012-0009544]; Bio & Medical Technology Development Program of the National Research Foundation - Korean government, MSIP [2015M3A9E6028949]; Development of Platform Technology for Innovative Medical Measurements Program from the Korea Research Institute of Standards and Science [KRISS-2016-16011064]	Seoul National University Hospital Research Grant; Pioneer Research Program of the National Research Foundation of Korea/Ministry of Education, Science and Technology; Bio & Medical Technology Development Program of the National Research Foundation - Korean government, MSIP; Development of Platform Technology for Innovative Medical Measurements Program from the Korea Research Institute of Standards and Science	This study was supported by Seoul National University Hospital Research Grant (04-2015-0270), the Pioneer Research Program of the National Research Foundation of Korea/Ministry of Education, Science and Technology (2012-0009544), the Bio & Medical Technology Development Program of the National Research Foundation funded by the Korean government, MSIP (2015M3A9E6028949), and the Development of Platform Technology for Innovative Medical Measurements Program from the Korea Research Institute of Standards and Science (KRISS-2016-16011064).	Barragan A, 2005, CELL MICROBIOL, V7, P561, DOI 10.1111/j.1462-5822.2005.00486.x; Barragan A, 2002, J EXP MED, V195, P1625, DOI 10.1084/jem.20020258; Braakenburg A, 2016, UVEITIS AN UPDATE, P1; Chaussabel D, 2003, BLOOD, V102, P672, DOI 10.1182/blood-2002-10-3232; Choi SH, 2011, ACTA OPHTHALMOL, V89, pE350, DOI 10.1111/j.1755-3768.2011.02113.x; Cohen-Hillel E, 2006, CYTOKINE, V33, P1, DOI 10.1016/j.cyto.2005.11.006; Courret N, 2006, BLOOD, V107, P309, DOI 10.1182/blood-2005-02-0666; DAVIDSON MG, 1993, INVEST OPHTH VIS SCI, V34, P3653; Dunn KC, 1996, EXP EYE RES, V62, P155, DOI 10.1006/exer.1996.0020; El Hajj H, 2007, PLOS PATHOG, V3, P200, DOI 10.1371/journal.ppat.0030014; Furtado JM, 2012, IMMUNOL CELL BIOL, V90, P912, DOI 10.1038/icb.2012.21; GREENWOOD J, 1994, LAB INVEST, V70, P39; Ivey NS, 2009, J NEUROVIROL, V15, P312, DOI 10.1080/13550280902998413; Joly S, 2009, AM J PATHOL, V174, P2310, DOI 10.2353/ajpath.2009.090023; Kim K, 2001, MOL BIOCHEM PARASIT, V113, P309, DOI 10.1016/S0166-6851(01)00212-2; Lee SS, 2009, CURR OPIN OPHTHALMOL, V20, P511, DOI 10.1097/ICU.0b013e328330ccb9; Leung KW, 2009, MOL IMMUNOL, V46, P1374, DOI 10.1016/j.molimm.2008.12.001; Luna JD, 1997, J NEUROSCI RES, V49, P268, DOI 10.1002/(SICI)1097-4547(19970801)49:3<268::AID-JNR2>3.0.CO;2-A; Ma YJ, 2013, BBA-MOL BASIS DIS, V1832, P151, DOI 10.1016/j.bbadis.2012.10.006; Maenz M, 2014, PROG RETIN EYE RES, V39, P77, DOI 10.1016/j.preteyeres.2013.12.005; Nagineni CN, 2002, CLIN EXP IMMUNOL, V128, P372, DOI 10.1046/j.1365-2249.2002.01815.x; Nagineni CN, 1996, INFECT IMMUN, V64, P4188, DOI 10.1128/IAI.64.10.4188-4196.1996; Norose K, 2003, INVEST OPHTH VIS SCI, V44, P4375, DOI 10.1167/iovs.03-0156; Park SW, 2015, ONCOTARGET, V6, P35263, DOI 10.18632/oncotarget.5894; Robert-Gangneux F, 2012, CLIN MICROBIOL REV, V25, P264, DOI 10.1128/CMR.05013-11; Schaller MD, 2010, J CELL SCI, V123, P1007, DOI 10.1242/jcs.045112; Shechter R, 2013, NAT REV IMMUNOL, V13, P206, DOI 10.1038/nri3391; Shi G, 2008, INVEST OPHTH VIS SCI, V49, P4620, DOI 10.1167/iovs.08-1816; Sieg DJ, 2000, NAT CELL BIOL, V2, P249, DOI 10.1038/35010517; Slack-Davis JK, 2007, J BIOL CHEM, V282, P14845, DOI 10.1074/jbc.M606695200; Su LL, 2011, P NATL ACAD SCI USA, V108, P19623, DOI 10.1073/pnas.1111414108; Tedesco RC, 2004, PARASITOL RES, V92, P467, DOI 10.1007/s00436-003-1031-2; TSUCHIYA S, 1980, INT J CANCER, V26, P171, DOI 10.1002/ijc.2910260208; Unno A, 2008, PARASITOL INT, V57, P515, DOI 10.1016/j.parint.2008.06.004; Van Grol J, 2013, INFECT IMMUN, V81, P2002, DOI 10.1128/IAI.01145-12; Xu HP, 2005, INVEST OPHTH VIS SCI, V46, P2487, DOI 10.1167/iovs.04-1333	36	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2017	12	4							e0175159	10.1371/journal.pone.0175159	http://dx.doi.org/10.1371/journal.pone.0175159			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0MB	28406972	Green Submitted, gold, Green Published			2022-12-27	WOS:000399955400031
J	Balasubramanian, P; Kinders, RJ; Kummar, S; Gupta, V; Hasegawa, D; Menachery, A; Lawrence, SM; Wang, LH; Ferry-Galow, K; Davis, D; Parchment, RE; Tomaszewski, JE; Doroshow, JH				Balasubramanian, Priya; Kinders, Robert J.; Kummar, Shivaani; Gupta, Vishal; Hasegawa, David; Menachery, Anoop; Lawrence, Scott M.; Wang, Lihua; Ferry-Galow, Katherine; Davis, Darren; Parchment, Ralph E.; Tomaszewski, Joseph E.; Doroshow, James H.			Antibody-independent capture of circulating tumor cells of non-epithelial origin with the ApoStream (R) system	PLOS ONE			English	Article							SOFT PART SARCOMA; FIELD-FLOW FRACTIONATION; CANCER; DIELECTROPHORESIS; NEOPLASMS; SURVIVAL; BLOOD; TFE3; GENE; HEAD	Circulating tumor cells (CTCs) are increasingly employed for research and clinical monitoring of cancer, though most current methods do not permit the isolation of non-epithelial tumor cells. Furthermore, CTCs isolated with antibody-dependent methods are not suitable for downstream experimental uses, including in vitro culturing and implantation in vivo. In the present study, we describe the development, validation, and transfer across laboratories of a new antibody-independent device for the enrichment of CTCs from blood samples of patients with various cancer diagnoses. The ApoStream (R) device uses dielectrophoresis (DEP) field-flow assist to separate non-hematopoietic cells from the peripheral blood mononuclear fraction by exposing cells in a laminar flow stream to a critical alternating current frequency. The ApoStream (R) device was calibrated and validated in a formal cross-laboratory protocol using 3 different cancer cell lines spanning a range of distinct phenotypes (A549, MDA-MB-231, and ASPS-1). In spike-recovery experiments, cancer cell recovery efficiencies appeared independent of spiking level and averaged between 68% and 55%, depending on the cell line. No inter-run carryover was detected in control samples. Moreover, the clinical-readiness of the device in the context of non-epithelial cancers was evaluated with blood specimens from fifteen patients with metastatic sarcoma. The ApoStream (R) device successfully isolated CTCs from all patients with sarcomas examined, and the phenotypic heterogeneity of the enriched cells was demonstrated by fluorescence in situ hybridization or with multiplex immunophenotyping panels. Therefore, the ApoStream (R) technology expands the clinical utility of CTC evaluation to mesenchymal cancers.	[Balasubramanian, Priya; Kinders, Robert J.; Lawrence, Scott M.; Wang, Lihua; Ferry-Galow, Katherine; Parchment, Ralph E.] Leidos Biomed Res Inc, Frederick Natl Lab Canc Res, Lab Human Toxicol & Pharmacol, Applied Dev Res Support Directorate, Frederick, MD 21701 USA; [Kummar, Shivaani; Tomaszewski, Joseph E.; Doroshow, James H.] NCI, Div Canc Treatment & Diag, Bethesda, MD 20892 USA; [Gupta, Vishal; Hasegawa, David; Menachery, Anoop; Davis, Darren] ApoCell Inc, Houston, TX USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Parchment, RE (corresponding author), Leidos Biomed Res Inc, Frederick Natl Lab Canc Res, Lab Human Toxicol & Pharmacol, Applied Dev Res Support Directorate, Frederick, MD 21701 USA.	parchmentr@mail.nih.gov			National Cancer Institute, National Institutes of Health [HHSN261200800001E]; federal government; NATIONAL CANCER INSTITUTE [ZIABC011078] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); federal government; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project has been funded in whole or in part with federal funds from the National Cancer Institute, National Institutes of Health, under Contract No. HHSN261200800001E. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government. The Frederick National Laboratory for Cancer Research, which is funded by the federal government and operated by Leidos Biomedical Research, Inc., provided support in the form of salaries for authors P.B., R.J.K., S.M.L., L.W., K.F.G., and R.E.P., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Leidos Biomedical Research, Inc. is the prime contractor for the operation of Frederick National Laboratory and is therefore precluded from conducting any business that represents a conflict of interest with this contract. ApoCell, Inc provided support in the form of salaries for authors V.G., D.H., A.M., and D.D, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of all authors are articulated in the 'author contributions' section.	Argani P, 2003, AM J SURG PATHOL, V27, P750, DOI 10.1097/00000478-200306000-00005; Balasubramanian P, 2014, CANCER RES, V74; Cohen SJ, 2008, J CLIN ONCOL, V26, P3213, DOI 10.1200/JCO.2007.15.8923; de Bono JS, 2008, CLIN CANCER RES, V14, P6302, DOI 10.1158/1078-0432.CCR-08-0872; Gascoyne PRC, 2014, CANCERS, V6, P545, DOI 10.3390/cancers6010545; Gascoyne PRC, 2013, ELECTROPHORESIS, V34, P1042, DOI 10.1002/elps.201200496; Gascoyne PRC, 2009, ELECTROPHORESIS, V30, P1388, DOI 10.1002/elps.200800373; Gupta V, 2012, BIOMICROFLUIDICS, V6, DOI 10.1063/1.4731647; Hodgkinson CL, 2014, NAT MED, V20, P897, DOI 10.1038/nm.3600; Jatana KR, 2010, ARCH OTOLARYNGOL, V136, P1274, DOI 10.1001/archoto.2010.223; Kenney S, 2011, J PEDIAT HEMATOL ONC, V33, P360, DOI 10.1097/MPH.0b013e3182002f9f; Kim MY, 2009, CELL, V139, P1315, DOI 10.1016/j.cell.2009.11.025; Kosemehmetoglu K, 2009, MODERN PATHOL, V22, P872, DOI 10.1038/modpathol.2009.47; Kummar S, 2013, J CLIN ONCOL, V31, P2296, DOI 10.1200/JCO.2012.47.4288; Ladanyi M, 2001, ONCOGENE, V20, P48, DOI 10.1038/sj.onc.1204074; Lin HK, 2010, CLIN CANCER RES, V16, P5011, DOI 10.1158/1078-0432.CCR-10-1105; Lustberg Maryam, 2012, Recent Results Cancer Res, V195, P97, DOI 10.1007/978-3-642-28160-0_9; Pethig R, 2010, BIOMICROFLUIDICS, V4, DOI 10.1063/1.3456626; Poo WC, 2011, AM J CLIN PATHOL, V135, P839, DOI 10.1309/AJCP45SSNAOPXYXU; Satelli A, 2014, CANCER RES, V74, P1645, DOI 10.1158/0008-5472.CAN-13-1739; Shim S, 2013, BIOMICROFLUIDICS, V7, DOI 10.1063/1.4774304; Shim S, 2011, INTEGR BIOL-UK, V3, P850, DOI 10.1039/c1ib00032b; Stott SL, 2010, P NATL ACAD SCI USA, V107, P18392, DOI 10.1073/pnas.1012539107; Sundaresan TK, 2016, CLIN CANCER RES, V22, P1103, DOI 10.1158/1078-0432.CCR-15-1031; Tellez-Gabriel M, 2016, FRONT ONCOL, V6, DOI 10.3389/fonc.2016.00202; Vistica DT, 2008, J PEDIAT HEMATOL ONC, V30, P46, DOI 10.1097/MPH.0b013e31815d1d6f; Wang LH, 2010, CLIN CANCER RES, V16, P1073, DOI 10.1158/1078-0432.CCR-09-2799; Williams Anthony, 2012, Recent Results Cancer Res, V195, P87, DOI 10.1007/978-3-642-28160-0_8; Williams SCP, 2013, P NATL ACAD SCI USA, V110, P4861, DOI 10.1073/pnas.1304186110; Yang LY, 2009, BIOTECHNOL BIOENG, V102, P521, DOI 10.1002/bit.22066; Yu M, 2014, SCIENCE, V345, P216, DOI 10.1126/science.1253533; Yu M, 2011, J CELL BIOL, V192, P373, DOI 10.1083/jcb.201010021	32	32	32	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2017	12	4							e0175414	10.1371/journal.pone.0175414	http://dx.doi.org/10.1371/journal.pone.0175414			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LZ	28403214	gold, Green Published, Green Submitted			2022-12-27	WOS:000399955200064
J	Gerth, HU; Pohlen, M; Tholking, G; Pavenstadt, H; Brand, M; Wilms, C; Husing-Kabar, A; Gorlich, D; Kabar, I; Schmidt, HHJ				Gerth, Hans U.; Pohlen, Michele; Thoelking, Gerold; Pavenstaedt, Hermann; Brand, Marcus; Wilms, Christian; Huesing-Kabar, Anna; Goerlich, Dennis; Kabar, Iyad; Schmidt, Hartmut H. J.			Molecular adsorbent recirculating system (MARS) in acute liver injury and graft dysfunction: Results from a case-control study	PLOS ONE			English	Article							EXTRACORPOREAL ALBUMIN DIALYSIS; HEPATORENAL-SYNDROME; HEPATIC-FAILURE; SUPPORT-SYSTEMS; TRANSPLANTATION; SURVIVAL; CIRRHOSIS; TRIAL; METAANALYSIS; CRITERIA	Background The primary therapeutic goals in the treatment of liver injury are to support liver regeneration or bridge the gap to liver transplantation (LT). Molecular adsorbent recirculating system (MARS) therapy has shown beneficial effects for specific symptoms of liver failure; however, general survival advantages have not yet been demonstrated. Aim We studied the effects of MARS therapy compared to standard medical treatment (SMT) in two patient cohorts: in patients with an acute liver injury and in those with graft dysfunction (GD). Methods We report on our experience over a 6.5-year period with 73 patients treated with SMT or with SMT and MARS (MARS group). In total, 53 patients suffered from acute liver injury in their native liver without a preexisting liver disease (SMT: n = 31, MARS: n = 22), and 20 patients showed a severe GD after LT (SMT: n = 10, MARS: n = 10). Results The entire cohort was predominantly characterized by hemodynamically and respiratorily stable patients with a low hepatic encephalopathy (HE) grade and a model of end-stage liver disease (MELD) score of 20.57 (MARS) or 22.51 (SMT, p = 0.555). Within the MARS group, the median number of extracorporeal therapy sessions was four (range = 3 - 5 sessions). Independent of the underlying etiology, MARS improved the patients' bilirubin values in the short term compared to SMT alone. In patients with acute liver injury, this response was sustained even after the end of MARS therapy. By contrast, the majority of patients with GD and an initial response to MARS therapy experienced worsened hyperbilirubinemia. No differences in 28-day mortality were observed with respect to acute liver injury (MARS 5.3% (95% CI: 0-15.3); SMT 3.3% (95% CI: 0 -9.8), p = 0.754) or GD (MARS 20.0% (95% CI: 0-44.7), SMT 11.1% (95% CI: 0-31.7), p = 0.478). Conclusions Although it did not improve 28-day mortality, MARS therapy improved the short-term response in patients with acute liver injury as well as in those with GD. In cases of acute hepatic injury, the use of MARS therapy resulted in the sustained stabilization of liver function and improved liver regeneration. A short-term response to MARS may predict the future course of the disease.	[Gerth, Hans U.; Thoelking, Gerold; Pavenstaedt, Hermann; Brand, Marcus] Univ Hosp Muenster, Div Gen Internal Med Nephrol & Rheumatol, Dept Med D, Munster, Germany; [Pohlen, Michele] Univ Hosp Muenster, Dept Med Hematol & Oncol A, Munster, Germany; [Wilms, Christian; Huesing-Kabar, Anna; Kabar, Iyad; Schmidt, Hartmut H. J.] Univ Hosp Muenster, Dept Transplant Med, Munster, Germany; [Goerlich, Dennis] Univ Munster, Inst Biostat & Clin Res, Munster, Germany	University of Munster; University of Munster; University of Munster; University of Munster	Gerth, HU (corresponding author), Univ Hosp Muenster, Div Gen Internal Med Nephrol & Rheumatol, Dept Med D, Munster, Germany.	ulrich.gerth@ukmuenster.de	Görlich, Dennis/C-8950-2012	Görlich, Dennis/0000-0002-2574-9419; Schmidt, Hartmut/0000-0002-2402-7764				Arroyo V, 1996, HEPATOLOGY, V23, P164, DOI 10.1053/jhep.1996.v23.ajhep0230164; Arroyo V, 2015, J HEPATOL, V62, pS131, DOI 10.1016/j.jhep.2014.11.045; Banares R, 2013, HEPATOLOGY, V57, P1153, DOI 10.1002/hep.26185; Bernal W, 2015, LANCET, V386, P1576, DOI 10.1016/S0140-6736(15)00309-8; Bernal W, 2013, NEW ENGL J MED, V369, P2525, DOI 10.1056/NEJMra1208937; Camus C, 2006, INTENS CARE MED, V32, P1817, DOI 10.1007/s00134-006-0340-1; Camus C, 2009, THER APHER DIAL, V13, P549, DOI 10.1111/j.1744-9987.2009.00708.x; Gustot T, 2015, HEPATOLOGY, V62, P243, DOI 10.1002/hep.27849; Hassanein TI, 2007, HEPATOLOGY, V46, P1853, DOI 10.1002/hep.21930; Kamath PS, 2001, HEPATOLOGY, V33, P464, DOI 10.1053/jhep.2001.22172; Kantola T, 2008, TRANSPL INT, V21, P857, DOI 10.1111/j.1432-2277.2008.00698.x; Kjaergard LL, 2003, JAMA-J AM MED ASSOC, V289, P217, DOI 10.1001/jama.289.2.217; Kribben A, 2012, GASTROENTEROLOGY, V142, P782, DOI 10.1053/j.gastro.2011.12.056; Larsen FS, 2016, J HEPATOL, V64, P69, DOI 10.1016/j.jhep.2015.08.018; Lee JY, 2010, TRANSPL P, V42, P2625, DOI 10.1016/j.transproceed.2010.04.070; Lee WM, 2012, HEPATOLOGY, V55, P965, DOI 10.1002/hep.25551; Mitzner SR, 2000, LIVER TRANSPLANT, V6, P277, DOI 10.1053/lv.2000.6355; Novelli G, 2009, THER APHER DIAL, V13, P404, DOI 10.1111/j.1744-9987.2009.00759.x; OGRADY JG, 1993, LANCET, V342, P273; Pares A, 2010, J HEPATOL, V53, P307, DOI 10.1016/j.jhep.2010.02.031; Saliba F, 2013, ANN INTERN MED, V159, P522, DOI 10.7326/0003-4819-159-8-201310150-00005; Sen S, 2004, LIVER TRANSPLANT, V10, P1109, DOI 10.1002/lt.20236; Shen Y, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002506; Singal AK, 2010, HEPATOLOGY, V52, p506A; Struecker B, 2014, NAT REV GASTRO HEPAT, V11, P166, DOI 10.1038/nrgastro.2013.204; Stutchfield BM, 2011, BRIT J SURG, V98, P623, DOI 10.1002/bjs.7418; Trey C, 1970, Prog Liver Dis, V3, P282; Zheng Z, 2013, EXP THER MED, V6, P929, DOI 10.3892/etm.2013.1241	28	23	23	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2017	12	4							e0175529	10.1371/journal.pone.0175529	http://dx.doi.org/10.1371/journal.pone.0175529			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LZ	28403210	gold, Green Published, Green Submitted			2022-12-27	WOS:000399955200077
J	Martinez-Marin, D; Jarvis, C; Nelius, T; de Riese, W; Volpert, OV; Filleur, S				Martinez-Marin, Dalia; Jarvis, Courtney; Nelius, Thomas; de Riese, Werner; Volpert, Olga V.; Filleur, Stephanie			PEDF increases the tumoricidal activity of macrophages towards prostate cancer cells in vitro	PLOS ONE			English	Article							TUMOR-ASSOCIATED MACROPHAGES; INTEGRIN-ASSOCIATED PROTEIN; ENDOGENOUS THROMBOSPONDIN-1; GENE-EXPRESSION; PHAGOCYTOSIS; SURVIVAL; INFILTRATION; RECEPTOR; SURFACE; CD47	Background Although inflammation and prostate cancer (PCa) have been linked, the molecular interactions between macrophages and PCa cells are poorly explored. Pigment Epithelium-Derived Factor (PEDF) is an anti-angiogenic and anti-tumor factor. We previously showed that PEDF induces macrophages recruitment in vitro, correlates with macrophages density in human prostate, and stimulates macrophages polarization towards the classically activated pathway. Here, we demonstrate that PEDF modulates the interaction between macrophages and PCa cells through a bidirectional signalling leading to tumor cell apoptosis and phagocytosis. Methods RAW 264.7 and THP-1 cells, and BMDMs were grown in vitro as mono-or co-cultures with PC3 or CL1 tumor cells. The effects of PEDF and its derived P18 peptide were measured on macrophages differentiation, migration, and superoxide production, and tumor cell apoptosis and phagocytosis. PEDF receptors (ATP5B, PNPLA2, and LRP6) and CD47 mRNA and protein expression were quantified in macrophages and tumor cells by quantitative RTPCR, western blot, immunofluorescence and flow cytometry. Results We found that PEDF induced the migration of macrophages towards tumor 3D spheroids and 2D cultures. In co-culture, PEDF increased PCa cells phagocytosis through an indirect apoptosis-dependent mechanism. Moreover, PEDF stimulated the production of superoxide by macrophages. Conditioned media from macrophages exposed to PEDF induced tumor cells apoptosis in contrast to control conditioned media suggesting that ROS may be D involved in tumor cells apoptosis. ATP5B and PNPLA2 PEDF receptors on macrophages and CD47 on tumor cells were respectively up-and down-regulated by PEDF. As PEDF, blocking CD47 induced phagocytosis. Inhibiting ATP5B reduced phagocytosis. Inversely, PNPLA2 inhibition blocks differentiation but maintains phagocytosis. CD47-induced phagocytosis was partially reverted by ATP5B inhibition suggesting a complementary action. Similar effects were observed with P18 PEDF-derived peptide. Conclusions These data established that modulating the molecular interactions between macrophages and PCa cells using PEDF may be a promising strategy for PCa treatment.	[Martinez-Marin, Dalia; Jarvis, Courtney; Nelius, Thomas; de Riese, Werner; Filleur, Stephanie] Texas Tech Univ, Hlth Sci Ctr, Dept Urol, Lubbock, TX 79430 USA; [Jarvis, Courtney; Filleur, Stephanie] Texas Tech Univ, Hlth Sci Ctr, Dept Immunol & Mol Microbiol, Lubbock, TX 79430 USA; [Volpert, Olga V.] Northwestern Univ, Feinberg Sch Med, Dept Urol, Chicago, IL 60611 USA; [Volpert, Olga V.] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA	Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Northwestern University; Feinberg School of Medicine; University of Texas System; UTMD Anderson Cancer Center	Filleur, S (corresponding author), Texas Tech Univ, Hlth Sci Ctr, Dept Urol, Lubbock, TX 79430 USA.; Filleur, S (corresponding author), Texas Tech Univ, Hlth Sci Ctr, Dept Immunol & Mol Microbiol, Lubbock, TX 79430 USA.	Stephanie.filleur@ttuhsc.edu		Filleur, Stephanie/0000-0002-3420-5536	NIH/NCI grant [R15 CA161634]; CH Foundation; South Plains Foundation (Lubbock, TX)	NIH/NCI grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CH Foundation; South Plains Foundation (Lubbock, TX)	The present study was performed with the financial support of the NIH/NCI grant R15 CA161634, The CH Foundation and South Plains Foundation (Lubbock, TX).	Aflaki E, 2011, CELL MOL LIFE SCI, V68, P3933, DOI 10.1007/s00018-011-0688-4; Barclay AN, 2014, ANNU REV IMMUNOL, V32, P25, DOI 10.1146/annurev-immunol-032713-120142; Bergstrom SE, 2015, IMMUNOLOGY, V144, P687, DOI 10.1111/imm.12424; Brown EJ, 2001, TRENDS CELL BIOL, V11, P130, DOI 10.1016/S0962-8924(00)01906-1; Burke B, 2003, AM J PATHOL, V163, P1233, DOI 10.1016/S0002-9440(10)63483-9; Chanmee T, 2014, CANCERS, V6, P1670, DOI 10.3390/cancers6031670; Chao MP, 2010, CELL, V142, P699, DOI 10.1016/j.cell.2010.07.044; Craword SE, 2013, EXPERT OPIN DRUG DIS, V8, P769, DOI 10.1517/17460441.2013.794781; DAS B, 1994, J EXP MED, V180, P273, DOI 10.1084/jem.180.1.273; de Coana YP, 2015, TRENDS MOL MED, V21, P482, DOI 10.1016/j.molmed.2015.05.005; De Palma M, 2013, CANCER CELL, V23, P277, DOI 10.1016/j.ccr.2013.02.013; Deshpande M, INT J ONCOLOGY, V41, P219; Dijkgraaf EM, 2013, CANCER RES, V73, P2480, DOI 10.1158/0008-5472.CAN-12-3542; Doll JA, 2003, NAT MED, V9, P774, DOI 10.1038/nm870; Du R, 2008, CANCER CELL, V13, P206, DOI 10.1016/j.ccr.2008.01.034; Edris B, 2012, P NATL ACAD SCI USA, V109, P6656, DOI 10.1073/pnas.1121629109; Fang WY, 2014, CARCINOGENESIS, V35, P1780, DOI 10.1093/carcin/bgu060; Feng MY, 2015, P NATL ACAD SCI USA, V112, P2145, DOI 10.1073/pnas.1424907112; Filleur S, 2005, CANCER RES, V65, P5144, DOI 10.1158/0008-5472.CAN-04-3744; Filleur S, 2009, J CELL BIOCHEM, V106, P769, DOI 10.1002/jcb.22072; Gannon PO, 2009, J IMMUNOL METHODS, V348, P9, DOI 10.1016/j.jim.2009.06.004; Gollapudi K, 2013, AM J CANCER RES, V3, P523; Gul N, 2014, J CLIN INVEST, V124, P812, DOI 10.1172/JCI66776; Guruvayoorappan C, 2008, INTEGR CANCER THER, V7, P90, DOI 10.1177/1534735408319060; Haemmerle G, 2006, SCIENCE, V312, P734, DOI 10.1126/science.1123965; Halin S, 2010, NEOPLASIA, V12, P336, DOI 10.1593/neo.92046; Hu H, 2016, TUMOUR BIOL J INT SO; Huynh KK, 2007, EMBO J, V26, P313, DOI 10.1038/sj.emboj.7601511; Jaiswal S, 2010, TRENDS IMMUNOL, V31, P212, DOI 10.1016/j.it.2010.04.001; Jiang PH, 1999, J BIOL CHEM, V274, P559, DOI 10.1074/jbc.274.2.559; Jinushi M, 2015, BIOCH BIOPHYSICA ACT; Jinushi M, 2014, CANCER METAST REV, V33, P737, DOI 10.1007/s10555-014-9501-9; Jung KY, 2015, J PATHOL TRANSL MED, V49, P318, DOI 10.4132/jptm.2015.06.01; Krishnan AV, 2007, J BONE MINER RES, V22, pV74, DOI 10.1359/JBMR.07S213; Kubler K, 2014, GYNECOL ONCOL, V135, P176, DOI 10.1016/j.ygyno.2014.08.028; Li J, 2016, ONCOTARGET, DOI 10.18632/oncotarget.9368; Li SS, 2006, BLOOD, V108, P3112, DOI 10.1182/blood-2006-04-016832; Lima L, 2014, UROL ONCOL-SEMIN ORI, V32, P449, DOI 10.1016/j.urolonc.2013.10.012; Lin L, 2015, ONCOTARGET, V6, P34758, DOI 10.18632/oncotarget.5325; LINDBERG FP, 1994, J BIOL CHEM, V269, P1567; Lissbrant IF, 2000, INT J ONCOL, V17, P445; Ma JL, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-112; Mirochnik Y, 2009, CLIN CANCER RES, V15, P1655, DOI 10.1158/1078-0432.CCR-08-2113; Mitchem JB, 2013, CANCER RES, V73, P1128, DOI 10.1158/0008-5472.CAN-12-2731; Moran JM, 2005, J BIOL CHEM, V280, P28162, DOI 10.1074/jbc.M500013200; Moransard M, 2010, GLIA, V58, P559, DOI 10.1002/glia.20945; Murata Y, 2014, J BIOCHEM, V155, P335, DOI 10.1093/jb/mvu017; Murdoch C, 2005, INT J CANCER, V117, P701, DOI 10.1002/ijc.21422; Nelius T, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.180; Nelius T, 2013, PROSTATE, V73, P549, DOI 10.1002/pros.22595; Nilsson A, 2012, BIOCHEM BIOPH RES CO, V417, P1304, DOI 10.1016/j.bbrc.2011.12.137; Nonomura N, 2011, BJU INT, V107, P1918, DOI 10.1111/j.1464-410X.2010.09804.x; Notari L, 2006, J BIOL CHEM, V281, P38022, DOI 10.1074/jbc.M600353200; Notari L, 2010, FEBS J, V277, P2192, DOI 10.1111/j.1742-4658.2010.07641.x; Noy R, 2014, IMMUNITY, V41, P49, DOI 10.1016/j.immuni.2014.06.010; Ostuni R, 2015, TRENDS IMMUNOL, V36, P229, DOI 10.1016/j.it.2015.02.004; Park JY, 2015, CLIN RES HEPATOLOGY; Perri SR, 2007, FASEB J, V21, P3928, DOI 10.1096/fj.07-8158com; Principe DR, 2016, ONCOTARGET, V7, P28218, DOI 10.18632/oncotarget.8587; Ruffell B, 2012, TRENDS IMMUNOL, V33, P119, DOI 10.1016/j.it.2011.12.001; Shimura S, 2000, CANCER RES, V60, P5857; Soto-Pantoja DR, 2013, EXPERT OPIN THER TAR, V17, P89, DOI 10.1517/14728222.2013.733699; Stern M, 1996, AM J PATHOL, V149, P911; Stukes S, 2016, J IMMUNOL, V197, P1252, DOI 10.4049/jimmunol.1501855; Tseng D, 2013, P NATL ACAD SCI USA, V110, P11103, DOI 10.1073/pnas.1305569110; Tso CL, 2000, CANCER J, V6, P220; Wagner BJ, 2011, J CELL SCI, V124, P1644, DOI 10.1242/jcs.078907; Weischenfeldt Joachim, 2008, CSH Protoc, V2008, DOI 10.1101/pdb.prot5080; Wu MH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134122; Xu L, 2014, ANN SURG ONCOL, V21, P3142, DOI 10.1245/s10434-014-3601-1; Xuan QJ, 2014, PATHOL ONCOL RES, V20, P619, DOI 10.1007/s12253-013-9740-z; Yan Q, 2010, BIOCHEMISTRY-US, V49, P3685, DOI 10.1021/bi902067f; Zhang H, 2015, GASTRIC CANCER, V18, P740, DOI 10.1007/s10120-014-0422-7; Zhang MY, 2014, J OVARIAN RES, V7, DOI 10.1186/1757-2215-7-19; Zhang QW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050946	75	22	22	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2017	12	4							e0174968	10.1371/journal.pone.0174968	http://dx.doi.org/10.1371/journal.pone.0174968			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LZ	28403150	gold, Green Submitted, Green Published			2022-12-27	WOS:000399955200026
J	Moore, LJ; Nilsen, TO; Jarungsriapisit, J; Fjelldal, PG; Stefansson, SO; Taranger, GL; Patel, S				Moore, Lindsey J.; Nilsen, Tom Ole; Jarungsriapisit, Jiraporn; Fjelldal, Per Gunnar; Stefansson, Sigurd O.; Taranger, Geir Lasse; Patel, Sonal			Triploid atlantic salmon (Salmo salar L.) post-smolts accumulate prevalence more slowly than diploid salmon following bath challenge with salmonid alphavirus subtype 3	PLOS ONE			English	Article							PANCREAS DISEASE PD; VERTEBRAL DEFORMITIES; INFECTION; GROWTH; WATER; FISH; TIME; PCR	Triploid Atlantic salmon (Salmo salar L.) may play an important role in the sustainable expansion of the Norwegian aquaculture industry. Therefore, the susceptibility of triploid salmon to common infections such as salmonid alphavirus (SAV), the causative agent of pancreas disease (PD), requires investigation. In this study, shortly after seawater transfer, diploid and triploid post-smolts were exposed to SAV type 3 (SAV3) using a bath challenge model where the infectious dose was 48 TCID50 ml(-1) of tank water. Copy number analysis of SAV3 RNA in heart tissue showed that there was no difference in viral loads between the diploids and triploids. Prevalence reached 100% by the end of the 35-day experimental period in both infected groups. However, prevalence accumulated more slowly in the triploid group reaching 19% and 56% at 14 and 21 days post exposure (dpe) respectively. Whereas prevalence in the diploid group was 82% and 100% at the same time points indicating some differences between diploid and triploid fish. Both heart and pancreas from infected groups at 14 dpe showed typical histopathological changes associated with pancreas disease. Observation of this slower accumulation of prevalence following a natural infection route was possible due to the early sampling points and the exposure to a relatively low dose of virus. The triploid salmon in this study were not more susceptible to SAV3 than diploid salmon indicating that they could be used commercially to reduce the environmental impact of escaped farmed fish interbreeding with wild salmon. This is important information regarding the future use of triploid fish in large scale aquaculture where SAV3 is a financial threat to increased production.	[Moore, Lindsey J.; Jarungsriapisit, Jiraporn; Taranger, Geir Lasse; Patel, Sonal] Inst Marine Res, Bergen, Norway; [Nilsen, Tom Ole] Uni Res Environm, Bergen, Norway; [Jarungsriapisit, Jiraporn; Stefansson, Sigurd O.] Univ Bergen, Dept Biol, Bergen, Norway; [Fjelldal, Per Gunnar] Inst Marine Res, Matre, Norway; [Moore, Lindsey J.] Univ Bergen, Dept Biol, Bergen, Norway	Institute of Marine Research - Norway; University of Bergen; Institute of Marine Research - Norway; University of Bergen	Patel, S (corresponding author), Inst Marine Res, Bergen, Norway.	sonal.patel@imr.no		Patel, Sonal/0000-0003-4107-0497	Research Council of Norway [224885/E40]	Research Council of Norway(Research Council of Norway)	This research was funded by the Research Council of Norway, Research grant #224885/E40 to SP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen L, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-198; BENFEY TJ, 1989, FISH PHYSIOL BIOCHEM, V6, P113, DOI 10.1007/BF01875483; Bruno D. W., 1990, Bulletin of the European Association of Fish Pathologists, V10, P45; Budino B, 2006, COMP BIOCHEM PHYS A, V145, P108, DOI 10.1016/j.cbpa.2006.05.007; Chalmers L, 2016, FISH SHELLFISH IMMUN, V57, P301, DOI 10.1016/j.fsi.2016.08.049; Ching B, 2010, HEREDITY, V104, P224, DOI 10.1038/hdy.2009.108; Fjelldal PG, 2016, AQUACULT NUTR, V22, P72, DOI 10.1111/anu.12238; Fjelldal PG, 2010, AQUACULTURE, V309, P131, DOI 10.1016/j.aquaculture.2010.09.027; Fraser TWK, 2012, FISH SHELLFISH IMMUN, V33, P60, DOI 10.1016/j.fsi.2012.04.001; Frenzl B, 2014, PEST MANAG SCI, V70, P982, DOI 10.1002/ps.3639; Galbreath PF, 2006, ENVIRON BIOL FISH, V75, P183, DOI 10.1007/s10641-006-0008-2; Glover KA, 2013, BMC GENET, V14, P1, DOI [10.1186/1471-2156-14-1, DOI 10.1186/1471-2156-14-1]; Glover KA, 2015, BMC GENET, V16, DOI 10.1186/s12863-015-0193-0; Graham DA, 2011, J FISH DIS, V34, P273, DOI 10.1111/j.1365-2761.2010.01234.x; Handeland SO, 2008, AQUACULTURE, V283, P36, DOI 10.1016/j.aquaculture.2008.06.042; Hansen TJ, 2015, AQUACULTURE, V435, P354, DOI 10.1016/j.aquaculture.2014.10.017; Hodneland K, 2006, J VIROL METHODS, V131, P184, DOI 10.1016/j.jviromet.2005.08.012; Jansen MD, 2010, J FISH DIS, V33, P391, DOI 10.1111/j.1365-2761.2009.01131.x; Jarungsriapisit J, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0520-8; Jarungsriapisit J, 2016, VET RES, V47, DOI 10.1186/s13567-016-0385-2; JOHNSTONE R, 1995, THEOR APPL GENET, V90, P819, DOI 10.1007/BF00222017; Kristoffersen AB, 2009, PREV VET MED, V90, P127, DOI 10.1016/j.prevetmed.2009.04.003; Lerfall J, 2012, AQUACULTURE, V324, P209, DOI 10.1016/j.aquaculture.2011.11.003; Lovoll M, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-8; Maxime V, 2008, FISH FISH, V9, P67, DOI 10.1111/j.1467-2979.2007.00269.x; MCCORMICK SD, 1993, CAN J FISH AQUAT SCI, V50, P656, DOI 10.1139/f93-075; McLoughlin MF, 2007, J FISH DIS, V30, P511, DOI 10.1111/j.1365-2761.2007.00848.x; Sambraus F, 2017, J FISH DIS; SAMBRAUS F, 2016, THESIS; Taksdal T, 2014, J FISH DIS; Xu C, 2010, J VIROL, V84, P8903, DOI 10.1128/JVI.00851-10	31	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2017	12	4							e0175468	10.1371/journal.pone.0175468	http://dx.doi.org/10.1371/journal.pone.0175468			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LZ	28403165	gold, Green Accepted, Green Submitted, Green Published			2022-12-27	WOS:000399955200072
J	Rocha-Santos, L; Benchimol, M; Mayfield, MM; Feria, D; Pessoa, MS; Talora, DC; Mariano-Neto, E; Cazetta, E				Rocha-Santos, Larissa; Benchimol, Maira; Mayfield, Margaret M.; Feria, Deborah; Pessoa, Michaele S.; Talora, Daniela C.; Mariano-Neto, Eduardo; Cazetta, Eliana			Functional decay in tree community within tropical fragmented landscapes: Effects of landscape-scale forest cover	PLOS ONE			English	Article							BRAZILIAN ATLANTIC FOREST; RAIN-FOREST; SOUTHERN BAHIA; HABITAT LOSS; PHYLOGENETIC DIVERSITY; FLORISTIC COMPOSITION; LARGE SEEDS; EDGE; THRESHOLDS; DISPERSAL	As tropical rainforests are cleared, forest remnants are increasingly isolated within agricultural landscapes. Understanding how forest loss impacts on species diversity can, therefore, contribute to identifying the minimum amount of habitat required for biodiversity maintenance in human-modified landscapes. Here, we evaluate how the amount of forest cover, at the landscape scale, affects patterns of species richness, abundance, key functional traits and common taxonomic families of adult trees in twenty Brazilian Atlantic rainforest landscapes. We found that as forest cover decreases, both tree community richness and abundance decline, without exhibiting a threshold. At the family-level, species richness and abundance of the Myrtaceae and Sapotaceae were also negatively impacted by the percent forest remaining at the landscape scale. For functional traits, we found a reduction in shadetolerant, animal-dispersed and small-seeded species following a decrease in the amount of forest retained in landscapes. These results suggest that the amount of forest in a landscape is driving non-random losses in phylogenetic and functional tree diversity in Brazil's remaining Atlantic rainforests. Our study highlights potential restraints on the conservation value of Atlantic rainforest remnants in deforested landscapes in the future.	[Rocha-Santos, Larissa; Benchimol, Maira; Feria, Deborah; Pessoa, Michaele S.; Talora, Daniela C.; Cazetta, Eliana] Univ Estadual Santa Cruz, Appl Ecol & Conservat Lab, Grad Program Ecol & Biodivers Conservat, Ilheus, BA, Brazil; [Mayfield, Margaret M.] Univ Queensland, Sch Biol Sci, St Lucia Campus, Brisbane, Qld 4072, Australia; [Mariano-Neto, Eduardo] Univ Fed Bahia, Inst Biol, Dept Bot, Salvador, BA, Brazil	Universidade Estadual de Santa Cruz; University of Queensland; Universidade Federal da Bahia	Rocha-Santos, L (corresponding author), Univ Estadual Santa Cruz, Appl Ecol & Conservat Lab, Grad Program Ecol & Biodivers Conservat, Ilheus, BA, Brazil.	rocha_larissa@yahoo.com.br	Mariano-Neto, Eduardo/F-3441-2010; Benchimol, Maíra MB/I-7664-2014; de Souza Pessoa, Michaele/ABA-2416-2020; Mayfield, Margaret M/B-7386-2012; faria, deborah/ABC-2757-2021; Cazetta, Eliana/F-3296-2010; Cazetta, Eliana/K-1880-2019; Faria, Deborah/F-2879-2010; Rocha-Santos, larissa/AAF-4812-2019	Mariano-Neto, Eduardo/0000-0002-4204-0882; Benchimol, Maíra MB/0000-0002-1238-1619; Mayfield, Margaret M/0000-0002-5101-6542; faria, deborah/0000-0002-0375-2887; Cazetta, Eliana/0000-0002-2209-2554; Cazetta, Eliana/0000-0002-2209-2554; Faria, Deborah/0000-0002-0375-2887; Rocha-Santos, Larissa/0000-0002-3231-5635; Pessoa, Michaele/0000-0002-0209-8289	Fapesb [B0L0176/2013]; CAPES [PDSE-BEX7518/14-5]; CNPq [307221/2012-1, 305812/2015-7]; Brazilian Council of Science and Technology-CNPq [563216/2010-7]; Research Support foundation of the State of Bahia - Fapesb [JCB0049/2013]; State University of Santa Cruz - UESC [00220.1100.1320]	Fapesb(Fundacao de Amparo a Pesquisa do Estado da Bahia (FAPESB)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Brazilian Council of Science and Technology-CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Research Support foundation of the State of Bahia - Fapesb; State University of Santa Cruz - UESC	LSR is grateful to Fapesb (B0L0176/2013) and CAPES (PDSE-BEX7518/14-5) for the doctoral studies scholarship. DF and EC is grateful to received a research productivity fellowship from CNPq (number 307221/2012-1, 305812/2015-7, respectively). This study was funded by the Brazilian Council of Science and Technology-CNPq (Proc. 563216/2010-7), Research Support foundation of the State of Bahia - Fapesb (JCB0049/2013) and State University of Santa Cruz - UESC (00220.1100.1320). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alofs KM, 2014, PLANT ECOL, V215, P1139, DOI 10.1007/s11258-014-0372-5; Andrade ER, 2015, FOREST ECOL MANAG, V349, P73, DOI 10.1016/j.foreco.2015.03.049; ANDREN H, 1994, OIKOS, V71, P355, DOI 10.2307/3545823; [Anonymous], COMUNICACAO TECNICA; ARMSTRONG DP, 1993, ECOLOGY, V74, P1092, DOI 10.2307/1940479; Arroyo-Rodriguez V, 2007, BIOTROPICA, V39, P760, DOI 10.1111/j.1744-7429.2007.00330.x; Arroyo-Rodriguez V, 2013, J ECOL, V101, P1449, DOI 10.1111/1365-2745.12153; Arroyo-Rodriguez V, 2012, J ECOL, V100, P702, DOI 10.1111/j.1365-2745.2011.01952.x; Baker TR, 2004, GLOBAL CHANGE BIOL, V10, P545, DOI 10.1111/j.1365-2486.2004.00751.x; Banks-Leite C, 2014, SCIENCE, V345, P1041, DOI 10.1126/science.1255768; Barnosky AD, 2011, NATURE, V471, P51, DOI 10.1038/nature09678; Barroso GM, 1999, FRUTOS E SEMENTES MO; Barton K, 2020, MUMIN MULTIMODEL INF; Bascompte J, 2001, ECOL LETT, V4, P417, DOI 10.1046/j.1461-0248.2001.00242.x; Bello C, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1501105; Benchimol M, 2015, J ECOL, V103, P408, DOI 10.1111/1365-2745.12371; Bolker B. M, 2008, ECOLOGICAL MODELS AN; Bolker BM, 2014, BBMLE TOOLS FOR GENE; Bongers F, 2009, ECOL LETT, V12, P798, DOI 10.1111/j.1461-0248.2009.01329.x; Burnham K. P., 2002, MODEL SELECTION AND; Canale GR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041671; Canale GR, 2016, FOLIA PRIMATOL, V87, P123, DOI 10.1159/000447712; Cassano CR, 2012, BIOTROPICA, V44, P818, DOI 10.1111/j.1744-7429.2012.00870.x; Cassano CR, 2009, BIODIVERS CONSERV, V18, P577, DOI 10.1007/s10531-008-9526-x; Cordeiro NJ, 2001, CONSERV BIOL, V15, P1733, DOI 10.1046/j.1523-1739.2001.99579.x; Cortes MC, 2009, AUSTRAL ECOL, V34, P249, DOI 10.1111/j.1442-9993.2009.01926.x; Crawley M.J., 2007, R BOOK; de Melo FPL, 2006, BIOL CONSERV, V132, P50, DOI 10.1016/j.biocon.2006.03.015; Dias MH, 2016, REV TERRIT FRONT, V9, P215, DOI DOI 10.22228/rt-f.v9i1.409; Diggle PJ, 2007, SPRINGER SERIES IN S; Dirzo R, 2014, SCIENCE, V345, P401, DOI 10.1126/science.1251817; Dormann CF, 2007, ECOGRAPHY, V30, P609, DOI 10.1111/j.2007.0906-7590.05171.x; dos Santos K, 2007, BIOL CONSERV, V135, P268, DOI 10.1016/j.biocon.2006.10.027; Echeverria C, 2007, GLOBAL ECOL BIOGEOGR, V16, P426, DOI 10.1111/j.1466-8238.2007.00311.x; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Fahrig L, 2013, J BIOGEOGR, V40, P1649, DOI 10.1111/jbi.12130; Faria D, 2009, FOREST ECOL MANAG, V257, P2226, DOI 10.1016/j.foreco.2009.02.032; FOSTER SA, 1986, BOT REV, V52, P260, DOI 10.1007/BF02860997; Galetti M, 2006, BOT J LINN SOC, V151, P141, DOI 10.1111/j.1095-8339.2006.00529.x; Galetti M., 1996, FRUITS AND FRUGIVORE; Galetti M, 2013, SCIENCE, V340, P1086, DOI 10.1126/science.1233774; Girao LC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000908; Rigueira DMG, 2013, BIODIVERS CONSERV, V22, P3141, DOI 10.1007/s10531-013-0575-4; Haddad NM, 2017, ECOGRAPHY, V40, P48, DOI 10.1111/ecog.02535; Hammond DS, 1996, FOREST ECOL MANAG, V83, P99, DOI 10.1016/0378-1127(95)03680-6; Harper KA, 2005, CONSERV BIOL, V19, P768, DOI 10.1111/j.1523-1739.2005.00045.x; Holland JD, 2004, BIOSCIENCE, V54, P227, DOI 10.1641/0006-3568(2004)054[0227:DTSSOS]2.0.CO;2; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; IBGE, MANUAL TECNICO DE US; Jackson HB, 2015, GLOBAL ECOL BIOGEOGR, V24, P52, DOI 10.1111/geb.12233; King RS, 2011, ECOL APPL, V21, P1659, DOI 10.1890/10-1357.1; King RS, 2010, J N AM BENTHOL SOC, V29, P998, DOI 10.1899/09-144.1; Landrum LR, 1997, BRITTONIA, V49, P508, DOI 10.2307/2807742; Laurance WF, 2000, NATURE, V404, P836, DOI 10.1038/35009032; Laurance WF, 2006, P NATL ACAD SCI USA, V103, P19010, DOI 10.1073/pnas.0609048103; Laurance William F, 2006, Ecology, V87, P469, DOI 10.1890/05-0064; Levey DJ, 2002, INTERNATIONAL SYMPOS; Lima MM, 2014, FOREST ECOL MANAG, V312, P260, DOI 10.1016/j.foreco.2013.09.003; Lobo D, 2011, DIVERS DISTRIB, V17, P287, DOI 10.1111/j.1472-4642.2010.00739.x; Melo FPL, 2007, ECOSCIENCE, V14, P124, DOI 10.2980/1195-6860(2007)14[124:EOLSFT]2.0.CO;2; Lorenzi, 2002, RVORES BRASILEIRAS M; Mariano-Neto E, 2004, THESIS; Martini AMZ, 2007, BIODIVERS CONSERV, V16, P3111, DOI 10.1007/s10531-007-9166-6; Melo GL, 2017, BIOL CONSERV, V209, P304, DOI 10.1016/j.biocon.2017.02.031; Montoya D, 2008, SCIENCE, V320, P1502, DOI 10.1126/science.1158404; Morante JC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128923; MORI SA, 1983, BOT REV, V49, P155, DOI 10.1007/BF02861011; MURCIA C, 1995, TRENDS ECOL EVOL, V10, P58, DOI 10.1016/S0169-5347(00)88977-6; Oliveira AT, 2000, BIOTROPICA, V32, P793, DOI 10.1646/0006-3606(2000)032[0793:POFDAA]2.0.CO;2; Oliveira LC, 2010, ANIM CONSERV, V13, P60, DOI 10.1111/j.1469-1795.2009.00296.x; Oliveira MA, 2008, FOREST ECOL MANAG, V256, P1910, DOI 10.1016/j.foreco.2008.07.014; Oliveira MA, 2004, ORYX, V38, P389, DOI 10.1017/S0030605304000754; Pardini R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013666; Pessoa MS, 2017, BIOTROPICA, V49, P45, DOI 10.1111/btp.12359; PIMM SL, 1995, SCIENCE, V269, P347, DOI 10.1126/science.269.5222.347; Pinheiro J, 2000, MIXED EFFECTS MODELS; Piotto D, 2009, PLANT ECOL, V205, P261, DOI 10.1007/s11258-009-9615-2; R Development Core Team RDC, 2013, R A LANGUAGE AND ENV; Ribeiro PJ, 2016, GEOR ANALYSIS OF GEO, P1; Rocha-Santos L, 2016, BIOL CONSERV, V196, P1, DOI 10.1016/j.biocon.2016.01.028; Rocha-Santos L, 2012, TROP CONSERV SCI, V5, P475, DOI 10.1177/194008291200500406; Santos BA, 2008, BIOL CONSERV, V141, P249, DOI 10.1016/j.biocon.2007.09.018; Santos BA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113109; Saracura F V., 1997, PLANO DE MANEJO RESE, P1; Magnago LFS, 2015, BIODIVERS CONSERV, V24, P2305, DOI 10.1007/s10531-015-0961-1; Soares LASS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133540; Stephenson NL, 2014, NATURE, V507, P90, DOI 10.1038/nature12914; SWAINE MD, 1988, VEGETATIO, V75, P81, DOI 10.1007/BF00044629; Swift TL, 2010, BIOL REV, V85, P35, DOI 10.1111/j.1469-185X.2009.00093.x; Tabarelli M, 1999, BIOL CONSERV, V91, P119, DOI 10.1016/S0006-3207(99)00085-3; Tabarelli M, 2002, BIOL CONSERV, V106, P165, DOI 10.1016/S0006-3207(01)00243-9; Tabarelli M, 2008, BIOTROPICA, V40, P657, DOI 10.1111/j.1744-7429.2008.00454.x; Tabarelli M, 2010, CONSERV BIOL, V24, P1654, DOI 10.1111/j.1523-1739.2010.01529.x; Thier O, 2016, TROP CONSERV SCI, V9, P852, DOI 10.1177/194008291600900217; Thomas W. Wayt, 2009, Braz. J. Bot., V32, P65, DOI 10.1590/S0100-84042009000100007; Thomas WW, 1998, BIODIVERS CONSERV, V7, P311, DOI 10.1023/A:1008825627656; Tilman D, 1997, SCIENCE, V277, P1300, DOI 10.1126/science.277.5330.1300; Tischendorf L, 2000, OIKOS, V90, P7, DOI 10.1034/j.1600-0706.2000.900102.x; VALIENTEBANUET A, 2014, FUNCTIONAL ECOLOGY, V29, P299, DOI DOI 10.1111/1365-2435.12356; WHITMORE TC, 1989, ECOLOGY, V70, P536, DOI 10.2307/1940195; Winfree R, 2007, CONSERV BIOL, V21, P213, DOI 10.1111/j.1523-1739.2006.00574.x	101	35	35	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2017	12	4							e0175545	10.1371/journal.pone.0175545	http://dx.doi.org/10.1371/journal.pone.0175545			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LZ	28403166	Green Submitted, gold, Green Published			2022-12-27	WOS:000399955200078
J	Koneff, MD; Zimmerman, GS; Dwyer, CP; Fleming, KK; Padding, PI; Devers, PK; Johnson, FA; Runge, MC; Roberts, AJ				Koneff, Mark D.; Zimmerman, Guthrie S.; Dwyer, Chris P.; Fleming, Kathleen K.; Padding, Paul I.; Devers, Patrick K.; Johnson, Fred A.; Runge, Michael C.; Roberts, Anthony J.			Evaluation of harvest and information needs for North American sea ducks	PLOS ONE			English	Article							BRITISH-COLUMBIA; UNCERTAINTY; POPULATION; MANAGEMENT; CONSERVATION; JUDGMENTS; LESSONS; PACKAGE; RATIOS; AGE	Wildlife managers routinely seek to establish sustainable limits of sport harvest or other regulated forms of take while confronted with considerable uncertainty. A growing body of ecological research focuses on methods to describe and account for uncertainty in management decision-making and to prioritize research and monitoring investments to reduce the most influential uncertainties. We used simulation methods incorporating measures of demographic uncertainty to evaluate risk of overharvest and prioritize information needs for North American sea ducks (Tribe Mergini). Sea ducks are popular game birds in North America, yet they are poorly monitored and their population dynamics are poorly understood relative to other North American waterfowl. There have been few attempts to assess the sustainability of harvest of North American sea ducks, and no formal harvest strategy exists in the U.S. or Canada to guide management. The popularity of sea duck hunting, extended hunting opportunity for some populations (i.e., special seasons and/or bag limits), and population declines have led to concern about potential overharvest. We used Monte Carlo simulation to contrast estimates of allowable harvest and observed harvest and assess risk of overharvest for 7 populations of North American sea ducks: the American subspecies of common eider (Somateria mollissima dresseri), eastern and western populations of black scoter (Melanitta americana) and surf scoter (M. perspicillata), and continental populations of white-winged scoter (M. fusca) and long-tailed duck (Clangula hyemalis). We combined information from empirical studies and the opinions of experts through formal elicitation to create probability distributions reflecting uncertainty in the individual demographic parameters used in this assessment. Estimates of maximum growth (rmax), and therefore of allowable harvest, were highly uncertain for all populations. Long-tailed duck and American common eider appeared to be at high risk of overharvest (i.e., observed harvest < allowable harvest in 5-7% and 19-26% of simulations, respectively depending on the functional form of density dependence), whereas the other populations appeared to be at moderate risk to low risk (observed harvest < allowable harvest in 22-68% of simulations, again conditional on the form of density dependence). We also evaluated the sensitivity of the difference between allowable and observed harvest estimates to uncertainty in individual demographic parameters to prioritize information needs. We found that uncertainty in overall fecundity had more influence on comparisons of allowable and observed harvest than adult survival or observed harvest for all species except long-tailed duck. Although adult survival was characterized by less uncertainty than individual components of fecundity, it was identified as a high priority information need given the sensitivity of growth rate and allowable harvest to this parameter. Uncertainty about population size was influential in the comparison of observed and allowable harvest for 5 of the 6 populations where it factored into the assessment. While this assessment highlights a high degree of uncertainty in allowable harvest, it provides a framework for integration of improved data from future research and monitoring. It could also serve as the basis for harvest strategy development as management objectives and regulatory alternatives are specified by the management community.	[Koneff, Mark D.] US Fish & Wildlife Serv, Div Migratory Bird Management, Orono, ME 04473 USA; [Zimmerman, Guthrie S.] US Fish & Wildlife Serv, Div Migratory Bird Management, Sacramento, CA USA; [Dwyer, Chris P.] US Fish & Wildlife Serv, Div Migratory Birds, Hadley, MA USA; [Fleming, Kathleen K.; Padding, Paul I.; Devers, Patrick K.; Roberts, Anthony J.] US Fish & Wildlife Serv, Div Migratory Bird Management, Laurel, MD USA; [Johnson, Fred A.] US Geol Survey, Wetland & Aquat Res Ctr, Gainesville, FL USA; [Runge, Michael C.] US Geol Survey, Patuxent Wildlife Res Ctr, Laurel, MD USA	United States Department of the Interior; US Fish & Wildlife Service; United States Department of the Interior; US Fish & Wildlife Service; United States Department of the Interior; US Fish & Wildlife Service; United States Department of the Interior; US Fish & Wildlife Service; United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey	Koneff, MD (corresponding author), US Fish & Wildlife Serv, Div Migratory Bird Management, Orono, ME 04473 USA.	mark_koneff@fws.gov	Johnson, Fred/GLU-6494-2022; Runge, Michael C/E-7331-2011	Runge, Michael C/0000-0002-8081-536X	Sea Duck Joint Venture Project [139]; U.S. Fish and Wildlife Service; U.S. Geological Survey	Sea Duck Joint Venture Project; U.S. Fish and Wildlife Service(US Fish & Wildlife Service); U.S. Geological Survey(United States Geological Survey)	Support was provided by: 1. Sea Duck Joint Venture Project No. 139; seaduckjv.org (Mark Koneff, Guthrie Zimmerman). While one co-author is presently a U.S. Fish and Wildlife Service representative on the Sea Duck Joint Venture Management Board, and the study was conducted at the request of the Sea Duck Joint Venture, the Sea Duck Joint Venture Management Board had no role in study design, analysis, decision to publish, or preparation of the manuscript. Individual members of the Sea Duck Joint Venture Continental Technical Team assisted in literature review and/or the expert elicitation panel. The Sea Duck Joint Venture is funded through the U.S. Fish and Wildlife Service. 2. Salary support for MD Koneff, GS Zimmerman, CP Dwyer, KK Fleming, PI Padding, PK Devers, and AJ Roberts was provided by the U.S. Fish and Wildlife Service. 3. Salary support for FA Johnson and MC Runge was provided by the U.S. Geological Survey.	Anderson EM, 2015, BIRDS N AM; ANDREWARTHA HG, 1954, DISTRIBUTION ABUNDAN; [Anonymous], 2014, R LANG ENV STAT COMP; Artelle KA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078041; Ayyub B.M., 2001, ELICITATION EXPERT O; Bellrose FC, 1980, GEESE SWANS N AM; Boomer GS, 2013, J WILDLIFE MANAGE, V77, P1059, DOI 10.1002/jwmg.570; Bordage D, 2011, BIRDS N AM; Bowman Timothy D., 2015, ECOLOGY CONSERVATION, V46, P1, DOI DOI 10.1111/jav.00478; Boyd W.S., 2015, ECOLOGY CONSERVATION, P529; Brown P.W., 1997, BIRDS N AM; Brownie C, 1985, US FISH WILDLIFE SER; Bunnefeld N, 2011, TRENDS ECOL EVOL, V26, P441, DOI 10.1016/j.tree.2011.05.003; Caithamer D. F., 2000, SEA DUCKS ATLANTIC F; Caswell H., MATRIX POPULATION MO, P2; Caughley G., 1977, ANAL VERTEBRATE POPU; Clark F, 2010, METHODS ECOL EVOL, V1, P253, DOI 10.1111/j.2041-210X.2010.00029.x; Conroy M. J., 2013, DECISION MAKING NATU; Delignette-Muller ML, 2015, J STAT SOFTW, V64, P1, DOI 10.18637/jss.v064.i04; Dooley J., 2016, ANAL EMPEROR GOOSE S; Flint PL., 2015, ECOLOGY CONSERVATION, P96; Garrettson P, 2007, ESTIMATING HARVEST P; Gilliland SG, 2009, WILDLIFE BIOL, V15, P24, DOI 10.2981/07-005; Goudie R. I., 2000, BIRDS N AM, DOI 10.2173/bna.546; Goudie R. Ian, 1994, Transactions of the North American Wildlife and Natural Resources Conference, V59, P27; Harwood J, 2003, TRENDS ECOL EVOL, V18, P617, DOI 10.1016/j.tree.2003.08.001; HILBORN R, 1992; Holt CA, 2006, CAN J FISH AQUAT SCI, V63, P2722, DOI 10.1139/F06-155; Iverson SA, 2004, CONDOR, V106, P252, DOI 10.1650/7386; Johnson FA, 1997, J WILDLIFE MANAGE, V61, P202, DOI 10.2307/3802429; Johnson FA, 2014, J WILDLIFE MANAGE, V78, P531, DOI 10.1002/jwmg.682; Johnson FA, 2012, ECOL APPL, V22, P1114, DOI 10.1890/11-1164.1; Kehoe P, 1994, STATUS SEA DUCKS ATL; Kellett DK, 2005, AUK, V122, P313, DOI 10.1642/0004-8038(2005)122[0313:BMOLDC]2.0.CO;2; KORSCHGEN CE, 1977, J WILDLIFE MANAGE, V41, P360, DOI 10.2307/3800505; Krementz DG, 1997, J WILDLIFE MANAGE, V61, P222, DOI 10.2307/3802431; Krementz DG, 1996, J WILDLIFE MANAGE, V60, P855, DOI 10.2307/3802386; Leafloor JO, 1996, WILSON BULL, V108, P567; Link WA, 2010, BAYESIAN INFERENCE WITH ECOLOGICAL APPLICATIONS, P1; Martin TG, 2012, CONSERV BIOL, V26, P29, DOI 10.1111/j.1523-1739.2011.01806.x; McBride MF, 2012, METHODS ECOL EVOL, V3, P906, DOI 10.1111/j.2041-210X.2012.00221.x; Natcher DC, 2011, ARCTIC, V64, P362; NELSON AL, 1953, J WILDLIFE MANAGE, V17, P36, DOI 10.2307/3796802; Niel C, 2005, CONSERV BIOL, V19, P826, DOI 10.1111/j.1523-1739.2005.00310.x; Padding PI, 2012, WILDLIFE RES; Padding PI, 2006, ESTIMATING WATERFOWL, P849; Punt AE, 2007, ICES J MAR SCI, V64, P603, DOI 10.1093/icesjms/fsm035; Robertson GJ, 2002, BIRDS N AM; Rodway Michael S., 2015, Marine Ornithology, V43, P141; Rothe T. C., 2015, ECOLOGY CONSERVATION, P417; Runge MC, 2004, BIRD ECOLOGY CONSERV; Runge MC, 2011, BIOL CONSERV, V144, P1214, DOI 10.1016/j.biocon.2010.12.020; Runge MC, 2009, J WILDLIFE MANAGE, V73, P556, DOI 10.2193/2008-090; Saether BE, 2002, PHILOS T ROY SOC B, V357, P1185, DOI 10.1098/rstb.2002.1119; Saether BE, 2002, SCIENCE, V295, P2070; *SEA DUCK JOINT VE, 2003, SPEC STAT REP; Sea Duck Joint Venture Management Board, 2008, SEA DUCK JOINT VENT; Seamans M, 2007, ESTIMATION POTENTIAL; Silverman E. D. J. B., 2012, ATLANTIC COAST WINTE; Silverman ED, 2013, J FISH WILDL MANAG, V4, P178, DOI 10.3996/122012-JFWM-107; SMITH GW, 1995, 5 US DEP INT NAT BIO; Speirs-Bridge A, 2010, RISK ANAL, V30, P512, DOI 10.1111/j.1539-6924.2009.01337.x; Stubben C, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i11; TOBIAS TN, 1994, ARCTIC, V47, P207; U.S. Fish and Wildlife Service, 2016, BALD GOLD EAGL POP D; U.S. Fish and Wildlife Service, 2015, BAND TAIL PIG POT TA; Vermeer K., 1984, P30; Wade PR, 1998, MAR MAMMAL SCI, V14, P1, DOI 10.1111/j.1748-7692.1998.tb00688.x; Walters C., 1986, ADAPTIVE MANAGEMENT; Waltho Chris, 2015, THE COMMON EIDER; Williams CK, 2013, J WILDLIFE MANAGE, V77, P4, DOI 10.1002/jwmg.429	71	15	15	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2017	12	4							e0175411	10.1371/journal.pone.0175411	http://dx.doi.org/10.1371/journal.pone.0175411			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KH	28419113	Green Submitted, gold, Green Published			2022-12-27	WOS:000399875200019
J	Kreizinger, Z; Sulyok, KM; Grozner, D; Beko, K; Dan, A; Szabo, Z; Gyuranecz, M				Kreizinger, Zsuzsa; Sulyok, Kinga Maria; Grozner, Denes; Beko, Katinka; Dan, Adam; Szabo, Zoltan; Gyuranecz, Miklos			Development of mismatch amplification mutation assays for the differentiation of MS1 vaccine strain from wild-type Mycoplasma synoviae and MS-H vaccine strains	PLOS ONE			English	Article							VLHA GENE; ABNORMALITIES; POLYMORPHISM; CLONES	Mycoplasma synoviae is an economically significant pathogen in the poultry industry, inducing respiratory disease and infectious synovitis in chickens and turkeys, and eggshell apex abnormality in chickens. Eradication, medication and vaccination are the options for controlling M. synoviae infection. Currently there are two commercial, live, attenuated vaccines available against M. synoviae: the temperature sensitive MS-H vaccine strain and the NAD independent MS1 vaccine strain. Differentiation of vaccine strains from field isolates is essential during vaccination and eradication programs. The present study provides melt-curve and agarose gel based mismatch amplification mutation assays (MAMA) to discriminate the MS1 vaccine strain from the MS-H vaccine strain and wild-type M. synoviae isolates. The assays are based on the A/C single nucleotide polymorphism at nt11 of a HIT family protein coding gene. The melt-and agarose-MAMAs reliably distinguish the MS1 vaccine strain genotype from the MS-H vaccine strain and wild-type M. synoviae isolate genotype from 10 2 template number/DNA sample. No cross-reactions with other avian Mycoplasma species were observed. The assays can be performed directly on clinical samples and they can be run simultaneously with the previously described MAMAs designed for the discrimination of the MS-H vaccine strain. The developed assays are applicable in laboratories with limited facilities and promote the rapid, simple and cost effective differentiation of the MS1 vaccine strain.	[Kreizinger, Zsuzsa; Sulyok, Kinga Maria; Grozner, Denes; Beko, Katinka; Gyuranecz, Miklos] Hungarian Acad Sci, Ctr Agr Res, Inst Vet Med Res, Budapest, Hungary; [Dan, Adam] Natl Food Chain Safety Off, Vet Diagnost Directorate, Budapest, Hungary; [Szabo, Zoltan] Intervet Hungaria Kft, Part MSD Anim Hlth, Budapest, Hungary	Hungarian Academy of Sciences; Hungarian Centre for Agricultural Research; Hungarian Veterinary Medical Research Institute; Merck & Company; Intervet International B.V.	Gyuranecz, M (corresponding author), Hungarian Acad Sci, Ctr Agr Res, Inst Vet Med Res, Budapest, Hungary.	m.gyuranecz@gmail.com	Dán, Ádám/G-6018-2012	Dán, Ádám/0000-0001-7849-7721; Gyuranecz, Miklos/0000-0002-5698-5713; Grozner, Denes/0000-0002-2154-7537	Hungarian Academy of Sciences [LP2012-22]; National Research, Development and Innovation Office [NKFI-119594]; Intervet Hungria Kft., part of MSD Animal Health, Budapest, Hungary	Hungarian Academy of Sciences(Hungarian Academy of Sciences); National Research, Development and Innovation Office(National Research, Development & Innovation Office (NRDIO) - Hungary); Intervet Hungria Kft., part of MSD Animal Health, Budapest, Hungary	This work and MG were funded by the LenduElet (Momentum) program (LP2012-22) of the Hungarian Academy of Sciences (http://mta.hu/lendulet/) and the NKFI-119594 grant of the National Research, Development and Innovation Office (http://nkfih.gov.hu/palyazatok/nemzeti-kutatasi/kutatoi-kezdemenyezesu).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funder (Intervet Hungria Kft., part of MSD Animal Health, Budapest, Hungary) provided support in the form of salaries for author ZS, but did not have any additional role in the study design, data collection and analysis, decision to publish,or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Bencina D, 2001, FEMS MICROBIOL LETT, V203, P115, DOI 10.1111/j.1574-6968.2001.tb10829.x; Birdsell DN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032866; Catania S, 2010, AVIAN DIS, V54, P961, DOI 10.1637/9121-110309-Case.1; Dijkman R, 2014, AVIAN PATHOL, V43, P465, DOI 10.1080/03079457.2014.958980; Dijkman R., 2014, 20 C INT ORG MYC; Dusanic D, 2009, VET MICROBIOL, V138, P114, DOI 10.1016/j.vetmic.2009.02.014; Feberwee A, 2009, AVIAN PATHOL, V38, P77, DOI 10.1080/03079450802662772; Jeffery N, 2007, MICROBIOL-SGM, V153, P2679, DOI 10.1099/mic.0.2006/005140-0; Kleven S., 2008, DIS POULTRY, P845; Kleven SH, 2008, AVIAN DIS, V52, P367, DOI 10.1637/8323-041808-Review.1; Kreizinger Z, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133554; Landman WJM, 2004, AVIAN PATHOL, V33, P591, DOI 10.1080/03079450400013170; Marois C, 2000, VET MICROBIOL, V73, P311, DOI 10.1016/S0378-1135(00)00178-4; Morrow CJ, 1998, AVIAN DIS, V42, P667, DOI 10.2307/1592700; Nicholas RAJ, 2009, J COMP PATHOL, V140, P85, DOI 10.1016/j.jcpa.2008.08.004; Shahid MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092215; Shahid MA, 2013, AVIAN PATHOL, V42, P185, DOI 10.1080/03079457.2013.779363; Slavec B, 2011, AVIAN PATHOL, V40, P481, DOI 10.1080/03079457.2011.604840; Staroscik A., 2004, CALCULATOR DETERMINI	19	8	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2017	12	4							e0175969	10.1371/journal.pone.0175969	http://dx.doi.org/10.1371/journal.pone.0175969			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KH	28419134	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000399875200058
J	Remo, SC; Hevroy, EM; Breck, O; Olsvik, PA; Waagbo, R				Remo, Sofie Charlotte; Hevroy, Ernst Morten; Breck, Olav; Olsvik, Pal Asgeir; Waagbo, Rune			Lens metabolomic profiling as a tool to understand cataractogenesis in Atlantic salmon and rainbow trout reared at optimum and high temperature	PLOS ONE			English	Article							ACETYL-L-CARNITINE; OXIDATIVE STRESS; SALAR L.; GOLDFISH TISSUES; L-HISTIDINE; ANTIOXIDANT; CARNOSINE; SYSTEM; GROWTH; ACID	Periods of high or fluctuating seawater temperatures result in several physiological challenges for farmed salmonids, including an increased prevalence and severity of cataracts. The aim of the present study was to compare cataractogenesis in Atlantic salmon (Salmo salar L.) and rainbow trout (Oncorhynchus mykiss) reared at two temperatures, and investigate whether temperature influences lens metabolism and cataract development. Atlantic salmon (101 +/- 2 g) and rainbow trout (125 +/- 3 g) were reared in seawater at either 13 C-omicron (optimum for growth) or 19 C-omicron during the 35 days experiment (n = 4 tanks for each treatment). At the end of the experiment, the prevalence of cataracts was nearly 100% for Atlantic salmon compared to similar to 50% for rainbow trout, irrespective of temperature. The severity of the cataracts, as evaluated by slit-lamp inspection of the lens, was almost three fold higher in Atlantic salmon compared to rainbow trout. The global metabolic profile revealed differences in lens composition and metabolism between the two species, which may explain the observed differences in cataract susceptibility between the species. The largest differences were seen in the metabolism of amino acids, especially the histidine metabolism, and this was confirmed by a separate quantitative analysis. The global metabolic profile showed temperature dependent differences in the lens carbohydrate metabolism, osmoregulation and redox homeostasis. The results from the present study give new insight in cataractogenesis in Atlantic salmon and rainbow trout reared at high temperature, in addition to identifying metabolic markers for cataract development.	[Remo, Sofie Charlotte; Hevroy, Ernst Morten; Olsvik, Pal Asgeir; Waagbo, Rune] Natl Inst Nutr & Seafood Res NIFES, Bergen, Norway; [Breck, Olav] Marine Harvest ASA, Bergen, Norway; [Hevroy, Ernst Morten] Cargill Innovat Ctr, Dirdal, Norway		Remo, SC (corresponding author), Natl Inst Nutr & Seafood Res NIFES, Bergen, Norway.	Sofie.Remo@nifes.no	Olsvik, Pål A/B-8232-2012; Waagbø, Rune/M-4567-2019	Olsvik, Pål A/0000-0002-5641-9420; Waagbo, Rune/0000-0001-6075-3221	Research Council of Norway [199683/S40]	Research Council of Norway(Research Council of Norway)	The present study was funded by the Research Council of Norway (grant number 199683/S40) to EMH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funder provided support in the form of salaries for authors SCR, RW, EMH, PAO and funds to carry out the experiment and analysis. OB's salary was paid by Marine Harvest ASA, but the company had no role in the study design or decision to publish. The specific roles of these authors are articulated in the 'author contributions' section.	Ahmed N, 2005, DIABETES RES CLIN PR, V67, P3, DOI 10.1016/j.diabres.2004.09.004; ANDLEY UP, 1994, INVEST OPHTH VIS SCI, V35, P374; Babizhayev Mark A, 2004, Drugs R D, V5, P125, DOI 10.2165/00126839-200405030-00001; Bagnyukova TV, 2007, J THERM BIOL, V32, P227, DOI 10.1016/j.jtherbio.2007.01.004; Baslow MH, 2002, NEUROCHEM INT, V40, P295, DOI 10.1016/S0197-0186(01)00095-X; Baslow MH, 1998, J MOL NEUROSCI, V10, P193, DOI 10.1007/BF02761774; Baslow MH, 1997, J NEUROCHEM, V68, P1335; Bjerkas E, 1996, ACTA VET SCAND, V37, P351; Bjerkas E, 2001, J FISH DIS, V24, P281, DOI 10.1046/j.1365-2761.2001.00299.x; Breck O, 2005, AQUACULT NUTR, V11, P321, DOI 10.1111/j.1365-2095.2005.00362.x; Breck O, 2005, J FISH DIS, V28, P357, DOI 10.1111/j.1365-2761.2005.00640.x; Breck O, 2003, AQUACULT NUTR, V9, P341, DOI 10.1046/j.1365-2095.2003.00269.x; Breck O, 2001, BULL EUR ASSN FISH P, V21, P91; Brennan LA, 2009, EXP EYE RES, V88, P195, DOI 10.1016/j.exer.2008.05.018; Brerkas E, 2006, CAB REV PERSPECTIVES, V1; Bridi R, 2005, METAB BRAIN DIS, V20, P155, DOI 10.1007/s11011-005-4152-8; Chan AWH, 2008, EXP EYE RES, V87, P454, DOI 10.1016/j.exer.2008.08.001; Chung SSM, 2003, J AM SOC NEPHROL, V14, pS233, DOI 10.1097/01.ASN.0000077408.15865.06; Deeley JM, 2010, J LIPID RES, V51, P2753, DOI 10.1194/jlr.M007716; DeHaven CD, 2010, J CHEMINFORMATICS, V2, DOI 10.1186/1758-2946-2-9; Dello SAWG, 2013, CLIN NUTR, V32, P325, DOI 10.1016/j.clnu.2012.10.008; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Elanchezhian R, 2010, CHEM-BIOL INTERACT, V184, P346, DOI 10.1016/j.cbi.2010.01.006; Evans AM, 2009, ANAL CHEM, V81, P6656, DOI 10.1021/ac901536h; Friedrich N, 2012, J ENDOCRINOL, V215, P29, DOI 10.1530/JOE-12-0120; Handeland SO, 2008, AQUACULTURE, V283, P36, DOI 10.1016/j.aquaculture.2008.06.042; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Hevroy EM, 2012, GEN COMP ENDOCR, V175, P118, DOI 10.1016/j.ygcen.2011.10.007; Hevroy EM, 2015, COMP BIOCHEM PHYS A, V188, P127, DOI 10.1016/j.cbpa.2015.06.030; Hevroy EM, 2013, J COMP PHYSIOL B, V183, P243, DOI 10.1007/s00360-012-0704-5; Hobart LJ, 2004, LIFE SCI, V75, P1379, DOI 10.1016/j.lfs.2004.05.002; Jobling M., 1994, FISH BIOENERGETICS; Jorgensen Sven Martin, 2014, BMC Physiology, V14, P2, DOI 10.1186/1472-6793-14-2; Kullgren A, 2013, COMP BIOCHEM PHYS A, V164, P44, DOI 10.1016/j.cbpa.2012.10.005; Lapko VN, 2003, PROTEIN SCI, V12, P1762, DOI 10.1110/ps.0305403; Lee AYW, 1999, FASEB J, V13, P23, DOI 10.1096/fasebj.13.1.23; Lee YT, 2005, EUR J PHARMACOL, V513, P145, DOI 10.1016/j.ejphar.2005.02.010; Lou MF, 2003, PROG RETIN EYE RES, V22, P657, DOI 10.1016/S1350-9462(03)00050-8; Lushchak VI, 2006, COMP BIOCHEM PHYS C, V143, P36, DOI 10.1016/j.cbpc.2005.11.018; Midelfart A, 2009, ACTA OPHTHALMOL, V87, P697, DOI 10.1111/j.1755-3768.2009.01516.x; Milligan CL, 1997, FISH PHYSIOL BIOCHEM, V16, P119, DOI 10.1007/BF00004669; NISHI O, 1992, BRIT J OPHTHALMOL, V76, P338, DOI 10.1136/bjo.76.6.338; NRC (National Research Council), 2011, NUTR REQ FISH SHRIMP; ODOWD JJ, 1990, J NEUROCHEM, V55, P446, DOI 10.1111/j.1471-4159.1990.tb04156.x; Reitman ZJ, 2011, P NATL ACAD SCI USA, V108, P3270, DOI 10.1073/pnas.1019393108; Remo SC, 2014, BRIT J NUTR, V111, P1759, DOI 10.1017/S0007114513004418; Remo SC, 2011, EXP EYE RES, V92, P414, DOI 10.1016/j.exer.2011.02.018; Rhodes JD, 2010, AM J PHYSIOL-REG I, V299, pR1075, DOI 10.1152/ajpregu.00214.2010; SPECTOR A, 1995, FASEB J, V9, P1173, DOI 10.1096/fasebj.9.12.7672510; Spector A, 1997, EXP EYE RES, V64, P477, DOI 10.1006/exer.1996.0250; Swamy-Mruthinti S, 1999, EXP EYE RES, V69, P109, DOI 10.1006/exer.1999.0680; TAO RVP, 1975, BIOCHIM BIOPHYS ACTA, V409, P329, DOI 10.1016/0005-2760(75)90029-6; Tocher DR, 2000, FISH PHYSIOL BIOCHEM, V23, P59, DOI 10.1023/A:1007807201093; Truscott RJW, 2012, EXP EYE RES, V99, P48, DOI 10.1016/j.exer.2012.04.002; Tsentalovich YP, 2015, EXP EYE RES, V134, P15, DOI 10.1016/j.exer.2015.03.008; Turk Z, 1997, ACTA DIABETOL, V34, P49, DOI 10.1007/s005920050066; VARMA SD, 1979, INVEST OPHTH VIS SCI, V18, P236; Viant MR, 2003, FISH PHYSIOL BIOCHEM, V29, P159, DOI 10.1023/B:FISH.0000035938.92027.81; Vinson Joe A, 2006, Pathophysiology, V13, P151, DOI 10.1016/j.pathophys.2006.05.006; Waagbo R, 2003, J FISH DIS, V26, P213, DOI 10.1046/j.1365-2761.2003.00449.x; Waagbo R, 2010, BRIT J NUTR, V104, P1460, DOI 10.1017/S0007114510002485; Waagbo R, 1996, J FISH DIS, V19, P365, DOI 10.1111/j.1365-2761.1996.tb00375.x; Wade AM, 1998, J NUTR BIOCHEM, V9, P308, DOI 10.1016/S0955-2863(98)00022-9; WALEY SG, 1958, BIOCHEM J, V68, P189, DOI 10.1042/bj0680189; Wall T, 1999, BULL EUR ASSN FISH P, V19, P162; Williams DL, 2006, VET OPHTHALMOL, V9, P292, DOI 10.1111/j.1463-5224.2006.00498.x; Yan H, 2008, MOL VIS, V14, P2282; Yanshole VV, 2014, EXP EYE RES, V125, P71, DOI 10.1016/j.exer.2014.05.016; YEAMAN SJ, 1989, BIOCHEM J, V257, P625, DOI 10.1042/bj2570625	69	13	13	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2017	12	4							e0175491	10.1371/journal.pone.0175491	http://dx.doi.org/10.1371/journal.pone.0175491			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KH	28419112	gold, Green Published, Green Submitted			2022-12-27	WOS:000399875200024
J	Ho, TW; Huang, CT; Ruan, SY; Tsai, YJ; Lai, FP; Yu, CJ				Ho, Te-Wei; Huang, Chun-Ta; Ruan, Sheng-Yuan; Tsai, Yi-Ju; Lai, Feipei; Yu, Chong-Jen			Diabetes mellitus in patients with chronic obstructive pulmonary disease-The impact on mortality	PLOS ONE			English	Article							LONG-TERM SURVIVAL; SYSTEMIC INFLAMMATION; MYOCARDIAL-INFARCTION; INSULIN-RESISTANCE; METABOLIC SYNDROME; HEART-FAILURE; BETA-BLOCKERS; LUNG-FUNCTION; COPD; PREVALENCE	Background Chronic obstructive pulmonary disease (COPD) is the leading cause of morbidity and mortality worldwide. There is evidence to support a connection between COPD and diabetes mellitus (DM), another common medical disorder. However, additional research is required to improve our knowledge of these relationships and their possible implications. In this study, we investigated the impact of DM on patient outcomes through the clinical course of COPD. Methods We conducted a cohort study in patients from the Taiwan Longitudinal Health Insurance Database between 2000 and 2013. Patients with COPD were identified and assessed for pre-existing and incident DM. A Cox proportional hazards model was built to identify factors associated with incident DM and to explore the prognostic effects of DM on COPD patients. A propensity score method was used to match COPD patients with incident DM to controls without incident DM. Results Pre-existing DM was present in 332 (16%) of 2015 COPD patients who had a significantly higher hazard ratio (HR) [1.244, 95% confidence interval (CI) 1.010-1.532] for mortality than that of the COPD patients without pre-existing DM. During the 10-year follow-up period, 304 (19%) of 1568 COPD patients developed incident DM; comorbid hypertension (HR, 1.810; 95% CI, 1.363-2.403), cerebrovascular disease (HR, 1.517; 95% CI, 1.146-2.008) and coronary artery disease (HR, 1.408; 95% CI 1.089-1.820) were significant factors associated with incident DM. Survival was worse for the COPD patients with incident DM than for the matched controls without incident DM (Log-rank, p = 0.027). Conclusions DM, either pre-existing or incident, was associated with worse outcomes in COPD patients. Targeted surveillance and management of DM may be important in clinical care of the COPD population.	[Ho, Te-Wei; Lai, Feipei] Natl Taiwan Univ, Grad Inst Biomed Elect & Bioinformat, Taipei, Taiwan; [Huang, Chun-Ta; Ruan, Sheng-Yuan; Yu, Chong-Jen] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei, Taiwan; [Huang, Chun-Ta] Natl Taiwan Univ Hosp, Dept Traumatol, Taipei, Taiwan; [Huang, Chun-Ta] Natl Taiwan Univ, Grad Inst Clin Med, Taipei, Taiwan; [Tsai, Yi-Ju] Fu Jen Catholic Univ, Coll Med, Grad Inst Biomed & Pharmaceut Sci, New Taipei, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; Fu Jen Catholic University	Huang, CT (corresponding author), Natl Taiwan Univ Hosp, Dept Internal Med, Taipei, Taiwan.; Huang, CT (corresponding author), Natl Taiwan Univ Hosp, Dept Traumatol, Taipei, Taiwan.; Huang, CT (corresponding author), Natl Taiwan Univ, Grad Inst Clin Med, Taipei, Taiwan.	huangct@ntu.edu.tw	Ho, Te-Wei/F-1309-2015	Ho, Te-Wei/0000-0002-4371-6936; Yu, Chong-Jen/0000-0001-5664-9392; RUAN, SHENG-YUAN/0000-0002-7949-7253; HUANG, CHUN-TA/0000-0002-5234-4986	Ministry of Science and Technology, Taiwan (MOST) [105-2221-E-002-155-MY3]; Eighth Core Lab; Department of Medical Research; National Taiwan University Hospital	Ministry of Science and Technology, Taiwan (MOST)(Ministry of Science and Technology, Taiwan); Eighth Core Lab; Department of Medical Research; National Taiwan University Hospital(National Taiwan University)	This study was supported in part by a grant from the Ministry of Science and Technology, Taiwan (MOST 105-2221-E-002-155-MY3). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the staff of the Eighth Core Lab, Department of Medical Research, National Taiwan University Hospital for technical support during the study.	Agusti A, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-122; Agusti Alvar G N, 2005, Proc Am Thorac Soc, V2, P367, DOI 10.1513/pats.200504-026SR; Akpinar EE, 2012, TUBERK TORAK, V60, P230, DOI 10.5578/tt.4018; Almagro P, 2010, THORAX, V65, P298, DOI 10.1136/thx.2009.124818; Andreas S, 2006, EUR RESPIR J, V27, P972, DOI 10.1183/09031936.06.00098105; Angeloni E, 2013, ANN THORAC SURG, V95, P525, DOI 10.1016/j.athoracsur.2012.07.080; Barnes PJ, 2009, EUR RESPIR J, V33, P1165, DOI 10.1183/09031936.00128008; Bhatt SP, 2013, TRANSL RES, V162, P237, DOI 10.1016/j.trsl.2013.05.001; Boudestein LCM, 2009, EUR J HEART FAIL, V11, P1182, DOI 10.1093/eurjhf/hfp148; Brennan AL, 2007, J CYST FIBROS, V6, P101, DOI 10.1016/j.jcf.2006.03.009; BURGHUBER OC, 1987, RESPIRATION, V52, P86, DOI 10.1159/000195309; Cazzola M, 2012, AM J RESP CELL MOL, V47, P509, DOI 10.1165/rcmb.2011-0449OC; Cazzola M, 2010, RESPIRATION, V80, P112, DOI 10.1159/000281880; Chatila Wissam M, 2008, Proc Am Thorac Soc, V5, P549, DOI 10.1513/pats.200709-148ET; Chen CH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167321; Cheng SL, 2015, INT J CHRONIC OBSTR, V10, P2459, DOI 10.2147/COPD.S89672; Crook M, 2004, DIABETIC MED, V21, P203, DOI 10.1046/j.1464-5491.2003.01030.x; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; Davis WA, 2004, DIABETES CARE, V27, P752, DOI 10.2337/diacare.27.3.752; Ehrlich SF, 2010, DIABETES CARE, V33, P55, DOI 10.2337/dc09-0880; Esposito K, 2002, CIRCULATION, V106, P2067, DOI 10.1161/01.CIR.0000034509.14906.AE; Feary JR, 2010, THORAX, V65, P956, DOI 10.1136/thx.2009.128082; Festa A, 2000, CIRCULATION, V102, P42, DOI 10.1161/01.CIR.102.1.42; Forgiarini LA, 2009, J BRAS PNEUMOL, V35, P788, DOI 10.1590/S1806-37132009000800011; Glaser S, 2015, RESPIRATION, V89, P253, DOI 10.1159/000369863; Global Initiative for Chronic Obstructive Lung Disease, 2017, GLOBAL STRATEGY DIAG; Gudmundsson G, 2012, INT J CHRONIC OBSTR, V7, P571, DOI 10.2147/COPD.S34466; Hawkins NM, 2009, EUR J HEART FAIL, V11, P130, DOI 10.1093/eurjhf/hfn013; Ho TW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114866; Horita N, 2014, RESP RES, V15, DOI 10.1186/1465-9921-15-80; Hurst JR, 2010, NEW ENGL J MED, V363, P1128, DOI 10.1056/NEJMoa0909883; Khedr EM, 2000, EUR J NEUROL, V7, P509, DOI 10.1046/j.1468-1331.2000.00104.x; Lahousse L, 2015, RESP MED, V109, P1371, DOI 10.1016/j.rmed.2015.07.014; Lawlor DA, 2004, DIABETOLOGIA, V47, P195, DOI 10.1007/s00125-003-1310-6; Lee CTC, 2013, EUR J CLIN INVEST, V43, P1113, DOI 10.1111/eci.12147; Leslie RD, 2016, DIABETOLOGIA, V59, P13, DOI 10.1007/s00125-015-3789-z; Lin CC, 2005, J FORMOS MED ASSOC, V104, P157; Lin CW, 2015, INT J CHRONIC OBSTR, V10, DOI 10.2147/COPD.S85432; Lin HW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130102; Lin JC, 2014, JAMA OPHTHALMOL, V132, P922, DOI 10.1001/jamaophthalmol.2014.859; Litonjua AA, 2005, RESP MED, V99, P1583, DOI 10.1016/j.rmed.2005.03.023; Luo Zhehui, 2010, Med Care Res Rev, V67, P528, DOI 10.1177/1077558710361486; Macchia A, 2012, EUR RESPIR J, V39, P51, DOI 10.1183/09031936.00044411; Mancini GBJ, 2006, J AM COLL CARDIOL, V47, P2554, DOI 10.1016/j.jacc.2006.04.039; Mannino DM, 2008, EUR RESPIR J, V32, P962, DOI 10.1183/09031936.00012408; MARHOFFER W, 1992, DIABETES CARE, V15, P256, DOI 10.2337/diacare.15.2.256; Martino R, 2005, STROKE, V36, P2756, DOI 10.1161/01.STR.0000190056.76543.eb; Miller J, 2013, RESP MED, V107, P1376, DOI 10.1016/j.rmed.2013.05.001; MOLS P, 1986, J CARDIOVASC PHARM, V8, P77, DOI 10.1097/00005344-198601000-00013; Mortensen EM, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-45; National Health Insurance Administration Ministry of Health and Welfare Taiwan ROC, 2014, NATL HLTH INSURANCE; Niewoehner DE, 2007, CHEST, V131, P20, DOI 10.1378/chest.06-1316; Parappil A, 2010, RESPIROLOGY, V15, P918, DOI 10.1111/j.1440-1843.2010.01781.x; Park SK, 2014, J CARDIOVASC NURS, V29, P499, DOI 10.1097/JCN.0000000000000096; Rogliani P., 2015, COPD RES PRACT, V1, P3, DOI [10.1186/s40749-015-0005-y, DOI 10.1186/S40749-015-0005-Y]; Short PM, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d2549; Sode BF, 2011, EUR HEART J, V32, P2365, DOI 10.1093/eurheartj/ehr338; Vos T, 2015, LANCET, V386, P743, DOI 10.1016/S0140-6736(15)60692-4; Wang MT, 2013, AM J MED, V126, P598, DOI 10.1016/j.amjmed.2013.01.036; Wang Y, 2014, INT J CHRONIC OBSTR, V9, P99, DOI 10.2147/COPD.S51467; Wu CS, 2014, J CLIN PSYCHIAT, V75, P31, DOI 10.4088/JCP.13m08421; Yang YW, 2011, CAN MED ASSOC J, V183, pE275, DOI 10.1503/cmaj.101137	62	34	37	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2017	12	4							e0175794	10.1371/journal.pone.0175794	http://dx.doi.org/10.1371/journal.pone.0175794			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0MD	28410410	gold, Green Submitted, Green Published			2022-12-27	WOS:000399955600043
J	Visagie, MH; van den Bout, I; Joubert, AM				Visagie, Michelle Helen; van den Bout, Iman; Joubert, Annie Margaretha			A bis-sulphamoylated estradiol derivative induces ROS-dependent cell cycle abnormalities and subsequent apoptosis	PLOS ONE			English	Article							ENDOGENOUS MAMMALIAN METABOLITE; INHIBITS TUBULIN POLYMERIZATION; SUPEROXIDE-DISMUTASE; 2-METHOXYESTRADIOL; ANGIOGENESIS; INDUCTION; DYNAMICS; ANALOGS; AGENT; LINE	Clinical trials have revealed that the potential anticancer agent, 2-methoxyestradiol (2ME2) has limitations due to its low bioavailability. Subsequently, 2ME2 derivatives including (8R, 13S, 14S, 17S)-2-ethyl-13-methyl-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[ a] phenanthrane-3,17-diyl bis(sulphamate) (EMBS) have shown improved efficacies in inducing apoptosis. However, no conclusive data exist to explain the mode of action exerted by these drugs. This study investigated the mode of action used by EMBS as a representative of the sulphamoylated 2ME2 derivatives. Hydrogen peroxide and superoxide production was quantified using dichlorofluorescein diacetate and hydroethidine. Cell proliferation and mitochondrial metabolism were investigated using crystal violet and Alamar Blue. Apoptosis was assessed using Annexin V-FITC while mitochondrial integrity was assessed using Mitocapture. Autophagy was visualised using LC3B II antibodies. The effects of EMBS on H2A phosphorylation and nuclei were visualised using phospho H2A antibody and 4', 6-diamidino-2-phenylindole, dihydrochloride. Data showed that EMBS exposure leads to increased reactive oxygen species (ROS) production which is correlated with loss of cell proliferation, mitochondrial membrane damage, decreased metabolic activity, G(2)/M arrest, endoreduplication, DNA double stranded breaks, micronuclei and apoptosis induction. Treatment of EMBS-exposed cells with the ROS scavenger, N-acetyl cysteine, abrogated ROS production, cell cycle arrest and apoptosis implying an essential role for ROS production in EMBS signaling. The inhibition of c-Jun N-terminal kinase (JNK) activity also inhibited EMBS-induced apoptosis suggesting that EMBS triggers apoptosis via the JNK pathway. Lastly, evaluation of LC3IIB protein levels indicated that autophagy is not activated in EMBS-exposed cells. Our data shows that EMBS targets a pathway that leads to increased ROS production as an early event that culminates in G(2)/M arrest and apoptosis by means of JNK-signaling in cancer cells. This study suggests a novel oxidative stress-dependent mode of action for sulphamoylated derivatives.	[Visagie, Michelle Helen; van den Bout, Iman; Joubert, Annie Margaretha] Univ Pretoria, Dept Physiol, Fac Hlth Sci, Pretoria, South Africa	University of Pretoria	Visagie, MH (corresponding author), Univ Pretoria, Dept Physiol, Fac Hlth Sci, Pretoria, South Africa.	michelle.visage@up.ac.za	Visagie, Michelle/W-3068-2019; Joubert, Annie/AAU-4562-2021; Visagie, Michelle/AAV-5541-2020	Visagie, Michelle/0000-0002-6820-7265; Joubert, Annie/0000-0002-6931-7554; van den Bout, Iman/0000-0001-6333-1470	Cancer Association of South Africa; Struwig Germeshuysen Trust; Research Committee of the Faculty of Health Sciences, University of Pretoria; National Research Foundation; Medical Research Council of South Africa; Research Committee of the Faculty of Health Sciences	Cancer Association of South Africa; Struwig Germeshuysen Trust; Research Committee of the Faculty of Health Sciences, University of Pretoria; National Research Foundation; Medical Research Council of South Africa(South African Medical Research Council); Research Committee of the Faculty of Health Sciences	This study was supported by grants from the Cancer Association of South Africa, the Struwig Germeshuysen Trust, the Research Committee of the Faculty of Health Sciences, University of Pretoria, the National Research Foundation and the Medical Research Council of South Africa awarded to Professor AM Joubert. Additional funds were supplied by the Research Committee of the Faculty of Health Sciences, awarded to Dr. MH Visagie. None of the funding sources had any involvement in the project.	Bampton ETW, 2005, AUTOPHAGY, V1, P23, DOI 10.4161/auto.1.1.1495; Bonnier F, 2015, TOXICOL IN VITRO, V29, P124, DOI 10.1016/j.tiv.2014.09.014; Bruce JY, 2012, INVEST NEW DRUG, V30, P794, DOI 10.1007/s10637-010-9618-9; CAILLEAU R, 1974, J NATL CANCER I, V53, P661, DOI 10.1093/jnci/53.3.661; CUSHMAN M, 1995, J MED CHEM, V38, P2041, DOI 10.1021/jm00012a003; Dahut WL, 2006, CANCER BIOL THER, V5, P22, DOI 10.4161/cbt.5.1.2349; DAMATO RJ, 1994, P NATL ACAD SCI USA, V91, P3964, DOI 10.1073/pnas.91.9.3964; Djavaheri-Mergny M, 2003, ONCOGENE, V22, P2558, DOI 10.1038/sj.onc.1206356; Fleury C, 2002, BIOCHIMIE, V84, P131, DOI 10.1016/S0300-9084(02)01369-X; Fridovich I, 2015, AMINO ACIDS, V47, P1605, DOI 10.1007/s00726-015-1996-z; GILLIES RJ, 1986, ANAL BIOCHEM, V159, P109, DOI 10.1016/0003-2697(86)90314-3; Hamel E, 1996, BIOCHEMISTRY-US, V35, P1304, DOI 10.1021/bi951559s; Huang P, 2000, NATURE, V407, P390, DOI 10.1038/35030140; Ireson CR, 2004, BRIT J CANCER, V90, P932, DOI 10.1038/sj.bjc.6601591; Jeggo P, 2007, ONCOGENE, V26, P7717, DOI 10.1038/sj.onc.1210868; Kachadourian R, 2001, ARCH BIOCHEM BIOPHYS, V392, P349, DOI 10.1006/abbi.2001.2455; Kamath K, 2006, MOL CANCER THER, V5, P2225, DOI 10.1158/1535-7163.MCT-06-0113; Kryston TB, 2011, MUTAT RES-FUND MOL M, V711, P193, DOI 10.1016/j.mrfmmm.2010.12.016; Lambert C, 2004, INT J CANCER, V108, P493, DOI 10.1002/ijc.11579; Leese MP, 2006, J MED CHEM, V49, P7683, DOI 10.1021/jm060705x; Mabjeesh NJ, 2003, CANCER CELL, V3, P363, DOI 10.1016/S1535-6108(03)00077-1; Mueck AO, 2010, STEROIDS, V75, P625, DOI 10.1016/j.steroids.2010.02.016; Myhre O, 2003, BIOCHEM PHARMACOL, V65, P1575, DOI 10.1016/S0006-2952(03)00083-2; O'Brien J, 2000, EUR J BIOCHEM, V267, P5421, DOI 10.1046/j.1432-1327.2000.01606.x; PAINE TM, 1992, INT J CANCER, V50, P463, DOI 10.1002/ijc.2910500323; Price BD, 2013, CELL, V152, P1344, DOI 10.1016/j.cell.2013.02.011; Riccardi C, 2006, NAT PROTOC, V1, P1458, DOI 10.1038/nprot.2006.238; Samuni Y, 2013, BBA-GEN SUBJECTS, V1830, P4117, DOI 10.1016/j.bbagen.2013.04.016; Shimada K, 2003, CARCINOGENESIS, V24, P1067, DOI 10.1093/carcin/bgg058; SOULE HD, 1973, J NATL CANCER I, V51, P1409, DOI 10.1093/jnci/51.5.1409; Stander A, 2011, CHEM BIOL DRUG DES, V77, P173, DOI 10.1111/j.1747-0285.2010.01064.x; Theron A, 2015, CANCER CHEMOTH PHARM, V75, P431, DOI 10.1007/s00280-014-2653-z; Ting CM, 2010, BIOCHEM PHARMACOL, V79, P825, DOI 10.1016/j.bcp.2009.10.018; Visagie M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071935; Visagie MH, 2016, BIOL RES, V49, DOI 10.1186/s40659-016-0104-5; Visagie MH, 2015, CELL BIOSCI, V5, DOI 10.1186/s13578-015-0010-5; Visagie MH, 2014, MICROSC RES TECHNIQ, V77, P236, DOI 10.1002/jemt.22334; Yue TL, 1997, MOL PHARMACOL, V51, P951, DOI 10.1124/mol.51.6.951; Zhao HT, 2003, FREE RADICAL BIO MED, V34, P1359, DOI 10.1016/S0891-5849(03)00142-4; Zou HC, 2006, CLIN CANCER RES, V12, P6532, DOI 10.1158/1078-0432.CCR-06-0678	40	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2017	12	4							e0176006	10.1371/journal.pone.0176006	http://dx.doi.org/10.1371/journal.pone.0176006			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0MD	28410397	Green Submitted, Green Published, gold			2022-12-27	WOS:000399955600055
J	Adinan, J; Damian, DJ; Mosha, NR; Mboya, IB; Mamseri, R; Msuya, SE				Adinan, Juma; Damian, Damian J.; Mosha, Neema R.; Mboya, Innocent B.; Mamseri, Redempta; Msuya, Sia E.			Individual and contextual factors associated with appropriate healthcare seeking behavior among febrile children in Tanzania	PLOS ONE			English	Article							EFFECTIVE MALARIA TREATMENT; IMPROVING ACCESS; RURAL TANZANIA; RUFIJI; FEVER; TRANSMISSION; BURDEN; PROMPT	Introduction Fever in malaria endemic areas, has been shown to strongly predict malaria infection and is a key symptom influencing malaria treatment. WHO recommended confirmation testing for Plasmodium spp. before initiation of antimalarials due to increased evidence of the decrease of morbidity and mortality from malaria, decreased malaria associated fever, and increased evidence of high prevalence of non-malaria fever. To immediately diagnose and promptly offer appropriate management, caretakers of children with fever should seek care where these services can be offered; in health facilities. Objectives This study was conducted to describe healthcare seeking behaviors among caretakers of febrile under five years, in Tanzania. And to determine children's, household and community-level factors associated with parents' healthcare seeking behavior in health facilities. Methods Secondary data analysis was done using the Tanzania HIV and Malaria Indicator Surveys (THMIS) 2011-2012. Three-level mixed effects logistic regression was used to assess children's, household and community-level factors associated with appropriate healthcare seeking behavior among care takers of febrile children as well as differentiating between household and community variabilities. Results Of the 8573 children under the age of five years surveyed, 1,675(19.5%) had a history of fever two weeks preceding the survey. Of these, 951 (56.8%) sought appropriate healthcare. Febrile children aged less than a year have 2.7 times higher odds of being taken to the health facilities compared to children with two or more years of age. (OR: 2.7; 95% CI: 1.50-4.88). Febrile children from households headed by female caretakers have almost three times higher odds of being taken to the health facilities (OR: 2.85; 95% CI; 1.41-5.74) compared to households headed by men. Febrile children with caretakers exposed to mass media (radio, television and newspaper) have more than two times higher odds of being taken to health facilities compared to those not exposed to mass media. Febrile children from regions with malaria prevalence above national level have 41% less odds of being taken to health facilities (OR: 0.49; 95% CI: 0.29-0.84) compared to those febrile children coming from areas with malaria prevalence below the national level. Furthermore, febrile children coming from areas with higher community education levels have 57% (OR: 1.57; 95% CI: 1.14-2.15) higher odds of being taken to health facilities compared to their counterparts coming from areas with low levels of community education. Conclusion and recommendation To effectively and appropriately manage and control febrile illnesses, the low proportion of febrile children taken to health facilities by their caretakers should be addressed through frequent advocacy of the importance of appropriate healthcare seeking behavior, using mass media particularly in areas with high malaria prevalence. Multifaceted approach needs to be used in malaria control and eradication as multiple factors are associated with appropriate healthcare seeking behavior.	[Adinan, Juma] KCMC Hosp, AMO Gen Teaching Coll, Moshi, Tanzania; [Adinan, Juma; Damian, Damian J.; Mosha, Neema R.; Mboya, Innocent B.; Mamseri, Redempta; Msuya, Sia E.] Kilimanjaro Christian Med Univ Coll, Inst Publ Hlth, Dept Community Hlth, Moshi, Tanzania; [Adinan, Juma; Damian, Damian J.; Mosha, Neema R.; Mboya, Innocent B.; Mamseri, Redempta; Msuya, Sia E.] Kilimanjaro Christian Med Ctr, Dept Community Hlth, Moshi, Tanzania; [Adinan, Juma; Damian, Damian J.; Mosha, Neema R.; Mboya, Innocent B.; Mamseri, Redempta; Msuya, Sia E.] Kilimanjaro Christian Med Univ Coll, Inst Publ Hlth, Dept Epidemiol & Biostat, Moshi, Tanzania	Kilimanjaro Christian Medical Centre	Adinan, J (corresponding author), KCMC Hosp, AMO Gen Teaching Coll, Moshi, Tanzania.; Adinan, J (corresponding author), Kilimanjaro Christian Med Univ Coll, Inst Publ Hlth, Dept Community Hlth, Moshi, Tanzania.; Adinan, J (corresponding author), Kilimanjaro Christian Med Ctr, Dept Community Hlth, Moshi, Tanzania.; Adinan, J (corresponding author), Kilimanjaro Christian Med Univ Coll, Inst Publ Hlth, Dept Epidemiol & Biostat, Moshi, Tanzania.	adinanjuma@gmail.com	Mboya, Innocent/AAE-6488-2020; Adinan, Juma/N-8259-2015	Mboya, Innocent/0000-0001-9861-5879; Adinan, Juma/0000-0002-7964-2879	London School of Hygiene and Tropical Medicine (LSHTM)	London School of Hygiene and Tropical Medicine (LSHTM)	The authors thank the Tanzanian community for their participation in the survey and DHS PROGRAM for allowing access to the data and the secondary analysis. In addition authors acknowledge important role played by Tara Mtuy, a research fellow with London School of Hygiene and Tropical Medicine (LSHTM) and Professor Pete Mhunzi, retired Linguistic in editing and proofreading the manuscript. We would also like to thank reviewers for devoting their time to improve this manuscript.	Ahorlu CK, 2006, TROP MED INT HEALTH, V11, P1022, DOI 10.1111/j.1365-3156.2006.01660.x; Alba S, 2014, INT J EPIDEMIOL, V43, P204, DOI 10.1093/ije/dyt231; [Anonymous], 2014, M REPORT; Chipwaza B, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-252; Chuma J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-144; D'Acremont V, 2014, NEW ENGL J MED, V370, P809, DOI 10.1056/NEJMoa1214482; Das A, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-377; Deressa W, 2007, ACTA TROP, V102, P1, DOI 10.1016/j.actatropica.2007.02.009; Ettarh R, 2011, HEALTH PLACE, V17, P320, DOI 10.1016/j.healthplace.2010.11.009; Farnert A, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-459; Ferdous F, 2013, SCI J PUBLIC HLTH, V1, P69, DOI DOI 10.11648/J.SJPH.20130102.14; Halwindi H, 2013, ISRN TROP MED, V2013, P1; Hetzel MW, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-83; Hwang J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011692; Kahabuka C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058789; Kizito J, 2012, MALARIA J, V11, DOI [10.1186/PREACCEPT-2317562776368437, 10.1186/1475-2875-11-55]; Masangwi S. J., 2010, Southern African Journal of Epidemiology & Infection, V25, P22; Mashauri FM, 2013, AM J TROP MED HYG, V88, P841, DOI 10.4269/ajtmh.12-0412; Metta E, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-249; Mustafa HS, 2009, TROP MED INT HEALTH, V14, P1488, DOI 10.1111/j.1365-3156.2009.02394.x; Najnin N, 2011, J HEALTH POPUL NUTR, V29, P523, DOI 10.3329/jhpn.v29i5.8907; National Bereau of statistics, 2012, RES 2011 12 TANZ HIV; Odaga J, 2011, COCHRANE DATABASE SY; Okiro EA, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-99; Rutebemberwa E, 2009, TROP MED INT HEALTH, V14, P472, DOI 10.1111/j.1365-3156.2009.02237.x; Simba DO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012104; Smithson P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141112; Spjeldnaes AO, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-200; Tanzania Bureau of Statistics and Macro International, 2010, TANZ DEM HLTH SURV 2, P1, DOI [10.1007/SpringerReference_187125, DOI 10.1007/SPRINGERREFERENCE_187125]; Tarimo D. S., 2015, Asian Pacific Journal of Tropical Disease, V5, P862, DOI 10.1016/S2222-1808(15)60946-X; Tarimo DS, 2014, MALAR CHEMOTHER CONT, V3, P1; Thandar MM, 2015, MALARIA J, V14, DOI 10.1186/1475-2875-14-1; World Health Organization, 2015, GUID TREATM MAL, P71, DOI DOI 10.1016/0035-9203(91)90261-V]; Yebyo H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124718	34	24	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2017	12	4							e0175446	10.1371/journal.pone.0175446	http://dx.doi.org/10.1371/journal.pone.0175446			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0MB	28406952	Green Submitted, Green Published, gold			2022-12-27	WOS:000399955400054
J	Bhavsar, AP; Gunaretnam, EP; Li, YL; Hasbullah, JS; Carleton, BC; Ross, CJD				Bhavsar, Amit P.; Gunaretnam, Erandika P.; Li, Yuling; Hasbullah, Jafar S.; Carleton, Bruce C.; Ross, Colin J. D.			Pharmacogenetic variants in TPMT alter cellular responses to cisplatin in inner ear cell lines	PLOS ONE			English	Article							THIOPURINE S-METHYLTRANSFERASE; PLATINUM-INDUCED OTOTOXICITY; COMT GENETIC-VARIATION; INDUCED HEARING-LOSS; CHILDREN; METABOLISM; MECHANISMS; PREVENTION; MANAGEMENT; CANCER	Cisplatin is a highly-effective and widely-used chemotherapeutic agent that causes ototoxicity in many patients. Pharmacogenomic studies of key genes controlling drug biotransformation identified variants in thiopurine methyltransferase (TPMT) as predictors of cisplatin-induced ototoxicity, although the mechanistic basis of this interaction has not been reported. Expression constructs of TPMT*3A, *3B and *3C variants were generated and monitored in cultured cells. Cellular TPMT*3A levels were detected at >20-fold lower amounts than the wild type confirming the unstable nature of this variant. The expression of wild type TPMT (TPMT*1) in two murine ear cell lines, HEI-OC1 and UB/OC-1, significantly mitigated their susceptibility to cisplatin toxicity. Cisplatin treatment induced Tlr4 gene expression in HEI-OC1 cells and this response was blunted by the expression of wild type TPMT but not TPMT*3A. In line with the significant mitigation of TPMT*1-expressing cells to cisplatin cytotoxicity, these findings demonstrate a drug-gene interaction between increased TPMT activity and decreased susceptibility to cisplatin-induced toxicity of inner ear cells.	[Bhavsar, Amit P.; Gunaretnam, Erandika P.; Ross, Colin J. D.] Univ British Columbia, Fac Pharmaceut Sci, Vancouver, BC, Canada; [Bhavsar, Amit P.; Gunaretnam, Erandika P.; Li, Yuling; Hasbullah, Jafar S.; Carleton, Bruce C.; Ross, Colin J. D.] BC Childrens Hosp, Res Inst, Vancouver, BC, Canada; [Gunaretnam, Erandika P.; Li, Yuling; Carleton, Bruce C.] Univ British Columbia, Div Translat Therapeut, Dept Pediat, Fac Med, Vancouver, BC, Canada; [Hasbullah, Jafar S.] Univ British Columbia, Dept Med Genet, Fac Med, Vancouver, BC, Canada; [Bhavsar, Amit P.] Univ Alberta, Fac Med & Dent, Dept Med Microbiol & Immunol, Edmonton, AB, Canada	University of British Columbia; BC Childrens Hospital; University of British Columbia; University of British Columbia; University of British Columbia; University of Alberta	Ross, CJD (corresponding author), Univ British Columbia, Fac Pharmaceut Sci, Vancouver, BC, Canada.; Ross, CJD (corresponding author), BC Childrens Hosp, Res Inst, Vancouver, BC, Canada.	colin.ross@ubc.ca		Ross, Colin/0000-0003-1476-7037; Carleton, Bruce/0000-0002-4485-4054	Canadian Gene Cure Foundation; BC Childrens Hospital Research Institute; The Hearing Foundation of Canada; Canada Foundation for Innovation; Development Fund; UBC Faculty of Medicine; Canadian Institutes of Health Research [FRN-88362]	Canadian Gene Cure Foundation; BC Childrens Hospital Research Institute; The Hearing Foundation of Canada; Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Development Fund; UBC Faculty of Medicine; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This research was supported by funding from the Canadian Gene Cure Foundation (genecure.ca) to CJDR, BC Childrens Hospital Research Institute (bcchr.ca) to BCC and CJDR, The Hearing Foundation of Canada (www.hearingfoundation.ca), Canada Foundation for Innovation (www.innovation.ca) to BCC and CJDR, BC Knowledge Development Fund to BCC and CJDR, UBC Faculty of Medicine to CJDR, and the Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca; FRN-88362) to BCC and CJDR. CJDR is a Michael Smith Foundation for Health Research Scholar (www.msfhr.org) and CIHR New Investigator. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brock PR, 2012, J CLIN ONCOL, V30, P2408, DOI 10.1200/JCO.2011.39.1110; Carleton BC, 2014, CLIN PHARMACOL THER, V95, P253, DOI 10.1038/clpt.2013.219; Estlin EJ, 2003, CANCER TREAT REV, V29, P253, DOI 10.1016/S0305-7372(02)00109-3; Hagleitner MM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115869; Hayes-Lattin B, 2009, SEMIN ONCOL, V36, P432, DOI 10.1053/j.seminoncol.2009.07.006; Ho GY, 2016, CRIT REV ONCOL HEMAT, V102, P37, DOI 10.1016/j.critrevonc.2016.03.014; Hosni-Ahmed A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029163; Kalinec F, 1999, CELL BIOL INT, V23, P175, DOI 10.1006/cbir.1998.0339; Langer T, 2013, TRENDS PHARMACOL SCI, V34, P458, DOI 10.1016/j.tips.2013.05.006; Lee JW, 2016, THER DRUG MONIT, V38, P423, DOI 10.1097/FTD.0000000000000298; Milek M, 2012, BIOCHEM PHARMACOL, V83, P969, DOI 10.1016/j.bcp.2012.01.010; Mukherjea D, 2011, PHARMACOGENOMICS, V12, P1039, DOI [10.2217/PGS.11.48, 10.2217/pgs.11.48]; Ochoa B, 2009, ARCH MED RES, V40, P54, DOI 10.1016/j.arcmed.2008.10.006; Oh GS, 2011, J IMMUNOL, V186, P1140, DOI 10.4049/jimmunol.1002183; Pussegoda K, 2013, CLIN PHARMACOL THER, V94, P243, DOI 10.1038/clpt.2013.80; Relling MV, 2011, CLIN PHARMACOL THER, V89, P387, DOI 10.1038/clpt.2010.320; Rivolta MN, 1998, P ROY SOC B-BIOL SCI, V265, P1595, DOI 10.1098/rspb.1998.0477; Ross CJD, 2009, NAT GENET, V41, P1345, DOI 10.1038/ng.478; Rybak LP, 2007, HEARING RES, V226, P157, DOI 10.1016/j.heares.2006.09.015; Salavaggione OE, 2005, PHARMACOGENET GENOM, V15, P801, DOI 10.1097/01.fpc.0000174788.69991.6b; Tai HL, 1999, PHARMACOGENETICS, V9, P641, DOI 10.1097/01213011-199910000-00011; Townsend DM, 2003, J AM SOC NEPHROL, V14, P1, DOI 10.1097/01.ASN.0000042803.28024.92; Travis LB, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju044; van Dalen EC, 2016, COCHRANE DB SYST REV, V8, DOI DOI 10.1038/CIPT.2013.80; von Stechow L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076476; Waissbluth S, 2016, EUROPEAN ARCH OTO RH; Wang LW, 2005, P NATL ACAD SCI USA, V102, P9394, DOI 10.1073/pnas.0502352102; Yancey A, 2012, PEDIATR BLOOD CANCER, V59, P144, DOI 10.1002/pbc.24138; Yang JJ, 2013, CLIN PHARMACOL THER, V94, P252, DOI 10.1038/clpt.2013.121; Zhang J, 2016, ACS CHEM BIOL, V11, P583, DOI 10.1021/acschembio.5b00812; Zhang L, 2003, J PHARMACOL EXP THER, V306, P988, DOI 10.1124/jpet.103.052225	31	9	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2017	12	4							e0175711	10.1371/journal.pone.0175711	http://dx.doi.org/10.1371/journal.pone.0175711			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0MB	28406961	Green Published, gold, Green Submitted			2022-12-27	WOS:000399955400085
J	Buck, E; Zugel, M; Schumann, U; Merz, T; Gumpp, AM; Witting, A; Steinacker, JM; Landwehrmeyer, GB; Weydt, P; Calzia, E; Lindenberg, KS				Buck, Eva; Zuegel, Martina; Schumann, Uwe; Merz, Tamara; Gumpp, Anja M.; Witting, Anke; Steinacker, Juergen M.; Landwehrmeyer, G. Bernhard; Weydt, Patrick; Calzia, Enrico; Lindenberg, Katrin S.			High-resolution respirometry of fine-needle muscle biopsies in pre-manifest Huntington's disease expansion mutation carriers shows normal mitochondrial respiratory function	PLOS ONE			English	Article							SKELETAL-MUSCLE; GENE-EXPRESSION; WEIGHT-LOSS; MODEL; DYSFUNCTION; BRAIN; ONSET; AGE; ABNORMALITIES; PATHOGENESIS	Alterations in mitochondrial respiration are an important hallmark of Huntington's disease (HD), one of the most common monogenetic causes of neurodegeneration. The ubiquitous expression of the disease causing mutant huntingtin gene raises the prospect that mitochondrial respiratory deficits can be detected in skeletal muscle. While this tissue is readily accessible in humans, transgenic animal models offer the opportunity to cross-validate findings and allow for comparisons across organs, including the brain. The integrated respiratory chain function of the human vastus lateralis muscle was measured by high-resolution respirometry (HRR) in freshly taken fine-needle biopsies from seven pre-manifest HD expansion mutation carriers and nine controls. The respiratory parameters were unaffected. For comparison skeletal muscle isolated from HD knock-in mice (Hdh(Q111)) as well as a broader spectrum of tissues including cortex, liver and heart muscle were examined by HRR. Significant changes of mitochondrial respiration in the HdhQ knock-in mouse model were restricted to the liver and the cortex. Mitochondrial mass as quantified by mitochondrial DNA copy number and citrate synthase activity was stable in murine HD-model tissue compared to control. mRNA levels of key enzymes were determined to characterize mitochondrial metabolic pathways in HdhQ mice. We demonstrated the feasibility to perform high-resolution respirometry measurements from small human HD muscle biopsies. Furthermore, we conclude that alterations in respiratory parameters of pre-manifest human muscle biopsies are rather limited and mirrored by a similar absence of marked alterations in HdhQ skeletal muscle. In contrast, the Hdh Q111 murine cortex and liver did show respiratory alterations highlighting the tissue specific nature of mutant huntingtin effects on respiration.	[Buck, Eva; Merz, Tamara; Gumpp, Anja M.; Witting, Anke; Landwehrmeyer, G. Bernhard; Weydt, Patrick; Lindenberg, Katrin S.] Univ Ulm, Dept Neurol, Ulm, Germany; [Zuegel, Martina; Schumann, Uwe; Steinacker, Juergen M.] Univ Ulm, Div Sports & Rehabil Med, Med Ctr, Ulm, Germany; [Weydt, Patrick] Univ Bonn, Dept Neurodegenerat Dis, Bonn, Germany; [Calzia, Enrico] Univ Ulm, Inst Anesthesiol Pathophysiol & Proc Dev, Ulm, Germany	Ulm University; Ulm University; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Bonn; Ulm University	Lindenberg, KS (corresponding author), Univ Ulm, Dept Neurol, Ulm, Germany.	katrin.lindenberg@uni-ulm.de	Merz, Tamara/AAJ-5453-2020; Weydt, Patrick/F-5114-2015; Merz, Tamara/AAW-2848-2020; Landwehrmeyer, Georg Bernhard/AHB-4443-2022; Steinacker, Juergen M. M/E-6876-2015	Weydt, Patrick/0000-0003-2344-5662; Merz, Tamara/0000-0002-5519-9171; Landwehrmeyer, Georg Bernhard/0000-0003-3375-790X; Steinacker, Juergen M. M/0000-0001-8901-9450; Gumpp, Anja M./0000-0002-6705-1430	Virtual Helmholtz Institute "RNA dysmetabolism in Amyotrophic lateral sclerosis and frontotemporal dementia"; seed fund grant of the EINSTEIN study from the European Huntington's disease network [584/14]; Deutsche Forschungsgemeinschaft [GRK1789]	Virtual Helmholtz Institute "RNA dysmetabolism in Amyotrophic lateral sclerosis and frontotemporal dementia"; seed fund grant of the EINSTEIN study from the European Huntington's disease network; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Virtual Helmholtz Institute "RNA dysmetabolism in Amyotrophic lateral sclerosis and frontotemporal dementia" (AW), the seed fund grant of the EINSTEIN study from the European Huntington's disease network (no 584/14, https://www.euro-hd. net/, MZ KL EC) and the Deutsche Forschungsgemeinschaft (GRK1789 Cellular and molecular mechanisms of aging, AW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews ZB, 2005, NAT REV NEUROSCI, V6, P829, DOI 10.1038/nrn1767; Arning L, 2007, HUM GENET, V122, P175, DOI 10.1007/s00439-007-0393-4; AVERBACK P, 1980, J PATHOL, V132, P55, DOI 10.1002/path.1711320106; Aziz NA, 2008, NEUROLOGY, V71, P1506, DOI 10.1212/01.wnl.0000334276.09729.0e; Burtscher J, 2015, MITOCHONDRION, V25, P104, DOI 10.1016/j.mito.2015.10.007; Carroll JB, 2015, LANCET NEUROL, V14, P1135, DOI 10.1016/S1474-4422(15)00177-5; Choo YS, 2004, HUM MOL GENET, V13, P1407, DOI 10.1093/hmg/ddh162; Costa V, 2012, EMBO J, V31, P1853, DOI 10.1038/emboj.2012.65; Dando I, 2013, BBA-MOL CELL RES, V1833, P672, DOI 10.1016/j.bbamcr.2012.10.028; Djousse L, 2002, NEUROLOGY, V59, P1325, DOI 10.1212/01.WNL.0000031791.10922.CF; Duan WZ, 2014, MOVEMENT DISORD, V29, P1366, DOI 10.1002/mds.25992; Eigentler A., 2020, MITOCHONDR PHYSL NET, V17, P1; FELL DA, 1992, BIOCHEM J, V286, P313, DOI 10.1042/bj2860313; Guidetti P, 2001, EXP NEUROL, V169, P340, DOI 10.1006/exnr.2000.7626; Hadzi TC, 2012, NEUROLOGY, V79, P1708, DOI 10.1212/WNL.0b013e31826e9a5d; Hafner S, 2015, SHOCK, V43, P140, DOI 10.1097/SHK.0000000000000277; Hagen CM, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0071904, 10.1371/currents.hd.d8917b4862929772c5a2f2a34ef1c201]; Haseler LJ, 1999, J APPL PHYSIOL, V86, P2013, DOI 10.1152/jappl.1999.86.6.2013; Herbst EAF, 2015, NEUROSCIENCE, V303, P515, DOI 10.1016/j.neuroscience.2015.07.025; Hering T, 2015, EXP NEUROL, V266, P22, DOI 10.1016/j.expneurol.2015.02.004; Holter SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080923; Hoffmann R, 2014, MOVEMENT DISORD, V29, P831, DOI 10.1002/mds.25862; Jacobs RA, 2013, J GERONTOL A-BIOL, V68, P1010, DOI 10.1093/gerona/gls335; Jacobs RA, 2013, EXP PHYSIOL, V98, P908, DOI 10.1113/expphysiol.2012.070037; Johnson ML, 2013, TRENDS ENDOCRIN MET, V24, P247, DOI 10.1016/j.tem.2012.12.003; Kehoe P, 1999, J MED GENET, V36, P108; Larsen S, 2014, ANAL BIOCHEM, V446, P64, DOI 10.1016/j.ab.2013.10.023; Larsen S, 2012, J PHYSIOL-LONDON, V590, P3349, DOI 10.1113/jphysiol.2012.230185; Liot G, 2016, BIOCH BIOPHYS RES CO; Lodi R, 2000, ANN NEUROL, V48, P72; Luthi-Carter R, 2002, HUM MOL GENET, V11, P1911, DOI 10.1093/hmg/11.17.1911; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Marder K, 2009, NEUROLOGY, V73, P385, DOI 10.1212/WNL.0b013e3181b04aa2; Mielcarek M, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004550; Mihm MJ, 2007, NEUROBIOL DIS, V25, P297, DOI 10.1016/j.nbd.2006.09.016; Oliveira JMA, 2010, J NEUROCHEM, V114, P1, DOI 10.1111/j.1471-4159.2010.06741.x; Panov AV, 2002, NAT NEUROSCI, V5, P731, DOI 10.1038/nn884; Pasquarelli N, 2015, NEUROPHARMACOLOGY, V91, P148, DOI 10.1016/j.neuropharm.2014.12.001; Penney JB, 1997, ANN NEUROL, V41, P689, DOI 10.1002/ana.410410521; Pesta D, 2012, METHODS MOL BIOL, V810, P25, DOI 10.1007/978-1-61779-382-0_3; Picard Martin, 2010, Aging Cell, V9, P1032, DOI 10.1111/j.1474-9726.2010.00628.x; Pickrell AM, 2011, J NEUROSCI, V31, P9895, DOI 10.1523/JNEUROSCI.6223-10.2011; Ribchester RR, 2004, EUR J NEUROSCI, V20, P3092, DOI 10.1111/j.1460-9568.2004.03783.x; Saft C, 2005, MOVEMENT DISORD, V20, P674, DOI 10.1002/mds.20373; Sanchez AME, 2008, ARCH MED RES, V39, P265, DOI 10.1016/j.arcmed.2007.11.011; Short KR, 2005, P NATL ACAD SCI USA, V102, P5618, DOI 10.1073/pnas.0501559102; Silva AC, 2013, MITOCHONDRION, V13, P801, DOI 10.1016/j.mito.2013.05.006; Strand AD, 2005, HUM MOL GENET, V14, P1863, DOI 10.1093/hmg/ddi192; Stuwe SH, 2013, NEUROLOGY, V80, P743, DOI 10.1212/WNL.0b013e318282514e; Turner C, 2007, MOVEMENT DISORD, V22, P1715, DOI 10.1002/mds.21540; van der Burg JMM, 2009, LANCET NEUROL, V8, P765, DOI 10.1016/S1474-4422(09)70178-4; Weydt P, 2014, BMC NEUROL, V14, DOI 10.1186/1471-2377-14-1; Wheeler VC, 1999, HUM MOL GENET, V8, P115, DOI 10.1093/hmg/8.1.115; Wheeler VC, 2002, HUM MOL GENET, V11, P633, DOI 10.1093/hmg/11.6.633; Zielonka D, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00380	55	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2017	12	4							e0175248	10.1371/journal.pone.0175248	http://dx.doi.org/10.1371/journal.pone.0175248			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0MB	28406926	Green Published, Green Submitted, gold			2022-12-27	WOS:000399955400036
J	Wright, MJ; Kuhn, LK				Wright, Michael J.; Kuhn, Lisa K.			Event-related potentials to changes in facial expression in two-phase transitions	PLOS ONE			English	Article							EMOTIONAL EXPRESSIONS; FACE PERCEPTION; BRAIN; RECOGNITION; ADAPTATION; DYNAMICS; INTENSITY; IDENTITY; MOTION; FMRI	The purpose of the study was to compare event-related potentials (ERPs) to different transitions between emotional and neutral facial expressions. The stimuli contained a single transition between two different images of the same face, giving a strong impression of changing expression though apparent motion whilst eliminating change in irrelevant stimulus variables such as image contrast or identity. Stimuli were calibrated for intensity, valence and perceived emotion category and only trials where the target emotion was correctly identified were included. In the first experiment, a magnification change (zoom) was a control condition. Transitions from neutral to angry expressions produced a more negative N1 with longer peak latency, and more positive P2 than did an increase in magnification. Critically, response to neutral following angry, relative to neutral following magnified, showed a generally more negative ERP with a delayed N1 peak and reduced P2 amplitude. In the second experiment, comparison of neutral-happy and neutral-frightened transitions showed significantly different ERPs to emotional expression change. Responses to the reversed direction of a transition (happy-neutral and frightened-neutral) were much reduced. Unlike the comparison of angry-neutral with magnified-neutral, there were minimal differences in the responses to neutral following happy and neutral following frightened. The results demonstrate in a young adult sample the directionality of responses to facial expression dynamics, and suggest a separation of neural mechanisms for detecting expression changes and magnification changes.	[Wright, Michael J.] Brunel Univ London, Coll Hlth & Life Sci, Dept Life Sci, Ctr Cognit Neurosci, Uxbridge, Middx, England; [Kuhn, Lisa K.] Saarland Univ, Dept Psychol, Expt Neuropsychol Unit, Saarbrucken, Germany	Brunel University; Saarland University	Wright, MJ (corresponding author), Brunel Univ London, Coll Hlth & Life Sci, Dept Life Sci, Ctr Cognit Neurosci, Uxbridge, Middx, England.	michael.wright@brunel.ac.uk	Kuhn, Lisa/AAM-7147-2020	Kuhn, Lisa/0000-0002-4763-2908; Wright, Michael/0000-0001-8969-6830				Allison T, 2000, TRENDS COGN SCI, V4, P267, DOI 10.1016/S1364-6613(00)01501-1; Ambadar Z, 2005, PSYCHOL SCI, V16, P403, DOI 10.1111/j.0956-7976.2005.01548.x; Barlow H, 2011, P ROY SOC B-BIOL SCI, V278, P2069, DOI 10.1098/rspb.2010.2170; BASSILI JN, 1978, J EXP PSYCHOL HUMAN, V4, P373, DOI 10.1037/0096-1523.4.3.373; Batty M, 2003, COGNITIVE BRAIN RES, V17, P613, DOI 10.1016/S0926-6410(03)00174-5; Bernstein M, 2015, NEUROSCI BIOBEHAV R, V55, P536, DOI 10.1016/j.neubiorev.2015.06.010; Bould E, 2008, COGNITION EMOTION, V22, P1569, DOI 10.1080/02699930801921156; Brooks BE, 2002, PERCEPTION, V31, P297, DOI 10.1068/p3283; Calder AJ, 2005, NAT REV NEUROSCI, V6, P641, DOI 10.1038/nrn1724; Calvo MG, 2016, EMOTION, V16, P1186, DOI 10.1037/emo0000192; Cook R, 2011, J VISION, V11, DOI 10.1167/11.4.2; de la Rosa S, 2013, J VISION, V13, DOI 10.1167/13.1.23; Eimer M, 2007, NEUROPSYCHOLOGIA, V45, P15, DOI 10.1016/j.neuropsychologia.2006.04.022; Ekman P., 1976, PICTURES FACIAL AFFE; ERWIN RJ, 1992, PSYCHIAT RES, V42, P231, DOI 10.1016/0165-1781(92)90115-J; Fox CJ, 2009, HUM BRAIN MAPP, V30, P1637, DOI 10.1002/hbm.20630; Groppe DM, 2011, PSYCHOPHYSIOLOGY, V48, P1711, DOI 10.1111/j.1469-8986.2011.01273.x; Guo K, 2013, PERCEPTION, V42, P1027, DOI 10.1068/p7552; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; Herrmann MJ, 2002, INT J PSYCHOPHYSIOL, V45, P241, DOI 10.1016/S0167-8760(02)00033-8; Hinojosa JA, 2015, NEUROSCI BIOBEHAV R, V55, P498, DOI 10.1016/j.neubiorev.2015.06.002; Juricevic I, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00004; Juth P, 2005, EMOTION, V5, P379, DOI 10.1037/1528-3542.5.4.379; Kohn A, 2007, J NEUROPHYSIOL, V97, P3155, DOI 10.1152/jn.00086.2007; Leppanen JM, 2003, J PSYCHOPHYSIOL, V17, P113, DOI 10.1027//0269-8803.17.3.113; Lyons MJ, 2007, DATABASE OF DIGITAL; Miki K, 2011, CLIN NEUROPHYSIOL, V122, P530, DOI 10.1016/j.clinph.2010.07.013; Miyoshi M, 2004, NEUROREPORT, V15, P911, DOI 10.1097/00001756-200404090-00035; O'Toole AJ, 2002, TRENDS COGN SCI, V6, P261, DOI 10.1016/S1364-6613(02)01908-3; Pike N, 2011, METHODS ECOL EVOL, V2, P278, DOI 10.1111/j.2041-210X.2010.00061.x; Puce A, 2000, COGNITIVE NEUROPSYCH, V17, P221, DOI 10.1080/026432900380580; Recio G, 2014, BIOL PSYCHOL, V96, P111, DOI 10.1016/j.biopsycho.2013.12.003; Recio G, 2011, BRAIN RES, V1376, P66, DOI 10.1016/j.brainres.2010.12.041; REGAN D, 1978, VISION RES, V18, P415, DOI 10.1016/0042-6989(78)90051-2; Reinl M, 2014, NEUROIMAGE, V102, P407, DOI 10.1016/j.neuroimage.2014.08.011; Sato W, 2007, J NONVERBAL BEHAV, V31, P119, DOI 10.1007/s10919-007-0025-7; Sato W, 2010, BRAIN RES, V1315, P92, DOI 10.1016/j.brainres.2009.12.003; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schyns PG, 2007, CURR BIOL, V17, P1580, DOI 10.1016/j.cub.2007.08.048; Skinner AL, 2010, PSYCHOL SCI, V21, P1248, DOI 10.1177/0956797610380702; Sprengelmeyer R, 2006, NEUROPSYCHOLOGIA, V44, P2899, DOI 10.1016/j.neuropsychologia.2006.06.020; Trautmann-Lengsfeld SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066997; Vagnoni E., CURR BIOL, V22, pR826; Valentine T, 2015, Q J EXP PSYCHOL; Winston JS, 2004, J NEUROPHYSIOL, V92, P1830, DOI 10.1152/jn.00155.2004; Yang CY, 2006, NEUROSCI LETT, V403, P40, DOI 10.1016/j.neulet.2006.04.046; Zhang DD, 2013, BRAIN RES, V1512, P78, DOI 10.1016/j.brainres.2013.03.044	47	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2017	12	4							e0175631	10.1371/journal.pone.0175631	http://dx.doi.org/10.1371/journal.pone.0175631			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET0MB	28406957	Green Published, gold			2022-12-27	WOS:000399955400074
J	Awad, F; Assrawi, E; Jumeau, C; Georgin-Lavialle, S; Cobret, L; Duquesnoy, P; Piterboth, W; Thomas, L; Stankovic-Stojanovic, K; Louvrier, C; Giurgea, I; Grateau, G; Amselem, S; Karabina, SA				Awad, Fawaz; Assrawi, Eman; Jumeau, Claire; Georgin-Lavialle, Sophie; Cobret, Laetitia; Duquesnoy, Philippe; Piterboth, William; Thomas, Lucie; Stankovic-Stojanovic, Katia; Louvrier, Camille; Giurgea, Irina; Grateau, Gilles; Amselem, Serge; Karabina, Sonia-Athina			Impact of human monocyte and macrophage polarization on NLR expression and NLRP3 inflammasome activation	PLOS ONE			English	Article							NF-KAPPA-B; HUMAN CASPASE-4; INTERLEUKIN-1-ALPHA SECRETION; AUTOINFLAMMATORY DISORDER; DIFFERENTIAL REQUIREMENT; IL-1-BETA RELEASE; HOST-DEFENSE; RECEPTOR; PROTEIN; MECHANISMS	Inflammasomes are multiprotein complexes nucleating around an NLR (Nucleotide-binding domain and Leucine-rich Repeat containing protein), which regulate the secretion of the pro-inflammatory interleukin (IL)-1 beta and IL-18 cytokines. Monocytes and macrophages, the main cells expressing the inflammasome genes, adapt to their surrounding micro environment by a phenotypic polarization towards a pro-inflammatory M1 phenotype that promotes inflammation or an anti-inflammatory M2 phenotype important for resolution of inflammation. Despite the importance of inflammasomes in health and disease, little is known about inflammasome gene expression in relevant human cells and the impact of monocyte and macrophage polarization in inflammasome gene expression. We examined the expression of several members of the NLR, caspase and cytokine family, and we studied the activation of the well-described NLRP3 inflammasome in an experimental model of polarized human primary monocytes and monocyte-derived macrophages (M1/M2 phenotypes) before and after activation with LPS, a well-characterized microbial pattern used in inflammasome activation studies. Our results show that the differentiation of monocytes to macrophages alters NLR expression. Polarization using IFN-gamma (M1 phenotype), induces among the NLRs studied, only the expression of NOD2. One of the key results of our study is that the induction of NLRP3 expression by LPS is inhibited in the presence of IL-4+IL-13 (M2 phenotype) at both mRNA and protein level in monocytes and macrophages. Unlike caspase-3, the expression of inflammasome-related CASP1 (encodes caspase-1) and CASP4 (encodes caspase-4) is up-regulated in M1 but not in M2 cells. Interestingly, the presence of LPS marginally influenced IL18 mRNA expression and secretion, unlike its impact on IL1B. Our data provide the basis for a better understanding of the role of different inflammasomes within a given environment (M1 and M2) in human cells and their impact in the pathophysiology of several important inflammatory disorders.	[Awad, Fawaz; Assrawi, Eman; Cobret, Laetitia; Duquesnoy, Philippe; Piterboth, William; Thomas, Lucie; Louvrier, Camille; Giurgea, Irina; Amselem, Serge; Karabina, Sonia-Athina] UPMC Univ Paris 06, Sorbonne Univ, INSERM, Hop Trousseau,Publ Hopitaux Paris,UMR S 933,Serv, Paris, France; [Georgin-Lavialle, Sophie; Stankovic-Stojanovic, Katia; Grateau, Gilles] UPMC Univ Paris 06, Sorbonne Univ, INSERM, Hop Tenon,Publ Hopitaux Paris,UMR S 933,Serv, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Karabina, SA (corresponding author), UPMC Univ Paris 06, Sorbonne Univ, INSERM, Hop Trousseau,Publ Hopitaux Paris,UMR S 933,Serv, Paris, France.	sonia.karabina@upmc.fr	AWAD, Fawaz/AAB-1825-2019; Giurgea, Irina/AGX-6879-2022	Giurgea, Irina/0000-0002-5035-2958; Awad, Fawaz/0000-0002-8214-394X	French government, Palestine; Fondation pour la Recherche Medicale [FDT20130928419]; Alquds University, Palestine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007822] Funding Source: NIH RePORTER	French government, Palestine; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Alquds University, Palestine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Fawaz Awad was supported from a grant from the French government and Alquds University, Palestine and from the "Fondation pour la Recherche Medicale" (FDT20130928419). Eman Assrawi is supported from a grant from the French government and An-Najah University, Palestine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9; CARTER DB, 1990, NATURE, V344, P633, DOI 10.1038/344633a0; Casson CN, 2015, P NATL ACAD SCI USA, V112, P6688, DOI 10.1073/pnas.1421699112; Chuang SY, 2013, P NATL ACAD SCI USA, V110, P16079, DOI 10.1073/pnas.1306556110; Copeland S, 2005, CLIN DIAGN LAB IMMUN, V12, P60, DOI 10.1128/CDLI.12.1.60-67.2005; Feldmann J, 2002, AM J HUM GENET, V71, P198, DOI 10.1086/341357; Ferrari D, 1997, J IMMUNOL, V159, P1451; Furman D, 2017, NAT MED, V23, P174, DOI 10.1038/nm.4267; Gaidt MM, 2016, IMMUNITY, V44, P833, DOI 10.1016/j.immuni.2016.01.012; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Grage-Griebenow E, 2001, J LEUKOCYTE BIOL, V69, P11; Grenier JM, 2002, FEBS LETT, V530, P73, DOI 10.1016/S0014-5793(02)03416-6; Gross O, 2012, IMMUNITY, V36, P388, DOI 10.1016/j.immuni.2012.01.018; Gross O, 2009, NATURE, V459, P433, DOI 10.1038/nature07965; Haverkamp MH, 2014, CLIN EXP IMMUNOL, V177, P720, DOI 10.1111/cei.12361; Hoffman HM, 2001, NAT GENET, V29, P301, DOI 10.1038/ng756; Huai WW, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5738; Hume DA, 2002, J LEUKOCYTE BIOL, V72, P621; Jeru I, 2010, ARTHRITIS RHEUM-US, V62, P1176, DOI 10.1002/art.27326; Juliana C, 2012, J BIOL CHEM, V287, P36617, DOI 10.1074/jbc.M112.407130; Kahlenberg JM, 2005, J IMMUNOL, V175, P7611, DOI 10.4049/jimmunol.175.11.7611; Kajiwara Y, 2014, J IMMUNOL, V193, P335, DOI 10.4049/jimmunol.1303424; Kanneganti TD, 2006, NATURE, V440, P233, DOI 10.1038/nature04517; Khare S, 2012, IMMUNITY, V36, P464, DOI 10.1016/j.immuni.2012.02.001; Lamkanfi M, 2012, ANNU REV CELL DEV BI, V28, P137, DOI 10.1146/annurev-cellbio-101011-155745; Lechtenberg BC, 2014, CURR OPIN STRUC BIOL, V29, P17, DOI 10.1016/j.sbi.2014.08.011; Man SM, 2014, P NATL ACAD SCI USA, V111, P7403, DOI 10.1073/pnas.1402911111; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Martinon F, 2007, CELL DEATH DIFFER, V14, P10, DOI 10.1038/sj.cdd.4402038; Martinon F, 2005, TRENDS IMMUNOL, V26, P447, DOI 10.1016/j.it.2005.06.004; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Mathews RJ, 2014, ANN RHEUM DIS, V73, P1202, DOI 10.1136/annrheumdis-2013-203276; Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731; Mostowy S, 2015, NAT REV IMMUNOL, V15, P559, DOI 10.1038/nri3877; Murray P. J., 2016, ANNU REV PHYSIOL; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Netea MG, 2009, BLOOD, V113, P2324, DOI 10.1182/blood-2008-03-146720; O'Connor W, 2003, J IMMUNOL, V171, P6329, DOI 10.4049/jimmunol.171.12.6329; Pegorier S, 2006, ATHEROSCLEROSIS, V188, P433, DOI 10.1016/j.atherosclerosis.2005.11.015; Pelegrin P, 2009, EMBO J, V28, P2114, DOI 10.1038/emboj.2009.163; PERREGAUX D, 1994, J BIOL CHEM, V269, P15195; Poyet JL, 2001, J BIOL CHEM, V276, P28309, DOI 10.1074/jbc.C100250200; Qiao Y, 2012, FEBS LETT, V586, P1022, DOI 10.1016/j.febslet.2012.02.045; Qu Y, 2016, J EXP MED; Rosengren S, 2005, ANN RHEUM DIS, V64, P708, DOI 10.1136/ard.2004.025577; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Strowig T, 2012, NATURE, V481, P278, DOI 10.1038/nature10759; Tenthorey JL, 2014, MOL CELL, V54, P17, DOI 10.1016/j.molcel.2014.02.018; Ting JPY, 2008, IMMUNITY, V28, P285, DOI 10.1016/j.immuni.2008.02.005; Tuncer S, 2014, J LEUKOC BIOL; Van Gorp H, 2016, P NATL ACAD SCI USA, V113, P14384, DOI 10.1073/pnas.1613156113; Vigano E, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9761; Wang L, 2002, J BIOL CHEM, V277, P29874, DOI 10.1074/jbc.M203915200; Wen HT, 2013, IMMUNITY, V39, P432, DOI 10.1016/j.immuni.2013.08.037; Yazdi AS, 2013, ANN RHEUM DIS, V72, P96, DOI 10.1136/annrheumdis-2012-202252; Yu JW, 2006, CELL DEATH DIFFER, V13, P236, DOI 10.1038/sj.cdd.4401734; Zhao Y, 2015, IMMUNOL REV, V265, P85, DOI 10.1111/imr.12293	59	106	108	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2017	12	4							e0175336	10.1371/journal.pone.0175336	http://dx.doi.org/10.1371/journal.pone.0175336			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LZ	28403163	gold, Green Published, Green Submitted			2022-12-27	WOS:000399955200052
J	Fenton, A; Jesky, MD; Ferro, CJ; Sorensen, J; Karsdal, MA; Cockwell, P; Genovese, F				Fenton, Anthony; Jesky, Mark D.; Ferro, Charles J.; Sorensen, Jacob; Karsdal, Morten A.; Cockwell, Paul; Genovese, Federica			Serum endotrophin, a type VI collagen cleavage product, is associated with increased mortality in chronic kidney disease	PLOS ONE			English	Article								Background Patients with chronic kidney disease (CKD) are at increased risk of end-stage renal disease (ESRD) and early mortality. The underlying pathophysiological processes are not entirely understood but may include dysregulation of extracellular matrix formation with accelerated systemic and renal fibrosis. We assessed the relationship between endotrophin (ETP), a marker of collagen type VI formation, and adverse outcomes in a cohort of patients with CKD. Methods We measured serum ETP levels in 500 patients from the Renal Impairment in Secondary Care (RIISC) study, a prospective observational study of patients with high-risk CKD. Patients were followed up until death or progression to ESRD. Cox regression analysis was used to assess the relationship between ETP and risk of adverse outcomes. Results During a median follow-up time of 37 months, 104 participants progressed to ESRD and 66 died. ETP level was significantly associated with progression to ESRD (HR 1.79 [95% CI 1.59-2.02] per 10 ng/mL increase; HR 11.05 [4.98-24.52] for highest vs lowest quartile; both P<0.0001). ETP level was also significantly associated with mortality ( HR 1.60 [1.35-1.89] per 10 ng/mL increase; HR 12.14 [4.26-34.54] for highest vs lowest quartile; both P<0.0001). After adjustment for confounding variables, ETP was no longer significantly associated with progression to ESRD but remained independently associated with mortality ( HR 1.51 [1.07-2.12] per 10 ng/mL increase, P = 0.019). Conclusions Serum ETP level is independently associated with mortality in CKD. This study provides the basis for further exploratory work to establish whether collagen type VI formation is mechanistically involved in the increased mortality risk associated with CKD.	[Fenton, Anthony; Jesky, Mark D.; Ferro, Charles J.; Cockwell, Paul] Queen Elizabeth Hosp, Dept Renal Med, Birmingham, W Midlands, England; [Fenton, Anthony; Jesky, Mark D.; Ferro, Charles J.; Cockwell, Paul] Univ Birmingham, Coll Med & Dent Sci, Birmingham, W Midlands, England; [Sorensen, Jacob; Karsdal, Morten A.; Genovese, Federica] Nord Biosci AS, Herlev, Denmark	University of Birmingham; University of Birmingham; Nordic Bioscience	Fenton, A (corresponding author), Queen Elizabeth Hosp, Dept Renal Med, Birmingham, W Midlands, England.; Fenton, A (corresponding author), Univ Birmingham, Coll Med & Dent Sci, Birmingham, W Midlands, England.	anthony.fenton@uhb.nhs.uk	ferro, charles/L-7250-2019; Ferro, Charles J./O-8912-2016	ferro, charles/0000-0003-0577-7081; Ferro, Charles J./0000-0003-0577-7081; Cockwell, Paul/0000-0003-1975-266X; Genovese, Federica/0000-0003-1984-1881; Karsdal, Morten/0000-0001-5026-8740; Fenton, Anthony/0000-0003-2665-6924	The Binding Site Ltd (Birmingham, UK); National Institute for Health Research [PDF-2012-05-205] Funding Source: researchfish	The Binding Site Ltd (Birmingham, UK); National Institute for Health Research(National Institute for Health Research (NIHR))	AF would like to acknowledge The Binding Site Ltd (Birmingham, UK) for the funding of his research fellowship. The Binding Site Ltd had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. JS, MAK and FG are full-time employees at Nordic Bioscience A/S, and MAK holds stocks in Nordic Bioscience A/S. Nordic Bioscience is a privately-owned, small medium size enterprise (SME) partly focused on the development of biomarkers, including the endotrophin ELISA used in this study. None of the authors received fees, bonuses or other benefits for the work described in the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; AF would like to acknowledge The Binding Site Ltd (Birmingham, UK) for the funding of his research fellowship.	Brothwell S, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-218; Cescon M, 2015, J CELL SCI, V128, P3525, DOI 10.1242/jcs.169748; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Department for Communities and Local Government, 2011, ENGLISH INDICES DEPR; Groma V, 1998, NEPHROL DIAL TRANSPL, V13, P305, DOI 10.1093/oxfordjournals.ndt.a027823; Karousou E, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/606458; Karsdal MA, 2016, DIABETOLOGIA; KATSUDA S, 1992, ARTERIOSCLER THROMB, V12, P494, DOI 10.1161/01.ATV.12.4.494; Kitamura M, 2001, CLIN CARDIOL, V24, P325, DOI 10.1002/clc.4960240413; Lennon R, 2014, J AM SOC NEPHROL, V25, P939, DOI 10.1681/ASN.2013030233; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Luther DJ, 2012, CIRC RES, V110, P851, DOI 10.1161/CIRCRESAHA.111.252734; Macy EM, 1997, CLIN CHEM, V43, P52; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; MOHAN PS, 1990, DIABETES, V39, P31, DOI 10.2337/diabetes.39.1.31; Mutsaers HAM, 2015, FRONT MED, V2, DOI 10.3389/fmed.2015.00060; National Institute for Health and Clinical Excellence, 2008, CHRON KIDN DIS EARL; Naugle JE, 2006, AM J PHYSIOL-HEART C, V290, pH323, DOI 10.1152/ajpheart.00321.2005; NERLICH AG, 1994, KIDNEY INT, V45, P1648, DOI 10.1038/ki.1994.216; Park J, 2012, ONCOTARGET, V3, P1487; Park J, 2012, J CLIN INVEST, V122, P4243, DOI 10.1172/JCI63930; Rick ME, 2016, BIOL NORMAL FUNCTION; ROSS JM, 1995, BLOOD, V85, P1826, DOI 10.1182/blood.V85.7.1826.bloodjournal8571826; SPIRO MJ, 1993, DIABETOLOGIA, V36, P93, DOI 10.1007/BF00400687; Stringer S, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-95; Sun K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4485; Sun S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144525; Vleming LJ, 1997, CLIN NEPHROL, V47, P158; Wu Q, 2001, AM J KIDNEY DIS, V37, P380, DOI 10.1053/ajkd.2001.21319; Wu XX, 1996, AM J PATHOL, V149, P283	30	36	36	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2017	12	4							e0175200	10.1371/journal.pone.0175200	http://dx.doi.org/10.1371/journal.pone.0175200			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LZ	28403201	Green Published, Green Submitted, gold			2022-12-27	WOS:000399955200043
J	Chang, YT; Shiu, JH; Huang, CH; Chen, YC; Chen, CY; Chang, YS; Chuang, WJ				Chang, Yao-Tsung; Shiu, Jia-Hau; Huang, Chun-Hao; Chen, Yi-Chun; Chen, Chiu-Yueh; Chang, Yung-Sheng; Chuang, Woei-Jer			Effects of the RGD loop and C-terminus of rhodostomin on regulating integrin alpha IIb beta 3 recognition	PLOS ONE			English	Article							GLYCOPROTEIN-IIB-IIIA; SNAKE-VENOM DISINTEGRINS; INDUCED BINDING-SITE; BETA 3 INTEGRINS; PICHIA-PASTORIS; MELANOMA-CELLS; VIPER VENOMS; ECHISTATIN; FIBRINOGEN; RECEPTOR	Rhodostomin (Rho) is a medium disintegrin containing a (48)PRGDMP motif. We here showed that Rho proteins with P48A, M52W, and P53N mutations can selectively inhibit integrin alpha IIb beta 3. To study the roles of the RGD loop and C-terminal region in disintegrins, we expressed Rho (48)PRGDMP and (48)ARGDWN mutants in Pichia pastoris containing P-65, (PR)-P-65, (PRYH)-P-65, (65)PRNGLYG, and (65)PRNPWNG C-terminal sequences. The effect of C-terminal region on their integrin binding affinities was alpha IIb beta 3 > alpha v beta 3 >= alpha 5 beta 1, and the (48)ARGDWN-(65)PRNPWNG protein was the most selective integrin alpha IIb beta 3 mutant. The (48)ARGDWN-(PRYH)-P-65, (48)ARGDWN-(65)PRNGLYG, and (48)ARGDWN-(65)PRNPWNG mutants had similar activities in inhibiting platelet aggregation and the binding of fibrinogen to platelet. In contrast, (48)ARGDWN-(PRYH)-P-65 and (48)ARGDWN-(65)PRNGLYG exhibited 2.9- and 3.0-fold decreases in inhibiting cell adhesion in comparison with that of (48)ARGDWN-(65)PRNPWNG. Based on the results of cell adhesion, platelet aggregation and the binding of fibrinogen to platelet inhibited by ARGDWN mutants, integrin alpha IIb beta 3 bound differently to immobilized and soluble fibrinogen. NMR structural analyses of (48)ARGDWN-(PRYH)-P-65, (48)ARGDWN-(65)PRNGLYG, and (48)ARGDWN-(65)PRNPWNG mutants demonstrated that their C-terminal regions interacted with the RGD loop. In particular, the W52 sidechain of (48)ARGDWN interacted with H68 of (PRYH)-P-65, L69 of (65)PRNGLYG, and N70 of (65)PRNPWNG, respectively. The docking of the (48)ARGDWN-(65)PRNPWNG mutant into integrin alpha IIb beta 3 showed that the N70 residue formed hydrogen bonds with the alpha IIb D159 residue, and the W69 residue formed cation-pi interaction with the beta 3 K125 residue. These results provide the first structural evidence that the interactions between the RGD loop and C- terminus of medium disintegrins depend on their amino acid sequences, resulting in their functional differences in the binding and selectivity of integrins.	[Chang, Yao-Tsung; Shiu, Jia-Hau; Huang, Chun-Hao; Chen, Yi-Chun; Chen, Chiu-Yueh; Chuang, Woei-Jer] Inst Basic Med Sci, Tainan, Taiwan; [Chang, Yao-Tsung; Shiu, Jia-Hau; Huang, Chun-Hao; Chen, Yi-Chun; Chen, Chiu-Yueh; Chuang, Woei-Jer] Dept Biochem & Mol Biol, Tainan, Taiwan; [Chang, Yung-Sheng; Chuang, Woei-Jer] Natl Cheng Kung Univ, Coll Med, Inst Biopharmaceut Sci, Tainan, Taiwan; [Chuang, Woei-Jer] Natl Cheng Kung Univ, Coll Med, Dept Biochem & Mol Biol, Tainan, Taiwan	National Cheng Kung University; National Cheng Kung University	Chuang, WJ (corresponding author), Inst Basic Med Sci, Tainan, Taiwan.; Chuang, WJ (corresponding author), Dept Biochem & Mol Biol, Tainan, Taiwan.; Chuang, WJ (corresponding author), Natl Cheng Kung Univ, Coll Med, Inst Biopharmaceut Sci, Tainan, Taiwan.; Chuang, WJ (corresponding author), Natl Cheng Kung Univ, Coll Med, Dept Biochem & Mol Biol, Tainan, Taiwan.	wjcnmr@mail.ncku.edu.tw			Ministry of Science and Technology, Taiwan, Republic of China [MOST-105-2325-6-006-004]	Ministry of Science and Technology, Taiwan, Republic of China	NMR spectra were obtained at National Cheng Kung University or from the High-Field Biomacromolecular NMR Core Facility supported by the National Research Program for Genomic Medicine. We are grateful to Drs. Wen-Mei Fu, Wenya Huang, and Tur-Fu Huang for helpful discussions. This work was supported by the research grants from the Ministry of Science and Technology (MOST-105-2325-6-006-004), Taiwan, Republic of China (https://www.most.gov.tw/).; NMR spectra were obtained at National Cheng Kung University or from the High-Field Biomacromolecular NMR Core Facility supported by the National Research Program for Genomic Medicine. We are grateful to Drs. Wen-Mei Fu, Wenya Huang, and Tur-Fu Huang for helpful discussions. This work was supported by the research grants from the Ministry of Science and Technology (MOST-105-2325-B-006-004), Taiwan, Republic of China.	Blobel Carl P., 1992, Current Opinion in Cell Biology, V4, P760; BrUnger A. T., 1992, X PLOR VERSION 3 1 S; Calvete JJ, 2005, TOXICON, V45, P1063, DOI 10.1016/j.toxicon.2005.02.024; Calvete JJ, 2003, BIOCHEM J, V372, P725, DOI 10.1042/BJ20021739; Chen CY, 2009, PROTEINS, V76, P808, DOI 10.1002/prot.22387; Chen CY, 2006, PROTEINS, V62, P279, DOI 10.1002/prot.20742; Chen YC, 2012, TOXICON, V60, P1342, DOI 10.1016/j.toxicon.2012.08.009; Cheng CH, 2012, PROTEIN SCI, V21, P1872, DOI 10.1002/pro.2169; CHERESH DA, 1989, CELL, V58, P945, DOI 10.1016/0092-8674(89)90946-X; De Vries SJ, 2010, NAT PROTOC, V5, P883, DOI 10.1038/nprot.2010.32; DENNIS MS, 1993, PROTEINS, V15, P312, DOI 10.1002/prot.340150308; FARRELL DH, 1992, P NATL ACAD SCI USA, V89, P10729, DOI 10.1073/pnas.89.22.10729; Fujii Y, 2003, J MOL BIOL, V332, P1115, DOI 10.1016/S0022-2836(03)00991-4; Gallivan JP, 1999, P NATL ACAD SCI USA, V96, P9459, DOI 10.1073/pnas.96.17.9459; GOULD RJ, 1990, P SOC EXP BIOL MED, V195, P168, DOI 10.3181/00379727-195-43129B; Guo RT, 2001, PROTEINS, V43, P499, DOI 10.1002/prot.1061; HUANG TF, 1987, J BIOL CHEM, V262, P16157; HUANG TF, 1991, J BIOCHEM-TOKYO, V109, P328; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Marcinkiewicz C, 1997, BLOOD, V90, P1565, DOI 10.1182/blood.V90.4.1565.1565_1565_1575; Mas-Moruno C, 2010, ANTI-CANCER AGENT ME, V10, P753, DOI 10.2174/187152010794728639; McLane MA, 2001, HAEMOSTASIS, V31, P177; MCLANE MA, 1994, BIOCHEM J, V301, P429, DOI 10.1042/bj3010429; McLane MA, 1996, FEBS LETT, V391, P139, DOI 10.1016/0014-5793(96)00716-8; McLane MA, 2005, PATHOPHYSIOL HAEMO T, V34, P164, DOI 10.1159/000092417; McLane Mary Ann, 2004, Current Drug Targets - Cardiovascular & Haematological Disorders, V4, P327, DOI 10.2174/1568006043335880; Monleon D, 2005, BIOCHEM J, V387, P57, DOI 10.1042/BJ20041343; Mousa SA, 1999, DRUG DISCOV TODAY, V4, P552, DOI 10.1016/S1359-6446(99)01394-X; NILGES M, 1988, FEBS LETT, V239, P129, DOI 10.1016/0014-5793(88)80559-3; Rahman S, 1998, BIOCHEM J, V335, P247, DOI 10.1042/bj3350247; SAVAGE B, 1995, J BIOL CHEM, V270, P28812, DOI 10.1074/jbc.270.48.28812; SCARBOROUGH RM, 1993, J BIOL CHEM, V268, P1058; SENN H, 1993, J MOL BIOL, V232, P907, DOI 10.1006/jmbi.1993.1439; Shanley DK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057491; Shiu JH, 2004, PROTEINS, V57, P839, DOI 10.1002/prot.20269; Shiu JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028833; Takagi J, 2007, CURR OPIN CELL BIOL, V19, P557, DOI 10.1016/j.ceb.2007.09.002; Wierzbicka-Patynowski I, 1999, J BIOL CHEM, V274, P37809, DOI 10.1074/jbc.274.53.37809; Yahalom D, 2002, BIOCHEMISTRY-US, V41, P8321, DOI 10.1021/bi025690t; ZAMARRON C, 1991, J BIOL CHEM, V266, P16193; Zhu JQ, 2013, J CELL BIOL, V201, P1053, DOI 10.1083/jcb.201212037	41	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2017	12	4							e0175321	10.1371/journal.pone.0175321	http://dx.doi.org/10.1371/journal.pone.0175321			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0JS	28399159	Green Published, gold, Green Submitted			2022-12-27	WOS:000399949000030
J	Skert, C; Perucca, S; Chiarini, M; Giustini, V; Sottini, A; Ghidini, C; Martellos, S; Cattina, F; Rambaldi, B; Cancelli, V; Malagola, M; Turra, A; Polverelli, N; Bernardi, S; Imberti, L; Russo, D				Skert, Cristina; Perucca, Simone; Chiarini, Marco; Giustini, Viviana; Sottini, Alessandra; Ghidini, Claudia; Martellos, Stefano; Cattina, Federica; Rambaldi, Benedetta; Cancelli, Valeria; Malagola, Michele; Turra, Alessandro; Polverelli, Nicola; Bernardi, Simona; Imberti, Luisa; Russo, Domenico			Sequential monitoring of lymphocyte subsets and of T-and-B cell neogenesis indexes to identify time-varying immunologic profiles in relation to graft-versus-host disease and relapse after allogeneic stem cell transplantation	PLOS ONE			English	Article							THYMIC FUNCTION; ACUTE GVHD; MEMORY; RECONSTITUTION; INFILTRATION; DEFICIENCY; RECIPIENTS; DIAGNOSIS; RECOVERY; NUMBERS	T and B lymphocyte subsets have been not univocally associated to Graft-versus-host disease (GVHD) and relapse of hematological malignancies after stem cell transplantation (SCT). Their sequential assessment together with B and T cell neogenesis indexes has been not thoroughly analysed in relation to these changing and interrelated immunologic/clinic events yet. Lymphocyte subsets in peripheral blood (PB) and B and T cell neogenesis indexes were analysed together at different time points in a prospective study of 50 patients. Principal component analysis (PCA) was used as first step of multivariate analysis to address issues related to a high number of variables versus a relatively low number of patients. Multivariate analysis was completed by Fine-Gray proportional hazard regression model. PCA identified 3 clusters of variables (PC1-3), which correlated with acute GVHD: PC1 (pre-SCT: KRECs >= 6608/ml, unswitched memory B <2.4%, CD4+T-CM cells <45%; HR 0.5, p = 0.001); PC2 (at aGVHD onset: CD4+>44%, CD8+T-CM cells>4%; HR 1.9, p = 0.01), and PC3 (at aGVHD onset: CD4+TEMRA <1, total Treg<4, Treg(EM) <2 cells/mu l; HR 0.5, p = 0.002). Chronic GVHD was associated with one PC (Treg(EM) <2 cells/mu l at day+28, CD8+TEMRA <43% at day+90, immature B cells<6 cells/mu l and KRECs<11710/ml at day+180; HR 0.4, P = 0.001). Two PC correlated with relapse: PC1 (pre-SCT: CD4+ <269, CD4+TCM <120, total Treg <18, Treg(CM) <8 cells/mu l; HR 4.0, p = 0.02); PC2 (pre-SCT mature CD19+ >69%, switched memory CD19+ = 0 cells and KRECs<6614/ml at +90; HR 0.1, p = 0.008). All these immunologic parameters were independent indicators of chronic GVHD and relapse, also considering the possible effect of previous steroid-therapy for acute GVHD. Specific time-varying immunologic profiles were associated to GVHD and relapse. Pre-SCT host immune- microenvironment and changes of B cell homeostasis could influence GVH- and Graft-versus-Tumor reactions. The paradoxical increase of EM Treg in PB of patients with GVHD could be explained by their compartmentalization outside lymphoid tissues, which are of critical relevance for regulation of GVH reactions.	[Skert, Cristina; Cattina, Federica; Rambaldi, Benedetta; Cancelli, Valeria; Malagola, Michele; Turra, Alessandro; Polverelli, Nicola; Russo, Domenico] Univ Brescia, Stem Cell Transplantat Unit, Chair Haematol, Brescia, Italy; [Perucca, Simone; Chiarini, Marco; Giustini, Viviana; Sottini, Alessandra; Ghidini, Claudia; Bernardi, Simona; Imberti, Luisa] Spedali Civili Brescia, Ctr Ric Ematooncol AIL CREA, Brescia, Italy; [Martellos, Stefano] Univ Trieste, Dept Life Sci, Res Unit Biodivers Informat, Trieste, Italy	University of Brescia; Hospital Spedali Civili Brescia; University of Trieste	Skert, C (corresponding author), Univ Brescia, Stem Cell Transplantat Unit, Chair Haematol, Brescia, Italy.	cristina_skert@yahoo.it	Giustini, Viviana/AAC-5242-2022; Polverelli, Nicola/AAJ-3718-2021	Polverelli, Nicola/0000-0001-6297-9697; Martellos, Stefano/0000-0001-5201-8948; Malagola, Michele/0000-0003-0907-130X; Imberti, Luisa/0000-0002-2075-8391; Bernardi, Simona/0000-0002-3494-2624				Alho AC, 2016, BLOOD, V127, P646, DOI 10.1182/blood-2015-10-672345; Beilhack A, 2005, BLOOD, V106, P1113, DOI 10.1182/blood-2005-02-0509; Bremm M, 2011, J IMMUNOL METHODS, V373, P36, DOI 10.1016/j.jim.2011.07.018; Clark FJ, 2004, BLOOD, V103, P2410, DOI 10.1182/blood-2003-06-2073; Clave E, 2005, BLOOD, V105, P2608, DOI 10.1182/blood-2004-04-1667; De Pauw B, 2008, CLIN INFECT DIS, V46, P1813, DOI 10.1086/588660; Dohner H, 2013, HAEMATOLOGICA, V98, P233, DOI 10.3324/haematol.2012.072264; Ermann J, 2005, BLOOD, V105, P2220, DOI 10.1182/blood-2004-05-2044; Ferrara JLM, 2009, LANCET, V373, P1550, DOI 10.1016/S0140-6736(09)60237-3; Filipovich AH, 2005, BIOL BLOOD MARROW TR, V11, P945, DOI 10.1016/j.bbmt.2005.09.004; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Fujioka T, 2013, BONE MARROW TRANSPL, V48, P859, DOI 10.1038/bmt.2012.232; Glauzy S, 2014, BLOOD, V124, P2459, DOI 10.1182/blood-2014-05-573303; GLUCKSBERG H, 1974, TRANSPLANTATION, V18, P295, DOI 10.1097/00007890-197410000-00001; Greinix HT, 2008, BIOL BLOOD MARROW TR, V14, P208, DOI 10.1016/j.bbmt.2007.10.009; Greinix HT, 2015, BIOL BLOOD MARROW TR, V21, P250, DOI 10.1016/j.bbmt.2014.11.010; Gress RE, 2013, BIOL BLOOD MARROW TR, V19, P1537, DOI 10.1016/j.bbmt.2013.08.010; Hilgendorf I, 2012, TRANSPL INT, V25, P87, DOI 10.1111/j.1432-2277.2011.01388.x; Jolliffe I., 2005, SPRINGERLINK PRINCIP, DOI 10.1007/b98835; Khoder A, 2014, BLOOD, V124, P2034, DOI 10.1182/blood-2014-04-571125; Kuzmina Z, 2011, BLOOD, V117, P2265, DOI 10.1182/blood-2010-07-295766; Lee J, 2015, INT J RHEUM DIS, V18, P200, DOI 10.1111/1756-185X.12432; Lu SY, 2011, CLIN EXP IMMUNOL, V165, P264, DOI 10.1111/j.1365-2249.2011.04418.x; Manjarrez-Orduno N, 2009, J INVEST DERMATOL, V129, P278, DOI 10.1038/jid.2008.240; Matsuoka K, 2010, J CLIN INVEST, V120, P1479, DOI 10.1172/JCI41072; Melchers F, 2015, J CLIN INVEST, V125, P2203, DOI 10.1172/JCI78083; Mensen A, 2014, BLOOD, V124, P963, DOI 10.1182/blood-2013-11-539031; Mensen A, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-188; Miller JS, 2010, BIOL BLOOD MARROW TR, V16, P565, DOI 10.1016/j.bbmt.2010.02.005; Pidala J, 2014, BONE MARROW TRANSPL, V49, P324, DOI 10.1038/bmt.2013.97; Podgorny PJ, 2014, BIOL BLOOD MARROW TR, V20, P450, DOI 10.1016/j.bbmt.2014.01.002; Poutsiaka DD, 2011, BONE MARROW TRANSPL, V46, P300, DOI 10.1038/bmt.2010.112; PRZEPIORKA D, 1995, BONE MARROW TRANSPL, V15, P825; Saglio F, 2015, BIOL BLOOD MARROW TR, V21, P1099, DOI 10.1016/j.bbmt.2015.02.010; Sarantopoulos S, 2015, BIOL BLOOD MARROW TR, V21, P16, DOI 10.1016/j.bbmt.2014.10.029; Schneider MA, 2007, J EXP MED, V204, P735, DOI 10.1084/jem.20061405; Schwarz A, 2013, J IMMUNOL, V190, P4965, DOI 10.4049/jimmunol.1203224; Scrucca L, 2010, BONE MARROW TRANSPL, V45, P1388, DOI 10.1038/bmt.2009.359; Segalen I, 2011, AUTOIMMUN REV, V10, P218, DOI 10.1016/j.autrev.2010.10.005; Shimabukuro-Vornhagen A, 2009, BLOOD, V114, P4919, DOI 10.1182/blood-2008-10-161638; Skert C, 2009, BONE MARROW TRANSPL, V44, P729, DOI 10.1038/bmt.2009.80; Sottini A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034493; Sottini A, 2010, CLIN IMMUNOL, V136, P217, DOI 10.1016/j.clim.2010.04.005; Tedder TF, 2009, NAT REV RHEUMATOL, V5, P572, DOI 10.1038/nrrheum.2009.184; Ukena SN, 2011, ANN HEMATOL, V90, P213, DOI 10.1007/s00277-010-1068-0; Vincent K, 2011, BLOOD, V118, P2951, DOI 10.1182/blood-2011-04-350868; Wang GC, 2014, TRANSL MED UNISA, V9, P1; Xhaard A, 2014, BONE MARROW TRANSPL, V49, P1089, DOI 10.1038/bmt.2014.105; Yakoub-Agha I, 2006, LEUKEMIA, V20, P1557, DOI 10.1038/sj.leu.2404308; Yakoub-Agha I, 2009, BIOL BLOOD MARROW TR, V15, P496, DOI 10.1016/j.bbmt.2008.11.038; Zhai ZM, 2007, TRANSPL INT, V20, P440, DOI 10.1111/j.1432-2277.2007.00462.x	51	12	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2017	12	4							e0175337	10.1371/journal.pone.0175337	http://dx.doi.org/10.1371/journal.pone.0175337			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0JS	28399164	Green Submitted, Green Published, gold			2022-12-27	WOS:000399949000032
J	Topalcengiz, Z; Strawn, LK; Danyluk, MD				Topalcengiz, Zeynal; Strawn, Laura K.; Danyluk, Michelle D.			Microbial quality of agricultural water in Central Florida	PLOS ONE			English	Article							ESCHERICHIA-COLI O157-H7; FECAL INDICATOR BACTERIA; SALMONELLA-ENTERICA; IRRIGATION WATER; SOUTHERN ALBERTA; SURFACE WATERS; PRODUCE FARMS; CONTAMINATION; PREVALENCE; PATHOGENS	The microbial quality of water that comes into the edible portion of produce is believed to directly relate to the safety of produce, and metrics describing indicator organisms are commonly used to ensure safety. The US FDA Produce Safety Rule (PSR) sets very specific microbiological water quality metrics for agricultural water that contacts the harvestable portion of produce. Validation of these metrics for agricultural water is essential for produce safety. Water samples (500 mL) from six agricultural ponds were collected during the 2012/2013 and 2013/2014 growing seasons (46 and 44 samples respectively, 540 from all ponds). Microbial indicator populations (total coliforms, generic Escherichia coli, and enterococci) were enumerated, environmental variables (temperature, pH, conductivity, redox potential, and turbidity) measured, and pathogen presence evaluated by PCR. Salmonella isolates were serotyped and analyzed by pulsed-field gel electrophoresis. Following rain events, coliforms increased up to 4.2 log MPN/100 mL. Populations of coliforms and enterococci ranged from 2 to 8 and 1 to 5 log MPN/100 mL, respectively. Microbial indicators did not correlate with environmental variables, except pH (P < 0.0001). The invA gene (Salmonella) was detected in 26/540 (4.8%) samples, in all ponds and growing seasons, and 14 serotypes detected. Six STEC genes were detected in samples: hly (83.3%), fliC (51.8%), eaeA (17.4%), rfbE (17.4%), stx-I (32.6%), stx-II (9.4%). While all ponds met the PSR requirements, at least one virulence gene from Salmonella (invA-4.8%) or STEC (stx-I-32.6%, stx-II-9.4%) was detected in each pond. Water quality for tested agricultural ponds, below recommended standards, did not guarantee the absence of pathogens. Investigating the relationships among physicochemical attributes, environmental factors, indicator microorganisms, and pathogen presence allows researchers to have a greater understanding of contamination risks from agricultural surface waters in the field.	[Topalcengiz, Zeynal; Danyluk, Michelle D.] Univ Florida, Citrus Res & Educ Ctr, Inst Food & Agr Sci, Dept Food Sci & Human Nutr, Lake Alfred, FL 32611 USA; [Strawn, Laura K.] Virginia Tech, Agr Res & Extens Ctr, Dept Food Sci & Technol, 33446 Res Dr, Painter, VA USA; [Topalcengiz, Zeynal] Mus Alparslan Univ, Fac Engn, Dept Food Engn, Mus, Turkey	State University System of Florida; University of Florida; Virginia Polytechnic Institute & State University; Mus Alparslan University	Danyluk, MD (corresponding author), Univ Florida, Citrus Res & Educ Ctr, Inst Food & Agr Sci, Dept Food Sci & Human Nutr, Lake Alfred, FL 32611 USA.	mddanyluk@ufl.edu	Strawn, Laura/B-1567-2019; Topalcengiz, Zeynal/AAH-8731-2020; Topalcengiz, Zeynal/AAY-3051-2021	Topalcengiz, Zeynal/0000-0002-2113-7319; Topalcengiz, Zeynal/0000-0002-2113-7319; Strawn, Laura/0000-0002-9523-0081; Danyluk, Michelle/0000-0001-5780-7911	National Institute of Food and Agriculture, U.S. Department of Agriculture [SCRI-2011-51181-30767]	National Institute of Food and Agriculture, U.S. Department of Agriculture(United States Department of Agriculture (USDA))	The National Institute of Food and Agriculture, U.S. Department of Agriculture, under award SCRI-2011-51181-30767. No Role.	Andrews WH, 2011, BAM; [Anonymous], 2015, FED REG NOT STAND GR; Benjamin L, 2013, INT J FOOD MICROBIOL, V165, P65, DOI 10.1016/j.ijfoodmicro.2013.04.003; Cooley M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001159; Draper AD, 2016, J FOOD PROTECT, V79, P902, DOI 10.4315/0362-028X.JFP-15-479; DUPONTE MW, 1978, AM J VET RES, V39, P529; Gaertner JP, 2008, J WILDLIFE DIS, V44, P519, DOI 10.7589/0090-3558-44.2.519; Gannon VPJ, 2004, J TOXICOL ENV HEAL A, V67, P1643, DOI 10.1080/15287390490492421; Gonzalez RA, 2014, WATER RES, V48, P296, DOI 10.1016/j.watres.2013.09.038; Gonzalez RA, 2012, WATER RES, V46, P5871, DOI 10.1016/j.watres.2012.07.050; GOYAL SM, 1977, APPL ENVIRON MICROB, V34, P139, DOI 10.1128/AEM.34.2.139-149.1977; Gu GY, 2013, CAN J MICROBIOL, V59, P175, DOI 10.1139/cjm-2012-0599; Haley BJ, 2009, APPL ENVIRON MICROB, V75, P1248, DOI 10.1128/AEM.01648-08; Harris LJ, 2012, J FOOD PROTECT, V75, P2251, DOI 10.4315/0362-028X.JFP-12-252; Hu Y, 1999, J APPL MICROBIOL, V87, P867, DOI 10.1046/j.1365-2672.1999.00938.x; Ijabadeniyi OA, 2011, J FOOD SAFETY, V31, P452, DOI 10.1111/j.1745-4565.2011.00321.x; Johnson JYM, 2003, CAN J MICROBIOL, V49, P326, DOI [10.1139/w03-046, 10.1139/W03-046]; Johnston MA, 2010, J APPL MICROBIOL, V108, P965, DOI 10.1111/j.1365-2672.2009.04498.x; Luo ZY, 2015, APPL ENVIRON MICROB, V81, P4376, DOI 10.1128/AEM.04086-14; Manuel CS, 2011, THESIS, P184; Martinez-Urtaza J, 2004, APPL ENVIRON MICROB, V70, P2089, DOI 10.1128/AEM.70.4.2089-2097.2004; McEgan R, 2014, APPL ENV MICROBIOL; McEgan R, 2013, APPL ENVIRON MICROB, V79, P4094, DOI 10.1128/AEM.00777-13; Micallef SA, 2012, ENVIRON RES, V114, P31, DOI 10.1016/j.envres.2012.02.005; Moore BC, 2003, APPL ENVIRON MICROB, V69, P4556, DOI 10.1128/AEM.69.8.4556-4560.2003; Pachepsky Y, 2016, CRIT REV MICROBIOL, V42, P384, DOI 10.3109/1040841X.2014.954524; Pachepsky Y, 2011, ADV AGRON, V113, P73, DOI 10.1016/B978-0-12-386473-4.00007-5; Patchanee P, 2010, FOODBORNE PATHOG DIS, V7, P1113, DOI 10.1089/fpd.2010.0572; Payment P, 2011, GROUND WATER, V49, P4, DOI 10.1111/j.1745-6584.2010.00710.x; RAHN K, 1992, MOL CELL PROBE, V6, P271, DOI 10.1016/0890-8508(92)90002-F; Rajabi M, 2011, INT J MICROBIOL; Ribot EM, 2006, FOODBORNE PATHOG DIS, V3, P59, DOI 10.1089/fpd.2006.3.59; Santiago-Rodriguez TM, 2012, APPL ENVIRON MICROB, V78, P5160, DOI 10.1128/AEM.07773-11; Schets FM, 2005, WATER RES, V39, P4485, DOI 10.1016/j.watres.2005.08.025; Smith CJ, 2009, APPL ENVIRON MICROB, V75, P316, DOI 10.1128/AEM.01205-08; Steele M, 2005, J FOOD PROTECT, V68, P1388, DOI 10.4315/0362-028X-68.7.1388; Strawn LK, 2014, APPL ENVIRON MICROB, V80, P3982, DOI 10.1128/AEM.00348-14; Strawn LK, 2013, APPL ENVIRON MICROB, V79, P588, DOI 10.1128/AEM.02491-12; Tanaro JD, 2014, FOODBORNE PATHOG DIS, V11, P960, DOI 10.1089/fpd.2014.1770; US Food and Drug Administration, 2013, STAND GROW HARV PACK; Walters SP, 2011, WATER RES, V45, P1752, DOI 10.1016/j.watres.2010.11.032; Won G, 2013, AGR WATER MANAGE, V116, P73, DOI 10.1016/j.agwat.2012.10.007	42	32	32	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2017	12	4							e0174889	10.1371/journal.pone.0174889	http://dx.doi.org/10.1371/journal.pone.0174889			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0JS	28399144	Green Submitted, Green Published, gold			2022-12-27	WOS:000399949000014
J	Doebel, S; Barker, JE; Chevalier, N; Michaelson, LE; Fisher, AV; Munakata, Y				Doebel, Sabine; Barker, Jane E.; Chevalier, Nicolas; Michaelson, Laura E.; Fisher, Anna V.; Munakata, Yuko			Getting ready to use control: Advances in the measurement of young children's use of proactive control	PLOS ONE			English	Article							EXECUTIVE FUNCTIONS; COGNITIVE CONTROL; WORKING-MEMORY; INDIVIDUAL-DIFFERENCES; NEURAL MECHANISMS; PERFORMANCE	A key developmental transition in executive function is in the temporal dynamics of its engagement: children shift from reactively calling to mind task-relevant information as needed, to being able to proactively maintain information across time in anticipation of upcoming demands. This transition is important for understanding individual differences and developmental changes in executive function; however, methods targeting its assessment are limited. We tested the possibility that Track-It, a paradigm developed to measure selective sustained attention, also indexes proactive control. In this task children must track a target shape as it moves unpredictably among moving distractors, and identify where it disappears, which may require proactively maintaining information about the target or goal. In two experiments ( 5-6 year-olds, Ns = 33, 64), children's performance on Track-It predicted proactive control across two established paradigms. These findings suggest Track-It measures proactive control in children. Theoretical possibilities regarding how proactive control and selective sustained attention may be related are also discussed.	[Doebel, Sabine; Barker, Jane E.; Michaelson, Laura E.; Munakata, Yuko] Univ Colorado, Dept Psychol & Neurosci, Boulder, CO 80309 USA; [Chevalier, Nicolas] Univ Edinburgh, Sch Philosophy Psychol & Language Sci, Edinburgh, Midlothian, Scotland; [Fisher, Anna V.] Carnegie Mellon Univ, Dept Psychol, Pittsburgh, PA 15213 USA	University of Colorado System; University of Colorado Boulder; University of Edinburgh; Carnegie Mellon University	Doebel, S (corresponding author), Univ Colorado, Dept Psychol & Neurosci, Boulder, CO 80309 USA.	sabine.doebel@colorado.edu		Michaelson, Laura/0000-0003-0321-025X; MUNAKATA, YUKO/0000-0001-8192-5379	Eunice Kennedy Shriver National Institute of Child Health & Human Development of the National Institutes of Health [F32HD079191]; University of Colorado Boulder Libraries Open Access Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD086184] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health & Human Development of the National Institutes of Health; University of Colorado Boulder Libraries Open Access Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This research was supported by the Eunice Kennedy Shriver National Institute of Child Health & Human Development of the National Institutes of Health under Award Number F32HD079191. Publication of this article was funded by the University of Colorado Boulder Libraries Open Access Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amso D, 2014, COGNITION, V133, P201, DOI 10.1016/j.cognition.2014.06.012; Barr DJ, 2013, J MEM LANG, V68, P255, DOI 10.1016/j.jml.2012.11.001; Bates D, LME4 LINEAR MIXED EF; Blackwell KA, 2014, DEVELOPMENTAL SCI, V17, P203, DOI 10.1111/desc.12113; Blair C, 2007, CHILD DEV, V78, P647, DOI 10.1111/j.1467-8624.2007.01019.x; Braver TS, 2012, TRENDS COGN SCI, V16, P106, DOI 10.1016/j.tics.2011.12.010; Braver TS, 2009, P NATL ACAD SCI USA, V106, P7351, DOI 10.1073/pnas.0808187106; Braver TS, 2001, J EXP PSYCHOL GEN, V130, P746, DOI 10.1037//0096-3445.130.4.746; Bunge SA, 2006, CURR DIR PSYCHOL SCI, V15, P118, DOI 10.1111/j.0963-7214.2006.00419.x; Carlson SA, 2005, DEV NEUROPSYCHOL, V28, P595, DOI 10.1207/s15326942dn2802_3; Chatham CH, UNPUB; Chatham CH, 2009, P NATL ACAD SCI USA, V106, P5529, DOI 10.1073/pnas.0810002106; Chevalier N, 2016, CHILD DEV, V87, P1264, DOI 10.1111/cdev.12537; Chevalier N, 2015, J COGNITIVE NEUROSCI, V27, P1125, DOI 10.1162/jocn_a_00782; Chevalier N, 2014, DEV PSYCHOL, V50, P1999, DOI 10.1037/a0036644; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Diamond A, 2013, ANNU REV PSYCHOL, V64, P135, DOI 10.1146/annurev-psych-113011-143750; Dosenbach NUF, 2008, TRENDS COGN SCI, V12, P99, DOI 10.1016/j.tics.2008.01.001; Fisher A, 2013, J EXP CHILD PSYCHOL, V114, P275, DOI 10.1016/j.jecp.2012.07.006; Friedman NP, 2008, J EXP PSYCHOL GEN, V137, P201, DOI 10.1037/0096-3445.137.2.201; Gathercole SE, 2004, DEV PSYCHOL, V40, P177, DOI 10.1037/0012-1649.40.2.177; GERSTADT CL, 1994, COGNITION, V53, P129, DOI 10.1016/0010-0277(94)90068-X; Lucenet J, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00831; Marcovitch S, 2007, DEVELOPMENTAL SCI, V10, P559, DOI 10.1111/j.1467-7687.2007.00611.x; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Miyake A, 2012, CURR DIR PSYCHOL SCI, V21, P8, DOI 10.1177/0963721411429458; Moffitt TE, 2011, P NATL ACAD SCI USA, V108, P2693, DOI 10.1073/pnas.1010076108; Monette S, 2015, J EXP CHILD PSYCHOL, V140, P120, DOI 10.1016/j.jecp.2015.07.005; Munakata Y, 2012, CURR DIR PSYCHOL SCI, V21, P71, DOI 10.1177/0963721412436807; Simmons JP, 2011, PSYCHOL SCI, V22, P1359, DOI 10.1177/0956797611417632; Tamnes CK, 2012, J NEUROSCI, V32, P972, DOI 10.1523/JNEUROSCI.4779-11.2012; Thompson-Schill SL, 2009, CURR DIR PSYCHOL SCI, V18, P259, DOI 10.1111/j.1467-8721.2009.01648.x; Wiebe SA, 2008, DEV PSYCHOL, V44, P575, DOI 10.1037/0012-1649.44.2.575; Wiebe SA, 2011, J EXP CHILD PSYCHOL, V108, P436, DOI 10.1016/j.jecp.2010.08.008; Willoughby MT, 2012, PSYCHOL ASSESSMENT, V24, P418, DOI 10.1037/a0025779; Winter B, 2013, ARXIV13085499; Zelazo P. D., 2013, OXFORD HDB DEV PSYCH, P3, DOI DOI 10.1093/OXFORDHB/9780199958450.001.0001	37	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2017	12	4							e0175072	10.1371/journal.pone.0175072	http://dx.doi.org/10.1371/journal.pone.0175072			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES9KH	28419099	Green Published, Green Submitted, gold			2022-12-27	WOS:000399875200010
J	Ndithia, HK; Matson, KD; Versteegh, MA; Muchai, M; Tieleman, BI				Ndithia, Henry K.; Matson, Kevin D.; Versteegh, Maaike A.; Muchai, Muchane; Tieleman, B. Irene			Year-round breeding equatorial Larks from three climatically-distinct populations do not use rainfall, temperature or invertebrate biomass to time reproduction	PLOS ONE			English	Article							ARIDITY GRADIENT; NEST PREDATION; TROPICAL BIRDS; CLUTCH-SIZE; FOOD AVAILABILITY; FIELD EXPERIMENT; ARABIAN DESERT; HOOPOE-LARKS; ANNUAL CYCLE; FOREST BIRD	Timing of reproduction in birds is important for reproductive success and is known to depend on environmental cues such as day length and food availability. However, in equatorial regions, where day length is nearly constant, other factors such as rainfall and temperature are thought to determine timing of reproduction. Rainfall can vary at small spatial and temporal scales, providing a highly fluctuating and unpredictable environmental cue. In this study we investigated the extent to which spatio-temporal variation in environmental conditions can explain the timing of breeding of Red-capped Lark, Calandrella cinerea, a species that is capable of reproducing during every month of the year in our equatorial east African study locations. For 39 months in three climatically-distinct locations, we monitored nesting activities, sampled ground and flying invertebrates, and quantified rainfall, maximum (T-max) and minimum (T-min) temperatures. Among locations we found that lower rainfall and higher temperatures did not coincide with lower invertebrate biomasses and decreased nesting activities, as predicted. Within locations, we found that rainfall, Tmax, and Tmin varied unpredictably among months and years. The only consistent annually recurring observations in all locations were that January and February had low rainfall, high Tmax, and low Tmin. Ground and flying invertebrate biomasses varied unpredictably among months and years, but invertebrates were captured in all months in all locations. Red-capped Larks bred in all calendar months overall but not in every month in every year in every location. Using model selection, we found no clear support for any relationship between the environmental variables and breeding in any of the three locations. Contrary to popular understanding, this study suggests that rainfall and invertebrate biomass as proxy for food do not influence breeding in equatorial Larks. Instead, we propose that factors such as nest predation, female protein reserves, and competition are more important in environments where weather and food meet minimum requirements for breeding during most of the year.	[Ndithia, Henry K.; Muchai, Muchane] Natl Museums Kenya, Ornithol Sect, Dept Zool, Nairobi, Kenya; [Ndithia, Henry K.; Matson, Kevin D.; Versteegh, Maaike A.; Tieleman, B. Irene] Univ Groningen, Groningen Inst Evolutionary Life Sci, Groningen, Netherlands; [Matson, Kevin D.] Wageningen Univ, Dept Environm Sci, Resource Ecol Grp, Droevendaalsesteeg 3a, Wageningen, Netherlands; [Muchai, Muchane] Univ Nairobi, Coll Agr & Vet Sci, Dept Clin Studies Wildlife & Conservat, Nairobi, Kenya	University of Groningen; Wageningen University & Research; University of Nairobi	Ndithia, HK (corresponding author), Natl Museums Kenya, Ornithol Sect, Dept Zool, Nairobi, Kenya.; Ndithia, HK (corresponding author), Univ Groningen, Groningen Inst Evolutionary Life Sci, Groningen, Netherlands.	hndithia@gmail.com	Muchai, Muchane/B-4076-2008; Matson, Kevin D./R-1986-2019; Matson, Kevin David/G-3855-2010	Matson, Kevin David/0000-0002-4373-5926; Muchai, Muchane/0000-0002-2387-4486	Nuffic/NFP [CF6833/2010]; The Netherlands Fellowship Programme of Nuffic [CF6833/2010]; Netherlands Organization for Scientific Research (NWO-VIDI); The Young Academy project grant; University of Groningen; Schure-Beijerinck-Popping Fonds; Dr. J.L. Dobberke foundation; National Museums of Kenya	Nuffic/NFP; The Netherlands Fellowship Programme of Nuffic; Netherlands Organization for Scientific Research (NWO-VIDI)(Netherlands Organization for Scientific Research (NWO)); The Young Academy project grant; University of Groningen; Schure-Beijerinck-Popping Fonds; Dr. J.L. Dobberke foundation; National Museums of Kenya	This work was supported by Nuffic/NFP CF6833/2010 - https://www.epnuffic.nl/en/scholarships/nfp-and-msp.; This study was funded by The Netherlands Fellowship Programme of Nuffic (grant No. CF6833/2010 to B.I.T and H.K.N.), the Netherlands Organization for Scientific Research (NWO-VIDI to B.I.T.), The Young Academy project grant (B.I.T.), the University of Groningen, the Schure-Beijerinck-Popping Fonds, and Dr. J.L. Dobberke foundation. The National Museums of Kenya provided paid study leave and organized permission letters for access to study areas. Capture and handling of birds was done by skilled bird ringers in adherence to the animal welfare protocols of National Museums of Kenya.	[Anonymous], 2014, R LANG ENV STAT COMP; Benke AC, 1999, J N AM BENTHOL SOC, V18, P308, DOI 10.2307/1468447; BOAG PT, 1984, ECOL MONOGR, V54, P463, DOI 10.2307/1942596; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Chapman A, 1995, TROP ZOOL, V8, P227, DOI 10.1080/03946975.1995.10539283; COLWELL RK, 1974, ECOLOGY, V55, P1148, DOI 10.2307/1940366; Conway D, 2005, PHILOS T ROY SOC A, V363, P49, DOI 10.1098/rsta.2004.1475; Decker KL, 2012, EVOLUTIONARY ECOLOGY, V26, P983; DITTAMI JP, 1985, J ZOOL, V207, P357; DITTAMI JP, 1986, J COMP PHYSIOL B, V156, P641, DOI 10.1007/BF00692741; FOGDEN MPL, 1979, J ZOOL, V189, P233; FOGDEN MPL, 1972, IBIS, V114, P307, DOI 10.1111/j.1474-919X.1972.tb00831.x; Fontaine JJ, 2006, ECOL LETT, V9, P428, DOI 10.1111/j.1461-0248.2006.00892.x; FOSTER MS, 1974, AUK, V91, P722, DOI 10.2307/4084724; Ganihar SR, 1997, J BIOSCIENCE, V22, P219, DOI 10.1007/BF02704734; Ghalambor CK, 2002, BEHAV ECOL, V13, P101, DOI 10.1093/beheco/13.1.101; GRANT PR, 1980, AUK, V97, P227; Grant PR, 2000, ECOLOGY, V81, P2442, DOI 10.2307/177466; Gruner Daniel S., 2003, Pacific Science, V57, P325, DOI 10.1353/psc.2003.0021; Gwinner E, 2003, CURR OPIN NEUROBIOL, V13, P770, DOI 10.1016/j.conb.2003.10.010; Hau M, 2001, HORM BEHAV, V40, P281, DOI 10.1006/hbeh.2001.1673; Hau M, 2000, J EXP ZOOL, V286, P494, DOI 10.1002/(SICI)1097-010X(20000401)286:5<494::AID-JEZ7>3.0.CO;2-3; JONES PJ, 1976, IBIS, V118, P547, DOI 10.1111/j.1474-919X.1976.tb03516.x; Komdeur J, 1996, J BIOL RHYTHM, V11, P333, DOI 10.1177/074873049601100407; Lambrechts MM, 1996, P ROY SOC B-BIOL SCI, V263, P19, DOI 10.1098/rspb.1996.0004; Langen TA, 2000, BEHAV ECOL, V11, P367, DOI 10.1093/beheco/11.4.367; Lepage D, 2004, OSTRICH, V75, P259, DOI 10.2989/00306520409485453; Lloyd P, 2001, OSTRICH, V72, P50, DOI 10.2989/00306520109485287; MARTIN TE, 1995, ECOL MONOGR, V65, P101, DOI 10.2307/2937160; McMullen LE, 2012, ECOL APPL, V22, P2164, DOI 10.1890/11-1650.1; MINOT EO, 1981, J ANIM ECOL, V50, P375, DOI 10.2307/4061; Monadjem A, 2009, IBIS, V151, P344, DOI 10.1111/j.1474-919X.2009.00912.x; Moore IT, 2005, BEHAV ECOL, V16, P755, DOI 10.1093/beheco/ari049; MOREAU RE, 1949, IBIS, V91, P256, DOI 10.1111/j.1474-919X.1949.tb02265.x; NAGER RG, 1995, AM NAT, V146, P454, DOI 10.1086/285809; Ndithia H, 2007, OSTRICH, V78, P13, DOI 10.2989/OSTRICH.2007.78.1.3.47; Penuelas J, 2007, GLOBAL CHANGE BIOL, V13, P2563, DOI 10.1111/j.1365-2486.2007.01464.x; Perez-Sanchez AJ, 2013, NEOTROP ENTOMOL, V42, P128, DOI 10.1007/s13744-012-0096-y; Picker M., 2004, FIELD GUIDE INSECTS; Poiani A, 2006, ADV ECOL RES, V39, P63, DOI 10.1016/S0065-2504(06)39004-6; POULIN B, 1992, ECOLOGY, V73, P2295, DOI 10.2307/1941476; Praus L, 2014, ARDEA, V102, P87, DOI 10.5253/078.102.0112; SAMPLE BE, 1993, AM MIDL NAT, V129, P234, DOI 10.2307/2426503; Sansom A, 2009, BEHAV ECOL, V20, P1168, DOI 10.1093/beheco/arp110; Scheuerlein A, 2002, J BIOL RHYTHM, V17, P171, DOI 10.1177/074873002129002465; SCOTT DM, 1987, WILSON BULL, V99, P708; Stutchbury B.J.M., 2001, BEHAV ECOLOGY TROPIC; Tieleman BI, 2003, P ROY SOC B-BIOL SCI, V270, P207, DOI 10.1098/rspb.2002.2205; Tieleman BI, 2004, ECOLOGY, V85, P1399, DOI 10.1890/03-0170; Tieleman BI, 2003, FUNCT ECOL, V17, P869, DOI 10.1046/j.0269-8463.2003.00801.x; Tieleman BI, 2002, ANIM BEHAV, V63, P519, DOI 10.1006/anbe.2001.1927; Tieleman BI, 2005, SEEKING NATURES LIMI; Toyama M, 2015, CAN J ZOOL, V93, P841, DOI 10.1139/cjz-2015-0060; TYE H, 1992, IBIS, V134, P154, DOI 10.1111/j.1474-919X.1992.tb08392.x; van Klink R, 2015, BIOL REV, V90, P347, DOI 10.1111/brv.12113; VANNOORDWIJK AJ, 1995, J ANIM ECOL, V64, P451, DOI 10.2307/5648; Veen GF, 2010, ECOLOGY, V91, P828, DOI 10.1890/09-0134.1; WARD P, 1969, J ZOOL, V157, P25; Wikelski M, 2000, ECOLOGY, V81, P2458, DOI 10.1890/0012-9658(2000)081[2458:SORIAN]2.0.CO;2; WREGE PH, 1991, AUK, V108, P673, DOI 10.2307/4088107; YOUNG BE, 1994, CONDOR, V96, P341, DOI 10.2307/1369319; ZANN RA, 1995, EMU, V95, P208, DOI 10.1071/MU9950208	62	9	9	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2017	12	4							e0175275	10.1371/journal.pone.0175275	http://dx.doi.org/10.1371/journal.pone.0175275			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KH	28419105	Green Published, Green Submitted, gold			2022-12-27	WOS:000399875200015
J	Wang, BJ; Naidu, RK; Qu, XM				Wang, Bingjie; Naidu, Rajeev K.; Qu, Xiaomei			Factors related to axial length elongation and myopia progression in orthokeratology practice	PLOS ONE			English	Article							CONTACT-LENSES; HONG-KONG; CHILDREN; PREVALENCE; REFRACTION; CHILDHOOD; AGE	Purpose To investigate which baseline factors are predictive for axial length growth over an average period of 2.5 years in a group of children wearing orthokeratology (OK) contact lenses. Methods In this retrospective study, the clinical records of 249 new OK wearers between January 2012 and December 2013 from the contact lens clinic at the Eye and ENT Hospital of Fudan University were reviewed. The primary outcome measure was axial length change from baseline to the time of review (July-August 2015). Independent variables included baseline measures of age at initiation of OK wear, gender, refractive error (spherical equivalent), astigmatism, average keratometry, corneal toricity, central corneal thickness, white-to-white corneal diameter, pupil size, corneal topography eccentricity value (e-value), intraocular pressure (IOP) and total time in follow-up (months total). The contributions of all independent variables on axial length change at the time of review were assessed using univariate and multivariable regression analyses. Results Univariate analyses of the right eyes of 249 OK patients showed that smaller increases in axial length were associated with older age at the onset of OK lens wear, greater baseline spherical equivalent myopic refractive error, less time in follow-up and a smaller e-value. Multivariable analyses of the significant right eye variables showed that the factors associated with smaller axial length growth were older age at the onset of OK lens wear (p < 0.0001), greater baseline spherical equivalent myopic refractive error (p = 0.0046) and less time in follow-up (p < 0.0001). Conclusions The baseline factors demonstrating the greatest correlation with reduced axial length elongation during OK lens wear in myopic children included greater baseline spherical equivalent myopic refractive error and older age at the onset of OK lens wear.	[Wang, Bingjie; Qu, Xiaomei] Fudan Univ, Eye & ENT Hosp, Shanghai, Peoples R China; [Naidu, Rajeev K.] Univ Sydney, Sch Med, Camperdown, NSW, Australia; [Qu, Xiaomei] Fudan Univ, Minist Hlth, Key Lab Myopia, Shanghai, Peoples R China	Fudan University; University of Sydney; Fudan University	Qu, XM (corresponding author), Fudan Univ, Eye & ENT Hosp, Shanghai, Peoples R China.; Qu, XM (corresponding author), Fudan Univ, Minist Hlth, Key Lab Myopia, Shanghai, Peoples R China.	quxiaomei2002@126.com	Naidu, Rajeev/U-5889-2019	Wang, Bingjie/0000-0002-1199-6240	Shanghai Scientific Research Plan Project [14411969500]; Shanghai Municipal Health Bureau Research Projects [201540366]; Shanghai Committee of Science and Technology, China [14411969500]	Shanghai Scientific Research Plan Project; Shanghai Municipal Health Bureau Research Projects; Shanghai Committee of Science and Technology, China(Shanghai Science & Technology Committee)	This study was supported by the Shanghai Scientific Research Plan Project (Grant NO. 14411969500) and the Shanghai Municipal Health Bureau Research Projects (Grant NO. 201540366).r Support was provided by: Shanghai Committee of Science and Technology, China (Grant NO. 14411969500) (Funding received by XQ) [https://www.stcsm.gov.cn/]; Shanghai Municipal Health Bureau Research Projects (Grant NO. 201540366) (Funding received by XQ) [https://www.wsjsw.gov.cn/wsj/]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aller TA, 2014, EYE, V28, P147, DOI 10.1038/eye.2013.259; Chan B, 2006, CLIN EXP OPTOM, V89, P160, DOI 10.1111/j.1444-0938.2006.00029.x; Chang L, 2013, AM J OPHTHALMOL, V155, P991, DOI 10.1016/j.ajo.2013.01.016; Charm J, 2013, OPTOMETRY VISION SCI, V90, P530, DOI 10.1097/OPX.0b013e318293657d; Charman WN, 2006, OPTOMETRY VISION SCI, V83, P641, DOI 10.1097/01.opx.0000232840.66716.af; Chen CN, 2013, INVEST OPHTH VIS SCI, V54, P6510, DOI 10.1167/iovs.13-12527; Cheng SCK, 2013, OPHTHAL PHYSL OPT, V33, P652, DOI 10.1111/opo.12082; Chia A, 2016, OPHTHALMOLOGY, V123, P391, DOI 10.1016/j.ophtha.2015.07.004; Cho P, 2005, CURR EYE RES, V30, P71, DOI 10.1080/02713680590907256; Cho P, 2012, INVEST OPHTH VIS SCI, V53, P7077, DOI 10.1167/iovs.12-10565; Cooper MSJ, 2012, OPTOMETRY, V83, P179; Fan DSP, 2004, INVEST OPHTH VIS SCI, V45, P1071, DOI 10.1167/iovs.03-1151; Fu AC, 2016, CONTACT LENS ANTERIO, V39, P62, DOI 10.1016/j.clae.2015.07.006; Hiraoka T, 2012, INVEST OPHTH VIS SCI, V53, P3913, DOI 10.1167/iovs.11-8453; Huang JH, 2016, OPHTHALMOLOGY, V123, P697, DOI 10.1016/j.ophtha.2015.11.010; Hyman L, 2005, ARCH OPHTHALMOL-CHIC, V123, P977, DOI 10.1001/archopht.123.7.977; Kakita T, 2011, INVEST OPHTH VIS SCI, V52, P2170, DOI 10.1167/iovs.10-5485; Koffler BH, 2013, AM J OPHTHALMOL, V156, P1076, DOI 10.1016/j.ajo.2013.04.039; Li SM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134514; Liu YM, 2016, EYE CONTACT LENS, V42, P35, DOI 10.1097/ICL.0000000000000219; Luo Ming, 2014, Eye Sci, V29, P209; Maseedupally VK, 2016, OPTOMETRY VISION SCI; Ramamurthy D, 2015, CLIN EXP OPTOM, V98, P497, DOI 10.1111/cxo.12346; Russo A, 2014, INT OPHTHALMOL, V34, P693, DOI 10.1007/s10792-013-9844-1; Santodomingo-Rubido J, 2013, OPTOMETRY VISION SCI, V90, P1225, DOI 10.1097/OPX.0000000000000034; Santodomingo-Rubido J, 2012, INVEST OPHTH VIS SCI, V53, P5060, DOI 10.1167/iovs.11-8005; Saw SM, 2000, OPTOMETRY VISION SCI, V77, P549, DOI 10.1097/00006324-200010000-00009; Smith MJ, 2015, ADOLESC HEALTH MED T, V6, P133, DOI 10.2147/AHMT.S55834; Tong L, 2009, OPHTHALMOLOGY, V116, P572, DOI 10.1016/j.ophtha.2008.10.020; Twelker JD, 2009, OPTOMETRY VISION SCI, V86, P918, DOI 10.1097/OPX.0b013e3181b2f903; Walline JJ, 2009, BRIT J OPHTHALMOL, V93, P1181, DOI 10.1136/bjo.2008.151365; Walline JJ, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004916.pub3; Wang TJ, 2009, EYE, V23, P1168, DOI 10.1038/eye.2008.184; Wen DZ, 2015, J OPHTHALMOL, V2015, DOI 10.1155/2015/360806; Zhong YY, 2014, OPTOMETRY VISION SCI, V91, P404, DOI 10.1097/OPX.0000000000000183; Zhu M., 2012, CHINESE J OPTOMETRY, V14, P82	36	36	40	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2017	12	4							e0175913	10.1371/journal.pone.0175913	http://dx.doi.org/10.1371/journal.pone.0175913			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KH	28419129	gold, Green Published, Green Submitted			2022-12-27	WOS:000399875200053
J	Nakamura, S; Koyama, T; Izawa, N; Nomura, S; Fujita, T; Omata, Y; Minami, T; Matsumoto, M; Nakamura, M; Fujita-Jimbo, E; Momoi, T; Miyamoto, T; Aburatani, H; Tanaka, S				Nakamura, Shinya; Koyama, Takuma; Izawa, Naohiro; Nomura, Seitaro; Fujita, Takanori; Omata, Yasunori; Minami, Takashi; Matsumoto, Morio; Nakamura, Masaya; Fujita-Jimbo, Eriko; Momoi, Takashi; Miyamoto, Takeshi; Aburatani, Hiroyuki; Tanaka, Sakae			Negative feedback loop of bone resorption by NFATc1-dependent induction of Cadm1	PLOS ONE			English	Article							T-CELLS; IMMUNOGLOBULIN SUPERFAMILY; NUCLEAR FACTOR; OSTEOCLAST DIFFERENTIATION; FUNCTIONAL OSTEOCLASTS; CHROMATIN-STRUCTURE; LUNG-CANCER; GENE; ASSOCIATION; EXPRESSION	Trimethylation of histone H3 lysine 4 and lysine 27 (H3K4me3 and H3K27me3) at gene promoter regions critically regulates gene expression. Key developmental genes tend to exhibit changes in histone modification patterns from the H3K4me3/H3K27me3 bivalent pattern to the H3K4me3 monovalent pattern. Using comprehensive chromatin immunoprecipitation followed by sequencing in bone marrow-derived macrophages (BMMs) and mature osteoclasts, we found that cell surface adhesion molecule 1 (Cadm1) is a direct target of nuclear factor of activated T cells 1 (NFATc1) and exhibits a bivalent histone pattern in BMMs and a monovalent pattern in osteoclasts. Cadm1 expression was upregulated in BMMs by receptor activator of nuclear factor kappa B ligand (RANKL), and blocked by a calcineurin/ NFATc1 inhibitor, FK506. Cadm1-deficient mice exhibited significantly reduced bone mass compared with wild-type mice, which was due to the increased osteoclast differentiation, survival and bone-resorbing activity in Cadm1-deficient osteoclasts. These results suggest that Cadm1 is a direct target of NFATc1, which is induced by RANKL through epigenetic modification, and regulates osteoclastic bone resorption in a negative feedback manner.	[Nakamura, Shinya; Koyama, Takuma; Izawa, Naohiro; Omata, Yasunori; Miyamoto, Takeshi; Tanaka, Sakae] Univ Tokyo, Dept Orthopaed Surg, Fac Med, Bunkyo Ku, Tokyo, Japan; [Nomura, Seitaro; Fujita, Takanori; Aburatani, Hiroyuki] Univ Tokyo, RCAST, Genome Sci Div, Tokyo, Japan; [Minami, Takashi] Kumamoto Univ, Inst Resource Dev & Anal, Div Phenotype Dis Anal, Kumamoto, Kumamoto, Japan; [Matsumoto, Morio; Nakamura, Masaya; Miyamoto, Takeshi] Keio Univ, Dept Orthoped Surg, Tokyo, Japan; [Fujita-Jimbo, Eriko] Jichi Med Univ, Dept Pediat, Sch Med, Shimotsuke, Tochigi, Japan; [Momoi, Takashi] Tokyo Med Univ, Dept Pathophysiol, Shinjuku Ku, Tokyo, Japan	University of Tokyo; University of Tokyo; Kumamoto University; Keio University; Jichi Medical University; Tokyo Medical University	Tanaka, S (corresponding author), Univ Tokyo, Dept Orthopaed Surg, Fac Med, Bunkyo Ku, Tokyo, Japan.	TANAKAS-ORT@h.u-tokyo.ac.jp	Tanaka, Sakae/Y-3061-2019; Nakamura, Masaya/K-4111-2013	Tanaka, Sakae/0000-0001-9210-9414; 	Ministry of Education, Culture, Sports, Science and Technology of Japan; Grants-in-Aid for Scientific Research [26253075] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan.; We thank Ms. J. Sugita (Department of Orthopaedic Surgery, The University of Tokyo) for providing expert technical assistance. This work was supported in part by Grants-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Asagiri M, 2005, J EXP MED, V202, P1261, DOI 10.1084/jem.20051150; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Biederer T, 2008, CURR OPIN NEUROBIOL, V18, P261, DOI 10.1016/j.conb.2008.07.014; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Fujita E, 2006, MOL CELL BIOL, V26, P718, DOI 10.1128/MCB.26.2.718-726.2006; Furuno T, 2012, J NEUROIMMUNOL, V250, P50, DOI 10.1016/j.jneuroim.2012.05.016; Goldberg AD, 2007, CELL, V128, P635, DOI 10.1016/j.cell.2007.02.006; Gomyo H, 1999, GENOMICS, V62, P139, DOI 10.1006/geno.1999.6001; Hirotani H, 2004, J BIOL CHEM, V279, P13984, DOI 10.1074/jbc.M213067200; Ishida-Kitagawa N, 2012, J BIOL CHEM, V287, P17493, DOI 10.1074/jbc.M111.324194; Kameda Y, 2013, J BONE MINER RES, V28, P2463, DOI 10.1002/jbmr.1989; Kim Y, 2005, J BIOL CHEM, V280, P32905, DOI 10.1074/jbc.M505820200; Koga T, 2004, NATURE, V428, P758, DOI 10.1038/nature02444; Kuramochi M, 2001, NAT GENET, V27, P427, DOI 10.1038/86934; Lazner F, 1999, HUM MOL GENET, V8, P1839, DOI 10.1093/hmg/8.10.1839; Margueron R, 2005, CURR OPIN GENET DEV, V15, P163, DOI 10.1016/j.gde.2005.01.005; Matsumoto M, 2004, J BIOL CHEM, V279, P45969, DOI 10.1074/jbc.M408795200; Matsuo K, 2004, J BIOL CHEM, V279, P26475, DOI 10.1074/jbc.M313973200; Mersfelder EL, 2006, NUCLEIC ACIDS RES, V34, P2653, DOI 10.1093/nar/gkl338; Miyamoto K, 2009, BIOCHEM BIOPH RES CO, V383, P373, DOI 10.1016/j.bbrc.2009.04.020; Mocsai A, 2004, P NATL ACAD SCI USA, V101, P6158, DOI 10.1073/pnas.0401602101; Murakami S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110062; Nakamura H, 2014, BIOCHEM BIOPH RES CO, V455, P305, DOI 10.1016/j.bbrc.2014.11.009; Negishi-Koga T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7637; Omata Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157992; Ray BJ, 2012, J LEUKOCYTE BIOL, V92, P1021, DOI 10.1189/jlb.0512259; Schwartz YB, 2007, NAT REV GENET, V8, P9, DOI 10.1038/nrg1981; SLY WS, 1995, ANNU REV BIOCHEM, V64, P375, DOI 10.1146/annurev.bi.64.070195.002111; Stagi M, 2010, P NATL ACAD SCI USA, V107, P7568, DOI 10.1073/pnas.0911798107; Strahl BD, 1999, P NATL ACAD SCI USA, V96, P14967, DOI 10.1073/pnas.96.26.14967; Suehiro J, 2014, J BIOL CHEM, V289, P29044, DOI 10.1074/jbc.M114.555235; Takai Y, 2008, NAT REV MOL CELL BIO, V9, P603, DOI 10.1038/nrm2457; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Takayanagi H, 2007, NAT REV IMMUNOL, V7, P292, DOI 10.1038/nri2062; Takayanagi Y, 2010, BIOCHEM BIOPH RES CO, V396, P703, DOI 10.1016/j.bbrc.2010.04.165; TANAKA S, 1995, J CELL BIOCHEM, V58, P424, DOI 10.1002/jcb.240580405; Tanaka S, 2007, AM J NEPHROL, V27, P466, DOI 10.1159/000106484; Theill LE, 2002, ANNU REV IMMUNOL, V20, P795, DOI 10.1146/annurev.immunol.20.100301.064753; Urase K, 2001, NEUROREPORT, V12, P3217, DOI 10.1097/00001756-200110290-00015; Wakayama T, 2001, MOL REPROD DEV, V60, P158, DOI 10.1002/mrd.1072; Xiong WC, 2003, FRONT BIOSCI-LANDMRK, V8, pD1219, DOI 10.2741/1117; Yageta M, 2002, CANCER RES, V62, P5129; Yasui T, 2011, J BONE MINER RES, V26, P1447, DOI 10.1002/jbmr.357; Zhiling Y, 2008, BIOCHEM BIOPH RES CO, V377, P926, DOI 10.1016/j.bbrc.2008.10.107; Zou W, 2010, J CELL SCI, V123, P2955, DOI 10.1242/jcs.069872	45	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2017	12	4							e0175632	10.1371/journal.pone.0175632	http://dx.doi.org/10.1371/journal.pone.0175632			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KD	28414795	gold, Green Published, Green Submitted			2022-12-27	WOS:000399874800041
J	Teoh, JJ; Iwano, T; Kunii, M; Atik, N; Avriyanti, E; Yoshimura, S; Moriwaki, K; Harada, A				Teoh, Jia-Jie; Iwano, Tomohiko; Kunii, Masataka; Atik, Nur; Avriyanti, Erda; Yoshimura, Shin-ichiro; Moriwaki, Kenta; Harada, Akihiro			BIG1 is required for the survival of deep layer neurons, neuronal polarity, and the formation of axonal tracts between the thalamus and neocortex in developing brain	PLOS ONE			English	Article							NUCLEOTIDE-EXCHANGE PROTEIN; ADP-RIBOSYLATION FACTORS; BREFELDIN-A; CELL POLARITY; MIGRATION; LOCALIZATION; EXPRESSION; CONNECTIONS; CORTEX; GOLGI	BIG1, an activator protein of the small GTPase, Arf, and encoded by the Arfgef1 gene, is one of candidate genes for epileptic encephalopathy. To know the involvement of BIG1 in epileptic encephalopathy, we analyzed BIG1-deficient mice and found that BIG1 regulates neurite outgrowth and brain development in vitro and in vivo. The loss of BIG1 decreased the size of the neocortex and hippocampus. In BIG1-deficient mice, the neuronal progenitor cells (NPCs) and the interneurons were unaffected. However, Tbr1(+) and Ctip2(+) deep layer (DL) neurons showed spatial-temporal dependent apoptosis. This apoptosis gradually progressed from the piriform cortex (PIR), peaked in the neocortex, and then progressed into the hippocampus from embryonic day 13.5 (E13.5) to E17.5. The upper layer (UL) and DL order in the neocortex was maintained in BIG1-deficient mice, but the excitatory neurons tended to accumulate before their destination layers. Further pulse-chase migration assay showed that the migration defect was non-cell autonomous and secondary to the progression of apoptosis into the BIG1-deficient neocortex after E15.5. In BIG1-deficient mice, we observed an ectopic projection of corticothalamic axons from the primary somatosensory cortex (S1) into the dorsal lateral geniculate nucleus (dLGN). The thalamocortical axons were unable to cross the diencephalon-telencephalon boundary (DTB). In vitro, BIG1-deficient neurons showed a delay in neuronal polarization. BIG1-deficient neurons were also hypersensitive to low dose glutamate (5 mu M), and died via apoptosis. This study showed the role of BIG1 in the survival of DL neurons in developing embryonic brain and in the generation of neuronal polarity.	[Teoh, Jia-Jie; Kunii, Masataka; Atik, Nur; Avriyanti, Erda; Yoshimura, Shin-ichiro; Moriwaki, Kenta; Harada, Akihiro] Osaka Univ, Grad Sch Med, Dept Cell Biol, Suita, Osaka, Japan; [Iwano, Tomohiko] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Anat & Cell Biol, Chuo Ku, Kofu, Yamanashi, Japan; [Atik, Nur] Padjadjaran State Univ, Dept Anat & Cell Biol, Fac Med, Bandung, Indonesia; [Avriyanti, Erda] Padjadjaran State Univ, Dept Dermatol & Venereol, Fac Med, Bandung, Indonesia	Osaka University; University of Yamanashi; Universitas Padjadjaran; Universitas Padjadjaran	Harada, A (corresponding author), Osaka Univ, Grad Sch Med, Dept Cell Biol, Suita, Osaka, Japan.	aharada@acb.med.osaka-u.jp		Moriwaki, Kenta/0000-0002-8724-4715; atik, nur/0000-0001-5951-4733; Teoh, Jiajie/0000-0001-7100-5763; Avriyanti, Erda/0000-0002-3359-6950	Japanese Ministry of Education, Culture, Sports, Science, and Technology (KAKENHI) [JP24390046]	Japanese Ministry of Education, Culture, Sports, Science, and Technology (KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Support was provided by the Japanese Ministry of Education, Culture, Sports, Science, and Technology (KAKENHI grants JP24390046). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen Institute for Brain Science, 2017, DAT ALL BRAIN ATL DA; Appenzeller S, 2014, AM J HUM GENET, V95, P360, DOI 10.1016/j.ajhg.2014.08.013; Atlante A, 2001, FEBS LETT, V497, P1, DOI 10.1016/S0014-5793(01)02437-1; BENDOTTI C, 1990, DEV BRAIN RES, V53, P26, DOI 10.1016/0165-3806(90)90121-E; Blaustein MP, 1999, PHYSIOL REV, V79, P763, DOI 10.1152/physrev.1999.79.3.763; Boal F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009898; Cauli B, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00052; Chapman AG, 1998, PROG BRAIN RES, V116, P371, DOI 10.1016/S0079-6123(08)60449-5; Chen YJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033105; Cho CH, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00127; Cooper JA, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00386; Costa MR, 2015, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00449; de Anda FC, 2005, NATURE, V436, P704, DOI 10.1038/nature03811; Deck M, 2013, NEURON, V77, P472, DOI 10.1016/j.neuron.2012.11.031; Fath T, 2009, NAT PROTOC, V4, P78, DOI 10.1038/nprot.2008.199; Faux C, 2010, J COMP NEUROL, V518, P1232, DOI 10.1002/cne.22271; Ganguly K, 2001, CELL, V105, P521, DOI 10.1016/S0092-8674(01)00341-5; Garel S, 2014, CURR OPIN NEUROBIOL, V27, P143, DOI 10.1016/j.conb.2014.03.013; Govek EE, 2005, GENE DEV, V19, P1, DOI 10.1101/gad.1256405; Grant RA, 2012, FRONT BEHAV NEUROSCI, V6, DOI 10.3389/fnbeh.2012.00039; Hevner RF, 2002, J COMP NEUROL, V447, P8, DOI 10.1002/cne.10219; Hevner RF, 2001, NEURON, V29, P353, DOI 10.1016/S0896-6273(01)00211-2; Jackson CL, 2004, SEC7 FAMILY ART GEFS, P79; Jacobs EC, 2007, EUR J NEUROSCI, V25, P17, DOI 10.1111/j.1460-9568.2006.05258.x; Kawaguchi Y, 1997, CEREB CORTEX, V7, P476, DOI 10.1093/cercor/7.6.476; Ketelaars SOM, 2004, EPILEPSIA, V45, P1189, DOI 10.1111/j.0013-9580.2004.03304.x; Kriegstein AR, 2004, TRENDS NEUROSCI, V27, P392, DOI 10.1016/j.tins.2004.05.001; Kwan KY, 2012, DEVELOPMENT, V139, P1535, DOI 10.1242/dev.069963; Le K, 2013, P NATL ACAD SCI USA, V110, pE3162, DOI 10.1073/pnas.1312531110; Lee KH, 2012, J NEUROSCI, V32, P4102, DOI 10.1523/JNEUROSCI.6331-11.2012; Leyva-Diaz E, 2013, NEUROSCIENCE, V254, P26, DOI 10.1016/j.neuroscience.2013.08.070; Li CC, 2011, P NATL ACAD SCI USA, V108, P19228, DOI 10.1073/pnas.1117011108; LIPPINCOTTSCHWARTZ J, 1989, CELL, V56, P801, DOI 10.1016/0092-8674(89)90685-5; Lu J, 2006, J COMP NEUROL, V494, P476, DOI 10.1002/cne.20806; Mansour SJ, 1999, P NATL ACAD SCI USA, V96, P7968, DOI 10.1073/pnas.96.14.7968; Meechan DW, 2012, P NATL ACAD SCI USA, V109, P18601, DOI 10.1073/pnas.1211507109; Meijering E, 2004, CYTOM PART A, V58A, P167, DOI 10.1002/cyto.a.20022; MELDRUM BS, 1994, NEUROLOGY, V44, P14; Miyoshi G, 2015, J NEUROSCI, V35, P12869, DOI 10.1523/JNEUROSCI.1164-15.2015; Molnar Z, 1998, J NEUROSCI, V18, P5723; Parsons MP, 2014, NEURON, V82, P279, DOI 10.1016/j.neuron.2014.03.030; PRICE J, 1988, DEVELOPMENT, V104, P473; Rodriguez-Tornos FM, 2016, NEURON, V89, P494, DOI 10.1016/j.neuron.2015.12.020; Sato M, 2011, TRAFFIC, V12, P1383, DOI 10.1111/j.1600-0854.2011.01247.x; Sato T, 2007, NATURE, V448, P366, DOI 10.1038/nature05929; SATOYOSHITAKE R, 1989, NEURON, V3, P229, DOI 10.1016/0896-6273(89)90036-6; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Shen XY, 2008, P NATL ACAD SCI USA, V105, P18788, DOI 10.1073/pnas.0810104105; Sultan KT, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00221; Tan X, 2013, WIRES DEV BIOL, V2, P443, DOI 10.1002/wdev.88; Thomas TC, 2012, J NEUROTRAUM, V29, P187, DOI 10.1089/neu.2011.2091; Togawa A, 1999, J BIOL CHEM, V274, P12308, DOI 10.1074/jbc.274.18.12308; Toma K, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00274; Toma K, 2014, J NEUROSCI, V34, P13259, DOI 10.1523/JNEUROSCI.2334-14.2014; Vaarmann A, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2012.194; Voglis G, 2006, EMBO REP, V7, P1104, DOI 10.1038/sj.embor.7400830; WALSH C, 1990, EXPERIENTIA, V46, P940, DOI 10.1007/BF01939387; Wright J, 2014, CELL MOL LIFE SCI, V71, P3419, DOI 10.1007/s00018-014-1602-7; Wu YK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118482; Yamaji R, 2000, P NATL ACAD SCI USA, V97, P2567, DOI 10.1073/pnas.97.6.2567; Yoshimura S, 2004, J BIOCHEM, V135, P201, DOI 10.1093/jb/mvh024; Zhang JP, 2012, J NEUROSCI, V32, P12619, DOI 10.1523/JNEUROSCI.1063-12.2012; Zhang YM, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-49; Zhao XH, 2002, MOL BIOL CELL, V13, P119, DOI 10.1091/mbc.01-08-0420; Zhou C, 2013, NEUROSCIENCE, V254, P361, DOI 10.1016/j.neuroscience.2013.09.045; Zhou X, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.82	66	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2017	12	4							e0175888	10.1371/journal.pone.0175888	http://dx.doi.org/10.1371/journal.pone.0175888			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KD	28414797	Green Submitted, Green Published, gold			2022-12-27	WOS:000399874800073
J	Zhang, JJ; Yu, GZ; Zheng, ZH; Liu, YF; Du, YY; Quan, SX; Liu, YJ; Lv, JC; Zhang, H				Zhang, Jun-Jun; Yu, Gui-Zhen; Zheng, Zhao-Hui; Liu, Ya-Fei; Du, Yang-Yang; Quan, Song-Xia; Liu, Yu-Jie; Lv, Ji-Cheng; Zhang, Hong			Dividing CKD stage 3 into G3a and G3b could better predict the prognosis of IgA nephropathy	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; PROGRESSION; PHOSPHORUS; MORTALITY; RISKS; DEATH	Chronic kidney disease (CKD) stage 3 was divided into stage G3a and stage G3b in the 2013 Kidney Disease Improving Global Outcomes guidelines. Whether it is appropriate to regard 45 mL/min/per 1.73 m(2) as the threshold value of G3a/G3b staging and whether dividing CKD stage 3 into G3a/G3b plays a useful role in assessing the prognosis of patients with IgA nephropathy (IgAN) remain unknown. Three hundred and ninety patients from the First Affiliated Hospital of Zhengzhou University and Peking University First Hospital diagnosed with IgAN in CKD stage 3 were enrolled and successfully followed up. Cox proportional hazards model was used to analyze hazard ratios of reaching the composite endpoints (doubling of serum creatinine, end-stage renal disease: estimated glomerular filtration rate (eGFR) < 15 ml/min/per 1.73 m(2) or renal replacement therapy, or death) for patients with different eGFR and risk factors affecting composite endpoints. The Kaplan-Meier method was used to calculate the cumulative renal survival rate of patients. When eGFR was lower than 45 ml/min/per 1.73 m(2), the hazard ratio increased sharply for patients in CKD stage 3 who reached the composite endpoints. Renal injury and prognosis were significantly different between patients in the G3a and G3b groups. Stage G3b was a major risk factor affecting prognosis. A threshold value of 45 ml/min/per 1.73 m(2) appears appropriate to assess the prognosis of IgAN patients with CKD stage 3. Dividing IgAN patients with CKD stage 3 into G3a and G3b is very useful to help understand disease conditions and for predicting the risk for disease progression.	[Zhang, Jun-Jun; Yu, Gui-Zhen; Liu, Ya-Fei; Du, Yang-Yang; Quan, Song-Xia] Zhengzhou Univ, Affiliated Hosp 1, Dept Nephrol, Zhengzhou, Henan, Peoples R China; [Zhang, Jun-Jun; Yu, Gui-Zhen; Zheng, Zhao-Hui; Liu, Ya-Fei; Du, Yang-Yang; Quan, Song-Xia] Zhengzhou Univ, Res Inst Nephropathy, Zhengzhou, Henan, Peoples R China; [Zheng, Zhao-Hui] Zhengzhou Univ, Affiliated Hosp 1, Dept Rheumatism Immun, Zhengzhou, Henan, Peoples R China; [Liu, Yu-Jie] Childrens Hosp Zhengzhou City, Dept Nephrol & Rheumatol, Zhengzhou, Henan, Peoples R China; [Lv, Ji-Cheng; Zhang, Hong] Peking Univ, Hosp 1, Renal Div, Beijing, Peoples R China	Zhengzhou University; Zhengzhou University; Zhengzhou University; Peking University	Zhang, JJ (corresponding author), Zhengzhou Univ, Affiliated Hosp 1, Dept Nephrol, Zhengzhou, Henan, Peoples R China.; Zhang, JJ (corresponding author), Zhengzhou Univ, Res Inst Nephropathy, Zhengzhou, Henan, Peoples R China.	zhangjj0123@126.com	liu, yafei/B-1916-2016; Liu, Ya-Fei/AAO-4134-2020	liu, yafei/0000-0002-4141-5259; Liu, Ya-Fei/0000-0002-4141-5259	National Natural Science Foundation of China [81570645/H0509]; Major Project of Program for Medical Science and Technology Development of Henan Province [201501018]; Youth Innovation Fund of the First Affiliated Hospital of Zhengzhou University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major Project of Program for Medical Science and Technology Development of Henan Province; Youth Innovation Fund of the First Affiliated Hospital of Zhengzhou University	This work was supported by grants from the National Natural Science Foundation of China (No. 81570645/H0509), Major Project of Program for Medical Science and Technology Development of Henan Province (No. 201501018) and the Youth Innovation Fund of the First Affiliated Hospital of Zhengzhou University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by grants from the National Natural Science Foundation of China (No. 81570645/H0509), Major Project of Program for Medical Science and Technology Development of Henan Province (No.201501018) and the Youth Innovation Fund of the First Affiliated Hospital of Zhengzhou University.	Block GA, 2004, J AM SOC NEPHROL, V15, P2208, DOI 10.1097/01.ASN.0000133041.27682.A2; Da JJ, 2015, AM J KIDNEY DIS, V66, P258, DOI 10.1053/j.ajkd.2015.01.009; Ekart R, 2013, THER APHER DIAL, V17, P363, DOI 10.1111/1744-9987.12079; Floege J, 2014, SEMIN IMMUNOPATHOL, V36, P431, DOI 10.1007/s00281-013-0411-7; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Katafuchi R, 1998, CLIN NEPHROL, V49, P1; KDIGO C-M, 2009, KIDNEY INT S113, V76, pS1, DOI DOI 10.1038/KI.2009.188; Kendrick J, 2011, AM J KIDNEY DIS, V58, P826, DOI 10.1053/j.ajkd.2011.07.020; Komatsu H, 2005, RENAL FAILURE, V27, P45, DOI 10.1081/JDI-200044919; Le WB, 2012, NEPHROL DIAL TRANSPL, V27, P1479, DOI 10.1093/ndt/gfr527; Levey AS, 2011, KIDNEY INT, V80, P17, DOI 10.1038/ki.2010.483; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levin A, 2013, KIDNEY INT SUPPL, V3, P5, DOI 10.1038/kisup.2012.77; Li LS, 2004, KIDNEY INT, V66, P920, DOI 10.1111/j.1523-1755.2004.00837.x; Palmer SC, 2011, JAMA-J AM MED ASSOC, V305, P1119, DOI 10.1001/jama.2011.308; Reich HN, 2007, J AM SOC NEPHROL, V18, P3177, DOI 10.1681/ASN.2007050526; Seliger SL, 2008, J AM SOC NEPHROL, V19, P2414, DOI 10.1681/ASN.2008010022; Tsubakihara Y, 2010, THER APHER DIAL, V14, P240, DOI 10.1111/j.1744-9987.2010.00836.x	18	1	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2017	12	4							e0175828	10.1371/journal.pone.0175828	http://dx.doi.org/10.1371/journal.pone.0175828			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KD	28414748	Green Submitted, gold, Green Published			2022-12-27	WOS:000399874800062
J	Borte, S; Winsvold, BS; Stensland, SO; Smastuen, MC; Zwart, JA				Borte, Sigrid; Winsvold, Bendik S.; Stensland, Synne Oien; Smastuen, Milada Cvancarova; Zwart, John-Anker			The effect of foetal growth restriction on the development of migraine and tension-type headache in adulthood. The HUNT Study	PLOS ONE			English	Article							GESTATIONAL-AGE; SEX-DIFFERENCES; BIRTH-WEIGHT; INTRAUTERINE GROWTH; BORN SMALL; EPIDEMIOLOGY; CHILDHOOD; DISORDER; CLASSIFICATION; MANAGEMENT	Background There is little knowledge about how factors early in life affect the development of migraine and tension-type headache. We aimed to examine whether growth restriction in utero is associated with development of migraine and frequent tension-type headache in adults. Methods The population-based Nord-Trondelag Health Study (HUNT 3) contained a validated headache questionnaire, which differentiated between migraine and tension-type headache. These data were linked to information on weight and gestational age at birth from the Norwegian Medical Birth Registry. In total 4557 females and 2789 males, aged 19-41 years, were included in this registry-based study. Participants were categorized as appropriate for gestational age (AGA, 10th-90th percentile), small for gestational age (SGA, 3rd-10th percentile) or very small for gestational age (VSGA,< 3 rd percentile). Logistic regression was used to calculate odds ratios (OR) with 95% confidence intervals (CI) for migraine and tension-type headache, with exposure being growth restriction at birth. Results The effect of growth restriction on migraine was modified by sex, with a significant association in males (p<0.001), but not in females (p = 0.20). In particular, males born VSGA were at increased risk of developing migraine (OR 2.73, 95% CI 1.63-4.58, p<0.001), with an intermediate risk among those born SGA (OR 1.50, 95% CI 0.96-2.35, p = 0.08) compared to those born AGA. There was no significant association between growth restriction and frequent TTH (p = 0.051). Conclusion Growth restriction was associated with increased risk of migraine in adulthood among males, but not among females. This suggests that migraine might, in part, be influenced by early life events, and that males seem to be particularly vulnerable.	[Borte, Sigrid; Zwart, John-Anker] Univ Oslo, Inst Clin Med, Fac Med, Oslo, Norway; [Borte, Sigrid; Winsvold, Bendik S.; Stensland, Synne Oien; Smastuen, Milada Cvancarova; Zwart, John-Anker] Oslo Univ Hosp, FORMI, Oslo, Norway; [Winsvold, Bendik S.; Zwart, John-Anker] Oslo Univ Hosp, Dept Neurol, Oslo, Norway; [Stensland, Synne Oien] Norwegian Ctr Violence & Traumat Stress Studies, Oslo, Norway; [Smastuen, Milada Cvancarova] Oslo & Akershus Univ, Dept Nursing & Hlth Promot, Fac Hlth Sci, Coll Appl Sci, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; Oslo Metropolitan University (OsloMet)	Borte, S (corresponding author), Univ Oslo, Inst Clin Med, Fac Med, Oslo, Norway.; Borte, S (corresponding author), Oslo Univ Hosp, FORMI, Oslo, Norway.	sigrid.borte@gmail.com	Winsvold, Bendik/ABF-7839-2021	Winsvold, Bendik/0000-0003-4171-8919	South Eastern Norway Regional Health Authority [2015089]; Research Council of Norway [231187/F20]	South Eastern Norway Regional Health Authority; Research Council of Norway(Research Council of Norway)	This work was supported by the South Eastern Norway Regional Health Authority, grant 2015089 to SB (https://www.helse-sorost.no/south-eastern-norway-regional-health-authority) and the Research Council of Norway, grant 231187/F20 to BSW (http://www.forskningsradet.no/en/Home_page/1177315753906). The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Aamodt AH, 2006, EUR J NEUROL, V13, P1233, DOI 10.1111/j.1468-1331.2006.01492.x; Alberry M, 2007, ARCH DIS CHILD-FETAL, V92, pF62, DOI 10.1136/adc.2005.082297; Arruda MA, 2011, ARQ NEURO-PSIQUIAT, V69, P27, DOI 10.1590/S0004-282X2011000100007; Ashina Sait, 2005, Curr Pain Headache Rep, V9, P415, DOI 10.1007/s11916-005-0021-8; Barbanti P, 2013, NEUROL SCI, V34, pS67, DOI 10.1007/s10072-013-1415-8; BATTAGLI.FC, 1967, J PEDIATR-US, V71, P159, DOI 10.1016/S0022-3476(67)80066-0; Bernstein PS, 1997, CLIN OBSTET GYNECOL, V40, P723, DOI 10.1097/00003081-199712000-00006; Carberry AE, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008549.pub2; Clifton VL, 2010, PLACENTA, V31, pS33, DOI 10.1016/j.placenta.2009.11.010; Cohen E, 2016, PEDIATR RES, V79, P821, DOI 10.1038/pr.2016.24; D'Andrea G, 2012, HEADACHE, V52, P1155, DOI 10.1111/j.1526-4610.2012.02168.x; Demicheva E, 2014, FETAL DIAGN THER, V36, P143, DOI 10.1159/000353633; DeVore GR, 2015, AM J OBSTET GYNECOL, V213, P5, DOI 10.1016/j.ajog.2015.05.024; Di Renzo GC, 2007, GENDER MED, V4, P19, DOI 10.1016/S1550-8579(07)80004-0; Dussor G, 2014, CURR OPIN SUPPORT PA, V8, P137, DOI 10.1097/SPC.0000000000000044; Dyb G, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0479-y; Figueras F, 2014, FETAL DIAGN THER, V36, P86, DOI 10.1159/000357592; Gardosi J, 2006, HORM RES, V65, P15, DOI 10.1159/000091501; Hagen K, 2010, J HEADACHE PAIN, V11, P67, DOI 10.1007/s10194-009-0174-7; Heinonen K, 2010, BMC PEDIATR, V10, DOI 10.1186/1471-2431-10-91; Hernandez-Andrade E, 2015, NEUROSCI LETT, V584, P60, DOI 10.1016/j.neulet.2014.09.051; Hintz SR, 2006, ACTA PAEDIATR, V95, P1239, DOI 10.1080/08035250600599727; Jensen A, 1996, REPROD FERT DEVELOP, V8, P355, DOI 10.1071/RD9960355; Kelman L, 2011, EXPERT REV NEUROTHER, V11, P363, DOI [10.1586/ern.10.128, 10.1586/ERN.10.128]; Langhammer A, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-143; Maneyapanda SB, 2005, PEDIATRICS, V116, pE555, DOI 10.1542/peds.2005-0454; Miller SL, 2016, J PHYSIOL-LONDON, V594, P807, DOI 10.1113/JP271402; Minkowski A, 1981, Prog Clin Biol Res, V77, P643; Morsing E, 2011, PEDIATRICS, V127, pE874, DOI 10.1542/peds.2010-1821; Nguyen BN, 2016, CEPHALALGIA, V36, P5, DOI 10.1177/0333102415576725; Nielsen CS, 2012, CLIN GENET, V82, P331, DOI 10.1111/j.1399-0004.2012.01938.x; Norwegian Institute of Public Health, 2012, MED BIRTH REG NORW; PARKINSON CE, 1981, DEV MED CHILD NEUROL, V23, P41; Paulsson L, 2009, ACTA ODONTOL SCAND, V67, P30, DOI 10.1080/00016350802541152; Peterlin BL, 2011, HEADACHE, V51, P860, DOI 10.1111/j.1526-4610.2011.01907.x; Robberstad L, 2010, NEUROLOGY, V75, P712, DOI 10.1212/WNL.0b013e3181eee244; Roth CL, 2012, REV ENDOCR METAB DIS, V13, P129, DOI 10.1007/s11154-012-9212-x; Sacco S, 2012, J HEADACHE PAIN, V13, P177, DOI 10.1007/s10194-012-0424-y; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; Simchen MJ, 2014, J MATERN-FETAL NEO M, V27, P839, DOI 10.3109/14767058.2013.845658; Skjaerven R, 2000, ACTA OBSTET GYN SCAN, V79, P440, DOI 10.1034/j.1600-0412.2000.079006440.x; Stovner LJ, 2006, EUR J NEUROL, V13, P333, DOI 10.1111/j.1468-1331.2006.01184.x; Sun Y, 2008, AM J EPIDEMIOL, V167, P262, DOI 10.1093/aje/kwm316; Tietjen GE, 2009, CEPHALALGIA, V29, P989, DOI 10.1111/j.1468-2982.2009.01937.x; Tietjen GE, 2011, HEADACHE, V51, P869, DOI 10.1111/j.1526-4610.2011.01906.x; Unterscheider J, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-63; Vecchia D, 2012, TRENDS NEUROSCI, V35, P507, DOI 10.1016/j.tins.2012.04.007; Vetvik KG, 2017, LANCET NEUROL, V16, P76, DOI 10.1016/S1474-4422(16)30293-9; Vos T, 2015, LANCET, V386, P743, DOI 10.1016/S0140-6736(15)60692-4; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Waldie KE, 2014, J HEADACHE PAIN, V15, DOI 10.1186/1129-2377-15-60; WHO. World Health Organization, 2012, HEAD DIS	52	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2017	12	4							e0175908	10.1371/journal.pone.0175908	http://dx.doi.org/10.1371/journal.pone.0175908			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0MD	28410431	Green Submitted, Green Published, gold			2022-12-27	WOS:000399955600052
J	Yamada, M; Hashimoto, Y; Kumano, T; Tsujimura, S; Kobayashi, M				Yamada, Masatoshi; Hashimoto, Yoshiteru; Kumano, Takuto; Tsujimura, Seiya; Kobayashi, Michihiko			New function of aldoxime dehydratase: Redox catalysis and the formation of an expected product	PLOS ONE			English	Article							NITROGEN TRIPLE-BOND; RHODOCOCCUS-RHODOCHROUS J1; PSEUDOMONAS-CHLORORAPHIS B23; MASS NITRILE HYDRATASE; CYTOCHROME-C PEROXIDASE; CRYSTAL-STRUCTURE; HYDROGEN-PEROXIDE; HEME ENVIRONMENT; CYANIDE BINDING; GENE-CLUSTER	In general, hemoproteins are capable of catalyzing redox reactions. Aldoxime dehydratase (OxdA), which is a unique heme-containing enzyme, catalyzes the dehydration of aldoximes to the corresponding nitriles. Its reaction is a rare example of heme directly activating an ;organic substrate, unlike the utilization of H2O2 or O-2 as a mediator of catalysis by other heme-containing enzymes. While it is unknown whether OxdA catalyzes redox reactions or not, we here for the first time detected catalase activity (which is one of the redox activities) of wild-type OxdA, OxdA(WT). Furthermore, we constructed a His320 -> Asp mutant of OxdA [OxdA(H320D)], and found it exhibits catalase activity. Determination of the kinetic parameters of OxdA(WT) and OxdA(H320D) revealed that their Km values for H2O2 were similar to each other, but the k(cat) value of OxdA(H320D) was 30 times higher than that of OxdA(WT). Next, we examined another redox activity and found it was the peroxidase activity of OxdAs. While both OxdA(WT) and OxdA(H320D) showed the activity, the activity of OxdA(H320D) was dozens of times higher than that of OxdA(WT). These findings demonstrated that the H320D mutation enhances the peroxidase activity of OxdA. OxdAs (WT and H320D) were found to catalyze another redox reaction, a peroxygenase reaction. During this reaction of OxdA(H320D) with 1-methoxynaphthalene as a substrate, surprisingly, the reaction mixture changed to a color different from that with OxdA(WT), which was due to the known product, Russig's blue. We purified and identified the new product as 1-methoxy-2-naphthalenol, which has never been reported as a product of the peroxygenase reaction, to the best of our knowledge. These findings indicated that the H320D mutation not only enhanced redox activities, but also significantly altered the hydroxylation site of the substrate.	[Yamada, Masatoshi; Hashimoto, Yoshiteru; Kumano, Takuto; Kobayashi, Michihiko] Univ Tsukuba, Inst Appl Biochem, Tsukuba, Ibaraki, Japan; [Yamada, Masatoshi; Hashimoto, Yoshiteru; Kumano, Takuto; Kobayashi, Michihiko] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan; [Tsujimura, Seiya] Univ Tsukuba, Fac Pure & Appl Sci, Div Mat Sci, Tsukuba, Ibaraki, Japan	University of Tsukuba; University of Tsukuba; University of Tsukuba	Kobayashi, M (corresponding author), Univ Tsukuba, Inst Appl Biochem, Tsukuba, Ibaraki, Japan.; Kobayashi, M (corresponding author), Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan.	kobayashi.m.fe@u.tsukuba.ac.jp	Kumano, Takuto/ABC-3242-2020; Tsujimura, Seiya/O-4758-2018	Kumano, Takuto/0000-0002-9240-4074; Tsujimura, Seiya/0000-0001-9603-2418	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Grant-in Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan.; We thank Dr. Kazunobu Konishi for the helpful discussions, Mr. Nobuto Ohkubo for the helpful technical advice. This work was supported by a Grant-in -Aidfor Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan.	ASANO Y, 1980, AGR BIOL CHEM TOKYO, V44, P2251, DOI 10.1080/00021369.1980.10864311; Beltran J, 2015, NAT CHEM BIOL, V11, P598, DOI [10.1038/NCHEMBIO.1840, 10.1038/nchembio.1840]; BRANCACCIO A, 1994, J BIOL CHEM, V269, P13843; Dou Y, 1996, BIOCHEMISTRY-US, V35, P7107, DOI 10.1021/bi9600299; Endo I, 1999, TRENDS BIOTECHNOL, V17, P244, DOI 10.1016/S0167-7799(99)01303-7; Fukatsu H, 2004, P NATL ACAD SCI USA, V101, P13726, DOI 10.1073/pnas.0405082101; Goda M, 2002, J BIOL CHEM, V277, P45860, DOI 10.1074/jbc.M208571200; Goda M, 2001, J BIOL CHEM, V276, P23480, DOI 10.1074/jbc.M007856200; Green MT, 2004, SCIENCE, V304, P1653, DOI 10.1126/science.1096897; Hashimoto Y, 2005, J BIOL CHEM, V280, P8660, DOI 10.1074/jbc.M405686200; HAYASHI Y, 1979, J BIOL CHEM, V254, P9101; Ho R.Y.N., 1995, ACTIVE OXYGEN BIOCH, P1, DOI [10.1007/978-94-011-0609-2_1, DOI 10.1007/978-94-011-0609-2_1]; Kato Y, 2000, BIOCHEMISTRY-US, V39, P800, DOI 10.1021/bi991598u; Kawasaki C., 1970, J FOOD HYG SOC JPN, V11, P155; Kobayashi M, 1998, FEBS LETT, V439, P325, DOI 10.1016/S0014-5793(98)01406-9; KOBAYASHI M, 1995, P NATL ACAD SCI USA, V92, P714, DOI 10.1073/pnas.92.3.714; Kobayashi M, 1997, P NATL ACAD SCI USA, V94, P11986, DOI 10.1073/pnas.94.22.11986; KOBAYASHI M, 1993, EUR J BIOCHEM, V217, P327, DOI 10.1111/j.1432-1033.1993.tb18250.x; Kobayashi M, 1999, EUR J BIOCHEM, V261, P1, DOI 10.1046/j.1432-1327.1999.00186.x; KOBAYASHI M, 1993, P NATL ACAD SCI USA, V90, P247, DOI 10.1073/pnas.90.1.247; KOBAYASHI M, 1992, BIOCHEMISTRY-US, V31, P9000, DOI 10.1021/bi00152a042; KOBAYASHI M, 1992, J BIOL CHEM, V267, P20746; Kobayashi M, 1998, NAT BIOTECHNOL, V16, P733, DOI 10.1038/nbt0898-733; KOBAYASHI M, 1992, TRENDS BIOTECHNOL, V10, P402, DOI 10.1016/0167-7799(92)90283-2; Komeda H, 1996, P NATL ACAD SCI USA, V93, P4267, DOI 10.1073/pnas.93.9.4267; Komeda H, 1996, J BIOL CHEM, V271, P15796, DOI 10.1074/jbc.271.26.15796; Komeda H, 1996, P NATL ACAD SCI USA, V93, P10572, DOI 10.1073/pnas.93.20.10572; Konishi K, 2006, P NATL ACAD SCI USA, V103, P564, DOI 10.1073/pnas.0505412103; Konishi K, 2004, J BIOL CHEM, V279, P47619, DOI 10.1074/jbc.M407223200; Krishna MC, 1996, J BIOL CHEM, V271, P26018, DOI 10.1074/jbc.271.42.26018; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Liao RZ, 2012, J PHYS CHEM B, V116, P9396, DOI 10.1021/jp305510c; Matsui T, 1999, J BIOL CHEM, V274, P2838, DOI 10.1074/jbc.274.5.2838; Matsui T, 1999, J AM CHEM SOC, V121, P9952, DOI 10.1021/ja9914846; MURTHY MRN, 1981, J MOL BIOL, V152, P465, DOI 10.1016/0022-2836(81)90254-0; NAGASAWA T, 1987, EUR J BIOCHEM, V162, P691, DOI 10.1111/j.1432-1033.1987.tb10692.x; NAGASAWA T, 1989, EXPERIENTIA, V45, P1066, DOI 10.1007/BF01950160; Nomura J, 2013, P NATL ACAD SCI USA, V110, P2810, DOI 10.1073/pnas.1200338110; Oinuma KI, 2003, J BIOL CHEM, V278, P29600, DOI 10.1074/jbc.M211832200; Oinuma KI, 2005, FEBS LETT, V579, P1394, DOI 10.1016/j.febslet.2005.01.037; Oinuma KI, 2004, FEBS LETT, V568, P44, DOI 10.1016/j.febslet.2004.05.008; Olson JS, 1996, J BIOL CHEM, V271, P17593, DOI 10.1074/jbc.271.30.17593; Onoda H, 2015, DALTON T, V44, P15316, DOI 10.1039/c5dt00797f; Pinakoulaki E, 2011, J PHYS CHEM B, V115, P13012, DOI 10.1021/jp205944e; Popescu VC, 2001, BIOCHEMISTRY-US, V40, P7984, DOI 10.1021/bi010198f; POULOS TL, 1980, J BIOL CHEM, V255, P575; Sawai H, 2009, J BIOL CHEM, V284, P32089, DOI 10.1074/jbc.M109.018762; Shoji O, 2010, J BIOL INORG CHEM, V15, P1109, DOI 10.1007/s00775-010-0671-9; Sundaramoorthy M, 1995, STRUCTURE, V3, P1367, DOI 10.1016/S0969-2126(01)00274-X; Yamada H, 2001, CHEM REC, V1, P152; Yamada H, 1996, BIOSCI BIOTECH BIOCH, V60, P1391, DOI 10.1271/bbb.60.1391; YONETANI T, 1967, J BIOL CHEM, V242, P1974	52	4	4	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2017	12	4							e0175846	10.1371/journal.pone.0175846	http://dx.doi.org/10.1371/journal.pone.0175846			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0MD	28410434	Green Submitted, Green Published, gold			2022-12-27	WOS:000399955600049
J	Deguchi, Y; Iwasakii, S; Ishimoto, H; Ogawa, K; Fukuda, Y; Nitta, T; Mitake, T; Nogi, Y; Inoue, K				Deguchi, Yasuhiko; Iwasakii, Shinichi; Ishimoto, Hideyuki; Ogawa, Koichiro; Fukuda, Yuichi; Nitta, Tomoko; Mitake, Tomoe; Nogi, Yukako; Inoue, Koki			Relationships between temperaments, occupational stress, and insomnia among Japanese workers	PLOS ONE			English	Article							JOB STRESS; TEMPS-A; SOCIAL SUPPORT; SLEEP QUALITY; BIPOLAR; VALIDATION; INSTRUMENT; DISORDERS; VERSION; SCALE	Insomnia among workers reduces the quality of life, contributes toward the economic burden of healthcare costs and losses in work performance. The relationship between occupational stress and insomnia has been reported in previous studies, but there has been little attention to temperament in occupational safety and health research. The aim of this study was to clarify the relationships between temperament, occupational stress, and insomnia. The subjects were 133 Japanese daytime local government employees. Temperament was assessed using the Temperament Evaluation of Memphis, Pisa, Paris, and San Diego-Auto questionnaire (TEMPS-A). Occupational stress was assessed using the Generic Job Stress Questionnaire (GJSQ). Insomnia was assessed using the Athens Insomnia Scale (AIS). Stepwise multiple logistic regression analyses were conducted. In a stepwise multivariate logistic regression analysis, it was found that the higher subdivided stress group by "role conflict" (OR = 5.29, 95% CI, 1.61-17.32) and anxious temperament score (OR = 1.33; 95% CI, 1.19-1.49) was associated with the presence of insomnia using an adjusted model, whereas other factors were excluded from the model. The study limitations were the sample size and the fact that only Japanese local government employees were surveyed. This study demonstrated the relationships between workers' anxious temperament, role conflict, and insomnia. Recognizing one's own anxious temperament would lead to self-insight, and the recognition of anxious temperament and reduction of role conflict by their supervisors or coworkers would reduce the prevalence of insomnia among workers in the workplace.	[Deguchi, Yasuhiko; Iwasakii, Shinichi; Ishimoto, Hideyuki; Ogawa, Koichiro; Fukuda, Yuichi; Nitta, Tomoko; Mitake, Tomoe; Nogi, Yukako; Inoue, Koki] Osaka City Univ, Grad Sch Med, Dept Neuropsychiat, Osaka, Japan	Osaka Metropolitan University	Deguchi, Y (corresponding author), Osaka City Univ, Grad Sch Med, Dept Neuropsychiat, Osaka, Japan.	m2012567@med.osaka-cu.ac.jp			JSPS KAKENHI [26860440]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the JSPS KAKENHI Grant Number 26860440.	Akerstedt T, 2002, J PSYCHOSOM RES, V53, P585, DOI 10.1016/S0022-3999(02)00447-6; Akiskal H.S., 1992, CYCLOTHYMIC HYPERTHY, P43; Akiskal HS, 2005, J AFFECT DISORDERS, V85, P3, DOI 10.1016/j.jad.2004.12.001; Akiskal HS, 2005, J AFFECT DISORDERS, V85, P45, DOI 10.1016/j.jad.2003.10.012; Akiskal HS, 2005, J AFFECT DISORDERS, V85, P29, DOI 10.1016/j.jad.2003.12.009; Akiskal HS, 1998, ACTA PSYCHIAT SCAND, V98, P66, DOI 10.1111/j.1600-0447.1998.tb05969.x; Baba H, 2014, J AFFECT DISORDERS, V161, P1, DOI 10.1016/j.jad.2014.03.004; Baglioni C, 2011, J AFFECT DISORDERS, V135, P10, DOI 10.1016/j.jad.2011.01.011; CLONINGER CR, 1993, ARCH GEN PSYCHIAT, V50, P975, DOI 10.1001/archpsyc.1993.01820240059008; De Lange AH, 2009, J SLEEP RES, V18, P374, DOI 10.1111/j.1365-2869.2009.00735.x; Deguchi Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156339; Espie Colin A, 2012, J Clin Psychiatry, V73, pe1478, DOI 10.4088/JCP.12m07954; Gadinger MC, 2009, J SLEEP RES, V18, P229, DOI 10.1111/j.1365-2869.2008.00715.x; GOLDSMITH HH, 1987, CHILD DEV, V58, P505, DOI 10.1111/j.1467-8624.1987.tb01398.x; Guilford J.P., 1957, FUNDAMENTAL STAT PSY, V41st, DOI https://doi.org/10.1002/sce.3730410357; Gyorffy Z, 2016, HUM RESOUR HEALTH, V14, DOI 10.1186/s12960-016-0108-9; Hantouche EG, 1998, J AFFECT DISORDERS, V50, P163, DOI 10.1016/S0165-0327(98)00112-8; Haratani T, 1996, 25 INT C OCC HLTH 2, P393; Haratani T, 1993, SANGYO IGAKU S, V35, pS214; Hillman DR, 2006, SLEEP, V29, P299, DOI 10.1093/sleep/29.3.299; HURRELL JJ, 1988, SCAND J WORK ENV HEA, V14, P27; KALES A, 1992, ARCH INTERN MED, V152, P1570, DOI 10.1001/archinte.152.8.1570; Karam EG, 2015, J AFFECT DISORDERS, V184, P123, DOI 10.1016/j.jad.2015.05.047; Karam EG, 2010, WORLD PSYCHIATRY, V9, P103; Kawamura Y, 2010, PSYCHOPATHOLOGY, V43, P240, DOI 10.1159/000313522; Kessler RC, 2011, SLEEP, V34, P1161, DOI 10.5665/SLEEP.1230; Khazaal Y, 2013, PSYCHIAT QUART, V84, P429, DOI 10.1007/s11126-013-9257-3; Kikuchi Y, 2014, INT J OCCUP MED ENV, V27, P426, DOI 10.2478/s13382-014-0270-z; Kim HC, 2011, J OCCUP HEALTH, V53, P164, DOI 10.1539/joh.10-0032-OA; Knudsen HK, 2007, SOC SCI MED, V64, P1997, DOI 10.1016/j.socscimed.2007.02.020; Maremmani I, 2009, J AFFECT DISORDERS, V117, P186, DOI 10.1016/j.jad.2009.01.007; Matsumoto S, 2005, J AFFECT DISORDERS, V85, P85, DOI 10.1016/j.jad.2003.10.001; Mazzarini L, 2009, J AFFECT DISORDERS, V119, P28, DOI 10.1016/j.jad.2009.03.016; McCall WV, 2010, SLEEP MED, V11, P822, DOI 10.1016/j.sleep.2010.04.004; Mendlowicz MV, 2005, J AFFECT DISORDERS, V84, P219, DOI 10.1016/j.jad.2004.01.013; Millon T., 1981, DISORDERS PERSONALIT; Nakata A, 2004, SOC SCI MED, V59, P1719, DOI 10.1016/j.socscimed.2004.02.002; Nishitani N, 2010, IND HEALTH, V48, P178, DOI 10.2486/indhealth.48.178; Nomura K, 2009, SLEEP MED, V10, P626, DOI 10.1016/j.sleep.2008.06.010; Ohayon MM, 2002, SLEEP MED REV, V6, P97, DOI 10.1053/smrv.2002.0186; Okajima I, 2013, PSYCHIAT CLIN NEUROS, V67, P420, DOI 10.1111/pcn.12073; Ottoni GL, 2011, J AFFECT DISORDERS, V128, P120, DOI 10.1016/j.jad.2010.06.014; Pacini M, 2009, ALCOHOL, V43, P397, DOI 10.1016/j.alcohol.2009.05.002; Portela LF, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/820610; Riemann D, 2010, SLEEP MED REV, V14, P19, DOI 10.1016/j.smrv.2009.04.002; RIZZO JR, 1970, ADMIN SCI QUART, V15, P150, DOI 10.2307/2391486; Saijo Y, 2015, INT ARCH OCC ENV HEA, V88, P143, DOI 10.1007/s00420-014-0945-6; Sakai Y, 2005, J AFFECT DISORDERS, V85, P101, DOI 10.1016/j.jad.2004.03.012; Shahly V, 2012, ARCH GEN PSYCHIAT, V69, P1054, DOI 10.1001/archgenpsychiatry.2011.2188; Soldatos CR, 2000, J PSYCHOSOM RES, V48, P555, DOI 10.1016/S0022-3999(00)00095-7; Soldatos CR, 2003, J PSYCHOSOM RES, V55, P263, DOI 10.1016/S0022-3999(02)00604-9; Tei-Tominaga M, 2012, DEPRESS RES TREAT, V2012, DOI [DOI 10.1155/2012/469384, 10.1155/2012/469384]; Tokuyama M, 2003, PSYCHIAT CLIN NEUROS, V57, P523, DOI 10.1046/j.1440-1819.2003.01158.x; Utsugi M, 2005, SLEEP, V28, P728, DOI 10.1093/sleep/28.6.728; Vazquez GH, 2010, J AFFECT DISORDERS, V127, P38, DOI 10.1016/j.jad.2010.04.015; Vazquez GH, 2008, J AFFECT DISORDERS, V108, P25, DOI 10.1016/j.jad.2007.09.011; Vyssoki B, 2011, J AFFECT DISORDERS, V135, P177, DOI 10.1016/j.jad.2011.07.007; Yoshioka E, 2013, INT J BEHAV MED, V20, P355, DOI 10.1007/s12529-012-9230-9; Zammit GK, 1999, SLEEP, V22, pS379	59	18	19	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2017	12	4							e0175346	10.1371/journal.pone.0175346	http://dx.doi.org/10.1371/journal.pone.0175346			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET0MB	28407025	Green Published, Green Submitted, gold			2022-12-27	WOS:000399955400043
J	Dimarchopoulou, D; Stergiou, KI; Tsikliras, AC				Dimarchopoulou, Donna; Stergiou, Konstantinos I.; Tsikliras, Athanassios C.			Gap analysis on the biology of Mediterranean marine fishes	PLOS ONE			English	Article							NATURAL MORTALITY; GROWTH-PARAMETERS; LIFE-HISTORY; TEMPERATURE; CHIMERAS; MATURITY; TRAITS; SHARKS; TRENDS; SIZE	We estimated the current level of knowledge concerning several biological characteristics of the Mediterranean marine fishes by carrying out a gap analysis based on information extracted from the literature, aiming to identify research trends and future needs in the field of Mediterranean fish biology that can be used in stock assessments, ecosystem modeling and fisheries management. Based on the datasets that emerged from the literature review, there is no information on any biological characteristic for 43% (n = 310) of the Mediterranean fish species, whereas for an additional 15% (n = 109) of them there is information about just one characteristic. The gap between current and desired knowledge (defined here as having information on most biological characteristics for at least half of the Mediterranean marine fishes) is smaller in length-weight relationships, which have been studied for 43% of the species, followed by spawning (39%), diet (29%), growth (25%), maturity (24%), lifespan (19%) and fecundity (17%). The gap is larger in natural mortality for which information is very scarce (8%). European hake (Merluccius merluccius), red mullet (Mullus barbatus), annular seabream (Diplodus annularis), common pandora (Pagellus erythrinus), European anchovy (Engraulis encrasicolus), European pilchard (Sardina pilchardus) and bogue (Boops boops) were the most studied species, while sharks and rays were among the least studied ones. Only 25 species were fully studied, i.e. there was available information on all their biological characteristics. The knowledge gaps per characteristic varied among the western, central and eastern Mediterranean subregions. The number of available records per species was positively related to total landings, while no relationship emerged with its maximum reported length, trophic level and commercial value. Future research priorities that should be focused on less studied species (e.g. sharks and rays) and mortality/fecundity instead of length-weight relationships, as well as the economy of scientific sampling (using the entire catch to acquire data on as many biological characteristics as possible) are discussed.	[Dimarchopoulou, Donna; Stergiou, Konstantinos I.; Tsikliras, Athanassios C.] Aristotle Univ Thessaloniki, Sch Biol, Dept Zool, Lab Ichthyol, Thessaloniki, Greece; [Stergiou, Konstantinos I.] Hellen Ctr Marine Res, Inst Marine Biol Resources & Inland Waters, Athens, Greece	Aristotle University of Thessaloniki; Hellenic Centre for Marine Research	Tsikliras, AC (corresponding author), Aristotle Univ Thessaloniki, Sch Biol, Dept Zool, Lab Ichthyol, Thessaloniki, Greece.	atsik@bio.auth.gr	Tsikliras, Athanassios C./G-6548-2015	Tsikliras, Athanassios C./0000-0002-9074-3259; Dimarchopoulou, Donna/0000-0003-3412-3503				Aksnes DW, 2016, ICES J MAR SCI, V73, P1004, DOI 10.1093/icesjms/fsv248; Apostolidis C, 2014, J APPL ICHTHYOL, V30, P189, DOI 10.1111/jai.12303; Baran E., 2002, LEADERSHIP ORG DEV J, P1; BARAN E, 2002, FISHERIES AQUACULTUR, P1; Claudet J, 2010, ECOL APPL, V20, P830, DOI 10.1890/08-2131.1; DESPOTI S, 2013, MORE FISH AND MORE, P62; Despoti S, 2016, P HELL ICHTHYOL CONT, P62; Dimarchopoulou D, 2016, RAPP COMM INT EXPLOR, V16, P45; *FAO, 2016, FISHSTAT J D UNIVERS; Field IC, 2009, ADV MAR BIOL, V56, P275, DOI 10.1016/S0065-2881(09)56004-X; FRASER-BRUNNER A., 1951, BULL BRIT MUS [NAT HIST] ZOOL, V1, P87; Froese R, 2006, J APPL ICHTHYOL, V22, P241, DOI 10.1111/j.1439-0426.2006.00805.x; Froese R, 1998, J APPL ICHTHYOL, V14, P117, DOI 10.1111/j.1439-0426.1998.tb00626.x; FROESE R, 2016, RAPP COMM INT EXPLOR, V41, P333; Froese R., 2016, FISHBASE WORLD WIDE; Froese R, 2017, FISH FISH, V18, P506, DOI 10.1111/faf.12190; Bianchi G., 2008, The ecosystem approach to fisheries, px, DOI 10.1079/9781845934149.0000; Gislason H, 2010, FISH FISH, V11, P149, DOI 10.1111/j.1467-2979.2009.00350.x; Hart P.J., 2002, HDB FISH BIOL FISHER; Jaric I, 2012, REV FISH SCI, V20, P70, DOI 10.1080/10641262.2012.659775; KARACHLE PK, 2017, MEDIT MAR S IN PRESS; Karachle PK, 2017, THESIS; Leonardos I., 1996, IEMED MEDITERRANEAN; Martell S, 2013, FISH FISH, V14, P504, DOI 10.1111/j.1467-2979.2012.00485.x; Mytilineou C, 2013, J NAT HIST, V47, P1645, DOI 10.1080/00222933.2013.775372; PAULY D, 1980, J CONSEIL, V39, P175; Pilling GM, 2008, ADVANCES IN FISHERIES SCIENCE: 50 YEARS ON FROM BEVERTON AND HOLT, P280, DOI 10.1002/9781444302653.ch12; Rochet MJ, 1998, ICES J MAR SCI, V55, P371, DOI 10.1006/jmsc.1997.0324; SCOTT J M, 1993, MORE FISH AND MORE, V123, P3; SCOTT JM, 1993, WILDLIFE MONOGR, P1; Stergiou K.I., 2011, HUMANITIES MEET ECOL, P95; Stergiou KI, 2001, REV FISH BIOL FISHER, V11, P217, DOI 10.1023/A:1020556722822; Stergiou KI, 2013, ETHICS SCI ENV POLIT, P77, DOI DOI 10.3354/ESEP006015; Stergiou KI, 2006, J BIOL RES-THESSALON, V6, P199; Stergiou KI, 2016, ENVIRON DEV, V17, P57, DOI 10.1016/j.envdev.2015.09.001; Stevens JD, 2000, ICES J MAR SCI, V57, P476, DOI 10.1006/jmsc.2000.0724; Tipton Jason A., 2008, Archives of Natural History, V35, P164, DOI 10.3366/E0260954108000156; Tsikliras AC, 2015, MEDITERR MAR SCI, V16, P5, DOI 10.12681/mms.659; Tsikliras AC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121188; Tsikliras AC, 2014, REV FISH BIOL FISHER, V24, P219, DOI 10.1007/s11160-013-9330-x; Tsikliras AC, 2013, ACTA ICHTHYOL PISCAT, V43, P1, DOI 10.3750/AIP2013.43.1.01; Tsikliras AC, 2010, REV FISH BIOL FISHER, V20, P499, DOI 10.1007/s11160-010-9158-6; Voultsiadou E, 2005, J BIOGEOGR, V32, P1875, DOI 10.1111/j.1365-2699.2005.01335.x; Wegner NC, 2015, SCIENCE, V348, P786, DOI 10.1126/science.aaa8902	44	21	23	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2017	12	4							e0175949	10.1371/journal.pone.0175949	http://dx.doi.org/10.1371/journal.pone.0175949			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0MB	28407022	Green Submitted, Green Published, gold			2022-12-27	WOS:000399955400108
J	Hubner, D; Verhoeven, T; Schmid, K; Muller, KR; Tangermann, M; Kindermans, PJ				Huebner, David; Verhoeven, Thibault; Schmid, Konstantin; Mueller, Klaus-Robert; Tangermann, Michael; Kindermans, Pieter-Jan			Learning from label proportions in brain-computer interfaces: Online unsupervised learning with guarantees	PLOS ONE			English	Article							CLASSIFICATION	Objective Using traditional approaches, a brain-computer interface (BCI) requires the collection of calibration data for new subjects prior to online use. Calibration time can be reduced or eliminated e.g., by subject-to-subject transfer of a pre-trained classifier or unsupervised adaptive classification methods which learn from scratch and adapt over time. While such heuristics work well in practice, none of them can provide theoretical guarantees. Our objective is to modify an event-related potential (ERP) paradigm to work in unison with the machine learning decoder, and thus to achieve a reliable unsupervised calibrationless decoding with a guarantee to recover the true class means. Method We introduce learning from label proportions (LLP) to the BCI community as a new unsupervised, and easy-to-implement classification approach for ERP-based BCIs. The LLP estimates the mean target and non-target responses based on known proportions of these two classes in different groups of the data. We present a visual ERP speller to meet the requirements of LLP. For evaluation, we ran simulations on artificially created data sets and conducted an online BCI study with 13 subjects performing a copy-spelling task. Results Theoretical considerations show that LLP is guaranteed to minimize the loss function similar to a corresponding supervised classifier. LLP performed well in simulations and in the online application, where 84.5% of characters were spelled correctly on average without prior calibration. Significance The continuously adapting LLP classifier is the first unsupervised decoder for ERP BCIs guaranteed to find the optimal decoder. This makes it an ideal solution to avoid tedious calibration sessions. Additionally, LLP works on complementary principles compared to existing unsupervised methods, opening the door for their further enhancement when combined with LLP.	[Huebner, David; Schmid, Konstantin; Tangermann, Michael] Albert Ludwigs Univ, Dept Comp Sci, Brain State Decoding Lab, Cluster Excellence BrainLinks BrainTools, Freiburg, Germany; [Mueller, Klaus-Robert; Kindermans, Pieter-Jan] Berlin Inst Technol, Machine Learning Grp, Berlin, Germany; [Verhoeven, Thibault] Univ Ghent, Elect & Informat Syst, Ghent, Belgium; [Mueller, Klaus-Robert] Korea Univ, Dept Brain & Cognit Engn, Seoul, South Korea	University of Freiburg; Technical University of Berlin; Ghent University; Korea University	Hubner, D; Tangermann, M (corresponding author), Albert Ludwigs Univ, Dept Comp Sci, Brain State Decoding Lab, Cluster Excellence BrainLinks BrainTools, Freiburg, Germany.; Kindermans, PJ (corresponding author), Berlin Inst Technol, Machine Learning Grp, Berlin, Germany.	david.huebner@blbt.uni-freiburg.de; michael.tangermann@blbt.uni-freiburg.de; p.kindermans@tu-berlin.de	Mueller, Klaus-Robert/Y-3547-2019; Tangermann, Michael/ABE-4178-2020	Mueller, Klaus-Robert/0000-0002-3861-7685; Hubner, David/0000-0003-4085-9154	Brain Links-Brain Tools Cluster of Excellence - German Research Foundation (DFG) [EXC 1086]; bwHPC initiative [INST 39/963-1 FUGG]; European Union's Horizon research and innovation programme under the Marie Sklodowska-Curie grant [657679]; Special Research Fund from Ghent University; BK21 program - Korean National Research Foundation [2012-005741]	Brain Links-Brain Tools Cluster of Excellence - German Research Foundation (DFG)(German Research Foundation (DFG)); bwHPC initiative; European Union's Horizon research and innovation programme under the Marie Sklodowska-Curie grant; Special Research Fund from Ghent University; BK21 program - Korean National Research Foundation	This work was supported by Brain Links-Brain Tools Cluster of Excellence funded by the German Research Foundation (DFG), grant number EXC 1086; by the bwHPC initiative, grant INST 39/963-1 FUGG; by the European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement No 657679; by the Special Research Fund from Ghent University, and the BK21 program funded by Korean National Research Foundation grant No. 2012-005741. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barachant A., 2014, ARXIV PREPRINT ARXIV; Bensch Michael, 2007, Comput Intell Neurosci, P71863, DOI 10.1155/2007/71863; Bishop C. M., 2006, MACH LEARN, V128, P1, DOI DOI 10.1002/9780471740360.EBS0904; Blankertz B, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00198; Blankertz B, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00530; Blankertz B, 2011, NEUROIMAGE, V56, P814, DOI 10.1016/j.neuroimage.2010.06.048; Brouwer AM, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00019; Chen XG, 2015, P NATL ACAD SCI USA, V112, pE6058, DOI 10.1073/pnas.1508080112; Congedo M., 2011, P 5 INT BRAIN COMP I, P280; FARWELL LA, 1988, ELECTROEN CLIN NEURO, V70, P510, DOI 10.1016/0013-4694(88)90149-6; Fazel-Rezai Reza, 2012, Front Neuroeng, V5, P14, DOI 10.3389/fneng.2012.00014; Fazli S, 2015, P IEEE, V103, P891, DOI 10.1109/JPROC.2015.2413993; Fazli S, 2009, NEURAL NETWORKS, V22, P1305, DOI 10.1016/j.neunet.2009.06.003; Finke A, 2009, NEURAL NETWORKS, V22, P1329, DOI 10.1016/j.neunet.2009.07.003; Furdea A, 2009, PSYCHOPHYSIOLOGY, V46, P617, DOI 10.1111/j.1469-8986.2008.00783.x; Gonsalvez CJ, 2002, PSYCHOPHYSIOLOGY, V39, P388, DOI 10.1017/S0048577201393137; Guger C, 2009, NEUROSCI LETT, V462, P94, DOI 10.1016/j.neulet.2009.06.045; Hong B, 2009, CLIN NEUROPHYSIOL, V120, P1658, DOI 10.1016/j.clinph.2009.06.026; Jayaram V, 2016, IEEE COMPUT INTELL M, V11, P20, DOI 10.1109/MCI.2015.2501545; Jin J, 2012, J NEUROSCI METH, V205, P265, DOI 10.1016/j.jneumeth.2012.01.004; JOHANNES S, 1995, COGNITIVE BRAIN RES, V2, P189, DOI 10.1016/0926-6410(95)90008-X; Kaplan AY, 2013, IEEE T COMP INTEL AI, V5, P141, DOI 10.1109/TCIAIG.2012.2237517; Kaufmann T, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/5/056016; Kindermans PJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102504; Kindermans PJ, 2014, J NEURAL ENG, V11, DOI 10.1088/1741-2560/11/3/035005; Kindermans PJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033758; Krauledat M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002967; Ledoit O, 2004, J MULTIVARIATE ANAL, V88, P365, DOI 10.1016/S0047-259X(03)00096-4; Lu SJ, 2009, IEEE T NEUR SYS REH, V17, P135, DOI 10.1109/TNSRE.2009.2015197; Munssinger JI, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00182; Parra LC, 2005, NEUROIMAGE, V28, P326, DOI 10.1016/j.neuroimage.2005.05.032; Patrini Giorgio, 2014, ADV NEURAL INFORM PR, P190; Quadrianto N, 2009, J MACH LEARN RES, V10, P2349; Schafer J, 2005, STAT APPL GENET MO B, V4, DOI 10.2202/1544-6115.1175; Schreuder M, 2012, IEEE ENG MED BIO, P6707, DOI 10.1109/EMBC.2012.6347533; Schreuder M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009813; Sellers EW, 2006, CLIN NEUROPHYSIOL, V117, P538, DOI 10.1016/j.clinph.2005.06.027; Shenoy P, 2006, J NEURAL ENG, V3, pR13, DOI 10.1088/1741-2560/3/1/R02; SIMON N, 2015, FRONT HUM NEUROSCI, V8, DOI DOI 10.3389/fnhum.2014.01039; Sugiyama M, 2007, J MACH LEARN RES, V8, P1027; Tangermann M, 2011, INT J BIOELECTROMAGN, V13, P119; Tangermann M, 2011, P 5 INT BRAIN COMP I, P160; Thompson DE, 2014, J NEURAL ENG, V11, DOI 10.1088/1741-2560/11/3/035001; Townsend G, 2010, CLIN NEUROPHYSIOL, V121, P1109, DOI 10.1016/j.clinph.2010.01.030; Treder MS, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-28; Verhoeven T, 2015, J NEURAL ENG, V12, DOI 10.1088/1741-2560/12/6/066027; Vidaurre C, 2011, IEEE T BIO-MED ENG, V58, P587, DOI 10.1109/TBME.2010.2093133; Vidaurre C, 2009, NEURAL NETWORKS, V22, P1313, DOI 10.1016/j.neunet.2009.07.020; von Bunau P, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.214101; Wolpaw JR, 2002, CLIN NEUROPHYSIOL, V113, P767, DOI 10.1016/S1388-2457(02)00057-3; Yeom SK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111157	51	27	27	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2017	12	4							e0175856	10.1371/journal.pone.0175856	http://dx.doi.org/10.1371/journal.pone.0175856			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0MB	28407016	Green Published, Green Submitted, gold			2022-12-27	WOS:000399955400104
J	Briones-Robiero, CI; Hernandez-Garcia, JA; Gonzalez-Escobedo, R; Soto-Robles, LV; Rivera-Orduna, FN; Zuniga, G				Ivan Briones-Robiero, Carlos; Alfredo Hernandez-Garcia, Juan; Gonzalez-Escobedo, Roman; Viridiana Soto-Robles, L.; Rivera-Orduna, Flor N.; Zuniga, Gerardo			Structure and dynamics of the gut bacterial microbiota of the bark beetle, Dendroctonus rhizophagus (Curculionidae: Scolytinae) across their life stages	PLOS ONE			English	Article							COLEOPTERA-CURCULIONIDAE; PINE-BEETLE; COMMUNITIES; DIVERSITY; MICANS; FUNGI; DIVERSIFICATION; PSEUDOMONAS; PONDEROSAE; RUFIPENNIS	Bark beetles play an important role as agents of natural renovation and regeneration in coniferous forests. Several studies have documented the metabolic capacity of bacteria associated with the gut, body surface, and oral secretions of these insects; however, little is known about how the bacterial community structure changes during the life cycle of the beetles. This study represents the first comprehensive analysis of the bacterial community of the gut of the bark beetle D. rhizophagus during the insect's life cycle using 454 pyrosequencing. A total of 4 bacterial phyla, 7 classes, 15 families and 23 genera were identified. The adiversity was low, as demonstrated in previous studies. The dominant bacterial taxa belonged to the Enterobacteriaceae and Pseudomonadaceae families. This low alpha-diversity can be attributed to the presence of defensive chemical compounds in conifers or due to different morpho-physiological factors in the gut of these insects acting as strong selective factors. Members of the genera Rahnella, Serratia, Pseudomonas and Propionibacterium were found at all life stages, and the first three genera, particularly Rahnella, were predominant suggesting the presence of a core microbiome in the gut. Significant differences in beta-diversity were observed, mainly due to bacterial taxa present at low frequencies and only in certain life stages. The predictive functional profiling indicated metabolic pathways related to metabolism of amino acids and carbohydrates, and membrane transport as the most significant in the community. These differences in the community structure might be due to several selective factors, such as gut compartmentalization, physicochemical conditions, and microbial interactions.	[Ivan Briones-Robiero, Carlos; Alfredo Hernandez-Garcia, Juan; Gonzalez-Escobedo, Roman; Viridiana Soto-Robles, L.] Inst Politecn Nacl, Posgrad Ciencias Quimicobiol, Mexico City, DF, Mexico; [Ivan Briones-Robiero, Carlos; Alfredo Hernandez-Garcia, Juan; Gonzalez-Escobedo, Roman; Viridiana Soto-Robles, L.; Zuniga, Gerardo] Inst Politecn Nacl, Dept Zool, Mexico City, DF, Mexico; [Zuniga, Gerardo] Inst Politecn Nacl, Dept Microbiol, Mexico City, DF, Mexico	Instituto Politecnico Nacional - Mexico; Instituto Politecnico Nacional - Mexico; Instituto Politecnico Nacional - Mexico	Zuniga, G (corresponding author), Inst Politecn Nacl, Dept Zool, Mexico City, DF, Mexico.	capotezu@hotmail.com	González-Escobedo, Román/N-8296-2019; Gonzalez-Escobedo, Roman/G-1936-2018; Hernandez-Garcia, Juan Alfredo/S-2168-2018	González-Escobedo, Román/0000-0003-4606-3026; Gonzalez-Escobedo, Roman/0000-0003-4606-3026; Soto-Robles, L. Viridiana/0000-0002-8864-9239; Hernandez-Garcia, Juan Alfredo/0000-0001-7094-7900	Consejo Nacional de Ciencia y Tecnologia (CONACyT) [169494/CB2011]; Secretaria de Investigacion y Posgrado del Institute Politecnico Nacional (SIP) [20120753]	Consejo Nacional de Ciencia y Tecnologia (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Secretaria de Investigacion y Posgrado del Institute Politecnico Nacional (SIP)	This work was supported by Consejo Nacional de Ciencia y Tecnologia (CONACyT 169494/CB2011) and Secretaria de Investigacion y Posgrado del Institute Politecnico Nacional (SIP 20120753).	Adams AS, 2009, CAN J FOREST RES, V39, P1133, DOI 10.1139/X09-034; Adams AS, 2013, APPL ENVIRON MICROB, V79, P3468, DOI 10.1128/AEM.00068-13; Adams AS, 2011, J CHEM ECOL, V37, P808, DOI 10.1007/s10886-011-9992-6; Adams AS, 2010, ENVIRON ENTOMOL, V39, P406, DOI 10.1603/EN09221; Amend AS, 2010, MOL ECOL, V19, P5555, DOI 10.1111/j.1365-294X.2010.04898.x; Andreotti R, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-6; Ayres MP, 2000, ECOLOGY, V81, P2198, DOI 10.1890/0012-9658(2000)081[2198:NBOPFB]2.0.CO;2; Bentz BJ, 2006, ANN ENTOMOL SOC AM, V99, P189, DOI 10.1603/0013-8746(2006)099[0189:ECOFAW]2.0.CO;2; Bleiker KP, 2007, ENVIRON ENTOMOL, V36, P1384, DOI 10.1603/0046-225X(2007)36[1384:DBOFAT]2.0.CO;2; Boone CK, 2013, J CHEM ECOL, V39, P1003, DOI 10.1007/s10886-013-0313-0; Bornscheuer UT, 2002, FEMS MICROBIOL REV, V26, P73, DOI 10.1016/S0168-6445(01)00075-4; Brand JM, 1976, J CHEM ECOL, V2, P195, DOI 10.1007/BF00987742; BRIDGES JR, 1981, MICROBIAL ECOL, V7, P131, DOI 10.1007/BF02032495; Briones-Roblero CI, 2016, FOLIA MICROBIOL PRAH; Brune A, 2015, ANNU REV MICROBIOL, V69, P145, DOI 10.1146/annurev-micro-092412-155715; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cardoza YJ, 2006, ECOL ENTOMOL, V31, P636, DOI 10.1111/j.1365-2311.2006.00829.x; Ceja-Navarro JA, 2014, ISME J, V8, P6, DOI 10.1038/ismej.2013.134; Chao A, 1998, CHIN J MATH, V16, P189; Charyulu EM, 2009, INDIAN J EXP BIOL, V47, P964; Cibrian Tovar D, 1995, INSECTOS FORESTALES, V6; Diaz E, 1998, ANN ENTOMOL SOC AM, V91, P479, DOI 10.1093/aesa/91.4.479; Diaz E, 2003, ANN ENTOMOL SOC AM, V96, P144, DOI 10.1603/0013-8746(2003)096[0144:AAHCOT]2.0.CO;2; Dohet L, 2016, FEMS MICROBIOL ECOL, V92, DOI 10.1093/femsec/fiw129; Durand AA, 2015, SCI REP-UK, V5, DOI 10.1038/srep17190; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Engel P, 2013, FEMS MICROBIOL REV, V37, P699, DOI 10.1111/1574-6976.12025; Faith DP, 2006, EVOL BIOINFORM, V2, P121; Farrell BD, 1998, SCIENCE, V281, P555, DOI 10.1126/science.281.5376.555; Franceschi VR, 2005, NEW PHYTOL, V167, P353, DOI 10.1111/j.1469-8137.2005.01436.x; Mendoza MG, 2011, ENVIRON ENTOMOL, V40, P549, DOI 10.1603/EN10059; Guo YB, 2009, APPL ENVIRON MICROB, V75, P6792, DOI 10.1128/AEM.00902-09; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Hail D, 2011, ENVIRON ENTOMOL, V40, P23, DOI 10.1603/EN10115; Hu X, 2014, FORESTS, V5, P455, DOI 10.3390/f5030455; Hu X, 2013, INT J MOL SCI, V14, P21006, DOI 10.3390/ijms141021006; Ishak HD, 2011, MICROB ECOL, V61, P821, DOI 10.1007/s00248-010-9793-4; Kirkendall LR, 2015, BARK BEETLES BIOL EC, P85, DOI [DOI 10.1016/B978-0-12-417156-5.00003-4, 10.1016/B978-0-12-417156-5.00003-4]; Klepzig KD, 2009, ENVIRON ENTOMOL, V38, P67, DOI 10.1603/022.038.0109; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Liu XG, 2007, FEMS MICROBIOL LETT, V270, P299, DOI 10.1111/j.1574-6968.2007.00681.x; Lozupone C, 2011, ISME J, V5, P169, DOI 10.1038/ismej.2010.133; Magurran E, 1998, ECOLOGICAL DIVERSITY; Mason CJ, 2016, ENVIRON ENTOMOL, V45, P348, DOI 10.1093/ee/nvv184; Morales-Jimenez J, 2013, MICROB ECOL, V66, P200, DOI 10.1007/s00248-013-0206-3; Morales-Jimenez J, 2012, MICROB ECOL, V64, P268, DOI 10.1007/s00248-011-9999-0; Morales-Jimenez J, 2009, MICROB ECOL, V58, P879, DOI 10.1007/s00248-009-9548-2; Muratoglu H, 2011, TURK J BIOL, V35, P9, DOI 10.3906/biy-0902-12; Navarro-Noya YE, 2013, MICROB ECOL, V66, P19, DOI 10.1007/s00248-013-0222-3; Palavesam A, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0049493, 10.1371/journal.pone.0044390]; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; Raffa KF, 2008, BIOSCIENCE, V58, P501, DOI 10.1641/B580607; Scott JJ, 2008, SCIENCE, V322, P63, DOI 10.1126/science.1160423; Sequeira AS, 2000, P ROY SOC B-BIOL SCI, V267, P2359, DOI 10.1098/rspb.2000.1292; Sevim A, 2012, J BASIC MICROB, V52, P695, DOI 10.1002/jobm.201100564; Shi ZH, 2010, J INSECT PHYSIOL, V56, P1696, DOI 10.1016/j.jinsphys.2010.06.013; Six D., 2015, BARK BEETLES BIOL EC, P305, DOI [10.1016/B978-0-12-417156-5.00008-3, DOI 10.1016/B978-0-12-417156-5.00008-3]; Thompson JD., 1994, COEVOLUTIONARY PROCE; Vasanthakumar A, 2006, ENVIRON ENTOMOL, V35, P1710, DOI 10.1603/0046-225X(2006)35[1710:COGBIL]2.0.CO;2; Venturi V, 2006, FEMS MICROBIOL REV, V30, P274, DOI 10.1111/j.1574-6976.2005.00012.x; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wellborn GA, 2015, ECOL EVOL, V5, P176, DOI 10.1002/ece3.1347; Xu LT, 2016, INSECT SCI, V23, P183, DOI 10.1111/1744-7917.12255; Yaman M, 2010, FOLIA MICROBIOL, V55, P35, DOI 10.1007/s12223-010-0006-9; Yilmaz H, 2006, BIOLOGIA, V61, P679, DOI 10.2478/s11756-006-0140-7	65	34	35	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2017	12	4							e0175470	10.1371/journal.pone.0175470	http://dx.doi.org/10.1371/journal.pone.0175470			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0MB	28406998	Green Submitted, Green Published, gold			2022-12-27	WOS:000399955400059
J	Pereyra, D; Offensperger, F; Klinglmueller, F; Haegele, S; Oehlberger, L; Gruenberger, T; Brostjan, C; Starlinger, P				Pereyra, David; Offensperger, Florian; Klinglmueller, Florian; Haegele, Stefanie; Oehlberger, Lukas; Gruenberger, Thomas; Brostjan, Christine; Starlinger, Patrick			Early prediction of postoperative liver dysfunction and clinical outcome using antithrombin III-activity	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; COLORECTAL-CANCER; COAGULATION; DEFICIENCY; HEPATECTOMY; MORTALITY; CIRRHOSIS; FAILURE; RISK; ANTICOAGULANTS	Background and aims Antithrombin III (ATIII) has been reported to be associated with liver pathologies and was shown to predict outcome in patients undergoing liver resection for hepatocellular carcinoma. We now aimed to assess whether perioperative ATIII-activity could predict postoperative outcome in patients without underlying liver disease, as well as in a routine clinical setting of patients undergoing hepatic resection. Methods ATIII-activity was evaluated preoperatively and on the first (POD1) and fifth day after liver resection in a retrospective evaluation cohort of 228 colorectal cancer patients with liver metastasis (mCRC). We further aimed to prospectively validate our results in a set of 177 consecutive patients undergoing hepatic resection. Results Patients developing postoperative liver dysfunction (LD) had a more pronounced postoperative decrease in ATIII-activity (P<0.001). ATIII-activity on POD1 significantly predicted postoperative LD (P<0.001, AUC = 84.4%) and remained independent upon multivariable analysis. A cut-off value of 61.5% ATIII-activity was determined using ROC analysis. This cut-off was vital to identify high-risk patients for postoperative LD, morbidity, severe morbidity and mortality (P<0.001, respectively) with a highly accurate negative predictive value of 97%, which could be confirmed for LD (P<0.001) and mortality (P = 0.014) in our independent validation cohort. Further, mCRC patients below our cut-off suffered from a significantly decreased overall survival (OS) at 1 and 3 years after surgery (P = 0.011, P = 0.025). Conclusions The routine laboratory parameter ATIII-activity on POD1 independently predicted postoperative LD and was associated with clinical outcome. Patients with a postoperative ATIII-activity <61.5% might benefit from close monitoring and timely initiation of supportive therapy.	[Pereyra, David; Offensperger, Florian; Haegele, Stefanie; Brostjan, Christine; Starlinger, Patrick] Med Univ Vienna, Gen Hosp, Dept Surg, Vienna, Austria; [Klinglmueller, Florian] Med Univ Vienna, Core Unit Med Stat & Informat, Vienna, Austria; [Oehlberger, Lukas; Gruenberger, Thomas] Rudolfstiftung Hosp, Dept Surg 1, Vienna, Austria	Medical University of Vienna; Medical University of Vienna; Rudolfstiftung Hospital	Starlinger, P (corresponding author), Med Univ Vienna, Gen Hosp, Dept Surg, Vienna, Austria.	patrick.starlinger@meduniwen.ac.at	Gruenberger, Thomas/ABA-1661-2020	Gruenberger, Thomas/0000-0002-2671-0540; Pereyra, David/0000-0001-6700-9163; Brostjan, Christine/0000-0003-1462-5397; Klinglmueller, Florian/0000-0002-7346-3669				Abdalla EK, 2006, ANN SURG ONCOL, V13, P1271, DOI 10.1245/s10434-006-9045-5; Abildgaard U, 2007, THROMB HAEMOSTASIS, V98, P97, DOI 10.1160/Th07-040277; Assy N, 2009, WORLD J GASTROENTERO, V15, P3217, DOI 10.3748/wjg.15.3217; Beyer TA, 2008, EMBO J, V27, P212, DOI 10.1038/sj.emboj.7601950; Bianchini M, 2014, DIGEST DIS, V32, P609, DOI 10.1159/000360514; Breiman L., 1984, CLASSIFICATION REGRE; BULLER HR, 1989, AM J MED, V87, pS44, DOI 10.1016/0002-9343(89)80531-5; Chighizola CB, 2016, EXPERT REV HEMATOL, V9, P389, DOI 10.1586/17474086.2016.1140034; Desai UR, 1998, BIOCHEMISTRY-US, V37, P13033, DOI 10.1021/bi981426h; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; El-Serag HB, 2012, GASTROENTEROLOGY, V142, P1264, DOI 10.1053/j.gastro.2011.12.061; Girolami A, 2015, CLIN APPL THROMBOSIS; Harada N, 2008, CRIT CARE MED, V36, P971, DOI 10.1097/CCM.0B013E3181653642; He GL, 2015, INT J CLIN EXP MED, V8, P17046; Heinz S, 2015, METHODS MOL BIOL, V1250, P309, DOI 10.1007/978-1-4939-2074-7_23; Homan J, 2016, SURG OBES RELAT DIS, V12, P338, DOI 10.1016/j.soard.2015.09.021; Isik S, 2012, HEPATO-GASTROENTEROL, V59, P453, DOI 10.5754/hge11317; Iwako H, 2012, ANN SURG ONCOL, V19, P2888, DOI 10.1245/s10434-012-2338-y; Karlaftis V, 2016, BLOOD COAGUL FIBRIN, V27, P1, DOI 10.1097/MBC.0000000000000301; Kitade H, 2016, J PHARM HEALTH CARE, V2, DOI 10.1186/s40780-016-0050-y; Kopetz S, 2009, J CLIN ONCOL, V27, P3677, DOI 10.1200/JCO.2008.20.5278; Kuroda S, 2015, DIGEST SURG, V32, P173, DOI 10.1159/000379759; Mizuguchi T, 2012, HEPATO-GASTROENTEROL, V59, P551, DOI 10.5754/hge10052; Mullen JT, 2007, J AM COLL SURGEONS, V204, P854, DOI 10.1016/j.jamcollsurg.2006.12.032; Mulliez SMN, 2016, ACTA CLIN BELG, V71, P63, DOI 10.1179/2295333715Y.0000000073; Murata A, 2015, INT J CLIN PHARM-NET, V37, P139, DOI 10.1007/s11096-014-0052-5; Ornaghi S, 2014, THROMB RES, V133, P972, DOI 10.1016/j.thromres.2014.02.014; Patnaik MM, 2008, HAEMOPHILIA, V14, P1229, DOI 10.1111/j.1365-2516.2008.01830.x; Rahbari NN, 2011, SURGERY, V149, P713, DOI 10.1016/j.surg.2010.10.001; Rahman SH, 2008, ARCHIVES OF SURGERY, V143, P247; Raya-Sanchez JM, 1998, ALCOHOL, V15, P19, DOI 10.1016/S0741-8329(97)00082-7; Schiergens TS, 2015, SURGERY, V158, P1531, DOI 10.1016/j.surg.2015.07.019; Segal H, 1997, HEPATOLOGY, V25, P683, DOI 10.1002/hep.510250332; Sekiya A, 2016, INT J HEMATOLOGY; Simmonds PC, 2006, BRIT J CANCER, V94, P982, DOI 10.1038/sj.bjc.6603033; SPAET TH, 1979, NEW ENGL J MED, V301, P503; Strasberg SM, 2005, J HEPATO-BILIARY-PAN, V12, P351, DOI 10.1007/s00534-005-0999-7; Tang W, 2015, EUR J GASTROEN HEPAT, V27, P672, DOI 10.1097/MEG.0000000000000352; Testa S, 2016, J THROMB HAEMOST, V14, P2194, DOI 10.1111/jth.13486; Van Cutsem E, 2006, EUR J CANCER, V42, P2212, DOI 10.1016/j.ejca.2006.04.012; Wei AC, 2003, BRIT J SURG, V90, P33, DOI 10.1002/bjs.4018; White DL, 2012, CLIN GASTROENTEROL H, V10, P1342, DOI 10.1016/j.cgh.2012.10.001; Zhong JH, 2014, ANN SURG, V260, P329, DOI 10.1097/SLA.0000000000000236	43	10	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2017	12	4							e0175359	10.1371/journal.pone.0175359	http://dx.doi.org/10.1371/journal.pone.0175359			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0MB	28406940	Green Published, gold, Green Submitted			2022-12-27	WOS:000399955400045
J	Roy, U; Gopalakrishnan, M				Roy, Ushasi; Gopalakrishnan, Manoj			Ultrasensitivity and fluctuations in the Barkai-Leibler model of chemotaxis receptors in Escherichia coli	PLOS ONE			English	Article							BACTERIAL CHEMOTAXIS; BEHAVIORAL VARIABILITY; BIOCHEMICAL NETWORKS; PRECISE ADAPTATION; SENSITIVITY; PROTEINS; CELLS; MOTOR	A stochastic version of the Barkai-Leibler model of chemotaxis receptors in Escherichia coli is studied here with the goal of elucidating the effects of intrinsic network noise in their conformational dynamics. The model was originally proposed to explain the robust and near-perfect adaptation of E. coli observed across a wide range of spatially uniform attractant/repellent (ligand) concentrations. In the model, a receptor is either active or inactive and can stochastically switch between the two states. The enzyme CheR methylates inactive receptors while CheB demethylates active receptors and the probability for a receptor to be active depends on its level of methylation and ligand occupation. In a simple version of the model with two methylation sites per receptor (M = 2), we show rigorously, under a quasi-steady state approximation, that the mean active fraction of receptors is an ultrasensitive function of [CheR]/[CheB] in the limit of saturating receptor concentration. Hence the model shows zero-order ultrasensitivity (ZOU), similar to the classical two-state model of covalent modification studied by Goldbeter and Koshland (GK). We also find that in the limits of extremely small and extremely large ligand concentrations, the system reduces to two different two-state GK modules. A quantitative measure of the spontaneous fluctuations in activity is provided by the variance sigma(2)(a) in the active fraction, which is estimated mathematically under linear noise approximation (LNA). It is found that sigma(2)(a) peaks near the ZOU transition. The variance is a non-monotonic, but weak function of ligand concentration and a decreasing function of receptor concentration. Gillespie simulations are also performed in models with M = 2, 3 and 4. For M = 2, simulations show excellent agreement with analytical results obtained under LNA. Numerical results for M = 3 and M = 4 are qualitatively similar to our mathematical results in M = 2; while all the models show ZOU in mean activity, the variance is found to be smaller for larger M. The magnitude of receptor noise deduced from available experimental data is consistent with our predictions. A simple analysis of the downstream signaling pathway shows that this noise is large enough to affect the motility of the organism, and may have a beneficial effect on it. The response of mean receptor activity to small time-dependent changes in the external ligand concentration is computed within linear response theory, and found to have a bilobe form, in agreement with earlier experimental observations.	[Roy, Ushasi; Gopalakrishnan, Manoj] Indian Inst Technol, Dept Phys, Madras, Tamil Nadu, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Madras	Roy, U (corresponding author), Indian Inst Technol, Dept Phys, Madras, Tamil Nadu, India.	ushasi@physics.iitm.ac.in		Gopalakrishnan, Manoj/0000-0002-7931-5042				ASAKURA S, 1984, J MOL BIOL, V176, P349, DOI 10.1016/0022-2836(84)90494-7; Barkai N, 1997, NATURE, V387, P913, DOI 10.1038/43199; Berg OG, 2000, BIOPHYS J, V79, P1228, DOI 10.1016/S0006-3495(00)76377-6; Cluzel P, 2000, SCIENCE, V287, P1652, DOI 10.1126/science.287.5458.1652; Elf J, 2003, GENOME RES, V13, P2475, DOI 10.1101/gr.1196503; Emonet T, 2008, P NATL ACAD SCI USA, V105, P3304, DOI 10.1073/pnas.0705463105; Endres RG, 2006, P NATL ACAD SCI USA, V103, P13040, DOI 10.1073/pnas.0603101103; Ge H, 2008, J CHEM PHYS, V129, DOI 10.1063/1.2948965; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; GOLDBETER A, 1981, P NATL ACAD SCI-BIOL, V78, P6840, DOI 10.1073/pnas.78.11.6840; Hansen CH, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040001; Jithinraj PK, 2014, J THEOR BIOL, V344, P1, DOI 10.1016/j.jtbi.2013.11.014; Kollmann M, 2005, NATURE, V438, P504, DOI 10.1038/nature04228; Lipkow K, 2006, PLOS COMPUT BIOL, V2, P301, DOI 10.1371/journal.pcbi.0020039; Masson JB, 2012, P NATL ACAD SCI USA, V109, P1802, DOI 10.1073/pnas.1116772109; Mello BA, 2003, BIOPHYS J, V84, P2943, DOI 10.1016/S0006-3495(03)70021-6; Morton-Firth CJ, 1999, J MOL BIOL, V286, P1059, DOI 10.1006/jmbi.1999.2535; Park H, 2011, BIOPHYS J, V101, P2336, DOI 10.1016/j.bpj.2011.09.040; Park H, 2010, NATURE, V468, P819, DOI 10.1038/nature09551; Pontius W, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003230; Qian H, 2003, BIOPHYS CHEM, V105, P585, DOI 10.1016/S0301-4622(03)00068-1; Rao CV, 2004, PLOS BIOL, V2, P239, DOI 10.1371/journal.pbio.0020049; Rao CV, 2003, J CHEM PHYS, V118, P4999, DOI 10.1063/1.1545446; Reneaux M, 2010, J THEOR BIOL, V266, P99, DOI 10.1016/j.jtbi.2010.06.012; Schnoerr D, 2016, J PHYS A, DOI 10.1088:1751-8121; SEGALL JE, 1986, P NATL ACAD SCI USA, V83, P8987, DOI 10.1073/pnas.83.23.8987; Sourjik V, 2002, P NATL ACAD SCI USA, V99, P123, DOI 10.1073/pnas.011589998; Tindall MJ, 2008, B MATH BIOL, V70, P1525, DOI 10.1007/s11538-008-9321-6; VanKampen NG, 2007, NORTH-HOLL PERS LIBR, P1; Xu YQ, 2012, J THEOR BIOL, V311, P139, DOI 10.1016/j.jtbi.2012.07.012; Yuan JH, 2013, J MOL BIOL, V425, P1760, DOI 10.1016/j.jmb.2013.02.016; Yuan JH, 2012, NATURE, V484, P233, DOI 10.1038/nature10964	32	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2017	12	4							e0175309	10.1371/journal.pone.0175309	http://dx.doi.org/10.1371/journal.pone.0175309			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0MB	28406996	Green Published, gold, Green Submitted			2022-12-27	WOS:000399955400041
J	Shipitsyna, E; Rumyantseva, T; Golparian, D; Khayrullina, G; Lagos, AC; Edelstein, I; Joers, K; Jensen, JS; Savicheva, A; Rudneva, N; Sukhanova, L; Kozlov, R; Guschin, A; Unemo, M				Shipitsyna, Elena; Rumyantseva, Tatiana; Golparian, Daniel; Khayrullina, Guzel; Lagos, Amaya C.; Edelstein, Inna; Joers, Kai; Jensen, Jorgen S.; Savicheva, Alevtina; Rudneva, Natalia; Sukhanova, Larisa; Kozlov, Roman; Guschin, Alexander; Unemo, Magnus			Prevalence of macrolide and fluoroquinolone resistance-mediating mutations in Mycoplasma genitalium in five cities in Russia and Estonia	PLOS ONE			English	Article							2016 EUROPEAN GUIDELINE; NONGONOCOCCAL URETHRITIS; AZITHROMYCIN; FAILURE; ANTIBIOTICS; INFECTIONS; SELECTION; EFFICACY; STRAINS; COHORT	Background and objective Resistance in the sexually transmitted bacterium Mycoplasma genitalium to all recommended therapeutic antimicrobials have rapidly emerged. However, to date, internationally reported resistance surveillance data for M. genitalium strains circulating in Eastern Europe are entirely lacking. The aim of this study was to estimate the prevalence of macrolide and fluoroquinolone resistance-associated mutations in M. genitalium in four cities in Russia and one in Estonia, 2013-2016. Materials and methods Consecutive urogenital samples found positive for M. genitalium during diagnostic testing were retrospectively analyzed for resistance-associated mutations in the 23S rRNA and parC genes using pyrosequencing and conventional Sanger sequencing, respectively. Results In total, 867 M. genitalium positive samples from 2013-2016 were analyzed. Macrolide resistance-associated mutations were detected in 4.6% of the samples from Russia (0.7- 6.8% in different cities) and in 10% of the samples from Estonia. The mutations A2059G and A2058G were highly predominating in both Russia and Estonia, accounting together for 90.9% of the cases positive for nucleotide substitutions in the 23S rRNA gene. The rates of possible fluoroquinolone resistance-associated mutations were 6.2% in Russia (2.5-7.6% in different cities) and 5% in Estonia. The mutations S83I and S83N were the most frequent ones in Russia (24.4% each), whereas D87N highly predominated in Estonia (83.3% of all fluoroquinolone resistance-associated mutations). Approximately 1% of the samples in both countries harbored both macrolide and possible fluoroquinolone resistance-associated mutations, with A2058G and S83I being the most frequent combination (37.5%). Conclusions The prevalence of macrolide and fluoroquinolone resistance-associated mutations in M. genitalium was 4.6% and 6.2%, respectively, in Russia, and 10% and 5%, respectively, in Estonia. Despite the relatively low rates of macrolide and fluoroquinolone resistance in these countries, antimicrobial resistance surveillance and testing for resistance-associated mutations in M. genitalium positive cases would be valuable.	[Shipitsyna, Elena; Savicheva, Alevtina] DO Ott Res Inst Obstetr Gynaecol & Reproductol, Microbiol Lab, St Petersburg, Russia; [Shipitsyna, Elena; Golparian, Daniel; Lagos, Amaya C.; Unemo, Magnus] Univ Orebro, Fac Med & Hlth, WHO Collaborating Ctr Gonorrhoea & Other STIs, Dept Lab Med, Orebro, Sweden; [Rumyantseva, Tatiana; Khayrullina, Guzel; Guschin, Alexander] Cent res Inst Epidemiol, Lab Mol Diagnost, Moscow, Russia; [Edelstein, Inna; Kozlov, Roman] Smolensk State Med Univ, Inst Antimicrobial Chemotherapy, Smolensk, Russia; [Joers, Kai] Tartu Univ Hosp, United Labs, Tartu, Estonia; [Jensen, Jorgen S.] Statens Serum Inst, Res & Dev, Dept Microbiol & Infect Control Sexually Transmit, Copenhagen, Denmark; [Rudneva, Natalia; Sukhanova, Larisa] Minist Hlth Tula Reg, Tula Reg Clin Dermato Venerol, Tula, Russia	Russian Academy of Medical Sciences; Ott Institute of Obstetrics, Gynecology & Reproductology; Orebro University; Statens Serum Institut	Unemo, M (corresponding author), Univ Orebro, Fac Med & Hlth, WHO Collaborating Ctr Gonorrhoea & Other STIs, Dept Lab Med, Orebro, Sweden.	magnus.unemo@regionorebrolan.se	Shipitsyna, Elena/K-1271-2018; Kozlov, Roman/AAF-2366-2021; Golparian, Daniel/W-8557-2019; Unemo, Magnus/ABD-6653-2021; Golparian, Daniel/ABC-2431-2020	Shipitsyna, Elena/0000-0002-2309-3604; Golparian, Daniel/0000-0002-0688-2521	Orebro County Council Research Committee; Foundation for Medical Research at Orebro University Hospital, Sweden	Orebro County Council Research Committee; Foundation for Medical Research at Orebro University Hospital, Sweden	This study was supported by grants from the Orebro County Council Research Committee (2013) and Foundation for Medical Research (2013) at Orebro University Hospital, Sweden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anagrius C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061481; [Anonymous], 2015, FEDERAL CLINICAL REC; Bebear CM, 1999, ANTIMICROB AGENTS CH, V43, P954, DOI 10.1128/AAC.43.4.954; Bissessor M, 2015, CLIN INFECT DIS, V60, P1228, DOI 10.1093/cid/ciu1162; Chrisment D, 2012, J ANTIMICROB CHEMOTH, V67, P2598, DOI 10.1093/jac/dks263; Couldwell DL, 2013, INT J STD AIDS, V24, P822, DOI 10.1177/0956462413502008; Deguchi T, 2001, J ANTIMICROB CHEMOTH, V48, P742, DOI 10.1093/jac/48.5.742; Deguchi T, 2015, EMERG INFECT DIS, V21, P1062, DOI 10.3201/eid2106.142013; Dumke R, 2016, DIAGN MICR INFEC DIS, V86, P221, DOI 10.1016/j.diagmicrobio.2016.07.005; Falk L, 2015, J ANTIMICROB CHEMOTH, V70, P3134, DOI 10.1093/jac/dkv246; Furneri PM, 2001, ANTIMICROB AGENTS CH, V45, P2958, DOI 10.1128/AAC.45.10.2958-2960.2001; Gesink DC, 2012, INT J CIRCUMPOL HEAL, V71, DOI 10.3402/ijch.v71i0.18203; Getman D, 2016, J CLIN MICROBIOL, V54, P2278, DOI 10.1128/JCM.01053-16; Gruson D, 2005, ANTIMICROB AGENTS CH, V49, P1190, DOI 10.1128/AAC.49.3.1190-1193.2005; Guschin A, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0781-7; Hay B, 2015, SEX TRANSM DIS, V42, P140, DOI 10.1097/OLQ.0000000000000246; Horner PJ, 2016, INT J STD AIDS, V27, P928, DOI 10.1177/0956462416648585; Jensen JS, 2016, J EUR ACAD DERMATOL, V30, P1650, DOI 10.1111/jdv.13849; Jensen JS, 2008, CLIN INFECT DIS, V47, P1546, DOI 10.1086/593188; Kikuchi M, 2014, J ANTIMICROB CHEMOTH, V69, P2376, DOI 10.1093/jac/dku164; Lau A, 2015, CLIN INFECT DIS, V61, P1389, DOI 10.1093/cid/civ644; Le Roy C, 2016, EMERG INFECT DIS, V22, P1677, DOI 10.3201/eid2209.160446; Lis R, 2015, CLIN INFECT DIS, V61, P418, DOI 10.1093/cid/civ312; Nijhuis RHT, 2015, J ANTIMICROB CHEMOTH, V70, P2515, DOI 10.1093/jac/dkv136; Pereyre S, 2004, ANTIMICROB AGENTS CH, V48, P460, DOI 10.1128/AAC.48.2.460-465.2004; Pond MJ, 2014, CLIN INFECT DIS, V58, P631, DOI 10.1093/cid/cit752; RENAUDIN H, 1992, ANTIMICROB AGENTS CH, V36, P870, DOI 10.1128/AAC.36.4.870; Salado-Rasmussen K, 2014, CLIN INFECT DIS, V59, P24, DOI 10.1093/cid/ciu217; Shimada Y, 2010, INT J ANTIMICROB AG, V36, P255, DOI 10.1016/j.ijantimicag.2010.05.011; Shipitsyna E, 2009, J EUR ACAD DERMATOL, V23, P1164, DOI 10.1111/j.1468-3083.2009.03276.x; Tagg KA, 2013, J CLIN MICROBIOL, V51, P2245, DOI 10.1128/JCM.00495-13; Taylor-Robinson D, 2011, CLIN MICROBIOL REV, V24, P498, DOI 10.1128/CMR.00006-11; Terada M, 2012, J INFECT CHEMOTHER, V18, P313, DOI 10.1007/s10156-011-0329-8; Touati A, 2014, J CLIN MICROBIOL, V52, P1549, DOI 10.1128/JCM.03318-13; Unemo M, 2017, NAT REV UROL, V14, P139, DOI 10.1038/nrurol.2016.268	35	25	31	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2017	12	4							e0175763	10.1371/journal.pone.0175763	http://dx.doi.org/10.1371/journal.pone.0175763			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0MB	28407014	Green Published, Green Submitted, gold			2022-12-27	WOS:000399955400093
J	Cheng, QJ; Chen, F; Yip, PSF				Cheng, Qijin; Chen, Feng; Yip, Paul S. F.			Media effects on suicide methods: A case study on Hong Kong 1998-2005	PLOS ONE			English	Article							CHARCOAL-BURNING SUICIDE; CELEBRITY SUICIDE; PREVENTION; IMPACT; DIVORCE; TAIWAN; NUMBER; RATES; ACTS	Background Previous studies have suggested that mass media's reports of new suicide methods will increase suicides using the same method. The same pattern seems not to apply to a conventional suicide method, unless it was used by a celebrity. Objective 1) to examine media effects on both new and non-new suicide methods during 1998 and 2005 in Hong Kong (HK), when a new method by burning charcoal (CB suicide) was spreading in the region. 2) to examine how CB competed with non-CB methods in terms of media coverage and "recruiting" suicidal persons in the socio-economic context. Methods A self-and mutual-exciting process model was fitted to the data, adjusting for divorce rate, unemployment rate, and property price index. Breaking the whole period into onset, peak, and post-peak stages, the model was fitted again to examine the differences. Results Comparable copycat effects were found on both CB and non-CB suicide news. The only cross-method media effects were found in the onset stage when non-CB suicide news showed suppressing effect on CB suicides. CB suicides reported a significant self-excitation effect. A higher divorce rate and lower property price index were associated with significantly more suicides incidences and more suicide news. Conclusions The emerging of CB suicide method did not substitute media coverage of non-CB suicide in HK. Media effects in this case were not limited to new suicide method or celebrity suicide. The effects were further fueled by adverse socio-economic conditions.	[Cheng, Qijin; Yip, Paul S. F.] Univ Hong Kong, Hong Kong Jockey Club Ctr Suicide Res & Prevent, Hong Kong, Hong Kong, Peoples R China; [Chen, Feng] Univ New South Wales, Sch Math & Stat, Sydney, NSW, Australia; [Yip, Paul S. F.] Univ Hong Kong, Dept Social Work & Social Adm, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of New South Wales Sydney; University of Hong Kong	Yip, PSF (corresponding author), Univ Hong Kong, Hong Kong Jockey Club Ctr Suicide Res & Prevent, Hong Kong, Hong Kong, Peoples R China.; Yip, PSF (corresponding author), Univ Hong Kong, Dept Social Work & Social Adm, Hong Kong, Hong Kong, Peoples R China.	sfpyip@hku.hk	Chen, Feng/B-5366-2009	Chen, Feng/0000-0002-9646-3338; Cheng, Qijin/0000-0002-6223-5345	Univerisity of New South Wales Australia SFRG grant; FOGARTY INTERNATIONAL CENTER [D43TW009101] Funding Source: NIH RePORTER	Univerisity of New South Wales Australia SFRG grant; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	FC was supported by a Univerisity of New South Wales Australia SFRG grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brockwell AE, 2007, STAT PROBABIL LETT, V77, P1473, DOI 10.1016/j.spl.2007.02.008; Chan KPM, 2005, BRIT J PSYCHIAT, V186, P67, DOI 10.1192/bjp.186.1.67; Chan Wincy S C, 2007, Arch Suicide Res, V11, P327, DOI 10.1080/13811110701541905; Chang SS, 2015, SOC PSYCH PSYCH EPID, V50, P1451, DOI 10.1007/s00127-015-1057-7; Chang SS, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001622; Chen F, 2008, COMMUN STAT-THEOR M, V37, P294, DOI 10.1080/03610920701649035; Chen YY, 2015, SOC PSYCH PSYCH EPID, V50, P227, DOI 10.1007/s00127-014-0910-4; Chen YY, 2013, J PUBLIC HEALTH-UK, V35, P223, DOI 10.1093/pubmed/fds095; Chen YY, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0055000, 10.1371/journal.pone.0059263]; Chen YY, 2011, J EPIDEMIOL COMMUN H, V65, P934, DOI 10.1136/jech.2010.117903; Cheng QJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140686; Cheng QJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108724; Cheng QJ, 2014, CRISIS, V35, P74, DOI 10.1027/0227-5910/a000241; Cheng QJ, 2012, J AFFECT DISORDERS, V141, P270, DOI 10.1016/j.jad.2012.03.036; Czado C, 2009, BIOMETRICS, V65, P1254, DOI 10.1111/j.1541-0420.2009.01191.x; Ferguson CJ, 2015, PERSPECT PSYCHOL SCI, V10, P646, DOI 10.1177/1745691615592234; Florentine JB, 2010, SOC SCI MED, V70, P1626, DOI 10.1016/j.socscimed.2010.01.029; Fu KW, 2007, J EPIDEMIOL COMMUN H, V61, P540, DOI 10.1136/jech.2005.045005; Fu KW, 2011, J EPIDEMIOL COMMUN H, V65, P928, DOI 10.1136/jech.2009.105650; Hegerl U, 2013, J AFFECT DISORDERS, V146, P39, DOI 10.1016/j.jad.2012.08.032; Kedem B, 2005, REGRESSION MODELS TI, V488; Ladwig KH, 2012, J AFFECT DISORDERS, V136, P194, DOI 10.1016/j.jad.2011.09.044; Lin JJ, 2008, J EPIDEMIOL COMMUN H, V62, P566, DOI 10.1136/jech.2007.065771; Niederkrotenthaler T, 2012, J EPIDEMIOL COMMUN H, V66, P1037, DOI 10.1136/jech-2011-200707; Niederkrotenthaler T, 2010, BRIT J PSYCHIAT, V197, P234, DOI 10.1192/bjp.bp.109.074633; Niederkrotenthaler T, 2009, EUR J PUBLIC HEALTH, V19, P361, DOI 10.1093/eurpub/ckp034; NORSTROM T, 1995, SOC FORCES, V74, P293, DOI 10.2307/2580633; PHILLIPS DP, 1974, AM SOCIOL REV, V39, P340, DOI 10.2307/2094294; Rating and Valuation Department, 2016, HONG KONG PROP REV M; Rubin D. B., 2004, MULTIPLE IMPUTATION; Sisask M, 2012, INT J ENV RES PUB HE, V9, P123, DOI 10.3390/ijerph9010123; Stack S, 2000, SOC SCI QUART, V81, P957; Valkenburg PM, 2015, PERSPECT PSYCHOL SCI, V10, P680, DOI 10.1177/1745691615592237; Valkenburg PM, 2013, INT J COMMUN-US, V7, P197; Wong PWC, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-147; Wong PWC, 2014, SOC PSYCH PSYCH EPID, V49, P211, DOI 10.1007/s00127-013-0743-6; Yip PSF, 2013, J AFFECT DISORDERS, V148, P98, DOI 10.1016/j.jad.2012.11.056; Yip PSF, 2012, LANCET, V379, P2393, DOI 10.1016/S0140-6736(12)60521-2; Yip PSF, 2012, SOC SCI MED, V75, P358, DOI 10.1016/j.socscimed.2012.03.009; Yip PSF, 2006, J AFFECT DISORDERS, V93, P245, DOI 10.1016/j.jad.2006.03.015	40	9	9	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2017	12	4							e0175580	10.1371/journal.pone.0175580	http://dx.doi.org/10.1371/journal.pone.0175580			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET0LZ	28403231	Green Submitted, Green Published, gold			2022-12-27	WOS:000399955200083
J	Katz, DM; Bommarito, MJ; Blackman, J				Katz, Daniel Martin; Bommarito, Michael J., II; Blackman, Josh			A general approach for predicting the behavior of the Supreme Court of the United States	PLOS ONE			English	Article							JUSTICES; VOTES; LEGAL; TIME; LAW	Building on developments in machine learning and prior work in the science of judicial prediction, we construct a model designed to predict the behavior of the Supreme Court of the United States in a generalized, out-of-sample context. To do so, we develop a time-evolving random forest classifier that leverages unique feature engineering to predict more than 240,000 justice votes and 28,000 cases outcomes over nearly two centuries (1816-2015). Using only data available prior to decision, our model outperforms null (baseline) models at both the justice and case level under both parametric and non-parametric tests. Over nearly two centuries, we achieve 70.2% accuracy at the case outcome level and 71.9% at the justice vote level. More recently, over the past century, we outperform an in-sample optimized null model by nearly 5%. Our performance is consistent with, and improves on the general level of prediction demonstrated by prior work; however, our model is distinctive because it can be applied out-of-sample to the entire past and future of the Court, not a single term. Our results represent an important advance for the science of quantitative legal prediction and portend a range of other potential applications.	[Katz, Daniel Martin; Bommarito, Michael J., II] Illinois Tech, Chicago Kent Coll Law, Chicago, IL 60661 USA; [Katz, Daniel Martin; Bommarito, Michael J., II] CodeX Stanford Ctr Legal Informat, Stanford, CA 94305 USA; [Blackman, Josh] South Texas Coll Law Houston, Houston, TX USA		Katz, DM (corresponding author), Illinois Tech, Chicago Kent Coll Law, Chicago, IL 60661 USA.; Katz, DM (corresponding author), CodeX Stanford Ctr Legal Informat, Stanford, CA 94305 USA.	dkatz3@kentlaw.iit.edu		Bommarito, Michael/0000-0002-2236-1187				Aletras N, 2016, PEERJ COMPUT SCI, DOI 10.7717/peerj-cs.93; Ashley KD, 2009, ARTIF INTELL LAW, V17, P125, DOI 10.1007/s10506-009-9077-9; Bailey MA, 2008, AM POLIT SCI REV, V102, P369, DOI 10.1017/S0003055408080283; Benjamin StuartMinor., 2012, J LEGAL ANAL, V4, P445, DOI [DOI 10.1093/JLA/LAS016, 10.1093/jla/las016]; Blackman Josh, 2012, NW J TECH INTELL PRO, V10, P125; Bommarito MJ., SUPREME COURT PREDIC; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Breiman L, 1984, CLASSIFICATION AND R; Caldeira GA, 1998, AM J POLIT SCI, V42, P874, DOI 10.2307/2991733; Caruana R., 2006, P 23 INT C MACH LEAR, P161, DOI DOI 10.1145/1143844.1143865; Casillas CJ, 2011, AM J POLIT SCI, V55, P74, DOI 10.1111/j.1540-5907.2010.00485.x; Chollet F., 2015, KERAS DEEP LEARNING; Cormack GV, 2014, SIGIR'14: PROCEEDINGS OF THE 37TH INTERNATIONAL ACM SIGIR CONFERENCE ON RESEARCH AND DEVELOPMENT IN INFORMATION RETRIEVAL, P153, DOI 10.1145/2600428.2609601; Epstein L, 2007, NORTHWEST U LAW REV, V101, P1483; Guimera R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027188; Harbert T, 2013, IEEE SPECTRUM, V50, P30, DOI 10.1109/MSPEC.2013.6655836; Ho Daniel E, 2010, J LEGAL ANAL, V2, P69, DOI DOI 10.1093/JLA/2.1.69>; Hofer Roy E., 2010, LANDSLIDE, V2, P8; Katz Daniel Martin, 2013, EMORY LAW J, V62, P909; Katz DM, 2014, ARXIV 1407 6333; Katz DM, 2015, ARXIV 1508 05751; Katz DM, 2016, VAND C ART INT LAW V; Kim P.T., 2004, PERSP POL, V2, P761, DOI DOI 10.1017/S1537592704040502; Lee ED, 2015, J STAT PHYS, V160, P275, DOI 10.1007/s10955-015-1253-6; Leicht EA, 2007, EUR PHYS J B, V59, P75, DOI 10.1140/epjb/e2007-00271-7; Louppe G., 2014, ARXIV14077502, DOI [10. 13140/2.1.1570.5928, DOI 10.13140/2.1.1570.5928]; Martin A. A., 2002, POLIT ANAL, V10, P134, DOI [DOI 10.1093/PAN/10.2.134, 10.1093/pan/10.2.134]; Martin AD, 2007, J LAW ECON ORGAN, V23, P365, DOI 10.1093/jleo/ewm028; McShane BB, 2012, J EMPIR LEGAL STUD, V9, P482, DOI 10.1111/j.1740-1461.2012.01260.x; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Ruger TW, 2004, COLUMBIA LAW REV, V104, P1150, DOI 10.2307/4099370; Saad D., 1999, ON LINE LEARNING IN; Sanga S, 2014, J EMPIR LEGAL STUD, V11, P894, DOI 10.1111/jels.12059; Segal JA, 1997, AM POLIT SCI REV, V91, P28, DOI 10.2307/2952257; Segal JA, 1996, AM J POLIT SCI, V40, P971, DOI 10.2307/2111738; SEGAL JA, 1995, J POLIT, V57, P812, DOI 10.2307/2960194; SEGAL JEFFREY A., 2002, THE SUPREME COURT AN; Shalev-Shwartz S, 2012, FOUND TRENDS MACH LE, V4, P107, DOI 10.1561/2200000018; Shapiro C, 2009, HASTINGS LAW J, V60, P477; Spaeth HJ, 2015, SUPREME COURT DATABA; Surden H, 2014, WASH LAW REV, V89, P87; Talley E, 2012, J INST THEOR ECON, V168, P181, DOI 10.1628/093245612799440177	42	119	123	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2017	12	4							e0174698	10.1371/journal.pone.0174698	http://dx.doi.org/10.1371/journal.pone.0174698			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET0LZ	28403140	Green Published, Green Submitted, gold			2022-12-27	WOS:000399955200018
J	Mahmoud, AN; Elgendy, AY; Rambarat, C; Mahtta, D; Elgendy, IY; Bavry, AA				Mahmoud, Ahmed N.; Elgendy, Akram Y.; Rambarat, Cecil; Mahtta, Dhruv; Elgendy, Islam Y.; Bavry, Anthony A.			Efficacy and safety of aspirin in patients with peripheral vascular disease: An updated systematic review and meta-analysis of randomized controlled trials	PLOS ONE			English	Review							ANKLE BRACHIAL INDEX; CARDIOVASCULAR EVENTS; MYOCARDIAL-INFARCTION; ACETYLSALICYLIC-ACID; ARTERIAL-DISEASE; PREVENTION; PROGRESSION; RISK	Background Although considered a cornerstone therapy, the efficacy and safety of aspirin for prevention of ischemic events in patients with peripheral vascular disease (PVD) remains uncertain. Thus, we aimed to evaluate aspirin use in both symptomatic and asymptomatic patients with PVD. Methods An electronic search of databases was conducted from inception until January 2017 for all randomized trials comparing aspirin with either placebo or control (no aspirin) in patients with PVD. The primary efficacy outcome was all-cause mortality, and the primary safety outcome was major bleeding. Other outcomes of interest were major adverse cardiac and cerebrovascular events (MACCE), myocardial infarction (MI), stroke and intracranial hemorrhage. Random-effects summary risk ratios (RR) were calculated using Der-Simonian and Liard model. The quality of evidence was assessed by GRADE tool and Cochrane risk of bias assessment tool. Results A total of 6,560 patients from 11 trials were included. Only two trials were considered to have low risk of bias. Compared with control, aspirin was associated with similar incidence of all-cause mortality (RR = 0.93, 95% confidence interval [CI] 0.8-1.1), MACCE (RR = 1.0, 95% CI 0.83-1.20), MI (RR = 0.91, 95% CI 0.67-1.23) and stroke (RR = 0.72, 95% CI 0.43-1.22), major bleeding (RR = 1.59, 95% CI 0.96-2.62) and intracranial hemorrhage (RR = 1.38, 95% CI 0.59-3.21). Conclusions Aspirin use in PVD might not be associated with improved cardiovascular outcomes or worse bleeding outcomes. Larger randomized trials assessing the efficacy and safety of aspirin in the contemporary era are mandatory to confirm the current findings. Guideline recommendations regarding the use of aspirin among patients with PVD need to be updated.	[Mahmoud, Ahmed N.; Elgendy, Akram Y.; Rambarat, Cecil; Mahtta, Dhruv; Elgendy, Islam Y.; Bavry, Anthony A.] Univ Florida, Dept Med, Gainesville, FL 32611 USA; [Bavry, Anthony A.] North Florida South Georgia Vet Hlth Syst, Gainesville, FL 32608 USA	State University System of Florida; University of Florida	Bavry, AA (corresponding author), Univ Florida, Dept Med, Gainesville, FL 32611 USA.; Bavry, AA (corresponding author), North Florida South Georgia Vet Hlth Syst, Gainesville, FL 32608 USA.	anthony.bavry@va.gov	Mahmoud, Ahmed Naguib/C-3239-2017; Elgendy, Islam Y/C-3900-2017; Elgendy, Akram Y/I-2553-2019	Mahmoud, Ahmed Naguib/0000-0003-2459-5195; Elgendy, Islam Y/0000-0001-9853-7591; Elgendy, Akram Y/0000-0002-8869-3731				Alonso-Coello P, 2012, CHEST, V141, pE669S, DOI 10.1378/chest.11-2307; [Anonymous], 1988, Br Med J (Clin Res Ed), V296, P320; [Anonymous], 1994, BMJ-BRIT MED J, V308, P81, DOI DOI 10.1136/BMJ.308.6921.81; Arbyn M, 2009, J CELL MOL MED, V13, P648, DOI 10.1111/j.1582-4934.2008.00631.x; Bavry AA, 2015, AM J MED, V128, P137, DOI 10.1016/j.amjmed.2014.09.028; Belch J, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1840; Berger JS, 2009, JAMA-J AM MED ASSOC, V301, P1909, DOI 10.1001/jama.2009.623; Bibbins-Domingo K, 2016, ANN INTERN MED, V164, P836, DOI 10.7326/M16-0577; Campbell CL, 2007, JAMA-J AM MED ASSOC, V297, P2018, DOI 10.1001/jama.297.18.2018; Collins R, 2009, LANCET, V373, P1849, DOI 10.1016/S0140-6736(09)60503-1; Delamothe T, 2004, BMJ-BRIT MED J, V328, P1, DOI 10.1136/bmj.328.7430.1; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; EHRESMANN U, 1977, MED WELT, V28, P1157; Ferrari E, 2005, J AM COLL CARDIOL, V45, P456, DOI 10.1016/j.jacc.2004.11.041; Fowkes FGR, 2008, JAMA-J AM MED ASSOC, V300, P197, DOI 10.1001/jama.300.2.197; Fowkes FGR, 2013, LANCET, V382, P1329, DOI 10.1016/S0140-6736(13)61249-0; Fowkes FGR, 2010, JAMA-J AM MED ASSOC, V303, P841, DOI 10.1001/jama.2010.221; Gerhard-Herman MD, 2016, J AM COLL CARDIOL; GREEN RM, 1982, SURGERY, V92, P1016; HARJOLA P, 1981, J CARDIOVASC SURG, V22, P141; HESS H, 1985, LANCET, V1, P415; Hess H, 1975, P COLF S 3 KOLN, P80; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Jones WS, 2017, CIRCULATION, V135, P241, DOI 10.1161/CIRCULATIONAHA.116.025880; LASSILA R, 1991, WORLD J SURG, V15, P378, DOI 10.1007/BF01658734; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Nyaga VN, 2014, ARCH PUBLIC HEALTH, V72, DOI 10.1186/2049-3258-72-39; Pilger E, 2007, J INTERN MED, V261, P276, DOI 10.1111/j.1365-2796.2006.01763.x; Robless P, 2001, BRIT J SURG, V88, P787, DOI 10.1046/j.0007-1323.2001.01774.x; ROZTOCIL K, 1989, COR VASA, V31, P128; YUSUF S, 1985, PROG CARDIOVASC DIS, V27, P335, DOI 10.1016/S0033-0620(85)80003-7; Zekert F., 1975, THROMBOSEN EMBOLIEN, P68	34	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2017	12	4							e0175283	10.1371/journal.pone.0175283	http://dx.doi.org/10.1371/journal.pone.0175283			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LZ	28403216	Green Submitted, gold, Green Published			2022-12-27	WOS:000399955200047
J	Mazzoni, G; Salleh, SM; Freude, K; Pedersen, HS; Stroebech, L; Callesen, H; Hyttel, P; Kadarmideen, HN				Mazzoni, Gianluca; Salleh, Suraya M.; Freude, Kristine; Pedersen, Hanne S.; Stroebech, Lotte; Callesen, Henrik; Hyttel, Poul; Kadarmideen, Haja N.			Identification of potential biomarkers in donor cows for in vitro embryo production by granulosa cell transcriptomics	PLOS ONE			English	Article							OOCYTE DEVELOPMENTAL COMPETENCE; GLOBAL GENE-EXPRESSION; BOVINE OOCYTES; MOLECULAR MARKERS; OVARIAN-FOLLICLES; FOLLICULAR CELLS; ACYL-COENZYME; MATURATION; CUMULUS; APOPTOSIS	The Ovum Pick Up-In vitro Production (OPU-IVP) of embryos is an advanced reproductive technology used in cattle production but the complex biological mechanisms behind IVP outcomes are not fully understood. In this study we sequenced RNA of granulosa cells collected from Holstein cows at oocyte aspiration prior to IVP, to identify candidate genes and biological mechanisms for favourable IVP-related traits in donor cows where IVP was performed separately for each animal. We identified 56 genes significantly associated with IVP scores (BL rate, kinetic and morphology). Among these, BEX2, HEY2, RGN, TNFAIP6 and TXNDC11 were negatively associated while Mx1 and STC1 were positively associated with all IVP scores. Functional analysis highlighted a wide range of biological mechanisms including apoptosis, cell development and proliferation and four key upstream regulators (COX2, IL1, PRL, TRIM24) involved in these mechanisms. We found a range of evidence that good IVP outcome is positively correlated with early follicular atresia. Furthermore we showed that high genetic index bulls can be used in breeding without reducing the IVP performances. These findings can contribute to the development of biomarkers from follicular fluid content and to improving Genomic Selection (GS) methods that utilize functional information in cattle breeding, allowing a widespread large scale application of GS-IVP.	[Mazzoni, Gianluca; Salleh, Suraya M.] Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet & Anim Sci, Anim Breeding Quantitat Genet & Syst Biol AQS Grp, Frederiksberg C, Denmark; [Freude, Kristine; Stroebech, Lotte; Hyttel, Poul] Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet & Anim Sci, Frederiksberg C, Denmark; [Pedersen, Hanne S.; Callesen, Henrik] Aarhus Univ, Dept Anim Sci, Tjele, Denmark; [Stroebech, Lotte] EmbryoTrans Biotech AS, Haslev, Denmark; [Kadarmideen, Haja N.] Tech Univ Denmark, Dept Bio & Hlth Informat, Lyngby, Denmark	University of Copenhagen; University of Copenhagen; Aarhus University; Technical University of Denmark	Kadarmideen, HN (corresponding author), Tech Univ Denmark, Dept Bio & Hlth Informat, Lyngby, Denmark.	hajak@dtu.dk	Hyttel, Poul/AAP-9918-2020; Mazzoni, Gianluca/AAC-6041-2019	Mazzoni, Gianluca/0000-0003-2397-1064; Kadarmideen, Haja/0000-0001-6294-382X; Freude, Kristine/0000-0001-9480-2386; Callesen, Henrik/0000-0002-0185-7300	Danish Innovation Fund [0603-00509B]; University of Copenhagen	Danish Innovation Fund; University of Copenhagen	This work was supported by the Danish Innovation Fund (grant number 0603-00509B, website: http://Innovationsfonden.dk/en) funded the GIFT (Genomic Improvement of Fertilization Traits) project. GM received a PhD Fellowship from the Danish Innovation Fund and the University of Copenhagen. EmbryoTrans Biotech A/S. provided support in the form of salaries for author LS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.; The authors thank the Danish Innovation Fund, which funded the GIFT (Genomic Improvement of Fertilization Traits) project (grant number 0603-00509B and project website: www. gift.ku.dk). GM received a PhD Fellowship from the Danish Innovation Fund and the University of Copenhagen. The authors thank SEGES Danish Cattle for providing the data regarding the cows used in this experiment and all the staff at the slaughterhouse for ovarian sampling and at EmbryoTrans Biotech A/S for IVP work.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Andrews S., 2010, FASTQC QUALITY CONTR; ASSEY RJ, 1994, MOL REPROD DEV, V37, P335, DOI 10.1002/mrd.1080370313; Besnard N, 2001, ACTA PHYSIOL SCAND, V172, P17, DOI 10.1046/j.1365-201X.2001.00813.x; BEST CL, 1995, AM J OBSTET GYNECOL, V172, P1505, DOI 10.1016/0002-9378(95)90488-3; Best CL, 2000, CYTOKINES HUMAN REPR, P43; BIGGERS JD, 1967, P NATL ACAD SCI USA, V58, P560, DOI 10.1073/pnas.58.2.560; Broad Institute, 2012, GEN SET ENR AN GSEA; Comizzoli P, 2000, BIOL REPROD, V62, P1677, DOI 10.1095/biolreprod62.6.1677; de Wit AAC, 2000, J ANIM SCI, V78, P1277; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; DONAHUE RP, 1968, J REPROD FERTIL, V17, P395, DOI 10.1530/jrf.0.0170395; Dunning KR, 2014, REPRODUCTION, V148, pR15, DOI 10.1530/REP-13-0251; Eppig JJ, 2001, REPRODUCTION, V122, P829, DOI 10.1530/rep.0.1220829; Fan CY, 1996, J BIOL CHEM, V271, P24698, DOI 10.1074/jbc.271.40.24698; Feng WG, 2007, THERIOGENOLOGY, V67, P1339, DOI 10.1016/j.theriogenology.2007.01.017; Ferdinandusse S, 2007, HUM MUTAT, V28, P904, DOI 10.1002/humu.20535; Forde N, 2011, ANIM REPROD SCI, V124, P163, DOI 10.1016/j.anireprosci.2010.08.025; Fridman JS, 2003, ONCOGENE, V22, P9030, DOI 10.1038/sj.onc.1207116; Garcia-Alcalde F, 2012, BIOINFORMATICS, V28, P2678, DOI 10.1093/bioinformatics/bts503; Gilbert I, 2012, REPRODUCTION, V143, P735, DOI 10.1530/REP-11-0460; Girard A, 2015, REPROD BIOL ENDOCRIN, V13, DOI 10.1186/s12958-015-0010-7; Hamel M, 2008, HUM REPROD, V23, P1118, DOI 10.1093/humrep/den048; Hansen KD, 2012, BIOSTATISTICS, V13, P204, DOI 10.1093/biostatistics/kxr054; Hatzirodos N, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-40; Hatzirodos N, 2014, BMC GENOMICS, V15, DOI [10.1186/1471-2164-15-24, 10.1186/1471-2164-15-40]; Heleil B, 2010, JOURNAL OF AMERICAN, V6; Hyttel P, 1997, THERIOGENOLOGY, V47, P23, DOI 10.1016/S0093-691X(96)00336-6; Ikeda S, 2006, REPRODUCTION, V132, P549, DOI 10.1530/rep.1.01066; Jiang JY, 2010, J OVARIAN RES, V3, DOI 10.1186/1757-2215-3-6; Kadarmideen HN, 2014, LIVEST SCI, V166, P232, DOI 10.1016/j.livsci.2014.04.028; KING WA, 1988, J REPROD FERTIL, V82, P87, DOI 10.1530/jrf.0.0820087; Krisher R.L., 2004, J ANIM SCI, V82, pE14, DOI 10.2527/2004.8213_supplE14x; Kuz'mina TI, 2001, RUSS J DEV BIOL, V32, P112, DOI DOI 10.1023/A:1012660101432; Lebedeva IY, 1998, THERIOGENOLOGY, V49, P509, DOI 10.1016/S0093-691X(98)00002-8; Ledee N, 2008, HUM REPROD, V23, P2001, DOI 10.1093/humrep/den192; Lee DL, 2009, J INTERF CYTOK RES, V29, P801, DOI 10.1089/jir.2009.0024; LEESE HJ, 1985, J EXP ZOOL, V234, P231, DOI 10.1002/jez.1402340208; Li P, 2016, INTERNATIONAL JOURNA, V2016; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Luo CW, 2004, MOL ENDOCRINOL, V18, P2085, DOI 10.1210/me.2004-0066; Macaulay AD, 2015, BIOL REPROD; Macaulay AD, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.114.119867; Mamo S, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-151; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Matoba S, 2014, REPROD FERT DEVELOP, V26, P337, DOI 10.1071/RD13007; Mayes MA, 2001, THERIOGENOLOGY, V55, P911, DOI 10.1016/S0093-691X(01)00453-8; Memili E, 2000, ZYGOTE, V8, P87, DOI 10.1017/S0967199400000861; Mermillod P, 2008, REPROD DOMEST ANIM, V43, P393, DOI 10.1111/j.1439-0531.2008.01190.x; Merton J, 2003, THERIOGENOLOGY, V59, P651, DOI 10.1016/S0093-691X(02)01246-3; Merton JS, 2009, THERIOGENOLOGY, V72, P885, DOI 10.1016/j.theriogenology.2009.06.003; MOOR RM, 1977, J REPROD FERTIL, V49, P101, DOI 10.1530/jrf.0.0490101; Naderi A, 2010, INT J CANCER, V126, P1596, DOI 10.1002/ijc.24866; Nivet AL, 2013, REPRODUCTION, V145, P555, DOI 10.1530/REP-13-0032; Nivet AL, 2012, REPRODUCTION, V143, P165, DOI 10.1530/REP-11-0391; Oaxaca-Castillo D, 2007, BIOCHEM BIOPH RES CO, V360, P314, DOI 10.1016/j.bbrc.2007.06.059; Orozco-Lucero E, 2014, ANIM REPROD, V11, P183; Palma GA, 2004, ANAT HISTOL EMBRYOL, V33, P257, DOI 10.1111/j.1439-0264.2004.00543.x; Ploutarchou P, 2015, REPRODUCTION, V149, P533, DOI 10.1530/REP-14-0503; Revelli A, 2009, REPROD BIOL ENDOCRIN, V7, P4330, DOI DOI 10.1186/1477-7827-7-40; RODGERS RJ, 1986, J REPROD FERTIL, V78, P627, DOI 10.1530/jrf.0.0780627; Salilew-Wondim D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106795; Sayasith K, 2008, ENDOCRINOLOGY, V149, P6213, DOI 10.1210/en.2008-0459; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Sirard MA, 2006, THERIOGENOLOGY, V65, P126, DOI 10.1016/j.theriogenology.2005.09.020; Sirard MA, 1996, ANIM REPROD SCI, V42, P417, DOI 10.1016/0378-4320(96)01518-7; Sirard MA., 2011, REPROD DOMEST RUMIN, VVII, P145; Smedley D, 2015, NUCLEIC ACIDS RES, V43, pW589, DOI 10.1093/nar/gkv350; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sugiura K, 2005, DEV BIOL, V279, P20, DOI 10.1016/j.ydbio.2004.11.027; Suravajhala P, 2016, GENET SEL EVOL, V48, DOI 10.1186/s12711-016-0217-x; Tamassia M, 2003, REPRODUCTION, V126, P629, DOI 10.1530/rep.0.1260629; Tarazona S., 2011, EMBNET J, V17, P18, DOI [10.14806/ej.17.B.265, DOI 10.14806/EJ.17.B.265]; Townson DH, 2012, OVARIAN TOLLICULAR A; Uyar A, 2013, FERTIL STERIL, V99, P979, DOI 10.1016/j.fertnstert.2013.01.129; Woodruff Teresa K, 2007, Reprod Sci, V14, P6, DOI 10.1177/1933719107309818; Wurth Y, 1992, P 12 INT C AN REPR H, P387; Yan W, 2005, MOL CELL BIOL, V25, P4615, DOI 10.1128/MCB.25.11.4615-4624.2005; Yates A, 2016, NUCLEIC ACIDS RES, V44, pD710, DOI 10.1093/nar/gkv1157; Zhang CP, 2011, ENDOCRINOLOGY, V152, P2437, DOI 10.1210/en.2010-1182; ZHANG L, 1995, MOL REPROD DEV, V40, P338, DOI 10.1002/mrd.1080400310	81	6	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2017	12	4							e0175464	10.1371/journal.pone.0175464	http://dx.doi.org/10.1371/journal.pone.0175464			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LZ	28403200	Green Published, Green Submitted, gold			2022-12-27	WOS:000399955200071
J	Panzer, S; Wittig, H; Zesch, S; Rosendahl, W; Blache, S; Muller-Gerbl, M; Hotz, G				Panzer, Stephanie; Wittig, Holger; Zesch, Stephanie; Rosendahl, Wilfried; Blache, Sandra; Mueller-Gerbl, Magdalena; Hotz, Gerhard			Evidence of neurofibromatosis type 1 in a multi-morbid Inca child mummy: A paleoradiological investigation using computed tomography	PLOS ONE			English	Article							ANCIENT EGYPTIAN MUMMIES; SOUTH-AMERICAN MUMMIES; MUMMIFIED HUMAN TISSUE; TRYPANOSOMA-CRUZI DNA; CHAGAS-DISEASE; RADIOLOGY REPORTS; MULTIDETECTOR CT; NEW-WORLD; TUBERCULOSIS; SACRIFICE	Objective In this study, an Inca bundle was examined using computed tomography (CT). The primary aim was to determine the preservation status of bony and soft tissues, the sex, the age at the time of death, possible indicators for disease or even the cause of death, as well as the kind of mummification. A secondary aim was to obtain a brief overview of the wrapping in order to gain additional information on the cultural background. Materials and methods The bundle belongs to the Museum of Cultures in Basel, Switzerland, and was bought in Munich, Germany, in 1921. Radiocarbon dating of the superficial textile yielded a calibrated age between 1480 and 1650 AD. The mummy was investigated using multi-slice CT with slice thickness of 0.75 mm and 110 kilovolt. For standardized assessment of soft tissue preservation, a recently developed checklist was applied. Results CT revealed the mummy of a seven to nine year old boy with superior preservation of bony and soft tissues allowing detailed assessment. Indicators of neurofibromatosis type 1 (paravertebral and cutaneous neurofibromas, a breast neurofibroma, sphenoid wing dysplasia), Chagas disease (dilatation of the esophagus, stomach, rectum, and large amounts of feces), and lung infection (pleural adherence, calcifications), probably due to tuberculosis, were found. Furthermore, signs of peri-mortem violence (transection of the chest and a defect in the abdominal wall) were detected. CT images revealed a carefully performed wrapping. Conclusion CT examination of the Inca bundle proved to be an important non-destructive examination method. Standardized assessment, especially of the soft tissue structures, allowed for diagnoses of several diseases, indicating a multi-morbid child at the time of death. The careful wrapping pointed to a ceremonial burial. Within the cultural background, the signs of fatal violence were discussed as a possible result of war, murder, accident, or human sacrifice.	[Panzer, Stephanie] Trauma Ctr Murnau, Dept Radiol, Murnau, Germany; [Panzer, Stephanie] Trauma Ctr Murnau, Inst Biomech, Murnau, Germany; [Panzer, Stephanie] Paracelsus Med Univ Salzburg, Murnau, Germany; [Wittig, Holger] Univ Basel, Inst Legal Med, Basel, Switzerland; [Zesch, Stephanie; Rosendahl, Wilfried] Reiss Engelhorn Museen Mannheim, German Mummy Project, Mannheim, Germany; [Blache, Sandra; Mueller-Gerbl, Magdalena] Univ Basel, Anat, Basel, Switzerland; [Hotz, Gerhard] Nat Hist Museum Basel, Anthropol, Basel, Switzerland	University of Basel; University of Basel	Panzer, S (corresponding author), Trauma Ctr Murnau, Dept Radiol, Murnau, Germany.; Panzer, S (corresponding author), Trauma Ctr Murnau, Inst Biomech, Murnau, Germany.; Panzer, S (corresponding author), Paracelsus Med Univ Salzburg, Murnau, Germany.	stephanie.panzer@bgu-murnau.de	Wittig, Holger/AAA-5421-2021	Wittig, Holger/0000-0002-3454-0721; Zesch, Stephanie/0000-0003-4529-0366				ALLISON MJ, 1973, AM REV RESPIR DIS, V107, P985; [Anonymous], 1946, HDB S AM INDIANDS; Arriaza BT., 1998, MUMMIES, P190; Aufderheide A.C., 2003, SCI STUDY MUMMIES; Aufderheide AC, 2004, P NATL ACAD SCI USA, V101, P2034, DOI 10.1073/pnas.0307312101; Bianucci Raffaella, 2016, Lancet Neurol, V15, P1123, DOI 10.1016/S1474-4422(16)30210-1; Blaser SI, 2004, DIAGNOSTIC IMAGING B; Bos KI, 2014, NATURE, V514, P494, DOI 10.1038/nature13591; Brook OR, 2015, RADIOLOGY, V274, P464, DOI 10.1148/radiol.14140206; Brosius S, 2010, J HIST NEUROSCI, V19, P333, DOI 10.1080/09647041003642885; Buikstra J., 2006, BIOARCHEOLOGY CONTEX; Cesarani F, 2003, AM J ROENTGENOL, V180, P597, DOI 10.2214/ajr.180.3.1800597; Chhem R.K., 2008, PALEORADIOLOGY IMAGI, DOI [10.1007/978-3-540-48833-0, DOI 10.1007/978-3-540-48833-0]; Ceruti MC, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/439428; Dageforde KL, 2014, HOMO, V65, P214, DOI 10.1016/j.jchb.2014.03.001; Dahnert W., 1999, RADIOLOGY REV MANUAL, P337; Eeckhout P, 2008, LAT AM ANTIQ, V19, P375, DOI 10.2307/25478240; Feldman F, 2002, DIAGNOSIS BONE JOINT, P4792; FORNACIARI G, 1992, LANCET, V339, P128, DOI 10.1016/0140-6736(92)91043-8; Gaither CM, 2012, J ARCHAEOL SCI, V39, P467, DOI 10.1016/j.jas.2011.10.002; Gerszten PC, 2001, NEUROSURGERY, V48, P208, DOI 10.1097/00006123-200101000-00039; Gostner P, 2011, J ARCHAEOL SCI, V38, P3425, DOI 10.1016/j.jas.2011.08.003; Guhl F, 1999, AM J PHYS ANTHROPOL, V108, P401, DOI 10.1002/(SICI)1096-8644(199904)108:4&lt;401::AID-AJPA2&gt;3.0.CO;2-P; Guhl F, 1997, LANCET, V349, P1370, DOI 10.1016/S0140-6736(05)63207-2; Gupta N, 2010, PEDIATR ONCOL-BERLIN, P1, DOI 10.1007/978-3-540-87979-4; HARWOODNASH DCF, 1979, J COMPUT ASSIST TOMO, V3, P768; Hawass Z, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e8268; Hoffman H, 2002, RADIOGRAPHICS, V22, P377, DOI 10.1148/radiographics.22.2.g02mr13377; Hong Y, 2013, J DIGIT IMAGING, V26, P843, DOI 10.1007/s10278-013-9597-4; Hubener K H, 1981, Rofo, V135, P213, DOI 10.1055/s-2008-1056862; Knipe H, 2016, NEUROFIBROMATOSIS TY; KNUSEL CJ, 1996, INT J OSTEOARCHAEOL, V6, P202; Larson DB, 2013, RADIOLOGY, V267, P240, DOI 10.1148/radiol.12121502; Lu-Emerson Christine, 2009, Rev Neurol Dis, V6, pE47; Lynnerup N, 2007, YEARB PHYS ANTHROPOL, V50, P162, DOI 10.1002/ajpa.20728; Malpass MM, 1996, DAILY LIFE INCA EMPI; Marcovici PA, 2014, AM J ROENTGENOL, V203, P1265, DOI 10.2214/AJR.14.12636; Matsuda NM, 2009, CLINICS, V64, P1219, DOI 10.1590/S1807-59322009001200013; MORELL V, 1994, SCIENCE, V263, P1686, DOI 10.1126/science.8134831; Murphy EM, 1998, INT J OSTEOARCHAEOL, V8, P424, DOI 10.1002/(SICI)1099-1212(199811/12)8:6<424::AID-OA431>3.3.CO;2-N; O'Brien JJ, 2009, INT J OSTEOARCHAEOL, V19, P90, DOI 10.1002/oa.967; Ohrstrom LM, 2013, RADIOGRAPHICS, V33, P291, DOI 10.1148/rg.331125711; Ortner D. J., 2003, IDENTIFICATION PATHO, P435; Panzer S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133364; Panzer S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089528; Panzer S, 2013, ANN ANAT, V195, P401, DOI 10.1016/j.aanat.2013.03.009; Panzer S, 2013, SKELETAL RADIOL, V42, P1527, DOI 10.1007/s00256-013-1696-2; Panzer S, 2010, RADIOGRAPHICS, V30, P1123, DOI 10.1148/rg.304095174; Petrella E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154349; PLATO CC, 1984, AM J PHYS ANTHROPOL, V63, P57, DOI 10.1002/ajpa.1330630108; Pollack JF, 2007, PRINCIPLES PRACTICE, P735; Prat JGI, 2003, MEM I OSWALDO CRUZ, V98, P151, DOI 10.1590/S0074-02762003000900023; Previgliano CH, 2003, AM J ROENTGENOL, V181, P1473, DOI 10.2214/ajr.181.6.1811473; RAGGE NK, 1994, NATURE, V368, P815, DOI 10.1038/368815a0; Rassi A, 2010, LANCET, V375, P1388, DOI 10.1016/S0140-6736(10)60061-X; ROTHHAMMER F, 1985, AM J PHYS ANTHROPOL, V68, P495, DOI 10.1002/ajpa.1330680405; Ruhli FJ, 2000, INT J OSTEOARCHAEOL, V10, P153; Ruhli FJ, 2004, CAN ASSOC RADIOL J, V55, P218; SALO WL, 1994, P NATL ACAD SCI USA, V91, P2091, DOI 10.1073/pnas.91.6.2091; Sanchez Gonzalo M, 2002, S D J Med, V55, P529; Scheuer L., 2000, DEV JUVENILE OSTEOLO; Schorry EK, 2013, NEUROFIBROMTATOSIS T, P101; STEAD WW, 1995, AM J RESP CRIT CARE, V151, P1267; STLOUKAL M, 1978, HOMO, V29, P53; Todman D, 2008, J HIST NEUROSCI, V17, P141, DOI 10.1080/09647040601079607; Tung TA, 2010, LAT AM ANTIQ, V21, P44, DOI 10.7183/1045-6635.21.1.44; Ubelaker DH, 1978, HUMAN SKELETAL REMAI; Verano J. W., 2001, RITUAL SACRIFICE ANC, P165; Verano J.W., 1986, PACATNAMU PAPERS, P117; Verano JW, 2006, 784405 ROG THAYER ST; Vreeland James M., 1998, MUMMIES DIS ANCIENT, P154, DOI [10.1017/CBO9781139878340.013, DOI 10.1017/CBO9781139878340.013]; Williams VC, 2009, PEDIATRICS, V123, P124, DOI 10.1542/peds.2007-3204; Wilson AS, 2013, P NATL ACAD SCI USA, V110, P13322, DOI 10.1073/pnas.1305117110; Zesch S, 2016, EUR J RADIOL OPEN, V3, P172, DOI 10.1016/j.ejro.2016.07.002	74	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2017	12	4							e0175000	10.1371/journal.pone.0175000	http://dx.doi.org/10.1371/journal.pone.0175000			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET0LZ	28403237	gold, Green Published, Green Submitted			2022-12-27	WOS:000399955200028
J	Jiang, H; Shen, SM; Yin, J; Zhang, PP; Shi, Y				Jiang, Hao; Shen, Si-mei; Yin, Jie; Zhang, Peng-peng; Shi, Yi			Sphingosine 1-phosphate receptor 1 (S1PR1) agonist CYM5442 inhibits expression of intracellular adhesion molecule 1 (ICAM1) in endothelial cells infected with influenza A viruses	PLOS ONE			English	Article							RESPIRATORY-DISTRESS-SYNDROME; INFLAMMATION; PATHOGENESIS; VIRULENCE; DISEASE; S1P(1)	Background Influenza A virus infection and its complications effect a large population worldwide. Endothelial cells are an important component in lung inflammation caused by influenza A virus infection. The roles of endothelial sphingosine 1-phophate receptor 1 (S1PR1) in the regulation of molecules involved in leukocyte recruitment during influenza A virus infection still remain unknown. In this report, we tested our hypothesis that S1PR1 agonist CYM5442 inhibits expression of intracellular adhesion molecules 1 (ICAM1) in endothelial cells infected with influenza A virus. Methods Human pulmonary microvascular endothelial cells (HPMEC) were infected with influenza A virus H1N1. Expression of cytokines, chemokines, interferons, and cellular adhesion molecules was measured by q-PCR. Expression of ICAM1 was further tested by Western Blotting. A S1PR1 agonist CYM5442 was added to the culture media to assess CYM5442's inhibitory effects during virus infection. Results HPMEC could be infected with H1N1 and responded to produce pro-inflammatory cytokines, chemokines, type I interferons, and cellular adhesion molecules. Addition of CYM5442 in culture media reduced the production of ICAM1 via a dosage-and time-dependent manner. CYM5442 inhibited the activation of nuclear factor (NF)-kappa B. The regulatory effects of CYM5442 were beta-arrestin2-dependent. Conclusion Activated S1PR1 signaling regulates the production of cellular adhesion molecules by inhibiting NF-kappa B activation via a beta-arrestin2-dependent manner.	[Jiang, Hao; Shen, Si-mei; Yin, Jie; Zhang, Peng-peng; Shi, Yi] Nanjing Univ, Jinling Hosp, Sch Med, Dept Resp & Crit Care Med, Nanjing, Jiangsu, Peoples R China; [Jiang, Hao] Southeast Univ, Affiliated Hosp 2, Dept Emergency Med, Nanjing, Jiangsu, Peoples R China	Nanjing University; Southeast University - China	Shi, Y (corresponding author), Nanjing Univ, Jinling Hosp, Sch Med, Dept Resp & Crit Care Med, Nanjing, Jiangsu, Peoples R China.	yishi201607@163.com			National Natural Science Foundation of China [81470206]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This project was supported by National Natural Science Foundation of China (81470206, to Dr. Yi Shi). The funder did not have any role in the experiment design, data collection and analysis, decision to publish, or manuscript preparation.	Baker RG, 2011, CELL METAB, V13, P11, DOI 10.1016/j.cmet.2010.12.008; Blaho VA, 2014, J LIPID RES, V55, P1596, DOI 10.1194/jlr.R046300; Blaho VA, 2011, CHEM REV, V111, P6299, DOI 10.1021/cr200273u; Galvani S, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aaa2581; Gao W., 2012, PLOS ONE, V7; Ishiguro N, 2004, ARCH VIROL, V149, P17, DOI 10.1007/s00705-003-0208-4; Kobasa D, 2004, NATURE, V431, P703, DOI 10.1038/nature02951; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Liu YJ, 2000, J CLIN INVEST, V106, P951, DOI 10.1172/JCI10905; Luyt Charles-Edouard, 2011, Presse Med, V40, pe561, DOI 10.1016/j.lpm.2011.05.027; McCaughey Conall, 2010, Ulster Med J, V79, P46; Nourshargh S, 2014, IMMUNITY, V41, P694, DOI 10.1016/j.immuni.2014.10.008; Obinata H, 2014, J LIPID RES, V55, P2665, DOI 10.1194/jlr.P054163; Piantadosi CA, 2004, ANN INTERN MED, V141, P460, DOI 10.7326/0003-4819-141-6-200409210-00012; Pober JS, 2007, NAT REV IMMUNOL, V7, P803, DOI 10.1038/nri2171; Pyne NJ, 2010, NAT REV CANCER, V10, P489, DOI 10.1038/nrc2875; Ramsey C, 2011, CURR OPIN CRIT CARE, V17, P64, DOI 10.1097/MCC.0b013e3283427259; Shenoy Sudha K, 2005, Sci STKE, V2005, pcm10, DOI 10.1126/stke.2005/308/cm10; Short KR, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00653; Short KR, 2014, LANCET INFECT DIS, V14, P57, DOI 10.1016/S1473-3099(13)70286-X; Subbarao K, 1998, SCIENCE, V279, P393, DOI 10.1126/science.279.5349.393; Teijaro JR, 2011, CELL, V146, P980, DOI 10.1016/j.cell.2011.08.015; To KKW, 2010, CLIN INFECT DIS, V50, P850, DOI 10.1086/650581; Tscherne DM, 2011, J CLIN INVEST, V121, P6, DOI 10.1172/JCI44947; Visseren FLJ, 1999, J LAB CLIN MED, V134, P623, DOI 10.1016/S0022-2143(99)90103-8	27	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2017	12	4							e0175188	10.1371/journal.pone.0175188	http://dx.doi.org/10.1371/journal.pone.0175188			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0JS	28399143	Green Submitted, Green Published, gold			2022-12-27	WOS:000399949000022
J	Quesada, A; Segarra, AB; Montoro-Molina, S; de Gracia, MD; Osuna, A; O'Valle, F; Gomez-Guzman, M; Vargas, F; Wangensteen, R				Quesada, Andres; Belen Segarra, Ana; Montoro-Molina, Sebastian; del Carmen de Gracia, Maria; Osuna, Antonio; O'Valle, Francisco; Gomez-Guzman, Manuel; Vargas, Felix; Wangensteen, Rosemary			Glutamyl aminopeptidase in microvesicular and exosomal fractions of urine is related with renal dysfunction in cisplatin-treated rats	PLOS ONE			English	Article							ACUTE KIDNEY INJURY; BIOMARKER DISCOVERY; MEMBRANE; NEPHROTOXICITY; PROTEOMICS; VESICLES; DISEASE; PLASMA	Purpose The aim of this work was to investigate if the content of glutamyl aminopeptidase (GluAp) in microvesicular and exosomal fractions of urine is related with renal dysfunction in cisplatin-treated rats. Methods Urine samples were collected 24 hours after injection of cisplatin (7 mg/kg, n = 10) or saline serum (n = 10), and they were subjected to differential centrifugation at 1.000, 17.000 and 200.000 g to obtain microvesicular and exosomal fractions. GluAp was measured with a commercial ELISA kit in both fractions. Serum creatinine (SCr) and body weight were measured 15 days after treatment. We analyzed if early excretion of GluAp in microsomal and exosomal fractions was correlated with final SCr and body weight increase. In a second experiment, enzymatic activities of GluAp and alanyl aminopeptidase (AlaAp) in urine, microvesicular and exosomal fractions were measured three days after injection. We analyzed the correlation of both markers with SCr determined at this point. Finally, we studied the expression of GluAp and extracellular vesicles markers Alix and tumor susceptibility gene (TSG101) in both fractions by immunoblotting. Results GluAp excretion was increased in all fractions of urine after cisplatin treatment, even if data were normalized per mg of creatinine, per body weight or per total protein content of each fraction. We found significant predictive correlations with SCr concentration, and inverse correlations with body weight increase determined 15 days later. Three days after injection, amino-peptidasic activities were markedly increased in all fractions of urine in cisplatin-treated rats. The highest correlation coefficient with SCr was found for GluAp in microvesicular fraction.Increase of GluAp in microvesicular and exosomal fractions from cisplatin-treated rats was confirmed by immunoblotting. Alix and TSG101 showed different patterns of expression in each fraction. Conclusions Determination of GluAp content or its enzymatic activity in microvesicular and exosomal fractions of urine is an early and predictive biomarker of renal dysfunction in cisplatin-induced nephrotoxicity. Measurement of GluAp in these fractions can serve to detect proximal tubular damage independently of glomerular filtration status.	[Quesada, Andres; del Carmen de Gracia, Maria; Osuna, Antonio] FIBAO, Hosp Virgen Nieves, Unidad Nefrol, Granada, Spain; [Belen Segarra, Ana; Montoro-Molina, Sebastian; Gomez-Guzman, Manuel; Wangensteen, Rosemary] Univ Jaen, Dept Ciencias Salud, Area Fisiol, Jaen, Spain; [O'Valle, Francisco] Univ Granada, IBIMER, Dept Anat Patol, Granada, Spain; [Vargas, Felix] Univ Granada, Fac Med, Dept Fisiol, Granada, Spain	Hospital Universitario Virgen de las Nieves; Universidad de Jaen; University of Granada; University of Granada	Wangensteen, R (corresponding author), Univ Jaen, Dept Ciencias Salud, Area Fisiol, Jaen, Spain.	rwangens@ujaen.es	Segarra, Ana Belén/C-6219-2017; Belen, Segarra Ana/T-2002-2019; OValle, Francisco/AAA-9151-2019; Gómez-Guzmán, M/E-3341-2012; Wangensteen Fuentes, Rosemary/M-9856-2015	Segarra, Ana Belén/0000-0002-9409-6052; Gómez-Guzmán, M/0000-0003-2452-9286; Wangensteen Fuentes, Rosemary/0000-0001-7161-9925; Quesada, Andres/0000-0002-9584-5756; Montoro-Molina, Sebastian/0000-0003-3683-3357	Carlos III Health Institute of Spain [PI13/02743, PI13/02384]; Red de Investigacion Renal REDinREN [RD16/0009/0033]	Carlos III Health Institute of Spain(Instituto de Salud Carlos III); Red de Investigacion Renal REDinREN	This study was supported by the grants PI13/02743 (AO) and PI13/02384 (RW) from the Carlos III Health Institute of Spain, and the Red de Investigacion Renal REDinREN RD16/0009/0033 (AO). "FEDER una manera de hacer Europa". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez S, 2013, TRANSPL P, V45, P3719, DOI 10.1016/j.transproceed.2013.08.079; Arany I, 2003, SEMIN NEPHROL, V23, P460, DOI 10.1016/S0270-9295(03)00089-5; Bonventre JV, 2010, NAT BIOTECHNOL, V28, P436, DOI 10.1038/nbt0510-436; Dear JW, 2013, PROTEOMICS, V13, P1572, DOI 10.1002/pmic.201200285; Devarajan P, 2007, CONTRIB NEPHROL, V156, P203; Dimov I, 2009, THESCIENTIFICWORLDJO, V9, P1107, DOI 10.1100/tsw.2009.128; Fang DYP, 2013, NEPHROLOGY, V18, P1, DOI 10.1111/nep.12005; Gamez-Valero A, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00006; Gonzales PA, 2009, J AM SOC NEPHROL, V20, P363, DOI 10.1681/ASN.2008040406; Jayachandran M, 2015, BIOL SEX DIFFER, V6, DOI 10.1186/s13293-015-0021-2; Kawai Y, 2009, J PHARMACOL SCI, V111, P433, DOI 10.1254/jphs.09185FP; KENNY AJ, 1982, PHYSIOL REV, V62, P91, DOI 10.1152/physrev.1982.62.1.91; Lisowska-Myjak B, 2010, BLOOD PURIFICAT, V29, P357, DOI 10.1159/000309421; Lv LL, 2013, INT J BIOL SCI, V9, P1021, DOI 10.7150/ijbs.6100; Montoro-Molina S, 2015, PROTEOM CLIN APPL, V9, P630, DOI 10.1002/prca.201400096; Morita E, 2007, EMBO J, V26, P4215, DOI 10.1038/sj.emboj.7601850; Murakami T, 2014, PLOS ONE, V2; Nabhan JF, 2012, P NATL ACAD SCI USA, V109, P4146, DOI 10.1073/pnas.1200448109; Ohno S, 2013, ADV DRUG DELIVER REV, V65, P398, DOI 10.1016/j.addr.2012.07.019; Palmisano G, 2012, MOL CELL PROTEOMICS, V11, P230, DOI 10.1074/mcp.M111.012732; Pisitkun T, 2006, MOL CELL PROTEOMICS, V5, P1760, DOI 10.1074/mcp.R600004-MCP200; Quesada A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040402; Salih M, 2014, AM J PHYSIOL-RENAL, V306, pF1251, DOI 10.1152/ajprenal.00128.2014; SONG LJ, 1994, AM J PHYSIOL-RENAL, V267, pF546, DOI 10.1152/ajprenal.1994.267.4.F546; Thery C, 2001, J IMMUNOL, V166, P7309, DOI 10.4049/jimmunol.166.12.7309; Vaidya VS, 2008, ANNU REV PHARMACOL, V48, P463, DOI 10.1146/annurev.pharmtox.48.113006.094615; Vinuela-Berni V, 2015, CLIN EXP IMMUNOL, V180, P442, DOI 10.1111/cei.12598; Yao X, 2007, AM J MED SCI, V334, P115, DOI 10.1097/MAJ.0b013e31812dfe1e; Zhou H, 2006, KIDNEY INT, V69, P1471, DOI 10.1038/sj.ki.5000273	29	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2017	12	4							e0175462	10.1371/journal.pone.0175462	http://dx.doi.org/10.1371/journal.pone.0175462			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0JS	28399178	Green Published, Green Submitted, gold			2022-12-27	WOS:000399949000040
J	Zhu, KJ; Spaink, HP; Durston, AJ				Zhu, Kongju; Spaink, Herman P.; Durston, Antony J.			Collinear Hox-Hox interactions are involved in patterning the vertebrate anteroposterior (A-P) axis	PLOS ONE			English	Article							GENE-EXPRESSION; SPEMANN ORGANIZER; BITHORAX COMPLEX; HOMEOTIC GENES; DROSOPHILA; SPACE; TIME; MAINTENANCE; MESODERM; SPECIFICATION	Investigating regulation and function of the Hox genes, key regulators of positional identity in the embryo, opened a new vista in developmental biology. One of their most striking features is collinearity: the temporal and spatial orders of expression of these clustered genes each match their 3 ' to 5 ' order on the chromosome. Despite recent progress, the mechanisms underlying collinearity are not understood. Here we show that ectopic expression of 4 different single Hox genes predictably induces and represses expression of others, leading to development of different predictable specific sections of the body axis. We use ectopic expression in wild-type and noggin-dorsalised (Hox-free) Xenopus embryos, to show that two Hox-Hox interactions are important. Posterior induction (induction of posterior Hox genes by anterior ones: PI), drives Hox temporal collinearity (Hox timer), which itself drives anteroposterior (A-P) patterning. Posterior prevalence (repression of anterior Hox genes by posterior ones: PP) is important in translating temporal to spatial collinearity. We thus demonstrate for the first time that two collinear Hox interactions are important for vertebrate axial patterning. These findings considerably extend and clarify earlier work suggesting the existence and importance of PP and PI, and provide a major new insight into genesis of the body axis.	[Zhu, Kongju; Spaink, Herman P.; Durston, Antony J.] Leiden Univ, Inst Biol, Leiden, Netherlands	Leiden University; Leiden University - Excl LUMC	Durston, AJ (corresponding author), Leiden Univ, Inst Biol, Leiden, Netherlands.	a.j.durston@gmail.com	Spaink, Herman P./S-3586-2017; Zhu, Kongju/GNM-6714-2022	Spaink, Herman P./0000-0003-4128-9501; Zhu, Kongju/0000-0002-9720-8128				Alexander T, 2009, ANNU REV CELL DEV BI, V25, P431, DOI 10.1146/annurev.cellbio.042308.113423; Almirantis Y, 2013, CURR GENOMICS, V14, P279, DOI 10.2174/13892029113149990003; Carapuco M, 2005, GENE DEV, V19, P2116, DOI 10.1101/gad.338705; CARRASCO AE, 1984, CELL, V37, P409, DOI 10.1016/0092-8674(84)90371-4; Deschamps J, 2005, DEVELOPMENT, V132, P2931, DOI 10.1242/dev.01897; Deschamps J, 1999, INT J DEV BIOL, V43, P635; Duboule D, 2007, DEVELOPMENT, V134, P2549, DOI 10.1242/dev.001065; Durston AJ, 2015, SEMIN CELL DEV BIOL, V42, P86, DOI 10.1016/j.semcdb.2015.06.001; Durston AJ, 2015, SEMIN CELL DEV BIOL, V42, P66, DOI 10.1016/j.semcdb.2015.05.005; Faial T, 2015, DEVELOPMENT, V142, P2121, DOI 10.1242/dev.117838; FAIELLA A, 1994, P NATL ACAD SCI USA, V91, P5335, DOI 10.1073/pnas.91.12.5335; Gestri G, 2005, DEVELOPMENT, V132, P2401, DOI 10.1242/dev.01814; HAFEN E, 1984, NATURE, V307, P287, DOI 10.1038/307287a0; HARDING K, 1985, SCIENCE, V229, P1236, DOI 10.1126/science.3898362; Hashiguchi M, 2013, DEVELOPMENT, V140, P1970, DOI 10.1242/dev.088104; HASTY P, 1991, NATURE, V350, P243, DOI 10.1038/350243a0; Hooiveld MHW, 1999, INT J DEV BIOL, V43, P665; Howell JC, 2011, REGEN MED, V6, P743, DOI [10.2217/RME.11.90, 10.2217/rme.11.90]; Iimura T, 2007, DEV GROWTH DIFFER, V49, P265, DOI 10.1111/j.1440-169x.2007.00928.x; Iimura T, 2006, NATURE, V442, P568, DOI 10.1038/nature04838; Juan AH, 2003, DEVELOPMENT, V130, P4823, DOI 10.1242/dev.00672; Kikuta H, 2003, DEV DYNAM, V228, P433, DOI 10.1002/dvdy.10409; Kmita M, 2003, SCIENCE, V301, P331, DOI 10.1126/science.1085753; KRUMLAUF R, 1994, CELL, V78, P191, DOI 10.1016/0092-8674(94)90290-9; LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0; Lippmann ES, 2015, STEM CELL REP, V4, P632, DOI 10.1016/j.stemcr.2015.02.018; McNulty CL, 2005, DEVELOPMENT, V132, P2861, DOI 10.1242/dev.01872; Miller DFB, 2001, MECH DEVELOP, V102, P3, DOI 10.1016/S0925-4773(01)00301-X; Naguibneva I, 2006, NAT CELL BIOL, V8, P278, DOI 10.1038/ncb1373; Nakamura Y, 2016, DEVELOPMENT, V143, P1914, DOI 10.1242/dev.131664; NIEUWKOOP P, 1994, NORMAL TABLE OF XENO; Noordermeer D, 2014, ELIFE, P3; Pearson JC, 2005, NAT REV GENET, V6, P893, DOI 10.1038/nrg1726; Plaza S, 2008, P NATL ACAD SCI USA, V105, P13439, DOI 10.1073/pnas.0806106105; SCHNEUWLY S, 1987, NATURE, V325, P816, DOI 10.1038/325816a0; Shah N, 2010, NAT REV CANCER, V10, P361, DOI 10.1038/nrc2826; SMITH WC, 1993, NATURE, V361, P547, DOI 10.1038/361547a0; SMITH WC, 1992, CELL, V70, P829, DOI 10.1016/0092-8674(92)90316-5; STRUHL G, 1983, J EMBRYOL EXP MORPH, V76, P297; STRUHL G, 1985, CELL, V43, P507, DOI 10.1016/0092-8674(85)90180-1; Tschopp P, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000398; Tucker JA, 2008, DEV CELL, V14, P108, DOI 10.1016/j.devcel.2007.11.004; Vasiliauskas D, 2001, CELL, V106, P133, DOI 10.1016/S0092-8674(01)00442-1; Wacker SA, 2004, DEV BIOL, V268, P207, DOI 10.1016/j.ydbio.2003.12.022; Wacker SA, 2004, DEV BIOL, V266, P123, DOI 10.1016/j.ydbio.2003.10.011; Wellik DM, 2009, CURR TOP DEV BIOL, V88, P257, DOI 10.1016/S0070-2153(09)88009-5; Woltering JM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001396; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434; Zaghloul NA, 2007, DEV BIOL, V306, P222, DOI 10.1016/j.ydbio.2007.03.017; Zuber ME, 2003, DEVELOPMENT, V130, P5155, DOI 10.1242/dev.00723	50	14	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2017	12	4							e0175287	10.1371/journal.pone.0175287	http://dx.doi.org/10.1371/journal.pone.0175287			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0JS	28399140	Green Published, Green Submitted, gold			2022-12-27	WOS:000399949000026
J	Al Faruque, H; Kang, JH; Hwang, SR; Sung, S; Alam, MM; Sa, KH; Nam, EJ; Byun, YR; Kang, YM				Al Faruque, Hasan; Kang, Jin Hee; Hwang, Seung Rim; Sung, Shijin; Alam, Md. Mahmudul; Sa, Keum Hee; Nam, Eon Jeong; Byun, Young Ro; Kang, Young Mo			Stepwise inhibition of T cell recruitment at post-capillary venules by orally active desulfated heparins in inflammatory arthritis	PLOS ONE			English	Article							COLLAGEN-INDUCED ARTHRITIS; MOLECULAR-WEIGHT HEPARINS; INDUCIBLE GENE H3; RHEUMATOID-ARTHRITIS; ENDOTHELIAL-CELLS; NONANTICOAGULANT HEPARIN; ARRIVE GUIDELINES; ADHESION CASCADE; MIGRATION; MICE	Identification of the structure-function relationship of heparin, particularly between 2-O-, 6-O-, and N-sulfation and its anticoagulant or anti-inflammatory activities, is critical in order to evaluate the biological effects of heparin, especially in conjunction with modifications for oral formulation. In this study, we demonstrated that removal of 2-O, 6-O, or N-desulfation and their hydrophobic modifications have differential effects on the blocking of interactions between sLe(X) and P-and L-selectins, with highest inhibition by 6-O desulfation, which was consistent with their in vivo therapeutic efficacies on CIA mice. The 6-O desulfation of lower molecular weight heparin ( LMWH) retained the ability of LMWH to interfere with T cell adhesion via selectin-sLe(X) interactions. Furthermore, 6DSHbD coated on the apical surface of inflamed endothelium directly blocked the adhesive interactions of circulating T cells, which was confirmed in vivo by suppressing T cell adhesion at post-capillary venular endothelium. Thus, in series with our previous study demonstrating inhibition of transendothelial migration, oral delivery of low anticoagulant LMWH to venular endothelium of inflamed joint tissues ameliorated arthritis by the stepwise inhibition of T cell recruitment and provides a rationale for the development of modified oral heparins as innovative agents for the treatment of chronic inflammatory arthritis.	[Al Faruque, Hasan; Kang, Jin Hee; Sung, Shijin; Alam, Md. Mahmudul; Sa, Keum Hee; Nam, Eon Jeong; Kang, Young Mo] Kyungpook Natl Univ, Sch Med, Dept Internal Med, Div Rheumatol, Daegu, South Korea; [Al Faruque, Hasan; Kang, Jin Hee; Sung, Shijin; Alam, Md. Mahmudul; Sa, Keum Hee; Kang, Young Mo] Kyungpook Natl Univ, Sch Med, Dept Biochem & Cellular Biol, Daegu, South Korea; [Hwang, Seung Rim] Chosun Univ, Coll Pharm, Gwangju, South Korea; [Byun, Young Ro] Seoul Natl Univ, Coll Pharm, Res Inst Pharmaceut Sci, Seoul, South Korea	Kyungpook National University; Kyungpook National University; Chosun University; Seoul National University (SNU)	Kang, YM (corresponding author), Kyungpook Natl Univ, Sch Med, Dept Internal Med, Div Rheumatol, Daegu, South Korea.; Kang, YM (corresponding author), Kyungpook Natl Univ, Sch Med, Dept Biochem & Cellular Biol, Daegu, South Korea.	ymkang@knu.ac.kr	Alam, Mahmudul/AAX-4097-2020; Al, Faruque Md Hasan/U-9865-2019	Alam, Mahmudul/0000-0002-3464-4125; Al, Faruque Md Hasan/0000-0001-5003-7053	Basic Research Program of the National Research Foundation, Republic of Korea [NRF2014R1A1A4A01007662]; Korean Healthcare Technology RD Project [HI14C0381]	Basic Research Program of the National Research Foundation, Republic of Korea; Korean Healthcare Technology RD Project	This work was supported by the Basic Research Program of the National Research Foundation, Republic of Korea (No. NRF2014R1A1A4A01007662, http://www.nrf.re.kr) and the Korean Healthcare Technology R&D Project (Grant No. HI14C0381, https://www.htdream.kr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMED T, 1993, NEW ENGL J MED, V329, P90, DOI 10.1056/NEJM199307083290204; Ashikari-Hada S, 2004, J BIOL CHEM, V279, P12346, DOI 10.1074/jbc.M313523200; BARZU T, 1987, THROMB RES, V47, P601, DOI 10.1016/0049-3848(87)90365-3; Berkowitz SD, 2003, J THROMB HAEMOST, V1, P1914, DOI 10.1046/j.1538-7836.2003.00340.x; Buatois V, 2010, J IMMUNOL, V185, P2544, DOI 10.4049/jimmunol.1000182; Capila I, 2002, ANGEW CHEM INT EDIT, V41, P391; Chande N, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006774.pub2; Christopherson KW, 2002, J PHARMACOL EXP THER, V302, P290, DOI 10.1124/jpet.302.1.290; Dyer DP, 2016, GLYCOBIOLOGY, V26, P312, DOI 10.1093/glycob/cwv100; Firestein GS, 2003, NATURE, V423, P356, DOI 10.1038/nature01661; Friedrich M, 2006, ARCH DERMATOL RES, V297, P345, DOI 10.1007/s00403-005-0626-0; Fryer A, 1997, J PHARMACOL EXP THER, V282, P208; Hwang SR, 2012, J CONTROL RELEASE, V163, P374, DOI 10.1016/j.jconrel.2012.09.013; Jiao YY, 2002, CIRCULATION, V105, P230, DOI 10.1161/hc0202.101988; JONES DA, 1994, J CLIN INVEST, V94, P2443, DOI 10.1172/JCI117612; Kaneider NC, 2006, FEBS J, V273, P4416, DOI 10.1111/j.1742-4658.2006.05441.x; Kang JH, 2014, J CONTROL RELEASE, V183, P9, DOI 10.1016/j.jconrel.2014.03.029; Kilkenny C, 2010, BRIT J PHARMACOL, V160, P1577, DOI [10.1113/expphysiol.2010.053793, 10.1111/j.1476-5381.2010.00872.x, 10.1113/jphysiol.2010.192278]; Koenig A, 1998, J CLIN INVEST, V101, P877, DOI 10.1172/JCI1509; LEHR HA, 1993, AM J PATHOL, V143, P1055; Lever R, 2002, NAT REV DRUG DISCOV, V1, P140, DOI 10.1038/nrd724; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Luster AD, 2005, NAT IMMUNOL, V6, P1182, DOI 10.1038/ni1275; Mackay CR, 2008, NAT IMMUNOL, V9, P988, DOI 10.1038/ni.f.210; McEver RP, 1997, J CLIN INVEST, V100, P485, DOI 10.1172/JCI119556; McGrath JC, 2010, BRIT J PHARMACOL, V160, P1573, DOI 10.1111/j.1476-5381.2010.00873.x; McInnes IB, 2007, NAT REV IMMUNOL, V7, P429, DOI 10.1038/nri2094; Mueller SN, 2007, SCIENCE, V317, P670, DOI 10.1126/science.1144830; Nam EJ, 2006, ARTHRITIS RHEUM-US, V54, P2734, DOI 10.1002/art.22076; Nam EJ, 2013, ARTHRITIS RHEUM-US, V65, P1753, DOI 10.1002/art.37932; Palmer GM, 2011, NAT PROTOC, V6, P1355, DOI 10.1038/nprot.2011.349; Park JW, 2010, MOL PHARMACEUT, V7, P836, DOI 10.1021/mp900319k; Rao NV, 2010, AM J PHYSIOL-CELL PH, V299, pC97, DOI 10.1152/ajpcell.00009.2010; Sissi C, 2003, SEMIN THROMB HEMOST, V29, P661; Son SJ, 2006, J CONTROL RELEASE, V114, P143, DOI 10.1016/j.jconrel.2006.06.004; TAKAI Y, 1989, ARTHRITIS RHEUM, V32, P594, DOI 10.1002/anr.1780320513; Thanou M, 2001, J PHARM SCI, V90, P38, DOI 10.1002/1520-6017(200101)90:1<38::AID-JPS5>3.0.CO;2-3; Thourani VH, 2000, AM J PHYSIOL-HEART C, V278, pH2084, DOI 10.1152/ajpheart.2000.278.6.H2084; TRENTHAM DE, 1978, J CLIN INVEST, V62, P359, DOI 10.1172/JCI109136; Tyrrell DJ, 1999, ADV PHARMACOL, V46, P151, DOI 10.1016/S1054-3589(08)60471-8; VANNUCCHI S, 1986, BIOCHEM BIOPH RES CO, V140, P294, DOI 10.1016/0006-291X(86)91089-2; von Andrian UH, 2000, NEW ENGL J MED, V343, P1020, DOI 10.1056/NEJM200010053431407; Wang LC, 2002, J CLIN INVEST, V110, P127, DOI 10.1172/JCI200214996; Young E, 1999, THROMB RES, V96, P373, DOI 10.1016/S0049-3848(99)00125-5; Young E, 2008, THROMB RES, V122, P743, DOI 10.1016/j.thromres.2006.10.026	45	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2017	12	4							e0176110	10.1371/journal.pone.0176110	http://dx.doi.org/10.1371/journal.pone.0176110			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KH	28419144	Green Published, Green Submitted, gold			2022-12-27	WOS:000399875200075
J	Lagerstedt, L; Egea-Guerrero, JJ; Bustamante, A; Montaner, J; Rodriguez-Rodriguez, A; El Rahal, A; Turck, N; Quintana, M; Garcia-Armengol, R; Prica, CM; Andereggen, E; Rinaldi, L; Sarrafzadeh, A; Schaller, K; Sanchez, JC				Lagerstedt, Linnea; Jose Egea-Guerrero, Juan; Bustamante, Alejandro; Montaner, Joan; Rodriguez-Rodriguez, Ana; El Rahal, Amir; Turck, Natacha; Quintana, Manuel; Garcia-Armengol, Roser; Melinda Prica, Carmen; Andereggen, Elisabeth; Rinaldi, Lara; Sarrafzadeh, Asita; Schaller, Karl; Sanchez, Jean-Charles			H-FABP: A new biomarker to differentiate between CT-positive and CT-negative patients with mild traumatic brain injury	PLOS ONE			English	Article							ACID-BINDING PROTEIN; INTRACRANIAL LESIONS; COMPUTED-TOMOGRAPHY; SERUM-LEVELS; AGE; MARKER; S100B; MANAGEMENT; S100-BETA	The majority of patients with mild traumatic brain injury (mTBI) will have normal Glasgow coma scale (GCS) of 15. Furthermore, only 5%-8% of them will be CT-positive for an mTBI. Having a useful biomarker would help clinicians evaluate a patient's risk of developing intracranial lesions. The S100B protein is currently the most studied and promising biomarker for this purpose. Heart fatty-acid binding protein (H-FABP) has been highlighted in brain injury models and investigated as a biomarker for stroke and severe TBI, for example. Here, we evaluate the performances of S100B and H-FABP for differentiating between CT-positive and CT-negative patients. A total of 261 patients with a GCS score of 15 and at least one clinical symptom of mTBI were recruited at three different European sites. Blood samples from 172 of them were collected <= 6 h after trauma. Patients underwent a CT scan and were dichotomised into CT-positive and CT-negative groups for statistical analyses. H-FABP and S100B levels were measured using commercial kits, and their capacities to detect all CT-positive scans were evaluated, with sensitivity set to 100%. For patients recruited <= 6 h after trauma, the CT-positive group demonstrated significantly higher levels of both H-FABP (p = 0.004) and S100B (p = 0.003) than the CT-negative group. At 100% sensitivity, specificity reached 6% (95% CI 2.8-10.7) for S100B and 29% (95% CI 21.4-37.1) for H-FABP. Similar results were obtained when including all the patients recruited, i.e. hospital arrival within 24 h of trauma onset. H-FABP out-performed S100B and thus seems to be an interesting protein for detecting all CT-positive mTBI patients with a GCS score of 15 and at least one clinical symptom.	[Lagerstedt, Linnea; Turck, Natacha; Sanchez, Jean-Charles] Univ Geneva, Dept Human Prot Sci, Fac Med, Geneva, Switzerland; [Jose Egea-Guerrero, Juan; Rodriguez-Rodriguez, Ana] Virgen del Rocio Univ Hosp, NeuroCrit Care Unit, Seville, Spain; [Bustamante, Alejandro; Montaner, Joan] Univ Autonoma Barcelona, VHIR, Neurovasc Res Lab, Barcelona, Spain; [El Rahal, Amir; Schaller, Karl] Geneva Univ Hosp, Div Neurosurg, Dept Clin Neurosci, Geneva Neurosci Ctr, Geneva, Switzerland; [Quintana, Manuel] Univ Autonoma Madrid, Intens Med Unit, Hosp Univ La Paz, IdiPAZ,Dept Med, Madrid, Spain; [Garcia-Armengol, Roser] Hosp Badalona Germans Trias & Pujol, Dept Neurosurg, Neurosci Unit, Badalona, Spain; [Melinda Prica, Carmen] Hosp Tortosa Verge Cinta, Emergency Dept, Tortosa, Spain; [Andereggen, Elisabeth; Rinaldi, Lara] Geneva Univ Hosp, Emergency Ctr, Geneva, Switzerland; [Andereggen, Elisabeth] Geneva Univ Hosp, Dept Surg, Geneva, Switzerland; [Sarrafzadeh, Asita] Univ Hosp Heidelberg, Dept Neurosurg, Heidelberg, Germany	University of Geneva; Virgen del Rocio University Hospital; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); University of Geneva; Autonomous University of Madrid; Hospital Universitario La Paz; Hospital Germans Trias i Pujol; University of Geneva; University of Geneva; Ruprecht Karls University Heidelberg	Sanchez, JC (corresponding author), Univ Geneva, Dept Human Prot Sci, Fac Med, Geneva, Switzerland.	Jean-Charles.Sanchez@unige.ch	Montaner, Joan/D-3063-2015; IBiS, Neurovascular/P-5842-2016; Egea-Guerrero, Juan José JJ/P-5080-2014	Montaner, Joan/0000-0003-4845-2279; IBiS, Neurovascular/0000-0001-9511-0672; Egea-Guerrero, Juan José JJ/0000-0002-4166-313X; Garcia-Armengol, Roser/0000-0002-9315-0985; Lagerstedt, Linnea/0000-0002-3405-9938				Barbosa RR, 2012, J TRAUMA ACUTE CARE, V73, pS307, DOI 10.1097/TA.0b013e3182701885; Biberthaler P, 2006, SHOCK, V25, P446, DOI 10.1097/01.shk.0000209534.61058.35; Borg J, 2004, J REHABIL MED, V36, P61, DOI 10.1080/16501960410023822; Calcagnile O, 2013, SCAND J TRAUMA RESUS, V21, DOI 10.1186/1757-7241-21-52; Egea-Guerrero JJ, 2012, BRAIN INJURY, V26, P76, DOI 10.3109/02699052.2011.635360; Erenler AK, 2013, J PAK MED ASSOC, V63, P1176; Hainard A, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000459; Heidari K, 2015, BRAIN INJURY, V29, P1146, DOI [10.3109/02699052.2014.948068, 10.3109/02699052.2015.1037349]; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; Jeter CB, 2013, J NEUROTRAUM, V30, P657, DOI 10.1089/neu.2012.2439; Kawata K, 2016, NEUROSCI BIOBEHAV R, V68, P460, DOI 10.1016/j.neubiorev.2016.05.009; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [DOI 10.1097/00001199-199309000-00010, 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00009]; Lescuyer P, 2004, PROTEOMICS, V4, P2234, DOI 10.1002/pmic.200300822; Lescuyer Pierre, 2005, Mol Diagn, V9, P1, DOI 10.2165/00066982-200509010-00001; Melnick ER, 2012, JT COMM J QUAL PATIE, V38, P483, DOI 10.1016/S1553-7250(12)38064-1; Neher MD, 2014, SOUTH MED J, V107, P248, DOI 10.1097/SMJ.0000000000000086; Okonkwo DO, 2013, J NEUROTRAUM, V30, P1490, DOI 10.1089/neu.2013.2883; Papa L., 2016, JAMA NEUROL; Papa L, 2014, J NEUROTRAUM, V31, P1815, DOI 10.1089/neu.2013.3245; Papa L, 2012, ANN EMERG MED, V59, P471, DOI 10.1016/j.annemergmed.2011.08.021; Papa L, 2012, J TRAUMA ACUTE CARE, V72, P1335, DOI 10.1097/TA.0b013e3182491e3d; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Pelsers MMAL, 2005, CLIN CHEM LAB MED, V43, P802, DOI 10.1515/CCLM.2005.135; Pelsers MMAL, 2004, CLIN CHEM, V50, P1568, DOI 10.1373/clinchem.2003.030361; Pelsers MMAL, 1999, CLIN CHEM, V45, P441; Raj R, 2013, SCAND J TRAUMA RESUS, V21, DOI 10.1186/1757-7241-21-67; Salottolo K, 2014, JAMA SURG, V149, P727, DOI 10.1001/jamasurg.2014.13; Turck N, 2010, INTENS CARE MED, V36, P107, DOI 10.1007/s00134-009-1641-y; Unden J, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-50; VANENGELEN BGM, 1992, CLIN CHEM, V38, P813; Walder B, 2013, J NEUROTRAUM, V30, P1631, DOI 10.1089/neu.2012.2791; Welch RD, 2016, J NEUROTRAUMA; Welch RD, 2016, J NEUROTRAUM, V33, P203, DOI 10.1089/neu.2015.4149; Wolf H, 2015, J NEUROTRAUM, V32, P23, DOI 10.1089/neu.2013.3202; Wunderlich MT, 2005, J NEUROL, V252, P718, DOI 10.1007/s00415-005-0725-z; Zimmermann-Ivol CG, 2004, MOL CELL PROTEOMICS, V3, P66, DOI 10.1074/mcp.M300066-MCP200	36	24	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2017	12	4							e0175572	10.1371/journal.pone.0175572	http://dx.doi.org/10.1371/journal.pone.0175572			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KH	28419114	Green Published, gold, Green Submitted			2022-12-27	WOS:000399875200027
J	Chen, S; He, H; Liu, XL				Chen, Si; He, Hua; Liu, Xiaolin			Tissue expression profiles and transcriptional regulation of elongase of very long chain fatty acid 6 in bovine mammary epithelial cells	PLOS ONE			English	Article							ELEMENT-BINDING PROTEINS; GENE-EXPRESSION; PROMOTER; METABOLISM; TARGET; SP1; SREBP-1C; FIBROSIS; DISEASE; ROLES	In mammals, very long chain fatty acids (VLCFAs) perform pleiotropic roles in a wide range of biological processes, such as cell membrane formation, cell signal transduction, and endocrine regulation. Beef and milk are abundant of palmitic acid which can be further elongated into stearic acid for synthesizing VLCFAs. Elongase of very long chain fatty acid 6 (ELOVL6) is a rate-limiting enzyme for converting palmitic acid to stearic acid. Consequently, investigating the tissue expression patterns and transcriptional regulation of bovine ELOVL6 can provide new insights into improving the composition of beneficial fats in cattle and expanding the knowledge of transcriptional regulation mechanism among domestic animals. In the current study, we found that bovine ELOVL6 expressed ubiquitously. Dual-luciferase reporter assay identified that the core promoter region (-130/-41 bp) was located in the second CpG island. In addition, the deletion mutation of binding sites demonstrated that sterol regulatory element binding transcription factor 1 (SREBF1) and specific protein 1 (SP1) both were able to stimulate bovine ELOVL6 promoter activity independently, while resulting the similar effect. To confirm these findings, further RNA interference assays were executed in bovine mammary epithelial cells (BMECs). In summary, these data suggest that bovine ELOVL6 expressed ubiquitously and is activated by SREBF1 and SP1, via two binding sites present in the ELOVL6 promoter region between -130 bp to -41bp.	[Chen, Si; He, Hua; Liu, Xiaolin] Northwest A&F Univ, Coll Anim Sci & Technol, Shaanxi Key Lab Mol Biol Agr, Yangling, Shaanxi, Peoples R China; [He, Hua] Northwest A&F Univ, Coll Vet Med, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China; Northwest A&F University - China	Liu, XL (corresponding author), Northwest A&F Univ, Coll Anim Sci & Technol, Shaanxi Key Lab Mol Biol Agr, Yangling, Shaanxi, Peoples R China.	liuxiaolin@nwsuaf.edu.cn		Chen, Si/0000-0002-0435-1954	China Postdoctoral Science Foundation [2015M570856]; Shaanxi Province Postdoctoral Science Foundation [2016BSHYDZZ44]; National 12th"Five-Year"National Science and Technology Key Project [2011AA100307]; Sci-Tech Integrated Innovation Engineering Projects of Shaanxi Province [2015KTCL02-11]; Science and Technology funds from Northwest AF University [A2990215123]	China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Shaanxi Province Postdoctoral Science Foundation; National 12th"Five-Year"National Science and Technology Key Project; Sci-Tech Integrated Innovation Engineering Projects of Shaanxi Province; Science and Technology funds from Northwest AF University	This work was financially supported by the First-Class General Financial Grant from the China Postdoctoral Science Foundation (2015M570856); the First-Class General Financial Grant from the Shaanxi Province Postdoctoral Science Foundation (2016BSHYDZZ44); the National 12th"Five-Year"National Science and Technology Key Project (2011AA100307); the Sci-Tech Integrated Innovation Engineering Projects of Shaanxi Province (2015KTCL02-11); the Science and Technology funds from Northwest A&F University (A2990215123). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Si Chen and Xiaolin Liu conceived the experiments. Si Chen conducted the experiments and analyzed the results. Xiaolin Liu and Hua He contributed reagents and materials. The manuscript was written by Si Chen. All authors reviewed the manuscript. In addition, the financial disclosure was amended as follows: This work was financially supported by the Sci-Tech Integrated Innovation Engineering Projects of Shaanxi Province (2015KTCL02-11); the First-Class General Financial Grant from the China Postdoctoral Science Foundation (2015M570856); the First-Class General Financial Grant from the Shaanxi Province Postdoctoral Science Foundation (2016BSHYDZZ44); the National 12th"Five-Year"National Science and Technology Key Project (2011AA100307); the Science and Technology funds from Northwest A&F University (A2990215123). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae JS, 2016, BIOCHEM BIOPH RES CO, V478, P1060, DOI 10.1016/j.bbrc.2016.08.061; Bazinet RP, 2014, NAT REV NEUROSCI, V15, P771, DOI 10.1038/nrn3820; Bonfatti V, 2016, J DAIRY SCI, V99, P8216, DOI 10.3168/jds.2016-10953; D'Aquila T, BIOCH BIOPHYSICA ACT; Desvergne B, 2006, PHYSIOL REV, V86, P465, DOI 10.1152/physrev.00025.2005; Dowell RD, 2010, TRENDS GENET, V26, P468, DOI 10.1016/j.tig.2010.08.005; Edwards PA, 2000, BBA-MOL CELL BIOL L, V1529, P103, DOI 10.1016/S1388-1981(00)00140-2; Feng YH, 2016, ONCOL LETT, V12, P207, DOI 10.3892/ol.2016.4587; Guillou H, 2010, PROG LIPID RES, V49, P186, DOI 10.1016/j.plipres.2009.12.002; Hammad S, 2016, LIPIDS, V51, P507, DOI 10.1007/s11745-015-4113-x; Jakobsson A, 2006, PROG LIPID RES, V45, P237, DOI 10.1016/j.plipres.2006.01.004; Jeon BN, 2012, J LIPID RES, V53, P755, DOI 10.1194/jlr.M022178; Kumadaki S, 2008, BIOCHEM BIOPH RES CO, V368, P261, DOI 10.1016/j.bbrc.2008.01.075; Ladeira MM, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17060918; Laggai S, 2014, J LIPID RES, V55, P1087, DOI 10.1194/jlr.M045500; Leonard AE, 2004, PROG LIPID RES, V43, P36, DOI 10.1016/S0163-7827(03)00040-7; Li N, 2014, INT J MOL SCI, V15, P16998, DOI 10.3390/ijms150916998; Liu X, 2016, OBESITY, V24, P2261, DOI 10.1002/oby.21584; Lomakin IB, 2007, CELL, V129, P319, DOI 10.1016/j.cell.2007.03.013; Lu SY, 2010, INT J CANCER, V126, P416, DOI 10.1002/ijc.24761; Ma L, 2012, J DAIRY SCI, V95, P3743, DOI 10.3168/jds.2011-5083; Marien E, 2016, ONCOTARGET, V7, P12582, DOI 10.18632/oncotarget.7179; Matsuzaka T, 2002, J LIPID RES, V43, P911; Matsuzaka T, 2009, J MOL MED, V87, P379, DOI 10.1007/s00109-009-0449-0; Mennella I, 2015, FOOD FUNCT, V6, P204, DOI 10.1039/c4fo00697f; Moon YA, 2001, J BIOL CHEM, V276, P45358, DOI 10.1074/jbc.M108413200; Nizar NNA, 2013, J OLEO SCI, V62, P459, DOI 10.5650/jos.62.459; Ohno Y, 2010, P NATL ACAD SCI USA, V107, P18439, DOI 10.1073/pnas.1005572107; Oishi Y, 2016, CELL METABOLISM; Ordovas L, 2008, PHYSIOL GENOMICS, V34, P144, DOI 10.1152/physiolgenomics.00043.2008; Shimano H, 2001, PROG LIPID RES, V40, P439, DOI 10.1016/S0163-7827(01)00010-8; Sunaga H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3563; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Tan CY, 2015, CELL REP, V13, P2039, DOI 10.1016/j.celrep.2015.11.004; Thomsen KF, 2011, LIPIDS, V46, P669, DOI 10.1007/s11745-011-3563-z; Tu WC, 2010, PROSTAG LEUKOTR ESS, V83, P61, DOI 10.1016/j.plefa.2010.04.001; Uchida A, 2013, METHOD CELL BIOL, V116, P151, DOI 10.1016/B978-0-12-408051-5.00014-0; Valenzuela R, 2015, PROSTAG LEUKOTR ESS, V98, P7, DOI 10.1016/j.plefa.2015.04.002; Wang WP, 2015, INT J MOL SCI, V16, P16440, DOI 10.3390/ijms160716440; White UA, 2010, MOL CELL ENDOCRINOL, V318, P10, DOI 10.1016/j.mce.2009.08.023; Yao DW, 2017, J CELL PHYSIOL, V232, P635, DOI 10.1002/jcp.25469; Zhao ZD, 2016, SCI REP-UK, V6, DOI 10.1038/srep19661; Zhu JJ, 2015, INT J MOL SCI, V16, P1806, DOI 10.3390/ijms16011806	44	14	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2017	12	4							e0175777	10.1371/journal.pone.0175777	http://dx.doi.org/10.1371/journal.pone.0175777			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KD	28414811	Green Submitted, Green Published, gold			2022-12-27	WOS:000399874800054
J	Finstad, AG; Nilsen, EB; Hendrichsen, DK; Schmidt, NM				Finstad, Anders G.; Nilsen, Erlend B.; Hendrichsen, Ditte K.; Schmidt, Niels Martin			Catchment vegetation and temperature mediating trophic interactions and production in plankton communities	PLOS ONE			English	Article							FOOD-WEB STRUCTURE; ECOLOGICAL DYNAMICS; TOP-DOWN; CLIMATE; ZOOPLANKTON; PREDATION; ECOSYSTEMS; DEPENDENCE; RESPONSES; DEPOSITION	Climatic factors influence the interactions among trophic levels in an ecosystem in multiple ways. However, whereas most studies focus on single factors in isolation, mainly due to interrelation and correlation among drivers complicating interpretation and analyses, there are still only few studies on how multiple ecosystems respond to climate related factors at the same time. Here, we use a hierarchical Bayesian model with a bioenergetic predatorprey framework to study how different climatic factors affect trophic interactions and production in small Arctic lakes. Natural variation in temperature and catchment land-cover was used as a natural experiment to exemplify how interactions between and production of primary producers (phytoplankton) and grazers (zooplankton) are driven by direct (temperature) and indirect (catchment vegetation) factors, as well as the presence or absence of apex predators (fish). The results show that increased vegetation cover increased phytoplankton growth rate by mediating lake nutrient concentration. At the same time, increased temperature also increased grazing rates by zooplankton. Presence of fish increased zooplankton mortality rates, thus reducing grazing. The Arctic is currently experiencing an increase in both temperature and shrub vegetation cover due to climate change, a trend, which is likely to continue. Our results point towards a possible future general weakening of zooplankton grazing on phytoplankton and greening of arctic lakes with increasing temperatures. At the same time, the impact of the presence of an apex predator indicate considerable local variation in the response. This makes direction and strength of global change impacts difficult to forecast.	[Finstad, Anders G.] Norwegian Univ Sci & Technol, NTNU Univ Museum, Ctr Biodivers Dynam, Dept Nat Hist, Trondheim, Norway; [Finstad, Anders G.; Nilsen, Erlend B.; Hendrichsen, Ditte K.] Norwegian Inst Nat Res, Trondheim, Norway; [Schmidt, Niels Martin] Aarhus Univ, Arctic Res Ctr, Dept Biosci, Roskilde, Denmark	Norwegian University of Science & Technology (NTNU); Norwegian Institute Nature Research; Aarhus University	Finstad, AG (corresponding author), Norwegian Univ Sci & Technol, NTNU Univ Museum, Ctr Biodivers Dynam, Dept Nat Hist, Trondheim, Norway.; Finstad, AG (corresponding author), Norwegian Inst Nat Res, Trondheim, Norway.	anders.finstad@ntnu.no	Schmidt, Niels Martin/G-3843-2011; Nilsen, Erlend B./G-3134-2017; Finstad, Anders Gravbrot/H-6519-2015	Schmidt, Niels Martin/0000-0002-4166-6218; Nilsen, Erlend B./0000-0002-5119-8331; Finstad, Anders Gravbrot/0000-0003-4529-6266	INTERACT [262693]; Aarhus University at Zacken berg; Research Council of Norway; Norwegian Institute for Nature research strategic institute program on climate change	INTERACT; Aarhus University at Zacken berg; Research Council of Norway(Research Council of Norway); Norwegian Institute for Nature research strategic institute program on climate change	Funding was received from INTERACT transnational access (grant agreement 262693) and Aarhus University for logistic support at Zacken berg, the Research Council of Norway and the Norwegian Institute for Nature research strategic institute program on climate change for financial support.; We acknowledge INTERACT for transnational access (grant agreement 262693) and Aarhus University for logistic support at Zackenberg, Kirsten Christoffersen for early comments on the study design, and the Research Council of Norway and the Norwegian Institute for Nature research strategic institute program on climate change for financial support.	[Anonymous], 2014, CONSERV BIOL; Barros V, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT A: GLOBAL AND SECTORAL ASPECTS, pIX; BOTTRELL HH, 1976, NORW J ZOOL, V24, P419; Brennan G, 2015, NAT CLIM CHANGE, V5, P892, DOI 10.1038/NCLIMATE2682; Callaghan TV, 2011, AMBIO, V40, P705, DOI 10.1007/s13280-011-0179-8; Caning K, 1998, ZACKENBERG ECOLOGICA; Craig N, 2015, LIMNOL OCEANOGR; Dell AI, 2014, J ANIM ECOL, V83, P70, DOI 10.1111/1365-2656.12081; DUMONT HJ, 1975, OECOLOGIA, V19, P75, DOI 10.1007/BF00377592; Elser JJ, 2012, FRESHW BIOL; Englund G, 2011, ECOL LETT, V14, P914, DOI 10.1111/j.1461-0248.2011.01661.x; Faithfull CL, 2011, OIKOS, V120, P311, DOI 10.1111/j.1600-0706.2010.18683.x; Falkowski PG, 1998, SCIENCE, V281, P200, DOI 10.1126/science.281.5374.200; Finstad AG, 2014, ECOL LETT, V17, P36, DOI 10.1111/ele.12201; Fukami T, 2005, P ROY SOC B-BIOL SCI, V272, P2105, DOI 10.1098/rspb.2005.3277; Gilbert B, 2014, ECOL LETT, V17, P902, DOI 10.1111/ele.12307; Gilman SE, 2010, TRENDS ECOL EVOL, V25, P325, DOI 10.1016/j.tree.2010.03.002; GRABHERR G, 1994, NATURE, V369, P448, DOI 10.1038/369448a0; Hansson LA, 2013, NAT CLIM CHANGE, V3, P228, DOI 10.1038/NCLIMATE1689; Hessen DO, 2009, LIMNOL OCEANOGR, V54, P2520, DOI 10.4319/lo.2009.54.6_part_2.2520; JESPERSEN AM, 1987, ARCH HYDROBIOL, V109, P445; Karlsson J, 2009, NATURE, V460, P506, DOI 10.1038/nature08179; Knight TM, 2005, NATURE, V437, P880, DOI 10.1038/nature03962; Kvile KO, 2016, P NATL ACAD SCI USA, V113, P1841, DOI 10.1073/pnas.1525130113; Larsen S., 2011, GLOB BIOGEOCHEM CYCL, V25; Larsen S, 2011, GLOBAL CHANGE BIOL, V17, P1186, DOI 10.1111/j.1365-2486.2010.02257.x; Legagneux P, 2014, NAT CLIM CHANGE, V4, P379, DOI [10.1038/nclimate2168, 10.1038/NCLIMATE2168]; Lindholm M, 2016, FRESHWATER BIOL, V61, P340, DOI 10.1111/fwb.12712; Link WA, 2010, BAYESIAN INFERENCE WITH ECOLOGICAL APPLICATIONS, P1; Meltotte H, 1998, ZACKENBERG ECOLOGICA; Nakano S, 2001, P NATL ACAD SCI USA, V98, P166, DOI 10.1073/pnas.98.1.166; O'Connor MI, 2011, AM NAT, V178, P626, DOI 10.1086/662171; Owen-Smith N, 2011, J ANIM ECOL, V80, P731, DOI 10.1111/j.1365-2656.2011.01820.x; Peltzer DA, 2010, GLOBAL CHANGE BIOL, V16, P732, DOI 10.1111/j.1365-2486.2009.02038.x; Petchey OL, 1999, NATURE, V402, P69, DOI 10.1038/47023; Piovia-Scott J, 2011, SCIENCE, V331, P461, DOI 10.1126/science.1200282; Post, 2013, ECOLOGY CLIMATE CHAN; Post E, 2009, SCIENCE, V325, P1355, DOI 10.1126/science.1173113; R Core Team, 2013, R LANG ENV STAT COMP; Rall BC, 2012, PHILOS T R SOC B, V367, P2923, DOI 10.1098/rstb.2012.0242; Richardson AJ, 2004, SCIENCE, V305, P1609, DOI 10.1126/science.1100958; Richardson AJ, 2008, ICES J MAR SCI, V65, P279, DOI 10.1093/icesjms/fsn028; Savage VM, 2004, AM NAT, V163, P429, DOI 10.1086/381872; Schielzeth H, 2010, METHODS ECOL EVOL, V1, P103, DOI 10.1111/j.2041-210X.2010.00012.x; Schmidt IK, 2002, PLANT SOIL, V242, P93, DOI 10.1023/A:1019642007929; Schmidt N.M., 2012, BIOBASIS MANUAL CONC; Shurin JB, 2012, PHILOS T R SOC B, V367, P3008, DOI 10.1098/rstb.2012.0243; Su YS., 2015, R2JAGS USING R RUN J; Thrane JE, 2014, ECOSYSTEMS, V17, P1040, DOI 10.1007/s10021-014-9776-2; Tommervik H, 2009, FOREST ECOL MANAG, V257, P244, DOI 10.1016/j.foreco.2008.08.038; VANNI MJ, 1987, ECOL MONOGR, V57, P61, DOI 10.2307/1942639; West DC, 2016, J ANIM ECOL, V85, P671, DOI 10.1111/1365-2656.12491; Winder M, 2004, ECOLOGY, V85, P2100, DOI 10.1890/04-0151; Wissel B, 2003, LIMNOL OCEANOGR, V48, P1965, DOI 10.4319/lo.2003.48.5.1965; Xu L, 2013, NAT CLIM CHANGE, V3, P581, DOI [10.1038/nclimate1836, 10.1038/NCLIMATE1836]; Yvon-Durocher G, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002324	56	3	3	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2017	12	4							e0174904	10.1371/journal.pone.0174904	http://dx.doi.org/10.1371/journal.pone.0174904			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KD	28414736	Green Submitted, Green Published, gold			2022-12-27	WOS:000399874800010
J	Georgantzis, N; Vasileiou, E; Kotzaivazoglou, I				Georgantzis, Nikolaos; Vasileiou, Efi; Kotzaivazoglou, Iordanis			Peer norm guesses and self-reported attitudes towards performance-related pay	PLOS ONE			English	Article							JOB-SATISFACTION; PUBLIC-SECTOR; MOTIVATION; BEHAVIOR; INCENTIVES	Due to a variety of reasons, people see themselves differently from how they see others. This basic asymmetry has broad consequences. It leads people to judge themselves and their own behavior differently from how they judge others and others' behavior. This research, first, studies the perceptions and attitudes of Greek Public Sector employees towards the introduction of Performance-Related Pay (PRP) systems trying to reveal whether there is a divergence between individual attitudes and guesses on peers' attitudes. Secondly, it is investigated whether divergence between own self-reported and peer norm guesses could mediate the acceptance of the aforementioned implementation once job status has been controlled for. This study uses a unique questionnaire of 520 observations which was designed to address the questions outlined in the preceding lines. Our econometric results indicate that workers have heterogeneous attitudes and hold heterogeneous beliefs on others' expectations regarding a successful implementation of PRP. Specifically, individual perceptions are less skeptical towards PRP than are beliefs on others' attitudes. Additionally, we found that managers are significantly more optimistic than lower rank employees regarding the expected success of PRP systems in their jobs. However, they both expect their peers to be more negative than they themselves are.	[Georgantzis, Nikolaos] Univ Reading, Sch Agr Policy & Dev, Reading, Berks, England; [Georgantzis, Nikolaos; Vasileiou, Efi] Univ Jaume 1, Lab Econ Expt, Castellon de La Plana, Spain; [Georgantzis, Nikolaos; Vasileiou, Efi] Univ Jaume 1, Econ Dept, Castellon de La Plana, Spain; [Vasileiou, Efi] Univ Sheffield, Int Fac, City Coll, Thessaloniki, Greece; [Kotzaivazoglou, Iordanis] Technol Educ Inst Cent Macedonia, Serres, Greece	University of Reading; Universitat Jaume I; Universitat Jaume I	Georgantzis, N (corresponding author), Univ Reading, Sch Agr Policy & Dev, Reading, Berks, England.; Georgantzis, N (corresponding author), Univ Jaume 1, Lab Econ Expt, Castellon de La Plana, Spain.; Georgantzis, N (corresponding author), Univ Jaume 1, Econ Dept, Castellon de La Plana, Spain.	n.georgantzis@reading.ac.uk	Vasileiou, Efi/HIR-2921-2022	Vasileiou, Efi/0000-0003-0871-0237; Georgantzis, Nikolaos/0000-0002-9697-5368				AKERLOF GA, 1982, Q J ECON, V97, P543, DOI 10.2307/1885099; Ames DR, 2004, J PERS SOC PSYCHOL, V87, P340, DOI 10.1037/0022-3514.87.3.340; Baron J.N., 1999, STRATEGIC HUMAN RESO; Benabou R, 2006, AM ECON REV, V96, P1652, DOI 10.1257/aer.96.5.1652; Brown M., 2001, HUM RESOUR MANAG J, V11, P38, DOI [10.1111/j.1748-8583.2001.tb00050.x, DOI 10.1111/J.1748-8583.2001.TB00050.X]; BUEHLER R, 1994, J PERS SOC PSYCHOL, V67, P366, DOI 10.1037/0022-3514.67.3.366; Epley N, 2006, PERS SOC PSYCHOL B, V32, P641, DOI 10.1177/0146167205284007; FREEMAN RB, 1978, AM ECON REV, V68, P135; Frey BS, 2001, J ECON SURV, V15, P589, DOI 10.1111/1467-6419.00150; Herzberg F., 1964, PERS ADMIN, V27, P3; HOLMSTROM B, 1979, BELL J ECON, V10, P74, DOI 10.2307/3003320; HUMPHREY R, 1985, AM SOCIOL REV, V50, P242, DOI 10.2307/2095412; KAHN LM, 1990, IND LABOR RELAT REV, V43, pS107, DOI 10.2307/2523574; Lally P, 2011, APPETITE, V57, P623, DOI 10.1016/j.appet.2011.07.015; LeBlanc P., 1998, COMPENSATION BENEFIT, V30, P24, DOI DOI 10.1177/088636879803000104; Lucifora C, 2015, PERFORMANCE RELATED; MARSDEN D, 1994, BRIT J IND RELAT, V32, P243, DOI 10.1111/j.1467-8543.1994.tb01043.x; Maslow AH, 1943, PSYCHOL REV, V50, P370, DOI 10.1037/h0054346; Paluck EL, 2012, J PERS SOC PSYCHOL, V103, P899, DOI 10.1037/a0030015; Perry JL, 2009, PUBLIC ADMIN REV, V69, P39, DOI 10.1111/j.1540-6210.2008.01939_2.x; Pfeffer J., 2006, IND MANAG, V48, P12; Pouliakas K, 2009, SCOT J POLIT ECON, V56, P662, DOI 10.1111/j.1467-9485.2009.00502.x; Pronin E, 2008, SCIENCE, V320, P1177, DOI 10.1126/science.1154199; Reilly P, 2003, PUBLIC MONEY MANAGE, V23, P245, DOI 10.1111/1467-9302.00379; Ryan RM, 2000, AM PSYCHOL, V55, P68, DOI 10.1037/0003-066X.55.1.68; Schmidt W, 2011, EMPL RELAT, V33, P140, DOI 10.1108/01425451111096686; Susseles E. R., 2005, BENEFITS COMPENSATIO, V42, P32; Weibel A, 2010, J PUBL ADM RES THEOR, V20, P387, DOI 10.1093/jopart/mup009; Wright TA, 2002, CAN J BEHAV SCI, V34, P146, DOI 10.1037/h0087165	29	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2017	12	4							e0174724	10.1371/journal.pone.0174724	http://dx.doi.org/10.1371/journal.pone.0174724			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES9KD	28414737	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000399874800007
J	Jackson, R; Mount, S; Ye, B; Mayfield, AE; Chan, V; Boodhwani, M; Davies, RA; Haddad, H; Davis, DR				Jackson, Robyn; Mount, Seth; Ye, Bin; Mayfield, Audrey E.; Chan, Vincent; Boodhwani, Munir; Davies, Ross A.; Haddad, Haissam; Davis, Darryl R.			Isolation of human explant derived cardiac stem cells from cryopreserved heart tissue	PLOS ONE			English	Article							TRANSPLANTATION; EFFICIENT	The value of preserving high quality bio specimens for fundamental research is significant as linking cellular and molecular changes to clinical and epidemiological data has fueled many recent advances in medicine. Unfortunately, storage of traditional biospecimens is limited to fixed samples or isolated genetic material. Here, we report the effect of cryopreservation of routine myocardial biopsies on explant derived cardiac stem cell (EDC) culture outcomes. We demonstrate that immediate cryopreservation or delayed cryopreservation after suspension within cardioplegia for 12 hours did not alter EDC yields, proliferative capacity, antigenic phenotype or paracrine signature. Cryopreservation had negligible effects on the ability of EDCs to adopt a cardiac lineage, stimulate new vessel growth, attract circulating angiogenic cells and repair injured myocardium. Finally, cryopreservation did not influence the ability of EDCs to undergo genetic reprogramming into inducible pluripotent stem cells. This study establishes a means of storing cardiac samples as a retrievable live cell source for cardiac repair or disease modeling.	[Jackson, Robyn; Mount, Seth; Ye, Bin; Mayfield, Audrey E.; Chan, Vincent; Boodhwani, Munir; Davies, Ross A.; Davis, Darryl R.] Univ Ottawa, Heart Inst, Ottawa, ON, Canada; [Haddad, Haissam] Univ Saskatchewan, Saskatoon, SK, Canada	University of Ottawa; University of Ottawa Heart Institute; University of Saskatchewan	Davis, DR (corresponding author), Univ Ottawa, Heart Inst, Ottawa, ON, Canada.	ddavis@ottawaheart.ca		Davis, Darryl/0000-0001-9642-3910	Canadian Institutes of Health Research [229694]; Heart and Stroke Foundation of Canada [NA-7346]; Canadian Institutes of Health Research (Clinician Scientist Award) [MC2-121291]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Canadian Institutes of Health Research (Clinician Scientist Award)(Canadian Institutes of Health Research (CIHR))	This study was funded by the Canadian Institutes of Health Research (Operating Grant #229694) and the Heart and Stroke Foundation of Canada (NA-7346). Dr. Davis is funded by the Canadian Institutes of Health Research (Clinician Scientist Award MC2-121291). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awad M, 2014, TRANSPL P, V46, P3580, DOI 10.1016/j.transproceed.2014.05.084; Baker M, 2012, NATURE, V486, P141, DOI 10.1038/486141a; Bearzi C, 2007, P NATL ACAD SCI USA, V104, P14068, DOI 10.1073/pnas.0706760104; Davis DR, 2010, J MOL CELL CARDIOL, V49, P312, DOI 10.1016/j.yjmcc.2010.02.019; Davis DR, 2010, STEM CELLS, V28, P903, DOI 10.1002/stem.413; Eiseman E, 2000, HDB HUMAN TISSUE SOU; Fujioka T, 2004, INT J DEV BIOL, V48, P1149, DOI 10.1387/ijdb.041852tf; Jackson R, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.115.002104; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Latham N, 2013, CIRCULATION, V128, pS1; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; Makkar RR, 2012, LANCET, V379, P895, DOI 10.1016/S0140-6736(12)60195-0; Mayfield AE, 2016, STEM CELL RES THER, V7, DOI 10.1186/s13287-016-0321-4; Molgat ASD, 2014, CIRCULATION, V130, pS70, DOI 10.1161/CIRCULATIONAHA.113.007908; Ott Harald C, 2007, Nat Clin Pract Cardiovasc Med, V4 Suppl 1, pS27, DOI 10.1038/ncpcardio0771; Reubinoff BE, 2001, HUM REPROD, V16, P2187, DOI 10.1093/humrep/16.10.2187; Richards M, 2004, STEM CELLS, V22, P779, DOI 10.1634/stemcells.22-5-779; Sastry L, 2002, GENE THER, V9, P1155, DOI 10.1038/sj.gt.3301731; Smith RR, 2007, CIRCULATION, V115, P896, DOI 10.1161/CIRCULATIONAHA.106.655209; Sofrenovic T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048067; Tilokee EL, 2016, STEM CELLS; Yokomuro H, 2003, MOL CELL BIOCHEM, V242, P109, DOI 10.1023/A:1021193813856	22	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2017	12	4							e0176000	10.1371/journal.pone.0176000	http://dx.doi.org/10.1371/journal.pone.0176000			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KD	28414815	Green Published, Green Submitted, gold			2022-12-27	WOS:000399874800086
J	Diaz, MH; Desai, HP; Morrison, SS; Benitez, AJ; Wolff, BJ; Caravas, J; Read, TD; Dean, D; Winchell, JM				Diaz, Maureen H.; Desai, Heta P.; Morrison, Shatavia S.; Benitez, Alvaro J.; Wolff, Bernard J.; Caravas, Jason; Read, Timothy D.; Dean, Deborah; Winchell, Jonas M.			Comprehensive bioinformatics analysis of Mycoplasma pneumoniae genomes to investigate underlying population structure and type-specific determinants	PLOS ONE			English	Article							TANDEM-REPEAT ANALYSIS; REAL-TIME PCR; MACROLIDE RESISTANCE; PHYLOGENETIC ANALYSIS; RESPIRATORY ILLNESS; SEQUENCE; OUTBREAK; GENE; STRAINS; EPIDEMIOLOGY	Mycoplasma pneumoniae is a significant cause of respiratory illness worldwide. Despite a minimal and highly conserved genome, genetic diversity within the species may impact disease. We performed whole genome sequencing (WGS) analysis of 107 M. pneumoniae isolates, including 67 newly sequenced using the Pacific BioSciences RS II and/or Illumina MiSeq sequencing platforms. Comparative genomic analysis of 107 genomes revealed > 3,000 single nucleotide polymorphisms (SNPs) in total, including 520 type-specific SNPs. Population structure analysis supported the existence of six distinct subgroups, three within each type. We developed a predictive model to classify an isolate based on whole genome SNPs called against the reference genome into the identified subtypes, obviating the need for genome assembly. This study is the most comprehensive WGS analysis for M. pneumoniae to date, underscoring the power of combining complementary sequencing technologies to overcome difficult-to-sequence regions and highlighting potential differential genomic signatures in M. pneumoniae.	[Diaz, Maureen H.; Desai, Heta P.; Morrison, Shatavia S.; Benitez, Alvaro J.; Wolff, Bernard J.; Caravas, Jason; Winchell, Jonas M.] Ctr Dis Control & Prevent, Resp Dis Branch, Div Bacterial Dis, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA; [Read, Timothy D.] Emory Univ, Sch Med, Dept Med, Div Infect Dis, Atlanta, GA USA; [Dean, Deborah] Univ Calif San Francisco, Benioff Childrens Hosp, Oakland Res Inst, Ctr Immunobiol & Vaccine Res, Oakland, CA USA; [Dean, Deborah] Univ Calif San Francisco, Joint Grad Program Bioengn, Oakland, CA USA; [Dean, Deborah] Univ Calif Berkeley, Oakland, CA USA	Centers for Disease Control & Prevention - USA; Emory University; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; University of California System; University of California San Francisco; University of California System; University of California Berkeley	Winchell, JM (corresponding author), Ctr Dis Control & Prevent, Resp Dis Branch, Div Bacterial Dis, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA.	zdx2@cdc.gov	Diaz, Maureen/AAM-4587-2020	Read, Timothy/0000-0001-8966-9680	Office of Advanced Molecular Detection (CDC); Public Health Service grant from the National Institutes of Health [R01 A1098843-01]	Office of Advanced Molecular Detection (CDC); Public Health Service grant from the National Institutes of Health	This study was supported, in part, by funds made available through the Office of Advanced Molecular Detection (CDC) and Public Health Service grant from the National Institutes of Health R01 A1098843-01 (to DD and TDR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alikhan NF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-402; Atkinson TP, 2008, FEMS MICROBIOL REV, V32, P956, DOI 10.1111/j.1574-6976.2008.00129.x; Benitez AJ, 2012, J CLIN MICROBIOL, V50, P3620, DOI 10.1128/JCM.01755-12; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Brown RJ, 2015, J CLIN MICROBIOL, V53, P3195, DOI 10.1128/JCM.01301-15; Chalker VJ, 2012, EURO SURVEILL, V17; Cheng L, 2013, MOL BIOL EVOL, V30, P1224, DOI 10.1093/molbev/mst028; Chin CS, 2013, NAT METHODS, V10, P563, DOI [10.1038/NMETH.2474, 10.1038/nmeth.2474]; Cousin-Allery A, 2000, EPIDEMIOL INFECT, V124, P103, DOI 10.1017/S0950268899003313; Croucher NJ, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gku1196; DALLO SF, 1990, INFECT IMMUN, V58, P2017, DOI 10.1128/IAI.58.6.2017-2020.1990; Dandekar T, 2000, NUCLEIC ACIDS RES, V28, P3278, DOI 10.1093/nar/28.17.3278; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Degrange S, 2009, J CLIN MICROBIOL, V47, P914, DOI 10.1128/JCM.01935-08; Diaz MH, 2015, OPEN FORUM INFECT DI, V2, DOI 10.1093/ofid/ofv106; Diaz MH, 2015, J CLIN MICROBIOL, V53, P124, DOI 10.1128/JCM.02597-14; Dumke R, 2010, EPIDEMIOL INFECT, V138, P1829, DOI 10.1017/S0950268810000622; Dumke R, 2006, J CLIN MICROBIOL, V44, P2567, DOI 10.1128/JCM.00495-06; Dumke R, 2011, J MICROBIOL METH, V86, P393, DOI 10.1016/j.mimet.2011.06.008; Fouts DE, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks757; Gladman SS, 2012, VELVETOPTIMISER A MU; Guell M, 2009, SCIENCE, V326, P1268, DOI 10.1126/science.1176951; Hasan NA, 2010, P NATL ACAD SCI USA, V107, P21134, DOI 10.1073/pnas.1013825107; Hastings DL, 2015, MMWR-MORBID MORTAL W, V64, P296; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; INAMINE JM, 1990, J BACTERIOL, V172, P504, DOI 10.1128/JB.172.1.504-506.1990; Jones P, 2014, BIOINFORMATICS, V30, P1236, DOI 10.1093/bioinformatics/btu031; Kenri T, 2012, J MED MICROBIOL, V61, P1633, DOI 10.1099/jmm.0.046441-0; Kenri T, 2012, J BACTERIOL, V194, P1253, DOI 10.1128/JB.06553-11; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Liu W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035698; Liu Y, 2012, J CLIN MICROBIOL, V50, P2793, DOI 10.1128/JCM.00678-12; Lluch-Senar M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137354; Martin M, 2011, CUTADAPT REMOVES ADA, V17; Musatovova O, 2008, INFECT IMMUN, V76, P1639, DOI 10.1128/IAI.01621-07; Musatovova O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047625; Narita M, 2010, J INFECT CHEMOTHER, V16, P162, DOI 10.1007/s10156-010-0044-x; Newell L, 2012, MMWR-MORBID MORTAL W, V61; Newell Leann, 2012, Morbidity and Mortality Weekly Report, V61, P834; Olson D, 2015, PEDIATRICS, V136, pE386, DOI 10.1542/peds.2015-0278; Pereyre S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038585; R Core Team, 2021, R LANGUAGE ENV STAT; Rambaut A, FIGTREE VERSION 1 4; Ranwez V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022594; Rocha EPC, 2006, J THEOR BIOL, V239, P226, DOI 10.1016/j.jtbi.2005.08.037; Schwartz SB, 2009, J CLIN MICROBIOL, V47, P4117, DOI 10.1128/JCM.01696-09; Sievers F, 2011, CLUSTAL OMEGA; Simmons WL, 2013, MICROBIOL-SGM, V159, P737, DOI 10.1099/mic.0.064782-0; Simon A., 2010, FASTQC A QUALITY CON; Smith LG, 2010, INFECT DIS CLIN N AM, V24, P57, DOI 10.1016/j.idc.2009.10.006; Spuesens EBM, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01701; Spuesens EBM, 2010, J MICROBIOL METH, V82, P214, DOI 10.1016/j.mimet.2010.06.004; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Steffens I, 2012, MYCOPLASMA PNEUMONIA; SU CJ, 1990, J CLIN MICROBIOL, V28, P1538, DOI 10.1128/JCM.28.7.1538-1540.1990; SU CJ, 1990, INFECT IMMUN, V58, P2669, DOI 10.1128/IAI.58.8.2669-2674.1990; Sun HM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064607; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Touati A, 2015, J CLIN MICROBIOL, V53, P3182, DOI 10.1128/JCM.01156-15; TULLY JG, 1979, J INFECT DIS, V139, P478, DOI 10.1093/infdis/139.4.478; Waites KB, 2004, CLIN MICROBIOL REV, V17, P697, DOI 10.1128/CMR.17.4.697-728.2004; Waites Ken B, 2009, Curr Infect Dis Rep, V11, P198, DOI 10.1007/s11908-009-0030-6; Waller JL, 2014, J CLIN MICROBIOL, V52, P849, DOI 10.1128/JCM.02810-13; Walter ND, 2008, J INFECT DIS, V198, P1365, DOI 10.1086/592281; Watkins LK, 2017, PEDIAT INFECT DIS J; Winchell JM, 2008, J CLIN MICROBIOL, V46, P3116, DOI 10.1128/JCM.00440-08; Winchell JM, 2013, CURR PEDIATR REV, V9, P324, DOI 10.2174/15733963113099990009; Wolff BJ, 2008, ANTIMICROB AGENTS CH, V52, P3542, DOI 10.1128/AAC.00582-08; Wolff BJ, 2016, DIAGN MICROBIOL INFE; Xiao L, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1801-0; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhao F, 2013, J CLIN MICROBIOL, V51, P636, DOI 10.1128/JCM.02567-12; Zhao F, 2011, J CLIN MICROBIOL, V49, P3000, DOI 10.1128/JCM.00105-11	75	20	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2017	12	4							e0174701	10.1371/journal.pone.0174701	http://dx.doi.org/10.1371/journal.pone.0174701			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0MD	28410368	Green Published, Green Submitted, gold			2022-12-27	WOS:000399955600007
J	Hori, S; Miyake, M; Tatsumi, Y; Onishi, S; Morizawa, Y; Nakai, Y; Tanaka, N; Fujimoto, K				Hori, Shunta; Miyake, Makito; Tatsumi, Yoshihiro; Onishi, Sayuri; Morizawa, Yosuke; Nakai, Yasushi; Tanaka, Nobumichi; Fujimoto, Kiyohide			Topical and systemic immunoreaction triggered by intravesical chemotherapy in an N-butyl-N-(4-hydroxybutyl) nitorosamine induced bladder cancer mouse model	PLOS ONE			English	Article							BACILLUS-CALMETTE-GUERIN; REGULATORY T-CELLS; SUPPRESSOR-CELLS; TUMOR-IMMUNITY; CARCINOMA; THERAPY; GROWTH; IMMUNOTHERAPY; SURVIVAL; GEMCITABINE	Intravesical bacillus Calmette-Guerin (BCG) treatment is the most common therapy to prevent progression and recurrence of non-muscle invasive bladder cancer (NMIBC). Although the immunoreaction elicited by BCG treatment is well documented, those induced by intravesical treatment with chemotherapeutic agents are much less known. We investigated the immunological profiles caused by mitomycin C, gemcitabine, adriamycin and docetaxel in the N-butylN-( 4-hydroxybutyl) nitrosamine (BBN)-induced orthotopic bladder cancer mouse model. Ninety mice bearing orthotopic bladder cancer induced by BBN were randomly divided into six groups and treated with chemotherapeutic agents once a week for four weeks. After last treatment, bladder and serum samples were analyzed for cell surface and immunological markers (CD4, CD8, CD56, CD204, Foxp3, and PD-L1) using immunohistochemistry staining. Serum and urine cytokine levels were evaluated by ELISA. All chemotherapeutic agents presented antitumor properties similar to those of BCG. These included changes in immune cells that resulted in fewer M2 macrophages and regulatory T cells around tumors. This result was compatible with those in human samples. Intravesical chemotherapy also induced systemic changes in cytokines, especially urinary interleukin (IL)-17A and granulocyte colony stimulating factor (G-CSF), as well as in the distribution of blood neutrophils, lymphocytes, and monocytes. Our findings suggest that intravesical treatment with mitomycin C and adriamycin suppresses protumoral immunity while enhancing anti-tumor immunity, possibly through the action of specific cytokines. A better understanding of the immunoreaction induced by chemotherapeutic agents can lead to improved outcomes and fewer side effects in intravesical chemotherapy against NMIBC.	[Hori, Shunta; Miyake, Makito; Tatsumi, Yoshihiro; Onishi, Sayuri; Morizawa, Yosuke; Nakai, Yasushi; Tanaka, Nobumichi; Fujimoto, Kiyohide] Nara Med Univ, Dept Urol, Nara, Japan	Nara Medical University	Fujimoto, K (corresponding author), Nara Med Univ, Dept Urol, Nara, Japan.	kiyokun@naramed-u.ac.ip	Morizawa, Yosuke/AAJ-3343-2021		JSPS KAKENHI [15K10605]; Nara Medical University; Fiscal Years	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Nara Medical University; Fiscal Years	This work was supported by JSPS KAKENHI grant number 15K10605 (KF) and Fiscal Years 2015-2016 Nara Medical University Grant-in Aid for Collaborative Research Projects (KF and MM).	Alizadeh D, 2014, CANCER RES, V74, P104, DOI 10.1158/0008-5472.CAN-13-1545; Askeland EJ, 2012, ADV UROL, V2012, DOI 10.1155/2012/181987; Babjuk M, 2013, EUR UROL, V64, P639, DOI 10.1016/j.eururo.2013.06.003; Bandyopadhyay A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010365; Barlow LJ, 2013, J UROLOGY, V189, P834, DOI 10.1016/j.juro.2012.10.068; BECICH MJ, 1991, J UROLOGY, V145, P1316, DOI 10.1016/S0022-5347(17)38622-6; Bevers RFM, 2004, BRIT J CANCER, V91, P607, DOI 10.1038/sj.bjc.6602026; Beyer M, 2006, BLOOD, V108, P804, DOI 10.1182/blood-2006-02-002774; BOHLE A, 1990, J UROLOGY, V144, P53, DOI 10.1016/S0022-5347(17)39365-5; Clark PE, 2013, J NATL COMPR CANC NE, V11, P446, DOI 10.6004/jnccn.2013.0059; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Hayata K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053131; Hendricksen K, 2007, CURR OPIN UROL, V17, P352, DOI 10.1097/MOU.0b013e3281c55f2b; Herr HW, 2008, J UROLOGY, V179, P53, DOI 10.1016/j.juro.2007.08.122; Herr HW, 2012, J UROLOGY, V187, P435, DOI 10.1016/j.juro.2011.10.032; Hirahara N, 2001, ONCOLOGY-BASEL, V61, P79, DOI 10.1159/000055357; Kan S, 2012, ANTICANCER RES, V32, P5363; Kikuchi E, 2009, INT J UROL, V16, P279, DOI 10.1111/j.1442-2042.2008.02235.x; Kitamura Hiroshi, 2011, Cancers (Basel), V3, P3055, DOI 10.3390/cancers3033055; Kolls JK, 2004, IMMUNITY, V21, P467, DOI 10.1016/j.immuni.2004.08.018; Kryczek I, 2009, BLOOD, V114, P357, DOI 10.1182/blood-2008-09-177360; Li JY, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/286170; Loskog A, 2007, J UROLOGY, V177, P353, DOI 10.1016/j.juro.2006.08.078; Ludwig AT, 2004, CANCER RES, V64, P3386, DOI 10.1158/0008-5472.CAN-04-0374; Matsushima M, 2011, ONCOL LETT, V2, P13, DOI 10.3892/ol.2010.217; Mattarollo SR, 2011, CANCER RES, V71, P4809, DOI 10.1158/0008-5472.CAN-11-0753; Miyake M, 2010, UROL INT, V85, P355, DOI 10.1159/000317785; Nakamura R, 2009, EUR J CANCER, V45, P2123, DOI 10.1016/j.ejca.2009.03.024; Nam JS, 2008, CANCER RES, V68, P3915, DOI 10.1158/0008-5472.CAN-08-0206; Nepple Kenneth G, 2009, Can Urol Assoc J, V3, pS188; Numasaki M, 2005, J IMMUNOL, V175, P6177, DOI 10.4049/jimmunol.175.9.6177; Obeid M, 2007, NAT MED, V13, P54, DOI 10.1038/nm1523; Peyromaure M, 2003, J UROLOGY, V169, P2110, DOI 10.1097/01.ju.0000066840.42991.4a; Ramakrishnan R, 2010, J CLIN INVEST, V120, P1111, DOI 10.1172/JCI40269; Saban MR, 2007, BMC IMMUNOL, V8, DOI 10.1186/1471-2172-8-6; Saint F, 2003, INT J CANCER, V107, P434, DOI 10.1002/ijc.11352; Sakaguchi S, 2001, IMMUNOL REV, V182, P18, DOI 10.1034/j.1600-065X.2001.1820102.x; Shahin O, 2003, J UROLOGY, V169, P96, DOI 10.1016/S0022-5347(05)64044-X; Shevchenko I, 2013, INT J CANCER, V133, P98, DOI 10.1002/ijc.27990; Shintani Y, 2007, INT J UROL, V14, P140, DOI 10.1111/j.1442-2042.2007.01696.x; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Simons MP, 2007, IMMUNOL RES, V39, P79, DOI 10.1007/s12026-007-0084-1; Svatek RS, 2015, CLIN CANCER RES, V21, P303, DOI 10.1158/1078-0432.CCR-14-1781; Takahashi H, 2005, IMMUNOL LETT, V98, P189, DOI 10.1016/j.imlet.2004.11.012; Temraz S, 2014, BMC UROL, V14, DOI 10.1186/1471-2490-14-76; Terabe M, 2004, CURR OPIN IMMUNOL, V16, P157, DOI 10.1016/j.coi.2004.01.010; Turk MJ, 2004, J EXP MED, V200, P771, DOI 10.1084/jem.20041130; Wei Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092079; Zhao Y, 2015, ONCOTARGET, V6, P39196, DOI 10.18632/oncotarget.5538; Zheng YW, 2015, CELL IMMUNOL, V294, P54, DOI 10.1016/j.cellimm.2015.02.003	50	9	9	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2017	12	4							e0175494	10.1371/journal.pone.0175494	http://dx.doi.org/10.1371/journal.pone.0175494			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0MB	28406993	Green Published, gold, Green Submitted			2022-12-27	WOS:000399955400063
J	Kang, B; Huang, XX; Wu, YF				Kang, Bin; Huang, Xiaoxia; Wu, Yunfei			Palaeolake isolation and biogeographical process of freshwater fishes in the Yellow River	PLOS ONE			English	Article							TAXONOMIC DISTINCTNESS; DIVERSITY PATTERNS; CLIMATE-CHANGE; HISTORY; CHINA; BIODIVERSITY; ASSEMBLAGES; XIZANG; ISLAND; BASIN	The Yellow River, one of the very few in the Earth, originated from many dispersive palaeo-lakes. Taking this unique advantage, we examined the roles of palaeolake isolation vs. geological processes vs. climate in determining current fish biogeographic pattern. We reviewed available data on fish species and their geographical distribution in the river, as well as palaeolake development, geological and climatic parameters. The 138 fish species recorded in the river could be divided into 8 biogeographic regions, corresponding to the distribution of palaeolakes and respective endemic species. Through variation partitioning analysis, palaeolake isolation was the most influential factor explaining 43.6% of the total variance on the current fish distribution. The Quaternary Ice Age produced a transitional distribution for fishes from the glacier to warm water, especially for the subfamily Schizothoracinae, which showed various degrees of specialisation along altitudes. We suggested that fish biogeography in the Yellow river was basically shaped by palaeolake isolation, and further carved under serials of geologic events and contemporary climate change.	[Kang, Bin] Jimei Univ, Fisheries Coll, Xiamen, Peoples R China; [Huang, Xiaoxia] Yunnan Univ, Yunnan Inst Geog, Sch Earth Sci, Kunming, Peoples R China; [Wu, Yunfei] Ocean Univ China, Fisheries Coll, Qingdao, Peoples R China	Jimei University; Yunnan University; Ocean University of China	Kang, B (corresponding author), Jimei Univ, Fisheries Coll, Xiamen, Peoples R China.	binkang@163.com			National Natural Science Foundation of China [41476149, 31560181]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (No. 41476149, No. 31560181).	Ashworth PJ, 2012, EARTH-SCI REV, V114, P84, DOI 10.1016/j.earscirev.2012.05.003; Barber CB, 1996, ACM T MATH SOFTWARE, V22, P469, DOI 10.1145/235815.235821; Bhat A, 2006, ECOGRAPHY, V29, P104, DOI 10.1111/j.2006.0906-7590.04418.x; Bhatt JP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046237; BORCARD D, 1992, ECOLOGY, V73, P1045, DOI 10.2307/1940179; Buisson L, 2008, GLOBAL CHANGE BIOL, V14, P2232, DOI 10.1111/j.1365-2486.2008.01657.x; Cai W. X., 2013, FISHES YELLOW RIVER; Cao W X, 1981, STUDIES PERIOD AMPLI, P118; Chakrabarty P, 2004, FISH FISH, V5, P97, DOI 10.1111/j.1467-2979.2004.00148.x; Chang Mee-Mann, 2000, Vertebrata Palasiatica, V38, P161; Chang MM, 2001, B CHIN ACAD SCI, V16, P39; Chen Y.Y., 1998, FAUNA SINICA OSTEICH; CHU X, 1999, FAUNA SINICA; Craddock WH, 2010, NAT GEOSCI, V3, P209, DOI 10.1038/NGEO777; Crisp MD, 2011, TRENDS ECOL EVOL, V26, P66, DOI 10.1016/j.tree.2010.11.005; Cui BS, 2009, J NAT CONSERV, V17, P129, DOI 10.1016/j.jnc.2009.01.003; Cussac V, 2004, J BIOGEOGR, V31, P103, DOI 10.1046/j.0305-0270.2003.01000.x; Dudgeon D, 2006, BIOL REV, V81, P163, DOI 10.1017/S1464793105006950; FAITH DP, 1987, VEGETATIO, V69, P57, DOI 10.1007/BF00038687; Flint R.F., 1957, GLACIAL PLEISTOCENE; Griffiths D, 2014, J BIOGEOGR, V41, P452, DOI 10.1111/jbi.12216; Hao FQ, 2005, STUDY ECOENVIRONMENT; He DK, 2006, J BIOGEOGR, V33, P1448, DOI 10.1111/j.1365-2699.2006.01510.x; Heino J, 2011, FRESHWATER BIOL, V56, P1703, DOI 10.1111/j.1365-2427.2011.02610.x; Hoagstrom CW, 2015, GLOBAL CHANGE BIOL, V21, P4, DOI 10.1111/gcb.12578; [胡小猛 Hu Xiaomeng], 2002, [地理学报, Acta Geographica Sinica], V57, P317; Hubert N, 2006, J BIOGEOGR, V33, P1414, DOI 10.1111/j.1365-2699.2006.01518.x; Jacquemin SJ, 2011, J BIOGEOGR, V38, P982, DOI 10.1111/j.1365-2699.2010.02457.x; Jijun L., 2001, QUAT SCI, V21, P381, DOI DOI 10.3321/J.ISSN:1001-7410.2001.05.001; Kang B, 2013, REV FISH BIOL FISHER, V23, P523, DOI 10.1007/s11160-013-9314-x; Kang B, 2009, REV FISH BIOL FISHER, V19, P465, DOI 10.1007/s11160-009-9114-5; Korner C, 2007, TRENDS ECOL EVOL, V22, P569, DOI 10.1016/j.tree.2007.09.006; LI JJ, 1991, QUATERNARY SCI REV, V10, P479, DOI 10.1016/0277-3791(91)90041-R; Lomolino MV, 2001, GLOBAL ECOL BIOGEOGR, V10, P3, DOI 10.1046/j.1466-822x.2001.00229.x; Lu H. Y., 2001, QUATERNARY SCI, V21, P416; McDowall RM, 1996, J BIOGEOGR, V23, P139, DOI 10.1046/j.1365-2699.1996.00960.x; MILLIMAN JD, 1983, J GEOL, V91, P1, DOI 10.1086/628741; Oberdorff T, 1999, ECOL LETT, V2, P75, DOI 10.1046/j.1461-0248.1999.t01-2-22051.x; [潘保田 Pan Baotian], 2012, [第四纪研究, Quaternary Sciences], V32, P111; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Peterson AT, 2011, J BIOGEOGR, V38, P817, DOI 10.1111/j.1365-2699.2010.02456.x; Pietz D, 2009, MANAGING YELLOW RIVE, P99; Preparata F. P., 1995, COMPUTATIONAL GEOMET; Ru HuiJun, 2010, Biodiversity Science, V18, P169, DOI 10.3724/SP.J.1003.2010.179; Shi YF, 2006, QUATERNARY GLACIAL E; Smith SA, 2005, J BIOGEOGR, V32, P1835, DOI 10.1111/j.1365-2699.2005.01317.x; Stendera S, 2012, HYDROBIOLOGIA, V696, P1, DOI 10.1007/s10750-012-1183-0; Tedesco PA, 2005, J BIOGEOGR, V32, P1899, DOI 10.1111/j.1365-2699.2005.01345.x; Tilman D, 1996, ECOLOGY, V77, P350, DOI 10.2307/2265614; Tregear T.R., 1965, A GEOGRAPHY OF CHINA; Wang JK, 1981, GUANGDONG PALAEONT C, V22, P1; Ward J.V., 1983, DYNAMICS LOTIC ECOSY, P29, DOI DOI 10.1007/S10661-006-9218-5; Warwick RM, 1998, J APPL ECOL, V35, P532, DOI 10.1046/j.1365-2664.1998.3540532.x; Whittaker RJ, 2005, DIVERS DISTRIB, V11, P3, DOI 10.1111/j.1366-9516.2005.00143.x; Wu Y, 1992, FISHES QINGHAI XIZAN; Wu Y.-F., 1991, Acta Zoologica Sinica, V37, P135; WU YF, 1980, VERTEBRAT PALASIATIC, V18, P15; [徐宗学 Xu Zongxue], 2006, [地理研究, Geographical Research], V25, P27; Yang JQ, 2012, INT J MOL SCI, V13, P1405, DOI 10.3390/ijms13021405; Yap SY, 2002, J BIOGEOGR, V29, P1187, DOI 10.1046/j.1365-2699.2002.00771.x; YRCCMWR (The Yellow River Conservancy Commission of Ministry of Water Resources), 2007, WAT RES B YELL RIV; Yu LS, 2002, CONT SHELF RES, V22, P389, DOI 10.1016/S0278-4343(01)00088-7; Yue P, 2000, FAUNA SINICA OSTEICH; [张智勇 Zhang Zhiyong], 2003, [地球科学, Earth science], V28, P621; Zhou GS, 1996, ACTA PHYTOECOLOGICA, V19, P193; Zhu S.Q., 1995, SYNOPSIS FRESHWATER; Zhu Z.Y., 1989, ACTA GEOGR SIN, V44, P429, DOI [10.11821/xb198904006, DOI 10.3321/J, DOI 10.11821/XB198904006]; 潘保田, 2007, [自然科学进展, Progress in Natural Science], V17, P1063	68	7	7	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2017	12	4							e0175665	10.1371/journal.pone.0175665	http://dx.doi.org/10.1371/journal.pone.0175665			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0MB	28406965	Green Published, gold, Green Submitted			2022-12-27	WOS:000399955400079
J	Lohse, C; Bock, A; Maiellaro, I; Hannawacker, A; Schad, LR; Lohse, MJ; Bauer, WR				Lohse, Christian; Bock, Andreas; Maiellaro, Isabella; Hannawacker, Annette; Schad, Lothar R.; Lohse, Martin J.; Bauer, Wolfgang R.			Experimental and mathematical analysis of cAMP nanodomains	PLOS ONE			English	Article							CYCLIC-NUCLEOTIDE PHOSPHODIESTERASES; CARDIAC MYOCYTES; PROTEIN-KINASE; VENTRICULAR MYOCYTES; AMP; COMPARTMENTATION; SIGNALS; MICRODOMAINS; INHIBITION; MECHANISMS	In their role as second messengers, cyclic nucleotides such as cAMP have a variety of intracellular effects. These complex tasks demand a highly organized orchestration of spatially and temporally confined cAMP action which should be best achieved by compartmentalization of the latter. A great body of evidence suggests that cAMP compartments may be established and maintained by cAMP degrading enzymes, e.g. phosphodiesterases (PDEs). However, the molecular and biophysical details of how PDEs can orchestrate cAMP gradients are entirely unclear. In this paper, using fusion proteins of cAMP FRET-sensors and PDEs in living cells, we provide direct experimental evidence that the cAMP concentration in the vicinity of an individual PDE molecule is below the detection limit of our FRET sensors (< 100nM). This cAMP gradient persists in crude cytosol preparations. We developed mathematical models based on diffusion-reaction equations which describe the creation of nanocompartments around a single PDE molecule and more complex spatial PDE arrangements. The analytically solvable equations derived here explicitly determine how the capability of a single PDE, or PDE complexes, to create a nanocompartment depend on the cAMP degradation rate, the diffusive mobility of cAMP, and geometrical and topological parameters. We apply these generic models to our experimental data and determine the diffusive mobility and degradation rate of cAMP. The results obtained for these parameters differ by far from data in literature for free soluble cAMP interacting with PDE. Hence, restricted cAMP diffusion in the vincinity of PDE is necessary to create cAMP nanocompartments in cells.	[Lohse, Christian; Bock, Andreas; Maiellaro, Isabella; Hannawacker, Annette; Lohse, Martin J.] Univ Wurzburg, Inst Pharmacol & Toxicol, Wurzburg, Germany; [Lohse, Christian; Schad, Lothar R.] Heidelberg Univ, Comp Assisted Clin Med, Heidelberg, Germany; [Lohse, Martin J.; Bauer, Wolfgang R.] Univ Wurzburg, Comprehens Heart Failure Ctr, Wurzburg, Germany; [Bauer, Wolfgang R.] Univ Hosp Wurzburg, Dept Med 1, Wurzburg, Germany	University of Wurzburg; Ruprecht Karls University Heidelberg; University of Wurzburg; University of Wurzburg	Lohse, MJ (corresponding author), Univ Wurzburg, Inst Pharmacol & Toxicol, Wurzburg, Germany.; Lohse, MJ (corresponding author), Univ Wurzburg, Comprehens Heart Failure Ctr, Wurzburg, Germany.	lohse@toxi.uni-wuerzburg.de	Lohse, Martin J/A-7160-2012	Lohse, Martin J/0000-0002-0599-3510; Bauer, Wolfgang/0000-0002-4652-7313; Bock, Andreas/0000-0002-6344-6494; Maiellaro, Isabella/0000-0001-5595-8011	Deutsche Forschungsgemeinschaft [SFB688]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft (URL: http://www.dfg.de), Grant number: SFB688.	Agarwal SR, 2016, SCI REP-UK, V6, DOI 10.1038/srep19577; BACSKAI BJ, 1993, SCIENCE, V260, P222, DOI 10.1126/science.7682336; Beavo JA, 2002, NAT REV MOL CELL BIO, V175; Bender AT, 2006, PHARMACOL REV, V58, P488, DOI 10.1124/pr.58.3.5; BETHKE T, 1992, BRIT J PHARMACOL, V107, P127, DOI 10.1111/j.1476-5381.1992.tb14474.x; Borner S, 2011, NAT PROTOC, V6, P427, DOI 10.1038/nprot.2010.198; BUXTON ILO, 1983, J BIOL CHEM, V258, P233; Cedervall P, 2015, P NATL ACAD SCI USA, V112, pE1414, DOI 10.1073/pnas.1419906112; Chen W, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.041901; Chen W, 2008, PHYS BIOL, V5, DOI 10.1088/1478-3975/5/4/046006; Conti M, 2014, J GEN PHYSIOL, V143, P29, DOI 10.1085/jgp.201311083; Cooper DMF, 2014, BIOCHEM J, V462, P199, DOI 10.1042/BJ20140560; Davies JJ, 1975, J THEOR BIOL, V53; Dodge-Kafka KL, 2005, NATURE, V437, P574, DOI 10.1038/nature03966; Feinstein WP, 2012, AM J PHYSIOL-CELL PH, V302, pC839, DOI 10.1152/ajpcell.00361.2011; Froese A, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00172; Guellich A, 2014, PFLUG ARCH EUR J PHY, V466, P1163, DOI 10.1007/s00424-014-1515-1; Herget S, 2008, CELL SIGNAL, V20, P1423, DOI 10.1016/j.cellsig.2008.03.011; Iancu RV, 2007, BIOPHYS J, V92, P3317, DOI 10.1529/biophysj.106.095356; Jurevicius J, 1996, P NATL ACAD SCI USA, V93, P295, DOI 10.1073/pnas.93.1.295; Kokkonen K, 2017, ANNU REV PHARMACOL, V57, P455, DOI 10.1146/annurev-pharmtox-010716-104756; Kuimova MK, 2009, NAT CHEM, V1, P69, DOI [10.1038/nchem.120, 10.1038/NCHEM.120]; Leroy J, 2008, CIRC RES, V102, P1091, DOI 10.1161/CIRCRESAHA.107.167817; Maiellaro I, 2016, CELL REP, V17, P1238, DOI 10.1016/j.celrep.2016.09.090; Mika D, 2012, J MOL CELL CARDIOL, V52, P323, DOI 10.1016/j.yjmcc.2011.08.016; Mongillo M, 2004, CIRC RES, V95, P67, DOI 10.1161/01.RES.0000134629.84732.11; Nikolaev VO, 2006, CIRC RES, V99, P1084, DOI 10.1161/01.RES.0000250046.69918.d5; Nikolaev VO, 2004, J BIOL CHEM, V279, P37215, DOI 10.1074/jbc.C400302200; Oliveira RF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011725; Rich TC, 2001, P NATL ACAD SCI USA, V98, P13049, DOI 10.1073/pnas.221381398; Richards M, 2016, CARDIOVASC RES, V110, P395, DOI 10.1093/cvr/cvw080; Rochais F, 2004, J BIOL CHEM, V279, P52095, DOI 10.1074/jbc.M405697200; Saucerman JJ, 2014, J GEN PHYSIOL, V143, P39, DOI 10.1085/jgp.201311044; SCHRADER J, 1976, PFLUG ARCH EUR J PHY, V367, P129, DOI 10.1007/BF00585148; Shcherbakova OG, 2007, J CELL BIOL, V176, P521, DOI 10.1083/jcb.200604167; Stangherlin A, 2012, BIOCHEM SOC T, V40, P11, DOI 10.1042/BST20110655; Tasken K, 2004, PHYSIOL REV, V84, P137, DOI 10.1152/physrev.00021.2003; Terrin A, 2006, J CELL BIOL, V175, P441, DOI 10.1083/jcb.200605050; WILSON M, 1994, BIOCHEM J, V304, P407, DOI 10.1042/bj3040407; Wong W, 2004, NAT REV MOL CELL BIO, V5, P959, DOI 10.1038/nrm1527; Xu RX, 2000, SCIENCE, V288, P1822, DOI 10.1126/science.288.5472.1822; Yang PC, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1005005; Zaccolo M, 2002, SCIENCE, V295, P1711, DOI 10.1126/science.1069982	43	33	33	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2017	12	4							e0174856	10.1371/journal.pone.0174856	http://dx.doi.org/10.1371/journal.pone.0174856			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0MB	28406920	Green Published, Green Submitted, gold			2022-12-27	WOS:000399955400018
J	Roehri, N; Pizzo, F; Bartolomei, F; Wendling, F; Benar, CG				Roehri, Nicolas; Pizzo, Francesca; Bartolomei, Fabrice; Wendling, Fabrice; Benar, Christian-George			What are the assets and weaknesses of HFO detectors? A benchmark framework based on realistic simulations	PLOS ONE			English	Article							HIGH-FREQUENCY OSCILLATIONS; HZ; MACROELECTRODES; EEG	High-frequency oscillations (HFO) have been suggested as biomarkers of epileptic tissues. While visual marking of these short and small oscillations is tedious and time-consuming, automatic HFO detectors have not yet met a large consensus. Even though detectors have been shown to perform well when validated against visual marking, the large number of false detections due to their lack of robustness hinder their clinical application. In this study, we developed a validation framework based on realistic and controlled simulations to quantify precisely the assets and weaknesses of current detectors. We constructed a dictionary of synthesized elements-HFOs and epileptic spikes-from different patients and brain areas by extracting these elements from the original data using discrete wavelet transform coefficients. These elements were then added to their corresponding simulated background activity (preserving patient- and region- specific spectra). We tested five existing detectors against this benchmark. Compared to other studies confronting detectors, we did not only ranked them according their performance but we investigated the reasons leading to these results. Our simulations, thanks to their realism and their variability, enabled us to highlight unreported issues of current detectors: (1) the lack of robust estimation of the background activity, (2) the underestimated impact of the 1/f spectrum, and (3) the inadequate criteria defining an HFO. We believe that our benchmark framework could be a valuable tool to translate HFOs into a clinical environment.	[Roehri, Nicolas; Pizzo, Francesca; Bartolomei, Fabrice; Benar, Christian-George] Aix Marseille Univ, INSERM, INS, Marseille, France; [Pizzo, Francesca; Bartolomei, Fabrice] Timone Hosp, AP HM, Clin Neurophysiol, Marseille, France; [Wendling, Fabrice] Univ Rennes 1, LTSI, INSERM, U1099, Rennes, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes	Benar, CG (corresponding author), Aix Marseille Univ, INSERM, INS, Marseille, France.	christian.benar@univ-amu.fr	WENDLING, Fabrice/P-9574-2019; Wendling, Fabrice/F-8924-2013	WENDLING, Fabrice/0000-0003-2428-9665; Roehri, Nicolas/0000-0002-6948-1055; Pizzo, Francesca/0000-0001-6345-1288	FHU EPINEXT of the A*MIDEX project - Investissements d'Avenir" French Government program [ANR-11-IDEX-0001-02]; ANR project FORCE [ANR-13TECS-0013]	FHU EPINEXT of the A*MIDEX project - Investissements d'Avenir" French Government program(French National Research Agency (ANR)); ANR project FORCE(French National Research Agency (ANR))	This work has been carried out within the FHU EPINEXT with the support of the A*MIDEX project (ANR-11-IDEX-0001-02) funded by the "Investissements d'Avenir" French Government program managed by the French National Research Agency (ANR). This study was also supported by the ANR project FORCE (ANR-13TECS-0013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work has been carried out within the FHU EPINEXT with the support of the A*MIDEX project (ANR-11-IDEX-0001-02) funded by the "Investissements d'Avenir" French Government program managed by the French National Research Agency (ANR). This study was also supported by the ANR project FORCE (ANR-13-TECS-0013).	Bagshaw AP, 2009, EPILEPSIA, V50, P617, DOI 10.1111/j.1528-1167.2008.01784.x; Birot G, 2013, J NEUROSCI METH, V213, P236, DOI 10.1016/j.jneumeth.2012.12.013; Burnos S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094381; Carmona R., 1998, PRACTICAL TIME FREQU, V9; Crepon B, 2010, BRAIN, V133, P33, DOI 10.1093/brain/awp277; de la Prida LM, 2015, J CLIN NEUROPHYSIOL, V32, P207, DOI 10.1097/WNP.0000000000000150; Gardner AB, 2007, CLIN NEUROPHYSIOL, V118, P1134, DOI 10.1016/j.clinph.2006.12.019; Holler Y, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00574; Jacobs J, 2012, PROG NEUROBIOL, V98, P302, DOI 10.1016/j.pneurobio.2012.03.001; Jrad N., 2016, IEEE T BIOMEDICAL EN, VPP, P1; Staba RJ, 2002, J NEUROPHYSIOL, V88, P1743, DOI 10.1152/jn.2002.88.4.1743; Urrestarazu E, 2007, BRAIN, V130, P2354, DOI 10.1093/brain/awm149; Worrell GA, 2012, PROG NEUROBIOL, V98, P265, DOI 10.1016/j.pneurobio.2012.02.006; Zelmann R, 2012, CLIN NEUROPHYSIOL, V123, P106, DOI [10.1016/j.clinph.2011.06.006, 10.1016/j.clinph.2011.02.022]	14	39	39	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2017	12	4							e0174702	10.1371/journal.pone.0174702	http://dx.doi.org/10.1371/journal.pone.0174702			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0MB	28406919	Green Published, gold, Green Submitted			2022-12-27	WOS:000399955400013
J	Yoshinaga, T; Nishimata, H; Kajiya, Y; Yokoyama, S				Yoshinaga, Takuma; Nishimata, Hiroto; Kajiya, Yoriko; Yokoyama, Shunichi			Combined assessment of serum folate and hemoglobin as biomarkers of brain amyloid beta accumulation	PLOS ONE			English	Article							ALZHEIMERS ASSOCIATION WORKGROUPS; MILD COGNITIVE IMPAIRMENT; PITTSBURGH COMPOUND-B; APOLIPOPROTEIN-E; FOLIC-ACID; DIAGNOSTIC GUIDELINES; NATIONAL INSTITUTE; DISEASE; NEURONS; RECOMMENDATIONS	A relationship between Alzheimer's disease (AD) and folate has been reported. Amyloid positron emission tomography (PET) is currently one of the most reliable biomarkers for AD. We investigated the correlation between serum folate levels and amyloid imaging to clarify whether serum folate could be a biomarker for AD. We also examined the usefulness of a combined assessment of serum folate levels and red blood cell hemoglobin content. Apolipoprotein E (APOE) gene polymorphisms were also assessed. Serum folate levels and hemoglobin content were evaluated by receiver operating characteristic analysis for their diagnostic capability as AD biomarkers relating to brain amyloid beta accumulation. The area under the ROC curve (AUC) for serum folate was 0.136 (95% confidence interval [Cl]: 0.000-0.312; p = 0.016). The AUC for hemoglobin content was 0.848 (95% CI: 0.661-1.000; p = 0.021). Therefore, the folate deficiency with low folate levels or the non- anaemia with high hemoglobin content levels were found to have a high probability of also testing positive for amyloid. Furthermore, eight patients were found to be folate deficiency and nonanaemia, those who were consist of 7 amyloid positive patients (87.5%), and only one of the amyloid negative patients (12.5%). These results suggest that a deficiency of serum folate and high hemoglobin levels may reflect an increased risk of amyloid beta accumulation in the brain. Additionally, we demonstrated that these biomarkers could enhance the effectiveness of APOE as an AD biomarker. This study reveals that the combined assessment of serum folate levels and red blood cell hemoglobin content may be a useful biomarker for amyloid beta accumulation in the brain. We also found that the combination of serum folate levels and hemoglobin content is a more specific and sensitive blood biomarker for AD than APOE or folate alone. These findings may be used to support clinical diagnosis of AD using a simple blood test.	[Yoshinaga, Takuma] Nanpuh Hosp, Div Clin Applicat, Kagoshima, Japan; [Nishimata, Hiroto] Nanpuh Hosp, Gastroenterol, Kagoshima, Japan; [Kajiya, Yoriko] Nanpuh Hosp, Radiol, Kagoshima, Japan; [Yokoyama, Shunichi] Nanpuh Hosp, Neurosurg, Kagoshima, Japan		Yoshinaga, T (corresponding author), Nanpuh Hosp, Div Clin Applicat, Kagoshima, Japan.	t-yoshinaga@nanpuh.or.jp			Division of Radiological Technology; Clinical Laboratory of Nanpuh Hospital	Division of Radiological Technology; Clinical Laboratory of Nanpuh Hospital	We appreciate the support by the Division of Radiological Technology and the Clinical Laboratory of Nanpuh Hospital.	Albert MS, 2011, ALZHEIMERS DEMENT, V7, P270, DOI 10.1016/j.jalz.2011.03.008; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; [Anonymous], 2012, SERUM RED BLOOD CELL; Bie BH, 2014, NAT NEUROSCI, V17, P223, DOI 10.1038/nn.3618; Chuang JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033120; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Dlugaj M, 2016, J ALZHEIMERS DIS, V49, P1031, DOI 10.3233/JAD-150434; Guo X, 2011, NEUROSCIENCE, V194, P272, DOI 10.1016/j.neuroscience.2011.07.012; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Heyward FD, 2015, NEUROSCIENTIST, V21, P475, DOI 10.1177/1073858415579635; Higuchi M., 1999, MOL DIAGN THER, V11, P411; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; Klunk WE, 2004, ANN NEUROL, V55, P306, DOI 10.1002/ana.20009; Kruman II, 2002, J NEUROSCI, V22, P1752, DOI 10.1523/JNEUROSCI.22-05-01752.2002; Li W, 2015, INT J MOL SCI, V16, P25002, DOI 10.3390/ijms161025002; LOO DT, 1993, P NATL ACAD SCI USA, V90, P7951, DOI 10.1073/pnas.90.17.7951; MARK RJ, 1995, J NEUROSCI, V15, P6239; Mark RJ, 1997, J NEUROSCI, V17, P1046; Mattson MP, 2000, NAT REV MOL CELL BIO, V1, P120, DOI 10.1038/35040009; Mattson MP, 1997, PHYSIOL REV, V77, P1081, DOI 10.1152/physrev.1997.77.4.1081; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; McNamee RL, 2009, J NUCL MED, V50, P348, DOI 10.2967/jnumed.108.057612; O'Donnell HC, 2000, NEW ENGL J MED, V342, P240, DOI 10.1056/NEJM200001273420403; Petersen RC, 1999, ARCH NEUROL-CHICAGO, V56, P303, DOI 10.1001/archneur.56.3.303; Reiman EM, 1996, NEW ENGL J MED, V334, P752, DOI 10.1056/NEJM199603213341202; Shimada H, 2011, J GERIATR PSYCH NEUR, V24, P123, DOI 10.1177/0891988711409410; Small DH, 1999, J NEUROCHEM, V73, P443, DOI 10.1046/j.1471-4159.1999.0730443.x; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P280, DOI 10.1016/j.jalz.2011.03.003; The Ronald and Nancy Reagan Research Institute of the Alzheimer's Association and National Institute on Aging Working Group, 1998, NEUROBIOL AGING, V19, P109; Tian T, 2016, NUTRIENTS, V8, DOI 10.3390/nu8090556; World Health Organization (WHO), 2011, HEM CONC DIAGN AN AS	31	7	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2017	12	4							e0175854	10.1371/journal.pone.0175854	http://dx.doi.org/10.1371/journal.pone.0175854			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0MB	28406978	Green Published, Green Submitted, gold			2022-12-27	WOS:000399955400103
J	Betancor, MB; Li, KS; Sprague, M; Bardal, T; Sayanova, O; Usher, S; Han, L; Masoval, K; Torrissen, O; Napier, JA; Tocher, DR; Olsen, RE				Betancor, Monica B.; Li, Keshuai; Sprague, Matthew; Bardal, Tora; Sayanova, Olga; Usher, Sarah; Han, Lihua; Masoval, Kjell; Torrissen, Ole; Napier, Johnathan A.; Tocher, Douglas R.; Olsen, Rolf Erik			An oil containing EPA and DHA from transgenic Camelina sativa to replace marine fish oil in feeds for Atlantic salmon (Salmo salar L.): Effects on intestinal transcriptome, histology, tissue fatty acid profiles and plasma biochemistry	PLOS ONE			English	Article							SOLE SOLEA-SENEGALENSIS; GROWTH-PERFORMANCE; VEGETABLE-OILS; INTERMEDIARY METABOLISM; EICOSAPENTAENOIC ACID; GLYCOGEN-SYNTHESIS; DIGESTIVE ENZYMES; LIPID-METABOLISM; PLANT OILS; HIGH-LEVEL	New de novo sources of omega 3 (n-3) long chain polyunsaturated fatty acids (LC-PUFA) are required as alternatives to fish oil in aquafeeds in order to maintain adequate levels of the beneficial fatty acids, eicosapentaenoic and docosahexaenoic (EPA and DHA, respectively). The present study investigated the use of an EPA+DHA oil derived from transgenic Camelina sativa in Atlantic salmon (Salmo salar) feeds containing low levels of fishmeal (35%) and fish oil (10%), reflecting current commercial formulations, to determine the impacts on tissue fatty acid profile, intestinal transcriptome, and health of farmed salmon. Post-smolt Atlantic salmon were fed for 12-weeks with one of three experimental diets containing either a blend of fish oil/rapeseed oil (FO), wild-type camelina oil (WCO) or transgenic camelina oil (DCO) as added lipid source. The DCO diet did not affect any of the fish performance or health parameters studied. Analyses of the mid and hindgut transcriptomes showed only mild effects on metabolism. Flesh of fish fed the DCO diet accumulated almost double the amount of n-3 LC-PUFA than fish fed the FO or WCO diets, indicating that these oils from transgenic oilseeds offer the opportunity to increase the n-3 LC-PUFA in farmed fish to levels comparable to those found a decade ago.	[Betancor, Monica B.; Sprague, Matthew; Tocher, Douglas R.] Univ Stirling, Inst Aquaculture, Fac Nat Sci, Stirling, Scotland; [Li, Keshuai; Bardal, Tora; Olsen, Rolf Erik] Norwegian Univ Sci & Technol, Dept Biol, Trondheim, Norway; [Sayanova, Olga; Usher, Sarah; Han, Lihua; Napier, Johnathan A.] Rothamsted Res, Dept Biol Chem & Crop Protect, Harpenden, Herts, England; [Masoval, Kjell] Biomar AS, Trondheim, Norway; [Torrissen, Ole] Inst Marine Res, Matre, Matredal, Norway	University of Stirling; Norwegian University of Science & Technology (NTNU); UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research; Institute of Marine Research - Norway	Betancor, MB (corresponding author), Univ Stirling, Inst Aquaculture, Fac Nat Sci, Stirling, Scotland.	m.b.betancor@stir.ac.uk	Tocher, Douglas R/C-5652-2011	Tocher, Douglas R/0000-0002-8603-9410; Betancor, Monica/0000-0003-1626-7458; Napier, Johnathan/0000-0003-3580-3607; Sprague, Matthew/0000-0002-0723-2387; Olsen, Rolf Erik/0000-0002-6633-5837	Research Council of Norway-Havbruk Programme [245327]; Biotechnology and Biological Sciences Research Council [BBS/E/C/00005207, BB/N022157/1, BB/J001252/1] Funding Source: researchfish; BBSRC [BB/J001252/1, BB/N022157/1, BBS/E/C/00005207] Funding Source: UKRI	Research Council of Norway-Havbruk Programme; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This project was funded by a Research Council of Norway-Havbruk Programme Award (project no. 245327) where 2.2% of the total project cost was met by the industrial partner. The Research Council of Norway had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. KM was employed by and received salary from the commercial partner BioMar AS, and contributed to the study design and preparation of the manuscript. No additional external funding was received for this study.; This trial was supported by a Research Council of Norway-Havbruk Programme award (project no. 245327) where 2.2% of the total project cost was met by the industrial partner. One of the authors (KM) was employed by the commercial partner, BioMar AS, and contributed to the study design and preparation of the manuscript. The authors wish to thank Dr. John B. Taggart for advice and direction with the microarray analyses.	ACKMAN RG, 1978, FETT WISS TECHNOL, V80, P21, DOI 10.1002/lipi.19780800104; Ahmed AA, 2014, NUTR METAB, V11, DOI 10.1186/1743-7075-11-6; [Anonymous], 2015, AQUACULTURE, V448, P365, DOI DOI 10.1016/J.AQUACULTURE.2015.06.023; Aoac, 1997, OFFICIAL METHODS ANA, DOI DOI 10.1016/0165-9936(90)87098-7; Baeverfjord G, 1996, J FISH DIS, V19, P375, DOI 10.1111/j.1365-2761.1996.tb00376.x; Bell J.G., 2011, FISH OIL REPLACEMENT; Bell MV, 2009, LIPIDS IN AQUATIC ECOSYSTEMS, P211, DOI 10.1007/978-0-387-89366-2_9; Benedito-Palos L, 2013, BRIT J NUTR, V109, P1175, DOI 10.1017/S000711451200311X; Betancor MB, 2015, AQUACULTURE, V444, P1, DOI 10.1016/j.aquaculture.2015.03.020; Betancor MB, 2015, SCI REP-UK, V5, DOI 10.1038/srep08104; Betancor MB, 2016, LIPIDS, V51, P1171, DOI 10.1007/s11745-016-4191-4; Betancor MB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159934; Betancor MB, 2014, COMP BIOCHEM PHYS B, V172, P74, DOI 10.1016/j.cbpb.2014.04.007; Bleau H, 1996, AQUAT TOXICOL, V34, P221, DOI 10.1016/0166-445X(95)00040-B; Bonacic K, 2016, AQUACULTURE, V450, P383, DOI 10.1016/j.aquaculture.2015.07.009; Bonga SEW, 1997, PHYSIOL REV, V77, P591, DOI 10.1152/physrev.1997.77.3.591; Borges P, 2013, BRIT J NUTR, V109, P1373, DOI 10.1017/S0007114512003418; Bransden MP, 2003, COMP BIOCHEM PHYS B, V135, P611, DOI 10.1016/S1096-4959(03)00143-X; Campoy C, 2012, BRIT J NUTR, V107, pS85, DOI 10.1017/S0007114512001493; Castro C, 2016, FISH PHYSIOL BIOCHEM, V42, P203, DOI 10.1007/s10695-015-0130-1; Delgado-Lista J, 2012, BRIT J NUTR, V107, pS201, DOI 10.1017/S0007114512001596; Demissie M, 2008, BIOINFORMATICS, V24, P1168, DOI 10.1093/bioinformatics/btn100; Dentin R, 2005, J CLIN INVEST, V115, P2843, DOI 10.1172/JCI25256; Dias J, 1998, AQUAT LIVING RESOUR, V11, P219, DOI 10.1016/S0990-7440(98)89004-9; Ducasse-Cabanot S, 2007, ANIMAL, V1, P1272, DOI 10.1017/S1751731107000596; Ekmann KS, 2013, BRIT J NUTR, V109, P2135, DOI 10.1017/S000711451200445X; FAO, 2016, CONTRIBUTING FOOD SE; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fountoulaki E, 2009, AQUACULTURE, V289, P317, DOI 10.1016/j.aquaculture.2009.01.023; Ganga R, 2011, AQUACULTURE, V311, P215, DOI 10.1016/j.aquaculture.2010.11.050; Geay F, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-522; Gil A, 2012, BRIT J NUTR, V107, pS1, DOI 10.1017/S0007114512001420; GOED, 2014, GLOB REC EPA DHA INT; Harwood JL, 2009, BIOCHIMIE, V91, P679, DOI 10.1016/j.biochi.2008.11.004; Hemre GI, 2002, AQUACULT NUTR, V8, P175, DOI 10.1046/j.1365-2095.2002.00200.x; Kiron V, 2011, AQUACULT NUTR, V17, P130, DOI 10.1111/j.1365-2095.2009.00715.x; Kuda O, 2009, DIABETOLOGIA, V52, P941, DOI 10.1007/s00125-009-1305-z; Laporte J, 2012, J ANIM PHYSIOL AN N, V96, P513, DOI 10.1111/j.1439-0396.2011.01174.x; Leaver MJ, 2008, REV FISH SCI, V16, P73, DOI 10.1080/10641260802325278; McFadzen IRB, 1997, J EXP MAR BIOL ECOL, V212, P239, DOI 10.1016/S0022-0981(96)02755-4; Moldal T, 2014, BMC VET RES, V10, DOI 10.1186/1746-6148-10-60; Montero D, 2008, FISH SHELLFISH IMMUN, V24, P147, DOI 10.1016/j.fsi.2007.08.002; Mourente G, 2007, BRIT J NUTR, V98, P770, DOI 10.1017/S000711450773461X; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Oxley A, 2010, BRIT J NUTR, V103, P851, DOI 10.1017/S0007114509992467; Peng M, 2014, AQUACULTURE, V433, P442, DOI 10.1016/j.aquaculture.2014.07.005; Penn MH, 2011, AQUACULTURE, V310, P267, DOI 10.1016/j.aquaculture.2010.10.040; PEREIRA C, 1995, J COMP PHYSIOL B, V165, P62, DOI 10.1007/BF00264687; Perez-Sanchez J, 2013, COMP BIOCHEM PHYS D, V8, P123, DOI 10.1016/j.cbd.2013.02.001; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Rimoldi S, 2016, REV FISH BIOL FISHER, V26, P93, DOI 10.1007/s11160-015-9408-8; ROMBOUT JHWM, 1989, J FISH BIOL, V35, P13, DOI 10.1111/j.1095-8649.1989.tb03388.x; Rozen S, 2000, Methods Mol Biol, V132, P365; Ruiz-Lopez N, 2014, PLANT J, V77, P198, DOI 10.1111/tpj.12378; Shepherd CJ, 2017, AQUACULTURE, V467, P49, DOI 10.1016/j.aquaculture.2016.08.021; Sissener NH, AQUACULT NU IN PRESS; Sprague M, 2016, SCI REP, P21892; Tejera N, 2016, J NUTR, V146, P227, DOI 10.3945/jn.115.223941; Tocher DR, 2006, LIPIDS, V41, P1003, DOI 10.1007/s11745-006-5051-4; Tocher DR, 2015, AQUACULTURE, V449, P94, DOI 10.1016/j.aquaculture.2015.01.010; Tocher DR, 2010, AQUAC RES, V41, P717, DOI 10.1111/j.1365-2109.2008.02150.x; Tocher DR, 2002, FISH PHYSIOL BIOCHEM, V26, P157, DOI 10.1023/A:1025416731014; Torrecillas S, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00397; Torstensen B. E., 2011, FISH OIL REPLACEMENT, P405, DOI 10.1201/9781439808634-c13; Uran PA, 2008, FISH SHELLFISH IMMUN, V25, P751, DOI 10.1016/j.fsi.2008.02.013; Vagner M, 2011, AQUACULTURE, V315, P131, DOI 10.1016/j.aquaculture.2010.11.031; Viegas I, 2012, COMP BIOCHEM PHYS A, V163, P22, DOI 10.1016/j.cbpa.2012.04.023; Yilmaz HR, 2004, PROSTAG LEUKOTR ESS, V71, P131, DOI 10.1016/j.plefa.2004.03.002; Zheng XZ, 2009, COMP BIOCHEM PHYS B, V154, P255, DOI 10.1016/j.cbpb.2009.06.010	70	38	40	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2017	12	4							e017541	10.1371/journal.pone.0175415	http://dx.doi.org/10.1371/journal.pone.0175415			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LZ	28403232	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000399955200065
J	Regenthal, P; Hansen, JS; Andre, I; Lindkvist-Petersson, K				Regenthal, Paulina; Hansen, Jesper S.; Andre, Ingemar; Lindkvist-Petersson, Karin			Thermal stability and structural changes in bacterial toxins responsible for food poisoning (vol 12, e0172445, 2017)	PLOS ONE			English	Correction													André, Ingemar/O-4777-2014	André, Ingemar/0000-0002-4753-8233; Lindkvist, Karin/0000-0002-5209-3160	Novo Nordisk Fonden [NNF15OC0015906, NNF14OC0009807] Funding Source: researchfish	Novo Nordisk Fonden(Novo Nordisk Foundation)		Regenthal P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172445	1	0	1	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2017	12	4							e0175989	10.1371/journal.pone.0175989	http://dx.doi.org/10.1371/journal.pone.0175989			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LZ	28403221	Green Submitted, gold, Green Published			2022-12-27	WOS:000399955200096
J	Yiming, G; Zhou, XH; Lv, WK; Peng, Y; Zhang, WH; Cheng, XC; Li, YD; Xing, Q; Zhang, JH; Zhou, QN; Zhang, L; Lul, YM; Wang, HL; Tang, BP				Yiming, Gulinuer; Zhou, Xianhui; Lv, Wenkui; Peng, Yi; Zhang, Wenhui; Cheng, Xinchun; Li, Yaodong; Xing, Qiang; Zhang, Jianghua; Zhou, Qina; Zhang, Ling; Lul, Yanmei; Wang, Hongli; Tang, Baopeng			Reference values of brachial-ankle pulse wave velocity according to age and blood pressure in a central Asia population	PLOS ONE			English	Article							ARTERIAL STIFFNESS; CARDIOVASCULAR EVENTS; INDEPENDENT PREDICTOR; HYPERTENSIVE PATIENTS; AORTIC STIFFNESS; ALL-CAUSE; DISEASE; MORTALITY; ATHEROSCLEROSIS; CHINESE	Background Brachial-ankle pulse wave velocity (baPWV), a direct measure of aortic stiffness, has increasingly become an important assessment for cardiovascular risk. The present study established the reference and normal values of baPWV in a Central Asia population in Xinjiang, China. Methods We recruited participants from a central Asia population in Xinjiang, China. We performed multiple regression analysis to investigate the determinants of baPWV. The median and 10th-90th percentiles were calculated to establish the reference and normal values based on these categories. Results In total, 5,757 Han participants aged 15-88 years were included in the present study. Spearman correlation analysis showed that age (r = 0.587, p < 0.001) and mean blood pressure (MBP, r = 0.599, p < 0.001) were the major factors influencing the values of baPWV in the reference population. Furthermore, in the multiple linear regression analysis, the standardized regression coefficients of age (0.445) and MBP (0.460) were much higher than those of body mass index, triglyceride, and glycemia (-0.054, 0.035, and 0.033, respectively). In the covariance analysis, after adjustment for age and MBP, only diabetes was the significant independent determinant of baPWV (p = 0.009). Thus, participants with diabetes were excluded from the reference value population. The reference values ranged from 14.3 to 25.2 m/s, and the normal values ranged from 13.9 to 21.2 m/s. Conclusions This is the first study that has established the reference and normal values for baPWV according to age and blood pressure in a Central Asia population.	[Yiming, Gulinuer; Zhou, Xianhui; Lv, Wenkui; Zhang, Wenhui; Cheng, Xinchun; Li, Yaodong; Xing, Qiang; Zhang, Jianghua; Zhou, Qina; Zhang, Ling; Lul, Yanmei; Wang, Hongli; Tang, Baopeng] Xinjiang Med Univ, Affiliated Hosp 1, Pacing & Electrophysiol Dept, Urumqi, Xinjiang, Peoples R China; [Yiming, Gulinuer; Peng, Yi] Xinjiang Med Univ, Affiliated Hosp 1, Dept Cardiac Funct, Urumqi, Xinjiang, Peoples R China	Xinjiang Medical University; Xinjiang Medical University	Tang, BP (corresponding author), Xinjiang Med Univ, Affiliated Hosp 1, Pacing & Electrophysiol Dept, Urumqi, Xinjiang, Peoples R China.	tangbaopeng@hotmail.com	Stefanadis, Christodoulos/ABH-2232-2020; Zhou, Qina/L-1907-2017; Li, Yao/AAE-3550-2019	Stefanadis, Christodoulos/0000-0001-5974-6454; 	National Natural Science Foundation of China [81570297]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The authors received specific funding for this work. This work was supported by National Natural Science Foundation of China (81570297).	Adams MR, 2004, ARTERIOSCL THROM VAS, V24, pE190, DOI 10.1161/01.ATV.0000146176.62463.87; Agabiti-Rosei E, 2009, VASC HEALTH RISK MAN, V5, P353; Ai ZS, 2011, BRAZ J MED BIOL RES, V44, P1000; AVOLIO AP, 1983, CIRCULATION, V68, P50, DOI 10.1161/01.CIR.68.1.50; Chung CM, 2014, AM J MED SCI, V348, P294, DOI 10.1097/MAJ.0000000000000285; Cortez-Cooper MY, 2003, AM J CARDIOL, V91, P1519, DOI 10.1016/S0002-9149(03)00416-8; Han JY, 2013, AM J MED SCI, V346, P92, DOI 10.1097/MAJ.0b013e318268c05a; Kang S, 2010, EUR HEART J, V31, P2799, DOI 10.1093/eurheartj/ehq296; Kim J, 2014, HYPERTENSION, V64, P240, DOI 10.1161/HYPERTENSIONAHA.114.03304; Laurent S, 2003, STROKE, V34, P1203, DOI 10.1161/01.STR.0000065428.03209.64; Laurent S, 2001, HYPERTENSION, V37, P1236, DOI 10.1161/01.HYP.37.5.1236; LEVENSON J, 1987, ARTERIOSCLEROSIS, V7, P572, DOI 10.1161/01.ATV.7.6.572; London GM, 2004, CLIN EXP HYPERTENS, V26, P689, DOI 10.1081/CEH-200031982; Mattace-Raso FUS, 2006, CIRCULATION, V113, P657, DOI 10.1161/CIRCULATIONAHA.105.555235; Miyai N, 2013, CLIN EXP HYPERTENS, V35, P95, DOI 10.3109/10641963.2012.690473; Ninomiya T, 2013, J HYPERTENS, V31, P477, DOI 10.1097/HJH.0b013e32835c5c23; Ohnishi H, 2003, DIABETES CARE, V26, P437, DOI 10.2337/diacare.26.2.437; Pan S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080185; Rajkumar C, 1997, J AM COLL CARDIOL, V30, P350, DOI 10.1016/S0735-1097(97)00191-5; Sawabe M, 2005, ATHEROSCLEROSIS, V179, P345, DOI 10.1016/j.atherosclerosis.2004.09.023; Sheng CS, 2014, HYPERTENSION, V64, P1124, DOI 10.1161/HYPERTENSIONAHA.114.04063; Smulyan H, 2001, J AM COLL CARDIOL, V37, P1374, DOI 10.1016/S0735-1097(01)01166-4; Snijder MB, 2015, INT J CARDIOL, V191, P28, DOI 10.1016/j.ijcard.2015.04.234; Takahashi R, 2010, J ATHEROSCLER THROMB, V17, P1282, DOI 10.5551/jat.5272; Terai M, 2008, HYPERTENS RES, V31, P1135, DOI 10.1291/hypres.31.1135; TOTOMOUKOUO JJ, 1986, AM HEART J, V112, P136, DOI 10.1016/0002-8703(86)90691-5; Tsuchikura S, 2010, J ATHEROSCLER THROMB, V17, P658, DOI 10.5551/jat.3616; van Sloten TT, 2015, NEUROSCI BIOBEHAV R, V53, P121, DOI 10.1016/j.neubiorev.2015.03.011; Vlachopoulos C, 2012, HYPERTENSION, V60, P556, DOI 10.1161/HYPERTENSIONAHA.112.194779; Wang JW, 2012, BMC CARDIOVASC DISOR, V12, DOI 10.1186/1471-2261-12-119; WATANABE H, 1993, J AM COLL CARDIOL, V21, P1497, DOI 10.1016/0735-1097(93)90330-4; Xie X, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013997; Yamashina A, 2003, HYPERTENS RES, V26, P615, DOI 10.1291/hypres.26.615; Yamashina A, 2002, HYPERTENS RES, V25, P359, DOI 10.1291/hypres.25.359	34	31	32	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2017	12	4							e0171737	10.1371/journal.pone.0171737	http://dx.doi.org/10.1371/journal.pone.0171737			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LZ	28403173	Green Submitted, Green Published, gold			2022-12-27	WOS:000399955200003
J	Miletic, V; Odorcic, I; Nikolic, P; Svedruziz, ZM				Miletic, Vedran; Odorcic, Ivica; Nikolic, Patrik; Svedruziz, Zeljko M.			In silico design of the first DNA-independent mechanism-based inhibitor of mammalian DNA methyltransferase Dnmt1	PLOS ONE			English	Article							ELASTIC BAND METHOD; STRUCTURAL INSIGHT; METHYLATION; AUTOINHIBITION; EFFICIENT; COMPLEX	Background We use our earlier experimental studies of the catalytic mechanism of DNA methyltrans-ferases to prepare in silico a family of novel mechanism-based inhibitors of human Dnmt1. Highly specific inhibitors of DNA methylation can be used for analysis of human epigenome and for the creation of iPS cells. Results We describe a set of adenosyl-1-methyl-pyrimidin-2-one derivatives as novel mechanism-based inhibitors of mammalian DNA methyltransferase Dnmt1. The inhibitors have been designed to bind simultaneously in the active site and the cofactor site and thus act as transition-state analogues. Molecular dynamics studies showed that the lead compound can form between 6 to 9 binding interactions with Dnmt1. QM/MM analysis showed that the upon binding to Dnmt1 the inhibitor can form a covalent adduct with active site Cys1226 and thus act as a mechanism-based suicide-inhibitor. The inhibitor can target DNA-bond and DNA-free form of Dnmt1, however the suicide-inhibition step is more likely to happen when DNA is bound to Dnmt1. The validity of presented analysis is described in detail using 69 modifications in the lead compound structure. In total 18 of the presented 69 modifications can be used to prepare a family of highly specific inhibitors that can differentiate even between closely related enzymes such as Dnmt1 and Dnmt3a DNA methyltransferases. Conclusions Presented results can be used for preparation of some highly specific and potent inhibitors of mammalian DNA methylation with specific pharmacological properties.	[Miletic, Vedran] Heidelberg Univ, HITS, Mol Biomech Grp, Heidelberg, Germany; [Odorcic, Ivica; Nikolic, Patrik; Svedruziz, Zeljko M.] Univ Rijeka, Ctr Adv Comp & Modelling CNRM, Dept BioMed Technol, Lab Biomol Struct & Funct, Rijeka, Croatia	Ruprecht Karls University Heidelberg; University of Rijeka	Miletic, V (corresponding author), Heidelberg Univ, HITS, Mol Biomech Grp, Heidelberg, Germany.; Svedruziz, ZM (corresponding author), Univ Rijeka, Ctr Adv Comp & Modelling CNRM, Dept BioMed Technol, Lab Biomol Struct & Funct, Rijeka, Croatia.	Vedran.Miletic@h-its.org; zeljko.svedruzic@biotech.uniri.hr	Svedruzic, Zeljko M/R-3281-2018; Miletić, Vedran/N-6545-2013	Svedruzic, Zeljko M/0000-0002-0736-6182; Miletić, Vedran/0000-0003-3981-8806; Nikolic, Patrik/0000-0003-1930-7451	University of Rijeka [511-12]; Croatian Ministry of Science; Croatian Science Foundation's [0-1505-2015]	University of Rijeka; Croatian Ministry of Science(Ministry of Science, Education and Sports, Republic of Croatia); Croatian Science Foundation's	This work has been supported by the University of Rijeka project number 511-12; and the Croatian Ministry of Science. We gratefully acknowledge services of NVIDIA CUDA Teaching Center, and high performance computing facility at the Center for Advanced Computing and Modeling provided by the University of Rijeka. ZMS is recipient of funds from Croatian Science Foundation's project number 0-1505-2015, and a paid consultant for Jiva Pharmaceuticals. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work has been supported by the; University of Rijeka project number 511-12; and the Croatian Ministry of Science. We gratefully acknowledge services of NVIDIA CUDA Teaching Center, and high-performance computing facility at the Center for Advanced Computing and Modeling provided by the University of Rijeka. ZMS is a recipient of funds from Croatian Science Foundation's project number 0-1505-2015, and a paid consultant for Jiva Pharmaceuticals. None of the funding sources had any influence on design, interpretation, or dissemination of the results presented in these studies. We are proud supporters and contributors to freedom, versatility, and convenience of free and open-source software.	Babenko O, 2012, BRAIN RES, V1444, P96, DOI 10.1016/j.brainres.2012.01.038; ChemAxon, 2015, MARV WAS US DRAW DIS; Covic M, 2010, HEREDITY, V105, P122, DOI 10.1038/hdy.2010.27; Daigle SR, 2013, BLOOD, V122, P1017, DOI 10.1182/blood-2013-04-497644; Di Ruscio A, 2013, NATURE, V503, P371, DOI 10.1038/nature12598; Estabrook RA, 2009, J BIOL CHEM, V284, P22690, DOI 10.1074/jbc.M109.015966; Fersht A., 1999, STRUCTURE MECH PROTE; Gordon MS, 2005, THEORY AND APPLICATIONS OF COMPUTATIONAL CHEMISTRY: THE FIRST FORTY YEARS, P1167, DOI 10.1016/B978-044451719-7/50084-6; Gros C, 2012, BIOCHIMIE, V94, P2280, DOI 10.1016/j.biochi.2012.07.025; Guo X, 2015, NATURE, V517, P640, DOI 10.1038/nature13899; Hanwell MD, 2012, J CHEMINFORMATICS, V4, DOI 10.1186/1758-2946-4-17; Heerboth S, 2014, GENET EPIGENETICS, V6, P9, DOI 10.4137/GEG.S12270; Henkelman G, 2000, J CHEM PHYS, V113, P9901, DOI 10.1063/1.1329672; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Insilico M., 2016, EPI INFORM DISCOVERY, P440; Isakovic L, 2009, BIOORG MED CHEM LETT, V19, P2742, DOI 10.1016/j.bmcl.2009.03.132; Khavari DA, 2010, CELL CYCLE, V9, P3880, DOI 10.4161/cc.9.19.13385; Li SS, 2013, J MOL CELL BIOL, V5, P64, DOI 10.1093/jmcb/mjs057; Medina-Franco JL, 2011, DRUG DISCOV TODAY, V16, P418, DOI 10.1016/j.drudis.2011.02.003; Merino P., 2013, CHEM SYNTHESIS NUCLE; Pennarossa G, 2013, P NATL ACAD SCI USA, V110, P8948, DOI 10.1073/pnas.1220637110; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Qin WH, 2011, NUCLEUS-PHILA, V2, P392, DOI 10.4161/nucl.2.5.17928; Romanoski CE, 2015, NATURE, V518, P314, DOI 10.1038/518314a; Sen GL, 2010, NATURE, V463, P563, DOI 10.1038/nature08683; Song JK, 2012, SCIENCE, V335, P709, DOI 10.1126/science.1214453; Song JK, 2011, SCIENCE, V331, P1036, DOI 10.1126/science.1195380; Sousa da Silva Alan W, 2012, BMC Res Notes, V5, P367, DOI 10.1186/1756-0500-5-367; Svedruzic ZM, 2008, CURR MED CHEM, V15, P92, DOI 10.2174/092986708783330700; Svedruzic ZM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032293; Svedruzic ZM, 2011, PROG MOL BIOL TRANSL, V101, P221, DOI 10.1016/B978-0-12-387685-0.00006-8; Svedruzic ZM, 2005, BIOCHEMISTRY-US, V44, P14977, DOI 10.1021/bi050988f; Svedruzic ZM, 2004, BIOCHEMISTRY-US, V43, P11460, DOI 10.1021/bi0496743; Svedruzic ZM, 2005, BIOCHEMISTRY-US, V44, P9472, DOI 10.1021/bi050295z; Svedruzic ZM, 2015, DECREASE CATAL UNPUB; Takeshita K, 2011, P NATL ACAD SCI USA, V108, P9055, DOI 10.1073/pnas.1019629108; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; VandeVondele J, 2005, COMPUT PHYS COMMUN, V167, P103, DOI 10.1016/j.cpc.2004.12.014; Vorbruggen H., 2001, HDB NUCLEOSIDE SYNTH; WU JC, 1987, J BIOL CHEM, V262, P4778; Xu F, 2010, CURR MED CHEM, V17, P4052, DOI 10.2174/092986710793205372; Yang J, 2013, BIOCHEMISTRY-US, V52, P2828, DOI 10.1021/bi400163k; Zhou L, 2002, J MOL BIOL, V321, P591, DOI 10.1016/S0022-2836(02)00676-9	45	14	14	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2017	12	4							e0174410	10.1371/journal.pone.0174410	http://dx.doi.org/10.1371/journal.pone.0174410			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0JS	28399172	Green Submitted, gold, Green Published			2022-12-27	WOS:000399949000010
J	Khatun, M; Sorjamaa, A; Kangasniemi, M; Sutinen, M; Saio, T; Liakka, A; Lehenkari, P; Tapanainen, JS; Vuolteenaho, O; Chen, JC; Lehtonen, S; Piltonen, TT				Khatun, Masuma; Sorjamaa, Anna; Kangasniemi, Marika; Sutinen, Meeri; Saio, Tuuia; Liakka, Annikki; Lehenkari, Petri; Tapanainen, Juha S.; Vuolteenaho, Olli; Chen, Joseph C.; Lehtonen, Siri; Piltonen, Terhi T.			Niche matters: The comparison between bone marrow stem cells and endometrial stem cells and stromal fibroblasts reveal distinct migration and cytokine profiles in response to inflammatory stimulus	PLOS ONE			English	Article							POLYCYSTIC-OVARY-SYNDROME; ENDOTHELIAL GROWTH-FACTOR; GENE-EXPRESSION; IMMUNE-SYSTEM; RECEPTOR 4; IMPLANTATION; MECHANISMS; PROGESTERONE; RECRUITMENT; PHENOTYPE	Objective Intrinsic inflammatory characteristics play a pivotal role in stem cell recruitment and homing through migration where the subsequent change in niche has been shown to alter these characteristics. The bone marrow mesenchymal stem cells (bmMSCs) have been demonstrated to migrate to the endometrium contributing to the stem cell reservoir and regeneration of endometrial tissue. Thus, the aim of the present study was to compare the inflammation-driven migration and cytokine secretion profile of human bmMSCs to endometrial mesenchymal stem cells (eMSCs) and endometrial fibroblasts (eSFs). Materials and methods The bmMSCs were isolated from bone marrow aspirates through culturing, whereas eMSCs and eSFs were FACS-isolated. All cell types were tested for their surface marker, proliferation profiles and migration properties towards serum and inflammatory attractants. The cytokine/chemokine secretion profile of 35 targets was analysed in each cell type at basal level along with lipopolysaccharide (LPS)-induced state. Results Both stem cell types, bmMSCs and eMSCs, presented with similar stem cell surface marker profiles as well as possessed high proliferation and migration potential compared to eSFs. In multiplex assays, the secretion of 16 cytokine targets was detected and LPS stimulation expanded the cytokine secretion pattern by triggering the secretion of several targets. The bmMSCs exhibited higher cytokine secretion of vascular endothelial growth factor (VEGF)A, stromal cell-derived factor-1 alpha (SDF)-1 alpha, interleukin-1 receptor antagonist (IL-1RA), IL-6, interferon-gamma inducible protein (IP)-10, monocyte chemoattractant protein (MCP)1, macrophage inflammatory protein (MIP) 1 alpha and RANTES compared to eMSCs and/or eSFs after stimulation with LPS. The basal IL-8 secretion was higher in both endometrial cell types compared to bmMSCs. Conclusion Our results highlight that similar to bmMSCs, the eMSCs possess high migration activity while the differentiation process towards stromal fibroblasts seemed to result in loss of stem cell surface markers, minimal migration activity and a subtler cytokine profile likely contributing to normal endometrial function	[Khatun, Masuma; Sorjamaa, Anna; Kangasniemi, Marika; Tapanainen, Juha S.; Lehtonen, Siri; Piltonen, Terhi T.] Univ Oulu, Med Res Ctr, PEDEGO Res Unit, Dept Obstet & Gynecol, Oulu, Finland; [Khatun, Masuma; Sorjamaa, Anna; Kangasniemi, Marika; Sutinen, Meeri; Saio, Tuuia; Liakka, Annikki; Lehenkari, Petri; Tapanainen, Juha S.; Lehtonen, Siri; Piltonen, Terhi T.] Oulu Univ Hosp, Oulu, Finland; [Sutinen, Meeri; Saio, Tuuia] Univ Oulu, Med Res Ctr, Canc & Translat Med Res Unit, Oulu, Finland; [Liakka, Annikki] Univ Oulu, Med Res Ctr, Dept Pathol, Oulu, Finland; [Lehenkari, Petri] Univ Oulu, Dept Anat, Oulu, Finland; [Lehenkari, Petri] Univ Oulu, Med Res Ctr, Dept Internal Med, Oulu, Finland; [Tapanainen, Juha S.] Univ Helsinki, Dept Obstet & Gynecol, Helsinki, Finland; [Tapanainen, Juha S.] Helsinki Univ Cent Hosp, Helsinki, Finland; [Vuolteenaho, Olli] Univ Oulu, Res Unit Biomed, Oulu, Finland; [Chen, Joseph C.] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA 94143 USA	University of Oulu; University of Oulu; University of Oulu; University of Oulu; University of Oulu; University of Oulu; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Oulu; University of California System; University of California San Francisco	Piltonen, TT (corresponding author), Univ Oulu, Med Res Ctr, PEDEGO Res Unit, Dept Obstet & Gynecol, Oulu, Finland.; Piltonen, TT (corresponding author), Oulu Univ Hosp, Oulu, Finland.	terhi.piltonen@oulu.fi	Kaisanlahti, Anna/HHN-0068-2022; Khatun, Ph.D, Masuma/AAU-6746-2021; Kangasniemi, Marika H./HGB-2931-2022; Lehenkari, Petri/O-3009-2016	Kaisanlahti, Anna/0000-0003-2778-5621; Khatun, Ph.D, Masuma/0000-0003-2976-2319; Kangasniemi, Marika H./0000-0003-0514-5981; Lehenkari, Petri/0000-0002-0055-5183; Piltonen, Terhi/0000-0002-9921-7300	Sigrid Juselius Foundation; Academy of Finland; Finnish Medical Foundation; Orion-Farmos Research Foundation	Sigrid Juselius Foundation(Sigrid Juselius Foundation); Academy of Finland(Academy of Finland); Finnish Medical Foundation; Orion-Farmos Research Foundation	This work was supported by Sigrid Juselius Foundation, Academy of Finland, Finnish Medical Foundation, and Orion-Farmos Research Foundation.	Aghajanova L, 2010, BIOL REPROD, V82, P1076, DOI 10.1095/biolreprod.109.082867; Almeida CR, 2016, STEM CELL REP, V6, P466, DOI 10.1016/j.stemcr.2016.02.012; Anton K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035036; Arici A, 1998, J CLIN ENDOCR METAB, V83, P1783, DOI 10.1210/jc.83.5.1783; Arici A, 1999, BIOL REPROD, V61, P85, DOI 10.1095/biolreprod61.1.85; Barragan F, 2016, BIOL REPROD, V94, DOI 10.1095/biolreprod.115.136010; Beane OS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115963; Bellehumeur C, 2009, HUM REPROD, V24, P2193, DOI 10.1093/humrep/dep192; Bernardo ME, 2013, CELL STEM CELL, V13, P392, DOI 10.1016/j.stem.2013.09.006; Boomsma CM, 2009, HUM REPROD, V24, P1427, DOI 10.1093/humrep/dep011; Chang KK, 2014, INT J CLIN EXP PATHO, V7, P1889; Chau SE, 2013, HUM REPROD, V28, P1497, DOI 10.1093/humrep/det060; Chen JC, 2015, BIO PROTOC, V5, DOI DOI 10.21769/BI0PR0T0C.1623; Chen JC, 2013, FERTIL STERIL, V100, P1132, DOI 10.1016/j.fertnstert.2013.06.007; Cronin JG, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.092718; Dazzi F, 2011, BEST PRACT RES CL HA, V24, P49, DOI 10.1016/j.beha.2011.01.002; Ding DC, 2011, CELL TRANSPLANT, V20, P5, DOI 10.3727/096368910X; Dominguez F, 2008, MOL HUM REPROD, V14, P423, DOI 10.1093/molehr/gan032; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Eseonu OI, 2015, RHEUMATOLOGY, V54, P210, DOI 10.1093/rheumatology/keu377; Evans J, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.113.108175; Evans J, 2012, REV ENDOCR METAB DIS, V13, P277, DOI 10.1007/s11154-012-9223-7; Gaafar T, 2014, MOL CELL BIOCHEM, V395, P29, DOI 10.1007/s11010-014-2109-0; Gao D, 2009, TRENDS MOL MED, V15, P333, DOI 10.1016/j.molmed.2009.06.006; Gao Y, 2016, STEM CELLS, V34, P1112, DOI 10.1002/stem.2275; Gargett CE, 2016, HUM REPROD UPDATE, V22, P137, DOI 10.1093/humupd/dmv051; Gargett CE, 2012, FERTIL STERIL, V98, DOI 10.1016/j.fertnstert.2012.05.004; Gargett CE, 2010, MOL HUM REPROD, V16, P818, DOI 10.1093/molehr/gaq061; Gargett CE, 2009, BIOL REPROD, V80, P1136, DOI 10.1095/biolreprod.108.075226; Gnainsky Y, 2010, FERTIL STERIL, V94, P2030, DOI 10.1016/j.fertnstert.2010.02.022; Guo J, 2016, SCI REP-UK, V6, DOI 10.1038/srep21416; Hu CJ, 2013, J SURG RES, V183, P427, DOI 10.1016/j.jss.2013.01.019; Ikoma T, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.07.026; Jabbour HN, 2006, ENDOCR REV, V27, P17, DOI 10.1210/er.2004-0021; Kilpinen L, 2013, J LIPID RES, V54, P622, DOI 10.1194/jlr.M030650; Koivunen P, 2016, PHARMACOL RES, V114, P265, DOI 10.1016/j.phrs.2016.11.003; Kyurkchiev Dobroslav, 2014, World J Stem Cells, V6, P552, DOI 10.4252/wjsc.v6.i5.552; Lee RH, 2004, CELL PHYSIOL BIOCHEM, V14, P311, DOI 10.1159/000080341; Lehtonen ST, 2014, APMIS, V122, P301, DOI 10.1111/apm.12146; Leskela HV, 2003, BIOCHEM BIOPH RES CO, V311, P1008, DOI 10.1016/j.bbrc.2003.10.095; Liu NM, 2013, J CELL BIOCHEM, V114, P2677, DOI 10.1002/jcb.24615; Lockwood CJ, 2011, MENOPAUSE, V18, P408, DOI [10.1097/GME.0b013e31820bf288, 10.1097/gme.0b013e31820bf288]; LYDON JP, 1995, GENE DEV, V9, P2266, DOI 10.1101/gad.9.18.2266; Machairiotis N, 2013, DIAGN PATHOL, V8, DOI 10.1186/1746-1596-8-194; Figueira PGM, 2011, ANN NY ACAD SCI, V1221, P10, DOI 10.1111/j.1749-6632.2011.05969.x; Maruyama T, 2008, ENDOCR J, V55, P795, DOI 10.1507/endocrj.K08E-067; Matteo M, 2010, FERTIL STERIL, V94, P2222, DOI 10.1016/j.fertnstert.2010.01.049; Maybin JA, 2011, J CLIN ENDOCR METAB, V96, P2475, DOI 10.1210/jc.2010-2971; Montazeri M, 2016, HUM REPROD, V31, P2098, DOI 10.1093/humrep/dew171; Mor G, 2011, ANN NY ACAD SCI, V1221, P80, DOI 10.1111/j.1749-6632.2010.05938.x; Nap AW, 2004, J CLIN ENDOCR METAB, V89, P1089, DOI 10.1210/jc.2003-031406; Newman Robert E., 2009, Inflammation & Allergy Drug Targets, V8, P110; Norwitz ER, 2001, NEW ENGL J MED, V345, P1400, DOI 10.1056/NEJMra000763; Pendleton C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058198; Peng H, 2006, GLIA, V54, P619, DOI 10.1002/glia.20409; Piltonen TT, 2013, J CLIN ENDOCR METAB, V98, P3765, DOI 10.1210/jc.2013-1923; Pretto CM, 2008, J CLIN ENDOCR METAB, V93, P4126, DOI 10.1210/jc.2007-2636; Robertson SA, 1999, BIOL REPROD, V60, P251, DOI 10.1095/biolreprod60.2.251; Rossi M, 2005, REPRODUCTION, V130, P721, DOI 10.1530/rep.1.00688; Santamaria X, 2016, HUM REPROD, V31, P1087, DOI 10.1093/humrep/dew042; Schwab KE, 2007, HUM REPROD, V22, P2903, DOI 10.1093/humrep/dem265; Segers VFM, 2007, CIRCULATION, V116, P1683, DOI 10.1161/CIRCULATIONAHA.107.718718; Sela HY, 2013, PLACENTA, V34, P222, DOI 10.1016/j.placenta.2012.12.008; Sharkey AM, 2000, J CLIN ENDOCR METAB, V85, P402, DOI 10.1210/jc.85.1.402; Spitzer TLB, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.095885; Srivastava A, 2013, REPROD BIOL ENDOCRIN, V11, DOI 10.1186/1477-7827-11-116; Stagg J, 2007, TISSUE ANTIGENS, V69, P1, DOI 10.1111/j.1399-0039.2006.00739.x; Taylor HS, 2004, JAMA-J AM MED ASSOC, V292, P81, DOI 10.1001/jama.292.1.81; van Mourik MSM, 2009, J LEUKOCYTE BIOL, V85, P4, DOI 10.1189/jlb.0708395; Wang XL, 2015, STEM CELL RES, V15, P14, DOI 10.1016/j.scr.2015.04.004; Yan H, 2014, BIOCHEM BIOPH RES CO, V448, P212, DOI 10.1016/j.bbrc.2014.04.097; Zhang Y, 2015, FEBS J, V282, P891, DOI 10.1111/febs.13187	72	19	20	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2017	12	4							e0175986	10.1371/journal.pone.0175986	http://dx.doi.org/10.1371/journal.pone.0175986			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KH	28419140	Green Published, gold, Green Submitted			2022-12-27	WOS:000399875200059
J	Leligdowicz, A; Conroy, AL; Hawkes, M; Zhong, K; Lebovic, G; Matthay, MA; Kain, KC				Leligdowicz, Aleksandra; Conroy, Andrea L.; Hawkes, Michael; Zhong, Kathleen; Lebovic, Gerald; Matthay, Michael A.; Kain, Kevin C.			Validation of two multiplex platforms to quantify circulating markers of inflammation and endothelial injury in severe infection	PLOS ONE			English	Article							BEAD ARRAY ASSAYS; GROWTH-FACTOR; SEPSIS; ELISA; BIOMARKERS; SENSITIVITY; ACTIVATION; MORTALITY; AGREEMENT; CYTOKINES	Biomarkers can prognosticate outcome and enable risk-stratification. In severe infection, focusing on multiple markers reflecting pathophysiological mechanisms of organ injury could enhance management and pathway-directed therapeutics. Limited data exist on the performance of multiplex biomarker platforms. Our goal was to compare endothelial and immune activation biomarkers in severe pediatric infections using two multiplex platforms. Frozen plasma from 410 children presenting to the Jinja Regional Hospital in Uganda with suspected infection was used to measure biomarkers of endothelial (Angiopoietin-2, sFlt-1, sVCAM-1, sICAM-1) and immune (IL-6, IP-10, sTNFR-1, CHI3L1) activation. Two multiplex platforms (Luminex (R), Ella (TM)) based on monoclonal antibody sandwich immunoassays using biotin-streptavidin conjugate chemistry were selected with reagents from R&D Systems. The two platforms differed in ease and time of completion, number of samples per assay, and dynamic concentration range. Intra-assay variability assessed using a coefficient of variation (CV%) was 2.2-3.4 for Luminex (R) and 1.2-2.9 for Ella TM. Correlations for biomarker concentrations within dynamic range of both platforms were best for IL-6 (p = 0.96, p<0.0001), IP-10 (p = 0.94, p<0.0001) and sFlt-1 (p = 0.94, p<0.0001). Agreement between concentrations obtained by both methods assessed by the Bland-Altman test varied, with best agreement for CHI3L1. Our data suggest that biomarkers of endothelial and immune activation can be readily measured with multiplex platforms. Luminex (R) and Ella (TM) produced reliable results with excellent CV% values. The Ella TM platform was more automated and completed in 75 minutes, potentially compatible with near-patient use. Trends in concentrations obtained by these methods were highly correlated, although absolute values varied, suggesting caution is required when comparing data from different multiplex platforms.	[Leligdowicz, Aleksandra; Zhong, Kathleen; Kain, Kevin C.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Leligdowicz, Aleksandra; Kain, Kevin C.] Univ Hlth Network, Sandra Rotman Ctr Global Hlth, Sandra A Rotman Labs, Toronto, ON, Canada; [Conroy, Andrea L.] Indiana Univ Sch Med, Dept Pediat, Indianapolis, IN 46202 USA; [Hawkes, Michael] Univ Alberta, Div Pediat Infect Dis, Edmonton, AB, Canada; [Lebovic, Gerald] Univ Toronto, Li Ka Shing Knowledge Inst, HUB, Appl Hlth Res Ctr, Toronto, ON, Canada; [Matthay, Michael A.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Matthay, Michael A.] Univ Calif San Francisco, Dept Anesthesia, San Francisco, CA USA; [Matthay, Michael A.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA USA	University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Indiana University System; Indiana University Bloomington; University of Alberta; University of Toronto; Li Ka Shing Knowledge Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Kain, KC (corresponding author), Univ Toronto, Dept Med, Toronto, ON, Canada.; Kain, KC (corresponding author), Univ Hlth Network, Sandra Rotman Ctr Global Hlth, Sandra A Rotman Labs, Toronto, ON, Canada.	kevin.kain@uhn.ca	Leligdowicz, Aleksandra/GLS-9028-2022; Conroy, Andrea/ABC-5715-2020; Leligdowicz, Aleksandra/Q-2494-2016; Conroy, Andrea/AAA-8356-2020; , Michael/AAP-3049-2020	Leligdowicz, Aleksandra/0000-0001-6055-4644; Conroy, Andrea/0000-0002-5328-6511; Leligdowicz, Aleksandra/0000-0001-6055-4644; Conroy, Andrea/0000-0002-5328-6511; Lebovic, Gerald/0000-0003-3540-3339; Kain, Kevin/0000-0001-6068-1272	Canadian Institutes of Health Research (CIHR) [MOP-13721, MOP-115160, MOP-136813]; CIHR Foundation [KCK FDN-148439]; Canada Research Chair Program; CIHR Banting fellowship; Amgen; GlaxoSmithKline	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR Foundation(Canadian Institutes of Health Research (CIHR)); Canada Research Chair Program(Canada Research Chairs); CIHR Banting fellowship(Canadian Institutes of Health Research (CIHR)); Amgen(Amgen); GlaxoSmithKline(GlaxoSmithKline)	This work was supported by the Canadian Institutes of Health Research (CIHR) grants MOP-13721, MOP-115160, MOP-136813, a CIHR Foundation grant (KCK FDN-148439), the Canada Research Chair Program (KCK), a CIHR Banting fellowship (AL), and donations from Kim Kertland and the Tesari Foundation. MAM has received grants from Amgen for experimental studies on acute lung injury and from GlaxoSmithKline for studies of sepsis in patients; consultancy agreements for ARDS or lung diseases with Boehringer-Ingelheim, Bayer Inc, Cerus Therapeutics, Biomarck Pharmaceuticals, Quark Pharmaceuticals, Thesan Pharmaceuticals, Incardia Inc, Biogen, and GlaxoSmithKline; DSMB Chair for clinical trials for Roche-Genentec. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank the children and their care givers from the Jinja Regional Referral Hospital for participation in the prospective observational study to investigate the relationship between biomarkers of endothelial and immune activation and mortality. We also thank the biostatistics faculty members of the Training in Clinical Research program at the University of California, San Francisco, for their guidance in statistical analysis selection. This work was supported by the Canadian Institutes of Health Research (CIHR) grants MOP-13721, MOP 115160, MOP-136813, a CIHR Foundation grant FDN-148439 (K.C.K.), the Canada Research Chair Program (K.C.K), a CIHR Banting fellowship (A.L.), and donations from Kim Kertland and the Tesari Foundation. M.A.M. has received grants from Amgen for experimental studies on acute lung injury and from GlaxoSmithKline for studies of sepsis in patients; consultancy agreements for ARDS or lung diseases with Boehringer-Ingelheim, Bayer Inc, Cerus Therapeutics, Biomarck Pharmaceuticals, Quark Pharmaceuticals, Thesan Pharmaceuticals, Incardia Inc, Biogen, and GlaxoSmithKline; DSMB Chair for clinical trials for Roche-Genentec. This does not alter our adherence to PLOS ONE policies on sharing data and materials.	Aldo P, 2016, AM J REPROD IMMUNOL, V75, P678, DOI 10.1111/aji.12512; Baker HN, 2012, JOVE-J VIS EXP, DOI 10.3791/4084; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Calfee CS, 2014, LANCET RESP MED, V2, P611, DOI 10.1016/S2213-2600(14)70097-9; Cao J, 2015, CLIN PROTEOM, V12, DOI 10.1186/s12014-015-9101-x; Carrick DM, 2015, CANC EPIDEMIOL BIOMA; Cohen J, 2015, LANCET INFECT DIS, V15, P581, DOI 10.1016/S1473-3099(15)70112-X; Conroy AL, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0773-4; de Pablo R, 2013, EUR J INTERN MED, V24, P132, DOI 10.1016/j.ejim.2012.10.009; de Pablo Raul, 2011, J Intensive Care Med, V26, P125, DOI 10.1177/0885066610384465; Delano MJ, 2016, J CLIN INVEST, V126, P23, DOI 10.1172/JCI82224; Ellington AA, 2010, CLIN CHEM, V56, P186, DOI 10.1373/clinchem.2009.127514; Elshal MF, 2006, METHODS, V38, P317, DOI 10.1016/j.ymeth.2005.11.010; ENGVALL E, 1971, IMMUNOCHEMISTRY, V8, P871, DOI 10.1016/0019-2791(71)90454-X; FDA, GUID IND BIOAN METH; Fulton RJ, 1997, CLIN CHEM, V43, P1749; HACK CE, 1989, BLOOD, V74, P1704; Higgins SJ, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf6812; Hotchkiss RS, 2013, NAT REV IMMUNOL, V13, P862, DOI 10.1038/nri3552; Khan SS, 2004, CYTOM PART B-CLIN CY, V61B, P35, DOI 10.1002/cyto.b.20021; Kojic Dubravka, 2015, World J Exp Med, V5, P50, DOI 10.5493/wjem.v5.i2.50; Kornblit B, 2013, IMMUNOBIOLOGY, V218, P1227, DOI 10.1016/j.imbio.2013.04.010; Lee WL, 2010, NEW ENGL J MED, V363, P689, DOI 10.1056/NEJMcibr1007320; Luiz RR, 2005, J CLIN EPIDEMIOL, V58, P215, DOI 10.1016/j.jclinepi.2004.07.007; Matthay MA, 2016, JAMA-J AM MED ASSOC, V315, P747, DOI 10.1001/jama.2016.0661; Mikacenic C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141251; Ng PC, 2007, PEDIATR RES, V61, P93, DOI 10.1203/01.pdr.0000250207.95723.96; Nolan JP, 2006, CYTOM PART A, V69A, P318, DOI 10.1002/cyto.a.20266; Pene F, 2009, CRIT CARE MED, V37, pS50, DOI 10.1097/CCM.0b013e3181921349; Pitman EJG, 1939, BIOMETRIKA, V31, P9, DOI 10.2307/2334971; Reed GF, 2002, CLIN DIAGN LAB IMMUN, V9, P1235, DOI 10.1128/CDLI.9.6.1235-1239.2002; Reinhart K, 2012, CLIN MICROBIOL REV, V25, P609, DOI 10.1128/CMR.00016-12; Ricciuto DR, 2011, CRIT CARE MED, V39, P702, DOI 10.1097/CCM.0b013e318206d285; Shapiro NI, 2008, SHOCK, V29, P452, DOI 10.1097/SHK.0b013e31815072c1; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Skibsted S, 2013, SHOCK, V39, P427, DOI 10.1097/SHK.0b013e3182903f0d; Tighe PJ, 2015, PROTEOM CLIN APPL, V9, P406, DOI 10.1002/prca.201400130; Tsao PN, 2007, CRIT CARE MED, V35, P1955, DOI 10.1097/01.CCM.0000275273.56547.B8; van der Heijden M, 2009, EXPERT OPIN THER TAR, V13, P39, DOI 10.1517/14728220802626256 ; Xing K, 2012, CRIT CARE, V16, DOI 10.1186/cc11145; Zaki R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037908	41	32	32	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2017	12	4							e0175130	10.1371/journal.pone.0175130	http://dx.doi.org/10.1371/journal.pone.0175130			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KH	28419100	Green Published, gold			2022-12-27	WOS:000399875200011
J	Grasset, L; Joly, P; Jacqmin-Gaddal, H; Letenneur, L; Wittwer, J; Amieva, H; Helmer, C; Dartigues, JF				Grasset, Leslie; Joly, Pierre; Jacqmin-Gaddal, Helene; Letenneur, Luc; Wittwer, Jerome; Amieva, Helene; Helmer, Catherine; Dartigues, Jean Francois			Real benefit of a protective factor against dementia: Importance of controlling for death. Example of sport practice	PLOS ONE			English	Article							FREE LIFE EXPECTANCY; PHYSICAL-ACTIVITY; ELDERLY POPULATION; ALZHEIMERS-DISEASE; RISK; ASSOCIATION; PREVALENCE; MORBIDITY; MORTALITY; OLDER	Objectives To analyse the impact of a risk factor on several epidemiological indicators of death and dementia; the example of sport practice is presented. Methods A population of 3670 non-demented subjects living at home and aged 65 and older from the PAQUID study were followed for 22 years. Sport practice was documented at baseline. Dementia (according to DSM-III-R criteria) and death were assessed at each visit. Analyses were performed with an Illness-Death model, providing results on the risks of dementia and death, probabilities and life expectancies. Results A total of 743 subjects (20.2%) participated in regular sport practice. During the follow-up, the proportion of death was lower in the elderly people practicing sport (EPPS), whereas the proportion of incident dementia cases was the same. The adjusted model showed a decreased risk of dementia (HR = 0.84 (0.72 - 1.00)) and of death for non-demented subjects (HR = 0.61 (0.51 - 0.71)) for EPPS but a similar risk of death with dementia in both sport groups. The probability of remaining alive without dementia was higher in EPPS, whereas the probability of dying was lower. The mean lifetime without dementia was 3 years higher for the EPPS, but the mean lifetime with dementia was the same. Discussion A preventive measure on a protective factor that is more effective for preventing death than dementia could lead to an increased lifetime without dementia; however, the number of demented cases may remain unchanged, even if the risk of developing dementia is reduced. This dynamic is important to forecast the need for health care and social services for the elderly.	[Grasset, Leslie; Joly, Pierre; Jacqmin-Gaddal, Helene; Letenneur, Luc; Wittwer, Jerome; Amieva, Helene; Helmer, Catherine; Dartigues, Jean Francois] Univ Bordeaux, INSERM, Bordeaux Populat Hlth Res Ctr, UMR, Talence, France; [Dartigues, Jean Francois] Bordeaux Univ Hosp, CMRR, Memory Consultat, Bordeaux, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; CHU Bordeaux	Grasset, L (corresponding author), Univ Bordeaux, INSERM, Bordeaux Populat Hlth Res Ctr, UMR, Talence, France.	Leslie.Grasset@ispedx-bordeaux2.fr	Grasset, Leslie/T-8148-2019; Joly, Pierre/T-9797-2019; Wittwer, Jérôme/T-5174-2019; Amieva, Helene/T-4170-2019; HELMER, Catherine/I-6581-2015; LETENNEUR, Luc/T-4424-2019; DARTIGUES, Jean François/T-4513-2019; Jacqmin-Gadda, Helene/E-5144-2014; HELMER, Catherine/AAG-5126-2021; Grasset, Leslie/A-3351-2016	Amieva, Helene/0000-0002-0119-7242; HELMER, Catherine/0000-0002-5169-7421; LETENNEUR, Luc/0000-0002-3274-937X; Jacqmin-Gadda, Helene/0000-0002-7727-6625; Grasset, Leslie/0000-0003-2812-0103	IPSEN France; NOVARTIS Pharma France; CNSA (Caisse Nationale de Solidarite et d'Autonomie)	IPSEN France(Ipsen); NOVARTIS Pharma France; CNSA (Caisse Nationale de Solidarite et d'Autonomie)	The PAQUID cohort was supported by IPSEN France, NOVARTIS Pharma France, and the CNSA (Caisse Nationale de Solidarite et d'Autonomie). The research presented in this manuscript is original. The contents of this article are solely the responsibility of the authors. IPSEN, NOVARTIS and the CNSA did not fund this specific study. The funders had no role in the collection, management, analysis, or interpretation of the data and had no role in the preparation, review or approval of the manuscript.	Alzheimer's Disease International, 2015, WORLD ALZHEIMER REPO; Andrieu S, 2015, LANCET NEUROL; Andrieu S, 2015, LANCET NEUROL, V14, P926, DOI 10.1016/S1474-4422(15)00153-2; DARTIGUES JF, 1992, AM J EPIDEMIOL, V135, P981, DOI 10.1093/oxfordjournals.aje.a116410; de Bruijn RFAG, 2013, EUR J EPIDEMIOL, V28, P277, DOI 10.1007/s10654-013-9773-3; FRIES JF, 1988, PERSPECT BIOL MED, V31, P407; FRIES JF, 1980, NEW ENGL J MED, V303, P130, DOI 10.1056/NEJM198007173030304; Grasset L, 2016, ALZHEIMERS DEMENT, V12, P272, DOI 10.1016/j.jalz.2015.11.001; Iso-Markku P, 2015, ANN MED, V47, P81, DOI 10.3109/07853890.2014.994675; Jacqmin-Gadda H, 2013, EUR J EPIDEMIOL, V28, P493, DOI 10.1007/s10654-013-9818-7; Larson EB, 2006, ANN INTERN MED, V144, P73, DOI 10.7326/0003-4819-144-2-200601170-00004; Leffondre K, 2013, INT J EPIDEMIOL, V42, P1177, DOI 10.1093/ije/dyt126; Lobo A, 2007, ACTA PSYCHIAT SCAND, V116, P299, DOI 10.1111/j.1600-0447.2007.01006.x; MANTON KG, 1982, MILBANK FUND Q, V60, P183, DOI 10.2307/3349767; Matthews FE, 2013, LANCET, V382, P1405, DOI 10.1016/S0140-6736(13)61570-6; Newman AB, 2006, JAMA-J AM MED ASSOC, V295, P2018, DOI 10.1001/jama.295.17.2018; Perenboom RJM, 1996, SOC SCI MED, V43, P1703, DOI 10.1016/S0277-9536(96)00058-5; Qiu CX, 2013, NEUROLOGY, V80, P1888, DOI 10.1212/WNL.0b013e318292a2f9; RITCHIE K, 1994, AM J PUBLIC HEALTH, V84, P232, DOI 10.2105/AJPH.84.2.232; RITCHIE K, 1994, AUST J PUBLIC HEALTH, V18, P149; Rovio S, 2005, LANCET NEUROL, V4, P705, DOI 10.1016/S1474-4422(05)70198-8; Satizabal CL, 2016, NEW ENGL J MED, V374, P523, DOI 10.1056/NEJMoa1504327; Sauvaget C, 1997, GERONTOLOGY, V43, P168; Schrijvers EMC, 2012, NEUROLOGY, V78, P1456, DOI 10.1212/WNL.0b013e3182553be6; Sink KM, 2015, JAMA-J AM MED ASSOC, V314, P781, DOI 10.1001/jama.2015.9617; Touraine C, 2013, STAT METHODS MED RES; Yazdanyar A, 2014, J AGING HEALTH, V26, P583, DOI 10.1177/0898264314525665	27	2	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2017	12	4							e0174950	10.1371/journal.pone.0174950	http://dx.doi.org/10.1371/journal.pone.0174950			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES9KD	28414760	Green Published, Green Submitted, gold			2022-12-27	WOS:000399874800012
J	Hadjialirezaei, S; Picco, G; Beatson, R; Burchell, J; Stokke, BT; Sletmoen, M				Hadjialirezaei, Soosan; Picco, Gianfranco; Beatson, Richard; Burchell, Joy; Stokke, Bjorn Torger; Sletmoen, Marit			Interactions between the breast cancer-associated MUC1 mucins and C-type lectin characterized by optical tweezers	PLOS ONE			English	Article							MOLECULE FORCE SPECTROSCOPY; ALA-D-ALA; TN-ANTIGEN; SIALYL-TN; O-GLYCOSYLATION; EXPRESSION; ADHESION; CELLS; VANCOMYCIN; BINDING	Carbohydrate-protein interactions govern many crucial processes in biological systems including cell recognition events. We have used the sensitive force probe optical tweezers to quantify the interactions occurring between MGL lectins and MUC1 carrying the cancer-associated glycan antigens mucins Tn and STn. Unbinding forces of 7.6 pN and 7.1 pN were determined for the MUC1(Tn)-MGL and MUC1(STn)-MGL interactions, at a force loading rate of similar to 40 pN/s. The interaction strength increased with increasing force loading rate, to 27 and 37 pN at a force loading rate of similar to 310 pN/s. No interactions were detected between MGL and MUC1(ST), a glycoform of MUC1 also expressed by breast carcinoma cells. Interestingly, this glycan (ST) can be found on proteins expressed by normal cells, although in this case not on MUC1. Additionally, GalNAc decorated polyethylene glycol displayed similar rupture forces as observed for MUC1(Tn) and MUC1(STn) when forced to unbind from MGL, indicating that GalNAc is an essential group in these interactions. Since the STn glycan decoration is more frequently found on the surface of carcinomas than the Tn glycan, the binding of MUC1 carrying STn to MGL may be more physiologically relevant and may be in part responsible for some of the characteristics of STn expressing tumours.	[Hadjialirezaei, Soosan; Stokke, Bjorn Torger] NTNU Norwegian Univ Sci & Technol, Dept Phys, Biophys & Med Technol, Trondheim, Norway; [Picco, Gianfranco; Beatson, Richard; Burchell, Joy] Kings Coll London, Guys Hosp, Breast Canc Biol, London, England; [Sletmoen, Marit] NTNU Norwegian Univ Sci & Technol, Dept Biotechnol, Trondheim, Norway	Norwegian University of Science & Technology (NTNU); Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Norwegian University of Science & Technology (NTNU)	Sletmoen, M (corresponding author), NTNU Norwegian Univ Sci & Technol, Dept Biotechnol, Trondheim, Norway.	marit.sletmoen@ntnu.no	Beatson, Richard/AAB-1029-2021; Sletmoen, Marit/H-8896-2016; Stokke, Bjørn T/C-4957-2009; Beatson, Richard/AAB-8945-2021	Beatson, Richard/0000-0002-0411-932X; Stokke, Bjørn T/0000-0003-2991-8088; Burchell, Joy/0000-0003-0413-3823	Breast Cancer Now [2011NovPR43]; MRC [MR/J007196/1] Funding Source: UKRI	Breast Cancer Now; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The work was supported by a project grant from Breast Cancer Now, number 2011NovPR43 to Joy Burchell.; The work was supported by a project grant from Breast Cancer Now, number 2011NovPR43. We thank Katsiaryna Siarpilina for collecting the data shown in Fig 6C.	Adhya M, 2016, FISH SHELLFISH IMMUN, V50, P242, DOI 10.1016/j.fsi.2016.01.036; AnandKumar A, 2013, SCAND J IMMUNOL, V78, P1, DOI 10.1111/sji.12019; ASHKIN A, 1986, OPT LETT, V11, P288, DOI 10.1364/OL.11.000288; Aspholm M, METHODS ENZYMOLOGY, P293; Babino A, 2000, INT J CANCER, V86, P753, DOI 10.1002/(SICI)1097-0215(20000615)86:6<753::AID-IJC1>3.0.CO;2-#; Backstrom M, 2003, BIOCHEM J, V376, P677, DOI 10.1042/BJ20031130; Beatson R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125994; BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575; Berg-Sorensen K, 2004, REV SCI INSTRUM, V75, P594, DOI 10.1063/1.1645654; Brockhausen I, 2006, EMBO REP, V7, P599, DOI 10.1038/sj.embor.7400705; Capitanio M, 2013, BIOPHYS J, V105, P1293, DOI 10.1016/j.bpj.2013.08.007; Carrascal MA, 2014, MOL ONCOL, V8, P753, DOI 10.1016/j.molonc.2014.02.008; Coceano G, 2016, NANOTECHNOLOGY, V27, DOI 10.1088/0957-4484/27/6/065102; Dalziel M, 2001, J BIOL CHEM, V276, P11007, DOI 10.1074/jbc.M006523200; Dube DH, 2005, NAT REV DRUG DISCOV, V4, P477, DOI 10.1038/nrd1751; Dudko OK, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.108101; Dudko OK, 2008, P NATL ACAD SCI USA, V105, P15755, DOI 10.1073/pnas.0806085105; Dudko OK, 2007, BIOPHYS J, V92, P4188, DOI 10.1529/biophysj.106.102855; Evans E, 1997, BIOPHYS J, V72, P1541, DOI 10.1016/S0006-3495(97)78802-7; Evans E, 2001, ANNU REV BIOPH BIOM, V30, P105, DOI 10.1146/annurev.biophys.30.1.105; Evans EB, 1999, BIOPHYS CHEM, V82, P83, DOI 10.1016/S0301-4622(99)00108-8; Fernandez-Busquets X, 2009, MOL BIOL EVOL, V26, P2551, DOI 10.1093/molbev/msp170; Gilbert Y, 2007, NANO LETT, V7, P796, DOI 10.1021/nl0700853; Gill DJ, 2013, P NATL ACAD SCI USA, V110, pE3152, DOI 10.1073/pnas.1305269110; Godula K, 2012, J AM CHEM SOC, V134, P15732, DOI 10.1021/ja302193u; Harder A, 2015, BIOPHYS J, V108, P1709, DOI 10.1016/j.bpj.2015.02.028; Hati AG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141237; Hollingsworth MA, 2004, NAT REV CANCER, V4, P45, DOI 10.1038/nrc1251; Ishida A, 2008, PROTEOMICS, V8, P3342, DOI 10.1002/pmic.200800039; ITZKOWITZ SH, 1992, GUT, V33, P518, DOI 10.1136/gut.33.4.518; Ju TZ, 2011, ANGEW CHEM INT EDIT, V50, P1770, DOI 10.1002/anie.201002313; Julien S, 2006, GLYCOBIOLOGY, V16, P54, DOI 10.1093/glycob/cwj033; Kunze A, 2013, SCI REP-UK, V3, DOI 10.1038/srep01452; Link T, 2004, J BIOTECHNOL, V110, P51, DOI 10.1016/j.jbiotec.2003.12.008; Lis H, 1998, CHEM REV, V98, P637, DOI 10.1021/cr940413g; Liu SX, 2014, BIOPHYS J, V106, P1844, DOI 10.1016/j.bpj.2014.03.029; Lloyd KO, 1996, J BIOL CHEM, V271, P33325, DOI 10.1074/jbc.271.52.33325; Lorenz B, 2012, J AM CHEM SOC, V134, P3326, DOI 10.1021/ja210304j; Mantovani A, 2010, CURR OPIN IMMUNOL, V22, P231, DOI 10.1016/j.coi.2010.01.009; Marcelo F, 2014, CHEM-EUR J, V20, P16147, DOI 10.1002/chem.201404566; Merkel R, 2001, PHYS REP, V346, P344; MILES DW, 1994, BRIT J CANCER, V70, P1272, DOI 10.1038/bjc.1994.486; MILES DW, 1995, BRIT J CANCER, V71, P1074, DOI 10.1038/bjc.1995.207; Mortezai N, 2013, GLYCOBIOLOGY, V23, P844, DOI 10.1093/glycob/cwt021; Napoletano C, 2007, CANCER RES, V67, P8358, DOI 10.1158/0008-5472.CAN-07-1035; Neuman KC, 2007, ANNU REV MATER RES, V37, P33, DOI 10.1146/annurev.matsci.37.052506.084336; OGATA S, 1992, CANCER RES, V52, P4741; Oshima Y, 2016, BIOL PHARM BULL, V39, P435, DOI 10.1248/bpb.b15-00643; Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014; Radhakrishnan P, 2014, P NATL ACAD SCI USA, V111, pE4066, DOI 10.1073/pnas.1406619111; Raible M, 2004, J BIOTECHNOL, V112, P13, DOI 10.1016/j.jbiotec.2004.04.017; Rao JH, 1998, SCIENCE, V280, P708, DOI 10.1126/science.280.5364.708; Rao JH, 1997, J AM CHEM SOC, V119, P10286, DOI 10.1021/ja971225l; Reichardt NC, 2013, CHEM SOC REV, V42, P4358, DOI 10.1039/c2cs35427f; Ritchie DB, 2015, CURR OPIN STRUC BIOL, V34, P43, DOI 10.1016/j.sbi.2015.06.006; Sletmoen M, 2004, BIOMACROMOLECULES, V5, P1288, DOI 10.1021/bm0345211; Sletmoen M, 2009, BIOPOLYMERS, V91, P719, DOI 10.1002/bip.21213; Solinas G, 2010, J IMMUNOL, V185, P642, DOI 10.4049/jimmunol.1000413; Sorensen AL, 2006, GLYCOBIOLOGY, V16, P96, DOI 10.1093/glycob/cwj044; SPRINGER GF, 1995, CRIT REV ONCOGENESIS, V6, P57, DOI 10.1615/CritRevOncog.v6.i1.50; SPRINGER GF, 1984, SCIENCE, V224, P1198, DOI 10.1126/science.6729450; Stangner T, 2015, PHYS BIOL, V12, DOI 10.1088/1478-3975/12/6/066018; Sundram UN, 1996, J AM CHEM SOC, V118, P13107, DOI 10.1021/ja9621298; Suzuki N, 1996, J IMMUNOL, V156, P128; Talaga ML, 2014, BIOCHEMISTRY-US, V53, P4445, DOI 10.1021/bi5001307; Taylor-Papadimitriou J, 2002, J MAMMARY GLAND BIOL, V7, P209, DOI 10.1023/A:1020360121451; Terasawa K, 1996, CANCER RES, V56, P2229; Tromas C, 2001, ANGEW CHEM INT EDIT, V40, P3052, DOI 10.1002/1521-3773(20010817)40:16<3052::AID-ANIE3052>3.0.CO;2-Q; van Vliet SJ, 2008, J IMMUNOL, V181, P3148, DOI 10.4049/jimmunol.181.5.3148	69	8	8	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2017	12	4							e0175323	10.1371/journal.pone.0175323	http://dx.doi.org/10.1371/journal.pone.0175323			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KD	28414807	Green Published, gold			2022-12-27	WOS:000399874800021
J	Bombeke, K; Langford, ZD; Notebaert, W; Boehler, CN				Bombeke, Klaas; Langford, Zachary D.; Notebaert, Wim; Boehler, C. Nico			The role of temporal predictability for early attentional adjustments after conflict	PLOS ONE			English	Article							COGNITIVE CONTROL; PROACTIVE CONTROL; TASK-RELEVANT; ALPHA POWER; ADAPTATION; INFORMATION; POTENTIALS; ACTIVATION; GO/NOGO; CORTEX	A frequently-studied phenomenon in cognitive-control research is conflict adaptation, or the finding that congruency effects are smaller after incongruent trials. Prominent cognitive control accounts suggest that this adaptation effect can be explained by transient conflict-induced modulations of selective attention, reducing congruency effects on the next trial. In the present study, we investigated these possible attentional modulations in four experiments using the Stroop and Flanker tasks, dissociating possible enhancements of task-relevant information from suppression of task-irrelevant information by varying when this information was presented. In two experiments, the irrelevant stimulus information was randomly presented shortly before, at the same time, or briefly after the presentation of the relevant dimension. In the other two, irrelevant information was always presented first, making this aspect fully predictable. Despite the central role that attentional adjustments play in theoretical accounts of conflict adaption, we only found evidence for such processes in one of the four experiments. Specifically, we found a modulation of the attention-related posterior N1 event-related potential component that was consistent with paying less attention to the irrelevant information after incongruent trials. This was accompanied by increased inter-trial mid-frontal theta power and a theta-power conflict adaptation effect. We interpret these results as evidence for an adaptive mechanism based on relative attentional inhibition. Importantly, this mechanism only clearly seems to be implemented in a very specific context of high temporal predictability, and only in the Flanker task.	[Bombeke, Klaas; Langford, Zachary D.; Notebaert, Wim; Boehler, C. Nico] Univ Ghent, Dept Expt Psychol, Ghent, Belgium	Ghent University	Bombeke, K (corresponding author), Univ Ghent, Dept Expt Psychol, Ghent, Belgium.	klaas.bombeke@ugent.be	Boehler, C. Nico/J-8619-2015	Boehler, C. Nico/0000-0001-5963-2780; Bombeke, Klaas/0000-0003-2056-1246; Langford, Zachary/0000-0003-4805-9119	Flemish Research Foundation (FWO) [3G022513]; Ghent University Multidisciplinary Research Platform "The integrative neuroscience of behavioral control"	Flemish Research Foundation (FWO)(FWO); Ghent University Multidisciplinary Research Platform "The integrative neuroscience of behavioral control"	This work was supported by the Flemish Research Foundation (FWO; 3G022513) and the Ghent University Multidisciplinary Research Platform "The integrative neuroscience of behavioral control". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamse E, 2016, PSYCHOL BULL, V142, P693, DOI 10.1037/bul0000047; Appelbaum LG, 2009, CEREB CORTEX, V19, P2508, DOI 10.1093/cercor/bhp036; Appelbaum LG, 2012, J COGNITIVE NEUROSCI, V24, P1834, DOI 10.1162/jocn_a_00209; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Brier MR, 2010, INT J PSYCHOPHYSIOL, V78, P215, DOI 10.1016/j.ijpsycho.2010.07.011; Carp J, 2009, PSYCHOPHYSIOLOGY, V46, P336, DOI 10.1111/j.1469-8986.2008.00773.x; Clawson A, 2011, PSYCHOPHYSIOLOGY, V48, pS73; Clayson PE, 2011, PSYCHOPHYSIOLOGY, V48, P1621, DOI 10.1111/j.1469-8986.2011.01265.x; Clayson PE, 2011, NEUROPSYCHOLOGIA, V49, P1953, DOI 10.1016/j.neuropsychologia.2011.03.023; Cohen MX, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00030; Compton RJ, 2012, PSYCHOPHYSIOLOGY, V49, P583, DOI 10.1111/j.1469-8986.2012.01354.x; Compton RJ, 2011, PSYCHOPHYSIOLOGY, V48, P583, DOI 10.1111/j.1469-8986.2010.01124.x; Danielmeier C, 2011, J NEUROSCI, V31, P1780, DOI 10.1523/JNEUROSCI.4299-10.2011; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Duthoo W, 2014, PSYCHOL RES-PSYCH FO, V78, P483, DOI 10.1007/s00426-013-0498-4; Duthoo W., 2014, FRONT PSYCHOL, V5; Duthoo W, 2013, PSYCHONOMIC B REV, P1; Duthoo W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110462; Egner T, 2005, NAT NEUROSCI, V8, P1784, DOI 10.1038/nn1594; Egner T, 2007, COGN AFFECT BEHAV NE, V7, P380, DOI 10.3758/CABN.7.4.380; Egner T, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01247; GRATTON G, 1992, J EXP PSYCHOL GEN, V121, P480, DOI 10.1037/0096-3445.121.4.480; Hillyard SA, 1998, P NATL ACAD SCI USA, V95, P781, DOI 10.1073/pnas.95.3.781; Hommel B, 2004, PSYCHOL RES-PSYCH FO, V68, P1, DOI 10.1007/s00426-003-0132-y; Jeffreys H., 1998, THEORY PROBABILITY; Jimenez L, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01042; Jimenez L, 2013, J EXP PSYCHOL HUMAN, V39, P271, DOI 10.1037/a0027734; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; King JA, 2010, J NEUROSCI, V30, P12759, DOI 10.1523/JNEUROSCI.3274-10.2010; Kirmizi-Alsan E, 2006, BRAIN RES, V1104, P114, DOI 10.1016/j.brainres.2006.03.010; Kovacevic S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043957; Larson MJ, 2012, NEUROPSYCHOLOGIA, V50, P426, DOI 10.1016/j.neuropsychologia.2011.12.021; Larson MJ, 2011, INT J PSYCHOPHYSIOL, V82, P69, DOI 10.1016/j.ijpsycho.2011.02.018; Larson MJ, 2009, NEUROPSYCHOLOGIA, V47, P663, DOI 10.1016/j.neuropsychologia.2008.11.013; Lopez-Calderon J, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00213; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; Marco-Pallares J, 2008, J COGNITIVE NEUROSCI, V20, P1595, DOI 10.1162/jocn.2008.20117; Mayr U, 2003, NAT NEUROSCI, V6, P450, DOI 10.1038/nn1051; Nobre AC, 2001, NEUROPSYCHOLOGIA, V39, P1317; Notebaert W, 2006, PSYCHON B REV, V13, P1078, DOI 10.3758/BF03213929; Pastotter B, 2013, DYNAMIC ADJUSTMENTS; Polk TA, 2008, J NEUROSCI, V28, P13786, DOI 10.1523/JNEUROSCI.1026-08.2008; Roelofs A, 2010, ACTA PSYCHOL, V133, P146, DOI 10.1016/j.actpsy.2009.11.003; Scerif G, 2006, J COGNITIVE NEUROSCI, V18, P781, DOI 10.1162/jocn.2006.18.5.781; Schmidt JR, 2011, ACTA PSYCHOL, V138, P176, DOI 10.1016/j.actpsy.2011.06.002; Suzuki K, 2015, BRAIN COGNITION, V100, P7, DOI 10.1016/j.bandc.2015.09.001; Tang D, 2013, BIOL PSYCHOL, V93, P364, DOI 10.1016/j.biopsycho.2013.03.004; Ullsperger M, 2005, COGN AFFECT BEHAV NE, V5, P467, DOI 10.3758/CABN.5.4.467; Weissman DH, 2015, ACTA PSYCHOL, V156, P8, DOI 10.1016/j.actpsy.2015.01.003; Weissman DH, 2014, J EXP PSYCHOL HUMAN, V40, P2022, DOI 10.1037/a0037454	50	4	4	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2017	12	4							e0175694	10.1371/journal.pone.0175694	http://dx.doi.org/10.1371/journal.pone.0175694			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET0MD	28410395	gold, Green Published, Green Submitted			2022-12-27	WOS:000399955600036
J	Korom, RR; Onguka, S; Halestrap, P; McAlhaney, M; Adam, M				Korom, Robert Ryan; Onguka, Stephanie; Halestrap, Peter; McAlhaney, Maureen; Adam, Mary			Brief educational interventions to improve performance on novel quality metrics in ambulatory settings in Kenya: A multi-site pre-post effectiveness trial	PLOS ONE			English	Article							GUIDELINES; DIAGNOSIS	Background The quality of primary care delivered in resource-limited settings is low. While some progress has been made using educational interventions, it is not yet clear how to sustainably improve care for common acute illnesses in the outpatient setting. Management of urinary tract infection is particularly important in resource-limited settings, where it is commonly diagnosed and associated with high levels of antimicrobial resistance. We describe an educational programme targeting non-physician health care providers and its effects on various clinical quality metrics for urinary tract infection. Methods We used a series of educational interventions including 1) formal introduction of a clinical practice guideline, 2) peer-to-peer chart review, and 3) peer-reviewed literature describing local antimicrobial resistance patterns. Interventions were conducted for clinical officers (N = 24) at two outpatient centers near Nairobi, Kenya over a one-year period. The medical records of 474 patients with urinary tract infections were scored on five clinical quality metrics, with the primary outcome being the proportion of cases in which the guideline-recommended antibiotic was prescribed. The results at baseline and following each intervention were compared using chi-squared tests and unpaired two-tailed T-tests for significance. Logistic regression analysis was used to assess for possible confounders. Findings Clinician adherence to the guideline-recommended antibiotic improved significantly during the study period, from 19% at baseline to 68% following all interventions (X-2 = 150.7, p < 0.001). The secondary outcome of composite quality score also improved significantly from an average of 2.16 to 3.00 on a five-point scale (t = 6.58, p < 0.001). Interventions had different effects at different clinical sites; the primary outcome of appropriate antibiotic prescription was met 83% of the time at Penda Health, and 50% of the time at AICKH, possibly reflecting differences in onboarding and management of clinical officers. Logistic regression analysis showed that intervention stage and clinical site were independent predictors of the primary outcome (p < 0.0001), while all other features, including provider and patient age, were not significant at a conservative threshold of p < 0.05. Conclusion This study shows that brief educational interventions can dramatically improve the quality of care for routine acute illnesses in the outpatient setting. Measurement of quality metrics allows for further targeting of educational interventions depending on the needs of the providers and the community. Further study is needed to expand routine measurement of quality metrics and to identify the interventions that are most effective in improving quality of care.	[Korom, Robert Ryan] Penda Hlth, Nairobi, Kenya; [Korom, Robert Ryan] Harvard Univ, Massachusetts Gen Hosp, Dept Med, Boston, MA 02115 USA; [Onguka, Stephanie] Kabarak Univ, Kabarak, Kenya; [Halestrap, Peter; McAlhaney, Maureen; Adam, Mary] AIC Kijabe Hosp, Kijabe, Kenya	Harvard University; Massachusetts General Hospital	Korom, RR (corresponding author), Penda Hlth, Nairobi, Kenya.; Korom, RR (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Dept Med, Boston, MA 02115 USA.	Rob.Korom@gmail.com		Korom, Robert/0000-0003-1567-4991	Harvard Catalyst The Harvard Clinical and Translational Science Center [UL1 TR001102]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001102] Funding Source: NIH RePORTER	Harvard Catalyst The Harvard Clinical and Translational Science Center; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was conducted with support from Harvard Catalyst The Harvard Clinical and Translational Science Center (National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health Award UL1 TR001102) and financial contributions from Harvard University and its affiliated academic healthcare centers. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was conducted with support from Harvard Catalyst I The Harvard Clinical and Translational Science Center (National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health Award UL1 TR001102) and financial contributions from Harvard University and its affiliated academic healthcare centers. The content is solely the responsibility of the authors and does not necessarily represent the official views of Harvard Catalyst, Harvard University and its affiliated academic healthcare centers, or the National Institutes of Health.; Thanks to Patrick Beukema for assistance with statistical methods.	Barnes J, 2009, KENYA PRIVATE HLTH S; Berendes S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000433; Bishop TF, 2013, JAMA-J AM MED ASSOC, V309, P1353, DOI 10.1001/jama.2013.1220; Colgan R, 2011, AM FAM PHYSICIAN, V84, P771; Gathara D, 2015, IMPLEMENT SCI, V10, DOI 10.1186/s13012-015-0245-x; Global Antibiotic Resistance Partnership-Kenya Working Group, 2011, SIT AN REC ANT US RE; Grigoryan L, 2014, JAMA-J AM MED ASSOC, V312, P1677, DOI 10.1001/jama.2014.12842; Grimshaw JM, 2004, HEALTH TECHNOL ASSES, V8, P1, DOI 10.3310/hta8060; Gupta K, 2011, CLIN INFECT DIS, V52, pE103, DOI [10.1093/cid/ciq257, 10.1093/cid/cir102]; Kuehlein T, 2011, BMJ QUAL SAF, V20, P522, DOI 10.1136/bmjqs.2010.047357; McGlynn EA, 2014, JAMA-J AM MED ASSOC, V312, P1517, DOI 10.1001/jama.2014.12819; Ministry of Public Health and Sanitation, 2009, CLIN MAN REF GUID; Mwaniki P, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-312; Okinda N A, 2012, East Afr Med J, V89, P147; Scott KW, 2014, NEW ENGL J MED, V371, P3, DOI 10.1056/NEJMp1402157; Sodhi S, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-S1-S8; Spreng CP, 2014, INT J QUAL HEALTH C, V26, P388, DOI 10.1093/intqhc/mzu054	17	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2017	12	4							e0174566	10.1371/journal.pone.0174566	http://dx.doi.org/10.1371/journal.pone.0174566			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0MD	28410366	gold, Green Submitted, Green Published			2022-12-27	WOS:000399955600005
J	Pan, X; Hou, L; Liu, KC				Pan, Xue; Hou, Lei; Liu, Kecheng			Social influence on selection behaviour: Distinguishing local- and global-driven preferential attachment	PLOS ONE			English	Article							PEER INFLUENCE; NETWORKS; POPULARITY; SIMILARITY; EMERGENCE; CONTAGION; DYNAMICS; SPREAD	Social influence drives human selection behaviours when numerous objects competing for limited attentions, which leads to the 'rich get richer' dynamics where popular objects tend to get more attentions. However, evidences have been found that, both the global information of the whole system and the local information among one's friends have significant influence over the one's selection. Consequently, a key question raises that, it is the local information or the global information more determinative for one's selection? Here we compare the local-based influence and global-based influence. We show that, the selection behaviour is mainly driven by the local popularity of the objects while the global popularity plays a supplementary role driving the behaviour only when there is little local information for the user to refer to. Thereby, we propose a network model to describe the mechanism of user-object interaction evolution with social influence, where the users perform either local-driven or global-driven preferential attachments to the objects, i.e., the probability of an objects to be selected by a target user is proportional to either its local popularity or global popularity. The simulation suggests that, about 75% of the attachments should be driven by the local popularity to reproduce the empirical observations. It means that, at least in the studied context where users chose businesses on Yelp, there is a probability of 75% for a user to make a selection according to the local popularity. The proposed model and the numerical findings may shed some light on the study of social influence and evolving social systems.	[Pan, Xue; Hou, Lei; Liu, Kecheng] Univ Reading, Henley Business Sch, Informat Res Ctr, Reading RG6 6UD, Berks, England; [Liu, Kecheng] Shanghai Univ Finance & Econ, Data Sci & Cloud Serv Res Ctr, Shanghai 200433, Peoples R China	University of Reading; Shanghai University of Finance & Economics	Hou, L; Liu, KC (corresponding author), Univ Reading, Henley Business Sch, Informat Res Ctr, Reading RG6 6UD, Berks, England.; Liu, KC (corresponding author), Shanghai Univ Finance & Econ, Data Sci & Cloud Serv Res Ctr, Shanghai 200433, Peoples R China.	l.hou@pgr.reading.ac.uk; k.liu@henley.ac.uk	HOU, Lei/B-2899-2015	HOU, Lei/0000-0002-8022-0729				Aral S, 2011, MANAGE SCI, V57, P1623, DOI 10.1287/mnsc.1110.1421; Aral S, 2009, P NATL ACAD SCI USA, V106, P21544, DOI 10.1073/pnas.0908800106; BANERJEE AV, 1992, Q J ECON, V107, P797, DOI 10.2307/2118364; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Bikhchandani S, 1998, J ECON PERSPECT, V12, P151, DOI 10.1257/jep.12.3.151; Bond RM, 2012, NATURE, V489, P295, DOI 10.1038/nature11421; Centola D, 2010, SCIENCE, V329, P1194, DOI 10.1126/science.1185231; Chen YB, 2011, J MARKETING RES, V48, P238, DOI 10.1509/jmkr.48.2.238; Christakis NA, 2008, NEW ENGL J MED, V358, P2249, DOI 10.1056/NEJMsa0706154; Christakis NA, 2007, NEW ENGL J MED, V357, P370, DOI 10.1056/NEJMsa066082; Christakis NA, 2013, STAT MED, V32, P556, DOI 10.1002/sim.5408; Crandall David, 2008, P 14 ACM SIGKDD INT, P160, DOI DOI 10.1145/1401890.1401914; Diaz MB, 2010, CHAOS, V20, DOI 10.1063/1.3475411; Fortunato S, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.218701; Hou L, 2014, SCI REP-UK, V4, DOI 10.1038/srep06560; Ji L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121105; KENNY CB, 1992, AM J POLIT SCI, V36, P259, DOI 10.2307/2111432; Kossinets G, 2006, SCIENCE, V311, P88, DOI 10.1126/science.1116869; Lee YJ, 2015, MANAGE SCI, V61, P2241, DOI 10.1287/mnsc.2014.2082; Liu D, 2015, MIS QUART, V39, P729, DOI 10.25300/MISQ/2015/39.3.11; Liu JG, 2016, SCI REP-UK, V6, DOI 10.1038/srep18653; Liu JG, 2013, EUR PHYS J B, V86, DOI 10.1140/epjb/e2013-40328-4; Lorenz J, 2011, P NATL ACAD SCI USA, V108, P9020, DOI 10.1073/pnas.1008636108; McPherson M, 2001, ANNU REV SOCIOL, V27, P415, DOI 10.1146/annurev.soc.27.1.415; Muchnik L, 2013, SCIENCE, V341, P647, DOI 10.1126/science.1240466; Onnela JP, 2010, P NATL ACAD SCI USA, V107, P18375, DOI 10.1073/pnas.0914572107; Pan X, 2014, PHYS LETT A, V378, P2591, DOI 10.1016/j.physleta.2014.07.012; Papadopoulos F, 2012, NATURE, V489, P537, DOI 10.1038/nature11459; Ratkiewicz J, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.158701; Ren ZM, 2016, PHYSICA A, V453, P236, DOI 10.1016/j.physa.2016.02.019; Salganik MJ, 2006, SCIENCE, V311, P854, DOI 10.1126/science.1121066; Tucker CE, 2011, MANAGE SCI, V57, P828, DOI 10.1287/mnsc.1110.1312	33	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2017	12	4							e0175761	10.1371/journal.pone.0175761	http://dx.doi.org/10.1371/journal.pone.0175761			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET0MB	28406984	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000399955400092
J	Antonopoulos, CG; Baptista, MS				Antonopoulos, Chris G.; Baptista, Murilo S.			Maintaining extensivity in evolutionary multiplex networks	PLOS ONE			English	Article							CHARACTERISTIC EXPONENTS; CHAOS; LIMIT; LAW	In this paper, we explore the role of network topology on maintaining the extensive property of entropy. We study analytically and numerically how the topology contributes to maintaining extensivity of entropy in multiplex networks, i.e. networks of subnetworks (layers), by means of the sum of the positive Lyapunov exponents, HKS, a quantity related to entropy. We show that extensivity relies not only on the interplay between the coupling strengths of the dynamics associated to the intra (short-range) and inter (long-range) interactions, but also on the sum of the intra-degrees of the nodes of the layers. For the analytically treated networks of size N, among several other results, we show that if the sum of the intra-degrees (and the sum of inter-degrees) scales as N theta+1,theta> 0, extensivity can be maintained if the intra-coupling (and the inter-coupling) strength scales as N-theta, when evolution is driven by the maximisation of HKS. We then verify our analytical results by performing numerical simulations in multiplex networks formed by electrically and chemically coupled neurons.	[Antonopoulos, Chris G.] Univ Essex, Dept Math Sci, Wivenhoe Pk, Colchester, Essex, England; [Baptista, Murilo S.] Univ Aberdeen, Inst Complex Sci & Math Biol, SUPA, Aberdeen, Scotland	University of Essex; University of Aberdeen	Antonopoulos, CG (corresponding author), Univ Essex, Dept Math Sci, Wivenhoe Pk, Colchester, Essex, England.	canton@essex.ac.uk	Antonopoulos, Chris G./A-2354-2015; baptista, murilo s/B-7277-2008	Antonopoulos, Chris G./0000-0001-7195-6892; 	Engineering and Physical Sciences Research Council (EPSRC) [EP/I032606/1]; EPSRC [EP/I032606/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/I032606/1] Funding Source: researchfish	Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	C. G. A. and M. S. B. acknowledge financial support provided by the Engineering and Physical Sciences Research Council (EPSRC) (https://www.epsrc.ac.uk/) Ref: EP/I032606/1 grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Dr N. Rubido for discussions about the extensive character of complex networks, and Dr Rodrigo F. Pereira for valuable discussions, especially with regard to the finite nature of super-extensive behaviour. This work was performed using both the Maxwell high performance computing cluster and the ICSMB cluster of the University of Aberdeen. Both authors acknowledge financial support provided by the EPSRC Ref: EP/I032606/1 grant. C. G. A. contributed to this work while working at the University of Aberdeen and then, when working at the University of Essex.	Antonopoulos CG, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004372; Baptista M, 2013, SCI REPORTS, V6, P1; Baptista MS, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.026205; Baptista MS, 2011, PHYS LETT A, V375, P1309, DOI 10.1016/j.physleta.2011.01.054; Baptista MS, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.036203; Barreira L, 2002, LYAPUNOV EXPONENTS S, V23; Benettin G., 1980, MECCANICA, V15, P21, DOI [10.1007/BF02128237, DOI 10.1007/BF02128237]; Boccaletti S, 2014, PHYS REP, V544, P1, DOI 10.1016/j.physrep.2014.07.001; CHATE H, 1992, PROG THEOR PHYS, V87, P1, DOI 10.1143/PTP.87.1; Chung F.R., 1997, AM MATH SOC, V92, DOI DOI 10.1038/s41467-018-03133-y; ECKMANN JP, 1985, REV MOD PHYS, V57, P617, DOI 10.1103/RevModPhys.57.617; Giorgilli A., 1980, MECCANICA, V15, P9, DOI 10.1007/BF02128236; Gomez S, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.028701; He Y, 2007, CEREB CORTEX, V17, P2407, DOI 10.1093/cercor/bhl149; HINDMARSH JL, 1984, PROC R SOC SER B-BIO, V221, P87, DOI 10.1098/rspb.1984.0024; KANEKO K, 1990, PHYS REV LETT, V65, P1391, DOI 10.1103/PhysRevLett.65.1391; Kivela M, 2014, J COMPLEX NETW, V2, P203, DOI 10.1093/comnet/cnu016; LIVI R, 1986, J PHYS A-MATH GEN, V19, P2033, DOI 10.1088/0305-4470/19/11/012; Luccioli S, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.138103; Martin-Hernandez J, 2014, PHYSICA A, V404, P92, DOI 10.1016/j.physa.2014.02.043; Monteforte M, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.268104; Newman M.E.J., 2010, NETWORKS INTRO; Paul MR, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.045203; Pesin YB., 1977, RUSS MATH SURV, V32, P55, DOI [10.1070/RM1977v032n04ABEH001639, DOI 10.1070/RM1977V032N04ABEH001639]; Pesin YB, 1976, IZV AKAD NAUK SSSR M, V40, P1332; PIKOVSKY AS, 1994, PHYS REV LETT, V72, P1644, DOI 10.1103/PhysRevLett.72.1644; RUELLE D, 1982, COMMUN MATH PHYS, V87, P287, DOI 10.1007/BF01218566; Ruelle D., 1978, BOL SOC BRAS MAT, V9, P83, DOI DOI 10.1007/BF02584795; Skokos C, 2010, LECT NOTES PHYS, V790, P63, DOI 10.1007/978-3-642-04458-8_2; Sole-Ribalta A, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.032807; Takeuchi KA, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.124101; Takeuchi KA, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.154103; Van Mieghem P., 2010, GRAPH SPECTRA COMPLE; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; WOLF A, 1985, PHYSICA D, V16, P285, DOI 10.1016/0167-2789(85)90011-9	36	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2017	12	4							e0175389	10.1371/journal.pone.0175389	http://dx.doi.org/10.1371/journal.pone.0175389			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LZ	28403162	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000399955200058
J	Han, BY; Li, Y; Han, HT; Zhao, YF; Pan, QJ; Ren, LM				Han, Binyue; Li, Yan; Han, Haitang; Zhao, Yaofeng; Pan, Qingjie; Ren, Liming			Three IgH isotypes, IgM, IgA and IgY are expressed in Gentoo penguin and zebra finch	PLOS ONE			English	Article							IMMUNOGLOBULIN HEAVY-CHAIN; RAINBOW-TROUT; EXTENSIVE DIVERSIFICATION; GENES; LOCUS; REGION; BIRDS; EVOLUTION; IDENTIFICATION; REPERTOIRE	Previous studies on a limited number of birds suggested that the IgD-encoding gene was absent in birds. However, one of our recent studies showed that the gene was definitely expressed in the ostrich and emu. Interestingly, we also identified subclass diversification of IgM and IgY in these two birds. To better understand immunoglobulin genes in birds, in this study, we analyzed the immunoglobulin heavy chain genes in the zebra finch (Taeniopygia guttata) and Gentoo penguin (Pygoscelis papua), belonging respectively to the order Passeriformes, the most successful bird order in terms of species diversity and numbers, and Sphenisciformes, a relatively primitive avian order. Similar to the results obtained in chickens and ducks, only three genes encoding immunoglobulin heavy chain isotypes, IgM, IgA and IgY, were identified in both species. Besides, we detected a transcript encoding a short membrane-bound IgA lacking the last two CH exons in the Gentoo penguin. We did not find any evidence supporting the presence of IgD gene or subclass diversification of IgM/IgY in penguin or zebra finch. The obtained data in our study provide more insights into the immunoglobulin heavy chain genes in birds and may help to better understand the evolution of immunoglobulin genes in tetrapods.	[Han, Binyue; Han, Haitang; Zhao, Yaofeng; Ren, Liming] China Agr Univ, State Key Lab Agrobiotechnol, Beijing, Peoples R China; [Li, Yan; Pan, Qingjie] Qingdao Agr Univ, Key Lab Anim Reprod & Germplasm Enhancement Univ, Qingdao, Peoples R China	China Agricultural University; Qingdao Agricultural University	Ren, LM (corresponding author), China Agr Univ, State Key Lab Agrobiotechnol, Beijing, Peoples R China.; Pan, QJ (corresponding author), Qingdao Agr Univ, Key Lab Anim Reprod & Germplasm Enhancement Univ, Qingdao, Peoples R China.	qjpan@126.com; renim@cau.edu.cn						AMEMIYA CT, 1989, NUCLEIC ACIDS RES, V17, P5388, DOI 10.1093/nar/17.13.5388; Bengten E, 2000, CURR TOP MICROBIOL, V248, P189; Brown JW, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-6; Cheng G, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2317; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Choi JW, 2010, VET IMMUNOL IMMUNOP, V136, P248, DOI 10.1016/j.vetimm.2010.03.014; Danilova N, 2005, NAT IMMUNOL, V6, P295, DOI 10.1038/ni1166; Flajnik MF, 2010, NAT REV GENET, V11, P47, DOI 10.1038/nrg2703; Flajnik MF, 2002, NAT REV IMMUNOL, V2, P688, DOI 10.1038/nri889; GREENBERG AS, 1995, NATURE, V374, P168, DOI 10.1038/374168a0; Han BY, 2016, J IMMUNOL, V196, P5138, DOI 10.4049/jimmunol.1600307; Hansen JD, 2005, P NATL ACAD SCI USA, V102, P6919, DOI 10.1073/pnas.0500027102; Huang T, 2016, DEV COMP IMMUNOL, V60, P160, DOI 10.1016/j.dci.2016.02.024; Lanning DK, 2003, GENE, V309, P135, DOI 10.1016/S0378-1119(03)00500-6; Li LX, 2012, J IMMUNOL, V189, P3995, DOI 10.4049/jimmunol.1200188; Lundqvist ML, 2006, DEV COMP IMMUNOL, V30, P93, DOI 10.1016/j.dci.2005.06.019; Lundqvist ML, 2001, J BIOL CHEM, V276, P46729, DOI 10.1074/jbc.M106221200; Modesto SP, 2004, SYST BIOL, V53, P815, DOI 10.1080/10635150490503026; Ohta Y, 2006, P NATL ACAD SCI USA, V103, P10723, DOI 10.1073/pnas.0601407103; Olivieri DN, 2016, MOL IMMUNOL, V72, P81, DOI 10.1016/j.molimm.2016.03.003; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; PARVARI R, 1987, EMBO J, V6, P97, DOI 10.1002/j.1460-2075.1987.tb04724.x; Pereira SL, 2006, MOL BIOL EVOL, V23, P1731, DOI 10.1093/molbev/msl038; Prum RO, 2015, NATURE, V526, P569, DOI 10.1038/nature15697; Ramirez-Gomez F, 2012, J IMMUNOL, V188, P1341, DOI 10.4049/jimmunol.1101938; REYNAUD CA, 1987, CELL, V48, P379, DOI 10.1016/0092-8674(87)90189-9; ROMAN T, 1995, EUR J IMMUNOL, V25, P269, DOI 10.1002/eji.1830250144; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Schaerlinger B, 2008, MOL IMMUNOL, V45, P776, DOI 10.1016/j.molimm.2007.06.356; Shedlock AM, 2007, P NATL ACAD SCI USA, V104, P2767, DOI 10.1073/pnas.0606204104; Subramanian S, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0748; Sun Y, 2011, DEV COMP IMMUNOL, V35, P975, DOI 10.1016/j.dci.2010.12.010; Wang T, 2012, J IMMUNOL, V189, P3557, DOI 10.4049/jimmunol.1200212; Wang XX, 2009, IMMUNOGENETICS, V61, P581, DOI 10.1007/s00251-009-0385-8; WARR GW, 1995, IMMUNOL TODAY, V16, P392, DOI 10.1016/0167-5699(95)80008-5; Woof JM, 2006, J PATHOL, V208, P270, DOI 10.1002/path.1877; Zhao Y, 2000, IMMUNOLOGY, V101, P348, DOI 10.1046/j.1365-2567.2000.00106.x; Zhao YF, 2006, P NATL ACAD SCI USA, V103, P12087, DOI 10.1073/pnas.0600291103; Zhao YF, 2009, J IMMUNOL, V183, P3285, DOI 10.4049/jimmunol.0900469	39	4	5	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2017	12	4							e0173334	10.1371/journal.pone.0173334	http://dx.doi.org/10.1371/journal.pone.0173334			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LZ	28403146	gold, Green Published, Green Submitted			2022-12-27	WOS:000399955200005
J	Migeon, BR; Beer, MA; Bjornsson, HT				Migeon, Barbara R.; Beer, Michael A.; Bjornsson, Hans T.			Embryonic loss of human females with partial trisomy 19 identifies region critical for the single active X	PLOS ONE			English	Article							CHROMOSOME INACTIVATION; SPECIES-DIFFERENCES; ABNORMAL-X; GENES; CELLS; EMBRYOGENESIS; EXPRESSION; HYPOTHESIS; TRIPLOIDY; INTERACTS	To compensate for the sex difference in the number of X chromosomes, human females, like human males have only one active X. The other X chromosomes in cells of both sexes are silenced in utero by XIST, the Inactive X Specific Transcript gene, that is present on all X chromosomes. To investigate the means by which the human active X is protected from silencing by XIST, we updated the search for a key dosage sensitive XIST repressor using new cytogenetic data with more precise resolution. Here, based on a previously unknown sex bias in copy number variations, we identify a unique region in our genome, and propose candidate genes that lie within, as they could inactivate XIST. Unlike males, the females who duplicate this region of chromosome 19 (partial 19 trisomy) do not survive embryogenesis; this preimplantation loss of females may be one reason that more human males are born than females.	[Migeon, Barbara R.; Beer, Michael A.; Bjornsson, Hans T.] McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA; [Migeon, Barbara R.; Bjornsson, Hans T.] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA; [Beer, Michael A.] Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University	Migeon, BR (corresponding author), McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA.; Migeon, BR (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA.	bmigeon@jhmi.edu	Bjornsson, Hans/GSN-3911-2022; Beer, Michael/AFV-4282-2022	Bjornsson, Hans/0000-0001-6635-6753; Beer, Michael A/0000-0001-9955-3809; Migeon, Barbara/0000-0002-2932-5226	Wellcome Trust; National Institute of Health [DP5OD017877]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG009380, R01HG007348] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD017877] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We are grateful to many. We thank Patricia A Jacobs for her contributions to, and support of, the single active X hypothesis. Thanks to David Valle for directing us to the DECIPHER database. We also thank Andrew McCallion, Haig Kazazian, Kirby Smith, Hal Dietz, Dimitrios Avramopoulos and Geraldine Seydoux for their helpful comments about the paper, Cate Kiefe for her rendering of Fig 1 and Giovanni Carosso for help with formatting. This study makes use of data generated by the DECIPHER community. A full list of centres that contributed to the generation of the data is available from http://decipher.sanger.ac.uk and via email from decipher@sanger.ac.uk. Funding for the DECIPHER project was provided by the Wellcome Trust.; This work was supported in part by National Institute of Health (Director's Early Independence Award, DP5OD017877).	BARR M L, 1960, Can Med Assoc J, V83, P979; Boklage CE, 2005, HUM REPROD, V20, P583, DOI 10.1093/humrep/deh662; Bostick M, 2007, SCIENCE, V317, P1760, DOI 10.1126/science.1147939; Boulard M, 2016, EPIGENET CHROMATIN, V9, DOI 10.1186/s13072-016-0069-1; Casanova M, 2016, SEMIN CELL DEV BIOL, V56, P48, DOI 10.1016/j.semcdb.2016.05.003; Debril MB, 2005, J MOL ENDOCRINOL, V35, P503, DOI 10.1677/jme.1.01856; Deng XX, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000751; Durbin R., 1998, BIOL SEQUENCE ANAL P; Fukuda A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6464; Gartler SM, 2006, BMC GENET, V7, DOI 10.1186/1471-2156-7-41; Gontan C, 2012, NATURE, V485, P386, DOI 10.1038/nature11070; Grimwood J, 2004, NATURE, V428, P529, DOI 10.1038/nature02399; Grumbach M. M., 1963, P NATL ACAD SCI USA, V69, P3138; HENDRICH BD, 1993, HUM MOL GENET, V2, P663, DOI 10.1093/hmg/2.6.663; JACOBS PA, 1979, AM J HUM GENET, V31, P446; JACOBS PA, 1989, CYTOGENET CELL GENET, V50, P75, DOI 10.1159/000132727; Lukic S, 2014, CELL DEATH DIFFER, V21, P381, DOI 10.1038/cdd.2013.150; LYON MF, 1962, AM J HUM GENET, V14, P135; Mathews T J, 2005, Natl Vital Stat Rep, V53, P1; McGraw S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003873; McHugh CA, 2015, NATURE, V521, P232, DOI 10.1038/nature14443; Migeon B, 2014, FEMALES ARE MOSAICS; Migeon BR, 2008, EUR J HUM GENET, V16, P153, DOI 10.1038/sj.ejhg.5201944; Migeon BR, 2016, SEMIN CELL DEV BIOL, V56, P111, DOI 10.1016/j.semcdb.2016.01.024; Migeon BR, 2011, HUM GENET, V130, P281, DOI 10.1007/s00439-011-1016-7; MIGEON BR, 1979, CELL, V18, P637, DOI 10.1016/0092-8674(79)90118-1; Migeon BR, 2002, AM J HUM GENET, V71, P286, DOI 10.1086/341605; Moindrot B, 2016, SEMIN CELL DEV BIOL, V56, P58, DOI 10.1016/j.semcdb.2016.01.029; MUKHERJEE BB, 1964, P NATL ACAD SCI USA, V51, P252, DOI 10.1073/pnas.51.2.252; Okamoto I, 2009, CHROMOSOME RES, V17, P659, DOI 10.1007/s10577-009-9057-7; Panning B, 1996, GENE DEV, V10, P1991, DOI 10.1101/gad.10.16.1991; Percec I, 2003, GENETICS, V164, P1481; RUSSELL LB, 1964, T NEW YORK ACAD SCI, V26, P726, DOI 10.1111/j.2164-0947.1964.tb01939.x; Uysal F, 2015, BIOCHIMIE, V116, P103, DOI 10.1016/j.biochi.2015.06.019; von Meyenn F, 2016, MOL CELL, V62, P983, DOI 10.1016/j.molcel.2016.06.005; WEAVER DD, 1975, HUMANGENETIK, V28, P39, DOI 10.1007/BF00272480	36	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2017	12	4							e0170403	10.1371/journal.pone.0170403	http://dx.doi.org/10.1371/journal.pone.0170403			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LZ	28403217	Green Submitted, gold, Green Published			2022-12-27	WOS:000399955200001
J	Chen, X; Zhang, SJ; Cheng, ZR; Cooke, JS; Werling, D; Wathes, DC; Pollott, GE				Chen, Xing; Zhang, Shujun; Cheng, Zhangrui; Cooke, Jessica S.; Werling, Dirk; Wathes, D. Claire; Pollott, Geoffrey E.			Polymorphisms in the selectin gene cluster are associated with fertility and survival time in a population of Holstein Friesian cows	PLOS ONE			English	Article							SOLUBLE P-SELECTIN; AFFECTING CLINICAL MASTITIS; SOMATIC-CELL COUNT; LEUKOCYTE ADHESION; SPONTANEOUS-ABORTIONS; MILK-PRODUCTION; PREGNANCY LOSS; DAIRY FARMS; NEUTROPHILS; EXPRESSION	Selectins are adhesion molecules, which mediate attachment between leucocytes and endothelium. They aid extravasation of leucocytes from blood into inflamed tissue during the mammary gland's response to infection. Selectins are also involved in attachment of the conceptus to the endometrium and subsequent placental development. Poor fertility and udder health are major causes for culling dairy cows. The three identified bovine selectin genes SELP, SELL and SELE are located in a gene cluster. SELP is the most polymorphic of these genes. Several SNP in SELP and SELE are associated with human vascular disease, while SELP SNP rs6127 has been associated with recurrent pregnancy loss in women. This study describes the results of a gene association study for SNP in SELP (n = 5), SELL (n = 2) and SELE (n = 1) with fertility, milk production and longevity traits in a population of 337 Holstein Friesian dairy cows. Blood samples for PCR-RFLP were collected at 6 months of age and animals were monitored until either culling or 2,340 days from birth. Three SNP in SELPEx4-6 formed a haplotype block containing a Glu/Ala substitution at rs42312260. This region was associated with poor fertility and reduced survival times. SELPEx8 (rs378218397) coded for a Val475Met variant locus in the linking region between consensus repeats 4 and 5, which may influence glycosylation. The synonymous SNP rs110045112 in SELEEx14 deviated from Hardy Weinberg equilibrium. For both this SNP and rs378218397 there were too few AA homozygotes present in the population and AG heterozygotes had significantly worse fertility than GG homozygotes. Small changes in milk production associated with some SNP could not account for the reduced fertility and only SELPEx6 showed any association with somatic cell count. These results suggest that polymorphisms in SELP and SELE are associated with the likelihood of successful pregnancy, potentially through compromised implantation and placental development.	[Chen, Xing; Zhang, Shujun; Cheng, Zhangrui; Wathes, D. Claire] Huazhong Agr Univ, Minist Educ, Key Lab Agr Anim Genet Breeding & Reprod, Wuhan, Peoples R China; [Chen, Xing; Zhang, Shujun; Cheng, Zhangrui; Cooke, Jessica S.; Werling, Dirk; Wathes, D. Claire; Pollott, Geoffrey E.] Royal Vet Coll, Hatfield, Herts, England; [Cooke, Jessica S.] Volac Int Ltd, Orwell, Royston, England	Huazhong Agricultural University; University of London; University of London Royal Veterinary College	Wathes, DC (corresponding author), Huazhong Agr Univ, Minist Educ, Key Lab Agr Anim Genet Breeding & Reprod, Wuhan, Peoples R China.; Wathes, DC (corresponding author), Royal Vet Coll, Hatfield, Herts, England.	dcwathes@rvc.ac.uk	Werling, Dirk/F-5555-2013	Werling, Dirk/0000-0001-5411-4044; Wathes, D Claire/0000-0002-8206-6091	European Union FP7 projects [PIIF-GA-2012-328205, PIIFR-GA-2012-912205]; Ministry of Agriculture, China (Research platform of international cooperation and exchange in science and technology of Huazhong Agricultural University); Biotechnology and Biological Sciences Research Council [BB/G530333/1]; China Scholarship Council; DairyCo; Defra; BBSRC [BB/G530333/1] Funding Source: UKRI	European Union FP7 projects; Ministry of Agriculture, China (Research platform of international cooperation and exchange in science and technology of Huazhong Agricultural University); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); China Scholarship Council(China Scholarship Council); DairyCo; Defra(Department for Environment, Food & Rural Affairs (DEFRA)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by grants from the European Union FP7 projects (PIIF-GA-2012-328205 (DCW, SZ) and PIIFR-GA-2012-912205 (SZ); ec.europa.eu/research/mariecurieactions), the Ministry of Agriculture, China (Research platform of international cooperation and exchange in science and technology of Huazhong Agricultural University (SZ); http://english.agri.gov.cn) and the Biotechnology and Biological Sciences Research Council (BB/G530333/1 (DW, DCW); www.bbsrc.ac.uk). XC was the recipient of a scholarship from the China Scholarship Council (htip://en.csc.edu.cn). Sample collection was supported by a joint grant from DairyCo (now AHDB Dairy; https://dairy.andb.org.uk) and Defra (https://www.gov.uk/ government/organisationsidepartment-for-environment-food-rural-affairs) (DCW, JSC).	Adamczyk K, 2017, ANIMAL, V11, P327, DOI 10.1017/S1751731116001348; AHDB, 2010, HIGH REPL RAT CAN DA; Ay C, 2008, THROMB HAEMOSTASIS, V99, P899, DOI 10.1160/TH07-11-0672; Bai RL, 2015, BIOL REPROD, V93, DOI 10.1095/biolreprod.115.128652; BARGATZE RF, 1994, J EXP MED, V180, P1785, DOI 10.1084/jem.180.5.1785; Barreiro O, 2010, CARDIOVASC RES, V86, P174, DOI 10.1093/cvr/cvq001; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Berardi C, 2015, HUM GENET, V134, P393, DOI 10.1007/s00439-014-1527-0; Berg DK, 2010, THERIOGENOLOGY, V73, P250, DOI 10.1016/j.theriogenology.2009.09.005; BEVILACQUA MP, 1989, SCIENCE, V243, P1160, DOI 10.1126/science.2466335; Brickell JS, 2011, J DAIRY SCI, V94, P1831, DOI 10.3168/jds.2010-3710; Brickell JS, 2009, THERIOGENOLOGY, V72, P408, DOI 10.1016/j.theriogenology.2009.03.015; Butler ST, 2014, REPROD FERT DEVELOP, V26, P1, DOI 10.1071/RD13304; Charlier C, 2016, GENOME RES, V26, P1333, DOI 10.1101/gr.207076.116; Chen X, 2016, RES VET SCI, V108, P85, DOI 10.1016/j.rvsc.2016.08.004; Chen Xing, 2015, Open Journal of Animal Sciences, V5, P358, DOI 10.4236/ojas.2015.54040; Clempson AM, 2011, ANIMAL, V5, P1335, DOI 10.1017/S1751731111000346; Cole JB, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-408; Collins J, 2008, HUM REPROD UPDATE, V14, P293, DOI 10.1093/humupd/dmn009; Dendana M, 2012, GENE, V495, P72, DOI 10.1016/j.gene.2011.11.034; Diez-Fraile A, 2004, AM J VET RES, V65, P1421, DOI 10.2460/ajvr.2004.65.1421; Eskicioglu F, 2014, GINEKOL POL, V85, P287; Esslemont RJ, 1997, VET REC, V140, P36, DOI 10.1136/vr.140.2.36; Fernekorn U, 2007, BIOL REPROD, V76, P645, DOI 10.1095/biolreprod.106.056192; Foulk RA, 2007, J ASSIST REPROD GEN, V24, P316, DOI 10.1007/s10815-007-9151-8; Fukuda Michiko N., 2012, Shengli Xuebao, V64, P247; Fumagalli M, 2012, HEREDITY, V109, P117, DOI 10.1038/hdy.2012.20; Genbacev OD, 2003, SCIENCE, V299, P405, DOI 10.1126/science.1079546; Gilmour A. R., 2006, ASREML USER GUIDE; Hunt RC, 2014, TRENDS GENET, V30, P308, DOI 10.1016/j.tig.2014.04.006; Karsten CM, 2008, IMMUNOL INVEST, V37, P449, DOI 10.1080/08820130802191250; Khatib H, 2009, J DAIRY SCI, V92, P2238, DOI 10.3168/jds.2008-1767; Klungland H, 2001, MAMM GENOME, V12, P837, DOI 10.1007/s00335001-2081-3; Kropp J, 2014, J DAIRY SCI, V97, P1187, DOI 10.3168/jds.2013-7244; Lee DS, 2008, J THROMB HAEMOST, V6, P20; Ley K, 2003, TRENDS MOL MED, V9, P263, DOI 10.1016/S1471-4914(03)00071-6; Li XF, 2015, INT J CLIN EXP PATHO, V8, P7189; Liao BH, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000001255; Liu SA, 2011, MOL CELL BIOCHEM, V350, P185, DOI 10.1007/s11010-010-0697-x; Macklon NS, 2002, HUM REPROD UPDATE, V8, P333, DOI 10.1093/humupd/8.4.333; Margarit L, 2009, HUM REPROD, V24, P2767, DOI 10.1093/humrep/dep247; McEver RP, 2015, CARDIOVASC RES, V107, P331, DOI 10.1093/cvr/cvv154; McEver RP, 2010, ANNU REV CELL DEV BI, V26, P363, DOI 10.1146/annurev.cellbio.042308.113238; Micke GC, 2010, ANIM REPROD SCI, V118, P163, DOI 10.1016/j.anireprosci.2009.08.006; Mitterhuemer S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-138; Moyes KM, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-542; Nasibullin TR, 2016, MOL BIOL REP, V43, P11, DOI 10.1007/s11033-015-3933-3; Ouyang Y, 2015, HERZ, V40, P197, DOI 10.1007/s00059-014-4122-1; Patel KD, 1995, J CELL BIOL, V131, P1893, DOI 10.1083/jcb.131.6.1893; Preston RC, 2016, J MOL CELL BIOL, V8, P62, DOI 10.1093/jmcb/mjv046; Qi L, 2010, HUM MOL GENET, V19, P1856, DOI 10.1093/hmg/ddq057; Reiner AP, 2008, ARTERIOSCL THROM VAS, V28, P1549, DOI 10.1161/ATVBAHA.108.169532; Revelle BM, 1996, J BIOL CHEM, V271, P4289; Rowe JA, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001082; Schnabel RD, 2005, ANIM GENET, V36, P408, DOI 10.1111/j.1365-2052.2005.01337.x; Sironi M, 2010, MICROBES INFECT, V12, P421, DOI 10.1016/j.micinf.2010.02.002; Sodeland M, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-70; Sorensen LP, 2008, J DAIRY SCI, V91, P2493, DOI 10.3168/jds.2007-0583; Sperandio M, 2003, J EXP MED, V197, P1355, DOI 10.1084/jem.20021854; Stadtmann A, 2013, J EXP MED, V210, P2171, DOI 10.1084/jem.20130664; Subramanian H, 2012, THROMB HAEMOSTASIS, V108, P963, DOI 10.1160/TH12-01-0047; Sullivan TM, 2009, PLACENTA, V30, P348, DOI 10.1016/j.placenta.2009.01.008; Tometten M, 2006, BIOL REPROD, V74, P674, DOI 10.1095/biolreprod.105.044651; Tsuruta S, 2005, J DAIRY SCI, V88, P1156, DOI 10.3168/jds.S0022-0302(05)72782-X; Wall E, 2007, J DAIRY SCI, V90, P1527, DOI 10.3168/jds.S0022-0302(07)71638-7; Wang B, 2008, AM J REPROD IMMUNOL, V60, P127, DOI 10.1111/j.1600-0897.2008.00604.x; Wang HB, 2007, NAT IMMUNOL, V8, P882, DOI 10.1038/ni1491; Wang XY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079301; Wathes DC, 2008, ANIMAL, V2, P1135, DOI 10.1017/S1751731108002322; Wathes DC, 2012, REPROD DOMEST ANIM, V47, P304, DOI 10.1111/j.1439-0531.2012.02090.x; WATHES DC, 1980, AM J ANAT, V159, P285, DOI 10.1002/aja.1001590305; Windig JJ, 2006, J DAIRY SCI, V89, P1765, DOI 10.3168/jds.S0022-0302(06)72245-7; Yoshida T, 2012, ANIM SCI J, V83, P359, DOI 10.1111/j.1740-0929.2011.00972.x; Zenclussen AC, 2001, CELL IMMUNOL, V213, P94, DOI 10.1006/cimm.2001.1877	74	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2017	12	4							e0175555	10.1371/journal.pone.0175555	http://dx.doi.org/10.1371/journal.pone.0175555			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KH	28419109	gold, Green Published, Green Submitted			2022-12-27	WOS:000399875200026
J	Del Pin, SH; Sandberg, K; Bibby, BM; Overgaard, M				Del Pin, Simon Hviid; Sandberg, Kristian; Bibby, Bo Martin; Overgaard, Morten			Weak experiences sufficient for creating illusory figures that influence perception of actual lines	PLOS ONE			English	Article							CONSCIOUS PERCEPTION; ATTENTIONAL BLINK; AWARENESS; TASK; BLINDSIGHT; ACCESS; LEVEL	The question of whether conscious experience is best viewed as graded or dichotomous has received much scientific attention in recent years as the answer is relevant not only to models of consciousness, but also to the examination of neural markers of consciousness in patients and infants. Although some studies have found evidence of graded perception, it is unclear whether such perception is simply composed of individual stimulus features perceived in an all-or-none manner. Here, we examined whether the Kanizsa triangle (an illusory figure that is supposedly only perceived when all its parts are visible) has an impact on line length discrimination across four degrees of subjective visibility. We found that the presence of the Kanizsa triangle biases line length judgments (a phenomenon called the Ponzo illusion) when participants reported any experience (even a weak glimpse) of the stimulus. The results support the view that consciousness is a graded phenomenon. The strength of this support depends on the assumption that all parts of the illusory figure must be perceived for the illusion to work but this assumption is not resolved in the present literature. Currently, evidence can be found both for and against this notion.	[Del Pin, Simon Hviid; Sandberg, Kristian; Overgaard, Morten] Aarhus Univ, CFIN, Cognit Neurosci Res Unit, Aarhus, Denmark; [Del Pin, Simon Hviid] Jagiellonian Univ, Inst Psychol, Consciousness Lab, Krakow, Poland; [Sandberg, Kristian] Aarhus Univ Hosp, Hammel Neurorehabil & Res Ctr, Hammel, Denmark; [Sandberg, Kristian] UCL, Inst Cognit Neurosci, London, England; [Bibby, Bo Martin] Aarhus Univ, Dept Biostat, Aarhus, Denmark	Aarhus University; Jagiellonian University; Aarhus University; University of London; University College London; Aarhus University	Del Pin, SH (corresponding author), Aarhus Univ, CFIN, Cognit Neurosci Res Unit, Aarhus, Denmark.; Del Pin, SH (corresponding author), Jagiellonian Univ, Inst Psychol, Consciousness Lab, Krakow, Poland.	simon.dp@gmail.com		Del Pin, Simon Hviid/0000-0001-7512-3740; Overgaard, Morten/0000-0002-1215-5355; Sandberg, Kristian/0000-0001-6936-5487				Andersen LM, 2015, CEREB CORTEX N Y MAY, V1; Anzulewicz A, 2015, CONSCIOUS COGN, V36, P1, DOI 10.1016/j.concog.2015.05.004; Banica T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161177; Cleeremans A, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00086; Dehaene S, 1998, P NATL ACAD SCI USA, V95, P14529, DOI 10.1073/pnas.95.24.14529; Dehaene S., 2020, WE LEARN NEW SCI ED; Dehaene S, 2006, TRENDS COGN SCI, V10, P204, DOI 10.1016/j.tics.2006.03.007; Del Cul A, 2006, ARCH GEN PSYCHIAT, V63, P1313, DOI 10.1001/archpsyc.63.12.1313; Faugeras F, 2011, NEUROLOGY, V77, P264, DOI 10.1212/WNL.0b013e3182217ee8; Gillam B, 2014, PERCEPTION, V43, P977, DOI 10.1068/p7759; Harris JJ, 2011, PSYCHOL SCI, V22, P399, DOI 10.1177/0956797611399293; KANIZSA G, 1976, SCI AM, V234, P48, DOI 10.1038/scientificamerican0476-48; Kouider S, 2013, SCIENCE, V340, P376, DOI 10.1126/science.1232509; Kouider S, 2010, TRENDS COGN SCI, V14, P301, DOI 10.1016/j.tics.2010.04.006; Merikle PM, 1997, CARN S COGN, P109; Nieuwenhuis S, 2011, ATTEN PERCEPT PSYCHO, V73, P364, DOI 10.3758/s13414-010-0026-1; Overgaard M, 2006, CONSCIOUS COGN, V15, P700, DOI 10.1016/j.concog.2006.04.002; Overgaard M, 2015, CONSCIOUS COGN, V32, P33, DOI 10.1016/j.concog.2014.08.003; Overgaard M, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0209; Overgaard M, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00116; Overgaard M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003028; Persuh M, 2016, ATTEN PERCEPT PSYCHO, V78, P1692, DOI 10.3758/s13414-016-1146-z; Ponzo M, 1911, ARCH ITAL BIOL; Ramsoy T.Z., 2004, PHENOMENOL COGNIT SC, V3, P1, DOI [10.1023/b:phen.0000041900.30172.e8, DOI 10.1023/B:PHEN.0000041900.30172.E8, 10.1023/B:PHEN.0000041900.30172.e8]; Sandberg K, 2014, FRONT PSYCHOL; Sandberg K, 2013, J COGNITIVE NEUROSCI, V25, P969, DOI 10.1162/jocn_a_00353; Sandberg K, 2011, CONSCIOUS COGN, V20, P1659, DOI 10.1016/j.concog.2011.09.002; Sandberg K, 2010, CONSCIOUS COGN, V19, P1069, DOI 10.1016/j.concog.2009.12.013; Sergent C, 2005, NAT NEUROSCI, V8, P1391, DOI 10.1038/nn1549; Sergent C, 2004, PSYCHOL SCI, V15, P720, DOI 10.1111/j.0956-7976.2004.00748.x; Tononi G, 2015, PHILOS T R SOC LON B, V370; Wierzchon M, 2012, CONSCIOUS COGN, V21, P1141, DOI 10.1016/j.concog.2012.05.012; Windey B, 2013, COGNITION, V129, P404, DOI 10.1016/j.cognition.2013.07.012	34	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2017	12	4							e0175339	10.1371/journal.pone.0175339	http://dx.doi.org/10.1371/journal.pone.0175339			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES9KH	28419116	Green Published, Green Submitted, gold			2022-12-27	WOS:000399875200017
J	Rodrigo, JM; Zappacosta, DC; Selva, JP; Garbus, I; Albertini, E; Echenique, V				Manuel Rodrigo, Juan; Carlos Zappacosta, Diego; Pablo Selva, Juan; Garbus, Ingrid; Albertini, Emidio; Echenique, Viviana			Apomixis frequency under stress conditions in weeping lovegrass (Eragrostis curvula)	PLOS ONE			English	Article							GENE-EXPRESSION; APOMICTIC REPRODUCTION; EPIGENETIC REGULATION; METHYLATION; INHERITANCE; SEXUALITY; GENOTYPES; AFLP	To overcome environmental stress, plants develop physiological responses that are triggered by genetic or epigenetic changes, some of which involve DNA methylation. It has been proposed that apomixis, the formation of asexual seeds without meiosis, occurs through the temporal or spatial deregulation of the sexual process mediated by genetic and epigenetic factors influenced by the environment. Here, we explored whether there was a link between the occurrence of apomixis and various factors that generate stress, including drought stress, in vitro culture, and intraspecific hybridization. For this purpose, we monitored the embryo sacs of different weeping lovegrass (Eragrostis curvula [Schrad.] Nees) genotypes after the plants were subjected to these stress conditions. Progeny tests based on molecular markers and genome methylation status were analyzed following the stress treatment. When grown in the greenhouse, the cultivar Tanganyika INTA generated less than 2% of its progeny by sexual reproduction. Plants of this cultivar subjected to different stresses showed an increase of sexual embryo sacs, demonstrating an increased expression of sexuality compared to control plants. Plants of the cv. Tanganyika USDA did not demonstrate the ability to generate sexual embryo sacs under any conditions and is therefore classified as a fully apomictic cultivar. We found that this change in the prevalence of sexuality was correlated with genetic and epigenetic changes analyzed by MSAP and AFLPs profiles. Our results demonstrate that different stress conditions can alter the expression of sexual reproduction in facultative tetraploid apomictic cultivars and when the stress stops the reproductive mode shift back to the apomixis original level. These data together with previous observations allow us to generate a hypothetical model of the regulation of apomixis in weeping lovegrass in which the genetic/s region/s that condition apomixis, is/are affected by ploidy, and is/are subjected to epigenetic control.	[Manuel Rodrigo, Juan; Carlos Zappacosta, Diego; Pablo Selva, Juan; Garbus, Ingrid; Echenique, Viviana] CCT Bahia Blanca, CERZOS CONICET, Bahia Blanca, Buenos Aires, Argentina; [Manuel Rodrigo, Juan; Carlos Zappacosta, Diego; Echenique, Viviana] Univ Nacl Sur, Dept Agron, Bahia Blanca, Buenos Aires, Argentina; [Pablo Selva, Juan] Univ Nacl Sur, Dept Biol Bioquim & Farm, Bahia Blanca, Buenos Aires, Argentina; [Garbus, Ingrid] Univ Nacl Sur, Dept Ciencias Salud, Bahia Blanca, Buenos Aires, Argentina; [Albertini, Emidio] Univ Perugia, Dept Agr Food & Environm Sci, Perugia, Italy	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of the South; National University of the South; National University of the South; University of Perugia	Echenique, V (corresponding author), CCT Bahia Blanca, CERZOS CONICET, Bahia Blanca, Buenos Aires, Argentina.; Echenique, V (corresponding author), Univ Nacl Sur, Dept Agron, Bahia Blanca, Buenos Aires, Argentina.	echeniq@criba.edu.ar	Echenique, Viviana/GRX-7389-2022; Albertini, Emidio/F-7393-2014	Albertini, Emidio/0000-0003-2585-5649; Garbus, Ingrid/0000-0001-9646-689X; Echenique, Viviana/0000-0003-3755-9062	Universidad Nacional del Sur [PGI 24/A199, PIP 112-201101-00767]; Consejo Nacional de Investigaciones Cientificas y Tecnicas [PICT 14624]; Agencia Nacional de Promocion Cientifica y Tecnologica; European Union's Horizon 2020 Research and Innovation Programme under the Marie Sklodowska-Curie Grant [645674]	Universidad Nacional del Sur; Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); European Union's Horizon 2020 Research and Innovation Programme under the Marie Sklodowska-Curie Grant	This work was supported by: PGI 24/A199, Universidad Nacional del Sur, http://www.uns.edu.ar VE; PIP 112-201101-00767, Consejo Nacional de Investigaciones Cientificas y Tecnicas, http://www.conicet.gov.ar VE; PICT 14624, Agencia Nacional de Promocion Cientifica y Tecnologica, http://www.agencia.mincyt.gob.arVE; and European Union's Horizon 2020 Research and Innovation Programme under the Marie Sklodowska-Curie Grant Agreement No 645674, https://ec.europa.eu/programmes/horizon2020/en/h2020-section/marie-sklodowska-curie-actions EA.	Adams KL, 2005, TRENDS GENET, V21, P539, DOI 10.1016/j.tig.2005.07.009; Aliyu OM, 2010, AM J BOT, V97, P1719, DOI 10.3732/ajb.1000188; Arnholdt-Schmitt B, 2000, THEOR APPL GENET, V100, P906, DOI 10.1007/s001220051369; Barcaccia G, 2013, PLANT REPROD, V26, P159, DOI 10.1007/s00497-013-0222-y; Beck JB, 2012, EVOLUTION, V66, P985, DOI 10.1111/j.1558-5646.2011.01507.x; Berman J, 2012, TRENDS GENET, V28, P197, DOI 10.1016/j.tig.2012.01.004; Cardone S, 2006, EUPHYTICA, V151, P263, DOI 10.1007/s10681-006-9156-x; Carman J., BIOL J LINN SOC, V197, P51; Carman J.G., 2015, P PLANT AN GEN C SAN; Castonguay E, 2012, GENET RES INT, V2012, DOI 10.1155/2012/534289; Cervigni GDL, 2008, PLANT MOL BIOL, V67, P11, DOI 10.1007/s11103-008-9305-9; Cosendai AC, 2013, HEREDITY, V110, P560, DOI 10.1038/hdy.2013.1; Echenique V, 1996, PLANT CELL TISS ORG, V46, P123, DOI 10.1007/BF00034845; Echenique V, 2002, THEOR APPL GENET, V104, P840, DOI 10.1007/s00122-001-0849-1; EVANS LT, 1969, AUST J BOT, V17, P375, DOI 10.1071/BT9690375; Fedoroff N, SCIENCE, V338, P758; Fritz G, 1976, INTRO PLANT PHYSL, P445; Fulnecek J, 2014, BMC GENET, V15, DOI 10.1186/1471-2156-15-2; GIMENO CJ, 1992, CELL, V68, P1077, DOI 10.1016/0092-8674(92)90079-R; GOUNARIS EK, 1991, SEX PLANT REPROD, V4, P188, DOI 10.1007/BF00190003; Grimanelli D, 2012, CURR OPIN PLANT BIOL, V15, P57, DOI 10.1016/j.pbi.2011.10.002; Hirochika H, 1996, P NATL ACAD SCI USA, V93, P7783, DOI 10.1073/pnas.93.15.7783; Hiruta C, 2012, MEIOSIS MOL MECH CYT, P109; Horandl E, 2013, PLANT REPROD, V26, P351, DOI 10.1007/s00497-013-0234-7; Hojsgaard DH, 2013, NEW PHYTOL, V197, P336, DOI 10.1111/j.1469-8137.2012.04381.x; Houliston GJ, 2006, FOLIA GEOBOT, V41, P165, DOI 10.1007/BF02806477; JOHANSEN DONALD ALEXANDER, 1940; Klatt S, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00278; KNOX RB, 1967, SCIENCE, V157, P325, DOI 10.1126/science.157.3786.325; KOLTUNOW AM, 1993, PLANT CELL, V5, P1425, DOI 10.1105/tpc.5.10.1425; Koltunow AM, 2003, ANNU REV PLANT BIOL, V54, P547, DOI 10.1146/annurev.arplant.54.110901.160842; Madlung A, 2002, PLANT PHYSIOL, V129, P733, DOI 10.1104/pp.003095; Massicotte R, 2012, GENET RES INT, V2012, DOI 10.1155/2012/317175; Matzk F, 2005, PLANT CELL, V17, P13, DOI 10.1105/tpc.104.027359; Mecchia MA, 2007, J PLANT PHYSIOL, V164, P1051, DOI 10.1016/j.jplph.2006.07.002; Meier M, 2011, AUST J BOT, V59, P253, DOI 10.1071/BT10267; Nedelcu AM, 2004, P ROY SOC B-BIOL SCI, V271, P1591, DOI 10.1098/rspb.2004.2747; Nedelcu AM, 2003, P ROY SOC B-BIOL SCI, V270, pS136, DOI 10.1098/rsbl.2003.0062; Ong-Abdullah M, 2015, NATURE, V525, P533, DOI 10.1038/nature15365; Ortiz JPA, 2013, ANN BOT-LONDON, V112, P767, DOI 10.1093/aob/mct152; Ozias-Akins Peggy, 2003, Functional & Integrative Genomics, V3, P94, DOI 10.1007/s10142-003-0084-8; Rebozzio RN, 2011, BIOL PLANTARUM, V55, P391, DOI 10.1007/s10535-011-0062-2; Rey O, 2016, TRENDS ECOL IN PRESS; Rodriguez-Leal D, 2012, CURR OPIN PLANT BIOL, V15, P549, DOI 10.1016/j.pbi.2012.09.005; Romero J, 2015, BIOL PLANTARUM, V60, P1; Sahu PP, 2013, PLANT CELL REP, V32, P1151, DOI 10.1007/s00299-013-1462-x; Selva J. P., 2012, American Journal of Plant Sciences, V3, P403, DOI 10.4236/ajps.2012.33049; Slotkin RK, 2007, NAT REV GENET, V8, P272, DOI 10.1038/nrg2072; Stein J, 2004, THEOR APPL GENET, V109, P186, DOI 10.1007/s00122-004-1614-z; Streetman L., 1963, WRIGHTIA, V3, P41; TREIER U, 1989, ARCH MICROBIOL, V152, P572, DOI 10.1007/BF00425489; Voigt P, 1992, P AP WORKSH FEB 11 1, P8; VOIGT PW, 1976, CROP SCI, V16, P803, DOI 10.2135/cropsci1976.0011183X001600060017x; VOIGT PW, 1971, CROP SCI, V11, P424, DOI 10.2135/cropsci1971.0011183X001100030034x; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Xu ML, 2000, PLANT MOL BIOL REP, V18, P361, DOI 10.1007/BF02825064; Zappacosta D, 2011, PHYTON-INT J EXP BOT, V80, P211; Zappacosta DC, 2014, SCI REP-UK, V4, DOI 10.1038/srep04423	58	38	39	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2017	12	4							e0175852	10.1371/journal.pone.0175852	http://dx.doi.org/10.1371/journal.pone.0175852			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KH	28419145	Green Published, Green Submitted, gold			2022-12-27	WOS:000399875200049
J	Dagamac, NHA; Rojas, C; Novozhilov, YK; Moreno, GH; Schlueter, R; Schnittler, M				Dagamac, Nikki Heherson A.; Rojas, Carlos; Novozhilov, Yuri K.; Moreno, Gabriel H.; Schlueter, Rabea; Schnittler, Martin			Speciation in progress? A phylogeographic study among populations of Hemitrichia serpula (Myxomycetes)	PLOS ONE			English	Article							DIVERSITY; DISPERSAL; BIOGEOGRAPHY; PHYLOGENY; SOFTWARE; PATTERNS; PROTISTS; GENETICS; UBIQUITY; MODELS	Myxomycetes (plasmodial slime molds, Amoebozoa) are often perceived as widely distributed, confounding to the "everything is everywhere" hypothesis. To test if gene flow within these spore-dispersed protists is restricted by geographical barriers, we chose the widespread but morphologically unmistakable species Hemitrichia serpula for a phylogeographic study. Partial sequences from nuclear ribosomal RNA genes (SSU) revealed 40 ribotypes among 135 specimens, belonging to three major clades. Each clade is dominated by specimens from a certain region and by one of two morphological varieties which can be differentiated by SEM micrographs. Partial sequences of the protein elongation factor 1 alpha (EF1A) showed each clade to possess a unique combination of SSU and EF1A genotypes. This pattern is best explained assuming the existence of several putative biospecies dominating in a particular geographical region. However, occasional mismatches between molecular data and morphological characters, but as well heterogeneous SSU and heterozygous EF1A sequences, point to ongoing speciation. Environmental niche models suggest that the putative biospecies are rather restricted by geographical barriers than by macroecological conditions. Like other protists, myxomycetes seem to follow the moderate endemicity hypothesis and are in active speciation, which is most likely shaped by limited gene flow and reproductive isolation.	[Dagamac, Nikki Heherson A.; Schnittler, Martin] Ernst Moritz Arndt Univ Greifswald, Inst Bot & Landscape Ecol, Soldmannstr 15, Greifswald, Germany; [Rojas, Carlos] Univ Costa Rica, Engn Res Inst, San Pedro, Costa Rica; [Rojas, Carlos] Univ Costa Rica, Dept Agr Engn, San Pedro, Costa Rica; [Novozhilov, Yuri K.] Russian Acad Sci, Komarov Bot Inst, Lab Systemat & Geog Fungi, St Petersburg, Russia; [Moreno, Gabriel H.] Univ Alcala, Dept Biol Vegetal, Madrid, Spain; [Schlueter, Rabea] Ernst Moritz Arndt Univ Greifswald, Inst Microbiol, Lab Electron Microscopy, Greifswald, Germany	Ernst Moritz Arndt Universitat Greifswald; Universidad Costa Rica; Universidad Costa Rica; Russian Academy of Sciences; Komarov Botanical Institute, Russian Academy of Sciences; Universidad de Alcala; Ernst Moritz Arndt Universitat Greifswald	Dagamac, NHA; Schnittler, M (corresponding author), Ernst Moritz Arndt Univ Greifswald, Inst Bot & Landscape Ecol, Soldmannstr 15, Greifswald, Germany.	nhadagamac@gmail.com; martin.schnittler@uni-grefswald.de	Moreno, Gabriel/K-8537-2017; Rojas Cruz, Carlos Alberto/GZM-2307-2022; Dagamac, Nikki Heherson/AAM-6715-2020; Rojas Alvarado, Carlos/L-4361-2014	Rojas Cruz, Carlos Alberto/0000-0003-0915-6653; Dagamac, Nikki Heherson/0000-0002-5155-5415; Rojas Alvarado, Carlos/0000-0002-7968-4833	Deutsche Forschungsgemeinschaft (DFG) [SCHN 1080/2]; Komarov Botanical Institute RAS, St.-Petersburg, Russia [01201255603, 01201255604]; Greifswald University of DAAD scholarship [N11/96421]; DFG	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Komarov Botanical Institute RAS, St.-Petersburg, Russia; Greifswald University of DAAD scholarship; DFG(German Research Foundation (DFG))	Funding for this study was received from the Deutsche Forschungsgemeinschaft (DFG SCHN 1080/2). YKN acknowledges support by scientific programs No 01201255603 and No 01201255604, Komarov Botanical Institute RAS, St.-Petersburg, Russia. Additional Consumables for the study were financed by a support from Greifswald University in the frame of a DAAD scholarship (Grant Number: N11/96421) to NHAD.; NHAD wishes to thank the members of the DFG-funded Research Training Group RESPONSE (RTG 2010) for their help with data evaluation and fruitful discussions. We gratefully acknowledge technical support (SEM) provided by Ludmila A. Kartzeva (Core Facility Center "Cell and Molecular Technologies in Plant Science" at the Komarov Botanical Institute RAS, St. -Petersburg, Russia). For help with specimens of Hemitrichia serpula we are indebted to S.L. Stephenson (Arkansas, USA), A. Kuhnt (Bavaria, Germany), A. Ronikier (Krakow, Poland), T.E. Dela Cruz (Manila, Philippines), and R. McHugh (Wicklow Co., Ireland). The authors would also like to acknowledge P. Skaloud and A. Janke for valuable comments that helped to improve this manuscript.	Adl SM, 2014, SOIL BIOL BIOCHEM, V69, P328, DOI 10.1016/j.soilbio.2013.10.024; Aguilar M, 2014, ISME J, V8, P737, DOI 10.1038/ismej.2013.183; Anderson AM, 2013, FRESHW SCI, V32, P892, DOI 10.1899/12-026.1; Baldauf SL, 1997, P NATL ACAD SCI USA, V94, P12007, DOI 10.1073/pnas.94.22.12007; Bates ST, 2013, ISME J, V7, P652, DOI 10.1038/ismej.2012.147; CAVALCANTI L.H., 2001, ACTA BOT BRAS, V15, P133; Chao A, 2005, ECOL LETT, V8, P148, DOI 10.1111/j.1461-0248.2004.00707.x; Clark J, 2013, MYCOSPHERE, V4, P233, DOI 10.5943/mycosphere/4/2/6; Clark J., 2000, Stapfia, V73, P39; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; COLLINS O R, 1981, Journal of the Elisha Mitchell Scientific Society, V97, P101; COLWELL R. K., 2013, ESTIMATES STATISTICA; Cotterill FPD, 2008, BIODIVERS CONSERV, V17, P427, DOI 10.1007/s10531-007-9261-8; Dalgleish D, 2015, CONTEXTURE EXCEL TIP; Degerlund M, 2012, J PLANKTON RES, V34, P416, DOI 10.1093/plankt/fbs004; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fenchel T, 2004, BIOSCIENCE, V54, P777, DOI 10.1641/0006-3568(2004)054[0777:TUOSSP]2.0.CO;2; Feng Y, 2017, NOVA HEDWIGIA, V104, P359, DOI 10.1127/nova_hedwigia/2016/0326; Feng Y, 2016, PROTIST, V167, P234, DOI 10.1016/j.protis.2016.03.003; Feng Y, 2015, ORG DIVERS EVOL, V15, P631, DOI 10.1007/s13127-015-0230-x; FERRIS PJ, 1983, MOL CELL BIOL, V3, P635, DOI 10.1128/MCB.3.4.635; Finlay BJ, 2002, SCIENCE, V296, P1061, DOI 10.1126/science.1070710; Fiore-Donno AM, 2005, J EUKARYOT MICROBIOL, V52, P201, DOI 10.1111/j.1550-7408.2005.00032.x; Fiore-Donno AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062586; Fiore-Donno AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035359; Fiore-Donno AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022872; Fiore-Donno AM, 2010, PROTIST, V161, P55, DOI 10.1016/j.protis.2009.05.002; Foissner W, 1999, PROTIST, V150, P363, DOI 10.1016/S1434-4610(99)70037-4; Foissner W, 2008, BIODIVERS CONSERV, V17, P345, DOI 10.1007/s10531-007-9254-7; Foissner W, 2006, ACTA PROTOZOOL, V45, P111; Hall B. G., 2007, PHYLOGENETIC TREES M; Halling RE, 2008, MYCOL RES, V112, P437, DOI 10.1016/j.mycres.2007.11.021; Hood G.M., 2010, POPTOOLS VERSION 3 2; HUDSON RR, 1989, THEOR POPUL BIOL, V36, P23, DOI 10.1016/0040-5809(89)90021-X; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Kamono A, 2009, NATURWISSENSCHAFTEN, V96, P147, DOI 10.1007/s00114-008-0454-0; LADO C, 2015, LINE NOMENCLATURAL I; Lara E, 2011, FUNGAL DIVERS, V49, P93, DOI 10.1007/s13225-011-0098-9; Leontyev DV, 2015, MYCOLOGIA, V107, P959, DOI 10.3852/14-271; Leontyev DV, 2014, MYCOLOGIA, V106, P936, DOI 10.3852/13-314; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Linnaeus C., 1753, SPECIES PLANTARUM; Lizarraga M, 1999, ANN BOT FENN, V36, P187; Lizarraga M, 2008, MYCOTAXON, V103, P153; NANNENGABREMEKAMP NE, 1990, P K NED AKAD WETENSC, V93, P281; Novozhilov YK, 2013, FUNGAL DIVERS, V59, P109, DOI 10.1007/s13225-012-0199-0; Pawlowski J, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-40; Pawlowski J, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001419; Pawlowski J, 2009, J EUKARYOT MICROBIOL, V56, P16, DOI 10.1111/j.1550-7408.2008.00379.x; Proosdij ASJ, 2016, ECOGRAPHY, V39, P542, DOI DOI 10.1111/ECOG.01509; Rambaut A., 2009, MOL EVOLUTION PHYLOG; Rieux A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103225; ROJAS C., 2015, CURRENT RES ENV APP, V5, P153; Rysanek D, 2015, ENVIRON MICROBIOL, V17, P689, DOI 10.1111/1462-2920.12501; Saro I, 2014, HEREDITY, V113, P215, DOI 10.1038/hdy.2014.16; Schapire RE, 2016, MAXENT SOFTWARE SPEC; Schnittler M., 2000, Stapfia, V73, P55; Schnittler M, 2000, MYCOL RES, V104, P1518, DOI 10.1017/S0953756200002975; Schnittler M., 2012, ENGLERS SYLLABUS PLA, V4, P40; Skaloud P, 2013, J EUKARYOT MICROBIOL, V60, P350, DOI 10.1111/jeu.12040; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stephenson SL, 2008, BIODIVERS CONSERV, V17, P285, DOI 10.1007/s10531-007-9252-9; Stephenson SL, 2011, FUNGAL DIVERS, V50, P21, DOI 10.1007/s13225-011-0113-1; TEMPLETON AR, 1992, GENETICS, V132, P619; Tesmer J, 2007, MYCOL PROG, V6, P229, DOI 10.1007/s11557-007-0539-8; Unterseher M, 2008, FEMS MICROBIOL LETT, V282, P205, DOI 10.1111/j.1574-6968.2008.01128.x; Votypka J, 2012, PROTIST, V163, P616, DOI 10.1016/j.protis.2011.12.004; Walker LM, 2016, PROTIST, V167, P319, DOI 10.1016/j.protis.2016.05.003; Weiner AKM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092148; Winsett KE, 2011, MYCOSPHERE, V2, P135; Yu Y, 2015, MOL PHYLOGENET EVOL, V87, P46, DOI 10.1016/j.ympev.2015.03.008; Yu Y, 2010, MOL PHYLOGENET EVOL, V56, P848, DOI 10.1016/j.ympev.2010.04.011; Zhang Ping, 2015, Mycology-An International Journal On Fungal Biology, V6, P86, DOI 10.1080/21501203.2015.1042536	75	22	31	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2017	12	4							e0174825	10.1371/journal.pone.0174825	http://dx.doi.org/10.1371/journal.pone.0174825			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KD	28414791	Green Published, gold, Green Submitted			2022-12-27	WOS:000399874800009
J	Ikeda, N; Fuse, K; Nishi, N				Ikeda, Nayu; Fuse, Kana; Nishi, Nobuo			Changes in the effects of living with no siblings or living with grandparents on overweight and obesity in children: Results from a national cohort study in Japan	PLOS ONE			English	Article							CHILDHOOD OBESITY; FAMILY-STRUCTURE; BIRTH-ORDER; ASSOCIATIONS; WORLDWIDE; TRENDS; SIZE; RISK	Effects of living without siblings and living with grandparents on overweight and obesity may change with child's age. We aimed to examine these effects from early childhood to school age at the national level in Japan. Subjects were 43,046 children born in Japan during two weeks in 2001 who were followed annually from 2.5 to 13 years of age in the Longitudinal Survey of Newborns in the 21(st) Century. We used measured body height and weight reported by participants at each survey and followed the criteria of the International Obesity Task Force to define overweight and obesity. Random-effects logit models by sex, adjusted for time-varying and time-invariant covariates, assessed odds ratios of overweight and obesity for living without siblings and for living with grandparents at each age. The likelihood of overweight and obesity was significantly higher at 8 years and older among children living without siblings, compared with those living with siblings, and odds ratios were highest at 11 years of age in boys (1.87, 95% confidence interval [CI]: 1.49, 2.33) and at 10 and 13 years of age in girls (1.75 [95% CI: 1.36, 2.23] and 1.73 [95% CI: 1.30, 2.31], respectively). It was also significantly higher at 5.5 years and older among children living with grandparents, compared with those living without grandparents, and odds ratios were highest at 10 and 13 years of age in boys (1.53 [95% CI: 1.30, 1.80] and 1.54 [95% CI: 1.27, 1.86], respectively) and at 11 years of age in girls (1.51, 95% CI: 1.24, 1.84). In Japan, living without siblings and living with grandparents may increase the likelihood of overweight and obesity at 8 and 5.5 years and older, respectively. Child's age should be considered during formulation of strategies for prevention of overweight and obesity in these groups.	[Ikeda, Nayu; Nishi, Nobuo] Natl Inst Biomed Innovat Hlth & Nutr, Natl Inst Hlth & Nutr, Ctr Int Collaborat & Partnership, Tokyo, Japan; [Fuse, Kana] Natl Inst Populat & Social Secur Res, Dept Informat Collect & Anal, Tokyo, Japan	National Institute of Health & Nutrition - Japan	Ikeda, N (corresponding author), Natl Inst Biomed Innovat Hlth & Nutr, Natl Inst Hlth & Nutr, Ctr Int Collaborat & Partnership, Tokyo, Japan.	ikedan@nibiohn.go.jp	Ikeda, Nayu/J-9890-2019; NISHI, NOBUO/S-6195-2019	Ikeda, Nayu/0000-0002-3424-1991; 	Ministry of Health, Labour and Welfare of Japan [H27-Toukei-Ippan-005]	Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported by a Health and Labour Sciences Research Grant from the Ministry of Health, Labour and Welfare of Japan (N.I., grant number H27-Toukei-Ippan-005). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	[Anonymous], 2016, SUMM REP COMPR SURV; Bronfenbrenner U., 1994, INT ENCY ED, V3, P37; Chen AY, 2010, PREV CHRONIC DIS, V7; Chen AY, 2014, MATERN CHILD HLTH J, V18, P1772, DOI 10.1007/s10995-013-1422-7; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; DIETZ W, 1991, NUTRITION, V7, P290; Haugaard LK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056357; Hesketh K, 2006, INT J BEHAV NUTR PHY, V3, DOI 10.1186/1479-5868-3-36; Hesketh K, 2007, INT J PEDIATR OBES, V2, P86, DOI 10.1080/17477160601148554; Hunsberger M, 2012, NUTR DIABETES, V2, DOI 10.1038/nutd.2012.8; Li B, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/s12966-015-0251-z; Matsushita Y, 2004, OBES RES, V12, P205, DOI 10.1038/oby.2004.27; McKinney C., 2015, GRANDFAMILIES CONT J, V2; Ministry of Education Culture Sports Science and Technology, 2016, OV RES 2015 SCH HLTH; Ministry of Education Culture Sports Science and Technology Ministry of Health Labour and Welfare, 2014, ETH GUID MED HLTH RE; Ministry of Health Labour and Welfare, 2014, COMM REP 2 SUK OYAK; Ministry of Health Labour and Welfare, 2012, BAS DIR COMPR IMPL N; Ministry of Health Labour and Welfare, 2015, LONG SURV NEWB 21 CE; Mitchell CA, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13010130; Mosli RH, 2016, PEDIATR OBES, V11, P40, DOI 10.1111/ijpo.12018; Ochiai H, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-766; Pearce A, 2010, INT J OBESITY, V34, P1160, DOI 10.1038/ijo.2010.15; Reilly JJ, 2011, INT J OBESITY, V35, P891, DOI 10.1038/ijo.2010.222; Sata M, 2015, J EPIDEMIOL, V25, P600, DOI 10.2188/jea.JE20140078; Sisson SB, 2014, PREV MED, V61, P48, DOI 10.1016/j.ypmed.2014.01.010; UNICEF-WHO-The World Bank Group, 2016, JOINT CHILD MALN EST; Wang HB, 2007, PREV MED, V44, P45, DOI 10.1016/j.ypmed.2006.07.015; Wang Y, 2006, INT J PEDIATR OBES, V1, P11, DOI 10.1080/17477160600586747; Watanabe E, 2011, INT J OBESITY, V35, P945, DOI 10.1038/ijo.2011.82; Zong XN, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2265-5	30	22	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2017	12	4							e0175726	10.1371/journal.pone.0175726	http://dx.doi.org/10.1371/journal.pone.0175726			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KD	28414810	Green Submitted, Green Published, gold			2022-12-27	WOS:000399874800050
J	Lawson, GM; Camins, JS; Wisse, L; Wu, J; Duda, JT; Cook, PA; Gee, JC; Farah, MJ				Lawson, Gwendolyn M.; Camins, Joshua S.; Wisse, Laura; Wu, Jue; Duda, Jeffrey T.; Cook, Philip A.; Gee, James C.; Farah, Martha J.			Childhood socioeconomic status and childhood maltreatment: Distinct associations with brain structure	PLOS ONE			English	Article							NEURAL DEVELOPMENT DEPRIVATION; HIPPOCAMPAL VOLUME; FINANCIAL STRAIN; EARLY EXPERIENCE; SEX-DIFFERENCES; LIFE-SPAN; STRESS; ADULTS; AMYGDALA; YOUNG	The present study examined the relationship between childhood socioeconomic status (SES), childhood maltreatment, and the volumes of the hippocampus and amygdala between the ages of 25 and 36 years. Previous work has linked both low SES and maltreatment with reduced hippocampal volume in childhood, an effect attributed to childhood stress. In 46 adult subjects, only childhood maltreatment, and not childhood SES, predicted hippocampal volume in regression analyses, with greater maltreatment associated with lower volume. Neither factor was related to amygdala volume. When current SES and recent interpersonal stressful events were also considered, recent interpersonal stressful events predicted smaller hippocampal volumes over and above childhood maltreatment. Finally, exploratory analyses revealed a significant sex by childhood SES interaction, with women's childhood SES showing a significantly more positive relation (less negative) with hippocampus volume than men's. The overall effect of childhood maltreatment but not SES, and the sex-specific effect of childhood SES, indicate that different forms of stressful childhood adversity affect brain development differently.	[Lawson, Gwendolyn M.; Camins, Joshua S.; Farah, Martha J.] Univ Penn, Dept Psychol, 3815 Walnut St, Philadelphia, PA 19104 USA; [Wisse, Laura; Wu, Jue; Duda, Jeffrey T.; Cook, Philip A.; Gee, James C.] Univ Penn, Penn Image Comp & Sci Lab, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Lawson, GM (corresponding author), Univ Penn, Dept Psychol, 3815 Walnut St, Philadelphia, PA 19104 USA.	gmlawson@gmail.com	Wisse, Laura/I-5059-2019; Camins, Joshua/ABG-4387-2020	Lawson, Gwendolyn/0000-0003-4363-3169	National Institutes of Health [R01-HD055689]; Institute of Education Sciences Predoctoral Fellowship Grant	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institute of Education Sciences Predoctoral Fellowship Grant	This work was funded by National Institutes of Health, Award #: R01-HD055689, received by MJF, URL:https://www.nih.gov; and Institute of Education Sciences Predoctoral Fellowship Grant through Penn GSE awarded to GML. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avants BB, 2011, NEUROIMAGE, V54, P2033, DOI 10.1016/j.neuroimage.2010.09.025; Bale TL, 2015, NAT NEUROSCI, V18, P1413, DOI 10.1038/nn.4112; Butterworth P, 2012, SOC COGN AFFECT NEUR, V7, P548, DOI 10.1093/scan/nsr027; Edmiston EE, 2011, ARCH PEDIAT ADOL MED, V165, P1069, DOI 10.1001/archpediatrics.2011.565; Felitti VJ, 1998, AM J PREV MED, V14, P245, DOI 10.1016/S0749-3797(98)00017-8; Gianaros PJ, 2007, NEUROIMAGE, V35, P795, DOI 10.1016/j.neuroimage.2006.10.045; Hammen C, 2000, J CONSULT CLIN PSYCH, V68, P782, DOI 10.1037/0022-006X.68.5.782; Hanson JL, 2015, BIOL PSYCHIAT, V77, P314, DOI 10.1016/j.biopsych.2014.04.020; Hanson JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018712; Herrenkohl TI, 2012, VIOLENCE VICTIMS, V27, P764, DOI 10.1891/0886-6708.27.5.764; Hollingshead A.B., 1975, 4 FACTOR INDEX SOCIA; Jednorog K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042486; Luby J, 2013, JAMA PEDIATR, V167, P1135, DOI 10.1001/jamapediatrics.2013.3139; Lupien SJ, 2009, NAT REV NEUROSCI, V10, P434, DOI 10.1038/nrn2639; Marcus DS, 2007, J COGNITIVE NEUROSCI, V19, P1498, DOI 10.1162/jocn.2007.19.9.1498; McLaughlin KA, 2014, NEUROSCI BIOBEHAV R, V47, P578, DOI 10.1016/j.neubiorev.2014.10.012; McLaughlin KA, 2014, BIOL PSYCHIAT, V76, P629, DOI 10.1016/j.biopsych.2013.08.016; McLaughlin KJ, 2009, MOL NEUROBIOL, V40, P166, DOI 10.1007/s12035-009-8079-7; MCLOYD VC, 1994, CHILD DEV, V65, P562, DOI 10.1111/j.1467-8624.1994.tb00769.x; Mehta MA, 2009, J CHILD PSYCHOL PSYC, V50, P943, DOI 10.1111/j.1469-7610.2009.02084.x; Noble KG, 2015, NAT NEUROSCI, V18, P773, DOI 10.1038/nn.3983; Noble KG, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00307; Noble KG, 2012, DEVELOPMENTAL SCI, V15, P516, DOI 10.1111/j.1467-7687.2012.01147.x; Pechtel P, 2014, NEUROIMAGE, V97, P236, DOI 10.1016/j.neuroimage.2014.04.025; Pietromonaco PR, 2015, CURR OPIN PSYCHOL, V1, P34, DOI 10.1016/j.copsyc.2014.12.001; Puterman E, 2012, PSYCHOSOM MED, V74, P187, DOI 10.1097/PSY.0b013e3182448d74; Riem MME, 2015, DEV PSYCHOPATHOL, V27, P507, DOI 10.1017/S0954579415000127; Sacks V., 2014, USITC PUBL, V#2014-28; Samplin E, 2013, J PSYCHIATR RES, V47, P1174, DOI 10.1016/j.jpsychires.2013.05.008; SARASON IG, 1978, J CONSULT CLIN PSYCH, V46, P932, DOI 10.1037/0022-006X.46.5.932; Sheridan MA, 2014, TRENDS COGN SCI, V18, P580, DOI 10.1016/j.tics.2014.09.001; Sheridan MA, 2012, P NATL ACAD SCI USA, V109, P12927, DOI 10.1073/pnas.1200041109; Singh-Manoux A, 2005, ANN EPIDEMIOL, V15, P572, DOI 10.1016/j.annepidem.2004.10.007; Staff RT, 2012, ANN NEUROL, V71, P653, DOI 10.1002/ana.22631; Szanton SL, 2010, SOC SCI MED, V71, P259, DOI 10.1016/j.socscimed.2010.04.001; Teicher MH, 2012, P NATL ACAD SCI USA, V109, pE563, DOI 10.1073/pnas.1115396109; Tottenham N, 2010, DEVELOPMENTAL SCI, V13, P46, DOI 10.1111/j.1467-7687.2009.00852.x; Tustison NJ, 2010, IEEE T MED IMAGING, V29, P1310, DOI 10.1109/TMI.2010.2046908; van Harmelen AL, 2010, BIOL PSYCHIAT, V68, P832, DOI 10.1016/j.biopsych.2010.06.011; Wang HZ, 2011, NEUROIMAGE, V55, P968, DOI 10.1016/j.neuroimage.2011.01.006; Yanagisawa K, 2013, SOC COGN AFFECT NEUR, V8, P617, DOI 10.1093/scan/nss039	41	37	37	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2017	12	4							e0175690	10.1371/journal.pone.0175690	http://dx.doi.org/10.1371/journal.pone.0175690			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES9KD	28414755	Green Published, gold, Green Submitted			2022-12-27	WOS:000399874800047
J	Dziunyczn, PJ; Neu, J; Lefort, K; Djerbi, N; Freiberger, SN; Iotzova-Weiss, G; French, LE; Dotto, GP; Hofbauer, GF				Dziunyczn, Piotr J.; Neu, Johannes; Lefort, Karine; Djerbi, Nadia; Freiberger, Sandra N.; Iotzova-Weiss, Guergana; French, Lars E.; Dotto, Gian-Paolo; Hofbauer, Gunther F.			CYFIP1 is directly controlled by NOTCH1 and down-regulated in cutaneous squamous cell carcinoma	PLOS ONE			English	Article							PROGNOSTIC-FACTORS; TUMOR-SUPPRESSOR; TRANSCRIPTION; METASTASIS; SKIN; DIFFERENTIATION; KERATINOCYTES; RECURRENCE; EXPRESSION; SURVIVAL	Squamous cell carcinoma of the skin (SCC) represents one of the most common cancers in the general population and is associated with a substantial risk of metastasis. Previous work uncovered the functional role of CYFIP1 in epithelial tumors as an invasion inhibitor. It was down-regulated in some cancers and correlated with the metastatic properties of these malignant cells. We investigated its role and expression mechanisms in SCC. We analyzed the expression of CYFIP1 in patient derived SCC, primary keratinocytes and SCC cell lines, and correlated it to the differentiation and NOTCH1 levels. We analyzed the effects of Notch1 manipulation on CYFIP1 expression and confirmed the biding of Notch1 to the CYFIP1 promoter. CYFIP1 expression was down-regulated in SCC and correlated inversely with histological differentiation of tumors. As keratinocyte differentiation depends on Notch1 signaling, we investigated the influence of Notch1 on CYFIP1 expression. CYFIP1 mRNA was highly increased in human Notch1-overexpressing keratinocytes. Further manipulation of the Notch1 pathway in keratinocytes impacted CYFIP1 levels and chromatin immunoprecipitation assay confirmed the direct binding of Notch1 to the CYFIP1 promoter. CYFIP1 may be a link between loss of differentiation and invasive potential in malignant keratinocytes of cutaneous squamous cell carcinoma.	[Dziunyczn, Piotr J.; Neu, Johannes; Djerbi, Nadia; Freiberger, Sandra N.; Iotzova-Weiss, Guergana; French, Lars E.; Hofbauer, Gunther F.] Univ Zurich Hosp, Dept Dermatol, Zurich, Switzerland; [Lefort, Karine; Dotto, Gian-Paolo] Univ Lausanne, Dept Biochem, Epalinges, Switzerland	University of Zurich; University Zurich Hospital; University of Lausanne	Neu, J (corresponding author), Univ Zurich Hosp, Dept Dermatol, Zurich, Switzerland.	johannes.neu@usz.ch	Freiberger, Sandra/AAT-5527-2020; French, Lars/AAL-5977-2020; Hofbauer, Gunther/B-2671-2010	French, Lars/0000-0002-4629-1486; Hofbauer, Gunther/0000-0003-0542-7989	European Skin Research Foundation; Rene Touraine Foundation; EMDO Foundation	European Skin Research Foundation; Rene Touraine Foundation; EMDO Foundation	This work has been supported by research grants of European Skin Research Foundation (http://www.euroskiarecearch.orgh/, GH, 2012) Rene Touraine Foundation (www.fondation-r-touraine.org, PD and GH, 2010) and EMDO Foundation (emdo-stiftung@bluevvin.ch, PD, 2011).	Alam M, 2001, NEW ENGL J MED, V344, P975, DOI 10.1056/NEJM200103293441306; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Bostwick DG, 2000, ARCH PATHOL LAB MED, V124, P995; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; BREUNINGER H, 1990, AM J CLIN PATHOL, V94, P624, DOI 10.1093/ajcp/94.5.624; Cherpelis BS, 2002, DERMATOL SURG, V28, P268, DOI 10.1046/j.1524-4725.2002.01169.x; Cockerell CJ, 2000, J AM ACAD DERMATOL, V42, pS11, DOI 10.1067/mjd.2000.103344; CZARNECKI D, 1994, DERMATOLOGY, V189, P52, DOI 10.1159/000246783; Dotto GP, 2008, ONCOGENE, V27, P5115, DOI 10.1038/onc.2008.225; GIOANNI J, 1988, EUR J CANCER CLIN ON, V24, P1445, DOI 10.1016/0277-5379(88)90335-5; Hassan C, 2005, DIS COLON RECTUM, V48, P1588, DOI 10.1007/s10350-005-0063-3; Hu B, 2012, CELL, V149, P1207, DOI 10.1016/j.cell.2012.03.048; Iso T, 2003, J CELL PHYSIOL, V194, P237, DOI 10.1002/jcp.10208; Kobayashi K, 1998, J BIOL CHEM, V273, P291, DOI 10.1074/jbc.273.1.291; Kolev V, 2008, NAT CELL BIOL, V10, DOI 10.1038/ncb1750; Kunda P, 2003, CURR BIOL, V13, P1867, DOI 10.1016/j.cub.2003.10.005; Lefort K, 2007, GENE DEV, V21, P562, DOI 10.1101/gad.1484707; Lorenz K, 2009, CELLS TISSUES ORGANS, V189, P382, DOI 10.1159/000151291; Moriyama M, 2006, J CELL BIOL, V173, P333, DOI 10.1083/jcb.200509084; Nam Y, 2006, CELL, V124, P973, DOI 10.1016/j.cell.2005.12.037; Nguyen BC, 2006, GENE DEV, V20, P1028, DOI 10.1101/gad.1406006; Nicolas M, 2003, NAT GENET, V33, P416, DOI 10.1038/ng1099; Nobbe S, 2012, ACTA DERM-VENEREOL, V92, P24, DOI 10.2340/00015555-1191; Nocentini G, 1997, P NATL ACAD SCI USA, V94, P6216, DOI 10.1073/pnas.94.12.6216; Noguchi T, 2002, ONCOL REP, V9, P995; PRESTON DS, 1992, NEW ENGL J MED, V327, P1649, DOI 10.1056/NEJM199212033272307; Quaedvlieg PJF, 2006, HISTOPATHOLOGY, V49, P256, DOI 10.1111/j.1365-2559.2006.02472.x; Rangarajan A, 2001, EMBO J, V20, P3427, DOI 10.1093/emboj/20.13.3427; Restivo G, 2011, EMBO J, V30, P4571, DOI 10.1038/emboj.2011.325; ROWE DE, 1992, J AM ACAD DERMATOL, V26, P976, DOI 10.1016/0190-9622(92)70144-5; Schmitt AR, 2014, JAMA DERMATOL, V150, P19, DOI 10.1001/jamadermatol.2013.6675; Schmults CD, 2013, JAMA DERMATOL, V149, P541, DOI 10.1001/jamadermatol.2013.2139; Schroeder T, 2000, EMBO J, V19, P2558, DOI 10.1093/emboj/19.11.2558; Silva JM, 2009, CELL, V137, P1047, DOI 10.1016/j.cell.2009.04.013; Stradal TEB, 2004, TRENDS CELL BIOL, V14, P303, DOI 10.1016/j.tcb.2004.04.007; Takenawa T, 2007, NAT REV MOL CELL BIO, V8, P37, DOI 10.1038/nrm2069; Thomas JS, 2009, HISTOPATHOLOGY, V55, P724, DOI 10.1111/j.1365-2559.2009.03429.x; Wilson JJ, 2006, CELL, V124, P985, DOI 10.1016/j.cell.2006.01.035	38	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2017	12	4							e0173000	10.1371/journal.pone.0173000	http://dx.doi.org/10.1371/journal.pone.0173000			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0MD	28410392	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000399955600002
J	Moussouni, S; Pintaud, JC; Vigouroux, Y; Bouguedoura, N				Moussouni, Souhila; Pintaud, Jean-Christophe; Vigouroux, Yves; Bouguedoura, Nadia			Diversity of Algerian oases date palm (Phoenix dactylifera L., Arecaceae): Heterozygote excess and cryptic structure suggest farmer management had a major impact on diversity	PLOS ONE			English	Article							MICROSATELLITE MARKERS; POPULATION-STRUCTURE; GENETIC DIVERSITY; UTILITY; BIOGEOGRAPHY; SOFTWARE; INSIGHTS	Date palm (Phoenix dactyliferaL.) is the mainstay of oasis agriculture in the Saharan region. It is cultivated in a large part of the Mediterranean coastal area of the Sahara and in most isolated oases in the Algerian desert. We sampled 10 oases in Algeria to understand the structure of date palm diversity from the coastal area to a very isolated desert location. We used 18 microsatellite markers and a chloroplast minisatellite to characterize 414 individual palm trees corresponding to 114 named varieties. We found a significant negative inbreeding coefficient, suggesting active farmer selection for heterozygous individuals. Three distinct genetic clusters were identified, a ubiquitous set of varieties found across the different oases, and two clusters, one of which was specific to the northern area, and the other to the drier southern area of the Algerian Sahara. The ubiquitous cluster presented very striking chloroplast diversity, signing the frequency of haplotypes found in Saudi Arabia, the most eastern part of the date palm range. Exchanges of Middle Eastern and Algerian date palms are known to have occurred and could have led to the introduction of this particular chlorotype. However, Algerian nuclear diversity was not of eastern origin. Our study strongly suggests that the peculiar chloroplastic diversity of date palm is maintained by farmers and could originate from date palms introduced from the Middle East a long time ago, which since then, hasbeen strongly introgressed. This study illustrates the complex structure of date palm diversity in Algerian oases and the role of farmers in shaping such cryptic diversity.	[Moussouni, Souhila; Bouguedoura, Nadia] USTHB, Fac Sci Biol, LRZA, Algiers, Algeria; [Pintaud, Jean-Christophe; Vigouroux, Yves] Inst Rech Dev, UMR DIADE, DYNADIV, Montpellier, France	University Science & Technology Houari Boumediene; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier	Moussouni, S (corresponding author), USTHB, Fac Sci Biol, LRZA, Algiers, Algeria.	moussouni.souhila@gmail.com	vigouroux, Yves/A-9056-2011	vigouroux, Yves/0000-0002-8361-6040	AUF MeRSi project [6313PS001]; Algerian Ministere de l'Enseignement Superieur et de la Recherche Scientifique	AUF MeRSi project; Algerian Ministere de l'Enseignement Superieur et de la Recherche Scientifique	This work was financed by the AUF MeRSi project (6313PS001) and the Algerian Ministere de l'Enseignement Superieur et de la Recherche Scientifique. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberlenc-Bertossi F, 2014, APPL PLANT SCI, V2, DOI 10.3732/apps.1300058; Adam H, 2011, MOL BIOL EVOL, V28, P1439, DOI 10.1093/molbev/msq328; Arabnezhad H, 2012, SCI HORTIC-AMSTERDAM, V134, P150, DOI 10.1016/j.scienta.2011.11.032; Barrow Sasha C., 1998, Kew Bulletin, V53, P513, DOI 10.2307/4110478; Belkhir K, 2004, GENETIX 4 05 LOGICIE; Billotte N, 2004, MOL ECOL NOTES, V4, P256, DOI 10.1111/j.1471-8286.2004.00634.x; Bouguedoura N, 2012, PALMIER DATTIER DEV; Bouguedoura N., 2015, DATE PALM GENETIC RE, P125, DOI [DOI 10.1007/978-94-017-9694-1, DOI 10.1007/978-94-017-9694-1_4]; Bouguedoura N, 2008, ACT 3 SEM RES AUF BI; Chabrillange N, MICROSATELLITE MARKE; Chao CCT, 2008, ENCY FRUIT NUTS, P138; Cherif E, 2013, NEW PHYTOL, V197, P409, DOI 10.1111/nph.12069; Dransfield J., 2008, GENERA PALMARUM THE; Elmeer K, 2011, 3 BIOTECH, V1, P91, DOI 10.1007/s13205-011-0010-z; Elmeer K, 2012, 3 BIOTECH, V2, P241, DOI 10.1007/s13205-012-0052-x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Goudet J., 2002, FSTAT SOFTWARE V 2 9; Hamza H., 2013, Australian Journal of Crop Science, V7, P763; Henderson SA, 2006, CONSERV GENET, V7, P213, DOI 10.1007/s10592-006-9128-7; Khan A, 2012, PLANT MOL BIOL REP, V30, P666, DOI 10.1007/s11105-011-0373-7; Khierallah HSM, 2011, J AM SOC HORTIC SCI, V136, P282, DOI 10.21273/JASHS.136.4.282; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Ludena B, 2011, ANN BOT-LONDON, V108, P1433, DOI 10.1093/aob/mcr191; Mathew LS, 2015, G3-GENES GENOM GENET, V5, P1429, DOI 10.1534/g3.115.018341; Munier P, 1973, MAISONNEUVE LAROSE; Pintaud JC, 2013, ACTA HORTIC, V994, P19, DOI 10.17660/ActaHortic.2013.994.1; Pintaud Jean-Christophe, 2010, P267; Pritchard JK, 2000, GENETICS, V155, P945; Pujol B, 2002, ECON BOT, V56, P366, DOI [10.1663/0013-0001(2002)056[0366:GEOCME]2.0.CO;2, 10.1111/j.1461-0248.2004.00708.x]; R Core Team, 2021, R LANGUAGE ENV STAT; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Scarcelli N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019954; Terral JF, 2012, J BIOGEOGR, V39, P929, DOI 10.1111/j.1365-2699.2011.02649.x; Vigouroux Y, 2008, AM J BOT, V95, P1240, DOI 10.3732/ajb.0800097; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Zehdi S., 2004, African Journal of Biotechnology, V3, P215; Zehdi S, 2012, SCI HORTIC-AMSTERDAM, V148, P255, DOI 10.1016/j.scienta.2012.10.011; Zehdi-Azouzi S, 2015, ANN BOT-LONDON, V116, P101, DOI 10.1093/aob/mcv068	39	23	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2017	12	4							e0175232	10.1371/journal.pone.0175232	http://dx.doi.org/10.1371/journal.pone.0175232			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0MD	28410422	Green Published, Green Submitted, gold			2022-12-27	WOS:000399955600013
J	Aulck, L; West, J				Aulck, Lovenoor; West, Jevin			Attrition and performance of community college transfers	PLOS ONE			English	Article							EDUCATIONAL-ATTAINMENT; BACCALAUREATE DEGREE; 2-YEAR COLLEGES; STUDENTS	Community colleges are an important part of the US higher education landscape, yet the aptitude and preparedness of student transfers to baccalaureate institutions is often called into question. Examining transcript records and demographic information of nearly 70,000 students across over 15 years of registrar records at a public university, this study performed a descriptive analysis of the persistence, performance, and academic migration patterns of community college transfers, transfers from four-year institutions, and freshmen entrants. We found little difference between community college transfers and freshmen entrants in terms of post-transfer grades and persistence. Transfers from four-year institutions had higher grades but also had higher attrition rates than their peers. This study also found no strong evidence of transfer shock on students' post-transfer grades. When examining the tendencies of students to shift fields of study during their educational pursuits, the academic migration patterns of transfer students were more concentrated than those of freshmen entrants.	[Aulck, Lovenoor; West, Jevin] Univ Washington, Informat Sch, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Aulck, L (corresponding author), Univ Washington, Informat Sch, Seattle, WA 98195 USA.	laulck@uw.edu						Al-Sunbul A, 1987, COMMUNITY JUNIOR COL, V11, P1; Alfonso M, 2006, RES HIGH EDUC, V47, P873, DOI 10.1007/s11162-006-9019-2; [Anonymous], JUNIOR SENIOR COLL A; Attewell P, 2011, AM EDUC RES J, V48, P536, DOI 10.3102/0002831210392018; Aulck L., 2016, INT C MACH LEARN DAT; AVAKIAN AN, 1982, COLL UNIV, V57, P160; Brint S, 1989, THE DIVERTED DREAM C; Cejda B., 1997, COMMUNITY COLL J RES, V21, P279, DOI DOI 10.1080/1066892970210301; Chen X., 2013, 2014001 NCES, DOI DOI 10.3926/JOTSE.136; CLARK BR, 1960, AM J SOCIOL, V65, P569, DOI 10.1086/222787; Cohen A. M., 1989, AM COMMUNITY COLL; De Los Santos A G, 1989, EDUC REC, V70, P82; Diaz P. E., 1992, COMMUNITY JUNIOR COL, V16, P279, DOI DOI 10.1080/0361697920160307; Doucette DS, 1985, 25 ANN FOR ASS I RES; Dougherty K., 1994, SUNY SERIES FRONTIER; Doyle WR, 2009, ECON EDUC REV, V28, P199, DOI 10.1016/j.econedurev.2008.01.006; Eckland B., 1964, SOCIOL EDUC, V38, P60; Glass J. C., 2002, COMMUNITY COLL J RES, V26, P415, DOI DOI 10.1080/02776770290041774; Gonzalez A, 2006, ECON EDUC REV, V25, P249, DOI 10.1016/j.econedurev.2004.12.002; Heiser LM, 1989, 2 YEAR COMP TRANSFER; HILLS JR, 1965, J EXP EDUC, V33, P201, DOI 10.1080/00220973.1965.11010875; Hiss William C., 2014, DEFINING PROMISE OPT; LEE VE, 1993, AM J EDUC, V102, P80, DOI 10.1086/444059; Leigh DE, 2004, ECON EDUC REV, V23, P95, DOI 10.1016/S0272-7757(03)00063-3; Leigh DE, 2003, ECON EDUC REV, V22, P23, DOI 10.1016/S0272-7757(01)00057-7; Long BT, 2009, EDUC EVAL POLICY AN, V31, P30, DOI 10.3102/0162373708327756; Nickens J. M., 1972, ANNU M AM EDUC RES; Palmer VJ, 2011, COMP STUDY ACAD PERF; Peng S. S., 1977, RES HIGH EDUC, V7, P145; Porter S., 1999, ASSESSING TRANSFER N; Reynolds CL, 2012, ECON EDUC REV, V31, P345, DOI 10.1016/j.econedurev.2011.12.001; Rouse CE, 1998, J POLICY ANAL MANAG, V17, P595, DOI 10.1002/(SICI)1520-6688(199823)17:4<595::AID-PAM1>3.0.CO;2-5; ROUSE CE, 1995, J BUS ECON STAT, V13, P217, DOI 10.2307/1392376; Townsend B. K., 2001, COMMUNITY COLL REV, V29, P29, DOI DOI 10.1177/009155210102900203; Weiss D., 2011, COMP STUDENT SUCCESS	35	18	18	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2017	12	4							e0174683	10.1371/journal.pone.0174683	http://dx.doi.org/10.1371/journal.pone.0174683			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET0MB	28407002	Green Submitted, Green Published, gold			2022-12-27	WOS:000399955400012
J	Aegerter, J; Fouracre, D; Smith, GC				Aegerter, James; Fouracre, David; Smith, Graham C.			A first estimate of the structure and density of the populations of pet cats and dogs across Great Britain	PLOS ONE			English	Article							DOMESTIC CATS; FELIS-CATUS; PREDATION; OWNERSHIP; UK; TOXOPLASMA; BENEFITS; WILDLIFE; TOXOCARA; NUMBER	Policy development, implementation, and effective contingency response rely on a strong evidence base to ensure success and cost-effectiveness. Where this includes preventing the establishment or spread of zoonotic or veterinary diseases infecting companion cats and dogs, descriptions of the structure and density of the populations of these pets are useful. Similarly, such descriptions may help in supporting diverse fields of study such as; evidence- based veterinary practice, veterinary epidemiology, public health and ecology. As well as maps of where pets are, estimates of how many may rarely, or never, be seen by veterinarians and might not be appropriately managed in the event of a disease outbreak are also important. Unfortunately both sources of evidence are absent from the scientific and regulatory literatures. We make this first estimate of the structure and density of pet populations by using the most recent national population estimates of cats and dogs across Great Britain and subdividing these spatially, and categorically across ownership classes. For the spatial model we used the location and size of veterinary practises across GB to predict the local density of pets, using client travel time to define catchments around practises, and combined this with residential address data to estimate the rate of ownership. For the estimates of pets which may provoke problems in managing a veterinary or zoonotic disease we reviewed the literature and defined a comprehensive suite of ownership classes for cats and dogs, collated estimates of the sub-populations for each ownership class as well as their rates of interaction and produced a coherent scaled description of the structure of the national population. The predicted density of pets varied substantially, with the lowest densities in rural areas, and the highest in the centres of large cities where each species could exceed 2500 animals. km(-2). Conversely, the number of pets per household showed the opposite relationship. Both qualitative and quantitative validation support key assumptions in the model structure and suggest the model is useful at predicting the populations of cats at geographical scales important for decision-making, although it also indicates where further research may improve model performance. In the event of an animal health crisis, it appears that almost all dogs could be brought under control rapidly. For cats, a substantial and unknown number might never be bought under control and would be less likely to receive veterinary support to facilitate surveillance and disease management; we estimate this to be at least 1.5 million cats. In addition, the lack of spare capacity to care for unowned cats in welfare organisations suggests that any increase in their rate of acquisition of cats, or any decrease in the rate of re-homing might provoke problems during a period of crisis.	[Aegerter, James; Fouracre, David; Smith, Graham C.] Anim & Plant Hlth Agcy, Natl Wildlife Management Ctr, York, N Yorkshire, England	Animal & Plant Health Agency UK	Aegerter, J (corresponding author), Anim & Plant Hlth Agcy, Natl Wildlife Management Ctr, York, N Yorkshire, England.	james.aegerter@apha.gsi.gov.uk	Aegerter, James N/I-9854-2014; Smith, Graham C/J-2593-2013	Aegerter, James N/0000-0002-0608-508X; Smith, Graham C/0000-0002-9897-6794	Department for Environment, Food Rural Affairs	Department for Environment, Food Rural Affairs(Department for Environment, Food & Rural Affairs (DEFRA))	JNA, DF & GCS were all supported by the Department for Environment, Food & Rural Affairs (Defra). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anon, 2014, STAY DOGS SURVEY 201; Arshad SH, 2001, J INVEST ALLERG CLIN, V11, P94; Asher L, 2011, BMC VET RES, V7, DOI 10.1186/1746-6148-7-74; Baker PJ, 2005, MAMMAL REV, V35, P302, DOI 10.1111/j.1365-2907.2005.00071.x; Bonnington C, 2013, J APPL ECOL, V50, P15, DOI 10.1111/1365-2664.12025; CHURCHER PB, 1987, J ZOOL, V212, P439, DOI 10.1111/j.1469-7998.1987.tb02915.x; Clark CCA, 2012, VET REC, V170, P493, DOI 10.1136/vr.100524; Collin SM, 2015, CLIN EXP ALLERGY, V45, P200, DOI 10.1111/cea.12380; Deplazes P, 2011, VET PARASITOL, V182, P41, DOI 10.1016/j.vetpar.2011.07.014; Downes MJ, 2011, BMC VET RES, V7, DOI 10.1186/1746-6148-7-28; GETHINGS PM, 1987, VET REC, V121, P213, DOI 10.1136/vr.121.10.213; Halsby K, 2014, EPIDEMIOL INFECT, V142, P1653, DOI 10.1017/S095026881300246X; Hollings Tracey, 2013, International Journal for Parasitology Parasites and Wildlife, V2, P110, DOI 10.1016/j.ijppaw.2013.02.002; Hutchinson JP, 2011, VET REC, V169, P582, DOI 10.1136/vr.d5764; International Federation on A, 2014, MEAS BEN COMP AN HLT, P28; Kirchheimer R, 2008, VET REC, V163, P394, DOI 10.1136/vr.163.13.394; Knight S, 2008, J AGING HEALTH, V20, P437, DOI 10.1177/0898264308315875; Marzano M., 2012, FORESTRY COMMISSION; McConnell AR, 2011, J PERS SOC PSYCHOL, V101, P1239, DOI 10.1037/a0024506; Murray JK, 2010, VET REC, V166, P163, DOI 10.1136/vr.b4712; Murray JK, 2009, VET REC, V164, P137, DOI 10.1136/vr.164.5.137; Murray JK, 2012, VET J, V192, P461, DOI 10.1016/j.tvjl.2011.08.035; Murray JK, 2015, ASSESSING CHANGES UK; Nijsse R, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1009-9; PDSA, 2014, ISS IN FOC 2014; PFMA, 2015, REG PET POP; Raina P, 1999, J AM GERIATR SOC, V47, P323, DOI 10.1111/j.1532-5415.1999.tb02996.x; Sanchez-Vizcano F, 2015, VET REC, V177, P591, DOI 10.1136/vr.h6174; Sims V, 2008, DIVERS DISTRIB, V14, P387, DOI 10.1111/j.1472-4642.2007.00444.x; Stavisky J, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-163; Taylor K, 2005, ENGLISH NATURE RES R, V649; Thomas RL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049369; Westgarth C, 2010, VET REC, V166, P354, DOI 10.1136/vr.c1606; Woods M, 2003, MAMMAL REV, V33, P174, DOI 10.1046/j.1365-2907.2003.00017.x; Zito S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133293	35	16	16	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2017	12	4							e0174709	10.1371/journal.pone.0174709	http://dx.doi.org/10.1371/journal.pone.0174709			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LZ	28403172	Green Submitted, Green Published, gold			2022-12-27	WOS:000399955200019
J	Hara, Y; Obata, Y; Horikawa, K; Tasaki, Y; Suzuki, K; Murata, T; Shiina, I; Abe, R				Hara, Yasushi; Obata, Yuuki; Horikawa, Keita; Tasaki, Yasutaka; Suzuki, Kyohei; Murata, Takatsugu; Shiina, Isamu; Abe, Ryo			M-COPA suppresses endolysosomal Kit-Akt oncogenic signalling through inhibiting the secretory pathway in neoplastic mast cells	PLOS ONE			English	Article							GASTROINTESTINAL STROMAL TUMORS; LIGAND-INDEPENDENT ACTIVATION; ADP-RIBOSYLATION FACTOR-1; RECEPTOR TYROSINE KINASE; PROTOONCOGENE C-KIT; ENDOPLASMIC-RETICULUM; GOLGI SYSTEM; PI 3-KINASE; MUTATIONS; PROTEIN	Gain-of-function mutations in Kit receptor tyrosine kinase result in the development of a variety of cancers, such as mast cell tumours, gastrointestinal stromal tumours (GISTs), acute myeloid leukemia, and melanomas. The drug imatinib, a selective inhibitor of Kit, is used for treatment of mutant Kit-positive cancers. However, mutations in the Kit kinase domain, which are frequently found in neoplastic mast cells, confer an imatinib resistance, and cancers expressing the mutants can proliferate in the presence of imatinib. Recently, we showed that in neoplastic mast cells that endogenously express an imatinib-resistant Kit mutant, Kit causes oncogenic activation of the phosphatidylinositol 3-kinase-Akt (PI3K-Akt) pathway and the signal transducer and activator of transcription 5 (STAT5) but only on endolysosomes and on the endoplasmic reticulum (ER), respectively. Here, we show a strategy for inhibition of the Kit-PI3K-Akt pathway in neoplastic mast cells by M-COPA (2-methylcoprophilinamide), an inhibitor of this secretory pathway. In M-COPA-treated cells, Kit localization in the ER is significantly increased, whereas endolysosomal Kit disappears, indicating that M-COPA blocks the biosynthetic transport of Kit from the ER. The drug greatly inhibits oncogenic Akt activation without affecting the association of Kit with PI3K, indicating that ER-localized Kit-PI3K complex is unable to activate Akt. Importantly, MCOPA but not imatinib suppresses neoplastic mast cell proliferation through inhibiting antiapoptotic Akt activation. Results of our M-COPA treatment assay show that Kit can activate Erk not only on the ER but also on other compartments. Furthermore, Tyr568/570, Tyr703, Tyr721, and Tyr936 in Kit are phosphorylated on the ER, indicating that these five tyrosine residues are all phosphorylated before mutant Kit reaches the plasma membrane (PM). Our study provides evidence that Kit is tyrosine-phosphorylated soon after synthesis on the ER but is unable to activate Akt and also demonstrates that M-COPA is efficacious for growth suppression of neoplastic mast cells.	[Hara, Yasushi; Obata, Yuuki; Horikawa, Keita; Abe, Ryo] Tokyo Univ Sci, Res Inst Biomed Sci, Div Immunobiol, Noda, Chiba, Japan; [Tasaki, Yasutaka; Suzuki, Kyohei; Murata, Takatsugu; Shiina, Isamu] Tokyo Univ Sci, Dept Appl Chem, Fac Sci, Shinjuku Ku, Tokyo, Japan	Tokyo University of Science; Tokyo University of Science	Obata, Y (corresponding author), Tokyo Univ Sci, Res Inst Biomed Sci, Div Immunobiol, Noda, Chiba, Japan.	yobata@rs.tus.ac.jp	HARA, Yasushi/J-2072-2016; Murata, Takatsugu/D-4960-2017	HARA, Yasushi/0000-0002-0528-3252; Murata, Takatsugu/0000-0002-3933-8928	Japanese Ministry of Education, Culture, Sports, Science and Technology [16K18427, 15K06843]; Uehara Memorial Foundation; Scientific Research from the Japanese Ministry of Education, Culture, Sports, Science and Technology [16K18427, 15K06843]; Uehara Memorial Foundation [K15-148]; Grants-in-Aid for Scientific Research [16H05419, 16K18427] Funding Source: KAKEN	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Uehara Memorial Foundation(Uehara Memorial Foundation); Scientific Research from the Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Uehara Memorial Foundation(Uehara Memorial Foundation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The authors thank Dr. Yoshimi Ohashi, Dr. Akinori Akatsuka, and Dr. Shingo Dan (Japanese Foundation for Cancer Research), Dr. Kentaro Yoshimatsu (Eisai Inc.) and Dr. Takachika Azuma (Tokyo University of Science) for their helpful advice and sharing of materials throughout this study. This work was supported by a grant-in-aid for Scientific Research from the Japanese Ministry of Education, Culture, Sports, Science and Technology (16K18427 to Y.O., 15K06843 to R.A.) and from the Uehara Memorial Foundation (to Y.O.).; This work was supported by the Scientific Research from the Japanese Ministry of Education, Culture, Sports, Science and Technology (to Y. Obata 16K18427, and R. Abe 15K06843, http://www.jsps.go.jp) and the Uehara Memorial Foundation (to Y. Obata K15-148, http://www.ueharazaidan.or.jp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aichberger KJ, 2009, BLOOD, V114, P5342, DOI 10.1182/blood-2008-08-175190; Bahlawane C, 2015, CELL COMMUN SIGNAL, V13, DOI 10.1186/s12964-015-0096-8; Bauer S, 2007, ONCOGENE, V26, P7560, DOI 10.1038/sj.onc.1210558; Baumgartner C, 2009, AM J PATHOL, V175, P2416, DOI 10.2353/ajpath.2009.080953; BESMER P, 1986, NATURE, V320, P415, DOI 10.1038/320415a0; Bibi S, 2014, HAEMATOLOGICA, V99, P417, DOI 10.3324/haematol.2013.098442; Blume-Jensen P, 1998, CURR BIOL, V8, P779, DOI 10.1016/S0960-9822(98)70302-1; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Boissan M, 2000, J LEUKOCYTE BIOL, V67, P135, DOI 10.1002/jlb.67.2.135; Broudy VC, 1999, BLOOD, V94, P1979; Broudy VC, 1997, BLOOD, V90, P1345, DOI 10.1182/blood.V90.4.1345.1345_1345_1364; Chaix A, 2014, ONCOGENE, V33, P872, DOI 10.1038/onc.2013.12; Chaix A, 2011, J BIOL CHEM, V286, P5956, DOI 10.1074/jbc.M110.182642; Choudhary C, 2009, MOL CELL, V36, P326, DOI 10.1016/j.molcel.2009.09.019; Chung BM, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-84; Feng Y, 2003, P NATL ACAD SCI USA, V100, P6469, DOI 10.1073/pnas.0631766100; Feng Y, 2004, EMBO REP, V5, P596, DOI 10.1038/sj.embor.7400152; FURITSU T, 1993, J CLIN INVEST, V92, P1736, DOI 10.1172/JCI116761; Gibbs L, 2007, BBA-MOL CELL RES, V1773, P502, DOI 10.1016/j.bbamcr.2006.12.010; Gordon PM, 2010, J BIOL CHEM, V285, P14109, DOI 10.1074/jbc.M109.078592; Growney JD, 2005, BLOOD, V106, P721, DOI 10.1182/blood-2004-12-4617; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Hirota S, 1998, SCIENCE, V279, P577, DOI 10.1126/science.279.5350.577; Jaramillo S, 2012, REV ESP ENFERM DIG, V104, P128, DOI 10.4321/s1130-01082012000300005; Joensuu H, 2001, NEW ENGL J MED, V344, P1052, DOI 10.1056/NEJM200104053441404; Joffre C, 2011, NAT CELL BIOL, V13, P827, DOI 10.1038/ncb2257; Kim MS, 2008, TRENDS IMMUNOL, V29, P493, DOI 10.1016/j.it.2008.07.004; KLAUSNER RD, 1992, J CELL BIOL, V116, P1071, DOI 10.1083/jcb.116.5.1071; Kon S, 2014, CELL LOGIST, V18, P4; Kon S, 2013, J CLIN INVEST, V123, P1123, DOI 10.1172/JCI63711; Lasota J, 2008, HISTOPATHOLOGY, V53, P245, DOI 10.1111/j.1365-2559.2008.02977.x; Lennartsson J, 2012, PHYSIOL REV, V92, P1619, DOI 10.1152/physrev.00046.2011; Masson K, 2006, BIOCHEM J, V399, P59, DOI 10.1042/BJ20060464; Obata Y, 2017, ONCOGENE; Obata Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6715; Ohashi Y, 2016, CANCER RES, V76, P3895, DOI 10.1158/0008-5472.CAN-15-2220; Ohashi Y, 2012, J BIOL CHEM, V287, P3885, DOI 10.1074/jbc.M111.316125; Pan HL, 2008, J BIOL CHEM, V283, P31087, DOI 10.1074/jbc.M806592200; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Rinis N, 2014, CELL COMMUN SIGNAL, V12, DOI 10.1186/1478-811X-12-14; Ronchetti D, 2001, ONCOGENE, V20, P3553, DOI 10.1038/sj.onc.1204465; Roskoski R, 2005, BIOCHEM BIOPH RES CO, V338, P1307, DOI 10.1016/j.bbrc.2005.09.150; Rubin BP, 2006, LAB INVEST, V86, P981, DOI 10.1038/labinvest.3700466; Schmidt-Arras D, 2014, J CELL SCI, V127, P341, DOI 10.1242/jcs.130294; Shiina I, 2013, J MED CHEM, V56, P150, DOI 10.1021/jm301695c; Sivalenka RR, 2004, MOL CELL BIOL, V24, P10277, DOI 10.1128/MCB.24.23.10277-10288.2004; Tabone-Eglinger S, 2008, CLIN CANCER RES, V14, P2285, DOI 10.1158/1078-0432.CCR-07-4102; Timokhina I, 1998, EMBO J, V17, P6250, DOI 10.1093/emboj/17.21.6250; Toffalini F, 2010, BLOOD, V116, P2429, DOI 10.1182/blood-2010-04-279752; TSUJIMURA T, 1994, BLOOD, V83, P2619; Tuveson DA, 2001, ONCOGENE, V20, P5054, DOI 10.1038/sj.onc.1204704; Watanuki Z, 2014, BIOCHEM BIOPH RES CO, V455, P269, DOI 10.1016/j.bbrc.2014.11.003; Watari K, 2012, INT J CANCER, V131, P310, DOI 10.1002/ijc.26356; Williams AB, 2012, BLOOD, V120, P3069, DOI 10.1182/blood-2012-01-403493; YARDEN Y, 1987, EMBO J, V6, P3341, DOI 10.1002/j.1460-2075.1987.tb02655.x; Zermati Y, 2003, ONCOGENE, V22, P660, DOI 10.1038/sj.onc.1206120	56	8	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2017	12	4							e0175514	10.1371/journal.pone.0175514	http://dx.doi.org/10.1371/journal.pone.0175514			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LZ	28403213	Green Published, Green Submitted, gold			2022-12-27	WOS:000399955200076
J	Lund, J; Rustan, AC; Lovsletten, NG; Mudry, JM; Langleite, TM; Feng, YZ; Stensrud, C; Brubak, MG; Drevon, CA; Birkeland, KI; Kolnes, KJ; Johansen, EI; Tangen, DS; Stadheim, HK; Gulseth, HL; Krook, A; Kase, ET; Jensen, J; Thoresen, GH				Lund, Jenny; Rustan, Arild C.; Lovsletten, Nils G.; Mudry, Jonathan M.; Langleite, Torgrim M.; Feng, Yuan Z.; Stensrud, Camilla; Brubak, Mari G.; Drevon, Christian A.; Birkeland, Kare I.; Kolnes, Kristoffer J.; Johansen, Egil I.; Tangen, Daniel S.; Stadheim, Hans K.; Gulseth, Hanne L.; Krook, Anna; Kase, Eili T.; Jensen, Jorgen; Thoresen, G. Hege			Exercise in vivo marks human myotubes in vitro: Training-induced increase in lipid metabolism	PLOS ONE			English	Article							ENHANCED GLUCOSE-METABOLISM; FATTY-ACID-METABOLISM; HUMAN SKELETAL-MUSCLE; PROLONGED EXERCISE; INSULIN ACTION; OBESE; FLEXIBILITY; OXIDATION; PROTEIN; AMPK	Background and aims Physical activity has preventive as well as therapeutic benefits for overweight subjects. In this study we aimed to examine effects of in vivo exercise on in vitro metabolic adaptations by studying energy metabolism in cultured myotubes isolated from biopsies taken before and after 12 weeks of extensive endurance and strength training, from healthy sedentary normal weight and overweight men. Methods Healthy sedentary men, aged 40-62 years, with normal weight (body mass index (BMI) < 25 kg/m(2)) or overweight (BMI >= 25 kg/m(2)) were included. Fatty acid and glucose metabolism were studied in myotubes using [C-14] oleic acid and [C-14] glucose, respectively. Gene and protein expressions, as well as DNA methylation were measured for selected genes. Results The 12-week training intervention improved endurance, strength and insulin sensitivity in vivo, and reduced the participants' body weight. Biopsy-derived cultured human myotubes after exercise showed increased total cellular oleic acid uptake (30%), oxidation (46%) and lipid accumulation (34%), as well as increased fractional glucose oxidation (14%) compared to cultures established prior to exercise. Most of these exercise-induced increases were significant in the overweight group, whereas the normal weight group showed no change in oleic acid or glucose metabolism. Conclusions 12 weeks of combined endurance and strength training promoted increased lipid and glucose metabolism in biopsy-derived cultured human myotubes, showing that training in vivo are able to induce changes in human myotubes that are discernible in vitro.	[Lund, Jenny; Rustan, Arild C.; Lovsletten, Nils G.; Feng, Yuan Z.; Stensrud, Camilla; Brubak, Mari G.; Kase, Eili T.; Thoresen, G. Hege] Univ Oslo, Sch Pharm, Dept Pharmaceut Biosci, Oslo, Norway; [Mudry, Jonathan M.; Krook, Anna] Karolinska Inst, Dept Physiol & Pharmacol, Integrat Physiol, Stockholm, Sweden; [Langleite, Torgrim M.; Drevon, Christian A.] Univ Oslo, Inst Basic Med Sci, Dept Nutr, Oslo, Norway; [Birkeland, Kare I.; Gulseth, Hanne L.] Oslo Univ Hosp, Morbid Obes & Prevent Med, Dept Endocrinol, Oslo, Norway; [Birkeland, Kare I.; Gulseth, Hanne L.] Univ Oslo, Inst Clin Med, Oslo, Norway; [Kolnes, Kristoffer J.; Johansen, Egil I.; Tangen, Daniel S.; Stadheim, Hans K.; Jensen, Jorgen] Norwegian Sch Sport Sci, Dept Phys Performance, Oslo, Norway; [Thoresen, G. Hege] Univ Oslo, Inst Clin Med, Dept Pharmacol, Oslo, Norway	University of Oslo; Karolinska Institutet; University of Oslo; University of Oslo; University of Oslo; Norwegian School of Sport Sciences; University of Oslo	Lund, J (corresponding author), Univ Oslo, Sch Pharm, Dept Pharmaceut Biosci, Oslo, Norway.	jenny.lund@farmasi.uio.no	Krook, Anna/K-1192-2015; Løvsletten, Nils Gunnar/AAC-6346-2020; Birkeland, Kåre I/E-9750-2010	Krook, Anna/0000-0002-0891-0258; Løvsletten, Nils Gunnar/0000-0001-5940-6644; Kolnes, Kristoffer Jensen/0000-0001-8824-5173; , Jenny/0000-0002-0744-8268	University of Oslo; Karolinska Institutet; Norwegian Diabetes Association; Throne Holst Foundation of Nutrition Research; Aktieselskabet Freia Chocolade Fabriks Medical Foundation; Norwegian PhD School of Pharmacy; South Eastern Norway Regional Health Authority; Swedish Diabetes Association; Swedish Research council, Anders Jahres Foundation; EU-financed FP7 project (NutriTech) [289511]; Danish Diabetes Academy; Novo Nordisk Foundation; Novo Nordisk Fonden [NNF15SA0018346] Funding Source: researchfish	University of Oslo; Karolinska Institutet(Karolinska Institutet); Norwegian Diabetes Association; Throne Holst Foundation of Nutrition Research; Aktieselskabet Freia Chocolade Fabriks Medical Foundation; Norwegian PhD School of Pharmacy; South Eastern Norway Regional Health Authority; Swedish Diabetes Association; Swedish Research council, Anders Jahres Foundation(Swedish Research Council); EU-financed FP7 project (NutriTech); Danish Diabetes Academy; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Novo Nordisk Fonden(Novo Nordisk Foundation)	This work was funded by research grants from the University of Oslo, Karolinska Institutet, the Norwegian Diabetes Association, Throne Holst Foundation of Nutrition Research, Aktieselskabet Freia Chocolade Fabriks Medical Foundation, Norwegian PhD School of Pharmacy, South Eastern Norway Regional Health Authority, Swedish Diabetes Association, Swedish Research council, Anders Jahres Foundation, and EU-financed FP7 project (NutriTech grant agreement no.: 289511). JJ is a Visiting Professor at Department of Nutrition, Exercise and Sports, University of Copenhagen, supported by The Danish Diabetes Academy and Novo Nordisk Foundation.	Aas V, 2013, CELL TISSUE RES, V354, P671, DOI 10.1007/s00441-013-1655-1; AHLBORG G, 1974, J CLIN INVEST, V53, P1080, DOI 10.1172/JCI107645; Alberti KGMM, 2007, DIABETIC MED, V24, P451, DOI 10.1111/j.1464-5491.2007.02157.x; Baar K, 2002, FASEB J, V16, P1879, DOI 10.1096/fj.02-0367com; Bakke SS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119556; Barres R, 2012, CELL METAB, V15, P405, DOI 10.1016/j.cmet.2012.01.001; Battaglia GM, 2012, AM J PHYSIOL-ENDOC M, V303, pE1440, DOI 10.1152/ajpendo.00355.2012; Berggren JR, 2008, AM J PHYSIOL-ENDOC M, V294, pE726, DOI 10.1152/ajpendo.00354.2007; BLAU HM, 1981, P NATL ACAD SCI-BIOL, V78, P5623, DOI 10.1073/pnas.78.9.5623; Bosma M, 2012, DIABETES, V61, P2679, DOI 10.2337/db11-1402; Bostrom PA, 2013, IUBMB LIFE, V65, P845, DOI 10.1002/iub.1209; Bourlier V, 2013, J CLIN ENDOCR METAB, V98, P3739, DOI 10.1210/jc.2013-1727; DEFRONZO RA, 1985, J CLIN INVEST, V76, P149, DOI 10.1172/JCI111938; DeFronzo RA, 2009, DIABETES, V58, P773, DOI 10.2337/db09-9028; Egan B, 2013, CELL METAB, V17, P162, DOI 10.1016/j.cmet.2012.12.012; Ehrenborg E, 2009, PHARMACOL REV, V61, P373, DOI 10.1124/pr.109.001560; Feng YZ, 2015, AM J PHYSIOL-CELL PH, V308, pC548, DOI 10.1152/ajpcell.00314.2014; Feng YZ, 2014, ARCH PHYSIOL BIOCHEM, V120, P12, DOI 10.3109/13813455.2013.829105; Gaster M, 2001, APMIS, V109, P735, DOI 10.1034/j.1600-0463.2001.d01-140.x; Gaster M, 2001, APMIS, V109, P726, DOI 10.1034/j.1600-0463.2001.d01-139.x; Gaster M, 2007, J LIPID RES, V48, P207, DOI 10.1194/jlr.M600319-JLR200; Gerhart-Hines Z, 2007, EMBO J, V26, P1913, DOI 10.1038/sj.emboj.7601633; Ginter E, 2013, ADV EXP MED BIOL, V771, P42; Green CJ, 2013, J PHYSIOL-LONDON, V591, P4621, DOI 10.1113/jphysiol.2013.251421; Hardie DG, 2006, PHYSIOLOGY, V21, P48, DOI 10.1152/physiol.00044.2005; HENRY RR, 1995, DIABETES, V44, P936, DOI 10.2337/diabetes.44.8.936; Hessvik NP, 2010, J LIPID RES, V51, P2090, DOI 10.1194/jlr.M003319; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; James PT, 2004, CLIN DERMATOL, V22, P276, DOI 10.1016/j.clindermatol.2004.01.010; Johansson L, 1997, EUR J CLIN NUTR, V51, P346, DOI 10.1038/sj.ejcn.1600410; Kase ET, 2007, DIABETOLOGIA, V50, P2171, DOI 10.1007/s00125-007-0760-7; Kase ET, 2015, BBA-MOL CELL BIOL L, V1851, P1194, DOI 10.1016/j.bbalip.2015.03.005; Kase ET, 2006, BBA-MOL CELL BIOL L, V1761, P1515, DOI 10.1016/j.bbalip.2006.09.010; Kase ET, 2005, DIABETES, V54, P1108, DOI 10.2337/diabetes.54.4.1108; Kerner J, 2000, BBA-MOL CELL BIOL L, V1486, P1, DOI 10.1016/S1388-1981(00)00044-5; Kersten S, 2000, J BIOL CHEM, V275, P28488, DOI 10.1074/jbc.M004029200; Kiens B, 2006, PHYSIOL REV, V86, P205, DOI 10.1152/physrev.00023.2004; Koonen DPY, 2005, BBA-MOL CELL BIOL L, V1736, P163, DOI 10.1016/j.bbalip.2005.08.018; Koves TR, 2013, J LIPID RES, V54, P522, DOI 10.1194/jlr.P028910; Kulkarni SS, 2012, METABOLISM, V61, P175, DOI 10.1016/j.metabol.2011.06.014; Langleite TM, 2016, ARCH PHYSIOL BIOCHEM, V122, P167, DOI 10.1080/13813455.2016.1202985; Li Y, 2014, COMPUT INTEL NEUROSC, V2014, DOI 10.1155/2014/926371; Ling C, 2009, DIABETES, V58, P2718, DOI 10.2337/db09-1003; Lira VA, 2010, AM J PHYSIOL-ENDOC M, V299, pE145, DOI 10.1152/ajpendo.00755.2009; Ljubicic V, 2010, BBA-GEN SUBJECTS, V1800, P223, DOI 10.1016/j.bbagen.2009.07.031; Mandard S, 2004, J BIOL CHEM, V279, P34411, DOI 10.1074/jbc.M403058200; MAURO A, 1961, J BIOPHYS BIOCHEM CY, V9, P493, DOI 10.1083/jcb.9.2.493; McGee SL, 2003, DIABETES, V52, P926, DOI 10.2337/diabetes.52.4.926; Jorge MLMP, 2011, METABOLISM, V60, P1244, DOI 10.1016/j.metabol.2011.01.006; Nascimento EBM, 2015, SURG OBES RELAT DIS, V11, P592, DOI 10.1016/j.soard.2014.11.001; Nikolic N., 2012, PLOS ONE, V7; Nikolic NS, 2012, BIOCHEM RES INT, V2012, DOI 10.1155/2012/714074; Nitert MD, 2012, DIABETES, V61, P3322, DOI 10.2337/db11-1653; O'Gorman DJ, 2008, ENDOCRIN METAB CLIN, V37, P887, DOI 10.1016/j.ecl.2008.07.006; Perseghin G, 1996, NEW ENGL J MED, V335, P1357, DOI 10.1056/NEJM199610313351804; Ramos-Jimenez A, 2008, CLIN MED INSIGHTS-CI, V2; Reik W, 2007, NATURE, V447, P425, DOI 10.1038/nature05918; Samuel VT, 2012, CELL, V148, P852, DOI 10.1016/j.cell.2012.02.017; Sharples AP, 2016, AGING CELL; Shaw C, 2009, HISTOCHEM CELL BIOL, V131, P575, DOI 10.1007/s00418-009-0558-4; Smyth S, 2006, NAT MED, V12, P75, DOI 10.1038/nm0106-75; Staiger H, 2009, DIABETES, V58, P579, DOI 10.2337/db07-1438; Stuart CA, 2013, MED SCI SPORT EXER, V45, P2021, DOI 10.1249/MSS.0b013e31829a6ce8; Tuomilehto Jaakko, 2001, New England Journal of Medicine, V344, P1343, DOI 10.1056/NEJM200105033441801; Turcotte LP, 2008, PHYS THER, V88, P1279, DOI 10.2522/ptj.20080018; Wende AR, 2005, MOL CELL BIOL, V25, P10684, DOI 10.1128/MCB.25.24.10684-10694.2005; Wensaas AJ, 2007, J LIPID RES, V48, P961, DOI 10.1194/jlr.D600047-JLR200; Wensaas AJ, 2009, DIABETES, V58, P527, DOI 10.2337/db08-1043; YOUNG DR, 1967, J APPL PHYSIOL, V23, P734, DOI 10.1152/jappl.1967.23.5.734; Zhang LY, 2010, BBA-MOL CELL BIOL L, V1801, P1, DOI 10.1016/j.bbalip.2009.09.014	70	25	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2017	12	4							e0175441	10.1371/journal.pone.0175441	http://dx.doi.org/10.1371/journal.pone.0175441			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LZ	28403174	Green Published, Green Submitted, gold			2022-12-27	WOS:000399955200069
J	Tuo, SH; Yong, LQ; Deng, FA; Li, YH; Lin, Y; Lu, QJ				Tuo, Shouheng; Yong, Longquan; Deng, Fang'an; Li, Yanhai; Lin, Yong; Lu, Qiuju			HSTLBO: A hybrid algorithm based on Harmony Search and Teaching-Learning-Based Optimization for complex high-dimensional optimization problems	PLOS ONE			English	Article							GLOBAL OPTIMIZATION	Harmony Search (HS) and Teaching-Learning-Based Optimization (TLBO) as new swarm intelligent optimization algorithms have received much attention in recent years. Both of them have shown outstanding performance for solving NP-Hard optimization problems. However, they also suffer dramatic performance degradation for some complex high-dimensional optimization problems. Through a lot of experiments, we find that the HS and TLBO have strong complementarity each other. The HS has strong global exploration power but low convergence speed. Reversely, the TLBO has much fast convergence speed but it is easily trapped into local search. In this work, we propose a hybrid search algorithm named HSTLBO that merges the two algorithms together for synergistically solving complex optimization problems using a self-adaptive selection strategy. In the HSTLBO, both HS and TLBO are modified with the aim of balancing the global exploration and exploitation abilities, where the HS aims mainly to explore the unknown regions and the TLBO aims to rapidly exploit high-precision solutions in the known regions. Our experimental results demonstrate better performance and faster speed than five state-of-the-art HS variants and show better exploration power than five good TLBO variants with similar run time, which illustrates that our method is promising in solving complex high-dimensional optimization problems. The experiment on portfolio optimization problems also demonstrate that the HSTLBO is effective in solving complex read-world application.	[Tuo, Shouheng; Yong, Longquan; Deng, Fang'an; Li, Yanhai; Lin, Yong; Lu, Qiuju] Shaanxi Univ Technol, Sch Math & Comp Sci, Hanzhong, Peoples R China	Shaanxi University of Technology	Tuo, SH (corresponding author), Shaanxi Univ Technol, Sch Math & Comp Sci, Hanzhong, Peoples R China.	tuo_sh@126.com			Natural Science Foundation of China [11401357]; project of Youth star in Science and technology of Shaanxi Province [2016KJXX-95]; Shaanxi Provincial Education Department [16JK1157]; Projects Program of Shaanxi University of technology Academician Workstation [fckt201509]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); project of Youth star in Science and technology of Shaanxi Province; Shaanxi Provincial Education Department; Projects Program of Shaanxi University of technology Academician Workstation	This work was supported by the Natural Science Foundation of China under Grants 11401357, the project of Youth star in Science and technology of Shaanxi Province (2016KJXX-95), and the Scientific Research Program funded by Shaanxi Provincial Education Department (no. 16JK1157) and the Scientific Research Program funded by the Projects Program of Shaanxi University of technology Academician Workstation (No. fckt201509). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Natural Science Foundation of China under Grants 11401357, the project of Youth star in Science and technology of Shaanxi Province (2016KJXX-95), and the Scientific Research Program funded by Shaanxi Provincial Education Department (no. 16JK1157) and the Scientific Research Program funded by the Projects Program of Shaanxi University of technology Academician Workstation (No. fckt201509).	Alatas B, 2010, APPL MATH COMPUT, V216, P2687, DOI 10.1016/j.amc.2010.03.114; Alia OM, 2011, ARTIF INTELL REV, V36, P49, DOI 10.1007/s10462-010-9201-y; Chang T. J., 1999, COMPUTERS OPERATIONS, V27, P1271; Chen DB, 2015, INFORM SCIENCES, V297, P171, DOI 10.1016/j.ins.2014.11.001; Chen J, 2012, APPL MATH COMPUT, V219, P592, DOI 10.1016/j.amc.2012.06.048; Cheng M. - Y., 2016, NEURAL COMPUT APPL, P1; Cheng MY, 2016, AUTOMAT CONSTR, V69, P21, DOI 10.1016/j.autcon.2016.05.023; Cheng MY, 2014, COMPUT STRUCT, V139, P98, DOI 10.1016/j.compstruc.2014.03.007; Civicioglu P, 2013, APPL MATH COMPUT, V219, P8121, DOI 10.1016/j.amc.2013.02.017; Cobos C, 2011, APPL MATH COMPUT, V218, P2558, DOI 10.1016/j.amc.2011.07.073; Cura T, 2009, NONLINEAR ANAL-REAL, V10, P2396, DOI 10.1016/j.nonrwa.2008.04.023; Das S, 2011, IEEE T SYST MAN CY B, V41, P89, DOI 10.1109/TSMCB.2010.2046035; Derrac J, 2011, SWARM EVOL COMPUT, V1, P3, DOI 10.1016/j.swevo.2011.02.002; Enayatifar R, 2013, COMMUN NONLINEAR SCI, V18, P3481, DOI 10.1016/j.cnsns.2013.04.028; Geem ZW, 2001, SIMULATION, V76, P60, DOI 10.1177/003754970107600201; Goldberg D. E, 1989, OPTIMIZATION MACHINE, V7, P2104; Herrera F., TEST SUITE SPECIAL I; Karaboga D, 2007, J GLOBAL OPTIM, V39, P459, DOI 10.1007/s10898-007-9149-x; Kattan A, 2013, APPL MATH COMPUT, V219, P8542, DOI 10.1016/j.amc.2013.02.074; Kennedy J, 1995, 1995 IEEE INTERNATIONAL CONFERENCE ON NEURAL NETWORKS PROCEEDINGS, VOLS 1-6, P1942, DOI 10.1109/icnn.1995.488968; Li GQ, 2013, CHEMOMETR INTELL LAB, V126, P11, DOI 10.1016/j.chemolab.2013.04.012; Mahdavi M, 2007, APPL MATH COMPUT, V188, P1567, DOI 10.1016/j.amc.2006.11.033; Masao FUKUSHIMA, TEST FUNCTIONS UNCON; Omran MGH, 2008, APPL MATH COMPUT, V198, P643, DOI 10.1016/j.amc.2007.09.004; Ouyang HB, 2015, APPL MATH COMPUT, V265, P533, DOI 10.1016/j.amc.2015.05.012; Pan QK, 2010, ENG OPTIMIZ, V42, P101, DOI 10.1080/03052150903104366; Pan QK, 2010, APPL MATH COMPUT, V216, P830, DOI 10.1016/j.amc.2010.01.088; Rao RV, 2013, ENG APPL ARTIF INTEL, V26, P430, DOI 10.1016/j.engappai.2012.02.016; Satapathy SC., 2013, APPL MATH, P429, DOI [4, DOI 10.4236/AM.2013.43064]; Storn R, 1997, J GLOBAL OPTIM, V11, P341, DOI 10.1023/A:1008202821328; Tang K., 2009, TECHNICAL REPORT; Tang K., 2008, BENCHMARK FUNCTIONS; Tuo S., 2012, J COMPUTATIONAL INFO, V8, P4269; Tuo S., 2013, MATH PROBL ENG, V2013, P1, DOI DOI 10.1155/2013/413565; Tuo S H, 2016, MODIFIED HARMONY SEA, V50; Tuo SH, 2015, DIGIT SIGNAL PROCESS, V46, P151, DOI 10.1016/j.dsp.2015.08.008; Wang L, 2013, INFORM SCIENCES, V232, P58, DOI 10.1016/j.ins.2012.12.043; Wang Zhen, 2012, MODELS ALGORITHMS SO; Yadav P, 2012, INFORM SCIENCES, V196, P47, DOI 10.1016/j.ins.2011.12.035; Zou DX, 2010, NEUROCOMPUTING, V73, P3308, DOI 10.1016/j.neucom.2010.07.010	41	23	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2017	12	4							e0175114	10.1371/journal.pone.0175114	http://dx.doi.org/10.1371/journal.pone.0175114			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LZ	28403224	Green Submitted, Green Published, gold			2022-12-27	WOS:000399955200033
J	Zaidi, Z; Lan, KC				Zaidi, Zainab; Lan, Kun-chan			Wireless multihop backhauls for rural areas: A preliminary study	PLOS ONE			English	Article							AD HOC; NETWORKS	Rural areas have very low revenue potential. The major issue in providing low-cost broadband to rural areas is to provide reliable backhaul connections that spread over tens or even hundreds of miles, connecting villages to the nearest service provider. Along with aerial networks of Google and Facebook, there has been a considerable amount of research toward long-distance terrestrial WiFi links. As a comparison, WiFi routers are easier to be deployed and maintained by non-technical people from the local communities, whereas the aerial networks require professional support to operate. Moreover, they are still in the experimentation phase. However, the long distance WiFi links require high-gain directional antennas and very expensive tall towers for high data rates. On the other hand, multihop paths with stronger links may provide better data rates without the need of tall towers. In this paper, we evaluated the concept of using such multihop WiFi links for long backhaul connections. Our simulation results show that these networks can possibly be a cost-effective and practical solution for rural connectivity. These initial results can serve as a first step to understand the comprehensive feasibility of using multihop WiFi networks for backhaul connections in rural area.	[Lan, Kun-chan] Natl Cheng Kung Univ, Dept Comp Sci & Informat Engn, Tainan, Taiwan	National Cheng Kung University	Lan, KC (corresponding author), Natl Cheng Kung Univ, Dept Comp Sci & Informat Engn, Tainan, Taiwan.	klan@csie.ncku.edu.tw						Adeyeye M, 2011, EURASIP J WIREL COMM, DOI 10.1186/1687-1499-2011-78; Backens J, 2010, L N INST COMP SCI SO, V38, P32; Barsocchi P, 2007, CRAWDAD DATASET ISTI; Barsocchi P, 2007, 2007 5TH INTERNATIONAL SYMPOSIUM ON MODELING AND OPTIMIZATION IN MOBILE, AD HOC AND WIRELESS NETWORKS AND WORKSHOPS, VOLS 1-2, P551, DOI 10.1109/WIOPT.2007.4480105; Bernadette H., SENGEREMA WIRELESS M; Bernardi G., 2008, PROC ACM WORKSHOP WI, P9; Bhorkar AA, 2012, IEEE ACM T NETWORK, V20, P243, DOI 10.1109/TNET.2011.2159844; Biswas S, 2005, ACM SIGCOMM COMP COM, V35, P133, DOI 10.1145/1090191.1080108; Chachulski S, 2007, ACM SIGCOMM COMP COM, V37, P169, DOI 10.1145/1282427.1282400; Chakraborty Nilanjan, 2015, ScientificWorldJournal, V2015, P208649, DOI 10.1155/2015/208649; Chebrolu K, 2006, MOBICOM 2006, P74; Darbari F, 2010, IEEE GLOBE WORK, P731, DOI 10.1109/GLOCOMW.2010.5700419; De Couto DSJ, 2005, WIREL NETW, V11, P419, DOI 10.1007/s11276-005-1766-z; Du K., 2010, WIRELESS COMMUNICATI; Fang X, 2011, IEEE INFOCOM SER, P1907, DOI 10.1109/INFCOM.2011.5934993; Fette Aiello, 2007, RF WIRELESS TECHNOLO; Foschini G. J., 1998, Wireless Personal Communications, V6, P311, DOI 10.1023/A:1008889222784; Fuyler H, 2003, AD HOC NETW, V1, P351, DOI DOI 10.1016/S1570-8705(03)00038-6; Gokhale D, 2008, INFOCOM 2008; Goldsmith A., 2005, WIRELESS COMMUNICATI; Green DB, 2002, 2002 IEEE INTERNATIONAL CONFERENCE ON COMMUNICATIONS, VOLS 1-5, CONFERENCE PROCEEDINGS, P3424, DOI 10.1109/ICC.2002.997466; Hasan S, 2013, PROCEEDINGS OF THE 3RD ACM SYMPOSIUM ON COMPUTING FOR DEVELOPMENT (ACM DEV 2013); Hasan S, 2014, IEEE INT SYMP DYNAM, P271, DOI 10.1109/DySPAN.2014.6817804; HEIMERL K., 2010, P 4 ACM WORKSH NETW; Ishmael J, 2008, IEEE INTERNET COMPUT, V12, P22, DOI 10.1109/MIC.2008.76; Jacquet P, 2009, IEEE J SEL AREA COMM, V27, P1192, DOI 10.1109/JSAC.2009.090915; Johnson D. L., 2008, P ANN INT C MOBILE C, P17; Khandani AE, 2008, IEEE T WIREL COMMUN, V7, P4772, DOI 10.1109/T-WC.2008.070770; Kretschmer M., 2011, 2011 IEEE 8th International Conference on Mobile Ad-Hoc and Sensor Systems, P758, DOI 10.1109/MASS.2011.84; Laufer R, 2009, IEEE INFOCOM SER, P37, DOI 10.1109/INFCOM.2009.5061904; Lee JY, 2013, IEEE T MOBILE COMPUT, V12, P1879, DOI 10.1109/TMC.2012.159; Mark J. W., 2003, WIRELESS COMMUNICATI; Nishat K, 2014, IEEE CONF COMPUT, P145, DOI 10.1109/INFCOMW.2014.6849197; Patra R. K., 2007, PROC NSDI, V1, P87; Pentland AS, 2004, COMPUTER, V37, P78, DOI 10.1109/MC.2004.1260729; Phillips C, 2012, INT J ANTENN PROPAG, V2012, DOI 10.1155/2012/754158; Phillips C, 2011, LECT NOTES COMPUT SC, V6579, P42, DOI 10.1007/978-3-642-19260-9_5; Raman B, 2007, IEEE COMMUN MAG, V45, P104, DOI 10.1109/MCOM.2007.284545; Surana S., 2008, P NSDI, V8, P119; Thakur A, 2013, 2013 INTERNATIONAL CONFERENCE ON ADVANCES IN COMPUTING, COMMUNICATIONS AND INFORMATICS (ICACCI), P1335, DOI 10.1109/ICACCI.2013.6637371; Wang ZH, 2012, IEEE J SEL AREA COMM, V30, P289, DOI 10.1109/JSAC.2012.120207; Zaidi Z, 2013, 2013 IEEE WIRELESS COMMUNICATIONS AND NETWORKING CONFERENCE (WCNC), P2387; Zorzi M, 2003, IEEE T MOBILE COMPUT, V2, P337, DOI 10.1109/TMC.2003.1255648	43	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2017	12	4							e0175358	10.1371/journal.pone.0175358	http://dx.doi.org/10.1371/journal.pone.0175358			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LZ	28403167	Green Published, Green Submitted, gold			2022-12-27	WOS:000399955200055
J	Jacob, H; Pouil, S; Lecchini, D; Oberhansli, F; Swarzenski, P; Metian, M				Jacob, Hugo; Pouil, Simon; Lecchini, David; Oberhaensli, Francois; Swarzenski, Peter; Metian, Marc			Trophic transfer of essential elements in the clownfish Amphiprion ocellaris in the context of ocean acidification	PLOS ONE			English	Article							MARINE ORGANISMS; METAL; LARVAE; FISH; RADIONUCLIDES; PH	Little information exists on the effects of ocean acidification (OA) on the digestive and post-digestive processes in marine fish. Here, we investigated OA impacts (Delta pH = 0.5) on the trophic transfer of select trace elements in the clownfish Amphiprion ocellaris using radiotracer techniques. Assimilation efficiencies of three essential elements (Co, Mn and Zn) as well as their other short-term and long-term kinetic parameters in juvenile clownfish were not affected by this experimental pH change. In complement, their stomach pH during digestion were not affected by the variation in seawater pH. Such observations suggest that OA impacts do not affect element assimilation in these fish. This apparent pCO(2) tolerance may imply that clownfish have the ability to self-regulate pH shifts in their digestive tract, or that they can metabolically accommodate such shifts. Such results are important to accurately assess future OA impacts on diverse marine biota, as such impacts are highly species specific, complex, and may be modulated by species-specific metabolic processes.	[Jacob, Hugo; Pouil, Simon; Oberhaensli, Francois; Swarzenski, Peter; Metian, Marc] IAEA, Environm Labs, 4a Quai Antoine 1er, Monaco, Monaco; [Jacob, Hugo; Lecchini, David] Univ Perpignan, CNRS EPHE UPVD, USR 3278, PSL, Via Domitia, Perpignan, France; [Pouil, Simon] Univ La Rochelle, CNRS, Littoral Environm & Societes LIENSs, UMR 7266, 2 Rue Olympe Gouges, La Rochelle, France; [Lecchini, David] Lab Excellence CORAIL, Moorea, French Polynesi, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite Perpignan Via Domitia; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); La Rochelle Universite	Metian, M (corresponding author), IAEA, Environm Labs, 4a Quai Antoine 1er, Monaco, Monaco.	m.metian@iaea.org	Swarzenski, Peter/AAD-8562-2022; Pouil, Simon/J-6839-2019; Metian, Marc/F-8010-2018	Pouil, Simon/0000-0003-1531-0362; Metian, Marc/0000-0003-1485-5029; Jacob, Hugo/0000-0002-3376-8425; Swarzenski, Peter/0000-0003-0116-0578	IAEA; CNRS-EPHE-UPVD [USR 3278]; IAEA by the Government of the Principality of Monaco	IAEA(International Atomic Energy Agency); CNRS-EPHE-UPVD; IAEA by the Government of the Principality of Monaco	The work was supported by funds from IAEA and USR 3278 CNRS-EPHE-UPVD. The IAEA is grateful for the support provided to its Environment Laboratories by the Government of the Principality of Monaco. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank IAEA OA-ICC team and especially Jean-Louis Teyssie A for their very useful help in the experimental design of the experiments. The work was supported by funds from IAEA and USR 3278 CNRS-EPHE-UPVD. The IAEA is grateful for the support provided to its Environment Laboratories by the Government of the Principality of Monaco.	Bignami S, 2013, GLOBAL CHANGE BIOL, V19, P996, DOI 10.1111/gcb.12133; BREMNER I, 1981, PHILOS T R SOC B, V294, P75, DOI 10.1098/rstb.1981.0090; Bury NR, 2003, J EXP BIOL, V206, P11, DOI 10.1242/jeb.00068; Claiborne JB, 2002, J EXP ZOOL, V293, P302, DOI 10.1002/jez.10125; Deguara S, 2003, J FISH BIOL, V62, P1033, DOI 10.1046/j.1095-8649.2003.00094.x; Dickson A., 2007, PICES SPECIAL PUBLIC, V3, DOI 10.25607/OBP-1342; Frommel AY, 2014, ECOL APPL, V24, P1131, DOI 10.1890/13-0297.1; Frommel AY, 2012, NAT CLIM CHANGE, V2, P42, DOI 10.1038/nclimate1324; Gattuso J.-P., 2015, COMPREHENSIVE R ARCH; Guadayol O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085213; Heuer RM, 2016, SCI REP-UK, V6, DOI 10.1038/srep34480; Heuer RM, 2014, AM J PHYSIOL-REG I, V307, pR1061, DOI 10.1152/ajpregu.00064.2014; Heuer RM, 2012, PHYSIOL BIOCHEM ZOOL, V85, P450, DOI 10.1086/667617; Hurst TP, 2012, AQUAT BIOL, V17, P247, DOI 10.3354/ab00483; IPCC (Intergovernmental Panel on Climate Change), 2013, CLIMATE CHANGE 2013; Ivanina AV, 2015, CURR ZOOL, V61, P653, DOI 10.1093/czoolo/61.4.653; Kroeker KJ, 2013, GLOBAL CHANGE BIOL, V19, P1884, DOI 10.1111/gcb.12179; Melzner F, 2009, BIOGEOSCIENCES, V6, P2313, DOI 10.5194/bg-6-2313-2009; Metian M, 2010, MAR POLLUT BULL, V61, P576, DOI 10.1016/j.marpolbul.2010.06.035; Moran D, 2011, AQUAT TOXICOL, V102, P24, DOI 10.1016/j.aquatox.2010.12.014; Munday PL, 2011, MAR ECOL PROG SER, V423, P211, DOI 10.3354/meps08990; Norin T, 2016, J FISH BIOL, V88, P122, DOI 10.1111/jfb.12796; Perry DM, 2015, ECOL EVOL, V5, P4187, DOI 10.1002/ece3.1678; Perry SF, 2006, RESP PHYSIOL NEUROBI, V154, P199, DOI 10.1016/j.resp.2006.04.010; Pimentel MS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134082; Pimentel MS, 2014, J EXP BIOL, V217, P2062, DOI 10.1242/jeb.092635; Pouil S, 2016, MAR ECOL PROG SER, V550, P207, DOI 10.3354/meps11716; Pouil S, 2015, J ENVIRON RADIOACTIV, V150, P189, DOI 10.1016/j.jenvrad.2015.08.016; Reinardy HC, 2011, SCI TOTAL ENVIRON, V409, P3771, DOI 10.1016/j.scitotenv.2011.06.057; Rosa R, 2016, MAR BIOL, V163, DOI 10.1007/s00227-016-2840-z; Rosa R, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1738; Wallace WG, 2003, MAR ECOL PROG SER, V257, P125, DOI 10.3354/meps257125; Wang WX, 1999, SCI TOTAL ENVIRON, V238, P459; Warnau M, 1996, MAR ECOL PROG SER, V141, P83, DOI 10.3354/meps141083; Welch MJ, 2016, CORAL REEFS, V35, P485, DOI 10.1007/s00338-015-1385-9; Wittmann AC, 2013, NAT CLIM CHANGE, V3, P995, DOI 10.1038/NCLIMATE1982; Yufera M, 2004, MAR BIOL, V144, P863, DOI 10.1007/s00227-003-1255-9	37	7	7	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2017	12	4							e0174344	10.1371/journal.pone.0174344	http://dx.doi.org/10.1371/journal.pone.0174344			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0JS	28399186	Green Published, gold, Green Submitted			2022-12-27	WOS:000399949000009
J	Ke, Q; Ahn, YY; Sugimoto, CR				Ke, Qing; Ahn, Yong-Yeol; Sugimoto, Cassidy R.			A systematic identification and analysis of scientists on Twitter	PLOS ONE			English	Article							SOCIAL MEDIA; TWEETS; CITATIONS; METRICS; IMPACT; PHYSICIANS; ALTMETRICS	Metrics derived from Twitter and other social media-often referred to as altmetrics-are increasingly used to estimate the broader social impacts of scholarship. Such efforts, however, may produce highly misleading results, as the entities that participate in conversations about science on these platforms are largely unknown. For instance, if altmetric activities are generated mainly by scientists, does it really capture broader social impacts of science? Here we present a systematic approach to identifying and analyzing scientists on Twitter. Our method can identify scientists across many disciplines, without relying on external bibliographic data, and be easily adapted to identify other stakeholder groups in science. We investigate the demographics, sharing behaviors, and interconnectivity of the identified scientists. We find that Twitter has been employed by scholars across the disciplinary spectrum, with an over-representation of social and computer and information scientists; under-representation of mathematical, physical, and life scientists; and a better representation of women compared to scholarly publishing. Analysis of the sharing of URLs reveals a distinct imprint of scholarly sites, yet only a small fraction of shared URLs are science-related. We find an assortative mixing with respect to disciplines in the networks between scientists, suggesting the maintenance of disciplinary walls in social media. Our work contributes to the literature both methodologically and conceptually-we provide new methods for disambiguating and identifying particular actors on social media and describing the behaviors of scientists, thus providing foundational information for the construction and use of indicators on the basis of social media metrics.	[Ke, Qing; Ahn, Yong-Yeol; Sugimoto, Cassidy R.] Indiana Univ, Sch Informat & Comp, Bloomington, IN 47405 USA	Indiana University System; Indiana University Bloomington	Ke, Q (corresponding author), Indiana Univ, Sch Informat & Comp, Bloomington, IN 47405 USA.	qke@indiana.edu	Ke, Qing/T-1434-2019; Sugimoto, Cassidy R/AAV-2705-2021; Ahn, Yong-Yeol/C-6334-2011	Sugimoto, Cassidy R/0000-0001-8608-3203; Ahn, Yong-Yeol/0000-0002-4352-4301; Ke, Qing/0000-0002-2945-5274	Microsoft Research; Alfred P. Sloan Foundation Grant [G-2014-3-25]	Microsoft Research(Microsoft); Alfred P. Sloan Foundation Grant	YYA acknowledges support from Microsoft Research. CRS is supported by the Alfred P. Sloan Foundation Grant #G-2014-3-25. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Onur Varol for early discussions and Filippo Radicchi for providing the computing resource. YYA acknowledges support from Microsoft Research. CRS is supported by the Alfred P. Sloan Foundation Grant #G-2014-3-25.	Bornmann L, 2015, SCIENTOMETRICS, V103, P1123, DOI 10.1007/s11192-015-1565-y; Bornmann L, 2014, J INFORMETR, V8, P895, DOI 10.1016/j.joi.2014.09.005; Bowman TD, 2015, ASLIB J INFORM MANAG, V67, P356, DOI 10.1108/AJIM-12-2014-0180; Characterizing V., 2015, PLOS ONE, V10; Chretien KC, 2011, JAMA-J AM MED ASSOC, V305, P566, DOI 10.1001/jama.2011.68; Costas R, 2015, ASLIB J INFORM MANAG, V67, P260, DOI 10.1108/AJIM-12-2014-0173; Costas R, 2015, J ASSOC INF SCI TECH, V66, P2003, DOI 10.1002/asi.23309; Costello K. L., 2010, PROC AM SOC INFORM S, V47, P1, DOI DOI 10.1002/MEET.14504701201; Darling ES, 2013, IDEAS ECOL EVOL, V6, DOI 10.4033/iee.2013.6.6.f; de Winter JCF, 2015, SCIENTOMETRICS, V102, P1773, DOI 10.1007/s11192-014-1445-x; Eysenbach G, 2011, J MED INTERNET RES, V13, DOI 10.2196/jmir.2012; Faulkes Z, 2014, NEURON, V82, P258, DOI 10.1016/j.neuron.2014.03.032; Hadgu Asmelash Teka, 2014, P 2014 ACM C WEB SCI, P23, DOI DOI 10.1145/2615569.2615676; Hammarfelt B, 2014, SCIENTOMETRICS, V101, P1419, DOI 10.1007/s11192-014-1261-3; Haustein S, 2014, P ALTMETRICS14 EXP I; Haustein S, 2014, AJIM; Haustein S, 2014, SCIENTOMETRICS, V101, P1145, DOI 10.1007/s11192-013-1221-3; Haustein S, 2014, J ASSOC INF SCI TECH, V65, P656, DOI 10.1002/asi.23101; Holmberg K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106086; Holmberg KV, 2014, MONOGR ORAL SCI, V24, P1, DOI [10.1159/000358776, 10.1007/s11192-014-1229-3]; Jacomy M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098679; Kapp JM, 2015, ANN EPIDEMIOL, V25, P883, DOI 10.1016/j.annepidem.2015.09.002; Lariviere V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127502; Loeb S, 2014, BJU INT, V113, P993, DOI 10.1111/bju.12586; Lulic I, 2013, EMERG MED J, V30, P371, DOI 10.1136/emermed-2012-201132; Newman MEJ, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.026126; Priem J., 2010, ALTMETRICS MANIFESTO; Priem J., 2012, ARXIV12034745; Pujari SC, 2015, P 15 INT C KNOWL TEC; Rowlands I, 2011, LEARN PUBL, V24, P183, DOI 10.1087/20110306; Sharma NK, 2012, P 2012 ACM WORKSH WO, P55, DOI DOI 10.1145/2342549.2342563; Shuai X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047523; Sugimoto CR, 2013, NATURE, V504, P211, DOI 10.1038/504211a; Thelwall M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064841; Van Noorden R, 2014, NATURE, V512, P126, DOI 10.1038/512126a; Woolston C, 2015, NATURE, V524, P391, DOI 10.1038/524391f; Wu S., 2011, P 20 INT C WORLD WID, V20, P705, DOI [DOI 10.1145/1963405.1963504, 10.1145/1963405.1963504]; Zahedi Z, 2014, SCIENTOMETRICS, V101, P1491, DOI 10.1007/s11192-014-1264-0	38	71	74	4	92	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2017	12	4							e0175368	10.1371/journal.pone.0175368	http://dx.doi.org/10.1371/journal.pone.0175368			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET0JS	28399145	Green Submitted, gold, Green Published			2022-12-27	WOS:000399949000035
J	Li, YZ; Fan, XW; Chen, Q; Zhong, H				Li, You-Zhi; Fan, Xian-Wei; Chen, Qiang; Zhong, Hao			A photoperiod-responsive protein compendium and conceptual proteome roadmap outline in maize grown in growth chambers with controlled conditions	PLOS ONE			English	Article							CAT3 CATALASE GENE; CIRCADIAN REGULATION; ARABIDOPSIS; SENSITIVITY; PLANTS; LEAVES; COINCIDENCE; TRANSITION; EXPRESSION; TOLERANCE	Maize (Zea mays L.) is one of the major staple food crops of the world. However, high photoperiod sensitivity, especially for tropical germplasms, impedes attempts to improve maize agronomical traits by integration of tropical and temperate maize germplasms. Physiological and phenotypic responses of maize to photoperiod have widely been investigated based on multi-site field observations; however, proteome-based responsive mechanisms under controlled photoperiod regimes, nutrient and moisture soils are not yet well understood. In the present study, we sequenced and analyzed six proteomes of tropically-adapted and photo-period-sensitive M9 inbred line at the vegetative 3 stage and proteomes from tropically-adapted and photoperiod-sensitive Shuang M9 (SM9) inbred line at the vegetative-tasseling stage. All plants were grown in growth chambers with controlled soil and temperature and three photoperiod regimes, a short photoperiod (SP) of 10 h light/14 h dark, a control neutral photoperiod (NP) of 12 h light/12 h dark, and a long photoperiod (LP) of 16 h light/8 h dark for a daily cycle. We identified 4,395 proteins of which 401 and 425 differentially-expressed proteins (DPs) were found in abundance in M9 leaves and in SM9 leaves as per SP/LP vs. NP, respectively. Some DPs showed responses to both SP and LP while some only responded to either SP or LP, depending on M9 or SM9. Our study showed that the photoperiodic response pathway, circadian clock rhythm, and high light density/intensity crosstalk with each other, but apparently differ from dark signaling routes. Photoperiod response involves light-responsive or dark-responsive proteins or both. The DPs positioned on the signaling routes from photoperiod changes to RNA/DNA responses involve the mago nashi homolog and glycine-rich RNA-binding proteins. Moreover, the cell-to-cell movement of ZCN14 through plasmodesmata is likely blocked under a 16-h-light LP. Here, we propose a photoperiodic model based on our findings and those from previous studies.	[Li, You-Zhi; Fan, Xian-Wei; Chen, Qiang; Zhong, Hao] Guangxi Univ, Coll Life Sci & Technol, State Key Lab Conservat & Utilizat Subtrop Agrobi, Nanning, Peoples R China	Guangxi University	Li, YZ (corresponding author), Guangxi Univ, Coll Life Sci & Technol, State Key Lab Conservat & Utilizat Subtrop Agrobi, Nanning, Peoples R China.	dyzl@gxu.edu.cn			State Key Laboratory for Conservation and Utilization of Subtropical Agro-bioresources; High-Quality Teaching Project of Guangxi High Education -Subproject of Advantageous and Characteristic Specialty (Excellent Undergraduate Major), China	State Key Laboratory for Conservation and Utilization of Subtropical Agro-bioresources; High-Quality Teaching Project of Guangxi High Education -Subproject of Advantageous and Characteristic Specialty (Excellent Undergraduate Major), China	The State Key Laboratory for Conservation and Utilization of Subtropical Agro-bioresources, and the High-Quality Teaching Project of Guangxi High Education 2016-Subproject of Advantageous and Characteristic Specialty (Excellent Undergraduate Major), China.	Araki T, 2001, CURR OPIN PLANT BIOL, V4, P63, DOI 10.1016/S1369-5266(00)00137-0; Bartoli CG, 2006, J EXP BOT, V57, P1621, DOI 10.1093/jxb/erl005; Battey NH, 2002, CURR OPIN PLANT BIOL, V5, P62, DOI 10.1016/S1369-5266(01)00229-1; Becker B, 2006, PLANTA, V224, P380, DOI 10.1007/s00425-006-0222-3; BOLDT R, 1995, PLANT J, V7, P989, DOI 10.1046/j.1365-313X.1995.07060989.x; BROADWATER AH, 1993, GENE, V131, P227, DOI 10.1016/0378-1119(93)90297-G; Chen Q, 2015, PLANT CELL ENVIRON, V38, P1479, DOI 10.1111/pce.12361; Clarke JH, 1999, PLANT J, V20, P493, DOI 10.1046/j.1365-313x.1999.00623.x; Danilevskaya ON, 2008, PLANT PHYSIOL, V146, P250, DOI 10.1104/pp.107.109538; Dell'Amico J, 2001, PLANT SCI, V160, P481, DOI 10.1016/S0168-9452(00)00409-X; DELLAPORTA SL, 1993, PLANT CELL, V5, P1241, DOI 10.1105/tpc.5.10.1241; Dodd IC, 2008, PLANT CELL ENVIRON, V31, P1263, DOI 10.1111/j.1365-3040.2008.01831.x; Doebley J, 2004, ANNU REV GENET, V38, P37, DOI 10.1146/annurev.genet.38.072902.092425; Dong ZS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043450; Forestan C, 2010, PLANT PHYSIOL, V152, P1373, DOI 10.1104/pp.109.150193; Foyer CH, 2003, PHYSIOL PLANTARUM, V119, P355, DOI 10.1034/j.1399-3054.2003.00223.x; Gouesnard B, 2002, GENET RESOUR CROP EV, V49, P471, DOI 10.1023/A:1020982827604; Grigg SP, 2005, NATURE, V437, P1022, DOI 10.1038/nature04052; Grundy J, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00648; Gulyas Z, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-91; Gupta SC, 2010, LIFE SCI, V86, P377, DOI 10.1016/j.lfs.2009.12.015; Han X, 2016, MOL PLANT, V9, P46, DOI 10.1016/j.molp.2015.08.015; Imaizumi T, 2006, TRENDS PLANT SCI, V11, P550, DOI 10.1016/j.tplants.2006.09.004; Kataoka N, 2001, EMBO J, V20, P6424, DOI 10.1093/emboj/20.22.6424; Kellogg EA, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00250; Lewis RS, 2003, THEOR APPL GENET, V107, P798, DOI 10.1007/s00122-003-1341-x; Mallick P, 2010, NAT BIOTECHNOL, V28, P695, DOI 10.1038/nbt.1658; Meng X, 2011, PLANT CELL, V23, P942, DOI 10.1105/tpc.110.081406; Nozue K, 2007, NATURE, V448, P358, DOI 10.1038/nature05946; Pose D, 2012, CURR OPIN PLANT BIOL, V15, P45, DOI 10.1016/j.pbi.2011.09.002; REDINBAUGH MG, 1990, P NATL ACAD SCI USA, V87, P6853, DOI 10.1073/pnas.87.17.6853; Sager R, 2014, J EXP BOT, V65, P6337, DOI 10.1093/jxb/eru365; Sanchez A, 2011, PLANT SIGNAL BEHAV, V6, P223, DOI 10.4161/psb.6.2.14893; Shim JS, 2015, BIOCHEMISTRY-US, V54, P157, DOI 10.1021/bi500922q; Song YH, 2013, TRENDS PLANT SCI, V18, P575, DOI 10.1016/j.tplants.2013.05.003; Suzuki N, 2012, PLANT CELL ENVIRON, V35, P259, DOI 10.1111/j.1365-3040.2011.02336.x; Voss I, 2013, PLANT BIOLOGY, V15, P713, DOI 10.1111/j.1438-8677.2012.00710.x; Wang CL, 2008, THEOR APPL GENET, V117, P1129, DOI 10.1007/s00122-008-0851-y; Wang JW, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002012; Wang W, 2006, ACTA HISTOCHEM, V108, P395, DOI 10.1016/j.acthis.2006.06.003; WEISS CA, 1994, P NATL ACAD SCI USA, V91, P9554, DOI 10.1073/pnas.91.20.9554; Xu J, 2012, J INTEGR PLANT BIOL, V54, P358, DOI 10.1111/j.1744-7909.2012.01128.x; Yang Q, 2013, P NATL ACAD SCI USA, V110, P16969, DOI 10.1073/pnas.1310949110; Zhao DZ, 2009, SEX PLANT REPROD, V22, P221, DOI 10.1007/s00497-009-0106-3	44	7	7	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2017	12	4							e0174003	10.1371/journal.pone.0174003	http://dx.doi.org/10.1371/journal.pone.0174003			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0JS	28399169	Green Submitted, gold, Green Published			2022-12-27	WOS:000399949000007
J	Akkalkotkar, A; Brown, KS				Akkalkotkar, Ameya; Brown, Kevin Scott			An algorithm for separation of mixed sparse and Gaussian sources	PLOS ONE			English	Article							INDEPENDENT COMPONENT ANALYSIS; SIMULTANEOUS EEG-FMRI; BLIND SEPARATION; PRINCIPAL-COMPONENTS; STOPPING RULES	Independent component analysis (ICA) is a ubiquitous method for decomposing complex signal mixtures into a small set of statistically independent source signals. However, in cases in which the signal mixture consists of both nongaussian and Gaussian sources, the Gaussian sources will not be recoverable by ICA and will pollute estimates of the nongaussian sources. Therefore, it is desirable to have methods for mixed ICA/PCA which can separate mixtures of Gaussian and nongaussian sources. For mixtures of purely Gaussian sources, principal component analysis (PCA) can provide a basis for the Gaussian subspace. We introduce a new method for mixed ICA/PCA which we call Mixed ICA/PCA via Reproducibility Stability (MIPReSt). Our method uses a repeated estimations technique to rank sources by reproducibility, combined with decomposition of multiple subsamplings of the original data matrix. These multiple decompositions allow us to assess component stability as the size of the data matrix changes, which can be used to determinine the dimension of the nongaussian subspace in a mixture. We demonstrate the utility of MIPReSt for signal mixtures consisting of simulated sources and real-word (speech) sources, as well as mixture of unknown composition.	[Akkalkotkar, Ameya; Brown, Kevin Scott] Univ Connecticut, Dept Chem & Biomol Engn, Storrs, CT 06269 USA; [Brown, Kevin Scott] Univ Connecticut, Dept Biomed Engn, Storrs, CT 06269 USA; [Brown, Kevin Scott] Univ Connecticut, Dept Phys & Marine Sci, Storrs, CT 06269 USA; [Brown, Kevin Scott] Inst Syst Genom, Storrs, CT 06269 USA; [Brown, Kevin Scott] CT Inst Brain & Cognit Sci, Storrs, CT 06269 USA	University of Connecticut; University of Connecticut; University of Connecticut	Brown, KS (corresponding author), Univ Connecticut, Dept Chem & Biomol Engn, Storrs, CT 06269 USA.; Brown, KS (corresponding author), Univ Connecticut, Dept Biomed Engn, Storrs, CT 06269 USA.; Brown, KS (corresponding author), Univ Connecticut, Dept Phys & Marine Sci, Storrs, CT 06269 USA.; Brown, KS (corresponding author), Inst Syst Genom, Storrs, CT 06269 USA.; Brown, KS (corresponding author), CT Inst Brain & Cognit Sci, Storrs, CT 06269 USA.	kevin.s.brown@uconn.edu		Brown, Kevin/0000-0003-2959-2401	Office of the Vice President for Research at the University of Connecticut's Scholarship Facilitation Fund Award	Office of the Vice President for Research at the University of Connecticut's Scholarship Facilitation Fund Award	K.S.B. thanks the Office of the Vice President for Research at the University of Connecticut's Scholarship Facilitation Fund Award (http://research.uconn.edu) for support of this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aires F, 2002, J ATMOS SCI, V59, P111, DOI 10.1175/1520-0469(2002)059<0111:ROEBTI>2.0.CO;2; Aubry N., 1991, Theoretical and Computational Fluid Dynamics, V2, P339, DOI 10.1007/BF00271473; Babiloni F, 2002, METHOD INFORM MED, V41, P443; Baccigalupi C, 2000, MON NOT R ASTRON SOC, V318, P769, DOI 10.1046/j.1365-8711.2000.03751.x; BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; Belouchrani A, 1997, IEEE T SIGNAL PROCES, V45, P434, DOI 10.1109/78.554307; Bojak I, 2010, BRAIN TOPOGR, V23, P139, DOI 10.1007/s10548-010-0140-3; Brookings T, 2009, NEUROIMAGE, V44, P411, DOI 10.1016/j.neuroimage.2008.08.043; Brown KS, 2013, J NEUROSCI METH, V219, P205, DOI 10.1016/j.jneumeth.2013.07.012; Brown KS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050268; Brown KS, 2010, NEUROIMAGE, V49, P2401, DOI 10.1016/j.neuroimage.2009.10.011; Burkard  R., 2009, ASSIGNMENT PROBLEMS; Cangelosi R, 2007, BIOL DIRECT, V2, DOI 10.1186/1745-6150-2-2; Cardoso JF, 1997, IEEE SIGNAL PROC LET, V4, P112, DOI 10.1109/97.566704; Comon P, HANDBOOK OF BLIND SO; Daunizeau J, 2007, NEUROIMAGE, V36, P69, DOI 10.1016/j.neuroimage.2007.01.044; Debener S, 2006, TRENDS COGN SCI, V10, P558, DOI 10.1016/j.tics.2006.09.010; Eichele T, 2009, INT J PYSCHOPHYSIOL; Eichele T, 2008, INT J PSYCHOPHYSIOL, V67, P222, DOI 10.1016/j.ijpsycho.2007.04.010; Fisher R.A., 1936, ANN EUGEN, V7, P178; Fontier S., 1976, BIOL ECOL, V25, P67; GERBRANDS JJ, 1981, PATTERN RECOGN, V14, P375, DOI 10.1016/0031-3203(81)90082-0; Grouiller F, 2011, BRAIN, V134, P2867, DOI 10.1093/brain/awr156; Guttman L., 1954, PSYCHOMETRIKA, V19, P149, DOI 10.1007/BF02289162; Horn J., 1965, PSYCHOMETRIKA, P178; Hyvarinen A, 1997, NEURAL COMPUT, V9, P1483, DOI 10.1162/neco.1997.9.7.1483; JACKSON DA, 1993, ECOLOGY, V74, P2204, DOI 10.2307/1939574; Joliffe I. T., 2002, PRINCIPAL COMPONENT, V2nd; JUTTEN C, 1991, SIGNAL PROCESS, V24, P1, DOI 10.1016/0165-1684(91)90079-X; Legendre P., 2012, NUMERICAL ECOLOGY; Lichman M, 2013, UCI MACHINE LEARNING; Liu ZM, 2006, CLIN NEUROPHYSIOL, V117, P1610, DOI 10.1016/j.clinph.2006.03.031; Lorenz E.N., 1956, EMPIRICAL ORTHOGONAL, P1; MACARTHUR RH, 1957, P NATL ACAD SCI USA, V43, P293, DOI 10.1073/pnas.43.3.293; MAKEIG S, 1996, ADV NEURAL INFORM PR, V8, P7; McKeown MJ, 1998, HUM BRAIN MAPP, V6, P160, DOI 10.1002/(SICI)1097-0193(1998)6:3<160::AID-HBM5>3.0.CO;2-1; Miettinen J, 2014, IEEE T SIGNAL PROCES, V62, P5716, DOI 10.1109/TSP.2014.2356442; Moosmann M, 2008, INT J PSYCHOPHYSIOL, V67, P212, DOI 10.1016/j.ijpsycho.2007.05.016; MUNKRES J, 1957, J SOC IND APPL MATH, V5, P32, DOI 10.1137/0105003; NADAL JP, 1994, NETWORK-COMP NEURAL, V5, P565, DOI 10.1088/0954-898X/5/4/008; Ostwald D, 2010, NEUROIMAGE, V49, P498, DOI 10.1016/j.neuroimage.2009.07.038; Peres-Neto PR, 2005, COMPUT STAT DATA AN, V49, P974, DOI 10.1016/j.csda.2004.06.015; Rosenkranz K, 2010, MAGN RESON MATER PHY, V23, P309, DOI 10.1007/s10334-009-0196-9; Sato JR, 2010, NEUROIMAGE, V50, P1416, DOI 10.1016/j.neuroimage.2010.01.075; Schultze-Kraft M, 2011, PROG BIOPHYS MOL BIO, V105, P67, DOI 10.1016/j.pbiomolbio.2010.11.003; Ter Braak CJF, 1988, LWA8802 AGR MATH GRO; TONG L, 1990, 1990 IEEE INTERNATIONAL SYMP ON CIRCUITS AND SYSTEMS, VOLS 1-4, P1784, DOI 10.1109/ISCAS.1990.111981; Woods RP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118877; Yang Z, 2008, HUM BRAIN MAPP, V29, P711, DOI 10.1002/hbm.20432; Yuah H, 2012, NEUROIMAGE, V60, P2062	50	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2017	12	4							e0175775	10.1371/journal.pone.0175775	http://dx.doi.org/10.1371/journal.pone.0175775			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES9KD	28414814	Green Published, gold, Green Submitted			2022-12-27	WOS:000399874800053
J	Mortensen, R; Christensen, D; Hansen, LB; Christensen, JP; Andersen, P; Dietrich, J				Mortensen, Rasmus; Christensen, Dennis; Hansen, Lasse Bollehuus; Christensen, Jan Praysgaard; Andersen, Peter; Dietrich, Jes			Local Th17/IgA immunity correlate with protection against intranasal infection with Streptococcus pyogenes	PLOS ONE			English	Article							GROUP-A-STREPTOCOCCUS; M-PROTEIN; T-CELLS; IMMUNIZATION; CHALLENGE; VACCINE; BINDING; LACTOBACILLI; GENERATION; TGF-BETA-1	Streptococcus pyogenes (group A streptococcus, GAS) is responsible for a wide array of infections. Respiratory transmission via droplets is the most common mode of transmission but it may also infect the host via other routes such as lesions in the skin. To advance the development of a future vaccine against GAS, it is therefore important to investigate how protective immunity is related to the route of vaccine administration. To explore this, we examined whether a parenterally administered anti-GAS vaccine could protect against an intranasal GAS infection or if this would require locally primed immunity. We foundd that a parenteral CAF01 adjuvanted GAS vaccine offered no protection against intranasal infection despite inducing strong systemic Th1/Th17/IgG immunity that efficiently protected against an intraperitoneal GAS infection. However, the same vaccine administered via the intranasal route was able to induce protection against repeated intranasal GAS infections in a murine challenge model. The lack of intranasal protection induced by the parenteral vaccine correlated with a reduced mucosal recall response at the site of infection. Taken together, our results demonstrate that locally primed immunity is important for the defense against intranasal infection with Streptococcus pyogenes.	[Mortensen, Rasmus; Christensen, Dennis; Andersen, Peter; Dietrich, Jes] Statens Serum Inst, Dept Infect Dis Immunol, Copenhagen, Denmark; [Mortensen, Rasmus; Christensen, Jan Praysgaard] Univ Copenhagen, Dept Immunol & Microbiol, Copenhagen, Denmark; [Hansen, Lasse Bollehuus] Univ Copenhagen, Dept Growth & Reprod, Rigshosp, Copenhagen, Denmark	Statens Serum Institut; University of Copenhagen; Rigshospitalet; University of Copenhagen	Dietrich, J (corresponding author), Statens Serum Inst, Dept Infect Dis Immunol, Copenhagen, Denmark.	jdi@ssi.dk	Christensen, Dennis/C-6378-2008; Christensen, Jan Pravsgaard/I-4782-2017	Christensen, Dennis/0000-0003-2382-8639; Christensen, Jan Pravsgaard/0000-0002-4299-9479; Bollehuus Hansen, Lasse/0000-0001-7523-2306; Andersen, Peter/0000-0002-5869-2551	University of Copenhagen; Novo Nordisk Foundation; Centre for Nano-vaccines [06030-0322B]; Brd. Hartmann Fonden [A15422]	University of Copenhagen; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Centre for Nano-vaccines; Brd. Hartmann Fonden	This study was supported by University of Copenhagen, http://www.ku.dk/, The Novo Nordisk Foundation, http://novonordiskfonden.dk/en, Centre for Nano-vaccines, Grant # 0603-00322B, Brd. Hartmann Fonden, Grant # A15422, http://www.hartmannfonden.dk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agace WW, 2006, NAT REV IMMUNOL, V6, P682, DOI 10.1038/nri1869; Agger EM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003116; Anderson KG, 2014, NAT PROTOC, V9, P209, DOI 10.1038/nprot.2014.005; BAHR GM, 1991, J CLIN MICROBIOL, V29, P1789, DOI 10.1128/JCM.29.9.1789-1794.1991; Batzloff MR, 2003, J INFECT DIS, V187, P1598, DOI 10.1086/374800; Brandt ER, 2000, NAT MED, V6, P455, DOI 10.1038/74719; Christensen D, 2016, MUCOSAL IMMUNOL; Costalonga M, 2009, MUCOSAL IMMUNOL, V2, P85, DOI 10.1038/mi.2008.67; Dale JB, 1999, J CLIN INVEST, V103, P1261, DOI 10.1172/JCI5118; Dale JB, 2002, INFECT IMMUN, V70, P2166, DOI 10.1128/IAI.70.4.2166-2170.2002; DALESSANDRI R, 1978, J INFECT DIS, V138, P712, DOI 10.1093/infdis/138.6.712; Davidsen J, 2005, BBA-BIOMEMBRANES, V1718, P22, DOI 10.1016/j.bbamem.2005.10.011; DENNY FW, 1957, J CLIN INVEST, V36, P1092, DOI 10.1172/JCI103504; Desel C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053531; Dileepan T, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002252; Fan X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107638; Fujimoto T, 1997, J IMMUNOL, V158, P5619; Gillen CM, 2008, J BIOL CHEM, V283, P6359, DOI 10.1074/jbc.M706739200; Hall MA, 2004, INFECT IMMUN, V72, P2507, DOI 10.1128/IAI.72.5.2507-2512.2004; Hirota K, 2013, NAT IMMUNOL, V14, P372, DOI 10.1038/ni.2552; Jaffar Z, 2009, J IMMUNOL, V182, P4507, DOI 10.4049/jimmunol.0900237; Lannergard J, 2011, CELL HOST MICROBE, V10, P147, DOI 10.1016/j.chom.2011.06.011; Lindenstrom T, 2012, INFECT IMMUN, V80, P3533, DOI 10.1128/IAI.00550-12; Linehan JL, 2015, P NATL ACAD SCI USA, V112, P12782, DOI 10.1073/pnas.1513532112; Ma CQ, 2009, CELL MOL IMMUNOL, V6, P73, DOI 10.1038/cmi.2009.10; Marshall HS, 2015, PEDIAT INFECT DIS J; Miettinen M, 2000, J IMMUNOL, V164, P3733, DOI 10.4049/jimmunol.164.7.3733; Miettinen M, 1998, INFECT IMMUN, V66, P6058, DOI 10.1128/IAI.66.12.6058-6062.1998; Mortensen R, 2015, J IMMUNOL; Okamoto S, 2005, VACCINE, V23, P4852, DOI 10.1016/j.vaccine.2005.02.035; Pandey M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005147; ROTHBARD S, 1948, ARCH INTERN MED, V82, P229, DOI 10.1001/archinte.1948.00220270014002; Sanderson-Smith M, 2006, J BIOL CHEM, V281, P3217, DOI 10.1074/jbc.M508758200; Schulze K, 2006, VACCINE, V24, P1446, DOI 10.1016/j.vaccine.2005.06.039; SIEGEL AC, 1961, NEW ENGL J MED, V265, P566, DOI 10.1056/NEJM196109212651202; Steer AC, 2009, CURR OPIN INFECT DIS, V22, P544, DOI 10.1097/QCO.0b013e328332bbfe; STOLLERMAN GH, 1956, AM J MED, V20, P163, DOI 10.1016/0002-9343(56)90185-1; Thome JJC, 2015, TRENDS IMMUNOL, V36, P428, DOI 10.1016/j.it.2015.05.003; Turner DL, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00331; Veckman V, 2004, J LEUKOCYTE BIOL, V75, P764, DOI 10.1189/jlb.1003461; Wang BN, 2010, P NATL ACAD SCI USA, V107, P5937, DOI 10.1073/pnas.0904831107; Witowski J, 2000, J IMMUNOL, V165, P5814, DOI 10.4049/jimmunol.165.10.5814	42	14	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2017	12	4							e0175707	10.1371/journal.pone.0175707	http://dx.doi.org/10.1371/journal.pone.0175707			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KD	28414746	Green Published, gold, Green Submitted			2022-12-27	WOS:000399874800048
J	Yergey, AL; Blank, PS; Cologna, SM; Backlund, PS; Porter, FD; Darling, AJ				Yergey, Alfred L.; Blank, Paul S.; Cologna, Stephanie M.; Backlund, Peter S.; Porter, Forbes D.; Darling, Allan J.			Characterization of hydroxypropyl-betacyclodextrins used in the treatment of Niemann-Pick Disease type C1	PLOS ONE			English	Article							BETA-CYCLODEXTRIN	2-Hydroxypropyl-beta-cyclodextrin (HP beta CD) has gained recent attention as a potential therapeutic intervention in the treatment of the rare autosomal-recessive, neurodegenerative lysosomal storage disorder Niemann-Pick Disease Type C1 (NPC1). Notably, HP beta CD formulations are not comprised of a single molecular species, but instead are complex mixtures of species with differing degrees of hydroxypropylation of the cyclodextrin ring. The degree of substitution is a critical aspect of the complex mixture as it influences binding to other molecules and thus could potentially modulate biological effects. VTS-270 (Kleptose HPB) and Trappsol (R) Cyclo (TM) are HP beta CD products under investigation as novel treatments for NPC1. The purpose of the present work is to compare these two different products; analyses were based on ion distribution and abundance profiles using mass spectrometry methodology as a means for assessing key molecular distinctions between products. The method incorporated electrospray ionization and analysis with a linear low-field ion mobility quadrupole time-of-flight instrument. We observed that the number of hydroxypropyl groups (the degrees of substitution) are substantially different between the two products and greater in Trappsol Cyclo than in VTS-270. The principal ions of both samples are ammonium adducts. Isotope clusters for each of the major ions show doubly charged homodimers of the ammonium adducts. In addition, both products show doubly charged homodimers from adduction of both a proton and ammonium. Doubly charged heterodimers are also present, but are more intense in Trappsol Cyclo than in VTS-270. Based on the analytical differences observed between VTS-270 and Trappsol Cyclo with respect to the degree of substitution, the composition and fingerprint of the complex mixture, and the impurity profiles, these products cannot be considered to be the same; the potential biological and clinical implications of these differences are not presently known.	[Yergey, Alfred L.; Blank, Paul S.; Backlund, Peter S.; Porter, Forbes D.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, NIH, Bethesda, MD 20892 USA; [Cologna, Stephanie M.] Univ Illinois, Dept Chem, Chicago, IL USA; [Darling, Allan J.] Vtesse Inc, Gaithersburg, MD USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Yergey, AL (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, NIH, Bethesda, MD 20892 USA.	alyergey@gmail.com	Blank, Paul/Q-9673-2019		Intramural Program of The Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) of the National Institutes of Health (NIH); Vtesse, Inc., Gaithersburg, MD; Vtesse Inc.; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZICHD001421, ZIAHD000139] Funding Source: NIH RePORTER	Intramural Program of The Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) of the National Institutes of Health (NIH); Vtesse, Inc., Gaithersburg, MD; Vtesse Inc.; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by the Intramural Program of The Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) of the National Institutes of Health (NIH). Editorial assistance was provided by Peloton Advantage, LLC, Parsippany, NJ, USA, and funded by Vtesse, Inc., Gaithersburg, MD. Vtesse Inc. provided support in the form of salary for author AD, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Garcia-Robles AA, 2016, J NEUROL SCI, V366, P65, DOI 10.1016/j.jns.2016.04.048; Coisne C, 2016, MOLECULES, V21, DOI 10.3390/molecules21121748; Davidson CD, 2016, ANN CLIN TRANSL NEUR, V3, P366, DOI 10.1002/acn3.306; Davidson CD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006951; Kurulugama R., 2013, AGILENT ION MOBILITY; Loftsson Thorsteinn, 2005, Expert Opin Drug Deliv, V2, P335, DOI 10.1517/17425247.2.1.335; Mandal P, 2016, SCI REP-UK, V6, DOI 10.1038/srep26907; Mason E., 1988, TRANSPORT PROPERTIES; May JC, 2015, ANALYST, V14, P6824, DOI 10.1039/c5an00923e; Mengel E, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-166; Papandreou A, 2016, THER ADV NEUROL DISO, V9, P216, DOI 10.1177/1756285616635964; PITHA J, 1986, INT J PHARM, V29, P73, DOI 10.1016/0378-5173(86)90201-2; Porter FD, 2016, MOL GENET METAB, V117, pS97, DOI 10.1016/j.ymgme.2015.12.411; Ramirez CM, 2010, PEDIATR RES, V68, P309, DOI 10.1203/00006450-201011001-00604; Schneider HJ, 1998, CHEM REV, V98, P1755, DOI 10.1021/cr970019t; Vanier MT, 2015, J INHERIT METAB DIS, V38, P187, DOI 10.1007/s10545-014-9794-4; Vite C.H., 2015, SCI TRANSL MED, V7, p276ra26, DOI DOI 10.1126/SCI	17	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2017	12	4							e0175478	10.1371/journal.pone.0175478	http://dx.doi.org/10.1371/journal.pone.0175478			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KD	28414792	gold, Green Submitted, Green Published			2022-12-27	WOS:000399874800028
J	Li, Q; Zhao, J; Xiong, C; Li, XL; Chen, ZQ; Li, P; Huang, WL				Li, Qiang; Zhao, Jian; Xiong, Chuan; Li, Xiaolin; Chen, Zuqin; Li, Ping; Huang, Wenli			Tuber indicum shapes the microbial communities of ectomycorhizosphere soil and ectomycorrhizae of an indigenous tree (Pinus armandii)	PLOS ONE			English	Article							VOLATILE ORGANIC-COMPOUNDS; STRESS	The aim of this study was to investigate the effect of an ectomycorrhizal fungus (Tuber indicum) on the diversity of microbial communities associated with an indigenous tree, Pinus armandii, and the microbial communities in the surrounding ectomycorhizosphere soil. High-throughput sequencing was used to analyze the richness of microbial communities in the roots or rhizosphere of treatments with or without ectomycorrhizae. The results indicated that the bacterial diversity of ectomycorhizosphere soil was significantly lower compared with the control soil. Presumably, the dominance of truffle mycelia in ectomycorhizosphere soil (80.91%) and ectomycorrhizae (97.64%) was the main factor that resulted in lower diversity and abundance of endophytic pathogenic fungi, including Fusarium, Monographella, Ustilago and Rhizopus and other competitive mycorrhizal fungi, such as Amanita, Lactarius and Boletus. Bacterial genera Reyranena, Rhizomicrobium, Nordella, Pseudomonas and fungal genera, Cuphophyllus, Leucangium, Histoplasma were significantly more abundant in ectomycorrhizosphere soil and ectomycorrhizae. Hierarchical cluster analysis of the similarities between rhizosphere and ectomycorrhizosphere soil based on the soil properties differed significantly, indicating the mycorrhizal synthesis may have a feedback effect on soil properties. Meanwhile, some soil properties were significantly correlated with bacterial and fungal diversity in the rhizosphere or root tips. Overall, this work illustrates the interactive network that exists among ectomycorrhizal fungi, soil properties and microbial communities associated with the host plant and furthers our understanding of the ecology and cultivation of T. indicum.	[Li, Qiang; Xiong, Chuan; Chen, Zuqin; Li, Ping; Huang, Wenli] Sichuan Acad Agr Sci, Biotechnol & Nucl Technol Res Inst, Chengdu, Sichuan, Peoples R China; [Li, Qiang; Zhao, Jian] Sichuan Univ, Coll Life Sci, Chengdu, Sichuan, Peoples R China; [Li, Xiaolin] Sichuan Acad Agr Sci, Soil & Fertilizer Inst, Chengdu, Sichuan, Peoples R China; [Huang, Wenli] Sichuan Acad Agr Sci, Chengdu, Sichuan, Peoples R China	Sichuan Academy of Agricultural Sciences (SAAS); Sichuan University; Sichuan Academy of Agricultural Sciences (SAAS); Sichuan Academy of Agricultural Sciences (SAAS)	Huang, WL (corresponding author), Sichuan Acad Agr Sci, Biotechnol & Nucl Technol Res Inst, Chengdu, Sichuan, Peoples R China.; Huang, WL (corresponding author), Sichuan Acad Agr Sci, Chengdu, Sichuan, Peoples R China.	wenli11@126.com	huang, wen/GXW-0661-2022		National Science & Technology Pillar Program of Sichuan [2014FZ0004, 2016NZ0042]; State-level Spark Program of China [2015GA810006]; Foundation for Young Scholars of Sichuan Province [2014JQ0054]; Youth Foundation Program of the Financial & Innovational Capacity Building Project of Sichuan [2014CXSF-030]	National Science & Technology Pillar Program of Sichuan; State-level Spark Program of China; Foundation for Young Scholars of Sichuan Province; Youth Foundation Program of the Financial & Innovational Capacity Building Project of Sichuan	This research was funded by the National Science & Technology Pillar Program of Sichuan (2014FZ0004 &2016NZ0042), the State-level Spark Program of China (2015GA810006), the Foundation for Young Scholars of Sichuan Province (2014JQ0054) and the Youth Foundation Program of the Financial & Innovational Capacity Building Project of Sichuan (2014CXSF-030).	Ponce RA, 2014, MYCORRHIZA, V24, pS55, DOI 10.1007/s00572-014-0558-7; Barbieri E, 2007, ENVIRON MICROBIOL, V9, P2234, DOI 10.1111/j.1462-2920.2007.01338.x; Beara IN, 2014, FOOD CHEM, V165, P460, DOI 10.1016/j.foodchem.2014.05.116; Bokulich NA, 2013, NAT METHODS, V10, P57, DOI [10.1038/nmeth.2276, 10.1038/NMETH.2276]; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chalot M, 1998, FEMS MICROBIOL REV, V22, P21, DOI 10.1111/j.1574-6976.1998.tb00359.x; Chen J, 2011, PLOS ONE, V61; Dearnaley JDW, 2017, NEW PHYTOL, V213, P10, DOI 10.1111/nph.14357; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Deveau A, 2016, MYCORRHIZA, V26, P389, DOI 10.1007/s00572-015-0679-7; Dominguez JA, 2012, MYCORRHIZA, V22, P429, DOI 10.1007/s00572-011-0420-0; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Federico V, 2015, SCI REP-UK, V5, DOI 10.1038/srep12629; Fochi V, 2017, NEW PHYTOL, V213, P365, DOI 10.1111/nph.14279; Fu Y., 2016, P 2016 IEEE PES TRAN, P1, DOI [DOI 10.1139/CJM-2015-0350, DOI 10.1109/TDC.2016.7519951]; Garcia-Barreda S, 2015, FUNGAL BIOL-UK, V119, P1137, DOI 10.1016/j.funbio.2015.08.014; Garcia-Montero LG, 2006, AUST J SOIL RES, V44, P731, DOI 10.1071/SR06046; Garcia-Montero LG, 2009, SOIL BIOL BIOCHEM, V41, P1227, DOI 10.1016/j.soilbio.2009.03.003; Garcia-Montero L, 2008, MYCORRHIZA, V19, P7, DOI 10.1007/s00572-008-0198-x; Geng LY, 2009, MYCORRHIZA, V19, P461, DOI 10.1007/s00572-009-0247-0; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Healy RA, 2016, MYCORRHIZA, V26, P781, DOI 10.1007/s00572-016-0713-4; Henning JA, 2016, PEERJ, V4, DOI 10.7717/peerj.2606; Iotti M, 2016, MYCORRHIZA, V26, P793, DOI 10.1007/s00572-016-0703-6; Iotti M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115921; Jung SC, 2012, J CHEM ECOL, V38, P651, DOI 10.1007/s10886-012-0134-6; Khan AL, 2017, J ZHEJIANG UNIV-SC B, V18, P125, DOI [10.1631/jzus.B1500271, 10.1631/jzus.b1500271]; Lenoir I, 2016, PHYTOCHEMISTRY, V123, P4, DOI 10.1016/j.phytochem.2016.01.002; Leonardi M, 2013, MYCORRHIZA, V23, P349, DOI 10.1007/s00572-012-0474-7; Li Q, 2016, J MICROBIOL BIOTECHN, V26, P89, DOI 10.4014/jmb.1505.05008; Liu RS, 2015, SCI REP-UK, V5, DOI 10.1038/srep17954; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; De Miguel AM, 2014, MYCORRHIZA, V24, pS5, DOI 10.1007/s00572-013-0554-3; Marozzi G, 2016, MYCORRHIZA, P1; Mello A, 2015, FUNGAL BIOL-UK, V119, P518, DOI 10.1016/j.funbio.2015.02.003; Mello A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061945; Napoli C, 2010, NEW PHYTOL, V185, P237, DOI 10.1111/j.1469-8137.2009.03053.x; Pedranzani H, 2016, MYCORRHIZA, V26, P141, DOI 10.1007/s00572-015-0653-4; Pham V.T., 2017, ARCH MICROBIOL, V199, P1, DOI [10. 1007/s00203-016-1332-3 28070613, DOI 10.1007/S00203-016-1332-328070613]; Porcel R, 2015, J PLANT PHYSIOL, V185, P75, DOI 10.1016/j.jplph.2015.07.006; Qing Yuan, 2015, Yingyong Shengtai Xuebao, V26, P1793; Ray S, 2016, PLANT PHYSIOL BIOCH, V109, P430, DOI 10.1016/j.plaphy.2016.10.019; Reininger V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042865; Saha C, 2016, PLANT BIOLOGY, V18, P938, DOI 10.1111/plb.12485; Salerni E, 2014, MYCORRHIZA, V24, pS79, DOI 10.1007/s00572-013-0543-6; Streiblova E, 2012, FEMS MICROBIOL ECOL, V80, P1, DOI 10.1111/j.1574-6941.2011.01283.x; Szymanska S, 2016, MICROBIOL RES, V192, P37, DOI 10.1016/j.micres.2016.05.012; Tang YJ, 2015, APPL MICROBIOL BIOT, V99, P2041, DOI 10.1007/s00253-015-6379-6; Vahdatzadeh M, 2015, APPL ENVIRON MICROB, V81, P6946, DOI 10.1128/AEM.01098-15; Vergani L, 2017, SCI TOTAL ENVIRON, V575, P1395, DOI 10.1016/j.scitotenv.2016.09.218; Wan SP, 2016, MYCORRHIZA, V26, P249, DOI 10.1007/s00572-015-0663-2; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wemheuer F, 2017, SCI REP-UK, V7, DOI 10.1038/srep40914; Xiao C, 2014, J BASIC MICROB, V54, pS102, DOI 10.1002/jobm.201300018; Yanan Wang, 2015, Open Biomed Eng J, V9, P301, DOI 10.2174/1874120701509010301; Zampieri E, 2016, SCI REP-UK, V6, DOI 10.1038/srep25773; Zhao W, 2014, APPL MICROBIOL BIOT, V98, P1991, DOI 10.1007/s00253-013-5379-7	59	19	20	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2017	12	4							e0175720	10.1371/journal.pone.0175720	http://dx.doi.org/10.1371/journal.pone.0175720			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0MD	28410376	Green Published, Green Submitted, gold			2022-12-27	WOS:000399955600039
J	van Hout, A; D'huys, T; Oeyen, M; Schols, D; Van Loy, T				van Hout, Anneleen; D'huys, Thomas; Oeyen, Merel; Schols, Dominique; Van Loy, Tom			Comparison of cell-based assays for the identification and evaluation of competitive CXCR4 inhibitors	PLOS ONE			English	Article							CHEMOKINE RECEPTOR CXCR4; HIV ENTRY INHIBITOR; SMALL-MOLECULE; IN-VITRO; BETA-ARRESTIN; PEPTIDE T140; TUMOR-GROWTH; ANTAGONISTS; CANCER; CTCE-9908	The chemokine receptor CXCR4 is activated by its unique chemokine ligand CXCL12 and regulates many physiological and developmental processes such as hematopoietic cell trafficking. CXCR4 is also one of the main co-receptors for human immunodeficiency virus (HIV) entry. Dysfunction of the CXCL12/CXCR4 axis contributes to several human pathologies, including cancer and inflammatory diseases. Consequently, inhibition of CXCR4 activation is recognized as an attractive target for therapeutic intervention. In this regard, numerous agents modifying CXCR4 activity have been evaluated in in vitro experimental studies and pre-clinical models. Here, we evaluated a CXCL12 competition binding assay for its potential as a valuable initial screen for functional and competitive CXCR4 inhibitors. In total, 11 structurally diverse compounds were included in a side-by-side comparison of in vitro CXCR4 cell-based assays, such as CXCL12 competition binding, CXCL12-induced calcium signaling, CXCR4 internalization, CXCL12-guided cell migration and CXCR4-specific HIV-1 replication experiments. Our data indicated that agents that inhibit CXCL12 binding, i.e. the anti-CXCR4 peptide analogs T22, T140 and TC14012 and the small molecule antagonists AMD3100, AMD3465, AMD11070 and IT1t showed inhibitory activity with consistent relative potencies in all further applied CXCR4-related assays. Accordingly, agents exerting no or very weak receptor binding (i. e., CTCE-9908, WZ811, Me6TREN and gambogic acid) showed no or very poor anti-CXCR4 inhibitory activity. Thus, CXCL12 competition binding studies were proven to be highly valuable as an initial screening assay and indicative for the pharmacological and functional profile of competitive CXCR4 antagonists, which will help the design of new potent CXCR4 inhibitors.	[van Hout, Anneleen; D'huys, Thomas; Oeyen, Merel; Schols, Dominique; Van Loy, Tom] Katholieke Univ Leuven, Lab Virol & Chemotherapy, Dept Microbiol & Immunol, Rega Inst Med Res, Leuven, Belgium	KU Leuven	Van Loy, T (corresponding author), Katholieke Univ Leuven, Lab Virol & Chemotherapy, Dept Microbiol & Immunol, Rega Inst Med Res, Leuven, Belgium.	tom.vanloy@kuleuven.be	Schols, Dominique/AAC-1309-2021; Van Hout, Anneleen/H-9338-2018; Oeyen, Merel/G-3415-2018; Schols, Dominique/S-9057-2017; Van Loy, Tom/E-2374-2018; D'huys, Thomas/F-5936-2018	Schols, Dominique/0000-0003-3256-5850; Van Hout, Anneleen/0000-0001-9339-7550; Oeyen, Merel/0000-0002-7173-6651; Schols, Dominique/0000-0003-3256-5850; Van Loy, Tom/0000-0003-2524-7264; D'huys, Thomas/0000-0002-0871-5604	KU Leuven [PF/10/018]; Fonds voor Wetenschappelijk Onderzoek [G.485.08]; Fondation Dormeur Vaduz	KU Leuven(KU Leuven); Fonds voor Wetenschappelijk Onderzoek(FWO); Fondation Dormeur Vaduz	The research was sponsored by the KU Leuven (https://www.kuleuven.be, grant no. PF/10/018), the Fonds voor Wetenschappelijk Onderzoek (http://www.fwo.be, grant no. G.485.08) and the Fondation Dormeur Vaduz.	Bachelerie F, 2014, PHARMACOL REV, V66, P1, DOI 10.1124/pr.113.007724; Balkwill F, 2004, SEMIN CANCER BIOL, V14, P171, DOI 10.1016/j.semcancer.2003.10.003; Bleul CC, 1996, NATURE, V382, P829, DOI 10.1038/382829a0; Boerrigter G, 2011, CIRC-HEART FAIL, V4, P770, DOI 10.1161/CIRCHEARTFAILURE.111.962571; Busillo JM, 2007, BBA-BIOMEMBRANES, V1768, P952, DOI 10.1016/j.bbamem.2006.11.002; DE CLERCQ E, 1994, ANTIMICROB AGENTS CH, V38, P668, DOI 10.1128/AAC.38.4.668; Debnath B, 2013, THERANOSTICS, V3, P47, DOI 10.7150/thno.5376; Deng HK, 1996, NATURE, V381, P661, DOI 10.1038/381661a0; Domanska UM, 2013, EUR J CANCER, V49, P219, DOI 10.1016/j.ejca.2012.05.005; Drenckhan A, 2013, J SURG RES, V182, P250, DOI 10.1016/j.jss.2012.09.035; Faber A, 2007, J BIOMED BIOTECHNOL, DOI 10.1155/2007/26065; Flomenberg N, 2005, ACTA HAEMATOL-BASEL, V114, P198, DOI 10.1159/000088410; Gravel S, 2010, J BIOL CHEM, V285, P37939, DOI 10.1074/jbc.C110.147470; Hatse S, 2005, BIOCHEM PHARMACOL, V70, P752, DOI 10.1016/j.bcp.2005.05.035; Hatse S, 2004, CYTOM PART A, V61A, P178, DOI 10.1002/cyto.a.20070; Hernandez PA, 2003, NAT GENET, V34, P70, DOI 10.1038/ng1149; Juarez J, 2003, LEUKEMIA, V17, P1294, DOI 10.1038/sj.leu.2402998; Jung SH, 2014, ATHEROSCLEROSIS, V235, P503, DOI 10.1016/j.atherosclerosis.2014.05.955; Kawatkar SP, 2011, EXP BIOL MED, V236, P844, DOI 10.1258/ebm.2011.010345; Kim SY, 2008, CLIN EXP METASTAS, V25, P201, DOI 10.1007/s10585-007-9133-3; Magnan R, 2013, J AM CHEM SOC, V135, P2560, DOI 10.1021/ja308784w; Mosi RM, 2012, BIOCHEM PHARMACOL, V83, P472, DOI 10.1016/j.bcp.2011.11.020; Murakami T, 1997, J EXP MED, V186, P1389, DOI 10.1084/jem.186.8.1389; Nanki T, 2000, J IMMUNOL, V165, P6590, DOI 10.4049/jimmunol.165.11.6590; Pandey MK, 2014, EXP HEMATOL, V42, P883, DOI 10.1016/j.exphem.2014.07.261; Porvasnik S, 2009, PROSTATE, V69, P1460, DOI 10.1002/pros.21008; Princen Katrien, 2004, Retrovirology, V1, P2, DOI 10.1186/1742-4690-1-2; Raman D, 2011, EXP CELL RES, V317, P575, DOI 10.1016/j.yexcr.2011.01.005; Richert MM, 2009, ONCOL REP, V21, P761, DOI 10.3892/or_00000282; Schols D, 1997, J EXP MED, V186, P1383, DOI 10.1084/jem.186.8.1383; Stone ND, 2007, ANTIMICROB AGENTS CH, V51, P2351, DOI 10.1128/AAC.00013-07; Tamamura H, 2001, BIOORG MED CHEM LETT, V11, P1897, DOI 10.1016/S0960-894X(01)00323-7; Tamamura H, 1998, BIOCHEM BIOPH RES CO, V253, P877, DOI 10.1006/bbrc.1998.9871; Thoma G, 2008, J MED CHEM, V51, P7915, DOI 10.1021/jm801065q; Vandercappellen J, 2008, CANCER LETT, V267, P226, DOI 10.1016/j.canlet.2008.04.050; Vermeire K, 2004, AIDS, V18, P2115, DOI 10.1097/00002030-200411050-00003; Violin JD, 2014, TRENDS PHARMACOL SCI, V35, P308, DOI 10.1016/j.tips.2014.04.007; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Zhan WQ, 2007, J MED CHEM, V50, P5655, DOI 10.1021/jm070679i; Zhang H, 2016, EUR J MED CHEM, V114, P65, DOI 10.1016/j.ejmech.2016.02.051; Zhang J, 2014, BLOOD, V123, P428, DOI 10.1182/blood-2013-04-498535	41	31	32	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2017	12	4							e0176057	10.1371/journal.pone.0176057	http://dx.doi.org/10.1371/journal.pone.0176057			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0MD	28410420	gold, Green Published, Green Submitted			2022-12-27	WOS:000399955600056
J	Yang, CM; Yoon, JC; Park, JH; Lee, JM				Yang, Chang Mo; Yoon, Joo Chun; Park, Jeon Han; Lee, Jae Myun			Hepatitis C virus impairs natural killer cell activity via viral serine protease NS3	PLOS ONE			English	Article							ADAPTIVE IMMUNE-RESPONSES; INHIBITORY RECEPTOR GENES; NK CELLS; T-CELLS; INFECTION; CYTOTOXICITY; EXPRESSION; INNATE; CANCER; NKP30	Hepatitis C virus (HCV) infection is characterized by a high frequency of chronic cases owing to the impairment of innate and adaptive immune responses. The modulation of natural killer (NK) cell functions by HCV leads to an impaired innate immune response. However, the underling mechanisms and roles of HCV proteins in this immune evasion are controversial, especially in the early phase of HCV infection. To investigate the role of HCV nonstructural proteins especially NS3 in the impairment of NK functions, NK cells were isolated from the PBMCs by negative selection. To assess the direct cytotoxicity and IFN-gamma production capability of NK cells, co-cultured with uninfected, HCV-infected, HCV-NS3 DNA-transfected Huh-7.5, or HCV-NS replicon cells. To determine the effect of an NS3 serine protease inhibitor, HCV-infected Huh-7.5 cells were treated with BILN-2061. Then, NK cells were harvested and further co-cultured with K-562 target cells. NK cell functions were analyzed by flow cytometry and enzyme-linked immunosorbent assay. When co-cultured with HCV-infected Huh-7.5 cells, the natural cytotoxicity and IFN-gamma production capability of NK cells were significantly reduced. NK cell functions were inhibited to similar levels upon co-culture with HCV-NS replicon cells, NS3-transfected cells, and HCV-infected Huh-7.5 cells. These reductions were restored by BILN-2061-treatment. Furthermore, BILN-2061-treatment significantly increased degranulation against K-562 target cells and IFN-gamma productivity in NK cells. Consistent with these findings, the expression levels of activating NK cell receptors, such as NKp46 and NKp30, were also increased. In HCV-infected cells, the serine protease NS3 may play a role in the abrogation of NK cell functions in the early phase of infection through downregulation of NKp46 and NKp30 receptors on NK cells. Together, these results suggest that NS3 represents a novel drug target for the treatment of HCV infections.	[Yang, Chang Mo; Park, Jeon Han; Lee, Jae Myun] Yonsei Univ, Coll Med, Dept Microbiol & Immunol, Inst Immunol & Immunol Dis, Seoul, South Korea; [Yang, Chang Mo; Park, Jeon Han; Lee, Jae Myun] Yonsei Univ, Coll Med, Brain Korea PLUS Project Med Sci 21, Seoul, South Korea; [Yoon, Joo Chun] Ewha Womans Univ, Sch Med, Dept Microbiol, Seoul, South Korea; [Yoon, Joo Chun] Ewha Womans Univ, Sch Med, Tissue Injury Def Res Ctr, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Ewha Womans University; Ewha Womans University	Lee, JM (corresponding author), Yonsei Univ, Coll Med, Dept Microbiol & Immunol, Inst Immunol & Immunol Dis, Seoul, South Korea.; Lee, JM (corresponding author), Yonsei Univ, Coll Med, Brain Korea PLUS Project Med Sci 21, Seoul, South Korea.	jaemyun@yuhs.ac	Yoon, Joo Chun/D-3675-2012	Yoon, Joo Chun/0000-0001-9395-8418; Lee, Jae Myun/0000-0002-5273-3113; Park, Jeon Han/0000-0001-9604-3205	National Research Foundation of Korea (NRF) - Korea government [NRF-2015R1A2A2A01005412]; Yonsei University College of Medicine [6-2008-0231]	National Research Foundation of Korea (NRF) - Korea government(National Research Foundation of Korea); Yonsei University College of Medicine(General Electric)	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (NRF-2015R1A2A2A01005412) and by a faculty research grant of Yonsei University College of Medicine (6-2008-0231). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlenstiel G, 2010, GASTROENTEROLOGY, V138, P325, DOI 10.1053/j.gastro.2009.08.066; Altfeld M, 2011, NAT REV IMMUNOL, V11, P176, DOI 10.1038/nri2935; Arnon TI, 2005, NAT IMMUNOL, V6, P515, DOI 10.1038/ni1190; Bonorino P, 2009, J HEPATOL, V51, P458, DOI 10.1016/j.jhep.2009.05.030; Chretien AS, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00122; Cooper MA, 2001, TRENDS IMMUNOL, V22, P633, DOI 10.1016/S1471-4906(01)02060-9; Cox AL, 2005, J EXP MED, V201, P1741, DOI 10.1084/jem.20050121; De Maria A, 2007, EUR J IMMUNOL, V37, P445, DOI 10.1002/eji.200635989; Flores MV, 2009, BBA-PROTEINS PROTEOM, V1794, P1441, DOI 10.1016/j.bbapap.2009.06.004; Foy E, 2003, SCIENCE, V300, P1145, DOI 10.1126/science.1082604; Golden-Mason L, 2013, IMMUNOL REV, V255, P68, DOI 10.1111/imr.12090; Golden-Mason L, 2010, HEPATOLOGY, V52, P1581, DOI 10.1002/hep.23896; Harrison RJ, 2010, CLIN EXP IMMUNOL, V161, P306, DOI 10.1111/j.1365-2249.2010.04169.x; Heim MH, 2014, J HEPATOL, V61, pS14, DOI 10.1016/j.jhep.2014.06.035; Herzer K, 2003, J VIROL, V77, P8299, DOI 10.1128/JVI.77.15.8299-8309.2003; Holder KA, 2013, J IMMUNOL, V191, P3308, DOI 10.4049/jimmunol.1300164; Jinushi M, 2004, J IMMUNOL, V173, P6072, DOI 10.4049/jimmunol.173.10.6072; Kato T, 2006, NAT PROTOC, V1, P2334, DOI 10.1038/nprot.2006.395; Khakoo SI, 2004, SCIENCE, V305, P872, DOI 10.1126/science.1097670; Kim H, 2014, J VIROL, V88, P2564, DOI 10.1128/JVI.02988-13; Kruse PH, 2014, IMMUNOL CELL BIOL, V92, P221, DOI 10.1038/icb.2013.98; Lamarre D, 2003, NATURE, V426, P186, DOI 10.1038/nature02099; Lee SH, 2005, J IMMUNOL, V175, P8226, DOI 10.4049/jimmunol.175.12.8226; Li K, 2005, P NATL ACAD SCI USA, V102, P2992, DOI 10.1073/pnas.0408824102; Lindenbach BD, 2013, NAT REV MICROBIOL, V11, P688, DOI 10.1038/nrmicro3098; Long EO, 2007, IMMUNITY, V26, P385, DOI 10.1016/j.immuni.2007.04.001; Long EO, 2013, ANNU REV IMMUNOL, V31, P227, DOI 10.1146/annurev-immunol-020711-075005; Nattermann J, 2006, GUT, V55, P869, DOI 10.1136/gut.2005.076463; Nattermann J, 2005, AM J PATHOL, V166, P443, DOI 10.1016/S0002-9440(10)62267-5; Nellore A, 2011, CLIN INFECT DIS, V52, P369, DOI 10.1093/cid/ciq156; Park SB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158419; Parsons MS, 2014, J IMMUNOL, V192, P308, DOI 10.4049/jimmunol.1301247; Paulson MS, 2009, ANTIVIR RES, V83, P135, DOI 10.1016/j.antiviral.2009.04.003; Rehermann B, 2013, NAT MED, V19, P859, DOI 10.1038/nm.3251; Rehermann B, 2009, J CLIN INVEST, V119, P1745, DOI 10.1172/JCI39133; Romero V, 2008, MOL IMMUNOL, V45, P2429, DOI 10.1016/j.molimm.2008.01.002; Sainz B, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-30; Sene D, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001184; Tseng CTK, 2002, J EXP MED, V195, P43, DOI 10.1084/jem.20011145; Vivier E, 2012, NAT REV IMMUNOL, V12, P239, DOI 10.1038/nri3174; Vivier E, 2011, SCIENCE, V331, DOI 10.1126/science.1198687; Wedemeyer H, 2002, J IMMUNOL, V169, P3447, DOI 10.4049/jimmunol.169.6.3447; Yoon JC, 2016, WORLD J GASTROENTERO, V22, P1449, DOI 10.3748/wjg.v22.i4.1449; Yoon JC, 2011, J VIROL, V85, P12557, DOI 10.1128/JVI.00838-11; Yoon JC, 2009, HEPATOLOGY, V49, P12, DOI 10.1002/hep.22624; Zitvogel L, 2006, NAT REV IMMUNOL, V6, P715, DOI 10.1038/nri1936	46	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2017	12	4							e0175793	10.1371/journal.pone.0175793	http://dx.doi.org/10.1371/journal.pone.0175793			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0MD	28410411	Green Published, Green Submitted, gold			2022-12-27	WOS:000399955600042
J	Chen, TB; Yiao, SY; Sun, Y; Lee, HJ; Yang, SC; Chiu, MJ; Chen, TF; Lin, KN; Tang, LY; Lin, CC; Wang, PN				Chen, Ting-Bin; Yiao, Szu-Yu; Sun, Yu; Lee, Huey-Jane; Yang, Shu-Chien; Chiu, Ming-Jang; Chen, Ta-Fu; Lin, Ker-Neng; Tang, Li-Yu; Lin, Chung-Chih; Wang, Pei-Ning			Comorbidity and dementia: A nationwide survey in Taiwan	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; VASCULAR RISK-FACTORS; ALZHEIMERS-DISEASE; CARDIOVASCULAR-DISEASE; MEDICAL COMORBIDITY; CO-MORBIDITY; PRIMARY-CARE; DECLINE; PREVALENCE; ASSOCIATION	Background Comorbid medical diseases are highly prevalent in the geriatric population, imposing hardship on healthcare services for demented individuals. Dementia also complicates clinical care for other co-existing medical conditions. This study investigated the comorbidities associated with dementia in the elderly population aged 65 years and over in Taiwan. Methods We conducted a nationwide, population-based, cross-sectional survey; participants were selected by computerized random sampling from all 19 Taiwan counties between December 2011 and March 2013. After exclusion of incomplete or erroneous data, 8,456 subjects were enrolled. Of them, 6,183 were cognitively normal (control group), 1,576 had mild cognitive impairment (MCI), and 697 had dementia. We collected information about types of comorbidities (i.e., vascular risk factors, lung diseases, liver diseases, gastrointestinal diseases, and cancers), Charlson comorbidity index score, and demographic variables to compare subjects with normal cognition, MCI, and dementia. Results Regardless of the cognitive condition, over 60% of the individuals in each group had at least one comorbid disease. The proportion of subjects possessing at least three comorbidities was higher in those with cognitive impairment (MCI 20.9%, dementia 27.3%) than in control group (15%). Hypertension and diabetes mellitus were the most common comorbidities. The mean number of comorbidities and Charlson comorbidity index score were greater in MCI and dementia groups than in control group. Logistic regression demonstrated that the comorbidities significantly associated with MCI and dementia were cerebrovascular disease (OR 3.35, CI 2.62-4.28), cirrhosis (OR 3.29, CI 1.29-8.41), asthma (OR 1.56, CI 1.07-2.27), and diabetes mellitus (OR 1.24, CI 1.07-1.44). Conclusion Multiple medical comorbid diseases are common in older adults, especially in those with cognitive impairment. Cerebrovascular disease, cirrhosis, asthma, and diabetes mellitus are important contributors to cognitive deterioration in the elderly. Efforts to lower cumulative medical burden in the geriatric population may benefit cognitive function.	[Chen, Ting-Bin] Taichung Vet Gen Hosp, Neurol Inst, Dept Neurol, Taichung, Taiwan; [Yiao, Szu-Yu] Columbia Univ, Mailman Sch Publ Hlth, Dept Biostat, New York, NY USA; [Sun, Yu; Chiu, Ming-Jang; Chen, Ta-Fu] Natl Taiwan Univ Hosp, Dept Neurol, Taipei, Taiwan; [Sun, Yu] En Chu Kong Hosp, Dept Neurol, New Taipei, Taiwan; [Lee, Huey-Jane; Yang, Shu-Chien; Tang, Li-Yu] Taiwan Alzheimers Dis Assoc, Taipei, Taiwan; [Chiu, Ming-Jang] Natl Taiwan Univ, Grad Inst Brain & Mind Sci, Coll Med, Taipei, Taiwan; [Chiu, Ming-Jang] Natl Taiwan Univ, Grad Inst Psychol, Coll Sci, Taipei, Taiwan; [Lin, Ker-Neng] Soo Chow Univ, Dept Psychol, Taipei, Taiwan; [Lin, Ker-Neng; Wang, Pei-Ning] Taipei Vet Gen Hosp, Neurol Inst, Dept Neurol, Taipei, Taiwan; [Lin, Chung-Chih] Chung Gung Univ, Dept Comp Sci & Informat Engn, Tao Yuan, Taiwan; [Wang, Pei-Ning] Natl Yang Ming Univ, Dept Neurol, Sch Med, Taipei, Taiwan; [Wang, Pei-Ning] Natl Yang Ming Univ, Aging & Hlth Res Ctr, Taipei, Taiwan	Taichung Veterans General Hospital; Columbia University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; Soochow University; Taipei Veterans General Hospital; Chang Gung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Wang, PN (corresponding author), Taipei Vet Gen Hosp, Neurol Inst, Dept Neurol, Taipei, Taiwan.; Wang, PN (corresponding author), Natl Yang Ming Univ, Dept Neurol, Sch Med, Taipei, Taiwan.; Wang, PN (corresponding author), Natl Yang Ming Univ, Aging & Hlth Res Ctr, Taipei, Taiwan.	pnwang@vghtpe.gov.tw	Chiu, Ming-Jang/AAR-3940-2020	Chiu, Ming-Jang/0000-0002-4158-4423; Chen, Ta-Fu/0000-0003-1988-6924; Chen, Ting-Bin/0000-0002-9642-0928	Ministry of Health and Welfare of Taiwan [DOH100-TD-M113-100001]; National Science Council of Taiwan [NSC 101-2314-B-010, NSC 102-2314-B-010-051-MY2]; Taipei-Veterans General Hospital [V104C-059]; TADA (Taiwan Alzheimer's Disease Association)	Ministry of Health and Welfare of Taiwan; National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Taipei-Veterans General Hospital(Taipei Veterans General Hospital); TADA (Taiwan Alzheimer's Disease Association)	This project was supported in part by the Ministry of Health and Welfare of Taiwan (DOH100-TD-M113-100001), National Science Council of Taiwan (NSC 101-2314-B-010, NSC 102-2314-B-010-051-MY2), Taipei-Veterans General Hospital (V104C-059), and TADA (Taiwan Alzheimer's Disease Association). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert MS, 2011, ALZHEIMERS DEMENT, V7, P270, DOI 10.1016/j.jalz.2011.03.008; Artaz MA, 2006, REV MED INTERNE, V27, P91, DOI 10.1016/j.revmed.2005.10.007; Bajaj JS, 2009, HEPATOLOGY, V50, P2014, DOI 10.1002/hep.23216; Baumgart M, 2015, ALZHEIMERS DEMENT, V11, P718, DOI 10.1016/j.jalz.2015.05.016; Blazquez E, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00161; BRETELER MMB, 1994, BRIT MED J, V308, P1604, DOI 10.1136/bmj.308.6944.1604; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chen MH, 2014, J AM MED DIR ASSOC, V15, P763, DOI 10.1016/j.jamda.2014.06.003; Chen TF, 2007, NEUROEPIDEMIOLOGY, V28, P142, DOI 10.1159/000102142; Chung SD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105789; Dodd JW, 2015, ALZHEIMERS RES THER, V7, DOI 10.1186/s13195-015-0116-3; Duron E, 2008, ARCH CARDIOVASC DIS, V101, P181, DOI 10.1016/S1875-2136(08)71801-1; Duron E, 2008, VASC HEALTH RISK MAN, V4, P363; Duthie A, 2011, QJM-INT J MED, V104, P913, DOI 10.1093/qjmed/hcr118; Exalto LG, 2012, EXP GERONTOL, V47, P858, DOI 10.1016/j.exger.2012.07.014; Fan LY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139154; Formiga F, 2009, J NUTR HEALTH AGING, V13, P423, DOI 10.1007/s12603-009-0078-x; Huang SS, 2012, ARCH GERONTOL GERIAT, V55, P55, DOI 10.1016/j.archger.2011.04.009; Iadecola C, 2003, STROKE, V34, P335, DOI 10.1161/01.STR.0000054050.51530.76; Iadecola C, 2013, NEURON, V80, P844, DOI 10.1016/j.neuron.2013.10.008; Kahonen-Vare M, 2004, AGING CLIN EXP RES, V16, P147; Kloppenborg RP, 2008, EUR J PHARMACOL, V585, P97, DOI 10.1016/j.ejphar.2008.02.049; Li L, 2007, BRAIN RES REV, V56, P384, DOI 10.1016/j.brainresrev.2007.09.001; Liu CK, 1998, NEUROLOGY, V50, P1572, DOI 10.1212/WNL.50.6.1572; Liu HC, 1998, ALZ DIS ASSOC DIS, V12, P127, DOI 10.1097/00002093-199809000-00002; Lyketsos CG, 2005, AM J GERIAT PSYCHIAT, V13, P656, DOI 10.1176/appi.ajgp.13.8.656; Maslow K, 2004, NURS CLIN N AM, V39, P561, DOI 10.1016/j.cnur.2004.02.011; Nash DT, 2006, AM J CARDIOL, V97, P1262, DOI 10.1016/j.amjcard.2005.12.031; Panza F, 2006, BRAIN RES REV, V51, P275, DOI 10.1016/j.brainresrev.2005.11.007; Park HK, 2011, J KOREAN MED SCI, V26, P1219, DOI 10.3346/jkms.2011.26.9.1219; Peng YH, 2015, J EPIDEMIOL COMMUN H, V69, P123, DOI 10.1136/jech-2014-204445; Picano E, 2014, INT J CARDIOL, V175, P21, DOI 10.1016/j.ijcard.2014.05.004; Poblador-Plou B, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/1471-244X-14-84; Prasad Shikha, 2014, J Pharmacovigil, V2, P125; Reitz C, 2011, NAT REV NEUROL, V7, P137, DOI [10.1038/nrneurol.2011.2, 10.1101/cshperspect.a006239]; Sakurai H, 2010, GERIATR GERONTOL INT, V10, P216, DOI 10.1111/j.1447-0594.2010.00609.x; Sanderson Maureen, 2002, Am J Alzheimers Dis Other Demen, V17, P73, DOI 10.1177/153331750201700210; Schubert CC, 2006, J AM GERIATR SOC, V54, P104, DOI 10.1111/j.1532-5415.2005.00543.x; Snowdon DA, 1997, JAMA-J AM MED ASSOC, V277, P813, DOI 10.1001/jama.277.10.813; Solinas A, 2015, WORLD J HEPATOL, V7, P922, DOI 10.4254/wjh.v7.i7.922; Solomon A, 2011, INT J GERIATR PSYCH, V26, P1244, DOI 10.1002/gps.2670; Stephan BCM, 2011, AGE AGEING, V40, P501, DOI 10.1093/ageing/afr057; Sun Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100303; Wang PN, 1997, NEUROEPIDEMIOLOGY, V16, P234, DOI 10.1159/000109692; Wu YT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066252	45	57	57	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2017	12	4							e0175475	10.1371/journal.pone.0175475	http://dx.doi.org/10.1371/journal.pone.0175475			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET0LZ	28403222	gold, Green Published, Green Submitted			2022-12-27	WOS:000399955200073
J	Hitz, BC; Rowe, LD; Podduturi, NR; Glick, DI; Baymuradov, UK; Malladi, VS; Chan, ET; Davidson, JM; Gabdank, I; Narayana, AK; Onate, KC; Hilton, J; Ho, MC; Lee, BT; Miyasato, SR; Dreszer, TR; Sloan, CA; Strattan, JS; Tanaka, FY; Hong, EL; Cherry, JM				Hitz, Benjamin C.; Rowe, Laurence D.; Podduturi, Nikhil R.; Glick, David I.; Baymuradov, Ulugbek K.; Malladi, Venkat S.; Chan, Esther T.; Davidson, Jean M.; Gabdank, Idan; Narayana, Aditi K.; Onate, Kathrina C.; Hilton, Jason; Ho, Marcus C.; Lee, Brian T.; Miyasato, Stuart R.; Dreszer, Timothy R.; Sloan, Cricket A.; Strattan, J. Seth; Tanaka, Forrest Y.; Hong, Eurie L.; Cherry, J. Michael			SnoVault and encodeD: A novel object-based storage system and applications to ENCODE metadata	PLOS ONE			English	Article							REGULATORY INFORMATION; CHROMATIN; PRINCIPLES; ANNOTATION; EXPRESSION; ELEMENTS; MOUSE	The Encyclopedia of DNA elements (ENCODE) project is an ongoing collaborative effort to create a comprehensive catalog of functional elements initiated shortly after the completion of the Human Genome Project. The current database exceeds 6500 experiments across more than 450 cell lines and tissues using a wide array of experimental techniques to study the chromatin structure, regulatory and transcriptional landscape of the H. sapiens and M. musculus genomes. All ENCODE experimental data, metadata, and associated computational analyses are submitted to the ENCODE Data Coordination Center (DCC) for validation, tracking, storage, unified processing, and distribution to community resources and the scientific community. As the volume of data increases, the identification and organization of experimental details becomes increasingly intricate and demands careful curation. The ENCODE DCC has created a general purpose software system, known as SnoVault, that supports metadata and file submission, a database used for metadata storage, web pages for displaying the metadata and a robust API for querying the metadata. The software is fully open-source, code and installation instructions can be found at: http://github.com/ENCODE-DCC/snovault/ (for the generic database) and http://github.com/ENCODE-DCC/encoded/ to store genomic data in the manner of ENCODE. The core database engine, SnoVault (which is completely independent of ENCODE, genomic data, or bioinformatic data) has been released as a separate Python package.	[Hitz, Benjamin C.; Rowe, Laurence D.; Podduturi, Nikhil R.; Glick, David I.; Baymuradov, Ulugbek K.; Malladi, Venkat S.; Chan, Esther T.; Davidson, Jean M.; Gabdank, Idan; Narayana, Aditi K.; Onate, Kathrina C.; Hilton, Jason; Ho, Marcus C.; Miyasato, Stuart R.; Dreszer, Timothy R.; Sloan, Cricket A.; Strattan, J. Seth; Tanaka, Forrest Y.; Hong, Eurie L.; Cherry, J. Michael] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA; [Lee, Brian T.] Univ Calif Santa Cruz, Baskin Sch Engn, Ctr Biomol Sci & Engn, Santa Cruz, CA 95064 USA	Stanford University; University of California System; University of California Santa Cruz	Cherry, JM (corresponding author), Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA.	cherry@stanford.edu		Cherry, J. Michael/0000-0001-9163-5180; Onate, M. Kathrina/0000-0003-3495-6038; Rowe, Laurence/0000-0002-1420-0754; Lee, Brian/0000-0001-6382-9738; Chan, Esther/0000-0002-2406-2623	National Human Genome Resource Institute of the National Institute of Health [U41HG006992]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U41HG006992] Funding Source: NIH RePORTER	National Human Genome Resource Institute of the National Institute of Health; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was funded by the National Human Genome Resource Institute of the National Institute of Health (https://www.genome.gov/) under the following U41 grant and supplement: U41HG006992. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boley N, 2014, METHODS, V68, P38, DOI 10.1016/j.ymeth.2014.03.007; Boyle A.P., 2016, TRENDS GENET; Boyle AP, 2014, NATURE, V512, P453, DOI 10.1038/nature13668; Brown JB, 2015, ANNU REV GENOM HUM G, V16, P31, DOI 10.1146/annurev-genom-090413-025448; Cheng Y, 2014, NATURE, V515, P371, DOI 10.1038/nature13985; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Fan Y, 2015, J PROTEOME RES, V14, P3635, DOI 10.1021/acs.jproteome.5b00565; Gerstein MB, 2014, NATURE, V512, P445, DOI 10.1038/nature13424; Gerstein MB, 2012, NATURE, V489, P91, DOI 10.1038/nature11245; Haase K, 2015, BMC MED GENOMICS, V8, DOI 10.1186/s12920-015-0146-5; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Ho JWK, 2014, NATURE, V512, P449, DOI 10.1038/nature13415; Hoffman MM, 2013, NUCLEIC ACIDS RES, V41, P827, DOI 10.1093/nar/gks1284; Hong EL, 2016, DATABASE, V2016; Jupp S, 2014, BIOINFORMATICS, V30, P1338, DOI 10.1093/bioinformatics/btt765; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Li G, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r22; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Ma YY, 2016, MOL NUTR FOOD RES, V60, P410, DOI 10.1002/mnfr.201500436; Malladi VS, 2015, DATABASE, V2015; Mouse ENCODE Consortium, 2012, Genome Biol, V13, P418, DOI 10.1186/gb-2012-13-8-418; Myers RM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001046; Pazin Michael J, 2015, Cold Spring Harb Protoc, V2015, P522, DOI 10.1101/pdb.top084988; Raney BJ, 2014, BIOINFORMATICS, V30, P1003, DOI 10.1093/bioinformatics/btt637; Rosenbloom KR, 2013, NUCLEIC ACIDS RES, V41, pD56, DOI 10.1093/nar/gks1172; Siggens L, 2014, J INTERN MED, V276, P201, DOI 10.1111/joim.12231; Sloan CA, 2016, NUCLEIC ACIDS RES, V44, pD726, DOI 10.1093/nar/gkv1160; Speir ML, 2016, NUCLEIC ACIDS RES, V44, pD717, DOI 10.1093/nar/gkv1275; Vierstra J, 2016, NAT METHODS, V13, P213, DOI 10.1038/nmeth.3768; Yip KY, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r48; Yue F, 2014, NATURE, V515, P355, DOI 10.1038/nature13992; Zhao J, 2010, MOL CELL, V40, P939, DOI 10.1016/j.molcel.2010.12.011	34	7	7	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2017	12	4							e0175310	10.1371/journal.pone.0175310	http://dx.doi.org/10.1371/journal.pone.0175310			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LZ	28403240	Green Submitted, gold, Green Published			2022-12-27	WOS:000399955200049
J	Ogino, K; Ito, T; Eguchi, E; Nagaoka, K				Ogino, Keiki; Ito, Tatsuo; Eguchi, Eri; Nagaoka, Kenjiro			Association of arginase I or nitric oxide-related factors with job strain in healthy workers	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; C-REACTIVE PROTEIN; OXIDATIVE STRESS; BLOOD-PRESSURE; CONTENT QUESTIONNAIRE; JAPANESE VERSION; NATIONAL-HEALTH; DEPRESSIVE MOOD; L-ARGININE; WOMEN	This study evaluated the associations between job strain and arginase I in 378 healthy Japanese factory workers by a cross-sectional study measuring nitric oxide (NO)-related parameters (arginase I, L-arginine, exhaled nitric oxide (FeNO), and NOx), clinical parameters, and job strain using a Japanese version of the Job Content Questionnaire by Karasek. Arginase I and FEV1% were negatively correlated with job strain and positively correlated with job control and social support. FeNO and hs-CRP were negatively correlated with job strain. Multiple regression analysis showed negative association of arginase I with job strain and positive association with job control and social support in females. It is concluded that serum levels of arginase I may be useful biomarkers for the diagnosis of job stress in healthy female workers, although many factors can be influencing the data.	[Ogino, Keiki; Ito, Tatsuo; Eguchi, Eri; Nagaoka, Kenjiro] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Publ Hlth, Okayama, Japan	Okayama University	Ogino, K (corresponding author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Publ Hlth, Okayama, Japan.	kogino@md.okayama-u.ac.ip		Nagaoka, Kenjiro/0000-0002-7861-3910	JSPS KAKENHI [JP25870977]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant Number JP25870977, URL: hhtp:// www.jsps.go.jp/english/index.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asberg M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0003590; Black PH, 2003, BRAIN BEHAV IMMUN, V17, P350, DOI 10.1016/S0889-1591(03)00048-5; Blackwell S, 2009, CLIN CHIM ACTA, V401, P14, DOI 10.1016/j.cca.2008.10.032; Cepeda MS, 2016, J CLIN PSYCHIAT, V77, P1666, DOI 10.4088/JCP.15m10267; Ceylan E, 2005, RESP MED, V99, P871, DOI 10.1016/j.rmed.2004.12.001; Dhir A, 2011, NITRIC OXIDE-BIOL CH, V24, P125, DOI 10.1016/j.niox.2011.02.002; Elgun S, 2000, PROG NEURO-PSYCHOPH, V24, P227, DOI 10.1016/S0278-5846(99)00100-1; Eller NH, 2009, CARDIOL REV, V17, P83, DOI 10.1097/CRD.0b013e318198c8e9; Emeny R, 2012, BRAIN BEHAV IMMUN, V26, P1077, DOI 10.1016/j.bbi.2012.07.004; Fauvel JP, 2003, HYPERTENSION, V42, P1112, DOI 10.1161/01.HYP.0000102862.93418.EE; Forlenza MJ, 2006, PSYCHOSOM MED, V68, P1, DOI 10.1097/01.psy.0000195780.37277.2a; Fornari C, 2007, ERGONOMICS, V50, P1717, DOI 10.1080/00140130701674208; Fukuda H, 2008, INT NURS REV, V55, P407, DOI 10.1111/j.1466-7657.2008.00646.x; Hirose A, 2016, BIOPSYCHOSOC MED, V10, DOI 10.1186/s13030-016-0066-4; Karasek R.A., 1988, J PUBLIC HLTH, V78, P910; KARASEK RA, 1979, ADMIN SCI QUART, V24, P285, DOI 10.2307/2392498; Kawakami N, 1996, IND HEALTH, V34, P295, DOI 10.2486/indhealth.34.295; Kawakami N, 1995, INT J BEHAV MED, V2, P358, DOI 10.1207/s15327558ijbm0204_5; Kivimaki M, 2006, SCAND J WORK ENV HEA, V32, P431, DOI 10.5271/sjweh.1049; Kocyigit A, 2004, BIOL TRACE ELEM RES, V102, P11, DOI 10.1385/BTER:102:1-3:011; Kuper Hannah, 2002, Semin Vasc Med, V2, P267, DOI 10.1055/s-2002-35401; Kupper N, 2009, PSYCHOSOM MED, V71, P973, DOI 10.1097/PSY.0b013e3181bee6dc; Lee J. H., 2011, KOREAN J OCCUPATIONA, V23, P261; Lee S, 2004, ANN EPIDEMIOL, V14, P24, DOI 10.1016/S1047-2797(03)00074-7; LEU SY, 1992, CANCER, V70, P733, DOI 10.1002/1097-0142(19920815)70:4<733::AID-CNCR2820700403>3.0.CO;2-6; Maes M, 2001, ACTA PSYCHIAT SCAND, V103, P161; Maes M, 2009, NEUROENDOCRINOL LETT, V30, P462; Markovitz JH, 2004, ANN BEHAV MED, V28, P4, DOI 10.1207/s15324796abm2801_2; More A. G., 2007, GENDER WORK ORGAN, V14, P476; Morris CR, 2009, AM J HEMATOL, V84, P234, DOI 10.1002/ajh.21359; Ogino K, 2014, FREE RADICAL RES, V48, P137, DOI 10.3109/10715762.2013.842979; Ogino K, 2013, CLIN BIOCHEM, V46, P1717, DOI 10.1016/j.clinbiochem.2013.08.012; Ogino K, 2011, J ASTHMA, V48, P1, DOI 10.3109/02770903.2010.528496; Ogino K, 2011, FREE RADICAL RES, V45, P147, DOI 10.3109/10715762.2010.520318; Ritz T, 2014, PSYCHOSOM MED, V76, P716, DOI 10.1097/PSY.0000000000000118; Rozanski A, 1999, CIRCULATION, V99, P2192, DOI 10.1161/01.CIR.99.16.2192; See KC, 2013, CHEST, V143, P107, DOI 10.1378/chest.12-0416; Sharma J. N., 2007, Inflammopharmacology, V15, P252, DOI 10.1007/s10787-007-0013-x; Steptoe A, 2004, J HYPERTENS, V22, P915, DOI 10.1097/00004872-200405000-00012; THOMAS LT, 1995, J APPL PSYCHOL, V80, P6, DOI 10.1037/0021-9010.80.1.6; Trueba AF, 2013, BIOL PSYCHOL, V93, P206, DOI 10.1016/j.biopsycho.2013.01.017; Tsai SS, 2014, J OCCUP HEALTH PSYCH, V19, P336, DOI 10.1037/a0036600; Yang BK, 2003, FREE RADICAL RES, V37, P1, DOI 10.1080/1071576021000033112; Yang ZH, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00149	44	2	2	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2017	12	4							e0175696	10.1371/journal.pone.0175696	http://dx.doi.org/10.1371/journal.pone.0175696			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET0LZ	28403218	gold, Green Published, Green Submitted			2022-12-27	WOS:000399955200091
J	Yu, M; Zheng, YM; Jin, SQ; Gang, Q; Wang, QQ; Yu, P; Lv, H; Zhang, W; Yuan, Y; Wang, ZX				Yu, Meng; Zheng, Yiming; Jin, Suqin; Gang, Qiang; Wang, Qingqing; Yu, Peng; Lv, He; Zhang, Wei; Yuan, Yun; Wang, Zhaoxia			Mutational spectrum of Chinese LGMD patients by targeted next-generation sequencing	PLOS ONE			English	Article							GIRDLE MUSCULAR-DYSTROPHY; LIMB-GIRDLE; GENETIC DIAGNOSIS; DYSFERLIN GENE; GUIDELINE; FREQUENCY; DISEASES	This study aimed to study the diagnostic value of targeted next-generation sequencing (NGS) in limb-girdle muscular dystrophies (LGMDs), and investigate the mutational spectrum of Chinese LGMD patients. We performed targeted NGS covering 420 genes in 180 patients who were consecutively suspected of LGMDs and underwent muscle biopsies from January 2013 to May 2015. The association between genotype and myopathological profiles was analyzed in the genetically confirmed LGMD patients. With targeted NGS, one or more rare variants were detected in 138 patients, of whom 113 had causative mutations, 10 sporadic patients had one pathogenic heterozygous mutation related to a recessive pattern of LGMDs, and 15 had variants of uncertain significance. No disease-causing mutation was found in the remaining 42 patients. Combined with the myopathological findings, we achieved a positive genetic diagnostic rate as 68.3% (123/180). Totally 105 patients were diagnosed as LGMDs with genetic basis. Among these 105 patients, the most common subtypes were LGMD2B in 52 (49.5%), LGMD2A in 26 (24.8%) and LGMD 2D in eight (7.6%), followed by LGMD1B in seven (6.7%), LGMD1E in four (3.8%), LGMD2I in three (2.9%), and LGMD2E, 2F, 2H, 2K, 2L in one patient (1.0%), respectively. Although some characteristic pathological changes may suggest certain LGMD subtypes, both heterogeneous findings in a certain subtype and overlapping presentations among different subtypes were not uncommon. The application of NGS, together with thorough clinical and myopathological evaluation, can substantially improve the molecular diagnostic rate in LGMDs. Confirming the genetic diagnosis in LGMD patients can help improve our understanding of their myopathological changes.	[Yu, Meng; Zheng, Yiming; Jin, Suqin; Gang, Qiang; Wang, Qingqing; Lv, He; Zhang, Wei; Yuan, Yun; Wang, Zhaoxia] Peking Univ, Hosp 1, Dept Neurol, Beijing, Peoples R China; [Yu, Peng] Precisionmdx Inc, Sci & Technol, Beijing, Peoples R China	Peking University	Wang, ZX (corresponding author), Peking Univ, Hosp 1, Dept Neurol, Beijing, Peoples R China.	drwangxz@163.com	Zheng, Yiming/AFQ-9684-2022	Zheng, Yiming/0000-0001-7993-3054	Ministry of Science and Technology of China [2011ZX09307-001-07]; National Nature Science Foundation of China [81571219]; Beijing Municipal Science and Technology Commission [Z151100003915126]; Precisionmdx Inc.	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Municipal Science and Technology Commission(Beijing Municipal Science & Technology Commission); Precisionmdx Inc.	This study was funded by the Ministry of Science and Technology of China (No. 2011ZX09307-001-07), the National Nature Science Foundation of China (81571219), and the Beijing Municipal Science and Technology Commission (No. Z151100003915126). Precisionmdx Inc., provided support in the form of salaries for author Peng Yu, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author is articulated in the 'author contributions' section.	Ankala A, 2015, ANN NEUROL, V77, P206, DOI 10.1002/ana.24303; Aoki M, 2001, NEUROLOGY, V57, P271, DOI 10.1212/WNL.57.2.271; Bartoli M, 2014, MUSCLE NERVE, V50, P1007, DOI 10.1002/mus.24344; Bastian A, 2015, ROM J INTERN MED, V53, P13, DOI 10.1515/rjim-2015-0002; Bras J, 2012, NAT REV NEUROSCI, V13, P453, DOI 10.1038/nrn3271; Bushby Kate, 2009, Pract Neurol, V9, P314, DOI 10.1136/jnnp.2009.193938; BUSHBY KMD, 1995, NEUROMUSCULAR DISORD, V5, P337, DOI 10.1016/0960-8966(95)00005-8; Chae JH, 2015, J MED GENET, V52, P208, DOI 10.1136/jmedgenet-2014-102819; Fanin M, 2009, NEUROLOGY, V72, P1432, DOI 10.1212/WNL.0b013e3181a1885e; Ghaoui R, 2015, JAMA NEUROL, V72, P1424, DOI 10.1001/jamaneurol.2015.2274; Ghosh Partha S, 2012, J Clin Neuromuscul Dis, V14, P86, DOI 10.1097/CND.0b013e31824619e9; Jamuar SS, 2015, HUM GENOMICS, V9, DOI 10.1186/s40246-015-0031-5; Jin SQ, 2016, CHINESE MED J-PEKING, V129, P2287, DOI 10.4103/0366-6999.190671; Johansson LF, 2016, HUM MUTAT, V37, P457, DOI 10.1002/humu.22969; Kitamura Y, 2016, J HUM GENET; Klinge L, 2008, NEUROMUSCULAR DISORD, V18, P934, DOI 10.1016/j.nmd.2008.08.003; Kuhn M, 2016, J NEUROL; Levy SE, 2016, ANNU REV GENOMICS HU; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu F, 2015, INT J NEUROSCI; Lo HP, 2008, NEUROMUSCULAR DISORD, V18, P34, DOI 10.1016/j.nmd.2007.08.009; Luo SS, 2011, MUSCLE NERVE, V43, P402, DOI 10.1002/mus.21908; Mah JK, 2016, CAN J NEUROL SCI, V43, P163, DOI 10.1017/cjn.2015.311; Mahmood OA, 2013, NEURAL REGEN RES, V8, P1907, DOI 10.3969/j.issn.1673-5374.2013.20.010; Mitsuhashi S, 2012, SEMIN PEDIATR NEUROL, V19, P211, DOI 10.1016/j.spen.2012.09.008; Moore SA, 2006, J NEUROPATH EXP NEUR, V65, P995, DOI 10.1097/01.jnen.0000235854.77716.6c; Nadaj-Pakleza AA, 2013, NEUROL NEUROCHIR POL, V47, P214, DOI 10.5114/ninp.2013.35490; Narayanaswami P, 2014, NEUROLOGY, V83, P1453, DOI 10.1212/WNL.0000000000000892; Nigro V, 2016, CURR OPIN NEUROL; Nigro Vincenzo, 2014, Acta Myol, V33, P1; Norwood F, 2007, EUR J NEUROL, V14, P1305, DOI 10.1111/j.1468-1331.2007.01979.x; Norwood FLM, 2009, BRAIN, V132, P3175, DOI 10.1093/brain/awp236; Okubo M, 2016, J HUM GENET, V61, P483, DOI 10.1038/jhg.2016.7; Papadopoulos C, 2015, NEUROLOGIST, V20, P8, DOI 10.1097/NRL.0000000000000036; Park YE, 2012, NEUROMUSCULAR DISORD, V22, P505, DOI 10.1016/j.nmd.2011.12.007; Savarese M, 2016, NEUROLOGY, V87, P71, DOI 10.1212/WNL.0000000000002800; Seong MW, 2015, CLIN GENET; Tian X, 2015, NEUROL-GENET, V1, DOI 10.1212/NXG.0000000000000015; Vincent AE, 2016, NEUROMUSCULAR DISORD, V26, P782, DOI 10.1016/j.nmd.2016.08.008; Vissing J, 2016, BRAIN, V139, P2154, DOI 10.1093/brain/aww133; WALTON JN, 1954, BRAIN, V77, P169, DOI 10.1093/brain/77.2.169; Wang Y, 2014, MOL GENET GENOMICS, V289, P1013, DOI 10.1007/s00438-014-0847-z	42	41	46	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2017	12	4							e0175343	10.1371/journal.pone.0175343	http://dx.doi.org/10.1371/journal.pone.0175343			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LZ	28403181	Green Submitted, gold, Green Published			2022-12-27	WOS:000399955200053
J	Conceicao, T; de Lencastre, H; Aires-de-Sousa, M				Conceicao, Teresa; de Lencastre, Herminia; Aires-de-Sousa, Marta			Frequent isolation of methicillin resistant Staphylococcus aureus (MRSA) ST398 among healthy pigs in Portugal	PLOS ONE			English	Article							ANTIMICROBIAL RESISTANCE; HIGH PREVALENCE; CC398; BACTERIA; PATTERNS	Background Although livestock-associated ST398 methicillin-resistant Staphylococcus aureus (MRSA) has been widely reported in different geographic regions, MRSA carriage studies among healthy pigs in Portugal are very limited. Methods and findings In total, 101 swine nasal samples from two Portuguese farms were screened for MRSA. In addition five swine workers (including one veterinary and one engineer) and four household members were nasally screened. The isolates were characterized by spa typing, SCCmec typing and MLST. All isolates were tested for antimicrobial susceptibility, presence of mecA and mecC genes, and virulence determinants. MRSA prevalence in swine was 99% (100/101), 80% (4/5) in swine workers and 25% (1/4) in household members. All isolates belonged to ST398 distributed over two spa types-t011 (57%) and t108 (42%). SCCmec type V was present in most of the isolates (n = 95; 82%) while 21 isolates amplified the mecA gene only and were classified as nontypeable. The majority of the isolates were resistant to tetracycline (100%), clindamycin (97%), erythromycin (96%), chloramphenicol (84%) and gentamycin (69%). Notably, 12% showed resistance to quinupristin-dalfopristin (MICs 3-8 mu g/mL). Beta-hemolysin (81%) and gamma-hemolysin (74%) were the unique virulence determinants detected. None of the isolates harboured PVL or mecC gene. Conclusions This study showed a massive occurrence of ST398-MRSA in two independent swine farms, highlighting its establishment among healthy pigs in Portugal.	[Conceicao, Teresa; de Lencastre, Herminia] Univ Nova Lisboa, Inst Tecnol Quim & Biol Antonio Xavier ITQB, Lab Mol Genet, Oeiras, Portugal; [de Lencastre, Herminia] Rockefeller Univ, Lab Microbiol & Infect Dis, New York, NY 10021 USA; [Aires-de-Sousa, Marta] ESSCVP, Lisbon, Portugal	Universidade Nova de Lisboa; Rockefeller University	Aires-de-Sousa, M (corresponding author), ESSCVP, Lisbon, Portugal.	msousa@esscvp.eu	; Conceicao, Teresa/M-3449-2014	Aires-de-Sousa, Marta/0000-0001-5036-2446; /0000-0001-6816-8932; Conceicao, Teresa/0000-0002-9818-2767	FCT - Fundacao para a Ciencia e a Tecnologia, Portugal [PTDC/DTP-EPI/0842/2014]; FEDER funds through COMPETE - Programa Operacional Competitividade e Internacionalizacao (POCI) [LISBOA-01-0145-FEDER-007660]; FCT, Portugal [SFRH/BPD/72422/2010]	FCT - Fundacao para a Ciencia e a Tecnologia, Portugal(Portuguese Foundation for Science and Technology); FEDER funds through COMPETE - Programa Operacional Competitividade e Internacionalizacao (POCI); FCT, Portugal(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was supported by project PTDC/DTP-EPI/0842/2014 from FCT - Fundacao para a Ciencia e a Tecnologia, Portugal and by project LISBOA-01-0145-FEDER-007660 (Microbiologia Molecular, Estrutural e Celular) funded by FEDER funds through COMPETE2020 - Programa Operacional Competitividade e Internacionalizacao (POCI). TC was supported by grant SFRH/BPD/72422/2010 from FCT, Portugal.	Aires-de-Sousa M, 2006, J CLIN MICROBIOL, V44, P619, DOI 10.1128/JCM.44.2.619-621.2006; [Anonymous], 2009, EFSA J, V7, DOI 10.2903/j.efsa.2009.1376; Armand-Lefevre L, 2005, EMERG INFECT DIS, V11, P711, DOI 10.3201/eid1105.040866; Cavaco LM, 2010, ANTIMICROB AGENTS CH, V54, P3605, DOI 10.1128/AAC.00058-10; Chantziaras I, 2014, J ANTIMICROB CHEMOTH, V69, P827, DOI 10.1093/jac/dkt443; Conceicao T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077812; Couto N, 2015, J ANTIMICROB CHEMOTH, V70, P2483, DOI 10.1093/jac/dkv141; Cuny C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006800; de Neeling AJ, 2007, VET MICROBIOL, V122, P366, DOI 10.1016/j.vetmic.2007.01.027; Dierikx CM, 2016, J ANTIMICROB CHEMOTH, V71, P2414, DOI 10.1093/jac/dkw190; ECDC, 2017, ANTIMICROBIAL RESIST, DOI DOI 10.2900/6928; Hershberger E, 2004, CLIN INFECT DIS, V38, P92, DOI 10.1086/380125; Ito T, 2004, ANTIMICROB AGENTS CH, V48, P2637, DOI 10.1128/AAC.48.7.2637-2651.2004; Kim C, 2012, J BIOL CHEM, V287, P36854, DOI 10.1074/jbc.M112.395962; Li BB, 2013, J ANTIMICROB CHEMOTH, V68, P1251, DOI 10.1093/jac/dkt015; Okuma K, 2002, J CLIN MICROBIOL, V40, P4289, DOI 10.1128/JCM.40.11.4289-4294.2002; Peeters LEJ, 2015, VET MICROBIOL, V180, P151, DOI 10.1016/j.vetmic.2015.08.018; Pomba C, 2010, J ANTIMICROB CHEMOTH, V65, P2479, DOI 10.1093/jac/dkq330; Pomba CA, 2009, INT J ANTIMICROB AG, V34, P193, DOI 10.1016/j.ijantimicag.2009.02.019; Pyorala S, 2014, VET J, V200, P230, DOI 10.1016/j.tvjl.2014.02.028; van Alen S, 2017, VET MICROBIOL, V200, P19, DOI 10.1016/j.vetmic.2016.01.021; van Loo I, 2007, EMERG INFECT DIS, V13, P1834, DOI 10.3201/eid1312.070384; Vandenesch F, 2003, EMERG INFECT DIS, V9, P978; Voss A, 2005, EMERG INFECT DIS, V11, P1965, DOI 10.3201/eid1112.050428	24	22	23	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2017	12	4							e0175340	10.1371/journal.pone.0175340	http://dx.doi.org/10.1371/journal.pone.0175340			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0JS	28399155	Green Published, Green Submitted, gold			2022-12-27	WOS:000399949000034
J	Treu, C; de Souza, MDC; Lupi, O; Sicuro, FL; Maranhao, PA; Kraemer-Aguiar, LG; Bouskela, E				Treu, Curt; Coelho de Souza, Maria das Gracas; Lupi, Omar; Sicuro, Fernando Lencastre; Maranhao, Priscila Alves; Kraemer-Aguiar, Luiz Guilherme; Bouskela, Eliete			Structural and functional changes in the microcirculation of lepromatous leprosy patients - Observation using orthogonal polarization spectral imaging and laser Doppler flowmetry iontophoresis	PLOS ONE			English	Article							MICROVASCULAR ENDOTHELIAL FUNCTION; AGE-RELATED-CHANGES; CUTANEOUS MICROCIRCULATION; INSULIN-RESISTANCE; CIGARETTE-SMOKING; SMOOTH-MUSCLE; BLOOD-FLOW; HUMAN SKIN; DYSFUNCTION; DISEASE	Leprosy is a chronic granulomatous infection of skin and peripheral nerves caused by Mycobacterium leprae and is considered the main infectious cause of disability worldwide. Despite the several studies regarding leprosy, little is known about its effects on microvascular structure and function in vivo. Thus, we have aimed to compare skin capillary structure and functional density, cutaneous vasomotion (spontaneous oscillations of arteriolar diameter), which ensures optimal blood flow distribution to skin capillaries) and cutaneous microvascular blood flow and reactivity between ten men with lepromatous leprosy (without any other comorbidity) and ten age-and gender-matched healthy controls. Orthogonal polarization spectral imaging was used to evaluate skin capillary morphology and functional density and laser Doppler flowmetry to evaluate blood flow, vasomotion and spectral analysis of flowmotion (oscillations of blood flow generated by vasomotion) and microvascular reactivity, in response to iontophoresis of acetylcholine and sodium nitroprusside. The contribution of different frequency components of flowmotion (endothelial, neurogenic, myogenic, respiratory and cardiac) was not statistically different between groups. However, endothelial-dependent and -independent vasodilatations elicited by acetylcholine and sodium nitroprusside iontophoresis, respectively, were significantly reduced in lepromatous leprosy patients compared to controls, characterizing the existence of microvascular dysfunction. These patients also presented a significant increase in the number of capillaries with morphological abnormalities and in the diameters of the dermal papilla and capillary bulk when compared to controls. Our results suggest that lepromatous leprosy causes severe microvascular dysfunction and significant alterations in capillary structure. These structural and functional changes are probably induced by exposure of the microvascular bed to chronic inflammation evoked by the Mycobacterium leprae.	[Treu, Curt; Coelho de Souza, Maria das Gracas; Sicuro, Fernando Lencastre; Maranhao, Priscila Alves; Kraemer-Aguiar, Luiz Guilherme; Bouskela, Eliete] Univ Estado Rio de Janeiro, Ctr Biomed, Lab Pesquisas Clin & Expt Biol Vas, Rio De Janeiro, RJ, Brazil; [Lupi, Omar] Univ Fed Estado Rio de Janeiro Uni Rio, Dept Dermatol, Rio De Janeiro, RJ, Brazil; [Kraemer-Aguiar, Luiz Guilherme] Univ Estado Rio de Janeiro, Ctr Biomed, Fac Ciencias Med, Ambulatorio Obesidade,Policlin Piquet Carneiro,De, Rio De Janeiro, RJ, Brazil	Universidade do Estado do Rio de Janeiro; Universidade do Estado do Rio de Janeiro	de Souza, MDC (corresponding author), Univ Estado Rio de Janeiro, Ctr Biomed, Lab Pesquisas Clin & Expt Biol Vas, Rio De Janeiro, RJ, Brazil.	mgcsouza@gmail.com	Lupi, Omar/AAA-3653-2019; Sicuro, Fernando/ABB-5797-2020	Sicuro, Fernando/0000-0002-2091-1712; Kraemer-Aguiar, Luiz Guilherme/0000-0002-3528-5881; Maranhao, Priscila/0000-0002-4804-4999	National Research Council of Brazil (CNPq); Carlos Chagas Filho Foundation for Research Support in the State of Rio de Janeiro (FAPERJ)	National Research Council of Brazil (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Carlos Chagas Filho Foundation for Research Support in the State of Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	Support was provided by the National Research Council of Brazil (CNPq) and the Carlos Chagas Filho Foundation for Research Support in the State of Rio de Janeiro (FAPERJ).	Abularrage CJ, 2005, J VASC SURG, V42, P574, DOI 10.1016/j.jvs.2005.05.019; Agrawal A, 2005, CLIN NEUROL NEUROSUR, V107, P445, DOI 10.1016/j.clineuro.2005.03.007; AGUSNI I, 1988, INT J LEPROSY, V56, P394; [Anonymous], 2012, Wkly Epidemiol Rec, V87, P317; Antunes SLG, 2000, INT J LEPROSY, V68, P143; BOUSKELA E, 1992, AM J PHYSIOL, V262, pH478, DOI 10.1152/ajpheart.1992.262.2.H478; Britton WJ, 2004, LANCET, V363, P1209, DOI 10.1016/S0140-6736(04)15952-7; Buss C, 2012, PHYSIOL BEHAV, V105, P1082, DOI 10.1016/j.physbeh.2011.12.004; Cerny V, 2007, PHYSIOL RES, V56, P141, DOI 10.33549/physiolres.930922; Cohen RA, 1999, CIRC RES, V84, P210, DOI 10.1161/01.RES.84.2.210; Cracowski JL, 2006, TRENDS PHARMACOL SCI, V27, P503, DOI 10.1016/j.tips.2006.07.008; De Backer D, 2007, CRIT CARE, V11, DOI 10.1186/cc6118; de Jongh RT, 2008, MICROVASC RES, V75, P256, DOI 10.1016/j.mvr.2007.08.001; de Jongh RT, 2007, J HYPERTENS, V25, P1887, DOI 10.1097/HJH.0b013e32825e1db7; Deanfield JE, 2007, CIRCULATION, V115, P1285, DOI 10.1161/CIRCULATIONAHA.106.652859; Edvinsson ML, 2008, VASC HEALTH RISK MAN, V4, P699; Esper RJ, 2006, CARDIOVASC DIABETOL, V5, DOI 10.1186/1475-2840-5-4; Fagrell B., 1981, BIBL ANAT, V20, P645; Groner W, 1999, NAT MED, V5, P1209, DOI 10.1038/13529; Grossi L, 2005, J MED CHEM, V48, P2622, DOI 10.1021/jm049857n; IGNARRO LJ, 1985, ANNU REV PHARMACOL, V25, P171, DOI 10.1146/annurev.pharmtox.25.1.171; Ijzerman RG, 2003, CLIN SCI, V104, P247, DOI 10.1042/CS20020318; Jonk AM, 2011, DIABETES CARE, V34, pS342, DOI 10.2337/dc11-s240; Kraemer-Aguiar LG, 2008, METABOLISM, V57, P1740, DOI 10.1016/j.metabol.2008.07.034; Kvernmo HD, 1998, MICROVASC RES, V56, P173, DOI 10.1006/mvre.1998.2108; Langer S, 2002, ANN PLAS SURG, V48, P646, DOI 10.1097/00000637-200206000-00014; Lascasas-Porto CL, 2008, MICROVASC RES, V76, P66, DOI 10.1016/j.mvr.2008.02.002; Li L, 2006, GERONTOLOGY, V52, P142, DOI 10.1159/000091823; Li L, 2006, ARCH DERMATOL RES, V297, P412, DOI 10.1007/s00403-005-0628-y; Lindeboom JA, 2005, J CLIN PERIODONTOL, V32, P1208, DOI 10.1111/j.1600-051X.2005.00854.x; Lupi O, 2008, INT J DERMATOL, V47, P425, DOI 10.1111/j.1365-4632.2008.03694.x; Lupi Omar, 2007, J Cosmet Dermatol, V6, P102; Michiels C, 2003, J CELL PHYSIOL, V196, P430, DOI 10.1002/jcp.10333; Monfrecola G, 1998, DERMATOLOGY, V197, P115, DOI 10.1159/000017980; Pellaton C, 2002, AM HEART J, V144, P269, DOI 10.1067/mhj.2002.123842; Quattrini C, 2007, DIABETES CARE, V30, P655, DOI 10.2337/dc06-2154; Rodrigues LC, 2011, LANCET INFECT DIS, V11, P464, DOI 10.1016/S1473-3099(11)70006-8; Rossi M, 2006, BIOMED PHARMACOTHER, V60, P437, DOI 10.1016/j.biopha.2006.07.012; SAX FL, 1987, NEW ENGL J MED, V317, P1366, DOI 10.1056/NEJM198711263172202; Schiessler C, 2002, ANAESTHESIST, V51, P576, DOI 10.1007/s00101-002-0341-6; Scollard DM, 2015, CLIN DERMATOL, V33, P46, DOI 10.1016/j.clindermatol.2014.07.008; Serne EH, 2002, DIABETES, V51, P1515, DOI 10.2337/diabetes.51.5.1515; Stefanovska A, 1999, IEEE T BIO-MED ENG, V46, P1230, DOI 10.1109/10.790500; Struijker-Boudier HAJ, 2007, EUR HEART J, V28, P2834, DOI 10.1093/eurheartj/ehm448; Tesselaar E, 2011, MICROVASC RES, V81, P88, DOI 10.1016/j.mvr.2010.11.002; Treu CM, 2011, ARCH DERMATOL RES, V303, P69, DOI 10.1007/s00403-010-1087-7; TURKEL SB, 1982, INT J LEPROSY, V50, P164; Turner J, 2008, TRENDS CARDIOVAS MED, V18, P109, DOI 10.1016/j.tcm.2008.02.001; Ungvari Z, 2001, J APPL PHYSIOL, V91, P522, DOI 10.1152/jappl.2001.91.1.522; VANHOUTTE PM, 1994, TEX HEART I J, V21, P62; Virgini-Magalhaes CE, 2006, J VASC SURG, V43, P1037, DOI 10.1016/j.jvs.2005.12.065; Walker SL, 2007, CLIN DERMATOL, V25, P165, DOI 10.1016/j.clindermatol.2006.05.012; Wilder-Smith EPV, 2000, MUSCLE NERVE, V23, P1105, DOI 10.1002/1097-4598(200007)23:7<1105::AID-MUS14>3.0.CO;2-A; WilderSmith E, 1996, LEPROSY REV, V67, P306	54	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2017	12	4							e0175743	10.1371/journal.pone.0175743	http://dx.doi.org/10.1371/journal.pone.0175743			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KH	28419120	Green Published, Green Submitted, gold			2022-12-27	WOS:000399875200043
J	de Macedo, MSFC; Costa, KM; da Silva, M				de Macedo, Milena S. F. C.; Costa, Kaue M.; da Silva Filho, Manoel			Voice disorder in systemic lupus erythematosus	PLOS ONE			English	Article							QUALITY-OF-LIFE; THE-LITERATURE; DAMAGE INDEX; DYSPHONIA; THERAPY; REFLUX; DISEASE	Systemic lupus erythematosus (SLE) is a chronic disease characterized by progressive tissue damage. In recent decades, novel treatments have greatly extended the life span of SLE patients. This creates a high demand for identifying the overarching symptoms associated with SLE and developing therapies that improve their life quality under chronic care. We hypothesized that SLE patients would present dysphonic symptoms. Given that voice disorders can reduce life quality, identifying a potential SLE-related dysphonia could be relevant for the appraisal and management of this disease. We measured objective vocal parameters and perceived vocal quality with the GRBAS (Grade, Roughness, Breathiness, Asthenia, Strain) scale in SLE patients and compared them to matched healthy controls. SLE patients also filled a questionnaire reporting perceived vocal deficits. SLE patients had significantly lower vocal intensity and harmonics to noise ratio, as well as increased jitter and shimmer. All subjective parameters of the GRBAS scale were significantly abnormal in SLE patients. Additionally, the vast majority of SLE patients (29/36) reported at least one perceived vocal deficit, with the most prevalent deficits being vocal fatigue (19/36) and hoarseness (17/36). Self-reported voice deficits were highly correlated with altered GRBAS scores. Additionally, tissue damage scores in different organ systems correlated with dysphonic symptoms, suggesting that some features of SLE-related dysphonia are due to tissue damage. Our results show that a large fraction of SLE patients suffers from perceivable dysphonia and may benefit from voice therapy in order to improve quality of life.	[de Macedo, Milena S. F. C.; da Silva Filho, Manoel] Fed Univ Para, Inst Biol Sci, Belem, Para, Brazil; [de Macedo, Milena S. F. C.] Ophir Loyola Hosp, Belem, Para, Brazil; [Costa, Kaue M.] Goethe Univ, Interdisciplinary Ctr Neurosci, Inst Neu rophysiol, Frankfurt, Germany	Universidade Federal do Para; Goethe University Frankfurt	da Silva, M (corresponding author), Fed Univ Para, Inst Biol Sci, Belem, Para, Brazil.	manoel@utpa.br	Costa, Kauê M/H-5574-2012	Costa, Kauê M/0000-0002-5562-6495	Coordination for the Improvement of Higher Education Personnel (CAPES)	Coordination for the Improvement of Higher Education Personnel (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This study was supported by the Coordination for the Improvement of Higher Education Personnel (CAPES) [http/www/capes.gov.br/]. MSF is a research fellow of the National Council for Research and Development (CNPQ) (2032152778116209) [http Aug OA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baken RJ, 2000, CLIN MEASUREMENT SPE; Charuvanij S, 2009, PEDIATR RHEUMATOL, V7, DOI 10.1186/1546-0096-7-19; Deary IJ, 1997, BRIT J HEALTH PSYCH, V2, P333, DOI 10.1111/j.2044-8287.1997.tb00547.x; DeBodt MS, 1997, J VOICE, V11, P74, DOI 10.1016/S0892-1997(97)80026-4; Gladman D, 1996, ARTHRITIS RHEUM, V39, P363, DOI 10.1002/art.1780390303; Hirano M., 1981, CLIN EXAMINATION VOI; Ihre E, 2004, J VOICE, V18, P403, DOI 10.1016/j.jvoice.2003.05.003; Karim A, 2002, CHEST, V121, P990, DOI 10.1378/chest.121.3.990; Knight AM, 2016, J RHEUMATOL, V43, P1427, DOI 10.3899/jrheum.150967; Kosztyla-Hojna B, 2011, FOLIA HISTOCHEM CYTO, V49, P72, DOI 10.5603/FHC.2011.0011; Lourenco BM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096769; MARTIN L, 1992, J RHEUMATOL, V19, P1186; Martinucci I, 2013, THER ADV CHRONIC DIS, V4, P287, DOI 10.1177/2040622313503485; MCNALLY PR, 1989, DIGEST DIS SCI, V34, P1900; MERRELL M, 1955, J Chronic Dis, V1, P12, DOI 10.1016/0021-9681(55)90018-7; Mohamed EE, 2014, EGYPT J CHEST DIS TU, V63, P561, DOI 10.1016/j.ejcdt.2014.03.006; Mok CC, 2016, CLIN EXP RHEUMATOL, V34, P389; Murry T, 2004, J VOICE, V18, P183, DOI 10.1016/j.jvoice.2003.11.003; Nemr K, 2012, J VOICE, V26, DOI 10.1016/j.jvoice.2012.03.005; Nieves CEF, 2016, CURR RHEUMATOL REP, V18, DOI 10.1007/s11926-016-0571-2; Pontes Paulo A. L., 2002, Rev. Bras. Otorrinolaringol., V68, P182, DOI 10.1590/S0034-72992002000200005; Rubin JS, 2007, J VOICE, V21, P477, DOI 10.1016/j.jvoice.2005.02.001; Salturk Z, 2015, LARYNGOSCOPE, V125, P1908, DOI 10.1002/lary.25319; Schulz GM, 2000, J COMMUN DISORD, V33, P59, DOI 10.1016/S0021-9924(99)00025-8; Siupsinskiene N, 2007, LARYNGOSCOPE, V117, P480, DOI 10.1097/MLG.0b013e31802d83cf; Speyer R, 2008, J VOICE, V22, P565, DOI 10.1016/j.jvoice.2006.10.005; Stoll T, 1996, BRIT J RHEUMATOL, V35, P248; TEITEL AD, 1992, SEMIN ARTHRITIS RHEU, V22, P203, DOI 10.1016/0049-0172(92)90020-E; Van Houtte E, 2011, J VOICE, V25, P202, DOI 10.1016/j.jvoice.2009.10.009; Vashani K, 2010, DIS ESOPHAGUS, V23, P27, DOI 10.1111/j.1442-2050.2009.00992.x; Wilson JA, 2002, CLIN OTOLARYNGOL, V27, P179, DOI 10.1046/j.1365-2273.2002.00559.x	31	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2017	12	4							e0175893	10.1371/journal.pone.0175893	http://dx.doi.org/10.1371/journal.pone.0175893			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KD	28414781	Green Submitted, Green Published, gold			2022-12-27	WOS:000399874800074
J	Morimoto, T; Mineharu, Y; Ono, K; Nakatochi, M; Ichihara, S; Kabata, R; Takagi, Y; Cao, Y; Zhao, LY; Kobayashi, H; Harada, KH; Takenaka, K; Funaki, T; Yokota, M; Matsubara, T; Yamamoto, K; Izawa, H; Kimura, T; Miyamoto, S; Koizumi, A				Morimoto, Takaaki; Mineharu, Yohei; Ono, Koh; Nakatochi, Masahiro; Ichihara, Sahoko; Kabata, Risako; Takagi, Yasushi; Cao, Yang; Zhao, Lanying; Kobayashi, Hatasu; Harada, Kouji H.; Takenaka, Katsunobu; Funaki, Takeshi; Yokota, Mitsuhiro; Matsubara, Tatsuaki; Yamamoto, Ken; Izawa, Hideo; Kimura, Takeshi; Miyamoto, Susumu; Koizumi, Akio			Significant association of RNF213 p. R4810K, a moyamoya susceptibility variant, with coronary artery disease	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; HEART-DISEASE; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; SPONTANEOUS OCCLUSION; EARLY-ONSET; POPULATION; JAPANESE; RISK; C.14576G-GREATER-THAN-A	Background The genetic architecture of coronary artery disease has not been fully elucidated, especially in Asian countries. Moyamoya disease is a progressive cerebrovascular disease that is reported to be complicated by coronary artery disease. Because most Japanese patients with moyamoya disease carry the p.R4810K variant of the ring finger 213 gene (RNF213), this may also be a risk factor for coronary artery disease; however, this possibility has never been tested. Methods and results We genotyped the RNF213 p.R4810K variant in 956 coronary artery disease patients and 716 controls and tested the association between p.R4810K and coronary artery disease. We also validated the association in an independent population of 311 coronary artery disease patients and 494 controls. In the replication study, the p.R4810K genotypes were imputed from genome-wide genotyping data based on the 1000 Genomes Project. We used multivariate logistic regression analyses to adjust for well-known risk factors such as dyslipidemia and smoking habits. In the primary study population, the frequency of the minor variant allele was significantly higher in patients with coronary artery disease than in controls (2.04% vs. 0.98%), with an odds ratio of 2.11 (p = 0.017). Under a dominant model, after adjustment for risk factors, the association remained significant, with an odds ratio of 2.90 (95% confidence interval: 1.37-6.61; p = 0.005). In the replication study, the association was significant after adjustment for age and sex (odds ratio = 4.99; 95% confidence interval: 1.16-21.53; p = 0.031), although it did not reach statistical significance when further adjusted for risk factors (odds ratio = 3.82; 95% confidence interval: 0.87-16.77; p = 0.076). Conclusions The RNF213p.R4810K variant appears to be significantly associated with coronary artery disease in the Japanese population.	[Morimoto, Takaaki; Mineharu, Yohei; Takagi, Yasushi; Funaki, Takeshi; Miyamoto, Susumu] Kyoto Univ, Grad Sch Med, Dept Neurosurg, Kyoto, Japan; [Morimoto, Takaaki; Kabata, Risako; Cao, Yang; Kobayashi, Hatasu; Harada, Kouji H.; Koizumi, Akio] Kyoto Univ, Grad Sch Med, Dept Hlth & Environm Sci, Kyoto, Japan; [Ono, Koh; Kimura, Takeshi] Kyoto Univ, Grad Sch Med, Dept Cardiovasc Med, Kyoto, Japan; [Nakatochi, Masahiro] Nagoya Univ Hosp, Stat Anal Sect, Ctr Adv Med & Clin Res, Nagoya, Aichi, Japan; [Ichihara, Sahoko] Mie Univ, Grad Sch Reg Innovat Studies, Tsu, Mie, Japan; [Cao, Yang] St Marianna Univ, Dept Prevent Med, Sch Med, Kawasaki, Kanagawa, Japan; [Zhao, Lanying] Kyoto Univ, Grad Sch Med, Congenital Anomaly Res Ctr, Kyoto, Japan; [Takenaka, Katsunobu] Takayama Red Cross Hosp, Dept Neurosurg, Gifu, Japan; [Yokota, Mitsuhiro] Aichi Gakuin Univ, Sch Dent, Dept Genome Sci, Nagoya, Aichi, Japan; [Matsubara, Tatsuaki] Aichi Gakuin Univ, Sch Dent, Dept Internal Med, Nagoya, Aichi, Japan; [Yamamoto, Ken] Kurume Univ, Dept Med Biochem, Sch Med, Fukuoka, Japan; [Izawa, Hideo] Fujita Hlth Univ, Banbuntane Hotokukai Hosp, Dept Cardiol, Nagoya, Aichi, Japan	Kyoto University; Kyoto University; Kyoto University; Nagoya University; Mie University; Saint Marianna University; Kyoto University; Aichi Gakuin University; Aichi Gakuin University; Kurume University; Fujita Health University	Mineharu, Y (corresponding author), Kyoto Univ, Grad Sch Med, Dept Neurosurg, Kyoto, Japan.	mineharu@kuhp.kyoto-u.ac.jp	Nakatochi, Masahiro/Q-1247-2015; Kobayashi, Hatasu/R-8012-2019	Nakatochi, Masahiro/0000-0002-1838-4837; Kobayashi, Hatasu/0000-0002-5664-6869; Mineharu, Yohei/0000-0002-6346-3999; CAO, YANG/0000-0002-8510-8015	Ministry of Education, Culture, Sports, Science and Technology of Japan [25253047, 26293186, 15K19963, 15K19243, 24390169, 16H05250, 15K08290]; St. Luke Life Science Institute; Shimizu Foundation for Immunology and Neuroscience; Japan Brain Foundation; Fujiwara Foundation of Science; Scientific Research on Innovative Areas [16H06277]; Suzuken Memorial Foundation [14003]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); St. Luke Life Science Institute; Shimizu Foundation for Immunology and Neuroscience; Japan Brain Foundation; Fujiwara Foundation of Science; Scientific Research on Innovative Areas(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Suzuken Memorial Foundation	The primary study was supported by Grants-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan, including those for Scientific Research (A) to AK (25253047), Scientific Research (B) to KO (26293186), and Young Scientists (B) to YM (15K19963) and HK (15K19243), and grants from the St. Luke Life Science Institute to YM, the Shimizu Foundation for Immunology and Neuroscience to YM, the Japan Brain Foundation to YM, and the Fujiwara Foundation of Science to YM. The replication study was supported in part by Grants-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan, including those for Scientific Research (B) to MY (24390169, 16H05250), Scientific Research (C) to KY (15K08290), and Scientific Research on Innovative Areas to MN (16H06277), and grant from the Suzuken Memorial Foundation to MY (14003).	Asano H, 2010, DIABETOLOGIA, V53, P234, DOI 10.1007/s00125-009-1517-2; BABA S, 1994, CIRCULATION, V89, P109, DOI 10.1161/01.CIR.89.1.109; Cao Y, 2016, ENV HLTH PREV MED, V21; Cecchi AC, 2014, STROKE, V45, P3200, DOI 10.1161/STROKEAHA.114.006244; Celermajer DS, 2012, J AM COLL CARDIOL, V60, P1207, DOI 10.1016/j.jacc.2012.03.074; Delaneau O, 2013, NAT METHODS, V10, P5, DOI 10.1038/nmeth.2307; Ding D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135713; Do R, 2015, NATURE, V518, P102, DOI 10.1038/nature13917; Frazier L, 2005, J NURS SCHOLARSHIP, V37, P315, DOI 10.1111/j.1547-5069.2005.00055.x; Fukushima H, 2016, AM J MED GENET A, V170, P2453, DOI 10.1002/ajmg.a.37829; Guo DC, 2009, AM J HUM GENET, V84, P617, DOI 10.1016/j.ajhg.2009.04.007; Hamauchi S, 2015, BRAIN CIRC, V1, P88; Hamauchi S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163561; Health Labour and Welfare Statistic Association, 2014, J HEAL WELF STAT; Hitomi T, 2013, BIOCHEM BIOPH RES CO, V439, P419, DOI 10.1016/j.bbrc.2013.08.067; Hitomi T, 2013, BIOCHEM BIOPH RES CO, V438, P13, DOI 10.1016/j.bbrc.2013.07.004; Hosoda Y, 1997, CLIN NEUROL NEUROSUR, V99, pS203, DOI 10.1016/s0303-8467(97)00044-9; Ichihara S, 2013, CIRC-CARDIOVASC GENE, V6, P569, DOI 10.1161/CIRCGENETICS.111.000027; IKEDA E, 1991, STROKE, V22, P1358, DOI 10.1161/01.STR.22.11.1358; Jang MA, 2015, BMC MED GENET, V16, DOI 10.1186/s12881-015-0252-4; Jhun HJ, 2011, J KOREAN MED SCI, V26, P637, DOI 10.3346/jkms.2011.26.5.637; Kamada F, 2011, J HUM GENET, V56, P34, DOI 10.1038/jhg.2010.132; Kato N, 2015, NAT GENET, V47, P1282, DOI 10.1038/ng.3405; Kitamura A, 2008, J AM COLL CARDIOL, V52, P71, DOI 10.1016/j.jacc.2008.02.075; Kobayashi H, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.115.002146; Koizumi A, 2016, ENVIRON HEALTH PREV, V21, P55, DOI 10.1007/s12199-015-0498-7; Koizumi A, 2013, ENVIRON HEALTH PREV, V18, P121, DOI 10.1007/s12199-012-0299-1; Kotani Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep16161; Liu WY, 2012, NEUROL MED-CHIR, V52, P299, DOI 10.2176/nmc.52.299; Liu WY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022542; Marinou K, 2012, TRENDS ENDOCRIN MET, V23, P628, DOI 10.1016/j.tem.2012.06.001; Maruyama M, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000573; Mineharu Y, 2008, NEUROLOGY, V70, P2357, DOI 10.1212/01.wnl.0000291012.49986.f9; Mineharu Y, 2006, J NEUROL NEUROSUR PS, V77, P1025, DOI 10.1136/jnnp.2006.096040; Miyatake S, 2012, NEUROLOGY, V78, P803, DOI 10.1212/WNL.0b013e318249f71f; Miyawaki S, 2013, STROKE, V44, P2894, DOI 10.1161/STROKEAHA.113.002477; Morito D, 2014, SCI REP-UK, V4, DOI 10.1038/srep04442; Nakatochi M, 2011, DIABETES RES CLIN PR, V92, pE61, DOI 10.1016/j.diabres.2011.02.029; Nam TM, 2015, J KOREAN MED SCI, V30, P470, DOI 10.3346/jkms.2015.30.4.470; Ogihara T, 2009, HYPERTENS RES, V32, P3, DOI 10.1038/hr.2008.15; Ozaki K, 2015, J HUM GENET, V60, P1715; Saito I, 2000, INT J EPIDEMIOL, V29, P837, DOI 10.1093/ije/29.5.837; Scholz B, 2016, DEV CELL, V36, P79, DOI 10.1016/j.devcel.2015.12.015; Seino Y, 2010, J DIABETES INVEST, V1, P1, DOI 10.1111/j.2040-1124.2010.00005.x; SUZUKI J, 1969, ARCH NEUROL-CHICAGO, V20, P288, DOI 10.1001/archneur.1969.00480090076012; Takagi Y, 2007, NEUROL MED-CHIR, V47, P1, DOI 10.2176/nmc.47.1; Tanimura D, 2011, EUR J HUM GENET, V19, P262, DOI 10.1038/ejhg.2010.201; Teramoto T, 2007, J ATHEROSCLER THROMB, V14, P155, DOI 10.5551/jat.E537; VERSCHUREN WMM, 1995, JAMA-J AM MED ASSOC, V274, P131, DOI 10.1001/jama.274.2.131; Wu Y, 2014, HUM MOL GENET, V23, P1108, DOI 10.1093/hmg/ddt488; WU Z, 2012, PLOS ONE, V7; Yamada Y, 2002, NEW ENGL J MED, V347, P1916, DOI 10.1056/NEJMoa021445; YAMASHITA M, 1983, STROKE, V14, P50, DOI 10.1161/01.STR.14.1.50; Yang GH, 2008, LANCET, V372, P1697, DOI 10.1016/S0140-6736(08)61366-5	54	37	38	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2017	12	4							e0175649	10.1371/journal.pone.0175649	http://dx.doi.org/10.1371/journal.pone.0175649			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KD	28414759	gold, Green Submitted, Green Published			2022-12-27	WOS:000399874800043
J	Wang, LM; Shen, H; Feng, B; Zhu, D; Yu, L; Tian, X; Ren, C; Gao, C; Li, XM; Ma, D; Hu, Z; Wang, H				Wang, Liming; Shen, Hui; Feng, Bei; Zhu, Da; Yu, Lan; Tian, Xun; Ren, Ci; Gao, Chun; Li, Xiaomin; Ma, Ding; Hu, Zheng; Wang, Hui			Reduction in the copy number and expression level of the recurrent human papillomavirus integration gene fragile histidine triad (FHIT) predicts the transition of cervical lesions	PLOS ONE			English	Article							CANCER; TYPE-16; CARCINOMA; MUTATION; GENOME	Cervical cancer is the second most common cancer and the third leading cause of cancer death in females worldwide, especially in developing countries. High risk human papillomavirus (HR-HPV) infection causes cervical cancer and precancerous cervical intraepithelial neoplasia (CIN). Integration of the HR-HPV genome into the host chromatin is an important step in cervical carcinogenesis. The detection of integrated papillomavirus sequences-PCR (DIPS-PCR) allowed us to explore HPV integration in the human genome and to determine the pattern of this integration. We performed DIPS-PCR for 4 cell lines including 3 cervical cancer cell lines and 40 tissue samples. Overall, 32 HR-HPV integration loci were detected in the clinical samples and the HeLa and SiHa cell lines. Among all the integration loci, we identified three recurrent integration loci: 3p14.2 (3 samples), 13q22.1 (2 samples and a SiHa cell line) and 8q24 (1 sample and a HeLa cell line). To further explore the effect of HR-HPV integration in the 3p14.2 locus, we used fluorescence in situ hybridization (FISH) to determine the copy number of the 3p14.2 locus and immunohistochemistry (IHC) to determine the protein expression levels of the related FHIT gene in the clinical samples. Both the 3p14.2 locus copy number and FHIT protein expression levels showed significant decreases when CIN transitioned to cervical cancer. HPV copy number was also evaluated in these clinical samples, and the copy number of HPV increased significantly between CIN and cervical cancer samples. Finally, we employed receiver operating characteristic curve (ROC curve) analysis to evaluate the potential of all these indexes in distinguishing CIN and cervical cancer, and the HPV copy number, FHIT copy number and FHIT protein expression levels have good diagnostic efficiencies.	[Wang, Liming; Shen, Hui; Feng, Bei; Yu, Lan; Tian, Xun; Ren, Ci; Gao, Chun; Li, Xiaomin] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Minst Educ,Key Lab Canc Invas & Metastasis, Wuhan, Hunan, Peoples R China; [Zhu, Da; Ma, Ding; Hu, Zheng; Wang, Hui] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Obstet & Gynecol, Wuhan, Hunan, Peoples R China; [Hu, Zheng] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Obstet & Gynecol, Guangzhou, Guangdong, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Sun Yat Sen University	Ma, D; Hu, Z; Wang, H (corresponding author), Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Obstet & Gynecol, Wuhan, Hunan, Peoples R China.; Hu, Z (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Dept Obstet & Gynecol, Guangzhou, Guangdong, Peoples R China.	dma@tjh.tjmu.edu.cn; 18627803527@163.com; huit71@sohu.com			National Basic Research Program of China (973 Program) [2013C6911304, 2015C6553903]; Nature and Science Foundation of China [81372805, 81402158]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); Nature and Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by funds from the National Basic Research Program of China (973 Program, No. 2013C6911304 to Hui Wang and No. 2015C6553903 to Ding Ma), Nature and Science Foundation of China (81372805, 81402158).	Adey A, 2013, NATURE, V500, P207, DOI 10.1038/nature12064; Danaei G, 2005, LANCET, V366, P1784, DOI 10.1016/S0140-6736(05)67725-2; Gao G, 2014, GENE CHROMOSOME CANC, V53, P392, DOI 10.1002/gcc.22150; Hu Z, 2015, NAT GENET, V47, P158, DOI 10.1038/ng.3178; Kapitanovic S, 2014, EXP MOL PATHOL, V96, P92, DOI 10.1016/j.yexmp.2013.12.005; Ki Kyung-Do, 2008, J Gynecol Oncol, V19, P117, DOI 10.3802/jgo.2008.19.2.117; MUNGER K, 1989, J VIROL, V63, P4417; Neyaz MK, 2010, MOL CELL BIOCHEM, V335, P53, DOI 10.1007/s11010-009-0240-0; Ojesina AI, 2014, NATURE, V506, P371, DOI 10.1038/nature12881; Pichiorri F, 2009, J BIOL CHEM, V284, P1040, DOI 10.1074/jbc.M806638200; Ramp U, 2002, J PATHOL, V196, P430, DOI 10.1002/path.1062; Roychowdhury A, 2016, BIOCHIM BIOPHYS ACTA, V1861, P2899; Schmitz M, 2012, INT J CANCER, V131, pE593, DOI 10.1002/ijc.27433; Terry G, 2004, BRIT J CANCER, V91, P2056, DOI 10.1038/sj.bjc.6602253; Virmani AK, 2001, CLIN CANCER RES, V7, P584; VONKNEBELDOEBERITZ M, 1994, J VIROL, V68, P2811, DOI 10.1128/JVI.68.5.2811-2821.1994; Weiske J, 2007, P NATL ACAD SCI USA, V104, P20344, DOI 10.1073/pnas.0703664105; Wong YF, 1997, CANCER LETT, V115, P161, DOI 10.1016/S0304-3835(97)04723-X; Yang H, 2016, ARCH VIROL, V161, P449, DOI 10.1007/s00705-015-2673-y; Yoshino K, 1998, INT J CANCER, V76, P176, DOI 10.1002/(SICI)1097-0215(19980413)76:2<176::AID-IJC2>3.0.CO;2-U; Yu Y, 2015, ONCOL LETT, V10, P392, DOI 10.3892/ol.2015.3213	21	3	6	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2017	12	4							e0175520	10.1371/journal.pone.0175520	http://dx.doi.org/10.1371/journal.pone.0175520			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KD	28414756	Green Published, Green Submitted, gold			2022-12-27	WOS:000399874800032
J	O'Halloran, DM				O'Halloran, Damien M.			phylo-node: A molecular phylogenetic toolkit using Node.js	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; BIOLOGICAL DATA VISUALIZATION; MAXIMUM-LIKELIHOOD; 1,000-DOLLAR GENOME; HIGH-THROUGHPUT; 1ST REPORT; GENERATION; MODELS; ALGORITHM; INFERENCE	Background Node.js is an open-source and cross-platform environment that provides a JavaScript code-base for back-end server-side applications. JavaScript has been used to develop very fast and user-friendly front-end tools for bioinformatic and phylogenetic analyses. However, no such toolkits are available using Node. js to conduct comprehensive molecular phylogenetic analysis. Results To address this problem, I have developed, phylo-node, which was developed using Node. js and provides a stable and scalable toolkit that allows the user to perform diverse molecular and phylogenetic tasks. phylo-node can execute the analysis and process the resulting outputs from a suite of software options that provides tools for read processing and genome alignment, sequence retrieval, multiple sequence alignment, primer design, evolutionary modeling, and phylogeny reconstruction. Furthermore, phylo-node enables the user to deploy server dependent applications, and also provides simple integration and interoperation with other Node modules and languages using Node inheritance patterns, and a customized piping module to support the production of diverse pipelines. Conclusions phylo-node is open-source and freely available to all users without sign-up or login requirements. All source code and user guidelines are openly available at the GitHub repository: https://github.com/dohalloran/phylo-node.	[O'Halloran, Damien M.] George Washington Univ, Dept Biol Sci, Washington, DC 20052 USA; [O'Halloran, Damien M.] George Washington Univ, Inst Neurosci, Washington, DC 20052 USA	George Washington University; George Washington University	O'Halloran, DM (corresponding author), George Washington Univ, Dept Biol Sci, Washington, DC 20052 USA.; O'Halloran, DM (corresponding author), George Washington Univ, Inst Neurosci, Washington, DC 20052 USA.	damienoh@gwu.edu			George Washington University (GWU) Columbian College of Arts and Sciences, GWU Office of the Vice President for Research; GWU Department of Biological Sciences	George Washington University (GWU) Columbian College of Arts and Sciences, GWU Office of the Vice President for Research; GWU Department of Biological Sciences	This work was supported by the George Washington University (GWU) Columbian College of Arts and Sciences, GWU Office of the Vice President for Research, and the GWU Department of Biological Sciences.	Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Buels R, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0924-1; Conesa A, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0881-8; Cui Y, 2016, BIOINFORMATICS, V32, P1740, DOI 10.1093/bioinformatics/btw041; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; Delport W, 2010, BIOINFORMATICS, V26, P2455, DOI 10.1093/bioinformatics/btq429; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Franz M, 2016, BIOINFORMATICS, V32, P309, DOI 10.1093/bioinformatics/btv557; Garcia Leyla, 2014, F1000Res, V3, P47, DOI 10.12688/f1000research.3-47.v1; Gomez John, 2014, F1000Res, V3, P52, DOI 10.12688/f1000research.3-52.v1; Gomez J, 2013, BIOINFORMATICS, V29, P1103, DOI 10.1093/bioinformatics/btt100; Guesmi-Mzoughi I, 2016, J NEMATOL, V48, P136; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hayden EC, 2014, NATURE, V507, P294, DOI 10.1038/507294a; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Huerta-Cepas J, 2016, MOL BIOL EVOL, V33, P1635, DOI 10.1093/molbev/msw046; Kalderimis Alexis, 2014, F1000Res, V3, P51, DOI 10.12688/f1000research.3-51.v1; Kim J, 2014, BIOINFORMATICS, V30, P2826, DOI 10.1093/bioinformatics/btu377; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lassmann T, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-298; Mardis ER, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-112; Massingham T, 2005, GENETICS, V169, P1753, DOI 10.1534/genetics.104.032144; Matassi G, 2017, BMC EVOL BIOL, V17, DOI 10.1186/s12862-016-0850-6; Mazza G, 2016, ZOOTAXA, V4067, P577, DOI 10.11646/zootaxa.4067.5.4; Page Martin, 2016, BMC Res Notes, V9, P130, DOI 10.1186/s13104-016-1938-1; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rozen S, 2000, Methods Mol Biol, V132, P365; Salavert F., 2016, BIOINFORMATICS; Salazar Gustavo A, 2014, F1000Res, V3, P50, DOI 10.12688/f1000research.3-50.v1; Service RF, 2006, SCIENCE, V311, P1544, DOI 10.1126/science.311.5767.1544; Shaffer C, 2007, NAT BIOTECHNOL, V25, P149, DOI 10.1038/nbt0207-149; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Skinner ME, 2009, GENOME RES, V19, P1630, DOI 10.1101/gr.094607.109; Stajich JE, 2002, GENOME RES, V12, P1611, DOI 10.1101/gr.361602; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; Thompson JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018093; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Vanderkam D, 2016, BIOINFORMATICS; Villaveces Jose M, 2014, F1000Res, V3, P44, DOI 10.12688/f1000research.3-44.v1; Villaveces Jose M, 2014, F1000Res, V3, P43, DOI 10.12688/f1000research.3-43.v1; Wade N, 2006, QUEST 1000 HUMAN GEN; Yachdav G, 2015, ELIFE, V4, DOI 10.7554/eLife.07009; Yachdav Guy, 2014, F1000Res, V3, P48, DOI 10.12688/f1000research.3-48.v1; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; You FM, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-253; Zhang CJ, 2013, BIOINFORMATICS, V29, P645, DOI 10.1093/bioinformatics/btt009; Zou Q, 2016, IEEE INT C BIOINFORM, P53, DOI 10.1109/BIBM.2016.7822492	53	2	2	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2017	12	4							e0175480	10.1371/journal.pone.0175480	http://dx.doi.org/10.1371/journal.pone.0175480			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0MD	28410421	Green Submitted, Green Published, gold			2022-12-27	WOS:000399955600022
J	Park, S; Chiu, W; Won, D				Park, Sanghyun; Chiu, Weisheng; Won, Doyeon			Effects of physical education, extracurricular sports activities, and leisure satisfaction on adolescent aggressive behavior: A latent growth modeling approach	PLOS ONE			English	Article							OVERT AGGRESSION; SEX-DIFFERENCES; PEER VICTIMIZATION; GENDER-DIFFERENCES; MISSING DATA; SCHOOL; YOUTH; FRIENDSHIP; VIOLENCE; CURRICULUM	The present study aimed to investigate the longitudinal influence of physical education classes, extracurricular sports activities, and leisure satisfaction on aggressive behavior among South Korean adolescents. Data were drawn from the Korea Youth Panel Survey. We used latent growth curve modeling to explain the growth trajectory of adolescent aggressive behaviors and a multi-group analysis to investigate gender differences in aggressive behavior. The results indicated that adolescents' aggressive behavior significantly changed with age. There were significant gender-based differences in the level of and changes in aggressive behavior over time. Both extracurricular sports activities and leisure satisfaction had significant influences on the changes in adolescents' aggressive behavior with age, whereas physical education classes did not.	[Park, Sanghyun] Yonsei Univ, Dept Sport Ind Studies, Seoul, South Korea; [Chiu, Weisheng] Keimyung Univ, Dept Sport & Leisure Studies, Daegu, South Korea; [Won, Doyeon] Liverpool John Moores Univ, Sch Sport Studies Leisure & Nutr, Liverpool, Merseyside, England	Yonsei University; Keimyung University; Liverpool John Moores University	Won, D (corresponding author), Liverpool John Moores Univ, Sch Sport Studies Leisure & Nutr, Liverpool, Merseyside, England.	d.won@ijmu.ac.uk	Won, Doyeon/M-8245-2016; Chiu, Weisheng/D-3512-2018	Won, Doyeon/0000-0003-4336-9767; Chiu, Weisheng/0000-0002-8090-5082				Adams RE, 2005, INT J BEHAV DEV, V29, P139, DOI 10.1080/01650250444000397; Arbuckle JL., 1996, ADVANCED STRUCTURAL; Archer J, 2004, REV GEN PSYCHOL, V8, P291, DOI 10.1037/1089-2680.8.4.291; Bailey R, 2006, J SCHOOL HEALTH, V76, P397, DOI 10.1111/j.1746-1561.2006.00132.x; Belknap J., 2014, THE INVISIBLE WOMAN, V4th; BJORKQVIST K, 1994, SEX ROLES, V30, P177, DOI 10.1007/BF01420988; Bollen KA, 2006, WILEY SER PROBAB ST, P1; Bollmer JM, 2005, J INTERPERS VIOLENCE, V20, P701, DOI 10.1177/0886260504272897; BOULTON MJ, 1992, BRIT J EDUC PSYCHOL, V62, P73, DOI 10.1111/j.2044-8279.1992.tb01000.x; CALLAHAN CM, 1992, JAMA-J AM MED ASSOC, V267, P3038, DOI 10.1001/jama.267.22.3038; Coakley J., 1999, INSIDE SPORTS; Coie JD, 1998, HAND CHILD PSYCHOL, V3; COSTIN SE, 1992, DEV PSYCHOL, V28, P941, DOI 10.1037/0012-1649.28.5.941; Crick NR, 2006, J APPL DEV PSYCHOL, V27, P254, DOI 10.1016/j.appdev.2006.02.006; Dishion T.J., 1997, SOCIAL DEV, V6; Duncan T. E., 2013, INTRO LATENT VARIABL, DOI DOI 10.4324/9780203879962; Duncan TE, 2004, BEHAV THER, V35, P333, DOI 10.1016/S0005-7894(04)80042-X; Eccles JS, 2003, J SOC ISSUES, V59, P865, DOI 10.1046/j.0022-4537.2003.00095.x; Estevez E, 2005, ADOLESCENCE, V40, P183; Ewing ME, 2002, SUNY SER SPORT, P31; Farrell AD, 2015, J PRIM PREV, V36, P227, DOI 10.1007/s10935-015-0391-6; Finkelhor D, 2014, CHILD ABUSE NEGLECT, V38, P677, DOI 10.1016/j.chiabu.2014.01.010; Foundation for Preventing Youth Violence, 2012, KOR SCH VIOL SURV; Gruber J. J., 1986, EFFECTS PHYS ACTIVIT, P30; Hardy SA, 2009, INT J CLIN HLTH PSYC, V9, P51; Harvey J, 2005, UNPUBLISHED REPORT S; Hong S, 2003, EDUC PSYCHOL MEAS, V63, P636, DOI 10.1177/0013164403251332; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Jarvie G, 2003, SPORT RACISM AND ETH; Koo JE, 2014, J EXERC REHABIL, V10, P111, DOI 10.12965/jer.140093; Lee KC, 2014, PHYS EDUC SPORT PEDA, V19, P522, DOI 10.1080/17408989.2014.915299; Little R. J. A., 2002, STAT ANAL; Luck D., 1970, MARKETING RES; Mahoney JL, 2000, J ADOLESCENCE, V23, P113, DOI 10.1006/jado.2000.0302; McArdle JJ, 1996, ADVANCED STRUCTURAL; Misra R., 2000, AM J HLTH STUDIES, V16, P41, DOI DOI 10.4236/CE.2015.61007; Moretti MM, 2001, BEHAV SCI LAW, V19, P109, DOI 10.1002/bsl.429; Newman DA, 2003, ORGAN RES METHODS, V6, P328, DOI 10.1177/1094428103254673; Nichols TR, 2006, J APPL DEV PSYCHOL, V27, P78, DOI 10.1016/j.appdev.2005.12.006; Page J, 2015, SCH VIOLENCE CORRELA, P1; Paquette JA, 1999, MERRILL PALMER QUART, V45, P242; Parke R.D., 1983, HDB CHILD PSYCHOL, P547, DOI DOI 10.1002/9780470147658; PLECK JH, 1994, SEX ROLES, V30, P481, DOI 10.1007/BF01420798; Proctor CL, 2009, J HAPPINESS STUD, V10, P583, DOI 10.1007/s10902-008-9110-9; Rahm E., 2000, IEEE DATA ENG B, V23, P3; Ratey JJ, SPARK REVOLUTIONARY; Schlomer GL, 2010, J COUNS PSYCHOL, V57, P1, DOI 10.1037/a0018082; Schwartzman N, SKOREA SCH VIOLENCE; Smith RL, 2010, SOC DEV, V19, P243, DOI 10.1111/j.1467-9507.2009.00541.x; Stanton R, 2014, NURSING-RES REV, V4, P45, DOI 10.2147/NRR.S41956; Sugai G, 2000, J EMOT BEHAV DISORD, V8, P94, DOI 10.1177/106342660000800205; Tonts M, 2005, J RURAL STUD, V21, P137, DOI 10.1016/j.jrurstud.2005.03.001; Valois R.F., 2006, J CHILD FAM STUD, V15, P695, DOI [10.1007/s10826-006-9043-z, DOI 10.1007/S10826-006-9043-Z]; Zirpoli T. J., 2007, BEHAV MANAGEMENT APP	54	28	28	6	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2017	12	4							e0174674	10.1371/journal.pone.0174674	http://dx.doi.org/10.1371/journal.pone.0174674			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET0MD	28410365	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000399955600006
J	Kenigsberg, S; Lima, PDA; Maghen, L; Wyse, BA; Lackan, C; Cheung, ANY; Tsang, BK; Librach, CL				Kenigsberg, Shlomit; Lima, Patricia D. A.; Maghen, Leila; Wyse, Brandon A.; Lackan, Chantal; Cheung, Annie N. Y.; Tsang, Benjamin K.; Librach, Clifford L.			The elusive MAESTRO gene: Its human reproductive tissue-specific expression pattern	PLOS ONE			English	Article							OOCYTE-COMPLEXES; GRANULOSA-CELLS; MESSENGER-RNA; CUMULUS CELLS; PROFILES; PROTEINS; RESOURCE; INSIGHTS; OVARY; MRO	The encoded transcript of the Maestro D Male-specific Transcription in the developing Reproductive Organs (MRO) gene exhibits sexual dimorphic expression during murine gonadal development. The gene has no homology to any known gene and its expression pattern, protein function or structure are still unknown. Previously, studying gene expression in human ovarian cumulus cells, we found increased expression of MRO in lean-type Polycystic Ovarian Syndrome (PCOS) subjects, as compared to controls. In this study, we examined the MRO splice variants and protein expression pattern in various human tissues and cells. We found a differential expression pattern of the MRO 5'-UTR region in luteinized granulosacumulus cells and in testicular tissues as compared to non-gonadal tissues. Our study also shows a punctate nuclear expression pattern and disperse cytoplasmic expression pattern of the MRO protein in human granulosa-cumulus cells and in testicular germ cells, which was later validated by western blotting. The tentative and unique features of the protein hampered our efforts to gain more insight about this elusive protein. A better understanding of the tissue- specific MRO isoforms expression patterns and the unique structure of the protein may provide important insights into the function of this gene and possibly to the pathophysiology of PCOS.	[Kenigsberg, Shlomit; Maghen, Leila; Wyse, Brandon A.; Lackan, Chantal; Librach, Clifford L.] CReATe Fertil Ctr, Toronto, ON, Canada; [Lima, Patricia D. A.; Tsang, Benjamin K.] Univ Ottawa, Dept Obstet & Gynecol, Ottawa, ON, Canada; [Cheung, Annie N. Y.] Univ Hong Kong, Dept Pathol, Hong Kong, Hong Kong, Peoples R China; [Tsang, Benjamin K.] Macau Univ Sci & Technol, State Key Lab Qual Res Chinese Med, Macau Inst Appl Res Med & Hlth, Macau, Peoples R China; [Tsang, Benjamin K.] Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON, Canada; [Tsang, Benjamin K.] Univ Ottawa, Interdisciplinary Sch Hlth Sci, Ottawa, ON, Canada; [Tsang, Benjamin K.] Ottawa Hosp, Res Inst, Chron Dis Program, Ottawa, ON, Canada; [Librach, Clifford L.] Univ Toronto, Dept Obstet & Gynecol, Toronto, ON, Canada; [Librach, Clifford L.] Womens Coll Hosp, Dept Gynecol, Toronto, ON, Canada	University of Ottawa; University of Hong Kong; Macau University of Science & Technology; University of Ottawa; University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute; University of Toronto; University of Toronto; University Toronto Affiliates; Womens College Hospital	Kenigsberg, S (corresponding author), CReATe Fertil Ctr, Toronto, ON, Canada.; Tsang, BK (corresponding author), Univ Ottawa, Dept Obstet & Gynecol, Ottawa, ON, Canada.; Tsang, BK (corresponding author), Macau Univ Sci & Technol, State Key Lab Qual Res Chinese Med, Macau Inst Appl Res Med & Hlth, Macau, Peoples R China.; Tsang, BK (corresponding author), Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON, Canada.; Tsang, BK (corresponding author), Univ Ottawa, Interdisciplinary Sch Hlth Sci, Ottawa, ON, Canada.; Tsang, BK (corresponding author), Ottawa Hosp, Res Inst, Chron Dis Program, Ottawa, ON, Canada.	shlomit.kenig@gmail.com; btsang@ohri.ca	; Cheung, Annie Nga Yin/C-4231-2009	Wyse, Brandon/0000-0001-9266-1962; Tsang, Benjamin K./0000-0003-1213-3946; Cheung, Annie Nga Yin/0000-0002-1584-7568	Canadian Institute of Health Research [MOP 119381, MOP-119381]; CReATe Program Inc.; CIHR-QTNPR Postdoctoral Fellowship	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); CReATe Program Inc.; CIHR-QTNPR Postdoctoral Fellowship	This work was supported by grants from the Canadian Institute of Health Research (MOP 119381). The study was funded by CReATe Program Inc., and in part by grants from the Canadian Institute of Health Research (MOP-119381). Patricia Daniele Azevedo Lima (PDAL) is a recipient of a CIHR-QTNPR Postdoctoral Fellowship. CReATe Program Inc. provided support in the form of salaries for SK, CL, BAW and research materials. CReATe Program Inc. is part of the CReATe Fertility Centre, a private reproductive health care facility that commits a significant part of its annual earnings towards research in human reproduction. The principal investigator of this study, CLL, is the sole owner of CReATe Program Inc. and is affiliated with the University of Toronto. The specific roles of this author are articulated in the "author contributions" section of the manuscript, and include roles in study design and review of the manuscript.	Adams J, 2016, J CLIN ENDOCR METAB, V101, P3459, DOI 10.1210/jc.2015-4275; Aken BL, 2016, DATABASE-OXFORD, DOI 10.1093/database/baw093; ANDRADE MA, 1995, NAT GENET, V11, P115, DOI 10.1038/ng1095-115; Brown GR, 2015, NUCLEIC ACIDS RES, V43, pD36, DOI 10.1093/nar/gku1055; Bulun SE, 2004, SEMIN REPROD MED, V22, P5; Chang J, 2004, FERTIL STERIL, V81, P19, DOI 10.1016/j.fertnstert.2003.10.004; Chen M, 2009, NAT REV MOL CELL BIO, V10, P741, DOI 10.1038/nrm2777; Chew SL, 1997, TRENDS ENDOCRIN MET, V8, P405, DOI 10.1016/S1043-2760(97)00167-7; Chilvers RA, 2012, J ASSIST REPROD GEN, V29, P547, DOI 10.1007/s10815-012-9739-5; Chiu PCN, 2007, J BIOL CHEM, V282, P5378, DOI 10.1074/jbc.M607482200; Cingolani G, 1999, NATURE, V399, P221, DOI 10.1038/20367; Ebner T, 2011, J TURK-GER GYNECOL A, V12, P135, DOI 10.5152/jtgga.2011.32; Fan H, 2009, SCIENCE, V324, P1; Faustino NA, 2003, GENE DEV, V17, P419, DOI 10.1101/gad.1048803; Ferrero H, 2012, HUM REPROD, V27, P1781, DOI 10.1093/humrep/des096; Galea CA, 2008, BIOCHEMISTRY-US, V47, P7598, DOI 10.1021/bi8006803; George JW, 2011, BIOL REPROD, V84, P7, DOI 10.1095/biolreprod.110.085043; Gray KA, 2013, NUCLEIC ACIDS RES, V41, pD545, DOI 10.1093/nar/gks1066; Hernandez-Gonzalez I, 2006, MOL ENDOCRINOL, V20, P1300, DOI 10.1210/me.2005-0420; Hsu WL, 2011, PAC S BIOCOMPUT, P116; Hsueh AJW, 2015, ENDOCR REV, V36, P1, DOI 10.1210/er.2014-1020; Huang QL, 2009, GENETICA, V136, P127, DOI 10.1007/s10709-008-9323-1; Jacox E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012274; Kenigsberg S, 2009, MOL HUM REPROD, V15, P89, DOI 10.1093/molehr/gan082; Laszczynska M, 2008, HISTOL HISTOPATHOL, V23, P219, DOI 10.14670/HH-23.219; Lipowsky G, 2000, EMBO J, V19, P4362, DOI 10.1093/emboj/19.16.4362; Mitchell A, 2015, NUCLEIC ACIDS RES, V43, pD213, DOI 10.1093/nar/gku1243; Nugent T, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-169; Oldfield CJ, 2014, ANNU REV BIOCHEM, V83, P553, DOI 10.1146/annurev-biochem-072711-164947; Pinos T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013844; Plant PJ, 2009, J APPL PHYSIOL, V107, P224, DOI 10.1152/japplphysiol.90932.2008; RADOVICK S, 1994, HORM BEHAV, V28, P520, DOI 10.1006/hbeh.1994.1050; Rozen S, 2000, Methods Mol Biol, V132, P365; Smith L, 2003, DEV DYNAM, V227, P600, DOI 10.1002/dvdy.10342; Smith L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004091; Sun H, 2011, NUCLEIC ACIDS RES, V39, P190, DOI 10.1093/nar/gkq775; Tazi J, 2009, BBA-MOL BASIS DIS, V1792, P14, DOI 10.1016/j.bbadis.2008.09.017; Wright PE, 2015, NAT REV MOL CELL BIO, V16, P18, DOI 10.1038/nrm3920; Zhao H, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-37	40	3	3	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2017	12	4							e0174873	10.1371/journal.pone.0174873	http://dx.doi.org/10.1371/journal.pone.0174873			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0MB	28406912	gold, Green Submitted, Green Published			2022-12-27	WOS:000399955400021
J	Lee, K; Lee, S; Bang, H; Choi, JK				Lee, Kibaick; Lee, Seulkee; Bang, Hyoeun; Choi, Jung Kyoon			Predictive long-range allele-specific mapping of regulatory variants and target transcripts	PLOS ONE			English	Article							CHROMATIN STATES; ANALYSIS TOOLKIT; GENETIC-CONTROL; NATALIZUMAB; DISCOVERY; FRAMEWORK; BINDING; GWAS	Genome-wide association studies (GWASs) have identified a large number of noncoding associations, calling for systematic mapping to causal regulatory variants and their distal target genes. A widely used method, quantitative trait loci (QTL) mapping for chromatin or expression traits, suffers from sample-to-sample experimental variation and trans-acting or environmental effects. Instead, alleles at heterozygous loci can be compared within a sample, thereby controlling for those confounding factors. Here we introduce a method for chromatin structure-based allele-specific pairing of regulatory variants and target transcripts. With phased genotypes, much of allele-specific expression could be explained by paired allelic cis-regulation across a long range. This approach showed approximately two times greater sensitivity than QTL mapping. There are cases in which allele imbalance cannot be tested because heterozygotes are not available among reference samples. Therefore, we employed a machine learning method to predict missing positive cases based on various features shared by observed allele-specific pairs. We showed that only 10 reference samples are sufficient to achieve high prediction accuracy with a low sampling variation. In conclusion, our method enables highly sensitive fine mapping and target identification for traitassociated variants based on a small number of reference samples.	[Lee, Kibaick; Bang, Hyoeun; Choi, Jung Kyoon] Korea Adv Inst Sci & Technol, Dept Bio & Brain Engn, Daejeon, South Korea; [Lee, Seulkee] Korea Adv Inst Sci & Technol, Grad Sch Med Sci & Engn, Daejeon, South Korea	Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST)	Choi, JK (corresponding author), Korea Adv Inst Sci & Technol, Dept Bio & Brain Engn, Daejeon, South Korea.	jungkyoon@kaist.ac.kr		lee, seulkee/0000-0002-5551-4178	Korea Healthcare Technology RD Project; Ministry for Health & Welfare Affairs, Republic of Korea [HI13C0715]; KAIST Future Systems Healthcare Project; Ministry of Science, ICT and Future Planning [2013M3A9C4078139]	Korea Healthcare Technology RD Project; Ministry for Health & Welfare Affairs, Republic of Korea; KAIST Future Systems Healthcare Project; Ministry of Science, ICT and Future Planning(Ministry of Science, ICT & Future Planning, Republic of Korea)	This study was supported by a grant from the Korea Healthcare Technology R&D Project, Ministry for Health & Welfare Affairs, Republic of Korea (HI13C0715), by the KAIST Future Systems Healthcare Project, and by the Ministry of Science, ICT and Future Planning [2013M3A9C4078139].	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 2001, MACH LEARN, V45, P5; Claussnitzer M, 2015, NEW ENGL J MED; Conde L, 2013, AM J HUM GENET, V92, P126, DOI 10.1016/j.ajhg.2012.11.009; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; Degner JF, 2012, NATURE, V482, P390, DOI 10.1038/nature10808; del Rosario RCH, 2015, NAT METHODS, V12, P458, DOI [10.1038/NMETH.3326, 10.1038/nmeth.3326]; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Farh KKH, 2015, NATURE, V518, P337, DOI 10.1038/nature13835; Fisher R. A, 1925, STAT METHODS RES WOR, V1, DOI DOI 10.1111/J.2397-2335.1926.TB01837.X; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Ghosh S, 2003, NEW ENGL J MED, V348, P24, DOI 10.1056/NEJMoa020732; Grant CE, 2011, BIOINFORMATICS, V27, P1017, DOI 10.1093/bioinformatics/btr064; Grubert F, 2015, CELL, V162, P1051, DOI 10.1016/j.cell.2015.07.048; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Jin FL, 2013, NATURE, V503, P290, DOI 10.1038/nature12644; Kasowski M, 2013, SCIENCE, V342, P750, DOI 10.1126/science.1242510; Katagiri K, 2011, IMMUNITY, V34, P24, DOI 10.1016/j.immuni.2010.12.010; Kilpinen H, 2013, SCIENCE, V342, P744, DOI 10.1126/science.1242463; Lappalainen T, 2013, NATURE, V501, P506, DOI 10.1038/nature12531; Lee K, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003229; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McVicker G, 2013, SCIENCE, V342, P747, DOI 10.1126/science.1242429; Miller DH, 2003, NEW ENGL J MED, V348, P15, DOI 10.1056/NEJMoa020696; Montgomery SB, 2010, NATURE, V464, P773, DOI 10.1038/nature08903; Pastinen T, 2010, NAT REV GENET, V11, P533, DOI 10.1038/nrg2815; Pickrell JK, 2010, NATURE, V464, P768, DOI 10.1038/nature08872; Rosenbloom KR, 2015, NUCLEIC ACIDS RES, V43, pD670, DOI 10.1093/nar/gku1177; Rosenbloom KR, 2013, NUCLEIC ACIDS RES, V41, pD56, DOI 10.1093/nar/gks1172; Sanyal A, 2012, NATURE, V489, P109, DOI 10.1038/nature11279; Smemo S, 2014, NATURE, V507, P371, DOI 10.1038/nature13138; Tehranchi AK, 2016, CELL, V165, P730, DOI 10.1016/j.cell.2016.03.041; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Wang J, 2013, NUCLEIC ACIDS RES, V41, pW77, DOI 10.1093/nar/gkt439; Waszak SM, 2015, CELL, V162, P1039, DOI 10.1016/j.cell.2015.08.001; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229	43	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2017	12	4							e0175768	10.1371/journal.pone.0175768	http://dx.doi.org/10.1371/journal.pone.0175768			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0MB	28406955	Green Published, Green Submitted, gold			2022-12-27	WOS:000399955400096
J	Zaghloul, N; Patel, H; Ahmed, MN				Zaghloul, Nahla; Patel, Hardik; Ahmed, Mohamed Nagy			A model of Periventricular Leukomalacia (PVL) in neonate mice with histopathological and neurodevelopmental outcomes mimicking human PVL in neonates	PLOS ONE			English	Article							ISCHEMIC BRAIN-DAMAGE; WHITE-MATTER INJURY; HYPOXIA-ISCHEMIA; OLIGODENDROGLIAL PRECURSORS; EXCITOTOXIC LESIONS; OXIDATIVE STRESS; NERVOUS-SYSTEM; IN-VITRO; RAT; DEATH	Periventricular leukomalacia (PVL), a brain injury affecting premature infants is commonly associated with cerebral palsy. PVL results from hypoxia-ischemia (HI) with or without infection and is characterized by white matter necrotic lesions, hypomyelination, microglial activation, astrogliosis, and neuronal death. It is important to study a PVL mouse model that mimics human PVL in symptomatology, anatomic and molecular basis. In our neonate mice model, bilateral carotid arteries were temporary ligated at P5 followed by hypoxic exposure (FiO(2) of 8% for 20 min.). At P5 in mice, the white matter is more vulnerable to HI injury than the grey matter. In our PVL model, mice suffer from significant hind limb paresis, incoordination and feeding difficulties. Histologically they present with ventriculomegally, white matter loss, microglial activation and neuronal apoptosis. HI injury increases proinflammtory cytokines, activates NF-kB, activates microglia and causes nitrative stress. All these inflammatory mediators lead to oligodendroglial injury and white matter loss. Neurobehavioral analysis in the PVL mice model at P60 showed that the HI group had a significant decrease in hind limb strength, worsening rotarod testing and worsening performance in the open field test. This new PVL model has great advantages far beyond just mimicking human PVL in clinical features and histopathology. Long term survival, the development of cerebral palsy and the ability of using this model in transgenic animals will increase our understanding of the mechanistic pathways underlying PVL and defining specific targets for the development of suitable therapeutics.	[Zaghloul, Nahla; Ahmed, Mohamed Nagy] Cohen Childrens Med Ctr New York, Dept Pediat, Div Neonatol, New Hyde Pk, NY USA; [Zaghloul, Nahla; Patel, Hardik; Ahmed, Mohamed Nagy] Feinstein Inst Med Res, Manhasset, NY USA	Northwell Health; North Shore University Hospital; Steven & Alexandra Cohen Children's Medical Center of New York; Northwell Health	Zaghloul, N (corresponding author), Cohen Childrens Med Ctr New York, Dept Pediat, Div Neonatol, New Hyde Pk, NY USA.; Zaghloul, N (corresponding author), Feinstein Inst Med Res, Manhasset, NY USA.	nzaghloul@northwell.edu						Back SA, 1998, J NEUROSCI, V18, P6241; Billiards SS, 2006, J COMP NEUROL, V497, P199, DOI 10.1002/cne.20991; Brambilla R, 2009, J IMMUNOL, V182, P2628, DOI 10.4049/jimmunol.0802954; Brian JE, 1998, STROKE, V29, P509, DOI 10.1161/01.STR.29.2.509; Cai ZW, 2001, BRAIN RES, V898, P126, DOI 10.1016/S0006-8993(01)02180-1; Choi Ehn-Kyoung, 2011, Lab Anim Res, V27, P77, DOI 10.5625/lar.2011.27.2.77; Dommergues MA, 2000, ANN NEUROL, V47, P54, DOI 10.1002/1531-8249(200001)47:1<54::AID-ANA10>3.3.CO;2-P; Dommergues MA, 2003, NEUROSCIENCE, V121, P619, DOI 10.1016/S0306-4522(03)00558-X; Ferriero DM, 2001, DEV NEUROSCI-BASEL, V23, P198, DOI 10.1159/000046143; Follett PL, 2000, J NEUROSCI, V20, P9235; Fullerton HJ, 1998, ANN NEUROL, V44, P357, DOI 10.1002/ana.410440311; GEHRMANN J, 1995, NEUROPATH APPL NEURO, V21, P277, DOI 10.1111/j.1365-2990.1995.tb01062.x; Groenendaal F, 2000, PEDIATR RES, V48, P560, DOI 10.1203/00006450-200010000-00023; HAMADA Y, 1994, PEDIATR RES, V35, P10, DOI 10.1203/00006450-199401000-00003; Hartman R, 2009, BRAIN RES, V1280, P148, DOI 10.1016/j.brainres.2009.05.038; Haynes RL, 2003, J NEUROPATH EXP NEUR, V62, P441, DOI 10.1093/jnen/62.5.441; Haynes RL, 2009, ACTA NEUROPATHOL, V118, P391, DOI 10.1007/s00401-009-0540-1; Jelinski SE, 1999, BRAIN RES, V815, P150, DOI 10.1016/S0006-8993(98)01053-1; Lai AY, 2006, GLIA, V53, P809, DOI 10.1002/glia.20335; Lechpammer M, 2008, NEUROPATH APPL NEURO, V34, P379, DOI 10.1111/j.1365-2990.2007.00925.x; Levison SW, 2001, DEV NEUROSCI-BASEL, V23, P234, DOI 10.1159/000046149; MAYER M, 1994, P NATL ACAD SCI USA, V91, P7496, DOI 10.1073/pnas.91.16.7496; Park Dongsun, 2010, Laboratory Animal Research, V26, P345; Rezaie P, 2002, NEUROPATHOLOGY, V22, P106, DOI 10.1046/j.1440-1789.2002.00438.x; RICE JE, 1981, ANN NEUROL, V9, P131, DOI 10.1002/ana.410090206; Sheldon RA, 1996, BIOL NEONATE, V69, P327; Skoff RP, 2001, INT J DEV NEUROSCI, V19, P197, DOI 10.1016/S0736-5748(00)00075-7; Tahraoui SL, 2001, BRAIN PATHOL, V11, P56; Tan S, 2005, J CHILD NEUROL, V20, P972, DOI 10.1177/08830738050200120801; Thorburne SK, 1996, J NEUROCHEM, V67, P1014; Uehara H, 1999, BRAIN RES, V837, P213, DOI 10.1016/S0006-8993(99)01675-3; Van Bel F, 1998, PEDIATRICS, V101, P185, DOI 10.1542/peds.101.2.185; Volpe JJ, 2001, PEDIATR RES, V50, P553, DOI 10.1203/00006450-200111000-00003; Wilde GJC, 2000, EUR J NEUROSCI, V12, P3863, DOI 10.1046/j.1460-9568.2000.00273.x	34	9	10	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2017	12	4							e0175438	10.1371/journal.pone.0175438	http://dx.doi.org/10.1371/journal.pone.0175438			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0MB	28406931	Green Published, gold, Green Submitted			2022-12-27	WOS:000399955400053
J	Alsallaq, RA; Buttolph, J; Cleland, CM; Hallett, T; Inwani, I; Agot, K; Kurth, AE				Alsallaq, Ramzi A.; Buttolph, Jasmine; Cleland, Charles M.; Hallett, Timothy; Inwani, Irene; Agot, Kawango; Kurth, Ann E.			The potential impact and cost of focusing HIV prevention on young women and men: A modeling analysis in western Kenya	PLOS ONE			English	Article							CASH TRANSFER PROGRAM; SUB-SAHARAN AFRICA; ANTIRETROVIRAL THERAPY; MALE CIRCUMCISION; RISK-FACTORS; SEXUAL TRANSMISSION; COITAL-ACT; INFECTION; PREVALENCE; INTERVENTION	Objective We compared the impact and costs of HIV prevention strategies focusing on youth (15-24 year-old persons) versus on adults (15+year-old persons), in a high-HIV burden context of a large generalized epidemic. Design Compartmental age-structured mathematical model of HIV transmission in Nyanza, Kenya. Interventions The interventions focused on youth were high coverage HIV testing (80% of youth), treatment at diagnosis (TasP, i.e., immediate start of antiretroviral therapy [ART]) and 10% increased condom usage for HIV-positive diagnosed youth, male circumcision for HIV-negative young men, pre-exposure prophylaxis (PrEP) for high-risk HIV-negative females (ages 20-24 years), and cash transfer for in-school HIV-negative girls (ages 15-19 years). Permutations of these were compared to adult-focused HIV testing coverage with condoms and TasP. Results The youth-focused strategy with ART treatment at diagnosis and condom use without adding interventions for HIV-negative youth performed better than the adult-focused strategy with adult testing reaching 50-60% coverage and TasP/condoms. Over the long term, the youth-focused strategy approached the performance of 70% adult testing and TasP/condoms. When high coverage male circumcision also is added to the youth-focused strategy, the combined intervention outperformed the adult-focused strategy with 70% testing, for at least 35 years by averting 94,000 more infections, averting 5.0 million more disability-adjusted life years (DALYs), and saving US$46.0 million over this period. The addition of prevention interventions beyond circumcision to the youth-focused strategy would be more beneficial if HIV care costs are high, or when program delivery costs are relatively high for programs encompassing HIV testing coverage exceeding 70%, TasP and condoms to HIV-infected adults compared to combination prevention programs among youth. Conclusion For at least the next three decades, focusing in high burden settings on high coverage HIV testing, ART treatment upon diagnosis, condoms and male circumcision among youth may outperform adult-focused ART treatment upon diagnosis programs, unless the adult testing coverage in these programs reaches very high levels (>70% of all adults reached) at similar program costs. Our results indicate the potential importance of age-targeting for HIV prevention in the current era of 'test and start, ending AIDS' goals to ameliorate the HIV epidemic globally.	[Alsallaq, Ramzi A.; Buttolph, Jasmine; Cleland, Charles M.; Kurth, Ann E.] NYU, New York, NY 10003 USA; [Hallett, Timothy] Imperial Coll London, London, England; [Inwani, Irene] Univ Nairobi, Nairobi, Kenya; [Agot, Kawango] Impact Res & Dev Org, Kisumu, Kenya; [Alsallaq, Ramzi A.] Case Western Reserve Univ, Cleveland, OH 44106 USA; [Kurth, Ann E.] Yale Univ, New Haven, CT USA	New York University; Imperial College London; University of Nairobi; Case Western Reserve University; Yale University	Alsallaq, RA (corresponding author), NYU, New York, NY 10003 USA.; Alsallaq, RA (corresponding author), Case Western Reserve Univ, Cleveland, OH 44106 USA.	ramzi.alsallaq@gmail.com		Hallett, Timothy/0000-0002-9681-0424; Cleland, Charles/0000-0002-6931-9904	National Institute of Allergy and Infectious Diseases (NIAID) [R01AI094607]; Medical Research Council [MR/K010174/1B] Funding Source: researchfish	National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The authors acknowledge that the project described was supported by Award Number R01AI094607 from the National Institute of Allergy and Infectious Diseases (NIAID) (AEK and II). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIAID or the National Institutes of Health.	Amornkul PN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006470; Anne-Emmanuele Calves, 1996, ADOLESCENT SEXUAL AC; [Anonymous], 2002, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD003255, DOI 10.1002/14651858.CD003255]; Attia S, 2009, AIDS, V23, P1397, DOI 10.1097/QAD.0b013e32832b7dca; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Auvert B, 2001, AIDS, V15, pS15, DOI 10.1097/00002030-200108004-00003; Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Baird S, 2010, HEALTH ECON, V19, P55, DOI 10.1002/hec.1569; Baird SJ, 2012, LANCET, V379, P1320, DOI 10.1016/S0140-6736(11)61709-1; BARKER GK, 1992, STUD FAMILY PLANN, V23, P199, DOI 10.2307/1966728; Brinkhof MWG, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000066; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Cohen MS, 2011, N ENGL J MED; Cremin I, 2013, AIDS, V27, P447, DOI 10.1097/QAD.0b013e32835ca2dd; Cuadros DF, 2013, INT J HEALTH GEOGR, V12, DOI 10.1186/1476-072X-12-28; Denison JA, 2008, AIDS BEHAV, V12, P363, DOI 10.1007/s10461-007-9349-x; Donnell D, 2010, LANCET, V375, P2092, DOI 10.1016/S0140-6736(10)60705-2; Eaton JW, 2014, LANCET GLOB HEALTH, V2, pE23, DOI 10.1016/S2214-109X(13)70172-4; Edejer T, 2003, MAKING CHOICES HLTH; Geffen N, 2015, HIV MED, V16, P10, DOI 10.1111/hiv.12228; Ghys PD, 2010, SEX TRANSM INFECT, V86, pI1, DOI [10.1136/sti.2010.047852, 10.1136/sti.2010.044933]; Glynn JR, 2001, AIDS, V15, pS51, DOI 10.1097/00002030-200108004-00006; Government of Kenya, KEN POP HOUS CENS 19; Government of Kenya, 2003, KEN DEM HLTH SURV KD; Government of Kenya, 2009, KEN DEM HLTH SURV KD; Government of Kenya, 1998, KEN DEM HLTH SURV KD; Government of Kenya. National Bureau of Statistics (KNBS), KEN POP HOUS CENS 2; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Handa S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085473; Hollingsworth TD, 2008, J INFECT DIS, V198, P687, DOI 10.1086/590501; Hughes JP, 2012, J INFECT DIS, V205, P358, DOI 10.1093/infdis/jir747; Idele P, 2014, JAIDS-J ACQ IMM DEF, V66, pS144, DOI 10.1097/QAI.0000000000000176; Kadede K, AIDS, V30; KAIS, 2013, KEN AIDS IND SURV 20; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Kasedde S, 2013, CURR HIV-AIDS REP, V10, P159, DOI 10.1007/s11904-013-0159-7; Kennedy CE, 2014, AIDS CARE, V26, P275, DOI 10.1080/09540121.2013.824539; Kenya Ministry of Public Health and Sanitation, 2009, KEN NAT STR VOL MED; Larson BA, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18026; Mwandi Z, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001130; NACC, 2010, UN GEN ASS SPEC SESS; NASCOP, 2010, SENT SURV HIV SYPH P; NASCOP, 2009, DRAFT AN HLTH SECT H; NICOLOSI A, 1994, J ACQ IMMUN DEF SYND, V7, P296; Organization WH., 2014, GLOB HLTH SECT STR H; Ott MQ, 2011, AIDS, V25, P861, DOI 10.1097/QAD.0b013e32834344c9; PADIAN NS, 1991, JAMA-J AM MED ASSOC, V266, P1664; Paterson DL, 2002, JAIDS, V31, pS103, DOI 10.1097/00126334-200212153-00003; Rehle T, 2007, SAMJ S AFR MED J, V97, P194; Rodger A., 2014, 21 C RETR OPP INF, P3; Rosen S, 2007, PLOS MED, V4, P1691, DOI 10.1371/journal.pmed.0040298; Rosenberg NE, 2013, AIDS; Rudy BJ, 2009, AIDS PATIENT CARE ST, V23, P185, DOI 10.1089/apc.2008.0162; Salomon JA, 2012, LANCET, V380, P2129, DOI 10.1016/S0140-6736(12)61680-8; Schwartlander B, 2011, LANCET, V377, P2031, DOI 10.1016/S0140-6736(11)60702-2; Stover J, 2010, SEX TRANSM INFECT, V86, pII16, DOI 10.1136/sti.2010.044222; Thigpen MC, 2012, NEW ENGL J MED, V367, P423, DOI 10.1056/NEJMoa1110711; Todd J, 2007, AIDS, V21, pS55, DOI 10.1097/01.aids.0000299411.75269.e8; UNAIDS, 90 90 90 AMB TREATM; UNAIDS, 2012, UNAIDS GLOB REP UNAI; UNICEF, CHILDR AND AIDS; Walensky RP, 2009, ANN INTERN MED, V151, P157, DOI 10.7326/0003-4819-151-3-200908040-00138; Wawer MJ, 2005, J INFECT DIS, V191, P1403, DOI 10.1086/429411; Weiss HA, 2000, AIDS, V14, P2361, DOI 10.1097/00002030-200010200-00018; WHO, GUID START ANT THER; WHO, CONGUID UANT DRU; WHO, 2014, HLTH WORLDS AD 2 CHA; Zwahlen M, 2008, SEX TRANSM INFECT, V84, pI31, DOI 10.1136/sti.2008.029793	70	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2017	12	4							e0175447	10.1371/journal.pone.0175447	http://dx.doi.org/10.1371/journal.pone.0175447			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET0LZ	28403211	Green Published, Green Submitted, gold			2022-12-27	WOS:000399955200070
J	Dickerson, MT; Vierra, NC; Milian, SC; Dadi, PK; Jacobson, DA				Dickerson, Matthew T.; Vierra, Nicholas C.; Milian, Sarah C.; Dadi, Prasanna K.; Jacobson, David A.			Osteopontin activates the diabetes-associated potassium channel TALK-1 in pancreatic beta-cells	PLOS ONE			English	Article							INSULIN-SECRETION; K+ CHANNELS; SPLICE VARIANTS; NITRIC-OXIDE; ISLETS; TETRASPANINS; CLAUDIN-10; PHYSIOLOGY; EXPRESSION; REGULATOR	Glucose-stimulated insulin secretion (GSIS) relies on beta-cell Ca2+ influx, which is modulated by the two-pore-domain K+ (K2P) channel, TALK-1. A gain-of-function polymorphism in KCNK16, the gene encoding TALK-1, increases risk for developing type-2 diabetes. While TALK-1 serves an important role in modulating GSIS, the regulatory mechanism(s) that control beta-cell TALK-1 channels are unknown. Therefore, we employed a membrane-specific yeast two-hybrid (MYTH) assay to identify TALK-1-interacting proteins in human islets, which will assist in determining signaling modalities that modulate TALK-1 function. Twenty-one proteins from a human islet cDNA library interacted with TALK-1. Some of these interactions increased TALK-1 activity, including intracellular osteopontin (iOPN). Intracellular OPN is highly expressed in beta-cells and is upregulated under pre-diabetic conditions to help maintain normal beta-cell function; however, the functional role of iOPN in beta-cells is poorly understood. We found that iOPN colocalized with TALK-1 in pancreatic sections and coimmunoprecipitated with human islet TALK-1 channels. As human beta-cells express two K+ channel-forming variants of TALK-1, regulation of these TALK-1 variants by iOPN was assessed. At physiological voltages iOPN activated TALK-1 transcript variant 3 channels but not TALK-1 transcript variant 2 channels. Activation of TALK-1 channels by iOPN also hyperpolarized resting membrane potential (V-m) in HEK293 cells and in primary mouse beta-cells. Intracellular OPN was also knocked down in beta-cells to test its effect on beta-cell TALK-1 channel activity. Reducing beta-cell iOPN significantly decreased TALK-1 K+ currents and increased glucose-stimulated Ca2+ influx. Importantly, iOPN did not affect the function of other K2P channels or alter Ca2+ influx into TALK-1 deficient beta-cells. These results reveal the first protein interactions with the TALK-1 channel and found that an interaction with iOPN increased beta-cell TALK-1 K+ currents. The TALK-1/iOPN complex caused V-m hyperpolarization and reduced beta-cell glucose-stimulated Ca2+ influx, which is predicted to inhibit GSIS.	[Dickerson, Matthew T.; Vierra, Nicholas C.; Milian, Sarah C.; Dadi, Prasanna K.; Jacobson, David A.] Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA	Vanderbilt University	Jacobson, DA (corresponding author), Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA.	david.a.jacobson@vanderbilt.edu		Jacobson, David A./0000-0003-1816-5375	National Institutes of Health [DK081666, DK097392]; Vanderbilt University Diabetes Research Training Center; Vanderbilt Cell Imaging Shared Resource; NIH [DK081666, CA68485, DK20593, DK58404, DK59637, EY08126]; Vanderbilt Integrated Training in Engineering and Diabetes [DK097392, T32DK101003]; Pilot and Feasibility grant through the Vanderbilt University Diabetes Research Training Center [P60-DK-20593]; NATIONAL CANCER INSTITUTE [P30CA068485] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY008126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020593, U2CDK059637, P30DK058404, K01DK081666, T32DK101003, U24DK059637, P30DK020593, R01DK097392] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM062459] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD021630] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt University Diabetes Research Training Center; Vanderbilt Cell Imaging Shared Resource; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt Integrated Training in Engineering and Diabetes; Pilot and Feasibility grant through the Vanderbilt University Diabetes Research Training Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health, https://www.nih.gov/T32DK101003, DK081666, and DK097392; Vanderbilt University Diabetes Research Training Center. https://labnodes.vanderbilt.edu/drtcP60-DK-20593; Vanderbilt Cell Imaging Shared Resource, https://cisrweb.mc.vanderbilt.edu/CISR/; and NIH grants CA68485, DK20593, DK58404, DK59637 and EY08126.; M.T.D. was supported by the Vanderbilt Integrated Training in Engineering and Diabetes grant T32DK101003 and DK097392. Research in the laboratory of D.A.J. was also supported by NIH grant DK081666 and a Pilot and Feasibility grant through the Vanderbilt University Diabetes Research Training Center (P60-DK-20593). We would like to thank the Integrated Islet Distribution Program (IIDP) for providing human islets, the Cooperative Human Tissue Network (CHTN) for providing human pancreatic tissue, the Vanderbilt Translational Pathology Shared Resource for their assistance in the preparation of human pancreatic tissue slices, and the Vanderbilt Cell Imaging Shared Resource (supported by NIH grants CA68485, DK20593, DK58404, DK59637 and EY08126), which was employed for confocal imaging.	Arafat HA, 2006, EXP CLIN ENDOCR DIAB, V114, P555, DOI 10.1055/s-2006-948306; Arafat HA, 2007, ENDOCRINOLOGY, V148, P575, DOI 10.1210/en.2006-0970; Bagriantsev SN, 2012, EMBO J, V31, P3297, DOI 10.1038/emboj.2012.171; Benner C, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-620; Berditchevski F, 2007, TRAFFIC, V8, P89, DOI 10.1111/j.1600-0854.2006.00515.x; Blodgett D.M, 2015, DIABETES; Bramswig NC, 2013, J CLIN INVEST, V123, P1275, DOI 10.1172/JCI66514; Braun M, 2008, DIABETES, V57, P1618, DOI 10.2337/db07-0991; Charrin S, 2014, J CELL SCI, V127, P3641, DOI 10.1242/jcs.154906; Chatelain FC, 2012, P NATL ACAD SCI USA, V109, P5499, DOI 10.1073/pnas.1201132109; Cho YS, 2012, NAT GENET, V44, P67, DOI 10.1038/ng.1019; Dadi PK, 2015, MOL ENDOCRINOL, V29, P777, DOI 10.1210/me.2014-1321; Dadi PK, 2014, ENDOCRINOLOGY, V155, P3757, DOI 10.1210/en.2013-2051; Dorrell C, 2011, DIABETOLOGIA, V54, P2832, DOI 10.1007/s00125-011-2283-5; Duprat F, 2005, J PHYSIOL-LONDON, V562, P235, DOI 10.1113/jphysiol.2004.071266; Eizirik DL, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002552; Enyedi P, 2010, PHYSIOL REV, V90, P559, DOI 10.1152/physrev.00029.2009; Findley MK, 2009, IUBMB LIFE, V61, P431, DOI 10.1002/iub.175; Girard C, 2001, BIOCHEM BIOPH RES CO, V282, P249, DOI 10.1006/bbrc.2001.4562; Girault A, 2015, RESP RES, V16, DOI 10.1186/s12931-015-0263-x; Gong QK, 2009, ISLETS, V1, P34, DOI 10.4161/isl.1.1.8629; Gunzel D, 2013, PHYSIOL REV, V93, P525, DOI 10.1152/physrev.00019.2012; Gunzel D, 2009, J CELL SCI, V122, P1507, DOI 10.1242/jcs.040113; Han J, 2003, AM J PHYSIOL-CELL PH, V285, pC529, DOI 10.1152/ajpcell.00601.2002; Hemler ME, 2005, NAT REV MOL CELL BIO, V6, P801, DOI 10.1038/nrm1736; Honore E, 2007, NAT REV NEUROSCI, V8, P251, DOI 10.1038/nrn2117; HU DD, 1995, J BIOL CHEM, V270, P26232, DOI 10.1074/jbc.270.44.26232; Huang X, 2013, MOL ENDOCRINOL, V27, P1550, DOI 10.1210/me.2013-1047; Inoue M, 2011, IMMUNOL RES, V49, P160, DOI 10.1007/s12026-010-8179-5; JOHNSSON N, 1994, P NATL ACAD SCI USA, V91, P10340, DOI 10.1073/pnas.91.22.10340; Kahles F, 2014, MOL METAB, V3, P384, DOI 10.1016/j.molmet.2014.03.004; Kang DW, 2004, BIOCHEM BIOPH RES CO, V323, P323, DOI 10.1016/j.bbrc.2004.08.089; Kang DW, 2004, BIOCHEM BIOPH RES CO, V315, P836, DOI 10.1016/j.bbrc.2004.01.137; Katakam AK, 2005, J ENDOCRINOL, V187, P237, DOI 10.1677/joe.1.06411; Kazanecki CC, 2007, J CELL BIOCHEM, V102, P912, DOI 10.1002/jcb.21558; Khan FA, 2001, DIABETES, V50, P2192, DOI 10.2337/diabetes.50.10.2192; Kovalenko OV, 2005, BMC STRUCT BIOL, V5, DOI 10.1186/1472-6807-5-11; Lee JL, 2007, CANCER RES, V67, P2089, DOI 10.1158/0008-5472.CAN-06-3625; Lesage F, 2011, PHYSIOLOGY, V26, P424, DOI 10.1152/physiol.00029.2011; Li J, 2016, EMBO REP, V17, P178, DOI 10.15252/embr.201540946; Lyssenko V, 2011, DIABETES, V60, P2424, DOI 10.2337/db10-1532; MacDonald PE, 2014, ENDOCRINOLOGY, V155, P3729, DOI 10.1210/en.2014-1667; Mahajan A, 2014, NAT GENET, V46, P234, DOI 10.1038/ng.2897; Pardo LA, 2014, NAT REV CANCER, V14, P39, DOI 10.1038/nrc3635; PHILIPSON LH, 1994, J BIOL CHEM, V269, P27787; Plant LD, 2005, CURR OPIN NEUROBIOL, V15, P326, DOI 10.1016/j.conb.2005.05.008; Ren JH, 2013, AM J PHYSIOL-ENDOC M, V305, pE805, DOI 10.1152/ajpendo.00046.2013; Snider J, 2010, NAT PROTOC, V5, P1281, DOI 10.1038/nprot.2010.83; Stephens RF, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00153; Sun JH, 2015, MOL ASPECTS MED, V42, P105, DOI 10.1016/j.mam.2015.01.001; Szabat M, 2016, CELL METAB, V23, P179, DOI 10.1016/j.cmet.2015.10.016; Van Itallie CM, 2006, AM J PHYSIOL-RENAL, V291, pF1288, DOI 10.1152/ajprenal.00138.2006; Vierra NC, 2015, DIABETES, V64, P3818, DOI 10.2337/db15-0280; Wai PY, 2005, CARCINOGENESIS, V26, P741, DOI 10.1093/carcin/bgi027; Wang B, 2004, MOL CELL BIOL, V24, P2767, DOI 10.1128/MCB.24.7.2767-2778.2004; Wendt A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170498; Yang SN, 2006, ENDOCR REV, V27, P621, DOI 10.1210/er.2005-0888; Zhong J., 2013, ENDOPLASMIC RETICULU	58	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2017	12	4							e0175069	10.1371/journal.pone.0175069	http://dx.doi.org/10.1371/journal.pone.0175069			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LZ	28403169	Green Submitted, gold, Green Published			2022-12-27	WOS:000399955200031
J	Kanamori, K				Kanamori, Keiko			Faster flux of neurotransmitter glutamate during seizure - Evidence from C-13-enrichment of extracellular glutamate in kainate rat model	PLOS ONE			English	Article							HUMAN EPILEPTOGENIC HIPPOCAMPUS; KAINIC ACID; IN-VIVO; AMINO-ACIDS; RESONANCE-SPECTROSCOPY; EPILEPTIC HIPPOCAMPUS; ADENOSINE KINASE; CHRONIC PHASE; BRAIN; METABOLISM	The objective is to examine how the flux of neurotransmitter glutamate from neurons to the extracellular fluid, as measured by the rate of C-13 enrichment of extracellular glutamate (GLU(ECF)), changes in response to seizures in the kainate-induced rat model of temporallobe epilepsy. Following unilateral intrahippocampal injection of kainate, GLU(ECF) was collected by microdialysis from the CA1/CA3 region of awake rats, in combination with EEG recording of chronic-phase recurrent seizures and intravenous infusion of [2,5-C-13] glucose. The C-13 enrichment of GLU(ECF) C5 at similar to 10 picomol level was measured by gas-chromatography mass-spectrometry. The rate of C-13 enrichment, expressed as the increase of the fractional enrichment/min, was 0.0029 +/- 0.0001/min in frequently seizing rats (n = 4); this was significantly higher (p < 0.01) than in the control (0.00167 +/- 0.0001/min; n = 6) or in rats with infrequent seizures (0.00172 +/- 0.0001/min; n = 6). This result strongly suggests that the flux of the excitatory neurotransmitter from neurons to the extracellular fluid is significantly increased by frequent seizures. The extracellular [C-12 + C-13] glutamate concentration increased progressively in frequently seizing rats. Taken together, these results strongly suggest that the observed seizure-induced high flux of glutamate overstimulated glutamate receptors, which triggered a chain reaction of excitation in the CA3 recurrent glutamatergic networks. The rate of C-13 enrichment of extracellular glutamine (GLN(ECF)) at C5 was 0.00299 +/- 0.00027/min in frequently seizing rats, which was higher (p < 0.05) than in controls (0.00227 +/- 0.00008/min). For the first time in vivo, this study examined the effects of epileptic seizures on fluxes of the neurotransmitter glutamate and its precursor glutamine in the extracellular fluid of the hippocampus. The advantages, limitations and the potential for improvement of this approach for pre-clinical and clinical studies of temporal-lobe epilepsy are discussed.	[Kanamori, Keiko] Huntington Med Res Inst, Dept Epilepsy, Pasadena, CA 91101 USA; [Kanamori, Keiko] Lab Launch, Monrovia, CA 91016 USA	Huntington Medical Research Institutes	Kanamori, K (corresponding author), Huntington Med Res Inst, Dept Epilepsy, Pasadena, CA 91101 USA.; Kanamori, K (corresponding author), Lab Launch, Monrovia, CA 91016 USA.	kkanamori.hmri@gmail.com		Kanamori, Keiko/0000-0001-6931-724X	National Institute of Neurological Disorders and Stroke [R01-NS048589]; Huntington Medical Research Institutes; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048589] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Huntington Medical Research Institutes; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by Research Grant R01-NS048589 from the National Institute of Neurological Disorders and Stroke (KK) and Institute Fund from Huntington Medical Research Institutes (KK). The author is grateful for the generous funds donated by Ms. Rita Pudenz (KK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvestad S, 2008, NEUROCHEM RES, V33, P257, DOI 10.1007/s11064-007-9435-5; ANDERSEN P, 1971, EXP BRAIN RES, V13, P208; Bendotti C, 2000, EXP NEUROL, V161, P317, DOI 10.1006/exnr.1999.7262; Bjornsen LP, 2007, NEUROBIOL DIS, V25, P319, DOI 10.1016/j.nbd.2006.09.014; Bradford HF, 1995, PROG NEUROBIOL, V47, P477, DOI 10.1016/0301-0082(95)00030-5; Bragin A, 2005, EPILEPSIA, V46, P1592, DOI 10.1111/j.1528-1167.2005.00268.x; Bragin A, 1999, EPILEPSIA, V40, P1210, DOI 10.1111/j.1528-1157.1999.tb00849.x; Broer S, 2001, J NEUROCHEM, V77, P705, DOI 10.1046/j.1471-4159.2001.00322.x; Cavus I, 2005, ANN NEUROL, V57, P226, DOI 10.1002/ana.20380; Cavus I, 2008, EPILEPSIA, V49, P1358, DOI 10.1111/j.1528-1167.2008.01603.x; Cavus I, 2016, ANN NEUROL, V80, P35, DOI 10.1002/ana.24673; Chaudhry FA, 1999, CELL, V99, P769, DOI 10.1016/S0092-8674(00)81674-8; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; DURING MJ, 1993, LANCET, V341, P1607; Eid T, 2004, LANCET, V363, P28, DOI 10.1016/S0140-6736(03)15166-5; Eid T, 2012, NEUROCHEM RES, V37, P2339, DOI 10.1007/s11064-012-0766-5; Esclapez M, 1999, J COMP NEUROL, V408, P449, DOI 10.1002/(SICI)1096-9861(19990614)408:4<449::AID-CNE1>3.0.CO;2-R; FITZPATRICK SM, 1990, J CEREBR BLOOD F MET, V10, P170, DOI 10.1038/jcbfm.1990.32; Gouder N, 2004, J NEUROSCI, V24, P692, DOI 10.1523/JNEUROSCI.4781-03.2004; Hammer J, 2008, GLIA, V56, P856, DOI 10.1002/glia.20659; HAWKINS RA, 1995, CELL TISSUE RES, V281, P207, DOI 10.1007/s004410050417; Hertz L, 1999, J NEUROSCI RES, V57, P417, DOI 10.1002/(SICI)1097-4547(19990815)57:4<417::AID-JNR1>3.3.CO;2-E; HERTZ L, 1979, PROG NEUROBIOL, V13, P277, DOI 10.1016/0301-0082(79)90018-2; Kanamatsu T, 1999, BRAIN RES, V841, P11, DOI 10.1016/S0006-8993(99)01772-2; Kanamori K, 2005, J NEUROCHEM, V94, P74, DOI 10.1111/j.1471-4159.2005.03170.x; Kanamori K, 2001, J MAGN RESON, V153, P193, DOI 10.1006/jmre.2001.2432; Kanamori K, 2015, EPILEPSY RES, V114, P32, DOI 10.1016/j.eplepsyres.2015.03.009; Kanamori K, 2013, EPILEPSY RES, V107, P20, DOI 10.1016/j.eplepsyres.2013.08.007; Kanamori K, 2011, BRAIN RES, V1371, P180, DOI 10.1016/j.brainres.2010.11.064; Kondrat RW, 2002, J NEUROSCI METH, P120; LOSCHER W, 1989, J PHARMACOL EXP THER, V250, P1067; Mackenzie B, 2004, PFLUG ARCH EUR J PHY, V447, P784, DOI 10.1007/s00424-003-1117-9; MAGLOCZKY Z, 1993, NEUROSCIENCE, V56, P317, DOI 10.1016/0306-4522(93)90334-C; Mason GF, 2007, J NEUROCHEM, V100, P73, DOI 10.1111/j.1471-4159.2006.04200.x; MATHERN GW, 1993, ELECTROEN CLIN NEURO, V87, P326, DOI 10.1016/0013-4694(93)90186-Y; MILES R, 1986, J PHYSIOL-LONDON, V373, P397, DOI 10.1113/jphysiol.1986.sp016055; Montigon F, 2001, RAPID COMMUN MASS SP, V15, P116, DOI 10.1002/1097-0231(20010130)15:2<116::AID-RCM202>3.3.CO;2-V; NADLER JV, 1980, BRAIN RES, V182, P1; Nadler JV, 2003, NEUROCHEM RES, V28, P1649, DOI 10.1023/A:1026004904199; Nissen-Meyer LSH, 2011, J NEUROSCI, V31, P6565, DOI 10.1523/JNEUROSCI.3694-10.2011; NORENBERG MD, 1979, BRAIN RES, V161, P303, DOI 10.1016/0006-8993(79)90071-4; OLDENDORF WH, 1971, AM J PHYSIOL, V221, P1629, DOI 10.1152/ajplegacy.1971.221.6.1629; Otsuki T, 2005, NEUROREPORT, V16, P2057, DOI 10.1097/00001756-200512190-00018; Pan JW, 2008, EPILEPSIA, V49, P31, DOI 10.1111/j.1528-1167.2008.01508.x; Paxinos G., 1998, RAT BRAIN STEROTAXIC; Petroff OAC, 2002, EPILEPSIA, V43, P703, DOI 10.1046/j.1528-1157.2002.38901.x; PHELPS S, 1991, NEUROSCIENCE, V40, P687, DOI 10.1016/0306-4522(91)90005-9; Puttachary S, 2016, NEUROBIOL DIS, V93, P184, DOI 10.1016/j.nbd.2016.05.013; Riban V, 2002, NEUROSCIENCE, V112, P101, DOI 10.1016/S0306-4522(02)00064-7; RONNEENGSTROM E, 1992, J CEREBR BLOOD F MET, V12, P873, DOI 10.1038/jcbfm.1992.119; Rothstein JD, 1996, NEURON, V16, P675, DOI 10.1016/S0896-6273(00)80086-0; Ryan K, 2014, NEUROBIOL DIS, V64, P8, DOI 10.1016/j.nbd.2013.12.006; Sibson NR, 2001, J NEUROCHEM, V76, P975, DOI 10.1046/j.1471-4159.2001.00074.x; Simantov R, 1999, MOL BRAIN RES, V65, P112, DOI 10.1016/S0169-328X(98)00349-0; Smeland OB, 2013, J CEREBR BLOOD F MET, V33, P1090, DOI 10.1038/jcbfm.2013.54; TANAKA T, 1992, PROG NEUROBIOL, V38, P317, DOI 10.1016/0301-0082(92)90023-8; Thomas PM, 2004, ACTA NEUROCHIR, V146, P143, DOI 10.1007/s00701-003-0189-9; Ueda Y, 2001, J NEUROCHEM, V76, P892, DOI 10.1046/j.1471-4159.2001.00087.x; UHLHAAS S, 1988, BRAIN RES, V457, P196, DOI 10.1016/0006-8993(88)90076-5; van Vliet EA, 2014, NEUROBIOL DIS, V63, P74, DOI 10.1016/j.nbd.2013.11.019; Vezzani A, 1999, J NEUROSCI, V19, P5054; Wilson CL, 1996, EPILEPSY RES, V26, P245, DOI 10.1016/S0920-1211(96)00057-5; WOO KL, 1993, J CHROMATOGR, V638, P97, DOI 10.1016/0021-9673(93)85012-V; Young D, 2014, GENE THER, V21, P1029, DOI 10.1038/gt.2014.82; ZUCKER DK, 1983, EXP NEUROL, V79, P422, DOI 10.1016/0014-4886(83)90223-6	65	7	8	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2017	12	4							e0174845	10.1371/journal.pone.0174845	http://dx.doi.org/10.1371/journal.pone.0174845			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LZ	28403176	Green Published, Green Submitted, gold			2022-12-27	WOS:000399955200024
J	Huertas, I; Jesus, S; Garcia-Gomez, FJ; Lojo, JA; Bernal-Bernal, I; Bonilla-Toribio, M; Martin-Rodriguez, JF; Garcia-Solis, D; Gomez-Garre, P; Mir, P				Huertas, Ismael; Jesus, Silvia; Javier Garcia-Gomez, Francisco; Antonio Lojo, Jose; Bernal-Bernal, Inmaculada; Bonilla-Toribio, Marta; Francisco Martin-Rodriguez, Juan; Garcia-Solis, David; Gomez-Garre, Pilar; Mir, Pablo			Genetic factors influencing frontostriatal dysfunction and the development of dementia in Parkinson's disease	PLOS ONE			English	Article							GLUCOCEREBROSIDASE MUTATIONS; DOPAMINE; APOE; SUSCEPTIBILITY; POLYMORPHISM; ASSOCIATION; COGNITION; COHORT; SPECT; MOTOR	The dual syndrome hypothesis for cognitive impairment in Parkinson's disease (PD) establishes a dichotomy between a frontrostriatal dopamine-mediated syndrome, which leads to executive deficits, and a posterior cortical syndrome, which leads to dementia. Certain genes have been linked to these syndromes although the exact contribution is still controversial. The study's objective was to investigate the role of APOE, MAPT, COMT, SNCA and GBA genes in the dual syndromes. We genotyped APOE (rs429358 and rs7412), MAPT (rs9468), COMT (rs4680) and SNCA (rs356219) risk polymorphisms and sequenced GBA in a cohort of 298 PD patients. The degree of dopaminergic depletion was investigated with [I-123] FP-CIT SPECTs and the presence of dementia was ascertained with a long-term review based on established criteria. The association between genetic and imaging parameters was studied with linear regression, and the relationship with dementia onset with Cox regression. We found that APOE2 allele (P-put = 0.002; P-cau = 0.01), the minor allele 'G' in SNCA polymorphism (P-put = 0.02; P-cau = 0.006) and GBA deleterious variants in (P-put = 0.01; P-cau = 0.001) had a detrimental effect on striatal [I-123] FP-CIT uptake in PD. Conversely, Met/Met carriers in COMT polymorphism had increased caudate uptake (Pcau = 0.03). The development of dementia was influenced by APOE4 allele (HR = 1.90; P = 0.03) and GBA deleterious variants (HR = 2.44; P = 0.01). Finally, we observed no role of MAPT locus in any of the syndromes. As a conclusion, APOE2, SNCA, COMT and GBA influence frontostriatal dysfunction whereas APOE4 and GBA influence the development of dementia, suggesting a double-edged role of GBA. The dichotomy of the dual syndromes may be driven by a broad dichotomy in these genetic factors.	[Huertas, Ismael; Jesus, Silvia; Bernal-Bernal, Inmaculada; Bonilla-Toribio, Marta; Francisco Martin-Rodriguez, Juan; Gomez-Garre, Pilar; Mir, Pablo] Univ Seville, Hosp Univ Virgen Rocio, CSIC,Unidad Trastornos Movimiento, Inst Biomed Sevilla IBiS,Serv Neurol & Neurofisio, Seville, Spain; [Javier Garcia-Gomez, Francisco; Antonio Lojo, Jose; Garcia-Solis, David] Hosp Univ Virgen Rocio, UDIM, Serv Med Nucl, Seville, Spain; [Garcia-Solis, David; Gomez-Garre, Pilar; Mir, Pablo] Ctr Invest Biorned Red Enfermedades Neurodegenera, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital; Virgen del Rocio University Hospital	Mir, P (corresponding author), Univ Seville, Hosp Univ Virgen Rocio, CSIC,Unidad Trastornos Movimiento, Inst Biomed Sevilla IBiS,Serv Neurol & Neurofisio, Seville, Spain.; Mir, P (corresponding author), Ctr Invest Biorned Red Enfermedades Neurodegenera, Madrid, Spain.	pmir@us.es	Gómez-Garre, Pilar/AAG-8048-2020; Garcia Gomez, Francisco Javier/D-2553-2015	Gómez-Garre, Pilar/0000-0002-0437-6182; Garcia Gomez, Francisco Javier/0000-0001-9307-5017; Martin Rodriguez, Juan Francisco/0000-0003-1392-8775; Lojo Ramirez, Jose Antonio/0000-0003-4945-8250; JESUS MAESTRE, SILVIA/0000-0002-1874-4628; BERNAL, INMACULADA/0000-0002-4207-1208; Huertas, Ismael/0000-0002-4317-0662	Institute de Salud Carlos III-Fondo Europeo de Desarrollo Regional (ISCIII-FEDER) [PI14/01823, PI16/01575]; Consejeria de Economia, Innovacion, Ciencia y Empleo de la Junta de Andalucia [CVI-02526, CTS-7685]; Consejeria de Salud y Bienestar Social de la Junta de Andalucia [PI-0437-2012, PI-0471/2013]; Sociedad Andaluza de Neurologia; Fundacion Alicia Koplowitz; Fundacion Mutua Madrilena; PFIS doctoral programme from the ISCIII-FEDER [FI4/00497]; Rio Hortega programme from the ISCIII-FEDER; Sara Borrell programme from the ISCIII-FEDER; Miguel Servet programme from the ISCIII-FEDER	Institute de Salud Carlos III-Fondo Europeo de Desarrollo Regional (ISCIII-FEDER); Consejeria de Economia, Innovacion, Ciencia y Empleo de la Junta de Andalucia(Junta de Andalucia); Consejeria de Salud y Bienestar Social de la Junta de Andalucia; Sociedad Andaluza de Neurologia; Fundacion Alicia Koplowitz; Fundacion Mutua Madrilena(Instituto de Salud Carlos III); PFIS doctoral programme from the ISCIII-FEDER; Rio Hortega programme from the ISCIII-FEDER; Sara Borrell programme from the ISCIII-FEDER; Miguel Servet programme from the ISCIII-FEDER	This work was supported by grants from the Institute de Salud Carlos III-Fondo Europeo de Desarrollo Regional (ISCIII-FEDER) [PI14/01823, PI16/01575], the Consejeria de Economia, Innovacion, Ciencia y Empleo de la Junta de Andalucia [CVI-02526, CTS-7685], the Consejeria de Salud y Bienestar Social de la Junta de Andalucia [PI-0437-2012, PI-0471/2013], the Sociedad Andaluza de Neurologia, the Fundacion Alicia Koplowitz and the Fundacion Mutua Madrilena. Ismael Huertas was supported by the PFIS doctoral programme [FI4/00497], Silvia Jesus by the Rio Hortega programme, Juan Francisco Martin Rodriguez by the Sara Borrell programme, and Pilar Gomez-Garre by the Miguel Servet programme, all from the ISCIII-FEDER. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarsland D, 2011, CURR NEUROL NEUROSCI, V11, P371, DOI 10.1007/s11910-011-0203-1; Alcalay RN, 2015, BRAIN, V138, P2648, DOI 10.1093/brain/awv179; Brockmann K, 2015, MOVEMENT DISORD, V30, P407, DOI 10.1002/mds.26071; Brooks DJ, 2006, BIOL PSYCHIAT, V59, P908, DOI 10.1016/j.biopsych.2005.12.017; de la Fuente-Fernandez R, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00090; Emre M, 2007, MOVEMENT DISORD, V22, P1689, DOI 10.1002/mds.21507; Ezquerra M, 2008, NEUROSCI LETT, V448, P20, DOI 10.1016/j.neulet.2008.10.018; Federoff M, 2012, NEUROBIOL DIS, V46, P389, DOI 10.1016/j.nbd.2012.02.002; Gegg ME, 2012, ANN NEUROL, V72, P455, DOI 10.1002/ana.23614; Goker-Alpan O, 2012, BRAIN, V135, P2440, DOI 10.1093/brain/aws174; Goris A, 2007, ANN NEUROL, V62, P145, DOI 10.1002/ana.21192; Huang XM, 2004, NEUROLOGY, V62, P2198, DOI 10.1212/01.WNL.0000130159.28215.6A; Huertas-Fernandez I, 2015, EUR J NUCL MED MOL I, V42, P112, DOI 10.1007/s00259-014-2882-8; Jesus S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167749; Kehagia AA, 2013, NEURODEGENER DIS, V11, P79, DOI 10.1159/000341998; Mata IF, 2016, MOVEMENT DISORD, V31, P95, DOI 10.1002/mds.26359; Mata IF, 2014, JAMA NEUROL, V71, P1405, DOI 10.1001/jamaneurol.2014.1455; McNeill A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069190; Mollenhauer B, 2014, MOVEMENT DISORD, V29, P622, DOI 10.1002/mds.25846; Muellner J, 2015, PARKINSONISM RELAT D, V21, P471, DOI 10.1016/j.parkreldis.2015.02.009; Neumann J, 2009, BRAIN, V132, P1783, DOI 10.1093/brain/awp044; Nombela C, 2014, BRAIN, V137, P2743, DOI 10.1093/brain/awu201; Oh M, 2012, J NUCL MED, V53, P399, DOI 10.2967/jnumed.111.095224; Pagonabarraga J, 2010, MOVEMENT DISORD, V25, P440, DOI 10.1002/mds.22877; Pihlstrom L, 2011, NEUROGENETICS, V12, P283, DOI 10.1007/s10048-011-0292-7; Pirker W, 2003, MOVEMENT DISORD, V18, pS43, DOI 10.1002/mds.10579; Robbins TW, 2014, MOVEMENT DISORD, V29, P597, DOI 10.1002/mds.25853; Schillaci O, 2005, EUR J NUCL MED MOL I, V32, P1452, DOI 10.1007/s00259-005-1922-9; Seto-Salvia N, 2011, ARCH NEUROL-CHICAGO, V68, P359, DOI 10.1001/archneurol.2011.17; Sidransky E, 2009, NEW ENGL J MED, V361, P1651, DOI 10.1056/NEJMoa0901281; Williams-Gray CH, 2013, J NEUROL NEUROSUR PS, V84, P1258, DOI 10.1136/jnnp-2013-305277; Williams-Gray CH, 2009, J NEUROL, V256, P493, DOI 10.1007/s00415-009-0119-8; Winder-Rhodes SE, 2013, BRAIN, V136, P392, DOI 10.1093/brain/aws318; Wu K, 2012, BRAIN, V135, P2449, DOI 10.1093/brain/aws157	34	20	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2017	12	4							e0175560	10.1371/journal.pone.0175560	http://dx.doi.org/10.1371/journal.pone.0175560			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0JS	28399184	Green Published, gold, Green Submitted			2022-12-27	WOS:000399949000050
J	Nakao, M; Yamauchi, K; Ishihara, Y; Omori, H; Solongo, B; Ichinnorov, D				Nakao, Motoyuki; Yamauchi, Keiko; Ishihara, Yoko; Omori, Hisamitsu; Solongo, Bandi; Ichinnorov, Dashtseren			Prevalence and risk factors of airflow limitation in a Mongolian population in Ulaanbaatar: Cross-sectional studies	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; CHRONIC-BRONCHITIS; LUNG-FUNCTION; COPD; SMOKING; POLLUTION; HEALTH; BURDEN; ASTHMA	The burden of chronic obstructive pulmonary disease ( COPD) is expected to increase in the coming decades. In Ulaanbaatar, Mongolia, air pollution, which has been suggested to correlate with COPD, is a growing concern. However, the COPD prevalence in Ulaanbaatar is currently unknown. This study aims to estimate the prevalence of airflow limitation and investigate the association between airflow limitation and putative risk factors in the Mongolian population. Five cross-sectional studies were carried out in Ulaanbaatar. Administration of a self-completed questionnaire, body measurements, and medical examination including spirometry were performed in 746 subjects aged 40 to 79 years living in Ulaanbaatar. The age-and sex-standardized prevalence of airflow limitation in Ulaanbaatar varied widely from 4.0 to 10.9% depending on the criteria for asthma. Age, body mass index (BMI), and smoking habit were independent predictors for airflow limitation while residential area and household fuel type were not significant. In conclusion, prevalence of putative COPD was 10.0% when subjects with physician-diagnosed asthma were excluded from COPD. Older age, lower BMI, and current smoking status were putative risk factors for airflow limitation. This prevalence was consistent with reports from Asian countries.	[Nakao, Motoyuki; Yamauchi, Keiko; Ishihara, Yoko] Kurume Univ, Sch Med, Dept Publ Hlth, Kurume, Fukuoka, Japan; [Omori, Hisamitsu] Kumamoto Univ, Fac Life Sci, Dept Biomed Lab Sci, Kumamoto, Japan; [Solongo, Bandi; Ichinnorov, Dashtseren] Mongolian Natl Univ Med Sci, Dept Resp Med, Ulaanbaatar, Mongolia	Kurume University; Kumamoto University; Mongolian National University of Medical Sciences	Ishihara, Y (corresponding author), Kurume Univ, Sch Med, Dept Publ Hlth, Kurume, Fukuoka, Japan.	blackcat@med.kurume-u.a.c.jp			Ministry of Education, Culture, Sports, Science, and Technology [20406001, 23406001, 26340053]; Ministry of Education, Culture, Sports, Science, and Technology MEXT Program for the Strategic Research Foundation at Private Universities	Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science, and Technology MEXT Program for the Strategic Research Foundation at Private Universities	This work was supported by the Ministry of Education, Culture, Sports, Science, and Technology (B) 20406001 YI; Ministry of Education, Culture, Sports, Science, and Technology (B) 23406001 to YI; Ministry of Education, Culture, Sports, Science, and Technology (C) 26340053 to YI; Ministry of Education, Culture, Sports, Science, and Technology MEXT-Supported Program for the Strategic Research Foundation at Private Universities to YI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbey DE, 1998, AM J RESP CRIT CARE, V158, P289, DOI 10.1164/ajrccm.158.1.9710101; Amarsaikhan D., 2014, J GEOSCI ENV PROT, V2, P123, DOI [10.4236/gep.2014.22017, DOI 10.4236/GEP.2014.22017]; ANTHONISEN NR, 1994, JAMA-J AM MED ASSOC, V272, P1497, DOI 10.1001/jama.272.19.1497; Berend N, 2016, RESPIROLOGY, V21, P237, DOI 10.1111/resp.12644; Buist AS, 2007, LANCET, V370, P741, DOI 10.1016/S0140-6736(07)61377-4; Di Stefano A, 1998, AM J RESP CRIT CARE, V158, P1277, DOI 10.1164/ajrccm.158.4.9802078; Diagnosis of Diseases of Chronic Airflow Limitation: Asthma COPD and Asthma-COPD Overlap Syndrome (ACOS), 2015, BAS GLOB STRAT ASTHM; Ezzati M, 2005, LANCET, V366, P104, DOI 10.1016/S0140-6736(05)66845-6; Forey BA, 2011, BMC PULM MED, V11, DOI 10.1186/1471-2466-11-36; Fukuchi Y, 2004, RESPIROLOGY, V9, P458, DOI 10.1111/j.1440-1843.2004.00637.x; Global Initiative for Chronic Obstructive Lung Disease, 2015, GLOBAL STRATEGY DIAG; Halbert RJ, 2006, EUR RESPIR J, V28, P523, DOI 10.1183/09031936.06.00124605; Harik-Khan RI, 2002, CHEST, V121, P370, DOI 10.1378/chest.121.2.370; Hu GP, 2015, J THORAC DIS, V7, P59, DOI 10.3978/j.issn.2072-1439.2014.12.47; Islami F, 2015, TRANSL LUNG CANCER R, V4, P327, DOI 10.3978/j.issn.2218-6751.2015.08.04; Kanner RE, 1999, AM J MED, V106, P410, DOI 10.1016/S0002-9343(99)00056-X; Kessler R, 2011, EUR RESPIR J, V37, P264, DOI 10.1183/09031936.00051110; Kurmi OP, 2010, THORAX, V65, P221, DOI 10.1136/thx.2009.124644; Laniado-Laborin R, 2009, INT J ENV RES PUB HE, V6, P209, DOI 10.3390/ijerph6010209; Lopez AD, 2006, EUR RESPIR J, V27, P397, DOI 10.1183/09031936.06.00025805; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Murray RP, 1998, J CLIN EPIDEMIOL, V51, P1317, DOI 10.1016/S0895-4356(98)00120-6; Park H, 2015, KOREAN J FAM MED, V36, P128, DOI 10.4082/kjfm.2015.36.3.128; Quanjer PH, 2012, EUR RESPIR J, V40, P1324, DOI 10.1183/09031936.00080312; Salvi SS, 2009, LANCET, V374, P733, DOI 10.1016/S0140-6736(09)61303-9; Smith K.R., 2004, COMP QUANTIFICATION, V18, P1435; Sonomjamts M, 2014, ASIA PAC ALLERGY, V4, P25, DOI 10.5415/apallergy.2014.4.1.25; United Nations Economic and Social Commission for Asia and the Pacific ESCAP Statistical Database, 2014, ESCAP STAT DAT STAT; van den Boom G, 1998, EUR RESPIR J, V11, P67, DOI 10.1183/09031936.98.11010067; van Schayck C P Onno, 2006, Prim Care Respir J, V15, P81, DOI 10.1016/j.pcrj.2006.01.006; Viinanen A, 2005, ALLERGY, V60, P1370, DOI 10.1111/j.1398-9995.2005.00877.x; World Health Organization, AMBIENT OUTDOOR AIR; World Health Organization, TOP 10 CAUS DEATH; Zhong N, 2007, AM J RESP CRIT CARE, V176, P753, DOI 10.1164/rccm.200612-1749OC; Zhou Y., 2013, CURR BIOMARK FIND, V3, P1, DOI DOI 10.1155/2013/706156	35	4	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2017	12	4							e0175557	10.1371/journal.pone.0175557	http://dx.doi.org/10.1371/journal.pone.0175557			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0JS	28399185	Green Published, Green Submitted, gold			2022-12-27	WOS:000399949000049
J	Potvin, J; Werth, AJ				Potvin, Jean; Werth, Alexander J.			Oral cavity hydrodynamics and drag production in Balaenid whale suspension feeding	PLOS ONE			English	Article							BOWHEAD WHALE; FLOW; FILTRATION; MECHANISMS; ENGULFMENT; KINEMATICS	Balaenid whales feed on large aggregates of small and slow-moving prey (predominantly copepods) through a filtration process enabled by baleen. These whales exhibit continuous filtration, namely, with the mouth kept partially opened and the baleen exposed to oncoming prey-laden waters while fluking. The process is an example of crossflow filtration (CFF) in which most of the particulates (prey) are separated from the substrate (water) without ever coming into contact with the filtering surface (baleen). This paper discusses the simulation of baleen filtration hydrodynamics based on a type of hydraulic circuit modeling commonly used in microfluidics, but adapted to the much higher Reynolds number flows typical of whale hydrodynamics. This so-called Baleen Hydraulic Circuit (BHC) model uses as input the basic characteristics of the flows moving through a section of baleen observed in a previous flume study by the authors. The model has low-spatial resolution but incorporates the effects of fluid viscosity, which doubles or more a whale's total body drag in comparison to non-feeding travel. Modeling viscous friction is crucial here since exposing the baleen system to the open ocean ends up tripling a whale's total wetted surface area. Among other findings, the BHC shows how CFF is enhanced by a large filtration surface and hence large body size; how it is carried out via the establishment of rapid anteroposterior flows transporting most of the prey-water slurry towards the oropharyngeal wall; how slower intra-baleen flows manage to transfer most of the substrate out of the mouth, all the while contributing only a fraction to overall oral cavity drag; and how these anteroposterior and intra-baleen flows lose speed as they approach the oropharyngeal wall.	[Potvin, Jean] St Louis Univ, Dept Phys, St Louis, MO 63103 USA; [Werth, Alexander J.] Hampden Sydney Coll, Dept Biol, Hampden Sydney, VA 23943 USA	Saint Louis University	Potvin, J (corresponding author), St Louis Univ, Dept Phys, St Louis, MO 63103 USA.	potvinj@slu.edu		Werth, Alexander/0000-0002-7777-478X	Hampden-Sydney College; Virginia Foundation for Independent Colleges	Hampden-Sydney College; Virginia Foundation for Independent Colleges	JP did not get funding for the work performed in this manuscript. AJW acknowledges intramural funding provided by faculty grants from Hampden-Sydney College, and Mednick and Harris Awards from the Virginia Foundation for Independent Colleges.	Abbott IH., 1959, THEORY WING SECTIONS; [Anonymous], 1954, PIP FRICT MAN; Baumgartner MF, 2003, MAR ECOL PROG SER, V264, P123, DOI 10.3354/meps264123; Berthier J, 2010, ARTECH HSE INTEGR MI, P1; Blevins R. D., 1992, APPL FLUID DYNAMICS; Denny M., 1993, AIR WATER; Eppler R., 1990, AIRFOIL DESIGN DATA; Fish FE, 1998, J EXP BIOL, V201, P2867; Fontaine P-H., 2007, WHALES SEALS BIOL EC; Fox RW, 1978, INTRO FLUID MECH; Goldbogen JA, 2017, ANNU REV MAR SCI, V9, P367, DOI 10.1146/annurev-marine-122414-033905; Goldbogen JA, 2016, CRC MAR BIOL SER, P3; Goldbogen JA, 2012, FUNCT ECOL, V26, P216, DOI 10.1111/j.1365-2435.2011.01905.x; Goldbogen JA, 2010, AM SCI, V98, P124, DOI 10.1511/2010.83.124; Hain JHW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054340; Hertel H., 1966, STRUCTURE FORM MOVEM; KENNEY RD, 1986, MAR MAMMAL SCI, V2, P1, DOI 10.1111/j.1748-7692.1986.tb00024.x; Kesel AB, 2000, J EXP BIOL, V203, P3125; Kooyman G. L., 1989, DIVERSE DIVERS; Lambertsen RH, 2005, J MAMMAL, V86, P342, DOI 10.1644/BER-123.1; LOCKYER C, 1976, J CONSEIL, V36, P259, DOI 10.1093/icesjms/36.3.259; McGregor AE Nousek, 2010, THESIS; Nguyen L. A., 2011, THESIS; ORTON LS, 1987, CAN J ZOOL, V65, P2898, DOI 10.1139/z87-440; Paig-Tran EWM, 2013, J MORPHOL, V274, P1026, DOI 10.1002/jmor.20160; Potvin J, 2015, 23 AIAA AER DEC SYST; Potvin J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044854; Rae Jr WH, 1984, LOW SPEED WIND TUNNE, V2nd; Riedeberger D., 2012, HIGH PERFORMANCE COM, V32, P379; RUBENSTEIN DI, 1977, AM NAT, V111, P981, DOI 10.1086/283227; Sanderson S. Laurie, 1993, P37; SANDERSON SL, 1990, SCI AM, V262, P96, DOI 10.1038/scientificamerican0390-96; Shadwick RE, 2013, J EXP BIOL, V216, P2691, DOI 10.1242/jeb.081752; Shyy W, 2008, CAMB AERO SER, P1; Simon M, 2009, P ROY SOC B-BIOL SCI, V276, P3819, DOI 10.1098/rspb.2009.1135; van der Hoop JM, 2015, MARINE MAMMAL SCI; van der Hoop JM, 2013, MARINE MAMMAL SCI; Vogel S., 2003, COMP BIOMECHANICS LI; Werth AJ, 2004, J EXP BIOL, V207, P3569, DOI 10.1242/jeb.01202; Werth AJ., 2000, FEEDING FORM FUNCTIO, P475, DOI [10.1016/B978-012632590-4/50017-4, DOI 10.1016/B978-012632590-4/50017-4]; Werth AJ, 2016, J MORPHOL, V277, P453, DOI 10.1002/jmor.20510; Werth Alexander J., 2001, Bulletin of the Museum of Comparative Zoology, V156, P189; Werth Alexander J., 2012, International Journal of Ecology, P1; Werth AJ, 2013, J EXP BIOL, V216, P1152, DOI 10.1242/jeb.078931; Wilcox DC., 2006, TURBULENCE MODELING, V3	45	16	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2017	12	4							e0175220	10.1371/journal.pone.0175220	http://dx.doi.org/10.1371/journal.pone.0175220			37	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0JS	28399142	Green Submitted, gold, Green Published			2022-12-27	WOS:000399949000023
J	Zeng, P; Tan, QP; Meng, XK; Shao, ZM; Xie, QZ; Yan, Y; Cao, W; Xu, JJ				Zeng, Ping; Tan, Qingping; Meng, Xiankai; Shao, Zeming; Xie, Qinzheng; Yan, Ying; Cao, Wei; Xu, Jianjun			A multi-pattern hash-binary hybrid algorithm for URL matching in the HTTP protocol	PLOS ONE			English	Article								In this paper, based on our previous multi-pattern uniform resource locator (URL) binary-matching algorithm called HEM, we propose an improved multi-pattern matching algorithm called MH that is based on hash tables and binary tables. The MH algorithm can be applied to the fields of network security, data analysis, load balancing, cloud robotic communications, and so on-all of which require string matching from a fixed starting position. Our approach effectively solves the performance problems of the classical multi-pattern matching algorithms. This paper explores ways to improve string matching performance under the HTTP protocol by using a hash method combined with a binary method that transforms the symbol-space matching problem into a digital-space numerical-size comparison and hashing problem. The MH approach has a fast matching speed, requires little memory, performs better than both the classical algorithms and HEM for matching fields in an HTTP stream, and it has great promise for use in real-world applications.	[Zeng, Ping; Tan, Qingping; Meng, Xiankai; Shao, Zeming; Xie, Qinzheng; Yan, Ying; Xu, Jianjun] Natl Univ Def Technol, Coll Comp, Changsha, Hunan, Peoples R China; [Zeng, Ping; Tan, Qingping] Natl Univ Def Technol, Natl Key Lab Parallel & Distributed Proc, Changsha, Hunan, Peoples R China; [Cao, Wei] Changsha Univ Sci & Technol, Sch Comp & Commun Engn, Changsha, Hunan, Peoples R China	National University of Defense Technology - China; National University of Defense Technology - China; Changsha University of Science & Technology	Tan, QP (corresponding author), Natl Univ Def Technol, Coll Comp, Changsha, Hunan, Peoples R China.; Tan, QP (corresponding author), Natl Univ Def Technol, Natl Key Lab Parallel & Distributed Proc, Changsha, Hunan, Peoples R China.	eric_tan@nudt.edu.cn			Scientific Research Fund of the Hunan Provincial Education Department [15A007]; National Natural Science Foundation of China [61202116]	Scientific Research Fund of the Hunan Provincial Education Department(Hunan Provincial Education Department); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by Scientific Research Fund of the Hunan Provincial Education Department (No. 15A007) and National Natural Science Foundation of China (No. 61202116). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHO AV, 1975, COMMUN ACM, V18, P333, DOI 10.1145/360825.360855; Al-Ssulami AM, 2015, J INF SCI, V41, P82, DOI 10.1177/0165551514555668; Aldwairi M, 2015, 2015 2ND WORLD SYMPOSIUM ON WEB APPLICATIONS AND NETWORKING (WSWAN); Allauzen C, 1999, 9911 U MARN LA VALL; Baykan E, 2011, ACM T WEB, V5, DOI 10.1145/1993053.1993057; Ben-Kiki O, 2011, LEIBNIZ INT PR INFOR, V13, P423, DOI 10.4230/LIPIcs.FSTTCS.2011.423; Bremler-Barr A, 2016, 2016 IFIP NETWORKING CONFERENCE (IFIP NETWORKING) AND WORKSHOPS, P467, DOI 10.1109/IFIPNetworking.2016.7497218; Cantone D, 2010, LECT NOTES COMPUT SC, V6129, P288, DOI 10.1007/978-3-642-13509-5_26; Cantone D, 2010, LECT NOTES COMPUT SC, V6099, P166, DOI 10.1007/978-3-642-13122-6_18; Changsheng Miao, 2010, Proceedings of the 2010 Fourth International Conference on Genetic and Evolutionary Computing (ICGEC 2010), P582, DOI 10.1109/ICGEC.2010.149; Dogmus Z, 2015, ROBOT CIM-INT MANUF, V33, P100, DOI 10.1016/j.rcim.2014.08.010; Durian B, 2010, LECT NOTES COMPUT SC, V6049, P129, DOI 10.1007/978-3-642-13193-6_12; Faro Simone, 2012, Implementation and Application of Automata. Proceedings of the 17th International Conference (CIAA 2012), P149, DOI 10.1007/978-3-642-31606-7_13; Faro S., 2013, P 15 M ALGORITHM ENG, P113, DOI [DOI 10.1137/1.9781611972931.10, 10.1137/1.9781611972931.10]; Fielding R, 1997, RFC2068; He Long-Tao, 2005, Journal of Software, V16, P676, DOI 10.1360/jos160676; He SQ, 2006, APPL ELECT TECHNIQUE, V7, P30; Hlayel AA, 2014, J INF SCI, V40, P357, DOI 10.1177/0165551513519039; Kamei K, 2012, IEEE NETWORK, V26, P28, DOI 10.1109/MNET.2012.6201213; Kuffner J., 2010, HUMANOID ROBOTS HUMA, P519; Li Xiao-Ming, 2004, Journal of Software, V15, P179; [刘燕兵 Liu Yanbing], 2014, [计算机学报, Chinese Journal of Computers], V37, P1159; Navarro G, 2000, ACM J EXPT ALGORITHM, V5, P4, DOI DOI 10.1145/351827.384246; Ou W, 2007, MICROPROCESSORS, V28, P59; Peltola H, 2011, PROCEEDINGS OF THE PRAGUE STRINGOLOGY CONFERENCE 2011, P3; Wu S., 1994, TR9417 U AR DEP COMP; [薛颂东 XUE SongDong], 2008, [模式识别与人工智能, Pattern Recognition and Artificial Intelligence], V21, P177; Zeng P, 2015, 5 INT C COMM SYST NE, P2015; Zhang Heng, 2014, Application Research of Computers, V31, P2567, DOI 10.3969/j.issn.1001-3695.2014.09.002; Zhou X, 2010, PROCEEDINGS OF 2010 INTERNATIONAL CONFERENCE ON LOGISTICS SYSTEMS AND INTELLIGENT MANAGEMENT, VOLS 1-3, P1, DOI 10.1109/ICLSIM.2010.5461480	30	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2017	12	4							e0175500	10.1371/journal.pone.0175500	http://dx.doi.org/10.1371/journal.pone.0175500			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0JS	28399157	Green Submitted, gold, Green Published			2022-12-27	WOS:000399949000043
J	Kang, YM; Jung, CH; Cho, YK; Lee, SE; Lee, MJ; Hwang, JY; Kim, EH; Park, JY; Lee, WJ; Kim, HK				Kang, Yu Mi; Jung, Chang Hee; Cho, Yun Kyung; Lee, Seung Eun; Lee, Min Jung; Hwang, Jenie Yoonoo; Kim, Eun Hee; Park, Joong-Yeol; Lee, Woo Je; Kim, Hong-Kyu			Fatty liver disease determines the progression of coronary artery calcification in a metabolically healthy obese population	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; ALL-CAUSE; RISK; ASSOCIATION; CALCIUM; ATHEROSCLEROSIS; FRAMINGHAM; MORTALITY; DEFINITION; PREDICTION	Objectives Metabolically healthy obese (MHO) phenotype describes an obese state with a favorable metabolic profile. However, the prognosis of this subpopulation remains controversial. We aimed to examine whether MHO phenotype is associated with progression of atherosclerotic activity, reflected as the changes in coronary artery calcification (CAC) over time. If so, we sought to determine the role of fatty liver disease (FLD), the hallmark of hepatic steatosis, in this progression. Methods We enrolled 1,240 asymptomatic subjects who underwent repeated CAC score measurement during routine health examinations. CAC score progression was defined as either incident CAC in a population free of CAC at baseline, or an increase by >= 2.5 units between the baseline and final square root of CAC scores in participants with detectable CAC at baseline. Subjects were stratified by body mass index (cut-off, 25.0 kg/m(2)) and metabolic health state using Adult Treatment Panel-III criteria. FLD was assessed via ultrasonography. Results Over 2.9 years of follow-up, 25.2% of total subjects exhibited CAC score progression. The MHO phenotype was not significantly associated with CAC score progression (multivariate adjusted-odds ratio [OR], 1.45; 95% confidence interval [CI], 0.93-2.25), as compared to the metabolically healthy non-obese (MHNO) phenotype. However, subgroup analysis indicated that the MHO/FLD phenotype was significantly associated with CAC score progression (multivariate adjusted-OR, 2.37; 95% CI, 1.34-4.16), as compared to the MHNO/no FLD phenotype, whereas the MHO/no FLD phenotype was not (multivariate adjusted OR, 1.25; 95% CI, 0.71-2.24). Conclusions Obese individuals with FLD have an increased risk of atherosclerosis progression, despite their healthy metabolic profile. Preventive interventions targeting cardiometabolic risk factors should be considered in such individuals, regardless of the weight status.	[Kang, Yu Mi; Jung, Chang Hee; Cho, Yun Kyung; Lee, Seung Eun; Park, Joong-Yeol; Lee, Woo Je] Univ Ulsan, Coll Med, Dept Internal Med, Asan Med Ctr, Seoul, South Korea; [Lee, Min Jung; Hwang, Jenie Yoonoo; Kim, Eun Hee; Kim, Hong-Kyu] Univ Ulsan, Coll Med, Dept Hlth Screening & Promot Ctr, Asan Med Ctr, Seoul, South Korea	University of Ulsan; University of Ulsan	Jung, CH (corresponding author), Univ Ulsan, Coll Med, Dept Internal Med, Asan Med Ctr, Seoul, South Korea.; Kim, HK (corresponding author), Univ Ulsan, Coll Med, Dept Hlth Screening & Promot Ctr, Asan Med Ctr, Seoul, South Korea.	chjung0204@gmail.com; hkkim0801@amc.seoul.kr	Jung, Chang Hee/AAU-7897-2020; Kang, Yu Mi/AAW-2935-2020	Jung, Chang Hee/0000-0003-4043-2396				AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T; Amer Diabet Assoc, 2016, DIABETES CARE, V39, pS13, DOI 10.2337/dc16-S005; Bedogni Giorgio, 2004, Ann Hepatol, V3, P63; Bhatia LS, 2012, EUR HEART J, V33, P1190, DOI 10.1093/eurheartj/ehr453; Blackett PR, 2013, J CLIN LIPIDOL, V7, P65, DOI 10.1016/j.jacl.2012.04.079; Budoff MJ, 2010, JACC-CARDIOVASC IMAG, V3, P1229, DOI 10.1016/j.jcmg.2010.08.018; Carson AP, 2015, DIABETES CARE, V38, P66, DOI 10.2337/dc14-0360; Chang Y, 2016, AM J GASTROENTEROL, V111, P1133, DOI 10.1038/ajg.2016.178; Cho YK, 2015, ATHEROSCLEROSIS, V243, P300, DOI 10.1016/j.atherosclerosis.2015.09.027; Choi KM, 2013, CLIN ENDOCRINOL, V79, P364, DOI 10.1111/cen.12154; DeFilippis AP, 2011, J AM COLL CARDIOL, V58, P2076, DOI 10.1016/j.jacc.2011.08.022; Fan JY, 2013, INT J CARDIOL, V168, P4761, DOI 10.1016/j.ijcard.2013.07.230; Furusyo N, 2011, DIABETOLOGIA, V54, P3028, DOI 10.1007/s00125-011-2310-6; Gastaldelli A, 2009, HEPATOLOGY, V49, P1537, DOI 10.1002/hep.22845; Greenland P, 2004, JAMA-J AM MED ASSOC, V291, P210, DOI 10.1001/jama.291.2.210; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Hamer M, 2012, J CLIN ENDOCR METAB, V97, P2482, DOI 10.1210/jc.2011-3475; Heianza Y, 2014, J CLIN ENDOCR METAB, V99, P2952, DOI 10.1210/jc.2013-4427; Hernaez R, 2011, HEPATOLOGY, V54, P1082, DOI 10.1002/hep.24452; Hinnouho GM, 2013, DIABETES CARE, V36, P2294, DOI 10.2337/dc12-1654; Hokanson JE, 2004, AM J ROENTGENOL, V182, P1327, DOI 10.2214/ajr.182.5.1821327; Jung CH, 2016, OBESITY, V24, P1373, DOI 10.1002/oby.21483; Jung CH, 2015, KIDNEY INT, V88, P843, DOI 10.1038/ki.2015.183; Jung CH, 2015, J CLIN ENDOCR METAB, V100, P934, DOI 10.1210/jc.2014-3885; Jung CH, 2014, OBESITY, V22, P2613, DOI 10.1002/oby.20883; Kang YM, 2016, CLIN ENDOCRINOL, V85, P207, DOI 10.1111/cen.13074; Khan UI, 2011, ATHEROSCLEROSIS, V217, P179, DOI 10.1016/j.atherosclerosis.2011.01.007; Kramer CK, 2013, ANN INTERN MED, V159, P758, DOI 10.7326/0003-4819-159-11-201312030-00008; Kronmal RA, 2007, CIRCULATION, V115, P2722, DOI 10.1161/CIRCULATIONAHA.106.674143; Liu H, 2014, WORLD J GASTROENTERO, V20, P8407, DOI 10.3748/wjg.v20.i26.8407; Meigs JB, 2006, J CLIN ENDOCR METAB, V91, P2906, DOI 10.1210/jc.2006-0594; Oh SW, 2011, DIABETES METAB J, V35, P561, DOI 10.4093/dmj.2011.35.6.561; Ortega FB, 2013, EUR HEART J, V34, P390, DOI 10.1093/eurheartj/ehs174; Phillips CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076188; Rinella ME, 2015, JAMA-J AM MED ASSOC, V313, P2263, DOI 10.1001/jama.2015.5370; Rutter MK, 2004, CIRCULATION, V110, P380, DOI 10.1161/01.CIR.0000136581.59584.0E; Seo MH, 2014, ENDOCRINOL METAB, V29, P427, DOI 10.3803/EnM.2014.29.4.427; Stefan N, 2008, ARCH INTERN MED, V168, P1609, DOI 10.1001/archinte.168.15.1609; Stone NJ, 2014, CIRCULATION, V129, pS1, DOI 10.1161/01.cir.0000437738.63853.7a; Szczepaniak LS, 2005, AM J PHYSIOL-ENDOC M, V288, pE462, DOI 10.1152/ajpendo.00064.2004; Wildman RP, 2009, CURR OPIN CLIN NUTR, V12, P438, DOI 10.1097/MCO.0b013e32832c6db7; Wu SQ, 2016, SCI REP-UK, V6, DOI 10.1038/srep33386; Zheng RZ, 2016, J EPIDEMIOL COMMUN H, V70, P1024, DOI 10.1136/jech-2015-206948	43	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2017	12	4							e0175762	10.1371/journal.pone.0175762	http://dx.doi.org/10.1371/journal.pone.0175762			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KH	28419118	Green Published, Green Submitted, gold			2022-12-27	WOS:000399875200044
J	Lewis, ERG; Kilgore, PB; Mott, TM; Pradenas, GA; Torres, AG				Lewis, Eric R. G.; Kilgore, Paul B.; Mott, Tiffany M.; Pradenas, Gonzalo A.; Torres, Alfredo G.			Comparing in vitro and in vivo virulence phenotypes of Burkholderia pseudomallei type G strains	PLOS ONE			English	Article							MELIOIDOSIS	Burkholderia pseudomallei (Bpm) is a saprophytic rod-shaped gram-negative bacterium and the causative agent of melioidosis. This disease has previously been described as endemic in areas such as northern Australia and Southeast Asia, but, more recently, a better understanding of the epidemiology of melioidosis indicated that the disease is distributed worldwide, including regions of the Americas and Africa. A 16S-23S rDNA internal transcribed spacer (ITS) typing system has been developed for Bpm and has revealed that ITS types C, E, and hybrid CE are mainly associated with Australia and Southeast Asia while type G strains are more associated with cases of melioidosis in the Western Hemisphere. The purpose of the current study was to determine the in vitro and in vivo virulence profiles of the understudied Bpm type G strains Ca2009, Ca2013a, Mx2013, and 724644 and compared such phenotypes to the commonly studied Bpm type C strain K96243. We evaluated virulence by measuring invasion/uptake and survival of these Bpm strains in murine respiratory epithelial LA-4 cells and alveolar macrophage MH-S cells using different multiplicity of infections (MOIs of 1 and 10). We also calculated the lethal dose 50 values (LD50) in BALB/c mice that were inoculated intranasally with either Ca2009, Ca2013a, or Mx2013. Overall, the virulence and lethality phenotypes of Bpm type G strains were similar to the Bpm type C strain K96243. Additional comparative analyses between the Bpm ITS types may lead to a better understanding of the contribution of the ITS type to the epidemiology and ecology of Bpm strains.	[Lewis, Eric R. G.; Kilgore, Paul B.; Mott, Tiffany M.; Pradenas, Gonzalo A.; Torres, Alfredo G.] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA; [Torres, Alfredo G.] Univ Texas Med Branch, Dept Pathol, Sealy Ctr Vaccine Dev, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Torres, AG (corresponding author), Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA.; Torres, AG (corresponding author), Univ Texas Med Branch, Dept Pathol, Sealy Ctr Vaccine Dev, Galveston, TX 77555 USA.	altorres@utmb.edu	Kilgore, Paul E/L-1462-2013; Kilgore, Paul/AAD-2869-2019	Kilgore, Paul E/0000-0003-3214-4482; Kilgore, Paul/0000-0003-3214-4482; Torres, Alfredo/0000-0001-6450-0643	University of Texas Medical Branch; UTMB	University of Texas Medical Branch; UTMB	The study was partially funded by pilot funds from University of Texas Medical Branch. There was no additional external funding received for this study which was supported by pilot funds from UTMB.	Benoit TJ, 2015, AM J TROP MED HYG, V93, P1134, DOI 10.4269/ajtmh.15-0405; Brett PJ, 2007, MOL MICROBIOL, V63, P379, DOI 10.1111/j.1365-2958.2006.05519.x; Brilhante RSN, 2012, J CLIN MICROBIOL, V50, P3349, DOI 10.1128/JCM.01577-12; Burtnick MN, 2008, INFECT IMMUN, V76, P2991, DOI 10.1128/IAI.00263-08; Christenson Bernard, 2003, Bol Asoc Med P R, V95, P17; Currie BJ, 2015, SEMIN RESP CRIT CARE, V36, P111, DOI 10.1055/s-0034-1398389; David J, 2015, FRONT CELL INFECT MI, V5, DOI 10.3389/fcimb.2015.00080; Doker TJ, 2015, CLIN INFECT DIS, V60, P243, DOI 10.1093/cid/ciu764; Estes DM, 2010, EXPERT REV ANTI-INFE, V8, P325, DOI [10.1586/eri.10.4, 10.1586/ERI.10.4]; Gee JE, 2014, EMERG INFECT DIS, V20, P682, DOI 10.3201/eid2004.130960; Godoy D, 2003, J CLIN MICROBIOL, V41, P2068, DOI 10.1128/JCM.41.5.2068-2079.2003; Hatcher Christopher L, 2015, Curr Trop Med Rep, V2, P62; Holden MTG, 2004, P NATL ACAD SCI USA, V101, P14240, DOI 10.1073/pnas.0403302101; Judy BM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034176; Kespichayawattana W, 2004, MICROB PATHOGENESIS, V36, P287, DOI 10.1016/j.micpath.2004.01.001; Lewis ERG, 2016, PATHOG DIS, V74, DOI 10.1093/femspd/ftw070; Liguori AP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029323; Limmathurotsakul D, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2015.8, 10.1038/nmicrobiol.2015.8]; Limmathurotsakul D, 2011, BRIT MED BULL, V99, P125, DOI 10.1093/bmb/ldr007; Massey S, 2014, SCI REP-UK, V4, DOI 10.1038/srep04305; Mott TM, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003863; REED L. J., 1938, AMER JOUR HYG, V27, P493; Rolim DB, 2011, AM J TROP MED HYG, V84, P302, DOI 10.4269/ajtmh.2011.10-0220; Rotz LD, 2002, EMERG INFECT DIS, V8, P225, DOI 10.3201/eid0802.010164; Welkos SL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124667; Whitlock GC, 2009, J MED MICROBIOL, V58, P554, DOI 10.1099/jmm.0.007724-0; Wiersinga WJ, 2008, CELL MICROBIOL, V10, P81, DOI 10.1111/j.1462-5822.2007.01016.x; Willcocks SJ, 2016, CURR OPIN MICROBIOL, V29, P94, DOI 10.1016/j.mib.2015.11.007	28	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2017	12	4							e0175983	10.1371/journal.pone.0175983	http://dx.doi.org/10.1371/journal.pone.0175983			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KD	28414823	Green Published, gold, Green Submitted			2022-12-27	WOS:000399874800084
J	Lawson, RR; Gayle, JO; Wheaton, LA				Lawson, Regan R.; Gayle, Jordan O.; Wheaton, Lewis A.			Novel behavioral indicator of explicit awareness reveals temporal course of frontoparietal neural network facilitation during motor learning	PLOS ONE			English	Article							PERCEPTION; ATTENTION; IMPLICIT; MEMORY; ACTIVATION; KNOWLEDGE; DYNAMICS; BENEFITS; INSIGHTS; TASK	Deficits in sequential motor learning have been observed in many patient populations. Having an understanding of the individual neural progression associated with sequential learning in healthy individuals may provide valuable insights for effective interventions with these patients. Due to individual variability in motor skill acquisition, the temporal course of such learning will be vary, suggesting a need for a more individualized approach. Knowing when a subject becomes aware of movement patterns may provide a marker with which to identify each individual's learning time course. To avoid interfering with the incidental nature of discovery during learning, such an indicator requires an indirect, behaviorally-based approach. In Part I, our study aimed to identify a reliable behavioral indicator predictive of the presence of incidental explicit awareness in a sequential motor learning task. Part II, utilized the predictive indicator and EEG to provide neural validation of perceptual processing changes temporally correlated with the indicator. Results of Part I provide a reliable predictive indicator for the timing of explicit awareness development. Results from Part II demonstrates strong classification reliability, as well as a significant neural correlation with behavior for subjects developing awareness (EXP), not observed with subjects without awareness (NOEXP). Additionally, a temporal correlation of peak activation between neural regions was noted over frontoparietal regions, suggesting that the incidental discovery of motor patterns may involve a facilitative network during awareness development. The proposed indicator provides a tool in which to further examine potential impacts of awareness associated with incidental, or exploratory, motor learning, while the individual nature of the indicator provides a tool for monitoring progress in rehabilitative, exploratory motor learning paradigms.	[Lawson, Regan R.; Wheaton, Lewis A.] Georgia Inst Technol, Sch Biol Sci, Atlanta, GA 30332 USA; [Gayle, Jordan O.] Morehouse Coll, Sch Psychol, Atlanta, GA USA	University System of Georgia; Georgia Institute of Technology; Morehouse College	Wheaton, LA (corresponding author), Georgia Inst Technol, Sch Biol Sci, Atlanta, GA 30332 USA.	Iewis.wheaton@ap.gatech.edu	Wheaton, Lewis/B-4482-2009	Wheaton, Lewis/0000-0003-0771-0294	NIH Training Fellowship NICHD [5T32HD055180]	NIH Training Fellowship NICHD	Financial support was provided by NIH Training Fellowship NICHD 5T32HD055180 (www. nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appelbaum LG, 2012, J COGNITIVE NEUROSCI, V24, P1834, DOI 10.1162/jocn_a_00209; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bauer EP, 2001, NAT NEUROSCI, V4, P687, DOI 10.1038/89465; Beaulieu C, 2014, BMC NEUROSCI, P15; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Caporale N, 2008, ANNU REV NEUROSCI, V31, P25, DOI 10.1146/annurev.neuro.31.060407.125639; Dayan E, 2011, NEURON, V72, P443, DOI 10.1016/j.neuron.2011.10.008; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Fletcher PC, 2005, CEREB CORTEX, V15, P1002, DOI 10.1093/cercor/bhh201; Freyer F, 2013, J NEUROSCI, V33, P2900, DOI 10.1523/JNEUROSCI.4039-12.2013; Gerloff C, 1998, BRAIN, V121, P1513, DOI 10.1093/brain/121.8.1513; Gontier E, 2009, NEUROPSYCHOLOGY, V23, P668, DOI 10.1037/a0015757; Gonzalez A, 2015, P NATL ACAD SCI USA, V112, P11066, DOI 10.1073/pnas.1510749112; Habas C, 2010, NEURORADIOLOGY, V52, P47, DOI 10.1007/s00234-009-0572-1; Haider B, 2006, J NEUROSCI, V26, P4535, DOI 10.1523/JNEUROSCI.5297-05.2006; Hamame CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019221; Hughey L, 2016, J MOTOR BEHAV, V48, P519, DOI 10.1080/00222895.2016.1152223; James DRC, 2013, NEUROIMAGE, V64, P267, DOI 10.1016/j.neuroimage.2012.08.056; Kalpouzos G, 2013, PLOS ONE, V8; Keysers C, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0175; Krigolson OE, 2015, VISION RES, V110, P277, DOI 10.1016/j.visres.2014.12.024; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; Laubrock J, 2014, J EXP PSYCHOL HUMAN, V40, P1963, DOI 10.1037/a0037315; Lefebvre CD, 2005, CLIN NEUROPHYSIOL, V116, P1665, DOI 10.1016/j.clinph.2005.03.015; Lijffijt M, 2009, PSYCHOPHYSIOLOGY, V46, P1059, DOI 10.1111/j.1469-8986.2009.00845.x; Luck SJ, 2014, INTRODUCTION TO THE; Lukacs A, 2015, COGNITIVE SCI, V39, P383, DOI 10.1111/cogs.12143; Luu P, 2011, FRONTIERS IN HUMAN N, V5; Mahayana IT, 2014, BRAIN STIMUL, V7, P673, DOI 10.1016/j.brs.2014.06.012; Maier M, 2014, BRAIN COGNITION, V91, P1, DOI 10.1016/j.bandc.2014.07.008; Marangon M, 2016, FRONTIERS IN HUMAN N, P9; Marquez CMS, 2013, FRONTIERS IN HUMAN N, P7; Mayhew SD, 2012, J NEUROSCI, V32, P775, DOI 10.1523/JNEUROSCI.2033-11.2012; Moisello C, 2011, BRAIN RES BULL, V85, P104, DOI 10.1016/j.brainresbull.2011.03.023; Moisello C, 2009, EXP BRAIN RES, V194, P143, DOI 10.1007/s00221-008-1681-5; Nikolaev AR, 2008, BIOL PSYCHOL, V78, P53, DOI 10.1016/j.biopsycho.2007.12.010; NISSEN MJ, 1987, COGNITIVE PSYCHOL, V19, P1, DOI 10.1016/0010-0285(87)90002-8; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Oostenvelt R, 2003, TYPE; Orr JM, 2011, J NEUROSCI, V31, P5891, DOI 10.1523/JNEUROSCI.0279-11.2011; Paynter CA, 2009, NEUROPSYCHOLOGIA, V47, P796, DOI 10.1016/j.neuropsychologia.2008.12.009; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Robertson EM, 2007, J NEUROSCI, V27, P10073, DOI 10.1523/JNEUROSCI.2747-07.2007; Robertson EM, 2004, CURR BIOL, V14, P208, DOI 10.1016/j.cub.2004.01.027; Rose M, 2010, CEREB CORTEX, V20, P2787, DOI 10.1093/cercor/bhq025; Schwager S, 2012, ADV COGN PSYCHOL, V8, P132, DOI [10.5709/acp-0110-4, 10.2478/v10053-008-0110-4]; Shmuelof L, 2014, FRONTIERS IN HUMAN N, P8; Sukerkar P, 2010, TYPE; Taylor JA, 2013, IMPLICIT AND EXPLICI; Team RC, 2013, TYPE; Tremblay KL, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00028; Wenderoth N, 2006, NEUROIMAGE, V31, P264, DOI 10.1016/j.neuroimage.2005.11.033; Wessel JR, 2012, EXP BRAIN RES, V217, P153, DOI 10.1007/s00221-011-2982-7; Wheaton L, 2009, CLIN NEUROPHYSIOL, V120, P980, DOI 10.1016/j.clinph.2009.02.161; Willingham DB, 1998, PSYCHOL REV, V105, P558, DOI 10.1037/0033-295X.105.3.558; Wong AL, 2015, J NEUROPHYSIOL, V114, P219, DOI 10.1152/jn.00218.2015	56	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2017	12	4							e0175176	10.1371/journal.pone.0175176	http://dx.doi.org/10.1371/journal.pone.0175176			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET0MD	28410404	Green Submitted, Green Published, gold			2022-12-27	WOS:000399955600012
J	Li, Y; Xue, H; Sang, SQ; Lin, CL; Wang, XZ				Li, Yong; Xue, Han; Sang, Sheng-qi; Lin, Cai-li; Wang, Xi-zhuo			Phylogenetic analysis of family Neisseriaceae based on genome sequences and description of Populibacter corticis gen. nov., sp nov., a member of the family Neisseriaceae, isolated from symptomatic bark of Populus (x) euramericana canker	PLOS ONE			English	Article								Two Gram-stain negative aerobic bacterial strains were isolated from the bark tissue of Populus (x) euramericana. The novel isolates were investigated using a polyphasic approach including 16S rRNA gene sequencing, genome sequencing, average nucleotide identity (ANI) and both phenotypic and chemotaxonomic assays. The genome core gene sequence and 16S rRNA gene phylogenies suggest that the novel isolates are different from the genera Snodgrassella and Stenoxybacter. Additionally, the ANI, G+C content, main fatty acids and phospholipid profile data supported the distinctiveness of the novel strain from genus Snodgrassella. Therefore, based on the data presented, the strains constitute a novel species of a novel genus within the family Neisseriaceae, for which the name Populibacter corticis gen. nov., sp. nov. is proposed. The type strain is 15-3-5(T) (= CFCC 13594(T) = KCTC 42251(T)).	[Li, Yong; Xue, Han; Lin, Cai-li; Wang, Xi-zhuo] Chinese Acad Forestry, Key Lab State Forestry Adm Forest Protect, Res Inst Forest Ecol Environm & Protect, Beijing, Peoples R China; [Sang, Sheng-qi] Agr High & New Technol Dev Ctr Puyang, Puyang, Peoples R China; [Li, Yong] Chinese Acad Forestry, Res Inst Forest Ecol Environm & Protect, Beijing, Peoples R China	Chinese Academy of Forestry; Research Institute of Forest Ecology, Environment and Protection, CAF; Chinese Academy of Forestry; Research Institute of Forest Ecology, Environment and Protection, CAF	Li, Y (corresponding author), Chinese Acad Forestry, Key Lab State Forestry Adm Forest Protect, Res Inst Forest Ecol Environm & Protect, Beijing, Peoples R China.; Li, Y (corresponding author), Chinese Acad Forestry, Res Inst Forest Ecol Environm & Protect, Beijing, Peoples R China.	lylx78@hotmail.com	Li, Yong/GYJ-3895-2022		National Natural Science Foundation of China [31570640]; National Infrastructure of Microbial Resources [NIMR-2017-7]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Infrastructure of Microbial Resources	This study was funded by the National Natural Science Foundation of China (31570640) and National Infrastructure of Microbial Resources (NIMR-2017-7). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker GC, 2003, J MICROBIOL METH, V55, P541, DOI 10.1016/j.mimet.2003.08.009; COLLINS MD, 1977, J GEN MICROBIOL, V100, P221, DOI 10.1099/00221287-100-2-221; Du HJ, 2013, INT J SYST EVOL MICR, V63, P900, DOI 10.1099/ijs.0.041491-0; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Gerhardt P, 1981, MANUAL METHODS GEN B; Goris J, 2007, INT J SYST EVOL MICR, V57, P81, DOI 10.1099/ijs.0.64483-0; Groth I, 1997, INT J SYST BACTERIOL, V47, P1129, DOI 10.1099/00207713-47-4-1129; Kim OS, 2012, INT J SYST EVOL MICR, V62, P716, DOI 10.1099/ijs.0.038075-0; Kwong WK, 2013, INT J SYST EVOL MICR, V63, P2008, DOI 10.1099/ijs.0.044875-0; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI [DOI 10.4135/9781446279281.N7, DOI 10.1271/BBB.67.1048]; Lee I, 2016, INT J SYST EVOL MICR, V66, P1100, DOI 10.1099/ijsem.0.000760; Li Y, 2014, INT J SYST EVOL MICR, V64, P1043, DOI 10.1099/ijs.0.051995-0; Li Y, 2014, PLANT DIS, V98, P368, DOI 10.1094/PDIS-01-13-0115-RE; MINNIKIN DE, 1984, J MICROBIOL METH, V2, P233, DOI 10.1016/0167-7012(84)90018-6; Qin QL., J BACTERIOLOGY, V196, P2210; Richter M, 2009, P NATL ACAD SCI USA, V106, P19126, DOI 10.1073/pnas.0906412106; Romero-Hernandez B, 2015, ANTIMICROB AGENTS CH, V59, P2006, DOI 10.1128/AAC.04083-14; RYAN KJ, 2004, SHERRIS MED MICROBIO; Sasser M, 1990, IDENTIFICATION BACTE; Schroeter J., 1886, KRYPTOGAMENFLORA SCH, V3; Smibert Robert M., 1994, P607; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tindall BJ, 2010, INT J SYST EVOL MICR, V60, P249, DOI 10.1099/ijs.0.016949-0; Toth T, 2013, INT J SYST EVOL MICR, V63, P2309, DOI 10.1099/ijs.0.042911-0; Yarza P, 2008, SYST APPL MICROBIOL, V31, P241, DOI 10.1016/j.syapm.2008.07.001; Yarza P, 2014, NAT REV MICROBIOL, V12, P635, DOI 10.1038/nrmicro3330; Zhao YB, 2014, BIOINFORMATICS, V30, P1297, DOI 10.1093/bioinformatics/btu017	28	13	13	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2017	12	4							e0174506	10.1371/journal.pone.0174506	http://dx.doi.org/10.1371/journal.pone.0174506			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0MB	28406911	Green Published, gold, Green Submitted			2022-12-27	WOS:000399955400010
J	Dai, M; Yuan, FQ; Fu, C; Shen, GD; Hu, SL; Shen, G				Dai, Meng; Yuan, Fei; Fu, Cuiqun; Shen, Guodong; Hu, Shilian; Shen, Gan			Relationship between epithelial cell adhesion molecule (EpCAM) overexpression and gastric cancer patients: A systematic review and meta-analysis	PLOS ONE			English	Review							EP-CAM; IMMUNOTHERAPEUTIC TARGET; STEM-CELLS; EXPRESSION; ADENOCARCINOMA; PROLIFERATION	Objectives The epithelial cell adhesion molecule (EpCAM) is one of the most commonly used markers of cancer stem cells (CSCs), but the clinical and prognostic significance of EpCAM in gastric cancer (GC) remains disputable. Motivated by heterogeneous and inconclusive results, we conducted a systematic review and meta-analysis to systematically summarize and elucidate the association between EpCAM overexpression and GC patients. Methods The PubMed, Cochrane Library, Medline, Web of Knowledge and the China National Knowledge Infrastructure (CNKI) databases were searched to identify relevant studies. The RevMan 5.3 software was used for the meta-analysis. Fixed-effects or random-effects models were applied depending on the presence of heterogeneity. The pooled odds ratio (ORs) and 95% confidence intervals (CIs) were applied to estimate the associations between EpCAM and gastric cancer. For the significant heterogeneity studies, sensitivity analyses were applied based on the population to test the robustness of the pooled results and identify possible sources of heterogeneity. Results A total of 11 studies including 1960 GC patients met our inclusion criteria. The results of the meta-analyses revealed that there were significant differences in EpCAM overexpression and tumour size (OR = 2.97, 95% CI: 2.13 similar to 4.13, P < 0.00001), the nature of the tissue (OR = 80.30, 95% CI: 29.21 similar to 220.81, P < 0.00001), lymph node metastasis (OR = 2.78, 95% CI: 1.23 similar to 6.27, P = 0.01), and the cumulative 5-year overall survival rate (OR = 0.54, 95% CI: 0.29 similar to 0.99, P = 0.05). No significant associations were identified between EpCAM overexpression and gender (OR = 0.89, 95% CI: 0.66 similar to 1.19, P = 0.43), age (OR = 1.13, 95% CI: 0.58 similar to 2.20, P = 0.73), tumour stage (OR = 2.26, 95% CI: 0.79 similar to 6.45, P = 0.13), distant metastasis (OR = 2.15, 95% CI: 0.20 similar to 22.69, P = 0.52), TNM stage (OR = 5.14, 95% CI: 0.77 similar to 34.37, P = 0.09), Lauren type (OR = 1.18, 95% CI: 0.08 similar to 16.45, P = 0.9), differentiation (OR = 1.88, 95% CI: 0.65 similar to 5.41, P = 0.24). However, due to significant heterogeneity in tumor stage, lymph node metastasis, TNM stage, differentiation and Lauren type, these results should be taken carefully. Conclusions The meta-analysis demonstrated that the expression of EpCAM in the gastric cancer group was greater than that in the control group. Moreover, EpCAM overexpression was associated with larger tumour size, lymphnode metastasis and worse prognosis in gastric cancer. Due to significant heterogeneity, the sensitivity analysis suggests that population factor may be an important source of heterogeneity, and these results should be treated with caution. EpCAM may be useful as a novel prognostic factor, and large-scale and well-designed studies are needed to validate our results in the future.	[Dai, Meng; Fu, Cuiqun; Shen, Guodong; Hu, Shilian; Shen, Gan] Affiliated Anhui Med Univ, Anhui Prov Hosp, Dept Geriatr, Hefei, Anhui, Peoples R China; [Dai, Meng; Fu, Cuiqun; Shen, Guodong; Hu, Shilian; Shen, Gan] Anhui Prov Key Lab Tumour Immunotherapy & Nutr Th, Hefei, Anhui, Peoples R China; [Yuan, Fei] Yijishan Hosp Wannan Med Coll, Dept Pharm, Wuhu, Anhui, Peoples R China	Wannan Medical College	Shen, GD; Shen, G (corresponding author), Affiliated Anhui Med Univ, Anhui Prov Hosp, Dept Geriatr, Hefei, Anhui, Peoples R China.; Shen, GD; Shen, G (corresponding author), Anhui Prov Key Lab Tumour Immunotherapy & Nutr Th, Hefei, Anhui, Peoples R China.	gdshen@ustc.edu.cn; shenganustc@163.com	沈, 国栋/ABA-5925-2021	沈, 国栋/0000-0003-2521-8738	Anhui Provincial Natural Science Foundation [1408085MH167]; Anhui Provincial Science and Technology Key Projects in China [1501041164]	Anhui Provincial Natural Science Foundation(Natural Science Foundation of Anhui Province); Anhui Provincial Science and Technology Key Projects in China	This work was supported by the Anhui Provincial Natural Science Foundation (1408085MH167) and the Anhui Provincial Science and Technology Key Projects (1501041164) in China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Anhui Provincial Natural Science Foundation (1408085MH167, http://218.22.27.67/Ahzrj j/index.action?flag=zjps) and the Anhui Provincial Science and Technology Key Projects (1501041164, http://220.178.98.61/kjt/index.aspx) in China. The funders had no role in the study design, data collection and analysis, decision to publish, or the preparation of the manuscript.	Bao LD, 2012, ASIAN PAC J CANCER P, V13, P3687, DOI 10.7314/APJCP.2012.13.8.3687; Chaudry MA, 2007, BRIT J CANCER, V96, P1013, DOI 10.1038/sj.bjc.6603505; Crew KD, 2006, WORLD J GASTROENTERO, V12, P354, DOI 10.3748/wjg.v12.i3.354; Du WQ, 2010, DIGEST DIS SCI, V55, P2165, DOI 10.1007/s10620-009-1033-8; Du WQ, 2009, J CANCER RES CLIN, V135, P1277, DOI 10.1007/s00432-009-0569-5; Fong D, 2014, J CLIN PATHOL, V67, P408, DOI 10.1136/jclinpath-2013-201932; Gladden AB, 2005, J CELL BIOCHEM, V96, P906, DOI 10.1002/jcb.20613; Heideman DAM, 2001, CANCER GENE THER, V8, P342, DOI 10.1038/sj.cgt.7700313; Joo M, 2005, J GASTROEN HEPATOL, V20, P1039, DOI 10.1111/j.1440-1746.2005.03842.x; Kim JH, 2003, CLIN CANCER RES, V9, P4782; Kim S, 2005, INT J RADIAT ONCOL, V63, P1279, DOI 10.1016/j.ijrobp.2005.05.005; Kreso A, 2014, CELL STEM CELL, V14, P275, DOI 10.1016/j.stem.2014.02.006; Kroepil Feride, 2013, BMC Res Notes, V6, P253, DOI 10.1186/1756-0500-6-253; Lo CKL, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-45; Lu M D, 2011, ANHUI MED J, V32, P1801; Nguyen LV, 2012, NAT REV CANCER, V12, P133, DOI 10.1038/nrc3184; [彭云香 Peng Yunxiang], 2011, [吉林大学学报. 医学版, Journal of Jilin Univeristy. Medicine edition], V37, P296; Rycaj K, 2015, CANCER RES, V75, P4003, DOI 10.1158/0008-5472.CAN-15-0798; Seimetz D, 2010, CANCER TREAT REV, V36, P458, DOI 10.1016/j.ctrv.2010.03.001; Songun I, 2005, BRIT J CANCER, V92, P1767, DOI 10.1038/sj.bjc.6602519; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; van der Gun BTF, 2010, CARCINOGENESIS, V31, P1913, DOI 10.1093/carcin/bgq187; Wagner AD, 2006, J CLIN ONCOL, V24, P2903, DOI 10.1200/JCO.2005.05.0245; Wang T, 2015, ONCOTARGET, V6, P44191, DOI 10.18632/oncotarget.6176; Wang YY, 2013, J EXP CLIN CANC RES, V32, DOI 10.1186/1756-9966-32-66; Warneke VS, 2013, BRIT J CANCER, V109, P2217, DOI 10.1038/bjc.2013.536; Went P, 2006, BRIT J CANCER, V94, P128, DOI 10.1038/sj.bjc.6602924; [杨世斌 Yang Shibin], 2012, [中国病理生理杂志, Chinese Journal of Pathophysiology], V28, P1224; Yonaiyama S, 2013, BIOMED RES-TOKYO, V34, P87, DOI 10.2220/biomedres.34.87; Yu ZR, 2012, INT J BIOCHEM CELL B, V44, P2144, DOI 10.1016/j.biocel.2012.08.022; Zhao XZ, 2016, ONCOL LETT, V11, P442, DOI 10.3892/ol.2015.3884; Zhou MW, 2014, BMC OPHTHALMOL, V14, DOI 10.1186/1471-2415-14-41; 张旺清, 2011, [广东医学, Guangdong Medical Journal], V32, P2815	33	30	32	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2017	12	4							e0175357	10.1371/journal.pone.0175357	http://dx.doi.org/10.1371/journal.pone.0175357			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LZ	28403178	Green Published, Green Submitted, gold			2022-12-27	WOS:000399955200054
J	Pardeshi, P; Rao, KK; Balaji, PV				Pardeshi, Peehu; Rao, K. Krishnamurthy; Balaji, Petety V.			Rv3634c from Mycobacterium tuberculosis H37Rv encodes an enzyme with UDP-Gal/Glc and UDP-GalNAc 4-epimerase activities	PLOS ONE			English	Article							ESCHERICHIA-COLI O86-B7; MYCOBACTERIUM-TUBERCULOSIS; SUBSTRATE-SPECIFICITY; CELL-WALL; GALACTOSE 4'-EPIMERASE; HEXOSE 4-EPIMERASES; BIOCHEMICAL-CHARACTERIZATION; PSEUDOMONAS-AERUGINOSA; GLCNAC/GLC 4-EPIMERASE; CAMPYLOBACTER-JEJUNI	A bioinformatics study revealed that Mycobacterium tuberculosis H37Rv (Mtb) contains sequence homologs of Campylobacter jejuni protein glycosylation enzymes. The ORF Rv3634c from Mtb was identified as a sequence homolog of C. jejuni UDP-Gal/GalNAc 4-epimerase. This study reports the cloning of Rv3634c and its expression as an N-terminal His-tagged protein. The recombinant protein was shown to have UDP-Gal/Glc 4-epimerase activity by GOD-POD assay and by reverse phase HPLC. This enzyme was shown to have UDP-GalNAc 4-epimerase activity also. Residues Ser121, Tyr146 and Lys150 were shown by site-directed mutagenesis to be important for enzyme activity. Mutation of Ser121 and Tyr146 to Ala and Phe, respectively, led to complete loss of activity whereas mutation of Lys150 to Arg led to partial loss of activity. There were no gross changes in the secondary structures of any of these three mutants. These results suggest that Ser121 and Tyr146 are essential for epimerase activity of Rv3634c. UDP-Gal/Glc 4-epimerases from other organisms also have a catalytic triad consisting of Ser, Tyr and Lys. The triad carries out proton transfer from nucleotide sugar to NAD(+) and back, thus effecting the epimerization of the substrate. Addition of NAD(+) to Lys150 significantly abrogates the loss of activity, suggesting that, as in other epimerases, NAD(+) is associated with Rv3634c.	[Pardeshi, Peehu; Rao, K. Krishnamurthy; Balaji, Petety V.] Indian Inst Technol Bombay Powai, Dept Biosci & Bioengn, Mumbai, Maharashtra, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Bombay	Rao, KK; Balaji, PV (corresponding author), Indian Inst Technol Bombay Powai, Dept Biosci & Bioengn, Mumbai, Maharashtra, India.	kkr@iitb.ac.in; balaji@iitb.ac.in		Balaji, Petety/0000-0002-6018-6957	Department of Biotechnology, Ministry of Science and Technology [BT/PR14810/BRB/10/879/2010]; IIT Bombay	Department of Biotechnology, Ministry of Science and Technology; IIT Bombay	This work was funded by award no. BT/PR14810/BRB/10/879/2010 from the Department of Biotechnology, Ministry of Science and Technology; recipient: Petety V. Balaji. PP thanks IIT Bombay for a research fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Dr. Vinay Nandicoori, National Institute of Immunology, India for the generous gift of Mtb genomic DNA. The authors also thank Dr. G. Bashiri, University of Auckland, New Zealand for the generous gift of pYUB28b. PP thanks IIT Bombay for a research fellowship.	Bashiri G, 2010, METAB ENG, V5, P1; Beerens K, 2015, CARBOHYD RES, V414, P8, DOI 10.1016/j.carres.2015.06.006; Bernatchez S, 2005, J BIOL CHEM, V280, P4792, DOI 10.1074/jbc.M407767200; Betts JC, 2002, MOL MICROBIOL, V43, P717, DOI 10.1046/j.1365-2958.2002.02779.x; Boels IC, 2001, APPL ENVIRON MICROB, V67, P3033, DOI 10.1128/AEM.67.7.3033-3040.2001; Boshoff HIM, 2005, NAT REV MICROBIOL, V3, P70, DOI 10.1038/nrmicro1065; Casonato S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108893; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Creuzenet C, 2000, J BIOL CHEM, V275, P19060, DOI 10.1074/jbc.M001171200; DAUDE N, 1995, BIOCHEM MOL MED, V56, P1, DOI 10.1006/bmme.1995.1048; de Souza GA, 2011, J PROTEOMICS, V75, P502, DOI 10.1016/j.jprot.2011.08.016; Fontan PA, 2008, J INFECT DIS, V198, P877, DOI 10.1086/591098; Frey PA, 2013, ACCOUNTS CHEM RES, V46, P1417, DOI 10.1021/ar300246k; Fry BN, 2000, INFECT IMMUN, V68, P2594, DOI 10.1128/IAI.68.5.2594-2601.2000; Fu LM, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-37; Green MR, 2012, MOL CLONING LAB MANU, V1; Griffin JE, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002251; Gu S, 2003, MOL CELL PROTEOMICS, V2, P1284, DOI 10.1074/mcp.M300060-MCP200; Gu XL, 2005, PROTEIN EXPRES PURIF, V42, P47, DOI 10.1016/j.pep.2005.03.015; Guo HJ, 2007, BIOCHEM BIOPH RES CO, V356, P604, DOI 10.1016/j.bbrc.2007.03.015; Guo HJ, 2006, BIOCHEMISTRY-US, V45, P13760, DOI 10.1021/bi0612770; Holden HM, 2003, J BIOL CHEM, V278, P43885, DOI 10.1074/jbc.R300025200; Ishiyama N, 2004, J BIOL CHEM, V279, P22635, DOI 10.1074/jbc.M401642200; Kalpana G V., 1991, METHODS ENZYMOL, V204, p[537, 803]; Kaur Devinder, 2009, Adv Appl Microbiol, V69, P23, DOI 10.1016/S0065-2164(09)69002-X; Kavanagh K, 2008, CELL MOL LIFE SCI, V65, P3895, DOI 10.1007/s00018-008-8588-y; kovierova H, 2010, J BIOL CHEM, V285, P41348; Kumar M, 2011, MOL BIOSYST, V7, P1629, DOI 10.1039/c0mb00259c; Liu YJ, 1997, BIOCHEMISTRY-US, V36, P10675, DOI 10.1021/bi970430a; Ma YF, 2001, ANTIMICROB AGENTS CH, V45, P1407, DOI 10.1128/AAC.45.5.1407-1416.2001; Malen H, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-132; Mawuenyega KG, 2005, MOL BIOL CELL, V16, P396, DOI 10.1091/mbc.e04-04-0329; McCorvie TJ, 2012, BBA-MOL BASIS DIS, V1822, P1516, DOI 10.1016/j.bbadis.2012.05.007; Rosenkrands I, 2000, ELECTROPHORESIS, V21, P3740, DOI 10.1002/1522-2683(200011)21:17<3740::AID-ELPS3740>3.3.CO;2-V; RYLL T, 1991, J CHROMATOGR-BIOMED, V570, P77, DOI 10.1016/0378-4347(91)80202-N; Sassetti CM, 2003, P NATL ACAD SCI USA, V100, P12989, DOI 10.1073/pnas.2134250100; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Schulz JM, 2004, J BIOL CHEM, V279, P32796, DOI 10.1074/jbc.M405005200; Sidders B, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-12-r265; Singh V, 2007, FUNGAL GENET BIOL, V44, P563, DOI 10.1016/j.fgb.2006.11.006; Somoza JR, 2000, STRUCTURE, V8, P123, DOI 10.1016/S0969-2126(00)00088-5; Stern RJ, 1999, MICROBIOL-UK, V145, P663, DOI 10.1099/13500872-145-3-663; SWANSON BA, 1993, BIOCHEMISTRY-US, V32, P13231, DOI 10.1021/bi00211a035; Weston A, 1998, TUBERCLE LUNG DIS, V78, P123, DOI 10.1016/S0962-8479(98)80005-1; Wolfe LM, 2010, J PROTEOME RES, V9, P5816, DOI 10.1021/pr1005873; Zhou Y, 2011, ARCH MICROBIOL, V193, P751, DOI 10.1007/s00203-011-0715-8	46	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2017	12	4							e0175193	10.1371/journal.pone.0175193	http://dx.doi.org/10.1371/journal.pone.0175193			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LZ	28403215	Green Published, gold, Green Submitted			2022-12-27	WOS:000399955200041
J	Stoeckle, MY; Soboleva, L; Charlop-Powers, Z				Stoeckle, Mark Y.; Soboleva, Lyubov; Charlop-Powers, Zachary			Aquatic environmental DNA detects seasonal fish abundance and habitat preference in an urban estuary	PLOS ONE			English	Article							EDNA; QUANTIFICATION; BIODIVERSITY; INFERENCE; GENOME; RATES; WATER	The difficulty of censusing marine animal populations hampers effective ocean management. Analyzing water for DNA traces shed by organisms may aid assessment. Here we tested aquatic environmental DNA (eDNA) as an indicator of fish presence in the lower Hudson River estuary. A checklist of local marine fish and their relative abundance was prepared by compiling 12 traditional surveys conducted between 1988-2015. To improve eDNA identification success, 31 specimens representing 18 marine fish species were sequenced for two mitochondrial gene regions, boosting coverage of the 12S eDNA target sequence to 80% of local taxa. We collected 76 one-liter shoreline surface water samples at two contrasting estuary locations over six months beginning in January 2016. eDNA was amplified with vertebrate-specific 12S primers. Bioinformatic analysis of amplified DNA, using a reference library of GenBank and our newly generated 12S sequences, detected most (81%) locally abundant or common species and relatively few (23%) uncommon taxa, and corresponded to seasonal presence and habitat preference as determined by traditional surveys. Approximately 2% of fish reads were commonly consumed species that are rare or absent in local waters, consistent with wastewater input. Freshwater species were rarely detected despite Hudson River inflow. These results support further exploration and suggest eDNA will facilitate fine-scale geographic and temporal mapping of marine fish populations at relatively low cost.	[Stoeckle, Mark Y.; Soboleva, Lyubov] Univ Rochester, Program Human Environm, Rochester, NY 14627 USA; [Charlop-Powers, Zachary] Univ Rochester, Lab Genetically Encoded Small Mol, Rochester, NY 14627 USA	University of Rochester; University of Rochester	Stoeckle, MY (corresponding author), Univ Rochester, Program Human Environm, Rochester, NY 14627 USA.	mark.stoeckle@rockefeller.edu	Stoeckle, Mark/D-3729-2011	Stoeckle, Mark/0000-0002-8280-4795; Charlop-Powers, Zachary/0000-0001-8816-4680	The Rockefeller University-Monmouth University Marine Science Policy Initiative; National Institutes of Health [AI110029]	The Rockefeller University-Monmouth University Marine Science Policy Initiative; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by The Rockefeller University-Monmouth University Marine Science Policy Initiative (MYS) and the National Institutes of Health Grant AI110029 (ZCP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Able KW, 1992, 1 YEAR LIFE ESTUARIN, VRutgers University Press; [Anonymous], 2011, FIELD GUIDE COASTAL; ASA Analysis & Communication, 2015, 2013 YEAR CLASS REP; Bigelow H.B., 1953, FISHERIES B FISH WIL, V53, P307; Biggs J, 2015, BIOL CONSERV, V183, P19, DOI 10.1016/j.biocon.2014.11.029; Blumberg AF, 1997, J GEOPHYS RES-OCEANS, V102, P5685, DOI 10.1029/96JC03416; Bourlat SJ, 2013, MAR POLLUT BULL, V74, P19, DOI 10.1016/j.marpolbul.2013.05.042; Callahan BJ, 2016, NAT METHODS, V13, P581, DOI [10.1038/NMETH.3869, 10.1038/nmeth.3869]; Cooper J.C., 1988, AM FISHERIES SOC MON, V4, P11; Deagle BE, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2014.0562; Dejean T, 2012, J APPL ECOL, V49, P953, DOI 10.1111/j.1365-2664.2012.02171.x; Dejean T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023398; Evans NT, 2016, MOL ECOL RESOUR, V16, P29, DOI 10.1111/1755-0998.12433; Ficetola GF, 2015, MOL ECOL RESOUR, V15, P543, DOI 10.1111/1755-0998.12338; Ficetola GF, 2008, BIOL LETTERS, V4, P423, DOI 10.1098/rsbl.2008.0118; Foote AD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041781; Ivanova NV, 2006, MOL ECOL NOTES, V6, P998, DOI 10.1111/j.1471-8286.2006.01428.x; Jerde CL, 2011, CONSERV LETT, V4, P150, DOI 10.1111/j.1755-263X.2010.00158.x; Kelly RP, 2017, FRONT MAR SCI, V3, DOI 10.3389/fmars.2016.00283; Kelly RP, 2014, SCIENCE, V344, P1455, DOI 10.1126/science.1251156; Kelly RP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086175; Klymus KE, 2015, BIOL CONSERV, V183, P77, DOI 10.1016/j.biocon.2014.11.020; Krause J, 2010, NATURE, V464, P894, DOI 10.1038/nature08976; Lahoz-Monfort JJ, 2016, MOL ECOL RESOUR, V16, P673, DOI 10.1111/1755-0998.12486; Laramie MB, 2015, BIOL CONSERV, V183, P29, DOI 10.1016/j.biocon.2014.11.025; Leese F., 2016, RES IDEAS OUTCOMES, V2, DOI [10.3897/rio.2.e11321, DOI 10.3897/RIO.2.E11321]; Leonard JA, 2007, J ARCHAEOL SCI, V34, P1361, DOI 10.1016/j.jas.2006.10.023; Li CH, 2007, MOL PHYLOGENET EVOL, V44, P386, DOI 10.1016/j.ympev.2006.10.030; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Matsui K, 2001, AQUAT MICROB ECOL, V26, P95, DOI 10.3354/ame026095; Miya M, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.150088; National Oceanographic and Atmospheric Administration, 1999, NMFSNE121; New York City Department of Environmental Protection, 2011, NEW YORK HARBOR WATE; Page R., 2011, DARK TAXA GENBANK PO; Port JA, 2016, MOL ECOL, V25, P527, DOI 10.1111/mec.13481; Riaz T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr732; Riverkeeper, 2015, WAT FEC CONT HUDS RI; Sassoubre LM, 2016, ENVIRON SCI TECHNOL, V50, P10456, DOI 10.1021/acs.est.6b03114; Sigsgaard EE, 2017, NAT ECOL EVOL, V1, DOI 10.1038/s41559-016-0004; Simmons M, 2016, CAN J FISH AQUAT SCI, V73, P76, DOI 10.1139/cjfas-2015-0262; Takahara T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056584; Takahara T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035868; The River Project, FISH CAUGHT HUDS RIV; Thomsen PF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165252; Thomsen PF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041732; Thomsen PF, 2012, MOL ECOL, V21, P2565, DOI 10.1111/j.1365-294X.2011.05418.x; Turner CR, 2014, METHODS ECOL EVOL, V5, P676, DOI 10.1111/2041-210X.12206; U.S. Army Corps of Engineers, 2004, NEW YORK NEW JERS HA; Valentini A, 2016, MOL ECOL, V25, P929, DOI 10.1111/mec.13428; Waldman John R., 2006, P171, DOI 10.1017/CBO9780511550539.015; Wilson C, 2014, MANAG BIOL INVASION, V5, P225, DOI 10.3391/mbi.2014.5.3.05; Yamamoto S, 2017, SCI REP-UK, V7, DOI 10.1038/srep40368	52	85	97	6	123	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2017	12	4							e0175186	10.1371/journal.pone.0175186	http://dx.doi.org/10.1371/journal.pone.0175186			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LZ	28403183	Green Submitted, Green Published, gold			2022-12-27	WOS:000399955200039
J	Liu, F; Liang, JR; Shen, LL; Yang, M; Zhang, D; Lai, ZH				Liu, Feng; Liang, Jinrong; Shen, Linlin; Yang, Meng; Zhang, David; Lai, Zhihui			Case study of 3D fingerprints applications	PLOS ONE			English	Article							RECONSTRUCTION; RECOGNITION; ALIGNMENT	Human fingers are 3D objects. More information will be provided if three dimensional (3D) fingerprints are available compared with two dimensional (2D) fingerprints. Thus, this paper firstly collected 3D finger point cloud data by Structured-light Illumination method. Additional features from 3D fingerprint images are then studied and extracted. The applications of these features are finally discussed. A series of experiments are conducted to demonstrate the helpfulness of 3D information to fingerprint recognition. Results show that a quick alignment can be easily implemented under the guidance of 3D finger shape feature even though this feature does not work for fingerprint recognition directly. The newly defined distinctive 3D shape ridge feature can be used for personal authentication with Equal Error Rate (EER) of similar to 8.3%. Also, it is helpful to remove false core point. Furthermore, a promising of EER similar to 1.3% is realized by combining this feature with 2D features for fingerprint recognition which indicates the prospect of 3D fingerprint recognition.	[Liu, Feng; Liang, Jinrong; Shen, Linlin; Yang, Meng; Lai, Zhihui] Shenzhen Univ, Sch Comp Sci & Software Engn, Comp Vis Inst, Shenzhen, Guangdong, Peoples R China; [Zhang, David] Hong Kong Polytech Univ, Dept Comp, Kowloon, Hong Kong, Peoples R China	Shenzhen University; Hong Kong Polytechnic University	Liu, F (corresponding author), Shenzhen Univ, Sch Comp Sci & Software Engn, Comp Vis Inst, Shenzhen, Guangdong, Peoples R China.	feng.liu@szu.edu.cn	Shen, Linlin/AEX-9392-2022; Lai, Zhihui/R-1000-2019; Zhang, David/O-9396-2016	Shen, Linlin/0000-0003-1420-0815; Lai, Zhihui/0000-0002-4388-3080; Zhang, David/0000-0002-5027-5286	National Natural Science Foundation of China [61403257, 61402289, 61573248]; Shenzhen Fundamental Research fund [JCYJ20150324140036868]; National Science Foundation of Guangdong Province [2014A030313558]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shenzhen Fundamental Research fund; National Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province)	The work is supported by the National Natural Science Foundation of China (Grant no. 61403257, 61402289, 61573248),. Shenzhen Fundamental Research fund JCYJ20150324140036868, National Science Foundation of Guangdong Province (Grant no. 2014A030313558). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BESL PJ, 1992, IEEE T PATTERN ANAL, V14, P239, DOI 10.1109/34.121791; Do Q, 2016, IEEE T INF FOREN SEC, V11, P2174, DOI 10.1109/TIFS.2016.2578285; Fatehpuria A., 2006, SPIE DEFENSE SECURIT, V6202; Fu ZJ, 2016, IEEE T INF FOREN SEC, V11, P2706, DOI 10.1109/TIFS.2016.2596138; Gu B, 2016, IEEE T NEUR NET LEAR, DOI [DOI 10.1109/TNNLS.2016.2527796, 10.1109/TNNLS.2016.2527796]; Gu B, 2015, IEEE T NEUR NET LEAR, V26, P1403, DOI 10.1109/TNNLS.2014.2342533; Gu B, 2015, NEURAL NETWORKS, V67, P140, DOI 10.1016/j.neunet.2015.03.013; Guo ZH, 2016, IEEE T IMAGE PROCESS, V25, P687, DOI 10.1109/TIP.2015.2507408; Huang SJ, 2014, OPT LASER ENG, V52, P123, DOI 10.1016/j.optlaseng.2013.07.001; Kong AWK, 2004, INT C PATT RECOG, P520, DOI 10.1109/ICPR.2004.1334184; Kumar A., 2013, P CVPR 2013 PORTL OR, P4321; Kumar A, 2015, IEEE T PATTERN ANAL, V37, P681, DOI 10.1109/TPAMI.2014.2339818; Kumari S, 2017, FUTURE GENER COMP SY, V68, P320, DOI 10.1016/j.future.2016.10.004; Li W., 2012, P 10 INT C ADV MOB C, P297; Lindoso A, 2007, LECT NOTES COMPUT SC, V4642, P713; Liu F, 2014, THESIS CLEMSON U; Liu F, 2015, NEUROCOMPUTING, V168, P599, DOI 10.1016/j.neucom.2015.05.065; Liu F, 2014, PATTERN RECOGN, V47, P178, DOI 10.1016/j.patcog.2013.06.009; Liu F, 2013, IEEE T INF FOREN SEC, V8, P1446, DOI 10.1109/TIFS.2013.2272787; Liu LM, 2007, IMAGING SCI J, V55, P114, DOI 10.1179/174313107X189221; Lu XQ, 2017, IEEE T CYBERNETICS, V47, P884, DOI 10.1109/TCYB.2016.2531179; Maltoni D., 2009, HDB FINGERPRINT RECO; NetPreProc, MAX MIN GRAPH NORM; Pang XF, 2013, IEEE COMPUT GRAPH, V33, P73, DOI 10.1109/MCG.2012.128; Parziale G, 2006, LECT NOTES COMPUT SC, V3832, P244; Parziale G, 2004, LECT NOTES COMPUT SC, V3072, P241; Peng J, 2016, J NETW COMPUT APPL, V72, P14, DOI 10.1016/j.jnca.2016.06.012; Shen L., 2015, INT J PATTERN RECOGN, V25, P273; Shi XS, 2015, IEEE T IMAGE PROCESS, V24, P1341, DOI 10.1109/TIP.2015.2405474; Shi XS, 2014, PATTERN RECOGN, V47, P2447, DOI 10.1016/j.patcog.2014.01.007; SRINIVASAN V, 1984, APPL OPTICS, V23, P3105, DOI 10.1364/AO.23.003105; Troy M., 2011, SPIE MOEMS MEMS; Wang YC, 2010, IEEE T INF FOREN SEC, V5, P750, DOI 10.1109/TIFS.2010.2062177; Wang YC, 2010, APPL OPTICS, V49, P592, DOI 10.1364/AO.49.000592; Wong WK, 2015, IEEE T CYBERNETICS, V45, P2425, DOI 10.1109/TCYB.2014.2374452; Xie WY, 2010, LECT NOTES COMPUT SC, V6454, P31, DOI 10.1007/978-3-642-17274-8_4; Yager N, 2006, PATTERN RECOGN LETT, V27, P317, DOI 10.1016/j.patrec.2005.08.016; Yuan CS, 2016, CHINA COMMUN, V13, P60, DOI 10.1109/CC.2016.7559076; Yuan Y, 2015, IEEE T NEUR NET LEAR, V26, P2222, DOI 10.1109/TNNLS.2014.2359471; Zhang D, 2010, PATTERN RECOGN, V43, P358, DOI 10.1016/j.patcog.2009.04.026; Zhang DW, 2013, INT J POLYM SCI, V2013, DOI 10.1155/2013/175609; Zhao QJ, 2010, PATTERN RECOGN, V43, P1050, DOI 10.1016/j.patcog.2009.08.004; Zhou ZL, 2017, IEEE T INF FOREN SEC, V12, P48, DOI 10.1109/TIFS.2016.2601065; Zhu ZX, 2015, INFORM SCIENCES, V298, P274, DOI 10.1016/j.ins.2014.11.045	44	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2017	12	4							e0175261	10.1371/journal.pone.0175261	http://dx.doi.org/10.1371/journal.pone.0175261			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0JS	28399141	Green Published, Green Submitted, gold			2022-12-27	WOS:000399949000024
J	Liu, WF; Wu, JP; Fan, HB; Duan, HL; Li, Q; Yuan, YH; Zhang, H				Liu, Wenfei; Wu, Jianping; Fan, Houbao; Duan, Honglang; Li, Qiang; Yuan, Yinghong; Zhang, Hao			Estimations of evapotranspiration in an age sequence of Eucalyptus plantations in subtropical China	PLOS ONE			English	Article							WATER-USE; UROPHYLLA PLANTATIONS; CARBON STORAGE; FOREST; TRANSPIRATION; BALANCE; GROWTH; GRANDIS; PLANT; CAMALDULENSIS	Eucalyptus species are widely planted for reforestation in subtropical China. However, the effects of Eucalyptus plantations on the regional water use remain poorly understood. In an age sequence of 2-, 4- and 6-year-old Eucalyptus plantations, the tree water use and soil evaporation were examined by linking model estimations and field observations. Results showed that annual evapotranspiration of each age sequence Eucalyptus plantations was 876.7, 944.1 and 1000.7 mm, respectively, accounting for 49.81%, 53.64% and 56.86% of the annual rainfall. In addition, annual soil evaporations of 2-, 4- and 6-year-old were 318.6, 336.1, and 248.7 mm of the respective Eucalyptus plantations. Our results demonstrated that Eucalyptus plantations would potentially reduce water availability due to high evapotranspiration in subtropical regions. Sustainable management strategies should be implemented to reduce water consumption in Eucalyptus plantations in the context of future climate change scenarios such as drought and warming.	[Liu, Wenfei; Wu, Jianping; Fan, Houbao; Duan, Honglang; Yuan, Yinghong; Zhang, Hao] Nanchang Inst Technol, Jiangxi Prov Key Lab Restorat Degraded Ecosyst &, Nanchang, Jiangxi, Peoples R China; [Li, Qiang] Univ British Columbia Okanagan, Dept Earth Environm & Geog Sci, Kelowna, BC, Canada	Nanchang Institute Technology; University of British Columbia; University of British Columbia Okanagan	Fan, HB (corresponding author), Nanchang Inst Technol, Jiangxi Prov Key Lab Restorat Degraded Ecosyst &, Nanchang, Jiangxi, Peoples R China.	hbfan@nit.edu.cn	Fan, houbao/GQZ-7022-2022	Li, Qiang/0000-0003-2221-6905	National Science Foundation of China [31160153]; Jiangxi Provincial Department of Education [KJLD12097, GJJ14744]; Gan-po 555 Talent Project; Jiangxi Provincial Fund for Academic and Technical Leadership of Major Disciplines [20162BCB22021]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangxi Provincial Department of Education; Gan-po 555 Talent Project; Jiangxi Provincial Fund for Academic and Technical Leadership of Major Disciplines	This work was financially supported by the National Science Foundation of China (No. 31160153), Jiangxi Provincial Department of Education (KJLD12097; GJJ14744), Gan-po 555 Talent Project and Jiangxi Provincial Fund for Academic and Technical Leadership of Major Disciplines (20162BCB22021). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to the editor and all anonymous reviewers for their helpful comments on the manuscript. We thank Yingchun Liao for her field help. This work was financially supported by the National Science Foundation of China (No. 31160153), Jiangxi Provincial Department of Education (KJLD12097; GJJ14744), Gan-po 555 Talent Project and Jiangxi Provincial Fund for Academic and Technical Leadership of Major Disciplines (20162BCB22021). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida AC, 2007, FOREST ECOL MANAG, V251, P10, DOI 10.1016/j.foreco.2007.06.009; [Anonymous], 2001, CHINESE SOIL TAXOMOM; Benyon RG, 1999, AGR WATER MANAGE, V39, P229, DOI 10.1016/S0378-3774(98)00080-8; Bren L, 2010, J HYDROL, V384, P52, DOI 10.1016/j.jhydrol.2010.01.007; Cabral OMR, 2010, J HYDROL, V388, P208, DOI 10.1016/j.jhydrol.2010.04.041; Chen H, 1995, ADV WATERENCE; Chen JM, 2013, J FUJIAN FORESTRY SC, V40, P6; Chen YQ, 2015, FORESTS, V6, P794, DOI 10.3390/f6030794; Cramer VA, 1999, AGR WATER MANAGE, V39, P187, DOI 10.1016/S0378-3774(98)00078-X; Cui XiangHui, 2006, Scientia Silvae Sinicae, V42, P8; DIXON RK, 1994, SCIENCE, V263, P185, DOI 10.1126/science.263.5144.185; Dye P, 2013, FOREST ECOL MANAG, V301, P51, DOI 10.1016/j.foreco.2012.08.027; DYE PJ, 1993, PLANT CELL ENVIRON, V16, P45, DOI 10.1111/j.1365-3040.1993.tb00843.x; Engel V, 2005, WATER RESOUR RES, V41, P3053; Fan HB, 2015, PLANT SOIL, V392, P127, DOI 10.1007/s11104-015-2444-2; [冯建设 Feng Jianshe], 2011, [应用气象学报, Journal of Applied Meteorolgical Science], V22, P766; Feng XM, 2013, SCI REP-UK, V3, DOI 10.1038/srep02846; Forrester DI, 2010, FOREST ECOL MANAG, V259, P1754, DOI 10.1016/j.foreco.2009.04.023; Gong Z.T., 2007, PEDOGENESIS SOIL TAX; Hargreaves G. H., 1985, Applied Engineering in Agriculture, V1, P96; Hargreaves GH, 2003, J IRRIGATION DRAINAG, V129, P187; Hua Lei, 2014, Yingyong Shengtai Xuebao, V25, P1639; Hubbard RM, 2010, FOREST ECOL MANAG, V259, P1714, DOI 10.1016/j.foreco.2009.10.028; HULME M, 1992, CLIM DYNAM, V7, P57, DOI 10.1007/BF00209609; IPCC, 2007, CLIM CHANG 2007 PHYS; Kallarackal J, 1997, TREE PHYSIOL, V17, P195; Li Q, 2014, AGR ECOSYST ENVIRON, V196, P114, DOI 10.1016/j.agee.2014.06.028; LIMA W P, 1984, IPEF (Instituto de Pesquisas e Estudos Florestais), P11; Liu XD, 2015, ECOHYDROLOGY, V8, P1037, DOI 10.1002/eco.1561; Morris J, 2004, TREE PHYSIOL, V24, P1035, DOI 10.1093/treephys/24.9.1035; Myers BJ, 1996, TREE PHYSIOL, V16, P211; Pan YD, 2011, SCIENCE, V333, P988, DOI 10.1126/science.1201609; Roberts S, 2001, FOREST ECOL MANAG, V143, P153, DOI 10.1016/S0378-1127(00)00514-4; Rodriguez-Suarez JA, 2011, J HYDROL, V396, P321, DOI 10.1016/j.jhydrol.2010.11.027; Sankarasubramanian A, 2001, WATER RESOUR RES, V37, P1771, DOI 10.1029/2000WR900330; Scott DF, 1998, WATER SA, V24, P187; Scott DF, 2008, WATER RESOUR RES, V44, P297; Shi ZhongJie, 2009, Scientia Silvae Sinicae, V45, P135; Soares JV, 2001, J HYDROL, V253, P130, DOI 10.1016/S0022-1694(01)00477-2; Stape JL, 2010, FOREST ECOL MANAG, V259, P1684, DOI 10.1016/j.foreco.2010.01.012; STATE FOREST RESOURCES ADMINISTRATIONPRC'S MINISTRY OF FORESTRY [Guojia linyeju senlin ziyuan guanglisi], 2010, FOREST RESOURCES MAN, V1, P1; Vertessy RA, 2001, FOREST ECOL MANAG, V143, P13, DOI 10.1016/S0378-1127(00)00501-6; Wang FM, 2013, PLANT SOIL, V364, P207, DOI 10.1007/s11104-012-1353-x; Wang FM, 2010, RESTOR ECOL, V18, P313, DOI 10.1111/j.1526-100X.2009.00642.x; Wang HF, 2011, NEW FOREST, V42, P101, DOI 10.1007/s11056-010-9240-x; White DA, 2014, FOREST ECOL MANAG, V331, P272, DOI 10.1016/j.foreco.2014.08.020; Wu JP, 2015, ENVIRON MANAGE, V56, P1244, DOI 10.1007/s00267-015-0578-x; Wu JP, 2014, SCI REP-UK, V4, DOI 10.1038/srep06262; [闫俊华 Yan Junhua], 2003, [生态学报, Acta Ecologica Sinica], V23, P2359; Yang MS, 2011, RES EUCALYPTUS CHINA; Yu Z. Y., 1985, TROPICAL SUBTROPICAL, V3, P97, DOI DOI 10.1111/NPH.14119; Zhang L, 2001, WATER RESOUR RES, V37, P701, DOI 10.1029/2000WR900325; Zhang Ning-Nan, 2007, Forest Research, V20, P1; Zhao CJ, 2015, ACTA ECOLOGICA SINIC, V35, P692; [赵从举 Zhao Congju], 2015, [生态学报, Acta Ecologica Sinica], V35, P1734; Zheng H, 2008, FOREST ECOL MANAG, V255, P1113, DOI 10.1016/j.foreco.2007.10.015; Zhou GY, 2013, GLOBAL CHANGE BIOL, V19, P1197, DOI 10.1111/gcb.12128	57	17	19	5	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2017	12	4							e0174208	10.1371/journal.pone.0174208	http://dx.doi.org/10.1371/journal.pone.0174208			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0JS	28399174	Green Submitted, gold, Green Published			2022-12-27	WOS:000399949000008
J	Pelissari, DM; Diaz-Quijano, FA				Pelissari, Daniele Maria; Diaz-Quijano, Fredi Alexander			Household crowding as a potential mediator of socioeconomic determinants of tuberculosis incidence in Brazil	PLOS ONE			English	Article							RISK-FACTORS; INDICATORS; END	Although many studies have identified social conditions associated with tuberculosis, contextual and individual factors have rarely been analysed simultaneously. Consequently, we aimed to identify contextual and individual factors associated with tuberculosis incidence in general population in Brazil in 2010. We also assessed whether household crowding mediates the association between socioeconomic determinants and tuberculosis incidence. Individual data of tuberculosis cases were obtained from 5,565 municipalities in Brazil in 2010 (last year of national census), and merged with contextual variables. The associations were evaluated in a multilevel analysis using negative binomial regression. After adjusting for individual factors (age, sex and race) and geographic region, the following contextual factors were associated with tuberculosis incidence rate: AIDS incidence rate [incidence rate ratio (IRR), 1.21; 95% confidence interval (CI), 1.18-1.24], unemployment rate (IRR, 1.16; 95% CI, 1.13-1.19), Gini coefficient (IRR, 1.05; 95% CI, 1.02-1.08), proportion of inmates (IRR, 1.11; 95% CI, 1.09-1.14), mean per capita household income (IRR, 0.94; 95% CI, 0.91- 0.97) and primary care coverage (IRR, 0.94; 95% CI, 0.92-0.96). Inclusion of household crowding in the multivariate model led to a loss of the associations of both Gini coefficient and mean per capita household income. In conclusion, our findings suggest that income inequality and poverty, as determinants of tuberculosis incidence, can be mediated by household crowding. Moreover, prison population can represent a potential social reservoir of tuberculosis in Brazil and should be addressed as a priority for disease control. Finally, the negative association between primary health coverage and tuberculosis incidence highlights the importance of this level of care as a strategy to control this disease.	[Pelissari, Daniele Maria] Minist Hlth, Natl TB Program Brazil, Brasilia, DF, Brazil; [Pelissari, Daniele Maria; Diaz-Quijano, Fredi Alexander] Univ Sao Paulo, Sch Publ Hlth, Dept Epidemiol, Sao Paulo, Sao Paulo, Brazil; [Pelissari, Daniele Maria] Minist Hlth, Brasilia, DF, Brazil; [Diaz-Quijano, Fredi Alexander] Univ Sao Paulo, Sch Publ Hlth, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	Pelissari, DM (corresponding author), Minist Hlth, Natl TB Program Brazil, Brasilia, DF, Brazil.; Pelissari, DM (corresponding author), Univ Sao Paulo, Sch Publ Hlth, Dept Epidemiol, Sao Paulo, Sao Paulo, Brazil.; Pelissari, DM (corresponding author), Minist Hlth, Brasilia, DF, Brazil.	daniele.pelissan@gmail.com	Diaz-Quijano, Fredi Alexander/I-3740-2012	Diaz-Quijano, Fredi Alexander/0000-0002-1134-1930; Pelissari, Daniele Maria/0000-0002-0760-1875				Angelo JR, 2008, THESIS; Baker M, 2008, J EPIDEMIOL COMMUN H, V62, P715, DOI 10.1136/jech.2007.063610; Bartholomay P, 2016, REV PANAM SALUD PUBL, V39, P3; Baussano I, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000381; Brazilian Ministry of Health, 2010, NAT INF SYST NOT DIS; Brazilian Ministry of Health, 2004, CRIT DEF CAS AIDS AD; Brazilian Ministry of Justice, 2014, NAT SURV PEN INF; Cantwell MF, 1998, AM J RESP CRIT CARE, V157, P1016, DOI 10.1164/ajrccm.157.4.9704036; Castro DB, 2016, PLOS ONE; Chan-Yeung M, 2005, INT J TUBERC LUNG D, V9, P1320; Ximenes RAD, 2009, INT J EPIDEMIOL, V38, P1285, DOI 10.1093/ije/dyp224; Dhanaraj B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124260; Diaz de Quijano E, 2001, Rev Esp Salud Publica, V75, P517, DOI 10.1590/S1135-57272001000600004; Dye C, 2009, B WORLD HEALTH ORGAN, V87, P683, DOI 10.2471/BLT.08.058453; Ferrara G, 2012, CURR OPIN PULM MED, V18, P233, DOI 10.1097/MCP.0b013e328351f9d6; Janssens JP, 2008, EUR RESPIR J, V32, P1415, DOI 10.1183/09031936.00078708; Kraemer HC, 2001, AM J PSYCHIAT, V158, P848, DOI 10.1176/appi.ajp.158.6.848; Kufa T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111209; Kwan CK, 2011, CLIN MICROBIOL REV, V24, P351, DOI 10.1128/CMR.00042-10; Lacerda SNB, 2014, INT ARCH MED, V7, P1; Lienhardt C, 2005, INT J EPIDEMIOL, V34, P914, DOI 10.1093/ije/dyi100; Lonnroth K, 2010, LANCET, V375, P1814, DOI 10.1016/S0140-6736(10)60483-7; Marquieviz J, 2013, CIENC SAUDE COLETIVA, V18, P265, DOI 10.1590/S1413-81232013000100027; Molina Serpa Ivette, 2003, Cad. Saúde Pública, V19, P1305, DOI 10.1590/S0102-311X2003000500009; Myers WP, 2006, AM J PUBLIC HEALTH, V96, P685, DOI 10.2105/AJPH.2004.048132; Pang PTT, 2010, INT J TUBERC LUNG D, V14, P585; Ponticiello A, 2005, EUR J EPIDEMIOL, V20, P729, DOI 10.1007/s10654-005-0615-9; Prasad A, 2016, T ROY SOC TROP MED H, V110, P151, DOI 10.1093/trstmh/trw004; San Pedro A, 2013, REV PANAM SALUD PUBL, V33, P294, DOI 10.1590/S1020-49892013000400009; SCHWARTZ S, 1994, AM J PUBLIC HEALTH, V84, P819, DOI 10.2105/AJPH.84.5.819; Shetty P, 2011, LANCET, V377, P627, DOI 10.1016/S0140-6736(11)60215-8; Siqueira A. E. S. S., 2014, THESIS; Siroka A, 2016, LANCET INFECT DIS, V16, P473, DOI 10.1016/S1473-3099(15)00401-6; United Nations Development Programme, HUM DEV ATL; Uplekar M, 2015, LANCET, V385, P1799, DOI 10.1016/S0140-6736(15)60570-0; Victora CG, 2011, LANCET, V377, P85, DOI 10.1016/S0140-6736(10)60810-0; World Health Organisation (WHO), 2016, GLOB TUB REP 2016	37	22	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2017	12	4							e0176116	10.1371/journal.pone.0176116	http://dx.doi.org/10.1371/journal.pone.0176116			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES9KH	28419146	Green Published, Green Submitted, gold			2022-12-27	WOS:000399875200076
J	Akbar, S; Du, JJ; Jia, Y; Tian, XJ				Akbar, Siddiq; Du, Jingjing; Jia, Yong; Tian, Xingjun			The importance of calcium in improving resistance of Daphnia to Microcystis	PLOS ONE			English	Article							OFFSPRING DISEASE RESISTANCE; LIFE-HISTORY; CYANOBACTERIAL BLOOMS; ZOOPLANKTON; TOLERANCE; TEMPERATURE; DIVERSITY; QUALITY; FITNESS; MAGNA	Changing environmental calcium (Ca) and rising cyanobacterial blooms in lake habitats could strongly reduce Daphnia growth and survival. Here, we assessed the effects of maternal Ca in Daphnia on transfer of resistance to their offspring against Microcystis aeruginosa PCC7806 (M. aeruginosa). Laboratory microcosm experiments were performed to examine effects in Daphnia carinata (D. carinata) and Daphnia pulex (D. pulex), and that how Ca induce responses in their offspring. The results showed that growth and survival were increased in offspring from exposed Daphnia as compared to unexposed, when raised in high Ca and increasing M. aeruginosa concentration. Among exposed Daphnia, offspring from high Ca mothers, produced more neonates with large size and higher survival as compared to offspring from low maternal Ca. Exposed D. carinata and D. pulex offspring, when reared in Ca deficient medium and increasing M. aeruginosa concentration, time to first brood increased, size become large and total offspring decreased subsequently in three alternative broods in offspring from low maternal Ca. In contrast, growth and reproduction in offspring from high Ca exposed mothers were consistent in three alternative broods. Despite species specific responses in growth, survival and variant life history traits in two Daphnia species, our results not only show maternal induction in Daphnia but also highlight that offspring response to M. aeruginosa varies with maternal Ca. This study demonstrates that Ca have role in Daphnia maternal induction against Microcystis, and recent Ca decline and increasing Microcystis concentration in lakes may decrease Daphnia growth and survival. Our data provide insights into the interactive effect of maternal Ca and Microcystis exposure on Daphnia and their outcome on offspring life history traits and survival.	[Akbar, Siddiq; Tian, Xingjun] Nanjing Univ, Sch Life Sci, Nanjing, Jiangsu, Peoples R China; [Du, Jingjing] Zhengzhou Univ Light Ind, Sch Mat & Chem Engn, Henan Collaborat Innovat Ctr Environm Pollut Cont, Zhengzhou, Peoples R China; [Jia, Yong] Nanjing Normal Univ, Coll Life Sci, Jiangsu Engn & Technol Res Ctr Ind Microbial Reso, Jiangsu Key Lab Microbes & Funct Genom, Nanjing, Jiangsu, Peoples R China	Nanjing University; Zhengzhou University of Light Industry; Nanjing Normal University	Tian, XJ (corresponding author), Nanjing Univ, Sch Life Sci, Nanjing, Jiangsu, Peoples R China.	tianxj@nju.edu.cn	Akbar, Siddiq/L-6891-2019; Du, Jingjing/Y-3783-2019; Akbar, Siddiq/AAK-8034-2020	Akbar, Siddiq/0000-0003-1582-1744; Du, jingjing/0000-0001-6692-3703	State Key Program of National Natural Science Foundation of China [3153007]; Major Science and Technology Program for Water Pollution Control and Treatment [2012ZX07204-004-003]; Sanxin Forestry Project in Jiangsu Province [LYSX [2012]02]; Ph.D. Programs Foundation of the Ministry of Education of China [20110091110018]; Strategic Priority Research Program-Climate Change: Carbon Budget; Related Issues of the Chinese Academy of Sciences [XDA05050204]; specimen platform of China; teaching specimens sub-platform [2005DKA21403-JK]	State Key Program of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major Science and Technology Program for Water Pollution Control and Treatment; Sanxin Forestry Project in Jiangsu Province; Ph.D. Programs Foundation of the Ministry of Education of China(Ministry of Education, China); Strategic Priority Research Program-Climate Change: Carbon Budget; Related Issues of the Chinese Academy of Sciences; specimen platform of China; teaching specimens sub-platform	This work was supported by the State Key Program of National Natural Science Foundation of China (3153007), Major Science and Technology Program for Water Pollution Control and Treatment (No. 2012ZX07204-004-003), The Sanxin Forestry Project in Jiangsu Province (LYSX [2012]02), Ph.D. Programs Foundation of the Ministry of Education of China (No. 20110091110018), Strategic Priority Research Program-Climate Change: Carbon Budget and Related Issues of the Chinese Academy of Sciences (XDA05050204), The specimen platform of China, and the teaching specimens sub-platform (2005DKA21403-JK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AA, 1998, ACTA OECOL, V19, P331, DOI 10.1016/S1146-609X(98)80037-4; Alekseev VR, 2009, AQUAT ECOL, V43, P415, DOI 10.1007/s10452-008-9168-9; Alstad NEW, 1999, LIMNOL OCEANOGR, V44, P2011, DOI 10.4319/lo.1999.44.8.2011; Becker C, 2003, LIMNOL OCEANOGR, V48, P700, DOI 10.4319/lo.2003.48.2.0700; BRETT MT, 1993, J PLANKTON RES, V15, P403, DOI 10.1093/plankt/15.4.403; Brookes JD, 2011, SCIENCE, V334, P46, DOI 10.1126/science.1207349; Cairns A, 2009, ENVIRON REV, V17, P67, DOI 10.1139/A09-005; Calbet A, 2004, LIMNOL OCEANOGR, V49, P51, DOI 10.4319/lo.2004.49.1.0051; Declerck SAJ, 2011, BASIC APPL ECOL, V12, P466, DOI 10.1016/j.baae.2011.05.001; Dominguez DC, 2015, CELL CALCIUM, V57, P151, DOI 10.1016/j.ceca.2014.12.006; Du JJ, 2015, LIMNOLOGICA, V51, P94, DOI 10.1016/j.limno.2014.12.009; Edwards BA, 2015, HYDROBIOLOGIA, V744, P91, DOI 10.1007/s10750-014-2059-2; Fitzer SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071257; Freitas EC, 2014, HARMFUL ALGAE, V31, P143, DOI 10.1016/j.hal.2013.11.004; Frost PC, 2010, OECOLOGIA, V162, P865, DOI 10.1007/s00442-009-1517-4; Frost PC, 2005, FRESHWATER BIOL, V50, P1781, DOI 10.1111/j.1365-2427.2005.01457.x; Garbutt JS, 2014, FUNCT ECOL, V28, P424, DOI 10.1111/1365-2435.12197; Ger KA, 2014, FRESHWATER BIOL, V59, P1783, DOI 10.1111/fwb.12393; Ger KA, 2016, HARMFUL ALGAE, V54, P128, DOI 10.1016/j.hal.2015.12.005; Ghadouani A, 2003, FRESHWATER BIOL, V48, P363, DOI 10.1046/j.1365-2427.2003.01010.x; Giardini JL, 2015, J EXP BIOL, V218, P2005, DOI 10.1242/jeb.123513; Gustafsson S, 2005, ECOLOGY, V86, P2561, DOI 10.1890/04-1710; Gustafsson S, 2004, AQUAT ECOL, V38, P37, DOI 10.1023/B:AECO.0000020985.47348.5e; Hamilton DP, 2016, AQUAT ECOL, V50, P351, DOI 10.1007/s10452-016-9594-z; Hessen DO, 2000, LIMNOL OCEANOGR, V45, P1834, DOI 10.4319/lo.2000.45.8.1834; Jang MH, 2003, FRESHWATER BIOL, V48, P1540, DOI 10.1046/j.1365-2427.2003.01107.x; Jeziorski A, 2008, SCIENCE, V322, P1374, DOI 10.1126/science.1164949; Jeziorski A, 2012, AQUAT SCI, V74, P121, DOI 10.1007/s00027-011-0202-y; Jiang X, 2014, J PLANKTON RES; Jiang XD, 2014, FUND APPL LIMNOL, V185, P321, DOI 10.1127/fal/2014/0672; Jiang XD, 2013, ENVIRON POLLUT, V178, P142, DOI 10.1016/j.envpol.2013.03.017; Jiang X, 2013, J DIABETES RES, V2013, DOI 10.1155/2013/489095; Kilham SS, 1998, HYDROBIOLOGIA, V377, P147, DOI 10.1023/A:1003231628456; Kiorboe T, 2008, MAR ECOL PROG SER, V367, P15, DOI 10.3354/meps07572; Kosten S, 2012, GLOBAL CHANGE BIOL, V18, P118, DOI 10.1111/j.1365-2486.2011.02488.x; LaMontagne JM, 2001, ECOL LETT, V4, P64, DOI 10.1046/j.1461-0248.2001.00197.x; Liess A, 2005, J N AM BENTHOL SOC, V24, P256, DOI 10.1899/04-015.1; Loeuille N, 2010, FUNCT ECOL, V24, P18, DOI 10.1111/j.1365-2435.2009.01617.x; Martin-Creuzburg D, 2008, LIMNOLOGY OCEANOGRAP, V53; McKee D, 1996, OECOLOGIA, V107, P189, DOI 10.1007/BF00327902; Metcalfe NB, 2001, TRENDS ECOL EVOL, V16, P254, DOI 10.1016/S0169-5347(01)02124-3; Mitchell SE, 2005, P ROY SOC B-BIOL SCI, V272, P2601, DOI 10.1098/rspb.2005.3253; Paerl HW, 2008, SCIENCE, V320, P57, DOI 10.1126/science.1155398; Pajk F, 2012, LIMNOL OCEANOGR, V57, P281, DOI 10.4319/lo.2012.57.1.0281; Prater C, 2016, LIMNOL OCEANOGR, V61, P268, DOI 10.1002/lno.10208; Prepas EE, 2001, FRESHWATER BIOL, V46, P1049, DOI 10.1046/j.1365-2427.2001.00788.x; Quintana XD, 2015, AQUAT SCI, V77, P45, DOI 10.1007/s00027-014-0368-1; Riessen HP, 2012, P NATL ACAD SCI USA, V109, P15377, DOI 10.1073/pnas.1209938109; Rukke NA, 2002, J PLANKTON RES, V24, P527, DOI 10.1093/plankt/24.5.527; Sakwinska O, 2004, OECOLOGIA, V138, P379, DOI 10.1007/s00442-003-1434-x; Sarnelle O, 2005, J PLANKTON RES, V27, P1229, DOI 10.1093/plankt/fbi086; Sperfeld E, 2015, HYDROBIOLOGIA, V755, P267, DOI 10.1007/s10750-015-2244-y; Taipale SJ, 2011, OIKOS, V120, P1674, DOI 10.1111/j.1600-0706.2011.19415.x; Thor P, 2015, GLOBAL CHANGE BIOL, V21, P2261, DOI 10.1111/gcb.12815; Van Doorslaer W, 2010, CLIM RES, V43, P81, DOI 10.3354/cr00894; Wacker A, 2007, FUNCT ECOL, V21, P738, DOI 10.1111/j.1365-2435.2007.01274.x; Walsh MR, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2205; Whittington D, 2015, FRESHWATER BIOL, V60, P1880, DOI 10.1111/fwb.12618; Wolf DM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001700; Yoshida T, 2004, P ROY SOC B-BIOL SCI, V271, P1947, DOI 10.1098/rspb.2004.2818; Zhang JX, 2003, PHYSIOL BEHAV, V79, P549, DOI 10.1016/S0031-9384(03)00123-9; Zhu XX, 2016, SCI REP-UK, V6, DOI 10.1038/srep22594	62	8	8	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2017	12	4							e0175881	10.1371/journal.pone.0175881	http://dx.doi.org/10.1371/journal.pone.0175881			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KD	28414773	gold, Green Published, Green Submitted			2022-12-27	WOS:000399874800072
J	Liu, ZF; Ci, XQ; Li, L; Li, HW; Conran, JG; Li, J				Liu, Zhi-Fang; Ci, Xiu-Qin; Li, Lang; Li, Hsi-Wen; Conran, John G.; Li, Jie			DNA barcoding evaluation and implications for phylogenetic relationships in Lauraceae from China	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; SPECIES IDENTIFICATION; LITSEA COMPLEX; MATK; GENE; PLANTS; LOCI; CLASSIFICATION; AMPLIFICATION; DISCRIMINATE	Lauraceae are an important component of tropical and subtropical forests and have major ecological and economic significance. Owing to lack of clear-cut morphological differences between genera and species, this family is an ideal case for testing the efficacy of DNA barcoding in the identification and discrimination of species and genera. In this study, we evaluated five widely recommended plant DNA barcode loci matK, rbcL, trnH-psbA, ITS2 and the entire ITS region for 409 individuals representing 133 species, 12 genera from China. We tested the ability of DNA barcoding to distinguish species and as an alternative tool for correcting species misidentification. We also used the rbcL+matK+trnH-psbA+ITS loci to investigate the phylogenetic relationships of the species examined. Among the gene regions and their combinations, ITS was the most efficient for identifying species (57.5%) and genera (70%). DNA barcoding also had a positive role for correcting species misidentification (10.8%). Furthermore, based on the results of the phylogenetic analyses, Chinese Lauraceae species formed three supported monophyletic clades, with the Cryptocarya group strongly supported (PP = 1.00, BS = 100%) and the clade including the Persea group, Laureae and Cinnamomum also receiving strong support (PP = 1.00, BS = 98%), whereas the Caryodaphnopsis-Neocinnamomum received only moderate support (PP = 1.00 and BS = 85%). This study indicates that molecular barcoding can assist in screening difficult to identify families like Lauraceae, detecting errors of species identification, as well as helping to reconstruct phylogenetic relationships. DNA barcoding can thus help with large-scale biodiversity inventories and rare species conservation by improving accuracy, as well as reducing time and costs associated with species identification.	[Liu, Zhi-Fang; Ci, Xiu-Qin; Li, Lang; Li, Jie] Chinese Acad Sci, Xishuangbanna Trop Bot Garden, Ctr Integrat Conservat, Plant Phylogenet & Conservat Grp, Kunming, Yunnan, Peoples R China; [Liu, Zhi-Fang; Ci, Xiu-Qin] Univ Chinese Acad Sci, Beijing, Peoples R China; [Li, Hsi-Wen] Chinese Acad Sci, Kunming Inst Bot, Herbarium KUN, Kunming, Yunnan, Peoples R China; [Conran, John G.] Univ Adelaide, Sch Biol Sci, Australian Ctr Evolutionary Biol & Biodivers, Adelaide, SA, Australia; [Conran, John G.] Univ Adelaide, Sch Biol Sci, Sprigg Geobiol Ctr, Adelaide, SA, Australia	Chinese Academy of Sciences; Xishuangbanna Tropical Botanical Garden, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Kunming Institute of Botany, CAS; University of Adelaide; University of Adelaide	Li, J (corresponding author), Chinese Acad Sci, Xishuangbanna Trop Bot Garden, Ctr Integrat Conservat, Plant Phylogenet & Conservat Grp, Kunming, Yunnan, Peoples R China.	jieli@xtbg.ac.cn		Liu, Zhifang/0000-0002-4009-7906	National Natural Science Foundation of China [31370245, 31500454]; Ministry of Science and Technology (MOST) Grant [2011FY120200-4, 2012FY110400]; Southeast Asia Biodiversity Research Institute, Chinese Academy of Science [Y4ZK1111301]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology (MOST) Grant; Southeast Asia Biodiversity Research Institute, Chinese Academy of Science	This study was supported by the National Natural Science Foundation of China (31370245, 31500454) and a Ministry of Science and Technology (MOST) Grant (2011FY120200-4, 2012FY110400), as well as Southeast Asia Biodiversity Research Institute, Chinese Academy of Science (Y4ZK1111301).	Archaux F, 2006, J VEG SCI, V17, P299, DOI 10.1111/j.1654-1103.2006.tb02449.x; Aubriot X, 2013, MOL ECOL RESOUR, V13, P57, DOI 10.1111/1755-0998.12028; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0905845106, 10.1073/pnas.0812297106]; Blaxter M, 2005, PHILOS T R SOC B, V360, P1935, DOI 10.1098/rstb.2005.1725; Bolson M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143049; Cai ZM, 2012, J SYST EVOL, V50, P527, DOI 10.1111/j.1759-6831.2012.00216.x; Chanderbali AS, 2001, ANN MO BOT GARD, V88, P104, DOI 10.2307/2666133; Chase MW, 2007, TAXON, V56, P295, DOI 10.1002/tax.562004; Chen J, 2015, MOL ECOL RESOUR, V15, P337, DOI 10.1111/1755-0998.12319; Chen SL, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008613, 10.1371/journal.pone.0015633]; DeSalle R, 2006, CONSERV BIOL, V20, P1545, DOI 10.1111/j.1523-1739.2006.00543.x; Dexter KG, 2010, ECOL MONOGR, V80, P267, DOI 10.1890/09-0267.1; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Dunning LT, 2010, BOT J LINN SOC, V164, P1, DOI 10.1111/j.1095-8339.2010.01071.x; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edwards D, 2008, TAXON, V57, P1317, DOI 10.1002/tax.574021; Fazekas AJ, 2009, MOL ECOL RESOUR, V9, P130, DOI 10.1111/j.1755-0998.2009.02652.x; Fazekas AJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002802; Ferri G, 2009, INT J LEGAL MED, V123, P395, DOI 10.1007/s00414-009-0356-5; Fijridiyanto IA, 2009, J PLANT RES, V122, P283, DOI 10.1007/s10265-009-0218-8; Gonzalez MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007483; Hajibabaei M, 2007, TRENDS GENET, V23, P167, DOI 10.1016/j.tig.2007.02.001; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hebert PDN, 2005, SYST BIOL, V54, P852, DOI 10.1080/10635150500354886; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; HILLIS DM, 1993, SYST BIOL, V42, P182, DOI 10.2307/2992540; Hollingsworth ML, 2009, MOL ECOL RESOUR, V9, P439, DOI 10.1111/j.1755-0998.2008.02439.x; Hollingsworth PM, 2011, P NATL ACAD SCI USA, V108, P19451, DOI 10.1073/pnas.1116812108; Hollingsworth PM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019254; Huang JF, 2016, MOL PHYLOGENET EVOL, V96, P33, DOI 10.1016/j.ympev.2015.12.007; Huang XC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129295; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hull JM, 2010, J WILDLIFE MANAGE, V74, P1326, DOI 10.2193/2009-255; Hutchinson J., 1964, GENERA FLOWERING PLA, V1; Kostermans AJGH, 1957, PENGUMUMAN BALAI BES, V57, P1; Kress WJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000508; Kress WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/pnas.0503123102; Lahaye R, 2008, P NATL ACAD SCI USA, V105, P2923, DOI 10.1073/pnas.0709936105; Lew DK, 2017, ECOL ECON, V131, P87, DOI 10.1016/j.ecolecon.2016.08.009; Li DZ, 2011, P NATL ACAD SCI USA, V108, P19641, DOI 10.1073/pnas.1104551108; Li FW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026597; Li HQ, 2012, MOL ECOL RESOUR, V12, P783, DOI 10.1111/j.1755-0998.2012.03147.x; LI H.-W., 2008, FLORA CHINA, V7, P102, DOI DOI 10.1016/J.JMB.2008.05.062; Li HW, 1984, FLORA REIPUBLICAE PO, V31, P1; Li J, 2004, PLANT SYST EVOL, V246, P19, DOI 10.1007/s00606-003-0113-z; Li J, 2008, ANN MO BOT GARD, V95, P580, DOI 10.3417/2006125.9504; Li L, 2007, PLANT SYST EVOL, V269, P203, DOI 10.1007/s00606-007-0580-8; Li L, 2016, TAXON, V65, P433, DOI 10.12705/653.1; Li L, 2011, AM J BOT, V98, P1520, DOI 10.3732/ajb.1100006; Li YL, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01791; Lister DL, 2008, TAXON, V57, P254, DOI 10.2307/25065966; Liu J, 2012, INT J MOL SCI, V13, P8740, DOI 10.3390/ijms13078740; Loi DT, 1996, MED PLANTS MED TASTE; Mabry CM, 1998, BIOTROPICA, V30, P238, DOI 10.1111/j.1744-7429.1998.tb00058.x; Muellner AN, 2011, MOL ECOL RESOUR, V11, P450, DOI 10.1111/j.1755-0998.2011.02984.x; Newmaster SG, 2008, MOL ECOL RESOUR, V8, P480, DOI 10.1111/j.1471-8286.2007.02002.x; Oihana R, 2016, ZOOL SCR; Packer L, 2009, MOL ECOL RESOUR, V9, P42, DOI 10.1111/j.1755-0998.2009.02631.x; Percy DM, 2014, MOL ECOL, V23, P4737, DOI 10.1111/mec.12837; Piredda R, 2011, MOL ECOL RESOUR, V11, P72, DOI 10.1111/j.1755-0998.2010.02900.x; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Ralser M, 2006, BIOCHEM BIOPH RES CO, V347, P747, DOI 10.1016/j.bbrc.2006.06.151; Richter HG., 1981, ANATOMIE SEKUNDAREN, V5; Rohwer J. G., 1993, FAMILIES GENERA VASC, V2, P366, DOI DOI 10.1007/978-3-662-02899-5_46; Rohwer JG, 2014, PHYTOTAXA, V158, P111, DOI 10.11646/phytotaxa.158.2.1; Rohwer JG, 2009, TAXON, V58, P1153, DOI 10.1002/tax.584009; Rohwer JG, 2005, ANN MO BOT GARD, V92, P153; Rohwer JG, 2000, SYST BOT, V25, P60, DOI 10.2307/2666673; Roy S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013674; Scott WA, 2003, PLANT ECOL, V165, P101, DOI 10.1023/A:1021441331839; Starr JR, 2009, MOL ECOL RESOUR, V9, P151, DOI 10.1111/j.1755-0998.2009.02640.x; Sun B.S., 1991, J YUNNAN U, V13, P93, DOI DOI 10.3390/M0LECULES180910930; Suzuki Y, 2002, P NATL ACAD SCI USA, V99, P16138, DOI 10.1073/pnas.212646199; Swofford DL., 2003, PAUP PHYLOGENETIC AN; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tripathi AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057934; Van der Werff H, 2001, BLUMEA, V46, P125; vanderWerff H, 1996, ANN MO BOT GARD, V83, P409, DOI 10.2307/2399870; Wang FH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160611; Wang S, 2004, CHINA SPECIES RED LI, P330; Wang ZH, 2010, PLANT SYST EVOL, V290, P173, DOI 10.1007/s00606-010-0359-1; Xiao LQ, 2010, MOL PHYLOGENET EVOL, V55, P168, DOI 10.1016/j.ympev.2009.11.020; Yan LJ, 2015, MOL ECOL RESOUR, V15, P932, DOI 10.1111/1755-0998.12353; Yang JB, 2012, MOL ECOL RESOUR, V12, P267, DOI 10.1111/j.1755-0998.2011.03095.x; Yang Yong, 2015, Biodiversity Science, V23, P232, DOI 10.17520/biods.2015027; Yassin A, 2010, MOL PHYLOGENET EVOL, V57, P509, DOI 10.1016/j.ympev.2010.08.020; Young ND, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-6; Yu J, 2011, J SYST EVOL, V49, P176, DOI 10.1111/j.1759-6831.2011.00134.x; Yu WB, 2011, J SYST EVOL, V49, P425, DOI 10.1111/j.1759-6831.2011.00154.x; Zhang CY, 2012, MOL ECOL RESOUR, V12, P98, DOI 10.1111/j.1755-0998.2011.03076.x; Zhang JJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123025; ZHARKIKH A, 1992, MOL BIOL EVOL, V9, P1119	93	32	36	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2017	12	4							e0175788	10.1371/journal.pone.0175788	http://dx.doi.org/10.1371/journal.pone.0175788			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KD	28414813	Green Submitted, Green Published, gold			2022-12-27	WOS:000399874800056
J	Robson, AS; Trimble, MJ; Purdon, A; Young-Overton, KD; Pimm, SL; van Aarde, RJ				Robson, Ashley S.; Trimble, Morgan J.; Purdon, Andrew; Young-Overton, Kim D.; Pimm, Stuart L.; van Aarde, Rudi J.			Savanna elephant numbers are only a quarter of their expected values	PLOS ONE			English	Article							DENSITY-DEPENDENCE; POPULATION; AFRICA; VARIABILITY; ABUNDANCE; RAINFALL; SIZE	Savannas once constituted the range of many species that human encroachment has now reduced to a fraction of their former distribution. Many survive only in protected areas. Poaching reduces the savanna elephant, even where protected, likely to the detriment of savanna ecosystems. While resources go into estimating elephant populations, an ecological benchmark by which to assess counts is lacking. Knowing how many elephants there are and how many poachers kill is important, but on their own, such data lack context. We collated savanna elephant count data from 73 protected areas across the continent estimated to hold similar to 50% of Africa's elephants and extracted densities from 18 broadly stable population time series. We modeled these densities using primary productivity, water availability, and an index of poaching as predictors. We then used the model to predict stable densities given current conditions and poaching for all 73 populations. Next, to generate ecological benchmarks, we predicted such densities for a scenario of zero poaching. Where historical data are available, they corroborate or exceed benchmarks. According to recent counts, collectively, the 73 savanna elephant populations are at 75% of the size predicted based on current conditions and poaching levels. However, populations are at <25% of ecological benchmarks given a scenario of zero poaching (similar to 967,000)-a total deficit of similar to 730,000 elephants. Populations in 30% of the 73 protected areas were <5% of their benchmarks, and the median current density as a percentage of ecological benchmark across protected areas was just 13%. The ecological context provided by these benchmark values, in conjunction with ongoing census projects, allow efficient targeting of conservation efforts.	[Robson, Ashley S.; Trimble, Morgan J.; Purdon, Andrew; Young-Overton, Kim D.; van Aarde, Rudi J.] Univ Pretoria, Dept Zool & Entomol, CERU, Pretoria, South Africa; [Pimm, Stuart L.] Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA	University of Pretoria; Duke University	van Aarde, RJ (corresponding author), Univ Pretoria, Dept Zool & Entomol, CERU, Pretoria, South Africa.	rjvaarde@zoology.up.ac.za	Trimble, Morgan J/B-1161-2010; pimm, stuart/ABF-1082-2020	Trimble, Morgan J/0000-0002-9914-0788; Purdon, Andrew/0000-0001-5963-3740; Robson, Ashley/0000-0002-6433-0602	International Fund for Animal Welfare; National Research Foundation; University of Pretoria	International Fund for Animal Welfare; National Research Foundation; University of Pretoria	R.J.v.A. received funding from the International Fund for Animal Welfare (ifaw.org), the National Research Foundation (nrf.ac.za), and the University of Pretoria (up.ac.za). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2021, LANG ENV STAT COMP; Blanc J. J., 2007, OCCASIONAL PAPER SER, V33; Brook BW, 2006, ECOLOGY, V87, P1445, DOI 10.1890/0012-9658(2006)87[1445:SOEFDD]2.0.CO;2; Caughley G., 1975, AFR J ECOL, V13, P39; Chamaille-Jammes S, 2008, J ANIM ECOL, V77, P135, DOI 10.1111/j.1365-2656.2007.01307.x; Chamaille-Jammes S, 2007, J APPL ECOL, V44, P625, DOI 10.1111/j.1365-2664.2007.01300.x; Chomba C, 2012, J ECOL NAT ENV, V4, P186; CITES, 2013, 16 M C PART BANGK TH 16 M C PART BANGK TH; CITES MIKE Programme, 2015, DAT SIT LEV PIKE DAT; CORFIELD T F, 1973, East African Wildlife Journal, V11, P339; Craigie ID, 2010, BIOL CONSERV, V143, P2221, DOI 10.1016/j.biocon.2010.06.007; de Boer WF, 2013, BIOL CONSERV, V159, P468, DOI 10.1016/j.biocon.2012.10.015; Douglas-Hamilton I., 1987, Oryx, V6, P11; EAST R, 1984, AFR J ECOL, V22, P245, DOI 10.1111/j.1365-2028.1984.tb00700.x; Ferreira SM, 2012, PACHYDERM, P52; Hempson GP, 2015, SCIENCE, V350, P1056, DOI 10.1126/science.aac7978; LAWS R M, 1970, East African Wildlife Journal, V8, P163; Midgley GF, 2015, NAT CLIM CHANGE, V5, P823, DOI [10.1038/NCLIMATE2753, 10.1038/nclimate2753]; MYERS N, 1973, Biological Conservation, V5, P123, DOI 10.1016/0006-3207(73)90093-1; Ngene S, 2013, PACHYDERM, P38; Ogutu JO, 2008, J ANIM ECOL, V77, P814, DOI 10.1111/j.1365-2656.2008.01392.x; Owen-Smith N, 2010, DYNAMICS LARGE HER B; Owen-Smith N.R., 1988, MEGAHERBIVORES INFLU; Papworth SK, 2009, CONSERV LETT, V2, P93, DOI 10.1111/j.1755-263X.2009.00049.x; Pearce J, 2000, ECOL MODEL, V128, P127, DOI 10.1016/S0304-3800(99)00227-6; Pimm SL, 2014, SCIENCE, V344, P987, DOI 10.1126/science.1246752; Pringle RM, 2008, ECOLOGY, V89, P26, DOI 10.1890/07-0776.1; Riggio J, 2013, BIODIVERS CONSERV, V22, P17, DOI 10.1007/s10531-012-0381-4; Ripple WJ, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1400103; Trimble MJ, 2009, J ZOOL, V279, P18, DOI 10.1111/j.1469-7998.2009.00560.x; Turner WC, 2013, ECOSPHERE, V4, DOI 10.1890/ES12-00245.1; UNEP CITES IUCN TRAFFIC, 2013, EL DUST AFR EL CRIS; van Aarde RJ, 2007, BIOL CONSERV, V134, P289, DOI 10.1016/j.biocon.2006.08.027; Wasser SK, 2015, SCIENCE, V349, P84, DOI 10.1126/science.aaa2457; Western D., 1989, PACHYDERM, V12, P42; Wittemyer G, 2007, ECOGRAPHY, V30, P42, DOI 10.1111/j.2006.0906-7590.04900.x; Wittemyer G, 2014, P NATL ACAD SCI USA, V111, P13117, DOI 10.1073/pnas.1403984111; Young KD, 2010, J ANIM ECOL, V79, P662, DOI 10.1111/j.1365-2656.2010.01667.x; Young KD, 2009, AUSTRAL ECOL, V34, P329, DOI 10.1111/j.1442-9993.2009.01934.x; Zuur Alain F., 2009, P1	41	35	35	1	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2017	12	4							e0175942	10.1371/journal.pone.0175942	http://dx.doi.org/10.1371/journal.pone.0175942			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KD	28414784	Green Published, Green Submitted, gold			2022-12-27	WOS:000399874800078
J	Sliz, E; Taipale, M; Welling, M; Skarp, S; Alaraudanjoki, V; Ignatius, J; Ruddock, L; Nissi, R; Mannikko, M				Sliz, Eeva; Taipale, Mari; Welling, Maiju; Skarp, Sini; Alaraudanjoki, Viivi; Ignatius, Jaakko; Ruddock, Lloyd; Nissi, Ritva; Mannikko, Minna			TUFT1, a novel candidate gene for metatarsophalangeal osteoarthritis, plays a role in chondrogenesis on a calcium-related pathway	PLOS ONE			English	Article							HUMAN TUFTELIN GENE; CHONDROCYTE DIFFERENTIATION; SEQUENCING DATA; N-CADHERIN; CELL-LINE; IN-VITRO; EXPRESSION; CARTILAGE; MATRIX; VARIANTS	Osteoarthritis (OA) is the most common degenerative joint disorder and genetic factors have been shown to have a significant role in its etiology. The first metatarsophalangeal joint (MTP I) is highly susceptible to development of OA due to repetitive mechanical stress during walking. We used whole exome sequencing to study genetic defect(s) predisposing to familial early-onset bilateral MTP I OA inherited in an autosomal dominant manner. A non-synonymous single nucleotide variant rs41310883 (c.524C>T, p.Thr175Met) in TUFT1 gene was found to co-segregate perfectly with MTP I OA. The role of TUFT1 and the relevance of the identified variant in pathogenesis of MTP I OA were further assessed using functional in vitro analyses. The variant reduced TUFT1 mRNA and tuftelin protein expression in HEK293 cells. ATDC5 cells overexpressing wild type (wt) or mutant TUFT1 were cultured in calcifying conditions and chondrogenic differentiation was found to be inhibited in both cell populations, as indicated by decreased marker gene expression when compared with the empty vector control cells. Also, the formation of cartilage nodules was diminished in both TUFT1 overexpressing ATDC5 cell populations. At the end of the culturing period the calcium content of the extracellular matrix was significantly increased in cells overexpressing mutant TUFT1 compared to cells overexpressing wt TUFT1 and control cells, while the proteoglycan content was reduced. These data imply that overexpression of TUFT1 in ATDC5 inhibits chondrogenic differentiation, and the identified variant may contribute to the pathogenesis of OA by increasing calcification and reducing amount of proteoglycans in the articular cartilage extracellular matrix thus making cartilage susceptible for degeneration and osteophyte formation.	[Sliz, Eeva; Taipale, Mari; Welling, Maiju; Skarp, Sini; Mannikko, Minna] Univ Oulu, Ctr Life Course Hlth Res, Fac Med, Oulu, Finland; [Sliz, Eeva; Taipale, Mari; Welling, Maiju; Skarp, Sini; Ruddock, Lloyd; Mannikko, Minna] Univ Oulu, Fac Biochem & Mol Med, Oulu, Finland; [Sliz, Eeva; Taipale, Mari; Skarp, Sini; Ruddock, Lloyd] Univ Oulu, Bioctr Oulu, Oulu, Finland; [Welling, Maiju] Oulu Univ Hosp, Med Res Ctr Oulu, Oulu, Finland; [Welling, Maiju] Univ Oulu, Oulu, Finland; [Alaraudanjoki, Viivi] Univ Oulu, Res Unit Oral Hlth Sci, Oulu, Finland; [Ignatius, Jaakko] Turku Univ Hosp, Dept Clin Genet, Turku, Finland; [Nissi, Ritva] Oulu Univ Hosp, Dept Obstet & Gynecol, Oulu, Finland	University of Oulu; University of Oulu; University of Oulu; University of Oulu; University of Oulu; University of Oulu; University of Turku; University of Oulu	Mannikko, M (corresponding author), Univ Oulu, Ctr Life Course Hlth Res, Fac Med, Oulu, Finland.; Mannikko, M (corresponding author), Univ Oulu, Fac Biochem & Mol Med, Oulu, Finland.	minna.mannikko@oulu.fi	Skarp, Sini/AAH-2995-2021	Skarp, Sini/0000-0003-2336-4221; Sliz, Eeva/0000-0002-2316-058X; Taipale, Mari/0000-0001-6805-4599; Ruddock, Lloyd/0000-0002-6247-686X	University of Oulu	University of Oulu	This study was funded by the University of Oulu (university researcher recruitment funding, MM).	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Arden N, 2006, BEST PRACT RES CL RH, V20, P3, DOI 10.1016/j.berh.2005.09.007; Bergin SM, 2012, ARTHRIT CARE RES, V64, P1691, DOI 10.1002/acr.21729; Bi WM, 1999, NAT GENET, V22, P85, DOI 10.1038/8792; Burkhard P, 2001, TRENDS CELL BIOL, V11, P82, DOI 10.1016/S0962-8924(00)01898-5; de Crombrugghe B, 2000, MATRIX BIOL, V19, P389, DOI 10.1016/S0945-053X(00)00094-9; DeLise AM, 2000, OSTEOARTHR CARTILAGE, V8, P309, DOI 10.1053/joca.1999.0306; Delise AM, 2002, DEV DYNAM, V225, P195, DOI 10.1002/dvdy.10151; DEUTSCH D, 1991, J BIOL CHEM, V266, P16021; Deutsch D, 2002, CONNECT TISSUE RES, V43, P425, DOI 10.1080/03008200290001186; Ea HK, 2011, ARTHRITIS RHEUM-US, V63, P10, DOI 10.1002/art.27761; Eppig JT, 2015, NUCLEIC ACIDS RES, V43, pD726, DOI 10.1093/nar/gku967; Fujita T, 2001, JPN J PHARMACOL, V85, P278, DOI 10.1254/jjp.85.278; Gaulton KJ, 2010, NAT GENET, V42, P255, DOI 10.1038/ng.530; Goldring MB, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2592; Iagnocco A, 2013, MED ULTRASON, V15, P35, DOI 10.11152/mu.2013.2066.151.ai1ofr2; Ingvarsson T, 2001, ARTHRITIS RHEUM-US, V44, P2548, DOI 10.1002/1529-0131(200111)44:11<2548::AID-ART435>3.0.CO;2-S; Jakkula E, 2005, OSTEOARTHR CARTILAGE, V13, P497, DOI 10.1016/j.joca.2005.02.005; Johnson VL, 2014, BEST PRACT RES CL RH, V28, P5, DOI 10.1016/j.berh.2014.01.004; Karlson EW, 2003, AM J MED, V114, P93, DOI 10.1016/S0002-9343(02)01447-X; Kean W. F., 2004, Inflammopharmacology, V12, P3, DOI 10.1163/156856004773121347; Klambauer G, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks003; Koressaar T, 2007, BIOINFORMATICS, V23, P1289, DOI 10.1093/bioinformatics/btm091; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Leiser Y, 2011, J CELL PHYSIOL, V226, P165, DOI 10.1002/jcp.22318; Loeser RF, 2012, ARTHRITIS RHEUM-US, V64, P1697, DOI 10.1002/art.34453; Luo W, 2004, CELLS TISSUES ORGANS, V177, P212, DOI 10.1159/000080134; MacDonald JR, 2014, NUCLEIC ACIDS RES, V42, pD986, DOI 10.1093/nar/gkt958; MacDougall M, 1998, J DENT RES, V77, P1970, DOI 10.1177/00220345980770120401; Mackie EJ, 2008, INT J BIOCHEM CELL B, V40, P46, DOI 10.1016/j.biocel.2007.06.009; Majewski J, 2011, J MED GENET, V48, P580, DOI 10.1136/jmedgenet-2011-100223; Mao ZK, 2001, GENE, V279, P181, DOI 10.1016/S0378-1119(01)00749-1; Meulenbelt I, 1997, J MED GENET, V34, P1024, DOI 10.1136/jmg.34.12.1024; Mori Y, 2014, BIOMED RES-TOKYO, V35, P263, DOI 10.2220/biomedres.35.263; Musunuru K, 2010, NATURE, V466, P714, DOI 10.1038/nature09266; Newton PT, 2012, INT J MOL MED, V30, P1187, DOI 10.3892/ijmm.2012.1114; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; Nissi R, 2011, SCAND J RHEUMATOL, V40, P22, DOI 10.3109/03009742.2010.495081; OBERLENDER SA, 1994, DEVELOPMENT, V120, P177; Oliveira FS, 2012, J CELL BIOCHEM, V113, P204, DOI 10.1002/jcb.23345; Park H, 2010, NAT GENET, V42, P400, DOI 10.1038/ng.555; Saarikoski ST, 2002, FEBS LETT, V530, P186, DOI 10.1016/S0014-5793(02)03475-0; Schibler L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007633; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Shaffer JR, 2015, HUM GENET, V134, P159, DOI 10.1007/s00439-014-1504-7; Shukunami C, 1997, J BONE MINER RES, V12, P1174, DOI 10.1359/jbmr.1997.12.8.1174; Smith RL, 2007, BIOMED HEALTH RES, V70, P14; Spector TD, 1996, BRIT MED J, V312, P940; Stanton LA, 2003, DEV BIOL, V263, P165, DOI 10.1016/S0012-1606(03)00321-X; Sulonen AM, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-r94; TACCHETTI C, 1992, EXP CELL RES, V200, P26, DOI 10.1016/S0014-4827(05)80067-9; Taipale M, 2016, OSTEOARTHR CARTILAGE, V24, P655, DOI 10.1016/j.joca.2015.10.019; Trivedi B, 2010, OSTEOARTHR CARTILAGE, V18, P1027, DOI 10.1016/j.joca.2010.05.005; Venselaar H, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-548; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Westra HJ, 2013, NAT GENET, V45, P1238, DOI 10.1038/ng.2756	57	16	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2017	12	4							e0175474	10.1371/journal.pone.0175474	http://dx.doi.org/10.1371/journal.pone.0175474			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0MD	28410428	Green Published, gold			2022-12-27	WOS:000399955600020
J	Wang, CL; Li, XJ; Qian, R; Su, GS; Zhang, Q; Ding, XD				Wang, Chonglong; Li, Xiujin; Qian, Rong; Su, Guosheng; Zhang, Qin; Ding, Xiangdong			Bayesian methods for jointly estimating genomic breeding values of one continuous and one threshold trait	PLOS ONE			English	Article							WIDE EVALUATION; PREDICTION; SELECTION; ACCURACY	Genomic selection has become a useful tool for animal and plant breeding. Currently, genomic evaluation is usually carried out using a single-trait model. However, a multi-trait model has the advantage of using information on the correlated traits, leading to more accurate genomic prediction. To date, joint genomic prediction for a continuous and a threshold trait using a multi-trait model is scarce and needs more attention. Based on the previously proposed methods BayesC pi for single continuous trait and BayesTC pi for single threshold trait, we developed a novel method based on a linear-threshold model, i.e., LT-BayesC pi, for joint genomic prediction of a continuous trait and a threshold trait. Computing procedures of LT BayesC pi using Markov Chain Monte Carlo algorithm were derived. A simulation study was performed to investigate the advantages of LT-BayesC pi over BayesC pi and BayesTC pi with regard to the accuracy of genomic prediction on both traits. Factors affecting the performance of LT-BayesC pi were addressed. The results showed that, in all scenarios, the accuracy of genomic prediction obtained from LT-BayesC pi was significantly increased for the threshold trait compared to that from single trait prediction using BayesTC pi, while the accuracy for the continuous trait was comparable with that from single trait prediction using BayesC pi. The proposed LT-BayesC pi could be a method of choice for joint genomic prediction of one continuous and one threshold trait.	[Wang, Chonglong; Qian, Rong] Anhui Acad Agr Sci, Inst Anim Husb & Vet Med, Dept Pig Genet & Breeding, Hefei, Peoples R China; [Li, Xiujin; Zhang, Qin; Ding, Xiangdong] China Agr Univ, Coll Anim Sci & Technol, Lab Anim Genet Breeding & Reprod, Minist Agr China,Natl Engn Lab Anim Breeding, Beijing, Peoples R China; [Li, Xiujin] Aarhus Univ, Dept Mol Biol & Genet, Ctr Quantitat Genet & Genom, Tjele, Denmark; [Li, Xiujin] Sun Yat Sen Univ, Sch Life Sci, State Key Lab Biocontrol, Guangzhou Higher Educ Mega Ctr, North Third Rd, Guangzhou, Guangdong, Peoples R China	Anhui Academy of Agricultural Sciences; China Agricultural University; Ministry of Agriculture & Rural Affairs; Aarhus University; Sun Yat Sen University	Ding, XD (corresponding author), China Agr Univ, Coll Anim Sci & Technol, Lab Anim Genet Breeding & Reprod, Minist Agr China,Natl Engn Lab Anim Breeding, Beijing, Peoples R China.	xding@cau.edu.cn	li, xiu/GXV-1745-2022		National Natural Science Foundation of China [31371258, 31272418, 31601009]; Beijing City Committee of Science and Technology Key Project [D151100004615004]; Program for Changjiang Scholar and Innovation Research Team [IRT1191]; Anhui International Technology Cooperation Plan Project [1503062014]; Anhui Science and Technology Key Project [16030701069]; National Swine Industry Technology System [CARS-36]; Anhui Swine Industry Technology System [AHCYTX-0610]; Anhui Finance Project for Animal Husbandry Development; Anhui Modern Agricultural Projects; Maanshan Science and Technology Plan Project [NY-2015-01]; Anhui Academy of Agricultural Sciences President Innovation Fund Project for Outstanding Youth [1360405]; Anhui Academy of Agricultural Science and Technology Innovation Team Building Project [13C0405]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing City Committee of Science and Technology Key Project; Program for Changjiang Scholar and Innovation Research Team; Anhui International Technology Cooperation Plan Project; Anhui Science and Technology Key Project; National Swine Industry Technology System; Anhui Swine Industry Technology System; Anhui Finance Project for Animal Husbandry Development; Anhui Modern Agricultural Projects; Maanshan Science and Technology Plan Project; Anhui Academy of Agricultural Sciences President Innovation Fund Project for Outstanding Youth; Anhui Academy of Agricultural Science and Technology Innovation Team Building Project	This work was supported by grants from the National Natural Science Foundation of China (31371258, 31272418, 31601009), Beijing City Committee of Science and Technology Key Project (D151100004615004), the Program for Changjiang Scholar and Innovation Research Team (Grant No. IRT1191), the Anhui International Technology Cooperation Plan Project (1503062014), Anhui Science and Technology Key Project (16030701069), the National Swine Industry Technology System (CARS-36), the Anhui Swine Industry Technology System (AHCYTX-0610), the Anhui Finance Project for Animal Husbandry Development, the Anhui Modern Agricultural Projects, the Maanshan Science and Technology Plan Project (NY-2015-01), the Anhui Academy of Agricultural Sciences President Innovation Fund Project for Outstanding Youth (1360405) and the Anhui Academy of Agricultural Science and Technology Innovation Team Building Project (13C0405). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Calus MPL, 2011, GENET SEL EVOL, V43, P1; Coster A, 2010, GENET SEL EVOL, V42, DOI 10.1186/1297-9686-42-9; Daetwyler HD, 2010, GENETICS, V185, P1021, DOI 10.1534/genetics.110.116855; Ding X, 2013, J DAIRY SCI, V96, P5315, DOI 10.3168/jds.2012-6194; Gianola D, 2009, GENETICS, V183, P347, DOI 10.1534/genetics.109.103952; GILMOUR AR, 1985, BIOMETRIKA, V72, P593, DOI 10.1093/biomet/72.3.593; Gonzalez-Recio O, 2011, GENET SEL EVOL, V43, DOI 10.1186/1297-9686-43-7; Guo G, 2014, BMC GENET, V15, DOI 10.1186/1471-2156-15-30; Habier D, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-186; Hayashi T, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-34; Hayes BJ, 2009, J DAIRY SCI, V92, P433, DOI 10.3168/jds.2008-1646; HENDERSON CR, 1976, J ANIM SCI, V43, P1188, DOI 10.2527/jas1976.4361188x; Iwata H, 2009, THEOR APPL GENET, V118, P865, DOI 10.1007/s00122-008-0945-6; Jia Y, 2012, GENETICS, V192, P1513, DOI 10.1534/genetics.112.144246; Jiang J, 2015, HEREDITY, V115, P29, DOI 10.1038/hdy.2015.9; Korsgaard IR, 2003, GENET SEL EVOL, V35, P159, DOI [10.1186/1297-9686-35-2-159, 10.1051/gse:2003002]; Korsgaard IR, 1999, GENET SEL EVOL, V31, P177, DOI 10.1051/gse:19990206; Meuwissen THE, 2001, GENETICS, V157, P1819; Sorensen DA., 2002, STAT BIOL HEALTH; Su G, 2010, J DAIRY SCI, V93, P1175, DOI 10.3168/jds.2009-2192; Szydlowski Maciej, 2011, BMC Proc, V5 Suppl 3, pS3, DOI 10.1186/1753-6561-5-S3-S3; Varona L, 1999, J ANIM SCI, V77, P1994; Villanueva B, 2011, J ANIM SCI, V89, P3433, DOI 10.2527/jas.2010-3814; Wang CL, 2013, HEREDITY, V110, P213, DOI 10.1038/hdy.2012.65; Wang CS, 1997, BAYESIAN ANAL CALVIN; Zhang Z, 2015, BMC GENET, V16, DOI 10.1186/s12863-015-0173-4	26	6	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2017	12	4							e0175448	10.1371/journal.pone.0175448	http://dx.doi.org/10.1371/journal.pone.0175448			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0MD	28410429	gold, Green Published			2022-12-27	WOS:000399955600019
J	Gan, X; Wang, HF; Yu, YY; Yi, W; Zhu, SS; Li, E; Liang, Y				Gan, Xin; Wang, Haifeng; Yu, Yanyan; Yi, Wei; Zhu, Shanshan; Li, En; Liang, Yu			Epigenetically repressing human cytomegalovirus lytic infection and reactivation from latency in THP-1 model by targeting H3K9 and H3K27 histone demethylases	PLOS ONE			English	Article							GANCICLOVIR-RESISTANT CYTOMEGALOVIRUS; GENE-EXPRESSION; CHROMATIN-STRUCTURE; CELLS; METHYLATION; INHIBITION; DISEASE; REPLICATION; EMERGENCE; JMJD3	Human Cytomegalovirus (hCMV) infects a broad range of the population and establishes life-long latency in the infected individuals. Periodically the latently infected virus can reactivate and becomes a significant cause of morbidity and mortality in immunocompromised individuals. In latent infection, the viral genome is suppressed in a heterochromatic state and viral gene transcription is silenced. Upon reactivation, the repressive chromatin is remodeled to an active form, allowing viral lytic gene transcription, initiated by the expression of viral Immediate Early (IE) genes. During this process, a number of histone modification enzymes, including histone demethylases (HDMs), play important roles in driving IE expression, but the mechanisms involved are not fully understood. To get a better understanding of these mechanisms, we focused on two HDMs, KDM4 and KDM6, which reverse the repressive histone H3-lysine 9 and lysine 27 methylation, respectively. Our studies show that in lytic infection, both demethylases are important in the activation of viral IE gene expression. Simultaneous disruption of both via genetic or chemical methods leads to severely impaired viral IE gene expression and viral replication. Additionally, in an experimental latency-reactivation model in THP-1 cells, the KDM6 family member JMJD3 is induced upon viral reactivation and its knockdown resulted in reduced IE gene transcription. These findings suggest pharmacological inhibition of these HDMs may potentially block hCMV lytic infection and reactivation, and control the viral infection associated diseases, which are of significant unmet medical needs.	[Gan, Xin; Wang, Haifeng; Yu, Yanyan; Yi, Wei; Zhu, Shanshan; Li, En; Liang, Yu] China Novartis Inst Biomed Res, 4218 JinKe Rd, Shanghai, Peoples R China	Novartis	Liang, Y (corresponding author), China Novartis Inst Biomed Res, 4218 JinKe Rd, Shanghai, Peoples R China.	lye60191206@outlook.com	Yu, Yan/GYV-4514-2022					Abraham CG, 2013, J VIROL, V87, P13193, DOI 10.1128/JVI.02420-13; Allice T, 2009, J ANTIMICROB CHEMOTH, V63, P600, DOI 10.1093/jac/dkn521; Berry WL, 2013, CANCER RES, V73, P2936, DOI 10.1158/0008-5472.CAN-12-4300; Best JD, 2010, DRUG DISCOV TODAY, V15, P65, DOI 10.1016/j.drudis.2009.10.010; Bloom DC, 2010, BBA-GENE REGUL MECH, V1799, P246, DOI 10.1016/j.bbagrm.2009.12.001; Burns LJ, 1999, TRANSPLANTATION, V67, P137, DOI 10.1097/00007890-199901150-00023; Cobbs CS, 2008, CANCER RES, V68, P724, DOI 10.1158/0008-5472.CAN-07-2291; Cobbs CS, 2013, CURR OPIN ONCOL, V25, P682, DOI 10.1097/CCO.0000000000000005; Copeland RA, 2010, CURR OPIN CHEM BIOL, V14, P505, DOI 10.1016/j.cbpa.2010.06.174; Craigen JL, 1996, TRANSPLANTATION, V62, P1102, DOI 10.1097/00007890-199610270-00014; Cuevas-Bennett C, 2008, J VIROL, V82, P9525, DOI 10.1128/JVI.00946-08; De Santa F, 2007, CELL, V130, P1083, DOI 10.1016/j.cell.2007.08.019; Delannoy AS, 1997, PATHOL BIOL, V45, P394; Dziurzynski K, 2012, NEURO-ONCOLOGY, V14, P246, DOI 10.1093/neuonc/nor227; ERICE A, 1989, NEW ENGL J MED, V320, P289, DOI 10.1056/NEJM198902023200505; Fields BN, 2007, FIELDS VIROLOGY WOLT; Griffiths PD, 1998, J CLIN PATHOL, V51, P487; Groves IJ, 2009, J GEN VIROL, V90, P2364, DOI 10.1099/vir.0.012526-0; Gunther T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000935; Hill J.M., 2014, FRONT AGING NEUROSCI, V6, P1, DOI DOI 10.1126/SCITRANSLMED.3010643; Hopkinson RJ, 2013, CHEM SCI, V4, P3110, DOI [10.1039/c3sc51122g, 10.1039/C3SC51122G]; Ioudinkova E, 2006, GENE, V384, P120, DOI 10.1016/j.gene.2006.07.021; Iwamori N, 2011, BIOL REPROD, V84, P1225, DOI 10.1095/biolreprod.110.088955; Kelly TK, 2010, NAT BIOTECHNOL, V28, P1069, DOI 10.1038/nbt.1678; King ONF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015535; Klose RJ, 2007, NAT REV MOL CELL BIO, V8, P307, DOI 10.1038/nrm2143; Knipe DM, 2008, NAT REV MICROBIOL, V6, P211, DOI 10.1038/nrmicro1794; Knipe DM, 2013, VIROLOGY, V435, P141, DOI 10.1016/j.virol.2012.09.023; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kristie TM, 2015, VIROLOGY, V479, P555, DOI 10.1016/j.virol.2015.01.026; Kruidenier L, 2012, NATURE, V488, P404, DOI 10.1038/nature11262; Lee SH, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1501164; Lee TI, 2006, NAT PROTOC, V1, P729, DOI 10.1038/nprot.2006.98; Liang Y, 2013, MBIO, V4, DOI 10.1128/mBio.00558-12; Liang Y, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005145; Liang Y, 2009, NAT MED, V15, P1312, DOI 10.1038/nm.2051; Lieberman PM, 2006, TRENDS MICROBIOL, V14, P132, DOI 10.1016/j.tim.2006.01.001; Limaye AP, 2002, CLIN INFECT DIS, V35, P866, DOI 10.1086/342385; Liu XF, 2013, VIRUSES-BASEL, V5, P1325, DOI 10.3390/v5051325; McVoy MA, 2013, CLIN INFECT DIS, V57, pS196, DOI 10.1093/cid/cit587; Messer HGP, 2015, J VIROL, V89, P3417, DOI 10.1128/JVI.03052-14; Murphy JC, 2002, EMBO J, V21, P1112, DOI 10.1093/emboj/21.5.1112; Nevels M, 2011, REV MED VIROL, V21, P154, DOI 10.1002/rmv.690; Nitzsche A, 2008, J VIROL, V82, P11167, DOI 10.1128/JVI.01218-08; Paulus C, 2010, REV MED VIROL, V20, P34, DOI 10.1002/rmv.632; Rai G, 2010, PROBE REPORTS NIH MO; Reeves MB, 2011, VIRUS RES, V157, P134, DOI 10.1016/j.virusres.2010.09.019; Reeves MB, 2005, P NATL ACAD SCI USA, V102, P4140, DOI 10.1073/pnas.0408994102; Rossetto CC, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003366; Rossetto CC, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002680; Salzberger B, 1997, BLOOD, V90, P2502; Shi Y, 2007, MOL CELL, V25, P1, DOI 10.1016/j.molcel.2006.12.010; Sinclair J, 2008, J CLIN VIROL, V41, P180, DOI 10.1016/j.jcv.2007.11.014; Sinclair J, 2006, J GEN VIROL, V87, P1763, DOI 10.1099/vir.0.81891-0; Sinclair J, 2010, BBA-GENE REGUL MECH, V1799, P286, DOI 10.1016/j.bbagrm.2009.08.001; Sinzger C, 2008, J GEN VIROL, V89, P359, DOI 10.1099/vir.0.83286-0; Takacs M, 2010, BBA-GENE REGUL MECH, V1799, P228, DOI 10.1016/j.bbagrm.2009.10.005; Wang D, 2005, J VIROL, V79, P10330, DOI 10.1128/JVI.79.16.10330-10338.2005; WEINSHENKER BG, 1988, J IMMUNOL, V140, P1625; Wolf DG, 2003, BLOOD, V101, P463, DOI 10.1182/blood-2002-07-1982; Woodhall DL, 2006, J BIOL CHEM, V281, P37652, DOI 10.1074/jbc.M604273200; Yao H, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5386; Zalckvar E, 2013, P NATL ACAD SCI USA, V110, P13126, DOI 10.1073/pnas.1305548110	63	23	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2017	12	4							e0175390	10.1371/journal.pone.0175390	http://dx.doi.org/10.1371/journal.pone.0175390			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0MB	28407004	Green Published, gold, Green Submitted			2022-12-27	WOS:000399955400048
J	Meurisse, N; Pawson, S				Meurisse, Nicolas; Pawson, Stephen			Quantifying dispersal of a non-aggressive saprophytic bark beetle	PLOS ONE			English	Article							IPS-TYPOGRAPHUS L; SOUTHERN PINE BEETLES; TOMICUS-PINIPERDA COLEOPTERA; MARK-RECAPTURE; DENDROCTONUS-PSEUDOTSUGAE; HYLURGUS-LIGNIPERDA; FLIGHT BEHAVIOR; L COL; SCOLYTIDAE; MOVEMENT	Long distance dispersal to locate suitable breeding sites is recognized as a key trait influencing the population dynamics and distribution of bark beetles and other saprophytic insects. While dispersal behavior has been studied for a range of aggressive 'tree killing' bark beetles, few have considered the dispersal behaviour of non-aggressive saprophytic bark beetles that utilize kairomones (host volatiles). We present the results of a mark-recapture experiment that examined adult dispersal patterns of the saprophytic bark beetle Hylurgus ligniperda. Releases took place in summer and autumn 2014, in a clearcut pine forest in the central North Island, New Zealand. Both flight-experienced and flight-naive adults were marked and released in the center of a circular trap grid that extended to 960 m with 170 or 200 panel traps baited with a kairomone blend of alpha-pinene and ethanol. Of the 18,464 released H. ligniperda, 9,209 (49.9%) of the beetles flew, and 96 (1.04%) of the beetles that flew were recaptured. Individuals were recaptured at all distances. The recapture of flightexperienced beetles declined with dispersal distance, and a diffusion model showed heterogeneous dispersal tendencies within the population. Our best model estimated that 46% of flight-experienced beetles disperse > 1 km, and 1.6% > 5 km. Conversely, no declining pattern was shown in the recapture of flight-naive beetles, suggesting that emerging H. ligniperda may require a period of flight to initiate chemotropic orientation behavior and subsequent attraction to traps. We discuss the implications of these findings for the management of phytosanitary risks. For instance, combining landscape knowledge of source populations with dispersal processes facilitates estimation of pest pressure at economically sensitive areas such as harvest and timber storage sites. Quantitative dispersal estimates also inform pest risk assessments by predicting spread rates for H. ligniperda that has proven establishment capabilities in other countries.	[Meurisse, Nicolas] Scion, Rotorua, New Zealand; [Pawson, Stephen] Scion, Christchurch, New Zealand	Scion; Scion	Meurisse, N (corresponding author), Scion, Rotorua, New Zealand.	nicolas.meurisse@scionresearch.com	Meurisse, Nicolas/T-7971-2019		Stakeholders in Methyl Bromide Reduction Inc. (STIMBR); Ministry for Business, Innovation, and Employment (MBIE) [C04X1204]; Scion CORE funding [C04X1104]	Stakeholders in Methyl Bromide Reduction Inc. (STIMBR); Ministry for Business, Innovation, and Employment (MBIE)(New Zealand Ministry of Business, Innovation and Employment (MBIE)); Scion CORE funding	This work was funded by Stakeholders in Methyl Bromide Reduction Inc. (STIMBR), the Ministry for Business, Innovation, and Employment (MBIE, C04X1204), and Scion CORE funding (C04X1104). The funders had no role in study design, data collection and analysis. Dr John Armstrong, independent advisor to STIMBR, provided support for review and decision to publish.	[Anonymous], 2014, R LANG ENV STAT COMP; [Anonymous], 2011, CAB INT INVASIVE SPE; ATKINS MD, 1966, CAN ENTOMOL, V98, P285, DOI 10.4039/Ent98285-3; Aukema BH, 2008, ECOGRAPHY, V31, P348, DOI 10.1111/j.0906-7590.2007.05453.x; Bain J., 1977, HYLURGUS LIGNIPERDA; Balachowsky A, 1949, FAUNE FRANCE COLE SC; Barak AV, 2000, GREAT LAKES ENTOMOL, V33, P69; BENNETT RB, 1971, ANN ENTOMOL SOC AM, V64, P1273, DOI 10.1093/aesa/64.6.1273; BIRCH MC, 1982, J CHEM ECOL, V8, P125, DOI 10.1007/BF00984010; BOTTERWEG PF, 1982, Z ANGEW ENTOMOL, V94, P466; Brockerhoff EG, 2006, FOREST ECOL MANAG, V228, P234, DOI 10.1016/j.foreco.2006.02.046; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Byers JA, 2004, BARK AND WOOD BORING INSECTS IN LIVING TREES IN EUROPE, A SYNTHESIS, P89; Chase KD, 2017, ECOL ENTOMOL, V42, P173, DOI 10.1111/een.12371; CHOUDHURY JH, 1980, PHYSIOL ENTOMOL, V5, P207, DOI 10.1111/j.1365-3032.1980.tb00228.x; Clarke SR, 1999, J FOREST, V97, P26; Clobert J, 2012, DISPERSAL ECOLOGY AND EVOLUTION, P1, DOI 10.1093/acprof:oso/9780199608898.001.0001; COOK SP, 1992, J ENTOMOL SCI, V27, P269, DOI 10.18474/0749-8004-27.3.269; Costa A, 2013, AGR FOREST ENTOMOL, V15, P1, DOI 10.1111/j.1461-9563.2012.00585.x; Crawley M. J., 2012, R BOOK, DOI DOI 10.1111/j.1365-294X.2008.03806.x; Cronin JT, 2000, OIKOS, V90, P127, DOI 10.1034/j.1600-0706.2000.900113.x; Dodds KJ, 2002, CAN ENTOMOL, V134, P343, DOI 10.4039/Ent134343-3; Duelli P, 1997, J APPL ENTOMOL, V121, P297, DOI 10.1111/j.1439-0418.1997.tb01409.x; ELKINTON JS, 1980, ENVIRON ENTOMOL, V9, P729, DOI 10.1093/ee/9.6.729; FABRE J-P, 1975, Annales des Sciences Forestieres (Paris), V32, P55, DOI 10.1051/forest/19750104; FORSSE E, 1985, Z ANGEW ENTOMOL, V100, P47; FURNISS MM, 1972, CAN ENTOMOL, V104, P1471, DOI 10.4039/Ent1041471-9; GARA RI, 1963, CONTRIB BOYCE THOMPS, V22, P51; Glick PA, 1939, DISTRIBUTION INSECTS; GRIES G, 1985, Z ANGEW ENTOMOL, V99, P12; Heliovaara Kari, 1999, Ecological Bulletins, V47, P48; Higgins SI, 1999, AM NAT, V153, P464, DOI 10.1086/303193; IPPC, 2016, ISPM 14 US INT MEAS; IPPC, 2016, ISPM 22 REQ EST AR L; Jackson PL, 2008, CAN J FOREST RES, V38, P2313, DOI 10.1139/X08-066; JACTEL H, 1991, ANN SCI FOREST, V48, P417, DOI 10.1051/forest:19910405; KAREIVA PM, 1983, OECOLOGIA, V57, P322, DOI 10.1007/BF00377175; Kausrud K, 2012, BIOL REV, V87, P34, DOI 10.1111/j.1469-185X.2011.00183.x; Kot M, 1996, ECOLOGY, V77, P2027, DOI 10.2307/2265698; Levin SA, 2003, ANNU REV ECOL EVOL S, V34, P575, DOI 10.1146/annurev.ecolsys.34.011802.132428; Lindgren BS, 2013, CAN ENTOMOL, V145, P471, DOI 10.4039/tce.2013.27; Liu DG, 2008, PAN-PAC ENTOMOL, V84, P26, DOI 10.3956/2007-21.1; Mausel DL, 2007, CAN J FOREST RES, V37, P156, DOI 10.1139/X06-215; Mercader RJ, 2011, CAN J FOREST RES, V41, P254, DOI 10.1139/X10-201; Nathan R, 2003, OIKOS, V103, P261, DOI 10.1034/j.1600-0706.2003.12146.x; Nathan R, 2012, DISPERSAL ECOLOGY AND EVOLUTION, P187; Nathan Ran, 2001, Trends in Ecology and Evolution, V16, P481, DOI 10.1016/S0169-5347(01)02272-8; NEMEC V, 1993, J APPL ENTOMOL, V116, P358, DOI 10.1111/j.1439-0418.1993.tb01208.x; NILSSEN AC, 1984, ANN ENTOMOL FENN, V50, P37; Okubo A., 1980, DIFFUSION ECOLOGICAL; Pasek J. E., 2016, WEIGHTS R PACKAGE VE; Pawson SM, 2013, BIODIVERS CONSERV, V22, P1203, DOI 10.1007/s10531-013-0458-8; Pawson SM, PREDICTING FOREST IN; Pawson Stephen, 2014, New Zealand Journal of Forestry, V59, P22; Peltonen M, 2002, ECOLOGY, V83, P3120, DOI 10.1890/0012-9658(2002)083[3120:SSIFIO]2.0.CO;2; PERTTUNEN V, 1970, CONTRIB BOYCE THOMPS, V24, P293; Pinheiro J, R PACKAGE VERSION; Pinheiro J, 2001, MIXED EFFECTS MODELS; Poland TM, 2000, CAN ENTOMOL, V132, P853, DOI 10.4039/Ent132853-6; PULLIAM HR, 1988, AM NAT, V132, P652, DOI 10.1086/284880; Raffa K.F., 2015, BARK BEETLES BIOL EC, P1, DOI [10.1016/B978-0-12-417156-5.00014-9, DOI 10.1016/B978-0-12-417156-5.00001-0, 10.1016/B978-0-12-417156-5.00001-0]; Raffa Kenneth F., 1993, P103; Ranius T, 2006, POPUL ECOL, V48, P177, DOI 10.1007/s10144-006-0262-3; Reay Stephen D., 2001, New Zealand Entomologist, V24, P79; Rhodes DJ, 1998, J ENTOMOL SCI, V33, P221, DOI 10.18474/0749-8004-33.2.221; SCHLYTER F, 1987, PHYSIOL ENTOMOL, V12, P185, DOI 10.1111/j.1365-3032.1987.tb00741.x; SHORE TL, 1988, CAN J FOREST RES, V18, P1113, DOI 10.1139/x88-171; Skalski GT, 2000, ECOLOGY, V81, P1685, DOI 10.2307/177317; Skarpaas O, 2009, J APPL ECOL, V46, P55, DOI 10.1111/j.1365-2664.2008.01561.x; SOLBRECK C, 1980, ENTOMOL EXP APPL, V28, P123, DOI 10.1007/BF00287121; Stokland J.N., 2012, BIODIVERSITY DEAD WO; TURCHIN P, 1993, ECOL APPL, V3, P187, DOI 10.2307/1941801; Turchin P, 1996, ENVIRON ENTOMOL, V25, P582, DOI 10.1093/ee/25.3.582; Turchin Peter, 1998; Vega F.E., 2014, BARK BEETLES BIOL EC; Wagenmakers EJ, 2004, PSYCHON B REV, V11, P192, DOI 10.3758/BF03206482; Weed A.S., 2015, BARK BEETLES BIOL EC, P157, DOI [DOI 10.1016/B978-0-12-417156-5.00004-6, 10.1016/B978-0-12-417156-5.00004-6]; Wermelinger B, 2004, FOREST ECOL MANAG, V202, P67, DOI 10.1016/j.foreco.2004.07.018; WESLIEN J, 1989, HOLARCTIC ECOL, V12, P511; WOLLERMAN EH, 1979, J CHEM ECOL, V5, P781, DOI 10.1007/BF00986563; Wutzler T, 2013, TWNLME STANDARD ERRO; Yamamura K, 2002, POPUL ECOL, V44, P93, DOI 10.1007/s101440200011; Zhang XX, 2007, ECOL MODEL, V200, P79, DOI 10.1016/j.ecolmodel.2006.07.016; ZUMR V, 1992, J APPL ENTOMOL, V114, P348, DOI 10.1111/j.1439-0418.1992.tb01138.x; Zuur Alain F., 2009, P1	85	15	15	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2017	12	4							e0174111	10.1371/journal.pone.0174111	http://dx.doi.org/10.1371/journal.pone.0174111			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0MB	28406924	Green Submitted, Green Published, gold			2022-12-27	WOS:000399955400007
J	Perretti, M; Di Filippo, C; D'Amico, M; Dalli, J				Perretti, Mauro; Di Filippo, Clara; D'Amico, Michele; Dalli, Jesmond			Characterizing the anti-inflammatory and tissue protective actions of a novel Annexin A1 peptide	PLOS ONE			English	Article							A(4) RECEPTOR; RESOLUTION; INFLAMMATION; NEUTROPHILS; MEDIATORS; RESPONSES	Inflammation in now appreciated to be at the centre of may diseases that affect Western civilization. Current therapeutics for managing these conditions may interfere with the host response leading to immune suppression. We recently developed an annexin (Anx) A1-derived peptide, coined CR-AnxA12-50, which displays potent pro-resolving and tissue protective actions. Herein, we designed a novel peptide using CR-AnxA12-50 as a template that was significantly more resistant to neutrophil-mediated degradation. This peptide, termed CR-AnxA12-48, retained high affinity and specificity to the pro-resolving Lipoxin A4 receptor (ALX) with an IC50 of similar to 20nM. CR-AnxA12-48 dose dependently (100fM-10nM) promoted the efferocytosis of apoptotic neutrophils, an action that was mediated by the murine orthologue of human ALX. The neutrophil-directed actions were also retained with human primary cells were CR-AnxA12-48 reduced human neutrophil recruitment to activated endothelial cells at concentrations as low as 100 pM. This protective action was mediated by human ALX, since incubation of neutrophils with an anti-ALX antibody reversed this anti-inflammatory actions of CR-AnxA12-48. Administration of this peptide to mice during dermal inflammation led to a significant and dose dependent decrease in neutrophil recruitment. This reduction in neutrophil numbers was more pronounced than that displayed by the parent peptide CRAnxA12- 50. CR-AnxA12-48 was also cardioprotecitve reducing infarct size and systemic chemokine (C-C motif) ligand 5 concentration following ischemia reperfusion injury. These findings identify CR-AnxA12-48 as a new ALX agonist that regulates phagocyte responses and displays tissue-protective actions.	[Perretti, Mauro; Dalli, Jesmond] Queen Mary Univ London, Barts & London Sch Med, William Harvey Res Inst, Charterhouse Sq, London, England; [Di Filippo, Clara; D'Amico, Michele] Univ Naples 2, Dept Expt Med, Naples, Italy	University of London; Queen Mary University London; Universita della Campania Vanvitelli	Dalli, J (corresponding author), Queen Mary Univ London, Barts & London Sch Med, William Harvey Res Inst, Charterhouse Sq, London, England.	j.dalli@qmul.ac.uk		Dalli, Jesmond/0000-0001-6328-3640	Unigene Corp.; Queen Mary University of London; William Harvey Research Foundation; Sir Henry Dale Fellowship - Wellcome Trust; Royal Society [107613/Z/15/Z]; Wellcome Trust [086867/Z/08]	Unigene Corp.; Queen Mary University of London; William Harvey Research Foundation; Sir Henry Dale Fellowship - Wellcome Trust(Wellcome Trust); Royal Society(Royal Society of London); Wellcome Trust(Wellcome Trust)	This work was supported by a collaborative project between Unigene Corp. and Queen Mary University of London and by the William Harvey Research Foundation. JD is supported by a Sir Henry Dale Fellowship jointly funded by the Wellcome Trust and the Royal Society (grant no: 107613/Z/15/Z). MP was supported by the Wellcome Trust (grant no: 086867/Z/08). The authors also than Dr. Angelo Consalvo and Dr Noser Mehta (Unigene Corp.) for providing the peptides.; This work was supported by a collaborative project between Unigene Corp. and Queen Mary University of London and by the William Harvey Research Foundation. JD is supported by a Sir Henry Dale Fellowship jointly funded by the Wellcome Trust and the Royal Society (grant no: 107613/Z/15/Z). MP was supported by the Wellcome Trust (grant no: 086867/Z/08). The authors also than Dr. Angelo Consalvo and Dr Noser Mehta (Unigene Corp.) for providing the peptides. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen NN, 2014, WORLD J GASTROENTERO, V20, P16014, DOI 10.3748/wjg.v20.i43.16014; Cai BS, 2017, J CLIN INVEST, V127, P564, DOI 10.1172/JCI90520; Chiang N, 2013, J IMMUNOL, V190, P6378, DOI 10.4049/jimmunol.1202969; Cooray SN, 2013, P NATL ACAD SCI USA, V110, P18232, DOI 10.1073/pnas.1308253110; D'Acquisto F, 2008, BRIT J PHARMACOL, V155, P152, DOI 10.1038/bjp.2008.252; Dalli J, 2008, BLOOD, V112, P2512, DOI 10.1182/blood-2008-02-140533; Dalli J, 2013, J IMMUNOL, V190, P6478, DOI 10.4049/jimmunol.1203000; Dufton N, 2010, PHARMACOL THERAPEUT, V127, P175, DOI 10.1016/j.pharmthera.2010.04.010; Dufton N, 2010, J IMMUNOL, V184, P2611, DOI 10.4049/jimmunol.0903526; Flannigan KL, 2015, FASEB J, V29, P1591, DOI 10.1096/fj.14-266015; Fullerton JN, 2016, NAT REV DRUG DISCOV, V15, P551, DOI 10.1038/nrd.2016.39; Galvao I, 2016, EUROPEAN J IMMUNOLOG; Gavins FNE, 2007, FASEB J, V21, P1751, DOI 10.1096/fj.06-7842com; Gavins FNE, 2004, FASEB J, V18, P100, DOI 10.1096/fj.04-2178fje; Gobbetti T, 2014, P NATL ACAD SCI USA, V111, P18685, DOI 10.1073/pnas.1410938111; Hayhoe RPG, 2006, BLOOD, V107, P2123, DOI 10.1182/blood-2005-08-3099; Headland SE, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac5608; Krishnamoorthy S, 2010, P NATL ACAD SCI USA, V107, P1660, DOI 10.1073/pnas.0907342107; Lannan KL, 2017, J THROMB HAEMOST; Leoni G, 2016, BIOL CHEM, V397, P971, DOI 10.1515/hsz-2016-0180; Maderna P, 2005, J IMMUNOL, V174, P3727, DOI 10.4049/jimmunol.174.6.3727; Majno G., 2004, CELLS TISSUES DIS PR; Norling LV, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.85922; Norling LV, 2012, ARTERIOSCL THROM VAS, V32, P1970, DOI 10.1161/ATVBAHA.112.249508; Pederzoli-Ribeil M, 2010, BLOOD, V116, P4288, DOI 10.1182/blood-2010-02-270520; Perretti M, 2002, NAT MED, V8, P1296, DOI 10.1038/nm786; Perretti M, 2017, NAT REV RHEUMATOL, V13, P87, DOI 10.1038/nrrheum.2016.193; Perretti M, 2009, BRIT J PHARMACOL, V158, P936, DOI 10.1111/j.1476-5381.2009.00483.x; Ray MVL, 2002, PROTEIN EXPRES PURIF, V26, P249, DOI 10.1016/S1046-5928(02)00523-5; Schofield ZV, 2013, SHOCK, V40, P463, DOI 10.1097/SHK.0000000000000044; Serhan CN, 2015, SEMIN IMMUNOL, V27, P200, DOI 10.1016/j.smim.2015.03.004; Serhan CN, 2011, CURR TOP MED CHEM, V11, P629; Serhan CN, 2017, FASEB J OFFICIAL PUB; Xu ZH, 2015, J CLIN PHARMACOL, V55, pS60, DOI 10.1002/jcph.380	34	10	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2017	12	4							0175786	10.1371/journal.pone.0175786	http://dx.doi.org/10.1371/journal.pone.0175786			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0MB	28407017	Green Submitted, gold, Green Published			2022-12-27	WOS:000399955400099
J	McDermott, ME; DeGroote, LW				McDermott, Molly E.; DeGroote, Lucas W.			Linking phenological events in migratory passerines with a changing climate: 50 years in the Laurel Highlands of Pennsylvania	PLOS ONE			English	Article							EGG-LAYING TRENDS; TITS PARUS-MAJOR; GREAT TITS; SPRING TEMPERATURES; BREEDING PHENOLOGY; FICEDULA-HYPOLEUCA; PIED FLYCATCHERS; POPULATION-SIZE; BIRD MIGRATION; ARRIVAL DATE	Advanced timing of both seasonal migration and reproduction in birds has been strongly associated with a warming climate for many bird species. Phenological responses to climate linking these stages may ultimately impact fitness. We analyzed five decades of banding data from 17 migratory bird species to investigate 1) how spring arrival related to timing of breeding, 2) if the interval between arrival and breeding has changed with increasing spring temperatures, and 3) whether arrival timing or breeding timing best predicted local productivity. Four of 17 species, all mid-to long-distance migrants, hatched young earlier in years when migrants arrived earlier to the breeding grounds (similar to 1: 1 day advancement). The interval between arrival on breeding grounds and appearance of juveniles shortened with warmer spring temperatures for 12 species ( 1 - 6 days for every 1 degrees C increase) and over time for seven species ( 1 - 8 days per decade), suggesting that some migratory passerines adapt to climate change by laying more quickly after arrival or reducing the time from laying to fledging. We found more support for the former, that the rate of reproductive advancement was higher than that for arrival in warm years. Timing of spring arrival and breeding were both poor predictors of avian productivity for most migrants analyzed. Nevertheless, we found evidence that fitness benefits may occur from shifts to earlier spring arrival for the multibrooded Song Sparrow. Our results uniquely demonstrate that co-occurring avian species are phenologically plastic in their response to climate change on their breeding grounds. If migrants continue to show a weaker response to temperatures during migration than breeding, and the window between arrival and optimal breeding shortens further, biological constraints to plasticity may limit the ability of species to adapt successfully to future warming.	[McDermott, Molly E.; DeGroote, Lucas W.] Carnegie Museum Nat Hist, Powdermill Nat Reserve, Rector, PA 15677 USA		DeGroote, LW (corresponding author), Carnegie Museum Nat Hist, Powdermill Nat Reserve, Rector, PA 15677 USA.	DegrooteL@carnegieMNH.org			Colcom Foundation; Laurel Foundation; Powdermill Avian Research Center (PARC); Carnegie Museum of Natural History	Colcom Foundation; Laurel Foundation; Powdermill Avian Research Center (PARC); Carnegie Museum of Natural History	This research was supported by grants from Colcom Foundation, Laurel Foundation, and private donors who have supported the Powdermill Avian Research Center since its inception. This manuscript is a contribution of the Powdermill Avian Research Center, a long-term bird monitoring program located at Powdermill Nature Reserve, operated and supported by the Carnegie Museum of Natural History. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to R. Leberman, R. Mulvihill, A. Leppold, A. Vitz, M. Shidel, and countless seasonal technicians and volunteers for collecting field data, and to M. Niedermeier for maintaining the database for many years. Thanks to J. Wenzel, A. Kautz, and J. Slyder for providing constructive comments on earlier drafts of the manuscript. Funding for this research was generously provided by the Colcom Foundation, Laurel Foundation, and numerous private donors who have supported the Powdermill Avian Research Center (PARC) since its inception. This manuscript is a contribution of the PARC, a long-term bird monitoring program located at Powdermill Nature Reserve, operated and supported by the Carnegie Museum of Natural History.	Ahola M, 2004, GLOBAL CHANGE BIOL, V10, P1610, DOI 10.1111/j.1365-2486.2004.00823.x; [Anonymous], 2013, AICCMODAVG MODEL SEL; ARCESE P, 1988, J ANIM ECOL, V57, P119, DOI 10.2307/4768; Borgman CC, 2016, OECOLOGIA, V180, P279, DOI 10.1007/s00442-015-3456-6; Both C, 2005, ARDEA, V93, P79; Both C, 2005, GLOBAL CHANGE BIOL, V11, P1606, DOI 10.1111/j.1365-2486.2005.01038.x; Both C, 2001, NATURE, V411, P296, DOI 10.1038/35077063; Bourgault P, 2010, OECOLOGIA, V162, P885, DOI 10.1007/s00442-009-1545-0; Brown CR, 2014, ECOLOGY, V95, P2736, DOI 10.1890/14-0425.1; Bulluck L, 2013, ECOLOGY EVOLUTION; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Charmantier A, 2008, SCIENCE, V320, P800, DOI 10.1126/science.1157174; Cohen EB, 2015, STUDIES AVIAN BIOL, P63; Cotton PA, 2003, P NATL ACAD SCI USA, V100, P12219, DOI 10.1073/pnas.1930548100; Cresswell W, 2003, J ANIM ECOL, V72, P356, DOI 10.1046/j.1365-2656.2003.00701.x; Crick HQP, 1999, NATURE, V399, P423, DOI 10.1038/20839; Dawson A, 2008, PHILOS T R SOC B, V363, P1621, DOI 10.1098/rstb.2007.0004; DESANTE DF, 1987, CONDOR, V89, P636, DOI 10.2307/1368653; Desante DF, 1995, J APPL STAT, V22, P935, DOI 10.1080/02664769524720; Doxa A, 2012, AUK, V129, P753, DOI 10.1525/auk.2012.11213; Dunn P, 2004, ADV ECOL RES, V35, P69, DOI 10.1016/S0065-2504(04)35004-X; Dunn PO, 2014, J ANIM ECOL, V83, P729, DOI 10.1111/1365-2656.12162; Dunn PO, 2011, ECOLOGY, V92, P450, DOI 10.1890/10-0478.1; Dunn Peter O., 2010, P113; Dybala KE, 2013, GLOBAL CHANGE BIOL, V19, P2688, DOI 10.1111/gcb.12228; Forstmeier W, 2002, J ANIM ECOL, V71, P1, DOI 10.1046/j.0021-8790.2001.00569.x; Gienapp P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046165; Gordo O, 2007, CLIM RES, V35, P37, DOI 10.3354/cr00713; HAFTORN S, 1988, ORNIS SCAND, V19, P97, DOI 10.2307/3676458; Halupka L, 2008, J AVIAN BIOL, V39, P95, DOI 10.1111/j.0908-8857.2008.04047.x; Hotker H, 2002, ARDEA, V90, P379; Husby A, 2009, P ROY SOC B-BIOL SCI, V276, P1845, DOI 10.1098/rspb.2008.1937; Irons R., 2015, CHANGES TREE SWALLOW; JARVINEN A, 1989, IBIS, V131, P572, DOI 10.1111/j.1474-919X.1989.tb04792.x; Johansson J, 2012, AM NAT, V179, P463, DOI 10.1086/664624; Laaksonen T, 2006, OIKOS, V114, P277, DOI 10.1111/j.2006.0030-1299.14652.x; Lany NK, 2015, OIKOS; Lehikoinen Esa, 2010, P89; Low M, 2015, J AVIAN BIOL, V46, P325, DOI 10.1111/jav.00623; Lozano GA, 1996, J AVIAN BIOL, V27, P164, DOI 10.2307/3677146; Marra PP, 2005, OECOLOGIA, V142, P307, DOI 10.1007/s00442-004-1725-x; Matthysen E, 2011, GLOBAL CHANGE BIOL, V17, P1, DOI 10.1111/j.1365-2486.2010.02213.x; McCleery RH, 1998, NATURE, V391, P30, DOI 10.1038/34073; McDermott ME, 2016, GLOBAL CHANGE BIOL, V22, P3304, DOI 10.1111/gcb.13363; McKellar AE, 2013, OECOLOGIA, V172, P595, DOI 10.1007/s00442-012-2520-8; Mills AM, 2005, IBIS, V147, P259, DOI 10.1111/j.1474-919X.2005.00380.x; Moller AP, 2006, J ANIM ECOL, V75, P657, DOI 10.1111/j.1365-2656.2006.01086.x; MOLLER AP, 1994, BEHAV ECOL SOCIOBIOL, V35, P115, DOI 10.1007/BF00171501; Moller AP, 2002, J ANIM ECOL, V71, P201, DOI 10.1046/j.1365-2656.2002.00589.x; Morrison CA, 2015, BIRD STUDY, V62, P161, DOI 10.1080/00063657.2015.1006575; Moussus JP, 2010, METHODS ECOL EVOL, V1, P140, DOI 10.1111/j.2041-210X.2010.00020.x; Nagy LR, 2005, ECOLOGY, V86, P675, DOI 10.1890/04-0155; Newton I, 2007, IBIS, V149, P453, DOI 10.1111/j.1474-919X.2007.00704.x; Nur N, 2000, 3 PARTN FLIGHT WORKS, P185; Oberg M, 2015, ECOL EVOL, V5, P345, DOI 10.1002/ece3.1345; Pachauri R.K., 2014, CLIMATE CHANGE 2014, P151; Pearce-Higgins JW, 2015, J ANIM ECOL, V84, P943, DOI 10.1111/1365-2656.12364; PearceHiggins JW, 2014, ECOL BIODIVERS CONS, P1; R Core Team, 2013, R LANG ENV STAT COMP; Redfern Chris P. F., 2010, Ringing & Migration, V25, P27; Saino N, 2004, ECOL LETT, V7, P21, DOI 10.1046/j.1461-0248.2003.00553.x; Sanz JJ, 2003, ECOGRAPHY, V26, P45, DOI 10.1034/j.1600-0587.2003.03251.x; Schaefer T, 2006, J ORNITHOL, V147, P47, DOI 10.1007/s10336-005-0011-y; Schaper SV, 2012, AM NAT, V179, pE55, DOI 10.1086/663675; Seward AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111180; Shiao MT, 2015, AUK, V132, P671, DOI 10.1642/AUK-15-10.1; Smith RJ, 2005, BEHAV ECOL SOCIOBIOL, V57, P231, DOI 10.1007/s00265-004-0855-9; Sparks TH, 2005, GLOBAL CHANGE BIOL, V11, P22, DOI 10.1111/j.1365-2486.2004.00887.x; Studds CE, 2011, P ROY SOC LOND B BIO; Tarka M, 2015, J EVOLUTION BIOL, V28, P1024, DOI 10.1111/jeb.12638; Tomas G, 2015, J AVIAN BIOL, V46, P107, DOI 10.1111/jav.00499; Townsend AK, 2015, GLOBAL CHANGE BIOL; Townsend AK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059467; Vedder O, 2012, OECOLOGIA, V170, P619, DOI 10.1007/s00442-012-2335-7; Velmala W, 2015, ECOL EVOL, V5, P1205, DOI 10.1002/ece3.1423; Visser ME, 2009, P ROY SOC B-BIOL SCI, V276, P2323, DOI 10.1098/rspb.2009.0213; Visser ME, 1998, P ROY SOC B-BIOL SCI, V265, P1867, DOI 10.1098/rspb.1998.0514; Wiebe KL, 2010, AUK, V127, P917, DOI 10.1525/auk.2010.10025; Williams TD, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.140301; Wilson A.M., 2012, 2 ATLAS BREEDING BIR; Wilson S, 2003, P NATL ACAD SCI USA, V100, P11139, DOI 10.1073/pnas.1931407100; Winkel W, 1997, J AVIAN BIOL, V28, P187, DOI 10.2307/3677313	82	8	9	2	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2017	12	4							e0174247	10.1371/journal.pone.0174247	http://dx.doi.org/10.1371/journal.pone.0174247			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LZ	28403152	Green Published, gold, Green Submitted			2022-12-27	WOS:000399955200010
J	Soberon, J; Arroyo-Pena, B				Soberon, J.; Arroyo-Pena, B.			Are fundamental niches larger than the realized? Testing a 50-year-old prediction by Hutchinson	PLOS ONE			English	Article							RANGE SIZE; THERMAL TOLERANCE; EVOLUTION; RESPONSES; CLIMATE; BREADTH; MODEL; DISTRIBUTIONS; CONSERVATION; COMMUNITIES	For more than 50 years ecological niches have been defined as combinations of multidimensional environmental conditions permitting a species to survive and reproduce. A fundamental niche (N-F) is defined as the set of conditions within which a species can live in the absence of competitors, and a realized niche (N-R) is a N-F hypothetically reduced by competitive interactions (and some other limiting factors). This definition implies that N-F is "larger" than N-R, something that has been nearly universally accepted by ecologists. However, there have been few attempts at empirical tests. Here, we present a novel quantitative test using one-dimensional estimates of N-F for 105 species of reptiles and amphibians, and estimates of N-R obtained from similar to 1.4 x 10(4) field observations. To specify our test, we operationalize the original classification of niche types. Our results predominantly support the hypothesis that N-F 'is larger' than N-R and we highlight the theoretical and practical importance of quantifying niches.	[Soberon, J.; Arroyo-Pena, B.] Univ Kansas, Biodivers Res Ctr, Lawrence, KS 66045 USA; [Soberon, J.; Arroyo-Pena, B.] Univ Kansas, Dept Ecol & Evolutionary Biol, Lawrence, KS 66045 USA	University of Kansas; University of Kansas	Soberon, J (corresponding author), Univ Kansas, Biodivers Res Ctr, Lawrence, KS 66045 USA.	jsoberon@ku.edu	Soberon, Jorge/N-7444-2015; Soberon, Jorge/ABF-1306-2021	Soberon, Jorge/0000-0003-2160-4148; Soberon, Jorge/0000-0003-2160-4148	NSF [ARBOR 1208472, BIOTAPHY 1458640]; Consejo Mexiquense de Ciencia y Tecnologia - Consejo Nacional de Ciencia y Tecnologia (Mexico) [215842]; Blitzy Soberon	NSF(National Science Foundation (NSF)); Consejo Mexiquense de Ciencia y Tecnologia - Consejo Nacional de Ciencia y Tecnologia (Mexico); Blitzy Soberon	This work was partially supported by NSF's ARBOR 1208472, and BIOTAPHY 1458640 grants to JS and by a Consejo Mexiquense de Ciencia y Tecnologia - Consejo Nacional de Ciencia y Tecnologia 215842 scholarship for studies abroad (Mexico) for BA. JS would also like to acknowledge the support of Blitzy Soberon. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to Luis Osorio for his help writing R scripts, to T. Peterson for valuable advice on an early version of the MS, to A. Diniz-Filho for his insightful comments and to an anonymous reviewer for helpful suggestions. We are also grateful to the innumerable sources of GBIF data, primarily museums and herbaria worldwide. This work was partially supported by NSF's ARBOR 1208472, and BIOTAPHY 1458640 grants to JS and by a Consejo Mexiquense de Ciencia y Tecnologia - Consejo Nacional de Ciencia y Tecnologia 215842 scholarship for studies abroad (Mexico) for BA. JS would also like to acknowledge the support of Blitzi Soberon.	Aiello-Lammens ME, 2015, ECOGRAPHY, V38, P541, DOI 10.1111/ecog.01132; Angert AL, 2005, EVOLUTION, V59, P1671, DOI 10.1111/j.0014-3820.2005.tb01817.x; Angilletta MJ, 2009, BIO HABIT, P1, DOI 10.1093/acprof:oso/9780198570875.001.1; [Anonymous], 2011, ECOLOGICAL NICHES GE; Araujo MB, 2006, J BIOGEOGR, V33, P1677, DOI 10.1111/j.1365-2699.2006.01584.x; Araujo MB, 2013, ECOL LETT, V16, P1206, DOI 10.1111/ele.12155; Aspinall R, 1994, P 6 INT S SPAT DAT H, P1066; Austin MP, 1999, OIKOS, V86, P170, DOI 10.2307/3546582; Barve N, 2014, GLOBAL ECOL BIOGEOGR, V23, P633, DOI 10.1111/geb.12150; BIRCH LC, 1953, ECOLOGY, V34, P698, DOI 10.2307/1931333; Blonder B, 2014, GLOBAL ECOL BIOGEOGR, V23, P595, DOI 10.1111/geb.12146; Bozinovic F, 2011, ANNU REV ECOL EVOL S, V42, P155, DOI 10.1146/annurev-ecolsys-102710-145055; Bruno JF, 2003, TRENDS ECOL EVOL, V18, P119, DOI 10.1016/S0169-5347(02)00045-9; Cain S.A., 1944, FDN PLANT GEOGRAPHY; Calosi P, 2010, J ANIM ECOL, V79, P194, DOI 10.1111/j.1365-2656.2009.01611.x; Ceballos G, 2005, SCIENCE, V309, P603, DOI 10.1126/science.1114015; Chase J.M., 2009, ECOLOGICAL NICHES LI; Chase JM, 2002, NATURE, V416, P427, DOI 10.1038/416427a; Chown SL, 2004, FUNCT ECOL, V18, P159, DOI 10.1111/j.0269-8463.2004.00825.x; COLWELL RK, 1971, ECOLOGY, V52, P567, DOI 10.2307/1934144; Colwell RK, 2009, P NATL ACAD SCI USA, V106, P19651, DOI 10.1073/pnas.0901650106; Cooper VS, 2002, BMC EVOL BIOL, V2, DOI 10.1186/1471-2148-2-12; De Frenne P, 2013, P NATL ACAD SCI USA, V110, P18561, DOI 10.1073/pnas.1311190110; Dormann CF, 2007, ECOGRAPHY, V30, P609, DOI 10.1111/j.2007.0906-7590.05171.x; Drake JM, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0086; Gaston KJ, 2001, GLOBAL ECOL BIOGEOGR, V10, P179, DOI 10.1046/j.1466-822x.2001.00225.x; Gouveia SF, 2014, GLOBAL ECOL BIOGEOGR, V23, P446, DOI 10.1111/geb.12114; GRUBB PJ, 1977, BIOL REV, V52, P107, DOI 10.1111/j.1469-185X.1977.tb01347.x; Guisan A, 2014, TRENDS ECOL EVOL, V29, P260, DOI 10.1016/j.tree.2014.02.009; Higgins SI, 2014, P NATL ACAD SCI USA, V111, P10610, DOI 10.1073/pnas.1406075111; Higgins SI, 2012, J BIOGEOGR, V39, P2132, DOI 10.1111/j.1365-2699.2012.02752.x; Hijmans R.J., 2011, PACKAGE DISMO SPECIE; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hijmans RJ, 2013, R PACKAGE VERSION; Hof C, 2010, ECOGRAPHY, V33, P242, DOI 10.1111/j.1600-0587.2010.06309.x; Holt R.D., 1997, CASE STUDIES MATH MO, P25; Hutchinson G.E., 1978, INTRO POPULATION ECO; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; Jackson ST, 2000, PALEOBIOLOGY, V26, P194, DOI 10.1666/0094-8373(2000)26[194:ROPPAC]2.0.CO;2; Jimenez-Valverde A, 2008, DIVERS DISTRIB, V14, P885, DOI 10.1111/j.1472-4642.2008.00496.x; Kearney M, 2004, ECOLOGY, V85, P3119, DOI 10.1890/03-0820; Kearney MR, 2014, METHODS ECOL EVOL, V5, P273, DOI 10.1111/2041-210X.12148; Kelly MW, 2012, P ROY SOC B-BIOL SCI, V279, P349, DOI 10.1098/rspb.2011.0542; Kennedy AD, 1997, INT J BIOMETEOROL, V40, P119, DOI 10.1007/s004840050031; Kleidon A, 2000, GLOB CHANGE BIOL, V6, P507, DOI 10.1046/j.1365-2486.2000.00332.x; Leathwick JR, 1998, J VEG SCI, V9, P719, DOI 10.2307/3237290; LINDENMAYER DB, 1991, J BIOGEOGR, V18, P371, DOI 10.2307/2845479; Malanson GP, 1997, J VEG SCI, V8, P307, DOI 10.2307/3237360; MALANSON GP, 1992, ECOL MODEL, V64, P261, DOI 10.1016/0304-3800(92)90026-B; Pulliam HR, 2000, ECOL LETT, V3, P349, DOI 10.1046/j.1461-0248.2000.00143.x; Quinn GP, 2003, EXPT DESIGN DATA ANA; Sheth SN, 2014, EVOLUTION, V68, P2917, DOI 10.1111/evo.12494; Slatyer RA, 2013, ECOL LETT, V16, P1104, DOI 10.1111/ele.12140; Soberon J, 2007, ECOL LETT, V10, P1115, DOI 10.1111/j.1461-0248.2007.01107.x; Soberon J, 2011, REV MEX BIODIVERS, V82, P1348; Soberon J, 2009, P NATL ACAD SCI USA, V106, P19644, DOI 10.1073/pnas.0901637106; Soberon Jorge, 2005, Biodiversity Informatics, V2, P1; Stine RA, 2001, STAT MED, V20, P215, DOI 10.1002/1097-0258(20010130)20:2<215::AID-SIM642>3.0.CO;2-X; Sunday JM, 2011, P ROY SOC B-BIOL SCI, V278, P1823, DOI 10.1098/rspb.2010.1295; Svenning JC, 2004, ECOL LETT, V7, P565, DOI 10.1111/j.1461-0248.2004.00614.x	60	79	80	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2017	12	4							e0175138	10.1371/journal.pone.0175138	http://dx.doi.org/10.1371/journal.pone.0175138			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LZ	28403170	Green Submitted, gold, Green Published			2022-12-27	WOS:000399955200036
J	Stillfried, M; Gras, P; Busch, M; Borner, K; Kramer-Schadt, S; Ortmann, S				Stillfried, Milena; Gras, Pierre; Busch, Matthias; Boerner, Konstantin; Kramer-Schadt, Stephanie; Ortmann, Sylvia			Wild inside: Urban wild boar select natural, not anthropogenic food resources	PLOS ONE			English	Article							SUS-SCROFA L.; OPTIMAL FORAGING THEORY; CROP DAMAGE; DIET; FOREST; AVAILABILITY; BEHAVIOR; URBANIZATION; BIODIVERSITY; CONSUMPTION	Most wildlife species are urban avoiders, but some became urban utilizers and dwellers successfully living in cities. Often, they are assumed to be attracted into urban areas by easily accessible and highly energetic anthropogenic food sources. We macroscopically analysed stomachs of 247 wild boar (Sus scrofa, hereafter WB) from urban areas of Berlin and from the surrounding rural areas. From the stomach contents we determined as predictors of food quality modulus of fineness (MOF,), percentage of acid insoluble ash (AIA) and macronutrients such as amount of energy and percentage of protein, fat, fibre and starch. We run linear mixed models to test: (1) differences in the proportion of landscape variables, (2) differences of nutrients consumed in urban vs. rural WB and (3) the impact of landscape variables on gathered nutrients. We found only few cases of anthropogenic food in the qualitative macroscopic analysis. We categorized the WB into five stomach content categories but found no significant difference in the frequency of those categories between urban and rural WB. The amount of energy was higher in stomachs of urban WB than in rural WB. The analysis of landscape variables revealed that the energy of urban WB increased with increasing percentage of sealing, while an increased human density resulted in poor food quality for urban and rural WB. Although the percentage of protein decreased in areas with a high percentage of coniferous forests, the food quality increased. High percentage of grassland decreased the percentage of consumed fat and starch and increased the percentage of fibre, while a high percentage of agricultural areas increased the percentage of consumed starch. Anthropogenic food such as garbage might serve as fallback food when access to natural resources is limited. We infer that urban WB forage abundant, natural resources in urban areas. Urban WB might use anthropogenic resources (e.g. garbage) if those are easier to exploit and more abundant than natural resources. This study shows that access to natural resources still is mandatory and drives the amount of protein, starch, fat or fibre in wild boar stomachs in urban as well as rural environments.	[Stillfried, Milena; Gras, Pierre; Busch, Matthias; Boerner, Konstantin; Kramer-Schadt, Stephanie; Ortmann, Sylvia] Leibniz Inst Zoo & Wildlife Res IZW, Dept Evolutionary Ecol, Alfred Kowalke Str 17, Berlin, Germany; [Busch, Matthias] Julius Maximilians Univ Wurzburg, Dept Anim Ecol & Trop Biol, Wurzburg, Germany	Leibniz Institut fur Zoo und Wildtierforschung; University of Wurzburg	Stillfried, M (corresponding author), Leibniz Inst Zoo & Wildlife Res IZW, Dept Evolutionary Ecol, Alfred Kowalke Str 17, Berlin, Germany.	stillfried@izw-berlin.de	Kramer-Schadt, Stephanie/A-8778-2013; Ortmann, Sylvia/B-7088-2015; Gras, Pierre/E-4398-2016	Kramer-Schadt, Stephanie/0000-0002-9269-4446; Ortmann, Sylvia/0000-0003-2520-6251; Gras, Pierre/0000-0002-4269-0770	Stiftung Naturschutz Berlin; Leibniz Institute for Zoo and Wildlife Research; National Geographic; German Federal Ministry of Education and Research BMBF within the Collaborative Project "Bridging in Biodiversity Science-BIBS" [01LC1501A-H]	Stiftung Naturschutz Berlin; Leibniz Institute for Zoo and Wildlife Research; National Geographic(National Geographic Society); German Federal Ministry of Education and Research BMBF within the Collaborative Project "Bridging in Biodiversity Science-BIBS"	"Stiftung Naturschutz Berlin" and National Geographic and the Leibniz Institute for Zoo and Wildlife Research funded the wild boar project. Pierre Gras was funded by the German Federal Ministry of Education and Research BMBF within the Collaborative Project "Bridging in Biodiversity Science-BIBS" (funding number 01LC1501A-H).; We thank Heidrun Barleben, Linda Bistere and Tim Bornholdt for laboratory analyses and the Berlin and Brandenburg forestry departments for providing samples. Many thanks to "Stiftung Naturschutz Berlin", National Geographic and the Leibniz Institute for Zoo and Wildlife Research for funding. PG was funded by the German Federal Ministry of Education and Research BMBF within the Collaborative Project "Bridging in Biodiversity Science-BIBS" (funding number 01LC1501A-H).	Amici A, 2012, AGRON SUSTAIN DEV, V32, P683, DOI 10.1007/s13593-011-0057-6; Ballari SA, 2015, MAMMAL RES, V60, P81, DOI 10.1007/s13364-014-0202-0; Ballari SA, 2014, MAMMAL REV, V44, P124, DOI 10.1111/mam.12015; Barton K., 2011, MUMIN MULTIMODEL INF; Beninde J, 2015, ECOL LETT, V18, P581, DOI 10.1111/ele.12427; Berlin SfSuU, 2015, ALT BEST WALD; BEYER WN, 1994, J WILDLIFE MANAGE, V58, P375, DOI 10.2307/3809405; Bonnot N, 2013, EUR J WILDLIFE RES, V59, P185, DOI 10.1007/s10344-012-0665-8; Borner K, 2014, VERSCHIEDEN ANTHROPO; Briedermann L, 1976, ERGEBNISSE INHALTSAN, P157; Brown JS, 1999, J MAMMAL, V80, P385, DOI 10.2307/1383287; Bueno CG, 2009, J ZOOL, V279, P195, DOI 10.1111/j.1469-7998.2009.00607.x; Cahill S, 2012, ANIM BIODIV CONSERV, V35, P221; Cellina S, 2008, EFFECTS SUPPLEMENTAL; CHARNOV EL, 1976, THEOR POPUL BIOL, V9, P129, DOI 10.1016/0040-5809(76)90040-X; Ciuti S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050611; Clauss M, 2002, OECOLOGIA, V131, P343, DOI 10.1007/s00442-002-0894-8; Contesse P, 2004, MAMM BIOL, V69, P81, DOI 10.1078/1616-5047-00123; Copernicus, 2012, HIGH RES LAYER IMP D; EMLEN JM, 1966, AM NAT, V100, P611, DOI 10.1086/282455; Cuevas MF, 2013, ACTA THERIOL, V58, P63, DOI 10.1007/s13364-012-0105-x; Ficetola GF, 2014, CURR ZOOL, V60, P170, DOI 10.1093/czoolo/60.2.170; Fischer JD, 2015, CONSERV BIOL, V29, P1246, DOI 10.1111/cobi.12451; Fox J., 2014, J STAT SOFTW, V8, P1; Frackowiak W, 2013, PEST MANAG SCI, V69, P362, DOI 10.1002/ps.3368; Franusch M, 2014, BERLINER ZEITUNG; Franusch M, 2000, ERHOLUNGSMULL AKTION; Frid A, 2002, CONSERV ECOL, V6; Gea-Izquierdo G., 2006, Investigacion Agraria, Sistemas y Recursos Forestales, V15, P339; Hafeez S, 2012, TURK J ZOOL, V36, P676, DOI 10.3906/zoo-1108-21; Hafeez S, 2011, TURK J ZOOL, V35, P115, DOI 10.3906/zoo-0806-24; Herrero J, 2005, ITAL J ZOOL, V72, P49, DOI 10.1080/11250000509356652; Herrero J, 2006, EUR J WILDLIFE RES, V52, P245, DOI 10.1007/s10344-006-0045-3; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Jansen A, 2007, EMERG INFECT DIS, V13, P739, DOI 10.3201/eid1305.061302; Kaplan BS, 2011, INT J PRIMATOL, V32, P1397, DOI 10.1007/s10764-011-9541-8; Keuling O, 2009, MAMM BIOL, V74, P145, DOI 10.1016/j.mambio.2008.05.007; Kotulski York, 2008, Natura Croatica, V17, P233; Krebs J.R., 1978, P23; Laznik Z, 2014, ITAL J ANIM SCI, V13, DOI 10.4081/ijas.2014.3434; Lewis DL, 2015, ECOSPHERE, V6, DOI 10.1890/ES15-00137.1; Lowry H, 2013, BIOL REV, V88, P537, DOI 10.1111/brv.12012; MACARTHUR RH, 1966, AM NAT, V100, P603, DOI 10.1086/282454; Maibeche Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118596; Massei G, 1996, ACTA THERIOL, V41, P307, DOI 10.4098/AT.arch.96-29; Massei Giovanna, 2004, Galemys, V16, P135; McKinney ML, 2002, BIOSCIENCE, V52, P883, DOI 10.1641/0006-3568(2002)052[0883:UBAC]2.0.CO;2; Merkle JA, 2013, J MAMMAL, V94, P378, DOI 10.1644/12-MAMM-A-002.1; Merta D, 2014, FOLIA ZOOL, V63, P95; MILNE BT, 1992, THEOR POPUL BIOL, V41, P337, DOI 10.1016/0040-5809(92)90033-P; Morey PS, 2007, AM MIDL NAT, V158, P147, DOI 10.1674/0003-0031(2007)158[147:SATVIT]2.0.CO;2; Murray M, 2015, ECOGRAPHY, V38, P1235, DOI 10.1111/ecog.01128; Nasiadka P, 2015, SYLWAN, V159, P307; Navarro-Gonzalez N, 2013, VET MICROBIOL, V167, P686, DOI 10.1016/j.vetmic.2013.07.037; NOBLET J, 1993, J ANIM SCI, V71, P3389, DOI 10.2527/1993.71123389x; Nowak DJ, 2001, J FOREST, V99, P37; Ottoni I, 2009, APPL ANIM BEHAV SCI, V117, P42, DOI 10.1016/j.applanim.2008.11.002; Pauleit Stephan, 2002, Urban Forestry & Urban Greening, V1, P83, DOI 10.1078/1618-8667-00009; PIERCE GJ, 1987, OIKOS, V49, P111, DOI 10.2307/3565560; POPPI DP, 1980, J AGR SCI-CAMBRIDGE, V94, P275, DOI 10.1017/S0021859600028859; PUTMAN RJ, 1984, MAMMAL REV, V14, P79, DOI 10.1111/j.1365-2907.1984.tb00341.x; PYKE GH, 1977, Q REV BIOL, V52, P137, DOI 10.1086/409852; PYKE GH, 1984, ANNU REV ECOL SYST, V15, P523, DOI 10.1146/annurev.es.15.110184.002515; R Core Team, 2013, R LANG ENV STAT COMP; Rosner S, 2014, LANDSCAPE ECOL, V29, P55, DOI 10.1007/s10980-013-9964-z; Schielke A, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-58; Schley L, 2003, MAMMAL REV, V33, P43, DOI 10.1046/j.1365-2907.2003.00010.x; Schwarm A, 2006, J ANIM PHYSIOL AN N, V90, P300, DOI 10.1111/j.1439-0396.2005.00599.x; Seto KC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023777; StatIS-BBB, 2014, EINW 2014; Stillfried M, 2016, J APPL ECOLOGY; Stillfried M, SECRETS SUCCES UNPUB; Stillfried M, 2015, BEHAV PROCESS, V120, P30, DOI 10.1016/j.beproc.2015.08.003; Theimer TC, 2015, URBAN ECOSYST, V18, P895, DOI 10.1007/s11252-015-0436-x; Tryjanowski P, 2015, ENVIRON SCI POLLUT R, V22, P15097, DOI 10.1007/s11356-015-4723-0; Welander J, 2000, J ZOOL, V252, P263, DOI 10.1111/j.1469-7998.2000.tb00621.x; Wenk C, 2001, ANIM FEED SCI TECH, V90, P21, DOI 10.1016/S0377-8401(01)00194-8; Wenzler M, 2016, THESIS	78	16	16	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2017	12	4							e0175127	10.1371/journal.pone.0175127	http://dx.doi.org/10.1371/journal.pone.0175127			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LZ	28403244	Green Submitted, gold, Green Published			2022-12-27	WOS:000399955200034
J	Hasibuzzaman, MM; Hossain, S; Islam, MS; Rahman, A; Anjum, A; Hossain, F; Mohanto, NC; Karim, MR; Hoque, M; Saud, ZA; Miyataka, H; Himeno, S; Hossain, K				Hasibuzzaman, M. M.; Hossain, Shakhawoat; Islam, Md Shofikul; Rahman, Atiqur; Anjum, Adiba; Hossain, Faruk; Mohanto, Nayan Chandra; Karim, Md Rezaul; Hoque, Mominul; Saud, Zahangir Alam; Miyataka, Hideki; Himeno, Seiichiro; Hossain, Khaled			Association between arsenic exposure and soluble thrombomodulin: A cross sectional study in Bangladesh	PLOS ONE			English	Article							ENDOTHELIAL-CELL MARKERS; DRINKING-WATER; CIRCULATING MARKERS; CAROTID ATHEROSCLEROSIS; CARDIOVASCULAR-DISEASE; PLASMA THROMBOMODULIN; ADHESION MOLECULE-1; ELEVATED LEVELS; INCREASED RISK; HEART-DISEASE	Chronic exposure to arsenic is associated with increased morbidity and mortality from cardiovascular disease (CVD); however, plausible biomarker for early prediction and the underlying mechanism of arsenic-related CVD have not yet been clearly understood. Endothelial dysfunction plays a central role in the development of CVD. We hypothesized that endothelial damage or dysfunction is an important aspect and may be an early event of arsenic-related CVD. Soluble thrombomodulin (sTM) in serum is thought to be a specific and stable marker for endothelial damage or dysfunction. This study was designed to evaluate the association between chronic exposure to arsenic and sTM among human subjects in arsenic- endemic and non-endemic rural areas in Bangladesh. A total of 321 study subjects (217 from arsenic-endemic areas and 104 from a non-endemic area) were recruited. Subjects' arsenic exposure levels (i.e., drinking water, hair and nail arsenic concentrations) were measured by Inductively Coupled Plasma Mass Spectroscopy. The subjects' serum sTM levels were quantified by immunoassay kit. The average sTM levels of the subjects in arsenic-endemic and non-endemic areas were 4.58 +/- 2.20 and 2.84 +/- 1.29 (ng mL(-1)) respectively, and the difference was significant (p<0.001). Arsenic exposure levels showed a significant (water arsenic: rs = 0.339, p<0.001, hair arsenic: rs = 0.352, p<0.001 and nail arsenic: rs = 0.308, p<0.001) positive associations with sTM levels. Soluble TM levels were higher in the higher exposure gradients if we stratified the subjects into tertile groups (low, medium and high) based on the arsenic concentrations of the subjects' drinking water, hair and nails. Finally, increased levels of sTM were negatively correlated with high density lipoprotein cholesterol (HDL-C), and positively correlated with intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1). Results of this study show that chronic exposure to arsenic has mild to moderate association with sTM levels.	[Hasibuzzaman, M. M.; Hossain, Shakhawoat; Islam, Md Shofikul; Rahman, Atiqur; Anjum, Adiba; Hossain, Faruk; Mohanto, Nayan Chandra; Hoque, Mominul; Saud, Zahangir Alam; Hossain, Khaled] Univ Rajshahi, Dept Biochem & Mol Biol, Rajshahi, Bangladesh; [Islam, Md Shofikul; Karim, Md Rezaul] Islamic Univ, Dept Appl Nutr & Food Technol, Kushtia, Bangladesh; [Miyataka, Hideki; Himeno, Seiichiro] Tokushima Bunri Univ, Fac Pharmaceut Sci, Lab Mol Nutr & Toxicol, Tokushima, Japan	University of Rajshahi; Islamic University; Tokushima Bunri University	Hossain, K (corresponding author), Univ Rajshahi, Dept Biochem & Mol Biol, Rajshahi, Bangladesh.	khossainbio@gmail.com	Mohanto, Nayan Chandra/GLR-0463-2022; Himeno, Seiichiro/AAW-3421-2020; Rahman, Md Atiqur/GSE-2794-2022; Saud, Zahangir Alam/ADC-1753-2022	Mohanto, Nayan Chandra/0000-0002-5803-1534; Himeno, Seiichiro/0000-0002-0773-2373; Hasibuzzaman, MM/0000-0002-0081-6742; Saud, Zahangir Alam/0000-0003-0019-053X; Anjum, Adiba/0000-0003-2713-8109; Hossain, Khaled/0000-0003-0878-915X	R & D project, Ministry of Science and Technology, Government of the People's Republic of Bangladesh [39.012.002.02.01.016.2013-463]; Ministry of Science and Technology, Government of the People's Republic of Bangladesh [39.009.006.01.00.042.2012-2013/ES-21/558]; TWAS [12-103 RG/BIO/AS_I-UNESCO FR: 3240271353]; Japan Society for the Promotion of Science (JSPS) Kakenhi, Japan [24406009]; Grants-in-Aid for Scientific Research [16H05834] Funding Source: KAKEN	R & D project, Ministry of Science and Technology, Government of the People's Republic of Bangladesh; Ministry of Science and Technology, Government of the People's Republic of Bangladesh; TWAS(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); Japan Society for the Promotion of Science (JSPS) Kakenhi, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the R & D project, Ministry of Science and Technology, Government of the People's Republic of Bangladesh (Grant No. 39.012.002.02.01.016.2013-463), TWAS (Grant No. 12-103 RG/BIO/AS_I-UNESCO FR: 3240271353), Ministry of Science and Technology, Governent of the People's Republic of Bangladesh [Grant No. 39.009.006.01.00.042.2012-2013/ES-21/558], and Japan Society for the Promotion of Science (JSPS) Kakenhi, Japan (Grant No. 24406009). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Suwaidi J, 2000, CIRCULATION, V101, P948, DOI 10.1161/01.CIR.101.9.948; Ali N, 2010, ENVIRON HEALTH-GLOB, V9, DOI 10.1186/1476-069X-9-36; Blann AD, 1996, BRIT J HAEMATOL, V92, P498, DOI 10.1046/j.1365-2141.1996.d01-1486.x; Blann AD, 1997, EUR J HAEMATOL, V59, P115; Blann AD, 1997, EUR J CLIN INVEST, V27, P916, DOI 10.1046/j.1365-2362.1997.2180766.x; Boehme MWJ, 1996, IMMUNOLOGY, V87, P134; Boffa MC, 1998, LUPUS, V7, pS120, DOI 10.1177/096120339800700227; CELERMAJER DS, 1992, LANCET, V340, P1111, DOI 10.1016/0140-6736(92)93147-F; CHEN CJ, 1995, HYPERTENSION, V25, P53, DOI 10.1161/01.HYP.25.1.53; Chen Y., 2013, ENVIRON HEALTH PERSP, V121, P1; Chen Y, 2006, J HEALTH POPUL NUTR, V24, P253; Chen Y, 2013, AM J EPIDEMIOL, V178, P372, DOI 10.1093/aje/kwt001; Chen Y, 2013, ENVIRON HEALTH PERSP, V121, P832, DOI 10.1289/ehp.1205797; Chen Y, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d2431; Chowdhury AMR, 2004, SCI AM, V291, P86; Constans J, 2000, THROMB RES, V99, P557, DOI 10.1016/S0049-3848(00)00284-X; Constans J, 2006, CLIN CHIM ACTA, V368, P33, DOI 10.1016/j.cca.2005.12.030; Dohi Y, 2003, HYPERTENS RES, V26, P479, DOI 10.1291/hypres.26.479; Flammer AJ, 2012, CIRCULATION, V126, P753, DOI 10.1161/CIRCULATIONAHA.112.093245; Frisbie SH, 2002, ENVIRON HEALTH PERSP, V110, P1147, DOI 10.1289/ehp.021101147; Galkina E, 2007, ARTERIOSCL THROM VAS, V27, P2292, DOI 10.1161/ATVBAHA.107.149179; Hossain E, 2012, TOXICOL APPL PHARM, V259, P187, DOI 10.1016/j.taap.2011.12.023; Hsieh YC, 2011, ENVIRON RES, V111, P804, DOI 10.1016/j.envres.2011.05.003; Hsueh YM, 1998, ATHEROSCLEROSIS, V141, P249, DOI 10.1016/S0021-9150(98)00178-6; Huda N, 2014, TOXICOL APPL PHARM, V281, P11, DOI 10.1016/j.taap.2014.09.011; ISHII H, 1985, J CLIN INVEST, V76, P2178, DOI 10.1172/JCI112225; ISHII H, 1991, THROMB HAEMOSTASIS, V65, P618; Islam MS, 2015, ENVIRON HEALTH-GLOB, V14, DOI 10.1186/s12940-015-0079-7; IWASHIMA Y, 1990, DIABETES, V39, P983, DOI 10.2337/diabetes.39.8.983; Karim MR, 2013, TOXICOL SCI, V135, P17, DOI 10.1093/toxsci/kft130; Karim MR, 2010, SCI TOTAL ENVIRON, V409, P278, DOI 10.1016/j.scitotenv.2010.10.001; Kawauchi K, 2014, J CARDIOL, V64, P312, DOI 10.1016/j.jjcc.2014.02.004; Larsson PT, 2005, INT ANGIOL, V24, P43; MARKULJAK I, 1995, NOUV REV FR HEMATOL, V37, P137; MARUYAMA I, 1985, J CELL BIOL, V101, P363, DOI 10.1083/jcb.101.2.363; MCLENACHAN JM, 1990, CIRCULATION, V82, P1169, DOI 10.1161/01.CIR.82.4.1169; Murray CJL, 1997, LANCET, V349, P1269, DOI 10.1016/S0140-6736(96)07493-4; Olivot JM, 2004, STROKE, V35, P1946, DOI 10.1161/01.STR.0000133340.37712.9b; Peter K, 1997, ARTERIOSCL THROM VAS, V17, P505, DOI 10.1161/01.ATV.17.3.505; Porreca E, 2004, ATHEROSCLEROSIS, V172, P175, DOI 10.1016/j.atherosclerosis.2003.09.022; Rahman M, 2013, PLOS ONE, V8, P61; Rahman M, 2015, CHEMOSPHERE, V120, P336, DOI 10.1016/j.chemosphere.2014.08.003; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Sadler JE, 1997, THROMB HAEMOSTASIS, V78, P392; Salomaa V, 1999, LANCET, V353, P1729, DOI 10.1016/S0140-6736(98)09057-6; Salomaa V, 2001, ATHEROSCLEROSIS, V157, P309, DOI 10.1016/S0021-9150(00)00729-2; SEIGNEUR M, 1993, THROMB RES, V71, P423, DOI 10.1016/0049-3848(93)90116-6; Simeonova PP, 2004, TOXICOL APPL PHARM, V198, P444, DOI 10.1016/j.taap.2003.10.018; Sohel N, 2009, EPIDEMIOLOGY, V20, P824, DOI 10.1097/EDE.0b013e3181bb56ec; States JC, 2009, TOXICOL SCI, V107, P312, DOI 10.1093/toxsci/kfn236; Tseng CH, 2000, ENVIRON HEALTH PERSP, V108, P847, DOI 10.2307/3434992; Wade TJ, 2009, INT J ENV RES PUB HE, V6, P1107, DOI 10.3390/ijerph6031107; Wang CH, 2002, CIRCULATION, V105, P1804, DOI 10.1161/01.CIR.0000015862.64816.B2; Wang YH, 2007, ATHEROSCLEROSIS, V192, P305, DOI 10.1016/j.atherosclerosis.2006.07.029; Wu F, 2012, AM J EPIDEMIOL, V175, P1252, DOI 10.1093/aje/kwr464; Wu MM, 2010, TOXICOL APPL PHARM, V248, P226, DOI 10.1016/j.taap.2010.08.005; ZEIHER AM, 1991, CIRCULATION, V83, P391, DOI 10.1161/01.CIR.83.2.391	59	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2017	12	4							e0175154	10.1371/journal.pone.0175154	http://dx.doi.org/10.1371/journal.pone.0175154			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0JS	28399171	gold, Green Published, Green Submitted			2022-12-27	WOS:000399949000021
J	Wang, Y; Xuan, LY; Cui, XX; Wang, YL; Chen, SQ; Wei, CX; Zhao, M				Wang, Yu; Xuan, Liying; Cui, Xiaoxue; Wang, Yilin; Chen, Shaoqing; Wei, Chengxi; Zhao, Ming			Ibutilide treatment protects against ER stress induced apoptosis by regulating calumenin expression in tunicamycin treated cardiomyocytes	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; NEONATAL-RAT CARDIOMYOCYTES; ISCHEMIA/REPERFUSION INJURY; ATRIAL-FIBRILLATION; ENDOTHELIAL-CELLS; DEATH; HEART; ACTIVATION; INDUCTION; MODEL	Background Ibutilide, a class III antiarrhythmic agent has been shown to be cardioprotective in treating atrial fibrillation, promoting cardioconversion and recently this agent has been shown to protect against ER stress induced apoptosis in cardiomyocytes. In this study we begin to identify the mechanism by which ibutilide exerts its cardioprotection in tunicamycin treated cardiomyocytes. We examined ER stress markers including calumenin; a calcium binding ER chaperone protein that has recently been linked to ER stress in cardiomyocytes, in our treated cells. Methods To assess the effect of ibutilide we used the well characterized in vitro model of ER stress induced apoptosis in rat neonatal cardiomyocytes (RNC). RNC were treated with tunicamycin and the degree of ER stress was assessed by quantifying mRNA and protein levels of GRP78, GRP94 and calumenin, and examined the extent of apoptosis by assessing the protein levels of caspase-3/9/12, CHOP, ATF6, p-PERK, spliced XBP-1, the ratio of Bax/Bcl-2 and the percentage of deoxynucleotidyl-transferase- mediated dUTP nick end labeling (TUNEL) positive cells. Results We demonstrate ibutilide attenuated the up-regulation of ER stress markers GRP78 and GRP94 and rescued the decline in calumenin mRNA and protein levels in tunicamycin treated cardiomyocytes. The up-regulation of apoptotic markers caspase-3, CHOP, ATF6, p-PERK, spliced XBP-1, the ratio of Bax/Bcl-2 and the percentage of TUNEL positive cells were also attenuated after ibutilide treatment while the protein levels of Caspase-9 and Caspase-12 were unaffected. Conclusions This study suggests another cardioprotective effect of the antiarrhythmic agent ibutilide whereby pretreatment leads to the attenuation of ER stress induced apoptosis by regulating calumenin expression. This study provides further evidence for the role of calumenin in the cardiomyocyte ER stress response.	[Wang, Yu; Xuan, Liying; Wei, Chengxi] Inner Mongolia Univ Nationalities, Med Chem & Pharmacol Inst, Tongliao, Inner Mongolia, Peoples R China; [Wang, Yu; Xuan, Liying; Wei, Chengxi; Zhao, Ming] Inner Mongolia Prov Key Lab Mongolian Med Pharmac, Tongliao, Inner Mongolia, Peoples R China; [Cui, Xiaoxue; Wang, Yilin; Chen, Shaoqing; Zhao, Ming] Inner Mongolia Univ Nationalities, Clin Med Coll 1, Tongliao, Inner Mongolia, Peoples R China	Inner Mongolia University for Nationalities; Inner Mongolia University for Nationalities	Wei, CX (corresponding author), Inner Mongolia Univ Nationalities, Med Chem & Pharmacol Inst, Tongliao, Inner Mongolia, Peoples R China.; Wei, CX; Zhao, M (corresponding author), Inner Mongolia Prov Key Lab Mongolian Med Pharmac, Tongliao, Inner Mongolia, Peoples R China.; Zhao, M (corresponding author), Inner Mongolia Univ Nationalities, Clin Med Coll 1, Tongliao, Inner Mongolia, Peoples R China.	weichengxi1224@163.com; langzhe73@163.com			National Natural Science Foundation of China [81360587]; Natural Science Foundation of Inner Mongolia [2016BS0806]; Mongolian Medicine Systems Biology Science and Technology Innovation Team Plan of Inner Mongolia	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Inner Mongolia; Mongolian Medicine Systems Biology Science and Technology Innovation Team Plan of Inner Mongolia	The study was supported by a grant from the National Natural Science Foundation of China (No.81360587), the Natural Science Foundation of Inner Mongolia (No.2016BS0806) and the Mongolian Medicine Systems Biology Science and Technology Innovation Team Plan of Inner Mongolia.	Aime-Sempe C, 1999, J AM COLL CARDIOL, V34, P1577, DOI 10.1016/S0735-1097(99)00382-4; Anelli T, 2008, EMBO J, V27, P315, DOI 10.1038/sj.emboj.7601974; Glatter KA, 2001, CIRCULATION, V104, P1933, DOI 10.1161/hc4101.097538; Groenendyk J, 2010, CIRC RES, V107, P1185, DOI 10.1161/CIRCRESAHA.110.227033; Han W, 2008, INT J CARDIOL, V130, P165, DOI 10.1016/j.ijcard.2008.02.026; Kito H, 2011, BIOCHEM BIOPH RES CO, V411, P293, DOI 10.1016/j.bbrc.2011.06.128; Lee JH, 2013, BIOCHEM BIOPH RES CO, V439, P327, DOI 10.1016/j.bbrc.2013.08.087; Lievremont JP, 1997, J BIOL CHEM, V272, P30873, DOI 10.1074/jbc.272.49.30873; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; Martindale JJ, 2006, CIRC RES, V98, P1186, DOI 10.1161/01.RES.0000220643.65941.8d; MORILLO CA, 1995, CIRCULATION, V91, P1588, DOI 10.1161/01.CIR.91.5.1588; Murray KT, 1998, CIRCULATION, V97, P493; Narula J, 1999, P NATL ACAD SCI USA, V96, P8144, DOI 10.1073/pnas.96.14.8144; Pahl HL, 1999, PHYSIOL REV, V79, P683, DOI 10.1152/physrev.1999.79.3.683; Ren DY, 2012, J BIOMED RES, V26, P432, DOI 10.7555/JBR.26.20120006; Scarabelli TM, 2004, CELL DEATH DIFFER, V11, pS144, DOI 10.1038/sj.cdd.4401544; Shen M, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.479; Shen MZ, 2015, MOL MED REP, V12, P5149, DOI 10.3892/mmr.2015.4040; Shi JJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117567; Sobue K, 1999, NEUROSCI RES, V35, P155, DOI 10.1016/S0168-0102(99)00079-6; Toth Ambrus, 2007, Cardiovascular & Hematological Disorders - Drug Targets, V7, P205, DOI 10.2174/187152907781745260; Wang Y, 2016, HEART VESSELS	22	12	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2017	12	4							e0173469	10.1371/journal.pone.0173469	http://dx.doi.org/10.1371/journal.pone.0173469			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0JS	28399139	Green Published, Green Submitted, gold			2022-12-27	WOS:000399949000003
J	Char, JE; Dunn, C; Davies, Z; Milla, C; Moss, RB; Wine, JJ				Char, Jessica E.; Dunn, Colleen; Davies, Zoe; Milla, Carlos; Moss, Richard B.; Wine, Jeffrey J.			The magnitude of ivacaftor effects on fluid secretion via R117H-CFTR channels: Human in vivo measurements	PLOS ONE			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; MESSENGER-RNA TRANSCRIPTS; CYSTIC-FIBROSIS; PARTIAL PENETRANCE; CFTR POTENTIATOR; CODING SEQUENCES; MUTATION; DISEASE; GLANDS; GENE	We optically measured effects of orally available ivacaftor (Kalydeco (R)) on sweat rates of identified glands in 3 R117H subjects, each having a unique set of additional mutations, and compared them with 5 healthy control subjects tested contemporaneously. We injected beta-adrenergic agonists intradermally to stimulate CFTR-dependent 'C-sweat' and methacholine to stimulate 'M-sweat', which persists in CF subjects. We focused on an R117H-7T/F508del subject who produced quantifiable C-sweat off ivacaftor and was available for 1 blinded, 3 off ivacaftor, and 3 on ivacaftor tests, allowing us to estimate in vivo fold-increase in sweat rates produced by ivacaftor's effect on the open probability (P-O) of R117H-CFTR. Measured sweat rates must be corrected for sweat losses. With estimated sweat losses of 0.023 to 0.08 nl center dot gland(-1)center dot min(-1), ivacaftor increased the average C-sweat rates 3-7 fold, and estimated function as % of WT were 4.1-12% off ivacaftor and 21.9-32% on ivacaftor (larger values reflect increased loss estimates). Based on single tests, an R117H-7T/R117H-7T subject showed 6-9% WT function off ivacaftor and 28-43% on ivacaftor. Repeat testing of an R117H-5T/F508del subject detected only trace responding to ivacaftor. We conclude that in vivo, R117H P-O is strongly increased by ivacaftor, but channel number, mainly determined by variable deletion of exon 10, has a marked influence on outcomes.	[Char, Jessica E.; Wine, Jeffrey J.] Stanford Univ, Cyst Fibrosis Res Lab, Stanford, CA 94305 USA; [Dunn, Colleen; Davies, Zoe; Milla, Carlos; Moss, Richard B.; Wine, Jeffrey J.] Stanford Univ, Dept Pediat, Sch Med, Stanford, CA 94305 USA	Stanford University; Stanford University	Wine, JJ (corresponding author), Stanford Univ, Cyst Fibrosis Res Lab, Stanford, CA 94305 USA.; Wine, JJ (corresponding author), Stanford Univ, Dept Pediat, Sch Med, Stanford, CA 94305 USA.	wine@stanford.edu	Moss, Richard B./S-9218-2019	Moss, Richard B./0000-0003-3611-4221; Milla, Carlos/0000-0001-5515-3053	 [WINE14XX0]		This work was supported by Grant WINE14XX0 to JJW, http://www.ctorg/research/cfft/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accurso FJ, 2010, NEW ENGL J MED, V363, P1991, DOI 10.1056/NEJMoa0909825; BEHM JK, 1987, PEDIATR RES, V22, P271, DOI 10.1203/00006450-198709000-00007; BERSCHNEIDER HM, 1988, FASEB J, V2, P2625, DOI 10.1096/fasebj.2.10.2838365; BIJMAN J, 1984, AM J PHYSIOL, V247, pC3, DOI 10.1152/ajpcell.1984.247.1.C3; BIJMAN J, 1991, ADV EXP MED BIOL, V290, P287; Billet A, 2013, J BIOL CHEM, V288, DOI 10.1074/jbc.M113.479360; Char JE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088564; Cho HJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024424; CHU CS, 1991, EMBO J, V10, P1355, DOI 10.1002/j.1460-2075.1991.tb07655.x; CHU CS, 1993, NAT GENET, V3, P151, DOI 10.1038/ng0293-151; CHU CS, 1992, J CLIN INVEST, V90, P785, DOI 10.1172/JCI115952; Cuppens H, 1998, J CLIN INVEST, V101, P487, DOI 10.1172/JCI639; Darman RB, 2002, J BIOL CHEM, V277, P37542, DOI 10.1074/jbc.M206293200; de Meeus A, 1998, J MED GENET, V35, P594, DOI 10.1136/jmg.35.7.594; de Nooijer RA, 2011, J CYST FIBROS, V10, P326, DOI 10.1016/j.jcf.2011.03.009; Gamba Gerardo, 2005, Biochem J, V391, pe1; Gentzsch M, 2016, AM J PHYSL LUNG CELL, V311; GERVAIS R, 1993, NEW ENGL J MED, V328, P446, DOI 10.1056/NEJM199302113280619; GOCHBERG SH, 1956, PEDIATRICS, V18, P701; Harrison MJ, 2013, NEW ENGL J MED, V369, P1280, DOI 10.1056/NEJMc1213681; Joo NS, 2010, J CLIN INVEST, V120, P3161, DOI 10.1172/JCI43466; KIESEWETTER S, 1993, NAT GENET, V5, P274, DOI 10.1038/ng1193-274; Kuno Y., 1956, HUMAN PERSPIRATION; LYTLE C, 1992, AM J PHYSIOL, V262, pC1009, DOI 10.1152/ajpcell.1992.262.4.C1009; McGarry ME, 2013, CHEST, V144, P1376, DOI 10.1378/chest.13-0239; Monette Michelle Y, 2012, J Biol Chem, V287, P2210, DOI 10.1074/jbc.M111.309211; Moss RB, 2015, LANCET RESP MED, V3, P524, DOI 10.1016/S2213-2600(15)00201-5; Namkung W, 2010, MOL BIOL CELL, V21, P2639, DOI 10.1091/mbc.E09-12-1004; Quinton P, 2012, AM J RESP CRIT CARE, V186, P732, DOI 10.1164/rccm.201205-0922OC; Ramalho AS, 2002, AM J RESP CELL MOL, V27, P619, DOI 10.1165/rcmb.2001-0004OC; Ramsey BW, 2011, NEW ENGL J MED, V365, P1663, DOI 10.1056/NEJMoa1105185; RaveHarel N, 1997, AM J HUM GENET, V60, P87; SATO K, 1984, J CLIN INVEST, V73, P1763, DOI 10.1172/JCI111385; Shamsuddin AKM, 2008, EXP PHYSIOL, V93, P969, DOI 10.1113/expphysiol.2008.042283; SHEPPARD DN, 1993, NATURE, V362, P160, DOI 10.1038/362160a0; Sun XS, 2010, J CLIN INVEST, V120, P3149, DOI 10.1172/JCI43052; Suverza A, 2005, FASEB J, V19, pA48; SUZUKI Y, 1991, J MEMBRANE BIOL, V123, P33, DOI 10.1007/BF01993960; TAYLOR CJ, 1988, GUT, V29, P957, DOI 10.1136/gut.29.7.957; Van Goor F, 2014, PEDIATR PULM, V49, P216; Van Goor F, 2014, J CYST FIBROS, V13, P29, DOI 10.1016/j.jcf.2013.06.008; Van Goor F, 2009, P NATL ACAD SCI USA, V106, P18825, DOI 10.1073/pnas.0904709106; Vitari AC, 2006, BIOCHEM J, V397, P223, DOI 10.1042/BJ20060220; Wang Y, 2014, INT J BIOCH CELL BIO; Wine JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077114; Yu HH, 2012, J CYST FIBROS, V11, P237, DOI 10.1016/j.jcf.2011.12.005; Yu YC, 2016, J PHYSIOL-LONDON, V594, P3227, DOI 10.1113/JP271723	47	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2017	12	4							e0175486	10.1371/journal.pone.0175486	http://dx.doi.org/10.1371/journal.pone.0175486			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KH	28419121	Green Submitted, gold, Green Published			2022-12-27	WOS:000399875200023
J	Yi, Q; Tang, SH; Fan, XL; Zhang, M; Pang, YW; Huang, X; Huang, QY				Yi, Qiong; Tang, Shuanghu; Fan, Xiaolin; Zhang, Mu; Pang, Yuwan; Huang, Xu; Huang, Qiaoyi			Effects of nitrogen application rate, nitrogen synergist and biochar on nitrous oxide emissions from vegetable field in south China	PLOS ONE			English	Article							N2O EMISSIONS; NITRIFICATION INHIBITORS; FERTILIZER; DICYANDIAMIDE; SYSTEM; CROP; PH	Globally, vegetable fields are the primary source of greenhouse gas emissions. A closedchamber method together with gas chromatography was used to measure the fluxes of nitrous oxide (N2O) emissions in typical vegetable fields planted with four vegetables sequentially over time in the same field: endive, lettuce, cabbage and sweet corn. Results showed that N2O fluxes occurred in pulses with the N2O emission peak varying greatly among the crops. In addition, N2O emissions were linearly associated with the nitrogen (N) application rate (r = 0.8878, n = 16). Excessive fertilizer N application resulted in N loss through nitrous oxide gas emitted from the vegetable fields. Compared with a conventional fertilization (N2) treatment, the cumulative N2O emissions decreased significantly in the growing seasons of four plant species from an nitrogen synergist (a nitrification inhibitor, dicyandiamide and biochar treatments by 34.6% and 40.8%, respectively. However, the effects of biochar on reducing N2O emissions became more obvious than that of dicyandiamide over time. The yield-scaled N2O emissions in consecutive growing seasons for four species increased with an increase in the N fertilizer application rate, and with continuous application of N fertilizer. This was especially true for the high N fertilizer treatment that resulted in a risk of yield-scaled N2O emissions. Generally, the additions of dicyandiamide and biochar significantly decreased yield-scaled N2O-N emissions by an average of 45.9% and 45.7%, respectively, compared with N2 treatment from the consecutive four vegetable seasons. The results demonstrated that the addition of dicyandiamide or biochar in combination with application of a rational amount of N could provide the best strategy for the reduction of greenhouse gas emissions in vegetable field in south China.	[Yi, Qiong; Tang, Shuanghu; Zhang, Mu; Pang, Yuwan; Huang, Xu; Huang, Qiaoyi] Guangdong Acad Agr Sci, Inst Agr Resources & Environm, Guangzhou, Guangdong, Peoples R China; [Yi, Qiong; Tang, Shuanghu; Zhang, Mu; Pang, Yuwan; Huang, Xu; Huang, Qiaoyi] Minist Agr, Key Lab Plant Nutr & Fertilizer South Reg, Guangzhou, Guangdong, Peoples R China; [Yi, Qiong; Tang, Shuanghu; Zhang, Mu; Pang, Yuwan; Huang, Xu; Huang, Qiaoyi] Guangdong Key Lab Nutrient Cycling & Farmland Con, Guangzhou, Guangdong, Peoples R China; [Yi, Qiong; Fan, Xiaolin] South China Agr Univ, Coll Agr, Guangzhou, Guangdong, Peoples R China	Guangdong Academy of Agricultural Sciences; Ministry of Agriculture & Rural Affairs; South China Agricultural University	Tang, SH (corresponding author), Guangdong Acad Agr Sci, Inst Agr Resources & Environm, Guangzhou, Guangdong, Peoples R China.; Tang, SH (corresponding author), Minist Agr, Key Lab Plant Nutr & Fertilizer South Reg, Guangzhou, Guangdong, Peoples R China.; Tang, SH (corresponding author), Guangdong Key Lab Nutrient Cycling & Farmland Con, Guangzhou, Guangdong, Peoples R China.	tfstshu@aliyun.com.cn			Plan Project of Science and technology, Guangdong province [2014A020208051, 20146090904068, 2012A020100004]	Plan Project of Science and technology, Guangdong province	This research was financially supported by the Plan Project of Science and technology, Guangdong province (2014A020208051, 20146090904068, 2012A020100004). Both of the funders played great roles in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, WORLD METEOROLOGICAL, P9; Burzaco JP, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/3/035031; Cao B, 2006, PEDOSPHERE, V16, P390, DOI 10.1016/S1002-0160(06)60067-2; Case SDC, 2015, SOIL BIOL BIOCHEM, V81, P178, DOI 10.1016/j.soilbio.2014.11.012; Dai Y, 2013, SCI TOTAL ENVIRON, V465, P125, DOI 10.1016/j.scitotenv.2012.08.091; Dalal RC, 2003, AUST J SOIL RES, V41, P165, DOI 10.1071/SR02064; *FAO, 2003, WORLD AGR 2015 2030, P97; Gilsanz C, 2016, AGR ECOSYST ENVIRON, V216, P1, DOI 10.1016/j.agee.2015.09.030; Goglio P, 2014, SCI TOTAL ENVIRON, V490, P921, DOI 10.1016/j.scitotenv.2014.05.070; Guangdong rural statistical yearbook editing committee, 2015, GUANGD RUR STAT YB; Hansen M, 2014, SOIL BIOL BIOCHEM, V69, P17, DOI 10.1016/j.soilbio.2013.10.031; Henault C, 1998, BIOL FERT SOILS, V27, P299, DOI 10.1007/s003740050437; Jia JX, 2012, SOIL SCI PLANT NUTR, V58, P503, DOI 10.1080/00380768.2012.686436; Johnson JMF, 2012, SOIL SCI SOC AM J, V76, P1347, DOI 10.2136/sssaj2012.0017; Ju XT, 2011, ENVIRON POLLUT, V159, P1007, DOI 10.1016/j.envpol.2010.10.040; Kavdir Y, 2008, SOIL TILL RES, V98, P175, DOI 10.1016/j.still.2007.11.002; Li B, 2015, ATMOS ENVIRON, V100, P10, DOI 10.1016/j.atmosenv.2014.10.034; Li B, 2014, BIOGEOSCI DISCUSS, V11, P15185; Li D, 2007, ATMOS ENVIRON, V41, P9498, DOI 10.1016/j.atmosenv.2007.08.042; Liu Y-X, 2014, BIOMED RES INT, V2014, P13, DOI DOI 10.1155/2014/482926; Luo J, 2015, BIOL FERT SOILS, V51, P453, DOI 10.1007/s00374-015-0993-4; McSwiney CP, 2005, GLOBAL CHANGE BIOL, V11, P1712, DOI 10.1111/j.1365-2486.2005.01040.x; Min J, 2011, PEDOSPHERE, V21, P464, DOI 10.1016/S1002-0160(11)60148-3; National bureau of statistics of the People's Republic of China, 2015, STAT YB GUANGD; Nelissen V, 2014, SOIL BIOL BIOCHEM, V70, P244, DOI 10.1016/j.soilbio.2013.12.026; Qiu WH, 2010, J FOOD AGRIC ENVIRON, V8, P592; Rashti MR, 2015, ATMOS ENVIRON, V112, P225, DOI 10.1016/j.atmosenv.2015.04.036; Riya S, 2012, PEDOSPHERE, V22, P764, DOI 10.1016/S1002-0160(12)60062-9; Robinson A, 2014, J SOIL SEDIMENT, V14, P1434, DOI 10.1007/s11368-014-0888-2; US-EPA, 2006, 430R06003 USEPA; Van Groenigen JW, 2010, EUR J SOIL SCI, V61, P903, DOI 10.1111/j.1365-2389.2009.01217.x; van Kessel C, 2013, GLOBAL CHANGE BIOL, V19, P33, DOI 10.1111/j.1365-2486.2012.02779.x; Venterea RT, 2011, J ENVIRON QUAL, V40, P1521, DOI 10.2134/jeq2011.0039; Wang XB, 2015, SCI TOTAL ENVIRON, V538, P137, DOI 10.1016/j.scitotenv.2015.08.026; Xu J, 2009, CHINESE J SOIL SCI, V40, P325; Xu ZJ, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI [10.1029/2004GB002233, 10.1029/2003GB002167]; Yan HL, 2014, J ENVIRON MANAGE, V144, P316, DOI 10.1016/j.jenvman.2014.06.004; [阎宏亮 Yan Hongliang], 2014, [中国农业气象, Chinese Journal of Agrometeorology], V35, P141; [姚志生 Yao Zhisheng], 2006, [气候与环境研究, Climatic and environmental research], V11, P691; ZACHERL B, 1990, FERT RES, V22, P37, DOI 10.1007/BF01054805; Zhang M, 2015, AGR ECOSYST ENVIRON, V201, P43, DOI 10.1016/j.agee.2014.12.003	41	16	23	10	90	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2017	12	4							e0175325	10.1371/journal.pone.0175325	http://dx.doi.org/10.1371/journal.pone.0175325			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KH	28419127	gold, Green Submitted, Green Published			2022-12-27	WOS:000399875200016
J	PytlikZillig, LM; Kimbrough, CD; Shockley, E; Neal, TMS; Herian, MN; Hamm, JA; Bornstein, BH; Tomkins, AJ				PytlikZillig, Lisa M.; Kimbrough, Christopher D.; Shockley, Ellie; Neal, Tess M. S.; Herian, Mitchel N.; Hamm, Joseph A.; Bornstein, Brian H.; Tomkins, Alan J.			A longitudinal and experimental study of the impact of knowledge on the bases of institutional trust	PLOS ONE			English	Article							ORGANIZATIONAL TRUST; PROCEDURAL JUSTICE; INTEGRATIVE MODEL; POLITICAL ISSUES; UNITED-STATES; GOVERNMENT; PERSONALITY; CONFIDENCE; TIME; TRUSTWORTHINESS	This study examined a knowledge-centered theory of institutional trust development. In the context of trust in water regulatory institutions, the moderating impact of knowledge was tested to determine if there were longitudinal changes in the bases of institutional trust as a function of increases in knowledge about a target institution. We hypothesized that as people learn about an institution with which they were previously unfamiliar, they begin to form more nuanced perceptions, distinguishing the new institution from other institutions and relying less upon their generalized trust to estimate their trust in that institution. Prior to having specific, differential information about a new institution, we expected institutional trust to be a function of generalized trust variables such as dispositional trust and trust in government. The longitudinal experiment involved 185 college students randomly assigned to one of three information conditions. Every 3 months for 15 months, participants read information about water regulatory institutions or a control institution. At each time point, participants reported their trust in and perceptions of the trust- and distrust-worthiness of the water regulatory institutions. Participants also completed measures of knowledge of water regulatory institutions, dispositional trust, and governmental trust. Our manipulation check indicated that, as expected, those in the experimental group increased in subjective knowledge of water regulatory institutions to a greater extent than those in the control condition. Consistent with our hypotheses, there was some evidence that, compared to the control group, the experimental group relied less on their general trust in government as a basis for their trust in water regulatory institutions. However, contrary to our hypotheses, there was no evidence the experimental group relied less on dispositional trust as a basis for institutional trust. There also was some evidence the experimental group's trust in water regulatory institutions was less affected by fluctuations of trustworthiness (but not distrust-worthiness) perceptions over time. This suggests that knowledge results in the development of more stable institutional trust attitudes, but that trustworthiness and distrustworthiness perceptions may operate somewhat differently when impacting trust in specific institutions.	[PytlikZillig, Lisa M.; Shockley, Ellie; Neal, Tess M. S.; Herian, Mitchel N.; Tomkins, Alan J.] Univ Nebraska, Publ Policy Ctr, Lincoln, NE 68588 USA; [Kimbrough, Christopher D.; Bornstein, Brian H.] Univ Nebraska, Dept Psychol, Lincoln, NE USA; [Hamm, Joseph A.] Michigan State Univ, Sch Criminal Justice, E Lansing, MI 48824 USA; [Hamm, Joseph A.] Michigan State Univ, Environm Sci & Policy Program, E Lansing, MI 48824 USA; [Shockley, Ellie] Bismarck State Coll, Off Inst Res, Bismarck, ND USA; [Neal, Tess M. S.] Arizona State Univ, New Coll Interdisciplinary Arts & Sci, Glendale, AZ USA	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; Michigan State University; Michigan State University; Arizona State University	PytlikZillig, LM (corresponding author), Univ Nebraska, Publ Policy Ctr, Lincoln, NE 68588 USA.	lpytlikz@nebraska.edu	Hamm, Joseph A./M-6823-2016; PytlikZillig, LM/AAE-6467-2022	Hamm, Joseph A./0000-0001-9250-3681; PytlikZillig, LM/0000-0002-0962-8502; Neal, Tess/0000-0002-9528-8638	National Science Foundation (US) (NSF) [0965465, 1061635, 1154855, 1228559, 1228937, 1353980]; Divn Of Social and Economic Sciences [1228559] Funding Source: National Science Foundation	National Science Foundation (US) (NSF)(National Science Foundation (NSF)); Divn Of Social and Economic Sciences(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	This work was funded by the National Science Foundation (US) (NSF, www.nsf.gov) via grants 0965465 (LPZ), 1061635 (AT), 1154855 (AT), 1228559 (AT), 1228937 (LPZ), 1353980 (BB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The views expressed in this paper are those of the authors and do not reflect the views of NSF.	ABRAMSON PR, 1981, AM J POLIT SCI, V25, P297, DOI 10.2307/2110854; Alba JW, 2000, J CONSUM RES, V27, P123, DOI 10.1086/314317; ALVAREZ RM, 1994, J POLIT, V56, P671, DOI 10.2307/2132187; [Anonymous], 1998, TRUST ORG CONCEPTUAL; [Anonymous], 1999, DEMOCRACY TRUST; [Anonymous], 1095, ALBANY LAW R; Barnett TP, 2008, SCIENCE, V319, P1080, DOI 10.1126/science.1152538; Bassili JN, 2010, FRONT SOC PSYCHOL, P237; Baumeister R.F., 2001, REV GEN PSYCHOL, V5, P323, DOI [10.1037//1089-2680.5.4.323, DOI 10.1037//1089-2680.5.4.323, https://doi.org/10.1037/1089-2680.5.4.323, DOI 10.1037/1089-2680.5.4.323]; BERG J, 1995, GAME ECON BEHAV, V10, P122, DOI 10.1006/game.1995.1027; Biesanz JC, 2003, J PERS, V71, P905, DOI 10.1111/1467-6494.7106002; Bijlsma-Frankema K, 2015, ORGAN SCI, V26, P1018, DOI 10.1287/orsc.2015.0977; Blader SL, 2003, PERS SOC PSYCHOL B, V29, P747, DOI 10.1177/0146167203029006007; Bok D., 1997, WHY PEOPLE DONT TRUS, P55; Boninger DS., 1995, ATTITUDE STRENGTH AN, P159; Brockner J, 2003, ORGAN BEHAV HUM DEC, V91, P51, DOI 10.1016/S0749-5978(02)00531-9; BUTLER JK, 1991, J MANAGE, V17, P643, DOI 10.1177/014920639101700307; Camerer C.F., 2003, BEHAV GAME THEORY EX, DOI 10.1257/jep.9.2.209; Cao L., 2015, POLICING INT J POLIC, V38; Carlson JP, 2009, J CONSUM RES, V35, P864, DOI 10.1086/593688; Chanley VA, 2000, PUBLIC OPIN QUART, V64, P239, DOI 10.1086/317987; CITRIN J, 1974, AM POLIT SCI REV, V68, P973, DOI 10.2307/1959141; Colquitt JA, 2007, J APPL PSYCHOL, V92, P909, DOI 10.1037/0021-9010.92.4.909; Colquitt JA, 2011, ACAD MANAGE J, V54, P1183, DOI 10.5465/amj.2007.0572; Cook FL, 2010, J POLIT, V72, P397, DOI 10.1017/S0022381610000034; CRAIG SC, 1990, POLITICAL BEHAV, V0012; D'Amico LC, 2003, NAT PUBL MAN RES C 1; Dagger TS, 2010, EUR J MARKETING, V44, P1528, DOI 10.1108/03090561011062952; Delli Carpini M. X., 1996, WHAT AM DONT KNOW PO; Diamond L, 2015, J DEMOCR, V26, P141, DOI 10.1353/jod.2015.0009; DIENER E, 1984, J PERS SOC PSYCHOL, V47, P580, DOI 10.1037/0022-3514.47.3.580; Dietz G, 2006, PERS REV, V35, P557, DOI 10.1108/00483480610682299; Dimoka A, 2010, MIS QUART, V34, P373; Easton D, 1965, SYSTEMS ANAL POLITIC; Enns MW, 2006, J AFFECT DISORDERS, V93, P35, DOI 10.1016/j.jad.2006.01.030; Frazier M. L., J TRUST RES, V3, P76, DOI DOI 10.1080/21515581.2013.820026; Fukuyama F., 1995, TRUST SOCIAL VIRTUES; Gibson JL, 2015, AM J POLIT SCI, V59, P162, DOI 10.1111/ajps.12107; Gibson JL, 2005, POLIT RES QUART, V58, P187, DOI 10.1177/106591290505800201; Gibson JL, 2003, AM J POLIT SCI, V47, P354, DOI 10.2307/3186144; Giles MichealW., 1972, LAW SOC REV, V6, P631; Goren P, 2004, AM J POLIT SCI, V48, P462, DOI 10.1111/j.0092-5853.2004.00081.x; Ha S, 2011, MASS COMMUN SOC, V14, P315, DOI 10.1080/15205436.2010.490894; Hamm JA, 2013, ECOL SOC, V18, DOI 10.5751/ES-05849-180449; Hamm JA, 2011, BEHAV SCI LAW, V29, P95, DOI 10.1002/bsl.965; Hardin Russell, 2006, TRUST; Harrison McKnight D., 2001, P TRUST CYBER SOC, P27, DOI [10.1007/3-540-45547-7_3., DOI 10.1007/3-540-45547-7_3]; Hertting A, 2004, J ADV NURS, V45, P145, DOI 10.1046/j.1365-2648.2003.02876.x; Hetherington MarcJ., 2001, WHAT IS IT GOVT AM D, P134; Heuer L, 1999, PERS SOC PSYCHOL B, V25, P1279, DOI 10.1177/0146167299258009; Heuer L, 2002, PERS SOC PSYCHOL B, V28, P1468, DOI 10.1177/014616702237575; Hibbing JohnR., 1995, C PUBLIC ENEMY PUBLI; Hoffman, 2013, J TRUST RES, V3, P11; Hoffman L, 2015, MULTIVAR APPL SER, P1; Hoffman L, 2007, BEHAV RES METHODS, V39, P101, DOI 10.3758/BF03192848; Hoy WK, 2003, RES T EDUC ADM, P181; Koch JW, 2003, POLIT BEHAV, V25, P221, DOI 10.1023/A:1025115523298; Konrath SH, 2011, PERS SOC PSYCHOL REV, V15, P180, DOI 10.1177/1088868310377395; Levi M, 2000, ANNU REV POLIT SCI, V3, P475, DOI 10.1146/annurev.polisci.3.1.475; Lewicki RJ, 2006, J MANAGE, V32, P991, DOI 10.1177/0149206306294405; LIPSET SM, 1983, POLIT SCI QUART, V98, P379, DOI 10.2307/2150494; Lock ST, 1999, POLIT BEHAV, V21, P239, DOI 10.1023/A:1022035600676; Lubell M, 2007, J POLIT, V69, P237, DOI 10.1111/j.1468-2508.2007.00507.x; MAYER RC, 1995, ACAD MANAGE REV, V20, P709, DOI 10.2307/258792; McEvily B., 2011, J TRUST RES, V1, P23, DOI DOI 10.1080/21515581.2011.552424; MCFARLIN DB, 1992, ACAD MANAGE J, V35, P626, DOI 10.2307/256489; MILLER AH, 1974, AM POLIT SCI REV, V68, P951, DOI 10.2307/1959140; Mithas S, 2006, J MANAGE INFORM SYST, V23, P97, DOI 10.2753/MIS0742-1222230305; Newton K, 2001, INT POLIT SCI REV, V22, P201, DOI 10.1177/0192512101222004; Pettigrew TF, 2016, ANNU REV PSYCHOL, V67, P1, DOI 10.1146/annurev-psych-122414-033327; Pirson M., 2007, 39 HARV U HAUS CTR N; Pirson M, 2011, ORGAN SCI, V22, P1087, DOI 10.1287/orsc.1100.0581; PUTNAM RD, 1995, J DEMOCRACY, V0006; PytlikZillig L., 2016, INTERDISCIPLINARY PE, P17, DOI [DOI 10.1007/978-3-319-22261-5_2, DOI 10.1007/978-3-319-22261-5]; PytlikZillig L. M., 2016, J TRUST RES; Richardson Jr RC, 1983, ISSUES COMMUNITY COL, P186; Ross L., 2011, PERSON SITUATION PER; Rousseau DM, 1998, ACAD MANAGE REV, V23, P393, DOI 10.5465/AMR.1998.926617; Schoorman FD, 2007, ACAD MANAGE REV, V32, P344, DOI 10.5465/AMR.2007.24348410; SEARS DO, 1986, J PERS SOC PSYCHOL, V51, P515, DOI 10.1037/0022-3514.51.3.515; Serva MA, 2005, J ORGAN BEHAV, V26, P625, DOI 10.1002/job.331; Siegrist M, 2000, RISK ANAL, V20, P353, DOI 10.1111/0272-4332.203034; Six F, 2013, J COMP POLICY ANAL, P1; Smith T., 1981, MEASUREMENT SUBJECTI, P119; Snijders T, 1999, MULTILEVEL ANAL; Specht J, 2011, J PERS SOC PSYCHOL, V101, P862, DOI 10.1037/a0024950; Suh T., 2004, J SUPPLY CHAIN MANAG, V40, P4, DOI DOI 10.1111/J.1745-493X.2004.TB00165.X; Theiss-Morse E, 2015, NEBR SYM MOTIV, V62, P167, DOI 10.1007/978-3-319-16151-8_8; Twenge JM, 2014, PSYCHOL SCI, V25, P1914, DOI 10.1177/0956797614545133; Tyler Tom R., 2008, OHIO STATE J CRIMINA, V6, P231; TYLER TOM R., 2006, CONTEMP SOCIOL, DOI [DOI 10.2307/2076193, 10.1515/9781400828609]; Tyler Tom R, 2002, TRUST LAW ENCOURAGIN; Tyler TR, 2006, ANNU REV PSYCHOL, V57, P375, DOI 10.1146/annurev.psych.57.102904.190038; Uslaner E., 2002, MORAL FDN TRUST; vandenBos K, 1997, J PERS SOC PSYCHOL, V72, P95, DOI 10.1037/0022-3514.72.1.95; YAMAGISHI T, 1994, MOTIV EMOTION, V18, P129, DOI 10.1007/BF02249397; ZAJONC RB, 1968, J PERS SOC PSYCHOL, V9, P1, DOI 10.1037/h0025848; Zaller JohnR., 1992, NATURE ORIGINS MASS	98	14	14	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2017	12	4							e0175387	10.1371/journal.pone.0175387	http://dx.doi.org/10.1371/journal.pone.0175387			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES9KD	28414808	Green Published, Green Submitted, gold			2022-12-27	WOS:000399874800024
J	Antonini, Y; Machado, CD; Galetti, PM; Oliveira, M; Dirzo, R; Fernandes, GW				Antonini, Yasmine; Machado, Carolina de Barros; Galetti, Pedro Manoel, Jr.; Oliveira, Marcio; Dirzo, Rodolfo; Fernandes, Geraldo Wilson			Patterns of orchid bee species diversity and turnover among forested plateaus of central Amazonia	PLOS ONE			English	Article							EUGLOSSINE BEES; FAUNA HYMENOPTERA; BETA-DIVERSITY; DYNAMICS; APIDAE; MODEL; BIOGEOGRAPHY; COMMUNITIES; DISPERSAL; RICHNESS	The knowledge of spatial pattern and geographic beta-diversity is of great importance for biodiversity conservation and interpreting ecological information. Tropical forests, especially the Amazon Rainforest, are well known for their high species richness and low similarity in species composition between sites, both at local and regional scales. We aimed to determine the effect and relative importance of area, isolation and climate on species richness and turnover in orchid bee assemblages among plateaus in central Brazilian Amazonia. Variance partitioning techniques were applied to assess the relative effects of spatial and environmental variables on bee species richness, phylogeny and composition. We hypothesized that greater abundance and richness of orchid bees would be found on larger plateaus, with a set of core species occurring on all of them. We also hypothesized that smaller plateaus would possess lower phylogenetic diversity. We found 55 bee species distributed along the nine sampling sites ( plateaus) with 17 of them being singletons. There was a significant decrease in species richness with decreasing size of plateaus, and a significant decrease in the similarity in species composition with greater distance and climatic variation among sampling sites. Phylogenetic diversity varied among the sampling sites but was directly related to species richness. Although not significantly related to plateau area, smaller or larger PDFaith were observed in the smallest and the largest plateaus, respectively.	[Antonini, Yasmine] Univ Fed Ouro Preto, Dept Biodiversidade Evolucao & Meio Ambiente, Campus Morro Cruzeiro S-N, Ouro Preto, MG, Brazil; [Antonini, Yasmine; Galetti, Pedro Manoel, Jr.; Dirzo, Rodolfo; Fernandes, Geraldo Wilson] Stanford Univ, Biol Dept, Sierra Mall, Stanford, CA 94305 USA; [Machado, Carolina de Barros; Galetti, Pedro Manoel, Jr.] Univ Fed Sao Carlos, Dept Genet & Evolucao, Via Washington Luis Km 235, Sao Carlos, SP, Brazil; [Oliveira, Marcio] Inst Nacl de Pesquisas da Amazonia, Manaus, Amazonas, Brazil; [Fernandes, Geraldo Wilson] Univ Fed Minas Gerais, Dept Biol Geral, Av Antonio Carlos 6627, Belo Horizonte, MG, Brazil	Universidade Federal de Ouro Preto; Stanford University; Universidade Federal de Sao Carlos; Institute Nacional de Pesquisas da Amazonia; Universidade Federal de Minas Gerais	Antonini, Y (corresponding author), Univ Fed Ouro Preto, Dept Biodiversidade Evolucao & Meio Ambiente, Campus Morro Cruzeiro S-N, Ouro Preto, MG, Brazil.; Antonini, Y (corresponding author), Stanford Univ, Biol Dept, Sierra Mall, Stanford, CA 94305 USA.	Antonin.y@gmail.com	Galetti, Pedro M/ABC-1005-2020; Fernandes, Geraldo/AAN-5602-2021; Machado, Carolina/AAV-2539-2020	Galetti, Pedro M/0000-0001-5916-6126; Fernandes, Geraldo/0000-0003-1559-6049; Machado, Carolina/0000-0001-5195-5577; Antonini, Yasmine/0000-0002-5582-8193	CNPq; FAPEMIG	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	The authors YA, GWF, PMGJ and MO received research scholarships from CNPq. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Renzo Lanza, Emmanuel Almada and Matheus Freitas for help in field work. Terravision in a person of Allan Brandt, for the files with the shapes of the plateaus. Felipe Carvalho for drawing the map. MRN for the logistic support. CNPq for the scholarship to YA, GWF, PMGJ and MO. DW Roubik for the valuable contributions to improve the quality of the paper. FAPEMIG for financial support to cover the publication fees.	Abrahamczyk S, 2014, ECOGRAPHY, V37, P500, DOI 10.1111/j.1600-0587.2013.00417.x; Abrahamczyk S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027115; ACKERMAN JD, 1983, BIOL J LINN SOC, V20, P301, DOI 10.1111/j.1095-8312.1983.tb01878.x; Almada E, 2011, B MUS PARA E GOELDI, V6, P2; Alvares CA, 2013, METEOROL Z, V22, P711, DOI 10.1127/0941-2948/2013/0507; [Anonymous], 2014, TRACER V1 6; Antonini Y, 2016, SOCIOBIOLOGY, V63, P819, DOI 10.13102/sociobiology.v63i2.1038; BECKER P, 1991, BIOTROPICA, V23, P586, DOI 10.2307/2388396; Bezerra Cleomar Porto, 2001, Revista Brasileira de Zoologia, V18, P823, DOI 10.1590/S0101-81752001000300018; BORCARD D, 1992, ECOLOGY, V73, P1045, DOI 10.2307/1940179; Brasil, 2006, MAN FAUN FLOR COM AT; Brosi BJ, 2009, BIOL CONSERV, V142, P414, DOI 10.1016/j.biocon.2008.11.003; Costa FRC, 2005, J ECOL; DeVries PJ, 1997, BIOL J LINN SOC, V62, P343, DOI 10.1111/j.1095-8312.1997.tb01630.x; Dick CW, 2004, MOL ECOL, V13, P3775, DOI 10.1111/j.1365-294X.2004.02374.x; Diniz IR, 1998, REV BIOL TROP, V46, P109; dos Santos JG, 2015, BIODIVERS CONSERV, V24, P2853, DOI 10.1007/s10531-015-0981-x; DRESSLER RL, 1982, ANNU REV ECOL SYST, V13, P373, DOI 10.1146/annurev.es.13.110182.002105; Faith D., 1992, CONSERVATION EVALUAT; FITTKAU E J, 1973, Biotropica, V5, P2, DOI 10.2307/2989676; GENTRY AH, 1988, ANN MO BOT GARD, V75, P1, DOI 10.2307/2399464; HANSKI I, 1982, OIKOS, V38, P210, DOI 10.2307/3544021; Hawkins BA, 2003, ECOLOGY, V84, P3105, DOI 10.1890/03-8006; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hulcr J, LOW BETA DIVERSITY A; Instituto Brasileiro de Meio Ambiente e Recursos Naturais Renovaveis, 2016, EST IMP AMB SEIS PLA; Jablonski D, 2006, SCIENCE, V314, P102, DOI 10.1126/science.1130880; JANZEN DH, 1971, SCIENCE, V171, P203, DOI 10.1126/science.171.3967.203; Kembel SW, 2010, BIOINFORMATICS, V26, P1463, DOI 10.1093/bioinformatics/btq166; Koleff P, 2003, J ANIM ECOL, V72, P367, DOI 10.1046/j.1365-2656.2003.00710.x; Matos Darley C. Leal, 2013, Rodriguésia, V64, P357; Morato E. F., 1994, Boletim do Museu Paraense Emilio Goeldi Serie Zoologia, V10, P95; Moritz C, 2000, ANNU REV ECOL SYST, V31, P533, DOI 10.1146/annurev.ecolsys.31.1.533; Myster RW, 2009, BOT REV, V75, P271, DOI 10.1007/s12229-009-9032-1; Nekola JC, 1999, J BIOGEOGR, V26, P867, DOI 10.1046/j.1365-2699.1999.00305.x; Nemesio A, 2014, BRAZ J BIOL, V74, P33, DOI 10.1590/1519-6984.20412; Nemesio A., 2004, REV TECNOLOGIA AMBIE, V10, P71; Nemesio A, 2007, NEOTROP ENTOMOL, V36; Nemesio Andre, 2006, Lundiana, V7, P59; Nemesio A, 2013, BIODIVERS CONSERV, V22, P1647, DOI 10.1007/s10531-013-0500-x; Nemesio Andre, 2007, Revista Brasileira de Zoociencias, V9, P151; Novotny V, 2007, NATURE, V448, P692, DOI 10.1038/nature06021; Oliveira Marcio Luiz De, 1996, Revista Brasileira de Zoologia, V13, P1075; Peck JE., 2010, MJM SOFTWARE DESING; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; POWELL AH, 1987, BIOTROPICA, V19, P176, DOI 10.2307/2388742; Ramirez SR, 2010, BIOL J LINN SOC, V100, P552, DOI 10.1111/j.1095-8312.2010.01440.x; Rasmussen Claus, 2009, Neotrop Entomol, V38, P812; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; Roubik DW, 2015, CONSERV ECOL, V1, P2; Roubik DW., 2004, ORCHIDS BEES TROPICA; Salomao R. P., 2007, Boletim do Museu Paraense Emilio Goeldi, Ciencias Naturais, V2, P85; Schulman L, 2007, J BIOGEOGR, V34, P1388, DOI 10.1111/j.1365-2699.2007.01716.x; Storck-Tonon D, 2013, BIOTA NEOTROP, V13, P133, DOI 10.1590/S1676-06032013000100015; Ter Steege H, 2003, BIODIVERS CONSERV, V12, P2255, DOI 10.1023/A:1024593414624; Tuomisto H, 2003, SCIENCE, V299, P241, DOI 10.1126/science.1078037; Tuomisto H, 2014, ECOGRAPHY, V37, P1034, DOI 10.1111/ecog.00770; Vasconcelos HL, 2010, J BIOGEOGR, V37, P432, DOI 10.1111/j.1365-2699.2009.02230.x; Veloso HP, 1991, CLASSIFICAC UNIVERSA; Venail P, 2015, FUNCT ECOL, V29, P615, DOI 10.1111/1365-2435.12432; WCISLO WT, ANN REV ENTOMOL, V41, P257; Webb CO, 2000, AM NAT, V156, P145, DOI 10.1086/303378; Wiens JJ, 2004, TRENDS ECOL EVOL, V19, P639, DOI 10.1016/j.tree.2004.09.011; Wright David H., 1993, P66	65	5	5	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2017	12	4							e0175884	10.1371/journal.pone.0175884	http://dx.doi.org/10.1371/journal.pone.0175884			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0MD	28410432	Green Published, gold, Green Submitted			2022-12-27	WOS:000399955600051
J	Flax, VL; Hamela, G; Mofolo, I; Hosseinipour, MC; Hoffman, IF; Maman, S				Flax, Valerie L.; Hamela, Gloria; Mofolo, Innocent; Hosseinipour, Mina C.; Hoffman, Irving F.; Maman, Suzanne			Factors influencing postnatal Option B plus participation and breastfeeding duration among HIV-positive women in Lilongwe District, Malawi: A qualitative study	PLOS ONE			English	Article							TO-CHILD TRANSMISSION; ANTIRETROVIRAL THERAPY; FOLLOW-UP; SOUTH-AFRICA; PREVENTION; PMTCT; BARRIERS; PROGRAM; REASONS; ADHERENCE	To ensure the health of mothers and children, prevention of mother-to-child HIV transmission (PMTCT) programs test women for HIV, engage HIV-positive women in care, and promote recommended breastfeeding practices. Under Malawi's Option B+ PMTCT program, similar to 20% of women are lost-to-follow-up (LTFU) and little is known about their breastfeeding practices. The purpose of this study is to describe facilitators and barriers to Option B+ participation and how participation influences breastfeeding duration. We conducted in-depth interviews with HIV-positive women in Option B+ (n = 32) or LTFU from Option B+ (n = 32). They were recruited from four government clinics in Lilongwe District and had a child aged 0-23 months. Women in Option B+ had better disclosure experiences and more social support than LTFU women. The most common reasons for LTFU were fear of HIV disclosure, anticipated or experienced stigma, and insufficient social support. Other reasons included: non-acceptance of HIV status, antiretroviral therapy (ART) side effects, lack of funds for transport, and negative experiences with clinic staff. Worries about possible transmission, even while on ART, influenced timing of weaning for some women in Option B+. Despite their knowledge of the risk of HIV transmission to the child, most LTFU women continued to breastfeed after stopping ART because they considered breastmilk to be an important source of nutrients for the child. Given that HIV-positive Malawian women LTFU from Option B+ breastfeed in the absence of ART, efforts are needed to use evidence-based strategies to address the barriers to Option B+ participation and avert preventable transmission through breastmilk.	[Flax, Valerie L.] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Nutr, Chapel Hill, NC 27599 USA; [Flax, Valerie L.] RTI Int, Res Triangle Pk, NC 27709 USA; [Hamela, Gloria; Mofolo, Innocent; Hosseinipour, Mina C.; Hoffman, Irving F.] UNC Project Malawi, Lilongwe, Malawi; [Hosseinipour, Mina C.; Hoffman, Irving F.] Univ N Carolina, Sch Med, Dept Med, Chapel Hill, NC USA; [Maman, Suzanne] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Hlth Behav, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; Research Triangle Institute; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill	Flax, VL (corresponding author), Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Nutr, Chapel Hill, NC 27599 USA.; Flax, VL (corresponding author), RTI Int, Res Triangle Pk, NC 27709 USA.	flax@unc.edu		Flax, Valerie/0000-0003-0200-3355	Eunice Kennedy Shriver National Institute of Child Health & Human Development [5KHD001441-15]; University of North Carolina Center for AIDS Research - National Institute of Allergy and Infectious Diseases [P30 AI50410]; University of North Carolina University Research Council small grant; Carolina Population Center - Eunice Kennedy Shriver National Institute of Child Health & Human Development [P2C HD050924]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P2CHD050924] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI050410] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health & Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); University of North Carolina Center for AIDS Research - National Institute of Allergy and Infectious Diseases; University of North Carolina University Research Council small grant; Carolina Population Center - Eunice Kennedy Shriver National Institute of Child Health & Human Development; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by the Eunice Kennedy Shriver National Institute of Child Health & Human Development (https://www.nichd.nih.gov/Pages/index.aspx) grant 5KHD001441-15 BIRCWH Career Development Program (Flax Scholar); a development grant from the University of North Carolina Center for AIDS Research (P30 AI50410) funded by the National Institute of Allergy and Infectious Diseases (https://www.niaid.nih.gov/); a University of North Carolina University Research Council small grant; and the Carolina Population Center (P2C HD050924) funded by the Eunice Kennedy Shriver National Institute of Child Health & Human Development (https://www.nichd.nih.gov/Pages/index.aspx). The preparation of the manuscript was funded by RTI International. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bwirire LD, 2008, T ROY SOC TROP MED H, V102, P1195, DOI 10.1016/j.trstmh.2008.04.002; Chimbwandira F, 2013, MMWR-MORBID MORTAL W, V62, P148; Chinkonde JR, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-700; Clouse K, 2014, JAIDS-J ACQ IMM DEF, V67, pE12, DOI 10.1097/QAI.0000000000000263; Duff P, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-37; Elwell K, 2016, AIDS CARE, V28, P971, DOI 10.1080/09540121.2016.1153586; Flax VL, 2016, AIDS BEHAV, V20, P2612, DOI 10.1007/s10461-016-1378-x; Flax VL, 2015, MATERN CHILD NUTR, V11, P104, DOI 10.1111/mcn.12073; Flax VL, 2016, GENDER FACTORS INFLU; Futterman D, 2010, AIDS CARE, V22, P1093, DOI 10.1080/09540121003600352; Gibbs G.R., 2007, ANAL QUALITATIVE DAT; Golafshani N., 2003, QUAL REP, V8, P597; Gourlay A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106325; Gourlay A, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18588; Graneheim UH, 2004, NURS EDUC TODAY, V24, P105, DOI 10.1016/j.nedt.2003.10.001; Guest G, 2006, FIELD METHOD, V18, P59, DOI 10.1177/1525822X05279903; Hodgson I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111421; IATT, 2016, OPT B COUNTR PMTCT R; IDF (International Diabetes Federation), 2021, CONSOLIDATED GUIDELI, V10th ed.; Iroezi Ngozi D, 2013, Afr J Reprod Health, V17, P118; Kafulafula U. K., 2013, Health, V5, P1412; Kebaabetswe PM, 2007, AIDS CARE, V19, P355, DOI 10.1080/09540120600942407; Kim MH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149527; Kim MH, 2015, JAIDS-J ACQ IMM DEF, V68, pE77, DOI 10.1097/QAI.0000000000000517; Kohler P, 2012, J INT AIDS SOC, V15, P131; Lubega M, 2013, PATIENT PREFER ADHER, V7, P447, DOI 10.2147/PPA.S19327; Malawi Ministry of Health, 2015, MAL HIV PROGR DAT 20; Miles M.B., 2019, QUALITATIVE DATA ANA, Vfourth; Murithi LK, 2015, AIDS BEHAV, V19, P645, DOI 10.1007/s10461-014-0939-0; Ngarina M, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-450; Njunga J, 2010, INT BREASTFEED J, V5, DOI 10.1186/1746-4358-5-14; Osoti AO, 2014, AIDS, V28, P95, DOI 10.1097/QAD.0000000000000023; Parker ME, 2011, AIDS EDUC PREV, V23, P281, DOI 10.1521/aeap.2011.23.3.281; Prinsloo CD, 2016, J ASSOC NURSE AIDS C, V27, P166, DOI 10.1016/j.jana.2015.10.007; Pulerwitz J, 2015, AIDS BEHAV, V19, P246, DOI 10.1007/s10461-014-0935-4; Rosenberg NE, 2015, LANCET HIV, V2, pE483, DOI 10.1016/S2352-3018(15)00182-4; Shroufi A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064717; Tenthani L, 2014, AIDS, V28, P589, DOI 10.1097/QAD.0000000000000143; Turan JM, 2013, AIDS BEHAV, V17, P2528, DOI 10.1007/s10461-013-0446-8; Tweya H, 2014, TROP MED INT HEALTH, V19, P1360, DOI 10.1111/tmi.12369; Webb R, 2013, UNDERSTANDING PERSPE; WHO Regional Office for Africa, 2014, IMPL OPT B PREV MOTH; WHO UNICEF, 2016, GUID UPD HIV INF FEE; World Health Organization, 2010, GUID HIV INF FEED 20	44	26	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2017	12	4							e0175590	10.1371/journal.pone.0175590	http://dx.doi.org/10.1371/journal.pone.0175590			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET0MD	28410374	gold, Green Published, Green Submitted			2022-12-27	WOS:000399955600028
J	Lapierre, MD; Cropper, SJ; Howe, PDL				Lapierre, Mark D.; Cropper, Simon J.; Howe, Piers D. L.			Shared processing in multiple object tracking and visual working memory in the absence of response order and task order confounds	PLOS ONE			English	Article							SHORT-TERM-MEMORY; ATTENTIVE TRACKING; BRAIN; INFORMATION; ACTIVATION; COGNITION; BINDING; LIMITS; FOCUS	To understand how the visual system represents multiple moving objects and how those representations contribute to tracking, it is essential that we understand how the processes of attention and working memory interact. In the work described here we present an investigation of that interaction via a series of tracking and working memory dual-task experiments. Previously, it has been argued that tracking is resistant to disruption by a concurrent working memory task and that any apparent disruption is in fact due to observers making a response to the working memory task, rather than due to competition for shared resources. Contrary to this, in our experiments we find that when task order and response order confounds are avoided, all participants show a similar decrease in both tracking and working memory performance. However, if task and response order confounds are not adequately controlled for we find substantial individual differences, which could explain the previous conflicting reports on this topic. Our results provide clear evidence that tracking and working memory tasks share processing resources.	[Lapierre, Mark D.; Cropper, Simon J.; Howe, Piers D. L.] Univ Melbourne, Melbourne Sch Psychol Sci, Parkville, Vic, Australia	University of Melbourne	Cropper, SJ (corresponding author), Univ Melbourne, Melbourne Sch Psychol Sci, Parkville, Vic, Australia.	scropper@unimelb.edu.au		Lapierre, Mark/0000-0003-2621-5811; Howe, Piers/0000-0001-6171-1381; Cropper, Simon James/0000-0002-3574-6414				Allen R, 2006, Q J EXP PSYCHOL, V59, P1101, DOI 10.1080/02724980543000097; Allen RJ, 2006, J EXP PSYCHOL GEN, V135, P298, DOI 10.1037/0096-3445.135.2.298; Baddeley A, 2000, TRENDS COGN SCI, V4, P417, DOI 10.1016/S1364-6613(00)01538-2; Baddeley A.D., 1974, MOTIV ADV RES THEORY, V8, P47, DOI [DOI 10.1016/S0079-7421(08)60452-1, 10.1016/S0079-7421(08)60452-1]; Baddeley A, 2012, ANNU REV PSYCHOL, V63, P1, DOI 10.1146/annurev-psych-120710-100422; Baddeley AD, 2011, NEUROPSYCHOLOGIA, V49, P1393, DOI 10.1016/j.neuropsychologia.2010.12.042; Bettencourt KC, 2011, J VISION, V11, DOI 10.1167/11.10.22; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; BREITMEYER BG, 1984, VISUAL MASKING AN IN; Bundesen C, 2005, PSYCHOL REV, V112, P291, DOI 10.1037/0033-295X.112.2.291; BUNDESEN C, 1990, PSYCHOL REV, V97, P523, DOI 10.1037/0033-295X.97.4.523; Cowan N, 2001, BEHAV BRAIN SCI, V24, P87, DOI 10.1017/S0140525X01003922; Cowan N., 1995, ATTENTION AND MEMORY; Cowan N, 2011, NEUROPSYCHOLOGIA, V49, P1401, DOI 10.1016/j.neuropsychologia.2011.01.035; Culham JC, 2001, NEURON, V32, P737, DOI 10.1016/S0896-6273(01)00499-8; Drew T, 2013, COGNITION, V126, P213, DOI 10.1016/j.cognition.2012.10.003; Drew T, 2012, J COGNITIVE NEUROSCI, V24, P440, DOI 10.1162/jocn_a_00107; Drew T, 2011, J NEUROSCI, V31, P659, DOI 10.1523/JNEUROSCI.1339-10.2011; Drew T, 2009, PSYCHON B REV, V16, P411, DOI 10.3758/PBR.16.2.411; ERICSSON KA, 1995, PSYCHOL REV, V102, P211, DOI 10.1037/0033-295X.102.2.211; Feng J, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00103; Fougnie D, 2006, PSYCHOL SCI, V17, P526, DOI 10.1111/j.1467-9280.2006.01739.x; Franconeri SL, 2010, PSYCHOL SCI, V21, P920, DOI 10.1177/0956797610373935; Howe PD, 2009, J VISION, V9, DOI 10.1167/9.4.10; Iordanescu L, 2009, J VISION, V9, DOI 10.1167/9.4.1; Jahn G, 2012, BRAIN COGNITION, V78, P105, DOI 10.1016/j.bandc.2011.12.001; Jonides J, 2008, ANNU REV PSYCHOL, V59, P193, DOI 10.1146/annurev.psych.59.103006.093615; Jovicich J, 2001, J COGNITIVE NEUROSCI, V13, P1048, DOI 10.1162/089892901753294347; Levin JR, 1994, PSYCHOLOGICAL BULLET, V115; Makovski T, 2009, J EXP PSYCHOL HUMAN, V35, P1687, DOI 10.1037/a0016453; MATLAB, 2012, MATLAB; Oberauer K, 2002, J EXP PSYCHOL LEARN, V28, P411, DOI 10.1037//0278-7393.28.3.411; Oberauer K, 2016, PSYCHOL BULL, V142, P758, DOI 10.1037/bul0000046; Oberauer K, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00673; Oksama L, 2004, VIS COGN, V11, P631, DOI 10.1080/13506280344000473; Oksama L, 2008, COGNITIVE PSYCHOL, V56, P237, DOI 10.1016/j.cogpsych.2007.03.001; Pinto Y, 2010, J VISION, V10; PYLYSHYN Z W, 1988, Spatial Vision, V3, P179, DOI 10.1163/156856888X00122; Pylyshyn ZW, 2011, THINGS AND PLACES HO; Scholl BJ, 2009, COMPUTATION, COGNITION, AND PYLYSHYN, P49; Smith PL, 2009, PSYCHOL REV, V116, P283, DOI 10.1037/a0015156; Spencer JP, 2012, J INTEGR NEUROSCI, V11, P339, DOI 10.1142/S0219635212500227; Tas AC, 2016, J EXP PSYCHOL HUMAN, V42, P1121, DOI 10.1037/xhp0000212; Tombu M, 2008, COGNITION, V108, P1, DOI 10.1016/j.cognition.2007.12.014; Trick LM, 2006, Q J EXP PSYCHOL, V59, P1188, DOI 10.1080/17470210600673990; WATSON AB, 1983, PERCEPT PSYCHOPHYS, V33, P113, DOI 10.3758/BF03202828; Xu YD, 2006, NATURE, V440, P91, DOI 10.1038/nature04262; Zhang H, 2010, VIS COGN, V18, P617, DOI 10.1080/13506280903211142	48	11	11	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2017	12	4							e0175736	10.1371/journal.pone.0175736	http://dx.doi.org/10.1371/journal.pone.0175736			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET0MD	28410383	Green Published, gold			2022-12-27	WOS:000399955600041
J	Armando, M; Schneider, M; Pontillo, M; Vicari, S; Debbane, M; Schultze-Lutter, F; Eliez, S				Armando, Marco; Schneider, Maude; Pontillo, Maria; Vicari, Stefano; Debbane, Martin; Schultze-Lutter, Frauke; Eliez, Stephan			No age effect in the prevalence and clinical significance of ultra-high risk symptoms and criteria for psychosis in 22q11 deletion syndrome: Confirmation of the genetically driven risk for psychosis?	PLOS ONE			English	Article							POSITIVE SYMPTOMS; EPA GUIDANCE; ADOLESCENTS; CHILDHOOD; SCHIZOPHRENIA; CHILDREN; METAANALYSIS; DISORDERS; INTERVIEW; STATES	Background The 22q11.2 deletion syndrome (22q11DS) is one of the highest known risk factors for schizophrenia. Thus, the detection of 22q11DS patients at particularly high risk of psychosis is important, yet studies on the clinical significance of the widely used ultra-high risk (UHR) criteria in 22q11DS are inconclusive. Since age was reported to moderate clinical significance of UHR symptoms in community samples, we explored whether age at presentation of UHR symptoms and criteria may explain part of this heterogeneity. Methods 111 patients with 22q11DS (8-30 years; 15.7 +/- 4.7) were assessed for UHR symptoms/criteria. Information on diagnoses, psychosocial functioning, and IQ were collected. Results Any UHR symptom was reported by 38.7%, any UHR criterion by 27%. No significant influence of age on the prevalence of UHR symptoms or criteria was detected. Moreover, age did not significantly modulate the association between UHR symptoms and functioning. However, significant interaction terms suggested that younger age groups were more likely to meet UHR criteria in the presence of UHR symptoms compared to the adult group. Discussion Compared to the general population, prevalence of UHR symptoms and criteria was 3.8-fold and 20.8-fold in our 22q11DS sample. Contrary to the general population, age only modulated the prevalence of UHR criteria among those with UHR symptoms, but not their prevalence per se or their clinical significance. This suggests that UHR symptoms might develop as a trait factor in terms of a genetically driven schizotypal disposition in 22q11DS, thus necessitating future studies on psychosis-risk indicators in this genetic high-risk group.	[Armando, Marco; Pontillo, Maria; Vicari, Stefano] Children Hosp Bambino Gesu, Dept Neurosci, Child & Adolescence Neuropsychiat Unit, Rome, Italy; [Schneider, Maude; Debbane, Martin; Eliez, Stephan] Univ Geneva, Sch Med, Dept Psychiat, Dev Imaging & Psychopathol Lab, Geneva, Switzerland; [Schultze-Lutter, Frauke] Univ Bern, Univ Hosp Child & Adolescent Psychiat & Psychothe, Bern, Switzerland	IRCCS Bambino Gesu; University of Geneva; University of Bern; University Hospital of Bern	Armando, M (corresponding author), Children Hosp Bambino Gesu, Dept Neurosci, Child & Adolescence Neuropsychiat Unit, Rome, Italy.	marco.armando@opbg.net	Schultze-Lutter, Frauke/AAU-1724-2021; Vicari, Stefano/J-3008-2012	Armando, Marco/0000-0001-7074-7212; pontillo, maria/0000-0002-0083-0093; Schneider, Maude/0000-0001-7147-8915; Debbane, Martin/0000-0002-4677-8753	Swiss National Science Foundation [324730_121996, 324730_144260, 162006]; The National Centre of Competence in Research "Synapsy The Synaptic Bases of Mental Diseases"; Brain and Behavior Research Foundation (NARSAD) [21278]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); The National Centre of Competence in Research "Synapsy The Synaptic Bases of Mental Diseases"; Brain and Behavior Research Foundation (NARSAD)(NARSAD)	This work was supported by research grants from the Swiss National Science Foundation (grant nos. 324730_121996, 324730_144260) and The National Centre of Competence in Research "Synapsy The Synaptic Bases of Mental Diseases". Grants from the Brain and Behavior Research Foundation (formerly NARSAD) (grant no. 21278) and the Swiss National Science Foundation (grant no. 162006) also supported the present work.	Arinami T, 2006, J HUM GENET, V51, P1037, DOI 10.1007/s10038-006-0058-5; Armando M, 2015, SCHIZOPHR RES, V169, P186, DOI 10.1016/j.schres.2015.10.033; Armando M, 2012, SCHIZOPHR RES, V139, P151, DOI 10.1016/j.schres.2012.04.020; Armando M, 2012, CNS NEUROL DISORD-DR, V11, P273, DOI 10.2174/187152712800672526; Bartels-Velthuis AA, 2016, ACTA PSYCHIAT SCAND, V134, P6, DOI 10.1111/acps.12571; Bassett AS, 2011, J PEDIATR-US, V159, P332, DOI 10.1016/j.jpeds.2011.02.039; Bassett AS, 2003, AM J PSYCHIAT, V160, P1580, DOI 10.1176/appi.ajp.160.9.1580; Debbane M, 2008, PSYCHOL MED, V38, P811, DOI 10.1017/S003329170700222X; Debbane M, 2006, SCHIZOPHR RES, V84, P187, DOI 10.1016/j.schres.2006.01.019; Debbane M, 2010, BRIT J CLIN PSYCHOL, V49, P373, DOI 10.1348/014466509X468223; Fusar-Poli P, 2015, WORLD PSYCHIATRY, V14, P322, DOI 10.1002/wps.20250; Fusar-Poli P, 2013, JAMA PSYCHIAT, V70, P107, DOI 10.1001/jamapsychiatry.2013.269; Garety PA, 2001, PSYCHOL MED, V31, P189, DOI 10.1017/S0033291701003312; Gothelf D, 2013, J AM ACAD CHILD PSY, V52, P1192, DOI 10.1016/j.jaac.2013.08.008; Insel TR, 2010, NATURE, V468, P187, DOI 10.1038/nature09552; KARAYIORGOU P, 1995, P NATL ACAD SCI USA, V92, P7612, DOI 10.1073/pnas.92.17.7612; Kaufman J, 1997, J AM ACAD CHILD PSY, V36, P980, DOI 10.1097/00004583-199707000-00021; Kelleher I, 2012, PSYCHOL MED, V42, P1857, DOI 10.1017/S0033291711002960; Lin A, 2015, AM J PSYCHIAT, V172, P249, DOI 10.1176/appi.ajp.2014.13030418; Linscott RJ, 2010, ANNU REV CLIN PSYCHO, V6, P391, DOI 10.1146/annurev.clinpsy.032408.153506; Lo Cascio N, 2016, EUR CHILD ADOLES PSY, P1; Mervis CB, 2000, DEV NEUROPSYCHOL, V17, P111, DOI 10.1207/S15326942DN1701_07; Murphy KC, 2001, BRIT J PSYCHIAT, V179, P397, DOI 10.1192/bjp.179.5.397; Reich W, 2000, J AM ACAD CHILD PSY, V39, P59, DOI 10.1097/00004583-200001000-00017; Rockers K, 2009, J INTELL DISABIL RES, V53, P665, DOI 10.1111/j.1365-2788.2009.01178.x; Rubio JM, 2012, SCHIZOPHR RES; Schimmelmann BG, 2015, WORLD PSYCHIATRY, V14, P189, DOI 10.1002/wps.20216; Schmidt SJ, 2015, EUR PSYCHIAT, V30, P388, DOI 10.1016/j.eurpsy.2015.01.013; Schneider M, 2016, WORLD PSYCHIATRY, V15, P259, DOI 10.1002/wps.20347; Schneider M, 2014, AM J PSYCHIAT, V171, P627, DOI 10.1176/appi.ajp.2013.13070864; Schneider M, 2012, PSYCHIAT RES, V196, P277, DOI 10.1016/j.psychres.2011.08.017; Schultze-Lutter F, 2015, EUR PSYCHIAT, V30, P405, DOI 10.1016/j.eurpsy.2015.01.010; SHAFFER D, 1983, ARCH GEN PSYCHIAT, V40, P1228; Shapiro DI, 2011, SCHIZOPHR RES, V129, P20, DOI 10.1016/j.schres.2011.03.030; SPITZER RL, 1992, ARCH GEN PSYCHIAT, V49, P624; Sporn A, 2004, MOL PSYCHIATR, V9, P225, DOI 10.1038/sj.mp.4001477; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Stoddard J, 2010, SCHIZOPHR RES, V118, P118, DOI 10.1016/j.schres.2009.12.011; Sturmey P, 2005, MENT RETARD, V43, P55, DOI 10.1352/0047-6765(2005)43<55:APWPWH>2.0.CO;2; Tang SX, 2014, PSYCHOL MED, V44, P1267, DOI 10.1017/S0033291713001669; Tang SX, 2016, BIOL PSYCHIAT; Vittinghoff E, 2007, AM J EPIDEMIOL, V165, P710, DOI 10.1093/aje/kwk052; Vorstman JAS, 2015, JAMA PSYCHIAT, V72, P377, DOI 10.1001/jamapsychiatry.2014.2671; Wechsler D., 1991, WISC 3 WECHSLER INTE; Wechsler D., 1997, WECHSLER ADULT INTEL; Woods S., 2010, PSYCHOSIS RISK SYNDR, V1st ed.	46	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2017	12	4							e0174797	10.1371/journal.pone.0174797	http://dx.doi.org/10.1371/journal.pone.0174797			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET0MB	28406913	Green Published, Green Submitted, gold			2022-12-27	WOS:000399955400015
J	Bebell, LM; Ngonzi, J; Bazira, J; Fajardo, Y; Boatin, AA; Siedner, MJ; Bassett, IV; Nyehangane, D; Nanjebe, D; Jacquemyn, Y; van Geertruyden, JP; Mwanga-Amumpaire, J; Bangsberg, DR; Riley, LE; Boum, Y				Bebell, Lisa M.; Ngonzi, Joseph; Bazira, Joel; Fajardo, Yarine; Boatin, Adeline A.; Siedner, Mark J.; Bassett, Ingrid V.; Nyehangane, Dan; Nanjebe, Deborah; Jacquemyn, Yves; van Geertruyden, Jean-Pierre; Mwanga-Amumpaire, Juliet; Bangsberg, David R.; Riley, Laura E.; Boum, Yap, II			Antimicrobial-resistant infections among postpartum women at a Ugandan referral hospital	PLOS ONE			English	Article							PUERPERAL PYREXIA; SEPSIS; AFRICA; PREVENTION; PATHOGENS	Introduction Puerperal sepsis causes 10% of maternal deaths in Africa, but prospective studies on incidence, microbiology and antimicrobial resistance are lacking. Methods We performed a prospective cohort study of 4,231 Ugandan women presenting to a regional referral hospital for delivery or postpartum care, measured vital signs after delivery, performed structured physical exam, symptom questionnaire, and microbiologic evaluation of febrile and hypothermic women. Malaria rapid diagnostic testing, blood and urine cultures were performed aseptically and processed at Epicentre Mbarara Research Centre. Antimicrobial susceptibility and breakpoints were determined using disk diffusion per EUCAST standards. Hospital diagnoses, treatments and outcomes were abstracted from patient charts. Results Mean age was 25 years, 12% were HIV-infected, and 50% had cesarean deliveries. Approximately 5% (205/4176) with >= 1 temperature measurement recorded developed postpartum fever or hypothermia; blood and urine samples were collected from 174 (85%), and 17 others were evaluated clinically. Eighty-four (48%) had at least one confirmed source of infection: 39% (76/193) clinical postpartum endometritis, 14% (25/174) urinary tract infection (UTI), 3% (5/174) bloodstream infection. Another 3% (5/174) had malaria. Overall, 30/174 (17%) had positive blood or urine cultures, and Acinetobacter species were the most common bacteria isolated. Of 25 Gram-negatives isolated, 20 (80%) were multidrug-resistant and cefepime non-susceptible. Conclusions For women in rural Uganda with postpartum fever, we found a high rate of antibiotic resistance among cultured urinary and bloodstream infections, including cephalosporin-resistant Acinetobacter species. Increasing availability of microbiology testing to inform appropriate antibiotic use, development of antimicrobial stewardship programs, and strengthening infection control practices should be high priorities.	[Bebell, Lisa M.; Siedner, Mark J.; Bassett, Ingrid V.; Bangsberg, David R.] Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA; [Bebell, Lisa M.; Boatin, Adeline A.; Siedner, Mark J.; Bangsberg, David R.] Massachusetts Gen Hosp, Ctr Global Hlth, Boston, MA USA; [Ngonzi, Joseph; Bazira, Joel; Fajardo, Yarine; Siedner, Mark J.; Mwanga-Amumpaire, Juliet; Boum, Yap, II] Mbarara Univ Sci & Technol, Mbarara, Uganda; [Ngonzi, Joseph; Jacquemyn, Yves; van Geertruyden, Jean-Pierre] Univ Antwerp, Global Hlth Inst, Antwerp, Belgium; [Ngonzi, Joseph; Jacquemyn, Yves; van Geertruyden, Jean-Pierre] Massachusetts Gen Hosp, Div Obstet & Gynecol, Boston, MA USA; [Nyehangane, Dan; Nanjebe, Deborah; Mwanga-Amumpaire, Juliet; Boum, Yap, II] Epictr Mbarara Res Ctr, Mbarara, Uganda	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Mbarara University of Science & Technology; University of Antwerp; Harvard University; Massachusetts General Hospital	Bebell, LM (corresponding author), Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA.; Bebell, LM (corresponding author), Massachusetts Gen Hosp, Ctr Global Hlth, Boston, MA USA.	lbebell@mgh.harvard.edu	Van geertruyden, Jean-Pierre/K-6425-2014; Van geertruyden, Jean-Pierre/S-3254-2019; Ngonzi, Joseph/AAC-6536-2020; Bassett, Ingrid V./ABI-7674-2020	Van geertruyden, Jean-Pierre/0000-0001-5006-6364; Van geertruyden, Jean-Pierre/0000-0001-5006-6364; Bassett, Ingrid V./0000-0001-6920-6080; Bebell, Lisa/0000-0003-0077-6522	NIH Research Training Grant - Fogarty International Center [R25 TW009337]; National Institute of Mental Health; NIH T32 Ruth L. Kirschstein National Research Service Award [5T32A1007433-22]; Harvard Global Health Institute; NIH [P30 A1060354, K23 MH09916]; NIAID; Sullivan Family Foundation; NCI; NICHD; NHLBI; NIDA; NIMH; NIA; NIDDK; NIGMS; NIMHD; FIC; OAR; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007433] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K23MH099916, F32MH009916] Funding Source: NIH RePORTER	NIH Research Training Grant - Fogarty International Center; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIH T32 Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Global Health Institute; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Sullivan Family Foundation; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMHD; FIC; OAR; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	LMB-Salary supported by NIH Research Training Grant # R25 TW009337 funded by the Fogarty International Center and the National Institute of Mental Health and NIH T32 Ruth L. Kirschstein National Research Service Award # 5T32A1007433-22. Project funding was provided by the Harvard Global Health Institute, and travel funding for LMB was provided by the MGH Center for Global Health. IVB Harvard University Center for AIDS Research (CFAR), an NIH funded program (P30 A1060354), which is supported by the following NIH Co-Funding and Participating Institutes and Centers: NIAID, NCI, NICHD, NHLBI, NIDA, NIMH, NIA, NIDDK, NIGMS, NIMHD, FIC, and OAR. MJS-NIH (K23 MH09916). DRB- Sullivan Family Foundation. This work was conducted with logistical support from Harvard Catalyst. Becton, Dickinson and Company (BD) donated blood culture bottles for use in this study. The content is solely the responsibility of the authors and does not necessarily represent the official views of Harvard Catalyst, Harvard University and its affiliated academic healthcare centers, or the National Institutes of Health.	Alfirevic Z, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008726; Allegranzi B, 2011, LANCET, V377, P228, DOI 10.1016/S0140-6736(10)61458-4; Carlson AL, 2016, INFECT CONT HOSP EP, V37, P1114, DOI 10.1017/ice.2016.121; Dolea C, 2003, GLOBAL BURDEN MATERN; EUCAST,, 2019, BREAKPOINT TABLES IN; Gupta K, 2011, CLIN INFECT DIS, V52, pE103, DOI [10.1093/cid/ciq257, 10.1093/cid/cir102]; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hooton TM, 2010, CLIN INFECT DIS, V50, P625, DOI 10.1086/650482; Lapinsky SE, 2013, CRIT CARE CLIN, V29, P509, DOI 10.1016/j.ccc.2013.03.006; Laxminarayan R, 2013, LANCET INFECT DIS, V13, P1057, DOI 10.1016/S1473-3099(13)70318-9; Lob SH, 2016, INT J ANTIMICROB AG, V47, P317, DOI 10.1016/j.ijantimicag.2016.01.015; Lowings M, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1246-8; LUCAS MJ, 1993, CLIN OBSTET GYNECOL, V36, P855, DOI 10.1097/00003081-199312000-00009; Maharaj D, 2007, OBSTET GYNECOL SURV, V62, P400, DOI 10.1097/01.ogx.0000266063.84571.fb; Maharaj D, 2007, OBSTET GYNECOL SURV, V62, P393, DOI 10.1097/01.ogx.0000265998.40912.5e; Miller AE, 2013, INT J GYNECOL OBSTET, V123, P10, DOI 10.1016/j.ijgo.2013.06.006; Mivumbi VN, 2014, INT J GYNECOL OBSTET, V124, P244, DOI 10.1016/j.ijgo.2013.09.017; Munoz-Price LS, 2008, NEW ENGL J MED, V358, P1271, DOI 10.1056/NEJMra070741; Ngonzi J, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-0986-9; Onken A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145632; Petti CA, 2006, CLIN INFECT DIS, V42, P377, DOI 10.1086/499363; Say L, 2014, LANCET GLOB HEALTH, V2, pE323, DOI 10.1016/S2214-109X(14)70227-X; Scherbaum M, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-124; Schroeder LF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134578; Seale AC, 2013, PEDIATR RES, V74, P73, DOI 10.1038/pr.2013.207; Seale AC, 2009, LANCET INFECT DIS, V9, P428, DOI 10.1016/S1473-3099(09)70172-0; Smaill FM, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007482.pub3; STRAYPEDERSEN B, 1990, AM J OBSTET GYNECOL, V162, P792, DOI 10.1016/0002-9378(90)91012-2; van Dillen J, 2010, CURR OPIN INFECT DIS, V23, P249, DOI 10.1097/QCO.0b013e328339257c; WHO, 2015, WHO REC PREV TREAT M; Wilson ML, 2004, CLIN INFECT DIS, V38, P1150, DOI 10.1086/383029	31	22	23	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2017	12	4							e0175456	10.1371/journal.pone.0175456	http://dx.doi.org/10.1371/journal.pone.0175456			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0MB	28406949	Green Published, Green Submitted, gold			2022-12-27	WOS:000399955400056
J	Kolarik, AJ; Scarfe, AC; Moore, BCJ; Pardhan, S				Kolarik, Andrew J.; Scarfe, Amy C.; Moore, Brian C. J.; Pardhan, Shahina			Blindness enhances auditory obstacle circumvention: Assessing echolocation, sensory substitution, and visual-based navigation	PLOS ONE			English	Article							CONTROLLED LOCOMOTION; OCCIPITAL CORTEX; LATERAL POSITION; FACIAL VISION; OPTIC-FLOW; PERCEPTION; CUES; INDIVIDUALS; DIRECTION; DISTANCE	Performance for an obstacle circumvention task was assessed under conditions of visual, auditory only (using echolocation) and tactile (using a sensory substitution device, SSD) guidance. A Vicon motion capture system was used to measure human movement kinematics objectively. Ten normally sighted participants, 8 blind non-echolocators, and 1 blind expert echolocator navigated around a 0.6 x 2 m obstacle that was varied in position across trials, at the midline of the participant or 25 cm to the right or left. Although visual guidance was the most effective, participants successfully circumvented the obstacle in the majority of trials under auditory or SSD guidance. Using audition, blind non-echolocators navigated more effectively than blindfolded sighted individuals with fewer collisions, lower movement times, fewer velocity corrections and greater obstacle detection ranges. The blind expert echolocator displayed performance similar to or better than that for the other groups using audition, but was comparable to that for the other groups using the SSD. The generally better performance of blind than of sighted participants is consistent with the perceptual enhancement hypothesis that individuals with severe visual deficits develop improved auditory abilities to compensate for visual loss, here shown by faster, more fluid, and more accurate navigation around obstacles using sound.	[Kolarik, Andrew J.; Scarfe, Amy C.; Pardhan, Shahina] Anglia Ruskin Univ, Postgrad Med Inst, VERU, Cambridge, England; [Kolarik, Andrew J.; Moore, Brian C. J.] Univ Cambridge, Dept Psychol, Cambridge, England; [Kolarik, Andrew J.] Univ London, Inst Philosophy, Ctr Study Senses, London, England; [Scarfe, Amy C.] Sheffield Teaching Hosp NHS Fdn Trust, Dept Clin Engn, Med Imaging & Med Phys Directorate, Sheffield, S Yorkshire, England	Anglia Ruskin University; University of Cambridge; University of London; University of Sheffield	Kolarik, AJ (corresponding author), Anglia Ruskin Univ, Postgrad Med Inst, VERU, Cambridge, England.; Kolarik, AJ (corresponding author), Univ Cambridge, Dept Psychol, Cambridge, England.; Kolarik, AJ (corresponding author), Univ London, Inst Philosophy, Ctr Study Senses, London, England.	ak771@cam.ac.uk	Pardhan, Shahina/AAZ-7509-2020; Kolarik, Andrew/H-9097-2019	Kolarik, Andrew/0000-0002-5121-7512	Vision and Eye Research Unit, PostgraduateMedical Institute at Anglia Ruskin University; Medical Research Council [G0701870]; AHRC [AH/L007053/1] Funding Source: UKRI; MRC [G0701870] Funding Source: UKRI; Arts and Humanities Research Council [AH/L007053/1] Funding Source: researchfish	Vision and Eye Research Unit, PostgraduateMedical Institute at Anglia Ruskin University; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); AHRC(UK Research & Innovation (UKRI)Arts & Humanities Research Council (AHRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Arts and Humanities Research Council(UK Research & Innovation (UKRI)Arts & Humanities Research Council (AHRC))	This research was supported by the Vision and Eye Research Unit, Postgraduate Medical Institute at Anglia Ruskin University (awarded to SP), and the Medical Research Council (awarded to BCJM, Grant number G0701870), http://www.anglia.ac.uk/postgraduate-medical-institute/groups/visionand-eyeresearch-unit; http://www.mrc.ac.uk. The funders had no role in study design, data collection and analysis, decision topublish, or preparation of the manuscript.	AMMONS CH, 1953, AM J PSYCHOL, V66, P519, DOI 10.2307/1418950; Arnott SR, 2013, NEUROPSYCHOLOGIA, V51, P938, DOI 10.1016/j.neuropsychologia.2013.01.024; ASHMEAD DH, 1989, PERCEPT PSYCHOPHYS, V46, P425, DOI 10.3758/BF03210857; Axelrod S., 1959, EFFECTS EARLY BLINDN; BACH P, 1969, NATURE, V221, P963, DOI 10.1038/221963a0; British Society of Audiology, 2011, PUR TON AIR COND BON; CarlsonSmith C, 1996, J VISUAL IMPAIR BLIN, V90, P21; Chebat DR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126307; Chebat DR, 2011, NEUROREPORT, V22, P342, DOI 10.1097/WNR.0b013e3283462def; Crawford JR, 2010, COGN NEUROPSYCHOL, V27, P245, DOI 10.1080/02643294.2010.513967; Crawford JR, 1998, CLIN NEUROPSYCHOL, V12, P482, DOI 10.1076/clin.12.4.482.7241; Davies TC, 2011, DISABIL REHABIL-ASSI, V6, P500, DOI 10.3109/17483107.2010.542569; Dufour A, 2005, EXP BRAIN RES, V165, P515, DOI 10.1007/s00221-005-2329-3; Fajen BR, 2003, J EXP PSYCHOL HUMAN, V29, P343, DOI 10.1037/0096-1523.29.2.343; Fiehler K, 2015, MULTISENS RES, V28, P195, DOI 10.1163/22134808-00002491; Frenz H, 2005, VISION RES, V45, P1679, DOI 10.1016/j.visres.2004.12.019; Gerin-Lajoie M, 2008, GAIT POSTURE, V27, P239, DOI 10.1016/j.gaitpost.2007.03.015; GIBSON JJ, 1958, BRIT J PSYCHOL, V49, P182, DOI 10.1111/j.2044-8295.1958.tb00656.x; Gougoux F, 2005, PLOS BIOL, V3, P324, DOI 10.1371/journal.pbio.0030027; Hackney AL, 2014, GAIT POSTURE, V40, P113, DOI 10.1016/j.gaitpost.2014.03.005; Howell DC., 1997, STATISTICAL METHODS; Hughes B, 2001, HUM MOVEMENT SCI, V20, P371, DOI 10.1016/S0167-9457(01)00059-8; JONES B, 1975, BRIT J PSYCHOL, V66, P461, DOI 10.1111/j.2044-8295.1975.tb01481.x; Kolarik A.J., 2013, P M ACO ICA2013, V19, P50043, DOI DOI 10.1121/1.4799570; Kolarik AJ, 2017, EXP BRAIN RES, V235, P597, DOI 10.1007/s00221-016-4823-1; Kolarik AJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160872; Kolarik AJ, 2016, EXP BRAIN RES, V234, P1725, DOI 10.1007/s00221-016-4567-y; Kolarik AJ, 2016, ATTEN PERCEPT PSYCHO, V78, P373, DOI 10.3758/s13414-015-1015-1; Kolarik AJ, 2014, HEARING RES, V310, P60, DOI 10.1016/j.heares.2014.01.010; Kolarik AJ, 2014, EXP BRAIN RES, V232, P975, DOI 10.1007/s00221-013-3809-5; Kolarik AJ, 2013, EXP BRAIN RES, V224, P623, DOI 10.1007/s00221-012-3340-0; Kupers R, 2010, P NATL ACAD SCI USA, V107, P12716, DOI 10.1073/pnas.1006199107; LEE DN, 1992, J COMP PHYSIOL A, V171, P563, DOI 10.1007/BF00194105; Levy-Tzedek S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151593; Maidenbaum S, 2014, RESTOR NEUROL NEUROS, V32, P813, DOI 10.3233/RNN-130351; Maidenbaum S, 2014, NEUROSCI BIOBEHAV R, V41, P3, DOI 10.1016/j.neubiorev.2013.11.007; McCarty B, 1954, NEW OUTLOOK BLIND, V48, P316; Milne JL, 2015, NEUROCASE, V21, P465, DOI 10.1080/13554794.2014.922994; Milne JL, 2014, ATTEN PERCEPT PSYCHO, V76, P1828, DOI 10.3758/s13414-014-0695-2; Moffat SD, 2009, NEUROPSYCHOL REV, V19, P478, DOI 10.1007/s11065-009-9120-3; Nilsson ME, 2016, HEARING RES, V332, P223, DOI 10.1016/j.heares.2015.09.012; Pardhan S, 2011, OPHTHAL PHYSL OPT, V31, P233, DOI 10.1111/j.1475-1313.2010.00819.x; Philips G., 2015, MINIGUIDE MOBILITY A; Rice C., 1970, RES B AM FDN BLIND, V22, P1; Rosenblum L.D., 2011, SEE WHAT IM SAYING E; Rosenblum LD, 2000, ECOL PSYCHOL, V12, P181, DOI 10.1207/S15326969ECO1203_1; Rosenblum LD, 2016, J COGN PSYCHOL, P1; Rowan D, 2015, HEARING RES, V323, P32, DOI 10.1016/j.heares.2015.01.012; Rowan D, 2013, HEARING RES, V300, P56, DOI 10.1016/j.heares.2013.03.005; Schenkman BN, 2011, PERCEPTION, V40, P840, DOI 10.1068/p6898; Schenkman BN, 2010, PERCEPTION, V39, P483, DOI 10.1068/p6473; Schinazi VR, 2016, WIRES COGN SCI, V7, P37, DOI 10.1002/wcs.1375; Serino A, 2013, CONSCIOUS COGN, V22, P1239, DOI 10.1016/j.concog.2013.08.013; Stoffregen TA, 1995, ECOL PSYCHOL, V7, P181; Supa M, 1944, AM J PSYCHOL, V57, P133, DOI 10.2307/1416946; Teng S, 2012, EXP BRAIN RES, V216, P483, DOI 10.1007/s00221-011-2951-1; Teng S, 2011, J VISUAL IMPAIR BLIN, V105, P20, DOI 10.1177/0145482X1110500103; Thaler L, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00098; Thaler L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020162; Turano KA, 2005, VISION RES, V45, P3117, DOI 10.1016/j.visres.2005.06.017; VERAART C, 1987, PERCEPT PSYCHOPHYS, V42, P132, DOI 10.3758/BF03210501; Vercillo T, 2015, NEUROPSYCHOLOGIA, V67, P35, DOI 10.1016/j.neuropsychologia.2014.12.001; Voss P, 2015, J NEUROSCI, V35, P6051, DOI 10.1523/JNEUROSCI.4544-14.2015; Voss P, 2012, CURR BIOL, V22, pR168, DOI 10.1016/j.cub.2012.01.030; Voss P, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00048; Voss P, 2010, WIRES COGN SCI, V1, P308, DOI 10.1002/wcs.13; Wallmeier L, 2014, ROY SOC OPEN SCI, V1, DOI 10.1098/rsos.140185; Wallmeier L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115363; Warren WH, 1998, ECOL PSYCHOL, V10, P177, DOI 10.1207/s15326969eco103&4_3; WORCHEL P, 1950, J EXP PSYCHOL, V40, P746, DOI 10.1037/h0060950; WORCHEL P, 1951, J EXP PSYCHOL, V41, P170, DOI 10.1037/h0055653; World Health Organization, 1989, 10 REV INT CLASS DIS; Zwiers MP, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-09-j0002.2001	73	41	41	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2017	12	4							e0175750	10.1371/journal.pone.0175750	http://dx.doi.org/10.1371/journal.pone.0175750			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET0MB	28407000	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000399955400089
J	Martinez, JMM; Urias, J				Mendez Martinez, Jose Manuel; Urias, Jesus			An algorithm for constructing the skeleton graph of degenerate systems of linear inequalities	PLOS ONE			English	Article							CONVEX POLYTOPE; EXTREME-POINTS; ENUMERATION; VERTEX	Derive the quantitative predictions of constraint-based models require of conversion algorithms to enumerate and construct the skeleton graph conformed by the extreme points of the feasible region, where all constraints in the model are fulfilled. The conversion is problematic when the system of linear constraints is degenerate. This paper describes a conversion algorithm that combines the best of two methods: the incremental slicing of cones that defeats degeneracy and pivoting for a swift traversal of the set of extreme points. An extensive computational practice uncovers two complementary classes of conversion problems. The two classes are distinguished by a practical measure of complexity that involves the input and output sizes. Detailed characterizations of the complexity classes and the corresponding performances of the algorithm are presented. For the benefit of implementors, a simple example illustrates the stages of the exposition.	[Mendez Martinez, Jose Manuel; Urias, Jesus] Univ Autonoma San Luis Potosi, Inst Fis, San Luis Potosi, Slp, Mexico	Universidad Autonoma de San Luis Potosi	Martinez, JMM (corresponding author), Univ Autonoma San Luis Potosi, Inst Fis, San Luis Potosi, Slp, Mexico.	manolo@dec1.ifisica.uaslp.mx	Méndez Martínez, José Manuel/HCH-6208-2022	Mendez Martinez, Jose Manuel/0000-0003-2506-5727	Consejo Nacional de Ciencia y Tecnologia (CONACyT), Mexico; CONACyT through E. Ugalde's grant [CB-2014-01, 237324]	Consejo Nacional de Ciencia y Tecnologia (CONACyT), Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); CONACyT through E. Ugalde's grant	JMMM was supported by Consejo Nacional de Ciencia y Tecnologia (CONACyT), Mexico. The publication fees of this article were covered by CONACyT through E. Ugalde's grant CB-2014-01 No. 237324. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaris AJR, 2015, J MATH BIOL, V71, P735, DOI 10.1007/s00285-014-0841-4; AVIS D, 1992, DISCRETE COMPUT GEOM, V8, P295, DOI 10.1007/BF02293050; Avis D, 1997, COMP GEOM-THEOR APPL, V7, P265, DOI 10.1016/S0925-7721(96)00023-5; BALINSKI ML, 1961, J SOC IND APPL MATH, V9, P72, DOI 10.1137/0109008; Barrett J, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.140401; Barrett J, 2005, PHYS REV A, V71, DOI 10.1103/PhysRevA.71.022101; Bell J. S., 1964, PHYSICS, V1, P195, DOI [10.1103/Physics-PhysiqueFizika.1.195, DOI 10.1103/PHYSICSPHYSIQUEFIZIKA.1.195]; Bremner D, 1998, DISCRETE COMPUT GEOM, V20, P333, DOI 10.1007/PL00009389; Brualdi RA., 2014, HDB LINEAR IN PRESS; Cao SJ, 2014, INFORM SCIENCES, V278, P22, DOI 10.1016/j.ins.2014.03.133; Cerf NJ, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.220403; Chen ZQ, 2015, ENTROPY-SWITZ, V17, P3710, DOI 10.3390/e17063710; Dantzig G.B., 1955, PAC J MATH, V5, P183, DOI [10.2140/pjm.1955.5.183, DOI 10.2140/PJM.1955.5.183]; DYER ME, 1977, MATH PROGRAM, V12, P81, DOI 10.1007/BF01593771; Emmert-Streib F, 2016, INFORM SCIENCES, V346, P180, DOI 10.1016/j.ins.2016.01.074; Fukuda K., 1996, COMBINATORICS COMPUT, V1120, P91; Gagneur J, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-175; GAL T, 1992, OPER RES LETT, V11, P23, DOI 10.1016/0167-6377(92)90058-B; GAL T, 1985, J OPTIMIZ THEORY APP, V45, P576; Hart Y, 2015, NAT METHODS, V12, P233, DOI [10.1038/NMETH.3254, 10.1038/nmeth.3254]; Marti R, 2011, APPL MATH SCI, V175, P1, DOI 10.1007/978-3-642-16729-4_1; MCMULLEN P, 1970, MATHEMATIKA, V17, P179, DOI 10.1112/S0025579300002850; Mendez JM, 2015, J MATH PHYS, V56, DOI 10.1063/1.4914336; Motzkin TS, 1971, CONTRIBUTIO IN PRESS, V2; Pak I., 2000, ANN COMB, V4, P83, DOI [10.1007/PL00001277, DOI 10.1007/PL00001277]; Pironio S, 2011, J PHYS A-MATH THEOR, V44, DOI 10.1088/1751-8113/44/6/065303; Popescu S, 1994, PHYS, V24, P379; Stelling J, 2002, NATURE, V420, P190, DOI 10.1038/nature01166; Wang Z, 2008, IEEE T NANOBIOSCIENC, V7; YAMADA T, 1994, COMPUT OPER RES, V21, P397, DOI 10.1016/0305-0548(94)90027-2; Zolotykh NY, 2012, COMP MATH MATH PHYS+, V52, P146, DOI 10.1134/S0965542512010162	31	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2017	12	4							e0175819	10.1371/journal.pone.0175819	http://dx.doi.org/10.1371/journal.pone.0175819			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0MB	28406983	Green Published, Green Submitted, gold			2022-12-27	WOS:000399955400102
J	Tafuri, MA; Zangrando, AFJ; Tessone, A; Kochi, S; Cecchi, JM; Di Vincenzo, F; Profico, A; Manzi, G				Tafuri, Mary Anne; Javier Zangrando, Atilio Francisco; Tessone, Augusto; Kochi, Sayuri; Cecchi, Jacopo Moggi; Di Vincenzo, Fabio; Profico, Antonio; Manzi, Giorgio			Dietary resilience among hunter-gatherers of Tierra del Fuego: Isotopic evidence in a diachronic perspective	PLOS ONE			English	Article							COLLAGEN; BONE; PATAGONIA	The native groups of Patagonia have relied on a hunter-gatherer economy well after the first Europeans and North Americans reached this part of the world. The large exploitation of marine mammals (i.e., seals) by such allochthonous groups has had a strong impact on the local ecology in a way that might have forced the natives to adjust their subsistence strategies. Similarly, the introduction of new foods might have changed local diet. These are the premises of our isotopic-based analysis. There is a large set of paleonutritional investigations through isotopic analysis on Fuegians groups, however a systematic exploration of food practices across time in relation to possible pre- and post-contact changes is still lacking. In this paper we investigate dietary variation in hunter-gatherer groups of Tierra del Fuego in a diachronic perspective, through measuring the isotopic ratio of carbon (partial derivative C-13) and nitrogen (partial derivative N-15) in the bone collagen of human and a selection of terrestrial and marine animal samples. The data obtained reveal an unexpected isotopic uniformity across prehistoric and recent groups, with little variation in both carbon and nitrogen mean values, which we interpret as the possible evidence of resilience among these groups and persistence of subsistence strategies, allowing inferences on the dramatic contraction (and extinction) of Fuegian populations.	[Tafuri, Mary Anne; Di Vincenzo, Fabio; Profico, Antonio; Manzi, Giorgio] Sapienza Univ Roma, Dipartimento Biol Ambientale, Rome, Italy; [Javier Zangrando, Atilio Francisco] CADIC CONICET, Ushuaia, Argentina; [Tessone, Augusto; Kochi, Sayuri] INGEIS CONICET, Pabellon INGEIS, Buenos Aires, DF, Argentina; [Cecchi, Jacopo Moggi] Univ Florence, Dipartimento Biol, Florence, Italy	Sapienza University Rome; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Florence	Tafuri, MA (corresponding author), Sapienza Univ Roma, Dipartimento Biol Ambientale, Rome, Italy.; Zangrando, AFJ (corresponding author), CADIC CONICET, Ushuaia, Argentina.	maryanne.tafuri@uniroma1.it; panchozan@yahoo.com.ar	Tafuri, Mary Anne/I-7145-2017; Profico, Antonio/Q-3208-2018	Tafuri, Mary Anne/0000-0002-2913-7225; Profico, Antonio/0000-0003-2884-7118; Manzi, Giorgio/0000-0002-8611-1371; Tessone, Augusto/0000-0001-9722-1480	Marie Curie Action	Marie Curie Action(European Commission)	Part of this research was funded by the Marie Curie Action granted to MAT. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Orquera LA, 2011, QUATERN INT, V239, P61, DOI 10.1016/j.quaint.2011.02.032; Alfonso-Durrruty MP, 2015, AM J PHYS ANTHROPOL, V158, P607, DOI 10.1002/ajpa.22832; AMBROSE SH, 1990, J ARCHAEOL SCI, V17, P431, DOI 10.1016/0305-4403(90)90007-R; Bearez P, 2016, J ARCHAEOL SCI-REP, V8, P445, DOI 10.1016/j.jasrep.2016.07.002; Bitlloch E., 2005, ANTIGUOS PUEBLOS EXT; Borrero L.A., 2001, SERIE CIENCIAS HUMAN, V29, P119; Bove G., 1884, PATAGONIA TERRA FU 1; Bridges T, 1880, LETT S AM MISSIONARY, V37; Bridges T, 1874, LETT S AM MISSIONARY, V23; Bridges T, 1873, LETT S AM MISSIONARY, V89; BROWN TA, 1988, RADIOCARBON, V30, P171, DOI 10.1017/S0033822200044118; Burton RK, 2001, OECOLOGIA, V128, P107, DOI 10.1007/s004420100631; DENIRO MJ, 1985, NATURE, V317, P806, DOI 10.1038/317806a0; Ernesto Piana, 2006, Magallania, V34, P103, DOI 10.4067/S0718-22442006000100007; Zangrando AF, 2009, WORLD ARCHAEOL, V41, P589, DOI 10.1080/00438240903363848; FRIEDLI H, 1986, NATURE, V324, P237, DOI 10.1038/324237a0; Guichon R. A., 2001, SERIE CIENCIAS HUMAN, V29, P103; Gusinde M, 1986, YAMANA CTR ARGENTINO; HEUSSER CJ, 1990, REV PALAEOBOT PALYNO, V65, P9, DOI 10.1016/0034-6667(90)90051-J; HEUSSER CJ, 1995, PALAEOGEOGR PALAEOCL, V118, P1, DOI 10.1016/0031-0182(94)00138-X; Kochi S., 2016, PALEODIETAS CAZADORE; Longin R., 1971, NEW METHOD COLLAGEN; Piana EL, 2009, ARCTIC ANTHROPOL, V46, P103, DOI 10.1353/arc.0.0023; Marangoni A, 2011, MUSEOLOGIA SCI, V5; Obelic B, 1998, QUATERNARY S AM ANTA, V11; Orquera L.A., 1999, ARQUEOLOGIA REGION C; Orquera LA, 1996, RELACIONES SOC ARGEN, P21; Orquera Luis Abel, 2002, ARCHAEOL ANTHROP SCI, P145; PANARELLO HÉCTOR, 2006, Magallania, V34, P37, DOI 10.4067/S0718-22442006000200004; Pauketat Timothy R., 2001, ARCHAEOLOGY TRADITIO; Rasnake R.N., 1988, DOMINATION CULTURAL; Schiavini A. M., 1993, LAT AM ANTIQ, V4, P346, DOI DOI 10.2307/972072; Schneider C, 2003, PHYS GEOGR, V24, P97, DOI 10.2747/0272-3646.24.2.97; Scott J., 1985, WEAPONS WEAK EVERYDA; Sealy JC, 1986, INT SERIES; Suby JA, 2011, RELACIONES, V36, P249; Tessone A., 2003, REV ARGENT ANTROPOL, V5, P33; Tivoli A. M., 2010, FARMING, V2010, P1, DOI DOI 10.3828/BFARM.2010.2.3; Van Klinken GJ, 1999, J ARCHAEOL SCI, V26, P687, DOI 10.1006/jasc.1998.0385; Vila A, 2006, REV ESP ANTROPOL AM, V36, P45; Yesner DR, 2003, J ANTHROPOL ARCHAEOL, V22, P279, DOI 10.1016/S0278-4165(03)00040-0; Zangrando A.F., 2014, REV MUSEO ANTROPOLOG, V7, P11; Zangrando AFJ, 2016, ENVIRON ARCHAEOL, V21, P182, DOI 10.1080/14614103.2015.1130888; Zangrando F., 2009, HIST EVOLUTIVA SUBSI	44	12	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2017	12	4							e0175594	10.1371/journal.pone.0175594	http://dx.doi.org/10.1371/journal.pone.0175594			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	ET0MB	28407013	Green Published, gold			2022-12-27	WOS:000399955400072
J	Carvalho, AC; Leal, F; Sasse, AD				Carvalho, Adriana Camargo; Leal, Frederico; Sasse, Andre Deeke			Cost-effectiveness of cetuximab and panitumumab for chemotherapy-refractory metastatic colorectal cancer	PLOS ONE			English	Article							PHASE-III TRIAL; WILD-TYPE KRAS; 1ST-LINE TREATMENT; ANTICANCER DRUGS; OPEN-LABEL; CARE; METAANALYSIS; CHALLENGES; MANAGEMENT; EFFICACY	Background Cetuximab and panitumumab are monoclonal antibodies targeting the epidermal growth factor receptor. Both drugs are active against RAS wild type metastatic colorectal cancer after chemotherapy failure, with similar efficacy and toxicity profiles. However, their cost and limited survival benefits may compromise incorporation in the Brazilian public healthcare system, the Unified Heath System (Sistema Unico de Saude) (SUS). Methods A cost-effectiveness analysis was conducted using a Markov model from the Brazilian Public health perspective and a lifetime horizon in patients with RAS -wt mCRC. Transition probabilities and mortality rates were extracted from randomized studies. Treatment costs were obtained from price tables regulated by the Brazilian Health Ministry. The World Health Organization recommendation of three times GDP per capita was used to define the cost-effectiveness threshold. Results The use of cetuximab or panitumumab for chemotherapy-refractory mCRC patients resulted in 0.22 additional life-years relative to BSC, with incremental cost-effectiveness ratios (ICERs) of $58,240 and $52,772 per LY, respectively. That exceeds the pre-specified threshold for cost-effectiveness. Acquisition of biological agents was the major driver of increased costs. Conclusions Our economic evaluation demonstrates that both cetuximab and panitumumab are not a cost-effective approach in RAS-wt mCRC patients. Discussion about drug price should be prioritized to enable incorporation of these monoclonal antibodies in the SUS.	[Carvalho, Adriana Camargo; Leal, Frederico; Sasse, Andre Deeke] Univ Estadual Campinas, UNICAMP, Dept Internal Med, Ctr Evidence Oncol, Campinas, SP, Brazil	Universidade Estadual de Campinas	Sasse, AD (corresponding author), Univ Estadual Campinas, UNICAMP, Dept Internal Med, Ctr Evidence Oncol, Campinas, SP, Brazil.	sasse@cevon.com.br	Sasse, Andre/P-7272-2019; Sasse, Andre D/B-3375-2009	Sasse, Andre D/0000-0002-3038-3933; Carvalho, Adriana/0000-0002-2914-0010				Amado RG, 2008, J CLIN ONCOL, V26, P1626, DOI 10.1200/JCO.2007.14.7116; Asmis T, 2014, CURR ONCOL, V21, P318, DOI 10.3747/co.21.2146; Cunningham D, 2004, NEW ENGL J MED, V351, P337, DOI 10.1056/NEJMoa033025; Cunningham D, 2010, LANCET, V375, P1030, DOI 10.1016/S0140-6736(10)60353-4; Douillard JY, 2010, J CLIN ONCOL, V28, P4697, DOI 10.1200/JCO.2009.27.4860; Novaes HMD, 2006, REV SAUDE PUBL, V40, P133, DOI 10.1590/S0034-89102006000400018; Pepe VLE, 2010, CIENC SAUDE COLETIVA, V15, P2405, DOI 10.1590/S1413-81232010000500015; Estatistica I-IBdGe, PIB PER CAP 2015; Garattini S, 2002, BMJ-BRIT MED J, V325, P269, DOI 10.1136/bmj.325.7358.269; Glimelius B, 2012, SCAND J GASTROENTERO, V47, P296, DOI 10.3109/00365521.2012.640828; Goldberg RM, 2007, ONCOLOGIST, V12, P38, DOI 10.1634/theoncologist.12-1-38; Karapetis CS, 2008, NEW ENGL J MED, V359, P1757, DOI 10.1056/NEJMoa0804385; Lopes LC, 2010, REV SAUDE PUBL, V44, P620, DOI 10.1590/S0034-89102010000400005; Price TJ, 2014, LANCET ONCOL, V15, P569, DOI 10.1016/S1470-2045(14)70118-4; Qureshi A., 2010, BMJ CLIN EVID, V2010; Rinaldi F, 2012, LANCET ONCOL, V13, P233, DOI 10.1016/S1470-2045(12)70044-X; Rowland A, 2015, BR J CANC; Segelov E, 2014, BRIT J CANCER, V111, P1122, DOI 10.1038/bjc.2014.404; Sullivan R, 2011, LANCET ONCOL, V12, P933, DOI 10.1016/S1470-2045(11)70141-3; Van Cutsem E, 2010, ANN ONCOL, V21, pv93, DOI 10.1093/annonc/mdq222; Van Cutsem E, 2007, J CLIN ONCOL, V25, P1658, DOI 10.1200/JCO.2006.08.1620; Van Cutsem E, 2009, NEW ENGL J MED, V360, P1408, DOI 10.1056/NEJMoa0805019; WHO Commission on Macroeconomics and Health, 2001, MACR HLTH INV HLTH E	23	11	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2017	12	4							e0175409	10.1371/journal.pone.0175409	http://dx.doi.org/10.1371/journal.pone.0175409			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LZ	28403233	Green Submitted, gold, Green Published			2022-12-27	WOS:000399955200062
J	Lundqvist, S; Borjesson, M; Larsson, MEH; Hagberg, L; Cider, A				Lundqvist, Stefan; Borjesson, Mats; Larsson, Maria E. H.; Hagberg, Lars; Cider, Asa			Physical Activity on Prescription (PAP), in patients with metabolic risk factors. A 6-month follow-up study in primary health care	PLOS ONE			English	Article							QUALITY-OF-LIFE; RANDOMIZED CONTROLLED-TRIAL; EXERCISE REFERRAL PROGRAM; ACTIVITY QUESTIONNAIRE; SPORTS-MEDICINE; ACTIVITY LEVEL; VALIDITY; RELIABILITY; FITNESS; DISEASE	There is strong evidence that inadequate physical activity (PA) leads to an increased risk of lifestyle-related diseases and premature mortality. Physical activity on prescription (PAP) is a method to increase the level of PA of patients in primary care, but needs further evaluation. The aim of this observational study was to explore the association between PAP-treatment and the PA level of patients with metabolic risk factors and the relationship between changes in the PA level and health outcomes at the 6 month follow-up. This study included 444 patients in primary care, aged 27-85 years (56% females), who were physically inactive with at least one component of metabolic syndrome. The PAP-treatment model included: individualized dialogue concerning PA, prescribed PA, and a structured follow-up. A total of 368 patients (83%) completed the 6 months of follow-up. Of these patients, 73% increased their PA level and 42% moved from an inadequate PA level to sufficient, according to public health recommendations. There were significant improvements (p <= 0.05) in the following metabolic risk factors: body mass index, waist circumference, systolic blood pressure, fasting plasma glucose, cholesterol, and low density lipoprotein. There were also significant improvements regarding health-related quality of life, assessed by the Short Form 36, in: general health, vitality, social function, mental health, role limitation-physical/emotional, mental component summary, and physical component summary. Regression analysis showed a significant association between changes in the PA level and health outcomes. During the first 6-month period, the caregiver provided PAP support 1-2 times. This study indicates that an individual-based model of PAP-treatment has the potential to change people's PA behavior with improved metabolic risk factors and self-reported quality of life at the 6 month follow-up. Thus, PAP seems to be feasible in a clinical primary care practice, with minimum effort from healthcare professionals.	[Lundqvist, Stefan; Cider, Asa] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Hlth & Rehabil,Unit Physotherapy, Gothenburg, Sweden; [Lundqvist, Stefan] Narhalsan Rehabil FaR teamet Cent & western Gothe, Gothenburg, Sweden; [Borjesson, Mats] Univ Gothenburg, Fac Educ, Dept Food & Nutr & Sport Sci, Gothenburg, Sweden; [Borjesson, Mats] Sahlgrens Univ Hosp, Sahlgrenska Acad, Inst Neurosci & Physiol, Gothenburg, Sweden; [Larsson, Maria E. H.] Narhalsan Res & Dev Primary Hlth Care, Gothenburg, Sweden; [Hagberg, Lars] Univ Orebro, Univ Hlth Care Res Ctr, Fac Med & Hlth, Orebro, Sweden	University of Gothenburg; University of Gothenburg; Sahlgrenska University Hospital; University of Gothenburg; Orebro University	Lundqvist, S (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Hlth & Rehabil,Unit Physotherapy, Gothenburg, Sweden.; Lundqvist, S (corresponding author), Narhalsan Rehabil FaR teamet Cent & western Gothe, Gothenburg, Sweden.				Narhalsan Research & Development Primary Health Care, Region Vastra Gotaland	Narhalsan Research & Development Primary Health Care, Region Vastra Gotaland	Funding was provided as economic support for doctoral thesis by Narhalsan Research & Development Primary Health Care, Region Vastra Gotaland, http://www.nartialsan. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akobeng AK, 2008, J PEDIATR GASTR NUTR, V47, P277, DOI 10.1097/MPG.0b013e31816c749f; Anglemyer A, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000034.pub2; [Anonymous], 2009, GLOBAL HEALTH RISKS: MORTALITY AND BURDEN OF DISEASE ATTRIBUTABLE TO SELECTED MAJOR RISKS, P1; [Anonymous], 2009, NUTR REV, V67, P114, DOI 10.1111/j.1753-4887.2008.00136.x; [Anonymous], 2008, FYSS 2008 FYSISK AKT; Blomstrand A, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001154; Borg G, 1998, BORGS PERCEIVED EXER; Borjesson Mats, 2012, Lakartidningen, V109, P2340; CASPERSEN CJ, 1985, PUBLIC HEALTH REP, V0100; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Cohen J.E., 1988, STAT POWER ANAL BEHA; Cook CE, 2008, J MAN MANIP THER, V16, p82E, DOI 10.1179/jmt.2008.16.4.82E; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Duda JL, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/1479-5868-11-10; Edwardson CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034916; Ekblom O, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2316-y; Ekblom-Bak E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126336; Ekelund U, 2006, PUBLIC HEALTH NUTR, V9, P258, DOI 10.1079/PHN2005840; Elley CR, 2003, BRIT MED J, V326, P793, DOI 10.1136/bmj.326.7393.793; Feldman Inna, 2013, Cost Eff Resour Alloc, V11, P19, DOI 10.1186/1478-7547-11-19; Forouzanfar MH, 2015, LANCET, V386, P2287, DOI 10.1016/S0140-6736(15)00128-2; Frandin K., 1994, Scandinavian Journal of Medicine and Science in Sports, V4, P41; Grimby G, 2015, SCAND J MED SCI SPOR, V25, P119, DOI 10.1111/sms.12611; GRIMBY G, 1986, ACTA MED SCAND, P233; Grimes DA, 2002, LANCET, V359, P248, DOI 10.1016/S0140-6736(02)07451-2; Grundy SM, 2004, CIRCULATION, V109, P433, DOI 10.1161/01.CIR.0000111245.75752.C6; Gupta Sandeep K, 2011, Perspect Clin Res, V2, P109, DOI 10.4103/2229-3485.83221; Gusi N, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-231; Harrison RA, 2005, J PUBLIC HEALTH-UK, V27, P25, DOI 10.1093/pubmed/fdh197; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI [10.1249/mss.0b013e3180616b27, 10.1161/CIRCULATIONAHA.107.185649]; Hays RD, 2000, PHARMACOECONOMICS, V18, P419, DOI 10.2165/00019053-200018050-00001; Hollis S, 1999, BRIT MED J, V319, P670, DOI 10.1136/bmj.319.7211.670; Isaacs AJ, 2007, HEALTH TECHNOL ASSES, V11, P1; Joy E, 2013, BRIT J SPORT MED, V47, P49, DOI 10.1136/bjsports-2012-091620; Kallings LV, 2008, SCAND J MED SCI SPOR, V18, P154, DOI 10.1111/j.1600-0838.2007.00678.x; Kallings Lena V, 2012, Lakartidningen, V109, P2348; Kallings LV, 2009, EUR J CARDIOV PREV R, V16, P80, DOI 10.1097/HJR.0b013e32831e953a; Kennedy-Martin T, 2015, TRIALS, V16, DOI 10.1186/s13063-015-1023-4; Kerse N, 2005, J AM GERIATR SOC, V53, P1951, DOI 10.1111/j.1532-5415.2005.00466.x; Lawton BA, 2009, BRIT J SPORT MED, V43, P120, DOI 10.1136/bmj.a2509; Lee IM, 2001, MED SCI SPORT EXER, V33, pS459, DOI 10.1097/00005768-200106001-00016; Leijon ME, 2009, SCAND J MED SCI SPOR, V19, P627, DOI 10.1111/j.1600-0838.2008.00820.x; McAuley E, 2000, Exerc Sport Sci Rev, V28, P85; Morgan O, 2005, PUBLIC HEALTH, V119, P361, DOI 10.1016/j.puhe.2004.06.008; O'Brien E, 2003, J HYPERTENS, V21, P821, DOI 10.1097/00004872-200305000-00001; Oja P., 2001, MED SCI SPORTS EXERC, V33, pS52; Olsson SJG, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2036-3; Orrow G, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e1389; Parschau L, 2014, HEALTH EDUC BEHAV, V41, P414, DOI 10.1177/1090198114529132; Pavey TG, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d6462; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; Persson Gerthi, 2010, BMC Res Notes, V3, P304, DOI 10.1186/1756-0500-3-304; Persson G, 2013, BMC FAM PRACT, V14, DOI 10.1186/1471-2296-14-128; Prochaska JO, 2008, MED DECIS MAKING, V28, P845, DOI 10.1177/0272989X08327068; PROCHASKA JO, 1992, AM PSYCHOL, V47, P1102, DOI 10.1037/0003-066X.47.9.1102; Rejeski WJ, 2003, HEALTH PSYCHOL, V22, P414, DOI 10.1037/0278-6133.22.4.414; Rodjer Lars, 2012, BMC Public Health, V12, P693, DOI 10.1186/1471-2458-12-693; Rodjer L, 2016, SCAND J PRIM HEALTH, V34, P443, DOI 10.1080/02813432.2016.1253820; Rollnick S., 1999, HLTH BEHAV CHANGE GU, V1st; Rome A, 2009, SCAND J PRIM HEALTH, V27, P216, DOI 10.3109/02813430903438734; Sallis R, 2015, PROG CARDIOVASC DIS, V57, P375, DOI 10.1016/j.pcad.2014.10.003; SALTIN B, 1968, CIRCULATION, V38, P1104, DOI 10.1161/01.CIR.38.6.1104; Samsa G, 1999, PHARMACOECONOMICS, V15, P141, DOI 10.2165/00019053-199915020-00003; Socialstyrelsen, 2011, NAT RIKTL VUX 2011 S; Sorensen JB, 2008, SCAND J MED SCI SPOR, V18, P288, DOI 10.1111/j.1600-0838.2008.00811.x; Stewart KJ, 2005, AM J PREV MED, V28, P9, DOI 10.1016/j.amepre.2004.09.006; Stott NCH, 1995, FAM PRACT, V12, P413, DOI 10.1093/fampra/12.4.413; SULLIVAN M, 1995, SOC SCI MED, V41, P1349, DOI 10.1016/0277-9536(95)00125-Q; Taylor AH, 1998, J EPIDEMIOL COMMUN H, V52, P595, DOI 10.1136/jech.52.9.595; Thune I, 1998, ARCH INTERN MED, V158, P1633, DOI 10.1001/archinte.158.15.1633; Wen CP, 2011, LANCET, V378, P1244, DOI 10.1016/S0140-6736(11)60749-6; Wing RR, 2004, OBES RES, V12, P1426; World Health Organization, 2010, Global recommendations on physical activity for health	73	20	20	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2017	12	4							e0175190	10.1371/journal.pone.0175190	http://dx.doi.org/10.1371/journal.pone.0175190			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET0LZ	28403151	gold, Green Published, Green Submitted			2022-12-27	WOS:000399955200040
J	Simcock, NK; Wakeling, LA; Ford, D; Wright, GA				Simcock, Nicola K.; Wakeling, Luisa A.; Ford, Dianne; Wright, Geraldine A.			Effects of age and nutritional state on the expression of gustatory receptors in the honeybee (Apis mellifera)	PLOS ONE			English	Article							DIVISION-OF-LABOR; IONOTROPIC GLUTAMATE RECEPTORS; DROSOPHILA-MELANOGASTER; ADULT DROSOPHILA; GENE-EXPRESSION; SUGAR RECEPTION; METABOLIC-RATE; BEE; TASTE; SENSILLA	Gustatory receptors (Grs) expressed in insect taste neurons signal the presence of carbohydrates, sugar alcohols, CO2, bitter compounds and oviposition stimulants. The honeybee (Apis mellifera) has one of the smallest Gr gene sets (12 Gr genes) of any insect whose genome has been sequenced. Honeybees live in eusocial colonies with a division of labour and perform age-dependent behavioural tasks, primarily food collection. Here, we used RT-qPCR to quantify Gr mRNA in honeybees at two ages (newly-emerged and foraging-age adults) to examine the relationship between age-related physiology and expression of Gr genes. We measured the Gr mRNAs in the taste organs and also the brain and gut. The mRNA of all Gr genes was detected in all tissues analysed but showed plasticity in relative expression across tissues and in relation to age. Overall, Gr gene expression was higher in the taste organs than in the internal tissues but did not show an overall age-dependent difference. In contrast Gr gene expression in brain was generally higher in foragers, which may indicate greater reliance on internal nutrient sensing. Expression of the candidate sugar receptors AmGr1, AmGr2 and AmGr3 in forager brain was affected by the types of sugars bees fed on. The levels of expression in the brain were greater for AmGr1 but lower for AmGr2 and AmGr3 when bees were fed with glucose and fructose compared with sucrose. Additionally, AmGr3 mRNA was increased in starved bees compared to bees provided ad libitum sucrose. Thus, expression of these Grs in forager brain reflects both the satiety state of the bee (AmGr3) and the type of sugar on which the bee has fed.	[Simcock, Nicola K.; Wright, Geraldine A.] Newcastle Univ, Inst Neurosci, Newcastle Upon Tyne, Tyne & Wear, England; [Wakeling, Luisa A.] Newcastle Univ, Sch Dent Sci, Newcastle Upon Tyne, Tyne & Wear, England; [Ford, Dianne] Newcastle Univ, Sch Med, Inst Cell & Mol Biosci, Newcastle Upon Tyne, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK; Newcastle University - UK	Simcock, NK (corresponding author), Newcastle Univ, Inst Neurosci, Newcastle Upon Tyne, Tyne & Wear, England.	Nicola.simcock2@ncl.ac.uk	Simcock, Nicola/AAM-9073-2021	Simcock, Nicola/0000-0001-9382-2828	Newcastle University Faculty of Medical Sciences [C0169N3009]; Biotechnology and Biological Sciences Research Council [BB/M00709X/1]; Leverhulme Trust research project grant [RPG-2012-708]; Biotechnology and Biological Sciences Research Council; Natural Environment Research Council; Wellcome Trust; Department for Environment, Food and Rural Affairs, and the Scottish Government under the Insect Pollinators Initiative [BB/I000968/1]; BBSRC [BB/M00709X/1] Funding Source: UKRI	Newcastle University Faculty of Medical Sciences; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Leverhulme Trust research project grant(Leverhulme Trust); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Wellcome Trust(Wellcome TrustEuropean Commission); Department for Environment, Food and Rural Affairs, and the Scottish Government under the Insect Pollinators Initiative; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported jointly by the Newcastle University Faculty of Medical Sciences MRes/PhD, http://www.ncl.ac.uk/medicalsciences/ [C0169N3009 scholarship to NKS], the Biotechnology and Biological Sciences Research Council, http://www.bbsrc.ac.uk/ [BB/M00709X/1 to GAW and DF], a Leverhulme Trust research project grant, https://www.leverhulme.ac.uk/ [Grant number RPG-2012-708 to GAW] and a grant from the Biotechnology and Biological Sciences Research Council; Natural Environment Research Council; the Wellcome Trust; Department for Environment, Food and Rural Affairs, and the Scottish Government under the Insect Pollinators Initiative [Grant number BB/I000968/1 to GAW]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler LS, 2000, OIKOS, V91, P409, DOI 10.1034/j.1600-0706.2000.910301.x; Amdam GV, 2006, BEHAV BRAIN RES, V169, P201, DOI 10.1016/j.bbr.2006.01.006; Ament SA, 2011, INSECT MOL BIOL, V20, P335, DOI 10.1111/j.1365-2583.2011.01068.x; BALDERRAMA NM, 1992, J COMP PHYSIOL B, V162, P440, DOI 10.1007/BF00258967; Baldwin MW, 2014, SCIENCE, V345, P929, DOI 10.1126/science.1255097; Benton R, 2009, CELL, V136, P149, DOI 10.1016/j.cell.2008.12.001; Bernays EA, 1998, J COMP PHYSIOL A, V183, P69, DOI 10.1007/s003590050235; Candy DJ, 1997, COMP BIOCHEM PHYS B, V117, P497, DOI 10.1016/S0305-0491(97)00212-5; CRAILSHEIM K, 1992, J INSECT PHYSIOL, V38, P409, DOI 10.1016/0022-1910(92)90117-V; Croset V, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001064; Dahanukar A, 2007, NEURON, V56, P503, DOI 10.1016/j.neuron.2007.10.024; Dyer J, 2005, BIOCHEM SOC T, V33, P302, DOI 10.1042/BST0330302; FELL RD, 1990, COMP BIOCHEM PHYS A, V95, P539, DOI 10.1016/0300-9629(90)90735-B; FLURI P, 1982, J INSECT PHYSIOL, V28, P61, DOI 10.1016/0022-1910(82)90023-3; Gronke S, 2010, RES PERSPECT END INT, P105, DOI 10.1007/978-3-642-04302-4_9; HUANG ZY, 1994, J COMP PHYSIOL A, V174, P731, DOI 10.1007/BF00192722; Ishimoto H, 2005, EMBO J, V24, P3259, DOI 10.1038/sj.emboj.7600796; Jiang XJ, 2015, INSECT BIOCHEM MOLEC, V60, P39, DOI 10.1016/j.ibmb.2015.03.002; Jiao YC, 2008, CURR BIOL, V18, P1797, DOI 10.1016/j.cub.2008.10.009; Johnson BR, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-586; Jung JW, 2015, J ASIA-PAC ENTOMOL, V18, P19, DOI 10.1016/j.aspen.2014.10.011; Kain P, 2010, CHEM SENSES, V35, P663, DOI 10.1093/chemse/bjq055; Kessler S, NATURE, V21, P74; Kim SK, 2004, NATURE, V431, P316, DOI 10.1038/nature02897; KNECHT D, 1990, APIDOLOGIE, V21, P457, DOI 10.1051/apido:19900507; Kohno K, 2010, J NEUROSCI, V30, P12219, DOI 10.1523/JNEUROSCI.2001-10.2010; LE CONTE Y, 1990, NATURWISSENSCHAFTEN, V77, P334, DOI 10.1007/BF01138390; Lee Y, 2009, P NATL ACAD SCI USA, V106, P4495, DOI 10.1073/pnas.0811744106; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Margolskee RF, 2007, P NATL ACAD SCI USA, V104, P15075, DOI 10.1073/pnas.0706678104; Masumura M, 2000, GEN COMP ENDOCR, V118, P393, DOI 10.1006/gcen.1999.7438; Miyamoto T, 2012, CELL, V151, P1113, DOI 10.1016/j.cell.2012.10.024; Moffatt L, 2001, J EXP BIOL, V204, P759; MORITZ B, 1987, J INSECT PHYSIOL, V33, P923, DOI 10.1016/0022-1910(87)90004-7; NAYAK SV, 1983, INT J INSECT MORPHOL, V12, P273, DOI 10.1016/0020-7322(83)90023-5; Ni LN, 2013, NATURE, V500, P580, DOI 10.1038/nature12390; Nicolson Susan W., 2007, P215, DOI 10.1007/978-1-4020-5937-7_5; Nishimura A, 2012, J NEUROGENET, V26, P206, DOI 10.3109/01677063.2012.694931; Page RE, 1998, J COMP PHYSIOL A, V182, P489, DOI 10.1007/s003590050196; Paoli PP, 2014, AMINO ACIDS, V46, P1449, DOI 10.1007/s00726-014-1706-2; Park JM, 2011, MATH PROBL ENG, V2011, DOI 10.1155/2011/105637; Percival M. S, 2007, NEW PHYTOL, V60, P235; Pruitt KD, 2012, NUCLEIC ACIDS RES, V40, pD130, DOI 10.1093/nar/gkr1079; Robertson HM, 2006, GENOME RES, V16, P1395, DOI 10.1101/gr.5057506; ROBINSON GE, 1989, SCIENCE, V246, P109, DOI 10.1126/science.246.4926.109; Rogers SM, 1997, J EXP BIOL, V200, P2313; ROLLS BJ, 1986, NUTR REV, V44, P93, DOI 10.1111/j.1753-4887.1986.tb07593.x; Rytz R, 2013, INSECT BIOCHEM MOLEC, V43, P888, DOI 10.1016/j.ibmb.2013.02.007; Sadd BM, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0623-3; Sato K, 2011, P NATL ACAD SCI USA, V108, P11680, DOI 10.1073/pnas.1019622108; Schulz DJ, 1998, BEHAV ECOL SOCIOBIOL, V42, P295, DOI 10.1007/s002650050442; Schulz DJ, 2001, J COMP PHYSIOL A, V187, P53, DOI 10.1007/s003590000177; Slone J, 2007, CURR BIOL, V17, P1809, DOI 10.1016/j.cub.2007.09.027; Smith CD, 2011, P NATL ACAD SCI USA, V108, P5673, DOI 10.1073/pnas.1008617108; STOCKER RF, 1994, CELL TISSUE RES, V275, P3, DOI 10.1007/BF00305372; Toth AL, 2005, ANIM BEHAV, V69, P427, DOI 10.1016/j.anbehav.2004.03.017; Ueno K, 2006, J NEUROSCI, V26, P6143, DOI 10.1523/JNEUROSCI.0857-06.2006; Vannette RL, 2015, SCI REP-UK, V5, DOI 10.1038/srep16224; Wagener-Hulme C, 1999, J COMP PHYSIOL A, V184, P471, DOI 10.1007/s003590050347; Weiss LA, 2011, NEURON, V69, P258, DOI 10.1016/j.neuron.2011.01.001; Wheeler DE, 2006, INSECT MOL BIOL, V15, P597, DOI 10.1111/j.1365-2583.2006.00681.x; WHITEHEAD A T, 1976, International Journal of Insect Morphology and Embryology, V5, P301, DOI 10.1016/0020-7322(76)90030-1; WHITEHEAD AT, 1978, PHYSIOL ENTOMOL, V3, P241, DOI 10.1111/j.1365-3032.1978.tb00153.x; Whitfield CW, 2003, SCIENCE, V302, P296, DOI 10.1126/science.1086807; Winston ML, 1987, THE BIOLOGY OF THE H; Wright GA, 2013, SCIENCE, V339, P1202, DOI 10.1126/science.1228806; Wright GA, 2004, CHEM SENSES, V29, P127, DOI 10.1093/chemse/bjh016; Wright GA, 2010, CURR BIOL, V20, P2234, DOI 10.1016/j.cub.2010.11.040; Xu W, 2012, J CHEM ECOL, V38, P1513, DOI 10.1007/s10886-012-0221-8; Yang J, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0021128, 10.1371/journal.pone.0024111]	70	14	16	4	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2017	12	4							e0175158	10.1371/journal.pone.0175158	http://dx.doi.org/10.1371/journal.pone.0175158			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LZ	28403157	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000399955200037
J	Wu, Y; Ren, XQ; Yin, D; Wang, HY; Wan, ZW; Li, XF; Hu, GF; Tang, SX				Wu, Yue; Ren, Xuqi; Yin, Dan; Wang, Haiying; Wan, Zhengwei; Li, Xiufen; Hu, Guifang; Tang, Shixing			Characterization of a novel HIV-1 unique recombinant form between CRF07_BC and CRF55_01B in men who have sex with men in Guangzhou, China	PLOS ONE			English	Article							CIRCULATING RECOMBINANT; GENOME SEQUENCE; WESTERN YUNNAN; IDENTIFICATION; SHENZHEN; CRF01-AE; STRAINS	Here, we report the genetic diversity of HIV-1 and emergence of novel HIV-1 unique recombinant forms (URF) in both HIV-infected intravenous drug users (IDU) and men who have sex with men (MSM) in Guangzhou, China. We further characterized a novel URF strain isolated from an HIV-infected MSM, GD698. Near full-length genome (NFLG) phylogenic analysis showed that this novel URF was composed of CRF07_BC and CRF55_01B, with two recombinant breakpoints (nt 6,003 and 8,251 relative to the HXB2 genome) in the vpu/env and env genes, respectively. Twenty six percent of the genome is classified as CRF55_01B, spanning part of vpu and most of the env gene. The remaining 74% of the genome is classified as CRF07_BC. Both the backbone CRF07_BC sequence and CRF55_01B fragment were clustered with the HIV-1 isolates found in MSM. The emergence of the novel HIV-1 recombinant indicates the ongoing recombinants derived from the CRF07_BC and CRF55_01B isolates, and provides critical insights into our understanding of the dynamics and complexity of the HIV-1 epidemic in China.	[Wu, Yue; Yin, Dan; Wang, Haiying; Wan, Zhengwei; Li, Xiufen; Hu, Guifang; Tang, Shixing] Southern Med Univ, Sch Publ Hlth, Dept Epidemiol, Guangdong Prov Key Lab Trop Dis Res, Guangzhou, Guangdong, Peoples R China; [Ren, Xuqi] Southern Med Univ, Dermatol Hosp, Guangzhou, Guangdong, Peoples R China; [Ren, Xuqi] Guangdong Prov Dermatol Hosp, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China; Southern Medical University - China; Southern Medical University - China	Hu, GF; Tang, SX (corresponding author), Southern Med Univ, Sch Publ Hlth, Dept Epidemiol, Guangdong Prov Key Lab Trop Dis Res, Guangzhou, Guangdong, Peoples R China.	guif_hu@sina.com; tamgshixing@smu.edu.cn	Ren, Xu-Qi/GRX-4131-2022		Bureau of Science and Information Technology of Guangzhou Municipality [201508020018, 201604020011]; Guangdong Province Public Welfare Research and Capacity Building Project - Guangdong Provincial Department of Science and Technology [20146020212007]; Guangdong Provincial Department of Science and Technology [2014B020212007]	Bureau of Science and Information Technology of Guangzhou Municipality; Guangdong Province Public Welfare Research and Capacity Building Project - Guangdong Provincial Department of Science and Technology; Guangdong Provincial Department of Science and Technology	This research is supported by Bureau of Science and Information Technology of Guangzhou Municipality (no. 201508020018, 201604020011) for GH and ST, and Guangdong Province Public Welfare Research and Capacity Building Project sponsored by Guangdong Provincial Department of Science and Technology (no. 20146020212007) for GH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Dr. Judith G. Levin of the US National Institutes of Health (NIH) for her critical comments and editing. This research is supported by Bureau of Science and Information Technology of Guangzhou Municipality (no. 201508020018, 201604020011), and Guangdong Province Public Welfare Research and Capacity Building Project sponsored by Guangdong Provincial Department of Science and Technology (no. 2014B020212007).	Abubakar YF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080487; [Anonymous], GENOME ANNOUNC; Feng Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep19279; Feng Y, 2014, AIDS RES HUM RETROV, V30, P819, DOI [10.1089/aid.2014.0071, 10.1089/AID.2014.0071]; Feng Y, 2014, AIDS RES HUM RETROV, V30, P598, DOI [10.1089/aid.2013.0233, 10.1089/AID.2013.0233]; Gui T, 2015, AIDS RES HUM RETROV, V31, P559, DOI [10.1089/aid.2014.0337, 10.1089/AID.2014.0337]; Han Xiaohua, 2013, Evid Based Complement Alternat Med, V2013, P156489, DOI 10.1155/2013/156489; He X., 2012, INT J ANTENN PROPAG, V2012, P1, DOI DOI 10.1371/J0URNAL.P0NE.0047289; Hsi J, 2014, AIDS RES HUM RETROV, V30, P389, DOI [10.1089/aid.2013.0234, 10.1089/AID.2013.0234]; Huang SC, 2014, IEEE T FUZZY SYST, V1, P1, DOI DOI 10.1371/J0URNAL.P0NE.0114441; Jia DJ, 2017, AIDS RES HUM RETROV, V33, P82, DOI [10.1089/AID.2016.0162, 10.1089/aid.2016.0162]; Jiang YL, 2016, J VIROL METHODS, V229, P70, DOI 10.1016/j.jviromet.2015.12.013; Lin PH, 2013, EMERG MICROBES INFEC, V2, DOI 10.1038/emi.2013.83; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Meng ZF, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-60; Piyasirisilp S, 2000, J VIROL, V74, P11286, DOI 10.1128/JVI.74.23.11286-11295.2000; Ragupathy V, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-185; Schultz AK, 2009, NUCLEIC ACIDS RES, V37, pW647, DOI 10.1093/nar/gkp371; Song Y., 2016, ELECT J QUALIT THEOR, V2016, P1, DOI DOI 10.1089/AID.2015.0351; Song YH, 2007, ARCH VIROL, V152, P1553, DOI 10.1007/s00705-007-0973-6; Su L, 2000, J VIROL, V74, P11367, DOI 10.1128/JVI.74.23.11367-11376.2000; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tang WM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126604; Wang H., 2016, EC PSYCHOL PSYCHIAT, V1, P55; Wei HM, 2014, AIDS RES HUM RETROV, V30, P384, DOI [10.1089/aid.2013.0228, 10.1089/AID.2013.0228]; Wei HM, 2014, AIDS RES HUM RETROV, V30, P380, DOI [10.1089/aid.2013.0235, 10.1089/AID.2013.0235]; Xing YF, 2013, SCI WORLD J, DOI [10.1155/2013/381219, 10.1155/2013/630654]; Yu XY, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016239, 10.1371/journal.pone.0028397]; Zhang L, 2015, INT J STD AIDS, V26, P291, DOI 10.1177/0956462414543841; Zhao J, 2016, SCI REP-UK, V6, DOI 10.1038/srep28703; Zhao J, 2014, JAIDS-J ACQ IMM DEF, V66, pE65, DOI 10.1097/QAI.0000000000000144	31	13	15	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2017	12	4							e0175770	10.1371/journal.pone.0175770	http://dx.doi.org/10.1371/journal.pone.0175770			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LZ	28403241	Green Submitted, gold, Green Published			2022-12-27	WOS:000399955200092
J	McPherson, S; Wilkinson, N; Tiniakos, D; Wilkinson, J; Burt, AD; McColl, E; Stocken, DD; Steen, N; Barnes, J; Goudie, N; Stewart, S; Bury, Y; Mann, D; Anstee, QM; Day, CP				McPherson, Stuart; Wilkinson, Nina; Tiniakos, Dina; Wilkinson, Jennifer; Burt, Alastair D.; McColl, Elaine; Stocken, Deborah D.; Steen, Nick; Barnes, Jane; Goudie, Nicola; Stewart, Stephen; Bury, Yvonne; Mann, Derek; Anstee, Quentin M.; Day, Christopher P.			A randomised controlled trial of losartan as an anti-fibrotic agent in non-alcoholic steatohepatitis	PLOS ONE			English	Article							FATTY LIVER-DISEASE; RENIN-ANGIOTENSIN SYSTEM; HEPATIC STELLATE CELLS; RECEPTOR BLOCKERS; ADVANCED FIBROSIS; FOLLOW-UP; PROGRESSION; BIOPSIES; NAFLD; POPULATION	Introduction Non-alcoholic fatty liver disease (NAFLD) is a common liver disease worldwide. Experimental and small clinical trials have demonstrated that angiotensin II blockers (ARB) may be anti-fibrotic in the liver. The aim of this randomised controlled trial was to assess whether treatment with Losartan for 96 weeks slowed, halted or reversed the progression of fibrosis in patients with non-alcoholic steatohepatitis (NASH). Methods Double-blind randomised-controlled trial of Losartan 50 mg once a day versus placebo for 96 weeks in patients with histological evidence of NASH. The primary outcome for the study was change in histological fibrosis stage from pre-treatment to end-of-treatment. Results The study planned to recruit 214 patients. However, recruitment was slower than expected, and after 45 patients were randomised (median age 55; 56% male; 60% diabetic; median fibrosis stage 2), enrolment was suspended. Thirty-two patients (15 losartan and 17 placebo) completed follow up period: one patient (6.7%) treated with losartan and 4 patients (23.5%) in the placebo group were '' responders '' (lower fibrosis stage at follow up compared with baseline). The major reason for slow recruitment was that 39% of potentially eligible patients were already taking an ARB or angiotensin converting enzyme inhibitor (ACEI), and 15% were taking other prohibited medications. Conclusions Due to the widespread use of ACEI and ARB in patients with NASH this trial failed to recruit sufficient patients to determine whether losartan has anti-fibrotic effects in the liver.	[McPherson, Stuart; Tiniakos, Dina; Mann, Derek; Anstee, Quentin M.; Day, Christopher P.] Newcastle Univ, Fac Med Sci, Inst Cellular Med, Newcastle Upon Tyne, Tyne & Wear, England; [McPherson, Stuart; Anstee, Quentin M.; Day, Christopher P.] Freeman Rd Hosp, Newcastle Tyne Hosp NHS Trust, Liver Unit, Newcastle Upon Tyne, Tyne & Wear, England; [Wilkinson, Nina; McColl, Elaine; Stocken, Deborah D.; Steen, Nick] Newcastle Univ, Fac Med Sci, Inst Hlth & Soc, Newcastle Upon Tyne, Tyne & Wear, England; [Tiniakos, Dina] Royal Victoria Infirm, Newcastle Tyne Hosp NHS Trust, Dept Pathol, Newcastle Upon Tyne, Tyne & Wear, England; [Tiniakos, Dina; Bury, Yvonne] Natl & Kapodistrian Univ Athens, Sch Med, Athens, Greece; [Wilkinson, Jennifer; McColl, Elaine; Barnes, Jane; Goudie, Nicola] Newcastle Univ, Fac Med, Newcastle Clin Trials Unit, Newcastle Upon Tyne, Tyne & Wear, England; [Burt, Alastair D.] Univ Adelaide, Fac Hlth & Med Sci, Adelaide, SA, Australia; [Stewart, Stephen] Mater Misericordiae Univ Hosp, Dept Gastroenterol, Dublin, Ireland	Newcastle Freeman Hospital; Newcastle University - UK; Newcastle Upon Tyne Hospitals NHS Foundation Trust; Newcastle University - UK; Newcastle University - UK; Newcastle Upon Tyne Hospitals NHS Foundation Trust; Athens Medical School; National & Kapodistrian University of Athens; Newcastle University - UK; University of Adelaide; Mater Misericordiae University Hospital; University College Dublin	McPherson, S (corresponding author), Newcastle Univ, Fac Med Sci, Inst Cellular Med, Newcastle Upon Tyne, Tyne & Wear, England.; McPherson, S (corresponding author), Freeman Rd Hosp, Newcastle Tyne Hosp NHS Trust, Liver Unit, Newcastle Upon Tyne, Tyne & Wear, England.	stuart.mcpherson@nuth.nhs.uk	Anstee, Quentin M./L-2981-2013; Day, Christopher/Z-3305-2019; Tiniakos, Dina G/AAA-5708-2020; Bury, Yvonne/AAD-7371-2020; McColl, Elaine/V-9906-2019; Burt, Alastair/D-3634-2013	Anstee, Quentin M./0000-0002-9518-0088; Bury, Yvonne/0000-0003-3285-3991; McColl, Elaine/0000-0001-8300-3204; Mann, Derek/0000-0003-0950-243X; Stocken, Deborah/0000-0001-8031-1738; McPherson, Stuart/0000-0002-5638-2453; Burt, Alastair/0000-0002-3011-7774	United Kingdom National Institute for Health Reaearch (NIHR) Efficacy and Mechanism Evaluation Programme [08/43/15]; Newcastle National Institute for Health Reaearch (NIHR) Biomedical Research Centre [BH134439/PD0117]	United Kingdom National Institute for Health Reaearch (NIHR) Efficacy and Mechanism Evaluation Programme; Newcastle National Institute for Health Reaearch (NIHR) Biomedical Research Centre	This work was supported by United Kingdom National Institute for Health Reaearch (NIHR) Efficacy and Mechanism Evaluation Programme (grant 08/43/15), www.nets.nihr.ac.uk/programmes/eme; Newcastle National Institute for Health Reaearch (NIHR) Biomedical Research Centre (grant BH134439/PD0117). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. CP DAY recieved funding.	Aithal GP, 2008, GASTROENTEROLOGY, V135, P1176, DOI 10.1053/j.gastro.2008.06.047; Al-Mallah M, 2010, CARDIOL J, V17, P448; American Diabetes Association, 2004, Diabetes Care, V27 Suppl 1, pS5, DOI 10.2337/diacare.27.2007.S5; Ampurdanes S, 1996, J HEPATOL, V25, P827, DOI 10.1016/S0168-8278(96)80285-6; Angulo P, 2015, GASTROENTEROLOGY, V149, P389, DOI 10.1053/j.gastro.2015.04.043; Anstee Quentin M, 2011, BMJ, V343, pd3897, DOI 10.1136/bmj.d3897; Bataller R, 2005, HEPATOLOGY, V41, P1046, DOI 10.1002/hep.20665; Bataller R, 2003, GASTROENTEROLOGY, V125, P117, DOI 10.1016/S0016-5085(03)00695-4; Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466; Calvaruso V, 2009, HEPATOLOGY, V49, P1236, DOI 10.1002/hep.22745; Chalasani N, 2012, HEPATOLOGY, V55, P2005, DOI 10.1002/hep.25762; Colmenero J, 2007, HEPATOLOGY, V46, p716A; de Macedo SM, 2014, PEPTIDES, V62, P189, DOI 10.1016/j.peptides.2014.10.005; Dyson JK, 2014, FRONTLINE GASTROENTE, V5, P277, DOI 10.1136/flgastro-2013-100404; Ekstedt M, 2006, HEPATOLOGY, V44, P865, DOI 10.1002/hep.21327; Ekstedt M, 2015, HEPATOLOGY, V61, P1547, DOI 10.1002/hep.27368; Georgescu EF, 2009, WORLD J GASTROENTERO, V15, P942, DOI 10.3748/wjg.15.942; Goh GB, 2015, LIVER INT, V35, P979, DOI 10.1111/liv.12611; Guha IN, 2008, HEPATOLOGY, V47, P455, DOI 10.1002/hep.21984; Hirose A, 2007, HEPATOLOGY, V45, P1375, DOI 10.1002/hep.21638; Jonsson JR, 2001, GASTROENTEROLOGY, V121, P148, DOI 10.1053/gast.2001.25480; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Lee YA, 2015, GUT, V64, P1337, DOI 10.1136/gutjnl-2014-306842corr1; Lindor KD, 2004, HEPATOLOGY, V39, P770, DOI 10.1002/hep.20092; Liu Zhenqi, 2007, Curr Diab Rep, V7, P34, DOI 10.1007/s11892-007-0007-5; McPherson S, 2015, J HEPATOL, V62, P1148, DOI 10.1016/j.jhep.2014.11.034; McPherson S, 2010, GUT, V59, P1265, DOI 10.1136/gut.2010.216077; Moreno M, 2010, HEPATOLOGY, V51, P942, DOI 10.1002/hep.23419; NICE, 2011, NICE CLIN GUID CG127; Pais R, 2013, J HEPATOL, V59, P550, DOI 10.1016/j.jhep.2013.04.027; Paizis G, 2002, GASTROENTEROLOGY, V123, P1667, DOI 10.1053/gast.2002.36561; Paschos P, 2012, WORLD J HEPATOL, V4, P327, DOI 10.4254/wjh.v4.i12.327; Singh S, 2014, CLIN GASTROENTEROL H; Thoma C, 2012, J HEPATOL, V56, P255, DOI 10.1016/j.jhep.2011.06.010; Torres DM, 2011, HEPATOLOGY, V54, P1631, DOI 10.1002/hep.24558; Vilar-Gomez E, 2015, GASTROENTEROLOGY, V149, P367, DOI 10.1053/j.gastro.2015.04.005; Watson MR, 2008, J HEPATOL, V48, P589, DOI 10.1016/j.jhep.2007.12.019; Wong RJ, 2015, GASTROENTEROLOGY, V148, P547, DOI 10.1053/j.gastro.2014.11.039; Wong VWS, 2012, GUT, V61, P409, DOI 10.1136/gutjnl-2011-300342; Wong VWS, 2010, GUT, V59, P969, DOI 10.1136/gut.2009.205088; Yeh MM, 2014, GASTROENTEROLOGY, V147, P754, DOI 10.1053/j.gastro.2014.07.056; Yokohama S, 2004, HEPATOLOGY, V40, P1222, DOI 10.1002/hep.20420; Younossi ZM, 2011, HEPATOLOGY, V53, P1874, DOI 10.1002/hep.24268	43	33	33	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2017	12	4							e0175717	10.1371/journal.pone.0175717	http://dx.doi.org/10.1371/journal.pone.0175717			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KH	28419124	Green Published, gold			2022-12-27	WOS:000399875200037
J	Ogata, T; Nagatoshi, Y; Yamagishi, N; Yoshikawa, N; Fujita, Y				Ogata, Takuya; Nagatoshi, Yukari; Yamagishi, Noriko; Yoshikawa, Nobuyuki; Fujita, Yasunari			Virus-induced down-regulation of GmERA1A and GmERA1B genes enhances the stomatal response to abscisic acid and drought resistance in soybean	PLOS ONE			English	Article							LATENT-SPHERICAL-VIRUS; PLANT FUNCTIONAL GENOMICS; ARABIDOPSIS-THALIANA; SIGNAL-TRANSDUCTION; YIELD PROTECTION; TOLERANCE; FARNESYLATION; PROTEIN; STRESS; FARNESYLTRANSFERASE	Drought is a major threat to global soybean production. The limited transformation potential and polyploid nature of soybean have hindered functional analysis of soybean genes. Previous research has implicated farnesylation in the plant's response to abscisic acid (ABA) and drought tolerance. We therefore used virus-induced gene silencing (VIGS) to evaluate farnesyltransferase genes, GmERA1A and GmERA1B (Glycine max Enhanced Response to ABA1-A and -B), as potential targets for increasing drought resistance in soybean. Apple latent spherical virus (ALSV)-mediated GmERA1-down-regulated soybean leaves displayed an enhanced stomatal response to ABA and reduced water loss and wilting under dehydration conditions, suggesting that GmERA1A and GmERA1B negatively regulate ABA signaling in soybean guard cells. The findings provide evidence that the ALSV-VIGS system, which bypasses the need to generate transgenic plants, is a useful tool for analyzing gene function using only a single down-regulated leaf. Thus, the ALSV-VIGS system could constitute part of a next-generation molecular breeding pipeline to accelerate drought resistance breeding in soybean.	[Ogata, Takuya; Nagatoshi, Yukari; Fujita, Yasunari] JIRCAS, Biol Resources & Post Harvest Div, Tsukuba, Ibaraki, Japan; [Yamagishi, Noriko; Yoshikawa, Nobuyuki] Iwate Univ, Fac Agr, Plant Pathol Lab, Morioka, Iwate, Japan; [Fujita, Yasunari] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan	Japan International Research Center for Agricultural Sciences; Iwate University; University of Tsukuba	Fujita, Y (corresponding author), JIRCAS, Biol Resources & Post Harvest Div, Tsukuba, Ibaraki, Japan.; Fujita, Y (corresponding author), Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan.	yasuf@affrc.go.jp	Fujita, Yasunari/P-9861-2018	Fujita, Yasunari/0000-0002-5036-8319; Ogata, Takuya/0000-0003-3361-6234; Nagatoshi, Yukari/0000-0002-9029-7826; Yoshikawa, Nobuyuki/0000-0002-4758-9612	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [24510312, 16K07412]; Ministry of Agriculture, Forestry and Fisheries (MAFF) of Japan	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Agriculture, Forestry and Fisheries (MAFF) of Japan(Ministry of Agriculture Forestry & Fisheries - Japan)	This work was supported in part by the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan Grants-in-Aid for Scientific Research (C) (No. 24510312 and 16K07412 to YF) and the Ministry of Agriculture, Forestry and Fisheries (MAFF) of Japan (to YF).	Allen GJ, 2002, PLANT CELL, V14, P1649, DOI 10.1105/tpc.010448; Anai T, 2011, BREEDING SCI, V61, P462, DOI 10.1270/jsbbs.61.462; Baulcombe DC, 2015, CURR OPIN PLANT BIOL, V26, P141, DOI 10.1016/j.pbi.2015.06.007; Birch RG, 1997, ANNU REV PLANT PHYS, V48, P297, DOI 10.1146/annurev.arplant.48.1.297; Bonetta D, 2000, PLANTA, V211, P182, DOI 10.1007/s004250000283; BOYER JS, 1982, SCIENCE, V218, P443, DOI 10.1126/science.218.4571.443; Burch-Smith TM, 2004, PLANT J, V39, P734, DOI 10.1111/j.1365-313X.2004.02158.x; Cutler S, 1996, SCIENCE, V273, P1239, DOI 10.1126/science.273.5279.1239; Dutilleul C, 2016, PLANT CELL ENVIRON, V39, P185, DOI 10.1111/pce.12605; FEHR WR, 1971, CROP SCI, V11, P929, DOI 10.2135/cropsci1971.0011183X001100060051x; Finkelstein Ruth, 2013, Arabidopsis Book, V11, pe0166, DOI 10.1199/tab.0166; Fujita Y, 2005, PLANT CELL, V17, P3470, DOI 10.1105/tpc.105.035659; Fujita Y, 2013, PHYSIOL PLANTARUM, V147, P15, DOI 10.1111/j.1399-3054.2012.01635.x; Fujita Y, 2011, J PLANT RES, V124, P509, DOI 10.1007/s10265-011-0412-3; Fujita Yasunari, 2014, CLIMATE CHANGE PLANT, P521; Geng GP, 2016, INT J CLIMATOL, V36, P389, DOI 10.1002/joc.4356; Barbosa EGG, 2013, PLANT MOL BIOL REP, V31, P719, DOI 10.1007/s11105-012-0541-4; Hatfield J, 2014, CLIMATE CHANGE IMPAC, V841; Huang CJ, 2012, SCI CHINA LIFE SCI, V55, P99, DOI 10.1007/s11427-012-4280-4; Igarashi A, 2009, VIROLOGY, V386, P407, DOI 10.1016/j.virol.2009.01.039; Joshi T, 2014, NUCLEIC ACIDS RES, V42, pD1245, DOI 10.1093/nar/gkt905; Kasai M, 2011, BREEDING SCI, V61, P468, DOI 10.1270/jsbbs.61.468; KOGANEZAWA H, 1985, ANN PHYTOPATHOL SOC, V51, P363; Ku YS, 2013, COMPREHENSIVE SURVEY OF INTERNATIONAL SOYBEAN RESEARCH - GENETICS, PHYSIOLOGY, AGRONOMY AND NITROGEN RELATIONSHIPS, P209, DOI 10.5772/52945; Kunert KJ, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01015; Leite JP, 2014, GENET MOL RES, V13, P6272, DOI 10.4238/2014.August.15.10; Li C, 2004, ARCH VIROL, V149, P1541, DOI 10.1007/s00705-004-0310-2; Li CJ, 2000, J GEN VIROL, V81, P541, DOI 10.1099/0022-1317-81-2-541; Li C, 2013, INT J MOL SCI, V14, P21983, DOI 10.3390/ijms141121983; Manavalan LP, 2012, J EXP BOT, V63, P163, DOI 10.1093/jxb/err258; Manmathan H, 2013, J EXP BOT, V64, P1381, DOI 10.1093/jxb/ert003; Marinho JP, 2016, PLANT MOL BIOL REP, V34, P410, DOI 10.1007/s11105-015-0928-0; Miyakawa T, 2013, TRENDS PLANT SCI, V18, P259, DOI 10.1016/j.tplants.2012.11.002; Munemasa S, 2015, CURR OPIN PLANT BIOL, V28, P154, DOI 10.1016/j.pbi.2015.10.010; Nagamatsu A, 2007, PLANT BIOTECHNOL J, V5, P778, DOI 10.1111/j.1467-7652.2007.00288.x; Nakamura K, 2011, J GEN PLANT PATHOL, V77, P48, DOI 10.1007/s10327-010-0275-9; Northey JGB, 2016, NAT PLANTS, V2, DOI [10.1038/NPLANTS.2016.114, 10.1038/nplants.2016.114]; Pei ZM, 1998, SCIENCE, V282, P287, DOI 10.1126/science.282.5387.287; Ramegowda V, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00323; Running MP, 2004, P NATL ACAD SCI USA, V101, P7815, DOI 10.1073/pnas.0402385101; Senthil-Kumar M, 2011, TRENDS PLANT SCI, V16, P656, DOI 10.1016/j.tplants.2011.08.006; Shoemaker RC, 1996, GENETICS, V144, P329; Sinclair TR, 2007, FIELD CROP RES, V101, P68, DOI 10.1016/j.fcr.2006.09.010; Tsuda M, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2079-y; Umezawa T, 2006, CURR OPIN BIOTECH, V17, P113, DOI 10.1016/j.copbio.2006.02.002; Uno Y, 2000, P NATL ACAD SCI USA, V97, P11632, DOI 10.1073/pnas.190309197; Wang Y, 2005, PLANT J, V43, P413, DOI 10.1111/j.1365-313X.2005.02463.x; Wang Y, 2009, MOL PLANT, V2, P191, DOI 10.1093/mp/ssn088; Yalovsky S, 2000, PLANT CELL, V12, P1267, DOI 10.1105/tpc.12.8.1267; Yamada T, 2011, BREEDING SCI, V61, P480, DOI 10.1270/jsbbs.61.480; Yamagishi Noriko, 2013, Methods Mol Biol, V975, P167, DOI 10.1007/978-1-62703-278-0_13; Yamagishi N, 2011, SOYBEAN - MOLECULAR ASPECTS OF BREEDING, P43; Yamagishi N, 2009, PLANT MOL BIOL, V71, P15, DOI 10.1007/s11103-009-9505-y; Yasui Y., 2016, DNA RES; Yoshida T, 2015, PLANT CELL PHYSIOL, V56, P1043, DOI 10.1093/pcp/pcv060; Zhang CQ, 2006, VIROLOGY, V344, P401, DOI 10.1016/j.virol.2005.08.046; Ziegelhoffer EC, 2000, P NATL ACAD SCI USA, V97, P7633, DOI 10.1073/pnas.130189397; Zipper SC, 2016, ENVIRON RES LETT, V11, DOI 10.1088/1748-9326/11/9/094021	58	20	20	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2017	12	4							e0175650	10.1371/journal.pone.0175650	http://dx.doi.org/10.1371/journal.pone.0175650			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KH	28419130	gold, Green Published, Green Submitted			2022-12-27	WOS:000399875200032
J	Slusarczyk, M; Starzynski, J; Bernatowicz, P				Slusarczyk, Mirostaw; Starzynski, Jacek; Bernatowicz, Piotr			How long to rest in unpredictably changing habitats?	PLOS ONE			English	Article							DELAYED GERMINATION; DESERT ANNUALS; TRADE-OFF; DIAPAUSE; STRATEGIES; DISPERSAL; DAPHNIA; REPRODUCTION; PLASTICITY; DURATION	In the present study, we investigated the optimum length of prolonged dormancy (developmental arrest extending over favourable periods) of organisms under uncertain environmental conditions. We used an artificial life model to simulate the evolution of suspended development in the ontogenesis of organisms inhabiting unpredictably changing habitats. A virtual population of semelparous parthenogenetic individuals that varied in a duration of developmental arrest competed for limited resources. At a constant level of available resources, uninterrupted development was the superior life strategy. Once population fluctuations appeared (generated by the stochastic variability of available resources), temporal developmental arrest became more advantageous than continuous development. We did not observe the selection of the optimum length of dormancy, but rather the evolution of a diversified period of developmental arrest. The fittest organisms employed bet-hedging strategy and produced diversified dormant forms postponing development for a different number of generations (from 0 to several generations, in decreasing or equal proportions). The maximum length of suspended development increased asymptotically with increasing environmental variability and was inversely related to the mortality of dormant forms. The prolonged dormancy may appear beneficial not only in erratic habitats but also in seasonal ones that are exposed to long-term variability of environmental conditions during the growing seasons. In light of our simulations the phenomenon of very long diapause (VLD), lasting tens to thousands of generations, which is occasionally observed in ontogenesis of some living creatures, may not be explained by the benefits of bet-hedging revival strategies. We propose an alternative reasoning for the expression of VLD.	[Slusarczyk, Mirostaw] Univ Warsaw, Fac Biol, Dept Hydrobiol Biol, Warsaw, Poland; [Slusarczyk, Mirostaw; Bernatowicz, Piotr] Univ Warsaw, Fac Biol, Chem Res Ctr, Warsaw, Poland; [Starzynski, Jacek] Warsaw Univ Technol, Inst Theory Elect Engn Measurement & Informat Sys, Warsaw, Poland; [Bernatowicz, Piotr] Univ Warsaw, Fac Biol, Dept Paleobiol & Evolut Biol, Warsaw, Poland; [Bernatowicz, Piotr] Univ Warsaw, Fac Biol, Dept Anim Physiol, Warsaw, Poland	University of Warsaw; University of Warsaw; Warsaw University of Technology; University of Warsaw; University of Warsaw	Slusarczyk, M (corresponding author), Univ Warsaw, Fac Biol, Dept Hydrobiol Biol, Warsaw, Poland.; Slusarczyk, M (corresponding author), Univ Warsaw, Fac Biol, Chem Res Ctr, Warsaw, Poland.	m.slusarczyk@uw.edu.pl	Starzyński, Jacek/J-3918-2018; Slusarczyk, Miroslaw/Q-3958-2018	Starzyński, Jacek/0000-0002-1093-9500; Slusarczyk, Miroslaw/0000-0002-2311-5033; Bernatowicz, Piotr/0000-0002-4404-4924	Polish Committee for Scientific Research grant [2012/05/B/NZ8/01232]	Polish Committee for Scientific Research grant	The study was financed by Polish Committee for Scientific Research grant money: 2012/05/B/NZ8/01232 to MS, https://www.ncn.gov.pl. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamatzky A, 2005, ARTIFICIAL LIFE MODE; Baskin CC, 2014, SEEDS: ECOLOGY, BIOGEOGRAPHY, AND EVOLUTION OF DORMANCY AND GERMINATION, 2ND EDITION, P1, DOI 10.1016/B978-0-12-416677-6.00001-9; BAXENDALE FP, 1983, ENVIRON ENTOMOL, V12, P1078, DOI 10.1093/ee/12.4.1078; Bjornstad ON, 2001, SCIENCE, V293, P638, DOI 10.1126/science.1062226; Brendonck L, 1998, ERGEB LIMNOL, V52, P141; BROWN JS, 1986, AM NAT, V127, P31, DOI 10.1086/284465; BULMER MG, 1984, THEOR POPUL BIOL, V26, P367, DOI 10.1016/0040-5809(84)90040-6; CANO RJ, 1995, SCIENCE, V268, P1265; Childs DZ, 2010, P ROY SOC B-BIOL SCI, V277, P3055, DOI 10.1098/rspb.2010.0707; COHEN D, 1966, J THEOR BIOL, V12, P119, DOI 10.1016/0022-5193(66)90188-3; COHEN D, 1967, AM NAT, V101, P5, DOI 10.1086/282464; COHEN D, 1970, AM NAT, V104, P389, DOI 10.1086/282672; Danks H. V., 1987, BIOL SURVEY CANADA M, V1, P1; De Stasio Bart T., 2004, Journal of Limnology, V63, P26; dos Santos MMM, 1998, ERGEB LIMNOL, V52, P253; ELLNER S, 1985, THEOR POPUL BIOL, V28, P50, DOI 10.1016/0040-5809(85)90022-X; Frisch D, 2014, ECOL LETT, V17, P360, DOI 10.1111/ele.12237; Furness AI, 2015, EVOLUTION, V69, P1461, DOI 10.1111/evo.12669; Gourbiere S, 2009, EVOLUTION, V63, P1879, DOI 10.1111/j.1558-5646.2009.00731.x; Gremer JR, 2014, ECOL LETT, V17, P380, DOI 10.1111/ele.12241; Hahn DA, 2007, J INSECT PHYSIOL, V53, P760, DOI 10.1016/j.jinsphys.2007.03.018; Hairston N.G. Jr, 1987, P281; HAIRSTON NG, 1984, AM NAT, V123, P733, DOI 10.1086/284236; Hairston NG, 1996, HYDROBIOLOGIA, V320, P27, DOI 10.1007/BF00016802; Halvorsen G, 2004, HYDROBIOLOGIA, V521, P149, DOI 10.1023/B:HYDR.0000026357.80231.d2; HANSKI I, 1988, ANN ZOOL FENN, V25, P37; Hopper KR, 1999, ANNU REV ENTOMOL, V44, P535, DOI 10.1146/annurev.ento.44.1.535; Kroon A, 1998, ECOL ENTOMOL, V23, P298, DOI 10.1046/j.1365-2311.1998.00142.x; Lathrop F.H., 1932, BIOL CONTROL BLUEBER; LEVIN SA, 1984, THEOR POPUL BIOL, V26, P165, DOI 10.1016/0040-5809(84)90028-5; Martinez-Ruiz C, 2015, HYDROBIOLOGIA, V745, P111, DOI 10.1007/s10750-014-2098-8; McPeek MA, 1998, ERGEB LIMNOL, V52, P33; MELLORS WK, 1975, ECOLOGY, V56, P974, DOI 10.2307/1936308; MENU F, 1993, OECOLOGIA, V93, P367, DOI 10.1007/BF00317880; Menu F, 2000, AM NAT, V155, P724, DOI 10.1086/303355; Miller JS, 2002, AM J BOT, V89, P1907, DOI 10.3732/ajb.89.2.236; MOSSIN J, 1986, J CRUSTACEAN BIOL, V6, P693, DOI 10.2307/1548383; Pake CE, 1996, ECOLOGY, V77, P1427, DOI 10.2307/2265540; PHILIPPI T, 1989, TRENDS ECOL EVOL, V4, P41, DOI 10.1016/0169-5347(89)90138-9; PHILIPPI T, 1993, AM NAT, V142, P474, DOI 10.1086/285550; Piersma T, 2003, TRENDS ECOL EVOL, V18, P228, DOI 10.1016/S0169-5347(03)00036-3; Pietrzak B, 2006, POL J ECOL, V54, P709; REES M, 1994, AM NAT, V144, P43, DOI 10.1086/285660; Sallon S, 2008, SCIENCE, V320, P1464, DOI 10.1126/science.1153600; Seger J., 1987, Oxford Surveys in Evolutionary Biology, V4, P182; Simovich MA, 1997, J CRUSTACEAN BIOL, V17, P38, DOI 10.2307/1549460; Slusarczyk M, 2009, FRESHWATER BIOL, V54, P2252, DOI 10.1111/j.1365-2427.2009.02256.x; Starzynski J., 2016, GITHUB DIGITAL REPOS; Stenseth NC, 1999, OIKOS, V87, P427, DOI 10.2307/3546809; TAYLOR F, 1980, THEOR POPUL BIOL, V18, P125, DOI 10.1016/0040-5809(80)90044-1; Vanhaecke P., 1982, Aquacultural Engineering, V1, P263, DOI 10.1016/0144-8609(82)90035-8; Venable DL, 2007, ECOLOGY, V88, P1086, DOI 10.1890/06-1495; VENABLE DL, 1980, OECOLOGIA, V46, P272, DOI 10.1007/BF00540137; Vreeland RH, 2000, NATURE, V407, P897, DOI 10.1038/35038060; Willensdorfer M, 2007, PLOS COMPUT BIOL, V3, P2058, DOI 10.1371/journal.pcbi.0030203	55	5	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2017	12	4							e0175927	10.1371/journal.pone.0175927	http://dx.doi.org/10.1371/journal.pone.0175927			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KH	28419148	Green Published, Green Submitted, gold			2022-12-27	WOS:000399875200054
J	Wei, YZ; Dong, C; Zhang, HN; Zheng, XW; Shu, B; Shi, SY; Li, WC				Wei, Yongzan; Dong, Chen; Zhang, Hongna; Zheng, Xuewen; Shu, Bo; Shi, Shengyou; Li, Weicai			Transcriptional changes in litchi (Litchi chinensis Sonn.) inflorescences treated with uniconazole	PLOS ONE			English	Article							FLOWERING-LOCUS-T; SBP-BOX GENE; ARABIDOPSIS-THALIANA; PLANT-GROWTH; GIBBERELLIN; MERISTEM; BIOSYNTHESIS; EXPRESSION; INHIBITOR; PHOTOSYNTHESIS	In Arabidopsis, treating shoots with uniconazole can result in enhanced primary root elongation and bolting delay. Uniconazole spraying has become an important cultivation technique in controlling the flowering and improving the fruit-setting of litchi. However, the mechanism by which uniconazole regulates the complicated developmental processes in litchi remains unclear. This study aimed to determine which signal pathways and genes drive the responses of litchi inflorescences to uniconazole treatment. We monitored the transcriptional activity in inflorescences after uniconazole treatment by Illumina sequencing technology. The global expression profiles of uniconazole-treated litchi inflorescences were compared with those of the control, and 4051 differentially expressed genes were isolated. KEGG pathway enrichment analysis indicated that the plant hormone signal transduction pathway served key functions in the flower developmental stage under uniconazole treatment. Basing on the transcriptional analysis of genes involved in flower development, we hypothesized that uniconazole treatment increases the ratio of female flowers by activating the transcription of pistil-related genes. This phenomenon increases opportunities for pollination and fertilization, thereby enhancing the fruit-bearing rate. In addition, uniconazole treatment regulates the expression of unigenes involved in numerous transcription factor families, especially the bHLH and WRKY families. These findings suggest that the uniconazole-induced morphological changes in litchi inflorescences are related to the control of hormone signaling, the regulation of flowering genes, and the expression levels of various transcription factors. This study provides comprehensive inflorescence transcriptome data to elucidate the molecular mechanisms underlying the response of litchi flowers to uniconazole treatment and enumerates possible candidate genes that can be used to guide future research in controlling litchi flowering.	[Wei, Yongzan; Dong, Chen; Zhang, Hongna; Zheng, Xuewen; Shu, Bo; Shi, Shengyou; Li, Weicai] Chinese Acad Trop Agr Sci, South Subtrop Crops Res Inst, Minist Agr, Key Lab Trop Fruit Biol, Zhanjiang, Peoples R China	Chinese Academy of Tropical Agricultural Sciences; Ministry of Agriculture & Rural Affairs	Li, WC (corresponding author), Chinese Acad Trop Agr Sci, South Subtrop Crops Res Inst, Minist Agr, Key Lab Trop Fruit Biol, Zhanjiang, Peoples R China.	lwc_619@163.com		wei, yongzan/0000-0003-3516-5115	Central Public Research Institutes for Basic Research Funds [1630062016006, 1630062016009]; China Litchi and Longan Industry Technology Research System [CARS-33]; Natural Science Foundation of Hainan Province [20163107]; National Natural Science Fund of China [31201581]	Central Public Research Institutes for Basic Research Funds; China Litchi and Longan Industry Technology Research System; Natural Science Foundation of Hainan Province; National Natural Science Fund of China(National Natural Science Foundation of China (NSFC))	The project was supported by the Central Public Research Institutes for Basic Research Funds (No. 1630062016006, 1630062016009), the China Litchi and Longan Industry Technology Research System (Project No. CARS-33), the Natural Science Foundation of Hainan Province (Project No. 20163107), and the National Natural Science Fund of China (Project No. 31201581).; The project was supported by the Central Public Research Institutes for Basic Research Funds (Project No. 1630062016006), the China Litchi and Longan Industry Technology Research System (Project No. CARS-33), the Natural Science Foundation of Hainan Province (Project No. 20163107), and the National Natural Science Fund of China (Project No. 31201581).	Bidadi H, 2010, PLANT ROOT, V4, P4, DOI 10.3117/plantroot.4.4; BOWMAN JL, 1989, PLANT CELL, V1, P37, DOI 10.1105/tpc.1.1.37; Cai YH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102529; [曹尚银 Cao Shangyin], 2003, [植物生理与分子生物学学报, Journal of Plant Physiology and Molecular Biology], V29, P375; Cardon GH, 1997, PLANT J, V12, P367, DOI 10.1046/j.1365-313X.1997.12020367.x; Cheng H, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000440; Conner J, 2000, P NATL ACAD SCI USA, V97, P12902, DOI 10.1073/pnas.230352397; Eulgem T, 2000, TRENDS PLANT SCI, V5, P199, DOI 10.1016/S1360-1385(00)01600-9; Fletcher LC, 1999, SCIENCE, V283, P1911, DOI 10.1126/science.283.5409.1911; Gocal GFW, 2001, PLANT PHYSIOL, V127, P1682, DOI 10.1104/pp.010442; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Guan YF, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004384; Heisler MGB, 2001, DEVELOPMENT, V128, P1089; Hendelman A, 2013, J EXP BOT, V64, P5497, DOI 10.1093/jxb/ert324; Hu X., 2016, THESIS; HUALA E, 1992, PLANT CELL, V4, P901, DOI 10.1105/tpc.4.8.901; Huang X. M., 2007, LITCHI, P1; Husselman J. H., 2010, CULTIVATION LITCHI, P31; IRISH VF, 1990, PLANT CELL, V2, P741, DOI 10.1105/tpc.2.8.741; IZUMI K, 1988, PLANT CELL PHYSIOL, V29, P97; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kim SG, 2007, PLANTA, V226, P647, DOI 10.1007/s00425-007-0513-3; Klein J, 1996, MOL GEN GENET, V250, P7, DOI 10.1007/BF02191820; KUNST L, 1989, PLANT CELL, V1, P1195, DOI 10.1105/tpc.1.12.1195; Li WC, 2014, CHINESE J TROPICAL C, V35, P4525; Li WC, 2014, INT J MOL SCI, V15, P17667, DOI 10.3390/ijms151017667; Liu YX, 2016, 2016 12TH INTERNATIONAL CONFERENCE ON NATURAL COMPUTATION, FUZZY SYSTEMS AND KNOWLEDGE DISCOVERY (ICNC-FSKD), P29, DOI 10.1109/FSKD.2016.7603146; Liu ZC, 2000, PLANT CELL, V12, P1879, DOI 10.1105/tpc.12.10.1879; Luo X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073295; Miao Y, 2004, PLANT MOL BIOL, V55, P853, DOI 10.1007/s11103-005-2142-1; Millar AA, 2005, PLANT CELL, V17, P705, DOI 10.1105/tpc.104.027920; Mitsuda N, 2005, PLANT CELL, V17, P2993, DOI 10.1105/tpc.105.036004; Peng JR, 2009, J INTEGR PLANT BIOL, V51, P1064, DOI 10.1111/j.1744-7909.2009.00881.x; Peng ZY, 2009, NUCLEIC ACIDS RES, V37, pD975, DOI 10.1093/nar/gkn873; Rajani S, 2001, CURR BIOL, V11, P1914, DOI 10.1016/S0960-9822(01)00593-0; RAMACHANDRAN S, 1994, CURR OPIN GENET DEV, V4, P642, DOI 10.1016/0959-437X(94)90129-Q; Robatzek S, 2001, PLANT J, V28, P123, DOI 10.1046/j.1365-313X.2001.01131.x; Saito S, 2006, BIOSCI BIOTECH BIOCH, V70, P1731, DOI 10.1271/bbb.60077; Sakamoto T, 2001, PLANT PHYSIOL, V125, P1508, DOI 10.1104/pp.125.3.1508; Sasaki E, 2013, PHYTOCHEMISTRY, V87, P30, DOI 10.1016/j.phytochem.2012.11.023; SENARATNA T, 1988, J PLANT PHYSIOL, V133, P56, DOI 10.1016/S0176-1617(88)80084-1; SHANNON S, 1991, PLANT CELL, V3, P877, DOI 10.1105/tpc.3.9.877; Song Y, 2010, J BIOSCIENCES, V35, P459, DOI 10.1007/s12038-010-0051-1; Sorensen AM, 2003, PLANT J, V33, P413, DOI 10.1046/j.1365-313X.2003.01644.x; Souer E, 1996, CELL, V85, P159, DOI 10.1016/S0092-8674(00)81093-4; Unte US, 2003, PLANT CELL, V15, P1009, DOI 10.1105/tpc.010678; Vroemen CW, 2003, PLANT CELL, V15, P1563, DOI 10.1105/tpc.012203; Wang LX., 2012, CHIN HORTIC ABS, V28, P5; Wei YZ, 2013, SCI HORTIC-AMSTERDAM, V161, P273, DOI 10.1016/j.scienta.2013.07.017; Wei YZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019455; Wu G, 2006, DEVELOPMENT, V133, P3539, DOI 10.1242/dev.02521; [肖华山 Xiao Huashan], 2002, [福建农林大学学报. 自然科学版, Journal of Fujian Agriculture and Forestry University], V31, P334; Yan YH, 2015, PLANT PROD SCI, V18, P295, DOI 10.1626/pps.18.295; Yang WY, 2002, CHINESE AGR SCI B, V18, P38; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Yoo SY, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000642; Yu YC, 2016, PLANT J, V85, P96, DOI 10.1111/tpj.13092; [曾红 Zeng Hong], 2016, [核农学报, Journal of Nuclear Agricultural Sciences], V30, P1420; Zhang HN, 2014, PLANT CELL REP, V33, P1723, DOI 10.1007/s00299-014-1650-3; Zhang MC, 2007, J PLANT PHYSIOL, V164, P709, DOI 10.1016/j.jplph.2006.04.008; Zhang W, 2006, DEVELOPMENT, V133, P3085, DOI 10.1242/dev.02463; Zhang XM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042082; Zhang Y, 2007, PLANT MOL BIOL, V63, P429, DOI 10.1007/s11103-006-9099-6	63	6	12	4	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2017	12	4							e0176053	10.1371/journal.pone.0176053	http://dx.doi.org/10.1371/journal.pone.0176053			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KH	28419137	Green Published, gold, Green Submitted			2022-12-27	WOS:000399875200065
J	Gustafsson, JT; Lindberg, MH; Gunnarsson, I; Pettersson, S; Elvin, K; Ohrvik, J; Larsson, A; Jensen-Urstad, K; Svenungsson, E				Gustafsson, Johanna T.; Lindberg, Marie Herlitz; Gunnarsson, Iva; Pettersson, Susanne; Elvin, Kerstin; Ohrvik, John; Larsson, Anders; Jensen-Urstad, Kerstin; Svenungsson, Elisabet			Excess atherosclerosis in systemic lupus erythematosus,-A matter of renal involvement: Case control study of 281 SLE patients and 281 individually matched population controls	PLOS ONE			English	Article							INTIMA-MEDIA THICKNESS; CARDIOVASCULAR RISK-FACTORS; ACCELERATED ATHEROSCLEROSIS; ANTIPHOSPHOLIPID SYNDROME; RHEUMATOID-ARTHRITIS; PROSPECTIVE COHORT; WOMEN; DISEASE; PREDICTORS; NEPHRITIS	Background Systemic lupus erythematosus (SLE), is a heterogeneous disease which predominantly affects young females (90%). SLE is associated with a shorter life expectancy than in the general population. Standardized mortality ratios (SMR) of 2.4 have been reported, which is comparable to diabetes. In modern societies cardiovascular disease (CVD) is the major cause of premature mortality. Accelerated atherosclerosis is generally assumed to be the underlying cause for SLE related CVD. However, previous studies diverge regarding whether atherosclerosis is more common in SLE than in controls. With this in mind and based on own clinical experience we hypothesized that accelerated atherosclerosis is not a general feature of SLE, but prevails in SLE subgroups. Methods 281 SLE patients and 281 individually age and sex matched population controls, were investigated clinically. Fasting blood samples and risk factor data were collected. All participants were subject to B-mode ultrasonography of the carotid arteries. Carotid plaque occurrence and mean intima media thickness (mIMT) were recorded. Two SLE subgroups previously described to be at high CVD risk; 1) patients with nephritis and 2) patients with anti-phospholipid antibodies (aPL), and one subgroup reported to be at comparatively lower CVD risk; patients positive for Sjogrens syndrome antigens A/B (SSA/SSB) antibodies were analyzed separately in comparison with their respective matched controls. Results Median age was 49 (IQR 36-59) years, 93% were females. Manifest CVD; ischemic heart, cerebro-and peripheral vascular disease, prevailed in patients (12% vs. 1%, p<0.0001). Overall plaque prevalence did not differ (20% vs. 16%), but patients had slightly higher mIMT than controls (0.56 vs. 0.53 mm, p<0.0033). After age adjustment plaques, but not mIMT, remained associated with previous CVD events. Therefore we focused further analyses on plaques, a more robust measure of atherosclerosis. Patients with nephritis (40%), but neither aPL (25%) nor SSA/SSB (40%) positive patients, had more plaques than their respective controls (23% vs. 11%, p = 0.008). Notably, patients with nephritis were younger than other SLE patients (45 vs. 49 years, p = 0.02). To overcome the confounding effect of age we performed an age-matched nested case-control analysis, which demonstrated that patients with nephritis had twice as often plaques (23%) as both non-nephritis patients (11%, p = 0.038) and controls (12%, p = 0.035). Conclusions In SLE excess carotid plaques are essentially confined to the SLE subgroup with nephritis. This subgroup had plaques twice as often as age-matched non-nephritis SLE patients and population controls. Non-nephritis SLE patients, including the aPL positive subgroup, which has a high CVD risk, had similar prevalence of plaques as controls. To prevent later CVD events, this novel observation calls for risk factor screening and initiation of anti-atherosclerotic treatment selectively in SLE nephritis patients. Preferably at nephritis onset, which is often at a young age. In a general perspective this study demonstrates the importance to perform careful clinical subgroup analyses when investigating heterogeneous, hitherto not clearly defined, conditions like SLE.	[Gustafsson, Johanna T.; Gunnarsson, Iva; Pettersson, Susanne; Svenungsson, Elisabet] Karolinska Univ Hosp, Karolinska Inst, Unit Rheumatol, Dept Med, Stockholm, Sweden; [Lindberg, Marie Herlitz; Jensen-Urstad, Kerstin] Karolinska Inst, Sodersjukhuset, Dept Clin Physiol, Stockholm, Sweden; [Elvin, Kerstin] Karolinska Univ Hosp, Karolinska Inst, Unit Clin Immunol, Dept Clin Immunol & Transfus Med, Stockholm, Sweden; [Ohrvik, John] Karolinska Inst, Dept Med, Stockholm, Sweden; [Larsson, Anders] Uppsala Univ, Clin Chem, Dept Med Sci, Uppsala, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Sodersjukhuset Hospital; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Uppsala University	Svenungsson, E (corresponding author), Karolinska Univ Hosp, Karolinska Inst, Unit Rheumatol, Dept Med, Stockholm, Sweden.	elisabet.svenungsson@ki.se	Pettersson, Susanne/AGH-2470-2022	Pettersson, Susanne/0000-0001-7432-2756; Svenungsson, Elisabet/0000-0003-3396-3244	Swedish Heart-Lung foundation [20140436]; Swedish research council [2014-33867-111552-61]; Stockholm County Council (ALF) [20140166]; King Gustaf Vs 80th Birthday Fund [FAI-2015-0187]; Swedish Rheumatism Association [R-389789]; Swedish Society of Medicine [SLS-246491]; Ake Wiberg Foundation [8391202587]; Karolinska Instituters Foundations [FoBi0687]; Foundation in memory of Clas Groschinsky [M10 72]	Swedish Heart-Lung foundation(Swedish Heart-Lung Foundation); Swedish research council(Swedish Research CouncilEuropean Commission); Stockholm County Council (ALF)(Stockholm County Council); King Gustaf Vs 80th Birthday Fund; Swedish Rheumatism Association; Swedish Society of Medicine; Ake Wiberg Foundation; Karolinska Instituters Foundations(Karolinska Institutet); Foundation in memory of Clas Groschinsky	This work was supported by the Swedish Heart-Lung foundation (20140436), Swedish research council (2014-33867-111552-61), Stockholm County Council (ALF, 20140166), King Gustaf Vs 80th Birthday Fund (FAI-2015-0187), Swedish Rheumatism Association (R-389789), Swedish Society of Medicine (SLS-246491), The Ake Wiberg Foundation 8391202587), Karolinska Instituters Foundations (FoBi0687), and The Foundation in memory of Clas Groschinsky (M10 72). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad Y, 2007, RHEUMATOLOGY, V46, P983, DOI 10.1093/rheumatology/kem002; Artim-Esen B, 2014, J RHEUMATOL, V41, P1304, DOI 10.3899/jrheum.130984; Asanuma Y, 2003, NEW ENGL J MED, V349, P2407, DOI 10.1056/NEJMoa035611; Bernatsky S, 2006, ARTHRITIS RHEUM-US, V54, P2550, DOI 10.1002/art.21955; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; de Leeuw K, 2006, LUPUS, V15, P675, DOI 10.1177/0961203306069972; Esdaile JM, 2001, ARTHRITIS RHEUM, V44, P2331, DOI 10.1002/1529-0131(200110)44:10<2331::AID-ART395>3.0.CO;2-I; Faurschou M, 2011, J RHEUMATOL, V38, P2400, DOI 10.3899/jrheum.110329; Flodin M, 2007, SCAND J CLIN LAB INV, V67, P560, DOI 10.1080/00365510601187773; Gallelli B, 2010, CLIN EXP RHEUMATOL, V28, P386; Gladman D, 1996, ARTHRITIS RHEUM, V39, P363, DOI 10.1002/art.1780390303; Gustafsson J, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2878; Gustafsson JT, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3759; Hak AE, 2009, ARTHRIT CARE RES, V61, P1396, DOI 10.1002/art.24537; Kao AH, 2008, AM J CARDIOL, V102, P755, DOI 10.1016/j.amjcard.2008.04.059; Kao AH, 2013, AM J CARDIOL, V112, P1025, DOI 10.1016/j.amjcard.2013.05.040; Kiani AN, 2008, J RHEUMATOL, V35, P1300; Kiani AN, 2015, RHEUMATOLOGY, V54, P1976, DOI 10.1093/rheumatology/kev198; Kiani AN, 2011, RHEUMATOLOGY, V50, P2071, DOI 10.1093/rheumatology/ker285; LIANG MH, 1988, ARTHRITIS RHEUM, V31, P817, DOI 10.1002/art.1780310701; Lopez LR, 2006, LUPUS, V15, P80, DOI 10.1191/0961203306lu2267oa; Lorenz MW, 2007, CIRCULATION, V115, P459, DOI 10.1161/CIRCULATIONAHA.106.628875; Magder LS, 2012, AM J EPIDEMIOL, V176, P708, DOI 10.1093/aje/kws130; Maksimowicz-McKinnon K, 2006, J RHEUMATOL, V33, P2458; Manger K, 2003, ANN RHEUM DIS, V62, P846, DOI 10.1136/ard.62.9.846; Manzi S, 1997, AM J EPIDEMIOL, V145, P408; Manzi S, 1999, ARTHRITIS RHEUM-US, V42, P51, DOI 10.1002/1529-0131(199901)42:1<51::AID-ANR7>3.0.CO;2-D; McMahon M, 2011, ANN RHEUM DIS, V70, P1619, DOI 10.1136/ard.2010.142737; Miyakis S, 2006, J THROMB HAEMOST, V4, P295, DOI 10.1111/j.1538-7836.2006.01753.x; Naqvi TZ, 2014, JACC-CARDIOVASC IMAG, V7, P1025, DOI 10.1016/j.jcmg.2013.11.014; Nickolas TL, 2003, SEMIN NEPHROL, V23, P406, DOI 10.1016/S0270-9295(03)00058-5; Olson SW, 2013, CLIN J AM SOC NEPHRO, V8, P1702, DOI 10.2215/CJN.01910213; Ortega LM, 2010, LUPUS, V19, P557, DOI 10.1177/0961203309358187; Pengo V, 2006, PATHOPHYSIOL HAEMO T, V35, P175, DOI 10.1159/000093564; Reynolds HR, 2010, ATHEROSCLEROSIS, V210, P569, DOI 10.1016/j.atherosclerosis.2009.12.007; Rho YH, 2008, J RHEUMATOL, V35, P1789; Roman MJ, 2003, NEW ENGL J MED, V349, P2399, DOI 10.1056/NEJMoa035471; Romero-Diaz J, 2012, RHEUMATOLOGY, V51, P110, DOI 10.1093/rheumatology/ker307; Sarnak MJ, 2003, CIRCULATION, V108, P2154, DOI 10.1161/01.CIR.0000095676.90936.80; Svenungsson E, 2001, CIRCULATION, V104, P1887, DOI 10.1161/hc4101.097518; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; Thompson T, 2008, ARTHRITIS RHEUM-US, V58, P835, DOI 10.1002/art.23196; To CH, 2005, ARTHRITIS RHEUM-US, V52, P4003, DOI 10.1002/art.21414; Toloza SMA, 2004, ARTHRITIS RHEUM-US, V50, P3947, DOI 10.1002/art.20622; van Zanten JJCSV, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2345; Weening JJ, 2004, J AM SOC NEPHROL, V15, P241, DOI 10.1097/01.ASN.0000108969.21691.5D; WIKSTRAND J, 1994, J INTERN MED, V236, P555, DOI 10.1111/j.1365-2796.1994.tb00845.x	47	61	65	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2017	12	4							e0174572	10.1371/journal.pone.0174572	http://dx.doi.org/10.1371/journal.pone.0174572			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KD	28414714	Green Published, Green Submitted, gold			2022-12-27	WOS:000399874800004
J	Ossorio, M; Bajo, MA; del Peso, G; Martinez, V; Fernandez, M; Castro, MJ; Rodriguez-Sanz, A; Madero, R; Bellon, T; Selgas, R				Ossorio, Marta; Auxiliadora Bajo, Maria; del Peso, Gloria; Martinez, Virginia; Fernandez, Maria; Jose Castro, Maria; Rodriguez-Sanz, Aranzazu; Madero, Rosario; Bellon, Teresa; Selgas, Rafael			Sustained low peritoneal effluent CCL18 levels are associated with preservation of peritoneal membrane function in peritoneal dialysis	PLOS ONE			English	Article							MESENCHYMAL TRANSITION; PULMONARY-FIBROSIS; LONG-TERM; SCLEROSIS; MACROPHAGES; FIBROBLASTS; INTERVENTIONS; TRANSPORT	Peritoneal membrane failure (PMF) and, ultimately, encapsulating peritoneal sclerosis (EPS) are the most serious peritoneal dialysis (PD) complications. Combining clinical and peritoneal transport data with the measurement of molecular biomarkers, such as the chemokine CCL18, would improve the complex diagnosis and management of PMF. We measured CCL18 levels in 43 patients' effluent and serum at baseline and after 1, 2, and 3 years of PD treatment by retrospective longitudinal study, and evaluated their association with PMF/EPS development and peritoneal risk factors. To confirm the trends observed in the longitudinal study, a cross-sectional study was performed on 61 isolated samples from long-term (more than 3 years) patients treated with PD. We observed that the patients with no membrane dysfunction showed sustained low CCL18 levels in peritoneal effluent over time. An increase in CCL18 levels at any time was predictive of PMF development (final CCL18 increase over baseline, p = .014; and maximum CCL18 increase, p = .039). At year 3 of PD, CCL18 values in effluent under 3.15 ng/ml showed an 89.5% negative predictive value, and higher levels were associated with later PMF (odds ratio 4.3; 95% CI 0.90-20.89; p = .067). Moreover, CCL18 levels in effluent at year 3 of PD were independently associated with a risk of PMF development, adjusted for the classical (water and creatinine) peritoneal transport parameters. These trends were confirmed in a cross-sectional study of 61 long-term patients treated with PD. In conclusion, our study shows the diagnostic capacity of chemokine CCL18 levels in peritoneal effluent to predict PMF and suggests CCL18 as a new marker and mediator of this serious condition as well as a new potential therapeutic target.	[Ossorio, Marta; Auxiliadora Bajo, Maria; del Peso, Gloria; Fernandez, Maria; Jose Castro, Maria; Selgas, Rafael] La Paz Univ Hosp, Dept Nephrol, Hosp La Paz Hlth Res Inst IdiPAZ, REDinREN,Fibroteam, Madrid, Spain; [Martinez, Virginia; Rodriguez-Sanz, Aranzazu; Bellon, Teresa; Selgas, Rafael] Hosp La Paz Hlth Res Inst IdiPAZ, Madrid, Spain; [Madero, Rosario] La Paz Univ Hosp, Dept Stat, Hosp La Paz Hlth Res Inst IdiPAZ, Madrid, Spain	Hospital Universitario La Paz; Hospital Universitario La Paz	Bellon, T (corresponding author), Hosp La Paz Hlth Res Inst IdiPAZ, Madrid, Spain.	teresa.bellon@salud.madrid.org	Bajo, Maria A/ABF-6991-2020; Bellón, Teresa/ABF-4916-2020; Martínez, Virginia/F-2678-2016	Bajo, Maria A/0000-0001-7364-557X; Bellón, Teresa/0000-0002-0138-6879; Martínez, Virginia/0000-0002-8399-3874	Instiuto de Salud Carlos III-Ministerio de Economia y Competitividad FIS [PI12/0204]; FEDER; RETICS; REDinREn; Fundacion Renal lnip Alvarez de Toledo	Instiuto de Salud Carlos III-Ministerio de Economia y Competitividad FIS; FEDER(European Commission); RETICS; REDinREn; Fundacion Renal lnip Alvarez de Toledo	The study was funded by a research grant from the Instiuto de Salud Carlos III-Ministerio de Economia y Competitividad FIS PI12/0204 co-founded by FEDER to RS, RETICS 2012 REDinREn to RS, and Fundacion Renal lnip Alvarez de Toledo to RS. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Ahmad S, 2010, EUR J CLIN INVEST, V40, P1067, DOI 10.1111/j.1365-2362.2010.02353.x; Aroeira LS, 2007, J AM SOC NEPHROL, V18, P2004, DOI 10.1681/ASN.2006111292; Balasubramaniam G, 2009, NEPHROL DIAL TRANSPL, V24, P3209, DOI 10.1093/ndt/gfp008; Barreto DL, 2015, AM J KIDNEY DIS, V65, P748, DOI 10.1053/j.ajkd.2014.10.022; Bellon T, 2011, NEPHROL DIAL TRANSPL, V26, P2995, DOI 10.1093/ndt/gfq771; De Sousa-Amorim E, 2014, PERITON DIALYSIS INT, V34, P582, DOI 10.3747/pdi.2012.00286; del Peso G, 2008, KIDNEY INT, V73, pS26, DOI 10.1038/sj.ki.5002598; Estep JM, 2009, OBES SURG, V19, P617, DOI 10.1007/s11695-009-9814-x; Finkernagel F, 2016, ONCOTARGET, V7, P75339, DOI 10.18632/oncotarget.12180; Habib SM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120174; Johnson DW, 2010, KIDNEY INT, V77, P904, DOI 10.1038/ki.2010.16; Kollert F, 2012, J RHEUMATOL, V39, P1407, DOI 10.3899/jrheum.111143; Korte MR, 2011, NAT REV NEPHROL, V7, P528, DOI 10.1038/nrneph.2011.93; Krediet RT, 2013, NAT REV NEPHROL, V9, P419, DOI 10.1038/nrneph.2013.99; Lambie ML, 2010, KIDNEY INT, V78, P611, DOI 10.1038/ki.2010.186; Lucendo AJ, 2011, J ALLERGY CLIN IMMUN, V128, P1037, DOI 10.1016/j.jaci.2011.08.007; Luzina IG, 2006, AM J RESP CELL MOL, V35, P298, DOI 10.1165/rcmb.2006-0033OC; Martinez F.O., 2014, F1000PRIME REP, V6, DOI DOI 10.12703/P6-13; Morelle J, 2015, J AM SOC NEPHROL, V26, P2521, DOI 10.1681/ASN.2014090939; Prasse A, 2006, AM J RESP CRIT CARE, V173, P781, DOI 10.1164/rccm.200509-1518OC; Prassel A, 2009, AM J RESP CRIT CARE, V179, P717, DOI 10.1164/rccm.200808-1201OC; SELGAS R, 1994, AM J KIDNEY DIS, V23, P64, DOI 10.1016/S0272-6386(12)80814-6; Selgas R, 2006, NEPHROL DIAL TRANSPL, V21, DOI 10.1093/ndt/gfl183; Song EW, 2000, CELL IMMUNOL, V204, P19, DOI 10.1006/cimm.2000.1687; Tiev KP, 2011, EUR RESPIR J, V38, P1355, DOI 10.1183/09031936.00004711; Yanez-Mo M, 2003, NEW ENGL J MED, V348, P403, DOI 10.1056/NEJMoa020809	26	5	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2017	12	4							e0175835	10.1371/journal.pone.0175835	http://dx.doi.org/10.1371/journal.pone.0175835			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KD	28414753	Green Submitted, Green Published, gold			2022-12-27	WOS:000399874800065
J	Sharma, S; Zhang, YY				Sharma, Shrushrita; Zhang, Yunyan			Fourier transform power spectrum is a potential measure of tissue alignment in standard MRI: A multiple sclerosis study	PLOS ONE			English	Article							APPEARING WHITE-MATTER; IN-VIVO; ANISOTROPY	Loss of tissue coherency in brain white matter is found in many neurological diseases such as multiple sclerosis (MS). While several approaches have been proposed to evaluate white matter coherency including fractional anisotropy and fiber tracking in diffusion-weighted imaging, few are available for standard magnetic resonance imaging (MRI). Here we present an image post-processing method for this purpose based on Fourier transform (FT) power spectrum. T2-weighted images were collected from 19 patients (10 relapsing-remitting and 9 secondary progressive MS) and 19 age-and gender-matched controls. Image processing steps included: computation, normalization, and thresholding of FT power spectrum; determination of tissue alignment profile and dominant alignment direction; and calculation of alignment complexity using a new measure named angular entropy. To test the validity of this method, we used a highly organized brain white matter structure, corpus callosum. Six regions of interest were examined from the left, central and right aspects of both genu and splenium. We found that the dominant orientation of each ROI derived from our method was significantly correlated with the predicted directions based on anatomy. There was greater angular entropy in patients than controls, and a trend to be greater in secondary progressive MS patients. These findings suggest that it is possible to detect tissue alignment and anisotropy using traditional MRI, which are routinely acquired in clinical practice. Analysis of FT power spectrum may become a new approach for advancing the evaluation and management of patients with MS and similar disorders. Further confirmation is warranted.	[Sharma, Shrushrita; Zhang, Yunyan] Univ Calgary, Fac Grad Studies, Biomed Engn Program, Edmonton, AB, Canada; [Sharma, Shrushrita; Zhang, Yunyan] Univ Calgary, Hotchkiss Brain Inst, Edmonton, AB, Canada; [Zhang, Yunyan] Univ Calgary, Dept Clin Neurosci, Edmonton, AB, Canada; [Zhang, Yunyan] Univ Calgary, Dept Radiol, Edmonton, AB, Canada	University of Calgary; University of Calgary; University of Calgary; University of Calgary	Zhang, YY (corresponding author), Univ Calgary, Fac Grad Studies, Biomed Engn Program, Edmonton, AB, Canada.; Zhang, YY (corresponding author), Univ Calgary, Hotchkiss Brain Inst, Edmonton, AB, Canada.; Zhang, YY (corresponding author), Univ Calgary, Dept Clin Neurosci, Edmonton, AB, Canada.; Zhang, YY (corresponding author), Univ Calgary, Dept Radiol, Edmonton, AB, Canada.	yunyzhan@ucalgary.ca			Natural Sciences and Engineering Council of Canada [418737-2012]; Multiple Sclerosis Society of Canada [2705]; Alberta Innovates - Health Solutions; Queen Elizabeth II Graduate Scholarship, University of Calgary; CREATE i3T Graduate Scholarship, Natural Sciences and Engineering Council of Canada; Alberta Innovates [201300669] Funding Source: researchfish	Natural Sciences and Engineering Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Multiple Sclerosis Society of Canada; Alberta Innovates - Health Solutions; Queen Elizabeth II Graduate Scholarship, University of Calgary; CREATE i3T Graduate Scholarship, Natural Sciences and Engineering Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Alberta Innovates	This work was supported by the Natural Sciences and Engineering Council of Canada (ID: 418737-2012); Multiple Sclerosis Society of Canada (ID: 2705); Alberta Innovates - Health Solutions for YZ; Queen Elizabeth II Graduate Scholarship, University of Calgary, and CREATE i3T Graduate Scholarship, Natural Sciences and Engineering Council of Canada for SS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the patient and healthy volunteers for their support to this study, the clinical MS research team for recruiting and administrating the study, and Dr Lenora N Brown for initiating this study with the support of the MS Society of Canada. We are very grateful for the funding support for the imaging program from the MS Society of Canada (ID: 2750), Natural Sciences and Engineering Council of Canada (ID: 418737-2012), and Alberta Innovates Health Solutions. In addition, we thank the scholarship supports for S Sharma from the University of Calgary and NSERC CREATE I3T Program.	Ansari MK, 2014, J STRUCT BIOL, V188, P116, DOI 10.1016/j.jsb.2014.09.009; Bayan C, 2009, J APPL PHYS, V105, DOI 10.1063/1.3116626; Begin S, 2013, BIOMED OPT EXPRESS, V4, P2003, DOI 10.1364/BOE.4.002003; Berlucchi G, 2014, CORTEX, V56, P1, DOI 10.1016/j.cortex.2013.02.001; Budde MD, 2012, NEUROIMAGE, V63, P1, DOI 10.1016/j.neuroimage.2012.06.042; Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7; Concha L, 2014, NEUROSCIENCE, V276, P14, DOI 10.1016/j.neuroscience.2013.09.004; Evangelou N, 2000, ANN NEUROL, V47, P391, DOI 10.1002/1531-8249(200003)47:3<391::AID-ANA20>3.0.CO;2-J; Groeschel S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167274; Herron TJ, 2012, FRONT NEUROINFORM, V6, DOI 10.3389/fninf.2012.00025; Jayashree V, 2009, P WORLD C ENG, VI, P1; Jayashree V, 2011, MELLIAND INT, V17, P146; Kim A, 2006, EXP CELL RES, V312, P3683, DOI 10.1016/j.yexcr.2006.08.009; Lawrenz M, 2015, MAGN RESON MED, V73, P773, DOI 10.1002/mrm.25140; Li W, 2012, NEUROIMAGE, V59, P2088, DOI 10.1016/j.neuroimage.2011.10.038; Mori S, 2006, NEURON, V51, P527, DOI 10.1016/j.neuron.2006.08.012; Nazaran A, 2016, J NEUROSCI METH, V261, P75, DOI 10.1016/j.jneumeth.2015.11.023; Sastre-Garriga J, 2005, ARCH NEUROL-CHICAGO, V62, P569, DOI 10.1001/archneur.62.4.569; Stamile C, 2016, PLOS ONE, P1; Stikov N, 2015, NEUROIMAGE, V118, P397, DOI 10.1016/j.neuroimage.2015.05.023; Theocharakis P, 2009, MAGN RESON IMAGING, V27, P417, DOI 10.1016/j.mri.2008.07.014; Wang SH, 2016, IEEE ACCESS, V4, DOI 10.1109/ACCESS.2016.2620996; WITELSON SF, 1989, BRAIN, V112, P799, DOI 10.1093/brain/112.3.799; Zeis T, 2008, BRAIN, V131, P288, DOI 10.1093/brain/awm291	24	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2017	12	4							e0175979	10.1371/journal.pone.0175979	http://dx.doi.org/10.1371/journal.pone.0175979			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KD	28414816	gold, Green Published			2022-12-27	WOS:000399874800082
J	Vaz, J; Narayan, EJ; Kumar, RD; Thenmozhi, K; Thiyagesan, K; Baskaran, N				Vaz, Janice; Narayan, Edward J.; Kumar, R. Dileep; Thenmozhi, K.; Thiyagesan, Krishnamoorthy; Baskaran, Nagarajan			Prevalence and determinants of stereotypic behaviours and physiological stress among tigers and leopards in Indian zoos	PLOS ONE			English	Article							STARLINGS STURNUS-VULGARIS; ELEPHANTS ELEPHAS-MAXIMUS; HUMAN-ANIMAL RELATIONSHIP; CAPTIVE GIANT PANDAS; ENVIRONMENTAL ENRICHMENT; PLASMA-CORTICOSTERONE; PANTHERA-TIGRIS; CORTISOL; EXCRETION; RESPONSES	India's charismatic wildlife species are facing immense pressure from anthropogenicinduced environmental perturbations. Zoos play a major role in the conservation of threatened species, but their adaptation in captivity is posing a major challenge globally. Stress from inadequate adaptation could lead to suppression of cognitive functioning and increased display of stereotypic behaviour. It is thus necessary to measure biological traits like behaviour, stress physiology, and contextual factors driving the animals maintained at zoos. In this study, we assessed stereotypic behaviour and stress physiology employing standard behaviour scoring, non-invasive stress monitoring, and their contextual drivers in a sub-population of two large felid species managed in six Indian zoos. The prevalence and intensity of stereotypic behaviours and levels of faecal corticosterone metabolites (FCM) were ascertained among 41 Royal Bengal tigers Panthera tigris tigris and 21 Indian leopards Panthera pardus fusca between April 2014 and March 2015. Behavioural observations showed that tigers spent more time stereotyping (12%) than leopards (7%) during daylight hours. Stress levels assessed using FCM revealed that tigers (23.6 +/- 1.62 ng/g) had marginally lower level of corticosterone metabolites than leopards (27.2 +/- 1.36 ng/g). Stereotypic behaviour increased significantly with FCM level when the effect of heath status was controlled in tigers, and the effects tree cover, stone, den and keeper attitude controlled in leopards. Comparison of stereotypes of tigers with various biological and environmental factors using binary logistic regression revealed that stereotypic prevalence decreased with increased enclosure size, and enclosure enrichments like presence of pools and stones, when managed socially with conspecifics, and with positive keeper attitude, these factors accounting for 43% of variations in stereotypic prevalence among tigers. Stereotype among leopards was significantly absent when associated with increased tree cover and presence of pool, and den in the enclosure, age and among zoo-born than wild-born ones. These factors explain 81% of variations in stereotypic prevalence in them. A comparison of FCM levels with context-dependent factors revealed that stress levels among tigers decreased significantly with enclosure size and with individuals from nil to low, and severity of health issues. These factors explain 64% of variations in FCM levels. In leopards, the presence of stones in the enclosure and keepers with positive attitude resulted in significant decrease in FCM levels, these factors together accounting for 94% of variations. Multiple regressions on selected variables based on Factor Analysis of Mixed Data showed that in tigers the intensity of stereotype decreased significantly with enclosure size, sociality and positive keeper attitude and FCM level with health problems. Similarly, analyses in leopards revealed that intensity of stereotype decreased significantly with tree cover, age and FCM level with positive keeper attitude. Overall, our study suggests that to reduce stereotypes and stress level, tigers in captivity should be managed in larger enclosures enriched with pool, and stones, and in appropriate social conditions with adequate veterinary care. Leopards should be managed in enclosures with dense tree cover, pool, stones and den. Positive keeper attitude plays a crucial role in the welfare of both the species in captivity. Our study is promising and is comparable with their natural behaviour in the wild; for example, tigers require larger natural habitats, while leopards can manage even with smaller isolated patches but with dense vegetation cover.	[Vaz, Janice; Thenmozhi, K.; Thiyagesan, Krishnamoorthy; Baskaran, Nagarajan] AVC Coll Autonomous, Dept Zool & Wildlife Biol, Mayiladuthurai, Tamil Nadu, India; [Narayan, Edward J.] Western Sydney Univ, Sch Sci & Hlth, Hawkesbury Campus, Richmond, NSW, Australia; [Kumar, R. Dileep] Univ Kerala, Ctr Venom Informat, Dept Computat Biol & Bioinformat, Kariavattom North Campus, Thiruvananthapuram, Kerala, India	Western Sydney University; University of Kerala	Baskaran, N (corresponding author), AVC Coll Autonomous, Dept Zool & Wildlife Biol, Mayiladuthurai, Tamil Nadu, India.	nagarajan.baskaran@gmail.com	Narayan, Edward/E-8238-2016; Baskaran, Nagarajan/T-9880-2018	Narayan, Edward/0000-0003-2719-0900; VAZ, JANICE/0000-0003-1677-3182	Kerala Biotechnology Commission's Young Investigator's Programme in Biotechnology Scheme under Kerala State Council for Science, Technology and Environment	Kerala Biotechnology Commission's Young Investigator's Programme in Biotechnology Scheme under Kerala State Council for Science, Technology and Environment	The co-author R.D. was supported by Kerala Biotechnology Commission's Young Investigator's Programme in Biotechnology Scheme under Kerala State Council for Science, Technology and Environment. We are thankful to projectproposal.in, a crowd funding platform for scientific projects in India, and Publication Fee Assistance (pfa@plos.org) for their partial financial support towards publication cost of this manuscript in PLOS ONE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmann J., 1974, BEHAV, VXLIX; Athreya V, 2011, CONSERV BIOL, V25, P133, DOI 10.1111/j.1523-1739.2010.01599.x; AXELROD J, 1984, SCIENCE, V224, P452, DOI 10.1126/science.6143403; Bahr NI, 2000, GEN COMP ENDOCR, V117, P427, DOI 10.1006/gcen.1999.7431; Baker R., 2006, HUSBANDRY GUIDELINES; BARNETT JL, 1991, APPL ANIM BEHAV SCI, V32, P23, DOI 10.1016/S0168-1591(05)80160-1; Bashaw MJ, 2007, J APPL ANIM WELF SCI, V10, P95, DOI 10.1080/10888700701313116; Baskaran N, 2013, MAMM BIOL, V78, P470, DOI 10.1016/j.mambio.2013.04.007; Baskaran N, 2012, J NAT CONSERV, V20, P56, DOI 10.1016/j.jnc.2011.08.004; Baze W., 1957, TIGER TIGER; Bhattacharjee S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127626; BILDSOE M, 1991, BEHAV PROCESS, V25, P179, DOI 10.1016/0376-6357(91)90020-Z; Biolatti C, 2016, APPL ANIM BEHAV SCI, V174, P173, DOI 10.1016/j.applanim.2015.11.017; Bonal BS, 2014, 2014 LEGISLATION POL, P221; Bracke MBM, 2006, J AGR ENVIRON ETHIC, V19, P77, DOI 10.1007/s10806-005-4493-7; Bradshaw GA, 2005, NATURE, V433, P807, DOI 10.1038/433807a; Breton G, 2014, APPL ANIM BEHAV SCI, V154, P66, DOI 10.1016/j.applanim.2014.02.007; Carlstead K, 2005, ZOO BIOL, V24, P215, DOI 10.1002/zoo.20050; CARLSTEAD K, 1991, ZOO BIOL, V10, P3, DOI 10.1002/zoo.1430100103; Carlstead Kathy, 1996, P317; Carlstead Kathy, 1998, P172; Champion FW., 1934, JUNGLE SUNLIGHT SHAD; Chosy J, 2014, ZOO BIOL, V33, P267, DOI 10.1002/zoo.21142; Chundawat Raghunandan S., 1999, P123; Chundawat RS, 2016, BIOL CONSERV, V197, P146, DOI 10.1016/j.biocon.2016.03.004; CLARKE AS, 1988, AM J PRIMATOL, V14, P37, DOI 10.1002/ajp.1350140104; Claxton AM, 2011, APPL ANIM BEHAV SCI, V133, P1, DOI 10.1016/j.applanim.2011.03.002; Clubb R, 2007, APPL ANIM BEHAV SCI, V102, P303, DOI 10.1016/j.applanim.2006.05.033; Creel S, 2002, CONSERV BIOL, V16, P809, DOI 10.1046/j.1523-1739.2002.00554.x; CZA, 2009, INV AN IND ZOOS AN P; Dawkins MS, 2004, ANIM WELFARE, V13, pS3; DAWSON A, 1983, GEN COMP ENDOCR, V51, P303, DOI 10.1016/0016-6480(83)90085-0; Erwin J., 1979, CAPTIVITY BEHAV, P1; Goodrich JM, 2010, INTEGR ZOOL, V5, P300, DOI 10.1111/j.1749-4877.2010.00218.x; Hayward S, 2010, ENCY ANIMAL BEHAV, P382; Heath JA, 1998, PHYSIOL ZOOL, V71, P67, DOI 10.1086/515888; Hediger H., 1966, International Zoo Yearbook, V6, P37, DOI 10.1111/j.1748-1090.1966.tb01688.x; Hediger H., 1964, WILD ANIMALS CAPTIVI; Hediger H., 1950, WILD ANIMALS CAPTIVI; Hediger H., 1955, STUDIES PSYCHOL BEHA; Henschel P, 2008, PANTHERAPARDUS IUCN; Holberton RL, 1999, GEN COMP ENDOCR, V116, P49, DOI 10.1006/gcen.1999.7336; Hosey GR, 2000, ANIM WELFARE, V9, P343; Husband S, 2008, ENV ENRICHMENT; Jhala Y.V., 2015, STATUS TIGERS INDIA; Jhala Y, 2011, J APPL ECOL, V48, P14, DOI 10.1111/j.1365-2664.2010.01901.x; JHALA YV, 1991, CONSERV BIOL, V5, P476, DOI 10.1111/j.1523-1739.1991.tb00354.x; Joshi AD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044372; Karanth KU, 2010, TIGERS OF THE WORLD: THE SCIENCE, POLITICS, AND CONSERVATION OF PANTHERA TIGRIS, 2ND EDITION, P241; KARANTH KU, 1991, WILDLIFE CONSERVATIO, P156; KRISHNAMURTHY R, 1994, FOLIA PRIMATOL, V63, P91, DOI 10.1159/000156798; Kurt F., 2006, Z KOLLNER ZOO, V49, P97; Latham NR, 2008, APPL ANIM BEHAV SCI, V110, P84, DOI 10.1016/j.applanim.2007.03.026; Laws N, 2007, J APPL ANIM WELF SCI, V10, P349, DOI 10.1080/10888700701555600; Le S, 2008, J STAT SOFTW, V25, P1, DOI 10.18637/jss.v025.i01; Levy DM, 1944, AM J ORTHOPSYCHIAT, V14, P644, DOI 10.1111/j.1939-0025.1944.tb06500.x; Lewis KD, 2010, ZOO BIOL, V29, P221, DOI 10.1002/zoo.20291; Linnaeus C., 1758, SYSTEMA NATURAE REGN, V10th, P41; Liu J, 2006, ZOO BIOL, V25, P445, DOI 10.1002/zoo.20106; Lyons J, 1997, ZOO BIOL, V16, P71; Maple TL, 2013, ZOO ANIMAL WELFARE A; Marchant-Forde JN, 2015, FRONT VET SCI, V2, DOI 10.3389/fvets.2015.00016; MARRA PP, 1995, WILSON BULL, V107, P296; Martin S., 1999, WORLD ZOO C PRET S A; MASON GJ, 1991, ANIM BEHAV, V41, P1015, DOI 10.1016/S0003-3472(05)80640-2; MASON GJ, 1991, BEHAV PROCESS, V25, P103, DOI 10.1016/0376-6357(91)90013-P; Mason MF, 2007, SCIENCE, V315, P393, DOI 10.1126/science.1131295; Mazak V., 1981, AM SOC MAMMALOGISTS, V152, P1; McCusker JS, 1978, ANN P AM ASS ZOOL PA, P168; Mellen J.D., 1998, 2 NATURE ENV ENRICHM, P329; MELLEN JD, 1991, ZOO BIOL, V10, P95, DOI 10.1002/zoo.1430100202; Mellen Jill D., 1998, P184; Mellen Jill D., 1997, International Zoo Yearbook, V35, P191, DOI 10.1111/j.1748-1090.1997.tb01209.x; Mench Joy, 1998, ILAR J, V39, P20; Meyer FAA, 1794, ZOOLOGISCHE ANN, VI, P394; Miller CS, 2013, J MAMMAL, V94, P845, DOI 10.1644/12-MAMM-A-209.1; Millspaugh JJ, 2004, GEN COMP ENDOCR, V138, P189, DOI 10.1016/j.ygcen.2004.07.002; Millspaugh JJ, 2002, WILDLIFE SOC B, V30, P899; Moberg GP, 2000, BIOLOGY OF ANIMAL STRESS, P1, DOI 10.1079/9780851993591.0001; Moreira N, 2007, ZOO BIOL, V26, P441, DOI 10.1002/zoo.20139; Morgan KN, 2007, APPL ANIM BEHAV SCI, V102, P262, DOI 10.1016/j.applanim.2006.05.032; Mostl E, 1999, J VET MED A, V46, P621, DOI 10.1046/j.1439-0442.1999.00256.x; Mostl E, 2002, DOMEST ANIM ENDOCRIN, V23, P67, DOI 10.1016/S0739-7240(02)00146-7; MUNCK A, 1984, ENDOCR REV, V5, P25, DOI 10.1210/edrv-5-1-25; Narayan EJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073564; Narayan EJ, 2013, GEN COMP ENDOCR, V187, P39, DOI 10.1016/j.ygcen.2013.03.021; O'Regan HJ, 2005, MAMMAL REV, V35, P215, DOI 10.1111/j.1365-2907.2005.00070.x; ODBERG FO, 1989, NATO ADV SCI I D-BEH, V48, P229; Ohe CGVD, 2002, WILDLSOC B, V30, P1215; Pages J., 2004, REV STAT APPL, P93; Pitsko LE., 2003, WILD TIGERS CAPTIVIT; Powell DM, 2006, ZOO BIOL, V25, P391, DOI 10.1002/zoo.20098; Prater S.H., 1971, BOOK INDIAN ANIMALS, V3rd; Price EE, 2007, APPL ANIM BEHAV SCI, V103, P255, DOI 10.1016/j.applanim.2006.05.021; Raminelli JLF, 2001, BIOL RHYTHM RES, V32, P159; REDBO I, 1993, APPL ANIM BEHAV SCI, V38, P213, DOI 10.1016/0168-1591(93)90020-P; Romero LM, 2004, TRENDS ECOL EVOL, V19, P249, DOI 10.1016/j.tree.2004.03.008; Romero LM, 2000, GEN COMP ENDOCR, V119, P52, DOI 10.1006/gcen.2000.7491; Ross SR, 2006, BEHAV PROCESS, V73, P117, DOI 10.1016/j.beproc.2006.04.003; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; Schaller GB., 1998, WILDLIFE TIBETAN STE; Schmid J, 2001, ANIM WELFARE, V10, P357; Shepherdson DJ, 2004, ANIM WELFARE, V13, pS105; Sheriff MJ, 2011, OECOLOGIA, V166, P593, DOI 10.1007/s00442-011-1907-2; Shoemaker A. H, 1997, MINIMUM HUSBANDRY GU; Stewart PM, 2003, WILLIAMS TXB ENDOCRI, P491; Sunquist M. E., 1981, SMITHSONIAN CONTRIB, V336, P1, DOI DOI 10.5479/SI.00810282.336; Swaisgood RR, 2005, ZOO BIOL, V24, P499, DOI 10.1002/zoo.20066; Swanson WF, 2003, ZOO BIOL, V22, P421, DOI 10.1002/zoo.10093; Terio KA, 2004, J WILDLIFE DIS, V40, P259, DOI 10.7589/0090-3558-40.2.259; Teskey-Gerstl A, 2000, J COMP PHYSIOL B, V170, P163, DOI 10.1007/s003600050271; TILSON RL, 1994, SUMATRAN TIGER POPUL; Touma C, 2003, GEN COMP ENDOCR, V130, P267, DOI 10.1016/S0016-6480(02)00620-2; Vanitha V., 2008, J SCI T ENV TECHNOVA, V2, P87, DOI [10.20894/STET.116.002.002.005, DOI 10.20894/STET.116.002.002.005]; Vanitha V, 2016, APPL ANIM BEHAV SCI, V174, P137, DOI 10.1016/j.applanim.2015.10.006; Vanitha V, 2011, J APPL ANIM WELF SCI, V14, P42, DOI 10.1080/10888705.2011.527603; Vestergaard K., 1981, The welfare of pigs, P16; Waiblinger S, 2006, APPL ANIM BEHAV SCI, V101, P185, DOI 10.1016/j.applanim.2006.02.001; Watts E, 1996, WILD ANIMALS CAPTIVI, P70; White BC, 2003, ZOO BIOL, V22, P269, DOI 10.1002/zoo.10085; Wielebnowski NC, 2002, ZOO BIOL, V21, P77, DOI 10.1002/zoo.10005; Wilson ML, 2004, ANIM WELFARE, V13, P39; WINGFIELD JC, 1994, HORM BEHAV, V28, P1, DOI 10.1006/hbeh.1994.1001; Zar J.H., 1999, ZAR KUHR 5 2019, V4th	124	23	24	8	168	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2017	12	4							e0174711	10.1371/journal.pone.0174711	http://dx.doi.org/10.1371/journal.pone.0174711			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES9KD	28414723	Green Published, gold			2022-12-27	WOS:000399874800005
J	Ma, C				Ma, Chao			Non-fragile mixed H-infinity and passive synchronization of Markov jump neural networks with mixed time-varying delays and randomly occurring controller gain fluctuation	PLOS ONE			English	Article							ROBUST STABILITY; LEVY NOISE; STOCHASTIC RESONANCE; DICHOTOMOUS NOISE; BISTABLE SYSTEM; DISCRETE; PASSIFICATION; DRIVEN	This paper studies the non-fragile mixed H-infinity and passive synchronization problem for Markov jump neural networks. The randomly occurring controller gain fluctuation phenomenon is investigated for non-fragile strategy. Moreover, the mixed time-varying delays composed of discrete and distributed delays are considered. By employing stochastic stability theory, synchronization criteria are developed for the Markov jump neural networks. On the basis of the derived criteria, the non-fragile synchronization controller is designed. Finally, an illustrative example is presented to demonstrate the validity of the control approach.	[Ma, Chao] Univ Sci & Technol Beijing, Sch Automat & Elect Engn, Beijing 100083, Peoples R China	University of Science & Technology Beijing	Ma, C (corresponding author), Univ Sci & Technol Beijing, Sch Automat & Elect Engn, Beijing 100083, Peoples R China.	cma@ustb.edu.cn			Fundamental Research Funds for the Central Universities [FRF-TP-15-115A1]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the Fundamental Research Funds for the Central Universities under Grant FRF-TP-15-115A1.	Arunkumar A, 2014, ISA T, V53, P1006, DOI 10.1016/j.isatra.2014.05.002; Cao J, 2004, J MATH ANAL APPL, V296, P665, DOI 10.1016/j.jmaa.2004.04.039; Cao JD, 2005, IEEE T CIRCUITS-I, V52, P417, DOI 10.1109/TCSI.2004.841574; Du YK, 2014, ISA T, V53, P1015, DOI 10.1016/j.isatra.2014.03.005; Fang M, 2013, APPL MATH COMPUT, V219, P8009, DOI 10.1016/j.amc.2013.02.030; Gao HJ, 2007, SIAM J CONTROL OPTIM, V46, P1299, DOI 10.1137/060655110; Karimi HR, 2010, IEEE T SYST MAN CY B, V40, P173, DOI 10.1109/TSMCB.2009.2024408; Liao XF, 2002, NEURAL NETWORKS, V15, P855, DOI 10.1016/S0893-6080(02)00041-2; Liu H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095505; Liu PL, 2013, ISA T, V52, P711, DOI 10.1016/j.isatra.2013.06.011; Liu YR, 2009, IEEE T NEURAL NETWOR, V20, P1102, DOI 10.1109/TNN.2009.2016210; Ma C, 2014, NEUROCOMPUTING, V136, P321, DOI 10.1016/j.neucom.2013.12.028; Park P, 2011, AUTOMATICA, V47, P235, DOI 10.1016/j.automatica.2010.10.014; Qi DL, 2010, IEEE T NEURAL NETWOR, V21, P1358, DOI 10.1109/TNN.2010.2050904; Shen B, 2011, IEEE T NEURAL NETWOR, V22, P145, DOI 10.1109/TNN.2010.2090669; Shen H, 2012, NONLINEAR DYNAM, V69, P473, DOI 10.1007/s11071-011-0278-x; Wang WP, 2014, NEURAL NETWORKS, V53, P8, DOI 10.1016/j.neunet.2014.01.010; Wang ZD, 2005, PHYS LETT A, V345, P299, DOI 10.1016/j.physleta.2005.07.025; Wang ZQ, 2016, SCI CHINA TECHNOL SC, V59, P371, DOI 10.1007/s11431-015-6001-2; Wu M, 2004, AUTOMATICA, V40, P1435, DOI 10.1016/j.automatica.2004.03.004; Wu ZG, 2013, SIGNAL PROCESS, V93, P1705, DOI 10.1016/j.sigpro.2013.01.003; Xie LH, 1996, INT J CONTROL, V63, P741, DOI 10.1080/00207179608921866; Xu Y, 2015, J STAT PHYS, V158, P120, DOI 10.1007/s10955-014-1129-1; Xu Y, 2013, PHYSICA A, V392, P4739, DOI 10.1016/j.physa.2013.06.010; Xu Y, 2013, J STAT PHYS, V152, P753, DOI 10.1007/s10955-013-0782-0; Xu Y, 2013, CHAOS, V23, DOI 10.1063/1.4775758; Xu Y, 2012, NONLINEAR DYNAM, V70, P531, DOI 10.1007/s11071-012-0473-4; Yang X., 2016, IEEE T NEURAL NETWOR; Yang XS, 2017, NEURAL NETWORKS, V85, P157, DOI 10.1016/j.neunet.2016.10.006; Yang XS, 2016, IEEE T CYBERNETICS, V46, P3377, DOI 10.1109/TCYB.2015.2505903; Yang XS, 2016, IEEE T AUTOMAT CONTR, V61, P2256, DOI 10.1109/TAC.2015.2484328; Yang XS, 2015, IEEE T FUZZY SYST, V23, P2302, DOI 10.1109/TFUZZ.2015.2417973; Yang XS, 2013, IEEE T CIRCUITS-I, V60, P363, DOI 10.1109/TCSI.2012.2215804; Yang XS, 2012, IEEE T NEUR NET LEAR, V23, P60, DOI 10.1109/TNNLS.2011.2177671; Yu WW, 2007, PHYSICA A, V375, P467, DOI 10.1016/j.physa.2006.09.020; Zhang H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093838; Zhao XD, 2010, J FRANKLIN I, V347, P863, DOI 10.1016/j.jfranklin.2010.03.009; Zhu XL, 2008, IET CONTROL THEORY A, V2, P524, DOI 10.1049/iet-cta:20070298	38	1	1	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2017	12	4							e0175676	10.1371/journal.pone.0175676	http://dx.doi.org/10.1371/journal.pone.0175676			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0MD	28410394	Green Published, gold, Green Submitted			2022-12-27	WOS:000399955600033
J	Santos, FP; Pacheco, JM; Paiva, A; Santos, FC				Santos, Fernando P.; Pacheco, Jorge M.; Paiva, Ana; Santos, Francisco C.			Structural power and the evolution of collective fairness in social networks	PLOS ONE			English	Article							PUBLIC-GOODS GAME; COOPERATIVE BEHAVIOR; DYNAMICS; PROMOTES; IMPACT; PUNISHMENT; STRATEGY; TRAGEDY	From work contracts and group buying platforms to political coalitions and international climate and economical summits, often individuals assemble in groups that must collectively reach decisions that may favor each part unequally. Here we quantify to which extent our network ties promote the evolution of collective fairness in group interactions, modeled by means of Multiplayer Ultimatum Games (MUG). We show that a single topological feature of social networks-which we call structural power-has a profound impact on the tendency of individuals to take decisions that favor each part equally. Increased fair outcomes are attained whenever structural power is high, such that the networks that tie individuals allow them to meet the same partners in different groups, thus providing the opportunity to strongly influence each other. On the other hand, the absence of such close peer-influence relationships dismisses any positive effect created by the network. Interestingly, we show that increasing the structural power of a network leads to the appearance of well-defined modules-as found in human social networks that often exhibit community structure-providing an interaction environment that maximizes collective fairness.	[Santos, Fernando P.; Paiva, Ana; Santos, Francisco C.] Univ Lisbon, INESC ID, IST Tagusparque, Porto Salvo, Portugal; [Santos, Fernando P.; Paiva, Ana; Santos, Francisco C.] Univ Lisbon, Inst Super Tecn, IST Tagusparque, Porto Salvo, Portugal; [Santos, Fernando P.; Pacheco, Jorge M.; Santos, Francisco C.] ATP Grp, Porto Salvo, Portugal; [Pacheco, Jorge M.] Univ Minho, Ctr Biol Mol & Ambiental, Braga, Portugal; [Pacheco, Jorge M.] Univ Minho, Dept Matemat & Aplicacoes, Braga, Portugal	INESC-ID; Universidade de Lisboa; Instituto Superior Tecnico; Universidade de Lisboa; Instituto Superior Tecnico; Universidade do Minho; Universidade do Minho	Santos, FC (corresponding author), Univ Lisbon, INESC ID, IST Tagusparque, Porto Salvo, Portugal.; Santos, FC (corresponding author), Univ Lisbon, Inst Super Tecn, IST Tagusparque, Porto Salvo, Portugal.; Santos, FC (corresponding author), ATP Grp, Porto Salvo, Portugal.	franciscocsantos@tecnico.ulisboa.pt	Santos, Francisco C./D-2394-2010; Santos, Francisco C./W-7781-2019; Pacheco, Jorge M./O-8184-2019; Santos, Fernando P./AAA-7581-2021; Santos, Fernando/P-5004-2019; Paiva, Ana/B-9900-2011	Santos, Francisco C./0000-0002-9103-2862; Santos, Francisco C./0000-0002-9103-2862; Pacheco, Jorge M./0000-0002-2579-8499; Santos, Fernando/0000-0002-2310-6444; Paiva, Ana/0000-0003-3998-5188	Fundacao para a Ciencia e Tecnologia (FCT) [SFRH/BD/94736/2013, PTDC/EEI-SII/5081/2014, PTDC/MAT/STA/3358/2014]; CBMA; INESC-ID [UID/BIA/04050/2013, UID/CEC/50021/2013]	Fundacao para a Ciencia e Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); CBMA; INESC-ID	This research was supported by Fundacao para a Ciencia e Tecnologia (FCT) through grants SFRH/BD/94736/2013, PTDC/EEI-SII/5081/2014, PTDC/MAT/STA/3358/2014 and by multi-annual funding of CBMA and INESC-ID (under the projects UID/BIA/04050/2013 and UID/CEC/50021/2013) provided by FCT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2017, STANFORD LARGE NETWO; [Anonymous], 1998, THEORY LEARNING GAME; Bastian M, 2009, P INT AAAI C WEB SOC, V2009, P361, DOI 10.13140/2.1.1341.1520; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Call J., 1997, PRIMATE COGNITION; Camerer C.F., 2003, BEHAV GAME THEORY EX, DOI 10.1257/jep.9.2.209; Carman K.G, 2003, SOCIAL INFLUEN UNPUB; Chen MH, 2016, PHYS LETT A, V380, P40, DOI 10.1016/j.physleta.2015.09.047; Chen MH, 2015, APPL MATH COMPUT, V251, P192, DOI 10.1016/j.amc.2014.11.052; Christakis N.A., 2009, CONNECTED SURPRISING; Ciampaglia GL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099039; DAHL RA, 1957, BEHAV SCI, V2, P201, DOI 10.1002/bs.3830020303; Dorogovtsev S, 2010, COMPLEX NETWORKS; EMERSON RM, 1962, AM SOCIOL REV, V27, P31, DOI 10.2307/2089716; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; Fischbacher U, 2009, J ECON BEHAV ORGAN, V72, P527, DOI 10.1016/j.jebo.2009.05.021; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Fowler JH, 2010, P NATL ACAD SCI USA, V107, P5334, DOI 10.1073/pnas.0913149107; Granovetter M, 2005, J ECON PERSPECT, V19, P33, DOI 10.1257/0895330053147958; GRANOVETTER M, 1985, AM J SOCIOL, V91, P481, DOI 10.1086/228311; GUTH W, 1982, J ECON BEHAV ORGAN, V3, P367, DOI 10.1016/0167-2681(82)90011-7; Hagan J. D., 2001, INT STUDIES REV, V3, P169; Henrich J, 2010, SCIENCE, V327, P1480, DOI 10.1126/science.1182238; Jing XQ, 2011, MANAGE SCI, V57, P1354, DOI 10.1287/mnsc.1110.1366; Kauffman RJ, 2010, ELECTRON COMMER R A, V9, P249, DOI 10.1016/j.elerap.2008.11.009; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; Leskovec J, 2009, INTERNET MATH, V6, P29, DOI 10.1080/15427951.2009.10129177; Leskovec J, 2007, ACM T WEB, V1, DOI 10.1145/1232722.1232727; Li A, 2016, PHYS REV E, V93, DOI 10.1103/PhysRevE.93.022407; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; McAuley J, 2014, ACM T KNOWL DISCOV D, V8, P73, DOI 10.1145/2556612; NOWAK MA, 1992, NATURE, V359, P826, DOI 10.1038/359826a0; Onnela JP, 2007, P NATL ACAD SCI USA, V104, P7332, DOI 10.1073/pnas.0610245104; Oosterbeek H, 2004, EXP ECON, V7, P171, DOI 10.1023/B:EXEC.0000026978.14316.74; Osborne M. J., 2004, INTRO GAME THEORY; Ostrom E, 2010, AM ECON REV, V100, P641, DOI 10.1257/aer.100.3.641; OSTROM V, 1961, AM POLIT SCI REV, V55, P831, DOI 10.2307/1952530; Pacheco JM, 2009, P ROY SOC B-BIOL SCI, V276, P315, DOI 10.1098/rspb.2008.1126; Page KM, 2000, P ROY SOC B-BIOL SCI, V267, P2177, DOI 10.1098/rspb.2000.1266; Perc M, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0997; Perc M, 2010, BIOSYSTEMS, V99, P109, DOI 10.1016/j.biosystems.2009.10.003; Piff PK, 2010, J PERS SOC PSYCHOL, V99, P771, DOI 10.1037/a0020092; Pinheiro FL, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.098702; Rand DG, 2013, P NATL ACAD SCI USA, V110, P2581, DOI 10.1073/pnas.1214167110; Rees MA, 2009, NEW ENGL J MED, V360, P1096, DOI 10.1056/NEJMoa0803645; Rendell L, 2010, SCIENCE, V328, P208, DOI 10.1126/science.1184719; ROTH AE, 1991, AM ECON REV, V81, P1068; Rousseau DM, 1998, ACAD MANAGE REV, V23, P393, DOI 10.5465/AMR.1998.926617; Sanfey AG, 2003, SCIENCE, V300, P1755, DOI 10.1126/science.1082976; Santos FC, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.056128; Santos FC, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.098104; Santos FC, 2006, P NATL ACAD SCI USA, V103, P3490, DOI 10.1073/pnas.0508201103; Santos FP, 2016, LECT NOTES ARTIF INT, V10002, P107, DOI 10.1007/978-3-319-46882-2_7; Santos FP, 2015, PROCEEDINGS OF THE 2015 INTERNATIONAL CONFERENCE ON AUTONOMOUS AGENTS & MULTIAGENT SYSTEMS (AAMAS'15), P1847; Santos FP, 2016, FRONT ARTIF INTEL AP, V285, P1592, DOI 10.3233/978-1-61499-672-9-1592; Santos FP, 2015, J THEOR BIOL, V378, P96, DOI 10.1016/j.jtbi.2015.04.025; Santos FC, 2008, NATURE, V454, P213, DOI 10.1038/nature06940; Santos FC, 2006, PLOS COMPUT BIOL, V2, P1284, DOI 10.1371/journal.pcbi.0020140; Santos FC, 2011, P NATL ACAD SCI USA, V108, P10421, DOI 10.1073/pnas.1015648108; Santos MD, 2012, J THEOR BIOL, V315, P81, DOI 10.1016/j.jtbi.2012.09.001; Sigmund K, 2010, PRINC SER THEOR COMP, P1; Sigmund K, 2010, NATURE, V466, P861, DOI 10.1038/nature09203; Sinatra R, 2009, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2009/09/P09012; Szabo G, 2007, PHYS REP, V446, P97, DOI 10.1016/j.physrep.2007.04.004; Szolnoki A, 2012, EPL-EUROPHYS LETT, V100, DOI 10.1209/0295-5075/100/28005; Szolnoki A, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.078701; Tang CS., 2008, WALL STREET J E EDIT, V251; Tomasello M, 1997, PRIMATE COGNITION; Traulsen A, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.011909; Uzzi B, 1996, AM SOCIOL REV, V61, P674, DOI 10.2307/2096399; Vasconcelos VV, 2015, MATH MOD METH APPL S, P1; Vukov J, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002868; Vukov J, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/6/063031; Vukov J, 2011, J THEOR BIOL, V287, P37, DOI 10.1016/j.jtbi.2011.07.022; Vukov J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017939; Wang Z, 2013, SCI REP-UK, V3, DOI 10.1038/srep03055; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Xulvi-Brunet R, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.026118	79	9	9	4	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2017	12	4							e0175687	10.1371/journal.pone.0175687	http://dx.doi.org/10.1371/journal.pone.0175687			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET0MD	28410385	Green Published, Green Submitted, gold			2022-12-27	WOS:000399955600035
J	Chen, Q; Vieth, M; Timm, DE; Humblet, C; Schneidman-Duhovny, D; Chemmama, IE; Sali, A; Zeng, W; Lu, JR; Liu, L				Chen, Qi; Vieth, Michal; Timm, David E.; Humblet, Christine; Schneidman-Duhovny, Dina; Chemmama, Ilan E.; Sali, Andrej; Zeng, Wei; Lu, Jirong; Liu, Ling			Reconstruction of 3D structures of MET antibodies from electron microscopy 2D class averages	PLOS ONE			English	Article							CRYO-EM STRUCTURE; BETA-GALACTOSIDASE; LARGE NUMBER; MECHANISM; COMPLEX	Dynamics of three MET antibody constructs (IgG1, IgG2, and IgG4) and the IgG4-MET antigen complex was investigated by creating their atomic models with an integrative experimental and computational approach. In particular, we used two-dimensional (2D) Electron Microscopy (EM) images, image class averaging, homology modeling, Rapidly exploring Random Tree (RRT) structure sampling, and fitting of models to images, to find the relative orientations of antibody domains that are consistent with the EM images. We revealed that the conformational preferences of the constructs depend on the extent of the hinge flexibility. We also quantified how the MET antigen impacts on the conformational dynamics of IgG4. These observations allow to create testable hypothesis to investigate MET biology. Our protocol may also help describe structural diversity of other antigen systems at approximately 5 angstrom precision, as quantified by Root-Mean-Square Deviation (RMSD) among good-scoring models.	[Chen, Qi; Vieth, Michal; Timm, David E.; Humblet, Christine; Zeng, Wei; Lu, Jirong; Liu, Ling] Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA; [Schneidman-Duhovny, Dina; Chemmama, Ilan E.; Sali, Andrej] Univ Calif San Francisco, Dept Pharmaceut Chem, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA; [Schneidman-Duhovny, Dina; Chemmama, Ilan E.; Sali, Andrej] Univ Calif San Francisco, Calif Inst Quantitat Biosci, San Francisco, CA 94143 USA	Eli Lilly; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Chen, Q; Vieth, M (corresponding author), Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA.	chen_qi_qc@lilly.com; vieth_michal@lilly.com	Schneidman, Dina/ABH-6654-2020	Schneidman, Dina/0000-0003-0480-0438; Chemmama, Ilan E./0000-0002-5657-3516	Eli Lilly and Company; NIH [P41 GM109824, R01 GM083960]; NSF; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM109824, T32GM008284, R01GM083960] Funding Source: NIH RePORTER	Eli Lilly and Company(Eli Lilly); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Eli Lilly and Company provided support inthe form of research materials for authors (QC,MV, DET, CH, WZ, JL, LL). The IMP softwaredevelopment was funded in part by NIH grants toAS, including P41 GM109824 and R01 GM083960. IEC is supported by the NSF Graduate Student Research Fellowship. The funders had no role in study design, data collection and analysis, decisionto publish, or preparation of the manuscript.; The authors would like to thank Dr. Jeremy Desaphy for technical supports of protein structure analysis and Dr. Phil Hipskind for his help to initiate the EM studies. The authors would like to thank Dr. Bridget Carrager (Nanolmaging Services Inc.) for helpful discussions on interpreting EM images. The EM data collection was performed by Nanolmaging Services, Inc., 10835 Road to the Cure, Suite 150, San Diego, CA 92121. The IMP software development was funded in part by NIH grants to AS, including P41 GM109824 and R01 GM083960. I.E.C is supported by the NSF Graduate Student Research Fellowship.	Alber F, 2007, NATURE, V450, P683, DOI 10.1038/nature06404; [Anonymous], PYMOL MOL GRAPH SYST; [Anonymous], 2015, SCHROD REL 2015 4; Bai XC, 2015, NATURE, V525, P212, DOI 10.1038/nature14892; Banerjee S, 2016, SCIENCE, V351, P871, DOI 10.1126/science.aad7974; Bartesaghi A, 2015, SCIENCE, V348, P1147, DOI 10.1126/science.aab1576; Bartesaghi A, 2014, P NATL ACAD SCI USA, V111, P11709, DOI 10.1073/pnas.1402809111; Booth DS, 2011, JOVE-J VIS EXP, DOI 10.3791/3227; Brignole EJ, 2009, NAT STRUCT MOL BIOL, V16, P190, DOI 10.1038/nsmb.1532; Correia I, 2013, MABS-AUSTIN, V5, P364, DOI 10.4161/mabs.24258; Eisenstein M, 2016, NAT METHODS, V13, P19, DOI 10.1038/nmeth.3698; Fischer M, 2015, PROTEIN SCI, V24, P987, DOI 10.1002/pro.2678; Fischer N, 2015, NATURE, V520, P567, DOI 10.1038/nature14275; Glaeser RM, 2016, NAT METHODS, V13, P28, DOI 10.1038/nmeth.3695; Harris LJ, 1998, J MOL BIOL, V275, P861, DOI 10.1006/jmbi.1997.1508; Harris LJ, 1997, BIOCHEMISTRY-US, V36, P1581, DOI 10.1021/bi962514+; HODES L, 1991, J CHEM INF COMP SCI, V31, P347, DOI 10.1021/ci00002a023; HODES L, 1989, J CHEM INF COMP SCI, V29, P66, DOI 10.1021/ci00062a004; Lambert JM, 2015, MOL PHARMACEUT, V12, P1701, DOI 10.1021/acs.molpharmaceut.5b00302; Lander GC, 2009, J STRUCT BIOL, V166, P95, DOI 10.1016/j.jsb.2009.01.002; LaValle SMKJ, 2001, INT J ROBOTICS RES I, V20; Lavalle Steven M., 1998, TECHNICAL REPORT; Liu L, 2014, CLIN CANCER RES, V20, P6059, DOI 10.1158/1078-0432.CCR-14-0543; London N, 2008, STRUCTURE, V16, P269, DOI 10.1016/j.str.2007.11.013; Merchant M, 2013, P NATL ACAD SCI USA, V110, pE2987, DOI 10.1073/pnas.1302725110; Morton P, 2003, PROCEEDINGS OF THE 9; Niemann HH, 2007, CELL, V130, P235, DOI 10.1016/j.cell.2007.05.037; Prat M, 1998, J CELL SCI, V111, P237; Russel D, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001244; Saphire EO, 2001, SCIENCE, V293, P1155, DOI 10.1126/science.1061692; Sorzano COS, 2004, J STRUCT BIOL, V148, P194, DOI 10.1016/j.jsb.2004.06.006; Sun L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8548; Tong HM, 2013, SCI REP-UK, V3, DOI 10.1038/srep01089; Velazquez-Muriel J, 2012, P NATL ACAD SCI USA, V109, P18821, DOI 10.1073/pnas.1216549109; Zhang JJ, 2012, P NATL ACAD SCI USA, V109, P9845, DOI 10.1073/pnas.1205945109; Zhang XY, 2015, SCI REP-UK, V5, DOI [10.1038/srep09940, 10.1038/srep09803]; Zheng Z, 2003, P 94 ANN M AM ASS CA	37	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2017	12	4							e0175758	10.1371/journal.pone.0175758	http://dx.doi.org/10.1371/journal.pone.0175758			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0MB	28406969	Green Published, gold, Green Submitted			2022-12-27	WOS:000399955400090
J	Mun, SE; Sim, BW; Yoon, SB; Jeong, PS; Yang, HJ; Choi, SA; Park, YH; Kim, YH; Kang, P; Jeong, KJ; Lee, Y; Jin, YB; Song, BS; Kim, JS; Huh, JW; Lee, SR; Choo, YK; Kim, SU; Chang, KT				Mun, Seong-Eun; Sim, Bo-Woong; Yoon, Seung-Bin; Jeong, Pil-Soo; Yang, Hae-Jun; Choi, Seon-A; Park, Young-Ho; Kim, Young-Hyun; Kang, Philyong; Jeong, Kang-Jin; Lee, Youngjeon; Jin, Yeung Bae; Song, Bong-Seok; Kim, Ji-Su; Huh, Jae-Won; Lee, Sang-Rae; Choo, Young-Kuk; Kim, Sun-Uk; Chang, Kyu-Tae			Dual effect of fetal bovine serum on early development depends on stage-specific reactive oxygen species demands in pigs	PLOS ONE			English	Article							PORCINE PREIMPLANTATION EMBRYOS; IN-VITRO MATURATION; INNER CELL MASS; OXIDATIVE STRESS; CULTURE-MEDIA; OOCYTE MATURATION; NUCLEAR TRANSFER; GROWTH-FACTOR; STEM-CELLS; ROS	Despite the application of numerous supplements to improve in vitro culture (IVC) conditions of mammalian cells, studies regarding the effect of fetal bovine serum (FBS) on mammalian early embryogenesis, particularly in relation to redox homeostasis, are lacking. Herein, we demonstrated that early development of in vitro-produced (IVP) porcine embryos highly depends on the combination of FBS supplementation timing and embryonic reactive oxygen species (ROS) requirements. Interestingly, FBS significantly reduced intracellular ROS levels in parthenogenetically activated (PA) embryos regardless of the developmental stage. However, the beneficial effect of FBS on early embryogenesis was found only during the late phase (IVC 4-6 days) treatment group. In particular, developmental competence parameters, such as blastocyst formation rate, cellular survival, total cell number and trophectoderm proportion, were markedly increased by FBS supplementation during the late IVC phase. In addition, treatment with FBS elevated antioxidant transcript levels during the late IVC phase. In contrast, supplementation with FBS during the entire period (1-6 days) or during the early IVC phase (1-2 days) greatly impaired the developmental parameters. Consistent with the results from PA embryos, the developmental competence of in vitro fertilization (IVF) or somatic cell nuclear transfer (SCNT) embryos were markedly improved by treatment with FBS during the late IVC phase. Moreover, the embryonic stage-specific effects of FBS were reversed by the addition of an oxidant and were mimicked by treatment with an antioxidant. These findings may increase our understanding of redox-dependent early embryogenesis and contribute to the large-scale production of high-quality IVP embryos.	[Mun, Seong-Eun; Sim, Bo-Woong; Yoon, Seung-Bin; Jeong, Pil-Soo; Yang, Hae-Jun; Choi, Seon-A; Park, Young-Ho; Kim, Young-Hyun; Kang, Philyong; Jeong, Kang-Jin; Lee, Youngjeon; Jin, Yeung Bae; Song, Bong-Seok; Kim, Ji-Su; Huh, Jae-Won; Lee, Sang-Rae; Kim, Sun-Uk; Chang, Kyu-Tae] Korea Res Inst Biosci & Biotechnol, Natl Primate Res Ctr, Chungcheongbuk Do, South Korea; [Mun, Seong-Eun; Sim, Bo-Woong; Yoon, Seung-Bin; Jeong, Pil-Soo; Yang, Hae-Jun; Choi, Seon-A; Park, Young-Ho; Kim, Young-Hyun; Kang, Philyong; Jeong, Kang-Jin; Lee, Youngjeon; Jin, Yeung Bae; Song, Bong-Seok; Kim, Ji-Su; Huh, Jae-Won; Lee, Sang-Rae; Kim, Sun-Uk; Chang, Kyu-Tae] Korea Res Inst Biosci & Biotechnol, Futurist Anim Resource & Res Ctr, Chungcheongbuk Do, South Korea; [Mun, Seong-Eun; Yang, Hae-Jun; Choo, Young-Kuk] Wonkwang Univ, Dept Biol Sci, Coll Nat Sci, Jeollabuk Do, South Korea; [Park, Young-Ho; Kim, Young-Hyun; Kim, Ji-Su; Huh, Jae-Won; Lee, Sang-Rae; Kim, Sun-Uk; Chang, Kyu-Tae] Univ Sci & Technol, Dept Funct Genom, Daejeon, South Korea	Korea Research Institute of Bioscience & Biotechnology (KRIBB); Korea Research Institute of Bioscience & Biotechnology (KRIBB); Wonkwang University; University of Science & Technology (UST)	Kim, SU; Chang, KT (corresponding author), Korea Res Inst Biosci & Biotechnol, Natl Primate Res Ctr, Chungcheongbuk Do, South Korea.; Kim, SU; Chang, KT (corresponding author), Korea Res Inst Biosci & Biotechnol, Futurist Anim Resource & Res Ctr, Chungcheongbuk Do, South Korea.; Kim, SU; Chang, KT (corresponding author), Univ Sci & Technol, Dept Funct Genom, Daejeon, South Korea.	sunuk@kribb.re.kr; changkt@kribb.re.kr		Jeong, Pil-Soo/0000-0002-8477-4358; Lee, Youngjeon/0000-0002-5387-3441; YOON, SEUNG-BIN/0000-0002-0056-4995	KRIBB Research Initiative Programs [KGM4251723]; Bio & Medical Technology Development Program of the NRF - Korean government, MSIP [NRF2012M3A9B6055362]; Next-Generation BioGreen 21 Program, Rural Development Administration, Republic of Korea [PJ0099592016]	KRIBB Research Initiative Programs; Bio & Medical Technology Development Program of the NRF - Korean government, MSIP; Next-Generation BioGreen 21 Program, Rural Development Administration, Republic of Korea	This study was supported by grants from the KRIBB Research Initiative Programs (KGM4251723), the Bio & Medical Technology Development Program of the NRF funded by the Korean government, MSIP (NRF2012M3A9B6055362), and the Next-Generation BioGreen 21 Program (PJ0099592016), Rural Development Administration, Republic of Korea.	Agarwal A, 2005, REPROD BIOMED ONLINE, V11, P641, DOI 10.1016/S1472-6483(10)61174-1; AITKEN RJ, 1989, BIOL REPROD, V41, P183, DOI 10.1095/biolreprod41.1.183; Bain NT, 2011, REPROD FERT DEVELOP, V23, P561, DOI 10.1071/RD10148; Bauer BK, 2010, BIOL REPROD, V83, P791, DOI 10.1095/biolreprod.110.085936; Bavister BD, 1995, HUM REPROD UPDATE, V1, P91, DOI 10.1093/humupd/1.2.91; Beebe LFS, 2009, CLONING STEM CELLS, V11, P477, DOI 10.1089/clo.2009.0029; Bigarella CL, 2014, DEVELOPMENT, V141, P4206, DOI 10.1242/dev.107086; Booth PJ, 2005, THERIOGENOLOGY, V63, P2040, DOI 10.1016/j.theriogenology.2004.10.001; Consiglio AL, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-113; Cross P C, 1970, Biol Reprod, V3, P298; Cui Hang, 2012, J Signal Transduct, V2012, P646354, DOI 10.1155/2012/646354; Day BN, 2000, ANIM REPROD SCI, V60, P161, DOI 10.1016/S0378-4320(00)00079-8; deMoraes AAS, 1997, BIOL REPROD, V57, P1060, DOI 10.1095/biolreprod57.5.1060; Dobrinsky JR, 1996, BIOL REPROD, V55, P1069, DOI 10.1095/biolreprod55.5.1069; DUCIBELLA T, 1990, DEV BIOL, V137, P46, DOI 10.1016/0012-1606(90)90006-5; Fujii J, 2005, REPROD BIOL ENDOCRIN, V3, DOI 10.1186/1477-7827-3-43; Funahashi H, 2005, REPRODUCTION, V130, P889, DOI 10.1530/rep.1.00702; Gun G, 2014, BIORESEARCH OPEN ACC, V3, P255, DOI 10.1089/biores.2014.0039; Guerin P, 2001, HUM REPROD UPDATE, V7, P175, DOI 10.1093/humupd/7.2.175; Gupta MK, 2010, FERTIL STERIL, V93, P2602, DOI 10.1016/j.fertnstert.2010.01.043; HALLIWELL B, 1991, FEBS LETT, V281, P9, DOI 10.1016/0014-5793(91)80347-6; Han MS, 2003, J REPROD DEVELOP, V49, P235; Hashem MA, 2006, J REPROD DEVELOP, V52, P591, DOI 10.1262/jrd.18010; Hemann M, 2012, VET RES COMMUN, V36, P187, DOI 10.1007/s11259-012-9524-z; Heo JS, 2011, J CELL BIOCHEM, V112, P1880, DOI 10.1002/jcb.23108; Hu J, 2012, REPROD DOMEST ANIM, V47, P873, DOI 10.1111/j.1439-0531.2011.01982.x; Jimenez A, 2003, MOL REPROD DEV, V65, P180, DOI 10.1002/mrd.10286; Kikuchi K, 2004, J REPROD DEVELOP, V50, P21, DOI 10.1262/jrd.50.21; Kim J, 2010, P 2010 S CRYPT INF S, V22, P2010, DOI DOI 10.1071/RD08287; Kim S, 2006, MOL REPROD DEV, V73, P1523, DOI 10.1002/mrd.20531; Kitagawa Y, 2004, THERIOGENOLOGY, V62, P1186, DOI 10.1016/j.theriogenology.2004.01.011; Knijn HM, 2003, BIOL REPROD, V69, P1371, DOI 10.1095/biolreprod.103.017251; Koo DB, 2004, THERIOGENOLOGY, V62, P779, DOI 10.1016/j.theriogenology.2003.12.027; Koo DB, 2002, BIOL REPROD, V67, P487, DOI 10.1095/biolreprod67.2.487; Kwak SS, 2012, THERIOGENOLOGY, V78, P86, DOI 10.1016/j.theriogenology.2012.01.024; Lonergan P, 1999, THERIOGENOLOGY, V51, P1565, DOI 10.1016/S0093-691X(99)00099-0; Long CR, 1999, THERIOGENOLOGY, V51, P1375, DOI 10.1016/S0093-691X(99)00081-3; Lopes AS, 2010, HUM REPROD, V25, P2762, DOI 10.1093/humrep/deq221; Machaty Z, 1998, BIOL REPROD, V59, P451, DOI 10.1095/biolreprod59.2.451; Mingoti GZ, 2011, IN VITRO CELL DEV-AN, V47, P361, DOI 10.1007/s11626-011-9400-0; Nam DH, 2005, THERIOGENOLOGY, V63, P190, DOI 10.1016/j.theriogenology.2004.04.004; Nguyen NT, 2009, REPROD FERT DEVELOP, V21, P805, DOI 10.1071/RD08277; Nilsson EE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020087; Ou XH, 2012, HUM REPROD, V27, P2130, DOI 10.1093/humrep/des137; PAPAIOANNOU VE, 1988, DEVELOPMENT, V102, P793; Park SH, 2014, REPROD DOMEST ANIM, V49, P370, DOI 10.1111/rda.12281; Phelps CJ, 2003, SCIENCE, V299, P411, DOI 10.1126/science.1078942; Pi JB, 2010, TOXICOL APPL PHARM, V244, P77, DOI 10.1016/j.taap.2009.05.025; PINYOPUMMINTR T, 1991, BIOL REPROD, V45, P736, DOI 10.1095/biolreprod45.5.736; POLLARD JW, 1995, J REPROD FERTIL, V103, P331, DOI 10.1530/jrf.0.1030331; Pomar FJR, 2005, THERIOGENOLOGY, V63, P2254, DOI 10.1016/j.theriogenology.2004.10.015; Radak Z, 2013, ANTIOXID REDOX SIGN, V18, P1208, DOI 10.1089/ars.2011.4498; Rauch C, 2011, ALTEX-ALTERN ANIM EX, V28, P305, DOI 10.14573/altex.2011.4.305; Redel BK, 2016, MOL REPROD DEV, V83, P246, DOI 10.1002/mrd.22618; Riley JK, 2005, DEV BIOL, V284, P377, DOI 10.1016/j.ydbio.2005.05.033; Rios GL, 2015, THERIOGENOLOGY, V83, P874, DOI 10.1016/j.theriogenology.2014.11.022; ROMIJN HJ, 1984, NEUROSCI BIOBEHAV R, V8, P301, DOI 10.1016/0149-7634(84)90055-1; Schieber M, 2014, CURR BIOL, V24, pR453, DOI 10.1016/j.cub.2014.03.034; Sozen B, 2015, MECH DEVELOP, V138, P375, DOI 10.1016/j.mod.2015.05.002; Suzuki C, 2007, ZYGOTE, V15, P317, DOI 10.1017/S0967199407004273; Tareq KMA, 2012, J REPROD DEVELOP, V58, P621, DOI 10.1262/jrd.2012-064; Tornesi MB, 1996, VET RES COMMUN, V20, P15, DOI 10.1007/BF00346571; van der Valk J, 2010, TOXICOL IN VITRO, V24, P1053, DOI 10.1016/j.tiv.2010.03.016; Vaquero EC, 2004, J BIOL CHEM, V279, P34643, DOI 10.1074/jbc.M400078200; Watanabe M, 2012, TRANSGENIC RES, V21, P605, DOI 10.1007/s11248-011-9561-3; Wu GQ, 2011, THERIOGENOLOGY, V76, P785, DOI 10.1016/j.theriogenology.2011.04.011; Yang HW, 1998, HUM REPROD, V13, P998, DOI 10.1093/humrep/13.4.998; Yeo JE, 2008, CELL PHYSIOL BIOCHEM, V21, P225, DOI 10.1159/000113764; Yoon SB, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.113.113480; You J, 2010, THERIOGENOLOGY, V74, P777, DOI 10.1016/j.theriogenology.2010.04.002	70	21	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2017	12	4							e0175427	10.1371/journal.pone.0175427	http://dx.doi.org/10.1371/journal.pone.0175427			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0MB	28406938	Green Published, gold, Green Submitted			2022-12-27	WOS:000399955400050
J	Rudert, SC; Janke, S; Greifeneder, R				Rudert, Selma Carolin; Janke, Stefan; Greifeneder, Rainer			Under threat by popular vote: German-speaking immigrants' affect and cognitions following the Swiss vote against mass immigration	PLOS ONE			English	Article							LIFE SATISFACTION; SOCIAL EXCLUSION; INTERGROUP EMOTIONS; DESPISED OUTGROUP; SELF-ESTEEM; OSTRACISM; SUPPORT; REJECTION; NEED; HURT	A popular initiative in support of regulating future immigration to Switzerland was accepted by the electorate in 2014. Assuming that the initiative acted as an exclusionary threat for current immigrants of Switzerland, we conducted an online survey among a sample of highly-skilled German-speaking immigrants ("expats"). Participants reported having experienced negative affect following the vote. Moreover, having a more left-wing orientation, living in a political constituency that had voted pro-regulation and having proportionally few Swiss friends positively predicted negative affect following the vote. Negative affect was associated with a reported negative change in one's attitudes towards Switzerland, increased considerations to leave the country, and impaired satisfaction with life. In sum, the results suggest that a powerful exclusionary threat such as a national vote may be experienced as distressful by highly-skilled immigrants currently living in the country.	[Rudert, Selma Carolin; Greifeneder, Rainer] Univ Basel, Dept Psychol, Basel, Switzerland; [Janke, Stefan] Univ Mannheim, Dept Psychol, Mannheim, Germany	University of Basel; University of Mannheim	Rudert, SC (corresponding author), Univ Basel, Dept Psychol, Basel, Switzerland.	selma.rudert@unibas.ch	Janke, Stefan/J-7719-2016; Rudert, Selma C./X-3902-2019	Janke, Stefan/0000-0003-1799-8850; Rudert, Selma C./0000-0001-5986-2447; Greifeneder, Rainer/0000-0002-0725-5626				Asbrock F, 2014, SAGE OPEN, V4, DOI 10.1177/2158244014532819; BAUMEISTER RF, 1995, PSYCHOL BULL, V117, P497, DOI 10.1037/0033-2909.117.3.497; BENTLER PM, 1987, SOCIOL METHOD RES, V16, P78, DOI 10.1177/0049124187016001004; Blascovich J, 2001, J PERS SOC PSYCHOL, V80, P253, DOI 10.1037//0022-3514.80.2.253; Bundesamt fur Statistik, 2016, ERW TIGK ARB DET ERG; Bundesamt fur Statistik, 2016, POP SIZ POP COMP; Butera F, 2009, COPING MINORITY STAT; Chen ZS, 2008, PSYCHOL SCI, V19, P789, DOI 10.1111/j.1467-9280.2008.02158.x; Chow HPH, 2007, J ETHN MIGR STUD, V33, P511, DOI 10.1080/13691830701234830; Craig MA, 2014, POLIT PSYCHOL, V35, P417, DOI 10.1111/pops.12078; Eck J, SOCIAL EXCLUSION PSY; Eck J, 2016, EUROPEAN J SOCIAL PS; Eisenberger NI, 2003, SCIENCE, V302, P290, DOI 10.1126/science.1089134; Fayant MP, 2014, SOC PSYCHOL-GERMANY, V45, P489, DOI 10.1027/1864-9335/a000209; Fleishman J.A., 1978, US SOC PSYCHOL, V41, P306; Gardner W.L., 2005, SOCIAL OUTCAST OSTRA, P227, DOI DOI 10.4324/9780203942888; Gerber J, 2009, PERSPECT PSYCHOL SCI, V4, P468, DOI 10.1111/j.1745-6924.2009.01158.x; Glaesmer H, 2011, EUR J PSYCHOL ASSESS, V27, P127, DOI 10.1027/1015-5759/a000058; Gonsalkorale K, 2007, EUR J SOC PSYCHOL, V37, P1176, DOI 10.1002/ejsp.392; Gradstein M, 2006, J POPUL ECON, V19, P327, DOI 10.1007/s00148-005-0016-0; Green EGT, 2010, INT J CONFL VIOLENCE, V4, P177; Greene JD, 2008, COGNITION, V107, P1144, DOI 10.1016/j.cognition.2007.11.004; Haisken-DeNew JP, 2007, RUHR EC PAPERS, V31, P4; Helbling M, 2011, EUR SOC, V13, P5, DOI 10.1080/14616696.2010.533784; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Jasinskaja-Lahti I, 2006, J CROSS CULT PSYCHOL, V37, P293, DOI 10.1177/0022022106286925; Kahneman D, 2003, AM PSYCHOL, V58, P697, DOI 10.1037/0003-066X.58.9.697; Kerr NL, 2008, GROUP DYN-THEOR RES, V12, P39, DOI 10.1037/1089-2699.12.1.39; Knausenberger J, 2015, EUR J SOC PSYCHOL, V45, P279, DOI 10.1002/ejsp.2035; Koivumaa-Honkanen H, 2004, SOC PSYCH PSYCH EPID, V39, P994, DOI 10.1007/s00127-004-0833-6; Kurzban R, 2001, PSYCHOL BULL, V127, P187, DOI 10.1037//0033-2909.127.2.187; LEARY MR, 1995, J PERS SOC PSYCHOL, V68, P518, DOI 10.1037/0022-3514.68.3.518; Lucas T, 2014, POLIT PSYCHOL, V35, P775, DOI 10.1111/pops.12204; MacCallum RC, 1996, PSYCHOL METHODS, V1, P130, DOI 10.1037/1082-989X.1.2.130; MacDonald G, 2005, PSYCHOL BULL, V131, P202, DOI 10.1037/0033-2909.131.2.202; Mackie DM, 2008, SOC PERSONAL PSYCHOL, V2, P1866, DOI 10.1111/j.1751-9004.2008.00130.x; Mackie DM, 2000, J PERS SOC PSYCHOL, V79, P602, DOI 10.1037//0022-3514.79.4.602; Maner JK, 2007, J PERS SOC PSYCHOL, V92, P42, DOI 10.1037/0022-3514.92.1.42; Mellor D, 2008, PERS INDIV DIFFER, V45, P213, DOI 10.1016/j.paid.2008.03.020; Miguet F, 2008, EUR J POLIT ECON, V24, P628, DOI 10.1016/j.ejpoleco.2008.06.005; Moeckli D, 2011, HUM RIGHTS LAW REV, V11, P774, DOI 10.1093/hrlr/ngr026; Muthen L. K., 2017, MPLUS USERS GUIDE, DOI DOI 10.1111/J.1600-0447.2011.01711.X; Nezlek JB, 2012, GROUP DYN-THEOR RES, V16, P91, DOI 10.1037/a0028029; Nunnally JC, 1994, PSYCHOMETRIC THEORY, V3rd, DOI DOI 10.1037/018882; Pettigrew TF, 1997, PERS SOC PSYCHOL B, V23, P173, DOI 10.1177/0146167297232006; Pfattheicher S, PLOS ONE IN PRESS; Pfundmair M, 2015, PERS SOC PSYCHOL B, V41, P363, DOI 10.1177/0146167214566186; Reis HT, 2000, PERS SOC PSYCHOL B, V26, P419, DOI 10.1177/0146167200266002; Ren DM, 2016, SOC PSYCHOL PERS SCI, V7, P204, DOI 10.1177/1948550615616169; Riva P, 2016, J SOCIAL PERSONAL RE, V34, P1; Riva P, 2014, PAIN, V155, P485, DOI 10.1016/j.pain.2013.11.006; Rudert SC, 2017, PERSONALITY SOCIAL P; Rudert SC, 2016, PERS SOC PSYCHOL B, V42, P955, DOI 10.1177/0146167216649606; Rudert SC, 2017, J EXP SOC PSYCHOL, V68, P101, DOI 10.1016/j.jesp.2016.06.005; Safi M, 2010, EUR SOCIOL REV, V26, P159, DOI 10.1093/esr/jcp013; Sarrasin O, 2012, POLIT PSYCHOL, V33, P659, DOI 10.1111/j.1467-9221.2012.00895.x; Schermelleh-Engel K, 2003, METHODS PSYCHOL RES, V8, P23, DOI DOI 10.1002/0470010940; Schmitt MT, 2003, EUR J SOC PSYCHOL, V33, P1, DOI 10.1002/ejsp.131; Schoel C, 2014, SOC PSYCHOL PERS SCI, V5, P149, DOI 10.1177/1948550613488953; SCHWARZ N, 1991, PUBLIC OPIN QUART, V55, P3, DOI 10.1086/269239; Schweizerische Bundeskanzlei, 2016, VORL 580 RES KANT; Schweizerische Bundeskanzlei, 2016, EIDG VOLKS GEG MASS; Shnabel N, 2009, PERS SOC PSYCHOL B, V35, P1021, DOI 10.1177/0146167209336610; Siewert Peter, 2002, OSTRAKISMOS TESTIMON, VI; SILVER H, 1994, INT LABOUR REV, V133, P531; Slotwinski M, 2015, IZA DISCUSSION PAPER; Teng F, 2012, J EXP SOC PSYCHOL, V48, P1192, DOI 10.1016/j.jesp.2012.03.014; Turner RN, 2007, EUR REV SOC PSYCHOL, V18, P212, DOI 10.1080/10463280701680297; Tuscherer T, 2016, EUR J SOC PSYCHOL, V46, P280, DOI 10.1002/ejsp.2152; van Beest I, 2006, J PERS SOC PSYCHOL, V91, P918, DOI 10.1037/0022-3514.91.5.918; Verkuyten M, 2008, SOC INDIC RES, V89, P391, DOI 10.1007/s11205-008-9239-2; Walton GM, 2011, SCIENCE, V331, P1447, DOI 10.1126/science.1198364; Wesselmann E. D., 2012, J SOCIAL EVOLUTIONAR, V6, P309, DOI [10.1037/h0099249, DOI 10.1037/H0099249]; Wesselmann ED, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00153; Wesselmann ED, 2010, AGGRESSIVE BEHAV, V36, P232, DOI 10.1002/ab.20347; Wesselmann ED, 2009, J EXP SOC PSYCHOL, V45, P1308, DOI 10.1016/j.jesp.2009.08.003; Wessendorf S, 2008, SOC ANTHROPOL, V16, P187, DOI 10.1111/j.1469-8676.2008.00031.x; Williams KD, 2000, J PERS SOC PSYCHOL, V79, P748, DOI 10.1037/0022-3514.79.5.748; Williams KD, 2007, ANNU REV PSYCHOL, V58, P425, DOI 10.1146/annurev.psych.58.110405.085641; Williams KD, 2009, ADV EXP SOC PSYCHOL, V41, P275, DOI 10.1016/S0065-2601(08)00406-1; Wilson TC, 2001, SOCIOL PERSPECT, V44, P485, DOI 10.1525/sop.2001.44.4.485; Wirth JH, 2009, GROUP PROCESS INTERG, V12, P111, DOI 10.1177/1368430208098780; Zadro L, 2004, J EXP SOC PSYCHOL, V40, P560, DOI 10.1016/j.jesp.2003.11.006; Zadro L, 2006, J EXP SOC PSYCHOL, V42, P692, DOI 10.1016/j.jesp.2005.10.007; Zhou XY, 2008, PSYCHOL INQ, V19, P127, DOI 10.1080/10478400802587679	85	5	5	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2017	12	4							e0175896	10.1371/journal.pone.0175896	http://dx.doi.org/10.1371/journal.pone.0175896			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET0MB	28406990	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000399955400106
J	Remmers, IM; Martens, DE; Wijffels, RH; Lamers, PP				Remmers, Ilse M.; Martens, Dirk E.; Wijffels, Rene H.; Lamers, Packo P.			Dynamics of triacylglycerol and EPA production in Phaeodactylum tricornutum under nitrogen starvation at different light intensities	PLOS ONE			English	Article							MICROALGAL TAG PRODUCTION; CHLAMYDOMONAS-REINHARDTII; SCENEDESMUS-OBLIQUUS; CHLORELLA-VULGARIS; CONTINUOUS-CULTURE; LIPID PRODUCTION; ACID PRODUCTION; ACCUMULATION; DIATOM; PHOTOBIOREACTORS	Lipid production in microalgae is highly dependent on the applied light intensity. However, for the EPA producing model-diatom Phaeodactylum tricornutum, clear consensus on the impact of incident light intensity on lipid productivity is still lacking. This study quantifies the impact of different incident light intensities on the biomass, TAG and EPA yield on light in nitrogen starved batch cultures of P. tricornutum. The maximum biomass concentration and maximum TAG and EPA contents were found to be independent of the applied light intensity. The lipid yield on light was reduced at elevated light intensities (> 100 mu mol m(-2) s(-1)). The highest TAG yield on light (112 mg TAG mol(ph)(-1)) was found at the lowest light intensity tested (60 mu mol m(-2) s(-1)), which is still relatively low to values reported in literature for other algae. Furthermore, mass balance analysis showed that the EPA fraction in TAG may originate from photosynthetic membrane lipids.	[Remmers, Ilse M.; Martens, Dirk E.; Wijffels, Rene H.; Lamers, Packo P.] Wageningen Univ & Res, Bioproc Engn, Wageningen, Netherlands; [Remmers, Ilse M.; Martens, Dirk E.; Wijffels, Rene H.; Lamers, Packo P.] Wageningen Univ & Res, AlgaePARC, Wageningen, Netherlands; [Wijffels, Rene H.] Nord Univ, Biosci & Aquaculture, Bodo, Norway	Wageningen University & Research; Wageningen University & Research; Nord University	Remmers, IM (corresponding author), Wageningen Univ & Res, Bioproc Engn, Wageningen, Netherlands.; Remmers, IM (corresponding author), Wageningen Univ & Res, AlgaePARC, Wageningen, Netherlands.	ilse.remmers@wur.nl		Wijffels, Rene/0000-0001-7630-4295	European Union's Seventh Programme for Research and Technology Development (EU-FP7) [308983]	European Union's Seventh Programme for Research and Technology Development (EU-FP7)	This work was carried our within the EU project Fuel4Me. Fuel4Me was funded by the European Union's Seventh Programme for Research and Technology Development (EU-FP7) under grant agreement No. 308983. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abida H, 2015, PLANT PHYSIOL, V167, P118, DOI 10.1104/pp.114.252395; Adarme-Vega TC, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-96; Alonso DL, 2000, PHYTOCHEMISTRY, V54, P461, DOI 10.1016/S0031-9422(00)00084-4; Bailleul B, 2010, P NATL ACAD SCI USA, V107, P18214, DOI 10.1073/pnas.1007703107; Benvenuti G, 2016, J APPL PHYCOL, V28, P3167, DOI 10.1007/s10811-016-0897-1; Benvenuti G, 2016, BIOTECHNOL BIOFUELS, V9, DOI 10.1186/s13068-016-0475-4; Benvenuti G, 2015, J APPL PHYCOL, V27, P1425, DOI 10.1007/s10811-014-0470-8; Perez EB, 2008, BIOCHEM ENG J, V40, P520, DOI 10.1016/j.bej.2008.02.007; Breuer G, 2015, BIORESOURCE TECHNOL, V186, P294, DOI 10.1016/j.biortech.2015.03.085; Breuer G, 2014, BIOTECHNOL BIOFUELS, V7, DOI [10.1186/1754-6834-7-69, 10.1186/1754-6834-7-70]; Breuer G, 2013, BIORESOURCE TECHNOL, V143, P1, DOI 10.1016/j.biortech.2013.05.105; Breuer G, 2012, BIORESOURCE TECHNOL, V124, P217, DOI 10.1016/j.biortech.2012.08.003; Cabanelas ITD, 2016, BIOTECHNOL BIOFUELS, V9, DOI 10.1186/s13068-016-0595-x; Chauton MS, 2015, AQUACULTURE, V436, P95, DOI 10.1016/j.aquaculture.2014.10.038; Chauton MS, 2013, PLANT PHYSIOL, V161, P1034, DOI 10.1104/pp.112.206177; de Mooij T, 2016, J BIOTECHNOL, V240, P1, DOI 10.1016/j.jbiotec.2016.10.009; de Mooij T, 2015, J APPL PHYCOL, V27, P1063, DOI 10.1007/s10811-014-0427-y; Dillschneider R, 2013, BIORESOURCE TECHNOL, V142, P647, DOI 10.1016/j.biortech.2013.05.088; Fernandez FGA, 2003, J BIOTECHNOL, V103, P137, DOI 10.1016/S0168-1656(03)00101-9; Gatenby CM, 2003, J APPL PHYCOL, V15, P1, DOI 10.1023/A:1022929423011; GEIDER RJ, 1985, J PHYCOL, V21, P609; Griffiths MJ, 2012, J APPL PHYCOL, V24, P989, DOI 10.1007/s10811-011-9723-y; Guiheneuf F, 2013, MAR DRUGS, V11, P4246, DOI 10.3390/md11114246; Jallet D, 2016, ALGAL RES, V18, P51, DOI 10.1016/j.algal.2016.05.014; Jia J, 2015, ALGAL RES, V7, P66, DOI 10.1016/j.algal.2014.11.005; Juergens MT, 2016, PLANT PHYSIOL, V171, P2445, DOI 10.1104/pp.16.00761; KLEIN U, 1987, PLANT PHYSIOL, V85, P892, DOI 10.1104/pp.85.4.892; Lamers PP, 2010, BIOTECHNOL BIOENG, V106, P638, DOI 10.1002/bit.22725; Lavaud J, 2002, PLANT PHYSIOL, V129, P1398, DOI 10.1104/pp.002014; Munkel R, 2013, BIOTECHNOL BIOENG, V110, P2882, DOI 10.1002/bit.24948; Muhlroth A, 2013, MAR DRUGS, V11, P4662, DOI 10.3390/md11114662; Mulders KJM, 2014, ALGAL RES, V6, P8, DOI 10.1016/j.algal.2014.08.006; Norsker NH, 2011, BIOTECHNOL ADV, V29, P24, DOI 10.1016/j.biotechadv.2010.08.005; Olivieri G, 2014, J CHEM TECHNOL BIOT, V89, P178, DOI 10.1002/jctb.4218; Parkhill JP, 2001, J PHYCOL, V37, P517, DOI 10.1046/j.1529-8817.2001.037004517.x; Perin G, 2015, BIOTECHNOL BIOFUELS, V8, DOI 10.1186/s13068-015-0337-5; Postma PR, 2015, BIORESOURCE TECHNOL, V184, P297, DOI 10.1016/j.biortech.2014.09.033; Reis A, 1996, BIORESOURCE TECHNOL, V55, P83, DOI 10.1016/0960-8524(95)00157-3; Richmond A, 2008, HDB MICROALGAL CULTU; Ritchie RJ, 2008, PHOTOSYNTH RES, V96, P201, DOI 10.1007/s11120-008-9300-7; Ruiz J, 2016, ENERG ENVIRON SCI, V9, P3036, DOI 10.1039/c6ee01493c; Santos AM, 2014, BIORESOURCE TECHNOL, V152, P299, DOI 10.1016/j.biortech.2013.10.079; Santos-Ballardo DU, 2016, WORLD J MICROB BIOT, V32, P128, DOI 10.1007/s11274-016-2089-1; Tonon T, 2002, PHYTOCHEMISTRY, V61, P15, DOI 10.1016/S0031-9422(02)00201-7; Tredici MR, 1998, BIOTECHNOL BIOENG, V57, P187, DOI 10.1002/(SICI)1097-0290(19980120)57:2<187::AID-BIT7>3.0.CO;2-J; Van Vooren G, 2012, BIORESOURCE TECHNOL, V124, P421, DOI 10.1016/j.biortech.2012.08.009; Wagner H, 2016, PHOTOSYNTH RES, V128, P151, DOI 10.1007/s11120-015-0209-7; Waring J, 2010, J PHYCOL, V46, P1206, DOI 10.1111/j.1529-8817.2010.00919.x; Wiegman S, 2003, ENVIRON TOXICOL CHEM, V22, P591, DOI 10.1002/etc.5620220318; YONGMANITCHAI W, 1992, J AM OIL CHEM SOC, V69, P584, DOI 10.1007/BF02636113; Zhao Y, 2015, J PHYCOL, V51, P872, DOI 10.1111/jpy.12327	51	51	52	3	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2017	12	4							e0175630	10.1371/journal.pone.0175630	http://dx.doi.org/10.1371/journal.pone.0175630			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LZ	28403203	gold, Green Submitted, Green Published			2022-12-27	WOS:000399955200086
J	Seo, KY; Yang, H; Kim, WK; Nam, SM				Seo, Kyoung Yul; Yang, Hun; Kim, Wook Kyum; Nam, Sang Min			Calculations of actual corneal astigmatism using total corneal refractive power before and after myopic keratorefractive surgery	PLOS ONE			English	Article							CATARACT-SURGERY; EYES; PREVALENCE; ERROR	Purpose To calculate actual corneal astigmatism using the total corneal refractive astigmatism for the 4-mm apex zone of the Pentacam (TCRP4astig) and keratometric astigmatism (Kastig) before and after photorefractive keratectomy or laser in situ keratomileusis Methods Uncomplicated 56 eyes after more than 6 months from the surgery were recruited by chart review. Various corneal astigmatisms were measured using the Pentacam and autokeratometer before and after surgery. Three eyes were excluded and 53 eyes of 38 subjects with with-the-rule astigmatism (WTR) were finally included. The astigmatisms were investigated using polar value analysis. When TCRP4astig was set as an actual astigmatism, the efficacy of arithmetic or coefficient adjustment of Kastig was evaluated using bivariate analysis. Results The difference between the simulated keratometer astigmatism of the Pentacam (SimKastig) and Kastig was strongly correlated with the difference between TCRP4astig and Kastig. TCRP4astig was different from Kastig in magnitude rather than meridian before and after surgery; the preoperative difference was due to the posterior cornea only; however, the postoperative difference was observed in both anterior and posterior parts. For arithmetic adjustment, 0.28 D and 0.27 D were subtracted from the preoperative and postoperative magnitudes of Kastig, respectively. For coefficient adjustment, the preoperative and postoperative magnitudes of Kastig were multiplied by 0.80 and 0.66, respectively. By arithmetic or coefficient adjustment, the difference between TCRP4astig and adjusted Kastig would be less than 0.75 D in magnitude for 95% of cases. Conclusions Kastig was successfully adjusted to TCPR4astig before and after myopic keratorefractive surgery in cases of WTR. For use of TCRP4astig directly, SimKastig and Kastig should be matched.	[Seo, Kyoung Yul] Yonsei Univ, Coll Med, Eye & Ear Hosp, Dept Ophthalmol,Inst Vis Res,Severance Hosp, Seoul, South Korea; [Yang, Hun] SU Yonsei Eye Clin, Seoul, South Korea; [Kim, Wook Kyum] B&Viit Bright Eye Ctr, Seoul, South Korea; [Nam, Sang Min] CHA Univ, Dept Ophthalmol, CHA Bundang Med Ctr, Seongnam, South Korea	Yonsei University; Yonsei University Health System; Pochon Cha University	Nam, SM (corresponding author), CHA Univ, Dept Ophthalmol, CHA Bundang Med Ctr, Seongnam, South Korea.	forustous@cha.ac.kr	Seo, Kyoung Yul/I-5484-2019	Seo, Kyoung Yul/0000-0002-9855-1980; Nam, Sang Min/0000-0001-6903-6333	Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI14C1607010116]	Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea	For this study, SMN received a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant number: HI14C1607010116). URL: http://www.mohw.go.kr/engf. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borasio E, 2006, J CATARACT REFR SURG, V32, P2004, DOI 10.1016/j.jcrs.2006.08.037; Chan Clara C, 2012, Int Ophthalmol Clin, V52, P21, DOI 10.1097/IIO.0b013e31824b442c; Davison JA, 2015, CLIN OPHTHALMOL, V9, P1511, DOI 10.2147/OPTH.S88693; Goggin M, 2015, J REFRACT SURG, V31, P98, DOI 10.3928/1081597X-20150122-04; Goggin M, 2010, J CATARACT REFR SURG, V36, P1792, DOI 10.1016/j.jcrs.2010.07.005; Gyldenkerne A, 2015, OPHTHAL PHYSL OPT, V35, P299, DOI 10.1111/opo.12202; Holladay JT, 2009, J REFRACT SURG, V25, P862, DOI 10.3928/1081597X-20090917-07; Holladay JT, 2001, J CATARACT REFR SURG, V27, P61, DOI 10.1016/S0886-3350(00)00796-3; Kamiya K, 2015, J OPHTHALMOL, V2015, DOI 10.1155/2015/915853; Khairat YM, 2013, CLIN OPHTHALMOL, V7, P1771, DOI 10.2147/OPTH.S48077; Khan MI, 2011, J CATARACT REFR SURG, V37, P1751, DOI 10.1016/j.jcrs.2011.04.026; Koch DD, 2013, J CATARACT REFR SURG, V39, P1803, DOI 10.1016/j.jcrs.2013.06.027; Koch DD, 2012, J CATARACT REFR SURG, V38, P2080, DOI 10.1016/j.jcrs.2012.08.036; Miyake T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117194; Naeser K, 1999, OPHTHAL PHYSL OPT, V19, P50, DOI 10.1016/S0275-5408(98)00037-4; Naeser K, 2008, ACTA OPHTHALMOL, V86, P349, DOI 10.1111/j.1755-3768.2008.01287.x; Nemeth G, 2014, CORNEA, V33, P1214, DOI 10.1097/ICO.0000000000000238; OCULUS, CALC CORN POW; Read SA, 2014, OPHTHAL PHYSL OPT, V34, P267, DOI 10.1111/opo.12128; Savini G, 2015, INVEST OPHTH VIS SCI, V56, P827, DOI 10.1167/iovs.14-15903; Savini G, 2014, J CATARACT REFR SURG, V40, P1645, DOI 10.1016/j.jcrs.2014.01.046; Seo KY, 2014, J CATARACT REFR SURG, V40, P1834, DOI 10.1016/j.jcrs.2013.11.044; Tonn B, 2015, INVEST OPHTH VIS SCI, V56, P291, DOI 10.1167/iovs.14-15659; Vitale S, 2008, ARCH OPHTHALMOL-CHIC, V126, P1111, DOI 10.1001/archopht.126.8.1111; Wang L, 2011, INVEST OPHTH VIS SCI, V52, P1716, DOI 10.1167/iovs.09-4982; Wolffsohn JS, 2011, J CATARACT REFR SURG, V37, P454, DOI 10.1016/j.jcrs.2010.09.022	26	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2017	12	4							e0175268	10.1371/journal.pone.0175268	http://dx.doi.org/10.1371/journal.pone.0175268			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LZ	28403194	gold, Green Published, Green Submitted			2022-12-27	WOS:000399955200045
J	Earls, MR; Kinnevey, PM; Brennan, GI; Lazaris, A; Skally, M; O'Connell, B; Humphreys, H; Shore, AC; Coleman, DC				Earls, Megan R.; Kinnevey, Peter M.; Brennan, Grainne I.; Lazaris, Alexandros; Skally, Mairead; O'Connell, Brian; Humphreys, Hilary; Shore, Anna C.; Coleman, David C.			The recent emergence in hospitals of multidrug-resistant community-associated sequence type 1 and spa type t127 methicillin-resistant Staphylococcus aureus investigated by whole-genome sequencing: Implications for screening	PLOS ONE			English	Article							PANTON-VALENTINE LEUKOCIDIN; ANTIMICROBIAL SUSCEPTIBILITY; NOSOCOMIAL TRANSMISSION; GENTAMICIN-RESISTANT; MRSA; STRAINS; DUBLIN; MEC; IMPORTATION; INFECTION	Community-associated spa type t127/t922 methicillin-resistant Staphylococcus aureus (MRSA) prevalence increased from 1%-7% in Ireland between 2010-2015. This study tracked the spread of 89 such isolates from June 2013-June 2016. These included 78 healthcare-associated and 11 community associated-MRSA isolates from a prolonged hospital outbreak (H1) (n = 46), 16 other hospitals (n = 28), four other healthcare facilities (n = 4) and community-associated sources (n = 11). Isolates underwent antimicrobial susceptibility testing, DNA microarray profiling and whole-genome sequencing. Minimum spanning trees were generated following core-genome multilocus sequence typing and pairwise single nucleotide variation (SNV) analysis was performed. All isolates were sequence type 1 MRSA staphylococcal cassette chromosome mec type IV (ST1-MRSA-IV) and 76/89 were multidrug-resistant. Fifty isolates, including 40/46 from H1, were high-level mupirocin-resistant, carrying a conjugative 39 kb iles2-encoding plasmid. Two closely related ST1-MRSA-IV strains (I and II) and multiple sporadic strains were identified. Strain I isolates (57/89), including 43/46 H1 and all high-level mupirocin-resistant isolates, exhibited <= 80 SNVs. Two strain I isolates from separate H1 healthcare workers differed from other H1/strain I isolates by 7-47 and 12-53 SNVs, respectively, indicating healthcare worker involvement in this outbreak. Strain II isolates (19/89), including the remaining H1 isolates, exhibited <= 127 SNVs. For each strain, the pairwise SNVs exhibited by healthcare-associated and community-associated isolates indicated recent transmission of ST1-MRSA-IV within and between multiple hospitals, healthcare facilities and communities in Ireland. Given the interchange between healthcare-associated and community-associated isolates in hospitals, the risk factors that inform screening for MRSA require revision.	[Earls, Megan R.; Kinnevey, Peter M.; Brennan, Grainne I.; Lazaris, Alexandros; Shore, Anna C.; Coleman, David C.] Univ Dublin, Dublin Dent Univ Hosp, Trinity Coll, Microbiol Res Unit, Dublin, Ireland; [Brennan, Grainne I.; O'Connell, Brian] St James Hosp, Natl MRSA Reference Lab, Dublin 8, Ireland; [Skally, Mairead; Humphreys, Hilary] Beaumont Hosp, Dept Microbiol, Dublin, Ireland; [O'Connell, Brian] St James Hosp, Trinity Coll Dublin, Sch Med, Dept Clin Microbiol, Dublin 8, Ireland; [Humphreys, Hilary] Beaumont Hosp, Royal Coll Surg Ireland, Educ & Res Ctr, Dept Clin Microbiol, Dublin, Ireland	Trinity College Dublin; Trinity College Dublin; Trinity College Dublin; Royal College of Surgeons - Ireland	Coleman, DC (corresponding author), Univ Dublin, Dublin Dent Univ Hosp, Trinity Coll, Microbiol Res Unit, Dublin, Ireland.	david.coleman@dental.tcd.ie	Coleman, David C./C-2008-2009; Kinnevey, Peter M/O-1908-2015	Coleman, David C./0000-0003-1797-2888; Kinnevey, Peter M/0000-0001-7334-5745; Humphreys, Hilary/0000-0002-9646-2183	University of Dublin Faculty of Health Science Dean's Research Initiative Fund [DRI 02-2015-16]	University of Dublin Faculty of Health Science Dean's Research Initiative Fund	This study was supported by the University of Dublin Faculty of Health Science Dean's Research Initiative Fund 2015-16 (grant no. DRI 02-2015-16, Dr. Anna C Shore). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, NATIONAL MRSA REFERE; [Anonymous], 2015, NATIONAL MRSA REFERE; Ballhausen B, 2014, ANTIMICROB AGENTS CH, V58, P3791, DOI 10.1128/AAC.02731-13; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Bosch T, 2016, EUROSURVEILLANCE, V21, P22, DOI 10.2807/1560-7917.ES.2016.21.21.30236; Brennan GI, 2012, J CLIN MICROBIOL, V50, P841, DOI 10.1128/JCM.06354-11; Carfora V, 2016, J DAIRY SCI, V99, P4251, DOI 10.3168/jds.2016-10912; CARROLL D, 1995, MOL MICROBIOL, V16, P877, DOI 10.1111/j.1365-2958.1995.tb02315.x; CARROLL JD, 1989, J MED MICROBIOL, V28, P15, DOI 10.1099/00222615-28-1-15; Chambers HF, 2009, NAT REV MICROBIOL, V7, P629, DOI 10.1038/nrmicro2200; Chuang YY, 2013, LANCET INFECT DIS, V13, P698, DOI 10.1016/S1473-3099(13)70136-1; Clinical and Laboratory Standards Institute, 2015, CLSI DOCUMENT M100 S; COLEMAN DC, 1985, J MED MICROBIOL, V20, P157, DOI 10.1099/00222615-20-2-157; David MD, 2006, J HOSP INFECT, V64, P244, DOI 10.1016/j.jhin.2006.06.022; David MZ, 2014, PLOS ONE, V9; DeLeo FR, 2010, LANCET, V375, P1557, DOI 10.1016/S0140-6736(09)61999-1; Department of Mines and Petroleum, 2013, PUBL UN, P1; Caboclo RMF, 2013, AM J INFECT CONTROL, V41, pE21, DOI 10.1016/j.ajic.2012.08.008; Franco A, 2011, J ANTIMICROB CHEMOTH, V66, P1231, DOI 10.1093/jac/dkr115; Garcia-Alvarez L, 2011, LANCET INFECT DIS, V11, P595, DOI 10.1016/S1473-3099(11)70126-8; Giuffre Mario, 2012, BMC Pediatr, V12, P64, DOI 10.1186/1471-2431-12-64; Golubchik T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061319; Health Protection Surveillance Centre, 2015, PRIMARY CARE ANTIBIO; Herold BC, 1998, JAMA-J AM MED ASSOC, V279, P593, DOI 10.1001/jama.279.8.593; HUMPHREYS H, 1990, J HOSP INFECT, V15, P127, DOI 10.1016/0195-6701(90)90121-4; Joo EJ, 2012, J HOSP INFECT, V81, P149, DOI 10.1016/j.jhin.2012.04.018; Kim C, 2012, J BIOL CHEM, V287, P36854, DOI 10.1074/jbc.M112.395962; Kinnevey PM, 2016, J CLIN MICROBIOL, V54, P445, DOI 10.1128/JCM.02662-15; Kinnevey PM, 2014, ANTIMICROB AGENTS CH, V58, P1907, DOI 10.1128/AAC.02653-13; Koser CU, 2012, NEW ENGL J MED, V366, P2267, DOI 10.1056/NEJMoa1109910; Kong ZZ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149844; Lee SS, 2010, J CLIN MICROBIOL, V48, P311, DOI 10.1128/JCM.00297-09; Leopold SR, 2014, J CLIN MICROBIOL, V52, P2365, DOI 10.1128/JCM.00262-14; Li M, 2016, EMERG INFECT DIS, V22, P1988, DOI 10.3201/eid2211.160587; Loncaric I, 2014, VET MICROBIOL, V168, P381, DOI 10.1016/j.vetmic.2013.11.022; Luini M, 2015, VET MICROBIOL, V178, P270, DOI 10.1016/j.vetmic.2015.05.010; Monecke S, 2008, CLIN MICROBIOL INFEC, V14, P534, DOI 10.1111/j.1469-0691.2008.01986.x; Monecke S, 2008, FEMS IMMUNOL MED MIC, V53, P237, DOI 10.1111/j.1574-695X.2008.00426.x; Monecke S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017936; Muller-Premru M, 2005, EUR J CLIN MICROBIOL, V24, P848, DOI 10.1007/s10096-005-0048-0; Otter JA, 2011, J HOSP INFECT, V79, P189, DOI 10.1016/j.jhin.2011.04.028; Parisi A, 2016, FOOD MICROBIOL, V58, P36, DOI 10.1016/j.fm.2016.03.004; Perez-Roth E, 2010, ANTIMICROB AGENTS CH, V54, P2252, DOI 10.1128/AAC.01074-09; Price JR, 2013, J HOSP INFECT, V83, P14, DOI 10.1016/j.jhin.2012.10.003; Price JR, 2014, CLIN INFECT DIS, V58, P609, DOI 10.1093/cid/cit807; Ramsing BGU, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066904; Rossney AS, 2007, J CLIN MICROBIOL, V45, P2554, DOI 10.1128/JCM.00245-07; Rossney AS, 2002, EUR J CLIN MICROBIOL, V21, P123, DOI 10.1007/s10096-001-0677-x; Seidl K, 2015, ANN CLIN MICROB ANTI, V14, DOI 10.1186/s12941-015-0075-3; SenGupta DJ, 2014, J CLIN MICROBIOL, V52, P2787, DOI 10.1128/JCM.00759-14; Seybold U, 2006, CLIN INFECT DIS, V42, P647, DOI 10.1086/499815; Shore A, 2005, ANTIMICROB AGENTS CH, V49, P2070, DOI 10.1128/AAC.49.5.2070-2083.2005; Shore AC, 2016, ANTIMICROB AGENTS CH, V60, P3007, DOI 10.1128/AAC.02949-15; Shore AC, 2014, J CLIN MICROBIOL, V52, P859, DOI 10.1128/JCM.02799-13; Shore AC, 2013, INT J MED MICROBIOL, V303, P350, DOI 10.1016/j.ijmm.2013.02.002; Shore AC, 2011, ANTIMICROB AGENTS CH, V55, P3765, DOI 10.1128/AAC.00187-11; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; The European Committee on Antimicrobial Susceptibility Testing (EUCAST), 2016, BREAKPOINT TABLES FO; Udo EE, 1997, ANTIMICROB AGENTS CH, V41, P693, DOI 10.1128/AAC.41.3.693; Wang LJ, 2012, J MED MICROBIOL, V61, P1240, DOI 10.1099/jmm.0.042663-0; Zhang J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137593	61	36	37	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2017	12	4							e0175542	10.1371/journal.pone.0175542	http://dx.doi.org/10.1371/journal.pone.0175542			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0JS	28399151	Green Submitted, Green Published, gold			2022-12-27	WOS:000399949000046
J	Shirai, K; Kawashima, M; Saitoh, J; Abe, T; Fukata, K; Shigeta, Y; Irie, D; Shiba, S; Okano, N; Ohno, T; Nakano, T				Shirai, Katsuyuki; Kawashima, Motohiro; Saitoh, Jun-ichi; Abe, Takanori; Fukata, Kyohei; Shigeta, Yuka; Irie, Daisuke; Shiba, Shintaro; Okano, Naoko; Ohno, Tatsuya; Nakano, Takashi			Clinical outcomes using carbon-ion radiotherapy and dose-volume histogram comparison between carbon-ion radiotherapy and photon therapy for T2b-4N0M0 non-small cell lung cancer-A pilot study	PLOS ONE			English	Article							STEREOTACTIC BODY RADIOTHERAPY; RADIATION-THERAPY; CONCURRENT CHEMOTHERAPY; ELDERLY-PATIENTS; IRRADIATION; JAPAN; METAANALYSIS; COMBINATION; SURGERY; REGIMEN	The safety and efficacy of carbon-ion radiotherapy for advanced non-small cell lung cancer have not been established. We evaluated the clinical outcomes and dose-volume histogram parameters of carbon-ion radiotherapy compared with photon therapy in T2b-4N0M0 non-small cell lung cancer. Twenty-three patients were treated with carbon-ion radiotherapy between May 2011 and December 2015. Seven, 14, and 2 patients had T2b, T3, and T4, respectively. The median age was 78 (range, 53-91) years, with 22 male patients. There were 12 adenocarcinomas, 8 squamous cell carcinomas, 1 non-small cell lung carcinoma, and 2 clinically diagnosed lung cancers. Eleven patients were operable, and 12 patients were inoperable. Most patients (91%) were treated with carbon-ion radiotherapy of 60.0 Gy relative biological effectiveness (RBE) in 4 fractions or 64.0 Gy (RBE) in 16 fractions. Local control and overall survival rates were calculated. Dose-volume histogram parameters of normal lung and tumor coverages were compared between carbon-ion radiotherapy and photon therapies, including three-dimensional conformal radiotherapy (3DCRT) and intensity-modulated radiotherapy (IMRT). The median follow-up of surviving patients was 25 months. Three patients experienced local recurrence, and the 2-year local control rate was 81%. During follow-up, 5 patients died of lung cancer, and 1 died of intercurrent disease. The 2-year overall survival rate was 70%. Operable patients had a better overall survival rate compared with inoperable patients (100% vs. 43%; P = 0.04). There was no grade >= 2 radiation pneumonitis. In dose-volume histogram analysis, carbon-ion radiotherapy had a significantly lower dose to normal lung and greater tumor coverage compared with photon therapies. Carbon-ion radiotherapy was effectively and safely performed for T2b-4N0M0 non-small cell lung cancer, and the dose distribution was superior compared with those for photon therapies. A Japanese multi-institutional study is ongoing to prospectively evaluate these patients and establish the use of carbon-ion radiotherapy.	[Shirai, Katsuyuki; Kawashima, Motohiro; Saitoh, Jun-ichi; Abe, Takanori; Fukata, Kyohei; Shigeta, Yuka; Irie, Daisuke; Shiba, Shintaro; Okano, Naoko; Ohno, Tatsuya; Nakano, Takashi] Gunma Univ, Heavy Ion Med Ctr, Maebashi, Gunma, Japan	Gunma University	Shirai, K (corresponding author), Gunma Univ, Heavy Ion Med Ctr, Maebashi, Gunma, Japan.	kshirai@gunma-u.ac.jp	Fukata, Kyohei/G-9011-2018	Fukata, Kyohei/0000-0003-4015-6969; Shiba, Shintaro/0000-0002-1293-4113	Japan Society for the Promotion of Science (JSPS) [26461878]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Japan Society for the Promotion of Science (JSPS) Grants-in-Aid for Scientific Research (KAKENHI) Grant Number 26461878 (https://www.jsps.go.jp/index.html). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anagnostou VK, 2015, CLIN CANCER RES, V21, P976, DOI 10.1158/1078-0432.CCR-14-1187; Atagi S, 2012, LANCET ONCOL, V13, P671, DOI 10.1016/S1470-2045(12)70139-0; Bradley J, 2012, INT J RADIAT ONCOL, V82, P435, DOI 10.1016/j.ijrobp.2010.09.033; Ebara T, 2014, ANTICANCER RES, V34, P5099; Eriguchi T, 2016, J RADIAT RES, V57, P265, DOI 10.1093/jrr/rrw023; Fakiris AJ, 2009, INT J RADIAT ONCOL, V75, P677, DOI 10.1016/j.ijrobp.2008.11.042; Fennell DA, 2016, CANCER TREAT REV, V44, P42, DOI 10.1016/j.ctrv.2016.01.003; Gajra A, 2014, J CLIN ONCOL, V32, P2562, DOI 10.1200/JCO.2014.55.3099; Kamada T, 2015, LANCET ONCOL, V16, pE93, DOI 10.1016/S1470-2045(14)70412-7; Kanai T, 1999, INT J RADIAT ONCOL, V44, P201, DOI 10.1016/S0360-3016(98)00544-6; Kubo N, 2016, J RADIAT RES, V57, P548, DOI 10.1093/jrr/rrw041; Loeffler JS, 2013, NAT REV CLIN ONCOL, V10, P411, DOI 10.1038/nrclinonc.2013.79; MARINO P, 1995, CANCER, V76, P593, DOI 10.1002/1097-0142(19950815)76:4<593::AID-CNCR2820760409>3.0.CO;2-N; Meng MB, 2015, ONCOTARGET, V6, P15690, DOI 10.18632/oncotarget.3704; Miyamoto T, 2007, J THORAC ONCOL, V2, P916, DOI 10.1097/JTO.0b013e3181560a68; Miyamoto T, 2007, INT J RADIAT ONCOL, V67, P750, DOI 10.1016/j.ijrobp.2006.10.006; Mizobuchi T, 2016, EUR J CARDIO-THORAC, V49, P1503, DOI 10.1093/ejcts/ezv348; Nagata Y, 2015, INT J RADIAT ONCOL, V93, P989, DOI 10.1016/j.ijrobp.2015.07.2278; Onishi H, 2004, LUNG CANCER, V45, P45, DOI 10.1016/j.lungcan.2004.01.004; Pritchard RS, 1996, ANN INTERN MED, V125, P723, DOI 10.7326/0003-4819-125-9-199611010-00003; Nguyen QN, 2015, RADIOTHER ONCOL, V115, P367, DOI 10.1016/j.radonc.2015.05.014; Rosenzweig KE, 2007, J CLIN ONCOL, V25, P5557, DOI 10.1200/JCO.2007.13.2191; Rowell NP, 2001, THORAX, V56, P628, DOI 10.1136/thorax.56.8.628; Sawabata N, 2011, J THORAC ONCOL, V6, P1229, DOI 10.1097/JTO.0b013e318219aae2; Shirai K, 2012, INT J MOL IMAGING, V2012; Shirai K, 2016, ONCOL LETT IN PRESS; Takahashi W, 2015, CANCER-AM CANCER SOC, V121, P1321, DOI 10.1002/cncr.29195; Tan CS, 2016, LUNG CANCER, V93, P59, DOI 10.1016/j.lungcan.2016.01.003; Tashiro M, 2013, RADIOL PHYS TECHNOL, V6, P356, DOI 10.1007/s12194-013-0208-3; Walraven I, 2016, RADIOTHER ONCOL, V118, P442, DOI 10.1016/j.radonc.2016.02.011; Yuan SH, 2007, AM J CLIN ONCOL-CANC, V30, P239, DOI 10.1097/01.coc.0000256691.27796.24	31	19	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2017	12	4							e0175589	10.1371/journal.pone.0175589	http://dx.doi.org/10.1371/journal.pone.0175589			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0JS	28399182	Green Submitted, Green Published, gold			2022-12-27	WOS:000399949000051
J	McCarthy, EA; Subramaniam, HL; Prust, ML; Prescott, MR; Mpasela, F; Mwango, A; Namonje, L; Moyo, C; Chibuye, B; van den Broek, JW; Hehman, L; Moberley, S				McCarthy, Elizabeth A.; Subramaniam, Hamsa L.; Prust, Margaret L.; Prescott, Marta R.; Mpasela, Felton; Mwango, Albert; Namonje, Leah; Moyo, Crispin; Chibuye, Benjamin; van den Broek, Jan Willem; Hehman, Lindsey; Moberley, Sarah			Quality improvement intervention to increase adherence to ART prescription policy at HIV treatment clinics in Lusaka, Zambia: A cluster randomized trial	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; TREATMENT PROGRAM; CARE; IMPLEMENTATION; PREVENTION; EFFICIENCY; RETENTION; STRATEGY; OUTCOMES; MODELS	Introduction In urban areas, crowded HIV treatment facilities with long patient wait times can deter patients from attending their clinical appointments and picking up their medications, ultimately disrupting patient care and compromising patient retention and adherence. Methods Formative research at eight facilities in Lusaka revealed that only 46% of stable HIV treatment patients were receiving a three-month refill supply of antiretroviral drugs, despite it being national policy for stable adult patients. We designed a quality improvement intervention to improve the operationalization of this policy. We conducted a cluster-randomized controlled trial in sixteen facilities in Lusaka with the primary objective of examining the intervention's impact on the proportion of stable patients receiving three-month refills. The secondary objective was examining whether the quality improvement intervention reduced facility congestion measured through two proxy indicators: daily volume of clinic visits and average clinic wait times for services. Results The mean change in the proportion of three-month refills among control facilities from baseline to endline was 10% (from 38% to 48%), compared to a 25% mean change (an increase from 44% to 69%) among intervention facilities. This represents a significant 15% mean difference (95% CI: 2%-29%; P = 0.03) in the change in proportion of patients receiving three-month refills. On average, control facilities had 15 more visits per day in the endline than in the baseline, while intervention facilities had 20 fewer visits per day in endline than in baseline, a mean difference of 35 fewer visits per day (P = 0.1). The change in the mean facility total wait time for intervention facilities dropped 19 minutes between baseline and endline when compared to control facilities (95% CI: -10.2-48.5; P = 0.2). Conclusion A more patient-centred service delivery schedule of three-month prescription refills for stable patients is viable. We encourage the expansion of this sustainable intervention in Zambia's urban clinics.	[McCarthy, Elizabeth A.] Clinton Hlth Access Initiat, Appl Analyt, Lusaka, Zambia; [Subramaniam, Hamsa L.; Prust, Margaret L.; Prescott, Marta R.] Clinton Hlth Access Initiat, Appl Analyt, Boston, MA USA; [Mpasela, Felton; Chibuye, Benjamin] Clinton Hlth Access Initiat, Demand Driven Evaluat Decis, Lusaka, Zambia; [Mwango, Albert; Moyo, Crispin] Minist Hlth, Clin Care & Diagnost Serv, Lusaka, Zambia; [Namonje, Leah] Minist Community Dev, Mother & Child Hlth, Lusaka, Zambia; [van den Broek, Jan Willem] Clinton Hlth Access Initiat, Lusaka, Zambia; [Hehman, Lindsey] Clinton Hlth Access Initiat, Hlth Financing, Lusaka, Zambia; [Moberley, Sarah] Clinton Hlth Access Initiat, Appl Analyt, Kampala, Uganda		McCarthy, EA (corresponding author), Clinton Hlth Access Initiat, Appl Analyt, Lusaka, Zambia.	emccarthy@clintonhealthaccess.org		Moberley, Sarah/0000-0002-6081-4482	UKAid/DFID of the UK Government	UKAid/DFID of the UK Government	This work was made possible through funding support from UKAid/DFID of the UK Government to the Clinton Health Access Initiative. The study sponsor (DFID) did not have any role in the study design; in the collection, analysis, and interpretation of data, in the writing of the report; or in the decision to submit the paper for publication. The views expressed in this article are the opinions of the authors and do not necessarily reflect the official policies of DFID or the UK Government.	Alamo ST, 2013, AIDS BEHAV, V17, P274, DOI 10.1007/s10461-012-0199-9; Amanyire G, 2010, AIDS PATIENT CARE ST, V24, P719, DOI 10.1089/apc.2010.0108; [Anonymous], 2014, GLOB UPD HLTH SECT R; [Anonymous], 2013, REACH CLOS HOM PROGR; Bemelmans M, 2014, TROP MED INT HEALTH, V19, P968, DOI 10.1111/tmi.12332; Bemelmans M, 2010, TROP MED INT HEALTH, V15, P1413, DOI 10.1111/j.1365-3156.2010.02649.x; Bradley E, 2008, INT J QUAL HEALTH C, V20, P392, DOI 10.1093/intqhc/mzn042; Clarke CM, 2016, BMJ QUAL SAF, V25, P345, DOI 10.1136/bmjqs-2015-004269; Decroo T, 2014, TROP MED INT HEALTH, V19, P514, DOI 10.1111/tmi.12278; DIEHR P, 1995, STAT MED, V14, P1491, DOI 10.1002/sim.4780141309; Eldridge S, 2012, PRACTICAL GUIDE CLUS; Escamilla V, 2015, JAIDS-J ACQ IMM DEF, V70, pE94, DOI 10.1097/QAI.0000000000000739; Ferrinho P, 2011, HUM RESOUR HEALTH, V9, DOI 10.1186/1478-4491-9-30; Foy R, 2004, BJOG-INT J OBSTET GY, V111, P726, DOI 10.1111/j.1471-0528.2004.00168.x; Gao F, 2015, CONTEMP CLIN TRIALS, V42, P41, DOI 10.1016/j.cct.2015.02.011; Hayes RJ, 2009, INTERD STAT, P3; Hayes RJ, 1999, INT J EPIDEMIOL, V28, P319, DOI 10.1093/ije/28.2.319; Holmes CB, 2015, CURR OPIN HIV AIDS, V10, P447, DOI 10.1097/COH.0000000000000194; Khabala KB, 2015, TROP MED INT HLTH; Kredo T, 2013, COCHRANE DB SYST REV, V6, DOI DOI 10.102/14651858.CD009987; Lifson Alan R, 2013, J Int Assoc Provid AIDS Care, V12, P32, DOI 10.1177/1545109712456428; Ministry of Health Zambia, 2014, ZAMB CONS GUID TREAT; Ministry of Health Zambia, 2013, E HLTH STRAT 2013 20; Ministry of Health Zambia National AIDS Council Zambia, 2014, ZAMB COUNTR REP MON; Moberley S, 2015, 8 IAS C HIV PATH TRE; Nakiwogga-Muwanga A, 2014, INT J STD AIDS, V25, P105, DOI 10.1177/0956462413492715; Rich ML, 2012, JAIDS-J ACQ IMM DEF, V59, pE35, DOI 10.1097/QAI.0b013e31824476c4; Rochat TJ, 2011, FUTURE VIROL, V6, P687, DOI 10.2217/FVL.11.45; UNAIDS, 2015, FAST TRACK AIDS 2030; UNAIDS, 2015, FAST TRACK CIT UPD 2; UNAIDS, 2014, 90 90 90 AMB TREATM; Wang PC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141455; World Health Organization, 2015, CONS GUID US ANT DRU	33	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2017	12	4							e0175534	10.1371/journal.pone.0175534	http://dx.doi.org/10.1371/journal.pone.0175534			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES9KH	28419106	Green Published, Green Submitted, gold			2022-12-27	WOS:000399875200025
J	Tauber, S; Lauber, BA; Paulsen, K; Layer, LE; Lehmann, M; Hauschild, S; Shepherd, NR; Polzer, J; Segerer, J; Thiel, CS; Ullrich, O				Tauber, Svantje; Lauber, Beatrice A.; Paulsen, Katrin; Layer, Liliana E.; Lehmann, Martin; Hauschild, Swantje; Shepherd, Naomi R.; Polzer, Jennifer; Segerer, Juergen; Thiel, Cora S.; Ullrich, Oliver			Cytoskeletal stability and metabolic alterations in primary human macrophages in long-term microgravity	PLOS ONE			English	Article							GAS-CHROMATOGRAPHY; MECHANICAL-PROPERTIES; PARABOLIC FLIGHT; RHO-GTPASES; CELL-LINE; L-FUCOSE; CANCER; SPACE; MICROTUBULES; MARKER	The immune system is one of the most affected systems of the human body during space flight. The cells of the immune system are exceptionally sensitive to microgravity. Thus, serious concerns arise, whether space flight associated weakening of the immune system ultimately precludes the expansion of human presence beyond the Earth's orbit. For human space flight, it is an urgent need to understand the cellular and molecular mechanisms by which altered gravity influences and changes the functions of immune cells. The CELLBOXPRIME (= CellBox-Primary Human Macrophages in Microgravity Environment) experiment investigated for the first time microgravity-associated long-term alterations in primary human macrophages, one of the most important effector cells of the immune system. The experiment was conducted in the U. S. National Laboratory on board of the International Space Station ISS using the NanoRacks laboratory and Biorack type I standard CELLBOX EUE type IV containers. Upload and download were performed with the SpaceX CRS- 3 and the Dragon spaceship on April 18th, 2014 / May 18th, 2014. Surprisingly, primary human macrophages exhibited neither quantitative nor structural changes of the actin and vimentin cytoskeleton after 11 days in microgravity when compared to 1g controls. Neither CD18 or CD14 surface expression were altered in microgravity, however ICAM-1 expression was reduced. The analysis of 74 metabolites in the cell culture supernatant by GC-TOF-MS, revealed eight metabolites with significantly different quantities when compared to 1g controls. In particular, the significant increase of free fucose in the cell culture supernatant was associated with a significant decrease of cell surface-bound fucose. The reduced ICAM-1 expression and the loss of cell surface-bound fucose may contribute to functional impairments, e.g. the activation of T cells, migration and activation of the innate immune response. We assume that the surprisingly small and non-significant cytoskeletal alterations represent a '' stable-steady state '' after adaptive processes are initiated in the new microgravity environment. Due to the utmost importance of the human macrophage system for the elimination of pathogens and the clearance of apoptotic cells, its apparent robustness to a low gravity environment is crucial for human health and performance during long-term space missions.	[Tauber, Svantje; Lauber, Beatrice A.; Paulsen, Katrin; Layer, Liliana E.; Hauschild, Swantje; Shepherd, Naomi R.; Polzer, Jennifer; Thiel, Cora S.; Ullrich, Oliver] Univ Zurich, Fac Med, Inst Anat, Winterthurerstr 190, Zurich, Switzerland; [Tauber, Svantje; Hauschild, Swantje; Thiel, Cora S.; Ullrich, Oliver] Otto von Guericke Univ, Inst Engn Mech, Dept Machine Design Engn Design & Prod Dev, Magdeburg, Germany; [Lehmann, Martin] Biozentrum LMU Munchen, Dept Biol IBotany, Grosshaderner Str 2-4, Martinsried, Germany; [Segerer, Juergen] Airbus Def & Space GmbH, Claude Bornier Str, Immenstaad, Germany; [Ullrich, Oliver] Univ Zurich, Zurich Ctr Integrat Human Physiol ZIHP, Winterthurerstr 190, Zurich, Switzerland; [Ullrich, Oliver] Space Life Sci Lab, 505 Odyssey Way, Exporat Pk, Kennedy Space Ctr, FL 32899 USA	University of Geneva; University of Zurich; Otto von Guericke University; University of Munich; Airbus; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP)	Ullrich, O (corresponding author), Univ Zurich, Fac Med, Inst Anat, Winterthurerstr 190, Zurich, Switzerland.; Ullrich, O (corresponding author), Otto von Guericke Univ, Inst Engn Mech, Dept Machine Design Engn Design & Prod Dev, Magdeburg, Germany.; Ullrich, O (corresponding author), Univ Zurich, Zurich Ctr Integrat Human Physiol ZIHP, Winterthurerstr 190, Zurich, Switzerland.; Ullrich, O (corresponding author), Space Life Sci Lab, 505 Odyssey Way, Exporat Pk, Kennedy Space Ctr, FL 32899 USA.	oliver.ullrich@uzh.ch		Christoffel, Swantje/0000-0002-0466-9655	German Aerospace Center DLR, Federal Ministry for Economic Affairs and Energy of the Federal Republic of Germany [50WB1219]; Airbus Defense; Space GmbH	German Aerospace Center DLR, Federal Ministry for Economic Affairs and Energy of the Federal Republic of Germany; Airbus Defense; Space GmbH	The study was funded by the German Aerospace Center DLR, Federal Ministry for Economic Affairs and Energy of the Federal Republic of Germany, grant no. 50WB1219, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. JS is an employee of Airbus Defense and Space GmbH. Airbus Defense and Space GmbH provided support in the form of salaries for the co-author JS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. We declare that the authors have no competing, or other interests that may be perceived to influence the results and/or discussion reported in this paper. The specific roles of these authors are articulated in the author contributions section.	Adrian A, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-98; ARMSTRONG JW, 1995, EXP CELL RES, V216, P160, DOI 10.1006/excr.1995.1020; Becker DJ, 2003, GLYCOBIOLOGY, V13, p41R, DOI 10.1093/glycob/cwg054; CAMERON DJ, 1985, IMMUNOL LETT, V11, P39, DOI 10.1016/0165-2478(85)90140-3; Clement G, 2011, FUNDAMENTALS SPACE M, P273; Cogoli A, 1996, J Gravit Physiol, V3, P1; COGOLI A, 1984, SCIENCE, V225, P228, DOI 10.1126/science.6729481; COGOLI A, 1985, IMMUNOL TODAY, V6, P1, DOI 10.1016/0167-5699(85)90151-3; COGOLI A, 1988, BIORACK SPACELAB D1, P89; Comet B, 2001, HUMEXTN002; Corydon TJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep20043; del Pulgar TG, 2005, BIOESSAYS, V27, P602, DOI 10.1002/bies.20238; Elliott MR, 2010, J CELL BIOL, V189, P1059, DOI 10.1083/jcb.201004096; Erban Alexander, 2007, V358, P19, DOI 10.1007/978-1-59745-244-1_2; Fang LQ, 2011, J CHROMATOGR A, V1218, P7316, DOI 10.1016/j.chroma.2011.08.044; Faria EC, 2008, ANALYST, V133, P1498, DOI 10.1039/b803355b; Fox R, 2007, EMBO J, V26, P505, DOI 10.1038/sj.emboj.7601522; Frippiat JP, 2016, NPJ MICROGRAVITY, V2, DOI 10.1038/npjmgrav.2016.40; Grosse J, 2012, FASEB J, V26, P639, DOI 10.1096/fj.11-194886; Guck J, 2005, BIOPHYS J, V88, P3689, DOI 10.1529/biophysj.104.045476; Gueguinou N, 2009, J LEUKOCYTE BIOL, V86, P1027, DOI 10.1189/jlb.0309167; Guignandon A, 2014, FASEB J, V28, P4077, DOI 10.1096/fj.14-249714; Hashimoto D, 2013, IMMUNITY, V38, P792, DOI 10.1016/j.immuni.2013.04.004; Hijken PJ, 1991, ADV SPACE RES, V12, P145; Horneck G, 2006, ADV SPACE RES, V38, P752, DOI 10.1016/j.asr.2005.06.072; Hsieh CL, 2005, EUR J CLIN INVEST, V35, P591, DOI 10.1111/j.1365-2362.2005.01551.x; Hughes-Fulford M., 2008, LIFE SPACE LIFE EART, P22; HughesFulford M, 1996, EXP CELL RES, V224, P103, DOI 10.1006/excr.1996.0116; Infanger M, 2006, CELL TISSUE RES, V324, P267, DOI 10.1007/s00441-005-0142-8; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Kaur I, 2005, BRAIN BEHAV IMMUN, V19, P547, DOI 10.1016/j.bbi.2004.12.006; Kopp S, 2015, SCI REP-UK, V5, DOI 10.1038/srep16691; Kytzia A, 2006, CHEM-EUR J, V12, P8786, DOI 10.1002/chem.200600405; LASSMANN H, 1993, GLIA, V7, P19, DOI 10.1002/glia.440070106; Lekka M, 1999, EUR BIOPHYS J BIOPHY, V28, P312, DOI 10.1007/s002490050213; Lekka M, 2012, MICRON, V43, P1259, DOI 10.1016/j.micron.2012.01.019; Lewis ML, 1998, FASEB J, V12, P1007, DOI 10.1096/fasebj.12.11.1007; Li J, 2014, ARTHRITIS RHEUMATOL, V66, P2368, DOI 10.1002/art.38711; LIMOUSE M, 1991, EXP CELL RES, V197, P82, DOI 10.1016/0014-4827(91)90482-A; Lisec J, 2006, NAT PROTOC, V1, P387, DOI 10.1038/nprot.2006.59; Louis F, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/747693; Luedemann A, 2008, BIOINFORMATICS, V24, P732, DOI 10.1093/bioinformatics/btn023; Malgorzata Lekka, 2016, DISCRIMINATION NORMA, V6, P65; McEver RP, 1997, J CLIN INVEST, V100, pS97; Meloni MA, 2006, PROTOPLASMA, V229, P243, DOI 10.1007/s00709-006-0210-2; Meloni MA, 2011, CYTOSKELETON, V68, P125, DOI 10.1002/cm.20499; MOORE KL, 1994, J BIOL CHEM, V269, P23318; Mracek T, 2013, BBA-BIOENERGETICS, V1827, P401, DOI 10.1016/j.bbabio.2012.11.014; Murphy J, 2008, AM J RESP CELL MOL, V38, P380, DOI 10.1165/rcmb.2007-0224RC; Pachenari M, 2014, J BIOMECH, V47, P373, DOI 10.1016/j.jbiomech.2013.11.020; Paulsen K, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/538786; Paulsen K, 2014, ACTA ASTRONAUT, V94, P277, DOI 10.1016/j.actaastro.2013.06.007; Prabhune M, 2012, MICRON, V43, P1267, DOI 10.1016/j.micron.2012.03.023; Ravichandran KS, 2011, IMMUNITY, V35, P445, DOI 10.1016/j.immuni.2011.09.004; Robbins CS, 2013, NAT MED, V19, P1166, DOI 10.1038/nm.3258; Roessner U, 2001, PLANT CELL, V13, P11, DOI 10.1105/tpc.13.1.11; SAKAI T, 1990, CLIN CHEM, V36, P474; Schadewaldt P, 1999, J INHERIT METAB DIS, V22, P706, DOI 10.1023/A:1005540016376; Schmitt DA, 1996, FASEB J, V10, P1627, DOI 10.1096/fasebj.10.14.9002555; Sciola L, 1999, ADV SPACE RES, V24, P801, DOI 10.1016/S0273-1177(99)00078-2; Ulbrich C, 2011, CELL PHYSIOL BIOCHEM, V28, P185, DOI 10.1159/000331730; Ullrich Oliver, 2008, Cell Commun Signal, V6, P9, DOI 10.1186/1478-811X-6-9; Uva BM, 2002, BRAIN RES, V934, P132, DOI 10.1016/S0006-8993(02)02415-0; Vassy J., 2001, FASEB Journal, V15, P1104; Vega FM, 2008, FEBS LETT, V582, P2093, DOI 10.1016/j.febslet.2008.04.039; Vorselen D, 2014, FASEB J, V28, P536, DOI 10.1096/fj.13-236356; Wishart DS, 2007, NUCLEIC ACIDS RES, V35, pD521, DOI 10.1093/nar/gkl923; Wishart DS, 2013, NUCLEIC ACIDS RES, V41, pD801, DOI 10.1093/nar/gks1065; Wishart DS, 2009, NUCLEIC ACIDS RES, V37, pD603, DOI 10.1093/nar/gkn810; Xu WW, 2012, PLOS ONE, P7; Yamaguchi H, 2007, BBA-MOL CELL RES, V1773, P642, DOI 10.1016/j.bbamcr.2006.07.001; YAMAUCHI M, 1993, ALCOHOL CLIN EXP RES, V17, P268, DOI 10.1111/j.1530-0277.1993.tb00761.x; Yang F, 2008, CHINESE SCI BULL, V53, P1185, DOI 10.1007/s11434-008-0167-y; Zhang Y, 2010, ACTA ASTRONAUT, V67, P1073, DOI 10.1016/j.actaastro.2010.06.027	74	41	41	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2017	12	4							e0175599	10.1371/journal.pone.0175599	http://dx.doi.org/10.1371/journal.pone.0175599			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KH	28419128	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000399875200031
J	Zhou, YH; Badgett, MJ; Billard, L; Bowen, JH; Orlando, R; Willis, JH				Zhou, Yihong; Badgett, Majors J.; Billard, Lynne; Bowen, John Hunter; Orlando, Ron; Willis, Judith H.			Properties of the cuticular proteins of Anopheles gambiae as revealed by serial extraction of adults	PLOS ONE			English	Article							SCHISTOCERCA-GREGARIA; TENEBRIO-MOLITOR; LARVAL CUTICLE; INSECT CUTICLE; CROSS-LINKING; CHITIN; EXPRESSION; SEQUENCE; FAMILY; LOCUST	How cuticular proteins (CPs) interact with chitin and with each other in the cuticle remains unresolved. We employed LC-MS/MS to identify CPs from 5-6 day-old adults of Anopheles gambiae released after serial extraction with PBS, EDTA, 2-8M urea, and SDS as well as those that remained unextracted. Results were compared to published data on time of transcript abundance, localization of proteins within structures and within the cuticle, as well as properties of individual proteins, length, pI, percent histidine, tyrosine, glutamine, and number of AAP[A/V/L] repeats. Thirteen proteins were solubilized completely, all were CPRs, most belonging to the RR-1 group. Eleven CPs were identified in both soluble fractions and the final pellet, including 5 from other CP families. Forty-three were only detected from the final pellet. These included CPRs and members of the CPAP1, CPF, CPFL, CPLCA, CPLCG, CPLCP, and TWDL families, as well as several low complexity CPs, not assigned to families and named CPLX. For a given protein, many histidines or tyrosines or glutamines appear to be potential participants in cross-linking since we could not identify any peptide bearing these residues that was consistently absent. We failed to recover peptides from the amino-terminus of any CP. Whether this implicates that location in sclerotization or some modification that prevents detection is not known. Soluble CPRs had lower isoelectric points than those that remained in the final pellet; most members of other CP families had isoelectric points of 8 or higher. Obviously, techniques beyond analysis of differential solubility will be needed to learn how CPs interact with each other and with chitin.	[Zhou, Yihong; Bowen, John Hunter; Willis, Judith H.] Univ Georgia, Dept Cellular Biol, Athens, GA 30602 USA; [Badgett, Majors J.; Orlando, Ron] Univ Georgia, Complex Carbohydrate Res Ctr, 220 Riverbend Rd, Athens, GA 30602 USA; [Billard, Lynne] Univ Georgia, Dept Stat, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Willis, JH (corresponding author), Univ Georgia, Dept Cellular Biol, Athens, GA 30602 USA.	jhwillis@uga.edu		Willis, Judith/0000-0003-3257-0430	U.S. National Institutes of Health [R01A1055624]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD018530] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the U.S. National Institutes of Health R01A1055624. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberle B, 2016, ARTHROPOD STRUCT DEV; Andersen S. O., 1980, CUTICLE TECHNIQUES A, P185; ANDERSEN SO, 1978, INSECT BIOCHEM, V8, P99, DOI 10.1016/0020-1790(78)90045-8; Andersen SO, 2000, INSECT BIOCHEM MOLEC, V30, P569, DOI 10.1016/S0965-1748(00)00029-1; Andersen SO, 1998, INSECT BIOCHEM MOLEC, V28, P421, DOI 10.1016/S0965-1748(98)00028-9; ANDERSEN SO, 1974, J INSECT PHYSIOL, V20, P1537, DOI 10.1016/0022-1910(74)90085-7; ANDERSEN SO, 1995, INSECT BIOCHEM MOLEC, V25, P153, DOI 10.1016/0965-1748(94)00052-J; Andersen SO, 2012, INSECT MOLECULAR BIOLOGY AND BIOCHEMISTRY, P167, DOI 10.1016/B978-0-12-384747-8.10006-6; Andersen SO, 2007, INSECT BIOCHEM MOLEC, V37, P223, DOI 10.1016/j.ibmb.2006.11.006; Andersen SO, 2010, INSECT BIOCHEM MOLEC, V40, P166, DOI 10.1016/j.ibmb.2009.10.007; Arakane Y, 2009, INSECT BIOCH MOL BIO; BARRETT FM, 1981, INSECT BIOCHEM, V11, P17, DOI 10.1016/0020-1790(81)90036-6; Behr M, 2005, FEBS LETT, V579, P6827, DOI 10.1016/j.febslet.2005.11.021; Cornman RS, 2009, INSECT MOL BIOL, V18, P607, DOI 10.1111/j.1365-2583.2009.00902.x; Cornman RS, 2008, INSECT BIOCHEM MOLEC, V38, P661, DOI 10.1016/j.ibmb.2008.04.001; Cornman RS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012536; Dong ZM, 2016, J PROTEOME RES, V15, P1435, DOI 10.1021/acs.jproteome.5b00943; HACKMAN RH, 1978, INSECT BIOCHEM, V8, P353, DOI 10.1016/0020-1790(78)90021-5; HACKMAN RH, 1972, INSECT BIOCHEM, V2, P235, DOI 10.1016/0020-1790(72)90058-3; He NJ, 2007, INSECT BIOCHEM MOLEC, V37, P135, DOI 10.1016/j.ibmb.2006.10.011; Hua L, 2008, P NATL ACAD SCI USA, V105, P16928, DOI 10.1073/pnas.0808427105; Iconomidou VA, 2005, INSECT BIOCHEM MOLEC, V35, P553, DOI 10.1016/j.ibmb.2005.01.017; Iijima M, 2005, FEBS J, V272, P4774, DOI 10.1111/j.1742-4658.2005.04891.x; Jagtap P, 2013, PROTEOMICS, V13, P1352, DOI 10.1002/pmic.201200352; Jasrapuria S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049844; Jasrapuria S, 2010, INSECT BIOCHEM MOLEC, V40, P214, DOI 10.1016/j.ibmb.2010.01.011; Kerwin JL, 1999, ANAL BIOCHEM, V268, P229, DOI 10.1006/abio.1998.3069; Kramer KJ, 2001, TETRAHEDRON, V57, P385, DOI 10.1016/S0040-4020(00)00949-2; Mohanty SS, 2008, WORLD J MICROB BIOT, V24, P2283, DOI 10.1007/s11274-008-9742-2; Noh MY, 2015, DEV BIOL, V399, P315, DOI 10.1016/j.ydbio.2015.01.009; REBERS JE, 1988, J MOL BIOL, V203, P411, DOI 10.1016/0022-2836(88)90009-5; Rebers JE, 2001, INSECT BIOCHEM MOLEC, V31, P1083, DOI 10.1016/S0965-1748(01)00056-X; ROBERTS PE, 1980, DEV BIOL, V75, P59, DOI 10.1016/0012-1606(80)90143-8; Rosen J, 2016, NATURE, V536, P239, DOI 10.1038/nj7615-239a; Shibata T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013477; Suderman RJ, 2010, INSECT BIOCHEM MOLEC, V40, P252, DOI 10.1016/j.ibmb.2010.02.008; Tang L, 2010, INSECT BIOCHEM MOLEC, V40, P228, DOI 10.1016/j.ibmb.2010.01.010; Tetreau G, 2015, INSECT BIOCHEM MOLEC, V62, P127, DOI 10.1016/j.ibmb.2014.12.002; Tiklova K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067415; Togawa T, 2004, INSECT BIOCHEM MOLEC, V34, P1059, DOI 10.1016/j.ibmb.2004.06.008; Togawa T, 2008, INSECT BIOCHEM MOLEC, V38, P508, DOI 10.1016/j.ibmb.2007.12.008; Togawa T, 2007, INSECT BIOCHEM MOLEC, V37, P675, DOI 10.1016/j.ibmb.2007.03.011; Vannini L, 2017, ARTHROPOD STRUCT DEV, V46, P13, DOI 10.1016/j.asd.2016.10.002; Vannini L, 2016, ARTHROPOD STRUCT DEV, V45, P519, DOI 10.1016/j.asd.2016.10.006; Vannini L, 2015, INSECT BIOCHEM MOLEC, V65, P57, DOI 10.1016/j.ibmb.2015.07.002; Vannini L, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-24; Vannini L, 2014, INSECT BIOCHEM MOLEC, V44, P33, DOI 10.1016/j.ibmb.2013.11.002; Xu RD, 1996, ARCH BIOCHEM BIOPHYS, V329, P56, DOI 10.1006/abbi.1996.0191; Zangi R, 2009, J AM CHEM SOC, V131, P1535, DOI 10.1021/ja807887g; Zhang SG, 2014, INSECT BIOCHEM MOLEC, V47, P46, DOI 10.1016/j.ibmb.2014.02.002; Zhou RH, 2011, J PHYS CHEM B, V115, P1323, DOI 10.1021/jp105160a; Zhou YH, 2016, INSECT BIOCHEM MOLEC, V75, P45, DOI 10.1016/j.ibmb.2016.05.001	52	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2017	12	4							e0175423	10.1371/journal.pone.0175423	http://dx.doi.org/10.1371/journal.pone.0175423			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KH	28419115	Green Published, Green Submitted, gold			2022-12-27	WOS:000399875200022
J	Kaur, K; Wu, XQ; Fields, JK; Johnson, DK; Lan, L; Pratt, M; Somoza, AD; Wang, CCC; Karanicolas, J; Oakley, BR; Xu, L; De Guzman, RN				Kaur, Kawaljit; Wu, Xiaoqing; Fields, James K.; Johnson, David K.; Lan, Lan; Pratt, Miranda; Somoza, Amber D.; Wang, Clay C. C.; Karanicolas, John; Oakley, Berl R.; Xu, Liang; De Guzman, Roberto N.			The fungal natural product azaphilone-9 binds to HuR and inhibits HuR-RNA interaction in vitro	PLOS ONE			English	Article							AU-RICH ELEMENT; MESSENGER-RNA; PROTEIN HUR; METHYL-GROUPS; COLON-CANCER; TARGET RNA; STABILITY; EXPRESSION; CELLS; IDENTIFICATION	The RNA-binding protein Hu antigen R (HuR) binds to AU-rich elements (ARE) in the 3'-untranslated region (UTR) of target mRNAs. The HuR-ARE interactions stabilize many oncogenic mRNAs that play important roles in tumorigenesis. Thus, small molecules that interfere with the HuR-ARE interaction could potentially inhibit cancer cell growth and progression. Using a fluorescence polarization (FP) competition assay, we identified the compound azaphilone-9 (AZA-9) derived from the fungal natural product asperbenzaldehyde, binds to HuR and inhibits HuR-ARE interaction (IC50 similar to 1.2 mu M). Results from surface plasmon resonance (SPR) verified the direct binding of AZA-9 to HuR. NMR methods mapped the RNA-binding interface of HuR and identified the involvement of critical RNA-binding residues in binding of AZA-9. Computational docking was then used to propose a likely binding site for AZA-9 in the RNA-binding cleft of HuR. Our results show that AZA-9 blocks key RNA-binding residues of HuR and disrupts HuR-RNA interactions in vitro. This knowledge is needed in developing more potent AZA-9 derivatives that could lead to new cancer therapy.	[Kaur, Kawaljit; Wu, Xiaoqing; Fields, James K.; Lan, Lan; Pratt, Miranda; Karanicolas, John; Oakley, Berl R.; Xu, Liang; De Guzman, Roberto N.] Univ Kansas, Dept Mol Biosci, Lawrence, KS 66045 USA; [Johnson, David K.] Univ Kansas, Mol Graph & Modeling Lab & Computat Chem Biol Cor, Lawrence, KS 66045 USA; [Somoza, Amber D.; Wang, Clay C. C.] Univ Southern Calif, Dept Chem, Los Angeles, CA 90089 USA; [Wang, Clay C. C.] Univ Southern Calif, Sch Pharm, Dept Pharmacol & Pharmaceut Sci, Los Angeles, CA USA; [Karanicolas, John] Univ Kansas, Ctr Computat Biol, Lawrence, KS 66045 USA	University of Kansas; University of Kansas; University of Southern California; University of Southern California; University of Kansas	De Guzman, RN (corresponding author), Univ Kansas, Dept Mol Biosci, Lawrence, KS 66045 USA.	rdguzman@ku.edu	LAN, LAN/N-8872-2018; Wang, Clay/ABG-9056-2021	Wang, Clay/0000-0003-2955-7569; Fields, James/0000-0001-5923-108X; Johnson, David/0000-0003-4262-8173	NIH [A1074856, R01 CA178831, CA191785]; NIH COBRE-PSF at KU Pilot Project [P30 GM110761, P01-GM084077]; H.L. Snyder Medical Foundation; NATIONAL CANCER INSTITUTE [R01CA178831, R01CA191785] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI074856] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM110761] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH COBRE-PSF at KU Pilot Project; H.L. Snyder Medical Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grants A1074856 (R.N.D), R01 CA178831, CA191785, NIH COBRE-PSF at KU Pilot Project P30 GM110761 (L. X), P01-GM084077 (B.R.O and C.C.C.W) and H.L. Snyder Medical Foundation (B.R.O).	Abdelmohsen K, 2010, WIRES RNA, V1, P214, DOI 10.1002/wrna.4; Bazzoli A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140359; Brennan CM, 2001, CELL MOL LIFE SCI, V58, P266, DOI 10.1007/PL00000854; Chae MJ, 2009, EXP MOL MED, V41, P824, DOI 10.3858/emm.2009.41.11.088; D'Agostino VG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072426; D'Agostino VG, 2015, SCI REP-UK, V5, DOI 10.1038/srep16478; de Silanes IL, 2004, P NATL ACAD SCI USA, V101, P2987, DOI 10.1073/pnas.0306453101; de Silanes IL, 2003, ONCOGENE, V22, P7146, DOI 10.1038/sj.onc.1206862; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Denkert C, 2006, MODERN PATHOL, V19, P1261, DOI 10.1038/modpathol.3800645; Dixon DA, 2001, J CLIN INVEST, V108, P1657, DOI 10.1172/JCI200112973; Evidente A, 2014, NAT PROD REP, V31, P617, DOI 10.1039/c3np70078j; Fan XHC, 1998, P NATL ACAD SCI USA, V95, P15293, DOI 10.1073/pnas.95.26.15293; Fan XHC, 1998, EMBO J, V17, P3448, DOI 10.1093/emboj/17.12.3448; Fialcowitz-White EJ, 2007, J BIOL CHEM, V282, P20948, DOI 10.1074/jbc.M701751200; Gao JM, 2013, CHEM REV, V113, P4755, DOI 10.1021/cr300402y; Giannini G, 2003, FITOTERAPIA, V74, P323, DOI 10.1016/S0367-326X(03)00059-5; Hajduk PJ, 2000, J AM CHEM SOC, V122, P7898, DOI 10.1021/ja000350l; Hawkins PCD, 2010, J CHEM INF MODEL, V50, P572, DOI 10.1021/ci100031x; Heinonen M, 2007, CLIN CANCER RES, V13, P6959, DOI 10.1158/1078-0432.CCR-07-1432; Ishimaru D, 2009, MOL CANCER RES, V7, P1354, DOI 10.1158/1541-7786.MCR-08-0476; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Kim HS, 2011, NUCLEIC ACIDS RES, V39, P1117, DOI 10.1093/nar/gkq837; Kreishman-Deitrick M, 2003, BIOCHEMISTRY-US, V42, P8579, DOI 10.1021/bi034536j; Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/S0076-6879(11)87019-9, 10.1016/B978-0-12-381270-4.00019-6]; Ma WJ, 1996, J BIOL CHEM, V271, P8144, DOI 10.1074/jbc.271.14.8144; McGann M, 2011, J CHEM INF MODEL, V51, P578, DOI 10.1021/ci100436p; Meisner NC, 2007, NAT CHEM BIOL, V3, P508, DOI 10.1038/nchembio.2007.14; Osmanova N, 2010, PHYTOCHEM REV, V9, P315, DOI 10.1007/s11101-010-9171-3; Paranjape SR, 2015, ACS CHEM NEUROSCI, V6, P751, DOI 10.1021/acschemneuro.5b00013; Peng SSY, 1998, EMBO J, V17, P3461, DOI 10.1093/emboj/17.12.3461; ROSS J, 1995, MICROBIOL REV, V59, P423, DOI 10.1128/MMBR.59.3.423-450.1995; Somoza AD, 2012, ORG LETT, V14, P972, DOI 10.1021/ol203094k; Tugarinov V, 2005, CHEMBIOCHEM, V6, P1567, DOI 10.1002/cbic.200500110; Vo DT, 2012, MOL CANCER RES, V10, P143, DOI 10.1158/1541-7786.MCR-11-0208; Wang H, 2013, ACTA CRYSTALLOGR D, V69, P373, DOI 10.1107/S0907444912047828; Wang ZH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138780; Wu XQ, 2015, ACS CHEM BIOL, V10, P1476, DOI 10.1021/cb500851u; Yi XF, 2009, AUST NZ J OBSTET GYN, V49, P93, DOI 10.1111/j.1479-828X.2008.00937.x; Zhang X, 2009, NUCLEIC ACIDS RES, V37, P7623, DOI 10.1093/nar/gkp755; Zucal C, 2015, CURR DRUG TARGETS, V16, P499, DOI 10.2174/1389450116666150223163632	41	28	28	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2017	12	4							e0175471	10.1371/journal.pone.0175471	http://dx.doi.org/10.1371/journal.pone.0175471			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KD	28414767	gold, Green Published, Green Submitted			2022-12-27	WOS:000399874800027
J	Zank, S; Hanazaki, N				Zank, Sofia; Hanazaki, Natalia			The coexistence of traditional medicine and biomedicine: A study with local health experts in two Brazilian regions	PLOS ONE			English	Article							BOLIVIAN ANDES; KNOWLEDGE; PLANTS; COMMUNITIES; ETHNOBOTANY; HEALERS; FOREST; CARE	This study investigated the combined use of traditional medicine and biomedicine by local experts in Chapada do Araripe communities (Ceara A State) and maroon communities (Santa Catarina State), Brazil. The objective was to understand the perception of local health specialists regarding the number of healers, demand for healers and use of medicinal plants, and the dependence of different environments to obtain such plants. We also aimed to understand the role of medicinal plants to treat different categories of diseases and if there is a complementary use of medicinal plants and allopathic biomedicine, according to the context of each group. The research was conducted with local health specialists that answered structured interviews, created free lists and participated in guided tours to collect cited plants. Sixty-six local health specialists were identified in the Araripe communities and 22 specialists in the maroon communities. In the maroon communities, a greater number of specialists thought there was a decrease in the number and demand for healers, as well as the use of medicinal plants, due to changes in traditional livelihoods, since they are located in a region where the effects of the modernization were more intense. In the Chapada do Araripe communities the specialists knew more plants extracted from native vegetation, whereas in the maroon communities cultivated plants were better known, which may reflect the environmental conditions and the history of each region. Medicinal plants are preferred to treat simpler health problems that do not require medical care, such as gastrointestinal problems, general pain, flues and colds. The biomedicine is used principally for problems with blood pressure, general pains and endocrine and nutritional diseases. Even with the particularities of each region, in general the use of medicinal plants and biomedicines occurred in a complementary form in both regions; however, this coexistence may result from these different contexts. This study also found that there was knowledge and appreciation for traditional health practices in both regions.	[Zank, Sofia; Hanazaki, Natalia] Univ Fed Santa Catarina, Lab Human Ecol & Ethnobot, Dept Ecol & Zool, Florianopolis, SC, Brazil	Universidade Federal de Santa Catarina (UFSC)	Zank, S (corresponding author), Univ Fed Santa Catarina, Lab Human Ecol & Ethnobot, Dept Ecol & Zool, Florianopolis, SC, Brazil.	sofiazank@gmail.com	Zank, Sofia/E-6838-2017; Hanazaki, Natalia/AAT-3830-2021	Hanazaki, Natalia/0000-0002-7876-6044; Zank, Sofia/0000-0003-0779-423X	CNPq [306478/2012-9]; CAPES	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	Our research received finnancial support of CNPq through productivity grant supporting the research of N. Hanazaki (306478/2012-9) and of CAPES through PhD grant for S. Zank and financial support for fieldwork.	Albuquerque UP., 2010, METODOS TECNICAS PES, P21; Amorozo M C., 1999, REV SAUDE AMBIENTE, V2, P48; Amorozo M.D.M., 2004, J ETHNOBIOL, V24, P139; [Anonymous], 2008, PLANTAS MED BRASIL N; Avila J. V. da C., 2015, Ethnobotany Research and Applications, V14, P453; Azevedo Sheila Karla Santos de, 2006, Acta Bot. Bras., V20, P185, DOI 10.1590/S0102-33062006000100017; Baldauf C, 2013, ECON BOT, V67, P110, DOI 10.1007/s12231-013-9228-5; Benitez G, 2010, J ETHNOPHARMACOL, V129, P87, DOI 10.1016/j.jep.2010.02.016; Bennett BC, 2000, ECON BOT, V54, P90, DOI 10.1007/BF02866603; Boing L, 2013, ATELIE HIST UEPG, V1, P85; Calvet-Mir L, 2008, J ETHNOBIOL ETHNOMED, V4, DOI 10.1186/1746-4269-4-18; Cheikhyoussef A, 2011, J ETHNOBIOL ETHNOMED, V7, DOI 10.1186/1746-4269-7-10; Costa IR, ACTA BOT BRASILICA, V18, P759; Cunningham AB, 2001, APPL ETHNOBOTANY PEO; Da Silva GS, 2010, REV MOSAICO, V3, P33; de Albuquerque UP, 2006, J ETHNOBIOL ETHNOMED, V2, DOI 10.1186/1746-4269-2-30; de Albuquerque UP, 2007, J ETHNOPHARMACOL, V110, P76, DOI 10.1016/j.jep.2006.09.010; de Medeiros PM, 2013, J ETHNOPHARMACOL, V150, P729, DOI 10.1016/j.jep.2013.09.026; Campos LZD, 2015, J ARID ENVIRON, V115, P53, DOI 10.1016/j.jaridenv.2015.01.002; de Wet H, 2016, S AFR J BOT, V103, P78, DOI 10.1016/j.sajb.2015.08.011; Fundacao Cultural Palmares, 2015, FUND CULT PALM; Giovannini P, 2011, SOC SCI MED, V72, P928, DOI 10.1016/j.socscimed.2011.01.007; Giovannini P, 2009, J ETHNOPHARMACOL, V121, P383, DOI 10.1016/j.jep.2008.11.003; Giraldi M, 2016, ETHNOSCIENTIA, V1; Giraldi M, 2010, ACTA BOT BRAS, V24, P395, DOI 10.1590/S0102-33062010000200010; Lorenzi H., 2000, PLANTAS DANINHAS BRA, V3rd ed.; Lozano A, J ETHNOBIOLOGY ETHNO; Lunyera J, 2016, BMC COMPLEM ALTERN M, V16, DOI 10.1186/s12906-016-1262-2; Maciel Márcia Regina Antunes, 2006, Bol. Mus. Para. Emílio Goeldi. Ciênc. hum., V1, P61; Maneenoon K, 2015, J ETHNOBIOL ETHNOMED, V11, DOI 10.1186/s13002-015-0031-5; Mathez-Stiefel SL, 2012, J ETHNOBIOL ETHNOMED, V8, DOI 10.1186/1746-4269-8-26; Monteiro JM, 2010, ECON BOT, V64, P352, DOI 10.1007/s12231-010-9132-1; NGOKWEY N, 1995, SOC SCI MED, V40, P1141, DOI 10.1016/0277-9536(94)00241-K; Oliveira D.R., 2012, REV BRASILEIRA PROMO, V25, P278; Oliveira E.C.S., 2009, REV BRAS BIOCIENC, V7, P245; Pouliot M, 2011, SOC SCI MED, V73, P1498, DOI 10.1016/j.socscimed.2011.08.037; Reeve ME, 2000, MED ANTHROPOL Q, V14, P96, DOI 10.1525/maq.2000.14.1.96; Saethre EJ, 2007, OCEANIA, V77, P95, DOI 10.1002/j.1834-4461.2007.tb00007.x; Soldati GT, 2012, EVIDENCE BASED COMPL; Sousa JR, 2013, ECON BOT, V67, P225, DOI 10.1007/s12231-013-9241-8; Vandebroek I, 2004, SOC SCI MED, V59, P837, DOI 10.1016/j.socscimed.2003.11.030; Vandebroek I, 2004, B WORLD HEALTH ORGAN, V82, P243; Vandebroek I, 2013, J ETHNOPHARMACOL, V148, P746, DOI 10.1016/j.jep.2013.05.039; WHO, 2014, INT STAT CLASS DIS R; Williams VL, 2000, ECON BOT, V54, P310, DOI 10.1007/BF02864784; ZANK S., 2016, Rev. bras. plantas med., V18, P157, DOI 10.1590/1983-084X/15_142; Zank S, 2012, EVIDENCE BASED COMPL, V10; Zank S, 2016, ETHNOBIOL CONSERV, V5, DOI 10.15451/ec2016-6-5.3-1-15; Zank S, 2015, J ETHNOBIOL ETHNOMED, V11, DOI 10.1186/1746-4269-11-11	49	28	30	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2017	12	4							e0174731	10.1371/journal.pone.0174731	http://dx.doi.org/10.1371/journal.pone.0174731			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES9KD	28414735	gold, Green Published, Green Submitted			2022-12-27	WOS:000399874800008
J	Wen, HJ; Chen, CC; Wu, MT; Chen, ML; Sun, CW; Wu, WC; Huang, IW; Huang, PC; Yu, TY; Hsiung, CA; Wang, SL				Wen, Hui-Ju; Chen, Chu-Chih; Wu, Ming-Tsang; Chen, Mei-Lien; Sun, Chien-Wen; Wu, Wen-Chiu; Huang, I-Wen; Huang, Po-Chin; Yu, Tzu-Yun; Hsiung, Chao A.; Wang, Shu-Li		RAPIT Grp	Phthalate exposure and reproductive hormones and sex-hormone binding globulin before puberty - Phthalate contaminated-foodstuff episode in Taiwan	PLOS ONE			English	Article							DI-(2-ETHYLHEXYL) PHTHALATE; ACID ESTERS; BISPHENOL-A; FETAL-RAT; CHILDREN; STEROIDOGENESIS; METABOLITES; DEHP; DI(2-ETHYLHEXYL)PHTHALATE; MECHANISMS	Background In May 2011, a major incident involving phthalates-contaminated foodstuffs occurred in Taiwan. Di-(2-ethylhexyl) phthalate (DEHP) was added to foodstuffs, mainly juice, jelly, tea, sports drink, and dietary supplements. Concerns arose that normal pubertal development, especially reproductive hormone regulation in children, could be disrupted by DEHP exposure. Objective To investigate the association between phthalate exposure and reproductive hormone levels among children following potential exposure to phthalate-tainted foodstuffs. Methods A total of 239 children aged <12 years old were recruited from 3 hospitals in north, central, and south Taiwan after the episode. Structured questionnaires were used to collect the frequency and quantity of exposures to 5 categories of phthalate-contaminated foodstuffs to assess phthalate exposure in children. Urine samples were collected for the measurement of phthalate metabolites. The estimated daily intake of DEHP exposure at the time of the contamination incident occurred was calculated using both questionnaire data and urinary DEHP metabolite concentrations. Multiple regression analyses were applied to assess associations between phthalate exposure and reproductive hormone levels in children. Results After excluding children with missing data regarding exposure levels and hormone concentrations and girls with menstruation, 222 children were included in the statistical analyses. After adjustment for age and birth weight, girls with above median levels of urinary mono-(2ethyl-5-hydroxyhexyl) phthalate, mono-(2-ethyl-5-oxohexyl) phthalate, and sum of mono-(2-ethylhexyl) phthalate concentrations had higher odds of above median follicle-stimulating hormone concentrations. Girls with above median estimated average daily DEHP exposures following the contamination episode also had higher odds of sex hormone-binding globulin above median levels. Conclusions Phthalate exposure was associated with alterations of reproductive hormone levels in girls.	[Wen, Hui-Ju; Sun, Chien-Wen; Huang, Po-Chin; Wang, Shu-Li] Natl Hlth Res Inst, Natl Inst Environm Hlth Sci, Miaoli, Taiwan; [Chen, Chu-Chih; Yu, Tzu-Yun; Hsiung, Chao A.] Natl Hlth Res Inst, Inst Populat Hlth Sci, Div Biostat & Bioinformat, Miaoli, Taiwan; [Wu, Ming-Tsang; Wang, Shu-Li] Kaohsiung Med Univ, Dept Publ Hlth, Coll Hlth Sci, Kaohsiung, Taiwan; [Wu, Ming-Tsang] Kaohsiung Med Univ, Res Ctr Environm Med, Kaohsiung, Taiwan; [Wu, Ming-Tsang] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Family Med, Kaohsiung, Taiwan; [Chen, Mei-Lien] Natl Yang Ming Univ, Inst Environm & Occupat Hlth Sci, Coll Med, Taipei, Taiwan; [Wu, Wen-Chiu] Minist Hlth & Welf, Taipei Hosp, Taipei, Taiwan; [Huang, I-Wen] Minist Hlth & Welf, Taichung Hosp, Dept Gynecol & Obstet, Taichung, Taiwan; [Hsiung, Chao A.] Natl Hlth Res Inst, Inst Populat Hlth Sci, Div Hlth Policy Translat, Miaoli, Taiwan; [Wang, Shu-Li] China Med Univ, Dept Publ Hlth, Coll Publ Hlth, Taichung, Taiwan	National Health Research Institutes - Taiwan; National Health Research Institutes - Taiwan; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; National Yang Ming Chiao Tung University; National Health Research Institutes - Taiwan; China Medical University Taiwan	Wang, SL (corresponding author), Natl Hlth Res Inst, Natl Inst Environm Hlth Sci, Miaoli, Taiwan.; Hsiung, CA (corresponding author), Natl Hlth Res Inst, Inst Populat Hlth Sci, Div Biostat & Bioinformat, Miaoli, Taiwan.; Wang, SL (corresponding author), Kaohsiung Med Univ, Dept Publ Hlth, Coll Hlth Sci, Kaohsiung, Taiwan.; Hsiung, CA (corresponding author), Natl Hlth Res Inst, Inst Populat Hlth Sci, Div Hlth Policy Translat, Miaoli, Taiwan.; Wang, SL (corresponding author), China Med Univ, Dept Publ Hlth, Coll Publ Hlth, Taichung, Taiwan.	hsiung@nhri.org.tw; slwang@nhri.org.tw	Chen, Chu-Chih/B-8308-2015; Wu, Ming-Tsang/G-5637-2012	Chen, Chu-Chih/0000-0002-4594-4991; Wu, Ming-Tsang/0000-0001-7307-7816; Wen, Hui-Ju/0000-0003-1268-3120; Huang, Po-Chin/0000-0002-9243-0838; Chen, Bai Hsiun/0000-0001-9496-553X; Wang, Shu-Li/0000-0002-0686-4729	Department of National Health Research Institutes, Taiwan [EH-102-SP-01, EH-102-PP-05, EH-103-SP-01, EH-103-PP05, EH-104-SP-01, EH-104-PP05]; Ministry of Science and Technology [(NSC100-3114-Y-043-005]	Department of National Health Research Institutes, Taiwan; Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	Financial support received from the Department of National Health Research Institutes, Taiwan, is gratefully acknowledged (EH-102-SP-01, EH-102-PP-05, EH-103-SP-01, EH-103-PP05, EH-104-SP-01, and EH-104-PP05) and Ministry of Science and Technology (NSC100-3114-Y-043-005). The funding agents had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler NE, 2002, HEALTH AFFAIR, V21, P60, DOI 10.1377/hlthaff.21.2.60; Axelsson J, 2015, ENVIRON RES, V138, P264, DOI 10.1016/j.envres.2015.02.024; Beko G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062442; Borch J, 2006, TOXICOLOGY, V223, P144, DOI 10.1016/j.tox.2006.03.015; Bornehag CG, 2015, ENVIRON HEALTH PERSP, V123, P101, DOI 10.1289/ehp.1408163; Chen CC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151070; Dean A, 2013, J CLIN ENDOCR METAB, V98, P2230, DOI 10.1210/jc.2012-4057; Ferguson KK, 2014, REPROD TOXICOL, V47, P70, DOI 10.1016/j.reprotox.2014.06.002; Fong JP, 2015, OCCUP ENVIRON MED, V72, P346, DOI 10.1136/oemed-2014-102532; Costa EMF, 2014, ARQ BRAS ENDOCRINOL, V58, P153, DOI 10.1590/0004-2730000003031; Frederiksen H, 2012, INT J ANDROL, V35, P216, DOI 10.1111/j.1365-2605.2012.01260.x; Frederiksen H, 2011, ENVIRON RES, V111, P656, DOI 10.1016/j.envres.2011.03.005; Hallmark N, 2007, ENVIRON HEALTH PERSP, V115, P390, DOI 10.1289/ehp.9490; Hartmann C, 2015, INT J HYG ENVIR HEAL, V218, P489, DOI 10.1016/j.ijheh.2015.04.002; Hauser R, 2005, OCCUP ENVIRON MED, V62, DOI 10.1136/oem.2004.017590; HEINDEL JJ, 1989, FUND APPL TOXICOL, V12, P508, DOI 10.1016/0272-0590(89)90024-9; Hoyt LT, 2015, SOC SCI MED, V132, P103, DOI 10.1016/j.socscimed.2015.03.031; Koch HM, 2011, INT J HYG ENVIR HEAL, V214, P188, DOI 10.1016/j.ijheh.2011.01.009; Ku HY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123309; Kuiri-Hanninen T, 2014, HORM RES PAEDIAT, V82, P73, DOI 10.1159/000362414; Li JR, 2012, MOL ECOL, V21, P28, DOI 10.1111/j.1365-294X.2011.05308.x; Lin LC, 2011, CHEMOSPHERE, V83, P1192, DOI 10.1016/j.chemosphere.2010.12.079; Lin S, 2011, CHEMOSPHERE, V82, P947, DOI 10.1016/j.chemosphere.2010.10.073; Liu T, 2014, REPROD TOXICOL, V46, P141, DOI 10.1016/j.reprotox.2014.03.006; Ljungvall K, 2006, REPROD TOXICOL, V21, P160, DOI 10.1016/j.reprotox.2005.07.012; Lottrup G, 2006, INT J ANDROL, V29, P172, DOI 10.1111/j.1365-2605.2005.00642.x; Lovekamp-Swan T, 2003, ENVIRON HEALTH PERSP, V111, P139, DOI 10.1289/ehp.5658; Martinez-Arguelles DB, 2016, ANDROLOGY-US, V4, P573, DOI 10.1111/andr.12175; Meltzer D, 2015, REPROD TOXICOL, V51, P47, DOI 10.1016/j.reprotox.2014.12.005; Mouritsen A, 2013, J CLIN ENDOCR METAB, V98, P3755, DOI 10.1210/jc.2013-1284; Myridakis A, 2015, ENVIRON INT, V83, P1, DOI 10.1016/j.envint.2015.05.014; Pasquali R, 1997, METABOLISM, V46, P5, DOI 10.1016/S0026-0495(97)90159-1; Sharma A, 2020, REPROD MED BIOL, V19, P243, DOI [10.1002/rmb2.12326, 10.1007/s42600-020-00106-3]; Su PH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102788; Svechnikova I, 2007, J ENDOCRINOL, V194, P603, DOI 10.1677/JOE-07-0238; Thaler MA, 2015, BEST PRACT RES CL EN, V29, P749, DOI 10.1016/j.beem.2015.06.005; Wang YX, 2015, ENVIRON RES, V142, P1, DOI 10.1016/j.envres.2015.06.010; Wittassek M, 2007, INT J HYG ENVIR HEAL, V210, P35, DOI 10.1016/j.ijheh.2006.11.009; Wittassek M, 2011, MOL NUTR FOOD RES, V55, P7, DOI 10.1002/mnfr.201000121; Wormuth M, 2006, RISK ANAL, V26, P803, DOI 10.1111/j.1539-6924.2006.00770.x; Wu CF, 2013, ENVIRON SCI TECHNOL, V47, P13754, DOI 10.1021/es403141u; Wu MT, 2012, ENVIRON INT, V44, P75, DOI 10.1016/j.envint.2012.01.014; Ye T, 2014, AQUAT TOXICOL, V146, P115, DOI 10.1016/j.aquatox.2013.10.025; Yeung Bonnie Hy, 2011, Spermatogenesis, V1, P231	44	19	20	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2017	12	4							e0175536	10.1371/journal.pone.0175536	http://dx.doi.org/10.1371/journal.pone.0175536			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0MD	28410414	Green Published, gold, Green Submitted			2022-12-27	WOS:000399955600024
J	Mori, Y; Murakami, T; Suzuma, K; Ishihara, K; Yoshitake, S; Fujimoto, M; Dodo, Y; Yoshitake, T; Miwa, Y; Tsujikawa, A				Mori, Yuki; Murakami, Tomoaki; Suzuma, Kiyoshi; Ishihara, Kenji; Yoshitake, Shin; Fujimoto, Masahiro; Dodo, Yoko; Yoshitake, Tatsuya; Miwa, Yuko; Tsujikawa, Akitaka			Relation between macular morphology and treatment frequency during twelve months with ranibizumab for diabetic macular edema	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; OPTICAL COHERENCE TOMOGRAPHY; INTRAVITREAL RANIBIZUMAB; RANDOMIZED-TRIAL; DEFERRED LASER; VISUAL-ACUITY; COST-EFFECTIVENESS; RETINAL THICKNESS; FACTOR THERAPY; PLUS PROMPT	Purpose To investigate whether baseline optical coherence tomography (OCT) parameters can predict the treatment frequency of intravitreal ranibizumab (IVR) injections during the first year in patients with diabetic macular edema (DME) treated with pro re nata (PRN) IVR injections. Methods We retrospectively reviewed 68 eyes of 63 patients with center-involved DME who received IVR injections for 12 months or longer according to three monthly IVR injections followed by the PRN dosing. We measured the mean retinal thicknesses in the individual subfields of the Early Treatment Diabetic Retinopathy Study grid and evaluated the qualitative and quantitative parameters on OCT sectional images. We investigated the relationship between these OCT parameters at baseline and the number of IVR injections during the 12-month follow-up. Results Three loading doses were administered to 10 eyes; four to seven annualized IVR injections were administered to 34 eyes. The number of eyes that received IVR injections decreased gradually until month 6 and was almost constant from months 7 to 11. No relationships were seen between the treatment frequency and baseline systemic factors and the ophthalmic examination findings. Univariate analyses showed that the number of IVR injections during the first year was associated with the mean retinal thickness in the individual subfields and the transverse length of the disrupted external limiting membrane (ELM) and ellipsoid zone of the photoreceptors. Multivariate analysis showed a significant association with the thickness in the inferior subfield alone. The treatment frequency during the 12-month follow-up was not correlated with improved visual acuity but was associated with the decrease in the central subfield thickness and disrupted ELM. Conclusion The retinal thickness in the inferior subfield predicts the treatment frequency during the first year in eyes with DME treated with PRN IVR injections.	[Mori, Yuki; Murakami, Tomoaki; Suzuma, Kiyoshi; Ishihara, Kenji; Yoshitake, Shin; Fujimoto, Masahiro; Dodo, Yoko; Yoshitake, Tatsuya; Miwa, Yuko; Tsujikawa, Akitaka] Kyoto Univ, Grad Sch Med, Dept Ophthalmol & Visual Sci, Kyoto, Japan	Kyoto University	Murakami, T (corresponding author), Kyoto Univ, Grad Sch Med, Dept Ophthalmol & Visual Sci, Kyoto, Japan.	mutomo@kuhp.kyoto-u.ac.jp		Murakami, Tomoaki/0000-0002-0314-8807; Tsujikawa, Akitaka/0000-0003-0779-7799	Japan Society for the Promotion of Science [26462637]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was funded by the Grant-in-Aid for Scientific Research of the Japan Society for the Promotion of Science (TM) (26462637). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIELLO LP, 1994, NEW ENGL J MED, V331, P1480, DOI 10.1056/NEJM199412013312203; Al Faran A, 2014, RETINA-J RET VIT DIS, V34, P1208, DOI 10.1097/IAE.0000000000000059; Antonetti DA, 2012, NEW ENGL J MED, V366, P1227, DOI 10.1056/NEJMra1005073; Avery RL, 2016, JAMA OPHTHALMOL, V134, P21, DOI 10.1001/jamaophthalmol.2015.4070; Bressler SB, 2015, RETINA-J RET VIT DIS, V35, P2516, DOI 10.1097/IAE.0000000000000617; Bressler SB, 2012, ARCH OPHTHALMOL-CHIC, V130, P1153, DOI 10.1001/archophthalmol.2012.1107; Brown GC, 2015, OPHTHALMOLOGY, V122, P1416, DOI 10.1016/j.ophtha.2015.03.032; Browning DJ, 2007, OPHTHALMOLOGY, V114, P525, DOI 10.1016/j.ophtha.2006.06.052; Campochiaro PA, 2014, OPHTHALMOLOGY, V121, P1783, DOI 10.1016/j.ophtha.2014.03.021; Chalam KV, 2012, INVEST OPHTH VIS SCI, V53, P8154, DOI 10.1167/iovs.12-10290; Cunningham ET, 2005, OPHTHALMOLOGY, V112, P1747, DOI 10.1016/j.ophtha.2005.06.007; Domalpally A, 2015, OPHTHALMOLOGY, V122, P779, DOI 10.1016/j.ophtha.2014.10.028; Elman MJ, 2015, OPHTHALMOLOGY, V122, P375, DOI 10.1016/j.ophtha.2014.08.047; Elman MJ, 2010, OPHTHALMOLOGY, V117, P1064, DOI 10.1016/j.ophtha.2010.02.031; Funatsu H, 2002, AM J OPHTHALMOL, V133, P70, DOI 10.1016/S0002-9394(01)01269-7; Greenberg JI, 2008, NATURE, V456, P809, DOI 10.1038/nature07424; Haller JA, 2010, OPHTHALMOLOGY, V117, P1087, DOI 10.1016/j.ophtha.2009.10.040; Ip MS, 2012, ARCH OPHTHALMOL-CHIC, V130, P1145, DOI 10.1001/archophthalmol.2012.1043; Ishida S, 2003, NAT MED, V9, P781, DOI 10.1038/nm877; Korobelnik JF, 2014, OPHTHALMOLOGY, V121, P2247, DOI 10.1016/j.ophtha.2014.05.006; Lee J, 2016, OPHTHALMOLOGY, V123, P2368, DOI 10.1016/j.ophtha.2016.07.010; Mitchell P, 2011, OPHTHALMOLOGY, V118, P615, DOI 10.1016/j.ophtha.2011.01.031; Miyamoto K, 1999, P NATL ACAD SCI USA, V96, P10836, DOI 10.1073/pnas.96.19.10836; Miyamoto K, 2000, AM J PATHOL, V156, P1733, DOI 10.1016/S0002-9440(10)65044-4; Mori Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep39161; Murakami T, 2014, INVEST OPHTH VIS SCI, V55, P1994, DOI 10.1167/iovs.13-13417; Murakami T, 2012, DIABETES, V61, P1573, DOI 10.2337/db11-1367; Murakami T, 2012, INVEST OPHTH VIS SCI, V53, P1506, DOI 10.1167/iovs.11-9231; Murakami T, 2011, OPHTHALMOLOGY, V118, P359, DOI 10.1016/j.ophtha.2010.03.035; Murakami T, 2011, AM J OPHTHALMOL, V151, P310, DOI 10.1016/j.ajo.2010.08.022; Payne JF, 2017, OPHTHALMOLOGY, V124, P74, DOI 10.1016/j.ophtha.2016.09.021; Prunte C, 2016, BRIT J OPHTHALMOL, V100, P787, DOI 10.1136/bjophthalmol-2015-307249; Nguyen QD, 2012, OPHTHALMOLOGY, V119, P789, DOI 10.1016/j.ophtha.2011.12.039; QUHONG, 1995, J HISTOCHEM CYTOCHEM, V43, P381, DOI 10.1177/43.4.7534783; Sadiq MA, 2016, OPHTHALMOLOGY, V123, P324, DOI 10.1016/j.ophtha.2015.09.032; Schmidt-Erfurth U, 2014, OPHTHALMOLOGY, V121, P1045, DOI 10.1016/j.ophtha.2013.11.041; Shimura M, 2016, JPN J OPHTHALMOL, V60, P401, DOI 10.1007/s10384-016-0458-9; Shimura M, 2013, RETINA-J RET VIT DIS, V33, P740, DOI 10.1097/IAE.0b013e31826b6763; Smiddy WE, 2012, OPHTHALMOLOGY, V119, P2558, DOI 10.1016/j.ophtha.2012.09.015; Sonoda S, 2013, INVEST OPHTH VIS SCI, V54, P5367, DOI 10.1167/iovs.13-12382; Sophie R, 2015, OPHTHALMOLOGY, V122, P1395, DOI 10.1016/j.ophtha.2015.02.036; Stein JD, 2013, OPHTHALMOLOGY, V120, P1835, DOI 10.1016/j.ophtha.2013.02.002; Sun JK, 2014, JAMA OPHTHALMOL, V132, P1309, DOI 10.1001/jamaophthalmol.2014.2350; Wykoff CC, 2016, OPHTHALMOLOGY, V123, P1716, DOI 10.1016/j.ophtha.2016.04.004; Yau JWY, 2012, DIABETES CARE, V35, P556, DOI 10.2337/dc11-1909	45	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2017	12	4							e0175809	10.1371/journal.pone.0175809	http://dx.doi.org/10.1371/journal.pone.0175809			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0MB	28407012	Green Submitted, Green Published, gold			2022-12-27	WOS:000399955400100
J	Potprommanee, L; Wang, XQ; Han, YJ; Nyobe, D; Peng, YP; Huang, Q; Liu, JY; Liao, YL; Chang, KL				Potprommanee, Laddawan; Wang, Xiao-Qin; Han, Ye-Ju; Nyobe, Didonc; Peng, Yen-Ping; Huang, Qing; Liu, Jing-yong; Liao, Yu-Ling; Chang, Ken-Lin			Characterization of a thermophilic cellulase from Geobacillus sp HTA426, an efficient cellulase-producer on alkali pretreated of lignocellulosic biomass	PLOS ONE			English	Article							ENZYMATIC-HYDROLYSIS; ETHANOL-PRODUCTION; SUGAR PRODUCTION; CORN STOVER; BACTERIA; ENZYMES; SACCHARIFICATION; STRAIN; KEY; FERMENTATION	A themophilic cellulase-producing bacterium was isolated from a hot spring district and identified as Geobacillus sp. HTA426. The cellulase enzyme produced by the Geobacillus sp. HTA426 was purified through ammonium sulfate precipitation and ion exchange chromatography, with the recovery yield and fold purification of 10.14% and 5.12, respectively. The purified cellulase has a molecular weight of 40 kDa. The optimum temperature and pH for carboxymethyl cellulase (CMCase) activity of the purified cellulase were 60 degrees C and pH 7.0, respectively. The enzyme was also stable over a wide temperature range of 50 degrees C to 70 degrees C after 5 h of incubation. Moreover, the strain HTA426 was able to grow and produce cellulase on alkali-treated sugarcane bagasse, rice straw and water hyacinth as carbon sources. Enzymatic hydrolysis of sugarcane bagasse, which was regarded as the most effective carbon source for cellulase production (CMCase activity = 103.67 U/mL), followed by rice straw (74.70 U/mL) and water hyacinth (51.10 U/mL). This strain producing an efficient thermostable cellulose is a potential candidate for developing a more efficient and cost-effective process for converting lignocellulosic biomass into biofuel and other industrial process.	[Potprommanee, Laddawan; Wang, Xiao-Qin; Han, Ye-Ju; Nyobe, Didonc; Liu, Jing-yong; Chang, Ken-Lin] Guangdong Univ Technol, Sch Environm Sci & Engn, Guangzhou, Guangdong, Peoples R China; [Potprommanee, Laddawan; Wang, Xiao-Qin; Han, Ye-Ju; Nyobe, Didonc; Liu, Jing-yong; Chang, Ken-Lin] Guangdong Univ Technol, Inst Environm Hlth & Pollut Control, Guangzhou, Guangdong, Peoples R China; [Peng, Yen-Ping] Tunghai Univ, Dept Environm Sci & Engn, Taichung, Taiwan; [Huang, Qing] Chinese Acad Sci, Key Lab Urban Environm & Hlth, Inst Urban Environm, Xiamen, Peoples R China; [Liao, Yu-Ling; Chang, Ken-Lin] Natl Sun Yat Sen Univ, Inst Environm Engn, Kaohsiung, Taiwan	Guangdong University of Technology; Guangdong University of Technology; Tunghai University; Chinese Academy of Sciences; Institute of Urban Environment, CAS; National Sun Yat Sen University	Chang, KL (corresponding author), Guangdong Univ Technol, Sch Environm Sci & Engn, Guangzhou, Guangdong, Peoples R China.; Chang, KL (corresponding author), Guangdong Univ Technol, Inst Environm Hlth & Pollut Control, Guangzhou, Guangdong, Peoples R China.; Chang, KL (corresponding author), Natl Sun Yat Sen Univ, Inst Environm Engn, Kaohsiung, Taiwan.	kenny@gdut.edu.cn	liu, Jingyong/C-8626-2017; CAS, KLUEH/T-5743-2019; Huang, Qing/W-1971-2019	Dieudonne, NYOBE/0000-0001-6931-484X	Science and Technology Planning Project of Guangdong Province, China [2016A040402006, 2016A040403068]; One-Hundred Young Talents (Class A) of the Guangdong University of Technology [1143-220413105]; Guangdong Special Support Program for Training High Level Talents, China [2015TQ01Z039]; Youths Foundation of the Guangdong University of Technology [14QNZD005]; National Natural Science Foundation of China [41571288]; Special Fund of University Discipline Construction of Department of Education of Guangdong Province [2014KTSP022]	Science and Technology Planning Project of Guangdong Province, China; One-Hundred Young Talents (Class A) of the Guangdong University of Technology; Guangdong Special Support Program for Training High Level Talents, China; Youths Foundation of the Guangdong University of Technology; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Fund of University Discipline Construction of Department of Education of Guangdong Province	This research was partially financed by a grant from the Youths Foundation of the Guangdong University of Technology (Grant NO. 14QNZD005); the One-Hundred Young Talents (Class A) of the Guangdong University of Technology (Grant NO. 1143-220413105); National Natural Science Foundation of China (No. 41571288), and Special Fund of University Discipline Construction of Department of Education of Guangdong Province (No. 2014KTSP022); the Science and Technology Planning Project of Guangdong Province, China (No. 2016A040402006; No. 2016A040403068); and the Guangdong Special Support Program for Training High Level Talents, China (2015TQ01Z039). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was partially financed by the Science and Technology Planning Project of Guangdong Province, China (No. 2016A040402006; No. 2016A040403068); the One-Hundred Young Talents (Class A) of the Guangdong University of Technology (Grant NO. 1143-220413105) and Guangdong Special Support Program for Training High Level Talents, China (2015TQ01Z039).	Abdel-Fattah Y. R., 2007, Research Journal of Microbiology, V2, P13; Asha BM, 2012, J MICROBIOL BIOTECHN, V22, P1501, DOI 10.4014/jmb.1202.02013; Assareh R, 2012, BIORESOURCE TECHNOL, V120, P99, DOI 10.1016/j.biortech.2012.06.027; Banerjee G, 2010, BIOENERG RES, V3, P82, DOI 10.1007/s12155-009-9067-5; BERG B, 1972, J APPL BACTERIOL, V35, P201, DOI 10.1111/j.1365-2672.1972.tb03691.x; Bhat MK, 1997, BIOTECHNOL ADV, V15, P583, DOI 10.1016/S0734-9750(97)00006-2; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cabrera E, 2014, BIORESOURCE TECHNOL, V167, P1, DOI 10.1016/j.biortech.2014.05.103; Chandra RP, 2007, ADV BIOCHEM ENG BIOT, V108, P67, DOI 10.1007/10_2007_064; Chang VS, 2000, APPL BIOCHEM BIOTECH, V84-6, P5, DOI 10.1385/ABAB:84-86:1-9:5; Galbe M, 2012, BIOMASS BIOENERG, V46, P70, DOI 10.1016/j.biombioe.2012.03.026; Gaur R, 2015, BMC BIOTECHNOL, V15, DOI [10.1186/s12896-015-0129-9, 10.1155/2015/132635]; Guan WJ, 2016, BIORESOURCE TECHNOL, V200, P713, DOI 10.1016/j.biortech.2015.10.102; Ji L, 2016, BMC BIOTECHNOL, V16, DOI 10.1186/s12896-016-0278-5; Jung SJ, 2015, BIOMASS BIOENERG, V83, P322, DOI 10.1016/j.biombioe.2015.10.007; Karimi K., 2013, BIOFUEL TECHNOLOGIES, P53, DOI DOI 10.1007/978-3-642-34519-7_3; Kluepfel D, 1998, METHOD ENZYMOL, V160, P180; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee HV, 2014, SCI WORLD J, DOI [10.1155/2014/631013, 10.1155/2014/815123]; Lee YJ, 2008, BIORESOURCE TECHNOL, V99, P378, DOI 10.1016/j.biortech.2006.12.013; Liang YN, 2010, APPL BIOCHEM BIOTECH, V160, P1841, DOI 10.1007/s12010-009-8677-x; Lima MA, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/1754-6834-7-10; Lin L, 2015, ELECTRON J BIOTECHN, P15; Liu CG, 2014, BIORESOURCE TECHNOL, V166, P368, DOI 10.1016/j.biortech.2014.05.069; Lo YC, 2009, ENZYME MICROB TECH, V44, P417, DOI 10.1016/j.enzmictec.2009.03.002; Lu WJ, 2005, J GEN APPL MICROBIOL, V51, P353, DOI 10.2323/jgam.51.353; MACDONALD DG, 1983, BIOTECHNOL BIOENG, V25, P2067, DOI 10.1002/bit.260250815; Maki M, 2009, INT J BIOL SCI, V5, P500; MANDELS M, 1957, J BACTERIOL, V73, P269, DOI 10.1128/JB.73.2.269-278.1957; Mayende L, 2006, SOIL BIOL BIOCHEM, V38, P2963, DOI 10.1016/j.soilbio.2006.03.019; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Ng IS, 2009, EXTREMOPHILES, V13, P425, DOI 10.1007/s00792-009-0228-4; OGUNTIMEIN GB, 1991, WORLD J MICROB BIOT, V7, P4, DOI 10.1007/BF02310911; Pervez S, 2014, BMC BIOTECHNOL, V14, DOI 10.1186/1472-6750-14-49; Rajmane S. D., 2012, Current Botany, V3, P13; Rastogi G, 2010, BIORESOURCE TECHNOL, V101, P8798, DOI 10.1016/j.biortech.2010.06.001; Sandhya C, 2005, PROCESS BIOCHEM, V40, P2689, DOI 10.1016/j.procbio.2004.12.001; Sangrila Sadhu, 2013, British Microbiology Research Journal, V3, P235; Seki Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138902; Shah A, 2005, WORLD J MICROB BIOT, V21, P233, DOI 10.1007/s11274-004-3622-1; Shridha Chaurasia, 2013, Indian Journal of Fundamental and Applied Life Sciences, V3, P73; Sivakumar G, 2010, ENG LIFE SCI, V10, P8, DOI 10.1002/elsc.200900061; Sun Y, 2002, BIORESOURCE TECHNOL, V83, P1, DOI 10.1016/S0960-8524(01)00212-7; Tai SK, 2004, EXTREMOPHILES, V8, P345, DOI 10.1007/s00792-004-0395-2; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; TEATHER RM, 1982, APPL ENVIRON MICROB, V43, P777, DOI 10.1128/AEM.43.4.777-780.1982; Viikari L, 2007, ADV BIOCHEM ENG BIOT, V108, P121, DOI 10.1007/10_2007_065; Wu J, 1998, BIOTECHNOL PROGR, V14, P649, DOI 10.1021/bp980040v; Xue SS, 2015, BIOTECHNOL BIOFUELS, V8, DOI 10.1186/s13068-015-0378-9; Yang B, 2008, BIOFUEL BIOPROD BIOR, V2, P26, DOI 10.1002/bbb.49; Zu S, 2014, BIORESOURCE TECHNOL, V152, P364, DOI 10.1016/j.biortech.2013.11.034	51	35	36	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2017	12	4							e0175004	10.1371/journal.pone.0175004	http://dx.doi.org/10.1371/journal.pone.0175004			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0MB	28406925	Green Published, gold, Green Submitted			2022-12-27	WOS:000399955400026
J	Rach, J; Bergmann, T; Paknia, O; DeSalle, R; Schierwater, B; Hadrys, H				Rach, Jessica; Bergmann, Tjard; Paknia, Omid; DeSalle, Rob; Schierwater, Bernd; Hadrys, Heike			The marker choice: Unexpected resolving power of an unexplored CO1 region for layered DNA barcoding approaches	PLOS ONE			English	Article							OXIDASE SUBUNIT-I; MITOCHONDRIAL-DNA; SEQUENCE EVOLUTION; IDENTIFICATION; PRIMERS; VARIABILITY; PHYLOGENY; HOMOPLASY; PATTERNS; GENOMICS	The potential of DNA barcoding approaches to identify single species and characterize species compositions strongly depends on the marker choice. The prominent "Folmer region", a 648 basepair fragment at the 5' end of the mitochondrial CO1 gene, has been traditionally applied as a universal DNA barcoding region for metazoans. In order to find a suitable marker for biomonitoring odonates (dragonflies and damselflies), we here explore a new region of the CO1 gene (CO1B) for DNA barcoding in 51 populations of 23 dragonfly and damselfly species. We compare the "Folmer region", the mitochondrial ND1 gene (NADH dehydrogenase 1) and the new CO1 region with regard to (i) speed and reproducibility of sequence generation, (ii) levels of homoplasy and (iii) numbers of diagnostic characters for discriminating closely related sister taxa and populations. The performances of the gene regions regarding these criteria were quite different. Both, the amplification of CO1B and ND1 was highly reproducible and CO1B showed the highest potential for discriminating sister taxa at different taxonomic levels. In contrast, the amplification of the "Folmer region" using the universal primers was difficult and the third codon positions of this fragment have experienced nucleotide substitution saturation. Most important, exploring this new barcode region of the CO1 gene identified a higher discriminating power between closely related sister taxa. Together with the design of layered barcode approaches adapted to the specific taxonomic "environment", this new marker will further enhance the discrimination power at the species level.	[Rach, Jessica; Bergmann, Tjard; Paknia, Omid; Schierwater, Bernd; Hadrys, Heike] TiHo Hannover, ITZ Ecol & Evolut, D-30559 Hannover, Germany; [DeSalle, Rob; Schierwater, Bernd; Hadrys, Heike] Amer Museum Nat Hist, Sackler Inst Comparat Genom, New York, NY 10024 USA	University of Veterinary Medicine Hannover, Foundation; American Museum of Natural History (AMNH)	Hadrys, H (corresponding author), TiHo Hannover, ITZ Ecol & Evolut, D-30559 Hannover, Germany.; Hadrys, H (corresponding author), Amer Museum Nat Hist, Sackler Inst Comparat Genom, New York, NY 10024 USA.	heike.hadrys@ecolevol.de			fellowship of the Evangelische Studienstiftung; H. Wilhelm Schaumann Stiftung; DFG; program BIOTA South (S08); BIOTA East (E09) of the German Federal Ministry of Education and Research (BMBF)	fellowship of the Evangelische Studienstiftung; H. Wilhelm Schaumann Stiftung; DFG(German Research Foundation (DFG)); program BIOTA South (S08); BIOTA East (E09) of the German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	Jessica Rach was supported by a fellowship of the Evangelische Studienstiftung. Tjard Bergmann was financed by the H. Wilhelm Schaumann Stiftung. The publication fee was sponsored by the DFG. The sampling in Africa was supported by the program BIOTA South (S08) and BIOTA East (E09) of the German Federal Ministry of Education and Research (BMBF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The sampling in Africa was supported by the program BIOTA South (S08; given to H.H.) and BIOTA East (E09; given to Viola Clausnitzer) of the German Federal Ministry of Education and Research (BMBF). We are grateful to Frank Suhling, Sandra Damm and all collaborators for providing us with specimen from South Africa. We are grateful to Viola Clausnitzer for providing us specimen from East Africa. We thank Lynn Groenefeldt for collecting tissue samples in Germany. We thank Eugene Marais (National Museum of Namibia) for his support and all collaborators for helping collect samples during our stay in Namibia. We thank the editor Ph.D Bi-Song Yue and the reviewers for their constructive comments and guidance.	Ali MA, 2014, SAUDI J BIOL SCI, V21, P204, DOI 10.1016/j.sjbs.2014.03.003; Avise John C., 2004, P1; Barco A, 2016, MOL ECOL RESOUR, V16, P288, DOI 10.1111/1755-0998.12440; Barnes MA, 2016, CONSERV GENET, V17, P1, DOI 10.1007/s10592-015-0775-4; Bergmann T, 2013, MOL ECOL RESOUR, V13, P1069, DOI 10.1111/1755-0998.12125; Blagoev GA, 2016, MOL ECOL RESOUR, V16, P325, DOI 10.1111/1755-0998.12444; Breman FC, 2016, MOL ECOL RESOUR, V16, P1455, DOI 10.1111/1755-0998.12523; Cameron SL, 2014, ANNU REV ENTOMOL, V59, P95, DOI 10.1146/annurev-ento-011613-162007; Chaves BRN, 2015, MOL ECOL RESOUR, V15, P921, DOI 10.1111/1755-0998.12344; Che J, 2012, MOL ECOL RESOUR, V12, P247, DOI 10.1111/j.1755-0998.2011.03090.x; Deagle BE, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2014.0562; Dijkstra Klaas-Douwe B., 2007, International Journal of Odonatology, V10, P31; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Elbrecht V, 2016, PEERJ, V4, DOI 10.7717/peerj.1966; Elias M, 2007, P ROY SOC B-BIOL SCI, V274, P2881, DOI 10.1098/rspb.2007.1035; Engstrom TN, 2004, SYST BIOL, V53, P693, DOI 10.1080/10635150490503053; Erpenbeck D, 2006, MOL ECOL NOTES, V6, P550, DOI 10.1111/j.1471-8286.2005.01259.x; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Francoso E, 2013, MOL ECOL RESOUR, V13, P844, DOI 10.1111/1755-0998.12135; Geller J, 2013, MOL ECOL RESOUR, V13, P851, DOI 10.1111/1755-0998.12138; Groeneveld LF, 2007, MOL PHYLOGENET EVOL, V42, P339, DOI 10.1016/j.ympev.2006.05.040; Hadrys H, 1992, MOL ECOL, V1, P55, DOI 10.1111/j.1365-294X.1992.tb00155.x; Hadrys H, 2006, THE PRESENT ROLE AND, P279; Hanfling B, 2016, MOL ECOL, V25, P3101, DOI 10.1111/mec.13660; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hoy MA, 2003, INSECT MOL GENETICS; Huang DW, 2008, J MOL EVOL, V66, P167, DOI 10.1007/s00239-008-9069-5; Ivanova Natalia V, 2012, Methods Mol Biol, V858, P153, DOI 10.1007/978-1-61779-591-6_8; Kerr Kevin C R, 2007, Mol Ecol Notes, V7, P535; Lanzen A, 2016, MOL ECOL; Lijtmaer DA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020744; Lin CP, 2004, MOL PHYLOGENET EVOL, V30, P686, DOI 10.1016/S1055-7903(03)00241-0; Lockwood CA, 1999, YEARB PHYS ANTHROPOL, V42, P189; Lunt DH, 1997, NATURE, V387, P247, DOI 10.1038/387247a0; Meier R, 2006, SYST BIOL, V55, P715, DOI 10.1080/10635150600969864; Nolan L, 2007, NEW ZEAL J ZOOL, V34, P371, DOI 10.1080/03014220709510097; Paknia O, 2015, MOL ECOL RESOUR, V15, P1262, DOI 10.1111/1755-0998.12395; Park MH, 2007, MOL CELLS, V23, P220; Rach J, 2008, P ROY SOC B-BIOL SCI, V275, P237, DOI 10.1098/rspb.2007.1290; Radel D, 2013, MOL PHYLOGENET EVOL, V69, P1186, DOI 10.1016/j.ympev.2013.08.001; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Remigio EA, 2003, MOL PHYLOGENET EVOL, V29, P641, DOI 10.1016/S1055-7903(03)00140-4; Roe AD, 2007, MOL PHYLOGENET EVOL, V44, P325, DOI 10.1016/j.ympev.2006.12.005; Saccone C, 1999, GENE, V238, P195, DOI 10.1016/S0378-1119(99)00270-X; SARASTE M, 1990, Q REV BIOPHYS, V23, P331, DOI 10.1017/S0033583500005588; Sarkar IN, 2002, J BIOMED INFORM, V35, P111, DOI 10.1016/S1532-0464(02)00504-X; Sarkar IN, 2002, MOL PHYLOGENET EVOL, V24, P388; Sarkar IN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014689; Schmidt S, 2015, MOL ECOL RESOUR, V15, P985, DOI 10.1111/1755-0998.12363; Shearer TL, 2002, MOL ECOL, V11, P2475, DOI 10.1046/j.1365-294X.2002.01652.x; Staats M, 2016, ANAL BIOANAL CHEM, V408, P4615, DOI 10.1007/s00216-016-9595-8; Valentini A, 2016, MOL ECOL, V25, P929, DOI 10.1111/mec.13428; Ward RD, 2009, J FISH BIOL, V74, P329, DOI 10.1111/j.1095-8649.2008.02080.x; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371	55	23	24	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2017	12	4							e0174842	10.1371/journal.pone.0174842	http://dx.doi.org/10.1371/journal.pone.0174842			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0MB	28406914	Green Published, gold			2022-12-27	WOS:000399955400017
J	Renna, JM; Stukel, JM; Willits, RK; Engeberg, ED				Renna, Jordan M.; Stukel, Jessica M.; Willits, Rebecca Kuntz; Engeberg, Erik D.			Dorsal root ganglia neurite outgrowth measured as a function of changes in microelectrode array resistance	PLOS ONE			English	Article							IN-VITRO; IMPEDANCE; BEHAVIOR; COLLAGEN	Current research in prosthetic device design aims to mimic natural movements using a feedback system that connects to the patient's own nerves to control the device. The first step in using neurons to control motion is to make and maintain contact between neurons and the feedback sensors. Therefore, the goal of this project was to determine if changes in electrode resistance could be detected when a neuron extended a neurite to contact a sensor. Dorsal root ganglia (DRG) were harvested from chick embryos and cultured on a collagen-coated carbon nanotube microelectrode array for two days. The DRG were seeded along one side of the array so the processes extended across the array, contacting about half of the electrodes. Electrode resistance was measured both prior to culture and after the two day culture period. Phase contrast images of the microelectrode array were taken after two days to visually determine which electrodes were in contact with one or more DRG neurite or tissue. Electrodes in contact with DRG neurites had an average change in resistance of 0.15 M Omega compared with the electrodes without DRG neurites. Using this method, we determined that resistance values can be used as a criterion for identifying electrodes in contact with a DRG neurite. These data are the foundation for future development of an autonomous feedback resistance measurement system to continuously monitor DRG neurite outgrowth at specific spatial locations.	[Renna, Jordan M.] Univ Akron, Dept Biol, Akron, OH 44325 USA; [Stukel, Jessica M.; Willits, Rebecca Kuntz] Univ Akron, Dept Biomed Engn, Akron, OH 44325 USA; [Engeberg, Erik D.] Florida Atlantic Univ, Ocean & Mech Engn Dept, Boca Raton, FL 33431 USA	University of Akron; University of Akron; State University System of Florida; Florida Atlantic University	Renna, JM (corresponding author), Univ Akron, Dept Biol, Akron, OH 44325 USA.; Willits, RK (corresponding author), Univ Akron, Dept Biomed Engn, Akron, OH 44325 USA.	jrenna@uakron.edu; willits@uakron.edu	Willits, Rebecca/B-5017-2010	Willits, Rebecca/0000-0002-1866-6789	University of Akron Biomimicry Research and Innovation Center Initiative (BRIC) grant [1000002425]; National Science Foundation award [1317952/1536136]; Directorate For Engineering [1536136] Funding Source: National Science Foundation	University of Akron Biomimicry Research and Innovation Center Initiative (BRIC) grant; National Science Foundation award(National Science Foundation (NSF)); Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This project was partially supported by the University of Akron Biomimicry Research and Innovation Center Initiative (BRIC) grant #1000002425. JS and RKW were partially supported by the Margaret F. Donovan Endowment for Women in Engineering. EE was partially supported by National Science Foundation award #1317952/1536136.	Blau A, 2013, CURR OPIN COLLOID IN, V18, P481, DOI 10.1016/j.cocis.2013.07.005; Buzsaki G, 2012, NAT REV NEUROSCI, V13, P407, DOI 10.1038/nrn3241; CHANDRAKASAN G, 1976, J BIOL CHEM, V251, P6062; Debnath S, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00104; Ehret R, 1997, BIOSENS BIOELECTRON, V12, P29, DOI 10.1016/0956-5663(96)89087-7; Exner AA, 2016, ANN BIOMED ENG, V44, P619, DOI 10.1007/s10439-016-1565-y; Henze DA, 2000, J NEUROPHYSIOL, V84, P390, DOI 10.1152/jn.2000.84.1.390; Holinski BJ, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/5/056008; Horch K, 2011, IEEE T NEUR SYS REH, V19, P483, DOI 10.1109/TNSRE.2011.2162635; Lin SP, 2009, BIOMATERIALS, V30, P3110, DOI 10.1016/j.biomaterials.2009.03.017; Liu QJ, 2009, BIOSENS BIOELECTRON, V24, P1305, DOI 10.1016/j.bios.2008.07.044; Merrill DR, 2005, IEEE T BIO-MED ENG, V52, P1960, DOI 10.1109/TBME.2005.856245; Obien MEJ, 2015, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00423; Schiefer M, 2016, J NEURAL ENG, V13, DOI 10.1088/1741-2560/13/1/016001; SILVER FH, 1980, J BIOL CHEM, V255, P9427; Smith GM, 2012, TRENDS NEUROSCI, V35, P156, DOI 10.1016/j.tins.2011.10.006	16	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2017	12	4							e0175550	10.1371/journal.pone.0175550	http://dx.doi.org/10.1371/journal.pone.0175550			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0MB	28406999	Green Published, gold, Green Submitted			2022-12-27	WOS:000399955400068
J	Zec, S; Popovic, D; Matovic, V; Nikolic, V; Bojovic, K; Jovic, J; Denic, LM; Milosavljevic, T; Alempijevic, T				Zec, Simon; Popovic, Dusan; Matovic, Vera; Nikolic, Vladimir; Bojovic, Ksenija; Jovic, Jasna; Denic, Ljiljana Markovic; Milosavljevic, Tomica; Alempijevic, Tamara			Translation and validation of the Serbian primary biliary cholangitis-40 questionnaire	PLOS ONE			English	Article							QUALITY-OF-LIFE; LIVER-DISEASE QUESTIONNAIRE; CIRRHOSIS; PATHOPHYSIOLOGY; FATIGUE; VERSION	Background and aims To translate into Serbian and validate the Primary Biliary Cholangitis-40 (PBC-40) and PBC-27 questionnaires. Materials and methods Ninety-four consecutive outpatients with the diagnosis of PBC from three departments across two tertiary care institutions in Belgrade were enrolled from February to October 2016. Standard methodology for cultural adaption of healthcare related quality of life questionnaires was used, and included: a forward translation, backward translation and a pilot test of the Serbian PBC-40 on five patients who gave suggestions and comments. For evaluation of the questionnaires, acceptance was shown by the proportion of missing items and the internal consistency was assessed using Cronbach's alpha coefficient. The PBC-40 was self-administered under the supervision of an experienced hepatologist. The PBC-27 is a shorter version of the PBC-40. Results A total of 92 (97.9%) of the patients were females. The mean age was 59.26 +/- 1.05 years and the average length of disease was 60.45 +/- 48.314 months. The average PBC-40 score was 85.62 +/- 30.46. The total time needed to complete the questionnaire ranged from 7 to 16 minutes. The proportion of missing items was 5.45% (205/3760). Cronbach's alpha for the entire scale was 0.93. Reliability for all of the domains of the PBC-40 was above 0.70, except for the domain "Symptoms" (alpha = 0.52). Overall reliability of the PBC-27 was alpha = 0.90. Domains "Dryness", "Symptoms" and "Fatigue" demonstrated reliability below alpha = 0.70. Conclusions The Serbian PBC-40 is a valid and reasonably adequate for use in Serbian PBC patients. The PBC-40 is preferred over the PBC-27.	[Zec, Simon; Popovic, Dusan; Nikolic, Vladimir; Bojovic, Ksenija; Denic, Ljiljana Markovic; Milosavljevic, Tomica; Alempijevic, Tamara] Univ Belgrade, Sch Med, Dept Internal Med, Belgrade, Serbia; [Popovic, Dusan; Matovic, Vera; Milosavljevic, Tomica; Alempijevic, Tamara] Clin Ctr Serbia, Clin Gastroenterol & Hepatol, Belgrade, Serbia; [Bojovic, Ksenija] Clin Ctr Serbia, Dept Gastroenterol & Hepatol, Clin Trop & Infect Dis, Belgrade, Serbia; [Jovic, Jasna] Mil Med Acad, Dept Gastroenterol & Hepatol, Belgrade, Serbia; [Denic, Ljiljana Markovic] Univ Belgrade, Inst Epidemiol, Sch Med, Belgrade, Serbia	University of Belgrade; Clinical Centre of Serbia; Clinical Centre of Serbia; University of Belgrade	Zec, S (corresponding author), Univ Belgrade, Sch Med, Dept Internal Med, Belgrade, Serbia.	simon21zec@hotmail.com	Popovic, Dusan Dj./S-1177-2019	Popovic, Dusan Dj./0000-0002-5912-0360; Zec, Simon/0000-0002-4353-8535; Nikolic, Vladimir/0000-0002-0216-6392				Acquadro C, 2008, VALUE HEALTH, V11, P509, DOI 10.1111/j.1524-4733.2007.00292.x; Angulo P, 1999, LIVER, V19, P115, DOI 10.1111/j.1478-3231.1999.tb00020.x; Beuers U, 2009, J HEPATOL, V51, P237, DOI 10.1016/j.jhep.2009.04.009; Corrigan M, 2015, DIGEST DIS, V33, P102, DOI 10.1159/000440755; Cronbach LJ, 1954, PSYCHOMETRIKA, V16, P297; DICKSON ER, 1989, HEPATOLOGY, V10, P1, DOI 10.1002/hep.1840100102; Ferrer M, 2006, LIVER TRANSPLANT, V12, P95, DOI 10.1002/lt.20551; Hauser W, 2004, EUR J GASTROEN HEPAT, V16, P599, DOI 10.1097/01.meg.000108324.52416.18; Jacoby A, 2005, GUT, V54, P1622, DOI 10.1136/gut.2005.065862; Jones DEJ, 2006, GUT, V55, P536, DOI 10.1136/gut.2005.080317; Jopson L, 2015, DIGEST DIS, V33, P109, DOI 10.1159/000440757; LUDWIG J, 1978, VIRCHOWS ARCH A, V379, P103, DOI 10.1007/BF00432479; Mells GF, 2013, HEPATOLOGY, V58, P273, DOI 10.1002/hep.26365; Montali L, 2010, DIGEST LIVER DIS, V42, P718, DOI 10.1016/j.dld.2010.01.004; Nunnally JC, 1994, PSYCHOMETRIC THEORY, V3rd, DOI DOI 10.1037/018882; Popovic DD, 2013, WORLD J GASTROENTERO, V19, P4950, DOI 10.3748/wjg.v19.i30.4950; Poupon RE, 2004, HEPATOLOGY, V40, P489, DOI 10.1002/hep.20276; Purohit T, 2015, WORLD J HEPATOL, V7, P926, DOI 10.4254/wjh.v7.i7.926; Rannard A, 2004, CLIN GASTROENTEROL H, V2, P164, DOI 10.1016/S1542-3565(03)00323-9; Raszeja-Wyszornirska J, 2016, CLIN RES HEPATOL GAS, V40, P471, DOI 10.1016/j.clinre.2015.10.006; Schulz KH, 2008, QUAL LIFE RES, V17, P575, DOI 10.1007/s11136-008-9332-7; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Wild D, 2005, VALUE HEALTH, V8, P94, DOI 10.1111/j.1524-4733.2005.04054.x; Younossi ZM, 2000, AM J GASTROENTEROL, V95, P497; Younossi ZM, 1999, GUT, V45, P295, DOI 10.1136/gut.45.2.295	25	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2017	12	4							e0175697	10.1371/journal.pone.0175697	http://dx.doi.org/10.1371/journal.pone.0175697			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0MB	28406960	Green Published, Green Submitted, gold			2022-12-27	WOS:000399955400083
J	Chuartzman, SG; Nevo, R; Waichman, S; Shental, D; Piehler, J; Levy, Y; Reich, Z; Kapon, R				Chuartzman, Silvia G.; Nevo, Reinat; Waichman, Sharon; Shental, Dalit; Piehler, Jacob; Levy, Yaakov; Reich, Ziv; Kapon, Ruti			Binding of interferon reduces the force of unfolding for interferon receptor 1	PLOS ONE			English	Article							MUTATIONAL ANALYSIS; STRUCTURAL BASIS; PHAGE DISPLAY; I INTERFERONS; PROTEIN; IFNAR1; CYTOKINE; SPECTROSCOPY; ACTIVATION; IFN-ALPHA-2	Differential signaling of the type I interferon receptor (IFNAR) has been correlated with the ability of its subunit, IFNAR1, to differentially recognize a large spectrum of different ligands, which involves intricate conformational re-arrangements of multiple interacting domains. To shed light onto the structural determinants governing ligand recognition, we compared the force-induced unfolding of the IFNAR1 ectodomain when bound to interferon and when free, using the atomic force microscope and steered molecular dynamics simulations. Unexpectedly, we find that IFNAR1 is easier to mechanically unfold when bound to interferon than when free. Analysis of the structures indicated that the origin of the reduction in unfolding forces is a conformational change in IFNAR1 induced by ligand binding.	[Chuartzman, Silvia G.; Nevo, Reinat; Reich, Ziv; Kapon, Ruti] Weizmann Inst Sci, Dept Biomol Sci, Rehovot, Israel; [Waichman, Sharon; Piehler, Jacob] Univ Osnabruck, Dept Biol, Osnabruck, Germany; [Shental, Dalit; Levy, Yaakov] Weizmann Inst Sci, Dept Struct Biol, Rehovot, Israel; [Chuartzman, Silvia G.] Weizmann Inst Sci, Dept Neurobiol, Rehovot, Israel; [Waichman, Sharon] Rotem Ind Ltd, Adv Coatings R&D Ctr, Mishor Yamin, Israel; [Shental, Dalit] Weizmann Inst Sci, Davidson Inst Sci Educ, Rehovot, Israel	Weizmann Institute of Science; University Osnabruck; Weizmann Institute of Science; Weizmann Institute of Science; Weizmann Institute of Science	Reich, Z; Kapon, R (corresponding author), Weizmann Inst Sci, Dept Biomol Sci, Rehovot, Israel.	ziv.reich@weizmann.ac.il; ruti.kaport@weizmann.ac.il			ERA-NET NanoScience program; DFG [PI 405/4]; ISF [2135/06-88.0]	ERA-NET NanoScience program; DFG(German Research Foundation (DFG)); ISF(Israel Science Foundation)	JP and RK recieved funding from the ERA-NET NanoScience program, DFG grant no. PI 405/4, ISF grant no. 2135/06-88.0 https://ec.europa.eu/research/fp7/index_en.cfm?pg=eranet-projects-home). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal V, 2011, J BIOL CHEM, V286, P28056, DOI 10.1074/jbc.M111.249045; Arad-Haase G, 2010, BIOPHYS J, V99, P238, DOI 10.1016/j.bpj.2010.04.004; Arkhipov A, 2013, CELL, V152, P557, DOI 10.1016/j.cell.2012.12.030; Atanasova M, 2012, CRIT REV BIOCHEM MOL, V47, P502, DOI 10.3109/10409238.2012.729561; Batey S, 2006, BIOPHYS J, V90, P2120, DOI 10.1529/biophysj.105.072710; Berko D, 2012, MOL CELL, V48, P601, DOI 10.1016/j.molcel.2012.08.029; BUSTAMANTE C, 1994, SCIENCE, V265, P1599, DOI 10.1126/science.8079175; Cieplak M, 2005, J CHEM PHYS, V123, DOI 10.1063/1.2046609; Cieplak M, 2002, PROTEINS, V49, P104, DOI 10.1002/prot.10188; Craig D, 2004, STRUCTURE, V12, P21, DOI 10.1016/j.str.2003.11.024; de Weerd NA, 2013, NAT IMMUNOL, V14, P901, DOI 10.1038/ni.2667; Deonarain R, 2002, CURR PHARM DESIGN, V8, P2131, DOI 10.2174/1381612023393288; Evans EB, 1999, BIOPHYS CHEM, V82, P83, DOI 10.1016/S0301-4622(99)00108-8; Francois-Newton V, 2012, BIOCHEM J, V446, P509, DOI 10.1042/BJ20120541; Francois-Newton V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022200; Hoffmann HH, 2015, TRENDS IMMUNOL, V36, P124, DOI 10.1016/j.it.2015.01.004; Hoffmann T, 2012, CHEM SOC REV, V41, P4781, DOI 10.1039/c2cs35033e; Jaitin DA, 2006, MOL CELL BIOL, V26, P1888, DOI 10.1128/MCB.26.5.1888-1897.2006; Jaks E, 2007, J MOL BIOL, V366, P525, DOI 10.1016/j.jmb.2006.11.053; Junttila IS, 2012, NAT CHEM BIOL, V8, P990, DOI [10.1038/NCHEMBIO.1096, 10.1038/nchembio.1096]; Kalie E, 2008, J BIOL CHEM, V283, P32925, DOI 10.1074/jbc.M806019200; Kalie E, 2007, J BIOL CHEM, V282, P11602, DOI 10.1074/jbc.M610115200; Kim AR, 2017, CELL, V168, P1053, DOI 10.1016/j.cell.2017.02.026; Kotamarthi HC, 2013, J AM CHEM SOC, V135, P14768, DOI 10.1021/ja406238q; Lamken P, 2005, J MOL BIOL, V350, P476, DOI 10.1016/j.jmb.2005.05.008; LaPorte SL, 2008, CELL, V132, P259, DOI 10.1016/j.cell.2007.12.030; Lata S, 2005, ANAL CHEM, V77, P1096, DOI 10.1021/ac048813j; Lavoie TB, 2011, CYTOKINE, V56, P282, DOI 10.1016/j.cyto.2011.07.019; Levy Y, 2004, P NATL ACAD SCI USA, V101, P511, DOI 10.1073/pnas.2534828100; Li ZL, 2008, J MOL BIOL, V377, P715, DOI 10.1016/j.jmb.2007.12.005; Oberhauser AF, 2002, J MOL BIOL, V319, P433, DOI 10.1016/S0022-2836(02)00306-6; Pestka S, IMMUNOLOGICAL REV, V202, P8; Piehler J, 1999, J MOL BIOL, V289, P57, DOI 10.1006/jmbi.1999.2726; Piehler J, 2000, J BIOL CHEM, V275, P40425, DOI 10.1074/jbc.M006854200; Piehler J, 2012, IMMUNOL REV, V250, P317, DOI 10.1111/imr.12001; Rief M, 1997, SCIENCE, V276, P1109, DOI 10.1126/science.276.5315.1109; Riener CK, 2003, ANAL CHIM ACTA, V497, P101, DOI 10.1016/j.aca.2003.08.041; Ring AM, 2012, NAT IMMUNOL, V13, P1187, DOI 10.1038/ni.2449; Roisman LC, 2005, J MOL BIOL, V353, P271, DOI 10.1016/j.jmb.2005.08.042; Schreiber G, 2015, TRENDS IMMUNOL, V36, P139, DOI 10.1016/j.it.2015.01.002; Sidhu SS, 2000, METHOD ENZYMOL, V328, P333, DOI 10.1016/S0076-6879(00)28406-1; Sobolev V, 1996, PROTEINS, V25, P120, DOI 10.1002/(SICI)1097-0134(199605)25:1<120::AID-PROT10>3.3.CO;2-1; Struckmeier J, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/38/384020; Strunk JJ, 2008, J MOL BIOL, V377, P725, DOI 10.1016/j.jmb.2008.01.017; Sulkowska JI, 2007, J PHYS-CONDENS MAT, V19, DOI 10.1088/0953-8984/19/28/283201; Thomas C, 2011, CELL, V146, P621, DOI 10.1016/j.cell.2011.06.048; Uze G, 2007, CURR TOP MICROBIOL, V316, P71; Walter MR, 2004, ADV PROTEIN CHEM, V68, P171; Waters MJ, 2015, BIOCHEM J, V466, P1, DOI 10.1042/BJ20141293; Whitford PC, 2012, REP PROG PHYS, V75, DOI 10.1088/0034-4885/75/7/076601; Whitford PC, 2009, PROTEINS, V75, P430, DOI 10.1002/prot.22253; Wilmes S, 2015, J CELL BIOL, V209, P579, DOI 10.1083/jcb.201412049; Yoon SI, 2005, STRUCTURE, V13, P551, DOI 10.1016/j.str.2005.01.016; Yoon SI, 2012, J BIOL CHEM, V287, P26586, DOI 10.1074/jbc.M112.376707; You CJ, 2010, ANGEW CHEM INT EDIT, V49, P4108, DOI 10.1002/anie.200907032; Zdanov A, 2010, CYTOKINE GROWTH F R, V21, P325, DOI 10.1016/j.cytogfr.2010.08.003	57	3	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2017	12	4							e0175413	10.1371/journal.pone.0175413	http://dx.doi.org/10.1371/journal.pone.0175413			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LZ	28403186	gold, Green Published, Green Submitted			2022-12-27	WOS:000399955200063
J	Schlecht, I; Gronwald, W; Behrens, G; Baumeister, SE; Hertel, J; Hochrein, J; Zacharias, HU; Fischer, B; Oefner, PJ; Leitzmann, MF				Schlecht, Inga; Gronwald, Wolfram; Behrens, Gundula; Baumeister, Sebastian E.; Hertel, Johannes; Hochrein, Jochen; Zacharias, Helena U.; Fischer, Beate; Oefner, Peter J.; Leitzmann, Michael F.			Visceral adipose tissue but not subcutaneous adipose tissue is associated with urine and serum metabolites	PLOS ONE			English	Article							BODY-MASS INDEX; INSULIN-RESISTANCE; NMR-SPECTROSCOPY; SYSTEMS EPIDEMIOLOGY; HEALTHY-ADULTS; RISK-FACTORS; OBESITY; PROFILES; CHOLINE; MICE	Obesity is a complex multifactorial phenotype that influences several metabolic pathways. Yet, few studies have examined the relations of different body fat compartments to urinary and serum metabolites. Anthropometric phenotypes (visceral adipose tissue (VAT), subcutaneous adipose tissue (SAT), the ratio between VAT and SAT (VSR), body mass index (BMI), waist circumference (WC)) and urinary and serum metabolite concentrations measured by nuclear magnetic resonance spectroscopy were measured in a population-based sample of 228 healthy adults. Multivariable linear and logistic regression models, corrected for multiple testing using the false discovery rate, were used to associate anthropometric phenotypes with metabolites. We adjusted for potential confounding variables: age, sex, smoking, physical activity, menopausal status, estimated glomerular filtration rate (eGFR), urinary glucose, and fasting status. In a fully adjusted logistic regression model dichotomized for the absence or presence of quantifiable metabolite amounts, VAT, BMI and WC were inversely related to urinary choline (beta = -0.18, p = 2.73*10(-3)), glycolic acid (beta = -0.20, 0.02), and guanidinoacetic acid (beta = -0.12, p = 0.04), and positively related to ethanolamine (beta = 0.18, p = 0.02) and dimethylamine (beta = 0.32, p = 0.02). BMI and WC were additionally inversely related to urinary glutamine and lactic acid. Moreover, WC was inversely associated with the detection of serine. VAT, but none of the other anthropometric parameters, was related to serum essential amino acids, such as valine, isoleucine, and phenylalanine among men. Compared to other adiposity measures, VAT demonstrated the strongest and most significant relations to urinary and serum metabolites. The distinct relations of VAT, SAT, VSR, BMI, and WC to metabolites emphasize the importance of accurately differentiating between body fat compartments when evaluating the potential role of metabolic regulation in the development of obesity-related diseases, such as insulin resistance, type 2 diabetes, and cardiovascular disease.	[Schlecht, Inga; Behrens, Gundula; Baumeister, Sebastian E.; Fischer, Beate; Leitzmann, Michael F.] Univ Regensburg, Dept Epidemiol & Prevent Med, Regensburg, Germany; [Gronwald, Wolfram; Hochrein, Jochen; Zacharias, Helena U.; Oefner, Peter J.] Univ Regensburg, Inst Funct Genom, Regensburg, Germany; [Baumeister, Sebastian E.] Univ Med Greifswald, Inst Community Med, Greifswald, Germany; [Hertel, Johannes] German Ctr Neurodegenerat Dis DZNE, Rostock, Germany	University of Regensburg; University of Regensburg; Greifswald Medical School; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE)	Schlecht, I (corresponding author), Univ Regensburg, Dept Epidemiol & Prevent Med, Regensburg, Germany.	Inga.Schlecht@ukr.de	Zacharias, Helena/AAM-5361-2020; Stefanadis, Christodoulos/ABH-2232-2020; Baumeister, Sebastian-Edgar/P-7894-2019	Stefanadis, Christodoulos/0000-0001-5974-6454; Baumeister, Sebastian-Edgar/0000-0002-9391-6602; Behrens, Gundula/0000-0002-9355-6491	German National Cohort [01ER1001A-1]	German National Cohort	This study was conducted within the framework of the pilot studies of the German National Cohort (www.nationale-kohorte.de), grant number 01ER1001A-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was conducted within the framework of the pilot studies of the German National Cohort (www.naiionale-kohorie.de), grant number 01ER1001A-I. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors' responsibilities were as follows: I.S., W.G., P.O., B.F., and M.L. conceived and designed the study; I.S., W.G., J.Hochrein., H.Z. were responsible for NMR analyses. I.S., G.B., S.B., J.Hertel. were responsible for data analysis and I.S. was responsible for interpretation and writing of the manuscript; all authors were responsible for the critical revision of the manuscript and its important intellectual content; M.L. was responsible for study supervision. None of the authors had a conflict of interest.	Ainsworth BE, 2011, MED SCI SPORT EXER, V43, P1575, DOI 10.1249/MSS.0b013e31821ece12; Bastard JP, 2006, EUR CYTOKINE NETW, V17, P4; Bays HE, 2010, METAB SYNDR RELAT D, V8, P307, DOI 10.1089/met.2009.0089; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bodi V, 2012, J AM COLL CARDIOL, V59, P1629, DOI 10.1016/j.jacc.2011.09.083; Booth A, 2014, HORM MOL BIOL CLIN I, V17, P13, DOI 10.1515/hmbci-2014-0009; Bosy-Westphal A, 2006, INT J OBESITY, V30, P475, DOI 10.1038/sj.ijo.0803144; Bouatra S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073076; Brun P, 2007, AM J PHYSIOL-GASTR L, V292, pG518, DOI 10.1152/ajpgi.00024.2006; Butelli E, 2008, NAT BIOTECHNOL, V26, P1301, DOI 10.1038/nbt.1506; Bye A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042330; Cloarec O, 2005, ANAL CHEM, V77, P1282, DOI 10.1021/ac048630x; Detopoulou P, 2008, AM J CLIN NUTR, V87, P424, DOI 10.1093/ajcn/87.2.424; DiBaise JK, 2012, AM J GASTROENTEROL S, V1, P22, DOI [10.1038/ajgsup.2012.5, DOI 10.1038/AJGSUP.2012.5]; Dumas ME, 2006, P NATL ACAD SCI USA, V103, P12511, DOI 10.1073/pnas.0601056103; EL Oudi M, 2010, EXP CLIN CARDIOL, V15, pE25; Elliott P, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa5680; Floegel A, 2013, DIABETES, V62, P639, DOI 10.2337/db12-0495; Floegel A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021103; Ford ES, 2009, ARCH INTERN MED, V169, P1355, DOI 10.1001/archinternmed.2009.237; Fox CS, 2007, CIRCULATION, V116, P39, DOI 10.1161/CIRCULATIONAHA.106.675355; Gibney MJ, 2005, AM J CLIN NUTR, V82, P497, DOI 10.1093/ajcn/82.3.497; Gowda GAN, 2014, ANAL CHEM, V86, P5433, DOI 10.1021/ac5005103; Gronwald W, 2008, ANAL CHEM, V80, P9288, DOI 10.1021/ac801627c; Hartiala J, 2014, ARTERIOSCL THROM VAS, V34, P1307, DOI 10.1161/ATVBAHA.114.303252; Herman MA, 2010, J BIOL CHEM, V285, P11348, DOI 10.1074/jbc.M109.075184; Holmes E, 2007, ANAL CHEM, V79, P2629, DOI 10.1021/ac062305n; Hu FB, 2011, CLIN CHEM, V57, P1224, DOI 10.1373/clinchem.2011.167056; Jacobs DM, 2012, ANAL BIOANAL CHEM, V404, P2349, DOI 10.1007/s00216-012-6339-2; Jourdan C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040009; Jung UJ, 2014, INT J MOL SCI, V15, P6184, DOI 10.3390/ijms15046184; Kim SK, 2004, AM J CLIN NUTR, V79, P593; Klein MS, 2013, BIOTECHNIQUES, V54, P251, DOI 10.2144/000114026; Krug S, 2012, FASEB J, V26, P2607, DOI 10.1096/fj.11-198093; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Lund E, 2008, CANCER EPIDEM BIOMAR, V17, P2954, DOI 10.1158/1055-9965.EPI-08-0519; Lustgarten MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084034; Martin FPJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073445; Moore SC, 2014, METABOLOMICS, V10, P259, DOI 10.1007/s11306-013-0574-1; Morris C, 2013, MOL NUTR FOOD RES, V57, P1246, DOI 10.1002/mnfr.201200629; Muller G, 2010, PHARMACOLOGY, V85, P168, DOI 10.1159/000283780; Neeland IJ, 2013, OBESITY, V21, pE439, DOI [10.1002/oby.20135, 10.1038/oby.20135]; Newgard CB, 2012, CELL METAB, V15, P606, DOI 10.1016/j.cmet.2012.01.024; Newgard CB, 2009, CELL METAB, V9, P311, DOI 10.1016/j.cmet.2009.02.002; Penry JT, 2008, INT J SPORT NUTR EXE, V18, P191, DOI 10.1123/ijsnem.18.2.191; Primrose Sandy, 2011, Br J Nutr, V105, P1277, DOI 10.1017/S0007114510004812; Psychogios N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016957; Renehan AG, 2008, LANCET, V371, P569, DOI 10.1016/S0140-6736(08)60269-X; Rheaume C, 2011, J CLIN ENDOCR METAB, V96, P1462, DOI 10.1210/jc.2010-2432; Rosner B, 2011, FUNDAMENTALS OF BIOS; Ross R, 2009, NAT REV ENDOCRINOL, V5, P319, DOI 10.1038/nrendo.2009.78; Schlecht I, 2014, METABOLISM, V63, P1512, DOI 10.1016/j.metabol.2014.07.012; Schulze MB, 2007, DIABETES CARE, V30, P510, DOI 10.2337/dc06-2089; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.2307/2333709; Szymanska E, 2012, OMICS, V16, P652, DOI 10.1089/omi.2012.0062; Tsuda T, 2003, J NUTR, V133, P2125, DOI 10.1093/jn/133.7.2125; van Dorsten FA, 2010, MOL NUTR FOOD RES, V54, P897, DOI 10.1002/mnfr.200900212; Wang TJ, 2011, NAT MED, V17, P448, DOI 10.1038/nm.2307; Wang ZN, 2011, NATURE, V472, P57, DOI 10.1038/nature09922; Wishart DS, 2013, NUCLEIC ACIDS RES, V41, pD801, DOI 10.1093/nar/gks1065; Xie GX, 2014, J PROTEOME RES, V13, P4062, DOI 10.1021/pr500434s; Zacharias HU, 2013, CURR METABOL, V1, P253, DOI 10.2174/2213235X113019990001; Zeisel SH, 2009, NUTR REV, V67, P615, DOI 10.1111/j.1753-4887.2009.00246.x; Zhang XY, 2009, J PROTEOME RES, V8, P5188, DOI 10.1021/pr900524z	64	20	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2017	12	4							e0175133	10.1371/journal.pone.0175133	http://dx.doi.org/10.1371/journal.pone.0175133			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LZ	28403191	Green Submitted, Green Published, gold			2022-12-27	WOS:000399955200035
J	Hsieh, IJ; Chen, YY				Hsieh, I-Ju; Chen, Yung Y.			Determinants of aggressive behavior: Interactive effects of emotional regulation and inhibitory control	PLOS ONE			English	Article							TRAIT AGGRESSIVENESS; HEART-RATE; PROVOCATION; IMPULSIVITY; MEDITATION; IMPACT; SEX	Aggressive behavior can be defined as any behavior intended to hurt another person, and it is associated with many individual and social factors. This study examined the relationship between emotional regulation and inhibitory control in predicting aggressive behavior. Seventy-eight participants (40 males) completed self-report measures (Negative Mood Regulation Scale and Buss-Perry Aggression Questionnaire), a stop signal task, and engaged in a modified version of Taylor Aggression Paradigm (TAP) exercise, in which the outcome was used as a measure of direct physical aggression. We used a hierarchical, mixed-model multiple regression analysis test to examine the effects of emotion regulation and inhibitory control on physical reactive aggression. Results indicated an interaction between emotion regulation and inhibitory control on aggression. For participants with low inhibitory control only, there was a significant difference between high and low emotion regulation on aggression, such that low emotion regulation participants registered higher aggression than high emotion regulation participants. This difference was not found among participants with high inhibitory control. These results have implications for refining and targeting training and rehabilitation programs aimed at reducing aggressive behavior.	[Hsieh, I-Ju; Chen, Yung Y.] Natl Cent Univ, Inst Cognit Neurosci, Taoyuan, Taiwan	National Central University	Chen, YY (corresponding author), Natl Cent Univ, Inst Cognit Neurosci, Taoyuan, Taiwan.	superego100@gmail.com						Aiken L. S., 1991, MULTIPLE REGRESSION; Anderson CA, 1996, PERS SOC PSYCHOL B, V22, P366, DOI 10.1177/0146167296224004; Barnes VA, 2004, PSYCHOSOM MED, V66, P909, DOI 10.1097/01.psy.0000145902.91749.35; Baron R.A., 1977, HUMAN AGGRESSION, DOI [10.1007/978-1-4615-7195-7, DOI 10.1007/978-1-4615-7195-7]; Buckholtz JW, 2015, CURR OPIN BEHAV SCI, V3, P122, DOI 10.1016/j.cobeha.2015.03.004; BUSHMAN BJ, 1995, J PERS SOC PSYCHOL, V69, P950, DOI 10.1037/0022-3514.69.5.950; BUSS AH, 1992, J PERS SOC PSYCHOL, V63, P452, DOI 10.1037/0022-3514.63.3.452; CATANZARO SJ, 1990, J PERS ASSESS, V54, P546, DOI 10.1207/s15327752jpa5403&4_11; Chermack ST, 1997, AGGRESSIVE BEHAV, V23, P1, DOI 10.1002/(SICI)1098-2337(1997)23:1<1::AID-AB1>3.0.CO;2-S; Critchfield KL, 2004, J PERS DISORD, V18, P555, DOI 10.1521/pedi.18.6.555.54795; CRYSTAL DS, 1994, CHILD DEV, V65, P738, DOI 10.1111/j.1467-8624.1994.tb00780.x; de Castro BO, 2003, COGNITIVE THER RES, V27, P153, DOI 10.1023/A:1023557125265; Denson TF, 2011, J RES PERS, V45, P252, DOI 10.1016/j.jrp.2011.02.001; Derefinko K, 2011, AGGRESSIVE BEHAV, V37, P223, DOI 10.1002/ab.20387; DeWall CN, 2009, J PERS SOC PSYCHOL, V96, P45, DOI 10.1037/a0013196; DeWall CN, 2007, J EXPT SOCIAL PSYCHO, V43; Finkel E. J., 2014, ADV EXPT SOCIAL PSYC, V49; Finkel EJ, 2009, J PERS SOC PSYCHOL, V97, P483, DOI 10.1037/a0015433; Forbes G, 2009, AGGRESSIVE BEHAV, V35, P24, DOI 10.1002/ab.20292; Giancola PR, 2008, AGGRESSIVE BEHAV, V34, P214, DOI 10.1002/ab.20235; Giancola PR, 2002, J STUD ALCOHOL, V63, P64; Goghari VM, 2009, BRAIN COGNITION, V71, P72, DOI 10.1016/j.bandc.2009.04.004; Gross JJ., 1998, REV GEN PSYCHOL, V2, P271, DOI 10.1037/1089-2680.2.3.271; Haller J., 2014, NEUROBIOLOGICAL BASE; Hoaken PNS, 2003, AGGRESSIVE BEHAV, V29, P15, DOI 10.1002/ab.10023; Kramer UM, 2008, J COGNITIVE NEUROSCI, V20, P1464, DOI 10.1162/jocn.2008.20103; Krygier JR, 2013, INT J PSYCHOPHYSIOL, V89, P305, DOI 10.1016/j.ijpsycho.2013.06.017; Logan GD, 1997, PSYCHOL SCI, V8, P60, DOI 10.1111/j.1467-9280.1997.tb00545.x; Papousek I, 2016, BRAIN IMAGING BEHAV; Quirk GJ, 2006, CURR OPIN NEUROBIOL, V16, P723, DOI 10.1016/j.conb.2006.07.004; Raaijmakers MAJ, 2008, J ABNORM CHILD PSYCH, V36, P1097, DOI 10.1007/s10802-008-9235-7; Ramirez JM, 2001, AGGRESSIVE BEHAV, V27, P313, DOI 10.1002/ab.1014; Ridderinkhof KR, 2004, BRAIN COGNITION, V56, P129, DOI 10.1016/j.bandc.2004.09.016; Roberton T, 2012, AGGRESS VIOLENT BEH, V17, P72, DOI 10.1016/j.avb.2011.09.006; Stadler C, 2006, SWISS J PSYCHOL, V65, P117, DOI 10.1024/1421-0185.65.2.117; Sullivan TN, 2010, SOC DEV, V19, P30, DOI 10.1111/j.1467-9507.2008.00531.x; TAYLOR SP, 1967, J PERS, V35, P474, DOI 10.1111/j.1467-6494.1967.tb01441.x; van den Hurk PAM, 2010, INT J PSYCHOPHYSIOL, V78, P151, DOI 10.1016/j.ijpsycho.2010.07.002	38	25	26	3	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2017	12	4							e0175651	10.1371/journal.pone.0175651	http://dx.doi.org/10.1371/journal.pone.0175651			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET0JS	28399150	gold, Green Submitted, Green Published			2022-12-27	WOS:000399949000055
J	McInnes, K; Friesen, CL; MacKenzie, DE; Westwood, DA; Boe, SG				McInnes, Kerry; Friesen, Christopher L.; MacKenzie, Diane E.; Westwood, David A.; Boe, Shaun G.			Mild Traumatic Brain Injury (mTBI) and chronic cognitive impairment: A scoping review	PLOS ONE			English	Review							DIFFUSE AXONAL INJURY; POST-CONCUSSION SYNDROME; WHITE-MATTER INTEGRITY; HEAD-INJURY; HIGH-SCHOOL; NEUROCOGNITIVE OUTCOMES; PROSPECTIVE MEMORY; SYMPTOMS; RECOVERY; TIME	Mild traumatic brain injury (mTBI), or concussion, is the most common type of traumatic brain injury. With mTBI comes symptoms that include headaches, fatigue, depression, anxiety and irritability, as well as impaired cognitive function. Symptom resolution is thought to occur within 3 months post-injury, with the exception of a small percentage of individuals who are said to experience persistent post-concussion syndrome. The number of individuals who experience persistent symptoms appears to be low despite clear evidence of longer-term pathophysiological changes resulting from mTBI. In light of the incongruency between these longer-term changes in brain pathology and the number of individuals with longer-term mTBI-related symptoms, particularly impaired cognitive function, we performed a scoping review of the literature that behaviourally assessed short-and long-term cognitive function in individuals with a single mTBI, with the goal of identifying the impact of a single concussion on cognitive function in the chronic stage post-injury. CINAHL, Embase, and Medline/Ovid were searched July 2015 for studies related to concussion and cognitive impairment. Data relating to the presence/absence of cognitive impairment were extracted from 45 studies meeting our inclusion criteria. Results indicate that, in contrast to the prevailing view that most symptoms of concussion are resolved within 3 months post-injury, approximately half of individuals with a single mTBI demonstrate long-term cognitive impairment. Study limitations notwithstanding, these findings highlight the need to carefully examine the long-term implications of a single mTBI.	[McInnes, Kerry; Friesen, Christopher L.; Boe, Shaun G.] Dalhousie Univ, Lab Brain Recovery & Funct, Halifax, NS, Canada; [McInnes, Kerry; MacKenzie, Diane E.; Westwood, David A.; Boe, Shaun G.] Dalhousie Univ, Sch Physiotherapy, Halifax, NS, Canada; [Friesen, Christopher L.; Westwood, David A.; Boe, Shaun G.] Dalhousie Univ, Dept Psychol & Neurosci, Halifax, NS, Canada; [MacKenzie, Diane E.] Dalhousie Univ, Sch Occupat Therapy, Halifax, NS, Canada; [Westwood, David A.; Boe, Shaun G.] Dalhousie Univ, Sch Hlth & Human Performance, Halifax, NS, Canada; [Boe, Shaun G.] Dalhousie Univ, Sch Physiotherapy, Halifax, NS, Canada	Dalhousie University; Dalhousie University; Dalhousie University; Dalhousie University; Dalhousie University; Dalhousie University	Boe, SG (corresponding author), Dalhousie Univ, Lab Brain Recovery & Funct, Halifax, NS, Canada.; Boe, SG (corresponding author), Dalhousie Univ, Sch Physiotherapy, Halifax, NS, Canada.; Boe, SG (corresponding author), Dalhousie Univ, Dept Psychol & Neurosci, Halifax, NS, Canada.; Boe, SG (corresponding author), Dalhousie Univ, Sch Hlth & Human Performance, Halifax, NS, Canada.; Boe, SG (corresponding author), Dalhousie Univ, Sch Physiotherapy, Halifax, NS, Canada.	s.boe@dal.ca		Boe, Shaun/0000-0001-7477-0049; Westwood, David/0000-0003-3317-0447; MacKenzie, Diane/0000-0002-0815-0682	Canadian Institutes of Health Research (CGS-M)	Canadian Institutes of Health Research (CGS-M)	KM received personnel funding from the Canadian Institutes of Health Research (CGS-M). The authors received no specific funding to support the formal research project.	Alexander M., 1996, MILD TRAUMATIC BRAIN, V5, P1489; American College of Rehabilitative Medicine, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Anderson V, 2001, J CLIN EXP NEUROPSYC, V23, P705, DOI 10.1076/jcen.23.6.705.1015; Arksey H., 2005, INT J SOC RES METHOD, V8, P19, DOI [10.1080/1364557032000119616, DOI 10.1080/1364557032000119616]; Babikian T, 2013, J INT NEUROPSYCH SOC, V19, P145, DOI 10.1017/S135561771200104X; Babikian T, 2011, J INT NEUROPSYCH SOC, V17, P886, DOI 10.1017/S1355617711000907; Barrow I, 2006, INFLUENCE AUDITORY D; BOHNEN N, 1993, NEUROPSY NEUROPSY BE, V6, P193; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Catale C, 2009, J CLIN EXP NEUROPSYC, V31, P331, DOI 10.1080/13803390802134616; CHADWICK O, 1981, PSYCHOL MED, V11, P49, DOI 10.1017/S0033291700053277; Choe MC, 2016, CURR PAIN HEADACHE R, V20, DOI 10.1007/s11916-016-0573-9; Colquhoun HL, 2014, J CLIN EPIDEMIOL, V67, P1291, DOI 10.1016/j.jclinepi.2014.03.013; Covassin T, 2013, AM J SPORT MED, V41, P2885, DOI 10.1177/0363546513499230; Croall ID, 2014, NEUROLOGY, V83, P494, DOI 10.1212/WNL.0000000000000666; Daneshvar DH, 2011, PHYS MED REH CLIN N, V22, P683, DOI 10.1016/j.pmr.2011.08.009; Davenport EM, 2014, J NEUROTRAUM, V31, P1617, DOI 10.1089/neu.2013.3233; de Boussard CN, 2005, J REHABIL MED, V37, P53, DOI 10.1080/16501970410015587; Dikmen S, 2001, J CLIN EXP NEUROPSYC, V23, P729, DOI 10.1076/jcen.23.6.729.1019; Ellemberg D, 2007, CLIN J SPORT MED, V17, P369, DOI 10.1097/JSM.0b013e31814c3e3e; Geary EK, 2010, J INT NEUROPSYCH SOC, V16, P506, DOI 10.1017/S135561771000010X; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Grant MJ, 2009, HEALTH INFO LIBR J, V26, P91, DOI 10.1111/j.1471-1842.2009.00848.x; Hall RCW, 2005, PSYCHOSOMATICS, V46, P195, DOI 10.1176/appi.psy.46.3.195; Hanten G, 2013, J NEUROTRAUM, V30, P618, DOI 10.1089/neu.2012.2392; Heitger MH, 2006, BRAIN INJURY, V20, P807, DOI 10.1080/02699050600676354; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; JAFFE KM, 1995, ARCH PHYS MED REHAB, V76, P17, DOI 10.1016/S0003-9993(95)80037-9; Kashluba S, 2008, ARCH PHYS MED REHAB, V89, P904, DOI 10.1016/j.apmr.2007.12.029; Kinsella GJ, 2014, J INT NEUROPSYCH SOC, V20, P663, DOI 10.1017/S1355617714000447; Konrad C, 2011, PSYCHOL MED, V41, P1197, DOI 10.1017/S0033291710001728; Kwok FY, 2008, BRAIN INJURY, V22, P740, DOI 10.1080/02699050802336989; Larson MJ, 2011, INT J PSYCHOPHYSIOL, V82, P69, DOI 10.1016/j.ijpsycho.2011.02.018; Lee H, 2008, J NEUROTRAUM, V25, P1049, DOI 10.1089/neu.2008.0566; Levac D, 2010, IMPLEMENT SCI, V5, DOI 10.1186/1748-5908-5-69; Levin HS, 1996, CORTEX, V32, P461, DOI 10.1016/S0010-9452(96)80004-9; Maillard-Wermelinger A, 2009, DEV NEUROREHABIL, V12, P330, DOI 10.3109/17518420903087251; Mangels JA, 2002, NEUROPSYCHOLOGIA, V40, P2369, DOI 10.1016/S0028-3932(02)00084-2; MARSH NV, 1995, BRAIN INJURY, V9, P553, DOI 10.3109/02699059509008214; Marshall S, 2012, CAN FAM PHYSICIAN, V58, P257; McCauley SR, 2004, DEV NEUROPSYCHOL, V25, P5, DOI 10.1207/s15326942dn2501&2_2; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; Miles L, 2008, BRAIN INJURY, V22, P115, DOI 10.1080/02699050801888816; MITTL RL, 1994, AM J NEURORADIOL, V15, P1583; Muller K, 2009, NEUROSURGERY, V64, P698, DOI 10.1227/01.NEU.0000340978.42892.78; Pare N, 2009, NEUROPSYCHOL REHABIL, V19, P110, DOI 10.1080/09602010802106486; Phillipou A, 2014, DEV MED CHILD NEUROL, V56, P337, DOI 10.1111/dmcn.12345; POLISSAR NL, 1994, BRAIN INJURY, V8, P249, DOI 10.3109/02699059409150977; Ponsford J, 1999, J HEAD TRAUMA REHAB, V14, P360, DOI 10.1097/00001199-199908000-00005; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Ponsford J, 2011, J NEUROTRAUM, V28, P937, DOI 10.1089/neu.2010.1516; Pontifex MB, 2009, NEUROPSYCHOLOGIA, V47, P3210, DOI 10.1016/j.neuropsychologia.2009.07.021; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Rieger BP, 2013, BRAIN INJURY, V27, P169, DOI 10.3109/02699052.2012.729290; Romero K, 2015, PSYCHIAT RES-NEUROIM, V231, P15, DOI 10.1016/j.pscychresns.2014.11.003; Rotarescu Virginia, 2008, J Med Life, V1, P307; RUTHERFORD WH, 1977, LANCET, V1, P1; RUTHERFORD WH, 1979, INJURY, V10, P225, DOI 10.1016/0020-1383(79)90015-9; Shaw NA, 2002, PROG NEUROBIOL, V67, P281, DOI 10.1016/S0301-0082(02)00018-7; Siman R, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00190; Spinos P, 2010, J TRAUMA, V69, P789, DOI 10.1097/TA.0b013e3181edea67; Stalnacke BM, 2007, J REHABIL MED, V39, P405, DOI 10.2340/16501977-0057; Sterr A, 2006, BMC NEUROL, V6, DOI 10.1186/1471-2377-6-7; Su SH, 2014, BRAIN BEHAV IMMUN, V38, P111, DOI 10.1016/j.bbi.2014.01.009; Tay SY, 2010, J NEUROTRAUM, V27, P77, DOI 10.1089/neu.2009.1074; Topal NB, 2008, NEUROL RES, V30, P974, DOI 10.1179/016164108X323799; Vanderploeg RD, 2005, J INT NEUROPSYCH SOC, V11, P228, DOI 10.1017/S1355617705050289; Waljas M, 2015, J NEUROTRAUM, V32, P534, DOI 10.1089/neu.2014.3339; Wong MN, 2010, APHASIOLOGY, V24, P1155, DOI 10.1080/02687030903168212; WRIGHTSON P, 1995, J NEUROL NEUROSUR PS, V59, P375, DOI 10.1136/jnnp.59.4.375; Xiong KL, 2014, BRAIN RES, V1591, P86, DOI 10.1016/j.brainres.2014.10.030; Xu L, 2014, EXPERIMENTAL NEUROLO; Zhou YX, 2013, RADIOLOGY, V267, P880, DOI 10.1148/radiol.13122542	74	212	216	5	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2017	12	4							e0174847	10.1371/journal.pone.0174847	http://dx.doi.org/10.1371/journal.pone.0174847			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET0JS	28399158	Green Published, gold			2022-12-27	WOS:000399949000012
J	Pannier, L; Merino, E; Marchal, K; Collado-Vides, J				Pannier, Lucia; Merino, Enrique; Marchal, Kathleen; Collado-Vides, Julio			Effect of genomic distance on coexpression of coregulated genes in E. coli	PLOS ONE			English	Article							NUCLEOID-ASSOCIATED PROTEINS; DIVERGENT PROMOTERS; ESCHERICHIA-COLI; OPERON; NETWORKS; CONTEXT	In prokaryotes, genomic distance is a feature that in addition to coregulation affects coexpression. Several observations, such as genomic clustering of highly coexpressed small regulons, support the idea that coexpression behavior of coregulated genes is affected by the distance between the coregulated genes. However, the specific contribution of distance in addition to coregulation in determining the degree of coexpression has not yet been studied systematically. In this work, we exploit the rich information in RegulonDB to study how the genomic distance between coregulated genes affects their degree of coexpression, measured by pairwise similarity of expression profiles obtained under a large number of conditions. We observed that, in general, coregulated genes display higher degrees of coexpression as they are more closely located on the genome. This contribution of genomic distance in determining the degree of coexpression was relatively small compared to the degree of coexpression that was determined by the tightness of the coregulation (degree of overlap of regulatory programs) but was shown to be evolutionary constrained. In addition, the distance effect was sufficient to guarantee coexpression of coregulated genes that are located at very short distances, irrespective of their tightness of coregulation. This is partly but definitely not always because the close distance is also the cause of the coregulation. In cases where it is not, we hypothesize that the effect of the distance on coexpression could be caused by the fact that coregulated genes closely located to each other are also relatively more equidistantly located from their common TF and therefore subject to more similar levels of TF molecules. The absolute genomic distance of the coregulated genes to their common TF-coding gene tends to be less important in determining the degree of coexpression. Our results pinpoint the importance of taking into account the combined effect of distance and coregulation when studying prokaryotic coexpression and transcriptional regulation.	[Pannier, Lucia; Collado-Vides, Julio] Univ Nacl Autonoma Mexico, Ctr Ciencias Genom, Programa Genom Comp, Cuernavaca, Morelos, Mexico; [Merino, Enrique] Univ Nacl Autonoma Mexico, Inst Biotecnol, Dept Microbiol Mol, Cuernavaca, Morelos, Mexico; [Marchal, Kathleen] Katholieke Univ Leuven, Ctr Microbial & Plant Genet, Dept Microbial & Mol Syst, Leuven, Belgium; [Marchal, Kathleen] Univ Ghent, Dept Plant Biotechnol & Bioinformat, Technol Pk, Ghent, Belgium; [Marchal, Kathleen] Univ Ghent, Dept Informat Technol, IMinds, Ghent, Belgium; [Marchal, Kathleen] Univ Pretoria, Dept Genet, Hatfield Campus, Pretoria, South Africa	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; KU Leuven; Ghent University; Ghent University; IMEC; University of Pretoria	Collado-Vides, J (corresponding author), Univ Nacl Autonoma Mexico, Ctr Ciencias Genom, Programa Genom Comp, Cuernavaca, Morelos, Mexico.; Marchal, K (corresponding author), Katholieke Univ Leuven, Ctr Microbial & Plant Genet, Dept Microbial & Mol Syst, Leuven, Belgium.; Marchal, K (corresponding author), Univ Ghent, Dept Plant Biotechnol & Bioinformat, Technol Pk, Ghent, Belgium.; Marchal, K (corresponding author), Univ Ghent, Dept Informat Technol, IMinds, Ghent, Belgium.; Marchal, K (corresponding author), Univ Pretoria, Dept Genet, Hatfield Campus, Pretoria, South Africa.	Kathleen.Marchal@intec.ugent.be; collado@ccg.unam.mx	Marchal, Kathleen/B-5001-2013; Marchal, Kathleen/O-7936-2017	Marchal, Kathleen/0000-0002-2169-4588; Marchal, Kathleen/0000-0002-2169-4588; Collado-Vides, Julio/0000-0001-8780-7664; Merino, Enrique/0000-0002-0374-0640	doctoral student from Programa de Doctorado en Ciencias Biomedicas (PDCB) in Centro de Ciencias Genomicas (CCG) of Univerdidad Nacional Autonoma de Mexico (UNAM); Consejo Nacional de Ciencia y Tecnologia Mexico (CONACyT) [420430]; National Institutes of Health [R01GM110597]; FOINS CONACyt Fronteras de la Ciencia [15]; Ghent University Multidisciplinary Research Partnership "Bioinformatics: from nucleotides to networks"; Fonds Wetenschappelijk Onderzoek-Vlaanderen (FWO) [G.0329.09, 3G042813, G.0A53.15N]; Agentschap voor Innovate door Wetenschap en Technologie (IWT) [NEMOA]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM110597] Funding Source: NIH RePORTER	doctoral student from Programa de Doctorado en Ciencias Biomedicas (PDCB) in Centro de Ciencias Genomicas (CCG) of Univerdidad Nacional Autonoma de Mexico (UNAM); Consejo Nacional de Ciencia y Tecnologia Mexico (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FOINS CONACyt Fronteras de la Ciencia; Ghent University Multidisciplinary Research Partnership "Bioinformatics: from nucleotides to networks"; Fonds Wetenschappelijk Onderzoek-Vlaanderen (FWO); Agentschap voor Innovate door Wetenschap en Technologie (IWT) [NEMOA]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Lucia Pannier is a doctoral student from Programa de Doctorado en Ciencias Biomedicas (PDCB) in Centro de Ciencias Genomicas (CCG) of Univerdidad Nacional Autonoma de Mexico (UNAM) and received PhD fellowship (420430) from Consejo Nacional de Ciencia y Tecnologia Mexico (CONACyT) and was partially supported by the National Institutes of Health under grant number R01GM110597 and FOINS CONACyt Fronteras de la Ciencia under project number 15. Ghent University Multidisciplinary Research Partnership "Bioinformatics: from nucleotides to networks"; Fonds Wetenschappelijk Onderzoek-Vlaanderen (FWO) [G.0329.09, 3G042813, G.0A53.15N]; Agentschap voor Innovate door Wetenschap en Technologie (IWT) [NEMOA]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Lucia Pannier is a doctoral student from Programa de Doctorado en Ciencias Biomedicas (PDCB) in Centro de Ciencias Genomicas (CCG) of Univerdidad Nacional AutOnoma de Mexico (UNAM) and received PhD fellowship (420430) from Consejo Nacional de Ciencia y Tecnologia Mexico (CONACyT) and was partially supported by the National Institutes of Health under grant number RO1GM110597 and FOINS CONACyt Fronteras de la Ciencia under project number 15. We would like to thank Cesar Bonavides-Martinez for technical support. Ghent University Multidisciplinary Research Partnership 'Bioinformatics: from nucleotides to networks'; Fonds Wetenschappelijk Onderzoek-Vlaanderen (FWO) [G.0329.09, 3G042813, G.0A53.15N]; Agentschap voor Innovatie door Wetenschap en Technologie (IWT) [NEMOA]. We thank the anonymous reviewers for their careful reading of our manuscript and their many insightful comments and suggestions.	BECK CF, 1988, MICROBIOL REV, V52, P318, DOI 10.1128/MMBR.52.3.318-326.1988; Browning DF, 2010, CURR OPIN MICROBIOL, V13, P773, DOI 10.1016/j.mib.2010.09.013; Ciria R, 2004, BIOINFORMATICS, V20, P2307, DOI 10.1093/bioinformatics/bth216; Dillon SC, 2010, NAT REV MICROBIOL, V8, P185, DOI 10.1038/nrmicro2261; Dilthey A, 2015, BIOL DIRECT, V10, DOI 10.1186/s13062-015-0102-5; Dorman CJ, 2013, BIOCHEM SOC T, V41, P542, DOI 10.1042/BST20120222; Gama-Castro S, 2015, NUCL ACIDS RES; Perez AG, 2007, NUCLEIC ACIDS RES, V35, pD132, DOI 10.1093/nar/gkl800; Perez ADG, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-128; Halford SE, 2004, NUCLEIC ACIDS RES, V32, P3040, DOI 10.1093/nar/gkh624; Homouz D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054699; Janga SC, 2009, NUCLEIC ACIDS RES, V37, P3680, DOI 10.1093/nar/gkp231; Korbel JO, 2004, NAT BIOTECHNOL, V22, P911, DOI 10.1038/nbt988; Kruglyak S, 2000, TRENDS GENET, V16, P109, DOI 10.1016/S0168-9525(99)01941-1; Kuhlman TE, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.42; LEE F, 1977, P NATL ACAD SCI USA, V74, P4365, DOI 10.1073/pnas.74.10.4365; Lemmens K, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r27; Lozada-Chavez I, 2006, NUCLEIC ACIDS RES, V34, P3434, DOI 10.1093/nar/gkl423; Marr C, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-18; Michoel T, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-49; Moretto M, 2016, NUCLEIC ACIDS RES, V44, pD620, DOI 10.1093/nar/gkv1251; Mutwil M, 2011, PLANT CELL, V23, P895, DOI 10.1105/tpc.111.083667; Ng YK, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-42; Obayashi T, 2009, DNA RES, V16, P249, DOI 10.1093/dnares/dsp016; Peter BJ, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-11-r87; Rhee KY, 1999, P NATL ACAD SCI USA, V96, P14294, DOI 10.1073/pnas.96.25.14294; Riley TR, 2014, METHODS MOL BIOL, V1196, P255, DOI 10.1007/978-1-4939-1242-1_16; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Sobetzko P, 2016, NUCLEIC ACIDS RES, V44, P1514, DOI 10.1093/nar/gkw007; Taboada B, 2012, NUCLEIC ACIDS RES, V40, pD627, DOI 10.1093/nar/gkr1020; TOTH A, 1992, J APPL PHYSIOL, V73, P296, DOI 10.1152/jappl.1992.73.1.296; Williams EJB, 2004, GENOME RES, V14, P1060, DOI 10.1101/gr.2131104; Yu GC, 2010, BIOINFORMATICS, V26, P976, DOI 10.1093/bioinformatics/btq064; Yu HY, 2003, TRENDS GENET, V19, P422, DOI 10.1016/S0168-9525(03)00175-6; Zampieri M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002981; Zhang H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029496	36	10	10	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2017	12	4							e0174887	10.1371/journal.pone.0174887	http://dx.doi.org/10.1371/journal.pone.0174887			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KH	28419102	Green Submitted, Green Published, gold			2022-12-27	WOS:000399875200005
J	Friciu, M; Roullin, VG; Leclair, G				Friciu, Mihaela; Roullin, V. Gaelle; Leclair, Gregoire			Stability of gabapentin in extemporaneously compounded oral suspensions	PLOS ONE			English	Article							MANAGEMENT; HYDROCHLORIDE	This study reports the stability of extemporaneously prepared gabapentin oral suspensions prepared at 100 mg/mL from bulk drug and capsules in either Oral Mix or Oral Mix SF suspending vehicles. Suspensions were packaged in amber plastic bottles and amber plastic syringes at 25 degrees C / 60% RH for up to 90 days. Throughout the study period, the following tests were performed to evaluate the stability of the preparations: organoleptic inspection to detect homogeneity, color or odor changes; pH measurements; and gabapentin assay using a stability-indicating HPLC-UV method. As crystallization was observed at 5 degrees C, storage at this temperature condition is not recommended. All preparations stored at 25 degrees C / 60% RH remained stable for the whole study duration of 90 days.	[Friciu, Mihaela; Roullin, V. Gaelle; Leclair, Gregoire] Univ Montreal, Fac Pharm, Montreal, PQ, Canada	Universite de Montreal	Leclair, G (corresponding author), Univ Montreal, Fac Pharm, Montreal, PQ, Canada.	gregoire.leclair@umontreal.ca	Roullin, V Gaelle/AAD-9187-2021; Leclair, Grégoire/E-3095-2013	Roullin, V Gaelle/0000-0002-0790-5246; Leclair, Grégoire/0000-0003-3087-2646	Medisca Pharmaceutique Inc.	Medisca Pharmaceutique Inc.	This study was supported by an unrestricted grant from Medisca Pharmaceutique Inc. In compliance with Pr. Leclair's standard protocol, this study was conducted to evaluate the stability of extemporaneously compounded diazoxide suspensions prepared from bulk drug and commercial capsules in Oral Mix and Oral Mix SF vehicles and stored in plastic bottles and oral syringes. Oral Mix and Oral Mix SF are proprietary vehicles of Medisca Pharmaceutique Inc. Funding for this project was only conditional to the execution of the study and no commitments were taken regarding the outcome results of this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. If accepted for publication in PLOS One, the publication costs will be covered by Medisca Pharmaceutique Inc.	[Anonymous], 2015, NEURONTIN GABAPENTIN; [Anonymous], 2016, NEUR GAB PROD MON; [Anonymous], 2016, US PHARM 39 D NAT FO, P1640; Blackmer AB, 2016, PHARMACOTHERAPY, V36, P84, DOI 10.1002/phar.1686; Bockbrader HN, 2010, CLIN PHARMACOKINET, V49, P661, DOI 10.2165/11536200-000000000-00000; Edwards L, 2016, J PEDIATR-US, V169, P310, DOI 10.1016/j.jpeds.2015.10.013; Ensom Mary H H, 2016, Can J Hosp Pharm, V69, P49; Ferreira AO, 2016, J PHARMACEUT BIOMED, V118, P105, DOI 10.1016/j.jpba.2015.10.032; Li Q, 2016, AM J HEALTH-SYST PH, V73, P1331, DOI 10.2146/ajhp150581; Moulin DE, 2014, PAIN RES MANAG, V19, P328; Nahata MC, 1999, PEDIATR NEUROL, V20, P195, DOI 10.1016/S0887-8994(98)00134-9; Nahata Milap C, 2016, Int J Pharm Compd, V20, P164; Pinchefsky E, 2015, PEDIATR NEUROL, V52, P270, DOI 10.1016/j.pediatrneurol.2014.10.015; Polonini HC, 2016, PHARMAZIE, V71, P185, DOI 10.1691/ph.2016.5177; Prohotsky Daniel L, 2014, J Pain Palliat Care Pharmacother, V28, P367, DOI 10.3109/15360288.2014.969874; Radzik I, 2015, PHARMACOL REP, V67, P663, DOI 10.1016/j.pharep.2015.01.016; Soliman II, 2014, LAT AM J PHARM, V33, P746; Sorenson Bridget, 2012, Int J Pharm Compd, V16, P347; Stanisz BJ, 2014, ACTA POL PHARM, V71, P661; Vrignaud S, 2015, INT J PHARMACEUT, V487, P270, DOI 10.1016/j.ijpharm.2015.04.016; Wishart DS, 2006, NUCLEIC ACIDS RES, V34, pD668, DOI 10.1093/nar/gkj067	21	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2017	12	4							e0175208	10.1371/journal.pone.0175208	http://dx.doi.org/10.1371/journal.pone.0175208			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KD	28414771	Green Published, gold			2022-12-27	WOS:000399874800017
J	Guizar-Sahagun, G; Martinez-Cruz, A; Franco-Bourland, RE; Cruz-Garcia, E; Corona-Juarez, A; Diaz-Ruiz, A; Grijalva, I; Reyes-Alva, HJ; Madrazo, I				Guizar-Sahagun, Gabriel; Martinez-Cruz, Angelina; Franco-Bourland, Rebecca E.; Cruz-Garcia, Eduardo; Corona-Juarez, Alvaro; Diaz-Ruiz, Araceli; Grijalva, Israel; Reyes-Alva, Horacio J.; Madrazo, Ignacio			Creation of an intramedullary cavity by hemorrhagic necrosis removal 24 h after spinal cord contusion in rats for eventual intralesional implantation of restorative materials	PLOS ONE			English	Article							STEM-CELLS; INFLAMMATORY RESPONSE; LESION EXPANSION; INJURY; MODEL; TRANSPLANTATION; REGENERATION; HEMOGLOBIN; MYELOTOMY; RECOVERY	Intramedullary hemorrhagic necrosis occurs early after spinal cord injury at the site of injury and adjacent segments. It is considered harmful because of its potential to aggravate secondary injury, and to interfere with axonal regeneration; it might also lead to an unfavorable environment for intralesional implants. Removal of hemorrhagic necrosis has been attempted before with variable results. The invasive nature of these procedures carries the risk of exacerbating damage to the injured cord. The overall objective for this study was to test several strategies for non-damaging removal of hemorrhagic necrosis and characterize the resulting cavity looking for a space for future intralesional therapeutic implants in rats with acute cord injury. Rats were subjected to graded cord contusion, and hemorrhagic necrosis was removed after 24h. Three grades of myelotomy (extensive, medium sized, and small) were tested. Using the small surgical approach to debridement, early and late effects of the intervention were determined by histology and by analytical and behavioral analysis. Appearance and capacity of the resulting cavity were characterized. Satisfactory removal of hemorrhagic necrosis was achieved with all three surgical approaches to debridement. However, bleeding in spared cord tissue was excessive after medium sized and extensive myelotomies but similar to control injured rats after small cord surgery. Small surgical approach to debridement produced no swelling nor acute inflammation changes, nor did it affect long-term spontaneous locomotor recovery, but resulted in modest improvement of myelination in rats subjected to both moderate and severe injuries. Cavity created after intervention was filled with 10 to 15 mu L of hydrogel. In conclusion, by small surgical approach to debridement, removal of hemorrhagic necrosis was achieved after acute cord contusion thereby creating intramedullary spaces without further damaging the injured spinal cord. Resulting cavities appear suitable for future intralesional placement of pro-reparative cells or other regenerative biomaterials in a clinically relevant model of spinal cord injury.	[Guizar-Sahagun, Gabriel; Cruz-Garcia, Eduardo; Grijalva, Israel; Madrazo, Ignacio] Inst Mexicano Seguro Social, Res Unit Neurol Dis, Mexico City, DF, Mexico; [Guizar-Sahagun, Gabriel; Martinez-Cruz, Angelina; Franco-Bourland, Rebecca E.; Corona-Juarez, Alvaro; Grijalva, Israel; Madrazo, Ignacio] Proyecto Camina AC, Dept Expt Surg, Mexico City, DF, Mexico; [Franco-Bourland, Rebecca E.] Inst Nacl Rehabil, Dept Biochem, Mexico City, DF, Mexico; [Diaz-Ruiz, Araceli] Inst Nacl Neurol & Neurocirug, Dept Neurochem, Mexico City, DF, Mexico; [Reyes-Alva, Horacio J.] Univ Autonoma Estado Mexico, Sch Vet Med, Dept Neurol, Toluca, Mexico	Instituto Mexicano del Seguro Social	Guizar-Sahagun, G (corresponding author), Inst Mexicano Seguro Social, Res Unit Neurol Dis, Mexico City, DF, Mexico.; Guizar-Sahagun, G (corresponding author), Proyecto Camina AC, Dept Expt Surg, Mexico City, DF, Mexico.	guizarg@gmail.com		Guizar-Sahagun, Gabriel/0000-0002-2722-5758; REYES-ALVA, HORACIO J/0000-0002-6678-8588; Diaz-Ruiz, Araceli/0000-0002-1481-0966	Fund for Health Research from the Institute Mexicano del Seguro Social [FIS/IMSS/PROT/G13/1217]	Fund for Health Research from the Institute Mexicano del Seguro Social	This work was supported by the Fund for Health Research (Grant FIS/IMSS/PROT/G13/1217) from the Institute Mexicano del Seguro Social. GG-S is the author who received the funding. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarabi B, 2012, J NEUROSURG-SPINE, V17, P243, DOI 10.3171/2012.6.SPINE12122; Abdanipour A, 2014, NEURAL REGEN RES, V9, P1003, DOI 10.4103/1673-5374.133159; Allen AR, 1914, J NERV MENT DIS, V41, P141, DOI 10.1097/00005053-191403000-00002; Allen AR, 1911, JAMA 57, P878, DOI [10.1001/jama.1911.04260090100008, DOI 10.1001/JAMA.1911.04260090100008]; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Beck KD, 2010, BRAIN, V133, P433, DOI 10.1093/brain/awp322; Boido M, 2014, WORLD NEUROSURG, V81, P183, DOI 10.1016/j.wneu.2012.08.014; Boldin C, 2006, SPINE, V31, P554, DOI 10.1097/01.brs.0000201274.59427.a4; Campbell J B, 1973, Surg Neurol, V1, P102; Carlson SL, 1998, EXP NEUROL, V151, P77, DOI 10.1006/exnr.1998.6785; Di Giovanni S, 2006, EXPERT OPIN THER TAR, V10, P363, DOI 10.1517/14728222.10.3.363; Diaz-Ruiz A, 2011, J NEUROSCI RES, V89, P373, DOI 10.1002/jnr.22555; Fleming JC, 2006, BRAIN, V129, P3249, DOI 10.1093/brain/awl296; FREEMAN LW, 1953, ANN SURG, V137, P433, DOI 10.1097/00000658-195304000-00001; Gerzanich V, 2009, NAT MED, V15, P185, DOI 10.1038/nm.1899; Guest J, 2011, BRAIN RES BULL, V84, P267, DOI 10.1016/j.brainresbull.2010.11.007; Hagg T, 2006, J NEUROTRAUM, V23, P264, DOI 10.1089/neu.2006.23.263; Hu AM, 2015, SPINAL CORD, V53, P98, DOI 10.1038/sc.2014.209; Hua Y, 2006, NEUROSURGERY, V58, P542, DOI 10.1227/01.NEU.0000197333.55473.AD; Iorgulescu JB, 2015, NEURAL PLAST, V2015, DOI 10.1155/2015/186385; IWASAKI Y, 1987, Hokkaido Journal of Medical Science, V62, P820; Kjell J, 2016, DIS MODEL MECH, V9, P1125, DOI 10.1242/dmm.025833; Koyanagi I, 1989, Neurol Med Chir (Tokyo), V29, P302, DOI 10.2176/nmc.29.302; Krishna V, 2013, J SPINAL CORD MED, V36, P174, DOI 10.1179/2045772313Y.0000000095; Losey P, 2014, BRAIN RES, V1569, P9, DOI 10.1016/j.brainres.2014.04.033; Mautes AEM, 2000, PHYS THER, V80, P673, DOI 10.1093/ptj/80.7.673; Metz GAS, 2000, J NEUROTRAUM, V17, P1, DOI 10.1089/neu.2000.17.1; Mortazavi MM, 2015, CLIN ANAT, V28, P37, DOI 10.1002/ca.22443; Mothe AJ, 2011, SPINAL CORD, V49, P967, DOI 10.1038/sc.2011.46; Mothe AJ, 2013, BIOMATERIALS, V34, P3775, DOI 10.1016/j.biomaterials.2013.02.002; Norenberg MD, 2004, J NEUROTRAUM, V21, P429, DOI 10.1089/089771504323004575; Oudega M, 2012, CELL TISSUE RES, V349, P269, DOI 10.1007/s00441-012-1440-6; Regan RF, 1998, J NEUROTRAUM, V15, P645, DOI 10.1089/neu.1998.15.645; Reyes-Alva HJ, 2009, ACTA NEUROBIOL EXP, V69, P494; RIVLIN AS, 1979, J NEUROSURG, V50, P349, DOI 10.3171/jns.1979.50.3.0349; Rowland JW, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.11.E2; SADRZADEH SMH, 1987, J CLIN INVEST, V79, P662, DOI 10.1172/JCI112865; Shin DA, 2013, ACTA NEUROCHIR, V155, P1943, DOI 10.1007/s00701-013-1799-5; Shrestha B, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt480; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Simard JM, 2013, SPINAL CORD, V51, P823, DOI 10.1038/sc.2013.99; Simard JM, 2007, J CLIN INVEST, V117, P2105, DOI 10.1172/JCI32041; Simard JM, 2013, J SPINE S4; Sinescu Crina, 2010, J Med Life, V3, P254; TACHIBANA S, 1984, Neurological Surgery, V12, P183; Tator CH, 1997, J NEUROSURG, V86, P483, DOI 10.3171/jns.1997.86.3.0483; Tetzlaff W, 2011, J NEUROTRAUM, V28, P1611, DOI 10.1089/neu.2009.1177; Vardjan N, 2016, GLIA, V64, P1034, DOI 10.1002/glia.22981; Wang XY, 2002, STROKE, V33, P1882, DOI 10.1161/01.STR.0000020121.41527.5D; WEIRICH SD, 1990, SPINE, V15, P630, DOI 10.1097/00007632-199007000-00004; Wilems TS, 2015, ACTA BIOMATER, V28, P23, DOI 10.1016/j.actbio.2015.09.018; Yang DG, 2013, SPINAL CORD, V51, P673, DOI 10.1038/sc.2013.56; Zhu H, 2008, CHINESE MED J-PEKING, V121, P2473, DOI 10.1097/00029330-200812020-00002	53	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2017	12	4							e0176105	10.1371/journal.pone.0176105	http://dx.doi.org/10.1371/journal.pone.0176105			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KD	28414769	Green Published, gold, Green Submitted			2022-12-27	WOS:000399874800089
J	Merciai, R; Molons-Sierra, C; Sabater, S; Garcia-Berthou, E				Merciai, Roberto; Molons-Sierra, Carlota; Sabater, Sergi; Garcia-Berthou, Emili			Water abstraction affects abundance, size-structure and growth of two threatened cyprinid fishes	PLOS ONE			English	Article							CHUB LEUCISCUS-PYRENAICUS; GUADALQUIVIR RIVER-BASIN; BARBEL BARBUS-BARBUS; HABITAT QUALITY; MEDITERRANEAN BARBEL; INTERMITTENT-STREAM; LENGTH; AGE; RESPONSES; DROUGHT	Hydrologic alteration is a major threat to freshwater biota, and particularly fish, in many river courses around the world. We analyzed and compared the effects of water abstraction on two threatened cyprinid fishes of contrasting ecology (the Mediterranean barbel Barbus meridionalis and the Catalan chub Squalius laietanus) in a Mediterranean stream. We compared abundance, size-structure, growth, and condition of both species across perennial and artificially intermittent reaches affected by water abstraction. Both species were less abundant, had scarce large individuals, and displayed slower growth rates (length-at-age) in intermittent reaches, showing clear detrimental effects of water diversion. Mixed-effect models of scale increments showed variation among individuals and among sites, years and age classes for both species. The larger-sized, water-column species (chub) disappeared or was rare in many intermittent reaches. The barbel present in intermittent reaches showed better somatic condition than in sites with permanent flow, perhaps due to reduced competition after rewetting or colonization by better fitted individuals. This benthic, rheophilic species seems more resilient to moderate water abstraction than chub. Many effects of water flow intermittency were only detected on fish life-history traits when accounting for natural, often non-linear, variation, along upstream-downstream gradients. Our results suggest that abundance was the strongest indicator of effects of water abstraction on fish populations, whereas condition was a more labile trait, rapidly recovering from anthropogenic disturbance.	[Merciai, Roberto; Molons-Sierra, Carlota; Sabater, Sergi; Garcia-Berthou, Emili] Univ Girona, Inst Aquat Ecol, GRECO, Girona, Catalonia, Spain; [Sabater, Sergi] Univ Girona, Catalan Inst Water Res ICRA, Sci & Technol Pk, Girona, Catalonia, Spain	Universitat de Girona; Institut Catala de Recerca de l'Aigua (ICRA); Universitat de Girona	Garcia-Berthou, E (corresponding author), Univ Girona, Inst Aquat Ecol, GRECO, Girona, Catalonia, Spain.	emili.garcia@udg.edu	Sabater, Sergi/A-7549-2008; García-Berthou, Emili/A-5392-2008	Sabater, Sergi/0000-0003-3730-0261; García-Berthou, Emili/0000-0001-8412-741X	Spanish Ministry of Education [AP2010-4025]; European Union (FP7) project GLOBAQUA [603629]; Government of Catalonia [2014 SGR 484, 2014 SGR 291]	Spanish Ministry of Education(Spanish Government); European Union (FP7) project GLOBAQUA; Government of Catalonia(Generalitat de Catalunya)	RM held a doctoral fellowship from the Spanish Ministry of Education (AP2010-4025), http //www.mecd.gob.es/portada-mecd/en/. This research was funded by European Union (FP7 project GLOBAQUA, Grant agreement No. 603629), http://www.globaqua-project.eu/en/home/; and Government of Catalonia (ref.2014 SGR 484 and 2014 SGR 291), http/web.gencat.cat/en/inci/Index.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACA (Agencia Catalana de l'Aigua), 2002, EST ACT AV REC DRICS; Albanese B, 2004, CAN J FISH AQUAT SCI, V61, P857, DOI 10.1139/F04-096; Alexandre CM, 2015, ECOHYDROLOGY, V8, P1137, DOI 10.1002/eco.1572; Alexandre CM, 2014, ECOL FRESHW FISH, V23, P244, DOI 10.1111/eff.12073; Almodovar A, 1999, REGUL RIVER, V15, P477, DOI 10.1002/(SICI)1099-1646(199909/10)15:5<477::AID-RRR560>3.0.CO;2-B; [Anonymous], 2021, LANG ENV STAT COMP; Aparicio E, 2000, ENVIRON BIOL FISH, V59, P11, DOI 10.1023/A:1007618517557; Aparicio E, 2001, 3 TROB EST MONTN COR, P49; Aparicio E, 2004, 4 TROB EST MONTN COR, P119; Bae MJ, 2016, RIVER RES APPL, V32, P309, DOI 10.1002/rra.2871; Beardsley H, 2012, AQUAT ECOL, V46, P143, DOI 10.1007/s10452-011-9387-3; Benejam L, 2008, HYDROBIOLOGIA, V603, P197, DOI 10.1007/s10750-007-9272-1; Benejam L, 2016, ECOL FRESHW FISH, V25, P295, DOI 10.1111/eff.12210; Benejam L, 2012, FISH RES, V123, P9, DOI 10.1016/j.fishres.2011.11.022; Benejam L, 2010, FRESHWATER BIOL, V55, P628, DOI 10.1111/j.1365-2427.2009.02299.x; Boada M, 2006, OBSERVATORI ESTACIO; Bolland JD, 2007, J FISH BIOL, V71, P1810, DOI 10.1111/j.1095-8649.2007.01650.x; Britton JR, 2013, ECOL FRESHW FISH, V22, P21, DOI 10.1111/j.1600-0633.2012.00588.x; Carmona-Catot G, 2011, DIVERS DISTRIB, V17, P214, DOI 10.1111/j.1472-4642.2011.00743.x; Carmona-Catot G, 2010, N AM J FISH MANAGE, V30, P1315, DOI 10.1577/M10-077.1; Casals i Marti F, 2005, THESIS; CASTLEBERRY DT, 1986, ECOLOGY, V67, P912, DOI 10.2307/1939813; Chugunova L.P., 1963, AGE GROWTH STUDIES F; Cooper SD, 2013, HYDROBIOLOGIA, V719, P383, DOI 10.1007/s10750-012-1333-4; Davey AJH, 2007, FRESHWATER BIOL, V52, P1719, DOI 10.1111/j.1365-2427.2007.01800.x; Davidson RS, 2010, J ANIM ECOL, V79, P1113, DOI 10.1111/j.1365-2656.2010.01708.x; Deegan LA, 1999, T AM FISH SOC, V128, P1163, DOI 10.1577/1548-8659(1999)128<1163:IOEVOT>2.0.CO;2; Doadrio I., 2011, ICTIOFAUNA CONTINENT; Doadrio I, 2007, ICHTHYOL EXPLOR FRES, V18, P247; Dudgeon D., 2013, RIVER CONSERVATION C, P129; FERNANDEZDELGADO C, 1995, J FISH BIOL, V46, P371, DOI 10.1111/j.1095-8649.1995.tb05977.x; FRANCIS RICC, 1990, J FISH BIOL, V36, P883, DOI 10.1111/j.1095-8649.1990.tb05636.x; Freyhof J., 2007, HDB EUROPEAN FRESHWA; FSA, 2021, FISH STOCK AN; Garcia-Berthou E, 2000, ARCH HYDROBIOL, V149, P271; Garcia-Berthou E, 1993, CAN J FISH AQUAT SCI, V50, P1394, DOI 10.1139/f93-159; Garcia-Berthou E, 1992, J FISH BIOL, V40, P929, DOI 10.1111/j.1095-8649.1992.tb02638.x; Garcia-Ruiz JM, 2011, EARTH-SCI REV, V105, P121, DOI 10.1016/j.earscirev.2011.01.006; Gasith A, 1999, ANNU REV ECOL SYST, V30, P51, DOI 10.1146/annurev.ecolsys.30.1.51; GERALDES AM, 1995, FOLIA ZOOL, V44, P159; Grossman GD, 1998, ECOL MONOGR, V68, P395, DOI 10.1890/0012-9615(1998)068[0395:AOISFE]2.0.CO;2; Guy Christopher S., 1995, North American Journal of Fisheries Management, V15, P754, DOI 10.1577/1548-8675(1995)015<0754:PCOBCI>2.3.CO;2; Harvey BC, 2006, T AM FISH SOC, V135, P998, DOI 10.1577/T05-233.1; Harvey BC, 2014, N AM J FISH MANAGE, V34, P247, DOI 10.1080/02755947.2013.860062; Hermoso V, 2011, MAR FRESHWATER RES, V62, P244, DOI 10.1071/MF09300; HERRERA M, 1994, J FISH BIOL, V44, P11, DOI 10.1111/j.1095-8649.1994.tb01581.x; Herrera M, 1992, ECOL FRESHW FISH, V1, P42; HOENIG JM, 1995, CAN J FISH AQUAT SCI, V52, P364, DOI 10.1139/f95-038; Huitema B., 2011, ANAL COVARIANCE ALTE; Klinger SA, 1992, ENVIRON BIOL FISH, V7, P113; Kubecka J, 1997, REGUL RIVER, V13, P101, DOI 10.1002/(SICI)1099-1646(199703)13:2<101::AID-RRR439>3.0.CO;2-U; Kuznetsova A., 2013, LMERTEST TESTS RANDO; Lake PS, 2003, FRESHWATER BIOL, V48, P1161, DOI 10.1046/j.1365-2427.2003.01086.x; Lappalainen A, 2001, BOREAL ENVIRON RES, V6, P107; LOBONCERVIA J, 1984, FOLIA ZOOL, V33, P371; Magalhaes MF, 2007, FRESHWATER BIOL, V52, P1494, DOI 10.1111/j.1365-2427.2007.01781.x; MAGALHAES MF, 1993, J FISH BIOL, V42, P875, DOI 10.1006/jfbi.1993.1097; Magoulick DD, 2003, FRESHWATER BIOL, V48, P1186, DOI 10.1046/j.1365-2427.2003.01089.x; Marshall CT, 1999, CAN J FISH AQUAT SCI, V56, P347, DOI 10.1139/cjfas-56-3-347; Mas-Marti E, 2010, HYDROBIOLOGIA, V657, P167, DOI 10.1007/s10750-010-0292-x; Matthews W. J., 1998, PATTERNS FRESHWATER; Matthews WJ, 2003, FRESHWATER BIOL, V48, P1232, DOI 10.1046/j.1365-2427.2003.01087.x; Merciai R, ECOLOGY FRE IN PRESS; Merseburger GC, 2005, SCI TOTAL ENVIRON, V347, P217, DOI 10.1016/j.scitotenv.2004.12.022; Moyle P. B., 1996, FISHES INTRO ICHTHYO; Murphy CA, 2013, ECOL INDIC, V34, P571, DOI 10.1016/j.ecolind.2013.06.007; Nunn AD, 2007, J FISH BIOL, V70, P1254, DOI 10.1111/j.1095-8649.2007.01415.x; Nunn AD, 2002, ECOL FRESHW FISH, V11, P74, DOI 10.1034/j.1600-0633.2002.t01-1-00001.x; Oliva-Paterna FJ, 2003, J FISH BIOL, V63, P699, DOI 10.1046/j.1095-8649.2003.00183.x; Oliva-Paterna FJ, 2003, ENVIRON BIOL FISH, V67, P13, DOI 10.1023/A:1024481928161; Ortiz JD, 2007, RIVER RES APPL, V23, P155, DOI 10.1002/rra.971; Otero I, 2011, LAND USE POLICY, V28, P207, DOI 10.1016/j.landusepol.2010.06.002; Pankhurst N.W., 1997, P73; PARAGAMIAN V L, 1987, North American Journal of Fisheries Management, V7, P357, DOI 10.1577/1548-8659(1987)7<357:EOVSOG>2.0.CO;2; PATTERSON KR, 1992, J FISH BIOL, V40, P821, DOI 10.1111/j.1095-8649.1992.tb02629.x; Pires AM, 1999, J FISH BIOL, V54, P235; Poff NL, 2010, FRESHWATER BIOL, V55, P147, DOI 10.1111/j.1365-2427.2009.02204.x; Prat N, 2002, QUALITAT ECOLAGICA L; Rovira A, 2006, GEOMORPHOLOGY, V79, P58, DOI 10.1016/j.geomorph.2005.09.016; Sabater S, 2010, HANDB ENVIRON CHEM, V8, P15, DOI 10.1007/698_2009_24; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; SECOR DH, 1989, CAN J FISH AQUAT SCI, V46, P113, DOI 10.1139/f89-015; Smith K. G., 2006, STATUS DISTRIBUTION, V1; Spranza JJ, 2000, ENVIRON BIOL FISH, V59, P99, DOI 10.1023/A:1007630417266; Teichert MAK, 2010, J FISH BIOL, V76, P1751, DOI 10.1111/j.1095-8649.2010.02614.x; Vila-Gispert A, 2000, ARCH HYDROBIOL, V148, P135; Vila-Gispert A, 2001, J FISH BIOL, V59, P824, DOI 10.1111/j.1095-8649.2001.tb00153.x; Weisberg S, 2012, MIXED EFFECTS MODELS; Weisberg S, 2010, CAN J FISH AQUAT SCI, V67, P269, DOI 10.1139/F09-181; Whittingham MJ, 2006, J ANIM ECOL, V75, P1182, DOI 10.1111/j.1365-2656.2006.01141.x; WINTERS GH, 1994, CAN J FISH AQUAT SCI, V51, P1169, DOI 10.1139/f94-116	91	7	7	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2017	12	4							e0175932	10.1371/journal.pone.0175932	http://dx.doi.org/10.1371/journal.pone.0175932			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KD	28414787	Green Published, gold, Green Submitted			2022-12-27	WOS:000399874800077
J	Nguyen, NTH; Soto, AJ; Kontonatsios, G; Batista-Navarro, R; Ananiadou, S				Nguyen, Nhung T. H.; Soto, Axel J.; Kontonatsios, Georgios; Batista-Navarro, Riza; Ananiadou, Sophia			Constructing a biodiversity terminological inventory	PLOS ONE			English	Article							SEMANTIC SIMILARITY; ENTITIES; SYSTEM; NAMES	The increasing growth of literature in biodiversity presents challenges to users who need to discover pertinent information in an efficient and timely manner. In response, text mining techniques offer solutions by facilitating the automated discovery of knowledge from large textual data. An important step in text mining is the recognition of concepts via their linguistic realisation, i.e., terms. However, a given concept may be referred to in text using various synonyms or term variants, making search systems likely to overlook documents mentioning less known variants, which are albeit relevant to a query term. Domain-specific terminological resources, which include term variants, synonyms and related terms, are thus important in supporting semantic search over large textual archives. This article describes the use of text mining methods for the automatic construction of a large-scale biodiversity term inventory. The inventory consists of names of species, amongst which naming variations are prevalent. We apply a number of distributional semantic techniques on all of the titles in the Biodiversity Heritage Library, to compute semantic similarity between species names and support the automated construction of the resource. With the construction of our biodiversity term inventory, we demonstrate that distributional semantic models are able to identify semantically similar names that are not yet recorded in existing taxonomies. Such methods can thus be used to update existing taxonomies semi-automatically by deriving semantically related taxonomic names from a text corpus and allowing expert curators to validate them. We also evaluate our inventory as a means to improve search by facilitating automatic query expansion. Specifically, we developed a visual search interface that suggests semantically related species names, which are available in our inventory but not always in other repositories, to incorporate into the search query. An assessment of the interface by domain experts reveals that our query expansion based on related names is useful for increasing the number of relevant documents retrieved. Its exploitation can benefit both users and developers of search engines and text mining applications.	[Nguyen, Nhung T. H.; Soto, Axel J.; Kontonatsios, Georgios; Batista-Navarro, Riza; Ananiadou, Sophia] Univ Manchester, Sch Comp Sci, Natl Ctr Text Min, Manchester, Lancs, England	University of Manchester	Ananiadou, S (corresponding author), Univ Manchester, Sch Comp Sci, Natl Ctr Text Min, Manchester, Lancs, England.	Sophia.Ananiadou@manchester.ac.uk	Soto, Axel J./AAH-8622-2020; Batista-Navarro, Riza/ABD-6210-2021	Nguyen, Nhung/0000-0001-5935-9235; Batista-Navarro, Riza/0000-0001-6693-7531; Soto, Axel/0000-0002-9021-7566; Kontonatsios, Georgios/0000-0001-5935-4709	British Council, Newton Fund [172722806]; The British Council [172722806] Funding Source: researchfish	British Council, Newton Fund; The British Council	This project was funded by the British Council, Newton Fund 172722806. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akella LM, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-211; AlLAboutBirds, 2016, INF TREE SWALL; [Anonymous], 2013, BIODIVERSITY HERITAG; [Anonymous], 2016, INTEGRATED TAXONOMIC; Arkive, 2016, REL SPEC IND RHIN; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baroni M, 2014, PROCEEDINGS OF THE 52ND ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS, VOL 1, P238; Batet M, 2011, J BIOMED INFORM, V44, P118, DOI 10.1016/j.jbi.2010.09.002; Bengio Y, 2003, J MACH LEARN RES, V3, P1137, DOI 10.1162/153244303322533223; Bobadilla J, 2013, KNOWL-BASED SYST, V46, P109, DOI 10.1016/j.knosys.2013.03.012; Bodenreider O, 2004, NUCLEIC ACIDS RES, V32, pD267, DOI 10.1093/nar/gkh061; Boyle B, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-16; Cantino PD, 1998, TAXON, V47, P425, DOI 10.2307/1223773; Carpineto C, 2012, ACM COMPUT SURV, V44, DOI 10.1145/2071389.2071390; Clark S., 2013, HDB CONT SEMANTICS; Cockburn A, 2008, ACM COMPUT SURV, V41, DOI 10.1145/1456650.1456652; Cohen WW, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-440; DUNNETT CW, 1955, J AM STAT ASSOC, V50, P1096, DOI 10.2307/2281208; Erk K, 2012, LANG LINGUIST COMPAS, V6, P635, DOI 10.1002/Inc3.362; Frantzi K., 2000, INT J DIGITAL LIB, V3, P115, DOI [DOI 10.1007/S007999900023, 10.1007/s007999900023]; Gerner M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-85; Golub GH., 2013, MATRIX COMPUTATIONS; Guala GF, PLOS ONE, V11, P1; Gwinn NE, 2009, IFLA J-INT FED LIBR, V35, P25, DOI 10.1177/0340035208102032; Harispe S, 2014, J BIOMED INFORM, V48, P38, DOI 10.1016/j.jbi.2013.11.006; Henriksson A, 2014, J BIOMED SEMANT, V5, DOI 10.1186/2041-1480-5-6; International Commission on Zoological Nomenclature, 1999, INT CODE ZOOLOGICAL, V4th; Koning Drew, 2005, Biodiversity Informatics, V2, P79; Leary PR, 2007, BIOINFORMATICS, V23, P1434, DOI 10.1093/bioinformatics/btm109; Lee WN, 2008, COMP ONTOLOGY BASED; Levy O., 2015, T ASS COMPUT LINGUIS, V3, P211, DOI [10.1162/tacl_a_00134, DOI 10.1162/TACL_A_00134]; MIKOLOV T, 2013, P INT C LEARN REPR W; MILLER GA, 1995, COMMUN ACM, V38, P39, DOI 10.1145/219717.219748; Mitchell J., 2008, P ASS COMP LING HUM, P236, DOI DOI 10.1039/9781847558633-00236; Naderi N, 2011, BIOINFORMATICS, V27, P2721, DOI 10.1093/bioinformatics/btr452; Pafilis E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065390; Parr Cynthia S, 2014, Biodivers Data J, pe1079, DOI 10.3897/BDJ.2.e1079; Patterson D, 2016, BIODIVERS DATA J, V4, DOI 10.3897/BDJ.4.e8080; Pedersen T, 2007, J BIOMED INFORM, V40, P288, DOI 10.1016/j.jbi.2006.06.004; Pennington J, 2014, EMNLP, V14, P1532, DOI DOI 10.3115/V1/D14-1162; Pivovarov R, 2012, J BIOMED INFORM, V45, P471, DOI 10.1016/j.jbi.2012.01.002; Pyle RL, 2016, ZOOKEYS, P261, DOI 10.3897/zookeys.550.10009; Rees T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107510; Roskov Y A, 2015, SPECIES 2000 ITIS CA; SASAKI Y, 2009, P EACL DEM SESS, P61; Sasaki Yutaka, 2010, Journal of Bioinformatics and Computational Biology, V8, P147, DOI 10.1142/S0219720010004513; Sasaki Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S11-S5; Schutze H., 2008, INTRO INFORM RETRIEV, V39; Socher R, 2013, P 2013 C EMP METH NA, P1631; Strube M., 2006, P AAAI, V6, P1419; Tamura A., 2012, P 2012 JOINT C EMP M, P24; Thompson P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0144717; Thompson P, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-397; Tsuruoka Y, 2007, BIOINFORMATICS, V23, P2768, DOI 10.1093/bioinformatics/btm393; Turney PD, 2010, J ARTIF INTELL RES, V37, P141, DOI 10.1613/jair.2934; USDA  NRCS, 2016, PLANTS DAT; Vanden Berghe E, 2015, ECOL INFORM, V28, P29, DOI 10.1016/j.ecoinf.2015.05.004; Wang JZ, 2007, BIOINFORMATICS, V23, P1274, DOI 10.1093/bioinformatics/btm087; Wang XL, 2010, BIOINFORMATICS, V26, P661, DOI 10.1093/bioinformatics/btq002; Winkler W.E, 1990, P SECT SURV RES ISS; Zanzotto Fabio Massimo, 2010, P 23 INT C COMP LING, V2, P1263	61	9	9	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2017	12	4							e0175277	10.1371/journal.pone.0175277	http://dx.doi.org/10.1371/journal.pone.0175277			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KD	28414821	Green Published, Green Submitted, gold			2022-12-27	WOS:000399874800020
J	von Klitzing, E; Ekmekciu, I; Kuhl, AA; Bereswill, S; Heimesaat, MM				von Klitzing, Eliane; Ekmekciu, Ira; Kuehl, Anja A.; Bereswill, Stefan; Heimesaat, Markus M.			Intestinal, extra-intestinal and systemic sequelae of Toxoplasma gondii induced acute ileitis in mice harboring a human gut microbiota	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; ESCHERICHIA-COLI; GNOTOBIOTIC MICE; CROHNS-DISEASE; ORAL INFECTION; GERM-FREE; PERORAL INFECTION; EARLY SURVIVAL; MODEL; IMMUNOPATHOLOGY	Background Within seven days following peroral high dose infection with Toxoplasma gondii susceptible conventionally colonized mice develop acute ileitis due to an underlying T helper cell (Th) - 1 type immunopathology. We here addressed whether mice harboring a human intestinal microbiota developed intestinal, extra-intestinal and systemic sequelae upon ileitis induction. Methodology/Principal findings Secondary abiotic mice were generated by broad-spectrum antibiotic treatment and associated with a complex human intestinal microbiota following peroral fecal microbiota transplantation. Within three weeks the human microbiota had stably established in the murine intestinal tract as assessed by quantitative cultural and culture-independent (i.e. molecular 16S rRNA based) methods. At day 7 post infection (p.i.) with 50 cysts of T. gondii strain ME49 by gavage human microbiota associated (hma) mice displayed severe clinical, macroscopic and microscopic sequelae indicating acute ileitis. In diseased hma mice increased numbers of innate and adaptive immune cells within the ileal mucosa and lamina propria and elevated intestinal secretion of pro-inflammatory mediators including IFN-gamma, IL-12 and nitric oxide could be observed at day 7 p.i. Ileitis development was accompanied by substantial shifts in intestinal microbiota composition of hma mice characterized by elevated total bacterial loads and increased numbers of intestinal Gram-negative commensals such as enterobacteria and Bacteroides / Prevotella species overgrowing the small and large intestinal lumen. Furthermore, viable bacteria translocated from the inflamed ileum to extra-intestinal including systemic compartments. Notably, pro-inflammatory immune responses were not restricted to the intestinal tract as indicated by increased pro-inflammatory cytokine secretion in extra-intestinal (i.e. liver and kidney) and systemic compartments including spleen and serum. Conclusion/Significance With respect to the intestinal microbiota composition "humanized" mice display acute ileitis following peroral high dose T. gondii infection. Thus, hma mice constitute a suitable model to further dissect the interactions between pathogens, human microbiota and vertebrate host immunity during acute intestinal inflammation.	[von Klitzing, Eliane; Ekmekciu, Ira; Bereswill, Stefan; Heimesaat, Markus M.] Charite Univ Med Berlin, Dept Microbiol & Hyg, Berlin, Germany; [Kuehl, Anja A.] Charite Univ Med Berlin, Res Ctr ImmunoSci, Dept Med Gastroenterol Infect Dis & Rheumatol, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Heimesaat, MM (corresponding author), Charite Univ Med Berlin, Dept Microbiol & Hyg, Berlin, Germany.	markus.heimesaat@charite.de		Heimesaat, Markus/0000-0001-6399-651X; Kuhl, Anja/0000-0003-2293-5387	German Research Foundation (DFG) [SFB633]	German Research Foundation (DFG)(German Research Foundation (DFG))	This work was supported by grants from the German Research Foundation (DFG) to EVK and IE (SFB633, Immuco), SB (SFB633, TP A7), MMH (SFB633, TP B6), and MK (SFB633, TP Z1). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Almanza LCB, 2013, EUR J MICROBIOL IMMU, V3, P211, DOI 10.1556/EuJMI.3.2013.3.10; Alter T, 2011, BUNDESGESUNDHEITSBLA, V54, P728, DOI 10.1007/s00103-011-1289-y; Alutis ME, 2015, EUR J MICROBIOL IMMU, V5, P256, DOI 10.1556/1886.2015.00033; Bereswill S, 2014, GUT PATHOG, V6, DOI 10.1186/1757-4749-6-19; Bereswill S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020953; Bereswill S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015099; Collins J, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0097-2; Darfeuille-Michaud A, 2004, GASTROENTEROLOGY, V127, P412, DOI 10.1053/j.gastro.2004.04.061; Dianda L, 1997, AM J PATHOL, V150, P91; Erridge C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009125; Eun CS, 2014, INFECT IMMUN, V82, P2239, DOI 10.1128/IAI.01513-13; Faith JJ, 2011, SCIENCE, V333, P101, DOI 10.1126/science.1206025; Fiebiger U, 2016, EUR J MICROBIOL IMMU, V6, P253, DOI 10.1556/1886.2016.00036; Golz G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139402; Goodman AL, 2011, P NATL ACAD SCI USA, V108, P6252, DOI 10.1073/pnas.1102938108; Hansen AK, 2014, WORLD J GASTROENTERO, V20, P17727, DOI 10.3748/wjg.v20.i47.17727; Hazebrouck S, 2009, INT ARCH ALLERGY IMM, V148, P65, DOI 10.1159/000151507; Heimesaat MM, 2007, GUT, V56, P941, DOI 10.1136/gut.2006.104497; Heimesaat MM, 2013, EUR J MICROBIOL IMMU, V3, P36, DOI 10.1556/EuJMI.3.2013.1.5; Heimesaat MM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000662; Heimesaat MM, 2006, J IMMUNOL, V177, P8785, DOI 10.4049/jimmunol.177.12.8785; Heimesaat MM, 2015, EUR J MICROBIOL IMMU, V5, P210, DOI 10.1556/1886.2015.00025; Heimesaat MM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108389; Heimesaat MM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105120; Heimesaat MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040758; Heimesaat MM, 2010, GUT, V59, P1079, DOI 10.1136/gut.2009.197434; Jankovic D, 2010, MUCOSAL IMMUNOL, V3, P239, DOI 10.1038/mi.2010.8; Liesenfeld O, 2002, J INFECT DIS, V185, pS96, DOI 10.1086/338006; Liesenfeld O, 1999, PARASITE IMMUNOL, V21, P365, DOI 10.1046/j.1365-3024.1999.00237.x; Liesenfeld O, 1996, J EXP MED, V184, P597, DOI 10.1084/jem.184.2.597; Masanta WO, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/526860; Masseret E, 2001, GUT, V48, P320, DOI 10.1136/gut.48.3.320; MCLEOD R, 1989, J IMMUNOL, V143, P3031; MCLEOD R, 1989, J IMMUNOL, V142, P3247; McNulty NP, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002701; Munoz M, 2011, IMMUNOL REV, V240, P269, DOI 10.1111/j.1600-065X.2010.00992.x; Munoz M, 2009, J EXP MED, V206, P3047, DOI 10.1084/jem.20090900; Natividad JM, 2015, INFLAMM BOWEL DIS, V21, P1883, DOI 10.1097/MIB.0000000000000422; Rausch S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074026; Seksik P, 2003, GUT, V52, P237, DOI 10.1136/gut.52.2.237; Struck D, 2012, EUR J MICROBIOL IMMU, V2, P249, DOI 10.1556/EuJMI.2.2012.3.11; Swidsinski A, 2005, J CLIN MICROBIOL, V43, P3380, DOI 10.1128/JCM.43.7.3380-3389.2005; TAUROG JD, 1994, J EXP MED, V180, P2359, DOI 10.1084/jem.180.6.2359; Thoene-Reineke C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113406; Turnbaugh PJ, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000322; Vossenkamper A, 2004, EUR J IMMUNOL, V34, P3197, DOI 10.1002/eji.200424993	46	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2017	12	4							e0176144	10.1371/journal.pone.0176144	http://dx.doi.org/10.1371/journal.pone.0176144			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KD	28414794	Green Published, gold, Green Submitted			2022-12-27	WOS:000399874800091
J	Yeganeh, N; Simon, M; Mindry, D; Nielsen-Saines, K; Chaves, MC; Santos, B; Melo, M; Mendoza, B; Gorbach, P				Yeganeh, Nava; Simon, Mariana; Mindry, Deborah; Nielsen-Saines, Karin; Chaves, Maria Cristina; Santos, Breno; Melo, Marineide; Mendoza, Brenna; Gorbach, Pamina			Barriers and facilitators for men to attend prenatal care and obtain HIV voluntary counseling and testing in Brazil	PLOS ONE			English	Article							TO-CHILD TRANSMISSION; MALE-PARTNER PARTICIPATION; NORTHERN TANZANIA; MALE INVOLVEMENT; SOUTH-AFRICA; INCIDENT HIV; PREVENTION; PROGRAMS; INFECTION; PREGNANCY	Background Providing HIV voluntary counseling and testing (VCT) to men who attend their partner's prenatal care is an intervention with potential to reduce HIV transmission to women and infants during the vulnerable period of pregnancy. Little is known about the acceptability of this intervention in global settings outside of Africa. Methods We conducted in-depth qualitative interviews to evaluate potential barriers and facilitators to prenatal care attendance for HIV VCT with 20 men who did and 15 men who did not attend prenatal care with their partners at Hospital Conceicao in Porto Alegre, Brazil. Men were recruited at the labor and delivery unit at Hospital Conceicao via a scripted invitation while visiting their newborn infant. Interviews lasted from 35-55 minutes and were conducted in Portuguese by a local resident trained extensively in qualitative methods. All interviews were transcribed verbatim, translated, and then analyzed using Atlast.ti software. An analysis of themes was then conducted using direct quotes and statements. We applied and adapted the AIDS Risk Reduction Theoretical Model and HIV Testing Decisions Model to the qualitative data to identify themes in the 35 interviews. Results If offered HIV testing during prenatal care, all men in both groups stated they would accept this intervention. Yet, individual, relationship and systemic factors were identified that affect these Brazilian men's decision to attend prenatal care, informing our final conceptual model. The men interviewed had a general understanding of the value of HIV prevention of mother to child transmission. They also described open and communicative relationships with their significant others and displayed a high level of enthusiasm towards optimizing the health of their expanding family. The major barriers to attending prenatal care included perceived stigma against HIV infected individuals, men's lack of involvement in planning of the pregnancy as well as inconvenient scheduling of prenatal care, due to conflicting work schedules. Conclusions Brazilian men displayed high levels of HIV-related knowledge as well as open communication about HIV testing; especially when compared to findings from African studies. Future efforts should reorient prenatal care towards providing care to the entire family with a clear focus on protecting the infant from preventable diseases. Formally inviting men to prenatal care and providing them an acceptable medical excuse from work may enhance male involvement.	[Yeganeh, Nava; Nielsen-Saines, Karin; Mendoza, Brenna] Univ Calif Los Angeles, Dept Pediat, Div Infect Dis, David Geffen Sch Med, Los Angeles, CA 90024 USA; [Simon, Mariana; Chaves, Maria Cristina; Santos, Breno; Melo, Marineide] Hosp Nossa Senhora Conceicao GHC, Serv Infectol, Grp Hosp Conceicao, Porto Alegre, RS, Brazil; [Mindry, Deborah] Univ Calif Los Angeles, Ctr Culture & Hlth, Dept Psychiat & Behav Sci, NPI Semel Inst Neurosci, Los Angeles, CA USA; [Gorbach, Pamina] Univ Calif Los Angeles, Dept Epidemiol, Fielding Sch Publ Hlth, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Yeganeh, N (corresponding author), Univ Calif Los Angeles, Dept Pediat, Div Infect Dis, David Geffen Sch Med, Los Angeles, CA 90024 USA.	nyeganeh@mednet.ucla.edu			NIAID [1K23AI118584-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI118584] Funding Source: NIH RePORTER	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by NIAID 1K23AI118584-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarnio P, 2009, AIDS CARE, V21, P1537, DOI 10.1080/09540120902903719; Allen S, 2003, AIDS, V17, P733, DOI 10.1097/00002030-200303280-00012; Aluisio A, 2011, JAIDS-J ACQ IMM DEF, V56, P76, DOI 10.1097/QAI.0b013e3181fdb4c4; Desgrees-Du-Lou A, 2009, AIDS BEHAV, V13, P348, DOI 10.1007/s10461-007-9316-6; Drake AL, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001608; Falnes EF, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-21; Farquhar C, 2004, JAIDS-J ACQ IMM DEF, V37, P1620, DOI 10.1097/00126334-200412150-00016; Ferigolo Maristela, 2004, Rev. Bras. Psiquiatr., V26, P10, DOI 10.1590/S1516-44462004000100006; Gray RH, 2005, LANCET, V366, P1182, DOI 10.1016/S0140-6736(05)67481-8; Kakimoto K, 2007, AIDS CARE, V19, P381, DOI 10.1080/09540120500520998; Kalembo FW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066517; Katz DA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007602; Koo K, 2013, AIDS EDUC PREV, V25, P14, DOI 10.1521/aeap.2013.25.1.14; Kuehlkamp VM, 2013, BRAZ J INFECT DIS, V17, P455, DOI 10.1016/j.bjid.2012.10.023; Melo M, 2013, SEX TRANSM DIS, V40, P704, DOI 10.1097/01.OLQ.0000430799.69098.c6; Ministerio da Saude. Secretaria de Vigilancia em Saude-Departamento de DST AeHV, 2015, B EPID AIDS DST; Moodley D, 2011, J INFECT DIS, V203, P1231, DOI 10.1093/infdis/jir017; Moodley D, 2009, AIDS, V23, P1255, DOI 10.1097/QAD.0b013e32832a5934; Morfaw F, 2013, SYST REV, V2, DOI 10.1186/2046-4053-2-5; Moses SE, 2008, J CLIN VIROL, V41, P152, DOI 10.1016/j.jcv.2007.10.013; Msuya SE, 2008, AIDS CARE, V20, P700, DOI 10.1080/09540120701687059; Mugo NR, 2011, AIDS, V25, P1887, DOI 10.1097/QAD.0b013e32834a9338; Nielsen K, 2001, PILOT STUDY USING RA; Nielsen-Saines K, 2008, RETROVIROLOGY S1, V5, P01; Nielsen-Saines K, 2012, NEW ENGL J MED, V366, P2368, DOI 10.1056/NEJMoa1108275; Nkuoh GN, 2010, J MIDWIFERY WOM HEAL, V55, P363, DOI 10.1016/j.jmwh.2010.02.009; Orne-Gliemann J, 2013, AIDS, V27, P1167, DOI 10.1097/QAD.0b013e32835f1d8c; Orne-Gliemann J, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-197; Pechansky F, 2003, J URBAN HEALTH, V80, P115, DOI 10.1093/jurban/jtg115; Reece M, 2010, AIDS CARE, V22, P743, DOI 10.1080/09540120903431330; Rocha T, 2016, 9 WORLD C SOC WORLD; Secretaria Estadual da Saude, 2016, RS RED; Serafim AS, 2014, REV SOC BRAS MED TRO, V47, P170, DOI 10.1590/0037-8682-0045-2014; Singh D, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-68; Spielberg F, 2001, AIDS EDUC PREV, V13, P524, DOI 10.1521/aeap.13.6.524.21436; [SUS Prefeitura Municipal de Porto Alegre Saude. SMd], 2012, REL AN GEST 2011; Theuring S, 2009, AIDS BEHAV, V13, pS92, DOI 10.1007/s10461-009-9543-0; UNICEF, 2007, STAT WORLDS CHILDR 2; Veloso VG, 2010, REV SAUDE PUBL, V44, P803, DOI 10.1590/S0034-89102010005000034; Yeganeh N, 2013, HIV TESTING MALE PAR; Yeganeh N, 2012, INFECT DIS OBSTET GY, V2012; Yeganeh N, 2015, PEDIATR INFECT DIS J, V34, pE52, DOI 10.1097/INF.0000000000000578	42	9	10	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2017	12	4							e0175505	10.1371/journal.pone.0175505	http://dx.doi.org/10.1371/journal.pone.0175505			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES9KD	28414738	Green Published, gold, Green Submitted			2022-12-27	WOS:000399874800029
J	van Gijsel-Bonnello, M; Baranger, K; Benech, P; Rivera, S; Khrestchatisky, M; de Reggi, M; Gharib, B				van Gijsel-Bonnello, Manuel; Baranger, Kevin; Benech, Philippe; Rivera, Santiago; Khrestchatisky, Michel; de Reggi, Max; Gharib, Bouchra			Metabolic changes and inflammation in cultured astrocytes from the 5xFAD mouse model of Alzheimer's disease: Alleviation by pantethine	PLOS ONE			English	Article							A-BETA; TRANSGENIC MICE; IN-VITRO; DEHYDROGENASE; ACTIVATION; EXPRESSION; ALPHA; BRAIN; HIPPOCAMPUS; INHIBITION	Astrocytes play critical roles in central nervous system homeostasis and support of neuronal function. A better knowledge of their response may both help understand the pathophysiology of Alzheimer's disease (AD) and implement new therapeutic strategies. We used the 5xFAD transgenic mouse model of AD (Tg thereafter) to generate astrocyte cultures and investigate the impact of the genotype on metabolic changes and astrocytes activation. Metabolomic analysis showed that Tg astrocytes exhibited changes in the glycolytic pathway and tricarboxylic acid (TCA) cycle, compared to wild type (WT) cells. Tg astrocytes displayed also a prominent basal inflammatory status, with accentuated reactivity and increased expression of the inflammatory cytokine interleukin-1 beta (IL-1 beta). Compensatory mechanisms were activated in Tg astrocytes, including: i) the hexose monophosphate shunt with the consequent production of reducing species; ii) the induction of hypoxia inducible factor-1 alpha (HIF-1 alpha), known to protect against amyloid-beta (A beta) toxicity. Such events were associated with the expression by Tg astrocytes of human isoforms of both amyloid precursor protein (APP) and presenilin-1 (PS1). Similar metabolic and inflammatory changes were induced in WT astrocytes by exogenous A beta peptide. Pantethine, the vitamin B5 precursor, known to be neuroprotective and anti-inflammatory, alleviated the pathological pattern in Tg astrocytes as well as WT astrocytes treated with A beta. In conclusion, our data enlighten the dual pathogenic/protective role of astrocytes in AD pathology and the potential protective role of pantethine.	[van Gijsel-Bonnello, Manuel; Baranger, Kevin; Benech, Philippe; Rivera, Santiago; Khrestchatisky, Michel; de Reggi, Max; Gharib, Bouchra] Aix Marseille Univ, CNRS, NICN, Marseille, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Gharib, B (corresponding author), Aix Marseille Univ, CNRS, NICN, Marseille, France.	bouchra.gharib@univ-amu.fr			CNRS; Aix Marseille universite [ANR-11-MALZ-0007, ANR-15-CE16-0006]; Fonds Europeen de developpement regional (FEDER in PACA); A*MIDEX; Association France Alzheimer; LECMA; Management de talents (A* MIDEX); Fondation Plan Alzheimer; DHUNE project	CNRS(Centre National de la Recherche Scientifique (CNRS)); Aix Marseille universite; Fonds Europeen de developpement regional (FEDER in PACA); A*MIDEX(French National Research Agency (ANR)); Association France Alzheimer; LECMA; Management de talents (A* MIDEX)(Agency for Science Technology & Research (A*STAR)); Fondation Plan Alzheimer; DHUNE project	Support was provided by: CNRS and Aix Marseille universite (MvGB, BG, MK, SR, KB, PB); ANR-11-MALZ-0007 (MK), ANR-15-CE16-0006 (SR) [www agence nationals-recherche.fr]; Fonds Europeen de developpement regional (FEDER in PACA) (MK, SR) [www.europe regionpaca.fr]; DHUNE project supported by A*MIDEX (MK, SR) [www.dhune.org]; Association France Alzheimer (SR) [www.francealzheimer.org]; LECMA (MK, SR) [www.maladiealzheimer.fr]; Fondation Plan Alzheimer (KB) [www.fondation-alzheimer.org]; Post-doctoral support from the Management de talents (A* MIDEX) [www.amidex.univ-amu.fr]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre-Rueda D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122843; Allaman I, 2010, J NEUROSCI, V30, P3326, DOI 10.1523/JNEUROSCI.5098-09.2010; Almeida AS, 2012, J BIOL CHEM, V287, P10761, DOI 10.1074/jbc.M111.306738; Ashok BS, 2016, CLIN EXP PHARM PHYSL; Bahety P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090123; Baranger K, 2016, CELL MOL LIFE SCI, V73, P217, DOI 10.1007/s00018-015-1992-1; Bergmeyer HU, 1983, METHODS ENZYMATIC AN; Birch-Machin MA, 2001, METHOD CELL BIOL, V65, P97, DOI 10.1016/S0091-679X(01)65006-4; Bouzier-Sore AK, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00089; Brunetti D, 2014, BRAIN, V137, P57, DOI 10.1093/brain/awt325; Cornille E, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-51; Dahlgren KN, 2002, J BIOL CHEM, V277, P32046, DOI 10.1074/jbc.M201750200; Fu W, 2015, J BIOL CHEM, V290, P12504, DOI 10.1074/jbc.M114.618157; Garwood CJ, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.50; Gibson GE, 2000, NEUROCHEM INT, V36, P97, DOI 10.1016/S0197-0186(99)00114-X; Girard SD, 2014, HIPPOCAMPUS, V24, P762, DOI 10.1002/hipo.22267; Gonzalez-Dominguez R, 2014, BBA-MOL BASIS DIS, V1842, P2395, DOI 10.1016/j.bbadis.2014.09.014; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Heneka MT, 2010, J NEURAL TRANSM, V117, P919, DOI 10.1007/s00702-010-0438-z; Hong HS, 2003, BIOCHEM BIOPH RES CO, V307, P922, DOI 10.1016/S0006-291X(03)01270-1; Hou LL, 2011, IN VITRO CELL DEV-AN, V47, P573, DOI 10.1007/s11626-011-9439-y; Iram T, 2016, NEUROBIOL DIS, V96, P84, DOI 10.1016/j.nbd.2016.08.001; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Kallio PJ, 1999, J BIOL CHEM, V274, P6519, DOI 10.1074/jbc.274.10.6519; Kalman M, 2004, ADV MOL CEL, P787; KANEKO I, 1995, J NEUROCHEM, V65, P2585; Kavian N, 2015, ARTHRITIS RHEUMATOL, V67, P1881, DOI 10.1002/art.39121; Kisselev AF, 2005, METHOD ENZYMOL, V398, P364, DOI 10.1016/S0076-6879(05)98030-0; Koivunen P, 2007, J BIOL CHEM, V282, P4524, DOI 10.1074/jbc.M610415200; Kraft AW, 2013, FASEB J, V27, P187, DOI 10.1096/fj.12-208660; Landel V, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-33; Lanzrein AS, 1998, ALZ DIS ASSOC DIS, V12, P215, DOI 10.1097/00002093-199809000-00016; Lauritzen I, 2016, ACTA NEUROPATHOL, V132, P257, DOI 10.1007/s00401-016-1577-6; Lauritzen I, 2012, J NEUROSCI, V32, P16243, DOI 10.1523/JNEUROSCI.2775-12.2012; Liu YB, 1997, J NEUROCHEM, V69, P581, DOI 10.1046/j.1471-4159.1997.69020581.x; Lynch MA, 1998, PROG NEUROBIOL, V56, P571, DOI 10.1016/S0301-0082(98)00054-9; Mechlovich D, 2014, CURR ALZHEIMER RES, V11, P119, DOI 10.2174/1567205010666131212112529; Morimoto K, 2011, J ALZHEIMERS DIS, V25, P59, DOI 10.3233/JAD-2011-101815; Narayan P, 2014, BIOCHEMISTRY-US, V53, P2442, DOI 10.1021/bi401606f; Nilsen LH, 2014, J CEREBR BLOOD F MET, V34, P906, DOI 10.1038/jcbfm.2014.37; Oakley H, 2006, J NEUROSCI, V26, P10129, DOI 10.1523/JNEUROSCI.1202-06.2006; Ogier C, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-68; Orre M, 2014, NEUROBIOL AGING, V35, P2746, DOI 10.1016/j.neurobiolaging.2014.06.004; Pedros I, 2014, BBA-MOL BASIS DIS, V1842, P1556, DOI 10.1016/j.bbadis.2014.05.025; Penet MF, 2008, P NATL ACAD SCI USA, V105, P1321, DOI 10.1073/pnas.0706867105; PRUSS RM, 1979, NATURE, V280, P688, DOI 10.1038/280688a0; Py NA, 2014, FRONT AGING NEUROSCI, V6, DOI [10.3389/tnagi.2014.00247, 10.3389/fnagi.2014.00247]; Rana A, 2010, P NATL ACAD SCI USA, V107, P6988, DOI 10.1073/pnas.0912105107; Rothmann M, 2013, J AM CHEM SOC, V135, P5962, DOI 10.1021/ja400795m; Sauer SW, 2005, J BIOL CHEM, V280, P21830, DOI 10.1074/jbc.M502845200; Sbai O, 2010, GLIA, V58, P344, DOI 10.1002/glia.20927; Schubert D, 2009, EUR J NEUROSCI, V29, P1323, DOI 10.1111/j.1460-9568.2009.06712.x; Serra-Perez A, 2010, J BIOL CHEM, V285, P18217, DOI 10.1074/jbc.M110.101048; Shaftel SS, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-7; Shi QL, 2011, J BIOL CHEM, V286, P17640, DOI 10.1074/jbc.M110.203018; Soucek T, 2003, NEURON, V39, P43, DOI 10.1016/S0896-6273(03)00367-2; STANTON RC, 1991, J BIOL CHEM, V266, P12442; Stenovec M, 2016, GLIA, V64, P317, DOI 10.1002/glia.22931; Stine WB, 2003, J BIOL CHEM, V278, P11612, DOI 10.1074/jbc.M210207200; Tuppo EE, 2005, INT J BIOCHEM CELL B, V37, P289, DOI 10.1016/j.biocel.2004.07.009; Valles SL, 2010, BRAIN RES, V1312, P138, DOI 10.1016/j.brainres.2009.11.044; van Gijsel-Bonnello M, 2015, J CELL PHYSL; Wang G, 2008, GLIA, V56, P449, DOI 10.1002/glia.20626; Wilkins HM, 2016, CURR TOP MED CHEM, V16, P849, DOI 10.2174/1568026615666150827095102; Xu JS, 2016, BBA-MOL BASIS DIS, V1862, P1084, DOI 10.1016/j.bbadis.2016.03.001; Zhang W, 2012, NEUROBIOL AGING, V33, P2661, DOI 10.1016/j.neurobiolaging.2011.12.023; Zhang ZQ, 2000, ANAL BIOCHEM, V285, P163, DOI 10.1006/abio.2000.4701; Zhao J, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-150	68	27	29	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2017	12	4							e0175369	10.1371/journal.pone.0175369	http://dx.doi.org/10.1371/journal.pone.0175369			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0MD	28410378	Green Published, gold, Green Submitted			2022-12-27	WOS:000399955600016
J	Artzi, M; Even-Sapir, E; Shacham, HL; Thaler, A; Urterger, AO; Bressman, S; Marder, K; Hendler, T; Giladi, N; Ben Bashat, D; Mirelman, A				Artzi, Moran; Even-Sapir, Einat; Shacham, Hedva Lerman; Thaler, Avner; Urterger, Avi Orr; Bressman, Susan; Marder, Karen; Hendler, Talma; Giladi, Nir; Ben Bashat, Dafna; Mirelman, Anat			DaT-SPECT assessment depicts dopamine depletion among asymptomatic G2019S LRRK2 mutation carriers	PLOS ONE			English	Article							PARKINSONS-DISEASE; NONMOTOR SYMPTOMS; PENETRANCE; QUESTIONNAIRE; DYSFUNCTION; DIAGNOSIS; PET	Identification of early changes in Dopamine-Transporter (DaT) SPECT imaging expected in the prodromal phase of Parkinson's disease (PD), are usually overlooked. Carriers of the G2019S LRRK2 mutation are known to be at high risk for developing PD, compared to non-carriers. In this work we aimed to study early changes in Dopamine uptake in non-manifesting PD carriers (NMC) of the G2019S LRRK2 mutation using quantitative DaT-SPECT analysis and to examine the potential for early prediction of PD. Eighty Ashkenazi-Jewish subjects were included in this study: eighteen patients with PD; thirty-one NMC and thirty-one non-manifesting non-carriers (NMNC). All subjects underwent a through clinical assessment including evaluation of motor, olfactory, affective and non-motor symptoms and DaT-SPECT imaging. A population based DaT-SPECT template was created based on the NMNC cohort, and data driven volumes-of-interest (VOIs) were defined. Comparisons between groups were performed based on VOIs and voxel-wise analysis. The striatum area of all three cohorts was segmented into four VOIs, corresponding to the right/left dorsal and ventral striatum. Significant differences in clinical measures were found between patients with PD and non-manifesting subjects with no differences between NMC and NMNC. Significantly lower uptake (p<0.001) was detected in the right and left dorsal striatum in the PD group (2.2 +/- 0.3, 2.3 +/- 0.4) compared to the NMC (4.2 +/- 0.6, 4.3 +/- 0.5) and NMNC (4.5 +/- 0.6, 4.6 +/- 0.6), and significantly (p = 0.05) lower uptake in the right dorsal striatum in the NMC group compared to NMNC. Converging results were obtained using voxel-wise analysis. Two NMC participants, who later phenoconverted into PD, demonstrated reduced uptake mainly in the dorsal striatum. No significant correlations were found between the DaT-SPECT uptake in the different VOIs and clinical and behavioral assessments in the non-manifesting groups. This study shows the clinical value of quantitative assessment of DaT-SPECT imaging and the potential for predicting PD by detection of dopamine depletion, already at the pre-symptomatic stage.	[Artzi, Moran; Hendler, Talma; Ben Bashat, Dafna] Tel Aviv Sourasky Med Ctr, Wohl Inst Adv Imaging, Funct Brain Ctr, Tel Aviv, Israel; [Artzi, Moran; Even-Sapir, Einat; Thaler, Avner; Urterger, Avi Orr; Hendler, Talma; Giladi, Nir; Ben Bashat, Dafna; Mirelman, Anat] Tel Aviv Univ, Sackler Sch Med, Tel Aviv, Israel; [Even-Sapir, Einat; Shacham, Hedva Lerman] Tel Aviv Sourasky Med Ctr, Dept Nucl Med, Tel Aviv, Israel; [Thaler, Avner; Giladi, Nir; Mirelman, Anat] Tel Aviv Sourasky Med Ctr, Neurol Inst, Movement Disorders Unit, Tel Aviv, Israel; [Urterger, Avi Orr] Tel Aviv Sourasky Med Ctr, Genet Inst, Tel Aviv, Israel; [Bressman, Susan] Columbia Univ, Med Ctr, New York, NY USA; [Marder, Karen] Mt Sinai Beth Israel Med Ctr, New York, NY USA; [Hendler, Talma; Giladi, Nir; Ben Bashat, Dafna] Tel Aviv Univ, Sagol Sch Neurosci, Tel Aviv, Israel; [Hendler, Talma] Tel Aviv Univ, Dept Psychol, Tel Aviv, Israel; [Mirelman, Anat] Tel Aviv Sourasky Med Ctr, Neurol Inst, Lab Early Markers Neurodegenert, Tel Aviv, Israel	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Columbia University; Tel Aviv University; Tel Aviv University; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center	Ben Bashat, D (corresponding author), Tel Aviv Sourasky Med Ctr, Wohl Inst Adv Imaging, Funct Brain Ctr, Tel Aviv, Israel.; Ben Bashat, D (corresponding author), Tel Aviv Univ, Sackler Sch Med, Tel Aviv, Israel.; Ben Bashat, D (corresponding author), Tel Aviv Univ, Sagol Sch Neurosci, Tel Aviv, Israel.	dafnab@tlvmc.gov.il	Giladi, Nir/AAU-8660-2020; Artzi, Moran/AAF-5167-2020	Giladi, Nir/0000-0003-1482-8522; Ben Bashat, Dafna/0000-0001-8396-1031	Michael J. Fox Foundation for Parkinson Research; Netherlands Organization for Scientific Research (VIDI) [016.076.352]	Michael J. Fox Foundation for Parkinson Research; Netherlands Organization for Scientific Research (VIDI)(Netherlands Organization for Scientific Research (NWO))	This study was funded by the Michael J. Fox Foundation for Parkinson Research and the Netherlands Organization for Scientific Research (VIDI grant no. 016.076.352 to BRB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarsland D, 2009, NEUROLOGY, V72, P1121, DOI 10.1212/01.wnl.0000338632.00552.cb; Adams Jr, 2005, BRAIN, V128, P2777, DOI 10.1093/brain/awh607; Ben Sassi S, 2012, PARKINSONISM RELAT D, V18, P243, DOI 10.1016/j.parkreldis.2011.10.009; Berg D, 2015, MOVEMENT DISORD, V30, P1600, DOI 10.1002/mds.26431; Bergareche A, 2016, MOVEMENT DISORD, V31, P335, DOI 10.1002/mds.26478; Brooks DJ, 2010, J NUCL MED, V51, P596, DOI 10.2967/jnumed.108.059998; Chaudhuri KR, 2006, MOVEMENT DISORD, V21, P916, DOI 10.1002/mds.20844; Connolly BS, 2014, JAMA-J AM MED ASSOC, V311, P1670, DOI 10.1001/jama.2014.3654; de Lau LML, 2004, NEUROLOGY, V63, P1240, DOI 10.1212/01.WNL.0000140706.52798.BE; Eriksen JL, 2005, ARCH NEUROL-CHICAGO, V62, P353, DOI 10.1001/archneur.62.3.353; Fahn S., 1987, UNIFIED PARKINSONS D; FEARNLEY JM, 1991, BRAIN, V114, P2283, DOI 10.1093/brain/114.5.2283; Gayed I, 2015, CLIN NUCL MED, V40, P390, DOI 10.1097/RLU.0000000000000766; Goetz CG, 2003, MOVEMENT DISORD, V18, P738, DOI 10.1002/mds.10473; Goldwurm S, 2005, J MED GENET, V42, DOI 10.1136/jmg.2005.035568; Goldwurm S, 2011, MOVEMENT DISORD, V26, P2144, DOI 10.1002/mds.23807; Hagell P, 2007, J SLEEP RES, V16, P102, DOI 10.1111/j.1365-2869.2007.00570.x; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Infante J, 2006, NEUROSCI LETT, V395, P224, DOI 10.1016/j.neulet.2005.10.083; Kachergus J, 2005, AM J HUM GENET, V76, P672, DOI 10.1086/429256; Kas A, 2007, J NUCL MED, V48, P1459, DOI 10.2967/jnumed.106.038646; Lavisse S, 2014, MDS 18 INT C PARKINS; Lee HM, 2015, J MOV DISORD, V8, P92, DOI 10.14802/jmd.15003; Marder K, 2015, NEUROLOGY, V85, P89, DOI 10.1212/WNL.0000000000001708; Meissner WG, 2012, REV NEUROL-FRANCE, V168, P809, DOI 10.1016/j.neurol.2012.07.004; MORRISH PK, 1995, J NEUROL NEUROSUR PS, V59, P597, DOI 10.1136/jnnp.59.6.597; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Ninerola A, 2014, 13 MED C MED BIOL EN; Ninerola A, 2013, 13 MED C MED BIOL EN; Ozelius LJ, 2006, NEW ENGL J MED, V354, P424, DOI 10.1056/NEJMc055509; Pyatigorskaya N, 2013, THERAPEUTIC ADV NEUR; Reetz K, 2010, NEUROBIOL DIS, V39, P402, DOI 10.1016/j.nbd.2010.05.006; Schwingenschuh P, 2010, MOVEMENT DISORD, V25, P560, DOI 10.1002/mds.23019; Sierra M, 2013, NEUROLOGY, V80, P621, DOI 10.1212/WNL.0b013e31828250d6; Sierra M, 2011, MOVEMENT DISORD, V26, P2343, DOI 10.1002/mds.23965; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Spanaki C, 2006, NEUROLOGY, V67, P1518, DOI 10.1212/01.wnl.0000239829.33936.73; Stiasny-Kolster K, 2007, MOVEMENT DISORD, V22, P2386, DOI 10.1002/mds.21740; Stoessl A Jon, 2014, Parkinsonism Relat Disord, V20 Suppl 1, pS180, DOI 10.1016/S1353-8020(13)70042-7; Thaler A, 2014, MOVEMENT DISORDERS O, P29; Thaler A, 2009, J NEURAL TRANSM, V116, P1473, DOI 10.1007/s00702-009-0303-0; Trinh J, 2014, JAMA NEUROL, V71, P1535, DOI 10.1001/jamaneurol.2014.1909; Visser M, 2004, MOVEMENT DISORD, V19, P1306, DOI 10.1002/mds.20153; Zubal IG, 2007, J NUCL MED, V48, P857, DOI 10.2967/jnumed.106.037432	44	17	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2017	12	4							e0175424	10.1371/journal.pone.0175424	http://dx.doi.org/10.1371/journal.pone.0175424			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0MB	28406934	Green Published, gold, Green Submitted			2022-12-27	WOS:000399955400049
J	Franckowiak, RP; Panasci, M; Jarvis, KJ; Acuna-Rodriguez, IS; Landguth, EL; Fortin, MJ; Wagner, HH				Franckowiak, Ryan P.; Panasci, Michael; Jarvis, Karl J.; Acuna-Rodriguez, Ian S.; Landguth, Erin L.; Fortin, Marie-Josee; Wagner, Helene H.			Model selection with multiple regression on distance matrices leads to incorrect inferences	PLOS ONE			English	Article							LANDSCAPE GENETICS; MANTEL TEST; SPATIAL-ANALYSIS; ECOLOGY; FLOW; TESTS	In landscape genetics, model selection procedures based on Information Theoretic and Bayesian principles have been used with multiple regression on distance matrices (MRM) to test the relationship between multiple vectors of pairwise genetic, geographic, and environmental distance. Using Monte Carlo simulations, we examined the ability of model selection criteria based on Akaike's information criterion (AIC), its small-sample correction (AICc), and the Bayesian information criterion (BIC) to reliably rank candidate models when applied with MRM while varying the sample size. The results showed a serious problem: all three criteria exhibit a systematic bias toward selecting unnecessarily complex models containing spurious random variables and erroneously suggest a high level of support for the incorrectly ranked best model. These problems effectively increased with increasing sample size. The failure of AIC, AICc, and BIC was likely driven by the inflated sample size and different sum-of-squares partitioned by MRM, and the resulting effect on delta values. Based on these findings, we strongly discourage the continued application of AIC, AICc, and BIC for model selection with MRM.	[Franckowiak, Ryan P.] Trent Univ, Environm & Life Sci Grad Program, Peterborough, ON, Canada; [Panasci, Michael] Texas Tech Univ, Dept Nat Resources Management, Lubbock, TX 79409 USA; [Jarvis, Karl J.] Southern Utah Univ, Dept Biol, Cedar City, UT USA; [Acuna-Rodriguez, Ian S.] Univ Talca, Inst Ciencias Biol, Ctr Ecol Mol & Aplicac Evolut Agroecosistemas CEM, Talca, Chile; [Acuna-Rodriguez, Ian S.] Univ La Serena, Fac Ciencias, Dept Biol, La Serena, Chile; [Landguth, Erin L.] Univ Montana, Div Biol Sci, Missoula, MT 59812 USA; [Fortin, Marie-Josee; Wagner, Helene H.] Univ Toronto, Dept Ecol & Evolutionary Biol, Toronto, ON, Canada	Trent University; Texas Tech University System; Texas Tech University; Utah System of Higher Education; Southern Utah University; Universidad de Talca; Universidad de La Serena; University of Montana System; University of Montana; University of Toronto	Franckowiak, RP (corresponding author), Trent Univ, Environm & Life Sci Grad Program, Peterborough, ON, Canada.	ryanfranckowiak@trentu.ca	Landguth, Erin/ABB-8941-2020; Franckowiak, Ryan/AAR-6001-2021; Wagner, Helene/E-6090-2011; Jarvis, Karl J./M-6537-2015	Franckowiak, Ryan/0000-0002-0454-4860; Wagner, Helene/0000-0001-6261-5922; Jarvis, Karl J./0000-0002-9658-6872	National Science and Engineering Research Council of Canada (NSERC)	National Science and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	Funding for this research comes from Discovery Grants by the National Science and Engineering Research Council of Canada (NSERC) to H. Wagner and to M-J. Fortin.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Balkenhol N, 2009, LANDSCAPE ECOL, V24, P455, DOI 10.1007/s10980-009-9334-z; Barton K., 2013, MUMIN MULTI MODEL IN; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Bradburd GS, 2013, EVOLUTION, V67, P3258, DOI 10.1111/evo.12193; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Clarke RT, 2002, J AGRIC BIOL ENVIR S, V7, P361, DOI 10.1198/108571102320; Cushman SA, 2006, AM NAT, V168, P486, DOI 10.1086/506976; Cushman Samuel A., 2013, Diversity-Basel, V5, P51; DOW MM, 1987, AM J PHYS ANTHROPOL, V72, P343, DOI 10.1002/ajpa.1330720307; Dudaniec RY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036769; Dutilleul P, 2000, J AGRIC BIOL ENVIR S, V5, P131, DOI 10.2307/1400528; Dziak J.J., 2012, SENSITIVITY SPECIFIC, P1, DOI DOI 10.7287/PEERJ.PREPRINTS.1103V3; Emaresi G, 2011, CONSERV GENET, V12, P41, DOI 10.1007/s10592-009-9985-y; Engler JO, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106526; Fitzpatrick SW, 2014, CONSERV GENET, V15, P771, DOI 10.1007/s10592-014-0577-0; Galecki A, 2013, SPRINGER TEXTS STAT, P1, DOI 10.1007/978-1-4614-3900-4; Guillot G, 2014, METHODS ECOL EVOL, V5, P329, DOI 10.1111/2041-210X.12167; Guillot G, 2013, METHODS ECOL EVOL, V4, P336, DOI 10.1111/2041-210x.12018; Holderegger R, 2008, BIOSCIENCE, V58, P199, DOI 10.1641/B580306; Holderegger R, 2006, LANDSCAPE ECOL, V21, P793, DOI 10.1007/s10980-005-6058-6; HURVICH CM, 1989, BIOMETRIKA, V76, P297, DOI 10.2307/2336663; Igawa T, 2013, HEREDITY, V110, P46, DOI 10.1038/hdy.2012.59; Jaquiery J, 2011, MOL ECOL, V20, P692, DOI 10.1111/j.1365-294X.2010.04966.x; Jenkins DA, 2016, BIOL LETTERS, V12, DOI 10.1098/rsbl.2016.0235; KRACKHARDT D, 1988, SOC NETWORKS, V10, P359, DOI 10.1016/0378-8733(88)90004-4; LEDUC A, 1992, J VEG SCI, V3, P69, DOI 10.2307/3236000; Legendre P, 1999, ECOL MONOGR, V69, P1, DOI 10.1890/0012-9615(1999)069[0001:DBRATM]2.0.CO;2; LEGENDRE P, 1988, LIMNOL OCEANOGR, V33, P1055, DOI 10.4319/lo.1988.33.5.1055; LEGENDRE P, 1989, VEGETATIO, V80, P107, DOI 10.1007/BF00048036; Legendre P, 2015, METHODS ECOL EVOL, V6, P1239, DOI 10.1111/2041-210X.12425; Legendre P, 2010, MOL ECOL RESOUR, V10, P831, DOI 10.1111/j.1755-0998.2010.02866.x; Lichstein JW, 2007, PLANT ECOL, V188, P117, DOI 10.1007/s11258-006-9126-3; Manel S, 2005, TRENDS ECOL EVOL, V20, P136, DOI 10.1016/j.tree.2004.12.004; MANLY BFJ, 1986, RES POPUL ECOL, V28, P201, DOI 10.1007/BF02515450; MANTEL N, 1967, CANCER RES, V27, P209; Medley KA, 2014, MOL ECOL, V24, P1; Meirmans PG, 2012, MOL ECOL, V21, P2839, DOI 10.1111/j.1365-294X.2012.05578.x; Murphy MA, 2010, MOL ECOL, V19, P3634, DOI 10.1111/j.1365-294X.2010.04723.x; NANTEL P, 1992, ECOLOGY, V73, P99; Paz A, 2015, MOL ECOL, V24, P3723, DOI 10.1111/mec.13275; Peres-Neto PR, 2006, ECOLOGY, V87, P2614, DOI 10.1890/0012-9658(2006)87[2614:VPOSDM]2.0.CO;2; R Core Team, 2021, R LANGUAGE ENV STAT; Roach JL, 2001, J MAMMAL, V82, P946, DOI 10.1644/1545-1542(2001)082<0946:GSOAMO>2.0.CO;2; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Shirk AJ, 2010, MOL ECOL, V19, P3603, DOI 10.1111/j.1365-294X.2010.04745.x; SMOUSE PE, 1986, SYST ZOOL, V35, P627, DOI 10.2307/2413122; Sokal R.R., 2012, BIOMETRY PRINCIPLES; Spear SF, 2005, MOL ECOL, V14, P2553, DOI 10.1111/j.1365-294X.2005.02573.x; Spear SF, 2010, MOL ECOL, V19, P3576, DOI 10.1111/j.1365-294X.2010.04657.x; Storfer A, 2007, HEREDITY, V98, P128, DOI 10.1038/sj.hdy.6800917; Storfer A, 2010, MOL ECOL, V19, P3496, DOI 10.1111/j.1365-294X.2010.04691.x; Van Strien MJ, 2012, MOL ECOL, V21, P4010, DOI 10.1111/j.1365-294X.2012.05687.x; Venables W.N., 2002, MODERN APPL STAT S, Vfourth, DOI [DOI 10.1007/978-0-387-21706-2, 10.1007/978-0-387-21706-2]; Wagner HH, 2013, CONSERV GENET, V14, P253, DOI 10.1007/s10592-012-0391-5; Wang IJ, 2009, MOL ECOL, V18, P3847, DOI 10.1111/j.1365-294X.2009.04338.x; Yang J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020144; Zuur Alain F., 2009, P1	59	19	19	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2017	12	4							e0175194	10.1371/journal.pone.0175194	http://dx.doi.org/10.1371/journal.pone.0175194			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0MB	28406923	Green Submitted, Green Published, gold			2022-12-27	WOS:000399955400033
J	Flynn, KE; Lin, L; Weinfurt, KP				Flynn, Kathryn E.; Lin, Li; Weinfurt, Kevin P.			Sexual function and satisfaction among heterosexual and sexual minority US adults: A cross-sectional survey	PLOS ONE			English	Article							HEALTH; GAY; PROMIS	Background Despite known health disparities for sexual minorities, few studies have described sexual function by sexual orientation using a robust approach to measurement of sexual function. We compared recent sexual function and satisfaction by sexual orientation among English-speaking US adults. Methods and findings Cross-sectional surveys were administered by KnowledgePanel((R)) (GfK), an online panel that uses address-based probability sampling and is representative of the civilian, noninstitutionalized US population. Data were collected in 2013 from the general population (n = 3314, 35% response rate) and in 2014 from self-identified lesbian, gay, and bisexual adults (n = 1011, 50% response rate). Sexual function and satisfaction were measured using the Patient-Reported Outcomes Measurement Information System((R)) Sexual Function and Satisfaction measure version 2.0 (PROMIS SexFS v2). The PROMIS SexFS v2 is a comprehensive, customizable measurement system with evidence for validity in diverse populations. A score of 50 (SD 10) on each domain corresponds to the average for US adults sexually active in the past 30 days. We adjusted all statistics for the complex sample designs and report differences within each sex where the 95% CIs do not overlap, corresponding to p < 0.01. Among US men who reported any sexual activity in the past 30 days, there were no differences in erectile function or orgasm-ability. Compared to heterosexual men, sexual minority men reported higher oral dryness and lower orgasm-pleasure and satisfaction. Compared to heterosexual men, gay men reported lower interest, higher anal discomfort and higher oral discomfort. Among sexually active women, there were no differences in the domains of vulvar discomfort-clitoral, orgasm-pleasure, or satisfaction. Compared to heterosexual women, sexual minority women reported higher oral dryness. Lesbian women reported lower vaginal discomfort than other women; lesbian women reported higher lubrication and orgasm-ability than heterosexual women. Bisexual women reported higherinterest, higher vulvar discomfort-labial and higher anal discomfort than other women, as well as higher oral discomfort compared to heterosexual women. Conclusions Recent sexual function and satisfaction differed by sexual orientation among US adults. Sexual minority men and women had decrements in domains of sexual function that have not traditionally been included in multi-dimensional self-report measures. Clinicians should make themselves aware of their patients' sexual concerns and recognize that sexual minority patients may be more vulnerable to certain sexual difficulties than heterosexual patients.	[Flynn, Kathryn E.] Med Coll Wisconsin, Ctr Patient Care & Outcomes Res, Milwaukee, WI 53226 USA; [Lin, Li; Weinfurt, Kevin P.] Duke Univ, Sch Med, Duke Clin Res Inst, Durham, NC USA; [Weinfurt, Kevin P.] Duke Univ, Sch Med, Dept Psychiat & Behav Sci, Durham, NC USA	Medical College of Wisconsin; Duke University; Duke University	Flynn, KE (corresponding author), Med Coll Wisconsin, Ctr Patient Care & Outcomes Res, Milwaukee, WI 53226 USA.	kflynn@mcw.edu	Flynn, Kathryn E/M-5346-2013	Flynn, Kathryn E/0000-0002-4427-3583	National Institute of Arthritis and Musculoskeletal and Skin Diseases [U01AR052186]; Research and Education Program Fund, a component of the Advancing a Healthier Wisconsin endowment at the Medical College of Wisconsin; National Institutes of Health; Advancing a Healthier Wisconsin	National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Research and Education Program Fund, a component of the Advancing a Healthier Wisconsin endowment at the Medical College of Wisconsin; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Advancing a Healthier Wisconsin	This study was supported by grant U01AR052186 from the National Institute of Arthritis and Musculoskeletal and Skin Diseases and the Research and Education Program Fund, a component of the Advancing a Healthier Wisconsin endowment at the Medical College of Wisconsin.; The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Arthritis and Musculoskeletal and Skin Diseases, the National Institutes of Health, or the Advancing a Healthier Wisconsin endowment.	Alexander AM, 2014, J SEX MED, V11, P1991, DOI 10.1111/jsm.12599; Bancroft J, 2005, ARCH SEX BEHAV, V34, P285, DOI 10.1007/s10508-005-3117-7; Conron KJ, 2010, AM J PUBLIC HEALTH, V100, P1953, DOI 10.2105/AJPH.2009.174169; Cumming G., 2011, UNDERSTANDING NEW ST UNDERSTANDING NEW ST; DeWalt DA, 2007, MED CARE, V45, pS12, DOI 10.1097/01.mlr.0000254567.79743.e2; Flynn K.E., 2016, J SEX MED; Flynn KE, 2011, PSYCHO-ONCOLOGY, V20, P378, DOI 10.1002/pon.1738; Fortune-Greeley AK, 2009, QUAL LIFE RES, V18, P1085, DOI 10.1007/s11136-009-9523-x; Henderson AW, 2009, ARCH SEX BEHAV, V38, P50, DOI 10.1007/s10508-008-9384-3; King M, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-127; Knowledge Networks, 2014, KNOWLEDGEPANEL DES S; Kuyper L, 2011, J SEX RES, V48, P263, DOI 10.1080/00224491003654473; Reese JB, 2016, J CANC SURVIV; Reeve BB, 2007, MED CARE, V45, pS22, DOI 10.1097/01.mlr.0000250483.85507.04; Weinfurt KP, 2016, JAMA CARDIOL, V1, P765, DOI 10.1001/jamacardio.2016.2436; Weinfurt KP, 2015, J SEX MED, V12, P1961, DOI 10.1111/jsm.12966; Weinfurt KP, 2013, J SEXUAL MED	17	27	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2017	12	4							e0174981	10.1371/journal.pone.0174981	http://dx.doi.org/10.1371/journal.pone.0174981			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET0LZ	28403193	Green Published, gold, Green Submitted			2022-12-27	WOS:000399955200027
J	Ibusuki, R; Uto, H; Oda, K; Ohshige, A; Tabu, K; Mawatari, S; Kumagai, K; Kanmura, S; Tamai, T; Moriuchi, A; Tsubouchi, H; Ido, A				Ibusuki, Rie; Uto, Hirofumi; Oda, Kohei; Ohshige, Akihiko; Tabu, Kazuaki; Mawatari, Seiichi; Kumagai, Kotaro; Kanmura, Shuji; Tamai, Tsutomu; Moriuchi, Akihiro; Tsubouchi, Hirohito; Ido, Akio			Human neutrophil peptide-1 promotes alcohol-induced hepatic fibrosis and hepatocyte apoptosis	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; INDUCED LIVER-INJURY; RAT-LIVER; DISEASE; MICE; DEFENSINS; CELLS; EXPRESSION; ALPHA-DEFENSIN-1; STEATOHEPATITIS	Background and aims Neutrophil infiltration of the liver is a typical feature of alcoholic liver injury. Human neutrophil peptide (HNP)-1 is an antimicrobial peptide secreted by neutrophils. The aim of this study was to determine if HNP-1 affects ethanol-induced liver injury and to examine the mechanism of liver injury induced by HNP-1. Methods Transgenic (TG) mice expressing HNP-1 under the control of a beta-actin-based promoter were established. Ethanol was orally administered to HNP-1 TG or wild-type C57BL/6N (WT) mice. SK-Hep1 hepatocellular carcinoma cells were used to investigate the effect of HNP-1 on hepatocytes in vitro. Results After 24 weeks of ethanol intake, hepatic fibrosis and hepatocyte apoptosis were significantly more severe in TG mice than in WT mice. Levels of CD14, TLR4, and IL-6 in liver tissues were higher in TG mice than in WT mice. Apoptosis was accompanied by higher protein levels of caspase-3, caspase-8, and cleaved PARP in liver tissue. In addition, phosphorylated ASK1, ASK1, phosphorylated JNK, JNK1, JNK2, Bax, Bak and Bim were all more abundant in TG mice than in WT mice. In contrast, the level of anti-apoptotic Bcl2 in the liver was significantly lower in TG mice than in WT mice. Analysis of microRNAs in liver tissue showed that miR-34a-5p expression was significantly higher in TG mice than in WT mice. Furthermore, in the presence of ethanol, HNP-1 increased the apoptosis with the decreased level of Bcl2 in a concentration-dependent manner in vitro. Conclusions HNP-1 secreted by neutrophils may exacerbate alcohol-induced hepatic fibrosis and hepatocyte apoptosis with a decrease in Bcl2 expression and an increase in miR-34a-5p expression.	[Ibusuki, Rie; Uto, Hirofumi; Ohshige, Akihiko; Tabu, Kazuaki; Mawatari, Seiichi; Kumagai, Kotaro; Kanmura, Shuji; Tamai, Tsutomu; Moriuchi, Akihiro; Ido, Akio] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Human & Environm Sci, Digest & Lifestyle Dis, Kagoshima, Japan; [Ibusuki, Rie] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Int Isl & Community Med, Kagoshima, Japan; [Uto, Hirofumi] Miyazaki Med Ctr Hosp, Ctr Digest & Liver Dis, Miyazaki, Japan; [Oda, Kohei; Tsubouchi, Hirohito; Ido, Akio] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept HGF Tissue Repair & Regenerat Med, Kagoshima, Japan; [Tsubouchi, Hirohito] Kagoshima City Hosp, Kagoshima, Japan	Kagoshima University; Kagoshima University; Kagoshima University; Kagoshima City Hospital	Uto, H (corresponding author), Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Human & Environm Sci, Digest & Lifestyle Dis, Kagoshima, Japan.; Uto, H (corresponding author), Miyazaki Med Ctr Hosp, Ctr Digest & Liver Dis, Miyazaki, Japan.	hirouto@m2.kufm.kagoshima-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [23249043]; Ministry of Health, Labour and Welfare of Japan [H20-Hepatitis-general-008]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported in part by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan (No. 23249043), and the Ministry of Health, Labour and Welfare of Japan (H20-Hepatitis-general-008).	Angulo P, 1999, HEPATOLOGY, V30, P1356, DOI 10.1002/hep.510300604; Bautista AP, 2002, ALCOHOL, V27, P17, DOI 10.1016/S0741-8329(02)00206-9; BENEDETTI A, 1988, J HEPATOL, V6, P137, DOI 10.1016/S0168-8278(88)80024-2; BORTNER CD, 1995, TRENDS CELL BIOL, V5, P21, DOI 10.1016/S0962-8924(00)88932-1; Brandon-Warner E, 2012, ALCOHOL, V46, P715, DOI 10.1016/j.alcohol.2012.08.004; BUSAM KJ, 1990, J HEPATOL, V11, P367, DOI 10.1016/0168-8278(90)90223-E; CH P., 1952, ALCOHOL CULTURE AND; Chang TC, 2007, MOL CELL, V26, P745, DOI 10.1016/j.molcel.2007.05.010; Dabirian S, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002491; Dippold RP, 2013, ALCOHOL CLIN EXP RES, V37, pE59, DOI 10.1111/j.1530-0277.2012.01852.x; Fujimoto M, 2000, ALCOHOL CLIN EXP RES, V24, p48S, DOI 10.1111/j.1530-0277.2000.tb00012.x; Gao B, 2011, GASTROENTEROLOGY, V141, P1572, DOI 10.1053/j.gastro.2011.09.002; Gao B, 2011, AM J PHYSIOL-GASTR L, V300, pG516, DOI 10.1152/ajpgi.00537.2010; Gaspar D, 2015, BBA-MOL CELL RES, V1853, P308, DOI 10.1016/j.bbamcr.2014.11.006; Gotoh T, 2004, CELL DEATH DIFFER, V11, P390, DOI 10.1038/sj.cdd.4401369; Grigat J, 2007, J IMMUNOL, V179, P3958, DOI 10.4049/jimmunol.179.6.3958; Hashimoto S, 2012, INFLAMM BOWEL DIS, V18, P667, DOI 10.1002/ibd.21855; Horie Y, 2011, CLIN RES HEPATOL GAS, V35, P738, DOI 10.1016/j.clinre.2011.07.005; Hui CK, 2003, J HEPATOL, V38, P511, DOI 10.1016/S0168-8278(03)00004-7; Ibusuki R, 2013, LIVER INT, V33, P1549, DOI 10.1111/liv.12203; Iloeje UH, 2006, GASTROENTEROLOGY, V130, P678, DOI 10.1053/j.gastro.2005.11.016; JAESCHKE H, 1991, AM J PHYSIOL, V260, pG355, DOI 10.1152/ajpgi.1991.260.3.G355; Jaeschke H, 2002, ALCOHOL, V27, P23, DOI 10.1016/S0741-8329(02)00200-8; Jaeschke H, 1997, J LEUKOCYTE BIOL, V61, P647, DOI 10.1002/jlb.61.6.647; Kanmura S, 2009, INFLAMM BOWEL DIS, V15, P909, DOI 10.1002/ibd.20854; Khandoga A, 2005, BLOOD, V106, P725, DOI 10.1182/blood-2004-11-4416; LEHRER RI, 1993, ANNU REV IMMUNOL, V11, P105, DOI 10.1146/annurev.iy.11.040193.000541; Li D, 2014, ONCOL REP, V31, P1287, DOI 10.3892/or.2013.2947; Liu CY, 2007, LIFE SCI, V80, P749, DOI 10.1016/j.lfs.2006.11.016; LUDWIG J, 1980, MAYO CLIN PROC, V55, P434; McDaniel K, 2014, J CELL MOL MED, V18, P197, DOI 10.1111/jcmm.12223; Meng FY, 2012, AM J PATHOL, V181, P804, DOI 10.1016/j.ajpath.2012.06.010; Morio Y, 2013, TOXICOL IN VITRO, V27, P1820, DOI 10.1016/j.tiv.2013.05.009; Natori S, 2001, J HEPATOL, V34, P248, DOI 10.1016/S0168-8278(00)00089-1; O'Shea RS, 2010, HEPATOLOGY, V51, P307, DOI 10.1002/hep.23258; Panopoulos AD, 2008, CYTOKINE, V42, P277, DOI 10.1016/j.cyto.2008.03.002; Ramaiah SK, 2004, INT J TOXICOL, V23, P217, DOI 10.1080/10915810490502069; Rehm J, 2013, ALCOHOL RES-CURR REV, V35, P174; Rehm J, 2009, LANCET, V373, P2223, DOI 10.1016/S0140-6736(09)60746-7; Ren DC, 2010, SCIENCE, V330, P1390, DOI 10.1126/science.1190217; SELSTED ME, 1985, J CLIN INVEST, V76, P1436, DOI 10.1172/JCI112121; Szabo G, 2015, GASTROENTEROLOGY, V148, P30, DOI 10.1053/j.gastro.2014.10.042; Szyk A, 2006, PROTEIN SCI, V15, P2749, DOI 10.1110/ps.062336606; Takehara T, 2004, GASTROENTEROLOGY, V127, P1189, DOI 10.1053/j.gastro.2004.07.019; Uesugi T, 2002, J IMMUNOL, V168, P2963, DOI 10.4049/jimmunol.168.6.2963; van den Broek I, 2010, J CHROMATOGR B, V878, P1085, DOI 10.1016/j.jchromb.2010.03.014; Wang XY, 2009, BRAIN RES BULL, V80, P268, DOI 10.1016/j.brainresbull.2009.08.006; Wang YS, 2009, CLIN CANCER RES, V15, P6901, DOI 10.1158/1078-0432.CCR-09-0484; Welling MM, 1998, J CLIN INVEST, V102, P1583, DOI 10.1172/JCI3664; Xu N, 2008, MOL CANCER THER, V7, P1588, DOI 10.1158/1535-7163.MCT-08-0010; Xu RN, 2014, CELL MOL IMMUNOL, V11, P224, DOI 10.1038/cmi.2014.2; Yin M, 2001, J IMMUNOL, V166, P4737, DOI 10.4049/jimmunol.166.7.4737	52	13	14	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2017	12	4							e0174913	10.1371/journal.pone.0174913	http://dx.doi.org/10.1371/journal.pone.0174913			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LZ	28403148	gold, Green Published, Green Submitted			2022-12-27	WOS:000399955200025
J	Subramanian, ER; Daisy, NG; Sudalaimani, DK; Ramamoorthy, K; Balakrishnan, S; Christyraj, JDS; Arumugaswami, V; Sivasubramaniaml, S				Subramanian, Elaiya Raja; Daisy, Nino Gopi; Sudalaimani, Dinesh Kumar; Ramamoorthy, Kalidas; Balakrishnan, Subburathinam; Christyraj, Jackson Durairaj Selvan; Arumugaswami, Vaithilingaraja; Sivasubramaniaml, Sudhakar			Function of translationally controlled tumor protein (TCTP) in Eudrilus eugeniae regeneration	PLOS ONE			English	Article							STEM-CELLS; LIVER-REGENERATION; BINDING-PROTEIN; HUMAN PROSTATE; BETA-CATENIN; EXPRESSION; ACTIVATION; GROWTH; PROLIFERATION; CANCER	TCTP (Translationally Controlled Tumour Protein) is a multifunctional protein that plays a role in the development, immune system, tumour reversion, and maintenance of stem cells. The mRNA of the Tpt1 gene is over-expressed during liver regeneration. But, the function of the protein in regeneration is not known. To study the role of the protein in regeneration, the earthworm Eudrilus eugeniae was chosen. First, the full length cDNA of the Tpt1 gene was sequenced. The size of the cDNA is 504 bp and the protein has 167 amino acids. The highest level of TCTP expression was documented in the worm after three days of regeneration. The protein was found to be expressed specifically in the epithelial layer of the skin. During regeneration, the protein expression was found to be the highest at the tip of blastema. The pharmacological suppression of TCTP using nutlin-3 and TCTP RNAi experiments resulted in the failure of the regeneration process. The suppression of TCTP caused the arrest of proliferation in posterior amputated worms. The severe cell death was documented in the amputated region of nutlin-3 injected worm. The silencing of TCTP has blocked the modification of clitellar segments. The experiments confirm that TCTP has major functions in the upstream signalling of cell proliferation in the early regeneration process in E. eugeniae.	[Subramanian, Elaiya Raja; Daisy, Nino Gopi; Sudalaimani, Dinesh Kumar; Ramamoorthy, Kalidas; Balakrishnan, Subburathinam; Christyraj, Jackson Durairaj Selvan; Sivasubramaniaml, Sudhakar] Manonmaniam Sundaranar Univ, Dept Biotechnol, Tirunelveli, Tamil Nadu, India; [Arumugaswami, Vaithilingaraja] Univ Calif Los Angeles, CSMC Viral Vector Core, Viral Hepatitis & Gene, Cell Therapy Lab, Los Angeles, CA USA	Manonmaniam Sundaranar University; University of California System; University of California Los Angeles	Sivasubramaniaml, S (corresponding author), Manonmaniam Sundaranar Univ, Dept Biotechnol, Tirunelveli, Tamil Nadu, India.	sudhakarmsu@yahoo.com	Sivasubramaniam, Sudhakar/M-6388-2019; Selvan Christyraj, Jackson Durairaj/ABH-2420-2021; Selvan Christyraj, Jackson Durairaj/E-4669-2017	Sivasubramaniam, Sudhakar/0000-0002-1648-5474; Selvan Christyraj, Jackson Durairaj/0000-0003-0363-0529	Department of Biotechnology (DBT), New Delhi, India; Silencing of gene expression to study regeneration [Ref BT/PR12899/AGR/36/634/ 2009]	Department of Biotechnology (DBT), New Delhi, India(Department of Biotechnology (DBT) India); Silencing of gene expression to study regeneration	This work was financially supported by the Department of Biotechnology (DBT), New Delhi, India, under the project name and grant number of "Silencing of gene expression to study regeneration" (Ref BT/PR12899/AGR/36/634/ 2009).; This work was financially supported by the Department of Biotechnology (DBT), New Delhi, India. We sincerely thank Jason Nefalar, Viral Hepatitis and Gene/cell Therapy Laboratory, University of California at Los Angeles, USA for editing the manuscript.	Amson R, 2012, NAT MED, V18, P91, DOI 10.1038/nm.2546; Amzallag N, 2004, J BIOL CHEM, V279, P46104, DOI 10.1074/jbc.M404850200; Arcuri F, 2005, BIOL REPROD, V73, P745, DOI 10.1095/biolreprod.105.042077; Arcuri F, 2004, PROSTATE, V60, P130, DOI 10.1002/pros.20054; BAGUNA J, 1989, DEVELOPMENT, V107, P77; Bazile F, 2009, CARCINOGENESIS; Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1; Bely AE, 2010, TRENDS ECOL EVOL, V25, P161, DOI 10.1016/j.tree.2009.08.005; Bommer UA, 2004, INT J BIOCHEM CELL B, V36, P379, DOI 10.1016/S1357-2725(03)00213-9; Brioudes F, 2010, P NATL ACAD SCI USA, V107, P16384, DOI 10.1073/pnas.1007926107; Cao BH, 2010, PLANT CELL TISS ORG, V103, P217, DOI 10.1007/s11240-010-9769-6; Carlson BM., 2011, PRINCIPLES REGENERAT; Chen K, 2013, BIOL CELL, V105, P208, DOI 10.1111/boc.201200080; Chen SH, 2007, MOL BIOL CELL, V18, P2525, DOI 10.1091/mbc.E07-02-0188; Chen YJ, 2011, J BIOL CHEM, V286, P32575, DOI 10.1074/jbc.M110.217836; Chen ZK, 2007, COMP BIOCHEM PHYS B, V147, P460, DOI 10.1016/j.cbpb.2007.02.012; Cordero JB, 2014, EMBO J; Daisy NG, 2016, INVERTEBR NEUROSCI, V16, DOI 10.1007/s10158-016-0189-0; Edwards CA, 1996, BIOL ECOLOGY EARTHWO, DOI DOI 10.1016/S0167-8809(97)88859-7; EWART HS, 1995, AM J PHYSIOL-CELL PH, V269, pC295, DOI 10.1152/ajpcell.1995.269.2.C295; Gachet Y, 1999, J CELL SCI, V112, P1257; Gnanasekar M, 2009, INT J ONCOL, V34, P1241, DOI 10.3892/ijo_00000252; Goessling W, 2009, CELL, V136, P1136, DOI 10.1016/j.cell.2009.01.015; GROSS B, 1989, NUCLEIC ACIDS RES, V17, P8367, DOI 10.1093/nar/17.20.8367; Gu X, 2013, NEURO-ONCOLOGY; Guo Y, 2011, NEUROSCIENCE, V172, P329, DOI 10.1016/j.neuroscience.2010.10.026; Gurley KA, 2008, SCIENCE, V319, P323, DOI 10.1126/science.1150029; Haga S, 2009, HEPATOLOGY, V49, P204, DOI 10.1002/hep.22583; Hong ST, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3986; Hsu YC, 2007, NATURE, V445, P785, DOI 10.1038/nature05528; Jung J, 2004, J BIOL CHEM, V279, P49868, DOI 10.1074/jbc.M400895200; Jung J, 2011, ONCOGENE, V30, P2264, DOI 10.1038/onc.2010.604; Kalidas RM, 2015, CELL MOL BIOL LETT, V20, P294, DOI 10.1515/cmble-2015-0018; Kalidas RM, 2015, CELL BIOL INT; Kawakami Y, 2006, GENE DEV, V20, P3232, DOI 10.1101/gad.1475106; Kim M, 2000, ARCH PHARM RES, V23, P633, DOI 10.1007/BF02975253; Kim M, 2009, ARCH BIOCHEM BIOPHYS, V485, P82, DOI 10.1016/j.abb.2009.02.002; Langdon JM, 2008, J LEUKOCYTE BIOL, V84, P1151, DOI 10.1189/jlb.0308172; Li F, 2001, J BIOL CHEM, V276, P47542, DOI 10.1074/jbc.M108954200; Liu H, 2005, MOL CELL BIOL, V25, P3117, DOI 10.1128/MCB.25.8.3117-3126.2005; Ma YP, 2012, BIOCHEM RES INT, V2012, DOI 10.1155/2012/871728; Maimets T, 2008, ONCOGENE, V27, P5277, DOI 10.1038/onc.2008.166; Maki N, 2009, DEV DYNAM, V238, P1613, DOI 10.1002/dvdy.21959; Mashanov VS, 2012, GENE EXPR PATTERNS, V12, P24, DOI 10.1016/j.gep.2011.10.003; Munch J, 2013, DEVELOPMENT, V140, P1402, DOI 10.1242/dev.087346; Rho SB, 2011, FEBS LETT, V585, P29, DOI 10.1016/j.febslet.2010.11.014; Rimini R, 1999, MECH DEVELOP, V89, P167, DOI 10.1016/S0925-4773(99)00199-9; Sadot E, 2001, MOL CELL BIOL, V21, P6768, DOI 10.1128/MCB.21.20.6768-6781.2001; Samuel SCJR, 2012, STEM CELLS DEV, V21, P2071, DOI 10.1089/scd.2011.0485; Sheverdin V, 2012, MICROSC RES TECHNIQ, V75, P1576, DOI 10.1002/jemt.22103; SUBRAMANIAN ER, DURAIRAJ J STUDIES O, V2; Tovar C, 2006, P NATL ACAD SCI USA, V103, P1888, DOI 10.1073/pnas.0507493103; Tuynder M, 2002, P NATL ACAD SCI USA, V99, P14976, DOI 10.1073/pnas.222470799; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Vonakis BM, 2008, BLOOD, V111, P1789, DOI 10.1182/blood-2007-07-104364; Weissman IL, 2000, CELL, V100, P157, DOI 10.1016/S0092-8674(00)81692-X; Wu D, 2012, EXP THER MED, V3, P437, DOI 10.3892/etm.2011.439; Yagci M, 2013, LEUKEMIA RES, V37, P665, DOI 10.1016/j.leukres.2013.01.005; Zhu WL, 2008, ANTICANCER RES, V28, P1575	59	6	6	7	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2017	12	4							e0175319	10.1371/journal.pone.0175319	http://dx.doi.org/10.1371/journal.pone.0175319			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LZ	28403226	Green Published, gold, Green Submitted			2022-12-27	WOS:000399955200051
J	Wires, ES; Henderson, MJ; Yan, XK; Back, S; Trychta, KA; Lutrey, MH; Harvey, BK				Wires, Emily S.; Henderson, Mark J.; Yan, Xiaokang; Back, Susanne; Trychta, Kathleen A.; Lutrey, Molly H.; Harvey, Brandon K.			Longitudinal monitoring of Gaussia and Nano luciferase activities to concurrently assess ER calcium homeostasis and ER stress in vivo	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; ENDOPLASMIC-RETICULUM; GENE-EXPRESSION; ATF6; ACTIVATION; REPORTER; PATHWAY; CULTURE; BINDING; MODEL	The endoplasmic reticulum (ER) is essential to many cellular processes including protein processing, lipid metabolism and calcium storage. The ability to longitudinally monitor ER homeostasis in the same organism would offer insight into progressive molecular and cellular adaptations to physiologic or pathologic states, but has been challenging. We recently described the creation of a Gaussia luciferase (GLuc)-based secreted ER calcium-modulated protein (SERCaMP or GLuc-SERCaMP) to longitudinally monitor ER calcium homeostasis. Here we describe a complementary tool to measure the unfolded protein response (UPR), utilizing a UPRE-driven secreted Nano luciferase (UPRE-secNLuc) to examine the activating transcription factor-6 (ATF6) and inositol-requiring enzyme 1 (IRE1) pathways of the UPR. We observed an upregulation of endogenous ATF6- and XBP1-regulated genes following pharmacologically-induced ER stress that was consistent with responsiveness of the UPRE sensor. Both GLuc and NLuc-based reporters have favorable properties for in vivo studies, however, they are not easily used in combination due to overlapping substrate activities. We describe a method to measure the enzymatic activities of both reporters from a single sample and validated the approach using culture medium and rat blood samples to measure GLuc-SERCaMP and UPRE-secNLuc. Measuring GLuc and NLuc activities from the same sample allows for the robust and quantitative measurement of two cellular events or cell populations from a single biological sample. This study is the first to describe the in vivo measurement of UPRE activation by sampling blood, using an approach that allows concurrent interrogation of two components of ER homeostasis.	[Wires, Emily S.; Henderson, Mark J.; Yan, Xiaokang; Back, Susanne; Trychta, Kathleen A.; Lutrey, Molly H.; Harvey, Brandon K.] NIDA, Intramural Res Program, Baltimore, MD 21224 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA)	Harvey, BK (corresponding author), NIDA, Intramural Res Program, Baltimore, MD 21224 USA.	BHarvey@intra.nida.nih.gov	Harvey, Brandon Keith/AAY-4080-2021; Harvey, Brandon K/A-5559-2010	Harvey, Brandon Keith/0000-0002-4036-1383; Henderson, Mark/0000-0001-8590-7338; Back, Susanne/0000-0002-8446-3744	NIDA Intramural Research Program; Intramural Research Program at NIDA; NATIONAL INSTITUTE ON DRUG ABUSE [ZICDA000555, ZIADA000618, ZIADA000526, ZIADA000443] Funding Source: NIH RePORTER	NIDA Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Intramural Research Program at NIDA; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the NIDA Intramural Research Program.; This work was supported by the Intramural Research Program at NIDA. We thank the Opto-genetics and Transgenic Technology Core (OTTC) at NIDA for vector production and characterization. Specifically, we thank Mr. Doug Howard for virus production and titering, Ms. Lowella Fortuno for primary cortical preparation, and Dr. Chris Richie for advice, assistance with molecular biology and Addgene registration.	Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Burdakov D, 2005, CELL CALCIUM, V38, P303, DOI 10.1016/j.ceca.2005.06.010; Celli A, 2011, BRIT J DERMATOL, V164, P16, DOI 10.1111/j.1365-2133.2010.10046.x; Fu SN, 2012, CELL METAB, V15, P623, DOI 10.1016/j.cmet.2012.03.007; Gjymishka A, 2009, BIOCHEM J, V417, P695, DOI 10.1042/BJ20081706; Hall MP, 2012, ACS CHEM BIOL, V7, P1848, DOI 10.1021/cb3002478; Heise K, 2013, ASSAY DRUG DEV TECHN, V11, P244, DOI 10.1089/adt.2013.509; Henderson MJ, 2015, JOVE-J VIS EXP, DOI 10.3791/53199; Henderson MJ, 2014, MOL BIOL CELL, V25, P2828, DOI 10.1091/mbc.E14-06-1141; Ho PI, 2013, ACS CHEM BIOL, V8, P1009, DOI 10.1021/cb3007264; Howard DB, 2008, VIROLOGY, V372, P24, DOI 10.1016/j.virol.2007.10.007; Huang ZM, 2005, MOL CELL BIOL, V25, P7522, DOI 10.1128/MCB.25.17.7522-7533.2005; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; Kobayashi MS, 2004, J NEUROSCI RES, V76, P512, DOI 10.1002/jnr.20094; Lee J, 2014, J BIOL CHEM, V289, P1203, DOI 10.1074/jbc.R113.534743; Li JL, 2015, MECH DEVELOP, V137, P33, DOI 10.1016/j.mod.2015.04.001; Li MQ, 2000, MOL CELL BIOL, V20, P5096, DOI 10.1128/MCB.20.14.5096-5106.2000; Lindholm D, 2006, CELL DEATH DIFFER, V13, P385, DOI 10.1038/sj.cdd.4401778; Loh JMS, 2014, BIOTECHNOL LETT, V36, P829, DOI 10.1007/s10529-013-1423-z; Martin CS, 1996, BIOTECHNIQUES, V21, P520; Mekahli D, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004317; Oslowski CM, 2011, METHOD ENZYMOL, V490, P71, DOI 10.1016/B978-0-12-385114-7.00004-0; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; RYAN MD, 1991, J GEN VIROL, V72, P2727, DOI 10.1099/0022-1317-72-11-2727; Shoulders MD, 2013, CELL REP, V3, P1279, DOI 10.1016/j.celrep.2013.03.024; Tannous BA, 2005, MOL THER, V11, P435, DOI 10.1016/j.ymthe.2004.10.016; Thuerauf DJ, 2001, J BIOL CHEM, V276, P48309, DOI 10.1074/jbc.M107146200; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wang Y, 2000, J BIOL CHEM, V275, P27013; Wu ZJ, 2006, J VIROL, V80, P9093, DOI 10.1128/JVI.00895-06; Yang S, 2008, GENE THER, V15, P1411, DOI 10.1038/gt.2008.90	31	8	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2017	12	4							e0175481	10.1371/journal.pone.0175481	http://dx.doi.org/10.1371/journal.pone.0175481			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LZ	28403212	Green Published, gold, Green Submitted			2022-12-27	WOS:000399955200075
J	He, YX; Qin, J; Hong, J				He, Yuxin; Qin, Jin; Hong, Jian			Comparative analysis of quantitative efficiency evaluation methods for transportation networks	PLOS ONE			English	Article							SMALL-WORLD NETWORK; PERFORMANCE	An effective evaluation of transportation network efficiency could offer guidance for the optimal control of urban traffic. Based on the introduction and related mathematical analysis of three quantitative evaluation methods for transportation network efficiency, this paper compares the information measured by them, including network structure, traffic demand, travel choice behavior and other factors which affect network efficiency. Accordingly, the applicability of various evaluation methods is discussed. Through analyzing different transportation network examples it is obtained that Q-H method could reflect the influence of network structure, traffic demand and user route choice behavior on transportation network efficiency well. In addition, the transportation network efficiency measured by this method and Braess's Paradox can be explained with each other, which indicates a better evaluation of the real operation condition of transportation network. Through the analysis of the network efficiency calculated by Q-H method, it can also be drawn that a specific appropriate demand is existed to a given transportation network. Meanwhile, under the fixed demand, both the critical network structure that guarantees the stability and the basic operation of the network and a specific network structure contributing to the largest value of the transportation network efficiency can be identified.	[He, Yuxin; Qin, Jin; Hong, Jian] Cent S Univ, Sch Traff & Transportat Engn, Changsha, Hunan, Peoples R China	Central South University	Qin, J (corresponding author), Cent S Univ, Sch Traff & Transportat Engn, Changsha, Hunan, Peoples R China.	qinjin@csu.edu.cn		HE, Yuxin/0000-0001-8857-9990	National Natural Science foundation of China [71101155]; Natural Science Foundation of Hunan Province [2015JJ2184]; Independent Exploration and Innovation Project of Central South University [2015zzts208]	National Natural Science foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hunan Province(Natural Science Foundation of Hunan Province); Independent Exploration and Innovation Project of Central South University	This work was supported by National Natural Science foundation of China (Grant No. 71101155 to JQ), Natural Science Foundation of Hunan Province (Grant No. 2015JJ2184 to JQ), and Independent Exploration and Innovation Project of Central South University (Grant No.2015zzts208 to YH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen A, 2002, MATH COMPUT SIMULAT, V59, P509, DOI 10.1016/S0378-4754(01)00437-2; Costa A, 1997, TRANSPORT RES C-EMER, V5, P301, DOI 10.1016/S0968-090X(97)00017-X; Crucitti P, 2003, PHYSICA A, V320, P622, DOI 10.1016/S0378-4371(02)01545-5; Crucitti P, 2011, J INFORMETR, V5, P422; Du WB, 2016, TRANSPORT RES E-LOG, V89, P108, DOI 10.1016/j.tre.2016.03.009; Du WB, 2017, CHINESE J AERONAUT, V30, P330, DOI 10.1016/j.cja.2016.12.001; Fotakis D, 2016, ALGORITHMICA, V8289, P1; Gudmundsson S, 2004, TRANSPORT RES E-LOG, V40, P439, DOI 10.1016/j.tre.2004.08.001; Guo XL, 2010, EUR J OPER RES, V201, P463, DOI 10.1016/j.ejor.2009.03.023; Hsu CI, 2008, J AIR TRANSP MANAG, V14, P123, DOI 10.1016/j.jairtraman.2008.02.007; Latora V, 2002, PHYSICA A, V314, P109, DOI 10.1016/S0378-4371(02)01089-0; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Latora V, 2004, CHAOS SOLITON FRACT, V20, P69, DOI 10.1016/S0960-0779(03)00429-6; Latora V, 2003, EUR PHYS J B, V32, P249, DOI 10.1140/epjb/e2003-00095-5; Levinson D, 2002, INT J TRANSP MANAG, V1, P145; Nagurney A, 2007, EPL-EUROPHYS LETT, V79, DOI 10.1209/0295-5075/79/38005; Nagurney A, 2008, J GLOBAL OPTIM, V40, P261, DOI 10.1007/s10898-007-9198-1; Nait-Sidi-Moh A, 2009, EUR J OPER RES, V193, P289, DOI 10.1016/j.ejor.2007.08.047; Qiang Q, 2008, OPTIM LETT, V2, P127, DOI 10.1007/s11590-007-0049-2; Qin J, 2013, SCI WORLD J, V7, P944; Qin J, 2014, SUSTAINABILITY-BASEL, V6, P8364, DOI 10.3390/su6128364; Ruan JH, 2016, INFORM SCIENCES, V373, P557, DOI 10.1016/j.ins.2016.07.014; Yu MM, 2008, OMEGA-INT J MANAGE S, V36, P1005, DOI 10.1016/j.omega.2007.06.003	23	4	4	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2017	12	4							e0175526	10.1371/journal.pone.0175526	http://dx.doi.org/10.1371/journal.pone.0175526			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0JS	28399165	gold, Green Published, Green Submitted			2022-12-27	WOS:000399949000044
J	Lempp, C; Jungwirth, N; Grilo, ML; Reckendorf, A; Ulrich, A; van Neer, A; Bodewes, R; Pfankuche, VM; Bauer, C; Osterhaus, ADME; Baumgartner, W; Siebertf, U				Lempp, Charlotte; Jungwirth, Nicole; Grilo, Miguel L.; Reckendorf, Anja; Ulrich, Arlene; van Neer, Abbo; Bodewes, Rogier; Pfankuche, Vanessa M.; Bauer, Christian; Osterhaus, Albert D. M. E.; Baumgaertner, Wolfgang; Siebertf, Ursula			Pathological findings in the red fox (Vulpes vulpes), stone marten (Martes foina) and raccoon dog (Nyctereutes procyonoides), with special emphasis on infectious and zoonotic agents in Northern Germany	PLOS ONE			English	Article							CANINE-DISTEMPER VIRUS; FELINE LEUKEMIA-VIRUS; TOXOPLASMA-GONDII; NEOSPORA-CANINUM; HUMAN ANELLOVIRUSES; WILD CARNIVORES; VIRAL-PROTEINS; DOMESTIC DOGS; SAXONY-ANHALT; EXPRESSION	Anthropogenic landscape changes contributed to the reduction of availability of habitats to wild animals. Hence, the presence of wild terrestrial carnivores in urban and peri-urban sites has increased considerably over the years implying an increased risk of interspecies spill-over of infectious diseases and the transmission of zoonoses. The present study provides a detailed characterisation of the health status of the red fox (Vulpes vulpes), stone marten (Martes foina) and raccoon dog (Nyctereutes procyonoides) in their natural rural and peri-urban habitats in Schleswig-Holstein, Germany between November 2013 and January 2016 with focus on zoonoses and infectious diseases that are potentially threatening to other wildlife or domestic animal species. 79 red foxes, 17 stone martens and 10 raccoon dogs were collected from traps or hunts. In order to detect morphological changes and potential infectious diseases, necropsy and pathohistological work-up was performed. Additionally, in selected animals immunohistochemistry (influenza A virus, parvovirus, feline leukemia virus, Borna disease virus, tick-borne encephalitis, canine adenovirus, Neospora caninum, Toxoplasma gondii and Listeria monocytogenes), next-generation sequencing, polymerase chain reaction (fox circovirus) and serum-neutralisation analysis (canine distemper virus) were performed. Furthermore, all animals were screened for fox rabies virus (immunofluorescence), canine distemper virus (immunohistochemistry) and Aujeszky's disease (virus cultivation). The most important findings included encephalitis (n = 16) and pneumonia (n = 20). None of the investigations revealed a specific cause for the observed morphological alterations except for one animal with an elevated serum titer of 1:160 for canine distemper. Animals displayed macroscopically and/or histopathologically detectable infections with parasites, including Taenia sp., Toxocara sp. and Alaria alata. In summary, wildlife predators carry zoonotic parasitic disease and suffer from inflammatory diseases of yet unknown etiology, possibly bearing infectious potential for other animal species and humans. This study highlights the value of monitoring terrestrial wildlife following the "One Health" notion, to estimate the incidence and the possible spread of zoonotic pathogens and to avoid animal to animal spillover as well as transmission to humans.	[Lempp, Charlotte; Jungwirth, Nicole; Pfankuche, Vanessa M.; Baumgaertner, Wolfgang] Univ Vet Med Hannover, Dept Pathol, Hannover, Lower Saxony, Germany; [Jungwirth, Nicole; Pfankuche, Vanessa M.; Baumgaertner, Wolfgang] Ctr Syst Neurosci, Hannover, Germany; [Grilo, Miguel L.; Reckendorf, Anja; Ulrich, Arlene; van Neer, Abbo; Siebertf, Ursula] Univ Vet Med Hannover, Inst Terr & Aquat Wildlife Res, Busum, Schleswig Holst, Germany; [Bodewes, Rogier] Erasmus Univ, Med Ctr, Dept Virosci, Rotterdam, Netherlands; [Bauer, Christian] Justus Liebig Univ, Inst Parasitol, Giessen, Germany; [Osterhaus, Albert D. M. E.] Univ Vet Med Hannover, Res Ctr Emerging Infect & Zoonoses, Hannover, Lower Saxony, Germany; [Bodewes, Rogier] Univ Utrecht, Fac Vet Med, Dept Farm Anim Hlth, Utrecht, Netherlands	University of Veterinary Medicine Hannover, Foundation; University of Veterinary Medicine Hannover, Foundation; Erasmus University Rotterdam; Erasmus MC; Justus Liebig University Giessen; University of Veterinary Medicine Hannover, Foundation; Utrecht University	Baumgartner, W (corresponding author), Univ Vet Med Hannover, Dept Pathol, Hannover, Lower Saxony, Germany.; Baumgartner, W (corresponding author), Ctr Syst Neurosci, Hannover, Germany.	wolfgang.baumgaertner@tiho-hannover.de	Christian, Bauer/P-7293-2017	Christian, Bauer/0000-0002-6671-2102; Bodewes, Rogier/0000-0002-0689-7889; Reckendorf, PhD, Anja/0000-0002-2428-6280; van Neer, Abbo/0000-0002-3519-0356; Grilo, Miguel/0000-0001-7364-821X	Ministry of Energy, Agriculture, the Environment and Rural Affairs of Schleswig-Holstein; German Hunting Union; Niedersachsen-Research Network on Neuroinfectiology (N-RENNT) of the Ministry of Science and Culture of Lower Saxony, Germany; COMPARE project; European Union's Horizon research and innovation program COMPARE [643476]	Ministry of Energy, Agriculture, the Environment and Rural Affairs of Schleswig-Holstein; German Hunting Union; Niedersachsen-Research Network on Neuroinfectiology (N-RENNT) of the Ministry of Science and Culture of Lower Saxony, Germany; COMPARE project; European Union's Horizon research and innovation program COMPARE	The investigation was funded by the Ministry of Energy, Agriculture, the Environment and Rural Affairs of Schleswig-Holstein and the German Hunting Union and partly supported by the Niedersachsen-Research Network on Neuroinfectiology (N-RENNT) of the Ministry of Science and Culture of Lower Saxony, Germany, and by the COMPARE project and received funding from the European Union's Horizon 2020 research and innovation program COMPARE (grant agreement no. 643476). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The investigation was funded by the Ministry of Energy, Agriculture, the Environment and Rural Affairs of Schleswig-Holstein and the German Hunting Union and partly supported by the Niedersachsen-Research Network on Neuroinfectiology (N-RENNT) of the Ministry of Science and Culture of Lower Saxony, Germany and by the COMPARE project. Funding was also received from the European Union's Horizon 2020 research and innovation program COMPARE (grant agreement no. 643476). The authors wish to thank Bettina Buck, Petra Grunig, Caroline Schutz and Danuta Waschke for their excellent technical assistance. Furthermore, the authors would like to thank the local hunters for their cooperation in handing over animals, as well as Jorg Driver, Neele Gundlach, Eva Ludes-Wehrmeister, Steffen Mumme, Emilie Ulrikka Andersen-Ranberg, Peter Wohlsein, Frauke Seehusen, Christina Puff, Ingo Gerhauser, Kathrin Becker, Iris Volker, Stefanie Lapp, Aimara Bello, Barbara Raddatz and Malgorzata Ciurkiewicz for sampling and examining animals and for their scientific advice and assistance.	Akerstedt J, 2010, J WILDLIFE DIS, V46, P474, DOI 10.7589/0090-3558-46.2.474; ALLDINGER S, 1993, ARCH VIROL, V132, P421, DOI 10.1007/BF01309550; ALLDINGER S, 1993, ACTA NEUROPATHOL, V85, P635, DOI 10.1007/BF00334674; [Anonymous], 2007, WILDSCHWEINFLEISCH K; [Anonymous], 2016, WORLD POPULATION TRE; [Anonymous], 2015, JAGD ARTENSCHUTZ JAH; [Anonymous], 2016, ECHINOCOCCOSIS WHO; APPEL M, 1973, AM J VET RES, V34, P1459; Ballard WB, 2001, J WILDLIFE DIS, V37, P133, DOI 10.7589/0090-3558-37.1.133; Bartova E, 2016, ANN AGR ENV MED, V23, P84, DOI 10.5604/12321966.1196858; Bateman PW, 2012, J ZOOL, V287, P1, DOI 10.1111/j.1469-7998.2011.00887.x; Baumgartner W, 2003, DEUT TIERARZTL WOCH, V110, P137; BAUMGARTNER W, 1989, ACTA NEUROPATHOL, V78, P504, DOI 10.1007/BF00687712; Beineke A, 2015, ONE HEALTH, V1, P49, DOI 10.1016/j.onehlt.2015.09.002; Bexton S, 2015, EMERG INFECT DIS, V21, P1205, DOI 10.3201/eid2107.150228; Bodewes R, 2013, VIROLOGY, V440, P84, DOI 10.1016/j.virol.2013.02.011; Bodewes R, 2015, EMERG INFECT DIS, V21, P720, DOI 10.3201/eid2104.141675; Bodewes R, 2015, J VIROL METHODS, V214, P54, DOI 10.1016/j.jviromet.2015.02.002; Bodewes R, 2014, VET MICROBIOL, V174, P1, DOI 10.1016/j.vetmic.2014.08.025; Bodewes R, 2014, J GEN VIROL, V95, P2480, DOI 10.1099/vir.0.068700-0; Bourg M, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0608-1; Brack M., 1998, Primate Report, V50, P71; Bradley CA, 2007, TRENDS ECOL EVOL, V22, P95, DOI 10.1016/j.tree.2006.11.001; Butina TV, 2010, VET MICROBIOL, V144, P192, DOI 10.1016/j.vetmic.2009.12.027; Delwart E, 2012, CURR OPIN VIROL, V2, P344, DOI 10.1016/j.coviro.2012.02.012; Denzin N, 2014, TRANSBOUND EMERG DIS, V61, P239, DOI 10.1111/tbed.12026; Denzin N, 2013, VET MICROBIOL, V162, P214, DOI 10.1016/j.vetmic.2012.08.031; Deplazes P, 2004, TRENDS PARASITOL, V20, P77, DOI 10.1016/j.pt.2003.11.011; Deplazes P, 2004, TRENDS PARASITOL, P20; Eckert J, 2004, CLIN MICROBIOL REV, V17, P107, DOI 10.1128/CMR.17.1.107-135.2004; Eckert J., 2001, WHO OIE MANUAL ECHIN; ELDER JH, 1987, J VIROL, V61, P8, DOI 10.1128/JVI.61.1.8-15.1987; Frisk AL, 1999, J CLIN MICROBIOL, V37, P3634, DOI 10.1128/JCM.37.11.3634-3643.1999; Furtado JM, 2011, J GLOB INFECT DIS, V3, P281, DOI 10.4103/0974-777X.83536; Gibbs EPJ, 2014, VET REC, V174, P85, DOI 10.1136/vr.g143; Gottstein B, 2015, TRENDS PARASITOL, V31, P407, DOI 10.1016/j.pt.2015.06.001; Gozdzik K, 2011, PARASITOL RES, V108, P991, DOI 10.1007/s00436-010-2143-0; Haist V, 2008, EMERG INFECT DIS, V14, P988, DOI 10.3201/eid1406.071463; Heinrich F, 2015, VET IMMUNOL IMMUNOP, V168, P140, DOI 10.1016/j.vetimm.2015.10.015; Herr J, 2008, DISSERTATION; Hino S, 2007, REV MED VIROL, V17, P45, DOI 10.1002/rmv.524; Institut RK., 2006, EP FUCHSB DEUTSCHL D; Junginger J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130573; Jungwirth N, 2014, VET MICROBIOL, V170, P403, DOI 10.1016/j.vetmic.2014.02.029; Kapil S, 2011, VET CLIN N AM-SMALL, V41, P1069, DOI 10.1016/j.cvsm.2011.08.005; Kauhala K, 2011, CURR ZOOL, V57, P584, DOI 10.1093/czoolo/57.5.584; Kipar A, 2000, VET PATHOL, V37, P129, DOI 10.1354/vp.37-2-129; Klein S, 2010, J COMP PATHOL, V142, P228, DOI 10.1016/j.jcpa.2009.08.155; Klopfleisch R, 2007, J COMP PATHOL, V137, P155, DOI 10.1016/j.jcpa.2007.06.001; Kreutzer M, 2008, ARCH VIROL, V153, P187, DOI 10.1007/s00705-007-1070-6; Kuiken T, 2006, VET PATHOL, V43, P321, DOI 10.1354/vp.43-3-321; Laurimaa L, 2016, VET PARASITOL, V219, P24, DOI 10.1016/j.vetpar.2016.01.020; Leal FE, 2007, CLIN INFECT DIS, V44, pE62, DOI 10.1086/511871; Lobato J, 2006, CLIN VACCINE IMMUNOL, V13, P84, DOI 10.1128/CVI.13.1.84-89.2006; Mackenstedt U, 2015, INT J PARASITOL-PAR, V4, P71, DOI 10.1016/j.ijppaw.2015.01.006; Maggi F, 2010, REV MED VIROL, V20, P392, DOI 10.1002/rmv.668; Manzin A, 2015, J INFECT DEV COUNTR, V9, P562, DOI 10.3855/jidc.6912; Meredith AL, 2015, TRANSBOUND EMERG DIS, V62, P148, DOI 10.1111/tbed.12091; Mohl K, 2009, PARASITOL RES, V105, P1, DOI 10.1007/s00436-009-1444-7; Muller T, 2015, VET J, V203, P10, DOI 10.1016/j.tvjl.2014.10.026; Murphy TM, 2007, VET PARASITOL, V146, P227, DOI 10.1016/j.vetpar.2007.02.017; Nouvellet P, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0061588, 10.1371/currents.outbreaks.097a904d3f3619db2fe78d24bc776098]; Pawlowski ZS., 2001, WHO OIE MANUAL ECHIN; Plumer L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115124; Prachayangprecha S, 2014, J CLIN MICROBIOL, V52, P3722, DOI 10.1128/JCM.01641-14; Pruss H, 2015, SCI REP-UK, V5, DOI 10.1038/srep12805; Qiu W, 2011, EMERG INFECT DIS, V17, P1541, DOI 10.3201/eid1708.101153; REED L. J., 1938, AMER JOUR HYG, V27, P493; Reperant LA, 2008, EMERG INFECT DIS, V14, P1835, DOI 10.3201/eid1412.080470; Reynolds BS, 2013, J FELINE MED SURG, V15, P3, DOI 10.1177/1098612X13495234; Schaudien D, 2007, J COMP PATHOL, V137, P151, DOI 10.1016/j.jcpa.2007.05.007; Schaudien D, 2010, J CLIN MICROBIOL, V48, P3169, DOI 10.1128/JCM.01582-09; Schurch AC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105227; Schwab S, 2007, J COMP PATHOL, V136, P96, DOI 10.1016/j.jcpa.2006.11.006; Scott DM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099059; Seehusen F, 2007, ACTA NEUROPATHOL, V114, P597, DOI 10.1007/s00401-007-0307-5; Seeley KE, 2016, J ZOO WILDLIFE MED, V47, P83, DOI 10.1638/2014-0198.1; Sekulin K, 2011, VET J, V187, P399, DOI 10.1016/j.tvjl.2009.12.029; Spandole S, 2015, ARCH VIROL, V160, P893, DOI 10.1007/s00705-015-2363-9; Stuart P, 2013, PARASITOL RES, V112, P3587, DOI 10.1007/s00436-013-3544-7; Tabaran F, 2013, EMERG INFECT DIS, V19, P1547, DOI 10.3201/eid1909.130081; van Baalen CA, 2014, J CLIN MICROBIOL, V52, P1672, DOI 10.1128/JCM.03575-13; van Leeuwen M, 2010, J CLIN MICROBIOL, V48, P1787, DOI 10.1128/JCM.02452-09; VANMOLL P, 1995, VET MICROBIOL, V44, P193, DOI 10.1016/0378-1135(95)00012-Y; Viana M, 2015, P NATL ACAD SCI USA, V112, P1464, DOI 10.1073/pnas.1411623112; Wandeler P, 2003, MOL ECOL, V12, P647, DOI 10.1046/j.1365-294X.2003.01768.x; Weber A., 2003, HEIMTIERHALTUNG CHAN; Weissenbock H, 1998, ACTA NEUROPATHOL, V95, P361, DOI 10.1007/s004010050811	88	31	31	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2017	12	4							e0175469	10.1371/journal.pone.0175469	http://dx.doi.org/10.1371/journal.pone.0175469			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0JS	28399176	Green Submitted, Green Published, gold			2022-12-27	WOS:000399949000042
J	Khuluza, F; Heide, L				Khuluza, Felix; Heide, Lutz			Availability and affordability of antimalarial and antibiotic medicines in Malawi	PLOS ONE			English	Article							UNIVERSAL HEALTH COVERAGE; MIDDLE-INCOME COUNTRIES; DISEASES	Background Availability and affordability of medicines are key determinants of universal health coverage, yet achieving them presents a major challenge especially in low-income countries. We here present an analysis of availability and prices of antimalarial and antibiotic medicines in public, faith-based and private health facilities in Malawi. Medicines are provided free of charge in the public health care system of Malawi. In contrast, facilities of the Christian Health Association of Malawi (CHAM) usually charge their patients for medicines, as do private for-profit facilities. Methods As part of a study on medicine quality, samples of six antimalarial and six antibiotic medicines were collected in 31 health facilities in four districts of southern Malawi. These included 15 public facilities (i.e. health centres, district hospitals and central hospitals), eight CHAM and eight private facilities. Random selection was used in choosing the included health facilities. The availability of medicines was recorded, including the number of units which could be collected of each medicine, as well as the prices of medicines which were charged in CHAM and private facilities. These data were analyzed using the standard methodology developed by the World Health Organization (WHO) and Health Action International (HAI). Results Availability of the antimalarials artemether/lumefantrine and sulfadoxine/pyrimethamine, which are provided with financial support from international donors, was high in public and CHAM facilities (93% and 100%, respectively). However, availability of antibiotics was much lower (e.g. 40% availability of amoxicillin tablets/capsules in public health centres). Medicine prices were lower than reported from many other countries. The median price ratio (MPR) to a wholesale international procurement price was 2.8 in CHAM facilities and even lower in the private sector (MPR 2.3). Nevertheless, for 10 of the 12 investigated medicines the cost for one course of treatment exceeded the daily wage of a low-paid government worker in Malawi and therefore had to be considered as unaffordable for a major part of the population. Conclusions Continued efforts are required to improve the availability of essential medicines in Malawi. The free provision of medicines in the public health care system remains important in order to achieve universal health coverage, due to the low income in this country.	[Khuluza, Felix] Univ Malawi, Pharm Dept, Coll Med, Blantyre, Malawi; [Heide, Lutz] Eberhard Karls Univ Tubingen, Inst Pharmaceut, Tubingen, Germany	University of Malawi; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Heide, L (corresponding author), Eberhard Karls Univ Tubingen, Inst Pharmaceut, Tubingen, Germany.	heide@uni-tuebingen.de	Khuluza, Felix/HGC-0661-2022	Khuluza, Felix/0000-0002-8334-0160; Heide, Lutz/0000-0001-7809-7453	Malawian-German Health Programme of the Gesellschaft fur Internationale Zusammenarbeit (GIZ) GmbH [FA 83182402]; German Federal Ministry for Economic Cooperation and Development (BMZ); Consortium for Advanced Research Training in Africa (CARTA); Wellcome Trust (UK) [087547/Z/08/Z]; Carnegie Corporation of New York [B 8606.R02]; Sida [54100029]	Malawian-German Health Programme of the Gesellschaft fur Internationale Zusammenarbeit (GIZ) GmbH; German Federal Ministry for Economic Cooperation and Development (BMZ); Consortium for Advanced Research Training in Africa (CARTA); Wellcome Trust (UK)(Wellcome Trust); Carnegie Corporation of New York; Sida	This study was financially supported by grant FA 83182402 of the Malawian-German Health Programme of the Gesellschaft fur Internationale Zusammenarbeit (GIZ) GmbH and the German Federal Ministry for Economic Cooperation and Development (BMZ). The contribution by FK was supported by the Consortium for Advanced Research Training in Africa (CARTA). CARTA is jointly led by the African Population and Health Research Center and the University of the Witwatersrand and funded by the Wellcome Trust (UK) (Grant No. 087547/Z/08/Z), the Carnegie Corporation of New York (Grant No. B 8606.R02) and Sida (Grant No. 54100029). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abiiro GA, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-234; Amuasi JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047733; [Anonymous], 2009, MAL STAND TREATM GUI; Ashwood-Smith Hannah, 2002, Malawi Med J, V14, P8; Babar ZUD, 2013, PHARMACOECONOMICS, V31, P1063, DOI 10.1007/s40273-013-0095-9; Bazargani YT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087576; Cameron A, 2009, LANCET, V373, P240, DOI 10.1016/S0140-6736(08)61762-6; Cameron A, 2012, EPILEPSIA, V53, P962, DOI 10.1111/j.1528-1167.2012.03446.x; Cameron A, 2011, B WORLD HEALTH ORGAN, V89, P412, DOI 10.2471/BLT.10.084327; Choi Y, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-266; Ewen M, 2017, J Pharm Policy Pract, V10, P7, DOI 10.1186/s40545-016-0095-1; Freye JE, 2014, INT DRUG PRICE INDIC; Gelders S, 2006, WHOEMEDB068E05063000; Health Action International and WHO, 2008, MEAS MED PRIC AV AFF; Khuluza F, 2017, AM J TROP M IN PRESS; Lufesi NN, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-86; Masanja H, 2013, TANZANIA SERVICE AVA; Mendis S, 2007, B WORLD HEALTH ORGAN, V85, P279, DOI 10.2471/BLT.06.033647; Ministry of Health Malawi, 2015, MAL STAND TREATM GUI, V5; O'Neill K, 2013, B WORLD HEALTH ORGAN, V91, P923, DOI 10.2471/BLT.12.116798; Republic of Zambia Minstry or Health, 2010, ZAMB SERV AV READ AS; Robertson J, 2015, GLOBALIZATION HEALTH, V11, DOI 10.1186/s12992-015-0105-0; Robertson J, 2009, B WORLD HEALTH ORGAN, V87, P231, DOI 10.2471/BLT.08.053645; United Nations, 2012, MILL DEV GOAL 8 GLOB; van Mourik MSM, 2010, BMC CARDIOVASC DISOR, V10, DOI 10.1186/1471-2261-10-25; WageIndicator Foundation, MIN WAG MAL EFF 01 0; WHO, 2016, WHO TECH REP SER, V996, P1; WHO, 2008, WHO MOD FORM 2008; Wong-Beringer A, 2009, PHARMACOTHERAPY, V29, P736, DOI 10.1592/phco.29.6.736; World Health Organization, 2015, 19 WHO MOD LIST ESS; World Health Organization, 2015, GUID TREATM MAL, Vthird; World Health Organization Collaborating Centre for Drug Statisctics Methodology, 2016, ATC DDD IND; Wright C, 2013, ASSESSMENT INTEGRATE	33	16	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2017	12	4							e0175399	10.1371/journal.pone.0175399	http://dx.doi.org/10.1371/journal.pone.0175399			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KH	28419126	Green Published, Green Submitted, gold			2022-12-27	WOS:000399875200018
J	Yirgu, R; Molla, M; Sibley, L				Yirgu, Robel; Molla, Mitike; Sibley, Lynn			Determinants of neonatal mortality in rural Northern Ethiopia: A population based nested case control study	PLOS ONE			English	Article							PERINATAL-MORTALITY; HEALTH	Introduction In low income and middle income countries, neonatal mortality remains high despite the gradual reduction in under five mortality. Newborn death contributes for about 38% of all under five deaths. This study has identified the magnitude and independent predictors of neonatal mortality in rural Ethiopia. Methods This population based nested case control study was conducted in rural West Gojam zone, Northern Ethiopia, among a cohort of pregnant women who gave birth between March 2011 and Feb 2012. The cohort was established by Maternal and Newborn Health in Ethiopia Partnership (MaNHEP) project in 2010 by recruiting mothers in their third trimester, as identified by trained community volunteers. Once identified, women stayed in the cohort throughout their pregnancy period receiving Community Maternal and Newborn Health (CMNH) training by health extension workers and community volunteers till the end of the first 48 hours postpartum. Cases were 75 mothers who lost their newborns to neonatal death and controls were 150 randomly selected mothers with neonates who survived the neonatal period. Data to identify cause of death were collected using the WHO standard verbal autopsy questionnaire after the culturally appropriate 40 days of bereavement period. Binomial logistic regression model was used to identify independent contributors to neonatal mortality. Result The neonatal mortality rate was AOR(95% CI) = 18.6 (14.8, 23.2) per 1000 live births. Neonatal mortality declined with an increase in family size, neonates who were born among a family of more than two had lesser odds of death in the neonatal period than those who were born in a family of two AOR (95% CI) = 0.13 (0.02, 0.71). Mothers who gave birth to 2-4 AOR(95% CI) = 0.15 (0.05, 0.48) and 5+ children AOR(95% CI) = 0.08 (0.02, 0.26) had lesser odds of losing their newborns to neonatal mortality. Previous history of losing a newborn to neonatal death also increased the odds of neonatal mortality during the last birth AOR (95% CI) = 0.25 (0.11, 0.53). Conclusion The neonatal mortality rate in our study was three times lower than the regional neonatal mortality rate estimate, indicating community based interventions could significantly decrease neonatal mortality. The identified determinants, which are amenable for change, emphasize the need to improve quality of care during pregnancy, labour and delivery to improve pregnancy outcome.	[Yirgu, Robel] Addis Ababa Univ, Coll Hlth Sci, Sch Publ Hlth, Dept Reprod Hlth & Hlth Serv Management, Addis Ababa, Ethiopia; [Molla, Mitike] Addis Ababa Univ, Coll Hlth Sci, Sch Publ Hlth, Dept Prevent Med, Addis Ababa, Ethiopia; [Sibley, Lynn] Emory Univ, Nell Hodgson Woodruff Sch Nursing, Atlanta, GA 30322 USA; [Sibley, Lynn] Emory Univ, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA	Addis Ababa University; Addis Ababa University; Emory University; Emory University; Rollins School Public Health	Yirgu, R (corresponding author), Addis Ababa Univ, Coll Hlth Sci, Sch Publ Hlth, Dept Reprod Hlth & Hlth Serv Management, Addis Ababa, Ethiopia.	yirgurob@gmail.com						[Anonymous], 2015, ATT SPANK; [Anonymous], 2006, ETH DEM HLTH SURV 20; Banteyerga H, 2011, MEDICC REV, V13, P46, DOI 10.37757/MR2011V13.N3.11; Barry D, 2014, J MIDWIFERY WOM HEAL, V59, pS44, DOI 10.1111/jmwh.12171; Central Statistical Agency,, 2012, ETH DEM HLTH SURV 20; Central Statistical Agency, 2000, ETH DEM HLTH SURV 20; Emory University, 2010, REP BILL M GAT FDN 2; Federal Democratic Republic of Ethiopia Population Census Commission, 2008, SUMM STAT REP POP HO; Hinderaker SG, 2003, J HEALTH POPUL NUTR, V21, P8; IBRAHIM SA, 1994, PAEDIATR PERINAT EP, V8, P193, DOI 10.1111/j.1365-3016.1994.tb00450.x; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; McDermott J, 1996, B WORLD HEALTH ORGAN, V74, P165; Mekonnen Y, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-483; Sibley LM, 2014, J MIDWIFERY WOM HEAL, V59, pS6, DOI 10.1111/jmwh.12147; Sisay MM, 2014, J MIDWIFERY WOM HEAL, V59, pS110, DOI 10.1111/jmwh.12156; Unicef, 2015, LEV TRENDS CHILD MOR; United Nations, 2015, 2030 AG SUST DEV; VAJPAYEE A, 1987, J TROP PEDIATRICS, V33, P261, DOI 10.1093/tropej/33.5.261; World Health Organization, 2006, NEON PER MORT COUNTR	19	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2017	12	4							e0172875	10.1371/journal.pone.0172875	http://dx.doi.org/10.1371/journal.pone.0172875			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KH	28419096	gold, Green Published, Green Submitted			2022-12-27	WOS:000399875200001
J	Ahn, J; Park, YJ; Chen, P; Lee, TJ; Jeon, YJ; Croce, CM; Suh, Y; Hwang, S; Kwon, WS; Pang, MG; Kim, CH; Lee, SS; Lee, K				Ahn, Jinsoo; Park, Yoo-Jin; Chen, Paula; Lee, Tae Jin; Jeon, Young-Jun; Croce, Carlo M.; Suh, Yeunsu; Hwang, Seongsoo; Kwon, Woo-Sung; Pang, Myung-Geol; Kim, Cheorl-Ho; Lee, Sang Suk; Lee, Kichoon			Comparative expression profiling of testis-enriched genes regulated during the development of spermatogonial cells	PLOS ONE			English	Article							LACTATE-DEHYDROGENASE-C; DENSE FIBER PROTEINS; NIMA-RELATED KINASE; INHIBITOR HUSI-II; MALE-FERTILITY; MESSENGER-RNA; CHROMOSOMAL LOCALIZATION; MOLECULAR-CLONING; GERM-CELLS; TESTICULAR DEVELOPMENT	The testis has been identified as the organ in which a large number of tissue-enriched genes are present. However, a large portion of transcripts related to each stage or cell type in the testis still remains unknown. In this study, databases combined with confirmatory measurements were used to investigate testis-enriched genes, localization in the testis, developmental regulation, gene expression profiles of testicular disease, and signaling pathways. Our comparative analysis of GEO DataSets showed that 24 genes are predominantly expressed in testis. Cellular locations of 15 testis-enriched proteins in human testis have been identified and most of them were located in spermatocytes and round spermatids. Real-time PCR revealed that expressions of these 15 genes are significantly increased during testis development. Also, an analysis of GEO DataSets indicated that expressions of these 15 genes were significantly decreased in teratozoospermic patients and polyubiquitin knockout mice, suggesting their involvement in normal testis development. Pathway analysis revealed that most of those 15 genes are implicated in various sperm-related cell processes and disease conditions. This approach provides effective strategies for discovering novel testis-enriched genes and their expression patterns, paving the way for future characterization of their functions regarding infertility and providing new biomarkers for specific stages of spematogenesis.	[Ahn, Jinsoo; Chen, Paula; Suh, Yeunsu; Lee, Kichoon] Ohio State Univ, Dept Anim Sci, Columbus, OH 43210 USA; [Park, Yoo-Jin] Massachusetts Gen Hosp, Ctr Syst Biol, MA & Harvard Med Sch, Program Membrane Biol Nephrol Div, Boston, MA 02114 USA; [Park, Yoo-Jin; Lee, Tae Jin; Croce, Carlo M.] Ohio State Univ, Dept Canc Biol & Genet, Columbus, OH 43210 USA; [Jeon, Young-Jun] Stanford Univ, Stanford Canc Inst, Stanford, CA 94305 USA; [Hwang, Seongsoo] Natl Inst Anim Sci, RDA, Anim Biotechnol Div, Jeonbuk, South Korea; [Kwon, Woo-Sung] Kyungpook Natl Univ, Dept Anim Biotechnol, Sangju, South Korea; [Kwon, Woo-Sung; Pang, Myung-Geol] Chung Ang Univ, Dept Anim Sci & Technol, Anseong, Gyeonggi, South Korea; [Kim, Cheorl-Ho] Sungkyunkwan Univ, Dept Biol Sci, Suwon, South Korea; [Lee, Sang Suk] Sunchon Natl Univ, Dept Anim Sci & Technol, Sunchon, South Korea	University System of Ohio; Ohio State University; Harvard University; Massachusetts General Hospital; University System of Ohio; Ohio State University; Stanford Cancer Institute; Stanford University; National Institute of Animal Science, Republic of Korea; Rural Development Administration (RDA), Republic of Korea; Kyungpook National University; Chung Ang University; Sungkyunkwan University (SKKU); Sunchon National University	Lee, K (corresponding author), Ohio State Univ, Dept Anim Sci, Columbus, OH 43210 USA.	lee.2626@osu.edu	Kwon, Woo-Sung/J-6731-2019; Pang, Myung-Geol/AAV-2014-2021; Kim, Cheorl-Ho/T-6753-2019; Young, Richard A/F-6495-2012	Kwon, Woo-Sung/0000-0002-0848-7189; Pang, Myung-Geol/0000-0003-2019-3789; Kim, Cheorl-Ho/0000-0002-6323-0714; Young, Richard A/0000-0001-8855-8647; Chen, Paula/0000-0003-4134-5235; Jeon, Young-Jun/0000-0002-5998-9605	Cooperative Research Program for Animal Science & Technology Development, RDA of Republic of Korea [PJ010906, PJ01095601]; Ohio Agricultural Research and Development Center, Ohio State University [2017-069]; Select Sires Competitive Research Grants Program [PJ1]; NATIONAL CANCER INSTITUTE [R35CA197706] Funding Source: NIH RePORTER	Cooperative Research Program for Animal Science & Technology Development, RDA of Republic of Korea; Ohio Agricultural Research and Development Center, Ohio State University(Ohio State University); Select Sires Competitive Research Grants Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was partially carried out with the support of grants from the Cooperative Research Program for Animal Science & Technology Development, RDA of Republic of Korea (PJ010906 to SS. Lee, and PJ01095601 to S. Hwang), the Ohio Agricultural Research and Development Center, Ohio State University (2017-069 to K. Lee), and the Select Sires Competitive Research Grants Program (PJ1 to K. Lee). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agathanggelou A, 2003, ONCOGENE, V22, P1580, DOI 10.1038/sj.onc.1206243; Aho H, 1996, GENOMICS, V32, P184, DOI 10.1006/geno.1996.0104; BALTZ JM, 1990, BIOL REPROD, V43, P485, DOI 10.1095/biolreprod43.3.485; Barbagallo F, 2009, J PATHOL, V217, P431, DOI 10.1002/path.2471; Castrillon DH, 2000, P NATL ACAD SCI USA, V97, P9585, DOI 10.1073/pnas.160274797; Cataldo L, 1996, MOL REPROD DEV, V45, P320, DOI 10.1002/(SICI)1098-2795(199611)45:3&lt;320::AID-MRD9&gt;3.0.CO;2-U; Chadwick BP, 1999, GENOMICS, V58, P302, DOI 10.1006/geno.1999.5848; Chen T, 2009, PROTEINS, V77, P209, DOI 10.1002/prot.22432; De-Leon SBT, 2007, ANNU REV BIOPH BIOM, V36, P191, DOI 10.1146/annurev.biophys.35.040405.102002; Djureinovic D, 2014, MOL HUM REPROD, V20, P476, DOI 10.1093/molehr/gau018; Du Y, 2006, FERTIL STERIL, V85, P1852, DOI 10.1016/j.fertnstert.2005.11.064; DUFAU ML, 1988, ANNU REV PHYSIOL, V50, P483, DOI 10.1146/annurev.ph.50.030188.002411; Esakky P, 2013, REPROD SCI, V20, P238, DOI 10.1177/1933719112452939; Florman HM, 2010, CELL, V140, P310, DOI 10.1016/j.cell.2010.01.035; Fok KL, 2014, SEMIN CELL DEV BIOL, V29, P31, DOI 10.1016/j.semcdb.2014.02.008; Fraser LR., 1988, HUM REPROD S4, V13, P1; Fu J, 2012, FERTIL STERIL, V97, P1226, DOI 10.1016/j.fertnstert.2012.02.023; GASTMANN O, 1993, MOL REPROD DEV, V36, P407, DOI 10.1002/mrd.1080360402; Goldberg E, 2010, J ANDROL, V31, P86, DOI 10.2164/jandrol.109.008367; Montoto LG, 2012, REPRODUCTION, V143, P333, DOI 10.1530/REP-11-0245; Griswold MD, 1998, SEMIN CELL DEV BIOL, V9, P411, DOI 10.1006/scdb.1998.0203; Gu W, 1998, BIOL REPROD, V59, P1266, DOI 10.1095/biolreprod59.5.1266; Hopkins J, 2014, PLOS GENET, V10; HOSSEINI R, 1994, MECH DEVELOP, V47, P73, DOI 10.1016/0925-4773(94)90097-3; Hoyer-Fender S, 1998, MOL REPROD DEV, V51, P167, DOI 10.1002/(SICI)1098-2795(199810)51:2&lt;167::AID-MRD6&gt;3.0.CO;2-O; Ikeda T, 2005, FEBS LETT, V579, P819, DOI 10.1016/j.febslet.2004.12.070; Kratzschmar J, 1996, EUR J BIOCHEM, V236, P827, DOI 10.1111/j.1432-1033.1996.t01-1-00827.x; Lee B, 2011, J BIOL CHEM, V286, P29108, DOI 10.1074/jbc.M111.244905; Lefevre A, 1999, BIOCHEM BIOPH RES CO, V259, P60, DOI 10.1006/bbrc.1999.0728; Li B, 2009, ENDOCRINOLOGY, V150, P1217, DOI 10.1210/en.2008-0727; Lin YN, 2007, MOL CELL BIOL, V27, P6794, DOI 10.1128/MCB.01029-07; Liu YY, 2011, TOHOKU J EXP MED, V224, P111, DOI 10.1620/tjem.224.111; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mandal A, 1999, BIOL REPROD, V61, P1184, DOI 10.1095/biolreprod61.5.1184; Maruyama O, 1998, CYTOGENET CELL GENET, V82, P41, DOI 10.1159/000015061; Meklat F, 2009, BRIT J HAEMATOL, V144, P660, DOI 10.1111/j.1365-2141.2008.07502.x; Miki K, 2004, P NATL ACAD SCI USA, V101, P16501, DOI 10.1073/pnas.0407708101; Miyata H, 2016, P NATL ACAD SCI USA, V113, P7704, DOI 10.1073/pnas.1608458113; Moore DJ, 2013, AM J HUM GENET, V93, P346, DOI 10.1016/j.ajhg.2013.07.009; MORITZ A, 1993, GENE, V123, P277, DOI 10.1016/0378-1119(93)90138-S; MORITZ A, 1991, FEBS LETT, V278, P127, DOI 10.1016/0014-5793(91)80099-O; Najafipour R, 2015, CELL J, V17, P121; Nam SY, 1997, J VET MED SCI, V59, P983, DOI 10.1292/jvms.59.983; Nayernia K, 2004, MOL REPROD DEV, V67, P458, DOI 10.1002/mrd.20039; O'Shaughnessy PJ, 2002, BIOL REPROD, V66, P966, DOI 10.1095/biolreprod66.4.966; Oh C, 2003, MOL HUM REPROD, V9, P321, DOI 10.1093/molehr/gag047; Peterson C, 1999, MOL HUM REPROD, V5, P627, DOI 10.1093/molehr/5.7.627; Pezzi N, 2000, FASEB J, V14, P581, DOI 10.1096/fasebj.14.3.581; Platts AE, 2007, HUM MOL GENET, V16, P763, DOI 10.1093/hmg/ddm012; Prieto I, 2001, NAT CELL BIOL, V3, P761, DOI 10.1038/35087082; Rhee K, 1997, DEVELOPMENT, V124, P2167; Ryu KY, 2008, MOL CELL BIOL, V28, P1136, DOI 10.1128/MCB.01566-07; SAKAI I, 1987, BIOCHEM J, V242, P619, DOI 10.1042/bj2420619; Shi Y, 2013, ANDROLOGY-US, V1, P431, DOI 10.1111/j.2047-2927.2013.00069.x; Siep M, 2004, NUCLEIC ACIDS RES, V32, P6425, DOI 10.1093/nar/gkh979; Sogawa C, 2014, REPROD BIOL ENDOCRIN, V12, DOI 10.1186/1477-7827-12-64; Song MH, 2012, ONCOL REP, V28, P1792, DOI 10.3892/or.2012.2002; Song Y., 2013, PLOS ONE, V31; Steger K, 1998, MOL HUM REPROD, V4, P939, DOI 10.1093/molehr/4.10.939; STOREY BT, 1975, FERTIL STERIL, V26, P1257; Sutovsky P, 2001, J CELL SCI, V114, P1665; Sutovsky P, 2015, ASIAN J ANDROL, V17, P554, DOI 10.4103/1008-682X.153847; TANAKA H, 1994, FEBS LETT, V355, P4, DOI 10.1016/0014-5793(94)01155-9; Tanaka H, 2003, BIOL REPROD, V69, P475, DOI 10.1095/biolreprod.103.015867; Tanaka K, 1997, EXP CELL RES, V237, P264, DOI 10.1006/excr.1997.3788; Tang HH, 2008, BIOL REPROD, V78, P455, DOI 10.1095/biolreprod.107.064964; Tang HH, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.107011; Tekur S, 1999, J ANDROL, V20, P135; Toshimori Kiyotaka, 2004, Anatomical Science International, V79, P101, DOI 10.1111/j.1447-073x.2004.00076.x; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Vijayaraghavan S, 1999, MOL ENDOCRINOL, V13, P705, DOI 10.1210/me.13.5.705; Welch JE, 2000, J ANDROL, V21, P328; WYKES SM, 1995, DNA CELL BIOL, V14, P155, DOI 10.1089/dna.1995.14.155; Xiao JH, 2002, BIOCHEM BIOPH RES CO, V291, P101, DOI 10.1006/bbrc.2002.6396; Yang KF, 2012, MOL CELL BIOL, V32, P216, DOI 10.1128/MCB.06158-11; Yang SY, 2012, DEV CELL, V22, P1041, DOI 10.1016/j.devcel.2012.04.013; YELICK P C, 1989, Molecular Reproduction and Development, V1, P193, DOI 10.1002/mrd.1080010307; Yu XP, 2006, NUCLEIC ACIDS RES, V34, P4925, DOI 10.1093/nar/gkl595; Yu Y, 2009, MICROSC RES TECHNIQ, V72, P558, DOI 10.1002/jemt.20696; Yuan SQ, 2015, P NATL ACAD SCI USA, V112, pE430, DOI 10.1073/pnas.1424648112; Zhang J, 2014, ANIMAL, V8, P800, DOI 10.1017/S1751731114000469; Zhong J, 2001, BIOL REPROD, V64, P1784, DOI 10.1095/biolreprod64.6.1784	82	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2017	12	4							e0175787	10.1371/journal.pone.0175787	http://dx.doi.org/10.1371/journal.pone.0175787			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KD	28414809	Green Published, gold, Green Submitted			2022-12-27	WOS:000399874800055
J	Arrigucci, R; Pozzi, G				Arrigucci, Riccardo; Pozzi, Gianni			Identification of the chain-dispersing peptidoglycan hydrolase LytB of Streptococcus gordonii	PLOS ONE			English	Article							HOST-VECTOR SYSTEM; N-ACETYLGLUCOSAMINIDASE; LACTOCOCCUS-LACTIS; VIRIDANS STREPTOCOCCI; MITIS; IMMUNIZATION; CHOLINE; PROTEIN; DOMAIN; DNA	Bacterial cell division ends with the separation of the daughter cells, a process that requires peptidoglycan hydrolases (PGHs). Bacteria lacking cell separating PGHs are impaired in cell separation with the formation of long chains or clusters. We identified a gene in Streptococcus gordonii encoding for a putative glucosaminidase (lytB). The lytB isogenic mutant grew in long bacterial chains and resulted in impaired biofilm formation. Purified recombinant LytB showed a murolytic activity on Micrococcus lysodeikticus cell suspension and was able to disperse the long chains of the mutant, restoring the wild type diplococci/short chain phenotype. LytB protein was localized only in culture supernatant cell fraction of S. gordonii, and co-cultures of wild type and lytB mutant showed a significant reduction of bacterial chain length, indicating that LytB is a secreted enzyme. Our results demonstrate that LytB is a secreted peptidoglycan hydrolase required for S. gordonii cell separation.	[Arrigucci, Riccardo] Rutgers State Univ, Publ Hlth Res Inst, Newark, NJ 08901 USA; [Pozzi, Gianni] Univ Siena, Dept Med Biotechnol, LAMMB, Siena, Italy	Rutgers State University Newark; Rutgers State University New Brunswick; University of Siena	Arrigucci, R (corresponding author), Rutgers State Univ, Publ Hlth Res Inst, Newark, NJ 08901 USA.	riccardo.arrigucci@rutgers.edu	Pozzi, Gianni/Q-2713-2018	Pozzi, Gianni/0000-0002-9557-4714				Anderson VJ, 2011, MOL MICROBIOL, V81, P192, DOI 10.1111/j.1365-2958.2011.07688.x; BUIST G, 1995, J BACTERIOL, V177, P1554, DOI 10.1128/jb.177.6.1554-1563.1995; Camiade E, 2010, J BACTERIOL, V192, P2373, DOI 10.1128/JB.01546-09; Carroll SA, 2003, J BACTERIOL, V185, P6801, DOI 10.1128/JB.185.23.6801-6808.2003; Chapot-Chartier MP, 2010, PROKARYOTIC CELL WALL COMPOUNDS: STRUCTURE AND BIOCHEMISTRY, P383, DOI 10.1007/978-3-642-05062-6_13; Ciabattini A, 2008, VACCINE, V26, P4244, DOI 10.1016/j.vaccine.2008.05.049; Cibik R, 2001, APPL ENVIRON MICROB, V67, P858, DOI 10.1128/AEM.67.2.858-864.2001; De las Rivas B, 2002, J BACTERIOL, V184, P4988, DOI 10.1128/JB.184.18.4988-5000.2002; DOUGLAS CWI, 1993, J MED MICROBIOL, V39, P179, DOI 10.1099/00222615-39-3-179; Egan AJF, 2013, ANN NY ACAD SCI, V1277, P8, DOI 10.1111/j.1749-6632.2012.06818.x; Huard C, 2004, APPL ENVIRON MICROB, V70, P3493, DOI 10.1128/AEM.70.6.3493-3499.2004; Husson-Kao C, 2000, FEMS MICROBIOL LETT, V187, P69, DOI 10.1111/j.1574-6968.2000.tb09139.x; Iannelli F, 2004, MOL BIOTECHNOL, V26, P81, DOI 10.1385/MB:26:1:81; KAWAMURA Y, 1995, INT J SYST BACTERIOL, V45, P406, DOI 10.1099/00207713-45-2-406; KILIAN M, 1989, INT J SYST BACTERIOL, V39, P471, DOI 10.1099/00207713-39-4-471; Kolenbrander PE, 2010, NAT REV MICROBIOL, V8, P471, DOI 10.1038/nrmicro2381; Layec S, 2008, RES MICROBIOL, V159, P507, DOI 10.1016/j.resmic.2008.06.008; Layec S, 2009, MOL MICROBIOL, V71, P1205, DOI 10.1111/j.1365-2958.2009.06595.x; Medaglini D, 2001, VACCINE, V19, P1931, DOI 10.1016/S0264-410X(00)00434-5; Moscoso M, 2005, APPL ENVIRON MICROB, V71, P8706, DOI 10.1128/AEM.71.12.8706-8713.2005; Moscoso M, 2006, J BACTERIOL, V188, P7785, DOI 10.1128/JB.00673-06; NYVAD B, 1990, CARIES RES, V24, P267, DOI 10.1159/000261281; Oggioni MR, 1996, GENE, V169, P85, DOI 10.1016/0378-1119(95)00775-X; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; POZZI G, 1994, VACCINE, V12, P1071, DOI 10.1016/0264-410X(94)90175-9; POZZI G, 1988, J BACTERIOL, V170, P1969, DOI 10.1128/jb.170.4.1969-1972.1988; Ramos-Sevillano E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023626; Richard J., 2010, ORAL MICROBIOLOGY GL; Rolain T, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-137; SCANNAPIECO FA, 1994, J DENT RES, V73, P1627, DOI 10.1177/00220345940730100701; Smith TJ, 2000, MICROBIOL-UK, V146, P249, DOI 10.1099/00221287-146-2-249; Steen A, 2005, FEBS J, V272, P2854, DOI 10.1111/j.1742-4658.2005.04706.x; Visweswaran GRR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072167; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P259, DOI 10.1111/j.1574-6976.2007.00099.x; WATANAKUNAKORN C, 1993, SCAND J INFECT DIS, V25, P403, DOI 10.3109/00365549309008519; Zapun A, 2008, FEMS MICROBIOL REV, V32, P345, DOI 10.1111/j.1574-6976.2007.00098.x	36	10	10	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2017	12	4							e0176117	10.1371/journal.pone.0176117	http://dx.doi.org/10.1371/journal.pone.0176117			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KD	28414782	gold, Green Published, Green Submitted			2022-12-27	WOS:000399874800090
J	Li, X; Zhang, YY; Shi, YH; Wu, SY; Xiao, Y; Gu, XJ; Zhen, X; Zhou, LH				Li, Xin; Zhang, Yuyu; Shi, Yinghua; Wu, Shuyu; Xiao, Yang; Gu, Xuejun; Zhen, Xin; Zhou, Linghong			Comprehensive evaluation of ten deformable image registration algorithms for contour propagation between CT and cone-beam CT images in adaptive head & neck radiotherapy	PLOS ONE			English	Article							INTENSITY-MODULATED RADIOTHERAPY; NASOPHARYNGEAL CANCER-PATIENTS; RADIATION-THERAPY; PAROTID-GLANDS; NONRIGID REGISTRATION; SUBMANDIBULAR-GLANDS; GEOMETRIC CHANGES; PROSTATE-CANCER; PLANNING CT; DELINEATION	Deformable image registration (DIR) is a critical technic in adaptive radiotherapy (ART) for propagating contours between planning computerized tomography (CT) images and treatment CT/cone-beam CT (CBCT) images to account for organ deformation for treatment re-planning. To validate the ability and accuracy of DIR algorithms in organ at risk (OAR) contour mapping, ten intensity-based DIR strategies, which were classified into four categories D optical flow-based, demons-based, level-set-based and spline-based D were tested on planning CT and fractional CBCT images acquired from twenty-one head & neck (H&N) cancer patients who underwent 6-7-week intensity-modulated radiation therapy (IMRT). Three similarity metrics, i.e., the Dice similarity coefficient (DSC), the percentage error (PE) and the Hausdorff distance (HD), were employed to measure the agreement between the propagated contours and the physician-delineated ground truths of four OARs, including the vertebra (VTB), the vertebral foramen (VF), the parotid gland (PG) and the submandibular gland (SMG). It was found that the evaluated DIRs in this work did not necessarily outperform rigid registration. DIR performed better for bony structures than soft-tissue organs, and the DIR performance tended to vary for different ROIs with different degrees of deformation as the treatment proceeded. Generally, the optical flow-based DIR performed best, while the demons-based DIR usually ranked last except for a modified demons-based DISC used for CT-CBCT DIR. These experimental results suggest that the choice of a specific DIR algorithm depends on the image modality, anatomic site, magnitude of deformation and application. Therefore, careful examinations and modifications are required before accepting the auto-propagated contours, especially for automatic re-planning ART systems.	[Li, Xin; Wu, Shuyu; Xiao, Yang; Zhen, Xin; Zhou, Linghong] Southern Med Univ, Dept Biomed Engn, Guangzhou, Guangdong, Peoples R China; [Zhang, Yuyu; Shi, Yinghua] Jilin Univ, Hosp 1, Dept Radiotherapy Oncol, Changchun, Jilin, Peoples R China; [Gu, Xuejun] Univ Texas Southwestern Med Ctr Dallas, Dept Radiotherapy Oncol, Dallas, TX 75390 USA	Southern Medical University - China; Jilin University; University of Texas System; University of Texas Southwestern Medical Center Dallas	Zhen, X; Zhou, LH (corresponding author), Southern Med Univ, Dept Biomed Engn, Guangzhou, Guangdong, Peoples R China.	xinzhen@smu.edu.cn; smart@smu.edu.cn		Shi, Yinghua/0000-0002-1362-4686	National Natural Science Foundation of China [81301940, 81571771]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by The National Natural Science Foundation of China (No 81301940 and No 81571771, http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker JL, 2004, INT J RADIAT ONCOL, V59, P960, DOI 10.1016/j.ijrobp.2003.12.024; Beadle BM, 2014, CANCER-AM CANCER SOC, V120, P702, DOI 10.1002/cncr.28372; Bruhn A, 2005, INT J COMPUT VISION, V61, P211, DOI 10.1023/B:VISI.0000045324.43199.43; Castadot P, 2008, RADIOTHER ONCOL, V89, P1, DOI 10.1016/j.radonc.2008.04.010; Castadot P, 2010, SEMIN RADIAT ONCOL, V20, P84, DOI 10.1016/j.semradonc.2009.11.002; Castadot P, 2010, RADIOTHER ONCOL, V95, P209, DOI 10.1016/j.radonc.2010.03.007; Chen AM, 2014, HEAD NECK-J SCI SPEC, V36, P1541, DOI 10.1002/hed.23477; Cheng HCY, 2012, RADIOTHER ONCOL, V104, P317, DOI 10.1016/j.radonc.2012.03.013; Fedorov A, 2012, MAGN RESON IMAGING, V30, P1323, DOI 10.1016/j.mri.2012.05.001; Fiorentino A, 2014, RADIOL MED, V119, P201, DOI 10.1007/s11547-013-0326-3; Fung WWK, 2014, J RADIAT RES, V55, P293, DOI 10.1093/jrr/rrt103; Han CH, 2008, INT J RADIAT ONCOL, V70, P1256, DOI 10.1016/j.ijrobp.2007.10.067; Hansen EK, 2006, INT J RADIAT ONCOL, V64, P355, DOI 10.1016/j.ijrobp.2005.07.957; Hardcastle N, 2013, RADIAT ONCOL, V8, DOI 10.1186/1748-717X-8-243; Hardcastle N, 2012, RADIAT ONCOL, V7, DOI 10.1186/1748-717X-7-90; HORN BKP, 1981, ARTIF INTELL, V17, P185, DOI 10.1016/0004-3702(81)90024-2; Hou JD, 2011, MED PHYS, V38, P2088, DOI 10.1118/1.3554647; Huang HX, 2015, RADIAT ONCOL, V10, DOI 10.1186/s13014-015-0498-1; Imura M, 2005, INT J RADIAT ONCOL, V63, P1442, DOI 10.1016/j.ijrobp.2005.04.024; Janssens G, 2009, MED PHYS, V36, P4268, DOI 10.1118/1.3194750; Jin XC, 2013, RADIAT ONCOL, V8, DOI 10.1186/1748-717X-8-279; Klein S, 2010, IEEE T MED IMAGING, V29, P196, DOI 10.1109/TMI.2009.2035616; Lee C, 2008, RADIOTHER ONCOL, V89, P81, DOI 10.1016/j.radonc.2008.07.006; Lee N, 2003, INT J RADIAT ONCOL, V57, P49, DOI 10.1016/S0360-3016(03)00405-X; Lou YF, 2013, MED IMAGE ANAL, V17, P387, DOI 10.1016/j.media.2013.01.005; Lu WG, 2006, PHYS MED BIOL, V51, P1077, DOI 10.1088/0031-9155/51/5/002; Lu WG, 2004, PHYS MED BIOL, V49, P3067, DOI 10.1088/0031-9155/49/14/003; Marta GN, 2014, RADIOTHER ONCOL, V110, P9, DOI 10.1016/j.radonc.2013.11.010; Mohamed ASR, 2015, RADIOLOGY, V274, P752, DOI 10.1148/radiol.14132871; Nithiananthan S, 2009, MED PHYS, V36, P4755, DOI 10.1118/1.3223631; Nithiananthan S, 2011, MED PHYS, V38, P1785, DOI 10.1118/1.3555037; Osorio EMV, 2008, INT J RADIAT ONCOL, V70, P875, DOI 10.1016/j.ijrobp.2007.10.063; Riboldi M, 2012, LANCET ONCOL, V13, pE383, DOI 10.1016/S1470-2045(12)70243-7; Rigaud B, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/726268; Robar JL, 2007, INT J RADIAT ONCOL, V68, P1121, DOI 10.1016/j.ijrobp.2007.01.030; Rogelj P, 2006, MED IMAGE ANAL, V10, P484, DOI 10.1016/j.media.2005.03.003; Schwartz DL, 2012, CURR ONCOL REP, V14, P139, DOI 10.1007/s11912-012-0221-4; Thirion J P, 1998, Med Image Anal, V2, P243, DOI 10.1016/S1361-8415(98)80022-4; Thor M, 2011, ACTA ONCOL, V50, P918, DOI 10.3109/0284186X.2011.577806; Uneri A, 2013, MED PHYS, V40, DOI 10.1118/1.4767757; Veiga C, 2014, MED PHYS, V41, DOI 10.1118/1.4864240; Vemuri BC, 2000, MATH METHODS BIOMEDI; Wang H, 2005, PHYS MED BIOL, V50, P2887, DOI 10.1088/0031-9155/50/12/011; Wang ZH, 2009, LARYNGOSCOPE, V119, P1966, DOI 10.1002/lary.20601; Wen N, 2012, PHYS MED BIOL, V57, P5361, DOI 10.1088/0031-9155/57/17/5361; Xie YQ, 2008, MED PHYS, V35, P4450, DOI 10.1118/1.2975230; Yan D, 1997, PHYS MED BIOL, V42, P123, DOI 10.1088/0031-9155/42/1/008; Yang DS, 2011, MED PHYS, V38, P67, DOI 10.1118/1.3521468; Yeo BTT, 2008, LECT NOTES COMPUT SC, V5241, P745, DOI 10.1007/978-3-540-85988-8_89; Yeo UJ, 2013, MED PHYS, V40, DOI 10.1118/1.4819945; Zhang TZ, 2007, INT J RADIAT ONCOL, V68, P522, DOI 10.1016/j.ijrobp.2007.01.038; Zhen X, 2013, PHYS MED BIOL, V58, P7979, DOI 10.1088/0031-9155/58/22/7979; Zhen X, 2012, PHYS MED BIOL, V57, P6807, DOI 10.1088/0031-9155/57/21/6807	53	24	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2017	12	4							e0175906	10.1371/journal.pone.0175906	http://dx.doi.org/10.1371/journal.pone.0175906			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KD	28414799	Green Published, gold, Green Submitted			2022-12-27	WOS:000399874800076
J	Vaclavik, T; Beckmann, M; Cord, AF; Bindewald, AM				Vaclavik, Tomas; Beckmann, Michael; Cord, Anna F.; Bindewald, Anja M.			Effects of UV-B radiation on leaf hair traits of invasive plants-Combining historical herbarium records with novel remote sensing data	PLOS ONE			English	Article							ALPINE LIFE ZONE; NEW-ZEALAND; PHYSIOLOGICAL-RESPONSES; LATITUDINAL GRADIENT; REGRESSION TREES; OZONE DEPLETION; HIERACIUM; CLIMATE; PHOTOSYNTHESIS; ACCLIMATION	Ultraviolet-B (UV-B) radiation is a key but under-researched environmental factor that initiates diverse responses in plants, potentially affecting their distribution. To date, only a few macroecological studies have examined adaptations of plant species to different levels of UV-B. Here, we combined herbarium specimens of Hieracium pilosella L. and Echium vulgare L. with a novel UV-B dataset to examine differences in leaf hair traits between the plants' native and alien ranges. We analysed scans of 336 herbarium specimens using standardized measurements of leaf area, hair density (both species) and hair length (H. pilosella only). While accounting for other bioclimatic variables (i.e. temperature, precipitation) and effects of herbivory, we examined whether UV-B exposure explains the variability and geographical distribution of these traits in the native (Northern Hemisphere) vs. the alien (Southern Hemisphere) range. UV-B explained the largest proportion of the variability and geographical distribution of hair length in H. pilosella (relative influence 67.1%), and hair density in E. vulgare (66.2%). Corresponding with higher UV-B, foliar hairs were 25% longer for H. pilosella and 25% denser for E. vulgare in records from the Southern as compared to those from the Northern Hemisphere. However, focusing on each hemisphere separately or controlling for its effect in a regression analysis, we found no apparent influence of UV-B radiation on hair traits. Thus, our findings did not confirm previous experimental studies which suggested that foliar hairs may respond to higher UV-B intensities, presumably offering protection against detrimental levels of radiation. We cannot rule out UV-B radiation as a possible driver because UV-B radiation was the only considered variable that differed substantially between the hemispheres, while bioclimatic conditions (e.g. temperature, precipitation) and other considered variables (herbivory damage, collection date) were at similar levels. However, given that either non-significant or inconclusive relationships were detected within hemispheres, alternative explanations of the differences in foliar hairs are more likely, including the effects of environment, genotypes or herbivory.	[Vaclavik, Tomas; Beckmann, Michael; Cord, Anna F.; Bindewald, Anja M.] UFZ Helmholtz Ctr Environm Res, Dept Computat Landscape Ecol, Leipzig, Germany; [Vaclavik, Tomas] Palacky Univ, Dept Ecol & Environm Sci, Fac Sci, Olomouc, Czech Republic; [Bindewald, Anja M.] Univ Appl Sci Bremen, Bremen, Germany	Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Palacky University Olomouc; Bremen University of Applied Sciences	Vaclavik, T (corresponding author), UFZ Helmholtz Ctr Environm Res, Dept Computat Landscape Ecol, Leipzig, Germany.; Vaclavik, T (corresponding author), Palacky Univ, Dept Ecol & Environm Sci, Fac Sci, Olomouc, Czech Republic.	tomas.vaclavik@ufz.de	VÁCLAVÍK, Tomáš/N-3163-2019; Vaclavik, Tomas/B-4668-2013; Cord, Anna/AAE-8327-2022	VÁCLAVÍK, Tomáš/0000-0002-1113-6320; Vaclavik, Tomas/0000-0002-1113-6320; Beckmann, Michael/0000-0002-5678-265X; Cord, Anna F./0000-0003-3183-8482	German National Academic Foundation; Global Assessment of Land Use Dynamics, Greenhouse Gas Emissions and Ecosystem Services GLUES (German Federal Ministry of Education and Research) [01LL0901A]	German National Academic Foundation; Global Assessment of Land Use Dynamics, Greenhouse Gas Emissions and Ecosystem Services GLUES (German Federal Ministry of Education and Research)	The work was supported by the German National Academic Foundation that funded a research stay in New Zealand in order to collect the herbarium data and by grant 01LL0901A: Global Assessment of Land Use Dynamics, Greenhouse Gas Emissions and Ecosystem Services GLUES (German Federal Ministry of Education and Research). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aikio S, 2012, GLOBAL ECOL BIOGEOGR, V21, P778, DOI 10.1111/j.1466-8238.2011.00711.x; Barnes PW, 2013, PHYSIOL PLANTARUM, V149, P200, DOI 10.1111/ppl.12025; Bastlova-Hanzelyova D, 2001, PLANT INVASIONS: SPECIES ECOLOGY AND ECOSYSTEM MANAGEMENT, P33; Beckmann M, 2014, AUSTRAL ECOL, V39, P378, DOI 10.1111/aec.12087; Beckmann M, 2014, METHODS ECOL EVOL, V5, P372, DOI 10.1111/2041-210X.12168; Beckmann M, 2012, ENVIRON EXP BOT, V75, P173, DOI 10.1016/j.envexpbot.2011.09.010; BISHOP GF, 1994, J ECOL, V82, P195, DOI 10.2307/2261400; Bjorn Lars Olof, 1996, International Journal of Environmental Studies, V51, P217, DOI 10.1080/00207239608711082; Blumenthal DM, 2014, CABI INVASIVE SER, V4, P62, DOI 10.1079/9781780641645.0062; Broennimann O, 2014, J BIOGEOGR, V41, P1126, DOI 10.1111/jbi.12274; Brosche M, 2003, PHYSIOL PLANTARUM, V117, P1, DOI 10.1034/j.1399-3054.2003.1170101.x; Burns KC, 2012, GLOBAL ECOL BIOGEOGR, V21, P819, DOI 10.1111/j.1466-8238.2011.00730.x; CALDWELL MM, 1980, ECOLOGY, V61, P600, DOI 10.2307/1937426; CLIFF A, 1972, GEOGR ANAL, V4, P267; Crooks Jeffrey A., 1999, Population and Community Biology Series, V24, P103; Dalin Peter, 2008, P89, DOI 10.1007/978-1-4020-8182-8_4; De'Ath G, 2002, ECOLOGY, V83, P1105, DOI 10.2307/3071917; Drenovsky RE, 2012, ANN BOT-LONDON, V110, P141, DOI 10.1093/aob/mcs100; Elith J, 2008, J ANIM ECOL, V77, P802, DOI 10.1111/j.1365-2656.2008.01390.x; ESPIE P, 2001, HIERACIUM NZ ECOLOGY; Filella I, 1999, PLANT ECOL, V145, P157, DOI 10.1023/A:1009826803540; Godar DE, 2005, PHOTOCHEM PHOTOBIOL, V81, P736, DOI 10.1562/2004-09-07-IR-308R.1; Grinnell J, 1919, AM NAT, V53, P468, DOI 10.1086/279725; Groves RH, 2006, EUPHYTICA, V148, P111, DOI 10.1007/s10681-006-5945-5; Guerin GR, 2012, BIOL LETTERS, V8, P882, DOI 10.1098/rsbl.2012.0458; Hay WW, 1997, GEOL RUNDSCH, V86, P471, DOI 10.1007/s005310050155; Herman JR, 1996, GEOPHYS RES LETT, V23, P2117, DOI 10.1029/96GL01958; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hock M., 2012, THESIS; Hofmann RW, 2011, PLANT BIOLOGY, V13, P896, DOI 10.1111/j.1438-8677.2011.00458.x; Jager EJ, 2002, GEFASSPFLANZEN KRITI, V9; Jakobs G, 2004, DIVERS DISTRIB, V10, P11, DOI 10.1111/j.1472-4642.2004.00052.x; Jansen MAK, 1998, TRENDS PLANT SCI, V3, P131, DOI 10.1016/S1360-1385(98)01215-1; Marcel AK, 2012, PHYSIOL PLANTARUM, V145, P501, DOI 10.1111/j.1399-3054.2012.01656.x; Kattge J, 2011, GLOBAL CHANGE BIOL, V17, P2905, DOI 10.1111/j.1365-2486.2011.02451.x; Klemow KM, 2002, CAN J PLANT SCI, V82, P235, DOI 10.4141/P01-058; Lake JA, 2009, PLANT CELL ENVIRON, V32, P1377, DOI 10.1111/j.1365-3040.2009.02005.x; Lee CE, 2002, TRENDS ECOL EVOL, V17, P386, DOI 10.1016/S0169-5347(02)02554-5; Leger EA, 2013, GLOBAL CHANGE BIOL, V19, P2229, DOI 10.1111/gcb.12208; Liakoura V, 1997, ENVIRON EXP BOT, V38, P223, DOI 10.1016/S0098-8472(97)00005-1; Manetas Y, 2003, NEW PHYTOL, V158, P503, DOI 10.1046/j.1469-8137.2003.00768.x; Navas ML, 2002, ACTA OECOL, V23, P375, DOI 10.1016/S1146-609X(02)01168-2; Newsham KK, 2009, GLOBAL CHANGE BIOL, V15, P2574, DOI 10.1111/j.1365-2486.2009.01944.x; Paul ND, 2012, PHYSIOL PLANTARUM, V145, P565, DOI 10.1111/j.1399-3054.2011.01553.x; Qaderi MM, 2008, ECOSCIENCE, V15, P150, DOI 10.2980/15-2-3052; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Reef R, 2014, GLOBAL ECOL BIOGEOGR, V23, P1209, DOI 10.1111/geb.12211; Rejmanek M, 1996, ECOLOGY, V77, P1655, DOI 10.2307/2265768; RIDGEWAY G, 2006, R PACKAGE VERSION, V1, P55; ROBBERECHT R, 1980, ECOLOGY, V61, P612, DOI 10.2307/1937427; Robinson SA, 2015, GLOBAL CHANGE BIOL, V21, P515, DOI 10.1111/gcb.12739; Robson TM, 2015, PLANT CELL ENVIRON, V38, P856, DOI 10.1111/pce.12374; Robson TM, 2012, PHYSIOL PLANTARUM, V144, P146, DOI 10.1111/j.1399-3054.2011.01546.x; Roy BA, 1999, J EVOLUTION BIOL, V12, P1089, DOI 10.1046/j.1420-9101.1999.00107.x; SECKMEYER G, 1992, NATURE, V359, P135, DOI 10.1038/359135a0; TRESKONOVA M, 1991, NEW ZEAL J ECOL, V15, P65; Trewick SA, 2004, AM J BOT, V91, P73, DOI 10.3732/ajb.91.1.73; Wargent JJ, 2013, NEW PHYTOL, V197, P1058, DOI 10.1111/nph.12132; Watanabe S, 2012, ATMOS CHEM PHYS, V12, P5249, DOI 10.5194/acp-12-5249-2012; Webb CJ, 1988, FLORA NZ; Wilson L. M., 1997, Rangelands, V19, P18; Xiong FS, 2001, PLANT PHYSIOL, V125, P738, DOI 10.1104/pp.125.2.738; Yamasaki Seiji, 2014, Environmental Control in Biology, V52, P203, DOI 10.2525/ecb.52.203	63	13	13	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2017	12	4							e0715671	10.1371/journal.pone.0175671	http://dx.doi.org/10.1371/journal.pone.0175671			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KD	28414764	Green Published, Green Submitted, gold			2022-12-27	WOS:000399874800045
J	Mitaka, Y; Kobayashi, K; Matsuura, K				Mitaka, Yuki; Kobayashi, Kazuya; Matsuura, Kenji			Caste-, sex-, and age-dependent expression of immune-related genes in a Japanese subterranean termite, Reticulitermes speratus	PLOS ONE			English	Article							WOOD-FEEDING TERMITE; FUNGAL-INFECTION; DAMPWOOD TERMITE; INSECT IMMUNITY; LYSOZYME; DROSOPHILA; ANTIFUNGAL; IDENTIFICATION; DEFENSES; SUPPRESSION	Insects protect themselves from microbial infections through innate immune responses, including pathogen recognition, phagocytosis, the activation of proteolytic cascades, and the synthesis of antimicrobial peptides. Termites, eusocial insects inhabiting microbe-rich wood, live in closely-related family groups that are susceptible to shared pathogen infections. To resist pathogenic infection, termite families have evolved diverse immune adaptations at both individual and societal levels, and a strategy of trade-offs between reproduction and immunity has been suggested. Although termite immune-inducible genes have been identified, few studies have investigated the differential expression of these genes between reproductive and neuter castes, and between sexes in each caste. In this study, we compared the expression levels of immune-related genes among castes, sexes, and ages in a Japanese subterranean termite, Reticulitermes speratus. Using RNA-seq, we found 197 immune-related genes, including 40 pattern recognition proteins, 97 signalling proteins, 60 effectors. Among these genes, 174 showed differential expression among castes. Comparing expression levels between males and females in each caste, we found sexually dimorphic expression of immune-related genes not only in reproductive castes, but also in neuter castes. Moreover, we identified age-related differential expression of 162 genes in male and/or female reproductives. In addition, although R. speratus is known to use the antibacterial peptide C-type lysozyme as an egg recognition pheromone, we determined that R. speratus has not only C-type, but also P-type and I-type lysozymes, as well as other termite species. Our transcriptomic analyses revealed immune response plasticity among all castes, and sex-biased expression of immune genes even in neuter castes, suggesting a sexual division of labor in the immune system of R. speratus. This study heightens the understanding of the evolution of antimicrobial strategies in eusocial insects, and of sexual roles in insect societies as a whole.	[Mitaka, Yuki; Kobayashi, Kazuya; Matsuura, Kenji] Kyoto Univ, Grad Sch Agr, Lab Insect Ecol, Kyoto, Japan	Kyoto University	Mitaka, Y (corresponding author), Kyoto Univ, Grad Sch Agr, Lab Insect Ecol, Kyoto, Japan.	ymitaka@kais.kyoto-u.ac.jp	kobayashi, kazuya/J-5507-2013; Mitaka, Yuki/AAS-2227-2020	kobayashi, kazuya/0000-0002-9475-6807; Mitaka, Yuki/0000-0002-3399-3470	Japan Society for the Promotion of Science [25221206]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Japan Society for the Promotion of Science (http://www. isps.go.jp/ienglish/Andex.html, No. 25221206 to KM). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avulova S, 2011, J INSECT PHYSIOL, V57, P966, DOI 10.1016/j.jinsphys.2011.04.009; Bachali S, 2002, J MOL EVOL, V54, P652, DOI 10.1007/s00239-001-0061-6; Boehnisch C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024619; Bulmer MS, 2009, P NATL ACAD SCI USA, V106, P12652, DOI 10.1073/pnas.0904063106; Bulmer MS, 2006, MOL BIOL EVOL, V23, P317, DOI 10.1093/molbev/msj037; Calleri DV, 2007, PHYSIOL ENTOMOL, V32, P136, DOI 10.1111/j.1365-3032.2007.00559.x; Carton Y, 2001, IMMUNOGENETICS, V52, P157; Chen J, 1998, J AGR FOOD CHEM, V46, P2337, DOI 10.1021/jf9709717; Chouvenc T, 2009, J INVERTEBR PATHOL, V101, P234, DOI 10.1016/j.jip.2009.05.008; Conus S, 2010, SWISS MED WEEKLY; Cremer S, 2007, CURR BIOL, V17, pR693, DOI 10.1016/j.cub.2007.06.008; DAFFRE S, 1994, MOL GEN GENET, V242, P152, DOI 10.1007/BF00391008; Dimopoulos G, 2003, CELL MICROBIOL, V5, P3, DOI 10.1046/j.1462-5822.2003.00252.x; Eggleton P, 2011, BIOLOGY OF TERMITES: A MODERN SYNTHESIS, P1, DOI 10.1007/978-90-481-3977-4_1; Evans JD, 2006, INSECT MOL BIOL, V15, P645, DOI 10.1111/j.1365-2583.2006.00682.x; Fujita A, 2002, INSECT BIOCHEM MOLEC, V32, P1615, DOI 10.1016/S0965-1748(02)00100-5; Fujita A, 2001, PHYSIOL ENTOMOL, V26, P116, DOI 10.1046/j.1365-3032.2001.00224.x; Gao Q, 2012, ARCH INSECT BIOCHEM, V80, P63, DOI 10.1002/arch.21026; Gerardo NM, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r21; Gorman MJ, 2001, INSECT BIOCHEM MOLEC, V31, P257, DOI 10.1016/S0965-1748(00)00145-4; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Hamilton C, 2012, DEV COMP IMMUNOL, V36, P372, DOI 10.1016/j.dci.2011.07.008; Hamilton C, 2011, BIOL LETTERS, V7, P89, DOI 10.1098/rsbl.2010.0466; Howard KJ, 2011, BIOLOGY OF TERMITES: A MODERN SYNTHESIS, P97, DOI 10.1007/978-90-481-3977-4_5; Hultmark D, 2003, CURR OPIN IMMUNOL, V15, P12, DOI 10.1016/S0952-7915(02)00005-5; Hussain A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069543; JOLLES P, 1984, MOL CELL BIOCHEM, V63, P165; Kanost MR, 1999, DEV COMP IMMUNOL, V23, P291, DOI 10.1016/S0145-305X(99)00012-9; Kim JH, 2011, INSECT BIOCHEM MOLEC, V41, P332, DOI 10.1016/j.ibmb.2011.01.011; Kobayashi K, 2013, NAT COMMUN, V4, DOI [10.1038/ncomms3048, 10.1038/ncomms3792]; Konrad M, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001300; Kuraishi T, 2007, EXP CELL RES, V313, P500, DOI 10.1016/j.yexcr.2006.10.027; Lamberty M, 2001, J BIOL CHEM, V276, P4085, DOI 10.1074/jbc.M002998200; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Ligoxygakis P, 2002, SCIENCE, V297, P114, DOI 10.1126/science.1072391; Liu L, 2015, SCI REP-UK, V5, DOI 10.1038/srep15106; MALEHORN DE, 1994, PLANT PHYSIOL, V106, P1471, DOI 10.1104/pp.106.4.1471; Matsuura K, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000813; Matsuura K, 2015, ECOL RES, V30, P93, DOI 10.1007/s11284-014-1213-7; Matsuura K, 2010, P NATL ACAD SCI USA, V107, P12963, DOI 10.1073/pnas.1004675107; Matz M, 1999, NUCLEIC ACIDS RES, V27, P1558, DOI 10.1093/nar/27.6.1558; Mitaka Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146125; Nikapitiya C, 2010, FISH SHELLFISH IMMUN, V29, P334, DOI 10.1016/j.fsi.2010.04.004; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rosengaus RB, 2011, BIOLOGY OF TERMITES: A MODERN SYNTHESIS, P165, DOI 10.1007/978-90-481-3977-4_7; Rosengaus RB, 2007, NATURWISSENSCHAFTEN, V94, P25, DOI 10.1007/s00114-006-0151-9; Shathasivam T, 2010, J CELL MOL MED, V14, P2702, DOI 10.1111/j.1582-4934.2010.01176.x; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tasaki E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0167412; Terrapon N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4636; Thompson GJ, 2003, INSECT MOL BIOL, V12, P1, DOI 10.1046/j.1365-2583.2003.00381.x; Ulvila J, 2011, J LEUKOCYTE BIOL, V89, P649, DOI 10.1189/jlb.0410195; Ursic-Bedoya R, 2011, INSECT MOL BIOL, V20, P775, DOI 10.1111/j.1365-2583.2011.01107.x; Wang WX, 2009, J INSECT SCI, V9, DOI 10.1673/031.009.1701; Wang Y, 2011, INSECT BIOCHEM MOLEC, V41, P322, DOI 10.1016/j.ibmb.2011.01.010; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Xu P, 2012, GENET MOL RES, V11, P2247, DOI 10.4238/2012.May.10.2; Yashiro T, 2014, P NATL ACAD SCI USA, V111, P17212, DOI 10.1073/pnas.1412481111; Yuki M, 2008, ZOOL SCI, V25, P401, DOI 10.2108/zsj.25.401; Zelensky AN, 2005, FEBS J, V272, P6179, DOI 10.1111/j.1742-4658.2005.05031.x; Zettervall CJ, 2004, P NATL ACAD SCI USA, V101, P14192, DOI 10.1073/pnas.0403789101	63	21	23	3	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2017	12	4							e0175417	10.1371/journal.pone.0175417	http://dx.doi.org/10.1371/journal.pone.0175417			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0MD	28410430	Green Published, Green Submitted, gold			2022-12-27	WOS:000399955600017
J	Tewawong, N; Vichiwattana, P; Korkong, S; Klinfueng, S; Suntronwong, N; Thongmee, T; Theamboonlers, A; Vongpunsawad, S; Poovorawan, Y				Tewawong, Nipaporn; Vichiwattana, Preeyaporn; Korkong, Sumeth; Klinfueng, Sirapa; Suntronwong, Nungruthai; Thongmee, Thanunrat; Theamboonlers, Apiradee; Vongpunsawad, Sompong; Poovorawan, Yong			Evolution of the neuraminidase gene of seasonal influenza A and B viruses in Thailand between 2010 and 2015	PLOS ONE			English	Article							H1N1 INFLUENZA; PHYLOGENETIC ANALYSIS; ADVISORY-COMMITTEE; PANDEMIC H1N1; UNITED-STATES; ACTIVE-SITE; OSELTAMIVIR; RESISTANCE; INHIBITORS; EMERGENCE	The neuraminidase inhibitors (NAIs) oseltamivir and zanamivir are commonly used for the treatment and control of influenza A and B virus infection. However, the emergence of new influenza virus strains with reduced susceptibility to NAIs may appear with the use of these antivirals or even naturally. We therefore screened the neuraminidase (NA) sequences of seasonal influenza virus A(H1N1), A(H1N1)pdm09, A(H3N2), and influenza B virus strains identified in Thailand for the presence of substitutions previously reported to reduce susceptibility to NAIs. We initially examined oseltamivir resistance (characterized by the H275Y mutation in the NA gene) in 485 A(H1N1) pdm09 strains circulating in Thailand and found that 0.82% (4/485) had this substitution. To further evaluate the evolution of the NA gene, we also randomly selected 98 A(H1N1) pdm09, 158 A(H3N2), and 69 influenza B virus strains for NA gene amplification and sequencing, which revealed various amino acid mutations in the active site of the NA protein previously shown to be associated with reduced susceptibility to NAIs. Phylogenetic analysis of the influenza virus strains from this study and elsewhere around the world, together with the estimations of nucleotide substitution rates and selection pressure, and the predictions of B-cell epitopes and N-linked glycosylation sites all provided evidence for the ongoing evolution of NA. The overall rates of NA evolution for influenza A viruses were higher than for influenza B virus at the nucleotide level, although influenza B virus possessed more genealogical diversity than that of influenza A viruses. The continual surveillance of the antigenic changes associated with the NA protein will not only contribute to the influenza virus database but may also provide a better understanding of selection pressure exerted by antiviral use.	[Tewawong, Nipaporn; Vichiwattana, Preeyaporn; Korkong, Sumeth; Klinfueng, Sirapa; Suntronwong, Nungruthai; Thongmee, Thanunrat; Theamboonlers, Apiradee; Vongpunsawad, Sompong; Poovorawan, Yong] Chulalongkorn Univ, Fac Med, Dept Pediat, Ctr Excellence Clin Virol, Bangkok, Thailand	Chulalongkorn University	Poovorawan, Y (corresponding author), Chulalongkorn Univ, Fac Med, Dept Pediat, Ctr Excellence Clin Virol, Bangkok, Thailand.	yong.p@chula.ac.th	ภู่วรวรรณ, ศนพ.ยง/GZK-8615-2022	vongpunsawad, sompong/0000-0001-7520-8728; Tewawong, Nipaporn/0000-0003-1098-3701	Research Chair Grant from the National Science and Technology Development Agency [P-15-50004]; National Research University Project, Office of Higher Education Commission [NRU59-002-HR]; Chulalongkorn University Centenary Academic Development Project [CU56-HR01]; Ratchadaphiseksomphot Endowment Fund of Chulalongkorn University [RES560530093]; Outstanding Professor of Thailand Research Fund [DPG5480002]; Center of Excellence in Clinical Virology of Chulalongkorn University [GCE 58-014-30-004]; Overseas Research Experience Scholarship for Graduate Students of Chulalongkorn University	Research Chair Grant from the National Science and Technology Development Agency; National Research University Project, Office of Higher Education Commission; Chulalongkorn University Centenary Academic Development Project; Ratchadaphiseksomphot Endowment Fund of Chulalongkorn University(Chulalongkorn University); Outstanding Professor of Thailand Research Fund; Center of Excellence in Clinical Virology of Chulalongkorn University; Overseas Research Experience Scholarship for Graduate Students of Chulalongkorn University(Chulalongkorn University)	This work was supported by the following funding sources: The Research Chair Grant from the National Science and Technology Development Agency (P-15-50004), The National Research University Project, Office of Higher Education Commission (NRU59-002-HR), Chulalongkorn University Centenary Academic Development Project (CU56-HR01), Ratchadaphiseksomphot Endowment Fund of Chulalongkorn University (RES560530093), The Outstanding Professor of Thailand Research Fund (DPG5480002), and The Center of Excellence in Clinical Virology of Chulalongkorn University (GCE 58-014-30-004). NT received the Overseas Research Experience Scholarship for Graduate Students of Chulalongkorn University. The specific roles of these authors are articulated in the 'author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abed Y, 2006, ANTIVIR THER, V11, P971; Baz M, 2009, NEW ENGL J MED, V361, P2296, DOI 10.1056/NEJMc0910060; Bedford T, 2015, NATURE, V523, P217, DOI 10.1038/nature14460; Butler J, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004065; Chutinimitkul S, 2008, VIRUS RES, V132, P122, DOI 10.1016/j.virusres.2007.11.007; COLMAN PM, 1983, NATURE, V303, P41, DOI 10.1038/303041a0; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; de Jong MD, 2014, CLIN INFECT DIS, V59, pE172, DOI 10.1093/cid/ciu632; Delport W, 2010, BIOINFORMATICS, V26, P2455, DOI 10.1093/bioinformatics/btq429; Dharan NJ, 2009, JAMA-J AM MED ASSOC, V301, P1034, DOI 10.1001/jama.2009.294; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Duan S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6029; Fiore Anthony E., 2011, Morbidity and Mortality Weekly Report, V60, P1; Ghedin E, 2012, J INFECT DIS, V206, P1504, DOI 10.1093/infdis/jis571; Gupta R, 2004, PREDICTION OF N GLYC; Hatakeyama S, 2007, JAMA-J AM MED ASSOC, V297, P1435, DOI 10.1001/jama.297.13.1435; Hayden FG, 1999, NEW ENGL J MED, V341, P1336, DOI 10.1056/NEJM199910283411802; Huang WJ, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0317-1; Hurt AC, 2011, EUROSURVEILLANCE, V16, P24; Hurt AC, 2014, CURR OPIN VIROL, V8, P22, DOI 10.1016/j.coviro.2014.04.009; Hurt AC, 2012, LANCET INFECT DIS, V12, P240, DOI 10.1016/S1473-3099(11)70318-8; Jain S, 2009, NEW ENGL J MED, V361, P1935, DOI 10.1056/NEJMoa0906695; Kim CU, 1997, J AM CHEM SOC, V119, P681, DOI 10.1021/ja963036t; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Larsen Jens Erik Pontoppidan, 2006, Immunome Res, V2, P2, DOI 10.1186/1745-7580-2-2; Leang SK, 2014, INFLUENZA OTHER RESP, V8, P135, DOI 10.1111/irv.12187; LI SQ, 1993, J VIROL, V67, P6667, DOI 10.1128/JVI.67.11.6667-6673.1993; Li TCM, 2015, VIRUSES-BASEL, V7, P4929, DOI 10.3390/v7092850; Li WF, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-183; Lin JH, 2011, CLIN MICROBIOL INFEC, V17, P214, DOI 10.1111/j.1469-0691.2010.03228.x; Makkoch J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051275; Mazurek Gerald H., 2010, Morbidity and Mortality Weekly Report, V59, P1; McCauley J, REPORT PREPARED WHO; Meijer A, 2009, EMERG INFECT DIS, V15, P552, DOI [10.3201/eid1504.081280, 10.3201/eid1504.181280]; Mostafa A, 2016, ARCH VIROL, V161, P1505, DOI 10.1007/s00705-016-2815-x; Nei M., 2000, MOL EVOLUTION PHYLOG; Nelson MI, 2006, PLOS PATHOG, V2, P1144, DOI 10.1371/journal.ppat.0020125; Nelson MI, 2007, NAT REV GENET, V8, P196, DOI 10.1038/nrg2053; Okomo-Adhiambo M, 2015, EMERG INFECT DIS, V21, P136, DOI [10.3201/eid2101.141006, 10.3201/eid2101/141006]; Oong XY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136254; PALESE P, 1974, VIROLOGY, V61, P397, DOI 10.1016/0042-6822(74)90276-1; Payungporn S, 2011, J VIROL METHODS, V177, P133, DOI 10.1016/j.jviromet.2011.07.008; Rambaut A, 2008, NATURE, V453, P615, DOI 10.1038/nature06945; Richard M, 2011, ANTIMICROB AGENTS CH, V55, P2942, DOI 10.1128/AAC.01699-10; Saito T, 1997, J VET MED SCI, V59, P923, DOI 10.1292/jvms.59.923; SAUTER NK, 1989, BIOCHEMISTRY-US, V28, P8388, DOI 10.1021/bi00447a018; SCHILD GC, 1974, B WORLD HEALTH ORGAN, V51, P1; STEINHAUER DA, 1987, ANNU REV MICROBIOL, V41, P409, DOI 10.1146/annurev.mi.41.100187.002205; Su YCF, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8952; Suzuki Y, 2006, MOL BIOL EVOL, V23, P1902, DOI 10.1093/molbev/msl050; Takahashi T, 2003, FEBS LETT, V543, P71, DOI 10.1016/S0014-5793(03)00403-4; Takahashi T, 2013, PLOS ONE, V5; Takashita E, 2015, ANTIVIR RES, V117, P27, DOI 10.1016/j.antiviral.2015.02.003; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tewawong N, 2016, ARCH VIROL, V161, P1425, DOI 10.1007/s00705-016-2802-2; Tewawong N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116302; The WHO GISRS antiviral susceptibility expert working group (AVWG), SUMM NEUR AM AC SUBS; Vijaykrishna D, 2015, ELIFE, V4, DOI 10.7554/eLife.05055; Wan HQ, 2013, J VIROL, V87, P9290, DOI 10.1128/JVI.01203-13; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Westgeest KB, 2014, J VIROL, V88, P2844, DOI 10.1128/JVI.02163-13; Whitley RJ, 2013, CLIN INFECT DIS, V56, P1197, DOI 10.1093/cid/cis1220; Xu R, 2012, J VIROL, V86, P9221, DOI 10.1128/JVI.00697-12	63	14	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2017	12	4							e0175655	10.1371/journal.pone.0175655	http://dx.doi.org/10.1371/journal.pone.0175655			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0MD	28410396	Green Submitted, gold, Green Published			2022-12-27	WOS:000399955600031
J	de Carvalho, DB; Congrains, C; Chahad-Ehlers, S; Pinotti, H; de Brito, RA; da Rosa, JA				de Carvalho, Danila Blanco; Congrains, Carlos; Chahad-Ehlers, Samira; Pinotti, Heloisa; de Brito, Reinaldo Alves; da Rosa, Joao Aristeu			Differential transcriptome analysis supports Rhodnius montenegrensis and Rhodnius robustus (Hemiptera, Reduviidae, Triatominae) as distinct species	PLOS ONE			English	Article							CHAGAS-DISEASE; CLATHRIN FUNCTION; BLOODSUCKING BUG; BINDING-PROTEIN; INVADING HOUSES; HIGH-THROUGHPUT; PROLIXUS; INSIGHT; RNA; VECTOR	Chagas disease is one of the main parasitic diseases found in Latin America and it is estimated that between six and seven million people are infected worldwide. Its etiologic agent, the protozoan Trypanosoma cruzi, is transmitted by triatomines, some of which from the genus Rhodnius. Twenty species are currently recognized in this genus, including some closely related species with low levels of morphological differentiation, such as Rhodnius montenegrensis and Rhodnius robustus. In order to investigate genetic differences between these two species, we generated large-scale RNA-sequencing data (consisting of four RNA-seq libraries) from the heads and salivary glands of males of R. montenegrensis and R. robustus. Transcriptome assemblies produced for each species resulted in 64,952 contigs for R. montenegrensis and 70,894 contigs for R. robustus, with N50 of approximately 2,100 for both species. SNP calling based on the more complete R. robustus assembly revealed 3,055 fixed interspecific differences and 216 transcripts with high levels of divergence which contained only fixed differences between the two species. A gene ontology enrichment analysis revealed that these highly differentiated transcripts were enriched for eight GO terms related to AP-2 adaptor complex, as well as other interesting genes that could be involved in their differentiation. The results show that R. montenegrensis and R. robustus have a substantial quantity of fixed interspecific polymorphisms, which suggests a high degree of genetic divergence between the two species and likely corroborates the species status of R. montenegrensis.	[de Carvalho, Danila Blanco; Pinotti, Heloisa; da Rosa, Joao Aristeu] Sao Paulo State Univ UNESP, Dept Parasitol, Sch Pharmaceut Sci, Sao Paulo, Brazil; [Congrains, Carlos; Chahad-Ehlers, Samira; de Brito, Reinaldo Alves] Fed Univ Sao Carlos UFSCar, Dept Genet & Evolut, Sao Paulo, Brazil	Universidade Estadual Paulista; Universidade Federal de Sao Carlos	da Rosa, JA (corresponding author), Sao Paulo State Univ UNESP, Dept Parasitol, Sch Pharmaceut Sci, Sao Paulo, Brazil.	rosaja@fcfar.unesp.br	da Rosa, João Aristeu/AAP-6781-2020; Chahad-Ehlers, Samira/H-8024-2015; de Brito, Reinaldo/G-3043-2012; da Rosa, João Aristeu Aristeu/U-9885-2017; Congrains, Carlos/E-5709-2017	Chahad-Ehlers, Samira/0000-0003-2321-4389; de Brito, Reinaldo/0000-0002-9441-6255; da Rosa, João Aristeu Aristeu/0000-0001-6318-3025; Congrains, Carlos/0000-0001-7506-6133; Carvalho, Danila Blanco/0000-0002-8463-4777	Coordenagao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) [AUXPE N.23038.005285/2011-12]; CAPES\Programa de Excelencia Academica (Proex); Programa de Apoio ao Desenvolvimento Cientifico da Faculdade de Ciencias Farmaceuticas - UNESP Araraquara (PADC); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [150626/2012-6, 160002/2013-3]	Coordenagao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); CAPES\Programa de Excelencia Academica (Proex); Programa de Apoio ao Desenvolvimento Cientifico da Faculdade de Ciencias Farmaceuticas - UNESP Araraquara (PADC); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported in part by Coordenagao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) (www.capes.gov.br), research project AUXPE N.23038.005285/2011-12 (JAR) supplying scholarships to DBC and HP; by CAPES\Programa de Excelencia Academica (Proex) (http.//www.capes.gov.br/bolsas/balsas-nopais/proex) awarded to Programa de Pos Graduacao em Biociencias e Biotecnologia Aplicadas a Farmacia da Faculdade de Ciencias Farmaceuticas, UNESP Araraquara; by Programa de Apoio ao Desenvolvimento Cientifico da Faculdade de Ciencias Farmaceuticas - UNESP Araraquara (PADC); by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (http://cnpq.br/), research grants 150626/2012-6 (SC-E) and 160002/2013-3 (CC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad-Franch F, 2015, ACTA TROP, V151, P126, DOI 10.1016/j.actatropica.2015.07.005; Abad-Franch F, 2013, MEM I OSWALDO CRUZ, V108, P92, DOI 10.1590/0074-0276130434; Abad-Franch F, 2009, ACTA TROP, V110, P159, DOI 10.1016/j.actatropica.2008.06.005; Abascal F, 2010, NUCLEIC ACIDS RES, V38, pW7, DOI 10.1093/nar/gkq291; Aguilar HM, 2007, MEM I OSWALDO CRUZ, V102, P47, DOI 10.1590/S0074-02762007005000098; Alexa A, 2006, BIOINFORMATICS, V22, P1600, DOI 10.1093/bioinformatics/btl140; Almeida CE, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004447; Andres JA, 2013, GENETICS, V193, P501, DOI 10.1534/genetics.112.142299; Anisimova M, 2009, MOL BIOL EVOL, V26, P255, DOI 10.1093/molbev/msn232; Assumpcao TCF, 2008, INSECT BIOCHEM MOLEC, V38, P213, DOI 10.1016/j.ibmb.2007.11.001; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berdan EL, 2015, MOL ECOL, V24, P3918, DOI 10.1111/mec.13276; Briggs MW, 1998, J BIOL CHEM, V273, P13255, DOI 10.1074/jbc.273.21.13255; Brodsky FM, 2012, ANNU REV CELL DEV BI, V28, P309, DOI 10.1146/annurev-cellbio-101011-155716; Brower AVZ, 2006, SYST BIODIVERS, V4, P127, DOI 10.1017/S147720000500191X; Carvalho DB, 2014, ACTA TROP, V130, P35, DOI 10.1016/j.actatropica.2013.10.009; CATHALA G, 1983, DNA-J MOLEC CELL BIO, V2, P329, DOI 10.1089/dna.1983.2.329; CHAMPAGNE DE, 1995, J BIOL CHEM, V270, P8691, DOI 10.1074/jbc.270.15.8691; Chang HC, 2002, J CELL BIOL, V159, P477, DOI 10.1083/jcb.200205086; CHOMCZYNSKI P, 1995, BIOTECHNIQUES, V19, P942; Christeller JT, 2005, FEBS J, V272, P5710, DOI 10.1111/j.1742-4658.2005.04975.x; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Rodrigues VLCC, 2014, REV INST MED TROP SP, V56, P213, DOI 10.1590/S0036-46652014000300006; Coura J. R., 2014, MEM I O CRUZ; da Rosa JA, 2003, REV SAUDE PUBL, V37, P528, DOI 10.1590/S0034-89102003000400020; DANSAPETRETSKI M, 1995, J BIOL CHEM, V270, P10893, DOI 10.1074/jbc.270.18.10893; DUJARDIN JP, 1991, T ROY SOC TROP MED H, V85, P679, DOI 10.1016/0035-9203(91)90394-E; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Emerson KJ, 2010, P NATL ACAD SCI USA, V107, P16196, DOI 10.1073/pnas.1006538107; Fontaine A, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-187; Fu BD, 2012, DNA RES, V19, P131, DOI 10.1093/dnares/dsr046; Galvao C, 2014, VETORES DOENCA CHAGA; Galvao C, 2003, ZOOTAXA, V202, P36; Galvao C, 2015, ACTA TROP, V151, P116, DOI 10.1016/j.actatropica.2015.06.006; Gouaux E, 1998, J STRUCT BIOL, V121, P110, DOI 10.1006/jsbi.1998.3959; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; GRAUR D, 1988, J MOL EVOL, V28, P131, DOI 10.1007/BF02143504; Gurgel-Goncalves R, 2008, ACTA TROP, V107, P90, DOI 10.1016/j.actatropica.2008.04.020; Hurt JA, 2009, J CELL BIOL, V185, P265, DOI 10.1083/jcb.200811072; Jurberg J, 2009, BIOTA NEOTROP, V9, P5; Justi SA, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-149; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Kupke T, 2001, J BIOL CHEM, V276, P27597, DOI 10.1074/jbc.M103342200; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lee JH, 2001, GENE, V271, P233, DOI 10.1016/S0378-1119(01)00515-7; Lent H., 1979, B AM MUS NAT HIST, V163, P397; Lent H, 1993, MEMORIAS I OSWALDO C, V88; Lyman DE, 1999, AM J TROP MED HYG, V60, P377, DOI 10.4269/ajtmh.1999.60.377; Matias A, 2003, TROP MED INT HEALTH, V8, P264, DOI 10.1046/j.1365-3156.2003.01021.x; Mesquita RD, 2015, P NATL ACAD SCI USA, V112, P14936, DOI 10.1073/pnas.1506226112; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Monteiro FA, 2003, MOL ECOL, V12, P997, DOI 10.1046/j.1365-294X.2003.01802.x; Monteiro FA, 2000, AM J TROP MED HYG, V62, P460, DOI 10.4269/ajtmh.2000.62.460; Montfort WR, 2000, BBA-PROTEIN STRUCT M, V1482, P110, DOI 10.1016/S0167-4838(00)00165-5; Moritz C, 2004, PLOS BIOL, V2, P1529, DOI 10.1371/journal.pbio.0020354; Neiva A, 1923, BRAS MED, p[73, 6]; Nosil P, 2012, PHILOS T R SOC B, V367, P332, DOI 10.1098/rstb.2011.0263; Ribeiro JMC, 2015, J MED ENTOMOL, V52, P351, DOI 10.1093/jme/tjv023; Ribeiro JMC, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002594; Ribeiro JMC, 2012, J MED ENTOMOL, V49, P563, DOI 10.1603/ME11243; Riesgo A, 2012, FRONT ZOOL, V9, DOI 10.1186/1742-9994-9-33; Rimphanitchayakit V, 2010, DEV COMP IMMUNOL, V34, P377, DOI 10.1016/j.dci.2009.12.004; Rosa J.A.D., 2012, ZOOTAXA, V3478, P62; Santiago PB, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004581; Schwarz A, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003372; Seehausen O, 2014, NAT REV GENET, V15, P176, DOI 10.1038/nrg3644; Seo H, 2011, BIOL REPROD, V84, P279, DOI 10.1095/biolreprod.110.086934; Simao FA, 2015, BIOINFORMATICS, V31, P3210, DOI 10.1093/bioinformatics/btv351; Souza ED, 2016, ZOOKEYS, P45, DOI 10.3897/zookeys.621.9662; Strauss E, 2004, BIOCHEMISTRY-US, V43, P15520, DOI 10.1021/bi048340a; Tavares ES, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-81; TERRA WR, 1988, BRAZ J MED BIOL RES, V21, P675; Virgilio M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-206; VOGT RG, 1991, J NEUROBIOL, V22, P74, DOI 10.1002/neu.480220108; Watanabe RMO, 2011, BIOCHIMIE, V93, P618, DOI 10.1016/j.biochi.2010.12.006; Watanabe RMO, 2010, BIOCHIMIE, V92, P933, DOI 10.1016/j.biochi.2010.03.024; Wilson John James, 2012, Methods Mol Biol, V858, P17, DOI 10.1007/978-1-61779-591-6_3; Wu CI, 2001, J EVOLUTION BIOL, V14, P851, DOI 10.1046/j.1420-9101.2001.00335.x; Zhang Zhang, 2006, Genomics Proteomics & Bioinformatics, V4, P259, DOI 10.1016/S1672-0229(07)60007-2	79	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2017	12	4							e0174997	10.1371/journal.pone.0174997	http://dx.doi.org/10.1371/journal.pone.0174997			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0MB	28406967	gold, Green Published, Green Submitted			2022-12-27	WOS:000399955400025
J	Eshak, ES; Iso, H; Honjo, K; Noda, A; Sawada, N; Tsugane, S				Eshak, Ehab Salah; Iso, Hiroyasu; Honjo, Kaori; Noda, Ai; Sawada, Norie; Tsugane, Shoichiro		Japan Public Hlth Based Cohort	Changes in the living arrangement and risk of stroke in Japan; does it matter who lives in the household? Who among the family matters?	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; HEALTH BEHAVIORS; MARITAL-STATUS; ISCHEMIC-STROKE; MORTALITY; WOMEN; DEATH; INTERSECTION; TRANSITIONS; DISSOLUTION	Previous studies have suggested associations of family composition with morbidity and mortality; however, the evidence of associations with risk of stroke is limited. We sought to examine the impact of changes in the household composition on risk of stroke and its types in Japanese population. Cox proportional hazard modelling was used to assess the risk of incident stroke and stroke types within a cohort of 77,001 Japanese men and women aged 45-74 years who experienced addition and/or loss of family members [spouse, child(ren), parent(s) and others] to their households over a five years interval (between 1990-1993 and 1995-1998). During 1,043,446 person-years of the follow-up for 35,247 men and 41,758 women, a total of 3,858 cases of incident stroke (1485 hemorrhagic and 2373 ischemic) were documented. When compared with a stable family composition, losing at least one family member was associated with 11-15% increased risk of stroke in women and men; hazard ratios (95% confidence interval) were 1.11 (1.01-1.22) and 1.15 (1.05-1.26), respectively. The increased risk was associated with the loss of a spouse, and was evident for ischemic stroke in men and hemorrhagic stroke in women. The addition of any family members to the household was not associated with risk of stroke in men, whereas the addition of a parent (s) to the household was associated with increased risk in women: 1.49 (1.09-2.28). When the loss of a spouse was accompanied by the addition of other family members to the household, the increased risk of stroke disappeared in men: 1.18 (0.85-1.63), but exacerbated in women: 1.58 (1.19-2.10). In conclusion, men who have lost family members, specifically a spouse have higher risk of ischemic stroke, and women who gained family members; specifically a parent (s) had the higher risk of hemorrhagic stroke than those with a stable family composition.	[Eshak, Ehab Salah] Menia Univ, Fac Med, Dept Publ Hlth & Community Med, Al Minya, Egypt; [Eshak, Ehab Salah; Iso, Hiroyasu; Honjo, Kaori] Osaka Univ, Grad Sch Med, Dept Social Med, Publ Hlth, Suita, Osaka, Japan; [Noda, Ai; Sawada, Norie; Tsugane, Shoichiro] Natl Canc Ctr, Epidemiol & Prevent Div, Res Ctr Canc Prevent & Screening, Tokyo, Japan	Egyptian Knowledge Bank (EKB); Minia University; Osaka University; National Cancer Center - Japan	Iso, H (corresponding author), Osaka Univ, Grad Sch Med, Dept Social Med, Publ Hlth, Suita, Osaka, Japan.	iso@pbhel.med.osaka-u.ac.jp	Tsugane, Shoichiro/A-2424-2015; Shimazu, Taichi/A-4470-2015	Tsugane, Shoichiro/0000-0003-4105-2774; Ishihara, Junko/0000-0002-9516-5646; Eshak, Ehab/0000-0002-3564-1938; Shimazu, Taichi/0000-0001-6000-9830; Yamagishi, Kazumasa/0000-0003-3301-5519	National Cancer Center Research and Development Fund [23-A-31[toku], 26-A-2]; Ministry of Health, Labour and Welfare of Japan; Japan Society for the Promotion of Science KAKENHI [26460744, 26253043]	National Cancer Center Research and Development Fund(National Cancer Center - Japan); Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The Japan Public Health Centre-based Prospective Study (JPHC) was supported by National Cancer Center Research and Development Fund (23-A-31[toku] and 26-A-2; since 2011) and a Grant-in-Aid for Cancer Research from the Ministry of Health, Labour and Welfare of Japan (from 1989 to 2010). This work was also supported by Japan Society for the Promotion of Science KAKENHI Grant Numbers 26460744 and 26253043.	Cheung YB, 2000, INT J EPIDEMIOL, V29, P93, DOI 10.1093/ije/29.1.93; Eng PM, 2005, J EPIDEMIOL COMMUN H, V59, P56, DOI 10.1136/jech.2004.020073; Engstrom G, 2004, CEREBROVASC DIS, V18, P318, DOI 10.1159/000080770; Fuhrer R, 2002, SOC SCI MED, V54, P811, DOI 10.1016/S0277-9536(01)00111-3; GLIKSMAN MD, 1995, SOC SCI MED, V40, P811, DOI 10.1016/0277-9536(94)00149-N; Guiraud V, 2010, STROKE, V41, P2669, DOI 10.1161/STROKEAHA.110.597443; Health and welfare statistics association, 2004, ANN STAT REPORT NATL, V51, P35; Hendrickson Karrie Cummings, 2009, Palliat Support Care, V7, P109, DOI 10.1017/S1478951509000133; Honjo K, 2016, STROKE, V47, P991, DOI 10.1161/STROKEAHA.115.011926; Ikeda A, 2009, HEART, V95, P577, DOI 10.1136/hrt.2008.149575; Iso H, 2002, CIRCULATION, V106, P1229, DOI 10.1161/01.CIR.0000028145.58654.41; Kasiman K, 2012, CIRC-CARDIOVASC GENE, V5, P226, DOI 10.1161/CIRCGENETICS.111.962241; Lee S, 2005, INT J EPIDEMIOL, V34, P69, DOI 10.1093/ije/dyh258; Marshall IJ, 2015, LANCET NEUROL, V14, P1206, DOI 10.1016/S1474-4422(15)00200-8; Martikainen P, 1996, AM J PUBLIC HEALTH, V86, P1087, DOI 10.2105/AJPH.86.8_Pt_1.1087; Maselko J, 2009, J AM GERIATR SOC, V57, P2293, DOI 10.1111/j.1532-5415.2009.02555.x; Ministry of Public Management, 2000, HOM AFF POSTS TEL JA; Ministry of Public Management Home Affairs, 2010, HOM AFF POSTS TEL JA; National Institute of Population and Social Security Research Japan, 1998, 2 NAT SURV FAM JAP; Ohira T, 2013, CIRC J, V77, P1646, DOI 10.1253/circj.CJ-13-0702; Poudel-Tandukar K, 2011, J AFFECT DISORDERS, V131, P113, DOI 10.1016/j.jad.2010.11.027; Rostila M, 2012, AM J EPIDEMIOL, V176, P338, DOI 10.1093/aje/kws163; Rostila M, 2011, J MARRIAGE FAM, V73, P236, DOI 10.1111/j.1741-3737.2010.00801.x; Rutledge T, 2008, PSYCHOSOM MED, V70, P282, DOI 10.1097/PSY.0b013e3181656e09; Seeman TE, 1996, ANN EPIDEMIOL, V6, P442, DOI 10.1016/S1047-2797(96)00095-6; Shirahase S, 2014, NISSAN I ROUTL JPN S, P147; Shor E, 2012, SOC SCI MED, V75, P46, DOI 10.1016/j.socscimed.2012.03.010; Takeda Y, 2004, SOC SCI MED, V59, P69, DOI 10.1016/j.socscimed.2003.10.003; Tanihara S, 2014, AUSTRALAS J AGEING, V33, pE12, DOI 10.1111/ajag.12071; Tsugane S, 2014, JPN J CLIN ONCOL, V44, P777, DOI 10.1093/jjco/hyu096; Udell JA, 2012, ARCH INTERN MED, V172, P1086, DOI 10.1001/archinternmed.2012.2782; WALKER AE, 1981, STROKE, V119, P837; Wicks AF, 2012, EPIDEMIOLOGY, V23, P482, DOI 10.1097/EDE.0b013e31824d5d82; Young L E, 2005, Health Care Women Int, V26, P604, DOI 10.1080/07399330591004845	34	2	2	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2017	12	4							e0173860	10.1371/journal.pone.0173860	http://dx.doi.org/10.1371/journal.pone.0173860			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET0MB	28406897	Green Published, gold, Green Submitted			2022-12-27	WOS:000399955400005
J	Kallemeijn, MJ; de Ridder, D; Schilperoord-Vermeulen, J; van der Klift, MY; Sandberg, Y; van Dongen, JJM; Langerak, AW				Kallemeijn, Martine J.; de Ridder, Dick; Schilperoord-Vermeulen, Joyce; van der Klift, Michele Y.; Sandberg, Yorick; van Dongen, Jacques J. M.; Langerak, Anton W.			Dysregulated signaling, proliferation and apoptosis impact on the pathogenesis of TCR gamma delta plus T cell large granular lymphocyte leukemia	PLOS ONE			English	Article							LARGE GENE LISTS; EXPRESSION; DIAGNOSIS; DISEASE; LYMPHOPROLIFERATIONS; MICROARRAYS; MUTATIONS; SPECTRUM; SURVIVAL; CANCER	TCR gamma delta+ T-LGL leukemia is a rare form of chronic mature T cell disorders in elderly, which is generally characterized by a persistently enlarged CD3+CD57+TCR gamma delta+ large granular lymphocyte population in the peripheral blood with a monoclonal phenotype. Clinically, the disease is heterogeneous, most patients being largely asymptomatic, although neutropenia, fatigue and B symptoms and underlying diseases such as autoimmune diseases or malignancies are also often observed. The etiology of TCR gamma delta+ T-LGL proliferations is largely unknown. Here, we aimed to investigate underlying molecular mechanisms of these rare proliferations by performing gene expression profiling of TCR gamma delta+ T-LGL versus normal TCR gamma delta+ T cell subsets. From our initial microarray dataset we observed that TCR gamma delta+ T-LGL leukemia forms a separate group when compared with different healthy control TCR gamma delta+ T cell subsets, correlating best with the healthy TemRA subset. The lowest correlation was seen with the naive subset. Based on specific comparison between healthy control cells and TCR gamma delta+ T-LGL leukemia cells we observed up-regulation of survival, proliferation and hematopoietic system related genes, with a remarkable down-regulation of apoptotic pathway genes. RQ-PCR validation of important genes representative for the dataset, including apoptosis (XIAP, CASP1, BCLAF1 and CFLAR), proliferation/development (ID3) and inflammation (CD28, CCR7, CX3CR1 and IFNG) processes largely confirmed the dysregulation in proliferation and apoptosis. Based on these expression data we conclude that TCR gamma delta+ T-LGL leukemia is likely the result of an underlying aberrant molecular mechanisms leading to increased proliferation and reduced apoptosis.	[Kallemeijn, Martine J.; Schilperoord-Vermeulen, Joyce; van der Klift, Michele Y.; Sandberg, Yorick; van Dongen, Jacques J. M.; Langerak, Anton W.] Erasmus MC, Dept Immunol, Lab Med Immunol, Rotterdam, Netherlands; [de Ridder, Dick] Wageningen Univ, Dept Bioinformat, Wageningen, Netherlands	Erasmus University Rotterdam; Erasmus MC; Wageningen University & Research	Langerak, AW (corresponding author), Erasmus MC, Dept Immunol, Lab Med Immunol, Rotterdam, Netherlands.	a.langerak@erasmusmc.nl		van Dongen, Jacques J.M./0000-0002-3650-7087; Langerak, Anton W/0000-0002-2078-3220	Roche	Roche(Roche Holding)	This work was supported by Roche-unrestricted grant. The funder had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Alonzo ES, 2010, J IMMUNOL, V184, P1268, DOI 10.4049/jimmunol.0903218; Beillard E, 2003, LEUKEMIA, V17, P2474, DOI 10.1038/sj.leu.2403136; Bonneville M, 2010, NAT REV IMMUNOL, V10, P467, DOI 10.1038/nri2781; Chandrasekaran Y, 2006, BIOL REPROD, V74, P560, DOI 10.1095/biolreprod.105.045146; Clemente MJ, 2011, BLOOD, V118, P4384, DOI 10.1182/blood-2011-02-338517; Dik WA, 2005, J EXP MED, V201, P1715, DOI 10.1084/jem.20042524; Fulda S, 2013, EXPERT OPIN THER TAR, V17, P195, DOI 10.1517/14728222.2013.736499; Garrido P, 2007, BLOOD; HARRIS NL, 2001, WHO CLASSIFICATION T; He MX, 2013, AUTOPHAGY, V9, P791, DOI 10.4161/auto.23785; Holcik M, 2001, APOPTOSIS, V6, P253, DOI 10.1023/A:1011379307472; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kim Y, 2009, BMC GASTROENTEROL, V9, DOI 10.1186/1471-230X-9-4; Koskela HLM, 2012, NEW ENGL J MED, V366, P1905, DOI 10.1056/NEJMoa1114885; Kotas ME, 2013, P NATL ACAD SCI USA, V110, P4810, DOI 10.1073/pnas.1301996110; Lamy T, 2003, SEMIN HEMATOL, V40, P185, DOI 10.1016/S0037-1963(03)00133-1; Langerak AW, 2003, BRIT J HAEMATOL, V123, P561, DOI 10.1046/j.1365-2141.2003.04647.x; Lefranc MP, 2009, NUCLEIC ACIDS RES, V37, pD1006, DOI 10.1093/nar/gkn838; Nodland SE, 2011, BLOOD, V118, P2116, DOI 10.1182/blood-2010-08-302513; Rajala HLM, 2013, BLOOD, V121, P4541, DOI 10.1182/blood-2012-12-474577; Rose MG, 2004, ONCOLOGIST, V9, P247, DOI 10.1634/theoncologist.9-3-247; Sanchez IP, 2004, LEUKEMIA LYMPHOMA, V45, P1935, DOI 10.1080/10428190410001687495; Sandberg Y, 2006, LEUKEMIA, V20, P505, DOI 10.1038/sj.leu.2404112; Sandberg Y, 2014, BLOOD CANCER J, V4, DOI 10.1038/bcj.2013.70; Sarras H, 2010, THESCIENTIFICWORLDJO, V10, P1450, DOI 10.1100/tsw.2010.132; Semenzato G, 1997, BLOOD, V89, P256; Shah MV, 2008, BLOOD, V112, P770, DOI 10.1182/blood-2007-11-121871; Shaw Gene R, 2008, J Hematop, V1, P139, DOI 10.1007/s12308-008-0016-6; SKEEN MJ, 1995, J IMMUNOL, V154, P5832; Sokol L, 2006, ONCOLOGIST, V11, P263, DOI 10.1007/s11899-007-0038-7; Staal FJT, 2003, LEUKEMIA, V17, P1324, DOI 10.1038/sj.leu.2402974; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; van Dongen JJM, 2012, LEUKEMIA, V26, P1908, DOI 10.1038/leu.2012.120; van Dongen JJM, 2003, LEUKEMIA, V17, P2257, DOI 10.1038/sj.leu.2403202; van Zelm MC, 2005, J IMMUNOL, V175, P5912, DOI 10.4049/jimmunol.175.9.5912; Wlodarski MW, 2008, J LEUKOCYTE BIOL, V83, P589, DOI 10.1189/jlb.0107073; Zhang RR, 2008, P NATL ACAD SCI USA, V105, P16308, DOI 10.1073/pnas.0806447105	40	9	9	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2017	12	4							e0175670	10.1371/journal.pone.0175670	http://dx.doi.org/10.1371/journal.pone.0175670			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0MB	28407008	gold, Green Published, Green Submitted			2022-12-27	WOS:000399955400080
J	Kniep, R; Zahn, D; Wulfes, J; Walther, LE				Kniep, Ruediger; Zahn, Dirk; Wulfes, Jana; Walther, Leif Erik			The sense of balance in humans: Structural features of otoconia and their response to linear acceleration	PLOS ONE			English	Article								We explored the functional role of individual otoconia within the otolith system of mammalians responsible for the detection of linear accelerations and head tilts in relation to the gravity vector. Details of the inner structure and the shape of intact human and artificial otoconia were studied using environmental scanning electron microscopy (ESEM), including decalcification by ethylenediaminetetraacetic acid (EDTA) to discriminate local calcium carbonate density. Considerable differences between the rhombohedral faces of human and artificial otoconia already indicate that the inner architecture of otoconia is not consistent with the point group -3m. This is clearly confirmed by decalcified otoconia specimen which are characterized by a non-centrosymmetric volume distribution of the compact 3+3 branches. This structural evidence for asymmetric mass distribution was further supported by light microscopy in combination with a high speed camera showing the movement of single otoconia specimen (artificial specimen) under gravitational influence within a viscous medium (artificial endolymph). Moreover, the response of otoconia to linear acceleration forces was investigated by particle dynamics simulations. Both, time-resolved microscopy and computer simulations of otoconia acceleration show that the dislocation of otoconia include significant rotational movement stemming from density asymmetry. Based on these findings, we suggest an otolith membrane expansion/stiffening mechanism for enhanced response to linear acceleration transmitted to the vestibular hair cells.	[Kniep, Ruediger; Wulfes, Jana] Max Planck Inst Chem Phys Solids, Dresden, Germany; [Zahn, Dirk] Friedrich Alexander Univ Erlangen Nurnberg, Comp Chem Ctr, Dept Chem & Pharm, Erlangen, Germany; [Walther, Leif Erik] Heidelberg Univ, Univ Med Mannheim, Dept Otorhinolaryngol Head & Neck Surg, Mannheim, Germany	Max Planck Society; University of Erlangen Nuremberg; Ruprecht Karls University Heidelberg	Walther, LE (corresponding author), Heidelberg Univ, Univ Med Mannheim, Dept Otorhinolaryngol Head & Neck Surg, Mannheim, Germany.	Leif.Walther@hno-praxis-sulzbach.de		Zahn, Dirk/0000-0002-4303-3422				Andrade LR, 2012, HEARING RES, V292, P14, DOI 10.1016/j.heares.2012.07.003; CARLSTROM D., 1955, ACTA OTO LARYNGOL, V45, P14, DOI 10.3109/00016485509118139; DAI MJ, 1989, BIOL CYBERN, V60, P185, DOI 10.1007/BF00207286; Grant J W, 1990, J Vestib Res, V1, P139; Huang YX, 2008, ANGEW CHEM INT EDIT, V47, P8280, DOI 10.1002/anie.200800968; Kniep R, 2015, PURE APPL CHEM, V87, P719, DOI 10.1515/pac-2015-0201; Lindeman H H, 1973, Adv Otorhinolaryngol, V20, P405; Lins U, 2000, J STRUCT BIOL, V131, P67, DOI 10.1006/jsbi.2000.4260; Lundberg YXW, 2006, BRAIN RES, V1091, P47, DOI 10.1016/j.brainres.2006.02.083; Lychakov DV, 2004, J EVOL BIOCHEM PHYS+, V40, P331, DOI 10.1023/B:JOEY.0000042638.35785.f3; MARCUS DC, 1981, HEARING RES, V5, P231, DOI 10.1016/0378-5955(81)90048-4; Simon P, 2011, EUR J INORG CHEM, P5370, DOI 10.1002/ejic.201100756; Smith W, 1996, J MOL GRAPHICS, V14, P136, DOI 10.1016/S0263-7855(96)00043-4; Thalmann R, 2001, ANN NY ACAD SCI, V942, P162; Walther LE, 2014, EUR ARCH OTO-RHINO-L, V271, P3133, DOI 10.1007/s00405-013-2784-6; Walther LE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102516; Walther LE, 2014, OTOL NEUROTOL, V35, P686, DOI 10.1097/MAO.0000000000000206; Walther LE, 2014, ACTA OTO-LARYNGOL, V134, P111, DOI 10.3109/00016489.2013.849384	18	11	11	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2017	12	4							e0175769	10.1371/journal.pone.0175769	http://dx.doi.org/10.1371/journal.pone.0175769			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0MB	28406968	Green Published, Green Submitted, gold			2022-12-27	WOS:000399955400097
J	Panayiotou, E; Fella, E; Papacharalambous, R; Malas, S; Saraiva, MJ; Kyriakides, T				Panayiotou, Elena; Fella, Eleni; Papacharalambous, Revekka; Malas, Stavros; Saraiva, Maria Joao; Kyriakides, Theodoros			C1q ablation exacerbates amyloid deposition: A study in a transgenic mouse model of ATTRV30M amyloid neuropathy	PLOS ONE			English	Article							GENERATION IN-VIVO; COMPLEMENT ACTIVATION; ALZHEIMERS-DISEASE; ALTERNATIVE PATHWAY; MULTIPLE-SCLEROSIS; APOPTOTIC CELLS; POLYNEUROPATHY; C5A; COMPONENT; TRANSTHYRETIN	ATTRV30M amyloid neuropathy is a lethal autosomal dominant sensorimotor and autonomic neuropathy, caused by deposition of amyloid fibrils composed of aberrant transthyretin (TTR). Ages of onset and penetrance exhibit great variability and genetic factors have been implicated. Complement activation co-localizes with amyloid deposits in amyloidotic neuropathy and is possibly involved in the kinetics of amyloidogenesis. A candidate gene approach has recently identified C1q polymorphisms to correlate with disease onset in a Cypriot cohort of patients with ATTRV30M amyloid neuropathy. In the current study we use a double transgenic mouse model of ATTRV30M amyloid neuropathy in which C1q is ablated to elucidate further a possible modifier role for C1q. Amyloid deposition is found to be increased by 60% in the absence of C1q. Significant up regulation is also recorded in apoptotic and cellular stress markers reflecting extracellular toxicity of pre-fibrillar and fibrillar TTR. Our data further indicate that in the absence of C1q there is marked reduction of macrophages in association with amyloid deposits and thus less effective phagocytosis of TTR.	[Panayiotou, Elena; Papacharalambous, Revekka; Malas, Stavros; Kyriakides, Theodoros] Cyprus Inst Neurol & Genet, Dept Neuropathol, Ciln A, Nicosia, Cyprus; [Fella, Eleni; Kyriakides, Theodoros] Cyprus Sch Mol Med, Nicosia, Cyprus; [Saraiva, Maria Joao] Univ Porto, Inst Inovacao & Invest Saude I3S, Oporto, Portugal; [Saraiva, Maria Joao] Univ Porto, Neurobiol Mol Inst Biol Mol, IBMC, Oporto, Portugal	Universidade do Porto; i3S - Instituto de Investigacao e Inovacao em Saude, Universidade do Porto; Universidade do Porto	Kyriakides, T (corresponding author), Cyprus Inst Neurol & Genet, Dept Neuropathol, Ciln A, Nicosia, Cyprus.; Kyriakides, T (corresponding author), Cyprus Sch Mol Med, Nicosia, Cyprus.	theodore@cing.ac.cy	Worth, Elena Panagiotou/AAK-6557-2021; Kyriakides, Theodoros/AAW-4251-2021; Saraiva, Maria Joao/K-3907-2013	Worth, Elena Panagiotou/0000-0001-5211-3427; Kyriakides, Theodoros/0000-0002-0017-7143; Malas, Stavros/0000-0002-5223-9772; Saraiva, Maria Joao/0000-0002-3360-6899	Cyprus Research Promotion Foundation [YGammaEIA/BIOSigma/0308(BIE)/02]	Cyprus Research Promotion Foundation	The work was supported by a grant from the Cyprus Research Promotion Foundation Y Gamma EIA/BIO Sigma/0308(BIE)/02 (http://www.research.org.cy/).; The work was supported by a grant from the Cyprus Research Promotion Foundation Y Gamma EIA/BIO Sigma/0308(BIE)/02.	Andersson R, 1976, Acta Med Scand Suppl, V590, P1; Ando Y, 1997, BIOCHEM BIOPH RES CO, V232, P497, DOI 10.1006/bbrc.1996.5997; ANDRADE C, 1952, BRAIN, V75, P408, DOI 10.1093/brain/75.3.408; ARAKI S, 1968, ARCH NEUROL-CHICAGO, V18, P593, DOI 10.1001/archneur.1968.00470360015001; BLAKE CCF, 1978, J MOL BIOL, V121, P339, DOI 10.1016/0022-2836(78)90368-6; BOBAK DA, 1988, EUR J IMMUNOL, V18, P2001, DOI 10.1002/eji.1830181220; Bodin K, 2010, NATURE, V468, P93, DOI 10.1038/nature09494; Botto M, 1998, NAT GENET, V19, P56, DOI 10.1038/ng0598-56; Boyett KW, 2003, NEUROCHEM RES, V28, P83, DOI 10.1023/A:1021600212829; Chenoweth D E, 1983, Agents Actions Suppl, V12, P252; CHU KT, 1995, P NATL ACAD SCI USA, V92, P11894, DOI 10.1073/pnas.92.25.11894; Dardiotis E, 2009, J NEUROL SCI, V284, P158, DOI 10.1016/j.jns.2009.05.018; Dardiotis E, 2009, AMYLOID, V16, P32, DOI 10.1080/13506120802676948; EIKELENBOOM P, 1982, ACTA NEUROPATHOL, V57, P239, DOI 10.1007/BF00685397; Ernst JD, 1998, INFECT IMMUN, V66, P1277, DOI 10.1128/IAI.66.4.1277-1281.1998; FISHELSON Z, 1987, MOL IMMUNOL, V24, P987, DOI 10.1016/0161-5890(87)90011-3; Foley JH, 2016, EBIOMEDICINE, V5, P175, DOI 10.1016/j.ebiom.2016.02.011; Fonseca MI, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-4; Fonseca MI, 2004, J NEUROSCI, V24, P6457, DOI 10.1523/JNEUROSCI.0901-04.2004; Fraser DA, 2010, J NEUROCHEM, V112, P733, DOI 10.1111/j.1471-4159.2009.06494.x; Galvan MD, 2012, J LEUKOCYTE BIOL, V92, P489, DOI 10.1189/jlb.0212099; Galvan MD, 2012, J IMMUNOL, V188, P3716, DOI 10.4049/jimmunol.1102920; Guo RF, 2005, ANNU REV IMMUNOL, V23, P821, DOI 10.1146/annurev.immunol.23.021704.115835; Hafer-Macko CE, 2000, J PERIPHER NERV SYST, V5, P131, DOI 10.1046/j.1529-8027.2000.00018.x; Hellman U, 2008, AMYLOID, V15, P181, DOI 10.1080/13506120802193720; Hetland G, 1997, ANN THORAC SURG, V63, P1076, DOI 10.1016/S0003-4975(96)01255-6; Hourcade DE, 2006, J BIOL CHEM, V281, P2128, DOI 10.1074/jbc.M508928200; Kaplan B, 1997, AMYLOID, V4, P80, DOI 10.3109/13506129708995275; Klickstein LB, 1997, IMMUNITY, V7, P345, DOI 10.1016/S1074-7613(00)80356-8; Kohno K, 1997, AM J PATHOL, V150, P1497; Krisinger MJ, 2012, BLOOD, V120, P1717, DOI 10.1182/blood-2012-02-412080; Lee H, 2008, EURASIP J IMAGE VIDE, DOI 10.1155/2008/380867; Leslie RGQ, 2004, IMMUNOLOGY, V111, P86, DOI 10.1111/j.1365-2567.2004.01780.x; Macedo B, 2007, MOL MED, V13, P584, DOI 10.2119/2007-00068.Macedo; Manderson AP, 2001, J EXP MED, V194, P747, DOI 10.1084/jem.194.6.747; Mitchell DA, 1999, J IMMUNOL, V162, P5676; MOLLNES T E, 1985, Complement, V2, P156; Monk PN, 2007, BRIT J PHARMACOL, V152, P429, DOI 10.1038/sj.bjp.0707332; Pisalyaput K, 2008, J NEUROCHEM, V104, P696, DOI 10.1111/j.1471-4159.2007.05012.x; ROHER AE, 1993, J BIOL CHEM, V268, P3072; ROLLINS SA, 1991, J IMMUNOL, V146, P2345; Rus H, 2005, ANN MED, V37, P97, DOI 10.1080/07853890510007278; SARAIVA MJM, 1983, T ASSOC AM PHYSICIAN, V96, P261; SARAIVA MJM, 1995, HUM MUTAT, V5, P191; Schwaeble WJ, 1999, IMMUNOL TODAY, V20, P17, DOI 10.1016/S0167-5699(98)01376-0; Shen Yiding, 1997, FINE CHEM, V5, P11; Sousa MM, 2001, AM J PATHOL, V159, P1993; Storch MK, 1998, ANN NEUROL, V43, P465, DOI 10.1002/ana.410430409; Taylor PR, 2000, J EXP MED, V192, P359, DOI 10.1084/jem.192.3.359; VOGT W, 1992, MOL IMMUNOL, V29, P251, DOI 10.1016/0161-5890(92)90106-8; Volokhina EB, 2015, BLOOD, V126, P278, DOI 10.1182/blood-2015-03-637645; Walsh JG, 2008, P NATL ACAD SCI USA, V105, P12815, DOI 10.1073/pnas.0707715105; Waring P, 1999, IMMUNOL CELL BIOL, V77, P312, DOI 10.1046/j.1440-1711.1999.00837.x; WEBSTER RO, 1982, J CLIN INVEST, V70, P1177, DOI 10.1172/JCI110716; Webster SD, 2001, J IMMUNOL, V166, P7496, DOI 10.4049/jimmunol.166.12.7496	55	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2017	12	4							e0175767	10.1371/journal.pone.0175767	http://dx.doi.org/10.1371/journal.pone.0175767			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0MB	28407005	Green Published, Green Submitted, gold			2022-12-27	WOS:000399955400095
J	Vautherot, JF; Jean, C; Fragnet-Trapp, L; Remy, S; Chabanne-Vautherot, D; Montillet, G; Fuet, A; Denesvre, C; Pain, B				Vautherot, Jean-Francois; Jean, Christian; Fragnet-Trapp, Laetitia; Remy, Sylvie; Chabanne-Vautherot, Daniele; Montillet, Guillaume; Fuet, Aurelie; Denesvre, Caroline; Pain, Bertrand			ESCDL-1, a new cell line derived from chicken embryonic stem cells, supports efficient replication of Mardiviruses	PLOS ONE			English	Article							MAREKS-DISEASE VIRUS; BACTERIAL ARTIFICIAL CHROMOSOME; OPEN READING FRAME; RETINOIC ACID; SEROTYPE-1 MDV-1; GENE-EXPRESSION; IN-VITRO; ES CELLS; PROTEIN; ESTABLISHMENT	Marek's disease virus is the etiological agent of a major lymphoproliferative disorder in poultry and the prototype of the Mardivirus genus. Primary avian somatic cells are currently used for virus replication and vaccine production, but they are largely refractory to any genetic modification compatible with the preservation of intact viral susceptibility. We explored the concept of induction of viral replication permissiveness in an established pluripotent chicken embryonic stem cell-line (cES) in order to derive a new fully susceptible cell-line. Chicken ES cells were not permissive for Mardivirus infection, but as soon as differentiation was triggered, replication of Marek's disease virus was detected. From a panel of cyto-differentiating agents, hexamethylene bis (acetamide) (HMBA) was found to be the most efficient regarding the induction of permissiveness. These initial findings prompted us to analyse the effect of HMBA on gene expression, to derive a new mesenchymal cell line, the so-called ESCDL-1, and monitor its susceptibility for Mardivirus replication. All Mardiviruses tested so far replicated equally well on primary embryonic skin cells and on ESCDL-1, and the latter showed no variation related to its passage number in its permissiveness for virus infection. Viral morphogenesis studies confirmed efficient multiplication with, as in other in vitro models, no extra-cellular virus production. We could show that ESCDL-1 can be transfected to express a transgene and subsequently cloned without any loss in permissiveness. Consequently, ESCDL-1 was genetically modified to complement viral gene deletions thus yielding stable trans-complementing cell lines. We herein claim that derivation of stable differentiated cell-lines from cES cell lines might be an alternative solution to the cultivation of primary cells for virology studies.	[Vautherot, Jean-Francois; Fragnet-Trapp, Laetitia; Remy, Sylvie; Chabanne-Vautherot, Daniele; Denesvre, Caroline] Univ Francois Rabelais Tours, INRA, ISP, UMR 1282, Nouzilly, France; [Jean, Christian; Montillet, Guillaume; Fuet, Aurelie; Pain, Bertrand] Univ Lyon 1, INSERM, INRA, Stem Cell & Brain Res Inst,U1208,USC1361, Bron, France	INRAE; INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Vautherot, JF (corresponding author), Univ Francois Rabelais Tours, INRA, ISP, UMR 1282, Nouzilly, France.	jean-francois.vautherot@tours.inra.fr	Pain, Bertrand/A-7686-2015	Pain, Bertrand/0000-0002-1210-8444	internal "INRA-Transferr grant "prevalorisation" MadiCell	internal "INRA-Transferr grant "prevalorisation" MadiCell	JFV and BP were supported by internal "INRA-Transferr grant "prevalorisation" MadiCell. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Abaitua F, 2012, J VIROL, V86, P8998, DOI 10.1128/JVI.01209-12; Abujoub A, 1995, VIROLOGY, V214, P541, DOI 10.1006/viro.1995.0065; Aubel P, 2013, METHODS MOL BIOL, V1074, P137, DOI 10.1007/978-1-62703-628-3_11; Bianchi A, 2010, CELL CYCLE, V9, P1647, DOI 10.4161/cc.9.8.11517; Blondeau C, 2008, J VIROL; Blondeau C, 2007, VET RES, V38, P419, DOI 10.1051/vetres:2007009; CALNEK BW, 1970, AVIAN DIS, V14, P219, DOI 10.2307/1588466; Chbab N, 2009, VET RES, V40, DOI 10.1051/vetres/2009012; Coraux C, 2003, CURR BIOL, V13, P849, DOI 10.1016/S0960-9822(03)00296-3; Couteaudier M, 2016, VIROL J, V13, DOI 10.1186/s12985-015-0458-2; Couteaudier M, 2015, STEM CELL RES, V14, P224, DOI 10.1016/j.scr.2015.01.002; Crucillo KL, 2010, AVIAN DIS, V54, P126, DOI 10.1637/8722-032309-ResNote.1; Davison AJ, 2009, ARCH VIROL, V154, P171, DOI 10.1007/s00705-008-0278-4; Denesvre C, 2007, J VIROL, V81, P12348, DOI 10.1128/JVI.01177-07; Denesvre C, 2015, J GEN VIROL; Desai P, 2001, J VIROL, V75, P10259, DOI 10.1128/JVI.75.21.10259-10271.2001; Ding V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072823; Donofrio G, 2004, J VIROL METHODS, V116, P203, DOI 10.1016/j.jviromet.2003.11.019; Dorange F, 2002, J VIROL, V76, P1959, DOI 10.1128/JVI.76.4.1959-1970.2002; Dorange F, 2000, J GEN VIROL, V81, P2219, DOI 10.1099/0022-1317-81-9-2219; Dukhovny A, 2012, J VIROL, V86, P3211, DOI 10.1128/JVI.06810-11; Elliott G, 2005, J VIROL, V79, P9735, DOI 10.1128/JVI.79.15.9735-9745.2005; Esnault E, 2011, VIRUS RES, V159, P32, DOI 10.1016/j.virusres.2011.04.022; EVERETT RD, 1984, NUCLEIC ACIDS RES, V12, P5969, DOI 10.1093/nar/12.15.5969; Fragnet L, 2003, J VIROL, V77, P5985, DOI 10.1128/JVI.77.10.5985-5996.2003; Fuchs W, 2007, VET RES, V38, P261, DOI 10.1051/vetres:200657; Gailbreath KL, 2008, J WILDLIFE DIS, V44, P427, DOI 10.7589/0090-3558-44.2.427; Geerligs H, 2008, VACCINE, V26, P5595, DOI 10.1016/j.vaccine.2008.07.080; GUILBAUD NF, 1990, J CELL PHYSIOL, V145, P162, DOI 10.1002/jcp.1041450122; Heidari M, 2010, VIRAL IMMUNOL, V23, P309, DOI 10.1089/vim.2009.0079; ISAACS WB, 1989, J BIOL CHEM, V264, P17953; Jarosinski KW, 2007, J VIROL, V81, P10575, DOI 10.1128/JVI.01065-07; Jarosinski KW, 2015, VIROLOGY, V484, P213, DOI 10.1016/j.virol.2015.06.012; Jarosinski KW, 2012, AVIAN DIS, V56, P725, DOI 10.1637/10252-052212-Reg.1; Jarosinski KW, 2005, J VIROL, V79, P11647, DOI 10.1128/JVI.79.18.11647-11659.2005; Jean C, 2015, STEM CELL RES, V14, P54, DOI 10.1016/j.scr.2014.11.005; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Johnson DC, 2011, NAT REV MICROBIOL, V9, P382, DOI 10.1038/nrmicro2559; Kaleta EF, 2007, DEUT TIERARZTL WOCH, V114, P3; Kawasaki H, 2000, NEURON, V28, P31, DOI 10.1016/S0896-6273(00)00083-0; Kelly BJ, 2014, VIROLOGY, V454, P67, DOI 10.1016/j.virol.2014.02.003; Korn N, 2002, POULTRY SCI, V81, P1077, DOI 10.1093/ps/81.7.1077; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee J, 2013, POULTRY SCI, V92, P1604, DOI 10.3382/ps.2012-02582; LIN JJC, 1981, P NATL ACAD SCI-BIOL, V78, P2335, DOI 10.1073/pnas.78.4.2335; Liu ZM, 2014, J VIROL, V88, P4657, DOI 10.1128/JVI.00137-14; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; MARKS PA, 1989, ENVIRON HEALTH PERSP, V80, P181, DOI 10.2307/3430743; Maruzuru Y, 2014, J VIROL, V88, P7445, DOI 10.1128/JVI.01057-14; Matsukage S, 2006, BIRTH DEFECTS RES A, V76, P115, DOI 10.1002/bdra.20233; Metallo CM, 2008, STEM CELLS, V26, P372, DOI 10.1634/stemcells.2007-0501; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; NAZERIAN K, 1970, J VIROL, V5, P388, DOI 10.1128/JVI.5.3.388-397.1970; Nowak-Imialek M, 2013, REPROD FERT DEVELOP, V25, P103, DOI 10.1071/RD12265; OGURA H, 1987, ACTA MED OKAYAMA, V41, P141; Osterrieder K., 2004, MAREKS DIS EVOLVING, P17; Osterrieder N, 2006, NAT REV MICROBIOL, V4, P283, DOI 10.1038/nrmicro1382; Pain B, 1996, DEVELOPMENT, V122, P2339; Petherbridge L, 2004, J VIROL, V78, P13376, DOI 10.1128/JVI.78.23.13376-13380.2004; Qin P, 2002, TERATOLOGY, V66, P224, DOI 10.1002/tera.10082; Remy S, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-125; Richerioux N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044072; Schat KA, 2005, AVIAN PATHOL, V34, P91, DOI 10.1080/03079450500059289; Schumacher D, 2005, J VIROL, V79, P3987, DOI 10.1128/JVI.79.7.3987-3997.2005; Schumacher D, 2002, J GEN VIROL, V83, P1987, DOI 10.1099/0022-1317-83-8-1987; Schumacher D, 2000, J VIROL, V74, P11088, DOI 10.1128/JVI.74.23.11088-11098.2000; Storlie J, 2006, J VIROL, V80, P9544, DOI 10.1128/JVI.00668-06; Tischer BK, 2007, J VIROL, V81, P13200, DOI 10.1128/JVI.01148-07; Trapp-Fragnet L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100004; Vaidyanathan G, 2004, ONCOGENE, V23, P5858, DOI 10.1038/sj.onc.1207774; Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8; WITTER RL, 1969, AVIAN DIS, V13, P101, DOI 10.2307/1588419; Wu XF, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002617; Yang WC, 2002, J VIROL, V76, P12758, DOI 10.1128/JVI.76.24.12758-12774.2002	74	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2017	12	4							e0175259	10.1371/journal.pone.0175259	http://dx.doi.org/10.1371/journal.pone.0175259			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0MB	28406989	Green Published, Green Submitted, gold			2022-12-27	WOS:000399955400037
J	Wang, F; Ding, XF; Wang, T; Shan, ZZ; Wang, J; Wu, SX; Chi, YY; Zhang, YN; Lv, Z; Wang, LX; Fan, QX				Wang, Feng; Ding, Xianfei; Wang, Tao; Shan, Zhengzheng; Wang, Jun; Wu, Shaoxuan; Chi, Yanyan; Zhang, Yana; Lv, Zhuan; Wang, Liuxing; Fan, Qingxia			Metformin inhibited esophageal squamous cell carcinoma proliferation in vitro and in vivo and enhanced the anti-cancer effect of cisplatin	PLOS ONE			English	Article							ANTIDIABETIC DRUG METFORMIN; BREAST-CANCER; MTOR; CHEMOTHERAPY; RISK; RESISTANCE	Esophageal squamous cell carcinoma (ESCC) is an aggressive malignancy with poor prognosis in China. Chemotherapy now is one of the most frequently used treatments for patients with ESCC in middle or late stage, however the effects were often limited by increased chemoresistance or treatment toxicity. So it is urgent to find new drugs to treat ESCC patients. Metformin with low cost and toxicity has proved to have anti-cancer effects in a numerous cancers, while its role and mechanism in ESCC has seldom been studied. In the present study, we found that metformin exhibited not only an anti-proliferation ability in a dose and time dependent manner but also a proapoptosis effect in a dose dependent manner in ESCC cell line KYSE450. Our in vivo experiment also showed that metformin markedly inhibited KYSE450 xenograft tumors growth compared to those treated with normal saline. What's more, no obvious toxic reactions were observed. To further explore the underlying mechanism, we found that metformin treatment could significantly damp the expression of 4EBP1 and S6K1 in KYSE 450 cells in vitro and in vivo, furthermore, the p-4EBP1 and p-S6K1 expression in KYSE 450 cells were also inhibited greatly in vitro and in vivo. During the therapy of cancer, in order to overcome side effects, combination therapy was often used. In this paper, we demonstrated that metformin potentiated the effects of cisplatin via inhibiting cell proliferation and promoting cell apoptosis. Taken together, metformin owned the potential anti-cancer effect on ESCC in monotherapy or was combined with cisplatin and these results laid solid basis for the use of metformin in ESCC.	[Wang, Feng; Ding, Xianfei; Wang, Tao; Shan, Zhengzheng; Wang, Jun; Wu, Shaoxuan; Chi, Yanyan; Zhang, Yana; Lv, Zhuan; Wang, Liuxing; Fan, Qingxia] Zhengzhou Univ, Affiliated Hosp 1, Dept Oncol, Zhengzhou, Henan Province, Peoples R China	Zhengzhou University	Fan, QX (corresponding author), Zhengzhou Univ, Affiliated Hosp 1, Dept Oncol, Zhengzhou, Henan Province, Peoples R China.	fengw010@163.com			Fundamental Research Program of Henan Education Department [13A320638]; Fundamental and Advanced Technology Research Program of Henan Science and Technology Department [132300410127]	Fundamental Research Program of Henan Education Department; Fundamental and Advanced Technology Research Program of Henan Science and Technology Department	This study was supported by Fundamental Research Program of Henan Education Department (No. 13A320638) and Fundamental and Advanced Technology Research Program of Henan Science and Technology Department (No. 132300410127). The funder did the study, analyzed the data, decided the publication and prepared the manuscript.	Bodmer M, 2010, DIABETES CARE, V33, P1304, DOI 10.2337/dc09-1791; Bowker SL, 2006, DIABETES CARE, V29, P254, DOI 10.2337/diacare.29.02.06.dc05-1558; Clare SE, 2000, BREAST CANCER RES, V2, P430, DOI 10.1186/bcr90; Del Barco S, 2011, ONCOTARGET, V2, P896, DOI 10.18632/oncotarget.387; Arnal MJD, 2015, WORLD J GASTROENTERO, V21, P7933, DOI 10.3748/wjg.v21.i26.7933; Enzinger PC, 2003, NEW ENGL J MED, V349, P2241, DOI 10.1056/NEJMra035010; Evans JMM, 2005, BMJ-BRIT MED J, V330, P1304, DOI 10.1136/bmj.38415.708634.F7; Fujihara S, 2015, INT J ONCOL, V46, P2172, DOI 10.3892/ijo.2015.2903; Glasgow MDK, 2015, J BIOMED NANOTECHNOL, V11, P1859, DOI 10.1166/jbn.2015.2145; Griss T, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002309; Han G, 2015, CANCER BIOL THER, V16, P77, DOI 10.4161/15384047.2014.987021; Hatoum D, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/548436; Kanyilmaz G, 2016, CASE REP ONCOL MED, V2016, DOI 10.1155/2016/4568653; Karlsson E, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3557; Kato K, 2012, MOL CANCER THER, V11, P549, DOI 10.1158/1535-7163.MCT-11-0594; Landman GWD, 2010, DIABETES CARE, V33, P322, DOI 10.2337/dc09-1380; Leone A, 2014, CANCER TREAT RES, V159, P355, DOI 10.1007/978-3-642-38007-5_21; Micic D, 2011, HORM-INT J ENDOCRINO, V10, P5, DOI 10.14310/horm.2002.1288; Moschetta M, 2014, BRIT J PHARMACOL, V171, P3801, DOI 10.1111/bph.12749; Nair V, 2014, J BIOL CHEM, V289, P27692, DOI 10.1074/jbc.M114.592576; Noto H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033411; Panczyk M, 2014, WORLD J GASTROENTERO, V20, P9775, DOI 10.3748/wjg.v20.i29.9775; Pennathur A, 2009, ANN THORAC SURG, V87, P1048, DOI 10.1016/j.athoracsur.2008.12.060; Perez-Revuelta BI, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.175; Sesen J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123721; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Van de Voorde L, 2015, EJSO-EUR J SURG ONC, V41, P1333, DOI 10.1016/j.ejso.2015.05.012; Xu H, 2015, ONCOLOGIST, V20, P1236, DOI 10.1634/theoncologist.2015-0096; Zarogoulidis P, 2014, ONCOL LETT, V8, P2367, DOI 10.3892/ol.2014.2608	29	11	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2017	12	4							e0174276	10.1371/journal.pone.0174276	http://dx.doi.org/10.1371/journal.pone.0174276			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0MB	28406985	Green Submitted, Green Published, gold			2022-12-27	WOS:000399955400008
J	Balcells, ME; Garcia, P; Tiznado, C; Villarroel, L; Scioscia, N; Carvajal, C; Zegna-Rata, F; Hernandez, M; Meza, P; Gonzalez, LF; Pena, C; Naves, R				Elvira Balcells, Maria; Garcia, Patricia; Tiznado, Camila; Villarroel, Luis; Scioscia, Natalia; Carvajal, Camila; Zegna-Rata, Francesca; Hernandez, Mariluz; Meza, Pauline; Gonzalez, Luis F.; Pena, Carlos; Naves, Rodrigo			Association of vitamin D deficiency, season of the year, and latent tuberculosis infection among household contacts	PLOS ONE			English	Article							PULMONARY TUBERCULOSIS; UNITED-STATES; RISK-FACTORS; SKIN-TEST; POPULATION; EXPOSURE; MYCOBACTERIA; METAANALYSIS; PREVALENCE; AUTOPHAGY	Objectives Vitamin D (VD) enhances the immune response against Mycobacterium tuberculosis in vitro, and VD deficiency has been described in patients with active tuberculosis (TB). However, the role of hypovitaminosis D in the pathogenesis of early TB infection acquisition is unclear. We aimed to evaluate the association of VD deficiency, season of the year, and latent TB infection in household contacts (HHC), given that this is a potentially modifiable condition often related to nutritional deficiencies and lack of sun exposure. Methods We prospectively enrolled new pulmonary TB cases (n = 107) and their HHC (n = 144) over a 2-year period in Santiago, Chile. We compared plasma 25-hydroxycholecalciferol (25OHD) levels and examined the influence of season, ethnic background, living conditions, and country of origin. Results Over 77% of TB cases and 62.6% of HHC had VD deficiency (<20 ng/ml). Median 25OHD concentration was significantly lower in TB cases than in HHC (11.7 vs. 18.2 ng/ml, p<0.0001). Migrants HHC had lower 25OHD levels than non-migrants (14.6 vs. 19.0 ng/ml, p = 0.026), and a trend towards a higher burden of latent TB infection (52.9% vs. 35.2%, p = 0.066). Multivariate analysis found VD deficiency in HHC was strongly associated with being sampled in winter/spring (adOR 25.68, 95%CI 7.35-89.7), corresponding to the seasons with lowest solar radiation exposure. Spring enrollment-compared with other seasons-was the chief risk factor for latent TB infection in HHC (adOR 3.14, 95%CI 1.28-7.69). Conclusions Hypovitaminosis D was highly prevalent in TB cases and also in HHC. A marked seasonality was found for both VD levels and latent TB in HHC, with winter being the season with lowest VD levels and spring the season with the highest risk of latent TB infection.	[Elvira Balcells, Maria; Carvajal, Camila; Zegna-Rata, Francesca] Pontificia Univ Catolica Chile, Escuela Med, Dept Enfermedades Infecciosas Adulto, Santiago, Chile; [Garcia, Patricia; Tiznado, Camila; Scioscia, Natalia; Meza, Pauline] Pontificia Univ Catolica Chile, Escuela Med, Dept Labs Clin, Santiago, Chile; [Villarroel, Luis] Pontificia Univ Catolica Chile, Escuela Med, Dept Salud Publ, Santiago, Chile; [Hernandez, Mariluz] Univ Chile, Fac Med, Programa Microbiol & Micol, Santiago, Chile; [Pena, Carlos; Naves, Rodrigo] Univ Chile, Fac Med, Inst Ciencias Biomed, Santiago, Chile; [Pena, Carlos] Hosp San Borja Arriaran, Serv Resp, Santiago, Chile; [Tiznado, Camila] Univ Buenos Aires, Fac Med, Buenos Aires, DF, Argentina; [Zegna-Rata, Francesca] Univ Lagos, Escuela Enfermeria, Osorno, Chile	Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile; Universidad de Chile; Universidad de Chile; Universidad de Chile; University of Buenos Aires; Universidad de Los Lagos	Balcells, ME (corresponding author), Pontificia Univ Catolica Chile, Escuela Med, Dept Enfermedades Infecciosas Adulto, Santiago, Chile.; Naves, R (corresponding author), Univ Chile, Fac Med, Inst Ciencias Biomed, Santiago, Chile.	balcells@med.puc.cl; rodrigonaves@med.uchile.cl	Balcells, Maria Elvira/GRR-9067-2022; Naves, Rodrigo/H-4829-2014	Balcells, Maria Elvira/0000-0002-7223-9665; Naves, Rodrigo/0000-0002-1203-3593	Chilean national research agency CONICYT (Corporacion Nacional de Ciencia y Tecnologia); Chilean national research agency CONICYT (FONDECYT) [1130600, 1171570]	Chilean national research agency CONICYT (Corporacion Nacional de Ciencia y Tecnologia); Chilean national research agency CONICYT (FONDECYT)	This work was supported by a grant from Chilean national research agency CONICYT (Corporacion Nacional de Ciencia y Tecnologia; FONDECYT GRANT No1130600 and FONDECYT GRANT No1171570). The funding body had no role in the design of the study, the collection of data, the analysis and interpretation of data, or the manuscript preparation.	Adams JS, 2007, ANN NY ACAD SCI, V1117, P94, DOI 10.1196/annals.1402.036; Alkerwi A, 2016, CLIN NUTR; Arnedo-Pena A, 2015, INT J TUBERC LUNG D, V19, P65, DOI 10.5588/ijtld.14.0348; Arnedo-Pena A, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-349; Autier P, 2014, LANCET DIABETES ENDO, V2, P76, DOI 10.1016/S2213-8587(13)70165-7; Bhargava A, 2014, NATL MED J INDIA, V27, P128; Borella E, 2014, ANN NY ACAD SCI, V1317, P76, DOI 10.1111/nyas.12321; Campbell GR, 2012, PLOS PATHOG, V8; Cegielski JP, 2012, AM J EPIDEMIOL, V176, P409, DOI 10.1093/aje/kws007; Coussens AK, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003468; de Souza WN, 2016, NUTR RES, V36, P1, DOI 10.1016/j.nutres.2015.10.006; Fabri M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003045; Ganmaa D, 2012, AM J CLIN NUTR, V96, P391, DOI 10.3945/ajcn.112.034967; Gao L, 2010, INT J TUBERC LUNG D, V14, P15; Gibney KB, 2008, CLIN INFECT DIS, V46, P443, DOI 10.1086/525268; Gombart AF, 2009, FUTURE MICROBIOL, V4, P1151, DOI 10.2217/FMB.09.87; Gonzalez G, 2007, MENOPAUSE, V14, P455, DOI 10.1097/GME.0b013e31802c54c0; Guwatudde D, 2003, AM J EPIDEMIOL, V158, P887, DOI 10.1093/aje/kwg227; Ho-Pham LT, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-306; Holick MF, 2008, AM J CLIN NUTR, V87, p1080S; Huffman SA, 2012, SOC SCI MED, V74, P864, DOI 10.1016/j.socscimed.2011.07.019; Jiang CQ, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010946; Kasai H, 2000, J CLIN MICROBIOL, V38, P301; Koh GCKW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054961; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; Lonnroth K, 2015, EUR RESPIR J, V45, P928, DOI 10.1183/09031936.00214014; Martineau AR, 2007, AM J RESP CRIT CARE, V176, P208, DOI 10.1164/rccm.200701-007OC; Martineaua AR, 2011, P NATL ACAD SCI USA, V108, P19013, DOI 10.1073/pnas.1111825108; Matsunawa M, 2009, TOXICOL SCI, V109, P50, DOI 10.1093/toxsci/kfp044; Mulligan JK, 2014, J ALLERGY CLIN IMMUN, V134, P342, DOI 10.1016/j.jaci.2014.01.039; Nielsen NO, 2010, BRIT J NUTR, V104, P1487, DOI 10.1017/S0007114510002333; Nnoaham KE, 2008, INT J EPIDEMIOL, V37, P113, DOI 10.1093/ije/dym247; Owolabi O, 2016, TUBERCULOSIS, V98, P86, DOI 10.1016/j.tube.2016.02.007; Paker-Eichelkraut H. Suendues, 2013, Journal of Nutrition in Gerontology and Geriatrics, V32, P330, DOI 10.1080/21551197.2013.842198; Pareek M, 2015, THORAX, P1; Roth DE, 2004, J INFECT DIS, V190, P920, DOI 10.1086/423212; Ruwanpathirana T, 2014, BMC CARDIOVASC DISOR, V14, DOI 10.1186/1471-2261-14-157; Shin DM, 2010, CELL MICROBIOL, V12, P1648, DOI 10.1111/j.1462-5822.2010.01497.x; Sita-Lumsden A, 2007, THORAX, V62, P1003, DOI 10.1136/thx.2006.070060; Social CM de D., ENC CAS DEF IND; Talat N, 2010, EMERG INFECT DIS, V16, P853, DOI 10.3201/eid1605.091693; Ustianowski A, 2005, J INFECTION, V50, P432, DOI 10.1016/j.jinf.2004.07.006; Verway M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003407; Willis MD, 2012, CLIN INFECT DIS, V54, P1553, DOI 10.1093/cid/cis235; Wingfield T, 2014, J INFECT DIS, V210, P774, DOI 10.1093/infdis/jiu121; World Health Organization (WHO), 2016, WHO GLOB TUB REP 201; Yuk JM, 2009, CELL HOST MICROBE, V6, P231, DOI 10.1016/j.chom.2009.08.004; Zeng JL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126014	48	22	24	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2017	12	4							e0175400	10.1371/journal.pone.0175400	http://dx.doi.org/10.1371/journal.pone.0175400			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LZ	28403225	Green Published, gold, Green Submitted			2022-12-27	WOS:000399955200061
J	Ohsaki, K; Ohgaki, Y; Shimizu, N				Ohsaki, Kiwamu; Ohgaki, Yusuke; Shimizu, Noriaki			Amplification of a transgene within a long array of replication origins favors higher gene expression in animal cells	PLOS ONE			English	Article							DNA-REPLICATION; INITIATION REGION; INVERTED REPEATS; PROTEIN; STABILITY; BREAKAGE; PLASMIDS; LEVEL	Plasmids with both a mammalian replication initiation region (IR) and a matrix attachment region (MAR) are spontaneously amplified in transfected cells, and generate extrachromosomal double minute (DM) or chromosomal homogeneously staining region (HSR). We previously isolated the shortest core IR (G5) required for gene amplification. In this study, we ligated the G5 DNA to create direct or inverted repeats, mixed the repeats with an expression plasmid, and transfected the mixture into human COLO 320DM or hamster CHO DG44 cells. Consequently, we found that the transfected sequence generated DMs or HSR where, surprisingly, the plasmid sequence was embedded within a long stretch of G5 sequences. The amplified structure from the direct G5 repeats was stable, whereas that from the inverted repeats was not. The amplification might be explained by the efficient replication/ multimerization of the G5 repeat and recombination with the co-transfected plasmid in an extrachromosomal context. The product might then be integrated into a chromosome arm to generate a HSR. The expression from the plasmid within the long G5 array was much higher than that from a simple plasmid repeat. Because G5 is a core IR that favors gene expression, a long array of G5 provides an excellent environment for gene expression from the embedded plasmid.	[Ohsaki, Kiwamu; Ohgaki, Yusuke; Shimizu, Noriaki] Hiroshima Univ, Grad Sch Biosphere Sci, Hiroshima, Japan	Hiroshima University	Shimizu, N (corresponding author), Hiroshima Univ, Grad Sch Biosphere Sci, Hiroshima, Japan.	shimizu@hiroshima-u.ac.jp		Shimizu, Noriaki/0000-0002-7979-897X	Japan Society for the Promotion of Science [23380203, 24658290, 26660293]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by a Grant-in-Aid for Scientific Research (B) (23380203) and a Grant-in-Aid for Challenging Exploratory Research (24658290, 26660293), both from the Japan Society for the Promotion of Science (https://www.jsps.go.jp/english/) to N.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertson DG, 2006, TRENDS GENET, V22, P447, DOI 10.1016/j.tig.2006.06.007; Andersson DI, 2009, ANNU REV GENET, V43, P167, DOI 10.1146/annurev-genet-102108-134805; Araki Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041787; Brewer BJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002016; CHAN CSM, 1980, P NATL ACAD SCI-BIOL, V77, P6329, DOI 10.1073/pnas.77.11.6329; Fu HQ, 2006, NAT BIOTECHNOL, V24, P572, DOI 10.1038/nbt1202; Fukuma M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153338; Harada S, 2009, J BIOL CHEM, V284, P24320, DOI 10.1074/jbc.M109.008128; Harraghy N, 2011, J BIOTECHNOL, V154, P11, DOI 10.1016/j.jbiotec.2011.04.004; Hashizume T, 2007, J CELL BIOCHEM, V101, P552, DOI 10.1002/jcb.21210; Ho SCL, 2015, MOL BIOTECHNOL, V57, P138, DOI 10.1007/s12033-014-9809-2; Kawabe Y, 2012, CYTOTECHNOLOGY, V64, P267, DOI 10.1007/s10616-011-9397-y; Kito M, 2002, APPL MICROBIOL BIOT, V60, P442, DOI 10.1007/s00253-002-1134-1; Lawce HJ, 1991, THE ACT CYTOGETICS L, P31; Lobachev KS, 2007, FRONT BIOSCI-LANDMRK, V12, P4208, DOI 10.2741/2381; Majocchi S, 2014, NUCLEIC ACIDS RES, V42, P193, DOI 10.1093/nar/gkt880; Nakano M, 2008, DEV CELL, V14, P507, DOI 10.1016/j.devcel.2008.02.001; Narayanan V, 2006, CELL, V125, P1283, DOI 10.1016/j.cell.2006.04.042; Noguchi C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052990; Novac O, 2002, J BIOL CHEM, V277, P11174, DOI 10.1074/jbc.M107902200; Okada N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077350; Omasa T, 2002, J BIOSCI BIOENG, V94, P600, DOI 10.1016/S1389-1723(02)80201-8; PARRA I, 1993, NAT GENET, V5, P17, DOI 10.1038/ng0993-17; Pearson CE, 1996, J CELL BIOCHEM, V63, P1; Shimizu N, 2005, EXP CELL RES, V302, P233, DOI 10.1016/j.yexcr.2004.09.001; Shimizu N, 2003, CANCER RES, V63, P5281; Shimizu N, 2009, CYTOGENET GENOME RES, V124, P312, DOI 10.1159/000218135; Shimizu N, 2001, CANCER RES, V61, P6987; Shimizu N, 2007, J CELL BIOCHEM, V102, P515, DOI 10.1002/jcb.21313; Tanaka H, 2009, NAT REV CANCER, V9, P215, DOI 10.1038/nrc2591; TSUTSUI K, 1993, J BIOL CHEM, V268, P12886; Yoshimura H, 2011, PROTEIN EXPRES PURIF, V80, P41, DOI 10.1016/j.pep.2011.05.009; Zannis-Hadjopoulos M, 2008, TRENDS BIOCHEM SCI, V33, P44, DOI 10.1016/j.tibs.2007.09.012	33	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2017	12	4							e0175585	10.1371/journal.pone.0175585	http://dx.doi.org/10.1371/journal.pone.0175585			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LZ	28403180	Green Published, Green Submitted, gold			2022-12-27	WOS:000399955200084
J	Rijnbeek, PR; van den Berg, ME; van Herpen, G; van Eck, HJR; Kors, JA				Rijnbeek, Peter R.; van den Berg, Marten E.; van Herpen, Gerard; van Eck, Henk J. Ritsema; Kors, Jan A.			Validation of automatic measurement of QT interval variability	PLOS ONE			English	Article							SHORT-TERM VARIABILITY; SUDDEN CARDIAC DEATH; PROGRAMS	Background Increased variability of beat-to-beat QT-interval durations on the electrocardiogram (ECG) has been associated with increased risk for fatal and non-fatal cardiac events. However, techniques for the measurement of QT variability (QTV) have not been validated since a gold standard is not available. In this study, we propose a validation method and illustrate its use for the validation of two automatic QTV measurement techniques. Methods Our method generates artificial standard 12-lead ECGs based on the averaged P-QRS-T complexes from a variety of existing ECG signals, with simulated intrinsic (QT interval) and extrinsic (noise, baseline wander, signal length) variations. We quantified QTV by a commonly used measure, short-term QT variability (STV). Using 28,800 simulated ECGs, we assessed the performance of a conventional QTV measurement algorithm, resembling a manual QTV measurement approach, and a more advanced algorithm based on fiducial segment averaging (FSA). Results The results for the conventional algorithm show considerable median absolute differences between the simulated and estimated STV. For the highest noise level, median differences were 4-6 ms in the absence of QTV. Increasing signal length generally yields more accurate STV estimates, but the difference in performance between 30 or 60 beats is small. The FSA algorithm proved to be very accurate, with most median absolute differences less than 0.5 ms, even for the highest levels of disturbance. Conclusions Artificially constructed ECGs with a variety of disturbances allow validation of QTV measurement procedures. The FSA algorithm provides highly accurate STV estimates under varying signal conditions, and performs much better than traditional beat-by-beat analysis. The fully automatic operation of the FSA algorithm enables STV measurement in large sets of ECGs.	[Rijnbeek, Peter R.; van den Berg, Marten E.; van Herpen, Gerard; van Eck, Henk J. Ritsema; Kors, Jan A.] Erasmus Univ, Med Ctr, Dept Med Informat, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC	Rijnbeek, PR (corresponding author), Erasmus Univ, Med Ctr, Dept Med Informat, Rotterdam, Netherlands.	p.ribeek@erasmusmc.nl			Netherlands Organization for Health Research and Development (ZonMw) [113102005]	Netherlands Organization for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development)	This work was supported by a grant from the Netherlands Organization for Health Research and Development (ZonMw) [Priority Medicines Elderly 113102005 to PR and MB]. The funding agency had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumert M, 2016, EUROPACE, V18, P925, DOI 10.1093/europace/euv405; Baumert M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041920; Berger RD, 1997, CIRCULATION, V96, P1557, DOI 10.1161/01.CIR.96.5.1557; Lux RL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085689; Niemeijer MN, 2014, HEART, V100, P1831, DOI 10.1136/heartjnl-2014-305671; Oosterhoff P, 2011, HEART RHYTHM, V8, P1584, DOI 10.1016/j.hrthm.2011.04.033; Schmidt M, 2014, IEEE T SIGNAL PROCES, V62, P5577, DOI 10.1109/TSP.2014.2354313; Thomsen MB, 2004, CIRCULATION, V110, P2453, DOI 10.1161/01.CIR.0000145162.64183.C8; van Eck HJR, 2002, J ELECTROCARDIOL, V35, P89, DOI 10.1054/jelc.2002.37160; VANBEMMEL JH, 1990, METHOD INFORM MED, V29, P346; WILLEMS JL, 1987, J AM COLL CARDIOL, V10, P1313, DOI 10.1016/S0735-1097(87)80136-5; WILLEMS JL, 1991, NEW ENGL J MED, V325, P1767, DOI 10.1056/NEJM199112193252503	12	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2017	12	4							e0175087	10.1371/journal.pone.0175087	http://dx.doi.org/10.1371/journal.pone.0175087			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LZ	28403196	Green Published, gold, Green Submitted			2022-12-27	WOS:000399955200032
J	Snelling, SJB; Bas, S; Puskas, GJ; Dakin, SG; Suva, D; Finckh, A; Gabay, C; Hoffmeyer, P; Carr, AJ; Lubbeke, A				Snelling, Sarah J. B.; Bas, Sylvette; Puskas, Gabor J.; Dakin, Stephanie G.; Suva, Domizio; Finckh, Axel; Gabay, Cem; Hoffmeyer, Pierre; Carr, Andrew J.; Luebbeke, Anne			Presence of IL-17 in synovial fluid identifies a potential inflammatory osteoarthritic phenotype	PLOS ONE			English	Article							RHEUMATOID-ARTHRITIS; KNEE OSTEOARTHRITIS; HIP OSTEOARTHRITIS; UNITED-STATES; II COLLAGEN; TH17 CELLS; INTERLEUKIN-17; EXPRESSION; PREVALENCE; CYTOKINE	Purpose Osteoarthritis (OA) is a common and heterogeneous arthritic disorder. Patients suffer pain and their joints are characterized by articular cartilage loss and osteophyte formation. Risk factors for OA include age and obesity with inflammation identified as a key mediator of disease pathogenesis. Interleukin-17A (IL-17) is a pro-inflammatory cytokine that has been implicated in inflammatory diseases such as rheumatoid arthritis. IL-17 can upregulate expression of inflammatory cytokines and adipocytokines. The aim of this study was to evaluate IL-17 levels in the synovial fluid of patients with end-stage knee and hip OA in relation to inflammation-and pain-related cytokines and adipocytokines in synovial fluid and serum, and clinical and radiographic disease parameters. Methods This is a cross-sectional study of 152 patients undergoing total hip and knee arthroplasty for OA. IL-17, IL-6, leptin, adiponectin, visfatin, resistin, C-C Motif Chemokine Ligand 2 (CCL2), C-C Motif Chemokine Ligand 7 (CCL7) and nerve growth factor (NGF) protein levels were measured in synovial fluid and serum using enzyme-linked immunosorbent assay (ELISA). Baseline characteristics included age, sex, body mass index, co-morbidities, pain and function, and radiographic analyses (OA features, K&L grade, minimal joint space width). Results 14 patients (9.2%) had detectable IL-17 in synovial fluid. These patients had significantly higher median concentrations of IL-6, leptin, resistin, CCL7 and NGF. Osteophytes, sclerosis and minimum joint space width were significantly reduced in patients with detectable IL-17 in synovial fluid. No differences were found in pain, function and comorbidities. IL-17 concentrations in synovial fluid and serum were moderately correlated (r = 0.482). Conclusion The presence of IL-17 in the synovial fluid therefore identifies a substantial subset of primary end-stage OA patients with distinct biological and clinical features. Stratification of patients on the basis of IL-17 may identify those responsive to therapeutic targeting.	[Snelling, Sarah J. B.; Dakin, Stephanie G.; Carr, Andrew J.; Luebbeke, Anne] Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford, England; [Bas, Sylvette; Finckh, Axel; Gabay, Cem] Univ Hosp Geneva, Div Rheumatol, Geneva, Switzerland; [Puskas, Gabor J.; Suva, Domizio; Hoffmeyer, Pierre; Luebbeke, Anne] Univ Hosp Geneva, Div Orthopaed Surg & Traumatol, Geneva, Switzerland	University of Oxford; University of Geneva; University of Geneva	Snelling, SJB (corresponding author), Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford, England.	sarah.snelling@ndorms.ox.ac.uk	hoffmeyer, pierre/AAY-1392-2021; Hoffmeyer, Pierre/X-4491-2019	Lubbeke, Anne/0000-0002-6905-6120; Snelling, Sarah/0000-0002-7052-3793; Dakin, Stephanie Georgina/0000-0003-2470-1031; Hoffmeyer, Pierre/0000-0001-9736-828X	Medacta; Johnson Johnson; Zimmer; Arthritis Research UK [20087, 20506]; NIHR Musculoskeletal Biomedical Research Unit; Medical Research Council [MC_PC_15069, MC_PC_14103] Funding Source: researchfish; Versus Arthritis [20087, 20506] Funding Source: researchfish; MRC [MC_PC_15069, MC_PC_14103] Funding Source: UKRI	Medacta; Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA); Zimmer; Arthritis Research UK(Versus Arthritis); NIHR Musculoskeletal Biomedical Research Unit; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Versus Arthritis(Versus Arthritis); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Internal institutional funding was received for this study. Prof. Pierre Hoffmeyer received institutional financial support from Medacta, Johnson & Johnson, and Zimmer. SJBS was funded by Arthritis Research UK www.artritisresearchuk.org grant 20087. SGD was funded by Arthritis Research UK grant 20506. The NIHR Musculoskeletal Biomedical Research Unit also funded this work. The funding sources had no role in the collection, analysis, or interpretation of the data, in the preparation of the manuscript, or its submission for publication.	Atukorala I, 2014, ANN RHEUMATIC DIS; Benedetti G, 2014, EUR J IMMUNOL, V44, P339, DOI 10.1002/eji.201344184; Camporeale A, FRONT BIOSCI; Chabaud M, 1999, ARTHRITIS RHEUM-US, V42, P963, DOI 10.1002/1529-0131(199905)42:5<963::AID-ANR15>3.0.CO;2-E; Chen B, 2014, J INT MED RES, V42, P138, DOI 10.1177/0300060513501751; Chen L, 2011, OSTEOARTHR CARTILAGE, V19, P711, DOI 10.1016/j.joca.2011.01.018; Conrozier T, 2007, OSTEOARTHR CARTILAGE, V15, P462, DOI 10.1016/j.joca.2006.09.002; Dai J, 2010, J HUM GENET, V55, P77, DOI 10.1038/jhg.2009.137; Deligne C, 2015, OSTEOARTHR CARTILAGE, V23, P1843, DOI 10.1016/j.joca.2014.12.007; Deng J, 2012, ARTHRITIS RHEUM-US, V64, P3564, DOI 10.1002/art.34637; Furst DE, 2014, RHEUMATOLOGY, V53, P1560, DOI 10.1093/rheumatology/ket414; Gagliani N, 2015, NATURE, V523, P221, DOI 10.1038/nature14452; Garnero P, 2006, ANN RHEUM DIS, V65, P1639, DOI 10.1136/ard.2006.052621; Griffin TM, 2009, ARTHRITIS RHEUM-US, V60, P2935, DOI 10.1002/art.24854; Hwang SY, 2004, ARTHRITIS RES THER, V6, pR120, DOI 10.1186/ar1038; Kang XZ, 2009, ARTHRIT RHEUM-ARTHR, V61, P641, DOI 10.1002/art.24464; Kapoor M, 2011, NAT REV RHEUMATOL, V7, P33, DOI 10.1038/nrrheum.2010.196; Karvonen-Gutierrez CA, 2015, J GERONTOLOGY A; Kim YG, 2014, ARCH ORAL BIOL, V59, P897, DOI 10.1016/j.archoralbio.2014.05.009; Kimura A, 2007, P NATL ACAD SCI USA, V104, P12099, DOI 10.1073/pnas.0705268104; Koshy PJ, 2002, ANN RHEUM DIS, V61, P704, DOI 10.1136/ard.61.8.704; Kotake S, 1999, J CLIN INVEST, V103, P1345, DOI 10.1172/JCI5703; LAU EMC, 1995, ANN RHEUM DIS, V54, P965, DOI 10.1136/ard.54.12.965; Lawrence RC, 2008, ARTHRITIS RHEUM, V58, P26, DOI 10.1002/art.23176; Liu YS, 2015, MED SCI MONITOR, V21, P1732; Mabey T, 2015, WORLD J ORTHOP, V6, P95, DOI 10.5312/wjo.v6.i1.95; Makki Kassem, 2013, ISRN Inflamm, V2013, P139239, DOI 10.1155/2013/139239; Mease PJ, 2015, NEW ENGL J MED, V373, P1329, DOI 10.1056/NEJMoa1412679; Murphy L, 2012, ORTHOP NURS, V31, P85, DOI 10.1097/NOR.0b013e31824fcd42; Nevitt MC, 2002, ARTHRITIS RHEUM-US, V46, P1773, DOI 10.1002/art.10332; Noh M, 2012, BIOCHEM PHARMACOL, V83, P661, DOI 10.1016/j.bcp.2011.12.010; Poonpet T, 2014, WORLD J ORTHOP, V5, P319, DOI 10.5312/wjo.v5.i3.319; Richter F, 2012, ARTHRITIS RHEUM-US, V64, P4125, DOI 10.1002/art.37695; Richter M, 2015, INT ORTHOP, V39, P1211, DOI 10.1007/s00264-015-2707-9; Sandy JD, 2015, OSTEOARTHR CARTILAGE, V23, P1939, DOI 10.1016/j.joca.2015.03.027; Schett G, 2013, NAT MED, V19, P822, DOI 10.1038/nm.3260; Shahrara S, 2010, J IMMUNOL, V184, P4479, DOI 10.4049/jimmunol.0901942; Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070; Shin JH, 2009, BIOCHEM PHARMACOL, V77, P1835, DOI 10.1016/j.bcp.2009.03.008; Song YZ, 2015, J CLIN LAB ANAL; Toh ML, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013416; van Baarsen LGM, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/s13075-014-0426-z; Vida M, 2015, DIS MODEL MECH, V8, P721, DOI 10.1242/dmm.019166; Wilke CM, 2011, TRENDS IMMUNOL, V32, P603, DOI 10.1016/j.it.2011.08.003	44	49	54	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2017	12	4							e0175109	10.1371/journal.pone.0175109	http://dx.doi.org/10.1371/journal.pone.0175109			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0JS	28399156	Green Published, gold, Green Submitted			2022-12-27	WOS:000399949000020
J	van den Bos, R; Mes, W; Galligani, P; Heil, A; Zethof, J; Flik, G; Gorissen, M				van den Bos, Ruud; Mes, Wouter; Galligani, Pietro; Heil, Anthony; Zethof, Jan; Flik, Gert; Gorissen, Marnix			Further characterisation of differences between TL and AB zebrafish (Danio rerio): Gene expression, physiology and behaviour at day 5 of the larval stage	PLOS ONE			English	Article							CARP CYPRINUS-CARPIO; STRESS AXIS; BRAIN; STRAINS; GROWTH; NEUROGENESIS; MATURATION; CORTISOL; SYSTEM; MEMORY	Zebrafish (Danio rerio) have become popular as model organism in research. Many strains are readily available, which not only differ morphologically, but also genetically, physiologically and behaviourally. Here, we focus on the AB and Tupfel long-fin (TL) strain for which we have previously shown that adults differ in baseline hypothalamus-pituitary-interrenal (HPI)-axis activity (AB higher than TL) affecting inhibitory avoidance behaviour (absent in AB). To assess whether strain differences are already present in early life stages, we compared baseline HPI-axis related gene expression as well as cortisol levels, (neuro) development related as well as (innate) immune system related gene expression, and light-dark as well as startle behaviour in larvae 5 days post fertilisation. The data show that AB and TL larvae differ in baseline HPI-axis activity (AB higher than TL), expression of (neuro) development and immune system related genes (AB higher than TL), habituation to acoustic/vibrational stimuli (AB habituate faster than TL) and light-dark induced changes in motor behaviour (AB stronger than TL). Our data show that already in larval stages differences exist between zebrafish of the AB and TL strain confirming and extending data of earlier studies. To what extent the mutation in connexin 41.8, leading to spots rather than stripes in TL, but also (possibly) affecting eye, heart and brain function, is involved in the expression of (some of) these differences needs to be studied. These results emphasise that differences between strains need to be taken into account to enhance reproducibility both within, and between, laboratories.	[van den Bos, Ruud; Mes, Wouter; Galligani, Pietro; Heil, Anthony; Zethof, Jan; Flik, Gert; Gorissen, Marnix] Radboud Univ Nijmegen, Dept Anim Ecol & Physiol, Fac Sci, Nijmegen, Netherlands	Radboud University Nijmegen	van den Bos, R; Gorissen, M (corresponding author), Radboud Univ Nijmegen, Dept Anim Ecol & Physiol, Fac Sci, Nijmegen, Netherlands.	ruudvdbos@science.ru.nl; m.gorissen@science.ru.nl	Gorissen, Marnix/C-1077-2012; Flik, Gert/C-8229-2011	Gorissen, Marnix/0000-0001-5762-2917; Flik, Gert/0000-0001-9285-7957; Heil, Anthony/0000-0002-6256-9388	European Union's 7th Framework Programme (FP7) project copewell [265957]	European Union's 7th Framework Programme (FP7) project copewell	The authors received no specific funding for this work. M.G. was financially supported by the European Union's 7th Framework Programme (FP7/2010-2014) project copewell (grant agreement number 265957). The latter had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrous DN, 2005, PHYSIOL REV, V85, P523, DOI 10.1152/physrev.00055.2003; Ahmad F, 2014, THESIS, P1; Alderman SL, 2009, GEN COMP ENDOCR, V164, P61, DOI 10.1016/j.ygcen.2009.04.007; Alsop D, 2008, AM J PHYSIOL-REG I, V294, pR711, DOI 10.1152/ajpregu.00671.2007; Benard EL, 2015, J INNATE IMMUN, V7, P136, DOI 10.1159/000366103; Best C, 2017, SCI REP-UK, V7, DOI 10.1038/srep40905; Best JD, 2008, NEUROPSYCHOPHARMACOL, V33, P1206, DOI 10.1038/sj.npp.1301489; Bonga SEW, 1997, PHYSIOL REV, V77, P591, DOI 10.1152/physrev.1997.77.3.591; Butler MG, 2015, DEVELOPMENT, V142, P1542, DOI 10.1242/dev.118786; Cacialli P, 2016, PLOS ONE, P11; Chatzopoulou A, 2015, ENDOCRINOLOGY, V156, P1757, DOI 10.1210/en.2014-1941; Coe TS, 2009, ECOTOXICOLOGY, V18, P144, DOI 10.1007/s10646-008-0267-0; de Esch C, 2012, NEUROTOXICOL TERATOL, V34, P425, DOI 10.1016/j.ntt.2012.03.002; De Felice E, 2014, J ANAT, V224, P564, DOI 10.1111/joa.12168; Dyer AH, 2016, NEUROSCIENCE, V325, P89, DOI 10.1016/j.neuroscience.2016.03.056; Eivers E, 2004, INT J DEV BIOL, V48, P1131, DOI 10.1387/ijdb.041913ee; Eto K, 2014, MOLEC GENET METAB RE, V1, P373, DOI 10.1016/j.ymgmr.2014.08.003; Fernandes AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075002; Fernandes AM, 2013, BIOESSAYS, V35, P775, DOI 10.1002/bies.201300034; Fernandes AM, 2012, CURR BIOL, V22, P2042, DOI 10.1016/j.cub.2012.08.016; Gao Y, 2016, COMPUT BIOL MED, V69, P1, DOI 10.1016/j.compbiomed.2015.11.012; Gorissen M, 2015, GENES BRAIN BEHAV, V14, P428, DOI 10.1111/gbb.12220; Gorissen M, 2016, FISH PHYSIOL, V35, P75, DOI 10.1016/B978-0-12-802728-8.00003-5; Gorissen M, 2012, GEN COMP ENDOCR, V178, P75, DOI 10.1016/j.ygcen.2012.04.004; Guryev V, 2006, GENOME RES, V16, P491, DOI 10.1101/gr.4791006; Hartig EI, 2016, BIOL OPEN, P1; Kim WY, 2013, MOL CELLS, V35, P444, DOI 10.1007/s10059-013-0065-2; Korn H, 2005, NEURON, V47, P13, DOI 10.1016/j.neuron.2005.05.019; Lange M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070172; Liu Y, 2015, PLOS, V10; MacPhail RC, 2009, NEUROTOXICOLOGY, V30, P52, DOI 10.1016/j.neuro.2008.09.011; Maga G, 2003, J CELL SCI, V116, P3051, DOI 10.1242/jcs.00653; Mahabir S, 2013, BEHAV BRAIN RES, V247, P1, DOI 10.1016/j.bbr.2013.03.013; Maximino C, 2013, J CHEM NEUROANAT, V48-49, P1, DOI 10.1016/j.jchemneu.2012.10.001; McMenamin SK, 2013, ENDOCRINOLOGY, V154, P1476, DOI 10.1210/en.2012-1734; Medan V, 2014, J PHYSIOL-PARIS, V108, P129, DOI 10.1016/j.jphysparis.2014.07.006; Nesan D, 2016, SCI REP, P6; Roberts AC, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00126; Rogge G, 2008, NAT REV NEUROSCI, V9, P747, DOI 10.1038/nrn2493; Schaaf MJM, 2008, ENDOCRINOLOGY, V149, P1591, DOI 10.1210/en.2007-1364; Seguret A, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.160451; Spence R, 2008, BIOL REV, V83, P13, DOI 10.1111/j.1469-185X.2007.00030.x; Stewart AM, 2014, TRENDS NEUROSCI, V37, P264, DOI 10.1016/j.tins.2014.02.011; Stouthart AJHX, 1998, J ENDOCRINOL, V157, P127, DOI 10.1677/joe.0.1570127; Subhedar NK, 2014, PEPTIDES, V54, P108, DOI 10.1016/j.peptides.2014.01.004; van den Bos R., 2016, CURR PSYCHOPHARMACOL, V5, P152, DOI [10.2174/2211556005666160526111427, DOI 10.2174/2211556005666160526111427]; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vignet C, 2013, ZEBRAFISH, V10, P365, DOI 10.1089/zeb.2013.0871; Villamizar N, 2014, ZEBRAFISH, V11, P173, DOI 10.1089/zeb.2013.0926; Watanabe M, 2006, EMBO REP, V7, P893, DOI 10.1038/sj.embor.7400757; Watanabe M, 2016, J BIOL CHEM, V291, P1053, DOI 10.1074/jbc.M115.673129; Wilson KS, 2013, J PHYSIOL-LONDON, V591, P6209, DOI 10.1113/jphysiol.2013.256826; Wolman MA, 2015, NEURON, V85, P1200, DOI 10.1016/j.neuron.2015.02.025; Wolman MA, 2011, P NATL ACAD SCI USA, V108, P15468, DOI 10.1073/pnas.1107156108; Zhu XY, 2007, PHYSIOL REV, V87, P933, DOI 10.1152/physrev.00006.2006	55	56	56	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2017	12	4							e0175420	10.1371/journal.pone.0175420	http://dx.doi.org/10.1371/journal.pone.0175420			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KH	28419104	Green Published, Green Submitted, gold			2022-12-27	WOS:000399875200021
J	Wang, PY; Qiu, ZY; Xia, DG; Tang, SM; Shen, XJ; Zhao, QL				Wang, Pingyang; Qiu, Zhiyong; Xia, Dingguo; Tang, Shunming; Shen, Xingjia; Zhao, Qiaoling			Transcriptome analysis of the epidermis of the purple quail-like (q-l(p)) mutant of silkworm, Bombyx mori	PLOS ONE			English	Article							NUCLEAR RECEPTORS; DIFFERENTIAL EXPRESSION; N-ACETYLTRANSFERASE; CHITIN SYNTHASES; YELLOW GENE; DROSOPHILA; PIGMENTATION; EVOLUTION; MELANIN; HYDROXYLASE	A new purple quail-like (q-l(p)) mutant found from the plain silkworm strain 932VR has pigment dots on the epidermis similar to the pigment mutant quail (q). In addition, q-l(p) mutant larvae are inactive, consume little and grow slowly, with a high death rate and other developmental abnormalities. Pigmentation of the silkworm epidermis consists of melanin, ommochrome and pteridine. Silkworm development is regulated by ecdysone and juvenile hormone. In this study, we performed RNA-Seq on the epidermis of the q-l(p) mutant in the 4 th instar during molting, with 932VR serving as the control. The results showed 515 differentially expressed genes, of which 234 were upregulated and 281 downregulated in q-l(p). BLASTGO analysis indicated that the downregulated genes mainly encode protein-binding proteins, membrane components, oxidation/reduction enzymes, and proteolytic enzymes, whereas the upregulated genes largely encode cuticle structural constituents, membrane components, transport related proteins, and protein-binding proteins. Quantitative reverse transcription PCR was used to verify the accuracy of the RNA-Seq data, focusing on key genes for biosynthesis of the three pigments and chitin as well as genes encoding cuticular proteins and several related nuclear receptors, which are thought to play key roles in the q-l(p) mutant. We drew three conclusions based on the results: 1) melanin, ommochrome and pteridine pigments are all increased in the q-l(p) mutant; 2) more cuticle proteins are expressed in q-l(p) than in 932VR, and the number of upregulated cuticular genes is significantly greater than downregulated genes; 3) the downstream pathway regulated by ecdysone is blocked in the q-l(p) mutant. Our research findings lay the foundation for further research on the developmental changes responsible for the q-l(p) mutant.	[Wang, Pingyang; Qiu, Zhiyong; Xia, Dingguo; Tang, Shunming; Shen, Xingjia; Zhao, Qiaoling] Jiangsu Univ Sci & Technol, Sch Biotechnol, Zhenjiang, Jiangsu, Peoples R China; [Wang, Pingyang; Qiu, Zhiyong; Xia, Dingguo; Tang, Shunming; Shen, Xingjia; Zhao, Qiaoling] Chinese Acad Agr Sci, Sericulture Res Inst, Zhenjiang, Jiangsu, Peoples R China	Jiangsu University of Science & Technology; Chinese Academy of Agricultural Sciences	Zhao, QL (corresponding author), Jiangsu Univ Sci & Technol, Sch Biotechnol, Zhenjiang, Jiangsu, Peoples R China.; Zhao, QL (corresponding author), Chinese Acad Agr Sci, Sericulture Res Inst, Zhenjiang, Jiangsu, Peoples R China.	qlzhao302@126.com	Wang, Pingyang/HHC-2182-2022	Wang, Pingyang/0000-0003-3908-6561	National Natural Science Foundation of China [31372378]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (No. 31372378) (Qiaoling Zhao).; This work was supported by grants from the National Natural Science Foundation of China ( No. 31372378).	Allen AK, 2008, DEVELOPMENT, V135, P311, DOI 10.1242/dev.015156; Arakane Y, 2009, J BIOL CHEM, V284, P16584, DOI 10.1074/jbc.M901629200; Benoit G, 2006, PHARMACOL REV, V58, P798, DOI 10.1124/pr.58.4.10; Brodbeck D, 1998, DNA CELL BIOL, V17, P621, DOI 10.1089/dna.1998.17.621; CANDY DJ, 1962, J EXP BIOL, V39, P129; Carraway KL, 2007, CURR TOP DEV BIOL, V78, P1, DOI 10.1016/S0070-2153(06)78001-2; Christiaens O., 2013, KEY ROLE DIVERSITY E; Coates BS, 2005, J INSECT SCI, V5, DOI 10.1093/jis/5.1.19; Cohen E, 2001, PEST MANAG SCI, V57, P946, DOI 10.1002/ps.363; Crispi S, 1998, J MOL BIOL, V275, P561, DOI 10.1006/jmbi.1997.1473; Dai FY, 2010, J BIOL CHEM, V285, P19553, DOI 10.1074/jbc.M109.096743; EISENBERG E, 1985, SCIENCE, V227, P999, DOI 10.1126/science.3156404; Evans RM, 2014, CELL, V157, P255, DOI 10.1016/j.cell.2014.03.012; Fernandez AA, 2008, P NATL ACAD SCI USA, V105, P13503, DOI 10.1073/pnas.0803851105; FUKAMIZO T, 1985, INSECT BIOCHEM, V15, P141, DOI 10.1016/0020-1790(85)90001-0; Futahashi R, 2008, GENETICS, V180, P1995, DOI 10.1534/genetics.108.096388; Galko MJ, 2004, PLOS BIOL, V2, P1114, DOI 10.1371/journal.pbio.0020239; GELTOSKY JE, 1980, BIOCHEM GENET, V18, P781, DOI 10.1007/BF00484593; Gorman MJ, 2010, INSECT BIOCHEM MOLEC, V40, P267, DOI 10.1016/j.ibmb.2010.01.004; Gu SH, 2016, J INSECT PHYSIOL, V90, P8, DOI 10.1016/j.jinsphys.2016.04.003; Han D, 2002, BIOCHEM J, V368, P333; HAYASHI Y, 1960, NATURE, V186, P1053, DOI 10.1038/1861053a0; Helvig C, 2004, P NATL ACAD SCI USA, V101, P4024, DOI 10.1073/pnas.0306980101; Hu YG, 2013, ARCH INSECT BIOCHEM, V83, P41, DOI 10.1002/arch.21096; Insausti TC, 2008, J EXP BIOL, V211, P780, DOI 10.1242/jeb.014043; Kato T, 2006, PIGM CELL RES, V19, P337, DOI 10.1111/j.1600-0749.2006.00316.x; Kaur S, 2015, PLOS ONE, V10, P896; King-Jones K, 2005, NAT REV GENET, V6, P311, DOI 10.1038/nrg1581; Kozlova T, 2009, DEV DYNAM, V238, P701, DOI 10.1002/dvdy.21860; Linzen B., 1974, ADV INSECT PHYSL, P117, DOI DOI 10.1016/S0065-2806(08)60130-7; Liu C, 2010, P NATL ACAD SCI USA, V107, P12980, DOI 10.1073/pnas.1001725107; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MACKAY WJ, 1983, GENETICS, V105, P35; Meng Y, 2009, J BIOL CHEM, V284, P11698, DOI 10.1074/jbc.M900485200; Merzendorfer H, 2006, J COMP PHYSIOL B, V176, P1, DOI 10.1007/s00360-005-0005-3; Merzendorfer H, 2003, J EXP BIOL, V206, P4393, DOI 10.1242/jeb.00709; Namiki T, 2005, BIOCHEM BIOPH RES CO, V337, P367, DOI 10.1016/j.bbrc.2005.09.043; Nie HY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094185; Ohashi M, 1983, J SERICULT SCI JPN, V52, P498; Phillips JP, 1980, GENET BIOL DROSOPHIL, V46, P216; Ruaud AF, 2011, MOL ENDOCRINOL, V25, P83, DOI 10.1210/me.2010-0337; SUTHERLAND JD, 1995, P NATL ACAD SCI USA, V92, P7966, DOI 10.1073/pnas.92.17.7966; Talloen W, 2004, EVOLUTION, V58, P360, DOI 10.1111/j.0014-3820.2004.tb01651.x; Tatematsu K, 2011, GENES CELLS, V16, P331, DOI 10.1111/j.1365-2443.2011.01490.x; Urness LD, 1995, EMBO J, V14, P6239, DOI 10.1002/j.1460-2075.1995.tb00314.x; WALTER MF, 1991, DEV BIOL, V147, P32, DOI 10.1016/S0012-1606(05)80005-3; Wesolowski S, 2013, BIOSENSORS-BASEL, V3, P238, DOI 10.3390/bios3030238; Wittkopp PJ, 2009, SEMIN CELL DEV BIOL, V20, P65, DOI 10.1016/j.semcdb.2008.10.002; Wittkopp PJ, 2003, P NATL ACAD SCI USA, V100, P1808, DOI 10.1073/pnas.0336368100; Wittkopp PJ, 2002, CURR BIOL, V12, P1547, DOI 10.1016/S0960-9822(02)01113-2; Wittkopp PJ, 2002, DEVELOPMENT, V129, P1849; Xia QY, 2008, INSECT BIOCHEM MOLEC, V38, P1036, DOI [10.1016/j.ibmb.2009.01.004, 10.1016/j.ibmb.2008.11.004]; Yamada M, 2000, DEVELOPMENT, V127, P5083; YAO TP, 1993, NATURE, V366, P476, DOI 10.1038/366476a0; Zhan SA, 2010, DEVELOPMENT, V137, P4083, DOI 10.1242/dev.053678; Zhang J., 2004, J NW POLYTECHNICAL U, V1, P19; Zhao Qiaoling, 2014, Yichuan, V36, P369, DOI 10.3724/SP.J.1005.2014.0369	57	9	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2017	12	4							e0175994	10.1371/journal.pone.0175994	http://dx.doi.org/10.1371/journal.pone.0175994			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KD	28414820	gold, Green Submitted, Green Published			2022-12-27	WOS:000399874800085
J	Brencicova, E; Jagger, AL; Evans, HG; Georgouli, M; Laios, A; Montalto, SA; Mehra, G; Spencer, J; Ahmed, AA; Raju-Kankipati, S; Taams, LS; Diebold, SS				Brencicova, Eva; Jagger, Ann L.; Evans, Hayley G.; Georgouli, Mirella; Laios, Alex; Montalto, Steve Attard; Mehra, Gautam; Spencer, Jo; Ahmed, Ahmed A.; Raju-Kankipati, Shanti; Taams, Leonie S.; Diebold, Sandra S.			Interleukin-10 and prostaglandin E-2 have complementary but distinct suppressive effects on Toll-like receptor-mediated dendritic cell activation in ovarian carcinoma	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; REGULATORY T-CELLS; INDOLEAMINE 2,3-DIOXYGENASE; GROWTH-FACTOR; CANCER; IL-10; MACROPHAGES; EXPRESSION; INDUCTION; ASCITES	Dendritic cells (DC) have the potential to instigate a tumour-specific immune response, but their ability to prime naive lymphocytes depends on their activation status. Thus, for tumour immunotherapy to be effective, the provision of appropriate DC activation stimuli such as Tolllike receptor (TLR) agonists is crucial in order to overcome immunosuppression associated with the tumour microenvironment. To address this, we investigated how ovarian carcinoma (OC)-associated ascites impedes activation of DC by TLR agonists. Our results show that ascites reduces the TLR-mediated up-regulation of CD86 and partially inhibits the production of the pro-inflammatory cytokines interleukin 6 (IL-6), IL-12 and tumour necrosis factor a (TNF alpha) in monocyte-derived DC from healthy controls. We further observe an impaired T cell stimulatory capacity of DC upon activation with TLR agonists in the presence of ascites, indicating that their functionality is affected by the immunosuppressive factors. We identify IL-10 and prostaglandin E2 (PGE(2)) as the pivotal immunosuppressive components in OC-associated ascites compromising TLR-mediated DC activation. Interestingly, IL-10 is present in both ascites from patients with malignant OC and in peritoneal fluid from patients with benign ovarian conditions and both fluids have similar ability to reduce TLR-mediated DC activation. However, depletion of IL-10 from ascites revealed that the presence of paracrine IL-10 is not crucial for ascites-mediated suppression of DC activation in response to TLR activation. Unlike IL-10, PGE(2) is absent from peritoneal fluid of patients with benign conditions and selectively reduces TNFa induction in response to TLR-mediated activation in the presence of OC-associated ascites. Our study highlights PGE(2) as an immunosuppressive component of the malignant OC microenvironment rendering PGE(2) a potentially important target for immunotherapy in OC.	[Brencicova, Eva; Jagger, Ann L.; Evans, Hayley G.; Georgouli, Mirella; Spencer, Jo; Taams, Leonie S.; Diebold, Sandra S.] Kings Coll London, Peter Gorer Dept Immunobiol, Div Immunol Infect & Inflammatory Dis, London, England; [Evans, Hayley G.; Taams, Leonie S.] Kings Coll London, Div Immunol Infect & Inflammatory Dis, CMCBI, London, England; [Laios, Alex; Ahmed, Ahmed A.] Univ Oxford, Nuffield Dept Obstet & Gynaecol, Oxford, England; [Montalto, Steve Attard; Mehra, Gautam; Raju-Kankipati, Shanti] St Thomas Hosp, Dept Gynaecol Oncol, London, England; [Brencicova, Eva] Univ Bern, Inst Forens Med, Bern, Switzerland; [Diebold, Sandra S.] NIBSC, Potters Bar, Herts, England	University of London; King's College London; University of London; King's College London; University of Oxford; Guy's & St Thomas' NHS Foundation Trust; University of Bern; National Institute for Biological Standards & Control	Diebold, SS (corresponding author), Kings Coll London, Peter Gorer Dept Immunobiol, Div Immunol Infect & Inflammatory Dis, London, England.; Diebold, SS (corresponding author), NIBSC, Potters Bar, Herts, England.	sandra.diebold@nibsc.org	Laios, Alexandros/AAN-9433-2020; Laios, Alex/AAD-7618-2020	Laios, Alexandros/0000-0002-4870-7393; Taams, Leonie/0000-0002-9337-7194; Spencer, Jo/0000-0002-7202-2431	Cancer Research UK Career Development Award [A5593]; Cancer Research UK Ph.D. studentship [A11089]; MRC [G0902418] Funding Source: UKRI; Medical Research Council [G0902418] Funding Source: researchfish	Cancer Research UK Career Development Award(Cancer Research UK); Cancer Research UK Ph.D. studentship(Cancer Research UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by a Cancer Research UK Career Development Award to SD (A5593). EB was funded by a Cancer Research UK Ph.D. studentship (A11089) (http://www.cancerresearchuk.org). The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bekeredjian-Ding I, 2009, IMMUNOLOGY, V128, P439, DOI 10.1111/j.1365-2567.2009.03134.x; Boonstra A, 2006, J IMMUNOL, V177, P7551, DOI 10.4049/jimmunol.177.11.7551; Braun D, 2005, BLOOD, V106, P2375, DOI 10.1182/blood-2005-03-0979; Brencicova E, 2017, J IMMUNOL METHODS, V443, P18, DOI [10.1016/j.jim.2017,01.008, 10.1016/j.jim.2017.01.008]; Chen LL, 2009, J OBSTET GYNAECOL RE, V35, P212, DOI 10.1111/j.1447-0756.2008.00935.x; Coleman RL, 2013, NATURE REV CLIN ONCO; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; Diebold Sandra S, 2009, Handb Exp Pharmacol, P3, DOI 10.1007/978-3-540-71029-5_1; Garcia Rodriguez Luis A, 2013, Recent Results Cancer Res, V191, P67, DOI 10.1007/978-3-642-30331-9_4; Giuntoli RL, 2009, ANTICANCER RES, V29, P2875; Haas AR, 2006, CLIN CANCER RES, V12, P214, DOI 10.1158/1078-0432.CCR-05-1178; Hahn T, 2006, INT J CANCER, V118, P2220, DOI 10.1002/ijc.21616; Hart KM, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00029; Hawrylowicz CM, 2005, NAT REV IMMUNOL, V5, P271, DOI 10.1038/nri1589; Heusinkveld M, 2011, J IMMUNOL, V187, P1157, DOI 10.4049/jimmunol.1100889; Hubbard LLN, 2010, J IMMUNOL, V184, P6299, DOI 10.4049/jimmunol.0902828; Jarrossay D, 2001, EUR J IMMUNOL, V31, P3388, DOI 10.1002/1521-4141(200111)31:11<3388::AID-IMMU3388>3.0.CO;2-Q; Joffre O, 2009, IMMUNOL REV, V227, P234, DOI 10.1111/j.1600-065X.2008.00718.x; Joffre OP, 2012, NAT REV IMMUNOL, V12, P557, DOI 10.1038/nri3254; Johnson TS, 2012, IMMUNOL INVEST, V41, P765, DOI 10.3109/08820139.2012.689405; Kalinski P, 2001, BLOOD, V97, P3466, DOI 10.1182/blood.V97.11.3466; Kulbe H, 2007, CANCER RES, V67, P585, DOI 10.1158/0008-5472.CAN-06-2941; Kulbe H, 2012, CANCER RES, V72, P66, DOI 10.1158/0008-5472.CAN-11-2178; Laudanski K, 2004, SHOCK, V22, P204, DOI 10.1097/01.shk.0000135289.62159.ad; Lavoue V, 2012, INT J CANCER, V131, pE449, DOI 10.1002/ijc.27353; Legler DF, 2006, J IMMUNOL, V176, P966, DOI 10.4049/jimmunol.176.2.966; Liu B, 2010, J HEMATOL ONCOL, V3, DOI 10.1186/1756-8722-3-7; Llorente L, 2000, ARTHRITIS RHEUM, V43, P1790, DOI 10.1002/1529-0131(200008)43:8<1790::AID-ANR15>3.0.CO;2-2; Menter DG, 2010, CLIN CANCER RES, V16, P1384, DOI 10.1158/1078-0432.CCR-09-0788; Muste A, 2009, CYTOKINE, V45, P8, DOI 10.1016/j.cyto.2008.10.019; Mustea A, 2006, ANTICANCER RES, V26, P1715; Nowak M, 2010, NEUROENDOCRINOL LETT, V31, P375; Obermajer N, 2012, IMMUNOL INVEST, V41, P635, DOI 10.3109/08820139.2012.695417; Poloso NJ, 2013, MOL IMMUNOL, V54, P284, DOI 10.1016/j.molimm.2012.12.010; Rabinovich A, 2010, EUR CYTOKINE NETW, V21, P122, DOI 10.1684/ecn.2010.0188; Rask K, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-62; RENZ H, 1988, J IMMUNOL, V141, P2388; Santin AD, 1999, EUR J GYNAECOL ONCOL, V20, P177; Sato E, 2005, P NATL ACAD SCI USA, V102, P18538, DOI 10.1073/pnas.0509182102; Scarlett UK, 2009, CANCER RES, V69, P7329, DOI 10.1158/0008-5472.CAN-09-0835; Sims GP, 2010, ANNU REV IMMUNOL, V28, P367, DOI 10.1146/annurev.immunol.021908.132603; von Bergwelt-Baildon MS, 2006, BLOOD, V108, P228, DOI 10.1182/blood-2005-08-3507; Wang R, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-62; Wertel I, 2008, CYTOM PART B-CLIN CY, V74B, P251, DOI 10.1002/cyto.b.20410; Yigit R, 2010, GYNECOL ONCOL, V117, P366, DOI 10.1016/j.ygyno.2010.01.019; Zhang L, 2003, NEW ENGL J MED, V348, P203, DOI 10.1056/NEJMoa020177	46	24	25	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2017	12	4							e0175712	10.1371/journal.pone.0175712	http://dx.doi.org/10.1371/journal.pone.0175712			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0MD	28410380	Green Published, Green Submitted, gold			2022-12-27	WOS:000399955600037
J	Gronau, N; Izoutcheev, A; Nave, T; Henik, A				Gronau, Nurit; Izoutcheev, Anna; Nave, Tsafnat; Henik, Avishai			Counting distance: Effects of egocentric distance on numerical perception	PLOS ONE			English	Article							SCENE-SELECTIVE REGIONS; REAL-WORLD SIZE; PARIETAL CORTEX; VISUAL-CORTEX; REPRESENTATION; SPACE; INFORMATION; NUMBER; ORGANIZATION; MAGNITUDE	Numerical value is long known to be associated with a variety of magnitude representations, such as size, time and space. The present study focused on the interactive relations of numerical magnitude with a spatial factor which is dominant in everyday vision and is often overlooked, namely, egocentric distance, or depth. We hypothesized that digits denoting large magnitudes are associated with large perceived distances, and vice versa. While the relations of numerical value and size have been long documented, effects of egocentric distance on numeral perception have been scarcely investigated, presumably due to the difficulty to disentangle size and depth factors within three-dimensional visual displays. The current study aimed to assess the potential linkage between egocentric distance and number magnitude, while neutralizing any perceived and/or physical size parameters of target digits. In Experiment 1, participants conducted a numeral size-classification task ('bigger or smaller than 5'), to which they responded with a near-to-body or a far-from-body key. Results revealed shorter responses for small than for large numbers when responded with a key positioned close to the body, and for large than small numbers when responded with a key positioned far from the body (regardless of hand-key mapping). Experiment 2 used verbal stimuli denoting near/remote concepts as irrelevant primes to target digits, further demonstrating a priming effect of conceived distance on numerical value processing. Collectively, our results suggest that distance magnitudes are associatively linked to numerical magnitudes and may affect digit processing independently of the effects of visual size.	[Gronau, Nurit; Izoutcheev, Anna; Nave, Tsafnat] Open Univ, Dept Psychol & Cognit Sci Studies, Raanana, Israel; [Henik, Avishai] Ben Gurion Univ Negev, Dept Psychol, Beer Sheva, Israel; [Henik, Avishai] Ben Gurion Univ Negev, Zlotowski Ctr Neurosci, Beer Sheva, Israel	Open University Israel; Ben Gurion University; Ben Gurion University	Gronau, N (corresponding author), Open Univ, Dept Psychol & Cognit Sci Studies, Raanana, Israel.	nuritgro@openu.ac.il		Henik, Avishai/0000-0002-5665-6004	Israel Science Foundation [1622/15]	Israel Science Foundation(Israel Science Foundation)	This work was supported by the Israel Science Foundation, grant No. 1622/15 (to NG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre GK, 1996, NEUROIMAGE S, V3, pS527; Amit E, 2012, BRAIN COGNITION, V80, P201, DOI 10.1016/j.bandc.2012.06.006; Arend I, 2015, J EXP PSYCHOL LEARN, V41, P1821, DOI 10.1037/xlm0000135; Bainbridge WA, 2015, NEUROIMAGE, V122, P408, DOI 10.1016/j.neuroimage.2015.07.066; Barsalou LW, 2010, TOP COGN SCI, V2, P716, DOI 10.1111/j.1756-8765.2010.01115.x; BESNER D, 1979, NEUROPSYCHOLOGIA, V17, P467, DOI 10.1016/0028-3932(79)90053-8; Bueti D, 2009, PHILOS T R SOC B, V364, P1831, DOI 10.1098/rstb.2009.0028; Cate AD, 2011, BRAIN RES, V1388, P109, DOI 10.1016/j.brainres.2011.02.022; DEHAENE S, 1993, J EXP PSYCHOL GEN, V122, P371, DOI 10.1037/0278-7393.21.2.314; DEHAENE S, 1992, COGNITION, V44, P1, DOI 10.1016/0010-0277(92)90049-N; Dehaene S., 2011, NUMBER SENSE MIND CR; Engel AK, 2013, TRENDS COGN SCI, V17, P202, DOI 10.1016/j.tics.2013.03.006; Fischer MH, 2003, NAT NEUROSCI, V6, P555, DOI 10.1038/nn1066; Gabay S, 2016, NEUROPSYCHOLOGIA, V81, P198, DOI 10.1016/j.neuropsychologia.2015.12.029; Gabay S, 2013, COGNITION, V129, P18, DOI 10.1016/j.cognition.2013.06.001; Gevers W, 2006, ACTA PSYCHOL, V122, P221, DOI 10.1016/j.actpsy.2005.11.004; Gliksman Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep21446; Goldfarb L, 2005, PSYCHON B REV, V12, P751, DOI 10.3758/BF03196768; GOODALE MA, 1992, TRENDS NEUROSCI, V15, P20, DOI 10.1016/0166-2236(92)90344-8; Hartmann M, 2012, J EXP PSYCHOL HUMAN, V38, P1416, DOI 10.1037/a0026706; He CX, 2013, NEUROIMAGE, V79, P1, DOI 10.1016/j.neuroimage.2013.04.051; HENIK A, 1982, MEM COGNITION, V10, P389, DOI 10.3758/BF03202431; Hubbard EM, 2005, NAT REV NEUROSCI, V6, P435, DOI 10.1038/nrn1684; Ito Y, 2004, MEM COGNITION, V32, P662, DOI 10.3758/BF03195857; KILPATRICK FP, 1953, PSYCHOL REV, V60, P223, DOI 10.1037/h0060882; Konkle T, 2013, J NEUROSCI, V33, P10235, DOI 10.1523/JNEUROSCI.0983-13.2013; Konkle T, 2012, NEURON, V74, P1114, DOI 10.1016/j.neuron.2012.04.036; Konkle T, 2012, J EXP PSYCHOL HUMAN, V38, P561, DOI 10.1037/a0028294; Levy I, 2001, NAT NEUROSCI, V4, P533, DOI 10.1038/87490; LOFTUS GR, 1994, PSYCHON B REV, V1, P476, DOI 10.3758/BF03210951; Mullally SL, 2011, J NEUROSCI, V31, P7441, DOI 10.1523/JNEUROSCI.0267-11.2011; Park S, 2015, CEREB CORTEX, V25, P1792, DOI 10.1093/cercor/bht418; Sakata H, 1997, TRENDS NEUROSCI, V20, P350, DOI 10.1016/S0166-2236(97)01067-9; Schwarz W, 2004, PERCEPT PSYCHOPHYS, V66, P651, DOI 10.3758/BF03194909; Schwarz W, 1998, NEUROPSYCHOLOGIA, V36, P1167, DOI 10.1016/S0028-3932(98)00001-3; Sellaro R, 2015, PSYCHOL RES-PSYCH FO, V79, P950, DOI 10.1007/s00426-014-0636-7; STEIN JF, 1989, Q J EXP PHYSIOL CMS, V74, P583, DOI 10.1113/expphysiol.1989.sp003314; Troiani V, 2014, CEREB CORTEX, V24, P883, DOI 10.1093/cercor/bhs364; TZELGOV J, 1992, J EXP PSYCHOL LEARN, V18, P166, DOI 10.1037/0278-7393.18.1.166; Walsh V, 2003, TRENDS COGN SCI, V7, P483, DOI 10.1016/j.tics.2003.09.002; Wilson M, 2002, PSYCHON B REV, V9, P625, DOI 10.3758/BF03196322; Xuan B, 2007, J VISION, V7, DOI 10.1167/7.10.2	42	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2017	12	4							e0174772	10.1371/journal.pone.0174772	http://dx.doi.org/10.1371/journal.pone.0174772			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET0MD	28410393	gold, Green Published, Green Submitted			2022-12-27	WOS:000399955600008
J	Kouyoumdjian, FG; Andreev, EM; Borschmann, R; Kinner, SA; McConnon, A				Kouyoumdjian, Fiona G.; Andreev, Evgeny M.; Borschmann, Rohan; Kinner, Stuart A.; McConnon, Andres			Do people who experience incarceration age more quickly? Exploratory analyses using retrospective cohort data on mortality from Ontario, Canada	PLOS ONE			English	Article							HEALTH-CARE; PRISON; RELEASE; INMATES; DEATH; RISK	Objectives We aimed to explore whether mortality data are consistent with the view that aging is accelerated for people with a history of incarceration compared to the general population, using data on mortality rates and life expectancy for persons in Ontario, Canada. Methods We obtained data from the Ontario Ministry of Community Safety and Correctional Services on all adults admitted to provincial correctional facilities in Ontario in 2000, and linked these data with death records from provincial vital statistics between January 1, 2000 and December 31, 2012. We used life table methods to calculate mortality rates and life expectancies for this cohort by sex and 5-year age group. We similarly generated population comparison rates using publicly available data for the general population of Ontario in 2006 as the midpoint of the follow up period. We compared these mortality indices between the 2000 Ontario prison cohort and the general population by age group and sex. Results The difference in all-cause mortality rates between the 2000 Ontario prison cohort and the general population was greatest for younger adults, with the prison cohort experiencing rates of death that would be expected for persons at least 15 years older at ages 20 to 44 for men and ages 20 to 59 for women. Life expectancy in the 2000 Ontario prison cohort was most similar to life expectancy of persons five years older in the general population at age intervals 20 to 45 in men and 20 to 30 in women. Conclusions For most of adulthood, life expectancy and mortality rates are worse for adults with a history of incarceration than for the general population in Ontario, Canada. However, the association between mortality and incarceration status is modified by age, with the greatest relative burden of mortality experienced by younger persons with a history of incarceration and modified by sex, with worse relative mortality in women. Future research should explore the association between incarceration status and markers of aging including mortality, morbidity and physical appearance.	[Kouyoumdjian, Fiona G.; McConnon, Andres] McMaster Univ, Dept Family Med, Hamilton, ON, Canada; [Kouyoumdjian, Fiona G.] St Michaels Hosp, Ctr Urban Hlth Solut, Toronto, ON, Canada; [Kouyoumdjian, Fiona G.] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Andreev, Evgeny M.] Natl Res Univ, Higher Sch Econ, Moscow, Russia; [Borschmann, Rohan; Kinner, Stuart A.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Ctr Adolescent Hlth, Melbourne, Vic, Australia; [Borschmann, Rohan; Kinner, Stuart A.] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Ctr Mental Hlth, Melbourne, Vic, Australia; [Borschmann, Rohan] Kings Coll London, Inst Psychiat Psychol & Neurosci, Hlth Serv & Populat Res Dept, London, England; [Kinner, Stuart A.] Griffith Univ, Griffith Criminol Inst, Brisbane, Qld, Australia; [Kinner, Stuart A.] Monash Univ, Sch Publ Hlth & Prevent Med, Melbourne, Vic, Australia; [Kinner, Stuart A.] Univ Queensland, Mater Res Inst, St Lucia, Qld, Australia	McMaster University; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; HSE University (National Research University Higher School of Economics); Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne; University of London; King's College London; Griffith University; Monash University; Mater Research; University of Queensland	Kouyoumdjian, FG (corresponding author), McMaster Univ, Dept Family Med, Hamilton, ON, Canada.; Kouyoumdjian, FG (corresponding author), St Michaels Hosp, Ctr Urban Hlth Solut, Toronto, ON, Canada.; Kouyoumdjian, FG (corresponding author), Inst Clin Evaluat Sci, Toronto, ON, Canada.	kouyouf@mcmaster.ca		Kouyoumdjian, Fiona/0000-0002-6869-7516; Borschmann, Rohan/0000-0002-0365-7775	Institute for Clinical Evaluative Sciences (ICES) - Ontario Ministry of Health and Long-Term Care (MOHLTC)	Institute for Clinical Evaluative Sciences (ICES) - Ontario Ministry of Health and Long-Term Care (MOHLTC)(Ministry of Health and Long-Term Care, Ontario)	This study was supported by the Institute for Clinical Evaluative Sciences (ICES), which is funded by an annual grant from the Ontario Ministry of Health and Long-Term Care (MOHLTC). The opinions, results and conclusions reported in this paper are those of the authors and are independent from the funding sources. No endorsement by ICES or the Ontario MOHLTC is intended or should be inferred.; We would like to acknowledge Kathy Underhill in the Ontario Ministry of Community Safety and Correctional Services and Alexander Kopp and Alejandro Gonzalez at the Institute for Clinical Evaluative Sciences. We appreciate the contributions to the study design and analyses of Vladimir Shkolnikov at the Max Planck Institute for Demographic Research, Rostock, Germany. This study was supported by the Institute for Clinical Evaluative Sciences (ICES), which is funded by an annual grant from the Ontario Ministry of Health and Long-Term Care (MOHLTC). The opinions, results and conclusions reported in this paper are those of the authors and are independent from the funding sources. No endorsement by ICES or the Ontario MOHLTC is intended or should be inferred.	Aday RJ., 1994, FED PROBAT, P47; [Андреев Евгений Михайлович Andreev Evgeny], 2015, [Демографическое обозрение, Demograficheskoe obozrenie], V2, P24; Binswanger IA, 2007, NEW ENGL J MED, V356, P157, DOI 10.1056/NEJMsa064115; BORKAN GA, 1980, HUM BIOL, V52, P787; Chong N, 1998, IARC TECHNICAL REPOR; Comfort A, 1979, BIOL SENESCENE; Cornell S.C.U., 2008, STATNEWS CORNELL U S, V73, P3; Forsyth SJ, 2014, ADDICTION, V109, P1676, DOI 10.1111/add.12646; Harris K, 2017, GERONTOLOGIST; Kouyoumdjian F, 2016, CAN FAM PHYSICIAN, V62, P215; Kouyoumdjian Fiona G, 2016, CMAJ Open, V4, pE153, DOI 10.9778/cmajo.20150098; Loeb SJ, 2006, RES NURS HEALTH, V29, P556, DOI 10.1002/nur.20177; Mitka M, 2004, JAMA-J AM MED ASSOC, V292, P423, DOI 10.1001/jama.292.4.423; Rose M.R., 1991, EVOLUTIONARY BIOL AG; Rosner B., 2006, FUNDAMENTALS BIOSTAT; Rowland D. T., 2003, DEMOGRAPHIC METHODS; Spittal MJ, 2014, J EPIDEMIOL COMMUN H, V68, P993, DOI 10.1136/jech-2014-204295; Statistics Canada, VIT STAT DEATH DAT 2; Statistics Canada, CANSIM 2016; Szklo M., 2007, EPIDEMIOLOGY BASICS; U.S. Department of Justice., 2016, IMP AG INM POP FED B; van Dooren K, 2013, AUST NZ J PUBL HEAL, V37, P377, DOI 10.1111/1753-6405.12087; Williams BA, 2012, AM J PUBLIC HEALTH, V102, P1475, DOI 10.2105/AJPH.2012.300704	23	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2017	12	4							e0175837	10.1371/journal.pone.0175837	http://dx.doi.org/10.1371/journal.pone.0175837			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET0MD	28410398	Green Published, Green Submitted, gold			2022-12-27	WOS:000399955600048
J	Chen, SC; Lee, MY; Huang, JC; Mai, HC; Kuo, PL; Chang, JM; Chen, HC; Yang, YH				Chen, Szu-Chia; Lee, Mei-Yueh; Huang, Jiun-Chi; Mai, Hsiu-Chin; Kuo, Po-Lin; Chang, Jer-Ming; Chen, Hung-Chun; Yang, Yi-Hsin			Association of diabetes mellitus with decline in ankle-brachial index among patients on hemodialysis: A 6-year follow-up study	PLOS ONE			English	Article							PERIPHERAL ARTERIAL-DISEASE; STAGE RENAL-DISEASE; CORONARY-HEART-DISEASE; CHRONIC KIDNEY-DISEASE; RISK-FACTORS; REVERSE EPIDEMIOLOGY; VASCULAR-DISEASE; MONOSODIUM URATE; URIC-ACID; PROGRESSION	Peripheral artery occlusive disease is common among diabetes mellitus (DM) and endstage renal disease patients, and tends to progress faster and lead to worse outcomes. This study compared the association of DM with the decline in ankle-brachial index (ABI) among patients on hemodialysis (HD). This was a longitudinal analysis of ABI in HD patients from 2009 to 2015. Medical records and yearly ABI values were obtained. A longitudinal mixed-model analysis was used to evaluate ABI changing trends while accounting for within-patients correlation. There were 296 patients on HD in the period of 2009-2015. In a 6-year follow-up, those with DM had a more rapid ABI decline compared to non-DM patients (slopes: -0.014 vs. 0.010 per year, interaction p < 0.001). In DM patients, female sex, high pulse pressure, high triglyceride, low creatinine, and high uric acid were associated with a decrease in ABI. In non-DM patients, old age, high pulse pressure, high low-density lipoprotein cholesterol, and high uric acid were associated with a decreased in ABI. There were 49.6% of patients with a normal ABI experienced a decrease at least 0.1 of ABI from baseline, and 35.3% had a final ABI < 0.9 in patients with a baseline ABI >= 0.9 (n = 232). In this study, DM patients on HD tend to develop a more rapid decline in ABI than non-DM patients on HD. Age, sex, pulse pressure, lipid profile, creatinine, and uric acid are associated with a decreased in ABI.	[Chen, Szu-Chia; Lee, Mei-Yueh; Huang, Jiun-Chi; Kuo, Po-Lin] Kaohsiung Med Univ, Grad Inst Clin Med, Coll Med, Kaohsiung, Taiwan; [Chen, Szu-Chia; Huang, Jiun-Chi; Chang, Jer-Ming; Chen, Hung-Chun] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Div Nephrol, Dept Internal Med, Kaohsiung, Taiwan; [Chen, Szu-Chia; Lee, Mei-Yueh; Huang, Jiun-Chi] Kaohsiung Med Univ, Kaohsiung Municipal Hsiao Kang Hosp, Dept Internal Med, Kaohsiung, Taiwan; [Chen, Szu-Chia; Lee, Mei-Yueh; Chang, Jer-Ming; Chen, Hung-Chun] Kaohsiung Med Univ, Coll Med, Fac Med, Kaohsiung, Taiwan; [Lee, Mei-Yueh] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Div Endocrinol & Metab, Dept Internal Med, Kaohsiung, Taiwan; [Mai, Hsiu-Chin] Kaohsiung Med Univ, Kaohsiung Municipal Hsiao Kang Hosp, Dept Nursing, Kaohsiung, Taiwan; [Kuo, Po-Lin] Natl Sun Yat Sen Univ, Inst Med Sci & Technol, Kaohsiung, Taiwan; [Chang, Jer-Ming] Kaohsiung Med Univ, Kaohsiung Municipal Cijin Hosp, Dept Internal Med, Kaohsiung, Taiwan; [Yang, Yi-Hsin] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Div Med Stat & Bioinformat, Dept Med Res, Kaohsiung, Taiwan; [Yang, Yi-Hsin] Kaohsiung Med Univ, Sch Pharm, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Municipal Siao-Gang Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Municipal Siao-Gang Hospital; National Sun Yat Sen University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University	Yang, YH (corresponding author), Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Div Med Stat & Bioinformat, Dept Med Res, Kaohsiung, Taiwan.; Yang, YH (corresponding author), Kaohsiung Med Univ, Sch Pharm, Kaohsiung, Taiwan.	yihsya@kmu.edu.tw	Yang, Yi-Hsin/D-6471-2012; 蘇, 河名/AAE-9843-2019; Huang, Jiun-Chi/AAI-2494-2021	Yang, Yi-Hsin/0000-0002-9581-2778; Huang, Jiun-Chi/0000-0002-5897-2860	Kaohsiung Municipal Hsiao-Kang Hospital (kmhk) [105-002]; Kaohsiung Medical University, Kaohsiung, Taiwan	Kaohsiung Municipal Hsiao-Kang Hospital (kmhk); Kaohsiung Medical University, Kaohsiung, Taiwan	The research presented in this article is supported by the grants from Kaohsiung Municipal Hsiao-Kang Hospital (kmhk-105-002), Kaohsiung Medical University, Kaohsiung, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The research presented in this article is supported by the grants from Kaohsiung Municipal Hsiao-Kang Hospital (kmhk-105-002), Kaohsiung Medical University, Kaohsiung, Taiwan.	Aboyans V, 2006, CIRCULATION, V113, P2623, DOI 10.1161/CIRCULATIONAHA.105.608679; Althouse AD, 2014, DIABETES CARE, V37, P1346, DOI 10.2337/dc13-2303; Anker SD, 1997, HEART, V78, P39, DOI 10.1136/hrt.78.1.39; [Anonymous], J GEOPHYSICAL RES SO, V123, P2028, DOI [10.1002/2016jb013844, DOI 10.1002/2016JB013844, DOI 10.1002/14651858.CD002000]; [Anonymous], 2007, USRDS 2007 ANN DAT R, V1; Bird CE, 1999, VASC MED, V4, P15, DOI 10.1177/1358836X9900400103; Chen JH, 2009, KAOHSIUNG J MED SCI, V25, P366, DOI 10.1016/S1607-551X(09)70529-7; Chen YH, 2015, INT UROL NEPHROL, V47, P1565, DOI 10.1007/s11255-015-1056-3; Clark N, 2003, DIABETES CARE, V26, P3333; Criqui MH, 2001, AM J CARDIOL, V88, p43J; Daugirdas J T, 1995, Adv Ren Replace Ther, V2, P295; DeOreo PB, 1997, AM J KIDNEY DIS, V30, P204, DOI 10.1016/S0272-6386(97)90053-6; Dumaine RL, 2009, AM HEART J, V158, P141, DOI 10.1016/j.ahj.2009.05.011; EMMERSON BT, 1979, AUST NZ J MED, V9, P451, DOI 10.1111/j.1445-5994.1979.tb04180.x; GINSBERG MH, 1977, J CLIN INVEST, V60, P999, DOI 10.1172/JCI108880; Ginsburg ES, 1996, J CLIN ENDOCR METAB, V81, P4414, DOI 10.1210/jc.81.12.4414; Hoe J, 2012, DIABETIC MED, V29, pE304, DOI 10.1111/j.1464-5491.2012.03705.x; IFUDU O, 1994, JAMA-J AM MED ASSOC, V271, P29, DOI 10.1001/jama.271.1.29; Jiwakanon S, 2012, CLIN NEPHROL, V78, P335, DOI 10.5414/CN107463; Johansen KL, 2000, KIDNEY INT, V57, P2564, DOI 10.1046/j.1523-1755.2000.00116.x; Jude EB, 2001, DIABETES CARE, V24, P1433, DOI 10.2337/diacare.24.8.1433; Kalantar-Zadeh K, 2007, DIABETES CARE, V30, P1049, DOI 10.2337/dc06-2127; Kanellis J, 2004, NEPHROLOGY, V9, P394, DOI 10.1111/j.1440-1797.2004.00336.x; Khosla UM, 2005, KIDNEY INT, V67, P1739, DOI 10.1111/j.1523-1755.2005.00273.x; Kopple JD, 2005, AM J CLIN NUTR, V81, P1257; Levin NW, 2007, SEMIN DIALYSIS, V20, P586, DOI 10.1111/j.1525-139X.2007.00366.x; LOEB JN, 1972, ARTHRITIS RHEUM-US, V15, P189, DOI 10.1002/art.1780150209; Masjedi S, 2015, CARDIOVASC ENG TECHN, V6, P209, DOI 10.1007/s13239-015-0226-x; Masson W, 2016, ENDOCRINOL NUTR; Matsumae T, 2007, HYPERTENS RES, V30, P377, DOI 10.1291/hypres.30.377; Mooraki A, 1994, Adv Perit Dial, V10, P89; Newland H, 1975, Med Hypotheses, V1, P152, DOI 10.1016/0306-9877(75)90011-0; O'Hare A, 2001, J AM SOC NEPHROL, V12, P2838, DOI 10.1681/ASN.V12122838; O'Hare AM, 2002, J AM SOC NEPHROL, V13, P497, DOI 10.1681/ASN.V132497; Ono K, 2003, J AM SOC NEPHROL, V14, P1591, DOI 10.1097/01.ASN.0000065547.98258.3D; ORCHARD TJ, 1993, DIABETES CARE, V16, P1199, DOI 10.2337/diacare.16.8.1199; Peters SAE, 2014, LANCET, V383, P1973, DOI 10.1016/S0140-6736(14)60040-4; Pignone M, 2000, BRIT MED J, V321, P983, DOI 10.1136/bmj.321.7267.983; Raffaitin C, 2007, AM J CLIN NUTR, V85, P96, DOI 10.1093/ajcn/85.1.96; Rajagopalan S, 2006, CIRCULATION, V114, P1914, DOI 10.1161/CIRCULATIONAHA.105.607390; ROSE G, 1977, LANCET, V1, P105; Selvin E, 2004, CIRCULATION, V110, P738, DOI 10.1161/01.CIR.0000137913.26087.F0; Smith FB, 2003, J VASC SURG, V38, P1323, DOI 10.1016/S0741-5214(03)01021-8; Studenski S, 2011, JAMA-J AM MED ASSOC, V305, P50, DOI 10.1001/jama.2010.1923; Toriyama T, 2000, J Cardiol, V36, P165; US Renal Data System, 2020, USRDS 2020 ANN DAT R; VasquezVivar J, 1996, BIOCHEM J, V314, P869, DOI 10.1042/bj3140869; WEBB AT, 1993, EUR J VASCULAR SURG, V7, P523, DOI 10.1016/S0950-821X(05)80364-0; Yamashina A, 2002, HYPERTENS RES, V25, P359, DOI 10.1291/hypres.25.359	49	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2017	12	4							e0175363	10.1371/journal.pone.0175363	http://dx.doi.org/10.1371/journal.pone.0175363			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0MB	28406941	gold, Green Published, Green Submitted			2022-12-27	WOS:000399955400046
J	Gehricke, JG; Kruggel, F; Thampipop, T; Alejo, SD; Tatos, E; Fallon, J; Muftuler, LT				Gehricke, Jean-G.; Kruggel, Frithjof; Thampipop, Tanyaporn; Alejo, Sharina Dyan; Tatos, Erik; Fallon, James; Muftuler, L. Tugan			The brain anatomy of attention-deficit/hyperactivity disorder in young adults - a magnetic resonance imaging study	PLOS ONE			English	Article							DEFICIT-HYPERACTIVITY-DISORDER; WHITE-MATTER MICROSTRUCTURE; DT-MRI; ADHD; CHILDREN; ABNORMALITIES; SMOKERS; CORTEX; METHYLPHENIDATE; CONNECTIVITY	Background This is one of the first studies to examine the structural brain anatomy and connectivity associated with an ADHD diagnosis and child as well as adult ADHD symptoms in young adults. It was hypothesized that an adult ADHD diagnosis and in particular childhood symptoms, are associated with widespread changes in the brain macro-and microstructure, which can be used to develop a morphometric biomarker for ADHD. Methods Voxel-wise linear regression models were used to examine structural and diffusion-weighted MRI data in 72 participants (31 young adults with ADHD and 41 controls without ADHD) in relation to diagnosis and the number of self-reported child and adult symptoms. Results Findings revealed significant associations between ADHD diagnosis and widespread changes to the maturation of white matter fiber bundles and gray matter density in the brain, such as structural shape changes (incomplete maturation) of the middle and superior temporal gyrus, and fronto-basal portions of both frontal lobes. ADHD symptoms in childhood showed the strongest association with brain macro-and microstructural abnormalities. At the brain circuitry level, the superior longitudinal fasciculus (SLF) and cortico-limbic areas are dysfunctional in individuals with ADHD. The morphometric findings predicted an ADHD diagnosis correctly up to 83% of all cases. Conclusion An adult ADHD diagnosis and in particular childhood symptoms are associated with widespread micro-and macrostructural changes. The SLF and cortico-limbic findings suggest complex audio-visual, motivational, and emotional dysfunctions associated with ADHD in young adults. The sensitivity of the morphometric findings in predicting an ADHD diagnosis was sufficient, which indicates that MRI-based assessments are a promising strategy for the development of a biomarker.	[Gehricke, Jean-G.; Thampipop, Tanyaporn; Alejo, Sharina Dyan; Tatos, Erik] Univ Calif Irvine, Dept Pediat, Irvine, CA 92717 USA; [Gehricke, Jean-G.; Thampipop, Tanyaporn; Alejo, Sharina Dyan; Tatos, Erik] Ctr Autism & Neurodev Disorders, Santa Ana, CA USA; [Kruggel, Frithjof] Univ Calif Irvine, Dept Biomed Engn, Irvine, CA USA; [Fallon, James] Univ Calif Irvine, Dept Anat & Neurobiol, Irvine, CA USA; [Muftuler, L. Tugan] Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; Medical College of Wisconsin	Gehricke, JG (corresponding author), Univ Calif Irvine, Dept Pediat, Irvine, CA 92717 USA.; Gehricke, JG (corresponding author), Ctr Autism & Neurodev Disorders, Santa Ana, CA USA.	jgehrick@uci.edu	Hassan, Randa/AAW-3624-2021; Muftuler, L. Tugan/AAG-7539-2021	Muftuler, L. Tugan/0000-0002-6635-5678	National Institute on Drug Abuse of the National Institutes of Health [K01 DA25131]; National Center for Research Resources; National Center for Advancing Translational Sciences, National Institutes of Health [RR00827, UL1 TR000153]; The Center for Autism & Neurodevelopmental Disorders;  [The Center for Autism & Neurodevelopmental Disorders and Cheryl Cotman for graphics]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001414] Funding Source: NIH RePORTER	National Institute on Drug Abuse of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Advancing Translational Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); The Center for Autism & Neurodevelopmental Disorders; ; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This investigation was supported by grant K01 DA25131 to Jean-G. Gehricke from the National Institute on Drug Abuse of the National Institutes of Health. In addition, the project was supported by the National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health, through grants RR00827 and UL1 TR000153, respectively, and the generous financial support of The Center for Autism & Neurodevelopmental Disorders.; Thanks for the generous financial support of The Center for Autism & Neurodevelopmental Disorders and Cheryl Cotman for graphics. All authors declare no financial interests or potential conflicts of interest.	Alexander AL, 2007, NEUROTHERAPEUTICS, V4, P316, DOI 10.1016/j.nurt.2007.05.011; ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; American Psychiatric Association, 2000, DIAGN STAT MAN MENT, V4th; Amico F, 2011, PSYCHIAT RES-NEUROIM, V191, P31, DOI 10.1016/j.pscychresns.2010.08.011; Arnsten AFT, 2006, J CLIN PSYCHIAT, V67, P7; Ashtari M, 2005, BIOL PSYCHIAT, V57, P448, DOI 10.1016/j.biopsych.2004.11.047; Balleine BW, 2007, J NEUROSCI, V27, P8161, DOI 10.1523/JNEUROSCI.1554-07.2007; Barkley RA, 2011, J PSYCHOPATHOL BEHAV, V33, P137, DOI 10.1007/s10862-011-9217-x; Biederman J, 2008, J AM ACAD CHILD PSY, V47, P426, DOI 10.1097/CHI.0b013e31816429d3; Bisley JW, 2003, SCIENCE, V299, P81, DOI 10.1126/science.1077395; Bramham J, 2012, PSYCHOL MED, V42, P2225, DOI 10.1017/S0033291712000219; Bush G, 2005, BIOL PSYCHIAT, V57, P1273, DOI 10.1016/j.biopsych.2005.01.034; Cao QJ, 2010, BRAIN RES, V1310, P172, DOI 10.1016/j.brainres.2009.10.031; Carmona S, 2005, NEUROSCI LETT, V389, P88, DOI 10.1016/j.neulet.2005.07.020; Castellanos FX, 2002, JAMA-J AM MED ASSOC, V288, P1740, DOI 10.1001/jama.288.14.1740; Davenport ND, 2010, PSYCHIAT RES-NEUROIM, V181, P193, DOI 10.1016/j.pscychresns.2009.10.012; De La Fuente A, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00192; Dramsdahl M, 2012, PSYCHIAT RES-NEUROIM, V201, P168, DOI 10.1016/j.pscychresns.2011.08.005; Ellison-Wright I, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-51; Fan J, 2004, PSYCHIAT PRAX, V31, pS210, DOI 10.1055/s-2004-828484; Faraone SV, 2006, PSYCHOL MED, V36, P159, DOI 10.1017/S003329170500471X; Fillard P, 2007, IEEE T MED IMAGING, V26, P1472, DOI 10.1109/TMI.2007.899173; First M. B., 1996, USERS GUIDE FOR THE; Fonov V, 2011, NEUROIMAGE, V54, P313, DOI 10.1016/j.neuroimage.2010.07.033; Franzen JD, 2013, J PSYCHIATR NEUROSCI, V38, P333, DOI 10.1503/jpn.120054; Fried M, 2014, VISION RES, V101, P62, DOI 10.1016/j.visres.2014.05.004; Friston K.J., 1994, HUMAN BRAIN MAPPING, V1, P210; Frodl T, 2012, ACTA PSYCHIAT SCAND, V125, P114, DOI 10.1111/j.1600-0447.2011.01786.x; Gehricke JG, 2013, PHARMACOL BIOCHEM BE, V112, P78, DOI 10.1016/j.pbb.2013.10.001; Gehricke JG, 2011, PHARMACOL BIOCHEM BE, V98, P485, DOI 10.1016/j.pbb.2011.02.021; Gehricke JG, 2009, PSYCHOL ADDICT BEHAV, V23, P644, DOI 10.1037/a0017441; HALSBAND U, 1982, BRAIN RES, V240, P368, DOI 10.1016/0006-8993(82)90239-6; Hawk LW, 2003, PSYCHOPHARMACOLOGY, V165, P118, DOI 10.1007/s00213-002-1235-7; Hentschel S, 2004, LECT NOTES COMPUT SC, V3150, P253; Hong SB, 2014, BIOL PSYCHIAT, V76, P656, DOI 10.1016/j.biopsych.2013.12.013; Jensen PS, 2001, J AM ACAD CHILD PSY, V40, P147, DOI 10.1097/00004583-200102000-00009; Kim Soyeon, 2014, J Optom, V7, P22, DOI 10.1016/j.optom.2013.07.001; Konrad A, 2012, EUR ARCH PSY CLIN N, V262, P351, DOI 10.1007/s00406-011-0251-1; Konrad A, 2010, EUR J NEUROSCI, V31, P912, DOI 10.1111/j.1460-9568.2010.07110.x; Kruggel F, 1999, Med Image Anal, V3, P175; LACQUANITI F, 1995, CEREB CORTEX, V5, P391, DOI 10.1093/cercor/5.5.391; Lahey BB, 2011, ARCH GEN PSYCHIAT, V68, P181, DOI 10.1001/archgenpsychiatry.2010.192; Lancaster JL, 2007, HUM BRAIN MAPP, V28, P1194, DOI 10.1002/hbm.20345; Lawrence KE, 2013, J AM ACAD CHILD PSY, V52, P431, DOI 10.1016/j.jaac.2013.01.010; Liston C, 2011, BIOL PSYCHIAT, V69, P1168, DOI 10.1016/j.biopsych.2011.03.022; Ly C, 2013, PSYCHIAT RES, V210, P1310, DOI 10.1016/j.psychres.2013.08.003; Makris N, 2008, CEREB CORTEX, V18, P1210, DOI 10.1093/cercor/bhm156; Matsuo Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125573; Mehringer Ann M, 2002, J Atten Disord, V5, P223; MESULAM MM, 1981, ANN NEUROL, V10, P309, DOI 10.1002/ana.410100402; MILNER B, 1984, TRENDS NEUROSCI, V7, P403, DOI 10.1016/S0166-2236(84)80143-5; MOUNTCASTLE VB, 1975, J NEUROPHYSIOL, V38, P871, DOI 10.1152/jn.1975.38.4.871; Nagel BJ, 2011, J AM ACAD CHILD PSY, V50, P283, DOI 10.1016/j.jaac.2010.12.003; Nakao T, 2011, AM J PSYCHIAT, V168, P1154, DOI 10.1176/appi.ajp.2011.11020281; Onnink AMH, 2015, PROG NEURO-PSYCHOPH, V63, P14, DOI 10.1016/j.pnpbp.2015.04.008; Peterson DJ, 2011, J CHILD NEUROL, V26, P1296, DOI 10.1177/0883073811405662; Petrides M, 2002, EUR J NEUROSCI, V16, P291, DOI 10.1046/j.1460-9568.2001.02090.x; POSNER MI, 1984, J NEUROSCI, V4, P1863; Qiu MG, 2011, BRAIN TOPOGR, V24, P243, DOI 10.1007/s10548-010-0168-4; Rusch N, 2007, NEUROIMAGE, V35, P738, DOI 10.1016/j.neuroimage.2006.12.007; Shang CY, 2013, PSYCHOL MED, V43, P1093, DOI 10.1017/S0033291712001869; Shaw P, 2015, NEUROPSYCHOPHARMACOL, V40, P746, DOI 10.1038/npp.2014.241; Silk TJ, 2009, HUM BRAIN MAPP, V30, P2757, DOI 10.1002/hbm.20703; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Song SK, 2005, NEUROIMAGE, V26, P132, DOI 10.1016/j.neuroimage.2005.01.028; Svatkova A, 2016, HUM BRAIN MAPP, V37, P3323, DOI 10.1002/hbm.23243; Tievsky AL, 1999, AM J NEURORADIOL, V20, P1491; Tomasi D, 2012, BIOL PSYCHIAT, V71, P443, DOI 10.1016/j.biopsych.2011.11.003; Valera EM, 2007, BIOL PSYCHIAT, V61, P1361, DOI 10.1016/j.biopsych.2006.06.011; van Ewijk H, 2012, NEUROSCI BIOBEHAV R, V36, P1093, DOI 10.1016/j.neubiorev.2012.01.003; Vercauteren T, 2009, NEUROIMAGE, V45, pS61, DOI 10.1016/j.neuroimage.2008.10.040; Volkow ND, 2011, MOL PSYCHIATR, V16, P1147, DOI 10.1038/mp.2010.97; Volkow ND, 2007, NEUROIMAGE, V34, P1182, DOI 10.1016/j.neuroimage.2006.10.014; Volkow ND, 2012, J NEUROSCI, V32, P841, DOI 10.1523/JNEUROSCI.4461-11.2012; Volkow ND, 2009, JAMA-J AM MED ASSOC, V302, P1084, DOI 10.1001/jama.2009.1308; Werner J, 2011, BEHAV BRAIN FUNCT, V7, DOI 10.1186/1744-9081-7-38; Wigal T, 2007, ADV ADHD, V2, P17; Zhang Shao-Yan, 2013, ISRN Radiol, V2013, P874570, DOI 10.5402/2013/874570	79	42	42	3	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2017	12	4							e0175433	10.1371/journal.pone.0175433	http://dx.doi.org/10.1371/journal.pone.0175433			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0MB	28406942	Green Published, gold			2022-12-27	WOS:000399955400051
J	Kim, J; Kim, MK; Jung, S; Lim, JE; Shin, MH; Kim, YJ; Oh, B				Kim, Jihye; Kim, Mi Kyung; Jung, Sukyoung; Lim, Ji Eun; Shin, Myung-Hee; Kim, Yeon-Jung; Oh, Bermseok			Interaction of iron status with single nucleotide polymorphisms on incidence of type 2 diabetes	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; GLUCOSE-TOLERANCE; COMMON VARIANTS; GENETIC-FACTORS; SERUM FERRITIN; DANISH WOMEN; RISK; HEPCIDIN; CDKAL1; SUSCEPTIBILITY	The objective of this study is to find single nucleotide polymorphisms (SNPs) associated with a risk of Type 2 diabetes (T2D) in Korean adults and to investigate the longitudinal association between these SNPs and T2D and the interaction effects of iron intake and average hemoglobin level. Data from the KoGES_ Ansan and Ansung Study were used. Gene-iron interaction analysis was conducted using a two-step approach. To select candidate SNPs associated with T2D, a total of 7,935 adults at baseline were included in genome-wide association analysis (step one). After excluding T2D prevalent cases, prospective analyses were conducted with 7,024 adults aged 40-69 (step two). The association of selected SNPs and iron status with T2D and their interaction were determined using a Cox proportional hazard model. A total of 3 SNPs [rs9465871 (CDKAL1), rs10761745 (JMJD1C), and rs163177 (KCNQ1)] were selected as candidate SNPs related to T2D. Among them, rs10761745 (JMJD1C) and rs163177 (KCNQ1) were prospectively associated with T2D. High iron intake was also prospectively associated with the risk of T2D after adjusting for covariates. Average hemoglobin level was positively associated with T2D after adjusting for covariates in women. We also found significant interaction effects between rs10761745 (JMJD1C) and average hemoglobin levels on the risk of T2D among women with normal inflammation and without anemia at baseline. In conclusion, KCNQ1 and JMJD1C may prospectively contribute to the risk of T2D incidence among adults over the age of 40 and JMJD1C, but CDKAL1 may not, and iron status may interactively contribute to T2D incidence in women.	[Kim, Jihye; Kim, Mi Kyung; Jung, Sukyoung] Hanyang Univ, Dept Prevent Med, Coll Med, Seoul, South Korea; [Kim, Jihye; Kim, Mi Kyung; Jung, Sukyoung] Hanyang Univ, Inst Hlth & Soc, Seoul, South Korea; [Lim, Ji Eun; Oh, Bermseok] Kyung Hee Univ, Sch Med, Dept Biomed Engn, Seoul, South Korea; [Shin, Myung-Hee] Sungkyunkwan Univ, Social & Prevent Med, Sch Med, Seoul, South Korea; [Kim, Yeon-Jung] Korea Natl Inst Hlth, Ctr Genome Sci, Div Struct & Funct Genom, Chungcheongbuk Do, South Korea	Hanyang University; Hanyang University; Kyung Hee University; Sungkyunkwan University (SKKU); Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH); Korea CDC Center for Genome Science	Kim, MK (corresponding author), Hanyang Univ, Dept Prevent Med, Coll Med, Seoul, South Korea.; Kim, MK (corresponding author), Hanyang Univ, Inst Hlth & Soc, Seoul, South Korea.	kmkkim@hanyang.ac.kr		Jung, Sukyoung/0000-0001-9200-2158	Research of Korea Centers for Disease Control and Prevention [HD14B0005]; Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI16C2048]; Korea Centers for Disease Control & Prevention, Republic of Korea [4851-307, KBP-2014-000, 4845-301, 4845-302]	Research of Korea Centers for Disease Control and Prevention; Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea; Korea Centers for Disease Control & Prevention, Republic of Korea	This research was supported by a fund (HD14B0005) by Research of Korea Centers for Disease Control and Prevention and supported by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (HI16C2048). This study was provided with biospecimens and data from the Korean Genome Analysis Projects (4845-301), the Korean Genome and Epidemiology (4845-302), and Korea Biobank Project (4851-307, KBP-2014-000), which were supported by the Korea Centers for Disease Control & Prevention, Republic of Korea. The funders had no role in study design, data analysis, decision to publish, or preparation of the manuscript.; This research was supported by a fund (HD14B0005) by Research of Korea Centers for Disease Control and Prevention and supported by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (HI16C2048). This study was provided with biospecimens and data from the Korean Genome Analysis Projects (4845-301), the Korean Genome and Epidemiology (4845-302), and Korea Biobank Project (4851-307, KBP-2014-000), which were supported by the Korea Centers for Disease Control & Prevention, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn Y, 2007, EUR J CLIN NUTR, V61, P1435, DOI 10.1038/sj.ejcn.1602657; [Anonymous], 2000, C28A CLSI; Association KD, 2013, DIABETES FACT SHEET; Bachman E, 2014, J GERONTOL A-BIOL, V69, P725, DOI 10.1093/gerona/glt154; Bachman E, 2010, J CLIN ENDOCR METAB, V95, P4743, DOI 10.1210/jc.2010-0864; Baik I, 2008, ARCH INTERN MED, V168, P167, DOI 10.1001/archinternmed.2007.8; Bao W, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-119; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bu S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139039; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chasman DI, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000730; Cho YS, 2009, NAT GENET, V41, P527, DOI 10.1038/ng.357; Coviello AD, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002805; Dandona P, 2010, INT J CLIN PRACT, V64, P682, DOI 10.1111/j.1742-1241.2010.02355.x; Ding EL, 2006, JAMA-J AM MED ASSOC, V295, P1288, DOI 10.1001/jama.295.11.1288; Faerch K, 2010, DIABETOLOGIA, V53, P858, DOI 10.1007/s00125-010-1673-4; Fernandez-Real JM, 2002, DIABETES, V51, P2348, DOI 10.2337/diabetes.51.8.2348; Galan P, 1998, EUR J CLIN NUTR, V52, P383, DOI 10.1038/sj.ejcn.1600561; Ganz T, 2003, BLOOD, V102, P783, DOI 10.1182/blood-2003-03-0672; Guo X, 2013, BRIT J NUTR, V110, P2180, DOI 10.1017/S0007114513001827; Hilawe EH, 2013, B WORLD HEALTH ORGAN, V91, P671, DOI 10.2471/BLT.12.113415; Jin GF, 2012, HUM MOL GENET, V21, P5222, DOI 10.1093/hmg/dds361; Kato N, 2013, J DIABETES INVEST, V4, P233, DOI 10.1111/jdi.12067; Kroot JJC, 2011, CLIN CHEM, V57, P1650, DOI 10.1373/clinchem.2009.140053; Manolio TA, 2009, NAT GENET, V41, P5, DOI 10.1038/ng0109-5; Milman N, 1998, ANN HEMATOL, V77, P13, DOI 10.1007/s002770050405; MILMAN N, 1992, ANN HEMATOL, V65, P96, DOI 10.1007/BF01698138; Ministry of Health and Welfare KCfDCaP, 2013, KOR HLTH STAT 2013 K; Moore AF, 2008, DIABETES, V57, P2503, DOI 10.2337/db08-0284; Orban E, 2014, DIABETES-METAB RES, V30, P372, DOI 10.1002/dmrr.2506; Pan Q, 2010, MOL BIOL REP, V37, P1329, DOI 10.1007/s11033-009-9511-9; Pascoe L, 2007, DIABETES, V56, P3101, DOI 10.2337/db07-0634; Pasquale Louis R., 2013, Frontiers in Genetics, V4, P7, DOI 10.3389/fgene.2013.00007; Poulsen P, 1999, DIABETOLOGIA, V42, P139, DOI 10.1007/s001250051131; Qi L, 2005, DIABETES, V54, P3567, DOI 10.2337/diabetes.54.12.3567; Qi L, 2010, CURR OPIN LIPIDOL, V21, P31, DOI 10.1097/MOL.0b013e3283346cb6; Rabbee N, 2006, BIOINFORMATICS, V22, P7, DOI 10.1093/bioinformatics/bti741; Rajpathak SN, 2009, BBA-GEN SUBJECTS, V1790, P671, DOI 10.1016/j.bbagen.2008.04.005; Root MM, 1999, EUR J CLIN NUTR, V53, P199, DOI 10.1038/sj.ejcn.1600701; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; Shi ZM, 2006, DIABETES CARE, V29, P1878, DOI 10.2337/dc06-0327; Sirdah M, 2008, INT J HLTH RES, V1, P225; Steinthorsdottir V, 2007, NAT GENET, V39, P770, DOI 10.1038/ng2043; Sun Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031093; The Korean Nutrition Society, 2000, RECOMMENDED DIETARY, V7th; Tiedge M, 1997, DIABETES, V46, P1733, DOI 10.2337/diabetes.46.11.1733; Unoki H, 2008, NAT GENET, V40, P1098, DOI 10.1038/ng.208; van den Oord EJCG, 2003, TRENDS GENET, V19, P537, DOI 10.1016/j.tig.2003.08.003; Wen J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009153; Whiting DR, 2011, DIABETES RES CLIN PR, V94, P311, DOI 10.1016/j.diabres.2011.10.029; Willett W., 2013, NUTR EPIDEMIOLOGY, V3rd, DOI DOI 10.1093/ACPROF:OSO/9780199754038.001.0001; World Health Organization, 2006, DEF DIAGN DIAB MELL; Wu Y, 2008, DIABETES, V57, P2834, DOI 10.2337/db08-0047; Yasuda K, 2008, NAT GENET, V40, P1092, DOI 10.1038/ng.207; Ye KX, 2015, BMC GENET, V16, DOI 10.1186/s12863-015-0223-y; Yuan X, 2008, AM J HUM GENET, V83, P520, DOI 10.1016/j.ajhg.2008.09.012	56	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2017	12	4							e0175681	10.1371/journal.pone.0175681	http://dx.doi.org/10.1371/journal.pone.0175681			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0MB	28406950	gold, Green Submitted, Green Published			2022-12-27	WOS:000399955400081
J	Connette, GM; Oswald, P; Thura, MK; Connette, KJL; Grindley, ME; Songer, M; Zug, GR; Mulcahy, DG				Connette, Grant M.; Oswald, Patrick; Thura, Myint Kyaw; Connette, Katherine J. LaJeunesse; Grindley, Mark E.; Songer, Melissa; Zug, George R.; Mulcahy, Daniel G.			Rapid forest clearing in a Myanmar proposed national park threatens two newly discovered species of geckos (Gekkonidae: Cyrtodactylus)	PLOS ONE			English	Article							SQUAMATA GEKKONIDAE; PLANTATION FORESTS; SOUTHEAST-ASIA; CONSERVATION; EXTINCTION; BIODIVERSITY; AMPHIBIANS; SECONDARY; HOTSPOTS; PROVINCE	Myanmar's recent transition from military rule towards a more democratic government has largely ended decades of political and economic isolation. Although Myanmar remains heavily forested, increased development in recent years has been accompanied by exceptionally high rates of forest loss. In this study, we document the rapid progression of deforestation in and around the proposed Lenya National Park, which includes some of the largest remaining areas of lowland evergreen rainforest in mainland Southeast Asia. The globally unique forests in this area are rich in biodiversity and remain a critical stronghold for many threatened and endangered species, including large charismatic fauna such as tiger and Asian elephant. We also conducted a rapid assessment survey of the herpetofauna of the proposed national park, which resulted in the discovery of two new species of bent-toed geckos, genus Cyrtodactylus. We describe these new species, C. lenya sp. nov. and C. payarhtanensis sp. nov., which were found in association with karst (i.e., limestone) rock formations within mature lowland wet evergreen forest. The two species were discovered less than 35 km apart and are each known from only a single locality. Because of the isolated nature of the karst formations in the proposed Lenya National Park, these geckos likely have geographical ranges restricted to the proposed protected area and are threatened by approaching deforestation. Although lowland evergreen rainforest has vanished from most of continental Southeast Asia, Myanmar can still take decisive action to preserve one of the most biodiverse places on Earth.	[Connette, Grant M.; Connette, Katherine J. LaJeunesse; Songer, Melissa] Smithsonian Inst, Smithsonian Conservat Biol Inst, Conservat Ecol Ctr, Front Royal, VA 22630 USA; [Oswald, Patrick; Grindley, Mark E.] Fauna & Flora Int, San Chaung Township, Yangon, Myanmar; [Thura, Myint Kyaw] Myanmar Environm & Sustainable Conservat Co LTD M, Yangon, Myanmar; [Zug, George R.] Smithsonian Inst, Dept Vertebrate Zool, Natl Museum Nat Hist, Washington, DC 20560 USA; [Mulcahy, Daniel G.] Smithsonian Inst, Global Genome Initiat, Natl Museum Nat Hist, Washington, DC 20560 USA	Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute; Smithsonian Institution; Smithsonian National Museum of Natural History; Smithsonian Institution; Smithsonian National Museum of Natural History	Connette, GM (corresponding author), Smithsonian Inst, Smithsonian Conservat Biol Inst, Conservat Ecol Ctr, Front Royal, VA 22630 USA.	grmcco@gmail.com		Songer, Melissa/0000-0001-5536-6315; Connette, Grant/0000-0002-9424-6591; LaJeunesse Connette, Katie/0000-0002-9011-8859	Smithsonian Institution's Global Genome Initiative (GGI); Myanmar Environment & Sustainable Conservation Co., LTD (MESC)	Smithsonian Institution's Global Genome Initiative (GGI); Myanmar Environment & Sustainable Conservation Co., LTD (MESC)	The Smithsonian Institution's Global Genome Initiative (GGI) provided funding for the molecular lab work. Funding for international travel was provided by an award to Smithsonian Institution from the Leona M. and Harry B. Helmsley Charitable Trust. In-country expenses for field surveys were made possible through grants to Fauna and Flora International from the European Union, Segre Conservation Foundation, and the Leona M. and Harry B. Helmsley Charitable Trust. This included salary support for MKT of the Myanmar Environment & Sustainable Conservation Co., LTD (MESC), which is an environmental consulting firm specializing in biodiversity surveys in Myanmar. The funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of authors are articulated in the 'author contributions' section. Fauna and Flora International is a non-governmental organization based in the United Kingdom and had no commercial interest in this study.	Achard F, 2014, GLOBAL CHANGE BIOL, V20, P2540, DOI 10.1111/gcb.12605; Alstrom P, 2010, IBIS, V152, P145, DOI 10.1111/j.1474-919X.2009.00990.x; [Anonymous], 2015, GLOB FOR RES ASS; [Anonymous], 2015, ENVIRONMENTAL IMPACT; Aung SS, 2017, ORYX, V51, P15; Baskett J.P.C., 2015, MYANMAR OIL PALM PLA; Bauer AM, 2009, ZOOTAXA, P51, DOI 10.11646/zootaxa.2124.1.4; Bhagwat T, 2002, PLOS ONE IN PRESS; Brockerhoff EG, 2008, BIODIVERS CONSERV, V17, P925, DOI 10.1007/s10531-008-9380-x; Brooks TM, 2002, CONSERV BIOL, V16, P909, DOI 10.1046/j.1523-1739.2002.00530.x; Cardillo M, 2008, P ROY SOC B-BIOL SCI, V275, P1441, DOI 10.1098/rspb.2008.0179; Castaneda MD, 2011, MOL PHYLOGENET EVOL, V61, P784, DOI 10.1016/j.ympev.2011.07.004; Ceballos G, 2009, P NATL ACAD SCI USA, V106, P3841, DOI 10.1073/pnas.0812419106; Che J, 2012, MOL ECOL RESOUR, V12, P247, DOI 10.1111/j.1755-0998.2011.03090.x; Clements R, 2006, BIOSCIENCE, V56, P733, DOI 10.1641/0006-3568(2006)56[733:LKOSAI]2.0.CO;2; Coloma Luis A., 2007, Zootaxa, V1557, P1; Connette G, 2016, REMOTE SENS-BASEL, V8, DOI 10.3390/rs8110882; Culver DC, 2000, CONSERV BIOL, V14, P386, DOI 10.1046/j.1523-1739.2000.99026.x; Day M.J., 2000, CAVE KARST SCI, V27, P61; Donald PF, 2015, CONSERV BIOL, V29, P1485, DOI 10.1111/cobi.12501; Donald PF, 2014, BIRD CONSERV INT, V24, P354, DOI 10.1017/S0959270913000518; Gardner TA, 2007, CONSERV BIOL, V21, P775, DOI 10.1111/j.1523-1739.2007.00659.x; Giam XL, 2010, BIODIVERS CONSERV, V19, P943, DOI 10.1007/s10531-010-9792-2; Gibson L, 2011, NATURE, V478, P378, DOI 10.1038/nature10425; Gillespie GR, 2012, BIOL CONSERV, V152, P136, DOI 10.1016/j.biocon.2012.03.023; Grismer LL, 2016, ZOOTAXA, V4061, P1, DOI 10.11646/zootaxa.4061.1.1; Grismer LL, 2013, ZOOTAXA, V3746, P463, DOI 10.11646/zootaxa.3746.3.5; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Harris G, 2008, CONSERV BIOL, V22, P163, DOI 10.1111/j.1523-1739.2007.00798.x; Hosonuma N, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/4/044009; IUCN (International Union for Conservation of Nature), 2021, THE IUCN RED LIST TH, DOI [10.2305/IUCN.UK.2015-2.RLTS.T2446A22156678.en, DOI 10.2305/IUCN.UK.2015-2.RLTS.T2446A22156678.EN]; Jenkins PD, 2004, SYST BIODIVERS, V2, P419, DOI DOI 10.1017/S1477200004001549; Kiew R, 1991, THE LIMESTONE FLORA; Kissinger G, 2012, DRIVERS DEFORESTATIO; Kohler J, 2005, BIOSCIENCE, V55, P693, DOI 10.1641/0006-3568(2005)055[0693:NAAGCA]2.0.CO;2; Leimgruber P, 2005, ENVIRON CONSERV, V32, P356, DOI 10.1017/S0376892905002493; Macey JR, 1997, MOL BIOL EVOL, V14, P91, DOI 10.1093/oxfordjournals.molbev.a025706; Mendelson JR, 2010, ZOOTAXA, P61, DOI 10.11646/zootaxa.2396.1.5; Miettinen J, 2014, GLOB ECOL CONSERV, V2, P24, DOI 10.1016/j.gecco.2014.07.007; MOECAF, 2011, REP UN MYANM NAT BIO; Mulcahy DG, 2016, PEERJ, V4, DOI 10.7717/peerj.2528; Musser GG, 2005, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2005)497[0001:DOANGA]2.0.CO;2; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Pauwels OSG, 2016, ZOOTAXA, V4088, P409, DOI 10.11646/zootaxa.4088.3.6; Rodriguez-Robles JA, 2007, J BIOGEOGR, V34, P1546, DOI 10.1111/j.1365-2699.2007.01718.x; Round Philip D., 2014, Natural History Bulletin of the Siam Society, V60, P3; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Scheffers BR, 2012, TRENDS ECOL EVOL, V27, P501, DOI 10.1016/j.tree.2012.05.008; Songer M, 2009, BIODIVERS CONSERV, V18, P1001, DOI 10.1007/s10531-008-9490-5; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Stibig H-J, 2007, FOREST COVER CHANGE; Sumontha M, 2015, ZOOTAXA, V3911, P106, DOI 10.11646/zootaxa.3911.1.6; Sumontha Montri, 2010, Zootaxa, V2370, P53; Tedesco PA, 2014, CONSERV BIOL, V28, P1360, DOI 10.1111/cobi.12285; Terzopoulou S, 2015, BIOL LETTERS, V11, DOI 10.1098/rsbl.2015.0273; Uetz P., 2016, REPTILE DATABASE; Luu VQ, 2016, ZOOTAXA, V4067, P185, DOI 10.11646/zootaxa.4067.2.4; Weigt Lee A, 2012, Methods Mol Biol, V858, P109, DOI 10.1007/978-1-61779-591-6_6; Wiens JJ, 2007, SYST BIOL, V56, P875, DOI 10.1080/10635150701748506; Win SP., 2016, MYANMAR TIMES; Woods K, 2015, FOREST TRENDS; Yang JH, 2015, ZOOTAXA, V3980, P67, DOI 10.11646/zootaxa.3980.1.4	62	48	50	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2017	12	4							e0174432	10.1371/journal.pone.0174432	http://dx.doi.org/10.1371/journal.pone.0174432			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LZ	28403189	Green Submitted, Green Published, gold			2022-12-27	WOS:000399955200013
J	Hong, JK; Kim, HJ; Cho, JC				Hong, Jin-Kyung; Kim, Hye-Jin; Cho, Jae-Chang			Novel PCRPrimers for the Archaeal Phylum Thaumarchaeota Designed Based on the Comparative Analysis of 16S rRNA Gene Sequences (vol 9, e96197, 2014)	PLOS ONE			English	Correction																		Hong JK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096197	1	0	0	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2017	12	4							e0175937	10.1371/journal.pone.0175937	http://dx.doi.org/10.1371/journal.pone.0175937			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0JS	28399147	Green Submitted, Green Published, gold			2022-12-27	WOS:000399949000056
J	Oliveira, VD; Boechat, VC; Mendes, AAV; Madeira, MD; Ferreira, LC; Figueiredo, FB; Campos, MP; Rodrigues, FDD; de Oliveira, RDC; Amendoeira, MRR; Menezes, RC				Oliveira, Valeria da Costa; Boechat, Viviane Cardoso; Velho Mendes Junior, Artur Augusto; Madeira, Maria de Fatima; Ferreira, Luiz Claudio; Figueiredo, Fabiano Borges; Campos, Monique Paiva; de Carvalho Rodrigues, Francisco das Chagas; Carvalhaes de Oliveira, Raquel de Vasconcellos; Reis Amendoeira, Maria Regina; Menezes, Rodrigo Caldas			Occurrence of Leishmania infantum in the central nervous system of naturally infected dogs: Parasite load, viability, co-infections and histological alterations	PLOS ONE			English	Article							CANINE VISCERAL LEISHMANIASIS; CEREBROSPINAL-FLUID; AMASTIGOTES; DIAGNOSIS; ANTIBODIES; FEATURES; LESIONS; BRAIN; STATE; AREA	Zoonotic visceral leishmaniasis is caused by the protozoan Leishmania infantum and little is known about the occurrence and pathogenesis of this parasite in the CNS. The aims of this study were to evaluate the occurrence, viability and load of L. infantum in the CNS, and to identify the neurological histological alterations associated with this protozoan and its coinfections in naturally infected dogs. Forty-eight Leishmania-seropositive dogs from which L. infantum was isolated after necropsy were examined. Cerebrospinal fluid (CSF) samples were analyzed by parasitological culture, quantitative real-time PCR (qPCR) and the rapid immunochromatographic Dual Path Platform test. Brain, spinal cord and spleen samples were submitted to parasitological culture, qPCR, and histological techniques. Additionally, anti-Toxoplasma gondii and anti-Ehrlichia canis antibodies in serum and distemper virus antigens in CSF were investigated. None of the dogs showed neurological signs. All dogs tested positive for L. infantum in the CNS. Viable forms of L. infantum were isolated from CSF, brain and spinal cord in 25% of the dogs. Anti-L. infantum antibodies were detected in CSF in 61% of 36 dogs. Inflammatory histological alterations were observed in the CNS of 31% of the animals; of these, 66% were seropositive for E. canis and/or T. gondii. Amastigote forms were associated with granulomatous non-suppurative encephalomyelitis in a dog without evidence of co-infections. The highest frequency of L. infantum DNA was observed in the brain (98%), followed by the spinal cord (96%), spleen (95%), and CSF (50%). The highest L. infantum load in CNS was found in the spinal cord. These results demonstrate that L. infantum can cross the blood-brain barrier, spread through CSF, and cause active infection in the entire CNS of dogs. Additionally, L. infantum can cause inflammation in the CNS that can lead to neurological signs with progression of the disease.	[Oliveira, Valeria da Costa; Boechat, Viviane Cardoso; Velho Mendes Junior, Artur Augusto; Campos, Monique Paiva; Menezes, Rodrigo Caldas] Fundacao Oswaldo Cruz, Inst Nacl Infectol Evandro Chagas, Lab Pesquisa Clin Dermatozoonoses Anim Domest, Rio De Janeiro, Brazil; [Madeira, Maria de Fatima] Fundacao Oswaldo Cruz, Inst Nacl Infectol Evandro Chagas, Lab Vigilancia Leishmanioses, Rio De Janeiro, Brazil; [Ferreira, Luiz Claudio; de Carvalho Rodrigues, Francisco das Chagas] Fundacao Oswaldo Cruz, Inst Nacl Infectol Evandro Chagas, Serv Anat Patol, Rio De Janeiro, Brazil; [Figueiredo, Fabiano Borges] Fundacao Oswaldo Cruz, Inst Carlos Chagas, Lab Biol Celular, Curitiba, Parana, Brazil; [Carvalhaes de Oliveira, Raquel de Vasconcellos] Fundacao Oswaldo Cruz, Inst Nacl Infectol Evandro Chagas, Lab Epidemiol Clin, Rio De Janeiro, Brazil; [Reis Amendoeira, Maria Regina] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Toxoplasmose, Rio De Janeiro, Brazil	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz	Menezes, RC (corresponding author), Fundacao Oswaldo Cruz, Inst Nacl Infectol Evandro Chagas, Lab Pesquisa Clin Dermatozoonoses Anim Domest, Rio De Janeiro, Brazil.	rodrigo.menezes@ini.fiocruz.br	Menezes, Rodrigo/O-8722-2019; Oliveira, Raquel de V C de/S-7443-2016	Menezes, Rodrigo/0000-0003-1853-3449; Oliveira, Raquel de V C de/0000-0001-9387-8645; Velho Mendes Junior, Artur Augusto/0000-0002-7106-797X	Fundagao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro [JCNE E-26/201.495/2014, JCNE E-26/102.247/2013]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico	Fundagao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was supported by the state funding agency Fundagao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (Grants: JCNE E-26/201.495/2014 to FBF, JCNE E-26/102.247/2013 to RCM), http://www.faperj.br/; productivity fellowships from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico to FBF RCM MFM, littp://www.cnpq.br/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu-Silva AL, 2003, AM J TROP MED HYG, V68, P661, DOI 10.4269/ajtmh.2003.68.661; Boechat VC, 2016, PARASITOL RES, V115, P2371, DOI 10.1007/s00436-016-4987-4; Camargo M.E., 1974, REV BRASIL PATOL 150, V10, P143, DOI DOI 10.1136/JNNP.2005.075242; Cardinot CB, 2016, J PARASITOL, V102, P275, DOI 10.1645/15-821; Carson F.L., 2009, HISTOTECHNOLOGY SELF, V3rd; Cauduro A, 2011, J VET INTERN MED, V25, P398, DOI 10.1111/j.1939-1676.2010.0668.x; CUPOLILLO E, 1994, AM J TROP MED HYG, V50, P296, DOI 10.4269/ajtmh.1994.50.296; de Mello CX, 2014, REV SOC BRAS MED TRO, V47, P788, DOI 10.1590/0037-8682-0042-2014; Feitosa M. M., 2005, Veterinaria Noticias, V11, P61; Feitosa MM, 2000, CLIN VET, V5, P36; Pimentel MIF, 2014, REV SOC BRAS MED TRO, V47, P521, DOI 10.1590/0037-8682-0213-2013; Font A, 2004, J SMALL ANIM PRACT, V45, P199, DOI 10.1111/j.1748-5827.2004.tb00224.x; Francino O, 2006, VET PARASITOL, V137, P214, DOI 10.1016/j.vetpar.2006.01.011; GarciaAlonso M, 1996, PARASITE IMMUNOL, V18, P539, DOI 10.1046/j.1365-3024.1996.d01-28.x; Gontijo CM, 2004, REV BRAS EPIDEMIOL, V7, P1, DOI DOI 10.1590/S1415-790X2004000300011; Grano FG, 2014, VET PARASITOL, V204, P376, DOI 10.1016/j.vetpar.2014.05.015; Harrus S, 2003, VET IMMUNOL IMMUNOP, V96, P239, DOI 10.1016/j.vetimm.2003.08.005; Ikeda F. A., 2007, Brazilian Journal of Veterinary Research and Animal Science, V44, P5; Jose-Lopez R, 2014, JAVMA-J AM VET MED A, V244, P200, DOI 10.2460/javma.244.2.200; Lima VMF, 2003, BRAZ J MED BIOL RES, V36, P485, DOI 10.1590/S0100-879X2003000400010; Madeira MF, 2009, RES VET SCI, V87, P260, DOI 10.1016/j.rvsc.2009.03.008; Maia CSF, 2015, PARASITE IMMUNOL, V37, P385, DOI 10.1111/pim.12203; Marquez M, 2013, J VET DIAGN INVEST, V25, P142, DOI 10.1177/1040638712466728; Melo G. D., 2009, Brazilian Journal of Veterinary Pathology, V2, P69; Melo GD, 2009, VET PARASITOL, V162, P248, DOI 10.1016/j.vetpar.2009.03.002; Melo GD, 2015, J NEUROIMMUNOL, V289, P21, DOI 10.1016/j.jneuroim.2015.10.004; Mendonca C. C., 2013, Brazilian Journal of Veterinary Pathology, V6, P89; Menezes RC, 2013, J CLIN MICROBIOL, V51, P206, DOI 10.1128/JCM.02123-12; Ministerio da Saude, 2006, MAN VIG CONTR LEISHM; Ministerio da Saude, 2017, CAS CONF LEISHM VISC; Nieto CG, 1996, VET REC, V139, P346, DOI 10.1136/vr.139.14.346; Panciera RJ, 2001, VET PATHOL, V38, P43, DOI 10.1354/vp.38-1-43; Peixoto HM, 2015, TROP MED INT HEALTH, V20, P334, DOI 10.1111/tmi.12429; Petersen Christine Anne, 2011, J Neuroparasitology, V2; PINELLI E, 1994, INFECT IMMUN, V62, P229, DOI 10.1128/IAI.62.1.229-235.1994; Prasad LSN, 1996, AM J TROP MED HYG, V55, P652, DOI 10.4269/ajtmh.1996.55.652; Sakamoto Keila Priscilla, 2013, BMC Res Notes, V6, P226, DOI 10.1186/1756-0500-6-226; Schwardt T. F., 2012, Brazilian Journal of Veterinary Research and Animal Science, V49, P442, DOI 10.11606/issn.1678-4456.v49i6p442-451; Silva MR, 2008, CAD SAUDE PUBLICA, V24, P281, DOI 10.1590/S0102-311X2008000200006; Frade MTS, 2015, SEMIN-CIENC AGRAR, V36, P4251, DOI 10.5433/1679-0359.2015v36n6Supl2p4251; Vinuelas J, 2001, VET PARASITOL, V101, P23, DOI 10.1016/S0304-4017(01)00413-7; WHO, 2010, WHO TECH REP SER, V949, P1	42	19	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2017	12	4							e0175588	10.1371/journal.pone.0175588	http://dx.doi.org/10.1371/journal.pone.0175588			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KH	28419136	Green Published, gold, Green Submitted			2022-12-27	WOS:000399875200030
J	Dayal, S; Baumbach, GL; Arning, E; Bottiglieri, T; Faraci, FM; Lentz, SR				Dayal, Sanjana; Baumbach, Gary L.; Arning, Erland; Bottiglieri, Teodoro; Faraci, Frank M.; Lentz, Steven R.			Deficiency of superoxide dismutase promotes cerebral vascular hypertrophy and vascular dysfunction in hyperhomocysteinemia	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; NITRIC-OXIDE; B-VITAMINS; FOLIC-ACID; MICE DEFICIENT; HOMOCYSTEINE; STROKE; ARTERIOLES; PREVENTION; SYNTHASE	There is an emerging consensus that hyperhomocysteinemia is an independent risk factor for cerebral vascular disease and that homocysteine-lowering therapy protects from ischemic stroke. However, the mechanisms by which hyperhomocysteinemia produces abnormalities of cerebral vascular structure and function remain largely undefined. Our objective in this study was to define the mechanistic role of superoxide in hyperhomocysteinemia-induced cerebral vascular dysfunction and hypertrophy. Unlike previous studies, our experimental design included a genetic approach to alter superoxide levels by using superoxide dismutase 1 (SOD1)-deficient mice fed a high methionine/low folate diet to produce hyperhomocysteinemia. In wild-type mice, the hyperhomocysteinemic diet caused elevated superoxide levels and impaired responses to endothelium-dependent vasodilators in cerebral arterioles, and SOD1 deficiency compounded the severity of these effects. The cross-sectional area of the pial arteriolar wall was markedly increased in mice with SOD1 deficiency, and the hyperhomocysteinemic diet sensitized SOD1-deficient mice to this hypertrophic effect. Analysis of individual components of the vascular wall demonstrated a significant increase in the content of smooth muscle and elastin. We conclude that superoxide is a key driver of both cerebral vascular hypertrophy and vasomotor dysfunction in this model of dietary hyperhomocysteinemia. These findings provide insight into the mechanisms by which hyperhomocysteinemia promotes cerebral vascular disease and ischemic stroke.	[Dayal, Sanjana; Faraci, Frank M.; Lentz, Steven R.] Univ Iowa, Carver Coll Med, Dept Internal Med, Iowa City, IA 52242 USA; [Baumbach, Gary L.] Univ Iowa, Carver Coll Med, Dept Pathol, Iowa City, IA USA; [Arning, Erland; Bottiglieri, Teodoro] Baylor Inst Metab Dis, Dallas, TX USA; [Faraci, Frank M.] Univ Iowa, Carver Coll Med, Dept Pharmacol, Iowa City, IA USA	University of Iowa; University of Iowa; University of Iowa	Lentz, SR (corresponding author), Univ Iowa, Carver Coll Med, Dept Internal Med, Iowa City, IA 52242 USA.	steven-lentz@uiowa.edu		Faraci, Frank/0000-0002-0203-1690; dayal, sanjana/0000-0001-6156-2996; Lentz, Steven/0000-0002-8885-4718; Baumbach, Gary/0000-0002-0659-9494	American Heart Association (AHA) Postdoctoral Fellowship; AHA Beginning Grant; NIH grant [HL063943, NS024621, HL062984, HL113863, NS-096465]; Department of Veteran's Affair's [BX001399]; Fondation Leducq (a Transatlantic Network of Excellence)	American Heart Association (AHA) Postdoctoral Fellowship(American Heart Association); AHA Beginning Grant; NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veteran's Affair's(US Department of Veterans Affairs); Fondation Leducq (a Transatlantic Network of Excellence)(Leducq Foundation)	This study was supported in part by an American Heart Association (AHA) Postdoctoral Fellowship and an AHA Beginning Grant-in-Aid to SD and by NIH grants HL063943, NS024621, HL062984, HL113863, and NS-096465, the Department of Veteran's Affair's (BX001399), and the Fondation Leducq (a Transatlantic Network of Excellence).	Baumbach GL, 2006, STROKE, V37, P1850, DOI 10.1161/01.STR.0000227236.84546.5a; Baumbach GL, 2004, CIRC RES, V95, P822, DOI 10.1161/01.RES.0000146279.11923.14; Baumbach GL, 2002, CIRC RES, V91, P931, DOI 10.1161/01.RES.0000041408.64867.1D; Beard RS, 2011, BLOOD, V118, P2007, DOI 10.1182/blood-2011-02-338269; Bonaa KH, 2006, NEW ENGL J MED, V354, P1578, DOI 10.1056/NEJMoa055227; Buemi M, 2001, THROMB RES, V104, P207, DOI 10.1016/S0049-3848(01)00363-2; Channon KM, 2004, TRENDS CARDIOVAS MED, V14, P323, DOI 10.1016/j.tcm.2004.10.003; Chen CY, 2000, J SURG RES, V88, P26, DOI 10.1006/jsre.1999.5756; Clarke R, 2010, ARCH INTERN MED, V170, P1622, DOI 10.1001/archinternmed.2010.348; Dayal S, 2005, CIRCULATION, V112, P737, DOI 10.1161/CIRCULATIONAHA.104.529248; Dayal S, 2004, STROKE, V35, P1957, DOI 10.1161/01.STR.0000131749.81508.18; Dayal S, 2002, ARTERIOSCL THROM VAS, V22, P1996, DOI 10.1161/01.ATV.0000041629.92741.DC; Dayal S, 2006, BLOOD, V108, P2237, DOI 10.1182/blood-2006-02-005991; Dayal S, 2015, ATHEROSCLEROSIS: RISKS, MECHANISMS, AND THERAPIES, P53; Dayali S, 2007, ANTIOXID REDOX SIGN, V9, P1899, DOI 10.1089/ars.2007.1806; De Silva TM, 2016, CELL MOL NEUROBIOL, V36, P241, DOI 10.1007/s10571-015-0308-1; den Heijer M, 2007, BLOOD, V109, P139, DOI 10.1182/blood-2006-04-014654; Devlin AM, 2004, BLOOD, V103, P2624, DOI 10.1182/blood-2003-09-3078; Didion SP, 2002, CIRC RES, V91, P938, DOI 10.1161/01.RES.0000043280.65241.04; Faraci FM, 2004, ARTERIOSCL THROM VAS, V24, P1367, DOI 10.1161/01.ATV.0000133604.20182.cf; Hankey GJ, 2012, LANCET NEUROL, V11, P512, DOI 10.1016/S1474-4422(12)70091-1; *HOM STUD COLL, 2000, JAMA-J AM MED ASSOC, V288, P2015; Huang T, 2012, CLIN NUTR, V31, P448, DOI 10.1016/j.clnu.2011.01.003; Huo Y, 2015, JAMA-J AM MED ASSOC, V313, P1325, DOI 10.1001/jama.2015.2274; IGUCHI M, 1992, J PHARMACOL EXP THER, V263, P194; Lee M, 2010, STROKE, V41, P1205, DOI 10.1161/STROKEAHA.109.573410; Lonn E, 2006, NEW ENGL J MED, V354, P1567, DOI 10.1056/NEJMoa060900; Martin SC, 1999, BIOMED CHROMATOGR, V13, P81, DOI 10.1002/(SICI)1099-0801(199902)13:1<81::AID-BMC762>3.0.CO;2-U; Martyn KD, 2006, CELL SIGNAL, V18, P69, DOI 10.1016/j.cellsig.2005.03.023; Mudd SH, 2000, ARTERIOSCL THROM VAS, V20, P1704, DOI 10.1161/01.ATV.20.7.1704; Ovechkin AV, 2006, AM J PHYSIOL-LUNG C, V291, pL905, DOI 10.1152/ajplung.00543.2005; ROLLAND PH, 1995, CIRCULATION, V91, P1161, DOI 10.1161/01.CIR.91.4.1161; Sobey CG, 1997, STROKE, V28, P837, DOI 10.1161/01.STR.28.4.837; Sobey CG, 1997, AM J PHYSIOL-HEART C, V272, pH256, DOI 10.1152/ajpheart.1997.272.1.H256; Stasch JP, 2006, J CLIN INVEST, V116, P2552, DOI 10.1172/JCI28371; Wang XB, 2007, LANCET, V369, P1876, DOI 10.1016/S0140-6736(07)60854-X; Weiss N, 2001, P NATL ACAD SCI USA, V98, P12503, DOI 10.1073/pnas.231428998; Yang QH, 2006, CIRCULATION, V113, P1335, DOI 10.1161/CIRCULATIONAHA.105.570846; Zhang D, 2012, J MOL CELL CARDIOL	39	13	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2017	12	4							e0175732	10.1371/journal.pone.0175732	http://dx.doi.org/10.1371/journal.pone.0175732			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KD	28414812	Green Submitted, gold, Green Published			2022-12-27	WOS:000399874800051
J	Maynard, JJ; Karl, JW				Maynard, Jonathan J.; Karl, Jason W.			A hyper-temporal remote sensing protocol for high-resolution mapping of ecological sites	PLOS ONE			English	Article							VEGETATION DYNAMICS; QUANTITY DISAGREEMENT; CHIHUAHUAN DESERT; TRANSITION MODELS; COVER; LANDSAT; SUPPORT; SCALE; CLASSIFICATION; LANDSCAPES	Ecological site classification has emerged as a highly effective land management framework, but its utility at a regional scale has been limited due to the spatial ambiguity of ecological site locations in the U. S. or the absence of ecological site maps in other regions of the world. In response to these shortcomings, this study evaluated the use of hyper-temporal remote sensing (i. e., hundreds of images) for high spatial resolution mapping of ecological sites. We posit that hyper-temporal remote sensing can provide novel insights into the spatial variability of ecological sites by quantifying the temporal response of land surface spectral properties. This temporal response provides a spectral `fingerprint' of the soil-vegetation- climate relationship which is central to the concept of ecological sites. Consequently, the main objective of this study was to predict the spatial distribution of ecological sites in a semi-arid rangeland using a 28-year time series of normalized difference vegetation index from Landsat TM 5 data and modeled using support vector machine classification. Results from this study show that support vector machine classification using hyper-temporal remote sensing imagery was effective in modeling ecological site classes, with a 62% correct classification. These results were compared to Gridded Soil Survey Geographic database and expert delineated maps of ecological sites which had a 51 and 89% correct classification, respectively. An analysis of the effects of ecological state on ecological site misclassifications revealed that sites in degraded states (e. g., shrub-dominated/shrubland and bare/annuals) had a higher rate of misclassification due to their close spectral similarity with other ecological sites. This study identified three important factors that need to be addressed to improve future model predictions: 1) sampling designs need to fully represent the range of both within class (i. e., states) and between class (i. e., ecological sites) spectral variability through time, 2) field sampling protocols that accurately characterize key soil properties (e. g., texture, depth) need to be adopted, and 3) additional environmental covariates (e. g. terrain attributes) need to be evaluated that may help further differentiate sites with similar spectral signals. Finally, the proposed hyper-temporal remote sensing framework may provide a standardized approach to evaluate and test our ecological site concepts through examining differences in vegetation dynamics in response to climatic variability and other drivers of land-use change. Results from this study demonstrate the efficacy of the hyper-temporal remote sensing approach for high resolution mapping of ecological sites, (a)nd highlights its utility in terms of reduced cost and time investment relative to traditional manual mapping approaches.	[Maynard, Jonathan J.; Karl, Jason W.] New Mexico State Univ, USDA ARS, Jornada Expt Range, MSC 3JER, Las Cruces, NM 88012 USA	New Mexico State University; United States Department of Agriculture (USDA)	Maynard, JJ (corresponding author), New Mexico State Univ, USDA ARS, Jornada Expt Range, MSC 3JER, Las Cruces, NM 88012 USA.	jonathan.maynard@ars.usda.gov		Maynard, Jonathan/0000-0003-2546-0073	USDA-ARS CRIS [3050-11210-007-00D]; USDI Bureau of Land Management's Assessment, Inventory and Monitoring program; USDAARS Rangeland Management Research Unit, Jornada Experimental Range	USDA-ARS CRIS(United States Department of Agriculture (USDA)USDA Agricultural Research Service); USDI Bureau of Land Management's Assessment, Inventory and Monitoring program; USDAARS Rangeland Management Research Unit, Jornada Experimental Range	Funding for field data collection was provided by the USDA-ARS CRIS Project #3050-11210-007-00D. Support for JJM was from the USDI Bureau of Land Management's Assessment, Inventory and Monitoring program. Support for JWK was from appropriated funding to the USDAARS Rangeland Management Research Unit, Jornada Experimental Range.	Bestelmeyer BT, 2011, J APPL ECOL, V48, P746, DOI 10.1111/j.1365-2664.2011.01982.x; Bestelmeyer Brandon T., 2010, Rangelands, V32, P23, DOI 10.2111/RANGELANDS-D-10-00077.1; Bestelmeyer BT, 2009, RANGELAND ECOL MANAG, V62, P1, DOI 10.2111/08-146; Bestelmeyer BT, 2006, ECOLOGY, V87, P963, DOI 10.1890/0012-9658(2006)87[963:SHGPVD]2.0.CO;2; Bestelmeyer BT, 2004, ENVIRON MANAGE, V34, P38, DOI 10.1007/s00267-004-0047-4; Blanco PD, 2014, INT J APPL EARTH OBS, V29, P11, DOI 10.1016/j.jag.2013.12.011; Bradley BA, 2005, REMOTE SENS ENVIRON, V94, P204, DOI 10.1016/j.rse.2004.08.016; Briske DD, 2003, J APPL ECOL, V40, P601, DOI 10.1046/j.1365-2664.2003.00837.x; Browning DM, 2012, ECOL APPL, V22, P909, DOI 10.1890/11-1193.1; Burkett LM, 2011, AGR HDB; Caudle D., 2013, INTERAGENCY ECOLOGIC; Clements F.E., 1916, PLANT SUCCESSION ANA; Cleveland R.B., 1990, J OFF STAT, V6, P3; Congalton R.G., 2008, ASSESSING ACCURACY R, V2nd, DOI [10.1201/9781420055139, DOI 10.1201/9781420055139]; DUNIWAY M. C., 2010, RANGELANDS, V32, P9, DOI DOI 10.2111/RANGELANDS-D-10-00090.1; Elmore AJ, 2003, ECOL APPL, V13, P443, DOI 10.1890/1051-0761(2003)013[0443:RPOPCR]2.0.CO;2; Haddad NM, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500052; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Hernandez AJ, 2013, RANGELAND ECOL MANAG, V66, P71, DOI 10.2111/REM-D-11-00195.1; Herrick J, 2013, FRONT ECOL, V2012; Herrick JE, 2006, J ARID ENVIRON, V65, P319, DOI 10.1016/j.jaridenv.2005.09.003; Holling C.S., 1973, Annual Rev Ecol Syst, V4, P1, DOI 10.1146/annurev.es.04.110173.000245; Ireland AW, 2015, SOIL SCI SOC AM J, V79, P185, DOI 10.2136/sssaj2014.06.0271; Kawamura K, 2005, AGR ECOSYST ENVIRON, V107, P83, DOI 10.1016/j.agee.2004.09.008; Kuhn M., 2013, APPL PREDICTIVE MODE, DOI 10.1007/978-1-4614-6849-3; Levi MR, 2015, VADOSE ZONE J, V14, DOI 10.2136/vzj2014.09.0126; Masek JG, 2006, IEEE GEOSCI REMOTE S, V3, P68, DOI 10.1109/LGRS.2005.857030; Maynard JJ, 2017, GEODERMA, V285, P94, DOI 10.1016/j.geoderma.2016.09.024; Maynard JJ, 2016, LANDSCAPE ECOL, V31, P2045, DOI 10.1007/s10980-016-0381-y; MCAULIFFE JR, 1994, ECOL MONOGR, V64, P111, DOI 10.2307/2937038; MCKEE TB, 1993, P 8 C APPL CLIM AN C; Medeiros AS, 2012, ECOSCIENCE, V19, P148, DOI 10.2980/19-2-3485; Michaud GA, 2013, J ARID ENVIRON, V90, P45, DOI 10.1016/j.jaridenv.2012.10.001; Monger HC, 2006, J ARID ENVIRON, V65, P207, DOI 10.1016/j.jaridenv.2005.08.012; Mulder VL, 2011, GEODERMA, V162, P1, DOI 10.1016/j.geoderma.2010.12.018; Nauman TW, 2016, SOIL SCI SOC AM J, P3; PARKER KC, 1991, J BIOGEOGR, V18, P151, DOI 10.2307/2845289; Peters DPC, 2006, BIOSCIENCE, V56, P491, DOI 10.1641/0006-3568(2006)56[491:DCLNII]2.0.CO;2; Peters DPC, 2004, P NATL ACAD SCI USA, V101, P15130, DOI 10.1073/pnas.0403822101; Pontius RG, 2011, INT J REMOTE SENS, V32, P4407, DOI 10.1080/01431161.2011.552923; Purevdorj T, 1998, INT J REMOTE SENS, V19, P3519, DOI 10.1080/014311698213795; R Core Team, 2013, R LANG ENV STAT COMP; Reichmann LG, 2013, ECOLOGY, V94, P435, DOI 10.1890/12-1237.1; Sala OE, 2012, PHILOS T R SOC B, V367, P3135, DOI 10.1098/rstb.2011.0347; Sankey T.T., 2009, RANGELAND ASSESSMENT, P168; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; Scheffer M, 2003, TRENDS ECOL EVOL, V18, P648, DOI 10.1016/j.tree.2003.09.002; Shimwell D.W., 1971, DESCRIPTION CLASSIFI; Soil N, 2014, GRIDDED SOIL SURVEY; Stam C a., 2012, USING BIOPHYSICAL GE; Steele CM, 2012, RANGELAND ECOL MANAG, V65, P213, DOI 10.2111/REM-D-11-00047.1; SUTHERLAND JP, 1974, AM NAT, V108, P859, DOI 10.1086/282961; Tansley AG, 1935, ECOLOGY, V16, P284, DOI 10.2307/1930070; Twarakavi NKC, 2009, SOIL SCI SOC AM J, V73, P1443, DOI 10.2136/sssaj2008.0021; Twidwell D, 2013, ECOSPHERE, V4, DOI 10.1890/ES13-00124.1; Ustin S., 2009, REMOTE SENSING BASED, P1; Ustin SL, 2010, NEW PHYTOL, V186, P795, DOI 10.1111/j.1469-8137.2010.03284.x; Warrens MJ, 2015, INT J REMOTE SENS, V36, P1439, DOI 10.1080/01431161.2015.1011794; WHITTAKER RH, 1953, ECOL MONOGR, V23, P41, DOI 10.2307/1943519; Wu H, 2007, INT J CLIMATOL, V27, P65, DOI 10.1002/joc.1371; Wylie BK, 2002, REMOTE SENS ENVIRON, V79, P266, DOI 10.1016/S0034-4257(01)00278-4; Yang FH, 2006, IEEE T GEOSCI REMOTE, V44, P3452, DOI 10.1109/TGRS.2006.876297; Zha Y, 2003, REMOTE SENS ENVIRON, V87, P371, DOI 10.1016/j.rse.2003.05.001; Zhu Z, 2014, REMOTE SENS ENVIRON, V152, P217, DOI 10.1016/j.rse.2014.06.012	64	6	6	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2017	12	4							e0175201	10.1371/journal.pone.0175201	http://dx.doi.org/10.1371/journal.pone.0175201			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KD	28414731	gold, Green Published, Green Submitted			2022-12-27	WOS:000399874800016
J	Novotny, R; Slizova, D; Hlubocky, J; Krs, O; Spatenka, J; Burkert, J; Fiala, R; Mitas, P; Mericka, P; Spacek, M; Hlubocka, Z; Lindner, J				Novotny, Robert; Slizova, Dasa; Hlubocky, Jaroslav; Krs, Otakar; Spatenka, Jaroslav; Burkert, Jan; Fiala, Radovan; Mitas, Petr; Mericka, Pavel; Spacek, Miroslav; Hlubocka, Zuzana; Lindner, Jaroslav			Cryopreserved human aortic root allografts arterial wall: Structural changes occurring during thawing	PLOS ONE			English	Article							CLASS-I; REPLACEMENT; ENDOCARDITIS; INTEGRITY	Background The aim of our experimental work was to assess morphological changes of arterial wall that arise during different thawing protocols of a cryopreserved human aortic root allograft (CHARA) arterial wall. Methods The experiment was performed on CHARAs. Two thawing protocols were tested: 1, CHARAs were thawed at a room temperature at + 23 degrees C; 2, CHARAs were placed directly into a water bath at + 37 degrees C. Microscopic samples preparation After fixation, all samples were washed in distilled water for 5 min, and dehydrated in a graded ethanol series ( 70, 85, 95, and 100%) for 5 min at each level. The tissue samples were then immersed in 100% hexamethyldisilazane for 10 minutes and air dried in an exhaust hood at room temperature. Processed samples were mounted on stainless steel stubs, coated with gold. Results Thawing protocol 1: All 6 ( 100%) samples showed loss of the endothelium and damage to the subendothelial layers with randomly dispersed circular defects and micro-fractures without smooth muscle cells contractions in the tunica media. Thawing protocol 2: All 6 (100%) samples showed loss of endothelium from the luminal surface, longitudinal corrugations in the direction of blood flow caused by smooth muscle cells contractions in the tunica media with frequent fractures in the subendothelial layer Conclusion All the samples thawed at the room temperature showed smaller structural damage to the CHARA arterial wall with no smooth muscle cell contraction in tunica media when compared to the samples thawed in a water bath.	[Novotny, Robert; Hlubocky, Jaroslav; Mitas, Petr; Spacek, Miroslav; Lindner, Jaroslav] Charles Univ Prague, Gen Univ Hosp & 1st, Fac Med, Dept Cardiovasc Surg 2nd, Prague, Czech Republic; [Slizova, Dasa; Krs, Otakar] Charles Univ Prague, Fac Med, Dept Anat, Hradec Kralove, Czech Republic; [Spatenka, Jaroslav; Burkert, Jan] Univ Hosp Motol, Transplant Ctr, Dept Cardiac Surg, Prague, Czech Republic; [Fiala, Radovan] Charles Univ Prague, Fac Hosp Motol & Fac Med 2nd, Prague, Czech Republic; [Mericka, Pavel] Charles Univ Prague, Fac Med Hradec Kralove, Fac Hosp Hradec Kralove, Tissue Bank, Hradec Kralove, Czech Republic; [Hlubocka, Zuzana] Charles Univ Prague, Gen Univ Hosp & Fac Med Ist, Internal Dept Cardiol & Angiol 2nd, Prague, Czech Republic	Charles University Prague; General University Hospital Prague; Charles University Prague; University Hospital Hradec Kralove; Motol University Hospital; Charles University Prague; Charles University Prague; University Hospital Hradec Kralove; Charles University Prague; General University Hospital Prague	Novotny, R (corresponding author), Charles Univ Prague, Gen Univ Hosp & 1st, Fac Med, Dept Cardiovasc Surg 2nd, Prague, Czech Republic.	novotny_robert@hotmail.com	Špaček, MUDr./ABA-5193-2021; Hlubocká, Zuzana/N-6073-2017; Fiala, Radovan/C-2276-2019; Lindner, Jaroslav/I-4599-2017; Špaček, Miroslav/I-4534-2017; Hlubocky, Jaroslav/I-4517-2017; Novotny, Robert/J-7545-2017	Hlubocká, Zuzana/0000-0002-3578-2140; Fiala, Radovan/0000-0003-2926-5881; Lindner, Jaroslav/0000-0001-8432-4069; Špaček, Miroslav/0000-0001-8742-8330; Hlubocky, Jaroslav/0000-0003-4318-5490; Novotny, Robert/0000-0002-5876-2951; SPATENKA, Jaroslav/0000-0003-4307-6155				BREWIN E G, 1956, Guys Hosp Rep, V105, P328; Brockbank KGM, 2012, CELL TISSUE BANK, V13, P663, DOI 10.1007/s10561-011-9288-7; Buzzi M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112679; El-Hamamsy I, 2010, LANCET, V376, P524, DOI 10.1016/S0140-6736(10)60828-8; Gerson CJ, 2012, CRYOBIOLOGY, V64, P33, DOI 10.1016/j.cryobiol.2011.11.001; Huber AJT, 2012, CELLS TISSUES ORGANS, V196, P262, DOI 10.1159/000334544; Jashari R, 2013, CELL TISSUE BANK, V14, P589, DOI 10.1007/s10561-012-9359-4; Jassar AS, 2012, ANN THORAC SURG, V93, P480, DOI 10.1016/j.athoracsur.2011.09.074; Krs O., 2006, Cell and Tissue Banking, V7, P167, DOI 10.1007/s10561-004-1889-y; M'Bengue-Gaye A, 1999, Dakar Med, V44, P180; Manaa Jamel, 2003, Tunis Med, V81 Suppl 8, P645; Matia I, 2014, ANN TRANSPL, V19, P225, DOI 10.12659/AOT.889870; Merin G, 1973, Ann Thorac Surg, V16, P122; Moussa M, 2008, BIOTECHNOL BIOENG, V101, P1245, DOI 10.1002/bit.21981; Nakanishi T, 2015, TRANSPLANTATION, V99, P1598, DOI 10.1097/TP.0000000000000688; Pasquinelli G., 2007, Cell and Tissue Banking, V8, P195, DOI 10.1007/s10561-006-9025-9; Perrotta S, 2010, ANN THORAC SURG, V90, P1862, DOI 10.1016/j.athoracsur.2010.06.100; Preventza O, 2014, J THORAC CARDIOV SUR, V148, P989, DOI 10.1016/j.jtcvs.2014.06.025; Qin LF, 2013, JOVE-J VIS EXP, DOI 10.3791/50290; Rodriguez M, 2012, HISTOL HISTOPATHOL, V27, P873, DOI 10.14670/HH-27.873; ROSS DN, 1962, LANCET, V2, P487; Shahmansouri N, 2015, J BIOMECH, V48, P2205, DOI 10.1016/j.jbiomech.2015.03.033; Takkenberg JJM, 2003, ANN THORAC SURG, V75, P1482, DOI 10.1016/S0003-4975(02)04722-7; Verghese Susan, 2002, Indian Heart J, V54, P394; von Rossum A, 2015, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00684; Vrtik M, 2009, ANN THORAC SURG, V88, P1365, DOI 10.1016/j.athoracsur.2008.12.100; Weymann A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103588; Xu ZQ, 2015, IRAN J BASIC MED SCI, V18, P927	28	5	6	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2017	12	4							e0175007	10.1371/journal.pone.0175007	http://dx.doi.org/10.1371/journal.pone.0175007			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KD	28414740	Green Submitted, gold, Green Published			2022-12-27	WOS:000399874800013
J	Park, JY; Yoo, KD; Kim, YC; Kim, DK; Joo, KW; Kang, SW; Yang, CW; Kim, NH; Kim, YL; Lim, CS; Kim, YS; Lee, JP				Park, Jae Yoon; Yoo, Kyung Don; Kim, Yong Chul; Kim, Dong Ki; Joo, Kwon Wook; Kang, Shin-Wook; Yang, Chul Woo; Kim, Nam-Ho; Kim, Yong-Lim; Lim, Chun -Soo; Kim, Yon Su; Lee, Jung Pyo			Early dialysis initiation does not improve clinical outcomes in elderly end-stage renal disease patients: A multicenter prospective cohort study	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; QUALITY-OF-LIFE; SURVIVAL; HEALTH; START; COMORBIDITY; MORTALITY	Background The optimal timing for initiating dialysis in end-stage renal disease (ESRD) is controversial, especially in the elderly. Methods 665 patients >= 65 years old who began dialysis from August 2008 to February 2015 were prospectively enrolled in the Clinical Research Center for End-Stage Renal Disease cohort study. Participants were divided into 2 groups based on the median estimated glomerular filtration rate at the initiation of dialysis. Propensity score matching (PSM) was used to compare the overall survival rate, cardiovascular events, Kidney Disease Quality of Life Short Form 36 (KDQOL-36) results, Karnofsky performance scale values, Beck's depression inventory values, and subjective global assessments. Results The mean patient age was 72.0 years, and 61.7% of the patients were male. Overall, the cumulative survival rates were lower in the early initiation group, although the difference was not significant after PSM. Additionally, the survival rates of the 2 groups did not differ after adjusting for age, sex, Charlson comorbidity index and hemoglobin, serum albumin, serum calcium and phosphorus levels. Although the early initiation group showed a lower physical component summary score on the KDQOL-36 3 months after dialysis, the difference in scores was not significant 12 months after dialysis. Furthermore, the difference was not significant after PSM. The Karnofsky performance scale, Beck's depression inventory, and subjective global assessments were not significantly different 3 and 12 months after dialysis initiation. Conclusions The timing of dialysis initiation is not associated with clinical outcomes in elderly patients with ESRD.	[Park, Jae Yoon] Dongguk Univ, Ilsan Hosp, Dept Internal Med, Seoul, Gyeonggi Do, South Korea; [Yoo, Kyung Don] Dongguk Univ, Med Ctr, Dept Internal Med, Seoul, Gyeongsangbuk D, South Korea; [Kim, Yong Chul; Kim, Dong Ki; Joo, Kwon Wook; Kim, Yon Su] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Kang, Shin-Wook] Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Yang, Chul Woo] Catholic Univ Korea, Coll Med, Dept Internal Med, Seoul, South Korea; [Kim, Nam-Ho] Chonnam Natl Univ, Med Sch, Dept Internal Med, Gwangju, South Korea; [Kim, Yong-Lim] Kyungpook Natl Univ, Sch Med, Dept Internal Med, Daegu, South Korea; [Lim, Chun -Soo; Lee, Jung Pyo] Seoul Natl Univ, Boramae Med Ctr, Dept Internal Med, Seoul, South Korea	Dongguk University; NHIS Ilsan Hospital; Dongguk University; Seoul National University (SNU); Yonsei University; Yonsei University Health System; Catholic University of Korea; Chonnam National University; Kyungpook National University; Seoul National University (SNU); Seoul National University Hospital	Lee, JP (corresponding author), Seoul Natl Univ, Boramae Med Ctr, Dept Internal Med, Seoul, South Korea.	nephrolee@gmail.com	Yoo, Kyung Don/AAK-8096-2020; Kim, Yong Chul/L-8653-2019; Kim, Dong Ki/J-5389-2012	Yoo, Kyung Don/0000-0001-6545-6517; Kim, Dong Ki/0000-0002-5195-7852	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HC15C1129]	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea	This research was supported by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant number: HC15C1129).	Baek SH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128715; Bao YR, 2012, ARCH INTERN MED, V172, P1071, DOI 10.1001/archinternmed.2012.3020; Beddhu S, 2003, J AM SOC NEPHROL, V14, P2305, DOI 10.1097/01.ASN.0000080184.67406.11; Brookhart MA, 2006, AM J EPIDEMIOL, V163, P1149, DOI 10.1093/aje/kwj149; Carson RC, 2009, CLIN J AM SOC NEPHRO, V4, P1611, DOI 10.2215/CJN.00510109; Churchill DN, 1997, AM J KIDNEY DIS, V30, P899, DOI 10.1016/S0272-6386(97)90102-5; Cooper BA, 2003, PERITON DIALYSIS INT, V23, P291; Cooper BA, 2010, NEW ENGL J MED, V363, P609, DOI 10.1056/NEJMoa1000552; Coresh J, 2003, AM J KIDNEY DIS, V41, P1, DOI 10.1053/ajkd.2003.50007; Crews DC, 2014, J AM SOC NEPHROL, V25, P370, DOI 10.1681/ASN.2013050567; EPSTEIN M, 1979, FED PROC, V38, P168; Finkelstein FO, 2000, NEPHROL DIAL TRANSPL, V15, P1911, DOI 10.1093/ndt/15.12.1911; HAKIM RM, 1995, J AM SOC NEPHROL, V6, P1319; Hemodialysis Adequacy 2006, 2006, AM J KIDNEY DIS, V48, pS2, DOI [10.1053/j.ajkd.2006.03.051, DOI 10.1053/J.AJKD.2006.03.051]; Herzog CA, 2002, NEPHROL DIAL TRANSPL, V17, P7, DOI 10.1093/ndt/17.1.7; Jassal SV, 2007, CAN MED ASSOC J, V177, P1033, DOI 10.1503/cmaj.061765; Jin DC, 2016, KIDNEY RES CLIN PRAC, V35, P204, DOI 10.1016/j.krcp.2016.09.006; Kazmi WH, 2005, AM J KIDNEY DIS, V46, P887, DOI 10.1053/j.ajkd.2005.08.005; Kelly J, 2005, NEPHROLOGY, V10, pS46, DOI 10.1111/j.1440-1797.2005.00486_1.x; Kim DH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055323; Krishnan M, 2002, SEMIN DIALYSIS, V15, P79, DOI 10.1046/j.1525-139X.2002.00028.x; Kurella M, 2007, ANN INTERN MED, V146, P177, DOI 10.7326/0003-4819-146-3-200702060-00006; Lassalle M, 2010, KIDNEY INT, V77, P700, DOI 10.1038/ki.2010.14; Lee J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099460; Miskulin DC, 2014, AM J KIDNEY DIS, V63, P214, DOI 10.1053/j.ajkd.2013.08.017; Oh KH, 2014, BMC NEPHROL, V15, DOI 10.1186/1471-2369-15-80; Park HJ, 2007, TOHOKU J EXP MED, V211, P321, DOI 10.1620/tjem.211.321; Peritoneal Dialysis Adequacy Work Group, 2006, Am J Kidney Dis, V48 Suppl 1, pS98; Pupim LB, 2002, AM J KIDNEY DIS, V40, P143, DOI 10.1053/ajkd.2002.33923; Rosansky SJ, 2011, ARCH INTERN MED, V171, P396, DOI 10.1001/archinternmed.2010.415; Sawhney S, 2009, NEPHROL DIAL TRANSPL, V24, P3186, DOI 10.1093/ndt/gfp189; Somogyi-Zalud E, 2002, J AM GERIATR SOC, V50, P930, DOI 10.1046/j.1532-5415.2002.50222.x; Stevens LA, 2010, AM J KIDNEY DIS, V56, P486, DOI 10.1053/j.ajkd.2010.03.026; Traynor JP, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000025294.40179.E8; Wright S, 2010, CLIN J AM SOC NEPHRO, V5, P1828, DOI 10.2215/CJN.06230909	35	8	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2017	12	4							e0175830	10.1371/journal.pone.0175830	http://dx.doi.org/10.1371/journal.pone.0175830			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KD	28414758	gold, Green Published, Green Submitted			2022-12-27	WOS:000399874800063
J	Campo, C; Kohler, A; Figlioli, G; Elisei, R; Romei, C; Cipollini, M; Bambi, F; Hemminki, K; Gemignani, F; Landi, S; Forsti, A				Campo, Chiara; Koehler, Aleksandra; Figlioli, Gisella; Elisei, Rossella; Romei, Cristina; Cipollini, Monica; Bambi, Franco; Hemminki, Kari; Gemignani, Federica; Landi, Stefano; Foersti, Asta			Inherited variants in genes somatically mutated in thyroid cancer	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; GS-ALPHA MUTATIONS; ADENOMATOUS POLYPOSIS; THYROTROPIN RECEPTOR; COMMON VARIANTS; JAPANESE POPULATION; COLORECTAL-CANCER; GERMLINE MUTATION; TSH RECEPTOR; LIFE-STYLE	Background Tumour suppressor genes when mutated in the germline cause various cancers, but they can also be somatically mutated in sporadic tumours. We hypothesized that there may also be cancer-related germline variants in the genes commonly mutated in sporadic well-differentiated thyroid cancer (WDTC). Methods We performed a two-stage case-control association study with a total of 2214 cases and 2108 healthy controls from an Italian population. By genotyping 34 single nucleotide polymorphisms (SNPs), we covered a total of 59 missense SNPs and SNPs located in the 5' and 3' untranslated regions (UTRs) of 10 different genes. Results The Italian1 series showed a suggestive association for 8 SNPs, from which three were replicated in the Italian2 series. The meta-analysis revealed a study-wide significant association for rs459552 (OR: 0.84, 95% CI: 0.75-0.94) and rs1800900 (OR: 1.15, 95% CI: 1.05-1.27), located in the APC and GNAS genes, respectively. The APC rs459552 is a missense SNP, located in a conserved amino acid position, but without any functional consequences. The GNAS rs1800900 is located at a conserved 5'UTR and according to the experimental ENCODE data it may affect promoter and histone marks in different cell types. Conclusions The results of this study yield new insights on WDTC, showing that inherited variants in the APC and GNAS genes can play a role in the etiology of thyroid cancer. Further studies are necessary to better understand the role of the identified SNPs in the development of WDTC and to functionally validate our in silico predictions.	[Campo, Chiara; Koehler, Aleksandra; Figlioli, Gisella; Hemminki, Kari; Foersti, Asta] German Canc Res Ctr, Div Mol Genet Epidemiol, Heidelberg, Germany; [Campo, Chiara; Figlioli, Gisella; Cipollini, Monica; Gemignani, Federica; Landi, Stefano] Univ Pisa, Dept Biol, Pisa, Italy; [Elisei, Rossella; Romei, Cristina] Univ Pisa, Dept Endocrinol & Metab, Pisa, Italy; [Bambi, Franco] Azienda Osped Univ A Meyer, Blood Ctr, Florence, Italy; [Hemminki, Kari; Foersti, Asta] Lund Univ, Ctr Primary Hlth Care Res, Clin Res Ctr, Malmo, Sweden	Helmholtz Association; German Cancer Research Center (DKFZ); University of Pisa; University of Pisa; University of Florence; Azienda Ospedaliera Universitaria (AOU) MEYER; Lund University	Campo, C (corresponding author), German Canc Res Ctr, Div Mol Genet Epidemiol, Heidelberg, Germany.; Campo, C (corresponding author), Univ Pisa, Dept Biol, Pisa, Italy.	c.campo@dkfz.de		ELISEI, ROSSELLA/0000-0002-5333-9257; Bambi, Franco/0000-0002-1945-8324; GEMIGNANI, Federica/0000-0003-1297-0701; Figlioli, Gisella/0000-0002-0740-1363	Istituto Toscano Tumori	Istituto Toscano Tumori	We are grateful to the study participants and the study investigators and coordinators for work in recruitment of subjects. The study has received financial support from the; We are grateful to the study participants and the study investigators and coordinators for work in recruitment of subjects. The study has received financial support from the Istituto Toscano Tumori. All authors had full access to all the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.Istituto Toscano Tumori.	Agrawal N, 2014, CELL, V159, P676, DOI 10.1016/j.cell.2014.09.050; Cameselle-Teijeiro J, 2001, AM J CLIN PATHOL, V115, P486; Canzian F, 1998, AM J HUM GENET, V63, P1743, DOI 10.1086/302164; Damiola F, 2014, INT J CANCER, V134, P1659, DOI 10.1002/ijc.28483; Dilas Ljiljana Todorovic, 2012, Med Pregl, V65, P489; Dore LC, 2011, BLOOD, V118, P231, DOI 10.1182/blood-2011-04-285981; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Figlioli G, 2014, J CLIN ENDOCR METAB, V99, pE2084, DOI 10.1210/jc.2014-1734; Flanagan SE, 2010, GENET TEST MOL BIOMA, V14, P533, DOI 10.1089/gtmb.2010.0036; Garcia-Quispes WA, 2011, MUTAT RES-FUND MOL M, V709-10, P67, DOI 10.1016/j.mrfmmm.2011.03.003; Gozu HI, 2006, EUR J ENDOCRINOL, V155, P535, DOI 10.1530/eje.1.02253; Gudmundsson J, 2012, NAT GENET, V44, P319, DOI 10.1038/ng.1046; Gudmundsson J, 2009, NAT GENET, V41, P460, DOI 10.1038/ng.339; Guerreiro CS, 2007, AM J CLIN NUTR, V85, P1592, DOI 10.1093/ajcn/85.6.1592; Hemminki K, 2001, Fam Cancer, V1, P45, DOI 10.1023/A:1011530202868; Hu GQ, 2011, GENOME RES, V21, P1650, DOI 10.1101/gr.121145.111; Jones AM, 2012, J MED GENET, V49, P158, DOI 10.1136/jmedgenet-2011-100586; Kohler A, 2013, J CLIN ENDOCR METAB, V98, pE1674, DOI 10.1210/jc.2013-1941; Kosugi S, 2000, EUR J ENDOCRINOL, V143, P471, DOI 10.1530/eje.0.1430471; Kumamoto K, 2015, ONCOL LETT, V10, P2239, DOI 10.3892/ol.2015.3578; Landa I, 2011, J MOL ENDOCRINOL, V47, pR43, DOI 10.1530/JME-11-0005; Li H, 2010, GENETICA, V138, P915, DOI 10.1007/s10709-010-9480-x; Liyanarachchi S, 2013, THYROID, V23, P1532, DOI 10.1089/thy.2013.0102; LYONS J, 1990, SCIENCE, V249, P655, DOI 10.1126/science.2116665; Martayan A, 2010, J ENDOCRINOL INVEST, V33, P603, DOI 10.1007/BF03346656; Matsuse M, 2011, J MED GENET, V48, P645, DOI 10.1136/jmedgenet-2011-100063; Meinhold CL, 2010, AM J EPIDEMIOL, V171, P242, DOI 10.1093/aje/kwp354; Miyake N, 2001, PATHOL INT, V51, P680, DOI 10.1046/j.1440-1827.2001.01269.x; Morris LGT, 2013, THYROID, V23, P886, DOI 10.1089/thy.2013.0045; Niazi Asfandyar Khan, 2011, Indian J Endocrinol Metab, V15, P91, DOI 10.4103/2230-8210.81936; Nishihara E, 2009, ENDOCR J, V56, P791, DOI 10.1507/endocrj.K09E-073; PARMA J, 1993, NATURE, V365, P649, DOI 10.1038/365649a0; Paschke R, 2015, DTSCH ARZTEBL INT, V112, P452, DOI 10.3238/arztebl.2015.0452; Pellegriti G, 2013, J CANCER EPIDEMIOL, V2013, DOI 10.1155/2013/965212; Pereda CM, 2015, BMC GENET, V16, DOI 10.1186/s12863-015-0180-5; Slattery ML, 2001, CANCER RES, V61, P1000; Sturgis EM, 2009, THYROID, V19, P1031, DOI 10.1089/thy.2009.1597; Takahashi M, 2010, HUM MOL GENET, V19, P2516, DOI 10.1093/hmg/ddq123; Theodoratou E, 2008, CARCINOGENESIS, V29, P1774, DOI 10.1093/carcin/bgn082; Vanvooren V, 2002, EUR J ENDOCRINOL, V147, P287, DOI 10.1530/eje.0.1470287; Wang YL, 2013, J MED GENET, V50, P689, DOI 10.1136/jmedgenet-2013-101687; Ward LD, 2012, NUCLEIC ACIDS RES, V40, pD930, DOI 10.1093/nar/gkr917; Weinstein LS, 2001, ENDOCR REV, V22, P675, DOI 10.1210/er.22.5.675; ZEKI K, 1994, J CLIN ENDOCR METAB, V79, P1317, DOI 10.1210/jc.79.5.1317	44	4	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2017	12	4							e0174995	10.1371/journal.pone.0174995	http://dx.doi.org/10.1371/journal.pone.0174995			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0MD	28410400	Green Published, gold, Green Submitted			2022-12-27	WOS:000399955600010
J	den Harder, AM; Sucha, D; van Doormaal, PJ; Budde, RPJ; de Jong, PA; Schilham, AMR; Breur, JMPJ; Leiner, T				den Harder, Annemarie M.; Sucha, Dominika; van Doormaal, Pieter J.; Budde, Ricardo P. J.; de Jong, Pim A.; Schilham, Arnold M. R.; Breur, Johannes M. P. J.; Leiner, Tim			Radiation dose reduction in pediatric great vessel stent computed tomography using iterative reconstruction: A phantom study	PLOS ONE			English	Article							CONGENITAL HEART-DISEASE; HIGH-RESOLUTION KERNEL; CT ANGIOGRAPHY; CHILDREN; CANCER; HYBRID	Background To study dose reduction using iterative reconstruction (IR) for pediatric great vessel stent computed tomography (CT). Methods Five different great vessel stents were separately placed in a gel-containing plastic holder within an anthropomorphic chest phantom. The stent lumen was filled with diluted contrast gel. CT acquisitions were performed at routine dose, 52% and 81% reduced dose and reconstructed with filtered back projection (FBP) and IR. Objective image quality in terms of noise, signal-to-noise ratio (SNR) and contrast-to-noise ratio (CNR) as well as subjective image quality were evaluated. Results Noise, SNR and CNR were improved with IR at routine and 52% reduced dose, compared to FBP at routine dose. The lowest dose level resulted in decreased objective image quality with both FBP and IR. Subjective image quality was excellent at all dose levels. Conclusion IR resulted in improved objective image quality at routine dose and 52% reduced dose, while objective image quality deteriorated at 81% reduced dose. Subjective image quality was not affected by dose reduction.	[den Harder, Annemarie M.; Sucha, Dominika; van Doormaal, Pieter J.; de Jong, Pim A.; Schilham, Arnold M. R.; Leiner, Tim] Univ Utrecht, Med Ctr, Dept Radiol, Utrecht, Netherlands; [Budde, Ricardo P. J.] Erasmus MC, Dept Radiol, Rotterdam, Netherlands; [Breur, Johannes M. P. J.] Univ Utrecht, Med Ctr, Dept Pediat Cardiol, Utrecht, Netherlands	Utrecht University; Erasmus University Rotterdam; Erasmus MC; Utrecht University	den Harder, AM (corresponding author), Univ Utrecht, Med Ctr, Dept Radiol, Utrecht, Netherlands.	a.m.denharder@umcutrecht.nl	Harder, Annemarie M. den/J-3266-2019; Budde, Ricardo/E-4252-2015; breur, hans/AAY-2340-2020	Harder, Annemarie M. den/0000-0002-9679-396X; 				Almutairi A, 2015, INT J MOL SCI, V16, P11531, DOI 10.3390/ijms160511531; Baumgartner H, 2010, EUR HEART J, V31, P2915, DOI 10.1093/eurheartj/ehq249; Brenner DJ, 2001, AM J ROENTGENOL, V176, P289, DOI 10.2214/ajr.176.2.1760289; Cho YJ, 2014, J THORAC IMAG, V29, P198, DOI 10.1097/RTI.0000000000000041; den Harder AM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171138; den Harder AM, 2016, CLIN RADIOL, V71, P758, DOI 10.1016/j.crad.2016.01.022; Den Harder AM, 2015, BRIT J RADIOL; den Harder AM, 2015, AM J ROENTGENOL, V204, P645, DOI 10.2214/AJR.14.12590; Donnelly LF, 2005, AM J ROENTGENOL, V184, P655, DOI 10.2214/ajr.184.2.01840655; Ebersberger U, 2013, EUR RADIOL, V23, P125, DOI 10.1007/s00330-012-2580-5; Eichhorn JG, 2008, CATHETER CARDIO INTE, V72, P544, DOI 10.1002/ccd.21680; Erbel Raimund, 2014, Kardiol Pol, V72, P1169, DOI 10.5603/KP.2014.0225; Funama Y, 2012, ACAD RADIOL, V19, P1324, DOI 10.1016/j.acra.2012.06.013; Geryes Habib B, 2015, EUR RADIOL; Habets J, 2012, INT J CARDIOVAS IMAG, V28, P1567, DOI 10.1007/s10554-011-9954-7; Holzer R, 2010, CATHETER CARDIO INTE, V76, P553, DOI 10.1002/ccd.22587; Mangold S, 2015, EUR RADIOL; Miglioretti DL, 2013, JAMA PEDIATR, V167, P700, DOI 10.1001/jamapediatrics.2013.311; Oda S, 2013, EUR J RADIOL, V82, P288, DOI 10.1016/j.ejrad.2012.11.003; Quality Assurance in Radiology and Medicine (QRM) GmbH, 2008, ANTHR CARD PHANT; Slovis TL, 2003, PEDIATRICS, V112, P971, DOI 10.1542/peds.112.4.971; Sucha D, 2014, INT J CARDIOVASC IMA; Sucha D, 2014, INT J CARDIOVAS IMAG, V30, P785, DOI 10.1007/s10554-014-0379-y; Taylor AM, 2008, PEDIATR RADIOL, V38, pS433, DOI 10.1007/s00247-008-0843-8; Warnes CA, 2008, CIRCULATION, V118, P2395, DOI [10.1161/CIRCULATIONAHA.108.190811, 10.1016/j.jacc.2008.10.001]; Willemink MJ, 2013, EUR RADIOL, V23, P1623, DOI 10.1007/s00330-012-2765-y; Wuest W, 2013, J CARDIOVASC COMPUT, V7, P319, DOI 10.1016/j.jcct.2013.08.012	27	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2017	12	4							e0175714	10.1371/journal.pone.0175714	http://dx.doi.org/10.1371/journal.pone.0175714			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0MD	28410386	Green Submitted, Green Published, gold			2022-12-27	WOS:000399955600038
J	Muller, B; Ilg, W; Giese, MA; Ludolph, N				Mueller, Bjoern; Ilg, Winfried; Giese, Martin A.; Ludolph, Nicolas			Validation of enhanced kinect sensor based motion capturing for gait assessment	PLOS ONE			English	Article							XBOX ONE KINECT; MICROSOFT KINECT; CONCURRENT VALIDITY; PARKINSONS-DISEASE; RELIABILITY; BALANCE; ACCURACY; PEOPLE; ATAXIA	Optical motion capturing systems are expensive and require substantial dedicated space to be set up. On the other hand, they provide unsurpassed accuracy and reliability. In many situations however flexibility is required and the motion capturing system can only temporarily be placed. The Microsoft Kinect v2 sensor is comparatively cheap and with respect to gait analysis promising results have been published. We here present a motion capturing system that is easy to set up, flexible with respect to the sensor locations and delivers high accuracy in gait parameters comparable to a gold standard motion capturing system (VICON). Further, we demonstrate that sensor setups which track the person only from one-side are less accurate and should be replaced by two-sided setups. With respect to commonly analyzed gait parameters, especially step width, our system shows higher agreement with the VICON system than previous reports.	[Mueller, Bjoern; Ilg, Winfried; Giese, Martin A.; Ludolph, Nicolas] Univ Tubingen, Hertie Inst Clin Brain Res, Sect Computat Sensomotor, Dept Cognit Neurol, Tubingen, Baden Wuerttemb, Germany; [Mueller, Bjoern; Ilg, Winfried; Giese, Martin A.; Ludolph, Nicolas] Univ Tubingen, Ctr Integrat Neurosci, Tubingen, Baden Wuerttemb, Germany; [Ludolph, Nicolas] Int Max Planck Res Sch Cognit & Syst Neurosci, Tubingen, Baden Wuerttemb, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen	Ludolph, N (corresponding author), Univ Tubingen, Hertie Inst Clin Brain Res, Sect Computat Sensomotor, Dept Cognit Neurol, Tubingen, Baden Wuerttemb, Germany.; Ludolph, N (corresponding author), Univ Tubingen, Ctr Integrat Neurosci, Tubingen, Baden Wuerttemb, Germany.; Ludolph, N (corresponding author), Int Max Planck Res Sch Cognit & Syst Neurosci, Tubingen, Baden Wuerttemb, Germany.	nicolas.ludolph@uni-tuebingen.de		Ilg, Winfried/0000-0002-1537-1336	German National Academic Foundation; European Union Seventh Framework Programme (Koroibot FP7) [611909, DFG GI 305/4-1, DFG GZ: KA 1258/15-1, CoglMon H2020 ICT-644727]; Human Frontiers Science Program [RGP0036/2016]	German National Academic Foundation; European Union Seventh Framework Programme (Koroibot FP7); Human Frontiers Science Program(Human Frontier Science Program)	NL would like to thank the German National Academic Foundation for granting a doctoral student fellowship. Financial support for this study has been received from the European Union Seventh Framework Programme (Koroibot FP7-611909, DFG GI 305/4-1, DFG GZ: KA 1258/15-1, CoglMon H2020 ICT-644727) and the Human Frontiers Science Program (RGP0036/2016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Butler Alex D, 2012, P SIGCHI C HUM FACT, P1933, DOI [DOI 10.1145/2208276.2208335, 10.1145/2208276.2208335.]; Castagna A, 2016, MOVEMENT DISORD, V31, P1720, DOI 10.1002/mds.26672; Cicchetti D.V., 1994, PSYCHOL ASSESS, V6, P284, DOI [10.1037/1040-3590.6.4.284, DOI 10.1037/1040-3590.6.4.284]; Clark RA, 2015, GAIT POSTURE, V42, P210, DOI 10.1016/j.gaitpost.2015.03.005; Clark RA, 2015, J NEUROENG REHABIL, V12, DOI 10.1186/s12984-015-0006-8; Clark RA, 2013, J BIOMECH, V46, P2722, DOI 10.1016/j.jbiomech.2013.08.011; Dryden IL, 1998, STAT SHAPE ANAL, DOI DOI 10.5555/1046920.1088707; Galna B, 2014, GAIT POSTURE, V39, P1062, DOI 10.1016/j.gaitpost.2014.01.008; Geerse DJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139913; Hudson CC, 2000, EXP BRAIN RES, V132, P103, DOI 10.1007/s002219900291; Huo ZY, 2015, IEEE ENG MED BIO, P7059, DOI 10.1109/EMBC.2015.7320018; Ilg W, 2008, BRAIN, V131, P2913, DOI 10.1093/brain/awn246; Ilg W, 2007, BRAIN, V130, P786, DOI 10.1093/brain/awl376; Ilg W, 2016, MOVEMENT DISORD, V31, P1891, DOI 10.1002/mds.26835; Ilg W, 2012, NEUROLOGY, V79, P2056, DOI 10.1212/WNL.0b013e3182749e67; Kaenchan S, 2013, 2013 INTERNATIONAL COMPUTER SCIENCE AND ENGINEERING CONFERENCE (ICSEC), P245, DOI 10.1109/ICSEC.2013.6694787; Kowalski M, 2015, 2015 INTERNATIONAL CONFERENCE ON 3D VISION, P318, DOI 10.1109/3DV.2015.43; Lim D, 2015, CLIN INTERV AGING, V10, P1077, DOI 10.2147/CIA.S85299; Mastorakis G, 2014, J REAL-TIME IMAGE PR, V9, P635, DOI 10.1007/s11554-012-0246-9; Mentiplay BF, 2015, J BIOMECH, V48, P2166, DOI 10.1016/j.jbiomech.2015.05.021; Microsoft Corporation, KIN HARDW; Morris M, 2005, MOVEMENT DISORD, V20, P40, DOI 10.1002/mds.20278; Mortimer M, 2016, 11 SYSTEM SYSTEMS EN, P1; Mousavi Hondori Hossein, 2014, J Med Eng, V2014, P846514, DOI 10.1155/2014/846514; Oliver M, 2016, FRONT INFORM TECH EL, V17, P348, DOI 10.1631/FITEE.1500347; Springer S, 2016, SENSORS-BASEL, V16, DOI 10.3390/s16020194; Staranowicz AN, 2015, IEEE ENG MED BIO, P4994, DOI 10.1109/EMBC.2015.7319513; Stolze H, 2002, J NEUROL NEUROSUR PS, V73, P310, DOI 10.1136/jnnp.73.3.310; Stone EE, 2015, IEEE J BIOMED HEALTH, V19, P290, DOI 10.1109/JBHI.2014.2312180; Stone EE, 2011, IEEE ENG MED BIO, P6491, DOI 10.1109/IEMBS.2011.6091602; Svehlik M, 2009, ARCH PHYS MED REHAB, V90, P1880, DOI 10.1016/j.apmr.2009.06.017; Wang QF, 2015, 2015 IEEE INTERNATIONAL CONFERENCE ON HEALTHCARE INFORMATICS (ICHI 2015), P380, DOI 10.1109/ICHI.2015.54; Winter D, 2005, BIOMECHANICS MOTOR C; Yang L, 2015, IEEE SENS J, V15, P4275, DOI 10.1109/JSEN.2015.2416651; Zhu Y, 2016, PROCEEDINGS VRCAI 2016: 15TH ACM SIGGRAPH CONFERENCE ON VIRTUAL-REALITY CONTINUUM AND ITS APPLICATIONS IN INDUSTRY, P13, DOI 10.1145/3013971.3013979	37	71	72	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2017	12	4							e0175813	10.1371/journal.pone.0175813	http://dx.doi.org/10.1371/journal.pone.0175813			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0MD	28410413	Green Submitted, gold, Green Published			2022-12-27	WOS:000399955600044
J	Sneha, P; Kumar, DT; Doss, CGP; Siva, R; Zayed, H				Sneha, P.; Kumar, Thirumal D.; Doss, George Priya C.; Siva, R.; Zayed, Hatem			Determining the role of missense mutations in the POU domain of HNF1A that reduce the DNA-binding affinity: A computational approach	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; TRANSCRIPTION FACTOR; PROTEIN STABILITY; SALT BRIDGES; WEB SERVER; BETA-CELL; GENE; PREDICTION; SEQUENCE; ARGININE	Maturity-onset diabetes of the young type 3 (MODY3) is a non-ketotic form of diabetes associated with poor insulin secretion. Over the past years, several studies have reported the association of missense mutations in the Hepatocyte Nuclear Factor 1 Alpha (HNF1A) with MODY3. Missense mutations in the POU homeodomain (POUH) of HNF1A hinder binding to the DNA, thereby leading to a dysfunctional protein. Missense mutations of the HNF1A were retrieved from public databases and subjected to a three-step computational mutational analysis to identify the underlying mechanism. First, the pathogenicity and stability of the mutations were analyzed to determine whether they alter protein structure and function. Second, the sequence conservation and DNA-binding sites of the mutant positions were assessed; as HNF1A protein is a transcription factor. Finally, the biochemical properties of the biological system were validated using molecular dynamic simulations in Gromacs 4.6.3 package. Two arginine residues (131 and 203) in the HNF1A protein are highly conserved residues and contribute to the function of the protein. Furthermore, the R131W, R131Q, and R203C mutations were predicted to be highly deleterious by in silico tools and showed lower binding affinity with DNA when compared to the native protein using the molecular docking analysis. Triplicate runs of molecular dynamic (MD) simulations (50ns) revealed smaller changes in patterns of deviation, fluctuation, and compactness, in complexes containing the R131Q and R131W mutations, compared to complexes containing the R203C mutant complex. We observed reduction in the number of intermolecular hydrogen bonds, compactness, and electrostatic potential, as well as the loss of salt bridges, in the R203C mutant complex. Substitution of arginine with cysteine at position 203 decreases the affinity of the protein for DNA, thereby destabilizing the protein. Based on our current findings, the MD approach is an important tool for elucidating the impact and affinity of mutations in DNA- protein interactions and understanding their function.	[Sneha, P.; Kumar, Thirumal D.; Doss, George Priya C.; Siva, R.] Vellore Inst Technol, Sch BioSci & Technol, Vellore, Tamil Nadu, India; [Zayed, Hatem] Qatar Univ, Dept Biomed Sci, Coll Hlth Sci, Doha, Qatar	Vellore Institute of Technology; Qatar University	Doss, CGP (corresponding author), Vellore Inst Technol, Sch BioSci & Technol, Vellore, Tamil Nadu, India.; Zayed, H (corresponding author), Qatar Univ, Dept Biomed Sci, Coll Hlth Sci, Doha, Qatar.	georgepriyadoss@vit.ac.in; hatem.zayed@qu.edu.qa	Alizadeh/AAK-1398-2021; Ramamoorthy FLS, FRSB, FRSC, Prof. Siva/D-7133-2019; C, George/ABE-4676-2021; Zayed, Hatem/R-1800-2019; Kumar, Thirumal/G-2276-2017	Ramamoorthy FLS, FRSB, FRSC, Prof. Siva/0000-0001-7509-8602; Zayed, Hatem/0000-0001-8838-6638; Kumar, Thirumal/0000-0002-5545-606X; C, George Priya Doss/0000-0002-5971-8290	Qatar University grant [QUUG-CAS-DHS-14/15-3]	Qatar University grant(Qatar National Research Fund (QNRF))	This research work was funded by Qatar University grant, QUUG-CAS-DHS-14/15-3., Dr. Hatem Zayed.	Acharya V, 2012, HUM MUTAT, V33, P332, DOI 10.1002/humu.21642; Adzhubei Ivan, 2013, Curr Protoc Hum Genet, VChapter 7, DOI 10.1002/0471142905.hg0720s76; Ali S.K., 2016, J BIOMOL STRUCT DYN, P1; Andreou AM, 2007, AM J HUM GENET, V81, P700, DOI 10.1086/521033; Asamitsu K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119451; Ashcroft FM, 2012, CELL, V148, P1160, DOI 10.1016/j.cell.2012.02.010; Bayer TS, 2005, RNA, V11, P1848, DOI 10.1261/rna.2167605; Bellanne-Chantelot C, DIABETES, V57, P503; Benz RW, 2005, BIOPHYS J, V88, P805, DOI 10.1529/biophysj.104.046821; Bjorkhaug L, 2003, J CLIN ENDOCR METAB, V88, P920, DOI 10.1210/jc.2002-020945; Bjorkhaug L, 2005, DNA CELL BIOL, V24, P661, DOI 10.1089/dna.2005.24.661; Bloom JD, 2004, BIOPHYS J, V86, P2758, DOI 10.1016/S0006-3495(04)74329-5; BRENOWITZ M, 1986, METHOD ENZYMOL, V130, P132; Capriotti E, 2006, BIOINFORMATICS, V22, P2729, DOI 10.1093/bioinformatics/btl423; Capriotti E, 2005, NUCLEIC ACIDS RES, V33, pW306, DOI 10.1093/nar/gki375; Capriotti E, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-S3-S6; Cheng JL, 2006, PROTEINS, V62, P1125, DOI 10.1002/prot.20810; Chi YI, 2005, HUM GENET, V116, P433, DOI 10.1007/s00439-004-1252-1; Chi YI, 2002, MOL CELL, V10, P1129, DOI 10.1016/S1097-2765(02)00704-9; Cleary MA, 1997, P NATL ACAD SCI USA, V94, P8450, DOI 10.1073/pnas.94.16.8450; Costantini S, 2008, BIOINFORMATION, V3, P137, DOI 10.6026/97320630003137; Divine JK, 2003, HNF ENDODERMAL TRANS, V285, P62; Doss CGP, 2017, SCI REP-UK, V7, DOI 10.1038/srep39370; Doss CGP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031677; Drewett V, 2001, NUCLEIC ACIDS RES, V29, P479, DOI 10.1093/nar/29.2.479; DTK P S, 2017, J CELL BIOCH; Ellard S, 2007, DIABETOLOGIA, V50, P2313, DOI 10.1007/s00125-007-0798-6; Frayling TM, 2001, DIABETES, V50, pS94, DOI 10.2337/diabetes.50.2007.S94; Furuzawa Gilberto K, 2008, Diabetes Res Clin Pract, V81, pe12, DOI 10.1016/j.diabres.2008.06.011; Gade P, 2012, METHODS MOL BIOL, V809, P85, DOI 10.1007/978-1-61779-376-9_6; Glaser F, 2003, BIOINFORMATICS, V19, P163, DOI 10.1093/bioinformatics/19.1.163; Glucksmann MA, 1997, DIABETES, V46, P1081, DOI 10.2337/diabetes.46.6.1081; Goodeve AC, 2015, J THROMB HAEMOST, V13, P1184, DOI 10.1111/jth.12958; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hao DC, 2011, PHARMACOL REP, V63, P924, DOI 10.1016/S1734-1140(11)70608-9; Harries LW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007855; Hellman LM, 2007, NAT PROTOC, V2, P1849, DOI 10.1038/nprot.2007.249; Hicks S, 2011, HUM MUTAT, V32, P661, DOI 10.1002/humu.21490; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Husby J, 2012, J CHEM INF MODEL, V52, P1179, DOI 10.1021/ci200625q; Jelesarov Ilian, 2009, V490, P227, DOI 10.1007/978-1-59745-367-7_10; Johnson AD, 2008, BIOINFORMATICS, V24, P2938, DOI 10.1093/bioinformatics/btn564; Jones S, 2003, NUCLEIC ACIDS RES, V31, P7189, DOI 10.1093/nar/gkg922; Jutras Brandon L, 2012, Curr Protoc Microbiol, VChapter 1, DOI 10.1002/9780471729259.mc01f01s24; Kaisaki PJ, 1997, DIABETES, V46, P528, DOI 10.2337/diabetes.46.3.528; Laskowski RA, 2001, NUCLEIC ACIDS RES, V29, P221, DOI 10.1093/nar/29.1.221; Lee B, 1997, NAT GENET, V16, P307, DOI 10.1038/ng0797-307; Lehto M, 1999, DIABETOLOGIA, V42, P1131, DOI 10.1007/s001250051281; Luscombe NM, 2002, J MOL BIOL, V320, P991, DOI 10.1016/S0022-2836(02)00571-5; Luscombe NM, 2001, NUCLEIC ACIDS RES, V29, P2860, DOI 10.1093/nar/29.13.2860; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 2008, CURR OPIN STRUC BIOL, V18, P194, DOI 10.1016/j.sbi.2007.12.012; McNicholas S, 2011, ACTA CRYSTALLOGR D, V67, P386, DOI 10.1107/S0907444911007281; MENDEL DB, 1991, J BIOL CHEM, V266, P677; Morozov AV, 2005, NUCLEIC ACIDS RES, V33, P5781, DOI 10.1093/nar/gki875; Niroula A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117380; Odom DT, 2004, SCIENCE, V303, P1378, DOI 10.1126/science.1089769; Padhi AK, 2013, SCI REP-UK, V3, DOI 10.1038/srep01225; Phillips K, 2000, J MOL BIOL, V302, P1023, DOI 10.1006/jmbi.2000.4107; Pires DEV, 2014, NUCLEIC ACIDS RES, V42, pW314, DOI 10.1093/nar/gku411; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Prosdocimi Francisco OMJ, 2007, BRAZ S BIOINFORM, P149; Pruhova S, 2003, DIABETOLOGIA, V46, P291, DOI 10.1007/s00125-002-1010-7; Raghavan S.C., 2010, J NUCL ACIDS, V2010, P2010, DOI DOI 10.1109/INFC0M.2010.5462024; Saleem RA, 2001, AM J HUM GENET, V68, P627, DOI 10.1086/318792; Servitja JM, 2009, MOL CELL BIOL, V29, P2945, DOI 10.1128/MCB.01389-08; SHAFER WM, 1995, MICROBIOL-UK, V141, P907, DOI 10.1099/13500872-141-4-907; Shepherd M, 2001, PRACT DIAB INT, V18, P16, DOI [DOI 10.1002/PDI.108, 10.1002/pdi.108]; Shihab HA, 2013, HUM MUTAT, V34, P57, DOI 10.1002/humu.22225; SHOICHET BK, 1995, P NATL ACAD SCI USA, V92, P452, DOI 10.1073/pnas.92.2.452; Sieber M, 1998, BIOL CHEM, V379, P731; Sim NL, 2012, NUCLEIC ACIDS RES, V40, pW452, DOI 10.1093/nar/gks539; Sneha P, 2016, LIFE SCI, V166, P108, DOI 10.1016/j.lfs.2016.10.009; Sneha P, 2016, ADV PROTEIN CHEM STR, V102, P181, DOI 10.1016/bs.apcsb.2015.09.004; Stenson PD, 2003, HUM MUTAT, V21, P577, DOI 10.1002/humu.10212; Strub Caroline, 2004, BMC Biochemistry, V5, P9, DOI 10.1186/1471-2091-5-9; Studer RA, 2013, BIOCHEM J, V449, P581, DOI 10.1042/BJ20121221; Sudhakar N, 2016, J BIOMOL STRUCT DYN, P1; Tavtigian SV, 2006, J MED GENET, V43, P295, DOI 10.1136/jmg.2005.033878; Thomas PD, 2003, NUCLEIC ACIDS RES, V31, P334, DOI 10.1093/nar/gkg115; TRONCHE F, 1992, BIOESSAYS, V14, P579, DOI 10.1002/bies.950140902; van Dijk M, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn386; Vangone A, 2011, BIOINFORMATICS, V27, P2915, DOI 10.1093/bioinformatics/btr484; Wang LJ, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-S1-S3; Willson JSB, 2013, J HEPATOL, V59, P904, DOI 10.1016/j.jhep.2013.05.024; Yun SJ, 2011, J MOL GRAPH MODEL, V29, P663, DOI 10.1016/j.jmgm.2010.12.002	86	33	33	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2017	12	4							e0174953	10.1371/journal.pone.0174953	http://dx.doi.org/10.1371/journal.pone.0174953			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0MD	28410371	Green Published, gold, Green Submitted			2022-12-27	WOS:000399955600009
J	Cuesta-Seijo, JA; Ruzanski, C; Krucewicz, K; Meier, S; Hagglund, P; Svensson, B; Palcic, MM				Cuesta-Seijo, Jose A.; Ruzanski, Christian; Krucewicz, Katarzyna; Meier, Sebastian; Hagglund, Per; Svensson, Birte; Palcic, Monica M.			Functional and structural characterization of plastidic starch phosphorylase during barley endosperm development	PLOS ONE			English	Article							ALPHA-GLUCAN PHOSPHORYLASE; PROTEIN-PROTEIN INTERACTIONS; SOLANUM-TUBEROSUM L.; GLYCOGEN-PHOSPHORYLASE; ARABIDOPSIS-THALIANA; EXOGENOUS ACCEPTOR; CATALYZED REACTION; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; POTATO	The production of starch is essential for human nutrition and represents a major metabolic flux in the biosphere. The biosynthesis of starch in storage organs like barley endosperm operates via two main pathways using different substrates: starch synthases use ADP-glucose to produce amylose and amylopectin, the two major components of starch, whereas starch phosphorylase (Pho1) uses glucose-1-phosphate (G1P), a precursor for ADP-glucose production, to produce alpha-1,4 glucans. The significance of the Pho1 pathway in starch biosynthesis has remained unclear. To elucidate the importance of barley Pho1 (HvPho1) for starch biosynthesis in barley endosperm, we analyzed HvPho1 protein production and enzyme activity levels throughout barley endosperm development and characterized structure-function relationships of HvPho1. The molecular mechanisms underlying the initiation of starch granule biosynthesis, that is, the enzymes and substrates involved in the initial transition from simple sugars to polysaccharides, remain unclear. We found that HvPho1 is present as an active protein at the onset of barley endosperm development. Notably, purified recombinant protein can catalyze the de novo production of alpha-1,4-glucans using HvPho1 from G1P as the sole substrate. The structural properties of HvPho1 provide insights into the low affinity of HvPho1 for large polysaccharides like starch or amylopectin. Our results suggest that HvPho1 may play a role during the initiation of starch biosynthesis in barley.	[Cuesta-Seijo, Jose A.; Ruzanski, Christian; Krucewicz, Katarzyna; Meier, Sebastian; Palcic, Monica M.] Carlsberg Res Lab, JC Jacobsens Gade 4, DK-1799 Copenhagen V, Denmark; [Ruzanski, Christian] Novo Nordisk AS, Malov, Denmark; [Meier, Sebastian] Tech Univ Denmark, Dept Chem, DTU, Bldg 207, DK-2800 Lyngby, Denmark; [Hagglund, Per] Tech Univ Denmark, DTU Dept Biotechnol & Biomed, Prote Core, Bldg 301, DK-2800 Lyngby, Denmark; [Svensson, Birte] Tech Univ Denmark, Enzyme & Prot Chem, DTU Dept Biotechnol & Biomed, Elektrovej Bldg 375, DK-2800 Lyngby, Denmark; [Palcic, Monica M.] Univ Victoria, Dept Biochem & Microbiol, Victoria, BC, Canada	Novo Nordisk; Technical University of Denmark; Technical University of Denmark; Technical University of Denmark; University of Victoria	Cuesta-Seijo, JA; Ruzanski, C (corresponding author), Carlsberg Res Lab, JC Jacobsens Gade 4, DK-1799 Copenhagen V, Denmark.; Ruzanski, C (corresponding author), Novo Nordisk AS, Malov, Denmark.	josea.cuesta.seijo@carlsberg.com; cirz@novonordisk.com	Meier, Sebastian/A-4279-2015; Hägglund, Per/X-4881-2019	Meier, Sebastian/0000-0003-3761-3217; Svensson, Birte/0000-0002-2993-8196; Hagglund, Per/0000-0002-6627-7518; Cuesta-Seijo, Jose Antonio/0000-0002-3755-9305	Carlsberg Foundation; DANSCATT; John Innes Center; MALDI-TOF; Villum Fonden [00007303] Funding Source: researchfish	Carlsberg Foundation(Carlsberg Foundation); DANSCATT; John Innes Center(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MALDI-TOF; Villum Fonden(Villum Fonden)	This study was supported by Carlsberg Foundation, www.carlsbergfondet.dk/en, and DANSCATT, www.danscatt.dk. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. In particular Novo NordiskA/S had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.; We thank the Carlsberg Foundation for funding this research. Furthermore we thank Dr. Lyann Sim for assistance with the CrISA1 enzyme and Dr. Alexander Striebeck for the help in constructing multiple sequence alignments. Moreover we thank Prof Martin Steup for valuable suggestions and fruitful discussions regarding the manuscript preparation. We are very grateful to Dr. Gerhard Saalbach and the Proteomics Facility at the John Innes Center for support and technical help with MALDI-TOF. Access to synchrotron beam time at ESRF was made possible by support from DANSCATT and is greatly appreciated. 800 MHz NMR spectra were recorded on the spectrometer of the National Instrument Center for NMR Spectroscopy of Biological Macromolecules at the Carlsberg Research Center.	Albrecht T, 1998, EUR J BIOCHEM, V251, P343, DOI 10.1046/j.1432-1327.1998.2510343.x; Almagro G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115516; [Anonymous], 2011, MOLECULAR SYSTEMS BI, V7, P542; Beeren SR, 2013, CHEMBIOCHEM, V14, P2506, DOI 10.1002/cbic.201300461; BERNFELD P, 1948, NATURE, V162, P618, DOI 10.1038/162618b0; Bojstrup M, 2013, ANAL CHEM, V85, P8802, DOI 10.1021/ac401980m; BRISSON N, 1989, PLANT CELL, V1, P559, DOI 10.1105/tpc.1.5.559; Brust H., 2013, Journal of Applied Glycoscience, V60, P3, DOI 10.5458/jag.jag.JAG-2012_018; Cuesta-Seijo JA, 2016, FRONT PLANT SCI, P6; Dauvillee D, 2006, PLANT J, V48, P274, DOI 10.1111/j.1365-313X.2006.02870.x; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fettke J, 2004, PLANT J, V39, P933, DOI 10.1111/j.1365-313X.2004.02181.x; Fettke J, 2012, J EXP BOT, V63, P3011, DOI 10.1093/jxb/ers014; Glaring MA, 2012, PLANT PHYSIOL BIOCH, V58, P89, DOI 10.1016/j.plaphy.2012.06.017; Green DE, 1942, J BIOL CHEM, V142, P355; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; Hagglund P, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00151; Hanes CS, 1940, PROC R SOC SER B-BIO, V129, P174, DOI 10.1098/rspb.1940.0035; Higgins JE, 2013, J SCI FOOD AGR, V93, P2137, DOI 10.1002/jsfa.6019; Hwang SK, 2016, PLANTA, V243, P999, DOI 10.1007/s00425-015-2461-7; Hwang SK, 2010, ARCH BIOCHEM BIOPHYS, V495, P82, DOI 10.1016/j.abb.2009.12.023; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kirkensgaard KG, 2014, PROTEINS, V82, P607, DOI 10.1002/prot.24437; Lin YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035336; Malinova I, 2014, PLANT PHYSIOL, V164, P907, DOI 10.1104/pp.113.227843; MORI H, 1993, J BIOL CHEM, V268, P5574; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nakamura Y, 2012, PLANT CELL PHYSIOL, V53, P869, DOI 10.1093/pcp/pcs030; NAKANO K, 1986, J BIOL CHEM, V261, P8230; O'Neill EC, 2014, CHEM SCI, V5, P341, DOI 10.1039/c3sc51829a; Onda K, 2008, BIOORGAN MED CHEM, V16, P5452, DOI 10.1016/j.bmc.2008.04.010; Park JT, 2011, J BACTERIOL, V193, P2517, DOI 10.1128/JB.01238-10; Pfister B, 2016, CELLULAR MOL LIFE SC, P1; Pinotsis N, 2003, PROTEIN SCI, V12, P1914, DOI 10.1110/ps.03149503; Radchuk VV, 2009, PLANT PHYSIOL, V150, P190, DOI 10.1104/pp.108.133520; Rathore RS, 2009, CRIT REV BIOTECHNOL, V29, P214, DOI 10.1080/07388550902926063; ROBYT JF, 1994, CARBOHYD RES, V251, P187, DOI 10.1016/0008-6215(94)84285-X; Rodriguez-Lopez M, 2000, P NATL ACAD SCI USA, V97, P8705, DOI 10.1073/pnas.120168097; Ruzanski C, 2013, J BIOL CHEM, V288, P28581, DOI 10.1074/jbc.M113.497867; Satoh H, 2008, PLANT CELL, V20, P1833, DOI 10.1105/tpc.107.054007; Seung D, 2013, J BIOL CHEM, V288, P33620, DOI 10.1074/jbc.M113.514794; Sim L, 2014, J BIOL CHEM, V289, P22991, DOI 10.1074/jbc.M114.565044; SIVAK MN, 1981, ARCH BIOCHEM BIOPHYS, V212, P537, DOI 10.1016/0003-9861(81)90397-0; SIVAK MN, 1981, ARCH BIOCHEM BIOPHYS, V212, P525, DOI 10.1016/0003-9861(81)90396-9; Skryhan K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136997; Sokolov LN, 2006, P NATL ACAD SCI USA, V103, P9732, DOI 10.1073/pnas.0603329103; Sonnewald U, 2013, PLANT BIOTECHNOL J, V11, P223, DOI 10.1111/pbi.12029; SPRANG SR, 1988, NATURE, V336, P215, DOI 10.1038/336215a0; Subasinghe RM, 2014, PLANT PHYSIOL BIOCH, V83, P168, DOI 10.1016/j.plaphy.2014.07.016; Szydlowski N, 2009, PLANT CELL, V21, P2443, DOI 10.1105/tpc.109.066522; Tetlow IJ, 2004, PLANT CELL, V16, P694, DOI 10.1105/tpc.017400; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185; Waduge RN, 2012, MORPHOLOGY AND MOLEC; Watson KA, 1999, EMBO J, V18, P4619, DOI 10.1093/emboj/18.17.4619; Watson KA, 1997, EMBO J, V16, P1, DOI 10.1093/emboj/16.1.1; Weinhausel A, 1997, BIOCHEM J, V326, P773, DOI 10.1042/bj3260773; You C, 2013, P NATL ACAD SCI USA, V110, P7182, DOI 10.1073/pnas.1302420110; Young GH, 2006, PLANTA, V223, P468, DOI 10.1007/s00425-005-0103-1; Yu Y, 2001, PLANT PHYSIOL, V125, P351, DOI 10.1104/pp.125.1.351; Zeeman SC, 2004, PLANT PHYSIOL, V135, P849, DOI 10.1104/pp.103.032631	61	25	26	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2017	12	4							e0175488	10.1371/journal.pone.0175488	http://dx.doi.org/10.1371/journal.pone.0175488			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0MB	28407006	Green Published, Green Submitted, gold			2022-12-27	WOS:000399955400061
J	Ferrando, ML; Willemse, N; Zaccaria, E; Pannekoek, Y; van der Ende, A; Schultsz, C				Ferrando, Maria Laura; Willemse, Niels; Zaccaria, Edoardo; Pannekoek, Yvonne; van der Ende, Arie; Schultsz, Constance			Streptococcal Adhesin P (SadP) contributes to Streptococcus suis adhesion to the human intestinal epithelium	PLOS ONE			English	Article							BINDING-PROTEIN; VIRULENCE; PATHOGEN; TOXIN; IDENTIFICATION; SEROTYPE-2; DIVERSITY; ALGORITHM; CELLS; ACID	Background Streptococcus suis is a zoonotic pathogen, causing meningitis and septicemia. We previously demonstrated that the gastrointestinal tract (GIT) is an entry site for zoonotic S. suis infection. Here we studied the contribution of (S) under bar treptococcal (a) under bar(d) under bar hesin (P) under bar rotein (SadP) to host-pathogen interaction at GIT level. Methods SadP expression in presence of Intestinal Epithelial Cells (IEC) was compared with expression of other virulence factors by measuring transcript levels using quantitative Real Time PCR (qRT-PCR). SadP variants were identified by phylogenetic analysis of complete DNA sequences. The interaction of SadP knockout and complementation mutants with IEC was tested in vitro. Results Expression of sadP was significantly increased in presence of IEC. Sequence analysis of 116 invasive strains revealed five SadP sequence variants, correlating with genotype. SadP1, present in zoonotic isolates of clonal complex 1, contributed to binding to both human and porcine IEC and translocation across human IEC. Antibodies against the globotriaosylceramide Gb3/CD77 receptor significantly inhibited adhesion to human IEC. Conclusion SadP is involved in the host-pathogen interaction in the GIT. Differences between SadP variants may determine different affinities to the Gb3/CD77 host-receptor, contributing to variation in adhesion capacity to host IEC and thus to S. suis zoonotic potential.	[Ferrando, Maria Laura; Willemse, Niels; Pannekoek, Yvonne; van der Ende, Arie; Schultsz, Constance] Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, Ctr Infect & Immun, Amsterdam, Netherlands; [Ferrando, Maria Laura; Willemse, Niels; Schultsz, Constance] Univ Amsterdam, Acad Med Ctr, Amsterdam Inst Global Hlth & Dev, Dept Global Hlth, Amsterdam, Netherlands; [Zaccaria, Edoardo] Wageningen Univ, Host Microbe Interact, Anim Sci, Wageningen, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Wageningen University & Research	Ferrando, ML (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, Ctr Infect & Immun, Amsterdam, Netherlands.; Ferrando, ML (corresponding author), Univ Amsterdam, Acad Med Ctr, Amsterdam Inst Global Hlth & Dev, Dept Global Hlth, Amsterdam, Netherlands.	m.l.ferrando@amc.uva.nl	Ferrando, Maria Laura/M-3026-2018; Zaccaria, Edoardo/AAP-9740-2020	Ferrando, Maria Laura/0000-0002-1398-8244; Pannekoek, Yvonne/0000-0003-1154-652X; van der Ende, Arie/0000-0003-1298-3086	EU-FP7 program ANTIGONE [FP7-278976]	EU-FP7 program ANTIGONE	This study was supported by the EU-FP7 program ANTIGONE (Project No. FP7-278976). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Benga L, 2004, CELL MICROBIOL, V6, P867, DOI 10.1111/j.1462-5822.2004.00409.x; Bergmann S, 2006, MICROBIOL-SGM, V152, P295, DOI 10.1099/mic.0.28610-0; Bonifait L, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-47; Brosnahan AJ, 2012, VET MICROBIOL, V156, P229, DOI 10.1016/j.vetmic.2011.10.017; Chen B, 2010, FEMS MICROBIOL LETT, V307, P12, DOI 10.1111/j.1574-6968.2010.01944.x; Cooling L, 2015, CLIN MICROBIOL REV, V28, P801, DOI 10.1128/CMR.00109-14; de Greeff A, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-161; Devenica D, 2011, MED ONCOL, V28, pS675, DOI 10.1007/s12032-010-9732-8; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Esgleas M, 2008, MICROBIOL-SGM, V154, P2668, DOI 10.1099/mic.0.2008/017145-0; Ferrando ML, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089334; Ferrando ML, 2010, MICROBIOL-SGM, V156, P2818, DOI 10.1099/mic.0.037960-0; Ferrando ML, 2016, GUT MICROBES; Ferrando ML, 2014, J INFECT DIS; Fontaine MC, 2004, INFECT IMMUN, V72, P774, DOI 10.1128/IAI.72.2.774-781.2004; Ge JC, 2009, CURR MICROBIOL, V59, P248, DOI 10.1007/s00284-009-9425-8; Goyette-Desjardins G, 2014, EMERG MICROBES INFEC, V3, DOI 10.1038/emi.2014.45; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Karve SS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101173; Kerdsin A, 2015, J MICROBIOLOGY IMMUN; KIARASH A, 1994, J BIOL CHEM, V269, P11138; Kouki A, 2011, J BIOL CHEM, V286, P38854, DOI 10.1074/jbc.M111.260992; Ling H, 2000, STRUCTURE, V8, P253, DOI 10.1016/S0969-2126(00)00103-9; Martin M., 2011, EMBNET J, V17, P10, DOI 10.14806/ej.17.1.200; Moal VLL, 2013, MICROBIOL MOL BIOL R, V77, P380, DOI 10.1128/MMBR.00064-12; Muthing J, 2009, THROMB HAEMOSTASIS, V101, P252, DOI 10.1160/TH08-05-0317; Nghia H. D., 2011, PLOS ONE, V6, DOI DOI 10.1371/J0URNAL.P0NE.0017604; Okura M, 2011, J BACTERIOL, V193, P822, DOI 10.1128/JB.01555-09; Pian YY, 2012, INFECT IMMUN, V80, P2402, DOI 10.1128/IAI.06294-11; Roy D, 2016, PATHOGENS, V5, DOI 10.3390/pathogens5030047; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Schultsz C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033854; Seitz M, 2013, VET MICROBIOL, V167, P584, DOI 10.1016/j.vetmic.2013.09.010; Sharma CM, 2010, NATURE, V464, P250, DOI 10.1038/nature08756; Smith HE, 1999, INFECT IMMUN, V67, P1750; Sueoka H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144958; Sung CK, 2001, APPL ENVIRON MICROB, V67, P5190, DOI 10.1128/AEM.67.11.5190-5196.2001; Takeuchi D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031265; Vriesema AJM, 2000, APPL ENVIRON MICROB, V66, P535, DOI 10.1128/AEM.66.2.535-542.2000; Waddell TE, 1996, INFECT IMMUN, V64, P1714, DOI 10.1128/IAI.64.5.1714-1719.1996; Wang YC, 2013, INFECT IMMUN, V81, P4498, DOI 10.1128/IAI.00818-13; Weinert LA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7740; Wertheim HFL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005973; Wertheim HFL, 2009, CLIN INFECT DIS, V48, P617, DOI 10.1086/596763; Willemse N, 2016, SCI REP-UK, V6, DOI 10.1038/srep28984; Willenborg J, 2011, MICROBIOL-SGM, V157, P1823, DOI 10.1099/mic.0.046417-0; Winter KRK, 2004, INFECT IMMUN, V72, P6680, DOI 10.1128/IAI.72.11.6680-6684.2004; Yuan ZZ, 2013, J BIOL CHEM, V288, P956, DOI 10.1074/jbc.M112.388686; Zaccaria E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099394; Zhang CM, 2016, FEBS LETT, V590, P1384, DOI 10.1002/1873-3468.12174; Zhang CM, 2015, BIOCHEM BIOPH RES CO, V466, P413, DOI 10.1016/j.bbrc.2015.09.040; Zumbrun SD, 2010, INFECT IMMUN, V78, P4488, DOI 10.1128/IAI.00620-10	54	19	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2017	12	4							e0175639	10.1371/journal.pone.0175639	http://dx.doi.org/10.1371/journal.pone.0175639			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0MB	28407026	Green Submitted, Green Published, gold			2022-12-27	WOS:000399955400075
J	Marciano, H; Yeshurun, Y				Marciano, Hadas; Yeshurun, Yaffa			Large inter-individual and intra-individual variability in the effect of perceptual load	PLOS ONE			English	Article							INDIVIDUAL-DIFFERENCES; SELECTIVE ATTENTION; SPATIAL ATTENTION; VISUAL-ATTENTION; WORKING-MEMORY; TOP-DOWN; CAPACITY; DILUTION; COLOR; ANXIETY	This study examined whether the recurrent difficulty to replicate results obtained with paradigms measuring distractor processing as a function of perceptual load is due to individual differences. We first reanalyzed, at the individual level, the data of eight previously reported experiments. These reanalyses revealed substantial inter-individual differences, with particularly low percentage of participants whose performance matched the load theory's predictions (i.e., larger distractor interference with low than high levels of load). Moreover, frequently the results were opposite to the theory's predictions-larger interference in the high than low load condition; and often a reversed compatibility effect emerged-better performance in the incompatible than neutral condition. Subsequently, seven observers participated in five identical experimental sessions. If the observed inter-individual differences are due to some stable trait or perceptual capacity, similar results should have emerged in all sessions of a given participant. However, all seven participants showed large between-sessions variations with similar patterns to those found between participants. These findings question the theoretical foundation implemented with these paradigms, as none of the theories suggested thus far can account for such inter-and intra-individual differences. Thus, these paradigms should be used with caution until further research will provide better understanding of what they actually measure.	[Marciano, Hadas; Yeshurun, Yaffa] Univ Haifa, Inst Informat Proc & Decis Making, Haifa, Israel; [Yeshurun, Yaffa] Univ Haifa, Dept Psychol, Haifa, Israel	University of Haifa; University of Haifa	Marciano, H (corresponding author), Univ Haifa, Inst Informat Proc & Decis Making, Haifa, Israel.	hmarcia1@univ.haifa.ac.il	Marciano, Hadas/GLN-7540-2022; Yeshurun, Yaffa/AAC-9164-2021	Marciano, Hadas/0000-0002-6225-9873; Yeshurun, Yaffa/0000-0003-0513-9290	Ran Naor Foundation Grant [9228]; Israel National Road Safety Authority doctoral fellowship	Ran Naor Foundation Grant; Israel National Road Safety Authority doctoral fellowship	This study was supported by The Ran Naor Foundation Grant (no. 9228) to Y. Y. [http://www.rannaorf.org.il], and by The Israel National Road Safety Authority doctoral fellowship to H. M. [http://www.rsa.gov.il/Pages/default.aspx]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayliss AP, 2011, J AUTISM DEV DISORD, V41, P1573, DOI 10.1007/s10803-010-1159-8; Bender AD, 2016, ATTEN PERCEPT PSYCHO, P1; Benoni H, 2012, PSYCHON B REV, V19, P631, DOI 10.3758/s13423-012-0244-8; Biggs AT, 2010, ATTEN PERCEPT PSYCHO, V72, P53, DOI 10.3758/APP.72.1.53; Chen Z, 2003, PERCEPT PSYCHOPHYS, V65, P888, DOI 10.3758/BF03194822; Chen Z, 2014, VISION RES, V101, P125, DOI 10.1016/j.visres.2014.06.006; [陈宗平 Chen Zongping], 2013, [混凝土, Concrete], P10; Csatho A, 2012, J COGN PSYCHOL, V24, P511, DOI 10.1080/20445911.2012.658039; de Fockert JW, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00287; Eltiti S, 2005, PERCEPT PSYCHOPHYS, V67, P876, DOI 10.3758/BF03193540; ERIKSEN BA, 1974, PERCEPT PSYCHOPHYS, V16, P143, DOI 10.3758/BF03203267; Fitousi D, 2011, J EXP PSYCHOL HUMAN, V37, P781, DOI 10.1037/a0020675; Forster S, 2007, PSYCHOL SCI, V18, P377, DOI 10.1111/j.1467-9280.2007.01908.x; Gaspelin N, 2014, J EXP PSYCHOL HUMAN, V40, P1257, DOI 10.1037/a0036179; Green CS, 2006, J EXP PSYCHOL HUMAN, V32, P1465, DOI 10.1037/0096-1523.32.6.1465; Huang LQ, 2012, J EXP PSYCHOL HUMAN, V38, P414, DOI 10.1037/a0026314; Huang-Pollock CL, 2002, DEV PSYCHOL, V38, P363, DOI 10.1037//0012-1649.38.3.363; Johnson DW, 2000, METHODS, V1, P1, DOI DOI 10.1111/1467-9280.00452; LAVIE N, 1995, J EXP PSYCHOL HUMAN, V21, P451, DOI 10.1037/0096-1523.21.3.451; Lavie N, 1997, PSYCHOL SCI, V8, P395, DOI 10.1111/j.1467-9280.1997.tb00432.x; Marciano H, 2011, VIS COGN, V19, P367, DOI 10.1080/13506285.2010.537711; Mayfrank L, 1985, EYE MOVEMENTS PHYSL, P37; Maylor EA, 1998, PSYCHOL AGING, V13, P563, DOI 10.1037/0882-7974.13.4.563; Moriya J, 2010, COGNITION EMOTION, V24, P1329, DOI 10.1080/02699930903378503; Murphy G, 2016, PSYCHON B REV, V23, P1316, DOI 10.3758/s13423-015-0982-5; Sadeh N, 2011, COGNITION EMOTION, V25, P747, DOI 10.1080/02699931.2010.500566; Sato H, 2012, Q J EXP PSYCHOL, V65, P617, DOI 10.1080/17470218.2011.648944; Sewell DK, 2012, J EXP PSYCHOL HUMAN, V38, P1043, DOI 10.1037/a0026591; Shipstead Z, 2012, Q J EXP PSYCHOL, V65, P401, DOI 10.1080/17470218.2012.655698; Theeuwes J, 2004, PSYCHON B REV, V11, P697, DOI 10.3758/BF03196622; THEEUWES J, 1992, PERCEPT PSYCHOPHYS, V51, P599, DOI 10.3758/BF03211656; Tsal Y, 2010, J EXP PSYCHOL HUMAN, V36, P1645, DOI 10.1037/a0018172; Yeshurun Y, 1999, VISION RES, V39, P293, DOI 10.1016/S0042-6989(98)00114-X; Yeshurun Y, 2004, VISION RES, V44, P1375, DOI 10.1016/j.visres.2003.12.016; Yeshurun Y, 2013, FRONT PSYCHOL, V4, P1; Yeshurun Y, 2012, VISION RES, V74, P21, DOI 10.1016/j.visres.2012.06.006	36	8	8	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2017	12	4							e0175060	10.1371/journal.pone.0175060	http://dx.doi.org/10.1371/journal.pone.0175060			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET0MB	28406997	gold, Green Submitted, Green Published			2022-12-27	WOS:000399955400029
J	Michikawa, T; Suzuki, H; Moriguchi, M; Ogihara, N; Kondo, O; Kobayashi, Y				Michikawa, Takashi; Suzuki, Hiromasa; Moriguchi, Masaki; Ogihara, Naomichi; Kondo, Osamu; Kobayashi, Yasushi			Automatic extraction of endocranial surfaces from CT images of crania	PLOS ONE			English	Article							RECONSTRUCTION; ALGORITHM; EVOLUTION	The authors present a method for extracting polygon data of endocranial surfaces from CT images of human crania. Based on the fact that the endocast is the largest empty space in the crania, we automate a procedure for endocast extraction by integrating several image processing techniques. Given CT images of human crania, the proposed method extracts endocranial surfaces by the following three steps. The first step is binarization in order to fill void structures, such as diploic space and cracks in the skull. We use a void detection method based on mathematical morphology. The second step is watershed-based segmentation of the endocranial part from the binary image of the CT image. Here, we introduce an automatic initial seed assignment method for the endocranial region using the distance field of the binary image. The final step is partial polygonization of the CT images using the segmentation results as mask images. The resulting polygons represent only the endocranial part, and the closed manifold surfaces are computed even though the endocast is not isolated in the cranium. Since only the isovalue threshold and the size of void structures are required, the procedure is not dependent on the experience of the user. The present paper also demonstrates that the proposed method can extract polygon data of endocasts from CT images of various crania.	[Michikawa, Takashi] Osaka Univ, Ctr Environm Innovat Design Sustainabil, Suita, Osaka, Japan; [Suzuki, Hiromasa] Univ Tokyo, Dept Precis Engn, Bunkyo Ku, Tokyo, Japan; [Moriguchi, Masaki] Chuo Univ, Dept Informat & Syst Engn, Bunkyo Ku, Tokyo, Japan; [Ogihara, Naomichi] Keio Univ, Dept Mech Engn, Yokohama, Kanagawa, Japan; [Kondo, Osamu] Univ Tokyo, Dept Biol Sci, Bunkyo Ku, Tokyo, Japan; [Kobayashi, Yasushi] Natl Def Med Coll, Dept Anat, Tokorozawa, Saitama, Japan	Osaka University; University of Tokyo; Chuo University; Keio University; University of Tokyo; National Defense Medical College - Japan	Michikawa, T (corresponding author), Osaka Univ, Ctr Environm Innovat Design Sustainabil, Suita, Osaka, Japan.	michikawa@acm.org	KONDO, OSAMU/G-4933-2014; Ogihara, Naomichi/P-3092-2019; Kobayashi, Yasushi/CAG-9157-2022	Ogihara, Naomichi/0000-0002-1697-9263; Kobayashi, Yasushi/0000-0001-5072-5040; Michikawa, Takashi/0000-0002-0606-668X	Japanese Ministry of Education, Culture, Sports, Science and Technology [22101006]; Grants-in-Aid for Scientific Research [17H06381] Funding Source: KAKEN	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by a Grant-in-Aid for Scientific Research on Innovative Areas "Replacement of Neanderthals by Modern Humans: Testing Evolutionary Models of Learning" from the Japanese Ministry of Education, Culture, Sports, Science and Technology (Grant No. 22101006, Grant URL: https://kaken.nii.ac.jp/en/grant/KAKENHI-PLANNED-22101006/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano H, 2015, AM J PHYS ANTHROPOL, V158, P185, DOI 10.1002/ajpa.22777; Boykov Y, 2004, IEEE T PATTERN ANAL, V26, P1124, DOI 10.1109/TPAMI.2004.60; Bradski G., 2013, LEARNING OPENCV COMP, V2nd; Bruner E, 2004, J HUM EVOL, V47, P279, DOI 10.1016/j.jhevol.2004.03.009; Cherman JL, 1977, P S QUANT AN MICR MA, P374; Falk D, 2012, PROG BRAIN RES, V195, P255, DOI 10.1016/B978-0-444-53860-4.00012-X; Garland M., 1997, Computer Graphics Proceedings, SIGGRAPH 97, P209, DOI 10.1145/258734.258849; Guennebaud G., 2010, EIGEN V3; Gunz P, 2005, DEV PRIMATOL-PROG PR, P73, DOI 10.1007/0-387-27614-9_3; Holloway R. L., 2004, HUMAN FOSSIL RECORD, V3; Holloway RL, 2008, ANNU REV ANTHROPOL, V37, P1, DOI 10.1146/annurev.anthro.37.081407.085211; KALVIN AD, 1995, IEEE COMPUT GRAPH, V15, P12, DOI 10.1109/38.364954; KASS M, 1987, INT J COMPUT VISION, V1, P321, DOI 10.1007/BF00133570; Kobayashi Y., 2014, DYNAMICS LEARNING NE, P131, DOI DOI 10.1007/978-4-431-54553-8_; Liu X, 2010, P 2010 AS C DES DIG, P797; Lorensen William E., 1987, P ACM SIGGRAPH, P163, DOI [10.1145/37401.37422, DOI 10.1145/37401.37422]; Maurer CR, 2003, IEEE T PATTERN ANAL, V25, P265, DOI 10.1109/TPAMI.2003.1177156; Michikawa T, 2013, TOM MAT STRUCT, P175; Michikawa T, 2013, 2013 FIRST INTERNATIONAL SYMPOSIUM ON COMPUTING AND NETWORKING (CANDAR), P312, DOI 10.1109/CANDAR.2013.55; Morita Y, 2015, ANTHROPOL SCI, V123, P185, DOI 10.1537/ase.151008; Ogihara N, 2015, ANTHROPOL SCI, V123, P57, DOI 10.1537/ase.141109; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Sethian JA, 1999, LEVEL SET METHODS AN; Suwa G, 2009, SCIENCE, V326, DOI 10.1126/science.1175825; VINCENT L, 1991, IEEE T PATTERN ANAL, V13, P583, DOI 10.1109/34.87344; Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015; Zollikofer C.P.E., 2005, VIRTUAL RECONSTRUCTI; Zollikofer CPE, 2013, EVOL ANTHROPOL, V22, P20, DOI 10.1002/evan.21333; Zollikofer CPE, 2005, NATURE, V434, P755, DOI 10.1038/nature03397; ZOLLIKOFER CPE, 1995, NATURE, V375, P283, DOI 10.1038/375283b0	30	9	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2017	12	4							e0168516	10.1371/journal.pone.0168516	http://dx.doi.org/10.1371/journal.pone.0168516			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET0MB	28406901	gold, Green Submitted, Green Published			2022-12-27	WOS:000399955400002
J	Song, C; Luo, BL; Gong, L				Song, Chao; Luo, Bailing; Gong, Li			Resveratrol reduces the apoptosis induced by cigarette smoke extract by upregulating MFN2	PLOS ONE			English	Article							BRONCHIAL EPITHELIAL-CELLS; MITOCHONDRIAL FRAGMENTATION; MITOFUSIN 2; EXPOSURE; DYSFUNCTION; RESPONSES; FISSION; DISEASE; STRESS	Purpose The aim of this study was to investigate the effect of resveratrol (RSV) on cigarette smoke extract (CSE)-induced cell apoptosis and mitochondrial dysfunction in vitro, as well as changes in the MFN2 expression level. Methods Cultured human bronchial epithelial (HBE) cells were initially treated with CSE to induce apoptosis, followed by incubation either with or without RSV. Numerous techniques were used to evaluate the outcomes of the present study, including a cell counting kit-8 assay, real-time quantitative polymerase chain reaction (real-time qPCR), western blotting, JC-1 fluorescence, Hoechst 33342 staining, Annexin V-PI flow cytometry apoptosis analyses, and siRNA technology. Results A 24 h incubation in 3.5% CSE induced apoptosis in HBE cells, and pretreatment of HBE cells with RSV (20 mu M) significantly suppressed the CSE-induced apoptosis, prevented the CSE-induced decrease in MFN2 levels, suppressed BAX translocation to the mitochondria, and prevented mitochondrial membrane potential loss and cytochrome C release. However, following the transfection of MFN2 siRNA, the anti-apoptotic effects of RSV were significantly attenuated. Conclusion The results of the present study demonstrated that RSV may protect bronchial epithelial cells from CS-induced apoptosis in vitro by preventing mitochondrial dysfunction, and MFN2 may be associated with the anti-apoptotic functions of RSV in HBE cells.	[Song, Chao; Luo, Bailing; Gong, Li] Cent S Univ, Xiangya Hosp, Resp Dept, Changsha, Hunan, Peoples R China	Central South University	Luo, BL (corresponding author), Cent S Univ, Xiangya Hosp, Resp Dept, Changsha, Hunan, Peoples R China.	blluo181@163.com						Aravamudan B, 2014, AM J PHYSIOL-LUNG C, V306, pL840, DOI 10.1152/ajplung.00155.2013; Bazzini C, 2013, CELL PHYSIOL BIOCHEM, V32, P129, DOI 10.1159/000356633; Biel TG, 2016, CELL DEATH DIFFER, V23, P279, DOI 10.1038/cdd.2015.96; Bossy-Wetzel E, 2003, CURR OPIN CELL BIOL, V15, P706, DOI 10.1016/j.ceb.2003.10.015; Cartoni R, 2009, EXP NEUROL, V218, P268, DOI 10.1016/j.expneurol.2009.05.003; Chitra L, 2013, BRIT J PHARMACOL, V169, P1035, DOI 10.1111/bph.12179; Committee GE, GLOB STRAT DIAGN MAN; Dolinsky VW, 2013, AM J PHYSIOL-ENDOC M, V305, pE243, DOI 10.1152/ajpendo.00044.2013; Friedman JR, 2011, SCIENCE, V334, P358, DOI 10.1126/science.1207385; Hara H, 2013, AM J PHYSIOL-LUNG C, V305, pL737, DOI 10.1152/ajplung.00146.2013; Hodge S, 2005, EUR RESPIR J, V25, P447, DOI 10.1183/09031936.05.00077604; Hoffmann RF, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-97; Li Yuping, 2014, Zhonghua Jie He He Hu Xi Za Zhi, V37, P30; Ly JD, 2003, APOPTOSIS, V8, P115, DOI 10.1023/A:1022945107762; Ni HM, 2015, REDOX BIOL, V4, P6, DOI 10.1016/j.redox.2014.11.006; Pace E, 2008, IMMUNOLOGY, V124, P401, DOI 10.1111/j.1365-2567.2007.02788.x; Pang W, 2013, PLACENTA, V34, P613, DOI 10.1016/j.placenta.2013.03.013; Price NL, 2012, CELL METAB, V15, P675, DOI 10.1016/j.cmet.2012.04.003; Rowland AA, 2012, NAT REV MOL CELL BIO, V13, P607, DOI 10.1038/nrm3440; Schneeberger M, 2013, CELL, V155, P172, DOI 10.1016/j.cell.2013.09.003; Sekine S, 2015, BBA-GEN SUBJECTS, V1850, P274, DOI 10.1016/j.bbagen.2014.10.012; Song MS, 2015, CELL METAB, V21, P273, DOI 10.1016/j.cmet.2014.12.011; Tait SWG, 2010, NAT REV MOL CELL BIO, V11, P621, DOI 10.1038/nrm2952; Xuan LL, 2014, ACTA PHARMACOL SIN, V35, P779, DOI 10.1038/aps.2014.17; Yi CH, 2011, COLD SH Q B, V76, P375, DOI 10.1101/sqb.2011.76.010777; Zhang L, 2015, MOL MED REP, V11, P1752, DOI 10.3892/mmr.2014.2925; Zhao N, 2015, PLOS ONE, V10; Zhong N, 2007, AM J RESP CRIT CARE, V176, P753, DOI 10.1164/rccm.200612-1749OC	28	21	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2017	12	4							e0175009	10.1371/journal.pone.0175009	http://dx.doi.org/10.1371/journal.pone.0175009			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0MB	28406974	gold, Green Published, Green Submitted			2022-12-27	WOS:000399955400027
J	Tangsongcharoen, C; Jupatanakul, N; Promdonkoy, B; Dimopoulos, G; Boonserm, P				Tangsongcharoen, Chontida; Jupatanakul, Natapong; Promdonkoy, Boonhiang; Dimopoulos, George; Boonserm, Panadda			Molecular analysis of Culex quinquefasciatus larvae responses to Lysinibacillus sphaericus Bin toxin	PLOS ONE			English	Article							HELICOBACTER-PYLORI VACA; BACILLUS-SPHAERICUS; MITOCHONDRIAL CA2+; PIPIENS DIPTERA; GENE-EXPRESSION; MANDUCA-SEXTA; RECEPTOR; PROTEIN; THURINGIENSIS; RESISTANCE	Lysinibacillus sphaericus produces the mosquito larvicidal binary toxin consisting of BinA and BinB, which are both required for toxicity against Culex and Anopheles larvae. The molecular mechanisms behind Bin toxin-induced damage remain unexplored. We used whole-genome microarray-based transcriptome analysis to better understand how Culex larvae respond to Bin toxin treatment at the molecular level. Our analyses of Culex quinquefasciatus larvae transcriptome changes at 6, 12, and 18 h after Bin toxin treatment revealed a wide range of transcript signatures, including genes linked to the cytoskeleton, metabolism, immunity, and cellular stress, with a greater number of down-regulated genes than up-regulated genes. Bin toxin appears to mainly repress the expression of genes involved in metabolism, the mitochondrial electron transport chain, and the protein transporter of the outer/inner mitochondrial membrane. The induced genes encode proteins linked to mitochondrial-mediated apoptosis and cellular detoxification including autophagic processes and lysosomal compartments. This study is, to our knowledge, the first microarray analysis of Bin toxin-induced transcriptional responses in Culex larvae, providing a basis for an in-depth understanding of the molecular nature of Bin toxin-induced damage.	[Tangsongcharoen, Chontida; Boonserm, Panadda] Mahidol Univ, Inst Mol Biosci, Phuttamonthon, Nakhon Pathom, Thailand; [Jupatanakul, Natapong; Dimopoulos, George] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, W Harry Feinstone Dept Mol Microbiol & Immunol, Baltimore, MD 21218 USA; [Promdonkoy, Boonhiang] Natl Sci & Technol Dev Agcy, Genet Engn & Biotechnol, Khlong Luang, Pathum Thani, Thailand	Mahidol University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC)	Boonserm, P (corresponding author), Mahidol Univ, Inst Mol Biosci, Phuttamonthon, Nakhon Pathom, Thailand.; Dimopoulos, G (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, W Harry Feinstone Dept Mol Microbiol & Immunol, Baltimore, MD 21218 USA.	gdimopo1@jhu.edu; panadda.boo@mahidol.ac.th	Jupatanakul, Natapong/GPF-9058-2022; Promdonkoy, Boonhiang/E-5617-2010	Jupatanakul, Natapong/0000-0003-2326-4255; Promdonkoy, Boonhiang/0000-0002-0584-5016	Royal Golden Jubilee Ph.D. Program, Thailand; Thailand Research Fund [BRG5980016, IRG5780009]; Royal Thai Government Scholarship; National Institutes of Health, National Institute of Allergy and Infectious Diseases [R01A1101431]	Royal Golden Jubilee Ph.D. Program, Thailand(Thailand Research Fund (TRF)); Thailand Research Fund(Thailand Research Fund (TRF)); Royal Thai Government Scholarship; National Institutes of Health, National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Royal Golden Jubilee Ph.D. Program, Thailand (to CT) and the Thailand Research Fund (BRG5980016 and IRG5780009 to PB), and a Royal Thai Government Scholarship (to NJ), and a grant from the National Institutes of Health, National Institute of Allergy and Infectious Diseases R01A1101431. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Hamad S, 2006, P NATL ACAD SCI USA, V103, P5787, DOI 10.1073/pnas.0600103103; Arensburger P, 2010, SCIENCE, V330, P86, DOI 10.1126/science.1191864; Bel Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081927; BERRY C, 1993, J BACTERIOL, V175, P510, DOI 10.1128/JB.175.2.510-518.1993; Beyenbach KW, 2006, J EXP BIOL, V209, P577, DOI 10.1242/jeb.02014; BLOW DM, 1969, NATURE, V221, P337, DOI 10.1038/221337a0; Boonserm P, 2006, BIOCHEM BIOPH RES CO, V342, P1273, DOI 10.1016/j.bbrc.2006.02.086; BROADWELL AH, 1990, J BACTERIOL, V172, P2217, DOI 10.1128/jb.172.5.2217-2223.1990; Buchon N, 2009, CELL HOST MICROBE, V5, P200, DOI 10.1016/j.chom.2009.01.003; Charles JF, 1996, ANNU REV ENTOMOL, V41, P451, DOI 10.1146/annurev.en.41.010196.002315; COVER TL, 1993, INFECT IMMUN, V61, P1427, DOI 10.1128/IAI.61.4.1427-1431.1993; Cover TL, 2005, NAT REV MICROBIOL, V3, P320, DOI 10.1038/nrmicro1095; Darboux I, 2001, INSECT BIOCHEM MOLEC, V31, P981, DOI 10.1016/S0965-1748(01)00046-7; de Melo JV, 2008, MICRON, V39, P1342, DOI 10.1016/j.micron.2008.02.002; Eum JH, 2007, DEV COMP IMMUNOL, V31, P1107, DOI 10.1016/j.dci.2007.02.002; Fivaz M, 2002, EMBO J, V21, P3989, DOI 10.1093/emboj/cdf398; Fontanesi F, 2008, IUBMB LIFE, V60, P557, DOI 10.1002/iub.86; Foskett JK, 2007, PHYSIOL REV, V87, P593, DOI 10.1152/physrev.00035.2006; Ghosh D., 2012, STAT APPL GENET MOL, V11; Giorgi C, 2012, CELL CALCIUM, V52, P36, DOI 10.1016/j.ceca.2012.02.008; Graves AR, 2008, NATURE, V453, P788, DOI 10.1038/nature06907; GRUNDER S, 1992, NATURE, V360, P759, DOI 10.1038/360759a0; Haller M, 2014, AUTOPHAGY, V10, P2269, DOI 10.4161/15548627.2014.981914; Harris KP, 2010, TRAFFIC, V11, P1272, DOI 10.1111/j.1600-0854.2010.01102.x; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Huang LL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008098; Iijima M, 2009, ANTICANCER RES, V29, P977; Jentsch TJ, 2007, J PHYSIOL-LONDON, V578, P633, DOI 10.1113/jphysiol.2006.124719; Kania E, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/352794; Lee GH, 2014, SCI REP-UK, V4, DOI 10.1038/srep05194; Liu YB, 2002, J NEUROCHEM, V80, P780, DOI 10.1046/j.0022-3042.2002.00744.x; Lomonosova E, 2009, MOL CANCER RES, V7, P1268, DOI 10.1158/1541-7786.MCR-08-0183; MARTIN J, 1991, J BIOL CHEM, V266, P18051; Momeni HR, 2011, CELL J, V13, P65; Narbonne-Reveau K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017470; Nauen R, 2007, PEST MANAG SCI, V63, P628, DOI 10.1002/ps.1406; OEI C, 1992, J GEN MICROBIOL, V138, P1515, DOI 10.1099/00221287-138-7-1515; Opota O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014682; Oppert B, 1999, ARCH INSECT BIOCHEM, V42, P1, DOI 10.1002/(SICI)1520-6327(199909)42:1&lt;1::AID-ARCH2&gt;3.0.CO;2-#; Oppert B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034624; PACKER L, 1960, J BIOL CHEM, V235, P242; Ricci V, 2000, MOL BIOL CELL, V11, P3897, DOI 10.1091/mbc.11.11.3897; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Romao TP, 2006, FEBS J, V273, P1556, DOI 10.1111/j.1742-4658.2006.05177.x; Rubinstein AD, 2011, MOL CELL, V44, P698, DOI 10.1016/j.molcel.2011.10.014; Sanchis V, 2008, AGRON SUSTAIN DEV, V28, P11, DOI 10.1051/agro:2007054; Schwartz JL, 2001, J MEMBRANE BIOL, V184, P171, DOI 10.1007/s00232-001-0086-1; Silva-Filha MH, 1999, INSECT BIOCHEM MOLEC, V29, P711, DOI 10.1016/S0965-1748(99)00047-8; Srisucharitpanit K, 2014, PROTEINS, V82, P2703, DOI 10.1002/prot.24636; Srisucharitpanit K, 2012, PROTEIN EXPRES PURIF, V82, P368, DOI 10.1016/j.pep.2012.02.009; Sweeney AW, 1999, J MED MICROBIOL, V48, P879, DOI 10.1099/00222615-48-10-879; Szalai G, 1999, EMBO J, V18, P6349, DOI 10.1093/emboj/18.22.6349; Tan WZ, 2007, BBA-BIOMEMBRANES, V1768, P2510, DOI 10.1016/j.bbamem.2007.06.002; Tangsongcharoen C, 2015, J INVERTEBR PATHOL, V128, P57, DOI 10.1016/j.jip.2015.04.008; Tsang KY, 2010, J CELL SCI, V123, P2145, DOI 10.1242/jcs.068833; van Munster M, 2007, INSECT MOL BIOL, V16, P25, DOI 10.1111/j.1365-2583.2006.00692.x; Vander Heiden MG, 2000, P NATL ACAD SCI USA, V97, P4666, DOI 10.1073/pnas.090082297; Wojcik C, 2002, J CELL MOL MED, V6, P25, DOI 10.1111/j.1582-4934.2002.tb00309.x; Wu P, 2011, MOL BIOL REP, V38, P333, DOI 10.1007/s11033-010-0112-4; Zaim M, 2002, TRENDS PARASITOL, V18, P161, DOI 10.1016/S1471-4922(01)02220-6; Zou Z, 2005, J BIOL CHEM, V280, P14341, DOI 10.1074/jbc.M500570200	61	7	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2017	12	4							e0175473	10.1371/journal.pone.0175473	http://dx.doi.org/10.1371/journal.pone.0175473			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0MB	28406958	Green Published, gold, Green Submitted			2022-12-27	WOS:000399955400060
J	Tessema, RA				Tessema, Roba Argaw			Assessment of the implementation of community-led total sanitation, hygiene, and associated factors in Diretiyara district, Eastern Ethiopia	PLOS ONE			English	Article								Based on the sustainable development goals, the United Nations plans to achieve equitable sanitation and hygiene for all and to end open defecation by 2030. In Ethiopia, 60% to 80% of health problems are due to communicable diseases attributable to unsafe water supply, unhygienic and unsanitary waste management, which are directly linked to the practice of open defecation. This study has aimed at assessing the implementation of community-led total sanitation and hygiene (CLTSH) and associated factors. A community-based cross-sectional study design involving 420 of the 7,225 households found in Diretiyara district was conducted in June 2014. Both quantitative and qualitative data were collected. Using Logistic Regressions, bivariate and multivariate analyses were computed. This study showed that 66% of the respondents have knowledge of CLTSH. Eighty-nine percent of the respondents have latrine, of which 78% were constructed after the introduction of CLTSH. Eleven percent of the respondents reported to have defected in the open field and 15% of them reported that they had been recently exposed to diarrhea diseases. The occurrence of diarrheal disease was significantly associated with the extent of latrine ownership [AOR = 2.48; 95% CI 1.00, 6.12]. Attitude and perception parameters were significantly associated with consistent latrine utilization. Respondents who agreed that "Open defecation is preferred due to the unpleasant smell and heat from the Latrine'' [COR = 0.58; 95% CI 0.34, 0.99] were 58% less likely to use the latrine consistently. In conclusion, CLTSH has increased the extent of latrine ownership and decreased practice of open defecation, and yet, intermittent latrine use and poor hygienic practice were reported. Although some fundamental misconceptions were reported, the majority of the respondents have accepted CLTSH approach as a means to ending open defecation in their village. Health extension workers and local authorities should give emphasis to achieving sustainable behavioral change on improved sanitation and good hygiene practices.	[Tessema, Roba Argaw] Haramaya Univ, Dept Environm Hlth Sci, Coll Hlth & Med Sci, Dire Dawa, Ethiopia	Haramaya University	Tessema, RA (corresponding author), Haramaya Univ, Dept Environm Hlth Sci, Coll Hlth & Med Sci, Dire Dawa, Ethiopia.	robaargaw@gmail.com	Te, Roba A/I-3383-2019	Te, Roba A/0000-0001-8734-4030	HARAMAYA UNIVERSITY	HARAMAYA UNIVERSITY	This work was supported by HARAMAYA UNIVERSITY, email:haramaya.univ@ethio.net.	Araya M, 2016, UNICEF ETHIOPIA LEAD; Ayalew D, 2008, TROP MED INT HEALTH, V13, P472, DOI 10.1111/j.1365-3156.2008.02024.x; Azage M, 2015, ARCH PUBLIC HEALTH, V73, DOI 10.1186/s13690-015-0090-z; Bongartz P, 2016, SUSTAINABLE SANITATI; David D, 2015, UN SUMMIT ADOPTION P; Department for International Development, 2013, WAT SAN HYG; Department for International Development, POL PAP 2010 2015 GO; Eshete N, 2015, SCI J PUBLIC HLTH, V3, P669, DOI DOI 10.11648/j.sjph.20150305.22; Federal Democratic Republic of Ethiopia Ministry of Health (FDREMOH), 2011, NAT DRINK WAT QUAL M; Federal Ministry of Health (FMOH), 2014, HLTH HLTH REL IND VE, p14p; FMoH, 2011, HLTH HLTH REL IND; Gonzalez AH, 2013, PATHWAYS SUSTAINABIL; Harari Regional Health Bureau, 2011, ANN REPORT; Kedir AA, 2015, ABC RES ALERT 2015, V3, P2; Leonie K., 2011, OPPORTUNITIES CONSTR; Maria LA, 2015, FINAL REPORT IMPACT; Nucleus Research P.L.C. African Medical and Research Foundation in Ethiopia, 2011, AFR MED RES FDN ETH; Plan UNC Water Institute, 2015, TEST CLTS APPR SCAL; Pruss-Ustun A., 2008, SAFER WATER BETTER H; Robert Ch, 2009, GOING SCALE COMMUNIT; Sah S., 2009, DESALINATION, P1; Samuel G, 2016, UNICEF ETHIOPIA BABY; Thewodros B., 2016, INT J ENV AGRI BIOTE, V1, P1; UNICEF; WHO, 2015, WHO 25 YEARS PROGR S; Woldu W, 2016, TROP MED HEALTH, V44, DOI 10.1186/s41182-016-0040-7	25	20	21	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2017	12	4							e0175233	10.1371/journal.pone.0175233	http://dx.doi.org/10.1371/journal.pone.0175233			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0MB	28407003	Green Published, gold, Green Submitted			2022-12-27	WOS:000399955400035
J	Zhang, YF; Li, GL; Wang, XF; Sun, YQ; Zhang, SY				Zhang, Yong-Feng; Li, Guo-Long; Wang, Xue-Feng; Sun, Ya-Qing; Zhang, Shao-Ying			Transcriptomic profiling of taproot growth and sucrose accumulation in sugar beet (Beta vulgaris L.) at different developmental stages	PLOS ONE			English	Article							BRASSINOSTEROID SIGNAL-TRANSDUCTION; GENE-EXPRESSION; SEED SIZE; VASCULAR DEVELOPMENT; CLEAVING ENZYMES; STORAGE ROOTS; ARABIDOPSIS; AUXIN; ANNOTATION; PROTEIN	In sugar beet (Beta vulgaris L.), taproot weight and sucrose content are the important determinants of yield and quality. However, high yield and low sucrose content are two tightly bound agronomic traits. The advances in next-generation sequencing technology and the publication of sugar beet genome have provided a method for the study of molecular mechanism underlying the regulation of these two agronomic traits. In this work, we performed comparative transcriptomic analyses in the high taproot yield cultivar SD13829 and the high sucrose content cultivar BS02 at five developmental stages. More than 50,000,000 pair-end clean reads for each library were generated. When taproot turned into the rapid growth stage at the growth stage of 82 days after emergence (DAE), eighteen enriched gene ontology (GO) terms, including cell wall, cytoskeleton, and enzyme linked receptor protein signaling pathway, occurred in both cultivars. Differentially expressed genes (DEGs) of paired comparison in both cultivars were enriched in the cell wall GO term. For pathway enrichment analyses of DEGs that were respectively generated at 82 DAE compared to 59 DAE (the earlier developmental stage before taproot turning into the rapid growth stage), plant hormone signal transduction pathway was enriched. At 82 DAE, the rapid enlarging stage of taproot, several transcription factor family members were up-regulated in both cultivars. An antagonistic expression of brassinosteroid-and auxin-related genes was also detected. In SD13829, the growth strategy was relatively focused on cell enlargement promoted by brassinosteroid signaling, whereas in BS02, it was relatively focused on secondarily cambial cell division regulated by cytokinin, auxin and brassinosteroid signaling. Taken together, our data demonstrate that the weight and sucrose content of taproot rely on its growth strategy, which is controlled by brassinosteroid, auxin, cytokinin, and gibberellin.	[Zhang, Yong-Feng; Li, Guo-Long; Wang, Xue-Feng; Sun, Ya-Qing; Zhang, Shao-Ying] Inner Mongolia Agr Univ, Sugar Beet Physiol Res Inst, Hohhot, Peoples R China	Inner Mongolia Agricultural University	Zhang, SY (corresponding author), Inner Mongolia Agr Univ, Sugar Beet Physiol Res Inst, Hohhot, Peoples R China.	syzh36@aliyun.com			National Natural Science Foundation of China [31260347]; China Agriculture Research System (CARS) [210304]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Agriculture Research System (CARS)	This work has been jointly supported by the following grants: the National Natural Science Foundation of China (31260347) and China Agriculture Research System (CARS-210304). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Bancos S, 2002, PLANT PHYSIOL, V130, P504, DOI 10.1104/pp.005439; Bellin D, 2002, PLANT BIOLOGY, V4, P700, DOI 10.1055/s-2002-37405; Bellin D, 2007, J EXP BOT, V58, P699, DOI 10.1093/jxb/erl245; Chaiwanon J, 2015, CURR BIOL, V25, P1031, DOI 10.1016/j.cub.2015.02.046; Cheadle C, 2003, J MOL DIAGN, V5, P73, DOI 10.1016/S1525-1578(10)60455-2; CHEN X, 2015, BMC PLANT BIOL, V15; Cheung AY, 2011, CURR OPIN PLANT BIOL, V14, P632, DOI 10.1016/j.pbi.2011.09.001; Cho JI, 2011, MOL CELLS, V31, P553, DOI 10.1007/s10059-011-1038-y; Choe SW, 1998, PLANT CELL, V10, P231, DOI 10.1105/tpc.10.2.231; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Deng WK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111988; Dohm JC, 2014, NATURE, V505, P546, DOI 10.1038/nature12817; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; FIEUW S, 1990, J PLANT PHYSIOL, V137, P216, DOI 10.1016/S0176-1617(11)80084-2; Firon N, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-460; Friedrichsen D, 2001, BIOESSAYS, V23, P1028, DOI 10.1002/bies.1148; Gardiner J, 2010, INT J DEV BIOL, V54, P1389, DOI 10.1387/ijdb.093006jg; GILMOUR SJ, 1987, PLANT PHYSIOL, V85, P87, DOI 10.1104/pp.85.1.87; Godt D, 2006, PLANT PHYSIOL BIOCH, V44, P656, DOI 10.1016/j.plaphy.2006.09.019; Guo HQ, 2009, P NATL ACAD SCI USA, V106, P7648, DOI 10.1073/pnas.0812346106; Guo Y, 2009, PLANT CELL, V21, P3518, DOI 10.1105/tpc.108.064139; HE H., 1938, STRUCTURE EC PLANTS, P247; He JX, 2005, SCIENCE, V307, P1634, DOI 10.1126/science.1107580; Herwig R, 2002, PLANT J, V32, P845, DOI 10.1046/j.1365-313X.2002.01457.x; Himmelbach A, 2002, EMBO J, V21, P3029, DOI 10.1093/emboj/cdf316; Hosoda K, 2002, PLANT CELL, V14, P2015, DOI 10.1105/tpc.002733; Hou BK, 2004, J BIOL CHEM, V279, P47822, DOI 10.1074/jbc.M409569200; Jang G, 2015, J EXP BOT, V66, P4607, DOI 10.1093/jxb/erv220; Jiang WB, 2013, PLANT PHYSIOL, V162, P1965, DOI 10.1104/pp.113.217703; Kim H, 2006, BIOSCI BIOTECH BIOCH, V70, P768, DOI 10.1271/bbb.70.768; Kim HS, 2010, PLANT J, V64, P524, DOI 10.1111/j.1365-313X.2010.04346.x; Kim JY, 2005, GENE DEV, V19, P788, DOI 10.1101/gad.332805; Konishi M, 2007, PLANT PHYSIOL BIOCH, V45, P623, DOI 10.1016/j.plaphy.2007.05.001; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; LEIGH RA, 1979, BIOCHEM J, V178, P539, DOI 10.1042/bj1780539; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li J, 2015, CHEM GEOL, V406, P10, DOI 10.1016/j.chemgeo.2015.04.010; Li JM, 1997, CELL, V90, P929, DOI 10.1016/S0092-8674(00)80357-8; Li MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033055; Li XQ, 2003, PLANT CELL PHYSIOL, V44, P630, DOI 10.1093/pcp/pcg080; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo M, 2005, P NATL ACAD SCI USA, V102, P17531, DOI 10.1073/pnas.0508418102; Marrocco K, 2010, CURR OPIN PLANT BIOL, V13, P631, DOI 10.1016/j.pbi.2010.07.004; Mary H, 2015, J CELL SCI, V128, P3720, DOI 10.1242/jcs.160465; MILFORD GFJ, 1973, ANN APPL BIOL, V75, P427, DOI 10.1111/j.1744-7348.1973.tb07991.x; Mitsui Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep10835; Miyawaki K, 2006, P NATL ACAD SCI USA, V103, P16598, DOI 10.1073/pnas.0603522103; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; MOUSTACAS AM, 1991, BIOCHEM J, V279, P351, DOI 10.1042/bj2790351; Nagase T, 2015, PLANT BIOTECHNOL-NAR, V32, P125, DOI 10.5511/plantbiotechnology.15.0209a; Petricka JJ, 2012, ANNU REV PLANT BIOL, V63, P563, DOI 10.1146/annurev-arplant-042811-105501; Qu JZ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163814; Roh SW, 2010, TRENDS BIOTECHNOL, V28, P291, DOI 10.1016/j.tibtech.2010.03.001; Rojas CA, 2009, PLANT MOL BIOL, V71, P307, DOI 10.1007/s11103-009-9525-7; Seo D, 2015, SYMMETRY-BASEL, V7, P1275, DOI 10.3390/sym7031275; She J, 2011, NATURE, V474, P472, DOI 10.1038/nature10178; Smith HMS, 2004, CURR BIOL, V14, P812, DOI 10.1016/j.cub.2004.04.032; Sturm A, 1999, TRENDS PLANT SCI, V4, P401, DOI 10.1016/S1360-1385(99)01470-3; Sun Y, 2010, DEV CELL, V19, P765, DOI 10.1016/j.devcel.2010.10.010; Sun YY, 2015, GENE, V569, P118, DOI 10.1016/j.gene.2015.05.044; Tao X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036234; Thomas SG, 1999, P NATL ACAD SCI USA, V96, P4698, DOI 10.1073/pnas.96.8.4698; To JPC, 2004, PLANT CELL, V16, P658, DOI 10.1105/tpc.018978; Trebbi D, 2009, PHYSIOL PLANTARUM, V135, P84, DOI 10.1111/j.1399-3054.2008.01169.x; Turk EM, 2005, PLANT J, V42, P23, DOI 10.1111/j.1365-313X.2005.02358.x; Turk EM, 2003, PLANT PHYSIOL, V133, P1643, DOI 10.1104/pp.103.030882; Wang AH, 2010, PLANT J, V63, P670, DOI 10.1111/j.1365-313X.2010.04271.x; Wang GL, 2015, MOL GENET GENOMICS, V290, P1379, DOI 10.1007/s00438-015-0999-5; Wang HZ, 2010, P NATL ACAD SCI USA, V107, P22338, DOI 10.1073/pnas.1016436107; Wang Z, 2015, BMC PLANT BIOL, V15; Wang ZY, 2004, TRENDS PLANT SCI, V9, P91, DOI 10.1016/j.tplants.2003.12.009; Wang ZY, 2002, DEV CELL, V2, P505, DOI 10.1016/S1534-5807(02)00153-3; Weston MC., 1993, BIOL PHYSL SUGAR BEE, P37, DOI [10.1007/978-94-009-0373-9_2, DOI 10.1007/978-94-009-0373-9_2]; Xiao F, 2010, J PHYS CHEM B, V114, P15663, DOI 10.1021/jp1048869; XU W, 1995, PLANT CELL, V7, P1555, DOI 10.1105/tpc.7.10.1555; Xu Y, 2004, DNA SEQUENCE, V15, P104, DOI 10.1080/1042517042000199951; Yamaguchi S, 1998, PLANT CELL, V10, P2115, DOI 10.1105/tpc.10.12.2115; Yan A, 2014, J INTEGR PLANT BIOL, V56, P1112, DOI 10.1111/jipb.12221; Yanagisawa S, 2000, PLANT J, V21, P281, DOI 10.1046/j.1365-313x.2000.00685.x; Yang J., 2016, PLOS ONE, V11; Yu RG, 2016, FRONTIERS PLANT SCI, V7; Yu RG, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0427-3; Zhai RR, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-19; Zhao J, 2002, PLANT PHYSIOL, V130, P1221, DOI 10.1104/pp.102.010918; Zhao YD, 2012, MOL PLANT, V5, P334, DOI 10.1093/mp/ssr104; Zhou QY, 2008, PLANT BIOTECHNOL J, V6, P486, DOI 10.1111/j.1467-7652.2008.00336.x	87	20	22	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2017	12	4							e0175454	10.1371/journal.pone.0175454	http://dx.doi.org/10.1371/journal.pone.0175454			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0MB	28406933	gold, Green Published, Green Submitted			2022-12-27	WOS:000399955400055
J	Menni, C; Metrustry, SJ; Ehret, G; Dominiczak, AF; Chowienczyk, P; Spector, TD; Padmanabhan, S; Valdes, AM				Menni, Cristina; Metrustry, Sarah J.; Ehret, Georg; Dominiczak, Anna F.; Chowienczyk, Phil; Spector, Tim D.; Padmanabhan, Sandosh; Valdes, Ana M.			Molecular pathways associated with blood pressure and hexadecanedioate levels	PLOS ONE			English	Article							HYPERTENSION; ALCOHOL; METABOLOMICS; EXPRESSION; VARIANTS; COHORT	The dicarboxylic acid hexadecanedioate is associated with increased blood pressure (BP) and mortality in humans and feeding it to rats raises BP. Here we aim to characterise the molecular pathways that influence levels of hexadecanedioate linked to BP regulation, using genetic and transcriptomic studies. The top associations for hexadecanedioate in a genome-wide association scan (GWAS) conducted on 6447 individuals from the TwinsUK and KORA cohorts were tested for association with BP and hypertension in the International Consortium for BP and in a GWAS of BP extremes. Transcriptomic analyses correlating hexadecanedioate with gene expression levels in adipose tissue in 740 TwinsUK participants were further performed. GWAS showed 242 SNPs mapping to two independent loci achieving genome-wide significance. In rs414056 in the SCLO1B1 gene (Beta(SE) = -0.088 (0.006) P = 1.65 x 10(-51), P < 1 x 10(-51)), the allele previously associated with increased risk of statin associated myopathy is associated with higher hexadecanedioate levels. However this SNP did not show association with BP or hypertension. The top SNP in the second locus rs6663731 mapped to the intronic region of CYP4Z2P on chromosome 1 (0.045 (0.007), P = 5.49x10(-11)). Hexadecanedioate levels also correlate with adipose tissue gene-expression of the 3 out of 4 CYP4 probes (P<0.05) and of alcohol dehydrogenase probes (Beta(SE) = 0.12(0.02); P = 6.04x10(-11)). High circulating levels of hexadecanedioate determine a significant effect of alcohol intake on BP (SBP: 1.12(0.34), P = 0.001; DBP: 0.70 (0.22), P = 0.002), while no effect is seen in the lower hexadecanedioate level group. In conclusion, levels in fat of ADH1A, ADH1B and CYP4 encoding enzymes in the omega oxidation pathway, are correlated with hexadecanedioate levels. Hexadecanedioate appears to regulate the effect of alcohol on BP.	[Menni, Cristina; Metrustry, Sarah J.; Spector, Tim D.; Valdes, Ana M.] Kings Coll London, Dept Twin Res & Genet Epidemiol, London, England; [Ehret, Georg] Geneva Univ Hosp, Cardiol, Geneva, Switzerland; [Dominiczak, Anna F.; Padmanabhan, Sandosh] Univ Glasgow, Inst Cardiovasc & Med Sci, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland; [Chowienczyk, Phil] Kings Coll London, Dept Clin Pharmacol, London, England; [Valdes, Ana M.] Nottingham City Hosp, Acad Rheumatol Clin Sci Bldg, Nottingham, England	University of London; King's College London; University of Geneva; University of Glasgow; University of London; King's College London; Nottingham University Hospital NHS Trust; Nottingham City Hospital	Menni, C (corresponding author), Kings Coll London, Dept Twin Res & Genet Epidemiol, London, England.	cristina.menni@kcl.ac.uk	EHRET, Georg B/A-9532-2009; Dominiczak, Anna F/P-9390-2017	EHRET, Georg B/0000-0002-5730-0675; Dominiczak, Anna F/0000-0003-4913-3608; Chowienczyk, Phil/0000-0003-4507-038X; Menni, Cristina/0000-0001-9790-0571; Valdes, Ana M./0000-0003-1141-4471; Padmanabhan, Sandosh/0000-0003-3869-5808	MRC AimHY [MR/M016560/1]; Pfizer; Wellcome Trust; European Community's Seventh Framework Programme (FP7); National Institute for Health Research (NIHR) Clinical Research Facility at Guy's & St Thomas' NHS Foundation Trust; NIHR Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust and King's College London; British Heart Foundation (BHF) [CH/98001, RG/07/005/23633]; BHF [SP/08/005/25115]; European Union Ingenious HyperCare Consortium [LSHM-C7-2006-037093]	MRC AimHY(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Pfizer(Pfizer); Wellcome Trust(Wellcome TrustEuropean Commission); European Community's Seventh Framework Programme (FP7)(European Commission); National Institute for Health Research (NIHR) Clinical Research Facility at Guy's & St Thomas' NHS Foundation Trust; NIHR Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust and King's College London; British Heart Foundation (BHF)(British Heart Foundation); BHF(British Heart Foundation); European Union Ingenious HyperCare Consortium	This work was supported by: the MRC AimHY (MR/M016560/1) grant; Metabolomic analysis was funded by Pfizer; TwinsUK was funded by the Wellcome Trust; European Community's Seventh Framework Programme (FP7/2007-2013). The study also receives support from the National Institute for Health Research (NIHR) Clinical Research Facility at Guy's & St Thomas' NHS Foundation Trust and NIHR Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust and King's College London. Tim Spector is an NIHR senior Investigator and is holder of an ERC Advanced Principal Investigator award. The GWAS study of the BP extremes and the NORDIL cohort was supported by the following grants: British Heart Foundation (BHF) Chair CH/98001 BHF Program RG/07/005/23633; BHF Special Project Grant SP/08/005/25115 to S. Padmanabhan; European Union Ingenious HyperCare Consortium (LSHM-C7-2006-037093).	[Anonymous], 1993, J Hum Hypertens, V7, P159; Ehret GB, 2011, NATURE, V478, P103, DOI 10.1038/nature10405; Fagerberg L, 2014, MOL CELL PROTEOMICS, V13, P397, DOI 10.1074/mcp.M113.035600; Grundberg E, 2012, NAT GENET, V44, P1084, DOI 10.1038/ng.2394; Holmes E, 2008, NATURE, V453, P396, DOI 10.1038/nature06882; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Klatsky AL, 1995, PATHOPHYSIOLOGY DIAG; Link E, 2008, NEW ENGL J MED, V359, P789, DOI 10.1056/NEJMoa0801936; Marchi KC, 2014, WORLD J CARDIOL, V6, P283, DOI 10.4330/wjc.v6.i5.283; MARMOT MG, 1994, BRIT MED J, V308, P1263, DOI 10.1136/bmj.308.6939.1263; Menni C, 2015, HYPERTENSION, V66, P422, DOI 10.1161/HYPERTENSIONAHA.115.05544; Menni C, 2013, INT J EPIDEMIOL, V42, P1111, DOI 10.1093/ije/dyt094; Moayyeri A, 2013, INT J EPIDEMIOL, V42, P76, DOI 10.1093/ije/dyr207; Padmanabhan S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001177; Roth M, 2012, BRIT J PHARMACOL, V165, P1260, DOI 10.1111/j.1476-5381.2011.01724.x; Sanders RJ, 2008, FASEB J, V22, P2064, DOI 10.1096/fj.07-099150; Seta F, 2007, PROSTAG OTH LIPID M, V84, P116, DOI 10.1016/j.prostaglandins.2007.05.001; Shin SY, 2014, NAT GENET, V46, P543, DOI 10.1038/ng.2982; Suhre K, 2012, NAT REV GENET, V13, P759, DOI 10.1038/nrg3314; Suhre K, 2011, NATURE, V477, P54, DOI 10.1038/nature10354; van Deventer CA, 2015, J AM SOC HYPERTENS, V9, P104, DOI 10.1016/j.jash.2014.11.007; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; YASUNAMI M, 1990, GENOMICS, V7, P152, DOI 10.1016/0888-7543(90)90535-3; Yokoyama A, 2013, ALCOHOL CLIN EXP RES, V37, P1391, DOI 10.1111/acer.12108; Yu B, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600800; Zheng LF, 2015, BREAST CANCER RES TR, V150, P105, DOI 10.1007/s10549-015-3298-2; Zheng Y, 2013, HYPERTENSION, V62, P398, DOI 10.1161/HYPERTENSIONAHA.113.01166	27	7	8	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2017	12	4							e0175479	10.1371/journal.pone.0175479	http://dx.doi.org/10.1371/journal.pone.0175479			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LZ	28403188	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000399955200074
J	Zhang, S; Hu, XY; Guan, W; Luan, L; Li, B; Tang, QC; Fan, HG				Zhang, Shuai; Hu, Xueyuan; Guan, Wei; Luan, Li; Li, Bei; Tang, Qichao; Fan, Honggang			Isoflurane anesthesia promotes cognitive impairment by inducing expression of beta-amyloid protein-related factors in the hippocampus of aged rats	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; MICE LACKING; OLIGOMERS; PLAQUES; BRAIN; PATHOLOGY; APOPTOSIS; DENSITY; MODELS; APP	Isoflurane anesthesia has been shown to be responsible for cognitive impairment in Alzheimer's disease (AD) and development of AD in the older age groups. However, the pathogenesis of AD-related cognitive impairments induced by isoflurane anesthesia remains elusive. Thus, this study was designed to investigate the mechanism by which isoflurane anesthesia caused AD-related cognitive impairments. Aged Wistar rats were randomly divided into 6 groups (n = 12), 1 control group (CONT) and 5 isoflurane treated (ISO) groups (ISO 0, ISO 0.5D, ISO 1D, ISO 3D and ISO 7D). The CONT group inhaled 30% O-2 for 2 h without any anesthesia. ISO groups were placed under anesthesia with 3% isoflurane and then exposed to 1.5% isoflurane delivered in 30% O-2 for 2 h. Rats in each ISO group were then analyzed immediately (ISO 0) or at various time points (0.5, 1, 3 or 7 day) after this exposure. Cognitive function was assessed using the Morris water maze test. Protein levels of amyloid precursor protein (APP), beta-site APP cleavage enzyme-1 (BACE-1) and A beta(42) peptide were analyzed in hippocampal samples by Western blot. alpha-Amyloid (Abeta) plaques were detected in hippocampal sections by Congo red staining. Compared with controls, all ISO groups showed increased escape latency and impaired spatial memory. Isoflurane increased APP mRNA expression and APP protein depletion, promoting A beta(42) overproduction, oligomerization and accumulation. However, isoflurane did not affect BACE-1 expression. Abeta plaques were observed only in those ISO groups sacrificed at 3 or 7 d. Our data indicate that aged rats exposed to isoflurane had increased APP mRNA expression and APP protein depletion, with A beta(42) peptide overproduction and oligomerization, resulting in formation of Abeta plaques in the hippocampus. Such effects might have contributed to cognitive impairments, including in spatial memory, observed in these rats after isoflurane anesthesia.	[Zhang, Shuai; Hu, Xueyuan; Guan, Wei; Luan, Li; Li, Bei; Tang, Qichao; Fan, Honggang] Northeast Agr Univ, Dept Vet Med, Coll Vet Med, Harbin, Peoples R China	Northeast Agricultural University - China	Fan, HG (corresponding author), Northeast Agr Univ, Dept Vet Med, Coll Vet Med, Harbin, Peoples R China.	fanhonggang2002@163.com		Hu, Xueyuan/0000-0002-4775-928X	Postdoctoral Scientific Research Foundation of Heilongjiang Province [LBH-Q14018]; Academic Backbone Project of Northeast Agricultural University (Honggang Fan) [15XG18]	Postdoctoral Scientific Research Foundation of Heilongjiang Province(China Postdoctoral Science Foundation); Academic Backbone Project of Northeast Agricultural University (Honggang Fan)	This work was supported by Postdoctoral Scientific Research Foundation of Heilongjiang Province (LBH-Q14018) and "Academic Backbone" Project of Northeast Agricultural University (15XG18) (Honggang Fan).	Abreu RD, 2009, MOL BIOSYST, V5, P1512, DOI 10.1039/b908315d; Alzheimers Assoc, 2015, ALZHEIMERS DEMENT, V11, P332, DOI 10.1016/j.jalz.2015.02.003; Baron R, 2014, AGING CELL, V13, P584, DOI 10.1111/acel.12210; Benilova I, 2012, NAT NEUROSCI, V15, P349, DOI 10.1038/nn.3028; Bianchi SL, 2008, NEUROBIOL AGING, V29, P1002, DOI 10.1016/j.neurobiolaging.2007.02.009; BOHNEN NILJ, 1994, J AM GERIATR SOC, V42, P198, DOI 10.1111/j.1532-5415.1994.tb04952.x; Chang L, 2003, J MOL NEUROSCI, V20, P305, DOI 10.1385/JMN:20:3:305; Cole SL, 2008, CURR ALZHEIMER RES, V5, P100, DOI 10.2174/156720508783954758; Culley DJ, 2004, ANESTH ANALG, V99, P1393, DOI 10.1213/01.ANE.0000135408.14319.CC; Culley DJ, 2003, ANESTH ANALG, V96, P1004, DOI 10.1213/01.ANE.0000052712.67573.12; Dawson GR, 1999, NEUROSCIENCE, V90, P1, DOI 10.1016/S0306-4522(98)00410-2; Eckenhoff RG, 2004, ANESTHESIOLOGY, V101, P703, DOI 10.1097/00000542-200409000-00019; Ferreira ST, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00191; Gu L, 2013, J NEUROCHEM, V126, P305, DOI 10.1111/jnc.12202; Kowal P., 2002, PROPOSED WORKING DEF, V10; Krafft GA, 2010, NEUROPHARMACOLOGY, V59, P230, DOI 10.1016/j.neuropharm.2010.07.012; Larson ME, 2012, J NEUROCHEM, V120, P125, DOI 10.1111/j.1471-4159.2011.07478.x; Lee TA, 2005, J ALZHEIMERS DIS, V7, P319; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Li Xiang-yu, 2016, Zhen Ci Yan Jiu, V41, P24; Lin DW, 2011, NEUROPHARMACOLOGY, V61, P1354, DOI 10.1016/j.neuropharm.2011.08.011; Liu WR, 2012, NEUROL RES, V34, P3, DOI 10.1179/1743132811Y.0000000047; Liu X, 2014, J MOL NEUROSCI, V52, P124, DOI 10.1007/s12031-013-0216-0; Ludewig S, 2017, FRONT MOL NEUROSCI, V9, DOI 10.3389/fnmol.2016.00161; McGeer PL, 1995, BRAIN RES REV, V21, P195, DOI 10.1016/0165-0173(95)00011-9; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; Persa C, 2006, EXP EYE RES, V83, P817, DOI 10.1016/j.exer.2006.04.001; Perucho J, 2010, J ALZHEIMERS DIS, V19, P1245, DOI 10.3233/JAD-2010-1318; Planel E, 2009, FASEB J, V23, P2595, DOI 10.1096/fj.08-122424; Sclip A, 2013, J MOL CELL BIOL, V5, P277, DOI 10.1093/jmcb/mjt015; Selkoe DJ, 2004, ANN INTERN MED, V140, P627, DOI 10.7326/0003-4819-140-8-200404200-00047; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Stratmann G, 2009, ANESTHESIOLOGY, V110, P834, DOI 10.1097/ALN.0b013e31819c463d; Sundaram GSM, 2014, ORG LETT, V16, P3640, DOI 10.1021/ol501264q; Tian A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141596; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Wu X, 2012, NEUROBIOL AGING, V33, P1364, DOI 10.1016/j.neurobiolaging.2010.11.002; Xie ZC, 2006, ANESTHESIOLOGY, V104, P988, DOI 10.1097/00000542-200605000-00015; Xie ZC, 2007, J NEUROSCI, V27, P1247, DOI 10.1523/JNEUROSCI.5320-06.2007; Xie ZC, 2008, ANN NEUROL, V64, P618, DOI 10.1002/ana.21548; Xu XM, 2009, J ALZHEIMERS DIS, V16, P211, DOI 10.3233/JAD-2009-0957; Yang G, 2005, NEUROSCI LETT, V384, P66, DOI 10.1016/j.neulet.2005.04.040; Yue T, 2015, LIFE SCI, V143, P194, DOI 10.1016/j.lfs.2015.11.002; Zha ZH, 2011, J MED CHEM, V54, P8085, DOI 10.1021/jm2009106; Zhang D, 2015, CLIN RADIOL, V70, P74, DOI 10.1016/j.crad.2014.09.019; Zhao WQ, 2008, FASEB J, V22, P246, DOI 10.1096/fj.06-7703com; Zhou Y, 2012, NEUROTOX RES, V22, P335, DOI 10.1007/s12640-012-9318-7; Zohar O, 2003, MOL BRAIN RES, V115, P63, DOI 10.1016/S0169-328X(03)00182-7	48	24	24	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2017	12	4							e0175654	10.1371/journal.pone.0175654	http://dx.doi.org/10.1371/journal.pone.0175654			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LZ	28403230	Green Published, gold, Green Submitted			2022-12-27	WOS:000399955200088
J	Singh, AV; Baylan, S; Park, BW; Richter, G; Sitti, M				Singh, Ajay Vikram; Baylan, Semanur; Park, Byung-Wook; Richter, Gunther; Sitti, Metin			Hydrophobic pinning with copper nanowhiskers leads to bactericidal properties	PLOS ONE			English	Article							SURFACES; CELLS	The considerable morbidity associated with hospitalized patients and clinics in developed countries due to biofilm formation on biomedical implants and surgical instruments is a heavy economic burden. An alternative to chemically treated surfaces for bactericidal activity started emerging from micro/nanoscale topographical cues in the last decade. Here, we demonstrate a putative antibacterial surface using copper nanowhiskers deposited by molecular beam epitaxy. Furthermore, the control of biological response is based on hydrophobic pinning of water droplets in the Wenzel regime, causing mechanical injury and cell death. Scanning electron microscopy images revealed the details of the surface morphology and non-contact mode laser scanning of the surface revealed the microtopography-associated quantitative parameters. Introducing the bacterial culture over nanowhiskers produces mechanical injury to cells, leading to a reduction in cell density over time due to local pinning of culture medium to whisker surfaces. Extended culture to 72 hours to observe biofilm formation revealed biofilm inhibition with scattered microcolonies and significantly reduced bio-volume on nanowhiskers. Therefore, surfaces patterned with copper nanowhiskers can serve as potential antibiofilm surfaces. The topography-based antibacterial surfaces introduce a novel prospect in developing mechanoresponsive nanobiomaterials to reduce the risk of medical device biofilm-associated infections, contrary to chemical leaching of copper as a traditional bactericidal agent.	[Singh, Ajay Vikram; Park, Byung-Wook; Sitti, Metin] Max Planck Inst Intelligent Syst, Phys Intelligence Dept, Stuttgart, Germany; [Baylan, Semanur; Richter, Gunther] Max Planck Inst Intelligent Syst, CSF Thin Films Grp, Stuttgart, Germany	Max Planck Society; Max Planck Society	Sitti, M (corresponding author), Max Planck Inst Intelligent Syst, Phys Intelligence Dept, Stuttgart, Germany.	sitti@is.mpg.de	Richter, Gunther/F-6222-2011; Singh, Ajay Vikram/AAM-3665-2020; Sitti, Metin/AGP-6288-2022; Singh, Ajay/AAF-4414-2020; Singh, Ajay Vikram/R-9055-2017	Singh, Ajay Vikram/0000-0002-9875-7727; Sitti, Metin/0000-0001-8249-3854	Maxplanck Society	Maxplanck Society(Max Planck Society)	Authors acknowledge Maxplanck Society for financial support.	Cassie ABD, 1944, T FARADAY SOC, V40, P0546, DOI 10.1039/tf9444000546; Diu T, 2014, SCI REP-UK, V4, DOI 10.1038/srep07122; ELIMELECH M, 1994, DESALINATION, V95, P269, DOI 10.1016/0011-9164(94)00064-6; Friedlander RS, 2013, P NATL ACAD SCI USA, V110, P5624, DOI 10.1073/pnas.1219662110; Grass G, 2011, APPL ENVIRON MICROB, V77, P1541, DOI 10.1128/AEM.02766-10; Hasan J, 2013, APPL MICROBIOL BIOT, V97, P9257, DOI 10.1007/s00253-012-4628-5; Hosseinidoust Z, 2016, ADV DRUG DELIVERY RE; Ivanova EP, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3838; Ivanova EP, 2012, SMALL, V8, P2489, DOI 10.1002/smll.201200528; Marechal Y, 2011, J MOL STRUCT, V1004, P146, DOI 10.1016/j.molstruc.2011.07.054; May RM, 2014, CLIN TRANSL MED, V3, DOI 10.1186/2001-1326-3-8; Meng KK, 2014, J MATER SCI, V49, P3379, DOI 10.1007/s10853-014-8046-1; Park BW, 2016, ADV ENG MATER, V18, P518, DOI 10.1002/adem.201500282; Poulston S, 1996, SURF INTERFACE ANAL, V24, P811, DOI 10.1002/(SICI)1096-9918(199611)24:12<811::AID-SIA191>3.0.CO;2-Z; Richter G, 2009, NANO LETT, V9, P3048, DOI 10.1021/nl9015107; Singh AV, 2016, CURR PHARM DESIGN, V22, P1534, DOI 10.2174/1381612822666151210124001; Singh AV, 2015, SCI REP-UK, V5, DOI 10.1038/srep07847; Singh AV, 2012, MATER DESIGN, V36, P829, DOI 10.1016/j.matdes.2011.01.061; Singh AV, 2010, CURR NANOSCI, V6, P365; Singh AV, 2016, CURR PHARM DESIGN, V22, P1415, DOI 10.2174/1381612822999160122121713; Singh AV, 2016, CURR PHARM DESIGN, V22, P1418, DOI 10.2174/1381612822666151210124326; Singh AV, 2013, J BIOMED MATER RES A, V101, P3019, DOI 10.1002/jbm.a.34586; Singh AV, 2013, J BIOMED MATER RES A, V101, P2994, DOI 10.1002/jbm.a.34601; Singh AV, 2013, J NANOSCI NANOTECHNO, V13, P77, DOI 10.1166/jnn.2013.6727; Singh AV, 2012, BIOFABRICATION, V4, DOI 10.1088/1758-5082/4/2/025001; Singh AV, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0026803, 10.1371/journal.pone.0025029]; Son S, 2002, INT J MACH TOOL MANU, V42, P889, DOI 10.1016/S0890-6955(02)00030-5; Stewart PS, 2001, LANCET, V358, P135, DOI 10.1016/S0140-6736(01)05321-1; VANDERLAAN G, 1981, PHYS REV B, V23, P4369, DOI 10.1103/PhysRevB.23.4369; WHATMORE AM, 1990, J GEN MICROBIOL, V136, P2521, DOI 10.1099/00221287-136-12-2521	31	31	31	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2017	12	4							e0175428	10.1371/journal.pone.0175428	http://dx.doi.org/10.1371/journal.pone.0175428			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0JS	28399162	gold, Green Submitted, Green Published			2022-12-27	WOS:000399949000036
J	Nunes, CDO; de Carvalho, GBM; da Silva, MLC; da Silva, GP; Machado, BAS; Uetanabaro, APT				Oliveira Nunes, Cassiane da Silva; Mafra de Carvalho, Giovani Brendao; Cardoso da Silva, Marilia Lordelo; da Silva, Gervasio Paulo; Souza Machado, Bruna Aparecida; Trovatti Uetanabaro, Ana Paula			Cocoa pulp in beer production: Applicability and fermentative process performance	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; BREWERS-YEAST; LAGER YEAST; STRAINS; WINE; FLAVOR; PARAMETERS	This work evaluated the effect of cocoa pulp as a malt adjunct on the parameters of fermentation for beer production on a pilot scale. For this purpose, yeast isolated from the spontaneous fermentation of cachaca (SC52), belonging to the strain bank of the State University of Feira de Santana-Ba ( Brazil), and a commercial strain of ale yeast (Safale S-04 Belgium) were used. The beer produced was subjected to acceptance and purchase intention tests for sensorial analysis. At the beginning of fermentation, 30% cocoa pulp ( adjunct) was added to the wort at 12 degrees P concentration. The production of beer on a pilot scale was carried out in a bioreactor with a 100-liter capacity, a usable volume of 60 liters, a temperature of 22 E degrees C and a fermentation time of 96 hours. The fermentation parameters evaluated were consumption of fermentable sugars and production of ethanol, glycerol and esters. The beer produced using the adjunct and yeast SC52 showed better fermentation performance and better acceptance according to sensorial analysis.	[Oliveira Nunes, Cassiane da Silva; Trovatti Uetanabaro, Ana Paula] Univ Estadual Santa Cruz, Dept Biol & Biotechnol Microorganisms, Llheus, BA, Brazil; [Oliveira Nunes, Cassiane da Silva] Bahia Fed Inst Catu Campus, Catu, BA, Brazil; [Mafra de Carvalho, Giovani Brendao; Cardoso da Silva, Marilia Lordelo] Univ Estadual Feira de Santana, Dept Biotechnol, Feira De Santana, BA, Brazil; [da Silva, Gervasio Paulo] Univ Estado Bahia, Dept Educ, Senhor Bonfim, BA, Brazil; [Souza Machado, Bruna Aparecida] Natl Serv Ind Learning SENAI, Fac Technol, SENAI CIMATEC, Dept Biotechnol & Food, Salvador, BA, Brazil; [Souza Machado, Bruna Aparecida] Natl Serv Ind Learning SENAI, Fac Technol, SENAI CIMATEC, Inst Technol Hlth, Salvador, BA, Brazil	Universidade Estadual de Santa Cruz; Universidade Estadual de Feira de Santana; Universidade do Estado Bahia; Faculdade de Tecnologia Senai Cimatec; Faculdade de Tecnologia Senai Cimatec	Nunes, CDO (corresponding author), Univ Estadual Santa Cruz, Dept Biol & Biotechnol Microorganisms, Llheus, BA, Brazil.; Nunes, CDO (corresponding author), Bahia Fed Inst Catu Campus, Catu, BA, Brazil.	cassiane.oliveira@gmail.com	Machado, Bruna/AAP-6877-2021; Machado, Bruna Aparecida Souza/C-3130-2016	Machado, Bruna Aparecida Souza/0000-0003-1655-0325; da Silva, Gervasio Paulo/0000-0003-1076-9115; Uetanabaro, Ana Paula/0000-0003-3992-8474				Alves Z, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143641; American Society of Brewing Chemists (ASBC), 1996, METH AN AM SOC BREW; Aslankoohi E, 2013, APPL ENVIRON MICROB, V79, P7325, DOI 10.1128/AEM.02649-13; Attfield PV, 2000, LETT APPL MICROBIOL, V31, P323, DOI [10.1046/j.1472-765x.2000.00825.x, 10.1046/j.1472-765X.2000.00825.x]; Bing J, 2014, CURR BIOL, V24, pR380, DOI 10.1016/j.cub.2014.04.031; Boulton C, 2006, BREWING YEAST BREWIN, V1; Bravi E, 2017, FOOD CHEM, V215, P341, DOI 10.1016/j.foodchem.2016.07.153; Briggs D. E., 2004, BREWING SCI PRACTICE; Bvochora JM, 2001, PROCESS BIOCHEM, V37, P365, DOI 10.1016/S0032-9592(01)00224-2; Cano-Garcia L, 2014, FOOD CHEM, V151, P364, DOI 10.1016/j.foodchem.2013.11.051; Carvalho D. S. de, 2011, Alimentos e Nutricao, V22, P351; Carvalho GBM, 2009, APPL BIOCHEM BIOTECH, V155, P356, DOI 10.1007/s12010-008-8458-y; Cejnar R, 2016, APPL MICROBIOL BIOTE; da Silva GC, 2015, FOOD CHEM, V167, P71, DOI 10.1016/j.foodchem.2014.06.033; Dias DR, 2007, INT J FOOD SCI TECH, V42, P319, DOI 10.1111/j.1365-2621.2006.01226.x; Dietvorst J, 2007, YEAST, V24, P27, DOI 10.1002/yea.1436; Dufour J.-P., 1994, P 4 AV C MALT BREW D, P137; Ekberg J, ADAPTIVE EVOLUTION L; Freire ES, 1999, P 12 INT COC RES C, P1013; Gibson BR, 2007, FEMS MICROBIOL REV, V31, P535, DOI 10.1111/j.1574-6976.2007.00076.x; Goncalves M, 2016, CURR BIOL, V26, P2750, DOI 10.1016/j.cub.2016.08.040; Grassi S, 2014, FOOD RES INT, V62, P602, DOI 10.1016/j.foodres.2014.03.058; Guido LF, 2004, FOOD CHEM, V87, P187, DOI 10.1016/j.foodchem.2003.10.033; Hardwick W. A., 1995, HDB BREWING; Hiralal L, 2014, J BIOSCI BIOENG, V117, P57, DOI 10.1016/j.jbiosc.2013.06.002; Huuskonen A, 2010, APPL ENVIRON MICROB, V76, P1563, DOI 10.1128/AEM.03153-09; Kerr ED, 2016, PEERJ, V4, DOI 10.7717/peerj.2271; King BM, 1999, FOOD QUAL PREFER, V10, P315, DOI 10.1016/S0950-3293(98)00040-8; Kong ZQ, 2016, SCI REP-UK, V6, DOI 10.1038/srep33552; Leclercq-Perlat MN, 2004, J DAIRY RES, V71, P355, DOI 10.1017/S0022029904000202; LEDUY A, 1973, BIOTECHNOL BIOENG, V15, P805, DOI 10.1002/bit.260150412; Lei HJ, 2016, J BIOSCI BIOENG, V122, P583, DOI 10.1016/j.jbiosc.2016.05.004; Li H, 2015, FOOD CHEM, V185, P200, DOI 10.1016/j.foodchem.2015.03.135; Lodolo EJ, 2008, FEMS YEAST RES, V8, P1018, DOI 10.1111/j.1567-1364.2008.00433.x; Meilgaard M. C., 1975, TECH Q MASTER BREW A, V12, P151, DOI DOI 10.1007/978-3-662-09768-7_3; Minim, 2012, ANALISE SENSORIAL ES; Nogueira LC, 2005, J CHROMATOGR A, V1065, P207, DOI 10.1016/j.chroma.2004.12.074; Patel S, 2003, J FOOD COMPOS ANAL, V16, P469, DOI 10.1016/S0889-1575(03)00021-8; Patel S, 2002, J AGR FOOD CHEM, V50, P5649, DOI 10.1021/jf020337f; Piddocke MP, 2009, APPL MICROBIOL BIOT, V84, P453, DOI 10.1007/s00253-009-1930-y; RUSSELL I, 1995, BIOTECHNOLOGY, V9, P419; Saerens SMG, 2008, APPL ENVIRON MICROB, V74, P454, DOI 10.1128/AEM.01616-07; Saerens SMG, 2010, APPL MICROBIOL BIOT, V86, P1195, DOI 10.1007/s00253-010-2486-6; Schwan RF, 2004, CRIT REV FOOD SCI, V44, P205, DOI 10.1080/10408690490464104; Sodre GA, 2007, REV BRASILEIRA FRUTI, V29; Spitaels F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095384; Stewart G. G., 2006, Technical Quarterly, Master Brewers' Association of the Americas, V43, P265; Stewart G. G, 2007, NEW FOOD, V1, P42; Sun SY, 2013, FOOD CHEM, V138, P2233, DOI 10.1016/j.foodchem.2012.12.032; Tapsoba F, 2015, INT J FOOD MICROBIOL, V211, P128, DOI 10.1016/j.ijfoodmicro.2015.07.010; van Wyk S, 2016, BIOTECHNOL J, V11, P1667, DOI 10.1002/biot.201600497; Verstrepen KJ, 2003, J BIOSCI BIOENG, V96, P110, DOI 10.1016/S1389-1723(03)90112-5; Wang O, 2017, APPETITE, V108, P416, DOI 10.1016/j.appet.2016.10.029	53	4	6	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2017	12	4							e0175677	10.1371/journal.pone.017567	http://dx.doi.org/10.1371/journal.pone.017567			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KH	28419110				2022-12-27	WOS:000399875200033
J	Sun, IO; Shin, SH; Cho, AY; Yoon, HJ; Chang, MY; Lee, KY				Sun, In O.; Shin, Sung Hye; Cho, A. Young; Yoon, Hyun Ju; Chang, Mi Yok; Lee, Kwang Young			Clinical significance of NGAL and KIM-1 for acute kidney injury in patients with scrub typhus	PLOS ONE			English	Article							GELATINASE-ASSOCIATED LIPOCALIN; ACUTE-RENAL-FAILURE; URINARY BIOMARKERS; FEBRILE ILLNESS; DISEASE; RIFLE; RICKETTSIOSES; PREDICTS; OUTCOMES; NETWORK	Background The aim of this study is to investigate the clinical significance of neutrophil gelatinase-associated lipocalin (NGAL) and kidney injury molecule-1 (KIM-1) for acute kidney injury (AKI) in patients with scrub typhus. Methods From 2014 to 2015, 145 patients were diagnosed with scrub typhus. Of these, we enrolled 138 patients who were followed up until renal recovery or for at least 3 months. We measured serum and urine NGAL and KIM-1 levels and evaluated prognostic factors affecting scrub typhus-associated AKI. Results Of the 138 patients, 25 had scrub typhus-associated AKI. The incidence of AKI was 18.1%; of which 11.6%, 4.3%, and 2.2% were classified as risk, injury, and failure, respectively, according to RIFLE criteria. Compared with patients in the non-AKI group, patients in the AKI group were older and showed higher total leukocyte counts and hypoalbuminemia or one or more comorbidities such as hypertension (72% vs 33%, p < 0.01), diabetes (40% vs 14%, p < 0.01), or chronic kidney disease (32% vs 1%, p < 0.01). In addition, serum NGAL values (404 +/- 269 vs 116 +/- 78 ng/mL, P < 0.001), KIM-1 values (0.80 +/- 0.52 vs 0.33 +/- 0.68 ng/mL, P < 0.001), urine NGAL/creatinine values (371 +/- 672 vs 27 +/- 39 ng/mg, P < 0.001) and urine KIM-1/creatinine values (4.04 +/- 2.43 vs 2.38 +/- 1.89 ng/mg, P < 0.001) were higher in the AKI group than in the non-AKI group. By multivariate logistic regression, serum NGAL and the presence of chronic kidney disease were significant predictors of AKI. Conclusion Serum NGAL might be an additive predictor for scrub typhus-associated AKI.	[Sun, In O.; Cho, A. Young; Yoon, Hyun Ju; Lee, Kwang Young] Presbyterian Med Ctr, Dept Internal Med, Div Nephrol, Jeonju, South Korea; [Shin, Sung Hye; Lee, Kwang Young] Presbyterian Med Ctr, Christian Med Res Ctr, Jeonju, South Korea; [Chang, Mi Yok] Presbyterian Med Ctr, Dept Internal Med, Div Infect, Jeonju, South Korea		Lee, KY (corresponding author), Presbyterian Med Ctr, Dept Internal Med, Div Nephrol, Jeonju, South Korea.; Lee, KY (corresponding author), Presbyterian Med Ctr, Christian Med Res Ctr, Jeonju, South Korea.	kwangpmc@hanmail.net			Korean Society of Nephrology; Christian Medical Research Center; Presbyterian Medical Center, Jeonju, Korea	Korean Society of Nephrology; Christian Medical Research Center; Presbyterian Medical Center, Jeonju, Korea	The authors wish to acknowledge financial support of the Korean Society of Nephrology and Christian Medical Research Center, Presbyterian Medical Center, Jeonju, Korea. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors wish to acknowledge financial support of the Korean Society of Nephrology and Christian Medical Research Center, Presbyterian Medical Center, Jeonju, Korea. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alge JL, 2015, CLIN J AM SOC NEPHRO, V10, P147, DOI 10.2215/CJN.12191213; Astrup E, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002648; Attur RP, 2013, CLIN EXP NEPHROL, V17, P725, DOI 10.1007/s10157-012-0753-9; Basu G, 2011, NEPHROL DIAL TRANSPL, V26, P524, DOI 10.1093/ndt/gfq477; Bellomo R, 2004, CRIT CARE, V8, pR204, DOI 10.1186/cc2872; Bojan M, 2014, CLIN J AM SOC NEPHRO, V9, P285, DOI 10.2215/CJN.04730513; de Geus HRH, 2011, AM J RESP CRIT CARE, V183, P907, DOI 10.1164/rccm.200908-1214OC; Dent CL, 2007, CRIT CARE, V11, DOI 10.1186/cc6192; Eckardt KU, 2012, KIDNEY INT SUPPL, V2, P7, DOI 10.1038/kisup.2012.8; Greenberg JH, 2015, PEDIATR NEPHROL, V30, P1519, DOI 10.1007/s00467-015-3088-4; Hsu Gwo-Jong, 1993, Journal of the Formosan Medical Association, V92, P475; Hsu RK, 2016, CLIN J AM SOC NEPHRO, V11, P14, DOI 10.2215/CJN.04520415; Kim DM, 2008, J CLIN MICROBIOL, V46, P1548, DOI 10.1128/JCM.01040-07; Levey AS, 2007, CLIN CHEM, V53, P766, DOI 10.1373/clinchem.2006.077180; Mahajan S K, 2005, J Assoc Physicians India, V53, P954; Malhotra R, 2017, CLIN J AM SOC NEPHRO, V12, P149, DOI 10.2215/CJN.01300216; Mandell GL, 2010, PRINCIPLES PRACTICE, P2529; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; Nickolas TL, 2008, ANN INTERN MED, V148, P810, DOI 10.7326/0003-4819-148-11-200806030-00003; Nickolas TL, 2012, J AM COLL CARDIOL, V59, P246, DOI 10.1016/j.jacc.2011.10.854; Parikh CR, 2011, J AM SOC NEPHROL, V22, P1737, DOI 10.1681/ASN.2010111163; Parola P, 2005, CLIN MICROBIOL REV, V18, P719, DOI 10.1128/CMR.18.4.719-756.2005; Schrezenmeier EV, 2016, ACTA PHYSL; Singbartl K, 2015, CRIT CARE CLIN, V31, P751, DOI 10.1016/j.ccc.2015.06.010; Sun IO, 2014, J INFECT CHEMOTHER, V20, P93, DOI 10.1016/j.jiac.2013.08.007; Thap Lon Chan, 2002, Southeast Asian Journal of Tropical Medicine and Public Health, V33, P780; Vaidya VS, 2008, CTS-CLIN TRANSL SCI, V1, P200, DOI 10.1111/j.1752-8062.2008.00053.x; Valette X, 2013, J CRIT CARE, V28, P116, DOI 10.1016/j.jcrc.2012.06.012; Varghese GM, 2006, J INFECTION, V52, P56, DOI 10.1016/j.jinf.2005.02.001; Walker DH, 2008, NAT REV MICROBIOL, V6, P375, DOI 10.1038/nrmicro1866; Washburn KK, 2008, NEPHROL DIAL TRANSPL, V23, P566, DOI 10.1093/ndt/gfm638; Yen TH, 2003, RENAL FAILURE, V25, P397, DOI 10.1081/JDI-120021152; Young Park Chi, 2003, Korean Journal of Internal Medicine, V18, P248	33	18	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2017	12	4							e0175890	10.1371/journal.pone.0175890	http://dx.doi.org/10.1371/journal.pone.0175890			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KH	28419138	Green Published, Green Submitted, gold			2022-12-27	WOS:000399875200051
J	Choi, J; Kim, J; Hwang, JY; Je, M; Kim, JY; Kim, SY				Choi, Jaesuk; Kim, Jihun; Hwang, Jae Youn; Je, Minkyu; Kim, Jun-Young; Kim, Shin-Yoon			A novel smart navigation system for intramedullary nailing in orthopedic surgery	PLOS ONE			English	Article							LASER GUIDANCE-SYSTEM; DISTAL LOCKING	This paper proposes a novel smart surgical navigation system for intramedullary nailing in orthopedic surgery. Using a handle-integrated laser guidance module, the system can target a drill insertion point onto skin, indicating an accurate target position to perpendicularly access an invisible distal hole. The proposed handle-integration-based fixation of the laser guidance module precisely defines the relative position of the module with respect to the distal hole. Consequently, unlike conventional systems, the proposed system can indicate the target insertion point without any help from bulky and costly external position-tracking equipment that is usually required for compensating disturbances generated by external impacts. After insertion, a correct drilling direction toward the distal hole is guided by real-time drilling angle measurement modules-one integrated with the nail handle and the other with the drill body. Each module contains a 9-axis inertial sensor and a Bluetooth communication device. These two modules work together to provide real-time drilling angle data, allowing calculation of the directional error toward the center of the distal hole in real time. The proposed system removes the need for fluoroscopy and provides a compact and cost-effective solution compared with conventional systems.	[Choi, Jaesuk; Je, Minkyu] Korea Adv Inst Sci & Technol, Sch Elect Engn, Daejeon, South Korea; [Kim, Jihun; Hwang, Jae Youn] Daegu Gyeongbuk Inst Sci & Technol, Dept Informat & Commun Engn, Daegu, South Korea; [Kim, Jun-Young; Kim, Shin-Yoon] Kyungpook Natl Univ Hosp, Dept Orthoped Surg, Daegu, South Korea	Korea Advanced Institute of Science & Technology (KAIST); Daegu Gyeongbuk Institute of Science & Technology (DGIST); Kyungpook National University; Kyungpook National University Hospital	Kim, JY (corresponding author), Kyungpook Natl Univ Hosp, Dept Orthoped Surg, Daegu, South Korea.	dr.junyoung@gmail.com	Je, Minkyu/G-3056-2016; Je, Minkyu/Q-9864-2018; Je, Minkyu/P-5960-2019	Je, Minkyu/0000-0003-4580-2771	Biomedical Research Institute; Kyungpook National University Hospital [Shinjin-15-01]; Development of ICT-based software platform and service technologies for medical 3D printing applications; ICT R&D program of the Information and Communications Technology Promotion/Ministry of Science, ICT and Future Planning [B0101-16-1081]	Biomedical Research Institute; Kyungpook National University Hospital; Development of ICT-based software platform and service technologies for medical 3D printing applications; ICT R&D program of the Information and Communications Technology Promotion/Ministry of Science, ICT and Future Planning	Funded by 1) JYK, Biomedical Research Institute grant funded by Kyungpook National University Hospital, Shinjin-15-01,http://bmri.knu.ac.kr. 2) SYK, Development of ICT-based software platform and service technologies for medical 3D printing applications funded by the ICT R&D program of the Information and Communications Technology Promotion/Ministry of Science, ICT and Future Planning, B0101-16-1081, http.//www.litp.kr. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamek T, 2015, IEEE-ASME T MECH, V20, P506, DOI 10.1109/TMECH.2013.2297152; Bachmann ER, 1999, COMP INT ROB AUT CIR; Chu W, 2009, INJURY, V40, P1084, DOI 10.1016/j.injury.2009.04.008; Doke T, 2015, INT J COMPUT ASS RAD, V10, P275, DOI 10.1007/s11548-014-1079-8; GOODALL JD, 1991, INJURY, V22, P339, DOI 10.1016/0020-1383(91)90026-B; Han S., 2015, P IEEE ICCC, P1, DOI [10.1109/ICCChina.2015.7448615, DOI 10.1109/ICCCHINA.2015.7448615]; Hoffmann M, 2014, KNEE SURG SPORT TR A, V22, P2237, DOI 10.1007/s00167-013-2607-8; Kalman RE., 1960, J BASIC ENG, V82, P35, DOI [10.1115/1.3662552, DOI 10.1115/1.3662552]; Krettek C, 1998, J ORTHOPAED RES, V16, P572, DOI 10.1002/jor.1100160508; Lee M-S, 2012, SENSORS; Leloup T, 2008, IEEE T MED IMAGING, V27, P1202, DOI 10.1109/TMI.2008.920602; Liao HE, 2010, COMPUT MED IMAG GRAP, V34, P46, DOI 10.1016/j.compmedimag.2009.07.003; Madgwick SOH, 2011, INT C REHAB ROBOT; Marins JL, 2001, INT ROB SYST 2001 P; Moor BK, 2012, ORTHOP TRAUMATOL-SUR, V98, P85, DOI 10.1016/j.otsr.2011.08.010; Nakdhamabhorn S, 2011, ROB BIOM ROBIO 2011; Sabatini AM, 2006, IEEE T BIO-MED ENG, V53, P1346, DOI 10.1109/TBME.2006.875664; Yaniv Z, 2005, IEEE T MED IMAGING, V24, P624, DOI 10.1109/TMI.2005.844922; Yousef J, 2005, EUR J MED RES, V10, P254; Zheng GY, 2008, IEEE T MED IMAGING, V27, P171, DOI 10.1109/TMI.2007.904692	20	7	7	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2017	12	4							e0174407	10.1371/journal.pone.0174407	http://dx.doi.org/10.1371/journal.pone.0174407			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KD	28414721	gold, Green Published, Green Submitted			2022-12-27	WOS:000399874800003
J	Klanian, MG; Preciat, MT				Gullian Klanian, Mariel; Terrats Preciat, Montserrat			Effect of pH on temperature controlled degradation of reactive oxygen species, heat shock protein expression, and mucosal immunity in the sea cucumber Isostichopus badionotus	PLOS ONE			English	Article							APOSTICHOPUS-JAPONICUS; CRASSOSTREA-VIRGINICA; SUPEROXIDE-DISMUTASE; RESPONSES; STRESS; PHENOLOXIDASE; ENZYMES	This study evaluated the effect of pH on the activity of antioxidant and immune enzymes in the sea cucumber Isostichopus badionotus exposed to different temperatures. The organisms (530 +/- 110 g) were exposed to 16, 20, 24, 28, 30, 34 and 36 C-omicron for 6 h to evaluate thermal limits at two water pH values (treatment = 7.70; control = 8.17). For the thermal tolerance experiment, the organisms were exposed to sublethal temperature of 34 C-omicron for 3, 6, 12, 24, and 48 h. I. badionotus showed signs of thermal stress by synthesizing heat shock protein 70 (hsp70) at the cold (16 C-omicron) and warm thermal limits (34 C-omicron). The glutathione peroxidase (GPx) showed a negative correlation with superoxide dismutase (SOD) activity in modulating the effect of oxidative stress at different temperature levels. Specifically, GPx activity was maximal at the extremes of the cold and warm temperatures (16, 20, and 36 C-omicron) tested, while contrarily, the SOD activity increased significantly in the narrow range of temperature between 28 and 30 C-omicron, as a part of a reaction to offset oxidative damage. The effect of pH on the expression of hsp70 was not significant, whereas the antioxidant enzymes activity was stimulated at pH 7.70. Mucosal immunity, evidenced by the activation of the phenoloxidase (PO) system, increased above the basal level at pH 7.70 and at 28, 30, and 34 C-omicron. Independent of pH, the temperature of 34 C-omicron was identified as the 12 h-sublethal upper limit for I. badionotus.	[Gullian Klanian, Mariel; Terrats Preciat, Montserrat] Marist Univ Merida, Expt Unit, Merida, Yucatan, Mexico		Klanian, MG (corresponding author), Marist Univ Merida, Expt Unit, Merida, Yucatan, Mexico.	mgullian@marista.edu.mx	Klanian, Mariel Gullian/M-1387-2015	Klanian, Mariel Gullian/0000-0003-2195-7373	Consejo Nacional de Ciencia y Tecnologia of the Mexican Government, Mexico (FOMIX-CONACYT) [169961]; Consejo Nacional de Ciencia y Tecnologia of the Yucatan State, Mexico (FOMIX-CONACYT) [169961]	Consejo Nacional de Ciencia y Tecnologia of the Mexican Government, Mexico (FOMIX-CONACYT); Consejo Nacional de Ciencia y Tecnologia of the Yucatan State, Mexico (FOMIX-CONACYT)	This research was supported by Consejo Nacional de Ciencia y Tecnologia of the Mexican Government and Yucatan State, Mexico (FOMIX-CONACYT, no. 169961).	AEBI H, 1984, METHOD ENZYMOL, V105, P121; Dong YW, 2008, FISHERIES SCI, V74, P573, DOI 10.1111/j.1444-2906.2008.01560.x; Dong YW, 2008, AQUACULTURE, V276, P179, DOI 10.1016/j.aquaculture.2008.01.028; Dong Yunwei, 2007, Journal of Ocean University of China, V6, P275, DOI 10.1007/s11802-007-0275-3; Klanian MG, 2013, J EXP MAR BIOL ECOL, V444, P31, DOI 10.1016/j.jembe.2013.03.008; Gullian M, 2009, J SHELLFISH RES, V28, P439, DOI 10.2983/035.028.0303; Herrera-Silveira Jorge A., 1999, Aquatic Ecosystem Health & Management, V1, P353, DOI 10.1080/14634989808656930; Herrera-Silvera JA, 2004, OCEAN COAST MANAGE, V47, P625, DOI 10.1016/j.ocecoaman.2004.12.005; Heuer RM, 2014, AM J PHYSIOL-REG I, V307, pR1061, DOI 10.1152/ajpregu.00064.2014; Hu MH, 2015, FISH SHELLFISH IMMUN, V46, P573, DOI 10.1016/j.fsi.2015.07.025; Jiang JW, 2014, IMMUNOBIOLOGY, V219, P450, DOI 10.1016/j.imbio.2014.02.006; Lee YC, 2002, ANAL BIOCHEM, V310, P223, DOI 10.1016/S0003-2697(02)00320-2; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mannervik B, 1999, CURRENT PROTOCOLS TO, P721; Martin M, 1998, NEUROSCI RES, V31, P97, DOI 10.1016/S0168-0102(98)00028-5; Meng XL, 2009, AQUACULTURE, V294, P314, DOI 10.1016/j.aquaculture.2009.06.015; MILLER J E, 1984, Memoirs of the Hourglass Cruises, V7, P1; Murphy MP, 2011, CELL METAB, V13, P361, DOI 10.1016/j.cmet.2011.03.010; Parihar MS, 1997, J THERM BIOL, V22, P151, DOI 10.1016/S0306-4565(97)00006-5; Peskin AV, 2000, CLIN CHIM ACTA, V293, P157, DOI 10.1016/S0009-8981(99)00246-6; Portner HO, 2002, COMP BIOCHEM PHYS A, V132, P739, DOI 10.1016/S1095-6433(02)00045-4; Ray PD, 2012, CELL SIGNAL, V24, P981, DOI 10.1016/j.cellsig.2012.01.008; Regoli F, 1998, ARCH ENVIRON CON TOX, V35, P594, DOI 10.1007/s002449900421; SIMPSON BK, 1987, J AGR FOOD CHEM, V35, P918, DOI 10.1021/jf00078a017; SODERHALL K, 1991, AQUACULTURE, V92, P121, DOI 10.1016/0044-8486(91)90014-X; Sohal RS, 1985, BASIC LIFE SCI, DOI [10.1007/978-1-4899-2218-2_4, DOI 10.1007/978-1-4899-2218-2_4]; Somero GN, 2004, COMP BIOCHEM PHYS B, V139, P321, DOI 10.1016/j.cbpc.2004.05.003; Tomanek L, 2011, J EXP BIOL, V214, P1836, DOI 10.1242/jeb.055475; Wang FY, 2008, COMP BIOCHEM PHYS A, V151, P491, DOI 10.1016/j.cbpa.2008.06.024; Wang LU, 2005, FISH SHELLFISH IMMUN, V18, P269, DOI 10.1016/j.fsi.2004.07.008; Wittmann AC, 2013, NAT CLIM CHANGE, V3, P995, DOI 10.1038/NCLIMATE1982; Zeebe R.E., 2001, ELSEV OCEANOGR SERIE; Zetina Moguel Carlos, 2003, Proceedings of the Gulf and Caribbean Fisheries Institute, V54, P297; Zhang Q, 2010, FISH SHELLFISH IMMUN, V29, P204, DOI 10.1016/j.fsi.2010.03.009; Zhao H, 2010, CHINESE CHEM LETT, V21, P1216, DOI 10.1016/j.cclet.2010.06.010	35	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2017	12	4							e0175812	10.1371/journal.pone.0175812	http://dx.doi.org/10.1371/journal.pone.0175812			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KD	28414789	Green Published, gold			2022-12-27	WOS:000399874800059
J	Huang, HK; Lin, SM; Yang, CSH; Liang, CC; Cheng, HY				Huang, Huei Kai; Lin, Shu Man; Yang, Clement Shih Hsien; Liang, Chung Chao; Cheng, Hung Yu			Post-ischemic stroke rehabilitation is associated with a higher risk of fractures in older women: A population-based cohort study	PLOS ONE			English	Article							ISCHEMIC-STROKE; HIP FRACTURE; ELDERLY-WOMEN; MEDICAL COMPLICATIONS; FRAGILITY FRACTURES; FALLS PREVENTION; HOSPITAL-LEVEL; FOLLOW-UP; MORTALITY; INPATIENT	Background Rehabilitation can improve physical activity after stroke. However, patients may be more prone to falls and fractures because of balance and gait deficits. Few reports have studied the relationship between rehabilitation and subsequent fractures after ischemic stroke. Objective To investigate whether post-stroke rehabilitation affects fracture risk. Methods We conducted a population-based retrospective cohort study based on the Taiwan National Health Insurance Research Database. Patients with a newly diagnosed ischemic stroke between 2000 and 2012 were included. After propensity score matching, a total of 8,384 patients were enrolled. Half of the patients (4,192) received post-stroke rehabilitation within 1 month; the other half did not receive any post-stroke rehabilitation. Cox proportional hazards regression model was used to calculate hazard ratios (HRs) for fractures among patients with and without rehabilitation within 1 year after ischemic stroke. Patients were further stratified by sex and age (20-64 and >= 65 years). Results Patients receiving post-stroke rehabilitation had a higher incidence of fracture (6.2 per 100 person-years) than those who did not (4.1 per 100 person-years) after adjustment for socio-demographic and coexisting medical conditions [HR = 1.53, 95% confidence interval (CI) = 1.25-1.87, p < 0.001]. The analyses performed after stratifying for sex and age showed that only older women undergoing rehabilitation had a significantly higher risk of fracture (HR = 1.62, 95% CI = 1.21-2.17, p = 0.001). Conclusion Rehabilitation after ischemic stroke is associated with an increased fracture risk in older women.	[Huang, Huei Kai] Buddhist Tzu Chi Gen Hosp, Dept Family Med, Hualien, Taiwan; [Lin, Shu Man; Yang, Clement Shih Hsien; Liang, Chung Chao; Cheng, Hung Yu] Buddhist Tzu Chi Gen Hosp, Dept Phys Med & Rehabil, Hualien, Taiwan	Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital	Cheng, HY (corresponding author), Buddhist Tzu Chi Gen Hosp, Dept Phys Med & Rehabil, Hualien, Taiwan.	hycheng@tzuchi.com.tw	Huang, Huei-Kai/J-9220-2019	Huang, Huei-Kai/0000-0003-3612-653X; Lin, Shu-Man/0000-0002-3257-0038				Alegre-Lopez J, 2005, OSTEOPOROSIS INT, V16, P729, DOI 10.1007/s00198-004-1740-0; Alexandru Daniela, 2012, Perm J, V16, P46; Allen C, 1999, LANCET, V354, P1229, DOI 10.1016/S0140-6736(98)10063-6; Andersen KK, 2009, STROKE, V40, P2068, DOI 10.1161/STROKEAHA.108.540112; Batchelor F, 2010, STROKE, V41, P1715, DOI 10.1161/STROKEAHA.109.570390; Batchelor FA, 2012, ARCH PHYS MED REHAB, V93, P1648, DOI 10.1016/j.apmr.2012.03.031; Bernhardt J, 2004, STROKE, V35, P1005, DOI 10.1161/01.STR.0000120727.40792.40; Bernhardt J, 2008, STROKE, V39, P390, DOI 10.1161/STROKEAHA.107.492363; Bliuc D, 2015, J BONE MINER RES, V30, P637, DOI 10.1002/jbmr.2393; Bouza C, 2007, OSTEOPOROSIS INT, V18, P649, DOI 10.1007/s00198-006-0292-x; Callaly EL, 2015, AGE AGEING, V44, P882, DOI 10.1093/ageing/afv093; Cauley JA, 2000, OSTEOPOROSIS INT, V11, P556, DOI 10.1007/s001980070075; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chen HF, 2009, J WOMENS HEALTH, V18, P647, DOI 10.1089/jwh.2008.0918; Chen TT, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003620; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; Cheng PT, 2001, ARCH PHYS MED REHAB, V82, P1650, DOI 10.1053/apmr.2001.26256; Chiu HF, 2011, AM J GASTROENTEROL, V106, P894, DOI 10.1038/ajg.2010.475; Chou YC, 2012, J REHABIL MED, V44, P319, DOI 10.2340/16501977-0935; Dennis MS, 2002, STROKE, V33, P728, DOI 10.1161/hs0302.103621; Dionyssiotis Y, 2014, CLIN MED INSIGHTS-AR, V7, P33, DOI 10.4137/CMAMD.S14077; Diserens K, 2012, CLIN REHABIL, V26, P451, DOI 10.1177/0269215511425541; Empana JP, 2004, J AM GERIATR SOC, V52, P685, DOI 10.1111/j.1532-5415.2004.52203.x; Franzo A, 2005, EUR J EPIDEMIOL, V20, P985, DOI 10.1007/s10654-005-4280-9; Govan L, 2007, STROKE, V38, P2536, DOI 10.1161/STROKEAHA.106.478842; Green J, 2002, LANCET, V359, P199, DOI 10.1016/S0140-6736(02)07443-3; Harnod T, 2015, MEDICINE, V94, DOI [10.1097/MD.0000000000001506, 10.1097/MD.0000000000001571]; Indredavik B, 1999, STROKE, V30, P917, DOI 10.1161/01.STR.30.5.917; Jalayondeja C, 2014, GERIATR GERONTOL INT, V14, P778, DOI 10.1111/ggi.12164; Johansson J, 2016, J AM MED DIR ASSOC, V17, P535, DOI 10.1016/j.jamda.2016.02.009; Kanis J, 2001, STROKE, V32, P702, DOI 10.1161/01.STR.32.3.702; Kanis JA, 2004, OSTEOPOROSIS INT, V15, P108, DOI 10.1007/s00198-003-1516-y; Kapral MK, 2016, NEUROLOGY; Krakauer JW, 2012, NEUROREHAB NEURAL RE, V26, P923, DOI 10.1177/1545968312440745; Kwok T, 2006, J CLIN NURS, V15, P581, DOI 10.1111/j.1365-2702.2006.01354.x; Langhorne P, 1999, CEREBROVASC DIS, V9, P2, DOI 10.1159/000047570; Langhorne P, 2000, STROKE, V31, P1223, DOI 10.1161/01.STR.31.6.1223; Lee A. Y. J., 2007, SMJ Singapore Medical Journal, V48, P996; Lee HC, 2013, J CHIN MED ASSOC, V76, P703, DOI 10.1016/j.jcma.2013.08.003; Lee HC, 2010, AM J MANAG CARE, V16, pE67; Levesque LE, 2010, BRIT MED J, V340, DOI 10.1136/bmj.b5087; Lin HC, 2008, STROKE, V39, P2744, DOI 10.1161/STROKEAHA.108.519090; Liu CY., 2006, J HLTH MANAGEMENT, V4, P1, DOI DOI 10.29805/JHM.200606.0001; Lofman O, 2007, ACTA ORTHOP, V78, P813, DOI 10.1080/17453670710014608; Marigold DS, 2005, J AM GERIATR SOC, V53, P416, DOI 10.1111/j.1532-5415.2005.53158.x; MAYO NE, 1994, ARCH PHYS MED REHAB, V75, P1302; McLean DE, 2004, ARCH PHYS MED REHAB, V85, P466, DOI 10.1016/S0003-9993(03)00484-2; Mittmann N, 2012, CAN J NEUROL SCI, V39, P793, DOI 10.1017/S0317167100015638; Murphy TH, 2009, NAT REV NEUROSCI, V10, P861, DOI 10.1038/nrn2735; Naves M, 2003, OSTEOPOROSIS INT, V14, P520, DOI 10.1007/s00198-003-1405-4; NEVITT MC, 1993, J AM GERIATR SOC, V41, P1226, DOI 10.1111/j.1532-5415.1993.tb07307.x; NYBERG L, 1995, STROKE, V26, P838, DOI 10.1161/01.STR.26.5.838; OLOUGHLIN JL, 1993, AM J EPIDEMIOL, V137, P342, DOI 10.1093/oxfordjournals.aje.a116681; Palvanen M, 2000, OSTEOPOROSIS INT, V11, P822, DOI 10.1007/s001980070040; Panula J, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-105; Pfeifer M, 2004, J BONE MINER RES, V19, P1208, DOI 10.1359/JBMR.040507; Pisani P, 2016, WORLD J ORTHOP, V7, P171, DOI 10.5312/wjo.v7.i3.171; Pouwels S, 2009, STROKE, V40, P3281, DOI 10.1161/STROKEAHA.109.554055; Ramnemark A, 1998, OSTEOPOROSIS INT, V8, P92, DOI 10.1007/s001980050053; Ramnemark A, 2000, STROKE, V31, P1572, DOI 10.1161/01.STR.31.7.1572; Scheffer AC, 2008, AGE AGEING, V37, P19, DOI 10.1093/ageing/afm169; Schmid AA, 2012, ARCH PHYS MED REHAB, V93, P1101, DOI 10.1016/j.apmr.2012.01.020; Simpson LA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019431; SPEECHLEY M, 1991, J AM GERIATR SOC, V39, P46, DOI 10.1111/j.1532-5415.1991.tb05905.x; Sung SF, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1769-8; Sung SF, 2015, J CLIN EPIDEMIOL, V68, P1292, DOI 10.1016/j.jclinepi.2015.01.009; Teng GG, 2008, CLIN EXP RHEUMATOL, V26, pS125; Tsan YT, 2012, J CLIN ONCOL, V30, P623, DOI 10.1200/JCO.2011.36.0917; Tung YC, 2015, INT J QUAL HEALTH C, V27, P260, DOI 10.1093/intqhc/mzv038; Verheyden GSAF, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008728.pub2; von Koch L, 2001, CEREBROVASC DIS, V12, P131, DOI 10.1159/000047692; Wang WJ, 2014, J BONE MINER RES, V29, P676, DOI 10.1002/jbmr.2061; Weerdesteyn V, 2008, J REHABIL RES DEV, V45, P1195, DOI 10.1682/JRRD.2007.09.0145; Woolcott JC, 2009, ARCH INTERN MED, V169, P1952, DOI 10.1001/archinternmed.2009.357; Wu CH, 2011, ARCH PHYS MED REHAB, V92, P1987, DOI 10.1016/j.apmr.2011.06.028; Wu JC, 2012, NEUROSURGERY, V70, P594, DOI 10.1227/NEU.0b013e318232d4f2; Yang NP, 2010, INJURY, V41, P1266, DOI 10.1016/j.injury.2010.05.025	77	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2017	12	4							e0175825	10.1371/journal.pone.0175825	http://dx.doi.org/10.1371/journal.pone.0175825			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES9KD	28414796	Green Submitted, gold, Green Published			2022-12-27	WOS:000399874800060
J	Fernandez-Caballero, JA; Alvarez, M; Chueca, N; Perez, AB; Garcia, F				Fernandez-Caballero, J. A.; Alvarez, M.; Chueca, N.; Perez, A. B.; Garcia, F.			The cobas (R) HCV GT is a new tool that accurately identifies Hepatitis C virus genotypes for clinical practice	PLOS ONE			English	Article							ASSAY	Objective We aimed to evaluate the correct assignment of HCV genotype/subtypes 1a and 1b by cobas (R) HCV genotyping (GT) assay (Roche Molecular Diagnostics) compared with nonstructural protein 5B (NS5B) sequencing. Patients and methods Clinical samples from 153 patients submitted for HCV genotyping were studied. After genotyping with the cobas (R) HCV GT, sequencing of a 387 bp fragment in the NS5B gene and phylogenetic analysis was employed to compare genotyping results. Major discrepancies were defined as differences in the assigned genotype by cobas (R) HCV GT and NS5B sequencing (including genotype 1 subtypes 1a and 1b misclassification). Results Overall agreement between the cobas (R) HCV GT and NS5B sequencing was 98%; all the 1a, 1b, 2, 3 and 4 genotypes identified by cobas (R) HCV GT were concordant with NS5B sequencing. Three samples tested "indetermined" by cobas (R) HCV GT assay and were genotyped as 1a, 3a, and 4d by NS5B sequencing. Conclussion These results indicate that the cobas (R) HCV GT assay correctly identifies HCV genotypes, and points out the importance of additional methods based on DNA sequencing for resolving indeterminate results.	[Fernandez-Caballero, J. A.; Alvarez, M.; Chueca, N.; Perez, A. B.; Garcia, F.] Complejo Hosp Univ Granada, Hosp PTS, Inst Invest Biosanitaria IBS, Serv Microbiol, Granada, Spain	Instituto de Investigacion Biosanitaria IBS Granada; University of Granada	Alvarez, M (corresponding author), Complejo Hosp Univ Granada, Hosp PTS, Inst Invest Biosanitaria IBS, Serv Microbiol, Granada, Spain.	Martaalvest@yahoo.es	Chueca, Natalia/T-9734-2019; Chueca, Natalia/K-5225-2014; Garcia, Federico/AAA-3175-2020	Chueca, Natalia/0000-0002-3420-3290; Chueca, Natalia/0000-0002-3420-3290; Garcia, Federico/0000-0001-7611-781X; Perez, Ana Belen/0000-0001-9655-817X	Fondo de Investigacion Sanitaria [PI15/00713]; Plan Nacional de I+D+I and Fondo Europeo de Desarrollo Regional-FEDER [RD12/0017/006]; Fundacion Progreso y salud, Junta de Andalucia [PI-0411-2014]; Programa de Intensificacion de la Actividad de Investigacion del Servicio Andaluz de Salud	Fondo de Investigacion Sanitaria(Instituto de Salud Carlos III); Plan Nacional de I+D+I and Fondo Europeo de Desarrollo Regional-FEDER; Fundacion Progreso y salud, Junta de Andalucia(Junta de Andalucia); Programa de Intensificacion de la Actividad de Investigacion del Servicio Andaluz de Salud	This work was supported in part by grants from Fondo de Investigacion Sanitaria (www.isciii.es) (PI15/00713), Plan Nacional de I+D+I and Fondo Europeo de Desarrollo Regional-FEDER (www.red.es/redes/inicio) (RD12/0017/006), and Fundacion Progreso y salud, Junta de Andalucia (www.fps2.junta-andalucia.es/fundacionprogresoysalud/es/home) (PI-0411-2014). Federico Garcia has received a research extension grant from the Programa de Intensificacion de la Actividad de Investigacion del Servicio Andaluz de Salud.	Benedet M, 2014, J CLIN VIROL, V60, P301, DOI 10.1016/j.jcv.2014.04.005; Chevaliez S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008209; Chueca N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153754; Chung RT, 2015, HEPATOLOGY, V62, P932, DOI 10.1002/hep.27950; European Ass Study Liver, 2017, J HEPATOL, V66, P153, DOI 10.1016/j.jhep.2016.09.001; Gonzalez V, 2013, J CLIN VIROL, V58, P249, DOI 10.1016/j.jcv.2013.05.005; Lontok E, 2015, HEPATOLOGY, V62, P1623, DOI 10.1002/hep.27934; Messina JP, 2015, HEPATOLOGY, V61, P77, DOI 10.1002/hep.27259; Schuermans W, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17091384; Silberstein FC, 2016, HEPATOLOGY, V63, P1058, DOI 10.1002/hep.27895; Sistema Nacional de Salud, 2015, PLAN ESTR AB HEP C S; Smith DB, 2014, HEPATOLOGY, V59, P318, DOI 10.1002/hep.26744; Stelzl E, 2017, CLIN CHEM LAB MED, V55, P517, DOI 10.1515/cclm-2016-0620	13	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2017	12	4							e0175564	10.1371/journal.pone.0175564	http://dx.doi.org/10.1371/journal.pone.0175564			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0MD	28410425	Green Published, gold, Green Submitted			2022-12-27	WOS:000399955600026
J	Vullings, R; Verdurmen, KMJ; Hulsenboom, ADJ; Scheffer, S; de Lau, H; Kwee, A; Wijn, PFF; Amer-Wahlin, I; van Laar, JEH; Oei, SG				Vullings, Rik; Verdurmen, Kim M. J.; Hulsenboom, Alexandra D. J.; Scheffer, Stephanie; de Lau, Hinke; Kwee, Anneke; Wijn, Pieter F. F.; Amer-Wahlin, Isis; van Laar, Judith E. H.; Oei, S. Guid			The electrical heart axis and ST events in fetal monitoring: A post-hoc analysis following a multicentre randomised controlled trial	PLOS ONE			English	Article							WAVE-FORM ANALYSIS; LAMB ELECTROCARDIOGRAM; CARDIOTOCOGRAPHY; PHOSPHATE; GLYCOGEN	Objective Reducing perinatal morbidity and mortality is one of the major challenges in modern health care. Analysing the ST segment of the fetal electrocardiogram was thought to be the breakthrough in fetal monitoring during labour. However, its implementation in clinical practice yields many false alarms and ST monitoring is highly dependent on cardiotocogram assessment, limiting its value for the prediction of fetal distress during labour. This study aims to evaluate the relation between physiological variations in the orientation of the fetal electrical heart axis and the occurrence of ST events. Methods A post-hoc analysis was performed following a multicentre randomised controlled trial, including 1097 patients from two participating centres. All women were monitored with ST analysis during labour. Cases of fetal metabolic acidosis, poor signal quality, missing blood gas analysis, and congenital heart disease were excluded. The orientation of the fetal electrical heart axis affects the height of the initial T/QRS baseline, and therefore the incidence of ST events. We grouped tracings with the same initial baseline T/QRS value. We depicted the number of ST events as a function of the initial baseline T/QRS value with a linear regression model. Results A significant increment of ST events was observed with increasing height of the initial T/QRS baseline, irrespective of the fetal condition; correlation coefficient 0.63, p<0.001. The most frequent T/QRS baseline is 0.12. Conclusion The orientation of the fetal electrical heart axis and accordingly the height of the initial T/QRS baseline should be taken into account in fetal monitoring with ST analysis.	[Vullings, Rik; Oei, S. Guid] Eindhoven Univ Technol, Dept Elect Engn, Eindhoven, Netherlands; [Verdurmen, Kim M. J.; Hulsenboom, Alexandra D. J.; Scheffer, Stephanie; de Lau, Hinke; van Laar, Judith E. H.; Oei, S. Guid] Maxima Med Ctr, Dept Obstet & Gynaecol, Veldhoven, Netherlands; [Kwee, Anneke] Univ Med Ctr Utrecht, Dept Obstet & Gynaecol, Utrecht, Netherlands; [Wijn, Pieter F. F.] Maxima Med Ctr, Dept Clin Phys, Veldhoven, Netherlands; [Amer-Wahlin, Isis] Karolinska Inst, Dept Women & Child Hlth, Stockholm, Sweden	Eindhoven University of Technology; Maxima Medical Center; Utrecht University; Utrecht University Medical Center; Maxima Medical Center; Karolinska Institutet	Verdurmen, KMJ (corresponding author), Maxima Med Ctr, Dept Obstet & Gynaecol, Veldhoven, Netherlands.	kimverdurmen@live.nl	Vullings, Rik/GQP-6225-2022	Vullings, Rik/0000-0002-2392-6098	Dutch Technology Foundation STW	Dutch Technology Foundation STW(Technologiestichting STW)	This research was financially supported by Dutch Technology Foundation STW. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Funding was received by RV.	Alfirevic Z, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006066.pub2; Amer-Wahlin I, 2001, LANCET, V358, P534, DOI 10.1016/S0140-6736(01)05703-8; Becker JH, 2012, ACTA OBSTET GYN SCAN, V91, P189, DOI 10.1111/j.1600-0412.2011.01320.x; Belfort MA, 2015, NEW ENGL J MED, V373, P632, DOI 10.1056/NEJMoa1500600; Blix E, 2016, ACTA OBSTET GYN SCAN, V95, P16, DOI 10.1111/aogs.12828; DEPASQUALE NP, 1963, AM J CARDIOL, V12, P482, DOI 10.1016/0002-9149(63)90187-5; EINTHOVEN W, 1950, AM HEART J, V40, P163, DOI 10.1016/0002-8703(50)90165-7; Fenn WO, 1939, J BIOL CHEM, V128, P297; Goodacre S, 2002, BRIT MED J, V324, P1382, DOI 10.1136/bmj.324.7350.1382; GREENE KR, 1982, AM J OBSTET GYNECOL, V144, P950, DOI 10.1016/0002-9378(82)90190-9; Holzmann M, 2015, J PERINAT MED, V184, P97; Anneke K, 2007, EUR J OBSTET GYN R B, V135, P28, DOI 10.1016/j.ejogrb.2006.10.022; LARKS SD, 1965, AM J OBSTET GYNECOL, V91, P46, DOI 10.1016/0002-9378(65)90585-5; Neilson JP, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000116.pub5; Ojala K, 2006, BJOG-INT J OBSTET GY, V113, P419, DOI 10.1111/j.1471-0528.2006.00886.x; ROSEN KG, 1976, BIOL NEONATE, V30, P17; Saccone G, 2016, OBSTET GYNECOL, V127, P127, DOI 10.1097/AOG.0000000000001198; SCHAFFER AI, 1952, AM HEART J, V44, P89, DOI 10.1016/0002-8703(52)90175-0; Schuit E, 2013, AM J OBSTET GYNECOL, V208, DOI 10.1016/j.ajog.2013.01.028; Van Laar JOEH, 2014, ACTA OBSTET GYN SCAN, V93, P93, DOI 10.1111/aogs.12286; Vayssiere C, 2016, ACTA OBSTET GYN SCAN, V95, P1190, DOI 10.1111/aogs.12923; Vayssiere C, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.07.007; Verdurmen KMJ, 2016, EUR J OBSTE IN PRESS; Wagner Galen S, 2014, MARRIOTTS PRACTICAL; Westerhuis MEMH, 2009, BJOG-INT J OBSTET GY, V116, P545, DOI 10.1111/j.1471-0528.2008.02092.x; Westerhuis MEMH, 2011, OBSTET GYNECOL, V117, P406, DOI 10.1097/AOG.0b013e3182083dcd; WESTGATE J, 1993, AM J OBSTET GYNECOL, V169, P1151, DOI 10.1016/0002-9378(93)90273-L; WESTGATE J, 1992, LANCET, V340, P194, DOI 10.1016/0140-6736(92)90465-F; Westgate JA, 2001, AM J OBSTET GYNECOL, V184, P743, DOI 10.1067/mob.2001.111932; WIDMARK C, 1992, J DEV PHYSIOL, V18, P99	30	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2017	12	4							e0175823	10.1371/journal.pone.0175823	http://dx.doi.org/10.1371/journal.pone.0175823			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0MD	28410419	gold, Green Published, Green Submitted			2022-12-27	WOS:000399955600046
J	Eskes, M; van Alphen, MJA; Balm, AJM; Smeele, LE; Brandsma, D; van der Heijden, F				Eskes, Merijn; van Alphen, Maarten J. A.; Balm, Alfons J. M.; Smeele, Ludi E.; Brandsma, Dieta; van der Heijden, Ferdinand			Predicting 3D lip shapes using facial surface EMG	PLOS ONE			English	Article							ELECTROMYOGRAPHY; RECOGNITION; SURGERY; CANCER; MODEL	Aim The aim of this study is to prove that facial surface electromyography (sEMG) conveys sufficient information to predict 3D lip shapes. High sEMG predictive accuracy implies we could train a neural control model for activation of biomechanical models by simultaneously recording sEMG signals and their associated motions. Materials and methods With a stereo camera set-up, we recorded 3D lip shapes and simultaneously performed sEMG measurements of the facial muscles, applying principal component analysis (PCA) and a modified general regression neural network (GRNN) to link the sEMG measurements to 3D lip shapes. To test reproducibility, we conducted our experiment on five volunteers, evaluating several sEMG features and window lengths in unipolar and bipolar configurations in search of the optimal settings for facial sEMG. Conclusions The errors of the two methods were comparable. We managed to predict 3D lip shapes with a mean accuracy of 2.76 mm when using the PCA method and 2.78 mm when using modified GRNN. Whereas performance improved with shorter window lengths, feature type and configuration had little influence.	[Eskes, Merijn; van Alphen, Maarten J. A.; Balm, Alfons J. M.; Smeele, Ludi E.; van der Heijden, Ferdinand] Netherlands Canc Inst, Dept Head & Neck Oncol & Surg, Amsterdam, Netherlands; [Eskes, Merijn; van der Heijden, Ferdinand] Univ Twente, MIRA Inst Biomed Engn & Tech Med, Enschede, Netherlands; [Balm, Alfons J. M.; Smeele, Ludi E.] Acad Med Ctr, Dept Oral & Maxillofacial Surg, Amsterdam, Netherlands; [Brandsma, Dieta] Netherlands Canc Inst, Dept Neurooncol, Amsterdam, Netherlands; [Brandsma, Dieta] Slotervaart Hosp, Dept Neurol, Amsterdam, Netherlands	Netherlands Cancer Institute; University of Twente; University of Amsterdam; Academic Medical Center Amsterdam; Netherlands Cancer Institute; Slotervaart Hospital	Eskes, M (corresponding author), Netherlands Canc Inst, Dept Head & Neck Oncol & Surg, Amsterdam, Netherlands.; Eskes, M (corresponding author), Univ Twente, MIRA Inst Biomed Engn & Tech Med, Enschede, Netherlands.	m.eskes@nki.nl		van Alphen, Maarten/0000-0002-3551-6707; van der Heijden, Ferdinand/0000-0001-8065-8053				Arjunan SP, 2008, LECT NOTES BUS INF P, V12, P366; Beskow J., 2003, TALKING HEADS MODELS; Betts BJ, 2006, INTERACT COMPUT, V18, P1242, DOI 10.1016/j.intcom.2006.08.012; Brumberg JS, 2010, SPEECH COMMUN, V52, P367, DOI 10.1016/j.specom.2010.01.001; Denby B, 2010, SPEECH COMMUN, V52, P270, DOI 10.1016/j.specom.2009.08.002; Gore SM, 2015, HEAD NECK-J SCI SPEC, V37, P518, DOI 10.1002/hed.23626; Hamedi Mahyar, 2011, Journal of Computer Sciences, V7, P1407, DOI 10.3844/jcssp.2011.1407.1415; Hamedi M, 2011, INT J NANOMED, V6, P3461, DOI 10.2147/IJN.S26619; HONDA K, 1995, J PHONETICS, V23, P243, DOI 10.1016/S0095-4470(95)80046-8; Jou SC, 2006, INT CONF ACOUST SPEE, P605; Kreeft A, 2009, CLIN OTOLARYNGOL, V34, P140, DOI 10.1111/j.1749-4486.2009.01884.x; Kreeft AM, 2009, EUR ARCH OTO-RHINO-L, V266, P1687, DOI 10.1007/s00405-009-1089-2; Langkvist M, 2014, PATTERN RECOGN LETT, V42, P11, DOI 10.1016/j.patrec.2014.01.008; Lapatki BG, 2010, PSYCHOPHYSIOLOGY, V47, P299, DOI 10.1111/j.1469-8986.2009.00935.x; Lapatki BG, 2005, FACIAL PALSIES COMPL, P89; Lucero JC, 1999, J ACOUST SOC AM, V106, P2834, DOI 10.1121/1.428108; Meltzner GS, 2011, IEEE ENG MED BIO, P4848, DOI 10.1109/IEMBS.2011.6091201; Meltzner GS, 2008, INTERSPEECH 2008: 9TH ANNUAL CONFERENCE OF THE INTERNATIONAL SPEECH COMMUNICATION ASSOCIATION 2008, VOLS 1-5, P2667; Phinyomark A, 2012, ELEKTRON ELEKTROTECH, V122, P27, DOI 10.5755/j01.eee.122.6.1816; Schuenke M, 2010, THIEME ATLAS ANATOMY, P44; Schultz T, 2010, SPEECH COMMUN, V52, P341, DOI 10.1016/j.specom.2009.12.002; SPECHT DF, 1991, IEEE T NEURAL NETWOR, V2, P568, DOI 10.1109/72.97934; Staudenmann D, 2005, J ELECTROMYOGR KINES, V15, P1, DOI 10.1016/j.jelekin.2004.06.008; Stavness I, 2012, J BIOMECH, V45, P2841, DOI 10.1016/j.jbiomech.2012.08.031; van Alphen MJA, 2013, BRIT J ORAL MAX SURG, V51, P747, DOI 10.1016/j.bjoms.2013.06.012; Van Der Heijden F., 2005, CLASSIFICATION PARAM; Wand M, 2014, IEEE ENG MED BIO, P4200, DOI 10.1109/EMBC.2014.6944550	27	6	6	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2017	12	4							e0175025	10.1371/journal.pone.0175025	http://dx.doi.org/10.1371/journal.pone.0175025			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0MB	28406945	Green Published, Green Submitted, gold			2022-12-27	WOS:000399955400028
J	Foreman, J; Xie, J; Keel, S; Taylor, HR; Dirani, M				Foreman, Joshua; Xie, Jing; Keel, Stuart; Taylor, Hugh R.; Dirani, Mohamed			Treatment coverage rates for refractive error in the National Eye Health survey	PLOS ONE			English	Article							BLUE MOUNTAINS EYE; OLDER POPULATION; AUTOREFRACTION; AUSTRALIANS; PREVALENCE; SERVICES; VISION; ACCESS; MYOPIA	Objective To present treatment coverage rates and risk factors associated with uncorrected refractive error in Australia. Methods Thirty population clusters were randomly selected from all geographic remoteness strata in Australia to provide samples of 1738 Indigenous Australians aged 40 years and older and 3098 non-Indigenous Australians aged 50 years and older. Presenting visual acuity was measured and those with vision loss (worse than 6/12) underwent pinhole testing and handheld auto-refraction. Participants whose corrected visual acuity improved to be 6/12 or better were assigned as having uncorrected refractive error as the main cause of vision loss. The treatment coverage rates of refractive error were calculated (proportion of participants with refractive error that had distance correction and presenting visual acuity better than 6/12), and risk factor analysis for refractive correction was performed. Results The refractive error treatment coverage rate in Indigenous Australians of 82.2% (95% CI 78.6-85.3) was significantly lower than in non-Indigenous Australians (93.5%, 92.0-94.8) (Odds ratio [OR] 0.51, 0.35-0.75). In Indigenous participants, remoteness (OR 0.41, 0.19-0.89 and OR 0.55, 0.35-0.85 in Outer Regional and Very Remote areas, respectively), having never undergone an eye examination (OR 0.08, 0.02-0.43) and having consulted a health worker other than an optometrist or ophthalmologist (OR 0.30, 0.11-0.84) were risk factors for low coverage. On the other hand, speaking English was a protective factor (OR 2.72, 1.13-6.45) for treatment of refractive error. Compared to non-Indigenous Australians who had an eye examination within one year, participants who had not undergone an eye examination within the past five years (OR 0.08, 0.03-0.21) or had never been examined (OR 0.05, 0.10-0.23) had lower coverage. Conclusion Interventions that increase integrated optometry services in regional and remote Indigenous communities may improve the treatment coverage rate of refractive error. Increasing refractive error treatment coverage rates in both Indigenous and non-Indigenous Australians through at least five-yearly eye examinations and the provision of affordable spectacles will significantly reduce the national burden of vision loss in Australia.	[Foreman, Joshua; Xie, Jing; Keel, Stuart; Dirani, Mohamed] Royal Victorian Eye & Ear Hosp, Ctr Eye Res Australia, Melbourne, Vic, Australia; [Foreman, Joshua; Xie, Jing; Keel, Stuart; Dirani, Mohamed] Univ Melbourne, Dept Surg, Ophthalmol, Melbourne, Vic, Australia; [Taylor, Hugh R.] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Indigenous Eye Hlth Unit, Melbourne, Vic, Australia	Centre for Eye Research Australia; Royal Victorian Eye & Ear Hospital; University of Melbourne; University of Melbourne	Foreman, J (corresponding author), Royal Victorian Eye & Ear Hosp, Ctr Eye Res Australia, Melbourne, Vic, Australia.; Foreman, J (corresponding author), Univ Melbourne, Dept Surg, Ophthalmol, Melbourne, Vic, Australia.	foreman.j@unmelb.edu.au	xie, jing/GRY-1689-2022	/0000-0001-6694-3587; Foreman, Joshua/0000-0002-3685-4054	National Eye Health Survey from Australian Government Department of Health; Novartis Pharmaceuticals	National Eye Health Survey from Australian Government Department of Health; Novartis Pharmaceuticals(Novartis)	The National Eye Health Survey received funding from the Australian Government Department of Health and Novartis Pharmaceuticals. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anjou MD, 2013, CLIN EXP OPHTHALMOL, V41, P320, DOI 10.1111/j.1442-9071.2012.02886.x; [Anonymous], 2013, UNIVERSAL EYE HLTH G; Attebo K, 1999, OPHTHALMOLOGY, V106, P1066, DOI 10.1016/S0161-6420(99)90251-8; Australian Government Department of Health, 2014, IMPL PLAN NAT FRAM A; Australian Institute of Health and Welfare AIHW, 2005, BULLETIN, V27; Bourne RRA, 2013, LANCET GLOB HEALTH, V1, pE339, DOI 10.1016/S2214-109X(13)70113-X; de Juan V, 2012, CLIN EXP OPHTHALMOL, V40, P134, DOI 10.1111/j.1442-9071.2011.02650.x; DeCarlo DK, 2013, INVEST OPHTH VIS SCI, V54, P19, DOI 10.1167/iovs.12-10508; Foreman J, 2016, CLIN EXP OPHTHALMOL; Keeffe JE, 2002, BRIT J OPHTHALMOL, V86, P24, DOI 10.1136/bjo.86.1.24; Kelaher M, 2012, BMC OPHTHALMOL, V12, DOI 10.1186/1471-2415-12-51; Kempen AH, 2004, ARCH OPHTHALMOL-CHIC, V122, P495; Kiely PM, 2011, CLIN EXP OPTOM, V94, P468, DOI 10.1111/j.1444-0938.2011.00590.x; Liou HL, 1999, AM J OPHTHALMOL, V127, P590, DOI 10.1016/S0002-9394(98)00449-8; Muller A, 2007, CLIN EXP OPHTHALMOL, V35, P305, DOI 10.1111/j.1442-9071.2007.01450.x; Productivity Commission, 2005, RES REPORT; Saw SM, 2005, OPHTHAL PHYSL OPT, V25, P381, DOI 10.1111/j.1475-1313.2005.00298.x; Taylor HR, 2004, INVEST OPHTH VIS SCI, V45, P2539, DOI 10.1167/iovs.03-1198; Taylor HR, 2012, MED J AUSTRALIA, V197, P613, DOI 10.5694/mja12.10544; Thiagalingam S, 2002, BRIT J OPHTHALMOL, V86, P1041, DOI 10.1136/bjo.86.9.1041; Tuncer I, 2014, INT J OPHTHALMOL-CHI, V7, P491, DOI 10.3980/j.issn.2222-3959.2014.03.19; Turner AW, 2011, CLIN EXP OPHTHALMOL, V39, P598, DOI 10.1111/j.1442-9071.2011.02529.x; Wensor M, 1999, ARCH OPHTHALMOL-CHIC, V117, P658	23	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2017	12	4							e0175353	10.1371/journal.pone.0175353	http://dx.doi.org/10.1371/journal.pone.0175353			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0MB	28407009	Green Published, gold			2022-12-27	WOS:000399955400044
J	Lee, SH; Kim, AR; Lee, DH; Rubino, I; Choi, HJ; Quan, FS				Lee, Su-Hwa; Kim, Ah-Ra; Lee, Dong-Hun; Rubino, Ilaria; Choi, Hyo-Jick; Quan, Fu-Shi			Protection induced by virus-like particles containing Toxoplasma gondii microneme protein 8 against highly virulent RH strain of Toxoplasma gondii infection	PLOS ONE			English	Article							IMMUNE-RESPONSES; INFLUENZA-VIRUS; BALB/C MICE; VACCINATION; VACCINES; SAG1; IMMUNOGENICITY; INVASION; GENES	Toxoplasma gondii (T. gondii) microneme protein 8 (MIC8) represents a novel, functional distinct invasion factor. In this study, we generated virus-like particles (VLPs) targeting Toxoplasma gondii MIC8 for the first time, and investigated the protection against highly virulent RH strain of T. gondii in a mouse model. We found that VLP vaccination induced Toxoplasma gondii-specific IgG and IgG1 antibody responses in the sera. Upon challenge infection with RH strain of T. gondii tachyzoites, vaccinated mice showed a significant increase of both IgG antibodies in sera and IgA antibodies in feces compared to those before challenge, and a rapid expansion of both germinal center B cell (B220(+), GL7(+)) and T cell (CD4(+), CD8(+)) populations. Importantly, intranasally immunized mice showed higher neutralizing antibodies and displayed no proinflammatory cytokine IFN-gamma in the spleen. Mice were completely protected from a lethal challenge infection with the highly virulent T. gondii (RH) showing no body weight loss (100% survival). Our study shows the effective protection against T. gondii infection provided by VLPs containing microneme protein 8 of T. gondii, thus indicating a potential T. gondii vaccine candidate.	[Lee, Su-Hwa; Kim, Ah-Ra; Lee, Dong-Hun] Kyung Hee Univ, Grad Sch, Dept Biomed Sci, Seoul, South Korea; [Rubino, Ilaria; Choi, Hyo-Jick] Univ Alberta, Dept Chem & Mat Engn, Edmonton, AB, Canada; [Quan, Fu-Shi] Kyung Hee Univ, Dept Med Zool, Sch Med, Seoul, South Korea	Kyung Hee University; University of Alberta; Kyung Hee University	Quan, FS (corresponding author), Kyung Hee Univ, Dept Med Zool, Sch Med, Seoul, South Korea.	fsquan@khu.ac.kr	Quan, Fu-Shi/V-1826-2019	Choi, Hyo-Jick/0000-0001-8233-5864; Rubino, Ilaria/0000-0003-1589-1566	National Research Foundation of Korea [NRF-2014R1A2A2A01004899]; Agri-Bio Industry Technology Development Program [315030-03-1-HD020]; Ministry of Health and Welfare, Republic of Korea [HI15C2928]	National Research Foundation of Korea(National Research Foundation of Korea); Agri-Bio Industry Technology Development Program; Ministry of Health and Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	The National Research Foundation of Korea (NRF-2014R1A2A2A01004899) to Dr. Fu-Shi Quan; the Agri-Bio Industry Technology Development Program (315030-03-1-HD020) to Dr. Fu-ShiQuan; and the Ministry of Health and Welfare, Republic of Korea (HI15C2928) to Dr. FuS hi Quan.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cuellar JA, 2012, BIOMEDICA, V32, P461, DOI [10.7705/biomedica.v32i3.485, 10.1590/S0120-41572012000300017]; Besteiro S, 2011, CELL MICROBIOL, V13, P797, DOI 10.1111/j.1462-5822.2011.01597.x; Chen HF, 2003, CHINESE MED J-PEKING, V116, P1561; Chen J, 2013, VACCINE, V31, P1734, DOI 10.1016/j.vaccine.2013.01.027; Choi HJ, 2012, BIOMATERIALS, V33, P3756, DOI 10.1016/j.biomaterials.2012.01.054; Crisci E, 2012, VET IMMUNOL IMMUNOP, V148, P211, DOI 10.1016/j.vetimm.2012.04.026; da Costa-Silva TA, 2012, EXP PARASITOL, V130, P463, DOI 10.1016/j.exppara.2012.01.005; Dubey JP, 2005, J PARASITOL, V91, P1082, DOI 10.1645/GE-683.1; Fang R, 2010, VACCINE, V28, P1803, DOI 10.1016/j.vaccine.2009.12.005; Fayer R, 2004, TRENDS PARASITOL, V20, P531, DOI 10.1016/j.pt.2004.08.008; Flegr J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090203; Gavrilescu LC, 2001, J IMMUNOL, V167, P902, DOI 10.4049/jimmunol.167.2.902; Gibson-Corley KN, 2012, AM J PATHOL, V180, P2009, DOI 10.1016/j.ajpath.2012.01.012; Innes EA, 2010, EXPERT REV VACCINES, V9, P1117, DOI 10.1586/ERV.10.113; Jongert E, 2008, VACCINE, V26, P1025, DOI 10.1016/j.vaccine.2007.11.058; Joyce BR, 2010, P NATL ACAD SCI USA, V107, P17200, DOI 10.1073/pnas.1007610107; Lau YL, 2008, EXP PARASITOL, V119, P373, DOI 10.1016/j.exppara.2008.03.016; Lee DH, 2016, VIRUS LIKE NANOPARTI, V11; Lee S, 2016, EVALUATION PROTECTIV, V9, P384; Li ZY, 2014, VACCINE, V32, P3058, DOI 10.1016/j.vaccine.2014.03.042; Liu MM, 2010, PARASITOL RES, V106, P1079, DOI 10.1007/s00436-010-1742-0; Lourenco EV, 2006, MICROBES INFECT, V8, P1244, DOI 10.1016/j.micinf.2005.11.013; Mevelec MN, 2005, VACCINE, V23, P4489, DOI 10.1016/j.vaccine.2005.04.025; Neutra MR, 2006, NAT REV IMMUNOL, V6, P148, DOI 10.1038/nri1777; Peng GH, 2009, VACCINE, V27, P6570, DOI 10.1016/j.vaccine.2009.08.043; Pinzan CF, 2015, VACCINATION RECOMBIN, V10; Quan FS, 2007, VACCINE, V25, P272, DOI 10.1016/j.vaccine.2006.07.041; Quan FS, 2007, J VIROL, V81, P3514, DOI 10.1128/JVI.02052-06; Quan FS, 2011, J INFECT DIS, V204, P987, DOI 10.1093/infdis/jir474; Sharma P, 2013, CURR OPIN MICROBIOL, V16, P432, DOI 10.1016/j.mib.2013.07.004; Stephens R, 2009, PARASITE IMMUNOL, V31, P20, DOI 10.1111/j.1365-3024.2008.01066.x; Wang HL, 2016, PARASITE, V23, DOI 10.1051/parasite/2016012; Wang HF, 2007, PARASITOL INT, V56, P263, DOI 10.1016/j.parint.2007.04.003; Wang PY, 2012, FRONT PHARMACOL, V13, P13, DOI DOI 10.1128/CVI.00397-12; Zaman M, 2013, DRUG DELIV TRANSL RE, V3, P100, DOI 10.1007/s13346-012-0085-z; Zhang Y, 2016, IMMUNOL REV, V270, P8, DOI 10.1111/imr.12396	36	25	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2017	12	4							e0175644	10.1371/journal.pone.0175644	http://dx.doi.org/10.1371/journal.pone.0175644			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0MB	28406951	Green Published, gold, Green Submitted			2022-12-27	WOS:000399955400077
J	Burmeister, K; Quagliata, L; Andreozzi, M; Eppenberger-Castori, S; Matter, MS; Perrina, V; Grobholz, R; Jochum, W; Horber, D; Moosmann, P; Lehmann, F; Koberle, D; Ng, CKY; Piscuoglio, S; Tornillo, L; Terracciano, LM				Burmeister, Katharina; Quagliata, Luca; Andreozzi, Mariacarla; Eppenberger-Castori, Serenella; Matter, Matthias S.; Perrina, Valeria; Grobholz, Rainer; Jochum, Wolfram; Horber, Daniel; Moosmann, Peter; Lehmann, Frank; Koberle, Dieter; Ng, Charlotte K. Y.; Piscuoglio, Salvatore; Tornillo, Luigi; Terracciano, Luigi M.			Vascular endothelial growth factor A amplification in colorectal cancer is associated with reduced M1 and M2 macrophages and diminished PD-1-expressing lymphocytes	PLOS ONE			English	Article							TUMOR-ASSOCIATED MACROPHAGES; PROGRAMMED DEATH-1 LIGAND-1; B7-H1 PD-L1; T-CELLS; CLINICAL-SIGNIFICANCE; EXPRESSION; SURVIVAL; VEGF; OVEREXPRESSION; INFILTRATION	VEGFA is an angiogenic factor secreted by tumors, in particular those with VEGFA amplification, as well as by macrophages and lymphocytes in the tumor microenvironment. Here we sought to define the presence of M1/M2 macrophages, PD-1-positive lymphocytes and PD-L1 tumoral and stromal expression in colorectal cancers harboring VEGFA amplification or chromosome 6 polysomy. 38 CRCs of which 13 harbored VEGFA amplification, 6 with Chr6 polysomy and 19 with neutral VEGFA copy number were assessed by immunohistochemistry for CD68 (marker for M1/M2 macrophages), CD163 (M2 macrophages), programmed death 1(PD-1)-tumor infiltrating and stromal lymphocytes as well as tumoral and stromal PD-1 ligand (PD-L1) expression. CRCs with VEGFA amplification or Chr6 polysomy were associated with decreased M1/M2 macrophages, reduced PD-1-expressing lymphocyte infiltration, as well as reduced stromal expression of PD-L1 at the tumor front. Compared to intermediate-grade CRCs, high-grade CRCs were associated with increased M1/M2 macrophages and increased tumoral expression of PD-L1. Our results suggest that VEGFA amplification or Chr6 polysomy is associated with an altered tumor immune microenvironment.	[Burmeister, Katharina; Quagliata, Luca; Andreozzi, Mariacarla; Eppenberger-Castori, Serenella; Matter, Matthias S.; Perrina, Valeria; Ng, Charlotte K. Y.; Piscuoglio, Salvatore; Tornillo, Luigi; Terracciano, Luigi M.] Univ Hosp Basel, Inst Pathol, Schonbeinstr 40, Basel, Switzerland; [Grobholz, Rainer] Cantonal Hosp Aarau, Inst Pathol, Tellstr 25, Aarau, Switzerland; [Jochum, Wolfram] Cantonal Hosp St Gallen, Inst Pathol, Rorschacher Str 95, St Gallen, Switzerland; [Horber, Daniel] Cantonal Hosp St Gallen, Med Oncol & Hematol, Rorschacher Str 95, St Gallen, Switzerland; [Moosmann, Peter] Cantonal Hosp Aarau, Med Oncol, Tellstr 25, Aarau, Switzerland; [Lehmann, Frank] Univ Hosp Basel, Div Gastroenterol, Schonbeinstr 40, Basel, Switzerland; [Koberle, Dieter] St Clara Hosp, Med Oncol, Kleinriehenstr 30, Basel, Switzerland; [Tornillo, Luigi] GI Lab AG, Lettenweg 118, Allschwil, Switzerland	University of Basel; Kantonsspital Aarau AG (KSA); Kantonsspital St. Gallen; Kantonsspital St. Gallen; Kantonsspital Aarau AG (KSA); University of Basel	Tornillo, L (corresponding author), Univ Hosp Basel, Inst Pathol, Schonbeinstr 40, Basel, Switzerland.; Tornillo, L (corresponding author), GI Lab AG, Lettenweg 118, Allschwil, Switzerland.	Luigi.Tornillo@unibas.ch	Piscuoglio, Salvatore/AAB-4959-2022; Ng, Charlotte K Y/AAY-3178-2021; Ng, Charlotte K Y/AAA-1670-2020; Tornillo, Luigi/I-1732-2019; Terracciano, Luigi M./AAB-5335-2022; Quagliata, Luca/B-8321-2015	Piscuoglio, Salvatore/0000-0003-2686-2939; Ng, Charlotte K Y/0000-0002-6100-0026; Terracciano, Luigi M./0000-0002-9393-9660; Matter, Matthias/0000-0002-2005-5266; Grobholz, Rainer/0000-0002-1901-7967; Quagliata, Luca/0000-0001-8249-9914; Marston, Katharina/0000-0002-7431-3531	Swiss National Science Foundation [PZ00P3_168165]; Oncosuisse [KLS-3639-02-2015, KLS-3169-02-2013]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Oncosuisse	Salvatore Piscuoglio is funded by Swiss National Science Foundation (Ambizione grant number PZ00P3_168165); The study was supported by grants from Oncosuisse KLS-3639-02-2015 (Luigi Maria Terracciano) and KLS-3169-02-2013 (Luigi Tornillo). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. LT is currently employed by GILab AG. GILab AG provided support in the form of salary for author LT, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergers G, 2000, NAT CELL BIOL, V2, P737, DOI 10.1038/35036374; Brahmer JR, 2010, J CLIN ONCOL, V28, P3167, DOI 10.1200/JCO.2009.26.7609; Chanmee T, 2014, CANCERS, V6, P1670, DOI 10.3390/cancers6031670; Chen WJ, 2015, INT J CLIN EXP MED, V8, P8709; Droeser RA, 2013, EUR J CANCER, V49, P2233, DOI 10.1016/j.ejca.2013.02.015; Edin S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047045; Engstrom A, 2014, INT J ONCOL, V44, P385, DOI 10.3892/ijo.2013.2203; Forssell J, 2007, CLIN CANCER RES, V13, P1472, DOI 10.1158/1078-0432.CCR-06-2073; FREEMAN MR, 1995, CANCER RES, V55, P4140; Fujiwara T, 2011, AM J PATHOL, V179, P1157, DOI 10.1016/j.ajpath.2011.05.034; Gabrilovich DI, 1996, NAT MED, V2, P1096, DOI 10.1038/nm1096-1096; Galdiero MR, 2013, IMMUNOBIOLOGY, V218, P1402, DOI 10.1016/j.imbio.2013.06.003; Galvan-Pena S, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00420; Gao Q, 2009, CLIN CANCER RES, V15, P971, DOI 10.1158/1078-0432.CCR-08-1608; Gatalica Z, 2014, CANCER EPIDEM BIOMAR, V23, P2965, DOI 10.1158/1055-9965.EPI-14-0654; Ghebeh H, 2006, NEOPLASIA, V8, P190, DOI 10.1593/neo.05733; Goel HL, 2013, NAT REV CANCER, V13, P871, DOI 10.1038/nrc3627; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Herrera M, 2013, CANCER SCI, V104, P437, DOI 10.1111/cas.12096; Hoeben A, 2004, PHARMACOL REV, V56, P549, DOI 10.1124/pr.56.4.3; Kamper P, 2011, HAEMATOL-HEMATOL J, V96, P269, DOI 10.3324/haematol.2010.031542; Kang MJ, 2013, TRANSL ONCOL, V6, P282, DOI 10.1593/tlo.13256; Kim JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082870; Laoui D, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00489; Lin EY, 2007, MOL ONCOL, V1, P288, DOI 10.1016/j.molonc.2007.10.003; MANTOVANI A, 1992, IMMUNOL TODAY, V13, P265, DOI 10.1016/0167-5699(92)90008-U; Mantovani A, 2006, CANCER METAST REV, V25, P315, DOI 10.1007/s10555-006-9001-7; Mantovani A, 2013, J PATHOL, V229, P176, DOI 10.1002/path.4133; Mei JD, 2016, ONCOTARGET, V7, P34217, DOI 10.18632/oncotarget.9079; Nakanishi J, 2007, CANCER IMMUNOL IMMUN, V56, P1173, DOI 10.1007/s00262-006-0266-z; Nomi T, 2007, CLIN CANCER RES, V13, P2151, DOI 10.1158/1078-0432.CCR-06-2746; Ohigashi Y, 2005, CLIN CANCER RES, V11, P2947, DOI 10.1158/1078-0432.CCR-04-1469; Ohm JE, 2003, BLOOD, V101, P4878, DOI 10.1182/blood-2002-07-1956; Piscuoglio S, 2012, J CLIN PATHOL, V65, P140, DOI 10.1136/jclinpath-2011-200043; Quagliata L, 2014, EUR J CANCER, V50, P731, DOI 10.1016/j.ejca.2013.11.018; Richendollar BG, 2011, HUM PATHOL, V42, P552, DOI 10.1016/j.humpath.2010.08.015; Sica A, 2014, HEPATOLOGY, V59, P2034, DOI 10.1002/hep.26754; Sun SY, 2014, CANCER IMMUNOL IMMUN, V63, P395, DOI 10.1007/s00262-014-1519-x; Sun T, 2013, ONCOL RES, V21, P227, DOI 10.3727/096504014X13890370410285; Sznol M, 2013, CLIN CANCER RES, V19, P5542, DOI 10.1158/1078-0432.CCR-13-2234; Tran TH, 2015, EXPERT OPIN DRUG DEL, V12, P393, DOI 10.1517/17425247.2015.972931; Thompson RH, 2005, CANCER, V104, P2084, DOI 10.1002/cncr.21470; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Vlajnic T, 2011, MODERN PATHOL, V24, P1404, DOI 10.1038/modpathol.2011.96; Voron T, 2015, J EXP MED, V212, P139, DOI 10.1084/jem.20140559; Wang X, 2016, ONCOTARGETS THER, V9, P5023, DOI 10.2147/OTT.S105862; Wu CP, 2006, ACTA HISTOCHEM, V108, P19, DOI 10.1016/j.acthis.2006.01.003; Yang M, 2014, CELL DEATH DIFFER, V21, P1290, DOI 10.1038/cdd.2014.45; Yin SC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170042; Zhan P, 2013, TRANSL ANDROL UROL, V2, P99, DOI 10.3978/j.issn.2223-4683.2013.06.03; Zhan P, 2009, J THORAC ONCOL, V4, P1094, DOI 10.1097/JTO.0b013e3181a97e31	51	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2017	12	4							e0175563	10.1371/journal.pone.0175563	http://dx.doi.org/10.1371/journal.pone.0175563			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LZ	28403223	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000399955200079
J	Fernandez, B; Moneim, AEA; Ortiz, F; Shen, YQ; Soto-Mercado, V; Mendivil-Perez, M; Guerra-Librero, A; Acuna-Castroviejo, D; Molina-Navarro, MM; Garcia-Verdugo, JM; Sayed, RKA; Florido, J; Luna, JD; Lopez, LC; Escames, G				Fernandez, Beatriz; Moneim, Ahmed E. Abdel; Ortiz, Francisco; Shen, Ying-Qiang; Soto-Mercado, Viviana; Mendivil-Perez, Miguel; Guerra-Librero, Ana; Acuna-Castroviejo, Dario; Molina-Navarro, Maria M.; Garcia-Verdugo, Jose M.; Sayed, Ramy K. A.; Florido, Javier; Luna, Juan D.; Carlos Lopez, Luis; Escames, Germaine			Melatonin protects rats from radiotherapy-induced small intestine toxicity	PLOS ONE			English	Article							INFLAMMASOME ACTIVATION; LIPID-PEROXIDATION; RADIATION-INJURY; MUCOSITIS; EXPRESSION; CANCER; PATHOBIOLOGY; GLUTATHIONE; APOPTOSIS; SEPSIS	Radiotherapy-induced gut toxicity is among the most prevalent dose-limiting toxicities following radiotherapy. Prevention of radiation enteropathy requires protection of the small intestine. However, despite the prevalence and burden of this pathology, there are currently no effective treatments for radiotherapy-induced gut toxicity, and this pathology remains unclear. The present study aimed to investigate the changes induced in the rat small intestine after external irradiation of the tongue, and to explore the potential radio-protective effects of melatonin gel. Male Wistar rats were subjected to irradiation of their tongues with an X-Ray YXLON Y. Tu 320-D03 irradiator, receiving a dose of 7.5 Gy/day for 5 days. For 21 days post-irradiation, rats were treated with 45 mg/day melatonin gel or vehicle, by local application into their mouths. Our results showed that mitochondrial oxidative stress, bioenergetic impairment, and subsequent NLRP3 inflammasome activation were involved in the development of radiotherapy-induced gut toxicity. Oral treatment with melatonin gel had a protective effect in the small intestine, which was associated with mitochondrial protection and, consequently, with a reduced inflammatory response, blunting the NF-kappa B/NLRP3 inflammasome signaling activation. Thus, rats treated with melatonin gel showed reduced intestinal apoptosis, relieving mucosal dysfunction and facilitating intestinal mucosa recovery. Our findings suggest that oral treatment with melatonin gel may be a potential preventive therapy for radiotherapy-induced gut toxicity in cancer patients.	[Fernandez, Beatriz; Ortiz, Francisco; Shen, Ying-Qiang; Guerra-Librero, Ana; Acuna-Castroviejo, Dario; Florido, Javier; Carlos Lopez, Luis; Escames, Germaine] Univ Granada, Inst Biotecnol, Ctr Invest Biomed, Granada, Spain; [Moneim, Ahmed E. Abdel] Helwan Univ, Fac Sci, Dept Zool & Entomol, Cairo, Egypt; [Soto-Mercado, Viviana; Mendivil-Perez, Miguel] Univ Antioquia, Med Res Inst, Neurosci Res Grp, Fac Med, Medellin, Colombia; [Acuna-Castroviejo, Dario; Carlos Lopez, Luis; Escames, Germaine] Univ Granada, Fac Med, Dept Fisiol, Granada, Spain; [Molina-Navarro, Maria M.; Garcia-Verdugo, Jose M.] Univ Valencia, Inst Cavanilles, Valencia, Spain; [Sayed, Ramy K. A.] Sohag Univ, Fac Vet Med, Dept Anat & Embryol, Sohag, Egypt; [Luna, Juan D.] Univ Granada, Fac Med, Dept Bioestadast, Granada, Spain; [Escames, Germaine] Ctr Invest Biomed, Parque Tecnol Ciencias Salud,Ave Conocimiento S-N, Granada, Spain	University of Granada; Egyptian Knowledge Bank (EKB); Helwan University; Universidad de Antioquia; University of Granada; University of Valencia; Egyptian Knowledge Bank (EKB); Sohag University; University of Granada	Escames, G (corresponding author), Univ Granada, Inst Biotecnol, Ctr Invest Biomed, Granada, Spain.; Escames, G (corresponding author), Univ Granada, Fac Med, Dept Fisiol, Granada, Spain.; Escames, G (corresponding author), Ctr Invest Biomed, Parque Tecnol Ciencias Salud,Ave Conocimiento S-N, Granada, Spain.	gescames@ugr.es	Sayed, Ramy K. A./AAD-2215-2019; Acuña-Castroviejo, Dario/N-7456-2016; Florido, Javier/B-8988-2019; de dios luna del castillo, juan/N-9183-2016; shen, ying/HHS-5635-2022; Lopez, Luis Carlos/AAP-9411-2020; Lopez, Luis Carlos/L-5129-2014; Moneim, Ahmed E. Abdel/C-7461-2012; García-Verdugo, José Manuel/L-8421-2017; Fernandez-Gil, Beatriz Irene/C-1723-2019; Guerra-Librero, Ana/B-8987-2019; Escames, Germaine/N-7501-2016	Sayed, Ramy K. A./0000-0003-4467-6742; Acuña-Castroviejo, Dario/0000-0002-9680-1560; Florido, Javier/0000-0001-7541-4898; Lopez, Luis Carlos/0000-0003-3355-0298; Lopez, Luis Carlos/0000-0003-3355-0298; Moneim, Ahmed E. Abdel/0000-0002-2654-2591; García-Verdugo, José Manuel/0000-0001-9872-6499; Fernandez-Gil, Beatriz Irene/0000-0003-2347-2687; Guerra-Librero, Ana/0000-0002-6243-6593; mendivil-perez, miguel/0000-0002-8824-379X; , Micaela/0000-0002-2103-0351; Escames, Germaine/0000-0003-1256-7656	Spanish Ministry of Economy and Competitivity (MINECO) [SAF2009-14037]; CEIBiotic Program of the University of Granada, Spain [GREIB.PT_2010_04]; Consejeria de Innovacion, Ciencia y Empresa, Junta de Andalucia, Spain [CTS-101]	Spanish Ministry of Economy and Competitivity (MINECO); CEIBiotic Program of the University of Granada, Spain; Consejeria de Innovacion, Ciencia y Empresa, Junta de Andalucia, Spain(Junta de Andalucia)	This study was partially supported by grant no. SAF2009-14037 from the Spanish Ministry of Economy and Competitivity (MINECO), GREIB.PT_2010_04 from the CEIBiotic Program of the University of Granada, Spain, and CTS-101 from the Consejeria de Innovacion, Ciencia y Empresa, Junta de Andalucia, Spain.	Acuna-Castroviejo D, 2014, CELL MOL LIFE SCI, V71, P2997, DOI 10.1007/s00018-014-1579-2; Al-Dasooqi N, 2013, SUPPORT CARE CANCER, V21, P2075, DOI 10.1007/s00520-013-1810-y; Arifa RDN, 2014, AM J PATHOL, V184, P2023, DOI 10.1016/j.ajpath.2014.03.012; Boerma M, 2006, INT J RADIAT ONCOL, V66, P552, DOI 10.1016/j.ijrobp.2006.05.067; Brown M, 2008, INT J RADIAT ONCOL, V70, P799, DOI 10.1016/j.ijrobp.2007.12.001; Cameron S, 2012, EXP MOL PATHOL, V92, P243, DOI 10.1016/j.yexmp.2011.11.007; Cassel SL, 2008, P NATL ACAD SCI USA, V105, P9035, DOI 10.1073/pnas.0803933105; Diaz-Casado ME, 2016, J PINEAL RES, V61, P96, DOI 10.1111/jpi.12332; Doerrier C, 2016, MITOCHONDRION, V27, P56, DOI 10.1016/j.mito.2015.12.010; Escames G, 2003, FASEB J, V17, P932, DOI 10.1096/fj.02-0692fje; Escames G, 2012, HUM GENET, V131, P161, DOI 10.1007/s00439-011-1057-y; ESTERBAUER H, 1990, METHOD ENZYMOL, V186, P407; Garcia JA, 2015, FASEB J, V29, P3863, DOI 10.1096/fj.15-273656; Glenister R., 2013, TRANSL GASTROINTEST, V2, P2; GREEN LC, 1981, P NATL ACAD SCI-BIOL, V78, P7764, DOI 10.1073/pnas.78.12.7764; HISSIN PJ, 1976, ANAL BIOCHEM, V74, P214, DOI 10.1016/0003-2697(76)90326-2; Hong Y, 2014, J PINEAL RES, V56, P264, DOI 10.1111/jpi.12119; JASKOT RH, 1983, J ANAL TOXICOL, V7, P86, DOI 10.1093/jat/7.2.86; Khan S, 2016, ENV TOXICOL; Lalla RV, 2015, EXPERT REV GASTROENT, V9, P127, DOI 10.1586/17474124.2015.965146; Lissoni P, 2000, ANTICANCER RES, V20, P2103; Logan RM, 2008, CANCER BIOL THER, V7, P1139; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Ma Z, 2016, ONCOTARGET, DOI 10.18632/oncotarget; Maj JG, 2003, CANCER RES, V63, P4338; Mariathasan S, 2007, MICROBES INFECT, V9, P664, DOI 10.1016/j.micinf.2007.01.017; Martin M, 2000, J PINEAL RES, V28, P242, DOI 10.1034/j.1600-079X.2000.280407.x; Matsuu-Matsuyama M, 2006, J RADIAT RES, V47, P1, DOI 10.1269/jrr.47.1; MISRA HP, 1972, J BIOL CHEM, V247, P3170; Murphy CK, 2008, CLIN CANCER RES, V14, P4292, DOI 10.1158/1078-0432.CCR-07-4669; Nakao T, 2012, J SURG RES, V173, P341, DOI 10.1016/j.jss.2010.10.003; Ong ZY, 2010, RADIAT ONCOL, V5, DOI 10.1186/1748-717X-5-22; Ortiz F, 2015, J PINEAL RES, V58, P34, DOI 10.1111/jpi.12191; Pacini N, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17030341; Puig A, 2016, EXP GERONTOL, V75, P1, DOI 10.1016/j.exger.2015.11.021; Shirazi A, 2007, J RADIAT RES, V48, P263, DOI 10.1269/jrr.06070; Son TG, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-103; SONIS ST, 1990, ORAL SURG ORAL MED O, V69, P437, DOI 10.1016/0030-4220(90)90376-4; Sonis ST, 2002, CELL PROLIFERAT, V35, P93, DOI 10.1046/j.1365-2184.35.s1.10.x; Sonis ST, 2004, NAT REV CANCER, V4, P277, DOI 10.1038/nrc1318; Tahamtan R, 2015, CELL J, V17, P111; Tan DX, 2015, MOLECULES, V20, P18886, DOI 10.3390/molecules201018886; Venegas C, 2013, J PINEAL RES, V54, P313, DOI 10.1111/jpi.12019; Venegas C, 2012, J PINEAL RES, V52, P217, DOI 10.1111/j.1600-079X.2011.00931.x; Villa A, 2015, CURR OPIN ONCOL, V27, P159, DOI 10.1097/CCO.0000000000000180; Volt H, 2016, J PINEAL RES, V60, P193, DOI 10.1111/jpi.12303; WANG Y, 2013, PLOS ONE, V2013; Xin ZL, 2015, J PINEAL RES, V58, P375, DOI 10.1111/jpi.12227; Zetner D, 2016, DRUG RES, V66, P281, DOI 10.1055/s-0035-1569358	49	83	85	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2017	12	4							e0174474	10.1371/journal.pone.0174474	http://dx.doi.org/10.1371/journal.pone.0174474			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LZ	28403142	Green Published, gold, Green Submitted			2022-12-27	WOS:000399955200014
J	Sanz-Cabanillas, JL; Ruano, J; Gomez-Garcia, F; Alcalde-Mellado, P; Gay-Mimbrera, J; Aguilar-Luque, M; Maestre-Lopez, B; Gonzalez-Padilla, M; Carmona-Fernandez, PJ; Garcia-Nieto, AV; Isla-Tejera, B				Luis Sanz-Cabanillas, Juan; Ruano, Juan; Gomez-Garcia, Francisco; Alcalde-Mellado, Patricia; Gay-Mimbrera, Jesus; Aguilar-Luque, Macarena; Maestre-Lopez, Beatriz; Gonzalez-Padilla, Marcelino; Carmona-Fernandez, Pedro J.; Velez Garcia-Nieto, Antonio; Isla-Tejera, Beatriz			Author-paper affiliation network architecture influences the methodological quality of systematic reviews and meta-analyses of psoriasis	PLOS ONE			English	Review							COLLABORATION	Moderate-to-severe psoriasis is associated with significant comorbidity, an impaired quality of life, and increased medical costs, including those associated with treatments. Systematic reviews (SRs) and meta-analyses (MAs) of randomized clinical trials are considered two of the best approaches to the summarization of high-quality evidence. However, methodological bias can reduce the validity of conclusions from these types of studies and subsequently impair the quality of decision making. As co-authorship is among the most well-documented forms of research collaboration, the present study aimed to explore whether authors' collaboration methods might influence the methodological quality of SRs and MAs of psoriasis. Methodological quality was assessed by two raters who extracted information from full articles. After calculating total and per-item Assessment of Multiple Systematic Reviews (AMSTAR) scores, reviews were classified as low (0-4), medium (5-8), or high (9-11) quality. Article metadata and journal-related bibliometric indices were also obtained. A total of 741 authors from 520 different institutions and 32 countries published 220 reviews that were classified as high (17.2%), moderate (55%), or low (27.7%) methodological quality. The high methodological quality subnetwork was larger but had a lower connection density than the low and moderate methodological quality subnetworks; specifically, the former contained relatively fewer nodes (authors and reviews), reviews by authors, and collaborators per author. Furthermore, the high methodological quality subnetwork was highly compart-mentalized, with several modules representing few poorly interconnected communities. In conclusion, structural differences in author-paper affiliation network may influence the methodological quality of SRs and MAs on psoriasis. As the author-paper affiliation network structure affects study quality in this research field, authors who maintain an appropriate balance between scientific quality and productivity are more likely to develop higher quality reviews.	[Luis Sanz-Cabanillas, Juan; Ruano, Juan; Gomez-Garcia, Francisco; Gonzalez-Padilla, Marcelino; Carmona-Fernandez, Pedro J.; Velez Garcia-Nieto, Antonio] Reina Sofia Univ Hosp, Dept Dermatol, Cordoba, Spain; [Luis Sanz-Cabanillas, Juan; Ruano, Juan; Gomez-Garcia, Francisco; Alcalde-Mellado, Patricia; Gay-Mimbrera, Jesus; Aguilar-Luque, Macarena; Maestre-Lopez, Beatriz; Gonzalez-Padilla, Marcelino; Carmona-Fernandez, Pedro J.; Velez Garcia-Nieto, Antonio; Isla-Tejera, Beatriz] Univ Cordoba, Inst Maimonides Invest Biomed Cordoba IMIBIC, Reina Sofia Univ Hosp, Cordoba, Spain; [Alcalde-Mellado, Patricia; Maestre-Lopez, Beatriz] Univ Cordoba, Sch Med, Cordoba, Spain; [Isla-Tejera, Beatriz] Reina Sofia Univ Hosp, Dept Pharm, Cordoba, Spain	Hospital Universitario Reina Sofia - Cordoba; Universidad de Cordoba; Universidad de Cordoba; Hospital Universitario Reina Sofia - Cordoba	Ruano, J (corresponding author), Reina Sofia Univ Hosp, Dept Dermatol, Cordoba, Spain.; Ruano, J (corresponding author), Univ Cordoba, Inst Maimonides Invest Biomed Cordoba IMIBIC, Reina Sofia Univ Hosp, Cordoba, Spain.	juanruanoruiz@mac.com	Gay-Mimbrera, Jesus/C-8376-2017; Maestre, Lorena/L-1352-2014; Ruano, Juan/T-1991-2018; Aguilar-Luque, Macarena/AAU-7891-2020; Sanz-Cabanillas, Juan-Luis/H-2566-2017; Aguilar-Luque, Macarena/C-6786-2018	Gay-Mimbrera, Jesus/0000-0001-7223-1922; Maestre, Lorena/0000-0001-8743-0422; Ruano, Juan/0000-0002-0286-4107; Carmona Fernandez, Pedro Jesus/0000-0003-4228-1173; Sanz-Cabanillas, Juan-Luis/0000-0002-8990-1459; ISLA, BEATRIZ/0000-0001-5233-7949; Aguilar-Luque, Macarena/0000-0001-8060-4506	National Plan of R+D+I [ICI1400136]; ISCIII-Subdireccion General de Evaluacion; European Regional Development Fund (ERDF); Plan Propio de movilidad para investigadores del Institute Maimonides de Investigacion Biomedica de Cordoba (IMIBIC) [PP13/009]	National Plan of R+D+I; ISCIII-Subdireccion General de Evaluacion; European Regional Development Fund (ERDF)(European Commission); Plan Propio de movilidad para investigadores del Institute Maimonides de Investigacion Biomedica de Cordoba (IMIBIC)	This work has been funded in part by project ICI1400136 to JR, integrated into the National Plan of R+D+I 2008-2011 and co-financed by the ISCIII-Subdireccion General de Evaluacion and European Regional Development Fund (ERDF), and by grant PP13/009 of Plan Propio de movilidad para investigadores del Institute Maimonides de Investigacion Biomedica de Cordoba (IMIBIC). No funding was received from any pharmaceutical company. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	de Montjoye YA, 2014, SCI REP-UK, V4, DOI 10.1038/srep05277; Delgado-Rodriguez M, 2006, J EPIDEMIOL COMMUN H, V60, P90, DOI 10.1136/jech.2005.035253; Gomez-Garcia F, 2017, BR J DERMATOL; Gonzalez-Alcaide G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144837; Hirsch JE, 2005, P NATL ACAD SCI USA, V102, P16569, DOI 10.1073/pnas.0507655102; Ioannidis JPA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002778; Knoben J, 2006, INT J MANAG REV, V8, P71, DOI 10.1111/j.1468-2370.2006.00121.x; Long JC, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-225; Long JC, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001434; Lowes MA, 2007, NATURE, V445, P866, DOI 10.1038/nature05663; Lowes MA, 2014, ANNU REV IMMUNOL, V32, P227, DOI 10.1146/annurev-immunol-032713-120225; Mayrose I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137856; Parker GB, 2007, MED J AUSTRALIA, V187, P650, DOI 10.5694/j.1326-5377.2007.tb01459.x; Sahu SR, 2014, SCIENTOMETRICS, V98, P2161, DOI 10.1007/s11192-013-1127-0; Sarigol E, 2014, EPJ DATA SCI, V3, DOI 10.1140/epjds/s13688-014-0009-x; Sendina-Nadal I, 2016, SCI REP-UK, V6, DOI 10.1038/srep21297; Shea BJ, 2009, J CLIN EPIDEMIOL, V62, P1013, DOI 10.1016/j.jclinepi.2008.10.009; Whitfield J, 2008, NATURE, V455, P720, DOI 10.1038/455720a; Wuchty S, 2007, SCIENCE, V316, P1036, DOI 10.1126/science.1136099	19	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2017	12	4							e0175419	10.1371/journal.pone.0175419	http://dx.doi.org/10.1371/journal.pone.0175419			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LZ	28403245	Green Published, gold, Green Submitted			2022-12-27	WOS:000399955200066
J	Muller, T; Thummell, K; Cornelissen, CG; Kruger, S; Dreher, M				Mueller, Tobias; Thuemmell, Kristina; Cornelissen, Christian G.; Krueger, Stefan; Dreher, Michael			Analogosedation during flexible bronchoscopy using a combination of midazolam, propofol and fentanyl - A retrospective analysis	PLOS ONE			English	Article							NONINFERIORITY TRIAL; COMBINED SEDATION; HYDROCODONE	Background According to current guidelines flexible bronchoscopy is usually performed under sedation. Previously it has been demonstrated that combined sedation with e.g. the combination of midazolam and propofol or an opioid might have several advantages over sedation with just one sedative drug. However, little is known about the efficacy and safety of combined sedation with midazolam, fentanyl and propofol (MFP) compared to sedation with midazolam and fentanyl (MF) or midazolam and propofol (MP). Methods We carried out a retrospective analysis of bronchoscopies performed under triple (MFP) or double sedation (MF and MP) in an academic hospital. 1392 procedures were analyzed (MFP: n = 824; MF: n = 272; MP: n = 296). In particular, we compared the occurrence of complications and the dosage of administered sedative drugs between the groups. Results The occurrence of adverse events (MFP vs. MF: odds ratio (OR) 1.116 [95% CI 0.7741 to 1.604]; MFP vs. MP: OR 0.8296 [95% CI 0.5939 to 1.16] and severe adverse events (MFP vs. MF: OR 1.581 [95% CI 0.5594 to 4.336]; MFP vs. MP: OR 3.47 [95% CI 0.908 to 15.15]; all p>0.05) was similar in all groups. The dosage of midazolam was lower in the MFP compared to the MF or MP group (MFP vs. MF: Cohen's d 0.075; MFP vs. MP: Cohen's d 0.225; all p<0.001). In addition patients in the MFP group received significantly less propofol compared to the MP group (Cohen's d 1.22; p<0.001). Conclusions In summary we were able to demonstrate that triple sedation can safely be administered during flexible bronchoscopy and is associated with a reduced dosage of midazolam and propofol.	[Mueller, Tobias; Thuemmell, Kristina; Cornelissen, Christian G.; Dreher, Michael] Univ Hosp RWTH, Div Pneumol, Aachen, Germany; [Mueller, Tobias] Univ Hosp, Dept Pneumol, Freiburg, Germany; [Krueger, Stefan] Florence Nightingale Hosp, Dept Pneumol, Dusseldorf, Germany	RWTH Aachen University; RWTH Aachen University Hospital; University of Freiburg	Muller, T (corresponding author), Univ Hosp RWTH, Div Pneumol, Aachen, Germany.; Muller, T (corresponding author), Univ Hosp, Dept Pneumol, Freiburg, Germany.	tobmueller@ukaachen.de	Müller, Tobias/ABH-7263-2020	Müller, Tobias/0000-0002-9801-3496				Akyuz U, 2010, HEPATO-GASTROENTEROL, V57, P685; Dreher M, 2010, RESPIRATION, V79, P307, DOI 10.1159/000267227; Du Rand IA, 2011, THORAX, V66, P1, DOI 10.1136/thoraxjnl-2011-200713; Franzen D, 2016, RESPIROLOGY, V21, P1445, DOI 10.1111/resp.12830; Goodchild CS, 2015, BRIT J ANAESTH, V115, P641, DOI 10.1093/bja/aev320; Grendelmeier P, 2014, EUR RESPIR J, V43, P591, DOI 10.1183/09031936.00200412; Schlatter L, 2011, EUR RESPIR J, V38, P529, DOI 10.1183/09031936.00121610; Seifert H, 2000, ALIMENT PHARM THERAP, V14, P1207; Stolz D, 2004, THORAX, V59, P773, DOI 10.1136/thx.2003.019836; Stolz D, 2009, EUR RESPIR J, V34, P1024, DOI 10.1183/09031936.00180808; Wahidi MM, 2011, CHEST, V140, P1342, DOI 10.1378/chest.10-3361	11	13	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2017	12	4							e0175394	10.1371/journal.pone.0175394	http://dx.doi.org/10.1371/journal.pone.0175394			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LZ	28403208	Green Published, gold, Green Submitted			2022-12-27	WOS:000399955200059
J	Shao, XL; Zou, C; Qin, B				Shao, Xiaolei; Zou, Chang; Qin, Bo			Correlation of choroidal thickness and ametropiain young adolescence	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; SPECTACLE LENSES; SPECTRAL-DOMAIN; MYOPIC EYES; SCLERA; GROWTH; COMPENSATION	Choroid has been proposed to participate in the regulation of light refraction by changing its thickness. The present study aims to analyze the characteristics of choroidal thickness (CT), and its correlation with refractive error, axial length and age in young ametropia. A total of 51 subjects (102 eyes), aged from 5 to 18 years old (mean age 10.04 +/- 2.78 years), with ametropia were included in the study. Choroidal imaging was obtained by enhanced depth imaging (EDI) of spectral domain Optical Coherence Tomography (OCT). CT was horizontally measured at 5 locations in across fovea with 1mm interval. We found that the spherical equivalent refractive diopter was from - 7.25D to 1.6D (mean, - 1.61D +/- 1.82D), the mean axial length was 24.14mm +/- 1.14mm. The closer to the optic disc the thinner the choroid is. CT between fovea and disc showed better correlation with refractive error (p<0,01), axial length (p< 0.01) and age (P< 0.05) than those temporal to fovea. Our results indicated that the choroid is least thick around the optic disc. Thickness between fovea and optic disc is significantly associated with refractive error, axial length and age in growing adolescences. This result may help us understand the function of choroid during ametropic progression.	[Shao, Xiaolei; Qin, Bo] Shenzhen Univ, Affiliated Shenzhen Eye Hosp,Shenzhen Eye Hosp, Ocular Trauma Treatment & Stem Cell Differentiat, Joint Coll Optometry,Shenzhen Key Lab Ophthalmol, Shenzhen, Guangdong, Peoples R China; [Zou, Chang] Jinan Univ, Shenzhen Peoples Hosp, Clin Coll 2, Clin Med Res Ctr, Shenzhen, Peoples R China	Shenzhen University; Jinan University	Qin, B (corresponding author), Shenzhen Univ, Affiliated Shenzhen Eye Hosp,Shenzhen Eye Hosp, Ocular Trauma Treatment & Stem Cell Differentiat, Joint Coll Optometry,Shenzhen Key Lab Ophthalmol, Shenzhen, Guangdong, Peoples R China.; Zou, C (corresponding author), Jinan Univ, Shenzhen Peoples Hosp, Clin Coll 2, Clin Med Res Ctr, Shenzhen, Peoples R China.	zouchang.cuhk@gmail.com; qinbozf@126.com	Zou, Chang/AAS-3356-2021	Zou, Chang/0000-0002-2003-7834	Shenzhen Science and Technology Innovation project [JCYJ20150403101146297]	Shenzhen Science and Technology Innovation project	This work was supported by Shenzhen Science and Technology Innovation project (NO. JCYJ20150403101146297).	[Anonymous], VERTEBRATE EYE ITS A, DOI 10.1097/00005053-194409000-00057; Chhablani J, 2014, INDIAN J OPHTHALMOL, V62, P1060, DOI 10.4103/0301-4738.146711; Chung SE, 2011, OPHTHALMOLOGY, V118, P840, DOI 10.1016/j.ophtha.2010.09.012; Ding XY, 2011, INVEST OPHTH VIS SCI, V52, P9555, DOI 10.1167/iovs.11-8076; Flores-Moreno I, 2013, BRIT J OPHTHALMOL, V97, P1010, DOI 10.1136/bjophthalmol-2012-302836; Fujiwara A, 2012, JPN J OPHTHALMOL, V56, P230, DOI 10.1007/s10384-012-0128-5; Gehl Z, 2014, BMC OPHTHALMOL, V14, DOI 10.1186/1471-2415-14-103; Ho M, 2013, OPHTHALMOLOGY, V120, P1909, DOI 10.1016/j.ophtha.2013.02.005; Ikuno Y, 2010, INVEST OPHTH VIS SCI, V51, P2173, DOI 10.1167/iovs.09-4383; Jonas JB, 2014, EYE, V28, P113, DOI 10.1038/eye.2013.223; Kim M, 2012, INVEST OPHTH VIS SCI, V53, P7710, DOI 10.1167/iovs.12-10464; Margolis R, 2009, AM J OPHTHALMOL, V147, P811, DOI 10.1016/j.ajo.2008.12.008; Nickla DL, 2010, PROG RETIN EYE RES, V29, P144, DOI 10.1016/j.preteyeres.2009.12.002; Nickla DL, 1997, CURR EYE RES, V16, P320, DOI 10.1076/ceyr.16.4.320.10697; Nishi T, 2014, BRIT J OPHTHALMOL, V98, P228, DOI 10.1136/bjophthalmol-2013-303938; NORTON TT, 1995, VISION RES, V35, P1271, DOI 10.1016/0042-6989(94)00243-F; Rada JA, 2000, INVEST OPHTH VIS SCI, V41, P1639; Rossou E, 2014, OPHTHALMOLOGICA, V232, P97, DOI 10.1159/000360797; Sayanagi K, 2014, GRAEF ARCH CLIN EXP, V252, P3, DOI 10.1007/s00417-013-2474-5; Summers JA, 2013, EXP EYE RES, V114, P120, DOI 10.1016/j.exer.2013.03.008; Wallman J, 2004, NEURON, V43, P447, DOI 10.1016/j.neuron.2004.08.008; Wang SM, 2015, BMC OPHTHALMOL, V15, DOI 10.1186/s12886-015-0059-2; Wei WB, 2013, OPHTHALMOLOGY, V120, P175, DOI 10.1016/j.ophtha.2012.07.048; WILDSOET C, 1995, VISION RES, V35, P1175, DOI 10.1016/0042-6989(94)00233-C; Woodman-Pieterse EC, 2015, INVEST OPHTH VIS SCI, V56, P6414, DOI 10.1167/iovs.15-17102	25	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2017	12	4							e0174385	10.1371/journal.pone.0174385	http://dx.doi.org/10.1371/journal.pone.0174385			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LZ	28403185	Green Submitted, Green Published, gold			2022-12-27	WOS:000399955200011
J	Szekely, N; Brocke, JV				Szekely, Nadine; Brocke, Jan Vom			What can we learn from corporate sustainability reporting? Deriving propositions for research and practice from over 9,500 corporate sustainability reports published between 1999 and 2015 using topic modelling technique	PLOS ONE			English	Article							SOCIAL-RESPONSIBILITY; INDUSTRIES; EDUCATION; SYSTEMS	Organizations are increasingly using sustainability reports to inform their stakeholders and the public about their sustainability practices. We apply topic modelling to 9,514 sustainability reports published between 1999 and 2015 in order to identify common topics and, thus, the most common practices described in these reports. In particular, we identify forty-two topics that reflect sustainability and focus on the coverage and trends of economic, environmental, and social sustainability topics. Among the first to analyse such a large amount of data on organizations' sustainability reporting, the paper serves as an example of how to apply natural language processing as a strategy of inquiry in sustainability research. The paper also derives from the data analysis ten propositions for future research and practice that are of immediate value for organizations and researchers.	[Szekely, Nadine; Brocke, Jan Vom] Univ Liechtenstein, Inst Informat Syst, Vaduz, Liechtenstein	University of Liechtenstein	Szekely, N (corresponding author), Univ Liechtenstein, Inst Informat Syst, Vaduz, Liechtenstein.	nadine.szekely@uni.li	Brocke, Jan vom/Q-3807-2019					Acharya VV, 2014, DP10108 CEPR; Ambec S, 2008, ACAD MANAGE PERSPECT, V23, P45, DOI 10.5465/AMP.2008.35590353; Ameer R, 2012, J BUS ETHICS, V108, P61, DOI 10.1007/s10551-011-1063-y; Amini M, 2014, J CLEAN PROD, V76, P12, DOI 10.1016/j.jclepro.2014.02.016; Azapagic A, 2003, PROCESS SAF ENVIRON, V81, P303, DOI 10.1205/095758203770224342; Belu C, 2009, SUSTAIN DEV, V17, P257, DOI 10.1002/sd.390; Blei DM, 2012, COMMUN ACM, V55, P77, DOI 10.1145/2133806.2133826; Blei DM, 2003, J MACH LEARN RES, V3, P993, DOI 10.1162/jmlr.2003.3.4-5.993; Crain S.P., 2012, MINING TEXT DATA, P129, DOI DOI 10.1007/978-1-4614-3223-4_5; Daily BF, 2001, INT J OPER PROD MAN, V21, P1539, DOI 10.1108/01443570110410892; DAVIS K, 1973, ACAD MANAGE J, V16, P312, DOI 10.2307/255331; Debortoli S., 2016, TEXT MINING INFORM S; Dyllick T., 2002, BUS STRATEG ENVIRON, V11, P130, DOI [10.1002/bse.323, DOI 10.1002/BSE.323]; Elkington J., 1997, CANNIBALS FORKS; Fifka MS, 2015, CSR SUSTAIN ETHIC, P143, DOI 10.1007/978-3-319-10909-1_7; Freundlieb M, 2013, INT J INNOV SUSTAIN, V7, P1, DOI 10.1504/IJISD.2013.052117; Geels FW, 2013, ENVIRON INNOV SOC TR, V6, P67, DOI 10.1016/j.eist.2012.11.004; Global Reporting Initiative, 2015, J CLEANER PRODUCTION; Hahn T., 2006, Corporate Social Responsibility and Environmental Management, V13, P150, DOI 10.1002/csr.100; Hahn T, 2015, J BUS ETHICS, V127, P297, DOI 10.1007/s10551-014-2047-5; Hall TJ, 2009, HORTSCIENCE, V44, P1346, DOI 10.21273/HORTSCI.44.5.1346; Hedberg C.-J., 2003, CORP SOC RESP ENV MA, V10, P153, DOI [10.1002/csr.38, DOI 10.1002/CSR.38]; Hockerts K, 2015, BUS STRATEG ENVIRON, V24, P102, DOI 10.1002/bse.1813; Johnson M., 2014, WINNING WAR TALENT A; Kolk A., 2004, INT J ENVIRON SUSTAI, V3, P51, DOI DOI 10.1504/IJESD.2004.004688; Kolk A., 2003, BUSINESS STRATEGY EN, V12, P279, DOI DOI 10.1002/BSE.370; Krestel R, 2009, LATENT DIRICHLET ALL, P61; Krug B.A, 2008, GMPRO, V28, P43; Liew WT, 2014, COMPUT IND, V65, P393, DOI 10.1016/j.compind.2014.01.004; Linnenluecke MK, 2010, J WORLD BUS, V45, P357, DOI 10.1016/j.jwb.2009.08.006; Matthews Chris, 2015, FORTUNE; Mitchell C, 2000, PROCESS SAF ENVIRON, V78, P237, DOI 10.1205/095758200530754; Modapothala JR, 2010, INNOVATIONS IN COMPUTING SCIENCES AND SOFTWARE ENGINEERING, P489, DOI 10.1007/978-90-481-9112-3_83; Modapothala JR, 2009, 2009 INTERNATIONAL CONFERENCE ON COMPUTER ENGINEERING AND TECHNOLOGY, VOL II, PROCEEDINGS, P543, DOI 10.1109/ICCET.2009.134; Montiel I, 2008, ORGAN ENVIRON, V21, P245, DOI 10.1177/1086026608321329; Panwar NL, 2011, RENEW SUST ENERG REV, V15, P1513, DOI 10.1016/j.rser.2010.11.037; Rands MRW, 2010, SCIENCE, V329, P1298, DOI 10.1126/science.1189138; Rowe D, 2007, SCIENCE, V317, P323, DOI 10.1126/science.1143552; Sannajust A., 2014, IMPACT WORLD FINANCI; Schmiedel T., 2015, BPM DRIVING INNOVATI, P3; Searcy C, 2014, J BUS ETHICS, V121, P149, DOI 10.1007/s10551-013-1701-7; Seidel S, 2010, ENABLERS BARRIERS OR, P1; Seidel S, 2013, MIS QUART, V37, P1275, DOI 10.25300/MISQ/2013/37.4.13; Svendsen A., 1999, CHOICE MIDDLETOWN, V36, P36; Sweeney L, 2008, J MARK COMMUN, V14, P113, DOI 10.1080/13527260701856657; Szekely F., 2005, European Management Journal, V23, P628, DOI 10.1016/j.emj.2005.10.009; Szekely N, 2015, GREEN IS ARE WE STIL; van Marrewijk M, 2003, J BUS ETHICS, V44, P107, DOI 10.1023/A:1023383229086; Wilkinson A, 2001, INT J OPER PROD MAN, V21, P1492, DOI 10.1108/01443570110410865; World Commission on Environment and Development, 1987, REPORT WORLD COMMISS; Zenghelis D., 2012, POLICY BRIEF; Zucca G., 2009, INT J WINE RES, DOI [10.2147/IJWR.S5788, DOI 10.2147/IJWR.S5788]	52	27	27	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2017	12	4							e0174807	10.1371/journal.pone.0174807	http://dx.doi.org/10.1371/journal.pone.0174807			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET0LZ	28403158	Green Published, gold, Green Submitted			2022-12-27	WOS:000399955200022
J	Bailey, KL; Agarwal, E; Chowdhury, S; Luo, JT; Brattain, MG; Black, JD; Wang, J				Bailey, Katie L.; Agarwal, Ekta; Chowdhury, Sanjib; Luo, Jiangtao; Brattain, Michael G.; Black, Jennifer D.; Wang, Jing			TGF beta/Smad3 regulates proliferation and apoptosis through IRS-1 inhibition in colon cancer cells	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; INSULIN-RECEPTOR SUBSTRATE-1; CARCINOMA CELLS; COLORECTAL-CANCER; I-RECEPTOR; TUMORIGENESIS; EXPRESSION; TUMORS; OVEREXPRESSION; PROTEINS	In this study, we have uncovered a novel crosstalk between TGF beta and IGF-1R signaling pathways. We show for the first time that expression and activation of IRS-1, an IGF-1R adaptor protein, is decreased by TGF beta/Smad3 signaling. Loss or attenuation of TGF beta activation leads to elevated expression and phosphorylation of IRS-1 in colon cancer cells, resulting in enhanced cell proliferation, decreased apoptosis and increased tumor growth in vitro and in vivo. Downregulation of IRS-1 expression reversed Smad3 knockdown-mediated oncogenic phenotypes, indicating that TGF beta/Smad3 signaling inhibits cell proliferation and increases apoptosis at least partially through the inhibition of IRS-1 expression and activation. Additionally, the TGF beta/Smad3/IRS-1 signaling axis regulates expression of cyclin D1 and XIAP, which may contribute to TGF beta/Smad3/IRS-1-mediated cell cycle progression and survival. Given that loss of TGF beta signaling occurs frequently in colon cancer, an important implication of our study is that IRS-1 could be a potential therapeutic target for colon cancer treatment.	[Bailey, Katie L.; Brattain, Michael G.; Black, Jennifer D.; Wang, Jing] Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA; [Agarwal, Ekta; Brattain, Michael G.; Wang, Jing] Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA; [Agarwal, Ekta] Wistar Inst Anat & Biol, 3601 Spruce St, Philadelphia, PA 19104 USA; [Chowdhury, Sanjib] Boston Univ, Med Ctr, Dept Med, Sect Gastroenterol, Boston, MA USA; [Luo, Jiangtao] Univ Nebraska Med Ctr, Coll Publ Hlth, Dept Biostat, Omaha, NE USA; [Wang, Jing] Univ Nebraska Med Ctr, Dept Genet Cell Biol & Anat, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; The Wistar Institute; Boston University; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Wang, J (corresponding author), Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA.; Wang, J (corresponding author), Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA.; Wang, J (corresponding author), Univ Nebraska Med Ctr, Dept Genet Cell Biol & Anat, Omaha, NE 68198 USA.	jjwang@unmc.edu		Agarwal, Ekta/0000-0002-5992-3358	National Institute of Health [CA038173, CA054807]; UNMC Cancer Center Support Grant [CA036727]; NIH [CA038173, CA054807]; NATIONAL CANCER INSTITUTE [P30CA036727, R01CA054807, R01CA038173, R01CA140988, R37CA038173] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM106397] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UNMC Cancer Center Support Grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	National Institute of Health R01 grants-CA038173 and CA054807 KB UNMC Cancer Center Support Grant-CA036727 K.; We would like to thank Dr. Staci Peters for her help with figure preparation. This work was supported by NIH R01 grants CA038173 and CA054807 to MGB, and by UNMC Cancer Center Support Grant CA036727.	Agarwal E, BMC CANC, V14, P145; Arber N, 1997, CANCER RES, V57, P1569; Bacman D, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-156; Baserga R, 2009, EXP CELL RES, V315, P727, DOI 10.1016/j.yexcr.2008.09.017; Bellam N, CANC TREAT RES, V155, P85; BOYD DD, 1988, CANCER RES, V48, P2469; Byron SA, 2006, BRIT J CANCER, V95, P1220, DOI 10.1038/sj.bjc.6603354; Chan B, 2008, J MAMMARY GLAND BIOL, V13, P415, DOI 10.1007/s10911-008-9101-9; Chang Q, 2002, CANCER RES, V62, P6035; Chowdhury S, PLOS ONE, V6; de Blaquiere GE, 2009, ENDOCR-RELAT CANCER, V16, P635, DOI 10.1677/ERC-08-0216; Dearth RK, 2006, MOL CELL BIOL, V26, P9302, DOI 10.1128/MCB.00260-06; Esposito DL, PLOS ONE, V7; Flanagan L, RAD ONCOL, V10, P131; Fu MF, 2004, ENDOCRINOLOGY, V145, P5439, DOI 10.1210/en.2004-0959; Geng L, 2014, ONCOGENE, V33, P5332, DOI 10.1038/onc.2013.478; Geng L, PLOS ONE, V8; Grady WM, 1999, CANCER RES, V59, P320; Hu YP, 2008, CANCER RES, V68, P8004, DOI 10.1158/0008-5472.CAN-08-0280; Huang SS, 2004, FEBS LETT, V565, P117, DOI 10.1016/j.febslet.2004.03.082; La Rocca G, 2009, J CELL PHYSIOL, V220, P485, DOI 10.1002/jcp.21796; Lampropoulos P, TUMOUR BIOL, V33, P1005; Mardilovich K, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-14; Meyer K, 2015, MOL CELL BIOL, V35, P2991, DOI 10.1128/MCB.01149-14; Musgrove EA, 2011, NAT REV CANCER, V11, P558, DOI 10.1038/nrc3090; Novosyadlyy R, J GERONTOL A, V67, P640; Obexer P, FRONT ONCOL, V4, P197; PARSONS R, 1995, CANCER RES, V55, P5548; Pekow J, AM J PHYSL GASTROINT, V308, pG179; Ramocki NM, 2008, ENDOCRINOLOGY, V149, P261, DOI 10.1210/en.2007-0869; Salovaara R, 2002, GUT, V51, P56, DOI 10.1136/gut.51.1.56; Shi B, 2007, J BIOL CHEM, V282, P32582, DOI 10.1074/jbc.M702806200; Simms NA, BMC CANC, V12, P221; Sodir NM, 2006, CANCER RES, V66, P8430, DOI 10.1158/0008-5472.CAN-06-1437; Takaku K, 1998, CELL, V92, P645, DOI 10.1016/S0092-8674(00)81132-0; Tanaka S, 1996, CANCER RES, V56, P3391; Tseng YH, 2002, J BIOL CHEM, V277, P31601, DOI 10.1074/jbc.M202932200; Ueno H, 2000, MOL BIOL CELL, V11, P735, DOI 10.1091/mbc.11.2.735; Ungefroren H, MOL CANC, V10, P67; Veenendaal LM, 2008, CELL ONCOL, V30, P1; Wang J, 2008, CANCER RES, V68, P3152, DOI 10.1158/0008-5472.CAN-07-5348; Weber MM, 2002, CANCER-AM CANCER SOC, V95, P2086, DOI 10.1002/cncr.10945; Wu L, 2015, ONCOL REP, V34, P2797, DOI 10.3892/or.2015.4251; Xiang GA, 2009, J SURG ONCOL, V100, P708, DOI 10.1002/jso.21408; Ye SC, 1999, CANCER RES, V59, P4725; Zha J, CLIN CANC RES, V16, P2512; Zhang Y, CELL DEATH DIS, V7, pe2525; Zhang Y, 2015, J BIOL CHEM, V290, P6215, DOI 10.1074/jbc.M114.620252; Zhou Y, PLOS ONE, V8	49	22	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2017	12	4							e0176096	10.1371/journal.pone.0176096	http://dx.doi.org/10.1371/journal.pone.0176096			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KD	28414818	Green Published, Green Submitted, gold			2022-12-27	WOS:000399874800088
J	Seshadri, C; Sedaghat, N; Campo, M; Peterson, G; Wells, RD; Olson, GS; Sherman, DR; Stein, CM; Mayanja-Kizza, H; Shojaie, A; Boom, WH; Hawn, TR				Seshadri, Chetan; Sedaghat, Nafiseh; Campo, Monica; Peterson, Glenna; Wells, Richard D.; Olson, Gregory S.; Sherman, David R.; Stein, Catherine M.; Mayanja-Kizza, Harriet; Shojaie, Ali; Boom, W. Henry; Hawn, Thomas R.		TB Res Unit	Transcriptional networks are associated with resistance to Mycobacterium tuberculosis infection	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS-INFECTION; HIV-1 INFECTION; HOUSEHOLD CONTACTS; IMMUNE-RESPONSES; KAMPALA; UGANDA; GENE; INDIVIDUALS; EXPRESSION; DISEASE	Rationale Understanding mechanisms of resistance to M. tuberculosis (M. tb) infection in humans could identify novel therapeutic strategies as it has for other infectious diseases, such as HIV. Objectives To compare the early transcriptional response of M. tb-infected monocytes between Ugandan household contacts of tuberculosis patients who demonstrate clinical resistance to M. tb infection (cases) and matched controls with latent tuberculosis infection. Methods Cases (n = 10) and controls (n = 18) were selected from a long-term household contact study in which cases did not convert their tuberculin skin test (TST) or develop tuberculosis over two years of follow up. We obtained genome-wide transcriptional profiles of M. tb-infected peripheral blood monocytes and used Gene Set Enrichment Analysis and interaction networks to identify cellular processes associated with resistance to clinical M. tb infection. Measurements and main results We discovered gene sets associated with histone deacetylases that were differentially expressed when comparing resistant and susceptible subjects. We used small molecule inhibitors to demonstrate that histone deacetylase function is important for the pro-inflammatory response to in-vitro M. tb infection in human monocytes. Conclusions Monocytes from individuals who appear to resist clinical M. tb infection differentially activate pathways controlled by histone deacetylase in response to in-vitro M. tb infection when compared to those who are susceptible and develop latent tuberculosis. These data identify a potential cellular mechanism underlying the clinical phenomenon of resistance to M. tb infection despite known exposure to an infectious contact.	[Seshadri, Chetan; Campo, Monica; Peterson, Glenna; Wells, Richard D.; Olson, Gregory S.; Hawn, Thomas R.] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Sedaghat, Nafiseh] Iran Univ Sci & Technol, Comp Engn Sch, Tehran, Iran; [Sherman, David R.] Ctr Infect Dis Res, Seattle, WA USA; [Stein, Catherine M.] Case Western Reserve Univ, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA; [Mayanja-Kizza, Harriet] Makerere Univ, Kampala, Uganda; [Shojaie, Ali] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Boom, W. Henry] Case Western Reserve Univ, Dept Med, Cleveland, OH 44106 USA	University of Washington; University of Washington Seattle; Iran University Science & Technology; Center for Infectious Disease Research; Walter Reed Army Institute of Research (WRAIR); Case Western Reserve University; Makerere University; University of Washington; University of Washington Seattle; Case Western Reserve University	Seshadri, C (corresponding author), Univ Washington, Dept Med, Seattle, WA 98195 USA.	seshadri@u.washington.edu	sedaghat, Nafiseh/AAN-6084-2021; Mayanja-Kizza, Harriet/AAM-5372-2020; Sedaghat, Nafiseh/X-8047-2019; Stein, Catherine/P-9498-2019	Mayanja-Kizza, Harriet/0000-0002-9297-6208; Sedaghat, Nafiseh/0000-0002-8675-8407; Stein, Catherine/0000-0002-9763-5023; Seshadri, Chetan/0000-0003-2783-7540; Olson, Gregory/0000-0001-7181-9636	Tuberculosis Research Unit, Case Western Reserve University; National Institute of Allergy and Infectious Diseases; National Institutes of Health; Department of Health and Human Services [N01-Al-95383, HHSN266200700022C/N01-Al 70022]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR002317] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K01HL124050] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI124348, U01AI115642] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007266, R01GM114029] Funding Source: NIH RePORTER	Tuberculosis Research Unit, Case Western Reserve University; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Health and Human Services; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Tuberculosis Research Unit, Case Western Reserve University, established with funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, and Department of Health and Human Services [N01-Al-95383 and HHSN266200700022C/N01-Al 70022]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, R LANG ENV STAT COMP; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Casanova JL, 2002, ANNU REV IMMUNOL, V20, P581, DOI 10.1146/annurev.immunol.20.081501.125851; Chandran A, 2015, FRONT CELL INFECT MI, V5, DOI 10.3389/fcimb.2015.00090; Chheng P, 2015, CLIN EPIDEMIOL, V7, P411, DOI 10.2147/CLEP.S82389; Cobat A, 2009, J EXP MED, V206, P2583, DOI 10.1084/jem.20090892; Coussens AK, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005007; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; FLYNN JL, 1993, J EXP MED, V178, P2249, DOI 10.1084/jem.178.6.2249; FLYNN JL, 1995, IMMUNITY, V2, P561, DOI 10.1016/1074-7613(95)90001-2; Grabiec AM, 2010, J IMMUNOL, V184, P2718, DOI 10.4049/jimmunol.0901467; Gulick RM, 2008, NEW ENGL J MED, V359, P1429, DOI 10.1056/NEJMoa0803152; Havlir DV, 1999, NEW ENGL J MED, V340, P367, DOI 10.1056/NEJM199902043400507; HEIMBECK J., 1948, TUBERCLE, V29, P84; JONES BE, 1993, AM REV RESPIR DIS, V148, P1292, DOI 10.1164/ajrccm/148.5.1292; Leroy V, 1997, AM J EPIDEMIOL, V145, P293; Liu R, 1996, CELL, V86, P367, DOI 10.1016/S0092-8674(00)80110-5; Ma NN, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-352; Mahan CS, 2012, AM J TROP MED HYG, V86, P690, DOI 10.4269/ajtmh.2012.11-0553; Mandalakas AM, 2012, INT J TUBERC LUNG D, V16, P1033, DOI 10.5588/ijtld.12.0027; Merico D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013984; Mily A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138340; Mogues T, 2001, J EXP MED, V193, P271, DOI 10.1084/jem.193.3.271; Mombelli M, 2011, J INFECT DIS, V204, P1367, DOI 10.1093/infdis/jir553; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Roger T, 2011, BLOOD, V117, P1205, DOI 10.1182/blood-2010-05-284711; Sales G, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-20; Samson M, 1996, NATURE, V382, P722, DOI 10.1038/382722a0; Shey MS, 2014, J IMMUNOL, V192, P4833, DOI 10.4049/jimmunol.1400062; Stein Catherine M., 2013, Frontiers in Genetics, V4, P61, DOI 10.3389/fgene.2013.00061; Stein CM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004094; STEINER P, 1980, AM J DIS CHILD, V134, P747, DOI 10.1001/archpedi.1980.02130200017007; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tarca AL, 2009, BIOINFORMATICS, V25, P75, DOI 10.1093/bioinformatics/btn577; Toossi Z, 2003, J INFECT DIS, V188, P1146, DOI 10.1086/378676; Whalen CC, 2006, AM J TROP MED HYG, V75, P55, DOI 10.4269/ajtmh.2006.75.55; Whittaker SJ, 2010, J CLIN ONCOL, V28, P4485, DOI 10.1200/JCO.2010.28.9066; World Health Organization, 2020, GLOBAL TUBERCULOSIS; Zumla A, 2013, NEW ENGL J MED, V368, P745, DOI 10.1056/NEJMra1200894	40	36	36	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2017	12	4							e0175844	10.1371/journal.pone.0175844	http://dx.doi.org/10.1371/journal.pone.0175844			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KD	28414762	Green Published, Green Submitted, gold			2022-12-27	WOS:000399874800067
J	Xu, ZJ; Yan, YL; Xiao, LF; Dai, S; Zeng, SS; Qian, L; Wang, L; Yang, X; Xiao, Y; Gong, ZC				Xu, Zhijie; Yan, Yuanliang; Xiao, Lingfang; Dai, Shuang; Zeng, Shuangshuang; Qian, Long; Wang, Lin; Yang, Xue; Xiao, Yi; Gong, Zhicheng			Radiosensitizing effect of diosmetin on radioresistant lung cancer cells via Akt signaling pathway	PLOS ONE			English	Article							NASOPHARYNGEAL CARCINOMA-CELLS; DNA-DAMAGE RESPONSE; STRAND BREAK REPAIR; IONIZING-RADIATION; ADENOCARCINOMA CELLS; RESISTANCE; INHIBITION; SUPPRESSES; ACTIVATION; EXPRESSION	Radiotherapy is a powerful tool in the treatment of cancer that has the advantage of preserving normal tissues. However, tumor radioresistance currently remains a major impediment to effective RT. Thus, exploring effective radiation sensitizers is urgently needed. In this study, we have shown that diosmetin, the aglycone of the lavonoid glycoside from olive leaves, citrus fruits and some medicinal herbs, has a promising effect on radiotherapy sensitization. In our results, DIO could induce G1 phase arrest and thus enhance the radiosensitivity of radioresistant A549/IR lung cancer cells. Furthermore, DIO also restrains the IR-induced DNA damage repair by inhibiting the activated Akt signaling pathway. The combination of Akt inhibition (DIO, LY294002 or MK-2206) and radiation potently blocked A549/IR cancer cell proliferation. In summary, these observations suggest that the natural compound DIO could act as a potential drug for the treatment of radioresistant lung cancer cells.	[Xu, Zhijie] Cent S Univ, Xiangya Hosp, Dept Pathol, Changsha, Hunan, Peoples R China; [Xu, Zhijie] Cent S Univ, Sch Basic Med, Dept Pathol, Changsha, Hunan, Peoples R China; [Xu, Zhijie; Yan, Yuanliang; Xiao, Lingfang; Dai, Shuang; Zeng, Shuangshuang; Qian, Long; Wang, Lin; Yang, Xue; Xiao, Yi; Gong, Zhicheng] Cent S Univ, Xiangya Hosp, Dept Pharm, Changsha, Hunan, Peoples R China; [Xu, Zhijie; Yan, Yuanliang; Xiao, Lingfang; Dai, Shuang; Zeng, Shuangshuang; Qian, Long; Wang, Lin; Yang, Xue; Xiao, Yi; Gong, Zhicheng] Cent S Univ, Inst Hosp Pharm, Changsha, Hunan, Peoples R China	Central South University; Central South University; Central South University; Central South University	Gong, ZC (corresponding author), Cent S Univ, Xiangya Hosp, Dept Pharm, Changsha, Hunan, Peoples R China.; Gong, ZC (corresponding author), Cent S Univ, Inst Hosp Pharm, Changsha, Hunan, Peoples R China.	gongzhicheng@csu.edu.cn	Yan, Yuanliang/K-7149-2019	Xu, Zhijie/0000-0003-2047-883X	National Natural Science Foundation of China [81572946]; Changsha Science and Technology Project [k1508024-31]; Clinical and Rehabilitation Research Foundation of Xiangya hospital - Beidaweiming	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Changsha Science and Technology Project; Clinical and Rehabilitation Research Foundation of Xiangya hospital - Beidaweiming	This work is supported by the National Natural Science Foundation of China (No. 81572946), Changsha Science and Technology Project (No. k1508024-31), and Clinical and Rehabilitation Research Foundation of Xiangya hospital - Beidaweiming.	Androutsopoulos V, 2009, CANCER LETT, V274, P54, DOI 10.1016/j.canlet.2008.08.032; Bhattacharjee S, 2016, CLIN TRANSL MED, V5, DOI 10.1186/s40169-016-0128-z; Bussink J, 2008, LANCET ONCOL, V9, P288, DOI 10.1016/S1470-2045(08)70073-1; Chang L, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.415; Chen JC, 2016, ONCOTARGET, V7, P70276, DOI 10.18632/oncotarget.11839; Cheng G, 2016, CANCER RES, V76, P3904, DOI 10.1158/0008-5472.CAN-15-2534; Choi SH, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-211; Dadey DY, 2016, CLIN CANC RES OFFICI; Eberhardt WEE, 2015, LANCET, V386, P1018, DOI 10.1016/S0140-6736(15)61083-2; Gao H, 2015, CANCER LETT, V365, P79, DOI 10.1016/j.canlet.2015.05.011; Gomez-Casal R, 2015, ONCOTARGET, V6, P44306, DOI 10.18632/oncotarget.6248; Gomez-Casal R, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-94; Guo W, 2015, MOL MED REP, V12, P1857, DOI 10.3892/mmr.2015.3600; Karagounis IV, 2016, BRIT J CANCER, V115, P312, DOI 10.1038/bjc.2016.202; Kriegs M, 2015, RADIOTHER ONCOL, V115, P120, DOI 10.1016/j.radonc.2015.02.018; Liu PD, 2014, NATURE, V508, P541, DOI 10.1038/nature13079; Lorat Y, 2016, CLIN CANCER RES, V22, P5300, DOI 10.1158/1078-0432.CCR-15-3081; Lu JC, 2016, CANCER LETT, V380, P191, DOI 10.1016/j.canlet.2016.05.032; Ma XQ, 2013, INT J ONCOL, V43, P1541, DOI 10.3892/ijo.2013.2098; Mahmood J, 2016, INT J RADIAT BIOL, V92, P747, DOI 10.1080/09553002.2016.1222096; Marampon F, 2016, ONCOTARGET, V7, P5383, DOI 10.18632/oncotarget.6579; Mayer IA, 2016, ANNU REV MED, V67, P11, DOI 10.1146/annurev-med-062913-051343; Morgan MA, 2015, CLIN CANCER RES, V21, P2898, DOI 10.1158/1078-0432.CCR-13-3229; Mundi PS, 2016, BRIT J CLIN PHARMACO, V82, P943, DOI 10.1111/bcp.13021; Ochodnicka-Mackovicova K, 2015, BLOOD, V126, P1324, DOI 10.1182/blood-2015-01-621623; Ruijtenberg S, 2015, CELL, V162, P300, DOI 10.1016/j.cell.2015.06.013; Stover EH, 2016, CLIN CANCER RES, V22, P5651, DOI 10.1158/1078-0432.CCR-16-0247; Visconti R, 2016, J EXP CLIN CANC RES, V35, DOI 10.1186/s13046-016-0433-9; Wada T, 2004, NAT CELL BIOL, V6, P215, DOI 10.1038/ncb1098; Wisinski KB, 2016, CLIN CANCER RES, V22, P2659, DOI 10.1158/1078-0432.CCR-15-2365; Yang LF, 2014, CANCER BIOL THER, V15, P61, DOI 10.4161/cbt.26606; Yim JH, 2016, BIOCHEM BIOPH RES CO, V469, P94, DOI 10.1016/j.bbrc.2015.11.077; You S, 2014, MOL CANCER THER, V13, P606, DOI 10.1158/1535-7163.MCT-13-0608; Zeng XJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166239; Zhan G, 2016, J FOOD SCI, V81, pH2578, DOI 10.1111/1750-3841.13434; Zhang L, 2016, AM J TRANSL RES, V8, P4857	36	33	35	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2017	12	4							e0175977	10.1371/journal.pone.0175977	http://dx.doi.org/10.1371/journal.pone.0175977			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KD	28414793	Green Submitted, gold, Green Published			2022-12-27	WOS:000399874800081
J	Oberbach, A; Schlichting, N; Feder, S; Lehmann, S; Kullnick, Y; Buschman, T; Blumert, C; Horn, F; Neuhaus, J; Neujahr, R; Bagaev, E; Hagl, C; Pichlmaier, M; Rodloff, AC; Graber, S; Kirsch, K; Sandri, M; Kumbhari, V; Behzadi, A; Behzadi, A; Correia, JC; Mohr, FW; Friedrich, M				Oberbach, Andreas; Schlichting, Nadine; Feder, Stefan; Lehmann, Stefanie; Kullnick, Yvonne; Buschman, Tilo; Blumert, Conny; Horn, Friedemann; Neuhaus, Jochen; Neujahr, Ralph; Bagaev, Erik; Hagl, Christian; Pichlmaier, Maximilian; Rodloff, Arne Christian; Graeber, Sandra; Kirsch, Katharina; Sandri, Marcus; Kumbhari, Vivek; Behzadi, Armirhossein; Behzadi, Amirali; Correia, Joao Carlos; Mohr, Friedrich Wilhelm; Friedrich, Maik			New insights into valve-related intramural and intracellular bacterial diversity in infective endocarditis	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; STAPHYLOCOCCUS-AUREUS; DIAGNOSIS; PCR; MORTALITY; SURVIVAL; PRIMERS; PATIENT; IMPACT; CELLS	Aims In infective endocarditis (IE), a severe inflammatory disease of the endocardium with an unchanged incidence and mortality rate over the past decades, only 1% of the cases have been described as polymicrobial infections based on microbiological approaches. The aim of this study was to identify potential biodiversity of bacterial species from infected native and prosthetic valves. Furthermore, we compared the ultrastructural micro-environments to detect the localization and distribution patterns of pathogens in IE. Material and methods Using next-generation sequencing (NGS) of 16S rDNA, which allows analysis of the entire bacterial community within a single sample, we investigated the biodiversity of infectious bacterial species from resected native and prosthetic valves in a clinical cohort of 8 IE patients. Furthermore, we investigated the ultrastructural infected valve micro-environment by focused ion beam scanning electron microscopy (FIB-SEM). Results Biodiversity was detected in 7 of 8 resected heart valves. This comprised 13 bacterial genera and 16 species. In addition to 11 pathogens already described as being IE related, 5 bacterial species were identified as having a novel association. In contrast, valve and blood culture-based diagnosis revealed only 4 species from 3 bacterial genera and did not show any relevant antibiotic resistance. The antibiotics chosen on this basis for treatment, however, did not cover the bacterial spectra identified by our amplicon sequencing analysis in 4 of 8 cases. In addition to intramural distribution patterns of infective bacteria, intracellular localization with evidence of bacterial immune escape mechanisms was identified. Conclusion The high frequency of polymicrobial infections, pathogen diversity, and intracellular persistence of common IE-causing bacteria may provide clues to help explain the persistent and devastating mortality rate observed for IE. Improved bacterial diagnosis by 16S rDNA NGS that increases the ability to tailor antibiotic therapy may result in improved outcomes.	[Oberbach, Andreas; Schlichting, Nadine; Lehmann, Stefanie; Buschman, Tilo; Blumert, Conny; Horn, Friedemann; Friedrich, Maik] Fraunhofer Inst Cell Therapy & Immunol, Dept Diagnost, Leipzig, Germany; [Oberbach, Andreas; Feder, Stefan; Behzadi, Armirhossein; Behzadi, Amirali; Correia, Joao Carlos; Mohr, Friedrich Wilhelm] Univ Leipzig, Heart Ctr Leipzig, Dept Cardiac Surg, Leipzig, Germany; [Oberbach, Andreas; Kumbhari, Vivek] Johns Hopkins Med Inst, Dept Med, Baltimore, MD 21205 USA; [Oberbach, Andreas; Kumbhari, Vivek] Johns Hopkins Med Inst, Div Gastroenterol & Hepatol, Baltimore, MD 21205 USA; [Horn, Friedemann] Univ Leipzig, Inst Clin Immunol, Leipzig, Germany; [Neuhaus, Jochen] Univ Leipzig, Dept Urol, Leipzig, Germany; [Neujahr, Ralph] Carl Zeiss Microscopy GmbH, Global Sales Support Life Sci Microscopy Labs Mun, Munich, Germany; [Bagaev, Erik; Hagl, Christian; Pichlmaier, Maximilian] Ludwig Maximilians Univ Munchen, Dept Cardiac Surg, Munich, Germany; [Rodloff, Arne Christian; Graeber, Sandra] Leipzig Univ Hosp, Inst Med Microbiol & Epidemiol Infect Dis, Leipzig, Germany; [Kirsch, Katharina; Sandri, Marcus] Univ Leipzig, Dept Internal Med Cardiol, Heart Ctr, Leipzig, Germany	Fraunhofer Gesellschaft; Heart Center Leipzig GMBH; Leipzig University; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Leipzig University; Leipzig University; Carl Zeiss AG; University of Munich; Leipzig University; Heart Center Leipzig GMBH; Leipzig University	Friedrich, M (corresponding author), Fraunhofer Inst Cell Therapy & Immunol, Dept Diagnost, Leipzig, Germany.	Maik.Friedrich@izi.fraunhofer.de						Abramczuk E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134021; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Breitkopf C, 2005, CIRCULATION, V111, P1415, DOI 10.1161/01.CIR.0000158481.07569.8D; Cabell CH, 2002, ARCH INTERN MED, V162, P90, DOI 10.1001/archinte.162.1.90; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Chan CH, 2003, FEMS MICROBIOL LETT, V224, P133, DOI 10.1016/S0378-1097(03)00443-9; de Sa DDC, 2010, MAYO CLIN PROC, V85, P422, DOI 10.4065/mcp.2009.0585; Deerinck TJ, 2013, NCMIR METHODS 3D EM; do Vale A, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00042; Dreier J, 2004, J CLIN MICROBIOL, V42, P4487, DOI 10.1128/JCM.42.10.4487-4493.2004; Duffett S, 2012, CAN J INFECT DIS MED, V23, P216, DOI 10.1155/2012/312607; Duval X, 2012, J AM COLL CARDIOL, V59, P1968, DOI 10.1016/j.jacc.2012.02.029; Fedeli U, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-48; Federspiel JJ, 2012, ARCH INTERN MED, V172, P363, DOI 10.1001/archinternmed.2011.1027; Friedman ND, 2002, ANN INTERN MED, V137, P791, DOI 10.7326/0003-4819-137-10-200211190-00007; Gresham HD, 2000, J IMMUNOL, V164, P3713, DOI 10.4049/jimmunol.164.7.3713; Greub G, 2005, AM J MED, V118, P230, DOI 10.1016/j.amjmed.2004.12.014; Habib G, 2009, EUR HEART J, V30, P2369, DOI 10.1093/eurheartj/ehp285; Hoen B, 2013, NEW ENGL J MED, V368, P1425, DOI 10.1056/NEJMcp1206782; Huson DH, 2012, METHODS MOL BIOL, V856, P415, DOI 10.1007/978-1-61779-585-5_17; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Kahl BC, 2014, INFECT GENET EVOL, V21, P515, DOI 10.1016/j.meegid.2013.05.016; Khatib R, 2006, EUR J CLIN MICROBIOL, V25, P181, DOI 10.1007/s10096-006-0096-0; Layton BA, 2010, J APPL MICROBIOL, V109, P539, DOI 10.1111/j.1365-2672.2010.04675.x; Martineau F, 1998, J CLIN MICROBIOL, V36, P618, DOI 10.1128/JCM.36.3.618-623.1998; Mascio CTM, 2007, ANTIMICROB AGENTS CH, V51, P4255, DOI 10.1128/AAC.00824-07; Medina E, 2003, INFECT IMMUN, V71, P5376, DOI 10.1128/IAI.71.9.5376-5380.2003; Moreillon P, 2004, LANCET, V363, P139, DOI 10.1016/S0140-6736(03)15266-X; Moter Annette, 2010, Curr Infect Dis Rep, V12, P244, DOI 10.1007/s11908-010-0111-6; Murdoch DR, 2009, ARCH INTERN MED, V169, P463, DOI 10.1001/archinternmed.2008.603; Pada S, 2009, INT J INFECT DIS, V13, pE511, DOI 10.1016/j.ijid.2009.02.019; Park SN, 2014, ARCH MICROBIOL, V196, P661, DOI 10.1007/s00203-014-1007-x; Selton-Suty C, 2012, CLIN INFECT DIS, V54, P1230, DOI 10.1093/cid/cis199; Sy RW, 2010, EUR HEART J, V31, P1890, DOI 10.1093/eurheartj/ehq110; Tariq M, 2004, INT J INFECT DIS, V8, P163, DOI 10.1016/j.ijid.2004.02.001; Vollmer T, 2010, EUR HEART J, V31, P1105, DOI 10.1093/eurheartj/ehp600; Vorland L H, 2001, Tidsskr Nor Laegeforen, V121, P3083; Wimmer MD, 2015, INT ORTHOPAEDICS; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134	39	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2017	12	4							e0175569	10.1371/journal.pone.0175569	http://dx.doi.org/10.1371/journal.pone.0175569			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0MD	28410379	Green Published, gold, Green Submitted			2022-12-27	WOS:000399955600027
J	Tadakamadla, J; Kumar, S; Lalloo, R; Johnson, NW				Tadakamadla, Jyothi; Kumar, Santhosh; Lalloo, Ratilal; Johnson, Newell W.			Qualitative analysis of the impact of Oral Potentially Malignant Disorders on daily life activities	PLOS ONE			English	Article							REPORTED OUTCOME MEASURES; OF-LIFE; SUBMUCOUS FIBROSIS; MUCOSAL DISEASE; CLASSIFICATION; INTERVENTIONS; QUESTIONNAIRE; INTERVIEWS; VALIDITY; SYSTEM	Objective To evaluate the impact of Oral Potentially Malignant Disorders (OPMD) on daily life activities. Materials and methods Patients diagnosed with Oral Leukoplakia, Oral submucous fibrosis and Oral Lichen Planus attending the Oral Medicine clinic of Panineeya Institute of Dental Sciences & Research Centre, Hyderabad, India were invited to participate. Eighteen interviews and three focus groups were conducted in a non-clinical setting. Voice recordings were transcribed and translated from Telugu to English. Data coding was performed using the NVivo software. Results Sample size for this qualitative study comprised 32 patients. Four main themes emerged: (1) difficulties with diagnosis and knowledge about the condition, (2) physical impairment and functional limitations, (3) psychological and social wellbeing and (4) effects of treatment on daily life. In a majority of the patients, most of the interview time was spent discussing physical impairment and functional limitations. Patients also reported their mouth condition having a debilitating effect on their psychological well-being and social interactions. Conclusions 'Physical impairment and functional limitations' was the most important theme for many of the patients. However, the impacts of OPMD also extended beyond physical impairment and functional limitations to aspects of daily living, notably psychological and social wellbeing.	[Tadakamadla, Jyothi; Kumar, Santhosh; Johnson, Newell W.] Griffith Univ, Menzies Hlth Inst Queensland, Gold Coast, Qld, Australia; [Tadakamadla, Jyothi; Kumar, Santhosh] Griffith Univ, Sch Dent & Oral Hlth, Gold Coast, Qld, Australia; [Lalloo, Ratilal] Univ Queensland, Sch Dent, Brisbane, Qld, Australia	Griffith University; Menzies Health Institute Queensland; Griffith University; University of Queensland	Tadakamadla, J (corresponding author), Griffith Univ, Menzies Hlth Inst Queensland, Gold Coast, Qld, Australia.; Tadakamadla, J (corresponding author), Griffith Univ, Sch Dent & Oral Hlth, Gold Coast, Qld, Australia.	jyothi.tadakamadla@griffithuni.edu.au	Tadakamadla, santosh kumar/Y-8446-2019; Johnson, Newell W/D-8152-2019; Lalloo, Ratilal/O-5624-2014	Tadakamadla, santosh kumar/0000-0003-2775-2897; Johnson, Newell W/0000-0001-5866-262X; Lalloo, Ratilal/0000-0001-5822-1269				Adulyanon S., 1997, MEASURING ORAL HLTH, P151; Al-Busaidi Zakiya Q, 2008, Sultan Qaboos Univ Med J, V8, P11; Ali MIR Shahid, 2014, INDIAN J HLTH WELLBE, V5, P681; Antunes B, 2014, PALLIATIVE MED, V28, P158, DOI 10.1177/0269216313491619; Bredart A, 2014, HEALTH QUAL LIFE OUT, V12, DOI 10.1186/1477-7525-12-15; Chandu A, 2006, J ORAL MAXIL SURG, V64, P495, DOI 10.1016/j.joms.2005.11.028; Dinshaw K. A., 2005, HLTH ADM, V7, P10; Escudier M, 2007, BRIT J DERMATOL, V157, P765, DOI 10.1111/j.1365-2133.2007.08106.x; Fedorowicz Z, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007156.pub2; Gill P, 2008, BRIT DENT J, V204, P291, DOI 10.1038/bdj.2008.192; Ishak N. M., 2012, ED RES J, V2, P94; Keles H, 2007, INTERN MED J, V37, P6, DOI 10.1111/j.1445-5994.2006.01215.x; Kerr AR, 2011, ORAL DIS, V17, P42, DOI 10.1111/j.1601-0825.2011.01791.x; Kerr C, 2010, EXPERT REV PHARM OUT, V10, P269, DOI 10.1586/ERP.10.30; Kulkarni Ravikumar S, 2015, J Nat Sci Biol Med, V6, P116, DOI 10.4103/0976-9668.149104; LAI DR, 1995, J ORAL PATHOL MED, V24, P402, DOI 10.1111/j.1600-0714.1995.tb01209.x; Lodi G, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001829.pub3; LODI G, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD001829.PUB2; MAHER R, 1994, J ORAL PATHOL MED, V23, P65, DOI 10.1111/j.1600-0714.1994.tb00258.x; McKenna SP, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-86; Morgan D.L., 1997, FOCUS GROUPS QUALITA, V2nd ed., DOI [10.4135/9781412984287, DOI 10.4135/9781412984287]; Mortazavi Hamed, 2014, J Dent Res Dent Clin Dent Prospects, V8, P6, DOI 10.5681/joddd.2014.002; Nelson EC, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.g7818; Nikander P., 2008, QUAL RES PSYCHOL, V5, P225, DOI DOI 10.1080/14780880802314346; Patrick DL, 2011, VALUE HEALTH, V14, P967, DOI 10.1016/j.jval.2011.06.014; Riordain RN, 2011, ORAL DIS, V17, P265, DOI 10.1111/j.1601-0825.2010.01734.x; Riordain RN, 2011, J ORAL PATHOL MED, V40, P604, DOI 10.1111/j.1600-0714.2011.01021.x; Rogers SN, 1999, INT J ORAL MAX SURG, V28, P99, DOI 10.1016/S0901-5027(99)80201-X; Sarode SC, 2012, ORAL ONCOL, V48, P759, DOI 10.1016/j.oraloncology.2012.02.025; Sarode SC, 2011, ORAL ONCOL, V47, P920, DOI 10.1016/j.oraloncology.2011.06.005; Satheeshkumar PS, 2014, ORAL ONCOL, V50, pE51, DOI 10.1016/j.oraloncology.2014.07.006; Shah AA, 2011, ORAL ONCOL, V47, P920; Shah AA, 2012, ORAL ONCOL, V48, pE26, DOI 10.1016/j.oraloncology.2012.05.003; Streiner DL, 2003, HLTH MEASUREMENT SCA, P15; Tadakamadla J, 2017, OR SURG OR MED OR PA, V123, P338, DOI 10.1016/j.oooo.2016.10.025; Tadakamadla J, 2015, OR SURG OR MED OR PA, V119, P644, DOI 10.1016/j.oooo.2015.01.025; Thongprasom K, 2011, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001168, 10.1002/14651858.CD001168.pub2]; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Torres-Pereira Cassius, 2010, Braz. oral res., V24, P37, DOI 10.1590/S1806-83242010000500007; van der Waal I, 2000, ORAL ONCOL, V36, P264, DOI 10.1016/S1368-8375(99)00092-5; van der Waal I, 2009, ORAL ONCOL, V45, P317, DOI 10.1016/j.oraloncology.2008.05.016; Villa A, 2011, AUST DENT J, V56, P253, DOI 10.1111/j.1834-7819.2011.01337.x; Walsh T, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010173.pub2; Warnakulasuriya S, 2007, J ORAL PATHOL MED, V36, P575, DOI 10.1111/j.1600-0714.2007.00582.x; Zide MF, 2008, J ORAL MAXIL SURG, V66, P1162, DOI 10.1016/j.joms.2008.01.047	45	9	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2017	12	4							e0175531	10.1371/journal.pone.0175531	http://dx.doi.org/10.1371/journal.pone.0175531			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0MD	28410381	Green Submitted, gold, Green Published			2022-12-27	WOS:000399955600023
J	Brax, H; Fadlallah, R; Al-Khaled, L; Kahale, LA; Nas, H; El-Jardali, F; Aki, EA				Brax, Hneine; Fadlallah, Racha; Al-Khaled, Lina; Kahale, Lara A.; Nas, Hala; El-Jardali, Fadi; Aki, Elie A.			Association between physicians' interaction with pharmaceutical companies and their clinical practices: A systematic review and meta-analysis	PLOS ONE			English	Article							SALES REPRESENTATIVES; PRESCRIBING PRACTICES; INDUSTRY PAYMENTS; DRUG INFORMATION; UNITED-STATES; DOCTORS; IMPACT; PATTERNS; SAMPLES; INTERVENTIONS	Background Pharmaceutical company representatives likely influence the prescribing habits and professional behaviors of physicians. The objective of this study was to systematically review the association between physicians' interactions with pharmaceutical companies and their clinical practices. Methods We used the standard systematic review methodology. Observational and experimental study designs examining any type of targeted interaction between practicing physicians and pharmaceutical companies were eligible. The search strategy included a search of MEDLINE and EMBASE databases up to July 2016. Two reviewers selected studies, abstracted data, and assessed risk of bias in duplicate and independently. We assessed the quality of evidence using the GRADE approach. Results Twenty articles reporting on 19 studies met our inclusion criteria. All of these studies were conducted in high-income countries and examined different types of interactions, including detailing, industry-funded continuing medical education, and receiving free gifts. While all included studies assessed prescribing behaviors, four studies also assessed financial outcomes, one assessed physicians' knowledge, and one assessed their beliefs. None of the studies assessed clinical outcomes. Out of the 19 studies, 15 found a consistent association between interactions promoting a medication, and inappropriately increased prescribing rates, lower prescribing quality, and/or increased prescribing costs. The remaining four studies found both associations and lack of significant associations for the different types of exposures and drugs examined in the studies. A meta-analysis of six of these studies found a statistically significant association between exposure and physicians' prescribing behaviors (OR = 2.52; 95% CI 1.82-3.50). The quality of evidence was downgraded to moderate for risk of bias and inconsistency. Sensitivity analysis excluding studies at high risk of bias did not substantially change these results. A subgroup analysis did not find a difference by type of exposure. Conclusion There is moderate quality evidence that physicians' interactions with pharmaceutical companies are associated with their prescribing patterns and quality.	[Brax, Hneine] Univ St Joseph, Fac Med, Beirut, Lebanon; [Fadlallah, Racha; El-Jardali, Fadi; Aki, Elie A.] Amer Univ Beirut, Ctr Systemat Reviews Hlth Policy & Syst Res SPARK, Beirut, Lebanon; [Al-Khaled, Lina] Amer Univ Beirut, Dept Pediat & Adolescent Med, Fac Med, Beirut, Lebanon; [Kahale, Lara A.; Aki, Elie A.] Amer Univ Beirut, Dept Internal Med, Beirut, Lebanon; [Nas, Hala] Univ Damascus, Fac Med, Damascus, Syria; [El-Jardali, Fadi] Amer Univ Beirut, Dept Hlth Management & Policy, Beirut, Lebanon; [El-Jardali, Fadi; Aki, Elie A.] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada	Saint Joseph University Beirut; American University of Beirut; American University of Beirut; American University of Beirut; American University of Beirut; McMaster University	Aki, EA (corresponding author), Amer Univ Beirut, Ctr Systemat Reviews Hlth Policy & Syst Res SPARK, Beirut, Lebanon.; Aki, EA (corresponding author), Amer Univ Beirut, Dept Internal Med, Beirut, Lebanon.; Aki, EA (corresponding author), McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada.	ea32@aub.edu.lb	Akl, Elie/K-5269-2019; Akl, Elie A./R-2079-2016	Akl, Elie A./0000-0002-3444-8618; Kahale, Lara/0000-0003-4466-0556				Alkhaled L, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-004880; Anderson BL, 2009, ACAD MED, V84, P994, DOI 10.1097/ACM.0b013e3181ace53a; Becker M H, 1972, Inquiry, V9, P30; Bowman M A, 1988, J Contin Educ Health Prof, V8, P13, DOI 10.1002/chp.4750080104; Caamano F, 2002, EUR J PUBLIC HEALTH, V12, P187, DOI 10.1093/eurpub/12.3.187; Carroll AE, 2007, PEDIATRICS, V120, pE1528, DOI 10.1542/peds.2007-0363; CHREN MM, 1994, JAMA-J AM MED ASSOC, V271, P684, DOI 10.1001/jama.271.9.684; Chressanthis GA, 2012, J CLIN HYPERTENS, V14, P435, DOI 10.1111/j.1751-7176.2012.00651.x; DeJong C, 2016, JAMA INTERN MED, V176, P1114, DOI 10.1001/jamainternmed.2016.2765; Figueiras A, 2000, EUR J CLIN PHARMACOL, V56, P747, DOI 10.1007/s002280000217; Fincham JE, 2008, AM J PHARM EDUC, V72, DOI 10.5688/aj720243; Gagnon MA, 2008, PLOS MED, V5, P29, DOI 10.1371/journal.pmed.0050001; Grande D, 2010, J GEN INTERN MED, V25, P79, DOI 10.1007/s11606-009-1016-7; Gross GA, 2011, OSTEOPATHIC FAMILY P, V3, P123; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P407, DOI 10.1016/j.jclinepi.2010.07.017; HAAYER F, 1982, SOC SCI MED, V16, P2017, DOI 10.1016/0277-9536(82)90158-7; Hurley MP, 2014, JAMA DERMATOL, V150, P487, DOI 10.1001/jamadermatol.2013.9715; Iorio A, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h870; Lexchin J, 2006, CAN FAM PHYSICIAN, V52, P573; Lexchin J, 2006, CAN FAM PHYSICIAN, V52, P578; Lieb K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110130; Miller DP, 2008, SOUTH MED J, V101, P888, DOI 10.1097/SMJ.0b013e3181814d52; Mintzes B, 2013, J GEN INTERN MED, V28, P1368, DOI 10.1007/s11606-013-2411-7; Mizik N, 2004, MANAGE SCI, V50, P1704, DOI 10.1287/mnsc.1040.0281; Morgan MA, 2006, J MED ETHICS, V32, P559, DOI 10.1136/jme.2005.014480; Muijrers PEM, 2005, FAM PRACT, V22, P624, DOI 10.1093/fampra/cmi074; Norris P, 2005, DRUG PROMOTION WHAT; O'Brien MA, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000409.pub2; ORLOWSKI JP, 1992, CHEST, V102, P270, DOI 10.1378/chest.102.1.270; Ostini R, 2009, ANN PHARMACOTHER, V43, P502, DOI 10.1345/aph.1L488; Othman N, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-743; Othman N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006350; PEAY MY, 1988, SOC SCI MED, V26, P1183, DOI 10.1016/0277-9536(88)90149-9; Pedan Alex, 2011, Health Mark Q, V28, P133, DOI 10.1080/07359683.2011.545341; Pew Charitable Trusts, 2013, PERS PRESCR PHARM IN; Pinckney RG, 2011, J GEN INTERN MED, V26, P40, DOI 10.1007/s11606-010-1483-x; Rosenthal MB, 2013, NEW ENGL J MED, V368, P2052, DOI 10.1056/NEJMp1305090; Rutledge P, 2003, PHARMACOEPIDEM DR S, V12, P663, DOI 10.1002/pds.884; Silversides A, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c6964; Sondergaard J, 2009, FAM PRACT, V26, P204, DOI 10.1093/fampra/cmp010; Spithoff S, 2014, CAN FAM PHYSICIAN, V60, P694; Spurling GK, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000352; Sterne JAC, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4002; Symm B, 2006, J AM BOARD FAM MED, V19, P443, DOI 10.3122/jabfm.19.5.443; The Hilltop Institute, 2009, AC DET REV LIT STAT; Wazana A, 2000, JAMA-J AM MED ASSOC, V283, P373, DOI 10.1001/jama.283.3.373; Yeh JS, 2016, JAMA INTERN MED, V176, P763, DOI 10.1001/jamainternmed.2016.1709; Zetterqvist AV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062609; ZIEGLER MG, 1995, JAMA-J AM MED ASSOC, V273, P1296, DOI 10.1001/jama.273.16.1296; Zipkin DA, 2005, J GEN INTERN MED, V20, P777, DOI 10.1111/j.1525-1497.2005.0134.x	50	61	62	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2017	12	4							e0175493	10.1371/journal.pone.0175493	http://dx.doi.org/10.1371/journal.pone.0175493			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET0MB	28406971	Green Submitted, Green Published, gold			2022-12-27	WOS:000399955400062
J	Chen, Y; Peng, ZQ; Wu, C; Ma, ZH; Ding, GC; Cao, GQ; Ruan, SN; Lin, SZ				Chen, Yu; Peng, Zhuqing; Wu, Chao; Ma, Zhihui; Ding, Guochang; Cao, Guangqiu; Ruan, Shaoning; Lin, Sizu			Genetic diversity and variation of Chinese fir from Fujian province and Taiwan, China, based on ISSR markers	PLOS ONE			English	Article							CUNNINGHAMIA-KONISHII CUPRESSACEAE; MICROSATELLITE MARKERS; DNA PHYLOGEOGRAPHY; POPULATIONS; CONIFER; ISLAND; LANCEOLATA; PINACEAE; FLOW; DIFFERENTIATION	Genetic diversity and variation among 11 populations of Chinese fir from Fujian province and Taiwan were assessed using inter-simple sequence repeat (ISSR) markers to reveal the evolutionary relationship in their distribution range in this report. Analysis of genetic parameters of the different populations showed that populations in Fujian province exhibited a greater level of genetic diversity than did the populations in Taiwan. Compared to Taiwan populations, significant limited gene flow were observed among Fujian populations. An UPGMA cluster analysis showed that the most individuals of Taiwan populations formed a single cluster, whereas 6 discrete clusters were formed by each population from Fujian. All populations were divided into 3 main groups and that all 5 populations from Taiwan were gathered into a subgroup combined with 2 populations, Dehua and Liancheng, formed one of the 3 main groups, which indicated relative stronger relatedness. It is supported by a genetic structure analysis. All those results are suggesting different levels of genetic diversity and variation of Chinese fir between Fujian and Taiwan, and indicating different patterns of evolutionary process and local environmental adaption.	[Chen, Yu; Cao, Guangqiu; Ruan, Shaoning; Lin, Sizu] Fujian Agr & Forestry Univ, Coll Forestry, Fuzhou, Fujian, Peoples R China; [Chen, Yu; Wu, Chao; Ding, Guochang; Cao, Guangqiu; Ruan, Shaoning; Lin, Sizu] State Forestry Adm Engn Res Ctr Chinese Fir, Fuzhou, Fujian, Peoples R China; [Peng, Zhuqing] Fujian Museum, Dept Nat, Fujian, Fujian, Peoples R China; [Wu, Chao] Fujian Agr & Forestry Univ, Coll Comp & Informat Sci, Fuzhou, Fujian, Peoples R China; [Ma, Zhihui] Fujian Agr & Forestry Univ, Coll Life Sci, Fuzhou, Fujian, Peoples R China	Fujian Agriculture & Forestry University; Fujian Agriculture & Forestry University; Fujian Agriculture & Forestry University	Ruan, SN; Lin, SZ (corresponding author), Fujian Agr & Forestry Univ, Coll Forestry, Fuzhou, Fujian, Peoples R China.; Ruan, SN; Lin, SZ (corresponding author), State Forestry Adm Engn Res Ctr Chinese Fir, Fuzhou, Fujian, Peoples R China.	fjrsn@126.com; sizulin53@126.com			Chinese fir plantation in colleges and universities cultivate innovative team building [6213c0111]	Chinese fir plantation in colleges and universities cultivate innovative team building	Funding for this report was provided by central financial support for local special program "Chinese fir plantation in colleges and universities cultivate innovative team building" (6213c0111). The corresponding author Sizu Lin is the recipient.; Funding for this report was provided by central financial support for local special program "Chinese fir plantation in colleges and universities cultivate innovative team building" (6213c0111). Here we thank the Daiyun Mountain Natural Reserve, Meihua Mountain Natural Reserve, Wuyi Mountain Natural Reserve, Jingshan Forest District and Taiping Forest District for providing plants materials.	Affre L, 1997, AM J BOT, V84, P437, DOI 10.2307/2446019; Arrigoni-Blank MF, 2016, GENETICS AND MOLECUL, V15; [陈永滨 Chen Yongbin], 2014, [福建农林大学学报. 自然科学版, Journal of Fujian Agriculture and Forestry University. Natural Science Edition], V43, P385; Chhatre VE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097291; Chilton NB, 2009, PARASITOL RES, V104, P229, DOI 10.1007/s00436-008-1178-y; Chung JD, 2004, MOL PHYLOGENET EVOL, V33, P791, DOI 10.1016/j.ympev.2004.08.011; Colosimo G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106963; Costa R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152972; Das K, 2016, PROTOPLASMA; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Edelist C, 2006, MOL ECOL, V15, P4623, DOI 10.1111/j.1365-294X.2006.03112.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Guo WL, 2006, PLANT CELL REP, V25, P896, DOI 10.1007/s00299-006-0131-8; Ho Chin-Shang, 2014, BMC Res Notes, V7, P255, DOI 10.1186/1756-0500-7-255; Hou BX, 1996, AGR ARCHEAOLOGY, V1, P161; Hsu KC, 2014, MOL BIOL REP, V41, P3733, DOI 10.1007/s11033-014-3238-y; Huang Y, 2009, J SYST EVOL, V47, P103, DOI 10.1111/j.1759-6831.2009.00008.x; Hwang SY, 2003, MOL ECOL, V12, P2689, DOI 10.1046/j.1365-294X.2003.01935.x; Kawase D, 2010, J HERED, V101, P292, DOI 10.1093/jhered/esp128; Kong HX, 2004, J WUHAN BOT RES, V28, P514; Lee YJ, 2006, J HERED, V97, P261, DOI 10.1093/jhered/esj030; [李单琦 Li Danqi], 2016, [中南林业科技大学学报, Journal of Central South University of Forestry & Technology], V36, P63; Li DQ, 2016, J CENTRAL S U FOREST, V36, P78; [李明 Li Ming], 2016, [森林与环境学报, Journal of Forest and Environment], V36, P312; Lin Feng, 2004, Journal of Nanjing Forestry University (Natural Sciences Edition), V28, P22; LOVELESS MD, 1984, ANNU REV ECOL SYST, V15, P65, DOI 10.1146/annurev.es.15.110184.000433; Lu SY, 2001, GENOME, V44, P797, DOI 10.1139/gen-44-5-797; Melnikova MN, 2014, DOKL BIOCHEM BIOPHYS, V459, P209, DOI 10.1134/S1607672914060076; Mercati F, 2015, GENETICA, V143, P473, DOI 10.1007/s10709-015-9846-1; MULLERSTARCK G, 1989, SILVAE GENET, V38, P172; NEI M, 1978, GENETICS, V89, P583; Nosil P, 2009, MOL ECOL, V18, P375, DOI 10.1111/j.1365-294X.2008.03946.x; Nystedt B, 2013, NATURE, V497, P579, DOI 10.1038/nature12211; Papadopulos AST, 2011, P NATL ACAD SCI USA, V108, P13188, DOI 10.1073/pnas.1106085108; Prunier J, 2016, NEW PHYTOL, V209, P44, DOI 10.1111/nph.13565; Qiu YJ, 2013, GENET MOL BIOL, V36, P598, DOI 10.1590/S1415-47572013000400019; Sharafi AA, 2016, PHYSIOL MOL BIOL PLA, V22, P87, DOI 10.1007/s12298-016-0336-4; Sharma P, 2016, PHYSIOL MOL BIOL PLA, V22, P115, DOI 10.1007/s12298-015-0333-z; Shi Q, 2008, PHYSIOGNOMY ENV ANCE, V26, P75; Shih FL, 2007, AM J BOT, V94, P194, DOI 10.3732/ajb.94.2.194; Stefenon VM, 2008, PLANT BIOLOGY, V10, P356, DOI 10.1111/j.1438-8677.2008.00048.x; Tan Y.K., 2001, THESIS; Wang N, 2016, MOL PHYLOGENET EVOL, V102, P62, DOI 10.1016/j.ympev.2016.05.022; Wu SH, 2006, J BIOGEOGR, V33, P936, DOI 10.1111/j.1365-2699.2006.01431.x; Xing PY, 2016, GENETICS AND MOLECUL, V15; YEH FC, 1994, THEOR APPL GENET, V88, P465, DOI 10.1007/BF00223662; Yu XT, 1997, CULTIVATION CHINESE, P9; Zeng WB, 1989, J XIAMEN U NATURAL S, V28, P41; Zeng WB, 1981, ACTA SCI NATURALIUM, V20, P487	50	13	15	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2017	12	4							e0175571	10.1371/journal.pone.0175571	http://dx.doi.org/10.1371/journal.pone.0175571			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0MB	28406956	Green Published, Green Submitted, gold			2022-12-27	WOS:000399955400071
J	Ni, JK; Liu, CX; Liu, H				Ni, Junkang; Liu, Chongxin; Liu, Hang			Continuous uniformly finite time exact disturbance observer based control for fixed-time stabilization of nonlinear systems with mismatched disturbances	PLOS ONE			English	Article							SLIDING MODE CONTROL; UNCERTAIN SYSTEMS; OUTPUT-FEEDBACK; LINEAR-SYSTEMS; CONSENSUS; STABILITY; DESIGN	This paper presents a continuous composite control scheme to achieve fixed-time stabilization for nonlinear systems with mismatched disturbances. The composite controller is constructed in two steps: First, uniformly finite time exact disturbance observers are proposed to estimate and compensate the disturbances. Then, based on adding a power integrator technique and fixed-time stability theory, continuous fixed-time stable state feedback controller and Lyapunov functions are constructed to achieve global fixed-time system stabilization. The proposed control method extends the existing fixed-time stable control results to high order nonlinear systems with mismatched disturbances and achieves global fixed-time system stabilization. Besides, the proposed control scheme improves the disturbance rejection performance and achieves performance recovery of nominal system. Simulation results are provided to show the effectiveness, the superiority and the applicability of the proposed control scheme.	[Ni, Junkang; Liu, Chongxin; Liu, Hang] Xi An Jiao Tong Univ, Sch Elect Engn, State Key Lab Elect Insulat & Power Equipment, Xian 710049, Peoples R China	Xi'an Jiaotong University	Ni, JK (corresponding author), Xi An Jiao Tong Univ, Sch Elect Engn, State Key Lab Elect Insulat & Power Equipment, Xian 710049, Peoples R China.	max12391@126.com			Creative Research Groups Fund of the National Natural Science Foundation of China [51521065]; National Natural Science Foundation of China [51177117]	Creative Research Groups Fund of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Creative Research Groups Fund of the National Natural Science Foundation of China under Grant 51521065 and the National Natural Science Foundation of China under Grant 51177117. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhat SP, 2000, SIAM J CONTROL OPTIM, V38, P751, DOI 10.1137/S0363012997321358; Castanos F, 2006, IEEE T AUTOMAT CONTR, V51, P853, DOI 10.1109/TAC.2006.875008; Chen WH, 2016, IEEE T IND ELECTRON, V63, P1083, DOI 10.1109/TIE.2015.2478397; Chiu CS, 2012, AUTOMATICA, V48, P316, DOI 10.1016/j.automatica.2011.08.055; Cruz-Zavala E, 2011, IEEE T AUTOMAT CONTR, V56, P2727, DOI 10.1109/TAC.2011.2160030; Defoort M, 2015, IET CONTROL THEORY A, V9, P2165, DOI 10.1049/iet-cta.2014.1301; Ding SH, 2015, IEEE T IND ELECTRON, V62, P5899, DOI 10.1109/TIE.2015.2448064; Ding SH, 2010, INT J SYST SCI, V41, P1301, DOI 10.1080/00207720902974579; Ding SH, 2011, INT J ROBUST NONLIN, V21, P271, DOI 10.1002/rnc.1591; Du HB, 2012, J GUID CONTROL DYNAM, V35, P740, DOI 10.2514/1.56262; de Loza AF, 2014, J FRANKLIN I, V351, P2397, DOI 10.1016/j.jfranklin.2013.12.011; Fu J, 2015, AUTOMATICA, V54, P360, DOI 10.1016/j.automatica.2015.02.023; Fu JJ, 2016, SYST CONTROL LETT, V93, P1, DOI 10.1016/j.sysconle.2016.03.006; Ginoya D, 2014, IEEE T IND ELECTRON, V61, P1983, DOI 10.1109/TIE.2013.2271597; Guo L, 2014, ISA T, V53, P846, DOI 10.1016/j.isatra.2013.10.005; Hardy G., 1951, INEQUALITIES; HERMES H, 1986, SIAM J CONTROL OPTIM, V24, P731, DOI 10.1137/0324045; Hong YG, 2002, SYST CONTROL LETT, V46, P243, DOI 10.1016/S0167-6911(02)00130-5; Huang JS, 2015, AUTOMATICA, V51, P292, DOI 10.1016/j.automatica.2014.10.093; Huang XQ, 2005, AUTOMATICA, V41, P881, DOI 10.1016/j.automatica.2004.11.036; Kim KS, 2000, AUTOMATICA, V36, P1041, DOI 10.1016/S0005-1098(00)00014-5; Kim KS, 2010, IEEE T AUTOMAT CONTR, V55, P1905, DOI 10.1109/TAC.2010.2049522; Li J, 2006, IEEE T AUTOMAT CONTR, V51, P879, DOI 10.1109/TAC.2006.874991; Li SH, 2015, IEEE T AUTOMAT CONTR, V60, P277, DOI 10.1109/TAC.2014.2324212; Li SH, 2012, IEEE T IND ELECTRON, V59, P4792, DOI 10.1109/TIE.2011.2182011; Lin W, 2000, SYST CONTROL LETT, V39, P339, DOI 10.1016/S0167-6911(99)00115-2; Liu YP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130135; Ni JK, 2017, IEEE T CIRCUITS-II, V64, P151, DOI 10.1109/TCSII.2016.2551539; Ni JK, 2016, NONLINEAR DYNAM, V86, P401, DOI 10.1007/s11071-016-2897-8; Pan JF, 2015, IET ELECTR POWER APP, V9, P620, DOI 10.1049/iet-epa.2014.0486; Polyakov A, 2012, IEEE T AUTOMAT CONTR, V57, P2106, DOI 10.1109/TAC.2011.2179869; Qian CJ, 2001, IEEE T AUTOMAT CONTR, V46, P1061, DOI 10.1109/9.935058; Shen YJ, 2009, IEEE T AUTOMAT CONTR, V54, P2621, DOI 10.1109/TAC.2009.2029298; Shtessel YB, 2007, AUTOMATICA, V43, P1470, DOI 10.1016/j.automatica.2007.01.008; Song RZ, 2014, IEEE T NEUR NET LEAR, V25, P1733, DOI 10.1109/TNNLS.2014.2306201; Sun GF, 2015, IEEE T NEUR NET LEAR, V26, P224, DOI 10.1109/TNNLS.2014.2312001; Tao CW, 2003, IEEE T SYST MAN CY B, V33, P283, DOI 10.1109/TSMCB.2003.810443; Angulo MT, 2013, AUTOMATICA, V49, P2489, DOI 10.1016/j.automatica.2013.04.034; Wang CN, 2015, COMPLEXITY, V21, P370, DOI 10.1002/cplx.21572; Wang JX, 2015, IET CONTROL THEORY A, V9, P579, DOI 10.1049/iet-cta.2014.0220; Wang S. W., 2012, INT J ENG SCI TECHNO, V3, P35, DOI DOI 10.4314/IJEST.V3I6.3S; Wei XJ, 2010, INT J ROBUST NONLIN, V20, P106, DOI 10.1002/rnc.1425; Yang J, 2011, IET CONTROL THEORY A, V5, P2053, DOI 10.1049/iet-cta.2010.0616; Yang J, 2014, IEEE T CIRCUITS-II, V61, P49, DOI 10.1109/TCSII.2013.2290912; Yang J, 2013, AUTOMATICA, V49, P2287, DOI 10.1016/j.automatica.2013.03.026; Yang J, 2013, IEEE T IND ELECTRON, V60, P160, DOI 10.1109/TIE.2012.2183841; Yu XH, 1998, AUTOMATICA, V34, P389, DOI 10.1016/S0005-1098(97)00205-7; Zhang HG, 2014, IEEE T CYBERNETICS, V44, P2706, DOI 10.1109/TCYB.2014.2313915; Zhang HG, 2009, IEEE T SYST MAN CY A, V39, P437, DOI 10.1109/TSMCA.2008.2010787; Zuo ZY, 2015, AUTOMATICA, V54, P305, DOI 10.1016/j.automatica.2015.01.021; Zuo ZY, 2015, IET CONTROL THEORY A, V9, P545, DOI 10.1049/iet-cta.2014.0202; Zuo ZY, 2014, INT J CONTROL, V87, P363, DOI 10.1080/00207179.2013.834484	52	7	7	4	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2017	12	4							e0175645	10.1371/journal.pone.0175645	http://dx.doi.org/10.1371/journal.pone.0175645			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0MB	28406966	Green Published, gold, Green Submitted			2022-12-27	WOS:000399955400078
J	Ruzafa, N; Rey-Santano, C; Mielgo, V; Pereiro, X; Vecino, E				Ruzafa, Noelia; Rey-Santano, Carmen; Mielgo, Victoria; Pereiro, Xandra; Vecino, Elena			Effect of hypoxia on the retina and superior colliculus of neonatal pigs	PLOS ONE			English	Article							GANGLION-CELL DEATH; REACTIVE ASTROCYTES; OPTIC TECTUM; MULLER GLIA; RAT RETINA; OXYGEN; BRAIN; ISCHEMIA; EYE; MODEL	Purpose To evaluate the effect of hypoxia on the neonatal pig retina and brain, we analysed the retinal ganglion cells (RGCs) and neurons in the superior colliculus, as well as the response of astrocytes in both these central nervous system (CNS) structures. Methods Newborn pigs were exposed to 120 minutes of hypoxia, induced by decreasing the inspiratory oxygen fraction (FiO(2): 10-15%), followed by a reoxygenation period of 240 minutes (FiO(2): 21-35%). RGCs were quantified using Brn3a, a specific nuclear marker for these cells, and apoptosis was assessed through the appearance of active caspase-3. A morphometric analysis of the cytoskeleton of astrocytes (identified with GFAP) was performed in both the retina and superior colliculus. Results Hypoxia produced no significant change in the RGCs, although, it did induce a 37.63% increase in the number of active caspase-3 positive cells in the superior colliculus. This increase was particularly evident in the superficial layers of the superior colliculus, where 56.93% of the cells were positive for active caspase-3. In addition, hypoxia induced changes in the morphology of the astrocytes in the superior colliculus but not in the retina. Conclusions Hypoxia in the neonatal pig does not affect the retina but it does affect more central structures in the brain, increasing the number of apoptotic cells in the superior colliculus and inducing changes in astrocyte morphology. This distinct sensibility to hypoxia may pave the way to design specific approaches to combat the effects of hypoxia in specific areas of the CNS.	[Ruzafa, Noelia; Pereiro, Xandra; Vecino, Elena] Univ Basque Country, UPV EHU, Dept Cell Biol & Histol, Leioa, Vizcaya, Spain; [Rey-Santano, Carmen; Mielgo, Victoria] Cruces Univ Hosp, Res Unit Expt Neonatal Resp Physiol, Baracaldo, Vizcaya, Spain	University of Basque Country; Hospital Universitario Cruces	Vecino, E (corresponding author), Univ Basque Country, UPV EHU, Dept Cell Biol & Histol, Leioa, Vizcaya, Spain.	elena.vecino@ehu.es	Blanco, Leire/O-5114-2017; Pereiro, Xandra/AAD-6697-2022; Vecino, Elena/AAO-3462-2021	Pereiro, Xandra/0000-0003-2973-0405; Vecino, Elena/0000-0002-1672-5132; Ruzafa, Noelia/0000-0002-1853-0099	Retos-MINECO Fondos Fender [RTC-2016-48231]; Grupos Consolidados del Gobierno Vasco [IT43710]	Retos-MINECO Fondos Fender; Grupos Consolidados del Gobierno Vasco	We acknowledge the support of Retos-MINECO Fondos Fender (RTC-2016-48231) and Grupos Consolidados del Gobierno Vasco (IT43710) to E.V.	Alonso-Alconada D, 2015, STROKE, V46, P275, DOI 10.1161/STROKEAHA.114.007330; Alvarez FJ, 2008, PEDIATR RES, V64, P653, DOI 10.1203/PDR.0b013e318186e5dd; AMES A, 1992, CAN J PHYSIOL PHARM, V70, pS158, DOI 10.1139/y92-257; ANDERSON B, 1964, ARCH OPHTHALMOL-CHIC, V72, P792; Anzenbacher P, 1998, DRUG METAB DISPOS, V26, P56; Arduini A, 2014, PEDIATR RES, V76, P127, DOI 10.1038/pr.2014.70; AREES EA, 1977, ANAT EMBRYOL, V151, P29, DOI 10.1007/BF00315295; Bay H, 2008, COMPUTER VISION IMAG, V110, P13; Bevensee MO, 2008, BRAIN RES, V1193, P143, DOI 10.1016/j.brainres.2007.12.002; Bhatti F, 2015, INVEST OPHTH VIS SCI, V56, P232, DOI 10.1167/iovs.13-13652; Caprara C, 2012, PROG RETIN EYE RES, V31, P89, DOI 10.1016/j.preteyeres.2011.11.003; Chen YN, 2007, BRAIN RES, V1148, P28, DOI 10.1016/j.brainres.2007.02.027; Cheung PY, 2011, JOVE-J VIS EXP, DOI 10.3791/3166; Cowan F, 2003, LANCET, V361, P736, DOI 10.1016/S0140-6736(03)12658-X; Cowan F, 2000, Semin Neonatol, V5, P127, DOI 10.1053/siny.2000.0011; Devoto VMP, 2006, NEUROSCIENCE, V142, P645, DOI 10.1016/j.neuroscience.2006.06.054; Dorrell MI, 2010, GLIA, V58, P43, DOI 10.1002/glia.20900; Eshaq RS, 2014, REDOX BIOL, V2, P661, DOI 10.1016/j.redox.2014.04.006; Fletcher EL, 2010, DOC OPHTHALMOL, V120, P67, DOI 10.1007/s10633-009-9193-6; GARCIA JH, 1993, AM J PATHOL, V142, P623; Garcia M, 2003, HISTOL HISTOPATHOL, V18, P1205, DOI 10.14670/HH-18.1205; Garcia M, 2002, INVEST OPHTH VIS SCI, V43, P3735; GIORDANO DL, 1980, J NEUROCYTOL, V9, P603, DOI 10.1007/BF01205028; Greisen G, 2005, EARLY HUM DEV, V81, P423, DOI 10.1016/j.earlhumdev.2005.03.005; Grimm C, 2012, HIGH ALT MED BIOL, V13, P169, DOI 10.1089/ham.2012.1031; Hallak M, 2000, OBSTET GYNECOL, V96, P124, DOI 10.1016/S0029-7844(00)00844-9; Halpern Michael T, 2002, Trans Am Ophthalmol Soc, V100, P109; Halpern MT, 2002, T AM OPHTHAL SOC, V100, P117; Hernandez M, 2009, MOL VIS, V15, P2696; Hol EM, 2015, CURR OPIN CELL BIOL, V32, P121, DOI 10.1016/j.ceb.2015.02.004; Kang K, 2014, GLIA, V62, P1328, DOI 10.1002/glia.22684; Kang WF, 2011, MOL NEUROBIOL, V43, P147, DOI 10.1007/s12035-011-8163-7; Kaur C, 2013, J PINEAL RES, V54, P190, DOI 10.1111/jpi.12016; Kaur C, 2009, INVEST OPHTH VIS SCI, V50, P5364, DOI 10.1167/iovs.09-3552; Kergoat H, 2006, INVEST OPHTH VIS SCI, V47, P5423, DOI 10.1167/iovs.06-0602; KIMBLE EA, 1980, EXP EYE RES, V31, P271, DOI 10.1016/S0014-4835(80)80037-6; Lafuente H, 2011, PEDIATR RES, V70, P272, DOI 10.1203/PDR.0b013e3182276b11; Laquis S, 1998, BRAIN RES, V784, P100, DOI 10.1016/S0006-8993(97)01189-X; LEVENTHAL AG, 1981, SCIENCE, V213, P1139, DOI 10.1126/science.7268423; Liu YL, 2012, MOL MED, V18, P1387, DOI 10.2119/molmed.2012.00008; Ma Q, 2014, DRUG DISCOVERY TODAY; Melamed S, 2002, DRUG EXP CLIN RES, V28, P63; Mielgo VE, 2017, PEDIAT RES; Nakayama M, 2011, MOL VIS, V17, P1784; Pinar-Sueiro S, 2013, EXP EYE RES, V110, P55, DOI 10.1016/j.exer.2013.02.009; Devoto VMP, 2013, NEUROSCIENCE, V252, P190, DOI 10.1016/j.neuroscience.2013.07.065; PRINCE JH, 1960, AM J OPHTHALMOL, V49, P1202; Quigley HA, 1999, PROG RETIN EYE RES, V18, P39, DOI 10.1016/S1350-9462(98)00014-7; Reichenbach A, 2013, GLIA, V61, P651, DOI 10.1002/glia.22477; Reichstein D, 2007, EXP EYE RES, V84, P13, DOI 10.1016/j.exer.2006.08.009; Rey-Santano C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090728; Roth WJ, 2013, AAPS J, V15, P763, DOI 10.1208/s12248-013-9482-6; Rovere G, 2015, INVEST OPHTH VIS SCI, V56, P4487, DOI 10.1167/iovs.15-17145; Ruiz-Ederra J, 2005, Arch Soc Esp Oftalmol, V80, P571; Ruiz-Ederra J, 2005, EXP EYE RES, V81, P561, DOI 10.1016/j.exer.2005.03.014; Salmaso N, 2014, NAT NEUROSCI, V17, P341, DOI 10.1038/nn.3604; Shannon C. E., 1949, MATH THEORY COMMUNIC; Singer D, 1999, COMP BIOCHEM PHYS A, V123, P221, DOI 10.1016/S1095-6433(99)00057-4; SPARKS DL, 1986, PHYSIOL REV, V66, P118, DOI 10.1152/physrev.1986.66.1.118; Sun D, 2012, NEUROSCIENTIST, V18, P567, DOI 10.1177/1073858411423441; TAILOI CL, 1992, INVEST OPHTH VIS SCI, V33, P2148; Urcola JH, 2006, EXP EYE RES, V83, P429, DOI 10.1016/j.exer.2006.01.025; Vanegas H, 1984, COMP NEUROLOGY OPTIC; Vangeison G, 2009, NEUROSCIENTIST, V15, P579, DOI 10.1177/1073858409332405; Vecino E, 2002, VISION RES, V42, P151, DOI 10.1016/S0042-6989(01)00251-6; Vecino E, 1998, GEN PHARMACOL-VASC S, V30, P305, DOI 10.1016/S0306-3623(97)00361-3; Vecino E, 2015, J CYTOLOGY HISTOLO S, VS3, P007; Vecino E., 2011, GLAUCOMA ANIMAL MODE, P319, DOI [10.5772/18498, DOI 10.5772/18498]; Vecino E, 2016, PROG RETIN EYE RES, V51, P1, DOI 10.1016/j.preteyeres.2015.06.003; Wang LP, 2010, J NEUROSCI, V30, P16573, DOI 10.1523/JNEUROSCI.3305-10.2010; Wilhelmsson U, 2006, P NATL ACAD SCI USA, V103, P17513, DOI 10.1073/pnas.0602841103; Winkler BS, 2000, INVEST OPHTH VIS SCI, V41, P3183; Zhao XY, 2014, NEURON, V84, P202, DOI 10.1016/j.neuron.2014.08.037	73	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2017	12	4							e0175301	10.1371/journal.pone.0175301	http://dx.doi.org/10.1371/journal.pone.0175301			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0MB	28407001	Green Published, gold, Green Submitted			2022-12-27	WOS:000399955400040
J	Troester, N; Palfner, M; Dominco, M; Wohlkoenig, C; Schmidberger, E; Trinker, M; Avian, A				Troester, Natascha; Palfner, Michael; Dominco, Markus; Wohlkoenig, Christoph; Schmidberger, Erich; Trinker, Martin; Avian, Alexander			Positional therapy in sleep apnoea - one fits all? What determines success in positional therapy in sleep apnoea syndrome	PLOS ONE			English	Article							TENNIS BALL TECHNIQUE; STOKES RESPIRATION; VARIABILITY; SEVERITY	Introduction Positional therapy is a simple means of therapy in sleep apnoea syndrome, but due to controversial or lacking evidence, it is not widely accepted as appropriate treatment. In this study, we analysed data to positional therapy with regard to successful reduction of AHI and predictors of success. Methods All consecutive patients undergoing polysomnography between 2007 and 2011 were analysed. We used a strict definition of positional sleep apnoea syndrome (supine-exclusive sleep apnoea syndrome) and of therapy used. Patients underwent polysomnography initially and during follow-up. Results 1275 patients were evaluated, 112 of which had supine-exclusive sleep apnoea syndrome (AHI 5-66/h, median 13/h), 105 received positional therapy. With this treatment alone 75% (70/105) reached an AHI<5/h, in the follow-up 1 year later 37% (37/105) of these still had AHI<5/h, 46% (43/105) yielded an AHI between 5 and 10/h. Nine patient switched to APAP due to deterioration, 3 wanted to try APAP due to comfort reasons. At the last follow-up, 32% patients (34/105) were still on positional therapy with AHI<5/h. BMI was a predictor for successful reduction of AHI, but success was independent of sex, the presence of obstructive versus central sleep apnoea, severity of sleep apnoea syndrome or co-morbidities. Conclusion Positional therapy may be a promising therapy option for patients with positional sleep apnoea. With appropriate adherence it yields a reasonable success rate in the clinical routine.	[Troester, Natascha; Palfner, Michael; Dominco, Markus; Wohlkoenig, Christoph; Trinker, Martin] Med Univ Graz, Dept Internal Med, Div Pulmonol, Graz, Austria; [Schmidberger, Erich; Avian, Alexander] Med Univ Graz, Inst Med Informat Stat & Documentat, Graz, Austria; [Avian, Alexander] Ludwig Boltzmann Inst Lung Vasc Res, Graz, Austria	Medical University of Graz; Medical University of Graz; Ludwig Boltzmann Institute	Troester, N (corresponding author), Med Univ Graz, Dept Internal Med, Div Pulmonol, Graz, Austria.	natascha.troester@klinikum-graz.at		Avian, Alexander/0000-0003-1084-5763				Bittencourt LRA, 2001, J SLEEP RES, V10, P245, DOI 10.1046/j.1365-2869.2001.00255.x; CARTWRIGHT R, 1991, SLEEP, V14, P546, DOI 10.1093/sleep/14.6.546; Eijsvogel MM, 2015, J CLIN SLEEP MED, V11, P139, DOI 10.5664/jcsm.4460; Ha SCN, 2014, SLEEP MED REV, V18, P19; Iber C., 2007, AASM MANUAL SCORING; Joho S, 2010, SLEEP MED, V11, P143, DOI 10.1016/j.sleep.2009.05.014; Jokic R, 1999, CHEST, V115, P771, DOI 10.1378/chest.115.3.771; Joosten SA, 2014, SLEEP MED REV, V18, P7, DOI 10.1016/j.smrv.2013.01.005; Mador MJ, 2005, CHEST, V128, P2130, DOI 10.1378/chest.128.4.2130; Oksenberg A, 1997, CHEST, V112, P629, DOI 10.1378/chest.112.3.629; Oksenberg Arie, 2002, Med Sci Monit, V8, pCS61; Oksenberg A, 2006, LARYNGOSCOPE, V116, P1995, DOI 10.1097/01.mlg.0000237674.66716.a7; Oksenberg A, 2014, J SLEEP RES, V23, P204, DOI 10.1111/jsr.12097; Oksenberg AS, 2014, SLEEP MED REV, V18, P3, DOI 10.1016/j.smrv.2013.08.003; Ravesloot MJL, 2013, SLEEP BREATH, V17, P39, DOI 10.1007/s11325-012-0683-5; Sahlin C, 2005, EUR RESPIR J, V25, P829, DOI 10.1183/09031936.05.00107904; Skinner MA, 2008, RESPIROLOGY, V13, P708, DOI 10.1111/j.1440-1843.2008.01328.x; Szollosi I, 2006, SLEEP, V29, P1045, DOI 10.1093/sleep/29.8.1045; White LH, 2015, J CLIN SLEEP MED, V11, P149, DOI 10.5664/jcsm.4462	19	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2017	12	4							e0174468	10.1371/journal.pone.0174468	http://dx.doi.org/10.1371/journal.pone.0174468			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0MB	28406975	Green Submitted, gold, Green Published			2022-12-27	WOS:000399955400009
J	Chevrinais, M; Sire, JY; Cloutier, R				Chevrinais, Marion; Sire, Jean -Yves; Cloutier, Richard			From body scale ontogeny to species ontogeny: Histological and morphological assessment of the Late Devonian acanthodian Triazeugacanthus affinis from Miguasha, Canada	PLOS ONE			English	Article							POLYPTERUS-SENEGALUS; ESCUMINAC FORMATION; ORIGIN; FISH; EVOLUTION; CHONDRICHTHYAN; PLACODERM; PATTERNS; GANOINE; GROWTH	Growth series of Palaeozoic fishes are rare because of the fragility of larval and juvenile specimens owing to their weak mineralisation and the scarcity of articulated specimens. This rarity makes it difficult to describe early vertebrate growth patterns and processes in extinct taxa. Indeed, only a few growth series of complete Palaeozoic fishes are available; however, they allow the growth of isolated elements to be described and individual growth from these isolated elements to be inferred. In addition, isolated and in situ scales are generally abundant and well-preserved, and bring information on (1) their morphology and structure relevant to phylogenetic relationships and (2) individual growth patterns and processes relative to species ontogeny. The Late Devonian acanthodian Triazeugacanthus affinis from the Miguasha Fossil-Lagerstatte preserves one of the best known fossilised ontogenies of early vertebrates because of the exceptional preservation, the large size range, and the abundance of complete specimens. Here, we present morphological, histological, and chemical data on scales from juvenile and adult specimens (scales not being formed in larvae). Histologically, Triazeugacanthus scales are composed of a basal layer of acellular bone housing Sharpey's fibers, a mid-layer of mesodentine, and a superficial layer of ganoine. Developmentally, scales grow first through concentric addition of mesodentine and bone around a central primordium and then through superposition of ganoine layers. Ontogenetically, scales form first in the region below the dorsal fin spine, then squamation spreads anteriorly and posteriorly, and on fin webs. Phylogenetically, Triazeugacanthus scales show similarities with acanthodians (e.g. "box-in-box" growth), chondrichthyans (e.g. squamation pattern), and actinopterygians (e.g. ganoine). Scale histology and growth are interpreted in the light of a new phylogenetic analysis of gnathostomes supporting acanthodians as stem chondrichthyans.	[Chevrinais, Marion; Cloutier, Richard] Univ Quebec, Rimouski, PQ G5L 3A1, Canada; [Sire, Jean -Yves] Univ Paris 06, UMR Evolut Paris Seine 7138, IBPS, Paris, France	University of Quebec; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite	Cloutier, R (corresponding author), Univ Quebec, Rimouski, PQ G5L 3A1, Canada.	richard_cloutier@uqar.ca		Chevrinais, Marion/0000-0002-7305-0485; Cloutier, Richard/0000-0001-5780-3304	NSERC; QCBS Excellence Award; Research Chair in Paleontology and Evolutionary Biology; UMR7138 (UPMC, CNRS); Natural Sciences and Engineering Research Council of Canada [238612]; Quebec Center for Biodiversity Sciences Excellence Award	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); QCBS Excellence Award; Research Chair in Paleontology and Evolutionary Biology; UMR7138 (UPMC, CNRS); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Quebec Center for Biodiversity Sciences Excellence Award	We appreciate discussion on histology with Hans-Peter Schultze (The University of Kansas), Louise Zylberberg (UPMC), Francois Meunier (MNHN) and Armand de Ricqles (UPMC). Zhu Min (IVPP) and John A. Long (Flinders University) shared pertinent information for the coding. We thank Virginie Bazin (IFR 83/FRE 3595, UPMC) and Claude Belzile (UQAR) for SEM and EDS X-ray analyses. We are grateful to Hayat Lamrous (UPMC), Vivian de Buffrenil (MNHN), and Vincent Rommeveaux (MNHN) for their help concerning histological protocols. For the access to museum collections, we thank Johanne Kerr, Olivier Matton, and France Charest (MHNM). We thank Carole Burrow (Queensland Museum) and Zerina Johanson (Natural History Museum) for constructive reviews on the manuscript. Funding comes from NSERC (RC), QCBS Excellence Award (MC), Research Chair in Paleontology and Evolutionary Biology (RC) and from UMR7138 (UPMC, CNRS).; This work was supported by Natural Sciences and Engineering Research Council of Canada 238612 attributed to RC (https://www.nserc-crsng.gc.ca/index_eng.asp), Quebec Center for Biodiversity Sciences Excellence Award attributed to MC https://qcbs.cs/, Research Chair in Paleontology and Evolutionary Biology (RC) and from UMR7138 (UPMC, CNRS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreev PS, 2015, PALAEONTOLOGY, V58, P691, DOI 10.1111/pala.12167; Arratia G, 2009, ACTA ZOOL-STOCKHOLM, V90, P220, DOI 10.1111/j.1463-6395.2008.00375.x; Bartsch P, 1997, ACTA ZOOL-STOCKHOLM, V78, P309, DOI 10.1111/j.1463-6395.1997.tb01014.x; BELAND P, 1985, CAN J EARTH SCI, V22, P514, DOI 10.1139/e85-053; Beznosov PA., 2000, P 9 SCI C STRUCT COM, P7; Beznosov P, 2009, ACTA ZOOL-STOCKHOLM, V90, P183, DOI 10.1111/j.1463-6395.2008.00352.x; Brazeau MD, 2015, NATURE, V520, P490, DOI 10.1038/nature14438; Brazeau MD, 2014, ZOOL J LINN SOC-LOND, V170, P779, DOI 10.1111/zoj.12111; Brazeau MD, 2012, PALAEONTOLOGY, V55, P355, DOI 10.1111/j.1475-4983.2012.01130.x; Brazeau MD, 2009, NATURE, V457, P305, DOI 10.1038/nature07436; Burrow Carole, 1994, Records of the South Australian Museum (Adelaide), V27, P175; Burrow Carole J., 2005, Memoirs of the Queensland Museum, V51, P3; Burrow CJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104171; Burrow CJ, 2012, HIST BIOL, V24, P349, DOI 10.1080/08912963.2012.660150; Burrow Carole J., 1995, Geobios Memoire Special (Villeurbanne), V19, P327; Burrow CJ, 1999, J VERTEBR PALEONTOL, V19, P204, DOI 10.1080/02724634.1999.10011135; Burrow CJ, 2016, PALAEONTOL ELECTRON, V19, P1; Chevrinais M, 2016, MINERALS-BASEL, V6, DOI 10.3390/min6010001; Chevrinais M, 2015, BIOL LETTERS, V11, DOI 10.1098/rsbl.2014.0950; Cloutier R, 1996, REV PALAEOBOT PALYNO, V93, P191, DOI 10.1016/0034-6667(95)00126-3; Cloutier R, 2010, SEMIN CELL DEV BIOL, V21, P400, DOI 10.1016/j.semcdb.2009.11.004; Cloutier R., 2004, RECENT ADV ORIGIN EA, P217; Cloutier Richard, 2011, Palaeobiodiversity Palaeoenvironments, V91, P293, DOI 10.1007/s12549-011-0058-0; Cloutier Richard, 2009, Naturaliste Canadien (Quebec), V133, P84; Coates M. I., 1993, Transactions of the Royal Society of Edinburgh Earth Sciences, V84, P317; Cunningham JA, 2014, TRENDS ECOL EVOL, V29, P347, DOI 10.1016/j.tree.2014.04.004; Davis SP, 2012, NATURE, V486, P247, DOI 10.1038/nature11080; Denison R., 1979, RECORS W AUSTR MUSEU, V5; Derycke Claire, 1995, Geobios Memoire Special (Villeurbanne), V19, P31; Donoghue PCJ, 2002, PALEOBIOLOGY, V28, P474, DOI 10.1666/0094-8373(2002)028<0474:EODOTV>2.0.CO;2; Dupret V, 2014, NATURE, V507, P500, DOI 10.1038/nature12980; Fisher JP, 2005, FISH B-NOAA, V103, P34; FOREY P L, 1985, Transactions of the Royal Society of Edinburgh Earth Sciences, V76, P53; Friedman M, 2010, J VERTEBR PALEONTOL, V30, P36, DOI 10.1080/02724630903409071; Gagnier Pierre-Yves, 1996, P149; Gagnier PY, 1996, PALAEONTOLOGY, V39, P241; Gardiner B.G., 1984, Bulletin of the British Museum (Natural History) Geology, V37, P173; Giles S, 2015, PALAEONTOLOGY, V58, P849, DOI 10.1111/pala.12182; Giles S, 2015, NATURE, V520, P82, DOI 10.1038/nature14065; Grande L, 1998, J VERTEBR PALEONTO S, V4, P690, DOI DOI 10.2307/3889331; Grande L, 2010, COPEIA, P1; Greeniaus JW, 2003, J VERTEBR PALEONTOL, V23, P483, DOI 10.1671/0272-4634(2003)023[0483:FJCHRR]2.0.CO;2; Gross W., 1973, Palaeontographica Abt A, V142, P51; Gross W., 1971, Palaeontographica A, V136, P1; Gross W., 1947, PALAEONTOGR ABT A, V96, P91; Hanke G.F., 2004, RECENT ADV ORIGIN EA, P703; Hanke GF, 2012, GEODIVERSITAS, V34, P469, DOI 10.5252/g2012n3a1; Hanke GF, 2001, J VERTEBR PALEONTOL, V21, P740, DOI 10.1671/0272-4634(2001)021[0740:NSOTAG]2.0.CO;2; Hawthorn JR, 2008, J VERTEBR PALEONTOL, V28, P951, DOI 10.1671/0272-4634-28.4.951; Heidtke UHJ, 1990, POLLICHIA, V19, P1; HUTCHINSON P, 1973, Bulletin of the British Museum (Natural History) Geology, V22, P233; Janvier P., 1996, EARLY VERTEBRATES; Jarvik Erik, 1996, P285; Johanson Z, 2008, BIOL LETTERS, V4, P87, DOI 10.1098/rsbl.2007.0502; Johanson Z, 2007, ACTA ZOOL-STOCKHOLM, V88, P249, DOI 10.1111/j.1463-6395.2007.00276.x; Johanson Z, 2010, J EXP ZOOL PART B, V314B, P347, DOI 10.1002/jez.b.21343; Jollie M., 1984, Gegenbaurs Morphologisches Jahrbuch, V130, P315; JOLLIE M, 1984, COPEIA, P476, DOI 10.2307/1445204; Karatajute-Talimaa Valentina, 1998, Mitteilungen aus dem Museum fuer Naturkunde in Berlin Geowissenschaftliche Reihe, V1, P21; KARATAJUTETALIM.V, 1992, FOSSIL FISHES LIVING, P223; Khoury BM, 2015, CONNECT TISSUE RES, V56, P106, DOI 10.3109/03008207.2015.1005211; LONG JA, 1986, ZOOL J LINN SOC-LOND, V87, P321, DOI 10.1111/j.1096-3642.1986.tb01339.x; Long JA, 2015, NATURE, V517, P196, DOI 10.1038/nature13825; Lund R., 1985, Journal of Vertebrate Paleontology, V5, P1; Marss T, 2011, EST J EARTH SCI, V60, P137, DOI 10.3176/earth.2011.3.02; Marss T, 2006, J VERTEBR PALEONTOL, V26, P235, DOI 10.1671/0272-4634(2006)26[235:EUOEV]2.0.CO;2; Marss T, EARTH SCI, V88, P143; MCCRIMMON HR, 1967, J FISH RES BOARD CAN, V24, P47, DOI 10.1139/f67-005; Miles R.S., 1973, Zoological J Linn Soc, V53, P63; Miller RF, 2003, NATURE, V425, P501, DOI 10.1038/nature02001; Mutter RJ, 2007, GEOL J, V42, P213, DOI 10.1002/gj.1081; Neave F., 1936, T ROYAL SOC CANADA, V30; Newman MJ, 2012, GEODIVERSITAS, V34, P739, DOI 10.5252/g2012n4a2; Orvig T., 1977, Linnean Soc Symp Ser, VNo. 4, P53; Orvig T., 1967, STRUCTURAL CHEMICAL, P45; OTTAWAY EM, 1978, J FISH BIOL, V12, P615, DOI 10.1111/j.1095-8649.1978.tb04209.x; PATTERSON C, 1982, AM ZOOL, V22, P241; Porro LB, 2015, PALAEONTOLOGY, V58, P1031, DOI 10.1111/pala.12192; Qu Q, 2016, BIOL REV; Qu QM, 2015, J MORPHOL, V276, P873, DOI 10.1002/jmor.20386; Qu QM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061485; Reif W.-E., 1985, Courier Forschungsinstitut Senckenberg, V78, P1; REIF W-E, 1979, Palaeontologische Zeitschrift, V53, P26; REIF WE, 1982, EVOL BIOL, V15, P287; Richter M, 1999, NEUES JAHRB GEOL P M, P728; RICHTER M, 1995, ZOOL J LINN SOC-LOND, V114, P173, DOI 10.1006/zjls.1995.0023; Rucklin M, 2011, EVOL DEV, V13, P523, DOI 10.1111/j.1525-142X.2011.00508.x; SCHLOSSER IJ, 1991, BIOSCIENCE, V41, P704, DOI 10.2307/1311765; Schultz H.-P., 1990, Journal of Vertebrate Paleontology, V10, P49; Schultze H.-P., 1987, Journal of Vertebrate Paleontology, V7, P1; Schultze H. P., 1966, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V126, P232; SCHULTZE H-P, 1977, Palaeontologische Zeitschrift, V51, P152; Schultze HP, 2016, CR PALEVOL, V15, P83, DOI 10.1016/j.crpv.2015.04.001; SCHULTZE HP, 1988, COPEIA, P257, DOI 10.2307/1445948; Sire J Y, 1995, Connect Tissue Res, V33, P213, DOI 10.3109/03008209509017006; Sire JY, 2009, J ANAT, V214, P409, DOI 10.1111/j.1469-7580.2009.01046.x; Sire JY, 2004, INT J DEV BIOL, V48, P233, DOI 10.1387/ijdb.15272389; SIRE JY, 1987, AM J ANAT, V180, P391; SIRE JY, 1994, ANAT REC, V240, P189, DOI 10.1002/ar.1092400206; SIRE JY, 1989, AM J ANAT, V186, P315, DOI 10.1002/aja.1001860308; Sire JY, 1997, J ANAT, V190, P545, DOI 10.1046/j.1469-7580.1997.19040545.x; Swofford D.L., 2003, PHYLOGENETIC HDB PRA, P160; Thomson K.S., 1984, Journal of Vertebrate Paleontology, V4, P422; Trinajstic Kate, 2001, Records of the Western Australian Museum, V20, P187; Turner S., 1992, FOSSIL FISHES LIVING, P21; Upeniece I, 2002, INT S GEOL DEV SYST; Upeniece I., 2011, THESIS; Upeniece Ieva, 1996, Modern Geology, V20, P383; Upeniece Ieva, 2001, Mitteilungen aus dem Museum fuer Naturkunde in Berlin Geowissenschaftliche Reihe, V4, P101; Valiukevicius Juozas, 2003, Geodiversitas, V25, P131; Valiukevicius Juozas, 1995, Geobios Memoire Special (Villeurbanne), V19, P157; Valiukevicus J, 2005, ACTA PALAEONTOL POL, V50, P635; Wada H, 2008, DEV DYNAM, V237, P2889, DOI 10.1002/dvdy.21710; Warren A, 2000, J VERTEBR PALEONTOL, V20, P225, DOI 10.1671/0272-4634(2000)020[0225:ARAROG]2.0.CO;2; Watson D. M. S., 1937, Philosophical Transactions London, V228B, P49, DOI 10.1098/rstb.1937.0009; WHITE DS, 1977, COPEIA, P400; YANG YZ, 1995, CELL, V80, P939, DOI 10.1016/0092-8674(95)90297-X; Young V.T., 1995, ICHTHYOL ISSUES SPEC, V1, P65; Zajic J., 2005, CZECH GEOL SURVEY SP, V18, P6; Zangerl R., 1981, Handbook of Paleoichthyology, V3, P1; Zhu M, 2013, NATURE, V502, P188, DOI 10.1038/nature12617; ZIDEK J, 1985, Palaeontologische Zeitschrift, V59, P147; Zidek J., 1976, 836 U KANS PAL CONTR, P1; Zylberberg L, 2016, ACTA PALAEONTOL POL, V61, P363, DOI 10.4202/app.00161.2015	125	19	19	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2017	12	4							e0174655	10.1371/journal.pone.0174655	http://dx.doi.org/10.1371/journal.pone.0174655			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LZ	28403168	Green Submitted, gold, Green Published			2022-12-27	WOS:000399955200016
J	Kass, L; Rosanoff, A; Tanner, A; Sullivan, K; McAuley, W; Plesset, M				Kass, Lindsy; Rosanoff, Andrea; Tanner, Amy; Sullivan, Keith; McAuley, William; Plesset, Michael			Effect of transdermal magnesium cream on serum and urinary magnesium levels in humans: A pilot study	PLOS ONE			English	Article							BLOOD-PRESSURE; DIETARY MAGNESIUM; SUPPLEMENTATION; RISK; METAANALYSIS; EXERCISE; DISEASE	Background Oral magnesium supplementation is commonly used to support a low magnesium diet. This investigation set out to determine whether magnesium in a cream could be absorbed transdermally in humans to improve magnesium status. Methods and findings In this single blind, parallel designed pilot study, n = 25 participants (aged 34.3+/-14.8y, height 171.5+/-11cm, weight 75.9 +/- 14 Kg) were randomly assigned to either a 56mg/day magnesium cream or placebo cream group for two weeks. Magnesium serum and 24hour urinary excretion were measured at baseline and at 14 days intervention. Food diaries were recorded for 8 days during this period. Mg test and placebo groups' serum and urinary Mg did not differ at baseline. After the Mg2+ cream intervention there was a clinically relevant increase in serum magnesium (0.82 to 0.89 mmol/l,p = 0.29) that was not seen in the placebo group (0.77 to 0.79 mmol/L), but was only statistically significant (p = 0.02)) in a subgroup of non-athletes. Magnesium urinary excretion increased from baseline slightly in the Mg2+ group but with no statistical significance (p = 0.48). The Mg2+ group showed an 8.54% increase in serum Mg2+ and a 9.1% increase in urinary Mg2+ while these figures for the placebo group were smaller, i.e. +2.6% for serum Mg2+ and -32% for urinary Mg2+. In the placebo group, both serum and urine concentrations showed no statistically significant change after the application of the placebo cream. Conclusion No previous studies have looked at transdermal absorbency of Mg2+ in human subjects. In this pilot study, transdermal delivery of 56 mg Mg/day (a low dose compared with commercial transdermal Mg2+ products available) showed a larger percentage rise in both serum and urinary markers from pre to post intervention compared with subjects using the placebo cream, but statistical significance was achieved only for serum Mg2+ in a subgroup of nonathletes. Future studies should look at higher dosage of magnesium cream for longer durations.	[Kass, Lindsy; Tanner, Amy; Sullivan, Keith; McAuley, William] Univ Hertfordshire, Hatfield, Herts, England; [Rosanoff, Andrea; Plesset, Michael] Ctr Magnesium Educ & Res, Pahoa, HI USA	University of Hertfordshire	Kass, L (corresponding author), Univ Hertfordshire, Hatfield, Herts, England.	l.s.kass@herts.ac.uk	Rosanoff, Andrea/L-6869-2019	McAuley, William/0000-0003-3065-4649				Bain LKM, 2015, INT J CARDIOL, V196, P108, DOI 10.1016/j.ijcard.2015.05.166; Chen K, 2016, ADV MATER INTERFACES, V3, DOI 10.1002/admi.201600115; Cunha AR, 2012, INT J HYPERTENS, V2012, DOI 10.1155/2012/754250; Del Gobbo LC, 2013, AM J CLIN NUTR, V98, P160, DOI 10.3945/ajcn.112.053132; DJURHUUS MS, 1995, SCAND J CLIN LAB INV, V55, P549, DOI 10.3109/00365519509075394; Elin RJ, 2010, MAGNESIUM RES, V23, pS194, DOI 10.1684/mrh.2010.0213; Guerrero-Romero F, 2002, ACTA DIABETOL, V39, P209, DOI 10.1007/s005920200036; Hostynek JJ, 2003, FOOD CHEM TOXICOL, V41, P327, DOI 10.1016/S0278-6915(02)00257-0; Jahnen-Dechent W, 2012, CLIN KIDNEY J, V5, P3, DOI 10.1093/ndtplus/sfr163; Kass L, 2012, EUR J CLIN NUTR, V66, P411, DOI 10.1038/ejcn.2012.4; Laires MJ, 2008, MAGNESIUM RES, V21, P92; Larsson SC, 2013, AM J CLIN NUTR, V97, P1159, DOI 10.3945/ajcn.113.063354; Laurant P, 2000, J HYPERTENS, V18, P1177, DOI 10.1097/00004872-200018090-00003; LUKASKI HC, 1995, INT J SPORT NUTR, V5, pS74, DOI 10.1123/ijsn.5.s1.s74; Lutsey PL, 2014, AM J CLIN NUTR, V100, P756, DOI 10.3945/ajcn.114.085167; Newhouse IJ, 2000, CLIN J SPORT MED, V10, P195, DOI 10.1097/00042752-200007000-00008; Nielsen FH, 2006, MAGNESIUM RES, V19, P180; Royal College of Physicians and surgeons C, 2015, CLIN LAB TESTS REF V; Staff K, 2011, TOXICOL LETT, V202, P155, DOI 10.1016/j.toxlet.2011.01.017; Trauninger A, 2002, HEADACHE, V42, P114, DOI 10.1046/j.1526-4610.2002.02026.x; Zhang X, 2016, HYPERTENSION, V68, P324, DOI 10.1161/HYPERTENSIONAHA.116.07664	21	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2017	12	4							e0174817	10.1371/journal.pone.0174817	http://dx.doi.org/10.1371/journal.pone.0174817			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LZ	28403154	Green Published, Green Submitted, gold			2022-12-27	WOS:000399955200023
J	Zhang, C; Wu, XD; Zhang, BB; Chen, QS; Liu, M; Xin, DW; Qi, ZM; Li, SN; Ma, YL; Wang, LS; Jin, YM; Li, WB; Wu, XX; Su, AY				Zhang, Chao; Wu, Xiaodong; Zhang, Binbin; Chen, Qingshan; Liu, Ming; Xin, Dawei; Qi, Zhaoming; Li, Sinan; Ma, Yanlong; Wang, Lingshuang; Jin, Yangmei; Li, Wenbin; Wu, Xiaoxia; Su, An-yu			Functional analysis of the GmESR1 gene associated with soybean regeneration	PLOS ONE			English	Article							VITRO SHOOT REGENERATION; AGROBACTERIUM-MEDIATED TRANSFORMATION; ETHYLENE-RESPONSIVE ELEMENT; DNA-BINDING PROTEINS; IN-VITRO; TRANSCRIPTION FACTOR; ERF GENE; ARABIDOPSIS-THALIANA; EXPRESSION PATTERNS; SIGNALING PATHWAY	Plant regeneration can occur via in vitro tissue culture through somatic embryogenesis or de novo shoot organogenesis. Transformation of soybean (Glycine max) is difficult, hence optimization of the transformation system for soybean regeneration is required. This study investigated ENHANCER OF SHOOT REGENERATION 1 (GmESR1), a soybean transcription factor that targets regeneration-associated genes. Sequence analysis showed that GmESR1 contained a conserved 57 amino acid APETALA 2 (AP2)/ETHYLENE RESPONSE FACTOR (ERF) DNA-binding domain. The relative expression level of GmESR1 was highest in young embryos, flowers and stems in the soybean cultivar 'Dongnong 50'. To examine the function of GmESR1, transgenic Arabidopsis (Arabidopsis thaliana) and soybean plants overexpressing GmESR1 were generated. In Arabidopsis, overexpression of GmESR1 resulted in accelerated seed germination, and seedling shoot and root elongation. In soybean overexpression of GmESR1 also led to faster seed germination, and shoot and root elongation. GmESR1 specifically bound to the GCC-box. The results provide a foundation for the establishment of an efficient and stable transformation system for soybean.	[Zhang, Chao; Wu, Xiaodong; Zhang, Binbin; Chen, Qingshan; Liu, Ming; Xin, Dawei; Qi, Zhaoming; Li, Sinan; Ma, Yanlong; Wang, Lingshuang; Jin, Yangmei; Li, Wenbin; Wu, Xiaoxia] Northeast Agr Univ, Soybean Res Inst, Key Lab Soybean Biol, Chinese Educ Minist, Harbin, Heilongjiang, Peoples R China; [Su, An-yu] Northeast Agr Univ, Coll Resources & Environm, Harbin, Heilongjiang, Peoples R China	Northeast Agricultural University - China; Northeast Agricultural University - China	Wu, XX (corresponding author), Northeast Agr Univ, Soybean Res Inst, Key Lab Soybean Biol, Chinese Educ Minist, Harbin, Heilongjiang, Peoples R China.; Su, AY (corresponding author), Northeast Agr Univ, Coll Resources & Environm, Harbin, Heilongjiang, Peoples R China.	xxwu2013@126.com; unu123@163.com			Natural Science Foundation of China [31071438]; Natural Science Foundation of Heilongjiang Province of China [ZD201117]; Key Project of Heilongjiang Province Department of Education [12531z001]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Heilongjiang Province of China(Natural Science Foundation of Heilongjiang Province); Key Project of Heilongjiang Province Department of Education	The research was supported through funding from the Natural Science Foundation of China (31071438), Natural Science Foundation of Heilongjiang Province of China (ZD201117), and Key Project of Heilongjiang Province Department of Education (12531z001).	Allen MD, 1998, EMBO J, V17, P5484, DOI 10.1093/emboj/17.18.5484; [Anonymous], 2003, PLANT CELL, V15, p694 ~ 705; Arumuganathan K, 1991, PLANT MOL BIOL REP, V9, P208, DOI DOI 10.1007/BF02672069; Banno H, 2001, PLANT CELL, V13, P2609, DOI 10.1105/tpc.13.12.2609; Banno H, 2006, PLANT BIOTECHNOL, V23, P303; Brand U, 2002, PLANT PHYSIOL, V129, P565, DOI 10.1104/pp.001867; Brand U, 2000, SCIENCE, V289, P617, DOI 10.1126/science.289.5479.617; Burian A, 2016, CURR BIOL, V26, P1385, DOI 10.1016/j.cub.2016.03.067; Chandler JW, 2007, DEVELOPMENT, V134, P1653, DOI 10.1242/dev.001016; Chandler JW, 2011, PLANT MOL BIOL, V75, P223, DOI 10.1007/s11103-010-9721-5; Chandler JW, 2009, PLANT MOL BIOL, V69, P57, DOI 10.1007/s11103-008-9405-6; Chang C, 1999, CURR OPIN PLANT BIOL, V2, P352, DOI 10.1016/S1369-5266(99)00004-7; CHENG TY, 1980, PLANT SCI LETT, V19, P91, DOI 10.1016/0304-4211(80)90084-X; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Daimon Y, 2003, PLANT CELL PHYSIOL, V44, P113, DOI 10.1093/pcp/pcg038; Dang W, 2007, PLANT SCI, V173, P381, DOI 10.1016/j.plantsci.2007.06.010; Dong LD, 2015, J EXP BOT, V66, P2635, DOI 10.1093/jxb/erv078; FEHR WR, 1971, CROP SCI, V11, P929, DOI 10.2135/cropsci1971.0011183X001100060051x; Fletcher JC, 2002, BIOESSAYS, V24, P27, DOI 10.1002/bies.10020; Gruel J, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1500989; Guo HW, 2004, CURR OPIN PLANT BIOL, V7, P40, DOI 10.1016/j.pbi.2003.11.011; Gutterson N, 2004, CURR OPIN PLANT BIOL, V7, P465, DOI 10.1016/j.pbi.2004.04.007; Hu YB, 2008, J PLANT PHYSIOL, V165, P1717, DOI 10.1016/j.jplph.2007.12.006; Ikeda Y, 2006, PLANT CELL PHYSIOL, V47, P1443, DOI 10.1093/pcp/pcl023; JOFUKU KD, 1994, PLANT CELL, V6, P1211, DOI 10.1105/tpc.6.9.1211; Kass J, 2000, DROS INFORM SERV, V83, P185; Kieffer M, 2006, PLANT CELL, V18, P560, DOI 10.1105/tpc.105.039107; Long JA, 2006, SCIENCE, V312, P1520, DOI 10.1126/science.1123841; Mase H, 2007, PLANT BIOTECHNOL-NAR, V24, P481, DOI 10.5511/plantbiotechnology.24.481; Matsuo N, 2008, PLANT PHYSIOL BIOCH, V46, P1045, DOI 10.1016/j.plaphy.2008.07.007; Matsuo N, 2012, PLANT BIOTECHNOL-NAR, V29, P367, DOI 10.5511/plantbiotechnology.12.0514a; Matsuo N, 2011, PLANT SCI, V181, P39, DOI 10.1016/j.plantsci.2011.03.007; Matsuo N, 2009, PLANT BIOTECHNOL-NAR, V26, P385, DOI 10.5511/plantbiotechnology.26.385; Mazarei M, 2002, MOL PLANT MICROBE IN, V15, P577, DOI 10.1094/MPMI.2002.15.6.577; McGrath KC, 2005, PLANT PHYSIOL, V139, P949, DOI 10.1104/pp.105.068544; Motte H, 2014, BIOTECHNOL ADV, V32, P107, DOI 10.1016/j.biotechadv.2013.12.002; Nakano T, 2006, PLANT PHYSIOL, V140, P411, DOI 10.1104/pp.105.073783; Narbonne P, 2015, DEVELOPMENT, V142, P4230, DOI 10.1242/dev.130252; Nomura Y, 2009, PLANT BIOTECHNOL, V26, P395, DOI 10.5511/plantbiotechnology.26.395; OHMETAKAGI M, 1995, PLANT CELL, V7, P173, DOI 10.1105/tpc.7.2.173; Okamuro JK, 1997, P NATL ACAD SCI USA, V94, P7076, DOI 10.1073/pnas.94.13.7076; Pacurar DI, 2011, PHYSIOL MOL PLANT P, V76, P76, DOI 10.1016/j.pmpp.2011.06.004; Paz MM, 2004, EUPHYTICA, V136, P167, DOI 10.1023/B:EUPH.0000030670.36730.a4; Rao AQ, 2009, BIOTECHNOL ADV, V27, P753, DOI 10.1016/j.biotechadv.2009.04.028; Riechmann JL, 1998, BIOL CHEM, V379, P633; Rojo E, 2002, PLANT CELL, V14, P969, DOI 10.1105/tpc.002196; Sakuma Y, 2002, BIOCHEM BIOPH RES CO, V290, P998, DOI 10.1006/bbrc.2001.6299; Shaul O, 1996, ANN BOT-LONDON, V78, P283, DOI 10.1006/anbo.1996.0122; Shigyo M, 2006, GENE, V366, P256, DOI 10.1016/j.gene.2005.08.009; Sugiyama M, 1999, CURR OPIN PLANT BIOL, V2, P61, DOI 10.1016/S1369-5266(99)80012-0; Szemenyei H, 2008, SCIENCE, V319, P1384, DOI 10.1126/science.1151461; VALVEKENS D, 1988, P NATL ACAD SCI USA, V85, P5536, DOI 10.1073/pnas.85.15.5536; Velasco R, 2010, NAT GENET, V42, P833, DOI 10.1038/ng.654; Vyacheslavova AO, 2012, RUSS J GENET+, V48, P1067, DOI 10.1134/S1022795412110130; WEIGEL D, 1995, PLANT CELL, V7, P388, DOI 10.1105/tpc.7.4.388; Zhai Y, 2013, BIOL PLANTARUM, V57, P26, DOI 10.1007/s10535-012-0146-7; Zhai Y, 2013, GENE, V513, P174, DOI 10.1016/j.gene.2012.10.018; Zhang GY, 2010, MOL BIOL REP, V37, P809, DOI 10.1007/s11033-009-9616-1; Zhang GY, 2009, J EXP BOT, V60, P3781, DOI 10.1093/jxb/erp214; Zhang GY, 2008, J EXP BOT, V59, P4095, DOI 10.1093/jxb/ern248; Zimmermann R, 2007, GENE EXPR PATTERNS, V7, P158, DOI 10.1016/j.modgep.2006.06.005; Zuo JR, 2000, PLANT J, V24, P265, DOI 10.1046/j.1365-313x.2000.00868.x	62	4	8	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2017	12	4							e0175656	10.1371/journal.pone.0175656	http://dx.doi.org/10.1371/journal.pone.0175656			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LZ	28403182	Green Submitted, Green Published, gold			2022-12-27	WOS:000399955200089
J	Dos Santos, JFA; du Montcel, ST; Gargiulo, M; Behar, C; Montel, S; Hergueta, T; Navarro, S; Belaid, H; Cloitre, P; Karachi, C; Mallet, L; Welter, ML				Dos Santos, Joao Flores Alves; du Montcel, Sophie Tezenas; Gargiulo, Marcella; Behar, Cecile; Montel, Sebastien; Hergueta, Thierry; Navarro, Soledad; Belaid, Hayat; Cloitre, Pauline; Karachi, Carine; Mallet, Luc; Welter, Marie-Laure			Tackling psychosocial maladjustment in Parkinson's disease patients following subthalamic deep-brain stimulation: A randomised clinical trial	PLOS ONE			English	Article							QUALITY-OF-LIFE; NUCLEUS STIMULATION; PATIENTS EXPECTATIONS; TEMPORAL LOBECTOMY; SURGERY; MOOD; VALIDATION; BEHAVIOR; BURDEN; SCALE	Background Subthalamic nucleus deep brain stimulation (STN-DBS) is an effective treatment for the motor and non-motor signs of Parkinson's disease (PD), however, psychological disorders and social maladjustment have been reported in about one third of patients after STN-DBS. We propose here a perioperative psychoeducation programme to limit such social and familial disruption. Methods Nineteen PD patients and carers were included in a randomised single blind study. Social adjustment scale (SAS) scores from patients and carers that received the psychoeducation programme (n = 9) were compared, both 1 and 2 years after surgery, with patients and carers with usual care (n = 10). Depression, anxiety, cognitive status, apathy, coping, parkinsonian disability, quality-of-life, carers' anxiety and burden were also analysed. Results Seventeen patients completed the study, 2 were excluded from the final analysis because of adverse events. At 1 year, 2/7 patients with psychoeducation and 8/10 with usual care had an aggravation in at least one domain of the SAS (p = .058). At 2 years, only 1 patient with psychoeducation suffered persistent aggravated social adjustment as compared to 8 patients with usual care (p = .015). At 1 year, anxiety, depression and instrumental coping ratings improved more in the psychoeducation than in the usual care group (p = .038, p = .050 and p = .050, respectively). No significant differences were found between groups for quality of life, cognitive status, apathy or motor disability. Conclusions Our results suggest that a perioperative psychoeducation programme prevents social maladjustment in PD patients following STN-DBS and improves anxiety and depression compared to usual care. These preliminary data need to be confirmed in larger studies.	[Dos Santos, Joao Flores Alves; Belaid, Hayat; Karachi, Carine; Mallet, Luc; Welter, Marie-Laure] UPMC Univ Paris 06, Sorbonne Univ, CNRS,UMR S 1127, Inst Cerveau & Moelle Einiere,ICM,Inserm U 1127,U, Paris, France; [Dos Santos, Joao Flores Alves; Mallet, Luc] Univ Paris Est Creteil, Hop Univ Henri Mondor Albert Chenevier, AP HP, Personalised Neurol & Psychiat Univ Dept, Creteil, France; [Dos Santos, Joao Flores Alves; Mallet, Luc] Univ Geneva, Univ Hosp Geneva, Dept Mental Hlth & Psychiat, Geneva, Switzerland; [du Montcel, Sophie Tezenas; Cloitre, Pauline] Grp Hosp Pitie Salpetriere, AP HP, Biostat Unit, Paris, France; [du Montcel, Sophie Tezenas; Cloitre, Pauline] Clin Res Unit, Paris, France; [du Montcel, Sophie Tezenas] UPMC Univ Paris 06, Sorbonne Univ, UMR S1136, Paris, France; [du Montcel, Sophie Tezenas] INSERM, Inst Pierre Louis Epiderniol & Sante Publ, UMR S 1136, Paris, France; [Gargiulo, Marcella] Hop La Pitie Salpetriere, AP HP, Genet Dept, Paris, France; [Behar, Cecile; Montel, Sebastien; Hergueta, Thierry; Welter, Marie-Laure] Hop La Pitie Salpetriere, AP HP, Neurol Dept, Paris, France; [Behar, Cecile; Montel, Sebastien; Karachi, Carine; Mallet, Luc; Welter, Marie-Laure] Hop La Pitie Salpetriere, AP HP, Ctr Invest Clin, Paris, France; [Navarro, Soledad; Belaid, Hayat; Karachi, Carine] Hop La Pitie Salpetriere, AP HP, Neurosurg Dept, Paris, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; University of Geneva; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Welter, ML (corresponding author), UPMC Univ Paris 06, Sorbonne Univ, CNRS,UMR S 1127, Inst Cerveau & Moelle Einiere,ICM,Inserm U 1127,U, Paris, France.; Welter, ML (corresponding author), Hop La Pitie Salpetriere, AP HP, Neurol Dept, Paris, France.; Welter, ML (corresponding author), Hop La Pitie Salpetriere, AP HP, Ctr Invest Clin, Paris, France.	marie-laure.welter@icm-institute.org	Mallet, Luc/F-7156-2013; Tezenas du Montcel, Sophie/A-6207-2012	Mallet, Luc/0000-0001-8061-1167; Tezenas du Montcel, Sophie/0000-0002-2866-4330; Gargiulo, Marcela/0000-0003-1056-0653	Association France Parkinson	Association France Parkinson	This work was supported by Association France Parkinson. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agid Y, 2006, J NEURAL TRANSM-SUPP, P409; ANDERSON EA, 1987, J CONSULT CLIN PSYCH, V55, P513, DOI 10.1037/0022-006X.55.4.513; Beaulac J, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-1558-6; Berney A, 2002, NEUROLOGY, V59, P1427, DOI 10.1212/01.WNL.0000032756.14298.18; BLADIN PF, 1992, EPILEPSIA, V33, P898, DOI 10.1111/j.1528-1157.1992.tb02198.x; Burkhard PR, 2004, NEUROLOGY, V63, P2170, DOI 10.1212/01.WNL.0000145603.48221.B5; Carey M, 2007, EUR J CANCER CARE, V16, P417, DOI 10.1111/j.1365-2354.2006.00772.x; Cloninger C. R., 1994, TEMPERAMENT CHARACTE; CRAVEN JL, 1990, CLIN CHEST MED, V11, P247; Dubois B, 2000, NEUROLOGY, V55, P1621, DOI 10.1212/WNL.55.11.1621; Endler NS, 1998, PSYCHOL ASSESSMENT, V10, P195, DOI 10.1037/1040-3590.10.3.195; Fahn S, 1987, RECENT DEV PARKINSOS, V2, p[p153, 293]; Funkiewiez A, 2004, J NEUROL NEUROSUR PS, V75, P834, DOI 10.1136/jnnp.2002.009803; Gilbert F, 2012, J MED ETHICS, V38, P408, DOI 10.1136/medethics-2011-100044; Haahr A, 2013, J ADV NURS, V69, P338, DOI 10.1111/j.1365-2648.2012.06012.x; Hariz M, 2014, WORLD NEUROSURG, V82, DOI 10.1016/j.wneu.2014.03.026; Hasegawa H, 2014, WORLD NEUROSURG, V82, DOI 10.1016/j.wneu.2014.02.001; Herzog J, 2003, MOVEMENT DISORD, V18, P1382, DOI 10.1002/mds.10530; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; Hoon LS, 2013, EUR J ONCOL NURS, V17, P883, DOI 10.1016/j.ejon.2013.05.001; Houeto JL, 2006, ARCH NEUROL-CHICAGO, V63, P1090, DOI 10.1001/archneur.63.8.1090; Houeto JL, 2002, J NEUROL NEUROSUR PS, V72, P701, DOI 10.1136/jnnp.72.6.701; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Jenkinson C, 1997, AGE AGEING, V26, P353, DOI 10.1093/ageing/26.5.353; Joint C, 2014, WORLD NEUROSURG, V82, DOI 10.1016/j.wneu.2014.03.027; Krack P, 2003, NEW ENGL J MED, V349, P1925, DOI 10.1056/NEJMoa035275; Krack P, 2001, MOVEMENT DISORD, V16, P867, DOI 10.1002/mds.1174; Lewis CJ, 2015, PSYCHOL MED, V45, P73, DOI 10.1017/S0033291714001081; Lewis CJ, 2014, PARKINSONISM RELAT D, V20, P514, DOI 10.1016/j.parkreldis.2014.02.009; Maier F, 2013, J NEUROL NEUROSUR PS, V84, P1273, DOI 10.1136/jnnp-2012-303670; Mallet L, 2007, P NATL ACAD SCI USA, V104, P10661, DOI 10.1073/pnas.0610849104; Mattis S, 1988, DEMENTIA RATING SCAL; MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382; Ohlsson-Nevo E, 2016, EUR J ONCOL NURS, V21, P181, DOI 10.1016/j.ejon.2015.10.002; Okun MS, 2009, ANN NEUROL, V65, P586, DOI 10.1002/ana.21596; PAULHAN I, 1994, ANN MED-PSYCHOL, V152, P292; Perozzo P, 2001, NEUROL SCI, V22, P81, DOI 10.1007/s100720170057; Perry D, 2000, SOC WORK HEALTH CARE, V30, P71, DOI 10.1300/J010v30n04_05; Porat O, 2009, J NEUROPSYCH CLIN N, V21, P398, DOI 10.1176/jnp.2009.21.4.398; Power M, 1998, SOC SCI MED, V46, P1569, DOI 10.1016/s0277-9536(98)00009-4; SCHMIDT R, 1994, NEUROLOGY, V44, P964, DOI 10.1212/WNL.44.5.964; Schupbach M, 2006, NEUROLOGY, V66, P1811, DOI 10.1212/01.wnl.0000234880.51322.16; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Spielberger C. D., 1989, STATE TRAIT ANXIETY; STARKSTEIN SE, 1992, J NEUROPSYCH CLIN N, V4, P134; Steele AC, 2015, PEDIATR BLOOD CANCER, V62, pS585, DOI 10.1002/pbc.25701; WEISSMAN MM, 1975, ARCH GEN PSYCHIAT, V32, P357; Wilson S, 2001, J NEUROL NEUROSUR PS, V70, P649, DOI 10.1136/jnnp.70.5.649; Wilson SJ, 1999, EPILEPSY RES, V36, P1, DOI 10.1016/S0920-1211(99)00016-9; Wilson SJ, 1998, EPILEPSIA, V39, P167, DOI 10.1111/j.1528-1157.1998.tb01354.x; Witt K, 2008, LANCET NEUROL, V7, P605, DOI 10.1016/S1474-4422(08)70114-5; ZARIT SH, 1986, GERONTOLOGIST, V26, P260, DOI 10.1093/geront/26.3.260	52	23	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2017	12	4							e0174512	10.1371/journal.pone.0174512	http://dx.doi.org/10.1371/journal.pone.0174512			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET0JS	28399152	Green Published, Green Submitted, gold			2022-12-27	WOS:000399949000011
J	Jia, XG; Zhu, GQ; Han, QH; Lu, ZH				Jia, Xingang; Zhu, Guanqun; Han, Qiuhong; Lu, Zuhong			The biological knowledge discovery by PCCF measure and PCA-F projection	PLOS ONE			English	Article							VISUALIZATION	In the process of biological knowledge discovery, PCA is commonly used to complement the clustering analysis, but PCA typically gives the poor visualizations for most gene expression data sets. Here, we propose a PCCF measure, and use PCA-F to display clusters of PCCF, where PCCF and PCA-F are modeled from the modified cumulative probabilities of genes. From the analysis of simulated and experimental data sets, we demonstrate that PCCF is more appropriate and reliable for analyzing gene expression data compared to other commonly used distances or similarity measures, and PCA-F is a good visualization technique for identifying clusters of PCCF, where we aim at such data sets that the expression values of genes are collected at different time points.	[Jia, Xingang] Southeast Univ, Dept Math, Nanjing 210096, Jiangsu, Peoples R China; [Jia, Xingang; Lu, Zuhong] Southeast Univ, Sch Biol Sci & Med Engn, State Key Lab Bioelect, Nanjing 210096, Jiangsu, Peoples R China; [Zhu, Guanqun] Nanjing Agr Univ, Dept Chem, Nanjing 210000, Jiangsu, Peoples R China; [Han, Qiuhong] Nanjing Forestry Univ, Dept Math, Nanjing 210037, Jiangsu, Peoples R China	Southeast University - China; Southeast University - China; Nanjing Agricultural University; Nanjing Forestry University	Jia, XG (corresponding author), Southeast Univ, Dept Math, Nanjing 210096, Jiangsu, Peoples R China.; Jia, XG (corresponding author), Southeast Univ, Sch Biol Sci & Med Engn, State Key Lab Bioelect, Nanjing 210096, Jiangsu, Peoples R China.	hanqh15@163.com		Lu, Zuhong/0000-0003-3332-2615				Bushati N, 2011, NUCLEIC ACIDS RES, V39, P7380, DOI 10.1093/nar/gkr462; Cai L, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-7-r51; Fang H, 2010, DEV CELL, V19, P174, DOI 10.1016/j.devcel.2010.06.014; Gehlenborg N, 2010, NAT METHODS, V7, pS56, DOI [10.1038/NMETH.1436, 10.1038/nmeth.1436]; Hinton G., 2003, ADV NEURAL INFORM PR, P857; Jaskowiak PA, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-S2-S2; Kim K, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-29; Limb JK, 2009, CELL MOL LIFE SCI, V66, P1962, DOI 10.1007/s00018-009-8775-5; Lotfi E, 2014, COMPUT BIOL MED, V54, P180, DOI 10.1016/j.compbiomed.2014.09.008; Quackenbush J, 2001, NAT REV GENET, V2, P418, DOI 10.1038/35076576; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Sanguinetti G, 2008, IEEE T PATTERN ANAL, V30, P535, DOI 10.1109/TPAMI.2007.70819; Taskesen E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149853; Tavazoie S, 1999, NAT GENET, V22, P281, DOI 10.1038/10343; Tu BP, 2005, SCIENCE, V310, P1152, DOI 10.1126/science.1120499; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579	18	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2017	12	4							e0175104	10.1371/journal.pone.0175104	http://dx.doi.org/10.1371/journal.pone.0175104			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0JS	28399180	Green Published, gold, Green Submitted			2022-12-27	WOS:000399949000019
J	Texier, BD; Ibarra, A; Melo, F				Darbois Texier, Baptiste; Ibarra, Alejandro; Melo, Francisco			Low-resistive vibratory penetration in granular media	PLOS ONE			English	Article							TRANSITION; PATTERNS; DRIVEN; DRAG	Non-cohesive materials such as sand, dry snow or cereals are encountered in various common circumstances, from everyday situations to industry. The process of digging into these materials remains a challenge to most animals and machines. Within the animal kingdom, different strategies are employed to overcome this issue, including excavation methods used by ants, the two-anchor strategy employed by soft burrowers such as razor-clams, and undulatory motions exhibited by sandfish lizards. Despite the development of technology to mimic these techniques in diggers and robots, the limitations of animals and machines may differ, and mimicry of natural processes is not necessarily the most efficient technological strategy. This study presents evidence that the resisting force for the penetration of an intruder into a dry granular media can be reduced by one order of magnitude with small amplitude (A similar or equal to 10 mu m) and low frequency (f = 50-200 Hz) mechanical vibrations. This observed result is attributed to the local fluidization of the granular bed which induces the rupture of force chains. The drop in resistive force on entering dry granular materials may be relevant in technological development in order to increase the efficiency of diggers and robots.	[Darbois Texier, Baptiste; Ibarra, Alejandro; Melo, Francisco] Univ Santiago Chile, Dept Fis, Ave Ecuador 3493,9170124 Estn Cent, Santiago, Chile	Universidad de Santiago de Chile	Texier, BD (corresponding author), Univ Santiago Chile, Dept Fis, Ave Ecuador 3493,9170124 Estn Cent, Santiago, Chile.	baptiste.darbois@usach.cl	Darbois Texier, Baptiste/F-2747-2015	Darbois Texier, Baptiste/0000-0002-8772-3433; Ibarra, Alejandro/0000-0002-6916-8608	El Fondo Nacional de Desarrollo Cientifico y Tecnologico by the way of the Fondecyt [3160167]; Anillo [ACT-1412]	El Fondo Nacional de Desarrollo Cientifico y Tecnologico by the way of the Fondecyt; Anillo(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT PIA/ANILLOS)	The research was funded by El Fondo Nacional de Desarrollo Cientifico y Tecnologico by the way of the Fondecyt No. 3160167 and the Anillo ACT-1412. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDALLA AM, 1969, J AGR ENG RES, V14, P236, DOI 10.1016/0021-8634(69)90126-7; Albert R, 1999, PHYS REV LETT, V82, P205, DOI 10.1103/PhysRevLett.82.205; Bizon C, 1998, PHYS REV LETT, V80, P57, DOI 10.1103/PhysRevLett.80.57; Brzinski  TA, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.168002; Clerc MG, 2008, NAT PHYS, V4, P249, DOI 10.1038/nphys884; DOUADY S, 1989, EUROPHYS LETT, V8, P621, DOI 10.1209/0295-5075/8/7/007; Espindola D, 2016, PHYS REV E, V94, DOI 10.1103/PhysRevE.94.012901; Espindola D, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.158301; Evangelisti PS, 2001, P SOC PHOTO-OPT INS, V4359, P731; EVESQUE P, 1989, PHYS REV LETT, V62, P44, DOI 10.1103/PhysRevLett.62.44; Fall A, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.175502; GALLAS JAC, 1992, PHYS REV LETT, V69, P1371, DOI 10.1103/PhysRevLett.69.1371; Gravish N, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.128301; Hamm E, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.041304; Hill G, 2005, EUROPHYS LETT, V72, P137, DOI 10.1209/epl/i2005-10203-3; Hosoi AE, 2015, ANNU REV FLUID MECH, V47, P431, DOI 10.1146/annurev-fluid-010313-141324; HUANG AB, 1994, CAN GEOTECH J, V31, P91, DOI 10.1139/t94-010; Huerta DA, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.114301; Jia X, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.020301; KNIGHT JB, 1993, PHYS REV LETT, V70, P3728, DOI 10.1103/PhysRevLett.70.3728; LAROCHE C, 1989, J PHYS-PARIS, V50, P699, DOI 10.1051/jphys:01989005007069900; Lastakowski H, SCI REPORTS, V5, P13455; Ludewig F, 2008, EPL-EUROPHYS LETT, V84, DOI 10.1209/0295-5075/84/44001; MELO F, 1995, PHYS REV LETT, V75, P3838, DOI 10.1103/PhysRevLett.75.3838; MELO F, 1994, PHYS REV LETT, V72, P172, DOI 10.1103/PhysRevLett.72.172; Melosh HJ, 1996, NATURE, V379, P601, DOI 10.1038/379601a0; Mujica N, 1998, PHYS REV LETT, V80, P5121, DOI 10.1103/PhysRevLett.80.5121; Opsomer E, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.051306; Philippe P, 2002, EUROPHYS LETT, V60, P677, DOI 10.1209/epl/i2002-00362-7; Seguin A, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.048001; Seguin A, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.010301; Sharpe SS, 2015, PHYS BIOL, V12, DOI 10.1088/1478-3975/12/4/046009; Umbanhowar PB, 1996, NATURE, V382, P793, DOI 10.1038/382793a0; Winter GAG, 2014, BIOINSPIR BIOMIM, V9, DOI 10.1088/1748-3182/9/3/036009	34	11	11	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2017	12	4							e0175412	10.1371/journal.pone.0175412	http://dx.doi.org/10.1371/journal.pone.0175412			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KH	28419123	gold, Green Published, Green Submitted			2022-12-27	WOS:000399875200020
J	Gronberg, M; Ahlin, C; Naeser, Y; Janson, ET; Holmberg, L; Fjallskog, ML				Gronberg, Malin; Ahlin, Cecilia; Naeser, Ylva; Janson, Eva Tiensuu; Holmberg, Lars; Fjallskog, Marie-Louise			Ghrelin is a prognostic marker and a potential therapeutic target in breast cancer	PLOS ONE			English	Article							HORMONE-RELEASING-HORMONE; FOOD-INTAKE; CELL-LINES; CYCLIN-A; EXPRESSION; OBESTATIN; STOMACH; IDENTIFICATION; SECRETION; RECEPTOR	Ghrelin and obestatin are gastrointestinal peptides, encoded by the same preproghrelin gene. Both are expressed in breast cancer tissue and ghrelin has been implicated in breast cancer tumorigenesis. Despite recent advances in breast cancer management the need for new prognostic markers and potential therapeutic targets in breast cancer remains high. We studied the prognostic impact of ghrelin and obestatin in women with node negative breast cancer. Within a cohort of women with breast cancer with tumor size <= 50 mm, no lymph node metastases and no initiation of adjuvant chemotherapy, 190 women were identified who died from breast cancer and randomly selected 190 women alive at the corresponding time as controls. Tumor tissues were immunostained with antibodies versus the peptides. Ghrelin expression was associated with better breast cancer specific survival in univariate analyses (OR 0.55, 95% CI 0.36-0.84) and in multivariate models, adjusted for endocrine treatment and age (OR 0.57, 95% CI 0.36-0.89). Obestatin expression was non-informative (OR 1.2, 95% CI 0.60-2.46). Ghrelin expression is independent prognostic factor for breast cancer death in node negative patients-halving the risk for dying of breast cancer. Our data implies that ghrelin could be a potential therapeutic target in breast cancer treatment.	[Gronberg, Malin; Naeser, Ylva; Janson, Eva Tiensuu; Fjallskog, Marie-Louise] Uppsala Univ, Sect Endocrine Oncol, Dept Med Sci, Uppsala, Sweden; [Ahlin, Cecilia] Orebro Univ, Fac Med & Hlth, Dept Oncol, Orebro, Sweden; [Holmberg, Lars] Uppsala Univ, Dept Surg Sci, Uppsala, Sweden; [Holmberg, Lars] Kings Coll London, Fac Life Sci & Med, London, England	Uppsala University; Orebro University; Uppsala University; University of London; King's College London	Gronberg, M (corresponding author), Uppsala Univ, Sect Endocrine Oncol, Dept Med Sci, Uppsala, Sweden.	malin.gronberg@medsci.uu.se	Grönberg, Malin/A-9331-2010	Gronberg, Malin/0000-0003-4001-0572	Lion's Cancer foundation; Swedish Cancer Society [ETJ: CAN 2014/558, MLF: CAN 2011/461]; Swedish Breast Cancer Association; Karlsson fund; Selanders foundation	Lion's Cancer foundation; Swedish Cancer Society(Swedish Cancer Society); Swedish Breast Cancer Association; Karlsson fund; Selanders foundation	This work was supported by the Lion's Cancer foundation (www.icff.se, CA, ETJ, MLF), the Swedish Cancer Society (www.cancerforiden.se, ETJ: CAN 2014/558, MLF: CAN 2011/461), the Swedish Breast Cancer Association (www.bro.org.se, MLF), the A Karlsson fund (MG) and the Selanders foundation (MG, ETJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlin C, 2007, HISTOPATHOLOGY, V51, P491, DOI 10.1111/j.1365-2559.2007.02798.x; Ahlin C, 2009, CANCER EPIDEM BIOMAR, V18, P2501, DOI 10.1158/1055-9965.EPI-09-0169; Altman D.G., 1991, PRACTICAL STATISTIC; Asakawa A, 2001, GASTROENTEROLOGY, V120, P337, DOI 10.1053/gast.2001.22158; Cassoni P, 2001, J CLIN ENDOCR METAB, V86, P1738, DOI 10.1210/jc.86.4.1738; Chopin LK, 2012, ENDOCR REV, V33, P849, DOI 10.1210/er.2011-1007; Costantini VJA, 2011, NEUROENDOCRINOLOGY, V94, P158, DOI 10.1159/000328968; Dossus L, 2008, CARCINOGENESIS, V29, P1360, DOI 10.1093/carcin/bgn083; ELSTON CW, 1991, HISTOPATHOLOGY, V19, P403, DOI 10.1111/j.1365-2559.1991.tb00229.x; Gahete MD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023302; Gahete MD, 2010, J ALZHEIMERS DIS, V22, P819, DOI 10.3233/JAD-2010-100873; Garcia JM, 2013, J CLIN ENDOCR METAB, V98, P2422, DOI 10.1210/jc.2013-1157; Gourcerol G, 2006, PEPTIDES, V27, P2811, DOI 10.1016/j.peptides.2006.07.012; Gronberg M, 2008, J HISTOCHEM CYTOCHEM, V56, P793, DOI 10.1369/jhc.2008.951145; Gronberg M, 2012, ACTA ONCOL, V51, P386, DOI 10.3109/0284186X.2011.631576; Gronberg M, 2010, REGUL PEPTIDES, V160, P68, DOI 10.1016/j.regpep.2009.12.011; Inui A, 2001, NAT REV NEUROSCI, V2, P551, DOI 10.1038/35086018; Jeffery PL, 2005, ENDOCR-RELAT CANCER, V12, P839, DOI 10.1677/erc.1.00984; Kahan Z, 1999, J CLIN ENDOCR METAB, V84, P582, DOI 10.1210/jc.84.2.582; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Korbonits M, 2004, FRONT NEUROENDOCRIN, V25, P27, DOI 10.1016/j.yfrne.2004.03.002; Mantzoros C, 2004, J CLIN ENDOCR METAB, V89, P1102, DOI 10.1210/jc.2003-031804; Nakahara K, 2003, BIOCHEM BIOPH RES CO, V303, P751, DOI 10.1016/S0006-291X(03)00414-5; Nass R, 2011, MOL CELL ENDOCRINOL, V340, P10, DOI 10.1016/j.mce.2011.03.021; Nimeus-Malmstrom E, 2010, INT J CANCER, V127, P961, DOI 10.1002/ijc.25091; Perks CM, 2011, ENDOCRIN METAB CLIN, V40, P485, DOI 10.1016/j.ecl.2011.05.010; Perks CM, 2011, ENDOCRIN METAB CLIN, V40, pvii; Schally AV, 1999, TRENDS ENDOCRIN MET, V10, P383, DOI 10.1016/S1043-2760(99)00209-X; Seim I, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-298; Seim I, 2009, CYTOKINE GROWTH F R, V20, P297, DOI 10.1016/j.cytogfr.2009.07.006; Spirtes P., 2000, CAUSATION PREDICTION; Tack J, 2006, GUT, V55, P327, DOI 10.1136/gut.2004.060426; VanderWeele TJ, 2008, EPIDEMIOLOGY, V19, P720, DOI 10.1097/EDE.0b013e3181810e29; Yin XF, 2009, ACTA BIOCH BIOPH SIN, V41, P188, DOI 10.1093/abbs/gmp001; Zhang JV, 2005, SCIENCE, V310, P996, DOI 10.1126/science.1117255	36	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2017	12	4							e0176059	10.1371/journal.pone.0176059	http://dx.doi.org/10.1371/journal.pone.0176059			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KH	28419141	Green Submitted, Green Published, gold			2022-12-27	WOS:000399875200066
J	Kim, SH; Kim, JW; Byun, J; Jeong, JB; Kim, BG; Lee, KL				Kim, Su Hwan; Kim, Ji Won; Byun, Junsu; Jeong, Ji Bong; Kim, Byeong Gwan; Lee, Kook Lae			Plasma ghrelin level and plasma ghrelin/obestatin ratio are related to intestinal metaplasia in elderly patients with functional dyspepsia	PLOS ONE			English	Article							HELICOBACTER-PYLORI INFECTION; CIRCULATING GHRELIN; OBESTATIN LEVELS; ATROPHIC GASTRITIS; ENERGY-BALANCE; FOOD-INTAKE; STOMACH; GENE; IDENTIFICATION; ERADICATION	Background Whether plasma ghrelin/obestatin levels are associated with Helicobacter pylori (H. pylori) infection, subtypes of functional dyspepsia (FD), and gastric mucosal histology has not yet been established in elderly patients. Objective The aim of this study was to determine whether plasma ghrelin and obestatin levels are related to gastric mucosal histology, H. pylori infection, and FD subtypes in elderly patients with FD. Methods Ninety-two patients diagnosed with FD and older than 60 years (median age 69.4; range 60-88) were included. Clinical symptoms investigated included postprandial fullness, epigastric pain, epigastric soreness, nausea, and vomiting. According to the Rome III criteria, patients diagnosed with FD were divided into two subtypes: epigastric pain syndrome (EPS) and postprandial distress syndrome (PDS). Plasma ghrelin and obestatin levels were measured using enzyme immunoassay, and histological examination of gastric mucosa was performed. H. pylori infection was determined by histopathological examination of gastric mucosal biopsy and/or Campylobacter-like organism test. Results In our study, plasma ghrelin levels and plasma ghrelin/obestatin (G/O) ratio were significantly lower in subjects with intestinal metaplasia compared with those without intestinal metaplasia (ghrelin, p = 0.010; G/O ratio, p = 0.012). On the other hand, there were no significant differences in plasma ghrelin and obestatin levels between H. pylori-positive and H. pylori-negative groups. (ghrelin, p = 0.130; obestatin, p = 0.888). Similarly, no significant differences were detected between the EPS and PDS groups (ghrelin, p = 0.238; obestatin, p = 0.710). Conclusions Patients with intestinal metaplasia, a known precursor of gastric cancer, had significantly less plasma ghrelin levels and G/O ratio than those without intestinal metaplasia.	[Kim, Su Hwan; Kim, Ji Won; Byun, Junsu; Jeong, Ji Bong; Kim, Byeong Gwan; Lee, Kook Lae] Seoul Metropolitan Govt Seoul Natl Univ, Boramae Med Ctr, Dept Internal Med, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital	Kim, JW (corresponding author), Seoul Metropolitan Govt Seoul Natl Univ, Boramae Med Ctr, Dept Internal Med, Seoul, South Korea.	giwkim@hanmail.net		Jeong, Ji Bong/0000-0003-4553-1721	Seoul Metropolitan Government Seoul National University Boramae Medical Center [03-2007-1]	Seoul Metropolitan Government Seoul National University Boramae Medical Center	This study was supported by research funding from the Seoul Metropolitan Government Seoul National University Boramae Medical Center (03-2007-1). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandridis E, 2009, INFLAMM BOWEL DIS, V15, P1557, DOI 10.1002/ibd.20940; Ariyasu H, 2001, J CLIN ENDOCR METAB, V86, P4753, DOI 10.1210/jc.86.10.4753; Asakawa A, 2005, GUT, V54, P18, DOI 10.1136/gut.2004.038737; Chanoine JP, 2006, HORM RES, V66, P81, DOI 10.1159/000093585; Chen CY, 2009, PHARMACOL REV, V61, P430, DOI 10.1124/pr.109.001958; Cindoruk M, 2007, WORLD J GASTROENTERO, V13, P1595, DOI 10.3748/wjg.v13.i10.1595; De Souza MJ, 2004, J CLIN ENDOCR METAB, V89, P3536, DOI 10.1210/jc.2003-032007; Dixon MF, 1996, AM J SURG PATHOL, V20, P1161, DOI 10.1097/00000478-199610000-00001; Dun SL, 2006, J ENDOCRINOL, V191, P481, DOI 10.1677/joe.1.06944; Ford AC, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3174; Gao XY, 2008, PEPTIDES, V29, P1749, DOI 10.1016/j.peptides.2008.05.027; Gao XY, 2009, NUTRITION, V25, P506, DOI 10.1016/j.nut.2008.11.002; Hosoda H, 2003, J BIOL CHEM, V278, P64, DOI 10.1074/jbc.M205366200; Huda MSB, 2008, INT J OBESITY, V32, P129, DOI 10.1038/sj.ijo.0803694; Ikeda K, 2011, HEPATO-GASTROENTEROL, V58, P1622, DOI 10.5754/hge10271; Inui A, 2001, NAT REV NEUROSCI, V2, P551, DOI 10.1038/35086018; Isomoto H, 2005, AM J GASTROENTEROL, V100, P1711, DOI 10.1111/j.1572-0241.2005.41492.x; Isomoto H, 2005, DIGEST DIS SCI, V50, P833, DOI 10.1007/s10620-005-2648-z; Jung JY, 2015, INTEST RES, V13, P68, DOI 10.5217/ir.2015.13.1.68; Kawashima J, 2009, J GASTROENTEROL, V44, P1046, DOI 10.1007/s00535-009-0120-0; Kim N, 2008, J CLIN GASTROENTEROL, V42, P448, DOI 10.1097/MCG.0b013e318046eac3; Kimura K, 1969, ENDOSCOPY, V1, P87, DOI DOI 10.1055/S-0028-1098086; Lee KJ, 2009, DIGESTION, V80, P58, DOI 10.1159/000215389; Leung WK, 2002, ALIMENT PHARM THER, V16, P1209, DOI 10.1046/j.1365-2036.2002.01300.x; Nweneka CV, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-7; Ogiso K, 2011, J GASTROEN HEPATOL, V26, P67, DOI 10.1111/j.1440-1746.2011.06630.x; Osawa H, 2005, J CLIN ENDOCR METAB, V90, P10, DOI 10.1210/jc.2004-1330; Ozbay Y, 2008, BMB REP, V41, P55, DOI 10.5483/BMBRep.2008.41.1.055; Salles N, 2006, J GERONTOL A-BIOL, V61, P1144, DOI 10.1093/gerona/61.11.1144; Sarnelli G, 2003, AM J GASTROENTEROL, V98, P783, DOI 10.1111/j.1572-0241.2003.07389.x; Seim I, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-298; Serra-Prat M, 2009, CLIN ENDOCRINOL, V70, P227, DOI 10.1111/j.1365-2265.2008.03307.x; St Pierre DH, 2003, NEWS PHYSIOL SCI, V18, P242; Tack J, 2006, GASTROENTEROLOGY, V130, P1466, DOI 10.1053/j.gastro.2005.11.059; Takamori K, 2007, J CLIN GASTROENTEROL, V41, P477, DOI 10.1097/01.mcg.0000225614.94470.47; Ulasoglu C, 2013, WORLD J GASTROENTERO, V19, P2388, DOI 10.3748/wjg.v19.i15.2388; Yagi T, 2013, INT J MOL MED, V32, P523, DOI 10.3892/ijmm.2013.1418; Zhang JV, 2005, SCIENCE, V310, P996, DOI 10.1126/science.1117255; Zhao CM, 2008, CELL TISSUE RES, V331, P575, DOI 10.1007/s00441-007-0514-3	39	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2017	12	4							e0175231	10.1371/journal.pone.0175231	http://dx.doi.org/10.1371/journal.pone.0175231			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KH	28419119	Green Submitted, gold, Green Published			2022-12-27	WOS:000399875200013
J	Gooch, JL; King, C; Francis, CE; Garcia, PS; Bai, Y				Gooch, Jennifer L.; King, Clayton; Francis, Cynthia E.; Garcia, Paul S.; Bai, Yun			Cyclosporine A alters expression of renal microRNAs: New insights into calcineurin inhibitor nephrotoxicity	PLOS ONE			English	Article							FIBROSIS; TRANSPLANTATION; MIR-21; MODEL; PATHWAY; TARGETS; INJURY; HEART	Calcineurin inhibitors are powerful immunosuppressants that revolutionized organ transplantation. However, non-immune effects of the calcineurin inhibitor, such as cyclosporine A (CsA), have significantly hindered their use. Specifically, nephrotoxicity, which is associated with tubulointerstitial fibrosis, inflammation, and podocyte damage, affects up to half of all transplant patients. Calcineurin is involved in many aspects of kidney development and function; therefore, mechanisms of CsA-induced nephrotoxicity are complex and not yet fully understood. MicroRNAs are short non-coding RNAs that regulate protein-coding RNA expression through post-translational repression of target messenger RNAs. MicroRNA dysregulation is known to be involved in kidney diseases including fibrosis. In this study, we compared the renal microRNA expression profiles between mice that received CsA (20 mg/kg) or vehicle daily for six weeks. The results demonstrate that CsA induces significant changes in renal microRNA expression profile. We used combined criteria of False Discovery Rate (<= 0.1), fold change (>= 2) and median signal strength (>= 50) and identified 76 differencially expressed microRNAs. This approach identified microRNAs previously linked to renal fibrosis that includes let-7d, miR-21, miR-29, miR-30, miR-130, miR-192, and miR-200 as well as microRNAs that have not been reported to be related to nephrotoxicity or immunosuppression. Pathway analysis of microRNA/mRNA changes highlights the Wnt, TGF- beta, mTOR, and VEGF pathways. The mRNA expression profiles were compared in the same samples. The change of mRNA and microRNA profiles showed close correlations. To validate that the observed microRNA and mRNA expression level changes in mice kidney tissue were directly related to CsA treatment, the expression change induced by CsA treatment of three microRNAs (miR-21, miR-186, and miR-709) and three mRNAs (BMPR1a, SMURF1 and SMAD7) were compared in HEK293 cell line. A similar trend of expression level change was induced by CsA treatment in all selected microRNAs and mRNAs in the in vitro cell model. These data provide a roadmap for future work to study the role of the known and novel candidate microRNAs in the mechanism of nephrotoxicity and their further therapeutic potential.	[Gooch, Jennifer L.; King, Clayton; Francis, Cynthia E.; Bai, Yun] Philadelphia Coll Osteopath Med, Sch Pharm, Dept Pharmaceut Sci, Suwanee, GA 30024 USA; [Garcia, Paul S.] Emory Univ, Sch Med, Dept Anesthesiol, Atlanta, GA 30322 USA	Emory University	Bai, Y (corresponding author), Philadelphia Coll Osteopath Med, Sch Pharm, Dept Pharmaceut Sci, Suwanee, GA 30024 USA.	yunba@pcom.edu			NIH [1R15GM113120-01]; Philadelphia College of Osteopathic Medicine, Chief Research and Science Officer (CRSO); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM113120] Funding Source: NIH RePORTER; Veterans Affairs [IK2BX001677] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Philadelphia College of Osteopathic Medicine, Chief Research and Science Officer (CRSO); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by NIH grant 1R15GM113120-01 to YB and Philadelphia College of Osteopathic Medicine, Chief Research and Science Officer (CRSO) grant to YB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameres SL, 2013, NAT REV MOL CELL BIO, V14, P475, DOI 10.1038/nrm3611; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Castro NE, 2014, J BIOL CHEM, V289, P29001, DOI 10.1074/jbc.M114.600783; Chen JG, 2015, TRANSPL INT, V28, P232, DOI 10.1111/tri.12471; Chung ACK, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00050; Chung ACK, 2010, J AM SOC NEPHROL, V21, P1317, DOI 10.1681/ASN.2010020134; Colombo D, 2011, J BIOL REG HOMEOS AG, V25, P493; Glowacki F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058014; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Gude E, 2010, CLIN TRANSPLANT, V24, pE207, DOI 10.1111/j.1399-0012.2010.01225.x; Huang LH, 2013, NEPHRON EXTRA, V3, P12, DOI 10.1159/000346180; Iorio MV, 2012, EMBO MOL MED, V4, P143, DOI 10.1002/emmm.201100209; Kato M, 2015, ANNALS OF THE NEW YO; Kida Y, 2003, NEW ENGL J MED, V349, P2564; Kida Y., 2003, THE NEW ENGLAND JOUR, V349, P2565; Koga K, 2015, DIABETOLOGIA, V58, P2169, DOI 10.1007/s00125-015-3642-4; Lang QL, 2011, J NANOSCI NANOTECHNO, V11, P3115, DOI 10.1166/jnn.2011.3860; Liang Y, 2014, J CELL BIOCHEM, V115, P690, DOI 10.1002/jcb.24710; Luo Y, 2014, BBA-GENE REGUL MECH, V1839, P97, DOI 10.1016/j.bbagrm.2013.12.005; Murakami Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016081; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pham PTT, 2009, ADV CHRONIC KIDNEY D, V16, P256, DOI 10.1053/j.ackd.2009.04.002; Piva R, 2013, INT J ONCOL, V43, P985, DOI 10.3892/ijo.2013.2059; Qin W, 2011, J AM SOC NEPHROL, V22, P1462, DOI 10.1681/ASN.2010121308; Sansone F, 2011, TRANSPLANT REV-ORLAN, V25, P131, DOI 10.1016/j.trre.2011.02.002; Shi SL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075572; Sun L, 2011, J PATHOL, V225, P364, DOI 10.1002/path.2961; Szeto CC, 2012, DIS MARKERS, V33, P137, DOI 10.1155/2012/842764; Tang R, 2012, CELL RES, V22, P504, DOI 10.1038/cr.2011.137; Tijsen AJ, 2014, CARDIOVASC RES, V104, P61, DOI 10.1093/cvr/cvu184; Wang G, 2012, AM J NEPHROL, V36, P412, DOI 10.1159/000343452; Wang JY, 2013, CELL BIOCHEM BIOPHYS, V67, P537, DOI 10.1007/s12013-013-9539-2; Wilflingseder J, 2013, TRANSPLANTATION, V95, P835, DOI 10.1097/TP.0b013e318280b385; Wu JH, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/5469371; Xiong MX, 2012, AM J PHYSIOL-RENAL, V302, pF369, DOI 10.1152/ajprenal.00268.2011; Zarjou A, 2011, AM J PHYSIOL-RENAL, V301, pF793, DOI 10.1152/ajprenal.00273.2011; Zhong X, 2011, J AM SOC NEPHROL, V22, P1668, DOI 10.1681/ASN.2010111168	38	29	30	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2017	12	4							e0175242	10.1371/journal.pone.0175242	http://dx.doi.org/10.1371/journal.pone.0175242			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KD	28414804	Green Published, gold, Green Submitted			2022-12-27	WOS:000399874800018
J	Grau, C; Starkovich, M; Azamian, MS; Xia, F; Cheung, SW; Evans, P; Henderson, A; Lalani, SR; Scott, DA				Grau, Christina; Starkovich, Molly; Azamian, Mahshid S.; Xia, Fan; Cheung, Sau Wai; Evans, Patricia; Henderson, Alex; Lalani, Seema R.; Scott, Daryl A.			Xp11.22 deletions encompassing CENPVL1, CENPVL2, MAGED1 and GSPT2 as a cause of syndromic X-linked intellectual disability	PLOS ONE			English	Article							MENTAL-RETARDATION; GROWTH-RETARDATION; BRAIN-DEVELOPMENT; GENE; MUTATIONS; AUTISM; MICRODUPLICATIONS; TRANSLATION; PHENOTYPE; PROTEIN	By searching a clinical database of over 60,000 individuals referred for array-based CNV analyses and online resources, we identified four males from three families with intellectual disability, developmental delay, hypotonia, joint hypermobility and relative macrocephaly who carried small, overlapping deletions of Xp11.22. The maximum region of overlap between their deletions spanned similar to 430 kb and included two pseudogenes, CENPVL1 and CENPVL2, whose functions are not known, and two protein coding genes-the G1 to S phase transition 2 gene (GSPT2) and the MAGE family member D1 gene (MAGED1). Deletions of this similar to 430 kb region have not been previously implicated in human disease. Duplications of GSPT2 have been documented in individuals with intellectual disability, but the phenotypic consequences of a loss of GSPT2 function have not been elucidated in humans or mouse models. Changes in MAGED1 have not been associated with intellectual disability in humans, but loss of MAGED1 function is associated with neurocognitive and neurobehavioral phenotypes in mice. In all cases, the Xp11.22 deletion was inherited from an unaffected mother. Studies performed on DNA from one of these mothers did not show evidence of skewed X-inactivation. These results suggest that deletions of an similar to 430 kb region on chromosome Xp11.22 that encompass CENPVL1, CENPVL2, GSPT2 and MAGED1 cause a distinct X-linked syndrome characterized by intellectual disability, developmental delay, hypotonia, joint hypermobility and relative macrocephaly. Loss of GSPT2 and/or MAGED1 function may contribute to the intellectual disability and developmental delay seen in males with these deletions.	[Grau, Christina; Starkovich, Molly; Azamian, Mahshid S.; Xia, Fan; Cheung, Sau Wai; Lalani, Seema R.; Scott, Daryl A.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Xia, Fan; Cheung, Sau Wai] Baylor Genet, Houston, TX USA; [Evans, Patricia] Univ Texas Southwestern Med Sch, Dept Pediat, Dallas, TX USA; [Evans, Patricia] Univ Texas Southwestern Med Sch, Dept Neurol, Dallas, TX USA; [Henderson, Alex] Newcastle upon Tyne Hosp, Newcastle Upon Tyne, Tyne & Wear, England; [Scott, Daryl A.] Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA	Baylor College of Medicine; Newcastle University - UK; Baylor College of Medicine	Scott, DA (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.; Scott, DA (corresponding author), Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA.	dscott@bcm.edu	Lalani, Seema/AAI-5090-2020	Cheung, Sau W/0000-0002-3813-5256; Azamian, Mahshid/0000-0002-8543-8284	National Institutes of Health/National Institute of General Medical Sciences Initiative for Maximizing Student Development [R25 GM056929-16]; Baylor Genetics; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM056929] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of General Medical Sciences Initiative for Maximizing Student Development; Baylor Genetics; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in part, by the National Institutes of Health/National Institute of General Medical Sciences Initiative for Maximizing Student Development [R25 GM056929-16]. Baylor Genetics provided support in the form of salaries for authors FX and SWC. The specific roles of these authors are articulated in the 'author contributions'section. The Department of Molecular and Human Genetics at Baylor College of Medicine derives revenue from genetic analyses offered through Baylor Genetics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armanet N, 2015, MOL CYTOGENET, V8, DOI 10.1186/s13039-015-0107-x; BEIGHTON P, 1973, ANN RHEUM DIS, V32, P413, DOI 10.1136/ard.32.5.413; Bertrand M, 2004, DEV DYNAM, V230, P325, DOI 10.1002/dvdy.20026; Boudewijns M, 2007, J MOL DIAGN, V9, P337, DOI 10.2353/jmoldx.2007.060155; BROOKS SS, 1994, AM J MED GENET, V51, P586, DOI 10.1002/ajmg.1320510458; CASERO RA, 1991, J BIOL CHEM, V266, P810; Chauvin C, 2005, MOL CELL BIOL, V25, P5801, DOI 10.1128/MCB.25.14.5801-5811.2005; Chung BHY, 2011, EUR J MED GENET, V54, pE516, DOI 10.1016/j.ejmg.2011.05.008; De Rubeis S, 2013, NEURON, V79, P1169, DOI 10.1016/j.neuron.2013.06.039; De Wolf V, 2014, AM J MED GENET A, V164, P3035, DOI 10.1002/ajmg.a.36752; Dombret C, 2012, HUM MOL GENET, V21, P4703, DOI 10.1093/hmg/dds310; dos Santos RCS, 2003, AM J MED GENET A, V118A, P255, DOI 10.1002/ajmg.a.20021; Edens AC, 2011, DEV MED CHILD NEUROL, V53, P463, DOI 10.1111/j.1469-8749.2010.03909.x; Evers C, 2015, AM J MED GENET A, V167, P553, DOI 10.1002/ajmg.a.36897; Fieremans N, 2015, EUR J MED GENET, V58, P324, DOI 10.1016/j.ejmg.2015.03.003; Friez MJ, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009537; Froyen G, 2012, AM J HUM GENET, V91, P252, DOI 10.1016/j.ajhg.2012.06.010; Geserick P, 2004, INT IMMUNOL, V16, P1535, DOI 10.1093/intimm/dxh155; Giorda R, 2009, AM J HUM GENET, V85, P394, DOI 10.1016/j.ajhg.2009.08.001; Grams SE, 2016, AM J MED GENET A, V170, P967, DOI 10.1002/ajmg.a.37519; Guo XY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093972; Hagens O, 2006, HUM GENET, V118, P578, DOI 10.1007/s00439-005-0072-2; Honda Z, 2009, GENES CELLS, V14, P1383, DOI 10.1111/j.1365-2443.2009.01355.x; Hoshino S, 1998, J BIOL CHEM, V273, P22254, DOI 10.1074/jbc.273.35.22254; Hunt MC, 2006, FASEB J, V20, P1855, DOI 10.1096/fj.06-6042com; Jakobsen CG, 2001, MOL BIOL+, V35, P575, DOI 10.1023/A:1010527127440; Jensen LR, 2005, AM J HUM GENET, V76, P227, DOI 10.1086/427563; Jiang YY, 2005, J NEUROSCI, V25, P6962, DOI 10.1523/JNEUROSCI.1446-05.2005; Johnsson P, 2013, NAT STRUCT MOL BIOL, V20, P440, DOI 10.1038/nsmb.2516; JUBERG RC, 1980, AM J HUM GENET, V32, P714; Kalyana-Sundaram S, 2012, CELL, V149, P1622, DOI 10.1016/j.cell.2012.04.041; Laumonnier F, 2005, J MED GENET, V42, P780, DOI 10.1136/jmg.2004.029439; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Li MQ, 2012, NATURE, V491, P125, DOI 10.1038/nature11433; Lin YX, 2008, NATURE, V455, P1198, DOI 10.1038/nature07319; Michaud JL, 2001, HUM MOL GENET, V10, P1465, DOI 10.1093/hmg/10.14.1465; Moey C, 2016, EUR J HUM GENET, V24, P373, DOI 10.1038/ejhg.2015.123; Mouri A, 2012, J NEUROSCI, V32, P4562, DOI 10.1523/JNEUROSCI.6458-11.2012; Najm J, 2008, NAT GENET, V40, P1065, DOI 10.1038/ng.194; Nizon M, 2015, AM J MED GENET A, V167, P111, DOI 10.1002/ajmg.a.36807; Orivoli S, 2016, NEUROPEDIATRICS, V47, P51, DOI 10.1055/s-0035-1566233; Pietila M, 1997, J BIOL CHEM, V272, P18746, DOI 10.1074/jbc.272.30.18746; Piluso G, 2009, AM J HUM GENET, V84, P162, DOI 10.1016/j.ajhg.2008.12.018; Pink RC, 2011, RNA, V17, P792, DOI 10.1261/rna.2658311; Piton A, 2013, AM J HUM GENET, V93, P368, DOI 10.1016/j.ajhg.2013.06.013; Poliseno L, 2010, NATURE, V465, P1033, DOI 10.1038/nature09144; Qiao Y, 2008, CLIN GENET, V74, P134, DOI 10.1111/j.1399-0004.2008.01028.x; Santos-Reboucas CB, 2015, J HUM GENET, V60, P207, DOI 10.1038/jhg.2015.1; Shoubridge C, 2010, NAT GENET, V42, P486, DOI 10.1038/ng.588; Siderius LE, 1999, AM J MED GENET, V85, P216, DOI 10.1002/(SICI)1096-8628(19990730)85:3<216::AID-AJMG6>3.3.CO;2-O; Sullivan AE, 2016, FEBS J, V283, P3488, DOI 10.1111/febs.13824; Tadeu AMB, 2008, EMBO J, V27, P2510, DOI 10.1038/emboj.2008.175; Tarpey PS, 2009, NAT GENET, V41, P535, DOI 10.1038/ng.367; Wang GS, 2004, NEURON, V42, P113, DOI 10.1016/S0896-6273(04)00139-4; Webb EA, 2013, BRAIN, V136, P3096, DOI 10.1093/brain/awt218; Whibley AC, 2010, AM J HUM GENET, V87, P173, DOI 10.1016/j.ajhg.2010.06.017; Xiao RL, 2013, CELL BIOL INT, V37, P359, DOI 10.1002/cbin.10043; Yang JJ, 2015, MOL NEUROBIOL, V51, P8, DOI 10.1007/s12035-014-8677-x	58	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2017	12	4							e0175962	10.1371/journal.pone.0175962	http://dx.doi.org/10.1371/journal.pone.0175962			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KD	28414775	Green Published, Green Submitted, gold			2022-12-27	WOS:000399874800080
J	Hause, AM; Henke, DM; Avadhanula, V; Shaw, CA; Tapia, LI; Piedra, PA				Hause, Anne M.; Henke, David M.; Avadhanula, Vasanthi; Shaw, Chad A.; Tapia, Lorena I.; Piedra, Pedro A.			Sequence variability of the respiratory syncytial virus (RSV) fusion gene among contemporary and historical genotypes of RSV/A and RSV/B	PLOS ONE			English	Article							CIRCULATION PATTERNS; NEUTRALIZING ANTIBODY; F-GLYCOPROTEIN; SOUTH-AFRICA; SUBGROUP-B; GROUP-A; PROTEIN; DUPLICATION; STRAINS; VACCINE	Background The fusion (F) protein of RSV is the major vaccine target. This protein undergoes a conformational change from pre-fusion to post-fusion. Both conformations share antigenic sites II and IV. Pre-fusion F has unique antigenic sites p27, empty set , alpha 2 alpha 3 beta 3 beta 4, and MPE8; whereas, post-fusion F has unique antigenic site I. Our objective was to determine the antigenic variability for RSV/A and RSV/B isolates from contemporary and historical genotypes compared to a historical RSV/A strain. Methods The F sequences of isolates from GenBank, Houston, and Chile (N = 1,090) were used for this analysis. Sequences were compared pair-wise to a reference sequence, a historical RSV/A Long strain. Variability (calculated as %) was defined as changes at each amino acid (aa) position when compared to the reference sequence. Only aa at antigenic sites with variability >= 5% were reported. Results A total of 1,090 sequences (822 RSV/A and 268 RSV/B) were analyzed. When compared to the reference F, those domains with the greatest number of non-synonymous changes included the signal peptide, p27, heptad repeat domain 2, antigenic site empty set, and the transmembrane domain. RSV/A subgroup had 7 aa changes in the antigenic sites: site I (N = 1), II (N = 1), p27 (N = 4), alpha 2 alpha 3 beta 3 beta 4(AM14) (N = 1), ranging in frequency from 7-91%. In comparison, RSV/B had 19 aa changes in antigenic sites: I ( N = 3), II ( N = 1), p27 ( N = 9), empty set ( N = 4), alpha 2 alpha 3 beta 3 beta 4( AM14) ( N = 1), and MPE8 ( N = 1), ranging in frequency from 79-100%. Discussion Although antigenic sites of RSV F are generally well conserved, differences are observed when comparing the two subgroups to the reference RSV/A Long strain. Further, these discrepancies are accented in the antigenic sites in pre-fusion F of RSV/B isolates, often occurring with a frequency of 100%. This could be of importance if a monovalent F protein from the historical GA1 genotype of RSV/A is used for vaccine development.	[Hause, Anne M.; Avadhanula, Vasanthi; Piedra, Pedro A.] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; [Hause, Anne M.] Baylor Coll Med, Dept Translat Biol & Mol Med, Houston, TX 77030 USA; [Henke, David M.; Shaw, Chad A.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Tapia, Lorena I.] Univ Chile, Dept Pediat & Pediat Surg, Santiago, Chile; [Tapia, Lorena I.] Univ Chile, Fac Med, Inst Biomed Sci ICBM, Virol Program, Santiago, Chile; [Piedra, Pedro A.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Universidad de Chile; Universidad de Chile; Baylor College of Medicine	Piedra, PA (corresponding author), Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA.; Piedra, PA (corresponding author), Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA.	ppiedra@bcm.edu	, VA/AAO-6566-2020	Piedra, Pedro/0000-0002-5839-0879	Baylor College of Medicine	Baylor College of Medicine	This study was funded by Baylor College of Medicine to PAP. No other funds were used in this study. The fund was used to support the salary of the first author (AMH) and the second author (DMH). The funder (Baylor College of Medicine) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agenbach E, 2005, VIRUS GENES, V30, P267, DOI 10.1007/s11262-004-5633-2; ARBIZA J, 1992, J GEN VIROL, V73, P2225, DOI 10.1099/0022-1317-73-9-2225; Avadhanula V, 2015, J INFECT DIS, V211, P582, DOI 10.1093/infdis/jiu473; Chi H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064012; Connor AL, 2001, J MED VIROL, V63, P168, DOI 10.1002/1096-9071(20000201)63:2&lt;168::AID-JMV1012&gt;3.0.CO;2-U; Corti D, 2013, NATURE, V501, P439, DOI 10.1038/nature12442; Eshaghi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032807; Fuentes S, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005554; Gilman MSA, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005035; Glenn GM, 2013, VACCINE, V31, P524, DOI 10.1016/j.vaccine.2012.11.009; JOHNSON PR, 1987, P NATL ACAD SCI USA, V84, P5625, DOI 10.1073/pnas.84.16.5625; Kim YK, 2007, J MED VIROL, V79, P820, DOI 10.1002/jmv.20891; Krzyzaniak MA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003309; LOPEZ JA, 1990, J VIROL, V64, P927; Lopez JA, 1998, J VIROL, V72, P6922; Magro M, 2012, P NATL ACAD SCI USA, V109, P3089, DOI 10.1073/pnas.1115941109; McLellan JS, 2013, SCIENCE, V342, P592, DOI 10.1126/science.1243283; McLellan JS, 2013, SCIENCE, V340, P1113, DOI 10.1126/science.1234914; PATH, 2016, RSV VACC SNAPSH; Peret TCT, 1998, J GEN VIROL, V79, P2221, DOI 10.1099/0022-1317-79-9-2221; Peret TCT, 2000, J INFECT DIS, V181, P1891, DOI 10.1086/315508; Shobugawa Y, 2009, J CLIN MICROBIOL, V47, P2475, DOI 10.1128/JCM.00115-09; Sun ZW, 2013, VIRUSES-BASEL, V5, P211, DOI 10.3390/v5010211; Swanson KA, 2011, P NATL ACAD SCI USA, V108, P9619, DOI 10.1073/pnas.1106536108; Tan L, 2013, J VIROL, V87, P8213, DOI 10.1128/JVI.03278-12; Tapia LI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090786; Trento A, 2006, J VIROL, V80, P975, DOI 10.1128/JVI.80.2.975-984.2006; Trento A, 2003, J GEN VIROL, V84, P3115, DOI 10.1099/vir.0.19357-0; Venter M, 2001, J GEN VIROL, V82, P2117, DOI 10.1099/0022-1317-82-9-2117	29	35	36	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2017	12	4							e0175792	10.1371/journal.pone.0175792	http://dx.doi.org/10.1371/journal.pone.0175792			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KD	28414749	Green Submitted, gold, Green Published			2022-12-27	WOS:000399874800057
J	Roth, JA; Widmer, AF; Tschudin-Sutter, S; Dangel, M; Frei, R; Battegay, M; Hug, BL				Roth, Jan A.; Widmer, Andreas F.; Tschudin-Sutter, Sarah; Dangel, Marc; Frei, Reno; Battegay, Manuel; Hug, Balthasar L.			The Model for End-stage Liver Disease (MELD) as a predictor of short-term mortality in Staphylococcus aureus bloodstream infection: A single-centre observational study	PLOS ONE			English	Article							VALIDATION; SURVIVAL; TRAUMA	Background Automated laboratory-based prediction models may support clinical decisions in Staphylococcus aureus bloodstream infections (BSIs), which carry a particularly high mortality. Small studies indicated that the laboratory-based Model for End-stage Liver Disease (MELD) score is a risk factor for mortality in critically ill patients with infections. For S. aureus BSIs, we therefore aimed to assess a potential association of the MELD score with mortality. Methods In this single-centre observational study, all consecutive patients with a first episode of methicillin-susceptible S. aureus BSI occurring between 2001 and 2013 were eligible. Relevant patient data were retrieved from our prospective in-house BSI database. We assessed the association of the MELD score at day of BSI onset (range +/- two days) with 30-day allcause mortality using uni- and multivariable logistic regression analysis. Results 561 patients were included in the final analysis. The MELD score at BSI onset was associated with 30-day mortality in S. aureus BSIs (odds ratio per 1-point increase, 1.06; 95% confidence interval, 1.03-1.09; P < 0.001). After adjustment for relevant patient and infection characteristics, an increased MELD score remained a predictor of 30-day mortality (adjusted odds ratio per 1-point increase, 1.05; 95% confidence interval, 1.01-1.08; P = 0.005). Conclusions In our study population, the MELD score at BSI onset was an independent predictor of mortality in S. aureus BSIs. We therefore suggest to prospectively validate the MELD score as part of clinical decision support systems in inpatients with suspected or confirmed BSI.	[Roth, Jan A.; Widmer, Andreas F.; Tschudin-Sutter, Sarah; Dangel, Marc; Battegay, Manuel] Univ Basel Hosp, Div Infect Dis & Hosp Epidemiol, Basel, Switzerland; [Roth, Jan A.; Widmer, Andreas F.; Tschudin-Sutter, Sarah; Dangel, Marc; Frei, Reno; Battegay, Manuel; Hug, Balthasar L.] Univ Basel, Basel, Switzerland; [Frei, Reno] Univ Basel Hosp, Div Clin Microbiol, Basel, Switzerland; [Hug, Balthasar L.] Kantonsspital Luzern, Dept Internal Med, Luzern, Switzerland	University of Basel; University of Basel; University of Basel; Lucerne Cantonal Hospital	Hug, BL (corresponding author), Univ Basel, Basel, Switzerland.; Hug, BL (corresponding author), Kantonsspital Luzern, Dept Internal Med, Luzern, Switzerland.	b.hug@unibas.ch	Tschudin-Sutter, Sarah/K-2212-2019	Tschudin-Sutter, Sarah/0000-0003-4875-5368; Roth, Jan Adam/0000-0003-4502-1123; Hug, Balthasar/0000-0003-4235-1995				Borgman MA, 2011, PEDIATRICS, V127, pE892, DOI 10.1542/peds.2010-2439; CHARLSON M, 1994, J CLIN EPIDEMIOL, V47, P1245, DOI 10.1016/0895-4356(94)90129-5; Chen SY, 2009, DIAGN MICR INFEC DIS, V64, P124, DOI 10.1016/j.diagmicrobio.2009.01.008; Chertow GM, 2005, J AM SOC NEPHROL, V16, P3365, DOI 10.1681/ASN.2004090740; Claushuis TAM, 2016, BLOOD, V127, P3062, DOI 10.1182/blood-2015-11-680744; Coca SG, 2009, AM J KIDNEY DIS, V53, P961, DOI 10.1053/j.ajkd.2008.11.034; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI [DOI 10.1007/s00134-012-2769-8, 10.1007/s00134-012-2769-8]; Fischer CM, 2012, J EMERG MED, V42, P127, DOI 10.1016/j.jemermed.2010.05.007; Hampton DA, 2014, AM J SURG, V207, P642, DOI 10.1016/j.amjsurg.2013.12.009; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; Huang KC, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003720; Hurley JC, 2003, CLIN INFECT DIS, V37, P866, DOI 10.1086/377611; Juntermanns B, 2015, ANN TRANSPL, V20, P297, DOI 10.12659/AOT.893122; Kamath PS, 2007, HEPATOLOGY, V45, P797, DOI 10.1002/hep.21563; Kamath PS, 2001, HEPATOLOGY, V33, P464, DOI 10.1053/jhep.2001.22172; Khan Rustam, 2009, J Coll Physicians Surg Pak, V19, P694, DOI 11.2009/JCPSP.694698; Laupland KB, 2013, CLIN MICROBIOL INFEC, V19, P492, DOI 10.1111/1469-0691.12144; Lopez-Cortes LE, 2013, CLIN INFECT DIS, V57, P1225, DOI 10.1093/cid/cit499; Malinchoc M, 2000, HEPATOLOGY, V31, P864, DOI 10.1053/he.2000.5852; Minne L, 2008, CRIT CARE, V12, DOI 10.1186/cc7160; Osthoff M, 2016, CRIT CARE MED, V44, P773, DOI 10.1097/CCM.0000000000001554; Patel JJ, 2015, J INTENSIVE CARE MED, V30, P23, DOI 10.1177/0885066613488739; Peng Y, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002877; Porte RJ, 2010, AM J TRANSPLANT, V10, P1349, DOI 10.1111/j.1600-6143.2010.03064.x; Raj R, 2013, NEUROSURGERY, V73, P305, DOI 10.1227/01.neu.0000430326.40763.ec; Said A, 2004, J HEPATOL, V40, P897, DOI 10.1016/j.jhep.2004.02.010; Sivayoham N, 2014, EUR J EMERG MED, V21, P30, DOI 10.1097/MEJ.0b013e328364a8d4; Tacconelli E, 2007, INT J ANTIMICROB AG, V30, pS88, DOI 10.1016/j.ijantimicag.2007.06.013; van Hal SJ, 2012, CLIN MICROBIOL REV, V25, P362, DOI 10.1128/CMR.05022-11; Wiesner R, 2003, GASTROENTEROLOGY, V124, P91, DOI 10.1053/gast.2003.50016	30	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2017	12	4							e0175669	10.1371/journal.pone.0175669	http://dx.doi.org/10.1371/journal.pone.0175669			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KD	28414786	Green Submitted, gold, Green Published			2022-12-27	WOS:000399874800044
J	Davies, J; Patel, M; Gridelli, C; de Marinis, F; Waterkamp, D; McCusker, ME				Davies, Jessica; Patel, Manali; Gridelli, Cesare; de Marinis, Filippo; Waterkamp, Daniel; McCusker, Margaret E.			Real-world treatment patterns for patients receiving second-line and third-line treatment for advanced non-small cell lung cancer: A systematic review of recently published studies	PLOS ONE			English	Review							ADVANCED NSCLC; CHEMOTHERAPY; DOCETAXEL; THERAPY; POPULATION; CRIZOTINIB; MANAGEMENT; NIVOLUMAB; ERLOTINIB; MEDICARE	Most patients with advanced non-small cell lung cancer (NSCLC) have a poor prognosis and receive limited benefit from conventional treatments, especially in later lines of therapy. In recent years, several novel therapies have been approved for second-and third-line treatment of advanced NSCLC. In light of these approvals, it is valuable to understand the uptake of these new treatments in routine clinical practice and their impact on patient care. A systematic literature search was conducted in multiple scientific databases to identify observational cohort studies published between January 2010 and March 2017 that described second-or third-line treatment patterns and clinical outcomes in patients with advanced NSCLC. A qualitative data synthesis was performed because a meta-analysis was not possible due to the heterogeneity of the study populations. A total of 12 different study cohorts in 15 articles were identified. In these cohorts, single-agent chemotherapy was the most commonly administered treatment in both the second-and third-line settings. In the 5 studies that described survival from the time of second-line treatment initiation, median overall survival ranged from 4.6 months ( 95% CI, 3.8-5.7) to 12.8 months ( 95% CI, 10.7-14.5). There was limited information on the use of biomarker-directed therapy in these patient populations. This systematic literature review offers insights into the adoption of novel therapies into routine clinical practice for second-and third-line treatment of patients with advanced NSCLC. This information provides a valuable real-world context for the impact of recently approved treatments for advanced NSCLC.	[Davies, Jessica] F Hoffmann La Roche Inc, Welwyn Garden City, Herts, England; [Patel, Manali] Stanford Univ, Sch Med, Div Oncol, Stanford, CA USA; [Gridelli, Cesare] SG Moscati Hosp, Div Med Oncol, Avellino, Italy; [de Marinis, Filippo] IEO, Div Thorac Oncol, Milan, Italy; [Waterkamp, Daniel; McCusker, Margaret E.] F Hoffmann La Roche & Cie AG, Diagnost Informat Solut, Pleasanton, CA USA	Stanford University; San Giuseppe Moscati Hospital; IRCCS European Institute of Oncology (IEO)	Davies, J (corresponding author), F Hoffmann La Roche Inc, Welwyn Garden City, Herts, England.	Jessica.Davies@roche.com	de Marinis, Filippo/AAR-2826-2020; Patel, Manali/Z-1666-2019; Gridelli, Cesare/AAA-8621-2019		F. Hoffmann-La Roche, Ltd.	F. Hoffmann-La Roche, Ltd.(Hoffmann-La Roche)	This study was sponsored by F. Hoffmann-La Roche, Ltd. Ms. Davies, Dr. Waterkamp and Dr. McCusker are employed by F. Hoffmann-La Roche. F. Hoffmann-La Roche provided support in the form of salaries for authors [JD, MM, DW] and also played a role in the decision to publish, and preparation of the manuscript, but did not play a role in the study design, data collection and analysis. The specific roles of these authors are articulated in the 'author contributions' section.; This study was sponsored by F. Hoffmann-La Roche, Ltd. Medical writing assistance for this manuscript was provided by Health Interactions, Inc, paid for by F. Hoffmann-La Roche, Ltd.	Allemani C, 2015, LANCET, V385, P977, DOI 10.1016/S0140-6736(14)62038-9; Asahina H, 2012, CLIN LUNG CANCER, V13, P39, DOI [10.1016/j.cllc.2011.06.008, 10.1016/j.cllc.2011.06.010]; Bischoff HG, 2010, CURR MED RES OPIN, V26, P1461, DOI 10.1185/03007991003799180; Borghaei H, 2015, NEW ENGL J MED, V373, P1627, DOI 10.1056/NEJMoa1507643; Bradley CJ, 2008, J CLIN ONCOL, V26, P5067, DOI 10.1200/JCO.2008.16.3071; Brzezianska E, 2006, MUTAT RES-FUND MOL M, V599, P26, DOI 10.1016/j.mrfmmm.2005.12.013; Carpentier O, 2015, CLIN LUNG CANCER, V16, P496, DOI 10.1016/j.cllc.2015.05.001; Cohen MH, 2005, ONCOLOGIST, V10, P461, DOI 10.1634/theoncologist.10-7-461; Davis KL, 2015, LUNG CANCER, V87, P176, DOI 10.1016/j.lungcan.2014.11.002; de Marinis F, 2014, CLIN LUNG CANCER, V15, P338, DOI 10.1016/j.cllc.2014.04.004; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Frampton JE, 2013, DRUGS, V73, P2031, DOI 10.1007/s40265-013-0142-z; Gridelli C, 2014, J CANCER RES CLIN, V140, P1783, DOI 10.1007/s00432-014-1715-2; Gridelli C, 2011, LUNG CANCER, V74, P462, DOI 10.1016/j.lungcan.2011.04.011; Gupta SK, 2014, SOUTH ASIAN J CANCER, V3, P138, DOI 10.4103/2278-330X.130468; Hanly P, 2015, INT J CANCER, V136, pE136, DOI 10.1002/ijc.29105; Hanna Nasser H, 2004, Clin Lung Cancer, V5 Suppl 2, pS75, DOI 10.3816/CLC.2004.s.007; Howlader N, 2015, SEER CANCER STATISTI; Johnson DH, 2014, J CLIN ONCOL, V32, P973, DOI 10.1200/JCO.2013.53.1228; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; Mariotto AB, 2011, JNCI-J NATL CANCER I, V103, P117, DOI 10.1093/jnci/djq495; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; Moro-Sibilot D, 2010, CURR MED RES OPIN, V26, P2661, DOI 10.1185/03007995.2010.525489; National Comprehensive Cancer Network, NON SMALL CELL LUNG; Novello S, 2016, ANN ONCOL, V27, pv1, DOI 10.1093/annonc/mdw326; Pan IW, 2013, LUNG CANCER, V82, P469, DOI 10.1016/j.lungcan.2013.09.018; Reinmuth N, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-139; Sacher AG, 2015, CANCER-AM CANCER SOC, V121, P2562, DOI 10.1002/cncr.29386; Schiller JH, 2002, NEW ENGL J MED, V346, P92, DOI 10.1056/NEJMoa011954; Shepherd FA, 2005, NEW ENGL J MED, V353, P123, DOI 10.1056/NEJMoa050753; Shepherd FA, 2000, J CLIN ONCOL, V18, P2095, DOI 10.1200/JCO.2000.18.10.2095; Soerjomataram I, 2012, LANCET, V380, P1840, DOI 10.1016/S0140-6736(12)60919-2; Vergnenegre A, 2012, CURR MED RES OPIN, V28, P1253, DOI 10.1185/03007995.2012.703133; Viswanathan M, 2012, J CLIN EPIDEMIOL, V65, P163, DOI 10.1016/j.jclinepi.2011.05.008; Younes RN, 2011, REV ASSOC MED BRAS, V57, P686, DOI 10.1590/S0104-42302011000600017; Zietemann V, 2011, LUNG CANCER, V73, P70, DOI 10.1016/j.lungcan.2010.10.017; Zietemann V, 2010, LUNG CANCER, V68, P273, DOI 10.1016/j.lungcan.2009.06.023	37	61	62	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2017	12	4							e0175679	10.1371/journal.pone.0175679	http://dx.doi.org/10.1371/journal.pone.0175679			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0MD	28410405	gold, Green Published, Green Submitted			2022-12-27	WOS:000399955600034
J	Gomes-Fernandes, M; Laabei, M; Pagan, N; Hidalgo, J; Molinos, S; Hernandez, RV; Dominguez-Villanueva, D; Jenkins, ATA; Lacoma, A; Prat, C				Gomes-Fernandes, Meissiner; Laabei, Maisem; Pagan, Natalia; Hidalgo, Jessica; Molinos, Sonia; Villar Hernandez, Raquel; Dominguez-Villanueva, Didac; Jenkins, A. Toby A.; Lacoma, Alicia; Prat, Cristina			Accessory gene regulator (Agr) functionality in Staphylococcus aureus derived from lower respiratory tract infections	PLOS ONE			English	Article							VENTILATOR-ASSOCIATED PNEUMONIA; METHICILLIN-RESISTANT; NUCLEOTIDE-SEQUENCE; PULMONARY INFECTION; CLONAL COMPLEXES; ALPHA-HEMOLYSIN; DELTA-TOXIN; VIRULENCE; DYSFUNCTION; BACTEREMIA	Objective Characterization of Staphylococcus aureus clinical isolates derived from lower respiratory tract infections (LRTIs), and correlation between the functionality of the accessory gene regulator (Agr) and genotypic and phenotypic characteristics, clinical variables and clinical outcome. Methods S aureus isolates derived from LRTIs and control groups (nasal carriage and bacteraemia) were genotyped using StaphyType DNA microarray. Agr activity was evaluated using the CAMP synergistic haemolysis assay and the Vesicle Lysis Test (VLT). Discordant strains were analysed by quantitative reverse-transcriptase real-time PCR (qRT-PCR). Results Agr was functional in 79.7% and 84.5% of strains according to the CAMP and VLT assays respectively. Higher concordance with RNAIII expression measured by qRT-PCR was observed with the VLT assay (76.2%) compared with the CAMP assay (23.8%). No statistically significant differences were observed in Agr functionality between the study groups, nor the phenotypical/ genotypical bacterial characteristics. No association between increased mortality/respiratory complications and Agr function was observed. Conclusions Agr activity was high (82.2%) in isolates from LRTIs suggesting the importance of this global regulator in lower respiratory tract colonisation and infection. However, equally high Agr activity was observed in isolates derived from nasal carriage and bacteraemia, contradictory to previous observations. Agr functionality measured by the VLT assay was superior to CAMP assay.	[Gomes-Fernandes, Meissiner; Laabei, Maisem; Pagan, Natalia; Hidalgo, Jessica; Molinos, Sonia; Villar Hernandez, Raquel; Dominguez-Villanueva, Didac; Lacoma, Alicia; Prat, Cristina] Univ Autonoma Barcelona, Inst Invest Germans Trias & Pujol, Hosp Univ Germans Trias & Pujol, Microbiol Dept, Badalona, Spain; [Gomes-Fernandes, Meissiner] Minist Educ Brazil, CAPES Fdn, Brasilia, DF, Brazil; [Laabei, Maisem] Univ Bath, Dept Biol & Biochem, Bath, Avon, England; [Jenkins, A. Toby A.] Univ Bath, Dept Chem, Bath, Avon, England; [Lacoma, Alicia; Prat, Cristina] Inst Salud Carlos III, GIBER, GIBER Enfermedades Resp, Badalona, Spain	Autonomous University of Barcelona; Hospital Germans Trias i Pujol; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); University of Bath; University of Bath; Instituto de Salud Carlos III	Prat, C (corresponding author), Univ Autonoma Barcelona, Inst Invest Germans Trias & Pujol, Hosp Univ Germans Trias & Pujol, Microbiol Dept, Badalona, Spain.; Prat, C (corresponding author), Inst Salud Carlos III, GIBER, GIBER Enfermedades Resp, Badalona, Spain.	crisprat2010@gmail.com	Lacoma, Alicia/H-8516-2017; Aymerich, Cristina Prat/R-3484-2016; Laabei, Maisem/AAH-6383-2021; Villar-Hernández, Raquel/AGD-6666-2022; Villar Hernández, Raquel/AFN-3894-2022; Jenkins, Toby/C-2124-2009	Lacoma, Alicia/0000-0002-2049-3872; Aymerich, Cristina Prat/0000-0001-6974-9165; Laabei, Maisem/0000-0002-8425-3704; Villar-Hernández, Raquel/0000-0002-2249-0579; Villar Hernández, Raquel/0000-0002-2249-0579; Jenkins, Toby/0000-0002-8981-3029; Gomes Fernandes, Meissiner/0000-0002-9454-8848	Plan Nacional de I+D +I [PI13/01418]; ISCIII-Subdireccion General de Evaluacion; "Fondo Europeo de Desarrollo Regional" (FEDER); CAPES Foundation, Ministry of Education of Brazil (Brasilia, Brazil); ERS/SEPAR fellowship; Spanish Society of Pneumology and Thoracic Surgery [SEPAR 054/2011]	Plan Nacional de I+D +I; ISCIII-Subdireccion General de Evaluacion; "Fondo Europeo de Desarrollo Regional" (FEDER); CAPES Foundation, Ministry of Education of Brazil (Brasilia, Brazil); ERS/SEPAR fellowship; Spanish Society of Pneumology and Thoracic Surgery	This work has been funded by the project PI13/01418 which is part of "Plan Nacional de I+D +I" and co-funded by ISCIII-Subdireccion General de Evaluacion and "Fondo Europeo de Desarrollo Regional" (FEDER). D. Dominguez-Villanueva is funded by "Plan Nacional de I+D +I" and co-funded by ISCIII-Subdireccion General de Evaluacion and "Fondo Europeo de Desarrollo Regional" (FEDER). M. Gomes-Fernandes is funded by CAPES Foundation, Ministry of Education of Brazil (Brasilia, Brazil). Maisem Laabei was supported by a joint ERS/SEPAR fellowship (LTRF 2015). This work also received a grant from the Spanish Society of Pneumology and Thoracic Surgery (SEPAR 054/2011). The funding sources did not have a role in study design, data collection and interpretation of data, or the decision to submit the work for publication.	ABDELNOUR A, 1993, INFECT IMMUN, V61, P3879, DOI 10.1128/IAI.61.9.3879-3885.1993; Argudin MA, 2009, J CLIN MICROBIOL, V47, P2097, DOI 10.1128/JCM.01486-08; Bronner S, 2004, FEMS MICROBIOL REV, V28, P183, DOI 10.1016/j.femsre.2003.09.003; BUNCE C, 1992, INFECT IMMUN, V60, P2636, DOI 10.1128/IAI.60.7.2636-2640.1992; Chaffin DO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041329; CHEUNG AL, 1994, J CLIN INVEST, V94, P1815, DOI 10.1172/JCI117530; Chong YP, 2013, ANTIMICROB AGENTS CH, V57, P1509, DOI 10.1128/AAC.01260-12; Cramton SE, 2001, INFECT IMMUN, V69, P4079, DOI 10.1128/IAI.69.6.4079-4085.2001; Diekema D, 2001, CLIN INFECT DIS   S2, V32, P114; ELEK SD, 1950, J PATHOL BACTERIOL, V62, P541, DOI 10.1002/path.1700620405; Fowler VG, 2004, J INFECT DIS, V190, P1140, DOI 10.1086/423145; Gagnaire J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040660; Giese B, 2011, CELL MICROBIOL, V13, P316, DOI 10.1111/j.1462-5822.2010.01538.x; JANZON L, 1989, MOL GEN GENET, V219, P480, DOI 10.1007/BF00259623; Jones RN, 2010, CLIN INFECT DIS, V51, pS81, DOI 10.1086/653053; Laabei M, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002229; Laabei M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087270; Lacoma A, 2015, EUROPEAN RESPIRA S59; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Malachowa N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018617; Monecke S, 2008, CLIN MICROBIOL INFEC, V14, P534, DOI 10.1111/j.1469-0691.2008.01986.x; Monecke S, 2008, FEMS IMMUNOL MED MIC, V53, P237, DOI 10.1111/j.1574-695X.2008.00426.x; Monecke S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017936; Munzenmayer L, 2016, CELL MICROBIOL, V18, P1172, DOI 10.1111/cmi.12577; Novick RP, 2008, ANNU REV GENET, V42, P541, DOI 10.1146/annurev.genet.42.110807.091640; Novick RP, 2003, MOL MICROBIOL, V48, P1429, DOI 10.1046/j.1365-2958.2003.03526.x; NOVICK RP, 1993, EMBO J, V12, P3967, DOI 10.1002/j.1460-2075.1993.tb06074.x; Otto M, 2000, BIOTECHNIQUES, V28, P1088, DOI 10.2144/00286bm07; Painter KL, 2014, TRENDS MICROBIOL, V22, P676, DOI 10.1016/j.tim.2014.09.002; Parker D, 2012, SEMIN IMMUNOPATHOL, V34, P281, DOI 10.1007/s00281-011-0291-7; Peschel A, 2013, NAT REV MICROBIOL, V11, P667, DOI 10.1038/nrmicro3110; Prat C, 2016, INT J INFECT DIS, V51, P113, DOI 10.1016/j.ijid.2016.09.005; Proctor RA, 2006, NAT REV MICROBIOL, V4, P295, DOI 10.1038/nrmicro1384; Queck SY, 2008, MOL CELL, V32, P150, DOI 10.1016/j.molcel.2008.08.005; Ross RA, 2000, INFECT IMMUN, V68, P5205, DOI 10.1128/IAI.68.9.5205-5209.2000; Sakoulas G, 2009, J INFECT DIS, V199, P1558, DOI 10.1086/598607; Schweizer ML, 2011, ANTIMICROB AGENTS CH, V55, P1082, DOI 10.1128/AAC.00918-10; Seidl K, 2011, ANTIMICROB AGENTS CH, V55, P5631, DOI 10.1128/AAC.05251-11; Smyth DS, 2012, J INFECT DIS, V206, P1168, DOI 10.1093/infdis/jis483; Somerville GA, 2002, J BACTERIOL, V184, P1430, DOI 10.1128/JB.184.5.1430-1437.2002; Stulik L, 2014, AM J RESP CRIT CARE, V190, P1139, DOI 10.1164/rccm.201406-1012OC; Surewaard BGJ, 2013, JOVE-J VIS EXP, DOI 10.3791/50788; Traber K, 2006, MOL MICROBIOL, V59, P1519, DOI 10.1111/j.1365-2958.2006.04986.x; Traber KE, 2008, MICROBIOL-SGM, V154, P2265, DOI 10.1099/mic.0.2007/011874-0; Tuchscherr L, 2011, EMBO MOL MED, V3, P129, DOI 10.1002/emmm.201000115; Valour F, 2015, Clin Microbiol Infect, V21, DOI 10.1016/j.cmi.2015.01.026; Viedma E, 2014, J ANTIMICROB CHEMOTH, V69, P51, DOI 10.1093/jac/dkt337; Wang LN, 2014, BBA-BIOMEMBRANES, V1838, P988, DOI 10.1016/j.bbamem.2013.12.006; Yarwood JM, 2003, J CLIN INVEST, V112, P1620, DOI 10.1172/JCI200320442; Zilberberg MD, 2010, CLIN INFECT DIS, V51, pS131, DOI 10.1086/653062	50	21	24	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2017	12	4							e0175552	10.1371/journal.pone.0175552	http://dx.doi.org/10.1371/journal.pone.0175552			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0MD	28410390	Green Published, gold, Green Submitted			2022-12-27	WOS:000399955600025
J	Chen, L; Li, CX; Guo, J; Luo, N; Qu, XY; Kang, L; Liu, MM; Cheng, ZP				Chen, Li; Li, Caixia; Guo, Jing; Luo, Ning; Qu, Xiaoyan; Kang, Le; Liu, Mingmin; Cheng, Zhongping			Eutopic/ectopic endometrial apoptosis initiated by bilateral uterine artery occlusion: A new therapeutic mechanism for uterus-sparing surgery in adenomyosis	PLOS ONE			English	Article							LAPAROSCOPIC BIPOLAR COAGULATION; ENDOPLASMIC-RETICULUM STRESS; SYMPTOMATIC ADENOMYOSIS; PARTIAL RESECTION; CELLS; MYOMECTOMY; EMBOLIZATION; VESSELS	The objective of the present study was to investigate differences in the expression of apoptosis-related factors in the eutopic and ectopic endometrium (EuE/EE) in women with adenomyosis before and after laparoscopic bilateral uterine artery occlusion (LUAO). Ten patients with uterine adenomyosis who received LUAO were selected as the research subjects, from whom EuE and EE tissues were obtained before and after LUAO and detected for the expression of apoptosis-related molecules in EuE and EE by PT-PCR and Western blot, and changes in the mitochondrial structure by electron microscopy. Normal endometrial stromal cells (NESC), and EuE/EE stromal cells in women with adenomyosis were cultured in a 1% O2, 5% CO2 incubator to establish a physical anoxia state in an in vitro stromal cell model. The expression of apoptosis-related molecules was observed at 0, 6, 12, 24 and 48h of hypoxic. The results showed that the expression of apoptosis-related factors in EuE and EE were increased significantly after LUAO and under hypoxic conditions in vitro, suggesting that transient ischemia and hypoxia were involved in the apoptosis of adenomysis lesions, and that uterine artery occlusion could remove adenomyosis lesions on tissue/cell level by cytoreduction, thus reaching the goal of treating adenomyosis effectively.	[Chen, Li; Li, Caixia; Guo, Jing; Luo, Ning; Qu, Xiaoyan; Kang, Le; Liu, Mingmin; Cheng, Zhongping] Tongji Univ, Yangpu Hosp, Dept Obstet & Gynaecol, Sch Med, Shanghai, Peoples R China; [Chen, Li; Li, Caixia; Guo, Jing; Luo, Ning; Qu, Xiaoyan; Kang, Le; Liu, Mingmin; Cheng, Zhongping] Tongji Univ, Sch Med, Inst Gynaecol Minimally Invas Med, Shanghai, Peoples R China	Tongji University; Tongji University	Cheng, ZP (corresponding author), Tongji Univ, Yangpu Hosp, Dept Obstet & Gynaecol, Sch Med, Shanghai, Peoples R China.; Cheng, ZP (corresponding author), Tongji Univ, Sch Med, Inst Gynaecol Minimally Invas Med, Shanghai, Peoples R China.	mdcheng18@263.net						Benagiano G, 2006, BEST PRACT RES CL OB, V20, P449, DOI 10.1016/j.bpobgyn.2006.01.007; Brozzi F, 2015, DIABETOLOGIA, V58, P2307, DOI 10.1007/s00125-015-3669-6; Cheng ZP, 2009, EUR J OBSTET GYN R B, V145, P113, DOI 10.1016/j.ejogrb.2009.03.027; Cheng ZP, 2008, J MINIM INVAS GYN, V15, P346, DOI 10.1016/j.jmig.2008.01.005; Dubuisson J, 2015, ARCH GYNECOL OBSTET, V291, P737, DOI 10.1007/s00404-014-3546-4; Exacoustos C, 2014, BEST PRACT RES CL OB, V28, P655, DOI 10.1016/j.bpobgyn.2014.04.010; Garcia L, 2011, J MINIM INVAS GYN, V18, P428, DOI 10.1016/j.jmig.2011.04.004; Grimbizis GF, 2014, FERTIL STERIL, V101, P472, DOI 10.1016/j.fertnstert.2013.10.025; Guo J, 2016, SCI REP-UK, V6, DOI 10.1038/srep21416; Jonas EA, 2009, EXP NEUROL, V218, P203, DOI 10.1016/j.expneurol.2009.03.025; Kang L, 2009, J MINIM INVAS GYN, V16, P169, DOI 10.1016/j.jmig.2008.12.003; Liu MM, 2014, EUR J OBSTET GYN R B, V176, P20, DOI 10.1016/j.ejogrb.2013.11.014; Liu WM, 2000, J AM ASSOC GYN LAP, V7, P125, DOI 10.1016/S1074-3804(00)80022-5; Liu WM, 2001, FERTIL STERIL, V75, P417, DOI 10.1016/S0015-0282(00)01724-6; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Nijenhuis RJ, 2015, CARDIOVASC INTER RAD, V38, P65, DOI 10.1007/s00270-014-0878-1; Popovic M, 2011, J VASC INTERV RADIOL, V22, P901, DOI 10.1016/j.jvir.2011.03.013; Qu XY, 2010, J MINIM INVAS GYN, V17, P47, DOI 10.1016/j.jmig.2009.10.001; Shveiky D, 2009, FERTIL STERIL, V91, P575, DOI 10.1016/j.fertnstert.2007.12.001; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Xie Y, 2014, ARCH GYNECOL OBSTET, V289, P1039, DOI 10.1007/s00404-013-3100-9; Yang W, 2016, EUR J OBSTET GYN R B, V204, P9, DOI 10.1016/j.ejogrb.2016.05.033; Yang WH, 2014, EUR J OBSTET GYN R B, V174, P123, DOI 10.1016/j.ejogrb.2013.12.013; Zhang Y., 2014, ENV HLTH, V13, P13, DOI DOI 10.1109/TRUSTC0M.2014.42	24	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2017	12	4							e0175511	10.1371/journal.pone.0175511	http://dx.doi.org/10.1371/journal.pone.0175511			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0MB	28406930	Green Submitted, Green Published, gold			2022-12-27	WOS:000399955400064
J	Chlibek, R; Smetana, J; Sosovickova, R; Gal, P; Dite, P; Stepanova, V; Pliskova, L; Plisek, S				Chlibek, Roman; Smetana, Jan; Sosovickova, Renata; Gal, Peter; Dite, Petr; Stepanova, Vlasta; Pliskova, Lenka; Plisek, Stanislav			Prevalence of hepatitis C virus in adult population in the Czech Republic - time for birth cohort screening	PLOS ONE			English	Article							ANTI-HCV; INFECTION; EPIDEMIOLOGY	Chronic hepatitis C is curable disease. Low detection rate could be one of the reasons of poor treatment uptake. It is important to identify HCV prevalence and anti-hepatitis C virus (HCV) positive patients in population by effective screening strategy such as risk-based or birth cohort screening programs. There are no national population-based estimates of the HCV prevalence in the Czech Republic (CZ). The most recent seroprevalence survey determined a prevalence of positive anti-HCV antibodies of 0.2% (in 2001). The aim of the study was to determine the seroprevalence of HCV, HCV viraemia and HCV genotype in the CZ adult population. We also estimated the number of persons living with chronic hepatitis C in CZ. The examined group included 3000 adults, 18-90 years of age enrolled in 2015. All serum samples were examined to determined anti-HCV antibodies positivity, HCV-RNA positivity and genotypes. Of the 3000 samples, 50 were found to be anti-HCV-positive, for a seroprevalence of 1.67% (2.39% in males, 0.98% in females). The overall prevalence of positive HCV RNA was 0.93%: 1.5% in males, 0.39% in females. HCV genotype (GT) 1a was determined in 25%, GT 1b in 25% and GT 3a in 46%. Since 2001, the HCV seroprevalence has increased 8-fold. The highest HCV seroprevalence occurred in males aged 30-44 years. We can estimate that there are more than 140,000 people with HCV antibodies and more than 80,000 people with chronic hepatitis C living in the CZ. The introduction of birth cohort HCV screening could be beneficial for the country.	[Chlibek, Roman; Smetana, Jan; Sosovickova, Renata] Univ Def, Fac Mil Hlth Sci, Dept Epidemiol, Hradec Kralove, Czech Republic; [Gal, Peter; Dite, Petr] Mil Hlth Inst, Prague, Czech Republic; [Stepanova, Vlasta] Univ Hosp Hradec Kralove, Dept Clin Microbiol, Hradec Kralove, Czech Republic; [Pliskova, Lenka] Univ Hosp Hradec Kralove, Dept Clin Chem & Diagnost, Hradec Kralove, Czech Republic; [Plisek, Stanislav] Charles Univ Prague, Med Fac, Dept Infect Dis, Prague, Czech Republic; [Plisek, Stanislav] Univ Hosp Hradec Kralove, Hradec Kralove, Czech Republic	University of Defence - Czech Republic; University Hospital Hradec Kralove; University Hospital Hradec Kralove; Charles University Prague; University Hospital Hradec Kralove	Chlibek, R; Smetana, J (corresponding author), Univ Def, Fac Mil Hlth Sci, Dept Epidemiol, Hradec Kralove, Czech Republic.	roman.chlibek@unob.cz; jan.smetana@unob.uo	Plisek, Stanislav/AAP-6660-2021; Stepanova, Vlasta/K-8068-2017	Smetana, Jan/0000-0002-4566-3356; Stepanova, Vlasta/0000-0002-0297-1463	Research Project of Long-term Development Plan 1011 of Faculty of Military Health Sciences Hradec Kralove an by Gilead	Research Project of Long-term Development Plan 1011 of Faculty of Military Health Sciences Hradec Kralove an by Gilead	Funding for this study was provided by Research Project of Long-term Development Plan 1011 of Faculty of Military Health Sciences Hradec Kralove an by Gilead. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], INF CZECH REP EPIDAT; Chlabicz S, 2008, J CLIN VIROL, V42, P156, DOI 10.1016/j.jcv.2008.02.001; Chlibek R, 2014, PRACTICUS, V8, P14; Christensen PB, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-178; Cornberg M, 2011, LIVER INT, V31, P30, DOI 10.1111/j.1478-3231.2011.02539.x; Costella Annastella and Health Protection Agency United Kingdom, 2008, HEP C UK 2008 HLTH P; Deuffic-Burban S, 2012, GASTROENTEROLOGY, V143, P974, DOI 10.1053/j.gastro.2012.05.054; European Association for the Study of the Liver (EASL), 2014, EASL RECOMMENDATIONS; Jonas G, 2005, J CLIN VIROL, V34, P97, DOI 10.1016/j.jcv.2005.08.001; Kartashev V, 2016, J CLIN VIROL, V81, P82, DOI 10.1016/j.jcv.2016.05.010; Krekulova L, 2001, CLIN INFECT DIS, V33, P1435, DOI 10.1086/323199; Messina JP, 2015, HEPATOLOGY, V61, P77, DOI 10.1002/hep.27259; Ministry of Health Czech Republic, 2014, PRAHA, P113; Muehlberger N, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-34; Negro F, 2014, DIGEST LIVER DIS, V46, pS158, DOI 10.1016/j.dld.2014.09.023; Nemecek V, 2003, Cent Eur J Public Health, V11 Suppl, pS54; Nemecek V, 2009, EPIDEMIOL MIKROBI IM, V58, P63; OKAMOTO H, 1992, J GEN VIROL, V73, P673, DOI 10.1099/0022-1317-73-3-673; Omland LH, 2011, CLIN GASTROENTEROL H, V9, P71, DOI 10.1016/j.cgh.2010.09.014; Omland LH, 2010, J HEPATOL, V53, P36, DOI 10.1016/j.jhep.2010.01.033; Perz JF, 2006, J HEPATOL, V45, P529, DOI 10.1016/j.jhep.2006.05.013; Prasad L, 2007, INT J EPIDEMIOL, V36, P731, DOI 10.1093/ije/dym096; Raptopoulou M, 2011, HIPPOKRATIA, V15, P26; Razavi H, 2014, J VIRAL HEPATITIS, V21, P34, DOI 10.1111/jvh.12248; Ross RS, 2000, J CLIN MICROBIOL, V38, P3581, DOI 10.1128/JCM.38.10.3581-3584.2000; Schreter I, 2007, Klin Mikrobiol Infekc Lek, V13, P54; Schroter M, 2002, J CLIN MICROBIOL, V40, P1866, DOI 10.1128/JCM.40.5.1866-1868.2002; Smith Bryce D., 2012, Morbidity and Mortality Weekly Report, V61, P1; Sperl J, 2013, GASTROENTEROLOGIE HE, V67, P407; Wolffram I, 2015, J HEPATOL, V62, P1256, DOI 10.1016/j.jhep.2015.01.011	30	21	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2017	12	4							e0175525	10.1371/journal.pone.0175525	http://dx.doi.org/10.1371/journal.pone.0175525			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0MB	28406947	gold, Green Published, Green Submitted			2022-12-27	WOS:000399955400065
J	Ong, ML; Tan, PF; Holbrook, JD				Ong, Mei-Lyn; Tan, Pei Fang; Holbrook, Joanna D.			Predicting functional decline and survival in amyotrophic lateral sclerosis	PLOS ONE			English	Article							BILIRUBIN	Background Better predictors of amyotrophic lateral sclerosis disease course could enable smaller and more targeted clinical trials. Partially to address this aim, the Prize for Life foundation collected de-identified records from amyotrophic lateral sclerosis sufferers who participated in clinical trials of investigational drugs and made them available to researchers in the PRO-ACT database. Methods In this study, time series data from PRO-ACT subjects were fitted to exponential models. Binary classes for decline in the total score of amyotrophic lateral sclerosis functional rating scale revised (ALSFRS-R) (fast/slow progression) and survival (high/low death risk) were derived. Data was segregated into training and test sets via cross validation. Learning algorithms were applied to the demographic, clinical and laboratory parameters in the training set to predict ALSFRS-R decline and the derived fast/slow progression and high/low death risk categories. The performance of predictive models was assessed by cross-validation in the test set using Receiver Operator Curves and root mean squared errors. Results A model created using a boosting algorithm containing the decline in four parameters (weight, alkaline phosphatase, albumin and creatine kinase) post baseline, was able to predict functional decline class (fast or slow) with fair accuracy (AUC = 0.82). However similar approaches to build a predictive model for decline class by baseline subject characteristics were not successful. In contrast, baseline values of total bilirubin, gamma glutamyltransferase, urine specific gravity and ALSFRS-R item score-climbing stairs were sufficient to predict survival class. Conclusions Using combinations of small numbers of variables it was possible to predict classes of functional decline and survival across the 1-2 year timeframe available in PRO-ACT. These findings may have utility for design of future ALS clinical trials.	[Ong, Mei-Lyn; Tan, Pei Fang; Holbrook, Joanna D.] ASTAR, SICS, Brenner Ctr Mol Med, 30 Med Dr, Singapore, Singapore; [Holbrook, Joanna D.] Univ Southampton, Southampton Gen Hosp, NIHR Biomed Res Ctr, Tremona Rd, Southampton, Hants, England; [Ong, Mei-Lyn] Danone Nutr Early Life Nutr, Matrix Bldg 05-01B, Singapore, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Institute for Clinical Sciences (SICS); University of Southampton; Danone Nutricia	Holbrook, JD (corresponding author), ASTAR, SICS, Brenner Ctr Mol Med, 30 Med Dr, Singapore, Singapore.; Holbrook, JD (corresponding author), Univ Southampton, Southampton Gen Hosp, NIHR Biomed Res Ctr, Tremona Rd, Southampton, Hants, England.	J.Holbrook@soton.ac.uk		Holbrook, Joanna/0000-0003-1791-6894	Singapore Institute for Clinical Sciences, Agency for Science Technology and Research (A*STAR), Singapore; GlaxoSmithkline plc.	Singapore Institute for Clinical Sciences, Agency for Science Technology and Research (A*STAR), Singapore; GlaxoSmithkline plc.(GlaxoSmithKline)	Funding is provided by the Singapore Institute for Clinical Sciences, Agency for Science Technology and Research (A*STAR), Singapore and in part from GlaxoSmithkline plc. The funders were involved in study design, interpretation of results, decision to publish and preparation of the manuscript. GSK was not involved in data collection and analysis.	Atassi N, 2014, NEUROLOGY, V83, P1719, DOI 10.1212/WNL.0000000000000951; Chio A, 2014, JAMA NEUROL, V71, P1134, DOI 10.1001/jamaneurol.2014.1129; Coveney PV, 2014, COMPUTATIONAL BIOMED; Dorst J, 2011, J NEUROL, V258, P613, DOI 10.1007/s00415-010-5805-z; Dziak JJ, SENSITIVITY SPECIFIC; Gomeni R, 2014, AMYOTROPH LAT SCL FR, V15, P119, DOI 10.3109/21678421.2013.838970; Gordon PH, 2006, NEUROLOGY, V67, P1314, DOI 10.1212/01.wnl.0000243812.25517.87; Henriques A, 2015, HUM MOL GENET, V24, P7390, DOI 10.1093/hmg/ddv439; Ilzecka J, 2003, CLIN NEUROL NEUROSUR, V105, P237, DOI 10.1016/S0303-8467(03)00031-3; Iwasaki Y, 2005, CLIN NEUROL NEUROSUR, V107, P160, DOI 10.1016/j.clineuro.2004.07.008; Kuffner R, 2015, NAT BIOTECHNOL, V33, P51, DOI 10.1038/nbt.3051; Lunetta C, 2016, AMYOTROPH LAT SCL FR, V17, P93, DOI 10.3109/21678421.2015.1083585; Marin B, 2016, J NEUROL, V263, P100, DOI 10.1007/s00415-015-7940-z; Miller RG, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001447.pub3; Nalbandian A, 2011, J MOL NEUROSCI, V45, P522, DOI 10.1007/s12031-011-9627-y; Paganoni S, 2011, MUSCLE NERVE, V44, P20, DOI 10.1002/mus.22114; Proudfoot M., 2016, AMYOTROPH LATERAL SC, P1; Rafiq MK, 2016, EUR J NEUROL, V23, P1071, DOI 10.1111/ene.12995; Robberecht W, 2013, NAT REV NEUROSCI, V14, P248, DOI 10.1038/nrn3430; Talbot Kevin, 2009, Pract Neurol, V9, P303, DOI 10.1136/jnnp.2009.188151; Zach N, 2015, NEUROTHERAPEUTICS, V12, P417, DOI 10.1007/s13311-015-0336-z	21	32	32	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2017	12	4							e0174925	10.1371/journal.pone.0174925	http://dx.doi.org/10.1371/journal.pone.0174925			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0MB	28406915	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000399955400023
J	Rivollier, F; Chaumette, B; Bendjemaa, N; Chayet, M; Millet, B; Jaafari, N; Barhdadi, A; Perreault, LPL; Provost, S; Dube, MP; Gaillard, R; Krebs, MO; Kebir, O				Rivollier, Fabrice; Chaumette, Boris; Bendjemaa, Narjes; Chayet, Melanie; Millet, Bruno; Jaafari, Nematollah; Barhdadi, Amina; Perreault, Louis-Philippe Lemieux; Provost, Sylvie; Dube, Marie-Pierre; Gaillard, Raphael; Krebs, Marie-Odile; Kebir, Oussama			Methylomic changes in individuals with psychosis, prenatally exposed to endocrine disrupting compounds: Lessons from diethylstilbestrol	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; DNA METHYLATION; IN-UTERO; BISPHENOL-A; DEVELOPMENTAL NEUROTOXICITY; SEXUAL-DIFFERENTIATION; SPECTRUM DISORDERS; EPIGENETIC CHANGES; NEONATAL EXPOSURE; GENE FAMILY	Background In the Western world, between 1940 and 1970, more than 2 million people were exposed in utero to diethylstilbestrol (DES). In exposed individuals, and in their descendants, adverse outcomes have been linked to such exposure, including cancers, genital malformations, and less consistently, psychiatric disorders. We aimed to explore whether prenatal DES exposure would be associated with DNA methylation changes, and whether these epigenetic modifications would be associated with increased risk of psychosis. Methods From 247 individuals born from mothers exposed to DES, we selected 69 siblings from 30 families. In each family, at least one sibling was exposed in utero to DES. We performed a methylome-wide association study using HumanMethylation450 DNA Analysis BeadChip (R) in peripheral blood. We analyzed methylation changes at individual CpGs or regions in exposed (n = 37) versus unexposed individuals (n = 32). We also compared exposed individuals with (n = 7) and without psychosis (n = 30). Results There were more individuals with schizophrenia in the DES-exposed group. We found no significant differences between exposed and unexposed individuals with respect to differentially methylated CpGs or regions. The largest difference was in a region near the promoter of an ADAMTS proteoglycanase gene (ADAMTS9). Compared to exposed individuals without psychosis, exposed individuals with psychosis had differential methylation in the region encompassing the gene encoding the zinc finger protein 57 ( ZFP57). Conclusions In utero exposure to DES was not associated with methylation changes at specific CpGs or regions. In exposed individuals, however, psychosis was associated with specific methylomic modifications that could impact neurodevelopment and neuroplasticity.	[Rivollier, Fabrice; Chaumette, Boris; Bendjemaa, Narjes; Gaillard, Raphael; Krebs, Marie-Odile; Kebir, Oussama] Univ Paris 05, Univ Paris Sorbonne Paris Cite, Ctr Psychiat & Neurosci, UMR S 894, Paris, France; [Rivollier, Fabrice; Chaumette, Boris; Bendjemaa, Narjes; Gaillard, Raphael; Krebs, Marie-Odile; Kebir, Oussama] INSERM, UMR S 894, Lab Physiopathol Malad Psychiat, Ctr Psychiat & Neurosci, Paris, France; [Rivollier, Fabrice; Chaumette, Boris; Bendjemaa, Narjes; Gaillard, Raphael; Krebs, Marie-Odile; Kebir, Oussama] CNRS, GDR3557 Inst Psychiat, Paris, France; [Rivollier, Fabrice; Chaumette, Boris; Bendjemaa, Narjes; Chayet, Melanie; Gaillard, Raphael; Krebs, Marie-Odile; Kebir, Oussama] Serv Hosp Univ, Ctr Hosp St Anne, Fac Med Paris Descartes, Paris, France; [Millet, Bruno] INSERM, Dept Adults Psychiat, CNRS UMR 7225,U1127, GH Pitie Salpetriere,UPMC UMR S 975,ICM A IHU, Paris, France; [Jaafari, Nematollah] Univ Poitiers, CHU Poitiers,Lab Expt & Clin Neurosci,Grp Rech, Ctr Hosp Henri Laborit,INSERM CIC P 1402,U1084, CNRS 3557,Unite Rech Clin Psychiat Pierre Deniker, Poitiers, France; [Barhdadi, Amina; Perreault, Louis-Philippe Lemieux; Provost, Sylvie; Dube, Marie-Pierre] Univ Montreal, Montreal Heart Inst, Beaulieu Saucier Pharmacogen Ctr, Montreal, PQ, Canada	UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Assistance Publique Hopitaux Paris (APHP); GHU PARIS Psychiatrie Neurosciences; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; CHU Poitiers; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Poitiers; Universite de Montreal	Krebs, MO (corresponding author), Univ Paris 05, Univ Paris Sorbonne Paris Cite, Ctr Psychiat & Neurosci, UMR S 894, Paris, France.; Krebs, MO (corresponding author), INSERM, UMR S 894, Lab Physiopathol Malad Psychiat, Ctr Psychiat & Neurosci, Paris, France.; Krebs, MO (corresponding author), CNRS, GDR3557 Inst Psychiat, Paris, France.; Krebs, MO (corresponding author), Serv Hosp Univ, Ctr Hosp St Anne, Fac Med Paris Descartes, Paris, France.	marie-odile.krebs@inserm.fr	Krebs, Marie-Odile/O-2104-2017; Gaillard, Raphael/J-6527-2015; Dube, Marie-Pierre/B-9364-2008	Krebs, Marie-Odile/0000-0002-4715-9890; Gaillard, Raphael/0000-0002-1297-4369; Dube, Marie-Pierre/0000-0001-8442-4393; Rivollier, Fabrice/0000-0001-5805-0770; Chaumette, Boris/0000-0002-1313-2788	French Governement Agence Nationale pour la Recherche (ANR) [08-MNP-007]; Ile-de-France; Partenariat institutions-citoyens pour la recherche et; Universite Paris Descartes; Fondation Deniker; Fonds Quebecois de Recherche sur la Societe et la Culture-INSERM joint grant (Marie-Odile KREBS, Oussama KEBIR)	French Governement Agence Nationale pour la Recherche (ANR)(French National Research Agency (ANR)); Ile-de-France; Partenariat institutions-citoyens pour la recherche et; Universite Paris Descartes; Fondation Deniker; Fonds Quebecois de Recherche sur la Societe et la Culture-INSERM joint grant (Marie-Odile KREBS, Oussama KEBIR)	This work was supported by the French Governement Agence Nationale pour la Recherche grant (ANR, 08-MNP-007) and by a competitive grant from Ile-de-France, Partenariat institutions-citoyens pour la recherche et ('innovation (PICRI 2007). The Institut National de la Sante et de la Recherche Medicale (INSERM) promoted the study. Additional financial support was obtained from Universite Paris Descartes (recurrent funding), Fondation Deniker and Fonds Quebecois de Recherche sur la Societe et la Culture-INSERM joint grant (Marie-Odile KREBS, Oussama KEBIR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberg KA, 2014, JAMA PSYCHIAT, V71, P255, DOI 10.1001/jamapsychiatry.2013.3730; Aberg KA, 2013, EPIGENOMICS-UK, V5, P367, DOI [10.2217/epi.13.36, 10.2217/EPI.13.36]; Amarasekera M, 2014, FASEB J, V28, P4068, DOI 10.1096/fj.13-249029; Bimonte HA, 1999, PSYCHONEUROENDOCRINO, V24, P161, DOI 10.1016/S0306-4530(98)00068-7; Braun JM, 2009, ENVIRON HEALTH PERSP, V117, P1945, DOI 10.1289/ehp.0900979; BRIDGES RS, 1984, ENDOCRINOLOGY, V114, P930, DOI 10.1210/endo-114-3-930; Bromer JG, 2009, ENDOCRINOLOGY, V150, P3376, DOI 10.1210/en.2009-0071; Brouwers MM, 2006, HUM REPROD, V21, P666, DOI 10.1093/humrep/dei398; Chisholm K, 2015, NEUROSCI BIOBEHAV R, V55, P173, DOI 10.1016/j.neubiorev.2015.04.012; Cirillo A, 2014, CANCER BIOL THER, V15, P735, DOI 10.4161/cbt.28408; Clark ME, 2000, GENOMICS, V67, P343, DOI 10.1006/geno.2000.6246; de Castilhos J, 2010, NEUROSCI LETT, V469, P19, DOI 10.1016/j.neulet.2009.11.036; Dempster E, 2013, SCHIZOPHRENIA BULL, V39, P11, DOI 10.1093/schbul/sbs139; Dempster EL, 2011, HUM MOL GENET, V20, P4786, DOI 10.1093/hmg/ddr416; Haddad R, 2013, TOXICOL APPL PHARM, V266, P27, DOI 10.1016/j.taap.2012.10.018; Harlid S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118757; HERBST AL, 1970, CANCER, V25, P745, DOI 10.1002/1097-0142(197004)25:4<745::AID-CNCR2820250402>3.0.CO;2-2; HINES M, 1987, HORM BEHAV, V21, P402, DOI 10.1016/0018-506X(87)90024-9; Hoover RN, 2011, NEW ENGL J MED, V365, P1304, DOI 10.1056/NEJMoa1013961; Kaminsky Z, 2012, MOL PSYCHIATR, V17, P728, DOI 10.1038/mp.2011.64; Kawato Suguru, 2004, Environ Sci, V11, P1; Kebir O, 2016, MOL PSYCHIAT; Kebir O, 2012, WORLD J BIOL PSYCHIA, V13, P84, DOI 10.3109/15622975.2011.560280; Klip H, 2002, LANCET, V359, P1102, DOI 10.1016/S0140-6736(02)08152-7; Kubo K, 2003, NEUROSCI RES, V45, P345, DOI 10.1016/S0168-0102(02)00251-1; Labrie V, 2012, TRENDS GENET, V28, P427, DOI 10.1016/j.tig.2012.04.002; Ladd-Acosta C, 2014, MOL PSYCHIATR, V19, P862, DOI 10.1038/mp.2013.114; Lemarchant S, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-133; Li XJ, 2008, DEV CELL, V15, P547, DOI 10.1016/j.devcel.2008.08.014; Li Y, 2014, ENVIRON HEALTH PERSP, V122, P262, DOI 10.1289/ehp.1307351; Masliah E, 2013, EPIGENETICS-US, V8, P1030, DOI 10.4161/epi.25865; Mittaz L, 2004, BIOL REPROD, V70, P1096, DOI 10.1095/biolreprod.103.023911; Ogiue-Ikeda M, 2008, BRAIN RES REV, V57, P363, DOI 10.1016/j.brainresrev.2007.06.010; Okada N, 2016, MOL PSYCHIAT; OKAZAKI S, 1994, J BIOL CHEM, V269, P6900; Ovsyannikova IG, 2015, IMMUNOGENETICS, V67, P547, DOI 10.1007/s00251-015-0864-z; Palanza P, 1999, PHARMACOL BIOCHEM BE, V64, P665, DOI 10.1016/S0091-3057(99)00151-3; Plant K, 2014, EUR J HUM GENET, V22, P568, DOI 10.1038/ejhg.2013.244; Quenneville S, 2011, MOL CELL, V44, P361, DOI 10.1016/j.molcel.2011.08.032; Rapoport J, 2009, J AM ACAD CHILD PSY, V48, P10, DOI 10.1097/CHI.0b013e31818b1c63; Ricceri L, 2006, TOXICOL SCI, V93, P105, DOI 10.1093/toxsci/kfl032; Sato K, 2006, ENDOCR J, V53, P331, DOI 10.1507/endocrj.K06-009; Shindo T, 2000, J CLIN INVEST, V105, P1345, DOI 10.1172/JCI8635; Slotkin TA, 2007, BRAIN RES BULL, V72, P232, DOI 10.1016/j.brainresbull.2007.01.005; SMITH OW, 1948, AM J OBSTET GYNECOL, V56, P821; Tournaire M, 2016, THERAPIE, V71, P395, DOI 10.1016/j.therap.2016.01.006; WHITEHEAD ED, 1981, J UROLOGY, V125, P47, DOI 10.1016/S0022-5347(17)54895-8; Winneke G, 2011, J NEUROL SCI, V308, P9, DOI 10.1016/j.jns.2011.05.020; WOLFSBERG TG, 1995, DEV BIOL, V169, P378, DOI 10.1006/dbio.1995.1152; Xu XH, 2015, CHEMOSPHERE, V120, P258, DOI 10.1016/j.chemosphere.2014.07.021; Xu XH, 2011, NEUROPHARMACOLOGY, V61, P565, DOI 10.1016/j.neuropharm.2011.04.027; Zhang CZ, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-229; Zuo XP, 2012, J BIOL CHEM, V287, P2107, DOI 10.1074/jbc.M111.322644	53	11	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2017	12	4							e0174783	10.1371/journal.pone.0174783	http://dx.doi.org/10.1371/journal.pone.0174783			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0MB	28406917	Green Published, Green Submitted, gold			2022-12-27	WOS:000399955400014
J	Shaikh, AG; Ghasia, FF				Shaikh, Aasef G.; Ghasia, Fatema F.			Fixational saccades are more disconjugate in adults than in children	PLOS ONE			English	Article							PURSUIT EYE-MOVEMENTS; MICROSACCADES; STABILITY; HETEROPHORIA; AMBLYOPIA; MISALIGNMENTS; GENERATION; TRACKING; INFANTS; VISION	Purpose Fixational eye movements are of particular interest for three reasons. They are critical for preventing visual fading and enhancing visual perception; their disconjugacy allows scanning in three dimensions, and their neural correlates span through the cortico-striatal, striato-collicular and brainstem networks. Fixational eye movements are altered in various pediatric ophthalmologic and neurologic disorders. The goal of this study was to compare the dynamics of fixational eye movements in normal children and adults. Methods We measured the fixational saccades and inter-saccadic drifts in eye positions using infrared video-oculography in children and adults. We assessed the frequency, amplitude, main-sequence, and disconjugacy of fixational saccades as well as the intra-saccadic drift velocity and variance between these two groups. Results We found a similar frequency but an increase in the amplitude of fixational saccades in children compared to adults. We also found that the fixational saccades were more conjugate in children than in adults. The inter-saccadic drifts were comparable between the two groups. Discussion This study provides normative values of dynamics of fixational eye movement in children and adults. The greater disconjugacy of fixational saccades in adults suggests the existence of neural mechanisms that can independently regulate the movements of two eyes. The differences between adult and pediatric populations could be due to completion of the development of binocularly independent regulation of fixational saccades nearing adulthood. The alternate possibility is that the increased disconjugacy between the two eyes may represent a deficiency in the eye movement performance as a function of increasing age.	[Shaikh, Aasef G.] Case Western Reserve Univ, Dept Neurol, Cleveland, OH 44106 USA; [Shaikh, Aasef G.] Louis Stokes Cleveland VA Med Ctr, Neurol Serv, Cleveland, OH USA; [Shaikh, Aasef G.; Ghasia, Fatema F.] Louis Stokes Cleveland VA Med Ctr, Daroff Del Osso Ocular Motil Lab, Cleveland, OH 44106 USA; [Ghasia, Fatema F.] Cleveland Clin, Cole Eye Inst, Cleveland, OH 44106 USA	Case Western Reserve University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; Cleveland Clinic Foundation	Ghasia, FF (corresponding author), Louis Stokes Cleveland VA Med Ctr, Daroff Del Osso Ocular Motil Lab, Cleveland, OH 44106 USA.; Ghasia, FF (corresponding author), Cleveland Clin, Cole Eye Inst, Cleveland, OH 44106 USA.	fatemaghasia@gmail.com			Knights Templar Eye Foundation; Blind Children Center; Dystonia Medical Research Foundation; CCLCM-CWRU; Fight for Sight Foundation (FG); Dystonia Medical Research Foundation/Dystonia Coalition career development [NIH U54TR001456-08];  [NIH RO1 EY06717]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [U54TR001456] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY006717] Funding Source: NIH RePORTER	Knights Templar Eye Foundation; Blind Children Center; Dystonia Medical Research Foundation; CCLCM-CWRU; Fight for Sight Foundation (FG); Dystonia Medical Research Foundation/Dystonia Coalition career development; ; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the Knights Templar Eye Foundation (knightstemplar.org); the Blind Children Center (blindchildrenscenter.org) and the Dystonia Medical Research Foundation (dystonia_foundation.org). RPB Unrestricted grant CCLCM-CWRU. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by grants from Knights Templar Research Foundation (FG), and Fight for Sight Foundation (FG), Blind Children's Center (FG), RPB Unrestricted grant CCLCM-CWRU and Dystonia Medical Research Foundation/Dystonia Coalition career development award (NIH U54TR001456-08) (AS). Some resources used for these experiments were supported by NIH RO1 EY06717 to Dr. R. John Leigh. Authors have no conflict of interests.	Chung STL, 2015, VISION RES, V114, P87, DOI 10.1016/j.visres.2015.01.016; CIUFFREDA KJ, 1979, J AM OPTOM ASSOC, V50, P1251; Collewijn H, 2008, J VISION, V8, DOI 10.1167/8.14.20; Costela FM, 2013, PEERJ, V1, DOI 10.7717/peerj.119; Engbert R, 2003, VISION RES, V43, P1035, DOI 10.1016/S0042-6989(03)00084-1; Engbert R, 2004, PSYCHOL SCI, V15, P431, DOI 10.1111/j.0956-7976.2004.00697.x; FENDER D, 1967, J OPT SOC AM, V57, P819, DOI 10.1364/JOSA.57.000819; FIORAVANTI F, 1995, VISION RES, V35, P3217, DOI 10.1016/0042-6989(95)00152-5; FUNK CJ, 1977, PERCEPT MOTOR SKILL, V44, P599, DOI 10.2466/pms.1977.44.2.599; Ghasia FF, 2015, INVEST OPHTH VIS SCI, V56, P2531, DOI 10.1167/iovs.14-15882; GOLDBERG ME, 1986, EXP BRAIN RES, V61, P579; Gonzalez EG, 2012, INVEST OPHTH VIS SCI, V53, P5386, DOI 10.1167/iovs.12-9941; Hafed ZM, 2012, J NEUROPHYSIOL, V107, P1904, DOI 10.1152/jn.01125.2011; Hafed ZM, 2009, SCIENCE, V323, P940, DOI 10.1126/science.1166112; HAINLINE L, 1984, VISION RES, V24, P1771, DOI 10.1016/0042-6989(84)90008-7; Haishi K, 1998, PERCEPT MOTOR SKILL, V86, P146, DOI 10.2466/pms.1998.86.1.146; Horwood A, 2003, BRIT J OPHTHALMOL, V87, P1146, DOI 10.1136/bjo.87.9.1146; Horwood AM, 2004, INVEST OPHTH VIS SCI, V45, P714, DOI 10.1167/iovs.03-0454; Huttenlocher PR, 1997, J COMP NEUROL, V387, P167, DOI 10.1002/(SICI)1096-9861(19971020)387:2<167::AID-CNE1>3.0.CO;2-Z; HUTTENLOCHER PR, 1990, NEUROPSYCHOLOGIA, V28, P517, DOI 10.1016/0028-3932(90)90031-I; Irving EL, 2006, INVEST OPHTH VIS SCI, V47, P2478, DOI 10.1167/iovs.05-1311; Jacobson L, 1998, BRIT J OPHTHALMOL, V82, P1026, DOI 10.1136/bjo.82.9.1026; Kagan I, 2012, CURR BIOL, V22, pR186, DOI 10.1016/j.cub.2012.02.009; Klein C, 2001, PSYCHOPHYSIOLOGY, V38, P179; Larsen DA, 2016, ACTA OPHTHALMOL; Marita EA, 2007, GRAEF ARCH CLIN EXP, V245, P1659, DOI 10.1007/s00417-007-0585-6; Martinez-Conde S, 2006, NEURON, V49, P297, DOI 10.1016/j.neuron.2005.11.033; Martinez-Conde S, 2004, NAT REV NEUROSCI, V5, P229, DOI 10.1038/nrn1348; Martinez-Conde S, 2006, PROG BRAIN RES, V154, P151; Martinez-Conde S, 2015, PERCEPTION, V44, P884, DOI 10.1177/0301006615594963; Martinez-Conde S, 2013, NAT REV NEUROSCI, V14, P83, DOI 10.1038/nrn3405; Martinez-Conde S, 2009, TRENDS NEUROSCI, V32, P463, DOI 10.1016/j.tins.2009.05.006; McCamy MB, 2014, J PHYSIOL-LONDON, V592, P4381, DOI 10.1113/jphysiol.2014.279059; McCamy MB, 2014, J NEUROSCI, V34, P2956, DOI 10.1523/JNEUROSCI.4448-13.2014; McCamy MB, 2012, J NEUROSCI, V32, P9194, DOI 10.1523/JNEUROSCI.0515-12.2012; Otero-Millan J, 2014, J VISION, V14, DOI 10.1167/14.2.18; Otero-Millan J, 2013, P NATL ACAD SCI USA, V110, P6175, DOI 10.1073/pnas.1222715110; Otero-Millan J, 2011, ANN NY ACAD SCI, V1233, P107, DOI 10.1111/j.1749-6632.2011.06177.x; Otero-Millan J, 2011, J NEUROSCI, V31, P4379, DOI 10.1523/JNEUROSCI.2600-10.2011; Otero-Millan J, 2008, J VISION, V8, DOI 10.1167/8.14.21; PFEFFERBAUM A, 1994, ARCH NEUROL-CHICAGO, V51, P874, DOI 10.1001/archneur.1994.00540210046012; Poletti M, 2010, J VISION, V10, DOI 10.1167/10.3.6; Radakovic M, 2012, MED GLAS, V9, P293; Rolfs M, 2008, J VISION, V8, DOI 10.1167/8.11.5; Rosander K, 2002, EXP BRAIN RES, V146, P257, DOI 10.1007/s00221-002-1161-2; Rosander K, 2007, PROG BRAIN RES, V164, P105, DOI 10.1016/S0079-6123(07)64006-0; ROUCOUX A, 1983, BEHAV BRAIN RES, V10, P133, DOI 10.1016/0166-4328(83)90159-6; Rucci M, 2008, NETWORK-COMP NEURAL, V19, P253, DOI 10.1080/09548980802520992; Rucci M, 2007, NATURE, V447, P851, DOI 10.1038/nature05866; Salati R, 2002, DEV MED CHILD NEUROL, V44, P542; SCHOR CM, 1981, VISION RES, V21, P683, DOI 10.1016/0042-6989(81)90076-6; SCHOR CM, 1994, OPHTHAL PHYSL OPT, V14, P279, DOI 10.1111/j.1475-1313.1994.tb00008.x; Shaikh AG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149953; SHEA SL, 1990, VISION RES, V30, P1077, DOI 10.1016/0042-6989(90)90116-3; Shi XFF, 2012, RESTOR NEUROL NEUROS, V30, P445, DOI 10.3233/RNN-2012-129000; Simons D, 2006, J VISION, V6, P1093, DOI 10.1167/6.10.9; Sreenivasan V, 2016, INVEST OPHTH VIS SCI, V57, P2678, DOI 10.1167/iovs.15-17877; Steinman R M, 1982, Hum Neurobiol, V1, P97; Subramanian V, 2013, INVEST OPHTH VIS SCI, V54, P1998, DOI 10.1167/iovs.12-11054; Sweeney JA, 2004, CURR OPIN NEUROL, V17, P37, DOI 10.1097/00019052-200402000-00007; Troncoso XG, 2008, J VISION, V8, DOI 10.1167/8.14.15; Troyer ME, 2017, OPHTHAL PHYSL OPT, V37, P7, DOI 10.1111/opo.12342; Van Horn MR, 2012, J NEUROSCI, V32, P1974, DOI 10.1523/JNEUROSCI.5054-11.2012; Von Noorden G. K., 2002, BINOCULAR VISION OCU, V6th; Ygge J, 2005, ANN NY ACAD SCI, V1039, P480, DOI 10.1196/annals.1325.049	65	13	13	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2017	12	4							e0175295	10.1371/journal.pone.0175295	http://dx.doi.org/10.1371/journal.pone.0175295			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0MB	28406944	Green Published, Green Submitted, gold			2022-12-27	WOS:000399955400038
J	Speier, W; Deshpande, A; Cui, L; Chandravadia, N; Roberts, D; Pouratian, N				Speier, William; Deshpande, Aniket; Cui, Lucy; Chandravadia, Nand; Roberts, Dustin; Pouratian, Nader			A comparison of stimulus types in online classification of the P300 speller using language models	PLOS ONE			English	Article							BCI; COMMUNICATION	The P300 Speller is a common brain-computer interface communication system. There are many parallel lines of research underway to overcome the system's low signal to noise ratio and thereby improve performance, including using famous face stimuli and integrating language information into the classifier. While both have been shown separately to provide significant improvements, the two methods have not yet been implemented together to demonstrate that the improvements are complimentary. The goal of this study is therefore twofold. First, we aim to compare the famous faces stimulus paradigm with an existing alternative stimulus paradigm currently used in commercial systems (i.e., character inversion). Second, we test these methods with language model integration to assess whether different optimization approaches can be combined to further improve BCI communication. In offline analysis using a previously published particle filter method, famous faces stimuli yielded superior results to both standard and inverting stimuli. In online trials using the particle filter method, all 10 subjects achieved a higher selection rate when using the famous faces flashing paradigm than when using inverting flashes. The improvements achieved by these methods are therefore complementary and a combination yields superior results to either method implemented individually when tested in healthy subjects.	[Speier, William; Roberts, Dustin; Pouratian, Nader] Univ Calif Los Angeles, Dept Neurosurg, Los Angeles, CA 90095 USA; [Deshpande, Aniket; Pouratian, Nader] Univ Calif Los Angeles, Dept Bioengn, Los Angeles, CA 90095 USA; [Cui, Lucy; Chandravadia, Nand; Pouratian, Nader] Univ Calif Los Angeles, Neurosci Interdept Program, Los Angeles, CA 90095 USA; [Pouratian, Nader] Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Pouratian, N (corresponding author), Univ Calif Los Angeles, Dept Neurosurg, Los Angeles, CA 90095 USA.; Pouratian, N (corresponding author), Univ Calif Los Angeles, Dept Bioengn, Los Angeles, CA 90095 USA.; Pouratian, N (corresponding author), Univ Calif Los Angeles, Neurosci Interdept Program, Los Angeles, CA 90095 USA.; Pouratian, N (corresponding author), Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90024 USA.	npouratian@mednet.ucla.edu	Speier, William/H-9974-2019; Cui, Lucy/GSD-9251-2022	Speier, William/0000-0002-0890-8684; Pouratian, Nader/0000-0002-0426-3241	National Institute of Biomedical Imaging and Bioengineering [K23EB014326]; UCLA Scholars in Translational Medicine Program; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [K23EB014326] Funding Source: NIH RePORTER	National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); UCLA Scholars in Translational Medicine Program; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by the National Institute of Biomedical Imaging and Bioengineering Award Number K23EB014326 (NP) and the UCLA Scholars in Translational Medicine Program (NP).	Eimer M, 2000, CLIN NEUROPHYSIOL, V111, P694, DOI 10.1016/S1388-2457(99)00285-0; FARWELL LA, 1988, ELECTROEN CLIN NEURO, V70, P510, DOI 10.1016/0013-4694(88)90149-6; Fatourechi M, 2006, 2006 IEEE INTERNATIONAL SYMPOSIUM ON SIGNAL PROCESSING AND INFORMATION TECHNOLOGY, VOLS 1 AND 2, P212, DOI 10.1109/ISSPIT.2006.270799; Jelinek F., 1998, STAT METHODS SPEECH; Jin J, 2010, BIOMED TECH, V55, P203, DOI 10.1515/BMT.2010.029; Kaper M, 2004, IEEE T BIO-MED ENG, V51, P1073, DOI 10.1109/TBME.2004.826698; Kaufmann T, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/5/056016; Kaufmann T, 2013, CLIN NEUROPHYSIOL, V124, P893, DOI 10.1016/j.clinph.2012.11.006; Kindermans PJ, 2013, IEEE T BIO-MED ENG, V60, P2696, DOI 10.1109/TBME.2013.2262524; Krusienski DJ, 2006, J NEURAL ENG, V3, P299, DOI 10.1088/1741-2560/3/4/007; Li YaoMing, 2014, Transactions of the Chinese Society of Agricultural Engineering, V30, P30; Liu YY, 2010, INT CONF COMP SCI, P227, DOI 10.1109/ICCSIT.2010.5563570; Lu J, 2013, CLIN NEUROPHYSIOL, V124, P306, DOI 10.1016/j.clinph.2012.08.002; McFarland DJ, 2011, CLIN NEUROPHYSIOL, V122, P731, DOI 10.1016/j.clinph.2010.10.029; Park J, 2012, IEEE T NEUR SYS REH, V20, P584, DOI 10.1109/TNSRE.2012.2191979; Pierce JR, 1980, INTRO INFORM THEORY; Salvaris M, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/4/046011; Schalk G, 2004, IEEE T BIO-MED ENG, V51, P1034, DOI 10.1109/TBME.2004.827072; Sellers EW, 2006, BIOL PSYCHOL, V73, P242, DOI 10.1016/j.biopsycho.2006.04.007; Serby H, 2005, IEEE T NEUR SYS REH, V13, P89, DOI 10.1109/TNSRE.2004.841878; Speier W, 2016, J NEURAL ENG, V13, DOI 10.1088/1741-2560/13/3/031002; Speier W, 2015, J NEURAL ENG, V12, DOI 10.1088/1741-2560/12/4/046018; Speier W, 2014, IEEE T NEUR SYS REH, V22, P678, DOI 10.1109/TNSRE.2014.2300091; Speier W, 2013, I IEEE EMBS C NEUR E, P707, DOI 10.1109/NER.2013.6696032; Speier W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078432; Speier W, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/1/016004; Takano K, 2009, CLIN NEUROPHYSIOL, V120, P1562, DOI 10.1016/j.clinph.2009.06.002; Townsend G, 2010, CLIN NEUROPHYSIOL, V121, P1109, DOI 10.1016/j.clinph.2010.01.030; Townsend G, 2012, NEUROSCI LETT, V531, P63, DOI 10.1016/j.neulet.2012.08.041; Xu N, 2004, IEEE T BIO-MED ENG, V51, P1067, DOI 10.1109/TBME.2004.826699	31	21	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2017	12	4							e0175382	10.1371/journal.pone.0175382	http://dx.doi.org/10.1371/journal.pone.0175382			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0MB	28406932	Green Submitted, Green Published, gold			2022-12-27	WOS:000399955400047
J	Wang, YN; Wang, K; Li, XP; Wei, QH; Chai, WH; Wang, SZ; Che, Y; Lu, TL; Zhang, B				Wang, Yanen; Wang, Kai; Li, Xinpei; Wei, Qinghua; Chai, Weihong; Wang, Shuzhi; Che, Yu; Lu, Tingli; Zhang, Bo			3D fabrication and characterization of phosphoric acid scaffold with a HA/beta-TCP weight ratio of 60: 40 for bone tissue engineering applications	PLOS ONE			English	Article							CELL-MATERIALS INTERACTIONS; IN-SITU SYNTHESIS; CALCIUM-PHOSPHATE; BIOCERAMIC IMPLANTS; HYDROXYAPATITE; SURFACE; MINERALIZATION; COMPOSITES; CERAMICS; STRENGTH	A key requirement for three-dimensional printing (3-DP) at room temperature of medical implants depends on the availability of printable and biocompatible binder-powder systems. Different concentration polyvinyl alcohol (PVA) and phosphoric acid solutions were chosen as the binders to make the artificial stent biocompatible with sufficient compressive strength. In order to achieve an optimum balance between the bioceramic powder and binder solution, the biocompatibility and mechanical properties of these artificial stent samples were tested using two kinds of binder solutions. This study demonstrated the printable binder formulation at room temperature for the 3D artificial bone scaffolds. 0.6 wt% PVA solution was ejected easily via inkjet printing, with a supplementation of 0.25 wt% Tween 80 to reduce the surface tension of the polyvinyl alcohol solution. Compared with the polyvinyl alcohol scaffolds, the phosphoric acid scaffolds had better mechanical properties. Though both scaffolds supported the cell proliferation, the absorbance of the polyvinyl alcohol scaffolds was higher than that of the phosphoric acid scaffolds. The artificial stents with a hydroxyapatite/beta-tricalcium phosphate (HA/beta-TCP) weight ratios of 60: 40 depicted good biocompatibility for both scaffolds. Considering the scaffolds' mechanical and biocompatible properties, the phosphoric acid scaffolds with a HA/beta-TCP weight ratio of 60: 40 may be the best combination for bone tissue engineering applications.	[Wang, Yanen; Wang, Kai; Li, Xinpei; Wei, Qinghua; Chai, Weihong; Wang, Shuzhi; Che, Yu] Northwestern Polytech Univ, Sch Mech Engn, Ind Engn Dept, Xian, Peoples R China; [Lu, Tingli] Northwestern Polytech Univ, Sch Life Sci, Key Lab Space Biosci & Biotechnol, Xian, Peoples R China; [Zhang, Bo] Fourth Mil Med Univ, Tangdu Hosp, Dept Urol, Xian, Peoples R China	Northwestern Polytechnical University; Northwestern Polytechnical University; Air Force Military Medical University	Lu, TL (corresponding author), Northwestern Polytech Univ, Sch Life Sci, Key Lab Space Biosci & Biotechnol, Xian, Peoples R China.; Zhang, B (corresponding author), Fourth Mil Med Univ, Tangdu Hosp, Dept Urol, Xian, Peoples R China.	lutinglixinxin@nwpu.edu.cn; 18710952475@163.com			National Natural Science Foundation of China [51175432]; Doctor Special Science and Technological Funding of the China Ministry of Education [20116102110046]; Fundamental Research Funds for the Central Universities [3102014JCS05007]; key Industrial Science and Technology projects of Shaanxi [2015GY047]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Doctor Special Science and Technological Funding of the China Ministry of Education; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); key Industrial Science and Technology projects of Shaanxi	This work was funded by the National Natural Science Foundation of China (Grant No. 51175432), the Doctor Special Science and Technological Funding of the China Ministry of Education (Grant No. 20116102110046), the Fundamental Research Funds for the Central Universities (Grant No. 3102014JCS05007), and the key Industrial Science and Technology projects of Shaanxi (No. 2015GY047).r This project is sponsored by the National Natural Science Foundation of China, (Grant No. 51175432), the Doctor Special Science and Technological Funding of the China Ministry of Education (Grant No.20116102110046), the Fundamental Research Funds for the Central Universities (Grant No.3102014JCS05007), the key Industrial Science and technology projects of Shaanxi (No.2015GY047).	Bodhak S, 2009, ACTA BIOMATER, V5, P2178, DOI 10.1016/j.actbio.2009.02.023; Bose S, 2013, MATER TODAY, V16, P496, DOI 10.1016/j.mattod.2013.11.017; Butscher A, 2012, ACTA BIOMATER, V8, P373, DOI 10.1016/j.actbio.2011.08.027; Castilho M, 2011, INT J ADV MANUF TECH, V56, P561, DOI 10.1007/s00170-011-3219-4; Daculsi G., 2006, ENCY BIOMATERIALS BI, P1; Das K, 2007, ACTA BIOMATER, V3, P573, DOI 10.1016/j.actbio.2006.12.003; Deligianni DD, 2001, BIOMATERIALS, V22, P87, DOI 10.1016/S0142-9612(00)00174-5; Ding B, 2004, POLYMER, V45, P1895, DOI 10.1016/j.polymer.2004.01.026; Gbureck U, 2007, ADV FUNCT MATER, V17, P3940, DOI 10.1002/adfm.200700019; Gbureck U, 2007, ADV MATER, V19, P795, DOI 10.1002/adma.200601370; Guo DG, 2009, J BIOMED MATER RES A, V88A, P43, DOI 10.1002/jbm.a.31844; Habibovic P, 2008, BIOMATERIALS, V29, P944, DOI 10.1016/j.biomaterials.2007.10.023; Hussain R, 2016, APPL SURF SCI, V364, P117, DOI 10.1016/j.apsusc.2015.12.057; Igawa Kazuyo, 2006, J Artif Organs, V9, P234, DOI 10.1007/s10047-006-0347-y; Inzana JA, 2014, BIOMATERIALS, V35, P4026, DOI 10.1016/j.biomaterials.2014.01.064; Jones AC, 2007, BIOMATERIALS, V28, P2491, DOI 10.1016/j.biomaterials.2007.01.046; Keaveny TM, 1993, BONE A TREATISE, V7, P285; Kruyt MC, 2003, TISSUE ENG, V9, P327, DOI 10.1089/107632703764664792; Kumar A, 2016, MAT SCI ENG R, V103, pIII, DOI 10.1016/j.mser.2016.01.001; LEHUEC JC, 1995, BIOMATERIALS, V16, P113, DOI 10.1016/0142-9612(95)98272-G; Li SH, 2003, TISSUE ENG, V9, P535, DOI 10.1089/107632703322066714; Qiu WT, 2016, RSC ADV, V6, P99940, DOI 10.1039/c6ra22929h; Suzuki T, 1996, J FERMENT BIOENG, V81, P226, DOI 10.1016/0922-338X(96)82213-6; Vallet-Regi M, 2001, J CHEM SOC DALTON, P97, DOI 10.1039/b007852m; Vorndran E, 2015, MRS BULL, V40, P127, DOI 10.1557/mrs.2015.326; Vorndran E, 2008, ADV ENG MATER, V10, pB67, DOI 10.1002/adem.200800179; Wang MB, 2008, J BIOMED MATER RES A, V85A, P418, DOI 10.1002/jbm.a.31585; Wang YE, 2015, J MATER SCI, V50, P5014, DOI 10.1007/s10853-015-9050-9; Wang YN, 2017, J MOL GRAPH MODEL, V71, P40, DOI 10.1016/j.jmgm.2016.11.001; Wu CT, 2011, ACTA BIOMATER, V7, P2644, DOI 10.1016/j.actbio.2011.03.009; Yoon JYS, 2012, INT J MATER RES, V103, P200, DOI 10.3139/146.110661	31	27	31	8	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2017	12	4							e0174870	10.1371/journal.pone.0174870	http://dx.doi.org/10.1371/journal.pone.0174870			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0MB	28406922	Green Published, gold, Green Submitted			2022-12-27	WOS:000399955400020
J	Yamashiro, K; Tanaka, R; Urabe, T; Ueno, Y; Yamashiro, Y; Nomoto, K; Takahashi, T; Tsuji, H; Asahara, T; Hattori, N				Yamashiro, Kazuo; Tanaka, Ryota; Urabe, Takao; Ueno, Yuji; Yamashiro, Yuichiro; Nomoto, Koji; Takahashi, Takuya; Tsuji, Hirokazu; Asahara, Takashi; Hattori, Nobutaka			Gut dysbiosis is associated with metabolism and systemic inflammation in patients with ischemic stroke (vol 12, e0171521, 2017)	PLOS ONE			English	Correction													Ueno, Yuji/ABB-2492-2020; Hattori, Nobutaka/ACR-0069-2022	Hirokazu, Tsuji/0000-0003-2856-6447				Yamashiro K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171521	1	6	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2017	12	4							e0176062	10.1371/journal.pone.0176062	http://dx.doi.org/10.1371/journal.pone.0176062			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0MB	28406979	Green Published, Green Submitted, gold			2022-12-27	WOS:000399955400109
J	Martini, H; Detemmerman, L; Soetens, O; Yusuf, E; Pierard, D				Martini, Helena; Detemmerman, Liselot; Soetens, Oriane; Yusuf, Erlangga; Pierard, Denis			Improving specificity of Bordetella pertussis detection using a four target real-time PCR	PLOS ONE			English	Article							MASS-SPECTROMETRY; HOLMESII; PARAPERTUSSIS; ASSAY; AMPLIFICATION; IDENTIFICATION; INFECTIONS; DIAGNOSIS; DISCRIMINATION; SPECIMENS	The incidence of whooping cough, a contagious respiratory disease caused by Bordetella pertussis, is on the rise despite existing vaccination programmes. Similar, though usually milder, respiratory symptoms may be caused by other members of the Bordetella genus: B. parapertussis, B. holmesii, and B. bronchiseptica. Pertussis diagnosis is mostly done using PCR, but the use of multiple targets is necessary in order to differentiate the different Bordetella spp. with sufficient sensitivity and specificity. In this study we evaluate a multiplex PCR assay for the differentiation of B. pertussis from other Bordetella spp., using the targets IS481, IS1001, IS1002, and recA. Moreover, we retrospectively explore the epidemiology of Bordetella spp. infections in Belgium, using the aforementioned assay over a three-year period, from 2013 until 2015.	[Martini, Helena] VUB, Univ Ziekenhuis Brussel UZ Brussel, Dept Microbiol & Infect Control, Brussels, Belgium; Belgian Natl Reference Ctr Bordetella Pertussis, Brussels, Belgium; [Detemmerman, Liselot] LaCAR MDx Technol, Liege, Belgium; [Yusuf, Erlangga] Univ Antwerp, Univ Ziekenhuis Antwerpen, Dept Med Microbiol, Edegem, Belgium	University Hospital Brussels; Vrije Universiteit Brussel; University of Antwerp	Martini, H (corresponding author), VUB, Univ Ziekenhuis Brussel UZ Brussel, Dept Microbiol & Infect Control, Brussels, Belgium.	helena.martini@uzbrussel.be		Pierard, DEnis/0000-0002-7756-3691	Belgian Ministry of Social Affairs through a fund within the Health Insurance System	Belgian Ministry of Social Affairs through a fund within the Health Insurance System	This work was performed in the frame of the Belgian National Reference Centre for Bordetella pertussis, supported by the Belgian Ministry of Social Affairs through a fund within the Health Insurance System. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barlow RS, 2014, CLIN INFECT DIS, V58, P1523, DOI 10.1093/cid/ciu156; Bolding J, 2004, INFECT MED, V21, P305; Cherry JD, 2012, NEW ENGL J MED, V367, P785, DOI 10.1056/NEJMp1209051; Cherry JD, 2012, CLIN INFECT DIS, V54, P534, DOI 10.1093/cid/cir860; Crowcroft NS, 2003, ARCH DIS CHILD, V88, P802, DOI 10.1136/adc.88.9.802; Guthrie JL, 2010, J CLIN MICROBIOL, V48, P1435, DOI 10.1128/JCM.02417-09; Hasan MR, 2014, CAN J INFECT DIS MED, V25, P217, DOI 10.1155/2014/763128; KHELEF N, 1993, INFECT IMMUN, V61, P486, DOI 10.1128/IAI.61.2.486-490.1993; Knorr L, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-62; Kosters K, 2002, J CLIN MICROBIOL, V40, P1719, DOI 10.1128/JCM.40.5.1719-1722.2002; Mattoo S, 2001, FRONT BIOSCI-LANDMRK, V6, pE168, DOI 10.2741/Mattoo; Mellmann A, 2008, J CLIN MICROBIOL, V46, P1946, DOI 10.1128/JCM.00157-08; Menard A, 2007, CLIN MICROBIOL INFEC, V13, P419, DOI 10.1111/j.1469-0691.2006.01659.x; Niesters HGM, 2001, METHODS, V25, P419, DOI 10.1006/meth.2001.1264; Pittet LF, 2016, MICROBIOL SPECTR, V4, DOI 10.1128/microbiolspec.EI10-0003-2015; Pittet LF, 2014, LANCET INFECT DIS, V14, P510, DOI 10.1016/S1473-3099(14)70021-0; Probert WS, 2008, J CLIN MICROBIOL, V46, P3228, DOI 10.1128/JCM.00386-08; Reischl U, 2001, J CLIN MICROBIOL, V39, P1963, DOI 10.1128/JCM.39.5.1963-1966.2001; Riffelmann M, 2005, J CLIN MICROBIOL, V43, P4925, DOI 10.1128/JCM.43.10.4925-4929.2005; Roorda Lieuwe, 2011, BMC Res Notes, V4, P11, DOI 10.1186/1756-0500-4-11; Sauer S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002843; Sizaire V, 2014, EURO SURVEILL, V19; Snyder J, 2012, PEDIATR REV, V33, P412, DOI 10.1542/pir.33-9-412; Tatti KM, 2013, PEDIATR INFECT DIS J, V32, P942, DOI 10.1097/INF.0b013e3182947ef8; Tatti KM, 2011, J CLIN MICROBIOL, V49, P4059, DOI 10.1128/JCM.00601-11; Templeton KE, 2003, J CLIN MICROBIOL, V41, P4121, DOI 10.1128/JCM.41.9.4121-4126.2003; Van den Bossche D, 2013, ACTA CLIN BELG, V68, P341, DOI 10.2143/ACB.3341; van Doornum GJJ, 2003, J CLIN MICROBIOL, V41, P576, DOI 10.1128/JCM.41.2.576-580.2003; Versalovic J, 2012, MANUAL CLIN MICROBIO, P739; Vestrheim DF, 2012, J CLIN MICROBIOL, V50, P4114, DOI 10.1128/JCM.01553-12; Vincart B, 2007, J MED MICROBIOL, V56, P918, DOI 10.1099/jmm.0.46947-0; Xu YH, 2010, APMIS, V118, P685, DOI 10.1111/j.1600-0463.2010.02644.x; Zhang XQ, 2012, EMERG INFECT DIS, V18, P1771, DOI 10.3201/eid1811.111544	33	12	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2017	12	4							e0175587	10.1371/journal.pone.0175587	http://dx.doi.org/10.1371/journal.pone.0175587			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LZ	28403204	Green Published, gold, Green Submitted			2022-12-27	WOS:000399955200085
J	Gangoiti, J; Lamothe, L; van Leeuwen, SS; Vafiadi, C; Dijkhuizen, L				Gangoiti, Joana; Lamothe, Lisa; van Leeuwen, Sander Sebastiaan; Vafiadi, Christina; Dijkhuizen, Lubbert			Characterization of the Paenibacillus beijingensis DSM 24997 GtfD and its glucan polymer products representing a new glycoside hydrolase 70 subfamily of 4,6-alpha-glucanotransferase enzymes	PLOS ONE			English	Article							ALPHA-AMYLASE; STRUCTURAL-ANALYSIS; GLUCANSUCRASE GTFA; CRYSTAL-STRUCTURE; FAMILY; SEQUENCE; SPECIFICITY; MECHANISMS; SYNTHESIZE; PROVIDES	Previously we have reported that the Gram-negative bacterium Azotobacter chroococcum NCIMB 8003 uses the 4,6-alpha-glucanotransferase GtfD to convert maltodextrins and starch into a reuteran-like polymer consisting of (alpha 1 -> 4) glucan chains connected by alternating (alpha 1 -> 4)/(alpha 1 -> 6) linkages and (alpha 1 -> 4,6) branching points. This enzyme constituted the single evidence for this reaction and product specificity in the GH70 family, mostly containing glucansucrases encoded by lactic acid bacteria (http://www.CAZy.org). In this work, 4 additional GtfD-like proteins were identified in taxonomically diverse plant-associated bacteria forming a new GH70 subfamily with intermediate characteristics between the evolutionary related GH13 and GH70 families. The GtfD enzyme encoded by Paenibacillus beijingensis DSM 24997 was characterized providing the first example of a reuteran-like polymer synthesizing 4,6-alpha-glucanotransferase in a Gram-positive bacterium. Whereas the A. chroococcum GtfD activity on amylose resulted in the synthesis of a high molecular polymer, in addition to maltose and other small oligosaccharides, two reuteran-like polymer distributions are produced by P. beijingensis GtfD: a high-molecular mass polymer and a low-molecular mass polymer with an average M-w of 27 MDa and 19 kDa, respectively. Compared to the A. chroooccum GtfD product, both P. beijingensis GtfD polymers contain longer linear (alpha 1 -> 4) sequences in their structure reflecting a preference for transfer of even longer glucan chains by this enzyme. Overall, this study provides new insights into the evolutionary history of GH70 enzymes, and enlarges the diversity of natural enzymes that can be applied for modification of the starch present in food into less and/or more slowly digestible carbohydrate structures.	[Gangoiti, Joana; van Leeuwen, Sander Sebastiaan; Dijkhuizen, Lubbert] Univ Groningen, Groningen Biomol Sci & Biotechnol Inst GBB, Microbial Physiol, Groningen, Netherlands; [Lamothe, Lisa; Vafiadi, Christina] Nestle Res Ctr, Lausanne, Switzerland	University of Groningen; Nestle SA	Dijkhuizen, L (corresponding author), Univ Groningen, Groningen Biomol Sci & Biotechnol Inst GBB, Microbial Physiol, Groningen, Netherlands.	L.Dijkhuizen@rug.nl	Gangoiti, Joana/N-6863-2018; Dijkhuizen, Lubbert/K-3539-2019; van Leeuwen, Sander/C-7140-2012; Dijkhuizen, Lubbert/E-9454-2014	Gangoiti, Joana/0000-0001-6821-8143; Dijkhuizen, Lubbert/0000-0003-2312-7162; van Leeuwen, Sander/0000-0003-0017-2841; Lamothe, Lisa/0000-0002-5270-1875	Nestec Ltd; University of Groningen	Nestec Ltd; University of Groningen	This work was financially supported by Nestec Ltd and by the University of Groningen. Nestec Ltd provided support in the form of salaries for authors CV and LL. The University of Groningen provided support in the form of salaries for authors JG, SSvL, and LD. The specific roles of these authors are articulated in the author contributions section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai Y, 2015, NATURE, V528, P364, DOI 10.1038/nature16192; Bai YX, 2015, APPL ENVIRON MICROB, V81, P7223, DOI 10.1128/AEM.01860-15; Bogino PC, 2013, INT J MOL SCI, V14, P15838, DOI 10.3390/ijms140815838; Brison Y, 2012, J BIOL CHEM, V287, P7915, DOI 10.1074/jbc.M111.305078; Dona AC, 2010, CARBOHYD POLYM, V80, P599, DOI 10.1016/j.carbpol.2010.01.002; Ekhart P, 2006, Branched alpha-glucans for weight management, Patent No. [US 20060100171 A1, 20060100171]; Gangoiti J, 2016, SCI REP IN PRESS; Gangoiti J, 2016, BBA-GEN SUBJECTS, V1860, P1224, DOI 10.1016/j.bbagen.2016.02.005; Gangoiti J, 2016, APPL ENVIRON MICROB, V82, P756, DOI 10.1128/AEM.03420-15; Ito K, 2011, J MOL BIOL, V408, P177, DOI 10.1016/j.jmb.2011.02.028; Janecek S, 2016, CELL MOL LIFE SCI, V73, P2707, DOI 10.1007/s00018-016-2246-6; Kralj S, 2004, MICROBIOL-SGM, V150, P2099, DOI 10.1099/mic.0.27105-0; Kralj S, 2011, APPL ENVIRON MICROB, V77, P8154, DOI 10.1128/AEM.05735-11; Kwak Y, 2015, J BIOTECHNOL, V206, P75, DOI 10.1016/j.jbiotec.2015.04.015; Lee BH, 2016, PLOS ONE, V8; Leemhuis H, 2014, J AGR FOOD CHEM, V62, P12034, DOI 10.1021/jf503970a; Leemhuis H, 2013, APPL MICROBIOL BIOT, V97, P181, DOI 10.1007/s00253-012-3943-1; Leemhuis H, 2013, J BIOTECHNOL, V163, P250, DOI 10.1016/j.jbiotec.2012.06.037; Lin AHM, 2016, FOOD HYDROCOLLOID, V53, P163, DOI 10.1016/j.foodhyd.2015.03.002; MacGregor EA, 2001, BBA-PROTEIN STRUCT M, V1546, P1, DOI 10.1016/S0167-4838(00)00302-2; MACHIUS M, 1995, J MOL BIOL, V246, P545, DOI 10.1006/jmbi.1994.0106; Meng XF, 2016, CELL MOL LIFE SCI, V73, P2681, DOI 10.1007/s00018-016-2245-7; Monchois V, 1999, FEMS MICROBIOL REV, V23, P131, DOI 10.1016/S0168-6445(98)00041-2; Pijning T, 2012, ACTA CRYSTALLOGR F, V68, P1448, DOI 10.1107/S1744309112044168; Plijter J, 2009, Bread improver, Patent No. [US 20090297663 A1, 20090297663]; Przylas I, 2000, EUR J BIOCHEM, V267, P6903, DOI 10.1046/j.1432-1033.2000.01790.x; Raga-Carbajal E, 2016, GLYCOBIOLOGY, V26, P377, DOI 10.1093/glycob/cwv112; Robson RL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127997; Shin JE, 2008, J AGR FOOD CHEM, V56, P10879, DOI 10.1021/jf801073u; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Stam MR, 2006, PROTEIN ENG DES SEL, V19, P555, DOI 10.1093/protein/gzl044; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Uitdehaag JCM, 2000, BIOCHEMISTRY-US, V39, P7772, DOI 10.1021/bi000340x; van Hijum SAFT, 2006, MICROBIOL MOL BIOL R, V70, P157, DOI 10.1128/MMBR.70.1.157-176.2006; van Leeuwen SS, 2008, CARBOHYD RES, V343, P1251, DOI 10.1016/j.carres.2008.01.044; van Leeuwen SS, 2008, CARBOHYD RES, V343, P1237, DOI 10.1016/j.carres.2008.01.042; Vujicic-Zagar A, 2010, P NATL ACAD SCI USA, V107, P21406, DOI 10.1073/pnas.1007531107; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033	38	21	23	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2017	12	4							e0172622	10.1371/journal.pone.0172622	http://dx.doi.org/10.1371/journal.pone.0172622			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0JS	28399167	Green Submitted, Green Published, gold			2022-12-27	WOS:000399949000001
J	Baysal, M; Ilgin, S; Kilic, G; Kilic, V; Ucarcan, S; Atli, O				Baysal, Merve; Ilgin, Sinem; Kilic, Gozde; Kilic, Volkan; Ucarcan, Seyda; Atli, Ozlem			Reproductive toxicity after levetiracetam administration in male rats: Evidence for role of hormonal status and oxidative stress	PLOS ONE			English	Article							DNA-DAMAGE; ANTIEPILEPTIC DRUGS; COMET ASSAY; ENDOCRINE FUNCTION; SPERM; EXPOSURE; TOPIRAMATE; VALPROATE; IDENTIFICATION; CARBAMAZEPINE	Levetiracetam (LEV) is an antiepileptic drug commonly used in the treatment of epilepsy because of its excellent safety profile in all age groups. It is remarkable that there are no studies evaluating the toxic effects of this drug on the male reproductive system, as it is commonly used in male patients of reproductive age. From this point of view, our aim was to evaluate the possible toxic effects of LEV on the male reproductive system. Therefore, LEV was administered to male rats orally at 50, 150, and 300 mg/kg for 70 consecutive days. At the end of this period, alterations to body and organ weights were calculated, and sperm concentration, motility, and morphology were investigated by a computer-assisted sperm analysis system. Sperm DNA damage was determined by comet assay and histopathological examination of the testes was carried out. Serum testosterone, follicle-stimulating hormone (FSH), and luteinizing hormone (LH) levels were measured by ELISAs to determine the effects of hormonal status, while glutathione, superoxide dismutase, catalase, and malondialdehyde levels in the testes were measured by colorimetric assay kits to determine the role of oxidative status in potential toxicity. According to the results, sperm quality was decreased by LEV treatment in a dose-dependent manner. LEV induced significant DNA damage in the 150 and 300 mg/kg LEV-administered groups. Histopathology of the testes showed that LEV resulted in testicular injury in the 300 mg/kg LEV-administered group. Serum testosterone, FSH, and LH levels were significantly decreased in the 300 mg/kg LEV-administered group. Glutathione, superoxide dismutase, and catalase levels were significantly decreased in all experimental groups while malondialdehyde levels were significantly increased in 150 and 300 mg/kg LEV-administered groups. According to these results, it was determined that LEV administration decreased sperm quality and it was alleged that hormonal alteration and oxidative stress are potential contributors to reproductive toxicity.	[Baysal, Merve; Ilgin, Sinem; Atli, Ozlem] Anadolu Univ, Fac Pharm, Dept Pharmaceut Toxicol, Eskisehir, Turkey; [Kilic, Gozde; Kilic, Volkan; Ucarcan, Seyda] Anadolu Univ, Fac Sci, Dept Biol, Eskisehir, Turkey	Anadolu University; Anadolu University	Baysal, M (corresponding author), Anadolu Univ, Fac Pharm, Dept Pharmaceut Toxicol, Eskisehir, Turkey.	mbaysal@anadolu.edu.tr	eklioğlu, özlem atlı/AAG-4655-2019; Kılıç, Volkan/O-9949-2019; Kılıç, Gözde Aydoğan/P-9775-2019	Kılıç, Volkan/0000-0003-3535-8013; Kılıç, Gözde Aydoğan/0000-0002-4502-1820; Baysal, Merve/0000-0002-8099-0942	Anadolu University Scientific Research Projects Commission [1505S412]	Anadolu University Scientific Research Projects Commission(Anadolu University)	This study was supported by the Anadolu University Scientific Research Projects Commission under grant no 1505S412.	Abdel-Wahab BA, 2015, PHARMACOL BIOCHEM BE, V135, P105, DOI 10.1016/j.pbb.2015.05.020; Andretta RR, 2014, REPROD TOXICOL, V44, P52, DOI 10.1016/j.reprotox.2013.09.009; Antel J, 2012, Handb Exp Pharmacol, P433, DOI 10.1007/978-3-642-24716-3_20; Bancroft JD, 2002, THEORY AND PRACTICE; Ben-Menachem E, 2007, EPILEPSIA, V48, P42, DOI 10.1111/j.1528-1167.2007.01402.x; Calabro RS, 2013, SEIZURE-EUR J EPILEP, V22, P329, DOI 10.1016/j.seizure.2013.01.003; Calabro RS, 2011, EXPERT REV NEUROTHER, V11, P887, DOI [10.1586/ERN.11.58, 10.1586/ern.11.58]; CDER, ESTIMATING THE MAXIM; Chi Hee-Jun, 2011, Clin Exp Reprod Med, V38, P10, DOI 10.5653/cerm.2011.38.1.10; Csoka AB, 2006, PSYCHOTHER PSYCHOSOM, V75, P187, DOI 10.1159/000091777; Daoud AS, 2004, NEUROENDOCRINOL LETT, V25, P178; EL-Shorbagy M.H., 2016, INT J PHARM SCI, V8, P82; Fanaei Hamed, 2014, Iran J Reprod Med, V12, P103; Filler R., 1993, MALE REPROD TOXICOLO, P334, DOI DOI 10.1016/B978-0-12-461207-5.50025-0; Gelisse P, 2008, EPILEPSIA, V49, P308, DOI 10.1111/j.1528-1167.2007.01273.x; Giribabu N, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-291; Gromadzka-Ostrowska J, 2012, TOXICOL LETT, V214, P251, DOI 10.1016/j.toxlet.2012.08.028; Harden CL, 2010, EPILEPSIA, V51, P2348, DOI 10.1111/j.1528-1167.2010.02732.x; Hauser R, 2003, HUM REPROD, V18, P2525, DOI 10.1093/humrep/deg508; Hoyer PB, 2001, BIOCHEM PHARMACOL, V62, P1557, DOI 10.1016/S0006-2952(01)00814-0; Isojarvi J, 2008, SEIZURE-EUR J EPILEP, V17, P111, DOI 10.1016/j.seizure.2007.11.007; Jayachandra S, 2013, INT J BASIC CLIN PHA, V2, P83; Khan S, 2015, PESTIC BIOCHEM PHYS, V124, P8, DOI 10.1016/j.pestbp.2015.03.010; Kimmel G.L., 1995, REPROD TOXICOL, P75; Kitano Y, 2005, BRAIN RES, V1057, P168, DOI 10.1016/j.brainres.2005.07.052; Knopper L.D., 2005, TECHNICAL REPORT SER, V429; Kong L, 2014, INT J MOL SCI, V15, P21253, DOI 10.3390/ijms151121253; Kozlowski P., 2015, J ED HLTH SPORT, V5, P143, DOI [10.5281/ZENODO.16694, DOI 10.5281/ZENODO.16694]; Kumar S, 2014, EUR NEUROPSYCHOPHARM, V24, P1709, DOI 10.1016/j.euroneuro.2014.06.011; Kwong KL, 2012, PEDIATR NEUROL, V46, P281, DOI 10.1016/j.pediatrneurol.2012.02.019; Lewis SEM, 2013, REPROD BIOMED ONLINE, V27, P325, DOI 10.1016/j.rbmo.2013.06.014; Lin JF, 2014, CHINESE J PHYSIOL, V57, P19, DOI 10.4077/CJP.2014.BAB155; Liu LP, 2012, ENVIRON INT, V42, P78, DOI 10.1016/j.envint.2011.04.005; Lyseng-Williamson KA, 2011, DRUGS, V71, P489, DOI 10.2165/11204490-000000000-00000; Maree L, 2013, BIOTECH HISTOCHEM, V88, P181, DOI 10.3109/10520295.2012.757366; Margineanu DG, 2008, BRAIN RES BULL, V77, P282, DOI 10.1016/j.brainresbull.2008.07.006; Marini H, 2004, LIFE SCI, V74, P1253, DOI 10.1016/j.lfs.2003.08.006; Martinez CS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111202; MAZHAR F, 2014, J PHARMACOL TOX MET, V70, P313; McPhee SJ, 2000, PATHOPHYSIOLOGY OF D, P556; Moller P, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00217; Montouris G, 2005, EPILEPSY BEHAV, V7, pS7, DOI 10.1016/j.yebeh.2005.08.026; MORI K, 1991, BRIT J IND MED, V48, P270; Morris ID, 2002, HUM REPROD, V17, P990, DOI 10.1093/humrep/17.4.990; Narayana K, 2002, MUTAT RES-GEN TOX EN, V513, P193, DOI 10.1016/S1383-5718(01)00308-4; Olive PL, 2006, NAT PROTOC, V1, P23, DOI 10.1038/nprot.2006.5; Oliveira AA, 2007, CELL MOL NEUROBIOL, V27, P395, DOI 10.1007/s10571-006-9132-y; Ong CN, 2002, TOXICOL LETT, V134, P17, DOI 10.1016/S0378-4274(02)00159-5; Otoom S, 2004, NEUROENDOCRINOL LETT, V25, P351; Rasool EA, 2012, AL KINDY COL MED J, V8, P40; Rauchenzauner M, 2010, EPILEPSY RES, V88, P264, DOI 10.1016/j.eplepsyres.2009.11.003; Sarangi SC, 2013, J PHARMACOL TOX MET, V68, pE4, DOI 10.1016/j.vascn.2013.01.024; Shi JQ, 2013, CNS NEUROSCI THER, V19, P871, DOI 10.1111/cns.12144; Stettner M, 2011, J PERIPHER NERV SYST, V16, P250, DOI 10.1111/j.1529-8027.2011.00355.x; Svalheim S, 2008, SEIZURE-EUR J EPILEP, V17, P203, DOI 10.1016/j.seizure.2007.11.018; Svalheim S, 2015, SEIZURE-EUR J EPILEP, V28, P12, DOI 10.1016/j.seizure.2015.02.022; Svalheim S, 2009, EPILEPSY BEHAV, V16, P281, DOI 10.1016/j.yebeh.2009.07.033; Takeuchi K, 2014, J GASTROEN HEPATOL, V29, P37, DOI 10.1111/jgh.12774; Tauboll E, 2009, EPILEPSIA, V50, P1868, DOI 10.1111/j.1528-1167.2009.02131.x; Toman R., 2014, American Journal of Animal and Veterinary Sciences, V9, P194; Trivedi PP, 2010, MUTAT RES-GEN TOX EN, V703, P115, DOI 10.1016/j.mrgentox.2010.08.005; Ueda Y, 2009, BRAIN RES, V1266, P1, DOI 10.1016/j.brainres.2009.02.040; US EPA, 1996, GUIDELINES FOR REPRO; van der Horst G, 2009, BIOTECH HISTOCHEM, V84, P299, DOI 10.3109/10520290902984274; Varoglu AO, 2010, CLIN NEUROPHARMACOL, V33, P155, DOI 10.1097/WNF.0b013e3181d1e133; Verrotti A, 2011, REPROD TOXICOL, V31, P519, DOI 10.1016/j.reprotox.2011.02.002; WHO, 1999, WHO LABORATORY MANUA; Wisniewski P, 2015, TOXICOLOGY, V329, P1, DOI 10.1016/j.tox.2015.01.002; World Health Organization, WHO FACT SHEETS 2016	69	26	26	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2017	12	4							e0175990	10.1371/journal.pone.0175990	http://dx.doi.org/10.1371/journal.pone.0175990			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KH	28419133	gold, Green Published, Green Submitted			2022-12-27	WOS:000399875200060
J	Felker, ME; Bong, IW; DePuy, WH; Jihadah, LF				Felker, Mary Elizabeth; Bong, Indah Waty; DePuy, Walker Holton; Jihadah, Lina Farida			Considering land tenure in REDD plus participatory measurement, reporting, and verification: A case study from Indonesia	PLOS ONE			English	Article							SOCIAL SAFEGUARDS; CARBON GOVERNANCE; LOCAL PEOPLE; COMMUNITY; FOREST; CONSERVATION; KNOWLEDGE; PAYMENTS; SERVICES; BRAZIL	Measurement, Reporting, and Verification (MRV) systems are thought to be essential for effective carbon accounting and joint REDD+ carbon, conservation, and social development goals. Community participation in MRV (PMRV) has been shown to be both cost effective and accurate, as well as a method to potentially advance stakeholder empowerment and perceptions of legitimacy. Recognizing land tenure as a long-standing point of tension in REDD+ planning, we argue that its engagement also has a key role to play in developing a legitimate PMRV. Using household surveys, key informant interviews, and participatory mapping exercises, we present three 'lived' land tenure contexts in Indonesia to highlight their socially and ecologically situated natures and to consider the role of tenure pluralism in shaping PMRV. We then raise and interrogate three questions for incorporating lived land tenure contexts into a legitimate PMRV system: 1) Who holds the right to conduct PMRV activities?; 2) How are the impacts of PMRV differentially distributed within local communities?; and 3) What is the relationship between tenure security and motivation to participate in PMRV? We conclude with implementation lessons for REDD+ practitioners, including the benefits of collaborative practices, and point to critical areas for further research.	[Felker, Mary Elizabeth; Bong, Indah Waty; DePuy, Walker Holton; Jihadah, Lina Farida] Ctr Int Forestry Res, Bogor, Indonesia; [Felker, Mary Elizabeth] Yale Univ, Sch Forestry & Environm Studies, New Haven, CT 06511 USA; [DePuy, Walker Holton] Univ Georgia, Dept Anthropol, Athens, GA 30602 USA; [Jihadah, Lina Farida] Australian Natl Univ, Fenner Sch Environm & Soc, Canberra, ACT, Australia	CGIAR; Center for International Forestry Research (CIFOR); Yale University; University System of Georgia; University of Georgia; Australian National University	Felker, ME (corresponding author), Ctr Int Forestry Res, Bogor, Indonesia.; Felker, ME (corresponding author), Yale Univ, Sch Forestry & Environm Studies, New Haven, CT 06511 USA.	mary.felker@yale.edu			Center for International Forestry research (CIFOR) by the U.S. Agency for International Development (USAID) [MT0069018]; International Climate Initiative (IKI) of the German Federal Ministry for the Environment, Nature Conservation, Building and Nuclear Safety (BMUB); Norwegian Agency for Development Cooperation (NORAD) [GLO-3945, QZA 12/0882]	Center for International Forestry research (CIFOR) by the U.S. Agency for International Development (USAID)(United States Agency for International Development (USAID)); International Climate Initiative (IKI) of the German Federal Ministry for the Environment, Nature Conservation, Building and Nuclear Safety (BMUB); Norwegian Agency for Development Cooperation (NORAD)	This research was funded by grants to the Center for International Forestry research (CIFOR) by the U.S. Agency for International Development (USAID), http://www.usaid.gov/, through grant number MT0069018, the International Climate Initiative (IKI) of the German Federal Ministry for the Environment, Nature Conservation, Building and Nuclear Safety (BMUB), and the Norwegian Agency for Development Cooperation (NORAD), http:/www.norad.no/, through grant number GLO-3945, QZA 12/0882. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal A, 1999, WORLD DEV, V27, P629, DOI 10.1016/S0305-750X(98)00161-2; Agrawal A., 2009, REALISING REDD NATL, P201, DOI DOI 10.17528/CIFOR/002871; Aicher C, 2014, BIODIVERS CONSERV, V23, P3543, DOI 10.1007/s10531-014-0812-5; [Anonymous], 2010, PERM FOR IND ISS, P1; Babon A, 2014, ECOLOGY, V19; Badan Pusat Statistik Provinsi Jawa Tengah, 2016, JAW TENG FIG; Badan Pusat Statistik Provinsi Kalimantan Barat, 2016, KAL BAR FIG; Badan Pusat Statistik Provinsi Papua, 2016, PAP FIG; Barbier EB, 2012, FORESTS, V3, P881, DOI 10.3390/f3040881; Barr C., 2006, DECENTRALIZATION FOR; Berman PS, 2007, SOUTH CALIF LAW REV, V80, P1155; Biermann F, 2010, CURR OPIN ENV SUST, V2, P284, DOI 10.1016/j.cosust.2010.05.002; Birrell K, 2012, J HUM RIGHTS ENV SEP; Blom B, 2010, ENVIRON SCI POLICY, V13, P164, DOI 10.1016/j.envsci.2010.01.002; Boissiere M., 2007, PEOPLE PRIORITIES PE; Boissiere M, 2014, FORESTS, V5, P1855, DOI 10.3390/f5081855; Boyd W, 2010, ECOL LAW QUART, V37, P843; Chhatre A, 2012, CURR OPIN ENV SUST, V4, P654, DOI 10.1016/j.cosust.2012.08.006; Cooke B, 2001, PARTICIPATION NEW TY; Corbera E, 2012, CURR OPIN ENV SUST, V4, P612, DOI 10.1016/j.cosust.2012.09.010; Danielsen F, 2011, CONSERV LETT, V4, P158, DOI 10.1111/j.1755-263X.2010.00159.x; Dehm J, 2012, LOCAL GLOBAL, V10, P98; Dickson B, 2012, CURR OPIN ENV SUST, V4, P717, DOI 10.1016/j.cosust.2012.09.017; Doherty E, 2011, FOREST TENURE MULTIL, P66; Fogel C, 2004, EARTHLY POLITICS LOC; Fry B, 2011, ENVIRON SCI POLICY, V14, P181, DOI 10.1016/j.envsci.2010.12.004; Garnett ST, 2009, BIOTROPICA, V41, P571, DOI 10.1111/j.1744-7429.2009.00558.x; Griffiths J., 1986, J LEG PLUR, V24; Gupta A, 2012, CURR OPIN ENV SUST, V4, P726, DOI 10.1016/j.cosust.2012.10.004; Hawthorne S, PLOS ONE, V11; Holmes I, 2014, CONSERV BIOL, V28, P1380, DOI 10.1111/cobi.12301; Horowitz LS, 2010, GEOFORUM, V41, P617, DOI 10.1016/j.geoforum.2010.02.003; Hulme M, 2010, GLOBAL ENVIRON CHANG, V20, P558, DOI 10.1016/j.gloenvcha.2010.07.005; Initiative R, 2012, FOREST TENURE RIGHTS; Johnstone N, 2010, ASIAN PACIFIC LAW, V12, P93; Karsenty A, 2014, ENVIRON SCI POLICY, V35, P20, DOI 10.1016/j.envsci.2012.08.013; Kayoi M, 2006, POVERTY NATURAL RESO, P1; Krause T, 2014, ENVIRON SCI POLICY, V41, P44, DOI 10.1016/j.envsci.2014.04.015; Larrazabal A, 2012, CURR OPIN ENV SUST, V4, P707, DOI 10.1016/j.cosust.2012.10.008; Larson AM, 2012, TENURE RIGHTS ACCE 1; Larson AM, 2011, GLOBAL ENVIRON CHANG, V21, P540, DOI 10.1016/j.gloenvcha.2010.11.008; Lawry S., 2012, DEVOLUTION FOREST RI; Lederer M, 2011, ECOL ECON, V70, P1900, DOI 10.1016/j.ecolecon.2011.02.003; Leggett M, 2012, CLIM POLICY, V12, P115, DOI 10.1080/14693062.2011.579317; Li T.M., 2007, WILL IMPROVE GOVT DE; Constantino PDL, 2012, ECOL SOC, V17, DOI 10.5751/ES-05164-170422; Lowe C., 2006, WILD PROFUSION BIODI; Lyster R, 2011, ENVIRON SCI POLICY, V14, P118, DOI 10.1016/j.envsci.2010.11.008; Mahanty S, 2013, SINGAPORE J TROP GEO, V34, P188, DOI 10.1111/sjtg.12024; McGibbon R, 2004, POL STUD, V10, P1; Ministry of Forestry (MoF), 2012, FOR MAR AR MAPS W KA; Mosse D, 2004, DEV CHANGE, V35, P639, DOI 10.1111/j.0012-155X.2004.00374.x; PELUSO NL, 1995, ANTIPODE, V27, P383, DOI 10.1111/j.1467-8330.1995.tb00286.x; Phelps J, 2010, SCIENCE, V328, P312, DOI 10.1126/science.1187774; Resosudarmo IAP, 2014, WORLD DEV, V55, P68, DOI 10.1016/j.worlddev.2013.01.015; Rights and Resources Initiative, 2014, STAT FOR CARB RIGHTS; Runk JV, 2014, ECOL SOC, V19, DOI 10.5751/ES-06773-190437; Safitri M, 2011, DIVERS PATHS JUSTICE, P126; Savaresi A, 2013, ECOL SOC, V18, DOI 10.5751/ES-05549-180305; Schreckenberg K, 2006, DEV IMPACTS VERIFICA; Shankland A, 2011, IDS BULL-I DEV STUD, V42, P80, DOI 10.1111/j.1759-5436.2011.00225.x; Staddon S., 2009, Journal of Forest and Livelihood, V8, P25; Sunderlin WD, 2014, WORLD DEV, V55, P37, DOI 10.1016/j.worlddev.2013.01.013; Tamanaha BBZ., 2007, LEG STUD RES PAP SRE; Teubner G., 1997, GLOBAL LAW STATE; Thompson MC, 2011, ENVIRON SCI POLICY, V14, P100, DOI 10.1016/j.envsci.2010.11.006; Toomey AH, 2016, ECOL SOC, V21, DOI 10.5751/ES-08409-210228; Van Laake P, 2008, FCCCSBSTA2008L23; Walley CJ, 2004, ROUGH WATERS: NATURE AND DEVELOPMENT IN AN EAST AFRICAN MARINE PARK, P1; West Paige, 2006, CONSERVATION OUR GOV; Winterbottom Robert, 2014, SECURING RIGHTS COMB; Wollenberg E., 2004, WHY ARE FOREST AREAS	72	5	5	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2017	12	4							e0167943	10.1371/journal.pone.0167943	http://dx.doi.org/10.1371/journal.pone.0167943			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET0MB	28406908	Green Published, gold, Green Submitted			2022-12-27	WOS:000399955400001
J	Liu, W; Ma, LY; Qiu, B; Cui, MY; Ding, JW				Liu, Wei; Ma, Liyan; Qiu, Bo; Cui, Mingyue; Ding, Jianwei			An efficient depth map preprocessing method based on structure-aided domain transform smoothing for 3D view generation	PLOS ONE			English	Article								Depth image-based rendering (DIBR), which is used to render virtual views with a color image and the corresponding depth map, is one of the key techniques in the 2D to 3D conversion process. Due to the absence of knowledge about the 3D structure of a scene and its corresponding texture, DIBR in the 2D to 3D conversion process, inevitably leads to holes in the resulting 3D image as a result of newly-exposed areas. In this paper, we proposed a structure-aided depth map preprocessing framework in the transformed domain, which is inspired by recently proposed domain transform for its low complexity and high efficiency. Firstly, our framework integrates hybrid constraints including scene structure, edge consistency and visual saliency information in the transformed domain to improve the performance of depth map preprocess in an implicit way. Then, adaptive smooth localization is cooperated and realized in the proposed framework to further reduce over-smoothness and enhance optimization in the non-hole regions. Different from the other similar methods, the proposed method can simultaneously achieve the effects of hole filling, edge correction and local smoothing for typical depth maps in a united framework. Thanks to these advantages, it can yield visually satisfactory results with less computational complexity for high quality 2D to 3D conversion. Numerical experimental results demonstrate the excellent performances of the proposed method.	[Liu, Wei; Cui, Mingyue] Nanyang Normal Univ, Electromech Engn Coll, Nanyang, Henan, Peoples R China; [Liu, Wei; Ma, Liyan; Ding, Jianwei] Chinese Acad Sci, Ctr Internet Things, Inst Microelect, Beijing, Peoples R China; [Qiu, Bo] Hebei Univ Technol, Elect & Informat Engn Coll, Tianjin, Peoples R China; [Ding, Jianwei] Peoples Publ Secur Univ China, Informat Technol & Network Secur Coll, Beijing, Peoples R China	Nanyang Normal College; Chinese Academy of Sciences; Institute of Microelectronics, CAS; Hebei University of Technology; People's Public Security University of China	Liu, W (corresponding author), Nanyang Normal Univ, Electromech Engn Coll, Nanyang, Henan, Peoples R China.; Liu, W (corresponding author), Chinese Acad Sci, Ctr Internet Things, Inst Microelect, Beijing, Peoples R China.; Qiu, B (corresponding author), Hebei Univ Technol, Elect & Informat Engn Coll, Tianjin, Peoples R China.	lw3171796@163.com; qiubo@hebut.edu.cn			National Natural Science Foundation of China [61503202, 61402462]; Key scientific and technological project of Henan Province [152102210336]; Key scientific research project of Henan Provincial Education Department [15A413005]; Key scientific and technological project of Nanyang City [KJGG28]; Natural Science Foundation of Nanyang Normal University [ZX2015007]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key scientific and technological project of Henan Province; Key scientific research project of Henan Provincial Education Department; Key scientific and technological project of Nanyang City; Natural Science Foundation of Nanyang Normal University	This work was supported in part by National Natural Science Foundation of China (No. 61503202 and No. 61402462), Key scientific and technological project of Henan Province (No. 152102210336), Key scientific research project of Henan Provincial Education Department (No. 15A413005), Key scientific and technological project of Nanyang City (No. KJGG28) and Natural Science Foundation of Nanyang Normal University (No. ZX2015007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2017, MSR 3D VIDEO SEQUENC; Chen K., 2010, 2010 INT S SIGN SYST, V1, P1, DOI DOI 10.1103/PHYSREVC.81.044612; Chen Y, 2014, IEEE T MED IMAGING, V33, P2271, DOI 10.1109/TMI.2014.2336860; Cheng MM, 2015, IEEE T PATTERN ANAL, V37, P569, DOI 10.1109/TPAMI.2014.2345401; Daribo I, 2007, 2007 IEEE NINTH WORKSHOP ON MULTIMEDIA SIGNAL PROCESSING, P312, DOI 10.1109/MMSP.2007.4412880; Fehn C, 2004, PROC SPIE, V5599, P66, DOI 10.1117/12.583107; Fehn C, 2002, JTC1SC29WG11M ISOIEC, V9219; Fehn C., 2004, INT SOC OPTICS PHOTO, V2004, P93, DOI DOI 10.1117/12.524762; Gastal ESL, 2011, ACM T GRAPHIC, V30, DOI 10.1145/1964921.1964964; IJsselsteijn WA, 2002, P SOC PHOTO-OPT INS, P12; Kim D, 2008, IEEE T BROADCAST, V54, P188, DOI 10.1109/TBC.2007.914714; Kim MB, 2003, SIGNAL PROCESS-IMAGE, V18, P685, DOI 10.1016/S0923-5965(03)00059-6; Lee PJ, 2011, IEEE T MULTIMEDIA, V13, P246, DOI 10.1109/TMM.2010.2100372; Lee S., 2009, MEMS 2009, V2009, P3, DOI DOI 10.1038/0NC.2008.377; Li P., 2006, P 27 S INF THEOR BEN, P508; Liang-Hao Wang, 2011, Proceedings of the Sixth International Conference on Image and Graphics (ICIG 2011), P847, DOI 10.1109/ICIG.2011.68; Meesters LMJ, 2004, IEEE T CIRC SYST VID, V14, P381, DOI 10.1109/TCSVT.2004.823398; Plath N, 2013, IEEE T IMAGE PROCESS, V22, P3420, DOI 10.1109/TIP.2013.2268940; Sun WX, 2012, IEEE IMAGE PROC, P2721, DOI 10.1109/ICIP.2012.6467461; Tam W. J., 2004, OPTICS E, P162; Tao Li, 2008, 5th International Conference on Visual Information Engineering, VIE 2008, P256, DOI 10.1049/cp:20080318; Wang L, 2010, NANO RES, V3, P317, DOI DOI 10.1093/MP/SSQ042; Wei L.-Y., 2009, EUROGRAPHICS 2009 ST, P93; Woods AJ, 2002, P SOC PHOTO-OPT INS, V1915, P36; Yoon SU, 2007, IEEE T CIRC SYST VID, V17, P1450, DOI 10.1109/TCSVT.2007.905363; Yu-Cheng Fan, 2008, 2008 3DTV-Conference: The True Vision - Capture, Transmission and Display of 3D Video, P325; Zhang L, 2005, IEEE T BROADCAST, V51, P191, DOI 10.1109/TBC.2005.846190; Zhang L, 2011, IEEE T BROADCAST, V57, P372, DOI 10.1109/TBC.2011.2122930	28	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2017	12	4							e0175910	10.1371/journal.pone.0175910	http://dx.doi.org/10.1371/journal.pone.0175910			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0MB	28407027	Green Published, gold, Green Submitted			2022-12-27	WOS:000399955400107
J	Bello, A; Frei, S; Peters, M; Balkema-Buschmann, A; Baumgartner, W; Wohlsein, P				Bello, Aimara; Frei, Samuel; Peters, Martin; Balkema-Buschmann, Anne; Baumgaertner, Wolfgang; Wohlsein, Peter			Spontaneous diseases in captive ratites (Struthioniformes) in northwestern Germany: A retrospective study	PLOS ONE			English	Article							DISSECTING AORTIC-ANEURYSM; LIBYOSTRONGYLUS-DOUGLASSII; LAWSONIA-INTRACELLULARIS; OSTRICHES; CAMELUS; INFECTION; MYCOBACTERIOSIS; TRANSPORTATION; BRACHYSPIRA; SPIROCHETE	A retrospective study was carried out to define the spectrum of spontaneous diseases in ostriches and few other captive ratites, order Struthioniformes, in northwestern Germany. The investigation included 71 ratites necropsied between 1968 and 2014. They consisted of 54 ostriches, 5 emus, and 12 rheas with 37 adults, 23 juveniles and 11 neonates and embryonated eggs. Necropsy reports were reviewed, histologic preparations were re-examined and additional histochemical and immunohistochemical stains were carried out in selected cases. In many animals more than one morphologic diagnosis attributable to different disease processes was found. In adult animals (n = 37), the most commonly altered organ systems were the musculoskeletal system (49%), the digestive system (46%), and the cardiovascular system (46%) affected by traumatic lesions, inflammatory and degenerative changes, respectively. A spongy degeneration was found in the brain (35%); however, immunohistochemistry and western blotting failed to detect pathological prion protein. In juvenile animals (n = 23), the musculoskeletal (44%) and the digestive system (43%) were mainly affected by traumatic and inflammatory lesions, respectively. In embryonated eggs and neonates (n = 11) the major cause of death was circulatory failure associated with generalized subcutaneous edema as described for improper incubation conditions (64%). Summarized, most of the findings observed in adult and juvenile ratites in northwestern Germany are related to trauma, inflammatory and degenerative disorders, whereas death in embryonated eggs and neonates was most likely related to breeding conditions. A spongy encephalopathy awaits further studies to elucidate cause and pathogenesis.	[Bello, Aimara; Frei, Samuel; Baumgaertner, Wolfgang; Wohlsein, Peter] Univ Vet Med Hannover, Dept Pathol, Hannover, Lower Saxony, Germany; [Frei, Samuel] Zoo Wuppertal, Wuppertal, North Rhine Wes, Germany; [Peters, Martin] Chem & Vet Untersuchungsamt Westfalen, Arnsberg, North Rhine Wes, Germany; [Balkema-Buschmann, Anne] Friedrich Loeffler Inst, Inst Novel & Emerging Infect Dis, Insel Riems, Mecklenburg Wes, Germany	University of Veterinary Medicine Hannover, Foundation; Friedrich Loeffler Institute	Wohlsein, P (corresponding author), Univ Vet Med Hannover, Dept Pathol, Hannover, Lower Saxony, Germany.	peter.wohlsein@tiho-hannover.de			"Fundacion Gran Mariscal de Ayacucho", Venezuela; "Deutscher Akademischer Austauschdienst" (DAAD), Germany [A/12/94017]	"Fundacion Gran Mariscal de Ayacucho", Venezuela; "Deutscher Akademischer Austauschdienst" (DAAD), Germany(Deutscher Akademischer Austausch Dienst (DAAD))	A. Bello received a grant from "Fundacion Gran Mariscal de Ayacucho", Venezuela and from "Deutscher Akademischer Austauschdienst" (DAAD; A/12/94017), Germany.	Abimosleh SM, 2012, J GASTROEN HEPATOL, V27, P857, DOI 10.1111/j.1440-1746.2012.07098.x; Alexander DJ, 2000, VET MICROBIOL, V74, P3, DOI 10.1016/S0378-1135(00)00160-7; Anonymous, 2013, GESCHAFT AFRIKANISCH; [Anonymous], 2015, PATHOLOGY PET AVIARY; Baird GJ, 1997, VET REC, V140, P624, DOI 10.1136/vr.140.24.624; Baptiste KE, 1997, J AVIAN MED SURG, V11, P194; Beaufrere H, 2013, J EXOT PET MED, V22, P336, DOI 10.1053/j.jepm.2013.10.015; Brandt D, 2010, VET MICROBIOL, V146, P361, DOI 10.1016/j.vetmic.2010.05.021; Buckles EL, 1997, AVIAN DIS, V41, P144, DOI 10.2307/1592454; Cantile C, 2016, JUBB KENNEDY PALMERS, V6th, P250, DOI DOI 10.1016/B978-0-7020-5317-7.00004-7>; Charuta A, 2010, VET ZOOTECH-LITH, V52, P8; Cooper RG, 2005, ANIM SCI J, V76, P97, DOI DOI 10.1111/J.1740-0929.2005.00243.X; Cooper Ross Gordon, 2004, Animal Science Journal, V75, P89, DOI 10.1111/j.1740-0929.2004.00161.x; Deeming D.C., 1999, OSTRICH BIOL PRODUCT; Ferreras MC, 2001, AVIAN DIS, V45, P251, DOI 10.2307/1593037; FITZGERALD SD, 1995, AVIAN DIS, V39, P194, DOI 10.2307/1592003; Garcia A, 2001, J ZOO WILDLIFE MED, V32, P96, DOI 10.1638/1042-7260(2001)032[0096:MAIIAO]2.0.CO;2; Glatz PC, 2011, ANIM WELFARE SER, V11, P111, DOI 10.1007/978-3-642-19297-5_6; Gordo FP, 2002, VET PARASITOL, V107, P137; GRAHAM CLG, 1977, AVIAN DIS, V21, P113, DOI 10.2307/1589369; Guedes RMC, 2003, J VET DIAGN INVEST, V15, P438, DOI 10.1177/104063870301500506; Hicks-Alldredge K, 1998, VET CLIN N AM-FOOD A, V14, P437, DOI 10.1016/S0749-0720(15)30230-9; HOBERG EP, 1995, J PARASITOL, V81, P85, DOI 10.2307/3284011; Huchzermeyer FW, 2002, REV SCI TECH OIE, V21, P265, DOI 10.20506/rst.21.2.1334; Huchzermeyer FW, 1998, DISEASES OSTRICHES R; IUCN, IUCN RED LIST THREAT; Jeengar MK, 2015, NUTRITION, V31, P21, DOI 10.1016/j.nut.2014.04.004; Kelly P, 2013, AVIAN DIS, V57, P808, DOI 10.1637/10581-052313-Case.1; Korbel R, 2015, TIERAERZTL PRAX G N, V43, P232, DOI 10.15653/TPG-150490; Kosters J, 1996, DEUT TIERARZTL WOCH, V103, P100; Kummrow M.S., 2015, FOWLERS ZOO WILD ANI, VVolume 8, P75; Landman WJM, 2001, TIJDSCHR DIERGENEESK, V126, P484; Lemarchand TX, 1997, VET PATHOL, V34, P152, DOI 10.1177/030098589703400209; Macwhirter Patricia, 1994, P842; Mappley LJ, 2014, VET MICROBIOL, V168, P245, DOI 10.1016/j.vetmic.2013.11.019; McOrist S., 2012, DIS SWINE, P811; Menon DG, 2014, J OF ANIMALS, V2014; Minka NS, 2008, VET REC, V162, P846, DOI 10.1136/vr.162.26.846; MITCHINSON MJ, 1977, J COMP PATHOL, V87, P27, DOI 10.1016/0021-9975(77)90076-7; Neumann, 2007, 4 INT C COL SPIR INF; Nicholls JM, 2012, J VIROL METHODS, V179, P409, DOI 10.1016/j.jviromet.2011.11.006; Pocknell AM, 1996, VET PATHOL, V33, P346, DOI 10.1177/030098589603300314; Priemer G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067599; Reavill Drury R, 2004, Vet Clin North Am Exot Anim Pract, V7, P537, DOI 10.1016/j.cvex.2004.04.008; Reiner G., 2000, STRAUSSENHALTUNG DEU; Riedelsheimer B., 2010, ROMEIS MIKROSKOPISCH, P181; Rigter A, 2007, BMC BIOCH, V8, P1; Robinson NJ, 2017, J MAR BIOL ASSOC UK, V97, P1233, DOI 10.1017/S0025315416000734; SAGARTZ JE, 1992, AVIAN DIS, V36, P282, DOI 10.2307/1591502; Samson J, 1997, CAN VET J, V38, P425; Schoon H.-A., 1991, Erkrankungen der Zootiere, P309; Schoon H.-A., 1991, Tieraerztliche Praxis, V19, P263; Schulze C, 2006, DEUT TIERARZTL WOCH, V113, P240; Schwab S, 2007, J COMP PATHOL, V136, P96, DOI 10.1016/j.jcpa.2006.11.006; Shane S. M., 1996, RATITE MANAGEMENT ME; Shane SM, 1998, VET CLIN N AM-FOOD A, V14, P455, DOI 10.1016/S0749-0720(15)30231-0; Speer Brian L., 1996, P147; Spraker TR, 2002, J VET DIAGN INVEST, V14, P3, DOI 10.1177/104063870201400102; Stewart James, 1994, P1284; Tully TN, 2009, HDB AVIAN MED, P258; Vandevelde M, 2012, VET NEUROPATHOLOGY E, P182; VANHOOSER SL, 1994, VET HUM TOXICOL, V36, P226; Verwoerd DJ, 2000, REV SCI TECH OIE, V19, P638, DOI 10.20506/rst.19.2.1235; Wells GAH, 2007, PRIONS IN HUMANS AND ANIMALS, P279; Willems H, 2010, BERL MUNCH TIERARZTL, V123, P205, DOI 10.2376/0005-9366-123-205; Wohlsein P, 2011, VET MICROBIOL, V149, P456, DOI 10.1016/j.vetmic.2010.11.024; Wohr AC, 2005, DEUT TIERARZTL WOCH, V112, P87; Wotton SB, 1999, VET REC, V145, P725, DOI 10.1136/vr.145.25.725; Wyss F, 2010, MANGANESE DEFICIENCY	69	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2017	12	4							e0173873	10.1371/journal.pone.0173873	http://dx.doi.org/10.1371/journal.pone.0173873			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LZ	28403205	Green Published, gold, Green Submitted			2022-12-27	WOS:000399955200009
J	Bhandare, S; Goldberg, DS; Dowell, R				Bhandare, Shweta; Goldberg, Debra S.; Dowell, Robin			Discriminating between HuR and TTP binding sites using the k-spectrum kernel method (vol 12, e0174052, 2017)	PLOS ONE			English	Correction															University of Colorado Boulder Libraries Open Access Fund	University of Colorado Boulder Libraries Open Access Fund	The following information is missing from the Funding section of the paper: Publication of this article was funded by the University of Colorado Boulder Libraries Open Access Fund.	Bhandare S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174052	1	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2017	12	4							e0175988	10.1371/journal.pone.0175988	http://dx.doi.org/10.1371/journal.pone.0175988			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LZ	28403197	Green Published, gold, Green Submitted			2022-12-27	WOS:000399955200095
J	Campbell, ML; Bryant, DEP; Hewitt, CL				Campbell, Marnie L.; Bryant, Dominic E. P.; Hewitt, Chad L.			Biosecurity messages are lost in translation to citizens: Implications for devolving management to citizens	PLOS ONE			English	Article							MARINE BIOSECURITY; SCIENCE; VOLUNTEERS; QUALITY; SPREAD	The increasing focus of marine biosecurity agencies on transferring management responsibilities to citizens and industry begs the question whether devolved responsibility is a viable option for creating biosecurity outcomes. We examined recreational marine users' self-declared awareness of non-indigenous marine species (NIMS) at six locations in Tasmania, Australia and evaluated the accuracy of their awareness through recognition of four well-known NIMS with active awareness campaigns. We also investigated whether the activities of recreational marine users influence the accuracy of their NIMS recognition skills. We generally found that respondents declare NIMS awareness (70.45%), yet we found their recognition accuracy was variable ranging from low to fair (< 10% to 54.95%) and recreational activity did not influence accuracy. Based on our results, we conclude that marine users' awareness does not predict accuracy and therefore devolved management of biosecurity without additional resources may pose a risky biosecurity management strategy.	[Campbell, Marnie L.; Bryant, Dominic E. P.; Hewitt, Chad L.] Univ Tasmania, Natl Ctr Marine Conservat & Resource Sustainabil, Locked Bag 1370, Newnham, Tas 1370, Australia; [Campbell, Marnie L.] Univ Waikato, Environm Res Inst, Hamilton, New Zealand; [Hewitt, Chad L.] Univ Waikato, Sch Sci, Hamilton, New Zealand	University of Tasmania; University of Waikato; University of Waikato	Campbell, ML (corresponding author), Univ Tasmania, Natl Ctr Marine Conservat & Resource Sustainabil, Locked Bag 1370, Newnham, Tas 1370, Australia.; Campbell, ML (corresponding author), Univ Waikato, Environm Res Inst, Hamilton, New Zealand.	mcampbel@waikato.ac.nz	Hewitt, Chad L/J-2105-2019	Hewitt, Chad L/0000-0002-6859-6512; Campbell, Marnie/0000-0002-8716-0036				Anderson LG, 2012, PLOS ONE, V9; [Anonymous], 2001, GREAT RESHUFFLING HU; Barker K, 2010, T I BRIT GEOGR, V35, P350, DOI 10.1111/j.1475-5661.2010.00386.x; Beale R., 2008, ONE BIOSECURITY WORK; Bryant DEP, 2011, THESIS; Burgman M.A., 2001, AUSTRALAS J ENV MAN, V8, P219, DOI [10.1080/14486563.2001.10648532, DOI 10.1080/14486563.2001.10648532]; Campbell ML, 2008, ICES J MAR SCI, V65, P795, DOI 10.1093/icesjms/fsn083; Campbell ML, 2007, MAR POLLUT BULL, V55, P360, DOI 10.1016/j.marpolbul.2007.01.015; Campbell ML, 2016, MANAG BIOL INVASION, V7, P351, DOI 10.3391/mbi.2016.7.4.05; Campbell ML, 2015, MANAG BIOL INVASION, V6, P227, DOI 10.3391/mbi.2015.6.3.01; Campbell ML, 2011, ENVIRON RES, V111, P989, DOI 10.1016/j.envres.2011.02.004; Cliff N, 2012, AQUAT INVASIONS, V7, P387, DOI 10.3391/ai.2012.7.3.010; Cohn JP, 2008, BIOSCIENCE, V58, P192, DOI 10.1641/B580303; Crall AW, 2011, CONSERV LETT, V4, P433, DOI 10.1111/j.1755-263X.2011.00196.x; Crowl TA, 2008, FRONT ECOL ENVIRON, V6, P238, DOI 10.1890/070151; Dahlstrom A, 2012, AQUAT INVASIONS, V7, P567, DOI 10.3391/ai.2012.7.4.013; Dahlstrom A, 2011, MAR POLICY, V35, P208, DOI 10.1016/j.marpol.2010.10.001; Darwall WRT, 1996, BIOL CONSERV, V78, P223, DOI 10.1016/0006-3207(95)00147-6; Davidson AD, 2016, PLOS ONE, V10; Delaney DG, 2008, BIOL INVASIONS, V10, P117, DOI 10.1007/s10530-007-9114-0; Dresser C, 2013, BIOL INVASIONS, V15, P1049, DOI 10.1007/s10530-012-0349-z; Finn PG, 2010, ENVIRON CONSERV, V37, P83, DOI 10.1017/S0376892910000251; Grumbine RE, 1997, CONSERV BIOL, V11, P41, DOI 10.1046/j.1523-1739.1997.95479.x; Hall CM, 2005, TOURISM MANAGE, V26, P931, DOI 10.1016/j.tourman.2004.06.011; Hewitt CL, 2007, MAR POLLUT BULL, V55, P395, DOI 10.1016/j.marpolbul.2007.01.005; Hewitt CL, 2004, NEW ZEAL J MAR FRESH, V38, P429, DOI 10.1080/00288330.2004.9517250; Hourston M, 2015, MANAG BIOL INVASION, V6, P243, DOI 10.3391/mbi.2015.6.3.03; Kellert SR, 2000, SOC NATUR RESOUR, V13, P705, DOI 10.1080/089419200750035575; Meinzen-Dick R., 1999, WORKSHOP D; More SJ, 2010, PREV VET MED, V95, P198, DOI 10.1016/j.prevetmed.2010.04.011; Noss R. F., 1994, SAVING NATURES LEGAC; Riesch H, 2014, PUBLIC UNDERST SCI, V23, P107, DOI 10.1177/0963662513497324; Ruiz GM, 2000, ANNU REV ECOL SYST, V31, P481, DOI 10.1146/annurev.ecolsys.31.1.481; Shackleton S., 2002, ODI Natural Resource Perspectives; Tasmanian Biosecurity Committee, 2012, TASM BIOS STRAT 2013; Uusitalo L, 2007, ECOL MODEL, V203, P312, DOI 10.1016/j.ecolmodel.2006.11.033; [No title captured], DOI DOI 10.1002/FFEJ.10044	37	16	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2017	12	4							e0175439	10.1371/journal.pone.0175439	http://dx.doi.org/10.1371/journal.pone.0175439			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET0LZ	28403207	Green Submitted, Green Published, gold			2022-12-27	WOS:000399955200067
J	Fu, WC; Opazo, MA; Acuna, SM; Toledo, PG				Fu, Wei-Chun; Opazo, Mauricio A.; Acuna, Sergio M.; Toledo, Pedro G.			New route for self-assembly of alpha-lactalbumin nanotubes and their use as templates to grow silver nanotubes	PLOS ONE			English	Article							PROTEASE-INDUCED AGGREGATION; METAL NANOWIRES; PEPTIDE; FABRICATION; PROTEINS; BOVINE; NANOSTRUCTURES; NANOTECHNOLOGY; GELATION; FIBRILS	Nanotubes are formed by self-assembly of alpha-lactalbumin milk protein following a different route than established for the hydrolysis which involves V8 enzyme, phosphate buffer and appropriate amounts of calcium at neutral pH. The resulting nanotubes are used as templates for the growth of conductive silver nanotubes. TEM, SEM-EDS, AFM and FTIR are used for characterization.	[Fu, Wei-Chun; Opazo, Mauricio A.; Acuna, Sergio M.] Univ Bio Bio, Dept Food Engn, Ave Andres Bello S-N, Chillan, Chile; [Toledo, Pedro G.] Univ Concepcion, Dept Chem Engn, Correo 3, Concepcion, Chile; [Toledo, Pedro G.] Univ Concepcion, Lab Surface Anal, Correo 3, Concepcion, Chile	Universidad del Bio-Bio; Universidad de Concepcion; Universidad de Concepcion	Toledo, PG (corresponding author), Univ Concepcion, Dept Chem Engn, Correo 3, Concepcion, Chile.; Toledo, PG (corresponding author), Univ Concepcion, Lab Surface Anal, Correo 3, Concepcion, Chile.	petoledo@udec.cl	Acuña, Sergio M./N-3875-2019; Acuña, Sergio M./D-4071-2016; Toledo, Pedro/R-6094-2017	Acuña, Sergio M./0000-0003-1365-9851; Acuña, Sergio M./0000-0003-1365-9851; Toledo, Pedro/0000-0003-2863-7997	Fondecyt Project [1090781]; Centro CRHIAM Conicyt/Fondap Project [15130015]	Fondecyt Project(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Centro CRHIAM Conicyt/Fondap Project	We thank the finantial support of Fondecyt Project 1090781 and Centro CRHIAM Conicyt/Fondap Project 15130015.; We thank the support of Fondecyt Project 1090781 and Centro CRHIAM Conicyt/Fondap Project 15130015. We thank Gerardo Cabello for the SEM-EDS analysis.	Banerjee IA, 2003, P NATL ACAD SCI USA, V100, P14678, DOI 10.1073/pnas.2433456100; Braun E, 1998, NATURE, V391, P775, DOI 10.1038/35826; Bull SR, 2005, NANO LETT, V5, P1, DOI 10.1021/nl0484898; Carny O, 2006, NANO LETT, V6, P1594, DOI 10.1021/nl060468l; Djalali R, 2002, J AM CHEM SOC, V124, P13660, DOI 10.1021/ja028261r; Domigan Laura J, 2013, Methods Mol Biol, V996, P131, DOI 10.1007/978-1-62703-354-1_8; Gazit E, 2007, CHEM SOC REV, V36, P1263, DOI 10.1039/b605536m; Gazit E, 2007, FEBS J, V274, P317, DOI 10.1111/j.1742-4658.2006.05605.x; Gazit E, 2007, PRION, V1, P32, DOI 10.4161/pri.1.1.4095; Graveland-Bikker JF, 2006, TRENDS FOOD SCI TECH, V17, P196, DOI 10.1016/j.tifs.2005.12.009; Graveland-Bikker JF, 2006, NANO LETT, V6, P616, DOI 10.1021/nl052205h; Graveland-Bikker JF, 2006, J APPL CRYSTALLOGR, V39, P180, DOI 10.1107/S0021889805043 244; Graveland-Bikker JF, 2004, LANGMUIR, V20, P6841, DOI 10.1021/la049579v; Ipsen R, 2001, MILCHWISSENSCHAFT, V56, P492; Ipsen R, 2001, J DAIRY RES, V68, P277, DOI 10.1017/S0022029901004769; Ipsen R, 2007, BIOTECHNOL ADV, V25, P602, DOI 10.1016/j.biotechadv.2007.07.006; KRONMAN MJ, 1989, CRIT REV BIOCHEM MOL, V24, P565, DOI 10.3109/10409238909080054; Li, 2005, ANGEW CHEM, V117, P1867; Malisauskas M, 2008, BIOTECHNOL PROGR, V24, P1166, DOI 10.1002/btpr.49; Matsui H, 2000, J PHYS CHEM B, V104, P9576, DOI 10.1021/jp000762g; Matsui H, 2000, J PHYS CHEM B, V104, P3383, DOI 10.1021/jp994117p; Matsui H, 2001, NANO LETT, V1, P461, DOI 10.1021/nl015564v; Otte J, 2005, INT DAIRY J, V15, P219, DOI 10.1016/j.idairyj.2004.07.004; Otte J, 1996, J FOOD SCI, V61, P911, DOI 10.1111/j.1365-2621.1996.tb10900.x; Otte J, 2004, J DAIRY RES, V71, P88, DOI 10.1017/S0022029903006617; Petrov A, 2012, WIRES NANOMED NANOBI, V4, P575, DOI 10.1002/wnan.1180; Rajagopal K, 2004, CURR OPIN STRUC BIOL, V14, P480, DOI 10.1016/j.sbi.2004.06.006; Reches M, 2003, SCIENCE, V300, P625, DOI 10.1126/science.1082387; SEGAWA T, 1983, J BIOCHEM-TOKYO, V93, P1321, DOI 10.1093/oxfordjournals.jbchem.a134266; Song YJ, 2004, CHEM COMMUN, P1044, DOI 10.1039/b402126f; Taton TA, 2003, NAT MATER, V2, P73, DOI 10.1038/nmat824; Zhang SG, 2003, NAT BIOTECHNOL, V21, P1171, DOI 10.1038/nbt874; Zhang SG, 2002, CURR OPIN CHEM BIOL, V6, P865, DOI 10.1016/S1367-5931(02)00391-5	33	7	8	4	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2017	12	4							e0175680	10.1371/journal.pone.0175680	http://dx.doi.org/10.1371/journal.pone.0175680			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LZ	28403179	Green Published, gold, Green Submitted			2022-12-27	WOS:000399955200090
J	Malhotra, R; Kurian, N; Zhou, XH; Jiang, FY; Monkley, S; DeMicco, A; Clausen, IG; Dellgren, G; Edenro, G; Ahdesmaki, MJ; Clausen, M; Oberg, L; Israelsson, E; Belfield, G; Vaarala, O				Malhotra, Rajneesh; Kurian, Nisha; Zhou, Xiao-Hong; Jiang, Fanyi; Monkley, Susan; DeMicco, Amy; Clausen, Ib G.; Dellgren, Goeran; Edenro, Goran; Ahdesmaeki, Miika J.; Clausen, Maryam; Oeberg, Lisa; Israelsson, Elisabeth; Belfield, Graham; Vaarala, Outi			Altered regulation and expression of genes by BET family of proteins in COPD patients (vol 12, e0173115, 2017)	PLOS ONE			English	Correction													Kurian, Nisha/AAE-9279-2020	Kurian, Nisha/0000-0002-8384-9928; Monkley, Susan/0000-0001-9174-6278				Malhotra R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173115	1	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2017	12	4							e0175997	10.1371/journal.pone.0175997	http://dx.doi.org/10.1371/journal.pone.0175997			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LZ	28403235	Green Submitted, gold, Green Published			2022-12-27	WOS:000399955200097
J	DeFilippis, AP; Trainor, PJ; Hill, BG; Amraotkar, AR; Rai, SN; Hirsch, GA; Rouchka, EC; Bhatnagar, A				DeFilippis, Andrew P.; Trainor, Patrick J.; Hill, Bradford G.; Amraotkar, Alok R.; Rai, Shesh N.; Hirsch, Glenn A.; Rouchka, Eric C.; Bhatnagar, Aruni			Identification of a plasma metabolomic signature of thrombotic myocardial infarction that is distinct from non-thrombotic myocardial infarction and stable coronary artery disease	PLOS ONE			English	Article							PLATELET-ACTIVATING-FACTOR; IN-VIVO; CIRCADIAN VARIATION; CALCIFIED NODULE; PLAQUE EROSION; CLASSIFICATION; ISCHEMIA; PLASMINOGEN; ELEVATION; DIAGNOSIS	Aims Current non-invasive diagnostics for acute myocardial infarction (MI) identify myocardial necrosis rather than the primary cause and therapeutic target-plaque disruption and resultant thrombosis. The aim of this study was to identify changes specific to plaque disruption and pathological thrombosis that are distinct from acute myocardial necrosis. Methods and results We quantified 1,032 plasma metabolites by mass spectrometry in 11 thrombotic MI, 12 non-thrombotic MI, and 15 stable coronary artery disease (CAD) subjects at two acute phase (time of catheterization [T0], six hours [T6]) and one quiescent (> 3 months follow- up) time points. A statistical classifier was constructed utilizing baseline (T0) abundances of a parsimonious set of 17 qualifying metabolites. Qualifying metabolites were those that demonstrated a significant change between the quiescent phase and the acute phase and that were distinct from any change seen in non-thrombotic MI or stable CAD subjects. Classifier performance as estimated by 10-foldcross-validation was suggestive of high sensitivity and specificity for differentiating thrombotic from non-thrombotic MI and stable CAD subjects at presentation. Nineteen metabolites demonstrated an intra-subject change from time of acute thrombotic MI presentation to the quiescent state that was distinct from any change measured in both the non-thrombotic MI and stable CAD subjects undergoing cardiac catheterization over the same time course (false discovery rate < 5%). Conclusions We have identified a candidate metabolic signature that differentiates acute thrombotic MI from quiescent state after MI, from acute non-thrombotic MI, and from stable CAD. Further validation of these metabolites is warranted given their potential as diagnostic biomarkers and novel therapeutic targets for the prevention or treatment of acute MI.	[DeFilippis, Andrew P.; Hill, Bradford G.; Amraotkar, Alok R.; Hirsch, Glenn A.; Bhatnagar, Aruni] Univ Louisville, Diabet & Obes Ctr, Dept Med, Div Cardiovascr Med, Louisville, KY 40292 USA; [DeFilippis, Andrew P.] Johns Hopkins Univ, Baltimore, MD USA; [Trainor, Patrick J.] Univ Louisville, Dept Med, Div Bioinformat, Louisville, KY 40292 USA; [Rai, Shesh N.] Univ Louisville, Dept Bioinformat & Biostat, Louisville, KY 40292 USA; [Rouchka, Eric C.] Univ Louisville, Dept Comp Engn & Comp Sci, Louisville, KY 40292 USA	University of Louisville; Johns Hopkins University; University of Louisville; University of Louisville; University of Louisville	DeFilippis, AP (corresponding author), Univ Louisville, Diabet & Obes Ctr, Dept Med, Div Cardiovascr Med, Louisville, KY 40292 USA.	APDeFi01@louisville.edu	Hill, Bradford/I-4154-2013	Hill, Bradford/0000-0001-5332-8286; DeFilippis, Andrew/0000-0002-5135-9748; Trainor, Patrick/0000-0002-3012-9716	American Heart Association [11CRP7300003]; National Institutes of Health [1P20 GM103492]; National Institute of Health [1P20 GM103492, HL130174]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL130174] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103436, P20GM103492] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a grant from the American Heart Association [11CRP7300003]; and the National Institutes of Health [1P20 GM103492].; We would like to thank all of the subjects who generously consented to participate in this study. This work was supported by a grant from the American Heart Association [11CRP7300003]; and the National Institute of Health [1P20 GM103492 and HL130174].	Amsterdam EA, 2014, J AM COLL CARDIOL, V64, P2713, DOI 10.1016/j.jacc.2014.10.011; [Anonymous], 2002, J ROY STAT SOC, V64, P479; Arbab-Zadeh A, 2015, J AM COLL CARDIOL, V65, P846, DOI 10.1016/j.jacc.2014.11.041; BAIN RJI, 1989, INT J CARDIOL, V25, P69, DOI 10.1016/0167-5273(89)90164-2; Batta Kiran, 2007, Subcell Biochem, V41, P193; Blackmore PF, 2008, STEROIDS, V73, P738, DOI 10.1016/j.steroids.2008.02.008; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Brereton RG, 2009, CHEMOMETRICS PATTERN, pxvii; Brotman DJ, 2007, LANCET, V370, P1089, DOI 10.1016/S0140-6736(07)61305-1; COSGRIFF SW, 1951, JAMA-J AM MED ASSOC, V147, P924, DOI 10.1001/jama.1951.03670270014006; DeFilippis AP, 2016, J THROMB THROMBOLYS, V42, P61, DOI 10.1007/s11239-015-1292-5; DeFilippis AP, 2013, CIRC J, V77, P2786, DOI 10.1253/circj.CJ-12-1421; Diaz-Uriarte R, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-3; Eisen A, 2016, JAMA CARDIOLOGY; Hammarsten O, 2012, CLIN CHEM, V58, P628, DOI 10.1373/clinchem.2011.171496; Hand DJ, 2012, INT STAT REV, V80, P400, DOI 10.1111/j.1751-5823.2012.00183.x; Hastie T., 2009, ELEMENTS STAT LEARNI, V2nd ed.; Higuma T, 2015, JACC-CARDIOVASC INTE, V8, P1166, DOI 10.1016/j.jcin.2015.02.026; (HMDB) THMD, 2015, MET STAT; ISACSON S, 1970, SCAND J HAEMATOL, V7, P212; Jia HB, 2013, J AM COLL CARDIOL, V62, P1748, DOI 10.1016/j.jacc.2013.05.071; Keller T, 2009, NEW ENGL J MED, V361, P868, DOI 10.1056/NEJMoa0903515; KIM DK, 1991, AM J PHYSIOL, V260, pH1767, DOI 10.1152/ajpheart.1991.260.6.H1767; KONKLE BA, 1992, BLOOD, V79, P2636; Leor J, 1996, NEW ENGL J MED, V334, P413, DOI 10.1056/NEJM199602153340701; Lewis GD, 2008, J AM COLL CARDIOL, V52, P117, DOI 10.1016/j.jacc.2008.03.043; Li SQ, 1998, ACTA PHARMACOL SIN, V19, P493; Maisel A, 2013, J AM COLL CARDIOL, V62, P150, DOI 10.1016/j.jacc.2013.04.011; MASON JW, 1988, J NERV MENT DIS, V176, P498, DOI 10.1097/00005053-198808000-00008; McCarty MF, 2009, MED HYPOTHESES, V73, P263, DOI 10.1016/j.mehy.2008.12.021; MULLER JE, 1985, NEW ENGL J MED, V313, P1315, DOI 10.1056/NEJM198511213132103; MULLER JE, 1989, CIRCULATION, V79, P733, DOI 10.1161/01.CIR.79.4.733; Nater UM, 2013, CURR OPIN PSYCHIATR, V26, P440, DOI 10.1097/YCO.0b013e328363b4ed; Newby LK, 2012, J AM COLL CARDIOL, V60, P2427, DOI 10.1016/j.jacc.2012.08.969; NINIO E, 1982, BIOCHIM BIOPHYS ACTA, V710, P23, DOI 10.1016/0005-2760(82)90185-0; PATRASSI GM, 1992, BLOOD COAGUL FIBRIN, V3, P789, DOI 10.1097/00001721-199212000-00013; Pitts Stephen R, 2008, Natl Health Stat Report, P1; Pope JH, 2000, NEW ENGL J MED, V342, P1163, DOI 10.1056/NEJM200004203421603; Sabatine MS, 2016, JAMA-J AM MED ASSOC, V315, P2525, DOI 10.1001/jama.2016.6110; Sarkisian L, 2016, AM J MED, V129, P506, DOI 10.1016/j.amjmed.2015.12.009; SCHEIN RMH, 1990, CRIT CARE MED, V18, P259, DOI 10.1097/00003246-199003000-00002; Shimada T, 2005, J ENDOCRINOL, V184, P381, DOI 10.1677/joe.1.05937; Starheim KK, 2012, TRENDS BIOCHEM SCI, V37, P152, DOI 10.1016/j.tibs.2012.02.003; SUN JZ, 1993, CIRC RES, V73, P534, DOI 10.1161/01.RES.73.3.534; Tatum JL, 1997, ANN EMERG MED, V29, P116, DOI 10.1016/S0196-0644(97)70317-2; Thygesen K, 2012, GLOB HEART, V7, DOI 10.1016/j.gheart.2012.08.001; Van Damme P, 2011, FEBS J, V278, P3822, DOI 10.1111/j.1742-4658.2011.08230.x; Varmuza K, 2009, INTRO MULTIVARIATE S, pxiii; Virmani R, 2000, ARTERIOSCL THROM VAS, V20, P1262, DOI 10.1161/01.ATV.20.5.1262	50	20	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2017	12	4							e0175591	10.1371/journal.pone.0175591	http://dx.doi.org/10.1371/journal.pone.0175591			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KD	28414761	Green Published, Green Submitted, gold			2022-12-27	WOS:000399874800039
J	Li, GH; Zhou, Q; Qiu, LP; Yao, Q; Chen, KP; Tang, Q; Hu, ZY				Li, Guohui; Zhou, Qian; Qiu, Lipeng; Yao, Qin; Chen, Keping; Tang, Qi; Hu, Zhaoyang			Serine protease Bm-SP142 was differentially expressed in resistant and susceptible Bombyx mori strains, involving in the defence response to viral infection	PLOS ONE			English	Article							PARALYTIC PEPTIDE; ANALYSIS REVEALS; INSECT CYTOKINE; GENE-EXPRESSION; SILKWORM; IDENTIFICATION; BIDENSOVIRUS; PROTEINS; GENOME	Bm-SP142 is a 35 kDa protease in the silkworm, but its exact functions remain unknown. In this study, sequence alignment revealed that the His-Asp-Ser catalytic triad is embedded in the TAAHC-DIAL-GDSGGP sequence motif, establishing Bm-SP142 as a serine protease. Soluble recombinant GST-BmSP142 was expressed and purified, and serine protease activity was confirmed in vitro. RT-qPCR results indicated that Bm-SP142 was mainly expressed in the middle part of the silkworm midgut, and Bm-SP142 transcripts were significantly up-regulated at 24 hours post infection (hpi) in BmBDV-resistant strains (798) inoculated with BmBDV and BmNPV-resistant strains (NB) inoculated with BmNPV, but not in BmBDV-susceptible strains (306). Surprisingly, transcripts were significantly down-regulated at 12 hpi in BmNPV-susceptible strains (HuaBa 35) inoculated with BmNPV, compared with healthy silkworms. Recombinant BmNPV treated with purified Bm-SP142 effectively impaired its ability to infect BmN cells, and Bm-SP142 decreases the efficiency of BmNPV and BmBDV propagation in silkworms. Furthermore, overexpression of Bm-SP142 in BmN cells inhibited viral propagation.	[Li, Guohui; Zhou, Qian; Qiu, Lipeng; Yao, Qin; Chen, Keping; Tang, Qi; Hu, Zhaoyang] Jiangsu Univ, Inst Life Sci, Zhenjiang, Peoples R China	Jiangsu University	Tang, Q; Hu, ZY (corresponding author), Jiangsu Univ, Inst Life Sci, Zhenjiang, Peoples R China.	tangqi1224@163.com; sunnyhu163@163.com	Qiu, Lipeng/E-1079-2018	Qiu, Lipeng/0000-0003-4382-0976	National Natural Science Foundation of China [31270192, 31402016, 31570150]; Postdoctoral Research in Jiangsu Province [1501070C]; Youth Foundation of Jiangsu University [FCJJ2015028]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Postdoctoral Research in Jiangsu Province; Youth Foundation of Jiangsu University	This work was supported by the National Natural Science Foundation of China (nos. 31270192, 31402016 and 31570150), Postdoctoral Research in Jiangsu Province (1501070C), a project supported by the Youth Foundation of Jiangsu University (FCJJ2015028). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao YY, 2013, FEBS J, V280, P939, DOI 10.1111/febs.12088; Chen HQ, 2012, INTERVIROLOGY, V55, P21, DOI 10.1159/000322381; Cheng Y, 2014, J INSECT SCI, V14, DOI 10.1093/jis/14.1.76; Duan J, 2010, NUCLEIC ACIDS RES, V38, pD453, DOI 10.1093/nar/gkp801; Fujiyuki T, 2012, DRUG DISCOV THER, V6, P88, DOI 10.5582/ddt.2012.v6.2.88; Goldsmith MR, 2005, ANNU REV ENTOMOL, V50, P71, DOI 10.1146/annurev.ento.50.071803.130456; Hu ZY, 2016, J BASIC MICROB, V56, P1338, DOI 10.1002/jobm.201600120; Hu ZY, 2013, CHINESE SCI BULL, V58, P4528, DOI 10.1007/s11434-013-5876-1; Ishii K, 2015, ARCH INSECT BIOCHEM, V88, P18, DOI 10.1002/arch.21215; Ishii K, 2010, J BIOL CHEM, V285, P28635, DOI 10.1074/jbc.M110.138446; Jiang L, 2014, INSECT BIOCHEM MOLEC, V48, P1, DOI 10.1016/j.ibmb.2014.02.003; Jiang L, 2012, ARCH VIROL, V157, P1323, DOI 10.1007/s00705-012-1309-8; Lee YS, 2004, INSECT MOL BIOL, V13, P65, DOI 10.1111/j.1365-2583.2004.00462.x; Li GH, 2016, J INVERTEBR PATHOL, V133, P66, DOI 10.1016/j.jip.2015.12.006; Li GH, 2013, CURR MICROBIOL, V66, P527, DOI 10.1007/s00284-013-0306-9; Li WX, 2016, J PROTEOME RES, V15, P1810, DOI 10.1021/acs.jproteome.5b01127; Liu TH, 2016, SCI REP-UK, V6, DOI 10.1038/srep28946; Liu W, 2013, SILK CHINESE, V5, P72; Lu E P, 2013, PLOS ONE, V8; Lv M, 2011, INTERVIROLOGY, V54, P37, DOI 10.1159/000318888; Marques JT, 2016, CURR OPIN MICROBIOL, V32, P71, DOI 10.1016/j.mib.2016.05.002; Nwibo DD, 2015, DRUG DISCOV THER, V9, P133, DOI 10.5582/ddt.2015.01026; Page MJ, 2008, CELL MOL LIFE SCI, V65, P1220, DOI 10.1007/s00018-008-7565-9; Ponnuvel KM, 2003, J VIROL, V77, P10725, DOI 10.1128/JVI.77.19.10725-10729.2003; Qin LG, 2012, J PROTEOMICS, V75, P3630, DOI 10.1016/j.jprot.2012.04.015; Ruiz-Perez F, 2014, CELL MOL LIFE SCI, V71, P745, DOI 10.1007/s00018-013-1355-8; Shi XZ, 2014, INSECT BIOCHEM MOLEC, V52, P102, DOI 10.1016/j.ibmb.2014.06.010; Srinivasan A, 2006, CELL MOL BIOL LETT, V11, P132, DOI 10.2478/s11658-006-0012-8; Tang Q, 2013, J INVERTEBR PATHOL, V113, P70, DOI 10.1016/j.jip.2013.01.006; Veillard F, 2016, BIOCHIMIE, V122, P255, DOI 10.1016/j.biochi.2015.10.007; Viljakainen L, 2015, BRIEF FUNCT GENOMICS, V14, P407, DOI 10.1093/bfgp/elv002; Yamakawa M, 1999, DEV COMP IMMUNOL, V23, P281, DOI 10.1016/S0145-305X(99)00011-7; Zhao P, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-405; Zhou Y, 2013, GENOMICS, V101, P256, DOI 10.1016/j.ygeno.2013.02.004; Zou Z, 2006, INSECT MOL BIOL, V15, P603, DOI 10.1111/j.1365-2583.2006.00684.x	35	18	19	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2017	12	4							e0175518	10.1371/journal.pone.0175518	http://dx.doi.org/10.1371/journal.pone.0175518			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KD	28414724	Green Published, Green Submitted, gold			2022-12-27	WOS:000399874800031
J	Mbongwe, B; Tapera, R; Phaladze, N; Lord, A; Zetola, NM				Mbongwe, Bontle; Tapera, Roy; Phaladze, Nthabiseng; Lord, Andrew; Zetola, Nicola M.			Predictors of smoking among primary and secondary school students in Botswana	PLOS ONE			English	Article							ADOLESCENT SMOKING; CIGARETTE-SMOKING; TOBACCO USE; COLLEGE-STUDENTS; INITIATION; SURVEILLANCE; PNEUMONIA; YOUTH; RISK; AGE	This study seeks to determine the prevalence and risk factors for smoking among students aged 12-18 years in two cities in Botswana. Using a sample of 2554 students we adapted the Global Youth Tobacco Survey (GYTS) methodology to assess students' smoking practices, knowledge, beliefs and attitudes. Logistic regression models were used to evaluate factors associated with smoking. The results revealed that 10% of students were current tobacco smokers with 29% reporting having tried smoking. Self-image and acceptance by peers were the strongest predictors of smoking overall (adjusted Odds Ratio [aOR]: 3.13, 95%, Confidence Interval [CI]: 2.67-3.66). Intention to smoke or to continue to smoke and perceived norms in conformity with smoking were also independently associated with smoking (aOR: 1.81, 95% CI: 167-2.11 and aOR: 1.31, 95% CI: 1.10-1.57, respectively). Perceived prevalence and exposure to smoking by peers and family and access to tobacco products was stronger among females (aOR: 1.69, 95% CI: 1.52-1.91) compared to males (aOR: 0.93, 95% CI: 0.70-1.24). Our results indicate that anti-tobacco interventions in Botswana should prioritize intra-personal factors associated with smoking. Our findings also suggest that different interventions targeting male and female students should be explored.	[Mbongwe, Bontle; Tapera, Roy] Univ Botswana, Dept Environm Hlth, Gaborone, Botswana; [Phaladze, Nthabiseng] Univ Botswana, Sch Nursing, Gaborone, Botswana; [Lord, Andrew] Good Business, London, England; [Zetola, Nicola M.] Univ Penn, Dept Radiat Oncol, Philadelphia, PA 19104 USA	University of Botswana; University of Botswana; University of Pennsylvania	Mbongwe, B (corresponding author), Univ Botswana, Dept Environm Hlth, Gaborone, Botswana.	bontle.mbongwe@gmail.com	Mbongwe, Bontle/AAF-9888-2021	Mbongwe, Bontle/0000-0002-3839-1225	Bill & Melinda Gates Foundation [OPP1082662]	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This work was supported by the Bill & Melinda Gates Foundation, Grant Number OPP1082662 to BM. Good Business provided support in the form of salary for author AL. The funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the 'author contributions'section.	Ali MM, 2009, J ADOLESCENT HEALTH, V45, P402, DOI 10.1016/j.jadohealth.2009.02.004; Ariza-Cardenal C, 2002, HEALTH EDUC RES, V17, P750, DOI 10.1093/her/17.6.750; Biener L, 2000, AM J PUBLIC HEALTH, V90, P407, DOI 10.2105/AJPH.90.3.407; Breslau N, 1996, AM J PUBLIC HEALTH, V86, P214, DOI 10.2105/AJPH.86.2.214; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P842; Distefan JM, 1998, J ADOLESCENT HEALTH, V22, P466, DOI 10.1016/S1054-139X(98)00013-5; Doku D, 2010, AFR HEALTH SCI, V10, P201; Ekanem I, 2010, J COMMUNITY MED PRIM, V22; Everett SA, 1999, PREV MED, V29, P327, DOI 10.1006/pmed.1999.0560; Faeh D, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-169; Fooks GJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080864; Gilman SE, 2009, PEDIATRICS, V123, pE274, DOI 10.1542/peds.2008-2251; Gordin FM, 2008, AM J RESP CRIT CARE, V178, P630, DOI 10.1164/rccm.200804-617OC; HIRSCHTICK RE, 1995, NEW ENGL J MED, V333, P845, DOI 10.1056/NEJM199509283331305; Hoving C, 2007, PREV MED, V44, P485, DOI 10.1016/j.ypmed.2007.02.011; Jaquet A, 2009, INT J TUBERC LUNG D, V13, P1433; KANDEL DB, 1995, J RES ADOLESCENCE, V5, P225, DOI 10.1207/s15327795jra0502_4; Kaplan CP, 2001, ADDICT BEHAV, V26, P531, DOI 10.1016/S0306-4603(00)00143-X; Keetile M, 2014, J GLOBAL EC, V2014; Khader Y, 2008, SMOKING HABITS U STU; Lee S, 2012, CANCER CAUSE CONTROL, V23, P117, DOI 10.1007/s10552-012-9914-0; Madkour AS, 2014, TOB CONTROL, V23, P244, DOI 10.1136/tobaccocontrol-2012-050593; Ng M, 2014, JAMA-J AM MED ASSOC, V311, P183, DOI 10.1001/jama.2013.284692; Masisi EKM, 2011, OCCASION ANTITOBACCO; Mbongwe B, 2004, COUNTRY REPROT TOBAC; McGinnis JM, 1999, P ASSOC AM PHYSICIAN, V111, P109, DOI 10.1046/j.1525-1381.1999.09256.x; Morgenstern M, 2013, AM J PREV MED, V44, P339, DOI 10.1016/j.amepre.2012.11.037; Narain R, 2011, INDIAN J MED RES, V133, P300; Page RM, 2011, ADDICT BEHAV, V36, P470, DOI 10.1016/j.addbeh.2011.01.008; Peltzer K., 2011, AFRICAN HLTH SCI, V11; PIERCE JP, 1994, JAMA-J AM MED ASSOC, V271, P608, DOI 10.1001/jama.271.8.608; Primack BA, 2007, ARCH PEDIAT ADOL MED, V161, P434, DOI 10.1001/archpedi.161.5.434; Rigotti NA, 2000, JAMA-J AM MED ASSOC, V284, P699, DOI 10.1001/jama.284.6.699; Saloojee Y, 2004, TOBACCO PUBLIC HLTH, P267; Simons-Morton B, 2001, HEALTH EDUC BEHAV, V28, P95, DOI 10.1177/109019810102800109; Smith C, 1992, HEALTH PROMOT J AUST, V2, P41; Townsend L, 2006, J SUBST USE, V11, P245, DOI DOI 10.1080/14659890500420004; Townsend L, 2006, DRUG ALCOHOL DEPEN, V84, P14, DOI 10.1016/j.drugalcdep.2005.12.008; Warren Charles W., 2008, Morbidity and Mortality Weekly Report, V57, P1; Warren CW, 2000, B WORLD HEALTH ORGAN, V78, P868; Wechsler H, 1998, JAMA-J AM MED ASSOC, V280, P1673, DOI 10.1001/jama.280.19.1673; World Health Organization, 1999, CONFRONTING THE EPID, V14, P192; World Health Organization, 2015, EC HLTH BEN TOB TAX; World Health Organization-WHO, 2013, WHO REP GLOB TOB EP; Zavaleta A, 2008, BMC PUBLIC HEALTH, V8, P1; Zhang L, 2000, HEALTH EDUC RES, V15, P415, DOI 10.1093/her/15.4.415; Zulu R, 2008, MED J ZAMBIA, V35	47	16	16	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2017	12	4							e0175640	10.1371/journal.pone.0175640	http://dx.doi.org/10.1371/journal.pone.0175640			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES9KD	28414757	Green Published, gold			2022-12-27	WOS:000399874800042
J	Stadnikova, A; Dudakova, L; Skalicka, P; Valenta, Z; Filipec, M; Jirsova, K				Stadnikova, Andrea; Dudakova, Lubica; Skalicka, Pavlina; Valenta, Zdenek; Filipec, Martin; Jirsova, Katerina			Active transforming growth factor-beta 2 in the aqueous humor of posterior polymorphous corneal dystrophy patients	PLOS ONE			English	Article							TGF-BETA-2 LEVELS; ENDOTHELIAL-CELLS; EPITHELIAL-CELLS; EXPRESSION; MUTATIONS; ZEB1; GENE; IDENTIFICATION; INHIBITION; PHENOTYPES	Purpose Posterior polymorphous corneal dystrophy (PPCD) is characterized by abnormal proliferation of corneal endothelial cells. It was shown that TGF-beta 2 present in aqueous humor (AH) could help maintaining the corneal endothelium in a G1-phase-arrest state. We wanted to determine whether the levels of this protein are changed in AH of PPCD patients. Methods We determined the concentrations of active TGF-beta 2 in the AH of 29 PPCD patients (42 samples) and 40 cadaver controls (44 samples) by ELISA. For data analysis the PPCD patients were divided based on either the molecular genetic cause of their disease as PPCD1 (37 samples), PPCD3 (1 sample) and PPCDx (not linked to a known PPCD loci, 4 samples) or on the presence (17 samples) or absence (25 samples) of secondary glaucoma or on whether they had undergone penetrating keratoplasty (PK, 32 samples) or repeated PK (rePK, 7 samples). Results The level of active TGF-beta 2 in the AH of all PPCD patients (mean +/- SD; 386.98 +/- 114.88 pg/ml) in comparison to the control group (260.95 +/- 112.43 pg/ml) was significantly higher (P = 0.0001). Compared to the control group, a significantly higher level of active TGF-beta 2 was found in the PPCD1 (P = 0.0005) and PPCDx (P = 0.0022) groups. Among patients the levels of active TGF beta 2 were not significantly affected by gender, age, secondary glaucoma or by the progression of dystrophy when one or repeated PK were performed. Conclusion The levels of active TGF-beta 2 in the AH of PPCD patients are significantly higher than control values, and thus the increased levels of TGF-beta 2 could be a consequence of the PPCD phenotype and can be considered as another feature characterizing this disease.	[Stadnikova, Andrea; Dudakova, Lubica; Jirsova, Katerina] Charles Univ Prague, Fac Med 1, Inst Inherited Metab Disorders, Lab Biol & Pathol Eye, Prague, Czech Republic; [Stadnikova, Andrea; Dudakova, Lubica; Skalicka, Pavlina; Jirsova, Katerina] Gen Univ Hosp Prague, Prague, Czech Republic; [Skalicka, Pavlina] Charles Univ Prague, Fac Med 1, Dept Ophthalmol, Prague, Czech Republic; [Valenta, Zdenek] Czech Acad Sci, Inst Comp Sci, Dept Med Informat & Biostat, Prague, Czech Republic; [Filipec, Martin] European Eye Clin Lexum, Prague, Czech Republic	Charles University Prague; General University Hospital Prague; Charles University Prague; Czech Academy of Sciences; Institute of Computer Science of the Czech Academy of Sciences	Jirsova, K (corresponding author), Charles Univ Prague, Fac Med 1, Inst Inherited Metab Disorders, Lab Biol & Pathol Eye, Prague, Czech Republic.; Jirsova, K (corresponding author), Gen Univ Hosp Prague, Prague, Czech Republic.	katerina.jirsova@lf1.cuni.cz	Stadnikova, Andrea/J-4054-2017; Dudakova, Lubica/F-4781-2017; Valenta, Zdenek/E-5094-2011; Skalicka, Pavlina/N-5716-2017; Jirsova, Katerina/B-8301-2012	Stadnikova, Andrea/0000-0002-3571-3946; Dudakova, Lubica/0000-0003-4718-8955; Valenta, Zdenek/0000-0001-7119-9764; Jirsova, Katerina/0000-0002-4625-6701; Skalicka, Pavlina/0000-0002-7403-3433	Norwegian Financial Mechanism; Ministry of Education, Youth and Sports [MSMT-28477/2014, 7F14156]; program of the Charles University [PROGRES-Q26/LF1]; Institute of Computer Science [RVO: 67985807]; UNCE [204011/2012]; GACR [17-12355S]	Norwegian Financial Mechanism; Ministry of Education, Youth and Sports(Ministry of Education, Youth & Sports - Czech Republic); program of the Charles University; Institute of Computer Science; UNCE; GACR(Grant Agency of the Czech Republic)	The research leading to these results has received funding from the Norwegian Financial Mechanism 2009-2014 and the Ministry of Education, Youth and Sports under Project Contract no. MSMT-28477/2014, project 7F14156 (AS, KJ). This study was further supported by the PROGRES-Q26/LF1 program of the Charles University (KJ, LD). ZV was supported by the long-term strategic development financing of the Institute of Computer Science (RVO: 67985807). LD was supported by UNCE 204011/2012 and GACR 17-12355S.	Agarwal P, 2015, MOL VIS, V21, P612; Annes JP, 2003, J CELL SCI, V116, P217, DOI 10.1242/jcs.00229; Bahrami B, 2011, J APPL MICROBIOL, V110, P353, DOI 10.1111/j.1365-2672.2010.04889.x; Biswas S, 2001, HUM MOL GENET, V10, P2415, DOI 10.1093/hmg/10.21.2415; Chen KH, 1999, INVEST OPHTH VIS SCI, V40, P2513; Chen YY, 2013, HUM MOL GENET, V22, P1271, DOI 10.1093/hmg/dds527; CIBIS GW, 1977, ARCH OPHTHALMOL-CHIC, V95, P1529; Davidson AE, 2016, AM J HUM GENET, V98, P75, DOI 10.1016/j.ajhg.2015.11.018; DEBOER JH, 1994, INVEST OPHTH VIS SCI, V35, P3702; Dekaris I, 2001, CROAT MED J, V42, P650; Enomoto K, 2006, INVEST OPHTH VIS SCI, V47, P4330, DOI 10.1167/iovs.05-1581; Evans CJ, 2015, ANN HUM GENET, V79, P1, DOI 10.1111/ahg.12090; FOETS BJJ, 1992, BRIT J OPHTHALMOL, V76, P205, DOI 10.1136/bjo.76.4.205; HAYASHI K, 1986, GRAEF ARCH CLIN EXP, V224, P452, DOI 10.1007/BF02173362; HELBIG H, 1991, GRAEF ARCH CLIN EXP, V229, P84, DOI 10.1007/BF00172268; HENRIQUEZ AS, 1984, SURV OPHTHALMOL, V29, P139, DOI 10.1016/0039-6257(84)90171-1; Jirsova K, 2007, EXP EYE RES, V84, P680, DOI 10.1016/j.exer.2006.12.006; Jirsova K, 2010, EXP EYE RES, V91, P623, DOI 10.1016/j.exer.2010.08.002; Joko T, 2013, EXP EYE RES, V108, P23, DOI 10.1016/j.exer.2012.11.018; Joyce NC, 2012, EXP EYE RES, V95, P16, DOI 10.1016/j.exer.2011.08.014; Joyce NC, 2002, INVEST OPHTH VIS SCI, V43, P2152; Joyce NC, 1997, INVEST OPHTH VIS SCI, V38, P1922; Kim TY, 2001, INVEST OPHTH VIS SCI, V42, P3142; Krachmer J H, 1985, Trans Am Ophthalmol Soc, V83, P413; Krafchak CM, 2005, AM J HUM GENET, V77, P694, DOI 10.1086/497348; Kubiczkova L, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-183; LaGier AJ, 2007, INVEST OPHTH VIS SCI, V48, P1061, DOI 10.1167/iovs.06-0772; Liskova P, 2007, HUM MUTAT, V28, DOI 10.1002/humu.9495; Liskova P, 2016, EUR J HUM GENET, V24, P985, DOI 10.1038/ejhg.2015.232; Liskova P, 2013, JAMA OPHTHALMOL, V131, P1296, DOI 10.1001/jamaophthalmol.2013.405; Liskova P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045495; Liskova P, 2010, OPHTHALMIC GENET, V31, P230, DOI 10.3109/13816810.2010.518577; Maier P, 2008, EYE, V22, P569, DOI 10.1038/sj.eye.6703028; Maier P, 2007, MOL VIS, V13, P1198; Maier P, 2006, MOL VIS, V12, P1477; Merjava S, 2011, HISTOCHEM CELL BIOL, V136, P93, DOI 10.1007/s00418-011-0830-2; Merjava S, 2009, EXP EYE RES, V88, P945, DOI 10.1016/j.exer.2008.12.017; NISHIDA K, 1995, CURR EYE RES, V14, P235, DOI 10.3109/02713689509033520; PASQUALE LR, 1993, INVEST OPHTH VIS SCI, V34, P23; Principe DR, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/djt369; R Core Team, 2014, R FDN STAT COMP; RAPHAEL B, 1993, INVEST OPHTH VIS SCI, V34, P2305; Roca H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076773; RODRIGUES MM, 1980, INVEST OPHTH VIS SCI, V19, P832; Roy O, 2015, INVEST OPHTH VIS SCI, V56, P1228, DOI 10.1167/iovs.14-16166; SCHULTZ G, 1992, CORNEA, V11, P20, DOI 10.1097/00003226-199201000-00003; Threlkeld A B, 1994, Trans Am Ophthalmol Soc, V92, P133; Travis MA, 2014, ANNU REV IMMUNOL, V32, P51, DOI 10.1146/annurev-immunol-032713-120257; TRIPATHI RC, 1994, EXP EYE RES, V58, P523, DOI 10.1006/exer.1994.1046; Verrecchia F, 2002, J INVEST DERMATOL, V118, P211, DOI 10.1046/j.1523-1747.2002.01641.x; WARING GO, 1982, ARCH OPHTHALMOL-CHIC, V100, P122, DOI 10.1001/archopht.1982.01030030124015; Wen FQ, 2002, AM J RESP CELL MOL, V26, P484, DOI 10.1165/ajrcmb.26.4.4784	52	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2017	12	4							e0175509	10.1371/journal.pone.0175509	http://dx.doi.org/10.1371/journal.pone.0175509			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KD	28414732	Green Submitted, Green Published, gold			2022-12-27	WOS:000399874800030
J	Wang, P; Huang, Z				Wang, Pu; Huang, Zhen			A unified approach for determining the ultimate strength of RC members subjected to combined axial force, bending, shear and torsion	PLOS ONE			English	Article							SOFTENED TRUSS MODEL; STRESS-FIELD MODEL; REINFORCED-CONCRETE; MOMENT	This paper uses experimental investigation and theoretical derivation to study the unified failure mechanism and ultimate capacity model of reinforced concrete (RC) members under combined axial, bending, shear and torsion loading. Fifteen RC members are tested under different combinations of compressive axial force, bending, shear and torsion using experimental equipment designed by the authors. The failure mechanism and ultimate strength data for the four groups of tested RC members under different combined loading conditions are investigated and discussed in detail. The experimental research seeks to determine how the ultimate strength of RC members changes with changing combined loads. According to the experimental research, a unified theoretical model is established by determining the shape of the warped failure surface, assuming an appropriate stress distribution on the failure surface, and considering the equilibrium conditions. This unified failure model can be reasonably and systematically changed into well-known failure theories of concrete members under single or combined loading. The unified calculation model could be easily used in design applications with some assumptions and simplifications. Finally, the accuracy of this theoretical unified model is verified by comparisons with experimental results.	[Wang, Pu; Huang, Zhen] Shanghai Jiao Tong Univ, Sch Naval Architecture Ocean & Civil Engn, Shanghai, Peoples R China	Shanghai Jiao Tong University	Huang, Z (corresponding author), Shanghai Jiao Tong Univ, Sch Naval Architecture Ocean & Civil Engn, Shanghai, Peoples R China.	zhenhuang@sjtu.edu.cn			National Natural Science Foundation of China [51178265]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The authors acknowledge the National Natural Science Foundation of China for its financial support of this research project (No. 51178265).	Collins MP., 1973, TORQUE TWIST CHRACTE, P211; Gvozdev AA., 1968, RES REINFORCED CONCR; Hsu T. T. C., 2010, UNIFIED THEORY CONCR; HSU TTC, 1988, ACI STRUCT J, V85, P624; Huang L, 2013, ACI STRUCT J, V110, P127; Huang Z, 2007, J BRIDGE ENG, V12, P494, DOI 10.1061/(ASCE)1084-0702(2007)12:4(494); Huang Z, 2006, J BRIDGE ENG, V11, P59, DOI 10.1061/(ASCE)1084-0702(2006)11:1(59); Mitchell D, 1974, ACI J, V71; Nielsen M.P., 2011, LIMIT ANAL CONCRETE, V3rd ed); Pang XBD, 1996, ACI STRUCT J, V93, P197; Panjehpour M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130734; Rahal KN, 1996, ACI STRUCT J, V93, P658; Rossi PP, 2013, ENG STRUCT, V57, P339, DOI 10.1016/j.engstruct.2013.09.006; Rossi PP, 2013, J STRUCT ENG, V139, P915, DOI 10.1061/(ASCE)ST.1943-541X.0000724; Vecchio F, 1981, STRESS STRAIN CHARAC; Vecchio FJ, 2000, J STRUCT ENG-ASCE, V126, P1070, DOI 10.1061/(ASCE)0733-9445(2000)126:9(1070); VECCHIO FJ, 1986, J AM CONCRETE I, V83, P219; Vecchio FJ, 2001, J STRUCT ENG, V127, P12, DOI 10.1061/(ASCE)0733-9445(2001)127:1(12); Wang P, 2014, INT C SUST DEV CRIT	19	0	0	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2017	12	4							e0175834	10.1371/journal.pone.0175834	http://dx.doi.org/10.1371/journal.pone.0175834			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KD	28414777	Green Submitted, Green Published, gold			2022-12-27	WOS:000399874800064
J	Yoon, K; Jeong, WK; Kim, Y; Kim, MY; Kim, TY; Sohn, JH				Yoon, Kibo; Jeong, Woo Kyoung; Kim, Yongsoo; Kim, Min Yeong; Kim, Tae Yeob; Sohn, Joo Hyun			2-dimensional shear wave elastography: Interobserver agreement and factors related to interobserver discrepancy	PLOS ONE			English	Article							LIVER FIBROSIS; TRANSIENT ELASTOGRAPHY; RHEUMATOID-ARTHRITIS; HEPATITIS-C; STIFFNESS; RELIABILITY; REPRODUCIBILITY; ELASTICITY; ACCURACY; ARFI	Purpose To evaluate the interobserver reproducibility of two-dimensional shear wave elastography (2D-SWE) in measuring liver stiffness (LS) and to investigate factors related to liver 2D-SWE. Materials and methods A prospective study was conducted between August 2011 and August 2012 in rheumatoid arthritis patients who had been treated with methotrexate. Interobserver reproducibility of 2D-SWE was evaluated, and the relationship between interobserver difference in LS and related factors was analyzed using linear regression analyses. We considered age, sex, alanine transaminase, cholesterol, body mass index (BMI), and waist circumference as clinical factors, and the mean value of standard deviation (SDM), its difference between two examiners, mean diameter of the regions of interest (ROIM), and its difference in the elasticity map as investigation factors. The cut-off value for significant factors to predict interobserver discrepancies in LS-based fibrosis stage was also inspected. Results In total, 176 patients were enrolled. The intraclass correlation coefficient between the two examiners was 0.784. In the univariate analysis, SDM and ROIM were independently associated with interobserver differences in LS as well as BMI, waist circumference, and the difference of ROI, but SDM and ROIM were the only ones significantly related in multivariate analysis (p<0.001 and p = 0.021, respectively). The best cut-off value for SDM in predicting interobserver discrepancy in LS-based fibrosis stage was 1.4. Conclusions Interobserver reproducibility of 2D-SWE for measuring LS was good and SDM was the most significantly associated factor with interobserver differences in LS and interobserver discordance in LS-based fibrosis stage.	[Yoon, Kibo; Kim, Yongsoo] Hanyang Univ, Hanyang Univ Gun Hosp, Dept Radiol, Guri, Gyeonggi, South Korea; [Jeong, Woo Kyoung; Kim, Min Yeong] Sungkyunkwan Univ, Samsung Med Ctr, Sch Med, Dept Radiol, Seoul, South Korea; [Jeong, Woo Kyoung; Kim, Min Yeong] Sungkyunkwan Univ, Samsung Med Ctr, Sch Med, Ctr Imaging Sci, Seoul, South Korea; [Kim, Tae Yeob; Sohn, Joo Hyun] Hanyang Univ, Hanyang Univ Gun Hosp, Coll Med, Dept Internal Med, Guri, Gyeonggi, South Korea	Hanyang University; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Hanyang University	Jeong, WK (corresponding author), Sungkyunkwan Univ, Samsung Med Ctr, Sch Med, Dept Radiol, Seoul, South Korea.; Jeong, WK (corresponding author), Sungkyunkwan Univ, Samsung Med Ctr, Sch Med, Ctr Imaging Sci, Seoul, South Korea.	jeongwk@gmail.com	Jeong, Woo Kyoung/ABE-7025-2021	Jeong, Woo Kyoung/0000-0002-0676-2116				Arena U, 2012, DIGEST LIVER DIS, V44, P149, DOI 10.1016/j.dld.2011.08.013; Bavu E, 2011, ULTRASOUND MED BIOL, V37, P1361, DOI 10.1016/j.ultrasmedbio.2011.05.016; Bilgili Y, 2004, AM J NEURORADIOL, V25, P108; Bota S, 2013, LIVER INT, V33, P1138, DOI 10.1111/liv.12240; Cassinotto C, 2014, J HEPATOL, V61, P550, DOI 10.1016/j.jhep.2014.04.044; Choi SH, 2016, ULTRASONICS, V72, P158, DOI 10.1016/j.ultras.2016.08.005; Ferraioli G, 2012, HEPATOLOGY, V56, P2125, DOI 10.1002/hep.25936; Ferraioli G, 2012, EUR J RADIOL, V81, P3102, DOI 10.1016/j.ejrad.2012.05.030; Fraquelli M, 2007, GUT, V56, P968, DOI 10.1136/gut.2006.111302; Hollerieth K, 2016, ULTRASONOGRAPHY, V35, P345, DOI 10.14366/usg.16024; Hudson JM, 2013, ULTRASOUND MED BIOL, V39, P950, DOI 10.1016/j.ultrasmedbio.2012.12.011; Janssens F, 2010, J CLIN GASTROENTEROL, V44, P575, DOI 10.1097/MCG.0b013e3181cb4216; Jeong JY, 2014, WORLD J GASTROENTERO, V20, P13920, DOI 10.3748/wjg.v20.i38.13920; Jeong WK, 2014, ULTRASONOGRAPHY, V33, P149, DOI 10.14366/usg.14003; Jiang TA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157219; Jung KS, 2012, CLIN MOL HEPATOL, V18, P163, DOI 10.3350/cmh.2012.18.2.163; Kim SU, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032233; Kim TY, 2015, J ULTRAS MED, V34, P1621, DOI 10.7863/ultra.15.14.10035; Neukam K, 2010, EUR J GASTROEN HEPAT, V22, P801, DOI 10.1097/MEG.0b013e328331a5d0; Pellot-Barakat C, 2016, EUR J RADIOL, V85, P1645, DOI 10.1016/j.ejrad.2016.07.001; Rousselet MC, 2005, HEPATOLOGY, V41, P257, DOI 10.1002/hep.20535; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Staugaard B, 2016, SCAND J GASTROENTERO, V51, P1354, DOI 10.1080/00365521.2016.1193217; Thiele M, 2016, ULTRASCHALL MED; Wong GLH, 2015, CLIN MOL HEPATOL, V21, P200, DOI 10.3350/cmh.2015.21.3.200; Woo H, 2015, RADIOLOGY, V277, P881, DOI 10.1148/radiol.2015141975	26	9	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2017	12	4							e0175747	10.1371/journal.pone.0175747	http://dx.doi.org/10.1371/journal.pone.0175747			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KD	28414822	Green Published, Green Submitted, gold			2022-12-27	WOS:000399874800052
J	Li, JN; Jia, XY; Wang, YQ; Xie, C; Jiang, TJ; Cui, Z; Zhao, MH				Li, Jian-nan; Jia, Xiaoyu; Wang, Yongqiang; Xie, Can; Jiang, Taijiao; Cui, Zhao; Zhao, Ming-hui			Plasma from patients with anti-glomerular basement membrane disease could recognize microbial peptides	PLOS ONE			English	Article							T-CELL EPITOPE; MOLECULAR MIMICRY; GOODPASTURE AUTOANTIGEN; LINEAR EPITOPES; ALPHA-3 CHAIN; NC1 DOMAIN; ANTIBODIES; GBM; ASSOCIATION; GLOMERULONEPHRITIS	Infection has long been suspected as a trigger of autoimmune diseases, and molecular mimicry mechanism was hypothesized in this study. Microbe originated peptides were searched from the Uniprot database based on a previous defined critical amino acid motif within alpha 3(129-150), isoleucine137, tryptophan140, glycine142, phenylalanine 143 and phenylalanine 145. 23826 microbial peptides were identified using our searching strategy, among which seven were related with human infections. Circulating IgG and IgM antibodies against the seven microbial peptides were detected using ELISA in 76 patients with anti-GBM disease. Four peptides were recognized by both IgG and IgM antibodies, and one peptide was recognized by IgG antibodies only. Peptides from Bacteroides, Saccharomyces cerevisiae, and Bifidobacterium thermophilum possessed the highest recognition frequency with the prevalence of 73.7%, 61.8% and 67.1% for IgG, 56.6%, 44.7% and 67.1% for IgM in anti-GBM patients. Patients with antibodies against these microbial peptides showed more severe kidney injury, including higher serum creatinine and higher percentage of crescent formation. In conclusion, antibodies against microbial peptides were identified in the circulation of anti-GBM patients, implying its etiological role in eliciting autoimmune response against alpha 3(IV)NC1 through molecular mimicry.	[Li, Jian-nan; Jia, Xiaoyu; Cui, Zhao; Zhao, Ming-hui] Peking Univ, Hosp 1, Dept Med, Renal Div, Beijing, Peoples R China; [Li, Jian-nan; Jia, Xiaoyu; Cui, Zhao; Zhao, Ming-hui] Peking Univ, Inst Nephrol, Beijing, Peoples R China; [Li, Jian-nan; Jia, Xiaoyu; Cui, Zhao; Zhao, Ming-hui] Minist Hlth China, Key Lab Renal Dis, Beijing, Peoples R China; [Li, Jian-nan; Jia, Xiaoyu; Cui, Zhao; Zhao, Ming-hui] Minist Educ China, Key Lab CKD Prevent & Treatment, Beijing, Peoples R China; [Wang, Yongqiang; Jiang, Taijiao] Chinese Acad Sci, Inst Biophys, Key Lab Prot & Peptide Pharmaceut, Beijing, Peoples R China; [Xie, Can] Peking Univ, Sch Life Sci, State Key Lab Membrane Biol, Lab Mol Biophys, Beijing, Peoples R China; [Jiang, Taijiao] Chinese Acad Med Sci, Inst Basic Med Sci, Ctr Syst Med, Beijing, Peoples R China; [Jiang, Taijiao] Peking Union Med Coll, Beijing, Peoples R China; [Jiang, Taijiao] Suzhou Inst Syst Med, Suzhou, Jiangsu, Peoples R China; [Zhao, Ming-hui] Peking Tsinghua Ctr Life Sci, Beijing, Peoples R China	Peking University; Peking University; Ministry of Education, China; Chinese Academy of Sciences; Institute of Biophysics, CAS; Peking University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Cui, Z (corresponding author), Peking Univ, Hosp 1, Dept Med, Renal Div, Beijing, Peoples R China.; Cui, Z (corresponding author), Peking Univ, Inst Nephrol, Beijing, Peoples R China.; Cui, Z (corresponding author), Minist Hlth China, Key Lab Renal Dis, Beijing, Peoples R China.; Cui, Z (corresponding author), Minist Educ China, Key Lab CKD Prevent & Treatment, Beijing, Peoples R China.	cuizhao@bjmu.edu.cn	Cui, Zhao/ABZ-9262-2022; Li, Jiannan/AAD-2792-2022	Cui, Zhao/0000-0002-5837-1926; Li, Jiannan/0000-0003-4023-690X; Xie, Can/0000-0002-7412-3236	National Natural Science Foundation of China [81330020, 81400703]; Natural Science Fund of China to the Innovation Research Group [81621092]; National Natural Science Fund of China [81370801]; Natural Science Fund of China [81622009]; National Basic Research Program of China [2015CB910501]; Fundamental Research Funds for the Central Universities [2015RC310003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Fund of China to the Innovation Research Group; National Natural Science Fund of China(National Natural Science Foundation of China (NSFC)); Natural Science Fund of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by National Natural Science Foundation of China (CN) 81330020, Mr. Ming-hui Zhao; National Natural Science Foundation of China (CN) 81400703, Ms. Xiaoyu Jia; Natural Science Fund of China to the Innovation Research Group 81621092, Mr. Minghui Zhao; National Natural Science Fund of China 81370801, Mrs. Zhao Cui; Natural Science Fund of China to the Outstanding Young Scholar 81622009, Mrs. Zhao Cui; National Basic Research Program of China 2015CB910501, Mr. Taijiao Jiang, Fundamental Research Funds for the Central Universities 2015RC310003, Mr. Taijiao Jiang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aas-Hanssen K, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00382; Arends J, 2006, J IMMUNOL, V176, P1252, DOI 10.4049/jimmunol.176.2.1252; Bachmaier K, 1999, SCIENCE, V283, P1335, DOI 10.1126/science.283.5406.1335; Benoist C, 2001, NAT IMMUNOL, V2, P797, DOI 10.1038/ni0901-797; Borza DB, 2000, J BIOL CHEM, V275, P6030, DOI 10.1074/jbc.275.8.6030; Cairns LS, 2003, J AM SOC NEPHROL, V14, P2801, DOI 10.1097/01.ASN.0000091588.80007.0E; Chang DY, 2012, CLIN J AM SOC NEPHRO, V7, P1293, DOI 10.2215/CJN.13071211; Chen JL, 2013, CLIN J AM SOC NEPHRO, V8, P51, DOI 10.2215/CJN.05140512; Couser WG, 2014, KIDNEY INT, V86, P905, DOI 10.1038/ki.2014.49; Cusick MF, 2012, CLIN REV ALLERG IMMU, V42, P102, DOI [10.1007/s12016-011-8293-8, 10.1007/s12016-011-8294-7]; DAVIES DJ, 1982, BMJ-BRIT MED J, V285, P606, DOI 10.1136/bmj.285.6342.606; DERRY CJ, 1995, CLIN EXP IMMUNOL, V100, P262; Draborg AH, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/370516; Farris AD, 2000, CELL MOL LIFE SCI, V57, P569, DOI 10.1007/PL00000719; Goodpasture EW, 2009, AM J MED SCI, V338, P148, DOI 10.1097/MAJ.0b013e31818fff94; Harkiolaki M, 2009, IMMUNITY, V30, P348, DOI 10.1016/j.immuni.2009.01.009; Hellmark T, 1997, J AM SOC NEPHROL, V8, P376; JAYNE DRW, 1990, KIDNEY INT, V37, P965, DOI 10.1038/ki.1990.72; Jia XY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123277; Jia XY, 2012, CLIN J AM SOC NEPHRO, V7, P926, DOI 10.2215/CJN.09930911; Kain R, 2008, NAT MED, V14, P1088, DOI 10.1038/nm.1874; Li JN, 2016, CLIN J AM SOC NEPHRO, V11, P568, DOI 10.2215/CJN.05270515; Li ZQ, 2004, GENE DEV, V18, P1, DOI 10.1101/gad.1161904; Luo H, 2011, BMC NEPHROL, V12, DOI 10.1186/1471-2369-12-21; Lyons PA, 2012, NEW ENGL J MED, V367, P214, DOI 10.1056/NEJMoa1108735; Merkel F, 1996, KIDNEY INT, V49, P1127, DOI 10.1038/ki.1996.163; OLDSTONE MBA, 1987, CELL, V50, P819, DOI 10.1016/0092-8674(87)90507-1; Ooi JD, 2013, J AM SOC NEPHROL, V24, P419, DOI 10.1681/ASN.2012070705; Papavasiliou F, 1997, SCIENCE, V278, P298, DOI 10.1126/science.278.5336.298; Pedchenko V, 2010, NEW ENGL J MED, V363, P343, DOI 10.1056/NEJMoa0910500; Pendergraft WF, 2004, NAT MED, V10, P72, DOI 10.1038/nm968; Phelps RG, 1999, KIDNEY INT, V56, P1638, DOI 10.1046/j.1523-1755.1999.00720.x; PUDIFIN DJ, 1994, CLIN EXP IMMUNOL, V97, P48, DOI 10.1111/j.1365-2249.1994.tb06578.x; Robertson J, 2005, KIDNEY INT, V68, P1061, DOI 10.1111/j.1523-1755.2005.00498.x; Ruhl G, 2016, NEUROL-NEUROIMMUNOL, V3, DOI 10.1212/NXI.0000000000000241; Salama AD, 2001, LANCET, V358, P917, DOI 10.1016/S0140-6736(01)06077-9; Salama AD, 2001, J AM SOC NEPHROL, V12, P1908, DOI 10.1681/ASN.V1291908; SAVIGE JA, 1990, CLIN EXP IMMUNOL, V82, P238; SESSO RCC, 1986, CLIN NEPHROL, V26, P55; SHORT AK, 1995, AM J KIDNEY DIS, V26, P439, DOI 10.1016/0272-6386(95)90489-1; STEGEMAN CA, 1994, ANN INTERN MED, V120, P12, DOI 10.7326/0003-4819-120-1-199401010-00003; Summers SA, 2009, J AM SOC NEPHROL, V20, P2518, DOI 10.1681/ASN.2009030337; TURNER N, 1992, J CLIN INVEST, V89, P592, DOI 10.1172/JCI115625; WILSON CB, 1973, KIDNEY INT, V3, P74, DOI 10.1038/ki.1973.14; Wu J, 2002, J CLIN INVEST, V109, P517, DOI 10.1172/JCI200213876; WUCHERPFENNIG KW, 1995, CELL, V80, P695, DOI 10.1016/0092-8674(95)90348-8; Wyatt RJ, 2013, NEW ENGL J MED, V368, P2402, DOI 10.1056/NEJMra1206793; Yang R, 2009, CLIN IMMUNOL, V133, P245, DOI 10.1016/j.clim.2009.07.005	48	9	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2017	12	4							e0174553	10.1371/journal.pone.0174553	http://dx.doi.org/10.1371/journal.pone.0174553			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0MD	28410377	Green Submitted, Green Published, gold			2022-12-27	WOS:000399955600004
J	Matsuura, Y; Yamashita, A; Zhao, Y; Iwakiri, T; Yamasaki, K; Sugita, C; Koshimoto, C; Kitamura, K; Kawai, K; Tamaki, N; Zhao, SJ; Kuge, YJ; Asada, Y				Matsuura, Yunosuke; Yamashita, Atsushi; Zhao, Yan; Iwakiri, Takashi; Yamasaki, Kazuaki; Sugita, Chihiro; Koshimoto, Chihiro; Kitamura, Kazuo; Kawai, Keiichi; Tamaki, Nagara; Zhao, Songji; Kuge, Yuji; Asada, Yujiro			Altered glucose metabolism and hypoxic response in alloxan-induced diabetic atherosclerosis in rabbits	PLOS ONE			English	Article							FDG UPTAKE; COMPLICATIONS; HYPERGLYCEMIA; INFLAMMATION; CANCER; PLAQUE; RISK	Diabetes mellitus accelerates atherosclerosis that causes most cardiovascular events. Several metabolic pathways are considered to contribute to the development of atherosclerosis, but comprehensive metabolic alterations to atherosclerotic arterial cells remain unknown. The present study investigated metabolic changes and their relationship to vascular histopathological changes in the atherosclerotic arteries of rabbits with alloxan-induced diabetes. Diabetic atherosclerosis was induced in rabbit ilio-femoral arteries by injecting alloxan ( 100 mg/kg), injuring the arteries using a balloon, and feeding with a 0.5% cholesterol diet. We histologically assessed the atherosclerotic lesion development, cellular content, pimonidazole positive-hypoxic area, the nuclear localization of hypoxia-inducible factor-1 alpha, and apoptosis. We evaluated comprehensive arterial metabolism by performing metabolomic analyses using capillary electrophoresis-time of flight mass spectrometry. We evaluated glucose uptake and its relationship to vascular hypoxia using 18 F-fluorodeoxyglucose and pimonidazole. Plaque burden, macrophage content, and hypoxic areas were more prevalent in arteries with diabetic, than non-diabetic atherosclerosis. Metabolomic analyses highlighted 12 metabolites that were significantly altered between diabetic and non-diabetic atherosclerosis. A half of them were associated with glycolysis metabolites, and their levels were decreased in diabetic atherosclerosis. The uptake of glucose evaluated as 18 F-fluorodeoxyglucose in atherosclerotic lesions increased according to increased macrophage content or hypoxic areas in non-diabetic, but not diabetic rabbits. Despite profound hypoxic areas, the nuclear localization of hypoxia- inducible factor-1a decreased and the number of apoptotic cells increased in diabetic atherosclerotic lesions. Altered glycolysis metabolism and an impaired response to hypoxia in atherosclerotic lesions under conditions of insulin-dependent diabetes might be involved in the development of diabetic atherosclerosis.	[Matsuura, Yunosuke; Yamashita, Atsushi; Iwakiri, Takashi; Sugita, Chihiro; Asada, Yujiro] Univ Miyazaki, Dept Pathol, Fac Med, Miyazaki, Japan; [Matsuura, Yunosuke; Iwakiri, Takashi; Kitamura, Kazuo] Univ Miyazaki, Dept Internal Med, Fac Med, Miyazaki, Japan; [Zhao, Yan; Yamasaki, Kazuaki; Zhao, Songji] Hokkaido Univ, Grad Sch Med, Dept Tracer Kinet & Bioanal, Sapporo, Hokkaido, Japan; [Sugita, Chihiro] Kyusyu Univ Hlth & Welf, Fac Pharmaceut Sci, Dept Biochem & Microbiol, Nobeoka, Japan; [Koshimoto, Chihiro] Univ Miyazaki, Frontier Sci Res Ctr, Miyazaki, Japan; [Kawai, Keiichi] Kanazawa Univ, Inst Med Pharmaceut & Hlth Sci, Fac Hlth Sci, Kanazawa, Ishikawa, Japan; [Kawai, Keiichi] Univ Fukui, Biomed Imaging Res Ctr, Fukui, Japan; [Tamaki, Nagara] Hokkaido Univ, Grad Sch Med, Dept Nucl Med, Sapporo, Hokkaido, Japan; [Kuge, Yuji] Hokkaido Univ, Grad Sch Med, Dept Integrated Mol Imaging, Sapporo, Hokkaido, Japan; [Kuge, Yuji] Hokkaido Univ, Cent Inst Isotope Sci, Sapporo, Hokkaido, Japan	University of Miyazaki; University of Miyazaki; Hokkaido University; Kyushu University; University of Miyazaki; Kanazawa University; University of Fukui; Hokkaido University; Hokkaido University; Hokkaido University	Yamashita, A (corresponding author), Univ Miyazaki, Dept Pathol, Fac Med, Miyazaki, Japan.	atsushi_yamashita@med.miyazaki-u.ac.jp			Ministry of Education, Science, Sports and Culture of Japan [25460440, 23390084, 16K08670, 16H05163]; Clinical Research from Miyazaki University Hospital; SENSHIN Medical Research Foundation; Intramural Research Fund for Cardiovascular Diseases of the National Cerebral and Cardiovascular Center [25-4-3]; Bayer Scholarship for Cardiovascular Research	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Clinical Research from Miyazaki University Hospital; SENSHIN Medical Research Foundation(SENSHIN Medical Research Foundation); Intramural Research Fund for Cardiovascular Diseases of the National Cerebral and Cardiovascular Center; Bayer Scholarship for Cardiovascular Research	This study was supported in part by Grants-in-Aid for Scientific Research in Japan (Nos. 25460440, 23390084, 16K08670, and 16H05163) from the Ministry of Education, Science, Sports and Culture of Japan, http://www.jsps.go.jp, Clinical Research from Miyazaki University Hospital, http://www.med.miyazaki-u.ac.jp/home/Mitsui Life Welfare Foundation, http://www.kousei-zigyodan.or.jp/igakukenkyu_zyosei.html, SENSHIN Medical Research Foundation, https://www.smrf.or.jp, Intramural Research Fund (25-4-3) for Cardiovascular Diseases of the National Cerebral and Cardiovascular Center, http://www.ncyc.go.jp, and the Bayer Scholarship for Cardiovascular Research, http://www.jcvrf.jp/research/baieru.html.	Botusan IR, 2008, P NATL ACAD SCI USA, V105, P19426, DOI 10.1073/pnas.0805230105; Burke AP, 2004, ARTERIOSCL THROM VAS, V24, P1266, DOI 10.1161/01.ATV.0000131783.74034.97; Chen TL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162192; Filla LA, 2014, J PROTEOME RES, V13, P6121, DOI 10.1021/pr501030e; Gao Y, 2011, AM J CARDIOL, V108, P809, DOI 10.1016/j.amjcard.2011.04.032; Gerstein HC, 2011, NEW ENGL J MED, V364, P818, DOI 10.1056/NEJMoa1006524; Hellberg S, 2016, CARDIOVASC DIABETOL, V15, DOI 10.1186/s12933-016-0340-6; Kanter JE, 2007, CIRC RES, V100, P769, DOI 10.1161/01.RES.0000259589.34348.74; Laing SP, 2003, DIABETOLOGIA, V46, P760, DOI 10.1007/s00125-003-1116-6; LANGEN KJ, 1993, J NUCL MED, V34, P355; Lever M, 2012, PLOS ONE; Lever M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021666; Lever M, 2010, CLIN BIOCHEM, V43, P732, DOI 10.1016/j.clinbiochem.2010.03.009; Lindholm H, 2013, EJNMMI RES, V3, DOI 10.1186/2191-219X-3-50; LINDHOLM P, 1993, J NUCL MED, V34, P1; Loor G, 2008, CELL DEATH DIFFER, V15, P686, DOI 10.1038/cdd.2008.13; Mahendran Y, 2013, DIABETES, V62, P3618, DOI 10.2337/db12-1363; Malmberg K, 2000, CIRCULATION, V102, P1014, DOI 10.1161/01.CIR.102.9.1014; Moreno PR, 2000, CIRCULATION, V102, P2180; Naito R, 2016, J ATHEROSCLER THROMB, V23, P922, DOI 10.5551/jat.31948; Pasterkamp G, 2013, HEART, V99, P743, DOI 10.1136/heartjnl-2011-301172; Peiro C, 2016, CARDIOVASC DIABETOL, V15, DOI 10.1186/s12933-016-0397-2; Pomaro DR, 2005, J CARDIOVASC PHARM, V45, P295, DOI 10.1097/01.fjc.0000155384.64350.45; Preis SR, 2009, CIRCULATION, V119, P1728, DOI 10.1161/CIRCULATIONAHA.108.829176; Rabkin Z, 2010, J NUCL MED, V51, P1015, DOI 10.2967/jnumed.109.074294; Rask-Madsen C, 2013, CELL METAB, V17, P20, DOI 10.1016/j.cmet.2012.11.012; Scirica BM, 2013, NEW ENGL J MED, V369, P1317, DOI 10.1056/NEJMoa1307684; Shen X, 2007, ANN NY ACAD SCI, V1103, P202, DOI 10.1196/annals.1394.004; Wang TJ, 2011, NAT MED, V17, P448, DOI 10.1038/nm.2307; WELLMANN KF, 1967, DIABETES, V16, P242, DOI 10.2337/diab.16.4.242; Yamashita A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086426; Yamashita A, 2013, CIRC J, V77, P2626, DOI 10.1253/circj.CJ-12-1463; Yamashita A, 2009, ATHEROSCLEROSIS, V206, P418, DOI 10.1016/j.atherosclerosis.2009.03.014	33	8	9	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2017	12	4							e0175976	10.1371/journal.pone.0175976	http://dx.doi.org/10.1371/journal.pone.0175976			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0MD	28410399	gold, Green Submitted, Green Published			2022-12-27	WOS:000399955600053
J	Ferrer-Uris, B; Busquets, A; Lopez-Alonso, V; Fernandez-del-Olmo, M; Angulo-Barroso, R				Ferrer-Uris, Blai; Busquets, Albert; Lopez-Alonso, Virginia; Fernandez-del-Olmo, Miguel; Angulo-Barroso, Rosa			Enhancing consolidation of a rotational visuomotor adaptation task through acute exercise	PLOS ONE			English	Article							AEROBIC EXERCISE; CARDIOVASCULAR EXERCISE; SYNAPTIC PLASTICITY; NEUROTROPHIC FACTOR; GROWTH-FACTOR; MEMORY; BRAIN; PERFORMANCE; INTENSITY; BDNF	We assessed the effect of a single bout of intense exercise on the adaptation and consolidation of a rotational visuomotor task, together with the effect of the order of exercise presentation relative to the learning task. Healthy adult participants (n = 29) were randomly allocated to one of three experimental groups: (1) exercise before task practice, (2) exercise after task practice, and (3) task practice only. After familiarization with the learning task, participants undertook a baseline practice set. Then, four 60 E clockwise rotational sets were performed, comprising an adaptation set and three retention sets at 1 h, 24 h, and 7 days after the adaptation set. Depending on the experimental group, exercise was presented before or after the adaptation sets. We found that error reduction during adaptation was similar regardless of when exercise was presented. During retention, significant error reduction was found in the retention set at 1 h for both exercise groups, but this enhancement was not present during subsequent retention sets, with no differences present between exercise groups. We conclude that an acute bout of intense exercise could positively affect retention, although the order in which exercise is presented does not appear to influence its benefits during the early stages of consolidation.	[Ferrer-Uris, Blai; Busquets, Albert; Angulo-Barroso, Rosa] Univ Barcelona, Inst Nacl Educ Fis Catalunya, Barcelona, Spain; [Lopez-Alonso, Virginia; Fernandez-del-Olmo, Miguel] Univ A Coruna, INEF Galicia, Fac Ciencias Deporte & Educ Fis, La Coruna, Spain; [Angulo-Barroso, Rosa] Calif State Univ Northridge, Kinesiol, Northridge, CA 91330 USA	University of Barcelona; Universidade da Coruna; California State University System; California State University Northridge	Angulo-Barroso, R (corresponding author), Univ Barcelona, Inst Nacl Educ Fis Catalunya, Barcelona, Spain.; Angulo-Barroso, R (corresponding author), Calif State Univ Northridge, Kinesiol, Northridge, CA 91330 USA.	rangulo@umich.edu	Busquets, Albert/I-5544-2015; Ferrer-Uris, Blai/AAB-3786-2019; Angulo-Barroso, Rosa M/I-3562-2017; Lopez-Alonso, Virginia/G-4759-2015	Busquets, Albert/0000-0002-8879-1577; Ferrer-Uris, Blai/0000-0003-1562-0272; Angulo-Barroso, Rosa M/0000-0001-7757-6399; Lopez-Alonso, Virginia/0000-0002-4329-0656; Fernandez del Olmo, Miguel/0000-0001-5325-503X	Institut Nacional d'Educacio Fisica de Catalunya (INEFC); Agenda de Gestio d'Ajuts Universitaris i de Recerca (AGAUR) [PRE/2623]; Generalitat de Catalunya; Grup de Recerca en Activitat Fisica i Salut (GRAFiS) [SGR/1629]; Grup de Recerca en Activitat Fisica i Salut (GRAFiS, Generalitat de Catalunya) [SGR/1629]	Institut Nacional d'Educacio Fisica de Catalunya (INEFC); Agenda de Gestio d'Ajuts Universitaris i de Recerca (AGAUR); Generalitat de Catalunya(Generalitat de Catalunya); Grup de Recerca en Activitat Fisica i Salut (GRAFiS); Grup de Recerca en Activitat Fisica i Salut (GRAFiS, Generalitat de Catalunya)(Generalitat de Catalunya)	This study was supported by Institut Nacional d'Educacio Fisica de Catalunya (INEFC), Agenda de Gestio d'Ajuts Universitaris i de Recerca (AGAUR) (PRE/2623/2013), both from Generalitat de Catalunya, and Grup de Recerca en Activitat Fisica i Salut (GRAFiS, 2014SGR/1629). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We want to thank Binith Cheeran for his help with the equipment set-up. This study was supported by Grup de Recerca en Activitat Fisica i Salut (GRAFiS, Generalitat de Catalunya 2014SGR/1629). We also want to thank Binith Cheeran for his help with the equipment set-up.	Bekinschtein P, 2008, NEUROSCIENTIST, V14, P147, DOI 10.1177/1073858407305850; Bernard JA, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00027; Chang YK, 2012, BRAIN RES, V1453, P87, DOI 10.1016/j.brainres.2012.02.068; Coats RO, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085758; Cohen J.E., 1988, STAT POWER ANAL BEHA; Coles K, 2008, J SPORT SCI, V26, P333, DOI 10.1080/02640410701591417; Contreras-Vidal J, 2005, EXP BRAIN RES, V162, P155, DOI 10.1007/s00221-004-2123-7; Ding Q, 2006, NEUROSCIENCE, V140, P823, DOI 10.1016/j.neuroscience.2006.02.084; Griffin EW, 2011, PHYSIOL BEHAV, V104, P934, DOI 10.1016/j.physbeh.2011.06.005; Hillman CH, 2008, NAT REV NEUROSCI, V9, P58, DOI 10.1038/nrn2298; Krakauer JW, 2011, CURR OPIN NEUROBIOL, V21, P636, DOI 10.1016/j.conb.2011.06.012; Krakauer JW, 2006, TRENDS NEUROSCI, V29, P58, DOI 10.1016/j.tins.2005.10.003; Krakauer JW, 2005, J NEUROSCI, V25, P473, DOI 10.1523/JNEUROSCI.4218-04.2005; Labelle V, 2013, BRAIN COGNITION, V81, P10, DOI 10.1016/j.bandc.2012.10.001; Lambourne K, 2010, BRAIN RES, V1341, P12, DOI 10.1016/j.brainres.2010.03.091; Leger LA, 1988, J SPORT SCI, V6, P93, DOI 10.1080/02640418808729800; Mang CS, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/6797928; Mang CS, 2016, MED SCI SPORT EXER, V48, P2477, DOI 10.1249/MSS.0000000000001040; Mang CS, 2014, J APPL PHYSIOL, V117, P1325, DOI 10.1152/japplphysiol.00498.2014; McMorris T, 2012, BRAIN COGNITION, V80, P338, DOI 10.1016/j.bandc.2012.09.001; Neeper SA, 1996, BRAIN RES, V726, P49, DOI 10.1016/S0006-8993(96)00273-9; Robertson EM, 2004, NAT REV NEUROSCI, V5, P576, DOI 10.1038/nrn1426; Roig M, 2016, EXERC SPORT SCI REV, V44, P81, DOI 10.1249/JES.0000000000000078; Roig M, 2013, NEUROSCI BIOBEHAV R, V37, P1645, DOI 10.1016/j.neubiorev.2013.06.012; Roig M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044594; Skriver K, 2014, NEUROBIOL LEARN MEM, V116, P46, DOI 10.1016/j.nlm.2014.08.004; Smith PJ, 2010, PSYCHOSOM MED, V72, P239, DOI 10.1097/PSY.0b013e3181d14633; Snow NP, 2016, PLOS ONE, V11, DOI [10.1371/journal.pone.0150039, 10.1371/journal.pone.0146712]; Squire LR, 2004, NEUROBIOL LEARN MEM, V82, P171, DOI 10.1016/j.nlm.2004.06.005; Statton MA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141393; Strauss E, 2006, COMPENDIUM NEUROPSYC, DOI DOI 10.1212/WNL.41.11.1856-A; Thomas R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159589; van Praag H, 1999, P NATL ACAD SCI USA, V96, P13427, DOI 10.1073/pnas.96.23.13427; van Praag H, 2005, J NEUROSCI, V25, P8680, DOI 10.1523/JNEUROSCI.1731-05.2005; Vaynman S, 2004, EUR J NEUROSCI, V20, P2580, DOI 10.1111/j.1460-9568.2004.03720.x; Vaynman S, 2006, REV REVENGE SIT LIFE, V715, P699; Voss MW, 2011, J APPL PHYSIOL, V111, P1505, DOI 10.1152/japplphysiol.00210.2011; Winter B, 2007, NEUROBIOL LEARN MEM, V87, P597, DOI 10.1016/j.nlm.2006.11.003	38	20	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2017	12	4							e0175296	10.1371/journal.pone.0175296	http://dx.doi.org/10.1371/journal.pone.0175296			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0MB	28406936	Green Published, Green Submitted, gold			2022-12-27	WOS:000399955400039
J	Pierce, S; Coetzee, GA				Pierce, Steven; Coetzee, Gerhard A.			Parkinson's disease-associated genetic variation is linked to quantitative expression of inflammatory genes	PLOS ONE			English	Article							SUPER-ENHANCERS; RISK; SYNUCLEIN; IDENTIFICATION; METAANALYSIS; VARIANT; GWAS	Genome-wide association studies (GWAS) have linked dozens of single nucleotide polymorphisms (SNPs) with Parkinson's disease (PD) risk. Ascertaining the functional and eventual causal mechanisms underlying these relationships has proven difficult. The majority of risk SNPs, and nearby SNPs in linkage disequilibrium (LD), are found in intergenic or intronic regions and confer risk through allele-dependent expression of multiple unknown target genes. Combining GWAS results with publicly available GTEx data, generated through eQTL (expression quantitative trait loci) identification studies, enables a direct association of SNPs to gene expression levels and aids in narrowing the large population of potential genetic targets for hypothesis-driven experimental cell biology. Separately, overlapping of SNPs with putative enhancer segmentations can strengthen target filtering. We report here the results of analyzing 7,607 PD risk SNPs along with an additional 23,759 high linkage disequilibrium-associated variants paired with eQTL gene expression. We found that enrichment analysis on the set of genes following target filtering pointed to a single large LD block at 6p21 that contained multiple HLA-MHC-II genes. These MHC-II genes remain associated with PD when the genes were filtered for correlation between GWAS significance and eQTL levels, strongly indicating a direct effect on PD etiology.	[Pierce, Steven; Coetzee, Gerhard A.] Van Andel Res Inst, Ctr Neurodegenerat Sci, Grand Rapids, MI 49503 USA	Van Andel Institute	Coetzee, GA (corresponding author), Van Andel Res Inst, Ctr Neurodegenerat Sci, Grand Rapids, MI 49503 USA.	gerry.coetzee@vai.org	coetzee, Gerhard/AAT-6203-2020; Coetzee, Gerhard/AAG-8439-2019	Coetzee, Gerhard/0000-0001-8820-8364	Van Andel Institute internal funds; Center for Neurodegenerative Science at the Van Andel Research Institute	Van Andel Institute internal funds; Center for Neurodegenerative Science at the Van Andel Research Institute	This work was supported by Van Andel Institute internal funds.; We acknowledge the Center for Neurodegenerative Science at the Van Andel Research Institute for financial support and Drs. Patrik Brunden and Darrel Moore for helpful discussion. Simon Coetzee (Cedar-Sinai, Los Angeles) provided help with motifbreakR analyses. We acknowledge edits by Dr. David Nadziejka (VARI).	Coetzee SG, 2016, SCI REP-UK, V6, DOI 10.1038/srep30509; Coetzee SG, 2015, BIOINFORMATICS, V31, P3847, DOI 10.1093/bioinformatics/btv470; Driver JA, 2009, NEUROLOGY, V72, P432, DOI 10.1212/01.wnl.0000341769.50075.bb; Foulger RE, 2016, NEUROINFORMATICS, V14, P297, DOI 10.1007/s12021-015-9293-2; Hamza TH, 2010, NAT GENET, V42, P781, DOI 10.1038/ng.642; Harms AS, 2013, J NEUROSCI, V33, P9592, DOI 10.1523/JNEUROSCI.5610-12.2013; Hirsch Etienne C, 2012, Parkinsonism Relat Disord, V18 Suppl 1, pS210, DOI 10.1016/S1353-8020(11)70065-7; Holmans P, 2013, HUM MOL GENET, V22, P1039, DOI 10.1093/hmg/dds492; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kannarkat GT, 2015, NPJ PARKINSON DIS, V1, DOI 10.1038/npjparkd.2015.2; Khan A, 2016, NUCLEIC ACIDS RES, V44, pD164, DOI 10.1093/nar/gkv1002; Labbe C, 2016, ACTA NEUROPATHOL, V132, P515, DOI 10.1007/s00401-016-1590-9; Latourelle JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046199; Li JQ, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-47; Lill CM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002548; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Mi HY, 2016, NUCLEIC ACIDS RES, V44, pD336, DOI 10.1093/nar/gkv1194; Michalopoulos Ioannis, 2012, BMC Res Notes, V5, P265, DOI 10.1186/1756-0500-5-265; Nalls MA, 2011, LANCET, V377, P641, DOI 10.1016/S0140-6736(10)62345-8; Nalls MA, 2014, NAT GENET, V46, P989, DOI 10.1038/ng.3043; Niederriter AR, 2015, GENES-BASEL, V6, P1183, DOI 10.3390/genes6041183; Quang DX, 2015, EPIGENET CHROMATIN, V8, DOI 10.1186/s13072-015-0015-7; Rocha NP, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/628192; Sharon G, 2016, CELL, V167, P915, DOI 10.1016/j.cell.2016.10.027; Skibinski G, 2014, J NEUROSCI, V34, P418, DOI 10.1523/JNEUROSCI.2712-13.2014; Soldner F, 2016, NATURE, V533, P95, DOI 10.1038/nature17939; Tsika E, 2012, CURR NEUROL NEUROSCI, V12, P251, DOI 10.1007/s11910-012-0265-8; Wang QQ, 2015, TRANSL NEURODEGENER, V4, DOI 10.1186/s40035-015-0042-0; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229; Zhao YZ, 2016, MOL BIOSYST, V12, P2318, DOI 10.1039/c6mb00240d; Zhu ZH, 2016, NAT GENET, V48, P481, DOI 10.1038/ng.3538	31	31	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2017	12	4							e0175882	10.1371/journal.pone.0175882	http://dx.doi.org/10.1371/journal.pone.0175882			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0MB	28407015	Green Published, Green Submitted, gold			2022-12-27	WOS:000399955400105
J	Canchi, S; Sarntinoranont, M; Hong, Y; Flint, JJ; Subhash, G; King, MA				Canchi, Saranya; Sarntinoranont, Malisa; Hong, Yu; Flint, Jeremy J.; Subhash, Ghatu; King, Michael A.			Simulated blast overpressure induces specific astrocyte injury in an ex vivo brain slice model	PLOS ONE			English	Article							FIBRILLARY ACIDIC PROTEIN; VISCOELASTIC PROPERTIES; REACTIVE ASTROGLIOSIS; INTRACRANIAL-PRESSURE; DEATH; RATS; MECHANISMS; EXPRESSION; EXPOSURE; LESIONS	Exposure to explosive blasts can produce functional debilitation in the absence of brain pathology detectable at the scale of current diagnostic imaging. Transient (ms) overpressure components of the primary blast wave are considered to be potentially damaging to the brain. Astrocytes participate in neuronal metabolic maintenance, blood-brain barrier, regulation of homeostatic environment, and tissue remodeling. Damage to astrocytes via direct physical forces has the potential to disrupt local and global functioning of neuronal tissue. Using an ex vivo brain slice model, we tested the hypothesis that viable astrocytes within the slice could be injured simply by transit of a single blast wave consisting of overpressure alone. A polymer split Hopkinson pressure bar (PSHPB) system was adapted to impart a single positive pressure transient with a comparable magnitude to those that might be present inside the head. A custom built test chamber housing the brain tissue slice incorporated revised design elements to reduce fluid space and promote transit of a uniform planar waveform. Confocal microscopy, stereology, and morphometry of glial fibrillary acidic protein (GFAP) immunoreactivity revealed that two distinct astrocyte injury profiles were identified across a 4 hr post-test survival interval: (a) presumed conventional astrogliosis characterized by enhanced GFAP immunofluorescence intensity without significant change in tissue area fraction and (b) a process comparable to clasmatodendrosis, an autophagic degradation of distal processes that has not been previously associated with blast induced neurotrauma. Analysis of astrocyte branching revealed early, sustained, and progressive differences distinct from the effects of slice incubation absent overpressure testing. Astrocyte vulnerability to overpressure transients indicates a potential for significant involvement in brain blast pathology and emergent dysfunction. The testing platform can isolate overpressure injury phenomena to provide novel insight on physical and biological mechanisms.	[Canchi, Saranya; Sarntinoranont, Malisa; Hong, Yu; Subhash, Ghatu] Univ Florida, Dept Mech & Aerosp Engn, Gainesville, FL 32611 USA; [Flint, Jeremy J.] Univ Florida, Mcknight Brain Inst, Gainesville, FL 32611 USA; [King, Michael A.] Univ Florida, Dept Pharmacol & Therapeut, Gainesville, FL 32611 USA; [King, Michael A.] North Florida South Georgia VA Med Ctr, Gainesville, FL 32611 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	King, MA (corresponding author), Univ Florida, Dept Pharmacol & Therapeut, Gainesville, FL 32611 USA.; King, MA (corresponding author), North Florida South Georgia VA Med Ctr, Gainesville, FL 32611 USA.	making@ufl.edu	Subhash, Ghatu/J-4851-2017	Subhash, Ghatu/0000-0002-5996-0909	Army Research Office [W911NF-10-1-0276]	Army Research Office	Support was provided by the Army Research Office award number W911NF-10-1-0276 to GS (PI), MS, and MK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlers Stephen Thomas, 2012, Front Neurol, V3, P32, DOI 10.3389/fneur.2012.00032; AMADUCCI L, 1981, NEUROSCI LETT, V21, P27, DOI 10.1016/0304-3940(81)90052-5; Arun P, 2011, NEUROREPORT, V22, P379, DOI 10.1097/WNR.0b013e328346b138; Bar-Kochba E, 2016, SCI REP-UK, V6, DOI 10.1038/srep30550; Belanger HG, 2007, J NEUROPSYCH CLIN N, V19, P5, DOI 10.1176/appi.neuropsych.19.1.5; Bushong EA, 2002, J NEUROSCI, V22, P183, DOI 10.1523/JNEUROSCI.22-01-00183.2002; BUTT AM, 1989, GLIA, V2, P470, DOI 10.1002/glia.440020609; Cernak I, 2011, NEUROBIOL DIS, V41, P538, DOI 10.1016/j.nbd.2010.10.025; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203; Chafi MS, 2010, ANN BIOMED ENG, V38, P490, DOI 10.1007/s10439-009-9813-z; Chavko M, 2011, J NEUROSCI METH, V195, P61, DOI 10.1016/j.jneumeth.2010.11.019; Chen YC, 2009, J NEUROTRAUM, V26, P861, DOI 10.1089/neu.2008.0645; Duchen L.W., 1992, GREENFIELDS NEUROPAT, P1; ENG LF, 1989, GLIA, V2, P308, DOI 10.1002/glia.440020504; Floyd CL, 2007, PROG BRAIN RES, V161, P61, DOI 10.1016/S0079-6123(06)61005-4; Garman RH, 2011, J NEUROTRAUM, V28, P947, DOI 10.1089/neu.2010.1540; Giffard RG, 2005, GLIA, V50, P299, DOI 10.1002/glia.20167; Hardy WN, 2007, STAPP CAR CRASH JO, V51, P17; INAGAKI M, 1994, BRAIN PATHOL, V4, P239, DOI 10.1111/j.1750-3639.1994.tb00839.x; Kamnaksh A, 2011, J NEUROTRAUM, V28, P2145, DOI 10.1089/neu.2011.1983; Katano H, 2001, NEUROSCI LETT, V306, P101, DOI 10.1016/S0304-3940(01)01832-8; Kim DS, 2008, J COMP NEUROL, V511, P581, DOI 10.1002/cne.21851; Kochanek PM, 2013, J NEUROTRAUM, V30, P920, DOI 10.1089/neu.2013.2862; Kovesdi E, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00042; Lee SJ, 2014, J MECH BEHAV BIOMED, V29, P213, DOI 10.1016/j.jmbbm.2013.08.026; Lee SJ, 2011, J BIOMED MATER RES B, V97B, P84, DOI 10.1002/jbm.b.31789; Leonardi AD, 2013, ANN BIOMED ENG, V41, P2488, DOI 10.1007/s10439-013-0850-2; Liu QL, 2006, MECH MATER, V38, P1105, DOI 10.1016/j.mechmat.2006.01.001; Livet J, 2007, NATURE, V450, P56, DOI 10.1038/nature06293; Long JB, 2009, J NEUROTRAUM, V26, P827, DOI 10.1089/neu.2008.0748; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; MCLENDON RE, 1994, BRAIN PATHOL, V4, P221, DOI 10.1111/j.1750-3639.1994.tb00837.x; Miller W, 2013, STAT MEASUREMENT CON; Moss WC, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.108702; Nakagawa A, 2011, J NEUROTRAUM, V28, P1101, DOI 10.1089/neu.2010.1442; NAKAMURA Y, 1991, GLIA, V4, P101, DOI 10.1002/glia.440040112; Oberheim NA, 2009, J NEUROSCI, V29, P3276, DOI 10.1523/JNEUROSCI.4707-08.2009; Paxinos G., 1998, RAT BRAIN STEROTAXIC; Pekny M, 2014, PHYSIOL REV, V94, P1077, DOI 10.1152/physrev.00041.2013; Renner NA, 2013, J CELL PHYSIOL, V228, P1284, DOI 10.1002/jcp.24283; Ryu HJ, 2011, CELL MOL NEUROBIOL, V31, P1071, DOI 10.1007/s10571-011-9706-1; Sajja VSSS, 2012, NMR BIOMED, V25, P1331, DOI 10.1002/nbm.2805; Sakai K, 2013, BRAIN INJURY, V27, P1692, DOI 10.3109/02699052.2013.837198; Saljo A, 2011, NEUROIMAGE, V54, pS83, DOI 10.1016/j.neuroimage.2010.05.050; Saljo A, 2009, J NEUROTRAUM, V26, P1345, DOI [10.1089/neu.2008.0856, 10.1089/neu.2008-0856]; Sarntinoranont M, 2012, J NEUROTRAUM, V29, P418, DOI 10.1089/neu.2011.1772; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Scorcioni R, 2008, NAT PROTOC, V3, P866, DOI 10.1038/nprot.2008.51; Shridharani J, 2012, FRONT NEUROL, V3; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Subhash G, 2000, MECH TESTING EVALUAT, V8, P497; Svetlov Stanislav I, 2012, Front Neurol, V3, P15, DOI 10.3389/fneur.2012.00015; Takano T, 2014, GLIA, V62, P78, DOI 10.1002/glia.22588; Taylor PA, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3118765; Tomimoto H, 1997, ACTA NEUROPATHOL, V94, P146, DOI 10.1007/s004010050686; VandeVord PJ, 2008, NEUROSCI LETT, V434, P247, DOI 10.1016/j.neulet.2008.01.056; Wearne SL, 2005, NEUROSCIENCE, V136, P661, DOI 10.1016/j.neuroscience.2005.05.053; Wilhelmsson U, 2006, P NATL ACAD SCI USA, V103, P17513, DOI 10.1073/pnas.0602841103; Yang ZH, 2015, TRENDS NEUROSCI, V38, P364, DOI 10.1016/j.tins.2015.04.003	59	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2017	12	4							e0175396	10.1371/journal.pone.0175396	http://dx.doi.org/10.1371/journal.pone.0175396			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LZ	28403239	Green Published, gold, Green Submitted			2022-12-27	WOS:000399955200060
J	Flajsman, K; Jerina, K; Pokorny, B				Flajsman, Katarina; Jerina, Klemen; Pokorny, Bostjan			Age-related effects of body mass on fertility and litter size in roe deer	PLOS ONE			English	Article							FEMALE RED DEER; CONTRASTED POPULATIONS; FITNESS COMPONENTS; DENSITY-DEPENDENCE; 1ST REPRODUCTION; CERVUS-ELAPHUS; TOOTH WEAR; SENESCENCE; PATTERNS; FECUNDITY	We analysed effects of females' body mass and age on reproductive capacity of European roe deer (Capreolus capreolus) in a large sample set of 1312 females (305 yearlings and 1007 adults), hunted throughout Slovenia, central Europe, in the period 2013- 2015. Body mass positively affected probability of ovulation and potential litter size (number of corpora lutea), although its effect was more pronounced in yearlings than in adults. Between age groups, we found clear differences in responses of both reproductive parameters to body mass which influences primarily reproductive performance of younger, and in particular, lighter individuals: at the same body mass yearlings would at average have smaller litters than adults, and at lower body mass also young to middle-aged adults would have smaller litters than old ones. In addition, while yearlings have to reach a critical threshold body mass to attain reproductive maturity, adult females are fertile (produce ova) even at low body mass. However, at higher body mass also younger individuals shift their efforts into the reproduction, and after reaching an age-specific threshold the body mass does not have any further effects on the reproductive output of roe deer females. Increased reproductive capacity at more advanced age, combined with declining body mass suggests that old does allocate more of their resources in reproduction than in body condition.	[Flajsman, Katarina; Pokorny, Bostjan] Slovenian Forestry Inst, Ljubljana, Slovenia; [Jerina, Klemen] Univ Ljubljana, Biotech Fac, Dept Forestry & Renewable Forest Resources, Ljubljana, Slovenia; [Pokorny, Bostjan] Environm Protect Coll, Velenje, Slovenia; [Pokorny, Bostjan] Ecol Res & Ind Cooperat, Velenje, Slovenia	Slovenian Forestry Institute; University of Ljubljana	Flajsman, K (corresponding author), Slovenian Forestry Inst, Ljubljana, Slovenia.	katarina.flajsman@gozdis.si			Slovenian Research Agency [1000-12-0404]; Hunters Association of Slovenia	Slovenian Research Agency(Slovenian Research Agency - Slovenia); Hunters Association of Slovenia	The study was performed by the financial support of the Slovenian Research Agency, financing the education of Katarina Flajsman as a young researcher (Contract no. 1000-12-0404), and was financially supported also by the Hunters Association of Slovenia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AITKEN RJ, 1974, J REPROD FERTIL, V39, P225, DOI 10.1530/jrf.0.0390225; ALBON SD, 1986, J ZOOL, V209, P447, DOI 10.1111/j.1469-7998.1986.tb03603.x; ALBON SD, 1983, J ANIM ECOL, V52, P969, DOI 10.2307/4467; Andersen R, 2000, J WILDLIFE MANAGE, V64, P698, DOI 10.2307/3802739; Andersen R, 1998, EUROPEAN ROE DEER: THE BIOLOGY OF SUCCESS, P285; Andersen R, 2000, J ANIM ECOL, V69, P672, DOI 10.1046/j.1365-2656.2000.00425.x; [Anonymous], 1982, ACTA THERIOL, V27, P385; Apollonio M., 2010, EUROPEAN UNGULATES T; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bertouille SB, 2002, Z JAGDWISS, V48, P87, DOI 10.1007/BF02192396; Berube CH, 1999, ECOLOGY, V80, P2555, DOI 10.1890/0012-9658(1999)080[2555:IDLARS]2.0.CO;2; Borg K, 1970, VILTREVY, V7, P121; Borowik T., 2014, FACTORS AFFECTING FE; BRONSON FH, 1991, BIOL REPROD, V44, P945, DOI 10.1095/biolreprod44.6.945; Carranza J, 2004, NATURE, V432, P215, DOI 10.1038/nature03004; Clutton-Brock TH., 1982, RED DEER BEHAV ECOLO; Cook JG, 2004, WILDLIFE MONOGR, P1; Danilkin A, 1995, BEHAV ECOLOGY SIBERI; DelGiudice GD, 2007, J MAMMAL, V88, P427, DOI 10.1644/06-MAMM-A-164R.1; Flajsman K., 2017, EFFECTS OF INDIVIDUA; Flajsman K, 2013, ACTA SILVAE LIGNI, P1; Focardi S, 2002, OECOLOGIA, V130, P411, DOI 10.1007/s00442-001-0825-0; Gaillard JM, 2013, ECOL LETT, V16, P48, DOI 10.1111/ele.12059; Gaillard JM, 2000, ANNU REV ECOL SYST, V31, P367, DOI 10.1146/annurev.ecolsys.31.1.367; GAILLARD JM, 1992, CAN J ZOOL, V70, P1541, DOI 10.1139/z92-212; Gaillard JM, 2003, J WILDLIFE MANAGE, V67, P767, DOI 10.2307/3802684; Gaillard JM, 1998, EUROPEAN ROE DEER: THE BIOLOGY OF SUCCESS, P309; Garel M, 2009, AM NAT, V173, P89, DOI 10.1086/593359; Hamel S, 2009, ECOLOGY, V90, P1981, DOI 10.1890/08-0596.1; HAMILTON WJ, 1980, J AGR SCI, V95, P261, DOI 10.1017/S0021859600039289; Hewison AJM, 2011, OIKOS, V120, P1217, DOI 10.1111/j.1600-0706.2011.19316.x; Hewison AJM, 1999, CAN J ZOOL, V77, P58, DOI 10.1139/cjz-77-1-58; Hewison AJM, 1996, ACTA THERIOL, V41, P187, DOI 10.4098/AT.arch.96-18; Hewison AJM, 2001, J ANIM ECOL, V70, P600, DOI 10.1046/j.1365-2656.2001.00528.x; HUDSON RJ, 1991, SMALL RUMINANT RES, V4, P19, DOI 10.1016/0921-4488(91)90049-V; Jelenko I, 2013, OPLOJENOST PROSTOZIV; Jerina K, 2013, PROSTORSKA RAZSIRJEN; Kirkwood TBL, 2000, NATURE, V408, P233, DOI 10.1038/35041682; Kjellander P, 2004, OECOLOGIA, V139, P478, DOI 10.1007/s00442-004-1529-z; Kjellander P, 2000, DENSITY DEPENDENCE R; Langbein J., 1991, EFFECTS DENSITY AGE; Langbein Jochen, 1992, P293; Langvatn R, 1996, J ANIM ECOL, V65, P653, DOI 10.2307/5744; Langvatn R, 2004, AM NAT, V163, P763, DOI 10.1086/383594; Linnell JDC, 1998, EUROPEAN ROE DEER: THE BIOLOGY OF SUCCESS, P11; MacDonald DW, 2008, OECOLOGIA, V158, P361, DOI 10.1007/s00442-008-1142-7; Mauget C, 2003, ACTA THERIOL, V48, P197, DOI 10.1007/BF03194159; Mauget C, 1997, CAN J ZOOL, V75, P731, DOI 10.1139/z97-094; Mitchell B., 1974, XIth International Congress of Game Biologists, Stockholm, 3-7 Sep. 1973., P89; Mitchell B., 1977, Ecology of red deer. A research review relevant to their management in Scotland.; Morin A, 2016, CAN J ZOOL, V94, P311, DOI 10.1139/cjz-2015-0153; Nilsen EB, 2004, J ANIM ECOL, V73, P44, DOI 10.1111/j.1365-2656.2004.00790.x; Nussey DH, 2013, AGEING RES REV, V12, P214, DOI 10.1016/j.arr.2012.07.004; Nussey DH, 2011, ECOLOGY, V92, P1936, DOI 10.1890/11-0308.1; Oslis, 2016, OSR SLOV LOVSK INF S; PIANKA ER, 1975, AM NAT, V109, P453, DOI 10.1086/283013; Pokorny B., 2012, Zbornik Gozdarstva in Lesarstva, P3; Ratcliffe P. R., 1992, ROE DEER BIOL MANAGE; Red B. deer, 2016, J MAMMAL, V97, P1671; Sand H, 1996, OECOLOGIA, V106, P212, DOI 10.1007/BF00328601; Servanty S, 2009, J ANIM ECOL, V78, P1278, DOI 10.1111/j.1365-2656.2009.01579.x; SHORT R. V., 1966, SYMP ZOOL SOC LONDON, V15, P173; SKOGLAND T, 1988, OIKOS, V51, P238, DOI 10.2307/3565648; SKOGLAND T, 1985, J ANIM ECOL, V54, P359, DOI 10.2307/4484; StatSoft Inc, 2014, STAT DAT AN SOFTW SY; STRANDGAARD H, 1972, Danish Review of Game Biology, V6, P1; Toigo C, 2006, ECOGRAPHY, V29, P301, DOI 10.1111/j.2006.0906-7590.04394.x; Vetter SG, 2016, ANIM BEHAV, V115, P193, DOI 10.1016/j.anbehav.2016.03.026; Weladji R, 2003, ACTA AGR SCAND A-AN, V53, P35, DOI 10.1080/09064700310002026	69	17	17	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2017	12	4							e0175579	10.1371/journal.pone.0175579	http://dx.doi.org/10.1371/journal.pone.0175579			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LZ	28403161	Green Submitted, gold, Green Published			2022-12-27	WOS:000399955200082
J	Rodriguez, A; Zhang, HH; Wiklund, K; Brodin, T; Klaminder, J; Andersson, P; Andersson, M				Rodriguez, Alvaro; Zhang, Hanging; Wiklund, Krister; Brodin, Tomas; Klaminder, Jonatan; Andersson, Patrik; Andersson, Magnus			Refining particle positions using circular symmetry	PLOS ONE			English	Article							FORCE MEASUREMENT; TRACKING; INTERPOLATION; TWEEZERS; MOTION	Particle and object tracking is gaining attention in industrial applications and is commonly applied in: colloidal, biophysical, ecological, and micro-fluidic research. Reliable tracking information is heavily dependent on the system under study and algorithms that correctly determine particle position between images. However, in a real environmental context with the presence of noise including particular or dissolved matter in water, and low and fluctuating light conditions, many algorithms fail to obtain reliable information. We propose a new algorithm, the Circular Symmetry algorithm (C-Sym), for detecting the position of a circular particle with high accuracy and precision in noisy conditions. The algorithm takes advantage of the spatial symmetry of the particle allowing for subpixel accuracy. We compare the proposed algorithm with four different methods using both synthetic and experimental datasets. The results show that C-Sym is the most accurate and precise algorithm when tracking micro-particles in all tested conditions and it has the potential for use in applications including tracking biota in their environment.	[Rodriguez, Alvaro; Zhang, Hanging; Wiklund, Krister; Andersson, Magnus] Umea Univ, Dept Phys, Umea, Sweden; [Brodin, Tomas; Klaminder, Jonatan] Umea Univ, Dept Ecol & Environm Sci, Umea, Sweden; [Andersson, Patrik] Umea Univ, Dept Chem, Umea, Sweden	Umea University; Umea University; Umea University	Andersson, M (corresponding author), Umea Univ, Dept Phys, Umea, Sweden.	magnus.andersson@umu.se	Rodriguez, Alvaro/M-9208-2014; Andersson, Magnus/A-3591-2009	Rodriguez, Alvaro/0000-0002-2690-090X; Andersson, Magnus/0000-0002-9835-3263; Klaminder, Jonatan/0000-0001-8814-0013; Brodin, Tomas/0000-0003-1086-7567	Swedish Research Council [2013-5379]; Kempe foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Kempe foundation	This study was supported by the Swedish Research Council (2013-5379),www.vr.seMA; Kempestiftelserna, www.kempe.com,MA; AForsk, www.aforsk.se, PA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r This work was supported by the Swedish Research Council (2013 - 5379) and from the Kempe foundation to M.A, and from Angepanneforening to P.A.	Akinlar C, 2013, PATTERN RECOGN, V46, P725, DOI 10.1016/j.patcog.2012.09.020; Andersson M, 2011, J OPTICS-UK, V13, DOI 10.1088/2040-8978/13/4/044020; Anthony SM, 2008, LANGMUIR, V24, P6557, DOI 10.1021/la800424t; Berglund AJ, 2008, OPT EXPRESS, V16, P14064, DOI 10.1364/OE.16.014064; Blumberg S, 2005, BIOPHYS J, V89, P1272, DOI 10.1529/biophysj.105.061242; Chao J, 2012, P SOC PHOTO-OPT INS, V8227, P1; Cheezum MK, 2001, BIOPHYS J, V81, P2378, DOI 10.1016/S0006-3495(01)75884-5; Cnossen JP, 2014, REV SCI INSTRUM, V85, DOI 10.1063/1.4898178; Devasenathipathy S, 2003, EXP FLUIDS, V34, P504, DOI [10.1007/S00348-003-0588-y, 10.1007/S00348-003-0588-Y]; DUDA RO, 1972, COMMUN ACM, V15, P11, DOI 10.1145/361237.361242; Fallman E, 2004, BIOSENS BIOELECTRON, V19, P1429, DOI 10.1016/j.bios.2003.12.029; GELLES J, 1988, NATURE, V331, P450, DOI 10.1038/331450a0; GHOSH RN, 1994, BIOPHYS J, V66, P1301, DOI 10.1016/S0006-3495(94)80939-7; Gosse C, 2002, BIOPHYS J, V82, P3314, DOI 10.1016/S0006-3495(02)75672-5; Hollig K, 1996, COMPUT AIDED GEOM D, V13, P681, DOI 10.1016/0167-8396(96)00004-0; Kamsma D, 2016, METHODS, V105, P26, DOI 10.1016/j.ymeth.2016.05.002; Lafaye de Micheaux H, 2016, IEEE IMAGE PROC, P3489, DOI 10.1109/ICIP.2016.7533008; Lei YW, 1999, PATTERN RECOGN LETT, V20, P41, DOI 10.1016/S0167-8655(98)00127-5; Lin CY, 2011, MECHATRONICS, V21, P239, DOI 10.1016/j.mechatronics.2010.11.002; Manzo C, 2010, METHOD ENZYMOL, V475, P199, DOI 10.1016/S0076-6879(10)75009-6; Martin DS, 2002, BIOPHYS J, V83, P2109, DOI 10.1016/S0006-3495(02)73971-4; Mignotte M, 2016, PATTERN RECOGN LETT, V74, P53, DOI 10.1016/j.patrec.2016.01.014; Milner D, 2007, PATTERN RECOGN, V40, P2237, DOI 10.1016/j.patcog.2006.12.008; Nobach H, 2005, EXP FLUIDS, V39, P299, DOI 10.1007/s00348-005-0999-z; Norregaard K, 2014, NAT PROTOC, V9, P2206, DOI 10.1038/nprot.2014.152; Norregaard K, 2013, P NATL ACAD SCI USA, V110, P17386, DOI 10.1073/pnas.1215907110; Plenat T, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks250; Saxton MJ, 1997, ANNU REV BIOPH BIOM, V26, P373, DOI 10.1146/annurev.biophys.26.1.373; Schmitt O, 2008, PATTERN RECOGN, V41, P1905, DOI 10.1016/j.patcog.2007.11.006; Smith CS, 2010, NAT METHODS, V7, P373, DOI [10.1038/NMETH.1449, 10.1038/nmeth.1449]; Song D, 2015, AM J PHYS, V83, P418, DOI 10.1119/1.4902187; Stelzer EHK, 2002, NATURE, V417, P806, DOI 10.1038/417806a; van Loenhout MTJ, 2012, BIOPHYS J, V102, P2362, DOI 10.1016/j.bpj.2012.03.073; Waigh TA, 2005, REP PROG PHYS, V68, P685, DOI 10.1088/0034-4885/68/3/R04; WENG JY, 1992, IEEE T PATTERN ANAL, V14, P965, DOI 10.1109/34.159901; Wilson RS, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.160225; Xiao ZT, 2005, PATTERN RECOGN LETT, V26, P1985, DOI 10.1016/j.patrec.2005.02.003; Zakrisson J, 2015, APPL OPTICS, V54, P7442, DOI 10.1364/AO.54.007442; Zavidovique B, 2007, PATTERN RECOGN, V40, P839, DOI 10.1016/j.patcog.2006.04.013; Zhang H, 2017, UMUTRACKER A VERSATI; ZHANG HQ, 2016, PATTERN RECOGN, V54, P218; Zhang SC, 2005, PATTERN RECOGN, V38, P273, DOI 10.1016/j.patcog.2004.03.014; Zhengyou Zhang, 1999, Proceedings of the Seventh IEEE International Conference on Computer Vision, P666, DOI 10.1109/ICCV.1999.791289	43	8	8	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2017	12	4							e0175015	10.1371/journal.pone.0175015	http://dx.doi.org/10.1371/journal.pone.0175015			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LZ	28403228	Green Published, Green Submitted, gold			2022-12-27	WOS:000399955200030
J	St Clair, MC; Neufeld, S; Jones, PB; Fonagy, P; Bullmore, ET; Dolan, RJ; Moutoussis, M; Toseeb, U; Goodyer, IM				St Clair, Michelle C.; Neufeld, Sharon; Jones, Peter B.; Fonagy, Peter; Bullmore, Edward T.; Dolan, Raymond J.; Moutoussis, Michael; Toseeb, Umar; Goodyer, Ian M.			Characterising the latent structure and organisation of self-reported thoughts, feelings and behaviours in adolescents and young adults	PLOS ONE			English	Article							GENERAL PSYCHOPATHOLOGY FACTOR; CONFIRMATORY FACTOR-ANALYSES; MENTAL-HEALTH; PSYCHOLOGICAL DISTRESS; META-STRUCTURE; P FACTOR; DEPRESSION; DISORDERS; COMORBIDITY; SYMPTOMS	Little is known about the underlying relationships between self-reported mental health items measuring both positive and negative emotional and behavioural symptoms at the population level in young people. Improved measurement of the full range of mental wellbeing and mental illness may aid in understanding the aetiological substrates underlying the development of both mental wellness as well as specific psychiatric diagnoses. A general population sample aged 14 to 24 years completed self-report questionnaires on anxiety, depression, psychotic-like symptoms, obsessionality and well-being. Exploratory and confirmatory factor models for categorical data and latent profile analyses were used to evaluate the structure of both mental wellness and illness items. First order, second order and bifactor structures were evaluated on 118 self-reported items obtained from 2228 participants. A bifactor solution was the best fitting latent variable model with one general latent factor termed 'distress' and five 'distress independent' specific factors defined as self-confidence, antisocial behaviour, worry, aberrant thinking, and mood. Next, six distinct subgroups were derived from a person-centred latent profile analysis of the factor scores. Finally, concurrent validity was assessed using information on hazardous behaviours (alcohol use, substance misuse, self-harm) and treatment for mental ill health: both discriminated between the latent traits and latent profile subgroups. The findings suggest a complex, multidimensional mental health structure in the youth population rather than the previously assumed first or second order factor structure. Additionally, the analysis revealed a low hazardous behaviour/low mental illness risk subgroup not previously described. Population sub-groups show greater validity over single variable factors in revealing mental illness risks. In conclusion, our findings indicate that the structure of self reported mental health is multidimensional in nature and uniquely finds improved prediction to mental illness risk within person-centred subgroups derived from the multidimensional latent traits.	[St Clair, Michelle C.] Univ Bath, Dept Psychol, Bath, Avon, England; [Neufeld, Sharon; Jones, Peter B.; Bullmore, Edward T.; Goodyer, Ian M.] Univ Cambridge, Dept Psychiat, Cambridge, England; [Fonagy, Peter] UCL, Div Psychol & Language Sci, London, England; [Dolan, Raymond J.] UCL, Max Planck UCL Ctr Computat Psychiat & Ageing, London, England; [Moutoussis, Michael] UCL, Wellcome Trust Ctr Neuroimaging, London, England; [Toseeb, Umar] Manchester Metropolitan Univ, Dept Psychol, Manchester, Lancs, England	University of Bath; University of Cambridge; University of London; University College London; University of London; University College London; University of London; University College London; Manchester Metropolitan University	St Clair, MC (corresponding author), Univ Bath, Dept Psychol, Bath, Avon, England.; Goodyer, IM (corresponding author), Univ Cambridge, Dept Psychiat, Cambridge, England.	m.c.st.clair@bath.ac.uk; ig104@cam.ac.uk	Bullmore, Ed/C-1706-2012	Bullmore, Ed/0000-0002-8955-8283; Jones, Peter Brian/0000-0002-0387-880X; Fonagy, Peter/0000-0003-0229-0091; St Clair, Michelle/0000-0003-4015-7435; Toseeb, Umar/0000-0002-7536-2722; Moutoussis, Michael/0000-0002-4751-0425; Neufeld, Sharon/0000-0001-5470-3770	Wellcome Trust Strategic Award [095844]; Neuroscience in Psychiatry Network; UCLH Biomedical Research Council; NIHR Cambridge Biomedical Research Centre; National Institute for Health Research (NIHR) Senior Investigator Award [NF-SI-0514-10157]; NIHR Collaboration for Leadership in Applied Health Research and Care (CLAHRC) North Thames at Barts Health NHS Trust; National Institute for Health Research [NF-SI-0514-10157, NF-SI-0513-10051] Funding Source: researchfish	Wellcome Trust Strategic Award(Wellcome Trust); Neuroscience in Psychiatry Network; UCLH Biomedical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIHR Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); National Institute for Health Research (NIHR) Senior Investigator Award(National Institute for Health Research (NIHR)); NIHR Collaboration for Leadership in Applied Health Research and Care (CLAHRC) North Thames at Barts Health NHS Trust; National Institute for Health Research(National Institute for Health Research (NIHR))	This work has been supported by a Wellcome Trust Strategic Award (reference: 095844) to Ian Goodyer, Ray Dolan, Ed Bullmore, Peter Jones and Peter Fonagy which provides core funding for the Neuroscience in Psychiatry Network (NSPN.org.uk). The Wellcome trust had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. Michael Moutoussis is funded by the UCLH Biomedical Research Council. Additional support was provided by the NIHR Cambridge Biomedical Research Centre. Peter Fonagy is in receipt of a National Institute for Health Research (NIHR) Senior Investigator Award (NF-SI-0514-10157). Peter Fonagy was in part supported by the NIHR Collaboration for Leadership in Applied Health Research and Care (CLAHRC) North Thames at Barts Health NHS Trust. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health.; This research is supported by a Wellcome Trust Strategic Award (reference: 095844) to Ian Goodyer, Ray Dolan, Ed Bullmore, Peter Jones and Peter Fonagy which provides core funding for the Neuroscience in Psychiatry Network (NSPN.org.uk). Michael Moutoussis is funded by the UCLH Biomedical Research Council. Additional support was provided by the NIHR Cambridge Biomedical Research Centre. Peter Fonagy is in receipt of a National Institute for Health Research (NIHR) Senior Investigator Award (NF-SI-0514-10157). Peter Fonagy was in part supported by the NIHR Collaboration for Leadership in Applied Health Research and Care (CLAHRC) North Thames at Barts Health NHS Trust. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health. The authors acknowledge the whole of the NSPN team for ongoing feedback on this work from the early tentative stages, to the presentation of the final results. Particular thanks are due to Elzbieta Polek for help in thinking through psychometric problems and being a general sounding board and to Janet Bultitude for a useful perspective on the clarity of the manuscript. A huge amount of thanks goes to Cinly Ooi for collating the database, to Becky Inkster and Gita Prabhu for coordinating the study and to Laura Villis and Junaid Bhatti for providing invaluable administrative assistance in sending out the packs and entering the packs back in. Finally, we are grateful to all participants in the Neuroscience in Psychiatry Network without whom there would be no research programme.	American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Bamber D, 2002, J AM ACAD CHILD PSY, V41, P1246, DOI 10.1097/00004583-200210000-00015; Blakemore SJ, 2006, J CHILD PSYCHOL PSYC, V47, P296, DOI 10.1111/j.1469-7610.2006.01611.x; Bohnke JR, 2015, SOC PSYCH PSYCH EPID, V50, P515, DOI 10.1007/s00127-015-1022-5; Bohnke JR, 2015, BR J PSYCHIAT; Brodbeck J, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-191; Brown T.A., 2015, CONFIRMATORY FACTOR, V2nd ed., DOI DOI 10.5860/CHOICE.44-2769; Carragher N, 2016, PSYCHOL MED, V46, P981, DOI 10.1017/S0033291715002470; Carragher N, 2015, SOC PSYCH PSYCH EPID, V50, P339, DOI 10.1007/s00127-014-1004-z; Caspi A, 2014, CLIN PSYCHOL SCI, V2, P119, DOI 10.1177/2167702613497473; Castellanos-Ryan N, 2016, J ABNORM PSYCHOL, V125, P1039, DOI 10.1037/abn0000193; Chen FF, 2006, MULTIVAR BEHAV RES, V41, P189, DOI 10.1207/s15327906mbr4102_5; Conway CC, 2016, J ABNORM PSYCHOL, V125, P1079, DOI 10.1037/abn0000163; COSTELLO EJ, 1988, J AM ACAD CHILD PSY, V27, P726, DOI 10.1097/00004583-198811000-00011; Dolan RJ, 2013, NEURON, V80, P312, DOI 10.1016/j.neuron.2013.09.007; Dunn VJ, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-109; Fleer J, 2013, DIABETIC MED, V30, P88, DOI 10.1111/dme.12001; Forbes MK, 2016, DEV PSYCHOPATHOL, V28, P971, DOI 10.1017/S0954579416000651; Goodkind M, 2015, JAMA PSYCHIAT, V72, P305, DOI 10.1001/jamapsychiatry.2014.2206; Hankins Matthew, 2008, Clin Pract Epidemiol Ment Health, V4, P10, DOI 10.1186/1745-0179-4-10; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; HEADEY B, 1993, SOC INDIC RES, V29, P63, DOI 10.1007/BF01136197; Horwood J, 2008, BRIT J PSYCHIAT, V193, P185, DOI 10.1192/bjp.bp.108.051904; Hyman SE, 2010, ANNU REV CLIN PSYCHO, V6, P155, DOI 10.1146/annurev.clinpsy.3.022806.091532; Insel T, 2010, AM J PSYCHIAT, V167, P748, DOI 10.1176/appi.ajp.2010.09091379; Jones P B, 2013, Br J Psychiatry Suppl, V54, ps5, DOI 10.1192/bjp.bp.112.119164; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; KESSLER RC, 1994, ARCH GEN PSYCHIAT, V51, P8; Keyes CLM, 2005, J CONSULT CLIN PSYCH, V73, P539, DOI 10.1037/0022-006X.73.3.539; Keyes CLM, 2002, J HEALTH SOC BEHAV, V43, P207, DOI 10.2307/3090197; Keyes CLM, 2007, AM PSYCHOL, V62, P95, DOI 10.1037/0003-066X.62.2.95; Krueger RE, 2006, ANNU REV CLIN PSYCHO, V2, P111, DOI 10.1146/annurev.clinpsy.2.022305.095213; Laceulle OM, 2015, CLIN PSYCHOL SCI, V3, P850, DOI 10.1177/2167702614560750; Lahey BB, 2015, J CHILD PSYCHOL PSYC, V56, P415, DOI 10.1111/jcpp.12300; Lahey BB, 2012, J ABNORM PSYCHOL, V121, P971, DOI 10.1037/a0028355; Lahey BB, 2011, ARCH GEN PSYCHIAT, V68, P181, DOI 10.1001/archgenpsychiatry.2010.192; LIDDLE PF, 1987, BRIT J PSYCHIAT, V151, P145, DOI 10.1192/bjp.151.2.145; Lorenzo-Seva U, 2006, BEHAV RES METHODS, V38, P88, DOI 10.3758/BF03192753; Markon KE, 2010, PSYCHOL MED, V40, P273, DOI 10.1017/S0033291709990183; Masse R, 1998, SOC INDIC RES, V45, P475, DOI 10.1023/A:1006992032387; Meijer A, 2013, J PSYCHOSOM RES, V75, P1, DOI 10.1016/j.jpsychores.2013.01.012; Mellers JDC, 1996, ACTA PSYCHIAT SCAND, V93, P92, DOI 10.1111/j.1600-0447.1996.tb09808.x; Mishra S, 2011, PERS INDIV DIFFER, V50, P869, DOI 10.1016/j.paid.2010.11.037; Murray AL, 2016, J ABNORM CHILD PSYCH, V44, P1573, DOI 10.1007/s10802-016-0132-1; Muthen L. K., 2017, MPLUS USERS GUIDE, DOI DOI 10.1111/J.1600-0447.2011.01711.X; Neufeld S, PSYCHOL MED; Owens M, 2014, P NATL ACAD SCI USA, V111, P3638, DOI 10.1073/pnas.1318786111; Owens M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048482; Patalay P, 2015, BR J PSYCHIAT; RAINE A, 1991, SCHIZOPHRENIA BULL, V17, P555, DOI 10.1093/schbul/17.4.555; Reininghaus U, 2016, BRIT J PSYCHIAT, V209, P107, DOI 10.1192/bjp.bp.115.167882; Reise SP, 2013, MULTIVAR BEHAV RES, V48, P461, DOI 10.1080/00273171.2013.805106; REYNOLDS CR, 1978, J ABNORM CHILD PSYCH, V6, P271, DOI 10.1007/BF00919131; Rosenberg M., 1965, SOC ADOLESCENT SELF, DOI 10.1515/9781400876136; Russo SJ, 2012, NAT NEUROSCI, V15, P1475, DOI 10.1038/nn.3234; Sanislow CA, 2016, J ABNORM PSYCHOL, V125, P1158, DOI 10.1037/abn0000207; Sisk CL, 2005, FRONT NEUROENDOCRIN, V26, P163, DOI 10.1016/j.yfrne.2005.10.003; St Clair MC, 2012, SOC PSYCH PSYCH EPID, V47, P1333, DOI 10.1007/s00127-011-0441-1; StataCorp, 2013, STATA STAT SOFTW REL; Stochl J, 2015, PSYCHOL MED, V45, P1483, DOI 10.1017/S003329171400261X; Tennant R, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-63; Thombs BD, 2012, CAN MED ASSOC J, V184, P413, DOI 10.1503/cmaj.111035; VEIT CT, 1983, J CONSULT CLIN PSYCH, V51, P730, DOI 10.1037/0022-006X.51.5.730; Waldman ID, 2016, J ABNORM PSYCHOL, V125, P1053, DOI 10.1037/abn0000183; Wang L, 2011, PERS INDIV DIFFER, V50, P1056, DOI 10.1016/j.paid.2011.01.024; Wright AGC, 2013, J ABNORM PSYCHOL, V122, P281, DOI 10.1037/a0030133; Xu MK, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2015.86	67	33	33	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2017	12	4							e0175381	10.1371/journal.pone.0175381	http://dx.doi.org/10.1371/journal.pone.0175381			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET0LZ	28403164	Green Accepted, Green Published, gold			2022-12-27	WOS:000399955200057
J	Deinlein, T; Arzberger, E; Zalaudek, I; Massone, C; Garcias-Ladaria, J; Oliveira, A; Schulter, G; Hofmann-Wellenhof, R				Deinlein, Teresa; Arzberger, Edith; Zalaudek, Iris; Massone, Cesare; Garcias-Ladaria, Juan; Oliveira, Andre; Schulter, Guenter; Hofmann-Wellenhof, Rainer			Dermoscopic characteristics of melanoma according to the criteria "ulceration" and "mitotic rate" of the AJCC 2009 staging system for melanoma	PLOS ONE			English	Article							PIGMENTED SKIN-LESIONS; NAKED-EYE EXAMINATION; CUTANEOUS MELANOMA; PREOPERATIVE EVALUATION; THICKNESS; DIAGNOSIS	Objective The present study was conducted to identify possible dermoscopic patterns, associated with mitotic rate > 1/mm(2), histological ulceration in melanoma and metastatic disease. Methods For this retrospective data analysis all clinical and dermoscopic digital images of primary malignant melanomas between 2008 and 2013 documented at the Department of Dermatology Graz were included, using the internal image data-base. 550 patients with 559 melanomas were included. Results While clinical or dermoscopic analysis considered ulceration to be present in 120 (21.5%) and 117 (20.9%) of all lesions, respectively, histopathology reported ulceration in only 96 cases (17.2%). The presence of milky-red areas, shiny-white streaks, a blue-white veil and blue-grey areas in dermoscopy is highly correlated with histological ulceration and a mitotic rate > 1/mm(2). The dermoscopic patterns shiny-white streaks, milky-red areas and blue-white veil were also significantly associated with development of distant metastases. Conclusion Our study proves a significant correlation between the dermoscopic patterns "blue white veil", "milky-red areas" and "shiny-white streaks" and the histological findings "ulceration" and "mitotic rate > 1/mm(2)". Furthermore these dermoscopic patterns are highly related to distant metastases. Thus, dermoscopy renders earlier prognostic statements possible.	[Deinlein, Teresa; Arzberger, Edith; Zalaudek, Iris; Massone, Cesare; Hofmann-Wellenhof, Rainer] Med Univ Graz, Dept Dermatol, Graz, Austria; [Massone, Cesare] Galliera Hosp, Dept Dermatol, Genoa, Italy; [Garcias-Ladaria, Juan] Hosp Gen Univ Valencia, Valencia, Spain; [Oliveira, Andre] Hosp Curry Cabral, Ctr Hosp Lisboa Cent, Dept Dermatol, Lisbon, Portugal; [Schulter, Guenter] Karl Franzens Univ Graz, Dept Psychol, Biol Psychol Unit, Graz, Austria	Medical University of Graz; Ente Ospedaliero Ospedali Galliera; University of Genoa; Hospital Clinic Universitari de Valencia; Centro Hospitalar de Lisboa Central, EPE; Universidade de Lisboa; University of Graz	Hofmann-Wellenhof, R (corresponding author), Med Univ Graz, Dept Dermatol, Graz, Austria.	rainer.hofmann@medunigraz.at	Zalaudek, Iris/AAL-5436-2020; Ladaria, Juan Garcias/AAR-5480-2021; Zalaudek, Iris/E-5910-2010	Zalaudek, Iris/0000-0002-7878-4955; Ladaria, Juan Garcias/0000-0002-0831-9468; Zalaudek, Iris/0000-0002-7878-4955; massone, cesare/0000-0002-0996-643X				Argenziano G, 1999, J AM ACAD DERMATOL, V40, P61, DOI 10.1016/S0190-9622(99)70528-1; Argenziano G, 1997, J AM ACAD DERMATOL, V37, P68, DOI 10.1016/S0190-9622(97)70213-5; Argenziano G, 2003, J AM ACAD DERMATOL, V48, P679, DOI 10.1067/mjd.2003.281; Argenziano G, 2009, SEMIN CUTAN MED SURG, V28, P142, DOI 10.1016/j.sder.2009.06.001; Azzola MF, 2003, CANCER-AM CANCER SOC, V97, P1488, DOI 10.1002/cncr.11196; Balch CM, 2009, J CLIN ONCOL, V27, P6199, DOI 10.1200/JCO.2009.23.4799; Barnhill RL, 2005, J CUTAN PATHOL, V32, P268, DOI 10.1111/j.0303-6987.2005.00310.x; Carli P, 2004, J AM ACAD DERMATOL, V50, P683, DOI 10.1016/j.jaad.2003.09.009; Ciudad-Blanco C, 2014, ACTAS DERMO-SIFILOGR, V105, P683, DOI 10.1016/j.ad.2014.01.008; De Giorgi V, 2002, CLIN DERMATOL, V20, P305, DOI 10.1016/S0738-081X(02)00224-9; Ivarez T, 2014, BRIT J DERMATOLOGY; da Silva VPM, 2013, AN BRAS DERMATOL, V88, P712, DOI 10.1590/abd1806-4841.20132017; Pagnanelli G, 2007, ANTICANCER RES, V27, P2939; Shen S, 2014, JAMA DERMATOL, V150, P1048, DOI 10.1001/jamadermatol.2014.635; Shitara D, 2014, ACTA DERM-VENEREOL, V94, P132, DOI 10.2340/00015555-1683; SMOLLE J, 1989, J INVEST DERMATOL, V93, P178, DOI 10.1111/1523-1747.ep12277396; Stante M, 2001, MELANOMA RES, V11, P147, DOI 10.1097/00008390-200104000-00009; Vestergaard ME, 2008, BRIT J DERMATOL, V159, P669, DOI 10.1111/j.1365-2133.2008.08713.x; Wang Yan, 2013, Zhonghua Bing Li Xue Za Zhi, V42, P178, DOI 10.3760/cma.j.issn.0529-5807.2013.03.008	19	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2017	12	4							e0174871	10.1371/journal.pone.0174871	http://dx.doi.org/10.1371/journal.pone.0174871			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0JS	28399177	Green Published, Green Submitted, gold			2022-12-27	WOS:000399949000013
J	Wang, YR; Liu, QY; Jiang, LK; Yin, MH; Wang, SS				Wang, Yuru; Liu, Qiaoyuan; Jiang, Longkui; Yin, Minghao; Wang, Shengsheng			Sequential Monte Carlo-guided ensemble tracking	PLOS ONE			English	Article								A great deal of robustness is allowed when visual tracking is considered as a classification problem. This paper combines a finite number of weak classifiers in a SMC framework as a strong classifier. The time-varying ensemble parameters (confidence of weak classifiers) are regarded as sequential arriving states and their posterior distribution is estimated in a Bayesian manner. Therefore, both the adaptiveness and stability are kept for the ensemble classification in handling scene changes and target deformation. Moreover, to increase the tracking accuracy, weak classifiers including Support Vector Machine (SVM) and Large Margin Distribution Machine (LDM) are combined as a hybrid strong one, with adaptiveness to the sample scales. Comprehensive experiments are performed on benchmark videos with various tracking challenges, and the proposed method is demonstrated to be better than or comparable to the state-of-the-art trackers.	[Wang, Yuru; Liu, Qiaoyuan; Yin, Minghao] North East Normal Univ, Comp Sci & Informat Technol, Changchun, Jilin Province, Peoples R China; [Jiang, Longkui] Jilin Business & Technol Coll, Sch Informat Engn, Changchun, Jilin Province, Peoples R China; [Wang, Shengsheng] Jilin Univ, Key Lab Symbol Computat & Knowledge Engn, Minist Educ, Changchun, Jilin Province, Peoples R China	Northeast Normal University - China; Jilin Business & Technology College; Jilin University	Wang, YR (corresponding author), North East Normal Univ, Comp Sci & Informat Technol, Changchun, Jilin Province, Peoples R China.	wangyr915@nenu.edu.cn			National Natural Science Foundation of China [61300099]; China Postdoctoral Science Foundation [2015M570261]; Science and Technology Development Plan of Jilin Province [20170101144JC]; China key Laboratory of Symbolic Computation and Knowledge Engineering of Ministry of Education [93K172016K14]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Science and Technology Development Plan of Jilin Province; China key Laboratory of Symbolic Computation and Knowledge Engineering of Ministry of Education	This work is supported by the National Natural Science Foundation of China under Grant No. 61300099, the China Postdoctoral Science Foundation funded project under Grant No. 2015M570261, and the Science and Technology Development Plan of Jilin Province under grant No. 20170101144JC, the open fund of China key Laboratory of Symbolic Computation and Knowledge Engineering of Ministry of Education under Grand No. 93K172016K14.	Avidan S, 2004, IEEE T PATTERN ANAL, V26, P1064, DOI 10.1109/TPAMI.2004.53; Avidan S, 2007, IEEE T PATTERN ANAL, V29, P261, DOI 10.1109/TPAMI.2007.35; Babenko B., 2009, CVPR; Bai QX, 2013, IEEE I CONF COMP VIS, P2040, DOI 10.1109/ICCV.2013.255; Bertinetto L., 2016, IEEE C COMP VIS PATT; Chen J, 2016, MULTIMED TOOLS APPL, V75, P2801, DOI 10.1007/s11042-015-2546-0; Dalal N, 2005, PROC CVPR IEEE, P886, DOI 10.1109/cvpr.2005.177; Danelljan M, 2014, PROC CVPR IEEE, P1090, DOI 10.1109/CVPR.2014.143; Darrell T., 2007, MATCHING SETS FEATUR; Gao W, 2013, ARTIF INTELL, V203, P1, DOI 10.1016/j.artint.2013.07.002; Grabner H., 2006, BRIT MACH VIS C, P47; Gu B, 2016, IEEE T NEUR NET LEAR, DOI [DOI 10.1109/TNNLS.2016.2527796, 10.1109/TNNLS.2016.2527796]; Gu B, 2017, IEEE T NEUR NET LEAR, V28, P1646, DOI 10.1109/TNNLS.2016.2544779; Gu B, 2015, NEURAL NETWORKS, V67, P140, DOI 10.1016/j.neunet.2015.03.013; Hare S, 2011, IEEE I CONF COMP VIS, P263, DOI 10.1109/ICCV.2011.6126251; Henriques JF, 2015, IEEE T PATTERN ANAL, V37, P583, DOI 10.1109/TPAMI.2014.2345390; Isard M, 1998, INT J COMPUT VISION, V29, P5, DOI 10.1023/A:1008078328650; Khan Z, 2004, LECT NOTES COMPUT SC, V2034, P279; Kwon J, 2010, PROC CVPR IEEE, P1269, DOI 10.1109/CVPR.2010.5539821; Lin C, 2014, NEUROCOMPUTING, V123, P424, DOI 10.1016/j.neucom.2013.08.004; Mikolajczyk Kalal Zdenek, 2011, IEEE T PATTERN ANAL, P1409; Oron ShaulLocally Orderless Tracking, 2012, INT J COMPUTER VISIO, P1940; Penne T., 2010, P INT C IM PROC THEO, P363; Reyzin L., 2006, PROC 23 INT C MACH L, P753, DOI DOI 10.1145/1143844.1143939; Saffari Amir, 2009, 2009 IEEE 12th International Conference on Computer Vision Workshops, ICCV Workshops, P1393, DOI 10.1109/ICCVW.2009.5457447; Saffari A, 2010, PROC CVPR IEEE, P3570, DOI 10.1109/CVPR.2010.5539937; Sevilla-Lara L, 2012, PROC CVPR IEEE, P1910, DOI 10.1109/CVPR.2012.6247891; Tian M, 2007, LECT NOTES COMPUT SC, V4843, P355; Wen XZ, 2015, INFORM SCIENCES, V295, P395, DOI 10.1016/j.ins.2014.10.040; Zeng HQ, 2016, NEUROCOMPUTING, V217, P3, DOI 10.1016/j.neucom.2015.11.130; Zhang KH, 2014, IEEE T PATTERN ANAL, V36, P2002, DOI 10.1109/TPAMI.2014.2315808; Zhang T., 2013, P 20 ACM SIGKDD INT, P313; Zheng YH, 2015, J INTELL FUZZY SYST, V28, P961, DOI 10.3233/IFS-141378; Zhong BN, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/9406259; Zhong BN, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161808; Zhong B, 2014, PATTERN RECOGN, V47, P1395, DOI 10.1016/j.patcog.2013.10.002; Zhou ZL, 2017, IEEE T INF FOREN SEC, V12, P48, DOI 10.1109/TIFS.2016.2601065; Zou Q, 2016, NEUROCOMPUTING, V173, P346, DOI 10.1016/j.neucom.2014.12.123	38	1	1	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2017	12	4							e0173297	10.1371/journal.pone.0173297	http://dx.doi.org/10.1371/journal.pone.0173297			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0JS	28399149	Green Published, gold, Green Submitted			2022-12-27	WOS:000399949000002
J	Amosova, AV; Bolsheva, NL; Zoshchuk, SA; Twardovska, MO; Yurkevich, OY; Andreev, IO; Samatadze, TE; Badaeva, ED; Kunakh, VA; Muravenko, OV				Amosova, Alexandra V.; Bolsheva, Nadezhda L.; Zoshchuk, Svyatoslav A.; Twardovska, Maryana O.; Yurkevich, Olga Yu; Andreev, Igor O.; Samatadze, Tatiana E.; Badaeva, Ekaterina D.; Kunakh, Viktor A.; Muravenko, Olga V.			Comparative molecular cytogenetic characterization of seven Deschampsia (Poaceae) species	PLOS ONE			English	Article							ANTARCTICA DESV.; FREEZE TOLERANCE; POPULATIONS; POLYPLOIDY; EXPRESSION; EVOLUTION; PLANTS; WHEAT; CHROMOSOMES; MECHANISMS	The genus Deschampsia P. Beauv (Poaceae) involves a group of widespread polymorphic species. Some of them are highly tolerant to stressful and variable environmental conditions, and D. antarctica is one of the only two vascular plants growing in Antarctic. This species is a source of useful for selection traits and a valuable model for studying an environmental stress tolerance in plants. Genome diversity and comparative chromosomal phylogeny within the genus have not been studied yet as karyotypes of most Deschampsia species are poorly investigated. We firstly conducted a comparative molecular cytogenetic analysis of D. antarctica (Antarctic Peninsula) and related species from various localities (D. cespitosa, D. danthonioides, D. elongata, D. flexuosa (= Avenella flexuosa), D. parvula and D. sukatschewii by fluorescence in situ hybridization with 45S and 5S rDNA, DAPI-banding and sequential rapid in situ hybridization with genomic DNA of D. antarctica, D. cespitosa, and D. flexuosa. Based on patterns of distribution of the examined markers, chromosomes of the studied species were identified. Within these species, common features as well as species peculiarities in their karyotypic structure and chromosomal distribution of molecular cytogenetic markers were characterized. Different chromosomal rearrangements were detected in D. antarctica, D. flexuosa, D. elongata and D. sukatschewii. In karyotypes of D. antarctica, D. cespitosa, D. elongata and D. sukatschewii, 0-3 B chromosomes possessed distinct DAPI-bands were observed. Our findings suggest that the genome evolution of the genus Deschampsia involved polyploidy and also different chromosomal rearrangements. The obtained results will help clarify the relationships within the genus Deschampsia, and can be a basis for the further genetic and biotechnological studies as well as for selection of plants tolerant to extreme habitats.	[Amosova, Alexandra V.; Bolsheva, Nadezhda L.; Zoshchuk, Svyatoslav A.; Yurkevich, Olga Yu; Samatadze, Tatiana E.; Badaeva, Ekaterina D.; Muravenko, Olga V.] Russian Acad Sci, Engelhardt Mol Biol Inst, Moscow, Russia; [Twardovska, Maryana O.; Andreev, Igor O.; Kunakh, Viktor A.] Natl Acad Sci Ukraine, Inst Mol Biol & Genet, Kiev, Ukraine	Russian Academy of Sciences; Engelhardt Institute of Molecular Biology, RAS; National Academy of Sciences Ukraine; Institute of Molecular Biology & Genetics of NASU	Amosova, AV (corresponding author), Russian Acad Sci, Engelhardt Mol Biol Inst, Moscow, Russia.	amomar@mail.ru	Tatiana, Samatadze/AAD-4816-2019; Badaeva, Ekaterina D./N-4368-2017; Yurkevich, Olga Yu./CAF-7659-2022; Andreev, Igor/G-6194-2016; Yurkevich, Olga Yu./CAI-2654-2022; Muravenko, Olga/A-3889-2017	Tatiana, Samatadze/0000-0002-1012-3560; Badaeva, Ekaterina D./0000-0001-7101-9639; Yurkevich, Olga Yu./0000-0003-4124-2367; Andreev, Igor/0000-0002-3706-8514; Yurkevich, Olga Yu./0000-0003-4124-2367; Twardovska, Maryana/0000-0002-9132-1330; Kunakh, Viktor/0000-0002-9418-3172; Muravenko, Olga/0000-0003-3150-8598; amosova, alexandra/0000-0002-5208-6702	National Antarctic Scientific Center of the Ministry of Education and Science of Ukraine; Russian Foundation of Basic Research [15-04-05574 AA, 17-08-01504 OM]; Fundamental Research Program of the Russian Academy of Sciences "Dynamics of Plant, Animal and Human Genofonds" [0103-2015-0117 OM]	National Antarctic Scientific Center of the Ministry of Education and Science of Ukraine; Russian Foundation of Basic Research(Russian Foundation for Basic Research (RFBR)); Fundamental Research Program of the Russian Academy of Sciences "Dynamics of Plant, Animal and Human Genofonds"	The authors acknowledge the support of the National Antarctic Scientific Center of the Ministry of Education and Science of Ukraine. The research was performed in the frame of the National targeted scientific and technological program of research in Antarctic for 2011-2020. We thank Dr. Prof. Parnikoza I.Y., Dr. Prof. Polyschuk V.P. and Dr. Dykyy I.V.for collecting D. antartctica seeds.; This work was supported by the Russian Foundation of Basic Research [grants no. 15-04-05574 AA; 17-08-01504 OM] and Fundamental Research Program of the Russian Academy of Sciences "Dynamics of Plant, Animal and Human Genofonds" [grant no. 0103-2015-0117 OM]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberdi M, 2002, PHYSIOL PLANTARUM, V115, P479, DOI 10.1034/j.1399-3054.2002.1150401.x; Amosova AV, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138878; Asker S. E., 1992, APOMIXIS PLANTS; Silva AEBE, 2010, BIOTECH HISTOCHEM, V85, P115, DOI [10.3109/10520290903149596, 10.1080/10520290903149596]; Belyayev A, 2013, ANN BOT-LONDON, V111, P531, DOI 10.1093/aob/mct023; Bolsheva NL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122015; Bravo LA, 2005, J EXP BOT, V56, P1189, DOI 10.1093/jxb/eri112; Bravo LA, 2001, PHYSIOL PLANTARUM, V111, P55, DOI 10.1034/j.1399-3054.2001.1110108.x; Brochmann C, 2004, BIOL J LINN SOC, V82, P521, DOI 10.1111/j.1095-8312.2004.00337.x; Butorina A K, 2001, Tsitologiia, V43, P809; Byun MY, 2015, PLANT SCI, V236, P61, DOI 10.1016/j.plantsci.2015.03.020; Camacho JPM, 2000, PHILOS T R SOC B, V355, P163, DOI 10.1098/rstb.2000.0556; Cardone S, 2009, POLAR BIOL, V32, P427, DOI 10.1007/s00300-008-0535-8; Chew O, 2012, PLANT CELL ENVIRON, V35, P829, DOI 10.1111/j.1365-3040.2011.02456.x; Chiapella J, 2007, TAXON, V56, P55, DOI 10.2307/25065735; Chinnusamy V, 2009, CURR OPIN PLANT BIOL, V12, P133, DOI 10.1016/j.pbi.2008.12.006; Dhar MK, 2002, CHROMOSOMA, V111, P332, DOI 10.1007/s00412-002-0214-4; Doyle J. J., 1987, PHYTOCHEM B, P11; Souto DPF, 2006, PLANT SYST EVOL, V261, P1, DOI 10.1007/s00606-006-0425-x; FLAVELL RB, 1980, COLD SPRING HARB SYM, V45, P501, DOI 10.1101/SQB.1981.045.01.066; GAMBORG OL, 1968, CAN J BIOCHEM CELL B, V46, P417, DOI 10.1139/o68-063; GarciaSuarez R, 1997, PLANT SYST EVOL, V205, P99, DOI 10.1007/BF00982800; GERLACH WL, 1980, NUCLEIC ACIDS RES, V8, P4851, DOI 10.1093/nar/8.21.4851; GERLACH WL, 1979, NUCLEIC ACIDS RES, V7, P1869, DOI 10.1093/nar/7.7.1869; Holderegger R, 2003, ARCT ANTARCT ALP RES, V35, P214, DOI 10.1657/1523-0430(2003)035[0214:POAHDA]2.0.CO;2; Houben A, 2013, PLANT GENOME DIVERSI, V2, P149, DOI DOI 10.1007/978-3-7091-1160-4_10; Houben A, 2014, CELL MOL LIFE SCI, V71, P467, DOI 10.1007/s00018-013-1437-7; John UP, 2009, PLANT CELL ENVIRON, V32, P336, DOI [10.1111/j.1365-3040.2009.01925.x, 10.1111/j.1365-3040.2008.01925.x]; John UP, 2005, COMP FUNCT GENOM, V6, P230, DOI 10.1002/cfg.475; Jones N, 2003, TRENDS PLANT SCI, V8, P417, DOI 10.1016/S1360-1385(03)00187-0; KAWANO SHOICHI, 1963, CANADIAN JOUR BOT, V41, P719, DOI 10.1139/b63-059; Kravets AA, 2011, UAJ, V10-11, P302; Gonzalez ML, 2016, POLAR BIOL, V39, P1663, DOI 10.1007/s00300-016-1890-5; Lee J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092501; Lee J, 2013, PLANTA, V237, P823, DOI 10.1007/s00425-012-1797-5; Levy AA, 2002, PLANT PHYSIOL, V130, P1587, DOI 10.1104/pp.015727; Madlung A, 2004, ANN BOT-LONDON, V94, P481, DOI 10.1093/aob/mch172; Moore DM, 1967, BRIT ANTARCTIC SURVE, V14, P69; Muravenko OV, 2009, GENETICA, V135, P245, DOI 10.1007/s10709-008-9273-7; Nkongolo KK, 2001, GENOME, V44, P818, DOI 10.1139/gen-44-5-818; Parnikoza I., 2011, American Journal of Plant Sciences, V2, P381, DOI 10.4236/ajps.2011.23044; Parnikoza I, 2015, POLAR BIOL, V38, P1401, DOI 10.1007/s00300-015-1704-1; Pereira BK, 2009, J PHOTOCH PHOTOBIO B, V96, P117, DOI 10.1016/j.jphotobiol.2009.04.011; Pereira S, 2017, ANN BOT-LONDON, V119, P325, DOI 10.1093/aob/mcw206; Rabert C, 2014, INT J MOL SCI, V15, P2359, DOI 10.3390/ijms15022359; Ramsey J, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0352; Raskina O, 2008, CYTOGENET GENOME RES, V120, P351, DOI 10.1159/000121084; Rodionov A V, 2013, Tsitologiia, V55, P225; Ruban A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090214; Ruiz-Herrera A, 2008, CYTOGENET GENOME RES, V122, P219, DOI 10.1159/000167807; Saarela Jeffeg M., 2010, P557; Schneider J, 2014, SCHLECHTENDALIA, V28, P1; Soltis PS, 2009, ANNU REV PLANT BIOL, V60, P561, DOI 10.1146/annurev.arplant.043008.092039; Soreng RJ, 2015, J SYST EVOL, V53, P117, DOI 10.1111/jse.12150; Volkov RA, 2010, POLAR SCI, V4, P469, DOI 10.1016/j.polar.2010.04.011; White MJD, 1973, TH CHROMOSOMES; Winterfeld G, 2007, PLANT SYST EVOL, V264, P75, DOI 10.1007/s00606-006-0482-1; Winterfeld G, 2007, BOT J LINN SOC, V155, P193, DOI 10.1111/j.1095-8339.2007.00690.x; Xiong FS, 1999, PHYSIOL PLANTARUM, V106, P276, DOI 10.1034/j.1399-3054.1999.106304.x; Zagrichuk OM, 2011, UKR ANTARKT ZH, V10-11, P289; Zuniga GE, 1996, ENVIRON EXP BOT, V36, P393, DOI 10.1016/S0098-8472(96)01026-X	61	16	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2017	12	4							e0175760	10.1371/journal.pone.0175760	http://dx.doi.org/10.1371/journal.pone.0175760			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0MB	28407010	Green Published, gold, Green Submitted			2022-12-27	WOS:000399955400091
J	Sur, M; Suffredini, T; Wessells, SM; Bloom, PH; Lanzone, M; Blackshire, S; Sridhar, S; Katzner, T				Sur, Maitreyi; Suffredini, Tony; Wessells, Stephen M.; Bloom, Peter H.; Lanzone, Michael; Blackshire, Sheldon; Sridhar, Srisarguru; Katzner, Todd			Improved supervised classification of accelerometry data to distinguish behaviors of soaring birds	PLOS ONE			English	Article							BODY ACCELERATION; ENERGY; MIGRATION; ETHOGRAMS; MOVEMENT; ANIMALS; MODES; TIME; LIFE	Soaring birds can balance the energetic costs of movement by switching between flapping, soaring and gliding flight. Accelerometers can allow quantification of flight behavior and thus a context to interpret these energetic costs. However, models to interpret accelerometry data are still being developed, rarely trained with supervised datasets, and difficult to apply. We collected accelerometry data at 140Hz from a trained golden eagle (Aquila chrysaetos) whose flight we recorded with video that we used to characterize behavior. We applied two forms of supervised classifications, random forest (RF) models and K-nearest neighbor (KNN) models. The KNN model was substantially easier to implement than the RF approach but both were highly accurate in classifying basic behaviors such as flapping (85.5% and 83.6% accurate, respectively), soaring (92.8% and 87.6%) and sitting (84.1% and 88.9%) with overall accuracies of 86.6% and 92.3% respectively. More detailed classification schemes, with specific behaviors such as banking and straight flights were well classified only by the KNN model (91.24% accurate; RF = 61.64% accurate). The RF model maintained its accuracy of classifying basic behavior classification accuracy of basic behaviors at sampling frequencies as low as 10Hz, the KNN at sampling frequencies as low as 20Hz. Classification of accelerometer data collected from free ranging birds demonstrated a strong dependence of predicted behavior on the type of classification model used. Our analyses demonstrate the consequence of different approaches to classification of accelerometry data, the potential to optimize classification algorithms with validated flight behaviors to improve classification accuracy, ideal sampling frequencies for different classification algorithms, and a number of ways to improve commonly used analytical techniques and best practices for classification of accelerometry data.	[Sur, Maitreyi] Boise State Univ, Dept Biol Sci, Boise, ID 83725 USA; [Suffredini, Tony] Sky Patrol Abatement, Simi Valley, CA USA; [Wessells, Stephen M.] US Geol Survey, Henderson, NV USA; [Bloom, Peter H.] Bloom Biol, Santa Ana, CA USA; [Lanzone, Michael; Blackshire, Sheldon] Cellular Tracking Technol, Rio Grande, NJ USA; [Sridhar, Srisarguru] Boise State Univ, Dept Comp Sci, Boise, ID 83725 USA; [Katzner, Todd] US Geol Survey, Forest & Rangeland Ecosyst Sci Ctr, Boise, ID USA	Idaho; Boise State University; United States Department of the Interior; United States Geological Survey; Idaho; Boise State University; United States Department of the Interior; United States Geological Survey	Sur, M (corresponding author), Boise State Univ, Dept Biol Sci, Boise, ID 83725 USA.	maitreyisur@boisestate.edu		Sur, Maitreyi/0000-0002-7174-1813	U.S. Bureau of Land Management IAA [L14PG00265]	U.S. Bureau of Land Management IAA	This research was funded by the U.S. Bureau of Land Management IAA #L14PG00265 to TK. The commercial affiliations Bloom Biological, Cellular Tracking Technologies & Sky Patrol Abatement provided support in the form of salaries for authors [PB, ML, SB and TS], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Algar AC, 2007, GLOBAL ECOL BIOGEOGR, V16, P170, DOI 10.1111/j.1466-8238.2006.00275.x; Altun K, 2010, PATTERN RECOGN, V43, P3605, DOI 10.1016/j.patcog.2010.04.019; Ballance LT, 1997, ECOLOGY, V78, P1502, DOI 10.1890/0012-9658(1997)078[1502:SCSAAP]2.0.CO;2; Berlincourt M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139351; Bidder OR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088609; Bishop CM, 2015, SCIENCE, V347, P250, DOI 10.1126/science.1258732; Bom RA, 2014, MOV ECOL, V2, DOI 10.1186/2051-3933-2-6; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 2002, MANUAL SETTING USING; Brown DD, 2013, ANIM BIOTELEM, V1, P20, DOI DOI 10.1186/2050-3385-1-20; Duerr AE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035548; Halsey LG, 2009, COMP BIOCHEM PHYS A, V152, P197, DOI 10.1016/j.cbpa.2008.09.021; Hawkins DM, 2003, J QUAL TECHNOL, V35, P355, DOI 10.1080/00224065.2003.11980233; Holland RA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008264; Katzner TE, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0530; Kuhn M, 2021, CARET CLASSIFICATION, DOI DOI 10.1887/0750303123/B365C43; Lanzone MJ, 2012, BIOL LETTERS, V8, P710, DOI 10.1098/rsbl.2012.0359; Miller TA, 2014, CONSERV BIOL, V28, P745, DOI 10.1111/cobi.12227; Nathan R, 2012, J EXP BIOL, V215, P986, DOI 10.1242/jeb.058602; Nishizawa H, 2013, J ETHOL, V31, P315, DOI 10.1007/s10164-013-0381-1; Peters A., 2015, IPRED IMPROVED PREDI; Qasem L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031187; R Core Team, 2021, R LANGUAGE ENV STAT; Ravi N., 2005, P 17 C INN APPL ART, P1541, DOI DOI 10.1007/978-3-642-02481-8_120; Resheff YS, 2014, MOV ECOL, V2, DOI 10.1186/s40462-014-0027-0; Reynolds KV, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0645; Roshier DA, 2008, OECOLOGIA, V156, P465, DOI 10.1007/s00442-008-0987-0; Ross G.J, 2013, J STAT SOFTW, V78; Sakamoto KQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005379; Sapir N, 2011, P ROY SOC B-BIOL SCI, V278, P3380, DOI 10.1098/rspb.2011.0358; Shamoun-Baranes J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037997; Shepard Emily L. C., 2010, Endangered Species Research, V10, P47, DOI 10.3354/esr00084; Tomlinson S, 2014, TRENDS ECOL EVOL, V29, P280, DOI 10.1016/j.tree.2014.03.003; Venables WN., 2002, MODERN APPL STAT S, V4; Walker JS, 2015, VISUAL COMPUT, V31, P1067, DOI 10.1007/s00371-015-1112-0; Warrick D, 2012, CURR BIOL, V22, pR472, DOI 10.1016/j.cub.2012.04.057; Weimerskirch H, 2003, NATURE, V421, P333, DOI 10.1038/421333a; Wikelski M, 2003, NATURE, V423, P704, DOI 10.1038/423704a; Williams H.J., 2015, ANIM BIOTELEM, V1; Wilson Rory P., 2008, Endangered Species Research, V4, P123, DOI 10.3354/esr00064; Wilson RP, 2006, J ANIM ECOL, V75, P1081, DOI 10.1111/j.1365-2656.2006.01127.x; Wilson RP, 2008, ENDANGER SPECIES RES, V10, P29, DOI [10.3354/esr00091, DOI 10.3354/ESR00091]; Yoda K, 2004, P ROY SOC B-BIOL SCI, V271, pS240, DOI 10.1098/rsbl.2003.0157; Yoda K, 2001, J EXP BIOL, V204, P685; YOST M, 1983, BEHAV RES METH INSTR, V15, P258, DOI 10.3758/BF03203558	45	19	19	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2017	12	4							e0174785	10.1371/journal.pone.0174785	http://dx.doi.org/10.1371/journal.pone.0174785			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LZ	28403159	Green Published, gold, Green Submitted			2022-12-27	WOS:000399955200021
J	von Seck, P; Sander, FM; Lanzendorf, L; von Seck, S; Schmidt-Lucke, A; Zielonka, M; Schmidt-Lucke, C				von Seck, Peter; Sander, F. Martin; Lanzendorf, Leon; von Seck, Sabine; Schmidt-Lucke, Andre; Zielonka, Mirja; Schmidt-Lucke, Caroline			Persistent weight loss with a non-invasive novel medical device to change eating behaviour in obese individuals with high-risk cardiovascular risk profile	PLOS ONE			English	Article							DIETARY RESTRAINT; DISINHIBITION; PREVENTION; OVERWEIGHT	In evidence-based weight-loss programs weight regain is common after an initial weight reduction. Eating slowly significantly lowers meal energy intake and hunger ratings. Despite this knowledge, obese individuals do not implement this behaviour. We, thus tested the hypothesis of changing eating behaviour with an intra-oral medical device leading to constant weight reduction in overweight and obesity. Six obese patients (6 men, age 56 +/- 14, BMI 29 +/- 2 kg / m(2)) with increased CVRF profile were included in this prospective study. All patients had been treated for obesity during the last 10 years in a single centre and had at least 3 frustrate evidence-based diets. Patients received a novel non-invasive intra-oral medical device to slow eating time. Further advice included not to count calories, to avoid any other form of diet, to take their time with their meals, and to eat whatever they liked. This device was used only during meals for the first 4 to 8 weeks for a total of 88 [20 - 160] hours. Follow-up period was 23 [15 - 38] months. During this period, patients lost 11% [5 - 20%] (p< 0.001) of their initial weight. At 12 months, all patients had lost > 5%, and 67% (4/6) achieved a > 10% bodyweight loss. In the course of the study, altered eating patterns were observed. There were no complications with the medical device. Of note, all patients continued to lose weight after the initial intervention period (p< 0.001) and none of them had weight regain. With this medical device, overweight and obese patients with a history of previously frustrating attempts to lose weight achieved a significant and sustained weight loss over two years. These results warrant the ongoing prospective randomised controlled trial to prove concept and mechanism of action.	[Sander, F. Martin] Dent Clin, Frankfurt, Germany; [Lanzendorf, Leon] Tech Univ Berlin, Dept Hlth Care Management, Berlin, Germany; [von Seck, Sabine] MSD SHARP & DOHME GMBH, Berlin, Germany; [Schmidt-Lucke, Andre] Hygiea Hosp, Dept Internal Med, Berlin, Germany; [Zielonka, Mirja; Schmidt-Lucke, Caroline] Charite, Berlin, Germany; [Schmidt-Lucke, Caroline] Medicoacad Consultings, Berlin, Germany	Technical University of Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Schmidt-Lucke, C (corresponding author), Charite, Berlin, Germany.; Schmidt-Lucke, C (corresponding author), Medicoacad Consultings, Berlin, Germany.	carolina.schmidt-lucke@mediacc.org						Boling CL, 2009, NEW ENGL J MED, V360, P2247, DOI 10.1056/NEJMc096106; Bond MJ, 2001, INT J OBESITY, V25, P900, DOI 10.1038/sj.ijo.0801611; Chugay NCN, 2014, AM J COSEMETIC SURG, V31, P1; Cordido F, 2012, NEW ENGL J MED, V366, P380, DOI 10.1056/NEJMc1113675; Ebbeling CB, 2012, JAMA-J AM MED ASSOC, V307, P2627, DOI 10.1001/jama.2012.6607; Ebbert JO, 2014, CURR ATHEROSCLER REP, V16, DOI 10.1007/s11883-014-0445-x; FARQUHAR DL, 1986, SCOT MED J, V31, P180; Finkelstein EA, 2012, AM J PREV MED, V42, P563, DOI 10.1016/j.amepre.2011.10.026; Flegal KM, 2007, JAMA-J AM MED ASSOC, V298, P2028, DOI 10.1001/jama.298.17.2028; Flint A, 2000, INT J OBESITY, V24, P38, DOI 10.1038/sj.ijo.0801083; Gadde KM, 2013, JAMA-J AM MED ASSOC, V310, P2568, DOI 10.1001/jama.2013.282258; GARROW JS, 1981, BRIT MED J, V282, P858, DOI 10.1136/bmj.282.6267.858; Greenway FL, 2015, INT J OBESITY; HAUNER H, 2000, ADIPOSITAS, V10, P5; HERMAN CP, 1975, J PERS, V43, P647, DOI 10.1111/j.1467-6494.1975.tb00727.x; Lehnert T, 2012, OBES REV, V13, P537, DOI 10.1111/j.1467-789X.2011.00980.x; Mathieu J, 2009, J AM DIET ASSOC, V109, P1982, DOI 10.1016/j.jada.2009.10.023; McGee TL, 2012, OBESITY, V20, P126, DOI 10.1038/oby.2011.303; Mozaffarian D, 2011, NEW ENGL J MED, V364, P2392, DOI 10.1056/NEJMoa1014296; Murray CJL, 2013, NEW ENGL J MED, V369, P448, DOI 10.1056/NEJMra1201534; Pathak RK, 2015, J AM COLL CARDIOL, V65, P2159, DOI 10.1016/j.jacc.2015.03.002; RUDERMAN AJ, 1986, PSYCHOL BULL, V99, P247, DOI 10.1037/0033-2909.99.2.247; RUDERMAN AJ, 1985, J ABNORM PSYCHOL, V94, P78, DOI 10.1037/0021-843X.94.1.78; Ryan D, 2014, OBESITY, V22, pS1, DOI 10.1002/oby.20819; SPIEGEL TA, 1993, APPETITE, V21, P131, DOI 10.1016/0195-6663(93)90005-5; STUNKARD AJ, 1985, J PSYCHOSOM RES, V29, P71, DOI 10.1016/0022-3999(85)90010-8; SULLIVAN DH, 1993, J AM GERIATR SOC, V41, P725, DOI 10.1111/j.1532-5415.1993.tb07461.x; Vassimon HS, 2004, OBES SURG, V14, P829, DOI 10.1381/0960892041590881; VITA JA, 1990, CIRCULATION, V81, P491, DOI 10.1161/01.CIR.81.2.491; Walden HM, 2004, OBES RES, V12, P1773, DOI 10.1038/oby.2004.220; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; Wirth A, 2014, DTSCH ARZTEBL INT, V111, P705, DOI 10.3238/arztebl.2014.0705	32	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2017	12	4							e0174528	10.1371/journal.pone.0174528	http://dx.doi.org/10.1371/journal.pone.0174528			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET0LZ	28403206	Green Published, Green Submitted, gold			2022-12-27	WOS:000399955200015
J	Nakayasu, T; Yasugi, M; Shiraishi, S; Uchida, S; Watanabe, E				Nakayasu, Tomohiro; Yasugi, Masaki; Shiraishi, Soma; Uchida, Seiichi; Watanabe, Eiji			Three-dimensional computer graphic animations for studying social approach behaviour in medaka fish: Effects of systematic manipulation of morphological and motion cues	PLOS ONE			English	Article							DIRECTION-SELECTIVE NEURONS; ORYZIAS-LATIPES; DANIO-RERIO; MATE-CHOICE; SHOAL SIZE; FUNDULUS-DIAPHANUS; SCHOOLING BEHAVIOR; MATING PREFERENCES; BIOLOGICAL MOTION; INTERNAL-MODELS	We studied social approach behaviour in medaka fish using three-dimensional computer graphic (3DCG) animations based on the morphological features and motion characteristics obtained from real fish. This is the first study which used 3DCG animations and examined the relative effects of morphological and motion cues on social approach behaviour in medaka. Various visual stimuli, e.g., lack of motion, lack of colour, alternation in shape, lack of locomotion, lack of body motion, and normal virtual fish in which all four features (colour, shape, locomotion, and body motion) were reconstructed, were created and presented to fish using a computer display. Medaka fish presented with normal virtual fish spent a long time in proximity to the display, whereas time spent near the display was decreased in other groups when compared with normal virtual medaka group. The results suggested that the naturalness of visual cues contributes to the induction of social approach behaviour. Differential effects between body motion and locomotion were also detected. 3DCG animations can be a useful tool to study the mechanisms of visual processing and social behaviour in medaka.	[Nakayasu, Tomohiro; Yasugi, Masaki; Watanabe, Eiji] Natl Inst Basic Biol, Neurophysiol Lab, 5-1 Higashiyama,Myodaiji Cho, Okazaki, Aichi, Japan; [Nakayasu, Tomohiro] Shinshu Univ, Sch Med, Dept Mol & Cellular Physiol, 3-1-1 Asahi, Matsumoto, Nagano, Japan; [Shiraishi, Soma; Uchida, Seiichi] Kyushu Univ, Fac Informat Sci & Elect Engn, Dept Adv Informat Technol, Human Interface Lab,Nishi Ku, Fukuoka, Japan; [Shiraishi, Soma] NEC Corp Ltd, Minato Ku, 5-7-1 Shiba, Tokyo, Japan; [Watanabe, Eiji] SOKENDAI Grad Univ Adv Studies, Fac Life Sci, Dept Basic Biol, 5-1 Higashiyama,Myodaiji Cho, Okazaki, Aichi, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Shinshu University; Kyushu University; NEC Corporation; Graduate University for Advanced Studies - Japan	Nakayasu, T; Watanabe, E (corresponding author), Natl Inst Basic Biol, Neurophysiol Lab, 5-1 Higashiyama,Myodaiji Cho, Okazaki, Aichi, Japan.; Nakayasu, T (corresponding author), Shinshu Univ, Sch Med, Dept Mol & Cellular Physiol, 3-1-1 Asahi, Matsumoto, Nagano, Japan.; Watanabe, E (corresponding author), SOKENDAI Grad Univ Adv Studies, Fac Life Sci, Dept Basic Biol, 5-1 Higashiyama,Myodaiji Cho, Okazaki, Aichi, Japan.	tnakayasu0616@gmail.com; eiji@nibb.ac.jb		Yasugi, Masaki/0000-0001-7876-405X; Watanabe, Eiji/0000-0001-9089-8122	MEXT/JSPS KAKENHI Grant [26430028]	MEXT/JSPS KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	MEXT/JSPS KAKENHI Grant Number 26430028 Grant-in-Aid for Scientific Research (C) supported this work. The funder provided support in the form of salaries for SS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the "Author Contributions" section.	Abaid N, 2012, BEHAV BRAIN RES, V232, P406, DOI 10.1016/j.bbr.2012.03.028; Agrillo C, 2008, ETHOLOGY, V114, P479, DOI 10.1111/j.1439-0310.2008.01493.x; Allen JM, 1997, COPEIA, P195, DOI 10.2307/1447858; Ansai S, 2016, BEHAV BRAIN RES, V303, P126, DOI 10.1016/j.bbr.2016.01.050; Baldauf SA, 2009, J FISH BIOL, V75, P738, DOI 10.1111/j.1095-8649.2009.02347.x; Butkowski T, 2011, JOVE-J VIS EXP, DOI 10.3791/2374; Campbell MW, 2009, P R SOC B, V276, P4255, DOI 10.1098/rspb.2009.1087; Chouinard-Thuly L, 2017, CURR ZOOL, V63, P5, DOI 10.1093/cz/zow104; Engeszer RE, 2004, CURR BIOL, V14, P881, DOI 10.1016/j.cub.2004.04.042; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Fernandes Y, 2015, PHARMACOL BIOCHEM BE, V139, P94, DOI 10.1016/j.pbb.2015.01.011; Gebhardt C, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00111; Gierszewski S, 2017, CURR ZOOL, V63, P65, DOI 10.1093/cz/zow108; Gomez-Laplaza LM, 2009, BEHAV PROCESS, V82, P39, DOI 10.1016/j.beproc.2009.04.002; GOODALE MA, 1992, TRENDS NEUROSCI, V15, P20, DOI 10.1016/0166-2236(92)90344-8; Griffiths SW, 1997, ANIM BEHAV, V53, P945, DOI 10.1006/anbe.1996.0315; HALL DJ, 1979, J FISH RES BOARD CAN, V36, P1029, DOI 10.1139/f79-145; HURLBERT SH, 1984, ECOL MONOGR, V54, P187, DOI 10.2307/1942661; Imada H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011248; Ishikawa Y., 1999, FISH BIOL J MEDAKA, V10, P1; Isoe Y, 2016, ZOOL SCI, V33, P246, DOI 10.2108/zs150213; Ito M, 2008, NAT REV NEUROSCI, V9, P304, DOI 10.1038/nrn2332; Ito M, 2006, PROG NEUROBIOL, V78, P272, DOI 10.1016/j.pneurobio.2006.02.006; Iwamatsu T., 2006, INTEGRATED BOOK BIOL; JOHANSSON G, 1973, PERCEPT PSYCHOPHYS, V14, P201, DOI 10.3758/BF03212378; KAWATO M, 1993, NETWORK-COMP NEURAL, V4, P415, DOI 10.1088/0954-898X/4/4/001; Klar M, 2002, BRAIN RES BULL, V57, P431, DOI 10.1016/S0361-9230(01)00706-7; Kobayashi Y, 2007, ANN NY ACAD SCI, V1104, P310, DOI 10.1196/annals.1390.003; KRAUSE J, 1994, ETHOLOGY, V98, P128; Kunzler R, 2001, BEHAV ECOL, V12, P681, DOI 10.1093/beheco/12.6.681; Kunzler R, 1998, BEHAVIOUR, V135, P1137, DOI 10.1163/156853998792913537; Lachlan RF, 1998, ANIM BEHAV, V56, P181, DOI 10.1006/anbe.1998.0760; LANDEAU L, 1986, ANIM BEHAV, V34, P1372, DOI 10.1016/S0003-3472(86)80208-1; Levin LE, 1996, BEHAV PROCESS, V37, P1, DOI 10.1016/0376-6357(95)00067-4; Levy K, 2014, BIOL OPEN, V3, P1245, DOI 10.1242/bio.20149175; Masseck OA, 2008, J NEUROPHYSIOL, V99, P200, DOI 10.1152/jn.00926.2007; Masseck OA, 2009, J NEUROPHYSIOL, V102, P2781, DOI 10.1152/jn.00415.2009; Matsumoto Y, 2006, GENE, V371, P268, DOI 10.1016/j.gene.2005.12.005; Matsunaga W, 2012, SCI REP-UK, V2, DOI 10.1038/srep00219; McRobert SP, 1998, ANIM BEHAV, V56, P611, DOI 10.1006/anbe.1998.0846; MORGAN MJ, 1985, Z TIERPSYCHOL, V70, P236; MORGAN MJ, 1987, ENVIRON BIOL FISH, V20, P105, DOI 10.1007/BF00005290; Mori M., 1970, ENERGY, V7, P33, DOI DOI 10.1109/MRA.2012.2192811; NAKAMURA YOSHIO, 1952, BULL JAPANESE SOC SCI FISH, V18, P93; Nakayama K, 2005, ENVIRON TOXICOL CHEM, V24, P2588, DOI 10.1897/04-518R2.1; Nakayasu T, 2014, ANIM COGN, V17, P559, DOI 10.1007/s10071-013-0687-y; Neri P, 2012, ANIM BEHAV, V84, P485, DOI 10.1016/j.anbehav.2012.06.005; Ochiai T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071685; Okuyama T, 2014, SCIENCE, V343, P91, DOI 10.1126/science.1244724; PITCHER TJ, 1982, BEHAV ECOL SOCIOBIOL, V10, P149, DOI 10.1007/BF00300175; Pitcher TJ, 1993, BEHAV TELEOST FISHES, V2, P363; Polverino G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077589; Polverino G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054315; Pritchard VL, 2001, ANIM BEHAV, V62, P1085, DOI 10.1006/anbe.2001.1858; Qin MY, 2014, ZEBRAFISH, V11, P185, DOI 10.1089/zeb.2013.0969; RANTA E, 1990, ANN ZOOL FENN, V27, P67; Rosenthal GG, 2002, ANIM BEHAV, V63, P37, DOI 10.1006/anbe.2001.1887; Ruhl N, 2005, J FISH BIOL, V67, P1318, DOI 10.1111/j.0022-1112.2005.00826.x; SAJOVIC P, 1982, NEUROSCIENCE, V7, P2427, DOI 10.1016/0306-4522(82)90205-6; Salva OR, 2014, FRONT NEURAL CIRCUIT, V8, DOI 10.3389/fncir.2014.00119; Saverino C, 2008, BEHAV BRAIN RES, V191, P77, DOI 10.1016/j.bbr.2008.03.013; Schultz W, 2000, ANNU REV NEUROSCI, V23, P473, DOI 10.1146/annurev.neuro.23.1.473; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; Steckenfinger SA, 2009, P NATL ACAD SCI USA, V106, P18362, DOI 10.1073/pnas.0910063106; Svendsen JC, 2003, J FISH BIOL, V62, P834, DOI 10.1046/j.1095-8649.2003.00068.x; Takeda H, 2010, ANNU REV GENET, V44, P217, DOI 10.1146/annurev-genet-051710-151001; Taneda Koji, 1996, Memoirs of the Faculty of Science Kochi University Series D Biology, V16-17, P69; Tedore C, 2017, CURR ZOOL, V63, P27, DOI 10.1093/cz/zow076; Tsubokawa T, 2009, SOC NEUROSCI-UK, V4, P276, DOI 10.1080/17470910802625215; Turnell ER, 2003, BIOL BULL-US, V205, P225, DOI 10.2307/1543265; Van Dyk DA, 2008, BEHAV ECOL, V19, P895, DOI 10.1093/beheco/arn052; Ware ELR, 2017, CURR ZOOL, V63, P85, DOI 10.1093/cz/zow066; Watanabe E, 2010, VISION RES, V50, P2381, DOI 10.1016/j.visres.2010.09.021; Wittbrodt J, 2002, NAT REV GENET, V3, P53, DOI 10.1038/nrg704; Wolpert DM, 1998, TRENDS COGN SCI, V2, P338, DOI 10.1016/S1364-6613(98)01221-2; Wong BBM, 2006, AM NAT, V167, P136, DOI 10.1086/498278; Yokoi S, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005009	77	14	14	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2017	12	4							e0175059	10.1371/journal.pone.0175059	http://dx.doi.org/10.1371/journal.pone.0175059			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET0JS	28399163	Green Published, Green Submitted, gold			2022-12-27	WOS:000399949000016
J	Chang, HW; Lin, ZM; Wu, MJ; Wang, LY; Chow, YH; Jiang, SS; Ch'ang, HJ; Chang, VHS				Chang, Hsuen-Wen; Lin, Zih-Miao; Wu, Min-Ju; Wang, Li-Yu; Chow, Yen-Hung; Jiang, Shih Sheng; Ch'ang, Hui-Ju; Chang, Vincent H. S.			Characterization of a transgenic mouse model exhibiting spontaneous lung adenocarcinomas with a metastatic phenotype	PLOS ONE			English	Article							JAAGSIEKTE SHEEP RETROVIRUS; EXPRESSION; CANCER	Developing lung cancer in mouse models that display similarities of both phenotype and genotype will undoubtedly provide further and better insights into lung tumor biology. Moreover, a high degree of pathophysiological similarity between lung tumors from mouse models and their human counterparts will make it possible to use these mouse models for preclinical tests. Ovine pulmonary adenocarcinomas (OPAs) present the same symptoms as adenocarcinomas in humans and are caused by a betaretrovirus. OPAs have served as an exquisite model of carcinogenesis for human lung adenocarcinomas. In this study, we characterized the histopathology and transcriptome profiles of a jaagsiekte sheep retrovirus (JSRV)-envelope protein (Env) transgenic mouse model with spontaneous lung tumors, and associations of the transcriptome profiles with tumor invasion/metastasis, especially the phenomenon of the epithelial-mesenchymal transition (EMT). Genetic information obtained from an expression array was analyzed using an ingenuity pathways analysis (IPA) and human disease database (MalaCards). By careful examination, several novel EMT-related genes were identified from tumor cells using RT-qPCR, and these genes also scored high in MalaCards. We concluded that the JSRV-Env mouse model could serve as a spontaneous lung adenocarcinoma model with a metastatic phenotype, which will benefit the study of early-onset and progression of lung adenocarcinoma. In addition, it can also be a valuable tool for biomarkers and drug screening, which will be helpful in developing intervention therapies.	[Chang, Hsuen-Wen; Wu, Min-Ju] Taipei Med Univ, Lab Anim Ctr, Off Res & Dev, Taipei, Taiwan; [Lin, Zih-Miao; Wang, Li-Yu; Chang, Vincent H. S.] Taipei Med Univ, Coll Med Sci & Technol, PhD Program Translat Med, Taipei, Taiwan; [Chow, Yen-Hung] Natl Hlth Res Inst, Natl Inst Infect Dis & Vaccinol, Zhunan, Miaoli County, Taiwan; [Jiang, Shih Sheng; Ch'ang, Hui-Ju] Natl Hlth Res Inst, Natl Inst Canc Res, Zhunan, Miaoli County, Taiwan	Taipei Medical University; Taipei Medical University; National Health Research Institutes - Taiwan; National Health Research Institutes - Taiwan	Chang, VHS (corresponding author), Taipei Med Univ, Coll Med Sci & Technol, PhD Program Translat Med, Taipei, Taiwan.	vinhschang@tmu.edu.tw	Jiang, Shih Sheng/J-9671-2019	Jiang, Shih Sheng/0000-0003-1909-437X	Taipei Medical University [TMU102-AE1-B21]; Ministry of Science and Technology, Taiwan [MOST105-2320-B-038-05]	Taipei Medical University; Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	This study was funded in part by the Taipei Medical University (grant no. TMU102-AE1-B21). Dr. Vincent HS Chang has received a grant from Ministry of Science and Technology, Taiwan (grant no. MOST105-2320-B-038-05) for the translational research project. The authors have no conflict of interest to declare.	Bartis D, 2014, THORAX, V69, P760, DOI 10.1136/thoraxjnl-2013-204608; Chitra E, 2009, VIROLOGY, V393, P120, DOI 10.1016/j.virol.2009.07.023; De Langhe E, 2012, JOURNA, V7; De las Heras M, 2000, EUR RESPIR J, V16, P330, DOI 10.1034/j.1399-3003.2000.16b23.x; Ha SY, 2013, KOREAN J PATHOL, V47, P316, DOI 10.4132/KoreanJPathol.2013.47.4.316; Hanada S, 2008, J PATHOL, V216, P75, DOI 10.1002/path.2383; HAO NB, 2012, JOURNA, DOI DOI 10.1155/2012/948098; Henzy JE, 2013, J VIROL, V87, P1937, DOI 10.1128/JVI.01442-12; Izumchenko E, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9258; Jern P, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-50; Kitamura H, 2011, INT J CLIN EXP PATHO, V4, P97; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Lin WW, 2007, J CLIN INVEST, V117, P1175, DOI 10.1172/JCI31537; Markiewski MM, 2009, TRENDS IMMUNOL, V30, P286, DOI 10.1016/j.it.2009.04.002; Miller AD, 2017, RETROVIROLOGY, V14, DOI 10.1186/s12977-017-0329-6; Monot M, 2015, J VIROL, V89, P8462, DOI 10.1128/JVI.00590-15; Mori M, 2001, MODERN PATHOL, V14, P72, DOI 10.1038/modpathol.3880259; Panni RZ, 2013, IMMUNOTHERAPY-UK, V5, P1075, DOI 10.2217/imt.13.102; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Raz DJ, 2006, CLIN LUNG CANCER, V7, P313, DOI 10.3816/CLC.2006.n.012; Sun S, 2007, NAT REV CANCER, V7, P778, DOI 10.1038/nrc2190; Thatcher TH, 2016, IMMUNOLOGY, V147, P41, DOI 10.1111/imm.12540; Travis WD B E, 2004, JOURNA, P35; WIKENHEISER KA, 1992, CANCER RES, V52, P5342; Wootton SK, 2005, NATURE, V434, P904, DOI 10.1038/nature03492; Yang Ping, 2009, V471, P469, DOI 10.1007/978-1-59745-416-2_24; Yatabe Y, 2002, AM J SURG PATHOL, V26, P767, DOI 10.1097/00000478-200206000-00010; ZHANG W., 2014, MATH PROBL ENG, V2014, P1, DOI DOI 10.1371/J0URNAL.P0NE.0099693	28	6	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2017	12	4							e0175586	10.1371/journal.pone.0175586	http://dx.doi.org/10.1371/journal.pone.0175586			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KH	28419107	Green Submitted, Green Published, gold			2022-12-27	WOS:000399875200029
J	Fourcade, G; Germi, R; Guerber, F; Lupo, J; Baccard, M; Seigneurin, A; Semenova, T; Morand, P; Epaulard, O				Fourcade, Gregoire; Germi, Raphaele; Guerber, Fabrice; Lupo, Julien; Baccard, Monique; Seigneurin, Arnaud; Semenova, Touyana; Morand, Patrice; Epaulard, Olivier			Evolution of EBV seroprevalence and primary infection age in a French hospital and a city laboratory network, 2000-2016	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; UNIVERSITY-STUDENTS; MONONUCLEOSIS; RISK; PREVALENCE; SEVERITY; ENGLAND; HSV-1; WOMEN	Background According to rare studies, the age at EBV primary infection (PI) has recently risen in some developed countries. A later age at infection is generally considered a risk factor for severe EBV PI, although few studies exist on this subject. Our investigation aimed to determine whether EBV seroprevalence and EBV PI epidemiology have evolved in France, and to what extent age and infection intensity (regarding biological parameters) are correlated. Methods and findings We conducted a retrospective study of the following EBV serological tests databases: tests carried out at Grenoble University Hospital (2000-2016) (n = 53,553); and tests carried out by a network of city laboratories in Grenoble area (2008-2015) (n = 27,485). The hospital population showed a continuous, significant decrease in EBV seroprevalence over the studied period for patients aged 20 and over (p < 0.01). The seroprevalence also decreased for different age classes (< 10, 15-19, 20-30, and 30-40 years old) over the periods 2001-2005, 2006-2010, and 2011-2015. Consistently, the age at PI was significantly higher in the years 2008-2015 than in the years 2001-2007 (15.6 +/- 12.0vs. 13.7 +/- 11.0; p = 0.03). The city laboratory population showed the same trend of decreasing seroprevalence (p = 0.06); no significant variations in age at PI were observed. The age at PI was positively correlated with ASAT, ALAT, (Y)GT, and bilirubin blood levels (p < 0.01) and negatively correlated with platelet counts (p < 0.05). Conclusion In the last 15 years, the age at EBV PI has increased, whereas seroprevalence has decreased. Moreover, our findings confirm the positive correlation between age and	[Fourcade, Gregoire; Epaulard, Olivier] Grenoble Univ Hosp, Infect Dis Unit, Grenoble, France; [Fourcade, Gregoire; Germi, Raphaele; Lupo, Julien; Baccard, Monique; Semenova, Touyana; Morand, Patrice; Epaulard, Olivier] Univ Grenoble Alpes, Federat Infectiol Multidisciplinaire Arc Alpin, Grenoble, France; [Germi, Raphaele; Lupo, Julien; Baccard, Monique; Semenova, Touyana; Morand, Patrice] Grenoble Univ Hosp, Virol Lab, Grenoble, France; [Germi, Raphaele; Lupo, Julien; Morand, Patrice; Epaulard, Olivier] UGA, CNRS, UMR CEA 5075, Inst Biol Struct,Team HIV & Other Persistent hum, Grenoble, France; [Guerber, Fabrice] Oriade Lab, Vizille, France; [Seigneurin, Arnaud] Grenoble Univ Hosp, Unit Evaluat Med, Grenoble, France; [Seigneurin, Arnaud] Unite Mixte Rech, Tech Ingn Med & Comp informat Math & Applicat Gre, Grenoble, France	CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA)	Epaulard, O (corresponding author), Grenoble Univ Hosp, Infect Dis Unit, Grenoble, France.; Epaulard, O (corresponding author), Univ Grenoble Alpes, Federat Infectiol Multidisciplinaire Arc Alpin, Grenoble, France.; Epaulard, O (corresponding author), UGA, CNRS, UMR CEA 5075, Inst Biol Struct,Team HIV & Other Persistent hum, Grenoble, France.	oepaulard@chu-grenoble.fr	Lupo, Julien/C-4666-2016; Epaulard, Olivier/AHD-4798-2022; Seigneurin, Arnaud/M-6099-2014; Germi, Raphaële/AAU-6422-2020	GUERBER, fabrice/0000-0003-3202-0658; Lupo, Julien/0000-0002-6755-3115				Balfou HH, 2015, CLIN TRANSL IMMUNOL, V4, DOI 10.1038/cti.2015.1; Balfour HH, 2013, J INFECT DIS, V208, P1286, DOI 10.1093/infdis/jit321; Balfour HH, 2013, J INFECT DIS, V207, P80, DOI 10.1093/infdis/jis646; Crawford DH, 2006, CLIN INFECT DIS, V43, P276, DOI 10.1086/505400; Daud II, 2015, J INFECT DIS, V212, P1735, DOI 10.1093/infdis/jiv290; Elliott SL, 2008, J VIROL, V82, P1448, DOI 10.1128/JVI.01409-07; Fafi-Kremer S, 2005, J INFECT DIS, V191, P985, DOI 10.1086/428097; Fafi-Kremer S, 2005, J INFECT DIS, V192, P2108, DOI 10.1086/498215; Hjalgrim H, 2003, NEW ENGL J MED, V349, P1324, DOI 10.1056/NEJMoa023141; Hocqueloux L, 2015, CLIN MICROBIOL INFEC, V21, DOI 10.1016/j.cmi.2015.07.015; Levin LI, 2010, ANN NEUROL, V67, P824, DOI 10.1002/ana.21978; Macsween KF, 2010, CLIN INFECT DIS, V50, P699, DOI 10.1086/650456; Morris MC, 2002, J MED VIROL, V67, P522, DOI 10.1002/jmv.10132; Odame J, 2014, CAN J INFECT DIS MED, V25, P277, DOI 10.1155/2014/514164; Odumade OA, 2011, CLIN MICROBIOL REV, V24, P193, DOI 10.1128/CMR.00044-10; Puhakka L, 2016, INFECT DIS-NOR, V48, P406, DOI 10.3109/23744235.2015.1123290; Rostgaard K, 2014, INT J EPIDEMIOL, V43, P1607, DOI 10.1093/ije/dyu118; SALDANA NG, 2012, BMC RES NOTES, V5, pNIL1, DOI DOI 10.1186/1756-0500-5-361; Takeuchi K, 2006, PATHOL INT, V56, P112, DOI 10.1111/j.1440-1827.2006.01936.x; Taniguchi K, 2014, J CLIN VIROL, V59, P192, DOI 10.1016/j.jcv.2013.12.013; Tattevin P, 2006, J CLIN MICROBIOL, V44, P1873, DOI 10.1128/JCM.44.5.1873-1874.2006; Thacker EL, 2006, ANN NEUROL, V59, P499, DOI 10.1002/ana.20820; Thorley-Lawson DA, 2001, NAT REV IMMUNOL, V1, P75, DOI 10.1038/35095584; Vyse AJ, 2000, SEX TRANSM INFECT, V76, P183, DOI 10.1136/sti.76.3.183; Wang Y, 2013, CLIN MOL HEPATOL, V19, P382, DOI 10.3350/cmh.2013.19.4.382	25	27	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2017	12	4							e0175574	10.1371/journal.pone.0175574	http://dx.doi.org/10.1371/journal.pone.0175574			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KD	28414725	Green Published, Green Submitted, gold			2022-12-27	WOS:000399874800036
J	Margel, D; Mizrahi, M; Regev-Shoshani, G; Mary, KO; Moshe, M; Ozalvo, R; Shavit-Grievink, L; Baniel, J; Kedar, D; Yossepowitch, O; Lifshitz, D; Nadu, A; Greenberg, D; Av-Gay, Y				Margel, David; Mizrahi, Mark; Regev-Shoshani, Gili; Mary, K. O.; Moshe, Maya; Ozalvo, Rachel; Shavit-Grievink, Liat; Baniel, Jack; Kedar, Daniel; Yossepowitch, Ofer; Lifshitz, David; Nadu, Andrei; Greenberg, David; Av-Gay, Yossef			Nitric oxide charged catheters as a potential strategy for prevention of hospital acquired infections	PLOS ONE			English	Article							MODIFIED POLY(AMIDOAMINE) DENDRIMERS; ANTI-BIOFILM EFFICACY; PLATELET-AGGREGATION; BACTERIAL BIOFILMS; IN-VITRO; AGENTS	Background Catheter-Associated Hospital-Acquired Infections (HAI's) are caused by biofilm-forming bacteria. Using a novel approach, we generated anti-infective barrier on catheters by charging them with Nitric Oxide (NO), a naturally-produced gas molecule. NO is slowly released from the catheter upon contact with physiological fluids, and prevents bacterial colonization and biofilm formation onto catheter surfaces. Aims and methods The aim of the study was to assess the anti-infective properties of NO-charged catheters exposed to low concentration (up to 10(3) CFU/ml) of microbial cells in-vitro. We assessed NO-charged tracheal tubes using Pseudomonas aeruginosa, dialysis and biliary catheters using Escherichia coli, and urinary catheters using E. coli, Candida albicans or Enterococcus faecalis. Safety and tolerability of NO-charged urinary catheters were evaluated in a phase 1 clinical study in 12 patients. Six patients were catheterized with NO-charged catheters (NO-group), followed by 6 patients catheterized with regular control catheters (CT-group). Comparison of safety parameters between the study groups was performed. Results NO-charged tracheal, dialysis biliary and urinary catheters prevented P. aeruginosa, E. coli and C. albicans attachment and colonization onto their surfaces and eradicated corresponding planktonic microbial cells in the surrounding media after 24-48 hours, while E. faecalis colonization onto urinary catheters was reduced by 1 log compared to controls. All patients catheterized with an NO-charged urinary catheter successfully completed the study without experiencing NO-related AE's or serious AE's (SAE's). Conclusion These data highlight the potential of NO-based technology as potential platform for preventing catheter-associated HAI's.	[Margel, David; Moshe, Maya; Ozalvo, Rachel; Shavit-Grievink, Liat; Baniel, Jack; Kedar, Daniel; Yossepowitch, Ofer; Lifshitz, David; Nadu, Andrei] Rabin Med Ctr, Div Urol, Petah Tiqwa, Israel; [Margel, David; Moshe, Maya; Ozalvo, Rachel; Shavit-Grievink, Liat; Baniel, Jack; Kedar, Daniel; Yossepowitch, Ofer; Lifshitz, David; Nadu, Andrei] Tel Aviv Univ, Sackler Sch Med, Petah Tiqwa, Israel; [Mizrahi, Mark; Greenberg, David; Av-Gay, Yossef] ENOX Ltd, Habarzel 38, Tel Aviv, Israel; [Regev-Shoshani, Gili; Mary, K. O.; Av-Gay, Yossef] Univ British Columbia, Dept Med, Div Infect Dis, Vancouver, BC, Canada	Rabin Medical Center; Tel Aviv University; Sackler Faculty of Medicine; University of British Columbia	Av-Gay, Y (corresponding author), ENOX Ltd, Habarzel 38, Tel Aviv, Israel.; Av-Gay, Y (corresponding author), Univ British Columbia, Dept Med, Div Infect Dis, Vancouver, BC, Canada.	yossi@enoxbiopharma.com	Margel, David/AAP-4294-2020; Av-Gay, Yossef/H-5128-2019	Av-Gay, Yossef/0000-0002-9547-0237	ENOX Ltd.	ENOX Ltd.	The study was fully funded by ENOX Ltd. Some of the authors hold positions at ENOX and took part in the study design, data collection, data analysis, and preparation of this manuscript.	Akbari F, 2015, PATHOGENS, V4, P457, DOI 10.3390/pathogens4030457; Av-Gay Y, 2013, Patent No. [EP 2571541 A2, 2571541]; Burnett Arthur L, 2006, J Clin Hypertens (Greenwich), V8, P53; Centers for Disease Control and Prevention, HEALTHC ASS INF HAIS; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Davidson D, 1998, PEDIATRICS, V101, P325, DOI 10.1542/peds.101.3.325; Dunne WM, 2002, CLIN MICROBIOL REV, V15, P155, DOI 10.1128/CMR.15.2.155-166.2002; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; Gries A, 2000, THROMB HAEMOSTASIS, V83, P309; Gries A, 1998, CIRCULATION, V97, P1481; Hermann Matthias, 2006, J Clin Hypertens (Greenwich), V8, P17, DOI 10.1111/j.1524-6175.2006.06032.x; Hetrick EM, 2009, BIOMATERIALS, V30, P2782, DOI 10.1016/j.biomaterials.2009.01.052; Hoiby N, 2010, INT J ANTIMICROB AG, V35, P322, DOI 10.1016/j.ijantimicag.2009.12.011; Kermarrec N, 1998, AM J RESP CRIT CARE, V158, P833, DOI 10.1164/ajrccm.158.3.9709097; Koenig SM, 2006, CLIN MICROBIOL REV, V19, P637, DOI 10.1128/CMR.00051-05; Nicolle LE, 2014, ANTIMICROB RESIST IN, V3, DOI 10.1186/2047-2994-3-23; Olejnickova K, 2014, PATHOG DIS, V72, P87, DOI 10.1111/2049-632X.12188; Paoloni JA, 2003, AM J SPORT MED, V31, P915, DOI 10.1177/03635465030310062901; Regev-Shoshani G, 2011, UROLOGY, V78, P334, DOI 10.1016/j.urology.2011.02.063; Regev-Shoshani G, 2010, ANTIMICROB AGENTS CH, V54, P273, DOI 10.1128/AAC.00511-09; Schairer DO, 2012, VIRULENCE, V3, P271, DOI 10.4161/viru.20328; Stoodley P, 2002, ANNU REV MICROBIOL, V56, P187, DOI 10.1146/annurev.micro.56.012302.160705; Webb JS, 2003, CURR OPIN MICROBIOL, V6, P578, DOI 10.1016/j.mib.2003.10.014; Wessel DL, 1997, PEDIATRICS, V100, DOI 10.1542/peds.100.5.e7; Wilbert DM, 1991, INVEST UROL, V4, P81; World Health Organization, 2011, REP BURD END HLTH CA; Worley BV, 2015, MOL PHARMACEUT, V12, P1573, DOI 10.1021/acs.molpharmaceut.5b00006; Worley BV, 2014, BIOCONJUGATE CHEM, V25, P918, DOI 10.1021/bc5000719	28	14	15	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2017	12	4							e0174443	10.1371/journal.pone.0174443	http://dx.doi.org/10.1371/journal.pone.0174443			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0MD	28410367	Green Published, gold, Green Submitted			2022-12-27	WOS:000399955600003
J	Duan, X; Sandell, LJ; Chinzei, N; Holguin, N; Silva, MJ; Schiavinato, A; Rai, MF				Duan, Xin; Sandell, Linda J.; Chinzei, Nobuaki; Holguin, Nilsson; Silva, Matthew J.; Schiavinato, Antonella; Rai, Muhammad Farooq			Therapeutic efficacy of intra-articular hyaluronan derivative and platelet-rich plasma in mice following axial tibial loading	PLOS ONE			English	Article							SYMPTOMATIC KNEE OSTEOARTHRITIS; POSTTRAUMATIC OSTEOARTHRITIS; CHONDROCYTE APOPTOSIS; GROWTH-FACTORS; MODEL; ACID; CARTILAGE; MOUSE; INFLAMMATION; INJURY	Objective To investigate the therapeutic potential of intra-articular hyaluronan-derivative HYADD (R) 4-G and/or platelet-rich plasma (PRP) in a mouse model of non-invasive joint injury. Methods Non-invasive axial tibial loading was used to induce joint injury in 10-week-old C57BL/6J mice (n = 86). Mice underwent a single loading of either 6 Newton (N) or 9N axial tibial compression. HYADD (R) 4-G was injected intra-articularly at 8 mg/mL or 15 mg/mL either before or after loading with or without PRP. Phosphate-buffered-saline was injected as control. Knee joints were harvested at 5 or 56 days post-loading and prepared for micro-computed tomography scanning and subsequently processed for histology. Immunostaining was performed for aggrecan to monitor its distribution, for CD44 to monitor chondrocyte reactive changes and for COMP (cartilage oligomeric matrix protein) as an index for cartilage matrix changes related to loading and cartilage injury. TUNEL assay was performed to identify chondrocyte apoptosis. Results Loading initiated cartilage proteoglycan loss and chondrocyte apoptosis within 5 days with slowly progressive post-traumatic osteoarthritis (no cartilage degeneration, but increased synovitis and ectopic calcification after 9N loading) at 56 days. Mice treated with repeated HYADD (R) 4-G (15 mg/mL) or HYADD (R) 4-G (8 mg/mL) +/- PRP or PRP alone exhibited no significant improvement in the short-term (5 days) and long-term (56 days) consequences of joint loading except for a trend for improved bone changes compared to non-loaded joints. Conclusion While we failed to show an overall effect of intra-articular delivery of hyaluronan-derivative and/or PRP in reversing/protecting the pathological events in cartilage and synovium following joint injury, some bone alterations were relatively less severe with hyaluronan-derivative at higher concentration or in association with PRP.	[Duan, Xin; Sandell, Linda J.; Chinzei, Nobuaki; Holguin, Nilsson; Silva, Matthew J.; Rai, Muhammad Farooq] Washington Univ, Dept Orthopaed Surg, Musculoskeletal Res Ctr, Sch Med,Barnes Jewish Hosp, St Louis, MO 63130 USA; [Duan, Xin] Sun Yet San Univ, Dept Orthoped Surg, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China; [Sandell, Linda J.; Rai, Muhammad Farooq] Washington Univ, Sch Med, Dept Cell Biol & Physiol, Barnes Jewish Hosp, St Louis, MO 63110 USA; [Sandell, Linda J.; Silva, Matthew J.] Washington Univ, Dept Biomed Engn, St Louis, MO USA; [Schiavinato, Antonella] Fidia Farmaceut SpA, Padua, Italy	Barnes-Jewish Hospital; Washington University (WUSTL); Sun Yat Sen University; Barnes-Jewish Hospital; Washington University (WUSTL); Washington University (WUSTL)	Rai, MF (corresponding author), Washington Univ, Dept Orthopaed Surg, Musculoskeletal Res Ctr, Sch Med,Barnes Jewish Hosp, St Louis, MO 63130 USA.; Rai, MF (corresponding author), Washington Univ, Sch Med, Dept Cell Biol & Physiol, Barnes Jewish Hosp, St Louis, MO 63110 USA.	raim@wustl.edu	Farooq, Muhammad/ABE-6335-2021	Rai, Muhammad Farooq/0000-0003-4826-4331; Silva, Matthew/0000-0001-7375-4522	Fidia Farmaceutici, Abano Terme, Italy; National Institute of Arthritis and Musculoskeletal and Skin Diseases (National Institutes of Health) [1K99AR064837]; Fidia Farmaceutici; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR057235] Funding Source: NIH RePORTER	Fidia Farmaceutici, Abano Terme, Italy; National Institute of Arthritis and Musculoskeletal and Skin Diseases (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Fidia Farmaceutici; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	These studies were supported by research funds from Fidia Farmaceutici, Abano Terme, Italy. Dr. Rai was supported through Pathway to Independence Award (1K99AR064837) from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (National Institutes of Health). The content of this publication is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or the National Institute of Arthritis and Musculoskeletal and Skin Diseases. Fidia Farmaceutici supported in the form of salaries for Dr. Antonella Schiavinato, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of all authors are articulated in the "author contributions" section.	Andia I, 2013, NAT REV RHEUMATOL, V9, P721, DOI 10.1038/nrrheum.2013.141; BALAZS EA, 1993, J RHEUMATOL, V20, P3; Barreto RB, 2015, ACTA ORTOP BRAS, V23, P90, DOI 10.1590/1413-785220152302144341; Bonnevie ED, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143415; Brown TD, 2006, J ORTHOP TRAUMA, V20, P739, DOI 10.1097/01.bot.0000246468.80635.ef; Chen WH, 2014, BIOMATERIALS, V35, P9599, DOI 10.1016/j.biomaterials.2014.07.058; Cho BC, 2002, J CRANIOFAC SURG, V13, P783, DOI 10.1097/00001665-200211000-00014; CHOW G, 1995, J BIOL CHEM, V270, P27734, DOI 10.1074/jbc.270.46.27734; Christiansen BA, 2012, OSTEOARTHR CARTILAGE, V20, P773, DOI 10.1016/j.joca.2012.04.014; D'Lima DD, 2001, OSTEOARTHR CARTILAGE, V9, P712, DOI 10.1053/joca.2001.0468; de Rezende MU, 2011, ACTA ORTOP BRAS, V19, P102, DOI 10.1590/S1413-78522011000200008; Diekman BO, 2013, CELL TRANSPLANT, V22, P1395, DOI 10.3727/096368912X653264; Duan X, 2017, J ORTHOP RES, V35, P524, DOI 10.1002/jor.23413; Elmorsy S, 2014, OSTEOARTHR CARTILAGE, V22, P121, DOI 10.1016/j.joca.2013.10.005; FARNUM CE, 1990, J ORTHOPAED RES, V8, P750, DOI 10.1002/jor.1100080517; Felson DT, 2005, RHEUMATOLOGY, V44, P100, DOI 10.1093/rheumatology/keh411; Gigante A, 2011, RHEUMATOL INT, V31, P427, DOI 10.1007/s00296-010-1660-6; Glasson SS, 2007, OSTEOARTHR CARTILAGE, V15, P1061, DOI 10.1016/j.joca.2007.03.006; Glasson SS, 2010, OSTEOARTHR CARTILAGE, V18, pS17, DOI 10.1016/j.joca.2010.05.025; Goodwin W, 2010, J ORTHOP RES, V28, P1057, DOI 10.1002/jor.21091; Guyton GP, 2002, CLIN ORTHOP RELAT R, P302, DOI 10.1097/01.blo.0000030064.92399.ed; Hashimoto S, 2012, OSTEOARTHR CARTILAGE, V20, P562, DOI 10.1016/j.joca.2012.01.022; Henson FMD, 2012, AM J VET RES, V73, P306, DOI 10.2460/ajvr.73.2.306; Heybeli N, 2008, ACTA ORTHOP TRAUMATO, V42, P221, DOI 10.3944/AOTT.2008.221; Hildebrand T, 1997, J MICROSC-OXFORD, V185, P67, DOI 10.1046/j.1365-2818.1997.1340694.x; Joosten LAB, 2004, AM J PATHOL, V165, P959, DOI 10.1016/S0002-9440(10)63357-3; Kamekura S, 2005, OSTEOARTHR CARTILAGE, V13, P632, DOI 10.1016/j.joca.2005.03.004; Kazemi D, 2015, IRAN RED CRESCENT ME, V17, DOI 10.5812/ircmj.19594; Khoshbin A, 2013, ARTHROSCOPY, V29, P2037, DOI 10.1016/j.arthro.2013.09.006; Knudson CB, 2004, CLIN ORTHOP RELAT R, pS152, DOI 10.1097/01.blo.0000143804.26638.82; Kruger JP, 2012, J ORTHOP RES, V30, P845, DOI 10.1002/jor.22005; Lanyon P, 1998, ANN RHEUM DIS, V57, P595, DOI 10.1136/ard.57.10.595; Lee HR, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17010120; Lewis JS, 2011, OSTEOARTHR CARTILAGE, V19, P864, DOI 10.1016/j.joca.2011.04.011; Li T., 2005, MID TAIWAN J MED, V10, P8; Lisignoli G, 2001, ARTHRITIS RHEUM-US, V44, P1800, DOI 10.1002/1529-0131(200108)44:8<1800::AID-ART317>3.0.CO;2-1; Mainil-Varlet P, 2013, CARTILAGE, V4, P28, DOI 10.1177/1947603512455193; Masuko K, 2009, INT J GEN MED, V2, P77; Muramatsu Y, 2014, OSTEOARTHR CARTILAGE, V22, P831, DOI 10.1016/j.joca.2014.03.016; Park SI, 2012, MOL CELL BIOCHEM, V361, P9, DOI 10.1007/s11010-011-1081-1; Petrella RJ, 2006, J RHEUMATOL, V33, P951; Porcellini Giuseppe, 2015, Joints, V3, P116, DOI 10.11138/jts/2015.3.3.116; Poulet B, 2011, ARTHRITIS RHEUM-US, V63, P137, DOI 10.1002/art.27765; Raeissadat SA, 2015, CLIN MED INSIGHTS-AR, V8, P1, DOI 10.4137/CMAMD.S17894; Sanchez M, 2012, ARTHROSCOPY, V28, P1070, DOI 10.1016/j.arthro.2012.05.011; SASAKI T, 1995, BONE, V16, P9, DOI 10.1016/S8756-3282(94)00001-8; Schmidt MB, 2006, OSTEOARTHR CARTILAGE, V14, P403, DOI 10.1016/j.joca.2005.10.011; Sonmez TT, 2013, BIOMATERIALS, V34, P2674, DOI 10.1016/j.biomaterials.2013.01.016; Spakova T, 2012, AM J PHYS MED REHAB, V91, P411, DOI 10.1097/PHM.0b013e3182aab72; Takebe K, 2015, OSTEOARTHR CARTILAGE, V23, P454, DOI 10.1016/j.joca.2014.12.002; VANDERKRAAN PM, 1990, J EXP PATHOL, V71, P19; Wasterlain AS, 2013, AM J SPORT MED, V41, P186, DOI 10.1177/0363546512466383; Wu P, 2014, ARTHRITIS RHEUMATOL, V66, P1256, DOI 10.1002/art.38375; Zhou PH, 2008, J ORTHOP RES, V26, P1643, DOI 10.1002/jor.20683	54	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2017	12	4							e0175682	10.1371/journal.pone.0175682	http://dx.doi.org/10.1371/journal.pone.0175682			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0MB	28406954	gold, Green Published, Green Submitted			2022-12-27	WOS:000399955400082
J	Waugh, SM; Poupart, TA; Miskelly, CM; Stahl, JC; Arnould, JPY				Waugh, Susan M.; Poupart, Timothee A.; Miskelly, Colin M.; Stahl, Jean-Claude; Arnould, John P. Y.			Human exploitation assisting a threatened species? The case of muttonbirders and Buller's albatross	PLOS ONE			English	Article							NEW-ZEALAND; PUFFINUS-GRISEUS; SOOTY SHEARWATER; FORAGING STRATEGIES; RAKIURA-MAORI; DISCARDS; SNARES	Albatrosses are flexible and adaptable predators, relying on live prey as well as carrion. Use of predictable food sources and reliance on human-produced resources are well-known trait in long-range feeders like albatrosses and petrels. Breeding Buller's albatrosses studied at Solander I. (Hautere), New Zealand fed their chicks the remains of sooty shearwater juveniles ((ti) over bar in Maori), which are harvested from nearby muttonbirding sites. Evidence of this food type was found at over 10% of nests examined, and 17-40% birds that were fitted with GPS loggers visited muttonbirding sites in this and previous studies. Muttonbirding is a traditional practice that has continued for centuries, with up to 120 tonnes of offal discharged to the sea annually during the present day harvest. It coincides with the energetically-demanding early chick period for the albatrosses. Our finding suggests that the offal may be an important, but overlooked element in the albatross diet. As an important supplementary food for the albatrosses it is likely to have contributed to the 3% per annum growth of their populations since the first comprehensive population surveys in 1969.	[Waugh, Susan M.; Poupart, Timothee A.; Miskelly, Colin M.; Stahl, Jean-Claude] Museum New Zealand Te Papa Tongarewa, Wellington, New Zealand; [Poupart, Timothee A.; Arnould, John P. Y.] Deakin Univ, 221 Burwood Highway, Burwood, Vic, Australia	Deakin University	Waugh, SM (corresponding author), Museum New Zealand Te Papa Tongarewa, Wellington, New Zealand.	susan.waugh@tepapp.govt.nz			Museum of New Zealand Te Papa Tongarewa and Deakin University; Museum of New Zealand	Museum of New Zealand Te Papa Tongarewa and Deakin University; Museum of New Zealand	Study was funded through a student stipend (TAP) co-funded by the Museum of New Zealand Te Papa Tongarewa and Deakin University, and fieldwork was funded by the Museum of New Zealand. No grants were awarded specifically for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham ER, 2011, 79 MIN PRIM IND; ACAP, ACAP SPEC ASS BULL A; Anderson A., 1997, NZ J ARCHAEOLOGY, V17, P35; [Anonymous], 2016, COMMUNICATION; [Anonymous], 2016, COMMUNICATION; [Anonymous], 2016, CORRES Z MOSS; Auguie B, 2017, GRIDEXTRA MISCELLANE; Bost CA, 2009, J MARINE SYST, V78, P363, DOI 10.1016/j.jmarsys.2008.11.022; Calenge C, 2006, ECOL MODEL, V197, P516, DOI 10.1016/j.ecolmodel.2006.03.017; Cherel Y, 1998, ALBATROSS: BIOLOGY AND CONSERVATION, P113; Clucas R, 2012, NEW ZEAL J ZOOL, V39, P155, DOI 10.1080/03014223.2011.621438; Dacker B., 1994, PAIN LOVE HIST KAI T; de Ponte Machado M., 2007, IS PREDATION SEABIRD, P131; Francis RIC, 2012, NEW ZEAL J ZOOL, V39, P3, DOI 10.1080/03014223.2011.600766; Garthe S, 1996, MAR ECOL PROG SER, V136, P1, DOI 10.3354/meps136001; Goddard RF, 2016, THESIS; Grady D., 1986, SEALERS WHALERS NZ W; James GD, 2000, NEW ZEAL J MAR FRESH, V34, P435, DOI 10.1080/00288330.2000.9516946; Kitson J. C., 2006, THESIS; Lyver PO, 1999, MAR ECOL PROG SER, V188, P237, DOI 10.3354/meps188237; Lyver POB, 2002, WILDLIFE SOC B, V30, P29; MacKenzie R., 1972, SEARCH BIRDS NZ FIND; Moller H, 2004, ECOLOGY SOC, V9, P2, DOI DOI 10.5751/ES-00675-090302; Newman J, 2009, NEW ZEAL J ZOOL, V36, P307, DOI 10.1080/03014220909510157; Patrick SC, 2014, OIKOS, V123, P33, DOI 10.1111/j.1600-0706.2013.00406.x; POWLESLAND R G, 1992, Notornis, V39, P27; Quantum G. I. S. Development Team, 2012, QUANT GIS GEOGR INF; Richdale LE., 1946, MAORI MUTTON BIRD; Robertson Hugh A., 1992, Notornis, V39, P263; Sagar PM, 1995, ALBATROSS BIOL CONSE, P92; Scott Darren, 2008, Papers and Proceedings of the Royal Society of Tasmania, V142, P185; SECKER H L, 1969, Emu, V69, P155; Stahl JC, 2000, J ROY SOC NEW ZEAL, V30, P299, DOI 10.1080/03014223.2000.9517624; Stahl JC, 2000, J ROY SOC NEW ZEAL, V30, P319, DOI 10.1080/03014223.2000.9517625; Waitangi Tribunal, 1991, NGAI TAH FISH REP; Warham J., 1996, BEHAV POPULATION BIO; WEIMERSKIRCH H, 1993, AUK, V110, P325; Weimerskirch H, 2007, DEEP-SEA RES PT II, V54, P211, DOI 10.1016/j.dsr2.2006.11.013; WORTON BJ, 1989, ECOLOGY, V70, P164, DOI 10.2307/1938423	39	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2017	12	4							e0175458	10.1371/journal.pone.0175458	http://dx.doi.org/10.1371/journal.pone.0175458			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0MB	28406981	Green Published, gold, Green Submitted			2022-12-27	WOS:000399955400057
J	Rokke, G; Melo, TB; Hohmann-Marriott, MF				Rokke, Gunvor; Melo, Thor Bernt; Hohmann-Marriott, Martin Frank			The plastoquinone pool of Nannochloropsis oceanica is not completely reduced during bright light pulsese	PLOS ONE			English	Article							PHOTOSYSTEM-II; CHLAMYDOMONAS-REINHARDTII; CHLOROPHYLL FLUORESCENCE; STATE TRANSITIONS; PHAEODACTYLUM-TRICORNUTUM; PAM FLUOROMETRY; ACCEPTOR SIDE; REDOX STATE; PHOTOSYNTHESIS; GADITANA	The lipid-producing model alga Nannochloropsis oceanica has a distinct photosynthetic machinery. This organism possesses chlorophyll a as its only chlorophyll species, and has a high ratio of PSI to PSII. This high ratio of PSI to PSII may affect the redox state of the plastoquinone pool during exposure to light, and consequently may play a role in activating photoprotection mechanisms. We utilized pulse-amplitude modulated fluorometry to investigate the redox state of the plastoquinone pool during and after bright light pulses. Our data indicate that even very intense (5910 mu mol photons s(-1)m(-2) of blue light having a wavelength of 440 nm) light pulses of 0.8 second duration are not sufficient to completely reduce the plastoquinone pool in Nannochloropsis. In order to achieve extensive reduction of the plastoquinone pool by bright light pulses, anaerobic conditions or an inhibitor of the photosynthetic electron transport chain has to be utilized. The implication of this finding for the application of the widely used saturating pulse method in algae is discussed.	[Rokke, Gunvor; Hohmann-Marriott, Martin Frank] Norwegian Univ Sci & Technol, Dept Biotechnol, Trondheim, Norway; [Melo, Thor Bernt] Norwegian Univ Sci & Technol, Dept Phys, Trondheim, Norway	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU)	Hohmann-Marriott, MF (corresponding author), Norwegian Univ Sci & Technol, Dept Biotechnol, Trondheim, Norway.	martin.hohmann-marriott@ntnu.no			Faculty of Natural Sciences at the Norwegian University of Science and Technology (NTNU)	Faculty of Natural Sciences at the Norwegian University of Science and Technology (NTNU)	The Faculty of Natural Sciences (https://www.ntnu.no/nv) at the Norwegian University of Science and Technology (NTNU) founded the PhD position (G.R). Grant number is not available. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The Faculty of Natural Sciences and Technology at the Norwegian University of Science and Technology (NTNU) funded the PhD position (G. R.)	Baker NR, 2008, ANNU REV PLANT BIOL, V59, P89, DOI 10.1146/annurev.arplant.59.032607.092759; Basso S, 2014, BBA-BIOENERGETICS, V1837, P306, DOI 10.1016/j.bbabio.2013.11.019; Beer S, 2000, AQUAT BOT, V66, P69, DOI 10.1016/S0304-3770(99)00020-0; CAO J, 1990, BIOCHIM BIOPHYS ACTA, V1015, P180, DOI 10.1016/0005-2728(90)90018-Y; Cao SN, 2013, FEBS LETT, V587, P1310, DOI 10.1016/j.febslet.2012.12.031; Carbonera D, 2014, BBA-BIOENERGETICS, V1837, P1235, DOI 10.1016/j.bbabio.2014.03.014; Catalanotti C, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00150; de Wijn R, 2001, BIOCHEMISTRY-US, V40, P11912, DOI 10.1021/bi010852r; DINER BA, 1977, BIOCHIM BIOPHYS ACTA, V460, P247, DOI 10.1016/0005-2728(77)90211-0; Fan DY, 2007, BBA-BIOENERGETICS, V1767, P1064, DOI 10.1016/j.bbabio.2007.06.001; Finazzi G, 2002, EMBO REP, V3, P280, DOI 10.1093/embo-reports/kvf047; GOVINDJEE, 1995, AUST J PLANT PHYSIOL, V22, P131, DOI 10.1071/PP9950131; Govindjee, 2010, ENCY LIFE SCI ELS; GREEN BR, 2003, LIGHT HARVESTING ANT, P1; Haldimann P, 2005, BIOCHIM BIOPHYS ACTA, V17, P239; Haldrup A, 2001, TRENDS PLANT SCI, V6, P301, DOI 10.1016/S1360-1385(01)01953-7; Heber U, 2002, PHOTOSYNTH RES, V73, P223, DOI 10.1023/A:1020459416987; Hohmann-Marriott MF, 2010, FEBS LETT, V584, P1021, DOI 10.1016/j.febslet.2010.01.052; Jahns P, 2012, BBA-BIOENERGETICS, V1817, P182, DOI 10.1016/j.bbabio.2011.04.012; Kargul J, 2005, FEBS J, V272, P4797, DOI 10.1111/j.1742-4658.2005.04894.x; Laisk A, 2015, BBA-BIOENERGETICS, V1847, P565, DOI 10.1016/j.bbabio.2015.03.003; Liu XJ, 2009, J APPL PHYCOL, V21, P239, DOI 10.1007/s10811-008-9355-z; Lubian LM, 2000, J APPL PHYCOL, V12, P249, DOI 10.1023/A:1008170915932; Lui B, 2013, BIORESOURCE TECHNOL, V146, P210; Mitra M, 2015, BIORESOURCE TECHNOL, V193, P363, DOI 10.1016/j.biortech.2015.06.033; Muller P, 2001, PLANT PHYSIOL, V125, P1558, DOI 10.1104/pp.125.4.1558; NEUBAUER C, 1987, Z NATURFORSCH C, V42, P1246; Peltier G, 2002, ANNU REV PLANT BIOL, V53, P523, DOI 10.1146/annurev.arplant.53.100301.135242; Stirbet A, 2012, PHOTOSYNTH RES, V113, P15, DOI 10.1007/s11120-012-9754-5; TING CS, 1993, PLANT PHYSIOL, V101, P1323, DOI 10.1104/pp.101.4.1323; Unlu C, 2014, P NATL ACAD SCI USA, V111, P3460, DOI 10.1073/pnas.1319164111; VERNOTTE C, 1979, BIOCHIM BIOPHYS ACTA, V545, P519, DOI 10.1016/0005-2728(79)90160-9; White S, 2011, BIORESOURCE TECHNOL, V102, P1675, DOI 10.1016/j.biortech.2010.09.097	33	2	2	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2017	12	4							0175184	10.1371/journal.pone.0175184	http://dx.doi.org/10.1371/journal.pone.0175184			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LZ	28403199	Green Published, gold, Green Submitted			2022-12-27	WOS:000399955200038
J	Rouffaer, LO; Baert, K; Van den Abeele, AM; Cox, I; Vanantwerpen, G; De Zutter, L; Strubbe, D; Vranckx, K; Lens, L; Haesebrouck, F; Delmee, M; Pasmans, F; Martel, A				Rouffaer, Lieze Oscar; Baert, Kristof; Van den Abeele, Anne-Marie; Cox, Ivo; Vanantwerpen, Gerty; De Zutter, Lieven; Strubbe, Diederik; Vranckx, Katleen; Lens, Luc; Haesebrouck, Freddy; Delmee, Michel; Pasmans, Frank; Martel, An			Low prevalence of human enteropathogenic Yersinia spp. in brown rats (Rattus norvegicus) in Flanders	PLOS ONE			English	Article							ENTEROCOLITICA BIOTYPE 1A; TOF MASS-SPECTROMETRY; YST GENES; PSEUDOTUBERCULOSIS; IDENTIFICATION; WILDLIFE; STRAINS; FINLAND; MAMMALS	Brown rats (Rattus norvegicus) have been identified as potential carriers of Yersinia enterocolitica and Y. pseudotuberculosis, the etiological agents of yersiniosis, the third most reported bacterial zoonosis in Europe. Enteropathogenic Yersinia spp. are most often isolated from rats during yersiniosis cases in animals and humans, and from rats inhabiting farms and slaughterhouses. Information is however lacking regarding the extent to which rats act as carriers of these Yersinia spp.. In 2013, 1088 brown rats across Flanders, Belgium, were tested for the presence of Yersinia species by isolation method. Identification was performed using MALDI-TOF MS, PCR on chromosomal-and plasmid-borne virulence genes, biotyping and serotyping. Yersinia spp. were isolated from 38.4% of the rats. Of these, 53.4% were designated Y. enterocolitica, 0.7% Y. pseudotuberculosis and 49.0% other Yersinia species. Two Y. enterocolitica possessing the virF-, ail- and ystA-gene were isolated. Additionally, the ystB-gene was identified in 94.1% of the other Y. enterocolitica isolates, suggestive for biotype 1A. Three of these latter isolates simultaneously possessed the ail-virulence gene. Significantly more Y. enterocolitica were isolated during winter and spring compared to summer. Based on our findings we can conclude that brown rats are frequent carriers for various Yersinia spp., including Y. pseudotuberculosis and (human pathogenic) Y. enterocolitica which are more often isolated during winter and spring.	[Rouffaer, Lieze Oscar; Haesebrouck, Freddy; Pasmans, Frank; Martel, An] Univ Ghent, Dept Pathol Bacteriol & Avian Dis, Fac Vet Med, Ghent, Belgium; [Baert, Kristof] Res Inst Nat & Forest INBO, Brussels, Belgium; [Van den Abeele, Anne-Marie; Cox, Ivo] AZ Sint Lucas Ghent, Microbiol Lab, Ghent, Belgium; [Vanantwerpen, Gerty; De Zutter, Lieven] Univ Ghent, Dept Vet Publ Hlth & Food Safety, Fac Vet Med, Merelbeke, Belgium; [Strubbe, Diederik] Antwerp Univ, Dept Biol, Antwerp, Belgium; [Vranckx, Katleen] Appl Maths NV, Sint Martens Latem, Belgium; [Lens, Luc] Univ Ghent, Dept Biol, Terr Ecol Unit, Ghent, Belgium; [Delmee, Michel] Catholic Univ Louvain, Inst Expt & Clin Res, Brussels, Belgium	Ghent University; Research Institute for Nature & Forest; Ghent University; Ghent University; University of Antwerp; Ghent University; Universite Catholique Louvain	Rouffaer, LO (corresponding author), Univ Ghent, Dept Pathol Bacteriol & Avian Dis, Fac Vet Med, Ghent, Belgium.	Lieze.Rouffaer@UGent.be	Pasmans, Frank/D-3667-2014; Haesebrouck, Freddy/M-3857-2014; Strubbe, Diederik/J-4299-2015	Haesebrouck, Freddy/0000-0002-1709-933X; Strubbe, Diederik/0000-0002-2613-4985; Baert, Kristof/0000-0002-1910-1114; Lens, Luc/0000-0002-0241-2215	Fonds Wetenschappelijk Onderzoek, LOR [11L7516N]	Fonds Wetenschappelijk Onderzoek, LOR	Support was provided by Fonds Wetenschappelijk Onderzoek, LOR (11L7516N).	Artois M, 2001, VET J, V162, P141, DOI 10.1053/tvjl.2001.0601; Auguie B, 2017, GRIDEXTRA MISCELLANE; Ayyadurai S, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-285; Backhans A, 2011, EPIDEMIOL INFECT, V139, P1230, DOI 10.1017/S0950268810002463; Battersby SA, 2002, J ENV HLTH RES, V1; Bottone EJ, 1999, MICROBES INFECT, V1, P323, DOI 10.1016/S1286-4579(99)80028-8; Campioni F, 2014, APMIS, V122, P215, DOI 10.1111/apm.12126; Cork SC, 1999, AVIAN PATHOL, V28, P393, DOI 10.1080/03079459994669; Dormann CF, 2007, ECOGRAPHY, V30, P609, DOI 10.1111/j.2007.0906-7590.05171.x; European Food Safety Authority, 2015, EFSA J, V13, DOI 10.2903/j.efsa.2015.4329; European Food Safety Authority (EFSA), 2007, EFSA J, V595, P1; Fredriksson-Ahomaa M, 2006, FEMS IMMUNOL MED MIC, V47, P315, DOI 10.1111/j.1574-695X.2006.00095.x; Hothorn T.Bretz, 2016, PACKAGE MULTCOMP; HUBBERT WT, 1972, AM J TROP MED HYG, V21, P458, DOI 10.4269/ajtmh.1972.21.458; KANEKO KI, 1979, APPL ENVIRON MICROB, V37, P1; KANEKO KI, 1978, APPL ENVIRON MICROB, V36, P314, DOI 10.1128/AEM.36.2.314-318.1978; Kangas S, 2008, EMERG INFECT DIS, V14, P1959, DOI 10.3201/eid1412.080284; KAPPERUD G, 1975, ACTA PATH MICRO IM B, V83, P335; Kraushaar B, 2011, J APPL MICROBIOL, V111, P997, DOI 10.1111/j.1365-2672.2011.05112.x; KWAGA J, 1993, VET MICROBIOL, V36, P205, DOI 10.1016/0378-1135(93)90088-O; Liang JR, 2015, VET MICROBIOL, V178, P125, DOI 10.1016/j.vetmic.2015.05.006; MACKINTOSH CG, 1984, NEW ZEAL VET J, V32, P208, DOI 10.1080/00480169.1984.35123; Mair N.S., 1973, Journal Wildl Dis, V9, P64; MILLER VL, 1989, INFECT IMMUN, V57, P121, DOI 10.1128/IAI.57.1.121-131.1989; National Center for Biotechnology Information U.S. National Library of Medicine, BASIC LOCAL ALIGNMEN; Oda S, 2015, J WILDLIFE DIS, V51, P260, DOI [10.7589/2014-02-053, 10.7589]; Ramamurthy T, 1997, MICROB PATHOGENESIS, V23, P189, DOI 10.1006/mpat.1997.0146; Seng P, 2009, CLIN INFECT DIS, V49, P543, DOI 10.1086/600885; SERVAN J, 1979, COMP IMMUNOL MICROB, V1, P321, DOI 10.1016/0147-9571(79)90033-X; Singh I, 2004, J MED MICROBIOL, V53, P1065, DOI 10.1099/jmm.0.45527-0; Stephan R, 2013, EUR J CLIN MICROBIOL, V32, P869, DOI 10.1007/s10096-013-1820-1; Stephan R, 2011, J MICROBIOL METH, V87, P150, DOI 10.1016/j.mimet.2011.08.016; TASHIRO K, 1991, J VET MED SCI, V53, P23, DOI 10.1292/jvms.53.23; Tennant SM, 2003, FEMS IMMUNOL MED MIC, V38, P127, DOI 10.1016/S0928-8244(03)00180-9; Thoerner P, 2003, APPL ENVIRON MICROB, V69, P1810, DOI 10.1128/AEM.69.3.1810-1816.2003; Traweger D, 2005, J PEST SCI, V78, P17, DOI 10.1007/s10340-004-0062-5; Van Damme I, 2015, INT J FOOD MICROBIOL, V204, P33, DOI 10.1016/j.ijfoodmicro.2015.03.016; Weiner M, 2014, B VET I PULAWY, V58, P541, DOI 10.2478/bvip-2014-0083; Wu BL, 2003, BIOINFORMATICS, V19, P1636, DOI 10.1093/bioinformatics/btg210; WUTHE HH, 1992, ZBL BAKT-INT J MED M, V277, P403	40	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2017	12	4							e0175648	10.1371/journal.pone.0175648	http://dx.doi.org/10.1371/journal.pone.0175648			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LZ	28403184	gold, Green Published, Green Submitted			2022-12-27	WOS:000399955200087
J	Sumi, T; Miura, K; Miyatake, T				Sumi, Takuto; Miura, Kazuki; Miyatake, Takahisa			Wolbachia density changes seasonally amongst populations of the pale grass blue butterfly, Zizeeria maha (Lepidoptera: Lycaenidae)	PLOS ONE			English	Article							CYTOPLASMIC INCOMPATIBILITY; NATURAL-POPULATIONS; EUREMA-HECABE; INFECTION; SEX; ENDOSYMBIONT; PIPIENTIS; DIVERSITY; INSECTS; BIOLOGY	Previous studies showed that the survival rate of Wolbachia decreases under high temperature in incubators. It is also known that a high density of Wolbachia in the host body reduces the host emergence rate, while low densities fail to change reproduction rates. However, few studies have examined the density of Wolbachia in hosts in the field. Here, we focus on Wolbachia infection of the pale grass blue butterfly, Zizeeria maha (Lepidoptera: Lycaenidae), which is distributed throughout the Japanese islands. We examined the rate and density of Wolbachia infection in the bodies of butterflies at thirteen locations in Japan. At seven of these places, we collected butterflies in different seasons to determine seasonal differences in the infection rate and density and found that Wolbachia density has seasonal differences within the same population. Moreover, to determine whether Wolbachia density has a geographical cline, we compared the infection density of Wolbachia amongst all geographical populations. In addition, we determined the sequences of Wolbachia wsp and host mtDNA CO1 haplotypes of all populations. The results showed that Wolbachia density increased in early summer and decreased in autumn. Further, the density of Wolbachia infecting the same strain of Z. maha varied amongst populations, although no tendency in geographical cline was observed.	[Sumi, Takuto; Miyatake, Takahisa] Okayama Univ, Grad Sch Environm & Life Sci, Lab Evolutionary Ecol, Kita Ku, Okayama, Japan; [Miura, Kazuki] Natl Agr & Food Res Org, Western Region Agr Res Ctt, Fukuyama, Hiroshima, Japan	Okayama University; National Agriculture & Food Research Organization - Japan	Sumi, T (corresponding author), Okayama Univ, Grad Sch Environm & Life Sci, Lab Evolutionary Ecol, Kita Ku, Okayama, Japan.	gev422206@s.okayarna-u.ac.jp	Miyatake, Takahisa/B-6580-2017	Miyatake, Takahisa/0000-0002-5476-0676	Japan Society for the Promotion of Science (JSPS);  [KAKENHI 26291091];  [16K14810];  [14J07028]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); ; ; 	This work was supported by a Grant-in-A id for Scientific Research (KAKENHI 26291091 and 16K14810) to TM, and a Grant-in-Aid for JSPS Fellows (14J07028) to TS. Each fund is Japan Society for the Promotion of Science (JSPS, https://www.jsps.go.jp/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Mei Yamaguchi, Takashi Kuriwada, Tsuguo Kohama, Dai Haraguchi and Takahiro Hosokawa for support of specimen collection, and Yuma Takahashi for advice on Statistical analysis. This work was supported by a Grant-in-Aid for Scientific Research (KAKENHI 26291091 and 16K14810) to T. M. and a Grant-in-Aid for JSPS Fellows (14J07028) to T.S., both from the Japan Society for the Promotion of Science.	Baldo L, 2006, APPL ENVIRON MICROB, V72, P7098, DOI 10.1128/AEM.00731-06; Braig HR, 1998, J BACTERIOL, V180, P2373, DOI 10.1128/JB.180.9.2373-2378.1998; Charlat S, 2007, SCIENCE, V317, P214, DOI 10.1126/science.1143369; Duron O, 2006, EVOLUTION, V60, P303, DOI 10.1111/j.0014-3820.2006.tb01108.x; Dutton TJ, 2004, INSECT MOL BIOL, V13, P317, DOI 10.1111/j.0962-1075.2004.00490.x; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Hedges LM, 2008, SCIENCE, V322, P702, DOI 10.1126/science.1162418; Hiroki M, 2004, P ROY SOC B-BIOL SCI, V271, P1751, DOI 10.1098/rspb.2004.2769; Hiyama A, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-168; Johanowicz DL, 1998, ENTOMOL EXP APPL, V87, P51, DOI 10.1023/A:1003207830606; Mouton L, 2006, PARASITOLOGY, V132, P49, DOI 10.1017/S0031182005008723; Mouton L, 2007, BIOL LETT-UK, V3, P210, DOI 10.1098/rsbl.2006.0590; Narita S, 2007, APPL ENVIRON MICROB, V73, P4332, DOI 10.1128/AEM.00145-07; ONeill SL, 1997, INFLUENTIAL PASSENGE; PerrotMinnot MJ, 1996, GENETICS, V143, P961; RIGAUD T, 1992, HEREDITY, V68, P47, DOI 10.1038/hdy.1992.6; Salunke BK, 2012, APPL ENVIRON MICROB, V78, P4458, DOI 10.1128/AEM.07298-11; STOUTHAMER R, 1990, P NATL ACAD SCI USA, V87, P2424, DOI 10.1073/pnas.87.7.2424; Sumi T, 2013, APPL ENTOMOL ZOOL, V48, P35, DOI 10.1007/s13355-012-0152-4; Teixeira L, 2008, PLOS BIOL, V6, P2753, DOI 10.1371/journal.pbio.1000002; Toju H, 2011, MOL ECOL, V20, P853, DOI 10.1111/j.1365-294X.2010.04980.x; Unckless RL, 2009, P ROY SOC B-BIOL SCI, V276, P2805, DOI 10.1098/rspb.2009.0287; Van Opijnen T, 1999, EXP APPL ACAROL, V23, P871, DOI 10.1023/A:1006363604916; Werren JH, 1997, ANNU REV ENTOMOL, V42, P587, DOI 10.1146/annurev.ento.42.1.587; Werren John H, 2008, Nat Rev Microbiol, V6, P741, DOI 10.1038/nrmicro1969; Wild AL, 2008, MOL PHYLOGENET EVOL, V48, P877, DOI 10.1016/j.ympev.2008.05.023	26	17	19	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2017	12	4							e0175373	10.1371/journal.pone.0175373	http://dx.doi.org/10.1371/journal.pone.0175373			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LZ	28403227	Green Published, Green Submitted, gold			2022-12-27	WOS:000399955200056
J	Yoon, JH; Kim, TW; Mendez, P; Jablons, DM; Kim, IJ				Yoon, Jun-Hee; Kim, Thomas W.; Mendez, Pedro; Jablons, David M.; Kim, Il-Jin			Mobile Genome Express (MGE): A comprehensive automatic genetic analyses pipeline with a mobile device	PLOS ONE			English	Article							TUMOR DNA; CANCER; MUTATIONS; AMPLIFICATION; RESOLUTION; LANDSCAPE	The development of next-generation sequencing (NGS) technology allows to sequence whole exomes or genome. However, data analysis is still the biggest bottleneck for its wide implementation. Most laboratories still depend on manual procedures for data handling and analyses, which translates into a delay and decreased efficiency in the delivery of NGS results to doctors and patients. Thus, there is high demand for developing an automatic and an easy-to-use NGS data analyses system. We developed comprehensive, automatic genetic analyses controller named Mobile Genome Express (MGE) that works in smartphones or other mobile devices. MGE can handle all the steps for genetic analyses, such as: sample information submission, sequencing run quality check from the sequencer, secured data transfer and results review. We sequenced an Actrometrix control DNA containing multiple proven human mutations using a targeted sequencing panel, and the whole analysis was managed by MGE, and its data reviewing program called ELECTRO. All steps were processed automatically except for the final sequencing review procedure with ELECTRO to confirm mutations. The data analysis process was completed within several hours. We confirmed the mutations that we have identified were consistent with our previous results obtained by using multi-step, manual pipelines.	[Yoon, Jun-Hee; Mendez, Pedro; Jablons, David M.; Kim, Il-Jin] Univ Calif San Francisco, Dept Surg, Thorac Oncol Lab, San Francisco, CA 94143 USA; [Yoon, Jun-Hee; Mendez, Pedro; Jablons, David M.; Kim, Il-Jin] Univ Calif San Francisco, Ctr Comprehens Canc, San Francisco, CA 94143 USA; [Kim, Thomas W.] CureSeq Inc, Brisbane, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center	Jablons, DM; Kim, IJ (corresponding author), Univ Calif San Francisco, Dept Surg, Thorac Oncol Lab, San Francisco, CA 94143 USA.; Jablons, DM; Kim, IJ (corresponding author), Univ Calif San Francisco, Ctr Comprehens Canc, San Francisco, CA 94143 USA.	David.Jablons@ucsf.edu; Il-Jin.Kim@ucsf.edu			CureSeq Inc.; Thoracic Oncology Laboratory at University of California San Francisco (UCSF)	CureSeq Inc.; Thoracic Oncology Laboratory at University of California San Francisco (UCSF)	This study was supported by funds from CureSeq Inc. and Thoracic Oncology Laboratory at University of California San Francisco (UCSF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by funds from CureSeq Inc. and Thoracic Oncology Laboratory at University of California San Francisco (UCSF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. D.M.J. and I.J.K. are equity holders and consultants of CureSeq Inc. This does not alter our adherence to PLOS ONE policies on sharing data and materials.	Bragg LM, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003031; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Cloonan N, 2008, NAT METHODS, V5, P613, DOI 10.1038/nmeth.1223; Dawson SJ, 2013, NEW ENGL J MED, V368, P1199, DOI 10.1056/NEJMoa1213261; Favis R, 2000, NAT BIOTECHNOL, V18, P561, DOI 10.1038/75452; Forbes SA, 2015, NUCLEIC ACIDS RES, V43, pD805, DOI 10.1093/nar/gku1075; Forshew T, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003726; Han SW, 2013, PLOS ONE, V8; Hayden EC, 2014, NATURE, V507, P294, DOI 10.1038/507294a; Jovelet C, 2016, CLIN CANCER RES, V22, P2960, DOI 10.1158/1078-0432.CCR-15-2470; Kandoth C, 2013, NATURE, V502, P333, DOI 10.1038/nature12634; Kang HC, 2016, ONCOTARGET, V7, P8321, DOI 10.18632/oncotarget.7032; LEE MS, 1987, SCIENCE, V237, P175, DOI 10.1126/science.3110950; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mendez P, 2016, COMPREHENSIVE EVALUA, P235, DOI DOI 10.3892/IJO.2016.3497; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; Nikiforova MN, 2013, J CLIN ENDOCRINOL ME, V98; Pomeroy SL, 2002, NATURE, V415, P436, DOI 10.1038/415436a; Porreca GJ, 2007, NAT METHODS, V4, P931, DOI 10.1038/NMETH1110; Ross JS, 2015, JAMA ONCOL, V1, P40, DOI 10.1001/jamaoncol.2014.216; SAIKI RK, 1986, NATURE, V324, P163, DOI 10.1038/324163a0; SANGER F, 1975, J MOL BIOL, V94, P441, DOI 10.1016/0022-2836(75)90213-2; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Saunders CT, 2012, BIOINFORMATICS, V28, P1811, DOI 10.1093/bioinformatics/bts271; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Shi XH, 2016, SCI REP-UK, V6, DOI 10.1038/srep22297; Shipp MA, 2002, NAT MED, V8, P68, DOI 10.1038/nm0102-68; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; WATSON JD, 1953, COLD SPRING HARB SYM, V18, P123, DOI 10.1101/SQB.1953.018.01.020; WATSON JD, 1953, NATURE, V171, P737, DOI 10.1038/171737a0; Weinstein JN, 2013, NAT GENET, V45, P1113, DOI 10.1038/ng.2764; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884; Wilhelm BT, 2008, NATURE, V453, P1239, DOI 10.1038/nature07002; WONG C, 1987, NATURE, V330, P384, DOI 10.1038/330384a0	37	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2017	12	4							e0174696	10.1371/journal.pone.0174696	http://dx.doi.org/10.1371/journal.pone.0174696			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LZ	28403238	Green Published, Green Submitted, gold			2022-12-27	WOS:000399955200017
